id|nct_id|result_group_id|ctgov_group_code|period|reason|count
54|NCT03073798|413|P1|Overall Study|Withdrawal by Subject|1
55|NCT03073798|413|P1|Overall Study|Adverse Event|1
56|NCT03072719|426|P2|Overall Study|Adverse Event|1
57|NCT03072719|427|P1|Overall Study|Adverse Event|1
58|NCT03065933|573|P1|Overall Study|study terminated|5
59|NCT03055221|588|P1|Overall Study|Study terminated by Sponsor|3
60|NCT03055221|588|P1|Overall Study|Physician Decision|1
61|NCT03055221|588|P1|Overall Study|Death|6
62|NCT03055221|588|P1|Overall Study|Withdrawal by Subject|4
63|NCT03055221|588|P1|Overall Study|Adverse Event|2
64|NCT03023137|747|P2|Overall Study|Lost the baby in a car accident|0
65|NCT03023137|748|P1|Overall Study|Lost the baby in a car accident|1
66|NCT03023137|747|P2|Overall Study|Protocol Violation|4
67|NCT03023137|748|P1|Overall Study|Protocol Violation|0
68|NCT03023137|747|P2|Overall Study|Lost to Follow-up|1
69|NCT03023137|748|P1|Overall Study|Lost to Follow-up|1
70|NCT03023137|747|P2|Overall Study|Multiple pregnancy|4
71|NCT03023137|748|P1|Overall Study|Multiple pregnancy|2
72|NCT03022422|806|P6|Overall Study|3 subjects consented but not vaccinated|0
73|NCT03022422|807|P5|Overall Study|3 subjects consented but not vaccinated|0
74|NCT03022422|808|P4|Overall Study|3 subjects consented but not vaccinated|0
75|NCT03022422|809|P3|Overall Study|3 subjects consented but not vaccinated|3
76|NCT03022422|810|P2|Overall Study|3 subjects consented but not vaccinated|0
77|NCT03022422|811|P1|Overall Study|3 subjects consented but not vaccinated|0
78|NCT02990910|952|P2|Overall Study|Lack of Efficacy|10
79|NCT02990910|953|P1|Overall Study|Lack of Efficacy|6
80|NCT02988219|963|P2|Overall Study|Withdrawal by Subject|2
81|NCT02988219|964|P1|Overall Study|Withdrawal by Subject|0
82|NCT02988219|963|P2|Overall Study|Lack of Efficacy|1
83|NCT02988219|964|P1|Overall Study|Lack of Efficacy|1
84|NCT02977572|984|P2|Overall Study|Exclusion criterion|2
85|NCT02977572|985|P1|Overall Study|Exclusion criterion|2
86|NCT02974543|1009|P2|Overall Study|Withdrawal by Subject|0
87|NCT02974543|1010|P1|Overall Study|Withdrawal by Subject|1
88|NCT02971670|1034|P4|Overall Study|Withdrawal by Subject|2
89|NCT02971670|1035|P3|Overall Study|Withdrawal by Subject|1
90|NCT02971670|1036|P2|Overall Study|Withdrawal by Subject|1
91|NCT02971670|1037|P1|Overall Study|Withdrawal by Subject|4
92|NCT02961244|1067|P2|Overall Study|İnadequate data|2
93|NCT02961244|1068|P1|Overall Study|İnadequate data|0
94|NCT02961244|1067|P2|Overall Study|Lost to Follow-up|2
95|NCT02961244|1068|P1|Overall Study|Lost to Follow-up|0
96|NCT02961244|1067|P2|Overall Study|Surgery plan change after study approval|2
97|NCT02961244|1068|P1|Overall Study|Surgery plan change after study approval|0
98|NCT02961244|1067|P2|Overall Study|Withdrawal by Subject|2
99|NCT02961244|1068|P1|Overall Study|Withdrawal by Subject|1
100|NCT02961244|1067|P2|Overall Study|Protocol Violation|1
101|NCT02961244|1068|P1|Overall Study|Protocol Violation|0
102|NCT02951767|1160|P1|Overall Study|Lost to Follow-up|1
103|NCT02951767|1160|P1|Overall Study|Death|59
104|NCT02951767|1160|P1|Overall Study|Withdrawal by Subject|5
105|NCT02951767|1160|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
106|NCT02912650|1283|P4|Overall Study|Adverse Event|0
107|NCT02912650|1284|P3|Overall Study|Adverse Event|1
108|NCT02912650|1285|P2|Overall Study|Adverse Event|0
109|NCT02912650|1286|P1|Overall Study|Adverse Event|0
110|NCT02912650|1283|P4|Overall Study|Withdrawal by Subject|5
111|NCT02912650|1284|P3|Overall Study|Withdrawal by Subject|1
112|NCT02912650|1285|P2|Overall Study|Withdrawal by Subject|0
113|NCT02912650|1286|P1|Overall Study|Withdrawal by Subject|1
114|NCT02903238|1377|P1|Overall Study|Lost to Follow-up|4
115|NCT02895347|1388|P2|Overall Study|Withdrawal by Subject|1
116|NCT02895347|1389|P1|Overall Study|Withdrawal by Subject|3
117|NCT02886338|1412|P1|Overall Study|Withdrawal by Subject|1
118|NCT02882152|1437|P2|Overall Study|Lost to Follow-up|0
119|NCT02882152|1438|P1|Overall Study|Lost to Follow-up|1
120|NCT02873429|1448|P2|16 Weeks|Lost to Follow-up|0
121|NCT02873429|1449|P1|16 Weeks|Lost to Follow-up|3
122|NCT02873429|1448|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
123|NCT02873429|1449|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
124|NCT02873429|1448|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
125|NCT02873429|1449|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
126|NCT02862600|1482|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
127|NCT02862600|1482|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
128|NCT02862600|1482|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
129|NCT02862600|1482|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
130|NCT02862106|1495|P2|Overall Study|Subjects moved to other city|0
131|NCT02862106|1496|P1|Overall Study|Subjects moved to other city|1
132|NCT02862106|1495|P2|Overall Study|Withdrawal by Subject|0
133|NCT02862106|1496|P1|Overall Study|Withdrawal by Subject|2
134|NCT02862106|1495|P2|Overall Study|Lost to Follow-up|5
135|NCT02862106|1496|P1|Overall Study|Lost to Follow-up|15
136|NCT02862106|1495|P2|Overall Study|Protocol Violation|1
137|NCT02862106|1496|P1|Overall Study|Protocol Violation|16
138|NCT02862106|1495|P2|Overall Study|Adverse Event|0
139|NCT02862106|1496|P1|Overall Study|Adverse Event|4
140|NCT02856880|1554|P1|Overall Study|Withdrawal of consent|1
141|NCT02832375|1699|P2|Overall Study|Withdrawal of Consent|0
142|NCT02832375|1700|P1|Overall Study|Withdrawal of Consent|1
143|NCT02832375|1699|P2|Overall Study|Lost to Follow-up|0
144|NCT02832375|1700|P1|Overall Study|Lost to Follow-up|1
145|NCT02829775|1710|P1|Overall Study|Disease remission|1
146|NCT02829775|1710|P1|Overall Study|Withdrawal by Subject|3
147|NCT02829775|1710|P1|Overall Study|Death|1
148|NCT02826421|1741|P4|Overall Study|Reason not given|0
149|NCT02826421|1742|P3|Overall Study|Reason not given|1
150|NCT02826421|1743|P2|Overall Study|Reason not given|0
151|NCT02826421|1744|P1|Overall Study|Reason not given|1
152|NCT02826421|1741|P4|Overall Study|Withdrawal by Subject|1
153|NCT02826421|1742|P3|Overall Study|Withdrawal by Subject|1
154|NCT02826421|1743|P2|Overall Study|Withdrawal by Subject|3
155|NCT02826421|1744|P1|Overall Study|Withdrawal by Subject|1
156|NCT02826421|1741|P4|Overall Study|Adverse Event|1
157|NCT02826421|1742|P3|Overall Study|Adverse Event|0
158|NCT02826421|1743|P2|Overall Study|Adverse Event|0
159|NCT02826421|1744|P1|Overall Study|Adverse Event|1
160|NCT02815735|1844|P2|Second Intervention (4 Weeks)|Protocol Violation|0
161|NCT02815735|1845|P1|Second Intervention (4 Weeks)|Protocol Violation|1
162|NCT02815735|1844|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
163|NCT02815735|1845|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
164|NCT02815735|1844|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
165|NCT02815735|1845|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
166|NCT02815735|1844|P2|First Intervention (4 Weeks)|Discomfort|0
167|NCT02815735|1845|P1|First Intervention (4 Weeks)|Discomfort|1
168|NCT02809833|1903|P1|Overall Study|Missing Information|52
169|NCT02809833|1903|P1|Overall Study|Not Specified|5
170|NCT02809833|1903|P1|Overall Study|Adverse Event (AE)|24
171|NCT02809833|1903|P1|Overall Study|Lost to Follow-up|35
172|NCT02809833|1903|P1|Overall Study|Withdrawal by Subject|34
173|NCT02809833|1903|P1|Overall Study|Noncompliance|1
174|NCT02809833|1903|P1|Overall Study|Remission/Treatment No Longer Needed|3
175|NCT02809833|1903|P1|Overall Study|Lack of Efficacy|89
176|NCT02809833|1903|P1|Overall Study|Intolerance|54
177|NCT02809833|1903|P1|Overall Study|Death|3
178|NCT02806505|2025|P2|Overall Study|Insufficient therapeutic response|4
179|NCT02806505|2026|P1|Overall Study|Insufficient therapeutic response|2
180|NCT02806505|2025|P2|Overall Study|Failure to return|1
181|NCT02806505|2026|P1|Overall Study|Failure to return|0
182|NCT02806505|2025|P2|Overall Study|Did not cooperate/refused treatment|3
183|NCT02806505|2026|P1|Overall Study|Did not cooperate/refused treatment|3
184|NCT02806505|2025|P2|Overall Study|Death|0
185|NCT02806505|2026|P1|Overall Study|Death|4
186|NCT02806505|2025|P2|Overall Study|Adverse event/intercurrent illness|3
187|NCT02806505|2026|P1|Overall Study|Adverse event/intercurrent illness|1
188|NCT02805907|2038|P2|Overall Study|Lost to Follow-up|3
189|NCT02805907|2039|P1|Overall Study|Lost to Follow-up|3
190|NCT02801396|2051|P6|Period 1|Withdrawal by Subject|0
191|NCT02801396|2052|P5|Period 1|Withdrawal by Subject|1
192|NCT02801396|2053|P4|Period 1|Withdrawal by Subject|0
193|NCT02801396|2054|P3|Period 1|Withdrawal by Subject|0
194|NCT02801396|2055|P2|Period 1|Withdrawal by Subject|0
195|NCT02801396|2056|P1|Period 1|Withdrawal by Subject|0
196|NCT02799082|2075|P2|Overall Study|Protocol Violation|1
197|NCT02799082|2076|P1|Overall Study|Protocol Violation|0
198|NCT02799082|2075|P2|Overall Study|Refused second PDT or withdraw consent|3
199|NCT02799082|2076|P1|Overall Study|Refused second PDT or withdraw consent|4
200|NCT02799069|2113|P3|Overall Study|Protocol Violation|2
201|NCT02799069|2114|P2|Overall Study|Protocol Violation|0
202|NCT02799069|2115|P1|Overall Study|Protocol Violation|1
203|NCT02799069|2113|P3|Overall Study|Withdrawal by Subject|3
204|NCT02799069|2114|P2|Overall Study|Withdrawal by Subject|4
205|NCT02799069|2115|P1|Overall Study|Withdrawal by Subject|4
206|NCT02799069|2113|P3|Overall Study|Lost to Follow-up|0
207|NCT02799069|2114|P2|Overall Study|Lost to Follow-up|1
208|NCT02799069|2115|P1|Overall Study|Lost to Follow-up|1
209|NCT02799069|2113|P3|Overall Study|Lack of Efficacy|0
210|NCT02799069|2114|P2|Overall Study|Lack of Efficacy|0
211|NCT02799069|2115|P1|Overall Study|Lack of Efficacy|2
212|NCT02799069|2113|P3|Overall Study|Adverse Event|2
213|NCT02799069|2114|P2|Overall Study|Adverse Event|2
214|NCT02799069|2115|P1|Overall Study|Adverse Event|0
215|NCT02791659|2279|P2|Overall Study|Protocol Violation|1
216|NCT02791659|2280|P1|Overall Study|Protocol Violation|0
217|NCT02791269|2288|P2|Overall Study|Lost to Follow-up|1
218|NCT02791269|2289|P1|Overall Study|Lost to Follow-up|0
219|NCT02788357|2311|P2|Overall Study|Lost to Follow-up|0
220|NCT02788357|2312|P1|Overall Study|Lost to Follow-up|3
221|NCT02786927|2333|P1|Overall Study|Protocol Violation|4
222|NCT02786927|2333|P1|Overall Study|Adverse Event|1
223|NCT02777125|2420|P2|Overall Study|Protocol Violation|12
224|NCT02777125|2421|P1|Overall Study|Protocol Violation|8
225|NCT02777125|2420|P2|Overall Study|Assent form violation|23
226|NCT02777125|2421|P1|Overall Study|Assent form violation|21
227|NCT02777125|2420|P2|Overall Study|Consent form violation|12
228|NCT02777125|2421|P1|Overall Study|Consent form violation|14
229|NCT02774278|2435|P1|Overall Study|Protocol Violation|2
230|NCT02774278|2435|P1|Overall Study|Withdrawal by Subject|3
231|NCT02774278|2435|P1|Overall Study|Administrative reasons|6
232|NCT02774278|2435|P1|Overall Study|Refused treatment/did not cooperate|9
233|NCT02774278|2435|P1|Overall Study|Adverse event/intercurrent illness|16
234|NCT02774278|2435|P1|Overall Study|Death|29
235|NCT02774278|2435|P1|Overall Study|Lack of Efficacy|199
236|NCT02767765|2480|P1|Overall Study|Withdrawal by Subject|1
237|NCT02767765|2480|P1|Overall Study|Non-Compliance|1
238|NCT02767765|2480|P1|Overall Study|Investigator decision|1
239|NCT02767765|2480|P1|Overall Study|Lost to Follow-up|2
240|NCT02767765|2480|P1|Overall Study|Insufficient response|1
241|NCT02767765|2480|P1|Overall Study|Death|1
242|NCT02767765|2480|P1|Overall Study|Adverse Event|4
243|NCT02766400|2491|P2|Overall Study|Withdrawal by Subject|0
244|NCT02766400|2492|P1|Overall Study|Withdrawal by Subject|1
245|NCT02766400|2491|P2|Overall Study|Death|2
246|NCT02766400|2492|P1|Overall Study|Death|1
247|NCT02763189|2524|P2|Overall Study|Device failure|2
248|NCT02763189|2525|P1|Overall Study|Device failure|0
249|NCT02761733|2537|P4|Overall Study|Cognitive Impairment|0
250|NCT02761733|2538|P3|Overall Study|Cognitive Impairment|1
251|NCT02761733|2539|P2|Overall Study|Cognitive Impairment|0
252|NCT02761733|2540|P1|Overall Study|Cognitive Impairment|5
253|NCT02761733|2537|P4|Overall Study|Discharged from Study Site|11
254|NCT02761733|2538|P3|Overall Study|Discharged from Study Site|25
255|NCT02761733|2539|P2|Overall Study|Discharged from Study Site|9
256|NCT02761733|2540|P1|Overall Study|Discharged from Study Site|10
257|NCT02761733|2537|P4|Overall Study|Withdrawal by Subject|0
258|NCT02761733|2538|P3|Overall Study|Withdrawal by Subject|0
259|NCT02761733|2539|P2|Overall Study|Withdrawal by Subject|0
260|NCT02761733|2540|P1|Overall Study|Withdrawal by Subject|2
261|NCT02761733|2537|P4|Overall Study|Physician Decision|0
262|NCT02761733|2538|P3|Overall Study|Physician Decision|0
263|NCT02761733|2539|P2|Overall Study|Physician Decision|0
264|NCT02761733|2540|P1|Overall Study|Physician Decision|4
265|NCT02761733|2537|P4|Overall Study|Lost to Follow-up|3
266|NCT02761733|2538|P3|Overall Study|Lost to Follow-up|0
267|NCT02761733|2539|P2|Overall Study|Lost to Follow-up|7
268|NCT02761733|2540|P1|Overall Study|Lost to Follow-up|6
269|NCT02761733|2537|P4|Overall Study|Death|1
270|NCT02761733|2538|P3|Overall Study|Death|1
271|NCT02761733|2539|P2|Overall Study|Death|5
272|NCT02761733|2540|P1|Overall Study|Death|3
273|NCT02761629|2572|P2|Overall Study|Randomized But Not Treated|4
274|NCT02761629|2573|P1|Overall Study|Randomized But Not Treated|8
275|NCT02761629|2572|P2|Overall Study|Lost to Follow-up|1
276|NCT02761629|2573|P1|Overall Study|Lost to Follow-up|4
277|NCT02761629|2572|P2|Overall Study|Unspecified|2
278|NCT02761629|2573|P1|Overall Study|Unspecified|0
279|NCT02761629|2572|P2|Overall Study|Withdrawal by Subject|3
280|NCT02761629|2573|P1|Overall Study|Withdrawal by Subject|0
281|NCT02761629|2572|P2|Overall Study|Protocol Violation|2
282|NCT02761629|2573|P1|Overall Study|Protocol Violation|2
283|NCT02761629|2572|P2|Overall Study|Did not Cooperate/Refused Treatment|4
284|NCT02761629|2573|P1|Overall Study|Did not Cooperate/Refused Treatment|2
285|NCT02761629|2572|P2|Overall Study|Failure to Return|4
286|NCT02761629|2573|P1|Overall Study|Failure to Return|2
287|NCT02761629|2572|P2|Overall Study|Insufficient Therapeutic Response|7
288|NCT02761629|2573|P1|Overall Study|Insufficient Therapeutic Response|2
289|NCT02761629|2572|P2|Overall Study|Adverse Event/Intercurrent Illness|5
290|NCT02761629|2573|P1|Overall Study|Adverse Event/Intercurrent Illness|7
291|NCT02760810|2593|P1|Overall Study|Protocol Violation|1
292|NCT02760654|2601|P2|Overall Study|Withdrawal by Subject|3
293|NCT02760654|2602|P1|Overall Study|Withdrawal by Subject|4
294|NCT02760654|2601|P2|Overall Study|Lost to Follow-up|3
295|NCT02760654|2602|P1|Overall Study|Lost to Follow-up|3
296|NCT02759692|2626|P2|Period 2|Test article no longer available|1
297|NCT02759692|2627|P1|Period 2|Test article no longer available|0
298|NCT02759692|2626|P2|Period 2|Lost to Follow-up|0
299|NCT02759692|2627|P1|Period 2|Lost to Follow-up|1
300|NCT02759692|2626|P2|Period 1|Miss-Randomized|1
301|NCT02759692|2627|P1|Period 1|Miss-Randomized|1
302|NCT02759692|2626|P2|Period 1|No longer meets eligibility criteria.|0
303|NCT02759692|2627|P1|Period 1|No longer meets eligibility criteria.|1
304|NCT02759692|2626|P2|Period 1|Test article no longer available|1
305|NCT02759692|2627|P1|Period 1|Test article no longer available|1
306|NCT02759471|2643|P1|Overall Study|discomfort|2
307|NCT02756637|2655|P2|Overall Study|Did not complete curative therapy|0
308|NCT02756637|2656|P1|Overall Study|Did not complete curative therapy|33
309|NCT02756637|2655|P2|Overall Study|No available NLR value|44
310|NCT02756637|2656|P1|Overall Study|No available NLR value|44
311|NCT02756637|2655|P2|Overall Study|Not eligible for initial SWOG study|10
312|NCT02756637|2656|P1|Overall Study|Not eligible for initial SWOG study|10
5820|NCT02187744|37597|P1|Study|Death|1
313|NCT02755805|2690|P2|Overall Study|Withdrawal by Subject|2
314|NCT02755805|2691|P1|Overall Study|Withdrawal by Subject|0
315|NCT02755805|2690|P2|Overall Study|Refused assessments|0
316|NCT02755805|2691|P1|Overall Study|Refused assessments|1
317|NCT02755805|2690|P2|Overall Study|Lost to Follow-up|2
318|NCT02755805|2691|P1|Overall Study|Lost to Follow-up|1
319|NCT02753075|2760|P3|Overall Study|Physician Decision|0
320|NCT02753075|2761|P2|Overall Study|Physician Decision|1
321|NCT02753075|2762|P1|Overall Study|Physician Decision|3
322|NCT02753075|2760|P3|Overall Study|Withdrawal of Consent|3
323|NCT02753075|2761|P2|Overall Study|Withdrawal of Consent|1
324|NCT02753075|2762|P1|Overall Study|Withdrawal of Consent|1
325|NCT02753075|2760|P3|Overall Study|Lost to Follow-up|0
326|NCT02753075|2761|P2|Overall Study|Lost to Follow-up|0
327|NCT02753075|2762|P1|Overall Study|Lost to Follow-up|2
328|NCT02753075|2760|P3|Overall Study|Adverse Event|0
329|NCT02753075|2761|P2|Overall Study|Adverse Event|1
330|NCT02753075|2762|P1|Overall Study|Adverse Event|2
331|NCT02752802|2789|P2|Overall Study|Contrast Volume Not Collected|0
332|NCT02752802|2790|P1|Overall Study|Contrast Volume Not Collected|1
333|NCT02751450|2801|P2|Overall Study|Adverse Event|0
334|NCT02751450|2802|P1|Overall Study|Adverse Event|1
335|NCT02750943|2816|P2|Overall Study|Withdrawal by Subject|7
336|NCT02750943|2817|P1|Overall Study|Withdrawal by Subject|5
337|NCT02750943|2816|P2|Overall Study|Lost to Follow-up|2
338|NCT02750943|2817|P1|Overall Study|Lost to Follow-up|1
339|NCT02750709|2831|P6|Treatment Period 1|Adverse Event|1
340|NCT02750709|2832|P5|Treatment Period 1|Adverse Event|0
341|NCT02750709|2833|P4|Treatment Period 1|Adverse Event|0
342|NCT02750709|2834|P3|Treatment Period 1|Adverse Event|0
343|NCT02750709|2835|P2|Treatment Period 1|Adverse Event|0
344|NCT02750709|2836|P1|Treatment Period 1|Adverse Event|0
345|NCT02750345|2862|P6|Intervention 1|Adverse Event|0
346|NCT02750345|2863|P5|Intervention 1|Adverse Event|1
347|NCT02750345|2864|P4|Intervention 1|Adverse Event|0
348|NCT02750345|2865|P3|Intervention 1|Adverse Event|0
349|NCT02750345|2866|P2|Intervention 1|Adverse Event|0
350|NCT02750345|2867|P1|Intervention 1|Adverse Event|0
351|NCT02750332|2893|P2|Treatment Period 1|Withdrawal by Subject|1
352|NCT02750332|2894|P1|Treatment Period 1|Withdrawal by Subject|0
353|NCT02748213|2955|P2|Overall Study|Not Specified|29
354|NCT02748213|2956|P1|Overall Study|Not Specified|30
355|NCT02748213|2955|P2|Overall Study|Failure to Return|0
356|NCT02748213|2956|P1|Overall Study|Failure to Return|1
357|NCT02748213|2955|P2|Overall Study|Refused Treatment*|6
358|NCT02748213|2956|P1|Overall Study|Refused Treatment*|6
359|NCT02748213|2955|P2|Overall Study|Protocol Violation|4
360|NCT02748213|2956|P1|Overall Study|Protocol Violation|6
361|NCT02748213|2955|P2|Overall Study|Violation of Selection Criteria|0
362|NCT02748213|2956|P1|Overall Study|Violation of Selection Criteria|2
363|NCT02748213|2955|P2|Overall Study|Insufficient Therapeutic Response|57
364|NCT02748213|2956|P1|Overall Study|Insufficient Therapeutic Response|56
365|NCT02748213|2955|P2|Overall Study|Death|3
366|NCT02748213|2956|P1|Overall Study|Death|5
367|NCT02748213|2955|P2|Overall Study|Adverse Event or Intercurrent Illness|11
368|NCT02748213|2956|P1|Overall Study|Adverse Event or Intercurrent Illness|5
369|NCT02748213|2955|P2|Overall Study|Abnormal Laboratory Test|0
370|NCT02748213|2956|P1|Overall Study|Abnormal Laboratory Test|1
371|NCT02748213|2955|P2|Overall Study|Withdrawal Prior to Treatment|2
372|NCT02748213|2956|P1|Overall Study|Withdrawal Prior to Treatment|1
373|NCT02746679|2974|P2|Overall Study|Lost to Follow-up|6
374|NCT02746679|2975|P1|Overall Study|Lost to Follow-up|4
375|NCT02743780|3080|P5|Part 3 (7 Days)|Adverse Event|0
376|NCT02743780|3081|P4|Part 3 (7 Days)|Adverse Event|0
377|NCT02743780|3082|P3|Part 3 (7 Days)|Adverse Event|1
378|NCT02743780|3083|P2|Part 3 (7 Days)|Adverse Event|0
379|NCT02743780|3084|P1|Part 3 (7 Days)|Adverse Event|0
380|NCT02739594|3149|P2|Overall Study|Not Specified|2
381|NCT02739594|3150|P1|Overall Study|Not Specified|6
382|NCT02739594|3149|P2|Overall Study|Elevated Serum Creatinine|1
383|NCT02739594|3150|P1|Overall Study|Elevated Serum Creatinine|0
384|NCT02739594|3149|P2|Overall Study|Lost to Follow-up|1
385|NCT02739594|3150|P1|Overall Study|Lost to Follow-up|0
386|NCT02739594|3149|P2|Overall Study|Withdrawal by Subject|1
387|NCT02739594|3150|P1|Overall Study|Withdrawal by Subject|1
388|NCT02739594|3149|P2|Overall Study|Administrative Reasons|3
389|NCT02739594|3150|P1|Overall Study|Administrative Reasons|1
390|NCT02739594|3149|P2|Overall Study|Renal Insufficiency|6
391|NCT02739594|3150|P1|Overall Study|Renal Insufficiency|4
392|NCT02739594|3149|P2|Overall Study|Death|2
393|NCT02739594|3150|P1|Overall Study|Death|4
394|NCT02739594|3149|P2|Overall Study|Protocol Violation|6
395|NCT02739594|3150|P1|Overall Study|Protocol Violation|5
396|NCT02739594|3149|P2|Overall Study|Violation of Eligibility Criteria|2
397|NCT02739594|3150|P1|Overall Study|Violation of Eligibility Criteria|1
398|NCT02739594|3149|P2|Overall Study|Undesired Event|4
399|NCT02739594|3150|P1|Overall Study|Undesired Event|3
400|NCT02737852|3180|P1|Overall Study|Withdrawal by Subject|2
401|NCT02737592|3185|P1|Overall Study|Withdrawal by Subject|1
402|NCT02736721|3190|P1|Overall Study|Unspecified|5
403|NCT02736721|3190|P1|Overall Study|Lost to Follow-up|3
404|NCT02736721|3190|P1|Overall Study|Adverse Event|8
405|NCT02735200|3201|P2|Overall Study|Withdrawal by Subject|0
406|NCT02735200|3202|P1|Overall Study|Withdrawal by Subject|8
407|NCT02735200|3201|P2|Overall Study|Lost to Follow-up|5
408|NCT02735200|3202|P1|Overall Study|Lost to Follow-up|0
409|NCT02734212|3243|P2|Overall Study|Lost to Follow-up|10
410|NCT02734212|3244|P1|Overall Study|Lost to Follow-up|5
411|NCT02732639|3263|P1|Overall Study|Lost to Follow-up|1
412|NCT02732561|3276|P2|Overall Study|Withdrawal by Subject|0
413|NCT02732561|3277|P1|Overall Study|Withdrawal by Subject|1
414|NCT02732561|3276|P2|Overall Study|Lost to Follow-up|1
415|NCT02732561|3277|P1|Overall Study|Lost to Follow-up|1
416|NCT02732327|3287|P2|Overall Study|Protocol Violation|1
417|NCT02732327|3288|P1|Overall Study|Protocol Violation|0
418|NCT02732210|3296|P2|Overall Study|Missing|8
419|NCT02732210|3297|P1|Overall Study|Missing|0
420|NCT02732210|3296|P2|Overall Study|Other|103
421|NCT02732210|3297|P1|Overall Study|Other|35
422|NCT02732210|3296|P2|Overall Study|Death|15
423|NCT02732210|3297|P1|Overall Study|Death|4
424|NCT02732210|3296|P2|Overall Study|Lost to Follow-up|57
425|NCT02732210|3297|P1|Overall Study|Lost to Follow-up|5
426|NCT02732210|3296|P2|Overall Study|Withdrawal by Subject|87
427|NCT02732210|3297|P1|Overall Study|Withdrawal by Subject|28
428|NCT02732210|3296|P2|Overall Study|Study Ended|13
429|NCT02732210|3297|P1|Overall Study|Study Ended|13
430|NCT02732210|3296|P2|Overall Study|Site Closed|11
431|NCT02732210|3297|P1|Overall Study|Site Closed|0
432|NCT02731131|3349|P2|Overall Study|Refused Therapy|1
433|NCT02731131|3350|P1|Overall Study|Refused Therapy|0
434|NCT02731131|3349|P2|Overall Study|Psychiatric Disorder|1
435|NCT02731131|3350|P1|Overall Study|Psychiatric Disorder|0
436|NCT02726022|3397|P1|Overall Study|Treatment Failure and Poor Compliance|1
437|NCT02726022|3397|P1|Overall Study|Poor Compliance|13
438|NCT02726022|3397|P1|Overall Study|Treatment Failure|8
439|NCT02726022|3397|P1|Overall Study|Adverse Event|14
440|NCT02725788|3408|P2|Overall Study|Protocol Violation|1
441|NCT02725788|3409|P1|Overall Study|Protocol Violation|0
442|NCT02725788|3408|P2|Overall Study|Lost to Follow-up|1
443|NCT02725788|3409|P1|Overall Study|Lost to Follow-up|1
444|NCT02723188|3422|P3|Overall Study|Withdrawal by Subject|0
445|NCT02723188|3423|P2|Overall Study|Withdrawal by Subject|0
446|NCT02723188|3424|P1|Overall Study|Withdrawal by Subject|1
447|NCT02717754|3489|P6|Overall Study|Incorrect Infusion Duration|20
448|NCT02717754|3490|P5|Overall Study|Incorrect Infusion Duration|20
449|NCT02717754|3491|P4|Overall Study|Incorrect Infusion Duration|10
450|NCT02717754|3492|P3|Overall Study|Incorrect Infusion Duration|0
451|NCT02717754|3493|P2|Overall Study|Incorrect Infusion Duration|0
452|NCT02717754|3494|P1|Overall Study|Incorrect Infusion Duration|0
453|NCT02716779|3525|P3|Combination Therapy|Adverse Event|1
454|NCT02716779|3526|P2|Combination Therapy|Adverse Event|2
455|NCT02716779|3527|P1|Combination Therapy|Adverse Event|0
456|NCT02716779|3525|P3|Monotherapy|Adverse Event|1
457|NCT02716779|3526|P2|Monotherapy|Adverse Event|1
458|NCT02716779|3527|P1|Monotherapy|Adverse Event|0
459|NCT02716298|3571|P2|First Intervention (1 Month)|Lens discomfort|1
460|NCT02716298|3572|P1|First Intervention (1 Month)|Lens discomfort|1
461|NCT02713594|3589|P2|Overall Study|Lost to Follow-up|374
462|NCT02713594|3590|P1|Overall Study|Lost to Follow-up|358
463|NCT02713594|3589|P2|Overall Study|Withdrawal by Subject|22
464|NCT02713594|3590|P1|Overall Study|Withdrawal by Subject|32
465|NCT02709577|3621|P4|Overall Study|Withdrawal by Subject|0
466|NCT02709577|3622|P3|Overall Study|Withdrawal by Subject|2
467|NCT02709577|3623|P2|Overall Study|Withdrawal by Subject|3
468|NCT02709577|3624|P1|Overall Study|Withdrawal by Subject|2
469|NCT02709577|3621|P4|Overall Study|procedural complication|0
470|NCT02709577|3622|P3|Overall Study|procedural complication|0
471|NCT02709577|3623|P2|Overall Study|procedural complication|1
472|NCT02709577|3624|P1|Overall Study|procedural complication|0
473|NCT02709577|3621|P4|Overall Study|non-accommodating anatomy|0
474|NCT02709577|3622|P3|Overall Study|non-accommodating anatomy|0
475|NCT02709577|3623|P2|Overall Study|non-accommodating anatomy|1
476|NCT02709577|3624|P1|Overall Study|non-accommodating anatomy|0
477|NCT02708524|3640|P4|Overall Study|Subject lost study lens|0
478|NCT02708524|3641|P3|Overall Study|Subject lost study lens|0
479|NCT02708524|3642|P2|Overall Study|Subject lost study lens|0
480|NCT02708524|3643|P1|Overall Study|Subject lost study lens|1
481|NCT02708524|3640|P4|Overall Study|Did not wear lens at final visit|0
482|NCT02708524|3641|P3|Overall Study|Did not wear lens at final visit|0
483|NCT02708524|3642|P2|Overall Study|Did not wear lens at final visit|1
484|NCT02708524|3643|P1|Overall Study|Did not wear lens at final visit|0
485|NCT02708524|3640|P4|Overall Study|Dispensed incorrect study lens|0
486|NCT02708524|3641|P3|Overall Study|Dispensed incorrect study lens|1
487|NCT02708524|3642|P2|Overall Study|Dispensed incorrect study lens|1
488|NCT02708524|3643|P1|Overall Study|Dispensed incorrect study lens|0
489|NCT02708524|3640|P4|Overall Study|Withdrawal by Subject|0
490|NCT02708524|3641|P3|Overall Study|Withdrawal by Subject|0
491|NCT02708524|3642|P2|Overall Study|Withdrawal by Subject|1
492|NCT02708524|3643|P1|Overall Study|Withdrawal by Subject|1
493|NCT02708524|3640|P4|Overall Study|Protocol Violation|0
494|NCT02708524|3641|P3|Overall Study|Protocol Violation|0
495|NCT02708524|3642|P2|Overall Study|Protocol Violation|1
496|NCT02708524|3643|P1|Overall Study|Protocol Violation|0
497|NCT02708524|3640|P4|Overall Study|Lost to Follow-up|0
498|NCT02708524|3641|P3|Overall Study|Lost to Follow-up|1
499|NCT02708524|3642|P2|Overall Study|Lost to Follow-up|1
500|NCT02708524|3643|P1|Overall Study|Lost to Follow-up|1
501|NCT02708524|3640|P4|Overall Study|Lens Discomfort|0
502|NCT02708524|3641|P3|Overall Study|Lens Discomfort|1
503|NCT02708524|3642|P2|Overall Study|Lens Discomfort|0
504|NCT02708524|3643|P1|Overall Study|Lens Discomfort|1
505|NCT02708524|3640|P4|Overall Study|Adverse Event|0
506|NCT02708524|3641|P3|Overall Study|Adverse Event|0
507|NCT02708524|3642|P2|Overall Study|Adverse Event|1
508|NCT02708524|3643|P1|Overall Study|Adverse Event|0
509|NCT02708355|3692|P3|Overall Study|Adverse Event|0
510|NCT02708355|3693|P2|Overall Study|Adverse Event|0
511|NCT02708355|3694|P1|Overall Study|Adverse Event|1
512|NCT02708277|3707|P2|Overall Study|Lost to Follow-up|4
513|NCT02708277|3708|P1|Overall Study|Lost to Follow-up|7
514|NCT02707640|3751|P2|Overall Study|Sponsor Discretion|0
515|NCT02707640|3752|P1|Overall Study|Sponsor Discretion|1
516|NCT02707640|3751|P2|Overall Study|Participant's Personal Decision|2
517|NCT02707640|3752|P1|Overall Study|Participant's Personal Decision|1
518|NCT02707640|3751|P2|Overall Study|Withdrawal by Subject|1
519|NCT02707640|3752|P1|Overall Study|Withdrawal by Subject|0
520|NCT02707640|3751|P2|Overall Study|Physician Decision|0
521|NCT02707640|3752|P1|Overall Study|Physician Decision|2
522|NCT02707640|3751|P2|Overall Study|Death|2
523|NCT02707640|3752|P1|Overall Study|Death|1
524|NCT02707640|3751|P2|Overall Study|Adverse Event|2
525|NCT02707640|3752|P1|Overall Study|Adverse Event|4
526|NCT02706327|3778|P3|Overall Study|Lost to Follow-up|2
527|NCT02706327|3779|P2|Overall Study|Lost to Follow-up|1
528|NCT02706327|3780|P1|Overall Study|Lost to Follow-up|1
529|NCT02705716|3832|P2|Overall Study|Withdrawal of Consent|1
530|NCT02705716|3833|P1|Overall Study|Withdrawal of Consent|1
531|NCT02705716|3832|P2|Overall Study|Protocol Violation|0
532|NCT02705716|3833|P1|Overall Study|Protocol Violation|3
533|NCT02705716|3832|P2|Overall Study|Adverse Event|1
534|NCT02705716|3833|P1|Overall Study|Adverse Event|0
535|NCT02701296|3859|P2|Overall Study|Incomplete Data|2
536|NCT02701296|3860|P1|Overall Study|Incomplete Data|0
537|NCT02699892|3893|P1|Overall Study|Unspecified|36
538|NCT02699593|3898|P2|Period 2|Torn Contact Lens|0
539|NCT02699593|3899|P1|Period 2|Torn Contact Lens|1
540|NCT02699593|3898|P2|Period 2|Lost Contact Lens|1
541|NCT02699593|3899|P1|Period 2|Lost Contact Lens|0
542|NCT02699593|3898|P2|Period 2|Adverse Event|1
543|NCT02699593|3899|P1|Period 2|Adverse Event|1
544|NCT02699593|3898|P2|Period 1|Adverse Event|1
545|NCT02699593|3899|P1|Period 1|Adverse Event|1
546|NCT02699593|3898|P2|Period 1|Withdrawal by Subject|1
547|NCT02699593|3899|P1|Period 1|Withdrawal by Subject|0
548|NCT02699593|3898|P2|Period 1|Protocol Violation|1
549|NCT02699593|3899|P1|Period 1|Protocol Violation|0
550|NCT02699593|3898|P2|Period 1|Torn Contact Len|3
551|NCT02699593|3899|P1|Period 1|Torn Contact Len|4
552|NCT02699593|3898|P2|Period 1|Unsatisfactory Visual Response|1
553|NCT02699593|3899|P1|Period 1|Unsatisfactory Visual Response|0
554|NCT02698423|3915|P2|Overall Study|Lost to Follow-up|24
555|NCT02698423|3916|P1|Overall Study|Lost to Follow-up|19
556|NCT02696317|3937|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
557|NCT02696317|3938|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
558|NCT02696317|3937|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
559|NCT02696317|3938|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
560|NCT02694718|3952|P1|Overall Study|Withdrawal by Subject|1
561|NCT02694718|3952|P1|Overall Study|Death|1
562|NCT02694536|3962|P1|Overall Study|Not Specified|22
563|NCT02694536|3962|P1|Overall Study|Death|8
564|NCT02694536|3962|P1|Overall Study|Withdrawal by Subject|8
565|NCT02694536|3962|P1|Overall Study|Study Drug-Related Adverse Event|1
566|NCT02694536|3962|P1|Overall Study|Lost to Follow-up|1
567|NCT02694536|3962|P1|Overall Study|Progressive Disease|40
568|NCT02691507|4017|P2|Overall Study|Missed Visit 3|1
569|NCT02691507|4018|P1|Overall Study|Missed Visit 3|0
570|NCT02689804|4193|P2|Overall Study|Withdrawal by Subject|0
571|NCT02689804|4194|P1|Overall Study|Withdrawal by Subject|2
572|NCT02678923|4394|P2|Overall Study|Did Not Return for Study Visits|0
573|NCT02678923|4395|P1|Overall Study|Did Not Return for Study Visits|1
574|NCT02678923|4394|P2|Overall Study|Lost to Follow-up|0
575|NCT02678923|4395|P1|Overall Study|Lost to Follow-up|1
576|NCT02678923|4394|P2|Overall Study|Withdrawal by Subject|2
577|NCT02678923|4395|P1|Overall Study|Withdrawal by Subject|3
578|NCT02678923|4394|P2|Overall Study|Protocol Deviation (Not Dosed)|3
579|NCT02678923|4395|P1|Overall Study|Protocol Deviation (Not Dosed)|1
580|NCT02678676|4411|P2|Overall Study|Unconfirmed for lost to follow-up|67
581|NCT02678676|4412|P1|Overall Study|Unconfirmed for lost to follow-up|85
582|NCT02678676|4411|P2|Overall Study|Lost to Follow-up|151
583|NCT02678676|4412|P1|Overall Study|Lost to Follow-up|171
584|NCT02678676|4411|P2|Overall Study|Withdrawal by Subject|5
585|NCT02678676|4412|P1|Overall Study|Withdrawal by Subject|13
586|NCT02678676|4411|P2|Overall Study|Death|649
587|NCT02678676|4412|P1|Overall Study|Death|619
588|NCT02670473|4495|P1|Overall Study|Withdrawal by Subject|1
589|NCT02669095|4550|P2|Overall Study|Visit 5 assessments not completed|1
590|NCT02669095|4551|P1|Overall Study|Visit 5 assessments not completed|0
591|NCT02669095|4550|P2|Overall Study|Torn Lens|1
592|NCT02669095|4551|P1|Overall Study|Torn Lens|0
593|NCT02669095|4550|P2|Overall Study|Unsatisfactory Lens Fitting|1
594|NCT02669095|4551|P1|Overall Study|Unsatisfactory Lens Fitting|0
595|NCT02669095|4550|P2|Overall Study|Adverse Event|0
596|NCT02669095|4551|P1|Overall Study|Adverse Event|1
597|NCT02669043|4559|P1|Overall Study|Didn't meet I/E criteria|4
598|NCT02666222|4591|P1|Overall Study|Death|2
599|NCT02663453|4670|P2|Overall Study|Withdrawal by Subject|0
600|NCT02663453|4671|P1|Overall Study|Withdrawal by Subject|1
601|NCT02663453|4670|P2|Overall Study|Death|4
602|NCT02663453|4671|P1|Overall Study|Death|4
603|NCT02662556|4718|P1|Overall Study|Lack of Efficacy|4
604|NCT02662556|4718|P1|Overall Study|Adverse Event|4
605|NCT02651922|4844|P1|Overall Study|due to exclusion criteria|2
606|NCT02651467|4864|P3|Overall Study|Other (Not specified)|2
607|NCT02651467|4865|P2|Overall Study|Other (Not specified)|0
608|NCT02651467|4866|P1|Overall Study|Other (Not specified)|1
609|NCT02651467|4864|P3|Overall Study|Withdrawal by Subject|2
610|NCT02651467|4865|P2|Overall Study|Withdrawal by Subject|0
611|NCT02651467|4866|P1|Overall Study|Withdrawal by Subject|0
612|NCT02649634|4900|P2|Overall Study|Lost to Follow-up|1
613|NCT02649634|4901|P1|Overall Study|Lost to Follow-up|0
614|NCT02649634|4900|P2|Overall Study|Withdrawal by Subject|5
615|NCT02649634|4901|P1|Overall Study|Withdrawal by Subject|3
616|NCT02648438|4960|P3|Overall Study|Withdrawal by Subject|0
617|NCT02648438|4961|P2|Overall Study|Withdrawal by Subject|1
618|NCT02648438|4962|P1|Overall Study|Withdrawal by Subject|1
619|NCT02648438|4960|P3|Overall Study|Protocol Violation|0
620|NCT02648438|4961|P2|Overall Study|Protocol Violation|0
621|NCT02648438|4962|P1|Overall Study|Protocol Violation|2
622|NCT02648438|4960|P3|Overall Study|Eligibility criteria not fulfilled|0
623|NCT02648438|4961|P2|Overall Study|Eligibility criteria not fulfilled|2
624|NCT02648438|4962|P1|Overall Study|Eligibility criteria not fulfilled|0
625|NCT02644356|5063|P1|Overall Study|Withdrawal by Subject|2
626|NCT02644109|5075|P2|Overall Study|Adverse Event|4
627|NCT02644109|5076|P1|Overall Study|Adverse Event|0
628|NCT02644096|5084|P2|Overall Study|Withdrawal by Subject|25
629|NCT02644096|5085|P1|Overall Study|Withdrawal by Subject|28
630|NCT02643251|5108|P2|Overall Study|PI Decision to terminate patient|0
631|NCT02643251|5109|P1|Overall Study|PI Decision to terminate patient|1
632|NCT02643251|5108|P2|Overall Study|Protocol Violation|0
633|NCT02643251|5109|P1|Overall Study|Protocol Violation|1
634|NCT02643251|5108|P2|Overall Study|Lost to Follow-up|1
635|NCT02643251|5109|P1|Overall Study|Lost to Follow-up|4
636|NCT02643251|5108|P2|Overall Study|Withdrawal by Subject|0
637|NCT02643251|5109|P1|Overall Study|Withdrawal by Subject|2
638|NCT02643251|5108|P2|Overall Study|Adverse Event|1
639|NCT02643251|5109|P1|Overall Study|Adverse Event|3
640|NCT02641379|5295|P11|Overall Study|PCR positive|0
641|NCT02641379|5296|P10|Overall Study|PCR positive|0
642|NCT02641379|5297|P9|Overall Study|PCR positive|0
643|NCT02641379|5298|P8|Overall Study|PCR positive|0
644|NCT02641379|5299|P7|Overall Study|PCR positive|1
645|NCT02641379|5300|P6|Overall Study|PCR positive|0
646|NCT02641379|5301|P5|Overall Study|PCR positive|0
647|NCT02641379|5302|P4|Overall Study|PCR positive|0
648|NCT02641379|5303|P3|Overall Study|PCR positive|0
649|NCT02641379|5304|P2|Overall Study|PCR positive|0
650|NCT02641379|5305|P1|Overall Study|PCR positive|0
651|NCT02641379|5295|P11|Overall Study|Missing PCR result at Week 8|0
652|NCT02641379|5296|P10|Overall Study|Missing PCR result at Week 8|1
653|NCT02641379|5297|P9|Overall Study|Missing PCR result at Week 8|0
654|NCT02641379|5298|P8|Overall Study|Missing PCR result at Week 8|0
655|NCT02641379|5299|P7|Overall Study|Missing PCR result at Week 8|0
656|NCT02641379|5300|P6|Overall Study|Missing PCR result at Week 8|0
657|NCT02641379|5301|P5|Overall Study|Missing PCR result at Week 8|0
658|NCT02641379|5302|P4|Overall Study|Missing PCR result at Week 8|0
659|NCT02641379|5303|P3|Overall Study|Missing PCR result at Week 8|0
660|NCT02641379|5304|P2|Overall Study|Missing PCR result at Week 8|0
661|NCT02641379|5305|P1|Overall Study|Missing PCR result at Week 8|0
662|NCT02641379|5295|P11|Overall Study|Participant treated after Week 24|0
663|NCT02641379|5296|P10|Overall Study|Participant treated after Week 24|0
664|NCT02641379|5297|P9|Overall Study|Participant treated after Week 24|1
665|NCT02641379|5298|P8|Overall Study|Participant treated after Week 24|0
666|NCT02641379|5299|P7|Overall Study|Participant treated after Week 24|0
667|NCT02641379|5300|P6|Overall Study|Participant treated after Week 24|0
668|NCT02641379|5301|P5|Overall Study|Participant treated after Week 24|0
669|NCT02641379|5302|P4|Overall Study|Participant treated after Week 24|0
670|NCT02641379|5303|P3|Overall Study|Participant treated after Week 24|0
671|NCT02641379|5304|P2|Overall Study|Participant treated after Week 24|0
672|NCT02641379|5305|P1|Overall Study|Participant treated after Week 24|0
673|NCT02641379|5295|P11|Overall Study|Participant’s PCR high|0
674|NCT02641379|5296|P10|Overall Study|Participant’s PCR high|0
675|NCT02641379|5297|P9|Overall Study|Participant’s PCR high|0
676|NCT02641379|5298|P8|Overall Study|Participant’s PCR high|1
677|NCT02641379|5299|P7|Overall Study|Participant’s PCR high|0
678|NCT02641379|5300|P6|Overall Study|Participant’s PCR high|0
679|NCT02641379|5301|P5|Overall Study|Participant’s PCR high|0
680|NCT02641379|5302|P4|Overall Study|Participant’s PCR high|0
681|NCT02641379|5303|P3|Overall Study|Participant’s PCR high|0
682|NCT02641379|5304|P2|Overall Study|Participant’s PCR high|0
683|NCT02641379|5305|P1|Overall Study|Participant’s PCR high|0
684|NCT02641379|5295|P11|Overall Study|Negative PCR result|0
685|NCT02641379|5296|P10|Overall Study|Negative PCR result|1
686|NCT02641379|5297|P9|Overall Study|Negative PCR result|0
687|NCT02641379|5298|P8|Overall Study|Negative PCR result|0
688|NCT02641379|5299|P7|Overall Study|Negative PCR result|0
689|NCT02641379|5300|P6|Overall Study|Negative PCR result|0
690|NCT02641379|5301|P5|Overall Study|Negative PCR result|0
691|NCT02641379|5302|P4|Overall Study|Negative PCR result|0
692|NCT02641379|5303|P3|Overall Study|Negative PCR result|0
693|NCT02641379|5304|P2|Overall Study|Negative PCR result|0
694|NCT02641379|5305|P1|Overall Study|Negative PCR result|0
695|NCT02641379|5295|P11|Overall Study|No 2 Log drop at Week 12|1
696|NCT02641379|5296|P10|Overall Study|No 2 Log drop at Week 12|0
697|NCT02641379|5297|P9|Overall Study|No 2 Log drop at Week 12|0
698|NCT02641379|5298|P8|Overall Study|No 2 Log drop at Week 12|0
699|NCT02641379|5299|P7|Overall Study|No 2 Log drop at Week 12|0
700|NCT02641379|5300|P6|Overall Study|No 2 Log drop at Week 12|0
701|NCT02641379|5301|P5|Overall Study|No 2 Log drop at Week 12|0
702|NCT02641379|5302|P4|Overall Study|No 2 Log drop at Week 12|0
703|NCT02641379|5303|P3|Overall Study|No 2 Log drop at Week 12|0
704|NCT02641379|5304|P2|Overall Study|No 2 Log drop at Week 12|0
705|NCT02641379|5305|P1|Overall Study|No 2 Log drop at Week 12|0
706|NCT02641379|5295|P11|Overall Study|Non-response Week 12|0
707|NCT02641379|5296|P10|Overall Study|Non-response Week 12|0
708|NCT02641379|5297|P9|Overall Study|Non-response Week 12|0
709|NCT02641379|5298|P8|Overall Study|Non-response Week 12|1
710|NCT02641379|5299|P7|Overall Study|Non-response Week 12|0
711|NCT02641379|5300|P6|Overall Study|Non-response Week 12|0
712|NCT02641379|5301|P5|Overall Study|Non-response Week 12|0
713|NCT02641379|5302|P4|Overall Study|Non-response Week 12|0
714|NCT02641379|5303|P3|Overall Study|Non-response Week 12|0
715|NCT02641379|5304|P2|Overall Study|Non-response Week 12|0
716|NCT02641379|5305|P1|Overall Study|Non-response Week 12|0
717|NCT02641379|5295|P11|Overall Study|Participant showed weight reduction|0
718|NCT02641379|5296|P10|Overall Study|Participant showed weight reduction|0
719|NCT02641379|5297|P9|Overall Study|Participant showed weight reduction|0
720|NCT02641379|5298|P8|Overall Study|Participant showed weight reduction|1
721|NCT02641379|5299|P7|Overall Study|Participant showed weight reduction|0
722|NCT02641379|5300|P6|Overall Study|Participant showed weight reduction|0
723|NCT02641379|5301|P5|Overall Study|Participant showed weight reduction|0
724|NCT02641379|5302|P4|Overall Study|Participant showed weight reduction|0
725|NCT02641379|5303|P3|Overall Study|Participant showed weight reduction|0
726|NCT02641379|5304|P2|Overall Study|Participant showed weight reduction|0
727|NCT02641379|5305|P1|Overall Study|Participant showed weight reduction|0
728|NCT02641379|5295|P11|Overall Study|Source data not found|0
729|NCT02641379|5296|P10|Overall Study|Source data not found|0
730|NCT02641379|5297|P9|Overall Study|Source data not found|0
731|NCT02641379|5298|P8|Overall Study|Source data not found|0
732|NCT02641379|5299|P7|Overall Study|Source data not found|0
733|NCT02641379|5300|P6|Overall Study|Source data not found|1
734|NCT02641379|5301|P5|Overall Study|Source data not found|0
735|NCT02641379|5302|P4|Overall Study|Source data not found|0
736|NCT02641379|5303|P3|Overall Study|Source data not found|0
737|NCT02641379|5304|P2|Overall Study|Source data not found|0
738|NCT02641379|5305|P1|Overall Study|Source data not found|0
739|NCT02641379|5295|P11|Overall Study|Lost to Follow-up|0
740|NCT02641379|5296|P10|Overall Study|Lost to Follow-up|0
741|NCT02641379|5297|P9|Overall Study|Lost to Follow-up|1
742|NCT02641379|5298|P8|Overall Study|Lost to Follow-up|0
743|NCT02641379|5299|P7|Overall Study|Lost to Follow-up|0
744|NCT02641379|5300|P6|Overall Study|Lost to Follow-up|0
745|NCT02641379|5301|P5|Overall Study|Lost to Follow-up|0
746|NCT02641379|5302|P4|Overall Study|Lost to Follow-up|0
747|NCT02641379|5303|P3|Overall Study|Lost to Follow-up|0
748|NCT02641379|5304|P2|Overall Study|Lost to Follow-up|0
749|NCT02641379|5305|P1|Overall Study|Lost to Follow-up|0
750|NCT02641379|5295|P11|Overall Study|Participation in sili rescue study|0
751|NCT02641379|5296|P10|Overall Study|Participation in sili rescue study|0
752|NCT02641379|5297|P9|Overall Study|Participation in sili rescue study|0
753|NCT02641379|5298|P8|Overall Study|Participation in sili rescue study|0
754|NCT02641379|5299|P7|Overall Study|Participation in sili rescue study|0
755|NCT02641379|5300|P6|Overall Study|Participation in sili rescue study|1
756|NCT02641379|5301|P5|Overall Study|Participation in sili rescue study|0
757|NCT02641379|5302|P4|Overall Study|Participation in sili rescue study|0
758|NCT02641379|5303|P3|Overall Study|Participation in sili rescue study|0
759|NCT02641379|5304|P2|Overall Study|Participation in sili rescue study|0
760|NCT02641379|5305|P1|Overall Study|Participation in sili rescue study|0
761|NCT02641379|5295|P11|Overall Study|Protocol Violation|0
762|NCT02641379|5296|P10|Overall Study|Protocol Violation|0
763|NCT02641379|5297|P9|Overall Study|Protocol Violation|1
764|NCT02641379|5298|P8|Overall Study|Protocol Violation|0
765|NCT02641379|5299|P7|Overall Study|Protocol Violation|0
766|NCT02641379|5300|P6|Overall Study|Protocol Violation|0
767|NCT02641379|5301|P5|Overall Study|Protocol Violation|2
768|NCT02641379|5302|P4|Overall Study|Protocol Violation|0
769|NCT02641379|5303|P3|Overall Study|Protocol Violation|0
770|NCT02641379|5304|P2|Overall Study|Protocol Violation|0
771|NCT02641379|5305|P1|Overall Study|Protocol Violation|0
772|NCT02641379|5295|P11|Overall Study|Blood could not be drawn|0
773|NCT02641379|5296|P10|Overall Study|Blood could not be drawn|0
774|NCT02641379|5297|P9|Overall Study|Blood could not be drawn|0
775|NCT02641379|5298|P8|Overall Study|Blood could not be drawn|0
776|NCT02641379|5299|P7|Overall Study|Blood could not be drawn|0
777|NCT02641379|5300|P6|Overall Study|Blood could not be drawn|0
778|NCT02641379|5301|P5|Overall Study|Blood could not be drawn|1
779|NCT02641379|5302|P4|Overall Study|Blood could not be drawn|0
780|NCT02641379|5303|P3|Overall Study|Blood could not be drawn|0
781|NCT02641379|5304|P2|Overall Study|Blood could not be drawn|0
782|NCT02641379|5305|P1|Overall Study|Blood could not be drawn|0
783|NCT02641379|5295|P11|Overall Study|Baseline viral load unavailable|0
784|NCT02641379|5296|P10|Overall Study|Baseline viral load unavailable|0
785|NCT02641379|5297|P9|Overall Study|Baseline viral load unavailable|0
786|NCT02641379|5298|P8|Overall Study|Baseline viral load unavailable|0
787|NCT02641379|5299|P7|Overall Study|Baseline viral load unavailable|0
788|NCT02641379|5300|P6|Overall Study|Baseline viral load unavailable|0
789|NCT02641379|5301|P5|Overall Study|Baseline viral load unavailable|0
790|NCT02641379|5302|P4|Overall Study|Baseline viral load unavailable|1
791|NCT02641379|5303|P3|Overall Study|Baseline viral load unavailable|0
792|NCT02641379|5304|P2|Overall Study|Baseline viral load unavailable|0
793|NCT02641379|5305|P1|Overall Study|Baseline viral load unavailable|0
794|NCT02641379|5295|P11|Overall Study|Inclusion criteria not fulfilled|0
795|NCT02641379|5296|P10|Overall Study|Inclusion criteria not fulfilled|0
796|NCT02641379|5297|P9|Overall Study|Inclusion criteria not fulfilled|0
797|NCT02641379|5298|P8|Overall Study|Inclusion criteria not fulfilled|0
798|NCT02641379|5299|P7|Overall Study|Inclusion criteria not fulfilled|0
799|NCT02641379|5300|P6|Overall Study|Inclusion criteria not fulfilled|0
800|NCT02641379|5301|P5|Overall Study|Inclusion criteria not fulfilled|0
801|NCT02641379|5302|P4|Overall Study|Inclusion criteria not fulfilled|1
802|NCT02641379|5303|P3|Overall Study|Inclusion criteria not fulfilled|0
803|NCT02641379|5304|P2|Overall Study|Inclusion criteria not fulfilled|0
804|NCT02641379|5305|P1|Overall Study|Inclusion criteria not fulfilled|0
805|NCT02641379|5295|P11|Overall Study|PCR sample for Week 4 not drawn|0
806|NCT02641379|5296|P10|Overall Study|PCR sample for Week 4 not drawn|0
807|NCT02641379|5297|P9|Overall Study|PCR sample for Week 4 not drawn|0
808|NCT02641379|5298|P8|Overall Study|PCR sample for Week 4 not drawn|0
809|NCT02641379|5299|P7|Overall Study|PCR sample for Week 4 not drawn|0
810|NCT02641379|5300|P6|Overall Study|PCR sample for Week 4 not drawn|0
811|NCT02641379|5301|P5|Overall Study|PCR sample for Week 4 not drawn|0
812|NCT02641379|5302|P4|Overall Study|PCR sample for Week 4 not drawn|1
813|NCT02641379|5303|P3|Overall Study|PCR sample for Week 4 not drawn|0
814|NCT02641379|5304|P2|Overall Study|PCR sample for Week 4 not drawn|0
815|NCT02641379|5305|P1|Overall Study|PCR sample for Week 4 not drawn|0
816|NCT02641379|5295|P11|Overall Study|PCR positive at Week 28|0
817|NCT02641379|5296|P10|Overall Study|PCR positive at Week 28|0
818|NCT02641379|5297|P9|Overall Study|PCR positive at Week 28|0
819|NCT02641379|5298|P8|Overall Study|PCR positive at Week 28|0
820|NCT02641379|5299|P7|Overall Study|PCR positive at Week 28|0
821|NCT02641379|5300|P6|Overall Study|PCR positive at Week 28|0
822|NCT02641379|5301|P5|Overall Study|PCR positive at Week 28|0
823|NCT02641379|5302|P4|Overall Study|PCR positive at Week 28|0
824|NCT02641379|5303|P3|Overall Study|PCR positive at Week 28|1
825|NCT02641379|5304|P2|Overall Study|PCR positive at Week 28|0
826|NCT02641379|5305|P1|Overall Study|PCR positive at Week 28|0
827|NCT02641379|5295|P11|Overall Study|No PCR at baseline|0
828|NCT02641379|5296|P10|Overall Study|No PCR at baseline|0
829|NCT02641379|5297|P9|Overall Study|No PCR at baseline|0
830|NCT02641379|5298|P8|Overall Study|No PCR at baseline|0
831|NCT02641379|5299|P7|Overall Study|No PCR at baseline|0
832|NCT02641379|5300|P6|Overall Study|No PCR at baseline|0
833|NCT02641379|5301|P5|Overall Study|No PCR at baseline|0
834|NCT02641379|5302|P4|Overall Study|No PCR at baseline|0
835|NCT02641379|5303|P3|Overall Study|No PCR at baseline|1
836|NCT02641379|5304|P2|Overall Study|No PCR at baseline|0
837|NCT02641379|5305|P1|Overall Study|No PCR at baseline|0
838|NCT02641379|5295|P11|Overall Study|PCR not performed at Week 12|0
839|NCT02641379|5296|P10|Overall Study|PCR not performed at Week 12|0
840|NCT02641379|5297|P9|Overall Study|PCR not performed at Week 12|0
841|NCT02641379|5298|P8|Overall Study|PCR not performed at Week 12|0
842|NCT02641379|5299|P7|Overall Study|PCR not performed at Week 12|0
843|NCT02641379|5300|P6|Overall Study|PCR not performed at Week 12|0
844|NCT02641379|5301|P5|Overall Study|PCR not performed at Week 12|0
845|NCT02641379|5302|P4|Overall Study|PCR not performed at Week 12|0
846|NCT02641379|5303|P3|Overall Study|PCR not performed at Week 12|1
847|NCT02641379|5304|P2|Overall Study|PCR not performed at Week 12|0
848|NCT02641379|5305|P1|Overall Study|PCR not performed at Week 12|0
849|NCT02641379|5295|P11|Overall Study|PCR positive at Week 48|0
850|NCT02641379|5296|P10|Overall Study|PCR positive at Week 48|0
851|NCT02641379|5297|P9|Overall Study|PCR positive at Week 48|0
852|NCT02641379|5298|P8|Overall Study|PCR positive at Week 48|0
853|NCT02641379|5299|P7|Overall Study|PCR positive at Week 48|0
854|NCT02641379|5300|P6|Overall Study|PCR positive at Week 48|0
855|NCT02641379|5301|P5|Overall Study|PCR positive at Week 48|0
856|NCT02641379|5302|P4|Overall Study|PCR positive at Week 48|0
857|NCT02641379|5303|P3|Overall Study|PCR positive at Week 48|0
858|NCT02641379|5304|P2|Overall Study|PCR positive at Week 48|1
859|NCT02641379|5305|P1|Overall Study|PCR positive at Week 48|0
860|NCT02641379|5295|P11|Overall Study|PCR positive at Week 68|0
861|NCT02641379|5296|P10|Overall Study|PCR positive at Week 68|0
862|NCT02641379|5297|P9|Overall Study|PCR positive at Week 68|0
863|NCT02641379|5298|P8|Overall Study|PCR positive at Week 68|0
864|NCT02641379|5299|P7|Overall Study|PCR positive at Week 68|0
865|NCT02641379|5300|P6|Overall Study|PCR positive at Week 68|0
866|NCT02641379|5301|P5|Overall Study|PCR positive at Week 68|0
867|NCT02641379|5302|P4|Overall Study|PCR positive at Week 68|0
868|NCT02641379|5303|P3|Overall Study|PCR positive at Week 68|0
869|NCT02641379|5304|P2|Overall Study|PCR positive at Week 68|1
870|NCT02641379|5305|P1|Overall Study|PCR positive at Week 68|0
871|NCT02641379|5295|P11|Overall Study|Financial problems|0
872|NCT02641379|5296|P10|Overall Study|Financial problems|0
873|NCT02641379|5297|P9|Overall Study|Financial problems|0
874|NCT02641379|5298|P8|Overall Study|Financial problems|0
875|NCT02641379|5299|P7|Overall Study|Financial problems|0
876|NCT02641379|5300|P6|Overall Study|Financial problems|0
877|NCT02641379|5301|P5|Overall Study|Financial problems|0
878|NCT02641379|5302|P4|Overall Study|Financial problems|0
879|NCT02641379|5303|P3|Overall Study|Financial problems|0
880|NCT02641379|5304|P2|Overall Study|Financial problems|1
881|NCT02641379|5305|P1|Overall Study|Financial problems|0
882|NCT02641379|5295|P11|Overall Study|Therapy stopped due to misunderstanding|0
883|NCT02641379|5296|P10|Overall Study|Therapy stopped due to misunderstanding|0
884|NCT02641379|5297|P9|Overall Study|Therapy stopped due to misunderstanding|0
885|NCT02641379|5298|P8|Overall Study|Therapy stopped due to misunderstanding|0
886|NCT02641379|5299|P7|Overall Study|Therapy stopped due to misunderstanding|0
887|NCT02641379|5300|P6|Overall Study|Therapy stopped due to misunderstanding|0
888|NCT02641379|5301|P5|Overall Study|Therapy stopped due to misunderstanding|0
889|NCT02641379|5302|P4|Overall Study|Therapy stopped due to misunderstanding|0
890|NCT02641379|5303|P3|Overall Study|Therapy stopped due to misunderstanding|0
891|NCT02641379|5304|P2|Overall Study|Therapy stopped due to misunderstanding|0
892|NCT02641379|5305|P1|Overall Study|Therapy stopped due to misunderstanding|1
893|NCT02641379|5295|P11|Overall Study|Participant stopped study/treatment|0
894|NCT02641379|5296|P10|Overall Study|Participant stopped study/treatment|0
895|NCT02641379|5297|P9|Overall Study|Participant stopped study/treatment|1
896|NCT02641379|5298|P8|Overall Study|Participant stopped study/treatment|0
897|NCT02641379|5299|P7|Overall Study|Participant stopped study/treatment|2
898|NCT02641379|5300|P6|Overall Study|Participant stopped study/treatment|1
899|NCT02641379|5301|P5|Overall Study|Participant stopped study/treatment|0
900|NCT02641379|5302|P4|Overall Study|Participant stopped study/treatment|0
901|NCT02641379|5303|P3|Overall Study|Participant stopped study/treatment|1
902|NCT02641379|5304|P2|Overall Study|Participant stopped study/treatment|3
903|NCT02641379|5305|P1|Overall Study|Participant stopped study/treatment|1
904|NCT02641379|5295|P11|Overall Study|Participant showed relapse|0
905|NCT02641379|5296|P10|Overall Study|Participant showed relapse|0
906|NCT02641379|5297|P9|Overall Study|Participant showed relapse|0
907|NCT02641379|5298|P8|Overall Study|Participant showed relapse|0
908|NCT02641379|5299|P7|Overall Study|Participant showed relapse|1
909|NCT02641379|5300|P6|Overall Study|Participant showed relapse|0
910|NCT02641379|5301|P5|Overall Study|Participant showed relapse|0
911|NCT02641379|5302|P4|Overall Study|Participant showed relapse|0
912|NCT02641379|5303|P3|Overall Study|Participant showed relapse|0
913|NCT02641379|5304|P2|Overall Study|Participant showed relapse|0
914|NCT02641379|5305|P1|Overall Study|Participant showed relapse|1
915|NCT02641379|5295|P11|Overall Study|PCR positive at follow up 2|0
916|NCT02641379|5296|P10|Overall Study|PCR positive at follow up 2|0
917|NCT02641379|5297|P9|Overall Study|PCR positive at follow up 2|0
918|NCT02641379|5298|P8|Overall Study|PCR positive at follow up 2|0
919|NCT02641379|5299|P7|Overall Study|PCR positive at follow up 2|0
920|NCT02641379|5300|P6|Overall Study|PCR positive at follow up 2|0
921|NCT02641379|5301|P5|Overall Study|PCR positive at follow up 2|0
922|NCT02641379|5302|P4|Overall Study|PCR positive at follow up 2|0
923|NCT02641379|5303|P3|Overall Study|PCR positive at follow up 2|0
924|NCT02641379|5304|P2|Overall Study|PCR positive at follow up 2|0
925|NCT02641379|5305|P1|Overall Study|PCR positive at follow up 2|1
926|NCT02641379|5295|P11|Overall Study|PCR positive at Week 24|0
927|NCT02641379|5296|P10|Overall Study|PCR positive at Week 24|1
928|NCT02641379|5297|P9|Overall Study|PCR positive at Week 24|0
929|NCT02641379|5298|P8|Overall Study|PCR positive at Week 24|8
930|NCT02641379|5299|P7|Overall Study|PCR positive at Week 24|3
931|NCT02641379|5300|P6|Overall Study|PCR positive at Week 24|6
932|NCT02641379|5301|P5|Overall Study|PCR positive at Week 24|0
933|NCT02641379|5302|P4|Overall Study|PCR positive at Week 24|0
934|NCT02641379|5303|P3|Overall Study|PCR positive at Week 24|62
935|NCT02641379|5304|P2|Overall Study|PCR positive at Week 24|21
936|NCT02641379|5305|P1|Overall Study|PCR positive at Week 24|15
937|NCT02641379|5295|P11|Overall Study|Participant cannot be reached|1
938|NCT02641379|5296|P10|Overall Study|Participant cannot be reached|2
939|NCT02641379|5297|P9|Overall Study|Participant cannot be reached|0
940|NCT02641379|5298|P8|Overall Study|Participant cannot be reached|1
941|NCT02641379|5299|P7|Overall Study|Participant cannot be reached|0
942|NCT02641379|5300|P6|Overall Study|Participant cannot be reached|1
943|NCT02641379|5301|P5|Overall Study|Participant cannot be reached|2
944|NCT02641379|5302|P4|Overall Study|Participant cannot be reached|8
945|NCT02641379|5303|P3|Overall Study|Participant cannot be reached|0
946|NCT02641379|5304|P2|Overall Study|Participant cannot be reached|4
947|NCT02641379|5305|P1|Overall Study|Participant cannot be reached|4
948|NCT02641379|5295|P11|Overall Study|Participant’s compliance|1
949|NCT02641379|5296|P10|Overall Study|Participant’s compliance|1
950|NCT02641379|5297|P9|Overall Study|Participant’s compliance|1
951|NCT02641379|5298|P8|Overall Study|Participant’s compliance|0
952|NCT02641379|5299|P7|Overall Study|Participant’s compliance|0
953|NCT02641379|5300|P6|Overall Study|Participant’s compliance|2
954|NCT02641379|5301|P5|Overall Study|Participant’s compliance|0
955|NCT02641379|5302|P4|Overall Study|Participant’s compliance|1
956|NCT02641379|5303|P3|Overall Study|Participant’s compliance|0
957|NCT02641379|5304|P2|Overall Study|Participant’s compliance|1
958|NCT02641379|5305|P1|Overall Study|Participant’s compliance|0
959|NCT02641379|5295|P11|Overall Study|Participant unable to attend study visit|0
960|NCT02641379|5296|P10|Overall Study|Participant unable to attend study visit|2
961|NCT02641379|5297|P9|Overall Study|Participant unable to attend study visit|0
962|NCT02641379|5298|P8|Overall Study|Participant unable to attend study visit|1
963|NCT02641379|5299|P7|Overall Study|Participant unable to attend study visit|1
964|NCT02641379|5300|P6|Overall Study|Participant unable to attend study visit|1
965|NCT02641379|5301|P5|Overall Study|Participant unable to attend study visit|5
966|NCT02641379|5302|P4|Overall Study|Participant unable to attend study visit|2
967|NCT02641379|5303|P3|Overall Study|Participant unable to attend study visit|1
968|NCT02641379|5304|P2|Overall Study|Participant unable to attend study visit|10
969|NCT02641379|5305|P1|Overall Study|Participant unable to attend study visit|4
970|NCT02641379|5295|P11|Overall Study|Lack of Efficacy|0
971|NCT02641379|5296|P10|Overall Study|Lack of Efficacy|0
972|NCT02641379|5297|P9|Overall Study|Lack of Efficacy|0
973|NCT02641379|5298|P8|Overall Study|Lack of Efficacy|5
974|NCT02641379|5299|P7|Overall Study|Lack of Efficacy|0
975|NCT02641379|5300|P6|Overall Study|Lack of Efficacy|2
976|NCT02641379|5301|P5|Overall Study|Lack of Efficacy|0
977|NCT02641379|5302|P4|Overall Study|Lack of Efficacy|0
978|NCT02641379|5303|P3|Overall Study|Lack of Efficacy|2
979|NCT02641379|5304|P2|Overall Study|Lack of Efficacy|0
980|NCT02641379|5305|P1|Overall Study|Lack of Efficacy|0
981|NCT02641379|5295|P11|Overall Study|Adverse Event|5
982|NCT02641379|5296|P10|Overall Study|Adverse Event|1
983|NCT02641379|5297|P9|Overall Study|Adverse Event|1
984|NCT02641379|5298|P8|Overall Study|Adverse Event|0
985|NCT02641379|5299|P7|Overall Study|Adverse Event|5
986|NCT02641379|5300|P6|Overall Study|Adverse Event|1
987|NCT02641379|5301|P5|Overall Study|Adverse Event|5
988|NCT02641379|5302|P4|Overall Study|Adverse Event|2
989|NCT02641379|5303|P3|Overall Study|Adverse Event|2
990|NCT02641379|5304|P2|Overall Study|Adverse Event|8
991|NCT02641379|5305|P1|Overall Study|Adverse Event|7
992|NCT02641379|5295|P11|Overall Study|Withdrawal of informed consent|0
993|NCT02641379|5296|P10|Overall Study|Withdrawal of informed consent|0
994|NCT02641379|5297|P9|Overall Study|Withdrawal of informed consent|0
995|NCT02641379|5298|P8|Overall Study|Withdrawal of informed consent|1
996|NCT02641379|5299|P7|Overall Study|Withdrawal of informed consent|0
997|NCT02641379|5300|P6|Overall Study|Withdrawal of informed consent|0
998|NCT02641379|5301|P5|Overall Study|Withdrawal of informed consent|0
999|NCT02641379|5302|P4|Overall Study|Withdrawal of informed consent|0
1000|NCT02641379|5303|P3|Overall Study|Withdrawal of informed consent|0
1001|NCT02641379|5304|P2|Overall Study|Withdrawal of informed consent|1
1002|NCT02641379|5305|P1|Overall Study|Withdrawal of informed consent|0
1003|NCT02641379|5295|P11|Overall Study|Exclusion criterion during screening|0
1004|NCT02641379|5296|P10|Overall Study|Exclusion criterion during screening|0
1005|NCT02641379|5297|P9|Overall Study|Exclusion criterion during screening|0
1006|NCT02641379|5298|P8|Overall Study|Exclusion criterion during screening|0
1007|NCT02641379|5299|P7|Overall Study|Exclusion criterion during screening|0
1008|NCT02641379|5300|P6|Overall Study|Exclusion criterion during screening|0
1009|NCT02641379|5301|P5|Overall Study|Exclusion criterion during screening|2
1010|NCT02641379|5302|P4|Overall Study|Exclusion criterion during screening|1
1011|NCT02641379|5303|P3|Overall Study|Exclusion criterion during screening|0
1012|NCT02641379|5304|P2|Overall Study|Exclusion criterion during screening|0
1013|NCT02641379|5305|P1|Overall Study|Exclusion criterion during screening|1
1014|NCT02639052|5379|P1|Overall Study|Lost to Follow-up|1
1015|NCT02638493|5396|P3|Overall Study|Inability to provide semen samples|0
1016|NCT02638493|5397|P2|Overall Study|Inability to provide semen samples|0
1017|NCT02638493|5398|P1|Overall Study|Inability to provide semen samples|2
1018|NCT02638129|5429|P2|Overall Study|Study terminated|30
1019|NCT02638129|5430|P1|Overall Study|Study terminated|28
1020|NCT02637063|5458|P3|Overall Study|Withdrawal by Subject|3
1021|NCT02637063|5459|P2|Overall Study|Withdrawal by Subject|2
1022|NCT02637063|5460|P1|Overall Study|Withdrawal by Subject|2
1023|NCT02637063|5458|P3|Overall Study|Lost to Follow-up|3
1024|NCT02637063|5459|P2|Overall Study|Lost to Follow-up|2
1025|NCT02637063|5460|P1|Overall Study|Lost to Follow-up|3
1026|NCT02634788|5504|P4|Overall Study|Withdrawal by Subject|0
1027|NCT02634788|5505|P3|Overall Study|Withdrawal by Subject|1
1028|NCT02634788|5506|P2|Overall Study|Withdrawal by Subject|1
1029|NCT02634788|5507|P1|Overall Study|Withdrawal by Subject|0
1030|NCT02634788|5504|P4|Overall Study|Lost to Follow-up|0
1031|NCT02634788|5505|P3|Overall Study|Lost to Follow-up|0
1032|NCT02634788|5506|P2|Overall Study|Lost to Follow-up|1
1033|NCT02634788|5507|P1|Overall Study|Lost to Follow-up|0
1034|NCT02634788|5504|P4|Overall Study|Lack of Efficacy|4
1035|NCT02634788|5505|P3|Overall Study|Lack of Efficacy|1
1036|NCT02634788|5506|P2|Overall Study|Lack of Efficacy|0
1037|NCT02634788|5507|P1|Overall Study|Lack of Efficacy|4
1038|NCT02634788|5504|P4|Overall Study|Adverse Event|1
1039|NCT02634788|5505|P3|Overall Study|Adverse Event|3
1040|NCT02634788|5506|P2|Overall Study|Adverse Event|8
1041|NCT02634788|5507|P1|Overall Study|Adverse Event|0
1042|NCT02633787|5662|P1|Overall Study|Withdrawal by Subject|1
1043|NCT02633215|5670|P2|Overall Study|Lost to Follow-up|3
1044|NCT02633215|5671|P1|Overall Study|Lost to Follow-up|2
1045|NCT02630563|5702|P1|Overall Study|Administrative|1
1046|NCT02628938|5739|P3|Overall Study|Failure to comply with the instructions|3
1047|NCT02628938|5740|P2|Overall Study|Failure to comply with the instructions|0
1048|NCT02628938|5741|P1|Overall Study|Failure to comply with the instructions|3
1049|NCT02628938|5739|P3|Overall Study|Did not attend the follow up recall|1
1050|NCT02628938|5740|P2|Overall Study|Did not attend the follow up recall|2
1051|NCT02628938|5741|P1|Overall Study|Did not attend the follow up recall|2
1052|NCT02628418|5757|P2|Overall Study|Lost to Follow-up|2
1053|NCT02628418|5758|P1|Overall Study|Lost to Follow-up|1
1054|NCT02627144|5783|P1|Overall Study|Unspecified|17
1055|NCT02627144|5783|P1|Overall Study|Enrolled, not treated|6
1056|NCT02627144|5783|P1|Overall Study|Lost to Follow-up|8
1057|NCT02627144|5783|P1|Overall Study|Administrative reasons|65
1058|NCT02627144|5783|P1|Overall Study|Refusal of treatment / poor cooperation|38
1059|NCT02627144|5783|P1|Overall Study|Death from other cause|8
1060|NCT02627144|5783|P1|Overall Study|Death from cancer|20
1061|NCT02627144|5783|P1|Overall Study|Cancer progression|171
1062|NCT02627144|5783|P1|Overall Study|Serious adverse event|32
1063|NCT02625233|5817|P2|Overall Study|Adverse Event|0
1064|NCT02625233|5818|P1|Overall Study|Adverse Event|2
1065|NCT02625220|5826|P1|Overall Study|Study discontinued at site|2
1066|NCT02625220|5826|P1|Overall Study|Protocol Violation|1
1067|NCT02625220|5826|P1|Overall Study|Lost to Follow-up|2
1068|NCT02625220|5826|P1|Overall Study|Adverse Event|2
1069|NCT02624791|5926|P6|Overall Study|Withdrawal by Subject|0
1070|NCT02624791|5927|P5|Overall Study|Withdrawal by Subject|0
1071|NCT02624791|5928|P4|Overall Study|Withdrawal by Subject|0
1072|NCT02624791|5929|P3|Overall Study|Withdrawal by Subject|0
1073|NCT02624791|5930|P2|Overall Study|Withdrawal by Subject|0
1074|NCT02624791|5931|P1|Overall Study|Withdrawal by Subject|2
1075|NCT02621034|5939|P3|Overall Study|Lost to Follow-up|5
1076|NCT02621034|5940|P2|Overall Study|Lost to Follow-up|2
1077|NCT02621034|5941|P1|Overall Study|Lost to Follow-up|3
1078|NCT02619812|5958|P4|Overall Study|Withdrawal by Subject|2
1079|NCT02619812|5959|P3|Overall Study|Withdrawal by Subject|1
1080|NCT02619812|5960|P2|Overall Study|Withdrawal by Subject|0
1081|NCT02619812|5961|P1|Overall Study|Withdrawal by Subject|0
1082|NCT02613910|6204|P1|Overall Study|Termination of study|1
1083|NCT02612077|6253|P1|Overall Study|Unknown reason|2
1084|NCT02612077|6253|P1|Overall Study|Disease Progression|3
1085|NCT02612077|6253|P1|Overall Study|Enrollment in a Clinical Trial|1
1086|NCT02612077|6253|P1|Overall Study|Moved or Changed Medical Team|23
1087|NCT02612077|6253|P1|Overall Study|Death|377
1088|NCT02612077|6253|P1|Overall Study|Lost to Follow-up|20
1089|NCT02612077|6253|P1|Overall Study|Protocol Violation|28
1090|NCT02612077|6253|P1|Overall Study|Withdrawal by Subject|9
1091|NCT02612077|6253|P1|Overall Study|Adverse Event|3
1092|NCT02612064|6265|P2|Overall Study|Not Specified|2
1093|NCT02612064|6266|P1|Overall Study|Not Specified|0
1094|NCT02612064|6265|P2|Overall Study|Withdrawal by Subject|1
1095|NCT02612064|6266|P1|Overall Study|Withdrawal by Subject|1
1096|NCT02609672|6323|P2|Overall Study|Lost to Follow-up|1
1097|NCT02609672|6324|P1|Overall Study|Lost to Follow-up|3
1098|NCT02609178|6358|P6|First Crown|Withdrawal by Subject|0
1099|NCT02609178|6359|P5|First Crown|Withdrawal by Subject|0
1100|NCT02609178|6360|P4|First Crown|Withdrawal by Subject|1
1101|NCT02609178|6361|P3|First Crown|Withdrawal by Subject|1
1102|NCT02609178|6362|P2|First Crown|Withdrawal by Subject|0
1103|NCT02609178|6363|P1|First Crown|Withdrawal by Subject|0
1104|NCT02605928|6413|P1|Overall Study|Lack of Efficacy|5
1105|NCT02605928|6413|P1|Overall Study|Model tuning phase|28
1106|NCT02604589|6420|P3|Overall Study|catheter dislodgement|1
1107|NCT02604589|6421|P2|Overall Study|catheter dislodgement|0
1108|NCT02604589|6422|P1|Overall Study|catheter dislodgement|0
1109|NCT02604550|6450|P2|Overall Study|Incomplete data using paper journal|19
1110|NCT02604550|6451|P1|Overall Study|Incomplete data using paper journal|18
1111|NCT02604550|6450|P2|Overall Study|Withdrawal by Subject|1
1112|NCT02604550|6451|P1|Overall Study|Withdrawal by Subject|0
1113|NCT02604550|6450|P2|Overall Study|Lost to Follow-up|6
1114|NCT02604550|6451|P1|Overall Study|Lost to Follow-up|7
1115|NCT02604407|6478|P3|Overall Study|Unspecified|4
1116|NCT02604407|6479|P2|Overall Study|Unspecified|1
1117|NCT02604407|6480|P1|Overall Study|Unspecified|3
1118|NCT02604407|6478|P3|Overall Study|Lack of Efficacy|0
1119|NCT02604407|6479|P2|Overall Study|Lack of Efficacy|0
1120|NCT02604407|6480|P1|Overall Study|Lack of Efficacy|1
1121|NCT02604407|6478|P3|Overall Study|Lost to Follow-up|2
1122|NCT02604407|6479|P2|Overall Study|Lost to Follow-up|1
1123|NCT02604407|6480|P1|Overall Study|Lost to Follow-up|2
1124|NCT02604407|6478|P3|Overall Study|Withdrawal by Subject|5
1125|NCT02604407|6479|P2|Overall Study|Withdrawal by Subject|3
1126|NCT02604407|6480|P1|Overall Study|Withdrawal by Subject|3
1127|NCT02604407|6478|P3|Overall Study|Protocol Violation|0
1128|NCT02604407|6479|P2|Overall Study|Protocol Violation|0
1129|NCT02604407|6480|P1|Overall Study|Protocol Violation|2
1130|NCT02604407|6478|P3|Overall Study|Adverse Event|5
1131|NCT02604407|6479|P2|Overall Study|Adverse Event|7
1132|NCT02604407|6480|P1|Overall Study|Adverse Event|0
1133|NCT02604264|6493|P2|Overall Study|Had central venous catheter <21 days|242
1134|NCT02604264|6494|P1|Overall Study|Had central venous catheter <21 days|200
1135|NCT02598934|6522|P2|Overall Study|Protocol Violation|2
1136|NCT02598934|6523|P1|Overall Study|Protocol Violation|1
1137|NCT02598934|6522|P2|Overall Study|Administrative|1
1138|NCT02598934|6523|P1|Overall Study|Administrative|2
1139|NCT02598934|6522|P2|Overall Study|Withdrawal by Subject|3
1140|NCT02598934|6523|P1|Overall Study|Withdrawal by Subject|2
1141|NCT02598934|6522|P2|Overall Study|Failure to Return|3
1142|NCT02598934|6523|P1|Overall Study|Failure to Return|3
1143|NCT02598934|6522|P2|Overall Study|Adverse Event|13
1144|NCT02598934|6523|P1|Overall Study|Adverse Event|11
1145|NCT02598622|6535|P2|Overall Study|Physician Decision|0
1146|NCT02598622|6536|P1|Overall Study|Physician Decision|3
1147|NCT02598622|6535|P2|Overall Study|Withdrawal by Subject|0
1148|NCT02598622|6536|P1|Overall Study|Withdrawal by Subject|3
1149|NCT02598128|6542|P4|Period A: Days -7 to -1|Adverse Event|0
1150|NCT02598128|6543|P3|Period A: Days -7 to -1|Adverse Event|0
1151|NCT02598128|6544|P2|Period A: Days -7 to -1|Adverse Event|0
1152|NCT02598128|6545|P1|Period A: Days -7 to -1|Adverse Event|1
1153|NCT02597855|6568|P2|Overall Study|Lost to Follow-up|1
1154|NCT02597855|6569|P1|Overall Study|Lost to Follow-up|2
1155|NCT02596958|6615|P1|Overall Study|Excluded Due to Second Line Treatment|9
1156|NCT02596958|6615|P1|Overall Study|Missing|32
1157|NCT02596958|6615|P1|Overall Study|Lost to Follow-up|33
1158|NCT02596958|6615|P1|Overall Study|Administrative Reasons/Other|231
1159|NCT02596958|6615|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
1160|NCT02596958|6615|P1|Overall Study|Death From Other Cause|33
1161|NCT02596958|6615|P1|Overall Study|Death From Cancer|112
1162|NCT02596958|6615|P1|Overall Study|Cancer Progression|441
1163|NCT02596958|6615|P1|Overall Study|Serious Adverse Drug Reactions|44
1164|NCT02596945|6627|P1|Overall Study|Missing|1
1165|NCT02596945|6627|P1|Overall Study|Withdrawal by Subject|1
1166|NCT02596945|6627|P1|Overall Study|Other Erythropoietin stimulating agent|4
1167|NCT02596945|6627|P1|Overall Study|Change to hemodialysis|15
1168|NCT02596945|6627|P1|Overall Study|Unspecified|32
1169|NCT02596945|6627|P1|Overall Study|No documentation of study drug dosing|3
1170|NCT02596620|6635|P2|Overall Study|Lost to Follow-up|1
1171|NCT02596620|6636|P1|Overall Study|Lost to Follow-up|1
1172|NCT02595502|6654|P2|Period 3|Received Incorrect Treatment at period 3|1
1173|NCT02595502|6655|P1|Period 3|Received Incorrect Treatment at period 3|0
1174|NCT02595502|6654|P2|Period 3|Lost to Follow-up|0
1175|NCT02595502|6655|P1|Period 3|Lost to Follow-up|1
1176|NCT02595502|6654|P2|Period 3|Protocol Violation|1
1177|NCT02595502|6655|P1|Period 3|Protocol Violation|0
1178|NCT02595502|6654|P2|Period 2|Received incorrect lens at Period 1|1
1179|NCT02595502|6655|P1|Period 2|Received incorrect lens at Period 1|0
1180|NCT02595502|6654|P2|Period 2|Adverse Event|1
1181|NCT02595502|6655|P1|Period 2|Adverse Event|1
1182|NCT02595502|6654|P2|Period 1|Lost to Follow-up|1
1183|NCT02595502|6655|P1|Period 1|Lost to Follow-up|0
1184|NCT02595502|6654|P2|Period 1|Withdrawal by Subject|0
1185|NCT02595502|6655|P1|Period 1|Withdrawal by Subject|1
1186|NCT02595502|6654|P2|Period 1|Adverse Event|1
1187|NCT02595502|6655|P1|Period 1|Adverse Event|0
1188|NCT02595450|6661|P1|Overall Study|Enrolled, but not treated|8
1189|NCT02595450|6661|P1|Overall Study|Unspecified (only completed 1 cycle)|73
1190|NCT02591238|6697|P4|Overall Study|personal circumstances|0
1191|NCT02591238|6698|P3|Overall Study|personal circumstances|0
1192|NCT02591238|6699|P2|Overall Study|personal circumstances|1
1193|NCT02591238|6700|P1|Overall Study|personal circumstances|0
1194|NCT02591238|6697|P4|Overall Study|personal circumstances|1
1195|NCT02591238|6698|P3|Overall Study|personal circumstances|0
1196|NCT02591238|6699|P2|Overall Study|personal circumstances|0
1197|NCT02591238|6700|P1|Overall Study|personal circumstances|0
1198|NCT02591238|6697|P4|Overall Study|influenza|1
1199|NCT02591238|6698|P3|Overall Study|influenza|0
1200|NCT02591238|6699|P2|Overall Study|influenza|0
1201|NCT02591238|6700|P1|Overall Study|influenza|0
1202|NCT02591238|6697|P4|Overall Study|Withdrawal by Subject|1
1203|NCT02591238|6698|P3|Overall Study|Withdrawal by Subject|0
1204|NCT02591238|6699|P2|Overall Study|Withdrawal by Subject|0
1205|NCT02591238|6700|P1|Overall Study|Withdrawal by Subject|0
1206|NCT02591238|6697|P4|Overall Study|Pregnancy|0
1207|NCT02591238|6698|P3|Overall Study|Pregnancy|0
1208|NCT02591238|6699|P2|Overall Study|Pregnancy|0
1209|NCT02591238|6700|P1|Overall Study|Pregnancy|1
1210|NCT02590588|6734|P1|Overall Study|Adverse Event|1
1211|NCT02590562|6742|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
1212|NCT02587819|6821|P1|Overall Study|Lost to Follow-up|1
1213|NCT02587819|6821|P1|Overall Study|Adverse Event|1
1214|NCT02587234|6830|P2|Overall Study|Lost to Follow-up|2
1215|NCT02587234|6831|P1|Overall Study|Lost to Follow-up|0
1216|NCT02587234|6830|P2|Overall Study|Withdrawal by Subject|1
1217|NCT02587234|6831|P1|Overall Study|Withdrawal by Subject|1
1218|NCT02586506|6852|P1|Overall Study|Other Reason|2
1219|NCT02586506|6852|P1|Overall Study|Lost to Follow-up|1
1220|NCT02586506|6852|P1|Overall Study|Protocol Violation|6
1221|NCT02586493|6858|P1|Overall Study|Withdrawal by Subject|1
1222|NCT02586493|6858|P1|Overall Study|Lost to Follow-up|1
1223|NCT02586493|6858|P1|Overall Study|Protocol Violation|6
1224|NCT02586493|6858|P1|Overall Study|Adverse Event|4
1225|NCT02585999|6864|P1|Overall Study|Protocol Violation|1
1226|NCT02585999|6864|P1|Overall Study|Lost to Follow-up|1
1227|NCT02582983|6913|P1|Overall Study|Adverse Event|1
1228|NCT02582983|6913|P1|Overall Study|Withdrawal by Subject|2
1229|NCT02582983|6913|P1|Overall Study|Death|3
1230|NCT02580357|6968|P3|Overall Study|Protocol Violation|0
1231|NCT02580357|6969|P2|Overall Study|Protocol Violation|0
1232|NCT02580357|6970|P1|Overall Study|Protocol Violation|1
1233|NCT02580357|6968|P3|Overall Study|Lost to Follow-up|0
1234|NCT02580357|6969|P2|Overall Study|Lost to Follow-up|0
1235|NCT02580357|6970|P1|Overall Study|Lost to Follow-up|2
1236|NCT02580240|6983|P2|Overall Study|Physician Decision|0
1237|NCT02580240|6984|P1|Overall Study|Physician Decision|2
1238|NCT02578992|6994|P2|Overall Study|equipment not available or malfunction|3
1239|NCT02578992|6995|P1|Overall Study|equipment not available or malfunction|3
1240|NCT02578316|7007|P1|Extension Phase|Progression of disease|6
1241|NCT02578186|7036|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
1242|NCT02578186|7037|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
1243|NCT02578186|7036|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1244|NCT02578186|7037|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
1245|NCT02577315|7059|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
1246|NCT02577315|7060|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
1247|NCT02576639|7081|P5|Overall Study|Physician Decision|1
1248|NCT02576639|7082|P4|Overall Study|Physician Decision|0
1249|NCT02576639|7083|P3|Overall Study|Physician Decision|0
1250|NCT02576639|7084|P2|Overall Study|Physician Decision|0
1251|NCT02576639|7085|P1|Overall Study|Physician Decision|0
1252|NCT02576639|7081|P5|Overall Study|Adverse Event|2
1253|NCT02576639|7082|P4|Overall Study|Adverse Event|1
1254|NCT02576639|7083|P3|Overall Study|Adverse Event|1
1255|NCT02576639|7084|P2|Overall Study|Adverse Event|0
1256|NCT02576639|7085|P1|Overall Study|Adverse Event|1
1257|NCT02576639|7081|P5|Overall Study|Withdrawal by Subject|1
1258|NCT02576639|7082|P4|Overall Study|Withdrawal by Subject|0
1259|NCT02576639|7083|P3|Overall Study|Withdrawal by Subject|1
1260|NCT02576639|7084|P2|Overall Study|Withdrawal by Subject|2
1261|NCT02576639|7085|P1|Overall Study|Withdrawal by Subject|1
1262|NCT02576535|7142|P1|Overall Study|Withdrawal by Subject|2
1263|NCT02576145|7166|P2|Overall Study|Tetanus Titers Decreased|1
1264|NCT02576145|7167|P1|Overall Study|Tetanus Titers Decreased|0
1265|NCT02576145|7166|P2|Overall Study|Acute rejection|0
1266|NCT02576145|7167|P1|Overall Study|Acute rejection|1
1267|NCT02576145|7166|P2|Overall Study|Withdrawal by Subject|0
1268|NCT02576145|7167|P1|Overall Study|Withdrawal by Subject|1
1269|NCT02576145|7166|P2|Overall Study|Adverse Event|0
1270|NCT02576145|7167|P1|Overall Study|Adverse Event|1
1271|NCT02575911|7209|P1|Overall Study|Lost to Follow-up|1
1272|NCT02574845|7233|P6|Overall Study|Adverse Event|1
1273|NCT02574845|7234|P5|Overall Study|Adverse Event|0
1274|NCT02574845|7235|P4|Overall Study|Adverse Event|0
1275|NCT02574845|7236|P3|Overall Study|Adverse Event|0
1276|NCT02574845|7237|P2|Overall Study|Adverse Event|1
1277|NCT02574845|7238|P1|Overall Study|Adverse Event|0
1278|NCT02574845|7233|P6|Overall Study|Consent withdrawn further participation|0
1279|NCT02574845|7234|P5|Overall Study|Consent withdrawn further participation|1
1280|NCT02574845|7235|P4|Overall Study|Consent withdrawn further participation|0
1281|NCT02574845|7236|P3|Overall Study|Consent withdrawn further participation|0
1282|NCT02574845|7237|P2|Overall Study|Consent withdrawn further participation|0
1283|NCT02574845|7238|P1|Overall Study|Consent withdrawn further participation|0
1284|NCT02574260|7264|P1|Overall Study|Disease Progression|1
1285|NCT02573870|7272|P2|Overall Study|Other: Fail to Meet Visit|2
1286|NCT02573870|7273|P1|Overall Study|Other: Fail to Meet Visit|0
1287|NCT02573870|7272|P2|Overall Study|Lost to Follow-up|1
1288|NCT02573870|7273|P1|Overall Study|Lost to Follow-up|0
1289|NCT02573870|7272|P2|Overall Study|Other: Reached defined stopping criteria|1
1290|NCT02573870|7273|P1|Overall Study|Other: Reached defined stopping criteria|0
1291|NCT02573870|7272|P2|Overall Study|Lack of Efficacy|1
1292|NCT02573870|7273|P1|Overall Study|Lack of Efficacy|0
1293|NCT02573870|7272|P2|Overall Study|Adverse Event|2
1294|NCT02573870|7273|P1|Overall Study|Adverse Event|0
1295|NCT02570165|7440|P7|Overall Study|Withdrawal Request by GSK|0
1296|NCT02570165|7441|P6|Overall Study|Withdrawal Request by GSK|0
1297|NCT02570165|7442|P5|Overall Study|Withdrawal Request by GSK|0
1298|NCT02570165|7443|P4|Overall Study|Withdrawal Request by GSK|0
1299|NCT02570165|7444|P3|Overall Study|Withdrawal Request by GSK|2
1300|NCT02570165|7445|P2|Overall Study|Withdrawal Request by GSK|0
1301|NCT02570165|7446|P1|Overall Study|Withdrawal Request by GSK|0
1302|NCT02570165|7440|P7|Overall Study|Par. did not Meet Continuation Criteria|0
1303|NCT02570165|7441|P6|Overall Study|Par. did not Meet Continuation Criteria|1
1304|NCT02570165|7442|P5|Overall Study|Par. did not Meet Continuation Criteria|0
1305|NCT02570165|7443|P4|Overall Study|Par. did not Meet Continuation Criteria|0
1306|NCT02570165|7444|P3|Overall Study|Par. did not Meet Continuation Criteria|0
1307|NCT02570165|7445|P2|Overall Study|Par. did not Meet Continuation Criteria|0
1308|NCT02570165|7446|P1|Overall Study|Par. did not Meet Continuation Criteria|0
1309|NCT02570165|7440|P7|Overall Study|Withdrawal by Subject|0
1310|NCT02570165|7441|P6|Overall Study|Withdrawal by Subject|0
1311|NCT02570165|7442|P5|Overall Study|Withdrawal by Subject|1
1312|NCT02570165|7443|P4|Overall Study|Withdrawal by Subject|2
1313|NCT02570165|7444|P3|Overall Study|Withdrawal by Subject|0
1314|NCT02570165|7445|P2|Overall Study|Withdrawal by Subject|0
1315|NCT02570165|7446|P1|Overall Study|Withdrawal by Subject|0
1316|NCT02570165|7440|P7|Overall Study|Physician Decision|0
1317|NCT02570165|7441|P6|Overall Study|Physician Decision|0
1318|NCT02570165|7442|P5|Overall Study|Physician Decision|0
1319|NCT02570165|7443|P4|Overall Study|Physician Decision|0
1320|NCT02570165|7444|P3|Overall Study|Physician Decision|0
1321|NCT02570165|7445|P2|Overall Study|Physician Decision|1
1322|NCT02570165|7446|P1|Overall Study|Physician Decision|0
1323|NCT02570165|7440|P7|Overall Study|Lost to Follow-up|0
1324|NCT02570165|7441|P6|Overall Study|Lost to Follow-up|0
1325|NCT02570165|7442|P5|Overall Study|Lost to Follow-up|0
1326|NCT02570165|7443|P4|Overall Study|Lost to Follow-up|1
1327|NCT02570165|7444|P3|Overall Study|Lost to Follow-up|1
1328|NCT02570165|7445|P2|Overall Study|Lost to Follow-up|0
1329|NCT02570165|7446|P1|Overall Study|Lost to Follow-up|0
1330|NCT02570165|7440|P7|Overall Study|Par. Reached Stopping Criteria|0
1331|NCT02570165|7441|P6|Overall Study|Par. Reached Stopping Criteria|1
1332|NCT02570165|7442|P5|Overall Study|Par. Reached Stopping Criteria|1
1333|NCT02570165|7443|P4|Overall Study|Par. Reached Stopping Criteria|2
1334|NCT02570165|7444|P3|Overall Study|Par. Reached Stopping Criteria|0
1335|NCT02570165|7445|P2|Overall Study|Par. Reached Stopping Criteria|1
1336|NCT02570165|7446|P1|Overall Study|Par. Reached Stopping Criteria|1
1337|NCT02570165|7440|P7|Overall Study|Lack of Efficacy|0
1338|NCT02570165|7441|P6|Overall Study|Lack of Efficacy|0
1339|NCT02570165|7442|P5|Overall Study|Lack of Efficacy|4
1340|NCT02570165|7443|P4|Overall Study|Lack of Efficacy|0
1341|NCT02570165|7444|P3|Overall Study|Lack of Efficacy|0
1342|NCT02570165|7445|P2|Overall Study|Lack of Efficacy|1
1343|NCT02570165|7446|P1|Overall Study|Lack of Efficacy|0
1344|NCT02570165|7440|P7|Overall Study|Adverse Event|0
1345|NCT02570165|7441|P6|Overall Study|Adverse Event|0
1346|NCT02570165|7442|P5|Overall Study|Adverse Event|0
1347|NCT02570165|7443|P4|Overall Study|Adverse Event|0
1348|NCT02570165|7444|P3|Overall Study|Adverse Event|2
1349|NCT02570165|7445|P2|Overall Study|Adverse Event|0
1350|NCT02570165|7446|P1|Overall Study|Adverse Event|1
1351|NCT02569996|7480|P1|Overall Study|Unknown reason|1
1352|NCT02569996|7480|P1|Overall Study|Complete remission|7
1353|NCT02569996|7480|P1|Overall Study|Lost to Follow-up|5
1354|NCT02569996|7480|P1|Overall Study|Withdrawal by Subject|5
1355|NCT02569996|7480|P1|Overall Study|Non-compliance|9
1356|NCT02569996|7480|P1|Overall Study|New anti-lymphoma treatment|1
1357|NCT02569996|7480|P1|Overall Study|Progression of the disease|18
1358|NCT02569996|7480|P1|Overall Study|Physician Decision|3
1359|NCT02569996|7480|P1|Overall Study|Adverse Event|6
1360|NCT02568384|7548|P1|Overall Study|Mobile devices incompatible with App|2
1361|NCT02568254|7562|P6|Period 3|Unstatisfactory Lens fitting|0
1362|NCT02568254|7563|P5|Period 3|Unstatisfactory Lens fitting|1
1363|NCT02568254|7564|P4|Period 3|Unstatisfactory Lens fitting|0
1364|NCT02568254|7565|P3|Period 3|Unstatisfactory Lens fitting|0
1365|NCT02568254|7566|P2|Period 3|Unstatisfactory Lens fitting|0
1366|NCT02568254|7567|P1|Period 3|Unstatisfactory Lens fitting|0
1367|NCT02568254|7562|P6|Period 2|Adverse Event|0
1368|NCT02568254|7563|P5|Period 2|Adverse Event|0
1369|NCT02568254|7564|P4|Period 2|Adverse Event|0
1370|NCT02568254|7565|P3|Period 2|Adverse Event|1
1371|NCT02568254|7566|P2|Period 2|Adverse Event|0
1372|NCT02568254|7567|P1|Period 2|Adverse Event|0
1373|NCT02567188|7575|P1|Overall Study|Protocol Violation|5
1374|NCT02567188|7575|P1|Overall Study|Started Hemodialysis|2
1375|NCT02567188|7575|P1|Overall Study|Moved and Changed Clinic|1
1376|NCT02567188|7575|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
1377|NCT02567188|7575|P1|Overall Study|Withdrawal by Subject|1
1378|NCT02567188|7575|P1|Overall Study|Adverse Event|1
1379|NCT02567188|7575|P1|Overall Study|Lost to Follow-up|5
1380|NCT02567188|7575|P1|Overall Study|Terminated Mircera Treatment|9
1381|NCT02567188|7575|P1|Overall Study|Death|10
1382|NCT02565381|7638|P3|Overall Study|Lost to Follow-up|1
1383|NCT02565381|7639|P2|Overall Study|Lost to Follow-up|0
1384|NCT02565381|7640|P1|Overall Study|Lost to Follow-up|1
1385|NCT02561572|7732|P2|Overall Study|Protocol Violation|1
1386|NCT02561572|7733|P1|Overall Study|Protocol Violation|0
1387|NCT02561572|7732|P2|Overall Study|Inadequate time before surgery|1
1388|NCT02561572|7733|P1|Overall Study|Inadequate time before surgery|2
1389|NCT02559622|7753|P4|Overall Study|Patient/guardian decision|1
1390|NCT02559622|7754|P3|Overall Study|Patient/guardian decision|0
1391|NCT02559622|7755|P2|Overall Study|Patient/guardian decision|2
1392|NCT02559622|7756|P1|Overall Study|Patient/guardian decision|1
1393|NCT02559622|7753|P4|Overall Study|Adverse Event|2
1394|NCT02559622|7754|P3|Overall Study|Adverse Event|2
1395|NCT02559622|7755|P2|Overall Study|Adverse Event|2
1396|NCT02559622|7756|P1|Overall Study|Adverse Event|0
1397|NCT02559622|7753|P4|Overall Study|Progressive disease|0
1398|NCT02559622|7754|P3|Overall Study|Progressive disease|0
1399|NCT02559622|7755|P2|Overall Study|Progressive disease|1
1400|NCT02559622|7756|P1|Overall Study|Progressive disease|0
1401|NCT02557646|7902|P1|Overall Study|Unspecified|14
1402|NCT02557646|7902|P1|Overall Study|Lost to Follow-up|17
1403|NCT02557646|7902|P1|Overall Study|Withdrawal by Subject|18
1404|NCT02557646|7902|P1|Overall Study|Lack of Efficacy|186
1405|NCT02557646|7902|P1|Overall Study|Death|1
1406|NCT02557646|7902|P1|Overall Study|Adverse Event|40
1407|NCT02556307|7925|P1|Overall Study|Enrolled but not treated|2
1408|NCT02556307|7925|P1|Overall Study|Change to triple therapy|4
1409|NCT02556307|7925|P1|Overall Study|Lost to Follow-up|36
1410|NCT02556307|7925|P1|Overall Study|Premature treatment interruption|11
1411|NCT02555722|7937|P2|Month 2|Adverse Event|0
1412|NCT02555722|7938|P1|Month 2|Adverse Event|3
1413|NCT02555722|7937|P2|Month 1|Withdrawal by Subject|0
1414|NCT02555722|7938|P1|Month 1|Withdrawal by Subject|2
1415|NCT02555722|7937|P2|Week 2|Lens Discomfort|1
1416|NCT02555722|7938|P1|Week 2|Lens Discomfort|0
1417|NCT02555722|7937|P2|Week 1|Withdrawal by Subject|0
1418|NCT02555722|7938|P1|Week 1|Withdrawal by Subject|1
1419|NCT02555618|8098|P2|Overall Study|Sponsor's Circumstances|0
1420|NCT02555618|8099|P1|Overall Study|Sponsor's Circumstances|1
1421|NCT02554981|8156|P1|Overall Study|Other Miscellaneous Reasons|3
1422|NCT02554981|8156|P1|Overall Study|Administrative Reasons|1
1423|NCT02554981|8156|P1|Overall Study|Adverse Event|1
1424|NCT02554877|8184|P4|Overall Study|No longer willing to participate|0
1425|NCT02554877|8185|P3|Overall Study|No longer willing to participate|2
1426|NCT02554877|8186|P2|Overall Study|No longer willing to participate|2
1427|NCT02554877|8187|P1|Overall Study|No longer willing to participate|0
1428|NCT02554877|8184|P4|Overall Study|Insufficient clinical response|0
1429|NCT02554877|8185|P3|Overall Study|Insufficient clinical response|0
1430|NCT02554877|8186|P2|Overall Study|Insufficient clinical response|0
1431|NCT02554877|8187|P1|Overall Study|Insufficient clinical response|4
1432|NCT02554877|8184|P4|Overall Study|Unspecified|3
1433|NCT02554877|8185|P3|Overall Study|Unspecified|0
1434|NCT02554877|8186|P2|Overall Study|Unspecified|3
1435|NCT02554877|8187|P1|Overall Study|Unspecified|1
1436|NCT02554877|8184|P4|Overall Study|Protocol Violation|0
1437|NCT02554877|8185|P3|Overall Study|Protocol Violation|1
1438|NCT02554877|8186|P2|Overall Study|Protocol Violation|1
1439|NCT02554877|8187|P1|Overall Study|Protocol Violation|3
1440|NCT02554877|8184|P4|Overall Study|No longer met eligibility criteria|1
1441|NCT02554877|8185|P3|Overall Study|No longer met eligibility criteria|1
1442|NCT02554877|8186|P2|Overall Study|No longer met eligibility criteria|0
1443|NCT02554877|8187|P1|Overall Study|No longer met eligibility criteria|1
1444|NCT02554877|8184|P4|Overall Study|Did not meet entrance criteria|0
1445|NCT02554877|8185|P3|Overall Study|Did not meet entrance criteria|1
1446|NCT02554877|8186|P2|Overall Study|Did not meet entrance criteria|0
1447|NCT02554877|8187|P1|Overall Study|Did not meet entrance criteria|0
1448|NCT02554877|8184|P4|Overall Study|Lost to Follow-up|2
1449|NCT02554877|8185|P3|Overall Study|Lost to Follow-up|1
1450|NCT02554877|8186|P2|Overall Study|Lost to Follow-up|1
1451|NCT02554877|8187|P1|Overall Study|Lost to Follow-up|1
1452|NCT02554877|8184|P4|Overall Study|Adverse Event|1
1453|NCT02554877|8185|P3|Overall Study|Adverse Event|0
1454|NCT02554877|8186|P2|Overall Study|Adverse Event|0
1455|NCT02554877|8187|P1|Overall Study|Adverse Event|2
1456|NCT02553629|8251|P2|Overall Study|Logistic reasons|6
1457|NCT02553629|8252|P1|Overall Study|Logistic reasons|3
1458|NCT02553421|8276|P2|Overall Study|Improper Device Placement|0
1459|NCT02553421|8277|P1|Overall Study|Improper Device Placement|3
1460|NCT02553421|8276|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
1461|NCT02553421|8277|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
1462|NCT02553421|8276|P2|Overall Study|Lost to Follow-up|1
1463|NCT02553421|8277|P1|Overall Study|Lost to Follow-up|21
1464|NCT02552303|8308|P4|Follow-Up|ineligible|0
1465|NCT02552303|8309|P3|Follow-Up|ineligible|0
1466|NCT02552303|8310|P2|Follow-Up|ineligible|2
1467|NCT02552303|8311|P1|Follow-Up|ineligible|0
1468|NCT02552303|8308|P4|Follow-Up|Lost to Follow-up|0
1469|NCT02552303|8309|P3|Follow-Up|Lost to Follow-up|1
1470|NCT02552303|8310|P2|Follow-Up|Lost to Follow-up|0
1471|NCT02552303|8311|P1|Follow-Up|Lost to Follow-up|0
1472|NCT02552303|8308|P4|Allocation|ineligible|0
1473|NCT02552303|8309|P3|Allocation|ineligible|0
1474|NCT02552303|8310|P2|Allocation|ineligible|1
1475|NCT02552303|8311|P1|Allocation|ineligible|1
1476|NCT02552303|8308|P4|Allocation|Withdrawal by Subject|1
1477|NCT02552303|8309|P3|Allocation|Withdrawal by Subject|1
1478|NCT02552303|8310|P2|Allocation|Withdrawal by Subject|1
1479|NCT02552303|8311|P1|Allocation|Withdrawal by Subject|2
1480|NCT02550288|8346|P5|Overall Study|Withdrawal by Subject|0
1481|NCT02550288|8347|P4|Overall Study|Withdrawal by Subject|1
1482|NCT02550288|8348|P3|Overall Study|Withdrawal by Subject|0
1483|NCT02550288|8349|P2|Overall Study|Withdrawal by Subject|0
1484|NCT02550288|8350|P1|Overall Study|Withdrawal by Subject|0
1485|NCT02550288|8346|P5|Overall Study|Participant moved|0
1486|NCT02550288|8347|P4|Overall Study|Participant moved|1
1487|NCT02550288|8348|P3|Overall Study|Participant moved|0
1488|NCT02550288|8349|P2|Overall Study|Participant moved|0
1489|NCT02550288|8350|P1|Overall Study|Participant moved|0
1490|NCT02550288|8346|P5|Overall Study|Protocol Violation|3
1491|NCT02550288|8347|P4|Overall Study|Protocol Violation|0
1492|NCT02550288|8348|P3|Overall Study|Protocol Violation|1
1493|NCT02550288|8349|P2|Overall Study|Protocol Violation|2
1494|NCT02550288|8350|P1|Overall Study|Protocol Violation|2
1495|NCT02550288|8346|P5|Overall Study|Physician Decision|0
1496|NCT02550288|8347|P4|Overall Study|Physician Decision|1
1497|NCT02550288|8348|P3|Overall Study|Physician Decision|0
1498|NCT02550288|8349|P2|Overall Study|Physician Decision|0
1499|NCT02550288|8350|P1|Overall Study|Physician Decision|0
1500|NCT02550288|8346|P5|Overall Study|Adverse Event|0
1501|NCT02550288|8347|P4|Overall Study|Adverse Event|0
1502|NCT02550288|8348|P3|Overall Study|Adverse Event|0
1503|NCT02550288|8349|P2|Overall Study|Adverse Event|1
1504|NCT02550288|8350|P1|Overall Study|Adverse Event|0
1505|NCT02549027|8499|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1506|NCT02549027|8500|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
1593|NCT02538107|9183|P1|Overall Study|Withdrawal by Subject|17
1507|NCT02549027|8501|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1508|NCT02549027|8502|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1509|NCT02549027|8503|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1510|NCT02549027|8504|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
1511|NCT02549027|8499|P6|Washout After Period 4|Withdrawal by Subject|0
1512|NCT02549027|8500|P5|Washout After Period 4|Withdrawal by Subject|0
1513|NCT02549027|8501|P4|Washout After Period 4|Withdrawal by Subject|1
1514|NCT02549027|8502|P3|Washout After Period 4|Withdrawal by Subject|1
1515|NCT02549027|8503|P2|Washout After Period 4|Withdrawal by Subject|1
1516|NCT02549027|8504|P1|Washout After Period 4|Withdrawal by Subject|0
1517|NCT02548156|8632|P6|Washout Period 1|Lost to Follow-up|0
1518|NCT02548156|8633|P5|Washout Period 1|Lost to Follow-up|1
1519|NCT02548156|8634|P4|Washout Period 1|Lost to Follow-up|0
1520|NCT02548156|8635|P3|Washout Period 1|Lost to Follow-up|0
1521|NCT02548156|8636|P2|Washout Period 1|Lost to Follow-up|0
1522|NCT02548156|8637|P1|Washout Period 1|Lost to Follow-up|0
1523|NCT02547454|8664|P1|Overall Study|No data|11
1524|NCT02547454|8664|P1|Overall Study|Unspecified|39
1525|NCT02547454|8664|P1|Overall Study|Lost to Follow-up|26
1526|NCT02547454|8664|P1|Overall Study|Death|38
1527|NCT02547454|8664|P1|Overall Study|Due to no further need to treat|4
1528|NCT02547454|8664|P1|Overall Study|Due to transplantation|1
1529|NCT02547454|8664|P1|Overall Study|Due to hemodialysis|53
1530|NCT02545543|8723|P2|Overall Study|Enrolment of subject at >1 study site|1
1531|NCT02545543|8724|P1|Overall Study|Enrolment of subject at >1 study site|1
1532|NCT02545543|8723|P2|Overall Study|Noncomplaince|0
1533|NCT02545543|8724|P1|Overall Study|Noncomplaince|1
1534|NCT02545543|8723|P2|Overall Study|Withdrawal by Subject|8
1535|NCT02545543|8724|P1|Overall Study|Withdrawal by Subject|9
1536|NCT02545543|8723|P2|Overall Study|Physician Decision|0
1537|NCT02545543|8724|P1|Overall Study|Physician Decision|3
1538|NCT02545543|8723|P2|Overall Study|Lost to Follow-up|25
1539|NCT02545543|8724|P1|Overall Study|Lost to Follow-up|67
1540|NCT02545322|8748|P1|Overall Study|Withdrawal by Subject|3
1541|NCT02543918|8755|P2|Overall Study|Adverse Event|1
1542|NCT02543918|8756|P1|Overall Study|Adverse Event|1
1543|NCT02543918|8755|P2|Overall Study|Withdrawal by Subject|1
1544|NCT02543918|8756|P1|Overall Study|Withdrawal by Subject|1
1545|NCT02543918|8755|P2|Overall Study|Lost to Follow-up|1
1546|NCT02543918|8756|P1|Overall Study|Lost to Follow-up|1
1547|NCT02543918|8755|P2|Overall Study|Never treated|1
1548|NCT02543918|8756|P1|Overall Study|Never treated|0
1549|NCT02542943|8770|P3|Overall Study|Withdrawal by Subject|0
1550|NCT02542943|8771|P2|Overall Study|Withdrawal by Subject|1
1551|NCT02542943|8772|P1|Overall Study|Withdrawal by Subject|0
1552|NCT02542943|8770|P3|Overall Study|Lost to Follow-up|0
1553|NCT02542943|8771|P2|Overall Study|Lost to Follow-up|0
1554|NCT02542943|8772|P1|Overall Study|Lost to Follow-up|1
1555|NCT02542072|8808|P2|Second Intervention (1 Month)|Lens discomfort|0
1556|NCT02542072|8809|P1|Second Intervention (1 Month)|Lens discomfort|1
1557|NCT02542072|8808|P2|Second Intervention (1 Month)|Lost to Follow-up|0
1558|NCT02542072|8809|P1|Second Intervention (1 Month)|Lost to Follow-up|1
1559|NCT02542072|8808|P2|First Intervention (1 Month)|Protocol Violation|0
1560|NCT02542072|8809|P1|First Intervention (1 Month)|Protocol Violation|1
1561|NCT02542072|8808|P2|First Intervention (1 Month)|Lens discomfort|2
1562|NCT02542072|8809|P1|First Intervention (1 Month)|Lens discomfort|1
1563|NCT02542072|8808|P2|First Intervention (1 Month)|Lost to Follow-up|0
1564|NCT02542072|8809|P1|First Intervention (1 Month)|Lost to Follow-up|2
1565|NCT02542072|8808|P2|First Intervention (1 Month)|Adverse Event|1
1566|NCT02542072|8809|P1|First Intervention (1 Month)|Adverse Event|1
1567|NCT02540850|8921|P3|Overall Study|Lost to Follow-up|34
1568|NCT02540850|8922|P2|Overall Study|Lost to Follow-up|66
1569|NCT02540850|8923|P1|Overall Study|Lost to Follow-up|69
1570|NCT02540356|8994|P2|Overall Study|Terminated due to disease progression|0
1571|NCT02540356|8995|P1|Overall Study|Terminated due to disease progression|1
1572|NCT02540265|9029|P3|Overall Study|Lost to Follow-up|1
1573|NCT02540265|9030|P2|Overall Study|Lost to Follow-up|0
1574|NCT02540265|9031|P1|Overall Study|Lost to Follow-up|0
1575|NCT02540213|9051|P1|Overall Study|Enrolled but not treated|2
1576|NCT02540213|9051|P1|Overall Study|Consent withdrawn|7
1577|NCT02540213|9051|P1|Overall Study|Lack of Efficacy|6
1578|NCT02540213|9051|P1|Overall Study|Kidney transplant|3
1579|NCT02540213|9051|P1|Overall Study|Administrative reasons|3
1580|NCT02540213|9051|P1|Overall Study|Death/adverse event|18
1581|NCT02539134|9109|P6|Overall Study|Lost to Follow-up|0
1582|NCT02539134|9110|P5|Overall Study|Lost to Follow-up|0
1583|NCT02539134|9111|P4|Overall Study|Lost to Follow-up|0
1584|NCT02539134|9112|P3|Overall Study|Lost to Follow-up|0
1585|NCT02539134|9113|P2|Overall Study|Lost to Follow-up|0
1586|NCT02539134|9114|P1|Overall Study|Lost to Follow-up|1
1587|NCT02538107|9183|P1|Overall Study|Not recorded|7
1588|NCT02538107|9183|P1|Overall Study|Unspecified|7
1589|NCT02538107|9183|P1|Overall Study|Surgery|1
1590|NCT02538107|9183|P1|Overall Study|Adverse Event|4
1591|NCT02538107|9183|P1|Overall Study|Administrative reason|5
1592|NCT02538107|9183|P1|Overall Study|Death|4
1594|NCT02538107|9183|P1|Overall Study|No further treatment necessary|18
1595|NCT02538107|9183|P1|Overall Study|Administration of other ESA|11
1596|NCT02538107|9183|P1|Overall Study|Necessity of dialysis|20
1597|NCT02538107|9183|P1|Overall Study|Missing|5
1598|NCT02538107|9183|P1|Overall Study|Did not receive any Mircera dose|11
1599|NCT02537522|9216|P4|Phase II - Period 1 Bilateral|Adverse Event|1
1600|NCT02537522|9217|P3|Phase II - Period 1 Bilateral|Adverse Event|0
1601|NCT02537522|9218|P2|Phase II - Period 1 Bilateral|Adverse Event|0
1602|NCT02537522|9219|P1|Phase II - Period 1 Bilateral|Adverse Event|0
1603|NCT02537522|9216|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
1604|NCT02537522|9217|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
1605|NCT02537522|9218|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
1606|NCT02537522|9219|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
1607|NCT02537522|9216|P4|Phase I - Contralateral|incorrect randomization|0
1608|NCT02537522|9217|P3|Phase I - Contralateral|incorrect randomization|0
1609|NCT02537522|9218|P2|Phase I - Contralateral|incorrect randomization|1
1610|NCT02537522|9219|P1|Phase I - Contralateral|incorrect randomization|0
1611|NCT02537522|9216|P4|Phase I - Contralateral|Withdrawal by Subject|0
1612|NCT02537522|9217|P3|Phase I - Contralateral|Withdrawal by Subject|0
1613|NCT02537522|9218|P2|Phase I - Contralateral|Withdrawal by Subject|1
1614|NCT02537522|9219|P1|Phase I - Contralateral|Withdrawal by Subject|0
1615|NCT02537522|9216|P4|Phase I - Contralateral|Subject no longer eligible|0
1616|NCT02537522|9217|P3|Phase I - Contralateral|Subject no longer eligible|0
1617|NCT02537522|9218|P2|Phase I - Contralateral|Subject no longer eligible|7
1618|NCT02537522|9219|P1|Phase I - Contralateral|Subject no longer eligible|15
1619|NCT02536781|9229|P2|Overall Study|Lost to Follow-up|0
1620|NCT02536781|9230|P1|Overall Study|Lost to Follow-up|2
1621|NCT02536664|9240|P2|Overall Study|Missing|20
1622|NCT02536664|9241|P1|Overall Study|Missing|53
1623|NCT02536664|9240|P2|Overall Study|Unspecified|24
1624|NCT02536664|9241|P1|Overall Study|Unspecified|18
1625|NCT02536664|9240|P2|Overall Study|Withdrawal by Subject|5
1626|NCT02536664|9241|P1|Overall Study|Withdrawal by Subject|8
1627|NCT02536664|9240|P2|Overall Study|Intolerability|6
1628|NCT02536664|9241|P1|Overall Study|Intolerability|8
1629|NCT02536664|9240|P2|Overall Study|Death due to other reason|2
1630|NCT02536664|9241|P1|Overall Study|Death due to other reason|3
1631|NCT02536664|9240|P2|Overall Study|Death due to lymphoma|1
1632|NCT02536664|9241|P1|Overall Study|Death due to lymphoma|2
1633|NCT02536664|9240|P2|Overall Study|Progression|18
1634|NCT02536664|9241|P1|Overall Study|Progression|13
1635|NCT02536664|9240|P2|Overall Study|Inadequate completion of documentation|4
1636|NCT02536664|9241|P1|Overall Study|Inadequate completion of documentation|2
1637|NCT02535741|9259|P1|Overall Study|Missing data|6
1638|NCT02535741|9259|P1|Overall Study|Exclusion criteria: Bilateral implant|4
1639|NCT02535741|9259|P1|Overall Study|Lost to Follow-up|10
1640|NCT02535741|9259|P1|Overall Study|Withdrawal by Subject|9
1641|NCT02535741|9259|P1|Overall Study|Adverse Event|3
1642|NCT02534324|9317|P2|Overall Study|Adverse Event|0
1643|NCT02534324|9318|P1|Overall Study|Adverse Event|1
1644|NCT02534324|9317|P2|Overall Study|Lost to Follow-up|7
1645|NCT02534324|9318|P1|Overall Study|Lost to Follow-up|20
1646|NCT02534324|9317|P2|Overall Study|Protocol Violation|1
1647|NCT02534324|9318|P1|Overall Study|Protocol Violation|4
1648|NCT02533401|9355|P1|Overall Study|Violation of Selection Criteria|1
1649|NCT02533401|9355|P1|Overall Study|Lost to Follow-up|1
1650|NCT02533401|9355|P1|Overall Study|Insufficient Response/Progressed Disease|1
1651|NCT02533401|9355|P1|Overall Study|Death|5
1652|NCT02533401|9355|P1|Overall Study|Adverse Event/Intercurrent Disease|3
1653|NCT02532374|9445|P1|Overall Study|Physician Decision|1
1654|NCT02532374|9445|P1|Overall Study|Withdrawal by Subject|1
1655|NCT02531646|9476|P3|Overall Study|equip. image processing issue|0
1656|NCT02531646|9477|P2|Overall Study|equip. image processing issue|1
1657|NCT02531646|9478|P1|Overall Study|equip. image processing issue|5
1658|NCT02530671|9498|P2|Overall Study|Withdrawal by Subject|0
1659|NCT02530671|9499|P1|Overall Study|Withdrawal by Subject|1
1660|NCT02530671|9498|P2|Overall Study|Lost to Follow-up|0
1661|NCT02530671|9499|P1|Overall Study|Lost to Follow-up|2
1662|NCT02529995|9526|P2|Part A|Discontinued Study|0
1663|NCT02529995|9527|P1|Part A|Discontinued Study|1
1664|NCT02529995|9526|P2|Part A|Ongoing Study at Data Cut-off|16
1665|NCT02529995|9527|P1|Part A|Ongoing Study at Data Cut-off|14
1666|NCT02528331|9574|P1|Overall Study|Withdrawal by Subject|2
1667|NCT02527161|9592|P1|Overall Study|Consent violation|4
1668|NCT02527161|9592|P1|Overall Study|MRI contraindication|2
1669|NCT02527161|9592|P1|Overall Study|Delay in or unfit for surgery|5
1670|NCT02527161|9592|P1|Overall Study|Exclusion RA diagnosis|1
1671|NCT02527161|9592|P1|Overall Study|Exclusion for excessive deformity|1
1672|NCT02527161|9592|P1|Overall Study|Exclusion for BMI|2
1673|NCT02527161|9592|P1|Overall Study|Shape Match not used in surgery|2
1674|NCT02527161|9592|P1|Overall Study|Withdrawal by Subject|6
1675|NCT02527161|9592|P1|Overall Study|Failed MRI|39
1676|NCT02527148|9611|P2|Overall Study|Did not receive study intervention|0
1677|NCT02527148|9612|P1|Overall Study|Did not receive study intervention|1
1678|NCT02526550|9630|P1|Overall Study|Lost to Follow-up|1
1679|NCT02524665|9712|P1|Overall Study|Lost to Follow-up|1
1680|NCT02522624|9765|P2|Overall Study|Technical failure|0
1681|NCT02522624|9766|P1|Overall Study|Technical failure|1
1682|NCT02519855|9788|P2|Overall Study|Lost to Follow-up|3
1683|NCT02519855|9789|P1|Overall Study|Lost to Follow-up|3
1684|NCT02519855|9788|P2|Overall Study|Adverse Event|1
1685|NCT02519855|9789|P1|Overall Study|Adverse Event|0
1686|NCT02519595|9808|P3|Overall Study|Protocol Violation|16
1687|NCT02519595|9809|P2|Overall Study|Protocol Violation|22
1688|NCT02519595|9810|P1|Overall Study|Protocol Violation|8
1689|NCT02518048|9841|P1|Overall Study|Withdrawal by Subject|1
1690|NCT02516306|9854|P2|Period 2: Day 8 - 91|Protocol Violation|2
1691|NCT02516306|9855|P1|Period 2: Day 8 - 91|Protocol Violation|1
1692|NCT02516163|9861|P1|Overall Study|MRI contraindication exclusion|6
1693|NCT02516163|9861|P1|Overall Study|Data not recorded|2
1694|NCT02516163|9861|P1|Overall Study|Use of incorrect measurement technique|5
1695|NCT02516163|9861|P1|Overall Study|Unfit/delay in surgery|3
1696|NCT02516163|9861|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
1697|NCT02516163|9861|P1|Overall Study|Withdrawal by Subject|1
1698|NCT02516098|9875|P2|Period 2|Withdrawal by Subject|1
1699|NCT02516098|9876|P1|Period 2|Withdrawal by Subject|0
1700|NCT02516098|9875|P2|Washout After Period 1|Adverse Event|1
1701|NCT02516098|9876|P1|Washout After Period 1|Adverse Event|0
1702|NCT02516098|9875|P2|Period 1|Protocol Violation|0
1703|NCT02516098|9876|P1|Period 1|Protocol Violation|1
1704|NCT02515994|9890|P2|Overall Study|Withdrawal by Subject|0
1705|NCT02515994|9891|P1|Overall Study|Withdrawal by Subject|2
1706|NCT02515994|9890|P2|Overall Study|Adverse Event|1
1707|NCT02515994|9891|P1|Overall Study|Adverse Event|3
1708|NCT02515994|9890|P2|Overall Study|No Longer Meets Eligibility Criteria|1
1709|NCT02515994|9891|P1|Overall Study|No Longer Meets Eligibility Criteria|2
1710|NCT02515994|9890|P2|Overall Study|Protocol Violation|5
1711|NCT02515994|9891|P1|Overall Study|Protocol Violation|3
1712|NCT02515279|9903|P1|Overall Study|Unspecified|22
1713|NCT02515279|9903|P1|Overall Study|End-of-treatment visit not attended|17
1714|NCT02515279|9903|P1|Overall Study|Withdrawal by Subject|18
1715|NCT02515279|9903|P1|Overall Study|Lost to Follow-up|9
1716|NCT02515279|9903|P1|Overall Study|Lack of Efficacy|31
1717|NCT02515279|9903|P1|Overall Study|Adverse Event|7
1718|NCT02515045|9911|P3|Overall Study|Lost to Follow-up|1
1719|NCT02515045|9912|P2|Overall Study|Lost to Follow-up|1
1720|NCT02515045|9913|P1|Overall Study|Lost to Follow-up|0
1721|NCT02515045|9911|P3|Overall Study|Adverse Event|3
1722|NCT02515045|9912|P2|Overall Study|Adverse Event|3
1723|NCT02515045|9913|P1|Overall Study|Adverse Event|0
1724|NCT02513095|9929|P2|Overall Study|Stampede resulted in transfers out of ER|16
1725|NCT02513095|9930|P1|Overall Study|Stampede resulted in transfers out of ER|14
1726|NCT02511782|10095|P3|Overall Study|Withdrawal by Subject|0
1727|NCT02511782|10096|P2|Overall Study|Withdrawal by Subject|0
1728|NCT02511782|10097|P1|Overall Study|Withdrawal by Subject|1
1729|NCT02510820|10107|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
1730|NCT02510820|10108|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
1731|NCT02510820|10107|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
1732|NCT02510820|10108|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
1733|NCT02507752|10157|P1|Overall Study|Participant didn't perform visit Week 24|1
1734|NCT02507752|10157|P1|Overall Study|Participant didn't perform visit Week 12|1
1735|NCT02507752|10157|P1|Overall Study|Infusion reaction at first infusion|1
1736|NCT02507752|10157|P1|Overall Study|Lost to Follow-up|7
1737|NCT02507752|10157|P1|Overall Study|Protocol Violation|6
1738|NCT02507752|10157|P1|Overall Study|Adverse Event|1
1739|NCT02507375|10177|P2|Overall Study|Adverse Event|1
1740|NCT02507375|10178|P1|Overall Study|Adverse Event|0
1741|NCT02507375|10177|P2|Overall Study|Refused treatment|1
1742|NCT02507375|10178|P1|Overall Study|Refused treatment|0
1743|NCT02507375|10177|P2|Overall Study|Death|1
1744|NCT02507375|10178|P1|Overall Study|Death|0
1745|NCT02507375|10177|P2|Overall Study|Progressive Disease|5
1746|NCT02507375|10178|P1|Overall Study|Progressive Disease|4
1747|NCT02506881|10199|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
1748|NCT02506881|10200|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
1749|NCT02506881|10201|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
1750|NCT02506881|10202|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
1751|NCT02506881|10199|P4|First Intervention (Day 1)|Withdrawal by Subject|0
1752|NCT02506881|10200|P3|First Intervention (Day 1)|Withdrawal by Subject|0
1753|NCT02506881|10201|P2|First Intervention (Day 1)|Withdrawal by Subject|0
1754|NCT02506881|10202|P1|First Intervention (Day 1)|Withdrawal by Subject|1
1755|NCT02506881|10199|P4|First Intervention (Day 1)|Protocol Violation|0
1756|NCT02506881|10200|P3|First Intervention (Day 1)|Protocol Violation|1
1757|NCT02506881|10201|P2|First Intervention (Day 1)|Protocol Violation|0
1758|NCT02506881|10202|P1|First Intervention (Day 1)|Protocol Violation|0
1759|NCT02506257|10255|P4|Overall Study|Protocol Violation|0
1760|NCT02506257|10256|P3|Overall Study|Protocol Violation|1
1761|NCT02506257|10257|P2|Overall Study|Protocol Violation|0
1762|NCT02506257|10258|P1|Overall Study|Protocol Violation|0
1763|NCT02506257|10255|P4|Overall Study|Adverse Event|0
1764|NCT02506257|10256|P3|Overall Study|Adverse Event|3
1765|NCT02506257|10257|P2|Overall Study|Adverse Event|2
1766|NCT02506257|10258|P1|Overall Study|Adverse Event|0
1767|NCT02504502|10318|P2|Crossover to Enhanced Report|Lost to Follow-up|0
1768|NCT02504502|10319|P1|Crossover to Enhanced Report|Lost to Follow-up|5
1769|NCT02504502|10318|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
1770|NCT02504502|10319|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
1771|NCT02504320|10329|P4|Treatment Period 3|Adverse Event|0
1772|NCT02504320|10330|P3|Treatment Period 3|Adverse Event|1
1773|NCT02504320|10331|P2|Treatment Period 3|Adverse Event|0
1774|NCT02504320|10332|P1|Treatment Period 3|Adverse Event|0
1775|NCT02504320|10329|P4|Treatment Period 3|Positive Drug Screen|1
1776|NCT02504320|10330|P3|Treatment Period 3|Positive Drug Screen|0
1777|NCT02504320|10331|P2|Treatment Period 3|Positive Drug Screen|0
1778|NCT02504320|10332|P1|Treatment Period 3|Positive Drug Screen|0
1779|NCT02504320|10329|P4|Treatment Period 2|Positive Drug Screen|0
1780|NCT02504320|10330|P3|Treatment Period 2|Positive Drug Screen|0
1781|NCT02504320|10331|P2|Treatment Period 2|Positive Drug Screen|1
1782|NCT02504320|10332|P1|Treatment Period 2|Positive Drug Screen|0
1783|NCT02504320|10329|P4|Treatment Period 1|Positive Drug Screen|0
1784|NCT02504320|10330|P3|Treatment Period 1|Positive Drug Screen|1
1785|NCT02504320|10331|P2|Treatment Period 1|Positive Drug Screen|0
1786|NCT02504320|10332|P1|Treatment Period 1|Positive Drug Screen|0
1787|NCT02503865|10363|P3|Overall Study|Refused treatment|2
1788|NCT02503865|10364|P2|Overall Study|Refused treatment|39
1789|NCT02503865|10365|P1|Overall Study|Refused treatment|4
1790|NCT02503865|10363|P3|Overall Study|Moved out of area|0
1791|NCT02503865|10364|P2|Overall Study|Moved out of area|8
1792|NCT02503865|10365|P1|Overall Study|Moved out of area|1
1793|NCT02503215|10401|P1|Overall Study|Unable to use positive airway pressure|2
1794|NCT02503215|10401|P1|Overall Study|Unable to wear compression stockings|1
1795|NCT02502734|10407|P2|Washout Period|Adverse Event|0
1796|NCT02502734|10408|P1|Washout Period|Adverse Event|1
1797|NCT02502734|10407|P2|Double-blind Treatment Period 1|Adverse Event|0
1798|NCT02502734|10408|P1|Double-blind Treatment Period 1|Adverse Event|1
1799|NCT02500758|10514|P2|Second Intervention (2 Minutes)|Protocol Violation|1
1800|NCT02500758|10515|P1|Second Intervention (2 Minutes)|Protocol Violation|1
1801|NCT02500758|10514|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
1802|NCT02500758|10515|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
1803|NCT02500758|10514|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
1804|NCT02500758|10515|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
1805|NCT02500758|10514|P2|Washout (1 Week)|Lost to Follow-up|2
1806|NCT02500758|10515|P1|Washout (1 Week)|Lost to Follow-up|2
1807|NCT02500758|10514|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
1808|NCT02500758|10515|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
1809|NCT02500537|10525|P2|Overall Study|Withdrawal by Subject|0
1810|NCT02500537|10526|P1|Overall Study|Withdrawal by Subject|1
1811|NCT02500537|10525|P2|Overall Study|Lost to Follow-up|1
1812|NCT02500537|10526|P1|Overall Study|Lost to Follow-up|0
1813|NCT02500537|10525|P2|Overall Study|Death|0
1814|NCT02500537|10526|P1|Overall Study|Death|2
1815|NCT02500056|10595|P2|Overall Study|Death|1
1816|NCT02500056|10596|P1|Overall Study|Death|3
1817|NCT02500056|10595|P2|Overall Study|Recurrence|0
1818|NCT02500056|10596|P1|Overall Study|Recurrence|1
1819|NCT02500056|10595|P2|Overall Study|Lost to Follow-up|7
1820|NCT02500056|10596|P1|Overall Study|Lost to Follow-up|3
1821|NCT02499575|10617|P2|Overall Study|Protocol Violation|1
1822|NCT02499575|10618|P1|Overall Study|Protocol Violation|0
1823|NCT02498821|10630|P2|Overall Study|Screen failure|5
1824|NCT02498821|10631|P1|Overall Study|Screen failure|3
1825|NCT02498678|10660|P2|Overall Study|interference from the surgical team|2
1826|NCT02498678|10661|P1|Overall Study|interference from the surgical team|0
1827|NCT02496533|10725|P2|Overall Study|Late for radiologic testing|2
1828|NCT02496533|10726|P1|Overall Study|Late for radiologic testing|0
1829|NCT02496533|10725|P2|Overall Study|Patient did not complete all measures|4
1830|NCT02496533|10726|P1|Overall Study|Patient did not complete all measures|0
1831|NCT02496533|10725|P2|Overall Study|Lack of data on outcome|0
1832|NCT02496533|10726|P1|Overall Study|Lack of data on outcome|3
1833|NCT02496221|10738|P2|Treatment Period 2 - 4 Days|Physician Decision|0
1834|NCT02496221|10739|P1|Treatment Period 2 - 4 Days|Physician Decision|1
1835|NCT02496221|10738|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
1836|NCT02496221|10739|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
1837|NCT02496221|10738|P2|Treatment Period 2 - 4 Days|Adverse Event|1
1838|NCT02496221|10739|P1|Treatment Period 2 - 4 Days|Adverse Event|0
1839|NCT02496039|10773|P1|Overall Study|Protocol Violation|1
1840|NCT02496039|10773|P1|Overall Study|Adverse Event|3
1841|NCT02496000|10788|P3|Overall Study|undetermined|0
1842|NCT02496000|10789|P2|Overall Study|undetermined|1
1843|NCT02496000|10790|P1|Overall Study|undetermined|0
1844|NCT02496000|10788|P3|Overall Study|Non-compliance or lack of cooperation|0
1845|NCT02496000|10789|P2|Overall Study|Non-compliance or lack of cooperation|2
1846|NCT02496000|10790|P1|Overall Study|Non-compliance or lack of cooperation|0
1847|NCT02496000|10788|P3|Overall Study|Protocol Violation|1
1848|NCT02496000|10789|P2|Overall Study|Protocol Violation|0
1849|NCT02496000|10790|P1|Overall Study|Protocol Violation|0
1850|NCT02496000|10788|P3|Overall Study|Lost to Follow-up|1
1851|NCT02496000|10789|P2|Overall Study|Lost to Follow-up|0
1852|NCT02496000|10790|P1|Overall Study|Lost to Follow-up|1
1853|NCT02496000|10788|P3|Overall Study|Withdrawal by Subject|0
1854|NCT02496000|10789|P2|Overall Study|Withdrawal by Subject|2
1855|NCT02496000|10790|P1|Overall Study|Withdrawal by Subject|1
1856|NCT02495948|10799|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1857|NCT02495948|10800|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
1858|NCT02495948|10799|P2|Period 1, First 30 Days of Wear|Adverse Event|1
1859|NCT02495948|10800|P1|Period 1, First 30 Days of Wear|Adverse Event|0
1860|NCT02493855|10838|P3|Overall Study|Withdrawal by Subject|0
1861|NCT02493855|10839|P2|Overall Study|Withdrawal by Subject|0
1862|NCT02493855|10840|P1|Overall Study|Withdrawal by Subject|1
1863|NCT02493855|10838|P3|Overall Study|Adverse Event|0
1864|NCT02493855|10839|P2|Overall Study|Adverse Event|1
1865|NCT02493855|10840|P1|Overall Study|Adverse Event|0
1866|NCT02493855|10838|P3|Overall Study|Non-compliance|0
1867|NCT02493855|10839|P2|Overall Study|Non-compliance|0
1868|NCT02493855|10840|P1|Overall Study|Non-compliance|1
1869|NCT02494596|10848|P3|Overall Study|Refused Treatment|0
1870|NCT02494596|10849|P2|Overall Study|Refused Treatment|1
1871|NCT02494596|10850|P1|Overall Study|Refused Treatment|0
1872|NCT02494596|10848|P3|Overall Study|Adverse Event|0
1873|NCT02494596|10849|P2|Overall Study|Adverse Event|1
1874|NCT02494596|10850|P1|Overall Study|Adverse Event|0
1875|NCT02494596|10848|P3|Overall Study|Insufficient Therapeutic Response|1
1876|NCT02494596|10849|P2|Overall Study|Insufficient Therapeutic Response|3
1877|NCT02494596|10850|P1|Overall Study|Insufficient Therapeutic Response|3
1878|NCT02493127|10888|P2|Overall Study|Lost to Follow-up|1
1879|NCT02493127|10889|P1|Overall Study|Lost to Follow-up|1
1880|NCT02492984|10922|P2|Overall Study|Withdrawal by Subject|0
1881|NCT02492984|10923|P1|Overall Study|Withdrawal by Subject|1
1882|NCT02492984|10922|P2|Overall Study|Protocol Violation|0
1883|NCT02492984|10923|P1|Overall Study|Protocol Violation|1
1884|NCT02492984|10922|P2|Overall Study|Adverse Event|0
1885|NCT02492984|10923|P1|Overall Study|Adverse Event|1
1886|NCT02492841|10946|P3|Overall Study|Lost to Follow-up|35
1887|NCT02492841|10947|P2|Overall Study|Lost to Follow-up|31
1888|NCT02492841|10948|P1|Overall Study|Lost to Follow-up|34
1889|NCT02492165|10976|P4|Overall Study|Withdrawal by Subject|0
1890|NCT02492165|10977|P3|Overall Study|Withdrawal by Subject|0
1891|NCT02492165|10978|P2|Overall Study|Withdrawal by Subject|1
1892|NCT02492165|10979|P1|Overall Study|Withdrawal by Subject|0
1893|NCT02491892|11023|P2|Overall Study|Lost to Follow-up|0
1894|NCT02491892|11024|P1|Overall Study|Lost to Follow-up|1
1895|NCT02491892|11023|P2|Overall Study|Refused Treatment|0
1896|NCT02491892|11024|P1|Overall Study|Refused Treatment|1
1897|NCT02491892|11023|P2|Overall Study|Lack of Efficacy|36
1898|NCT02491892|11024|P1|Overall Study|Lack of Efficacy|37
1899|NCT02491892|11023|P2|Overall Study|Death|1
1900|NCT02491892|11024|P1|Overall Study|Death|1
1901|NCT02491892|11023|P2|Overall Study|Adverse Event|1
1902|NCT02491892|11024|P1|Overall Study|Adverse Event|1
1903|NCT02490475|11083|P4|Period 2: Extension Phase|Adverse Event|0
1904|NCT02490475|11084|P3|Period 2: Extension Phase|Adverse Event|1
1905|NCT02490475|11085|P2|Period 2: Extension Phase|Adverse Event|0
1906|NCT02490475|11086|P1|Period 2: Extension Phase|Adverse Event|0
1907|NCT02490475|11083|P4|Period 2: Extension Phase|Refused Treatment|1
1908|NCT02490475|11084|P3|Period 2: Extension Phase|Refused Treatment|0
1909|NCT02490475|11085|P2|Period 2: Extension Phase|Refused Treatment|0
1910|NCT02490475|11086|P1|Period 2: Extension Phase|Refused Treatment|0
1911|NCT02490475|11083|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1912|NCT02490475|11084|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
1913|NCT02490475|11085|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
1914|NCT02490475|11086|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
1915|NCT02490475|11083|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
1916|NCT02490475|11084|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
1917|NCT02490475|11085|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1918|NCT02490475|11086|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
1919|NCT02490475|11083|P4|Period 1: First 6 Cycles|Refused Treatment|0
1920|NCT02490475|11084|P3|Period 1: First 6 Cycles|Refused Treatment|0
1921|NCT02490475|11085|P2|Period 1: First 6 Cycles|Refused Treatment|0
1922|NCT02490475|11086|P1|Period 1: First 6 Cycles|Refused Treatment|1
1923|NCT02490475|11083|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1924|NCT02490475|11084|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1925|NCT02490475|11085|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
1926|NCT02490475|11086|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
1927|NCT02490475|11083|P4|Period 1: First 6 Cycles|Adverse Event|1
1928|NCT02490475|11084|P3|Period 1: First 6 Cycles|Adverse Event|0
1929|NCT02490475|11085|P2|Period 1: First 6 Cycles|Adverse Event|1
1930|NCT02490475|11086|P1|Period 1: First 6 Cycles|Adverse Event|2
1931|NCT02489799|11175|P2|Overall Study|Death|1
1932|NCT02489799|11176|P1|Overall Study|Death|0
1933|NCT02489799|11175|P2|Overall Study|Withdrawal by Subject|1
1934|NCT02489799|11176|P1|Overall Study|Withdrawal by Subject|1
1935|NCT02489799|11175|P2|Overall Study|Failure to Maintain Eligibility|6
1936|NCT02489799|11176|P1|Overall Study|Failure to Maintain Eligibility|4
1937|NCT02489799|11175|P2|Overall Study|Lost to Follow-up|1
1938|NCT02489799|11176|P1|Overall Study|Lost to Follow-up|4
1939|NCT02488980|11203|P3|Overall Study|Protocol Violation|2
1940|NCT02488980|11204|P2|Overall Study|Protocol Violation|2
1941|NCT02488980|11205|P1|Overall Study|Protocol Violation|2
1942|NCT02486952|11251|P1|Overall Study|Unspecified|2
1943|NCT02486952|11251|P1|Overall Study|Lost to Follow-up|26
1944|NCT02486952|11251|P1|Overall Study|Lack of Efficacy|3
1945|NCT02486952|11251|P1|Overall Study|Death|15
1946|NCT02486952|11251|P1|Overall Study|Adverse Event|1
1947|NCT02486952|11251|P1|Overall Study|Not Started Induction Therapy|3
1948|NCT02485483|11258|P2|Overall Study|Discontinued after baseline|0
1949|NCT02485483|11259|P1|Overall Study|Discontinued after baseline|39
1950|NCT02485483|11258|P2|Overall Study|Depression at baseline|0
1951|NCT02485483|11259|P1|Overall Study|Depression at baseline|15
1952|NCT02485158|11274|P1|Overall Study|expected drug side effect|1
1953|NCT02485158|11274|P1|Overall Study|Withdrawal by Subject|3
1954|NCT02484911|11363|P2|Overall Study|Protocol Violation|1
1955|NCT02484911|11364|P1|Overall Study|Protocol Violation|2
1956|NCT02484911|11363|P2|Overall Study|Withdrawal by Subject|1
1957|NCT02484911|11364|P1|Overall Study|Withdrawal by Subject|2
1958|NCT02484729|11406|P10|Overall Study|Failure of IntelliCap Error|1
1959|NCT02484729|11407|P9|Overall Study|Failure of IntelliCap Error|0
1960|NCT02484729|11408|P8|Overall Study|Failure of IntelliCap Error|0
1961|NCT02484729|11409|P7|Overall Study|Failure of IntelliCap Error|0
1962|NCT02484729|11410|P6|Overall Study|Failure of IntelliCap Error|0
1963|NCT02484729|11411|P5|Overall Study|Failure of IntelliCap Error|0
1964|NCT02484729|11412|P4|Overall Study|Failure of IntelliCap Error|0
1965|NCT02484729|11413|P3|Overall Study|Failure of IntelliCap Error|0
1966|NCT02484729|11414|P2|Overall Study|Failure of IntelliCap Error|0
1967|NCT02484729|11415|P1|Overall Study|Failure of IntelliCap Error|0
1968|NCT02483975|11613|P2|Overall Study|Physician Decision|0
1969|NCT02483975|11614|P1|Overall Study|Physician Decision|2
1970|NCT02483975|11613|P2|Overall Study|Lost to Follow-up|1
1971|NCT02483975|11614|P1|Overall Study|Lost to Follow-up|0
1972|NCT02483975|11613|P2|Overall Study|Adverse Event|1
1973|NCT02483975|11614|P1|Overall Study|Adverse Event|0
1974|NCT02483611|11631|P3|Overall Study|Protocol Violation|1
1975|NCT02483611|11632|P2|Overall Study|Protocol Violation|0
1976|NCT02483611|11633|P1|Overall Study|Protocol Violation|0
1977|NCT02482428|11733|P5|Overall Study|subject/guardian decision|2
1978|NCT02482428|11734|P4|Overall Study|subject/guardian decision|0
1979|NCT02482428|11735|P3|Overall Study|subject/guardian decision|0
1980|NCT02482428|11736|P2|Overall Study|subject/guardian decision|2
1981|NCT02482428|11737|P1|Overall Study|subject/guardian decision|4
1982|NCT02482428|11733|P5|Overall Study|protocol deviation|0
1983|NCT02482428|11734|P4|Overall Study|protocol deviation|0
1984|NCT02482428|11735|P3|Overall Study|protocol deviation|0
1985|NCT02482428|11736|P2|Overall Study|protocol deviation|1
1986|NCT02482428|11737|P1|Overall Study|protocol deviation|1
1987|NCT02482428|11733|P5|Overall Study|Physician Decision|1
1988|NCT02482428|11734|P4|Overall Study|Physician Decision|0
1989|NCT02482428|11735|P3|Overall Study|Physician Decision|0
1990|NCT02482428|11736|P2|Overall Study|Physician Decision|0
1991|NCT02482428|11737|P1|Overall Study|Physician Decision|0
1992|NCT02482428|11733|P5|Overall Study|Lost to Follow-up|4
1993|NCT02482428|11734|P4|Overall Study|Lost to Follow-up|2
1994|NCT02482428|11735|P3|Overall Study|Lost to Follow-up|1
1995|NCT02482428|11736|P2|Overall Study|Lost to Follow-up|9
1996|NCT02482428|11737|P1|Overall Study|Lost to Follow-up|4
1997|NCT02482129|11759|P2|Overall Study|Criteria not met|0
1998|NCT02482129|11760|P1|Overall Study|Criteria not met|1
1999|NCT02482129|11759|P2|Overall Study|Withdrawal by Subject|0
2000|NCT02482129|11760|P1|Overall Study|Withdrawal by Subject|2
2001|NCT02482129|11759|P2|Overall Study|Adverse Event|0
2002|NCT02482129|11760|P1|Overall Study|Adverse Event|1
2003|NCT02482129|11759|P2|Overall Study|Criteria not met-prior to treatment|0
2004|NCT02482129|11760|P1|Overall Study|Criteria not met-prior to treatment|1
2005|NCT02482129|11759|P2|Overall Study|Unable to draw blood-prior to treatment|0
2006|NCT02482129|11760|P1|Overall Study|Unable to draw blood-prior to treatment|1
2007|NCT02482129|11759|P2|Overall Study|Withdrawal by subject-prior to treatment|1
2008|NCT02482129|11760|P1|Overall Study|Withdrawal by subject-prior to treatment|0
2009|NCT02482129|11759|P2|Overall Study|Adverse Event-prior to treatment|1
2010|NCT02482129|11760|P1|Overall Study|Adverse Event-prior to treatment|0
2011|NCT02481934|11787|P1|Overall Study|Death|2
2012|NCT02480712|11811|P1|Overall Study|Lack of Efficacy|1
2013|NCT02480712|11811|P1|Overall Study|Death|1
2014|NCT02480712|11811|P1|Overall Study|Withdrew Consent|3
2015|NCT02480712|11811|P1|Overall Study|Lost to Follow-up|5
2016|NCT02480712|11811|P1|Overall Study|Enrolled but Never Treated|1
2017|NCT02480010|11883|P2|Overall Study|Refused Treatment|3
2018|NCT02480010|11884|P1|Overall Study|Refused Treatment|0
2019|NCT02480010|11883|P2|Overall Study|Insufficient therapeutic response|29
2020|NCT02480010|11884|P1|Overall Study|Insufficient therapeutic response|31
2021|NCT02480010|11883|P2|Overall Study|Death|0
2022|NCT02480010|11884|P1|Overall Study|Death|1
2023|NCT02480010|11883|P2|Overall Study|Adverse Event|1
2024|NCT02480010|11884|P1|Overall Study|Adverse Event|3
2025|NCT02479412|11946|P9|Overall Study|Randomization to wrong PK sampling group|0
2026|NCT02479412|11947|P8|Overall Study|Randomization to wrong PK sampling group|0
2027|NCT02479412|11948|P7|Overall Study|Randomization to wrong PK sampling group|0
2028|NCT02479412|11949|P6|Overall Study|Randomization to wrong PK sampling group|0
2029|NCT02479412|11950|P5|Overall Study|Randomization to wrong PK sampling group|1
2030|NCT02479412|11951|P4|Overall Study|Randomization to wrong PK sampling group|0
2031|NCT02479412|11952|P3|Overall Study|Randomization to wrong PK sampling group|0
2032|NCT02479412|11953|P2|Overall Study|Randomization to wrong PK sampling group|0
2033|NCT02479412|11954|P1|Overall Study|Randomization to wrong PK sampling group|0
2034|NCT02479412|11946|P9|Overall Study|Study-specific withdrawal criteria|1
2035|NCT02479412|11947|P8|Overall Study|Study-specific withdrawal criteria|1
2036|NCT02479412|11948|P7|Overall Study|Study-specific withdrawal criteria|0
2037|NCT02479412|11949|P6|Overall Study|Study-specific withdrawal criteria|0
2038|NCT02479412|11950|P5|Overall Study|Study-specific withdrawal criteria|0
2039|NCT02479412|11951|P4|Overall Study|Study-specific withdrawal criteria|1
2040|NCT02479412|11952|P3|Overall Study|Study-specific withdrawal criteria|1
2041|NCT02479412|11953|P2|Overall Study|Study-specific withdrawal criteria|0
2042|NCT02479412|11954|P1|Overall Study|Study-specific withdrawal criteria|0
2043|NCT02479412|11946|P9|Overall Study|Adverse Event|0
2044|NCT02479412|11947|P8|Overall Study|Adverse Event|0
2045|NCT02479412|11948|P7|Overall Study|Adverse Event|0
2046|NCT02479412|11949|P6|Overall Study|Adverse Event|0
2047|NCT02479412|11950|P5|Overall Study|Adverse Event|0
2048|NCT02479412|11951|P4|Overall Study|Adverse Event|0
2049|NCT02479412|11952|P3|Overall Study|Adverse Event|1
2050|NCT02479412|11953|P2|Overall Study|Adverse Event|0
2051|NCT02479412|11954|P1|Overall Study|Adverse Event|0
2052|NCT02478372|12041|P2|Overall Study|Death|2
2053|NCT02478372|12042|P1|Overall Study|Death|0
2054|NCT02478372|12041|P2|Overall Study|Lost to Follow-up|4
2055|NCT02478372|12042|P1|Overall Study|Lost to Follow-up|1
2056|NCT02478372|12041|P2|Overall Study|Protocol Violation|8
2057|NCT02478372|12042|P1|Overall Study|Protocol Violation|12
2058|NCT02477605|12070|P2|Overall Study|Administered gas during surgery|1
2059|NCT02477605|12071|P1|Overall Study|Administered gas during surgery|0
2060|NCT02477605|12070|P2|Overall Study|Withdrawal by Subject|1
2061|NCT02477605|12071|P1|Overall Study|Withdrawal by Subject|0
2062|NCT02477605|12070|P2|Overall Study|Lost to Follow-up|2
2063|NCT02477605|12071|P1|Overall Study|Lost to Follow-up|0
2064|NCT02477605|12070|P2|Overall Study|Discontinued prior to treatment|0
2065|NCT02477605|12071|P1|Overall Study|Discontinued prior to treatment|1
2066|NCT02477527|12085|P1|Overall Study|Screen Failure|3
2067|NCT02477527|12085|P1|Overall Study|Withdrawal by Subject|1
2068|NCT02477527|12085|P1|Overall Study|Lost to Follow-up|2
2069|NCT02476422|12095|P2|Overall Study|Subject/guardian decision|1
2070|NCT02476422|12096|P1|Overall Study|Subject/guardian decision|0
2071|NCT02475980|12126|P1|Overall Study|Withdrawal by Subject|1
2072|NCT02475980|12126|P1|Overall Study|Lost to Follow-up|4
2073|NCT02475564|12137|P2|Overall Study|Intense Menstrual bleeding|0
2074|NCT02475564|12138|P1|Overall Study|Intense Menstrual bleeding|1
2075|NCT02475564|12137|P2|Overall Study|Lost to Follow-up|1
2076|NCT02475564|12138|P1|Overall Study|Lost to Follow-up|2
2077|NCT02475564|12137|P2|Overall Study|Withdrawal by Subject|0
2078|NCT02475564|12138|P1|Overall Study|Withdrawal by Subject|1
2079|NCT02475395|12150|P2|Overall Study|Protocol Violation|3
2080|NCT02475395|12151|P1|Overall Study|Protocol Violation|30
2081|NCT02475278|12161|P1|Overall Study|Reason Not Specified|1
2082|NCT02475278|12161|P1|Overall Study|Lost to Follow-up|1
2083|NCT02473523|12217|P1|Overall Study|Lost to Follow-up|1
2084|NCT02473523|12217|P1|Overall Study|Death|1
2085|NCT02473510|12238|P2|Overall Study|Lost to Follow-up|2
2086|NCT02473510|12239|P1|Overall Study|Lost to Follow-up|1
2087|NCT02473367|12253|P1|Period 4|Lost to Follow-up|1
2088|NCT02473367|12253|P1|Wait 1|Withdrawal by Subject|1
2089|NCT02472886|12274|P3|Overall Study|Lack of Efficacy|1
2090|NCT02472886|12275|P2|Overall Study|Lack of Efficacy|2
2091|NCT02472886|12276|P1|Overall Study|Lack of Efficacy|0
2092|NCT02472847|12304|P2|Overall Study|Withdrawal by Subject|5
2093|NCT02472847|12305|P1|Overall Study|Withdrawal by Subject|1
2094|NCT02472756|12311|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
2095|NCT02472756|12311|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
2096|NCT02472756|12311|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
2097|NCT02472756|12311|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
2098|NCT02472756|12311|P1|Induction (Approximately 6 Months)|Adverse Event|1
2099|NCT02472366|12352|P2|Overall Study|Lost to Follow-up|0
2100|NCT02472366|12353|P1|Overall Study|Lost to Follow-up|1
2101|NCT02471755|12369|P2|Overall Study|Lost to Follow-up|1
2102|NCT02471755|12370|P1|Overall Study|Lost to Follow-up|0
2103|NCT02471755|12369|P2|Overall Study|Withdrawal by Subject|0
2104|NCT02471755|12370|P1|Overall Study|Withdrawal by Subject|1
2105|NCT02471612|12386|P1|Overall Study|Lost to Follow-up|2
2106|NCT02470429|12424|P2|Overall Study|Withdrawal by Subject|0
2107|NCT02470429|12425|P1|Overall Study|Withdrawal by Subject|1
2108|NCT02470429|12424|P2|Overall Study|Adverse Event|0
2109|NCT02470429|12425|P1|Overall Study|Adverse Event|1
2110|NCT02470403|12443|P5|Overall Study|Subject/guardian decision|0
2111|NCT02470403|12444|P4|Overall Study|Subject/guardian decision|4
2112|NCT02470403|12445|P3|Overall Study|Subject/guardian decision|0
2113|NCT02470403|12446|P2|Overall Study|Subject/guardian decision|0
2114|NCT02470403|12447|P1|Overall Study|Subject/guardian decision|1
2115|NCT02470403|12443|P5|Overall Study|Lost to Follow-up|0
2116|NCT02470403|12444|P4|Overall Study|Lost to Follow-up|0
2117|NCT02470403|12445|P3|Overall Study|Lost to Follow-up|0
2118|NCT02470403|12446|P2|Overall Study|Lost to Follow-up|1
2119|NCT02470403|12447|P1|Overall Study|Lost to Follow-up|0
2120|NCT02470403|12443|P5|Overall Study|Adverse Event|0
2121|NCT02470403|12444|P4|Overall Study|Adverse Event|0
2122|NCT02470403|12445|P3|Overall Study|Adverse Event|0
2123|NCT02470403|12446|P2|Overall Study|Adverse Event|0
2124|NCT02470403|12447|P1|Overall Study|Adverse Event|1
2125|NCT02469961|12487|P2|Overall Study|Physician Decision|1
2126|NCT02469961|12488|P1|Overall Study|Physician Decision|4
2127|NCT02469298|12523|P4|Overall Study|Withdrawal by Subject|1
2128|NCT02469298|12524|P3|Overall Study|Withdrawal by Subject|0
2129|NCT02469298|12525|P2|Overall Study|Withdrawal by Subject|0
2130|NCT02469298|12526|P1|Overall Study|Withdrawal by Subject|0
2131|NCT02469298|12523|P4|Overall Study|Physician Decision|1
2132|NCT02469298|12524|P3|Overall Study|Physician Decision|0
2133|NCT02469298|12525|P2|Overall Study|Physician Decision|0
2134|NCT02469298|12526|P1|Overall Study|Physician Decision|0
2135|NCT02469298|12523|P4|Overall Study|Lost to Follow-up|0
2136|NCT02469298|12524|P3|Overall Study|Lost to Follow-up|1
2137|NCT02469298|12525|P2|Overall Study|Lost to Follow-up|0
2138|NCT02469298|12526|P1|Overall Study|Lost to Follow-up|1
2139|NCT02469298|12523|P4|Overall Study|Protocol Violation|0
2140|NCT02469298|12524|P3|Overall Study|Protocol Violation|1
2141|NCT02469298|12525|P2|Overall Study|Protocol Violation|1
2142|NCT02469298|12526|P1|Overall Study|Protocol Violation|0
2143|NCT02468414|12676|P2|Overall Study|Screen Failure|0
2144|NCT02468414|12677|P1|Overall Study|Screen Failure|1
2145|NCT02468414|12676|P2|Overall Study|Poor in-vitro secreting TARGTs|0
2146|NCT02468414|12677|P1|Overall Study|Poor in-vitro secreting TARGTs|1
2147|NCT02468414|12676|P2|Overall Study|Early Study Termination by Sponsor|0
2148|NCT02468414|12677|P1|Overall Study|Early Study Termination by Sponsor|1
2149|NCT02466425|12737|P2|Overall Study|Withdrawal by Parent/Guardian|0
2150|NCT02466425|12738|P1|Overall Study|Withdrawal by Parent/Guardian|2
2151|NCT02466425|12737|P2|Overall Study|Unspecified|3
2152|NCT02466425|12738|P1|Overall Study|Unspecified|1
2153|NCT02466425|12737|P2|Overall Study|Withdrawal by Subject|1
2154|NCT02466425|12738|P1|Overall Study|Withdrawal by Subject|0
2155|NCT02466425|12737|P2|Overall Study|Protocol Violation|0
2156|NCT02466425|12738|P1|Overall Study|Protocol Violation|1
2157|NCT02466425|12737|P2|Overall Study|Lost to Follow-up|0
2158|NCT02466425|12738|P1|Overall Study|Lost to Follow-up|3
2159|NCT02466425|12737|P2|Overall Study|Lack of Efficacy|1
2160|NCT02466425|12738|P1|Overall Study|Lack of Efficacy|4
2161|NCT02466425|12737|P2|Overall Study|Adverse Event|11
2162|NCT02466425|12738|P1|Overall Study|Adverse Event|3
2163|NCT02465866|12758|P4|Period 3|Withdrawal by Subject|0
2164|NCT02465866|12759|P3|Period 3|Withdrawal by Subject|0
2165|NCT02465866|12760|P2|Period 3|Withdrawal by Subject|1
2166|NCT02465866|12761|P1|Period 3|Withdrawal by Subject|0
2167|NCT02465489|12847|P1|Overall Study|Adverse Event|5
2168|NCT02463409|12887|P1|Overall Study|Screen failure|1
2169|NCT02463409|12887|P1|Overall Study|Withdrawal by Subject|1
2170|NCT02463331|12895|P2|Overall Study|Physician Decision|0
2171|NCT02463331|12896|P1|Overall Study|Physician Decision|3
2172|NCT02463331|12895|P2|Overall Study|Lack of Efficacy|0
2173|NCT02463331|12896|P1|Overall Study|Lack of Efficacy|6
2174|NCT02463331|12895|P2|Overall Study|Pregnancy|3
2175|NCT02463331|12896|P1|Overall Study|Pregnancy|2
2176|NCT02463331|12895|P2|Overall Study|Lost to Follow-up|1
2177|NCT02463331|12896|P1|Overall Study|Lost to Follow-up|1
2178|NCT02463331|12895|P2|Overall Study|Adverse Event|2
2179|NCT02463331|12896|P1|Overall Study|Adverse Event|4
2180|NCT02463097|12912|P1|Overall Study|Withdrawal by Subject|1
2181|NCT02462473|12918|P1|Overall Study|Unspecified|3
2182|NCT02462473|12918|P1|Overall Study|Death|1
2183|NCT02461290|13002|P1|Overall Study|Lost to Follow-up|3
2184|NCT02461290|13002|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
2185|NCT02460822|13009|P1|Overall Study|Withdrawal by Subject|1
2186|NCT02457611|13060|P1|Overall Study|Lost to Follow-up|3
2187|NCT02457247|13076|P4|Period 2|Voluntary Withdrawal|0
2188|NCT02457247|13077|P3|Period 2|Voluntary Withdrawal|0
2189|NCT02457247|13078|P2|Period 2|Voluntary Withdrawal|1
2190|NCT02457247|13079|P1|Period 2|Voluntary Withdrawal|1
2191|NCT02457247|13076|P4|Period 2|Lost to Follow-up|0
2192|NCT02457247|13077|P3|Period 2|Lost to Follow-up|0
2193|NCT02457247|13078|P2|Period 2|Lost to Follow-up|1
2194|NCT02457247|13079|P1|Period 2|Lost to Follow-up|0
2195|NCT02457247|13076|P4|Period 2|Significant Protocol Deviation|0
2196|NCT02457247|13077|P3|Period 2|Significant Protocol Deviation|0
2197|NCT02457247|13078|P2|Period 2|Significant Protocol Deviation|0
2198|NCT02457247|13079|P1|Period 2|Significant Protocol Deviation|1
2199|NCT02457247|13076|P4|Period 2|Pretreatment Event/Adverse Event|0
2200|NCT02457247|13077|P3|Period 2|Pretreatment Event/Adverse Event|0
2201|NCT02457247|13078|P2|Period 2|Pretreatment Event/Adverse Event|1
2202|NCT02457247|13079|P1|Period 2|Pretreatment Event/Adverse Event|0
2203|NCT02457247|13076|P4|Period 1|Voluntary Withdrawal|0
2204|NCT02457247|13077|P3|Period 1|Voluntary Withdrawal|0
2205|NCT02457247|13078|P2|Period 1|Voluntary Withdrawal|0
2206|NCT02457247|13079|P1|Period 1|Voluntary Withdrawal|1
2207|NCT02457247|13076|P4|Period 1|Significant Protocol Deviation|0
2208|NCT02457247|13077|P3|Period 1|Significant Protocol Deviation|0
2209|NCT02457247|13078|P2|Period 1|Significant Protocol Deviation|1
2210|NCT02457247|13079|P1|Period 1|Significant Protocol Deviation|1
2211|NCT02457247|13076|P4|Period 1|Pretreatment Event/Adverse Event|0
2212|NCT02457247|13077|P3|Period 1|Pretreatment Event/Adverse Event|0
2213|NCT02457247|13078|P2|Period 1|Pretreatment Event/Adverse Event|1
2214|NCT02457247|13079|P1|Period 1|Pretreatment Event/Adverse Event|0
2215|NCT02455050|13103|P4|Treatment Period 2|Lost to Follow-up|1
2216|NCT02455050|13104|P3|Treatment Period 2|Lost to Follow-up|2
2217|NCT02455050|13105|P2|Treatment Period 2|Lost to Follow-up|0
2218|NCT02455050|13106|P1|Treatment Period 2|Lost to Follow-up|1
2219|NCT02455050|13103|P4|Treatment Period 1|Lost to Follow-up|2
2220|NCT02455050|13104|P3|Treatment Period 1|Lost to Follow-up|1
2221|NCT02455050|13105|P2|Treatment Period 1|Lost to Follow-up|1
2222|NCT02455050|13106|P1|Treatment Period 1|Lost to Follow-up|1
2223|NCT02454959|13170|P1|Overall Study|Adverse Event|2
2224|NCT02454959|13170|P1|Overall Study|Withdrawal by Subject|3
2225|NCT02454959|13170|P1|Overall Study|Physician Decision|1
2226|NCT02454959|13170|P1|Overall Study|Protocol-Specified Criteria|3
2227|NCT02454608|13190|P2|Overall Study|Lack of Efficacy|2
2228|NCT02454608|13191|P1|Overall Study|Lack of Efficacy|0
2229|NCT02454101|13280|P2|Overall Study|Lost to Follow-up|4
2230|NCT02454101|13281|P1|Overall Study|Lost to Follow-up|3
2231|NCT02454101|13280|P2|Overall Study|Adverse Event|3
2232|NCT02454101|13281|P1|Overall Study|Adverse Event|2
2233|NCT02449902|13416|P2|Overall Study|Withdrawal by Subject|1
2234|NCT02449902|13417|P1|Overall Study|Withdrawal by Subject|0
2235|NCT02449902|13416|P2|Overall Study|Adverse Event|1
2236|NCT02449902|13417|P1|Overall Study|Adverse Event|0
2237|NCT02449044|13472|P1|Overall Study|Sponsor Discontinued Trial|3
2238|NCT02449044|13472|P1|Overall Study|Physician Decision|9
2239|NCT02449044|13472|P1|Overall Study|Met Withdrawal Criteria|7
2240|NCT02449044|13472|P1|Overall Study|Adverse Event|30
2241|NCT02449044|13472|P1|Overall Study|Withdrawal by Subject|13
2242|NCT02449044|13472|P1|Overall Study|Lost to Follow-up|2
2243|NCT02448563|13529|P2|Overall Study|Withdrawal by Subject|1
2244|NCT02448563|13530|P1|Overall Study|Withdrawal by Subject|0
2245|NCT02448563|13529|P2|Overall Study|Lost to Follow-up|10
2246|NCT02448563|13530|P1|Overall Study|Lost to Follow-up|16
2247|NCT02447458|13555|P6|Overall Study|Other|0
2248|NCT02447458|13556|P5|Overall Study|Other|0
2249|NCT02447458|13557|P4|Overall Study|Other|0
2250|NCT02447458|13558|P3|Overall Study|Other|1
2251|NCT02447458|13559|P2|Overall Study|Other|0
2252|NCT02447458|13560|P1|Overall Study|Other|0
2253|NCT02447432|13658|P2|Epoch 001|Lost to Follow-up|3
2254|NCT02447432|13659|P1|Epoch 001|Lost to Follow-up|1
2255|NCT02447432|13658|P2|Epoch 001|Migrated/moved from study area|5
2256|NCT02447432|13659|P1|Epoch 001|Migrated/moved from study area|3
2257|NCT02447432|13658|P2|Epoch 001|Withdrawal by Subject|4
2258|NCT02447432|13659|P1|Epoch 001|Withdrawal by Subject|0
2259|NCT02447432|13658|P2|Epoch 001|Adverse Event|1
2260|NCT02447432|13659|P1|Epoch 001|Adverse Event|1
2261|NCT02447029|13699|P2|Overall Study|Withdrawal by Subject|2
2262|NCT02447029|13700|P1|Overall Study|Withdrawal by Subject|3
2263|NCT02446990|13720|P2|Overall Study|Withdrawal by Subject|199
2264|NCT02446990|13721|P1|Overall Study|Withdrawal by Subject|231
2265|NCT02446990|13720|P2|Overall Study|Physician Decision|0
2266|NCT02446990|13721|P1|Overall Study|Physician Decision|1
2267|NCT02446990|13720|P2|Overall Study|Lost to Follow-up|1
2268|NCT02446990|13721|P1|Overall Study|Lost to Follow-up|3
2269|NCT02446990|13720|P2|Overall Study|Death|458
2270|NCT02446990|13721|P1|Overall Study|Death|485
2271|NCT02446171|13807|P4|Overall Study|Withdrawal by Subject|0
2272|NCT02446171|13808|P3|Overall Study|Withdrawal by Subject|2
2273|NCT02446171|13809|P2|Overall Study|Withdrawal by Subject|0
2274|NCT02446171|13810|P1|Overall Study|Withdrawal by Subject|0
2275|NCT02446015|13881|P2|Overall Study|Withdrawal by Subject|0
2276|NCT02446015|13882|P1|Overall Study|Withdrawal by Subject|1
2277|NCT02446015|13881|P2|Overall Study|Adverse Event|1
2278|NCT02446015|13882|P1|Overall Study|Adverse Event|0
2279|NCT02445755|13893|P1|Overall Study|Screen Failure|5
2280|NCT02445755|13893|P1|Overall Study|Protocol Violation|6
2281|NCT02445755|13893|P1|Overall Study|Withdrawal by Subject|2
2282|NCT02445573|13902|P2|Overall Study|Lost to Follow-up|1
2283|NCT02445573|13903|P1|Overall Study|Lost to Follow-up|0
2284|NCT02445573|13902|P2|Overall Study|Withdrawal by Subject|1
2285|NCT02445573|13903|P1|Overall Study|Withdrawal by Subject|1
2286|NCT02444533|13983|P2|Overall Study|Only gave post-procedure complications|2
2287|NCT02444533|13984|P1|Overall Study|Only gave post-procedure complications|2
2288|NCT02444533|13983|P2|Overall Study|Not able to complete forms|2
2289|NCT02444533|13984|P1|Overall Study|Not able to complete forms|0
2290|NCT02444182|14000|P2|Overall Study|Lost to Follow-up|4
2291|NCT02444182|14001|P1|Overall Study|Lost to Follow-up|0
2292|NCT02444182|14000|P2|Overall Study|non-compliance|1
2293|NCT02444182|14001|P1|Overall Study|non-compliance|2
2294|NCT02442804|14028|P2|Overall Study|Adverse Event|0
2295|NCT02442804|14029|P1|Overall Study|Adverse Event|1
2296|NCT02442804|14028|P2|Overall Study|Withdrawal by Subject|1
2297|NCT02442804|14029|P1|Overall Study|Withdrawal by Subject|0
2298|NCT02442349|14068|P1|Overall Study|On-going Study at Data Cut-off|149
2299|NCT02442349|14068|P1|Overall Study|Withdrawal by Subject|8
2300|NCT02442349|14068|P1|Overall Study|Death|14
2301|NCT02442310|14073|P1|Overall Study|Withdrawal by Subject|1
2302|NCT02442310|14073|P1|Overall Study|Adverse Event|2
2303|NCT02442284|14095|P1|Overall Study|Not Specified|1
2304|NCT02442284|14095|P1|Overall Study|Lost to Follow-up|3
2305|NCT02442284|14095|P1|Overall Study|Withdrew Consent|2
2306|NCT02442284|14095|P1|Overall Study|Adverse Event|1
2307|NCT02442271|14102|P1|Overall Study|Not Specified|1
2308|NCT02442271|14102|P1|Overall Study|Lost to Follow-up|1
2309|NCT02442271|14102|P1|Overall Study|Withdrew Consent|1
2310|NCT02442271|14102|P1|Overall Study|Adverse Event|1
2311|NCT02441218|14128|P2|Overall Study|Lost to Follow-up|1
2312|NCT02441218|14129|P1|Overall Study|Lost to Follow-up|2
2313|NCT02441218|14128|P2|Overall Study|Withdrawal by Subject|58
2314|NCT02441218|14129|P1|Overall Study|Withdrawal by Subject|73
2315|NCT02441218|14128|P2|Overall Study|Death|553
2316|NCT02441218|14129|P1|Overall Study|Death|503
2317|NCT02441179|14155|P2|Overall Study|Withdrawal by Subject|1
2318|NCT02441179|14156|P1|Overall Study|Withdrawal by Subject|1
2319|NCT02441114|14174|P1|Washout2|Withdrawal by Subject|4
2320|NCT02439138|14228|P1|Overall Study|PI decision to terminate the study|2
2321|NCT02439138|14228|P1|Overall Study|Adverse Event|1
2322|NCT02438137|14284|P2|Overall Study|Physician Decision|1
2323|NCT02438137|14285|P1|Overall Study|Physician Decision|0
2324|NCT02438137|14284|P2|Overall Study|Withdrawal by Subject|3
2325|NCT02438137|14285|P1|Overall Study|Withdrawal by Subject|4
2326|NCT02438137|14284|P2|Overall Study|Adverse Event|0
2327|NCT02438137|14285|P1|Overall Study|Adverse Event|1
2328|NCT02438137|14284|P2|Overall Study|Lost to Follow-up|2
2329|NCT02438137|14285|P1|Overall Study|Lost to Follow-up|3
2330|NCT02437903|14293|P1|Overall Study|Lost to Follow-up|3
2331|NCT02437903|14293|P1|Overall Study|Withdrawal by Subject|1
2332|NCT02437903|14293|P1|Overall Study|Adverse Event|1
2333|NCT02437513|14301|P1|Overall Study|Withdrawal by Subject|2
2334|NCT02437409|14309|P1|Overall Study|Screening failure|12
2335|NCT02437409|14309|P1|Overall Study|Withdrawal by Subject|3
2336|NCT02437305|14320|P2|Overall Study|Lost to Follow-up|12
2337|NCT02437305|14321|P1|Overall Study|Lost to Follow-up|18
2338|NCT02436811|14332|P3|Overall Study|Lost to Follow-up|7
2339|NCT02436811|14333|P2|Overall Study|Lost to Follow-up|9
2340|NCT02436811|14334|P1|Overall Study|Lost to Follow-up|2
2341|NCT02436577|14348|P6|Overall Study|Protocol Deviation|0
2342|NCT02436577|14349|P5|Overall Study|Protocol Deviation|0
2343|NCT02436577|14350|P4|Overall Study|Protocol Deviation|0
2344|NCT02436577|14351|P3|Overall Study|Protocol Deviation|0
2345|NCT02436577|14352|P2|Overall Study|Protocol Deviation|1
2346|NCT02436577|14353|P1|Overall Study|Protocol Deviation|0
2347|NCT02436330|14408|P2|Cohort 6|Withdrawal by Subject|1
2348|NCT02436330|14409|P1|Cohort 6|Withdrawal by Subject|1
2349|NCT02436330|14408|P2|Cohort 6|Lost to Follow-up|0
2350|NCT02436330|14409|P1|Cohort 6|Lost to Follow-up|2
2351|NCT02436330|14408|P2|Cohort 5|Withdrawal by Subject|2
2352|NCT02436330|14409|P1|Cohort 5|Withdrawal by Subject|3
2353|NCT02436330|14408|P2|Cohort 5|Lost to Follow-up|2
2354|NCT02436330|14409|P1|Cohort 5|Lost to Follow-up|3
2355|NCT02436330|14408|P2|Cohort 4|Withdrawal by Subject|0
2356|NCT02436330|14409|P1|Cohort 4|Withdrawal by Subject|1
2357|NCT02436330|14408|P2|Cohort 4|Lost to Follow-up|0
2358|NCT02436330|14409|P1|Cohort 4|Lost to Follow-up|1
2359|NCT02436330|14408|P2|Cohort 3|Withdrawal by Subject|0
2360|NCT02436330|14409|P1|Cohort 3|Withdrawal by Subject|4
2361|NCT02436330|14408|P2|Cohort 3|Lost to Follow-up|0
2362|NCT02436330|14409|P1|Cohort 3|Lost to Follow-up|1
2363|NCT02436330|14408|P2|Cohort 2|Withdrawal by Subject|3
2364|NCT02436330|14409|P1|Cohort 2|Withdrawal by Subject|2
2365|NCT02436330|14408|P2|Cohort 2|Lost to Follow-up|0
2366|NCT02436330|14409|P1|Cohort 2|Lost to Follow-up|2
2367|NCT02436330|14408|P2|Cohort 1|Withdrawal by Subject|1
2368|NCT02436330|14409|P1|Cohort 1|Withdrawal by Subject|0
2369|NCT02436330|14408|P2|Cohort 1|Lost to Follow-up|2
2370|NCT02436330|14409|P1|Cohort 1|Lost to Follow-up|5
2371|NCT02436304|14454|P3|Overall Study|Randomized in error didn’t meet I/E crit|1
2372|NCT02436304|14455|P2|Overall Study|Randomized in error didn’t meet I/E crit|0
2373|NCT02436304|14456|P1|Overall Study|Randomized in error didn’t meet I/E crit|0
2374|NCT02436304|14454|P3|Overall Study|Withdrawal by Subject|0
2375|NCT02436304|14455|P2|Overall Study|Withdrawal by Subject|1
2376|NCT02436304|14456|P1|Overall Study|Withdrawal by Subject|0
2377|NCT02436304|14454|P3|Overall Study|Lost to Follow-up|0
2378|NCT02436304|14455|P2|Overall Study|Lost to Follow-up|1
2379|NCT02436304|14456|P1|Overall Study|Lost to Follow-up|0
2380|NCT02434939|14484|P2|Overall Study|Adverse Event|1
2381|NCT02434939|14485|P1|Overall Study|Adverse Event|0
2382|NCT02434939|14484|P2|Overall Study|Withdrawal by Subject|0
2383|NCT02434939|14485|P1|Overall Study|Withdrawal by Subject|3
2384|NCT02434939|14484|P2|Overall Study|Lack of Efficacy|48
2385|NCT02434939|14485|P1|Overall Study|Lack of Efficacy|34
2386|NCT02435966|14500|P3|Overall Study|Withdrawal by Subject|0
2387|NCT02435966|14501|P2|Overall Study|Withdrawal by Subject|1
2388|NCT02435966|14502|P1|Overall Study|Withdrawal by Subject|0
2389|NCT02435836|14510|P1|Overall Study|AE of Worsening Schizophrenia|96
2390|NCT02435836|14510|P1|Overall Study|Met Withdrawal Criteria|7
2391|NCT02435836|14510|P1|Overall Study|Protocol Violation|6
2392|NCT02435836|14510|P1|Overall Study|Noncompliance|27
2393|NCT02435836|14510|P1|Overall Study|Sponsor discontinued trial|167
2394|NCT02435836|14510|P1|Overall Study|Adverse Event|44
2395|NCT02435836|14510|P1|Overall Study|Insufficient Clinical Response|26
2396|NCT02435836|14510|P1|Overall Study|Withdrawal by Subject|236
2397|NCT02435836|14510|P1|Overall Study|Lack of Efficacy|1
2398|NCT02435836|14510|P1|Overall Study|Lost to Follow-up|21
2399|NCT02433834|14553|P1|Overall Study|Physician Decision|1
2400|NCT02433834|14553|P1|Overall Study|Adverse Event|6
2401|NCT02433834|14553|P1|Overall Study|Withdrawal by Subject|14
2402|NCT02433834|14553|P1|Overall Study|Lost to Follow-up|6
2403|NCT02433834|14553|P1|Overall Study|Protocol Violation|3
2404|NCT02433834|14553|P1|Overall Study|Protocol-specified criteria|7
2405|NCT02433340|14626|P4|Overall Study|Not Specified|0
2406|NCT02433340|14627|P3|Overall Study|Not Specified|0
2407|NCT02433340|14628|P2|Overall Study|Not Specified|1
2408|NCT02433340|14629|P1|Overall Study|Not Specified|0
2409|NCT02433340|14626|P4|Overall Study|Required Alternative/Prohibited Therapy|0
2410|NCT02433340|14627|P3|Overall Study|Required Alternative/Prohibited Therapy|0
2411|NCT02433340|14628|P2|Overall Study|Required Alternative/Prohibited Therapy|0
2412|NCT02433340|14629|P1|Overall Study|Required Alternative/Prohibited Therapy|1
2413|NCT02433340|14626|P4|Overall Study|Lost to Follow-up|0
2414|NCT02433340|14627|P3|Overall Study|Lost to Follow-up|0
2415|NCT02433340|14628|P2|Overall Study|Lost to Follow-up|1
2416|NCT02433340|14629|P1|Overall Study|Lost to Follow-up|0
2417|NCT02433340|14626|P4|Overall Study|Withdrawal by Subject|2
2418|NCT02433340|14627|P3|Overall Study|Withdrawal by Subject|1
2419|NCT02433340|14628|P2|Overall Study|Withdrawal by Subject|0
2420|NCT02433340|14629|P1|Overall Study|Withdrawal by Subject|1
2421|NCT02433340|14626|P4|Overall Study|Adverse Event|0
2422|NCT02433340|14627|P3|Overall Study|Adverse Event|1
2423|NCT02433340|14628|P2|Overall Study|Adverse Event|0
2424|NCT02433340|14629|P1|Overall Study|Adverse Event|0
2425|NCT02432105|15524|P3|Overall Study|Randomized in error|2
2426|NCT02432105|15525|P2|Overall Study|Randomized in error|0
2427|NCT02432105|15526|P1|Overall Study|Randomized in error|0
2428|NCT02432105|15524|P3|Overall Study|Culture positive for yeast|0
2429|NCT02432105|15525|P2|Overall Study|Culture positive for yeast|1
2430|NCT02432105|15526|P1|Overall Study|Culture positive for yeast|0
2431|NCT02432105|15524|P3|Overall Study|Withdrawal by Subject|1
2432|NCT02432105|15525|P2|Overall Study|Withdrawal by Subject|0
2433|NCT02432105|15526|P1|Overall Study|Withdrawal by Subject|1
2434|NCT02432105|15524|P3|Overall Study|Lost to Follow-up|0
2435|NCT02432105|15525|P2|Overall Study|Lost to Follow-up|1
2436|NCT02432105|15526|P1|Overall Study|Lost to Follow-up|1
2437|NCT02432040|15543|P2|Overall Study|Physician Decision|1
2438|NCT02432040|15544|P1|Overall Study|Physician Decision|1
2439|NCT02432040|15543|P2|Overall Study|Lost to Follow-up|5
2440|NCT02432040|15544|P1|Overall Study|Lost to Follow-up|4
2441|NCT02432040|15543|P2|Overall Study|Lack of Efficacy|0
2442|NCT02432040|15544|P1|Overall Study|Lack of Efficacy|3
2443|NCT02430870|15657|P8|Part 2|Other Reason Not Specified|1
2444|NCT02430870|15658|P7|Part 2|Other Reason Not Specified|0
2445|NCT02430870|15659|P6|Part 2|Other Reason Not Specified|0
2446|NCT02430870|15660|P5|Part 2|Other Reason Not Specified|0
2447|NCT02430870|15661|P4|Part 2|Other Reason Not Specified|0
2448|NCT02430870|15662|P3|Part 2|Other Reason Not Specified|0
2449|NCT02430870|15663|P2|Part 2|Other Reason Not Specified|0
2450|NCT02430870|15664|P1|Part 2|Other Reason Not Specified|0
2451|NCT02430870|15657|P8|Part 2|Voluntary Withdrawal|0
2452|NCT02430870|15658|P7|Part 2|Voluntary Withdrawal|1
2453|NCT02430870|15659|P6|Part 2|Voluntary Withdrawal|0
2454|NCT02430870|15660|P5|Part 2|Voluntary Withdrawal|0
2455|NCT02430870|15661|P4|Part 2|Voluntary Withdrawal|0
2456|NCT02430870|15662|P3|Part 2|Voluntary Withdrawal|0
2457|NCT02430870|15663|P2|Part 2|Voluntary Withdrawal|0
2458|NCT02430870|15664|P1|Part 2|Voluntary Withdrawal|0
2459|NCT02430532|15738|P2|Overall Study|Adverse Event|1
2460|NCT02430532|15739|P1|Overall Study|Adverse Event|0
2461|NCT02430532|15738|P2|Overall Study|Consent Withdrawn|2
2462|NCT02430532|15739|P1|Overall Study|Consent Withdrawn|0
2463|NCT02430532|15738|P2|Overall Study|Sponsor Decision to Stop Study Early|25
2464|NCT02430532|15739|P1|Overall Study|Sponsor Decision to Stop Study Early|30
2465|NCT02429258|15779|P2|Overall Study|Protocol Violation|1
2466|NCT02429258|15780|P1|Overall Study|Protocol Violation|0
2467|NCT02429258|15779|P2|Overall Study|Withdrawal by Subject|0
2468|NCT02429258|15780|P1|Overall Study|Withdrawal by Subject|2
2469|NCT02428413|15817|P2|Overall Study|Nurse Refusal|0
2470|NCT02428413|15818|P1|Overall Study|Nurse Refusal|1
2471|NCT02428413|15817|P2|Overall Study|Missed Cases|2
2472|NCT02428413|15818|P1|Overall Study|Missed Cases|1
2473|NCT02428413|15817|P2|Overall Study|Case Cancelled|0
2474|NCT02428413|15818|P1|Overall Study|Case Cancelled|2
2475|NCT02428413|15817|P2|Overall Study|Protocol Violation|2
2476|NCT02428413|15818|P1|Overall Study|Protocol Violation|1
2477|NCT02428413|15817|P2|Overall Study|Device to measure WAG malfunctioned|5
2478|NCT02428413|15818|P1|Overall Study|Device to measure WAG malfunctioned|3
2479|NCT02428231|15832|P2|Overall Study|Adverse Event|0
2480|NCT02428231|15833|P1|Overall Study|Adverse Event|3
2481|NCT02428231|15832|P2|Overall Study|Required Symptomatic Therapy|1
2482|NCT02428231|15833|P1|Overall Study|Required Symptomatic Therapy|0
2483|NCT02428231|15832|P2|Overall Study|Not Specified|16
2484|NCT02428231|15833|P1|Overall Study|Not Specified|10
2485|NCT02427984|15850|P3|Overall Study|Lost to Follow-up|18
2486|NCT02427984|15851|P2|Overall Study|Lost to Follow-up|5
2487|NCT02427984|15852|P1|Overall Study|Lost to Follow-up|13
2488|NCT02427477|15894|P2|Period 1|Adverse Event|0
2489|NCT02427477|15895|P1|Period 1|Adverse Event|1
2490|NCT02427399|15908|P5|Overall Study|Protocol Violation|15
2491|NCT02427399|15909|P4|Overall Study|Protocol Violation|18
2492|NCT02427399|15910|P3|Overall Study|Protocol Violation|12
2493|NCT02427399|15911|P2|Overall Study|Protocol Violation|16
2494|NCT02427399|15912|P1|Overall Study|Protocol Violation|14
2495|NCT02425826|15941|P2|Overall Study|Unspecified|3
2496|NCT02425826|15942|P1|Overall Study|Unspecified|1
2497|NCT02425826|15941|P2|Overall Study|Lost to Follow-up|10
2498|NCT02425826|15942|P1|Overall Study|Lost to Follow-up|4
2499|NCT02425826|15941|P2|Overall Study|Withdrawal by Subject|9
2500|NCT02425826|15942|P1|Overall Study|Withdrawal by Subject|1
2501|NCT02425826|15941|P2|Overall Study|Lack of Efficacy|0
2502|NCT02425826|15942|P1|Overall Study|Lack of Efficacy|1
2503|NCT02425826|15941|P2|Overall Study|Adverse Event|5
2504|NCT02425826|15942|P1|Overall Study|Adverse Event|2
2505|NCT02424591|15971|P2|Overall Study|Protocol Violation|3
2506|NCT02424591|15972|P1|Overall Study|Protocol Violation|2
2507|NCT02424578|15984|P2|Overall Study|Withdrawal by Subject|1
2508|NCT02424578|15985|P1|Overall Study|Withdrawal by Subject|0
2509|NCT02424565|15991|P2|Period 1 (D0)|Protocol Violation|1
2510|NCT02424565|15992|P1|Period 1 (D0)|Protocol Violation|0
2511|NCT02424149|16000|P2|Overall Study|Withdrawal by Subject|1
2512|NCT02424149|16001|P1|Overall Study|Withdrawal by Subject|0
2513|NCT02424149|16000|P2|Overall Study|surgery cancelled|0
2514|NCT02424149|16001|P1|Overall Study|surgery cancelled|2
2515|NCT02423291|16122|P1|Overall Study|Adverse Event|1
2516|NCT02423291|16122|P1|Overall Study|Lack of Efficacy|14
2517|NCT02421120|16173|P1|Overall Study|Adverse Event|1
2518|NCT02420093|16196|P2|Overall Study|Withdrawal by Subject|1
2519|NCT02420093|16197|P1|Overall Study|Withdrawal by Subject|1
2520|NCT02419313|16250|P2|Second Intervention|Lost to Follow-up|0
2521|NCT02419313|16251|P1|Second Intervention|Lost to Follow-up|1
2522|NCT02419313|16250|P2|First Intervention|Lost to Follow-up|0
2523|NCT02419313|16251|P1|First Intervention|Lost to Follow-up|2
2524|NCT02419001|16263|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
2525|NCT02419001|16264|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
2526|NCT02418468|16292|P2|Overall Study|Withdrawal of informed consent|1
2527|NCT02418468|16293|P1|Overall Study|Withdrawal of informed consent|1
2528|NCT02418468|16292|P2|Overall Study|Adverse Event|0
2529|NCT02418468|16293|P1|Overall Study|Adverse Event|1
2530|NCT02417961|16343|P1|Overall Study|Withdrawal by Subject|2
2531|NCT02417961|16343|P1|Overall Study|Lost to Follow-up|1
2532|NCT02417961|16343|P1|Overall Study|Adverse Event|1
2533|NCT02417753|16353|P1|Overall Study|Death|1
2534|NCT02417532|16363|P1|Overall Study|unable to complete exercises|4
2535|NCT02416180|16445|P1|Overall Study|Withdrawal by Subject|1
2536|NCT02415959|16457|P5|Overall Study|Protocol Violation|0
2537|NCT02415959|16458|P4|Overall Study|Protocol Violation|1
2538|NCT02415959|16459|P3|Overall Study|Protocol Violation|0
2539|NCT02415959|16460|P2|Overall Study|Protocol Violation|0
2540|NCT02415959|16461|P1|Overall Study|Protocol Violation|0
2541|NCT02415959|16457|P5|Overall Study|Adverse Event|0
2542|NCT02415959|16458|P4|Overall Study|Adverse Event|0
2543|NCT02415959|16459|P3|Overall Study|Adverse Event|0
2544|NCT02415959|16460|P2|Overall Study|Adverse Event|1
2545|NCT02415959|16461|P1|Overall Study|Adverse Event|0
2546|NCT02414828|16576|P4|Overall Study|Lost to Follow-up|2
2547|NCT02414828|16577|P3|Overall Study|Lost to Follow-up|1
2548|NCT02414828|16578|P2|Overall Study|Lost to Follow-up|1
2549|NCT02414828|16579|P1|Overall Study|Lost to Follow-up|0
2550|NCT02414152|16617|P1|Overall Study|Lack of Efficacy|1
2551|NCT02414152|16617|P1|Overall Study|Withdrawal by Subject|1
2552|NCT02413593|16627|P1|Overall Study|Adverse Event|1
2553|NCT02413593|16627|P1|Overall Study|Lost to Follow-up|3
2554|NCT02413333|16640|P2|Period 2|Protocol Deviation|0
2555|NCT02413333|16641|P1|Period 2|Protocol Deviation|1
2556|NCT02413333|16640|P2|Period 1|Reason Not Specified|1
2557|NCT02413333|16641|P1|Period 1|Reason Not Specified|0
2558|NCT02413333|16640|P2|Period 1|Adverse Event|0
2559|NCT02413333|16641|P1|Period 1|Adverse Event|1
2560|NCT02413294|16649|P1|Overall Study|Withdrawal by Subject|1
2561|NCT02412657|16704|P3|Overall Study|Protocol Violation|3
2562|NCT02412657|16705|P2|Overall Study|Protocol Violation|2
2563|NCT02412657|16706|P1|Overall Study|Protocol Violation|0
2564|NCT02412657|16704|P3|Overall Study|Lost to Follow-up|0
2565|NCT02412657|16705|P2|Overall Study|Lost to Follow-up|0
2566|NCT02412657|16706|P1|Overall Study|Lost to Follow-up|1
2567|NCT02411747|16746|P2|Overall Study|Protocol Violation|4
2568|NCT02411747|16747|P1|Overall Study|Protocol Violation|2
2569|NCT02411747|16746|P2|Overall Study|Withdrawal by Subject|0
2570|NCT02411747|16747|P1|Overall Study|Withdrawal by Subject|1
2571|NCT02411539|16755|P2|Overall Study|Confounding medical condition|1
2572|NCT02411539|16756|P1|Overall Study|Confounding medical condition|0
2573|NCT02411539|16755|P2|Overall Study|Lost to Follow-up|0
2574|NCT02411539|16756|P1|Overall Study|Lost to Follow-up|2
2575|NCT02411201|16825|P1|Overall Study|Age group completed|2
2576|NCT02411201|16825|P1|Overall Study|Withdrawal by Subject|2
2577|NCT02411201|16825|P1|Overall Study|Adverse Event|2
2578|NCT02410824|16836|P2|First Intervention (One Week)|Headache|1
2579|NCT02410824|16837|P1|First Intervention (One Week)|Headache|0
2580|NCT02410200|16878|P1|Overall Study|Adverse Event|2
2581|NCT02406586|16969|P3|Overall Study|Withdrawal by Subject|0
2582|NCT02406586|16970|P2|Overall Study|Withdrawal by Subject|0
2583|NCT02406586|16971|P1|Overall Study|Withdrawal by Subject|1
2584|NCT02406586|16969|P3|Overall Study|Lost to Follow-up|2
2585|NCT02406586|16970|P2|Overall Study|Lost to Follow-up|4
2586|NCT02406586|16971|P1|Overall Study|Lost to Follow-up|0
2587|NCT02404649|17084|P2|Overall Study|Adverse Event|2
2588|NCT02404649|17085|P1|Overall Study|Adverse Event|1
2589|NCT02404545|17093|P2|Overall Study|Sponsor Termination|6
2590|NCT02404545|17094|P1|Overall Study|Sponsor Termination|6
2591|NCT02404493|17103|P2|Overall Study|Adverse Event|1
2592|NCT02404493|17104|P1|Overall Study|Adverse Event|1
2593|NCT02403206|17357|P2|Overall Study|Reason not given|4
2594|NCT02403206|17358|P1|Overall Study|Reason not given|2
2595|NCT02403206|17357|P2|Overall Study|Withdrawal by Subject|3
2596|NCT02403206|17358|P1|Overall Study|Withdrawal by Subject|3
2597|NCT02403206|17357|P2|Overall Study|Physician Decision|0
2598|NCT02403206|17358|P1|Overall Study|Physician Decision|2
2599|NCT02403206|17357|P2|Overall Study|Lost to Follow-up|3
2600|NCT02403206|17358|P1|Overall Study|Lost to Follow-up|4
2601|NCT02403180|17369|P2|Period 2 (5 Days)|Withdrawal by Subject|1
2602|NCT02403180|17370|P1|Period 2 (5 Days)|Withdrawal by Subject|0
2603|NCT02403180|17369|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
2604|NCT02403180|17370|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
2605|NCT02402933|17378|P1|Overall Study|Sponsor Decision|10
2606|NCT02402933|17378|P1|Overall Study|Withdrawal by Subject|4
2607|NCT02402322|17396|P3|Follow-up|Withdrawal by Subject|24
2608|NCT02402322|17397|P2|Follow-up|Withdrawal by Subject|3
2609|NCT02402322|17398|P1|Follow-up|Withdrawal by Subject|6
2610|NCT02402322|17396|P3|Pretreatment|Withdrawal by Subject|1
2611|NCT02402322|17397|P2|Pretreatment|Withdrawal by Subject|1
2612|NCT02402322|17398|P1|Pretreatment|Withdrawal by Subject|3
2613|NCT02401867|17467|P1|Analysis|Cervical assay could not be conducted|9
2614|NCT02401867|17467|P1|Specimen Collection|Didn't receive 1 or more tests|10
2615|NCT02401529|17487|P2|Overall Study|Protocol Violation|0
2616|NCT02401529|17488|P1|Overall Study|Protocol Violation|5
2617|NCT02401529|17487|P2|Overall Study|Physician Decision|6
2618|NCT02401529|17488|P1|Overall Study|Physician Decision|2
2619|NCT02401529|17487|P2|Overall Study|Lost to Follow-up|1
2620|NCT02401529|17488|P1|Overall Study|Lost to Follow-up|2
2621|NCT02400346|17568|P1|Overall Study|Lost to Follow-up|1
2622|NCT02400346|17568|P1|Overall Study|Administrative or other reason(s)|2
2623|NCT02400346|17568|P1|Overall Study|Withdrawal by Subject|7
2624|NCT02400346|17568|P1|Overall Study|Non-compliance with IMP|1
2625|NCT02400346|17568|P1|Overall Study|Lack of Efficacy|9
2626|NCT02400346|17568|P1|Overall Study|Adverse Event|24
2627|NCT02400333|17576|P4|Overall Study|Protocol Violation|1
2628|NCT02400333|17577|P3|Overall Study|Protocol Violation|2
2629|NCT02400333|17578|P2|Overall Study|Protocol Violation|0
2630|NCT02400333|17579|P1|Overall Study|Protocol Violation|1
2631|NCT02400333|17576|P4|Overall Study|Withdrawal by Subject|1
2632|NCT02400333|17577|P3|Overall Study|Withdrawal by Subject|0
2633|NCT02400333|17578|P2|Overall Study|Withdrawal by Subject|1
2634|NCT02400333|17579|P1|Overall Study|Withdrawal by Subject|0
2635|NCT02399163|17643|P1|Overall Study|Withdrawal by Participant|5
2636|NCT02399163|17643|P1|Overall Study|Protocol Deviation|2
2637|NCT02399163|17643|P1|Overall Study|Adverse Event|2
2638|NCT02397915|17688|P4|Period 1|Physician Decision|0
2639|NCT02397915|17689|P3|Period 1|Physician Decision|0
2640|NCT02397915|17690|P2|Period 1|Physician Decision|0
2641|NCT02397915|17691|P1|Period 1|Physician Decision|1
2642|NCT02397915|17688|P4|Period 1|Protocol Violation|0
2643|NCT02397915|17689|P3|Period 1|Protocol Violation|0
2644|NCT02397915|17690|P2|Period 1|Protocol Violation|1
2645|NCT02397915|17691|P1|Period 1|Protocol Violation|0
2646|NCT02397655|17741|P1|Overall Study|data not completed|1301
2647|NCT02396537|17752|P2|Overall Study|Protocol Violation|1
2648|NCT02396537|17753|P1|Overall Study|Protocol Violation|0
2649|NCT02396316|17761|P2|Overall Study|Treatment unblinded|1
2650|NCT02396316|17762|P1|Overall Study|Treatment unblinded|0
2651|NCT02396316|17761|P2|Overall Study|Protocol Violation|1
2652|NCT02396316|17762|P1|Overall Study|Protocol Violation|0
2653|NCT02396316|17761|P2|Overall Study|Progressive disease|3
2654|NCT02396316|17762|P1|Overall Study|Progressive disease|6
2655|NCT02396316|17761|P2|Overall Study|Physician Decision|0
2656|NCT02396316|17762|P1|Overall Study|Physician Decision|1
2657|NCT02395302|17858|P1|Overall Study|Physician Decision|2
2658|NCT02395302|17858|P1|Overall Study|Withdrawal by Subject|2
2659|NCT02395302|17858|P1|Overall Study|Run In Failure|7
2660|NCT02395302|17858|P1|Overall Study|Screen Failure|3
2661|NCT02395055|17864|P2|Overall Study|Withdrawal by Subject|3
2662|NCT02395055|17865|P1|Overall Study|Withdrawal by Subject|7
2663|NCT02394925|17875|P1|Overall Study|Unsatisfactory Visual Response|5
2664|NCT02394925|17875|P1|Overall Study|No longer meet eligibility criteria|1
2665|NCT02394925|17875|P1|Overall Study|Protocol Violation|5
2666|NCT02394925|17875|P1|Overall Study|Lost to Follow-up|9
2667|NCT02394925|17875|P1|Overall Study|Lens handling difficulities|5
2668|NCT02394925|17875|P1|Overall Study|Lens Discomfort|3
2669|NCT02394925|17875|P1|Overall Study|Adverse Event|1
2670|NCT02394808|17879|P2|Period 2|Lost to Follow-up|0
2671|NCT02394808|17880|P1|Period 2|Lost to Follow-up|1
2672|NCT02394808|17879|P2|Period 1|Unsatisfactory lens fitting|1
2673|NCT02394808|17880|P1|Period 1|Unsatisfactory lens fitting|0
2674|NCT02394756|17888|P6|Period 2|Unsatisfactory Visual Response|0
2675|NCT02394756|17889|P5|Period 2|Unsatisfactory Visual Response|1
2676|NCT02394756|17890|P4|Period 2|Unsatisfactory Visual Response|0
2677|NCT02394756|17891|P3|Period 2|Unsatisfactory Visual Response|0
2678|NCT02394756|17892|P2|Period 2|Unsatisfactory Visual Response|0
2679|NCT02394756|17893|P1|Period 2|Unsatisfactory Visual Response|0
2680|NCT02394756|17888|P6|Period 1|Withdrawal by Subject|0
2681|NCT02394756|17889|P5|Period 1|Withdrawal by Subject|0
2682|NCT02394756|17890|P4|Period 1|Withdrawal by Subject|1
2683|NCT02394756|17891|P3|Period 1|Withdrawal by Subject|1
2684|NCT02394756|17892|P2|Period 1|Withdrawal by Subject|1
2685|NCT02394756|17893|P1|Period 1|Withdrawal by Subject|0
2686|NCT02394756|17888|P6|Period 1|Lens Discomfort|1
2687|NCT02394756|17889|P5|Period 1|Lens Discomfort|0
2688|NCT02394756|17890|P4|Period 1|Lens Discomfort|0
2689|NCT02394756|17891|P3|Period 1|Lens Discomfort|0
2690|NCT02394756|17892|P2|Period 1|Lens Discomfort|0
2691|NCT02394756|17893|P1|Period 1|Lens Discomfort|0
2692|NCT02394665|17907|P3|Overall Study|Physician Decision|0
2693|NCT02394665|17908|P2|Overall Study|Physician Decision|0
2694|NCT02394665|17909|P1|Overall Study|Physician Decision|1
2695|NCT02393950|17950|P2|Overall Study|Withdrawal by Subject|1
2696|NCT02393950|17951|P1|Overall Study|Withdrawal by Subject|0
2697|NCT02393950|17950|P2|Overall Study|Adverse Event|0
2698|NCT02393950|17951|P1|Overall Study|Adverse Event|1
2699|NCT02393547|18025|P1|Overall Study|Lost to Follow-up|1
2700|NCT02393547|18025|P1|Overall Study|Withdrawal by Subject|3
2701|NCT02393547|18025|P1|Overall Study|Adverse Event|2
2702|NCT02392247|18051|P1|Overall Study|Surgery cancelled; no data|1
2703|NCT02392247|18051|P1|Overall Study|Withdrawal by Subject|1
2704|NCT02391311|18081|P2|Overall Study|deemed ineligible after baseline|1
2705|NCT02391311|18082|P1|Overall Study|deemed ineligible after baseline|1
2706|NCT02391311|18081|P2|Overall Study|Lost to Follow-up|1
2707|NCT02391311|18082|P1|Overall Study|Lost to Follow-up|2
2708|NCT02391038|18090|P3|Overall Study|Progressive disease|6
2709|NCT02391038|18091|P2|Overall Study|Progressive disease|3
2710|NCT02391038|18092|P1|Overall Study|Progressive disease|3
2711|NCT02390167|18206|P1|Overall Study|Lost to Follow-up|1
2712|NCT02389452|18287|P1|Overall Study|Enrolled but Not Eligible for Study|6
2713|NCT02389452|18287|P1|Overall Study|Withdrawal by Subject|5
2714|NCT02389452|18287|P1|Overall Study|Adverse Event|1
2715|NCT02389452|18287|P1|Overall Study|Lost to Follow-up|13
2716|NCT02388763|18397|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2717|NCT02388763|18398|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
2718|NCT02388763|18397|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2719|NCT02388763|18398|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
2720|NCT02388347|18419|P5|Overall Study|Withdrawal by Subject|0
2721|NCT02388347|18420|P4|Overall Study|Withdrawal by Subject|0
2722|NCT02388347|18421|P3|Overall Study|Withdrawal by Subject|1
2723|NCT02388347|18422|P2|Overall Study|Withdrawal by Subject|0
2724|NCT02388347|18423|P1|Overall Study|Withdrawal by Subject|0
2725|NCT02388191|18490|P2|Overall Study|Patient did not receive IUD|0
2726|NCT02388191|18491|P1|Overall Study|Patient did not receive IUD|1
2727|NCT02388074|18505|P1|Overall Study|Sample Not Returned|1
2728|NCT02388074|18505|P1|Overall Study|Lost in Transit|2
2729|NCT02387996|18509|P1|Overall Study|Poor/Non-Compliance|1
2730|NCT02387996|18509|P1|Overall Study|Lost to Follow-up|1
2731|NCT02387996|18509|P1|Overall Study|Subject Withdrew Consent|1
2732|NCT02387996|18509|P1|Overall Study|Subject Request to Discontinue Treatment|9
2733|NCT02387996|18509|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
2734|NCT02387996|18509|P1|Overall Study|Study Drug Toxicity|14
2735|NCT02387996|18509|P1|Overall Study|Disease Progression|144
2736|NCT02387983|18520|P1|Overall Study|Withdrawal by Subject|2
2737|NCT02387983|18520|P1|Overall Study|Protocol Violation|1
2738|NCT02387983|18520|P1|Overall Study|Adverse Event|4
2739|NCT02387580|18570|P6|Overall Study|Withdrawal by Subject|0
2740|NCT02387580|18571|P5|Overall Study|Withdrawal by Subject|0
2741|NCT02387580|18572|P4|Overall Study|Withdrawal by Subject|1
2742|NCT02387580|18573|P3|Overall Study|Withdrawal by Subject|0
2743|NCT02387580|18574|P2|Overall Study|Withdrawal by Subject|0
2744|NCT02387580|18575|P1|Overall Study|Withdrawal by Subject|0
2745|NCT02384538|18639|P2|Overall Study|Not Specified|3
2746|NCT02384538|18640|P1|Overall Study|Not Specified|1
2747|NCT02384538|18639|P2|Overall Study|Withdrew Consent|4
2748|NCT02384538|18640|P1|Overall Study|Withdrew Consent|0
2749|NCT02384538|18639|P2|Overall Study|Lack of Efficacy|4
2750|NCT02384538|18640|P1|Overall Study|Lack of Efficacy|4
2751|NCT02384538|18639|P2|Overall Study|Adverse Event|4
2752|NCT02384538|18640|P1|Overall Study|Adverse Event|1
2753|NCT02383862|18679|P2|3 Month Follow up|Lost to Follow-up|21
2754|NCT02383862|18680|P1|3 Month Follow up|Lost to Follow-up|23
2755|NCT02382640|18787|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2756|NCT02382640|18788|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2757|NCT02382640|18789|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
2758|NCT02382640|18790|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
2759|NCT02382133|18828|P1|Overall Study|pressure injury both sites|1
2760|NCT02382133|18828|P1|Overall Study|arterial catheter loss|4
2761|NCT02382133|18828|P1|Overall Study|Physician Decision|2
2762|NCT02382133|18828|P1|Overall Study|transfer out of ICU|4
2763|NCT02382133|18828|P1|Overall Study|Death|22
2764|NCT02380742|18883|P2|Overall Study|Withdrawal by Subject|0
2765|NCT02380742|18884|P1|Overall Study|Withdrawal by Subject|1
2766|NCT02380287|18904|P8|Overall Study|Adverse Event|0
2767|NCT02380287|18905|P7|Overall Study|Adverse Event|0
2768|NCT02380287|18906|P6|Overall Study|Adverse Event|0
2769|NCT02380287|18907|P5|Overall Study|Adverse Event|0
2770|NCT02380287|18908|P4|Overall Study|Adverse Event|0
2771|NCT02380287|18909|P3|Overall Study|Adverse Event|1
2772|NCT02380287|18910|P2|Overall Study|Adverse Event|0
2773|NCT02380287|18911|P1|Overall Study|Adverse Event|0
2774|NCT02380248|18927|P1|Overall Study|Withdrawal by Subject|3
2775|NCT02380248|18927|P1|Overall Study|Lost to Follow-up|11
2776|NCT02379637|18934|P2|Overall Study|Withdrawal by Subject|0
2777|NCT02379637|18935|P1|Overall Study|Withdrawal by Subject|1
2778|NCT02379637|18934|P2|Overall Study|Adverse Event|0
2779|NCT02379637|18935|P1|Overall Study|Adverse Event|1
2780|NCT02379637|18934|P2|Overall Study|Protocol Violation|1
2781|NCT02379637|18935|P1|Overall Study|Protocol Violation|0
2782|NCT02378506|18943|P1|Overall Study|Randomized But Not Treated|1
2783|NCT02378506|18943|P1|Overall Study|Adverse Event|14
2784|NCT02378506|18943|P1|Overall Study|Death|1
2785|NCT02378506|18943|P1|Overall Study|Protocol Violation|2
2786|NCT02378506|18943|P1|Overall Study|Withdrawal by Subject|4
2787|NCT02378506|18943|P1|Overall Study|Lack of Efficacy|3
2788|NCT02375724|18983|P2|Overall Study|Adverse Event|4
2789|NCT02375724|18984|P1|Overall Study|Adverse Event|2
2790|NCT02375724|18983|P2|Overall Study|Protocol Violation|0
2791|NCT02375724|18984|P1|Overall Study|Protocol Violation|1
2792|NCT02375724|18983|P2|Overall Study|Lost to Follow-up|0
2793|NCT02375724|18984|P1|Overall Study|Lost to Follow-up|1
2794|NCT02375724|18983|P2|Overall Study|Withdrawal by Subject|1
2795|NCT02375724|18984|P1|Overall Study|Withdrawal by Subject|1
2796|NCT02375724|18983|P2|Overall Study|Lack of Efficacy|1
2797|NCT02375724|18984|P1|Overall Study|Lack of Efficacy|1
2798|NCT02375373|18994|P1|Overall Study|Withdrawal by Subject|11
2799|NCT02375347|18998|P1|Overall Study|Protocol Violation|1
2800|NCT02374346|19035|P1|Overall Study|operated or discharged during weekend|48
2801|NCT02372071|19108|P1|Overall Study|Protocol Violation|18
2802|NCT02372058|19113|P1|Overall Study|Withdrawal by Subject|3
2803|NCT02371759|19142|P8|Overall Study|Withdrawal by Subject|1
2804|NCT02371759|19143|P7|Overall Study|Withdrawal by Subject|0
2805|NCT02371759|19144|P6|Overall Study|Withdrawal by Subject|0
2806|NCT02371759|19145|P5|Overall Study|Withdrawal by Subject|0
2807|NCT02371759|19146|P4|Overall Study|Withdrawal by Subject|0
2808|NCT02371759|19147|P3|Overall Study|Withdrawal by Subject|0
2809|NCT02371759|19148|P2|Overall Study|Withdrawal by Subject|0
2810|NCT02371759|19149|P1|Overall Study|Withdrawal by Subject|0
2811|NCT02371759|19142|P8|Overall Study|Protocol Violation|3
2812|NCT02371759|19143|P7|Overall Study|Protocol Violation|0
2813|NCT02371759|19144|P6|Overall Study|Protocol Violation|1
2814|NCT02371759|19145|P5|Overall Study|Protocol Violation|3
2815|NCT02371759|19146|P4|Overall Study|Protocol Violation|0
2816|NCT02371759|19147|P3|Overall Study|Protocol Violation|1
2817|NCT02371759|19148|P2|Overall Study|Protocol Violation|1
2818|NCT02371759|19149|P1|Overall Study|Protocol Violation|3
2819|NCT02370914|19359|P1|Overall Study|Protocol Violation|2
2820|NCT02370667|19366|P3|Overall Study|Lost to Follow-up|0
2821|NCT02370667|19367|P2|Overall Study|Lost to Follow-up|1
2822|NCT02370667|19368|P1|Overall Study|Lost to Follow-up|0
2823|NCT02370615|19432|P2|Overall Study|Adverse Event|0
2824|NCT02370615|19433|P1|Overall Study|Adverse Event|1
2825|NCT02370602|19476|P6|Overall Study|Pretreatment Event/Adverse Event|0
2826|NCT02370602|19477|P5|Overall Study|Pretreatment Event/Adverse Event|0
2827|NCT02370602|19478|P4|Overall Study|Pretreatment Event/Adverse Event|0
2828|NCT02370602|19479|P3|Overall Study|Pretreatment Event/Adverse Event|0
2829|NCT02370602|19480|P2|Overall Study|Pretreatment Event/Adverse Event|0
2830|NCT02370602|19481|P1|Overall Study|Pretreatment Event/Adverse Event|1
2831|NCT02370537|19575|P3|Part B|Withdrawal by Subject|0
2832|NCT02370537|19576|P2|Part B|Withdrawal by Subject|1
2833|NCT02370537|19577|P1|Part B|Withdrawal by Subject|0
2834|NCT02370537|19575|P3|Part B|Not randomised to receive treatment|259
2835|NCT02370537|19576|P2|Part B|Not randomised to receive treatment|2
2836|NCT02370537|19577|P1|Part B|Not randomised to receive treatment|1
2837|NCT02370537|19575|P3|Part A (Open-label Recruitment)|Adverse Event|1
2838|NCT02370537|19576|P2|Part A (Open-label Recruitment)|Adverse Event|0
2839|NCT02370537|19577|P1|Part A (Open-label Recruitment)|Adverse Event|0
2840|NCT02370537|19575|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2841|NCT02370537|19576|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
2842|NCT02370537|19577|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
2843|NCT02370121|19651|P2|Overall Study|Lost to Follow-up|1
2844|NCT02370121|19652|P1|Overall Study|Lost to Follow-up|1
2845|NCT02369510|19741|P3|Overall Study|Epidural Activation|5
2846|NCT02369510|19742|P2|Overall Study|Epidural Activation|1
2847|NCT02369510|19743|P1|Overall Study|Epidural Activation|1
2848|NCT02369510|19741|P3|Overall Study|Spilled Medication|1
2849|NCT02369510|19742|P2|Overall Study|Spilled Medication|2
2850|NCT02369510|19743|P1|Overall Study|Spilled Medication|1
2851|NCT02369341|19774|P2|Overall Study|Migrated/moved from study area|0
2852|NCT02369341|19775|P1|Overall Study|Migrated/moved from study area|1
2853|NCT02368314|19842|P2|Overall Study|Adverse Event|2
2854|NCT02368314|19843|P1|Overall Study|Adverse Event|1
2855|NCT02368314|19842|P2|Overall Study|Withdrawal by Subject|1
2856|NCT02368314|19843|P1|Overall Study|Withdrawal by Subject|2
2857|NCT02367885|19865|P3|Overall Study|Withdrawal by Subject|0
2858|NCT02367885|19866|P2|Overall Study|Withdrawal by Subject|0
2859|NCT02367885|19867|P1|Overall Study|Withdrawal by Subject|1
2860|NCT02367885|19865|P3|Overall Study|Lost to Follow-up|0
2861|NCT02367885|19866|P2|Overall Study|Lost to Follow-up|0
2862|NCT02367885|19867|P1|Overall Study|Lost to Follow-up|1
2863|NCT02366936|20195|P1|Overall Study|Physician Decision|2
2864|NCT02366936|20195|P1|Overall Study|Lost to Follow-up|4
2865|NCT02366936|20195|P1|Overall Study|Withdrawal by Subject|2
2866|NCT02366923|20200|P1|Overall Study|High Astigmatism|3
2867|NCT02366923|20200|P1|Overall Study|Positive Slit Lamp Findings|2
2868|NCT02366923|20200|P1|Overall Study|Withdrawal by Subject|1
2869|NCT02366910|20213|P1|Overall Study|Screen Failure|3
2870|NCT02366910|20213|P1|Overall Study|Withdrawal by Subject|2
2871|NCT02366767|20227|P2|Overall Study|left for home after 1 day at camp|0
2872|NCT02366767|20228|P1|Overall Study|left for home after 1 day at camp|1
2873|NCT02366689|20241|P3|Overall Study|Pregnancy|1
2874|NCT02366689|20242|P2|Overall Study|Pregnancy|1
2875|NCT02366689|20243|P1|Overall Study|Pregnancy|0
2876|NCT02366689|20241|P3|Overall Study|Lost to Follow-up|0
2877|NCT02366689|20242|P2|Overall Study|Lost to Follow-up|2
2878|NCT02366689|20243|P1|Overall Study|Lost to Follow-up|3
2879|NCT02366689|20241|P3|Overall Study|Withdrawal by Subject|1
2880|NCT02366689|20242|P2|Overall Study|Withdrawal by Subject|0
2881|NCT02366689|20243|P1|Overall Study|Withdrawal by Subject|1
2882|NCT02366637|20266|P2|Second Intervention Period|Study Terminated by Sponsor|1
2883|NCT02366637|20267|P1|Second Intervention Period|Study Terminated by Sponsor|1
2884|NCT02366637|20266|P2|First Intervention Period|Study Terminated by Sponsor|4
2885|NCT02366637|20267|P1|First Intervention Period|Study Terminated by Sponsor|6
2886|NCT02366637|20266|P2|First Intervention Period|Adverse Event|1
2887|NCT02366637|20267|P1|First Intervention Period|Adverse Event|0
2888|NCT02365298|20308|P2|Period 2|Protocol Violation|1
2889|NCT02365298|20309|P1|Period 2|Protocol Violation|0
2890|NCT02365298|20308|P2|Period 2|Test Article longer available|1
2891|NCT02365298|20309|P1|Period 2|Test Article longer available|0
2892|NCT02365298|20308|P2|Period 2|Discontinued at request of Sponsor|0
2893|NCT02365298|20309|P1|Period 2|Discontinued at request of Sponsor|1
2894|NCT02365298|20308|P2|Period 2|incorrect Rx dispensed|0
2895|NCT02365298|20309|P1|Period 2|incorrect Rx dispensed|1
2896|NCT02364180|20348|P1|Overall Study|Screen Fail|1
2897|NCT02363478|20356|P1|Overall Study|Adverse Event|4
2898|NCT02363478|20356|P1|Overall Study|Lost to Follow-up|4
2899|NCT02362412|20363|P2|Treatment Period III|Lost to Follow-up|1
2900|NCT02362412|20364|P1|Treatment Period III|Lost to Follow-up|0
2901|NCT02362360|20398|P2|Period 1|Withdrawal by Subject|1
2902|NCT02362360|20399|P1|Period 1|Withdrawal by Subject|2
2903|NCT02362360|20398|P2|Period 1|Lack of Efficacy|0
2904|NCT02362360|20399|P1|Period 1|Lack of Efficacy|1
2905|NCT02361580|20437|P2|Overall Study|Lost to Follow-up|3
2906|NCT02361580|20438|P1|Overall Study|Lost to Follow-up|6
2907|NCT02360995|20451|P3|Overall Study|Withdrawal by Subject|0
2908|NCT02360995|20452|P2|Overall Study|Withdrawal by Subject|1
2909|NCT02360995|20453|P1|Overall Study|Withdrawal by Subject|0
2910|NCT02360995|20451|P3|Overall Study|Lost to Follow-up|2
2911|NCT02360995|20452|P2|Overall Study|Lost to Follow-up|0
2912|NCT02360995|20453|P1|Overall Study|Lost to Follow-up|2
2913|NCT02360475|20480|P4|Overall Study|Migrated/moved from study area|1
2914|NCT02360475|20481|P3|Overall Study|Migrated/moved from study area|0
2915|NCT02360475|20482|P2|Overall Study|Migrated/moved from study area|0
2916|NCT02360475|20483|P1|Overall Study|Migrated/moved from study area|0
2917|NCT02360475|20480|P4|Overall Study|Withdrawal by Subject|0
2918|NCT02360475|20481|P3|Overall Study|Withdrawal by Subject|2
2919|NCT02360475|20482|P2|Overall Study|Withdrawal by Subject|1
2920|NCT02360475|20483|P1|Overall Study|Withdrawal by Subject|0
2921|NCT02360475|20480|P4|Overall Study|Lost to Follow-up|4
2922|NCT02360475|20481|P3|Overall Study|Lost to Follow-up|6
2923|NCT02360475|20482|P2|Overall Study|Lost to Follow-up|12
2924|NCT02360475|20483|P1|Overall Study|Lost to Follow-up|4
2925|NCT02359903|20587|P2|Overall Study|Adverse Event|2
2926|NCT02359903|20588|P1|Overall Study|Adverse Event|0
2927|NCT02359877|20600|P4|Overall Study|Adverse Event|1
2928|NCT02359877|20601|P3|Overall Study|Adverse Event|0
2929|NCT02359877|20602|P2|Overall Study|Adverse Event|0
2930|NCT02359877|20603|P1|Overall Study|Adverse Event|0
2931|NCT02359877|20600|P4|Overall Study|Withdrawal by Subject|2
2932|NCT02359877|20601|P3|Overall Study|Withdrawal by Subject|0
2933|NCT02359877|20602|P2|Overall Study|Withdrawal by Subject|0
2934|NCT02359877|20603|P1|Overall Study|Withdrawal by Subject|1
2935|NCT02359435|20655|P2|Overall Study|Lost to Follow-up|4
2936|NCT02359435|20656|P1|Overall Study|Lost to Follow-up|4
2937|NCT02359045|20664|P2|Overall Study|Adverse Event|1
2938|NCT02359045|20665|P1|Overall Study|Adverse Event|0
2939|NCT02359045|20664|P2|Overall Study|Lost to Follow-up|1
2940|NCT02359045|20665|P1|Overall Study|Lost to Follow-up|1
2941|NCT02359045|20664|P2|Overall Study|Eligibility criteria not fulfilled|1
2942|NCT02359045|20665|P1|Overall Study|Eligibility criteria not fulfilled|3
2943|NCT02358668|20905|P3|Overall Study|Withdrawal by Subject|0
2944|NCT02358668|20906|P2|Overall Study|Withdrawal by Subject|1
2945|NCT02358668|20907|P1|Overall Study|Withdrawal by Subject|0
2946|NCT02358668|20905|P3|Overall Study|Adverse Event|0
2947|NCT02358668|20906|P2|Overall Study|Adverse Event|0
2948|NCT02358668|20907|P1|Overall Study|Adverse Event|2
2949|NCT02358044|21049|P2|Overall Study|Withdrawal by Subject|4
2950|NCT02358044|21050|P1|Overall Study|Withdrawal by Subject|0
2951|NCT02358044|21049|P2|Overall Study|Physician Decision|1
2952|NCT02358044|21050|P1|Overall Study|Physician Decision|0
2953|NCT02358044|21049|P2|Overall Study|Lost to Follow-up|1
2954|NCT02358044|21050|P1|Overall Study|Lost to Follow-up|2
2955|NCT02358044|21049|P2|Overall Study|Adverse Event|1
2956|NCT02358044|21050|P1|Overall Study|Adverse Event|0
2957|NCT02357940|21068|P2|Overall Study|Investigator's judgement|1
2958|NCT02357940|21069|P1|Overall Study|Investigator's judgement|0
2959|NCT02357940|21068|P2|Overall Study|Adverse Event|1
2960|NCT02357940|21069|P1|Overall Study|Adverse Event|0
2961|NCT02357342|21203|P2|First 6 Months|Death|0
2962|NCT02357342|21204|P1|First 6 Months|Death|2
2963|NCT02356588|21246|P2|Overall Study|Protocol Violation|1
2964|NCT02356588|21247|P1|Overall Study|Protocol Violation|0
2965|NCT02356588|21246|P2|Overall Study|Withdrawal by Subject|0
2966|NCT02356588|21247|P1|Overall Study|Withdrawal by Subject|1
2967|NCT02356588|21246|P2|Overall Study|Adverse Event|2
2968|NCT02356588|21247|P1|Overall Study|Adverse Event|0
2969|NCT02356588|21246|P2|Overall Study|Lack of Efficacy|10
2970|NCT02356588|21247|P1|Overall Study|Lack of Efficacy|4
2971|NCT02354599|21341|P6|Overall Study|Withdrawal by Subject|0
2972|NCT02354599|21342|P5|Overall Study|Withdrawal by Subject|0
2973|NCT02354599|21343|P4|Overall Study|Withdrawal by Subject|0
2974|NCT02354599|21344|P3|Overall Study|Withdrawal by Subject|0
2975|NCT02354599|21345|P2|Overall Study|Withdrawal by Subject|1
2976|NCT02354599|21346|P1|Overall Study|Withdrawal by Subject|1
2977|NCT02354599|21341|P6|Overall Study|Pretreatment Event/Adverse Event|1
2978|NCT02354599|21342|P5|Overall Study|Pretreatment Event/Adverse Event|0
2979|NCT02354599|21343|P4|Overall Study|Pretreatment Event/Adverse Event|0
2980|NCT02354599|21344|P3|Overall Study|Pretreatment Event/Adverse Event|0
2981|NCT02354599|21345|P2|Overall Study|Pretreatment Event/Adverse Event|0
2982|NCT02354599|21346|P1|Overall Study|Pretreatment Event/Adverse Event|0
2983|NCT02353572|21429|P1|Overall Study|Study terminated|2
2984|NCT02353572|21429|P1|Overall Study|Withdrawal by Subject|1
2985|NCT02353468|21433|P1|Overall Study|Study terminated|3
2986|NCT02353442|21439|P2|Overall Study|Withdrawal by Subject|4
2987|NCT02353442|21440|P1|Overall Study|Withdrawal by Subject|3
2988|NCT02352779|21457|P3|Overall Study|No Reason|1
2989|NCT02352779|21458|P2|Overall Study|No Reason|0
2990|NCT02352779|21459|P1|Overall Study|No Reason|0
2991|NCT02352779|21457|P3|Overall Study|Other Medical Reason|1
2992|NCT02352779|21458|P2|Overall Study|Other Medical Reason|0
2993|NCT02352779|21459|P1|Overall Study|Other Medical Reason|0
2994|NCT02352779|21457|P3|Overall Study|Absence of Symptoms|0
2995|NCT02352779|21458|P2|Overall Study|Absence of Symptoms|0
2996|NCT02352779|21459|P1|Overall Study|Absence of Symptoms|1
2997|NCT02352779|21457|P3|Overall Study|Study Related Symptoms|0
2998|NCT02352779|21458|P2|Overall Study|Study Related Symptoms|0
2999|NCT02352779|21459|P1|Overall Study|Study Related Symptoms|1
3000|NCT02352779|21457|P3|Overall Study|Changed Mind|0
3001|NCT02352779|21458|P2|Overall Study|Changed Mind|0
3002|NCT02352779|21459|P1|Overall Study|Changed Mind|1
3003|NCT02352779|21457|P3|Overall Study|Disliked Intervention|0
3004|NCT02352779|21458|P2|Overall Study|Disliked Intervention|0
3005|NCT02352779|21459|P1|Overall Study|Disliked Intervention|1
3006|NCT02352779|21457|P3|Overall Study|Feeling Overwhelmed|0
3007|NCT02352779|21458|P2|Overall Study|Feeling Overwhelmed|0
3008|NCT02352779|21459|P1|Overall Study|Feeling Overwhelmed|1
3009|NCT02352779|21457|P3|Overall Study|Too Many Forms|0
3010|NCT02352779|21458|P2|Overall Study|Too Many Forms|0
3011|NCT02352779|21459|P1|Overall Study|Too Many Forms|2
3012|NCT02352779|21457|P3|Overall Study|Personal Issues|0
3013|NCT02352779|21458|P2|Overall Study|Personal Issues|1
3014|NCT02352779|21459|P1|Overall Study|Personal Issues|1
3015|NCT02351934|21474|P2|Follow-Up|ERAS Noncompliant|10
3016|NCT02351934|21475|P1|Follow-Up|ERAS Noncompliant|0
3017|NCT02351934|21474|P2|Follow-Up|Acute Kidney Injury|0
3018|NCT02351934|21475|P1|Follow-Up|Acute Kidney Injury|7
3019|NCT02351934|21474|P2|Allocation|Hypotension preventing administration|0
3020|NCT02351934|21475|P1|Allocation|Hypotension preventing administration|3
3021|NCT02351934|21474|P2|Allocation|No medication due to complications|0
3022|NCT02351934|21475|P1|Allocation|No medication due to complications|8
3023|NCT02351817|21491|P2|Period 2|Protocol Violation|0
3024|NCT02351817|21492|P1|Period 2|Protocol Violation|1
3025|NCT02351817|21491|P2|Period 2|Adverse Event|2
3026|NCT02351817|21492|P1|Period 2|Adverse Event|0
3027|NCT02351817|21491|P2|Period 1|Lack of Efficacy|1
3028|NCT02351817|21492|P1|Period 1|Lack of Efficacy|0
3029|NCT02351817|21491|P2|Period 1|Adverse Event|2
3030|NCT02351817|21492|P1|Period 1|Adverse Event|1
3031|NCT02349711|21550|P2|Overall Study|Lost to Follow-up|1
3032|NCT02349711|21551|P1|Overall Study|Lost to Follow-up|1
3033|NCT02349711|21550|P2|Overall Study|Withdrawal by Subject|1
3034|NCT02349711|21551|P1|Overall Study|Withdrawal by Subject|2
3035|NCT02349542|21579|P1|Overall Study|Withdrawal by Subject|5
3036|NCT02349451|21588|P4|Overall Study|Withdrawal by Subject|1
3037|NCT02349451|21589|P3|Overall Study|Withdrawal by Subject|2
3038|NCT02349451|21590|P2|Overall Study|Withdrawal by Subject|1
3039|NCT02349451|21591|P1|Overall Study|Withdrawal by Subject|0
3040|NCT02349048|21640|P2|Overall Study|Lost to Follow-up|0
3041|NCT02349048|21641|P1|Overall Study|Lost to Follow-up|1
3042|NCT02349048|21640|P2|Overall Study|Withdrawal by Subject|0
3043|NCT02349048|21641|P1|Overall Study|Withdrawal by Subject|4
3044|NCT02347176|21710|P4|Overall Study|Unspecified|0
3045|NCT02347176|21711|P3|Overall Study|Unspecified|2
3046|NCT02347176|21712|P2|Overall Study|Unspecified|2
3047|NCT02347176|21713|P1|Overall Study|Unspecified|1
3048|NCT02347176|21710|P4|Overall Study|Withdrawal by Subject|3
3049|NCT02347176|21711|P3|Overall Study|Withdrawal by Subject|5
3050|NCT02347176|21712|P2|Overall Study|Withdrawal by Subject|5
3051|NCT02347176|21713|P1|Overall Study|Withdrawal by Subject|9
3052|NCT02347176|21710|P4|Overall Study|Lost to Follow-up|1
3053|NCT02347176|21711|P3|Overall Study|Lost to Follow-up|1
3054|NCT02347176|21712|P2|Overall Study|Lost to Follow-up|3
3055|NCT02347176|21713|P1|Overall Study|Lost to Follow-up|2
3056|NCT02347085|21759|P1|Overall Study|Protocol Criteria|2
3057|NCT02347085|21759|P1|Overall Study|Lost to Follow-up|1
3058|NCT02347085|21759|P1|Overall Study|Withdrawal by Subject|4
3059|NCT02347085|21759|P1|Overall Study|Lack of Efficacy|1
3060|NCT02347085|21759|P1|Overall Study|Adverse Event|2
3061|NCT02347072|21781|P1|Overall Study|Disc due to Protocol-specified Criteria|6
3062|NCT02347072|21781|P1|Overall Study|Protocol Violation|1
3063|NCT02347072|21781|P1|Overall Study|Lost to Follow-up|2
3064|NCT02347072|21781|P1|Overall Study|Physician Decision|1
3065|NCT02347072|21781|P1|Overall Study|Withdrawal by Subject|6
3066|NCT02347072|21781|P1|Overall Study|Adverse Event|2
3067|NCT02346877|21815|P2|Overall Study|Missing|0
3068|NCT02346877|21816|P1|Overall Study|Missing|5
3069|NCT02346877|21815|P2|Overall Study|Sponsor Decision|0
3070|NCT02346877|21816|P1|Overall Study|Sponsor Decision|12
3071|NCT02346877|21815|P2|Overall Study|Administrative Decision|0
3072|NCT02346877|21816|P1|Overall Study|Administrative Decision|1
3073|NCT02346877|21815|P2|Overall Study|Adverse Event|0
3074|NCT02346877|21816|P1|Overall Study|Adverse Event|1
3075|NCT02346721|21826|P1|Overall Study|Lack of Efficacy|1
3076|NCT02346721|21826|P1|Overall Study|Withdrew Consent|3
3077|NCT02344745|21843|P2|Overall Study|Data collection sheets were lost|0
3078|NCT02344745|21844|P1|Overall Study|Data collection sheets were lost|2
3079|NCT02344342|21876|P4|Overall Study|Industry partner dropped out|10
3080|NCT02344342|21877|P3|Overall Study|Industry partner dropped out|14
3081|NCT02344342|21878|P2|Overall Study|Industry partner dropped out|9
3082|NCT02344342|21879|P1|Overall Study|Industry partner dropped out|11
3083|NCT02343159|21917|P3|Overall Study|Enrollment Error|0
3084|NCT02343159|21918|P2|Overall Study|Enrollment Error|0
3085|NCT02343159|21919|P1|Overall Study|Enrollment Error|1
3086|NCT02343159|21917|P3|Overall Study|Sponsor Decision|0
3087|NCT02343159|21918|P2|Overall Study|Sponsor Decision|1
3088|NCT02343159|21919|P1|Overall Study|Sponsor Decision|0
3089|NCT02343159|21917|P3|Overall Study|Adverse Event|2
3090|NCT02343159|21918|P2|Overall Study|Adverse Event|4
3091|NCT02343159|21919|P1|Overall Study|Adverse Event|4
3092|NCT02343159|21917|P3|Overall Study|Lost to Follow-up|2
3093|NCT02343159|21918|P2|Overall Study|Lost to Follow-up|2
3094|NCT02343159|21919|P1|Overall Study|Lost to Follow-up|0
3095|NCT02343159|21917|P3|Overall Study|Withdrawal by Subject|2
3096|NCT02343159|21918|P2|Overall Study|Withdrawal by Subject|0
3097|NCT02343159|21919|P1|Overall Study|Withdrawal by Subject|3
3098|NCT02343159|21917|P3|Overall Study|Physician Decision|1
3099|NCT02343159|21918|P2|Overall Study|Physician Decision|0
3100|NCT02343159|21919|P1|Overall Study|Physician Decision|2
3101|NCT02343159|21917|P3|Overall Study|Early Study Termination|23
3102|NCT02343159|21918|P2|Overall Study|Early Study Termination|19
3103|NCT02343159|21919|P1|Overall Study|Early Study Termination|16
3104|NCT02342704|22117|P2|Overall Study|Adverse Event|3
3105|NCT02342704|22118|P1|Overall Study|Adverse Event|1
3106|NCT02342704|22117|P2|Overall Study|Lost to Follow-up|1
3107|NCT02342704|22118|P1|Overall Study|Lost to Follow-up|2
3108|NCT02342704|22117|P2|Overall Study|Withdrawal by Subject|0
3109|NCT02342704|22118|P1|Overall Study|Withdrawal by Subject|1
3110|NCT02342704|22117|P2|Overall Study|Not Specified|1
3111|NCT02342704|22118|P1|Overall Study|Not Specified|0
3112|NCT02342704|22117|P2|Overall Study|Sponsor Termination|43
3113|NCT02342704|22118|P1|Overall Study|Sponsor Termination|49
3114|NCT02342704|22117|P2|Overall Study|Physician Decision|3
3115|NCT02342704|22118|P1|Overall Study|Physician Decision|0
3116|NCT02342418|22158|P2|Overall Study|Adverse Event|1
3117|NCT02342418|22159|P1|Overall Study|Adverse Event|0
3118|NCT02342288|22169|P2|Overall Study|coordinator not available|2
3119|NCT02342288|22170|P1|Overall Study|coordinator not available|0
3120|NCT02342288|22169|P2|Overall Study|subject cannot tolerate numbing drops|1
3121|NCT02342288|22170|P1|Overall Study|subject cannot tolerate numbing drops|0
3122|NCT02342288|22169|P2|Overall Study|coordinator contaminated with blood|1
3123|NCT02342288|22170|P1|Overall Study|coordinator contaminated with blood|0
3124|NCT02342288|22169|P2|Overall Study|Withdrawal by Subject|0
3125|NCT02342288|22170|P1|Overall Study|Withdrawal by Subject|1
3126|NCT02342288|22169|P2|Overall Study|anesthesia leak in system|0
3127|NCT02342288|22170|P1|Overall Study|anesthesia leak in system|1
3128|NCT02342288|22169|P2|Overall Study|no protocol anesthesiologist available|2
3129|NCT02342288|22170|P1|Overall Study|no protocol anesthesiologist available|3
3130|NCT02342223|22176|P1|Overall Study|Lost to Follow-up|1
3131|NCT02341482|22194|P1|Overall Study|Adverse Event|1
3132|NCT02340000|22280|P2|Time Period 2|Lost to Follow-up|8
3133|NCT02340000|22281|P1|Time Period 2|Lost to Follow-up|10
3134|NCT02340000|22280|P2|Time Period 2|Withdrawal by Subject|7
3135|NCT02340000|22281|P1|Time Period 2|Withdrawal by Subject|9
3136|NCT02340000|22280|P2|Time Period 1|Lost to Follow-up|7
3137|NCT02340000|22281|P1|Time Period 1|Lost to Follow-up|6
3138|NCT02340000|22280|P2|Time Period 1|Withdrawal by Subject|8
3139|NCT02340000|22281|P1|Time Period 1|Withdrawal by Subject|6
3140|NCT02336607|22452|P4|Overall Study|Withdrawal by Subject|20
3141|NCT02336607|22453|P3|Overall Study|Withdrawal by Subject|0
3142|NCT02336607|22454|P2|Overall Study|Withdrawal by Subject|2
3143|NCT02336607|22455|P1|Overall Study|Withdrawal by Subject|0
3144|NCT02336607|22452|P4|Overall Study|Adverse Event|26
3145|NCT02336607|22453|P3|Overall Study|Adverse Event|2
3146|NCT02336607|22454|P2|Overall Study|Adverse Event|2
3147|NCT02336607|22455|P1|Overall Study|Adverse Event|0
3148|NCT02336607|22452|P4|Overall Study|Protocol Violation|3
3149|NCT02336607|22453|P3|Overall Study|Protocol Violation|1
3150|NCT02336607|22454|P2|Overall Study|Protocol Violation|1
3151|NCT02336607|22455|P1|Overall Study|Protocol Violation|0
3152|NCT02336607|22452|P4|Overall Study|Lost to Follow-up|21
3153|NCT02336607|22453|P3|Overall Study|Lost to Follow-up|0
3154|NCT02336607|22454|P2|Overall Study|Lost to Follow-up|1
3155|NCT02336607|22455|P1|Overall Study|Lost to Follow-up|2
3156|NCT02336607|22452|P4|Overall Study|Lack of Efficacy|2
3157|NCT02336607|22453|P3|Overall Study|Lack of Efficacy|0
3158|NCT02336607|22454|P2|Overall Study|Lack of Efficacy|0
3159|NCT02336607|22455|P1|Overall Study|Lack of Efficacy|1
3160|NCT02336607|22452|P4|Overall Study|Physician Decision|15
3161|NCT02336607|22453|P3|Overall Study|Physician Decision|3
3162|NCT02336607|22454|P2|Overall Study|Physician Decision|4
3163|NCT02336607|22455|P1|Overall Study|Physician Decision|1
3164|NCT02336425|22522|P4|Overall Study|Study terminated.|3
3165|NCT02336425|22523|P3|Overall Study|Study terminated.|3
3166|NCT02336425|22524|P2|Overall Study|Study terminated.|2
3167|NCT02336425|22525|P1|Overall Study|Study terminated.|2
3168|NCT02336178|22575|P1|Overall Study|Unspecified|1
3169|NCT02336178|22575|P1|Overall Study|Withdrawal by Subject|1
3170|NCT02336178|22575|P1|Overall Study|Protocol Violation|1
3171|NCT02336178|22575|P1|Overall Study|Lost to Follow-up|1
3172|NCT02335489|22689|P1|Overall Study|Lack of Efficacy|1
3173|NCT02335489|22689|P1|Overall Study|Physician Decision|2
3174|NCT02335489|22689|P1|Overall Study|Withdrawal by Subject|2
3175|NCT02335489|22689|P1|Overall Study|Lost to Follow-up|1
3176|NCT02335489|22689|P1|Overall Study|Sponsor terminated study|4
3177|NCT02332798|22871|P3|Overall Study|Abnormal laboratory findings|0
3178|NCT02332798|22872|P2|Overall Study|Abnormal laboratory findings|0
3179|NCT02332798|22873|P1|Overall Study|Abnormal laboratory findings|1
3180|NCT02332798|22871|P3|Overall Study|Positive urine drug test|0
3181|NCT02332798|22872|P2|Overall Study|Positive urine drug test|1
3182|NCT02332798|22873|P1|Overall Study|Positive urine drug test|0
3183|NCT02332798|22871|P3|Overall Study|Unwilling to participate in study|1
3184|NCT02332798|22872|P2|Overall Study|Unwilling to participate in study|1
3185|NCT02332798|22873|P1|Overall Study|Unwilling to participate in study|0
3186|NCT02332590|22925|P2|Overall Study|Other than specified above|5
3187|NCT02332590|22926|P1|Overall Study|Other than specified above|6
3188|NCT02332590|22925|P2|Overall Study|Randomized but not treated|0
3189|NCT02332590|22926|P1|Overall Study|Randomized but not treated|1
3190|NCT02332590|22925|P2|Overall Study|Poor compliance to protocol|1
3191|NCT02332590|22926|P1|Overall Study|Poor compliance to protocol|3
3192|NCT02332590|22925|P2|Overall Study|Lack of Efficacy|2
3193|NCT02332590|22926|P1|Overall Study|Lack of Efficacy|4
3194|NCT02332590|22925|P2|Overall Study|Adverse Event|11
3195|NCT02332590|22926|P1|Overall Study|Adverse Event|15
3196|NCT02331446|23022|P4|Overall Study|Lost before baseline analysis|0
3197|NCT02331446|23023|P3|Overall Study|Lost before baseline analysis|1
3198|NCT02331446|23024|P2|Overall Study|Lost before baseline analysis|1
3199|NCT02331446|23025|P1|Overall Study|Lost before baseline analysis|0
3200|NCT02331446|23022|P4|Overall Study|Physician Decision|1
3201|NCT02331446|23023|P3|Overall Study|Physician Decision|0
3202|NCT02331446|23024|P2|Overall Study|Physician Decision|1
3203|NCT02331446|23025|P1|Overall Study|Physician Decision|0
3204|NCT02331446|23022|P4|Overall Study|Disease|1
3205|NCT02331446|23023|P3|Overall Study|Disease|2
3206|NCT02331446|23024|P2|Overall Study|Disease|2
3207|NCT02331446|23025|P1|Overall Study|Disease|0
3208|NCT02331446|23022|P4|Overall Study|Personal Problem|0
3209|NCT02331446|23023|P3|Overall Study|Personal Problem|0
3210|NCT02331446|23024|P2|Overall Study|Personal Problem|0
3211|NCT02331446|23025|P1|Overall Study|Personal Problem|2
3212|NCT02331446|23022|P4|Overall Study|Lost to Follow-up|1
3213|NCT02331446|23023|P3|Overall Study|Lost to Follow-up|0
3214|NCT02331446|23024|P2|Overall Study|Lost to Follow-up|1
3215|NCT02331446|23025|P1|Overall Study|Lost to Follow-up|2
3216|NCT02329730|23240|P12|Overall Study|Withdrawal by Subject|0
3217|NCT02329730|23241|P11|Overall Study|Withdrawal by Subject|0
3218|NCT02329730|23242|P10|Overall Study|Withdrawal by Subject|1
3219|NCT02329730|23243|P9|Overall Study|Withdrawal by Subject|1
3220|NCT02329730|23244|P8|Overall Study|Withdrawal by Subject|1
3221|NCT02329730|23245|P7|Overall Study|Withdrawal by Subject|1
3222|NCT02329730|23246|P6|Overall Study|Withdrawal by Subject|0
3223|NCT02329730|23247|P5|Overall Study|Withdrawal by Subject|1
3224|NCT02329730|23248|P4|Overall Study|Withdrawal by Subject|0
3225|NCT02329730|23249|P3|Overall Study|Withdrawal by Subject|0
3226|NCT02329730|23250|P2|Overall Study|Withdrawal by Subject|0
3227|NCT02329730|23251|P1|Overall Study|Withdrawal by Subject|0
3228|NCT02329730|23240|P12|Overall Study|Protocol Violation|0
3229|NCT02329730|23241|P11|Overall Study|Protocol Violation|0
3230|NCT02329730|23242|P10|Overall Study|Protocol Violation|0
3231|NCT02329730|23243|P9|Overall Study|Protocol Violation|0
3232|NCT02329730|23244|P8|Overall Study|Protocol Violation|0
3233|NCT02329730|23245|P7|Overall Study|Protocol Violation|0
3234|NCT02329730|23246|P6|Overall Study|Protocol Violation|2
3235|NCT02329730|23247|P5|Overall Study|Protocol Violation|2
3236|NCT02329730|23248|P4|Overall Study|Protocol Violation|0
3237|NCT02329730|23249|P3|Overall Study|Protocol Violation|0
3238|NCT02329730|23250|P2|Overall Study|Protocol Violation|0
3239|NCT02329730|23251|P1|Overall Study|Protocol Violation|0
3240|NCT02329431|23343|P2|Overall Study|Lost to Follow-up|13
3241|NCT02329431|23344|P1|Overall Study|Lost to Follow-up|20
3242|NCT02329223|23363|P3|Overall Study|Adverse Event|0
3243|NCT02329223|23364|P2|Overall Study|Adverse Event|1
3244|NCT02329223|23365|P1|Overall Study|Adverse Event|0
3245|NCT02329223|23363|P3|Overall Study|Physician Decision|1
3246|NCT02329223|23364|P2|Overall Study|Physician Decision|0
3247|NCT02329223|23365|P1|Overall Study|Physician Decision|0
3248|NCT02329223|23363|P3|Overall Study|Withdrawal by Subject|5
3249|NCT02329223|23364|P2|Overall Study|Withdrawal by Subject|2
3250|NCT02329223|23365|P1|Overall Study|Withdrawal by Subject|1
3251|NCT02328937|23415|P6|Period 2|Adverse Event|0
3252|NCT02328937|23416|P5|Period 2|Adverse Event|0
3253|NCT02328937|23417|P4|Period 2|Adverse Event|0
3254|NCT02328937|23418|P3|Period 2|Adverse Event|1
3255|NCT02328937|23419|P2|Period 2|Adverse Event|0
3256|NCT02328937|23420|P1|Period 2|Adverse Event|0
3257|NCT02328937|23415|P6|Period 1|Lost to Follow-up|0
3258|NCT02328937|23416|P5|Period 1|Lost to Follow-up|0
3259|NCT02328937|23417|P4|Period 1|Lost to Follow-up|1
3260|NCT02328937|23418|P3|Period 1|Lost to Follow-up|0
3261|NCT02328937|23419|P2|Period 1|Lost to Follow-up|0
3262|NCT02328937|23420|P1|Period 1|Lost to Follow-up|0
3263|NCT02325713|23535|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3264|NCT02325713|23536|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3265|NCT02325713|23537|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3266|NCT02325713|23538|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3267|NCT02325713|23539|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3268|NCT02325713|23540|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3269|NCT02325713|23541|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
3270|NCT02325713|23542|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3271|NCT02325713|23543|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3272|NCT02325713|23544|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3273|NCT02325713|23545|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3274|NCT02325713|23546|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3275|NCT02325713|23547|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3276|NCT02325713|23548|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3277|NCT02325713|23549|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3278|NCT02325713|23550|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
3279|NCT02325713|23535|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3280|NCT02325713|23536|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3281|NCT02325713|23537|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3282|NCT02325713|23538|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3283|NCT02325713|23539|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3284|NCT02325713|23540|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3285|NCT02325713|23541|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3286|NCT02325713|23542|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3287|NCT02325713|23543|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3288|NCT02325713|23544|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3289|NCT02325713|23545|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3290|NCT02325713|23546|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3291|NCT02325713|23547|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3292|NCT02325713|23548|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3293|NCT02325713|23549|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
3294|NCT02325713|23550|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
3295|NCT02325713|23535|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3296|NCT02325713|23536|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3297|NCT02325713|23537|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3298|NCT02325713|23538|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3299|NCT02325713|23539|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3300|NCT02325713|23540|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
3301|NCT02325713|23541|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3302|NCT02325713|23542|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3303|NCT02325713|23543|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3304|NCT02325713|23544|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3305|NCT02325713|23545|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3306|NCT02325713|23546|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3307|NCT02325713|23547|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3308|NCT02325713|23548|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3309|NCT02325713|23549|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3310|NCT02325713|23550|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
3311|NCT02325518|23645|P2|Overall Study|Withdrawal by Subject|1
3312|NCT02325518|23646|P1|Overall Study|Withdrawal by Subject|0
3313|NCT02325518|23645|P2|Overall Study|Physician Decision|1
3314|NCT02325518|23646|P1|Overall Study|Physician Decision|0
3315|NCT02325518|23645|P2|Overall Study|Adverse Event|1
3316|NCT02325518|23646|P1|Overall Study|Adverse Event|4
3317|NCT02322892|23768|P2|Overall Study|Protocol Violation|0
3318|NCT02322892|23769|P1|Overall Study|Protocol Violation|1
3319|NCT02322892|23768|P2|Overall Study|Met exclusion criteria|1
3320|NCT02322892|23769|P1|Overall Study|Met exclusion criteria|0
3321|NCT02322892|23768|P2|Overall Study|Surgery cancelled|2
3322|NCT02322892|23769|P1|Overall Study|Surgery cancelled|1
3323|NCT02322775|23798|P2|Overall Study|Not willing to perform all FU visits|1
3324|NCT02322775|23799|P1|Overall Study|Not willing to perform all FU visits|0
3325|NCT02322775|23798|P2|Overall Study|Withdrawal by Subject|4
3326|NCT02322775|23799|P1|Overall Study|Withdrawal by Subject|3
3327|NCT02322775|23798|P2|Overall Study|Protocol Violation|0
3328|NCT02322775|23799|P1|Overall Study|Protocol Violation|1
3329|NCT02322775|23798|P2|Overall Study|Lost to Follow-up|1
3330|NCT02322775|23799|P1|Overall Study|Lost to Follow-up|0
3331|NCT02322775|23798|P2|Overall Study|Adverse Event|0
3332|NCT02322775|23799|P1|Overall Study|Adverse Event|1
3333|NCT02322749|23825|P6|Period 3|Withdrawal by Subject|0
3334|NCT02322749|23826|P5|Period 3|Withdrawal by Subject|0
3335|NCT02322749|23827|P4|Period 3|Withdrawal by Subject|0
3336|NCT02322749|23828|P3|Period 3|Withdrawal by Subject|1
3337|NCT02322749|23829|P2|Period 3|Withdrawal by Subject|0
3338|NCT02322749|23830|P1|Period 3|Withdrawal by Subject|0
3339|NCT02322749|23825|P6|Period 2|Withdrawal by Subject|0
3340|NCT02322749|23826|P5|Period 2|Withdrawal by Subject|0
3341|NCT02322749|23827|P4|Period 2|Withdrawal by Subject|1
3342|NCT02322749|23828|P3|Period 2|Withdrawal by Subject|0
3343|NCT02322749|23829|P2|Period 2|Withdrawal by Subject|0
3344|NCT02322749|23830|P1|Period 2|Withdrawal by Subject|0
3345|NCT02322749|23825|P6|Period 2|Adverse Event|0
3346|NCT02322749|23826|P5|Period 2|Adverse Event|0
3347|NCT02322749|23827|P4|Period 2|Adverse Event|1
3348|NCT02322749|23828|P3|Period 2|Adverse Event|0
3349|NCT02322749|23829|P2|Period 2|Adverse Event|0
3350|NCT02322749|23830|P1|Period 2|Adverse Event|0
3351|NCT02322216|23860|P2|Overall Study|Withdrawal by Subject|4
3352|NCT02322216|23861|P1|Overall Study|Withdrawal by Subject|1
3353|NCT02322216|23860|P2|Overall Study|Adverse Event|0
3354|NCT02322216|23861|P1|Overall Study|Adverse Event|1
3355|NCT02321436|23874|P2|Overall Study|Lost to Follow-up|1
3356|NCT02321436|23875|P1|Overall Study|Lost to Follow-up|0
3357|NCT02321436|23874|P2|Overall Study|Withdrawal by Subject|0
3358|NCT02321436|23875|P1|Overall Study|Withdrawal by Subject|1
3359|NCT02320721|23962|P2|Overall Study|Other than specified above|20
3360|NCT02320721|23963|P1|Overall Study|Other than specified above|15
3361|NCT02320721|23962|P2|Overall Study|Hypoglycemia|0
3362|NCT02320721|23963|P1|Overall Study|Hypoglycemia|1
3363|NCT02320721|23962|P2|Overall Study|Randomized but not treated|1
3364|NCT02320721|23963|P1|Overall Study|Randomized but not treated|0
3365|NCT02320721|23962|P2|Overall Study|Poor compliance to protocol|7
3366|NCT02320721|23963|P1|Overall Study|Poor compliance to protocol|3
3367|NCT02320721|23962|P2|Overall Study|Lack of Efficacy|0
3368|NCT02320721|23963|P1|Overall Study|Lack of Efficacy|2
3369|NCT02320721|23962|P2|Overall Study|Adverse Event|6
3370|NCT02320721|23963|P1|Overall Study|Adverse Event|6
3371|NCT02320396|24020|P2|Overall Study|Withdrawal by Subject|0
3372|NCT02320396|24021|P1|Overall Study|Withdrawal by Subject|2
3373|NCT02320396|24020|P2|Overall Study|Protocol Violation|1
3374|NCT02320396|24021|P1|Overall Study|Protocol Violation|0
3375|NCT02320396|24020|P2|Overall Study|Pregnancy|1
3376|NCT02320396|24021|P1|Overall Study|Pregnancy|0
3377|NCT02320396|24020|P2|Overall Study|Adverse Event|2
3378|NCT02320396|24021|P1|Overall Study|Adverse Event|2
3379|NCT02319668|24069|P2|Overall Study|Other (Not specified)|2
3380|NCT02319668|24070|P1|Overall Study|Other (Not specified)|0
3381|NCT02319525|24084|P2|Overall Study|Withdrawal by Subject|1
3382|NCT02319525|24085|P1|Overall Study|Withdrawal by Subject|2
3383|NCT02319148|24112|P4|Second Intervention Period|Unspecified|1
3384|NCT02319148|24113|P3|Second Intervention Period|Unspecified|0
3385|NCT02319148|24114|P2|Second Intervention Period|Unspecified|0
3386|NCT02319148|24115|P1|Second Intervention Period|Unspecified|0
3387|NCT02319148|24112|P4|Second Intervention Period|No longer willing to participate|0
3388|NCT02319148|24113|P3|Second Intervention Period|No longer willing to participate|0
3389|NCT02319148|24114|P2|Second Intervention Period|No longer willing to participate|1
3390|NCT02319148|24115|P1|Second Intervention Period|No longer willing to participate|0
3391|NCT02319148|24112|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
3392|NCT02319148|24113|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
3393|NCT02319148|24114|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
3394|NCT02319148|24115|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
3395|NCT02319031|24177|P2|Treatment Period|Death|0
3396|NCT02319031|24178|P1|Treatment Period|Death|1
3397|NCT02318940|24190|P2|Overall Study|lost the record|0
3398|NCT02318940|24191|P1|Overall Study|lost the record|1
3399|NCT02318693|24205|P2|Overall Study|Protocol Violation|1
3400|NCT02318693|24206|P1|Overall Study|Protocol Violation|0
3401|NCT02317809|24249|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
3402|NCT02317809|24250|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
3403|NCT02317809|24249|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
3404|NCT02317809|24250|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
3405|NCT02317510|24294|P2|Overall Study|Adverse Event|1
3406|NCT02317510|24295|P1|Overall Study|Adverse Event|0
3407|NCT02317016|24323|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
3408|NCT02317016|24323|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
3409|NCT02317016|24323|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
3410|NCT02317016|24323|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
3411|NCT02317016|24323|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
3412|NCT02317016|24323|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
3413|NCT02317016|24323|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
3414|NCT02316769|24351|P2|Overall Study|Withdrawal by Subject|0
3415|NCT02316769|24352|P1|Overall Study|Withdrawal by Subject|1
3416|NCT02316769|24351|P2|Overall Study|Physician Decision|0
3417|NCT02316769|24352|P1|Overall Study|Physician Decision|1
3418|NCT02316613|24369|P1|Overall Study|Did not met selection criteria|14
3419|NCT02316613|24369|P1|Overall Study|No data and duplicate cases|5
3420|NCT02316613|24369|P1|Overall Study|Participant moved/changed medical team|11
3421|NCT02316613|24369|P1|Overall Study|Lymphoma transformation|2
3422|NCT02316613|24369|P1|Overall Study|Lost to Follow-up|9
3423|NCT02316613|24369|P1|Overall Study|Death|63
3424|NCT02314637|24570|P2|Overall Study|Other Reason|0
3425|NCT02314637|24571|P1|Overall Study|Other Reason|1
3426|NCT02314637|24570|P2|Overall Study|Withdrawal by Subject|4
3427|NCT02314637|24571|P1|Overall Study|Withdrawal by Subject|5
3428|NCT02314637|24570|P2|Overall Study|Physician Decision|2
3429|NCT02314637|24571|P1|Overall Study|Physician Decision|5
3430|NCT02314637|24570|P2|Overall Study|Lack of Efficacy|0
3431|NCT02314637|24571|P1|Overall Study|Lack of Efficacy|1
3432|NCT02314637|24570|P2|Overall Study|Adverse Event|8
3433|NCT02314637|24571|P1|Overall Study|Adverse Event|4
3434|NCT02313766|24662|P3|Overall Study|Adverse Event|0
3435|NCT02313766|24663|P2|Overall Study|Adverse Event|1
3436|NCT02313766|24664|P1|Overall Study|Adverse Event|0
3437|NCT02313766|24662|P3|Overall Study|Lost to Follow-up|0
3438|NCT02313766|24663|P2|Overall Study|Lost to Follow-up|2
3439|NCT02313766|24664|P1|Overall Study|Lost to Follow-up|0
3440|NCT02313766|24662|P3|Overall Study|surgery cancelled|0
3441|NCT02313766|24663|P2|Overall Study|surgery cancelled|0
3442|NCT02313766|24664|P1|Overall Study|surgery cancelled|1
3443|NCT02313558|24680|P2|Overall Study|Lost to Follow-up|4
3444|NCT02313558|24681|P1|Overall Study|Lost to Follow-up|4
3445|NCT02313558|24680|P2|Overall Study|Withdrawal by Subject|0
3446|NCT02313558|24681|P1|Overall Study|Withdrawal by Subject|2
3447|NCT02313233|24695|P2|Overall Study|Administrative reason|1
3448|NCT02313233|24696|P1|Overall Study|Administrative reason|1
3449|NCT02313233|24695|P2|Overall Study|Withdrawal by Subject|2
3450|NCT02313233|24696|P1|Overall Study|Withdrawal by Subject|1
3451|NCT02313155|24718|P2|Overall Study|Lost to Follow-up|1
3452|NCT02313155|24719|P1|Overall Study|Lost to Follow-up|0
3453|NCT02311881|24861|P3|Overall Study|Serious Adverse Event|0
3454|NCT02311881|24862|P2|Overall Study|Serious Adverse Event|1
3455|NCT02311881|24863|P1|Overall Study|Serious Adverse Event|0
3456|NCT02311881|24861|P3|Overall Study|Participant taking another medication|1
3457|NCT02311881|24862|P2|Overall Study|Participant taking another medication|0
3458|NCT02311881|24863|P1|Overall Study|Participant taking another medication|0
3459|NCT02311881|24861|P3|Overall Study|Medical Monitor Discretion|1
3460|NCT02311881|24862|P2|Overall Study|Medical Monitor Discretion|0
3461|NCT02311881|24863|P1|Overall Study|Medical Monitor Discretion|0
3462|NCT02311881|24861|P3|Overall Study|Physician Decision|1
3463|NCT02311881|24862|P2|Overall Study|Physician Decision|0
3464|NCT02311881|24863|P1|Overall Study|Physician Decision|0
3465|NCT02311881|24861|P3|Overall Study|Non-Compliance|2
3466|NCT02311881|24862|P2|Overall Study|Non-Compliance|0
3467|NCT02311881|24863|P1|Overall Study|Non-Compliance|1
3468|NCT02311881|24861|P3|Overall Study|Protocol Deviation|0
3469|NCT02311881|24862|P2|Overall Study|Protocol Deviation|0
3470|NCT02311881|24863|P1|Overall Study|Protocol Deviation|1
3471|NCT02311881|24861|P3|Overall Study|Sponsor Decision|1
3472|NCT02311881|24862|P2|Overall Study|Sponsor Decision|1
3473|NCT02311881|24863|P1|Overall Study|Sponsor Decision|1
3474|NCT02311881|24861|P3|Overall Study|Withdrawal by Subject|4
3475|NCT02311881|24862|P2|Overall Study|Withdrawal by Subject|1
3476|NCT02311881|24863|P1|Overall Study|Withdrawal by Subject|3
3477|NCT02311881|24861|P3|Overall Study|Subject has border line pregnancy test|0
3478|NCT02311881|24862|P2|Overall Study|Subject has border line pregnancy test|0
3479|NCT02311881|24863|P1|Overall Study|Subject has border line pregnancy test|1
3480|NCT02311881|24861|P3|Overall Study|Lack of Efficacy|0
3481|NCT02311881|24862|P2|Overall Study|Lack of Efficacy|2
3482|NCT02311881|24863|P1|Overall Study|Lack of Efficacy|1
3483|NCT02311881|24861|P3|Overall Study|Not Specified|1
3484|NCT02311881|24862|P2|Overall Study|Not Specified|0
3485|NCT02311881|24863|P1|Overall Study|Not Specified|0
3486|NCT02311881|24861|P3|Overall Study|Withdrawal of consent|17
3487|NCT02311881|24862|P2|Overall Study|Withdrawal of consent|16
3488|NCT02311881|24863|P1|Overall Study|Withdrawal of consent|14
3489|NCT02311881|24861|P3|Overall Study|Protocol Violation|3
3490|NCT02311881|24862|P2|Overall Study|Protocol Violation|2
3491|NCT02311881|24863|P1|Overall Study|Protocol Violation|1
3492|NCT02311881|24861|P3|Overall Study|Lost to Follow-up|2
3493|NCT02311881|24862|P2|Overall Study|Lost to Follow-up|3
3494|NCT02311881|24863|P1|Overall Study|Lost to Follow-up|3
3495|NCT02311881|24861|P3|Overall Study|Adverse Event|8
3496|NCT02311881|24862|P2|Overall Study|Adverse Event|15
3497|NCT02311881|24863|P1|Overall Study|Adverse Event|7
3498|NCT02311881|24861|P3|Overall Study|Did not meet the study criteria|0
3499|NCT02311881|24862|P2|Overall Study|Did not meet the study criteria|2
3500|NCT02311881|24863|P1|Overall Study|Did not meet the study criteria|2
3501|NCT02310750|24929|P16|HP Washout 2|Lost to Follow-up|0
3502|NCT02310750|24930|P15|HP Washout 2|Lost to Follow-up|0
3503|NCT02310750|24931|P14|HP Washout 2|Lost to Follow-up|0
3504|NCT02310750|24932|P13|HP Washout 2|Lost to Follow-up|0
3505|NCT02310750|24933|P12|HP Washout 2|Lost to Follow-up|0
3506|NCT02310750|24934|P11|HP Washout 2|Lost to Follow-up|0
3507|NCT02310750|24935|P10|HP Washout 2|Lost to Follow-up|0
3508|NCT02310750|24936|P9|HP Washout 2|Lost to Follow-up|0
3509|NCT02310750|24937|P8|HP Washout 2|Lost to Follow-up|0
3510|NCT02310750|24938|P7|HP Washout 2|Lost to Follow-up|7
3511|NCT02310750|24939|P6|HP Washout 2|Lost to Follow-up|0
3512|NCT02310750|24940|P5|HP Washout 2|Lost to Follow-up|1
3513|NCT02310750|24941|P4|HP Washout 2|Lost to Follow-up|0
3514|NCT02310750|24942|P3|HP Washout 2|Lost to Follow-up|0
3515|NCT02310750|24943|P2|HP Washout 2|Lost to Follow-up|0
3516|NCT02310750|24944|P1|HP Washout 2|Lost to Follow-up|0
3517|NCT02310750|24929|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3518|NCT02310750|24930|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3519|NCT02310750|24931|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3520|NCT02310750|24932|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3521|NCT02310750|24933|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3522|NCT02310750|24934|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3523|NCT02310750|24935|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3524|NCT02310750|24936|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
3525|NCT02310750|24937|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
3526|NCT02310750|24938|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3527|NCT02310750|24939|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3528|NCT02310750|24940|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3529|NCT02310750|24941|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3530|NCT02310750|24942|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3531|NCT02310750|24943|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3532|NCT02310750|24944|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
3533|NCT02310750|24929|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3534|NCT02310750|24930|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3535|NCT02310750|24931|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3536|NCT02310750|24932|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3537|NCT02310750|24933|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3538|NCT02310750|24934|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3539|NCT02310750|24935|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
3540|NCT02310750|24936|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
3541|NCT02310750|24937|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
3542|NCT02310750|24938|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3543|NCT02310750|24939|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3544|NCT02310750|24940|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3545|NCT02310750|24941|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3546|NCT02310750|24942|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3547|NCT02310750|24943|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3548|NCT02310750|24944|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
3549|NCT02310750|24929|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3550|NCT02310750|24930|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3551|NCT02310750|24931|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3552|NCT02310750|24932|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3553|NCT02310750|24933|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3554|NCT02310750|24934|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3555|NCT02310750|24935|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
3556|NCT02310750|24936|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3557|NCT02310750|24937|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3558|NCT02310750|24938|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3559|NCT02310750|24939|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3560|NCT02310750|24940|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3561|NCT02310750|24941|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3562|NCT02310750|24942|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3563|NCT02310750|24943|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3564|NCT02310750|24944|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
3565|NCT02310750|24929|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3566|NCT02310750|24930|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3567|NCT02310750|24931|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3568|NCT02310750|24932|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3569|NCT02310750|24933|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3570|NCT02310750|24934|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3571|NCT02310750|24935|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
3572|NCT02310750|24936|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
3573|NCT02310750|24937|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3574|NCT02310750|24938|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3575|NCT02310750|24939|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
3576|NCT02310750|24940|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3577|NCT02310750|24941|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
3578|NCT02310750|24942|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3579|NCT02310750|24943|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3580|NCT02310750|24944|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
3581|NCT02310750|24929|P16|HP Washout 1|Lost to Follow-up|0
3582|NCT02310750|24930|P15|HP Washout 1|Lost to Follow-up|0
3583|NCT02310750|24931|P14|HP Washout 1|Lost to Follow-up|0
3584|NCT02310750|24932|P13|HP Washout 1|Lost to Follow-up|0
3585|NCT02310750|24933|P12|HP Washout 1|Lost to Follow-up|0
3586|NCT02310750|24934|P11|HP Washout 1|Lost to Follow-up|0
3587|NCT02310750|24935|P10|HP Washout 1|Lost to Follow-up|0
3588|NCT02310750|24936|P9|HP Washout 1|Lost to Follow-up|0
3589|NCT02310750|24937|P8|HP Washout 1|Lost to Follow-up|0
3590|NCT02310750|24938|P7|HP Washout 1|Lost to Follow-up|3
3591|NCT02310750|24939|P6|HP Washout 1|Lost to Follow-up|2
3592|NCT02310750|24940|P5|HP Washout 1|Lost to Follow-up|2
3593|NCT02310750|24941|P4|HP Washout 1|Lost to Follow-up|1
3594|NCT02310750|24942|P3|HP Washout 1|Lost to Follow-up|1
3595|NCT02310750|24943|P2|HP Washout 1|Lost to Follow-up|0
3596|NCT02310750|24944|P1|HP Washout 1|Lost to Follow-up|0
3597|NCT02310750|24929|P16|HP Period 1|Withdrawal by Subject|0
3598|NCT02310750|24930|P15|HP Period 1|Withdrawal by Subject|0
3599|NCT02310750|24931|P14|HP Period 1|Withdrawal by Subject|0
3600|NCT02310750|24932|P13|HP Period 1|Withdrawal by Subject|0
3601|NCT02310750|24933|P12|HP Period 1|Withdrawal by Subject|0
3602|NCT02310750|24934|P11|HP Period 1|Withdrawal by Subject|0
3603|NCT02310750|24935|P10|HP Period 1|Withdrawal by Subject|0
3604|NCT02310750|24936|P9|HP Period 1|Withdrawal by Subject|0
3605|NCT02310750|24937|P8|HP Period 1|Withdrawal by Subject|0
3606|NCT02310750|24938|P7|HP Period 1|Withdrawal by Subject|0
3607|NCT02310750|24939|P6|HP Period 1|Withdrawal by Subject|0
3608|NCT02310750|24940|P5|HP Period 1|Withdrawal by Subject|0
3609|NCT02310750|24941|P4|HP Period 1|Withdrawal by Subject|1
3610|NCT02310750|24942|P3|HP Period 1|Withdrawal by Subject|0
3611|NCT02310750|24943|P2|HP Period 1|Withdrawal by Subject|0
3612|NCT02310750|24944|P1|HP Period 1|Withdrawal by Subject|1
3613|NCT02310750|24929|P16|HP Period 1|Lost to Follow-up|0
3614|NCT02310750|24930|P15|HP Period 1|Lost to Follow-up|0
3615|NCT02310750|24931|P14|HP Period 1|Lost to Follow-up|0
3616|NCT02310750|24932|P13|HP Period 1|Lost to Follow-up|0
3617|NCT02310750|24933|P12|HP Period 1|Lost to Follow-up|0
3618|NCT02310750|24934|P11|HP Period 1|Lost to Follow-up|0
3619|NCT02310750|24935|P10|HP Period 1|Lost to Follow-up|0
3620|NCT02310750|24936|P9|HP Period 1|Lost to Follow-up|0
3621|NCT02310750|24937|P8|HP Period 1|Lost to Follow-up|0
3622|NCT02310750|24938|P7|HP Period 1|Lost to Follow-up|1
3623|NCT02310750|24939|P6|HP Period 1|Lost to Follow-up|0
3624|NCT02310750|24940|P5|HP Period 1|Lost to Follow-up|0
3625|NCT02310750|24941|P4|HP Period 1|Lost to Follow-up|0
3626|NCT02310750|24942|P3|HP Period 1|Lost to Follow-up|0
3627|NCT02310750|24943|P2|HP Period 1|Lost to Follow-up|0
3628|NCT02310750|24944|P1|HP Period 1|Lost to Follow-up|0
3629|NCT02310646|25385|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
3630|NCT02310646|25386|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
3631|NCT02310646|25385|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
3632|NCT02310646|25386|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
3633|NCT02310581|25414|P4|Overall Study|Withdrawal by Subject|1
3634|NCT02310581|25415|P3|Overall Study|Withdrawal by Subject|0
3635|NCT02310581|25416|P2|Overall Study|Withdrawal by Subject|1
3636|NCT02310581|25417|P1|Overall Study|Withdrawal by Subject|2
3637|NCT02310581|25414|P4|Overall Study|Adverse Event|0
3638|NCT02310581|25415|P3|Overall Study|Adverse Event|1
3639|NCT02310581|25416|P2|Overall Study|Adverse Event|1
3640|NCT02310581|25417|P1|Overall Study|Adverse Event|1
3641|NCT02310568|25456|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
3642|NCT02310568|25457|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
3643|NCT02310568|25458|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
3644|NCT02310568|25459|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
3645|NCT02310568|25460|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
3646|NCT02310568|25456|P5|Stage 2 (4 Weeks)|Protocol Violation|0
3647|NCT02310568|25457|P4|Stage 2 (4 Weeks)|Protocol Violation|1
3648|NCT02310568|25458|P3|Stage 2 (4 Weeks)|Protocol Violation|0
3649|NCT02310568|25459|P2|Stage 2 (4 Weeks)|Protocol Violation|0
3650|NCT02310568|25460|P1|Stage 2 (4 Weeks)|Protocol Violation|0
3651|NCT02310568|25456|P5|Stage 2 (4 Weeks)|Adverse Event|1
3652|NCT02310568|25457|P4|Stage 2 (4 Weeks)|Adverse Event|1
3653|NCT02310568|25458|P3|Stage 2 (4 Weeks)|Adverse Event|0
3654|NCT02310568|25459|P2|Stage 2 (4 Weeks)|Adverse Event|0
3655|NCT02310568|25460|P1|Stage 2 (4 Weeks)|Adverse Event|0
3656|NCT02310568|25456|P5|Stage 2 (4 Weeks)|Unspecified|0
3657|NCT02310568|25457|P4|Stage 2 (4 Weeks)|Unspecified|0
3658|NCT02310568|25458|P3|Stage 2 (4 Weeks)|Unspecified|1
3659|NCT02310568|25459|P2|Stage 2 (4 Weeks)|Unspecified|1
3660|NCT02310568|25460|P1|Stage 2 (4 Weeks)|Unspecified|0
3661|NCT02310568|25456|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
3662|NCT02310568|25457|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
3663|NCT02310568|25458|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
3664|NCT02310568|25459|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
3665|NCT02310568|25460|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
3666|NCT02310568|25456|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
3667|NCT02310568|25457|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
3668|NCT02310568|25458|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
3669|NCT02310568|25459|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
3670|NCT02310568|25460|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
3671|NCT02310568|25456|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
3672|NCT02310568|25457|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
3673|NCT02310568|25458|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
3674|NCT02310568|25459|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
3675|NCT02310568|25460|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
3676|NCT02310568|25456|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
3677|NCT02310568|25457|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
3678|NCT02310568|25458|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
3679|NCT02310568|25459|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
3680|NCT02310568|25460|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
3681|NCT02310568|25456|P5|Stage 1 ( 4 Weeks)|Unspecified|0
3682|NCT02310568|25457|P4|Stage 1 ( 4 Weeks)|Unspecified|0
3683|NCT02310568|25458|P3|Stage 1 ( 4 Weeks)|Unspecified|0
3684|NCT02310568|25459|P2|Stage 1 ( 4 Weeks)|Unspecified|1
3685|NCT02310568|25460|P1|Stage 1 ( 4 Weeks)|Unspecified|1
3686|NCT02310568|25456|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
3687|NCT02310568|25457|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
3688|NCT02310568|25458|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
3689|NCT02310568|25459|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
3690|NCT02310568|25460|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
3691|NCT02310568|25456|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
3692|NCT02310568|25457|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
3693|NCT02310568|25458|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
3694|NCT02310568|25459|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
3695|NCT02310568|25460|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
3696|NCT02310126|25540|P2|Period 1 (15 Minutes)|Protocol Violation|1
3697|NCT02310126|25541|P1|Period 1 (15 Minutes)|Protocol Violation|0
3698|NCT02310126|25540|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
3699|NCT02310126|25541|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
3700|NCT02309723|25550|P3|Overall Study|Withdrawal by Subject|24
3701|NCT02309723|25551|P2|Overall Study|Withdrawal by Subject|23
3702|NCT02309723|25552|P1|Overall Study|Withdrawal by Subject|24
3703|NCT02309294|25566|P1|Overall Study|Withdrawal by Subject|2
3704|NCT02309112|25573|P3|Overall Study|Lost to Follow-up|0
3705|NCT02309112|25574|P2|Overall Study|Lost to Follow-up|1
3706|NCT02309112|25575|P1|Overall Study|Lost to Follow-up|0
3707|NCT02309112|25573|P3|Overall Study|Withdrawal by Subject|1
3708|NCT02309112|25574|P2|Overall Study|Withdrawal by Subject|0
3709|NCT02309112|25575|P1|Overall Study|Withdrawal by Subject|1
3710|NCT02308748|25611|P10|Period 5|Adverse Event|0
3711|NCT02308748|25612|P9|Period 5|Adverse Event|1
3712|NCT02308748|25613|P8|Period 5|Adverse Event|0
3713|NCT02308748|25614|P7|Period 5|Adverse Event|0
3714|NCT02308748|25615|P6|Period 5|Adverse Event|0
3715|NCT02308748|25616|P5|Period 5|Adverse Event|0
3716|NCT02308748|25617|P4|Period 5|Adverse Event|0
3717|NCT02308748|25618|P3|Period 5|Adverse Event|0
3718|NCT02308748|25619|P2|Period 5|Adverse Event|0
3719|NCT02308748|25620|P1|Period 5|Adverse Event|1
3720|NCT02308748|25611|P10|Period 3|Protocol Violation|1
3721|NCT02308748|25612|P9|Period 3|Protocol Violation|0
3722|NCT02308748|25613|P8|Period 3|Protocol Violation|0
3723|NCT02308748|25614|P7|Period 3|Protocol Violation|0
3724|NCT02308748|25615|P6|Period 3|Protocol Violation|0
3725|NCT02308748|25616|P5|Period 3|Protocol Violation|0
3726|NCT02308748|25617|P4|Period 3|Protocol Violation|0
3727|NCT02308748|25618|P3|Period 3|Protocol Violation|0
3728|NCT02308748|25619|P2|Period 3|Protocol Violation|0
3729|NCT02308748|25620|P1|Period 3|Protocol Violation|0
3730|NCT02308748|25611|P10|Period 2|Adverse Event|0
3731|NCT02308748|25612|P9|Period 2|Adverse Event|0
3732|NCT02308748|25613|P8|Period 2|Adverse Event|1
3733|NCT02308748|25614|P7|Period 2|Adverse Event|0
3734|NCT02308748|25615|P6|Period 2|Adverse Event|0
3735|NCT02308748|25616|P5|Period 2|Adverse Event|0
3736|NCT02308748|25617|P4|Period 2|Adverse Event|0
3737|NCT02308748|25618|P3|Period 2|Adverse Event|0
3738|NCT02308748|25619|P2|Period 2|Adverse Event|0
3739|NCT02308748|25620|P1|Period 2|Adverse Event|0
3740|NCT02308748|25611|P10|Period 1|Withdrawal by Subject|0
3741|NCT02308748|25612|P9|Period 1|Withdrawal by Subject|0
3742|NCT02308748|25613|P8|Period 1|Withdrawal by Subject|0
3743|NCT02308748|25614|P7|Period 1|Withdrawal by Subject|0
3744|NCT02308748|25615|P6|Period 1|Withdrawal by Subject|0
3745|NCT02308748|25616|P5|Period 1|Withdrawal by Subject|0
3746|NCT02308748|25617|P4|Period 1|Withdrawal by Subject|0
3747|NCT02308748|25618|P3|Period 1|Withdrawal by Subject|1
3748|NCT02308748|25619|P2|Period 1|Withdrawal by Subject|0
3749|NCT02308748|25620|P1|Period 1|Withdrawal by Subject|0
3750|NCT02308124|25652|P3|Overall Study|Adverse Event|2
3751|NCT02308124|25653|P2|Overall Study|Adverse Event|2
3752|NCT02308124|25654|P1|Overall Study|Adverse Event|0
3753|NCT02308124|25652|P3|Overall Study|Lost to Follow-up|6
3754|NCT02308124|25653|P2|Overall Study|Lost to Follow-up|6
3755|NCT02308124|25654|P1|Overall Study|Lost to Follow-up|6
3756|NCT02307266|25746|P3|Overall Study|Lost to Follow-up|0
3757|NCT02307266|25747|P2|Overall Study|Lost to Follow-up|0
3758|NCT02307266|25748|P1|Overall Study|Lost to Follow-up|3
3759|NCT02307266|25746|P3|Overall Study|Withdrawal by Subject|1
3760|NCT02307266|25747|P2|Overall Study|Withdrawal by Subject|0
3761|NCT02307266|25748|P1|Overall Study|Withdrawal by Subject|2
3762|NCT02307266|25746|P3|Overall Study|Adverse Event|5
3763|NCT02307266|25747|P2|Overall Study|Adverse Event|1
3764|NCT02307266|25748|P1|Overall Study|Adverse Event|3
3765|NCT02305446|25790|P1|Overall Study|Adverse Event|1
3766|NCT02304926|25893|P2|Overall Study|Lost to Follow-up|1
3767|NCT02304926|25894|P1|Overall Study|Lost to Follow-up|2
3768|NCT02303704|25951|P2|Overall Study|Protocol Violation|9
3769|NCT02303704|25952|P1|Overall Study|Protocol Violation|5
3770|NCT02301975|25987|P3|Overall Study|Withdrawal by Subject|11
3771|NCT02301975|25988|P2|Overall Study|Withdrawal by Subject|12
3772|NCT02301975|25989|P1|Overall Study|Withdrawal by Subject|15
3773|NCT02301975|25987|P3|Overall Study|Physician Decision|3
3774|NCT02301975|25988|P2|Overall Study|Physician Decision|2
3775|NCT02301975|25989|P1|Overall Study|Physician Decision|4
3776|NCT02301975|25987|P3|Overall Study|Lost to Follow-up|2
3777|NCT02301975|25988|P2|Overall Study|Lost to Follow-up|2
3778|NCT02301975|25989|P1|Overall Study|Lost to Follow-up|0
3779|NCT02301975|25987|P3|Overall Study|Protocol Violation|3
3780|NCT02301975|25988|P2|Overall Study|Protocol Violation|5
3781|NCT02301975|25989|P1|Overall Study|Protocol Violation|3
3782|NCT02301975|25987|P3|Overall Study|Lack of Efficacy|1
3783|NCT02301975|25988|P2|Overall Study|Lack of Efficacy|1
3784|NCT02301975|25989|P1|Overall Study|Lack of Efficacy|1
3785|NCT02301975|25987|P3|Overall Study|Adverse Event|2
3786|NCT02301975|25988|P2|Overall Study|Adverse Event|3
3787|NCT02301975|25989|P1|Overall Study|Adverse Event|8
3788|NCT02301936|26017|P2|Overall Study|Lost to Follow-up|0
3789|NCT02301936|26018|P1|Overall Study|Lost to Follow-up|1
3790|NCT02301429|26040|P1|Overall Study|not acceptable vascular anatomy|3
3791|NCT02301169|26059|P2|Overall Study|Adverse Event|0
3792|NCT02301169|26060|P1|Overall Study|Adverse Event|1
3793|NCT02300311|26076|P2|Overall Study|Refused to continue taking medication|0
3794|NCT02300311|26077|P1|Overall Study|Refused to continue taking medication|18
3795|NCT02300311|26076|P2|Overall Study|Other than the reason specified|0
3796|NCT02300311|26077|P1|Overall Study|Other than the reason specified|1
3797|NCT02300129|26089|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
3798|NCT02300129|26090|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
3799|NCT02300129|26091|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
3800|NCT02300129|26092|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
3801|NCT02300129|26089|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
3802|NCT02300129|26090|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
3803|NCT02300129|26091|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
3804|NCT02300129|26092|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
3805|NCT02300129|26089|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
3806|NCT02300129|26090|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
3807|NCT02300129|26091|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
3808|NCT02300129|26092|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
3809|NCT02300103|26102|P1|Overall Study|Withdrew Consent|2
3810|NCT02300103|26102|P1|Overall Study|Protocol Violation|1
3811|NCT02300103|26102|P1|Overall Study|Lack of Efficacy|3
3812|NCT02299635|26190|P1|Overall Study|Unspecified|3
3813|NCT02299635|26190|P1|Overall Study|Withdrawal by Subject|2
3814|NCT02299635|26190|P1|Overall Study|Objective progression or relapse|10
3815|NCT02299635|26190|P1|Overall Study|Global deterioration of health status|1
3816|NCT02299635|26190|P1|Overall Study|Death|1
3817|NCT02299635|26190|P1|Overall Study|Adverse Event|2
3818|NCT02299427|26211|P2|Overall Study|not adherent to dog website use|0
3819|NCT02299427|26212|P1|Overall Study|not adherent to dog website use|21
3820|NCT02299427|26211|P2|Overall Study|Lost to Follow-up|3
3821|NCT02299427|26212|P1|Overall Study|Lost to Follow-up|1
3822|NCT02299427|26211|P2|Overall Study|Withdrawal by Subject|0
3823|NCT02299427|26212|P1|Overall Study|Withdrawal by Subject|1
3824|NCT02298868|26242|P1|Overall Study|Patient underwent transplant|1
3825|NCT02298868|26242|P1|Overall Study|Death|1
3826|NCT02298868|26242|P1|Overall Study|Adverse Event|1
3827|NCT02298192|26302|P2|Overall Study|Adverse Event|2
3828|NCT02298192|26303|P1|Overall Study|Adverse Event|6
3829|NCT02298192|26302|P2|Overall Study|Lost to Follow-up|1
3830|NCT02298192|26303|P1|Overall Study|Lost to Follow-up|2
3831|NCT02298192|26302|P2|Overall Study|Withdrawal by Subject|1
3832|NCT02298192|26303|P1|Overall Study|Withdrawal by Subject|6
3833|NCT02298192|26302|P2|Overall Study|Withdrawal criteria|0
3834|NCT02298192|26303|P1|Overall Study|Withdrawal criteria|2
3835|NCT02298192|26302|P2|Overall Study|Unclassified|2
3836|NCT02298192|26303|P1|Overall Study|Unclassified|3
3837|NCT02297841|26315|P1|Overall Study|Protocol Violation|7
3838|NCT02297841|26315|P1|Overall Study|Withdrawal by Subject|1
3839|NCT02296931|26326|P2|Overall Study|Protocol Violation|2
3840|NCT02296931|26327|P1|Overall Study|Protocol Violation|0
3841|NCT02295774|26333|P1|Overall Study|Withdrawal by Subject|2
3842|NCT02295774|26333|P1|Overall Study|Lost to Follow-up|1
3843|NCT02295020|26364|P2|Overall Study|Withdrawal by Subject|2
3844|NCT02295020|26365|P1|Overall Study|Withdrawal by Subject|3
3845|NCT02295020|26364|P2|Overall Study|Adverse Event|1
3846|NCT02295020|26365|P1|Overall Study|Adverse Event|0
3847|NCT02294773|26397|P2|Overall Study|Withdrawal by Subject|2
3848|NCT02294773|26398|P1|Overall Study|Withdrawal by Subject|0
3849|NCT02294734|26414|P2|Overall Study|Withdrawal by Subject|2
3850|NCT02294734|26415|P1|Overall Study|Withdrawal by Subject|4
3851|NCT02294734|26414|P2|Overall Study|Physician Decision|1
3852|NCT02294734|26415|P1|Overall Study|Physician Decision|2
3853|NCT02294734|26414|P2|Overall Study|Lost to Follow-up|0
3854|NCT02294734|26415|P1|Overall Study|Lost to Follow-up|2
3855|NCT02294734|26414|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
3856|NCT02294734|26415|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
3857|NCT02294734|26414|P2|Overall Study|Adverse Event|5
3858|NCT02294734|26415|P1|Overall Study|Adverse Event|5
3859|NCT02294682|26467|P2|Overall Study|Could not swallow pills|0
3860|NCT02294682|26468|P1|Overall Study|Could not swallow pills|1
3861|NCT02294604|26511|P3|Overall Study|Culture contamination|0
3862|NCT02294604|26512|P2|Overall Study|Culture contamination|2
3863|NCT02294604|26513|P1|Overall Study|Culture contamination|1
3864|NCT02294604|26511|P3|Overall Study|Did not provide samples for culture|0
3865|NCT02294604|26512|P2|Overall Study|Did not provide samples for culture|1
3866|NCT02294604|26513|P1|Overall Study|Did not provide samples for culture|0
3867|NCT02294461|26532|P2|Overall Study|Miscellaneous|34
3868|NCT02294461|26533|P1|Overall Study|Miscellaneous|13
3869|NCT02294461|26532|P2|Overall Study|Adverse Event|10
3870|NCT02294461|26533|P1|Overall Study|Adverse Event|12
3871|NCT02294461|26532|P2|Overall Study|Disease Progression|39
3872|NCT02294461|26533|P1|Overall Study|Disease Progression|23
3873|NCT02294461|26532|P2|Overall Study|Withdrawal by Subject|49
3874|NCT02294461|26533|P1|Overall Study|Withdrawal by Subject|14
3875|NCT02294461|26532|P2|Overall Study|Protocol Violation|2
3876|NCT02294461|26533|P1|Overall Study|Protocol Violation|0
3877|NCT02294461|26532|P2|Overall Study|Death|3
3878|NCT02294461|26533|P1|Overall Study|Death|3
3879|NCT02294019|26585|P1|Overall Study|Withdrawal by Subject|1
3880|NCT02294019|26585|P1|Overall Study|Unspecified|1
3881|NCT02294019|26585|P1|Overall Study|Lost to Follow-up|31
3882|NCT02294019|26585|P1|Overall Study|Protocol Violation|68
3883|NCT02294019|26585|P1|Overall Study|Adverse Event|2
3884|NCT02293538|26592|P2|Overall Study|Withdrawal by Subject|1
3885|NCT02293538|26593|P1|Overall Study|Withdrawal by Subject|0
3886|NCT02293538|26592|P2|Overall Study|Lost to Follow-up|0
3887|NCT02293538|26593|P1|Overall Study|Lost to Follow-up|1
3888|NCT02293538|26592|P2|Overall Study|Adverse Event|1
3889|NCT02293538|26593|P1|Overall Study|Adverse Event|0
3890|NCT02292212|26682|P1|ViE Phase|Protocol Violation|2
3891|NCT02292212|26682|P1|ViE Phase|Withdrawal by Subject|1
3892|NCT02291679|26739|P3|Overall Study|Not Specified|2
3893|NCT02291679|26740|P2|Overall Study|Not Specified|4
3894|NCT02291679|26741|P1|Overall Study|Not Specified|2
3895|NCT02291679|26739|P3|Overall Study|Insufficient Therapeutic Response|7
3896|NCT02291679|26740|P2|Overall Study|Insufficient Therapeutic Response|5
3897|NCT02291679|26741|P1|Overall Study|Insufficient Therapeutic Response|5
3898|NCT02291679|26739|P3|Overall Study|Lost to Follow-up|9
3899|NCT02291679|26740|P2|Overall Study|Lost to Follow-up|10
3900|NCT02291679|26741|P1|Overall Study|Lost to Follow-up|12
3901|NCT02291679|26739|P3|Overall Study|Withdrew Consent|15
3902|NCT02291679|26740|P2|Overall Study|Withdrew Consent|10
3903|NCT02291679|26741|P1|Overall Study|Withdrew Consent|18
3904|NCT02291679|26739|P3|Overall Study|Protocol Violation|7
3905|NCT02291679|26740|P2|Overall Study|Protocol Violation|1
3906|NCT02291679|26741|P1|Overall Study|Protocol Violation|5
3907|NCT02291679|26739|P3|Overall Study|Adverse Event|19
3908|NCT02291679|26740|P2|Overall Study|Adverse Event|12
3909|NCT02291679|26741|P1|Overall Study|Adverse Event|2
3910|NCT02291510|26774|P4|Overall Study|Adverse Event|1
3911|NCT02291510|26775|P3|Overall Study|Adverse Event|0
3912|NCT02291510|26776|P2|Overall Study|Adverse Event|0
3913|NCT02291510|26777|P1|Overall Study|Adverse Event|0
3914|NCT02291419|26793|P2|Overall Study|Early study termination|5
3915|NCT02291419|26794|P1|Overall Study|Early study termination|1
3916|NCT02290821|26812|P2|Overall Study|Lost to Follow-up|2
3917|NCT02290821|26813|P1|Overall Study|Lost to Follow-up|3
3918|NCT02290821|26812|P2|Overall Study|Unable or unwilling to cooperate with|0
3919|NCT02290821|26813|P1|Overall Study|Unable or unwilling to cooperate with|2
3920|NCT02290821|26812|P2|Overall Study|Withdrawal by Subject|1
3921|NCT02290821|26813|P1|Overall Study|Withdrawal by Subject|1
3922|NCT02289963|26855|P2|Overall Study|Other than specified above|2
3923|NCT02289963|26856|P1|Overall Study|Other than specified above|0
3924|NCT02289963|26855|P2|Overall Study|End treatment visit outside visit window|4
3925|NCT02289963|26856|P1|Overall Study|End treatment visit outside visit window|0
3926|NCT02289963|26855|P2|Overall Study|Last injection missed|2
3927|NCT02289963|26856|P1|Overall Study|Last injection missed|2
3928|NCT02289963|26855|P2|Overall Study|Withdrawal by Subject|0
3929|NCT02289963|26856|P1|Overall Study|Withdrawal by Subject|1
3930|NCT02289963|26855|P2|Overall Study|Poor compliance to protocol|0
3931|NCT02289963|26856|P1|Overall Study|Poor compliance to protocol|1
3932|NCT02289963|26855|P2|Overall Study|Adverse Event|2
3933|NCT02289963|26856|P1|Overall Study|Adverse Event|1
3934|NCT02289742|26911|P4|Third Wear Period|Reason not given|1
3935|NCT02289742|26912|P3|Third Wear Period|Reason not given|0
3936|NCT02289742|26913|P2|Third Wear Period|Reason not given|0
3937|NCT02289742|26914|P1|Third Wear Period|Reason not given|0
3938|NCT02289742|26911|P4|Third Wear Period|Adverse Event|0
3939|NCT02289742|26912|P3|Third Wear Period|Adverse Event|0
3940|NCT02289742|26913|P2|Third Wear Period|Adverse Event|1
3941|NCT02289742|26914|P1|Third Wear Period|Adverse Event|0
3942|NCT02289742|26911|P4|First Wear Period|Other prior to treatment|1
3943|NCT02289742|26912|P3|First Wear Period|Other prior to treatment|0
3944|NCT02289742|26913|P2|First Wear Period|Other prior to treatment|0
3945|NCT02289742|26914|P1|First Wear Period|Other prior to treatment|0
3946|NCT02289742|26911|P4|First Wear Period|Adverse Event|0
3947|NCT02289742|26912|P3|First Wear Period|Adverse Event|1
3948|NCT02289742|26913|P2|First Wear Period|Adverse Event|0
3949|NCT02289742|26914|P1|First Wear Period|Adverse Event|0
3950|NCT02289742|26911|P4|First Wear Period|Adverse event prior to treatment|0
3951|NCT02289742|26912|P3|First Wear Period|Adverse event prior to treatment|0
3952|NCT02289742|26913|P2|First Wear Period|Adverse event prior to treatment|1
3953|NCT02289742|26914|P1|First Wear Period|Adverse event prior to treatment|0
3954|NCT02289469|26933|P2|Overall Study|Unable to match a control|0
3955|NCT02289469|26934|P1|Overall Study|Unable to match a control|6
3956|NCT02289079|26957|P2|Overall Study|Lost to Follow-up|1
3957|NCT02289079|26958|P1|Overall Study|Lost to Follow-up|0
3958|NCT02289079|26957|P2|Overall Study|Physician Decision|0
3959|NCT02289079|26958|P1|Overall Study|Physician Decision|2
3960|NCT02288312|27000|P3|Overall Study|Pregnancy|0
3961|NCT02288312|27001|P2|Overall Study|Pregnancy|0
3962|NCT02288312|27002|P1|Overall Study|Pregnancy|1
3963|NCT02287623|27195|P2|Overall Study|Protocol Violation|1
3964|NCT02287623|27196|P1|Overall Study|Protocol Violation|0
3965|NCT02287610|27212|P1|Overall Study|Excluded-investigator non-responsiveness|5
3966|NCT02287610|27212|P1|Overall Study|Withdrawal by Subject|8
3967|NCT02287610|27212|P1|Overall Study|Lost to Follow-up|3
3968|NCT02287402|27251|P1|Follow-up|Voluntary Withdrawal|2
3969|NCT02287402|27251|P1|Follow-up|Lost to Follow-up|1
3970|NCT02287402|27251|P1|Treatment Period|Voluntary Withdrawal|10
3971|NCT02287402|27251|P1|Treatment Period|Adverse Event|17
3972|NCT02286193|27521|P1|Overall Study|Referred: Declined service|38
3973|NCT02286193|27521|P1|Overall Study|Referred: unable to reach/resource sent|104
3974|NCT02286193|27521|P1|Overall Study|Referred: CRS unable to make contact|62
3975|NCT02286102|27528|P2|Overall Study|Screen Failure|1
3976|NCT02286102|27529|P1|Overall Study|Screen Failure|1
3977|NCT02285998|27541|P2|Overall Study|Other Reasons|10
3978|NCT02285998|27542|P1|Overall Study|Other Reasons|7
3979|NCT02285998|27541|P2|Overall Study|Withdrawal by Subject|61
3980|NCT02285998|27542|P1|Overall Study|Withdrawal by Subject|53
3981|NCT02285998|27541|P2|Overall Study|Lost to Follow-up|172
3982|NCT02285998|27542|P1|Overall Study|Lost to Follow-up|176
3983|NCT02285998|27541|P2|Overall Study|Physician Decision|2
3984|NCT02285998|27542|P1|Overall Study|Physician Decision|1
3985|NCT02285998|27541|P2|Overall Study|Adverse Event|8
3986|NCT02285998|27542|P1|Overall Study|Adverse Event|9
3987|NCT02285270|27566|P1|Overall Study|Determined to be ineligible|1
3988|NCT02285270|27566|P1|Overall Study|Physician Decision|3
3989|NCT02285270|27566|P1|Overall Study|Lost to Follow-up|1
3990|NCT02284347|27659|P1|Overall Study|Withdrawn prior to treatment|1
3991|NCT02284347|27659|P1|Overall Study|Lost to Follow-up|2
3992|NCT02284243|27667|P2|Overall Study|Adverse Event|0
3993|NCT02284243|27668|P1|Overall Study|Adverse Event|1
3994|NCT02284243|27667|P2|Overall Study|Lack of Efficacy|3
3995|NCT02284243|27668|P1|Overall Study|Lack of Efficacy|3
3996|NCT02283788|27764|P4|Overall Study|Withdrawal by Subject|1
3997|NCT02283788|27765|P3|Overall Study|Withdrawal by Subject|0
3998|NCT02283788|27766|P2|Overall Study|Withdrawal by Subject|1
3999|NCT02283788|27767|P1|Overall Study|Withdrawal by Subject|0
4000|NCT02283788|27764|P4|Overall Study|Adverse Event|1
4001|NCT02283788|27765|P3|Overall Study|Adverse Event|5
4002|NCT02283788|27766|P2|Overall Study|Adverse Event|3
4003|NCT02283788|27767|P1|Overall Study|Adverse Event|1
4005|NCT02282982|27838|P1|Overall Study|Other, not specified|18
4006|NCT02282982|27838|P1|Overall Study|Palivizumab is ended|11
4007|NCT02282982|27838|P1|Overall Study|Lack of product|156
4008|NCT02282982|27838|P1|Overall Study|Death|4
4009|NCT02282982|27838|P1|Overall Study|Withdrew consent|2
4010|NCT02282982|27838|P1|Overall Study|Lost to Follow-up|15
4011|NCT02282813|27856|P3|Overall Study|Administrative reasons|0
4012|NCT02282813|27857|P2|Overall Study|Administrative reasons|1
4013|NCT02282813|27858|P1|Overall Study|Administrative reasons|0
4014|NCT02282813|27856|P3|Overall Study|Lack of Efficacy|0
4015|NCT02282813|27857|P2|Overall Study|Lack of Efficacy|0
4016|NCT02282813|27858|P1|Overall Study|Lack of Efficacy|1
4017|NCT02282813|27856|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
4018|NCT02282813|27857|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
4019|NCT02282813|27858|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
4020|NCT02282813|27856|P3|Overall Study|Lost to Follow-up|1
4021|NCT02282813|27857|P2|Overall Study|Lost to Follow-up|0
4022|NCT02282813|27858|P1|Overall Study|Lost to Follow-up|2
4023|NCT02282813|27856|P3|Overall Study|Physician Decision|1
4024|NCT02282813|27857|P2|Overall Study|Physician Decision|3
4025|NCT02282813|27858|P1|Overall Study|Physician Decision|0
4026|NCT02282813|27856|P3|Overall Study|Subject non-compliance|0
4027|NCT02282813|27857|P2|Overall Study|Subject non-compliance|4
4028|NCT02282813|27858|P1|Overall Study|Subject non-compliance|1
4029|NCT02282813|27856|P3|Overall Study|Adverse Event|1
4030|NCT02282813|27857|P2|Overall Study|Adverse Event|10
4031|NCT02282813|27858|P1|Overall Study|Adverse Event|3
4032|NCT02282813|27856|P3|Overall Study|Withdrawal by Subject|0
4033|NCT02282813|27857|P2|Overall Study|Withdrawal by Subject|5
4034|NCT02282813|27858|P1|Overall Study|Withdrawal by Subject|4
4035|NCT02282631|27877|P2|Overall Study|Lost to Follow-up|0
4036|NCT02282631|27878|P1|Overall Study|Lost to Follow-up|2
4037|NCT02282605|27919|P3|Overall Study|negative SA result on Day -1|0
4038|NCT02282605|27920|P2|Overall Study|negative SA result on Day -1|0
4039|NCT02282605|27921|P1|Overall Study|negative SA result on Day -1|3
4040|NCT02282527|27943|P2|Overall Study|Lack of home health aid|0
4041|NCT02282527|27944|P1|Overall Study|Lack of home health aid|1
4042|NCT02282527|27943|P2|Overall Study|Lost to Follow-up|1
4043|NCT02282527|27944|P1|Overall Study|Lost to Follow-up|0
4044|NCT02281318|28038|P2|Overall Study|Withdrawal by Subject|2
4045|NCT02281318|28039|P1|Overall Study|Withdrawal by Subject|6
4046|NCT02281318|28038|P2|Overall Study|Physician Decision|0
4047|NCT02281318|28039|P1|Overall Study|Physician Decision|2
4048|NCT02281318|28038|P2|Overall Study|Lost to Follow-up|1
4049|NCT02281318|28039|P1|Overall Study|Lost to Follow-up|2
4050|NCT02281318|28038|P2|Overall Study|Lack of Efficacy|0
4051|NCT02281318|28039|P1|Overall Study|Lack of Efficacy|2
4052|NCT02281318|28038|P2|Overall Study|Adverse Event|2
4053|NCT02281318|28039|P1|Overall Study|Adverse Event|2
4054|NCT02280499|28142|P1|Overall Study|Adverse Event|5
4055|NCT02280499|28142|P1|Overall Study|Lost to Follow-up|42
4056|NCT02280499|28142|P1|Overall Study|Death|14
4057|NCT02280473|28150|P2|Overall Study|Lost to Follow-up|1
4058|NCT02280473|28151|P1|Overall Study|Lost to Follow-up|0
4059|NCT02280473|28150|P2|Overall Study|Lack of Efficacy|1
4060|NCT02280473|28151|P1|Overall Study|Lack of Efficacy|0
4061|NCT02280473|28150|P2|Overall Study|Adverse Event|1
4062|NCT02280473|28151|P1|Overall Study|Adverse Event|1
4063|NCT02280187|28165|P1|Overall Study|Lost to Follow-up|218
4064|NCT02279420|28214|P1|Overall Study|Lost to Follow-up|23
4065|NCT02279407|28222|P4|Overall Study|Adverse Event|0
4066|NCT02279407|28223|P3|Overall Study|Adverse Event|2
4067|NCT02279407|28224|P2|Overall Study|Adverse Event|1
4068|NCT02279407|28225|P1|Overall Study|Adverse Event|1
4069|NCT02279407|28222|P4|Overall Study|Withdrawal by Subject|1
4070|NCT02279407|28223|P3|Overall Study|Withdrawal by Subject|1
4071|NCT02279407|28224|P2|Overall Study|Withdrawal by Subject|0
4072|NCT02279407|28225|P1|Overall Study|Withdrawal by Subject|1
4073|NCT02279407|28222|P4|Overall Study|Couldn't swallow IP; noncompliance|0
4074|NCT02279407|28223|P3|Overall Study|Couldn't swallow IP; noncompliance|2
4075|NCT02279407|28224|P2|Overall Study|Couldn't swallow IP; noncompliance|0
4076|NCT02279407|28225|P1|Overall Study|Couldn't swallow IP; noncompliance|0
4077|NCT02278614|28256|P2|Overall Study|left eye was not eligible|0
4078|NCT02278614|28257|P1|Overall Study|left eye was not eligible|1
4079|NCT02278614|28256|P2|Overall Study|Adverse Event|0
4080|NCT02278614|28257|P1|Overall Study|Adverse Event|1
4081|NCT02278614|28256|P2|Overall Study|Withdrawal by Subject|5
4082|NCT02278614|28257|P1|Overall Study|Withdrawal by Subject|3
4083|NCT02277691|28283|P1|Overall Study|Used Other Antihypertensive Drug|1
4084|NCT02277691|28283|P1|Overall Study|Lack of Efficacy|5
4085|NCT02277691|28283|P1|Overall Study|Voluntary Withdrawal|7
4086|NCT02277691|28283|P1|Overall Study|Pretreatment Event/Adverse Event|33
4087|NCT02277119|28320|P3|Overall Study|Protocol Violation|7
4088|NCT02277119|28321|P2|Overall Study|Protocol Violation|3
4089|NCT02277119|28322|P1|Overall Study|Protocol Violation|2
4090|NCT02277119|28320|P3|Overall Study|Lack of Efficacy|1
4091|NCT02277119|28321|P2|Overall Study|Lack of Efficacy|1
4092|NCT02277119|28322|P1|Overall Study|Lack of Efficacy|1
4093|NCT02276560|28350|P3|Overall Study|Adverse Event|0
4094|NCT02276560|28351|P2|Overall Study|Adverse Event|0
4095|NCT02276560|28352|P1|Overall Study|Adverse Event|1
4096|NCT02275611|28491|P4|Inpatient Withdrawal|Withdrawal by Subject|0
4097|NCT02275611|28492|P3|Inpatient Withdrawal|Withdrawal by Subject|0
4098|NCT02275611|28493|P2|Inpatient Withdrawal|Withdrawal by Subject|0
4099|NCT02275611|28494|P1|Inpatient Withdrawal|Withdrawal by Subject|1
4100|NCT02275546|28506|P2|Treatment Period 2|Protocol Violation|1
4101|NCT02275546|28507|P1|Treatment Period 2|Protocol Violation|0
4102|NCT02275546|28506|P2|Treatment Period 2|Withdrawal by Subject|1
4103|NCT02275546|28507|P1|Treatment Period 2|Withdrawal by Subject|2
4104|NCT02275364|28515|P2|Period 1|Other reason|0
4105|NCT02275364|28516|P1|Period 1|Other reason|1
4106|NCT02275364|28515|P2|Period 1|Withdrawal by Subject|0
4107|NCT02275364|28516|P1|Period 1|Withdrawal by Subject|1
4108|NCT02275052|28577|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
4109|NCT02275052|28578|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4110|NCT02275052|28579|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4111|NCT02275052|28580|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4112|NCT02275052|28577|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
4113|NCT02275052|28578|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4114|NCT02275052|28579|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4115|NCT02275052|28580|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4116|NCT02275052|28577|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
4117|NCT02275052|28578|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4118|NCT02275052|28579|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4119|NCT02275052|28580|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4120|NCT02275052|28577|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
4121|NCT02275052|28578|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
4122|NCT02275052|28579|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
4123|NCT02275052|28580|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
4124|NCT02275052|28577|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
4125|NCT02275052|28578|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
4126|NCT02275052|28579|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
4127|NCT02275052|28580|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
4128|NCT02275052|28577|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
4129|NCT02275052|28578|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
4130|NCT02275052|28579|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
4131|NCT02275052|28580|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
4132|NCT02275052|28577|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4133|NCT02275052|28578|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4134|NCT02275052|28579|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4135|NCT02275052|28580|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
4136|NCT02275052|28577|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4137|NCT02275052|28578|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4138|NCT02275052|28579|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4139|NCT02275052|28580|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
4140|NCT02275052|28577|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4141|NCT02275052|28578|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4142|NCT02275052|28579|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
4143|NCT02275052|28580|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
4144|NCT02275052|28577|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4145|NCT02275052|28578|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4146|NCT02275052|28579|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
4147|NCT02275052|28580|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4148|NCT02275052|28577|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4149|NCT02275052|28578|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4150|NCT02275052|28579|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4151|NCT02275052|28580|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4152|NCT02274948|28594|P2|Overall Study|Left the area|3
4153|NCT02274948|28595|P1|Overall Study|Left the area|4
4154|NCT02274948|28594|P2|Overall Study|Stopped on family Practitioner advice|5
4155|NCT02274948|28595|P1|Overall Study|Stopped on family Practitioner advice|2
4156|NCT02274948|28594|P2|Overall Study|Withdrawal by Subject|58
4157|NCT02274948|28595|P1|Overall Study|Withdrawal by Subject|64
4158|NCT02274948|28594|P2|Overall Study|Lost to Follow-up|25
4159|NCT02274948|28595|P1|Overall Study|Lost to Follow-up|28
4160|NCT02274792|28609|P1|Overall Study|Sponsor Decision|2
4161|NCT02274792|28609|P1|Overall Study|Protocol Specified Criteria|2
4162|NCT02274792|28609|P1|Overall Study|Lost to Follow-up|8
4163|NCT02274792|28609|P1|Overall Study|Withdrawal by Subject|13
4164|NCT02274558|28655|P3|Overall Study|Physician Decision|1
4165|NCT02274558|28656|P2|Overall Study|Physician Decision|2
4166|NCT02274558|28657|P1|Overall Study|Physician Decision|0
4167|NCT02274558|28655|P3|Overall Study|Lost to Follow-up|1
4168|NCT02274558|28656|P2|Overall Study|Lost to Follow-up|1
4169|NCT02274558|28657|P1|Overall Study|Lost to Follow-up|2
4170|NCT02274558|28655|P3|Overall Study|Death|1
4171|NCT02274558|28656|P2|Overall Study|Death|0
4172|NCT02274558|28657|P1|Overall Study|Death|0
4173|NCT02274558|28655|P3|Overall Study|Withdrawal by Subject|4
4174|NCT02274558|28656|P2|Overall Study|Withdrawal by Subject|5
4175|NCT02274558|28657|P1|Overall Study|Withdrawal by Subject|1
4176|NCT02274558|28655|P3|Overall Study|Non-compliance|0
4177|NCT02274558|28656|P2|Overall Study|Non-compliance|1
4178|NCT02274558|28657|P1|Overall Study|Non-compliance|2
4179|NCT02274558|28655|P3|Overall Study|Adverse Event|2
4180|NCT02274558|28656|P2|Overall Study|Adverse Event|4
4181|NCT02274558|28657|P1|Overall Study|Adverse Event|2
4182|NCT02273908|28673|P2|Overall Study|Withdrawal by Subject|2
4183|NCT02273908|28674|P1|Overall Study|Withdrawal by Subject|4
4184|NCT02273908|28673|P2|Overall Study|Did not meet entrance criteria|2
4185|NCT02273908|28674|P1|Overall Study|Did not meet entrance criteria|3
4186|NCT02273908|28673|P2|Overall Study|Lost to Follow-up|1
4187|NCT02273908|28674|P1|Overall Study|Lost to Follow-up|10
4188|NCT02273908|28673|P2|Overall Study|Adverse Event|0
4189|NCT02273908|28674|P1|Overall Study|Adverse Event|16
4190|NCT02273752|28696|P1|Overall Study|Trial was terminated early|2
4191|NCT02273167|28741|P3|Overall Study|Various|8
4192|NCT02273167|28742|P2|Overall Study|Various|9
4193|NCT02273167|28743|P1|Overall Study|Various|10
4194|NCT02273167|28741|P3|Overall Study|Withdrawal by Subject|11
4195|NCT02273167|28742|P2|Overall Study|Withdrawal by Subject|12
4196|NCT02273167|28743|P1|Overall Study|Withdrawal by Subject|10
4197|NCT02273167|28741|P3|Overall Study|Lost to Follow-up|1
4198|NCT02273167|28742|P2|Overall Study|Lost to Follow-up|1
4199|NCT02273167|28743|P1|Overall Study|Lost to Follow-up|0
4200|NCT02273167|28741|P3|Overall Study|Protocol Violation|1
4201|NCT02273167|28742|P2|Overall Study|Protocol Violation|1
4202|NCT02273167|28743|P1|Overall Study|Protocol Violation|3
4203|NCT02273167|28741|P3|Overall Study|Adverse Event|0
4204|NCT02273167|28742|P2|Overall Study|Adverse Event|0
4205|NCT02273167|28743|P1|Overall Study|Adverse Event|1
4206|NCT02273141|28768|P2|Overall Study|Various|6
4207|NCT02273141|28769|P1|Overall Study|Various|6
4208|NCT02273141|28768|P2|Overall Study|Withdrawal by Subject|15
4209|NCT02273141|28769|P1|Overall Study|Withdrawal by Subject|10
4210|NCT02273141|28768|P2|Overall Study|Lost to Follow-up|3
4211|NCT02273141|28769|P1|Overall Study|Lost to Follow-up|1
4212|NCT02273141|28768|P2|Overall Study|Adverse Event|1
4213|NCT02273141|28769|P1|Overall Study|Adverse Event|0
4214|NCT02272725|28836|P2|Overall Study|equipment malfunction|0
4215|NCT02272725|28837|P1|Overall Study|equipment malfunction|2
4216|NCT02271854|28847|P1|Overall Study|Lost to Follow-up|1
4217|NCT02271854|28847|P1|Overall Study|Unable or unwilling to cooperate with st|1
4218|NCT02271854|28847|P1|Overall Study|Withdrawal by Subject|2
4219|NCT02271529|28875|P1|Overall Study|Withdrawal by Subject|1
4220|NCT02270944|28896|P2|Overall Study|Withdrawal by Subject|1
4221|NCT02270944|28897|P1|Overall Study|Withdrawal by Subject|2
4222|NCT02270944|28896|P2|Overall Study|Lost to Follow-up|4
4223|NCT02270944|28897|P1|Overall Study|Lost to Follow-up|9
4224|NCT02270684|28913|P2|Overall Study|Study terminated|0
4225|NCT02270684|28914|P1|Overall Study|Study terminated|1
4226|NCT02270684|28913|P2|Overall Study|Lost to Follow-up|3
4227|NCT02270684|28914|P1|Overall Study|Lost to Follow-up|0
4228|NCT02270515|28920|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
4229|NCT02270515|28920|P1|Intervention Period 3: 12-18 Months|Death|3
4230|NCT02270515|28920|P1|Intervention Period 3: 12-18 Months|Received transplant|2
4231|NCT02270515|28920|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
4232|NCT02270515|28920|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
4233|NCT02270515|28920|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
4234|NCT02270515|28920|P1|Intervention Period 2: 6-12 Months|Death|5
4235|NCT02270515|28920|P1|Intervention Period 2: 6-12 Months|Received transplant|1
4236|NCT02270515|28920|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
4237|NCT02270515|28920|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
4238|NCT02270515|28920|P1|Intervention Period 1: 0-6 Months|Death|7
4239|NCT02270515|28920|P1|Intervention Period 1: 0-6 Months|Received transplant|3
4240|NCT02270515|28920|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
4241|NCT02270515|28920|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
4242|NCT02269709|28935|P1|Six Month Follow-up|Lost to Follow-up|12
4243|NCT02269709|28935|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
4244|NCT02269709|28935|P1|Time of Enrollment|Withdrawal by Subject|3
4245|NCT02269657|28940|P1|Overall Study|Protocol Violation|3
4246|NCT02269475|28960|P2|Overall Study|Withdrawal by Subject|1
4247|NCT02269475|28961|P1|Overall Study|Withdrawal by Subject|0
4248|NCT02269475|28960|P2|Overall Study|Meet Exclusion Criteria No. 17|0
4249|NCT02269475|28961|P1|Overall Study|Meet Exclusion Criteria No. 17|3
4250|NCT02269098|28974|P2|Overall Study|Lost to Follow-up|9
4251|NCT02269098|28975|P1|Overall Study|Lost to Follow-up|14
4252|NCT02268864|29003|P3|Overall Study|Death|0
4253|NCT02268864|29004|P2|Overall Study|Death|1
4254|NCT02268864|29005|P1|Overall Study|Death|0
4255|NCT02268864|29003|P3|Overall Study|Withdrawal by Subject|0
4256|NCT02268864|29004|P2|Overall Study|Withdrawal by Subject|0
4257|NCT02268864|29005|P1|Overall Study|Withdrawal by Subject|2
4258|NCT02268396|29027|P1|Overall Study|2 Subjects no Day 29 Assessment|2
4259|NCT02268396|29027|P1|Overall Study|Protocol-Specified Criteria|2
4260|NCT02268396|29027|P1|Overall Study|Lost to Follow-up|2
4261|NCT02268396|29027|P1|Overall Study|Withdrawal by Subject|1
4262|NCT02268396|29027|P1|Overall Study|Administrative|2
4263|NCT02268396|29027|P1|Overall Study|Adverse Event|3
4264|NCT02268058|29040|P4|Overall Study|Protocol Violation|0
4265|NCT02268058|29041|P3|Overall Study|Protocol Violation|0
4266|NCT02268058|29042|P2|Overall Study|Protocol Violation|0
4267|NCT02268058|29043|P1|Overall Study|Protocol Violation|1
4268|NCT02267824|29076|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
4269|NCT02267824|29077|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
4270|NCT02267824|29076|P2|Overall Study|Protocol Violation|0
4271|NCT02267824|29077|P1|Overall Study|Protocol Violation|3
4272|NCT02267824|29076|P2|Overall Study|Lost to Follow-up|0
4273|NCT02267824|29077|P1|Overall Study|Lost to Follow-up|4
4274|NCT02267824|29076|P2|Overall Study|Pregnancy|1
4275|NCT02267824|29077|P1|Overall Study|Pregnancy|1
4276|NCT02266381|29140|P3|Overall Study|Physician Decision|4
4277|NCT02266381|29141|P2|Overall Study|Physician Decision|5
4278|NCT02266381|29142|P1|Overall Study|Physician Decision|3
4279|NCT02265237|29215|P4|As Treated (Overall Study)|Other|1
4280|NCT02265237|29216|P3|As Treated (Overall Study)|Other|3
4281|NCT02265237|29217|P2|As Treated (Overall Study)|Other|0
4282|NCT02265237|29218|P1|As Treated (Overall Study)|Other|2
4283|NCT02265237|29215|P4|As Treated (Overall Study)|Lost to Follow-up|0
4284|NCT02265237|29216|P3|As Treated (Overall Study)|Lost to Follow-up|6
4285|NCT02265237|29217|P2|As Treated (Overall Study)|Lost to Follow-up|2
4286|NCT02265237|29218|P1|As Treated (Overall Study)|Lost to Follow-up|1
4287|NCT02265237|29215|P4|As Treated (Overall Study)|Withdrawal by Subject|0
4288|NCT02265237|29216|P3|As Treated (Overall Study)|Withdrawal by Subject|1
4289|NCT02265237|29217|P2|As Treated (Overall Study)|Withdrawal by Subject|0
4290|NCT02265237|29218|P1|As Treated (Overall Study)|Withdrawal by Subject|1
4291|NCT02265237|29215|P4|As Treated (Overall Study)|Adverse Event|0
4292|NCT02265237|29216|P3|As Treated (Overall Study)|Adverse Event|0
4293|NCT02265237|29217|P2|As Treated (Overall Study)|Adverse Event|1
4294|NCT02265237|29218|P1|As Treated (Overall Study)|Adverse Event|1
4295|NCT02264821|29248|P3|Overall Study|Protocol Violation|6
4296|NCT02264821|29249|P2|Overall Study|Protocol Violation|3
4297|NCT02264821|29250|P1|Overall Study|Protocol Violation|1
4298|NCT02262754|29353|P3|Overall Study|Unspecified|2
4299|NCT02262754|29354|P2|Overall Study|Unspecified|0
4300|NCT02262754|29355|P1|Overall Study|Unspecified|4
4301|NCT02262754|29353|P3|Overall Study|Withdrawal by Subject|1
4302|NCT02262754|29354|P2|Overall Study|Withdrawal by Subject|0
4303|NCT02262754|29355|P1|Overall Study|Withdrawal by Subject|1
4304|NCT02262754|29353|P3|Overall Study|Protocol Violation|0
4305|NCT02262754|29354|P2|Overall Study|Protocol Violation|0
4306|NCT02262754|29355|P1|Overall Study|Protocol Violation|1
4307|NCT02262754|29353|P3|Overall Study|Study terminated by sponsor|4
4308|NCT02262754|29354|P2|Overall Study|Study terminated by sponsor|4
4309|NCT02262754|29355|P1|Overall Study|Study terminated by sponsor|5
4310|NCT02262754|29353|P3|Overall Study|No longer meets eligibility criteria|0
4311|NCT02262754|29354|P2|Overall Study|No longer meets eligibility criteria|1
4312|NCT02262754|29355|P1|Overall Study|No longer meets eligibility criteria|0
4313|NCT02262754|29353|P3|Overall Study|Lost to Follow-up|1
4314|NCT02262754|29354|P2|Overall Study|Lost to Follow-up|0
4315|NCT02262754|29355|P1|Overall Study|Lost to Follow-up|0
4316|NCT02262754|29353|P3|Overall Study|Lack of Efficacy|1
4317|NCT02262754|29354|P2|Overall Study|Lack of Efficacy|0
4318|NCT02262754|29355|P1|Overall Study|Lack of Efficacy|2
4319|NCT02262754|29353|P3|Overall Study|Adverse Event|0
4320|NCT02262754|29354|P2|Overall Study|Adverse Event|4
4321|NCT02262754|29355|P1|Overall Study|Adverse Event|3
4322|NCT02261493|29505|P3|Overall Study|Adverse Event|0
4323|NCT02261493|29506|P2|Overall Study|Adverse Event|1
4324|NCT02261493|29507|P1|Overall Study|Adverse Event|0
4325|NCT02261493|29505|P3|Overall Study|Lack of Efficacy|0
4326|NCT02261493|29506|P2|Overall Study|Lack of Efficacy|1
4327|NCT02261493|29507|P1|Overall Study|Lack of Efficacy|0
4328|NCT02261493|29505|P3|Overall Study|Pregnancy|0
4329|NCT02261493|29506|P2|Overall Study|Pregnancy|2
4330|NCT02261493|29507|P1|Overall Study|Pregnancy|1
4331|NCT02261493|29505|P3|Overall Study|Lost to Follow-up|8
4332|NCT02261493|29506|P2|Overall Study|Lost to Follow-up|27
4333|NCT02261493|29507|P1|Overall Study|Lost to Follow-up|14
4334|NCT02261493|29505|P3|Overall Study|Personal Reasons|16
4335|NCT02261493|29506|P2|Overall Study|Personal Reasons|14
4336|NCT02261493|29507|P1|Overall Study|Personal Reasons|14
4337|NCT02261493|29505|P3|Overall Study|Protocol Violation|0
4338|NCT02261493|29506|P2|Overall Study|Protocol Violation|0
4339|NCT02261493|29507|P1|Overall Study|Protocol Violation|1
4340|NCT02261493|29505|P3|Overall Study|Undisclosed alcohol abuse|0
4341|NCT02261493|29506|P2|Overall Study|Undisclosed alcohol abuse|1
4342|NCT02261493|29507|P1|Overall Study|Undisclosed alcohol abuse|0
4343|NCT02261493|29505|P3|Overall Study|Physician Decision|0
4344|NCT02261493|29506|P2|Overall Study|Physician Decision|1
4345|NCT02261493|29507|P1|Overall Study|Physician Decision|0
4346|NCT02261493|29505|P3|Overall Study|Noncompliance|2
4347|NCT02261493|29506|P2|Overall Study|Noncompliance|0
4348|NCT02261493|29507|P1|Overall Study|Noncompliance|0
4349|NCT02261467|29535|P2|Overall Study|Adverse Event|1
4350|NCT02261467|29536|P1|Overall Study|Adverse Event|1
4351|NCT02261467|29535|P2|Overall Study|Lost to Follow-up|13
4352|NCT02261467|29536|P1|Overall Study|Lost to Follow-up|2
4353|NCT02261467|29535|P2|Overall Study|Personal Reasons|22
4354|NCT02261467|29536|P1|Overall Study|Personal Reasons|17
4355|NCT02261467|29535|P2|Overall Study|Protocol Violation|1
4356|NCT02261467|29536|P1|Overall Study|Protocol Violation|0
4357|NCT02261467|29535|P2|Overall Study|Enrolled in Error|0
4358|NCT02261467|29536|P1|Overall Study|Enrolled in Error|1
4359|NCT02260882|29577|P2|Overall Study|Protocol Violation|1
4360|NCT02260882|29578|P1|Overall Study|Protocol Violation|0
4361|NCT02260492|29603|P3|Overall Study|Withdrawal by Subject|2
4362|NCT02260492|29604|P2|Overall Study|Withdrawal by Subject|2
4363|NCT02260492|29605|P1|Overall Study|Withdrawal by Subject|3
4364|NCT02260492|29603|P3|Overall Study|Physician Decision|1
4365|NCT02260492|29604|P2|Overall Study|Physician Decision|0
4366|NCT02260492|29605|P1|Overall Study|Physician Decision|2
4367|NCT02260492|29603|P3|Overall Study|Lost to Follow-up|0
4368|NCT02260492|29604|P2|Overall Study|Lost to Follow-up|9
4369|NCT02260492|29605|P1|Overall Study|Lost to Follow-up|12
4370|NCT02260492|29603|P3|Overall Study|Death|0
4371|NCT02260492|29604|P2|Overall Study|Death|1
4372|NCT02260492|29605|P1|Overall Study|Death|0
4373|NCT02260492|29603|P3|Overall Study|Adverse Event|2
4374|NCT02260492|29604|P2|Overall Study|Adverse Event|1
4375|NCT02260492|29605|P1|Overall Study|Adverse Event|6
4376|NCT02259400|29641|P2|Overall Study|Death|2
4377|NCT02259400|29642|P1|Overall Study|Death|0
4378|NCT02259348|29674|P1|Overall Study|Death|4
4379|NCT02259348|29674|P1|Overall Study|Donors|6
4380|NCT02258529|29686|P1|Overall Study|Adverse Event|1
4381|NCT02258529|29686|P1|Overall Study|Study Terminated by Sponsor|9
4382|NCT02258334|29732|P4|Overall Study|Adverse Event|0
4383|NCT02258334|29733|P3|Overall Study|Adverse Event|0
4384|NCT02258334|29734|P2|Overall Study|Adverse Event|0
4385|NCT02258334|29735|P1|Overall Study|Adverse Event|1
4386|NCT02257918|29764|P3|Overall Study|Pregnancy|1
4387|NCT02257918|29765|P2|Overall Study|Pregnancy|0
4388|NCT02257918|29766|P1|Overall Study|Pregnancy|0
4389|NCT02257918|29764|P3|Overall Study|Withdrawal by Subject|1
4390|NCT02257918|29765|P2|Overall Study|Withdrawal by Subject|0
4391|NCT02257918|29766|P1|Overall Study|Withdrawal by Subject|0
4392|NCT02257918|29764|P3|Overall Study|Lost to Follow-up|0
4393|NCT02257918|29765|P2|Overall Study|Lost to Follow-up|1
4394|NCT02257918|29766|P1|Overall Study|Lost to Follow-up|4
4395|NCT02257684|29816|P1|Overall Study|Sponsor's Decision|1
4396|NCT02257684|29816|P1|Overall Study|Lack of Efficacy|1
4397|NCT02257684|29816|P1|Overall Study|Adverse Event|2
4398|NCT02257385|29826|P2|Overall Study|Withdrawal by Subject|4
4399|NCT02257385|29827|P1|Overall Study|Withdrawal by Subject|4
4400|NCT02257385|29826|P2|Overall Study|Lost to Follow-up|1
4401|NCT02257385|29827|P1|Overall Study|Lost to Follow-up|0
4402|NCT02257385|29826|P2|Overall Study|Protocol Violation|7
4403|NCT02257385|29827|P1|Overall Study|Protocol Violation|5
4404|NCT02257385|29826|P2|Overall Study|Lack of Efficacy|2
4405|NCT02257385|29827|P1|Overall Study|Lack of Efficacy|1
4406|NCT02257385|29826|P2|Overall Study|Adverse Event|8
4407|NCT02257385|29827|P1|Overall Study|Adverse Event|12
4408|NCT02257372|29837|P2|Overall Study|Withdrew consent|0
4409|NCT02257372|29838|P1|Overall Study|Withdrew consent|1
4410|NCT02257372|29837|P2|Overall Study|Lost to Follow-up|1
4411|NCT02257372|29838|P1|Overall Study|Lost to Follow-up|0
4412|NCT02257372|29837|P2|Overall Study|Protocol Violation|1
4413|NCT02257372|29838|P1|Overall Study|Protocol Violation|1
4414|NCT02257372|29837|P2|Overall Study|Lack of Efficacy|1
4415|NCT02257372|29838|P1|Overall Study|Lack of Efficacy|2
4416|NCT02257372|29837|P2|Overall Study|Adverse Event|7
4417|NCT02257372|29838|P1|Overall Study|Adverse Event|3
4418|NCT02256982|29848|P2|Overall Study|Disease Progression|1
4419|NCT02256982|29849|P1|Overall Study|Disease Progression|0
4420|NCT02256969|29858|P3|Overall Study|Screenfailed or withdrew|1
4421|NCT02256969|29859|P2|Overall Study|Screenfailed or withdrew|1
4422|NCT02256969|29860|P1|Overall Study|Screenfailed or withdrew|2
4423|NCT02256891|29879|P2|Overall Study|Equipment Malfunction|1
4424|NCT02256891|29880|P1|Overall Study|Equipment Malfunction|0
4425|NCT02256891|29879|P2|Overall Study|Screen Fail|4
4426|NCT02256891|29880|P1|Overall Study|Screen Fail|5
4427|NCT02256891|29879|P2|Overall Study|Physician Decision|3
4428|NCT02256891|29880|P1|Overall Study|Physician Decision|7
4429|NCT02256891|29879|P2|Overall Study|Lost to Follow-up|3
4430|NCT02256891|29880|P1|Overall Study|Lost to Follow-up|0
4431|NCT02256891|29879|P2|Overall Study|Death|2
4432|NCT02256891|29880|P1|Overall Study|Death|0
4433|NCT02256553|29904|P1|Period III|Adverse Event|3
4434|NCT02256553|29904|P1|Period II|Subject Moved|1
4435|NCT02256553|29904|P1|Period II|Adverse Event|1
4436|NCT02256553|29904|P1|Period I|Protocol Violation|1
4437|NCT02256553|29904|P1|Period I|Adverse Event|5
4438|NCT02256488|29917|P4|Overall Study|Withdrawal by Subject|2
4439|NCT02256488|29918|P3|Overall Study|Withdrawal by Subject|0
4440|NCT02256488|29919|P2|Overall Study|Withdrawal by Subject|0
4441|NCT02256488|29920|P1|Overall Study|Withdrawal by Subject|1
4442|NCT02256488|29917|P4|Overall Study|OTHER|1
4443|NCT02256488|29918|P3|Overall Study|OTHER|1
4444|NCT02256488|29919|P2|Overall Study|OTHER|0
4445|NCT02256488|29920|P1|Overall Study|OTHER|1
4446|NCT02256488|29917|P4|Overall Study|Lost to Follow-up|3
4447|NCT02256488|29918|P3|Overall Study|Lost to Follow-up|9
4448|NCT02256488|29919|P2|Overall Study|Lost to Follow-up|6
4449|NCT02256488|29920|P1|Overall Study|Lost to Follow-up|6
4450|NCT02256436|29936|P2|Overall Study|Ongoing in Study|67
4451|NCT02256436|29937|P1|Overall Study|Ongoing in Study|108
4452|NCT02256436|29936|P2|Overall Study|Withdrawal by Subject|30
4453|NCT02256436|29937|P1|Overall Study|Withdrawal by Subject|7
4454|NCT02256436|29936|P2|Overall Study|Protocol Violation|0
4455|NCT02256436|29937|P1|Overall Study|Protocol Violation|1
4456|NCT02256436|29936|P2|Overall Study|Physician Decision|3
4457|NCT02256436|29937|P1|Overall Study|Physician Decision|1
4458|NCT02256436|29936|P2|Overall Study|Lost to Follow-up|1
4459|NCT02256436|29937|P1|Overall Study|Lost to Follow-up|1
4460|NCT02256436|29936|P2|Overall Study|Death|158
4461|NCT02256436|29937|P1|Overall Study|Death|137
4462|NCT02256436|29936|P2|Overall Study|Adverse Event|13
4463|NCT02256436|29937|P1|Overall Study|Adverse Event|15
4464|NCT02255565|30002|P3|Overall Study|Withdrawal by Subject|0
4465|NCT02255565|30003|P2|Overall Study|Withdrawal by Subject|1
4466|NCT02255565|30004|P1|Overall Study|Withdrawal by Subject|0
4467|NCT02255279|30065|P2|Overall Study|Withdrawal by Subject|6
4468|NCT02255279|30066|P1|Overall Study|Withdrawal by Subject|3
4469|NCT02255279|30065|P2|Overall Study|Protocol Violation|1
4470|NCT02255279|30066|P1|Overall Study|Protocol Violation|0
4471|NCT02255279|30065|P2|Overall Study|Lost to Follow-up|2
4472|NCT02255279|30066|P1|Overall Study|Lost to Follow-up|2
4473|NCT02255149|30092|P1|Overall Study|Implant Failure|1
4474|NCT02255149|30092|P1|Overall Study|Withdrawal by PI|1
4475|NCT02255149|30092|P1|Overall Study|Withdrawal by Subject|1
4476|NCT02255149|30092|P1|Overall Study|Lost to Follow-up|2
4477|NCT02255097|30096|P1|Overall Study|Treatment Ongoing|36
4478|NCT02255097|30096|P1|Overall Study|Allocated but not treated|1
4479|NCT02255097|30096|P1|Overall Study|Withdrawal by Subject|2
4480|NCT02255097|30096|P1|Overall Study|Progressive Disease|80
4481|NCT02255097|30096|P1|Overall Study|Physician Decision|1
4482|NCT02255097|30096|P1|Overall Study|Lost to Follow-up|1
4483|NCT02255097|30096|P1|Overall Study|Death|2
4484|NCT02255097|30096|P1|Overall Study|Excluded Medication|1
4485|NCT02255097|30096|P1|Overall Study|Complete Response|1
4486|NCT02255097|30096|P1|Overall Study|Clinical Progression|23
4487|NCT02255097|30096|P1|Overall Study|Adverse Event|24
4488|NCT02254551|30117|P1|Dose Escalation|Dose-limiting toxicity|2
4489|NCT02254551|30117|P1|Dose Escalation|Physician Decision|1
4490|NCT02254486|30127|P2|Overall Study|Various|12
4491|NCT02254486|30128|P1|Overall Study|Various|12
4492|NCT02254486|30127|P2|Overall Study|GFR<60mL/min|21
4493|NCT02254486|30128|P1|Overall Study|GFR<60mL/min|16
4494|NCT02254486|30127|P2|Overall Study|Withdrawal by Subject|15
4495|NCT02254486|30128|P1|Overall Study|Withdrawal by Subject|17
4496|NCT02254486|30127|P2|Overall Study|Protocol Violation|2
4497|NCT02254486|30128|P1|Overall Study|Protocol Violation|1
4498|NCT02254486|30127|P2|Overall Study|Lost to Follow-up|4
4499|NCT02254486|30128|P1|Overall Study|Lost to Follow-up|2
4500|NCT02254486|30127|P2|Overall Study|Lack of Efficacy|0
4501|NCT02254486|30128|P1|Overall Study|Lack of Efficacy|1
4502|NCT02254486|30127|P2|Overall Study|Adverse Event|1
4503|NCT02254486|30128|P1|Overall Study|Adverse Event|1
4504|NCT02254460|30144|P2|Overall Study|Adverse Event|0
4505|NCT02254460|30145|P1|Overall Study|Adverse Event|1
4506|NCT02253654|30166|P2|Overall Study|Did Not Receive Study Treatment|1
4507|NCT02253654|30167|P1|Overall Study|Did Not Receive Study Treatment|4
4508|NCT02253654|30166|P2|Overall Study|Death|7
4509|NCT02253654|30167|P1|Overall Study|Death|4
4510|NCT02253654|30166|P2|Overall Study|Lost to Follow-up|5
4511|NCT02253654|30167|P1|Overall Study|Lost to Follow-up|2
4512|NCT02253654|30166|P2|Overall Study|Decision by Sponsor|1
4513|NCT02253654|30167|P1|Overall Study|Decision by Sponsor|1
4514|NCT02253654|30166|P2|Overall Study|Withdrawal by Subject|4
4515|NCT02253654|30167|P1|Overall Study|Withdrawal by Subject|12
4516|NCT02252965|30431|P2|Overall Study|Unspecified|5
4517|NCT02252965|30432|P1|Overall Study|Unspecified|4
4518|NCT02252965|30431|P2|Overall Study|Withdrawal by Subject|9
4519|NCT02252965|30432|P1|Overall Study|Withdrawal by Subject|7
4520|NCT02252965|30431|P2|Overall Study|Lack of Efficacy|2
4521|NCT02252965|30432|P1|Overall Study|Lack of Efficacy|0
4522|NCT02252965|30431|P2|Overall Study|Protocol Violation|5
4523|NCT02252965|30432|P1|Overall Study|Protocol Violation|4
4524|NCT02252965|30431|P2|Overall Study|Lost to Follow-up|8
4525|NCT02252965|30432|P1|Overall Study|Lost to Follow-up|16
4526|NCT02252965|30431|P2|Overall Study|Adverse Event|14
4527|NCT02252965|30432|P1|Overall Study|Adverse Event|9
4528|NCT02252016|30551|P2|Overall Study|Withdrawal by Subject|2
4529|NCT02252016|30552|P1|Overall Study|Withdrawal by Subject|0
4530|NCT02252016|30551|P2|Overall Study|Physician Decision|0
4531|NCT02252016|30552|P1|Overall Study|Physician Decision|1
4532|NCT02252016|30551|P2|Overall Study|Lost to Follow-up|1
4533|NCT02252016|30552|P1|Overall Study|Lost to Follow-up|2
4534|NCT02251912|30566|P2|Overall Study|Adverse Event|2
4535|NCT02251912|30567|P1|Overall Study|Adverse Event|0
4536|NCT02251912|30566|P2|Overall Study|Withdrawal by Subject|3
4537|NCT02251912|30567|P1|Overall Study|Withdrawal by Subject|2
4538|NCT02251652|30594|P1|Overall Study|Withdrawal by Subject|1
4539|NCT02250274|30647|P2|Overall Study|Insufficient blood draw amount|6
4540|NCT02250274|30648|P1|Overall Study|Insufficient blood draw amount|7
4541|NCT02248818|30701|P9|Randomised Study|Administrative - randomization error|0
4542|NCT02248818|30702|P8|Randomised Study|Administrative - randomization error|0
4543|NCT02248818|30703|P7|Randomised Study|Administrative - randomization error|0
4544|NCT02248818|30704|P6|Randomised Study|Administrative - randomization error|8
4545|NCT02248818|30705|P5|Randomised Study|Administrative - randomization error|0
4546|NCT02248818|30706|P4|Randomised Study|Administrative - randomization error|0
4547|NCT02248818|30707|P3|Randomised Study|Administrative - randomization error|0
4548|NCT02248818|30708|P2|Randomised Study|Administrative - randomization error|0
4549|NCT02248818|30709|P1|Randomised Study|Administrative - randomization error|0
4550|NCT02248818|30701|P9|Screening|Lost to Follow-up|7
4551|NCT02248818|30702|P8|Screening|Lost to Follow-up|0
4552|NCT02248818|30703|P7|Screening|Lost to Follow-up|0
4553|NCT02248818|30704|P6|Screening|Lost to Follow-up|0
4554|NCT02248818|30705|P5|Screening|Lost to Follow-up|0
4555|NCT02248818|30706|P4|Screening|Lost to Follow-up|0
4556|NCT02248818|30707|P3|Screening|Lost to Follow-up|0
4557|NCT02248818|30708|P2|Screening|Lost to Follow-up|0
4558|NCT02248818|30709|P1|Screening|Lost to Follow-up|0
4559|NCT02248818|30701|P9|Screening|Withdrawal by Subject|6
4560|NCT02248818|30702|P8|Screening|Withdrawal by Subject|0
4561|NCT02248818|30703|P7|Screening|Withdrawal by Subject|0
4562|NCT02248818|30704|P6|Screening|Withdrawal by Subject|0
4563|NCT02248818|30705|P5|Screening|Withdrawal by Subject|0
4564|NCT02248818|30706|P4|Screening|Withdrawal by Subject|0
4565|NCT02248818|30707|P3|Screening|Withdrawal by Subject|0
4566|NCT02248818|30708|P2|Screening|Withdrawal by Subject|0
4567|NCT02248818|30709|P1|Screening|Withdrawal by Subject|0
4568|NCT02248818|30701|P9|Screening|Physician Decision|73
4569|NCT02248818|30702|P8|Screening|Physician Decision|0
4570|NCT02248818|30703|P7|Screening|Physician Decision|0
4571|NCT02248818|30704|P6|Screening|Physician Decision|0
4572|NCT02248818|30705|P5|Screening|Physician Decision|0
4573|NCT02248818|30706|P4|Screening|Physician Decision|0
4574|NCT02248818|30707|P3|Screening|Physician Decision|0
4575|NCT02248818|30708|P2|Screening|Physician Decision|0
4576|NCT02248818|30709|P1|Screening|Physician Decision|0
4577|NCT02248818|30701|P9|Screening|Study fully enrolled|14
4578|NCT02248818|30702|P8|Screening|Study fully enrolled|0
4579|NCT02248818|30703|P7|Screening|Study fully enrolled|0
4580|NCT02248818|30704|P6|Screening|Study fully enrolled|0
4581|NCT02248818|30705|P5|Screening|Study fully enrolled|0
4582|NCT02248818|30706|P4|Screening|Study fully enrolled|0
4583|NCT02248818|30707|P3|Screening|Study fully enrolled|0
4584|NCT02248818|30708|P2|Screening|Study fully enrolled|0
4585|NCT02248818|30709|P1|Screening|Study fully enrolled|0
4586|NCT02248818|30701|P9|Screening|Protocol Violation|7
4587|NCT02248818|30702|P8|Screening|Protocol Violation|0
4588|NCT02248818|30703|P7|Screening|Protocol Violation|0
4589|NCT02248818|30704|P6|Screening|Protocol Violation|0
4590|NCT02248818|30705|P5|Screening|Protocol Violation|0
4591|NCT02248818|30706|P4|Screening|Protocol Violation|0
4592|NCT02248818|30707|P3|Screening|Protocol Violation|0
4593|NCT02248818|30708|P2|Screening|Protocol Violation|0
4594|NCT02248818|30709|P1|Screening|Protocol Violation|0
4595|NCT02248675|30872|P2|Overall Study|Lost to Follow-up|1
4596|NCT02248675|30873|P1|Overall Study|Lost to Follow-up|3
4597|NCT02248480|30900|P2|Overall Study|Other:Physician Decision|1
4598|NCT02248480|30901|P1|Overall Study|Other:Physician Decision|0
4599|NCT02248480|30900|P2|Overall Study|Entry Criteria Not Met|1
4600|NCT02248480|30901|P1|Overall Study|Entry Criteria Not Met|0
4601|NCT02248480|30900|P2|Overall Study|Withdrawal by Subject|4
4602|NCT02248480|30901|P1|Overall Study|Withdrawal by Subject|2
4603|NCT02248480|30900|P2|Overall Study|Adverse Event|2
4604|NCT02248480|30901|P1|Overall Study|Adverse Event|11
4605|NCT02248480|30900|P2|Overall Study|Lack of Efficacy|6
4606|NCT02248480|30901|P1|Overall Study|Lack of Efficacy|4
4607|NCT02247960|30959|P2|Catheter Removed|Lost to Follow-up|10
4608|NCT02247960|30960|P1|Catheter Removed|Lost to Follow-up|7
4609|NCT02247960|30959|P2|Patient Consent and Randomization|Withdrawal by Subject|4
4610|NCT02247960|30960|P1|Patient Consent and Randomization|Withdrawal by Subject|0
4611|NCT02247960|30959|P2|Patient Consent and Randomization|Physician Decision|2
4612|NCT02247960|30960|P1|Patient Consent and Randomization|Physician Decision|2
4613|NCT02247401|30978|P3|Overall Study|Lost to Follow-up|1
4614|NCT02247401|30979|P2|Overall Study|Lost to Follow-up|1
4615|NCT02247401|30980|P1|Overall Study|Lost to Follow-up|1
4616|NCT02247401|30978|P3|Overall Study|Withdrawal by Subject|1
4617|NCT02247401|30979|P2|Overall Study|Withdrawal by Subject|1
4618|NCT02247401|30980|P1|Overall Study|Withdrawal by Subject|4
4619|NCT02247401|30978|P3|Overall Study|Adverse Event|0
4620|NCT02247401|30979|P2|Overall Study|Adverse Event|0
4621|NCT02247401|30980|P1|Overall Study|Adverse Event|1
4622|NCT02247011|30999|P1|Overall Study|Poor quality of radiological results|125
4623|NCT02246673|31021|P5|Overall Study|Protocol Violation|0
4624|NCT02246673|31022|P4|Overall Study|Protocol Violation|1
4625|NCT02246673|31023|P3|Overall Study|Protocol Violation|0
4626|NCT02246673|31024|P2|Overall Study|Protocol Violation|0
4627|NCT02246673|31025|P1|Overall Study|Protocol Violation|0
4628|NCT02246673|31021|P5|Overall Study|Lost to Follow-up|0
4629|NCT02246673|31022|P4|Overall Study|Lost to Follow-up|1
4630|NCT02246673|31023|P3|Overall Study|Lost to Follow-up|0
4631|NCT02246673|31024|P2|Overall Study|Lost to Follow-up|0
4632|NCT02246673|31025|P1|Overall Study|Lost to Follow-up|0
4633|NCT02246673|31021|P5|Overall Study|Withdrawal by Subject|1
4634|NCT02246673|31022|P4|Overall Study|Withdrawal by Subject|0
4635|NCT02246673|31023|P3|Overall Study|Withdrawal by Subject|0
4636|NCT02246673|31024|P2|Overall Study|Withdrawal by Subject|0
4637|NCT02246673|31025|P1|Overall Study|Withdrawal by Subject|0
4638|NCT02246673|31021|P5|Overall Study|Sponsor Decision|0
4639|NCT02246673|31022|P4|Overall Study|Sponsor Decision|0
4640|NCT02246673|31023|P3|Overall Study|Sponsor Decision|0
4641|NCT02246673|31024|P2|Overall Study|Sponsor Decision|0
4642|NCT02246673|31025|P1|Overall Study|Sponsor Decision|1
4643|NCT02246582|31130|P2|Overall Study|Withdrawal by Subject|4
4644|NCT02246582|31131|P1|Overall Study|Withdrawal by Subject|3
4645|NCT02246166|31139|P2|Overall Study|Protocol Violation|0
4646|NCT02246166|31140|P1|Overall Study|Protocol Violation|1
4647|NCT02246114|31176|P2|Overall Study|miscarriage|0
4648|NCT02246114|31177|P1|Overall Study|miscarriage|1
4649|NCT02244619|31225|P2|Overall Study|Did not receive study intervention|21
4650|NCT02244619|31226|P1|Overall Study|Did not receive study intervention|8
4651|NCT02244580|31244|P1|Overall Study|No cancer tissues available|241
4652|NCT02243280|31276|P11|Treated|Lost to Follow-up|2
4653|NCT02243280|31277|P10|Treated|Lost to Follow-up|0
4654|NCT02243280|31278|P9|Treated|Lost to Follow-up|1
4655|NCT02243280|31279|P8|Treated|Lost to Follow-up|0
4656|NCT02243280|31280|P7|Treated|Lost to Follow-up|0
4657|NCT02243280|31281|P6|Treated|Lost to Follow-up|0
4658|NCT02243280|31282|P5|Treated|Lost to Follow-up|0
4659|NCT02243280|31283|P4|Treated|Lost to Follow-up|0
4660|NCT02243280|31284|P3|Treated|Lost to Follow-up|0
4661|NCT02243280|31285|P2|Treated|Lost to Follow-up|0
4662|NCT02243280|31286|P1|Treated|Lost to Follow-up|0
4663|NCT02243280|31276|P11|Treated|Adverse Event|1
4664|NCT02243280|31277|P10|Treated|Adverse Event|0
4665|NCT02243280|31278|P9|Treated|Adverse Event|0
4666|NCT02243280|31279|P8|Treated|Adverse Event|0
4667|NCT02243280|31280|P7|Treated|Adverse Event|0
4668|NCT02243280|31281|P6|Treated|Adverse Event|0
4669|NCT02243280|31282|P5|Treated|Adverse Event|0
4670|NCT02243280|31283|P4|Treated|Adverse Event|0
4671|NCT02243280|31284|P3|Treated|Adverse Event|0
4672|NCT02243280|31285|P2|Treated|Adverse Event|0
4673|NCT02243280|31286|P1|Treated|Adverse Event|1
4674|NCT02243202|31341|P4|Overall Study|Randomized but not received treatment|1
4675|NCT02243202|31342|P3|Overall Study|Randomized but not received treatment|0
4676|NCT02243202|31343|P2|Overall Study|Randomized but not received treatment|0
4677|NCT02243202|31344|P1|Overall Study|Randomized but not received treatment|0
4678|NCT02243202|31341|P4|Overall Study|Unspecified|2
4679|NCT02243202|31342|P3|Overall Study|Unspecified|1
4680|NCT02243202|31343|P2|Overall Study|Unspecified|3
4681|NCT02243202|31344|P1|Overall Study|Unspecified|1
4682|NCT02243202|31341|P4|Overall Study|Withdrawal by Subject|4
4683|NCT02243202|31342|P3|Overall Study|Withdrawal by Subject|4
4684|NCT02243202|31343|P2|Overall Study|Withdrawal by Subject|6
4685|NCT02243202|31344|P1|Overall Study|Withdrawal by Subject|7
4686|NCT02243202|31341|P4|Overall Study|Protocol Violation|1
4687|NCT02243202|31342|P3|Overall Study|Protocol Violation|2
4688|NCT02243202|31343|P2|Overall Study|Protocol Violation|1
4689|NCT02243202|31344|P1|Overall Study|Protocol Violation|3
4690|NCT02243202|31341|P4|Overall Study|Lost to Follow-up|11
4691|NCT02243202|31342|P3|Overall Study|Lost to Follow-up|14
4692|NCT02243202|31343|P2|Overall Study|Lost to Follow-up|9
4693|NCT02243202|31344|P1|Overall Study|Lost to Follow-up|9
4694|NCT02243202|31341|P4|Overall Study|Adverse Event|4
4695|NCT02243202|31342|P3|Overall Study|Adverse Event|10
4696|NCT02243202|31343|P2|Overall Study|Adverse Event|6
4697|NCT02243202|31344|P1|Overall Study|Adverse Event|5
4698|NCT02243176|31380|P2|Overall Study|Adverse Event|2
4699|NCT02243176|31381|P1|Overall Study|Adverse Event|2
4700|NCT02243176|31380|P2|Overall Study|Withdrawal by Subject|7
4701|NCT02243176|31381|P1|Overall Study|Withdrawal by Subject|8
4702|NCT02243176|31380|P2|Overall Study|Protocol Violation|1
4703|NCT02243176|31381|P1|Overall Study|Protocol Violation|2
4704|NCT02243176|31380|P2|Overall Study|protocol specified withdrawal critera|3
4705|NCT02243176|31381|P1|Overall Study|protocol specified withdrawal critera|1
4706|NCT02243176|31380|P2|Overall Study|Other reason|2
4707|NCT02243176|31381|P1|Overall Study|Other reason|1
4708|NCT02243046|31406|P3|Overall Study|Lost to Follow-up|4
4709|NCT02243046|31407|P2|Overall Study|Lost to Follow-up|1
4710|NCT02243046|31408|P1|Overall Study|Lost to Follow-up|1
4711|NCT02242643|31463|P2|Overall Study|Withdrawal by subject at Visit 2|1
4712|NCT02242643|31464|P1|Overall Study|Withdrawal by subject at Visit 2|0
4713|NCT02242643|31463|P2|Overall Study|Language barrier|0
4714|NCT02242643|31464|P1|Overall Study|Language barrier|1
4715|NCT02242643|31463|P2|Overall Study|Protocol requirements not followed|0
4716|NCT02242643|31464|P1|Overall Study|Protocol requirements not followed|1
4717|NCT02242643|31463|P2|Overall Study|Consent withdrawal by parent|0
4718|NCT02242643|31464|P1|Overall Study|Consent withdrawal by parent|1
4719|NCT02242643|31463|P2|Overall Study|Non-compliance|0
4720|NCT02242643|31464|P1|Overall Study|Non-compliance|1
4721|NCT02242643|31463|P2|Overall Study|Child placed in foster care by family|1
4722|NCT02242643|31464|P1|Overall Study|Child placed in foster care by family|0
4723|NCT02242643|31463|P2|Overall Study|Lost to Follow-up|61
4724|NCT02242643|31464|P1|Overall Study|Lost to Follow-up|54
4725|NCT02242643|31463|P2|Overall Study|Migrated/moved from study area|3
4726|NCT02242643|31464|P1|Overall Study|Migrated/moved from study area|1
4727|NCT02242643|31463|P2|Overall Study|Withdrawal by Subject|10
4728|NCT02242643|31464|P1|Overall Study|Withdrawal by Subject|15
4729|NCT02242643|31463|P2|Overall Study|Protocol Violation|2
4730|NCT02242643|31464|P1|Overall Study|Protocol Violation|1
4731|NCT02242305|31519|P2|Overall Study|Lost to Follow-up|0
4732|NCT02242305|31520|P1|Overall Study|Lost to Follow-up|2
4733|NCT02242305|31519|P2|Overall Study|Subject withdraws inform consent|4
4734|NCT02242305|31520|P1|Overall Study|Subject withdraws inform consent|0
4735|NCT02242305|31519|P2|Overall Study|Non-compliance dosing regimen or visit|2
4736|NCT02242305|31520|P1|Overall Study|Non-compliance dosing regimen or visit|2
4737|NCT02242305|31519|P2|Overall Study|Adverse Event|0
4738|NCT02242305|31520|P1|Overall Study|Adverse Event|1
4739|NCT02242305|31519|P2|Overall Study|Without spasm-like pain during 3 weeks|4
4740|NCT02242305|31520|P1|Overall Study|Without spasm-like pain during 3 weeks|1
4741|NCT02241889|31544|P6|Overall Study|Withdrawal by Subject|1
4742|NCT02241889|31545|P5|Overall Study|Withdrawal by Subject|0
4743|NCT02241889|31546|P4|Overall Study|Withdrawal by Subject|0
4744|NCT02241889|31547|P3|Overall Study|Withdrawal by Subject|0
4745|NCT02241889|31548|P2|Overall Study|Withdrawal by Subject|0
4746|NCT02241889|31549|P1|Overall Study|Withdrawal by Subject|0
4747|NCT02241889|31544|P6|Overall Study|device issues|0
4748|NCT02241889|31545|P5|Overall Study|device issues|0
4749|NCT02241889|31546|P4|Overall Study|device issues|0
4750|NCT02241889|31547|P3|Overall Study|device issues|1
4751|NCT02241889|31548|P2|Overall Study|device issues|0
4752|NCT02241889|31549|P1|Overall Study|device issues|0
4753|NCT02241785|31584|P1|Overall Study|Adverse Event|1
4754|NCT02241785|31584|P1|Overall Study|Lost to Follow-up|2
4755|NCT02241785|31584|P1|Overall Study|Withdrawal by Subject|1
4756|NCT02241785|31584|P1|Overall Study|Sponsor Termination|43
4757|NCT02240628|31598|P2|Overall Study|Physician Decision|5
4758|NCT02240628|31599|P1|Overall Study|Physician Decision|6
4759|NCT02240368|31633|P3|Overall Study|Entropy failed to detect more than 50%|1
4760|NCT02240368|31634|P2|Overall Study|Entropy failed to detect more than 50%|0
4761|NCT02240368|31635|P1|Overall Study|Entropy failed to detect more than 50%|0
4762|NCT02240368|31633|P3|Overall Study|Surgery lasted less then 20 minutes|0
4763|NCT02240368|31634|P2|Overall Study|Surgery lasted less then 20 minutes|0
4764|NCT02240368|31635|P1|Overall Study|Surgery lasted less then 20 minutes|1
4765|NCT02239978|31659|P2|Overall Study|Withdrawal by Subject|0
4766|NCT02239978|31660|P1|Overall Study|Withdrawal by Subject|2
4767|NCT02239926|31677|P2|Overall Study|Withdrawal by Subject|1
4768|NCT02239926|31678|P1|Overall Study|Withdrawal by Subject|0
4769|NCT02239692|31703|P2|Overall Study|Other reason|0
4770|NCT02239692|31704|P1|Overall Study|Other reason|1
4771|NCT02239692|31703|P2|Overall Study|Withdrawal by Subject|5
4772|NCT02239692|31704|P1|Overall Study|Withdrawal by Subject|3
4773|NCT02239692|31703|P2|Overall Study|Lost to Follow-up|4
4774|NCT02239692|31704|P1|Overall Study|Lost to Follow-up|1
4775|NCT02239692|31703|P2|Overall Study|Physician Decision|1
4776|NCT02239692|31704|P1|Overall Study|Physician Decision|0
4777|NCT02239692|31703|P2|Overall Study|Adverse Event|1
4778|NCT02239692|31704|P1|Overall Study|Adverse Event|0
4779|NCT02239692|31703|P2|Overall Study|Incomplete colonoscopy|2
4780|NCT02239692|31704|P1|Overall Study|Incomplete colonoscopy|1
4781|NCT02238379|31745|P2|Overall Study|Lost to Follow-up|0
4782|NCT02238379|31746|P1|Overall Study|Lost to Follow-up|1
4783|NCT02238080|31772|P1|Overall Study|Unspecified|4
4784|NCT02238080|31772|P1|Overall Study|Withdrawal by Subject|2
4785|NCT02238080|31772|P1|Overall Study|Treatment interrupted|6
4786|NCT02238080|31772|P1|Overall Study|Death|13
4787|NCT02238067|31786|P1|Overall Study|Not completed survey at Month 6|45
4788|NCT02237118|31831|P2|Overall Study|consent withdrawn|0
4789|NCT02237118|31832|P1|Overall Study|consent withdrawn|1
4790|NCT02237118|31831|P2|Overall Study|Protocol Violation|1
4791|NCT02237118|31832|P1|Overall Study|Protocol Violation|0
4792|NCT02236611|31869|P2|Overall Study|Withdrew consent|4
4793|NCT02236611|31870|P1|Overall Study|Withdrew consent|9
4794|NCT02236611|31869|P2|Overall Study|Protocol deviation|5
4795|NCT02236611|31870|P1|Overall Study|Protocol deviation|3
4796|NCT02236611|31869|P2|Overall Study|Lost to Follow-up|2
4797|NCT02236611|31870|P1|Overall Study|Lost to Follow-up|0
4798|NCT02236611|31869|P2|Overall Study|Lack of Efficacy|7
4799|NCT02236611|31870|P1|Overall Study|Lack of Efficacy|4
4800|NCT02236611|31869|P2|Overall Study|Adverse Event|16
4801|NCT02236611|31870|P1|Overall Study|Adverse Event|10
4802|NCT02236598|31878|P2|Overall Study|Withdrawal by Subject|1
4803|NCT02236598|31879|P1|Overall Study|Withdrawal by Subject|0
4804|NCT02236598|31878|P2|Overall Study|Adverse Event|1
4805|NCT02236598|31879|P1|Overall Study|Adverse Event|0
4806|NCT02236130|31900|P2|Overall Study|Lost to Follow-up|12
4807|NCT02236130|31901|P1|Overall Study|Lost to Follow-up|7
4808|NCT02235454|31926|P1|Overall Study|Withdrawal by Subject|2
4809|NCT02235311|31932|P2|Overall Study|Protocol Violation|1
4810|NCT02235311|31933|P1|Overall Study|Protocol Violation|0
4811|NCT02235311|31932|P2|Overall Study|Lost to Follow-up|1
4812|NCT02235311|31933|P1|Overall Study|Lost to Follow-up|0
4813|NCT02235077|31951|P2|Overall Study|Physician Decision|1
4814|NCT02235077|31952|P1|Overall Study|Physician Decision|0
4815|NCT02235077|31951|P2|Overall Study|Withdrawal by Subject|5
4816|NCT02235077|31952|P1|Overall Study|Withdrawal by Subject|8
4817|NCT02235077|31951|P2|Overall Study|Lost to Follow-up|6
4818|NCT02235077|31952|P1|Overall Study|Lost to Follow-up|5
4819|NCT02235077|31951|P2|Overall Study|Death|7
4820|NCT02235077|31952|P1|Overall Study|Death|5
4821|NCT02234479|32009|P2|Overall Study|Withdrawal by Subject|3
4822|NCT02234479|32010|P1|Overall Study|Withdrawal by Subject|1
4823|NCT02234362|32020|P1|Overall Study|Withdrawal by Subject|3
4824|NCT02234362|32020|P1|Overall Study|Lost to Follow-up|6
4825|NCT02234362|32020|P1|Overall Study|Not eligible after first screening visit|17
4826|NCT02233803|32096|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
4827|NCT02233803|32097|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
4828|NCT02233803|32096|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
4829|NCT02233803|32097|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
4830|NCT02233803|32096|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
4831|NCT02233803|32097|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
4832|NCT02233803|32096|P2|Washout Period (4-Wks)|Physician Decision|0
4833|NCT02233803|32097|P1|Washout Period (4-Wks)|Physician Decision|1
4834|NCT02233803|32096|P2|Washout Period (4-Wks)|Lost to Follow-up|1
4835|NCT02233803|32097|P1|Washout Period (4-Wks)|Lost to Follow-up|0
4836|NCT02233803|32096|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
4837|NCT02233803|32097|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
4838|NCT02233803|32096|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
4839|NCT02233803|32097|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
4840|NCT02233803|32096|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
4841|NCT02233803|32097|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
4842|NCT02233803|32096|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
4843|NCT02233803|32097|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
4844|NCT02233647|32107|P1|Overall Study|Adverse Event|1
4845|NCT02233309|32136|P1|Overall Study|Physician Decision|5
4846|NCT02232880|32170|P1|Overall Study|study stopped prior to randomization|1
4847|NCT02232698|32179|P2|Overall Study|Withdrawal by Subject|11
4848|NCT02232698|32180|P1|Overall Study|Withdrawal by Subject|0
4849|NCT02232698|32179|P2|Overall Study|Allocated to control group|3
4850|NCT02232698|32180|P1|Overall Study|Allocated to control group|0
4851|NCT02232698|32179|P2|Overall Study|Non-compliance with study device|4
4852|NCT02232698|32180|P1|Overall Study|Non-compliance with study device|1
4853|NCT02232698|32179|P2|Overall Study|Had device-associated symptoms|0
4854|NCT02232698|32180|P1|Overall Study|Had device-associated symptoms|7
4855|NCT02232698|32179|P2|Overall Study|Met exclusion criteria|1
4856|NCT02232698|32180|P1|Overall Study|Met exclusion criteria|1
4857|NCT02232698|32179|P2|Overall Study|Pregnancy|1
4858|NCT02232698|32180|P1|Overall Study|Pregnancy|1
4859|NCT02231918|32215|P3|Overall Study|Adverse Event|1
4860|NCT02231918|32216|P2|Overall Study|Adverse Event|0
4861|NCT02231918|32217|P1|Overall Study|Adverse Event|0
4862|NCT02231918|32215|P3|Overall Study|Withdrawal by Subject|0
4863|NCT02231918|32216|P2|Overall Study|Withdrawal by Subject|1
4864|NCT02231918|32217|P1|Overall Study|Withdrawal by Subject|0
4865|NCT02231164|32340|P2|Overall Study|Withdrawal by Subject|2
4866|NCT02231164|32341|P1|Overall Study|Withdrawal by Subject|1
4867|NCT02231164|32340|P2|Overall Study|Lack of Efficacy|3
4868|NCT02231164|32341|P1|Overall Study|Lack of Efficacy|4
4869|NCT02231164|32340|P2|Overall Study|Adverse Event|1
4870|NCT02231164|32341|P1|Overall Study|Adverse Event|1
4871|NCT02229864|32347|P1|1 - Year Visit|Missed Visits|1
4872|NCT02230956|32407|P3|Overall Study|Other Miscellaneous Reason|2
4873|NCT02230956|32408|P2|Overall Study|Other Miscellaneous Reason|1
4874|NCT02230956|32409|P1|Overall Study|Other Miscellaneous Reason|0
4875|NCT02230956|32407|P3|Overall Study|Protocol Violation|1
4876|NCT02230956|32408|P2|Overall Study|Protocol Violation|1
4877|NCT02230956|32409|P1|Overall Study|Protocol Violation|0
4878|NCT02230956|32407|P3|Overall Study|Personal Reasons|1
4879|NCT02230956|32408|P2|Overall Study|Personal Reasons|1
4880|NCT02230956|32409|P1|Overall Study|Personal Reasons|2
4881|NCT02230956|32407|P3|Overall Study|Lost to Follow-up|2
4882|NCT02230956|32408|P2|Overall Study|Lost to Follow-up|1
4883|NCT02230956|32409|P1|Overall Study|Lost to Follow-up|1
4884|NCT02230956|32407|P3|Overall Study|Lack of Efficacy|1
4885|NCT02230956|32408|P2|Overall Study|Lack of Efficacy|1
4886|NCT02230956|32409|P1|Overall Study|Lack of Efficacy|1
4887|NCT02230956|32407|P3|Overall Study|Adverse Event|0
4888|NCT02230956|32408|P2|Overall Study|Adverse Event|1
4889|NCT02230956|32409|P1|Overall Study|Adverse Event|1
4890|NCT02230904|32431|P2|Overall Study|Safety follow up could not take place|1
4891|NCT02230904|32432|P1|Overall Study|Safety follow up could not take place|0
4892|NCT02230683|32465|P1|Overall Study|Adverse Event|1
4893|NCT02230670|32482|P2|Overall Study|Progression to Child-Pugh C|2
4894|NCT02230670|32483|P1|Overall Study|Progression to Child-Pugh C|1
4895|NCT02230670|32482|P2|Overall Study|Protocol Violation|1
4896|NCT02230670|32483|P1|Overall Study|Protocol Violation|0
4897|NCT02230670|32482|P2|Overall Study|Physician Decision|1
4898|NCT02230670|32483|P1|Overall Study|Physician Decision|0
4899|NCT02230670|32482|P2|Overall Study|Withdrawal by Subject|2
4900|NCT02230670|32483|P1|Overall Study|Withdrawal by Subject|2
4901|NCT02230670|32482|P2|Overall Study|Adverse Event|2
4902|NCT02230670|32483|P1|Overall Study|Adverse Event|1
4903|NCT02230085|32498|P1|Overall Study|Withdrawal by Subject|3
4904|NCT02230085|32498|P1|Overall Study|Physician Decision|1
4905|NCT02229539|32505|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
4906|NCT02229539|32506|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
4907|NCT02229539|32507|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
4908|NCT02229539|32505|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
4909|NCT02229539|32506|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
4910|NCT02229539|32507|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
4911|NCT02229539|32505|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
4912|NCT02229539|32506|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
4913|NCT02229539|32507|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
4914|NCT02229539|32505|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
4915|NCT02229539|32506|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
4916|NCT02229539|32507|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
4917|NCT02229539|32505|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
4918|NCT02229539|32506|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
4919|NCT02229539|32507|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
4920|NCT02229539|32505|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
4921|NCT02229539|32506|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
4922|NCT02229539|32507|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
4923|NCT02229539|32505|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
4924|NCT02229539|32506|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
4925|NCT02229539|32507|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
4926|NCT02229539|32505|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
4927|NCT02229539|32506|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
4928|NCT02229539|32507|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
4929|NCT02229539|32505|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
4930|NCT02229539|32506|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
4931|NCT02229539|32507|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
4932|NCT02229214|32613|P2|Overall Study|Withdrawal by Subject|0
4933|NCT02229214|32614|P1|Overall Study|Withdrawal by Subject|4
4934|NCT02229214|32613|P2|Overall Study|Adverse Event|0
4935|NCT02229214|32614|P1|Overall Study|Adverse Event|2
4936|NCT02228980|32638|P4|Overall Study|Withdrawal by Subject|3
4937|NCT02228980|32639|P3|Overall Study|Withdrawal by Subject|2
4938|NCT02228980|32640|P2|Overall Study|Withdrawal by Subject|3
4939|NCT02228980|32641|P1|Overall Study|Withdrawal by Subject|3
4940|NCT02228980|32638|P4|Overall Study|Protocol Violation|0
4941|NCT02228980|32639|P3|Overall Study|Protocol Violation|0
4942|NCT02228980|32640|P2|Overall Study|Protocol Violation|0
4943|NCT02228980|32641|P1|Overall Study|Protocol Violation|7
4944|NCT02228980|32638|P4|Overall Study|Adverse Event|0
4945|NCT02228980|32639|P3|Overall Study|Adverse Event|0
4946|NCT02228980|32640|P2|Overall Study|Adverse Event|0
4947|NCT02228980|32641|P1|Overall Study|Adverse Event|14
4948|NCT02228720|32663|P1|Open Label - Day 30|Lost to Follow-up|1
4949|NCT02228395|32671|P3|First Intervention Period|Unable to comply with study dates|1
4950|NCT02228395|32672|P2|First Intervention Period|Unable to comply with study dates|1
4951|NCT02228395|32673|P1|First Intervention Period|Unable to comply with study dates|0
4952|NCT02228395|32671|P3|First Intervention Period|No longer willing to participate|0
4953|NCT02228395|32672|P2|First Intervention Period|No longer willing to participate|0
4954|NCT02228395|32673|P1|First Intervention Period|No longer willing to participate|1
4955|NCT02227368|32773|P2|Overall Study|Adverse Event|0
4956|NCT02227368|32774|P1|Overall Study|Adverse Event|1
4957|NCT02227368|32773|P2|Overall Study|Lost to Follow-up|0
4958|NCT02227368|32774|P1|Overall Study|Lost to Follow-up|1
4959|NCT02227368|32773|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
4960|NCT02227368|32774|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
4961|NCT02227108|32786|P1|Overall Study|Adverse Event|6
4962|NCT02227108|32786|P1|Overall Study|Investigator discretion|1
4963|NCT02227108|32786|P1|Overall Study|Initiation of alternative therapy|2
4964|NCT02227108|32786|P1|Overall Study|Progressive disease|17
4965|NCT02227108|32786|P1|Overall Study|Unspecified|3
4966|NCT02227108|32786|P1|Overall Study|Did not receive treatment|2
4967|NCT02226562|32815|P2|Overall Study|Lost to Follow-up|1
4968|NCT02226562|32816|P1|Overall Study|Lost to Follow-up|0
4969|NCT02226549|32834|P2|Overall Study|Lost to Follow-up|1
4970|NCT02226549|32835|P1|Overall Study|Lost to Follow-up|0
4971|NCT02226549|32834|P2|Overall Study|Randomized but Never Treated|0
4972|NCT02226549|32835|P1|Overall Study|Randomized but Never Treated|1
4973|NCT02226198|32845|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
4974|NCT02226198|32846|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
4975|NCT02226198|32847|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
4976|NCT02226198|32845|P3|Lead-in Phase|Protocol Violation|0
4977|NCT02226198|32846|P2|Lead-in Phase|Protocol Violation|0
4978|NCT02226198|32847|P1|Lead-in Phase|Protocol Violation|1
4979|NCT02226003|32923|P3|Overall Study|Withdrawal by Subject|3
4980|NCT02226003|32924|P2|Overall Study|Withdrawal by Subject|0
4981|NCT02226003|32925|P1|Overall Study|Withdrawal by Subject|0
4982|NCT02226003|32923|P3|Overall Study|Lost to Follow-up|3
4983|NCT02226003|32924|P2|Overall Study|Lost to Follow-up|1
4984|NCT02226003|32925|P1|Overall Study|Lost to Follow-up|2
4985|NCT02224664|32978|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
4986|NCT02224664|32979|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
4987|NCT02224664|32980|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4988|NCT02224664|32981|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4989|NCT02224664|32982|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4990|NCT02224664|32978|P5|Dose Escalation Period (21 Days)|Adverse Event|7
4991|NCT02224664|32979|P4|Dose Escalation Period (21 Days)|Adverse Event|2
4992|NCT02224664|32980|P3|Dose Escalation Period (21 Days)|Adverse Event|2
4993|NCT02224664|32981|P2|Dose Escalation Period (21 Days)|Adverse Event|0
4994|NCT02224664|32982|P1|Dose Escalation Period (21 Days)|Adverse Event|0
4995|NCT02224664|32978|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4996|NCT02224664|32979|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4997|NCT02224664|32980|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4998|NCT02224664|32981|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4999|NCT02224664|32982|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
5000|NCT02224625|33062|P1|Sensitization|Adverse Event|55
5001|NCT02224625|33062|P1|Irritation|Adverse Event|6
5002|NCT02224053|33092|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
5003|NCT02224053|33092|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
5004|NCT02224053|33092|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
5005|NCT02224053|33092|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
5006|NCT02224053|33092|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
5007|NCT02223754|33138|P2|Period 2|Test Article No Longer Available|1
5008|NCT02223754|33139|P1|Period 2|Test Article No Longer Available|0
5009|NCT02223754|33138|P2|Period 2|Lost to Follow-up|0
5010|NCT02223754|33139|P1|Period 2|Lost to Follow-up|1
5011|NCT02223754|33138|P2|Period 2|Lens Discomfort|1
5012|NCT02223754|33139|P1|Period 2|Lens Discomfort|1
5013|NCT02223754|33138|P2|Period 2|Protocol Violation|0
5014|NCT02223754|33139|P1|Period 2|Protocol Violation|1
5015|NCT02223754|33138|P2|Period 2|Adverse Event|1
5016|NCT02223754|33139|P1|Period 2|Adverse Event|0
5017|NCT02223754|33138|P2|Period 1|Unsatisfactory Visual Response|1
5018|NCT02223754|33139|P1|Period 1|Unsatisfactory Visual Response|0
5019|NCT02223754|33138|P2|Period 1|Test Article No Longer Available|5
5020|NCT02223754|33139|P1|Period 1|Test Article No Longer Available|1
5021|NCT02223754|33138|P2|Period 1|Withdrawal by Subject|4
5022|NCT02223754|33139|P1|Period 1|Withdrawal by Subject|0
5023|NCT02223754|33138|P2|Period 1|Protocol Violation|4
5024|NCT02223754|33139|P1|Period 1|Protocol Violation|2
5025|NCT02223754|33138|P2|Period 1|Lost to Follow-up|1
5026|NCT02223754|33139|P1|Period 1|Lost to Follow-up|0
5027|NCT02223754|33138|P2|Period 1|Adverse Event|0
5028|NCT02223754|33139|P1|Period 1|Adverse Event|1
5029|NCT02223715|33159|P1|Overall Study|Lost to Follow-up|73
5030|NCT02223715|33159|P1|Overall Study|Death|31
5040|NCT02222818|33343|P2|Period 1|Eligibility criteria not met|3
5041|NCT02222818|33344|P1|Period 1|Eligibility criteria not met|0
5042|NCT02222558|33351|P6|Period 3|Withdrawal by Subject|1
5043|NCT02222558|33352|P5|Period 3|Withdrawal by Subject|0
5044|NCT02222558|33353|P4|Period 3|Withdrawal by Subject|0
5045|NCT02222558|33354|P3|Period 3|Withdrawal by Subject|0
5046|NCT02222558|33355|P2|Period 3|Withdrawal by Subject|0
5047|NCT02222558|33356|P1|Period 3|Withdrawal by Subject|0
5048|NCT02222558|33351|P6|Period 1: Single Dose|Withdrawal by Subject|0
5049|NCT02222558|33352|P5|Period 1: Single Dose|Withdrawal by Subject|0
5050|NCT02222558|33353|P4|Period 1: Single Dose|Withdrawal by Subject|0
5051|NCT02222558|33354|P3|Period 1: Single Dose|Withdrawal by Subject|0
5052|NCT02222558|33355|P2|Period 1: Single Dose|Withdrawal by Subject|0
5053|NCT02222558|33356|P1|Period 1: Single Dose|Withdrawal by Subject|4
5054|NCT02222246|33372|P2|Overall Study|Physician Decision|1
5055|NCT02222246|33373|P1|Overall Study|Physician Decision|0
5056|NCT02222246|33372|P2|Overall Study|No Emergency Department Visits|26
5057|NCT02222246|33373|P1|Overall Study|No Emergency Department Visits|27
5058|NCT02222207|33401|P1|Overall Study|Adverse Event|1
5059|NCT02222207|33401|P1|Overall Study|Other reasons|2
5060|NCT02222207|33401|P1|Overall Study|Death|1
5061|NCT02221648|33438|P2|Overall Study|Withdrawal by Subject|3
5062|NCT02221648|33439|P1|Overall Study|Withdrawal by Subject|3
5063|NCT02220998|33455|P2|Overall Study|Lost to Follow-up|4
5064|NCT02220998|33456|P1|Overall Study|Lost to Follow-up|4
5065|NCT02220998|33455|P2|Overall Study|Lack of Efficacy|5
5066|NCT02220998|33456|P1|Overall Study|Lack of Efficacy|0
5067|NCT02220998|33455|P2|Overall Study|Death|0
5068|NCT02220998|33456|P1|Overall Study|Death|2
5069|NCT02220998|33455|P2|Overall Study|Randomized but Never Treated|2
5070|NCT02220998|33456|P1|Overall Study|Randomized but Never Treated|1
5071|NCT02220920|33474|P2|Overall Study|Conflict with the stopping criteria|2
5072|NCT02220920|33475|P1|Overall Study|Conflict with the stopping criteria|1
5073|NCT02220920|33474|P2|Overall Study|Withdrawal by Subject|0
5074|NCT02220920|33475|P1|Overall Study|Withdrawal by Subject|1
5075|NCT02220920|33474|P2|Overall Study|Lack of Efficacy|1
5076|NCT02220920|33475|P1|Overall Study|Lack of Efficacy|0
5077|NCT02220920|33474|P2|Overall Study|Adverse Event|0
5078|NCT02220920|33475|P1|Overall Study|Adverse Event|1
5079|NCT02220764|33491|P2|Overall Study|Death|0
5080|NCT02220764|33492|P1|Overall Study|Death|1
5081|NCT02220764|33491|P2|Overall Study|Lost to Follow-up|1
5082|NCT02220764|33492|P1|Overall Study|Lost to Follow-up|3
5083|NCT02220205|33504|P2|Overall Study|Withdrawal by Subject|0
5084|NCT02220205|33505|P1|Overall Study|Withdrawal by Subject|1
5085|NCT02219932|33530|P2|Overall Study|Adverse Event|21
5086|NCT02219932|33531|P1|Overall Study|Adverse Event|23
5087|NCT02219932|33530|P2|Overall Study|Lost to Follow-up|2
5088|NCT02219932|33531|P1|Overall Study|Lost to Follow-up|4
5089|NCT02219932|33530|P2|Overall Study|Pregnancy|0
5090|NCT02219932|33531|P1|Overall Study|Pregnancy|1
5091|NCT02219932|33530|P2|Overall Study|Protocol Violation|6
5092|NCT02219932|33531|P1|Overall Study|Protocol Violation|10
5093|NCT02219932|33530|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
5094|NCT02219932|33531|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
5095|NCT02219932|33530|P2|Overall Study|Consent Withdrawn|7
5096|NCT02219932|33531|P1|Overall Study|Consent Withdrawn|11
5097|NCT02219932|33530|P2|Overall Study|Investigator Decision|1
5098|NCT02219932|33531|P1|Overall Study|Investigator Decision|0
5099|NCT02219932|33530|P2|Overall Study|Death|1
5100|NCT02219932|33531|P1|Overall Study|Death|1
5101|NCT02219932|33530|P2|Overall Study|Not Specified|11
5102|NCT02219932|33531|P1|Overall Study|Not Specified|5
5103|NCT02219685|33547|P2|Blinded Treatment Phase|Withdrew Consent|0
5104|NCT02219685|33548|P1|Blinded Treatment Phase|Withdrew Consent|1
5105|NCT02219685|33547|P2|Blinded Treatment Phase|Lost to Follow-up|0
5106|NCT02219685|33548|P1|Blinded Treatment Phase|Lost to Follow-up|1
5107|NCT02219477|33654|P3|Overall Study|Withdrawal by Subject|0
5108|NCT02219477|33655|P2|Overall Study|Withdrawal by Subject|1
5109|NCT02219477|33656|P1|Overall Study|Withdrawal by Subject|0
5110|NCT02219477|33654|P3|Overall Study|Adverse Event|1
5111|NCT02219477|33655|P2|Overall Study|Adverse Event|1
5112|NCT02219477|33656|P1|Overall Study|Adverse Event|0
5113|NCT02219464|33684|P2|Overall Study|catheter malfunction|0
5114|NCT02219464|33685|P1|Overall Study|catheter malfunction|1
5115|NCT02219464|33684|P2|Overall Study|case cancelled|0
5116|NCT02219464|33685|P1|Overall Study|case cancelled|1
5117|NCT02219464|33684|P2|Overall Study|Withdrawal by Subject|0
5118|NCT02219464|33685|P1|Overall Study|Withdrawal by Subject|1
5119|NCT02218697|33845|P2|Overall Study|Withdrawal by Subject|3
5120|NCT02218697|33846|P1|Overall Study|Withdrawal by Subject|2
5121|NCT02218697|33845|P2|Overall Study|Unwilling to be vaccinated in left arm|1
5122|NCT02218697|33846|P1|Overall Study|Unwilling to be vaccinated in left arm|0
5123|NCT02218697|33845|P2|Overall Study|Adverse Event|2
5124|NCT02218697|33846|P1|Overall Study|Adverse Event|0
5125|NCT02218268|33895|P2|24 Hour Washout|Physician Decision|9
5126|NCT02218268|33896|P1|24 Hour Washout|Physician Decision|11
5127|NCT02218216|33904|P3|Overall Study|Study terminated before completed|0
5128|NCT02218216|33905|P2|Overall Study|Study terminated before completed|0
5129|NCT02218216|33906|P1|Overall Study|Study terminated before completed|6
5130|NCT02217982|33916|P2|Overall Study|Adverse Event|1
5131|NCT02217982|33917|P1|Overall Study|Adverse Event|0
5132|NCT02217982|33916|P2|Overall Study|Trial discontinued|0
5133|NCT02217982|33917|P1|Overall Study|Trial discontinued|1
5134|NCT02217878|33927|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
5135|NCT02217878|33928|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
5136|NCT02217878|33927|P2|Overall Study|required morphine due to chest pain|2
5137|NCT02217878|33928|P1|Overall Study|required morphine due to chest pain|1
5138|NCT02217280|34008|P1|Overall Study|Post-consent sceen fail|2
5139|NCT02217280|34008|P1|Overall Study|Withdrawal by Subject|2
5140|NCT02216591|34024|P2|Overall Study|Lost to Follow-up|1
5141|NCT02216591|34025|P1|Overall Study|Lost to Follow-up|0
5142|NCT02216357|34043|P2|Overall Study|Inclusion or exclusion criteria not met|1
5143|NCT02216357|34044|P1|Overall Study|Inclusion or exclusion criteria not met|2
5144|NCT02215954|34096|P3|Overall Study|Not exposed|3
5145|NCT02215954|34097|P2|Overall Study|Not exposed|1
5146|NCT02215954|34098|P1|Overall Study|Not exposed|1
5147|NCT02215954|34096|P3|Overall Study|Withdrawal by Subject|2
5148|NCT02215954|34097|P2|Overall Study|Withdrawal by Subject|0
5149|NCT02215954|34098|P1|Overall Study|Withdrawal by Subject|0
5150|NCT02215954|34096|P3|Overall Study|Adverse Event|1
5151|NCT02215954|34097|P2|Overall Study|Adverse Event|0
5152|NCT02215954|34098|P1|Overall Study|Adverse Event|0
5153|NCT02215252|34121|P3|Overall Study|Unspecified|1
5154|NCT02215252|34122|P2|Overall Study|Unspecified|1
5155|NCT02215252|34123|P1|Overall Study|Unspecified|0
5156|NCT02215252|34121|P3|Overall Study|Withdrawal by Subject|0
5157|NCT02215252|34122|P2|Overall Study|Withdrawal by Subject|0
5158|NCT02215252|34123|P1|Overall Study|Withdrawal by Subject|1
5159|NCT02215252|34121|P3|Overall Study|Protocol Violation|0
5160|NCT02215252|34122|P2|Overall Study|Protocol Violation|1
5161|NCT02215252|34123|P1|Overall Study|Protocol Violation|0
5162|NCT02215252|34121|P3|Overall Study|Does not Meet Entrance Criteria|0
5163|NCT02215252|34122|P2|Overall Study|Does not Meet Entrance Criteria|1
5164|NCT02215252|34123|P1|Overall Study|Does not Meet Entrance Criteria|0
5165|NCT02215252|34121|P3|Overall Study|Lost to Follow-up|1
5166|NCT02215252|34122|P2|Overall Study|Lost to Follow-up|0
5167|NCT02215252|34123|P1|Overall Study|Lost to Follow-up|0
5168|NCT02215252|34121|P3|Overall Study|Adverse Event|2
5169|NCT02215252|34122|P2|Overall Study|Adverse Event|5
5170|NCT02215252|34123|P1|Overall Study|Adverse Event|1
5171|NCT02214225|34207|P3|Overall Study|randomized in error, not vaccinated|1
5172|NCT02214225|34208|P2|Overall Study|randomized in error, not vaccinated|1
5173|NCT02214225|34209|P1|Overall Study|randomized in error, not vaccinated|2
5174|NCT02214225|34207|P3|Overall Study|Death|1
5175|NCT02214225|34208|P2|Overall Study|Death|0
5176|NCT02214225|34209|P1|Overall Study|Death|5
5177|NCT02214225|34207|P3|Overall Study|Withdrawal by Subject|2
5178|NCT02214225|34208|P2|Overall Study|Withdrawal by Subject|0
5179|NCT02214225|34209|P1|Overall Study|Withdrawal by Subject|2
5180|NCT02214225|34207|P3|Overall Study|Lost to Follow-up|18
5181|NCT02214225|34208|P2|Overall Study|Lost to Follow-up|18
5182|NCT02214225|34209|P1|Overall Study|Lost to Follow-up|46
5183|NCT02214186|34268|P2|Overall Study|Protocol Violation|1
5184|NCT02214186|34269|P1|Overall Study|Protocol Violation|1
5185|NCT02214186|34268|P2|Overall Study|Lost to Follow-up|1
5186|NCT02214186|34269|P1|Overall Study|Lost to Follow-up|1
5187|NCT02213666|34306|P1|Overall Study|Withdrawal by Subject|1
5188|NCT02213510|34312|P2|Overall Study|Lost to Follow-up|0
5189|NCT02213510|34313|P1|Overall Study|Lost to Follow-up|1
5190|NCT02213510|34312|P2|Overall Study|Death|1
5191|NCT02213510|34313|P1|Overall Study|Death|0
5192|NCT02213198|34371|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
5193|NCT02213198|34372|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
5194|NCT02213198|34371|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
5195|NCT02213198|34372|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
5196|NCT02213198|34371|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
5197|NCT02213198|34372|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
5198|NCT02213198|34371|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
5199|NCT02213198|34372|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
5200|NCT02213198|34371|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
5201|NCT02213198|34372|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
5202|NCT02213198|34371|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5203|NCT02213198|34372|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
5204|NCT02213198|34371|P2|Baseline|incarcerated,violent|1
5205|NCT02213198|34372|P1|Baseline|incarcerated,violent|0
5206|NCT02213198|34371|P2|Baseline|Lost to Follow-up|21
5207|NCT02213198|34372|P1|Baseline|Lost to Follow-up|40
5208|NCT02213198|34371|P2|Baseline|transferred out of clinic|9
5209|NCT02213198|34372|P1|Baseline|transferred out of clinic|7
5210|NCT02213198|34371|P2|Baseline|Withdrawal by Subject|11
5211|NCT02213198|34372|P1|Baseline|Withdrawal by Subject|34
5212|NCT02213198|34371|P2|Baseline|No show for intake|9
5213|NCT02213198|34372|P1|Baseline|No show for intake|7
5214|NCT02213055|34382|P2|Overall Study|Did not Return to School|0
5215|NCT02213055|34383|P1|Overall Study|Did not Return to School|5
5216|NCT02213055|34382|P2|Overall Study|Did not meet Inclusion Criteria|0
5217|NCT02213055|34383|P1|Overall Study|Did not meet Inclusion Criteria|6
5218|NCT02213055|34382|P2|Overall Study|Had another Treatment during the Study|0
5219|NCT02213055|34383|P1|Overall Study|Had another Treatment during the Study|3
5220|NCT02213055|34382|P2|Overall Study|Did not have Live Lice|0
5221|NCT02213055|34383|P1|Overall Study|Did not have Live Lice|8
5222|NCT02213055|34382|P2|Overall Study|Documentation Issue during Study|0
5223|NCT02213055|34383|P1|Overall Study|Documentation Issue during Study|10
5224|NCT02213055|34382|P2|Overall Study|Documentation Issue at Enrollment|0
5225|NCT02213055|34383|P1|Overall Study|Documentation Issue at Enrollment|1
5226|NCT02213055|34382|P2|Overall Study|Protocol was not Followed during Study|0
5227|NCT02213055|34383|P1|Overall Study|Protocol was not Followed during Study|1
5228|NCT02213055|34382|P2|Overall Study|Protocol was not Followed at Enrollment|0
5229|NCT02213055|34383|P1|Overall Study|Protocol was not Followed at Enrollment|5
5230|NCT02212457|34421|P6|Overall Study|Unspecified|1
5231|NCT02212457|34422|P5|Overall Study|Unspecified|0
5232|NCT02212457|34423|P4|Overall Study|Unspecified|1
5233|NCT02212457|34424|P3|Overall Study|Unspecified|2
5234|NCT02212457|34425|P2|Overall Study|Unspecified|1
5235|NCT02212457|34426|P1|Overall Study|Unspecified|2
5236|NCT02212457|34421|P6|Overall Study|Protocol Violation|3
5237|NCT02212457|34422|P5|Overall Study|Protocol Violation|2
5238|NCT02212457|34423|P4|Overall Study|Protocol Violation|1
5239|NCT02212457|34424|P3|Overall Study|Protocol Violation|0
5240|NCT02212457|34425|P2|Overall Study|Protocol Violation|1
5241|NCT02212457|34426|P1|Overall Study|Protocol Violation|2
5242|NCT02212457|34421|P6|Overall Study|Lost to Follow-up|4
5243|NCT02212457|34422|P5|Overall Study|Lost to Follow-up|8
5244|NCT02212457|34423|P4|Overall Study|Lost to Follow-up|1
5245|NCT02212457|34424|P3|Overall Study|Lost to Follow-up|4
5246|NCT02212457|34425|P2|Overall Study|Lost to Follow-up|7
5247|NCT02212457|34426|P1|Overall Study|Lost to Follow-up|6
5248|NCT02212457|34421|P6|Overall Study|Withdrawal by Subject|4
5249|NCT02212457|34422|P5|Overall Study|Withdrawal by Subject|5
5250|NCT02212457|34423|P4|Overall Study|Withdrawal by Subject|6
5251|NCT02212457|34424|P3|Overall Study|Withdrawal by Subject|8
5252|NCT02212457|34425|P2|Overall Study|Withdrawal by Subject|10
5253|NCT02212457|34426|P1|Overall Study|Withdrawal by Subject|8
5254|NCT02212457|34421|P6|Overall Study|Adverse Event|1
5255|NCT02212457|34422|P5|Overall Study|Adverse Event|0
5256|NCT02212457|34423|P4|Overall Study|Adverse Event|2
5257|NCT02212457|34424|P3|Overall Study|Adverse Event|2
5258|NCT02212457|34425|P2|Overall Study|Adverse Event|2
5259|NCT02212457|34426|P1|Overall Study|Adverse Event|1
5260|NCT02212301|34464|P2|Period 1|Lost to Follow-up|1
5261|NCT02212301|34465|P1|Period 1|Lost to Follow-up|0
5262|NCT02212197|34476|P3|Overall Study|Need for radiotherapy|0
5263|NCT02212197|34477|P2|Overall Study|Need for radiotherapy|0
5264|NCT02212197|34478|P1|Overall Study|Need for radiotherapy|1
5265|NCT02210091|34548|P2|Overall Study|Withdrawal by Sponsor|1
5266|NCT02210091|34549|P1|Overall Study|Withdrawal by Sponsor|0
5267|NCT02210091|34548|P2|Overall Study|Physician Decision|1
5268|NCT02210091|34549|P1|Overall Study|Physician Decision|0
5269|NCT02209766|34629|P5|Overall Study|Withdrawal by Subject|0
5270|NCT02209766|34630|P4|Overall Study|Withdrawal by Subject|1
5271|NCT02209766|34631|P3|Overall Study|Withdrawal by Subject|0
5272|NCT02209766|34632|P2|Overall Study|Withdrawal by Subject|0
5273|NCT02209766|34633|P1|Overall Study|Withdrawal by Subject|0
5274|NCT02209506|34684|P5|Overall Study|Withdrawal by Subject|1
5275|NCT02209506|34685|P4|Overall Study|Withdrawal by Subject|0
5276|NCT02209506|34686|P3|Overall Study|Withdrawal by Subject|0
5277|NCT02209506|34687|P2|Overall Study|Withdrawal by Subject|0
5278|NCT02209506|34688|P1|Overall Study|Withdrawal by Subject|0
5279|NCT02209454|34763|P2|Second Period|Adverse Event|0
5280|NCT02209454|34764|P1|Second Period|Adverse Event|1
5281|NCT02209181|34782|P4|Overall Study|Withdrawal by Subject|0
5282|NCT02209181|34783|P3|Overall Study|Withdrawal by Subject|0
5283|NCT02209181|34784|P2|Overall Study|Withdrawal by Subject|1
5284|NCT02209181|34785|P1|Overall Study|Withdrawal by Subject|0
5285|NCT02209181|34782|P4|Overall Study|Adverse Event|0
5286|NCT02209181|34783|P3|Overall Study|Adverse Event|1
5287|NCT02209181|34784|P2|Overall Study|Adverse Event|0
5288|NCT02209181|34785|P1|Overall Study|Adverse Event|1
5289|NCT02207907|34956|P2|Overall Study|Pregnancy|1
5290|NCT02207907|34957|P1|Overall Study|Pregnancy|0
5291|NCT02207907|34956|P2|Overall Study|Did not meet study criteria|0
5292|NCT02207907|34957|P1|Overall Study|Did not meet study criteria|3
5293|NCT02207907|34956|P2|Overall Study|Withdrawal by Subject|6
5294|NCT02207907|34957|P1|Overall Study|Withdrawal by Subject|5
5295|NCT02207907|34956|P2|Overall Study|Lost to Follow-up|1
5296|NCT02207907|34957|P1|Overall Study|Lost to Follow-up|3
5297|NCT02207829|34975|P2|Overall Study|Withdrew consent|14
5298|NCT02207829|34976|P1|Overall Study|Withdrew consent|18
5299|NCT02207829|34975|P2|Overall Study|Protocol deviation|4
5300|NCT02207829|34976|P1|Overall Study|Protocol deviation|5
5301|NCT02207829|34975|P2|Overall Study|Lost to Follow-up|2
5302|NCT02207829|34976|P1|Overall Study|Lost to Follow-up|2
5303|NCT02207829|34975|P2|Overall Study|Lack of Efficacy|5
5304|NCT02207829|34976|P1|Overall Study|Lack of Efficacy|7
5305|NCT02207829|34975|P2|Overall Study|Adverse Event|9
5306|NCT02207829|34976|P1|Overall Study|Adverse Event|10
5307|NCT02207608|34984|P2|Overall Study|Adverse Event|0
5308|NCT02207608|34985|P1|Overall Study|Adverse Event|1
5309|NCT02207413|35008|P6|Overall Study|Migrated/moved from study area|0
5310|NCT02207413|35009|P5|Overall Study|Migrated/moved from study area|1
5311|NCT02207413|35010|P4|Overall Study|Migrated/moved from study area|0
5312|NCT02207413|35011|P3|Overall Study|Migrated/moved from study area|0
5313|NCT02207413|35012|P2|Overall Study|Migrated/moved from study area|0
5314|NCT02207413|35013|P1|Overall Study|Migrated/moved from study area|0
5315|NCT02207413|35008|P6|Overall Study|Adverse Event|1
5316|NCT02207413|35009|P5|Overall Study|Adverse Event|2
5317|NCT02207413|35010|P4|Overall Study|Adverse Event|0
5318|NCT02207413|35011|P3|Overall Study|Adverse Event|0
5319|NCT02207413|35012|P2|Overall Study|Adverse Event|0
5320|NCT02207413|35013|P1|Overall Study|Adverse Event|0
5321|NCT02207413|35008|P6|Overall Study|Lost to Follow-up|5
5322|NCT02207413|35009|P5|Overall Study|Lost to Follow-up|1
5323|NCT02207413|35010|P4|Overall Study|Lost to Follow-up|1
5324|NCT02207413|35011|P3|Overall Study|Lost to Follow-up|0
5325|NCT02207413|35012|P2|Overall Study|Lost to Follow-up|0
5326|NCT02207413|35013|P1|Overall Study|Lost to Follow-up|0
5327|NCT02207413|35008|P6|Overall Study|Withdrawal by Subject|7
5328|NCT02207413|35009|P5|Overall Study|Withdrawal by Subject|3
5329|NCT02207413|35010|P4|Overall Study|Withdrawal by Subject|0
5330|NCT02207413|35011|P3|Overall Study|Withdrawal by Subject|0
5331|NCT02207413|35012|P2|Overall Study|Withdrawal by Subject|0
5332|NCT02207413|35013|P1|Overall Study|Withdrawal by Subject|1
5333|NCT02207400|35109|P2|Overall Study|Positive Urine Pregnancy Test|1
5334|NCT02207400|35110|P1|Overall Study|Positive Urine Pregnancy Test|0
5335|NCT02207400|35109|P2|Overall Study|Withdrawal by Subject|4
5336|NCT02207400|35110|P1|Overall Study|Withdrawal by Subject|8
5337|NCT02207400|35109|P2|Overall Study|Protocol Violation|1
5338|NCT02207400|35110|P1|Overall Study|Protocol Violation|1
5339|NCT02207400|35109|P2|Overall Study|Lost to Follow-up|7
5340|NCT02207400|35110|P1|Overall Study|Lost to Follow-up|6
5341|NCT02207400|35109|P2|Overall Study|Adverse Event|1
5342|NCT02207400|35110|P1|Overall Study|Adverse Event|1
5343|NCT02206607|35137|P5|Second Intervention Period|Insufficient Clinical Response|0
5344|NCT02206607|35138|P4|Second Intervention Period|Insufficient Clinical Response|1
5345|NCT02206607|35139|P3|Second Intervention Period|Insufficient Clinical Response|0
5346|NCT02206607|35140|P2|Second Intervention Period|Insufficient Clinical Response|0
5347|NCT02206607|35141|P1|Second Intervention Period|Insufficient Clinical Response|0
5348|NCT02206607|35137|P5|Open-Label Run-In|Withdrawal by Subject|0
5349|NCT02206607|35138|P4|Open-Label Run-In|Withdrawal by Subject|0
5350|NCT02206607|35139|P3|Open-Label Run-In|Withdrawal by Subject|0
5351|NCT02206607|35140|P2|Open-Label Run-In|Withdrawal by Subject|0
5352|NCT02206607|35141|P1|Open-Label Run-In|Withdrawal by Subject|3
5353|NCT02205814|35197|P4|Overall Study|not compliant with study procedures|0
5354|NCT02205814|35198|P3|Overall Study|not compliant with study procedures|1
5355|NCT02205814|35199|P2|Overall Study|not compliant with study procedures|0
5356|NCT02205814|35200|P1|Overall Study|not compliant with study procedures|0
5357|NCT02205814|35197|P4|Overall Study|Withdrawal by Subject|1
5358|NCT02205814|35198|P3|Overall Study|Withdrawal by Subject|2
5359|NCT02205814|35199|P2|Overall Study|Withdrawal by Subject|1
5360|NCT02205814|35200|P1|Overall Study|Withdrawal by Subject|0
5361|NCT02205814|35197|P4|Overall Study|Protocol Violation|1
5362|NCT02205814|35198|P3|Overall Study|Protocol Violation|0
5363|NCT02205814|35199|P2|Overall Study|Protocol Violation|0
5364|NCT02205814|35200|P1|Overall Study|Protocol Violation|1
5365|NCT02205814|35197|P4|Overall Study|Physician Decision|0
5366|NCT02205814|35198|P3|Overall Study|Physician Decision|1
5367|NCT02205814|35199|P2|Overall Study|Physician Decision|0
5368|NCT02205814|35200|P1|Overall Study|Physician Decision|0
5369|NCT02205814|35197|P4|Overall Study|Lack of Efficacy|1
5370|NCT02205814|35198|P3|Overall Study|Lack of Efficacy|1
5371|NCT02205814|35199|P2|Overall Study|Lack of Efficacy|0
5372|NCT02205814|35200|P1|Overall Study|Lack of Efficacy|1
5373|NCT02205814|35197|P4|Overall Study|Lost to Follow-up|1
5374|NCT02205814|35198|P3|Overall Study|Lost to Follow-up|0
5375|NCT02205814|35199|P2|Overall Study|Lost to Follow-up|0
5376|NCT02205814|35200|P1|Overall Study|Lost to Follow-up|0
5377|NCT02205476|35224|P2|Overall Study|Study termination by Sponsor|3
5378|NCT02205476|35225|P1|Overall Study|Study termination by Sponsor|7
5379|NCT02205333|35264|P9|Overall Study|Withdrawal by Subject|0
5380|NCT02205333|35265|P8|Overall Study|Withdrawal by Subject|0
5381|NCT02205333|35266|P7|Overall Study|Withdrawal by Subject|2
5382|NCT02205333|35267|P6|Overall Study|Withdrawal by Subject|0
5383|NCT02205333|35268|P5|Overall Study|Withdrawal by Subject|0
5384|NCT02205333|35269|P4|Overall Study|Withdrawal by Subject|1
5385|NCT02205333|35270|P3|Overall Study|Withdrawal by Subject|0
5386|NCT02205333|35271|P2|Overall Study|Withdrawal by Subject|0
5387|NCT02205333|35272|P1|Overall Study|Withdrawal by Subject|1
5388|NCT02205333|35264|P9|Overall Study|Death|0
5389|NCT02205333|35265|P8|Overall Study|Death|2
5390|NCT02205333|35266|P7|Overall Study|Death|3
5391|NCT02205333|35267|P6|Overall Study|Death|3
5392|NCT02205333|35268|P5|Overall Study|Death|5
5393|NCT02205333|35269|P4|Overall Study|Death|6
5394|NCT02205333|35270|P3|Overall Study|Death|2
5395|NCT02205333|35271|P2|Overall Study|Death|6
5396|NCT02205333|35272|P1|Overall Study|Death|5
5397|NCT02204579|35468|P1|Overall Study|Screen failures|2
5398|NCT02204449|35522|P2|Overall Study|Withdrawal by Subject|1
5399|NCT02204449|35523|P1|Overall Study|Withdrawal by Subject|0
5400|NCT02204449|35522|P2|Overall Study|Death|1
5401|NCT02204449|35523|P1|Overall Study|Death|0
5402|NCT02204449|35522|P2|Overall Study|Lost to Follow-up|9
5403|NCT02204449|35523|P1|Overall Study|Lost to Follow-up|7
5404|NCT02204410|35533|P1|Overall Study|Withdrawal by Subject|3
5405|NCT02204410|35533|P1|Overall Study|Protocol Violation|1
5406|NCT02204410|35533|P1|Overall Study|Physician Decision|2
5407|NCT02204410|35533|P1|Overall Study|Lost to Follow-up|5
5408|NCT02204371|35538|P1|Overall Study|Adverse Event|1
5409|NCT02204319|35561|P1|Overall Study|Withdrawal by Subject|2
5410|NCT02204319|35561|P1|Overall Study|Pregnancy|1
5411|NCT02204007|35569|P2|Overall Study|Surgery Canceled|1
5412|NCT02204007|35570|P1|Overall Study|Surgery Canceled|1
5413|NCT02203916|35581|P3|Overall Study|Reason Not Specified|1
5414|NCT02203916|35582|P2|Overall Study|Reason Not Specified|2
5415|NCT02203916|35583|P1|Overall Study|Reason Not Specified|0
5416|NCT02203916|35581|P3|Overall Study|Lack of Efficacy|0
5417|NCT02203916|35582|P2|Overall Study|Lack of Efficacy|0
5418|NCT02203916|35583|P1|Overall Study|Lack of Efficacy|3
5419|NCT02203916|35581|P3|Overall Study|Voluntary Withdrawal|8
5420|NCT02203916|35582|P2|Overall Study|Voluntary Withdrawal|3
5421|NCT02203916|35583|P1|Overall Study|Voluntary Withdrawal|3
5422|NCT02203916|35581|P3|Overall Study|Lost to Follow-up|0
5423|NCT02203916|35582|P2|Overall Study|Lost to Follow-up|1
5424|NCT02203916|35583|P1|Overall Study|Lost to Follow-up|0
5425|NCT02203916|35581|P3|Overall Study|Major Protocol Deviation|0
5426|NCT02203916|35582|P2|Overall Study|Major Protocol Deviation|1
5427|NCT02203916|35583|P1|Overall Study|Major Protocol Deviation|1
5428|NCT02203916|35581|P3|Overall Study|Pretreatment Event/Adverse Event|2
5429|NCT02203916|35582|P2|Overall Study|Pretreatment Event/Adverse Event|3
5430|NCT02203916|35583|P1|Overall Study|Pretreatment Event/Adverse Event|1
5431|NCT02203721|35653|P2|Overall Study|Illness|1
5432|NCT02203721|35654|P1|Overall Study|Illness|0
5433|NCT02203721|35653|P2|Overall Study|Death|2
5434|NCT02203721|35654|P1|Overall Study|Death|0
5435|NCT02203721|35653|P2|Overall Study|Lost to Follow-up|0
5436|NCT02203721|35654|P1|Overall Study|Lost to Follow-up|1
5437|NCT02203149|35687|P5|Part 2|Adverse Event|1
5438|NCT02203149|35688|P4|Part 2|Adverse Event|1
5439|NCT02203149|35689|P3|Part 2|Adverse Event|0
5440|NCT02203149|35690|P2|Part 2|Adverse Event|0
5441|NCT02203149|35691|P1|Part 2|Adverse Event|0
5442|NCT02203149|35687|P5|Part 2|Withdrawal by Subject|0
5443|NCT02203149|35688|P4|Part 2|Withdrawal by Subject|1
5444|NCT02203149|35689|P3|Part 2|Withdrawal by Subject|0
5445|NCT02203149|35690|P2|Part 2|Withdrawal by Subject|0
5446|NCT02203149|35691|P1|Part 2|Withdrawal by Subject|0
5447|NCT02203149|35687|P5|Part 2|Death|0
5448|NCT02203149|35688|P4|Part 2|Death|1
5449|NCT02203149|35689|P3|Part 2|Death|1
5450|NCT02203149|35690|P2|Part 2|Death|0
5451|NCT02203149|35691|P1|Part 2|Death|0
5452|NCT02203149|35687|P5|Part 1|Adverse Event|0
5453|NCT02203149|35688|P4|Part 1|Adverse Event|0
5454|NCT02203149|35689|P3|Part 1|Adverse Event|0
5455|NCT02203149|35690|P2|Part 1|Adverse Event|1
5456|NCT02203149|35691|P1|Part 1|Adverse Event|0
5457|NCT02203032|35724|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
5458|NCT02203032|35725|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
5459|NCT02203032|35726|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
5460|NCT02203032|35727|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
5461|NCT02203032|35724|P4|Blinded Phase (Week 16 to Week 44)|Death|1
5462|NCT02203032|35725|P3|Blinded Phase (Week 16 to Week 44)|Death|0
5463|NCT02203032|35726|P2|Blinded Phase (Week 16 to Week 44)|Death|0
5464|NCT02203032|35727|P1|Blinded Phase (Week 16 to Week 44)|Death|0
5465|NCT02203032|35724|P4|Blinded Phase (Week 16 to Week 44)|Unspecified|15
5466|NCT02203032|35725|P3|Blinded Phase (Week 16 to Week 44)|Unspecified|1
5467|NCT02203032|35726|P2|Blinded Phase (Week 16 to Week 44)|Unspecified|4
5468|NCT02203032|35727|P1|Blinded Phase (Week 16 to Week 44)|Unspecified|0
5469|NCT02203032|35724|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
5470|NCT02203032|35725|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
5471|NCT02203032|35726|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
5472|NCT02203032|35727|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
5473|NCT02203032|35724|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
5474|NCT02203032|35725|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
5475|NCT02203032|35726|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
5476|NCT02203032|35727|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
5477|NCT02203032|35724|P4|Open Label Run-in (Week 0 to Week 16)|Unspecified|0
5478|NCT02203032|35725|P3|Open Label Run-in (Week 0 to Week 16)|Unspecified|0
5479|NCT02203032|35726|P2|Open Label Run-in (Week 0 to Week 16)|Unspecified|0
5480|NCT02203032|35727|P1|Open Label Run-in (Week 0 to Week 16)|Unspecified|2
5481|NCT02203032|35724|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5482|NCT02203032|35725|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5483|NCT02203032|35726|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
5484|NCT02203032|35727|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
5485|NCT02203032|35724|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5486|NCT02203032|35725|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5487|NCT02203032|35726|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
5488|NCT02203032|35727|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
5489|NCT02203032|35724|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5490|NCT02203032|35725|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5491|NCT02203032|35726|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
5492|NCT02203032|35727|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
5493|NCT02203032|35724|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5494|NCT02203032|35725|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5495|NCT02203032|35726|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
5496|NCT02203032|35727|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
5497|NCT02203032|35724|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5498|NCT02203032|35725|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5499|NCT02203032|35726|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
5500|NCT02203032|35727|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
5501|NCT02202785|35744|P3|Overall Study|Reason not Specified|13
5502|NCT02202785|35745|P2|Overall Study|Reason not Specified|7
5503|NCT02202785|35746|P1|Overall Study|Reason not Specified|10
5504|NCT02202785|35744|P3|Overall Study|Lost to Follow-up|0
5505|NCT02202785|35745|P2|Overall Study|Lost to Follow-up|1
5506|NCT02202785|35746|P1|Overall Study|Lost to Follow-up|0
5507|NCT02202785|35744|P3|Overall Study|Withdrawal by Subject|0
5508|NCT02202785|35745|P2|Overall Study|Withdrawal by Subject|1
5509|NCT02202785|35746|P1|Overall Study|Withdrawal by Subject|0
5510|NCT02202785|35744|P3|Overall Study|Study Terminated by Sponsor|4
5511|NCT02202785|35745|P2|Overall Study|Study Terminated by Sponsor|6
5512|NCT02202785|35746|P1|Overall Study|Study Terminated by Sponsor|1
5513|NCT02202759|35783|P3|Overall Study|Reason not Specified|10
5514|NCT02202759|35784|P2|Overall Study|Reason not Specified|11
5515|NCT02202759|35785|P1|Overall Study|Reason not Specified|4
5516|NCT02202759|35783|P3|Overall Study|Withdrawal by Subject|1
5517|NCT02202759|35784|P2|Overall Study|Withdrawal by Subject|1
5518|NCT02202759|35785|P1|Overall Study|Withdrawal by Subject|2
5519|NCT02202759|35783|P3|Overall Study|Study Terminated by Sponsor|3
5520|NCT02202759|35784|P2|Overall Study|Study Terminated by Sponsor|3
5521|NCT02202759|35785|P1|Overall Study|Study Terminated by Sponsor|3
5522|NCT02202538|35819|P1|Overall Study|Investigator Decision|1
5523|NCT02202538|35819|P1|Overall Study|Did not meet all inclusion criteria|2
5524|NCT02202538|35819|P1|Overall Study|Withdrawal by Subject|5
5525|NCT02201953|35849|P2|Overall Study|Death|3
5526|NCT02201953|35850|P1|Overall Study|Death|0
5527|NCT02201953|35849|P2|Overall Study|Adverse Event|5
5528|NCT02201953|35850|P1|Overall Study|Adverse Event|0
5529|NCT02201953|35849|P2|Overall Study|Withdrew Consent|5
5530|NCT02201953|35850|P1|Overall Study|Withdrew Consent|2
5531|NCT02201953|35849|P2|Overall Study|Lost to Follow-up|8
5532|NCT02201953|35850|P1|Overall Study|Lost to Follow-up|8
5533|NCT02201953|35849|P2|Overall Study|Lack of Efficacy|30
5534|NCT02201953|35850|P1|Overall Study|Lack of Efficacy|9
5535|NCT02201953|35849|P2|Overall Study|Randomized but Never Treated|5
5536|NCT02201953|35850|P1|Overall Study|Randomized but Never Treated|1
5537|NCT02201940|35868|P2|Overall Study|Adverse Event|1
5538|NCT02201940|35869|P1|Overall Study|Adverse Event|0
5539|NCT02201940|35868|P2|Overall Study|Death|0
5540|NCT02201940|35869|P1|Overall Study|Death|1
5541|NCT02201940|35868|P2|Overall Study|Investigator's Discretion|1
5542|NCT02201940|35869|P1|Overall Study|Investigator's Discretion|1
5543|NCT02201940|35868|P2|Overall Study|Withdrew Consent|1
5544|NCT02201940|35869|P1|Overall Study|Withdrew Consent|2
5545|NCT02201940|35868|P2|Overall Study|Lost to Follow-up|0
5546|NCT02201940|35869|P1|Overall Study|Lost to Follow-up|5
5547|NCT02201940|35868|P2|Overall Study|Lack of Efficacy|113
5548|NCT02201940|35869|P1|Overall Study|Lack of Efficacy|2
5549|NCT02201940|35868|P2|Overall Study|Randomized/Enrolled but Never Treated|0
5550|NCT02201940|35869|P1|Overall Study|Randomized/Enrolled but Never Treated|1
5551|NCT02201901|35888|P3|Overall Study|Adverse Event|0
5552|NCT02201901|35889|P2|Overall Study|Adverse Event|1
5553|NCT02201901|35890|P1|Overall Study|Adverse Event|1
5554|NCT02201901|35888|P3|Overall Study|Withdrew Consent|2
5555|NCT02201901|35889|P2|Overall Study|Withdrew Consent|0
5556|NCT02201901|35890|P1|Overall Study|Withdrew Consent|2
5557|NCT02201901|35888|P3|Overall Study|Lost to Follow-up|2
5558|NCT02201901|35889|P2|Overall Study|Lost to Follow-up|3
5559|NCT02201901|35890|P1|Overall Study|Lost to Follow-up|2
5560|NCT02201901|35888|P3|Overall Study|Death|3
5561|NCT02201901|35889|P2|Overall Study|Death|3
5562|NCT02201901|35890|P1|Overall Study|Death|3
5563|NCT02201901|35888|P3|Overall Study|Lack of Efficacy|6
5564|NCT02201901|35889|P2|Overall Study|Lack of Efficacy|1
5565|NCT02201901|35890|P1|Overall Study|Lack of Efficacy|7
5566|NCT02201901|35888|P3|Overall Study|Randomized but never treated|0
5567|NCT02201901|35889|P2|Overall Study|Randomized but never treated|1
5568|NCT02201901|35890|P1|Overall Study|Randomized but never treated|0
5569|NCT02201784|35921|P2|Overall Study|Failure to achieve adequate block|0
5570|NCT02201784|35922|P1|Overall Study|Failure to achieve adequate block|2
5571|NCT02201524|35940|P4|Overall Study|Unspecified|0
5572|NCT02201524|35941|P3|Overall Study|Unspecified|0
5573|NCT02201524|35942|P2|Overall Study|Unspecified|1
5574|NCT02201524|35943|P1|Overall Study|Unspecified|1
5575|NCT02201524|35940|P4|Overall Study|Withdrawal by Subject|1
5576|NCT02201524|35941|P3|Overall Study|Withdrawal by Subject|1
5577|NCT02201524|35942|P2|Overall Study|Withdrawal by Subject|0
5578|NCT02201524|35943|P1|Overall Study|Withdrawal by Subject|0
5579|NCT02201524|35940|P4|Overall Study|Protocol Violation|1
5580|NCT02201524|35941|P3|Overall Study|Protocol Violation|0
5581|NCT02201524|35942|P2|Overall Study|Protocol Violation|0
5582|NCT02201524|35943|P1|Overall Study|Protocol Violation|0
5583|NCT02201524|35940|P4|Overall Study|No longer meets eligibility criteria|2
5584|NCT02201524|35941|P3|Overall Study|No longer meets eligibility criteria|0
5585|NCT02201524|35942|P2|Overall Study|No longer meets eligibility criteria|0
5586|NCT02201524|35943|P1|Overall Study|No longer meets eligibility criteria|0
5587|NCT02201524|35940|P4|Overall Study|Lost to Follow-up|0
5588|NCT02201524|35941|P3|Overall Study|Lost to Follow-up|2
5589|NCT02201524|35942|P2|Overall Study|Lost to Follow-up|0
5590|NCT02201524|35943|P1|Overall Study|Lost to Follow-up|0
5591|NCT02201524|35940|P4|Overall Study|Insufficient clinical response|0
5592|NCT02201524|35941|P3|Overall Study|Insufficient clinical response|0
5593|NCT02201524|35942|P2|Overall Study|Insufficient clinical response|0
5594|NCT02201524|35943|P1|Overall Study|Insufficient clinical response|1
5595|NCT02201524|35940|P4|Overall Study|Adverse Event|0
5596|NCT02201524|35941|P3|Overall Study|Adverse Event|1
5597|NCT02201524|35942|P2|Overall Study|Adverse Event|2
5598|NCT02201524|35943|P1|Overall Study|Adverse Event|0
5599|NCT02199509|36176|P2|Overall Study|Misunderstood titration schedule|0
5600|NCT02199509|36177|P1|Overall Study|Misunderstood titration schedule|1
5601|NCT02199509|36176|P2|Overall Study|Suicidal Ideation|1
5602|NCT02199509|36177|P1|Overall Study|Suicidal Ideation|0
5603|NCT02198963|36189|P1|Overall Study|Withdrawal by Subject|6
5604|NCT02198963|36189|P1|Overall Study|Adverse Event|1
5605|NCT02198235|36231|P3|Overall Study|Lost to Follow-up|2
5606|NCT02198235|36232|P2|Overall Study|Lost to Follow-up|2
5607|NCT02198235|36233|P1|Overall Study|Lost to Follow-up|3
5608|NCT02198040|36253|P3|Overall Study|Withdrawal by Subject|1
5609|NCT02198040|36254|P2|Overall Study|Withdrawal by Subject|0
5610|NCT02198040|36255|P1|Overall Study|Withdrawal by Subject|0
5611|NCT02198040|36253|P3|Overall Study|Work reasons|0
5612|NCT02198040|36254|P2|Overall Study|Work reasons|1
5613|NCT02198040|36255|P1|Overall Study|Work reasons|0
5614|NCT02197806|36285|P4|Overall Study|Adverse Event|1
5615|NCT02197806|36286|P3|Overall Study|Adverse Event|0
5616|NCT02197806|36287|P2|Overall Study|Adverse Event|1
5617|NCT02197806|36288|P1|Overall Study|Adverse Event|0
5618|NCT02197247|36316|P1|Period 3|Condition under investigation worsened|5
5619|NCT02197247|36316|P1|Period 2|Condition under investigation worsened|2
5620|NCT02197247|36316|P1|Period 2|Adverse Event|2
5621|NCT02197234|36359|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
5622|NCT02197234|36359|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
5623|NCT02197234|36359|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
5624|NCT02197234|36359|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
5625|NCT02197234|36359|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
5626|NCT02197234|36359|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
5627|NCT02197234|36359|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
5628|NCT02196714|36407|P4|Overall Study|Protocol Violation|0
5629|NCT02196714|36408|P3|Overall Study|Protocol Violation|1
5630|NCT02196714|36409|P2|Overall Study|Protocol Violation|0
5631|NCT02196714|36410|P1|Overall Study|Protocol Violation|0
5632|NCT02196675|36533|P3|Overall Study|Death|1
5633|NCT02196675|36534|P2|Overall Study|Death|0
5634|NCT02196675|36535|P1|Overall Study|Death|0
5635|NCT02196675|36533|P3|Overall Study|Protocol Violation|0
5636|NCT02196675|36534|P2|Overall Study|Protocol Violation|1
5637|NCT02196675|36535|P1|Overall Study|Protocol Violation|0
5638|NCT02196675|36533|P3|Overall Study|Intra-operative surgical exclusion|0
5639|NCT02196675|36534|P2|Overall Study|Intra-operative surgical exclusion|1
5640|NCT02196675|36535|P1|Overall Study|Intra-operative surgical exclusion|1
5641|NCT02196675|36533|P3|Overall Study|Withdrawal by Subject|0
5642|NCT02196675|36534|P2|Overall Study|Withdrawal by Subject|0
5643|NCT02196675|36535|P1|Overall Study|Withdrawal by Subject|1
5644|NCT02196259|36558|P3|Overall Study|Partial data analysis|0
5645|NCT02196259|36559|P2|Overall Study|Partial data analysis|3
5646|NCT02196259|36560|P1|Overall Study|Partial data analysis|0
5647|NCT02196259|36558|P3|Overall Study|Researcher choice|1
5648|NCT02196259|36559|P2|Overall Study|Researcher choice|0
5649|NCT02196259|36560|P1|Overall Study|Researcher choice|0
5650|NCT02196077|36588|P1|Overall Study|Protocol Violation|24
5651|NCT02196077|36588|P1|Overall Study|Lost to Follow-up|3
5652|NCT02196077|36588|P1|Overall Study|Physician Decision|1
5653|NCT02196077|36588|P1|Overall Study|Withdrawal by Subject|14
5654|NCT02196077|36588|P1|Overall Study|Lack of Efficacy|1
5655|NCT02196077|36588|P1|Overall Study|Adverse Event|4
5656|NCT02195687|36646|P2|Overall Study|Lost to Follow-up|1
5657|NCT02195687|36647|P1|Overall Study|Lost to Follow-up|4
5658|NCT02195687|36646|P2|Overall Study|Personal Reasons|1
5659|NCT02195687|36647|P1|Overall Study|Personal Reasons|1
5660|NCT02195583|36663|P1|Overall Study|Other Reason|2
5661|NCT02195583|36663|P1|Overall Study|Adverse Event|2
5662|NCT02195583|36663|P1|Overall Study|Withdrawal by Subject|4
5663|NCT02195583|36663|P1|Overall Study|Lost to Follow-up|1
5664|NCT02194621|36705|P3|Overall Study|Withdrawal by Subject|7
5665|NCT02194621|36706|P2|Overall Study|Withdrawal by Subject|4
5666|NCT02194621|36707|P1|Overall Study|Withdrawal by Subject|4
5667|NCT02194621|36705|P3|Overall Study|6 withdrew prior to randomization|2
5668|NCT02194621|36706|P2|Overall Study|6 withdrew prior to randomization|2
5669|NCT02194621|36707|P1|Overall Study|6 withdrew prior to randomization|2
5670|NCT02194062|36740|P3|Overall Study|Lost to Follow-up|5
5671|NCT02194062|36741|P2|Overall Study|Lost to Follow-up|2
5672|NCT02194062|36742|P1|Overall Study|Lost to Follow-up|2
5673|NCT02193828|36757|P4|Overall Study|Withdrawal by Subject|1
5674|NCT02193828|36758|P3|Overall Study|Withdrawal by Subject|1
5675|NCT02193828|36759|P2|Overall Study|Withdrawal by Subject|0
5676|NCT02193828|36760|P1|Overall Study|Withdrawal by Subject|0
5677|NCT02193178|36833|P1|Overall Study|Dry eyes|1
5678|NCT02193178|36833|P1|Overall Study|Lost to Follow-up|1
5679|NCT02193165|36883|P3|6 Week Product Use|Lost to Follow-up|0
5680|NCT02193165|36884|P2|6 Week Product Use|Lost to Follow-up|1
5681|NCT02193165|36885|P1|6 Week Product Use|Lost to Follow-up|0
5682|NCT02193165|36883|P3|4 Week Product Use|Lost to Follow-up|1
5683|NCT02193165|36884|P2|4 Week Product Use|Lost to Follow-up|1
5684|NCT02193165|36885|P1|4 Week Product Use|Lost to Follow-up|1
5685|NCT02193087|36912|P4|Overall Study|Did Not Receive Any Vaccination|1
5686|NCT02193087|36913|P3|Overall Study|Did Not Receive Any Vaccination|0
5687|NCT02193087|36914|P2|Overall Study|Did Not Receive Any Vaccination|3
5688|NCT02193087|36915|P1|Overall Study|Did Not Receive Any Vaccination|2
5689|NCT02193087|36912|P4|Overall Study|Other Reason Not Specified|9
5690|NCT02193087|36913|P3|Overall Study|Other Reason Not Specified|1
5691|NCT02193087|36914|P2|Overall Study|Other Reason Not Specified|2
5692|NCT02193087|36915|P1|Overall Study|Other Reason Not Specified|7
5693|NCT02193087|36912|P4|Overall Study|Withdrawal by Subject|19
5694|NCT02193087|36913|P3|Overall Study|Withdrawal by Subject|1
5695|NCT02193087|36914|P2|Overall Study|Withdrawal by Subject|3
5696|NCT02193087|36915|P1|Overall Study|Withdrawal by Subject|10
5697|NCT02193087|36912|P4|Overall Study|Protocol Violation|2
5698|NCT02193087|36913|P3|Overall Study|Protocol Violation|1
5699|NCT02193087|36914|P2|Overall Study|Protocol Violation|0
5700|NCT02193087|36915|P1|Overall Study|Protocol Violation|2
5701|NCT02193087|36912|P4|Overall Study|Lost to Follow-up|37
5702|NCT02193087|36913|P3|Overall Study|Lost to Follow-up|4
5703|NCT02193087|36914|P2|Overall Study|Lost to Follow-up|6
5704|NCT02193087|36915|P1|Overall Study|Lost to Follow-up|14
5705|NCT02193087|36912|P4|Overall Study|Adverse Event|11
5706|NCT02193087|36913|P3|Overall Study|Adverse Event|0
5707|NCT02193087|36914|P2|Overall Study|Adverse Event|0
5708|NCT02193087|36915|P1|Overall Study|Adverse Event|2
5709|NCT02193074|36960|P2|Overall Study|Adverse Event|13
5710|NCT02193074|36961|P1|Overall Study|Adverse Event|16
5711|NCT02193074|36960|P2|Overall Study|Withdrawal by Subject|2
5712|NCT02193074|36961|P1|Overall Study|Withdrawal by Subject|1
5713|NCT02192164|37044|P1|Overall Study|Did not meet the exclusion criteria|1
5714|NCT02192164|37044|P1|Overall Study|Physician Decision|4
5715|NCT02192164|37044|P1|Overall Study|Withdrawal by Subject|1
5716|NCT02192164|37044|P1|Overall Study|Unspecified|8
5717|NCT02191046|37087|P2|Overall Study|low compliance|1
5718|NCT02191046|37088|P1|Overall Study|low compliance|5
5719|NCT02190604|37126|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5720|NCT02190604|37127|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5721|NCT02190604|37128|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5722|NCT02190604|37129|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5723|NCT02190604|37130|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5724|NCT02190604|37131|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
5725|NCT02190604|37132|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5726|NCT02190604|37133|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5727|NCT02190604|37134|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5728|NCT02190604|37135|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5729|NCT02190604|37136|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5730|NCT02190604|37137|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5731|NCT02190604|37138|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5732|NCT02190604|37139|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5733|NCT02190604|37140|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5734|NCT02190604|37141|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5735|NCT02190604|37142|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5736|NCT02190604|37143|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5737|NCT02190604|37144|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
5738|NCT02190604|37126|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5739|NCT02190604|37127|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5740|NCT02190604|37128|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5741|NCT02190604|37129|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5742|NCT02190604|37130|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
5743|NCT02190604|37131|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5744|NCT02190604|37132|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5745|NCT02190604|37133|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5746|NCT02190604|37134|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5747|NCT02190604|37135|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5748|NCT02190604|37136|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5749|NCT02190604|37137|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5750|NCT02190604|37138|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5751|NCT02190604|37139|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5752|NCT02190604|37140|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5753|NCT02190604|37141|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5754|NCT02190604|37142|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5755|NCT02190604|37143|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5756|NCT02190604|37144|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
5757|NCT02190591|37335|P2|Overall Study|face presentation so she was ineligible|1
5758|NCT02190591|37336|P1|Overall Study|face presentation so she was ineligible|0
5759|NCT02190591|37335|P2|Overall Study|did not use peanut ball as instructed|2
5760|NCT02190591|37336|P1|Overall Study|did not use peanut ball as instructed|0
5761|NCT02190591|37335|P2|Overall Study|Protocol Violation|0
5762|NCT02190591|37336|P1|Overall Study|Protocol Violation|1
5763|NCT02190591|37335|P2|Overall Study|Withdrawal by Subject|8
5764|NCT02190591|37336|P1|Overall Study|Withdrawal by Subject|1
5765|NCT02190435|37348|P2|Overall Study|3 consented screen fails|0
5766|NCT02190435|37349|P1|Overall Study|3 consented screen fails|3
5767|NCT02190435|37348|P2|Overall Study|First 12 patients were lead-ins|0
5768|NCT02190435|37349|P1|Overall Study|First 12 patients were lead-ins|12
5769|NCT02189941|37368|P3|Overall Study|Non-compliance|1
5770|NCT02189941|37369|P2|Overall Study|Non-compliance|0
5771|NCT02189941|37370|P1|Overall Study|Non-compliance|0
5772|NCT02189863|37398|P2|First 2 Weeks|Motion Sickness|2
5773|NCT02189863|37399|P1|First 2 Weeks|Motion Sickness|4
5774|NCT02189837|37414|P4|Overall Study|Sponsor Decision|1
5775|NCT02189837|37415|P3|Overall Study|Sponsor Decision|0
5776|NCT02189837|37416|P2|Overall Study|Sponsor Decision|0
5777|NCT02189837|37417|P1|Overall Study|Sponsor Decision|0
5778|NCT02189837|37414|P4|Overall Study|Withdrawal by Subject|1
5779|NCT02189837|37415|P3|Overall Study|Withdrawal by Subject|3
5780|NCT02189837|37416|P2|Overall Study|Withdrawal by Subject|1
5781|NCT02189837|37417|P1|Overall Study|Withdrawal by Subject|2
5782|NCT02189759|37447|P4|Overall Study|Lost to Follow-up|5
5783|NCT02189759|37448|P3|Overall Study|Lost to Follow-up|2
5784|NCT02189759|37449|P2|Overall Study|Lost to Follow-up|0
5785|NCT02189759|37450|P1|Overall Study|Lost to Follow-up|0
5786|NCT02189252|37485|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5787|NCT02189252|37486|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5788|NCT02189252|37487|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
5789|NCT02189252|37488|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
5790|NCT02189252|37485|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5791|NCT02189252|37486|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5792|NCT02189252|37487|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
5793|NCT02189252|37488|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
5794|NCT02188849|37547|P2|Overall Study|Lost to Follow-up|8
5795|NCT02188849|37548|P1|Overall Study|Lost to Follow-up|3
5796|NCT02188784|37562|P2|Overall Study|Physician Decision|3
5797|NCT02188784|37563|P1|Overall Study|Physician Decision|2
5798|NCT02188784|37562|P2|Overall Study|Withdrawal by Subject|9
5799|NCT02188784|37563|P1|Overall Study|Withdrawal by Subject|3
5800|NCT02188784|37562|P2|Overall Study|Lost to Follow-up|0
5801|NCT02188784|37563|P1|Overall Study|Lost to Follow-up|1
5802|NCT02188784|37562|P2|Overall Study|Death|1
5803|NCT02188784|37563|P1|Overall Study|Death|3
5804|NCT02187809|37584|P1|Overall Study|The study was terminated|3
5805|NCT02187744|37596|P2|Treatment|Participant refused continued treatment|1
5806|NCT02187744|37597|P1|Treatment|Participant refused continued treatment|1
5807|NCT02187744|37596|P2|Treatment|Not specified|0
5808|NCT02187744|37597|P1|Treatment|Not specified|2
5809|NCT02187744|37596|P2|Treatment|Lost to Follow-up|1
5810|NCT02187744|37597|P1|Treatment|Lost to Follow-up|0
5811|NCT02187744|37596|P2|Treatment|Related adverse event, not serious|2
5812|NCT02187744|37597|P1|Treatment|Related adverse event, not serious|0
5813|NCT02187744|37596|P2|Treatment|Related adverse event, serious non-fatal|1
5814|NCT02187744|37597|P1|Treatment|Related adverse event, serious non-fatal|0
5815|NCT02187744|37596|P2|Treatment|Death|0
5816|NCT02187744|37597|P1|Treatment|Death|1
5817|NCT02187744|37596|P2|Study|Related adverse event, serious non-fatal|1
5818|NCT02187744|37597|P1|Study|Related adverse event, serious non-fatal|0
5819|NCT02187744|37596|P2|Study|Death|0
5821|NCT02187744|37596|P2|Study|Related adverse event, not serious|2
5822|NCT02187744|37597|P1|Study|Related adverse event, not serious|0
5823|NCT02187744|37596|P2|Study|Lost to Follow-up|2
5824|NCT02187744|37597|P1|Study|Lost to Follow-up|0
5825|NCT02187744|37596|P2|Study|Not specified|1
5826|NCT02187744|37597|P1|Study|Not specified|2
5827|NCT02187744|37596|P2|Study|Participant refused further follow-up|0
5828|NCT02187744|37597|P1|Study|Participant refused further follow-up|1
5829|NCT02187029|37617|P4|Overall Study|Withdrawal by Subject|0
5830|NCT02187029|37618|P3|Overall Study|Withdrawal by Subject|0
5831|NCT02187029|37619|P2|Overall Study|Withdrawal by Subject|0
5832|NCT02187029|37620|P1|Overall Study|Withdrawal by Subject|1
5833|NCT02187029|37617|P4|Overall Study|Study Terminated by Sponsor|3
5834|NCT02187029|37618|P3|Overall Study|Study Terminated by Sponsor|10
5835|NCT02187029|37619|P2|Overall Study|Study Terminated by Sponsor|0
5836|NCT02187029|37620|P1|Overall Study|Study Terminated by Sponsor|0
5837|NCT02187029|37617|P4|Overall Study|Adverse Event|0
5838|NCT02187029|37618|P3|Overall Study|Adverse Event|1
5839|NCT02187029|37619|P2|Overall Study|Adverse Event|1
5840|NCT02187029|37620|P1|Overall Study|Adverse Event|0
5841|NCT02186223|37751|P1|Overall Study|Device in place less than 48 hours|9
5842|NCT02186223|37751|P1|Overall Study|Death|3
5843|NCT02186223|37751|P1|Overall Study|Unable to obtain femoral access|3
5844|NCT02186223|37751|P1|Overall Study|Not eligible for device placement|6
5845|NCT02185534|37781|P6|First Washout Period|Protocol Violation|1
5846|NCT02185534|37782|P5|First Washout Period|Protocol Violation|0
5847|NCT02185534|37783|P4|First Washout Period|Protocol Violation|0
5848|NCT02185534|37784|P3|First Washout Period|Protocol Violation|0
5849|NCT02185534|37785|P2|First Washout Period|Protocol Violation|0
5850|NCT02185534|37786|P1|First Washout Period|Protocol Violation|0
5851|NCT02185534|37781|P6|First Washout Period|Withdrawal by Subject|0
5852|NCT02185534|37782|P5|First Washout Period|Withdrawal by Subject|1
5853|NCT02185534|37783|P4|First Washout Period|Withdrawal by Subject|0
5854|NCT02185534|37784|P3|First Washout Period|Withdrawal by Subject|0
5855|NCT02185534|37785|P2|First Washout Period|Withdrawal by Subject|0
5856|NCT02185534|37786|P1|First Washout Period|Withdrawal by Subject|1
5857|NCT02185534|37781|P6|First Period|Withdrawal by Subject|0
5858|NCT02185534|37782|P5|First Period|Withdrawal by Subject|0
5859|NCT02185534|37783|P4|First Period|Withdrawal by Subject|1
5860|NCT02185534|37784|P3|First Period|Withdrawal by Subject|0
5861|NCT02185534|37785|P2|First Period|Withdrawal by Subject|0
5862|NCT02185534|37786|P1|First Period|Withdrawal by Subject|0
5863|NCT02182895|37962|P2|Overall Study|Discharged from hospital within 24 hours|4
5864|NCT02182895|37963|P1|Overall Study|Discharged from hospital within 24 hours|2
5865|NCT02183675|37989|P6|Treatment Period 2 (10 Days)|Adverse Event|2
5866|NCT02183675|37990|P5|Treatment Period 2 (10 Days)|Adverse Event|0
5867|NCT02183675|37991|P4|Treatment Period 2 (10 Days)|Adverse Event|0
5868|NCT02183675|37992|P3|Treatment Period 2 (10 Days)|Adverse Event|0
5869|NCT02183675|37993|P2|Treatment Period 2 (10 Days)|Adverse Event|0
5870|NCT02183675|37994|P1|Treatment Period 2 (10 Days)|Adverse Event|0
5871|NCT02183519|38018|P2|Overall Study|Did not respond to cough inducter|3
5872|NCT02183519|38019|P1|Overall Study|Did not respond to cough inducter|0
5873|NCT02183519|38018|P2|Overall Study|computer error|0
5874|NCT02183519|38019|P1|Overall Study|computer error|3
5875|NCT02181790|38027|P2|Overall Study|study terminated|0
5876|NCT02181790|38028|P1|Overall Study|study terminated|2
5877|NCT02181504|38074|P3|Overall Study|Adverse Event|1
5878|NCT02181504|38075|P2|Overall Study|Adverse Event|1
5879|NCT02181504|38076|P1|Overall Study|Adverse Event|1
5880|NCT02180061|38176|P2|Overall Study|Continuing in Study|2
5881|NCT02180061|38177|P1|Overall Study|Continuing in Study|19
5882|NCT02180061|38176|P2|Overall Study|Progressive Disease|4
5883|NCT02180061|38177|P1|Overall Study|Progressive Disease|9
5884|NCT02180061|38176|P2|Overall Study|Clinical Progression|0
5885|NCT02180061|38177|P1|Overall Study|Clinical Progression|3
5886|NCT02180061|38176|P2|Overall Study|Adverse Event|2
5887|NCT02180061|38177|P1|Overall Study|Adverse Event|3
5888|NCT02179398|38230|P2|Overall Study|Lost to Follow-up|1
5889|NCT02179398|38231|P1|Overall Study|Lost to Follow-up|0
5890|NCT02179398|38230|P2|Overall Study|Lack of obligatory data|3
5891|NCT02179398|38231|P1|Overall Study|Lack of obligatory data|3
5892|NCT02178995|38251|P9|Open Label|Adverse Event|0
5893|NCT02178995|38252|P8|Open Label|Adverse Event|0
5894|NCT02178995|38253|P7|Open Label|Adverse Event|0
5895|NCT02178995|38254|P6|Open Label|Adverse Event|0
5896|NCT02178995|38255|P5|Open Label|Adverse Event|0
5897|NCT02178995|38256|P4|Open Label|Adverse Event|0
5898|NCT02178995|38257|P3|Open Label|Adverse Event|0
5899|NCT02178995|38258|P2|Open Label|Adverse Event|0
5900|NCT02178995|38259|P1|Open Label|Adverse Event|2
5901|NCT02178995|38251|P9|Double Blind|Lost to Follow-up|0
5902|NCT02178995|38252|P8|Double Blind|Lost to Follow-up|1
5903|NCT02178995|38253|P7|Double Blind|Lost to Follow-up|0
5904|NCT02178995|38254|P6|Double Blind|Lost to Follow-up|0
5905|NCT02178995|38255|P5|Double Blind|Lost to Follow-up|0
5906|NCT02178995|38256|P4|Double Blind|Lost to Follow-up|0
5907|NCT02178995|38257|P3|Double Blind|Lost to Follow-up|0
5908|NCT02178995|38258|P2|Double Blind|Lost to Follow-up|1
5909|NCT02178995|38259|P1|Double Blind|Lost to Follow-up|0
5910|NCT02178995|38251|P9|Double Blind|Adverse Event|1
5911|NCT02178995|38252|P8|Double Blind|Adverse Event|1
5912|NCT02178995|38253|P7|Double Blind|Adverse Event|0
5913|NCT02178995|38254|P6|Double Blind|Adverse Event|1
5914|NCT02178995|38255|P5|Double Blind|Adverse Event|0
5915|NCT02178995|38256|P4|Double Blind|Adverse Event|0
5916|NCT02178995|38257|P3|Double Blind|Adverse Event|0
5917|NCT02178995|38258|P2|Double Blind|Adverse Event|0
5918|NCT02178995|38259|P1|Double Blind|Adverse Event|0
5919|NCT02178787|38332|P2|Overall Study|Physician Decision|0
5920|NCT02178787|38333|P1|Overall Study|Physician Decision|1
5921|NCT02178787|38332|P2|Overall Study|No TCD window|7
5922|NCT02178787|38333|P1|Overall Study|No TCD window|3
5923|NCT02178787|38332|P2|Overall Study|Withdrawal by Subject|2
5924|NCT02178787|38333|P1|Overall Study|Withdrawal by Subject|0
5925|NCT02178787|38332|P2|Overall Study|Lost to Follow-up|0
5926|NCT02178787|38333|P1|Overall Study|Lost to Follow-up|1
5927|NCT02178059|38348|P2|Washout|Physician Decision|0
5928|NCT02178059|38349|P1|Washout|Physician Decision|1
5929|NCT02177266|38367|P2|Overall Study|Withdrawal by Subject|0
5930|NCT02177266|38368|P1|Overall Study|Withdrawal by Subject|1
5931|NCT02177266|38367|P2|Overall Study|Adverse Event|1
5932|NCT02177266|38368|P1|Overall Study|Adverse Event|0
5933|NCT02177032|38391|P4|Overall Study|Withdrawal by Subject|0
5934|NCT02177032|38392|P3|Overall Study|Withdrawal by Subject|1
5935|NCT02177032|38393|P2|Overall Study|Withdrawal by Subject|0
5936|NCT02177032|38394|P1|Overall Study|Withdrawal by Subject|1
5937|NCT02177032|38391|P4|Overall Study|OTHER|0
5938|NCT02177032|38392|P3|Overall Study|OTHER|1
5939|NCT02177032|38393|P2|Overall Study|OTHER|0
5940|NCT02177032|38394|P1|Overall Study|OTHER|2
5941|NCT02177032|38391|P4|Overall Study|Lost to Follow-up|0
5942|NCT02177032|38392|P3|Overall Study|Lost to Follow-up|0
5943|NCT02177032|38393|P2|Overall Study|Lost to Follow-up|2
5944|NCT02177032|38394|P1|Overall Study|Lost to Follow-up|0
5945|NCT02177032|38391|P4|Overall Study|ADMINISTRATIVE REASON|0
5946|NCT02177032|38392|P3|Overall Study|ADMINISTRATIVE REASON|1
5947|NCT02177032|38393|P2|Overall Study|ADMINISTRATIVE REASON|0
5948|NCT02177032|38394|P1|Overall Study|ADMINISTRATIVE REASON|2
5949|NCT02176655|38428|P1|Overall Study|Subjects did not treat|6
5950|NCT02176525|38457|P8|Overall Study|not treated|0
5951|NCT02176525|38458|P7|Overall Study|not treated|0
5952|NCT02176525|38459|P6|Overall Study|not treated|1
5953|NCT02176525|38460|P5|Overall Study|not treated|0
5954|NCT02176525|38461|P4|Overall Study|not treated|0
5955|NCT02176525|38462|P3|Overall Study|not treated|0
5956|NCT02176525|38463|P2|Overall Study|not treated|0
5957|NCT02176525|38464|P1|Overall Study|not treated|1
5958|NCT02176525|38457|P8|Overall Study|Adverse Event|0
5959|NCT02176525|38458|P7|Overall Study|Adverse Event|1
5960|NCT02176525|38459|P6|Overall Study|Adverse Event|0
5961|NCT02176525|38460|P5|Overall Study|Adverse Event|1
5962|NCT02176525|38461|P4|Overall Study|Adverse Event|1
5963|NCT02176525|38462|P3|Overall Study|Adverse Event|0
5964|NCT02176525|38463|P2|Overall Study|Adverse Event|0
5965|NCT02176525|38464|P1|Overall Study|Adverse Event|0
5966|NCT02176421|38641|P1|Overall Study|Adverse Event|1
5967|NCT02176421|38641|P1|Overall Study|Lost to Follow-up|4
5968|NCT02176356|38650|P1|Overall Study|Other Miscellaneous Reasons|2
5969|NCT02176356|38650|P1|Overall Study|Personal Reasons|3
5970|NCT02176356|38650|P1|Overall Study|Lost to Follow-up|4
5971|NCT02176356|38650|P1|Overall Study|Screen Failure|14
5972|NCT02175771|38686|P9|Treatment Period|Not specified|0
5973|NCT02175771|38687|P8|Treatment Period|Not specified|2
5974|NCT02175771|38688|P7|Treatment Period|Not specified|0
5975|NCT02175771|38689|P6|Treatment Period|Not specified|0
5976|NCT02175771|38690|P5|Treatment Period|Not specified|1
5977|NCT02175771|38691|P4|Treatment Period|Not specified|3
5978|NCT02175771|38692|P3|Treatment Period|Not specified|0
5979|NCT02175771|38693|P2|Treatment Period|Not specified|1
5980|NCT02175771|38694|P1|Treatment Period|Not specified|0
5981|NCT02175771|38686|P9|Treatment Period|Lack of Efficacy|0
5982|NCT02175771|38687|P8|Treatment Period|Lack of Efficacy|1
5983|NCT02175771|38688|P7|Treatment Period|Lack of Efficacy|0
5984|NCT02175771|38689|P6|Treatment Period|Lack of Efficacy|1
5985|NCT02175771|38690|P5|Treatment Period|Lack of Efficacy|0
5986|NCT02175771|38691|P4|Treatment Period|Lack of Efficacy|0
5987|NCT02175771|38692|P3|Treatment Period|Lack of Efficacy|0
5988|NCT02175771|38693|P2|Treatment Period|Lack of Efficacy|0
5989|NCT02175771|38694|P1|Treatment Period|Lack of Efficacy|0
5990|NCT02175771|38686|P9|Treatment Period|Lost to Follow-up|2
5991|NCT02175771|38687|P8|Treatment Period|Lost to Follow-up|2
5992|NCT02175771|38688|P7|Treatment Period|Lost to Follow-up|1
5993|NCT02175771|38689|P6|Treatment Period|Lost to Follow-up|2
5994|NCT02175771|38690|P5|Treatment Period|Lost to Follow-up|1
5995|NCT02175771|38691|P4|Treatment Period|Lost to Follow-up|3
5996|NCT02175771|38692|P3|Treatment Period|Lost to Follow-up|1
5997|NCT02175771|38693|P2|Treatment Period|Lost to Follow-up|3
5998|NCT02175771|38694|P1|Treatment Period|Lost to Follow-up|0
5999|NCT02175771|38686|P9|Treatment Period|Disease progression|0
6000|NCT02175771|38687|P8|Treatment Period|Disease progression|2
6001|NCT02175771|38688|P7|Treatment Period|Disease progression|0
6002|NCT02175771|38689|P6|Treatment Period|Disease progression|0
6003|NCT02175771|38690|P5|Treatment Period|Disease progression|0
6004|NCT02175771|38691|P4|Treatment Period|Disease progression|0
6005|NCT02175771|38692|P3|Treatment Period|Disease progression|0
6006|NCT02175771|38693|P2|Treatment Period|Disease progression|0
6007|NCT02175771|38694|P1|Treatment Period|Disease progression|0
6008|NCT02175771|38686|P9|Treatment Period|Protocol Violation|0
6009|NCT02175771|38687|P8|Treatment Period|Protocol Violation|1
6010|NCT02175771|38688|P7|Treatment Period|Protocol Violation|0
6011|NCT02175771|38689|P6|Treatment Period|Protocol Violation|0
6012|NCT02175771|38690|P5|Treatment Period|Protocol Violation|0
6013|NCT02175771|38691|P4|Treatment Period|Protocol Violation|0
6014|NCT02175771|38692|P3|Treatment Period|Protocol Violation|0
6015|NCT02175771|38693|P2|Treatment Period|Protocol Violation|0
6016|NCT02175771|38694|P1|Treatment Period|Protocol Violation|0
6017|NCT02175771|38686|P9|Treatment Period|Noncompliance|1
6018|NCT02175771|38687|P8|Treatment Period|Noncompliance|0
6019|NCT02175771|38688|P7|Treatment Period|Noncompliance|0
6020|NCT02175771|38689|P6|Treatment Period|Noncompliance|0
6021|NCT02175771|38690|P5|Treatment Period|Noncompliance|0
6022|NCT02175771|38691|P4|Treatment Period|Noncompliance|0
6023|NCT02175771|38692|P3|Treatment Period|Noncompliance|2
6024|NCT02175771|38693|P2|Treatment Period|Noncompliance|1
6025|NCT02175771|38694|P1|Treatment Period|Noncompliance|0
6026|NCT02175771|38686|P9|Treatment Period|Withdrawal by Subject|2
6027|NCT02175771|38687|P8|Treatment Period|Withdrawal by Subject|9
6028|NCT02175771|38688|P7|Treatment Period|Withdrawal by Subject|2
6029|NCT02175771|38689|P6|Treatment Period|Withdrawal by Subject|4
6030|NCT02175771|38690|P5|Treatment Period|Withdrawal by Subject|2
6031|NCT02175771|38691|P4|Treatment Period|Withdrawal by Subject|6
6032|NCT02175771|38692|P3|Treatment Period|Withdrawal by Subject|3
6033|NCT02175771|38693|P2|Treatment Period|Withdrawal by Subject|9
6034|NCT02175771|38694|P1|Treatment Period|Withdrawal by Subject|0
6035|NCT02175771|38686|P9|Treatment Period|Adverse Event|1
6036|NCT02175771|38687|P8|Treatment Period|Adverse Event|0
6037|NCT02175771|38688|P7|Treatment Period|Adverse Event|2
6038|NCT02175771|38689|P6|Treatment Period|Adverse Event|3
6039|NCT02175771|38690|P5|Treatment Period|Adverse Event|1
6040|NCT02175771|38691|P4|Treatment Period|Adverse Event|1
6041|NCT02175771|38692|P3|Treatment Period|Adverse Event|1
6042|NCT02175771|38693|P2|Treatment Period|Adverse Event|2
6043|NCT02175771|38694|P1|Treatment Period|Adverse Event|0
6044|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Not specified|0
6045|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Not specified|0
6046|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Not specified|0
6047|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Not specified|0
6048|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Not specified|0
6049|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Not specified|0
6050|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Not specified|0
6051|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Not specified|0
6052|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Not specified|8
6053|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6054|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6055|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6056|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6057|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6058|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6059|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6060|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6061|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
6062|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6063|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6064|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6065|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6066|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6067|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6068|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6069|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6070|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
6071|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Adverse Event|0
6072|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Adverse Event|0
6073|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Adverse Event|0
6074|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Adverse Event|0
6075|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Adverse Event|0
6076|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Adverse Event|0
6077|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Adverse Event|0
6078|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Adverse Event|0
6079|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Adverse Event|9
6080|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6081|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6082|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6083|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6084|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6085|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6086|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6087|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6088|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
6089|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6090|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6091|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6092|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6093|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6094|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6095|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6096|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6097|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
6098|NCT02175771|38686|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6099|NCT02175771|38687|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6100|NCT02175771|38688|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6101|NCT02175771|38689|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6102|NCT02175771|38690|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6103|NCT02175771|38691|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6104|NCT02175771|38692|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6105|NCT02175771|38693|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6106|NCT02175771|38694|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
6107|NCT02175745|38752|P1|Overall Study|Not Eligible|1
6108|NCT02175199|38776|P2|Overall Study|Sponsor Decision|0
6109|NCT02175199|38777|P1|Overall Study|Sponsor Decision|1
6110|NCT02175199|38776|P2|Overall Study|Randomized in Error|0
6111|NCT02175199|38777|P1|Overall Study|Randomized in Error|1
6112|NCT02175199|38776|P2|Overall Study|Withdrawal by Subject|5
6113|NCT02175199|38777|P1|Overall Study|Withdrawal by Subject|1
6114|NCT02175121|38791|P5|Overall Study|Time issues|0
6115|NCT02175121|38792|P4|Overall Study|Time issues|0
6116|NCT02175121|38793|P3|Overall Study|Time issues|1
6117|NCT02175121|38794|P2|Overall Study|Time issues|0
6118|NCT02175121|38795|P1|Overall Study|Time issues|0
6119|NCT02175121|38791|P5|Overall Study|Schedule conflict|0
6120|NCT02175121|38792|P4|Overall Study|Schedule conflict|0
6121|NCT02175121|38793|P3|Overall Study|Schedule conflict|1
6122|NCT02175121|38794|P2|Overall Study|Schedule conflict|0
6123|NCT02175121|38795|P1|Overall Study|Schedule conflict|0
6124|NCT02175121|38791|P5|Overall Study|Personal emergency|1
6125|NCT02175121|38792|P4|Overall Study|Personal emergency|0
6126|NCT02175121|38793|P3|Overall Study|Personal emergency|0
6127|NCT02175121|38794|P2|Overall Study|Personal emergency|0
6128|NCT02175121|38795|P1|Overall Study|Personal emergency|0
6129|NCT02175121|38791|P5|Overall Study|Lost to Follow-up|0
6130|NCT02175121|38792|P4|Overall Study|Lost to Follow-up|1
6131|NCT02175121|38793|P3|Overall Study|Lost to Follow-up|0
6132|NCT02175121|38794|P2|Overall Study|Lost to Follow-up|1
6133|NCT02175121|38795|P1|Overall Study|Lost to Follow-up|0
6134|NCT02175121|38791|P5|Overall Study|Lack of Efficacy|0
6135|NCT02175121|38792|P4|Overall Study|Lack of Efficacy|0
6136|NCT02175121|38793|P3|Overall Study|Lack of Efficacy|0
6137|NCT02175121|38794|P2|Overall Study|Lack of Efficacy|0
6138|NCT02175121|38795|P1|Overall Study|Lack of Efficacy|1
6139|NCT02173769|38922|P1|Overall Study|Protocol Violation|4
6140|NCT02173054|39025|P3|Overall Study|Withdrawal by Subject|1
6141|NCT02173054|39026|P2|Overall Study|Withdrawal by Subject|0
6142|NCT02173054|39027|P1|Overall Study|Withdrawal by Subject|0
6143|NCT02173054|39025|P3|Overall Study|lack of compliance|0
6144|NCT02173054|39026|P2|Overall Study|lack of compliance|0
6145|NCT02173054|39027|P1|Overall Study|lack of compliance|1
6146|NCT02172625|39072|P2|Overall Study|car accident|1
6147|NCT02172625|39073|P1|Overall Study|car accident|0
6148|NCT02172625|39072|P2|Overall Study|Pregnancy|1
6149|NCT02172625|39073|P1|Overall Study|Pregnancy|0
6150|NCT02172625|39072|P2|Overall Study|Adverse Event|1
6151|NCT02172625|39073|P1|Overall Study|Adverse Event|0
6152|NCT02170779|39247|P2|Overall Study|Lost to Follow-up|1
6153|NCT02170779|39248|P1|Overall Study|Lost to Follow-up|0
6154|NCT02170779|39247|P2|Overall Study|Withdrawal by Subject|0
6155|NCT02170779|39248|P1|Overall Study|Withdrawal by Subject|1
6156|NCT02170688|39275|P5|Overall Study|Physician Decision|0
6157|NCT02170688|39276|P4|Overall Study|Physician Decision|0
6158|NCT02170688|39277|P3|Overall Study|Physician Decision|1
6159|NCT02170688|39278|P2|Overall Study|Physician Decision|0
6160|NCT02170688|39279|P1|Overall Study|Physician Decision|0
6161|NCT02170688|39275|P5|Overall Study|Full dose not received|0
6162|NCT02170688|39276|P4|Overall Study|Full dose not received|0
6163|NCT02170688|39277|P3|Overall Study|Full dose not received|0
6164|NCT02170688|39278|P2|Overall Study|Full dose not received|1
6165|NCT02170688|39279|P1|Overall Study|Full dose not received|0
6166|NCT02170688|39275|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
6167|NCT02170688|39276|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
6168|NCT02170688|39277|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
6169|NCT02170688|39278|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
6170|NCT02170688|39279|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
6171|NCT02170207|39440|P1|Overall Study|Case report forms unavailable|5
6172|NCT02170077|39451|P3|Overall Study|Exacerbation of seizures|1
6173|NCT02170077|39452|P2|Overall Study|Exacerbation of seizures|2
6174|NCT02170077|39453|P1|Overall Study|Exacerbation of seizures|0
6175|NCT02170077|39451|P3|Overall Study|Exclusion criteria|5
6176|NCT02170077|39452|P2|Overall Study|Exclusion criteria|2
6177|NCT02170077|39453|P1|Overall Study|Exclusion criteria|2
6178|NCT02170077|39451|P3|Overall Study|Lost to Follow-up|0
6179|NCT02170077|39452|P2|Overall Study|Lost to Follow-up|1
6180|NCT02170077|39453|P1|Overall Study|Lost to Follow-up|0
6181|NCT02170077|39451|P3|Overall Study|Adverse Event|4
6182|NCT02170077|39452|P2|Overall Study|Adverse Event|4
6183|NCT02170077|39453|P1|Overall Study|Adverse Event|4
6184|NCT02170077|39451|P3|Overall Study|Withdrawal by Subject|2
6185|NCT02170077|39452|P2|Overall Study|Withdrawal by Subject|4
6186|NCT02170077|39453|P1|Overall Study|Withdrawal by Subject|3
6187|NCT02170064|39464|P3|Overall Study|Physician Decision|0
6188|NCT02170064|39465|P2|Overall Study|Physician Decision|1
6189|NCT02170064|39466|P1|Overall Study|Physician Decision|1
6190|NCT02170064|39464|P3|Overall Study|Withdrawal by Subject|1
6191|NCT02170064|39465|P2|Overall Study|Withdrawal by Subject|1
6192|NCT02170064|39466|P1|Overall Study|Withdrawal by Subject|5
6193|NCT02169414|39622|P4|Overall Study|Adverse Event|0
6194|NCT02169414|39623|P3|Overall Study|Adverse Event|0
6195|NCT02169414|39624|P2|Overall Study|Adverse Event|1
6196|NCT02169414|39625|P1|Overall Study|Adverse Event|0
6197|NCT02169414|39622|P4|Overall Study|Withdrawal by Subject|0
6198|NCT02169414|39623|P3|Overall Study|Withdrawal by Subject|0
6199|NCT02169414|39624|P2|Overall Study|Withdrawal by Subject|0
6200|NCT02169414|39625|P1|Overall Study|Withdrawal by Subject|1
6201|NCT02169336|39666|P3|Overall Study|Subject declined to continue dosing|1
6202|NCT02169336|39667|P2|Overall Study|Subject declined to continue dosing|0
6203|NCT02169336|39668|P1|Overall Study|Subject declined to continue dosing|0
6204|NCT02169336|39666|P3|Overall Study|Physician Decision|1
6205|NCT02169336|39667|P2|Overall Study|Physician Decision|0
6206|NCT02169336|39668|P1|Overall Study|Physician Decision|0
6207|NCT02169336|39666|P3|Overall Study|Withdrawal by Subject|0
6208|NCT02169336|39667|P2|Overall Study|Withdrawal by Subject|0
6209|NCT02169336|39668|P1|Overall Study|Withdrawal by Subject|1
6210|NCT02169336|39666|P3|Overall Study|Adverse Event|1
6211|NCT02169336|39667|P2|Overall Study|Adverse Event|3
6212|NCT02169336|39668|P1|Overall Study|Adverse Event|2
6213|NCT02169336|39666|P3|Overall Study|Lack of Efficacy|0
6214|NCT02169336|39667|P2|Overall Study|Lack of Efficacy|1
6215|NCT02169336|39668|P1|Overall Study|Lack of Efficacy|1
6216|NCT02168491|39689|P1|Overall Study|Withdrawal by Subject|1
6217|NCT02168478|39695|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
6218|NCT02168478|39695|P1|Overall Study|Did Not Consent to Participation|2
6219|NCT02168478|39695|P1|Overall Study|Withdrawal by Subject|1
6220|NCT02168439|39701|P2|Overall Study|Protocol Violation|2
6221|NCT02168439|39702|P1|Overall Study|Protocol Violation|0
6222|NCT02168387|39720|P2|Overall Study|Death|0
6223|NCT02168387|39721|P1|Overall Study|Death|1
6224|NCT02168387|39720|P2|Overall Study|Planned exubation|3
6225|NCT02168387|39721|P1|Overall Study|Planned exubation|6
6226|NCT02167893|39742|P1|Overall Study|Case report forms not collected|68
6227|NCT02167893|39742|P1|Overall Study|Investigator health reasons|10
6228|NCT02167893|39742|P1|Overall Study|Investigator transferred|85
6229|NCT02167139|39776|P4|Transition-extension|Lost to Follow-up|0
6230|NCT02167139|39777|P3|Transition-extension|Lost to Follow-up|0
6231|NCT02167139|39778|P2|Transition-extension|Lost to Follow-up|0
6232|NCT02167139|39779|P1|Transition-extension|Lost to Follow-up|1
6233|NCT02167139|39776|P4|Transition-extension|Other|0
6234|NCT02167139|39777|P3|Transition-extension|Other|1
6235|NCT02167139|39778|P2|Transition-extension|Other|0
6236|NCT02167139|39779|P1|Transition-extension|Other|1
6237|NCT02167139|39776|P4|Transition-extension|Lack of Efficacy|1
6238|NCT02167139|39777|P3|Transition-extension|Lack of Efficacy|1
6239|NCT02167139|39778|P2|Transition-extension|Lack of Efficacy|0
6240|NCT02167139|39779|P1|Transition-extension|Lack of Efficacy|0
6241|NCT02167139|39776|P4|Transition-extension|Withdrawal by Subject|1
6242|NCT02167139|39777|P3|Transition-extension|Withdrawal by Subject|4
6243|NCT02167139|39778|P2|Transition-extension|Withdrawal by Subject|0
6244|NCT02167139|39779|P1|Transition-extension|Withdrawal by Subject|2
6245|NCT02167139|39776|P4|Transition-extension|Adverse Event|3
6246|NCT02167139|39777|P3|Transition-extension|Adverse Event|2
6247|NCT02167139|39778|P2|Transition-extension|Adverse Event|0
6248|NCT02167139|39779|P1|Transition-extension|Adverse Event|2
6249|NCT02167139|39776|P4|Randomised, Double-blind|Other|0
6250|NCT02167139|39777|P3|Randomised, Double-blind|Other|0
6251|NCT02167139|39778|P2|Randomised, Double-blind|Other|0
6252|NCT02167139|39779|P1|Randomised, Double-blind|Other|3
6253|NCT02167139|39776|P4|Randomised, Double-blind|Lack of Efficacy|0
6254|NCT02167139|39777|P3|Randomised, Double-blind|Lack of Efficacy|0
6255|NCT02167139|39778|P2|Randomised, Double-blind|Lack of Efficacy|2
6256|NCT02167139|39779|P1|Randomised, Double-blind|Lack of Efficacy|1
6257|NCT02167139|39776|P4|Randomised, Double-blind|Adverse Event|0
6258|NCT02167139|39777|P3|Randomised, Double-blind|Adverse Event|0
6259|NCT02167139|39778|P2|Randomised, Double-blind|Adverse Event|9
6260|NCT02167139|39779|P1|Randomised, Double-blind|Adverse Event|2
6261|NCT02167139|39776|P4|Randomised, Double-blind|Withdrawal by Subject|0
6262|NCT02167139|39777|P3|Randomised, Double-blind|Withdrawal by Subject|0
6263|NCT02167139|39778|P2|Randomised, Double-blind|Withdrawal by Subject|8
6264|NCT02167139|39779|P1|Randomised, Double-blind|Withdrawal by Subject|11
6265|NCT02166697|39793|P1|Overall Study|Protocol Violation|347
6266|NCT02165826|39805|P3|Down-Titration Period|Reason Not Specified|2
6267|NCT02165826|39806|P2|Down-Titration Period|Reason Not Specified|0
6268|NCT02165826|39807|P1|Down-Titration Period|Reason Not Specified|1
6269|NCT02165826|39805|P3|Down-Titration Period|Voluntary Withdrawal|2
6270|NCT02165826|39806|P2|Down-Titration Period|Voluntary Withdrawal|1
6271|NCT02165826|39807|P1|Down-Titration Period|Voluntary Withdrawal|2
6272|NCT02165826|39805|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
6273|NCT02165826|39806|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
6274|NCT02165826|39807|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
6275|NCT02165826|39805|P3|Main Treatment Period|Did Not Receive Study Drug|0
6276|NCT02165826|39806|P2|Main Treatment Period|Did Not Receive Study Drug|2
6277|NCT02165826|39807|P1|Main Treatment Period|Did Not Receive Study Drug|0
6278|NCT02165826|39805|P3|Main Treatment Period|Reason Not Specified|16
6279|NCT02165826|39806|P2|Main Treatment Period|Reason Not Specified|5
6280|NCT02165826|39807|P1|Main Treatment Period|Reason Not Specified|8
6281|NCT02165826|39805|P3|Main Treatment Period|Lack of Efficacy|0
6282|NCT02165826|39806|P2|Main Treatment Period|Lack of Efficacy|0
6283|NCT02165826|39807|P1|Main Treatment Period|Lack of Efficacy|2
6284|NCT02165826|39805|P3|Main Treatment Period|Voluntary Withdrawal|21
6285|NCT02165826|39806|P2|Main Treatment Period|Voluntary Withdrawal|23
6286|NCT02165826|39807|P1|Main Treatment Period|Voluntary Withdrawal|23
6287|NCT02165826|39805|P3|Main Treatment Period|Lost to Follow-up|1
6288|NCT02165826|39806|P2|Main Treatment Period|Lost to Follow-up|2
6289|NCT02165826|39807|P1|Main Treatment Period|Lost to Follow-up|4
6290|NCT02165826|39805|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
6291|NCT02165826|39806|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
6292|NCT02165826|39807|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
6293|NCT02165826|39805|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
6294|NCT02165826|39806|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
6295|NCT02165826|39807|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
6296|NCT02164539|39911|P7|Treatment Phase C (1 Week)|Physician Decision|1
6297|NCT02164539|39912|P6|Treatment Phase C (1 Week)|Physician Decision|0
6298|NCT02164539|39913|P5|Treatment Phase C (1 Week)|Physician Decision|0
6299|NCT02164539|39914|P4|Treatment Phase C (1 Week)|Physician Decision|0
6300|NCT02164539|39915|P3|Treatment Phase C (1 Week)|Physician Decision|0
6301|NCT02164539|39916|P2|Treatment Phase C (1 Week)|Physician Decision|0
6302|NCT02164539|39917|P1|Treatment Phase C (1 Week)|Physician Decision|0
6303|NCT02164539|39911|P7|Treatment Phase C (1 Week)|Adverse Event|1
6304|NCT02164539|39912|P6|Treatment Phase C (1 Week)|Adverse Event|0
6305|NCT02164539|39913|P5|Treatment Phase C (1 Week)|Adverse Event|0
6306|NCT02164539|39914|P4|Treatment Phase C (1 Week)|Adverse Event|0
6307|NCT02164539|39915|P3|Treatment Phase C (1 Week)|Adverse Event|0
6308|NCT02164539|39916|P2|Treatment Phase C (1 Week)|Adverse Event|0
6309|NCT02164539|39917|P1|Treatment Phase C (1 Week)|Adverse Event|0
6310|NCT02164539|39911|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6311|NCT02164539|39912|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6312|NCT02164539|39913|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6313|NCT02164539|39914|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6314|NCT02164539|39915|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6315|NCT02164539|39916|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
6316|NCT02164539|39917|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
6317|NCT02164539|39911|P7|Treatment Phase B (1 Week)|Physician Decision|1
6318|NCT02164539|39912|P6|Treatment Phase B (1 Week)|Physician Decision|0
6319|NCT02164539|39913|P5|Treatment Phase B (1 Week)|Physician Decision|1
6320|NCT02164539|39914|P4|Treatment Phase B (1 Week)|Physician Decision|0
6321|NCT02164539|39915|P3|Treatment Phase B (1 Week)|Physician Decision|0
6322|NCT02164539|39916|P2|Treatment Phase B (1 Week)|Physician Decision|0
6323|NCT02164539|39917|P1|Treatment Phase B (1 Week)|Physician Decision|0
6324|NCT02164539|39911|P7|Treatment Phase B (1 Week)|Adverse Event|0
6325|NCT02164539|39912|P6|Treatment Phase B (1 Week)|Adverse Event|0
6326|NCT02164539|39913|P5|Treatment Phase B (1 Week)|Adverse Event|2
6327|NCT02164539|39914|P4|Treatment Phase B (1 Week)|Adverse Event|0
6328|NCT02164539|39915|P3|Treatment Phase B (1 Week)|Adverse Event|0
6329|NCT02164539|39916|P2|Treatment Phase B (1 Week)|Adverse Event|0
6330|NCT02164539|39917|P1|Treatment Phase B (1 Week)|Adverse Event|0
6331|NCT02164539|39911|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
6332|NCT02164539|39912|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
6333|NCT02164539|39913|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
6334|NCT02164539|39914|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
6335|NCT02164539|39915|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
6336|NCT02164539|39916|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
6337|NCT02164539|39917|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
6338|NCT02164318|39979|P4|Overall Study|Withdrawal by Subject|1
6339|NCT02164318|39980|P3|Overall Study|Withdrawal by Subject|0
6340|NCT02164318|39981|P2|Overall Study|Withdrawal by Subject|1
6341|NCT02164318|39982|P1|Overall Study|Withdrawal by Subject|0
6342|NCT02163915|40005|P5|Overall Study|Physician Decision|0
6343|NCT02163915|40006|P4|Overall Study|Physician Decision|1
6344|NCT02163915|40007|P3|Overall Study|Physician Decision|0
6345|NCT02163915|40008|P2|Overall Study|Physician Decision|0
6346|NCT02163915|40009|P1|Overall Study|Physician Decision|0
6347|NCT02163915|40005|P5|Overall Study|Study termination|2
6348|NCT02163915|40006|P4|Overall Study|Study termination|0
6349|NCT02163915|40007|P3|Overall Study|Study termination|0
6350|NCT02163915|40008|P2|Overall Study|Study termination|0
6351|NCT02163915|40009|P1|Overall Study|Study termination|1
6352|NCT02163915|40005|P5|Overall Study|Withdrawal by Subject|2
6353|NCT02163915|40006|P4|Overall Study|Withdrawal by Subject|2
6354|NCT02163915|40007|P3|Overall Study|Withdrawal by Subject|2
6355|NCT02163915|40008|P2|Overall Study|Withdrawal by Subject|0
6356|NCT02163915|40009|P1|Overall Study|Withdrawal by Subject|2
6357|NCT02163733|40064|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
6358|NCT02163733|40065|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
6359|NCT02163733|40066|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
6360|NCT02163733|40064|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
6361|NCT02163733|40065|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
6362|NCT02163733|40066|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
6363|NCT02163395|40115|P1|Overall Study|Adverse Event|1
6364|NCT02163395|40115|P1|Overall Study|Lost to Follow-up|3
6365|NCT02163395|40115|P1|Overall Study|Withdrawal by Subject|1
6366|NCT02162758|40133|P2|Overall Study|Study termination|1
6367|NCT02162758|40134|P1|Overall Study|Study termination|0
6368|NCT02161549|40161|P2|Overall Study|Physician Decision|2
6369|NCT02161549|40162|P1|Overall Study|Physician Decision|6
6370|NCT02161146|40173|P5|Overall Study|Other Miscellaneous Reasons|0
6371|NCT02161146|40174|P4|Overall Study|Other Miscellaneous Reasons|0
6372|NCT02161146|40175|P3|Overall Study|Other Miscellaneous Reasons|0
6373|NCT02161146|40176|P2|Overall Study|Other Miscellaneous Reasons|1
6374|NCT02161146|40177|P1|Overall Study|Other Miscellaneous Reasons|0
6375|NCT02161146|40173|P5|Overall Study|Personal Reasons|1
6376|NCT02161146|40174|P4|Overall Study|Personal Reasons|2
6377|NCT02161146|40175|P3|Overall Study|Personal Reasons|0
6378|NCT02161146|40176|P2|Overall Study|Personal Reasons|1
6379|NCT02161146|40177|P1|Overall Study|Personal Reasons|0
6380|NCT02161146|40173|P5|Overall Study|Lost to Follow-up|0
6381|NCT02161146|40174|P4|Overall Study|Lost to Follow-up|0
6382|NCT02161146|40175|P3|Overall Study|Lost to Follow-up|0
6383|NCT02161146|40176|P2|Overall Study|Lost to Follow-up|1
6384|NCT02161146|40177|P1|Overall Study|Lost to Follow-up|0
6385|NCT02161146|40173|P5|Overall Study|Adverse Event|0
6386|NCT02161146|40174|P4|Overall Study|Adverse Event|1
6387|NCT02161146|40175|P3|Overall Study|Adverse Event|0
6388|NCT02161146|40176|P2|Overall Study|Adverse Event|1
6389|NCT02161146|40177|P1|Overall Study|Adverse Event|1
6390|NCT02161016|40190|P1|Overall Study|withdrawn by IRB|1
6391|NCT02160977|40221|P2|Six Months After Surgery|Lost to Follow-up|1
6392|NCT02160977|40222|P1|Six Months After Surgery|Lost to Follow-up|2
6393|NCT02160977|40221|P2|Three Months After Surgery|Lost to Follow-up|2
6394|NCT02160977|40222|P1|Three Months After Surgery|Lost to Follow-up|0
6395|NCT02160977|40221|P2|Six Weeks After Surgery|Lost to Follow-up|0
6396|NCT02160977|40222|P1|Six Weeks After Surgery|Lost to Follow-up|1
6397|NCT02160314|40249|P2|Overall Study|Lost to Follow-up|1
6398|NCT02160314|40250|P1|Overall Study|Lost to Follow-up|0
6399|NCT02160314|40249|P2|Overall Study|Withdrawal by Subject|2
6400|NCT02160314|40250|P1|Overall Study|Withdrawal by Subject|1
6401|NCT02160314|40249|P2|Overall Study|Protocol Violation|4
6402|NCT02160314|40250|P1|Overall Study|Protocol Violation|0
6403|NCT02160314|40249|P2|Overall Study|Adverse Event|6
6404|NCT02160314|40250|P1|Overall Study|Adverse Event|0
6405|NCT02159950|40258|P2|Overall Study|Progression|1
6406|NCT02159950|40259|P1|Overall Study|Progression|0
6407|NCT02159950|40258|P2|Overall Study|Adverse Event|1
6408|NCT02159950|40259|P1|Overall Study|Adverse Event|0
6409|NCT02159482|40320|P1|Overall Study|Physician Decision|3
6410|NCT02159482|40320|P1|Overall Study|Withdrawal by Subject|2
6411|NCT02159365|40325|P1|Overall Study|Unspecified|1
6412|NCT02159365|40325|P1|Overall Study|Subject Withdrew Consent|1
6413|NCT02159365|40325|P1|Overall Study|Subject Request to Discontinue Treatment|1
6414|NCT02159365|40325|P1|Overall Study|Study Drug Toxicity|1
6415|NCT02159365|40325|P1|Overall Study|Lost to Follow-up|1
6416|NCT02159365|40325|P1|Overall Study|Adverse Event Unrelated to Study Drug|6
6417|NCT02159365|40325|P1|Overall Study|Disease Progression|11
6418|NCT02159352|40331|P2|Overall Study|Withdrawal by Subject|1
6419|NCT02159352|40332|P1|Overall Study|Withdrawal by Subject|0
6420|NCT02159352|40331|P2|Overall Study|Adverse Event|1
6421|NCT02159352|40332|P1|Overall Study|Adverse Event|3
6422|NCT02159040|40407|P1|Overall Study|Death|1
6423|NCT02158728|40420|P1|Overall Study|no qualified dataset|24
6424|NCT02158728|40420|P1|Overall Study|no procedure according to CIP done|3
6425|NCT02158442|40426|P2|Overall Study|Perfusion staff not available|0
6426|NCT02158442|40427|P1|Overall Study|Perfusion staff not available|1
6427|NCT02158442|40426|P2|Overall Study|Withdrawal by Subject|0
6428|NCT02158442|40427|P1|Overall Study|Withdrawal by Subject|1
6429|NCT02158247|40446|P1|Overall Study|Invisible vocal cords|5
6430|NCT02158039|40462|P1|Overall Study|Screen Failure|9
6431|NCT02158039|40462|P1|Overall Study|Withdrawal by Subject|1
6432|NCT02157948|40469|P2|Overall Study|Decision by Sponsor|1
6433|NCT02157948|40470|P1|Overall Study|Decision by Sponsor|0
6434|NCT02157948|40469|P2|Overall Study|Protocol Specified Criteria|1
6435|NCT02157948|40470|P1|Overall Study|Protocol Specified Criteria|2
6436|NCT02157948|40469|P2|Overall Study|Lost to Follow-up|2
6437|NCT02157948|40470|P1|Overall Study|Lost to Follow-up|3
6438|NCT02157948|40469|P2|Overall Study|Withdrawal by Subject|5
6439|NCT02157948|40470|P1|Overall Study|Withdrawal by Subject|4
6440|NCT02157935|40482|P2|Overall Study|Adverse Event|5
6441|NCT02157935|40483|P1|Overall Study|Adverse Event|3
6442|NCT02157935|40482|P2|Overall Study|Death|4
6443|NCT02157935|40483|P1|Overall Study|Death|4
6444|NCT02157935|40482|P2|Overall Study|Lack of Efficacy|1
6445|NCT02157935|40483|P1|Overall Study|Lack of Efficacy|0
6446|NCT02157935|40482|P2|Overall Study|Other|12
6447|NCT02157935|40483|P1|Overall Study|Other|5
6448|NCT02157935|40482|P2|Overall Study|Progressive disease|2
6449|NCT02157935|40483|P1|Overall Study|Progressive disease|0
6450|NCT02157935|40482|P2|Overall Study|Protocol Violation|0
6451|NCT02157935|40483|P1|Overall Study|Protocol Violation|1
6452|NCT02157935|40482|P2|Overall Study|Screen failure|2
6453|NCT02157935|40483|P1|Overall Study|Screen failure|1
6454|NCT02157935|40482|P2|Overall Study|Withdrawal by Subject|39
6455|NCT02157935|40483|P1|Overall Study|Withdrawal by Subject|25
6456|NCT02157883|40509|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
6457|NCT02157883|40509|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
6458|NCT02157883|40509|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
6459|NCT02157883|40509|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
6460|NCT02157883|40509|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
6461|NCT02157623|40540|P2|Overall Study|Physician Decision|3
6462|NCT02157623|40541|P1|Overall Study|Physician Decision|4
6463|NCT02157376|40549|P2|Overall Study|Investigator's misjudgement|2
6464|NCT02157376|40550|P1|Overall Study|Investigator's misjudgement|1
6465|NCT02157376|40549|P2|Overall Study|Not treated|3
6466|NCT02157376|40550|P1|Overall Study|Not treated|8
6467|NCT02157376|40549|P2|Overall Study|Withdrawal by Subject|8
6468|NCT02157376|40550|P1|Overall Study|Withdrawal by Subject|3
6469|NCT02157376|40549|P2|Overall Study|Eligibility criteria not fulfilled|1
6470|NCT02157376|40550|P1|Overall Study|Eligibility criteria not fulfilled|0
6471|NCT02157376|40549|P2|Overall Study|Death|4
6472|NCT02157376|40550|P1|Overall Study|Death|10
6473|NCT02157298|40560|P2|Overall Study|Withdrawal by Subject|0
6474|NCT02157298|40561|P1|Overall Study|Withdrawal by Subject|1
6475|NCT02157298|40560|P2|Overall Study|Poor/Non-compliance|0
6476|NCT02157298|40561|P1|Overall Study|Poor/Non-compliance|1
6477|NCT02157298|40560|P2|Overall Study|Subject no longer meets study criteria|2
6478|NCT02157298|40561|P1|Overall Study|Subject no longer meets study criteria|1
6479|NCT02157298|40560|P2|Overall Study|Adverse Event|0
6480|NCT02157298|40561|P1|Overall Study|Adverse Event|1
6481|NCT02157116|40575|P1|Overall Study|Failed Screening|2
6482|NCT02157116|40575|P1|Overall Study|Physician Decision|3
6483|NCT02157116|40575|P1|Overall Study|Withdrawal by Subject|4
6484|NCT02156466|40589|P5|Overall Study|Quantiferon Positivity|0
6485|NCT02156466|40590|P4|Overall Study|Quantiferon Positivity|1
6486|NCT02156466|40591|P3|Overall Study|Quantiferon Positivity|0
6487|NCT02156466|40592|P2|Overall Study|Quantiferon Positivity|0
6488|NCT02156466|40593|P1|Overall Study|Quantiferon Positivity|0
6489|NCT02156466|40589|P5|Overall Study|Adverse Event|0
6490|NCT02156466|40590|P4|Overall Study|Adverse Event|1
6491|NCT02156466|40591|P3|Overall Study|Adverse Event|1
6492|NCT02156466|40592|P2|Overall Study|Adverse Event|0
6493|NCT02156466|40593|P1|Overall Study|Adverse Event|0
6494|NCT02156271|40774|P2|Overall Study|Physician Decision|3
6495|NCT02156271|40775|P1|Overall Study|Physician Decision|4
6496|NCT02155985|40814|P3|Overall Study|Lost to Follow-up|0
6497|NCT02155985|40815|P2|Overall Study|Lost to Follow-up|0
6498|NCT02155985|40816|P1|Overall Study|Lost to Follow-up|1
6499|NCT02155985|40814|P3|Overall Study|Withdrawal by Subject|1
6500|NCT02155985|40815|P2|Overall Study|Withdrawal by Subject|0
6501|NCT02155985|40816|P1|Overall Study|Withdrawal by Subject|0
6502|NCT02155881|40883|P2|Overall Study|Inappropriately randomized|2
6503|NCT02155881|40884|P1|Overall Study|Inappropriately randomized|2
6504|NCT02155881|40883|P2|Overall Study|Withdrawal by Subject|2
6505|NCT02155881|40884|P1|Overall Study|Withdrawal by Subject|0
6506|NCT02155322|40936|P1|Overall Study|Withdrawal by Subject|4
6507|NCT02155322|40936|P1|Overall Study|Relapse/Recurrence|8
6508|NCT02155322|40936|P1|Overall Study|Physician Decision|1
6509|NCT02155322|40936|P1|Overall Study|Adverse Event|1
6510|NCT02155283|40941|P1|Overall Study|Protocol Violation|3
6511|NCT02155283|40941|P1|Overall Study|Withdrawal by Subject|1
6512|NCT02155283|40941|P1|Overall Study|Lost to Follow-up|3
6514|NCT02154139|41027|P1|Overall Study|Investigator transferred|3
6515|NCT02154139|41027|P1|Overall Study|Other|2
6516|NCT02154139|41027|P1|Overall Study|Injection not administered|2
6517|NCT02154087|41035|P1|Overall Study|Study Termination|1
6518|NCT02153827|41054|P2|Overall Study|Lost to Follow-up|9
6519|NCT02153827|41055|P1|Overall Study|Lost to Follow-up|3
6520|NCT02153788|41071|P2|Overall Study|Physician Decision|1
6521|NCT02153788|41072|P1|Overall Study|Physician Decision|2
6522|NCT02153398|41134|P5|Overall Study|Adverse Event|0
6523|NCT02153398|41135|P4|Overall Study|Adverse Event|1
6524|NCT02153398|41136|P3|Overall Study|Adverse Event|1
6525|NCT02153398|41137|P2|Overall Study|Adverse Event|0
6526|NCT02153398|41138|P1|Overall Study|Adverse Event|0
6527|NCT02153398|41134|P5|Overall Study|Withdrawal by Subject|0
6528|NCT02153398|41135|P4|Overall Study|Withdrawal by Subject|0
6529|NCT02153398|41136|P3|Overall Study|Withdrawal by Subject|0
6530|NCT02153398|41137|P2|Overall Study|Withdrawal by Subject|0
6531|NCT02153398|41138|P1|Overall Study|Withdrawal by Subject|1
6532|NCT02153346|41260|P1|Overall Study|Lost to Follow-up|11
6533|NCT02153086|41334|P1|Overall Study|Other|2
6534|NCT02153086|41334|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
6535|NCT02152605|41350|P2|Overall Study|Withdrew consent|2
6536|NCT02152605|41351|P1|Overall Study|Withdrew consent|4
6537|NCT02152605|41350|P2|Overall Study|Lost to Follow-up|0
6538|NCT02152605|41351|P1|Overall Study|Lost to Follow-up|1
6539|NCT02152605|41350|P2|Overall Study|Protocol deviation|4
6540|NCT02152605|41351|P1|Overall Study|Protocol deviation|1
6541|NCT02152605|41350|P2|Overall Study|Lack of Efficacy|4
6542|NCT02152605|41351|P1|Overall Study|Lack of Efficacy|7
6543|NCT02152605|41350|P2|Overall Study|Adverse Event|8
6544|NCT02152605|41351|P1|Overall Study|Adverse Event|6
6545|NCT02152566|41361|P1|Overall Study|Withdrawal by Subject|2
6546|NCT02152566|41361|P1|Overall Study|Lost to Follow-up|1
6547|NCT02152371|41367|P2|Overall Study|Reason Not Given|1
6548|NCT02152371|41368|P1|Overall Study|Reason Not Given|0
6549|NCT02152371|41367|P2|Overall Study|Physician Decision|2
6550|NCT02152371|41368|P1|Overall Study|Physician Decision|0
6551|NCT02152371|41367|P2|Overall Study|Lack of Efficacy|1
6552|NCT02152371|41368|P1|Overall Study|Lack of Efficacy|0
6553|NCT02152371|41367|P2|Overall Study|Lost to Follow-up|0
6554|NCT02152371|41368|P1|Overall Study|Lost to Follow-up|1
6555|NCT02152371|41367|P2|Overall Study|Protocol Violation|3
6556|NCT02152371|41368|P1|Overall Study|Protocol Violation|2
6557|NCT02152371|41367|P2|Overall Study|Withdrawal by Subject|7
6558|NCT02152371|41368|P1|Overall Study|Withdrawal by Subject|3
6559|NCT02152371|41367|P2|Overall Study|Adverse Event|2
6560|NCT02152371|41368|P1|Overall Study|Adverse Event|6
6561|NCT02152007|41404|P1|Overall Study|Withdrawal by Subject|1
6562|NCT02151981|41465|P2|Overall Study|Eligibility criteria not fulfilled|1
6563|NCT02151981|41466|P1|Overall Study|Eligibility criteria not fulfilled|0
6564|NCT02151981|41465|P2|Overall Study|Ongoing Study at Data Cut-off|95
6565|NCT02151981|41466|P1|Overall Study|Ongoing Study at Data Cut-off|224
6566|NCT02151981|41465|P2|Overall Study|Withdrawal by Subject|18
6567|NCT02151981|41466|P1|Overall Study|Withdrawal by Subject|19
6568|NCT02151981|41465|P2|Overall Study|Lost to Follow-up|0
6569|NCT02151981|41466|P1|Overall Study|Lost to Follow-up|1
6570|NCT02151981|41465|P2|Overall Study|Death|26
6571|NCT02151981|41466|P1|Overall Study|Death|35
6572|NCT02151786|41482|P1|Overall Study|Unavailability of Information|8
6573|NCT02151786|41482|P1|Overall Study|Randomized, not Treated|1
6574|NCT02151786|41482|P1|Overall Study|Outside the Contract Period|1
6575|NCT02151786|41482|P1|Overall Study|Unavailability of Case Report Form|26
6576|NCT02151773|41493|P1|Overall Study|Protocol Deviation|64
6577|NCT02151058|41516|P3|Overall Study|Lost to Follow-up|2
6578|NCT02151058|41517|P2|Overall Study|Lost to Follow-up|0
6579|NCT02151058|41518|P1|Overall Study|Lost to Follow-up|1
6580|NCT02151058|41516|P3|Overall Study|Withdrawal by Subject|3
6581|NCT02151058|41517|P2|Overall Study|Withdrawal by Subject|1
6582|NCT02151058|41518|P1|Overall Study|Withdrawal by Subject|1
6583|NCT02150954|41552|P2|Overall Study|Protocol Violation|0
6584|NCT02150954|41553|P1|Overall Study|Protocol Violation|1
6585|NCT02150213|41625|P1|Overall Study|Withdrawal by Subject|1
6586|NCT02150213|41625|P1|Overall Study|Lost to Follow-up|1
6587|NCT02149875|41651|P3|Overall Study|Physician Decision|2
6588|NCT02149875|41652|P2|Overall Study|Physician Decision|2
6589|NCT02149875|41653|P1|Overall Study|Physician Decision|1
6590|NCT02149875|41651|P3|Overall Study|Withdrawal by Subject|2
6591|NCT02149875|41652|P2|Overall Study|Withdrawal by Subject|2
6592|NCT02149875|41653|P1|Overall Study|Withdrawal by Subject|3
6593|NCT02149875|41651|P3|Overall Study|Lost to Follow-up|5
6594|NCT02149875|41652|P2|Overall Study|Lost to Follow-up|4
6595|NCT02149875|41653|P1|Overall Study|Lost to Follow-up|3
6596|NCT02149264|41682|P1|Overall Study|Protocol Violation|1
6597|NCT02149264|41682|P1|Overall Study|Physician Decision|3
6598|NCT02149264|41682|P1|Overall Study|Adverse Event|7
6599|NCT02149264|41682|P1|Overall Study|Withdrawal by Subject|9
6600|NCT02149108|41697|P2|Overall Study|Lost to Follow-up|0
6601|NCT02149108|41698|P1|Overall Study|Lost to Follow-up|1
6602|NCT02149108|41697|P2|Overall Study|Refusal to continue trial medication|11
6603|NCT02149108|41698|P1|Overall Study|Refusal to continue trial medication|15
6604|NCT02149108|41697|P2|Overall Study|Other not defined above|2
6605|NCT02149108|41698|P1|Overall Study|Other not defined above|0
6606|NCT02149108|41697|P2|Overall Study|Other Adverse Event (AE)|18
6607|NCT02149108|41698|P1|Overall Study|Other Adverse Event (AE)|8
6608|NCT02149108|41697|P2|Overall Study|Worsening/adverse event cancer disease|32
6609|NCT02149108|41698|P1|Overall Study|Worsening/adverse event cancer disease|31
6610|NCT02149108|41697|P2|Overall Study|Progressive Disease (PD)|318
6611|NCT02149108|41698|P1|Overall Study|Progressive Disease (PD)|324
6612|NCT02149108|41697|P2|Overall Study|Not treated|2
6613|NCT02149108|41698|P1|Overall Study|Not treated|1
6614|NCT02148445|41737|P2|Overall Study|Death|3
6615|NCT02148445|41738|P1|Overall Study|Death|1
6616|NCT02147691|41793|P2|Overall Study|Lost to Follow-up|1
6617|NCT02147691|41794|P1|Overall Study|Lost to Follow-up|0
6618|NCT02147691|41793|P2|Overall Study|Adverse Event|0
6619|NCT02147691|41794|P1|Overall Study|Adverse Event|2
6620|NCT02147691|41793|P2|Overall Study|Withdrawal by Subject|0
6621|NCT02147691|41794|P1|Overall Study|Withdrawal by Subject|2
6622|NCT02147561|41838|P1|Overall Study|Subjects who didn’t receive BOTOX|1
6623|NCT02147561|41838|P1|Overall Study|Lost to Follow-up|3
6624|NCT02147288|41859|P10|Overall Study|complications from concurrent hernia rep|0
6625|NCT02147288|41860|P9|Overall Study|complications from concurrent hernia rep|0
6626|NCT02147288|41861|P8|Overall Study|complications from concurrent hernia rep|0
6627|NCT02147288|41862|P7|Overall Study|complications from concurrent hernia rep|0
6628|NCT02147288|41863|P6|Overall Study|complications from concurrent hernia rep|0
6629|NCT02147288|41864|P5|Overall Study|complications from concurrent hernia rep|0
6630|NCT02147288|41865|P4|Overall Study|complications from concurrent hernia rep|0
6631|NCT02147288|41866|P3|Overall Study|complications from concurrent hernia rep|0
6632|NCT02147288|41867|P2|Overall Study|complications from concurrent hernia rep|1
6633|NCT02147288|41868|P1|Overall Study|complications from concurrent hernia rep|0
6634|NCT02147288|41859|P10|Overall Study|post-operative hematoma|0
6635|NCT02147288|41860|P9|Overall Study|post-operative hematoma|0
6636|NCT02147288|41861|P8|Overall Study|post-operative hematoma|0
6637|NCT02147288|41862|P7|Overall Study|post-operative hematoma|0
6638|NCT02147288|41863|P6|Overall Study|post-operative hematoma|0
6639|NCT02147288|41864|P5|Overall Study|post-operative hematoma|0
6640|NCT02147288|41865|P4|Overall Study|post-operative hematoma|0
6641|NCT02147288|41866|P3|Overall Study|post-operative hematoma|0
6642|NCT02147288|41867|P2|Overall Study|post-operative hematoma|1
6643|NCT02147288|41868|P1|Overall Study|post-operative hematoma|1
6644|NCT02147093|41876|P2|Period 2|Protocol Violation|0
6645|NCT02147093|41877|P1|Period 2|Protocol Violation|2
6646|NCT02147093|41876|P2|Period 1|Lost to Follow-up|1
6647|NCT02147093|41877|P1|Period 1|Lost to Follow-up|0
6648|NCT02146599|41885|P1|Overall Study|Failed to meet inclusion criteria|5
6649|NCT02146352|41898|P1|Overall Study|Patient entered hospice care|1
6650|NCT02146352|41898|P1|Overall Study|Death|1
6651|NCT02146326|41916|P4|Overall Study|Unable to complete interview|6
6652|NCT02146326|41917|P3|Overall Study|Unable to complete interview|10
6653|NCT02146326|41918|P2|Overall Study|Unable to complete interview|0
6654|NCT02146326|41919|P1|Overall Study|Unable to complete interview|0
6655|NCT02146326|41916|P4|Overall Study|Death|4
6656|NCT02146326|41917|P3|Overall Study|Death|4
6657|NCT02146326|41918|P2|Overall Study|Death|0
6658|NCT02146326|41919|P1|Overall Study|Death|0
6659|NCT02146326|41916|P4|Overall Study|Incarcerated|8
6660|NCT02146326|41917|P3|Overall Study|Incarcerated|3
6661|NCT02146326|41918|P2|Overall Study|Incarcerated|0
6662|NCT02146326|41919|P1|Overall Study|Incarcerated|0
6663|NCT02146326|41916|P4|Overall Study|Separated from mental health center|0
6664|NCT02146326|41917|P3|Overall Study|Separated from mental health center|0
6665|NCT02146326|41918|P2|Overall Study|Separated from mental health center|33
6666|NCT02146326|41919|P1|Overall Study|Separated from mental health center|23
6667|NCT02146326|41916|P4|Overall Study|Withdrawal by Subject|11
6668|NCT02146326|41917|P3|Overall Study|Withdrawal by Subject|15
6669|NCT02146326|41918|P2|Overall Study|Withdrawal by Subject|1
6670|NCT02146326|41919|P1|Overall Study|Withdrawal by Subject|2
6671|NCT02146326|41916|P4|Overall Study|Lost to Follow-up|19
6672|NCT02146326|41917|P3|Overall Study|Lost to Follow-up|11
6673|NCT02146326|41918|P2|Overall Study|Lost to Follow-up|3
6674|NCT02146326|41919|P1|Overall Study|Lost to Follow-up|3
6675|NCT02146248|42081|P1|Overall Study|Withdrawal by Subject|2
6676|NCT02146105|42089|P1|Overall Study|Withdrawal by Subject|5
6677|NCT02146105|42089|P1|Overall Study|Adverse Event|1
6678|NCT02145468|42140|P2|Overall Study|Withdrawal by Subject|8
6679|NCT02145468|42141|P1|Overall Study|Withdrawal by Subject|5
6680|NCT02145156|42229|P3|Overall Study|No match to vaccination records|41
6681|NCT02145156|42230|P2|Overall Study|No match to vaccination records|52
6682|NCT02145156|42231|P1|Overall Study|No match to vaccination records|60
6683|NCT02144337|42274|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
6684|NCT02144337|42275|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
6685|NCT02144337|42274|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
6686|NCT02144337|42275|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
6687|NCT02144337|42274|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
6688|NCT02144337|42275|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
6689|NCT02144337|42274|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
6690|NCT02144337|42275|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
6691|NCT02144337|42274|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
6692|NCT02144337|42275|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
6693|NCT02144220|42304|P1|Overall Study|Protocol Violation|1
6694|NCT02144220|42304|P1|Overall Study|Withdrawal by Subject|2
6695|NCT02144220|42304|P1|Overall Study|Physician Decision|3
6696|NCT02144220|42304|P1|Overall Study|Lack of Efficacy|4
6697|NCT02144220|42304|P1|Overall Study|technology incompatibility|9
6698|NCT02144012|42314|P2|Overall Study|Other|0
6699|NCT02144012|42315|P1|Overall Study|Other|3
6700|NCT02144012|42314|P2|Overall Study|Study Terminated by Sponsor|12
6701|NCT02144012|42315|P1|Overall Study|Study Terminated by Sponsor|18
6702|NCT02144012|42314|P2|Overall Study|Withdrawal by Subject|3
6703|NCT02144012|42315|P1|Overall Study|Withdrawal by Subject|11
6704|NCT02144012|42314|P2|Overall Study|Death|0
6705|NCT02144012|42315|P1|Overall Study|Death|1
6706|NCT02144012|42314|P2|Overall Study|Adverse Event|0
6707|NCT02144012|42315|P1|Overall Study|Adverse Event|1
6708|NCT02143947|42352|P2|Overall Study|Lost to Follow-up|2
6709|NCT02143947|42353|P1|Overall Study|Lost to Follow-up|4
6710|NCT02143583|42368|P3|Overall Study|husband illness|1
6711|NCT02143583|42369|P2|Overall Study|husband illness|0
6712|NCT02143583|42370|P1|Overall Study|husband illness|0
6713|NCT02143583|42368|P3|Overall Study|Withdrawal by Subject|1
6714|NCT02143583|42369|P2|Overall Study|Withdrawal by Subject|0
6715|NCT02143583|42370|P1|Overall Study|Withdrawal by Subject|1
6716|NCT02142738|42383|P2|Overall Study|Ongoing in Study|82
6717|NCT02142738|42384|P1|Overall Study|Ongoing in Study|107
6718|NCT02142738|42383|P2|Overall Study|Withdrawal by Subject|5
6719|NCT02142738|42384|P1|Overall Study|Withdrawal by Subject|5
6720|NCT02142738|42383|P2|Overall Study|Progressive Disease|1
6721|NCT02142738|42384|P1|Overall Study|Progressive Disease|0
6722|NCT02142738|42383|P2|Overall Study|Death|55
6723|NCT02142738|42384|P1|Overall Study|Death|33
6724|NCT02142738|42383|P2|Overall Study|Adverse Event|8
6725|NCT02142738|42384|P1|Overall Study|Adverse Event|9
6726|NCT02142712|42397|P4|Overall Study|Lost to Follow-up|0
6727|NCT02142712|42398|P3|Overall Study|Lost to Follow-up|1
6728|NCT02142712|42399|P2|Overall Study|Lost to Follow-up|1
6729|NCT02142712|42400|P1|Overall Study|Lost to Follow-up|1
6730|NCT02142504|42423|P3|Overall Study|Reason Not Specified|4
6731|NCT02142504|42424|P2|Overall Study|Reason Not Specified|5
6732|NCT02142504|42425|P1|Overall Study|Reason Not Specified|4
6733|NCT02142504|42423|P3|Overall Study|Physician Decision|3
6734|NCT02142504|42424|P2|Overall Study|Physician Decision|1
6735|NCT02142504|42425|P1|Overall Study|Physician Decision|0
6736|NCT02142504|42423|P3|Overall Study|Pregnancy|2
6737|NCT02142504|42424|P2|Overall Study|Pregnancy|4
6738|NCT02142504|42425|P1|Overall Study|Pregnancy|4
6739|NCT02142504|42423|P3|Overall Study|Withdrawal by Subject|11
6740|NCT02142504|42424|P2|Overall Study|Withdrawal by Subject|9
6741|NCT02142504|42425|P1|Overall Study|Withdrawal by Subject|7
6742|NCT02142504|42423|P3|Overall Study|Lost to Follow-up|17
6743|NCT02142504|42424|P2|Overall Study|Lost to Follow-up|19
6744|NCT02142504|42425|P1|Overall Study|Lost to Follow-up|12
6745|NCT02142504|42423|P3|Overall Study|Adverse Event|4
6746|NCT02142504|42424|P2|Overall Study|Adverse Event|3
6747|NCT02142504|42425|P1|Overall Study|Adverse Event|2
6748|NCT02142504|42423|P3|Overall Study|Protocol Violation|2
6749|NCT02142504|42424|P2|Overall Study|Protocol Violation|1
6750|NCT02142504|42425|P1|Overall Study|Protocol Violation|2
6751|NCT02141997|42667|P4|Overall Study|Not specified|0
6752|NCT02141997|42668|P3|Overall Study|Not specified|0
6753|NCT02141997|42669|P2|Overall Study|Not specified|4
6754|NCT02141997|42670|P1|Overall Study|Not specified|1
6755|NCT02141997|42667|P4|Overall Study|Withdrew consent|0
6756|NCT02141997|42668|P3|Overall Study|Withdrew consent|3
6757|NCT02141997|42669|P2|Overall Study|Withdrew consent|0
6758|NCT02141997|42670|P1|Overall Study|Withdrew consent|1
6759|NCT02141997|42667|P4|Overall Study|Participant noncompliance|0
6760|NCT02141997|42668|P3|Overall Study|Participant noncompliance|0
6761|NCT02141997|42669|P2|Overall Study|Participant noncompliance|0
6762|NCT02141997|42670|P1|Overall Study|Participant noncompliance|1
6763|NCT02141997|42667|P4|Overall Study|Adverse Event|1
6764|NCT02141997|42668|P3|Overall Study|Adverse Event|0
6765|NCT02141997|42669|P2|Overall Study|Adverse Event|2
6766|NCT02141997|42670|P1|Overall Study|Adverse Event|0
6767|NCT02141984|42708|P1|Overall Study|Lack of Efficacy|2
6768|NCT02141854|42727|P6|Treatment Period|Lost to Follow-up|1
6769|NCT02141854|42728|P5|Treatment Period|Lost to Follow-up|0
6770|NCT02141854|42729|P4|Treatment Period|Lost to Follow-up|1
6771|NCT02141854|42730|P3|Treatment Period|Lost to Follow-up|1
6772|NCT02141854|42731|P2|Treatment Period|Lost to Follow-up|1
6773|NCT02141854|42732|P1|Treatment Period|Lost to Follow-up|0
6774|NCT02141854|42727|P6|Treatment Period|Disease progression|18
6775|NCT02141854|42728|P5|Treatment Period|Disease progression|0
6776|NCT02141854|42729|P4|Treatment Period|Disease progression|3
6777|NCT02141854|42730|P3|Treatment Period|Disease progression|1
6778|NCT02141854|42731|P2|Treatment Period|Disease progression|2
6779|NCT02141854|42732|P1|Treatment Period|Disease progression|0
6780|NCT02141854|42727|P6|Treatment Period|Withdrawal by Subject|7
6781|NCT02141854|42728|P5|Treatment Period|Withdrawal by Subject|4
6782|NCT02141854|42729|P4|Treatment Period|Withdrawal by Subject|3
6783|NCT02141854|42730|P3|Treatment Period|Withdrawal by Subject|3
6784|NCT02141854|42731|P2|Treatment Period|Withdrawal by Subject|2
6785|NCT02141854|42732|P1|Treatment Period|Withdrawal by Subject|0
6786|NCT02141854|42727|P6|Treatment Period|Adverse Event|2
6787|NCT02141854|42728|P5|Treatment Period|Adverse Event|2
6788|NCT02141854|42729|P4|Treatment Period|Adverse Event|0
6789|NCT02141854|42730|P3|Treatment Period|Adverse Event|2
6790|NCT02141854|42731|P2|Treatment Period|Adverse Event|2
6791|NCT02141854|42732|P1|Treatment Period|Adverse Event|0
6792|NCT02141854|42727|P6|Treatment Period|Not specified|2
6793|NCT02141854|42728|P5|Treatment Period|Not specified|1
6794|NCT02141854|42729|P4|Treatment Period|Not specified|0
6795|NCT02141854|42730|P3|Treatment Period|Not specified|2
6796|NCT02141854|42731|P2|Treatment Period|Not specified|1
6797|NCT02141854|42732|P1|Treatment Period|Not specified|0
6798|NCT02141854|42727|P6|Treatment Period|Pregnancy|0
6799|NCT02141854|42728|P5|Treatment Period|Pregnancy|0
6800|NCT02141854|42729|P4|Treatment Period|Pregnancy|0
6801|NCT02141854|42730|P3|Treatment Period|Pregnancy|0
6802|NCT02141854|42731|P2|Treatment Period|Pregnancy|1
6803|NCT02141854|42732|P1|Treatment Period|Pregnancy|0
6804|NCT02141854|42727|P6|Treatment Period|Lack of Efficacy|7
6805|NCT02141854|42728|P5|Treatment Period|Lack of Efficacy|1
6806|NCT02141854|42729|P4|Treatment Period|Lack of Efficacy|1
6807|NCT02141854|42730|P3|Treatment Period|Lack of Efficacy|0
6808|NCT02141854|42731|P2|Treatment Period|Lack of Efficacy|0
6809|NCT02141854|42732|P1|Treatment Period|Lack of Efficacy|0
6810|NCT02141854|42727|P6|Treatment Period|Noncompliance|0
6811|NCT02141854|42728|P5|Treatment Period|Noncompliance|0
6812|NCT02141854|42729|P4|Treatment Period|Noncompliance|1
6813|NCT02141854|42730|P3|Treatment Period|Noncompliance|0
6814|NCT02141854|42731|P2|Treatment Period|Noncompliance|0
6815|NCT02141854|42732|P1|Treatment Period|Noncompliance|0
6816|NCT02141854|42727|P6|Treatment Period|Protocol Violation|1
6817|NCT02141854|42728|P5|Treatment Period|Protocol Violation|2
6818|NCT02141854|42729|P4|Treatment Period|Protocol Violation|2
6819|NCT02141854|42730|P3|Treatment Period|Protocol Violation|0
6820|NCT02141854|42731|P2|Treatment Period|Protocol Violation|1
6821|NCT02141854|42732|P1|Treatment Period|Protocol Violation|0
6822|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6823|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6824|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6825|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6826|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
6827|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
6828|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6829|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6830|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6831|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6832|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
6833|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
6834|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Adverse Event|0
6835|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Adverse Event|0
6836|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Adverse Event|0
6837|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Adverse Event|0
6838|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Adverse Event|0
6839|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Adverse Event|10
6840|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Not specified|0
6841|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Not specified|0
6842|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Not specified|0
6843|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Not specified|0
6844|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Not specified|0
6845|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Not specified|14
6846|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6847|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6848|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6849|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6850|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
6851|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
6852|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6853|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6854|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6855|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6856|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
6857|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
6858|NCT02141854|42727|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6859|NCT02141854|42728|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6860|NCT02141854|42729|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6861|NCT02141854|42730|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6862|NCT02141854|42731|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
6863|NCT02141854|42732|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
6864|NCT02141633|42786|P2|Overall Study|Physician Decision|0
6865|NCT02141633|42787|P1|Overall Study|Physician Decision|1
6866|NCT02141620|42795|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
6867|NCT02141620|42796|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
6868|NCT02141516|42873|P3|Overall Study|Other|0
6869|NCT02141516|42874|P2|Overall Study|Other|3
6870|NCT02141516|42875|P1|Overall Study|Other|0
6871|NCT02141516|42873|P3|Overall Study|Lost to Follow-up|0
6872|NCT02141516|42874|P2|Overall Study|Lost to Follow-up|1
6873|NCT02141516|42875|P1|Overall Study|Lost to Follow-up|0
6874|NCT02141516|42873|P3|Overall Study|Adverse Event|0
6875|NCT02141516|42874|P2|Overall Study|Adverse Event|1
6876|NCT02141516|42875|P1|Overall Study|Adverse Event|0
6877|NCT02141360|42925|P3|Overall Study|Study Terminated before Visit|0
6878|NCT02141360|42926|P2|Overall Study|Study Terminated before Visit|0
6879|NCT02141360|42927|P1|Overall Study|Study Terminated before Visit|1
6880|NCT02141360|42925|P3|Overall Study|Withdrawal by Subject|0
6881|NCT02141360|42926|P2|Overall Study|Withdrawal by Subject|0
6882|NCT02141360|42927|P1|Overall Study|Withdrawal by Subject|6
6883|NCT02140164|42935|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
6884|NCT02141217|42948|P2|Overall Study|Surgical Intervention|1
6885|NCT02141217|42949|P1|Overall Study|Surgical Intervention|1
6886|NCT02141217|42948|P2|Overall Study|Physician Decision|0
6887|NCT02141217|42949|P1|Overall Study|Physician Decision|1
6888|NCT02141217|42948|P2|Overall Study|Lost to Follow-up|1
6889|NCT02141217|42949|P1|Overall Study|Lost to Follow-up|1
6890|NCT02141217|42948|P2|Overall Study|Withdrawal by Subject|0
6891|NCT02141217|42949|P1|Overall Study|Withdrawal by Subject|6
6892|NCT02141217|42948|P2|Overall Study|Protocol Violation|4
6893|NCT02141217|42949|P1|Overall Study|Protocol Violation|1
6894|NCT02141217|42948|P2|Overall Study|Adverse Event|2
6895|NCT02141217|42949|P1|Overall Study|Adverse Event|1
6896|NCT02140645|43015|P6|Overall Study|Not linked|70896
6897|NCT02140645|43016|P5|Overall Study|Not linked|3286
6898|NCT02140645|43017|P4|Overall Study|Not linked|13833
6899|NCT02140645|43018|P3|Overall Study|Not linked|4236
6900|NCT02140645|43019|P2|Overall Study|Not linked|61654
6901|NCT02140645|43020|P1|Overall Study|Not linked|5489
6902|NCT02140060|43135|P6|Overall Study|Lack of Efficacy|0
6903|NCT02140060|43136|P5|Overall Study|Lack of Efficacy|0
6904|NCT02140060|43137|P4|Overall Study|Lack of Efficacy|1
6905|NCT02140060|43138|P3|Overall Study|Lack of Efficacy|0
6906|NCT02140060|43139|P2|Overall Study|Lack of Efficacy|0
6907|NCT02140060|43140|P1|Overall Study|Lack of Efficacy|0
6908|NCT02140060|43135|P6|Overall Study|Adverse Event|1
6909|NCT02140060|43136|P5|Overall Study|Adverse Event|1
6910|NCT02140060|43137|P4|Overall Study|Adverse Event|1
6911|NCT02140060|43138|P3|Overall Study|Adverse Event|0
6912|NCT02140060|43139|P2|Overall Study|Adverse Event|0
6913|NCT02140060|43140|P1|Overall Study|Adverse Event|0
6914|NCT02139982|43165|P10|Overall Study|Lack of Efficacy|0
6915|NCT02139982|43166|P9|Overall Study|Lack of Efficacy|0
6916|NCT02139982|43167|P8|Overall Study|Lack of Efficacy|0
6917|NCT02139982|43168|P7|Overall Study|Lack of Efficacy|0
6918|NCT02139982|43169|P6|Overall Study|Lack of Efficacy|0
6919|NCT02139982|43170|P5|Overall Study|Lack of Efficacy|0
6920|NCT02139982|43171|P4|Overall Study|Lack of Efficacy|1
6921|NCT02139982|43172|P3|Overall Study|Lack of Efficacy|0
6922|NCT02139982|43173|P2|Overall Study|Lack of Efficacy|1
6923|NCT02139982|43174|P1|Overall Study|Lack of Efficacy|0
6924|NCT02139943|43219|P3|Overall Study|eGFR Withdrawal Criteria|1
6925|NCT02139943|43220|P2|Overall Study|eGFR Withdrawal Criteria|0
6926|NCT02139943|43221|P1|Overall Study|eGFR Withdrawal Criteria|0
6927|NCT02139943|43219|P3|Overall Study|Participant in Poor Compliance|1
6928|NCT02139943|43220|P2|Overall Study|Participant in Poor Compliance|0
6929|NCT02139943|43221|P1|Overall Study|Participant in Poor Compliance|1
6930|NCT02139943|43219|P3|Overall Study|Participant wishes to discontinue|0
6931|NCT02139943|43220|P2|Overall Study|Participant wishes to discontinue|0
6932|NCT02139943|43221|P1|Overall Study|Participant wishes to discontinue|2
6933|NCT02139943|43219|P3|Overall Study|Unspecified|1
6934|NCT02139943|43220|P2|Overall Study|Unspecified|0
6935|NCT02139943|43221|P1|Overall Study|Unspecified|0
6936|NCT02139943|43219|P3|Overall Study|Withdrawal by Subject|0
6937|NCT02139943|43220|P2|Overall Study|Withdrawal by Subject|3
6938|NCT02139943|43221|P1|Overall Study|Withdrawal by Subject|4
6939|NCT02139943|43219|P3|Overall Study|Lost to Follow-up|2
6940|NCT02139943|43220|P2|Overall Study|Lost to Follow-up|2
6941|NCT02139943|43221|P1|Overall Study|Lost to Follow-up|3
6942|NCT02139943|43219|P3|Overall Study|Adverse Event|2
6943|NCT02139943|43220|P2|Overall Study|Adverse Event|1
6944|NCT02139943|43221|P1|Overall Study|Adverse Event|0
6945|NCT02139644|43246|P6|Treatment Period|Not specified|1
6946|NCT02139644|43247|P5|Treatment Period|Not specified|0
6947|NCT02139644|43248|P4|Treatment Period|Not specified|1
6948|NCT02139644|43249|P3|Treatment Period|Not specified|1
6949|NCT02139644|43250|P2|Treatment Period|Not specified|3
6950|NCT02139644|43251|P1|Treatment Period|Not specified|0
6951|NCT02139644|43246|P6|Treatment Period|Lack of Efficacy|4
6952|NCT02139644|43247|P5|Treatment Period|Lack of Efficacy|1
6953|NCT02139644|43248|P4|Treatment Period|Lack of Efficacy|0
6954|NCT02139644|43249|P3|Treatment Period|Lack of Efficacy|1
6955|NCT02139644|43250|P2|Treatment Period|Lack of Efficacy|0
6956|NCT02139644|43251|P1|Treatment Period|Lack of Efficacy|0
6957|NCT02139644|43246|P6|Treatment Period|Lost to Follow-up|1
6958|NCT02139644|43247|P5|Treatment Period|Lost to Follow-up|1
6959|NCT02139644|43248|P4|Treatment Period|Lost to Follow-up|1
6960|NCT02139644|43249|P3|Treatment Period|Lost to Follow-up|1
6961|NCT02139644|43250|P2|Treatment Period|Lost to Follow-up|0
6962|NCT02139644|43251|P1|Treatment Period|Lost to Follow-up|0
6963|NCT02139644|43246|P6|Treatment Period|Disease progression|2
6964|NCT02139644|43247|P5|Treatment Period|Disease progression|1
6965|NCT02139644|43248|P4|Treatment Period|Disease progression|1
6966|NCT02139644|43249|P3|Treatment Period|Disease progression|0
6967|NCT02139644|43250|P2|Treatment Period|Disease progression|0
6968|NCT02139644|43251|P1|Treatment Period|Disease progression|0
6969|NCT02139644|43246|P6|Treatment Period|Protocol Violation|1
6970|NCT02139644|43247|P5|Treatment Period|Protocol Violation|1
6971|NCT02139644|43248|P4|Treatment Period|Protocol Violation|1
6972|NCT02139644|43249|P3|Treatment Period|Protocol Violation|0
6973|NCT02139644|43250|P2|Treatment Period|Protocol Violation|0
6974|NCT02139644|43251|P1|Treatment Period|Protocol Violation|0
6975|NCT02139644|43246|P6|Treatment Period|Non-compliance|0
6976|NCT02139644|43247|P5|Treatment Period|Non-compliance|0
6977|NCT02139644|43248|P4|Treatment Period|Non-compliance|1
6978|NCT02139644|43249|P3|Treatment Period|Non-compliance|0
6979|NCT02139644|43250|P2|Treatment Period|Non-compliance|0
6980|NCT02139644|43251|P1|Treatment Period|Non-compliance|0
6981|NCT02139644|43246|P6|Treatment Period|Withdrawal by Subject|2
6982|NCT02139644|43247|P5|Treatment Period|Withdrawal by Subject|3
6983|NCT02139644|43248|P4|Treatment Period|Withdrawal by Subject|2
6984|NCT02139644|43249|P3|Treatment Period|Withdrawal by Subject|2
6985|NCT02139644|43250|P2|Treatment Period|Withdrawal by Subject|0
6986|NCT02139644|43251|P1|Treatment Period|Withdrawal by Subject|0
6987|NCT02139644|43246|P6|Treatment Period|Adverse Event|6
6988|NCT02139644|43247|P5|Treatment Period|Adverse Event|1
6989|NCT02139644|43248|P4|Treatment Period|Adverse Event|2
6990|NCT02139644|43249|P3|Treatment Period|Adverse Event|3
6991|NCT02139644|43250|P2|Treatment Period|Adverse Event|0
6992|NCT02139644|43251|P1|Treatment Period|Adverse Event|0
6993|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Not specified|0
6994|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Not specified|0
6995|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Not specified|0
6996|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Not specified|0
6997|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Not specified|0
6998|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Not specified|6
6999|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Adverse Event|0
7000|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Adverse Event|0
7001|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Adverse Event|0
7002|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Adverse Event|0
7003|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Adverse Event|0
7004|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Adverse Event|3
7005|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7006|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7007|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7008|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7009|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
7010|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
7011|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7012|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7013|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7014|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7015|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
7095|NCT02138747|43409|P1|Treatment Period 2|Protocol Violation|1
7016|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
7017|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7018|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7019|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7020|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7021|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
7022|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
7023|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7024|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7025|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7026|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7027|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
7028|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
7029|NCT02139644|43246|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7030|NCT02139644|43247|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7031|NCT02139644|43248|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7032|NCT02139644|43249|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7033|NCT02139644|43250|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
7034|NCT02139644|43251|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
7035|NCT02139046|43349|P5|Overall Study|Other Miscellaneous Reasons|12
7036|NCT02139046|43350|P4|Overall Study|Other Miscellaneous Reasons|9
7037|NCT02139046|43351|P3|Overall Study|Other Miscellaneous Reasons|4
7038|NCT02139046|43352|P2|Overall Study|Other Miscellaneous Reasons|9
7039|NCT02139046|43353|P1|Overall Study|Other Miscellaneous Reasons|10
7040|NCT02139046|43349|P5|Overall Study|Withdrawal due to a Gout Flare|1
7041|NCT02139046|43350|P4|Overall Study|Withdrawal due to a Gout Flare|0
7042|NCT02139046|43351|P3|Overall Study|Withdrawal due to a Gout Flare|1
7043|NCT02139046|43352|P2|Overall Study|Withdrawal due to a Gout Flare|1
7044|NCT02139046|43353|P1|Overall Study|Withdrawal due to a Gout Flare|1
7045|NCT02139046|43349|P5|Overall Study|Lack of Efficacy|2
7046|NCT02139046|43350|P4|Overall Study|Lack of Efficacy|1
7047|NCT02139046|43351|P3|Overall Study|Lack of Efficacy|2
7048|NCT02139046|43352|P2|Overall Study|Lack of Efficacy|1
7049|NCT02139046|43353|P1|Overall Study|Lack of Efficacy|0
7050|NCT02139046|43349|P5|Overall Study|Voluntary Withdrawal|16
7051|NCT02139046|43350|P4|Overall Study|Voluntary Withdrawal|15
7052|NCT02139046|43351|P3|Overall Study|Voluntary Withdrawal|10
7053|NCT02139046|43352|P2|Overall Study|Voluntary Withdrawal|8
7054|NCT02139046|43353|P1|Overall Study|Voluntary Withdrawal|20
7055|NCT02139046|43349|P5|Overall Study|Lost to Follow-up|13
7056|NCT02139046|43350|P4|Overall Study|Lost to Follow-up|18
7057|NCT02139046|43351|P3|Overall Study|Lost to Follow-up|16
7058|NCT02139046|43352|P2|Overall Study|Lost to Follow-up|16
7059|NCT02139046|43353|P1|Overall Study|Lost to Follow-up|13
7060|NCT02139046|43349|P5|Overall Study|Major Protocol Deviation|6
7061|NCT02139046|43350|P4|Overall Study|Major Protocol Deviation|12
7062|NCT02139046|43351|P3|Overall Study|Major Protocol Deviation|16
7063|NCT02139046|43352|P2|Overall Study|Major Protocol Deviation|10
7064|NCT02139046|43353|P1|Overall Study|Major Protocol Deviation|9
7065|NCT02139046|43349|P5|Overall Study|Pretreatment Event/Adverse Event|7
7066|NCT02139046|43350|P4|Overall Study|Pretreatment Event/Adverse Event|13
7067|NCT02139046|43351|P3|Overall Study|Pretreatment Event/Adverse Event|10
7068|NCT02139046|43352|P2|Overall Study|Pretreatment Event/Adverse Event|9
7069|NCT02139046|43353|P1|Overall Study|Pretreatment Event/Adverse Event|9
7070|NCT02138825|43393|P2|Main Study Treatment|Medical decision|0
7071|NCT02138825|43394|P1|Main Study Treatment|Medical decision|1
7072|NCT02138825|43393|P2|Main Study Treatment|Withdrawal by Subject|1
7073|NCT02138825|43394|P1|Main Study Treatment|Withdrawal by Subject|3
7074|NCT02138825|43393|P2|Main Study Treatment|Study terminated by sponsor|9
7075|NCT02138825|43394|P1|Main Study Treatment|Study terminated by sponsor|10
7076|NCT02138825|43393|P2|Main Study Treatment|Sponsor decision|18
7077|NCT02138825|43394|P1|Main Study Treatment|Sponsor decision|12
7078|NCT02138825|43393|P2|Main Study Treatment|Protocol Violation|2
7079|NCT02138825|43394|P1|Main Study Treatment|Protocol Violation|2
7080|NCT02138825|43393|P2|Main Study Treatment|Death|2
7081|NCT02138825|43394|P1|Main Study Treatment|Death|1
7082|NCT02138825|43393|P2|Main Study Treatment|Adverse Event|3
7083|NCT02138825|43394|P1|Main Study Treatment|Adverse Event|11
7084|NCT02138747|43406|P4|Treatment Period 2|Other - Miscellaneous|0
7085|NCT02138747|43407|P3|Treatment Period 2|Other - Miscellaneous|0
7086|NCT02138747|43408|P2|Treatment Period 2|Other - Miscellaneous|0
7087|NCT02138747|43409|P1|Treatment Period 2|Other - Miscellaneous|3
7088|NCT02138747|43406|P4|Treatment Period 2|Withdrawal by Subject|2
7089|NCT02138747|43407|P3|Treatment Period 2|Withdrawal by Subject|1
7090|NCT02138747|43408|P2|Treatment Period 2|Withdrawal by Subject|4
7091|NCT02138747|43409|P1|Treatment Period 2|Withdrawal by Subject|5
7092|NCT02138747|43406|P4|Treatment Period 2|Protocol Violation|0
7093|NCT02138747|43407|P3|Treatment Period 2|Protocol Violation|0
7094|NCT02138747|43408|P2|Treatment Period 2|Protocol Violation|0
7096|NCT02138747|43406|P4|Treatment Period 2|Lost to Follow-up|0
7097|NCT02138747|43407|P3|Treatment Period 2|Lost to Follow-up|0
7098|NCT02138747|43408|P2|Treatment Period 2|Lost to Follow-up|0
7099|NCT02138747|43409|P1|Treatment Period 2|Lost to Follow-up|2
7100|NCT02138747|43406|P4|Treatment Period 2|Adverse Event|1
7101|NCT02138747|43407|P3|Treatment Period 2|Adverse Event|1
7102|NCT02138747|43408|P2|Treatment Period 2|Adverse Event|3
7103|NCT02138747|43409|P1|Treatment Period 2|Adverse Event|6
7104|NCT02138747|43406|P4|Treatment Period 1|Other - Miscellaneous|0
7105|NCT02138747|43407|P3|Treatment Period 1|Other - Miscellaneous|0
7106|NCT02138747|43408|P2|Treatment Period 1|Other - Miscellaneous|4
7107|NCT02138747|43409|P1|Treatment Period 1|Other - Miscellaneous|2
7108|NCT02138747|43406|P4|Treatment Period 1|Withdrawal by Subject|3
7109|NCT02138747|43407|P3|Treatment Period 1|Withdrawal by Subject|1
7110|NCT02138747|43408|P2|Treatment Period 1|Withdrawal by Subject|4
7111|NCT02138747|43409|P1|Treatment Period 1|Withdrawal by Subject|8
7112|NCT02138747|43406|P4|Treatment Period 1|Protocol Violation|0
7113|NCT02138747|43407|P3|Treatment Period 1|Protocol Violation|0
7114|NCT02138747|43408|P2|Treatment Period 1|Protocol Violation|2
7115|NCT02138747|43409|P1|Treatment Period 1|Protocol Violation|0
7116|NCT02138747|43406|P4|Treatment Period 1|Lost to Follow-up|0
7117|NCT02138747|43407|P3|Treatment Period 1|Lost to Follow-up|1
7118|NCT02138747|43408|P2|Treatment Period 1|Lost to Follow-up|1
7119|NCT02138747|43409|P1|Treatment Period 1|Lost to Follow-up|0
7120|NCT02138747|43406|P4|Treatment Period 1|Adverse Event|1
7121|NCT02138747|43407|P3|Treatment Period 1|Adverse Event|2
7122|NCT02138747|43408|P2|Treatment Period 1|Adverse Event|14
7123|NCT02138747|43409|P1|Treatment Period 1|Adverse Event|10
7124|NCT02137785|43672|P2|Overall Study|subject moved out of state|0
7125|NCT02137785|43673|P1|Overall Study|subject moved out of state|1
7126|NCT02137785|43672|P2|Overall Study|Withdrawal by Subject|4
7127|NCT02137785|43673|P1|Overall Study|Withdrawal by Subject|1
7128|NCT02137785|43672|P2|Overall Study|Lost to Follow-up|0
7129|NCT02137785|43673|P1|Overall Study|Lost to Follow-up|1
7130|NCT02136134|43858|P2|Overall Study|Subjects randomized but not treated|8
7131|NCT02136134|43859|P1|Overall Study|Subjects randomized but not treated|10
7132|NCT02136134|43858|P2|Overall Study|Ongoing|207
7133|NCT02136134|43859|P1|Overall Study|Ongoing|185
7134|NCT02136134|43858|P2|Overall Study|Unspecified|3
7135|NCT02136134|43859|P1|Overall Study|Unspecified|3
7136|NCT02136134|43858|P2|Overall Study|Withdrawal by Subject|4
7137|NCT02136134|43859|P1|Overall Study|Withdrawal by Subject|14
7138|NCT02136134|43858|P2|Overall Study|Death|29
7139|NCT02136134|43859|P1|Overall Study|Death|35
7140|NCT02135445|43897|P2|Overall Study|Withdrawal by Subject|0
7141|NCT02135445|43898|P1|Overall Study|Withdrawal by Subject|1
7142|NCT02135445|43897|P2|Overall Study|Lost to Follow-up|0
7143|NCT02135445|43898|P1|Overall Study|Lost to Follow-up|1
7144|NCT02134977|43987|P1|Overall Study|Protocol Deviation|102
7145|NCT02134587|44012|P1|Overall Study|Did not completed all meetings|30
7146|NCT02133664|44096|P2|Overall Study|Adverse Event|6
7147|NCT02133664|44097|P1|Overall Study|Adverse Event|3
7148|NCT02133664|44096|P2|Overall Study|Lost to Follow-up|1
7149|NCT02133664|44097|P1|Overall Study|Lost to Follow-up|2
7150|NCT02133352|44113|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
7151|NCT02133131|44144|P7|Overall Study|Protocol Violation|1
7152|NCT02133131|44145|P6|Overall Study|Protocol Violation|0
7153|NCT02133131|44146|P5|Overall Study|Protocol Violation|0
7154|NCT02133131|44147|P4|Overall Study|Protocol Violation|0
7155|NCT02133131|44148|P3|Overall Study|Protocol Violation|0
7156|NCT02133131|44149|P2|Overall Study|Protocol Violation|0
7157|NCT02133131|44150|P1|Overall Study|Protocol Violation|0
7158|NCT02133131|44144|P7|Overall Study|Ongoing in study|11
7159|NCT02133131|44145|P6|Overall Study|Ongoing in study|14
7160|NCT02133131|44146|P5|Overall Study|Ongoing in study|15
7161|NCT02133131|44147|P4|Overall Study|Ongoing in study|0
7162|NCT02133131|44148|P3|Overall Study|Ongoing in study|0
7163|NCT02133131|44149|P2|Overall Study|Ongoing in study|0
7164|NCT02133131|44150|P1|Overall Study|Ongoing in study|0
7165|NCT02133131|44144|P7|Overall Study|Status not recorded|0
7166|NCT02133131|44145|P6|Overall Study|Status not recorded|0
7167|NCT02133131|44146|P5|Overall Study|Status not recorded|0
7168|NCT02133131|44147|P4|Overall Study|Status not recorded|4
7169|NCT02133131|44148|P3|Overall Study|Status not recorded|1
7170|NCT02133131|44149|P2|Overall Study|Status not recorded|5
7171|NCT02133131|44150|P1|Overall Study|Status not recorded|4
7172|NCT02133131|44144|P7|Overall Study|Lost to Follow-up|0
7173|NCT02133131|44145|P6|Overall Study|Lost to Follow-up|0
7174|NCT02133131|44146|P5|Overall Study|Lost to Follow-up|0
7175|NCT02133131|44147|P4|Overall Study|Lost to Follow-up|1
7176|NCT02133131|44148|P3|Overall Study|Lost to Follow-up|0
7177|NCT02133131|44149|P2|Overall Study|Lost to Follow-up|0
7178|NCT02133131|44150|P1|Overall Study|Lost to Follow-up|1
7179|NCT02133131|44144|P7|Overall Study|Adverse Event|0
7180|NCT02133131|44145|P6|Overall Study|Adverse Event|0
7181|NCT02133131|44146|P5|Overall Study|Adverse Event|0
7182|NCT02133131|44147|P4|Overall Study|Adverse Event|1
7183|NCT02133131|44148|P3|Overall Study|Adverse Event|0
7184|NCT02133131|44149|P2|Overall Study|Adverse Event|0
7185|NCT02133131|44150|P1|Overall Study|Adverse Event|0
7186|NCT02132949|44204|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
7187|NCT02132949|44205|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
7188|NCT02132949|44204|P2|Adjuvant Treatment Period|Protocol Deviation|0
7189|NCT02132949|44205|P1|Adjuvant Treatment Period|Protocol Deviation|1
7190|NCT02132949|44204|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
7191|NCT02132949|44205|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
7192|NCT02132949|44204|P2|Adjuvant Treatment Period|Physician Decision|0
7193|NCT02132949|44205|P1|Adjuvant Treatment Period|Physician Decision|1
7194|NCT02132949|44204|P2|Adjuvant Treatment Period|Disease Relapse|1
7195|NCT02132949|44205|P1|Adjuvant Treatment Period|Disease Relapse|0
7196|NCT02132949|44204|P2|Adjuvant Treatment Period|Disease Progression|1
7197|NCT02132949|44205|P1|Adjuvant Treatment Period|Disease Progression|0
7198|NCT02132949|44204|P2|Adjuvant Treatment Period|Reason unspecified|1
7199|NCT02132949|44205|P1|Adjuvant Treatment Period|Reason unspecified|0
7200|NCT02132949|44204|P2|Adjuvant Treatment Period|Adverse Event|6
7201|NCT02132949|44205|P1|Adjuvant Treatment Period|Adverse Event|4
7202|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
7203|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
7204|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Adverse Event|3
7205|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Adverse Event|6
7206|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Disease Progression|1
7207|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Disease Progression|1
7208|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
7209|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
7210|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Physician Decision|0
7211|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Physician Decision|2
7212|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
7213|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
7214|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Reason unspecified|1
7215|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Reason unspecified|3
7216|NCT02132949|44204|P2|Neoadjuvant Treatment Period|Early surgery|3
7217|NCT02132949|44205|P1|Neoadjuvant Treatment Period|Early surgery|4
7218|NCT02132767|44289|P2|Overall Study|Lost to Follow-up|4
7219|NCT02132767|44290|P1|Overall Study|Lost to Follow-up|4
7220|NCT02132767|44289|P2|Overall Study|Withdrawal by Subject|9
7221|NCT02132767|44290|P1|Overall Study|Withdrawal by Subject|10
7222|NCT02132767|44289|P2|Overall Study|Death|2
7223|NCT02132767|44290|P1|Overall Study|Death|3
7224|NCT02132611|44310|P1|Overall Study|Death|2
7225|NCT02132117|44336|P2|Overall Study|Other Miscellaneous Reasons|0
7226|NCT02132117|44337|P1|Overall Study|Other Miscellaneous Reasons|2
7227|NCT02132117|44336|P2|Overall Study|Personal Reasons|2
7228|NCT02132117|44337|P1|Overall Study|Personal Reasons|1
7229|NCT02132117|44336|P2|Overall Study|Lost to Follow-up|2
7230|NCT02132117|44337|P1|Overall Study|Lost to Follow-up|2
7231|NCT02132117|44336|P2|Overall Study|Adverse Event|1
7232|NCT02132117|44337|P1|Overall Study|Adverse Event|6
7233|NCT02131636|44355|P2|Overall Study|Adverse Event|1
7234|NCT02131636|44356|P1|Overall Study|Adverse Event|4
7235|NCT02131636|44355|P2|Overall Study|Lost to Follow-up|0
7236|NCT02131636|44356|P1|Overall Study|Lost to Follow-up|4
7237|NCT02131636|44355|P2|Overall Study|Personal Reasons|4
7238|NCT02131636|44356|P1|Overall Study|Personal Reasons|4
7239|NCT02131532|44372|P1|Overall Study|Other health conditions|2
7240|NCT02131532|44372|P1|Overall Study|Physician Decision|1
7241|NCT02131532|44372|P1|Overall Study|Withdrawal by Subject|1
7242|NCT02131311|44462|P1|Overall Study|Lost to Follow-up|1
7243|NCT02131311|44462|P1|Overall Study|Protocol Violation|1
7244|NCT02131311|44462|P1|Overall Study|Adverse Event|2
7245|NCT02131233|44474|P2|Overall Study|Withdrawal by Subject|8
7246|NCT02131233|44475|P1|Overall Study|Withdrawal by Subject|12
7247|NCT02131233|44474|P2|Overall Study|Pregnancy|0
7248|NCT02131233|44475|P1|Overall Study|Pregnancy|2
7249|NCT02131233|44474|P2|Overall Study|Physician Decision|0
7250|NCT02131233|44475|P1|Overall Study|Physician Decision|4
7251|NCT02131233|44474|P2|Overall Study|Non-Compliance With Study Drug|4
7252|NCT02131233|44475|P1|Overall Study|Non-Compliance With Study Drug|5
7253|NCT02131233|44474|P2|Overall Study|Lost to Follow-up|4
7254|NCT02131233|44475|P1|Overall Study|Lost to Follow-up|8
7255|NCT02131233|44474|P2|Overall Study|Lack of Efficacy|1
7256|NCT02131233|44475|P1|Overall Study|Lack of Efficacy|4
7257|NCT02131233|44474|P2|Overall Study|Death|1
7258|NCT02131233|44475|P1|Overall Study|Death|0
7259|NCT02131233|44474|P2|Overall Study|Adverse Event|6
7260|NCT02131233|44475|P1|Overall Study|Adverse Event|6
7261|NCT02131233|44474|P2|Overall Study|Not Treated|3
7262|NCT02131233|44475|P1|Overall Study|Not Treated|2
7263|NCT02131064|44495|P2|Overall Study|Unspecified|0
7264|NCT02131064|44496|P1|Overall Study|Unspecified|1
7265|NCT02131064|44495|P2|Overall Study|Ongoing|207
7266|NCT02131064|44496|P1|Overall Study|Ongoing|214
7267|NCT02131064|44495|P2|Overall Study|Withdrawal by Subject|14
7268|NCT02131064|44496|P1|Overall Study|Withdrawal by Subject|6
7269|NCT02131064|44495|P2|Overall Study|Lost to Follow-up|1
7270|NCT02131064|44496|P1|Overall Study|Lost to Follow-up|0
7271|NCT02131064|44495|P2|Overall Study|Death|1
7272|NCT02131064|44496|P1|Overall Study|Death|0
7273|NCT02130284|44744|P1|Overall Study|Screen Failure|1
7274|NCT02130284|44744|P1|Overall Study|Subject was screened as backup for study|3
7275|NCT02130284|44744|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
7276|NCT02130284|44744|P1|Overall Study|Subject Withdrew Consent|1
7277|NCT02130284|44744|P1|Overall Study|Withdrawal by Subject|3
7278|NCT02130193|44757|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7279|NCT02130193|44758|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
7280|NCT02130193|44759|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
7281|NCT02130193|44757|P3|Part B: 52-week Double-blind Period|Physician Decision|1
7282|NCT02130193|44758|P2|Part B: 52-week Double-blind Period|Physician Decision|0
7283|NCT02130193|44759|P1|Part B: 52-week Double-blind Period|Physician Decision|0
7284|NCT02130193|44757|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
7285|NCT02130193|44758|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
7286|NCT02130193|44759|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
7287|NCT02130193|44757|P3|Part B: 52-week Double-blind Period|Adverse Event|3
7288|NCT02130193|44758|P2|Part B: 52-week Double-blind Period|Adverse Event|5
7289|NCT02130193|44759|P1|Part B: 52-week Double-blind Period|Adverse Event|0
7290|NCT02129777|44828|P7|Open-Label Period|Study Termination|39
7291|NCT02129777|44829|P6|Open-Label Period|Study Termination|10
7292|NCT02129777|44830|P5|Open-Label Period|Study Termination|0
7293|NCT02129777|44831|P4|Open-Label Period|Study Termination|0
7294|NCT02129777|44832|P3|Open-Label Period|Study Termination|0
7295|NCT02129777|44833|P2|Open-Label Period|Study Termination|0
7296|NCT02129777|44834|P1|Open-Label Period|Study Termination|0
7297|NCT02129777|44828|P7|Open-Label Period|Withdrawal by Subject|3
7298|NCT02129777|44829|P6|Open-Label Period|Withdrawal by Subject|1
7299|NCT02129777|44830|P5|Open-Label Period|Withdrawal by Subject|0
7300|NCT02129777|44831|P4|Open-Label Period|Withdrawal by Subject|0
7301|NCT02129777|44832|P3|Open-Label Period|Withdrawal by Subject|0
7302|NCT02129777|44833|P2|Open-Label Period|Withdrawal by Subject|0
7303|NCT02129777|44834|P1|Open-Label Period|Withdrawal by Subject|0
7304|NCT02129777|44828|P7|Open-Label Period|Lost to Follow-up|1
7305|NCT02129777|44829|P6|Open-Label Period|Lost to Follow-up|1
7306|NCT02129777|44830|P5|Open-Label Period|Lost to Follow-up|0
7307|NCT02129777|44831|P4|Open-Label Period|Lost to Follow-up|0
7308|NCT02129777|44832|P3|Open-Label Period|Lost to Follow-up|0
7309|NCT02129777|44833|P2|Open-Label Period|Lost to Follow-up|0
7310|NCT02129777|44834|P1|Open-Label Period|Lost to Follow-up|0
7311|NCT02129777|44828|P7|Open-Label Period|Lack of Efficacy|5
7312|NCT02129777|44829|P6|Open-Label Period|Lack of Efficacy|0
7313|NCT02129777|44830|P5|Open-Label Period|Lack of Efficacy|0
7314|NCT02129777|44831|P4|Open-Label Period|Lack of Efficacy|0
7315|NCT02129777|44832|P3|Open-Label Period|Lack of Efficacy|0
7316|NCT02129777|44833|P2|Open-Label Period|Lack of Efficacy|0
7317|NCT02129777|44834|P1|Open-Label Period|Lack of Efficacy|0
7318|NCT02129777|44828|P7|Double-Blind Period|Other|0
7319|NCT02129777|44829|P6|Double-Blind Period|Other|0
7320|NCT02129777|44830|P5|Double-Blind Period|Other|0
7321|NCT02129777|44831|P4|Double-Blind Period|Other|0
7322|NCT02129777|44832|P3|Double-Blind Period|Other|0
7323|NCT02129777|44833|P2|Double-Blind Period|Other|2
7324|NCT02129777|44834|P1|Double-Blind Period|Other|1
7325|NCT02129777|44828|P7|Double-Blind Period|Lack of Efficacy|0
7326|NCT02129777|44829|P6|Double-Blind Period|Lack of Efficacy|0
7327|NCT02129777|44830|P5|Double-Blind Period|Lack of Efficacy|2
7328|NCT02129777|44831|P4|Double-Blind Period|Lack of Efficacy|3
7329|NCT02129777|44832|P3|Double-Blind Period|Lack of Efficacy|0
7330|NCT02129777|44833|P2|Double-Blind Period|Lack of Efficacy|1
7331|NCT02129777|44834|P1|Double-Blind Period|Lack of Efficacy|3
7332|NCT02129777|44828|P7|Double-Blind Period|Pregnancy|0
7333|NCT02129777|44829|P6|Double-Blind Period|Pregnancy|0
7334|NCT02129777|44830|P5|Double-Blind Period|Pregnancy|1
7335|NCT02129777|44831|P4|Double-Blind Period|Pregnancy|0
7336|NCT02129777|44832|P3|Double-Blind Period|Pregnancy|0
7337|NCT02129777|44833|P2|Double-Blind Period|Pregnancy|0
7338|NCT02129777|44834|P1|Double-Blind Period|Pregnancy|0
7339|NCT02129777|44828|P7|Double-Blind Period|Withdrawal by Subject|0
7340|NCT02129777|44829|P6|Double-Blind Period|Withdrawal by Subject|0
7341|NCT02129777|44830|P5|Double-Blind Period|Withdrawal by Subject|3
7342|NCT02129777|44831|P4|Double-Blind Period|Withdrawal by Subject|2
7343|NCT02129777|44832|P3|Double-Blind Period|Withdrawal by Subject|3
7344|NCT02129777|44833|P2|Double-Blind Period|Withdrawal by Subject|4
7345|NCT02129777|44834|P1|Double-Blind Period|Withdrawal by Subject|2
7346|NCT02129777|44828|P7|Double-Blind Period|Lost to Follow-up|0
7347|NCT02129777|44829|P6|Double-Blind Period|Lost to Follow-up|0
7348|NCT02129777|44830|P5|Double-Blind Period|Lost to Follow-up|0
7349|NCT02129777|44831|P4|Double-Blind Period|Lost to Follow-up|2
7350|NCT02129777|44832|P3|Double-Blind Period|Lost to Follow-up|1
7351|NCT02129777|44833|P2|Double-Blind Period|Lost to Follow-up|1
7352|NCT02129777|44834|P1|Double-Blind Period|Lost to Follow-up|1
7353|NCT02129777|44828|P7|Double-Blind Period|Adverse Event|0
7354|NCT02129777|44829|P6|Double-Blind Period|Adverse Event|0
7355|NCT02129777|44830|P5|Double-Blind Period|Adverse Event|1
7356|NCT02129777|44831|P4|Double-Blind Period|Adverse Event|0
7357|NCT02129777|44832|P3|Double-Blind Period|Adverse Event|0
7358|NCT02129777|44833|P2|Double-Blind Period|Adverse Event|0
7359|NCT02129777|44834|P1|Double-Blind Period|Adverse Event|0
7360|NCT02129608|44950|P3|Overall Study|Withdrawal by Subject|2
7361|NCT02129608|44951|P2|Overall Study|Withdrawal by Subject|0
7362|NCT02129608|44952|P1|Overall Study|Withdrawal by Subject|0
7363|NCT02129608|44950|P3|Overall Study|Lost to Follow-up|1
7364|NCT02129608|44951|P2|Overall Study|Lost to Follow-up|1
7365|NCT02129608|44952|P1|Overall Study|Lost to Follow-up|0
7366|NCT02129192|44965|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
7367|NCT02129192|44966|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
7368|NCT02129062|44983|P1|Overall Study|Disease Progression|2
7369|NCT02129062|44983|P1|Overall Study|Death|1
7370|NCT02128542|45016|P2|Overall Study|Withdrew Consent|0
7371|NCT02128542|45017|P1|Overall Study|Withdrew Consent|1
7372|NCT02128542|45016|P2|Overall Study|Lost to Follow-up|0
7373|NCT02128542|45017|P1|Overall Study|Lost to Follow-up|3
7374|NCT02128490|45035|P5|Overall Study|Other Miscellaneous Reasons|1
7375|NCT02128490|45036|P4|Overall Study|Other Miscellaneous Reasons|1
7376|NCT02128490|45037|P3|Overall Study|Other Miscellaneous Reasons|2
7377|NCT02128490|45038|P2|Overall Study|Other Miscellaneous Reasons|0
7378|NCT02128490|45039|P1|Overall Study|Other Miscellaneous Reasons|0
7379|NCT02128490|45035|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
7380|NCT02128490|45036|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
7381|NCT02128490|45037|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
7382|NCT02128490|45038|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
7383|NCT02128490|45039|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
7384|NCT02128490|45035|P5|Overall Study|Lack of Efficacy|0
7385|NCT02128490|45036|P4|Overall Study|Lack of Efficacy|0
7386|NCT02128490|45037|P3|Overall Study|Lack of Efficacy|0
7387|NCT02128490|45038|P2|Overall Study|Lack of Efficacy|1
7388|NCT02128490|45039|P1|Overall Study|Lack of Efficacy|0
7389|NCT02128490|45035|P5|Overall Study|Voluntary Withdrawal|2
7390|NCT02128490|45036|P4|Overall Study|Voluntary Withdrawal|1
7391|NCT02128490|45037|P3|Overall Study|Voluntary Withdrawal|1
7392|NCT02128490|45038|P2|Overall Study|Voluntary Withdrawal|3
7393|NCT02128490|45039|P1|Overall Study|Voluntary Withdrawal|3
7394|NCT02128490|45035|P5|Overall Study|Lost to Follow-up|1
7395|NCT02128490|45036|P4|Overall Study|Lost to Follow-up|1
7396|NCT02128490|45037|P3|Overall Study|Lost to Follow-up|1
7397|NCT02128490|45038|P2|Overall Study|Lost to Follow-up|0
7398|NCT02128490|45039|P1|Overall Study|Lost to Follow-up|0
7399|NCT02128490|45035|P5|Overall Study|Major Protocol Deviation|2
7400|NCT02128490|45036|P4|Overall Study|Major Protocol Deviation|2
7401|NCT02128490|45037|P3|Overall Study|Major Protocol Deviation|0
7402|NCT02128490|45038|P2|Overall Study|Major Protocol Deviation|2
7403|NCT02128490|45039|P1|Overall Study|Major Protocol Deviation|1
7404|NCT02128490|45035|P5|Overall Study|Pretreatment Event/Adverse Event|0
7405|NCT02128490|45036|P4|Overall Study|Pretreatment Event/Adverse Event|1
7406|NCT02128490|45037|P3|Overall Study|Pretreatment Event/Adverse Event|1
7407|NCT02128490|45038|P2|Overall Study|Pretreatment Event/Adverse Event|0
7408|NCT02128490|45039|P1|Overall Study|Pretreatment Event/Adverse Event|1
7409|NCT02128269|45061|P1|Treatment Period|Physician Decision|1
7410|NCT02128269|45061|P1|Treatment Period|Adverse Event|1
7411|NCT02127372|45087|P2|Overall Study|Withdrawal by Subject|0
7412|NCT02127372|45088|P1|Overall Study|Withdrawal by Subject|1
7413|NCT02127307|45098|P1|Overall Study|Other than specified above|169
7414|NCT02127307|45098|P1|Overall Study|Death|101
7415|NCT02127307|45098|P1|Overall Study|Lost to Follow-up|2
7416|NCT02127307|45098|P1|Overall Study|Protocol Violation|36
7417|NCT02126839|45104|P2|Overall Study|Not specified|5
7418|NCT02126839|45105|P1|Overall Study|Not specified|5
7419|NCT02126839|45104|P2|Overall Study|Lost to Follow-up|4
7420|NCT02126839|45105|P1|Overall Study|Lost to Follow-up|1
7421|NCT02126839|45104|P2|Overall Study|Sponsor request|1
7422|NCT02126839|45105|P1|Overall Study|Sponsor request|0
7423|NCT02126839|45104|P2|Overall Study|Protocol Violation|3
7424|NCT02126839|45105|P1|Overall Study|Protocol Violation|2
7425|NCT02126839|45104|P2|Overall Study|Withdrawal by parent/guardian|0
7426|NCT02126839|45105|P1|Overall Study|Withdrawal by parent/guardian|1
7427|NCT02126839|45104|P2|Overall Study|Withdrawal by Subject|0
7428|NCT02126839|45105|P1|Overall Study|Withdrawal by Subject|1
7429|NCT02126839|45104|P2|Overall Study|Adverse Event|1
7430|NCT02126839|45105|P1|Overall Study|Adverse Event|0
7431|NCT02126670|45132|P4|Overall Study|Withdrawal by Subject|1
7432|NCT02126670|45133|P3|Overall Study|Withdrawal by Subject|0
7433|NCT02126670|45134|P2|Overall Study|Withdrawal by Subject|0
7434|NCT02126670|45135|P1|Overall Study|Withdrawal by Subject|1
7435|NCT02125877|45187|P2|Overall Study|Adverse Event|4
7436|NCT02125877|45188|P1|Overall Study|Adverse Event|6
7437|NCT02125877|45187|P2|Overall Study|Protocol deviation|1
7438|NCT02125877|45188|P1|Overall Study|Protocol deviation|4
7439|NCT02125877|45187|P2|Overall Study|Withdrawal by Subject|1
7440|NCT02125877|45188|P1|Overall Study|Withdrawal by Subject|2
7441|NCT02125877|45187|P2|Overall Study|Participant/guardian decision|2
7442|NCT02125877|45188|P1|Overall Study|Participant/guardian decision|0
7443|NCT02125877|45187|P2|Overall Study|Administrative problems|1
7444|NCT02125877|45188|P1|Overall Study|Administrative problems|0
7445|NCT02125877|45187|P2|Overall Study|Death|1
7446|NCT02125877|45188|P1|Overall Study|Death|0
7447|NCT02125877|45187|P2|Overall Study|Physician Decision|0
7448|NCT02125877|45188|P1|Overall Study|Physician Decision|1
7449|NCT02125838|45218|P2|Overall Study|Lost to Follow-up|4
7450|NCT02125838|45219|P1|Overall Study|Lost to Follow-up|4
7451|NCT02125734|45237|P2|Period 2|Adverse Event|1
7452|NCT02125734|45238|P1|Period 2|Adverse Event|0
7453|NCT02125604|45248|P1|Overall Study|Adverse Event|20
7454|NCT02125604|45248|P1|Overall Study|Consent Withdrawn|4
7455|NCT02125604|45248|P1|Overall Study|Lost to Follow-up|2
7456|NCT02125604|45248|P1|Overall Study|Investigator Decision|1
7457|NCT02125604|45248|P1|Overall Study|Not Specified|4
7458|NCT02124798|45294|P1|Overall Study|Lost to Follow-up|1
7459|NCT02124798|45294|P1|Overall Study|Adverse Event|3
7460|NCT02124161|45352|P2|Overall Study|Lost to Follow-up|4
7461|NCT02124161|45353|P1|Overall Study|Lost to Follow-up|3
7462|NCT02124161|45352|P2|Overall Study|No longer meets eligibility criteria|4
7463|NCT02124161|45353|P1|Overall Study|No longer meets eligibility criteria|5
7464|NCT02124161|45352|P2|Overall Study|Does not meet entrance criteria|3
7465|NCT02124161|45353|P1|Overall Study|Does not meet entrance criteria|2
7466|NCT02124161|45352|P2|Overall Study|Adverse Event|0
7467|NCT02124161|45353|P1|Overall Study|Adverse Event|2
7468|NCT02124161|45352|P2|Overall Study|Withdrawal by Subject|2
7469|NCT02124161|45353|P1|Overall Study|Withdrawal by Subject|1
7470|NCT02124161|45352|P2|Overall Study|Protocol Violation|1
7471|NCT02124161|45353|P1|Overall Study|Protocol Violation|2
7472|NCT02124161|45352|P2|Overall Study|Death|0
7473|NCT02124161|45353|P1|Overall Study|Death|1
7474|NCT02124161|45352|P2|Overall Study|Other unspecified|1
7475|NCT02124161|45353|P1|Overall Study|Other unspecified|0
7476|NCT02123472|45411|P2|Period 2 (7 Days)|Withdrawal by Subject|1
7477|NCT02123472|45412|P1|Period 2 (7 Days)|Withdrawal by Subject|0
7478|NCT02123459|45422|P2|Washout Period (1 Day)|Adverse Event|0
7479|NCT02123459|45423|P1|Washout Period (1 Day)|Adverse Event|1
7480|NCT02123446|45433|P2|Washout Period (1 Day)|Physician Decision|0
7481|NCT02123446|45434|P1|Washout Period (1 Day)|Physician Decision|1
7482|NCT02121847|45505|P1|Overall Study|Adverse Event|2
7483|NCT02121847|45505|P1|Overall Study|Administrative Reasons|1
7484|NCT02121795|45526|P2|Overall Study|Still in Study up to the Data Cut Date|316
7485|NCT02121795|45527|P1|Overall Study|Still in Study up to the Data Cut Date|315
7486|NCT02121795|45526|P2|Overall Study|Lost to Follow-up|1
7487|NCT02121795|45527|P1|Overall Study|Lost to Follow-up|2
7488|NCT02121795|45526|P2|Overall Study|Withdrew Consent|10
7489|NCT02121795|45527|P1|Overall Study|Withdrew Consent|10
7490|NCT02121795|45526|P2|Overall Study|Protocol Violation|2
7491|NCT02121795|45527|P1|Overall Study|Protocol Violation|0
7492|NCT02121795|45526|P2|Overall Study|Non-Compliance with Study Drug|1
7493|NCT02121795|45527|P1|Overall Study|Non-Compliance with Study Drug|1
7494|NCT02121795|45526|P2|Overall Study|Investigator's Discretion|0
7495|NCT02121795|45527|P1|Overall Study|Investigator's Discretion|1
7496|NCT02121795|45526|P2|Overall Study|Adverse Event|0
7497|NCT02121795|45527|P1|Overall Study|Adverse Event|4
7498|NCT02121795|45526|P2|Overall Study|Randomized but Never Treated|4
7499|NCT02121795|45527|P1|Overall Study|Randomized but Never Treated|1
7500|NCT02121535|45543|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
7501|NCT02121535|45544|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
7502|NCT02121535|45543|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
7503|NCT02121535|45544|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
7504|NCT02121522|45567|P1|Overall Study|Adverse Event|1
7505|NCT02121509|45574|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
7506|NCT02121509|45575|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
7507|NCT02121509|45576|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
7508|NCT02121509|45577|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
7509|NCT02121509|45574|P4|Washout Period (35 Days)|Withdrawal by Subject|0
7510|NCT02121509|45575|P3|Washout Period (35 Days)|Withdrawal by Subject|0
7511|NCT02121509|45576|P2|Washout Period (35 Days)|Withdrawal by Subject|3
7512|NCT02121509|45577|P1|Washout Period (35 Days)|Withdrawal by Subject|0
7513|NCT02121509|45574|P4|Washout Period (35 Days)|Adverse Event|0
7514|NCT02121509|45575|P3|Washout Period (35 Days)|Adverse Event|0
7515|NCT02121509|45576|P2|Washout Period (35 Days)|Adverse Event|1
7516|NCT02121509|45577|P1|Washout Period (35 Days)|Adverse Event|1
7517|NCT02121210|45643|P2|Overall Study|Other than specified above|2
7518|NCT02121210|45644|P1|Overall Study|Other than specified above|0
7519|NCT02121210|45643|P2|Overall Study|Lack of Efficacy|0
7520|NCT02121210|45644|P1|Overall Study|Lack of Efficacy|2
7521|NCT02121210|45643|P2|Overall Study|Adverse Event|7
7522|NCT02121210|45644|P1|Overall Study|Adverse Event|5
7523|NCT02120833|45669|P2|Overall Study|Lost to Follow-up|1
7524|NCT02120833|45670|P1|Overall Study|Lost to Follow-up|1
7525|NCT02120833|45669|P2|Overall Study|Withdrawal by Subject|0
7526|NCT02120833|45670|P1|Overall Study|Withdrawal by Subject|2
7527|NCT02120833|45669|P2|Overall Study|Adverse Event|0
7528|NCT02120833|45670|P1|Overall Study|Adverse Event|1
7529|NCT02120664|45829|P5|Overall Study|Withdrawal by Subject|0
7530|NCT02120664|45830|P4|Overall Study|Withdrawal by Subject|1
7531|NCT02120664|45831|P3|Overall Study|Withdrawal by Subject|0
7532|NCT02120664|45832|P2|Overall Study|Withdrawal by Subject|0
7533|NCT02120664|45833|P1|Overall Study|Withdrawal by Subject|0
7534|NCT02120625|45851|P1|Overall Study|Physician Decision|2
7535|NCT02120417|45866|P2|Overall Study|Other unspecified|4
7536|NCT02120417|45867|P1|Overall Study|Other unspecified|5
7537|NCT02120417|45866|P2|Overall Study|Physician Decision|3
7538|NCT02120417|45867|P1|Overall Study|Physician Decision|2
7539|NCT02120417|45866|P2|Overall Study|Noncompliance with study treatment|2
7540|NCT02120417|45867|P1|Overall Study|Noncompliance with study treatment|0
7541|NCT02120417|45866|P2|Overall Study|Disease progression|45
7542|NCT02120417|45867|P1|Overall Study|Disease progression|41
7543|NCT02120417|45866|P2|Overall Study|Participant decision|4
7544|NCT02120417|45867|P1|Overall Study|Participant decision|4
7545|NCT02120417|45866|P2|Overall Study|Adverse Event|9
7546|NCT02120417|45867|P1|Overall Study|Adverse Event|3
7547|NCT02120417|45866|P2|Overall Study|Death|1
7548|NCT02120417|45867|P1|Overall Study|Death|5
7549|NCT02120300|45889|P4|Overall Study|Lost to Follow-up|0
7550|NCT02120300|45890|P3|Overall Study|Lost to Follow-up|0
7551|NCT02120300|45891|P2|Overall Study|Lost to Follow-up|0
7552|NCT02120300|45892|P1|Overall Study|Lost to Follow-up|1
7553|NCT02120300|45889|P4|Overall Study|Lack of Efficacy|1
7554|NCT02120300|45890|P3|Overall Study|Lack of Efficacy|0
7555|NCT02120300|45891|P2|Overall Study|Lack of Efficacy|0
7556|NCT02120300|45892|P1|Overall Study|Lack of Efficacy|0
7557|NCT02120300|45889|P4|Overall Study|Enrolled but Never Treated|0
7558|NCT02120300|45890|P3|Overall Study|Enrolled but Never Treated|0
7559|NCT02120300|45891|P2|Overall Study|Enrolled but Never Treated|0
7560|NCT02120300|45892|P1|Overall Study|Enrolled but Never Treated|2
7561|NCT02120027|45930|P2|Overall Study|Withdrawal by Subject|25
7562|NCT02120027|45931|P1|Overall Study|Withdrawal by Subject|33
7563|NCT02120027|45930|P2|Overall Study|Study terminated by Sponsor|47
7564|NCT02120027|45931|P1|Overall Study|Study terminated by Sponsor|45
7565|NCT02120027|45930|P2|Overall Study|Protocol Violation|21
7566|NCT02120027|45931|P1|Overall Study|Protocol Violation|18
7567|NCT02120027|45930|P2|Overall Study|Physician Decision|3
7568|NCT02120027|45931|P1|Overall Study|Physician Decision|4
7569|NCT02120027|45930|P2|Overall Study|Other|0
7570|NCT02120027|45931|P1|Overall Study|Other|4
7571|NCT02120027|45930|P2|Overall Study|Lost to Follow-up|13
7572|NCT02120027|45931|P1|Overall Study|Lost to Follow-up|5
7573|NCT02120027|45930|P2|Overall Study|Lack of Efficacy|5
7574|NCT02120027|45931|P1|Overall Study|Lack of Efficacy|3
7575|NCT02120027|45930|P2|Overall Study|Adverse Event|5
7576|NCT02120027|45931|P1|Overall Study|Adverse Event|4
7577|NCT02119676|45960|P4|Overall Study|Did not receive study med|5
7578|NCT02119676|45961|P3|Overall Study|Did not receive study med|4
7579|NCT02119676|45962|P2|Overall Study|Did not receive study med|2
7580|NCT02119676|45963|P1|Overall Study|Did not receive study med|2
7581|NCT02119676|45960|P4|Overall Study|Other, unspecified|4
7582|NCT02119676|45961|P3|Overall Study|Other, unspecified|3
7583|NCT02119676|45962|P2|Overall Study|Other, unspecified|1
7584|NCT02119676|45963|P1|Overall Study|Other, unspecified|2
7585|NCT02119676|45960|P4|Overall Study|Protocol deviation|0
7586|NCT02119676|45961|P3|Overall Study|Protocol deviation|1
7587|NCT02119676|45962|P2|Overall Study|Protocol deviation|0
7588|NCT02119676|45963|P1|Overall Study|Protocol deviation|0
7589|NCT02119676|45960|P4|Overall Study|Lost to Follow-up|0
7590|NCT02119676|45961|P3|Overall Study|Lost to Follow-up|1
7591|NCT02119676|45962|P2|Overall Study|Lost to Follow-up|0
7592|NCT02119676|45963|P1|Overall Study|Lost to Follow-up|0
7593|NCT02119676|45960|P4|Overall Study|Noncompliance|0
7594|NCT02119676|45961|P3|Overall Study|Noncompliance|0
7595|NCT02119676|45962|P2|Overall Study|Noncompliance|1
7596|NCT02119676|45963|P1|Overall Study|Noncompliance|0
7597|NCT02119676|45960|P4|Overall Study|Death|1
7598|NCT02119676|45961|P3|Overall Study|Death|2
7599|NCT02119676|45962|P2|Overall Study|Death|3
7600|NCT02119676|45963|P1|Overall Study|Death|9
7601|NCT02119676|45960|P4|Overall Study|Physician Decision|2
7602|NCT02119676|45961|P3|Overall Study|Physician Decision|3
7603|NCT02119676|45962|P2|Overall Study|Physician Decision|2
7604|NCT02119676|45963|P1|Overall Study|Physician Decision|4
7605|NCT02119676|45960|P4|Overall Study|Patient decision, inc. consent withdrawn|6
7606|NCT02119676|45961|P3|Overall Study|Patient decision, inc. consent withdrawn|5
7607|NCT02119676|45962|P2|Overall Study|Patient decision, inc. consent withdrawn|5
7608|NCT02119676|45963|P1|Overall Study|Patient decision, inc. consent withdrawn|4
7609|NCT02119676|45960|P4|Overall Study|Disease progression|73
7610|NCT02119676|45961|P3|Overall Study|Disease progression|68
7611|NCT02119676|45962|P2|Overall Study|Disease progression|55
7612|NCT02119676|45963|P1|Overall Study|Disease progression|53
7613|NCT02119676|45960|P4|Overall Study|Adverse Event|10
7614|NCT02119676|45961|P3|Overall Study|Adverse Event|10
7615|NCT02119676|45962|P2|Overall Study|Adverse Event|17
7616|NCT02119676|45963|P1|Overall Study|Adverse Event|9
7617|NCT02119663|45995|P2|Overall Study|Study Terminated by the Sponsor|4
7618|NCT02119663|45996|P1|Overall Study|Study Terminated by the Sponsor|3
7619|NCT02119663|45995|P2|Overall Study|Subject decision|1
7620|NCT02119663|45996|P1|Overall Study|Subject decision|0
7621|NCT02119663|45995|P2|Overall Study|Other unspecified|0
7622|NCT02119663|45996|P1|Overall Study|Other unspecified|2
7623|NCT02119663|45995|P2|Overall Study|Physician Decision|2
7624|NCT02119663|45996|P1|Overall Study|Physician Decision|1
7625|NCT02119663|45995|P2|Overall Study|Death|2
7626|NCT02119663|45996|P1|Overall Study|Death|3
7627|NCT02119663|45995|P2|Overall Study|Adverse Event|5
7628|NCT02119663|45996|P1|Overall Study|Adverse Event|5
7629|NCT02119663|45995|P2|Overall Study|Disease progression|27
7630|NCT02119663|45996|P1|Overall Study|Disease progression|26
7631|NCT02119650|46014|P2|Overall Study|Multiple reasons for termination|1
7632|NCT02119650|46015|P1|Overall Study|Multiple reasons for termination|2
7633|NCT02119650|46014|P2|Overall Study|Physician Decision|2
7634|NCT02119650|46015|P1|Overall Study|Physician Decision|0
7635|NCT02119650|46014|P2|Overall Study|Study terminated by the sponsor|0
7636|NCT02119650|46015|P1|Overall Study|Study terminated by the sponsor|1
7637|NCT02119650|46014|P2|Overall Study|Noncompliance with study treatment|1
7638|NCT02119650|46015|P1|Overall Study|Noncompliance with study treatment|1
7639|NCT02119650|46014|P2|Overall Study|Death|1
7640|NCT02119650|46015|P1|Overall Study|Death|5
7641|NCT02119650|46014|P2|Overall Study|Disease progression|14
7642|NCT02119650|46015|P1|Overall Study|Disease progression|11
7643|NCT02119650|46014|P2|Overall Study|Subject decision|3
7644|NCT02119650|46015|P1|Overall Study|Subject decision|2
7645|NCT02119650|46014|P2|Overall Study|Adverse Event|4
7646|NCT02119650|46015|P1|Overall Study|Adverse Event|3
7647|NCT02119325|46029|P2|Washout Period 1|Adverse Event|1
7648|NCT02119325|46030|P1|Washout Period 1|Adverse Event|0
7649|NCT02119299|46074|P1|Overall Study|Pregnancy|1
7650|NCT02119299|46074|P1|Overall Study|Lack of Efficacy|1
7651|NCT02119299|46074|P1|Overall Study|Withdrawal by Subject|7
7652|NCT02119286|46088|P3|Overall Study|Withdrawal by Subject|0
7653|NCT02119286|46089|P2|Overall Study|Withdrawal by Subject|1
7654|NCT02119286|46090|P1|Overall Study|Withdrawal by Subject|4
7655|NCT02119286|46088|P3|Overall Study|Lost to Follow-up|1
7656|NCT02119286|46089|P2|Overall Study|Lost to Follow-up|0
7657|NCT02119286|46090|P1|Overall Study|Lost to Follow-up|2
7658|NCT02119286|46088|P3|Overall Study|Lack of Efficacy|4
7659|NCT02119286|46089|P2|Overall Study|Lack of Efficacy|3
7660|NCT02119286|46090|P1|Overall Study|Lack of Efficacy|11
7661|NCT02119286|46088|P3|Overall Study|Adverse Event|2
7662|NCT02119286|46089|P2|Overall Study|Adverse Event|7
7663|NCT02119286|46090|P1|Overall Study|Adverse Event|9
7664|NCT02119104|46101|P1|Overall Study|Protocol Violation|16
7665|NCT02118961|46107|P2|Overall Study|Withdrawal by Subject|0
7666|NCT02118961|46108|P1|Overall Study|Withdrawal by Subject|1
7667|NCT02118896|46136|P10|Overall Study|Miscellaneous|0
7668|NCT02118896|46137|P9|Overall Study|Miscellaneous|0
7669|NCT02118896|46138|P8|Overall Study|Miscellaneous|0
7670|NCT02118896|46139|P7|Overall Study|Miscellaneous|0
7671|NCT02118896|46140|P6|Overall Study|Miscellaneous|4
7672|NCT02118896|46141|P5|Overall Study|Miscellaneous|0
7673|NCT02118896|46142|P4|Overall Study|Miscellaneous|2
7674|NCT02118896|46143|P3|Overall Study|Miscellaneous|0
7675|NCT02118896|46144|P2|Overall Study|Miscellaneous|2
7676|NCT02118896|46145|P1|Overall Study|Miscellaneous|1
7677|NCT02118896|46136|P10|Overall Study|Prohibited medication|0
7678|NCT02118896|46137|P9|Overall Study|Prohibited medication|0
7679|NCT02118896|46138|P8|Overall Study|Prohibited medication|0
7680|NCT02118896|46139|P7|Overall Study|Prohibited medication|0
7681|NCT02118896|46140|P6|Overall Study|Prohibited medication|3
7682|NCT02118896|46141|P5|Overall Study|Prohibited medication|1
7683|NCT02118896|46142|P4|Overall Study|Prohibited medication|0
7684|NCT02118896|46143|P3|Overall Study|Prohibited medication|0
7685|NCT02118896|46144|P2|Overall Study|Prohibited medication|0
7686|NCT02118896|46145|P1|Overall Study|Prohibited medication|0
7687|NCT02118896|46136|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
7688|NCT02118896|46137|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
7689|NCT02118896|46138|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
7690|NCT02118896|46139|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
7691|NCT02118896|46140|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
7692|NCT02118896|46141|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
7693|NCT02118896|46142|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
7694|NCT02118896|46143|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
7695|NCT02118896|46144|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
7696|NCT02118896|46145|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
7697|NCT02118896|46136|P10|Overall Study|Lost to Follow-up|0
7698|NCT02118896|46137|P9|Overall Study|Lost to Follow-up|0
7699|NCT02118896|46138|P8|Overall Study|Lost to Follow-up|0
7700|NCT02118896|46139|P7|Overall Study|Lost to Follow-up|0
7701|NCT02118896|46140|P6|Overall Study|Lost to Follow-up|1
7702|NCT02118896|46141|P5|Overall Study|Lost to Follow-up|2
7703|NCT02118896|46142|P4|Overall Study|Lost to Follow-up|0
7704|NCT02118896|46143|P3|Overall Study|Lost to Follow-up|1
7705|NCT02118896|46144|P2|Overall Study|Lost to Follow-up|2
7706|NCT02118896|46145|P1|Overall Study|Lost to Follow-up|1
7707|NCT02118896|46136|P10|Overall Study|Pregnancy|0
7708|NCT02118896|46137|P9|Overall Study|Pregnancy|0
7709|NCT02118896|46138|P8|Overall Study|Pregnancy|0
7710|NCT02118896|46139|P7|Overall Study|Pregnancy|1
7711|NCT02118896|46140|P6|Overall Study|Pregnancy|3
7712|NCT02118896|46141|P5|Overall Study|Pregnancy|1
7713|NCT02118896|46142|P4|Overall Study|Pregnancy|0
7714|NCT02118896|46143|P3|Overall Study|Pregnancy|0
7715|NCT02118896|46144|P2|Overall Study|Pregnancy|1
7716|NCT02118896|46145|P1|Overall Study|Pregnancy|1
7717|NCT02118896|46136|P10|Overall Study|Non-compliance|0
7718|NCT02118896|46137|P9|Overall Study|Non-compliance|0
7719|NCT02118896|46138|P8|Overall Study|Non-compliance|1
7720|NCT02118896|46139|P7|Overall Study|Non-compliance|0
7721|NCT02118896|46140|P6|Overall Study|Non-compliance|1
7722|NCT02118896|46141|P5|Overall Study|Non-compliance|0
7723|NCT02118896|46142|P4|Overall Study|Non-compliance|5
7724|NCT02118896|46143|P3|Overall Study|Non-compliance|1
7725|NCT02118896|46144|P2|Overall Study|Non-compliance|1
7726|NCT02118896|46145|P1|Overall Study|Non-compliance|2
7727|NCT02118896|46136|P10|Overall Study|Consent withdrawn|0
7728|NCT02118896|46137|P9|Overall Study|Consent withdrawn|0
7729|NCT02118896|46138|P8|Overall Study|Consent withdrawn|0
7730|NCT02118896|46139|P7|Overall Study|Consent withdrawn|0
7731|NCT02118896|46140|P6|Overall Study|Consent withdrawn|4
7732|NCT02118896|46141|P5|Overall Study|Consent withdrawn|1
7733|NCT02118896|46142|P4|Overall Study|Consent withdrawn|4
7734|NCT02118896|46143|P3|Overall Study|Consent withdrawn|3
7735|NCT02118896|46144|P2|Overall Study|Consent withdrawn|0
7736|NCT02118896|46145|P1|Overall Study|Consent withdrawn|2
7737|NCT02118896|46136|P10|Overall Study|Adverse Event|0
7738|NCT02118896|46137|P9|Overall Study|Adverse Event|4
7739|NCT02118896|46138|P8|Overall Study|Adverse Event|1
7740|NCT02118896|46139|P7|Overall Study|Adverse Event|1
7741|NCT02118896|46140|P6|Overall Study|Adverse Event|9
7742|NCT02118896|46141|P5|Overall Study|Adverse Event|5
7743|NCT02118896|46142|P4|Overall Study|Adverse Event|5
7744|NCT02118896|46143|P3|Overall Study|Adverse Event|4
7745|NCT02118896|46144|P2|Overall Study|Adverse Event|4
7746|NCT02118896|46145|P1|Overall Study|Adverse Event|5
7747|NCT02118896|46136|P10|Overall Study|Death|0
7748|NCT02118896|46137|P9|Overall Study|Death|0
7749|NCT02118896|46138|P8|Overall Study|Death|0
7750|NCT02118896|46139|P7|Overall Study|Death|0
7751|NCT02118896|46140|P6|Overall Study|Death|1
7752|NCT02118896|46141|P5|Overall Study|Death|3
7753|NCT02118896|46142|P4|Overall Study|Death|6
7754|NCT02118896|46143|P3|Overall Study|Death|4
7755|NCT02118896|46144|P2|Overall Study|Death|0
7756|NCT02118896|46145|P1|Overall Study|Death|4
7757|NCT02118792|46235|P2|Overall Study|Randomised but not treated|0
7758|NCT02118792|46236|P1|Overall Study|Randomised but not treated|1
7759|NCT02118792|46235|P2|Overall Study|Unspecified|6
7760|NCT02118792|46236|P1|Overall Study|Unspecified|1
7761|NCT02118792|46235|P2|Overall Study|Withdrawal by parent/guardian|20
7762|NCT02118792|46236|P1|Overall Study|Withdrawal by parent/guardian|14
7763|NCT02118792|46235|P2|Overall Study|Adverse Event|4
7764|NCT02118792|46236|P1|Overall Study|Adverse Event|5
7765|NCT02118792|46235|P2|Overall Study|Lost to Follow-up|4
7766|NCT02118792|46236|P1|Overall Study|Lost to Follow-up|4
7767|NCT02118792|46235|P2|Overall Study|Withdrawal by Subject|3
7768|NCT02118792|46236|P1|Overall Study|Withdrawal by Subject|6
7769|NCT02118766|46278|P2|Overall Study|Unspecified|1
7770|NCT02118766|46279|P1|Overall Study|Unspecified|3
7771|NCT02118766|46278|P2|Overall Study|Withdrawal by parent/guardian|18
7772|NCT02118766|46279|P1|Overall Study|Withdrawal by parent/guardian|12
7773|NCT02118766|46278|P2|Overall Study|Lost to Follow-up|4
7774|NCT02118766|46279|P1|Overall Study|Lost to Follow-up|5
7775|NCT02118766|46278|P2|Overall Study|Withdrawal by Subject|6
7776|NCT02118766|46279|P1|Overall Study|Withdrawal by Subject|3
7777|NCT02118766|46278|P2|Overall Study|Adverse Event|2
7778|NCT02118766|46279|P1|Overall Study|Adverse Event|7
7779|NCT02118597|46301|P1|Overall Study|Investigator's decision|1
7780|NCT02118597|46301|P1|Overall Study|Serious Adverse Event|1
7781|NCT02118597|46301|P1|Overall Study|Sponsor terminated the study|14
7782|NCT02117687|46332|P2|Overall Study|Other Reasons|1
7783|NCT02117687|46333|P1|Overall Study|Other Reasons|1
7784|NCT02117687|46332|P2|Overall Study|Adverse Event|2
7785|NCT02117687|46333|P1|Overall Study|Adverse Event|0
7786|NCT02117687|46332|P2|Overall Study|Lost to Follow-up|1
7787|NCT02117687|46333|P1|Overall Study|Lost to Follow-up|0
7788|NCT02117570|46368|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7789|NCT02117570|46369|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
7790|NCT02117570|46370|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
7791|NCT02117570|46368|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7880|NCT02114931|46710|P2|Overall Study|Adverse Event|6
7792|NCT02117570|46369|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
7793|NCT02117570|46370|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
7794|NCT02117570|46368|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
7795|NCT02117570|46369|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7796|NCT02117570|46370|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
7797|NCT02117570|46368|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
7798|NCT02117570|46369|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
7799|NCT02117570|46370|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
7800|NCT02117570|46368|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
7801|NCT02117570|46369|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7802|NCT02117570|46370|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
7803|NCT02117570|46368|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
7804|NCT02117570|46369|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7805|NCT02117570|46370|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
7806|NCT02117570|46368|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
7807|NCT02117570|46369|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
7808|NCT02117570|46370|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
7809|NCT02117544|46420|P2|Period 1|Lost to follow-up (prior to treatment)|0
7810|NCT02117544|46421|P1|Period 1|Lost to follow-up (prior to treatment)|2
7811|NCT02117479|46436|P2|Overall Study|Other unspecified|7
7812|NCT02117479|46437|P1|Overall Study|Other unspecified|11
7813|NCT02117479|46436|P2|Overall Study|Physician Decision|2
7814|NCT02117479|46437|P1|Overall Study|Physician Decision|7
7815|NCT02117479|46436|P2|Overall Study|Study terminated by the sponsor|6
7816|NCT02117479|46437|P1|Overall Study|Study terminated by the sponsor|4
7817|NCT02117479|46436|P2|Overall Study|Noncompliance with study treatment|0
7818|NCT02117479|46437|P1|Overall Study|Noncompliance with study treatment|1
7819|NCT02117479|46436|P2|Overall Study|Disease progression|108
7820|NCT02117479|46437|P1|Overall Study|Disease progression|104
7821|NCT02117479|46436|P2|Overall Study|Subject decision|9
7822|NCT02117479|46437|P1|Overall Study|Subject decision|8
7823|NCT02117479|46436|P2|Overall Study|Adverse Event|16
7824|NCT02117479|46437|P1|Overall Study|Adverse Event|8
7825|NCT02117479|46436|P2|Overall Study|Death|8
7826|NCT02117479|46437|P1|Overall Study|Death|13
7827|NCT02117414|46455|P2|Overall Study|Withdrawal by Subject|4
7828|NCT02117414|46456|P1|Overall Study|Withdrawal by Subject|10
7829|NCT02117414|46455|P2|Overall Study|Death|2
7830|NCT02117414|46456|P1|Overall Study|Death|5
7831|NCT02117050|46500|P1|Overall Study|Subject Enrolled but not Dosed|1
7839|NCT02116530|46522|P2|Overall Study|Other Medical Problems|2
7840|NCT02116530|46523|P1|Overall Study|Other Medical Problems|2
7841|NCT02116530|46522|P2|Overall Study|Lost to Follow-up|0
7842|NCT02116530|46523|P1|Overall Study|Lost to Follow-up|1
7843|NCT02116530|46522|P2|Overall Study|Physician Decision|0
7844|NCT02116530|46523|P1|Overall Study|Physician Decision|1
7845|NCT02116530|46522|P2|Overall Study|Adverse Event|0
7846|NCT02116530|46523|P1|Overall Study|Adverse Event|4
7847|NCT02116530|46522|P2|Overall Study|Withdrawal by Subject|2
7848|NCT02116530|46523|P1|Overall Study|Withdrawal by Subject|1
7849|NCT02115815|46558|P7|Overall Study|Missed appointment, randomized in error|0
7850|NCT02115815|46559|P6|Overall Study|Missed appointment, randomized in error|1
7851|NCT02115815|46560|P5|Overall Study|Missed appointment, randomized in error|0
7852|NCT02115815|46561|P4|Overall Study|Missed appointment, randomized in error|0
7853|NCT02115815|46562|P3|Overall Study|Missed appointment, randomized in error|0
7854|NCT02115815|46563|P2|Overall Study|Missed appointment, randomized in error|0
7855|NCT02115815|46564|P1|Overall Study|Missed appointment, randomized in error|0
7856|NCT02115815|46558|P7|Overall Study|Not enough drug to dose participant|0
7857|NCT02115815|46559|P6|Overall Study|Not enough drug to dose participant|1
7858|NCT02115815|46560|P5|Overall Study|Not enough drug to dose participant|0
7859|NCT02115815|46561|P4|Overall Study|Not enough drug to dose participant|0
7860|NCT02115815|46562|P3|Overall Study|Not enough drug to dose participant|0
7861|NCT02115815|46563|P2|Overall Study|Not enough drug to dose participant|0
7862|NCT02115815|46564|P1|Overall Study|Not enough drug to dose participant|0
7863|NCT02115815|46558|P7|Overall Study|Withdrawal by Subject|0
7864|NCT02115815|46559|P6|Overall Study|Withdrawal by Subject|0
7865|NCT02115815|46560|P5|Overall Study|Withdrawal by Subject|0
7866|NCT02115815|46561|P4|Overall Study|Withdrawal by Subject|0
7867|NCT02115815|46562|P3|Overall Study|Withdrawal by Subject|0
7868|NCT02115815|46563|P2|Overall Study|Withdrawal by Subject|0
7869|NCT02115815|46564|P1|Overall Study|Withdrawal by Subject|2
7870|NCT02115321|46672|P2|Overall Study|Death|0
7871|NCT02115321|46673|P1|Overall Study|Death|1
7872|NCT02115256|46695|P2|Overall Study|Withdrawal by Subject|1
7873|NCT02115256|46696|P1|Overall Study|Withdrawal by Subject|0
7874|NCT02114931|46710|P2|Overall Study|Other|1
7875|NCT02114931|46711|P1|Overall Study|Other|2
7876|NCT02114931|46710|P2|Overall Study|Physician Decision|2
7877|NCT02114931|46711|P1|Overall Study|Physician Decision|1
7878|NCT02114931|46710|P2|Overall Study|Lost to Follow-up|3
7879|NCT02114931|46711|P1|Overall Study|Lost to Follow-up|3
7881|NCT02114931|46711|P1|Overall Study|Adverse Event|4
7882|NCT02114931|46710|P2|Overall Study|Withdrawal by Subject|18
7883|NCT02114931|46711|P1|Overall Study|Withdrawal by Subject|15
7884|NCT02114892|46727|P2|Overall Study|Lost to Follow-up|2
7885|NCT02114892|46728|P1|Overall Study|Lost to Follow-up|1
7886|NCT02114268|46768|P6|Overall Study|Withdrawn by site due to noncompliance|0
7887|NCT02114268|46769|P5|Overall Study|Withdrawn by site due to noncompliance|0
7888|NCT02114268|46770|P4|Overall Study|Withdrawn by site due to noncompliance|0
7889|NCT02114268|46771|P3|Overall Study|Withdrawn by site due to noncompliance|0
7890|NCT02114268|46772|P2|Overall Study|Withdrawn by site due to noncompliance|0
7891|NCT02114268|46773|P1|Overall Study|Withdrawn by site due to noncompliance|1
7892|NCT02114268|46768|P6|Overall Study|Withdrawal by Subject|1
7893|NCT02114268|46769|P5|Overall Study|Withdrawal by Subject|0
7894|NCT02114268|46770|P4|Overall Study|Withdrawal by Subject|0
7895|NCT02114268|46771|P3|Overall Study|Withdrawal by Subject|0
7896|NCT02114268|46772|P2|Overall Study|Withdrawal by Subject|0
7897|NCT02114268|46773|P1|Overall Study|Withdrawal by Subject|1
7898|NCT02114268|46768|P6|Overall Study|Lost to Follow-up|2
7899|NCT02114268|46769|P5|Overall Study|Lost to Follow-up|0
7900|NCT02114268|46770|P4|Overall Study|Lost to Follow-up|0
7901|NCT02114268|46771|P3|Overall Study|Lost to Follow-up|1
7902|NCT02114268|46772|P2|Overall Study|Lost to Follow-up|1
7903|NCT02114268|46773|P1|Overall Study|Lost to Follow-up|4
7904|NCT02114177|46841|P2|Overall Study|Unspecified|1
7905|NCT02114177|46842|P1|Overall Study|Unspecified|2
7906|NCT02114177|46841|P2|Overall Study|Withdrawal by Subject|1
7907|NCT02114177|46842|P1|Overall Study|Withdrawal by Subject|6
7908|NCT02114177|46841|P2|Overall Study|Lost to Follow-up|2
7909|NCT02114177|46842|P1|Overall Study|Lost to Follow-up|1
7910|NCT02114151|46866|P1|Overall Study|Withdrawal by Subject|5
7911|NCT02114151|46866|P1|Overall Study|Lost to Follow-up|1
7912|NCT02114151|46866|P1|Overall Study|Death|1
7913|NCT02113579|46883|P2|Overall Study|Lost to Follow-up|2
7914|NCT02113579|46884|P1|Overall Study|Lost to Follow-up|6
7915|NCT02113579|46883|P2|Overall Study|Withdrawal by Subject|2
7916|NCT02113579|46884|P1|Overall Study|Withdrawal by Subject|3
7917|NCT02113579|46883|P2|Overall Study|Adverse Event|0
7918|NCT02113579|46884|P1|Overall Study|Adverse Event|1
7919|NCT02113449|46908|P1|Overall Study|Adverse Event|4
7920|NCT02113436|46924|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
7921|NCT02113436|46925|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
7922|NCT02113436|46926|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
7923|NCT02113436|46927|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
7924|NCT02113436|46924|P4|Period 2: 16 Weeks|Physician Decision|0
7925|NCT02113436|46925|P3|Period 2: 16 Weeks|Physician Decision|2
7926|NCT02113436|46926|P2|Period 2: 16 Weeks|Physician Decision|0
7927|NCT02113436|46927|P1|Period 2: 16 Weeks|Physician Decision|0
7928|NCT02113436|46924|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
7929|NCT02113436|46925|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
7930|NCT02113436|46926|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7931|NCT02113436|46927|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
7932|NCT02113436|46924|P4|Period 2: 16 Weeks|Adverse Event|5
7933|NCT02113436|46925|P3|Period 2: 16 Weeks|Adverse Event|4
7934|NCT02113436|46926|P2|Period 2: 16 Weeks|Adverse Event|0
7935|NCT02113436|46927|P1|Period 2: 16 Weeks|Adverse Event|0
7936|NCT02113436|46924|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
7937|NCT02113436|46925|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
7938|NCT02113436|46926|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
7939|NCT02113436|46927|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
7940|NCT02113436|46924|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7941|NCT02113436|46925|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
7942|NCT02113436|46926|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
7943|NCT02113436|46927|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
7944|NCT02113436|46924|P4|Period 1: 8 Weeks|Protocol Violation|0
7945|NCT02113436|46925|P3|Period 1: 8 Weeks|Protocol Violation|0
7946|NCT02113436|46926|P2|Period 1: 8 Weeks|Protocol Violation|0
7947|NCT02113436|46927|P1|Period 1: 8 Weeks|Protocol Violation|1
7948|NCT02113436|46924|P4|Period 1: 8 Weeks|Adverse Event|0
7949|NCT02113436|46925|P3|Period 1: 8 Weeks|Adverse Event|0
7950|NCT02113436|46926|P2|Period 1: 8 Weeks|Adverse Event|0
7951|NCT02113436|46927|P1|Period 1: 8 Weeks|Adverse Event|1
7952|NCT02113124|46950|P2|Overall Study|Unable to retrieve blood sample|1
7953|NCT02113124|46951|P1|Overall Study|Unable to retrieve blood sample|1
7954|NCT02113007|46957|P1|Overall Study|Progressive disease|2
7955|NCT02112448|46965|P2|Overall Study|required heparin so could not use ketoro|0
7956|NCT02112448|46966|P1|Overall Study|required heparin so could not use ketoro|1
7957|NCT02112448|46965|P2|Overall Study|Physician Decision|6
7958|NCT02112448|46966|P1|Overall Study|Physician Decision|4
7959|NCT02112448|46965|P2|Overall Study|Protocol Violation|2
7960|NCT02112448|46966|P1|Overall Study|Protocol Violation|1
7961|NCT02112448|46965|P2|Overall Study|lab values precluding use of ketorolac|2
7962|NCT02112448|46966|P1|Overall Study|lab values precluding use of ketorolac|2
7963|NCT02111603|46997|P1|Overall Study|Withdrawal by Subject|1
7964|NCT02111369|47006|P1|Overall Study|Withdrawal by Subject|1
7965|NCT02111369|47006|P1|Overall Study|Lost to Follow-up|2
7966|NCT02111083|47030|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
7967|NCT02111083|47031|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
7968|NCT02110238|47065|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
7969|NCT02110238|47066|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
7970|NCT02110238|47065|P2|14 Week Blinded Extension Phase|Protocol Violation|3
7971|NCT02110238|47066|P1|14 Week Blinded Extension Phase|Protocol Violation|2
7972|NCT02110238|47065|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
7973|NCT02110238|47066|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
7974|NCT02110238|47065|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
7975|NCT02110238|47066|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
7976|NCT02110238|47065|P2|14 Week Blinded Extension Phase|Adverse Event|1
7977|NCT02110238|47066|P1|14 Week Blinded Extension Phase|Adverse Event|1
7978|NCT02110238|47065|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
7979|NCT02110238|47066|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
7980|NCT02110238|47065|P2|12 Week Pivotal Phase|Protocol Violation|1
7981|NCT02110238|47066|P1|12 Week Pivotal Phase|Protocol Violation|0
7982|NCT02110238|47065|P2|12 Week Pivotal Phase|Physician Decision|2
7983|NCT02110238|47066|P1|12 Week Pivotal Phase|Physician Decision|0
7984|NCT02110238|47065|P2|12 Week Pivotal Phase|Lost to Follow-up|0
7985|NCT02110238|47066|P1|12 Week Pivotal Phase|Lost to Follow-up|2
7986|NCT02110238|47065|P2|12 Week Pivotal Phase|Lack of Efficacy|3
7987|NCT02110238|47066|P1|12 Week Pivotal Phase|Lack of Efficacy|2
7988|NCT02110238|47065|P2|12 Week Pivotal Phase|Adverse Event|0
7989|NCT02110238|47066|P1|12 Week Pivotal Phase|Adverse Event|3
7990|NCT02109445|47107|P1|Overall Study|Adverse Event|1
7991|NCT02109445|47107|P1|Overall Study|Symptomatic deterioration|2
7992|NCT02109172|47140|P6|Overall Study|Death|0
7993|NCT02109172|47141|P5|Overall Study|Death|1
7994|NCT02109172|47142|P4|Overall Study|Death|0
7995|NCT02109172|47143|P3|Overall Study|Death|0
7996|NCT02109172|47144|P2|Overall Study|Death|0
7997|NCT02109172|47145|P1|Overall Study|Death|0
7998|NCT02109172|47140|P6|Overall Study|Adverse Event|1
7999|NCT02109172|47141|P5|Overall Study|Adverse Event|0
8000|NCT02109172|47142|P4|Overall Study|Adverse Event|0
8001|NCT02109172|47143|P3|Overall Study|Adverse Event|1
8002|NCT02109172|47144|P2|Overall Study|Adverse Event|0
8003|NCT02109172|47145|P1|Overall Study|Adverse Event|0
8004|NCT02109172|47140|P6|Overall Study|Withdrawal by Subject|0
8005|NCT02109172|47141|P5|Overall Study|Withdrawal by Subject|0
8006|NCT02109172|47142|P4|Overall Study|Withdrawal by Subject|1
8007|NCT02109172|47143|P3|Overall Study|Withdrawal by Subject|0
8008|NCT02109172|47144|P2|Overall Study|Withdrawal by Subject|0
8009|NCT02109172|47145|P1|Overall Study|Withdrawal by Subject|1
8010|NCT02109133|47166|P2|Overall Study|Lost to Follow-up|0
8011|NCT02109133|47167|P1|Overall Study|Lost to Follow-up|1
8012|NCT02109107|47179|P1|Overall Study|Lost to Follow-up|2
8013|NCT02108652|47222|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
8014|NCT02108652|47222|P1|Overall Study|Withdrawal by Subject|8
8015|NCT02108652|47222|P1|Overall Study|Lost to Follow-up|2
8016|NCT02108652|47222|P1|Overall Study|Death|226
8017|NCT02107196|47263|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
8018|NCT02107196|47264|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
8019|NCT02107196|47263|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
8020|NCT02107196|47264|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
8021|NCT02107196|47263|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
8022|NCT02107196|47264|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
8023|NCT02107196|47263|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
8024|NCT02107196|47264|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
8025|NCT02107196|47263|P2|12-week Treatment Period|Reason Missing|8
8026|NCT02107196|47264|P1|12-week Treatment Period|Reason Missing|11
8027|NCT02107196|47263|P2|12-week Treatment Period|Protocol Violation|8
8028|NCT02107196|47264|P1|12-week Treatment Period|Protocol Violation|7
8029|NCT02107196|47263|P2|12-week Treatment Period|Withdrawal by Subject|12
8030|NCT02107196|47264|P1|12-week Treatment Period|Withdrawal by Subject|15
8031|NCT02107196|47263|P2|12-week Treatment Period|Physician Decision|1
8032|NCT02107196|47264|P1|12-week Treatment Period|Physician Decision|0
8033|NCT02107196|47263|P2|12-week Treatment Period|Lost to Follow-up|6
8034|NCT02107196|47264|P1|12-week Treatment Period|Lost to Follow-up|3
8035|NCT02107196|47263|P2|12-week Treatment Period|Lack of Efficacy|1
8036|NCT02107196|47264|P1|12-week Treatment Period|Lack of Efficacy|2
8037|NCT02107196|47263|P2|12-week Treatment Period|Adverse Event|3
8038|NCT02107196|47264|P1|12-week Treatment Period|Adverse Event|6
8039|NCT02107898|47407|P2|Overall Study|Randomized but not treated|1
8040|NCT02107898|47408|P1|Overall Study|Randomized but not treated|0
8041|NCT02107898|47407|P2|Overall Study|Consent withdrawn by participant|1
8042|NCT02107898|47408|P1|Overall Study|Consent withdrawn by participant|2
8043|NCT02107898|47407|P2|Overall Study|Participant moved|2
8044|NCT02107898|47408|P1|Overall Study|Participant moved|0
8045|NCT02107898|47407|P2|Overall Study|Poor compliance to protocol|1
8046|NCT02107898|47408|P1|Overall Study|Poor compliance to protocol|0
8047|NCT02107898|47407|P2|Overall Study|Adverse Event|7
8048|NCT02107898|47408|P1|Overall Study|Adverse Event|4
8049|NCT02107482|47467|P1|Overall Study|Lack of Efficacy|1
8050|NCT02107482|47467|P1|Overall Study|Lost to Follow-up|1
8051|NCT02107482|47467|P1|Overall Study|inconveinence|2
8052|NCT02107313|47504|P2|Overall Study|One participant did not do the FED cohor|1
8053|NCT02107313|47505|P1|Overall Study|One participant did not do the FED cohor|0
8054|NCT02107274|47515|P2|Control Phase|Adverse Event|1
8055|NCT02107274|47516|P1|Control Phase|Adverse Event|0
8056|NCT02107274|47515|P2|Control Phase|Death|0
8057|NCT02107274|47516|P1|Control Phase|Death|2
8058|NCT02107274|47515|P2|Control Phase|Lost to Follow-up|1
8059|NCT02107274|47516|P1|Control Phase|Lost to Follow-up|1
8060|NCT02107274|47515|P2|Treatment vs. Placebo|Lost to Follow-up|2
8061|NCT02107274|47516|P1|Treatment vs. Placebo|Lost to Follow-up|0
8062|NCT02107274|47515|P2|Treatment vs. Placebo|Adverse Event|0
8063|NCT02107274|47516|P1|Treatment vs. Placebo|Adverse Event|3
8064|NCT02107014|47528|P1|Overall Study|Withdrew before drug: moving interstate|1
8065|NCT02106923|47599|P6|Overall Study|Protocol Violation|1
8066|NCT02106923|47600|P5|Overall Study|Protocol Violation|0
8067|NCT02106923|47601|P4|Overall Study|Protocol Violation|0
8068|NCT02106923|47602|P3|Overall Study|Protocol Violation|0
8069|NCT02106923|47603|P2|Overall Study|Protocol Violation|0
8070|NCT02106923|47604|P1|Overall Study|Protocol Violation|0
8071|NCT02106403|47682|P6|Follow-Up Visit 3|Other Reason|1
8072|NCT02106403|47683|P5|Follow-Up Visit 3|Other Reason|0
8073|NCT02106403|47684|P4|Follow-Up Visit 3|Other Reason|0
8074|NCT02106403|47685|P3|Follow-Up Visit 3|Other Reason|0
8075|NCT02106403|47686|P2|Follow-Up Visit 3|Other Reason|0
8076|NCT02106403|47687|P1|Follow-Up Visit 3|Other Reason|0
8077|NCT02106156|47710|P3|Overall Study|Relocation/Change of Physician|0
8078|NCT02106156|47711|P2|Overall Study|Relocation/Change of Physician|1
8079|NCT02106156|47712|P1|Overall Study|Relocation/Change of Physician|40
8080|NCT02106156|47710|P3|Overall Study|Hospitalization/Surgical Intervention|0
8081|NCT02106156|47711|P2|Overall Study|Hospitalization/Surgical Intervention|0
8082|NCT02106156|47712|P1|Overall Study|Hospitalization/Surgical Intervention|6
8083|NCT02106156|47710|P3|Overall Study|Change of Laboratory Parameter|0
8084|NCT02106156|47711|P2|Overall Study|Change of Laboratory Parameter|0
8085|NCT02106156|47712|P1|Overall Study|Change of Laboratory Parameter|10
8086|NCT02106156|47710|P3|Overall Study|Unplanned Event|0
8087|NCT02106156|47711|P2|Overall Study|Unplanned Event|2
8088|NCT02106156|47712|P1|Overall Study|Unplanned Event|82
8089|NCT02106156|47710|P3|Overall Study|Lost to Follow-up|0
8090|NCT02106156|47711|P2|Overall Study|Lost to Follow-up|8
8091|NCT02106156|47712|P1|Overall Study|Lost to Follow-up|451
8092|NCT02106156|47710|P3|Overall Study|Patients Request|0
8093|NCT02106156|47711|P2|Overall Study|Patients Request|9
8094|NCT02106156|47712|P1|Overall Study|Patients Request|307
8095|NCT02106156|47710|P3|Overall Study|Lack of Compliance|0
8096|NCT02106156|47711|P2|Overall Study|Lack of Compliance|7
8097|NCT02106156|47712|P1|Overall Study|Lack of Compliance|211
8098|NCT02106156|47710|P3|Overall Study|Concomitant Disease|0
8099|NCT02106156|47711|P2|Overall Study|Concomitant Disease|2
8100|NCT02106156|47712|P1|Overall Study|Concomitant Disease|74
8101|NCT02106156|47710|P3|Overall Study|Lack of Virological Response|0
8102|NCT02106156|47711|P2|Overall Study|Lack of Virological Response|8
8103|NCT02106156|47712|P1|Overall Study|Lack of Virological Response|1044
8104|NCT02106156|47710|P3|Overall Study|Lack of Tolerability|0
8105|NCT02106156|47711|P2|Overall Study|Lack of Tolerability|3
8106|NCT02106156|47712|P1|Overall Study|Lack of Tolerability|305
8107|NCT02106156|47710|P3|Overall Study|Patient Died|0
8108|NCT02106156|47711|P2|Overall Study|Patient Died|0
8109|NCT02106156|47712|P1|Overall Study|Patient Died|19
8110|NCT02105987|47736|P6|Continuation Phase|Protocol Violation|0
8111|NCT02105987|47737|P5|Continuation Phase|Protocol Violation|1
8112|NCT02105987|47738|P4|Continuation Phase|Protocol Violation|0
8113|NCT02105987|47739|P3|Continuation Phase|Protocol Violation|0
8114|NCT02105987|47740|P2|Continuation Phase|Protocol Violation|0
8115|NCT02105987|47741|P1|Continuation Phase|Protocol Violation|0
8116|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
8117|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
8118|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
8119|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
8120|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
8121|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
8122|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
8123|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
8124|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
8125|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
8126|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
8127|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
8128|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
8129|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
8130|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
8131|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
8132|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
8133|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
8134|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
8135|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
8136|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
8137|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
8138|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
8139|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
8140|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
8141|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
8142|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
8143|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
8144|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
8145|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
8146|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
8147|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
8148|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
8149|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
8150|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
8151|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
8152|NCT02105987|47736|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
8153|NCT02105987|47737|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
8154|NCT02105987|47738|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
8155|NCT02105987|47739|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
8156|NCT02105987|47740|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
8157|NCT02105987|47741|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
8158|NCT02105987|47736|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
8159|NCT02105987|47737|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
8160|NCT02105987|47738|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
8161|NCT02105987|47739|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
8162|NCT02105987|47740|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
8163|NCT02105987|47741|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
8164|NCT02105987|47736|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
8165|NCT02105987|47737|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
8166|NCT02105987|47738|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
8167|NCT02105987|47739|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
8168|NCT02105987|47740|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
8169|NCT02105987|47741|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
8170|NCT02105987|47736|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
8171|NCT02105987|47737|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
8172|NCT02105987|47738|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
8173|NCT02105987|47739|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
8174|NCT02105987|47740|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
8175|NCT02105987|47741|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
8176|NCT02105987|47736|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
8177|NCT02105987|47737|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
8178|NCT02105987|47738|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
8179|NCT02105987|47739|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
8180|NCT02105987|47740|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
8181|NCT02105987|47741|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
8182|NCT02105987|47736|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
8183|NCT02105987|47737|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
8184|NCT02105987|47738|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
8185|NCT02105987|47739|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
8186|NCT02105987|47740|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
8187|NCT02105987|47741|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
8188|NCT02105987|47736|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
8189|NCT02105987|47737|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
8190|NCT02105987|47738|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
8191|NCT02105987|47739|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
8192|NCT02105987|47740|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
8193|NCT02105987|47741|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
8194|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
8195|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
8196|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
8197|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
8198|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
8199|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
8200|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
8201|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
8202|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
8203|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
8204|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
8205|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
8206|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
8207|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
8208|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
8209|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
8210|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
8211|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
8212|NCT02105974|47795|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
8213|NCT02105974|47796|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
8214|NCT02105974|47797|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
8215|NCT02105974|47795|P3|2 Week Run-in Period|Investigator discretion|0
8216|NCT02105974|47796|P2|2 Week Run-in Period|Investigator discretion|0
8217|NCT02105974|47797|P1|2 Week Run-in Period|Investigator discretion|8
8218|NCT02105974|47795|P3|2 Week Run-in Period|Withdrew consent|0
8219|NCT02105974|47796|P2|2 Week Run-in Period|Withdrew consent|0
8220|NCT02105974|47797|P1|2 Week Run-in Period|Withdrew consent|23
8221|NCT02105974|47795|P3|2 Week Run-in Period|Lost to Follow-up|0
8222|NCT02105974|47796|P2|2 Week Run-in Period|Lost to Follow-up|0
8223|NCT02105974|47797|P1|2 Week Run-in Period|Lost to Follow-up|2
8224|NCT02105974|47795|P3|2 Week Run-in Period|Study closed/terminated|0
8225|NCT02105974|47796|P2|2 Week Run-in Period|Study closed/terminated|0
8226|NCT02105974|47797|P1|2 Week Run-in Period|Study closed/terminated|1
8227|NCT02105974|47795|P3|2 Week Run-in Period|Adverse Event|0
8228|NCT02105974|47796|P2|2 Week Run-in Period|Adverse Event|0
8229|NCT02105974|47797|P1|2 Week Run-in Period|Adverse Event|6
8230|NCT02105974|47795|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
8231|NCT02105974|47796|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
8232|NCT02105974|47797|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
8233|NCT02105974|47795|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
8234|NCT02105974|47796|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
8235|NCT02105974|47797|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
8236|NCT02105701|47822|P4|Overall Study|Death|0
8237|NCT02105701|47823|P3|Overall Study|Death|0
8238|NCT02105701|47824|P2|Overall Study|Death|0
8239|NCT02105701|47825|P1|Overall Study|Death|1
8240|NCT02105701|47822|P4|Overall Study|Withdrawal by Subject|1
8241|NCT02105701|47823|P3|Overall Study|Withdrawal by Subject|0
8242|NCT02105701|47824|P2|Overall Study|Withdrawal by Subject|1
8243|NCT02105701|47825|P1|Overall Study|Withdrawal by Subject|2
8244|NCT02105701|47822|P4|Overall Study|Protocol Violation|0
8245|NCT02105701|47823|P3|Overall Study|Protocol Violation|1
8246|NCT02105701|47824|P2|Overall Study|Protocol Violation|0
8247|NCT02105701|47825|P1|Overall Study|Protocol Violation|0
8248|NCT02105701|47822|P4|Overall Study|Lost to Follow-up|1
8249|NCT02105701|47823|P3|Overall Study|Lost to Follow-up|2
8250|NCT02105701|47824|P2|Overall Study|Lost to Follow-up|0
8251|NCT02105701|47825|P1|Overall Study|Lost to Follow-up|1
8252|NCT02105688|47849|P2|Overall Study|Withdrawal by Subject|2
8253|NCT02105688|47850|P1|Overall Study|Withdrawal by Subject|4
8254|NCT02105688|47849|P2|Overall Study|Protocol Violation|1
8255|NCT02105688|47850|P1|Overall Study|Protocol Violation|0
8256|NCT02105688|47849|P2|Overall Study|Physician Decision|1
8257|NCT02105688|47850|P1|Overall Study|Physician Decision|0
8258|NCT02105688|47849|P2|Overall Study|Lost to Follow-up|4
8259|NCT02105688|47850|P1|Overall Study|Lost to Follow-up|9
8260|NCT02105688|47849|P2|Overall Study|Adverse Event|1
8261|NCT02105688|47850|P1|Overall Study|Adverse Event|1
8262|NCT02105688|47849|P2|Overall Study|Ongoing|90
8263|NCT02105688|47850|P1|Overall Study|Ongoing|12
8264|NCT02105662|47860|P1|Overall Study|Withdrawal by Subject|1
8265|NCT02105662|47860|P1|Overall Study|Lost to Follow-up|5
8266|NCT02105636|47869|P2|Overall Study|Not Reported|0
8267|NCT02105636|47870|P1|Overall Study|Not Reported|3
8268|NCT02105636|47869|P2|Overall Study|Reason Not Specified|2
8269|NCT02105636|47870|P1|Overall Study|Reason Not Specified|0
8270|NCT02105636|47869|P2|Overall Study|Poor/Non-compliance|1
8271|NCT02105636|47870|P1|Overall Study|Poor/Non-compliance|0
8272|NCT02105636|47869|P2|Overall Study|Maximum Clinical Benefit|1
8273|NCT02105636|47870|P1|Overall Study|Maximum Clinical Benefit|1
8274|NCT02105636|47869|P2|Overall Study|Subject Withdrew Consent|1
8275|NCT02105636|47870|P1|Overall Study|Subject Withdrew Consent|4
8276|NCT02105636|47869|P2|Overall Study|Subject Request to Discontinue Treatment|6
8277|NCT02105636|47870|P1|Overall Study|Subject Request to Discontinue Treatment|4
8278|NCT02105636|47869|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
8279|NCT02105636|47870|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
8280|NCT02105636|47869|P2|Overall Study|Study Drug Toxicity|11
8281|NCT02105636|47870|P1|Overall Study|Study Drug Toxicity|9
8282|NCT02105636|47869|P2|Overall Study|Disease Progression|83
8283|NCT02105636|47870|P1|Overall Study|Disease Progression|162
8284|NCT02105467|47882|P2|Period 3|Lost to Follow-up|1
8285|NCT02105467|47883|P1|Period 3|Lost to Follow-up|0
8286|NCT02105467|47882|P2|Period 2|Withdrawal by Subject|2
8287|NCT02105467|47883|P1|Period 2|Withdrawal by Subject|0
8288|NCT02105467|47882|P2|Period 2|Death|0
8289|NCT02105467|47883|P1|Period 2|Death|1
8290|NCT02105467|47882|P2|Period 2|Lost to Follow-up|0
8291|NCT02105467|47883|P1|Period 2|Lost to Follow-up|1
8292|NCT02105467|47882|P2|Period 1|Death|0
8293|NCT02105467|47883|P1|Period 1|Death|1
8294|NCT02105467|47882|P2|Period 1|Lost to Follow-up|0
8295|NCT02105467|47883|P1|Period 1|Lost to Follow-up|1
8296|NCT02105454|47895|P1|Overall Study|Withdrawal by Subject|1
8297|NCT02105285|47905|P3|Overall Study|Withdrawal by Subject|0
8298|NCT02105285|47906|P2|Overall Study|Withdrawal by Subject|0
8299|NCT02105285|47907|P1|Overall Study|Withdrawal by Subject|1
8300|NCT02105285|47905|P3|Overall Study|Protocol Violation|0
8301|NCT02105285|47906|P2|Overall Study|Protocol Violation|1
8302|NCT02105285|47907|P1|Overall Study|Protocol Violation|0
8303|NCT02105285|47905|P3|Overall Study|Adverse Event|0
8304|NCT02105285|47906|P2|Overall Study|Adverse Event|1
8305|NCT02105285|47907|P1|Overall Study|Adverse Event|1
8306|NCT02105272|47926|P2|Overall Study|Withdrawal by Subject|0
8307|NCT02105272|47927|P1|Overall Study|Withdrawal by Subject|2
8308|NCT02105272|47926|P2|Overall Study|Protocol Violation|0
8309|NCT02105272|47927|P1|Overall Study|Protocol Violation|2
8310|NCT02105272|47926|P2|Overall Study|Physician Decision|1
8311|NCT02105272|47927|P1|Overall Study|Physician Decision|0
8312|NCT02105272|47926|P2|Overall Study|Adverse Event|2
8313|NCT02105272|47927|P1|Overall Study|Adverse Event|1
8314|NCT02105012|47943|P1|Overall Study|Lack of Efficacy|1
8315|NCT02105012|47943|P1|Overall Study|Adverse Event|1
8316|NCT02105012|47943|P1|Overall Study|Physician Decision|3
8317|NCT02105012|47943|P1|Overall Study|Protocol Violation|4
8318|NCT02105012|47943|P1|Overall Study|Lost to Follow-up|4
8319|NCT02105012|47943|P1|Overall Study|Protocol Specified Criteria|9
8320|NCT02105012|47943|P1|Overall Study|Withdrawal by Subject|11
8321|NCT02104947|47977|P2|Overall Study|Other than stated above|3
8322|NCT02104947|47978|P1|Overall Study|Other than stated above|2
8323|NCT02104947|47977|P2|Overall Study|Adverse Event|38
8324|NCT02104947|47978|P1|Overall Study|Adverse Event|57
8325|NCT02104947|47977|P2|Overall Study|Protocol Violation|8
8326|NCT02104947|47978|P1|Overall Study|Protocol Violation|6
8327|NCT02104947|47977|P2|Overall Study|Lost to Follow-up|4
8328|NCT02104947|47978|P1|Overall Study|Lost to Follow-up|4
8329|NCT02104947|47977|P2|Overall Study|Withdrawal by Subject|3
8330|NCT02104947|47978|P1|Overall Study|Withdrawal by Subject|10
8331|NCT02104895|47996|P2|Overall Study|Withdrawal by Subject|14
8332|NCT02104895|47997|P1|Overall Study|Withdrawal by Subject|0
8333|NCT02103439|48052|P2|Overall Study|Withdrawal by Subject|1
8334|NCT02103439|48053|P1|Overall Study|Withdrawal by Subject|3
8335|NCT02103439|48052|P2|Overall Study|Adverse Event|2
8336|NCT02103439|48053|P1|Overall Study|Adverse Event|0
8337|NCT02103062|48145|P2|Overall Study|Death|1
8338|NCT02103062|48146|P1|Overall Study|Death|0
8339|NCT02103062|48145|P2|Overall Study|Progressive Disease|20
8340|NCT02103062|48146|P1|Overall Study|Progressive Disease|17
8341|NCT02103062|48145|P2|Overall Study|Adverse Event|2
8342|NCT02103062|48146|P1|Overall Study|Adverse Event|1
8343|NCT02102399|48239|P2|Overall Study|Withdrawal by Subject|4
8344|NCT02102399|48240|P1|Overall Study|Withdrawal by Subject|6
8345|NCT02101359|48290|P2|Overall Study|Protocol Violation|2
8346|NCT02101359|48291|P1|Overall Study|Protocol Violation|0
8347|NCT02101359|48290|P2|Overall Study|Lost to Follow-up|0
8348|NCT02101359|48291|P1|Overall Study|Lost to Follow-up|1
8349|NCT02101359|48290|P2|Overall Study|Withdrawal by Subject|4
8350|NCT02101359|48291|P1|Overall Study|Withdrawal by Subject|5
8351|NCT02101359|48290|P2|Overall Study|Not included|13
8352|NCT02101359|48291|P1|Overall Study|Not included|23
8353|NCT02101294|48297|P1|Overall Study|Lost to Follow-up|6
8354|NCT02101294|48297|P1|Overall Study|Withdrawal by Subject|5
8355|NCT02101112|48317|P6|Overall Study|Withdrawal by Subject|0
8356|NCT02101112|48318|P5|Overall Study|Withdrawal by Subject|1
8357|NCT02101112|48319|P4|Overall Study|Withdrawal by Subject|0
8358|NCT02101112|48320|P3|Overall Study|Withdrawal by Subject|0
8359|NCT02101112|48321|P2|Overall Study|Withdrawal by Subject|0
8360|NCT02101112|48322|P1|Overall Study|Withdrawal by Subject|0
8361|NCT02101112|48317|P6|Overall Study|Adverse Event|0
8362|NCT02101112|48318|P5|Overall Study|Adverse Event|0
8363|NCT02101112|48319|P4|Overall Study|Adverse Event|0
8364|NCT02101112|48320|P3|Overall Study|Adverse Event|1
8365|NCT02101112|48321|P2|Overall Study|Adverse Event|0
8366|NCT02101112|48322|P1|Overall Study|Adverse Event|0
8367|NCT02100839|48354|P2|Multiple Ascending Dose|Withdrawal by Subject|0
8368|NCT02100839|48355|P1|Multiple Ascending Dose|Withdrawal by Subject|2
8369|NCT02100839|48354|P2|Multiple Ascending Dose|Adverse Event|0
8370|NCT02100839|48355|P1|Multiple Ascending Dose|Adverse Event|2
8371|NCT02100644|48378|P3|LTG Escalation Phase|Withdrawal by Subject|0
8372|NCT02100644|48379|P2|LTG Escalation Phase|Withdrawal by Subject|0
8373|NCT02100644|48380|P1|LTG Escalation Phase|Withdrawal by Subject|3
8374|NCT02100644|48378|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
8375|NCT02100644|48379|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
8376|NCT02100644|48380|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
8377|NCT02100644|48378|P3|LTG Escalation Phase|Adverse Event|0
8378|NCT02100644|48379|P2|LTG Escalation Phase|Adverse Event|0
8379|NCT02100644|48380|P1|LTG Escalation Phase|Adverse Event|9
8380|NCT02100514|48405|P2|Overall Study|Unspecified|11
8381|NCT02100514|48406|P1|Overall Study|Unspecified|9
8382|NCT02100514|48405|P2|Overall Study|Withdrawal by Subject|37
8383|NCT02100514|48406|P1|Overall Study|Withdrawal by Subject|12
8384|NCT02100514|48405|P2|Overall Study|Protocol Violation|1
8385|NCT02100514|48406|P1|Overall Study|Protocol Violation|1
8386|NCT02100514|48405|P2|Overall Study|Did Not Meet Entrance Criteria|1
8387|NCT02100514|48406|P1|Overall Study|Did Not Meet Entrance Criteria|0
8388|NCT02100514|48405|P2|Overall Study|Lost to Follow-up|17
8389|NCT02100514|48406|P1|Overall Study|Lost to Follow-up|5
8390|NCT02100514|48405|P2|Overall Study|Death|2
8391|NCT02100514|48406|P1|Overall Study|Death|2
8392|NCT02100514|48405|P2|Overall Study|Adverse Event|5
8393|NCT02100514|48406|P1|Overall Study|Adverse Event|0
8394|NCT02100475|48466|P2|Overall Study|Withdrawal criteria|0
8395|NCT02100475|48467|P1|Overall Study|Withdrawal criteria|1
8396|NCT02100475|48466|P2|Overall Study|Unclassified|2
8397|NCT02100475|48467|P1|Overall Study|Unclassified|1
8398|NCT02099838|48507|P2|Overall Study|Withdrawal by Subject|1
8399|NCT02099838|48508|P1|Overall Study|Withdrawal by Subject|0
8400|NCT02099838|48507|P2|Overall Study|Lost to Follow-up|1
8401|NCT02099838|48508|P1|Overall Study|Lost to Follow-up|3
8402|NCT02099838|48507|P2|Overall Study|Death|0
8403|NCT02099838|48508|P1|Overall Study|Death|1
8404|NCT02099708|48538|P1|Overall Study|Other|29
8405|NCT02099708|48538|P1|Overall Study|Lost to Follow-up|141
8406|NCT02099708|48538|P1|Overall Study|Data Not Available|30
8407|NCT02099682|48549|P1|Overall Study|Other|29
8408|NCT02099682|48549|P1|Overall Study|Lost to Follow-up|31
8409|NCT02099682|48549|P1|Overall Study|Data Not Available|51
8410|NCT02099344|48575|P2|Overall Study|Physician Decision|0
8411|NCT02099344|48576|P1|Overall Study|Physician Decision|1
8412|NCT02098746|48633|P1|Overall Study|Data Not Available After Treatment|1
8413|NCT02098746|48633|P1|Overall Study|Enrolled 15 Days After the First Dose|1
8414|NCT02098746|48633|P1|Overall Study|Other Miscellaneous Reasons|1
8415|NCT02098746|48633|P1|Overall Study|Changes of Investigator|2
8416|NCT02098733|48641|P1|Overall Study|Lost to Follow-up|5
8417|NCT02098733|48641|P1|Overall Study|Data Not Available|5
8418|NCT02098395|48655|P4|Overall Study|Unclassified|2
8419|NCT02098395|48656|P3|Overall Study|Unclassified|3
8420|NCT02098395|48657|P2|Overall Study|Unclassified|0
8421|NCT02098395|48658|P1|Overall Study|Unclassified|0
8422|NCT02098395|48655|P4|Overall Study|Lost to Follow-up|3
8423|NCT02098395|48656|P3|Overall Study|Lost to Follow-up|0
8424|NCT02098395|48657|P2|Overall Study|Lost to Follow-up|1
8425|NCT02098395|48658|P1|Overall Study|Lost to Follow-up|2
8426|NCT02098395|48655|P4|Overall Study|Adverse Event|2
8427|NCT02098395|48656|P3|Overall Study|Adverse Event|34
8428|NCT02098395|48657|P2|Overall Study|Adverse Event|19
8429|NCT02098395|48658|P1|Overall Study|Adverse Event|12
8430|NCT02098395|48655|P4|Overall Study|Withdrawal by Subject|13
8431|NCT02098395|48656|P3|Overall Study|Withdrawal by Subject|5
8432|NCT02098395|48657|P2|Overall Study|Withdrawal by Subject|10
8433|NCT02098395|48658|P1|Overall Study|Withdrawal by Subject|10
8434|NCT02098395|48655|P4|Overall Study|Protocol Violation|7
8435|NCT02098395|48656|P3|Overall Study|Protocol Violation|0
8436|NCT02098395|48657|P2|Overall Study|Protocol Violation|2
8437|NCT02098395|48658|P1|Overall Study|Protocol Violation|2
8438|NCT02098109|48685|P2|Overall Study|Protocol Violation|0
8439|NCT02098109|48686|P1|Overall Study|Protocol Violation|3
8440|NCT02097823|48762|P2|Overall Study|Withdrawal by Subject|1
8441|NCT02097823|48763|P1|Overall Study|Withdrawal by Subject|1
8442|NCT02097745|48778|P1|Overall Study|Reason Not Specified|96
8443|NCT02097745|48778|P1|Overall Study|Administrative/Other|27
8444|NCT02097745|48778|P1|Overall Study|Failure to Return|14
8445|NCT02097745|48778|P1|Overall Study|Death|16
8446|NCT02097745|48778|P1|Overall Study|Adverse Event|25
8447|NCT02097719|48802|P2|Overall Study|Adverse Event|0
8448|NCT02097719|48803|P1|Overall Study|Adverse Event|2
8449|NCT02097719|48802|P2|Overall Study|Lost to Follow-up|1
8450|NCT02097719|48803|P1|Overall Study|Lost to Follow-up|0
8451|NCT02097719|48802|P2|Overall Study|Subject Withdrew Consent|0
8452|NCT02097719|48803|P1|Overall Study|Subject Withdrew Consent|1
8453|NCT02097108|48815|P1|Overall Study|patient was abroad for 6 months|1
8454|NCT02097108|48815|P1|Overall Study|Adverse Event|1
8455|NCT02097056|48822|P1|Overall Study|Not specified|2
8456|NCT02097056|48822|P1|Overall Study|Adverse Event|37
8457|NCT02097056|48822|P1|Overall Study|Lost to Follow-up|2
8458|NCT02097056|48822|P1|Overall Study|Withdrawal by Subject|15
8459|NCT02097056|48822|P1|Overall Study|Protocol Violation|2
8460|NCT02097030|48830|P2|First Intervention (3 Days)|Visual Acuity|1
8461|NCT02097030|48831|P1|First Intervention (3 Days)|Visual Acuity|0
8462|NCT02097030|48830|P2|First Intervention (3 Days)|Lost to Follow-up|0
8463|NCT02097030|48831|P1|First Intervention (3 Days)|Lost to Follow-up|1
8464|NCT02096900|48894|P2|Overall Study|Surgery cancelled- medication received|1
8465|NCT02096900|48895|P1|Overall Study|Surgery cancelled- medication received|1
8466|NCT02096900|48894|P2|Overall Study|Did not receive medication|1
8467|NCT02096900|48895|P1|Overall Study|Did not receive medication|3
8468|NCT02096835|48912|P3|Overall Study|Lost to Follow-up|1
8469|NCT02096835|48913|P2|Overall Study|Lost to Follow-up|0
8470|NCT02096835|48914|P1|Overall Study|Lost to Follow-up|1
8471|NCT02096835|48912|P3|Overall Study|converted to open procedures|0
8472|NCT02096835|48913|P2|Overall Study|converted to open procedures|0
8473|NCT02096835|48914|P1|Overall Study|converted to open procedures|1
8474|NCT02096835|48912|P3|Overall Study|Withdrawal by Subject|0
8475|NCT02096835|48913|P2|Overall Study|Withdrawal by Subject|0
8476|NCT02096835|48914|P1|Overall Study|Withdrawal by Subject|1
8477|NCT02096744|48931|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
8478|NCT02096744|48932|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
8479|NCT02096744|48931|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
8480|NCT02096744|48932|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
8481|NCT02096744|48931|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
8482|NCT02096744|48932|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
8483|NCT02096705|48986|P2|Follow-up|Subjects not reporting status|2
8484|NCT02096705|48987|P1|Follow-up|Subjects not reporting status|1
8485|NCT02096705|48986|P2|Follow-up|Adverse Event|2
8486|NCT02096705|48987|P1|Follow-up|Adverse Event|2
8487|NCT02096705|48986|P2|Follow-up|Withdrawal by Subject|0
8488|NCT02096705|48987|P1|Follow-up|Withdrawal by Subject|1
8489|NCT02096705|48986|P2|Treatment|Unspecified|1
8490|NCT02096705|48987|P1|Treatment|Unspecified|1
8491|NCT02096705|48986|P2|Treatment|Withdrawal by Subject|0
8492|NCT02096705|48987|P1|Treatment|Withdrawal by Subject|1
8493|NCT02096705|48986|P2|Treatment|Subject request to discontinue treatment|1
8494|NCT02096705|48987|P1|Treatment|Subject request to discontinue treatment|1
8495|NCT02096705|48986|P2|Treatment|Adverse Event|3
8496|NCT02096705|48987|P1|Treatment|Adverse Event|6
8497|NCT02095873|49087|P2|Second Intervention (8 Weeks)|Protocol Violation|0
8498|NCT02095873|49088|P1|Second Intervention (8 Weeks)|Protocol Violation|1
8499|NCT02095873|49087|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
8500|NCT02095873|49088|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
8501|NCT02095873|49087|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
8502|NCT02095873|49088|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
8503|NCT02095691|49100|P1|Overall Study|Physician Decision|1
8504|NCT02095535|49132|P1|Recruitment|Protocol Violation|2
8505|NCT02095223|49138|P2|Overall Study|Withdrawal by Subject|0
8506|NCT02095223|49139|P1|Overall Study|Withdrawal by Subject|1
8507|NCT02095197|49149|P2|Overall Study|Lost to Follow-up|3
8508|NCT02095197|49150|P1|Overall Study|Lost to Follow-up|0
8509|NCT02095158|49162|P1|Overall Study|Other Miscellaneous Reasons|1
8510|NCT02095158|49162|P1|Overall Study|Protocol Violation|1
8511|NCT02095158|49162|P1|Overall Study|Personal Reasons|35
8512|NCT02095158|49162|P1|Overall Study|Lost to Follow-up|20
8513|NCT02095158|49162|P1|Overall Study|Pregnancy|1
8514|NCT02095158|49162|P1|Overall Study|Lack of Efficacy|3
8515|NCT02095158|49162|P1|Overall Study|Adverse Event|14
8516|NCT02094937|49167|P4|12 Weeks in Period 2|Randomized incorrectly|0
8517|NCT02094937|49168|P3|12 Weeks in Period 2|Randomized incorrectly|0
8518|NCT02094937|49169|P2|12 Weeks in Period 2|Randomized incorrectly|1
8519|NCT02094937|49170|P1|12 Weeks in Period 2|Randomized incorrectly|0
8520|NCT02094937|49167|P4|12 Weeks in Period 2|Withdrawal by Subject|0
8521|NCT02094937|49168|P3|12 Weeks in Period 2|Withdrawal by Subject|2
8522|NCT02094937|49169|P2|12 Weeks in Period 2|Withdrawal by Subject|2
8523|NCT02094937|49170|P1|12 Weeks in Period 2|Withdrawal by Subject|0
8524|NCT02094937|49167|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
8525|NCT02094937|49168|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
8526|NCT02094937|49169|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
8527|NCT02094937|49170|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
8528|NCT02094937|49167|P4|12 Weeks in Period 2|Lack of Efficacy|0
8529|NCT02094937|49168|P3|12 Weeks in Period 2|Lack of Efficacy|0
8530|NCT02094937|49169|P2|12 Weeks in Period 2|Lack of Efficacy|1
8531|NCT02094937|49170|P1|12 Weeks in Period 2|Lack of Efficacy|0
8532|NCT02094937|49167|P4|12 Weeks in Period 2|Adverse Event|1
8533|NCT02094937|49168|P3|12 Weeks in Period 2|Adverse Event|4
8534|NCT02094937|49169|P2|12 Weeks in Period 2|Adverse Event|2
8535|NCT02094937|49170|P1|12 Weeks in Period 2|Adverse Event|0
8536|NCT02094937|49167|P4|8 Weeks in Period 1|Withdrawal by Subject|0
8537|NCT02094937|49168|P3|8 Weeks in Period 1|Withdrawal by Subject|0
8538|NCT02094937|49169|P2|8 Weeks in Period 1|Withdrawal by Subject|0
8539|NCT02094937|49170|P1|8 Weeks in Period 1|Withdrawal by Subject|4
8540|NCT02094937|49167|P4|8 Weeks in Period 1|Physician Decision|0
8541|NCT02094937|49168|P3|8 Weeks in Period 1|Physician Decision|0
8542|NCT02094937|49169|P2|8 Weeks in Period 1|Physician Decision|0
8543|NCT02094937|49170|P1|8 Weeks in Period 1|Physician Decision|1
8544|NCT02094937|49167|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
8545|NCT02094937|49168|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
8546|NCT02094937|49169|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
8547|NCT02094937|49170|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
8548|NCT02094937|49167|P4|8 Weeks in Period 1|Protocol Violation|0
8549|NCT02094937|49168|P3|8 Weeks in Period 1|Protocol Violation|0
8550|NCT02094937|49169|P2|8 Weeks in Period 1|Protocol Violation|0
8551|NCT02094937|49170|P1|8 Weeks in Period 1|Protocol Violation|2
8552|NCT02094937|49167|P4|8 Weeks in Period 1|Lack of Efficacy|0
8553|NCT02094937|49168|P3|8 Weeks in Period 1|Lack of Efficacy|0
8554|NCT02094937|49169|P2|8 Weeks in Period 1|Lack of Efficacy|0
8555|NCT02094937|49170|P1|8 Weeks in Period 1|Lack of Efficacy|3
8556|NCT02094937|49167|P4|8 Weeks in Period 1|Adverse Event|0
8557|NCT02094937|49168|P3|8 Weeks in Period 1|Adverse Event|0
8558|NCT02094937|49169|P2|8 Weeks in Period 1|Adverse Event|0
8559|NCT02094937|49170|P1|8 Weeks in Period 1|Adverse Event|9
8560|NCT02094898|49200|P1|Overall Study|Lack of Efficacy|1
8561|NCT02094898|49200|P1|Overall Study|Adverse Event|2
8562|NCT02094898|49200|P1|Overall Study|Clinical Worsening|2
8563|NCT02094885|49247|P2|Overall Study|Withdrawn due to age|0
8564|NCT02094885|49248|P1|Overall Study|Withdrawn due to age|1
8565|NCT02094885|49247|P2|Overall Study|Death|5
8566|NCT02094885|49248|P1|Overall Study|Death|1
8567|NCT02094677|49262|P2|Overall Study|Screening|1
8568|NCT02094677|49263|P1|Overall Study|Screening|3
8569|NCT02094612|49327|P2|Overall Study|Never started ADHD medication|23
8570|NCT02094612|49328|P1|Overall Study|Never started ADHD medication|32
8571|NCT02094612|49327|P2|Overall Study|Lost to Follow-up|47
8572|NCT02094612|49328|P1|Overall Study|Lost to Follow-up|47
8573|NCT02094573|49348|P2|Overall Study|Ongoing|76
8574|NCT02094573|49349|P1|Overall Study|Ongoing|64
8575|NCT02094573|49348|P2|Overall Study|Randomized but not treated|0
8576|NCT02094573|49349|P1|Overall Study|Randomized but not treated|3
8577|NCT02094573|49348|P2|Overall Study|Withdrawal by Subject|4
8578|NCT02094573|49349|P1|Overall Study|Withdrawal by Subject|2
8579|NCT02094573|49348|P2|Overall Study|Non-compliance with study drug|1
8580|NCT02094573|49349|P1|Overall Study|Non-compliance with study drug|0
8581|NCT02094573|49348|P2|Overall Study|Death|1
8582|NCT02094573|49349|P1|Overall Study|Death|7
8583|NCT02094573|49348|P2|Overall Study|Adverse Event|9
8584|NCT02094573|49349|P1|Overall Study|Adverse Event|3
8585|NCT02094573|49348|P2|Overall Study|Clinical Progressive Disease|3
8586|NCT02094573|49349|P1|Overall Study|Clinical Progressive Disease|4
8587|NCT02094573|49348|P2|Overall Study|Documented Progressive Disease|16
8588|NCT02094573|49349|P1|Overall Study|Documented Progressive Disease|29
8589|NCT02094300|49431|P1|Overall Study|Still be eligible for follow-up|3
8590|NCT02094300|49431|P1|Overall Study|Lost to Follow-up|10
8591|NCT02094300|49431|P1|Overall Study|Death|7
8592|NCT02094261|49435|P1|Overall Study|Ongoing Study at Data Cut-off|181
8593|NCT02094261|49435|P1|Overall Study|Withdrawal by Subject|4
8594|NCT02094261|49435|P1|Overall Study|Lost to Follow-up|1
8595|NCT02094261|49435|P1|Overall Study|Death|24
8596|NCT02093923|49477|P5|Overall Study|Screen failure after randomization|0
8597|NCT02093923|49478|P4|Overall Study|Screen failure after randomization|1
8598|NCT02093923|49479|P3|Overall Study|Screen failure after randomization|0
8599|NCT02093923|49480|P2|Overall Study|Screen failure after randomization|0
8600|NCT02093923|49481|P1|Overall Study|Screen failure after randomization|0
8601|NCT02093923|49477|P5|Overall Study|Lost to Follow-up|0
8602|NCT02093923|49478|P4|Overall Study|Lost to Follow-up|1
8603|NCT02093923|49479|P3|Overall Study|Lost to Follow-up|0
8604|NCT02093923|49480|P2|Overall Study|Lost to Follow-up|0
8605|NCT02093923|49481|P1|Overall Study|Lost to Follow-up|0
8606|NCT02093897|49536|P1|Overall Study|Adverse event, non-fatal|1
8607|NCT02093897|49536|P1|Overall Study|Planned age group closure - no's reached|17
8608|NCT02093897|49536|P1|Overall Study|Physician Decision|1
8609|NCT02093520|49638|P2|Overall Study|Not treated|22
8610|NCT02093520|49639|P1|Overall Study|Not treated|6
8611|NCT02093390|49651|P2|Overall Study|Withdrawal by Subject|1
8612|NCT02093390|49652|P1|Overall Study|Withdrawal by Subject|0
8613|NCT02093351|49691|P3|Overall Study|Death|0
8614|NCT02093351|49692|P2|Overall Study|Death|1
8615|NCT02093351|49693|P1|Overall Study|Death|0
8616|NCT02093351|49691|P3|Overall Study|Condition under investigation worsened|2
8617|NCT02093351|49692|P2|Overall Study|Condition under investigation worsened|0
8618|NCT02093351|49693|P1|Overall Study|Condition under investigation worsened|2
8619|NCT02093351|49691|P3|Overall Study|Adverse Event|1
8620|NCT02093351|49692|P2|Overall Study|Adverse Event|1
8621|NCT02093351|49693|P1|Overall Study|Adverse Event|0
8622|NCT02093026|49744|P1|Overall Study|Unspecified|157
8623|NCT02093026|49744|P1|Overall Study|Death|10
8624|NCT02093026|49744|P1|Overall Study|Adverse Event|26
8625|NCT02092961|49766|P3|Overall Study|Adverse Event|0
8626|NCT02092961|49767|P2|Overall Study|Adverse Event|4
8627|NCT02092961|49768|P1|Overall Study|Adverse Event|2
8628|NCT02092961|49766|P3|Overall Study|Dev. of study specific discont. criteria|0
8629|NCT02092961|49767|P2|Overall Study|Dev. of study specific discont. criteria|0
8630|NCT02092961|49768|P1|Overall Study|Dev. of study specific discont. criteria|3
8631|NCT02092961|49766|P3|Overall Study|Lack of therapeutic response|3
8632|NCT02092961|49767|P2|Overall Study|Lack of therapeutic response|1
8633|NCT02092961|49768|P1|Overall Study|Lack of therapeutic response|2
8634|NCT02092961|49766|P3|Overall Study|Study stopped|12
8635|NCT02092961|49767|P2|Overall Study|Study stopped|9
8636|NCT02092961|49768|P1|Overall Study|Study stopped|13
8637|NCT02092961|49766|P3|Overall Study|Not reported|1
8638|NCT02092961|49767|P2|Overall Study|Not reported|0
8639|NCT02092961|49768|P1|Overall Study|Not reported|1
8640|NCT02092662|49804|P2|Overall Study|Lost to Follow-up|0
8641|NCT02092662|49805|P1|Overall Study|Lost to Follow-up|13
8642|NCT02092389|49864|P1|Overall Study|Not specified|5
8643|NCT02092389|49864|P1|Overall Study|Adverse Event|1
8644|NCT02092350|49876|P2|Overall Study|Withdrawal by Subject|2
8645|NCT02092350|49877|P1|Overall Study|Withdrawal by Subject|2
8646|NCT02092350|49876|P2|Overall Study|Screen Failure|0
8647|NCT02092350|49877|P1|Overall Study|Screen Failure|1
8648|NCT02092350|49876|P2|Overall Study|Physician Decision|1
8649|NCT02092350|49877|P1|Overall Study|Physician Decision|1
8650|NCT02092350|49876|P2|Overall Study|Protocol Violation|0
8651|NCT02092350|49877|P1|Overall Study|Protocol Violation|1
8652|NCT02092350|49876|P2|Overall Study|Lost to Follow-up|1
8653|NCT02092350|49877|P1|Overall Study|Lost to Follow-up|3
8654|NCT02092350|49876|P2|Overall Study|Death|5
8655|NCT02092350|49877|P1|Overall Study|Death|2
8656|NCT02092350|49876|P2|Overall Study|Adverse Event|3
8657|NCT02092350|49877|P1|Overall Study|Adverse Event|0
8658|NCT02092116|49920|P2|Overall Study|Adverse Event|1
8659|NCT02092116|49921|P1|Overall Study|Adverse Event|0
8660|NCT02092116|49920|P2|Overall Study|Withdrawal by Subject|3
8661|NCT02092116|49921|P1|Overall Study|Withdrawal by Subject|0
8662|NCT02091986|49933|P3|Overall Study|Adverse Event|2
8663|NCT02091986|49934|P2|Overall Study|Adverse Event|0
8664|NCT02091986|49935|P1|Overall Study|Adverse Event|0
8665|NCT02091986|49933|P3|Overall Study|Withdrawal by Subject|3
8666|NCT02091986|49934|P2|Overall Study|Withdrawal by Subject|8
8667|NCT02091986|49935|P1|Overall Study|Withdrawal by Subject|4
8668|NCT02091986|49933|P3|Overall Study|Lost to Follow-up|0
8669|NCT02091986|49934|P2|Overall Study|Lost to Follow-up|0
8670|NCT02091986|49935|P1|Overall Study|Lost to Follow-up|1
8671|NCT02091986|49933|P3|Overall Study|7 rand in error 1 patient decision|3
8672|NCT02091986|49934|P2|Overall Study|7 rand in error 1 patient decision|3
8673|NCT02091986|49935|P1|Overall Study|7 rand in error 1 patient decision|2
8674|NCT02091869|49984|P2|Overall Study|Withdrawal by Subject|3
8675|NCT02091869|49985|P1|Overall Study|Withdrawal by Subject|0
8676|NCT02091752|50026|P1|Overall Study|Adverse Event|1
8677|NCT02091752|50026|P1|Overall Study|Study terminated by Sponsor|2
8678|NCT02091726|50037|P1|Overall Study|Lost to Follow-up|6
8679|NCT02091414|50054|P1|Overall Study|Death|2
8680|NCT02091414|50054|P1|Overall Study|Withdrawal by Subject|2
8681|NCT02090855|50066|P1|Overall Study|no evaluable Standard of Truth results|2
8682|NCT02090764|50079|P2|Overall Study|Lost to Follow-up|2
8683|NCT02090764|50080|P1|Overall Study|Lost to Follow-up|2
8684|NCT02090764|50079|P2|Overall Study|Intercurrent illness and other|1
8685|NCT02090764|50080|P1|Overall Study|Intercurrent illness and other|1
8686|NCT02090764|50079|P2|Overall Study|Withdrawal by Subject|1
8687|NCT02090764|50080|P1|Overall Study|Withdrawal by Subject|2
8688|NCT02090764|50079|P2|Overall Study|Lack of Efficacy|13
8689|NCT02090764|50080|P1|Overall Study|Lack of Efficacy|0
8690|NCT02090764|50079|P2|Overall Study|Adverse Event|3
8691|NCT02090764|50080|P1|Overall Study|Adverse Event|1
8692|NCT02090413|50089|P3|Overall Study|Lost to Follow-up|0
8693|NCT02090413|50090|P2|Overall Study|Lost to Follow-up|1
8694|NCT02090413|50091|P1|Overall Study|Lost to Follow-up|1
8695|NCT02090413|50089|P3|Overall Study|Not Specified|0
8696|NCT02090413|50090|P2|Overall Study|Not Specified|1
8697|NCT02090413|50091|P1|Overall Study|Not Specified|2
8698|NCT02090413|50089|P3|Overall Study|Investigator Decision|0
8699|NCT02090413|50090|P2|Overall Study|Investigator Decision|1
8700|NCT02090413|50091|P1|Overall Study|Investigator Decision|1
8701|NCT02090413|50089|P3|Overall Study|Withdrawal by Subject|2
8702|NCT02090413|50090|P2|Overall Study|Withdrawal by Subject|2
8703|NCT02090413|50091|P1|Overall Study|Withdrawal by Subject|2
8704|NCT02090413|50089|P3|Overall Study|Flushing event|1
8705|NCT02090413|50090|P2|Overall Study|Flushing event|0
8706|NCT02090413|50091|P1|Overall Study|Flushing event|2
8707|NCT02090413|50089|P3|Overall Study|Adverse Event|20
8708|NCT02090413|50090|P2|Overall Study|Adverse Event|15
8709|NCT02090413|50091|P1|Overall Study|Adverse Event|11
8710|NCT02089737|50177|P1|Overall Study|Not treated|1
8711|NCT02089737|50177|P1|Overall Study|Survey form not completed|5
8712|NCT02089347|50186|P2|Overall Study|Protocol Violation|0
8713|NCT02089347|50187|P1|Overall Study|Protocol Violation|1
8714|NCT02088957|50227|P2|Overall Study|Lack of Efficacy|0
8715|NCT02088957|50228|P1|Overall Study|Lack of Efficacy|1
8716|NCT02088177|50244|P1|Overall Study|Lost to Follow-up|3
8717|NCT02087943|50256|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
8718|NCT02087943|50257|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
8719|NCT02087943|50258|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
8720|NCT02087943|50259|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
8721|NCT02087943|50260|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
8722|NCT02087943|50256|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
8723|NCT02087943|50257|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
8724|NCT02087943|50258|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
8725|NCT02087943|50259|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
8726|NCT02087943|50260|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
8727|NCT02087943|50256|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
8728|NCT02087943|50257|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
8729|NCT02087943|50258|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
8730|NCT02087943|50259|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
8731|NCT02087943|50260|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
8732|NCT02087943|50256|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
8733|NCT02087943|50257|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
8734|NCT02087943|50258|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
8735|NCT02087943|50259|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
8736|NCT02087943|50260|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
8737|NCT02087943|50256|P5|Active Treatment Phase Week 12-24|Adverse Event|1
8738|NCT02087943|50257|P4|Active Treatment Phase Week 12-24|Adverse Event|0
8739|NCT02087943|50258|P3|Active Treatment Phase Week 12-24|Adverse Event|2
8740|NCT02087943|50259|P2|Active Treatment Phase Week 12-24|Adverse Event|1
8741|NCT02087943|50260|P1|Active Treatment Phase Week 12-24|Adverse Event|0
8742|NCT02087943|50256|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
8743|NCT02087943|50257|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
8744|NCT02087943|50258|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
8745|NCT02087943|50259|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
8746|NCT02087943|50260|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
8747|NCT02087943|50256|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
8748|NCT02087943|50257|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
8749|NCT02087943|50258|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
8750|NCT02087943|50259|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
8751|NCT02087943|50260|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
8752|NCT02087943|50256|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
8753|NCT02087943|50257|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
8754|NCT02087943|50258|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
8755|NCT02087943|50259|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
8756|NCT02087943|50260|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
8757|NCT02087943|50256|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
8758|NCT02087943|50257|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
8759|NCT02087943|50258|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
8760|NCT02087943|50259|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
8761|NCT02087943|50260|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
8762|NCT02087943|50256|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
8763|NCT02087943|50257|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
8764|NCT02087943|50258|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
8765|NCT02087943|50259|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
8766|NCT02087943|50260|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
8767|NCT02087774|50286|P2|Overall Study|Were absent day of data collection|20
8768|NCT02087774|50287|P1|Overall Study|Were absent day of data collection|8
8769|NCT02087670|50307|P2|Overall Study|Withdrawal by Subject|2
8770|NCT02087670|50308|P1|Overall Study|Withdrawal by Subject|3
8771|NCT02087241|50320|P4|Overall Study|Study Terminated by Sponsor|4
8772|NCT02087241|50321|P3|Overall Study|Study Terminated by Sponsor|0
8773|NCT02087241|50322|P2|Overall Study|Study Terminated by Sponsor|2
8774|NCT02087241|50323|P1|Overall Study|Study Terminated by Sponsor|0
8775|NCT02087241|50320|P4|Overall Study|Progressive Disease|1
8776|NCT02087241|50321|P3|Overall Study|Progressive Disease|0
8777|NCT02087241|50322|P2|Overall Study|Progressive Disease|0
8778|NCT02087241|50323|P1|Overall Study|Progressive Disease|0
8779|NCT02087241|50320|P4|Overall Study|Withdrawal by Subject|1
8780|NCT02087241|50321|P3|Overall Study|Withdrawal by Subject|0
8781|NCT02087241|50322|P2|Overall Study|Withdrawal by Subject|0
8782|NCT02087241|50323|P1|Overall Study|Withdrawal by Subject|1
8783|NCT02087241|50320|P4|Overall Study|Death|1
8784|NCT02087241|50321|P3|Overall Study|Death|1
8785|NCT02087241|50322|P2|Overall Study|Death|1
8786|NCT02087241|50323|P1|Overall Study|Death|2
8787|NCT02087176|50349|P1|Overall Study|Study Terminated by Sponsor|2
8788|NCT02087176|50349|P1|Overall Study|Censored|19
8789|NCT02087176|50349|P1|Overall Study|Death|10
8790|NCT02087176|50349|P1|Overall Study|Withdrawal by Subject|1
8791|NCT02087059|50354|P1|Overall Study|Lost to Follow-up|1
8792|NCT02087059|50354|P1|Overall Study|Adverse Event|5
8793|NCT02087059|50354|P1|Overall Study|Disease Progression|1
8794|NCT02086591|50401|P1|Overall Study|protocol terminated|3
8795|NCT02086591|50401|P1|Overall Study|Withdrawal by Subject|1
8796|NCT02086591|50401|P1|Overall Study|Adverse Event|1
8797|NCT02085785|50409|P2|Overall Study|Lost to Follow-up|1
8798|NCT02085785|50410|P1|Overall Study|Lost to Follow-up|0
8799|NCT02085785|50409|P2|Overall Study|Withdrawal by Subject|1
8800|NCT02085785|50410|P1|Overall Study|Withdrawal by Subject|2
8801|NCT02085161|50434|P4|Overall Study|Other Reason|1
8802|NCT02085161|50435|P3|Overall Study|Other Reason|1
8803|NCT02085161|50436|P2|Overall Study|Other Reason|0
8804|NCT02085161|50437|P1|Overall Study|Other Reason|1
8805|NCT02085161|50434|P4|Overall Study|Withdrawal by Subject|3
8806|NCT02085161|50435|P3|Overall Study|Withdrawal by Subject|0
8807|NCT02085161|50436|P2|Overall Study|Withdrawal by Subject|4
8808|NCT02085161|50437|P1|Overall Study|Withdrawal by Subject|2
8809|NCT02085161|50434|P4|Overall Study|Protocol Violation|1
8810|NCT02085161|50435|P3|Overall Study|Protocol Violation|0
8811|NCT02085161|50436|P2|Overall Study|Protocol Violation|1
8812|NCT02085161|50437|P1|Overall Study|Protocol Violation|0
8813|NCT02085161|50434|P4|Overall Study|Adverse Event|5
8814|NCT02085161|50435|P3|Overall Study|Adverse Event|4
8815|NCT02085161|50436|P2|Overall Study|Adverse Event|5
8816|NCT02085161|50437|P1|Overall Study|Adverse Event|8
8817|NCT02085161|50434|P4|Overall Study|Not Treated|0
8818|NCT02085161|50435|P3|Overall Study|Not Treated|0
8819|NCT02085161|50436|P2|Overall Study|Not Treated|0
8820|NCT02085161|50437|P1|Overall Study|Not Treated|1
8821|NCT02084238|50505|P1|Overall Study|Lost to Follow-up|2
8822|NCT02084082|50518|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
8823|NCT02084082|50519|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
8824|NCT02084082|50520|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
8825|NCT02084082|50521|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
8826|NCT02084082|50518|P4|Washout Period 1 (35 Days)|Adverse Event|1
8827|NCT02084082|50519|P3|Washout Period 1 (35 Days)|Adverse Event|1
8828|NCT02084082|50520|P2|Washout Period 1 (35 Days)|Adverse Event|0
8829|NCT02084082|50521|P1|Washout Period 1 (35 Days)|Adverse Event|0
8830|NCT02084056|50562|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
8831|NCT02084056|50563|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
8832|NCT02084056|50564|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
8833|NCT02084056|50565|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
8834|NCT02084056|50562|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
8835|NCT02084056|50563|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
8836|NCT02084056|50564|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
8837|NCT02084056|50565|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
8838|NCT02083965|50597|P2|Treatment Period|Not Specified|0
8839|NCT02083965|50598|P1|Treatment Period|Not Specified|1
8840|NCT02083380|50700|P3|Overall Study|Other|6
8841|NCT02083380|50701|P2|Overall Study|Other|4
8842|NCT02083380|50702|P1|Overall Study|Other|8
8843|NCT02083380|50700|P3|Overall Study|Lost to Follow-up|3
8844|NCT02083380|50701|P2|Overall Study|Lost to Follow-up|3
8845|NCT02083380|50702|P1|Overall Study|Lost to Follow-up|5
8846|NCT02083380|50700|P3|Overall Study|Adverse Event|1
8847|NCT02083380|50701|P2|Overall Study|Adverse Event|0
8848|NCT02083380|50702|P1|Overall Study|Adverse Event|0
8849|NCT02083380|50700|P3|Overall Study|Physician Decision|3
8850|NCT02083380|50701|P2|Overall Study|Physician Decision|6
8851|NCT02083380|50702|P1|Overall Study|Physician Decision|1
8852|NCT02083380|50700|P3|Overall Study|Withdrawal by Subject|7
8853|NCT02083380|50701|P2|Overall Study|Withdrawal by Subject|3
8854|NCT02083380|50702|P1|Overall Study|Withdrawal by Subject|9
8855|NCT02083380|50700|P3|Overall Study|Lack of Efficacy|64
8856|NCT02083380|50701|P2|Overall Study|Lack of Efficacy|79
8857|NCT02083380|50702|P1|Overall Study|Lack of Efficacy|68
8858|NCT02082912|50846|P2|Overall Study|Physician Decision|1
8859|NCT02082912|50847|P1|Overall Study|Physician Decision|0
8860|NCT02082262|50911|P1|Overall Study|Adverse Event|48
8861|NCT02082262|50911|P1|Overall Study|Withdrawal by Subject|3
8862|NCT02082184|50917|P2|Overall Study|Subject non-compliance|1
8863|NCT02082184|50918|P1|Overall Study|Subject non-compliance|0
8864|NCT02082184|50917|P2|Overall Study|Lost to Follow-up|2
8865|NCT02082184|50918|P1|Overall Study|Lost to Follow-up|0
8866|NCT02082184|50917|P2|Overall Study|Protocol Violation|6
8867|NCT02082184|50918|P1|Overall Study|Protocol Violation|0
8868|NCT02082184|50917|P2|Overall Study|Withdrawal by Subject|2
8869|NCT02082184|50918|P1|Overall Study|Withdrawal by Subject|3
8870|NCT02082184|50917|P2|Overall Study|Device associated symptoms|0
8871|NCT02082184|50918|P1|Overall Study|Device associated symptoms|5
8872|NCT02082184|50917|P2|Overall Study|Medical diagnosis|2
8873|NCT02082184|50918|P1|Overall Study|Medical diagnosis|1
8874|NCT02082184|50917|P2|Overall Study|Adverse Event|0
8875|NCT02082184|50918|P1|Overall Study|Adverse Event|1
8876|NCT02082158|50943|P6|Overall Study|Failed Fit-testing|7
8877|NCT02082158|50944|P5|Overall Study|Failed Fit-testing|3
8878|NCT02082158|50945|P4|Overall Study|Failed Fit-testing|4
8879|NCT02082158|50946|P3|Overall Study|Failed Fit-testing|14
8880|NCT02082158|50947|P2|Overall Study|Failed Fit-testing|8
8881|NCT02082158|50948|P1|Overall Study|Failed Fit-testing|8
8882|NCT02082158|50943|P6|Overall Study|Withdrawal by Subject|0
8883|NCT02082158|50944|P5|Overall Study|Withdrawal by Subject|1
8884|NCT02082158|50945|P4|Overall Study|Withdrawal by Subject|0
8885|NCT02082158|50946|P3|Overall Study|Withdrawal by Subject|0
8886|NCT02082158|50947|P2|Overall Study|Withdrawal by Subject|0
8887|NCT02082158|50948|P1|Overall Study|Withdrawal by Subject|0
8888|NCT02081859|50970|P2|Overall Study|Other reasons|0
8889|NCT02081859|50971|P1|Overall Study|Other reasons|2
8890|NCT02081859|50970|P2|Overall Study|< 4 embryos|23
8891|NCT02081859|50971|P1|Overall Study|< 4 embryos|27
8892|NCT02081859|50970|P2|Overall Study|Unanticipated freeze all cycle|6
8893|NCT02081859|50971|P1|Overall Study|Unanticipated freeze all cycle|2
8894|NCT02081859|50970|P2|Overall Study|No sperm|0
8895|NCT02081859|50971|P1|Overall Study|No sperm|1
8896|NCT02081859|50970|P2|Overall Study|No fertilization|2
8897|NCT02081859|50971|P1|Overall Study|No fertilization|2
8898|NCT02081677|50983|P4|Overall Study|Unsatisfactory Lens Fitting|0
8899|NCT02081677|50984|P3|Overall Study|Unsatisfactory Lens Fitting|0
8900|NCT02081677|50985|P2|Overall Study|Unsatisfactory Lens Fitting|1
8901|NCT02081677|50986|P1|Overall Study|Unsatisfactory Lens Fitting|0
8902|NCT02081677|50983|P4|Overall Study|Not comfortable with lens care system|0
8903|NCT02081677|50984|P3|Overall Study|Not comfortable with lens care system|0
8904|NCT02081677|50985|P2|Overall Study|Not comfortable with lens care system|0
8905|NCT02081677|50986|P1|Overall Study|Not comfortable with lens care system|1
8906|NCT02081677|50983|P4|Overall Study|No Longer Meets Eligibility Criteria|0
8907|NCT02081677|50984|P3|Overall Study|No Longer Meets Eligibility Criteria|1
8908|NCT02081677|50985|P2|Overall Study|No Longer Meets Eligibility Criteria|0
8909|NCT02081677|50986|P1|Overall Study|No Longer Meets Eligibility Criteria|0
8910|NCT02081677|50983|P4|Overall Study|Adverse Event|0
8911|NCT02081677|50984|P3|Overall Study|Adverse Event|1
8912|NCT02081677|50985|P2|Overall Study|Adverse Event|0
8913|NCT02081677|50986|P1|Overall Study|Adverse Event|0
8914|NCT02081599|51078|P2|Period 2：Open-label Period|Withdrawal by Subject|0
8915|NCT02081599|51079|P1|Period 2：Open-label Period|Withdrawal by Subject|2
8916|NCT02081599|51078|P2|Period 2：Open-label Period|Physician Decision|0
8917|NCT02081599|51079|P1|Period 2：Open-label Period|Physician Decision|1
8918|NCT02081599|51078|P2|Period 2：Open-label Period|Lack of Efficacy|4
8919|NCT02081599|51079|P1|Period 2：Open-label Period|Lack of Efficacy|2
8920|NCT02081599|51078|P2|Period 2：Open-label Period|Adverse Event|0
8921|NCT02081599|51079|P1|Period 2：Open-label Period|Adverse Event|1
8922|NCT02081599|51078|P2|Period 1：Double-blind Period|stopping criteria|0
8923|NCT02081599|51079|P1|Period 1：Double-blind Period|stopping criteria|1
8924|NCT02081599|51078|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
8925|NCT02081599|51079|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
8926|NCT02081599|51078|P2|Period 1：Double-blind Period|Protocol Violation|1
8927|NCT02081599|51079|P1|Period 1：Double-blind Period|Protocol Violation|0
8928|NCT02081599|51078|P2|Period 1：Double-blind Period|Physician Decision|0
8929|NCT02081599|51079|P1|Period 1：Double-blind Period|Physician Decision|1
8930|NCT02081599|51078|P2|Period 1：Double-blind Period|Lack of Efficacy|1
8931|NCT02081599|51079|P1|Period 1：Double-blind Period|Lack of Efficacy|2
8932|NCT02081599|51078|P2|Period 1：Double-blind Period|Adverse Event|0
8933|NCT02081599|51079|P1|Period 1：Double-blind Period|Adverse Event|3
8934|NCT02081586|51097|P4|Overall Study|Head injury not related to study|0
8935|NCT02081586|51098|P3|Overall Study|Head injury not related to study|1
8936|NCT02081586|51099|P2|Overall Study|Head injury not related to study|0
8937|NCT02081586|51100|P1|Overall Study|Head injury not related to study|0
8938|NCT02081586|51097|P4|Overall Study|Lost to Follow-up|1
8939|NCT02081586|51098|P3|Overall Study|Lost to Follow-up|0
8940|NCT02081586|51099|P2|Overall Study|Lost to Follow-up|1
8941|NCT02081586|51100|P1|Overall Study|Lost to Follow-up|0
8942|NCT02081183|51157|P2|Overall Study|Not specified|3
8943|NCT02081183|51158|P1|Overall Study|Not specified|3
8944|NCT02081183|51157|P2|Overall Study|Protocol Violation|0
8945|NCT02081183|51158|P1|Overall Study|Protocol Violation|1
8946|NCT02081183|51157|P2|Overall Study|Lost to Follow-up|1
8947|NCT02081183|51158|P1|Overall Study|Lost to Follow-up|0
8948|NCT02081079|51174|P2|Overall Study|Lost to Follow-up|0
8949|NCT02081079|51175|P1|Overall Study|Lost to Follow-up|1
8950|NCT02081079|51174|P2|Overall Study|Lack of Efficacy|2
8951|NCT02081079|51175|P1|Overall Study|Lack of Efficacy|3
8952|NCT02081001|51248|P12|Overall Study|Adverse Event|0
8953|NCT02081001|51249|P11|Overall Study|Adverse Event|0
8954|NCT02081001|51250|P10|Overall Study|Adverse Event|0
8955|NCT02081001|51251|P9|Overall Study|Adverse Event|0
8956|NCT02081001|51252|P8|Overall Study|Adverse Event|0
8957|NCT02081001|51253|P7|Overall Study|Adverse Event|0
8958|NCT02081001|51254|P6|Overall Study|Adverse Event|0
8959|NCT02081001|51255|P5|Overall Study|Adverse Event|1
8960|NCT02081001|51256|P4|Overall Study|Adverse Event|0
8961|NCT02081001|51257|P3|Overall Study|Adverse Event|0
8962|NCT02081001|51258|P2|Overall Study|Adverse Event|0
8963|NCT02081001|51259|P1|Overall Study|Adverse Event|0
8964|NCT02080481|51354|P2|Overall Study|Never received a block.|0
8965|NCT02080481|51355|P1|Overall Study|Never received a block.|1
8966|NCT02080091|51373|P1|Overall Study|Other|1
8967|NCT02080091|51373|P1|Overall Study|Withdrawal by Subject|1
8968|NCT02080091|51373|P1|Overall Study|Death|1
8969|NCT02080091|51373|P1|Overall Study|Study Terminated|22
8970|NCT02079844|51382|P3|Treatment Period 2|Voluntary Withdrawal|0
8971|NCT02079844|51383|P2|Treatment Period 2|Voluntary Withdrawal|1
8972|NCT02079844|51384|P1|Treatment Period 2|Voluntary Withdrawal|0
8973|NCT02079844|51382|P3|Treatment Period 1|Voluntary Withdrawal|2
8974|NCT02079844|51383|P2|Treatment Period 1|Voluntary Withdrawal|0
8975|NCT02079844|51384|P1|Treatment Period 1|Voluntary Withdrawal|0
8976|NCT02079805|51442|P2|Overall Study|Voluntary Withdrawal|1
8977|NCT02079805|51443|P1|Overall Study|Voluntary Withdrawal|0
8978|NCT02079805|51442|P2|Overall Study|Pretreatment Event/Adverse Event|1
8979|NCT02079805|51443|P1|Overall Study|Pretreatment Event/Adverse Event|0
8980|NCT02079649|51465|P4|Overall Study|Randomization error (prior to treatment)|0
8981|NCT02079649|51466|P3|Overall Study|Randomization error (prior to treatment)|1
8982|NCT02079649|51467|P2|Overall Study|Randomization error (prior to treatment)|0
8983|NCT02079649|51468|P1|Overall Study|Randomization error (prior to treatment)|1
8984|NCT02079649|51465|P4|Overall Study|Withdrawal by Subject|1
8985|NCT02079649|51466|P3|Overall Study|Withdrawal by Subject|0
8986|NCT02079649|51467|P2|Overall Study|Withdrawal by Subject|0
8987|NCT02079649|51468|P1|Overall Study|Withdrawal by Subject|0
8988|NCT02079649|51465|P4|Overall Study|Lost to Follow-up|1
8989|NCT02079649|51466|P3|Overall Study|Lost to Follow-up|0
8990|NCT02079649|51467|P2|Overall Study|Lost to Follow-up|0
8991|NCT02079649|51468|P1|Overall Study|Lost to Follow-up|0
8992|NCT02079532|51483|P1|Overall Study|Not specified|3
8993|NCT02079532|51483|P1|Overall Study|Inclusion into ReFIRST|3
8994|NCT02079532|51483|P1|Overall Study|Administrative problems|1
8995|NCT02079532|51483|P1|Overall Study|Withdrawal by Subject|1
8996|NCT02079532|51483|P1|Overall Study|Protocol Violation|3
8997|NCT02079532|51483|P1|Overall Study|Lack of Efficacy|9
8998|NCT02079532|51483|P1|Overall Study|Additional or changed therapy|2
8999|NCT02079532|51483|P1|Overall Study|Adverse Event|7
9000|NCT02079519|51505|P1|Overall Study|Adverse Event|1
9001|NCT02079519|51505|P1|Overall Study|Disease Progression|9
9002|NCT02077374|51548|P2|Overall Study|Protocol Violation|1
9003|NCT02077374|51549|P1|Overall Study|Protocol Violation|0
9004|NCT02077374|51548|P2|Overall Study|Withdrawal by Subject|1
9005|NCT02077374|51549|P1|Overall Study|Withdrawal by Subject|0
9006|NCT02076334|51682|P4|Overall Study|muscle soreness|1
9007|NCT02076334|51683|P3|Overall Study|muscle soreness|0
9008|NCT02076334|51684|P2|Overall Study|muscle soreness|0
9009|NCT02076334|51685|P1|Overall Study|muscle soreness|0
9010|NCT02076334|51682|P4|Overall Study|Lost to Follow-up|0
9011|NCT02076334|51683|P3|Overall Study|Lost to Follow-up|1
9012|NCT02076334|51684|P2|Overall Study|Lost to Follow-up|1
9013|NCT02076334|51685|P1|Overall Study|Lost to Follow-up|0
9014|NCT02076334|51682|P4|Overall Study|Protocol Violation|0
9015|NCT02076334|51683|P3|Overall Study|Protocol Violation|0
9016|NCT02076334|51684|P2|Overall Study|Protocol Violation|0
9017|NCT02076334|51685|P1|Overall Study|Protocol Violation|1
9018|NCT02076009|51701|P2|Overall Study|Subjects randomized but not treated|3
9019|NCT02076009|51702|P1|Overall Study|Subjects randomized but not treated|2
9020|NCT02076009|51701|P2|Overall Study|Ongoing|249
9021|NCT02076009|51702|P1|Overall Study|Ongoing|226
9022|NCT02076009|51701|P2|Overall Study|Progressive disease|0
9023|NCT02076009|51702|P1|Overall Study|Progressive disease|1
9024|NCT02076009|51701|P2|Overall Study|Lost to Follow-up|1
9025|NCT02076009|51702|P1|Overall Study|Lost to Follow-up|1
9026|NCT02076009|51701|P2|Overall Study|Withdrawal by Subject|3
9027|NCT02076009|51702|P1|Overall Study|Withdrawal by Subject|9
9028|NCT02076009|51701|P2|Overall Study|Death|30
9029|NCT02076009|51702|P1|Overall Study|Death|44
9030|NCT02075632|51724|P2|Overall Study|Withdrawal by Subject|1
9031|NCT02075632|51725|P1|Overall Study|Withdrawal by Subject|0
9032|NCT02075632|51724|P2|Overall Study|Lost to Follow-up|3
9033|NCT02075632|51725|P1|Overall Study|Lost to Follow-up|0
9034|NCT02075632|51724|P2|Overall Study|Adverse Event|1
9035|NCT02075632|51725|P1|Overall Study|Adverse Event|1
9036|NCT02075515|51738|P3|Overall Study|Lost to Follow-up|6
9037|NCT02075515|51739|P2|Overall Study|Lost to Follow-up|3
9038|NCT02075515|51740|P1|Overall Study|Lost to Follow-up|1
9039|NCT02075515|51738|P3|Overall Study|Withdrawal by Subject|1
9040|NCT02075515|51739|P2|Overall Study|Withdrawal by Subject|0
9041|NCT02075515|51740|P1|Overall Study|Withdrawal by Subject|2
9042|NCT02075515|51738|P3|Overall Study|Non-Serious Adverse Event|0
9043|NCT02075515|51739|P2|Overall Study|Non-Serious Adverse Event|1
9044|NCT02075515|51740|P1|Overall Study|Non-Serious Adverse Event|0
9045|NCT02075515|51738|P3|Overall Study|Serious Adverse Event|1
9046|NCT02075515|51739|P2|Overall Study|Serious Adverse Event|1
9047|NCT02075515|51740|P1|Overall Study|Serious Adverse Event|1
9048|NCT02075463|51775|P1|Overall Study|Withdrawal by Subject|1
9049|NCT02075463|51775|P1|Overall Study|Par. reached stopping criteria|4
9050|NCT02075463|51775|P1|Overall Study|Adverse Event|3
9051|NCT02075073|51849|P3|Overall Study|Withdrawal by Subject|0
9052|NCT02075073|51850|P2|Overall Study|Withdrawal by Subject|1
9053|NCT02075073|51851|P1|Overall Study|Withdrawal by Subject|0
9054|NCT02075008|51868|P1|Overall Study|Study terminated by Sponsor|159
9055|NCT02075008|51868|P1|Overall Study|Withdrawal by Subject|6
9056|NCT02075008|51868|P1|Overall Study|Adverse Event|5
9057|NCT02075008|51868|P1|Overall Study|Death|1
9058|NCT02075008|51868|P1|Overall Study|Lack of Efficacy|1
9059|NCT02075008|51868|P1|Overall Study|Lost to Follow-up|1
9060|NCT02075008|51868|P1|Overall Study|Physician Decision|1
9061|NCT02075008|51868|P1|Overall Study|Pregnancy|1
9062|NCT02075008|51868|P1|Overall Study|Technical problems|1
9063|NCT02074982|51891|P2|Overall Study|Death|2
9064|NCT02074982|51892|P1|Overall Study|Death|0
9065|NCT02074982|51891|P2|Overall Study|Subject/guardian decision|24
9066|NCT02074982|51892|P1|Overall Study|Subject/guardian decision|15
9067|NCT02074982|51891|P2|Overall Study|Technical problems|2
9068|NCT02074982|51892|P1|Overall Study|Technical problems|0
9069|NCT02074982|51891|P2|Overall Study|Protocol deviation|3
9070|NCT02074982|51892|P1|Overall Study|Protocol deviation|4
9071|NCT02074982|51891|P2|Overall Study|Pregnancy|2
9072|NCT02074982|51892|P1|Overall Study|Pregnancy|1
9073|NCT02074982|51891|P2|Overall Study|Physician Decision|1
9074|NCT02074982|51892|P1|Overall Study|Physician Decision|1
9075|NCT02074982|51891|P2|Overall Study|Non-compliance with study treatment|2
9076|NCT02074982|51892|P1|Overall Study|Non-compliance with study treatment|0
9077|NCT02074982|51891|P2|Overall Study|Lost to Follow-up|10
9078|NCT02074982|51892|P1|Overall Study|Lost to Follow-up|9
9079|NCT02074982|51891|P2|Overall Study|Lack of Efficacy|1
9080|NCT02074982|51892|P1|Overall Study|Lack of Efficacy|6
9081|NCT02074982|51891|P2|Overall Study|Adverse Event|7
9082|NCT02074982|51892|P1|Overall Study|Adverse Event|15
9083|NCT02074553|51913|P8|Washout Period 3|Physician Decision|1
9084|NCT02074553|51914|P7|Washout Period 3|Physician Decision|0
9085|NCT02074553|51915|P6|Washout Period 3|Physician Decision|0
9086|NCT02074553|51916|P5|Washout Period 3|Physician Decision|0
9087|NCT02074553|51917|P4|Washout Period 3|Physician Decision|0
9088|NCT02074553|51918|P3|Washout Period 3|Physician Decision|0
9089|NCT02074553|51919|P2|Washout Period 3|Physician Decision|0
9090|NCT02074553|51920|P1|Washout Period 3|Physician Decision|0
9091|NCT02074553|51913|P8|Washout Period 2|Lost to Follow-up|0
9092|NCT02074553|51914|P7|Washout Period 2|Lost to Follow-up|0
9093|NCT02074553|51915|P6|Washout Period 2|Lost to Follow-up|0
9094|NCT02074553|51916|P5|Washout Period 2|Lost to Follow-up|0
9095|NCT02074553|51917|P4|Washout Period 2|Lost to Follow-up|0
9096|NCT02074553|51918|P3|Washout Period 2|Lost to Follow-up|1
9097|NCT02074553|51919|P2|Washout Period 2|Lost to Follow-up|0
9098|NCT02074553|51920|P1|Washout Period 2|Lost to Follow-up|0
9099|NCT02074553|51913|P8|Washout Period 2|Physician Decision|0
9100|NCT02074553|51914|P7|Washout Period 2|Physician Decision|0
9101|NCT02074553|51915|P6|Washout Period 2|Physician Decision|1
9102|NCT02074553|51916|P5|Washout Period 2|Physician Decision|0
9103|NCT02074553|51917|P4|Washout Period 2|Physician Decision|0
9104|NCT02074553|51918|P3|Washout Period 2|Physician Decision|0
9105|NCT02074553|51919|P2|Washout Period 2|Physician Decision|0
9106|NCT02074553|51920|P1|Washout Period 2|Physician Decision|0
9107|NCT02074553|51913|P8|Washout Period 2|Adverse Event|0
9108|NCT02074553|51914|P7|Washout Period 2|Adverse Event|1
9109|NCT02074553|51915|P6|Washout Period 2|Adverse Event|0
9110|NCT02074553|51916|P5|Washout Period 2|Adverse Event|0
9111|NCT02074553|51917|P4|Washout Period 2|Adverse Event|0
9112|NCT02074553|51918|P3|Washout Period 2|Adverse Event|0
9113|NCT02074553|51919|P2|Washout Period 2|Adverse Event|0
9114|NCT02074553|51920|P1|Washout Period 2|Adverse Event|0
9115|NCT02074553|51913|P8|Washout Period 1|Unspecified|0
9116|NCT02074553|51914|P7|Washout Period 1|Unspecified|0
9117|NCT02074553|51915|P6|Washout Period 1|Unspecified|1
9118|NCT02074553|51916|P5|Washout Period 1|Unspecified|0
9119|NCT02074553|51917|P4|Washout Period 1|Unspecified|0
9120|NCT02074553|51918|P3|Washout Period 1|Unspecified|0
9121|NCT02074553|51919|P2|Washout Period 1|Unspecified|0
9122|NCT02074553|51920|P1|Washout Period 1|Unspecified|0
9123|NCT02074553|51913|P8|Washout Period 1|Physician Decision|0
9124|NCT02074553|51914|P7|Washout Period 1|Physician Decision|0
9125|NCT02074553|51915|P6|Washout Period 1|Physician Decision|0
9126|NCT02074553|51916|P5|Washout Period 1|Physician Decision|0
9127|NCT02074553|51917|P4|Washout Period 1|Physician Decision|1
9128|NCT02074553|51918|P3|Washout Period 1|Physician Decision|0
9129|NCT02074553|51919|P2|Washout Period 1|Physician Decision|0
9130|NCT02074553|51920|P1|Washout Period 1|Physician Decision|0
9131|NCT02074553|51913|P8|Washout Period 1|Adverse Event|0
9132|NCT02074553|51914|P7|Washout Period 1|Adverse Event|0
9133|NCT02074553|51915|P6|Washout Period 1|Adverse Event|0
9134|NCT02074553|51916|P5|Washout Period 1|Adverse Event|0
9135|NCT02074553|51917|P4|Washout Period 1|Adverse Event|0
9136|NCT02074553|51918|P3|Washout Period 1|Adverse Event|0
9137|NCT02074553|51919|P2|Washout Period 1|Adverse Event|0
9138|NCT02074553|51920|P1|Washout Period 1|Adverse Event|1
9139|NCT02074553|51913|P8|Intervention Period 1|Family Emergency|0
9140|NCT02074553|51914|P7|Intervention Period 1|Family Emergency|0
9141|NCT02074553|51915|P6|Intervention Period 1|Family Emergency|0
9142|NCT02074553|51916|P5|Intervention Period 1|Family Emergency|0
9143|NCT02074553|51917|P4|Intervention Period 1|Family Emergency|1
9144|NCT02074553|51918|P3|Intervention Period 1|Family Emergency|0
9145|NCT02074553|51919|P2|Intervention Period 1|Family Emergency|0
9146|NCT02074553|51920|P1|Intervention Period 1|Family Emergency|0
9147|NCT02074514|52102|P2|Overall Study|Withdrew Consent|1
9148|NCT02074514|52103|P1|Overall Study|Withdrew Consent|0
9149|NCT02074514|52102|P2|Overall Study|Lost to Follow-up|1
9150|NCT02074514|52103|P1|Overall Study|Lost to Follow-up|0
9151|NCT02074514|52102|P2|Overall Study|Lack of Efficacy|2
9152|NCT02074514|52103|P1|Overall Study|Lack of Efficacy|3
9153|NCT02074059|52244|P6|Overall Study|Death|1
9154|NCT02074059|52245|P5|Overall Study|Death|1
9155|NCT02074059|52246|P4|Overall Study|Death|0
9156|NCT02074059|52247|P3|Overall Study|Death|0
9157|NCT02074059|52248|P2|Overall Study|Death|0
9158|NCT02074059|52249|P1|Overall Study|Death|0
9159|NCT02073656|52296|P1|Primary Study|Withdrew Consent|1
9160|NCT02073656|52296|P1|Primary Study|Death|1
9161|NCT02073656|52296|P1|Primary Study|Lost to Follow-up|6
9162|NCT02072980|52374|P2|Period 2, Second Wear|Adverse Event|1
9163|NCT02072980|52375|P1|Period 2, Second Wear|Adverse Event|0
9164|NCT02072096|52397|P2|Overall Study|Lost to Follow-up|0
9165|NCT02072096|52398|P1|Overall Study|Lost to Follow-up|1
9166|NCT02072096|52397|P2|Overall Study|Study Terminated by Sponsor|30
9167|NCT02072096|52398|P1|Overall Study|Study Terminated by Sponsor|43
9168|NCT02072096|52397|P2|Overall Study|Physician Decision|1
9169|NCT02072096|52398|P1|Overall Study|Physician Decision|0
9170|NCT02072096|52397|P2|Overall Study|Death|0
9171|NCT02072096|52398|P1|Overall Study|Death|2
9172|NCT02072096|52397|P2|Overall Study|No Reason Provided|2
9173|NCT02072096|52398|P1|Overall Study|No Reason Provided|4
9174|NCT02072096|52397|P2|Overall Study|Adverse Event|2
9175|NCT02072096|52398|P1|Overall Study|Adverse Event|5
9176|NCT02072096|52397|P2|Overall Study|Withdrawal by Subject|7
9177|NCT02072096|52398|P1|Overall Study|Withdrawal by Subject|5
9178|NCT02072096|52397|P2|Overall Study|Protocol Violation|7
9179|NCT02072096|52398|P1|Overall Study|Protocol Violation|7
9180|NCT02072096|52397|P2|Overall Study|Lack of Efficacy|29
9181|NCT02072096|52398|P1|Overall Study|Lack of Efficacy|18
9182|NCT02071849|52420|P1|2-year Extended Follow-up|Adverse Event|1
9183|NCT02071849|52420|P1|6-month Primary Endpoint|Adverse Event|1
9184|NCT02071849|52420|P1|6-month Primary Endpoint|Did not receive device|4
9185|NCT02071771|52486|P2|Period 1: First 10 Days|Unavailable lens power|0
9186|NCT02071771|52487|P1|Period 1: First 10 Days|Unavailable lens power|1
9187|NCT02071771|52486|P2|Period 1: First 10 Days|Unacceptable lens fit|0
9188|NCT02071771|52487|P1|Period 1: First 10 Days|Unacceptable lens fit|1
9189|NCT02071082|52516|P2|Overall Study|Participants Still on Study|68
9190|NCT02071082|52517|P1|Overall Study|Participants Still on Study|3
9191|NCT02071082|52516|P2|Overall Study|Lost to Follow-up|1
9192|NCT02071082|52517|P1|Overall Study|Lost to Follow-up|0
9193|NCT02071082|52516|P2|Overall Study|Withdrew Consent|3
9194|NCT02071082|52517|P1|Overall Study|Withdrew Consent|0
9195|NCT02071082|52516|P2|Overall Study|Non-Compliance with Study Drug|1
9196|NCT02071082|52517|P1|Overall Study|Non-Compliance with Study Drug|0
9197|NCT02071082|52516|P2|Overall Study|Adverse Event|1
9198|NCT02071082|52517|P1|Overall Study|Adverse Event|0
9199|NCT02071082|52516|P2|Overall Study|Enrolled and Never Treated|1
9200|NCT02071082|52517|P1|Overall Study|Enrolled and Never Treated|1
9201|NCT02070965|52548|P3|Overall Study|Subject moved|0
9202|NCT02070965|52549|P2|Overall Study|Subject moved|0
9203|NCT02070965|52550|P1|Overall Study|Subject moved|1
9204|NCT02070965|52548|P3|Overall Study|Withdrawal by Subject|1
9205|NCT02070965|52549|P2|Overall Study|Withdrawal by Subject|1
9206|NCT02070965|52550|P1|Overall Study|Withdrawal by Subject|1
9207|NCT02070965|52548|P3|Overall Study|Lost to Follow-up|0
9208|NCT02070965|52549|P2|Overall Study|Lost to Follow-up|1
9209|NCT02070965|52550|P1|Overall Study|Lost to Follow-up|0
9210|NCT02070588|52591|P3|Overall Study|Adverse Event|0
9211|NCT02070588|52592|P2|Overall Study|Adverse Event|0
9212|NCT02070588|52593|P1|Overall Study|Adverse Event|1
9213|NCT02070588|52591|P3|Overall Study|Writhdrawal due to early termination|0
9214|NCT02070588|52592|P2|Overall Study|Writhdrawal due to early termination|0
9215|NCT02070588|52593|P1|Overall Study|Writhdrawal due to early termination|9
9216|NCT02070588|52591|P3|Overall Study|Withdrawal by Subject|0
9217|NCT02070588|52592|P2|Overall Study|Withdrawal by Subject|1
9218|NCT02070588|52593|P1|Overall Study|Withdrawal by Subject|29
9219|NCT02070380|52611|P4|Second Injection|Protocol Violation|5
9220|NCT02070380|52612|P3|Second Injection|Protocol Violation|1
9221|NCT02070380|52613|P2|Second Injection|Protocol Violation|1
9222|NCT02070380|52614|P1|Second Injection|Protocol Violation|0
9223|NCT02070380|52611|P4|Second Injection|Image sets missing or technically inadeq|0
9224|NCT02070380|52612|P3|Second Injection|Image sets missing or technically inadeq|0
9225|NCT02070380|52613|P2|Second Injection|Image sets missing or technically inadeq|1
9226|NCT02070380|52614|P1|Second Injection|Image sets missing or technically inadeq|0
9227|NCT02070380|52611|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
9228|NCT02070380|52612|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
9229|NCT02070380|52613|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
9230|NCT02070380|52614|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
9231|NCT02069093|52673|P1|Overall Study|Adverse Event|10
9232|NCT02069093|52673|P1|Overall Study|Abnormal laboratory values|1
9233|NCT02069093|52673|P1|Overall Study|Withdrawal by Subject|2
9234|NCT02069093|52673|P1|Overall Study|Administrative problems|1
9235|NCT02069093|52673|P1|Overall Study|Death|1
9236|NCT02069093|52673|P1|Overall Study|New cancer therapy|1
9237|NCT02069093|52673|P1|Overall Study|Disease progression|14
9238|NCT02068443|52685|P3|Overall Study|Other Reason Not Specified|0
9239|NCT02068443|52686|P2|Overall Study|Other Reason Not Specified|0
9240|NCT02068443|52687|P1|Overall Study|Other Reason Not Specified|1
9241|NCT02068443|52685|P3|Overall Study|Lack of Efficacy|0
9242|NCT02068443|52686|P2|Overall Study|Lack of Efficacy|1
9243|NCT02068443|52687|P1|Overall Study|Lack of Efficacy|2
9244|NCT02068443|52685|P3|Overall Study|Voluntary Withdrawal|1
9245|NCT02068443|52686|P2|Overall Study|Voluntary Withdrawal|0
9246|NCT02068443|52687|P1|Overall Study|Voluntary Withdrawal|4
9247|NCT02068443|52685|P3|Overall Study|Pretreatment Event/Adverse Event|2
9248|NCT02068443|52686|P2|Overall Study|Pretreatment Event/Adverse Event|5
9249|NCT02068443|52687|P1|Overall Study|Pretreatment Event/Adverse Event|0
9250|NCT02068222|52722|P1|Overall Study|Lost to Follow-up|1
9251|NCT02067728|52747|P2|6 Month Measurements|Unable to attend|97
9252|NCT02067728|52748|P1|6 Month Measurements|Unable to attend|114
9253|NCT02067728|52747|P2|6 Month Follow up Survey|Lost to Follow-up|60
9254|NCT02067728|52748|P1|6 Month Follow up Survey|Lost to Follow-up|48
9255|NCT02067728|52747|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
9256|NCT02067728|52748|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
9257|NCT02067533|52818|P2|Overall Study|Lost to Follow-up|2
9258|NCT02067533|52819|P1|Overall Study|Lost to Follow-up|4
9259|NCT02066922|52834|P1|Overall Study|Adverse Event|1
9260|NCT02066402|52888|P2|Overall Study|Protocol driven decision point|1
9261|NCT02066402|52889|P1|Overall Study|Protocol driven decision point|0
9262|NCT02066402|52888|P2|Overall Study|Progressive disease-clinical progression|1
9263|NCT02066402|52889|P1|Overall Study|Progressive disease-clinical progression|0
9264|NCT02066402|52888|P2|Overall Study|Withdrawal by Subject|11
9265|NCT02066402|52889|P1|Overall Study|Withdrawal by Subject|14
9266|NCT02066402|52888|P2|Overall Study|Lost to Follow-up|8
9267|NCT02066402|52889|P1|Overall Study|Lost to Follow-up|11
9268|NCT02066402|52888|P2|Overall Study|Adverse Event|2
9269|NCT02066402|52889|P1|Overall Study|Adverse Event|1
9270|NCT02066233|52917|P2|EG Scan II (Day 1)|difficulty intubating subject|6
9271|NCT02066233|52918|P1|EG Scan II (Day 1)|difficulty intubating subject|6
9272|NCT02066051|52926|P1|Overall Study|Subject developed active GVHD|1
9273|NCT02064920|53107|P2|Overall Study|Withdrawal by Subject|3
9274|NCT02064920|53108|P1|Overall Study|Withdrawal by Subject|1
9275|NCT02064920|53107|P2|Overall Study|Technical Problems|1
9276|NCT02064920|53108|P1|Overall Study|Technical Problems|0
9277|NCT02064920|53107|P2|Overall Study|Physician Decision|1
9278|NCT02064920|53108|P1|Overall Study|Physician Decision|0
9279|NCT02064920|53107|P2|Overall Study|Adverse Event|4
9280|NCT02064920|53108|P1|Overall Study|Adverse Event|0
9281|NCT02064894|53138|P3|Overall Study|Withdrawal by Subject|115
9282|NCT02064894|53139|P2|Overall Study|Withdrawal by Subject|102
9283|NCT02064894|53140|P1|Overall Study|Withdrawal by Subject|43
9284|NCT02064231|53151|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
9285|NCT02064231|53152|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
9286|NCT02064231|53153|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
9287|NCT02064231|53154|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
9288|NCT02064231|53151|P4|First Test Period (Test A or Test C)|Adverse Event|0
9289|NCT02064231|53152|P3|First Test Period (Test A or Test C)|Adverse Event|1
9290|NCT02064231|53153|P2|First Test Period (Test A or Test C)|Adverse Event|0
9291|NCT02064231|53154|P1|First Test Period (Test A or Test C)|Adverse Event|1
9292|NCT02064231|53151|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
9293|NCT02064231|53152|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
9294|NCT02064231|53153|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
9295|NCT02064231|53154|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
9296|NCT02064231|53151|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
9297|NCT02064231|53152|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
9298|NCT02064231|53153|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
9299|NCT02064231|53154|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
9300|NCT02064205|53166|P1|Overall Study|Withdrawal by Subject|1
9301|NCT02063880|53184|P2|Overall Study|Ineligible|2
9302|NCT02063880|53185|P1|Overall Study|Ineligible|0
9303|NCT02063880|53184|P2|Overall Study|Lost to Follow-up|7
9304|NCT02063880|53185|P1|Overall Study|Lost to Follow-up|7
9305|NCT02063880|53184|P2|Overall Study|Death|18
9306|NCT02063880|53185|P1|Overall Study|Death|21
9307|NCT02063854|53202|P7|Overall Study|Did Not Receive Study Drug|0
9308|NCT02063854|53203|P6|Overall Study|Did Not Receive Study Drug|1
9309|NCT02063854|53204|P5|Overall Study|Did Not Receive Study Drug|0
9310|NCT02063854|53205|P4|Overall Study|Did Not Receive Study Drug|0
9311|NCT02063854|53206|P3|Overall Study|Did Not Receive Study Drug|0
9312|NCT02063854|53207|P2|Overall Study|Did Not Receive Study Drug|0
9313|NCT02063854|53208|P1|Overall Study|Did Not Receive Study Drug|0
9314|NCT02063854|53202|P7|Overall Study|Reason Not Specified|0
9315|NCT02063854|53203|P6|Overall Study|Reason Not Specified|0
9316|NCT02063854|53204|P5|Overall Study|Reason Not Specified|0
9317|NCT02063854|53205|P4|Overall Study|Reason Not Specified|0
9318|NCT02063854|53206|P3|Overall Study|Reason Not Specified|0
9319|NCT02063854|53207|P2|Overall Study|Reason Not Specified|0
9320|NCT02063854|53208|P1|Overall Study|Reason Not Specified|1
9321|NCT02063854|53202|P7|Overall Study|Surgical Dental Work Performed/Planned|1
9322|NCT02063854|53203|P6|Overall Study|Surgical Dental Work Performed/Planned|6
9323|NCT02063854|53204|P5|Overall Study|Surgical Dental Work Performed/Planned|1
9324|NCT02063854|53205|P4|Overall Study|Surgical Dental Work Performed/Planned|1
9325|NCT02063854|53206|P3|Overall Study|Surgical Dental Work Performed/Planned|6
9326|NCT02063854|53207|P2|Overall Study|Surgical Dental Work Performed/Planned|2
9327|NCT02063854|53208|P1|Overall Study|Surgical Dental Work Performed/Planned|5
9328|NCT02063854|53202|P7|Overall Study|Voluntary Withdrawal|1
9329|NCT02063854|53203|P6|Overall Study|Voluntary Withdrawal|6
9330|NCT02063854|53204|P5|Overall Study|Voluntary Withdrawal|3
9331|NCT02063854|53205|P4|Overall Study|Voluntary Withdrawal|1
9332|NCT02063854|53206|P3|Overall Study|Voluntary Withdrawal|8
9333|NCT02063854|53207|P2|Overall Study|Voluntary Withdrawal|0
9334|NCT02063854|53208|P1|Overall Study|Voluntary Withdrawal|2
9335|NCT02063854|53202|P7|Overall Study|Major Protocol Deviation|0
9336|NCT02063854|53203|P6|Overall Study|Major Protocol Deviation|0
9337|NCT02063854|53204|P5|Overall Study|Major Protocol Deviation|0
9338|NCT02063854|53205|P4|Overall Study|Major Protocol Deviation|0
9339|NCT02063854|53206|P3|Overall Study|Major Protocol Deviation|3
9340|NCT02063854|53207|P2|Overall Study|Major Protocol Deviation|0
9341|NCT02063854|53208|P1|Overall Study|Major Protocol Deviation|0
9342|NCT02063854|53202|P7|Overall Study|Pretreatment Event/Adverse Event|4
9343|NCT02063854|53203|P6|Overall Study|Pretreatment Event/Adverse Event|18
9344|NCT02063854|53204|P5|Overall Study|Pretreatment Event/Adverse Event|7
9345|NCT02063854|53205|P4|Overall Study|Pretreatment Event/Adverse Event|8
9346|NCT02063854|53206|P3|Overall Study|Pretreatment Event/Adverse Event|13
9347|NCT02063854|53207|P2|Overall Study|Pretreatment Event/Adverse Event|10
9348|NCT02063854|53208|P1|Overall Study|Pretreatment Event/Adverse Event|13
9349|NCT02063737|53292|P2|Overall Study|Lost to Follow-up|4
9350|NCT02063737|53293|P1|Overall Study|Lost to Follow-up|11
9351|NCT02062658|53427|P1|Overall Study|Lack of Efficacy|1
9352|NCT02062658|53427|P1|Overall Study|Withdrawal by Subject|1
9353|NCT02062645|53431|P1|Overall Study|Lost to Follow-up|5
9354|NCT02062645|53431|P1|Overall Study|Protocol Violation|8
9355|NCT02062645|53431|P1|Overall Study|Adverse Event|2
9356|NCT02062450|53473|P1|Overall Study|No follow-up visit|124
9357|NCT02062437|53487|P1|Overall Study|Pt. couldn't come due to med. condition|1
9358|NCT02062437|53487|P1|Overall Study|Death|2
9359|NCT02062437|53487|P1|Overall Study|Patient not available for the 2y visit|18
9360|NCT02062437|53487|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
9361|NCT02062385|53500|P4|Overall Study|Lost to Follow-up|0
9362|NCT02062385|53501|P3|Overall Study|Lost to Follow-up|1
9363|NCT02062385|53502|P2|Overall Study|Lost to Follow-up|0
9364|NCT02062385|53503|P1|Overall Study|Lost to Follow-up|0
9365|NCT02062385|53500|P4|Overall Study|Death|1
9366|NCT02062385|53501|P3|Overall Study|Death|0
9367|NCT02062385|53502|P2|Overall Study|Death|0
9368|NCT02062385|53503|P1|Overall Study|Death|0
9369|NCT02062385|53500|P4|Overall Study|Withdrawn by parent/guardian|8
9370|NCT02062385|53501|P3|Overall Study|Withdrawn by parent/guardian|9
9371|NCT02062385|53502|P2|Overall Study|Withdrawn by parent/guardian|41
9372|NCT02062385|53503|P1|Overall Study|Withdrawn by parent/guardian|46
9373|NCT02062385|53500|P4|Overall Study|Moved|0
9374|NCT02062385|53501|P3|Overall Study|Moved|1
9375|NCT02062385|53502|P2|Overall Study|Moved|11
9376|NCT02062385|53503|P1|Overall Study|Moved|10
9377|NCT02062385|53500|P4|Overall Study|Incomplete EPI by database lock|0
9378|NCT02062385|53501|P3|Overall Study|Incomplete EPI by database lock|0
9379|NCT02062385|53502|P2|Overall Study|Incomplete EPI by database lock|0
9380|NCT02062385|53503|P1|Overall Study|Incomplete EPI by database lock|2
9381|NCT02062385|53500|P4|Overall Study|Protocol Violation|0
9382|NCT02062385|53501|P3|Overall Study|Protocol Violation|0
9383|NCT02062385|53502|P2|Overall Study|Protocol Violation|0
9384|NCT02062385|53503|P1|Overall Study|Protocol Violation|1
9385|NCT02062385|53500|P4|Overall Study|Adverse Event|0
9386|NCT02062385|53501|P3|Overall Study|Adverse Event|1
9387|NCT02062385|53502|P2|Overall Study|Adverse Event|13
9388|NCT02062385|53503|P1|Overall Study|Adverse Event|19
9389|NCT02061592|53638|P2|Period 2|Lost to Follow-up|1
9390|NCT02061592|53639|P1|Period 2|Lost to Follow-up|0
9391|NCT02061592|53638|P2|Period 1|Protocol Violation|0
9392|NCT02061592|53639|P1|Period 1|Protocol Violation|1
9393|NCT02061592|53638|P2|Period 1|Withdrawal by Subject|0
9394|NCT02061592|53639|P1|Period 1|Withdrawal by Subject|1
9395|NCT02061540|53651|P1|Overall Study|Withdrawal by Subject|2
9396|NCT02061540|53651|P1|Overall Study|Adverse Event|2
9397|NCT02059291|53953|P6|Overall Study|Withdrawal by Subject|1
9398|NCT02059291|53954|P5|Overall Study|Withdrawal by Subject|0
9399|NCT02059291|53955|P4|Overall Study|Withdrawal by Subject|0
9400|NCT02059291|53956|P3|Overall Study|Withdrawal by Subject|0
9401|NCT02059291|53957|P2|Overall Study|Withdrawal by Subject|1
9402|NCT02059291|53958|P1|Overall Study|Withdrawal by Subject|0
9403|NCT02059291|53953|P6|Overall Study|Adverse Event|0
9404|NCT02059291|53954|P5|Overall Study|Adverse Event|0
9405|NCT02059291|53955|P4|Overall Study|Adverse Event|1
9406|NCT02059291|53956|P3|Overall Study|Adverse Event|1
9407|NCT02059291|53957|P2|Overall Study|Adverse Event|0
9408|NCT02059291|53958|P1|Overall Study|Adverse Event|0
9409|NCT02059291|53953|P6|Overall Study|Lack of Efficacy|1
9410|NCT02059291|53954|P5|Overall Study|Lack of Efficacy|0
9411|NCT02059291|53955|P4|Overall Study|Lack of Efficacy|1
9412|NCT02059291|53956|P3|Overall Study|Lack of Efficacy|0
9413|NCT02059291|53957|P2|Overall Study|Lack of Efficacy|0
9414|NCT02059291|53958|P1|Overall Study|Lack of Efficacy|0
9415|NCT02059187|53974|P2|Overall Study|Withdrawal by Subject|8
9416|NCT02059187|53975|P1|Overall Study|Withdrawal by Subject|12
9417|NCT02059187|53974|P2|Overall Study|Protocol Violation|0
9418|NCT02059187|53975|P1|Overall Study|Protocol Violation|1
9419|NCT02059187|53974|P2|Overall Study|Physician Decision|2
9420|NCT02059187|53975|P1|Overall Study|Physician Decision|1
9421|NCT02059187|53974|P2|Overall Study|Non-compliance with study drug|0
9422|NCT02059187|53975|P1|Overall Study|Non-compliance with study drug|1
9423|NCT02059187|53974|P2|Overall Study|Lost to Follow-up|8
9424|NCT02059187|53975|P1|Overall Study|Lost to Follow-up|9
9425|NCT02059187|53974|P2|Overall Study|Death|1
9426|NCT02059187|53975|P1|Overall Study|Death|1
9427|NCT02059187|53974|P2|Overall Study|Adverse Event|3
9428|NCT02059187|53975|P1|Overall Study|Adverse Event|0
9429|NCT02059174|54001|P2|Period 3|Physician Decision|0
9430|NCT02059174|54002|P1|Period 3|Physician Decision|1
9431|NCT02059174|54001|P2|Period 2|Protocol Violation|0
9432|NCT02059174|54002|P1|Period 2|Protocol Violation|1
9433|NCT02059174|54001|P2|Period 2|Withdrawal by Subject|2
9434|NCT02059174|54002|P1|Period 2|Withdrawal by Subject|0
9435|NCT02059174|54001|P2|Period 1|Withdrawal by Subject|2
9436|NCT02059174|54002|P1|Period 1|Withdrawal by Subject|0
9437|NCT02059161|54026|P2|Overall Study|Non-compliance with study drug|2
9438|NCT02059161|54027|P1|Overall Study|Non-compliance with study drug|6
9439|NCT02059161|54026|P2|Overall Study|Randomized in error, no study drug|1
9440|NCT02059161|54027|P1|Overall Study|Randomized in error, no study drug|0
9441|NCT02059161|54026|P2|Overall Study|Withdrawal by Subject|13
9442|NCT02059161|54027|P1|Overall Study|Withdrawal by Subject|16
9443|NCT02059161|54026|P2|Overall Study|Protocol Violation|1
9444|NCT02059161|54027|P1|Overall Study|Protocol Violation|1
9445|NCT02059161|54026|P2|Overall Study|Physician Decision|4
9446|NCT02059161|54027|P1|Overall Study|Physician Decision|4
9447|NCT02059161|54026|P2|Overall Study|Lost to Follow-up|12
9448|NCT02059161|54027|P1|Overall Study|Lost to Follow-up|20
9449|NCT02059161|54026|P2|Overall Study|Adverse Event|6
9450|NCT02059161|54027|P1|Overall Study|Adverse Event|2
9451|NCT02059161|54026|P2|Overall Study|Pregnancy|2
9452|NCT02059161|54027|P1|Overall Study|Pregnancy|0
9453|NCT02059135|54089|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
9454|NCT02059135|54090|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
9455|NCT02059135|54089|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
9456|NCT02059135|54090|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
9457|NCT02059135|54089|P2|Neonatal Follow-up (Safety Population)|Death|2
9458|NCT02059135|54090|P1|Neonatal Follow-up (Safety Population)|Death|3
9459|NCT02059135|54089|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
9460|NCT02059135|54090|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
9461|NCT02059135|54089|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
9462|NCT02059135|54090|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
9463|NCT02059135|54089|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
9464|NCT02059135|54090|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
9465|NCT02059135|54089|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
9466|NCT02059135|54090|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
9467|NCT02059135|54089|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
9468|NCT02059135|54090|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
9469|NCT02058992|54117|P1|Overall Study|CRF Uncollected|20
9470|NCT02058992|54117|P1|Overall Study|Protocol Violation|92
9471|NCT02058992|54117|P1|Overall Study|Lost to Follow-up|4
9472|NCT02058628|54128|P2|Overall Study|Non compliance|0
9473|NCT02058628|54129|P1|Overall Study|Non compliance|1
9474|NCT02058628|54128|P2|Overall Study|A lot of time for study for participant|0
9475|NCT02058628|54129|P1|Overall Study|A lot of time for study for participant|1
9476|NCT02058628|54128|P2|Overall Study|The visit date was not in timeline|1
9477|NCT02058628|54129|P1|Overall Study|The visit date was not in timeline|0
9478|NCT02058628|54128|P2|Overall Study|Not in time schedule|1
9479|NCT02058628|54129|P1|Overall Study|Not in time schedule|0
9480|NCT02058628|54128|P2|Overall Study|Lost to Follow-up|4
9481|NCT02058628|54129|P1|Overall Study|Lost to Follow-up|2
9482|NCT02058628|54128|P2|Overall Study|Withdrawal by Subject|2
9483|NCT02058628|54129|P1|Overall Study|Withdrawal by Subject|2
9484|NCT02058628|54128|P2|Overall Study|Adverse Event|0
9485|NCT02058628|54129|P1|Overall Study|Adverse Event|1
9486|NCT02058563|54161|P2|Overall Study|Other (patient incarcerated)|1
9487|NCT02058563|54162|P1|Overall Study|Other (patient incarcerated)|0
9488|NCT02058563|54161|P2|Overall Study|Consent Withdrawal|1
9489|NCT02058563|54162|P1|Overall Study|Consent Withdrawal|1
9490|NCT02058563|54161|P2|Overall Study|Other (vaccinated later as new subject)|0
9491|NCT02058563|54162|P1|Overall Study|Other (vaccinated later as new subject)|1
9492|NCT02058563|54161|P2|Overall Study|Lost to Follow-up|22
9493|NCT02058563|54162|P1|Overall Study|Lost to Follow-up|26
9494|NCT02058537|54198|P1|Overall Study|Withdrawal by Subject|1
9495|NCT02058498|54204|P1|Overall Study|Withdrawal by Subject|4
9496|NCT02058290|54212|P2|Overall Study|Withdrawal by Subject|1
9497|NCT02058290|54213|P1|Overall Study|Withdrawal by Subject|0
9498|NCT02058290|54212|P2|Overall Study|Didn't meet intraoperative criteria|7
9499|NCT02058290|54213|P1|Overall Study|Didn't meet intraoperative criteria|8
9500|NCT02058290|54212|P2|Overall Study|Physician Decision|0
9501|NCT02058290|54213|P1|Overall Study|Physician Decision|1
9502|NCT02058290|54212|P2|Overall Study|Protocol Violation|1
9503|NCT02058290|54213|P1|Overall Study|Protocol Violation|2
9504|NCT02058160|54229|P2|Overall Study|Other than specified above|6
9505|NCT02058160|54230|P1|Overall Study|Other than specified above|12
9506|NCT02058160|54229|P2|Overall Study|Lost to Follow-up|0
9507|NCT02058160|54230|P1|Overall Study|Lost to Follow-up|1
9508|NCT02058160|54229|P2|Overall Study|Adverse Event|3
9509|NCT02058160|54230|P1|Overall Study|Adverse Event|12
9510|NCT02058160|54229|P2|Overall Study|Poor compliance to protocol|1
9511|NCT02058160|54230|P1|Overall Study|Poor compliance to protocol|4
9512|NCT02058160|54229|P2|Overall Study|Randomized but not treated|4
9513|NCT02058160|54230|P1|Overall Study|Randomized but not treated|2
9514|NCT02058147|54267|P3|Overall Study|Other than specified|0
9515|NCT02058147|54268|P2|Overall Study|Other than specified|9
9516|NCT02058147|54269|P1|Overall Study|Other than specified|8
9517|NCT02058147|54267|P3|Overall Study|Poor compliance to protocol|4
9518|NCT02058147|54268|P2|Overall Study|Poor compliance to protocol|9
9519|NCT02058147|54269|P1|Overall Study|Poor compliance to protocol|8
9520|NCT02058147|54267|P3|Overall Study|Lack of Efficacy|3
9521|NCT02058147|54268|P2|Overall Study|Lack of Efficacy|0
9522|NCT02058147|54269|P1|Overall Study|Lack of Efficacy|1
9523|NCT02058147|54267|P3|Overall Study|Adverse Event|21
9524|NCT02058147|54268|P2|Overall Study|Adverse Event|9
9525|NCT02058147|54269|P1|Overall Study|Adverse Event|12
9526|NCT02058147|54267|P3|Overall Study|Randomized but not treated|1
9527|NCT02058147|54268|P2|Overall Study|Randomized but not treated|0
9528|NCT02058147|54269|P1|Overall Study|Randomized but not treated|0
9529|NCT02058069|54318|P1|Overall Study|Withdrawal by Subject|6
9530|NCT02058069|54318|P1|Overall Study|Exclusion due to implant size|5
9531|NCT02057835|54337|P10|Overall Study|Withdrawal by Subject|0
9532|NCT02057835|54338|P9|Overall Study|Withdrawal by Subject|0
9533|NCT02057835|54339|P8|Overall Study|Withdrawal by Subject|0
9534|NCT02057835|54340|P7|Overall Study|Withdrawal by Subject|0
9535|NCT02057835|54341|P6|Overall Study|Withdrawal by Subject|0
9536|NCT02057835|54342|P5|Overall Study|Withdrawal by Subject|0
9537|NCT02057835|54343|P4|Overall Study|Withdrawal by Subject|0
9538|NCT02057835|54344|P3|Overall Study|Withdrawal by Subject|0
9539|NCT02057835|54345|P2|Overall Study|Withdrawal by Subject|2
9540|NCT02057835|54346|P1|Overall Study|Withdrawal by Subject|0
9541|NCT02057549|54425|P2|Overall Study|Withdrawal by Subject|0
9542|NCT02057549|54426|P1|Overall Study|Withdrawal by Subject|1
9543|NCT02057549|54425|P2|Overall Study|Physician Decision|0
9544|NCT02057549|54426|P1|Overall Study|Physician Decision|1
9545|NCT02057549|54425|P2|Overall Study|Lost to Follow-up|0
9546|NCT02057549|54426|P1|Overall Study|Lost to Follow-up|1
9547|NCT02057406|54449|P3|Overall Study|Patient transportation issues|1
9548|NCT02057406|54450|P2|Overall Study|Patient transportation issues|0
9549|NCT02057406|54451|P1|Overall Study|Patient transportation issues|0
9550|NCT02057406|54449|P3|Overall Study|Protocol Violation|0
9551|NCT02057406|54450|P2|Overall Study|Protocol Violation|1
9552|NCT02057406|54451|P1|Overall Study|Protocol Violation|0
9553|NCT02057406|54449|P3|Overall Study|Death|0
9554|NCT02057406|54450|P2|Overall Study|Death|0
9555|NCT02057406|54451|P1|Overall Study|Death|1
9556|NCT02057406|54449|P3|Overall Study|Lost to Follow-up|1
9557|NCT02057406|54450|P2|Overall Study|Lost to Follow-up|0
9558|NCT02057406|54451|P1|Overall Study|Lost to Follow-up|0
9559|NCT02057406|54449|P3|Overall Study|Withdrawal by Subject|0
9560|NCT02057406|54450|P2|Overall Study|Withdrawal by Subject|2
9561|NCT02057406|54451|P1|Overall Study|Withdrawal by Subject|0
9562|NCT02057406|54449|P3|Overall Study|Physician Decision|2
9563|NCT02057406|54450|P2|Overall Study|Physician Decision|0
9564|NCT02057406|54451|P1|Overall Study|Physician Decision|0
9565|NCT02057393|54462|P1|Overall Study|Patient did not meet criteria|1
9566|NCT02057393|54462|P1|Overall Study|Withdrawal by Subject|1
9567|NCT02057250|54483|P5|Extension Phase|Other than specified above|7
9568|NCT02057250|54484|P4|Extension Phase|Other than specified above|0
9569|NCT02057250|54485|P3|Extension Phase|Other than specified above|0
9570|NCT02057250|54486|P2|Extension Phase|Other than specified above|0
9571|NCT02057250|54487|P1|Extension Phase|Other than specified above|0
9572|NCT02057250|54483|P5|Extension Phase|Entered in this period but not treated|4
9573|NCT02057250|54484|P4|Extension Phase|Entered in this period but not treated|0
9574|NCT02057250|54485|P3|Extension Phase|Entered in this period but not treated|0
9575|NCT02057250|54486|P2|Extension Phase|Entered in this period but not treated|0
9576|NCT02057250|54487|P1|Extension Phase|Entered in this period but not treated|0
9577|NCT02057250|54483|P5|Extension Phase|Lack of Efficacy|10
9578|NCT02057250|54484|P4|Extension Phase|Lack of Efficacy|0
9579|NCT02057250|54485|P3|Extension Phase|Lack of Efficacy|0
9580|NCT02057250|54486|P2|Extension Phase|Lack of Efficacy|0
9581|NCT02057250|54487|P1|Extension Phase|Lack of Efficacy|0
9582|NCT02057250|54483|P5|Extension Phase|Adverse Event|15
9583|NCT02057250|54484|P4|Extension Phase|Adverse Event|0
9584|NCT02057250|54485|P3|Extension Phase|Adverse Event|0
9585|NCT02057250|54486|P2|Extension Phase|Adverse Event|0
9586|NCT02057250|54487|P1|Extension Phase|Adverse Event|0
9587|NCT02057250|54483|P5|AID Assessment Phase|Other than specified above|0
9588|NCT02057250|54484|P4|AID Assessment Phase|Other than specified above|1
9589|NCT02057250|54485|P3|AID Assessment Phase|Other than specified above|1
9590|NCT02057250|54486|P2|AID Assessment Phase|Other than specified above|1
9591|NCT02057250|54487|P1|AID Assessment Phase|Other than specified above|1
9592|NCT02057250|54483|P5|AID Assessment Phase|Adverse Event|0
9593|NCT02057250|54484|P4|AID Assessment Phase|Adverse Event|1
9594|NCT02057250|54485|P3|AID Assessment Phase|Adverse Event|6
9595|NCT02057250|54486|P2|AID Assessment Phase|Adverse Event|2
9596|NCT02057250|54487|P1|AID Assessment Phase|Adverse Event|3
9597|NCT02056834|54505|P1|Overall Study|Lost to Follow-up|7
9598|NCT02056392|54530|P6|Overall Study|Withdrawal by Subject|0
9599|NCT02056392|54531|P5|Overall Study|Withdrawal by Subject|1
9600|NCT02056392|54532|P4|Overall Study|Withdrawal by Subject|0
9601|NCT02056392|54533|P3|Overall Study|Withdrawal by Subject|0
9602|NCT02056392|54534|P2|Overall Study|Withdrawal by Subject|0
9603|NCT02056392|54535|P1|Overall Study|Withdrawal by Subject|1
9604|NCT02056392|54530|P6|Overall Study|Protocol Violation|0
9605|NCT02056392|54531|P5|Overall Study|Protocol Violation|0
9606|NCT02056392|54532|P4|Overall Study|Protocol Violation|0
9607|NCT02056392|54533|P3|Overall Study|Protocol Violation|1
9608|NCT02056392|54534|P2|Overall Study|Protocol Violation|0
9609|NCT02056392|54535|P1|Overall Study|Protocol Violation|1
9610|NCT02056392|54530|P6|Overall Study|Lost to Follow-up|0
9611|NCT02056392|54531|P5|Overall Study|Lost to Follow-up|0
9612|NCT02056392|54532|P4|Overall Study|Lost to Follow-up|0
9613|NCT02056392|54533|P3|Overall Study|Lost to Follow-up|2
9614|NCT02056392|54534|P2|Overall Study|Lost to Follow-up|1
9615|NCT02056392|54535|P1|Overall Study|Lost to Follow-up|0
9616|NCT02055352|54594|P2|Overall Study|Reason unknown|5
9617|NCT02055352|54595|P1|Overall Study|Reason unknown|1
9618|NCT02055352|54594|P2|Overall Study|Withdrawal of informed consent|0
9619|NCT02055352|54595|P1|Overall Study|Withdrawal of informed consent|1
9620|NCT02055352|54594|P2|Overall Study|AE, study drug would be detrimental|3
9621|NCT02055352|54595|P1|Overall Study|AE, study drug would be detrimental|1
9622|NCT02055352|54594|P2|Overall Study|Use of prohibited treatment|3
9623|NCT02055352|54595|P1|Overall Study|Use of prohibited treatment|0
9624|NCT02055352|54594|P2|Overall Study|Patient decision|1
9625|NCT02055352|54595|P1|Overall Study|Patient decision|1
9626|NCT02055352|54594|P2|Overall Study|Death|2
9627|NCT02055352|54595|P1|Overall Study|Death|1
9628|NCT02055352|54594|P2|Overall Study|Poor compliance|1
9629|NCT02055352|54595|P1|Overall Study|Poor compliance|1
9630|NCT02055352|54594|P2|Overall Study|Non-eligible|1
9631|NCT02055352|54595|P1|Overall Study|Non-eligible|0
9632|NCT02055352|54594|P2|Overall Study|Adverse Event|1
9633|NCT02055352|54595|P1|Overall Study|Adverse Event|0
9634|NCT02054910|54611|P2|Overall Study|Lost to Follow-up|1
9635|NCT02054910|54612|P1|Overall Study|Lost to Follow-up|4
9636|NCT02054715|54652|P2|Follow-up 2|Treatment Change or Delay|0
9637|NCT02054715|54653|P1|Follow-up 2|Treatment Change or Delay|1
9638|NCT02054715|54652|P2|Follow-up 2|No Reason|0
9639|NCT02054715|54653|P1|Follow-up 2|No Reason|2
9640|NCT02054715|54652|P2|Follow-up 2|Changed Mind|1
9641|NCT02054715|54653|P1|Follow-up 2|Changed Mind|0
9642|NCT02054715|54652|P2|Follow-up 2|Changed MD/Facility|1
9643|NCT02054715|54653|P1|Follow-up 2|Changed MD/Facility|0
9644|NCT02054715|54652|P2|Follow-up 2|Hospitalization|2
9645|NCT02054715|54653|P1|Follow-up 2|Hospitalization|0
9646|NCT02054715|54652|P2|Follow-up 2|Death|3
9647|NCT02054715|54653|P1|Follow-up 2|Death|3
9648|NCT02054715|54652|P2|Follow-up 2|Ineligible|5
9649|NCT02054715|54653|P1|Follow-up 2|Ineligible|4
9650|NCT02054715|54652|P2|Follow-up 2|Followup Not Completed|4
9651|NCT02054715|54653|P1|Follow-up 2|Followup Not Completed|3
9652|NCT02054715|54652|P2|Follow-up 2|Refused|2
9653|NCT02054715|54653|P1|Follow-up 2|Refused|3
9654|NCT02054715|54652|P2|Follow-up 2|Lost to Followup|1
9655|NCT02054715|54653|P1|Follow-up 2|Lost to Followup|3
9656|NCT02054715|54652|P2|Baseline/Follow-up 1|Changed Mind|0
9657|NCT02054715|54653|P1|Baseline/Follow-up 1|Changed Mind|1
9658|NCT02054715|54652|P2|Baseline/Follow-up 1|Hospitalization|0
9659|NCT02054715|54653|P1|Baseline/Follow-up 1|Hospitalization|1
9660|NCT02054715|54652|P2|Baseline/Follow-up 1|Ineligible|0
9661|NCT02054715|54653|P1|Baseline/Follow-up 1|Ineligible|3
9662|NCT02054715|54652|P2|Baseline/Follow-up 1|Overwhelmed|0
9663|NCT02054715|54653|P1|Baseline/Follow-up 1|Overwhelmed|2
9664|NCT02054715|54652|P2|Baseline/Follow-up 1|No Reason|1
9665|NCT02054715|54653|P1|Baseline/Follow-up 1|No Reason|0
9666|NCT02054715|54652|P2|Baseline/Follow-up 1|Disliked Procedure|1
9667|NCT02054715|54653|P1|Baseline/Follow-up 1|Disliked Procedure|0
9668|NCT02054715|54652|P2|Baseline/Follow-up 1|Changed MD/Facility|1
9669|NCT02054715|54653|P1|Baseline/Follow-up 1|Changed MD/Facility|0
9670|NCT02054715|54652|P2|Baseline/Follow-up 1|Medical|1
9671|NCT02054715|54653|P1|Baseline/Follow-up 1|Medical|0
9672|NCT02054715|54652|P2|Baseline/Follow-up 1|Refused|3
9673|NCT02054715|54653|P1|Baseline/Follow-up 1|Refused|1
9674|NCT02054702|54667|P2|Overall Study|Withdrawal by Subject|4
9675|NCT02054702|54668|P1|Overall Study|Withdrawal by Subject|14
9676|NCT02054702|54667|P2|Overall Study|Physician Decision|1
9677|NCT02054702|54668|P1|Overall Study|Physician Decision|0
9678|NCT02054702|54667|P2|Overall Study|Met Withdrawal Criteria|1
9679|NCT02054702|54668|P1|Overall Study|Met Withdrawal Criteria|4
9680|NCT02054702|54667|P2|Overall Study|Adverse Event|1
9681|NCT02054702|54668|P1|Overall Study|Adverse Event|3
9682|NCT02054702|54667|P2|Overall Study|Lost to Follow-up|5
9683|NCT02054702|54668|P1|Overall Study|Lost to Follow-up|3
9684|NCT02054481|54723|P4|Overall Study|Other reason|0
9685|NCT02054481|54724|P3|Overall Study|Other reason|2
9686|NCT02054481|54725|P2|Overall Study|Other reason|1
9687|NCT02054481|54726|P1|Overall Study|Other reason|2
9688|NCT02054481|54723|P4|Overall Study|Lost to Follow-up|0
9689|NCT02054481|54724|P3|Overall Study|Lost to Follow-up|0
9690|NCT02054481|54725|P2|Overall Study|Lost to Follow-up|0
9691|NCT02054481|54726|P1|Overall Study|Lost to Follow-up|1
9692|NCT02054481|54723|P4|Overall Study|Adverse Event|1
9693|NCT02054481|54724|P3|Overall Study|Adverse Event|0
9694|NCT02054481|54725|P2|Overall Study|Adverse Event|1
9695|NCT02054481|54726|P1|Overall Study|Adverse Event|1
9696|NCT02054325|54774|P2|Overall Study|Lost to Follow-up|5
9697|NCT02054325|54775|P1|Overall Study|Lost to Follow-up|8
9698|NCT02053610|54785|P2|Overall Study|Failure to Return|3
9699|NCT02053610|54786|P1|Overall Study|Failure to Return|4
9700|NCT02053610|54785|P2|Overall Study|Did not Receive Treatment|2
9701|NCT02053610|54786|P1|Overall Study|Did not Receive Treatment|0
9702|NCT02053610|54785|P2|Overall Study|Refused treatment/Did not cooperate|0
9703|NCT02053610|54786|P1|Overall Study|Refused treatment/Did not cooperate|3
9704|NCT02053610|54785|P2|Overall Study|Disease Progression|94
9705|NCT02053610|54786|P1|Overall Study|Disease Progression|148
9706|NCT02053610|54785|P2|Overall Study|Administrative/Other|27
9707|NCT02053610|54786|P1|Overall Study|Administrative/Other|34
9708|NCT02053610|54785|P2|Overall Study|Death|25
9709|NCT02053610|54786|P1|Overall Study|Death|31
9710|NCT02053610|54785|P2|Overall Study|Withdrew Consent|14
9711|NCT02053610|54786|P1|Overall Study|Withdrew Consent|12
9712|NCT02053610|54785|P2|Overall Study|Adverse Event/Intercurrent Illness|9
9713|NCT02053610|54786|P1|Overall Study|Adverse Event/Intercurrent Illness|3
9714|NCT02053493|54818|P2|Overall Study|Withdrawal by Subject|1
9715|NCT02053493|54819|P1|Overall Study|Withdrawal by Subject|1
9716|NCT02052466|54925|P1|Overall Study|Acromial fracture|1
9717|NCT02052466|54925|P1|Overall Study|Withdrawal by Subject|1
9718|NCT02052414|54940|P1|Overall Study|Withdrawal by Subject|3
9719|NCT02052414|54940|P1|Overall Study|Lack of Efficacy|2
9720|NCT02052414|54940|P1|Overall Study|Adverse Event|12
9721|NCT02052011|54950|P2|Overall Study|Withdrawal by Subject|2
9722|NCT02052011|54951|P1|Overall Study|Withdrawal by Subject|1
9723|NCT02052011|54950|P2|Overall Study|Lost to Follow-up|0
9724|NCT02052011|54951|P1|Overall Study|Lost to Follow-up|3
9725|NCT02050048|55097|P2|Overall Study|Ineligible after ERCP|1
9726|NCT02050048|55098|P1|Overall Study|Ineligible after ERCP|4
9727|NCT02050048|55097|P2|Overall Study|Death|0
9728|NCT02050048|55098|P1|Overall Study|Death|1
9729|NCT02050048|55097|P2|Overall Study|Lost to Follow-up|1
9730|NCT02050048|55098|P1|Overall Study|Lost to Follow-up|0
9731|NCT02049450|55117|P1|Overall Study|Patients/guardian decision|1
9732|NCT02049450|55117|P1|Overall Study|Withdrawal by Subject|1
9733|NCT02049450|55117|P1|Overall Study|Adverse Event|2
9734|NCT02048904|55148|P1|Overall Study|Physician Decision|70
9735|NCT02048904|55148|P1|Overall Study|Withdrawal by Subject|7
9736|NCT02048072|55161|P1|Overall Study|Lost to Follow-up|1
9737|NCT02048072|55161|P1|Overall Study|Adverse Event|3
9738|NCT02047227|55172|P2|Overall Study|Unspecified|9
9739|NCT02047227|55173|P1|Overall Study|Unspecified|10
9740|NCT02047227|55172|P2|Overall Study|All embryos discarded|11
9741|NCT02047227|55173|P1|Overall Study|All embryos discarded|12
9742|NCT02047227|55172|P2|Overall Study|Intention to freeze all embryos|0
9743|NCT02047227|55173|P1|Overall Study|Intention to freeze all embryos|1
9744|NCT02047227|55172|P2|Overall Study|No fertilization|51
9745|NCT02047227|55173|P1|Overall Study|No fertilization|61
9746|NCT02047227|55172|P2|Overall Study|No oocytes retrieved|20
9747|NCT02047227|55173|P1|Overall Study|No oocytes retrieved|21
9748|NCT02047227|55172|P2|Overall Study|Lack of ovarian response to stimulation|32
9749|NCT02047227|55173|P1|Overall Study|Lack of ovarian response to stimulation|35
9750|NCT02047227|55172|P2|Overall Study|Spontaneous pregnancy|0
9751|NCT02047227|55173|P1|Overall Study|Spontaneous pregnancy|1
9752|NCT02047227|55172|P2|Overall Study|Protocol Violation|0
9753|NCT02047227|55173|P1|Overall Study|Protocol Violation|1
9754|NCT02047227|55172|P2|Overall Study|Lost to Follow-up|3
9755|NCT02047227|55173|P1|Overall Study|Lost to Follow-up|0
9756|NCT02047227|55172|P2|Overall Study|Adverse Event|4
9757|NCT02047227|55173|P1|Overall Study|Adverse Event|2
9758|NCT02046993|55191|P2|Overall Study|Lost to Follow-up|1
9759|NCT02046993|55192|P1|Overall Study|Lost to Follow-up|1
9760|NCT02046993|55191|P2|Overall Study|Withdrawal by Subject|10
9761|NCT02046993|55192|P1|Overall Study|Withdrawal by Subject|2
9762|NCT02046226|55259|P1|Overall Study|Lost to Follow-up|7
9763|NCT02046148|55307|P2|Overall Study|Withdrawal by Subject|2
9764|NCT02046148|55308|P1|Overall Study|Withdrawal by Subject|0
9765|NCT02046148|55307|P2|Overall Study|Lost to Follow-up|1
9766|NCT02046148|55308|P1|Overall Study|Lost to Follow-up|1
9767|NCT02045836|55354|P2|Overall Study|Migrated from study area|2
9768|NCT02045836|55355|P1|Overall Study|Migrated from study area|0
9769|NCT02045836|55354|P2|Overall Study|Lost to Follow-up|7
9770|NCT02045836|55355|P1|Overall Study|Lost to Follow-up|4
9771|NCT02045836|55354|P2|Overall Study|Withdrawal by Subject|1
9772|NCT02045836|55355|P1|Overall Study|Withdrawal by Subject|1
9773|NCT02045836|55354|P2|Overall Study|Adverse Event|4
9774|NCT02045836|55355|P1|Overall Study|Adverse Event|4
9775|NCT02045732|55384|P2|Overall Study|At the discretion of the investigator|1
9776|NCT02045732|55385|P1|Overall Study|At the discretion of the investigator|1
9777|NCT02044848|55444|P2|Overall Study|Administrative Problems|3
9778|NCT02044848|55445|P1|Overall Study|Administrative Problems|2
9779|NCT02044822|55451|P1|Overall Study|Lost to Follow-up|1
9780|NCT02044822|55451|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
9781|NCT02044822|55451|P1|Overall Study|Withdrew Consent|3
9782|NCT02044822|55451|P1|Overall Study|Investigator's Discretion|10
9783|NCT02044822|55451|P1|Overall Study|Study Terminated by Sponsor|77
9784|NCT02044458|55463|P2|Overall Study|Protocol Violation|8
9785|NCT02044458|55464|P1|Overall Study|Protocol Violation|3
9786|NCT02044302|55522|P2|Overall Study|study terminated|0
9787|NCT02044302|55523|P1|Overall Study|study terminated|2
9788|NCT02043782|55570|P6|Period 1|Adverse Event|0
9789|NCT02043782|55571|P5|Period 1|Adverse Event|0
9790|NCT02043782|55572|P4|Period 1|Adverse Event|0
9791|NCT02043782|55573|P3|Period 1|Adverse Event|1
9792|NCT02043782|55574|P2|Period 1|Adverse Event|0
9793|NCT02043782|55575|P1|Period 1|Adverse Event|0
9794|NCT02043366|55648|P6|Overall Study|Lost to Follow-up|2
9795|NCT02043366|55649|P5|Overall Study|Lost to Follow-up|2
9796|NCT02043366|55650|P4|Overall Study|Lost to Follow-up|2
9797|NCT02043366|55651|P3|Overall Study|Lost to Follow-up|2
9798|NCT02043366|55652|P2|Overall Study|Lost to Follow-up|2
9799|NCT02043366|55653|P1|Overall Study|Lost to Follow-up|2
9800|NCT02043132|55691|P2|Overall Study|screen failures|8
9801|NCT02043132|55692|P1|Overall Study|screen failures|4
9802|NCT02043132|55691|P2|Overall Study|Lost to Follow-up|1
9803|NCT02043132|55692|P1|Overall Study|Lost to Follow-up|1
9804|NCT02042924|55712|P1|Overall Study|Early Death|1
9805|NCT02042443|55760|P2|Overall Study|Not eligible/not analyzable|6
9806|NCT02042443|55761|P1|Overall Study|Not eligible/not analyzable|3
9807|NCT02042443|55760|P2|Overall Study|not protocol specified|1
9808|NCT02042443|55761|P1|Overall Study|not protocol specified|1
9809|NCT02042443|55760|P2|Overall Study|Progression|17
9810|NCT02042443|55761|P1|Overall Study|Progression|21
9811|NCT02042443|55760|P2|Overall Study|Withdrawal by Subject|1
9812|NCT02042443|55761|P1|Overall Study|Withdrawal by Subject|0
9813|NCT02042443|55760|P2|Overall Study|Adverse Event|1
9814|NCT02042443|55761|P1|Overall Study|Adverse Event|2
9815|NCT02042404|55773|P2|Overall Study|Inability to meet time requirements|0
9816|NCT02042404|55774|P1|Overall Study|Inability to meet time requirements|1
9817|NCT02042404|55773|P2|Overall Study|Unrelated Adverse Event|0
9818|NCT02042404|55774|P1|Overall Study|Unrelated Adverse Event|3
9819|NCT02042404|55773|P2|Overall Study|Death|0
9820|NCT02042404|55774|P1|Overall Study|Death|1
9821|NCT02041533|55814|P2|Overall Study|Randomized, not treated|7
9822|NCT02041533|55815|P1|Overall Study|Randomized, not treated|4
9823|NCT02041533|55814|P2|Overall Study|Completed max number of chemo cycles|29
9824|NCT02041533|55815|P1|Overall Study|Completed max number of chemo cycles|0
9825|NCT02041533|55814|P2|Overall Study|Other reasons|1
9826|NCT02041533|55815|P1|Overall Study|Other reasons|0
9827|NCT02041533|55814|P2|Overall Study|Poor/non-compliance|0
9828|NCT02041533|55815|P1|Overall Study|Poor/non-compliance|1
9829|NCT02041533|55814|P2|Overall Study|Maximum clinical benefit|18
9830|NCT02041533|55815|P1|Overall Study|Maximum clinical benefit|0
9831|NCT02041533|55814|P2|Overall Study|Withdrawal by Subject|1
9832|NCT02041533|55815|P1|Overall Study|Withdrawal by Subject|2
9833|NCT02041533|55814|P2|Overall Study|Subject request to discontinue treatment|9
9834|NCT02041533|55815|P1|Overall Study|Subject request to discontinue treatment|5
9835|NCT02041533|55814|P2|Overall Study|Adverse Event unrelated to study drug|21
9836|NCT02041533|55815|P1|Overall Study|Adverse Event unrelated to study drug|20
9837|NCT02041533|55814|P2|Overall Study|Death|0
9838|NCT02041533|55815|P1|Overall Study|Death|1
9839|NCT02041533|55814|P2|Overall Study|Study drug toxicity|30
9840|NCT02041533|55815|P1|Overall Study|Study drug toxicity|27
9841|NCT02041533|55814|P2|Overall Study|Disease Progression|142
9842|NCT02041533|55815|P1|Overall Study|Disease Progression|168
9843|NCT02041520|55837|P2|Overall Study|Hypothiroidism identified during follow-|1
9932|NCT02038907|56133|P12|Overall Study|Protocol Violation|0
9844|NCT02041520|55838|P1|Overall Study|Hypothiroidism identified during follow-|0
9845|NCT02041520|55837|P2|Overall Study|Lost to Follow-up|1
9846|NCT02041520|55838|P1|Overall Study|Lost to Follow-up|0
9847|NCT02041520|55837|P2|Overall Study|Protocol Violation|0
9848|NCT02041520|55838|P1|Overall Study|Protocol Violation|1
9849|NCT02041520|55837|P2|Overall Study|Withdrawal by Subject|4
9850|NCT02041520|55838|P1|Overall Study|Withdrawal by Subject|3
9851|NCT02041520|55837|P2|Overall Study|Adverse Event|1
9852|NCT02041520|55838|P1|Overall Study|Adverse Event|2
9853|NCT02041286|55881|P1|Overall Study|Adverse Event|1
9854|NCT02040532|55948|P1|Overall Study|Withdrawal by Subject|3
9855|NCT02040532|55948|P1|Overall Study|Adverse Event|4
9856|NCT02040532|55948|P1|Overall Study|Physician Decision|4
9857|NCT02040532|55948|P1|Overall Study|Lost to Follow-up|1
9858|NCT02040428|55961|P2|Overall Study|Withdrawal by Subject|1
9859|NCT02040428|55962|P1|Overall Study|Withdrawal by Subject|1
9860|NCT02040428|55961|P2|Overall Study|Death|3
9861|NCT02040428|55962|P1|Overall Study|Death|4
9862|NCT02039778|55986|P1|Overall Study|Never started the protocol treatment|1
9863|NCT02039778|55986|P1|Overall Study|Withdrawal by Subject|1
9864|NCT02039778|55986|P1|Overall Study|Death|2
9865|NCT02039687|55998|P4|Overall Study|treatment assignment could not be confir|0
9866|NCT02039687|55999|P3|Overall Study|treatment assignment could not be confir|2
9867|NCT02039687|56000|P2|Overall Study|treatment assignment could not be confir|0
9868|NCT02039687|56001|P1|Overall Study|treatment assignment could not be confir|0
9869|NCT02039687|55998|P4|Overall Study|Withdrawal by Subject|0
9870|NCT02039687|55999|P3|Overall Study|Withdrawal by Subject|0
9871|NCT02039687|56000|P2|Overall Study|Withdrawal by Subject|1
9872|NCT02039687|56001|P1|Overall Study|Withdrawal by Subject|0
9873|NCT02039687|55998|P4|Overall Study|Adverse Event|0
9874|NCT02039687|55999|P3|Overall Study|Adverse Event|1
9875|NCT02039687|56000|P2|Overall Study|Adverse Event|0
9876|NCT02039687|56001|P1|Overall Study|Adverse Event|0
9877|NCT02039427|56031|P4|Overall Study|Steroid Use|0
9878|NCT02039427|56032|P3|Overall Study|Steroid Use|0
9879|NCT02039427|56033|P2|Overall Study|Steroid Use|0
9880|NCT02039427|56034|P1|Overall Study|Steroid Use|1
9881|NCT02039427|56031|P4|Overall Study|Loss of follow - up|4
9882|NCT02039427|56032|P3|Overall Study|Loss of follow - up|2
9883|NCT02039427|56033|P2|Overall Study|Loss of follow - up|0
9884|NCT02039427|56034|P1|Overall Study|Loss of follow - up|1
9885|NCT02039427|56031|P4|Overall Study|Cancellation of surgery|0
9886|NCT02039427|56032|P3|Overall Study|Cancellation of surgery|1
9887|NCT02039427|56033|P2|Overall Study|Cancellation of surgery|0
9888|NCT02039427|56034|P1|Overall Study|Cancellation of surgery|0
9889|NCT02039427|56031|P4|Overall Study|Withdrawal on concent|1
9890|NCT02039427|56032|P3|Overall Study|Withdrawal on concent|0
9891|NCT02039427|56033|P2|Overall Study|Withdrawal on concent|0
9892|NCT02039427|56034|P1|Overall Study|Withdrawal on concent|0
9893|NCT02039427|56031|P4|Overall Study|Duration of surgery > 3h|0
9894|NCT02039427|56032|P3|Overall Study|Duration of surgery > 3h|0
9895|NCT02039427|56033|P2|Overall Study|Duration of surgery > 3h|1
9896|NCT02039427|56034|P1|Overall Study|Duration of surgery > 3h|1
9897|NCT02039414|56054|P2|Overall Study|Protocol Violation|1
9898|NCT02039414|56055|P1|Overall Study|Protocol Violation|3
9899|NCT02039414|56054|P2|Overall Study|Lost to Follow-up|0
9900|NCT02039414|56055|P1|Overall Study|Lost to Follow-up|2
9901|NCT02039414|56054|P2|Overall Study|Delivered|1
9902|NCT02039414|56055|P1|Overall Study|Delivered|1
9903|NCT02038959|56069|P2|Overall Study|Withdrawal by Subject|8
9904|NCT02038959|56070|P1|Overall Study|Withdrawal by Subject|6
9905|NCT02038933|56098|P1|Follow-up|Disease Progression|2
9906|NCT02038933|56098|P1|Follow-up|Withdrawal by Subject|1
9907|NCT02038933|56098|P1|Follow-up|Lost to Follow-up|1
9908|NCT02038933|56098|P1|Follow-up|Adverse event unrelated to study drug|4
9909|NCT02038933|56098|P1|Follow-up|Death|11
9910|NCT02038933|56098|P1|Treatment|Withdrawal by Subject|1
9911|NCT02038933|56098|P1|Treatment|Disease Progression|101
9912|NCT02038933|56098|P1|Treatment|Study Drug Toxicity|4
9913|NCT02038933|56098|P1|Treatment|Adverse Event Unrelated to Study Drug|6
9914|NCT02038933|56098|P1|Treatment|Lost to Follow-up|1
9915|NCT02038933|56098|P1|Treatment|No longer meets study criteria|1
9916|NCT02038907|56131|P14|Overall Study|Withdrawal by Subject|0
9917|NCT02038907|56132|P13|Overall Study|Withdrawal by Subject|0
9918|NCT02038907|56133|P12|Overall Study|Withdrawal by Subject|0
9919|NCT02038907|56134|P11|Overall Study|Withdrawal by Subject|1
9920|NCT02038907|56135|P10|Overall Study|Withdrawal by Subject|0
9921|NCT02038907|56136|P9|Overall Study|Withdrawal by Subject|0
9922|NCT02038907|56137|P8|Overall Study|Withdrawal by Subject|0
9923|NCT02038907|56138|P7|Overall Study|Withdrawal by Subject|0
9924|NCT02038907|56139|P6|Overall Study|Withdrawal by Subject|0
9925|NCT02038907|56140|P5|Overall Study|Withdrawal by Subject|0
9926|NCT02038907|56141|P4|Overall Study|Withdrawal by Subject|0
9927|NCT02038907|56142|P3|Overall Study|Withdrawal by Subject|0
9928|NCT02038907|56143|P2|Overall Study|Withdrawal by Subject|0
9929|NCT02038907|56144|P1|Overall Study|Withdrawal by Subject|0
9930|NCT02038907|56131|P14|Overall Study|Protocol Violation|0
9931|NCT02038907|56132|P13|Overall Study|Protocol Violation|0
9933|NCT02038907|56134|P11|Overall Study|Protocol Violation|1
9934|NCT02038907|56135|P10|Overall Study|Protocol Violation|0
9935|NCT02038907|56136|P9|Overall Study|Protocol Violation|0
9936|NCT02038907|56137|P8|Overall Study|Protocol Violation|0
9937|NCT02038907|56138|P7|Overall Study|Protocol Violation|0
9938|NCT02038907|56139|P6|Overall Study|Protocol Violation|0
9939|NCT02038907|56140|P5|Overall Study|Protocol Violation|0
9940|NCT02038907|56141|P4|Overall Study|Protocol Violation|0
9941|NCT02038907|56142|P3|Overall Study|Protocol Violation|0
9942|NCT02038907|56143|P2|Overall Study|Protocol Violation|0
9943|NCT02038907|56144|P1|Overall Study|Protocol Violation|0
9944|NCT02038790|56672|P2|Day 0 - First Treatment|Withdrawal by Subject|1
9945|NCT02038790|56673|P1|Day 0 - First Treatment|Withdrawal by Subject|1
9946|NCT02038543|56708|P4|Overall Study|Withdrawal by Subject|1
9947|NCT02038543|56709|P3|Overall Study|Withdrawal by Subject|0
9948|NCT02038543|56710|P2|Overall Study|Withdrawal by Subject|0
9949|NCT02038543|56711|P1|Overall Study|Withdrawal by Subject|0
9950|NCT02038543|56708|P4|Overall Study|Screen Failure|1
9951|NCT02038543|56709|P3|Overall Study|Screen Failure|0
9952|NCT02038543|56710|P2|Overall Study|Screen Failure|0
9953|NCT02038543|56711|P1|Overall Study|Screen Failure|0
9954|NCT02038075|56727|P2|Overall Study|Withdrawal by Subject|0
9955|NCT02038075|56728|P1|Overall Study|Withdrawal by Subject|3
9956|NCT02037477|56761|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
9957|NCT02037477|56762|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
9958|NCT02037477|56763|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
9959|NCT02037477|56764|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
9960|NCT02036775|56842|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
9961|NCT02036775|56843|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
9962|NCT02036775|56844|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
9963|NCT02036775|56845|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
9964|NCT02036775|56846|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
9965|NCT02036775|56847|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
9966|NCT02036580|56888|P3|Overall Study|Adverse Event|0
9967|NCT02036580|56889|P2|Overall Study|Adverse Event|0
9968|NCT02036580|56890|P1|Overall Study|Adverse Event|1
9969|NCT02036580|56888|P3|Overall Study|Withdrawal by Subject|0
9970|NCT02036580|56889|P2|Overall Study|Withdrawal by Subject|1
9971|NCT02036580|56890|P1|Overall Study|Withdrawal by Subject|0
9972|NCT02036515|56911|P3|Overall Study|Hyperglycemia|1
9973|NCT02036515|56912|P2|Overall Study|Hyperglycemia|0
9974|NCT02036515|56913|P1|Overall Study|Hyperglycemia|0
9975|NCT02036515|56911|P3|Overall Study|Withdrawal by Subject|9
9976|NCT02036515|56912|P2|Overall Study|Withdrawal by Subject|7
9977|NCT02036515|56913|P1|Overall Study|Withdrawal by Subject|4
9978|NCT02036515|56911|P3|Overall Study|Screen failure|0
9979|NCT02036515|56912|P2|Overall Study|Screen failure|2
9980|NCT02036515|56913|P1|Overall Study|Screen failure|0
9981|NCT02036515|56911|P3|Overall Study|Non-compliance with study drug|2
9982|NCT02036515|56912|P2|Overall Study|Non-compliance with study drug|0
9983|NCT02036515|56913|P1|Overall Study|Non-compliance with study drug|0
9984|NCT02036515|56911|P3|Overall Study|Lost to Follow-up|0
9985|NCT02036515|56912|P2|Overall Study|Lost to Follow-up|2
9986|NCT02036515|56913|P1|Overall Study|Lost to Follow-up|0
9987|NCT02036515|56911|P3|Overall Study|Adverse Event|2
9988|NCT02036515|56912|P2|Overall Study|Adverse Event|1
9989|NCT02036515|56913|P1|Overall Study|Adverse Event|1
9990|NCT02035748|57012|P1|Overall Study|Progressive Disease|1
9991|NCT02035748|57012|P1|Overall Study|Withdrawal by Subject|6
9992|NCT02035748|57012|P1|Overall Study|Physician Decision|3
9993|NCT02035748|57012|P1|Overall Study|Lost to Follow-up|2
9994|NCT02035748|57012|P1|Overall Study|Death|3
9995|NCT02035748|57012|P1|Overall Study|Adverse Event|5
9996|NCT02035696|57026|P4|Overall Study|Withdrawal by Subject|1
9997|NCT02035696|57027|P3|Overall Study|Withdrawal by Subject|2
9998|NCT02035696|57028|P2|Overall Study|Withdrawal by Subject|0
9999|NCT02035696|57029|P1|Overall Study|Withdrawal by Subject|3
10000|NCT02035696|57026|P4|Overall Study|Lost to Follow-up|2
10001|NCT02035696|57027|P3|Overall Study|Lost to Follow-up|1
10002|NCT02035696|57028|P2|Overall Study|Lost to Follow-up|3
10003|NCT02035696|57029|P1|Overall Study|Lost to Follow-up|0
10004|NCT02035475|57071|P1|Overall Study|Equipment Error|1
10005|NCT02035475|57071|P1|Overall Study|Physician Decision|1
10006|NCT02035475|57071|P1|Overall Study|Withdrawal by Subject|4
10007|NCT02035332|57082|P1|Overall Study|Procedure Aborted due to Uterine Width|1
10008|NCT02034877|57090|P2|Overall Study|No Longer Willing to Participate|3
10009|NCT02034877|57091|P1|Overall Study|No Longer Willing to Participate|0
10010|NCT02034877|57090|P2|Overall Study|Lost to Follow-up|3
10011|NCT02034877|57091|P1|Overall Study|Lost to Follow-up|0
10012|NCT02034708|57109|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
10013|NCT02034708|57110|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
10014|NCT02034708|57109|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
10015|NCT02034708|57110|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
10016|NCT02034708|57109|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
10017|NCT02034708|57110|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
10018|NCT02034708|57109|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
10019|NCT02034708|57110|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
10020|NCT02034591|57121|P6|Overall Study|Withdrawal by Subject|0
10021|NCT02034591|57122|P5|Overall Study|Withdrawal by Subject|1
10022|NCT02034591|57123|P4|Overall Study|Withdrawal by Subject|0
10023|NCT02034591|57124|P3|Overall Study|Withdrawal by Subject|0
10024|NCT02034591|57125|P2|Overall Study|Withdrawal by Subject|0
10025|NCT02034591|57126|P1|Overall Study|Withdrawal by Subject|0
10026|NCT02034565|57181|P2|Overall Study|Adverse Event|0
10027|NCT02034565|57182|P1|Overall Study|Adverse Event|1
10028|NCT02034552|57199|P3|Overall Study|Non-compliance with study drug|1
10029|NCT02034552|57200|P2|Overall Study|Non-compliance with study drug|0
10030|NCT02034552|57201|P1|Overall Study|Non-compliance with study drug|0
10031|NCT02034552|57199|P3|Overall Study|Withdrawal by Subject|1
10032|NCT02034552|57200|P2|Overall Study|Withdrawal by Subject|0
10033|NCT02034552|57201|P1|Overall Study|Withdrawal by Subject|2
10034|NCT02034552|57199|P3|Overall Study|AE associated with disease progression|0
10035|NCT02034552|57200|P2|Overall Study|AE associated with disease progression|1
10036|NCT02034552|57201|P1|Overall Study|AE associated with disease progression|0
10037|NCT02034552|57199|P3|Overall Study|AE not assoc. with disease progression|2
10038|NCT02034552|57200|P2|Overall Study|AE not assoc. with disease progression|3
10039|NCT02034552|57201|P1|Overall Study|AE not assoc. with disease progression|1
10040|NCT02034552|57199|P3|Overall Study|Ongoing with treatment|11
10041|NCT02034552|57200|P2|Overall Study|Ongoing with treatment|11
10042|NCT02034552|57201|P1|Overall Study|Ongoing with treatment|0
10043|NCT02034552|57199|P3|Overall Study|Never treated|0
10044|NCT02034552|57200|P2|Overall Study|Never treated|2
10045|NCT02034552|57201|P1|Overall Study|Never treated|3
10046|NCT02034513|57226|P2|Overall Study|Unclassified|1
10047|NCT02034513|57227|P1|Overall Study|Unclassified|0
10048|NCT02034513|57226|P2|Overall Study|Withdrawal by Subject|25
10049|NCT02034513|57227|P1|Overall Study|Withdrawal by Subject|25
10050|NCT02034513|57226|P2|Overall Study|Protocol Violation|10
10051|NCT02034513|57227|P1|Overall Study|Protocol Violation|7
10052|NCT02034513|57226|P2|Overall Study|Pregnancy|3
10053|NCT02034513|57227|P1|Overall Study|Pregnancy|0
10054|NCT02034513|57226|P2|Overall Study|Lost to Follow-up|7
10055|NCT02034513|57227|P1|Overall Study|Lost to Follow-up|6
10056|NCT02034513|57226|P2|Overall Study|Lack of Efficacy|1
10057|NCT02034513|57227|P1|Overall Study|Lack of Efficacy|0
10058|NCT02034513|57226|P2|Overall Study|Adverse Event|10
10059|NCT02034513|57227|P1|Overall Study|Adverse Event|11
10060|NCT02034162|57245|P3|Double-blind|Withdrawal by Subject|0
10061|NCT02034162|57246|P2|Double-blind|Withdrawal by Subject|7
10062|NCT02034162|57247|P1|Double-blind|Withdrawal by Subject|5
10063|NCT02034162|57245|P3|Double-blind|Protocol Violation|0
10064|NCT02034162|57246|P2|Double-blind|Protocol Violation|1
10065|NCT02034162|57247|P1|Double-blind|Protocol Violation|0
10066|NCT02034162|57245|P3|Double-blind|Physician Decision|0
10067|NCT02034162|57246|P2|Double-blind|Physician Decision|0
10068|NCT02034162|57247|P1|Double-blind|Physician Decision|1
10069|NCT02034162|57245|P3|Double-blind|Lost to Follow-up|0
10070|NCT02034162|57246|P2|Double-blind|Lost to Follow-up|0
10071|NCT02034162|57247|P1|Double-blind|Lost to Follow-up|3
10072|NCT02032901|57331|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
10073|NCT02032901|57332|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
10074|NCT02032901|57331|P2|Treatment Period (12 Weeks)|Pregnancy|0
10075|NCT02032901|57332|P1|Treatment Period (12 Weeks)|Pregnancy|1
10076|NCT02032888|57356|P3|Follow-up Period|Not specified|0
10077|NCT02032888|57357|P2|Follow-up Period|Not specified|0
10078|NCT02032888|57358|P1|Follow-up Period|Not specified|1
10079|NCT02032888|57356|P3|Follow-up Period|Death|0
10080|NCT02032888|57357|P2|Follow-up Period|Death|1
10081|NCT02032888|57358|P1|Follow-up Period|Death|1
10082|NCT02032888|57356|P3|Follow-up Period|Lost to Follow-up|0
10083|NCT02032888|57357|P2|Follow-up Period|Lost to Follow-up|1
10084|NCT02032888|57358|P1|Follow-up Period|Lost to Follow-up|1
10085|NCT02032888|57356|P3|Treatment Period|Not specified|0
10086|NCT02032888|57357|P2|Treatment Period|Not specified|1
10087|NCT02032888|57358|P1|Treatment Period|Not specified|1
10088|NCT02032888|57356|P3|Treatment Period|Poor compliance/noncompliance|0
10089|NCT02032888|57357|P2|Treatment Period|Poor compliance/noncompliance|1
10090|NCT02032888|57358|P1|Treatment Period|Poor compliance/noncompliance|1
10091|NCT02032875|57389|P2|Follow-up Period|Virologic Relapse|10
10092|NCT02032875|57390|P1|Follow-up Period|Virologic Relapse|3
10093|NCT02032875|57389|P2|Follow-up Period|Death|1
10094|NCT02032875|57390|P1|Follow-up Period|Death|0
10095|NCT02032875|57389|P2|Treatment Period|Liver transplant, Treatment extension|3
10096|NCT02032875|57390|P1|Treatment Period|Liver transplant, Treatment extension|0
10097|NCT02032875|57389|P2|Treatment Period|Liver transplant, No extension needed|1
10098|NCT02032875|57390|P1|Treatment Period|Liver transplant, No extension needed|0
10099|NCT02032875|57389|P2|Treatment Period|Adverse Event|0
10100|NCT02032875|57390|P1|Treatment Period|Adverse Event|1
10101|NCT02032706|57419|P1|Overall Study|Protocol Violation|1
10102|NCT02032706|57419|P1|Overall Study|Did not qualify|5
10103|NCT02032407|57457|P1|Overall Study|Other Miscellaneous Reasons|2
10104|NCT02032407|57457|P1|Overall Study|Pregnancy|1
10105|NCT02032407|57457|P1|Overall Study|Lost to Follow-up|2
10106|NCT02032238|57470|P2|Overall Study|Lost to Follow-up|0
10107|NCT02032238|57471|P1|Overall Study|Lost to Follow-up|2
10108|NCT02031679|57512|P2|Overall Study|Lack of Efficacy|1
10109|NCT02031679|57513|P1|Overall Study|Lack of Efficacy|0
10110|NCT02031679|57512|P2|Overall Study|Protocol Violation|1
10111|NCT02031679|57513|P1|Overall Study|Protocol Violation|0
10112|NCT02031471|57523|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
10113|NCT02031471|57523|P1|Long Term Extension (LTE) Period|Adverse Event|1
10114|NCT02031471|57523|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
10115|NCT02031471|57523|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
10116|NCT02031471|57523|P1|24 Week Treatment Period|Protocol Violation|1
10117|NCT02031471|57523|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
10118|NCT02031471|57523|P1|24 Week Treatment Period|Adverse Event|6
10119|NCT02031458|57556|P3|Overall Study|Lost to Follow-up|2
10120|NCT02031458|57557|P2|Overall Study|Lost to Follow-up|1
10121|NCT02031458|57558|P1|Overall Study|Lost to Follow-up|1
10122|NCT02031458|57556|P3|Overall Study|On Treatment|73
10123|NCT02031458|57557|P2|Overall Study|On Treatment|81
10124|NCT02031458|57558|P1|Overall Study|On Treatment|43
10125|NCT02031458|57556|P3|Overall Study|On Survival Follow-Up|73
10126|NCT02031458|57557|P2|Overall Study|On Survival Follow-Up|83
10127|NCT02031458|57558|P1|Overall Study|On Survival Follow-Up|46
10128|NCT02031458|57556|P3|Overall Study|Withdrawal by Subject|3
10129|NCT02031458|57557|P2|Overall Study|Withdrawal by Subject|9
10130|NCT02031458|57558|P1|Overall Study|Withdrawal by Subject|6
10131|NCT02031458|57556|P3|Overall Study|Unknown Reason|2
10132|NCT02031458|57557|P2|Overall Study|Unknown Reason|1
10133|NCT02031458|57558|P1|Overall Study|Unknown Reason|0
10134|NCT02031458|57556|P3|Overall Study|Physician Decision|0
10135|NCT02031458|57557|P2|Overall Study|Physician Decision|1
10136|NCT02031458|57558|P1|Overall Study|Physician Decision|0
10137|NCT02031458|57556|P3|Overall Study|Protocol Violation|0
10138|NCT02031458|57557|P2|Overall Study|Protocol Violation|4
10139|NCT02031458|57558|P1|Overall Study|Protocol Violation|7
10140|NCT02031458|57556|P3|Overall Study|Death|100
10141|NCT02031458|57557|P2|Overall Study|Death|87
10142|NCT02031458|57558|P1|Overall Study|Death|36
10143|NCT02030600|57654|P2|Treatment Period 2|Unclassified|0
10144|NCT02030600|57655|P1|Treatment Period 2|Unclassified|1
10145|NCT02030600|57654|P2|Treatment Period 2|Withdrawal by Subject|9
10146|NCT02030600|57655|P1|Treatment Period 2|Withdrawal by Subject|13
10147|NCT02030600|57654|P2|Treatment Period 2|Protocol Violation|2
10148|NCT02030600|57655|P1|Treatment Period 2|Protocol Violation|1
10149|NCT02030600|57654|P2|Treatment Period 2|Lost to Follow-up|2
10150|NCT02030600|57655|P1|Treatment Period 2|Lost to Follow-up|4
10151|NCT02030600|57654|P2|Treatment Period 2|Lack of Efficacy|1
10152|NCT02030600|57655|P1|Treatment Period 2|Lack of Efficacy|2
10153|NCT02030600|57654|P2|Treatment Period 2|Adverse Event|4
10154|NCT02030600|57655|P1|Treatment Period 2|Adverse Event|4
10155|NCT02030600|57654|P2|Treatment Period 1|Unclassified|0
10156|NCT02030600|57655|P1|Treatment Period 1|Unclassified|1
10157|NCT02030600|57654|P2|Treatment Period 1|Casebook Unsigned|0
10158|NCT02030600|57655|P1|Treatment Period 1|Casebook Unsigned|1
10159|NCT02030600|57654|P2|Treatment Period 1|Withdrawal by Subject|17
10160|NCT02030600|57655|P1|Treatment Period 1|Withdrawal by Subject|13
10161|NCT02030600|57654|P2|Treatment Period 1|Protocol Violation|17
10162|NCT02030600|57655|P1|Treatment Period 1|Protocol Violation|22
10163|NCT02030600|57654|P2|Treatment Period 1|Lost to Follow-up|3
10164|NCT02030600|57655|P1|Treatment Period 1|Lost to Follow-up|11
10165|NCT02030600|57654|P2|Treatment Period 1|Lack of Efficacy|1
10166|NCT02030600|57655|P1|Treatment Period 1|Lack of Efficacy|0
10167|NCT02030600|57654|P2|Treatment Period 1|Adverse Event|7
10168|NCT02030600|57655|P1|Treatment Period 1|Adverse Event|5
10169|NCT02030535|57676|P1|Washout Period 1 (21 Days)|Adverse Event|1
10170|NCT02030405|57744|P1|Overall Study|Lost to Follow-up|1
10171|NCT02030405|57744|P1|Overall Study|Withdrawal by Subject|1
10172|NCT02030041|57752|P3|Overall Study|Withdrawal by Subject|1
10173|NCT02030041|57753|P2|Overall Study|Withdrawal by Subject|2
10174|NCT02030041|57754|P1|Overall Study|Withdrawal by Subject|2
10175|NCT02029989|57767|P2|Overall Study|Protocol Violation|0
10176|NCT02029989|57768|P1|Overall Study|Protocol Violation|1
10177|NCT02029989|57767|P2|Overall Study|Death|1
10178|NCT02029989|57768|P1|Overall Study|Death|0
10179|NCT02029989|57767|P2|Overall Study|Lost to Follow-up|7
10180|NCT02029989|57768|P1|Overall Study|Lost to Follow-up|9
10181|NCT02029989|57767|P2|Overall Study|Physician Decision|0
10182|NCT02029989|57768|P1|Overall Study|Physician Decision|2
10183|NCT02029989|57767|P2|Overall Study|Change of location|3
10184|NCT02029989|57768|P1|Overall Study|Change of location|2
10185|NCT02029989|57767|P2|Overall Study|Withdrawal: Fear of needles|0
10186|NCT02029989|57768|P1|Overall Study|Withdrawal: Fear of needles|1
10187|NCT02029989|57767|P2|Overall Study|Withdrawal by Subject|0
10188|NCT02029989|57768|P1|Overall Study|Withdrawal by Subject|1
10189|NCT02029521|57820|P2|Overall Study|Withdrawal by Subject|1
10190|NCT02029521|57821|P1|Overall Study|Withdrawal by Subject|1
10191|NCT02029521|57820|P2|Overall Study|Protocol Violation|0
10192|NCT02029521|57821|P1|Overall Study|Protocol Violation|1
10193|NCT02029417|57919|P1|Overall Study|Adverse Event|1
10194|NCT02029417|57919|P1|Overall Study|Death|1
10195|NCT02028767|58023|P2|Treatment Period 2|Reason other than those specified above|0
10196|NCT02028767|58024|P1|Treatment Period 2|Reason other than those specified above|1
10197|NCT02028767|58023|P2|Treatment Period 2|Non compliant with protocol|0
10198|NCT02028767|58024|P1|Treatment Period 2|Non compliant with protocol|1
10199|NCT02028169|58249|P1|Overall Study|Concomitant Medication Usage|1
10200|NCT02028169|58249|P1|Overall Study|Cessation of Drug|1
10201|NCT02028169|58249|P1|Overall Study|Adverse Event|1
10202|NCT02028169|58249|P1|Overall Study|Withdrawal by Subject|2
10203|NCT02028169|58249|P1|Overall Study|Lack of Efficacy|2
10204|NCT02028169|58249|P1|Overall Study|Lost to Follow-up|21
10205|NCT02028065|58275|P3|Treatment Through Study Completion|Adverse Event|5
10206|NCT02028065|58276|P2|Treatment Through Study Completion|Adverse Event|3
10207|NCT02028065|58277|P1|Treatment Through Study Completion|Adverse Event|3
10208|NCT02028065|58275|P3|Treatment Through Study Completion|Withdrawal by Subject|3
10209|NCT02028065|58276|P2|Treatment Through Study Completion|Withdrawal by Subject|4
10210|NCT02028065|58277|P1|Treatment Through Study Completion|Withdrawal by Subject|5
10211|NCT02028065|58275|P3|Treatment Through Study Completion|Protocol Violation|0
10212|NCT02028065|58276|P2|Treatment Through Study Completion|Protocol Violation|4
10213|NCT02028065|58277|P1|Treatment Through Study Completion|Protocol Violation|1
10214|NCT02028065|58275|P3|Treatment Through Study Completion|Physician Decision|0
10215|NCT02028065|58276|P2|Treatment Through Study Completion|Physician Decision|0
10216|NCT02028065|58277|P1|Treatment Through Study Completion|Physician Decision|1
10217|NCT02028065|58275|P3|Treatment Through Study Completion|Lost to Follow-up|6
10218|NCT02028065|58276|P2|Treatment Through Study Completion|Lost to Follow-up|4
10219|NCT02028065|58277|P1|Treatment Through Study Completion|Lost to Follow-up|2
10220|NCT02028065|58275|P3|Randomization Through Start Treatment|Not treated|3
10221|NCT02028065|58276|P2|Randomization Through Start Treatment|Not treated|3
10222|NCT02028065|58277|P1|Randomization Through Start Treatment|Not treated|1
10223|NCT02027844|58304|P3|Overall Study|Incomlete data|0
10224|NCT02027844|58305|P2|Overall Study|Incomlete data|0
10225|NCT02027844|58306|P1|Overall Study|Incomlete data|2
10226|NCT02027844|58304|P3|Overall Study|Protocol Violation|0
10227|NCT02027844|58305|P2|Overall Study|Protocol Violation|2
10228|NCT02027844|58306|P1|Overall Study|Protocol Violation|0
10229|NCT02027844|58304|P3|Overall Study|Lost to Follow-up|1
10230|NCT02027844|58305|P2|Overall Study|Lost to Follow-up|2
10231|NCT02027844|58306|P1|Overall Study|Lost to Follow-up|0
10232|NCT02027844|58304|P3|Overall Study|Withdrawal by Subject|1
10233|NCT02027844|58305|P2|Overall Study|Withdrawal by Subject|2
10234|NCT02027844|58306|P1|Overall Study|Withdrawal by Subject|3
10235|NCT02027402|58325|P2|Overall Study|Withdrawal by Subject|1
10236|NCT02027402|58326|P1|Overall Study|Withdrawal by Subject|4
10237|NCT02027311|58340|P2|Overall Study|Protocol Violation|2
10238|NCT02027311|58341|P1|Overall Study|Protocol Violation|3
10239|NCT02026258|58360|P2|Recieved Allocated Intervention|Lost to Follow-up|1
10240|NCT02026258|58361|P1|Recieved Allocated Intervention|Lost to Follow-up|0
10241|NCT02026258|58360|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
10242|NCT02026258|58361|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
10243|NCT02026258|58360|P2|Randomized|Presence of periodontal disease|1
10244|NCT02026258|58361|P1|Randomized|Presence of periodontal disease|1
10245|NCT02026258|58360|P2|Randomized|Change in treatment plan|0
10246|NCT02026258|58361|P1|Randomized|Change in treatment plan|1
10247|NCT02026258|58360|P2|Randomized|Did not start treatment|1
10248|NCT02026258|58361|P1|Randomized|Did not start treatment|2
10249|NCT02026141|58395|P2|Overall Study|Protocol Violation|1
10250|NCT02026141|58396|P1|Overall Study|Protocol Violation|0
10251|NCT02025907|58404|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
10252|NCT02025907|58405|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
10253|NCT02025907|58404|P2|Overall Study|Adverse Event|1
10254|NCT02025907|58405|P1|Overall Study|Adverse Event|3
10255|NCT02025907|58404|P2|Overall Study|Lost to Follow-up|2
10256|NCT02025907|58405|P1|Overall Study|Lost to Follow-up|2
10257|NCT02025907|58404|P2|Overall Study|Physician Decision|0
10258|NCT02025907|58405|P1|Overall Study|Physician Decision|2
10259|NCT02025907|58404|P2|Overall Study|Protocol Violation|0
10260|NCT02025907|58405|P1|Overall Study|Protocol Violation|2
10261|NCT02025907|58404|P2|Overall Study|Withdrawal by Subject|8
10262|NCT02025907|58405|P1|Overall Study|Withdrawal by Subject|15
10263|NCT02025907|58404|P2|Overall Study|Lack of Efficacy|0
10264|NCT02025907|58405|P1|Overall Study|Lack of Efficacy|1
10265|NCT02024971|58487|P1|Overall Study|Lost to Follow-up|6
10266|NCT02024971|58487|P1|Overall Study|Data Not Available|30
10267|NCT02024932|58500|P6|Overall Study|Abnormal laboratory value|0
10268|NCT02024932|58501|P5|Overall Study|Abnormal laboratory value|0
10269|NCT02024932|58502|P4|Overall Study|Abnormal laboratory value|2
10270|NCT02024932|58503|P3|Overall Study|Abnormal laboratory value|0
10271|NCT02024932|58504|P2|Overall Study|Abnormal laboratory value|0
10272|NCT02024932|58505|P1|Overall Study|Abnormal laboratory value|0
10273|NCT02024932|58500|P6|Overall Study|Adverse Event|0
10274|NCT02024932|58501|P5|Overall Study|Adverse Event|2
10275|NCT02024932|58502|P4|Overall Study|Adverse Event|0
10276|NCT02024932|58503|P3|Overall Study|Adverse Event|0
10277|NCT02024932|58504|P2|Overall Study|Adverse Event|3
10278|NCT02024932|58505|P1|Overall Study|Adverse Event|2
10279|NCT02024867|58564|P2|Overall Study|Lost to Follow-up|4
10280|NCT02024867|58565|P1|Overall Study|Lost to Follow-up|6
10281|NCT02024867|58564|P2|Overall Study|Protocol Violation|3
10282|NCT02024867|58565|P1|Overall Study|Protocol Violation|3
10283|NCT02024698|58590|P2|First Intervention (7 Days)|Withdrawal by Subject|1
10284|NCT02024698|58591|P1|First Intervention (7 Days)|Withdrawal by Subject|0
10285|NCT02023879|58669|P3|Overall Study|Other than specified above|1
10286|NCT02023879|58670|P2|Overall Study|Other than specified above|3
10287|NCT02023879|58671|P1|Overall Study|Other than specified above|1
10288|NCT02023879|58669|P3|Overall Study|Randomized but not treated|1
10289|NCT02023879|58670|P2|Overall Study|Randomized but not treated|1
10290|NCT02023879|58671|P1|Overall Study|Randomized but not treated|0
10291|NCT02023879|58669|P3|Overall Study|Consent withdrawn by participant|1
10292|NCT02023879|58670|P2|Overall Study|Consent withdrawn by participant|0
10293|NCT02023879|58671|P1|Overall Study|Consent withdrawn by participant|1
10294|NCT02023879|58669|P3|Overall Study|Physician Decision|0
10295|NCT02023879|58670|P2|Overall Study|Physician Decision|1
10296|NCT02023879|58671|P1|Overall Study|Physician Decision|0
10297|NCT02023879|58669|P3|Overall Study|Poor compliance to protocol|1
10298|NCT02023879|58670|P2|Overall Study|Poor compliance to protocol|2
10299|NCT02023879|58671|P1|Overall Study|Poor compliance to protocol|0
10300|NCT02023879|58669|P3|Overall Study|Adverse Event|5
10301|NCT02023879|58670|P2|Overall Study|Adverse Event|2
10302|NCT02023879|58671|P1|Overall Study|Adverse Event|2
10303|NCT02023268|58773|P2|Overall Study|Withdrawal by Subject|1
10304|NCT02023268|58774|P1|Overall Study|Withdrawal by Subject|0
10305|NCT02023268|58773|P2|Overall Study|Adverse Event|2
10306|NCT02023268|58774|P1|Overall Study|Adverse Event|0
10307|NCT02023268|58773|P2|Overall Study|Lack of Efficacy|1
10308|NCT02023268|58774|P1|Overall Study|Lack of Efficacy|0
10309|NCT02023112|58845|P2|Overall Study|Withdrawal by Subject|1
10310|NCT02023112|58846|P1|Overall Study|Withdrawal by Subject|2
10311|NCT02023099|58867|P3|Overall Study|Non-treatment-emergent Fatal AE|1
10312|NCT02023099|58868|P2|Overall Study|Non-treatment-emergent Fatal AE|0
10313|NCT02023099|58869|P1|Overall Study|Non-treatment-emergent Fatal AE|0
10314|NCT02023099|58867|P3|Overall Study|Withdrawn Consent|1
10315|NCT02023099|58868|P2|Overall Study|Withdrawn Consent|0
10316|NCT02023099|58869|P1|Overall Study|Withdrawn Consent|3
10317|NCT02023099|58867|P3|Overall Study|Non-fatal Adverse Event (AE)|1
10318|NCT02023099|58868|P2|Overall Study|Non-fatal Adverse Event (AE)|0
10319|NCT02023099|58869|P1|Overall Study|Non-fatal Adverse Event (AE)|0
10320|NCT02022670|58888|P3|Overall Study|Adverse Event|1
10321|NCT02022670|58889|P2|Overall Study|Adverse Event|0
10322|NCT02022670|58890|P1|Overall Study|Adverse Event|1
10323|NCT02022007|58934|P3|Overall Study|Noncompliant|1
10324|NCT02022007|58935|P2|Overall Study|Noncompliant|0
10325|NCT02022007|58936|P1|Overall Study|Noncompliant|0
10326|NCT02022007|58934|P3|Overall Study|Withdrawal by Subject|1
10327|NCT02022007|58935|P2|Overall Study|Withdrawal by Subject|1
10328|NCT02022007|58936|P1|Overall Study|Withdrawal by Subject|1
10329|NCT02021331|58993|P2|Overall Study|Adverse Event|2
10330|NCT02021331|58994|P1|Overall Study|Adverse Event|0
10331|NCT02020941|59014|P1|Overall Study|Disease Progression|4
10332|NCT02020941|59014|P1|Overall Study|Withdrawal by Subject|1
10333|NCT02020941|59014|P1|Overall Study|Physician Decision|2
10334|NCT02020941|59014|P1|Overall Study|Adverse Event|1
10335|NCT02020863|59023|P1|Overall Study|Team chose not to place an a line|1
10336|NCT02020863|59023|P1|Overall Study|Discovery of Metastatic disease|4
10337|NCT02020577|59029|P2|Overall Study|Other than stated above|1
10338|NCT02020577|59030|P1|Overall Study|Other than stated above|0
10339|NCT02020577|59029|P2|Overall Study|Withdrawal by Subject|1
10340|NCT02020577|59030|P1|Overall Study|Withdrawal by Subject|0
10341|NCT02020577|59029|P2|Overall Study|Other AE or clinical progression|15
10342|NCT02020577|59030|P1|Overall Study|Other AE or clinical progression|0
10343|NCT02020577|59029|P2|Overall Study|Progressive disease|38
10344|NCT02020577|59030|P1|Overall Study|Progressive disease|3
10345|NCT02020512|59057|P1|Overall Study|Protocol Violation|4
10346|NCT02020512|59057|P1|Overall Study|Lost to Follow-up|3
10347|NCT02020512|59057|P1|Overall Study|Adverse Event|1
10348|NCT02020031|59109|P2|Overall Study|Physician Decision|1
10349|NCT02020031|59110|P1|Overall Study|Physician Decision|1
10350|NCT02019550|59137|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
10351|NCT02019550|59138|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
10352|NCT02017015|59219|P1|Overall Study|Physician Decision|2
10353|NCT02017015|59219|P1|Overall Study|Non-compliance with study drug|2
10354|NCT02017015|59219|P1|Overall Study|Progressive Disease|31
10355|NCT02017015|59219|P1|Overall Study|Death|4
10356|NCT02017015|59219|P1|Overall Study|Withdrawal by Subject|21
10357|NCT02017015|59219|P1|Overall Study|Adverse Event|9
10358|NCT02016690|59242|P1|Overall Study|Hospitalized for RSV at study start|3
10359|NCT02016690|59242|P1|Overall Study|Did not meet inclusion criteria|13
10360|NCT02016690|59242|P1|Overall Study|Excluded from SAS: Ineligible for study|2
10361|NCT02016690|59242|P1|Overall Study|Excluded from SAS: Early treatment|2
10362|NCT02016690|59242|P1|Overall Study|Excluded from SAS: Duplication|2
10363|NCT02016690|59242|P1|Overall Study|Excluded from SAS: Enrollment violation|2
10364|NCT02016625|59255|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
10365|NCT02016625|59256|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
10366|NCT02016625|59255|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
10367|NCT02016625|59256|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
10368|NCT02016625|59255|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
10369|NCT02016625|59256|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
10370|NCT02016482|59290|P2|Period B|Required Alternative/Prohibited Therapy|2
10371|NCT02016482|59291|P1|Period B|Required Alternative/Prohibited Therapy|0
10372|NCT02016482|59290|P2|Period B|Not Specified|0
10373|NCT02016482|59291|P1|Period B|Not Specified|4
10374|NCT02016482|59290|P2|Period B|Lack of Efficacy|4
10375|NCT02016482|59291|P1|Period B|Lack of Efficacy|6
10376|NCT02016482|59290|P2|Period B|Lost to Follow-up|0
10377|NCT02016482|59291|P1|Period B|Lost to Follow-up|2
10378|NCT02016482|59290|P2|Period B|Withdrawal by Subject|1
10379|NCT02016482|59291|P1|Period B|Withdrawal by Subject|1
10380|NCT02016482|59290|P2|Period A|Required Alternative/Prohibited Therapy|1
10381|NCT02016482|59291|P1|Period A|Required Alternative/Prohibited Therapy|0
10382|NCT02016482|59290|P2|Period A|Protocol Violation|1
10383|NCT02016482|59291|P1|Period A|Protocol Violation|0
10384|NCT02016482|59290|P2|Period A|Not Specified|0
10385|NCT02016482|59291|P1|Period A|Not Specified|3
10386|NCT02016482|59290|P2|Period A|Lack of Efficacy|1
10387|NCT02016482|59291|P1|Period A|Lack of Efficacy|2
10388|NCT02016482|59290|P2|Period A|Lost to Follow-up|3
10389|NCT02016482|59291|P1|Period A|Lost to Follow-up|3
10390|NCT02016482|59290|P2|Period A|Withdrawal by Subject|4
10391|NCT02016482|59291|P1|Period A|Withdrawal by Subject|3
10392|NCT02016482|59290|P2|Period A|Adverse Event|5
10393|NCT02016482|59291|P1|Period A|Adverse Event|3
10394|NCT02016170|59382|P3|Overall Study|Protocol Violation|0
10395|NCT02016170|59383|P2|Overall Study|Protocol Violation|0
10396|NCT02016170|59384|P1|Overall Study|Protocol Violation|1
10397|NCT02016170|59382|P3|Overall Study|Adverse Event|0
10398|NCT02016170|59383|P2|Overall Study|Adverse Event|1
10399|NCT02016170|59384|P1|Overall Study|Adverse Event|1
10400|NCT02016105|59395|P6|EXTENSION PERIOD|Lost to Follow-up|2
10401|NCT02016105|59396|P5|EXTENSION PERIOD|Lost to Follow-up|0
10402|NCT02016105|59397|P4|EXTENSION PERIOD|Lost to Follow-up|0
10403|NCT02016105|59398|P3|EXTENSION PERIOD|Lost to Follow-up|0
10404|NCT02016105|59399|P2|EXTENSION PERIOD|Lost to Follow-up|0
10405|NCT02016105|59400|P1|EXTENSION PERIOD|Lost to Follow-up|0
10406|NCT02016105|59395|P6|EXTENSION PERIOD|Non-compliance with study indication|0
10407|NCT02016105|59396|P5|EXTENSION PERIOD|Non-compliance with study indication|1
10408|NCT02016105|59397|P4|EXTENSION PERIOD|Non-compliance with study indication|0
10409|NCT02016105|59398|P3|EXTENSION PERIOD|Non-compliance with study indication|0
10410|NCT02016105|59399|P2|EXTENSION PERIOD|Non-compliance with study indication|0
10411|NCT02016105|59400|P1|EXTENSION PERIOD|Non-compliance with study indication|0
10412|NCT02016105|59395|P6|EXTENSION PERIOD|Withdrawal by Subject|2
10413|NCT02016105|59396|P5|EXTENSION PERIOD|Withdrawal by Subject|2
10414|NCT02016105|59397|P4|EXTENSION PERIOD|Withdrawal by Subject|2
10415|NCT02016105|59398|P3|EXTENSION PERIOD|Withdrawal by Subject|2
10416|NCT02016105|59399|P2|EXTENSION PERIOD|Withdrawal by Subject|0
10417|NCT02016105|59400|P1|EXTENSION PERIOD|Withdrawal by Subject|0
10418|NCT02016105|59395|P6|EXTENSION PERIOD|Adverse Event|0
10419|NCT02016105|59396|P5|EXTENSION PERIOD|Adverse Event|1
10420|NCT02016105|59397|P4|EXTENSION PERIOD|Adverse Event|0
10421|NCT02016105|59398|P3|EXTENSION PERIOD|Adverse Event|2
10422|NCT02016105|59399|P2|EXTENSION PERIOD|Adverse Event|0
10423|NCT02016105|59400|P1|EXTENSION PERIOD|Adverse Event|0
10424|NCT02016105|59395|P6|EXTENSION PERIOD|Lack of Efficacy|1
10425|NCT02016105|59396|P5|EXTENSION PERIOD|Lack of Efficacy|1
10426|NCT02016105|59397|P4|EXTENSION PERIOD|Lack of Efficacy|3
10427|NCT02016105|59398|P3|EXTENSION PERIOD|Lack of Efficacy|1
10428|NCT02016105|59399|P2|EXTENSION PERIOD|Lack of Efficacy|0
10429|NCT02016105|59400|P1|EXTENSION PERIOD|Lack of Efficacy|0
10430|NCT02016105|59395|P6|EXTENSION PERIOD|New therapy for study indication|1
10431|NCT02016105|59396|P5|EXTENSION PERIOD|New therapy for study indication|1
10432|NCT02016105|59397|P4|EXTENSION PERIOD|New therapy for study indication|0
10433|NCT02016105|59398|P3|EXTENSION PERIOD|New therapy for study indication|0
10434|NCT02016105|59399|P2|EXTENSION PERIOD|New therapy for study indication|0
10435|NCT02016105|59400|P1|EXTENSION PERIOD|New therapy for study indication|0
10436|NCT02016105|59395|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
10437|NCT02016105|59396|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
10438|NCT02016105|59397|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
10439|NCT02016105|59398|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
10440|NCT02016105|59399|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
10441|NCT02016105|59400|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
10442|NCT02016105|59395|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
10443|NCT02016105|59396|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
10444|NCT02016105|59397|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
10445|NCT02016105|59398|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
10446|NCT02016105|59399|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
10447|NCT02016105|59400|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
10448|NCT02016105|59395|P6|TREATMENT PERIOD 2|Adverse Event|1
10449|NCT02016105|59396|P5|TREATMENT PERIOD 2|Adverse Event|0
10450|NCT02016105|59397|P4|TREATMENT PERIOD 2|Adverse Event|4
10451|NCT02016105|59398|P3|TREATMENT PERIOD 2|Adverse Event|0
10452|NCT02016105|59399|P2|TREATMENT PERIOD 2|Adverse Event|0
10453|NCT02016105|59400|P1|TREATMENT PERIOD 2|Adverse Event|0
10454|NCT02016105|59395|P6|TREATMENT PERIOD 2|Death|1
10455|NCT02016105|59396|P5|TREATMENT PERIOD 2|Death|0
10456|NCT02016105|59397|P4|TREATMENT PERIOD 2|Death|0
10457|NCT02016105|59398|P3|TREATMENT PERIOD 2|Death|0
10458|NCT02016105|59399|P2|TREATMENT PERIOD 2|Death|0
10459|NCT02016105|59400|P1|TREATMENT PERIOD 2|Death|0
10460|NCT02016105|59395|P6|TREATMENT PERIOD 2|Pregnancy|1
10461|NCT02016105|59396|P5|TREATMENT PERIOD 2|Pregnancy|0
10462|NCT02016105|59397|P4|TREATMENT PERIOD 2|Pregnancy|0
10463|NCT02016105|59398|P3|TREATMENT PERIOD 2|Pregnancy|0
10464|NCT02016105|59399|P2|TREATMENT PERIOD 2|Pregnancy|0
10465|NCT02016105|59400|P1|TREATMENT PERIOD 2|Pregnancy|0
10466|NCT02016105|59395|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
10467|NCT02016105|59396|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
10468|NCT02016105|59397|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
10469|NCT02016105|59398|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
10470|NCT02016105|59399|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
10471|NCT02016105|59400|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
10472|NCT02016105|59395|P6|TREATMENT PERIOD 2|Non compliance study medication|1
10473|NCT02016105|59396|P5|TREATMENT PERIOD 2|Non compliance study medication|0
10474|NCT02016105|59397|P4|TREATMENT PERIOD 2|Non compliance study medication|0
10475|NCT02016105|59398|P3|TREATMENT PERIOD 2|Non compliance study medication|0
10476|NCT02016105|59399|P2|TREATMENT PERIOD 2|Non compliance study medication|0
10477|NCT02016105|59400|P1|TREATMENT PERIOD 2|Non compliance study medication|0
10478|NCT02016105|59395|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
10479|NCT02016105|59396|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
10480|NCT02016105|59397|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
10481|NCT02016105|59398|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
10482|NCT02016105|59399|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
10483|NCT02016105|59400|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
10484|NCT02016105|59395|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
10485|NCT02016105|59396|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
10486|NCT02016105|59397|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
10487|NCT02016105|59398|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
10488|NCT02016105|59399|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
10489|NCT02016105|59400|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
10490|NCT02016105|59395|P6|TREATMENT PERIOD 1|Adverse Event|0
10491|NCT02016105|59396|P5|TREATMENT PERIOD 1|Adverse Event|0
10492|NCT02016105|59397|P4|TREATMENT PERIOD 1|Adverse Event|0
10493|NCT02016105|59398|P3|TREATMENT PERIOD 1|Adverse Event|0
10494|NCT02016105|59399|P2|TREATMENT PERIOD 1|Adverse Event|5
10495|NCT02016105|59400|P1|TREATMENT PERIOD 1|Adverse Event|3
10496|NCT02016105|59395|P6|TREATMENT PERIOD 1|Pregnancy|0
10497|NCT02016105|59396|P5|TREATMENT PERIOD 1|Pregnancy|0
10498|NCT02016105|59397|P4|TREATMENT PERIOD 1|Pregnancy|0
10499|NCT02016105|59398|P3|TREATMENT PERIOD 1|Pregnancy|0
10500|NCT02016105|59399|P2|TREATMENT PERIOD 1|Pregnancy|1
10501|NCT02016105|59400|P1|TREATMENT PERIOD 1|Pregnancy|0
10502|NCT02016105|59395|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
10503|NCT02016105|59396|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
10504|NCT02016105|59397|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
10505|NCT02016105|59398|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
10506|NCT02016105|59399|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
10507|NCT02016105|59400|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
10508|NCT02016105|59395|P6|TREATMENT PERIOD 1|Physician Decision|0
10509|NCT02016105|59396|P5|TREATMENT PERIOD 1|Physician Decision|0
10510|NCT02016105|59397|P4|TREATMENT PERIOD 1|Physician Decision|0
10511|NCT02016105|59398|P3|TREATMENT PERIOD 1|Physician Decision|0
10512|NCT02016105|59399|P2|TREATMENT PERIOD 1|Physician Decision|2
10513|NCT02016105|59400|P1|TREATMENT PERIOD 1|Physician Decision|0
10514|NCT02016105|59395|P6|TREATMENT PERIOD 1|Protocol Violation|0
10515|NCT02016105|59396|P5|TREATMENT PERIOD 1|Protocol Violation|0
10516|NCT02016105|59397|P4|TREATMENT PERIOD 1|Protocol Violation|0
10517|NCT02016105|59398|P3|TREATMENT PERIOD 1|Protocol Violation|0
10518|NCT02016105|59399|P2|TREATMENT PERIOD 1|Protocol Violation|8
10519|NCT02016105|59400|P1|TREATMENT PERIOD 1|Protocol Violation|2
10520|NCT02015793|59459|P2|Overall Study|Withdrawal by Subject|1
10521|NCT02015793|59460|P1|Overall Study|Withdrawal by Subject|1
10522|NCT02015793|59459|P2|Overall Study|Adverse Event|3
10523|NCT02015793|59460|P1|Overall Study|Adverse Event|3
10524|NCT02015676|59493|P3|Overall Study|Disease progression|1
10525|NCT02015676|59494|P2|Overall Study|Disease progression|1
10526|NCT02015676|59495|P1|Overall Study|Disease progression|3
10527|NCT02015676|59493|P3|Overall Study|Death|0
10528|NCT02015676|59494|P2|Overall Study|Death|1
10529|NCT02015676|59495|P1|Overall Study|Death|0
10530|NCT02015676|59493|P3|Overall Study|Administrative reasons|1
10531|NCT02015676|59494|P2|Overall Study|Administrative reasons|3
10532|NCT02015676|59495|P1|Overall Study|Administrative reasons|0
10533|NCT02015676|59493|P3|Overall Study|Withdrawal by Subject|1
10534|NCT02015676|59494|P2|Overall Study|Withdrawal by Subject|7
10535|NCT02015676|59495|P1|Overall Study|Withdrawal by Subject|1
10536|NCT02015676|59493|P3|Overall Study|Protocol Violation|0
10537|NCT02015676|59494|P2|Overall Study|Protocol Violation|0
10538|NCT02015676|59495|P1|Overall Study|Protocol Violation|1
10539|NCT02015676|59493|P3|Overall Study|Lack of Efficacy|0
10540|NCT02015676|59494|P2|Overall Study|Lack of Efficacy|4
10541|NCT02015676|59495|P1|Overall Study|Lack of Efficacy|2
10542|NCT02015676|59493|P3|Overall Study|Adverse Event|0
10543|NCT02015676|59494|P2|Overall Study|Adverse Event|18
10544|NCT02015676|59495|P1|Overall Study|Adverse Event|2
10545|NCT02015663|59511|P2|Overall Study|Administrative problems|11
10546|NCT02015663|59512|P1|Overall Study|Administrative problems|10
10547|NCT02015663|59511|P2|Overall Study|Adverse Event|0
10548|NCT02015663|59512|P1|Overall Study|Adverse Event|3
10549|NCT02015663|59511|P2|Overall Study|Protocol Violation|1
10550|NCT02015663|59512|P1|Overall Study|Protocol Violation|0
10551|NCT02015663|59511|P2|Overall Study|Withdrawal by Subject|0
10552|NCT02015663|59512|P1|Overall Study|Withdrawal by Subject|1
10553|NCT02015663|59511|P2|Overall Study|unsatisfactory therapeutic effect|0
10554|NCT02015663|59512|P1|Overall Study|unsatisfactory therapeutic effect|1
10555|NCT02015546|59544|P3|Overall Study|Screem Failure|3
10556|NCT02015546|59545|P2|Overall Study|Screem Failure|1
10557|NCT02015546|59546|P1|Overall Study|Screem Failure|2
10558|NCT02015546|59544|P3|Overall Study|Withdrawal by Subject|1
10559|NCT02015546|59545|P2|Overall Study|Withdrawal by Subject|1
10560|NCT02015546|59546|P1|Overall Study|Withdrawal by Subject|1
10561|NCT02015481|59578|P1|Overall Study|Death|1
10562|NCT02015221|59602|P2|Overall Study|Lost to Follow-up|0
10563|NCT02015221|59603|P1|Overall Study|Lost to Follow-up|1
10564|NCT02015221|59602|P2|Overall Study|Withdrawal by Subject|6
10565|NCT02015221|59603|P1|Overall Study|Withdrawal by Subject|8
10566|NCT02015195|59616|P7|Overall Study|Adverse Event|0
10567|NCT02015195|59617|P6|Overall Study|Adverse Event|0
10568|NCT02015195|59618|P5|Overall Study|Adverse Event|0
10569|NCT02015195|59619|P4|Overall Study|Adverse Event|1
10570|NCT02015195|59620|P3|Overall Study|Adverse Event|0
10571|NCT02015195|59621|P2|Overall Study|Adverse Event|0
10572|NCT02015195|59622|P1|Overall Study|Adverse Event|0
10573|NCT02014584|59645|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
10574|NCT02014584|59646|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
10575|NCT02014584|59647|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
10576|NCT02014584|59648|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
10577|NCT02014584|59649|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
10578|NCT02014584|59650|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
10579|NCT02014584|59645|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
10580|NCT02014584|59646|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
10581|NCT02014584|59647|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
10582|NCT02014584|59648|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
10583|NCT02014584|59649|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
10584|NCT02014584|59650|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
10585|NCT02014584|59645|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
10586|NCT02014584|59646|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
10587|NCT02014584|59647|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
10588|NCT02014584|59648|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
10589|NCT02014584|59649|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
10590|NCT02014584|59650|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
10591|NCT02014584|59645|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
10592|NCT02014584|59646|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
10593|NCT02014584|59647|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
10594|NCT02014584|59648|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
10595|NCT02014584|59649|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
10596|NCT02014584|59650|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
10597|NCT02014584|59645|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
10598|NCT02014584|59646|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
10599|NCT02014584|59647|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
10600|NCT02014584|59648|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
10601|NCT02014584|59649|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
10602|NCT02014584|59650|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
10603|NCT02014480|59767|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
10604|NCT02014480|59768|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
10605|NCT02014480|59769|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
10606|NCT02014480|59770|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
10607|NCT02014480|59771|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
10608|NCT02014480|59772|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
10609|NCT02014480|59767|P6|Treatment Period 3 (14 Days)|Adverse Event|1
10610|NCT02014480|59768|P5|Treatment Period 3 (14 Days)|Adverse Event|0
10611|NCT02014480|59769|P4|Treatment Period 3 (14 Days)|Adverse Event|0
10612|NCT02014480|59770|P3|Treatment Period 3 (14 Days)|Adverse Event|1
10613|NCT02014480|59771|P2|Treatment Period 3 (14 Days)|Adverse Event|0
10614|NCT02014480|59772|P1|Treatment Period 3 (14 Days)|Adverse Event|0
10615|NCT02014480|59767|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
10616|NCT02014480|59768|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
10617|NCT02014480|59769|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
10618|NCT02014480|59770|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
10619|NCT02014480|59771|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
10620|NCT02014480|59772|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
10621|NCT02014480|59767|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
10622|NCT02014480|59768|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
10623|NCT02014480|59769|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
10624|NCT02014480|59770|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
10625|NCT02014480|59771|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
10626|NCT02014480|59772|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
10627|NCT02014480|59767|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
10628|NCT02014480|59768|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
10629|NCT02014480|59769|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
10630|NCT02014480|59770|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
10631|NCT02014480|59771|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
10632|NCT02014480|59772|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
10633|NCT02014480|59767|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
10634|NCT02014480|59768|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
10635|NCT02014480|59769|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
10636|NCT02014480|59770|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
10637|NCT02014480|59771|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
10638|NCT02014480|59772|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
10639|NCT02014480|59767|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
10640|NCT02014480|59768|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
10641|NCT02014480|59769|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
10642|NCT02014480|59770|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
10643|NCT02014480|59771|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
10644|NCT02014480|59772|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
10645|NCT02014467|59791|P2|Overall Study|Withdrawal by Subject|4
10646|NCT02014467|59792|P1|Overall Study|Withdrawal by Subject|16
10647|NCT02014467|59791|P2|Overall Study|Physician Decision|3
10648|NCT02014467|59792|P1|Overall Study|Physician Decision|2
10649|NCT02014467|59791|P2|Overall Study|Protocol Violation|0
10650|NCT02014467|59792|P1|Overall Study|Protocol Violation|3
10651|NCT02014467|59791|P2|Overall Study|Adverse Event|0
10652|NCT02014467|59792|P1|Overall Study|Adverse Event|4
10653|NCT02014441|59852|P1|Overall Study|Continuing in Study|21
10654|NCT02014441|59852|P1|Overall Study|Withdrawal by Subject|9
10655|NCT02014402|59948|P4|Overall Study|Lost to Follow-up|2
10656|NCT02014402|59949|P3|Overall Study|Lost to Follow-up|1
10657|NCT02014402|59950|P2|Overall Study|Lost to Follow-up|0
10658|NCT02014402|59951|P1|Overall Study|Lost to Follow-up|0
10659|NCT02014402|59948|P4|Overall Study|Subject did not have transportation|0
10660|NCT02014402|59949|P3|Overall Study|Subject did not have transportation|0
10661|NCT02014402|59950|P2|Overall Study|Subject did not have transportation|1
10662|NCT02014402|59951|P1|Overall Study|Subject did not have transportation|0
10663|NCT02014402|59948|P4|Overall Study|Withdrawal by Subject|1
10664|NCT02014402|59949|P3|Overall Study|Withdrawal by Subject|2
10665|NCT02014402|59950|P2|Overall Study|Withdrawal by Subject|2
10666|NCT02014402|59951|P1|Overall Study|Withdrawal by Subject|1
10667|NCT02014402|59948|P4|Overall Study|Adverse Event|0
10668|NCT02014402|59949|P3|Overall Study|Adverse Event|0
10669|NCT02014402|59950|P2|Overall Study|Adverse Event|0
10670|NCT02014402|59951|P1|Overall Study|Adverse Event|1
10671|NCT02013206|60014|P2|Overall Study|Other reasons off treatment|2
10672|NCT02013206|60015|P1|Overall Study|Other reasons off treatment|5
10673|NCT02013206|60014|P2|Overall Study|Death|2
10674|NCT02013206|60015|P1|Overall Study|Death|1
10675|NCT02013206|60014|P2|Overall Study|Patient non-compliance|0
10676|NCT02013206|60015|P1|Overall Study|Patient non-compliance|1
10677|NCT02013206|60014|P2|Overall Study|Patient refusal|0
10678|NCT02013206|60015|P1|Overall Study|Patient refusal|2
10679|NCT02013206|60014|P2|Overall Study|Adverse Event|0
10680|NCT02013206|60015|P1|Overall Study|Adverse Event|1
10681|NCT02013206|60014|P2|Overall Study|Symptomatic deterioration|1
10682|NCT02013206|60015|P1|Overall Study|Symptomatic deterioration|3
10683|NCT02013206|60014|P2|Overall Study|Progressive disease (PD)|17
10684|NCT02013206|60015|P1|Overall Study|Progressive disease (PD)|14
10685|NCT02014272|60035|P2|Intervention Period 1|Adverse Event|1
10686|NCT02014272|60036|P1|Intervention Period 1|Adverse Event|0
10687|NCT02014272|60035|P2|Intervention Period 1|Withdrawal by Subject|0
10688|NCT02014272|60036|P1|Intervention Period 1|Withdrawal by Subject|1
10689|NCT02013830|60068|P1|Overall Study|Refused treatment|1
10690|NCT02013830|60068|P1|Overall Study|Insufficient therapeutic response|25
10691|NCT02013830|60068|P1|Overall Study|Death|1
10692|NCT02013830|60068|P1|Overall Study|Adverse Event|3
10693|NCT02013817|60079|P1|Overall Study|Not specified|9
10694|NCT02013817|60079|P1|Overall Study|Death|2
10695|NCT02013817|60079|P1|Overall Study|Withdrawal by Subject|4
10696|NCT02013817|60079|P1|Overall Study|Adverse Event|12
10697|NCT02013765|60088|P1|Overall Study|Trial was terminated by sponsor|1
10698|NCT02013687|60102|P4|Overall Study|Missed visits due to patient travel|0
10699|NCT02013687|60103|P3|Overall Study|Missed visits due to patient travel|1
10700|NCT02013687|60104|P2|Overall Study|Missed visits due to patient travel|0
10701|NCT02013687|60105|P1|Overall Study|Missed visits due to patient travel|0
10702|NCT02013687|60102|P4|Overall Study|Withdrawal by Subject|1
10703|NCT02013687|60103|P3|Overall Study|Withdrawal by Subject|0
10704|NCT02013687|60104|P2|Overall Study|Withdrawal by Subject|0
10705|NCT02013687|60105|P1|Overall Study|Withdrawal by Subject|0
10706|NCT02013687|60102|P4|Overall Study|Protocol Violation|1
10707|NCT02013687|60103|P3|Overall Study|Protocol Violation|0
10708|NCT02013687|60104|P2|Overall Study|Protocol Violation|0
10709|NCT02013687|60105|P1|Overall Study|Protocol Violation|0
10710|NCT02013687|60102|P4|Overall Study|Lost to Follow-up|0
10711|NCT02013687|60103|P3|Overall Study|Lost to Follow-up|1
10712|NCT02013687|60104|P2|Overall Study|Lost to Follow-up|0
10713|NCT02013687|60105|P1|Overall Study|Lost to Follow-up|0
10714|NCT02013622|60135|P1|Overall Study|Lack of Efficacy|1
10715|NCT02013622|60135|P1|Overall Study|Protocol Deviation|1
10716|NCT02013622|60135|P1|Overall Study|Withdrawal by Subject|6
10717|NCT02013622|60135|P1|Overall Study|Met Withdrawal Criteria|3
10718|NCT02013622|60135|P1|Overall Study|Adverse Event|3
10719|NCT02013622|60135|P1|Overall Study|Lost to Follow-up|10
10720|NCT02013609|60155|P1|Overall Study|Met Withdrawal Criteria|3
10721|NCT02013609|60155|P1|Overall Study|Adverse Event|3
10722|NCT02013609|60155|P1|Overall Study|Lost to Follow-up|3
10723|NCT02013609|60155|P1|Overall Study|Withdrawal by Subject|9
10724|NCT02013544|60180|P2|Overall Study|Entry criteria not met/non-compliance|3
10725|NCT02013544|60181|P1|Overall Study|Entry criteria not met/non-compliance|2
10726|NCT02013544|60180|P2|Overall Study|Physician Decision|1
10727|NCT02013544|60181|P1|Overall Study|Physician Decision|0
10728|NCT02013544|60180|P2|Overall Study|Withdrawal by Subject|8
10729|NCT02013544|60181|P1|Overall Study|Withdrawal by Subject|2
10730|NCT02013544|60180|P2|Overall Study|Lost to Follow-up|3
10731|NCT02013544|60181|P1|Overall Study|Lost to Follow-up|2
10732|NCT02013544|60180|P2|Overall Study|Adverse Event|5
10733|NCT02013544|60181|P1|Overall Study|Adverse Event|5
10734|NCT02013531|60203|P1|Overall Study|Withdrawal by Subject|1
10735|NCT02013531|60203|P1|Overall Study|Met Withdrawal Criteria|1
10736|NCT02013531|60203|P1|Overall Study|Lost to Follow-up|3
10737|NCT02013388|60233|P8|Overall Study|work emergency|0
10738|NCT02013388|60234|P7|Overall Study|work emergency|0
10739|NCT02013388|60235|P6|Overall Study|work emergency|0
10740|NCT02013388|60236|P5|Overall Study|work emergency|1
10741|NCT02013388|60237|P4|Overall Study|work emergency|0
10742|NCT02013388|60238|P3|Overall Study|work emergency|0
10743|NCT02013388|60239|P2|Overall Study|work emergency|0
10744|NCT02013388|60240|P1|Overall Study|work emergency|1
10745|NCT02013167|60276|P2|Overall Study|Death|160
10746|NCT02013167|60277|P1|Overall Study|Death|85
10747|NCT02013167|60276|P2|Overall Study|Lost to Follow-up|1
10748|NCT02013167|60277|P1|Overall Study|Lost to Follow-up|0
10749|NCT02013167|60276|P2|Overall Study|Sponsor Decision|3
10750|NCT02013167|60277|P1|Overall Study|Sponsor Decision|1
10751|NCT02013167|60276|P2|Overall Study|Withdrawal by Subject|14
10752|NCT02013167|60277|P1|Overall Study|Withdrawal by Subject|15
10753|NCT02012686|60355|P2|Overall Study|electrocardiography monitoring noise|1
10754|NCT02012686|60356|P1|Overall Study|electrocardiography monitoring noise|0
10755|NCT02012686|60355|P2|Overall Study|muscle contraction|1
10756|NCT02012686|60356|P1|Overall Study|muscle contraction|0
10757|NCT02012452|60403|P2|Overall Study|Withdrawal by Subject|0
10758|NCT02012452|60404|P1|Overall Study|Withdrawal by Subject|4
10759|NCT02012452|60403|P2|Overall Study|Lost to Follow-up|1
10760|NCT02012452|60404|P1|Overall Study|Lost to Follow-up|2
10761|NCT02012218|60417|P5|Overall Study|Protocol Deviation|0
10762|NCT02012218|60418|P4|Overall Study|Protocol Deviation|0
10763|NCT02012218|60419|P3|Overall Study|Protocol Deviation|0
10764|NCT02012218|60420|P2|Overall Study|Protocol Deviation|0
10765|NCT02012218|60421|P1|Overall Study|Protocol Deviation|1
10766|NCT02012218|60417|P5|Overall Study|Protocol Specified|0
10767|NCT02012218|60418|P4|Overall Study|Protocol Specified|0
10768|NCT02012218|60419|P3|Overall Study|Protocol Specified|0
10769|NCT02012218|60420|P2|Overall Study|Protocol Specified|0
10770|NCT02012218|60421|P1|Overall Study|Protocol Specified|1
10771|NCT02012218|60417|P5|Overall Study|Lost to Follow-up|0
10772|NCT02012218|60418|P4|Overall Study|Lost to Follow-up|0
10773|NCT02012218|60419|P3|Overall Study|Lost to Follow-up|1
10774|NCT02012218|60420|P2|Overall Study|Lost to Follow-up|1
10775|NCT02012218|60421|P1|Overall Study|Lost to Follow-up|0
10776|NCT02012218|60417|P5|Overall Study|Adverse Event|0
10777|NCT02012218|60418|P4|Overall Study|Adverse Event|1
10778|NCT02012218|60419|P3|Overall Study|Adverse Event|0
10779|NCT02012218|60420|P2|Overall Study|Adverse Event|0
10780|NCT02012218|60421|P1|Overall Study|Adverse Event|1
10781|NCT02012218|60417|P5|Overall Study|Withdrawal by Subject|1
10782|NCT02012218|60418|P4|Overall Study|Withdrawal by Subject|1
10783|NCT02012218|60419|P3|Overall Study|Withdrawal by Subject|1
10784|NCT02012218|60420|P2|Overall Study|Withdrawal by Subject|0
10785|NCT02012218|60421|P1|Overall Study|Withdrawal by Subject|1
10786|NCT02011893|60433|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
10787|NCT02011893|60434|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
10788|NCT02011893|60435|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
10789|NCT02011893|60433|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
10790|NCT02011893|60434|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
10791|NCT02011893|60435|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
10792|NCT02011893|60433|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
10793|NCT02011893|60434|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
10794|NCT02011893|60435|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
10795|NCT02011893|60433|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
10796|NCT02011893|60434|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
10797|NCT02011893|60435|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
10798|NCT02011893|60433|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
10799|NCT02011893|60434|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
10800|NCT02011893|60435|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
10801|NCT02011893|60433|P3|Enrollment to Randomization|Screening Failure|0
10802|NCT02011893|60434|P2|Enrollment to Randomization|Screening Failure|0
10803|NCT02011893|60435|P1|Enrollment to Randomization|Screening Failure|29
10804|NCT02011893|60433|P3|Enrollment to Randomization|Withdrawal by Subject|0
10805|NCT02011893|60434|P2|Enrollment to Randomization|Withdrawal by Subject|0
10806|NCT02011893|60435|P1|Enrollment to Randomization|Withdrawal by Subject|21
10807|NCT02011893|60433|P3|Enrollment to Randomization|Physician Decision|0
10808|NCT02011893|60434|P2|Enrollment to Randomization|Physician Decision|0
10809|NCT02011893|60435|P1|Enrollment to Randomization|Physician Decision|10
10810|NCT02011893|60433|P3|Enrollment to Randomization|Adverse Event|0
10811|NCT02011893|60434|P2|Enrollment to Randomization|Adverse Event|0
10812|NCT02011893|60435|P1|Enrollment to Randomization|Adverse Event|2
10813|NCT02011113|60572|P1|Overall Study|Study terminated by sponsor|11
10814|NCT02011113|60572|P1|Overall Study|Investigator's judgement- DP|3
10815|NCT02011113|60572|P1|Overall Study|Insufficient effect of Pomalidomide|1
10816|NCT02011113|60572|P1|Overall Study|Death|1
10817|NCT02011113|60572|P1|Overall Study|Disease Progression (DP)|16
10818|NCT02011113|60572|P1|Overall Study|Adverse Event|4
10819|NCT02010684|60601|P2|Overall Study|Withdrawal by Subject|5
10820|NCT02010684|60602|P1|Overall Study|Withdrawal by Subject|4
10821|NCT02010684|60601|P2|Overall Study|Lost to Follow-up|18
10822|NCT02010684|60602|P1|Overall Study|Lost to Follow-up|8
10823|NCT02010632|60620|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
10824|NCT02010632|60621|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
10825|NCT02010255|60641|P14|Overall Study|Randomized but Not Treated|1
10826|NCT02010255|60642|P13|Overall Study|Randomized but Not Treated|0
10827|NCT02010255|60643|P12|Overall Study|Randomized but Not Treated|0
10828|NCT02010255|60644|P11|Overall Study|Randomized but Not Treated|0
10829|NCT02010255|60645|P10|Overall Study|Randomized but Not Treated|0
10830|NCT02010255|60646|P9|Overall Study|Randomized but Not Treated|0
10831|NCT02010255|60647|P8|Overall Study|Randomized but Not Treated|0
10832|NCT02010255|60648|P7|Overall Study|Randomized but Not Treated|0
10833|NCT02010255|60649|P6|Overall Study|Randomized but Not Treated|0
10834|NCT02010255|60650|P5|Overall Study|Randomized but Not Treated|0
10835|NCT02010255|60651|P4|Overall Study|Randomized but Not Treated|0
10836|NCT02010255|60652|P3|Overall Study|Randomized but Not Treated|0
10837|NCT02010255|60653|P2|Overall Study|Randomized but Not Treated|0
10838|NCT02010255|60654|P1|Overall Study|Randomized but Not Treated|0
10839|NCT02010255|60641|P14|Overall Study|Lost to Follow-up|0
10840|NCT02010255|60642|P13|Overall Study|Lost to Follow-up|0
10841|NCT02010255|60643|P12|Overall Study|Lost to Follow-up|0
10842|NCT02010255|60644|P11|Overall Study|Lost to Follow-up|0
10843|NCT02010255|60645|P10|Overall Study|Lost to Follow-up|0
10844|NCT02010255|60646|P9|Overall Study|Lost to Follow-up|0
10845|NCT02010255|60647|P8|Overall Study|Lost to Follow-up|0
10846|NCT02010255|60648|P7|Overall Study|Lost to Follow-up|0
10847|NCT02010255|60649|P6|Overall Study|Lost to Follow-up|0
10848|NCT02010255|60650|P5|Overall Study|Lost to Follow-up|1
10849|NCT02010255|60651|P4|Overall Study|Lost to Follow-up|0
10850|NCT02010255|60652|P3|Overall Study|Lost to Follow-up|1
10851|NCT02010255|60653|P2|Overall Study|Lost to Follow-up|0
10852|NCT02010255|60654|P1|Overall Study|Lost to Follow-up|0
10853|NCT02010255|60641|P14|Overall Study|Adverse Event|0
10854|NCT02010255|60642|P13|Overall Study|Adverse Event|0
10855|NCT02010255|60643|P12|Overall Study|Adverse Event|0
10856|NCT02010255|60644|P11|Overall Study|Adverse Event|0
10857|NCT02010255|60645|P10|Overall Study|Adverse Event|0
10858|NCT02010255|60646|P9|Overall Study|Adverse Event|0
10859|NCT02010255|60647|P8|Overall Study|Adverse Event|0
10860|NCT02010255|60648|P7|Overall Study|Adverse Event|0
10861|NCT02010255|60649|P6|Overall Study|Adverse Event|0
10862|NCT02010255|60650|P5|Overall Study|Adverse Event|0
10863|NCT02010255|60651|P4|Overall Study|Adverse Event|0
10864|NCT02010255|60652|P3|Overall Study|Adverse Event|0
10865|NCT02010255|60653|P2|Overall Study|Adverse Event|0
10866|NCT02010255|60654|P1|Overall Study|Adverse Event|1
10867|NCT02010255|60641|P14|Overall Study|Withdrew Consent|0
10868|NCT02010255|60642|P13|Overall Study|Withdrew Consent|0
10869|NCT02010255|60643|P12|Overall Study|Withdrew Consent|0
10870|NCT02010255|60644|P11|Overall Study|Withdrew Consent|0
10871|NCT02010255|60645|P10|Overall Study|Withdrew Consent|0
10872|NCT02010255|60646|P9|Overall Study|Withdrew Consent|0
10873|NCT02010255|60647|P8|Overall Study|Withdrew Consent|0
10874|NCT02010255|60648|P7|Overall Study|Withdrew Consent|0
10875|NCT02010255|60649|P6|Overall Study|Withdrew Consent|0
10876|NCT02010255|60650|P5|Overall Study|Withdrew Consent|0
10877|NCT02010255|60651|P4|Overall Study|Withdrew Consent|1
10878|NCT02010255|60652|P3|Overall Study|Withdrew Consent|0
10879|NCT02010255|60653|P2|Overall Study|Withdrew Consent|0
10880|NCT02010255|60654|P1|Overall Study|Withdrew Consent|1
10881|NCT02010255|60641|P14|Overall Study|Lack of Efficacy|0
10882|NCT02010255|60642|P13|Overall Study|Lack of Efficacy|0
10883|NCT02010255|60643|P12|Overall Study|Lack of Efficacy|0
10884|NCT02010255|60644|P11|Overall Study|Lack of Efficacy|1
10885|NCT02010255|60645|P10|Overall Study|Lack of Efficacy|0
10886|NCT02010255|60646|P9|Overall Study|Lack of Efficacy|0
10887|NCT02010255|60647|P8|Overall Study|Lack of Efficacy|0
10888|NCT02010255|60648|P7|Overall Study|Lack of Efficacy|0
10889|NCT02010255|60649|P6|Overall Study|Lack of Efficacy|0
10890|NCT02010255|60650|P5|Overall Study|Lack of Efficacy|1
10891|NCT02010255|60651|P4|Overall Study|Lack of Efficacy|1
10892|NCT02010255|60652|P3|Overall Study|Lack of Efficacy|2
10893|NCT02010255|60653|P2|Overall Study|Lack of Efficacy|1
10894|NCT02010255|60654|P1|Overall Study|Lack of Efficacy|4
10895|NCT02010255|60641|P14|Overall Study|Death|0
10896|NCT02010255|60642|P13|Overall Study|Death|0
10897|NCT02010255|60643|P12|Overall Study|Death|1
10898|NCT02010255|60644|P11|Overall Study|Death|1
10899|NCT02010255|60645|P10|Overall Study|Death|0
10900|NCT02010255|60646|P9|Overall Study|Death|1
10901|NCT02010255|60647|P8|Overall Study|Death|1
10902|NCT02010255|60648|P7|Overall Study|Death|1
10903|NCT02010255|60649|P6|Overall Study|Death|0
10904|NCT02010255|60650|P5|Overall Study|Death|2
10905|NCT02010255|60651|P4|Overall Study|Death|4
10906|NCT02010255|60652|P3|Overall Study|Death|4
10907|NCT02010255|60653|P2|Overall Study|Death|1
10908|NCT02010255|60654|P1|Overall Study|Death|0
10909|NCT02009878|60998|P3|Overall Study|Participant Met Withdrawal Criteria|0
10910|NCT02009878|60999|P2|Overall Study|Participant Met Withdrawal Criteria|1
10911|NCT02009878|61000|P1|Overall Study|Participant Met Withdrawal Criteria|0
10912|NCT02009865|61034|P2|Overall Study|Withdrawal by Subject|1
10913|NCT02009865|61035|P1|Overall Study|Withdrawal by Subject|1
10914|NCT02009865|61034|P2|Overall Study|Protocol Violation|2
10915|NCT02009865|61035|P1|Overall Study|Protocol Violation|0
10916|NCT02009865|61034|P2|Overall Study|Adverse Event|2
10917|NCT02009865|61035|P1|Overall Study|Adverse Event|0
10918|NCT02009722|61051|P2|Overall Study|Did not receive intervention|1
10919|NCT02009722|61052|P1|Overall Study|Did not receive intervention|0
10920|NCT02009722|61051|P2|Overall Study|Protocol Violation|2
10921|NCT02009722|61052|P1|Overall Study|Protocol Violation|1
10922|NCT02009696|61076|P1|Overall Study|Withdrawal by Subject|2
10923|NCT02009163|61084|P3|Randomized-withdrawal Period|Not specified|5
10924|NCT02009163|61085|P2|Randomized-withdrawal Period|Not specified|9
10925|NCT02009163|61086|P1|Randomized-withdrawal Period|Not specified|0
10926|NCT02009163|61084|P3|Randomized-withdrawal Period|Pregnancy|2
10927|NCT02009163|61085|P2|Randomized-withdrawal Period|Pregnancy|0
10928|NCT02009163|61086|P1|Randomized-withdrawal Period|Pregnancy|0
10929|NCT02009163|61084|P3|Randomized-withdrawal Period|Protocol Violation|2
10930|NCT02009163|61085|P2|Randomized-withdrawal Period|Protocol Violation|1
10931|NCT02009163|61086|P1|Randomized-withdrawal Period|Protocol Violation|0
10932|NCT02009163|61084|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
10933|NCT02009163|61085|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
10934|NCT02009163|61086|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
10935|NCT02009163|61084|P3|Randomized-withdrawal Period|Adverse Event|6
10936|NCT02009163|61085|P2|Randomized-withdrawal Period|Adverse Event|0
10937|NCT02009163|61086|P1|Randomized-withdrawal Period|Adverse Event|0
10938|NCT02009163|61084|P3|Randomized-withdrawal Period|Lost to Follow-up|6
10939|NCT02009163|61085|P2|Randomized-withdrawal Period|Lost to Follow-up|13
10940|NCT02009163|61086|P1|Randomized-withdrawal Period|Lost to Follow-up|0
10941|NCT02009163|61084|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
10942|NCT02009163|61085|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
10943|NCT02009163|61086|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
10944|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Not specified|0
10945|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Not specified|0
10946|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Not specified|13
10947|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Pregnancy|0
10948|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Pregnancy|0
10949|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Pregnancy|1
10950|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Protocol Violation|0
10951|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Protocol Violation|0
10952|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Protocol Violation|10
10953|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
10954|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
10955|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
10956|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Adverse Event|0
10957|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Adverse Event|0
10958|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Adverse Event|22
10959|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
10960|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
10961|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
10962|NCT02009163|61084|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
10963|NCT02009163|61085|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
10964|NCT02009163|61086|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
10965|NCT02008227|61162|P2|Overall Study|Ongoing Survival Follow-up|106
10966|NCT02008227|61163|P1|Overall Study|Ongoing Survival Follow-up|135
10967|NCT02008227|61162|P2|Overall Study|Ongoing on Study Treatment|85
10968|NCT02008227|61163|P1|Overall Study|Ongoing on Study Treatment|4
10969|NCT02008227|61162|P2|Overall Study|Withdrawal by Subject|34
10970|NCT02008227|61163|P1|Overall Study|Withdrawal by Subject|63
10971|NCT02008227|61162|P2|Overall Study|Death|383
10972|NCT02008227|61163|P1|Overall Study|Death|407
10973|NCT02008227|61162|P2|Overall Study|Lost to Follow-up|5
10974|NCT02008227|61163|P1|Overall Study|Lost to Follow-up|3
10975|NCT02007954|61224|P1|Overall Study|Death|1
10976|NCT02007954|61224|P1|Overall Study|Disease progression and unrelated AE|1
10977|NCT02007954|61224|P1|Overall Study|Switch in treatment modality|2
10978|NCT02007954|61224|P1|Overall Study|Received liver transplant|3
10979|NCT02007577|61243|P2|Overall Study|Withdrawal by Subject|1
10980|NCT02007577|61244|P1|Overall Study|Withdrawal by Subject|0
10981|NCT02007577|61243|P2|Overall Study|Adverse Event|0
10982|NCT02007577|61244|P1|Overall Study|Adverse Event|1
10983|NCT02007434|61260|P8|Overall Study|Non-compliance|0
10984|NCT02007434|61261|P7|Overall Study|Non-compliance|0
10985|NCT02007434|61262|P6|Overall Study|Non-compliance|0
10986|NCT02007434|61263|P5|Overall Study|Non-compliance|0
10987|NCT02007434|61264|P4|Overall Study|Non-compliance|0
10988|NCT02007434|61265|P3|Overall Study|Non-compliance|1
10989|NCT02007434|61266|P2|Overall Study|Non-compliance|0
10990|NCT02007434|61267|P1|Overall Study|Non-compliance|1
10991|NCT02007434|61260|P8|Overall Study|Lost to Follow-up|0
10992|NCT02007434|61261|P7|Overall Study|Lost to Follow-up|0
10993|NCT02007434|61262|P6|Overall Study|Lost to Follow-up|0
10994|NCT02007434|61263|P5|Overall Study|Lost to Follow-up|0
10995|NCT02007434|61264|P4|Overall Study|Lost to Follow-up|0
10996|NCT02007434|61265|P3|Overall Study|Lost to Follow-up|0
10997|NCT02007434|61266|P2|Overall Study|Lost to Follow-up|1
10998|NCT02007434|61267|P1|Overall Study|Lost to Follow-up|0
10999|NCT02007278|61389|P2|Overall Study|Mis-randomization|1
11000|NCT02007278|61390|P1|Overall Study|Mis-randomization|1
11001|NCT02007278|61389|P2|Overall Study|Incorrect medication administration|0
11002|NCT02007278|61390|P1|Overall Study|Incorrect medication administration|1
11003|NCT02007278|61389|P2|Overall Study|Ingestion of drugs not allowed in study|1
11004|NCT02007278|61390|P1|Overall Study|Ingestion of drugs not allowed in study|0
11005|NCT02007278|61389|P2|Overall Study|Failure to comply with an eligibility|1
11006|NCT02007278|61390|P1|Overall Study|Failure to comply with an eligibility|0
11007|NCT02007252|61412|P2|Overall Study|Adverse Event|4
11008|NCT02007252|61413|P1|Overall Study|Adverse Event|7
11009|NCT02007252|61412|P2|Overall Study|Abnormal laboratory value(s)|0
11010|NCT02007252|61413|P1|Overall Study|Abnormal laboratory value(s)|1
11011|NCT02007252|61412|P2|Overall Study|Administrative problems|7
11012|NCT02007252|61413|P1|Overall Study|Administrative problems|3
11013|NCT02007070|61426|P1|Overall Study|Continuing|9
11014|NCT02007070|61426|P1|Overall Study|Progressive Disease|18
11015|NCT02007070|61426|P1|Overall Study|Physician Decision|1
11016|NCT02007070|61426|P1|Overall Study|Protocol Violation|2
11017|NCT02007070|61426|P1|Overall Study|Death|1
11018|NCT02007070|61426|P1|Overall Study|Clinical Progression|4
11019|NCT02007070|61426|P1|Overall Study|Adverse Event|3
11020|NCT02006732|61460|P4|Overall Study|Withdrawal by Subject|1
11021|NCT02006732|61461|P3|Overall Study|Withdrawal by Subject|4
11022|NCT02006732|61462|P2|Overall Study|Withdrawal by Subject|0
11023|NCT02006732|61463|P1|Overall Study|Withdrawal by Subject|3
11024|NCT02006732|61460|P4|Overall Study|Lost to Follow-up|0
11025|NCT02006732|61461|P3|Overall Study|Lost to Follow-up|0
11026|NCT02006732|61462|P2|Overall Study|Lost to Follow-up|1
11027|NCT02006732|61463|P1|Overall Study|Lost to Follow-up|0
11028|NCT02006732|61460|P4|Overall Study|Protocol Violation|0
11029|NCT02006732|61461|P3|Overall Study|Protocol Violation|0
11030|NCT02006732|61462|P2|Overall Study|Protocol Violation|1
11031|NCT02006732|61463|P1|Overall Study|Protocol Violation|1
11032|NCT02006732|61460|P4|Overall Study|Lack of Efficacy|1
11033|NCT02006732|61461|P3|Overall Study|Lack of Efficacy|1
11034|NCT02006732|61462|P2|Overall Study|Lack of Efficacy|3
11035|NCT02006732|61463|P1|Overall Study|Lack of Efficacy|6
11036|NCT02006732|61460|P4|Overall Study|Adverse Event|2
11037|NCT02006732|61461|P3|Overall Study|Adverse Event|4
11038|NCT02006732|61462|P2|Overall Study|Adverse Event|7
11039|NCT02006732|61463|P1|Overall Study|Adverse Event|10
11040|NCT02006719|61503|P2|Overall Study|Other/Unknown|1
11041|NCT02006719|61504|P1|Overall Study|Other/Unknown|0
11042|NCT02006719|61503|P2|Overall Study|Adverse Event|1
11043|NCT02006719|61504|P1|Overall Study|Adverse Event|1
11044|NCT02006719|61503|P2|Overall Study|Protocol Violation|0
11045|NCT02006719|61504|P1|Overall Study|Protocol Violation|2
11046|NCT02006719|61503|P2|Overall Study|Lost to Follow-up|1
11047|NCT02006719|61504|P1|Overall Study|Lost to Follow-up|5
11048|NCT02006719|61503|P2|Overall Study|Withdrawal by Subject|2
11049|NCT02006719|61504|P1|Overall Study|Withdrawal by Subject|10
11050|NCT02006706|61534|P1|Overall Study|Lost to Follow-up|1
11051|NCT02006667|61539|P1|Overall Study|Withdrawal by Subject|1
11052|NCT02006667|61539|P1|Overall Study|Death|2
11053|NCT02006667|61539|P1|Overall Study|Adverse Event|3
11054|NCT02005692|61577|P1|Overall Study|Discharged earlier than anticipated|5
11055|NCT02005692|61577|P1|Overall Study|Withdrawal by Subject|1
11056|NCT02005692|61577|P1|Overall Study|Protocol Violation|1
11057|NCT02005562|61597|P2|Overall Study|Physician Decision|1
11058|NCT02005562|61598|P1|Overall Study|Physician Decision|0
11059|NCT02005562|61597|P2|Overall Study|No transplant|4
11060|NCT02005562|61598|P1|Overall Study|No transplant|1
11061|NCT02005562|61597|P2|Overall Study|Withdrawal by Subject|2
11062|NCT02005562|61598|P1|Overall Study|Withdrawal by Subject|2
11063|NCT02005562|61597|P2|Overall Study|Graft loss|6
11064|NCT02005562|61598|P1|Overall Study|Graft loss|7
11065|NCT02005562|61597|P2|Overall Study|Death|2
11066|NCT02005562|61598|P1|Overall Study|Death|2
11067|NCT02005484|61640|P1|Overall Study|Sponsor decision|1
11068|NCT02005484|61640|P1|Overall Study|Changed to a Different Study|1
11069|NCT02005484|61640|P1|Overall Study|Disease progression|1
11070|NCT02005484|61640|P1|Overall Study|Death|1
11071|NCT02005211|61661|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
11072|NCT02005211|61662|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
11073|NCT02005211|61663|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
11074|NCT02005211|61664|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
11075|NCT02005211|61665|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
11076|NCT02005211|61666|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
11077|NCT02005211|61667|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
11078|NCT02005029|61702|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
11079|NCT02005029|61703|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
11080|NCT02004886|61738|P4|Overall Study|Unable to attend future visits|0
11081|NCT02004886|61739|P3|Overall Study|Unable to attend future visits|0
11082|NCT02004886|61740|P2|Overall Study|Unable to attend future visits|0
11083|NCT02004886|61741|P1|Overall Study|Unable to attend future visits|1
11084|NCT02004886|61738|P4|Overall Study|Adverse Event|0
11085|NCT02004886|61739|P3|Overall Study|Adverse Event|0
11086|NCT02004886|61740|P2|Overall Study|Adverse Event|1
11087|NCT02004886|61741|P1|Overall Study|Adverse Event|0
11088|NCT02004873|61791|P1|Overall Study|Withdrawal by Subject|1
11089|NCT02004873|61791|P1|Overall Study|Death|23
11090|NCT02004873|61791|P1|Overall Study|Missed 6-month visit|4
11091|NCT02004873|61791|P1|Overall Study|Awaiting 6-month visit|390
11092|NCT02004873|61791|P1|Overall Study|Implant unsuccessful|6
11093|NCT02004847|61800|P2|Overall Study|Protocol Violation|1
11094|NCT02004847|61801|P1|Overall Study|Protocol Violation|1
11095|NCT02004236|61848|P3|Overall Study|Lack of Efficacy|16
11096|NCT02004236|61849|P2|Overall Study|Lack of Efficacy|0
11097|NCT02004236|61850|P1|Overall Study|Lack of Efficacy|0
11098|NCT02004093|61910|P2|Overall Study|Not specified|1
11099|NCT02004093|61911|P1|Overall Study|Not specified|3
11100|NCT02004093|61910|P2|Overall Study|Withdrawal by Subject|7
11101|NCT02004093|61911|P1|Overall Study|Withdrawal by Subject|3
11102|NCT02004093|61910|P2|Overall Study|Lost to Follow-up|1
11103|NCT02004093|61911|P1|Overall Study|Lost to Follow-up|0
11104|NCT02004093|61910|P2|Overall Study|Protocol Violation|1
11105|NCT02004093|61911|P1|Overall Study|Protocol Violation|0
11106|NCT02004093|61910|P2|Overall Study|Lack of Efficacy|62
11107|NCT02004093|61911|P1|Overall Study|Lack of Efficacy|66
11108|NCT02004093|61910|P2|Overall Study|Death|1
11109|NCT02004093|61911|P1|Overall Study|Death|2
11110|NCT02003963|61943|P2|Overall Study|Lost to Follow-up|1
11111|NCT02003963|61944|P1|Overall Study|Lost to Follow-up|2
11112|NCT02003638|61962|P2|Overall Study|Withdrawal by Subject|0
11113|NCT02003638|61963|P1|Overall Study|Withdrawal by Subject|1
11114|NCT02003534|61969|P1|Overall Study|Lost to Follow-up|47
11115|NCT02003391|61981|P2|Overall Study|Adverse Event|0
11116|NCT02003391|61982|P1|Overall Study|Adverse Event|1
11117|NCT02003391|61981|P2|Overall Study|Protocol Violation|1
11118|NCT02003391|61982|P1|Overall Study|Protocol Violation|0
11119|NCT02003391|61981|P2|Overall Study|Withdrawal by Subject|1
11120|NCT02003391|61982|P1|Overall Study|Withdrawal by Subject|2
11121|NCT02003014|61996|P1|Overall Study|Investigator's transfer|4
11122|NCT02003014|61996|P1|Overall Study|Patient did not visit the study site|5
11123|NCT02003014|61996|P1|Overall Study|Treatment started after contract period|1
11124|NCT02003014|61996|P1|Overall Study|Case report forms uncollected|9
11125|NCT02002689|62078|P1|Overall Study|Adverse Event|3
11126|NCT02002689|62078|P1|Overall Study|Disease Progression|7
11127|NCT02002221|62097|P2|Overall Study|Patient withdrew consent|1
11128|NCT02002221|62098|P1|Overall Study|Patient withdrew consent|0
11129|NCT02002221|62097|P2|Overall Study|Unsatisfactory therapeutic effect|1
11130|NCT02002221|62098|P1|Overall Study|Unsatisfactory therapeutic effect|0
11131|NCT02002221|62097|P2|Overall Study|Adverse Event|1
11132|NCT02002221|62098|P1|Overall Study|Adverse Event|2
11133|NCT02001181|62125|P2|Overall Study|Withdrawal by Subject|1
11134|NCT02001181|62126|P1|Overall Study|Withdrawal by Subject|0
11135|NCT02001181|62125|P2|Overall Study|Lost to Follow-up|0
11136|NCT02001181|62126|P1|Overall Study|Lost to Follow-up|1
11137|NCT02001181|62125|P2|Overall Study|Adverse Event|2
11138|NCT02001181|62126|P1|Overall Study|Adverse Event|0
11139|NCT02000921|62172|P3|Overall Study|Physician Decision|0
11140|NCT02000921|62173|P2|Overall Study|Physician Decision|2
11141|NCT02000921|62174|P1|Overall Study|Physician Decision|0
11142|NCT02000921|62172|P3|Overall Study|Lost to Follow-up|5
11143|NCT02000921|62173|P2|Overall Study|Lost to Follow-up|4
11144|NCT02000921|62174|P1|Overall Study|Lost to Follow-up|2
11145|NCT02000921|62172|P3|Overall Study|Withdrawal by Subject|5
11146|NCT02000921|62173|P2|Overall Study|Withdrawal by Subject|10
11147|NCT02000921|62174|P1|Overall Study|Withdrawal by Subject|3
11148|NCT02000752|62193|P2|Overall Study|Shift Changes|5
11149|NCT02000752|62194|P1|Overall Study|Shift Changes|12
11150|NCT02000752|62193|P2|Overall Study|Dystocic delivery|8
11151|NCT02000752|62194|P1|Overall Study|Dystocic delivery|19
11152|NCT02000531|62208|P2|Overall Study|Discontinued due to data cut-off|8
11153|NCT02000531|62209|P1|Overall Study|Discontinued due to data cut-off|3
11154|NCT02000531|62208|P2|Overall Study|Lost to Follow-up|0
11155|NCT02000531|62209|P1|Overall Study|Lost to Follow-up|1
11156|NCT02000440|62217|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
11157|NCT02000440|62217|P1|Overall Study|Adverse Event|3
11158|NCT02000427|62237|P1|Overall Study|Death|22
11159|NCT01999894|62260|P1|Overall Study|Inclusion/exclusion criteria not met|1
11160|NCT01999894|62260|P1|Overall Study|Other Reason|3
11161|NCT01999894|62260|P1|Overall Study|Lost to Follow-up|10
11162|NCT01999894|62260|P1|Overall Study|Withdrawal by Subject|7
11163|NCT01999894|62260|P1|Overall Study|Protocol Violation|1
11164|NCT01999894|62260|P1|Overall Study|Lack of Efficacy|5
11165|NCT01999894|62260|P1|Overall Study|Adverse Event|9
11166|NCT01998919|62356|P2|Overall Study|Not specified|2
11167|NCT01998919|62357|P1|Overall Study|Not specified|5
11168|NCT01998919|62356|P2|Overall Study|Lost to Follow-up|0
11169|NCT01998919|62357|P1|Overall Study|Lost to Follow-up|2
11170|NCT01998919|62356|P2|Overall Study|Withdrawal by Subject|4
11171|NCT01998919|62357|P1|Overall Study|Withdrawal by Subject|2
11172|NCT01998919|62356|P2|Overall Study|Disease progression|22
11173|NCT01998919|62357|P1|Overall Study|Disease progression|31
11174|NCT01998919|62356|P2|Overall Study|Adverse Event|5
11175|NCT01998919|62357|P1|Overall Study|Adverse Event|0
11176|NCT01998919|62356|P2|Overall Study|Death|2
11177|NCT01998919|62357|P1|Overall Study|Death|2
11178|NCT01998906|62378|P3|Overall Study|Not specified|4
11179|NCT01998906|62379|P2|Overall Study|Not specified|8
11180|NCT01998906|62380|P1|Overall Study|Not specified|3
11181|NCT01998906|62378|P3|Overall Study|Administrative/Other|3
11182|NCT01998906|62379|P2|Overall Study|Administrative/Other|1
11183|NCT01998906|62380|P1|Overall Study|Administrative/Other|2
11184|NCT01998906|62378|P3|Overall Study|Withdrawal by Subject|3
11185|NCT01998906|62379|P2|Overall Study|Withdrawal by Subject|4
11186|NCT01998906|62380|P1|Overall Study|Withdrawal by Subject|1
11187|NCT01998906|62378|P3|Overall Study|Violation of Selection Criteria|1
11188|NCT01998906|62379|P2|Overall Study|Violation of Selection Criteria|0
11189|NCT01998906|62380|P1|Overall Study|Violation of Selection Criteria|0
11190|NCT01998906|62378|P3|Overall Study|Failure to return|4
11191|NCT01998906|62379|P2|Overall Study|Failure to return|2
11192|NCT01998906|62380|P1|Overall Study|Failure to return|0
11193|NCT01998906|62378|P3|Overall Study|Lack of Efficacy|8
11194|NCT01998906|62379|P2|Overall Study|Lack of Efficacy|9
11195|NCT01998906|62380|P1|Overall Study|Lack of Efficacy|10
11196|NCT01998906|62378|P3|Overall Study|Death|17
11197|NCT01998906|62379|P2|Overall Study|Death|30
11198|NCT01998906|62380|P1|Overall Study|Death|21
11199|NCT01998906|62378|P3|Overall Study|Participants ongoing in follow−up|58
11200|NCT01998906|62379|P2|Overall Study|Participants ongoing in follow−up|60
11201|NCT01998906|62380|P1|Overall Study|Participants ongoing in follow−up|77
11202|NCT01998893|62424|P1|Overall Study|Transformation to high-grade lymphoma|1
11203|NCT01998893|62424|P1|Overall Study|Withdrawal by Subject|1
11204|NCT01998893|62424|P1|Overall Study|Protocol Violation|2
11205|NCT01998893|62424|P1|Overall Study|Physician Decision|2
11206|NCT01998893|62424|P1|Overall Study|Lost to Follow-up|8
11207|NCT01998893|62424|P1|Overall Study|Death|1
11208|NCT01998893|62424|P1|Overall Study|Adverse Event|2
11209|NCT01998880|62436|P2|Overall Study|Violation of Selection Criteria at Entry|1
11210|NCT01998880|62437|P1|Overall Study|Violation of Selection Criteria at Entry|1
11211|NCT01998880|62436|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
11212|NCT01998880|62437|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
11213|NCT01998880|62436|P2|Overall Study|Other Protocol Violation|1
11214|NCT01998880|62437|P1|Overall Study|Other Protocol Violation|0
11215|NCT01998880|62436|P2|Overall Study|Administrative/Other|1
11216|NCT01998880|62437|P1|Overall Study|Administrative/Other|3
11217|NCT01998880|62436|P2|Overall Study|Insufficient Therapeutic Response|5
11218|NCT01998880|62437|P1|Overall Study|Insufficient Therapeutic Response|1
11219|NCT01998880|62436|P2|Overall Study|Death|6
11220|NCT01998880|62437|P1|Overall Study|Death|3
11221|NCT01998880|62436|P2|Overall Study|Withdrew Consent|2
11222|NCT01998880|62437|P1|Overall Study|Withdrew Consent|2
11223|NCT01998880|62436|P2|Overall Study|Progression of Disease|8
11224|NCT01998880|62437|P1|Overall Study|Progression of Disease|2
11225|NCT01998880|62436|P2|Overall Study|Adverse Events or Intercurrent Illness|16
11226|NCT01998880|62437|P1|Overall Study|Adverse Events or Intercurrent Illness|16
11227|NCT01998737|62455|P2|Overall Study|Corrupted database|0
11228|NCT01998737|62456|P1|Overall Study|Corrupted database|23
11229|NCT01998581|62468|P2|Overall Study|Randomized but withdrew before treatment|0
11230|NCT01998581|62469|P1|Overall Study|Randomized but withdrew before treatment|1
11231|NCT01998581|62468|P2|Overall Study|Other reasons|2
11232|NCT01998581|62469|P1|Overall Study|Other reasons|3
11233|NCT01998581|62468|P2|Overall Study|Adverse Event|1
11234|NCT01998581|62469|P1|Overall Study|Adverse Event|1
11235|NCT01998581|62468|P2|Overall Study|Lost to Follow-up|4
11236|NCT01998581|62469|P1|Overall Study|Lost to Follow-up|12
11237|NCT01998581|62468|P2|Overall Study|Withdrawal by Subject|1
11238|NCT01998581|62469|P1|Overall Study|Withdrawal by Subject|8
11239|NCT01998581|62468|P2|Overall Study|Protocol Violation|0
11240|NCT01998581|62469|P1|Overall Study|Protocol Violation|1
11241|NCT01998581|62468|P2|Overall Study|Refused repeat treatment|4
11242|NCT01998581|62469|P1|Overall Study|Refused repeat treatment|20
11243|NCT01998477|62481|P2|Overall Study|Withdrawal by Subject|0
11244|NCT01998477|62482|P1|Overall Study|Withdrawal by Subject|6
11245|NCT01998477|62481|P2|Overall Study|Lost to Follow-up|5
11246|NCT01998477|62482|P1|Overall Study|Lost to Follow-up|4
11247|NCT01998399|62528|P2|Overall Study|Withdrawal by Subject|1
11248|NCT01998399|62529|P1|Overall Study|Withdrawal by Subject|0
11249|NCT01998399|62528|P2|Overall Study|Study stopped before dosing completed|3
11250|NCT01998399|62529|P1|Overall Study|Study stopped before dosing completed|3
11251|NCT01998399|62528|P2|Overall Study|Death|2
11252|NCT01998399|62529|P1|Overall Study|Death|4
11253|NCT01998399|62528|P2|Overall Study|Lost to Follow-up|3
11254|NCT01998399|62529|P1|Overall Study|Lost to Follow-up|1
11255|NCT01997892|62565|P1|Overall Study|Study completion data not recorded|35
11256|NCT01997892|62565|P1|Overall Study|Other|3
11257|NCT01997892|62565|P1|Overall Study|Renal transplant|8
11258|NCT01997892|62565|P1|Overall Study|Death|14
11259|NCT01997892|62565|P1|Overall Study|Lost to Follow-up|6
11260|NCT01997892|62565|P1|Overall Study|Physician Decision|2
11261|NCT01996904|62723|P2|Overall Study|Lost to Follow-up|27
11262|NCT01996904|62724|P1|Overall Study|Lost to Follow-up|38
11263|NCT01996748|62737|P2|Overall Study|Lost to Follow-up|1
11264|NCT01996748|62738|P1|Overall Study|Lost to Follow-up|4
11265|NCT01996748|62737|P2|Overall Study|Withdrawal by Subject|1
11266|NCT01996748|62738|P1|Overall Study|Withdrawal by Subject|0
11267|NCT01996748|62737|P2|Overall Study|Adverse Event|4
11268|NCT01996748|62738|P1|Overall Study|Adverse Event|1
11269|NCT01996748|62737|P2|Overall Study|Physician Decision|0
11270|NCT01996748|62738|P1|Overall Study|Physician Decision|2
11271|NCT01996748|62737|P2|Overall Study|Personal reason|0
11272|NCT01996748|62738|P1|Overall Study|Personal reason|1
11273|NCT01996709|62752|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
11274|NCT01996709|62753|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
11275|NCT01996709|62752|P2|Overall Study|Subject Non-Compliant|0
11276|NCT01996709|62753|P1|Overall Study|Subject Non-Compliant|1
11277|NCT01996709|62752|P2|Overall Study|Lost to Follow-up|0
11278|NCT01996709|62753|P1|Overall Study|Lost to Follow-up|3
11279|NCT01996709|62752|P2|Overall Study|Withdrawal by Subject|0
11280|NCT01996709|62753|P1|Overall Study|Withdrawal by Subject|1
11281|NCT01996332|62813|P1|Overall Study|Lost to Follow-up|34
11282|NCT01996332|62813|P1|Overall Study|Physician Decision|17
11283|NCT01996332|62813|P1|Overall Study|Clinical Deterioration|28
11284|NCT01996332|62813|P1|Overall Study|Other|20
11285|NCT01996332|62813|P1|Overall Study|Withdrawal by Subject|71
11286|NCT01996332|62813|P1|Overall Study|Protocol Violation|9
11287|NCT01996332|62813|P1|Overall Study|Death|264
11288|NCT01996332|62813|P1|Overall Study|Lack of Efficacy|1245
11289|NCT01996332|62813|P1|Overall Study|Adverse Event|117
11290|NCT01996319|62821|P2|Overall Study|Adverse Event|2
11291|NCT01996319|62822|P1|Overall Study|Adverse Event|2
11292|NCT01996319|62821|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
11293|NCT01996319|62822|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
11294|NCT01996319|62821|P2|Overall Study|Protocol Violation|0
11295|NCT01996319|62822|P1|Overall Study|Protocol Violation|1
11296|NCT01995461|62842|P1|Overall Study|Withdrawal by Subject|2
11297|NCT01995461|62842|P1|Overall Study|Lost to Follow-up|2
11298|NCT01995461|62842|P1|Overall Study|Death|1
11299|NCT01995357|62848|P6|Period 5|Adverse Event|0
11300|NCT01995357|62849|P5|Period 5|Adverse Event|0
11301|NCT01995357|62850|P4|Period 5|Adverse Event|0
11302|NCT01995357|62851|P3|Period 5|Adverse Event|1
11303|NCT01995357|62852|P2|Period 5|Adverse Event|0
11304|NCT01995357|62853|P1|Period 5|Adverse Event|1
11305|NCT01995357|62848|P6|Period 5|Lack of Efficacy|0
11306|NCT01995357|62849|P5|Period 5|Lack of Efficacy|0
11307|NCT01995357|62850|P4|Period 5|Lack of Efficacy|0
11308|NCT01995357|62851|P3|Period 5|Lack of Efficacy|0
11309|NCT01995357|62852|P2|Period 5|Lack of Efficacy|0
11310|NCT01995357|62853|P1|Period 5|Lack of Efficacy|1
11311|NCT01995136|62869|P1|Overall Study|Change in residence|1
11312|NCT01994902|62888|P2|Test Period 2|not known|3
11313|NCT01994902|62889|P1|Test Period 2|not known|0
11314|NCT01994902|62888|P2|Test Period 2|Lack of Efficacy|1
11315|NCT01994902|62889|P1|Test Period 2|Lack of Efficacy|0
11316|NCT01994902|62888|P2|Test Period 2|Withdrawal by Subject|2
11317|NCT01994902|62889|P1|Test Period 2|Withdrawal by Subject|0
11318|NCT01994902|62888|P2|Test Period 1|bag too small|0
11319|NCT01994902|62889|P1|Test Period 1|bag too small|1
11320|NCT01994902|62888|P2|Test Period 1|Lack of Efficacy|1
11321|NCT01994902|62889|P1|Test Period 1|Lack of Efficacy|0
11322|NCT01994902|62888|P2|Test Period 1|Adverse Event|1
11323|NCT01994902|62889|P1|Test Period 1|Adverse Event|2
11324|NCT01994902|62888|P2|Test Period 1|device deficiency with adverse event|1
11325|NCT01994902|62889|P1|Test Period 1|device deficiency with adverse event|0
11326|NCT01994902|62888|P2|Test Period 1|Withdrawal by Subject|0
11327|NCT01994902|62889|P1|Test Period 1|Withdrawal by Subject|3
11328|NCT01994876|62895|P2|Test Period 2|Protocol Violation|1
11329|NCT01994876|62896|P1|Test Period 2|Protocol Violation|0
11330|NCT01994876|62895|P2|Test Period 2|Adverse Event|0
11331|NCT01994876|62896|P1|Test Period 2|Adverse Event|1
11332|NCT01994876|62895|P2|Test Period 1|Adverse Event|1
11333|NCT01994876|62896|P1|Test Period 1|Adverse Event|0
11334|NCT01994876|62895|P2|Test Period 1|Withdrawal by Subject|1
11335|NCT01994876|62896|P1|Test Period 1|Withdrawal by Subject|0
11336|NCT01994863|62904|P2|Period 2|Withdrawal by Subject|1
11337|NCT01994863|62905|P1|Period 2|Withdrawal by Subject|1
11338|NCT01994863|62904|P2|Period 2|Lack of Efficacy|2
11339|NCT01994863|62905|P1|Period 2|Lack of Efficacy|0
11340|NCT01994863|62904|P2|Period 2|Adverse Event|1
11341|NCT01994863|62905|P1|Period 2|Adverse Event|0
11342|NCT01994863|62904|P2|Period 1|Lack of Efficacy|0
11343|NCT01994863|62905|P1|Period 1|Lack of Efficacy|1
11344|NCT01994863|62904|P2|Period 1|Trial stopped by sponsor|3
11345|NCT01994863|62905|P1|Period 1|Trial stopped by sponsor|1
11346|NCT01994863|62904|P2|Period 1|Withdrawal by Subject|0
11347|NCT01994863|62905|P1|Period 1|Withdrawal by Subject|1
11348|NCT01994863|62904|P2|Period 1|Adverse Event|0
11349|NCT01994863|62905|P1|Period 1|Adverse Event|4
11350|NCT01994720|62937|P2|Overall Study|Withdrawal by Subject|56
11351|NCT01994720|62938|P1|Overall Study|Withdrawal by Subject|46
11352|NCT01994629|62980|P2|Overall Study|Lost to Follow-up|3
11353|NCT01994629|62981|P1|Overall Study|Lost to Follow-up|0
11354|NCT01994629|62980|P2|Overall Study|Withdrawal by Subject|0
11355|NCT01994629|62981|P1|Overall Study|Withdrawal by Subject|1
11356|NCT01994291|63017|P3|Overall Study|Unspecified|0
11357|NCT01994291|63018|P2|Overall Study|Unspecified|2
11358|NCT01994291|63019|P1|Overall Study|Unspecified|1
11359|NCT01994291|63017|P3|Overall Study|Withdrawal by Subject|5
11360|NCT01994291|63018|P2|Overall Study|Withdrawal by Subject|3
11361|NCT01994291|63019|P1|Overall Study|Withdrawal by Subject|6
11362|NCT01994291|63017|P3|Overall Study|Protocol Violation|0
11363|NCT01994291|63018|P2|Overall Study|Protocol Violation|0
11364|NCT01994291|63019|P1|Overall Study|Protocol Violation|1
11365|NCT01994291|63017|P3|Overall Study|Medication error without associated AE|1
11366|NCT01994291|63018|P2|Overall Study|Medication error without associated AE|0
11367|NCT01994291|63019|P1|Overall Study|Medication error without associated AE|1
11368|NCT01994291|63017|P3|Overall Study|Does not meet entrance criteria|0
11369|NCT01994291|63018|P2|Overall Study|Does not meet entrance criteria|0
11370|NCT01994291|63019|P1|Overall Study|Does not meet entrance criteria|1
11371|NCT01994291|63017|P3|Overall Study|Lost to Follow-up|0
11372|NCT01994291|63018|P2|Overall Study|Lost to Follow-up|1
11373|NCT01994291|63019|P1|Overall Study|Lost to Follow-up|1
11374|NCT01994291|63017|P3|Overall Study|Adverse Event|3
11375|NCT01994291|63018|P2|Overall Study|Adverse Event|1
11376|NCT01994291|63019|P1|Overall Study|Adverse Event|4
11377|NCT01993940|63075|P2|Overall Study|Other - Miscellaneous|1
11378|NCT01993940|63076|P1|Overall Study|Other - Miscellaneous|1
11379|NCT01993940|63075|P2|Overall Study|Death|0
11380|NCT01993940|63076|P1|Overall Study|Death|1
11381|NCT01993940|63075|P2|Overall Study|Protocol Violation|8
11382|NCT01993940|63076|P1|Overall Study|Protocol Violation|5
11383|NCT01993940|63075|P2|Overall Study|Lost to Follow-up|5
11384|NCT01993940|63076|P1|Overall Study|Lost to Follow-up|2
11385|NCT01993940|63075|P2|Overall Study|Withdrawal by Subject|19
11386|NCT01993940|63076|P1|Overall Study|Withdrawal by Subject|15
11387|NCT01993940|63075|P2|Overall Study|Adverse Event|11
11388|NCT01993940|63076|P1|Overall Study|Adverse Event|16
11389|NCT01993888|63092|P2|Overall Study|Withdrawal by Subject|1
11390|NCT01993888|63093|P1|Overall Study|Withdrawal by Subject|0
11391|NCT01993888|63092|P2|Overall Study|Lost to Follow-up|1
11392|NCT01993888|63093|P1|Overall Study|Lost to Follow-up|1
11393|NCT01993888|63092|P2|Overall Study|Death|1
11394|NCT01993888|63093|P1|Overall Study|Death|1
11395|NCT01993823|63111|P2|Overall Study|Lost to Follow-up|4
11396|NCT01993823|63112|P1|Overall Study|Lost to Follow-up|1
11397|NCT01993823|63111|P2|Overall Study|Protocol Violation|1
11398|NCT01993823|63112|P1|Overall Study|Protocol Violation|0
11399|NCT01993823|63111|P2|Overall Study|Requested by the patient|11
11400|NCT01993823|63112|P1|Overall Study|Requested by the patient|6
11401|NCT01993030|63127|P2|Overall Study|Adverse Event|4
11402|NCT01993030|63128|P1|Overall Study|Adverse Event|0
11403|NCT01992536|63182|P10|Overall Study|Withdrawal by Subject|0
11404|NCT01992536|63183|P9|Overall Study|Withdrawal by Subject|0
11405|NCT01992536|63184|P8|Overall Study|Withdrawal by Subject|0
11406|NCT01992536|63185|P7|Overall Study|Withdrawal by Subject|0
11407|NCT01992536|63186|P6|Overall Study|Withdrawal by Subject|0
11408|NCT01992536|63187|P5|Overall Study|Withdrawal by Subject|0
11409|NCT01992536|63188|P4|Overall Study|Withdrawal by Subject|2
11410|NCT01992536|63189|P3|Overall Study|Withdrawal by Subject|0
11411|NCT01992536|63190|P2|Overall Study|Withdrawal by Subject|1
11412|NCT01992536|63191|P1|Overall Study|Withdrawal by Subject|0
11413|NCT01992536|63182|P10|Overall Study|Lost to Follow-up|1
11414|NCT01992536|63183|P9|Overall Study|Lost to Follow-up|1
11415|NCT01992536|63184|P8|Overall Study|Lost to Follow-up|0
11416|NCT01992536|63185|P7|Overall Study|Lost to Follow-up|0
11417|NCT01992536|63186|P6|Overall Study|Lost to Follow-up|1
11418|NCT01992536|63187|P5|Overall Study|Lost to Follow-up|0
11419|NCT01992536|63188|P4|Overall Study|Lost to Follow-up|0
11420|NCT01992536|63189|P3|Overall Study|Lost to Follow-up|1
11421|NCT01992536|63190|P2|Overall Study|Lost to Follow-up|2
11422|NCT01992536|63191|P1|Overall Study|Lost to Follow-up|4
11423|NCT01992536|63182|P10|Overall Study|Administrative Reason|0
11424|NCT01992536|63183|P9|Overall Study|Administrative Reason|0
11425|NCT01992536|63184|P8|Overall Study|Administrative Reason|0
11426|NCT01992536|63185|P7|Overall Study|Administrative Reason|7
11427|NCT01992536|63186|P6|Overall Study|Administrative Reason|0
11428|NCT01992536|63187|P5|Overall Study|Administrative Reason|0
11429|NCT01992536|63188|P4|Overall Study|Administrative Reason|0
11430|NCT01992536|63189|P3|Overall Study|Administrative Reason|0
11431|NCT01992536|63190|P2|Overall Study|Administrative Reason|0
11432|NCT01992536|63191|P1|Overall Study|Administrative Reason|0
11433|NCT01992107|63442|P3|Overall Study|Withdrawal by Subject|8
11434|NCT01992107|63443|P2|Overall Study|Withdrawal by Subject|7
11435|NCT01992107|63444|P1|Overall Study|Withdrawal by Subject|13
11436|NCT01992107|63442|P3|Overall Study|noncompliance and were unavailable|2
11437|NCT01992107|63443|P2|Overall Study|noncompliance and were unavailable|3
11438|NCT01992107|63444|P1|Overall Study|noncompliance and were unavailable|7
11439|NCT01992107|63442|P3|Overall Study|Lost to Follow-up|26
11440|NCT01992107|63443|P2|Overall Study|Lost to Follow-up|22
11441|NCT01992107|63444|P1|Overall Study|Lost to Follow-up|46
11442|NCT01992107|63442|P3|Overall Study|Adverse Event|0
11443|NCT01992107|63443|P2|Overall Study|Adverse Event|1
11444|NCT01992107|63444|P1|Overall Study|Adverse Event|0
11445|NCT01992107|63442|P3|Overall Study|Administrative reasons|0
11446|NCT01992107|63443|P2|Overall Study|Administrative reasons|0
11447|NCT01992107|63444|P1|Overall Study|Administrative reasons|2
11448|NCT01992094|63500|P3|Overall Study|Withdrawal by Subject|4
11449|NCT01992094|63501|P2|Overall Study|Withdrawal by Subject|3
11450|NCT01992094|63502|P1|Overall Study|Withdrawal by Subject|7
11451|NCT01992094|63500|P3|Overall Study|Protocol Violation|1
11452|NCT01992094|63501|P2|Overall Study|Protocol Violation|0
11453|NCT01992094|63502|P1|Overall Study|Protocol Violation|1
11454|NCT01992094|63500|P3|Overall Study|OTHER|0
11455|NCT01992094|63501|P2|Overall Study|OTHER|0
11456|NCT01992094|63502|P1|Overall Study|OTHER|4
11457|NCT01992094|63500|P3|Overall Study|Lost to Follow-up|13
11458|NCT01992094|63501|P2|Overall Study|Lost to Follow-up|9
11459|NCT01992094|63502|P1|Overall Study|Lost to Follow-up|26
11460|NCT01992094|63500|P3|Overall Study|Death|2
11461|NCT01992094|63501|P2|Overall Study|Death|5
11462|NCT01992094|63502|P1|Overall Study|Death|5
11463|NCT01992094|63500|P3|Overall Study|Adverse Event|0
11464|NCT01992094|63501|P2|Overall Study|Adverse Event|0
11465|NCT01992094|63502|P1|Overall Study|Adverse Event|1
11466|NCT01992094|63500|P3|Overall Study|ADMINISTRATIVE REASON|1
11467|NCT01992094|63501|P2|Overall Study|ADMINISTRATIVE REASON|7
11468|NCT01992094|63502|P1|Overall Study|ADMINISTRATIVE REASON|6
11469|NCT01991314|63607|P2|Overall Study|Lost to Follow-up|10
11470|NCT01991314|63608|P1|Overall Study|Lost to Follow-up|6
11471|NCT01991314|63607|P2|Overall Study|Adverse Event|1
11472|NCT01991314|63608|P1|Overall Study|Adverse Event|5
11473|NCT01990859|63630|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
11474|NCT01990859|63630|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
11475|NCT01990664|63779|P2|Overall Study|Unsatisfactory Visual Response|1
11476|NCT01990664|63780|P1|Overall Study|Unsatisfactory Visual Response|0
11477|NCT01990664|63779|P2|Overall Study|Lens Handling Difficulties|0
11478|NCT01990664|63780|P1|Overall Study|Lens Handling Difficulties|1
11479|NCT01990664|63779|P2|Overall Study|Lens Discomfort|1
11480|NCT01990664|63780|P1|Overall Study|Lens Discomfort|1
11481|NCT01990664|63779|P2|Overall Study|Protocol Violation|0
11482|NCT01990664|63780|P1|Overall Study|Protocol Violation|1
11483|NCT01990664|63779|P2|Overall Study|Withdrawal by Subject|3
11484|NCT01990664|63780|P1|Overall Study|Withdrawal by Subject|2
11485|NCT01990664|63779|P2|Overall Study|Lost to Follow-up|6
11486|NCT01990664|63780|P1|Overall Study|Lost to Follow-up|2
11487|NCT01990534|63786|P1|Overall Study|Overall Survival Follow-up|25
11488|NCT01990534|63786|P1|Overall Study|Progression Free Survival Follow-up|11
11489|NCT01990534|63786|P1|Overall Study|Reason Not Specified|2
11490|NCT01990534|63786|P1|Overall Study|Withdrawal by Subject|3
11491|NCT01990534|63786|P1|Overall Study|Symptomatic Deterioration|1
11492|NCT01990534|63786|P1|Overall Study|Withdrawal of Informed Consent|2
11493|NCT01990534|63786|P1|Overall Study|Protocol Violation|1
11494|NCT01990534|63786|P1|Overall Study|Progressive disease|3
11495|NCT01990534|63786|P1|Overall Study|Death|12
11496|NCT01990339|63802|P1|Overall Study|Lost to Follow-up|861
11497|NCT01990339|63802|P1|Overall Study|Voluntary Withdrawal|1402
11498|NCT01990339|63802|P1|Overall Study|Data Not Available|49
11499|NCT01990261|63807|P1|Overall Study|Lost to Follow-up|2
11500|NCT01990261|63807|P1|Overall Study|Dossier not Approved|1
11501|NCT01990261|63807|P1|Overall Study|PD Before Treatment Start|1
11502|NCT01990261|63807|P1|Overall Study|Disease Progression (PD)|8
11503|NCT01990261|63807|P1|Overall Study|Death From other Causes|1
11504|NCT01990261|63807|P1|Overall Study|Death due to Disease Progression (PD)|10
11505|NCT01990261|63807|P1|Overall Study|Death Before Treatment Start|2
11506|NCT01989689|63819|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
11507|NCT01989689|63820|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
11508|NCT01989689|63819|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
11509|NCT01989689|63820|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
11510|NCT01989572|63836|P6|Overall Study|alternative therapy|3
11511|NCT01989572|63837|P5|Overall Study|alternative therapy|1
11512|NCT01989572|63838|P4|Overall Study|alternative therapy|0
11513|NCT01989572|63839|P3|Overall Study|alternative therapy|0
11514|NCT01989572|63840|P2|Overall Study|alternative therapy|0
11515|NCT01989572|63841|P1|Overall Study|alternative therapy|3
11516|NCT01989572|63836|P6|Overall Study|not start protocol therapy|18
11517|NCT01989572|63837|P5|Overall Study|not start protocol therapy|4
11518|NCT01989572|63838|P4|Overall Study|not start protocol therapy|3
11519|NCT01989572|63839|P3|Overall Study|not start protocol therapy|2
11520|NCT01989572|63840|P2|Overall Study|not start protocol therapy|1
11521|NCT01989572|63841|P1|Overall Study|not start protocol therapy|5
11522|NCT01989572|63836|P6|Overall Study|unknown/not specify|5
11523|NCT01989572|63837|P5|Overall Study|unknown/not specify|3
11524|NCT01989572|63838|P4|Overall Study|unknown/not specify|3
11525|NCT01989572|63839|P3|Overall Study|unknown/not specify|1
11526|NCT01989572|63840|P2|Overall Study|unknown/not specify|4
11527|NCT01989572|63841|P1|Overall Study|unknown/not specify|3
11528|NCT01989572|63836|P6|Overall Study|maximum dose reached|0
11529|NCT01989572|63837|P5|Overall Study|maximum dose reached|1
11530|NCT01989572|63838|P4|Overall Study|maximum dose reached|0
11531|NCT01989572|63839|P3|Overall Study|maximum dose reached|0
11532|NCT01989572|63840|P2|Overall Study|maximum dose reached|1
11533|NCT01989572|63841|P1|Overall Study|maximum dose reached|0
11534|NCT01989572|63836|P6|Overall Study|error|1
11535|NCT01989572|63837|P5|Overall Study|error|1
11536|NCT01989572|63838|P4|Overall Study|error|1
11537|NCT01989572|63839|P3|Overall Study|error|1
11538|NCT01989572|63840|P2|Overall Study|error|1
11539|NCT01989572|63841|P1|Overall Study|error|2
11540|NCT01989572|63836|P6|Overall Study|complicating disease|0
11541|NCT01989572|63837|P5|Overall Study|complicating disease|1
11542|NCT01989572|63838|P4|Overall Study|complicating disease|0
11543|NCT01989572|63839|P3|Overall Study|complicating disease|2
11544|NCT01989572|63840|P2|Overall Study|complicating disease|1
11545|NCT01989572|63841|P1|Overall Study|complicating disease|1
11546|NCT01989572|63836|P6|Overall Study|Withdrawal by Subject|4
11547|NCT01989572|63837|P5|Overall Study|Withdrawal by Subject|12
11548|NCT01989572|63838|P4|Overall Study|Withdrawal by Subject|1
11549|NCT01989572|63839|P3|Overall Study|Withdrawal by Subject|5
11550|NCT01989572|63840|P2|Overall Study|Withdrawal by Subject|1
11551|NCT01989572|63841|P1|Overall Study|Withdrawal by Subject|4
11552|NCT01989572|63836|P6|Overall Study|Death|0
11553|NCT01989572|63837|P5|Overall Study|Death|1
11554|NCT01989572|63838|P4|Overall Study|Death|0
11555|NCT01989572|63839|P3|Overall Study|Death|0
11556|NCT01989572|63840|P2|Overall Study|Death|0
11557|NCT01989572|63841|P1|Overall Study|Death|0
11558|NCT01989572|63836|P6|Overall Study|Adverse Event|0
11559|NCT01989572|63837|P5|Overall Study|Adverse Event|3
11560|NCT01989572|63838|P4|Overall Study|Adverse Event|0
11561|NCT01989572|63839|P3|Overall Study|Adverse Event|3
11562|NCT01989572|63840|P2|Overall Study|Adverse Event|1
11563|NCT01989572|63841|P1|Overall Study|Adverse Event|2
11564|NCT01989572|63836|P6|Overall Study|Lack of Efficacy|79
11565|NCT01989572|63837|P5|Overall Study|Lack of Efficacy|71
11566|NCT01989572|63838|P4|Overall Study|Lack of Efficacy|43
11567|NCT01989572|63839|P3|Overall Study|Lack of Efficacy|48
11568|NCT01989572|63840|P2|Overall Study|Lack of Efficacy|48
11569|NCT01989572|63841|P1|Overall Study|Lack of Efficacy|35
11570|NCT01989455|63874|P5|Overall Study|Technical problems with infusion|1
11571|NCT01989455|63875|P4|Overall Study|Technical problems with infusion|0
11572|NCT01989455|63876|P3|Overall Study|Technical problems with infusion|1
11573|NCT01989455|63877|P2|Overall Study|Technical problems with infusion|0
11574|NCT01989455|63878|P1|Overall Study|Technical problems with infusion|0
11575|NCT01989455|63874|P5|Overall Study|Withdrawal by Subject|0
11576|NCT01989455|63875|P4|Overall Study|Withdrawal by Subject|0
11577|NCT01989455|63876|P3|Overall Study|Withdrawal by Subject|0
11578|NCT01989455|63877|P2|Overall Study|Withdrawal by Subject|1
11579|NCT01989455|63878|P1|Overall Study|Withdrawal by Subject|0
11580|NCT01989455|63874|P5|Overall Study|Adverse Event|0
11581|NCT01989455|63875|P4|Overall Study|Adverse Event|0
11582|NCT01989455|63876|P3|Overall Study|Adverse Event|0
11583|NCT01989455|63877|P2|Overall Study|Adverse Event|1
11584|NCT01989455|63878|P1|Overall Study|Adverse Event|0
11585|NCT01989169|63922|P2|Period 2|Adverse Event|1
11586|NCT01989169|63923|P1|Period 2|Adverse Event|0
11587|NCT01989156|63936|P3|End of Study (Population at Day 90)|Employment Conflict|0
11588|NCT01989156|63937|P2|End of Study (Population at Day 90)|Employment Conflict|1
11589|NCT01989156|63938|P1|End of Study (Population at Day 90)|Employment Conflict|0
11590|NCT01989156|63936|P3|End of Study (Population at Day 90)|Moved out of state|0
11591|NCT01989156|63937|P2|End of Study (Population at Day 90)|Moved out of state|0
11592|NCT01989156|63938|P1|End of Study (Population at Day 90)|Moved out of state|1
11593|NCT01989156|63936|P3|End of Study (Population at Day 90)|Physician Decision|1
11594|NCT01989156|63937|P2|End of Study (Population at Day 90)|Physician Decision|0
11595|NCT01989156|63938|P1|End of Study (Population at Day 90)|Physician Decision|1
11596|NCT01989156|63936|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
11597|NCT01989156|63937|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
11598|NCT01989156|63938|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
11599|NCT01989156|63936|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
11600|NCT01989156|63937|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
11601|NCT01989156|63938|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
11602|NCT01989156|63936|P3|Confinement Period (Population at Day 5)|Adverse Event|1
11603|NCT01989156|63937|P2|Confinement Period (Population at Day 5)|Adverse Event|0
11604|NCT01989156|63938|P1|Confinement Period (Population at Day 5)|Adverse Event|0
11605|NCT01989156|63936|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
11606|NCT01989156|63937|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
11607|NCT01989156|63938|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
11608|NCT01989156|63936|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
11609|NCT01989156|63937|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
11610|NCT01989156|63938|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
11611|NCT01988662|63982|P2|Overall Study|Adverse Event|1
11612|NCT01988662|63983|P1|Overall Study|Adverse Event|3
11613|NCT01988662|63982|P2|Overall Study|Subject/guardian decision|1
11614|NCT01988662|63983|P1|Overall Study|Subject/guardian decision|1
11615|NCT01988402|64010|P2|Overall Study|Withdrawal by Subject|0
11616|NCT01988402|64011|P1|Overall Study|Withdrawal by Subject|1
11617|NCT01988402|64010|P2|Overall Study|Adverse Event|2
11618|NCT01988402|64011|P1|Overall Study|Adverse Event|1
11619|NCT01988012|64049|P1|Overall Study|Protocol Violation|1
11620|NCT01988012|64049|P1|Overall Study|Physician Decision|1
11621|NCT01988012|64049|P1|Overall Study|Lost to Follow-up|1
11622|NCT01988012|64049|P1|Overall Study|Patient Withdrawal of Consent|4
11623|NCT01988012|64049|P1|Overall Study|Insufficient Therapeutic Response|3
11624|NCT01988012|64049|P1|Overall Study|Adverse Event|5
11625|NCT01987986|64075|P4|Overall Study|Adverse Event|0
11626|NCT01987986|64076|P3|Overall Study|Adverse Event|2
11627|NCT01987986|64077|P2|Overall Study|Adverse Event|0
11628|NCT01987986|64078|P1|Overall Study|Adverse Event|1
11629|NCT01987986|64075|P4|Overall Study|Lost to Follow-up|0
11630|NCT01987986|64076|P3|Overall Study|Lost to Follow-up|0
11631|NCT01987986|64077|P2|Overall Study|Lost to Follow-up|0
11632|NCT01987986|64078|P1|Overall Study|Lost to Follow-up|1
11633|NCT01987960|64118|P4|Period 3|Administrative or other reason|43
11634|NCT01987960|64119|P3|Period 3|Administrative or other reason|0
11635|NCT01987960|64120|P2|Period 3|Administrative or other reason|0
11636|NCT01987960|64121|P1|Period 3|Administrative or other reason|0
11637|NCT01987960|64118|P4|Period 3|Lost to Follow-up|5
11638|NCT01987960|64119|P3|Period 3|Lost to Follow-up|0
11639|NCT01987960|64120|P2|Period 3|Lost to Follow-up|0
11640|NCT01987960|64121|P1|Period 3|Lost to Follow-up|0
11641|NCT01987960|64118|P4|Period 3|Withdrawal by Subject|9
11642|NCT01987960|64119|P3|Period 3|Withdrawal by Subject|0
11643|NCT01987960|64120|P2|Period 3|Withdrawal by Subject|0
11644|NCT01987960|64121|P1|Period 3|Withdrawal by Subject|0
11645|NCT01987960|64118|P4|Period 3|Protocol Violation|6
11646|NCT01987960|64119|P3|Period 3|Protocol Violation|0
11647|NCT01987960|64120|P2|Period 3|Protocol Violation|0
11648|NCT01987960|64121|P1|Period 3|Protocol Violation|0
11649|NCT01987960|64118|P4|Period 3|Non-compliance with IMP|1
11650|NCT01987960|64119|P3|Period 3|Non-compliance with IMP|0
11651|NCT01987960|64120|P2|Period 3|Non-compliance with IMP|0
11652|NCT01987960|64121|P1|Period 3|Non-compliance with IMP|0
11653|NCT01987960|64118|P4|Period 3|Adverse Event|7
11654|NCT01987960|64119|P3|Period 3|Adverse Event|0
11655|NCT01987960|64120|P2|Period 3|Adverse Event|0
11656|NCT01987960|64121|P1|Period 3|Adverse Event|0
11657|NCT01987960|64118|P4|Period 2|Administrative or other reason|0
11658|NCT01987960|64119|P3|Period 2|Administrative or other reason|7
11659|NCT01987960|64120|P2|Period 2|Administrative or other reason|5
11660|NCT01987960|64121|P1|Period 2|Administrative or other reason|0
11661|NCT01987960|64118|P4|Period 2|Withdrawal by Subject|0
11662|NCT01987960|64119|P3|Period 2|Withdrawal by Subject|1
11663|NCT01987960|64120|P2|Period 2|Withdrawal by Subject|0
11664|NCT01987960|64121|P1|Period 2|Withdrawal by Subject|0
11665|NCT01987960|64118|P4|Period 2|Adverse Event|0
11666|NCT01987960|64119|P3|Period 2|Adverse Event|1
11667|NCT01987960|64120|P2|Period 2|Adverse Event|0
11668|NCT01987960|64121|P1|Period 2|Adverse Event|0
11669|NCT01987960|64118|P4|Period 1|Withdrawal of consent before treatment|0
11670|NCT01987960|64119|P3|Period 1|Withdrawal of consent before treatment|0
11671|NCT01987960|64120|P2|Period 1|Withdrawal of consent before treatment|0
11672|NCT01987960|64121|P1|Period 1|Withdrawal of consent before treatment|4
11673|NCT01987960|64118|P4|Period 1|administrative or other reason|0
11674|NCT01987960|64119|P3|Period 1|administrative or other reason|0
11675|NCT01987960|64120|P2|Period 1|administrative or other reason|0
11676|NCT01987960|64121|P1|Period 1|administrative or other reason|75
11677|NCT01987960|64118|P4|Period 1|Lost to Follow-up|0
11678|NCT01987960|64119|P3|Period 1|Lost to Follow-up|0
11679|NCT01987960|64120|P2|Period 1|Lost to Follow-up|0
11680|NCT01987960|64121|P1|Period 1|Lost to Follow-up|40
11681|NCT01987960|64118|P4|Period 1|Withdrawal by Subject|0
11682|NCT01987960|64119|P3|Period 1|Withdrawal by Subject|0
11683|NCT01987960|64120|P2|Period 1|Withdrawal by Subject|0
11684|NCT01987960|64121|P1|Period 1|Withdrawal by Subject|21
11685|NCT01987960|64118|P4|Period 1|Protocol Violation|0
11686|NCT01987960|64119|P3|Period 1|Protocol Violation|0
11687|NCT01987960|64120|P2|Period 1|Protocol Violation|0
11688|NCT01987960|64121|P1|Period 1|Protocol Violation|12
11689|NCT01987960|64118|P4|Period 1|Non-compliance with IMP|0
11690|NCT01987960|64119|P3|Period 1|Non-compliance with IMP|0
11691|NCT01987960|64120|P2|Period 1|Non-compliance with IMP|0
11692|NCT01987960|64121|P1|Period 1|Non-compliance with IMP|6
11693|NCT01987960|64118|P4|Period 1|Lack of Efficacy|0
11694|NCT01987960|64119|P3|Period 1|Lack of Efficacy|0
11695|NCT01987960|64120|P2|Period 1|Lack of Efficacy|0
11696|NCT01987960|64121|P1|Period 1|Lack of Efficacy|4
11697|NCT01987960|64118|P4|Period 1|Adverse Event|0
11698|NCT01987960|64119|P3|Period 1|Adverse Event|0
11699|NCT01987960|64120|P2|Period 1|Adverse Event|0
11700|NCT01987960|64121|P1|Period 1|Adverse Event|24
11701|NCT01987908|64133|P3|Post-Treatment Observation Period|Other: Bad Veins|0
11702|NCT01987908|64134|P2|Post-Treatment Observation Period|Other: Bad Veins|1
11703|NCT01987908|64135|P1|Post-Treatment Observation Period|Other: Bad Veins|0
11704|NCT01987908|64133|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
11705|NCT01987908|64134|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
11706|NCT01987908|64135|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
11707|NCT01987908|64133|P3|Treatment Period|Adverse Event|1
11708|NCT01987908|64134|P2|Treatment Period|Adverse Event|1
11709|NCT01987908|64135|P1|Treatment Period|Adverse Event|0
11710|NCT01987908|64133|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
11799|NCT01984697|64648|P4|Overall Study|Adverse Event|0
11711|NCT01987908|64134|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
11712|NCT01987908|64135|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
11713|NCT01987908|64133|P3|Placebo Lead-in Period|Withdrawal by Subject|0
11714|NCT01987908|64134|P2|Placebo Lead-in Period|Withdrawal by Subject|0
11715|NCT01987908|64135|P1|Placebo Lead-in Period|Withdrawal by Subject|1
11716|NCT01987908|64133|P3|Placebo Lead-in Period|Physician Decision|0
11717|NCT01987908|64134|P2|Placebo Lead-in Period|Physician Decision|0
11718|NCT01987908|64135|P1|Placebo Lead-in Period|Physician Decision|2
11719|NCT01987908|64133|P3|Placebo Lead-in Period|Adverse Event|0
11720|NCT01987908|64134|P2|Placebo Lead-in Period|Adverse Event|0
11721|NCT01987908|64135|P1|Placebo Lead-in Period|Adverse Event|2
11722|NCT01987765|64216|P1|Overall Study|Lost to Follow-up|37
11723|NCT01987765|64216|P1|Overall Study|Protocol Violation|65
11724|NCT01987557|64240|P3|Overall Study|Adverse Event|0
11725|NCT01987557|64241|P2|Overall Study|Adverse Event|2
11726|NCT01987557|64242|P1|Overall Study|Adverse Event|0
11727|NCT01987557|64240|P3|Overall Study|Withdrawal by Subject|2
11728|NCT01987557|64241|P2|Overall Study|Withdrawal by Subject|1
11729|NCT01987557|64242|P1|Overall Study|Withdrawal by Subject|2
11730|NCT01987557|64240|P3|Overall Study|Protocol Violation|1
11731|NCT01987557|64241|P2|Overall Study|Protocol Violation|0
11732|NCT01987557|64242|P1|Overall Study|Protocol Violation|1
11733|NCT01987479|64250|P1|Overall Study|Adverse Event|7
11734|NCT01987479|64250|P1|Overall Study|Lost to Follow-up|1
11735|NCT01987479|64250|P1|Overall Study|Unspecified|5
11736|NCT01987479|64250|P1|Overall Study|Participant/legal guardian decision|1
11737|NCT01987479|64250|P1|Overall Study|Physician Decision|2
11738|NCT01987479|64250|P1|Overall Study|Protocol Violation|1
11739|NCT01987453|64278|P3|Overall Study|Lack of Efficacy|0
11740|NCT01987453|64279|P2|Overall Study|Lack of Efficacy|12
11741|NCT01987453|64280|P1|Overall Study|Lack of Efficacy|1
11742|NCT01987453|64278|P3|Overall Study|Death|1
11743|NCT01987453|64279|P2|Overall Study|Death|0
11744|NCT01987453|64280|P1|Overall Study|Death|0
11745|NCT01987232|64349|P5|Overall Study|Ongoing in Study|0
11746|NCT01987232|64350|P4|Overall Study|Ongoing in Study|1
11747|NCT01987232|64351|P3|Overall Study|Ongoing in Study|0
11748|NCT01987232|64352|P2|Overall Study|Ongoing in Study|0
11749|NCT01987232|64353|P1|Overall Study|Ongoing in Study|0
11750|NCT01986985|64440|P1|Overall Study|Scan not completed due to malfunction|3
11751|NCT01986985|64440|P1|Overall Study|Withdrawal by Subject|4
11752|NCT01986751|64498|P2|Overall Study|improperly consented|2
11753|NCT01986751|64499|P1|Overall Study|improperly consented|10
11754|NCT01986231|64544|P1|Overall Study|Adverse Event|1
11755|NCT01986062|64551|P2|Overall Study|Lost to Follow-up|1
11756|NCT01986062|64552|P1|Overall Study|Lost to Follow-up|1
11757|NCT01985321|64612|P2|Overall Study|Subject treated wrong type of sore|0
11758|NCT01985321|64613|P1|Overall Study|Subject treated wrong type of sore|1
11759|NCT01985321|64612|P2|Overall Study|Lost to Follow-up|2
11760|NCT01985321|64613|P1|Overall Study|Lost to Follow-up|5
11761|NCT01985321|64612|P2|Overall Study|Withdrawal by Subject|0
11762|NCT01985321|64613|P1|Overall Study|Withdrawal by Subject|1
11763|NCT01985321|64612|P2|Overall Study|Protocol Violation|3
11764|NCT01985321|64613|P1|Overall Study|Protocol Violation|4
11765|NCT01985126|64623|P2|Overall Study|Ongoing|67
11766|NCT01985126|64624|P1|Overall Study|Ongoing|9
11767|NCT01985126|64623|P2|Overall Study|Lost to Follow-up|3
11768|NCT01985126|64624|P1|Overall Study|Lost to Follow-up|0
11769|NCT01985126|64623|P2|Overall Study|Withdrawal by Subject|5
11770|NCT01985126|64624|P1|Overall Study|Withdrawal by Subject|2
11771|NCT01985126|64623|P2|Overall Study|Death|31
11772|NCT01985126|64624|P1|Overall Study|Death|7
11773|NCT01984697|64647|P5|Overall Study|Follow-up continues|308
11774|NCT01984697|64648|P4|Overall Study|Follow-up continues|290
11775|NCT01984697|64649|P3|Overall Study|Follow-up continues|292
11776|NCT01984697|64650|P2|Overall Study|Follow-up continues|294
11777|NCT01984697|64651|P1|Overall Study|Follow-up continues|290
11778|NCT01984697|64647|P5|Overall Study|Withdrawal by Subject|2
11779|NCT01984697|64648|P4|Overall Study|Withdrawal by Subject|7
11780|NCT01984697|64649|P3|Overall Study|Withdrawal by Subject|4
11781|NCT01984697|64650|P2|Overall Study|Withdrawal by Subject|5
11782|NCT01984697|64651|P1|Overall Study|Withdrawal by Subject|3
11783|NCT01984697|64647|P5|Overall Study|Protocol Violation|0
11784|NCT01984697|64648|P4|Overall Study|Protocol Violation|1
11785|NCT01984697|64649|P3|Overall Study|Protocol Violation|0
11786|NCT01984697|64650|P2|Overall Study|Protocol Violation|0
11787|NCT01984697|64651|P1|Overall Study|Protocol Violation|0
11788|NCT01984697|64647|P5|Overall Study|Physician Decision|0
11789|NCT01984697|64648|P4|Overall Study|Physician Decision|0
11790|NCT01984697|64649|P3|Overall Study|Physician Decision|0
11791|NCT01984697|64650|P2|Overall Study|Physician Decision|0
11792|NCT01984697|64651|P1|Overall Study|Physician Decision|1
11793|NCT01984697|64647|P5|Overall Study|Lost to Follow-up|4
11794|NCT01984697|64648|P4|Overall Study|Lost to Follow-up|3
11795|NCT01984697|64649|P3|Overall Study|Lost to Follow-up|4
11796|NCT01984697|64650|P2|Overall Study|Lost to Follow-up|2
11797|NCT01984697|64651|P1|Overall Study|Lost to Follow-up|7
11798|NCT01984697|64647|P5|Overall Study|Adverse Event|0
11800|NCT01984697|64649|P3|Overall Study|Adverse Event|1
11801|NCT01984697|64650|P2|Overall Study|Adverse Event|0
11802|NCT01984697|64651|P1|Overall Study|Adverse Event|0
11803|NCT01984684|64750|P2|Overall Study|Subject had inadequate IV access|1
11804|NCT01984684|64751|P1|Overall Study|Subject had inadequate IV access|0
11805|NCT01984684|64750|P2|Overall Study|Study drug not available at site|1
11806|NCT01984684|64751|P1|Overall Study|Study drug not available at site|1
11807|NCT01984684|64750|P2|Overall Study|Subject incarcerated|0
11808|NCT01984684|64751|P1|Overall Study|Subject incarcerated|1
11809|NCT01984684|64750|P2|Overall Study|Noncompliance with study drug|1
11810|NCT01984684|64751|P1|Overall Study|Noncompliance with study drug|2
11811|NCT01984684|64750|P2|Overall Study|Death|1
11812|NCT01984684|64751|P1|Overall Study|Death|0
11813|NCT01984684|64750|P2|Overall Study|Protocol Violation|2
11814|NCT01984684|64751|P1|Overall Study|Protocol Violation|4
11815|NCT01984684|64750|P2|Overall Study|Physician Decision|2
11816|NCT01984684|64751|P1|Overall Study|Physician Decision|4
11817|NCT01984684|64750|P2|Overall Study|Lack of Efficacy|6
11818|NCT01984684|64751|P1|Overall Study|Lack of Efficacy|3
11819|NCT01984684|64750|P2|Overall Study|Withdrawal by Subject|9
11820|NCT01984684|64751|P1|Overall Study|Withdrawal by Subject|9
11821|NCT01984684|64750|P2|Overall Study|Adverse Event|12
11822|NCT01984684|64751|P1|Overall Study|Adverse Event|8
11823|NCT01984684|64750|P2|Overall Study|Lost to Follow-up|24
11824|NCT01984684|64751|P1|Overall Study|Lost to Follow-up|25
11825|NCT01984294|64770|P3|Overall Study|Adverse Event|0
11826|NCT01984294|64771|P2|Overall Study|Adverse Event|1
11827|NCT01984294|64772|P1|Overall Study|Adverse Event|0
11828|NCT01984294|64770|P3|Overall Study|Lack of Efficacy|6
11829|NCT01984294|64771|P2|Overall Study|Lack of Efficacy|2
11830|NCT01984294|64772|P1|Overall Study|Lack of Efficacy|4
11831|NCT01984294|64770|P3|Overall Study|Randomized but Never Treated|1
11832|NCT01984294|64771|P2|Overall Study|Randomized but Never Treated|0
11833|NCT01984294|64772|P1|Overall Study|Randomized but Never Treated|0
11834|NCT01984229|64794|P2|Safety Follow-up Period|Lost to Follow-up|0
11835|NCT01984229|64795|P1|Safety Follow-up Period|Lost to Follow-up|1
11836|NCT01984229|64794|P2|Safety Follow-up Period|Adverse Event|1
11837|NCT01984229|64795|P1|Safety Follow-up Period|Adverse Event|1
11838|NCT01983254|64921|P2|Overall Study|too ill|8
11839|NCT01983254|64922|P1|Overall Study|too ill|11
11840|NCT01983254|64921|P2|Overall Study|Lost to Follow-up|16
11841|NCT01983254|64922|P1|Overall Study|Lost to Follow-up|17
11842|NCT01983254|64921|P2|Overall Study|Death|6
11843|NCT01983254|64922|P1|Overall Study|Death|6
11844|NCT01983111|64934|P2|Overall Study|Protocol Violation|1
11845|NCT01983111|64935|P1|Overall Study|Protocol Violation|0
11846|NCT01983111|64934|P2|Overall Study|Adverse Event|0
11847|NCT01983111|64935|P1|Overall Study|Adverse Event|4
11848|NCT01983111|64934|P2|Overall Study|Withdrawal by Subject|6
11849|NCT01983111|64935|P1|Overall Study|Withdrawal by Subject|8
11850|NCT01982812|64970|P2|Overall Study|Adverse Event|5
11851|NCT01982812|64971|P1|Overall Study|Adverse Event|0
11852|NCT01982812|64970|P2|Overall Study|Death|5
11853|NCT01982812|64971|P1|Overall Study|Death|1
11854|NCT01982435|64989|P2|Overall Study|Adverse Event|0
11855|NCT01982435|64990|P1|Overall Study|Adverse Event|1
11856|NCT01982292|65020|P2|Overall Study|Technical Problems|0
11857|NCT01982292|65021|P1|Overall Study|Technical Problems|2
11858|NCT01982292|65020|P2|Overall Study|Patient/Guardian Decision|1
11859|NCT01982292|65021|P1|Overall Study|Patient/Guardian Decision|3
11860|NCT01982292|65020|P2|Overall Study|Protocol Deviation|0
11861|NCT01982292|65021|P1|Overall Study|Protocol Deviation|1
11862|NCT01982292|65020|P2|Overall Study|Non-Compliance With Study Treatment|0
11863|NCT01982292|65021|P1|Overall Study|Non-Compliance With Study Treatment|1
11864|NCT01982292|65020|P2|Overall Study|Lost to Follow-up|0
11865|NCT01982292|65021|P1|Overall Study|Lost to Follow-up|2
11866|NCT01982292|65020|P2|Overall Study|Death|0
11867|NCT01982292|65021|P1|Overall Study|Death|1
11868|NCT01982292|65020|P2|Overall Study|Adverse Event|0
11869|NCT01982292|65021|P1|Overall Study|Adverse Event|2
11870|NCT01982253|65042|P3|Overall Study|Study terminated by sponsor|4
11871|NCT01982253|65043|P2|Overall Study|Study terminated by sponsor|4
11872|NCT01982253|65044|P1|Overall Study|Study terminated by sponsor|1
11873|NCT01982253|65042|P3|Overall Study|Withdrawal by Subject|0
11874|NCT01982253|65043|P2|Overall Study|Withdrawal by Subject|0
11875|NCT01982253|65044|P1|Overall Study|Withdrawal by Subject|1
11876|NCT01981616|65083|P2|Overall Study|Protocol Violation|0
11877|NCT01981616|65084|P1|Overall Study|Protocol Violation|1
11878|NCT01981616|65083|P2|Overall Study|Adverse Event|1
11879|NCT01981616|65084|P1|Overall Study|Adverse Event|0
11880|NCT01981473|65099|P3|Overall Study|Received treatment for >24 months|6
11881|NCT01981473|65100|P2|Overall Study|Received treatment for >24 months|0
11882|NCT01981473|65101|P1|Overall Study|Received treatment for >24 months|2
11883|NCT01981473|65099|P3|Overall Study|Received treatment for < 6 months|1
11884|NCT01981473|65100|P2|Overall Study|Received treatment for < 6 months|0
11885|NCT01981473|65101|P1|Overall Study|Received treatment for < 6 months|0
11886|NCT01981473|65099|P3|Overall Study|Incorrect diagnosis of RA|1
11887|NCT01981473|65100|P2|Overall Study|Incorrect diagnosis of RA|0
11888|NCT01981473|65101|P1|Overall Study|Incorrect diagnosis of RA|0
11889|NCT01981356|65142|P2|Overall Study|Protocol Violation|0
11890|NCT01981356|65143|P1|Overall Study|Protocol Violation|2
11891|NCT01981356|65142|P2|Overall Study|Withdrawal by Subject|1
11892|NCT01981356|65143|P1|Overall Study|Withdrawal by Subject|1
11893|NCT01981356|65142|P2|Overall Study|Lost to Follow-up|1
11894|NCT01981356|65143|P1|Overall Study|Lost to Follow-up|4
11895|NCT01980992|65179|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
11896|NCT01980992|65180|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
11897|NCT01980992|65179|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
11898|NCT01980992|65180|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
11899|NCT01980992|65179|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
11900|NCT01980992|65180|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
11901|NCT01980992|65179|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
11902|NCT01980992|65180|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
11903|NCT01980992|65179|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
11904|NCT01980992|65180|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
11905|NCT01980992|65179|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
11906|NCT01980992|65180|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
11907|NCT01980940|65194|P8|Overall Study|Protocol Violation|0
11908|NCT01980940|65195|P7|Overall Study|Protocol Violation|0
11909|NCT01980940|65196|P6|Overall Study|Protocol Violation|2
11910|NCT01980940|65197|P5|Overall Study|Protocol Violation|0
11911|NCT01980940|65198|P4|Overall Study|Protocol Violation|0
11912|NCT01980940|65199|P3|Overall Study|Protocol Violation|0
11913|NCT01980940|65200|P2|Overall Study|Protocol Violation|0
11914|NCT01980940|65201|P1|Overall Study|Protocol Violation|0
11915|NCT01980875|65256|P3|Overall Study|Lost to Follow-up|1
11916|NCT01980875|65257|P2|Overall Study|Lost to Follow-up|0
11917|NCT01980875|65258|P1|Overall Study|Lost to Follow-up|0
11918|NCT01980875|65256|P3|Overall Study|Study Terminated by Sponsor|22
11919|NCT01980875|65257|P2|Overall Study|Study Terminated by Sponsor|24
11920|NCT01980875|65258|P1|Overall Study|Study Terminated by Sponsor|7
11921|NCT01980875|65256|P3|Overall Study|Withdrew Consent|1
11922|NCT01980875|65257|P2|Overall Study|Withdrew Consent|1
11923|NCT01980875|65258|P1|Overall Study|Withdrew Consent|1
11924|NCT01980095|65321|P2|Overall Study|Study drug discontinued|0
11925|NCT01980095|65322|P1|Overall Study|Study drug discontinued|1
11926|NCT01980095|65321|P2|Overall Study|Safety issue|1
11927|NCT01980095|65322|P1|Overall Study|Safety issue|0
11928|NCT01980095|65321|P2|Overall Study|Poor compliance|0
11929|NCT01980095|65322|P1|Overall Study|Poor compliance|5
11930|NCT01980095|65321|P2|Overall Study|Withdrawal by Subject|3
11931|NCT01980095|65322|P1|Overall Study|Withdrawal by Subject|2
11932|NCT01980095|65321|P2|Overall Study|Lost to Follow-up|7
11933|NCT01980095|65322|P1|Overall Study|Lost to Follow-up|6
11934|NCT01979185|65332|P2|Period 2|Not specified|1
11935|NCT01979185|65333|P1|Period 2|Not specified|0
11936|NCT01978145|65398|P2|Treatment Period 2|Par. reached defined stopping criteria|5
11937|NCT01978145|65399|P1|Treatment Period 2|Par. reached defined stopping criteria|8
11938|NCT01978145|65398|P2|Treatment Period 2|Withdrawal by Subject|4
11939|NCT01978145|65399|P1|Treatment Period 2|Withdrawal by Subject|7
11940|NCT01978145|65398|P2|Treatment Period 2|Lost to Follow-up|1
11941|NCT01978145|65399|P1|Treatment Period 2|Lost to Follow-up|1
11942|NCT01978145|65398|P2|Treatment Period 2|Protocol Violation|1
11943|NCT01978145|65399|P1|Treatment Period 2|Protocol Violation|0
11944|NCT01978145|65398|P2|Treatment Period 2|Adverse Event|3
11945|NCT01978145|65399|P1|Treatment Period 2|Adverse Event|3
11946|NCT01978145|65398|P2|Washout Period 1|Par. reached defined stopping criteria|1
11947|NCT01978145|65399|P1|Washout Period 1|Par. reached defined stopping criteria|0
11948|NCT01978145|65398|P2|Washout Period 1|Withdrawal by Subject|1
11949|NCT01978145|65399|P1|Washout Period 1|Withdrawal by Subject|1
11950|NCT01978145|65398|P2|Washout Period 1|Adverse Event|1
11951|NCT01978145|65399|P1|Washout Period 1|Adverse Event|0
11952|NCT01978145|65398|P2|Treatment Period 1|Par. reached defined stopping criteria|3
11953|NCT01978145|65399|P1|Treatment Period 1|Par. reached defined stopping criteria|2
11954|NCT01978145|65398|P2|Treatment Period 1|Withdrawal by Subject|4
11955|NCT01978145|65399|P1|Treatment Period 1|Withdrawal by Subject|5
11956|NCT01978145|65398|P2|Treatment Period 1|Physician Decision|0
11957|NCT01978145|65399|P1|Treatment Period 1|Physician Decision|1
11958|NCT01978145|65398|P2|Treatment Period 1|Adverse Event|9
11959|NCT01978145|65399|P1|Treatment Period 1|Adverse Event|1
11960|NCT01978119|65415|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
11961|NCT01978119|65416|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
11962|NCT01978119|65415|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
11963|NCT01978119|65416|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
11964|NCT01978119|65415|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
11965|NCT01978119|65416|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
11966|NCT01977820|65442|P2|Overall Study|Sponsor terminated the study|1
11967|NCT01977820|65443|P1|Overall Study|Sponsor terminated the study|1
11968|NCT01977794|65451|P2|Overall Study|Unspecified|1
11969|NCT01977794|65452|P1|Overall Study|Unspecified|0
11970|NCT01977794|65451|P2|Overall Study|Withdrew consent|1
11971|NCT01977794|65452|P1|Overall Study|Withdrew consent|2
11972|NCT01977794|65451|P2|Overall Study|Death|1
11973|NCT01977794|65452|P1|Overall Study|Death|1
11974|NCT01977794|65451|P2|Overall Study|Protocol Violation|0
11975|NCT01977794|65452|P1|Overall Study|Protocol Violation|1
11976|NCT01977794|65451|P2|Overall Study|Lost to Follow-up|1
11977|NCT01977794|65452|P1|Overall Study|Lost to Follow-up|2
11978|NCT01977794|65451|P2|Overall Study|Adverse Event|2
11979|NCT01977794|65452|P1|Overall Study|Adverse Event|2
11980|NCT01977729|65487|P1|Overall Study|Study terminated|1
11981|NCT01977690|65499|P2|Overall Study|Withdrawal by Subject|4
11982|NCT01977690|65500|P1|Overall Study|Withdrawal by Subject|0
11983|NCT01977625|65506|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
11984|NCT01977625|65507|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
11985|NCT01977625|65506|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
11986|NCT01977625|65507|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
11987|NCT01977612|65517|P2|Overall Study|Lost to Follow-up|1
11988|NCT01977612|65518|P1|Overall Study|Lost to Follow-up|1
11989|NCT01977573|65540|P4|Overall Study|Withdrawal by Subject|1
11990|NCT01977573|65541|P3|Overall Study|Withdrawal by Subject|1
11991|NCT01977573|65542|P2|Overall Study|Withdrawal by Subject|1
11992|NCT01977573|65543|P1|Overall Study|Withdrawal by Subject|6
11993|NCT01977573|65540|P4|Overall Study|Reached Defined Stopping Criteria|0
11994|NCT01977573|65541|P3|Overall Study|Reached Defined Stopping Criteria|1
11995|NCT01977573|65542|P2|Overall Study|Reached Defined Stopping Criteria|1
11996|NCT01977573|65543|P1|Overall Study|Reached Defined Stopping Criteria|2
11997|NCT01977573|65540|P4|Overall Study|Protocol Violation|0
11998|NCT01977573|65541|P3|Overall Study|Protocol Violation|0
11999|NCT01977573|65542|P2|Overall Study|Protocol Violation|1
12000|NCT01977573|65543|P1|Overall Study|Protocol Violation|3
12001|NCT01977573|65540|P4|Overall Study|Physician Decision|0
12002|NCT01977573|65541|P3|Overall Study|Physician Decision|0
12003|NCT01977573|65542|P2|Overall Study|Physician Decision|0
12004|NCT01977573|65543|P1|Overall Study|Physician Decision|1
12005|NCT01977573|65540|P4|Overall Study|Lost to Follow-up|1
12006|NCT01977573|65541|P3|Overall Study|Lost to Follow-up|0
12007|NCT01977573|65542|P2|Overall Study|Lost to Follow-up|0
12008|NCT01977573|65543|P1|Overall Study|Lost to Follow-up|1
12009|NCT01977573|65540|P4|Overall Study|Adverse Event|1
12010|NCT01977573|65541|P3|Overall Study|Adverse Event|2
12011|NCT01977573|65542|P2|Overall Study|Adverse Event|0
12012|NCT01977573|65543|P1|Overall Study|Adverse Event|7
12013|NCT01977482|65657|P6|Overall Study|Withdrawal by Subject|5
12014|NCT01977482|65658|P5|Overall Study|Withdrawal by Subject|1
12015|NCT01977482|65659|P4|Overall Study|Withdrawal by Subject|3
12016|NCT01977482|65660|P3|Overall Study|Withdrawal by Subject|1
12017|NCT01977482|65661|P2|Overall Study|Withdrawal by Subject|4
12018|NCT01977482|65662|P1|Overall Study|Withdrawal by Subject|2
12019|NCT01977482|65657|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
12020|NCT01977482|65658|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
12021|NCT01977482|65659|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
12022|NCT01977482|65660|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
12023|NCT01977482|65661|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
12024|NCT01977482|65662|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
12025|NCT01977482|65657|P6|Overall Study|Protocol Violation|0
12026|NCT01977482|65658|P5|Overall Study|Protocol Violation|0
12027|NCT01977482|65659|P4|Overall Study|Protocol Violation|0
12028|NCT01977482|65660|P3|Overall Study|Protocol Violation|1
12029|NCT01977482|65661|P2|Overall Study|Protocol Violation|0
12030|NCT01977482|65662|P1|Overall Study|Protocol Violation|0
12031|NCT01977482|65657|P6|Overall Study|Physician Decision|0
12032|NCT01977482|65658|P5|Overall Study|Physician Decision|0
12033|NCT01977482|65659|P4|Overall Study|Physician Decision|0
12034|NCT01977482|65660|P3|Overall Study|Physician Decision|0
12035|NCT01977482|65661|P2|Overall Study|Physician Decision|1
12036|NCT01977482|65662|P1|Overall Study|Physician Decision|0
12037|NCT01977482|65657|P6|Overall Study|Lost to Follow-up|0
12038|NCT01977482|65658|P5|Overall Study|Lost to Follow-up|0
12039|NCT01977482|65659|P4|Overall Study|Lost to Follow-up|0
12040|NCT01977482|65660|P3|Overall Study|Lost to Follow-up|0
12041|NCT01977482|65661|P2|Overall Study|Lost to Follow-up|0
12042|NCT01977482|65662|P1|Overall Study|Lost to Follow-up|1
12043|NCT01977482|65657|P6|Overall Study|Adverse Event|0
12044|NCT01977482|65658|P5|Overall Study|Adverse Event|2
12045|NCT01977482|65659|P4|Overall Study|Adverse Event|0
12046|NCT01977482|65660|P3|Overall Study|Adverse Event|1
12047|NCT01977482|65661|P2|Overall Study|Adverse Event|1
12048|NCT01977482|65662|P1|Overall Study|Adverse Event|0
12049|NCT01977456|65777|P1|Overall Study|Death|5
12050|NCT01976845|65815|P3|Overall Study|Physician Decision|3
12051|NCT01976845|65816|P2|Overall Study|Physician Decision|8
12052|NCT01976845|65817|P1|Overall Study|Physician Decision|8
12053|NCT01976806|65842|P2|Overall Study|Withdrawal by Subject|1
12054|NCT01976806|65843|P1|Overall Study|Withdrawal by Subject|1
12055|NCT01976806|65842|P2|Overall Study|Adverse Event|1
12056|NCT01976806|65843|P1|Overall Study|Adverse Event|1
12057|NCT01976806|65842|P2|Overall Study|Lost to Follow-up|4
12058|NCT01976806|65843|P1|Overall Study|Lost to Follow-up|1
12059|NCT01976663|65849|P1|Overall Study|Lost to Follow-up|3
12060|NCT01976663|65849|P1|Overall Study|Adverse Event|2
12061|NCT01976663|65849|P1|Overall Study|Screen Failure|3
12062|NCT01976663|65849|P1|Overall Study|Withdrawal by Subject|4
12063|NCT01976663|65849|P1|Overall Study|Personal Reasons|6
12064|NCT01976663|65849|P1|Overall Study|Completed 18 mos but no repeat treatment|24
12065|NCT01976624|65868|P1|Overall Study|Participants age less than 19 years|12
12066|NCT01976624|65868|P1|Overall Study|Participants contraindicated|2
12067|NCT01976338|65913|P2|Overall Study|Adverse Event|1
12068|NCT01976338|65914|P1|Overall Study|Adverse Event|5
12069|NCT01976338|65913|P2|Overall Study|Withdrawal by Subject|2
12070|NCT01976338|65914|P1|Overall Study|Withdrawal by Subject|5
12071|NCT01976338|65913|P2|Overall Study|Lost to Follow-up|0
12072|NCT01976338|65914|P1|Overall Study|Lost to Follow-up|3
12073|NCT01976338|65913|P2|Overall Study|Physician Decision|1
12074|NCT01976338|65914|P1|Overall Study|Physician Decision|0
12075|NCT01976312|65941|P2|Overall Study|Protocol Violation|0
12076|NCT01976312|65942|P1|Overall Study|Protocol Violation|2
12077|NCT01976312|65941|P2|Overall Study|Adverse Event|6
12078|NCT01976312|65942|P1|Overall Study|Adverse Event|6
12079|NCT01976312|65941|P2|Overall Study|Withdrawal by Subject|2
12080|NCT01976312|65942|P1|Overall Study|Withdrawal by Subject|7
12081|NCT01976312|65941|P2|Overall Study|Lost to Follow-up|0
12082|NCT01976312|65942|P1|Overall Study|Lost to Follow-up|2
12083|NCT01976312|65941|P2|Overall Study|Pregnancy|1
12084|NCT01976312|65942|P1|Overall Study|Pregnancy|0
12085|NCT01976299|65963|P2|Overall Study|See clarification above in comments|2
12086|NCT01976299|65964|P1|Overall Study|See clarification above in comments|9
12087|NCT01976299|65963|P2|Overall Study|Lost to Follow-up|1
12088|NCT01976299|65964|P1|Overall Study|Lost to Follow-up|7
12089|NCT01976299|65963|P2|Overall Study|Death|2
12090|NCT01976299|65964|P1|Overall Study|Death|4
12091|NCT01976299|65963|P2|Overall Study|Withdrawal by Subject|1
12092|NCT01976299|65964|P1|Overall Study|Withdrawal by Subject|3
12093|NCT01975948|65995|P4|Overall Study|Withdrawal by Subject|6
12094|NCT01975948|65996|P3|Overall Study|Withdrawal by Subject|7
12095|NCT01975948|65997|P2|Overall Study|Withdrawal by Subject|21
12096|NCT01975948|65998|P1|Overall Study|Withdrawal by Subject|17
12097|NCT01975675|66058|P4|Overall Study|Death|0
12098|NCT01975675|66059|P3|Overall Study|Death|0
12099|NCT01975675|66060|P2|Overall Study|Death|1
12100|NCT01975675|66061|P1|Overall Study|Death|0
12101|NCT01975285|66094|P2|Overall Study|Failed Block and follow up|2
12102|NCT01975285|66095|P1|Overall Study|Failed Block and follow up|2
12103|NCT01975246|66111|P2|Overall Study|Other than stated|1
12104|NCT01975246|66112|P1|Overall Study|Other than stated|0
12105|NCT01975246|66111|P2|Overall Study|Protocol Violation|0
12106|NCT01975246|66112|P1|Overall Study|Protocol Violation|1
12107|NCT01975246|66111|P2|Overall Study|Lack of Efficacy|0
12108|NCT01975246|66112|P1|Overall Study|Lack of Efficacy|1
12109|NCT01975246|66111|P2|Overall Study|Adverse Event|1
12110|NCT01975246|66112|P1|Overall Study|Adverse Event|2
12111|NCT01975220|66125|P6|Test Period 1|Not treated|0
12112|NCT01975220|66126|P5|Test Period 1|Not treated|0
12113|NCT01975220|66127|P4|Test Period 1|Not treated|0
12114|NCT01975220|66128|P3|Test Period 1|Not treated|0
12115|NCT01975220|66129|P2|Test Period 1|Not treated|1
12116|NCT01975220|66130|P1|Test Period 1|Not treated|0
12117|NCT01974895|66176|P2|Overall Study|Other (Reason unknown)|8
12118|NCT01974895|66177|P1|Overall Study|Other (Reason unknown)|9
12119|NCT01974895|66176|P2|Overall Study|Other (Missed Visit)|0
12120|NCT01974895|66177|P1|Overall Study|Other (Missed Visit)|1
12121|NCT01974895|66176|P2|Overall Study|Withdrawal by Subject|1
12122|NCT01974895|66177|P1|Overall Study|Withdrawal by Subject|0
12123|NCT01974895|66176|P2|Overall Study|Lost to Follow-up|6
12124|NCT01974895|66177|P1|Overall Study|Lost to Follow-up|4
12125|NCT01974895|66176|P2|Overall Study|Protocol Violation|0
12126|NCT01974895|66177|P1|Overall Study|Protocol Violation|1
12127|NCT01974817|66207|P1|Overall Study|Protocol Violation|2
12128|NCT01974817|66207|P1|Overall Study|Lost to Follow-up|2
12129|NCT01974817|66207|P1|Overall Study|Death|4
12130|NCT01974752|66213|P2|Overall Study|Other Eligibility Criteria|1
12131|NCT01974752|66214|P1|Overall Study|Other Eligibility Criteria|0
12132|NCT01974752|66213|P2|Overall Study|Withdrawal by Subject|3
12133|NCT01974752|66214|P1|Overall Study|Withdrawal by Subject|2
12134|NCT01974752|66213|P2|Overall Study|Lost to Follow-up|0
12135|NCT01974752|66214|P1|Overall Study|Lost to Follow-up|2
12136|NCT01974752|66213|P2|Overall Study|Death|11
12137|NCT01974752|66214|P1|Overall Study|Death|33
12138|NCT01974323|66241|P2|Overall Study|Adverse Event|2
12139|NCT01974323|66242|P1|Overall Study|Adverse Event|2
12140|NCT01974323|66241|P2|Overall Study|Lack of Efficacy|1
12141|NCT01974323|66242|P1|Overall Study|Lack of Efficacy|1
12142|NCT01974323|66241|P2|Overall Study|Pregnancy|1
12143|NCT01974323|66242|P1|Overall Study|Pregnancy|2
12144|NCT01974323|66241|P2|Overall Study|Lost to Follow-up|40
12145|NCT01974323|66242|P1|Overall Study|Lost to Follow-up|45
12146|NCT01974323|66241|P2|Overall Study|Personal Reasons|19
12147|NCT01974323|66242|P1|Overall Study|Personal Reasons|15
12148|NCT01974323|66241|P2|Overall Study|Protocol Violation|2
12149|NCT01974323|66242|P1|Overall Study|Protocol Violation|2
12150|NCT01974323|66241|P2|Overall Study|Other Reasons|28
12151|NCT01974323|66242|P1|Overall Study|Other Reasons|25
12152|NCT01974141|66275|P2|Overall Study|Adverse Event|5
12153|NCT01974141|66276|P1|Overall Study|Adverse Event|4
12154|NCT01974141|66275|P2|Overall Study|Lack of Efficacy|1
12155|NCT01974141|66276|P1|Overall Study|Lack of Efficacy|0
12156|NCT01974141|66275|P2|Overall Study|Pregnancy|3
12157|NCT01974141|66276|P1|Overall Study|Pregnancy|3
12158|NCT01974141|66275|P2|Overall Study|Lost to Follow-up|29
12159|NCT01974141|66276|P1|Overall Study|Lost to Follow-up|38
12160|NCT01974141|66275|P2|Overall Study|Personal Reasons|20
12161|NCT01974141|66276|P1|Overall Study|Personal Reasons|21
12162|NCT01974141|66275|P2|Overall Study|Protocol Violation|6
12163|NCT01974141|66276|P1|Overall Study|Protocol Violation|2
12164|NCT01974141|66275|P2|Overall Study|Other Reasons|18
12165|NCT01974141|66276|P1|Overall Study|Other Reasons|28
12166|NCT01973595|66333|P4|Washout|Withdrawal by Subject|0
12167|NCT01973595|66334|P3|Washout|Withdrawal by Subject|1
12168|NCT01973595|66335|P2|Washout|Withdrawal by Subject|0
12169|NCT01973595|66336|P1|Washout|Withdrawal by Subject|1
12170|NCT01973491|66350|P1|Treatment Period (16 Weeks)|Adverse Event|1
12171|NCT01973491|66350|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
12172|NCT01973491|66350|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
12173|NCT01973439|66366|P1|Overall Study|PK curve incomplete|2
12174|NCT01973439|66366|P1|Overall Study|Vomiting after commencing once daily|1
12175|NCT01973439|66366|P1|Overall Study|Lost samples from one PK Day|2
12176|NCT01973387|66388|P2|Overall Study|Did not receive study drug|2
12177|NCT01973387|66389|P1|Overall Study|Did not receive study drug|2
12178|NCT01973387|66388|P2|Overall Study|Ongoing|0
12179|NCT01973387|66389|P1|Overall Study|Ongoing|72
12180|NCT01973387|66388|P2|Overall Study|Adverse Event|4
12181|NCT01973387|66389|P1|Overall Study|Adverse Event|13
12182|NCT01973387|66388|P2|Overall Study|Progressive disease or relapse|5
12183|NCT01973387|66389|P1|Overall Study|Progressive disease or relapse|10
12184|NCT01973387|66388|P2|Overall Study|Death|3
12185|NCT01973387|66389|P1|Overall Study|Death|3
12186|NCT01973387|66388|P2|Overall Study|Withdrawal by Subject|4
12187|NCT01973387|66389|P1|Overall Study|Withdrawal by Subject|6
12188|NCT01973231|66426|P2|Overall Study|Withdrawal by Subject|9
12189|NCT01973231|66427|P1|Overall Study|Withdrawal by Subject|7
12190|NCT01973231|66426|P2|Overall Study|unclassified|1
12191|NCT01973231|66427|P1|Overall Study|unclassified|2
12192|NCT01973231|66426|P2|Overall Study|Lost to Follow-up|1
12193|NCT01973231|66427|P1|Overall Study|Lost to Follow-up|1
12194|NCT01973231|66426|P2|Overall Study|Protocol Violation|1
12195|NCT01973231|66427|P1|Overall Study|Protocol Violation|1
12196|NCT01973218|66447|P2|Overall Study|Withdrawal by Subject|0
12197|NCT01973218|66448|P1|Overall Study|Withdrawal by Subject|1
12198|NCT01973218|66447|P2|Overall Study|Adverse Event|0
12199|NCT01973218|66448|P1|Overall Study|Adverse Event|1
12200|NCT01972776|66490|P6|Part 2|Administrative problems|7
12201|NCT01972776|66491|P5|Part 2|Administrative problems|10
12202|NCT01972776|66492|P4|Part 2|Administrative problems|0
12203|NCT01972776|66493|P3|Part 2|Administrative problems|0
12204|NCT01972776|66494|P2|Part 2|Administrative problems|0
12205|NCT01972776|66495|P1|Part 2|Administrative problems|0
12206|NCT01972776|66490|P6|Part 2|Adverse Event|0
12207|NCT01972776|66491|P5|Part 2|Adverse Event|3
12208|NCT01972776|66492|P4|Part 2|Adverse Event|0
12209|NCT01972776|66493|P3|Part 2|Adverse Event|0
12210|NCT01972776|66494|P2|Part 2|Adverse Event|0
12211|NCT01972776|66495|P1|Part 2|Adverse Event|0
12212|NCT01972776|66490|P6|Part 1|Adverse Event|0
12213|NCT01972776|66491|P5|Part 1|Adverse Event|0
12214|NCT01972776|66492|P4|Part 1|Adverse Event|1
12215|NCT01972776|66493|P3|Part 1|Adverse Event|1
12216|NCT01972776|66494|P2|Part 1|Adverse Event|0
12217|NCT01972776|66495|P1|Part 1|Adverse Event|0
12218|NCT01972776|66490|P6|Part 1|Withdrawal by Subject|0
12219|NCT01972776|66491|P5|Part 1|Withdrawal by Subject|0
12220|NCT01972776|66492|P4|Part 1|Withdrawal by Subject|0
12221|NCT01972776|66493|P3|Part 1|Withdrawal by Subject|1
12222|NCT01972776|66494|P2|Part 1|Withdrawal by Subject|0
12223|NCT01972776|66495|P1|Part 1|Withdrawal by Subject|0
12224|NCT01972659|66565|P2|Overall Study|problems realted to acceleromyograph|1
12225|NCT01972659|66566|P1|Overall Study|problems realted to acceleromyograph|2
12226|NCT01972659|66565|P2|Overall Study|Protocol Violation|2
12227|NCT01972659|66566|P1|Overall Study|Protocol Violation|2
12228|NCT01972438|66591|P2|Post Month 12 Study Period|Early Study Closure|4
12229|NCT01972438|66592|P1|Post Month 12 Study Period|Early Study Closure|3
12230|NCT01972438|66591|P2|Months 6-12 Study Period|Early Study Closure|2
12231|NCT01972438|66592|P1|Months 6-12 Study Period|Early Study Closure|2
12232|NCT01972438|66591|P2|Months 6-12 Study Period|Death|0
12233|NCT01972438|66592|P1|Months 6-12 Study Period|Death|1
12234|NCT01972438|66591|P2|Months 3-6 Crossover Period|Early Study Closure|1
12235|NCT01972438|66592|P1|Months 3-6 Crossover Period|Early Study Closure|0
12236|NCT01972438|66591|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
12237|NCT01972438|66592|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
12238|NCT01972438|66591|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
12239|NCT01972438|66592|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
12240|NCT01972438|66591|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
12241|NCT01972438|66592|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
12242|NCT01972438|66591|P2|Baseline-Month 3 Crossover Period|Death|0
12243|NCT01972438|66592|P1|Baseline-Month 3 Crossover Period|Death|1
12244|NCT01972152|66644|P6|Second Treatment Visit|Protocol Violation|0
12245|NCT01972152|66645|P5|Second Treatment Visit|Protocol Violation|0
12246|NCT01972152|66646|P4|Second Treatment Visit|Protocol Violation|0
12247|NCT01972152|66647|P3|Second Treatment Visit|Protocol Violation|0
12248|NCT01972152|66648|P2|Second Treatment Visit|Protocol Violation|1
12249|NCT01972152|66649|P1|Second Treatment Visit|Protocol Violation|0
12250|NCT01972152|66644|P6|First Treatment Visit|Lost to Follow-up|0
12251|NCT01972152|66645|P5|First Treatment Visit|Lost to Follow-up|0
12252|NCT01972152|66646|P4|First Treatment Visit|Lost to Follow-up|0
12253|NCT01972152|66647|P3|First Treatment Visit|Lost to Follow-up|0
12254|NCT01972152|66648|P2|First Treatment Visit|Lost to Follow-up|1
12255|NCT01972152|66649|P1|First Treatment Visit|Lost to Follow-up|0
12256|NCT01971723|66686|P2|Overall Study|Protocol Violation|2
12257|NCT01971723|66687|P1|Overall Study|Protocol Violation|1
12258|NCT01971723|66686|P2|Overall Study|Withdrawal by Subject|1
12259|NCT01971723|66687|P1|Overall Study|Withdrawal by Subject|1
12260|NCT01971554|66721|P4|Overall Study|Lost to Follow-up|0
12261|NCT01971554|66722|P3|Overall Study|Lost to Follow-up|0
12262|NCT01971554|66723|P2|Overall Study|Lost to Follow-up|0
12263|NCT01971554|66724|P1|Overall Study|Lost to Follow-up|1
12264|NCT01970995|66792|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
12265|NCT01970995|66793|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
12266|NCT01970995|66794|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
12267|NCT01970995|66792|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
12268|NCT01970995|66793|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
12269|NCT01970995|66794|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
12270|NCT01970982|66817|P3|Overall Study|Withdrawal by Subject|2
12271|NCT01970982|66818|P2|Overall Study|Withdrawal by Subject|0
12272|NCT01970982|66819|P1|Overall Study|Withdrawal by Subject|0
12273|NCT01970878|66841|P4|Overall Study|No Completion Status|0
12274|NCT01970878|66842|P3|Overall Study|No Completion Status|0
12275|NCT01970878|66843|P2|Overall Study|No Completion Status|1
12276|NCT01970878|66844|P1|Overall Study|No Completion Status|0
12277|NCT01970878|66841|P4|Overall Study|Physician Decision|0
12278|NCT01970878|66842|P3|Overall Study|Physician Decision|1
12279|NCT01970878|66843|P2|Overall Study|Physician Decision|1
12280|NCT01970878|66844|P1|Overall Study|Physician Decision|0
12281|NCT01970878|66841|P4|Overall Study|Protocol Specified Criteria|6
12282|NCT01970878|66842|P3|Overall Study|Protocol Specified Criteria|3
12283|NCT01970878|66843|P2|Overall Study|Protocol Specified Criteria|4
12284|NCT01970878|66844|P1|Overall Study|Protocol Specified Criteria|10
12285|NCT01970878|66841|P4|Overall Study|Adverse Event|3
12286|NCT01970878|66842|P3|Overall Study|Adverse Event|4
12287|NCT01970878|66843|P2|Overall Study|Adverse Event|7
12288|NCT01970878|66844|P1|Overall Study|Adverse Event|12
12289|NCT01970878|66841|P4|Overall Study|Lack of Efficacy|0
12290|NCT01970878|66842|P3|Overall Study|Lack of Efficacy|2
12291|NCT01970878|66843|P2|Overall Study|Lack of Efficacy|1
12292|NCT01970878|66844|P1|Overall Study|Lack of Efficacy|2
12293|NCT01970878|66841|P4|Overall Study|Administrative Reasons|4
12294|NCT01970878|66842|P3|Overall Study|Administrative Reasons|0
12295|NCT01970878|66843|P2|Overall Study|Administrative Reasons|0
12296|NCT01970878|66844|P1|Overall Study|Administrative Reasons|1
12297|NCT01970878|66841|P4|Overall Study|Lost to Follow-up|4
12298|NCT01970878|66842|P3|Overall Study|Lost to Follow-up|2
12299|NCT01970878|66843|P2|Overall Study|Lost to Follow-up|3
12300|NCT01970878|66844|P1|Overall Study|Lost to Follow-up|1
12301|NCT01970878|66841|P4|Overall Study|Withdrawal by Subject|7
12302|NCT01970878|66842|P3|Overall Study|Withdrawal by Subject|14
12303|NCT01970878|66843|P2|Overall Study|Withdrawal by Subject|10
12304|NCT01970878|66844|P1|Overall Study|Withdrawal by Subject|11
12305|NCT01970488|66880|P5|Part 2: Post Week 16|Lost to Follow-up|2
12306|NCT01970488|66881|P4|Part 2: Post Week 16|Lost to Follow-up|1
12307|NCT01970488|66882|P3|Part 2: Post Week 16|Lost to Follow-up|1
12308|NCT01970488|66883|P2|Part 2: Post Week 16|Lost to Follow-up|0
12309|NCT01970488|66884|P1|Part 2: Post Week 16|Lost to Follow-up|0
12310|NCT01970488|66880|P5|Part 2: Post Week 16|Withdrawal by Subject|3
12311|NCT01970488|66881|P4|Part 2: Post Week 16|Withdrawal by Subject|3
12312|NCT01970488|66882|P3|Part 2: Post Week 16|Withdrawal by Subject|8
12313|NCT01970488|66883|P2|Part 2: Post Week 16|Withdrawal by Subject|0
12314|NCT01970488|66884|P1|Part 2: Post Week 16|Withdrawal by Subject|0
12315|NCT01970488|66880|P5|Part 2: Post Week 16|Adverse Event|1
12316|NCT01970488|66881|P4|Part 2: Post Week 16|Adverse Event|1
12317|NCT01970488|66882|P3|Part 2: Post Week 16|Adverse Event|5
12318|NCT01970488|66883|P2|Part 2: Post Week 16|Adverse Event|0
12319|NCT01970488|66884|P1|Part 2: Post Week 16|Adverse Event|0
12320|NCT01970488|66880|P5|Part 2: Post Week 16|Lack of Efficacy|1
12321|NCT01970488|66881|P4|Part 2: Post Week 16|Lack of Efficacy|3
12322|NCT01970488|66882|P3|Part 2: Post Week 16|Lack of Efficacy|2
12323|NCT01970488|66883|P2|Part 2: Post Week 16|Lack of Efficacy|0
12324|NCT01970488|66884|P1|Part 2: Post Week 16|Lack of Efficacy|0
12325|NCT01970488|66880|P5|Part 2: Post Week 16|Non-compliance|0
12326|NCT01970488|66881|P4|Part 2: Post Week 16|Non-compliance|0
12327|NCT01970488|66882|P3|Part 2: Post Week 16|Non-compliance|1
12328|NCT01970488|66883|P2|Part 2: Post Week 16|Non-compliance|0
12329|NCT01970488|66884|P1|Part 2: Post Week 16|Non-compliance|0
12330|NCT01970488|66880|P5|Part 2: Post Week 16|Physician Decision|1
12331|NCT01970488|66881|P4|Part 2: Post Week 16|Physician Decision|0
12332|NCT01970488|66882|P3|Part 2: Post Week 16|Physician Decision|0
12333|NCT01970488|66883|P2|Part 2: Post Week 16|Physician Decision|0
12334|NCT01970488|66884|P1|Part 2: Post Week 16|Physician Decision|0
12335|NCT01970488|66880|P5|Part 1: Through Week 16|Lost to Follow-up|0
12336|NCT01970488|66881|P4|Part 1: Through Week 16|Lost to Follow-up|0
12337|NCT01970488|66882|P3|Part 1: Through Week 16|Lost to Follow-up|0
12338|NCT01970488|66883|P2|Part 1: Through Week 16|Lost to Follow-up|2
12339|NCT01970488|66884|P1|Part 1: Through Week 16|Lost to Follow-up|0
12340|NCT01970488|66880|P5|Part 1: Through Week 16|Withdrawal by Subject|0
12341|NCT01970488|66881|P4|Part 1: Through Week 16|Withdrawal by Subject|0
12342|NCT01970488|66882|P3|Part 1: Through Week 16|Withdrawal by Subject|0
12343|NCT01970488|66883|P2|Part 1: Through Week 16|Withdrawal by Subject|2
12344|NCT01970488|66884|P1|Part 1: Through Week 16|Withdrawal by Subject|3
12345|NCT01970488|66880|P5|Part 1: Through Week 16|Adverse Event|0
12346|NCT01970488|66881|P4|Part 1: Through Week 16|Adverse Event|0
12347|NCT01970488|66882|P3|Part 1: Through Week 16|Adverse Event|0
12348|NCT01970488|66883|P2|Part 1: Through Week 16|Adverse Event|5
12349|NCT01970488|66884|P1|Part 1: Through Week 16|Adverse Event|6
12350|NCT01970488|66880|P5|Part 1: Through Week 16|Protocol Violation|0
12351|NCT01970488|66881|P4|Part 1: Through Week 16|Protocol Violation|0
12352|NCT01970488|66882|P3|Part 1: Through Week 16|Protocol Violation|0
12353|NCT01970488|66883|P2|Part 1: Through Week 16|Protocol Violation|2
12354|NCT01970488|66884|P1|Part 1: Through Week 16|Protocol Violation|1
12355|NCT01970488|66880|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
12356|NCT01970488|66881|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
12357|NCT01970488|66882|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
12358|NCT01970488|66883|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
12359|NCT01970488|66884|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
12360|NCT01970475|66951|P2|Overall Study|Protocol Violation|0
12361|NCT01970475|66952|P1|Overall Study|Protocol Violation|1
12362|NCT01970475|66951|P2|Overall Study|Lost to Follow-up|2
12363|NCT01970475|66952|P1|Overall Study|Lost to Follow-up|2
12364|NCT01970475|66951|P2|Overall Study|Adverse Event|3
12365|NCT01970475|66952|P1|Overall Study|Adverse Event|7
12366|NCT01970475|66951|P2|Overall Study|Withdrawal by Subject|6
12367|NCT01970475|66952|P1|Overall Study|Withdrawal by Subject|11
12368|NCT01970397|66972|P2|Overall Study|Protocol Violation|1
12369|NCT01970397|66973|P1|Overall Study|Protocol Violation|1
12370|NCT01970397|66972|P2|Overall Study|Personal Reasons|2
12371|NCT01970397|66973|P1|Overall Study|Personal Reasons|1
12372|NCT01970397|66972|P2|Overall Study|Lost to Follow-up|1
12373|NCT01970397|66973|P1|Overall Study|Lost to Follow-up|0
12374|NCT01970397|66972|P2|Overall Study|Adverse Event|1
12375|NCT01970397|66973|P1|Overall Study|Adverse Event|0
12376|NCT01969799|66985|P2|Overall Study|Physician Decision|0
12377|NCT01969799|66986|P1|Overall Study|Physician Decision|1
12378|NCT01969799|66985|P2|Overall Study|Lost to Follow-up|2
12379|NCT01969799|66986|P1|Overall Study|Lost to Follow-up|0
12380|NCT01969799|66985|P2|Overall Study|Death|11
12381|NCT01969799|66986|P1|Overall Study|Death|16
12382|NCT01969799|66985|P2|Overall Study|Adverse Event|1
12383|NCT01969799|66986|P1|Overall Study|Adverse Event|0
12384|NCT01969721|67023|P4|Overall Study|Discontinued during washout periods.|2
12385|NCT01969721|67024|P3|Overall Study|Discontinued during washout periods.|1
12386|NCT01969721|67025|P2|Overall Study|Discontinued during washout periods.|1
12387|NCT01969721|67026|P1|Overall Study|Discontinued during washout periods.|0
12388|NCT01969721|67023|P4|Overall Study|Other not defined above|0
12389|NCT01969721|67024|P3|Overall Study|Other not defined above|0
12390|NCT01969721|67025|P2|Overall Study|Other not defined above|2
12391|NCT01969721|67026|P1|Overall Study|Other not defined above|0
12392|NCT01969721|67023|P4|Overall Study|Non compliant with protocol|2
12393|NCT01969721|67024|P3|Overall Study|Non compliant with protocol|0
12394|NCT01969721|67025|P2|Overall Study|Non compliant with protocol|1
12395|NCT01969721|67026|P1|Overall Study|Non compliant with protocol|1
12396|NCT01969721|67023|P4|Overall Study|Lack of Efficacy|0
12397|NCT01969721|67024|P3|Overall Study|Lack of Efficacy|1
12398|NCT01969721|67025|P2|Overall Study|Lack of Efficacy|0
12399|NCT01969721|67026|P1|Overall Study|Lack of Efficacy|0
12400|NCT01969721|67023|P4|Overall Study|Adverse Event|2
12401|NCT01969721|67024|P3|Overall Study|Adverse Event|3
12402|NCT01969721|67025|P2|Overall Study|Adverse Event|8
12403|NCT01969721|67026|P1|Overall Study|Adverse Event|3
12404|NCT01969565|67052|P1|Overall Study|Withdrawal by Subject|1
12405|NCT01969084|67081|P2|Overall Study|Adverse Event|1
12406|NCT01969084|67082|P1|Overall Study|Adverse Event|0
12407|NCT01968980|67098|P2|Overall Study|Other unspecified|2
12408|NCT01968980|67099|P1|Overall Study|Other unspecified|1
12409|NCT01968980|67098|P2|Overall Study|Withdrawal by Subject|5
12410|NCT01968980|67099|P1|Overall Study|Withdrawal by Subject|13
12411|NCT01968980|67098|P2|Overall Study|Does not meet entry criteria|3
12412|NCT01968980|67099|P1|Overall Study|Does not meet entry criteria|1
12413|NCT01968980|67098|P2|Overall Study|Adverse Event|3
12414|NCT01968980|67099|P1|Overall Study|Adverse Event|1
12415|NCT01968980|67098|P2|Overall Study|Death|1
12416|NCT01968980|67099|P1|Overall Study|Death|0
12417|NCT01968967|67161|P2|Overall Study|Randomized Not Treated|5
12418|NCT01968967|67162|P1|Overall Study|Randomized Not Treated|6
12419|NCT01968967|67161|P2|Overall Study|Death|2
12420|NCT01968967|67162|P1|Overall Study|Death|9
12421|NCT01968967|67161|P2|Overall Study|Adverse Event|8
12422|NCT01968967|67162|P1|Overall Study|Adverse Event|9
12423|NCT01968967|67161|P2|Overall Study|Protocol Violation|2
12424|NCT01968967|67162|P1|Overall Study|Protocol Violation|1
12425|NCT01968967|67161|P2|Overall Study|Lost to Follow-up|31
12426|NCT01968967|67162|P1|Overall Study|Lost to Follow-up|26
12427|NCT01968967|67161|P2|Overall Study|Did Not Meet Entrance Criteria|3
12428|NCT01968967|67162|P1|Overall Study|Did Not Meet Entrance Criteria|2
12429|NCT01968967|67161|P2|Overall Study|Withdrawal by Subject|61
12430|NCT01968967|67162|P1|Overall Study|Withdrawal by Subject|71
12431|NCT01968967|67161|P2|Overall Study|Unspecified|22
12432|NCT01968967|67162|P1|Overall Study|Unspecified|22
12433|NCT01968954|67223|P2|Overall Study|Did not met inclusion criteria|2
12434|NCT01968954|67224|P1|Overall Study|Did not met inclusion criteria|0
12435|NCT01968954|67223|P2|Overall Study|Protocol Violation|1
12436|NCT01968954|67224|P1|Overall Study|Protocol Violation|0
12437|NCT01968954|67223|P2|Overall Study|Unspecified|8
12438|NCT01968954|67224|P1|Overall Study|Unspecified|7
12439|NCT01968954|67223|P2|Overall Study|Withdrawal by Subject|23
12440|NCT01968954|67224|P1|Overall Study|Withdrawal by Subject|20
12441|NCT01968954|67223|P2|Overall Study|Lost to Follow-up|4
12442|NCT01968954|67224|P1|Overall Study|Lost to Follow-up|6
12443|NCT01968954|67223|P2|Overall Study|Death|2
12444|NCT01968954|67224|P1|Overall Study|Death|1
12445|NCT01968954|67223|P2|Overall Study|Adverse Event|3
12446|NCT01968954|67224|P1|Overall Study|Adverse Event|6
12447|NCT01968811|67288|P1|Overall Study|post op.ref. of subject to other hospita|1
12448|NCT01968811|67288|P1|Overall Study|Protocol Violation|4
12449|NCT01968694|67295|P2|Washout (1 Month)|Lost to Follow-up|1
12450|NCT01968694|67296|P1|Washout (1 Month)|Lost to Follow-up|0
12451|NCT01968551|67313|P3|Extension Phase|Lost to Follow-up|1
12452|NCT01968551|67314|P2|Extension Phase|Lost to Follow-up|0
12453|NCT01968551|67315|P1|Extension Phase|Lost to Follow-up|1
12454|NCT01968551|67313|P3|Extension Phase|Withdrew Consent|1
12455|NCT01968551|67314|P2|Extension Phase|Withdrew Consent|0
12456|NCT01968551|67315|P1|Extension Phase|Withdrew Consent|0
12457|NCT01968551|67313|P3|Extension Phase|Death|0
12458|NCT01968551|67314|P2|Extension Phase|Death|1
12459|NCT01968551|67315|P1|Extension Phase|Death|0
12460|NCT01968551|67313|P3|Extension Phase|Adverse Event|2
12461|NCT01968551|67314|P2|Extension Phase|Adverse Event|0
12462|NCT01968551|67315|P1|Extension Phase|Adverse Event|0
12463|NCT01968551|67313|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
12464|NCT01968551|67314|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
12465|NCT01968551|67315|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
12466|NCT01968551|67313|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
12467|NCT01968551|67314|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
12468|NCT01968551|67315|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
12469|NCT01968551|67313|P3|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
12470|NCT01968551|67314|P2|Open Label Phase (48 Weeks)|Investigator’s Discretion|1
12471|NCT01968551|67315|P1|Open Label Phase (48 Weeks)|Investigator’s Discretion|0
12472|NCT01968551|67313|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
12473|NCT01968551|67314|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
12474|NCT01968551|67315|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
12475|NCT01968434|67331|P2|Overall Study|Lost to Follow-up|6
12476|NCT01968434|67332|P1|Overall Study|Lost to Follow-up|3
12477|NCT01968226|67342|P1|Overall Study|[F-18] RDG-K5 was not available|2
12478|NCT01967940|67374|P3|Part 2|Still on Study|14
12479|NCT01967940|67375|P2|Part 2|Still on Study|16
12480|NCT01967940|67376|P1|Part 2|Still on Study|8
12481|NCT01967732|67403|P4|First Intervention (Day 1)|Poor venous access|0
12482|NCT01967732|67404|P3|First Intervention (Day 1)|Poor venous access|0
12483|NCT01967732|67405|P2|First Intervention (Day 1)|Poor venous access|1
12484|NCT01967732|67406|P1|First Intervention (Day 1)|Poor venous access|0
12485|NCT01967732|67403|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
12486|NCT01967732|67404|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
12487|NCT01967732|67405|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
12488|NCT01967732|67406|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
12489|NCT01967719|67420|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
12490|NCT01967719|67421|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
12491|NCT01967719|67422|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
12492|NCT01967719|67423|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
12493|NCT01967719|67420|P4|First Intervention (Day 1)|Withdrawal by Subject|1
12494|NCT01967719|67421|P3|First Intervention (Day 1)|Withdrawal by Subject|0
12495|NCT01967719|67422|P2|First Intervention (Day 1)|Withdrawal by Subject|1
12496|NCT01967719|67423|P1|First Intervention (Day 1)|Withdrawal by Subject|0
12497|NCT01967706|67438|P4|First Intervention (Day 1)|Withdrawal by Subject|0
12498|NCT01967706|67439|P3|First Intervention (Day 1)|Withdrawal by Subject|0
12499|NCT01967706|67440|P2|First Intervention (Day 1)|Withdrawal by Subject|0
12500|NCT01967706|67441|P1|First Intervention (Day 1)|Withdrawal by Subject|1
12501|NCT01967550|67452|P2|Overall Study|Non Compliance|1
12502|NCT01967550|67453|P1|Overall Study|Non Compliance|0
12503|NCT01967550|67452|P2|Overall Study|Protocol Violation|1
12504|NCT01967550|67453|P1|Overall Study|Protocol Violation|2
12505|NCT01967550|67452|P2|Overall Study|Adverse Event|0
12506|NCT01967550|67453|P1|Overall Study|Adverse Event|2
12507|NCT01967550|67452|P2|Overall Study|Withdrawal by Subject|0
12508|NCT01967550|67453|P1|Overall Study|Withdrawal by Subject|1
12509|NCT01967277|67483|P2|Overall Study|Unrelated illness|1
12510|NCT01967277|67484|P1|Overall Study|Unrelated illness|0
12511|NCT01967277|67483|P2|Overall Study|Lost to Follow-up|2
12512|NCT01967277|67484|P1|Overall Study|Lost to Follow-up|1
12513|NCT01967147|67494|P2|Overall Study|Other|5
12514|NCT01967147|67495|P1|Overall Study|Other|4
12515|NCT01967147|67494|P2|Overall Study|Non-compliance with Study Drug|3
12516|NCT01967147|67495|P1|Overall Study|Non-compliance with Study Drug|0
12517|NCT01967147|67494|P2|Overall Study|Withdrawal by Subject|4
12518|NCT01967147|67495|P1|Overall Study|Withdrawal by Subject|2
12519|NCT01967147|67494|P2|Overall Study|Lost to Follow-up|2
12520|NCT01967147|67495|P1|Overall Study|Lost to Follow-up|1
12521|NCT01967147|67494|P2|Overall Study|Lack of Efficacy|4
12522|NCT01967147|67495|P1|Overall Study|Lack of Efficacy|1
12523|NCT01967147|67494|P2|Overall Study|Adverse Event|2
12524|NCT01967147|67495|P1|Overall Study|Adverse Event|5
12525|NCT01967069|67525|P2|Overall Study|Lack of Efficacy|1
12526|NCT01967069|67526|P1|Overall Study|Lack of Efficacy|0
12527|NCT01967069|67525|P2|Overall Study|Withdrawal by Subject|3
12528|NCT01967069|67526|P1|Overall Study|Withdrawal by Subject|1
12529|NCT01967069|67525|P2|Overall Study|Lost to Follow-up|2
12530|NCT01967069|67526|P1|Overall Study|Lost to Follow-up|5
12531|NCT01967069|67525|P2|Overall Study|Adverse Event|2
12532|NCT01967069|67526|P1|Overall Study|Adverse Event|2
12533|NCT01966432|67671|P3|Overall Study|SBIRT program ended|20
12534|NCT01966432|67672|P2|Overall Study|SBIRT program ended|8
12535|NCT01966432|67673|P1|Overall Study|SBIRT program ended|1
12536|NCT01966432|67671|P3|Overall Study|Subject Incarcerated|1
12537|NCT01966432|67672|P2|Overall Study|Subject Incarcerated|0
12538|NCT01966432|67673|P1|Overall Study|Subject Incarcerated|0
12539|NCT01966432|67671|P3|Overall Study|Withdrawal by Subject|0
12540|NCT01966432|67672|P2|Overall Study|Withdrawal by Subject|3
12541|NCT01966432|67673|P1|Overall Study|Withdrawal by Subject|1
12542|NCT01966432|67671|P3|Overall Study|Lost to Follow-up|5
12543|NCT01966432|67672|P2|Overall Study|Lost to Follow-up|2
12544|NCT01966432|67673|P1|Overall Study|Lost to Follow-up|3
12545|NCT01966120|67743|P2|Overall Study|Lost to Follow-up|1
12546|NCT01966120|67744|P1|Overall Study|Lost to Follow-up|1
12547|NCT01966120|67743|P2|Overall Study|Withdrawal by Subject|5
12548|NCT01966120|67744|P1|Overall Study|Withdrawal by Subject|0
12549|NCT01966068|67768|P1|Overall Study|Lost to Follow-up|81
12550|NCT01966068|67768|P1|Overall Study|Withdrawal by Subject|57
12551|NCT01966042|67773|P1|Overall Study|Death|2
12552|NCT01965938|67782|P2|Overall Study|Withdrawal by Subject|0
12553|NCT01965938|67783|P1|Overall Study|Withdrawal by Subject|1
12554|NCT01965834|67814|P1|Overall Study|Lack of Efficacy|4
12555|NCT01965652|67828|P2|Overall Study|Pregnancy|1
12556|NCT01965652|67829|P1|Overall Study|Pregnancy|0
12557|NCT01965652|67828|P2|Overall Study|Other - Miscellaneous|21
12558|NCT01965652|67829|P1|Overall Study|Other - Miscellaneous|18
12559|NCT01965652|67828|P2|Overall Study|Death|4
12560|NCT01965652|67829|P1|Overall Study|Death|3
12561|NCT01965652|67828|P2|Overall Study|Protocol Violation|38
12562|NCT01965652|67829|P1|Overall Study|Protocol Violation|34
12563|NCT01965652|67828|P2|Overall Study|Lost to Follow-up|40
12564|NCT01965652|67829|P1|Overall Study|Lost to Follow-up|53
12565|NCT01965652|67828|P2|Overall Study|Withdrawal by Subject|69
12566|NCT01965652|67829|P1|Overall Study|Withdrawal by Subject|62
12567|NCT01965652|67828|P2|Overall Study|Adverse Event|37
12568|NCT01965652|67829|P1|Overall Study|Adverse Event|40
12569|NCT01965600|67859|P4|Second Intervention|Study terminated by Sponsor|2
12570|NCT01965600|67860|P3|Second Intervention|Study terminated by Sponsor|2
12571|NCT01965600|67861|P2|Second Intervention|Study terminated by Sponsor|0
12572|NCT01965600|67862|P1|Second Intervention|Study terminated by Sponsor|0
12573|NCT01965600|67859|P4|Washout Period of Approximately 15 Days|Adverse Event|1
12574|NCT01965600|67860|P3|Washout Period of Approximately 15 Days|Adverse Event|0
12657|NCT01964352|68389|P1|Overall Study|Lost to Follow-up|1
12575|NCT01965600|67861|P2|Washout Period of Approximately 15 Days|Adverse Event|0
12576|NCT01965600|67862|P1|Washout Period of Approximately 15 Days|Adverse Event|0
12577|NCT01965600|67859|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
12578|NCT01965600|67860|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
12579|NCT01965600|67861|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
12580|NCT01965600|67862|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
12581|NCT01965600|67859|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
12582|NCT01965600|67860|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
12583|NCT01965600|67861|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
12584|NCT01965600|67862|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
12585|NCT01965600|67859|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
12586|NCT01965600|67860|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
12587|NCT01965600|67861|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
12588|NCT01965600|67862|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
12589|NCT01965535|67919|P2|Overall Study|Lack of Efficacy|1
12590|NCT01965535|67920|P1|Overall Study|Lack of Efficacy|2
12591|NCT01965431|67934|P6|Overall Study|Other than stated above|6
12592|NCT01965431|67935|P5|Overall Study|Other than stated above|6
12593|NCT01965431|67936|P4|Overall Study|Other than stated above|6
12594|NCT01965431|67937|P3|Overall Study|Other than stated above|6
12595|NCT01965431|67938|P2|Overall Study|Other than stated above|5
12596|NCT01965431|67939|P1|Overall Study|Other than stated above|6
12597|NCT01965431|67934|P6|Overall Study|Adverse Event|0
12598|NCT01965431|67935|P5|Overall Study|Adverse Event|0
12599|NCT01965431|67936|P4|Overall Study|Adverse Event|0
12600|NCT01965431|67937|P3|Overall Study|Adverse Event|0
12601|NCT01965431|67938|P2|Overall Study|Adverse Event|1
12602|NCT01965431|67939|P1|Overall Study|Adverse Event|0
12603|NCT01965327|67952|P1|Overall Study|Physician Decision|2
12604|NCT01965262|68166|P2|Second Intervention (7 Days)|Poor visual acuity|0
12605|NCT01965262|68167|P1|Second Intervention (7 Days)|Poor visual acuity|1
12606|NCT01965262|68166|P2|Second Intervention (7 Days)|Poor lens fit|9
12607|NCT01965262|68167|P1|Second Intervention (7 Days)|Poor lens fit|0
12608|NCT01965262|68166|P2|Second Intervention (7 Days)|Discontinued|1
12609|NCT01965262|68167|P1|Second Intervention (7 Days)|Discontinued|0
12610|NCT01965158|68231|P2|Overall Study|Other - Miscellaneous|0
12611|NCT01965158|68232|P1|Overall Study|Other - Miscellaneous|3
12612|NCT01965158|68231|P2|Overall Study|Protocol Violation|1
12613|NCT01965158|68232|P1|Overall Study|Protocol Violation|1
12614|NCT01965158|68231|P2|Overall Study|Lost to Follow-up|5
12615|NCT01965158|68232|P1|Overall Study|Lost to Follow-up|7
12616|NCT01965158|68231|P2|Overall Study|Withdrawal by Subject|24
12617|NCT01965158|68232|P1|Overall Study|Withdrawal by Subject|16
12618|NCT01965158|68231|P2|Overall Study|Adverse Event|5
12619|NCT01965158|68232|P1|Overall Study|Adverse Event|14
12620|NCT01964976|68267|P1|Overall Study|Protocol Violation|31
12621|NCT01964950|68281|P1|Overall Study|Protocol Violation|25
12622|NCT01964898|68295|P2|Overall Study|Withdrawal by Subject|0
12623|NCT01964898|68296|P1|Overall Study|Withdrawal by Subject|1
12624|NCT01964898|68295|P2|Overall Study|Lost to Follow-up|5
12625|NCT01964898|68296|P1|Overall Study|Lost to Follow-up|3
12626|NCT01964898|68295|P2|Overall Study|did not receive the allocated interventi|1
12627|NCT01964898|68296|P1|Overall Study|did not receive the allocated interventi|2
12628|NCT01964898|68295|P2|Overall Study|ineligible post-randomization|1
12629|NCT01964898|68296|P1|Overall Study|ineligible post-randomization|1
12630|NCT01964716|68318|P2|Overall Study|Death|0
12631|NCT01964716|68319|P1|Overall Study|Death|1
12632|NCT01964716|68318|P2|Overall Study|No longer met eligibility criteria|1
12633|NCT01964716|68319|P1|Overall Study|No longer met eligibility criteria|1
12634|NCT01964716|68318|P2|Overall Study|Lost to Follow-up|2
12635|NCT01964716|68319|P1|Overall Study|Lost to Follow-up|1
12636|NCT01964716|68318|P2|Overall Study|Withdrawal by Subject|3
12637|NCT01964716|68319|P1|Overall Study|Withdrawal by Subject|2
12638|NCT01964547|68357|P2|Overall Study|Withdrawal by Investigator|1
12639|NCT01964547|68358|P1|Overall Study|Withdrawal by Investigator|0
12640|NCT01964547|68357|P2|Overall Study|Lost to Follow-up|1
12641|NCT01964547|68358|P1|Overall Study|Lost to Follow-up|0
12642|NCT01964547|68357|P2|Overall Study|Withdrawal by Subject|7
12643|NCT01964547|68358|P1|Overall Study|Withdrawal by Subject|4
12644|NCT01964547|68357|P2|Overall Study|Adverse Event|2
12645|NCT01964547|68358|P1|Overall Study|Adverse Event|8
12646|NCT01964352|68386|P4|Overall Study|Other than stated above|2
12647|NCT01964352|68387|P3|Overall Study|Other than stated above|1
12648|NCT01964352|68388|P2|Overall Study|Other than stated above|2
12649|NCT01964352|68389|P1|Overall Study|Other than stated above|0
12650|NCT01964352|68386|P4|Overall Study|Withdrawal by Subject|0
12651|NCT01964352|68387|P3|Overall Study|Withdrawal by Subject|1
12652|NCT01964352|68388|P2|Overall Study|Withdrawal by Subject|2
12653|NCT01964352|68389|P1|Overall Study|Withdrawal by Subject|4
12654|NCT01964352|68386|P4|Overall Study|Lost to Follow-up|1
12655|NCT01964352|68387|P3|Overall Study|Lost to Follow-up|0
12656|NCT01964352|68388|P2|Overall Study|Lost to Follow-up|0
12658|NCT01964352|68386|P4|Overall Study|Protocol Violation|2
12659|NCT01964352|68387|P3|Overall Study|Protocol Violation|0
12660|NCT01964352|68388|P2|Overall Study|Protocol Violation|4
12661|NCT01964352|68389|P1|Overall Study|Protocol Violation|2
12662|NCT01964352|68386|P4|Overall Study|Lack of Efficacy|0
12663|NCT01964352|68387|P3|Overall Study|Lack of Efficacy|0
12664|NCT01964352|68388|P2|Overall Study|Lack of Efficacy|0
12665|NCT01964352|68389|P1|Overall Study|Lack of Efficacy|6
12666|NCT01964352|68386|P4|Overall Study|Adverse Event|3
12667|NCT01964352|68387|P3|Overall Study|Adverse Event|4
12668|NCT01964352|68388|P2|Overall Study|Adverse Event|3
12669|NCT01964352|68389|P1|Overall Study|Adverse Event|13
12670|NCT01964326|68419|P1|Overall Study|Did not meet eligibility criteria|1
12671|NCT01964326|68419|P1|Overall Study|Unspecified|9
12672|NCT01964326|68419|P1|Overall Study|Investigator Discretion|1
12673|NCT01964326|68419|P1|Overall Study|Physician Decision|55
12674|NCT01964326|68419|P1|Overall Study|No Longer Meets Eligibility Criteria|1
12675|NCT01964326|68419|P1|Overall Study|Pregnancy|1
12676|NCT01964326|68419|P1|Overall Study|Withdrawal by Subject|87
12677|NCT01964326|68419|P1|Overall Study|Lost to Follow-up|88
12678|NCT01964326|68419|P1|Overall Study|Protocol Violation|4
12679|NCT01964326|68419|P1|Overall Study|Death|2
12680|NCT01964326|68419|P1|Overall Study|Adverse Event|48
12681|NCT01964222|68428|P2|Overall Study|Screening Failure|0
12682|NCT01964222|68429|P1|Overall Study|Screening Failure|2
12683|NCT01964222|68428|P2|Overall Study|Withdrawal by Subject|6
12684|NCT01964222|68429|P1|Overall Study|Withdrawal by Subject|6
12685|NCT01964222|68428|P2|Overall Study|Lost to Follow-up|5
12686|NCT01964222|68429|P1|Overall Study|Lost to Follow-up|7
12687|NCT01963767|68462|P2|Overall Study|Adverse Event|0
12688|NCT01963767|68463|P1|Overall Study|Adverse Event|2
12689|NCT01963767|68462|P2|Overall Study|Withdrawal by Subject|2
12690|NCT01963767|68463|P1|Overall Study|Withdrawal by Subject|4
12691|NCT01963676|68473|P2|Overall Study|Withdrawal by Subject|0
12692|NCT01963676|68474|P1|Overall Study|Withdrawal by Subject|1
12693|NCT01963611|68487|P5|Overall Study|Unspecified|45
12694|NCT01963611|68488|P4|Overall Study|Unspecified|45
12695|NCT01963611|68489|P3|Overall Study|Unspecified|48
12696|NCT01963611|68490|P2|Overall Study|Unspecified|46
12697|NCT01963611|68491|P1|Overall Study|Unspecified|47
12698|NCT01963611|68487|P5|Overall Study|Withdrawal by Subject|3
12699|NCT01963611|68488|P4|Overall Study|Withdrawal by Subject|1
12700|NCT01963611|68489|P3|Overall Study|Withdrawal by Subject|1
12701|NCT01963611|68490|P2|Overall Study|Withdrawal by Subject|2
12702|NCT01963611|68491|P1|Overall Study|Withdrawal by Subject|3
12703|NCT01963611|68487|P5|Overall Study|Lack of Efficacy|0
12704|NCT01963611|68488|P4|Overall Study|Lack of Efficacy|1
12705|NCT01963611|68489|P3|Overall Study|Lack of Efficacy|0
12706|NCT01963611|68490|P2|Overall Study|Lack of Efficacy|0
12707|NCT01963611|68491|P1|Overall Study|Lack of Efficacy|0
12708|NCT01963611|68487|P5|Overall Study|Protocol Violation|0
12709|NCT01963611|68488|P4|Overall Study|Protocol Violation|1
12710|NCT01963611|68489|P3|Overall Study|Protocol Violation|0
12711|NCT01963611|68490|P2|Overall Study|Protocol Violation|0
12712|NCT01963611|68491|P1|Overall Study|Protocol Violation|0
12713|NCT01963611|68487|P5|Overall Study|Adverse Event|3
12714|NCT01963611|68488|P4|Overall Study|Adverse Event|4
12715|NCT01963611|68489|P3|Overall Study|Adverse Event|3
12716|NCT01963611|68490|P2|Overall Study|Adverse Event|1
12717|NCT01963611|68491|P1|Overall Study|Adverse Event|1
12718|NCT01963403|68550|P2|Overall Study|Implant removal|1
12719|NCT01963403|68551|P1|Overall Study|Implant removal|0
12720|NCT01963403|68550|P2|Overall Study|Lost to Follow-up|3
12721|NCT01963403|68551|P1|Overall Study|Lost to Follow-up|2
12722|NCT01963260|68573|P10|Overall Study|Withdrawal by Subject|0
12723|NCT01963260|68574|P9|Overall Study|Withdrawal by Subject|0
12724|NCT01963260|68575|P8|Overall Study|Withdrawal by Subject|0
12725|NCT01963260|68576|P7|Overall Study|Withdrawal by Subject|0
12726|NCT01963260|68577|P6|Overall Study|Withdrawal by Subject|0
12727|NCT01963260|68578|P5|Overall Study|Withdrawal by Subject|2
12728|NCT01963260|68579|P4|Overall Study|Withdrawal by Subject|1
12729|NCT01963260|68580|P3|Overall Study|Withdrawal by Subject|0
12730|NCT01963260|68581|P2|Overall Study|Withdrawal by Subject|0
12731|NCT01963260|68582|P1|Overall Study|Withdrawal by Subject|2
12732|NCT01962974|68662|P1|Overall Study|Study termination|7
12733|NCT01962922|68689|P2|Extendion Portion (up to Month 6)|Physician Decision|0
12734|NCT01962922|68690|P1|Extendion Portion (up to Month 6)|Physician Decision|1
12735|NCT01962922|68689|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
12736|NCT01962922|68690|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
12737|NCT01962922|68689|P2|PK Portion Day 7|non-compliance|0
12738|NCT01962922|68690|P1|PK Portion Day 7|non-compliance|1
12739|NCT01962922|68689|P2|PK Portion Day 7|Withdrawal by Subject|0
12740|NCT01962922|68690|P1|PK Portion Day 7|Withdrawal by Subject|3
12741|NCT01962493|68729|P2|Overall Study|Withdrawal by Subject|2
12742|NCT01962493|68730|P1|Overall Study|Withdrawal by Subject|4
12743|NCT01962493|68729|P2|Overall Study|Protocol Violation|1
12744|NCT01962493|68730|P1|Overall Study|Protocol Violation|0
12745|NCT01962493|68729|P2|Overall Study|Adverse Event|2
12746|NCT01962493|68730|P1|Overall Study|Adverse Event|1
12747|NCT01962441|68753|P3|Retreatment Substudy|Lost to Follow-up|0
12748|NCT01962441|68754|P2|Retreatment Substudy|Lost to Follow-up|0
12749|NCT01962441|68755|P1|Retreatment Substudy|Lost to Follow-up|1
12750|NCT01962441|68753|P3|Retreatment Substudy|Lack of Efficacy|0
12751|NCT01962441|68754|P2|Retreatment Substudy|Lack of Efficacy|0
12752|NCT01962441|68755|P1|Retreatment Substudy|Lack of Efficacy|1
12753|NCT01962441|68753|P3|Randomized Period|Protocol Violation|0
12754|NCT01962441|68754|P2|Randomized Period|Protocol Violation|1
12755|NCT01962441|68755|P1|Randomized Period|Protocol Violation|0
12756|NCT01962441|68753|P3|Randomized Period|Death|2
12757|NCT01962441|68754|P2|Randomized Period|Death|0
12758|NCT01962441|68755|P1|Randomized Period|Death|0
12759|NCT01962441|68753|P3|Randomized Period|Adverse Event|0
12760|NCT01962441|68754|P2|Randomized Period|Adverse Event|1
12761|NCT01962441|68755|P1|Randomized Period|Adverse Event|1
12762|NCT01962441|68753|P3|Randomized Period|Withdrew Consent|2
12763|NCT01962441|68754|P2|Randomized Period|Withdrew Consent|3
12764|NCT01962441|68755|P1|Randomized Period|Withdrew Consent|3
12765|NCT01962441|68753|P3|Randomized Period|Lost to Follow-up|4
12766|NCT01962441|68754|P2|Randomized Period|Lost to Follow-up|4
12767|NCT01962441|68755|P1|Randomized Period|Lost to Follow-up|2
12768|NCT01962441|68753|P3|Randomized Period|Randomized but Never Treated|3
12769|NCT01962441|68754|P2|Randomized Period|Randomized but Never Treated|2
12770|NCT01962441|68755|P1|Randomized Period|Randomized but Never Treated|4
12771|NCT01961544|68794|P1|Overall Study|Aggravation of Steral Pain|1
12772|NCT01961544|68794|P1|Overall Study|Poor Tolerance|1
12773|NCT01961544|68794|P1|Overall Study|Physician Decision|2
12774|NCT01961544|68794|P1|Overall Study|Adverse Event|1
12775|NCT01961544|68794|P1|Overall Study|Withdrawal by Subject|7
12776|NCT01961544|68794|P1|Overall Study|Protocol Violation|1
12777|NCT01961349|68802|P3|Overall Study|registration error, personal reason etc|1
12778|NCT01961349|68803|P2|Overall Study|registration error, personal reason etc|2
12779|NCT01961349|68804|P1|Overall Study|registration error, personal reason etc|2
12780|NCT01961349|68802|P3|Overall Study|Adverse Event|1
12781|NCT01961349|68803|P2|Overall Study|Adverse Event|0
12782|NCT01961349|68804|P1|Overall Study|Adverse Event|0
12783|NCT01961349|68802|P3|Overall Study|Withdrawal by Subject|0
12784|NCT01961349|68803|P2|Overall Study|Withdrawal by Subject|4
12785|NCT01961349|68804|P1|Overall Study|Withdrawal by Subject|1
12786|NCT01960907|68826|P2|Overall Study|Withdrawal by Subject|42
12787|NCT01960907|68827|P1|Overall Study|Withdrawal by Subject|32
12788|NCT01960907|68826|P2|Overall Study|Death|3
12789|NCT01960907|68827|P1|Overall Study|Death|4
12790|NCT01960842|68837|P1|Overall Study|Withdrawal by Subject|2
12791|NCT01960842|68837|P1|Overall Study|Adverse Event|1
12792|NCT01960816|68860|P1|Overall Study|Lost to Follow-up|1
12793|NCT01960725|68868|P2|Overall Study|unable to obtain blood sample|2
12794|NCT01960725|68869|P1|Overall Study|unable to obtain blood sample|1
12795|NCT01960725|68868|P2|Overall Study|Withdrawal by Subject|0
12796|NCT01960725|68869|P1|Overall Study|Withdrawal by Subject|1
12797|NCT01960725|68868|P2|Overall Study|Lost to Follow-up|3
12798|NCT01960725|68869|P1|Overall Study|Lost to Follow-up|4
12799|NCT01960296|68948|P2|Overall Study|Received different procedure|3
12800|NCT01960296|68949|P1|Overall Study|Received different procedure|1
12801|NCT01960296|68948|P2|Overall Study|Postponed surgery|0
12802|NCT01960296|68949|P1|Overall Study|Postponed surgery|1
12803|NCT01960140|68969|P1|Period 2 (Days 3-18)|Adverse Event|2
12804|NCT01960114|68980|P2|Overall Study|Could not swallow study medication|1
12805|NCT01960114|68981|P1|Overall Study|Could not swallow study medication|0
12806|NCT01960114|68980|P2|Overall Study|Adverse Event|0
12807|NCT01960114|68981|P1|Overall Study|Adverse Event|1
12808|NCT01959932|69027|P3|Overall Study|Withdrawal by Subject|0
12809|NCT01959932|69028|P2|Overall Study|Withdrawal by Subject|0
12810|NCT01959932|69029|P1|Overall Study|Withdrawal by Subject|1
12811|NCT01959880|69051|P4|Overall Study|Study completed early-FDA approved|152
12812|NCT01959880|69052|P3|Overall Study|Study completed early-FDA approved|179
12813|NCT01959880|69053|P2|Overall Study|Study completed early-FDA approved|311
12814|NCT01959880|69054|P1|Overall Study|Study completed early-FDA approved|1003
12815|NCT01959880|69051|P4|Overall Study|Explantation w/o study device reimplant.|12
12816|NCT01959880|69052|P3|Overall Study|Explantation w/o study device reimplant.|5
12817|NCT01959880|69053|P2|Overall Study|Explantation w/o study device reimplant.|17
12818|NCT01959880|69054|P1|Overall Study|Explantation w/o study device reimplant.|22
12819|NCT01959880|69051|P4|Overall Study|Lost to Follow-up|8
12820|NCT01959880|69052|P3|Overall Study|Lost to Follow-up|15
12821|NCT01959880|69053|P2|Overall Study|Lost to Follow-up|18
12822|NCT01959880|69054|P1|Overall Study|Lost to Follow-up|95
12823|NCT01959880|69051|P4|Overall Study|Death|2
12824|NCT01959880|69052|P3|Overall Study|Death|1
12825|NCT01959880|69053|P2|Overall Study|Death|10
12826|NCT01959880|69054|P1|Overall Study|Death|1
12827|NCT01959880|69051|P4|Overall Study|Withdrawal by Subject|7
12828|NCT01959880|69052|P3|Overall Study|Withdrawal by Subject|8
12829|NCT01959880|69053|P2|Overall Study|Withdrawal by Subject|13
12830|NCT01959880|69054|P1|Overall Study|Withdrawal by Subject|11
12831|NCT01959607|69083|P4|First Intervention (Day 1)|Withdrawal by Subject|0
12832|NCT01959607|69084|P3|First Intervention (Day 1)|Withdrawal by Subject|0
12833|NCT01959607|69085|P2|First Intervention (Day 1)|Withdrawal by Subject|1
12834|NCT01959607|69086|P1|First Intervention (Day 1)|Withdrawal by Subject|1
12835|NCT01959581|69093|P1|Overall Study|Lost to Follow-up|5
12836|NCT01959516|69097|P2|Epoch 2|Moderate or severe COPD exacerbation|1
12837|NCT01959516|69098|P1|Epoch 2|Moderate or severe COPD exacerbation|0
12838|NCT01959516|69097|P2|Epoch 2|Subject withdrew consent|0
12839|NCT01959516|69098|P1|Epoch 2|Subject withdrew consent|1
12840|NCT01959516|69097|P2|Epoch 2|unsatisfactory therapeutic effect|0
12841|NCT01959516|69098|P1|Epoch 2|unsatisfactory therapeutic effect|1
12842|NCT01959516|69097|P2|Epoch 1|Protocol deviation|1
12843|NCT01959516|69098|P1|Epoch 1|Protocol deviation|0
12844|NCT01959516|69097|P2|Epoch 1|Moderate or severe COPD exacerbation|1
12845|NCT01959516|69098|P1|Epoch 1|Moderate or severe COPD exacerbation|0
12846|NCT01959516|69097|P2|Epoch 1|Use of prohibited treatment|0
12847|NCT01959516|69098|P1|Epoch 1|Use of prohibited treatment|1
12848|NCT01959516|69097|P2|Epoch 1|Administrative problems|0
12849|NCT01959516|69098|P1|Epoch 1|Administrative problems|1
12850|NCT01959516|69097|P2|Epoch 1|Subject withdrew consent|2
12851|NCT01959516|69098|P1|Epoch 1|Subject withdrew consent|3
12852|NCT01959516|69097|P2|Epoch 1|unsatisfactory therapeutic effect|0
12853|NCT01959516|69098|P1|Epoch 1|unsatisfactory therapeutic effect|1
12854|NCT01959516|69097|P2|Epoch 1|Adverse Event|1
12855|NCT01959516|69098|P1|Epoch 1|Adverse Event|4
12856|NCT01959503|69108|P2|Overall Study|Randomized but not treated|1
12857|NCT01959503|69109|P1|Overall Study|Randomized but not treated|1
12858|NCT01959503|69108|P2|Overall Study|Death|1
12859|NCT01959503|69109|P1|Overall Study|Death|2
12860|NCT01959412|69129|P6|Overall Study|Adverse Event|0
12861|NCT01959412|69130|P5|Overall Study|Adverse Event|0
12862|NCT01959412|69131|P4|Overall Study|Adverse Event|1
12863|NCT01959412|69132|P3|Overall Study|Adverse Event|0
12864|NCT01959412|69133|P2|Overall Study|Adverse Event|0
12865|NCT01959412|69134|P1|Overall Study|Adverse Event|0
12866|NCT01959412|69129|P6|Overall Study|Protocol deviation|0
12867|NCT01959412|69130|P5|Overall Study|Protocol deviation|3
12868|NCT01959412|69131|P4|Overall Study|Protocol deviation|1
12869|NCT01959412|69132|P3|Overall Study|Protocol deviation|0
12870|NCT01959412|69133|P2|Overall Study|Protocol deviation|1
12871|NCT01959412|69134|P1|Overall Study|Protocol deviation|1
12872|NCT01959035|69172|P1|Overall Study|Other (no primary reason given)|1
12873|NCT01959035|69172|P1|Overall Study|Lost to Follow-up|1
12874|NCT01959035|69172|P1|Overall Study|Withdrawal by Subject|4
12875|NCT01959035|69172|P1|Overall Study|Adverse Event|5
12876|NCT01958827|69198|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
12877|NCT01958827|69198|P1|Overall Study|Lack of Efficacy|6
12878|NCT01958827|69198|P1|Overall Study|Adverse Event|3
12879|NCT01958619|69259|P4|Overall Study|Protocol Violation|0
12880|NCT01958619|69260|P3|Overall Study|Protocol Violation|1
12881|NCT01958619|69261|P2|Overall Study|Protocol Violation|0
12882|NCT01958619|69262|P1|Overall Study|Protocol Violation|2
12883|NCT01958164|69336|P2|Overall Study|Lost to Follow-up|3
12884|NCT01958164|69337|P1|Overall Study|Lost to Follow-up|2
12885|NCT01958164|69336|P2|Overall Study|Adverse Event|2
12886|NCT01958164|69337|P1|Overall Study|Adverse Event|0
12887|NCT01958060|69356|P6|Overall Study|Not treated|0
12888|NCT01958060|69357|P5|Overall Study|Not treated|1
12889|NCT01958060|69358|P4|Overall Study|Not treated|0
12890|NCT01958060|69359|P3|Overall Study|Not treated|0
12891|NCT01958060|69360|P2|Overall Study|Not treated|0
12892|NCT01958060|69361|P1|Overall Study|Not treated|2
12893|NCT01958021|69386|P2|Overall Study|Death|0
12894|NCT01958021|69387|P1|Overall Study|Death|2
12895|NCT01958021|69386|P2|Overall Study|Protocol Violation|1
12896|NCT01958021|69387|P1|Overall Study|Protocol Violation|3
12897|NCT01958021|69386|P2|Overall Study|Physician Decision|13
12898|NCT01958021|69387|P1|Overall Study|Physician Decision|10
12899|NCT01958021|69386|P2|Overall Study|Subject/guardian decision|13
12900|NCT01958021|69387|P1|Overall Study|Subject/guardian decision|12
12901|NCT01958021|69386|P2|Overall Study|Adverse Event|7
12902|NCT01958021|69387|P1|Overall Study|Adverse Event|25
12903|NCT01958021|69386|P2|Overall Study|Progressive disease|146
12904|NCT01958021|69387|P1|Overall Study|Progressive disease|87
12905|NCT01958008|69399|P4|Overall Study|Other adverse event|0
12906|NCT01958008|69400|P3|Overall Study|Other adverse event|0
12907|NCT01958008|69401|P2|Overall Study|Other adverse event|0
12908|NCT01958008|69402|P1|Overall Study|Other adverse event|1
12909|NCT01958008|69399|P4|Overall Study|Worsening of disease under study|0
12910|NCT01958008|69400|P3|Overall Study|Worsening of disease under study|1
12911|NCT01958008|69401|P2|Overall Study|Worsening of disease under study|0
12912|NCT01958008|69402|P1|Overall Study|Worsening of disease under study|0
12913|NCT01957865|69442|P3|Overall Study|Lost to Follow-up|2
12914|NCT01957865|69443|P2|Overall Study|Lost to Follow-up|2
12915|NCT01957865|69444|P1|Overall Study|Lost to Follow-up|0
12916|NCT01957865|69442|P3|Overall Study|Found HIV negative|1
12917|NCT01957865|69443|P2|Overall Study|Found HIV negative|0
12918|NCT01957865|69444|P1|Overall Study|Found HIV negative|0
12919|NCT01957579|69477|P4|Overall Study|Death|0
12920|NCT01957579|69478|P3|Overall Study|Death|2
12921|NCT01957579|69479|P2|Overall Study|Death|0
12922|NCT01957579|69480|P1|Overall Study|Death|0
12923|NCT01957579|69477|P4|Overall Study|Withdrawal of concent|0
12924|NCT01957579|69478|P3|Overall Study|Withdrawal of concent|0
12925|NCT01957579|69479|P2|Overall Study|Withdrawal of concent|1
12926|NCT01957579|69480|P1|Overall Study|Withdrawal of concent|0
12927|NCT01957553|69547|P2|Test Period 2 (21 +- 1 Days)|Other|0
12928|NCT01957553|69548|P1|Test Period 2 (21 +- 1 Days)|Other|1
12929|NCT01957553|69547|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
12930|NCT01957553|69548|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
12931|NCT01957553|69547|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
12932|NCT01957553|69548|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
12933|NCT01957553|69547|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
12934|NCT01957553|69548|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
12935|NCT01957553|69547|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
12936|NCT01957553|69548|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
12937|NCT01957553|69547|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
12938|NCT01957553|69548|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
12939|NCT01957553|69547|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
12940|NCT01957553|69548|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
12941|NCT01957553|69547|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
12942|NCT01957553|69548|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
12943|NCT01957553|69547|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
12944|NCT01957553|69548|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
12945|NCT01957488|69554|P6|Test Period 3|Lack of Efficacy|0
12946|NCT01957488|69555|P5|Test Period 3|Lack of Efficacy|0
12947|NCT01957488|69556|P4|Test Period 3|Lack of Efficacy|0
12948|NCT01957488|69557|P3|Test Period 3|Lack of Efficacy|0
12949|NCT01957488|69558|P2|Test Period 3|Lack of Efficacy|1
12950|NCT01957488|69559|P1|Test Period 3|Lack of Efficacy|0
12951|NCT01957488|69554|P6|Test Period 3|Withdrawal by Subject|0
12952|NCT01957488|69555|P5|Test Period 3|Withdrawal by Subject|0
12953|NCT01957488|69556|P4|Test Period 3|Withdrawal by Subject|0
12954|NCT01957488|69557|P3|Test Period 3|Withdrawal by Subject|0
12955|NCT01957488|69558|P2|Test Period 3|Withdrawal by Subject|0
12956|NCT01957488|69559|P1|Test Period 3|Withdrawal by Subject|1
12957|NCT01957488|69554|P6|Test Period 2|Discontinue due to personal problems|1
12958|NCT01957488|69555|P5|Test Period 2|Discontinue due to personal problems|0
12959|NCT01957488|69556|P4|Test Period 2|Discontinue due to personal problems|0
12960|NCT01957488|69557|P3|Test Period 2|Discontinue due to personal problems|0
12961|NCT01957488|69558|P2|Test Period 2|Discontinue due to personal problems|0
12962|NCT01957488|69559|P1|Test Period 2|Discontinue due to personal problems|0
12963|NCT01957488|69554|P6|Test Period 2|Adverse Event|0
12964|NCT01957488|69555|P5|Test Period 2|Adverse Event|2
12965|NCT01957488|69556|P4|Test Period 2|Adverse Event|0
12966|NCT01957488|69557|P3|Test Period 2|Adverse Event|0
12967|NCT01957488|69558|P2|Test Period 2|Adverse Event|0
12968|NCT01957488|69559|P1|Test Period 2|Adverse Event|0
12969|NCT01957488|69554|P6|Test Period 2|Withdrawal by Subject|0
12970|NCT01957488|69555|P5|Test Period 2|Withdrawal by Subject|0
12971|NCT01957488|69556|P4|Test Period 2|Withdrawal by Subject|0
12972|NCT01957488|69557|P3|Test Period 2|Withdrawal by Subject|0
12973|NCT01957488|69558|P2|Test Period 2|Withdrawal by Subject|1
12974|NCT01957488|69559|P1|Test Period 2|Withdrawal by Subject|0
12975|NCT01957488|69554|P6|Test Period 2|not known|0
12976|NCT01957488|69555|P5|Test Period 2|not known|0
12977|NCT01957488|69556|P4|Test Period 2|not known|0
12978|NCT01957488|69557|P3|Test Period 2|not known|0
12979|NCT01957488|69558|P2|Test Period 2|not known|0
12980|NCT01957488|69559|P1|Test Period 2|not known|1
12981|NCT01957488|69554|P6|Test Period 2|Protocol Violation|0
12982|NCT01957488|69555|P5|Test Period 2|Protocol Violation|0
12983|NCT01957488|69556|P4|Test Period 2|Protocol Violation|1
12984|NCT01957488|69557|P3|Test Period 2|Protocol Violation|1
12985|NCT01957488|69558|P2|Test Period 2|Protocol Violation|0
12986|NCT01957488|69559|P1|Test Period 2|Protocol Violation|2
12987|NCT01957488|69554|P6|Test Period 1|screen failure|1
12988|NCT01957488|69555|P5|Test Period 1|screen failure|0
12989|NCT01957488|69556|P4|Test Period 1|screen failure|0
12990|NCT01957488|69557|P3|Test Period 1|screen failure|0
12991|NCT01957488|69558|P2|Test Period 1|screen failure|0
12992|NCT01957488|69559|P1|Test Period 1|screen failure|0
12993|NCT01957488|69554|P6|Test Period 1|subject did not want to wait for cut bag|0
12994|NCT01957488|69555|P5|Test Period 1|subject did not want to wait for cut bag|1
12995|NCT01957488|69556|P4|Test Period 1|subject did not want to wait for cut bag|0
12996|NCT01957488|69557|P3|Test Period 1|subject did not want to wait for cut bag|0
12997|NCT01957488|69558|P2|Test Period 1|subject did not want to wait for cut bag|0
12998|NCT01957488|69559|P1|Test Period 1|subject did not want to wait for cut bag|0
12999|NCT01957488|69554|P6|Test Period 1|Withdrawal by Subject|2
13000|NCT01957488|69555|P5|Test Period 1|Withdrawal by Subject|1
13001|NCT01957488|69556|P4|Test Period 1|Withdrawal by Subject|1
13002|NCT01957488|69557|P3|Test Period 1|Withdrawal by Subject|0
13003|NCT01957488|69558|P2|Test Period 1|Withdrawal by Subject|0
13004|NCT01957488|69559|P1|Test Period 1|Withdrawal by Subject|0
13005|NCT01957488|69554|P6|Test Period 1|Adverse Event|0
13006|NCT01957488|69555|P5|Test Period 1|Adverse Event|1
13007|NCT01957488|69556|P4|Test Period 1|Adverse Event|0
13008|NCT01957488|69557|P3|Test Period 1|Adverse Event|1
13009|NCT01957488|69558|P2|Test Period 1|Adverse Event|1
13010|NCT01957488|69559|P1|Test Period 1|Adverse Event|0
13011|NCT01957488|69554|P6|Test Period 1|Protocol Violation|3
13012|NCT01957488|69555|P5|Test Period 1|Protocol Violation|0
13013|NCT01957488|69556|P4|Test Period 1|Protocol Violation|1
13014|NCT01957488|69557|P3|Test Period 1|Protocol Violation|2
13015|NCT01957488|69558|P2|Test Period 1|Protocol Violation|2
13016|NCT01957488|69559|P1|Test Period 1|Protocol Violation|1
13017|NCT01957488|69554|P6|Test Period 1|Lost to Follow-up|0
13018|NCT01957488|69555|P5|Test Period 1|Lost to Follow-up|0
13019|NCT01957488|69556|P4|Test Period 1|Lost to Follow-up|1
13020|NCT01957488|69557|P3|Test Period 1|Lost to Follow-up|1
13021|NCT01957488|69558|P2|Test Period 1|Lost to Follow-up|0
13022|NCT01957488|69559|P1|Test Period 1|Lost to Follow-up|2
13023|NCT01957475|69567|P2|Test Period 2|Adverse Event|0
13024|NCT01957475|69568|P1|Test Period 2|Adverse Event|1
13025|NCT01957475|69567|P2|Test Period 1|Lack of Efficacy|1
13026|NCT01957475|69568|P1|Test Period 1|Lack of Efficacy|0
13027|NCT01957475|69567|P2|Test Period 1|Other|0
13028|NCT01957475|69568|P1|Test Period 1|Other|1
13029|NCT01957475|69567|P2|Test Period 1|Withdrawal by Subject|0
13030|NCT01957475|69568|P1|Test Period 1|Withdrawal by Subject|1
13031|NCT01957462|69574|P2|Test Period 1|Adverse Event|0
13032|NCT01957462|69575|P1|Test Period 1|Adverse Event|1
13033|NCT01957462|69574|P2|Test Period 1|Withdrawal by Subject|0
13034|NCT01957462|69575|P1|Test Period 1|Withdrawal by Subject|1
13035|NCT01957397|69586|P2|Test Period 3|the adhesive did not work|0
13036|NCT01957397|69587|P1|Test Period 3|the adhesive did not work|1
13037|NCT01957397|69586|P2|Test Period 3|Adverse Event|2
13038|NCT01957397|69587|P1|Test Period 3|Adverse Event|1
13039|NCT01957397|69586|P2|Test Period 2|Adverse Event|1
13040|NCT01957397|69587|P1|Test Period 2|Adverse Event|0
13041|NCT01957397|69586|P2|Test Period 1|Withdrawal by Subject|0
13042|NCT01957397|69587|P1|Test Period 1|Withdrawal by Subject|1
13043|NCT01957397|69586|P2|Test Period 1|sudden leakage/small bag|1
13044|NCT01957397|69587|P1|Test Period 1|sudden leakage/small bag|1
13045|NCT01957215|69612|P2|Overall Study|Withdrawal by Subject|5
13046|NCT01957215|69613|P1|Overall Study|Withdrawal by Subject|7
13047|NCT01957215|69612|P2|Overall Study|Protocol Violation|2
13048|NCT01957215|69613|P1|Overall Study|Protocol Violation|1
13049|NCT01957215|69612|P2|Overall Study|Lost to Follow-up|3
13050|NCT01957215|69613|P1|Overall Study|Lost to Follow-up|3
13051|NCT01957215|69612|P2|Overall Study|Adverse Event|2
13052|NCT01957215|69613|P1|Overall Study|Adverse Event|2
13053|NCT01957202|69641|P18|Treatment Period 3 (8 Days)|Adverse Event|0
13054|NCT01957202|69642|P17|Treatment Period 3 (8 Days)|Adverse Event|1
13055|NCT01957202|69643|P16|Treatment Period 3 (8 Days)|Adverse Event|0
13056|NCT01957202|69644|P15|Treatment Period 3 (8 Days)|Adverse Event|0
13057|NCT01957202|69645|P14|Treatment Period 3 (8 Days)|Adverse Event|0
13058|NCT01957202|69646|P13|Treatment Period 3 (8 Days)|Adverse Event|0
13059|NCT01957202|69647|P12|Treatment Period 3 (8 Days)|Adverse Event|0
13060|NCT01957202|69648|P11|Treatment Period 3 (8 Days)|Adverse Event|0
13061|NCT01957202|69649|P10|Treatment Period 3 (8 Days)|Adverse Event|0
13062|NCT01957202|69650|P9|Treatment Period 3 (8 Days)|Adverse Event|0
13063|NCT01957202|69651|P8|Treatment Period 3 (8 Days)|Adverse Event|0
13064|NCT01957202|69652|P7|Treatment Period 3 (8 Days)|Adverse Event|0
13065|NCT01957202|69653|P6|Treatment Period 3 (8 Days)|Adverse Event|0
13066|NCT01957202|69654|P5|Treatment Period 3 (8 Days)|Adverse Event|0
13067|NCT01957202|69655|P4|Treatment Period 3 (8 Days)|Adverse Event|0
13068|NCT01957202|69656|P3|Treatment Period 3 (8 Days)|Adverse Event|0
13069|NCT01957202|69657|P2|Treatment Period 3 (8 Days)|Adverse Event|0
13070|NCT01957202|69658|P1|Treatment Period 3 (8 Days)|Adverse Event|0
13071|NCT01957202|69641|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13072|NCT01957202|69642|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
13073|NCT01957202|69643|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13074|NCT01957202|69644|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13075|NCT01957202|69645|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13076|NCT01957202|69646|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13077|NCT01957202|69647|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13078|NCT01957202|69648|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13079|NCT01957202|69649|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13080|NCT01957202|69650|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13081|NCT01957202|69651|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13082|NCT01957202|69652|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13083|NCT01957202|69653|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13084|NCT01957202|69654|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13085|NCT01957202|69655|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13086|NCT01957202|69656|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13087|NCT01957202|69657|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
13088|NCT01957202|69658|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
13089|NCT01957163|69683|P3|Overall Study|Withdrawal by Subject|4
13090|NCT01957163|69684|P2|Overall Study|Withdrawal by Subject|2
13091|NCT01957163|69685|P1|Overall Study|Withdrawal by Subject|4
13092|NCT01957163|69683|P3|Overall Study|Lost to Follow-up|0
13093|NCT01957163|69684|P2|Overall Study|Lost to Follow-up|1
13094|NCT01957163|69685|P1|Overall Study|Lost to Follow-up|0
13095|NCT01957163|69683|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
13096|NCT01957163|69684|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
13097|NCT01957163|69685|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
13098|NCT01957163|69683|P3|Overall Study|Protocol Violation|0
13099|NCT01957163|69684|P2|Overall Study|Protocol Violation|2
13100|NCT01957163|69685|P1|Overall Study|Protocol Violation|1
13101|NCT01957163|69683|P3|Overall Study|Lack of Efficacy|9
13102|NCT01957163|69684|P2|Overall Study|Lack of Efficacy|4
13103|NCT01957163|69685|P1|Overall Study|Lack of Efficacy|5
13104|NCT01957163|69683|P3|Overall Study|Adverse Event|4
13105|NCT01957163|69684|P2|Overall Study|Adverse Event|2
13106|NCT01957163|69685|P1|Overall Study|Adverse Event|5
13107|NCT01957137|69696|P1|Randomized Portion|Withdrawal by Subject|1
13108|NCT01957137|69696|P1|Randomized Portion|Adverse Event|1
13109|NCT01957111|69726|P2|Overall Study|Withdrawal by Subject|1
13110|NCT01957111|69727|P1|Overall Study|Withdrawal by Subject|1
13111|NCT01956240|69737|P2|Overall Study|Adverse Event|4
13112|NCT01956240|69738|P1|Overall Study|Adverse Event|17
13113|NCT01956240|69737|P2|Overall Study|Lost to Follow-up|20
13114|NCT01956240|69738|P1|Overall Study|Lost to Follow-up|6
13115|NCT01955707|69888|P2|Overall Study|Not Specified|2
13116|NCT01955707|69889|P1|Overall Study|Not Specified|4
13117|NCT01955707|69888|P2|Overall Study|Death|14
13118|NCT01955707|69889|P1|Overall Study|Death|13
13119|NCT01955707|69888|P2|Overall Study|Withdrawal by Subject|3
13120|NCT01955707|69889|P1|Overall Study|Withdrawal by Subject|0
13121|NCT01955707|69888|P2|Overall Study|Lost to Follow-up|1
13122|NCT01955707|69889|P1|Overall Study|Lost to Follow-up|2
13123|NCT01955707|69888|P2|Overall Study|Adverse Event|2
13124|NCT01955707|69889|P1|Overall Study|Adverse Event|1
13125|NCT01955122|70137|P2|Overall Study|Physician Decision|5
13126|NCT01955122|70138|P1|Overall Study|Physician Decision|5
13127|NCT01955083|70158|P2|Overall Study|Lost to Follow-up|1
13128|NCT01955083|70159|P1|Overall Study|Lost to Follow-up|1
13129|NCT01955044|70192|P3|Overall Study|Death|0
13130|NCT01955044|70193|P2|Overall Study|Death|1
13131|NCT01955044|70194|P1|Overall Study|Death|1
13132|NCT01955005|70207|P2|Overall Study|Withdrawal by Subject|5
13133|NCT01955005|70208|P1|Overall Study|Withdrawal by Subject|3
13134|NCT01954771|70221|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
13135|NCT01954771|70222|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
13136|NCT01954771|70223|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
13137|NCT01954771|70221|P3|Overall Study|Missing CGMS of end-point|0
13138|NCT01954771|70222|P2|Overall Study|Missing CGMS of end-point|1
13139|NCT01954771|70223|P1|Overall Study|Missing CGMS of end-point|1
13140|NCT01954771|70221|P3|Overall Study|Missing HbA1c of end-point|0
13141|NCT01954771|70222|P2|Overall Study|Missing HbA1c of end-point|1
13142|NCT01954771|70223|P1|Overall Study|Missing HbA1c of end-point|1
13143|NCT01954745|70240|P1|Overall Study|Death|1
13144|NCT01954745|70240|P1|Overall Study|Adverse Event|2
13145|NCT01954745|70240|P1|Overall Study|Clinical Progression|5
13146|NCT01954745|70240|P1|Overall Study|Radiological Progression|11
13147|NCT01954251|70271|P2|Overall Study|Withdrawal by Subject|6
13148|NCT01954251|70272|P1|Overall Study|Withdrawal by Subject|2
13149|NCT01954251|70271|P2|Overall Study|Lost to Follow-up|6
13150|NCT01954251|70272|P1|Overall Study|Lost to Follow-up|6
13151|NCT01954251|70271|P2|Overall Study|Adverse Event|7
13152|NCT01954251|70272|P1|Overall Study|Adverse Event|5
13153|NCT01954121|70369|P2|Overall Study|Subject did not follow instructions|2
13154|NCT01954121|70370|P1|Overall Study|Subject did not follow instructions|0
13155|NCT01954121|70369|P2|Overall Study|Non-compliant patient|1
13156|NCT01954121|70370|P1|Overall Study|Non-compliant patient|1
13157|NCT01954121|70369|P2|Overall Study|Non-compliant with study procedures|0
13158|NCT01954121|70370|P1|Overall Study|Non-compliant with study procedures|1
13159|NCT01954121|70369|P2|Overall Study|SAE, non-fatal|4
13160|NCT01954121|70370|P1|Overall Study|SAE, non-fatal|1
13161|NCT01954121|70369|P2|Overall Study|AE, non-serious non-fatal|22
13162|NCT01954121|70370|P1|Overall Study|AE, non-serious non-fatal|5
13163|NCT01954121|70369|P2|Overall Study|AE, serious fatal|0
13164|NCT01954121|70370|P1|Overall Study|AE, serious fatal|1
13165|NCT01954121|70369|P2|Overall Study|Pregnancy|1
13166|NCT01954121|70370|P1|Overall Study|Pregnancy|1
13167|NCT01954121|70369|P2|Overall Study|Withdrawal by Subject|12
13168|NCT01954121|70370|P1|Overall Study|Withdrawal by Subject|18
13169|NCT01954121|70369|P2|Overall Study|Lost to Follow-up|6
13170|NCT01954121|70370|P1|Overall Study|Lost to Follow-up|5
13171|NCT01954121|70369|P2|Overall Study|Protocol Violation|2
13172|NCT01954121|70370|P1|Overall Study|Protocol Violation|0
13173|NCT01954121|70369|P2|Overall Study|Lack of Efficacy|41
13174|NCT01954121|70370|P1|Overall Study|Lack of Efficacy|94
13175|NCT01953354|70386|P2|Overall Study|Disease Exacerbation|0
13176|NCT01953354|70387|P1|Overall Study|Disease Exacerbation|1
13177|NCT01953354|70386|P2|Overall Study|Decision of Sponsor|1
13178|NCT01953354|70387|P1|Overall Study|Decision of Sponsor|0
13179|NCT01953354|70386|P2|Overall Study|Withdrawal by Subject|1
13180|NCT01953354|70387|P1|Overall Study|Withdrawal by Subject|0
13181|NCT01953328|70415|P8|Overall Study|Lost to Follow-up|0
13182|NCT01953328|70416|P7|Overall Study|Lost to Follow-up|0
13183|NCT01953328|70417|P6|Overall Study|Lost to Follow-up|0
13184|NCT01953328|70418|P5|Overall Study|Lost to Follow-up|1
13185|NCT01953328|70419|P4|Overall Study|Lost to Follow-up|0
13186|NCT01953328|70420|P3|Overall Study|Lost to Follow-up|0
13187|NCT01953328|70421|P2|Overall Study|Lost to Follow-up|0
13188|NCT01953328|70422|P1|Overall Study|Lost to Follow-up|0
13189|NCT01953328|70415|P8|Overall Study|Withdrawal by Subject|0
13190|NCT01953328|70416|P7|Overall Study|Withdrawal by Subject|0
13191|NCT01953328|70417|P6|Overall Study|Withdrawal by Subject|0
13192|NCT01953328|70418|P5|Overall Study|Withdrawal by Subject|1
13193|NCT01953328|70419|P4|Overall Study|Withdrawal by Subject|0
13194|NCT01953328|70420|P3|Overall Study|Withdrawal by Subject|0
13195|NCT01953328|70421|P2|Overall Study|Withdrawal by Subject|0
13196|NCT01953328|70422|P1|Overall Study|Withdrawal by Subject|0
13197|NCT01952834|70652|P1|Overall Study|Adverse Event|1
13198|NCT01952691|70659|P1|Overall Study|Lost to Follow-up|2
13199|NCT01952665|70667|P2|Overall Study|Protocol Violation|1
13200|NCT01952665|70668|P1|Overall Study|Protocol Violation|0
13201|NCT01952665|70667|P2|Overall Study|Adverse Event|1
13202|NCT01952665|70668|P1|Overall Study|Adverse Event|2
13203|NCT01952665|70667|P2|Overall Study|Lost to Follow-up|2
13204|NCT01952665|70668|P1|Overall Study|Lost to Follow-up|1
13205|NCT01952665|70667|P2|Overall Study|Physician Decision|2
13206|NCT01952665|70668|P1|Overall Study|Physician Decision|3
13207|NCT01952366|70834|P1|Overall Study|Withdrawal by Subject|9
13208|NCT01952366|70834|P1|Overall Study|Death|22
13209|NCT01952145|70848|P2|Overall Study|Unclassified|1
13210|NCT01952145|70849|P1|Overall Study|Unclassified|1
13211|NCT01952145|70848|P2|Overall Study|Withdrawal Criteria|11
13212|NCT01952145|70849|P1|Overall Study|Withdrawal Criteria|16
13213|NCT01952145|70848|P2|Overall Study|Adverse Event|0
13214|NCT01952145|70849|P1|Overall Study|Adverse Event|9
13215|NCT01952145|70848|P2|Overall Study|Death|1
13216|NCT01952145|70849|P1|Overall Study|Death|0
13217|NCT01952145|70848|P2|Overall Study|Protocol Violation|1
13218|NCT01952145|70849|P1|Overall Study|Protocol Violation|2
13219|NCT01952080|70863|P4|Overall Study|Protocol Non-compliance|0
13220|NCT01952080|70864|P3|Overall Study|Protocol Non-compliance|0
13221|NCT01952080|70865|P2|Overall Study|Protocol Non-compliance|1
13222|NCT01952080|70866|P1|Overall Study|Protocol Non-compliance|0
13223|NCT01952080|70863|P4|Overall Study|Withdrawal by Subject|1
13224|NCT01952080|70864|P3|Overall Study|Withdrawal by Subject|0
13225|NCT01952080|70865|P2|Overall Study|Withdrawal by Subject|0
13226|NCT01952080|70866|P1|Overall Study|Withdrawal by Subject|0
13227|NCT01951703|70932|P2|Second Intervention|Unsatisfactory Lens fitting|1
13228|NCT01951703|70933|P1|Second Intervention|Unsatisfactory Lens fitting|0
13229|NCT01951703|70932|P2|Second Intervention|Protocol Violation|1
13230|NCT01951703|70933|P1|Second Intervention|Protocol Violation|0
13231|NCT01951703|70932|P2|First Intervention|Physician Decision|0
13232|NCT01951703|70933|P1|First Intervention|Physician Decision|1
13233|NCT01951703|70932|P2|First Intervention|Subject was not compliant|1
13234|NCT01951703|70933|P1|First Intervention|Subject was not compliant|1
13235|NCT01951703|70932|P2|First Intervention|Withdrawal by Subject|0
13236|NCT01951703|70933|P1|First Intervention|Withdrawal by Subject|1
13237|NCT01951586|70958|P2|Overall Study|Withdrawal by Subject|13
13238|NCT01951586|70959|P1|Overall Study|Withdrawal by Subject|7
13239|NCT01951586|70958|P2|Overall Study|Death|100
13240|NCT01951586|70959|P1|Overall Study|Death|52
13241|NCT01951573|70983|P2|Washout Period|Adverse Event|1
13242|NCT01951573|70984|P1|Washout Period|Adverse Event|0
13243|NCT01951417|70994|P1|Overall Study|Lost to Follow-up|6
13244|NCT01951417|70994|P1|Overall Study|Protocol Violation|2
13245|NCT01951417|70994|P1|Overall Study|Withdrawal by Subject|1
13246|NCT01951170|71017|P1|Overall Study|Investigator decision|1
13247|NCT01951092|71040|P1|Overall Study|Transfer of Care|1
13248|NCT01951092|71040|P1|Overall Study|Incarceration|1
13249|NCT01951092|71040|P1|Overall Study|Lost to Follow-up|10
13250|NCT01950741|71051|P1|Overall Study|Withdrawal by Subject|1
13251|NCT01950741|71051|P1|Overall Study|Death|1
13252|NCT01950741|71051|P1|Overall Study|Lost to Follow-up|1
13253|NCT01950364|71066|P2|Overall Study|Protocol Violation|1
13254|NCT01950364|71067|P1|Overall Study|Protocol Violation|0
13255|NCT01950364|71066|P2|Overall Study|Withdrawal by Subject|1
13256|NCT01950364|71067|P1|Overall Study|Withdrawal by Subject|0
13257|NCT01950364|71066|P2|Overall Study|Disease Progression|2
13258|NCT01950364|71067|P1|Overall Study|Disease Progression|5
13259|NCT01950364|71066|P2|Overall Study|Stem Cell Transplant|6
13260|NCT01950364|71067|P1|Overall Study|Stem Cell Transplant|2
13261|NCT01950364|71066|P2|Overall Study|Adverse Event|0
13262|NCT01950364|71067|P1|Overall Study|Adverse Event|3
13263|NCT01949870|71176|P1|Overall Study|Eligibility requirements not fulfilled|2
13264|NCT01949870|71176|P1|Overall Study|Study termination|1
13265|NCT01949870|71176|P1|Overall Study|Adverse Event|1
13266|NCT01949870|71176|P1|Overall Study|Lack of Efficacy|2
13267|NCT01949532|71335|P2|Overall Study|On-study at the Data Cut-off Date|3
13268|NCT01949532|71336|P1|Overall Study|On-study at the Data Cut-off Date|3
13269|NCT01949155|71411|P2|Overall Study|Protocol Violation|0
13270|NCT01949155|71412|P1|Overall Study|Protocol Violation|1
13271|NCT01949155|71411|P2|Overall Study|Lost to Follow-up|0
13272|NCT01949155|71412|P1|Overall Study|Lost to Follow-up|1
13273|NCT01949142|71424|P2|Overall Study|Parent changed their mind|0
13274|NCT01949142|71425|P1|Overall Study|Parent changed their mind|1
13275|NCT01949142|71424|P2|Overall Study|Lost to Follow-up|1
13276|NCT01949142|71425|P1|Overall Study|Lost to Follow-up|1
13277|NCT01949142|71424|P2|Overall Study|Withdrawal of consent|0
13278|NCT01949142|71425|P1|Overall Study|Withdrawal of consent|1
13279|NCT01949051|71435|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
13280|NCT01949051|71436|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
13281|NCT01949051|71437|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
13282|NCT01949051|71438|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
13283|NCT01949051|71439|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
13284|NCT01949051|71440|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
13285|NCT01949051|71435|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
13286|NCT01949051|71436|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
13287|NCT01949051|71437|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
13288|NCT01949051|71438|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
13289|NCT01949051|71439|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
13290|NCT01949051|71440|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
13291|NCT01949051|71435|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
13292|NCT01949051|71436|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
13293|NCT01949051|71437|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
13294|NCT01949051|71438|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
13295|NCT01949051|71439|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
13296|NCT01949051|71440|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
13297|NCT01949051|71435|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
13298|NCT01949051|71436|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
13299|NCT01949051|71437|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
13300|NCT01949051|71438|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
13301|NCT01949051|71439|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
13302|NCT01949051|71440|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
13303|NCT01949051|71435|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
13304|NCT01949051|71436|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
13305|NCT01949051|71437|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
13306|NCT01949051|71438|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
13307|NCT01949051|71439|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
13308|NCT01949051|71440|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
13309|NCT01948908|71454|P3|Overall Study|Protocol Violation|2
13310|NCT01948908|71455|P2|Overall Study|Protocol Violation|0
13311|NCT01948908|71456|P1|Overall Study|Protocol Violation|1
13312|NCT01948830|71472|P2|Overall Study|Death|4
13313|NCT01948830|71473|P1|Overall Study|Death|3
13314|NCT01948830|71472|P2|Overall Study|Adverse Event|2
13315|NCT01948830|71473|P1|Overall Study|Adverse Event|9
13316|NCT01948830|71472|P2|Overall Study|Withdrawal by Subject|17
13317|NCT01948830|71473|P1|Overall Study|Withdrawal by Subject|14
13318|NCT01948830|71472|P2|Overall Study|Lost to Follow-up|4
13319|NCT01948830|71473|P1|Overall Study|Lost to Follow-up|5
13320|NCT01948830|71472|P2|Overall Study|Protocol deviation|2
13321|NCT01948830|71473|P1|Overall Study|Protocol deviation|1
13322|NCT01948830|71472|P2|Overall Study|Physician Decision|3
13323|NCT01948830|71473|P1|Overall Study|Physician Decision|1
13324|NCT01948791|71505|P1|Overall Study|Screening failure|35
13325|NCT01948791|71505|P1|Overall Study|Others|7
13326|NCT01948791|71505|P1|Overall Study|Management issues|1
13327|NCT01948791|71505|P1|Overall Study|Lost to Follow-up|6
13328|NCT01948791|71505|P1|Overall Study|Withdrawal by Subject|5
13329|NCT01948791|71505|P1|Overall Study|Protocol Violation|2
13330|NCT01948791|71505|P1|Overall Study|Lack of Efficacy|3
13331|NCT01948791|71505|P1|Overall Study|Adverse Event|12
13332|NCT01948193|71535|P1|Overall Study|Lost to Follow-up|7
13333|NCT01948193|71535|P1|Overall Study|Serious event|2
13334|NCT01948076|71557|P2|Overall Study|Withdrawal by Subject|1
13335|NCT01948076|71558|P1|Overall Study|Withdrawal by Subject|0
13336|NCT01948063|71568|P2|Overall Study|Blood samples were accidentally thawed|0
13337|NCT01948063|71569|P1|Overall Study|Blood samples were accidentally thawed|1
13338|NCT01948063|71568|P2|Overall Study|Discovered an enrollment in other study|1
13339|NCT01948063|71569|P1|Overall Study|Discovered an enrollment in other study|0
13340|NCT01948063|71568|P2|Overall Study|Boston MCI halted research protocol|1
13341|NCT01948063|71569|P1|Overall Study|Boston MCI halted research protocol|0
13342|NCT01948050|71577|P2|Overall Study|Withdrawal by Subject|1
13343|NCT01948050|71578|P1|Overall Study|Withdrawal by Subject|0
13344|NCT01947855|71646|P3|Overall Study|Withdrawal by Subject|0
13345|NCT01947855|71647|P2|Overall Study|Withdrawal by Subject|0
13346|NCT01947855|71648|P1|Overall Study|Withdrawal by Subject|1
13347|NCT01947582|71656|P1|Overall Study|Withdrawal by Subject|1
13348|NCT01947517|71665|P2|Overall Study|Withdrawal by Subject|1
13349|NCT01947517|71666|P1|Overall Study|Withdrawal by Subject|1
13350|NCT01947491|71684|P4|Overall Study|Adverse Event|2
13351|NCT01947491|71685|P3|Overall Study|Adverse Event|0
13352|NCT01947491|71686|P2|Overall Study|Adverse Event|1
13353|NCT01947491|71687|P1|Overall Study|Adverse Event|0
13354|NCT01947491|71684|P4|Overall Study|Worsening of condition|0
13355|NCT01947491|71685|P3|Overall Study|Worsening of condition|0
13356|NCT01947491|71686|P2|Overall Study|Worsening of condition|1
13357|NCT01947491|71687|P1|Overall Study|Worsening of condition|0
13358|NCT01947491|71684|P4|Overall Study|Withdrawal by Subject|0
13359|NCT01947491|71685|P3|Overall Study|Withdrawal by Subject|1
13360|NCT01947491|71686|P2|Overall Study|Withdrawal by Subject|1
13361|NCT01947491|71687|P1|Overall Study|Withdrawal by Subject|1
13362|NCT01947491|71684|P4|Overall Study|Protocol Violation|0
13363|NCT01947491|71685|P3|Overall Study|Protocol Violation|0
13364|NCT01947491|71686|P2|Overall Study|Protocol Violation|0
13365|NCT01947491|71687|P1|Overall Study|Protocol Violation|1
13366|NCT01947491|71684|P4|Overall Study|Lack of Efficacy|1
13367|NCT01947491|71685|P3|Overall Study|Lack of Efficacy|0
13368|NCT01947491|71686|P2|Overall Study|Lack of Efficacy|0
13369|NCT01947491|71687|P1|Overall Study|Lack of Efficacy|1
13370|NCT01947491|71684|P4|Overall Study|Lost to Follow-up|2
13371|NCT01947491|71685|P3|Overall Study|Lost to Follow-up|1
13372|NCT01947491|71686|P2|Overall Study|Lost to Follow-up|3
13373|NCT01947491|71687|P1|Overall Study|Lost to Follow-up|5
13374|NCT01947127|71731|P2|Overall Study|Data loss|4
13375|NCT01947127|71732|P1|Overall Study|Data loss|4
13376|NCT01947127|71731|P2|Overall Study|Withdrawal by Subject|1
13377|NCT01947127|71732|P1|Overall Study|Withdrawal by Subject|1
13378|NCT01947127|71731|P2|Overall Study|Protocol Violation|38
13379|NCT01947127|71732|P1|Overall Study|Protocol Violation|18
13380|NCT01946529|71756|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
13381|NCT01946529|71757|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
13382|NCT01946529|71758|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
13383|NCT01946529|71756|P3|End of Window Therapy (2 Courses)|Physician Decision|0
13384|NCT01946529|71757|P2|End of Window Therapy (2 Courses)|Physician Decision|1
13385|NCT01946529|71758|P1|End of Window Therapy (2 Courses)|Physician Decision|0
13386|NCT01946438|71769|P4|Overall Study|Withdrawal by Subject|0
13387|NCT01946438|71770|P3|Overall Study|Withdrawal by Subject|0
13388|NCT01946438|71771|P2|Overall Study|Withdrawal by Subject|0
13389|NCT01946438|71772|P1|Overall Study|Withdrawal by Subject|1
13390|NCT01946438|71769|P4|Overall Study|Protocol Violation|0
13391|NCT01946438|71770|P3|Overall Study|Protocol Violation|1
13392|NCT01946438|71771|P2|Overall Study|Protocol Violation|0
13393|NCT01946438|71772|P1|Overall Study|Protocol Violation|0
13394|NCT01946438|71769|P4|Overall Study|Serious Adverse event|0
13395|NCT01946438|71770|P3|Overall Study|Serious Adverse event|0
13396|NCT01946438|71771|P2|Overall Study|Serious Adverse event|0
13397|NCT01946438|71772|P1|Overall Study|Serious Adverse event|1
13398|NCT01946438|71769|P4|Overall Study|Adverse Event|1
13399|NCT01946438|71770|P3|Overall Study|Adverse Event|0
13400|NCT01946438|71771|P2|Overall Study|Adverse Event|0
13401|NCT01946438|71772|P1|Overall Study|Adverse Event|0
13402|NCT01946425|71800|P2|Overall Study|Withdrawal by Subject|0
13403|NCT01946425|71801|P1|Overall Study|Withdrawal by Subject|1
13404|NCT01946425|71800|P2|Overall Study|Protocol Violation|0
13405|NCT01946425|71801|P1|Overall Study|Protocol Violation|1
13406|NCT01946412|71815|P1|Overall Study|Difficulty in swallowing|1
13407|NCT01946412|71815|P1|Overall Study|Continued with commercial Kalydeco|2
13408|NCT01946412|71815|P1|Overall Study|Non-Compliance|1
13409|NCT01946412|71815|P1|Overall Study|Adverse Event|1
13410|NCT01946178|71858|P1|Overall Study|Lost to Follow-up|1
13411|NCT01946178|71858|P1|Overall Study|Pregnancy|1
13412|NCT01945944|71927|P2|Overall Study|Withdrawal by Subject|1
13413|NCT01945944|71928|P1|Overall Study|Withdrawal by Subject|0
13414|NCT01945944|71927|P2|Overall Study|Physician Decision|0
13415|NCT01945944|71928|P1|Overall Study|Physician Decision|1
13416|NCT01945944|71927|P2|Overall Study|Adverse Event|2
13417|NCT01945944|71928|P1|Overall Study|Adverse Event|0
13418|NCT01945242|71987|P2|Overall Study|Physician Decision|3
13419|NCT01945242|71988|P1|Overall Study|Physician Decision|3
13420|NCT01945086|72046|P3|Overall Study|Adverse Event|1
13421|NCT01945086|72047|P2|Overall Study|Adverse Event|0
13422|NCT01945086|72048|P1|Overall Study|Adverse Event|0
13423|NCT01945086|72046|P3|Overall Study|Withdrawal by Subject|1
13424|NCT01945086|72047|P2|Overall Study|Withdrawal by Subject|0
13425|NCT01945086|72048|P1|Overall Study|Withdrawal by Subject|1
13426|NCT01945034|72092|P3|Overall Study|Protocol Violation|1
13427|NCT01945034|72093|P2|Overall Study|Protocol Violation|0
13428|NCT01945034|72094|P1|Overall Study|Protocol Violation|1
13429|NCT01945034|72092|P3|Overall Study|Lost to Follow-up|2
13430|NCT01945034|72093|P2|Overall Study|Lost to Follow-up|0
13431|NCT01945034|72094|P1|Overall Study|Lost to Follow-up|0
13432|NCT01945034|72092|P3|Overall Study|Unspecified|3
13433|NCT01945034|72093|P2|Overall Study|Unspecified|1
13434|NCT01945034|72094|P1|Overall Study|Unspecified|0
13435|NCT01945034|72092|P3|Overall Study|Withdrawal by Subject|1
13436|NCT01945034|72093|P2|Overall Study|Withdrawal by Subject|3
13437|NCT01945034|72094|P1|Overall Study|Withdrawal by Subject|0
13438|NCT01945034|72092|P3|Overall Study|Medication Error|0
13439|NCT01945034|72093|P2|Overall Study|Medication Error|1
13440|NCT01945034|72094|P1|Overall Study|Medication Error|0
13441|NCT01945021|72144|P1|Overall Study|Non-RECIST disease progression|1
13442|NCT01945021|72144|P1|Overall Study|Withdrawal of consent|3
13443|NCT01945021|72144|P1|Overall Study|Withdrawal by Subject|2
13444|NCT01945021|72144|P1|Overall Study|Global deterioration of health-related s|1
13445|NCT01945021|72144|P1|Overall Study|Disease progression by RECIST v1.1|30
13446|NCT01945021|72144|P1|Overall Study|Pregnancy|1
13447|NCT01945021|72144|P1|Overall Study|Death|1
13448|NCT01945021|72144|P1|Overall Study|Adverse Event|8
13449|NCT01944969|72158|P1|Overall Study|Administrative or other reasons|23
13450|NCT01944969|72158|P1|Overall Study|Non-compliance with IMP|1
13451|NCT01944969|72158|P1|Overall Study|Lack of Efficacy|1
13452|NCT01944969|72158|P1|Overall Study|Adverse Event|1
13453|NCT01944774|72183|P3|Overall Study|Lost to Follow-up|0
13454|NCT01944774|72184|P2|Overall Study|Lost to Follow-up|1
13455|NCT01944774|72185|P1|Overall Study|Lost to Follow-up|0
13456|NCT01944774|72183|P3|Overall Study|Lack of Efficacy|2
13457|NCT01944774|72184|P2|Overall Study|Lack of Efficacy|2
13458|NCT01944774|72185|P1|Overall Study|Lack of Efficacy|1
13459|NCT01944774|72183|P3|Overall Study|Adverse Event|3
13460|NCT01944774|72184|P2|Overall Study|Adverse Event|2
13461|NCT01944774|72185|P1|Overall Study|Adverse Event|3
13462|NCT01944774|72183|P3|Overall Study|Withdrawal by Subject|3
13463|NCT01944774|72184|P2|Overall Study|Withdrawal by Subject|3
13464|NCT01944774|72185|P1|Overall Study|Withdrawal by Subject|2
13465|NCT01944670|72226|P1|Overall Study|Lost to Follow-up|2
13466|NCT01944631|72233|P2|Overall Study|Withdrawal by Subject|1
13467|NCT01944631|72234|P1|Overall Study|Withdrawal by Subject|0
13468|NCT01944631|72233|P2|Overall Study|Lost to Follow-up|1
13469|NCT01944631|72234|P1|Overall Study|Lost to Follow-up|3
13470|NCT01944631|72233|P2|Overall Study|Adverse Event|0
13471|NCT01944631|72234|P1|Overall Study|Adverse Event|1
13472|NCT01944059|72269|P1|Overall Study|Adverse Event|2
13473|NCT01944059|72269|P1|Overall Study|Withdrawal by Subject|1
13474|NCT01944059|72269|P1|Overall Study|Physician Decision|3
13475|NCT01944059|72269|P1|Overall Study|Lost to Follow-up|1
13476|NCT01943552|72342|P2|Overall Study|Other Reasons|17
13477|NCT01943552|72343|P1|Overall Study|Other Reasons|16
13478|NCT01943552|72342|P2|Overall Study|Withdrawal by Subject|6
13479|NCT01943552|72343|P1|Overall Study|Withdrawal by Subject|6
13480|NCT01943552|72342|P2|Overall Study|Adverse Event|2
13481|NCT01943552|72343|P1|Overall Study|Adverse Event|3
13482|NCT01943435|72386|P3|6 Month Follow up|Lost to Follow-up|15
13483|NCT01943435|72387|P2|6 Month Follow up|Lost to Follow-up|7
13484|NCT01943435|72388|P1|6 Month Follow up|Lost to Follow-up|12
13485|NCT01943435|72386|P3|2 Month Follow up|Lost to Follow-up|0
13486|NCT01943435|72387|P2|2 Month Follow up|Lost to Follow-up|3
13487|NCT01943435|72388|P1|2 Month Follow up|Lost to Follow-up|2
13488|NCT01943435|72386|P3|Intervention Period|Withdrawal by Subject|4
13489|NCT01943435|72387|P2|Intervention Period|Withdrawal by Subject|3
13490|NCT01943435|72388|P1|Intervention Period|Withdrawal by Subject|3
13491|NCT01943292|72409|P3|Overall Study|Withdrawal by Subject|0
13492|NCT01943292|72410|P2|Overall Study|Withdrawal by Subject|0
13493|NCT01943292|72411|P1|Overall Study|Withdrawal by Subject|1
13494|NCT01942785|72438|P1|Overall Study|Protocol Violation|1
13495|NCT01942785|72438|P1|Overall Study|Withdrawal by Subject|1
13496|NCT01942785|72438|P1|Overall Study|Adverse Event|2
13497|NCT01942733|72467|P1|Overall Study|Administrative|1
13498|NCT01942733|72467|P1|Overall Study|Non-compliance with IMP|1
13499|NCT01942733|72467|P1|Overall Study|Lost to Follow-up|1
13500|NCT01942161|72520|P3|Overall Study|Withdrawal by Subject|1
13501|NCT01942161|72521|P2|Overall Study|Withdrawal by Subject|3
13502|NCT01942161|72522|P1|Overall Study|Withdrawal by Subject|3
13503|NCT01942161|72520|P3|Overall Study|Protocol Violation|0
13504|NCT01942161|72521|P2|Overall Study|Protocol Violation|0
13505|NCT01942161|72522|P1|Overall Study|Protocol Violation|1
13506|NCT01942161|72520|P3|Overall Study|Physician Decision|0
13507|NCT01942161|72521|P2|Overall Study|Physician Decision|1
13508|NCT01942161|72522|P1|Overall Study|Physician Decision|3
13509|NCT01942161|72520|P3|Overall Study|Adverse Event|5
13510|NCT01942161|72521|P2|Overall Study|Adverse Event|2
13511|NCT01942161|72522|P1|Overall Study|Adverse Event|1
13512|NCT01942148|72542|P1|Overall Study|Use of the prohibition medicine|1
13513|NCT01942148|72542|P1|Overall Study|Withdrawal by Subject|8
13514|NCT01942148|72542|P1|Overall Study|Protocol Violation|1
13515|NCT01942148|72542|P1|Overall Study|Physician Decision|11
13516|NCT01942148|72542|P1|Overall Study|Lack of Efficacy|2
13517|NCT01942148|72542|P1|Overall Study|Adverse Event|4
13518|NCT01942135|72550|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
13519|NCT01942135|72551|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
13520|NCT01942135|72550|P2|Overall Study|Withdrawal by Subject|2
13521|NCT01942135|72551|P1|Overall Study|Withdrawal by Subject|4
13522|NCT01942135|72550|P2|Overall Study|Participant Refused toContinue Treatment|1
13523|NCT01942135|72551|P1|Overall Study|Participant Refused toContinue Treatment|1
13524|NCT01942135|72550|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
13525|NCT01942135|72551|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
13526|NCT01942135|72550|P2|Overall Study|Death|1
13527|NCT01942135|72551|P1|Overall Study|Death|0
13528|NCT01942135|72550|P2|Overall Study|Randomized Not Treated|2
13529|NCT01942135|72551|P1|Overall Study|Randomized Not Treated|2
13530|NCT01942135|72550|P2|Overall Study|Global deterioration of health status|3
13531|NCT01942135|72551|P1|Overall Study|Global deterioration of health status|8
13532|NCT01942135|72550|P2|Overall Study|Adverse Event|3
13533|NCT01942135|72551|P1|Overall Study|Adverse Event|9
13534|NCT01941940|72588|P1|Overall Study|Other|1
13535|NCT01941940|72588|P1|Overall Study|Unspecified|1
13536|NCT01941940|72588|P1|Overall Study|Death|1
13537|NCT01941940|72588|P1|Overall Study|Withdrawal by Subject|15
13538|NCT01941940|72588|P1|Overall Study|Physician Decision|2
13539|NCT01941940|72588|P1|Overall Study|Lost to Follow-up|2
13540|NCT01941940|72588|P1|Overall Study|Adverse Event|11
13541|NCT01941498|72637|P1|Overall Study|Relocated out of state|1
13542|NCT01941186|72755|P2|Follow-up|Lost to Follow-up|0
13543|NCT01941186|72756|P1|Follow-up|Lost to Follow-up|1
13544|NCT01940497|72826|P2|Overall Study|Ongoing at data cut-off|117
13545|NCT01940497|72827|P1|Overall Study|Ongoing at data cut-off|116
13546|NCT01940497|72826|P2|Overall Study|Withdrawal by Subject|0
13547|NCT01940497|72827|P1|Overall Study|Withdrawal by Subject|2
13548|NCT01940497|72826|P2|Overall Study|Protocol Violation|0
13549|NCT01940497|72827|P1|Overall Study|Protocol Violation|1
13550|NCT01940497|72826|P2|Overall Study|Failure to return|1
13551|NCT01940497|72827|P1|Overall Study|Failure to return|0
13552|NCT01940497|72826|P2|Overall Study|Adverse event/Intercurrent illness|0
13553|NCT01940497|72827|P1|Overall Study|Adverse event/Intercurrent illness|1
13554|NCT01940484|72866|P1|Overall Study|Adverse Event|1
13555|NCT01940484|72866|P1|Overall Study|Death|2
13556|NCT01940484|72866|P1|Overall Study|Underwent transplantation|4
13557|NCT01940484|72866|P1|Overall Study|Withdrawal by Subject|3
13558|NCT01940471|72886|P2|Open-Label Extension|Still on Open-Label Treatment|8
13559|NCT01940471|72887|P1|Open-Label Extension|Still on Open-Label Treatment|14
13560|NCT01940471|72886|P2|Double-Blind Phase|Still on Double-Blind Treatment|270
13561|NCT01940471|72887|P1|Double-Blind Phase|Still on Double-Blind Treatment|537
13562|NCT01940471|72886|P2|Double-Blind Phase|HBsAg Seroconversion|0
13563|NCT01940471|72887|P1|Double-Blind Phase|HBsAg Seroconversion|1
13564|NCT01940471|72886|P2|Double-Blind Phase|Protocol Violation|1
13565|NCT01940471|72887|P1|Double-Blind Phase|Protocol Violation|0
13566|NCT01940471|72886|P2|Double-Blind Phase|Lack of Efficacy|0
13567|NCT01940471|72887|P1|Double-Blind Phase|Lack of Efficacy|1
13568|NCT01940471|72886|P2|Double-Blind Phase|Death|0
13569|NCT01940471|72887|P1|Double-Blind Phase|Death|1
13570|NCT01940471|72886|P2|Double-Blind Phase|Protocol-Specified Criteria|0
13571|NCT01940471|72887|P1|Double-Blind Phase|Protocol-Specified Criteria|2
13572|NCT01940471|72886|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
13573|NCT01940471|72887|P1|Double-Blind Phase|Non-Compliance with Study Drug|2
13574|NCT01940471|72886|P2|Double-Blind Phase|Investigator's Discretion|1
13575|NCT01940471|72887|P1|Double-Blind Phase|Investigator's Discretion|2
13576|NCT01940471|72886|P2|Double-Blind Phase|Pregnancy|1
13577|NCT01940471|72887|P1|Double-Blind Phase|Pregnancy|2
13578|NCT01940471|72886|P2|Double-Blind Phase|Lost to Follow-up|2
13579|NCT01940471|72887|P1|Double-Blind Phase|Lost to Follow-up|2
13580|NCT01940471|72886|P2|Double-Blind Phase|Adverse Event|3
13581|NCT01940471|72887|P1|Double-Blind Phase|Adverse Event|6
13582|NCT01940471|72886|P2|Double-Blind Phase|Withdrew Consent|5
13583|NCT01940471|72887|P1|Double-Blind Phase|Withdrew Consent|11
13584|NCT01940471|72886|P2|Double-Blind Phase|Randomized but Never Treated|1
13585|NCT01940471|72887|P1|Double-Blind Phase|Randomized but Never Treated|1
13586|NCT01940341|72905|P2|Open-label Extension Phase|Still on Study|1
13587|NCT01940341|72906|P1|Open-label Extension Phase|Still on Study|4
13588|NCT01940341|72905|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
13589|NCT01940341|72906|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
13590|NCT01940341|72905|P2|Double-Blind Phase|Protocol Specified Criteria|0
13591|NCT01940341|72906|P1|Double-Blind Phase|Protocol Specified Criteria|1
13592|NCT01940341|72905|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
13593|NCT01940341|72906|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
13594|NCT01940341|72905|P2|Double-Blind Phase|Investigator's Discretion|0
13595|NCT01940341|72906|P1|Double-Blind Phase|Investigator's Discretion|1
13596|NCT01940341|72905|P2|Double-Blind Phase|Pregnancy|1
13597|NCT01940341|72906|P1|Double-Blind Phase|Pregnancy|0
13598|NCT01940341|72905|P2|Double-Blind Phase|Lost to Follow-up|1
13599|NCT01940341|72906|P1|Double-Blind Phase|Lost to Follow-up|4
13600|NCT01940341|72905|P2|Double-Blind Phase|Withdrew Consent|2
13601|NCT01940341|72906|P1|Double-Blind Phase|Withdrew Consent|3
13602|NCT01940341|72905|P2|Double-Blind Phase|Adverse Event|2
13603|NCT01940341|72906|P1|Double-Blind Phase|Adverse Event|3
13604|NCT01940341|72905|P2|Double-Blind Phase|Randomized but Never Treated|1
13605|NCT01940341|72906|P1|Double-Blind Phase|Randomized but Never Treated|0
13606|NCT01940120|72937|P1|Overall Study|Lost to Follow-up|4
13607|NCT01940120|72937|P1|Overall Study|Withdrawal by Subject|7
13608|NCT01940120|72937|P1|Overall Study|Death|33
13609|NCT01939548|73067|P3|Overall Study|Did not complete follow-up|0
13610|NCT01939548|73068|P2|Overall Study|Did not complete follow-up|1
13611|NCT01939548|73069|P1|Overall Study|Did not complete follow-up|0
13612|NCT01939548|73067|P3|Overall Study|Participant withdrew consent|0
13613|NCT01939548|73068|P2|Overall Study|Participant withdrew consent|2
13614|NCT01939548|73069|P1|Overall Study|Participant withdrew consent|0
13615|NCT01939548|73067|P3|Overall Study|Participant unwilling to continue|0
13616|NCT01939548|73068|P2|Overall Study|Participant unwilling to continue|1
13617|NCT01939548|73069|P1|Overall Study|Participant unwilling to continue|0
13618|NCT01939548|73067|P3|Overall Study|Participant dropped|1
13619|NCT01939548|73068|P2|Overall Study|Participant dropped|0
13620|NCT01939548|73069|P1|Overall Study|Participant dropped|0
13621|NCT01939548|73067|P3|Overall Study|Death|1
13622|NCT01939548|73068|P2|Overall Study|Death|0
13623|NCT01939548|73069|P1|Overall Study|Death|0
13624|NCT01939548|73067|P3|Overall Study|Adverse Event|7
13625|NCT01939548|73068|P2|Overall Study|Adverse Event|9
13626|NCT01939548|73069|P1|Overall Study|Adverse Event|2
13627|NCT01939548|73067|P3|Overall Study|Lost to Follow-up|3
13628|NCT01939548|73068|P2|Overall Study|Lost to Follow-up|5
13629|NCT01939548|73069|P1|Overall Study|Lost to Follow-up|5
13630|NCT01939548|73067|P3|Overall Study|Protocol Violation|5
13631|NCT01939548|73068|P2|Overall Study|Protocol Violation|6
13632|NCT01939548|73069|P1|Overall Study|Protocol Violation|7
13633|NCT01939548|73067|P3|Overall Study|Withdrawal by Subject|1
13634|NCT01939548|73068|P2|Overall Study|Withdrawal by Subject|4
13635|NCT01939548|73069|P1|Overall Study|Withdrawal by Subject|4
13636|NCT01939548|73067|P3|Overall Study|Did Not Meet Entrance Criteria|0
13637|NCT01939548|73068|P2|Overall Study|Did Not Meet Entrance Criteria|0
13638|NCT01939548|73069|P1|Overall Study|Did Not Meet Entrance Criteria|1
13639|NCT01939548|73067|P3|Overall Study|Insufficient Clinical Response|0
13640|NCT01939548|73068|P2|Overall Study|Insufficient Clinical Response|0
13641|NCT01939548|73069|P1|Overall Study|Insufficient Clinical Response|1
13642|NCT01939548|73067|P3|Overall Study|Study Terminated by Sponsor|12
13643|NCT01939548|73068|P2|Overall Study|Study Terminated by Sponsor|19
13644|NCT01939548|73069|P1|Overall Study|Study Terminated by Sponsor|17
13645|NCT01939548|73067|P3|Overall Study|Non compliance|0
13646|NCT01939548|73068|P2|Overall Study|Non compliance|2
13647|NCT01939548|73069|P1|Overall Study|Non compliance|0
13648|NCT01939496|73143|P3|Overall Study|Unspecified|1
13649|NCT01939496|73144|P2|Overall Study|Unspecified|0
13650|NCT01939496|73145|P1|Overall Study|Unspecified|2
13651|NCT01939496|73143|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
13652|NCT01939496|73144|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
13653|NCT01939496|73145|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
13654|NCT01939496|73143|P3|Overall Study|Withdrawal by Subject|1
13655|NCT01939496|73144|P2|Overall Study|Withdrawal by Subject|1
13656|NCT01939496|73145|P1|Overall Study|Withdrawal by Subject|0
13657|NCT01939496|73143|P3|Overall Study|Protocol Violation|0
13658|NCT01939496|73144|P2|Overall Study|Protocol Violation|0
13659|NCT01939496|73145|P1|Overall Study|Protocol Violation|3
13660|NCT01939496|73143|P3|Overall Study|Physician Decision|0
13661|NCT01939496|73144|P2|Overall Study|Physician Decision|0
13662|NCT01939496|73145|P1|Overall Study|Physician Decision|1
13663|NCT01939496|73143|P3|Overall Study|Lost to Follow-up|0
13664|NCT01939496|73144|P2|Overall Study|Lost to Follow-up|1
13665|NCT01939496|73145|P1|Overall Study|Lost to Follow-up|1
13666|NCT01939496|73143|P3|Overall Study|Adverse Event|0
13667|NCT01939496|73144|P2|Overall Study|Adverse Event|0
13668|NCT01939496|73145|P1|Overall Study|Adverse Event|2
13669|NCT01939314|73197|P2|Overall Study|Lost to Follow-up|6
13670|NCT01939314|73198|P1|Overall Study|Lost to Follow-up|5
13671|NCT01939314|73197|P2|Overall Study|Pregnancy|1
13672|NCT01939314|73198|P1|Overall Study|Pregnancy|0
13673|NCT01939314|73197|P2|Overall Study|Protocol Violation|0
13674|NCT01939314|73198|P1|Overall Study|Protocol Violation|1
13675|NCT01939314|73197|P2|Overall Study|Withdrawal by Subject|1
13676|NCT01939314|73198|P1|Overall Study|Withdrawal by Subject|3
13677|NCT01939002|73221|P2|Overall Study|Not Specified|2
13678|NCT01939002|73222|P1|Overall Study|Not Specified|1
13679|NCT01939002|73221|P2|Overall Study|Withdrawal by Subject|3
13680|NCT01939002|73222|P1|Overall Study|Withdrawal by Subject|5
13681|NCT01939002|73221|P2|Overall Study|Adverse Event|13
13682|NCT01939002|73222|P1|Overall Study|Adverse Event|13
13683|NCT01938430|73309|P14|Overall Study|Withdrew Consent|0
13684|NCT01938430|73310|P13|Overall Study|Withdrew Consent|0
13685|NCT01938430|73311|P12|Overall Study|Withdrew Consent|0
13686|NCT01938430|73312|P11|Overall Study|Withdrew Consent|0
13687|NCT01938430|73313|P10|Overall Study|Withdrew Consent|0
13688|NCT01938430|73314|P9|Overall Study|Withdrew Consent|1
13689|NCT01938430|73315|P8|Overall Study|Withdrew Consent|0
13690|NCT01938430|73316|P7|Overall Study|Withdrew Consent|0
13691|NCT01938430|73317|P6|Overall Study|Withdrew Consent|0
13692|NCT01938430|73318|P5|Overall Study|Withdrew Consent|0
13693|NCT01938430|73319|P4|Overall Study|Withdrew Consent|0
13694|NCT01938430|73320|P3|Overall Study|Withdrew Consent|0
13695|NCT01938430|73321|P2|Overall Study|Withdrew Consent|0
13696|NCT01938430|73322|P1|Overall Study|Withdrew Consent|0
13697|NCT01938430|73309|P14|Overall Study|Lost to Follow-up|0
13698|NCT01938430|73310|P13|Overall Study|Lost to Follow-up|0
13699|NCT01938430|73311|P12|Overall Study|Lost to Follow-up|0
13700|NCT01938430|73312|P11|Overall Study|Lost to Follow-up|0
13701|NCT01938430|73313|P10|Overall Study|Lost to Follow-up|0
13702|NCT01938430|73314|P9|Overall Study|Lost to Follow-up|0
13703|NCT01938430|73315|P8|Overall Study|Lost to Follow-up|0
13704|NCT01938430|73316|P7|Overall Study|Lost to Follow-up|0
13705|NCT01938430|73317|P6|Overall Study|Lost to Follow-up|1
13706|NCT01938430|73318|P5|Overall Study|Lost to Follow-up|0
13707|NCT01938430|73319|P4|Overall Study|Lost to Follow-up|0
13708|NCT01938430|73320|P3|Overall Study|Lost to Follow-up|1
13709|NCT01938430|73321|P2|Overall Study|Lost to Follow-up|0
13710|NCT01938430|73322|P1|Overall Study|Lost to Follow-up|0
13711|NCT01938430|73309|P14|Overall Study|Lack of Efficacy|0
13712|NCT01938430|73310|P13|Overall Study|Lack of Efficacy|0
13713|NCT01938430|73311|P12|Overall Study|Lack of Efficacy|1
13714|NCT01938430|73312|P11|Overall Study|Lack of Efficacy|2
13715|NCT01938430|73313|P10|Overall Study|Lack of Efficacy|0
13716|NCT01938430|73314|P9|Overall Study|Lack of Efficacy|1
13717|NCT01938430|73315|P8|Overall Study|Lack of Efficacy|0
13718|NCT01938430|73316|P7|Overall Study|Lack of Efficacy|0
13719|NCT01938430|73317|P6|Overall Study|Lack of Efficacy|0
13720|NCT01938430|73318|P5|Overall Study|Lack of Efficacy|0
13721|NCT01938430|73319|P4|Overall Study|Lack of Efficacy|1
13722|NCT01938430|73320|P3|Overall Study|Lack of Efficacy|1
13723|NCT01938430|73321|P2|Overall Study|Lack of Efficacy|1
13724|NCT01938430|73322|P1|Overall Study|Lack of Efficacy|3
13725|NCT01938430|73309|P14|Overall Study|Investigator's Discretion|0
13726|NCT01938430|73310|P13|Overall Study|Investigator's Discretion|0
13727|NCT01938430|73311|P12|Overall Study|Investigator's Discretion|0
13728|NCT01938430|73312|P11|Overall Study|Investigator's Discretion|0
13729|NCT01938430|73313|P10|Overall Study|Investigator's Discretion|0
13730|NCT01938430|73314|P9|Overall Study|Investigator's Discretion|0
13731|NCT01938430|73315|P8|Overall Study|Investigator's Discretion|0
13732|NCT01938430|73316|P7|Overall Study|Investigator's Discretion|0
13733|NCT01938430|73317|P6|Overall Study|Investigator's Discretion|0
13734|NCT01938430|73318|P5|Overall Study|Investigator's Discretion|0
13735|NCT01938430|73319|P4|Overall Study|Investigator's Discretion|0
13736|NCT01938430|73320|P3|Overall Study|Investigator's Discretion|1
13737|NCT01938430|73321|P2|Overall Study|Investigator's Discretion|0
13738|NCT01938430|73322|P1|Overall Study|Investigator's Discretion|0
13739|NCT01938430|73309|P14|Overall Study|Death|0
13740|NCT01938430|73310|P13|Overall Study|Death|0
13741|NCT01938430|73311|P12|Overall Study|Death|0
13742|NCT01938430|73312|P11|Overall Study|Death|0
13743|NCT01938430|73313|P10|Overall Study|Death|3
13744|NCT01938430|73314|P9|Overall Study|Death|2
13745|NCT01938430|73315|P8|Overall Study|Death|1
13746|NCT01938430|73316|P7|Overall Study|Death|1
13747|NCT01938430|73317|P6|Overall Study|Death|0
13748|NCT01938430|73318|P5|Overall Study|Death|0
13749|NCT01938430|73319|P4|Overall Study|Death|1
13750|NCT01938430|73320|P3|Overall Study|Death|2
13751|NCT01938430|73321|P2|Overall Study|Death|2
13752|NCT01938430|73322|P1|Overall Study|Death|1
13753|NCT01938430|73309|P14|Overall Study|Adverse Event|0
13754|NCT01938430|73310|P13|Overall Study|Adverse Event|0
13755|NCT01938430|73311|P12|Overall Study|Adverse Event|0
13756|NCT01938430|73312|P11|Overall Study|Adverse Event|0
13757|NCT01938430|73313|P10|Overall Study|Adverse Event|0
13758|NCT01938430|73314|P9|Overall Study|Adverse Event|0
13759|NCT01938430|73315|P8|Overall Study|Adverse Event|0
13760|NCT01938430|73316|P7|Overall Study|Adverse Event|1
13761|NCT01938430|73317|P6|Overall Study|Adverse Event|0
13762|NCT01938430|73318|P5|Overall Study|Adverse Event|0
13763|NCT01938430|73319|P4|Overall Study|Adverse Event|0
13764|NCT01938430|73320|P3|Overall Study|Adverse Event|0
13765|NCT01938430|73321|P2|Overall Study|Adverse Event|0
13766|NCT01938430|73322|P1|Overall Study|Adverse Event|0
13767|NCT01938430|73309|P14|Overall Study|Randomized but Not Treated|1
13768|NCT01938430|73310|P13|Overall Study|Randomized but Not Treated|0
13769|NCT01938430|73311|P12|Overall Study|Randomized but Not Treated|0
13770|NCT01938430|73312|P11|Overall Study|Randomized but Not Treated|1
13771|NCT01938430|73313|P10|Overall Study|Randomized but Not Treated|0
13772|NCT01938430|73314|P9|Overall Study|Randomized but Not Treated|0
13773|NCT01938430|73315|P8|Overall Study|Randomized but Not Treated|0
13774|NCT01938430|73316|P7|Overall Study|Randomized but Not Treated|0
13775|NCT01938430|73317|P6|Overall Study|Randomized but Not Treated|0
13776|NCT01938430|73318|P5|Overall Study|Randomized but Not Treated|0
13777|NCT01938430|73319|P4|Overall Study|Randomized but Not Treated|0
13778|NCT01938430|73320|P3|Overall Study|Randomized but Not Treated|0
13779|NCT01938430|73321|P2|Overall Study|Randomized but Not Treated|0
13780|NCT01938430|73322|P1|Overall Study|Randomized but Not Treated|0
13781|NCT01938391|73647|P1|12 Month Follow up|Withdrawal by Subject|1
13782|NCT01938391|73647|P1|12 Month Follow up|Physician Decision|1
13783|NCT01938391|73647|P1|6 Month Follow up|Withdrawal by Subject|1
13784|NCT01937871|73766|P3|Overall Study|Entry Criteria Not Met|1
13785|NCT01937871|73767|P2|Overall Study|Entry Criteria Not Met|2
13786|NCT01937871|73768|P1|Overall Study|Entry Criteria Not Met|1
13787|NCT01937871|73766|P3|Overall Study|Physician Decision|0
13788|NCT01937871|73767|P2|Overall Study|Physician Decision|1
13789|NCT01937871|73768|P1|Overall Study|Physician Decision|0
13790|NCT01937871|73766|P3|Overall Study|Withdrawal by Subject|4
13791|NCT01937871|73767|P2|Overall Study|Withdrawal by Subject|6
13792|NCT01937871|73768|P1|Overall Study|Withdrawal by Subject|9
13793|NCT01937871|73766|P3|Overall Study|Lost to Follow-up|4
13794|NCT01937871|73767|P2|Overall Study|Lost to Follow-up|2
13795|NCT01937871|73768|P1|Overall Study|Lost to Follow-up|8
13796|NCT01937871|73766|P3|Overall Study|Adverse Event|2
13797|NCT01937871|73767|P2|Overall Study|Adverse Event|6
13798|NCT01937871|73768|P1|Overall Study|Adverse Event|6
13799|NCT01937715|73844|P5|Overall Study|Unspecified|0
13800|NCT01937715|73845|P4|Overall Study|Unspecified|3
13801|NCT01937715|73846|P3|Overall Study|Unspecified|0
13802|NCT01937715|73847|P2|Overall Study|Unspecified|0
13803|NCT01937715|73848|P1|Overall Study|Unspecified|0
13804|NCT01937715|73844|P5|Overall Study|Withdrawal by Subject|2
13805|NCT01937715|73845|P4|Overall Study|Withdrawal by Subject|0
13806|NCT01937715|73846|P3|Overall Study|Withdrawal by Subject|0
13807|NCT01937715|73847|P2|Overall Study|Withdrawal by Subject|1
13808|NCT01937715|73848|P1|Overall Study|Withdrawal by Subject|0
13809|NCT01937715|73844|P5|Overall Study|Death|0
13810|NCT01937715|73845|P4|Overall Study|Death|1
13811|NCT01937715|73846|P3|Overall Study|Death|0
13812|NCT01937715|73847|P2|Overall Study|Death|0
13813|NCT01937715|73848|P1|Overall Study|Death|0
13814|NCT01937364|74034|P2|Overall Study|Adverse Event|1
13815|NCT01937364|74035|P1|Overall Study|Adverse Event|2
13816|NCT01937351|74047|P2|Overall Study|Not treated w device, per protocol fail|0
13817|NCT01937351|74048|P1|Overall Study|Not treated w device, per protocol fail|4
13818|NCT01937351|74047|P2|Overall Study|Death|0
13819|NCT01937351|74048|P1|Overall Study|Death|1
13820|NCT01937351|74047|P2|Overall Study|Withdrawal by Subject|2
13821|NCT01937351|74048|P1|Overall Study|Withdrawal by Subject|4
13822|NCT01937312|74056|P2|Overall Study|Withdrawal of subject prior to treatment|1
13823|NCT01937312|74057|P1|Overall Study|Withdrawal of subject prior to treatment|1
13824|NCT01937312|74056|P2|Overall Study|Lack of Efficacy|1
13825|NCT01937312|74057|P1|Overall Study|Lack of Efficacy|0
13826|NCT01937312|74056|P2|Overall Study|Adverse Event|1
13827|NCT01937312|74057|P1|Overall Study|Adverse Event|10
13828|NCT01937299|74072|P2|Overall Study|Withdrawal by Subject|0
13829|NCT01937299|74073|P1|Overall Study|Withdrawal by Subject|1
13830|NCT01937299|74072|P2|Overall Study|Lack of Efficacy|4
13831|NCT01937299|74073|P1|Overall Study|Lack of Efficacy|0
13832|NCT01937299|74072|P2|Overall Study|Adverse Event|0
13833|NCT01937299|74073|P1|Overall Study|Adverse Event|13
13834|NCT01937130|74108|P4|Overall Study|Patient lost to FU due to death|0
13835|NCT01937130|74109|P3|Overall Study|Patient lost to FU due to death|0
13836|NCT01937130|74110|P2|Overall Study|Patient lost to FU due to death|0
13837|NCT01937130|74111|P1|Overall Study|Patient lost to FU due to death|2
13838|NCT01937130|74108|P4|Overall Study|Patients unable to swallow|0
13839|NCT01937130|74109|P3|Overall Study|Patients unable to swallow|0
13840|NCT01937130|74110|P2|Overall Study|Patients unable to swallow|1
13841|NCT01937130|74111|P1|Overall Study|Patients unable to swallow|0
13842|NCT01937130|74108|P4|Overall Study|Physician Decision|0
13843|NCT01937130|74109|P3|Overall Study|Physician Decision|0
13844|NCT01937130|74110|P2|Overall Study|Physician Decision|1
13845|NCT01937130|74111|P1|Overall Study|Physician Decision|0
13846|NCT01937130|74108|P4|Overall Study|Lost to Follow-up|0
13847|NCT01937130|74109|P3|Overall Study|Lost to Follow-up|2
13848|NCT01937130|74110|P2|Overall Study|Lost to Follow-up|0
13849|NCT01937130|74111|P1|Overall Study|Lost to Follow-up|2
13850|NCT01937130|74108|P4|Overall Study|Death|0
13851|NCT01937130|74109|P3|Overall Study|Death|1
13852|NCT01937130|74110|P2|Overall Study|Death|1
13853|NCT01937130|74111|P1|Overall Study|Death|1
13854|NCT01937130|74108|P4|Overall Study|Adverse Event|1
13855|NCT01937130|74109|P3|Overall Study|Adverse Event|0
13856|NCT01937130|74110|P2|Overall Study|Adverse Event|1
13857|NCT01937130|74111|P1|Overall Study|Adverse Event|0
13858|NCT01937130|74108|P4|Overall Study|Withdrawal by Subject|1
13859|NCT01937130|74109|P3|Overall Study|Withdrawal by Subject|0
13860|NCT01937130|74110|P2|Overall Study|Withdrawal by Subject|0
13861|NCT01937130|74111|P1|Overall Study|Withdrawal by Subject|0
13862|NCT01936870|74152|P1|Overall Study|No Drug Administration|1
13863|NCT01936870|74152|P1|Overall Study|Protocol Violation|12
13864|NCT01936870|74152|P1|Overall Study|No Visit After Treatment|176
13865|NCT01936649|74189|P1|Overall Study|Other than specified above|5
13866|NCT01936649|74189|P1|Overall Study|Protocol Violation|2
13867|NCT01936649|74189|P1|Overall Study|Physician Decision|2
13868|NCT01936649|74189|P1|Overall Study|Withdrawal by Subject|4
13869|NCT01936623|74196|P2|Overall Study|Lost to Follow-up|5
13870|NCT01936623|74197|P1|Overall Study|Lost to Follow-up|0
13871|NCT01936363|74241|P2|Overall Study|Ongoing|5
13872|NCT01936363|74242|P1|Overall Study|Ongoing|7
13873|NCT01936181|74268|P4|Transition-extension|Withdrawal by Subject|1
13874|NCT01936181|74269|P3|Transition-extension|Withdrawal by Subject|2
13875|NCT01936181|74270|P2|Transition-extension|Withdrawal by Subject|0
13876|NCT01936181|74271|P1|Transition-extension|Withdrawal by Subject|7
13877|NCT01936181|74268|P4|Transition-extension|Physician Decision|1
13878|NCT01936181|74269|P3|Transition-extension|Physician Decision|0
13879|NCT01936181|74270|P2|Transition-extension|Physician Decision|0
13880|NCT01936181|74271|P1|Transition-extension|Physician Decision|2
13881|NCT01936181|74268|P4|Transition-extension|Lost to Follow-up|2
13882|NCT01936181|74269|P3|Transition-extension|Lost to Follow-up|1
13883|NCT01936181|74270|P2|Transition-extension|Lost to Follow-up|0
13884|NCT01936181|74271|P1|Transition-extension|Lost to Follow-up|3
13885|NCT01936181|74268|P4|Transition-extension|Adverse Event|1
13886|NCT01936181|74269|P3|Transition-extension|Adverse Event|3
13887|NCT01936181|74270|P2|Transition-extension|Adverse Event|0
13888|NCT01936181|74271|P1|Transition-extension|Adverse Event|3
13889|NCT01936181|74268|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
13890|NCT01936181|74269|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
13891|NCT01936181|74270|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
13892|NCT01936181|74271|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
13893|NCT01936181|74268|P4|Randomised, Double-blind|Withdrawal by Subject|0
13894|NCT01936181|74269|P3|Randomised, Double-blind|Withdrawal by Subject|0
13895|NCT01936181|74270|P2|Randomised, Double-blind|Withdrawal by Subject|26
13896|NCT01936181|74271|P1|Randomised, Double-blind|Withdrawal by Subject|23
13897|NCT01936181|74268|P4|Randomised, Double-blind|Physician Decision|0
13898|NCT01936181|74269|P3|Randomised, Double-blind|Physician Decision|0
13899|NCT01936181|74270|P2|Randomised, Double-blind|Physician Decision|4
13900|NCT01936181|74271|P1|Randomised, Double-blind|Physician Decision|4
13901|NCT01936181|74268|P4|Randomised, Double-blind|Pregnancy|0
13902|NCT01936181|74269|P3|Randomised, Double-blind|Pregnancy|0
13903|NCT01936181|74270|P2|Randomised, Double-blind|Pregnancy|1
13904|NCT01936181|74271|P1|Randomised, Double-blind|Pregnancy|0
13905|NCT01936181|74268|P4|Randomised, Double-blind|Lost to Follow-up|0
13906|NCT01936181|74269|P3|Randomised, Double-blind|Lost to Follow-up|0
13907|NCT01936181|74270|P2|Randomised, Double-blind|Lost to Follow-up|1
13908|NCT01936181|74271|P1|Randomised, Double-blind|Lost to Follow-up|0
13909|NCT01936181|74268|P4|Randomised, Double-blind|Lack of Efficacy|0
13910|NCT01936181|74269|P3|Randomised, Double-blind|Lack of Efficacy|0
13911|NCT01936181|74270|P2|Randomised, Double-blind|Lack of Efficacy|6
13912|NCT01936181|74271|P1|Randomised, Double-blind|Lack of Efficacy|5
13913|NCT01936181|74268|P4|Randomised, Double-blind|Protocol Violation|0
13914|NCT01936181|74269|P3|Randomised, Double-blind|Protocol Violation|0
13915|NCT01936181|74270|P2|Randomised, Double-blind|Protocol Violation|5
13916|NCT01936181|74271|P1|Randomised, Double-blind|Protocol Violation|1
13917|NCT01936181|74268|P4|Randomised, Double-blind|Adverse Event|0
13918|NCT01936181|74269|P3|Randomised, Double-blind|Adverse Event|0
13919|NCT01936181|74270|P2|Randomised, Double-blind|Adverse Event|21
13920|NCT01936181|74271|P1|Randomised, Double-blind|Adverse Event|27
13921|NCT01934894|74318|P2|Overall Study|Progressive Disease|2
13922|NCT01934894|74319|P1|Overall Study|Progressive Disease|3
13923|NCT01934894|74318|P2|Overall Study|Withdrawal by Subject|1
13924|NCT01934894|74319|P1|Overall Study|Withdrawal by Subject|0
13925|NCT01934894|74318|P2|Overall Study|Death|0
13926|NCT01934894|74319|P1|Overall Study|Death|2
13927|NCT01934894|74318|P2|Overall Study|Adverse Event|2
13928|NCT01934894|74319|P1|Overall Study|Adverse Event|1
13929|NCT01934790|74334|P1|Overall Study|Study drug never administered|1
13930|NCT01934790|74334|P1|Overall Study|Withdrawal by Subject|2
13931|NCT01934790|74334|P1|Overall Study|Radiological progression|4
13932|NCT01934790|74334|P1|Overall Study|Clinical progression|6
13933|NCT01934790|74334|P1|Overall Study|Adverse Event|3
13934|NCT01934504|74380|P4|Overall Study|Study Terminated by Sponsor|5
13935|NCT01934504|74381|P3|Overall Study|Study Terminated by Sponsor|5
13936|NCT01934504|74382|P2|Overall Study|Study Terminated by Sponsor|0
13937|NCT01934504|74383|P1|Overall Study|Study Terminated by Sponsor|1
13938|NCT01934504|74380|P4|Overall Study|Protocol Deviation|2
13939|NCT01934504|74381|P3|Overall Study|Protocol Deviation|0
13940|NCT01934504|74382|P2|Overall Study|Protocol Deviation|0
13941|NCT01934504|74383|P1|Overall Study|Protocol Deviation|0
13942|NCT01934218|74416|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
13943|NCT01934218|74417|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
13944|NCT01934218|74416|P2|Open-Label Phase|Noncompliance with Study Protocol|2
13945|NCT01934218|74417|P1|Open-Label Phase|Noncompliance with Study Protocol|4
13946|NCT01934218|74416|P2|Open-Label Phase|Withdrawal by Subject|11
13947|NCT01934218|74417|P1|Open-Label Phase|Withdrawal by Subject|13
13948|NCT01934218|74416|P2|Open-Label Phase|Protocol Violation|0
13949|NCT01934218|74417|P1|Open-Label Phase|Protocol Violation|1
13950|NCT01934218|74416|P2|Open-Label Phase|Physician Decision|0
13951|NCT01934218|74417|P1|Open-Label Phase|Physician Decision|1
13952|NCT01934218|74416|P2|Open-Label Phase|Lost to Follow-up|2
13953|NCT01934218|74417|P1|Open-Label Phase|Lost to Follow-up|4
13954|NCT01934218|74416|P2|Open-Label Phase|Lack of Efficacy|4
13955|NCT01934218|74417|P1|Open-Label Phase|Lack of Efficacy|1
13956|NCT01934218|74416|P2|Open-Label Phase|Adverse Event|4
13957|NCT01934218|74417|P1|Open-Label Phase|Adverse Event|2
13958|NCT01934218|74416|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
13959|NCT01934218|74417|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
13960|NCT01934218|74416|P2|Double-blind Phase|Noncompliance with Study Protocol|8
13961|NCT01934218|74417|P1|Double-blind Phase|Noncompliance with Study Protocol|5
13962|NCT01934218|74416|P2|Double-blind Phase|Withdrawal by Subject|13
13963|NCT01934218|74417|P1|Double-blind Phase|Withdrawal by Subject|16
13964|NCT01934218|74416|P2|Double-blind Phase|Protocol Violation|0
13965|NCT01934218|74417|P1|Double-blind Phase|Protocol Violation|4
13966|NCT01934218|74416|P2|Double-blind Phase|Physician Decision|2
13967|NCT01934218|74417|P1|Double-blind Phase|Physician Decision|1
13968|NCT01934218|74416|P2|Double-blind Phase|Lost to Follow-up|14
13969|NCT01934218|74417|P1|Double-blind Phase|Lost to Follow-up|7
13970|NCT01934218|74416|P2|Double-blind Phase|Lack of Efficacy|7
13971|NCT01934218|74417|P1|Double-blind Phase|Lack of Efficacy|6
13972|NCT01934218|74416|P2|Double-blind Phase|Adverse Event|8
13973|NCT01934218|74417|P1|Double-blind Phase|Adverse Event|8
13974|NCT01933932|74426|P2|Overall Study|Eligibility criteria not fulfilled|1
13975|NCT01933932|74427|P1|Overall Study|Eligibility criteria not fulfilled|0
13976|NCT01933932|74426|P2|Overall Study|Withdrawal by Subject|14
13977|NCT01933932|74427|P1|Overall Study|Withdrawal by Subject|11
13978|NCT01933932|74426|P2|Overall Study|Death|163
13979|NCT01933932|74427|P1|Overall Study|Death|173
13980|NCT01933880|74445|P2|Overall Study|Protocol Violation|0
13981|NCT01933880|74446|P1|Overall Study|Protocol Violation|1
13982|NCT01933880|74445|P2|Overall Study|Unspecified|0
13983|NCT01933880|74446|P1|Overall Study|Unspecified|4
13984|NCT01933880|74445|P2|Overall Study|Followup exceeded 4 days to visit window|0
13985|NCT01933880|74446|P1|Overall Study|Followup exceeded 4 days to visit window|19
13986|NCT01933880|74445|P2|Overall Study|Concomitant medication Interference|1
13987|NCT01933880|74446|P1|Overall Study|Concomitant medication Interference|0
13988|NCT01933880|74445|P2|Overall Study|Lack of Efficacy|0
13989|NCT01933880|74446|P1|Overall Study|Lack of Efficacy|1
13990|NCT01933880|74445|P2|Overall Study|Withdrawal by Subject|0
13991|NCT01933880|74446|P1|Overall Study|Withdrawal by Subject|5
13992|NCT01933672|74522|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
13993|NCT01933672|74523|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
13994|NCT01933672|74524|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
13995|NCT01933672|74525|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
13996|NCT01933672|74526|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
13997|NCT01933672|74527|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
13998|NCT01933672|74528|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
13999|NCT01933672|74522|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
14000|NCT01933672|74523|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
14001|NCT01933672|74524|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
14002|NCT01933672|74525|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
14003|NCT01933672|74526|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
14004|NCT01933672|74527|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
14005|NCT01933672|74528|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
14006|NCT01933672|74522|P7|Second Intervention Period (12-16 Days)|Unspecified|0
14007|NCT01933672|74523|P6|Second Intervention Period (12-16 Days)|Unspecified|0
14008|NCT01933672|74524|P5|Second Intervention Period (12-16 Days)|Unspecified|0
14009|NCT01933672|74525|P4|Second Intervention Period (12-16 Days)|Unspecified|0
14010|NCT01933672|74526|P3|Second Intervention Period (12-16 Days)|Unspecified|1
14011|NCT01933672|74527|P2|Second Intervention Period (12-16 Days)|Unspecified|1
14012|NCT01933672|74528|P1|Second Intervention Period (12-16 Days)|Unspecified|0
14013|NCT01933672|74522|P7|First Intervention Period (12-16 Days)|Unspecified|0
14014|NCT01933672|74523|P6|First Intervention Period (12-16 Days)|Unspecified|1
14015|NCT01933672|74524|P5|First Intervention Period (12-16 Days)|Unspecified|0
14016|NCT01933672|74525|P4|First Intervention Period (12-16 Days)|Unspecified|0
14017|NCT01933672|74526|P3|First Intervention Period (12-16 Days)|Unspecified|1
14018|NCT01933672|74527|P2|First Intervention Period (12-16 Days)|Unspecified|0
14019|NCT01933672|74528|P1|First Intervention Period (12-16 Days)|Unspecified|0
14020|NCT01933672|74522|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
14021|NCT01933672|74523|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
14022|NCT01933672|74524|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
14023|NCT01933672|74525|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
14024|NCT01933672|74526|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
14025|NCT01933672|74527|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
14026|NCT01933672|74528|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
14027|NCT01933672|74522|P7|Metformin Run-in Period|Unspecified|0
14028|NCT01933672|74523|P6|Metformin Run-in Period|Unspecified|0
14029|NCT01933672|74524|P5|Metformin Run-in Period|Unspecified|0
14030|NCT01933672|74525|P4|Metformin Run-in Period|Unspecified|0
14031|NCT01933672|74526|P3|Metformin Run-in Period|Unspecified|0
14032|NCT01933672|74527|P2|Metformin Run-in Period|Unspecified|0
14033|NCT01933672|74528|P1|Metformin Run-in Period|Unspecified|5
14034|NCT01933672|74522|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
14035|NCT01933672|74523|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
14036|NCT01933672|74524|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
14037|NCT01933672|74525|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
14038|NCT01933672|74526|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
14039|NCT01933672|74527|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
14040|NCT01933672|74528|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
14041|NCT01933672|74522|P7|Metformin Run-in Period|Adverse Event|0
14042|NCT01933672|74523|P6|Metformin Run-in Period|Adverse Event|0
14043|NCT01933672|74524|P5|Metformin Run-in Period|Adverse Event|0
14044|NCT01933672|74525|P4|Metformin Run-in Period|Adverse Event|0
14045|NCT01933672|74526|P3|Metformin Run-in Period|Adverse Event|0
14046|NCT01933672|74527|P2|Metformin Run-in Period|Adverse Event|0
14047|NCT01933672|74528|P1|Metformin Run-in Period|Adverse Event|1
14048|NCT01933334|74603|P2|Overall Study|Withdrawal by Subject|1
14049|NCT01933334|74604|P1|Overall Study|Withdrawal by Subject|0
14050|NCT01933334|74603|P2|Overall Study|Adverse Event|1
14051|NCT01933334|74604|P1|Overall Study|Adverse Event|5
14052|NCT01932970|74618|P1|Overall Study|Protocol Specified Criteria|10
14053|NCT01932970|74618|P1|Overall Study|Lost to Follow-up|2
14054|NCT01932970|74618|P1|Overall Study|Death|1
14055|NCT01932970|74618|P1|Overall Study|Withdrawal by Subject|5
14056|NCT01932762|74630|P4|Overall Study|Physician Decision|0
14057|NCT01932762|74631|P3|Overall Study|Physician Decision|0
14058|NCT01932762|74632|P2|Overall Study|Physician Decision|0
14059|NCT01932762|74633|P1|Overall Study|Physician Decision|1
14060|NCT01932762|74630|P4|Overall Study|Lost to Follow-up|1
14061|NCT01932762|74631|P3|Overall Study|Lost to Follow-up|0
14062|NCT01932762|74632|P2|Overall Study|Lost to Follow-up|0
14063|NCT01932762|74633|P1|Overall Study|Lost to Follow-up|4
14064|NCT01932762|74630|P4|Overall Study|Withdrawal by Subject|0
14065|NCT01932762|74631|P3|Overall Study|Withdrawal by Subject|0
14066|NCT01932762|74632|P2|Overall Study|Withdrawal by Subject|2
14067|NCT01932762|74633|P1|Overall Study|Withdrawal by Subject|1
14068|NCT01931956|74741|P2|Overall Study|Withdrawal by Subject|0
14069|NCT01931956|74742|P1|Overall Study|Withdrawal by Subject|2
14070|NCT01931956|74741|P2|Overall Study|Lost to Follow-up|1
14071|NCT01931956|74742|P1|Overall Study|Lost to Follow-up|3
14072|NCT01931956|74741|P2|Overall Study|Death|5
14073|NCT01931956|74742|P1|Overall Study|Death|18
14074|NCT01931865|74799|P1|Overall Study|Withdrawal by Subject|2
14075|NCT01931865|74799|P1|Overall Study|Lost to Follow-up|2
14076|NCT01931839|74812|P7|Overall Study|Unspecified|0
14077|NCT01931839|74813|P6|Overall Study|Unspecified|0
14078|NCT01931839|74814|P5|Overall Study|Unspecified|0
14079|NCT01931839|74815|P4|Overall Study|Unspecified|0
14080|NCT01931839|74816|P3|Overall Study|Unspecified|6
14081|NCT01931839|74817|P2|Overall Study|Unspecified|2
14082|NCT01931839|74818|P1|Overall Study|Unspecified|4
14083|NCT01931839|74812|P7|Overall Study|Lost to Follow-up|0
14084|NCT01931839|74813|P6|Overall Study|Lost to Follow-up|0
14085|NCT01931839|74814|P5|Overall Study|Lost to Follow-up|0
14086|NCT01931839|74815|P4|Overall Study|Lost to Follow-up|5
14087|NCT01931839|74816|P3|Overall Study|Lost to Follow-up|4
14088|NCT01931839|74817|P2|Overall Study|Lost to Follow-up|2
14089|NCT01931839|74818|P1|Overall Study|Lost to Follow-up|1
14090|NCT01931839|74812|P7|Overall Study|Other non-compliance|0
14091|NCT01931839|74813|P6|Overall Study|Other non-compliance|3
14092|NCT01931839|74814|P5|Overall Study|Other non-compliance|0
14093|NCT01931839|74815|P4|Overall Study|Other non-compliance|3
14094|NCT01931839|74816|P3|Overall Study|Other non-compliance|12
14095|NCT01931839|74817|P2|Overall Study|Other non-compliance|9
14096|NCT01931839|74818|P1|Overall Study|Other non-compliance|15
14097|NCT01931839|74812|P7|Overall Study|Withdrawal of consent (not due to AE)|2
14098|NCT01931839|74813|P6|Overall Study|Withdrawal of consent (not due to AE)|2
14099|NCT01931839|74814|P5|Overall Study|Withdrawal of consent (not due to AE)|0
14100|NCT01931839|74815|P4|Overall Study|Withdrawal of consent (not due to AE)|3
14101|NCT01931839|74816|P3|Overall Study|Withdrawal of consent (not due to AE)|13
14102|NCT01931839|74817|P2|Overall Study|Withdrawal of consent (not due to AE)|8
14103|NCT01931839|74818|P1|Overall Study|Withdrawal of consent (not due to AE)|11
14104|NCT01931839|74812|P7|Overall Study|Adverse Event|1
14105|NCT01931839|74813|P6|Overall Study|Adverse Event|0
14106|NCT01931839|74814|P5|Overall Study|Adverse Event|0
14107|NCT01931839|74815|P4|Overall Study|Adverse Event|3
14108|NCT01931839|74816|P3|Overall Study|Adverse Event|1
14109|NCT01931839|74817|P2|Overall Study|Adverse Event|4
14110|NCT01931839|74818|P1|Overall Study|Adverse Event|9
14111|NCT01931839|74812|P7|Overall Study|Withdrawal of consent|0
14112|NCT01931839|74813|P6|Overall Study|Withdrawal of consent|0
14113|NCT01931839|74814|P5|Overall Study|Withdrawal of consent|1
14114|NCT01931839|74815|P4|Overall Study|Withdrawal of consent|0
14115|NCT01931839|74816|P3|Overall Study|Withdrawal of consent|0
14116|NCT01931839|74817|P2|Overall Study|Withdrawal of consent|0
14117|NCT01931839|74818|P1|Overall Study|Withdrawal of consent|0
14118|NCT01931839|74812|P7|Overall Study|Physician Decision|1
14119|NCT01931839|74813|P6|Overall Study|Physician Decision|0
14120|NCT01931839|74814|P5|Overall Study|Physician Decision|0
14121|NCT01931839|74815|P4|Overall Study|Physician Decision|0
14122|NCT01931839|74816|P3|Overall Study|Physician Decision|1
14123|NCT01931839|74817|P2|Overall Study|Physician Decision|0
14124|NCT01931839|74818|P1|Overall Study|Physician Decision|1
14125|NCT01931839|74812|P7|Overall Study|Death|0
14126|NCT01931839|74813|P6|Overall Study|Death|0
14127|NCT01931839|74814|P5|Overall Study|Death|0
14128|NCT01931839|74815|P4|Overall Study|Death|0
14129|NCT01931839|74816|P3|Overall Study|Death|2
14130|NCT01931839|74817|P2|Overall Study|Death|1
14131|NCT01931839|74818|P1|Overall Study|Death|0
14132|NCT01931475|74909|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
14133|NCT01931475|74910|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
14134|NCT01931475|74909|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
14135|NCT01931475|74910|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
14136|NCT01931475|74909|P2|Period 2: Extension Treatment Phase|Physician Decision|1
14137|NCT01931475|74910|P1|Period 2: Extension Treatment Phase|Physician Decision|1
14138|NCT01931475|74909|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
14139|NCT01931475|74910|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
14140|NCT01931475|74909|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
14141|NCT01931475|74910|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
14142|NCT01931475|74909|P2|Period 2: Extension Treatment Phase|Adverse Event|8
14143|NCT01931475|74910|P1|Period 2: Extension Treatment Phase|Adverse Event|0
14144|NCT01931475|74909|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
14145|NCT01931475|74910|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
14146|NCT01931475|74909|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
14147|NCT01931475|74910|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
14148|NCT01931475|74909|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
14149|NCT01931475|74910|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
14150|NCT01931475|74909|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
14151|NCT01931475|74910|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
14152|NCT01931475|74909|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
14153|NCT01931475|74910|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
14154|NCT01931397|74937|P1|Overall Study|moved out of state|1
14155|NCT01931397|74937|P1|Overall Study|Withdrawal by Subject|8
14156|NCT01931397|74937|P1|Overall Study|Physician Decision|2
14157|NCT01931150|74948|P2|Overall Study|Withdrawal by Subject|2
14158|NCT01931150|74949|P1|Overall Study|Withdrawal by Subject|1
14159|NCT01930890|74959|P4|Overall Study|Adverse Event|0
14160|NCT01930890|74960|P3|Overall Study|Adverse Event|0
14161|NCT01930890|74961|P2|Overall Study|Adverse Event|1
14162|NCT01930890|74962|P1|Overall Study|Adverse Event|0
14163|NCT01930890|74959|P4|Overall Study|Consent Withdrawn|1
14164|NCT01930890|74960|P3|Overall Study|Consent Withdrawn|0
14165|NCT01930890|74961|P2|Overall Study|Consent Withdrawn|3
14166|NCT01930890|74962|P1|Overall Study|Consent Withdrawn|0
14167|NCT01930890|74959|P4|Overall Study|Investigator Decision|0
14168|NCT01930890|74960|P3|Overall Study|Investigator Decision|0
14169|NCT01930890|74961|P2|Overall Study|Investigator Decision|1
14170|NCT01930890|74962|P1|Overall Study|Investigator Decision|0
14171|NCT01930890|74959|P4|Overall Study|Death|1
14172|NCT01930890|74960|P3|Overall Study|Death|0
14173|NCT01930890|74961|P2|Overall Study|Death|0
14174|NCT01930890|74962|P1|Overall Study|Death|0
14175|NCT01930890|74959|P4|Overall Study|Study Termination|25
14176|NCT01930890|74960|P3|Overall Study|Study Termination|13
14177|NCT01930890|74961|P2|Overall Study|Study Termination|28
14178|NCT01930890|74962|P1|Overall Study|Study Termination|14
14179|NCT01930799|74976|P1|Overall Study|Lost to Follow-up|5
14180|NCT01930799|74976|P1|Overall Study|Withdrawal by Subject|3
14181|NCT01930162|75084|P1|Overall Study|Death|1
14182|NCT01930162|75084|P1|Overall Study|Abnormal test procedure result(s)|4
14183|NCT01930045|75120|P6|Pause (up to 37 Days)|Protocol Violation|1
14184|NCT01930045|75121|P5|Pause (up to 37 Days)|Protocol Violation|0
14185|NCT01930045|75122|P4|Pause (up to 37 Days)|Protocol Violation|0
14186|NCT01930045|75123|P3|Pause (up to 37 Days)|Protocol Violation|0
14187|NCT01930045|75124|P2|Pause (up to 37 Days)|Protocol Violation|0
14188|NCT01930045|75125|P1|Pause (up to 37 Days)|Protocol Violation|0
14189|NCT01930045|75120|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
14190|NCT01930045|75121|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
14191|NCT01930045|75122|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
14192|NCT01930045|75123|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
14193|NCT01930045|75124|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
14194|NCT01930045|75125|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
14195|NCT01929993|75152|P2|Overall Study|Absent CIN, invasion present or artifact|22
14196|NCT01929993|75153|P1|Overall Study|Absent CIN, invasion present or artifact|26
14197|NCT01929993|75152|P2|Overall Study|Protocol Violation|6
14198|NCT01929993|75153|P1|Overall Study|Protocol Violation|4
14199|NCT01929980|75159|P1|Overall Study|Physician Decision|1
14200|NCT01929876|75167|P1|Period 2|Non-Compliance|1
14201|NCT01929863|75180|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
14202|NCT01929863|75181|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
14203|NCT01929863|75180|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
14204|NCT01929863|75181|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
14205|NCT01929863|75180|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
14206|NCT01929863|75181|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
14207|NCT01929681|75238|P2|Overall Study|Physician Decision|1
14208|NCT01929681|75239|P1|Overall Study|Physician Decision|1
14209|NCT01929681|75238|P2|Overall Study|Withdrawal by Subject|0
14210|NCT01929681|75239|P1|Overall Study|Withdrawal by Subject|1
14211|NCT01929317|75284|P2|Long-term Phase|Study Closed/Terminated|3
14212|NCT01929317|75285|P1|Long-term Phase|Study Closed/Terminated|5
14213|NCT01929317|75284|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
14214|NCT01929317|75285|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
14215|NCT01929317|75284|P2|Long-term Phase|Protocol Violation|0
14216|NCT01929317|75285|P1|Long-term Phase|Protocol Violation|1
14217|NCT01929317|75284|P2|Long-term Phase|Withdrawal by Subject|0
14218|NCT01929317|75285|P1|Long-term Phase|Withdrawal by Subject|4
14219|NCT01929317|75284|P2|Long-term Phase|Physician Decision|0
14220|NCT01929317|75285|P1|Long-term Phase|Physician Decision|3
14221|NCT01929317|75284|P2|Long-term Phase|Adverse Event|1
14222|NCT01929317|75285|P1|Long-term Phase|Adverse Event|5
14223|NCT01929317|75284|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
14224|NCT01929317|75285|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
14225|NCT01929317|75284|P2|Dose Increase Effect Verification Phase|Physician Decision|0
14226|NCT01929317|75285|P1|Dose Increase Effect Verification Phase|Physician Decision|1
14227|NCT01929317|75284|P2|Dose Increase Effect Verification Phase|Adverse Event|1
14228|NCT01929317|75285|P1|Dose Increase Effect Verification Phase|Adverse Event|5
14229|NCT01929135|75354|P2|Overall Study|Lost to Follow-up|1
14230|NCT01929135|75355|P1|Overall Study|Lost to Follow-up|1
14231|NCT01929083|75369|P2|Intervention 2|Adverse Event|1
14232|NCT01929083|75370|P1|Intervention 2|Adverse Event|0
14233|NCT01929083|75369|P2|Intervention 1|Nonadherent to study medications|0
14234|NCT01929083|75370|P1|Intervention 1|Nonadherent to study medications|1
14235|NCT01929083|75369|P2|Intervention 1|Lost to Follow-up|0
14236|NCT01929083|75370|P1|Intervention 1|Lost to Follow-up|2
14237|NCT01929044|75396|P2|Overall Study|Not Treated|3
14238|NCT01929044|75397|P1|Overall Study|Not Treated|1
14239|NCT01929044|75396|P2|Overall Study|Protocol Violation|14
14240|NCT01929044|75397|P1|Overall Study|Protocol Violation|9
14241|NCT01929044|75396|P2|Overall Study|Adverse Event|0
14242|NCT01929044|75397|P1|Overall Study|Adverse Event|1
14243|NCT01929031|75419|P6|Overall Study|Reason other than specified above|0
14244|NCT01929031|75420|P5|Overall Study|Reason other than specified above|1
14245|NCT01929031|75421|P4|Overall Study|Reason other than specified above|0
14246|NCT01929031|75422|P3|Overall Study|Reason other than specified above|0
14247|NCT01929031|75423|P2|Overall Study|Reason other than specified above|1
14248|NCT01929031|75424|P1|Overall Study|Reason other than specified above|0
14249|NCT01929031|75419|P6|Overall Study|Protocol Violation|1
14250|NCT01929031|75420|P5|Overall Study|Protocol Violation|0
14251|NCT01929031|75421|P4|Overall Study|Protocol Violation|0
14252|NCT01929031|75422|P3|Overall Study|Protocol Violation|0
14253|NCT01929031|75423|P2|Overall Study|Protocol Violation|0
14254|NCT01929031|75424|P1|Overall Study|Protocol Violation|1
14255|NCT01929031|75419|P6|Overall Study|Adverse Event|0
14256|NCT01929031|75420|P5|Overall Study|Adverse Event|0
14257|NCT01929031|75421|P4|Overall Study|Adverse Event|0
14258|NCT01929031|75422|P3|Overall Study|Adverse Event|1
14259|NCT01929031|75423|P2|Overall Study|Adverse Event|1
14260|NCT01929031|75424|P1|Overall Study|Adverse Event|3
14261|NCT01928940|75448|P2|Overall Study|Adverse Event|1
14262|NCT01928940|75449|P1|Overall Study|Adverse Event|0
14263|NCT01928927|75492|P2|Overall Study|Withdrawal by Subject|1
14264|NCT01928927|75493|P1|Overall Study|Withdrawal by Subject|1
14265|NCT01928927|75492|P2|Overall Study|Lost to Follow-up|0
14266|NCT01928927|75493|P1|Overall Study|Lost to Follow-up|1
14267|NCT01928771|75618|P3|Overall Study|Severe Non-Compliance to Protocol|2
14268|NCT01928771|75619|P2|Overall Study|Severe Non-Compliance to Protocol|2
14269|NCT01928771|75620|P1|Overall Study|Severe Non-Compliance to Protocol|4
14270|NCT01928771|75618|P3|Overall Study|Other Reasons|14
14271|NCT01928771|75619|P2|Overall Study|Other Reasons|9
14272|NCT01928771|75620|P1|Overall Study|Other Reasons|9
14273|NCT01928771|75618|P3|Overall Study|Study-Specific Withdrawal Criteria|1
14274|NCT01928771|75619|P2|Overall Study|Study-Specific Withdrawal Criteria|1
14275|NCT01928771|75620|P1|Overall Study|Study-Specific Withdrawal Criteria|0
14276|NCT01928771|75618|P3|Overall Study|Withdrawal by Subject|17
14277|NCT01928771|75619|P2|Overall Study|Withdrawal by Subject|15
14278|NCT01928771|75620|P1|Overall Study|Withdrawal by Subject|20
14279|NCT01928771|75618|P3|Overall Study|Lost to Follow-up|3
14280|NCT01928771|75619|P2|Overall Study|Lost to Follow-up|6
14281|NCT01928771|75620|P1|Overall Study|Lost to Follow-up|5
14282|NCT01928771|75618|P3|Overall Study|Death|2
14283|NCT01928771|75619|P2|Overall Study|Death|2
14284|NCT01928771|75620|P1|Overall Study|Death|2
14285|NCT01928771|75618|P3|Overall Study|Adverse Event|1
14286|NCT01928771|75619|P2|Overall Study|Adverse Event|5
14287|NCT01928771|75620|P1|Overall Study|Adverse Event|6
14288|NCT01928615|75732|P1|Overall Study|Study Terminated by Sponsor|2
14289|NCT01928472|75751|P4|Overall Study|Unclassified|0
14290|NCT01928472|75752|P3|Overall Study|Unclassified|1
14291|NCT01928472|75753|P2|Overall Study|Unclassified|0
14292|NCT01928472|75754|P1|Overall Study|Unclassified|0
14293|NCT01928472|75751|P4|Overall Study|Administrative Reason|0
14294|NCT01928472|75752|P3|Overall Study|Administrative Reason|0
14295|NCT01928472|75753|P2|Overall Study|Administrative Reason|1
14296|NCT01928472|75754|P1|Overall Study|Administrative Reason|2
14297|NCT01928472|75751|P4|Overall Study|Lost to Follow-up|0
14298|NCT01928472|75752|P3|Overall Study|Lost to Follow-up|4
14299|NCT01928472|75753|P2|Overall Study|Lost to Follow-up|3
14300|NCT01928472|75754|P1|Overall Study|Lost to Follow-up|2
14301|NCT01928472|75751|P4|Overall Study|Withdrawal by Subject|2
14302|NCT01928472|75752|P3|Overall Study|Withdrawal by Subject|1
14303|NCT01928472|75753|P2|Overall Study|Withdrawal by Subject|4
14304|NCT01928472|75754|P1|Overall Study|Withdrawal by Subject|4
14305|NCT01928472|75751|P4|Overall Study|Death|0
14306|NCT01928472|75752|P3|Overall Study|Death|1
14307|NCT01928472|75753|P2|Overall Study|Death|0
14308|NCT01928472|75754|P1|Overall Study|Death|0
14309|NCT01928433|75824|P3|Overall Study|Other reasons|4
14310|NCT01928433|75825|P2|Overall Study|Other reasons|3
14311|NCT01928433|75826|P1|Overall Study|Other reasons|3
14312|NCT01928433|75824|P3|Overall Study|Lost to Follow-up|3
14313|NCT01928433|75825|P2|Overall Study|Lost to Follow-up|2
14314|NCT01928433|75826|P1|Overall Study|Lost to Follow-up|0
14315|NCT01928433|75824|P3|Overall Study|Negative screening urine culture|10
14316|NCT01928433|75825|P2|Overall Study|Negative screening urine culture|6
14317|NCT01928433|75826|P1|Overall Study|Negative screening urine culture|7
14318|NCT01928433|75824|P3|Overall Study|Withdrawal by Subject|0
14319|NCT01928433|75825|P2|Overall Study|Withdrawal by Subject|4
14320|NCT01928433|75826|P1|Overall Study|Withdrawal by Subject|0
14321|NCT01928433|75824|P3|Overall Study|Lack of Efficacy|4
14322|NCT01928433|75825|P2|Overall Study|Lack of Efficacy|4
14323|NCT01928433|75826|P1|Overall Study|Lack of Efficacy|5
14324|NCT01928433|75824|P3|Overall Study|Protocol Violation|2
14325|NCT01928433|75825|P2|Overall Study|Protocol Violation|0
14326|NCT01928433|75826|P1|Overall Study|Protocol Violation|0
14327|NCT01928433|75824|P3|Overall Study|Adverse Event|5
14328|NCT01928433|75825|P2|Overall Study|Adverse Event|2
14329|NCT01928433|75826|P1|Overall Study|Adverse Event|5
14330|NCT01928381|75849|P7|Part 2 - Post Third Intervention|Protocol Violation|0
14331|NCT01928381|75850|P6|Part 2 - Post Third Intervention|Protocol Violation|0
14332|NCT01928381|75851|P5|Part 2 - Post Third Intervention|Protocol Violation|0
14333|NCT01928381|75852|P4|Part 2 - Post Third Intervention|Protocol Violation|0
14334|NCT01928381|75853|P3|Part 2 - Post Third Intervention|Protocol Violation|1
14335|NCT01928381|75854|P2|Part 2 - Post Third Intervention|Protocol Violation|0
14336|NCT01928381|75855|P1|Part 2 - Post Third Intervention|Protocol Violation|0
14337|NCT01928381|75849|P7|Part 2 - Second Intervention|Lost to Follow-up|0
14338|NCT01928381|75850|P6|Part 2 - Second Intervention|Lost to Follow-up|0
14339|NCT01928381|75851|P5|Part 2 - Second Intervention|Lost to Follow-up|0
14340|NCT01928381|75852|P4|Part 2 - Second Intervention|Lost to Follow-up|1
14341|NCT01928381|75853|P3|Part 2 - Second Intervention|Lost to Follow-up|0
14342|NCT01928381|75854|P2|Part 2 - Second Intervention|Lost to Follow-up|1
14343|NCT01928381|75855|P1|Part 2 - Second Intervention|Lost to Follow-up|0
14344|NCT01928381|75849|P7|Washout First Intervention|Protocol Violation|0
14345|NCT01928381|75850|P6|Washout First Intervention|Protocol Violation|0
14346|NCT01928381|75851|P5|Washout First Intervention|Protocol Violation|1
14347|NCT01928381|75852|P4|Washout First Intervention|Protocol Violation|0
14348|NCT01928381|75853|P3|Washout First Intervention|Protocol Violation|0
14349|NCT01928381|75854|P2|Washout First Intervention|Protocol Violation|0
14350|NCT01928381|75855|P1|Washout First Intervention|Protocol Violation|0
14351|NCT01928381|75849|P7|Part 2 - First Intervention|Lost to Follow-up|0
14352|NCT01928381|75850|P6|Part 2 - First Intervention|Lost to Follow-up|0
14353|NCT01928381|75851|P5|Part 2 - First Intervention|Lost to Follow-up|0
14354|NCT01928381|75852|P4|Part 2 - First Intervention|Lost to Follow-up|1
14355|NCT01928381|75853|P3|Part 2 - First Intervention|Lost to Follow-up|0
14356|NCT01928381|75854|P2|Part 2 - First Intervention|Lost to Follow-up|0
14357|NCT01928381|75855|P1|Part 2 - First Intervention|Lost to Follow-up|0
14358|NCT01928381|75849|P7|Part 2 - First Intervention|Eligibility criterion not met|1
14359|NCT01928381|75850|P6|Part 2 - First Intervention|Eligibility criterion not met|1
14360|NCT01928381|75851|P5|Part 2 - First Intervention|Eligibility criterion not met|0
14361|NCT01928381|75852|P4|Part 2 - First Intervention|Eligibility criterion not met|0
14362|NCT01928381|75853|P3|Part 2 - First Intervention|Eligibility criterion not met|0
14363|NCT01928381|75854|P2|Part 2 - First Intervention|Eligibility criterion not met|0
14364|NCT01928381|75855|P1|Part 2 - First Intervention|Eligibility criterion not met|0
14365|NCT01928381|75849|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
14366|NCT01928381|75850|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
14367|NCT01928381|75851|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
14368|NCT01928381|75852|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
14369|NCT01928381|75853|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
14370|NCT01928381|75854|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
14371|NCT01928381|75855|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
14372|NCT01928381|75849|P7|Part 2 - First Intervention|Withdrawal by Subject|0
14373|NCT01928381|75850|P6|Part 2 - First Intervention|Withdrawal by Subject|0
14374|NCT01928381|75851|P5|Part 2 - First Intervention|Withdrawal by Subject|0
14375|NCT01928381|75852|P4|Part 2 - First Intervention|Withdrawal by Subject|0
14376|NCT01928381|75853|P3|Part 2 - First Intervention|Withdrawal by Subject|1
14377|NCT01928381|75854|P2|Part 2 - First Intervention|Withdrawal by Subject|0
14378|NCT01928381|75855|P1|Part 2 - First Intervention|Withdrawal by Subject|0
14379|NCT01928381|75849|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
14380|NCT01928381|75850|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
14381|NCT01928381|75851|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
14382|NCT01928381|75852|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
14383|NCT01928381|75853|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
14384|NCT01928381|75854|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
14385|NCT01928381|75855|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
14386|NCT01928381|75849|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
14387|NCT01928381|75850|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
14388|NCT01928381|75851|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
14389|NCT01928381|75852|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
14390|NCT01928381|75853|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
14391|NCT01928381|75854|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
14392|NCT01928381|75855|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
14393|NCT01928381|75849|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
14474|NCT01927055|75946|P2|Double-Blind|Protocol Violation|0
14394|NCT01928381|75850|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
14395|NCT01928381|75851|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
14396|NCT01928381|75852|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
14397|NCT01928381|75853|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
14398|NCT01928381|75854|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
14399|NCT01928381|75855|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
14400|NCT01928381|75849|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
14401|NCT01928381|75850|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
14402|NCT01928381|75851|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
14403|NCT01928381|75852|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
14404|NCT01928381|75853|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
14405|NCT01928381|75854|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
14406|NCT01928381|75855|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
14407|NCT01928381|75849|P7|Part 1 - Pain Training|Protocol Violation|0
14408|NCT01928381|75850|P6|Part 1 - Pain Training|Protocol Violation|0
14409|NCT01928381|75851|P5|Part 1 - Pain Training|Protocol Violation|0
14410|NCT01928381|75852|P4|Part 1 - Pain Training|Protocol Violation|0
14411|NCT01928381|75853|P3|Part 1 - Pain Training|Protocol Violation|0
14412|NCT01928381|75854|P2|Part 1 - Pain Training|Protocol Violation|0
14413|NCT01928381|75855|P1|Part 1 - Pain Training|Protocol Violation|1
14414|NCT01928381|75849|P7|Part 1 - Pain Training|Lost to Follow-up|0
14415|NCT01928381|75850|P6|Part 1 - Pain Training|Lost to Follow-up|0
14416|NCT01928381|75851|P5|Part 1 - Pain Training|Lost to Follow-up|0
14417|NCT01928381|75852|P4|Part 1 - Pain Training|Lost to Follow-up|0
14418|NCT01928381|75853|P3|Part 1 - Pain Training|Lost to Follow-up|0
14419|NCT01928381|75854|P2|Part 1 - Pain Training|Lost to Follow-up|0
14420|NCT01928381|75855|P1|Part 1 - Pain Training|Lost to Follow-up|4
14421|NCT01928381|75849|P7|Part 1 - Pain Training|Withdrawal by Subject|0
14422|NCT01928381|75850|P6|Part 1 - Pain Training|Withdrawal by Subject|0
14423|NCT01928381|75851|P5|Part 1 - Pain Training|Withdrawal by Subject|0
14424|NCT01928381|75852|P4|Part 1 - Pain Training|Withdrawal by Subject|0
14425|NCT01928381|75853|P3|Part 1 - Pain Training|Withdrawal by Subject|0
14426|NCT01928381|75854|P2|Part 1 - Pain Training|Withdrawal by Subject|0
14427|NCT01928381|75855|P1|Part 1 - Pain Training|Withdrawal by Subject|1
14428|NCT01928381|75849|P7|Part 1 - Pain Training|Pain training criteria not met|0
14429|NCT01928381|75850|P6|Part 1 - Pain Training|Pain training criteria not met|0
14430|NCT01928381|75851|P5|Part 1 - Pain Training|Pain training criteria not met|0
14431|NCT01928381|75852|P4|Part 1 - Pain Training|Pain training criteria not met|0
14432|NCT01928381|75853|P3|Part 1 - Pain Training|Pain training criteria not met|0
14433|NCT01928381|75854|P2|Part 1 - Pain Training|Pain training criteria not met|0
14434|NCT01928381|75855|P1|Part 1 - Pain Training|Pain training criteria not met|29
14435|NCT01928381|75849|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
14436|NCT01928381|75850|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
14437|NCT01928381|75851|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
14438|NCT01928381|75852|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
14439|NCT01928381|75853|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
14440|NCT01928381|75854|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
14441|NCT01928381|75855|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
14442|NCT01927757|75882|P1|Overall Study|Ethical Reasons|4
14443|NCT01927757|75882|P1|Overall Study|Other|1
14444|NCT01927757|75882|P1|Overall Study|Decision by Sponsor|2
14445|NCT01927757|75882|P1|Overall Study|Lost to Follow-up|2
14446|NCT01927757|75882|P1|Overall Study|Withdrawal by Subject|14
14447|NCT01927419|75910|P2|Overall Study|Not reported|0
14448|NCT01927419|75911|P1|Overall Study|Not reported|1
14449|NCT01927419|75910|P2|Overall Study|Not specified|1
14450|NCT01927419|75911|P1|Overall Study|Not specified|2
14451|NCT01927419|75910|P2|Overall Study|Withdrawal by Subject|1
14452|NCT01927419|75911|P1|Overall Study|Withdrawal by Subject|3
14453|NCT01927419|75910|P2|Overall Study|Adverse event unrelated to study drug|1
14454|NCT01927419|75911|P1|Overall Study|Adverse event unrelated to study drug|6
14455|NCT01927419|75910|P2|Overall Study|Death|1
14456|NCT01927419|75911|P1|Overall Study|Death|0
14457|NCT01927419|75910|P2|Overall Study|Study drug toxicity|7
14458|NCT01927419|75911|P1|Overall Study|Study drug toxicity|43
14459|NCT01927419|75910|P2|Overall Study|Disease progression|17
14460|NCT01927419|75911|P1|Overall Study|Disease progression|15
14461|NCT01927055|75945|P3|Double-Blind|Extended Vacation|0
14462|NCT01927055|75946|P2|Double-Blind|Extended Vacation|1
14463|NCT01927055|75947|P1|Double-Blind|Extended Vacation|0
14464|NCT01927055|75945|P3|Double-Blind|Supine Hypertension|1
14465|NCT01927055|75946|P2|Double-Blind|Supine Hypertension|0
14466|NCT01927055|75947|P1|Double-Blind|Supine Hypertension|0
14467|NCT01927055|75945|P3|Double-Blind|Study Stopped|7
14468|NCT01927055|75946|P2|Double-Blind|Study Stopped|7
14469|NCT01927055|75947|P1|Double-Blind|Study Stopped|0
14470|NCT01927055|75945|P3|Double-Blind|Withdrawal by Subject|3
14471|NCT01927055|75946|P2|Double-Blind|Withdrawal by Subject|2
14472|NCT01927055|75947|P1|Double-Blind|Withdrawal by Subject|0
14473|NCT01927055|75945|P3|Double-Blind|Protocol Violation|1
14475|NCT01927055|75947|P1|Double-Blind|Protocol Violation|0
14476|NCT01927055|75945|P3|Double-Blind|Adverse Event|1
14477|NCT01927055|75946|P2|Double-Blind|Adverse Event|1
14478|NCT01927055|75947|P1|Double-Blind|Adverse Event|0
14479|NCT01927055|75945|P3|Open-label|Difficulty attending study visits|0
14480|NCT01927055|75946|P2|Open-label|Difficulty attending study visits|0
14481|NCT01927055|75947|P1|Open-label|Difficulty attending study visits|1
14482|NCT01927055|75945|P3|Open-label|Supine Hypertension|0
14483|NCT01927055|75946|P2|Open-label|Supine Hypertension|0
14484|NCT01927055|75947|P1|Open-label|Supine Hypertension|4
14485|NCT01927055|75945|P3|Open-label|Study Stopped|0
14486|NCT01927055|75946|P2|Open-label|Study Stopped|0
14487|NCT01927055|75947|P1|Open-label|Study Stopped|4
14488|NCT01927055|75945|P3|Open-label|Withdrawal by Subject|0
14489|NCT01927055|75946|P2|Open-label|Withdrawal by Subject|0
14490|NCT01927055|75947|P1|Open-label|Withdrawal by Subject|1
14491|NCT01927055|75945|P3|Open-label|Adverse Event|0
14492|NCT01927055|75946|P2|Open-label|Adverse Event|0
14493|NCT01927055|75947|P1|Open-label|Adverse Event|6
14494|NCT01926782|75971|P6|Overall Study|Related to study drug administration|2
14495|NCT01926782|75972|P5|Overall Study|Related to study drug administration|0
14496|NCT01926782|75973|P4|Overall Study|Related to study drug administration|0
14497|NCT01926782|75974|P3|Overall Study|Related to study drug administration|0
14498|NCT01926782|75975|P2|Overall Study|Related to study drug administration|0
14499|NCT01926782|75976|P1|Overall Study|Related to study drug administration|0
14500|NCT01926782|75971|P6|Overall Study|Withdrawal by Subject|5
14501|NCT01926782|75972|P5|Overall Study|Withdrawal by Subject|0
14502|NCT01926782|75973|P4|Overall Study|Withdrawal by Subject|1
14503|NCT01926782|75974|P3|Overall Study|Withdrawal by Subject|8
14504|NCT01926782|75975|P2|Overall Study|Withdrawal by Subject|1
14505|NCT01926782|75976|P1|Overall Study|Withdrawal by Subject|6
14506|NCT01926782|75971|P6|Overall Study|Randomized and not treated|0
14507|NCT01926782|75972|P5|Overall Study|Randomized and not treated|0
14508|NCT01926782|75973|P4|Overall Study|Randomized and not treated|1
14509|NCT01926782|75974|P3|Overall Study|Randomized and not treated|0
14510|NCT01926782|75975|P2|Overall Study|Randomized and not treated|0
14511|NCT01926782|75976|P1|Overall Study|Randomized and not treated|0
14512|NCT01926782|75971|P6|Overall Study|Poor compliance to protocol|6
14513|NCT01926782|75972|P5|Overall Study|Poor compliance to protocol|1
14514|NCT01926782|75973|P4|Overall Study|Poor compliance to protocol|0
14515|NCT01926782|75974|P3|Overall Study|Poor compliance to protocol|8
14516|NCT01926782|75975|P2|Overall Study|Poor compliance to protocol|3
14517|NCT01926782|75976|P1|Overall Study|Poor compliance to protocol|5
14518|NCT01926782|75971|P6|Overall Study|Adverse Event|14
14519|NCT01926782|75972|P5|Overall Study|Adverse Event|3
14520|NCT01926782|75973|P4|Overall Study|Adverse Event|4
14521|NCT01926782|75974|P3|Overall Study|Adverse Event|17
14522|NCT01926782|75975|P2|Overall Study|Adverse Event|4
14523|NCT01926782|75976|P1|Overall Study|Adverse Event|13
14524|NCT01926782|75971|P6|Overall Study|Other than specified|11
14525|NCT01926782|75972|P5|Overall Study|Other than specified|4
14526|NCT01926782|75973|P4|Overall Study|Other than specified|12
14527|NCT01926782|75974|P3|Overall Study|Other than specified|5
14528|NCT01926782|75975|P2|Overall Study|Other than specified|3
14529|NCT01926782|75976|P1|Overall Study|Other than specified|2
14530|NCT01926782|75971|P6|Overall Study|Physician Decision|0
14531|NCT01926782|75972|P5|Overall Study|Physician Decision|0
14532|NCT01926782|75973|P4|Overall Study|Physician Decision|1
14533|NCT01926782|75974|P3|Overall Study|Physician Decision|1
14534|NCT01926782|75975|P2|Overall Study|Physician Decision|2
14535|NCT01926782|75976|P1|Overall Study|Physician Decision|0
14536|NCT01926782|75971|P6|Overall Study|Participant moved|3
14537|NCT01926782|75972|P5|Overall Study|Participant moved|0
14538|NCT01926782|75973|P4|Overall Study|Participant moved|1
14539|NCT01926782|75974|P3|Overall Study|Participant moved|1
14540|NCT01926782|75975|P2|Overall Study|Participant moved|0
14541|NCT01926782|75976|P1|Overall Study|Participant moved|2
14542|NCT01926626|76125|P1|Overall Study|Lost to Follow-up|7
14543|NCT01926626|76125|P1|Overall Study|Withdrawal by Subject|15
14544|NCT01926119|76135|P1|Overall Study|Withdrawal by Subject|1
14545|NCT01926015|76147|P2|Overall Study|Randomized not treated|0
14546|NCT01926015|76148|P1|Overall Study|Randomized not treated|2
14547|NCT01926015|76147|P2|Overall Study|Withdrawal by parent/guardian|1
14548|NCT01926015|76148|P1|Overall Study|Withdrawal by parent/guardian|0
14549|NCT01925768|76191|P2|Overall Study|Non-compliance with study drug|1
14550|NCT01925768|76192|P1|Overall Study|Non-compliance with study drug|0
14551|NCT01925768|76191|P2|Overall Study|Withdrawal by Subject|4
14552|NCT01925768|76192|P1|Overall Study|Withdrawal by Subject|1
14553|NCT01925768|76191|P2|Overall Study|Lack of Efficacy|6
14554|NCT01925768|76192|P1|Overall Study|Lack of Efficacy|3
14555|NCT01925768|76191|P2|Overall Study|Adverse Event|10
14556|NCT01925768|76192|P1|Overall Study|Adverse Event|5
14557|NCT01925768|76191|P2|Overall Study|Protocol Violation|2
14558|NCT01925768|76192|P1|Overall Study|Protocol Violation|1
14559|NCT01925768|76191|P2|Overall Study|Lost to Follow-up|0
14560|NCT01925768|76192|P1|Overall Study|Lost to Follow-up|1
14561|NCT01925703|76200|P1|Overall Study|Discharge prior to full iron repletion|1
14562|NCT01925703|76200|P1|Overall Study|Lost to Follow-up|2
14563|NCT01925703|76200|P1|Overall Study|Physician Decision|1
14564|NCT01925417|76219|P1|Overall Study|Death|1
14565|NCT01925417|76219|P1|Overall Study|Withdrawal by Subject|2
14566|NCT01925274|76229|P3|Overall Study|Protocol amendment|6
14567|NCT01925274|76230|P2|Overall Study|Protocol amendment|3
14568|NCT01925274|76231|P1|Overall Study|Protocol amendment|1
14569|NCT01925274|76229|P3|Overall Study|Study terminated by sponsor|0
14570|NCT01925274|76230|P2|Overall Study|Study terminated by sponsor|0
14571|NCT01925274|76231|P1|Overall Study|Study terminated by sponsor|4
14572|NCT01925274|76229|P3|Overall Study|Withdrawal by Subject|0
14573|NCT01925274|76230|P2|Overall Study|Withdrawal by Subject|2
14574|NCT01925274|76231|P1|Overall Study|Withdrawal by Subject|1
14575|NCT01925274|76229|P3|Overall Study|Lost to Follow-up|0
14576|NCT01925274|76230|P2|Overall Study|Lost to Follow-up|1
14577|NCT01925274|76231|P1|Overall Study|Lost to Follow-up|0
14578|NCT01925274|76229|P3|Overall Study|Death|0
14579|NCT01925274|76230|P2|Overall Study|Death|0
14580|NCT01925274|76231|P1|Overall Study|Death|1
14581|NCT01925209|76312|P4|Follow-up|Withdrawal by Subject|2
14582|NCT01925209|76313|P3|Follow-up|Withdrawal by Subject|0
14583|NCT01925209|76314|P2|Follow-up|Withdrawal by Subject|2
14584|NCT01925209|76315|P1|Follow-up|Withdrawal by Subject|0
14585|NCT01925209|76312|P4|Follow-up|Non-compliance with study treatment|1
14586|NCT01925209|76313|P3|Follow-up|Non-compliance with study treatment|0
14587|NCT01925209|76314|P2|Follow-up|Non-compliance with study treatment|0
14588|NCT01925209|76315|P1|Follow-up|Non-compliance with study treatment|0
14589|NCT01925209|76312|P4|Follow-up|Physician Decision|0
14590|NCT01925209|76313|P3|Follow-up|Physician Decision|1
14591|NCT01925209|76314|P2|Follow-up|Physician Decision|0
14592|NCT01925209|76315|P1|Follow-up|Physician Decision|0
14593|NCT01925209|76312|P4|Follow-up|Adverse Event|1
14594|NCT01925209|76313|P3|Follow-up|Adverse Event|0
14595|NCT01925209|76314|P2|Follow-up|Adverse Event|4
14596|NCT01925209|76315|P1|Follow-up|Adverse Event|1
14597|NCT01925209|76312|P4|Maintenance Treatment Epoch|Adverse Event|0
14598|NCT01925209|76313|P3|Maintenance Treatment Epoch|Adverse Event|1
14599|NCT01925209|76314|P2|Maintenance Treatment Epoch|Adverse Event|0
14600|NCT01925209|76315|P1|Maintenance Treatment Epoch|Adverse Event|0
14601|NCT01925209|76312|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
14602|NCT01925209|76313|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
14603|NCT01925209|76314|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
14604|NCT01925209|76315|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
14605|NCT01925209|76312|P4|Treatment Epoch|Adverse Event|1
14606|NCT01925209|76313|P3|Treatment Epoch|Adverse Event|3
14607|NCT01925209|76314|P2|Treatment Epoch|Adverse Event|5
14608|NCT01925209|76315|P1|Treatment Epoch|Adverse Event|3
14609|NCT01925209|76312|P4|Treatment Epoch|Withdrawal by Subject|2
14610|NCT01925209|76313|P3|Treatment Epoch|Withdrawal by Subject|3
14611|NCT01925209|76314|P2|Treatment Epoch|Withdrawal by Subject|3
14612|NCT01925209|76315|P1|Treatment Epoch|Withdrawal by Subject|4
14613|NCT01925209|76312|P4|Treatment Epoch|Protocol deviation|1
14614|NCT01925209|76313|P3|Treatment Epoch|Protocol deviation|1
14615|NCT01925209|76314|P2|Treatment Epoch|Protocol deviation|0
14616|NCT01925209|76315|P1|Treatment Epoch|Protocol deviation|0
14617|NCT01925209|76312|P4|Treatment Epoch|Death|0
14618|NCT01925209|76313|P3|Treatment Epoch|Death|0
14619|NCT01925209|76314|P2|Treatment Epoch|Death|0
14620|NCT01925209|76315|P1|Treatment Epoch|Death|1
14621|NCT01925209|76312|P4|Treatment Epoch|Non-compliance with study treatment|1
14622|NCT01925209|76313|P3|Treatment Epoch|Non-compliance with study treatment|0
14623|NCT01925209|76314|P2|Treatment Epoch|Non-compliance with study treatment|0
14624|NCT01925209|76315|P1|Treatment Epoch|Non-compliance with study treatment|0
14625|NCT01925209|76312|P4|Treatment Epoch|Physician Decision|0
14626|NCT01925209|76313|P3|Treatment Epoch|Physician Decision|0
14627|NCT01925209|76314|P2|Treatment Epoch|Physician Decision|0
14628|NCT01925209|76315|P1|Treatment Epoch|Physician Decision|1
14629|NCT01925183|76347|P2|Overall Study|Adverse Event|0
14630|NCT01925183|76348|P1|Overall Study|Adverse Event|1
14631|NCT01925170|76356|P1|Overall Study|Unverified cancer status|53
14632|NCT01924767|76417|P5|Overall Study|Adverse Event|0
14633|NCT01924767|76418|P4|Overall Study|Adverse Event|0
14634|NCT01924767|76419|P3|Overall Study|Adverse Event|1
14635|NCT01924767|76420|P2|Overall Study|Adverse Event|0
14636|NCT01924767|76421|P1|Overall Study|Adverse Event|1
14637|NCT01924299|76550|P2|Period 2|Adverse Event|1
14638|NCT01924299|76551|P1|Period 2|Adverse Event|0
14639|NCT01924299|76550|P2|Period 2|Withdrawal by Subject|0
14640|NCT01924299|76551|P1|Period 2|Withdrawal by Subject|1
14641|NCT01924182|76573|P2|Overall Study|Withdrawal by Subject|0
14642|NCT01924182|76574|P1|Overall Study|Withdrawal by Subject|1
14643|NCT01923896|76582|P2|Overall Study|Adverse Event|0
14644|NCT01923896|76583|P1|Overall Study|Adverse Event|1
14645|NCT01923467|76767|P1|Overall Study|Subject non-interest|479
14646|NCT01923467|76767|P1|Overall Study|Lost to Follow-up|62
14647|NCT01923389|76773|P2|Overall Study|Protocol Violation|0
14648|NCT01923389|76774|P1|Overall Study|Protocol Violation|1
14649|NCT01922934|76811|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
14650|NCT01922934|76812|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
14651|NCT01922934|76811|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
14652|NCT01922934|76812|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
14653|NCT01922934|76811|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
14654|NCT01922934|76812|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
14655|NCT01922934|76811|P2|Eligible Patients|Did not meet inclusion criteria|81
14656|NCT01922934|76812|P1|Eligible Patients|Did not meet inclusion criteria|36
14657|NCT01922934|76811|P2|Eligible Patients|Physician Decision|0
14658|NCT01922934|76812|P1|Eligible Patients|Physician Decision|17
14659|NCT01922934|76811|P2|Eligible Patients|Death|7
14660|NCT01922934|76812|P1|Eligible Patients|Death|0
14661|NCT01922739|76824|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
14662|NCT01922739|76824|P1|Open-label Treatment Period|Physician Decision|1
14663|NCT01922739|76824|P1|Open-label Treatment Period|Lost to Follow-up|2
14664|NCT01922739|76824|P1|Open-label Treatment Period|Noncompliance to study procedures|1
14665|NCT01922739|76824|P1|Open-label Treatment Period|Pregnancy|1
14666|NCT01922739|76824|P1|Open-label Treatment Period|Protocol Violation|5
14667|NCT01922739|76824|P1|Open-label Treatment Period|Noncompliance to study medication|3
14668|NCT01922739|76824|P1|Open-label Treatment Period|Withdrawal by Subject|14
14669|NCT01922739|76824|P1|Open-label Treatment Period|Adverse Event|6
14670|NCT01922739|76824|P1|Titration/Adjustment Period|Lack of Efficacy|3
14671|NCT01922739|76824|P1|Titration/Adjustment Period|Lost to Follow-up|1
14672|NCT01922739|76824|P1|Titration/Adjustment Period|Withdrawal by Subject|5
14673|NCT01922739|76824|P1|Titration/Adjustment Period|Adverse Event|3
14674|NCT01922349|76853|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
14675|NCT01922349|76854|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
14676|NCT01922349|76855|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
14677|NCT01922349|76856|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
14678|NCT01922271|76963|P2|WASHOUT Period|Withdrawal by Subject|0
14679|NCT01922271|76964|P1|WASHOUT Period|Withdrawal by Subject|1
14680|NCT01922089|77003|P2|Overall Study|Lost to Follow-up|1
14681|NCT01922089|77004|P1|Overall Study|Lost to Follow-up|0
14682|NCT01922089|77003|P2|Overall Study|Death|1
14683|NCT01922089|77004|P1|Overall Study|Death|2
14684|NCT01922089|77003|P2|Overall Study|Physician Decision|3
14685|NCT01922089|77004|P1|Overall Study|Physician Decision|2
14686|NCT01922089|77003|P2|Overall Study|administrative problems|1
14687|NCT01922089|77004|P1|Overall Study|administrative problems|4
14688|NCT01922089|77003|P2|Overall Study|Withdrawal by Subject|4
14689|NCT01922089|77004|P1|Overall Study|Withdrawal by Subject|3
14690|NCT01922089|77003|P2|Overall Study|Protocol Deviation|7
14691|NCT01922089|77004|P1|Overall Study|Protocol Deviation|10
14692|NCT01922089|77003|P2|Overall Study|Adverse Event|13
14693|NCT01922089|77004|P1|Overall Study|Adverse Event|18
14694|NCT01922011|77016|P2|Overall Study|Randomized in error|0
14695|NCT01922011|77017|P1|Overall Study|Randomized in error|1
14696|NCT01922011|77016|P2|Overall Study|Lack of willing home health agency|0
14697|NCT01922011|77017|P1|Overall Study|Lack of willing home health agency|1
14698|NCT01922011|77016|P2|Overall Study|Not Treated|0
14699|NCT01922011|77017|P1|Overall Study|Not Treated|1
14700|NCT01922011|77016|P2|Overall Study|Missed Test-of-Cure Visit|2
14701|NCT01922011|77017|P1|Overall Study|Missed Test-of-Cure Visit|0
14702|NCT01922011|77016|P2|Overall Study|Lost to Follow-up|1
14703|NCT01922011|77017|P1|Overall Study|Lost to Follow-up|0
14704|NCT01922011|77016|P2|Overall Study|Parent/Guardian Decision|0
14705|NCT01922011|77017|P1|Overall Study|Parent/Guardian Decision|3
14706|NCT01922011|77016|P2|Overall Study|Physician Decision|1
14707|NCT01922011|77017|P1|Overall Study|Physician Decision|0
14708|NCT01922011|77016|P2|Overall Study|Protocol Violation|1
14709|NCT01922011|77017|P1|Overall Study|Protocol Violation|0
14710|NCT01921829|77084|P2|Overall Study|Withdrawal by Subject|1
14711|NCT01921829|77085|P1|Overall Study|Withdrawal by Subject|0
14712|NCT01921348|77138|P2|Overall Study|Lost to Follow-up|2
14713|NCT01921348|77139|P1|Overall Study|Lost to Follow-up|0
14714|NCT01921348|77138|P2|Overall Study|Withdrawal by Subject|0
14715|NCT01921348|77139|P1|Overall Study|Withdrawal by Subject|1
14716|NCT01921101|77170|P2|Overall Study|Death|6
14717|NCT01921101|77171|P1|Overall Study|Death|16
14718|NCT01920958|77179|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
14719|NCT01920893|77197|P2|Overall Study|Lack of Efficacy|0
14720|NCT01920893|77198|P1|Overall Study|Lack of Efficacy|2
14721|NCT01920893|77197|P2|Overall Study|Adverse Event|2
14722|NCT01920893|77198|P1|Overall Study|Adverse Event|5
14723|NCT01920854|77231|P7|Overall Study|Withdrawal by Subject|1
14724|NCT01920854|77232|P6|Overall Study|Withdrawal by Subject|0
14725|NCT01920854|77233|P5|Overall Study|Withdrawal by Subject|1
14726|NCT01920854|77234|P4|Overall Study|Withdrawal by Subject|0
14727|NCT01920854|77235|P3|Overall Study|Withdrawal by Subject|0
14728|NCT01920854|77236|P2|Overall Study|Withdrawal by Subject|0
14729|NCT01920854|77237|P1|Overall Study|Withdrawal by Subject|1
14730|NCT01920568|77397|P2|Overall Study|Death due to disease progression|12
14731|NCT01920568|77398|P1|Overall Study|Death due to disease progression|25
14732|NCT01920568|77397|P2|Overall Study|Withdrawal by Subject|55
14733|NCT01920568|77398|P1|Overall Study|Withdrawal by Subject|79
14734|NCT01920568|77397|P2|Overall Study|Physician Decision|4
14735|NCT01920568|77398|P1|Overall Study|Physician Decision|13
14736|NCT01920568|77397|P2|Overall Study|Lost to Follow-up|2
14737|NCT01920568|77398|P1|Overall Study|Lost to Follow-up|2
14738|NCT01920568|77397|P2|Overall Study|Protocol Violation|3
14739|NCT01920568|77398|P1|Overall Study|Protocol Violation|5
14740|NCT01920568|77397|P2|Overall Study|Adverse Event|8
14741|NCT01920568|77398|P1|Overall Study|Adverse Event|27
14742|NCT01920178|77437|P2|Overall Study|Lost to Follow-up|1
14743|NCT01920178|77438|P1|Overall Study|Lost to Follow-up|2
14744|NCT01919801|77456|P2|Overall Study|Unspecified|1
14745|NCT01919801|77457|P1|Overall Study|Unspecified|0
14746|NCT01919801|77456|P2|Overall Study|Lost to Follow-up|1
14747|NCT01919801|77457|P1|Overall Study|Lost to Follow-up|0
14748|NCT01919801|77456|P2|Overall Study|Physician Decision|1
14749|NCT01919801|77457|P1|Overall Study|Physician Decision|0
14750|NCT01919801|77456|P2|Overall Study|Withdrawal by Subject|0
14751|NCT01919801|77457|P1|Overall Study|Withdrawal by Subject|1
14752|NCT01919723|77482|P2|Overall Study|Blood Samples Hemolyzed|2
14753|NCT01919723|77483|P1|Overall Study|Blood Samples Hemolyzed|2
14754|NCT01919229|77526|P3|Overall Study|Subject/guardian decision|1
14755|NCT01919229|77527|P2|Overall Study|Subject/guardian decision|0
14756|NCT01919229|77528|P1|Overall Study|Subject/guardian decision|0
14757|NCT01918371|77580|P2|Overall Study|Missing Data|1
14758|NCT01918371|77581|P1|Overall Study|Missing Data|1
14759|NCT01918332|77659|P4|Overall Study|lipid result by central lab did not meet|0
14760|NCT01918332|77660|P3|Overall Study|lipid result by central lab did not meet|1
14761|NCT01918332|77661|P2|Overall Study|lipid result by central lab did not meet|0
14762|NCT01918332|77662|P1|Overall Study|lipid result by central lab did not meet|0
14763|NCT01918332|77659|P4|Overall Study|Protocol Violation|3
14764|NCT01918332|77660|P3|Overall Study|Protocol Violation|6
14765|NCT01918332|77661|P2|Overall Study|Protocol Violation|2
14766|NCT01918332|77662|P1|Overall Study|Protocol Violation|6
14767|NCT01918332|77659|P4|Overall Study|Withdrawal by Subject|3
14768|NCT01918332|77660|P3|Overall Study|Withdrawal by Subject|2
14769|NCT01918332|77661|P2|Overall Study|Withdrawal by Subject|3
14770|NCT01918332|77662|P1|Overall Study|Withdrawal by Subject|2
14771|NCT01918332|77659|P4|Overall Study|Adverse Event|1
14772|NCT01918332|77660|P3|Overall Study|Adverse Event|0
14773|NCT01918332|77661|P2|Overall Study|Adverse Event|0
14774|NCT01918332|77662|P1|Overall Study|Adverse Event|0
14775|NCT01918306|77674|P4|Overall Study|progress disease, crossover|0
14776|NCT01918306|77675|P3|Overall Study|progress disease, crossover|1
14777|NCT01918306|77676|P2|Overall Study|progress disease, crossover|0
14778|NCT01918306|77677|P1|Overall Study|progress disease, crossover|0
14779|NCT01918306|77674|P4|Overall Study|Lack of Efficacy|0
14780|NCT01918306|77675|P3|Overall Study|Lack of Efficacy|0
14781|NCT01918306|77676|P2|Overall Study|Lack of Efficacy|0
14782|NCT01918306|77677|P1|Overall Study|Lack of Efficacy|1
14783|NCT01918306|77674|P4|Overall Study|neutropenia|0
14784|NCT01918306|77675|P3|Overall Study|neutropenia|0
14785|NCT01918306|77676|P2|Overall Study|neutropenia|0
14786|NCT01918306|77677|P1|Overall Study|neutropenia|1
14787|NCT01918306|77674|P4|Overall Study|Withdrawal by Subject|2
14788|NCT01918306|77675|P3|Overall Study|Withdrawal by Subject|0
14789|NCT01918306|77676|P2|Overall Study|Withdrawal by Subject|0
14790|NCT01918306|77677|P1|Overall Study|Withdrawal by Subject|0
14791|NCT01918306|77674|P4|Overall Study|progresive disease|1
14792|NCT01918306|77675|P3|Overall Study|progresive disease|1
14793|NCT01918306|77676|P2|Overall Study|progresive disease|0
14794|NCT01918306|77677|P1|Overall Study|progresive disease|4
14795|NCT01918085|77699|P2|Test Period 1: Strata Strip|Adverse Event|1
14796|NCT01918085|77700|P1|Test Period 1: Strata Strip|Adverse Event|0
14797|NCT01918033|77711|P3|Overall Study|Withdrawal by Subject|0
14798|NCT01918033|77712|P2|Overall Study|Withdrawal by Subject|1
14799|NCT01918033|77713|P1|Overall Study|Withdrawal by Subject|2
14800|NCT01918033|77711|P3|Overall Study|Protocol Violation|1
14801|NCT01918033|77712|P2|Overall Study|Protocol Violation|0
14802|NCT01918033|77713|P1|Overall Study|Protocol Violation|2
14803|NCT01918033|77711|P3|Overall Study|Lost to Follow-up|0
14804|NCT01918033|77712|P2|Overall Study|Lost to Follow-up|1
14805|NCT01918033|77713|P1|Overall Study|Lost to Follow-up|0
14806|NCT01918033|77711|P3|Overall Study|Adverse Event|2
14807|NCT01918033|77712|P2|Overall Study|Adverse Event|0
14808|NCT01918033|77713|P1|Overall Study|Adverse Event|1
14809|NCT01917656|77784|P2|Overall Study|Lost to Follow-up|4
14810|NCT01917656|77785|P1|Overall Study|Lost to Follow-up|3
14811|NCT01917656|77784|P2|Overall Study|Withdrawal by Subject|3
14812|NCT01917656|77785|P1|Overall Study|Withdrawal by Subject|4
14813|NCT01917656|77784|P2|Overall Study|Unclassified|3
14814|NCT01917656|77785|P1|Overall Study|Unclassified|0
14815|NCT01917656|77784|P2|Overall Study|Withdrawal criteria|14
14816|NCT01917656|77785|P1|Overall Study|Withdrawal criteria|8
14817|NCT01917656|77784|P2|Overall Study|Adverse Event|0
14818|NCT01917656|77785|P1|Overall Study|Adverse Event|11
14819|NCT01917526|77811|P2|Overall Study|Protocol Violation|1
14820|NCT01917526|77812|P1|Overall Study|Protocol Violation|1
14821|NCT01917344|77820|P1|Overall Study|Withdrawal by Subject|1
14822|NCT01916980|77835|P2|Overall Study|Withdrawal by Subject|0
14823|NCT01916980|77836|P1|Overall Study|Withdrawal by Subject|1
14824|NCT01916980|77835|P2|Overall Study|Lack of Efficacy|2
14825|NCT01916980|77836|P1|Overall Study|Lack of Efficacy|2
14826|NCT01916980|77835|P2|Overall Study|Adverse Event|2
14827|NCT01916980|77836|P1|Overall Study|Adverse Event|4
14828|NCT01916967|77855|P3|Overall Study|Protocol Violation|0
14829|NCT01916967|77856|P2|Overall Study|Protocol Violation|1
14830|NCT01916967|77857|P1|Overall Study|Protocol Violation|0
14831|NCT01916967|77855|P3|Overall Study|Physician Decision|1
14832|NCT01916967|77856|P2|Overall Study|Physician Decision|0
14833|NCT01916967|77857|P1|Overall Study|Physician Decision|0
14834|NCT01916967|77855|P3|Overall Study|Lack of Efficacy|6
14835|NCT01916967|77856|P2|Overall Study|Lack of Efficacy|0
14836|NCT01916967|77857|P1|Overall Study|Lack of Efficacy|0
14837|NCT01916967|77855|P3|Overall Study|Adverse Event|2
14838|NCT01916967|77856|P2|Overall Study|Adverse Event|0
14839|NCT01916967|77857|P1|Overall Study|Adverse Event|0
14840|NCT01916304|77965|P1|Overall Study|Screening failure|17
14841|NCT01916226|77977|P4|Overall Study|Physician Decision|1
14842|NCT01916226|77978|P3|Overall Study|Physician Decision|0
14843|NCT01916226|77979|P2|Overall Study|Physician Decision|0
14844|NCT01916226|77980|P1|Overall Study|Physician Decision|0
14845|NCT01916226|77977|P4|Overall Study|Protocol Violation|1
14846|NCT01916226|77978|P3|Overall Study|Protocol Violation|0
14847|NCT01916226|77979|P2|Overall Study|Protocol Violation|1
14848|NCT01916226|77980|P1|Overall Study|Protocol Violation|0
14849|NCT01916226|77977|P4|Overall Study|Lack of Efficacy|1
14850|NCT01916226|77978|P3|Overall Study|Lack of Efficacy|2
14851|NCT01916226|77979|P2|Overall Study|Lack of Efficacy|0
14852|NCT01916226|77980|P1|Overall Study|Lack of Efficacy|0
14853|NCT01916226|77977|P4|Overall Study|Adverse Event|1
14854|NCT01916226|77978|P3|Overall Study|Adverse Event|1
14855|NCT01916226|77979|P2|Overall Study|Adverse Event|0
14856|NCT01916226|77980|P1|Overall Study|Adverse Event|1
14857|NCT01916109|78014|P1|Overall Study|Withdrawal by Subject|1
14858|NCT01915914|78018|P4|Follow-up Phase|Physician Decision|1
14859|NCT01915914|78019|P3|Follow-up Phase|Physician Decision|0
14860|NCT01915914|78020|P2|Follow-up Phase|Physician Decision|0
14861|NCT01915914|78021|P1|Follow-up Phase|Physician Decision|0
14862|NCT01915914|78018|P4|Follow-up Phase|Withdrawal by Subject|1
14863|NCT01915914|78019|P3|Follow-up Phase|Withdrawal by Subject|0
14864|NCT01915914|78020|P2|Follow-up Phase|Withdrawal by Subject|0
14865|NCT01915914|78021|P1|Follow-up Phase|Withdrawal by Subject|0
14866|NCT01915914|78018|P4|Maintenance Phase|Missing|0
14867|NCT01915914|78019|P3|Maintenance Phase|Missing|0
14868|NCT01915914|78020|P2|Maintenance Phase|Missing|1
14869|NCT01915914|78021|P1|Maintenance Phase|Missing|0
14870|NCT01915914|78018|P4|Maintenance Phase|Lost to Follow-up|0
14871|NCT01915914|78019|P3|Maintenance Phase|Lost to Follow-up|1
14872|NCT01915914|78020|P2|Maintenance Phase|Lost to Follow-up|4
14873|NCT01915914|78021|P1|Maintenance Phase|Lost to Follow-up|0
14874|NCT01915914|78018|P4|Maintenance Phase|Withdrawal by Subject|0
14875|NCT01915914|78019|P3|Maintenance Phase|Withdrawal by Subject|1
14876|NCT01915914|78020|P2|Maintenance Phase|Withdrawal by Subject|1
14877|NCT01915914|78021|P1|Maintenance Phase|Withdrawal by Subject|0
14878|NCT01915914|78018|P4|Acute Phase|Missing|0
14879|NCT01915914|78019|P3|Acute Phase|Missing|0
14880|NCT01915914|78020|P2|Acute Phase|Missing|0
14881|NCT01915914|78021|P1|Acute Phase|Missing|1
14882|NCT01915914|78018|P4|Acute Phase|"Not Achieved treatment success"|0
14883|NCT01915914|78019|P3|Acute Phase|"Not Achieved treatment success"|0
14884|NCT01915914|78020|P2|Acute Phase|"Not Achieved treatment success"|0
14885|NCT01915914|78021|P1|Acute Phase|"Not Achieved treatment success"|1
14886|NCT01915914|78018|P4|Acute Phase|Accepted Other Topic Therapies|0
14887|NCT01915914|78019|P3|Acute Phase|Accepted Other Topic Therapies|0
14888|NCT01915914|78020|P2|Acute Phase|Accepted Other Topic Therapies|0
14889|NCT01915914|78021|P1|Acute Phase|Accepted Other Topic Therapies|1
14890|NCT01915914|78018|P4|Acute Phase|Physician Decision|0
14891|NCT01915914|78019|P3|Acute Phase|Physician Decision|0
14892|NCT01915914|78020|P2|Acute Phase|Physician Decision|0
14893|NCT01915914|78021|P1|Acute Phase|Physician Decision|1
14894|NCT01915914|78018|P4|Acute Phase|Lost to Follow-up|0
14895|NCT01915914|78019|P3|Acute Phase|Lost to Follow-up|0
14896|NCT01915914|78020|P2|Acute Phase|Lost to Follow-up|0
14897|NCT01915914|78021|P1|Acute Phase|Lost to Follow-up|4
14898|NCT01915914|78018|P4|Acute Phase|Withdrawal by Subject|0
14899|NCT01915914|78019|P3|Acute Phase|Withdrawal by Subject|0
14900|NCT01915914|78020|P2|Acute Phase|Withdrawal by Subject|0
14901|NCT01915914|78021|P1|Acute Phase|Withdrawal by Subject|4
14902|NCT01915849|78053|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
14903|NCT01915849|78054|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
14904|NCT01915849|78055|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
14905|NCT01915849|78056|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
14906|NCT01915849|78053|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
14907|NCT01915849|78054|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
14908|NCT01915849|78055|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
14909|NCT01915849|78056|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
14910|NCT01915732|78081|P2|Overall Study|Poor Conscious Effect|1
14911|NCT01915732|78082|P1|Overall Study|Poor Conscious Effect|0
14912|NCT01915732|78081|P2|Overall Study|Improper Facial Procedure|1
14913|NCT01915732|78082|P1|Overall Study|Improper Facial Procedure|0
14914|NCT01915732|78081|P2|Overall Study|Job Transfer|1
14915|NCT01915732|78082|P1|Overall Study|Job Transfer|0
14916|NCT01915732|78081|P2|Overall Study|Par. Refused to Hospital Visits|1
14917|NCT01915732|78082|P1|Overall Study|Par. Refused to Hospital Visits|0
14918|NCT01915732|78081|P2|Overall Study|Par. not Willing to Continue Treatment|1
14919|NCT01915732|78082|P1|Overall Study|Par. not Willing to Continue Treatment|0
14920|NCT01915732|78081|P2|Overall Study|Got Well|1
14921|NCT01915732|78082|P1|Overall Study|Got Well|0
14922|NCT01915732|78081|P2|Overall Study|Par. Unable to Come to the Hospital|1
14923|NCT01915732|78082|P1|Overall Study|Par. Unable to Come to the Hospital|0
14924|NCT01915732|78081|P2|Overall Study|Poor Perceived Efficacy|0
14925|NCT01915732|78082|P1|Overall Study|Poor Perceived Efficacy|1
14926|NCT01915732|78081|P2|Overall Study|Pregnancy|0
14927|NCT01915732|78082|P1|Overall Study|Pregnancy|1
14928|NCT01915732|78081|P2|Overall Study|Recovered|0
14929|NCT01915732|78082|P1|Overall Study|Recovered|1
14930|NCT01915732|78081|P2|Overall Study|Drug Release Error|0
14931|NCT01915732|78082|P1|Overall Study|Drug Release Error|1
14932|NCT01915732|78081|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
14933|NCT01915732|78082|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
14934|NCT01915732|78081|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
14935|NCT01915732|78082|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
14936|NCT01915732|78081|P2|Overall Study|Lost to Follow-up|26
14937|NCT01915732|78082|P1|Overall Study|Lost to Follow-up|22
14938|NCT01915732|78081|P2|Overall Study|Lack of Efficacy|11
14939|NCT01915732|78082|P1|Overall Study|Lack of Efficacy|6
14940|NCT01915732|78081|P2|Overall Study|Protocol Violation|5
14941|NCT01915732|78082|P1|Overall Study|Protocol Violation|5
14942|NCT01915732|78081|P2|Overall Study|Adverse Event|4
14943|NCT01915732|78082|P1|Overall Study|Adverse Event|12
14944|NCT01915732|78081|P2|Overall Study|Failure to Meet Randomization Criteria|0
14945|NCT01915732|78082|P1|Overall Study|Failure to Meet Randomization Criteria|1
14946|NCT01915732|78081|P2|Overall Study|Withdrawal by Subject|18
14947|NCT01915732|78082|P1|Overall Study|Withdrawal by Subject|18
14948|NCT01914926|78150|P2|Overall Study|uncooperative, agitated and removed|1
14949|NCT01914926|78151|P1|Overall Study|uncooperative, agitated and removed|0
14950|NCT01914926|78150|P2|Overall Study|Adverse Event|0
14951|NCT01914926|78151|P1|Overall Study|Adverse Event|1
14952|NCT01914757|78160|P3|Overall Study|Other reasons|4
14953|NCT01914757|78161|P2|Overall Study|Other reasons|9
14954|NCT01914757|78162|P1|Overall Study|Other reasons|5
14955|NCT01914757|78160|P3|Overall Study|Eligibility criteria not fulfilled|2
14956|NCT01914757|78161|P2|Overall Study|Eligibility criteria not fulfilled|0
14957|NCT01914757|78162|P1|Overall Study|Eligibility criteria not fulfilled|2
14958|NCT01914757|78160|P3|Overall Study|Study specific withdrawal criteria|0
14959|NCT01914757|78161|P2|Overall Study|Study specific withdrawal criteria|1
14960|NCT01914757|78162|P1|Overall Study|Study specific withdrawal criteria|0
14961|NCT01914757|78160|P3|Overall Study|Adverse Event|4
14962|NCT01914757|78161|P2|Overall Study|Adverse Event|3
14963|NCT01914757|78162|P1|Overall Study|Adverse Event|4
14964|NCT01914757|78160|P3|Overall Study|Death|1
14965|NCT01914757|78161|P2|Overall Study|Death|2
14966|NCT01914757|78162|P1|Overall Study|Death|2
14967|NCT01914757|78160|P3|Overall Study|Withdrawal by Subject|19
14968|NCT01914757|78161|P2|Overall Study|Withdrawal by Subject|27
14969|NCT01914757|78162|P1|Overall Study|Withdrawal by Subject|15
14970|NCT01914757|78160|P3|Overall Study|Lost to Follow-up|6
14971|NCT01914757|78161|P2|Overall Study|Lost to Follow-up|8
14972|NCT01914757|78162|P1|Overall Study|Lost to Follow-up|5
14973|NCT01914757|78160|P3|Overall Study|Severe non-compliance to protocol|2
14974|NCT01914757|78161|P2|Overall Study|Severe non-compliance to protocol|1
14975|NCT01914757|78162|P1|Overall Study|Severe non-compliance to protocol|3
14976|NCT01914679|78236|P1|Overall Study|Sponsor terminated study|4
14977|NCT01914679|78236|P1|Overall Study|Lack of Efficacy|1
14978|NCT01914666|78243|P3|Treatment Period|Physician Decision|2
14979|NCT01914666|78244|P2|Treatment Period|Physician Decision|0
14980|NCT01914666|78245|P1|Treatment Period|Physician Decision|0
14981|NCT01914666|78243|P3|Treatment Period|Withdrawal by Subject|2
14982|NCT01914666|78244|P2|Treatment Period|Withdrawal by Subject|2
14983|NCT01914666|78245|P1|Treatment Period|Withdrawal by Subject|3
14984|NCT01914666|78243|P3|Treatment Period|Adverse Event|2
14985|NCT01914666|78244|P2|Treatment Period|Adverse Event|4
14986|NCT01914666|78245|P1|Treatment Period|Adverse Event|10
14987|NCT01914666|78243|P3|Treatment Period|Lack of Efficacy|2
14988|NCT01914666|78244|P2|Treatment Period|Lack of Efficacy|0
14989|NCT01914666|78245|P1|Treatment Period|Lack of Efficacy|0
14990|NCT01913483|78350|P2|Overall Study|Death|17
14991|NCT01913483|78351|P1|Overall Study|Death|14
14992|NCT01913483|78350|P2|Overall Study|Lost to Follow-up|3
14993|NCT01913483|78351|P1|Overall Study|Lost to Follow-up|6
14994|NCT01913483|78350|P2|Overall Study|Withdrawal by Subject|2
14995|NCT01913483|78351|P1|Overall Study|Withdrawal by Subject|1
14996|NCT01913470|78363|P2|Overall Study|Withdrawal by Subject|1
14997|NCT01913470|78364|P1|Overall Study|Withdrawal by Subject|0
14998|NCT01913470|78363|P2|Overall Study|Physician Decision|1
14999|NCT01913470|78364|P1|Overall Study|Physician Decision|0
15000|NCT01913470|78363|P2|Overall Study|Lost to Follow-up|1
15001|NCT01913470|78364|P1|Overall Study|Lost to Follow-up|0
15002|NCT01913041|78382|P1|Overall Study|Physician Decision|1
15003|NCT01913041|78382|P1|Overall Study|Withdrawal by Subject|3
15004|NCT01913041|78382|P1|Overall Study|Protocol Violation|35
15005|NCT01912781|78388|P2|Overall Study|Withdrawal by Subject|0
15006|NCT01912781|78389|P1|Overall Study|Withdrawal by Subject|2
15007|NCT01912768|78420|P2|Overall Study|Randomized in error|0
15008|NCT01912768|78421|P1|Overall Study|Randomized in error|1
15009|NCT01912768|78420|P2|Overall Study|Withdrawal by Subject|3
15010|NCT01912768|78421|P1|Overall Study|Withdrawal by Subject|5
15011|NCT01912768|78420|P2|Overall Study|Lost to Follow-up|1
15012|NCT01912768|78421|P1|Overall Study|Lost to Follow-up|2
15013|NCT01912768|78420|P2|Overall Study|Adverse Event|0
15014|NCT01912768|78421|P1|Overall Study|Adverse Event|2
15015|NCT01912599|78452|P2|Overall Study|Withdrawal by Subject|1
15016|NCT01912599|78453|P1|Overall Study|Withdrawal by Subject|0
15017|NCT01912404|78478|P2|Overall Study|Due to personal reasons|0
15018|NCT01912404|78479|P1|Overall Study|Due to personal reasons|1
15019|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
15020|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
15021|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
15022|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
15023|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
15024|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
15025|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
15026|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
15027|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
15028|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
15029|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
15030|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
15031|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
15032|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
15033|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
15034|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
15035|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
15036|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
15037|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
15038|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
15039|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
15040|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
15041|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
15042|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
15043|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
15044|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
15045|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
15214|NCT01909804|79100|P10|Overall Study|Withdrew Consent|0
15046|NCT01912339|78492|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
15047|NCT01912339|78493|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
15048|NCT01912339|78494|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
15049|NCT01912339|78492|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
15050|NCT01912339|78493|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
15051|NCT01912339|78494|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
15052|NCT01912339|78492|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
15053|NCT01912339|78493|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
15054|NCT01912339|78494|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
15055|NCT01912339|78492|P3|Blinded (0 to 3 Months)|Declined to participate|0
15056|NCT01912339|78493|P2|Blinded (0 to 3 Months)|Declined to participate|0
15057|NCT01912339|78494|P1|Blinded (0 to 3 Months)|Declined to participate|1
15058|NCT01912222|78511|P3|Part B: Treatment Period|Withdrawal by Subject|2
15059|NCT01912222|78512|P2|Part B: Treatment Period|Withdrawal by Subject|1
15060|NCT01912222|78513|P1|Part B: Treatment Period|Withdrawal by Subject|2
15061|NCT01912222|78511|P3|Part B: Treatment Period|Adverse Event|3
15062|NCT01912222|78512|P2|Part B: Treatment Period|Adverse Event|2
15063|NCT01912222|78513|P1|Part B: Treatment Period|Adverse Event|1
15064|NCT01912222|78511|P3|Part B: Treatment Period|Progressive disease|15
15065|NCT01912222|78512|P2|Part B: Treatment Period|Progressive disease|12
15066|NCT01912222|78513|P1|Part B: Treatment Period|Progressive disease|10
15067|NCT01912222|78511|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
15068|NCT01912222|78512|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
15069|NCT01912222|78513|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
15070|NCT01911845|78536|P1|Overall Study|Other (not specified)|3
15071|NCT01911845|78536|P1|Overall Study|Lost to Follow-up|1
15072|NCT01911845|78536|P1|Overall Study|Adverse Event|2
15073|NCT01911793|78552|P2|Overall Study|Physician Decision|5
15074|NCT01911793|78553|P1|Overall Study|Physician Decision|1
15075|NCT01911780|78575|P2|Extension Period (52 Weeks)|Personal reason|1
15076|NCT01911780|78576|P1|Extension Period (52 Weeks)|Personal reason|1
15077|NCT01911780|78575|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
15078|NCT01911780|78576|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
15079|NCT01911780|78575|P2|Extension Period (52 Weeks)|Adverse Event|0
15080|NCT01911780|78576|P1|Extension Period (52 Weeks)|Adverse Event|3
15081|NCT01911780|78575|P2|Double-blind Period (8 Weeks)|Personal reason|0
15082|NCT01911780|78576|P1|Double-blind Period (8 Weeks)|Personal reason|1
15083|NCT01911780|78575|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
15084|NCT01911780|78576|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
15085|NCT01911780|78575|P2|Double-blind Period (8 Weeks)|Adverse Event|2
15086|NCT01911780|78576|P1|Double-blind Period (8 Weeks)|Adverse Event|1
15087|NCT01911442|78613|P3|Overall Study|Mother's Work Schedule|0
15088|NCT01911442|78614|P2|Overall Study|Mother's Work Schedule|1
15089|NCT01911442|78615|P1|Overall Study|Mother's Work Schedule|0
15090|NCT01911442|78613|P3|Overall Study|Withdrawal by Subject|6
15091|NCT01911442|78614|P2|Overall Study|Withdrawal by Subject|0
15092|NCT01911442|78615|P1|Overall Study|Withdrawal by Subject|1
15093|NCT01911442|78613|P3|Overall Study|Lost to Follow-up|1
15094|NCT01911442|78614|P2|Overall Study|Lost to Follow-up|0
15095|NCT01911442|78615|P1|Overall Study|Lost to Follow-up|2
15096|NCT01911442|78613|P3|Overall Study|Lack of Efficacy|1
15097|NCT01911442|78614|P2|Overall Study|Lack of Efficacy|1
15098|NCT01911442|78615|P1|Overall Study|Lack of Efficacy|1
15099|NCT01911442|78613|P3|Overall Study|Adverse Event|4
15100|NCT01911442|78614|P2|Overall Study|Adverse Event|2
15101|NCT01911442|78615|P1|Overall Study|Adverse Event|2
15102|NCT01911429|78644|P3|Overall Study|subject left study|0
15103|NCT01911429|78645|P2|Overall Study|subject left study|0
15104|NCT01911429|78646|P1|Overall Study|subject left study|1
15105|NCT01911429|78644|P3|Overall Study|Accidental randomization|1
15106|NCT01911429|78645|P2|Overall Study|Accidental randomization|0
15107|NCT01911429|78646|P1|Overall Study|Accidental randomization|0
15108|NCT01911429|78644|P3|Overall Study|Withdrawal by Subject|4
15109|NCT01911429|78645|P2|Overall Study|Withdrawal by Subject|5
15110|NCT01911429|78646|P1|Overall Study|Withdrawal by Subject|5
15111|NCT01911429|78644|P3|Overall Study|Protocol Violation|1
15112|NCT01911429|78645|P2|Overall Study|Protocol Violation|0
15113|NCT01911429|78646|P1|Overall Study|Protocol Violation|0
15114|NCT01911429|78644|P3|Overall Study|Lost to Follow-up|1
15115|NCT01911429|78645|P2|Overall Study|Lost to Follow-up|0
15116|NCT01911429|78646|P1|Overall Study|Lost to Follow-up|0
15117|NCT01911429|78644|P3|Overall Study|Lack of Efficacy|4
15118|NCT01911429|78645|P2|Overall Study|Lack of Efficacy|2
15119|NCT01911429|78646|P1|Overall Study|Lack of Efficacy|1
15120|NCT01911429|78644|P3|Overall Study|Adverse Event|9
15121|NCT01911429|78645|P2|Overall Study|Adverse Event|3
15122|NCT01911429|78646|P1|Overall Study|Adverse Event|5
15123|NCT01911273|78738|P2|Overall Study|Withdrawal by Subject|2
15124|NCT01911273|78739|P1|Overall Study|Withdrawal by Subject|0
15125|NCT01911273|78738|P2|Overall Study|Progression of Disease|0
15126|NCT01911273|78739|P1|Overall Study|Progression of Disease|1
15127|NCT01911260|78773|P4|Follow-up Period|transference or evasion of school|12
15128|NCT01911260|78774|P3|Follow-up Period|transference or evasion of school|15
15129|NCT01911260|78775|P2|Follow-up Period|transference or evasion of school|20
15130|NCT01911260|78776|P1|Follow-up Period|transference or evasion of school|13
15131|NCT01911260|78773|P4|Supplementation Period|less than 12 weeks supplementation|2
15132|NCT01911260|78774|P3|Supplementation Period|less than 12 weeks supplementation|1
15133|NCT01911260|78775|P2|Supplementation Period|less than 12 weeks supplementation|3
15134|NCT01911260|78776|P1|Supplementation Period|less than 12 weeks supplementation|0
15135|NCT01911260|78773|P4|Supplementation Period|refused to receive supplement|0
15136|NCT01911260|78774|P3|Supplementation Period|refused to receive supplement|1
15137|NCT01911260|78775|P2|Supplementation Period|refused to receive supplement|0
15138|NCT01911260|78776|P1|Supplementation Period|refused to receive supplement|1
15139|NCT01911260|78773|P4|Supplementation Period|Adverse Event|0
15140|NCT01911260|78774|P3|Supplementation Period|Adverse Event|1
15141|NCT01911260|78775|P2|Supplementation Period|Adverse Event|0
15142|NCT01911260|78776|P1|Supplementation Period|Adverse Event|2
15143|NCT01911260|78773|P4|Supplementation Period|transference or evasion of school|6
15144|NCT01911260|78774|P3|Supplementation Period|transference or evasion of school|7
15145|NCT01911260|78775|P2|Supplementation Period|transference or evasion of school|9
15146|NCT01911260|78776|P1|Supplementation Period|transference or evasion of school|7
15147|NCT01910441|78851|P2|Overall Study|Physician Decision|1
15148|NCT01910441|78852|P1|Overall Study|Physician Decision|0
15149|NCT01910441|78851|P2|Overall Study|Adverse Event|0
15150|NCT01910441|78852|P1|Overall Study|Adverse Event|1
15151|NCT01910441|78851|P2|Overall Study|Non-compliance|1
15152|NCT01910441|78852|P1|Overall Study|Non-compliance|0
15153|NCT01910441|78851|P2|Overall Study|Withdrawal by Subject|1
15154|NCT01910441|78852|P1|Overall Study|Withdrawal by Subject|0
15155|NCT01910441|78851|P2|Overall Study|Lost to Follow-up|5
15156|NCT01910441|78852|P1|Overall Study|Lost to Follow-up|6
15157|NCT01910441|78851|P2|Overall Study|Sponsor decision|2
15158|NCT01910441|78852|P1|Overall Study|Sponsor decision|0
15159|NCT01910402|78860|P2|Continuation Phase|Withdrawal by Subject|0
15160|NCT01910402|78861|P1|Continuation Phase|Withdrawal by Subject|2
15161|NCT01910402|78860|P2|Continuation Phase|Protocol Violation|0
15162|NCT01910402|78861|P1|Continuation Phase|Protocol Violation|3
15163|NCT01910402|78860|P2|Continuation Phase|Adverse Event|0
15164|NCT01910402|78861|P1|Continuation Phase|Adverse Event|1
15165|NCT01910402|78860|P2|Continuation Phase|Ongoing|0
15166|NCT01910402|78861|P1|Continuation Phase|Ongoing|84
15167|NCT01910402|78860|P2|Randomized Phase|Withdrawal by Subject|7
15168|NCT01910402|78861|P1|Randomized Phase|Withdrawal by Subject|5
15169|NCT01910402|78860|P2|Randomized Phase|Protocol Violation|13
15170|NCT01910402|78861|P1|Randomized Phase|Protocol Violation|10
15171|NCT01910402|78860|P2|Randomized Phase|Lost to Follow-up|13
15172|NCT01910402|78861|P1|Randomized Phase|Lost to Follow-up|11
15173|NCT01910402|78860|P2|Randomized Phase|Lack of Efficacy|4
15174|NCT01910402|78861|P1|Randomized Phase|Lack of Efficacy|5
15175|NCT01910402|78860|P2|Randomized Phase|Physician Decision|0
15176|NCT01910402|78861|P1|Randomized Phase|Physician Decision|1
15177|NCT01910402|78860|P2|Randomized Phase|Adverse Event|18
15178|NCT01910402|78861|P1|Randomized Phase|Adverse Event|10
15179|NCT01910389|78931|P2|Overall Study|Study Closed|8
15180|NCT01910389|78932|P1|Overall Study|Study Closed|13
15181|NCT01910389|78931|P2|Overall Study|Withdrawal by Subject|0
15182|NCT01910389|78932|P1|Overall Study|Withdrawal by Subject|2
15183|NCT01910181|78973|P1|Overall Study|Alive in Follow-Up|12
15184|NCT01910181|78973|P1|Overall Study|Alive on Treatment|14
15185|NCT01910181|78973|P1|Overall Study|Death|20
15186|NCT01910116|79000|P2|Overall Study|incomplete data|1
15187|NCT01910116|79001|P1|Overall Study|incomplete data|0
15188|NCT01910116|79000|P2|Overall Study|uncertain allocation|3
15189|NCT01910116|79001|P1|Overall Study|uncertain allocation|1
15190|NCT01910116|79000|P2|Overall Study|Withdrawal by Subject|3
15191|NCT01910116|79001|P1|Overall Study|Withdrawal by Subject|8
15192|NCT01910116|79000|P2|Overall Study|Protocol Violation|2
15193|NCT01910116|79001|P1|Overall Study|Protocol Violation|1
15194|NCT01910116|79000|P2|Overall Study|Lost to Follow-up|0
15195|NCT01910116|79001|P1|Overall Study|Lost to Follow-up|1
15196|NCT01910116|79000|P2|Overall Study|Lack of Efficacy|4
15197|NCT01910116|79001|P1|Overall Study|Lack of Efficacy|3
15198|NCT01910116|79000|P2|Overall Study|Adverse Event|3
15199|NCT01910116|79001|P1|Overall Study|Adverse Event|0
15200|NCT01909804|79098|P12|Overall Study|Protocol Violation|1
15201|NCT01909804|79099|P11|Overall Study|Protocol Violation|0
15202|NCT01909804|79100|P10|Overall Study|Protocol Violation|0
15203|NCT01909804|79101|P9|Overall Study|Protocol Violation|0
15204|NCT01909804|79102|P8|Overall Study|Protocol Violation|0
15205|NCT01909804|79103|P7|Overall Study|Protocol Violation|0
15206|NCT01909804|79104|P6|Overall Study|Protocol Violation|0
15207|NCT01909804|79105|P5|Overall Study|Protocol Violation|0
15208|NCT01909804|79106|P4|Overall Study|Protocol Violation|0
15209|NCT01909804|79107|P3|Overall Study|Protocol Violation|0
15210|NCT01909804|79108|P2|Overall Study|Protocol Violation|0
15211|NCT01909804|79109|P1|Overall Study|Protocol Violation|0
15212|NCT01909804|79098|P12|Overall Study|Withdrew Consent|0
15213|NCT01909804|79099|P11|Overall Study|Withdrew Consent|0
15215|NCT01909804|79101|P9|Overall Study|Withdrew Consent|0
15216|NCT01909804|79102|P8|Overall Study|Withdrew Consent|0
15217|NCT01909804|79103|P7|Overall Study|Withdrew Consent|0
15218|NCT01909804|79104|P6|Overall Study|Withdrew Consent|1
15219|NCT01909804|79105|P5|Overall Study|Withdrew Consent|1
15220|NCT01909804|79106|P4|Overall Study|Withdrew Consent|0
15221|NCT01909804|79107|P3|Overall Study|Withdrew Consent|0
15222|NCT01909804|79108|P2|Overall Study|Withdrew Consent|0
15223|NCT01909804|79109|P1|Overall Study|Withdrew Consent|0
15224|NCT01909804|79098|P12|Overall Study|Lack of Efficacy|1
15225|NCT01909804|79099|P11|Overall Study|Lack of Efficacy|0
15226|NCT01909804|79100|P10|Overall Study|Lack of Efficacy|1
15227|NCT01909804|79101|P9|Overall Study|Lack of Efficacy|0
15228|NCT01909804|79102|P8|Overall Study|Lack of Efficacy|1
15229|NCT01909804|79103|P7|Overall Study|Lack of Efficacy|1
15230|NCT01909804|79104|P6|Overall Study|Lack of Efficacy|3
15231|NCT01909804|79105|P5|Overall Study|Lack of Efficacy|7
15232|NCT01909804|79106|P4|Overall Study|Lack of Efficacy|0
15233|NCT01909804|79107|P3|Overall Study|Lack of Efficacy|0
15234|NCT01909804|79108|P2|Overall Study|Lack of Efficacy|1
15235|NCT01909804|79109|P1|Overall Study|Lack of Efficacy|4
15236|NCT01909804|79098|P12|Overall Study|Death|0
15237|NCT01909804|79099|P11|Overall Study|Death|1
15238|NCT01909804|79100|P10|Overall Study|Death|0
15239|NCT01909804|79101|P9|Overall Study|Death|0
15240|NCT01909804|79102|P8|Overall Study|Death|0
15241|NCT01909804|79103|P7|Overall Study|Death|0
15242|NCT01909804|79104|P6|Overall Study|Death|0
15243|NCT01909804|79105|P5|Overall Study|Death|0
15244|NCT01909804|79106|P4|Overall Study|Death|0
15245|NCT01909804|79107|P3|Overall Study|Death|0
15246|NCT01909804|79108|P2|Overall Study|Death|0
15247|NCT01909804|79109|P1|Overall Study|Death|0
15248|NCT01909804|79098|P12|Overall Study|Randomized but Never Treated|1
15249|NCT01909804|79099|P11|Overall Study|Randomized but Never Treated|0
15250|NCT01909804|79100|P10|Overall Study|Randomized but Never Treated|0
15251|NCT01909804|79101|P9|Overall Study|Randomized but Never Treated|0
15252|NCT01909804|79102|P8|Overall Study|Randomized but Never Treated|0
15253|NCT01909804|79103|P7|Overall Study|Randomized but Never Treated|1
15254|NCT01909804|79104|P6|Overall Study|Randomized but Never Treated|0
15255|NCT01909804|79105|P5|Overall Study|Randomized but Never Treated|0
15256|NCT01909804|79106|P4|Overall Study|Randomized but Never Treated|0
15257|NCT01909804|79107|P3|Overall Study|Randomized but Never Treated|0
15258|NCT01909804|79108|P2|Overall Study|Randomized but Never Treated|0
15259|NCT01909804|79109|P1|Overall Study|Randomized but Never Treated|0
15260|NCT01909778|79155|P1|Overall Study|failed screening|1
15261|NCT01909674|79234|P2|Overall Study|Withdrawal by Subject|2
15262|NCT01909674|79235|P1|Overall Study|Withdrawal by Subject|5
15263|NCT01909466|79254|P2|Overall Study|Lack of Efficacy|0
15264|NCT01909466|79255|P1|Overall Study|Lack of Efficacy|1
15265|NCT01909466|79254|P2|Overall Study|Withdrawal by Subject|9
15266|NCT01909466|79255|P1|Overall Study|Withdrawal by Subject|11
15267|NCT01909466|79254|P2|Overall Study|Physician Decision|0
15268|NCT01909466|79255|P1|Overall Study|Physician Decision|2
15269|NCT01909466|79254|P2|Overall Study|Met Withdrawal Criteria|3
15270|NCT01909466|79255|P1|Overall Study|Met Withdrawal Criteria|0
15271|NCT01909466|79254|P2|Overall Study|Adverse Event|4
15272|NCT01909466|79255|P1|Overall Study|Adverse Event|3
15273|NCT01909466|79254|P2|Overall Study|Lost to Follow-up|7
15274|NCT01909466|79255|P1|Overall Study|Lost to Follow-up|5
15275|NCT01909336|79278|P3|Overall Study|Physician Decision|1
15276|NCT01909336|79279|P2|Overall Study|Physician Decision|1
15277|NCT01909336|79280|P1|Overall Study|Physician Decision|0
15278|NCT01909336|79278|P3|Overall Study|Lost to Follow-up|2
15279|NCT01909336|79279|P2|Overall Study|Lost to Follow-up|2
15280|NCT01909336|79280|P1|Overall Study|Lost to Follow-up|4
15281|NCT01908803|79353|P2|Overall Study|Adverse Event (pre-treatment)|0
15282|NCT01908803|79354|P1|Overall Study|Adverse Event (pre-treatment)|1
15283|NCT01908803|79353|P2|Overall Study|Randomization Error|0
15284|NCT01908803|79354|P1|Overall Study|Randomization Error|1
15285|NCT01908803|79353|P2|Overall Study|Withdrawal by Subject|0
15286|NCT01908803|79354|P1|Overall Study|Withdrawal by Subject|1
15287|NCT01908803|79353|P2|Overall Study|Physician Decision|1
15288|NCT01908803|79354|P1|Overall Study|Physician Decision|0
15289|NCT01908803|79353|P2|Overall Study|Adverse Event|0
15290|NCT01908803|79354|P1|Overall Study|Adverse Event|1
15291|NCT01908140|79367|P2|Overall Study|Adverse Event|23
15292|NCT01908140|79368|P1|Overall Study|Adverse Event|22
15293|NCT01908140|79367|P2|Overall Study|Protocol Violation|9
15294|NCT01908140|79368|P1|Overall Study|Protocol Violation|8
15295|NCT01908140|79367|P2|Overall Study|Lost to Follow-up|6
15296|NCT01908140|79368|P1|Overall Study|Lost to Follow-up|1
15297|NCT01908140|79367|P2|Overall Study|Withdrawal by Subject|24
15298|NCT01908140|79368|P1|Overall Study|Withdrawal by Subject|23
15299|NCT01908140|79367|P2|Overall Study|Lack of Efficacy|5
15300|NCT01908140|79368|P1|Overall Study|Lack of Efficacy|7
15301|NCT01908140|79367|P2|Overall Study|Other or Progressive Disease|12
15302|NCT01908140|79368|P1|Overall Study|Other or Progressive Disease|5
15303|NCT01907906|79389|P2|Overall Study|Physician Decision|1
15304|NCT01907906|79390|P1|Overall Study|Physician Decision|3
15305|NCT01907906|79389|P2|Overall Study|Withdrawal by Subject|0
15306|NCT01907906|79390|P1|Overall Study|Withdrawal by Subject|1
15307|NCT01907854|79470|P2|Overall Study|Unclassified|3
15308|NCT01907854|79471|P1|Overall Study|Unclassified|4
15309|NCT01907854|79470|P2|Overall Study|Lost to Follow-up|2
15310|NCT01907854|79471|P1|Overall Study|Lost to Follow-up|2
15311|NCT01907854|79470|P2|Overall Study|Withdrawal by Subject|7
15312|NCT01907854|79471|P1|Overall Study|Withdrawal by Subject|9
15313|NCT01907854|79470|P2|Overall Study|Protocol Violation|1
15314|NCT01907854|79471|P1|Overall Study|Protocol Violation|1
15315|NCT01907516|79491|P2|First Intervention (3 Weeks)|Developed DKA during study|0
15316|NCT01907516|79492|P1|First Intervention (3 Weeks)|Developed DKA during study|1
15317|NCT01907516|79491|P2|First Intervention (3 Weeks)|Delivered before second arm|4
15318|NCT01907516|79492|P1|First Intervention (3 Weeks)|Delivered before second arm|3
15319|NCT01907516|79491|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
15320|NCT01907516|79492|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
15321|NCT01907516|79491|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
15322|NCT01907516|79492|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
15323|NCT01906372|79650|P1|Overall Study|Withdrawal by Subject|2
15324|NCT01905657|79683|P3|Overall Study|Excluded from Efficacy Analysis|0
15325|NCT01905657|79684|P2|Overall Study|Excluded from Efficacy Analysis|0
15326|NCT01905657|79685|P1|Overall Study|Excluded from Efficacy Analysis|1
15327|NCT01905657|79683|P3|Overall Study|Continuing in Study|11
15328|NCT01905657|79684|P2|Overall Study|Continuing in Study|74
15329|NCT01905657|79685|P1|Overall Study|Continuing in Study|74
15330|NCT01905657|79683|P3|Overall Study|Withdrawal by Subject|45
15331|NCT01905657|79684|P2|Overall Study|Withdrawal by Subject|10
15332|NCT01905657|79685|P1|Overall Study|Withdrawal by Subject|5
15333|NCT01905657|79683|P3|Overall Study|Protocol Violation|1
15334|NCT01905657|79684|P2|Overall Study|Protocol Violation|1
15335|NCT01905657|79685|P1|Overall Study|Protocol Violation|2
15336|NCT01905657|79683|P3|Overall Study|Progressive Disease|89
15337|NCT01905657|79684|P2|Overall Study|Progressive Disease|126
15338|NCT01905657|79685|P1|Overall Study|Progressive Disease|124
15339|NCT01905657|79683|P3|Overall Study|Physician Decision|113
15340|NCT01905657|79684|P2|Overall Study|Physician Decision|74
15341|NCT01905657|79685|P1|Overall Study|Physician Decision|82
15342|NCT01905657|79683|P3|Overall Study|Unspecified|1
15343|NCT01905657|79684|P2|Overall Study|Unspecified|7
15344|NCT01905657|79685|P1|Overall Study|Unspecified|3
15345|NCT01905657|79683|P3|Overall Study|Death|21
15346|NCT01905657|79684|P2|Overall Study|Death|21
15347|NCT01905657|79685|P1|Overall Study|Death|21
15348|NCT01905657|79683|P3|Overall Study|Adverse Event|47
15349|NCT01905657|79684|P2|Overall Study|Adverse Event|32
15350|NCT01905657|79685|P1|Overall Study|Adverse Event|33
15351|NCT01905657|79683|P3|Overall Study|Not Treated|0
15352|NCT01905657|79684|P2|Overall Study|Not Treated|1
15353|NCT01905657|79685|P1|Overall Study|Not Treated|0
15354|NCT01905553|79710|P2|Period 2|Adverse Event|0
15355|NCT01905553|79711|P1|Period 2|Adverse Event|1
15356|NCT01905540|79725|P4|Period 3|Not specified|1
15357|NCT01905540|79726|P3|Period 3|Not specified|1
15358|NCT01905540|79727|P2|Period 3|Not specified|0
15359|NCT01905540|79728|P1|Period 3|Not specified|1
15360|NCT01904773|79750|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15361|NCT01904773|79751|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15362|NCT01904773|79752|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15363|NCT01904773|79753|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15364|NCT01904773|79754|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15365|NCT01904773|79755|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15366|NCT01904773|79756|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15367|NCT01904773|79757|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
15368|NCT01904773|79758|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
15369|NCT01904773|79750|P9|Fifth Intervention|Adverse Event|0
15370|NCT01904773|79751|P8|Fifth Intervention|Adverse Event|1
15371|NCT01904773|79752|P7|Fifth Intervention|Adverse Event|0
15372|NCT01904773|79753|P6|Fifth Intervention|Adverse Event|0
15373|NCT01904773|79754|P5|Fifth Intervention|Adverse Event|0
15374|NCT01904773|79755|P4|Fifth Intervention|Adverse Event|0
15375|NCT01904773|79756|P3|Fifth Intervention|Adverse Event|0
15376|NCT01904773|79757|P2|Fifth Intervention|Adverse Event|0
15377|NCT01904773|79758|P1|Fifth Intervention|Adverse Event|0
15378|NCT01904773|79750|P9|Placebo Washout First Intervention|Condition worsened|0
15379|NCT01904773|79751|P8|Placebo Washout First Intervention|Condition worsened|0
15380|NCT01904773|79752|P7|Placebo Washout First Intervention|Condition worsened|0
15381|NCT01904773|79753|P6|Placebo Washout First Intervention|Condition worsened|0
15382|NCT01904773|79754|P5|Placebo Washout First Intervention|Condition worsened|0
15383|NCT01904773|79755|P4|Placebo Washout First Intervention|Condition worsened|0
15384|NCT01904773|79756|P3|Placebo Washout First Intervention|Condition worsened|0
15385|NCT01904773|79757|P2|Placebo Washout First Intervention|Condition worsened|1
15386|NCT01904773|79758|P1|Placebo Washout First Intervention|Condition worsened|0
15387|NCT01904773|79750|P9|First Intervention|Adverse Event|0
15388|NCT01904773|79751|P8|First Intervention|Adverse Event|0
15389|NCT01904773|79752|P7|First Intervention|Adverse Event|1
15390|NCT01904773|79753|P6|First Intervention|Adverse Event|0
15391|NCT01904773|79754|P5|First Intervention|Adverse Event|0
15392|NCT01904773|79755|P4|First Intervention|Adverse Event|0
15393|NCT01904773|79756|P3|First Intervention|Adverse Event|0
15394|NCT01904773|79757|P2|First Intervention|Adverse Event|0
15395|NCT01904773|79758|P1|First Intervention|Adverse Event|0
15396|NCT01904773|79750|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15397|NCT01904773|79751|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15398|NCT01904773|79752|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15399|NCT01904773|79753|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15400|NCT01904773|79754|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15401|NCT01904773|79755|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15402|NCT01904773|79756|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15403|NCT01904773|79757|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
15404|NCT01904773|79758|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
15405|NCT01904773|79750|P9|Screen|Withdrawal by Subject|0
15406|NCT01904773|79751|P8|Screen|Withdrawal by Subject|0
15407|NCT01904773|79752|P7|Screen|Withdrawal by Subject|0
15408|NCT01904773|79753|P6|Screen|Withdrawal by Subject|0
15409|NCT01904773|79754|P5|Screen|Withdrawal by Subject|0
15410|NCT01904773|79755|P4|Screen|Withdrawal by Subject|0
15411|NCT01904773|79756|P3|Screen|Withdrawal by Subject|0
15412|NCT01904773|79757|P2|Screen|Withdrawal by Subject|0
15413|NCT01904773|79758|P1|Screen|Withdrawal by Subject|1
15414|NCT01904773|79750|P9|Screen|Screen failure|0
15415|NCT01904773|79751|P8|Screen|Screen failure|0
15416|NCT01904773|79752|P7|Screen|Screen failure|0
15417|NCT01904773|79753|P6|Screen|Screen failure|0
15418|NCT01904773|79754|P5|Screen|Screen failure|0
15419|NCT01904773|79755|P4|Screen|Screen failure|0
15420|NCT01904773|79756|P3|Screen|Screen failure|0
15421|NCT01904773|79757|P2|Screen|Screen failure|0
15422|NCT01904773|79758|P1|Screen|Screen failure|3
15423|NCT01904760|79775|P2|Overall Study|Protocol Violation|0
15424|NCT01904760|79776|P1|Overall Study|Protocol Violation|1
15425|NCT01904721|79791|P7|Overall Study|Adverse Event|0
15426|NCT01904721|79792|P6|Overall Study|Adverse Event|1
15427|NCT01904721|79793|P5|Overall Study|Adverse Event|3
15428|NCT01904721|79794|P4|Overall Study|Adverse Event|0
15429|NCT01904721|79795|P3|Overall Study|Adverse Event|0
15430|NCT01904721|79796|P2|Overall Study|Adverse Event|0
15431|NCT01904721|79797|P1|Overall Study|Adverse Event|0
15432|NCT01904721|79791|P7|Overall Study|Lack of Efficacy|1
15433|NCT01904721|79792|P6|Overall Study|Lack of Efficacy|0
15434|NCT01904721|79793|P5|Overall Study|Lack of Efficacy|0
15435|NCT01904721|79794|P4|Overall Study|Lack of Efficacy|0
15436|NCT01904721|79795|P3|Overall Study|Lack of Efficacy|0
15437|NCT01904721|79796|P2|Overall Study|Lack of Efficacy|0
15438|NCT01904721|79797|P1|Overall Study|Lack of Efficacy|0
15439|NCT01904721|79791|P7|Overall Study|Lost to Follow-up|1
15440|NCT01904721|79792|P6|Overall Study|Lost to Follow-up|3
15441|NCT01904721|79793|P5|Overall Study|Lost to Follow-up|1
15442|NCT01904721|79794|P4|Overall Study|Lost to Follow-up|0
15443|NCT01904721|79795|P3|Overall Study|Lost to Follow-up|0
15444|NCT01904721|79796|P2|Overall Study|Lost to Follow-up|0
15445|NCT01904721|79797|P1|Overall Study|Lost to Follow-up|0
15446|NCT01904721|79791|P7|Overall Study|Personal Reasons|3
15447|NCT01904721|79792|P6|Overall Study|Personal Reasons|3
15448|NCT01904721|79793|P5|Overall Study|Personal Reasons|2
15449|NCT01904721|79794|P4|Overall Study|Personal Reasons|0
15450|NCT01904721|79795|P3|Overall Study|Personal Reasons|0
15451|NCT01904721|79796|P2|Overall Study|Personal Reasons|0
15452|NCT01904721|79797|P1|Overall Study|Personal Reasons|0
15453|NCT01904721|79791|P7|Overall Study|Other Reasons|2
15454|NCT01904721|79792|P6|Overall Study|Other Reasons|2
15455|NCT01904721|79793|P5|Overall Study|Other Reasons|2
15456|NCT01904721|79794|P4|Overall Study|Other Reasons|1
15457|NCT01904721|79795|P3|Overall Study|Other Reasons|1
15458|NCT01904721|79796|P2|Overall Study|Other Reasons|0
15459|NCT01904721|79797|P1|Overall Study|Other Reasons|0
15460|NCT01904604|79827|P3|Overall Study|Unrelated illness|0
15461|NCT01904604|79828|P2|Overall Study|Unrelated illness|1
15462|NCT01904604|79829|P1|Overall Study|Unrelated illness|0
15463|NCT01904604|79827|P3|Overall Study|Increased syncope|0
15464|NCT01904604|79828|P2|Overall Study|Increased syncope|1
15465|NCT01904604|79829|P1|Overall Study|Increased syncope|0
15466|NCT01904604|79827|P3|Overall Study|Patch site reactions|0
15467|NCT01904604|79828|P2|Overall Study|Patch site reactions|1
15468|NCT01904604|79829|P1|Overall Study|Patch site reactions|0
15469|NCT01904604|79827|P3|Overall Study|Anxiety about OFC/Refused OFC|0
15470|NCT01904604|79828|P2|Overall Study|Anxiety about OFC/Refused OFC|0
15471|NCT01904604|79829|P1|Overall Study|Anxiety about OFC/Refused OFC|2
15472|NCT01904604|79827|P3|Overall Study|Non-compliance|0
15473|NCT01904604|79828|P2|Overall Study|Non-compliance|0
15474|NCT01904604|79829|P1|Overall Study|Non-compliance|1
15475|NCT01904604|79827|P3|Overall Study|Withdrew before receiving dosing|0
15476|NCT01904604|79828|P2|Overall Study|Withdrew before receiving dosing|1
15477|NCT01904604|79829|P1|Overall Study|Withdrew before receiving dosing|0
15478|NCT01904279|79847|P2|Overall Study|Withdrawal by Subject|0
15479|NCT01904279|79848|P1|Overall Study|Withdrawal by Subject|1
15480|NCT01904279|79847|P2|Overall Study|Lack of Efficacy|3
15481|NCT01904279|79848|P1|Overall Study|Lack of Efficacy|2
15482|NCT01904149|79874|P6|Overall Study|non compliance with study drug|0
15483|NCT01904149|79875|P5|Overall Study|non compliance with study drug|0
15484|NCT01904149|79876|P4|Overall Study|non compliance with study drug|0
15485|NCT01904149|79877|P3|Overall Study|non compliance with study drug|0
15486|NCT01904149|79878|P2|Overall Study|non compliance with study drug|0
15487|NCT01904149|79879|P1|Overall Study|non compliance with study drug|1
15488|NCT01904149|79874|P6|Overall Study|Protocol Violation|0
15489|NCT01904149|79875|P5|Overall Study|Protocol Violation|0
15490|NCT01904149|79876|P4|Overall Study|Protocol Violation|0
15491|NCT01904149|79877|P3|Overall Study|Protocol Violation|0
15492|NCT01904149|79878|P2|Overall Study|Protocol Violation|1
15493|NCT01904149|79879|P1|Overall Study|Protocol Violation|0
15494|NCT01904149|79874|P6|Overall Study|Withdrawal by Subject|0
15495|NCT01904149|79875|P5|Overall Study|Withdrawal by Subject|1
15496|NCT01904149|79876|P4|Overall Study|Withdrawal by Subject|0
15497|NCT01904149|79877|P3|Overall Study|Withdrawal by Subject|1
15498|NCT01904149|79878|P2|Overall Study|Withdrawal by Subject|3
15499|NCT01904149|79879|P1|Overall Study|Withdrawal by Subject|1
15500|NCT01904149|79874|P6|Overall Study|Lack of Efficacy|1
15501|NCT01904149|79875|P5|Overall Study|Lack of Efficacy|3
15502|NCT01904149|79876|P4|Overall Study|Lack of Efficacy|3
15503|NCT01904149|79877|P3|Overall Study|Lack of Efficacy|1
15504|NCT01904149|79878|P2|Overall Study|Lack of Efficacy|3
15505|NCT01904149|79879|P1|Overall Study|Lack of Efficacy|0
15506|NCT01904149|79874|P6|Overall Study|Adverse Event|2
15507|NCT01904149|79875|P5|Overall Study|Adverse Event|1
15508|NCT01904149|79876|P4|Overall Study|Adverse Event|1
15509|NCT01904149|79877|P3|Overall Study|Adverse Event|0
15510|NCT01904149|79878|P2|Overall Study|Adverse Event|4
15511|NCT01904149|79879|P1|Overall Study|Adverse Event|3
15512|NCT01904058|79930|P4|Overall Study|Pregnancy|1
15513|NCT01904058|79931|P3|Overall Study|Pregnancy|0
15514|NCT01904058|79932|P2|Overall Study|Pregnancy|0
15515|NCT01904058|79933|P1|Overall Study|Pregnancy|0
15516|NCT01904058|79930|P4|Overall Study|Withdrawal by Subject|0
15517|NCT01904058|79931|P3|Overall Study|Withdrawal by Subject|1
15518|NCT01904058|79932|P2|Overall Study|Withdrawal by Subject|0
15519|NCT01904058|79933|P1|Overall Study|Withdrawal by Subject|1
15520|NCT01904058|79930|P4|Overall Study|Adverse Event|0
15521|NCT01904058|79931|P3|Overall Study|Adverse Event|0
15522|NCT01904058|79932|P2|Overall Study|Adverse Event|0
15523|NCT01904058|79933|P1|Overall Study|Adverse Event|2
15524|NCT01903993|79973|P2|Overall Study|Lost to Follow-up|1
15525|NCT01903993|79974|P1|Overall Study|Lost to Follow-up|2
15526|NCT01903993|79973|P2|Overall Study|Withdrawal by Subject|5
15527|NCT01903993|79974|P1|Overall Study|Withdrawal by Subject|13
15528|NCT01903993|79973|P2|Overall Study|Death|89
15529|NCT01903993|79974|P1|Overall Study|Death|108
15530|NCT01903876|79991|P2|Six-Month Follow-up Period|Lost to Follow-up|145
15531|NCT01903876|79992|P1|Six-Month Follow-up Period|Lost to Follow-up|91
15532|NCT01903876|79991|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
15533|NCT01903876|79992|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
15534|NCT01903863|80002|P2|Overall Study|Physician Decision|0
15535|NCT01903863|80003|P1|Overall Study|Physician Decision|2
15536|NCT01903720|80023|P1|Overall Study|Treatment with alternative drug|1
15537|NCT01903720|80023|P1|Overall Study|Lost to Follow-up|2
15538|NCT01903720|80023|P1|Overall Study|Rescinding of informed consent|2
15539|NCT01903720|80023|P1|Overall Study|Adverse Event|1
15540|NCT01903720|80023|P1|Overall Study|Inclusion / exclusion criteria not met|6
15541|NCT01903460|80042|P4|Overall Study|Adverse Event|1
15542|NCT01903460|80043|P3|Overall Study|Adverse Event|0
15543|NCT01903460|80044|P2|Overall Study|Adverse Event|0
15544|NCT01903460|80045|P1|Overall Study|Adverse Event|0
15545|NCT01902888|80128|P1|Overall Study|Study Terminated|3
15546|NCT01902303|80144|P2|Overall Study|Did not develop a cold sore|19
15547|NCT01902303|80145|P1|Overall Study|Did not develop a cold sore|21
15548|NCT01902303|80144|P2|Overall Study|subject lost investigational product|1
15549|NCT01902303|80145|P1|Overall Study|subject lost investigational product|0
15550|NCT01902303|80144|P2|Overall Study|Protocol Violation|2
15551|NCT01902303|80145|P1|Overall Study|Protocol Violation|2
15552|NCT01902303|80144|P2|Overall Study|Lost to Follow-up|1
15553|NCT01902303|80145|P1|Overall Study|Lost to Follow-up|0
15554|NCT01902303|80144|P2|Overall Study|Adverse Event|1
15555|NCT01902303|80145|P1|Overall Study|Adverse Event|0
15556|NCT01902134|80159|P6|Overall Study|not specified|0
15557|NCT01902134|80160|P5|Overall Study|not specified|1
15558|NCT01902134|80161|P4|Overall Study|not specified|0
15559|NCT01902134|80162|P3|Overall Study|not specified|2
15560|NCT01902134|80163|P2|Overall Study|not specified|1
15561|NCT01902134|80164|P1|Overall Study|not specified|0
15562|NCT01902134|80159|P6|Overall Study|no compliance|0
15563|NCT01902134|80160|P5|Overall Study|no compliance|0
15564|NCT01902134|80161|P4|Overall Study|no compliance|0
15565|NCT01902134|80162|P3|Overall Study|no compliance|0
15566|NCT01902134|80163|P2|Overall Study|no compliance|0
15567|NCT01902134|80164|P1|Overall Study|no compliance|1
15568|NCT01902134|80159|P6|Overall Study|Withdrawal by Subject|4
15569|NCT01902134|80160|P5|Overall Study|Withdrawal by Subject|5
15570|NCT01902134|80161|P4|Overall Study|Withdrawal by Subject|1
15571|NCT01902134|80162|P3|Overall Study|Withdrawal by Subject|9
15572|NCT01902134|80163|P2|Overall Study|Withdrawal by Subject|8
15573|NCT01902134|80164|P1|Overall Study|Withdrawal by Subject|4
15574|NCT01902134|80159|P6|Overall Study|Protocol Violation|1
15575|NCT01902134|80160|P5|Overall Study|Protocol Violation|0
15576|NCT01902134|80161|P4|Overall Study|Protocol Violation|0
15577|NCT01902134|80162|P3|Overall Study|Protocol Violation|0
15578|NCT01902134|80163|P2|Overall Study|Protocol Violation|0
15579|NCT01902134|80164|P1|Overall Study|Protocol Violation|0
15580|NCT01902134|80159|P6|Overall Study|Physician Decision|0
15581|NCT01902134|80160|P5|Overall Study|Physician Decision|0
15582|NCT01902134|80161|P4|Overall Study|Physician Decision|0
15583|NCT01902134|80162|P3|Overall Study|Physician Decision|0
15584|NCT01902134|80163|P2|Overall Study|Physician Decision|1
15585|NCT01902134|80164|P1|Overall Study|Physician Decision|0
15586|NCT01902134|80159|P6|Overall Study|Lack of Efficacy|1
15587|NCT01902134|80160|P5|Overall Study|Lack of Efficacy|0
15588|NCT01902134|80161|P4|Overall Study|Lack of Efficacy|0
15589|NCT01902134|80162|P3|Overall Study|Lack of Efficacy|2
15590|NCT01902134|80163|P2|Overall Study|Lack of Efficacy|0
15591|NCT01902134|80164|P1|Overall Study|Lack of Efficacy|0
15592|NCT01902134|80159|P6|Overall Study|Adverse Event|3
15593|NCT01902134|80160|P5|Overall Study|Adverse Event|1
15594|NCT01902134|80161|P4|Overall Study|Adverse Event|1
15595|NCT01902134|80162|P3|Overall Study|Adverse Event|2
15596|NCT01902134|80163|P2|Overall Study|Adverse Event|1
15597|NCT01902134|80164|P1|Overall Study|Adverse Event|3
15598|NCT01901393|80211|P2|Overall Study|Adverse Event|0
15599|NCT01901393|80212|P1|Overall Study|Adverse Event|1
15600|NCT01901341|80230|P2|Overall Study|Withdrawal by Subject|1
15601|NCT01901341|80231|P1|Overall Study|Withdrawal by Subject|1
15602|NCT01901341|80230|P2|Overall Study|Study Terminated by Sponsor|15
15603|NCT01901341|80231|P1|Overall Study|Study Terminated by Sponsor|13
15604|NCT01901341|80230|P2|Overall Study|Protocol Violation|0
15605|NCT01901341|80231|P1|Overall Study|Protocol Violation|2
15606|NCT01901341|80230|P2|Overall Study|Lost to Follow-up|1
15607|NCT01901341|80231|P1|Overall Study|Lost to Follow-up|0
15608|NCT01901341|80230|P2|Overall Study|Lack of Efficacy|2
15609|NCT01901341|80231|P1|Overall Study|Lack of Efficacy|0
15610|NCT01901341|80230|P2|Overall Study|Adverse Event|2
15611|NCT01901341|80231|P1|Overall Study|Adverse Event|4
15612|NCT01901328|80245|P2|Overall Study|Lack of Efficacy|1
15613|NCT01901328|80246|P1|Overall Study|Lack of Efficacy|0
15614|NCT01901328|80245|P2|Overall Study|Withdrawal by Subject|2
15615|NCT01901328|80246|P1|Overall Study|Withdrawal by Subject|1
15616|NCT01901328|80245|P2|Overall Study|Study Terminated by Sponsor|16
15617|NCT01901328|80246|P1|Overall Study|Study Terminated by Sponsor|19
15618|NCT01901328|80245|P2|Overall Study|Protocol Violation|1
15619|NCT01901328|80246|P1|Overall Study|Protocol Violation|1
15620|NCT01901328|80245|P2|Overall Study|Physician Decision|1
15621|NCT01901328|80246|P1|Overall Study|Physician Decision|0
15622|NCT01901328|80245|P2|Overall Study|Lost to Follow-up|0
15623|NCT01901328|80246|P1|Overall Study|Lost to Follow-up|1
15624|NCT01901302|80260|P2|Overall Study|Withdrawal by Subject|0
15625|NCT01901302|80261|P1|Overall Study|Withdrawal by Subject|2
15626|NCT01901302|80260|P2|Overall Study|Study Terminated by Sponsor|20
15627|NCT01901302|80261|P1|Overall Study|Study Terminated by Sponsor|23
15628|NCT01901302|80260|P2|Overall Study|Lack of Efficacy|2
15629|NCT01901302|80261|P1|Overall Study|Lack of Efficacy|0
15630|NCT01901302|80260|P2|Overall Study|Adverse Event|1
15631|NCT01901302|80261|P1|Overall Study|Adverse Event|2
15632|NCT01901185|80291|P1|Overall Study|Withdrawal by Subject|2
15633|NCT01900431|80300|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
15634|NCT01900431|80301|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
15635|NCT01900431|80302|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
15636|NCT01900431|80300|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
15637|NCT01900431|80301|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
15638|NCT01900431|80302|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
15639|NCT01900431|80300|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
15640|NCT01900431|80301|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
15641|NCT01900431|80302|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
15642|NCT01900431|80300|P3|Extended Treatment Period (Part B)|Other than specified above|0
15643|NCT01900431|80301|P2|Extended Treatment Period (Part B)|Other than specified above|1
15644|NCT01900431|80302|P1|Extended Treatment Period (Part B)|Other than specified above|0
15645|NCT01900431|80300|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
15646|NCT01900431|80301|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
15647|NCT01900431|80302|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
15733|NCT01898208|80730|P3|Overall Study|Positive blood culture|15
15648|NCT01900431|80300|P3|Extended Treatment Period (Part B)|Adverse Event|0
15649|NCT01900431|80301|P2|Extended Treatment Period (Part B)|Adverse Event|2
15650|NCT01900431|80302|P1|Extended Treatment Period (Part B)|Adverse Event|0
15651|NCT01900431|80300|P3|Principal Treatment Period (Part A)|Other than specified above|0
15652|NCT01900431|80301|P2|Principal Treatment Period (Part A)|Other than specified above|1
15653|NCT01900431|80302|P1|Principal Treatment Period (Part A)|Other than specified above|0
15654|NCT01900431|80300|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
15655|NCT01900431|80301|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
15656|NCT01900431|80302|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
15657|NCT01900431|80300|P3|Principal Treatment Period (Part A)|Adverse Event|0
15658|NCT01900431|80301|P2|Principal Treatment Period (Part A)|Adverse Event|3
15659|NCT01900431|80302|P1|Principal Treatment Period (Part A)|Adverse Event|1
15660|NCT01900314|80328|P2|Overall Study|Withdrawal by Subject|3
15661|NCT01900314|80329|P1|Overall Study|Withdrawal by Subject|3
15662|NCT01900314|80328|P2|Overall Study|Protocol Violation|1
15663|NCT01900314|80329|P1|Overall Study|Protocol Violation|0
15664|NCT01900314|80328|P2|Overall Study|Lost to Follow-up|0
15665|NCT01900314|80329|P1|Overall Study|Lost to Follow-up|1
15666|NCT01900054|80359|P1|Overall Study|Withdrawal by Subject|1
15667|NCT01900054|80359|P1|Overall Study|Physician Decision|1
15668|NCT01899768|80368|P1|Part B|Withdrawal by Subject|1
15669|NCT01899768|80368|P1|Part B|Adverse Event|1
15670|NCT01899768|80368|P1|Part A|Withdrawal by Subject|1
15671|NCT01899768|80368|P1|Part A|Adverse Event|2
15672|NCT01899742|80442|P2|Overall Study|Withdrawal by Subject|5
15673|NCT01899742|80443|P1|Overall Study|Withdrawal by Subject|9
15674|NCT01899742|80442|P2|Overall Study|Protocol Violation|2
15675|NCT01899742|80443|P1|Overall Study|Protocol Violation|2
15676|NCT01899742|80442|P2|Overall Study|Lack of Efficacy|5
15677|NCT01899742|80443|P1|Overall Study|Lack of Efficacy|1
15678|NCT01899742|80442|P2|Overall Study|Adverse Event|4
15679|NCT01899742|80443|P1|Overall Study|Adverse Event|5
15680|NCT01899144|80482|P1|Treatment Period 5|Not specified|1
15681|NCT01899144|80482|P1|Treatment Period 3|Not specified|2
15682|NCT01899144|80482|P1|Treatment Period 2|Not specified|1
15683|NCT01898884|80509|P9|Multiple Dose Period|Randomized Not Treated|1
15684|NCT01898884|80510|P8|Multiple Dose Period|Randomized Not Treated|0
15685|NCT01898884|80511|P7|Multiple Dose Period|Randomized Not Treated|0
15686|NCT01898884|80512|P6|Multiple Dose Period|Randomized Not Treated|0
15687|NCT01898884|80513|P5|Multiple Dose Period|Randomized Not Treated|0
15688|NCT01898884|80514|P4|Multiple Dose Period|Randomized Not Treated|0
15689|NCT01898884|80515|P3|Multiple Dose Period|Randomized Not Treated|0
15690|NCT01898884|80516|P2|Multiple Dose Period|Randomized Not Treated|0
15691|NCT01898884|80517|P1|Multiple Dose Period|Randomized Not Treated|0
15692|NCT01898884|80509|P9|Multiple Dose Period|Adverse Event|0
15693|NCT01898884|80510|P8|Multiple Dose Period|Adverse Event|0
15694|NCT01898884|80511|P7|Multiple Dose Period|Adverse Event|1
15695|NCT01898884|80512|P6|Multiple Dose Period|Adverse Event|0
15696|NCT01898884|80513|P5|Multiple Dose Period|Adverse Event|0
15697|NCT01898884|80514|P4|Multiple Dose Period|Adverse Event|0
15698|NCT01898884|80515|P3|Multiple Dose Period|Adverse Event|0
15699|NCT01898884|80516|P2|Multiple Dose Period|Adverse Event|0
15700|NCT01898884|80517|P1|Multiple Dose Period|Adverse Event|0
15701|NCT01898598|80669|P2|Overall Study|Unspecified|1
15702|NCT01898598|80670|P1|Overall Study|Unspecified|0
15703|NCT01898598|80669|P2|Overall Study|Lost to Follow-up|1
15704|NCT01898598|80670|P1|Overall Study|Lost to Follow-up|0
15705|NCT01898598|80669|P2|Overall Study|Withdrawal by Subject|0
15706|NCT01898598|80670|P1|Overall Study|Withdrawal by Subject|3
15707|NCT01898598|80669|P2|Overall Study|Adverse Event|0
15708|NCT01898598|80670|P1|Overall Study|Adverse Event|1
15709|NCT01898442|80689|P3|Overall Study|Patient vomited pills|1
15710|NCT01898442|80690|P2|Overall Study|Patient vomited pills|0
15711|NCT01898442|80691|P1|Overall Study|Patient vomited pills|0
15712|NCT01898442|80689|P3|Overall Study|Hemolysis/technical problems|2
15713|NCT01898442|80690|P2|Overall Study|Hemolysis/technical problems|2
15714|NCT01898442|80691|P1|Overall Study|Hemolysis/technical problems|1
15715|NCT01898286|80720|P1|Overall Study|Lost to Follow-up|1
15716|NCT01898286|80720|P1|Overall Study|Protocol Violation|1
15717|NCT01898286|80720|P1|Overall Study|Withdrawal by Subject|1
15718|NCT01898208|80730|P3|Overall Study|Lost to Follow-up|1
15719|NCT01898208|80731|P2|Overall Study|Lost to Follow-up|1
15720|NCT01898208|80732|P1|Overall Study|Lost to Follow-up|3
15721|NCT01898208|80730|P3|Overall Study|System/Technical Error|3
15722|NCT01898208|80731|P2|Overall Study|System/Technical Error|2
15723|NCT01898208|80732|P1|Overall Study|System/Technical Error|1
15724|NCT01898208|80730|P3|Overall Study|Non-Blood Specimens in Bottles|4
15725|NCT01898208|80731|P2|Overall Study|Non-Blood Specimens in Bottles|5
15726|NCT01898208|80732|P1|Overall Study|Non-Blood Specimens in Bottles|3
15727|NCT01898208|80730|P3|Overall Study|Negative Gram Stain|6
15728|NCT01898208|80731|P2|Overall Study|Negative Gram Stain|9
15729|NCT01898208|80732|P1|Overall Study|Negative Gram Stain|6
15730|NCT01898208|80730|P3|Overall Study|Death/comfort care within 24 hours|8
15731|NCT01898208|80731|P2|Overall Study|Death/comfort care within 24 hours|9
15732|NCT01898208|80732|P1|Overall Study|Death/comfort care within 24 hours|10
15734|NCT01898208|80731|P2|Overall Study|Positive blood culture|23
15735|NCT01898208|80732|P1|Overall Study|Positive blood culture|17
15736|NCT01898195|80779|P3|Smoking Abstinence|Did not have good measurements|36
15737|NCT01898195|80780|P2|Smoking Abstinence|Did not have good measurements|38
15738|NCT01898195|80781|P1|Smoking Abstinence|Did not have good measurements|35
15739|NCT01898091|80794|P2|Overall Study|Withdrawal by Subject|5
15740|NCT01898091|80795|P1|Overall Study|Withdrawal by Subject|1
15741|NCT01898091|80794|P2|Overall Study|Lost to Follow-up|1
15742|NCT01898091|80795|P1|Overall Study|Lost to Follow-up|1
15743|NCT01897727|80830|P2|Overall Study|Exclusion: central sleep apnea|1
15744|NCT01897727|80831|P1|Overall Study|Exclusion: central sleep apnea|0
15745|NCT01897233|80860|P1|Part B (24 Weeks)|Physician Decision|1
15746|NCT01897233|80860|P1|Part B (24 Weeks)|Withdrawal by Subject|2
15747|NCT01897233|80860|P1|Part B (24 Weeks)|Adverse Event|1
15748|NCT01896986|80893|P2|Overall Study|samples lost|23
15749|NCT01896986|80894|P1|Overall Study|samples lost|14
15750|NCT01896934|80900|P1|Overall Study|Withdrawal by Subject|1
15751|NCT01896934|80900|P1|Overall Study|Adverse Event|1
15752|NCT01896726|80906|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
15753|NCT01896726|80906|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
15754|NCT01896557|80930|P2|Clopidogrel + GI Protector|Reading error|3
15755|NCT01896557|80931|P1|Clopidogrel + GI Protector|Reading error|1
15756|NCT01896557|80930|P2|Clopidogrel + GI Protector|low adherence|1
15757|NCT01896557|80931|P1|Clopidogrel + GI Protector|low adherence|1
15758|NCT01896557|80930|P2|Clopidogrel Alone|Adverse Event|0
15759|NCT01896557|80931|P1|Clopidogrel Alone|Adverse Event|1
15760|NCT01896297|80964|P1|Overall Study|Died in post treatment phase|1
15761|NCT01896232|80971|P2|Overall Study|Lost to Follow-up|12
15762|NCT01896232|80972|P1|Overall Study|Lost to Follow-up|9
15763|NCT01896232|80971|P2|Overall Study|Sponsor Decision|0
15764|NCT01896232|80972|P1|Overall Study|Sponsor Decision|2
15765|NCT01896232|80971|P2|Overall Study|Withdrawal by Subject|31
15766|NCT01896232|80972|P1|Overall Study|Withdrawal by Subject|32
15767|NCT01896232|80971|P2|Overall Study|Death|10
15768|NCT01896232|80972|P1|Overall Study|Death|6
15769|NCT01896193|81000|P2|Overall Study|Withdrew Consent|0
15770|NCT01896193|81001|P1|Overall Study|Withdrew Consent|1
15771|NCT01896193|81000|P2|Overall Study|Protocol Violation|1
15772|NCT01896193|81001|P1|Overall Study|Protocol Violation|0
15773|NCT01896193|81000|P2|Overall Study|Lack of Efficacy|11
15774|NCT01896193|81001|P1|Overall Study|Lack of Efficacy|20
15775|NCT01896050|81050|P2|Overall Study|Death|0
15776|NCT01896050|81051|P1|Overall Study|Death|1
15777|NCT01896050|81050|P2|Overall Study|Adverse Event|2
15778|NCT01896050|81051|P1|Overall Study|Adverse Event|37
15779|NCT01895608|81094|P4|Overall Study|Withdrawal by Subject|0
15780|NCT01895608|81095|P3|Overall Study|Withdrawal by Subject|2
15781|NCT01895608|81096|P2|Overall Study|Withdrawal by Subject|0
15782|NCT01895608|81097|P1|Overall Study|Withdrawal by Subject|0
15783|NCT01895608|81094|P4|Overall Study|change in health status|0
15784|NCT01895608|81095|P3|Overall Study|change in health status|1
15785|NCT01895608|81096|P2|Overall Study|change in health status|1
15786|NCT01895608|81097|P1|Overall Study|change in health status|0
15787|NCT01895543|81127|P1|Overall Study|Other (Not fulfilling above criteria)|24
15788|NCT01895543|81127|P1|Overall Study|Physician Decision|2
15789|NCT01895543|81127|P1|Overall Study|Protocol Violation|1
15790|NCT01895543|81127|P1|Overall Study|Subject's substantial non-compliance|6
15791|NCT01895543|81127|P1|Overall Study|Adverse Event|28
15792|NCT01895543|81127|P1|Overall Study|Lost to Follow-up|25
15793|NCT01895543|81127|P1|Overall Study|Withdrawal by Subject|43
15794|NCT01895452|81143|P2|Overall Study|Noncompliance with study drug|1
15795|NCT01895452|81144|P1|Overall Study|Noncompliance with study drug|0
15796|NCT01895452|81143|P2|Overall Study|Underlying disease|3
15797|NCT01895452|81144|P1|Overall Study|Underlying disease|0
15798|NCT01895452|81143|P2|Overall Study|Withdrawal by Subject|14
15799|NCT01895452|81144|P1|Overall Study|Withdrawal by Subject|2
15800|NCT01895452|81143|P2|Overall Study|Pregnancy|1
15801|NCT01895452|81144|P1|Overall Study|Pregnancy|0
15802|NCT01895452|81143|P2|Overall Study|Lost to Follow-up|5
15803|NCT01895452|81144|P1|Overall Study|Lost to Follow-up|1
15804|NCT01895452|81143|P2|Overall Study|Adverse Event|4
15805|NCT01895452|81144|P1|Overall Study|Adverse Event|1
15806|NCT01895335|81154|P1|Overall Study|Other than Specified Above|44
15807|NCT01895335|81154|P1|Overall Study|Included But Not treated|1
15808|NCT01895335|81154|P1|Overall Study|Poor Compliance to Protocol|11
15809|NCT01895335|81154|P1|Overall Study|Lack of Efficacy|53
15810|NCT01895335|81154|P1|Overall Study|Adverse Event|106
15811|NCT01895322|81171|P1|Overall Study|Protocol Violation|10
15812|NCT01895322|81171|P1|Overall Study|Withdrawal by Subject|2
15813|NCT01895322|81171|P1|Overall Study|Adverse Event|1
15814|NCT01895309|81180|P2|Overall Study|Withdrawal by Subject|18
15815|NCT01895309|81181|P1|Overall Study|Withdrawal by Subject|9
15816|NCT01895309|81180|P2|Overall Study|Physician Decision|10
15817|NCT01895309|81181|P1|Overall Study|Physician Decision|15
15818|NCT01895309|81180|P2|Overall Study|Lost to Follow-up|3
15819|NCT01895309|81181|P1|Overall Study|Lost to Follow-up|1
15820|NCT01895309|81180|P2|Overall Study|Lack of Efficacy|3
15821|NCT01895309|81181|P1|Overall Study|Lack of Efficacy|1
15822|NCT01895309|81180|P2|Overall Study|Protocol Violation|0
15823|NCT01895309|81181|P1|Overall Study|Protocol Violation|1
15824|NCT01895309|81180|P2|Overall Study|Adverse Event|17
15825|NCT01895309|81181|P1|Overall Study|Adverse Event|13
15826|NCT01895270|81195|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
15827|NCT01895270|81196|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
15828|NCT01895270|81195|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
15829|NCT01895270|81196|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
15830|NCT01895270|81195|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
15831|NCT01895270|81196|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
15832|NCT01895270|81195|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
15833|NCT01895270|81196|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
15834|NCT01895270|81195|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
15835|NCT01895270|81196|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
15836|NCT01895270|81195|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
15837|NCT01895270|81196|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
15838|NCT01895270|81195|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
15839|NCT01895270|81196|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
15840|NCT01895101|81205|P3|Overall Study|coagulation disorder|0
15841|NCT01895101|81206|P2|Overall Study|coagulation disorder|1
15842|NCT01895101|81207|P1|Overall Study|coagulation disorder|0
15843|NCT01895101|81205|P3|Overall Study|Death|0
15844|NCT01895101|81206|P2|Overall Study|Death|1
15845|NCT01895101|81207|P1|Overall Study|Death|0
15846|NCT01895101|81205|P3|Overall Study|another study, enrolled in other study|0
15847|NCT01895101|81206|P2|Overall Study|another study, enrolled in other study|1
15848|NCT01895101|81207|P1|Overall Study|another study, enrolled in other study|0
15849|NCT01895101|81205|P3|Overall Study|Withdrawal by Subject|2
15850|NCT01895101|81206|P2|Overall Study|Withdrawal by Subject|1
15851|NCT01895101|81207|P1|Overall Study|Withdrawal by Subject|0
15852|NCT01895101|81205|P3|Overall Study|OPCAB procedure|3
15853|NCT01895101|81206|P2|Overall Study|OPCAB procedure|1
15854|NCT01895101|81207|P1|Overall Study|OPCAB procedure|1
15855|NCT01894984|81238|P2|Overall Study|Unspecified|175
15856|NCT01894984|81239|P1|Overall Study|Unspecified|314
15857|NCT01894607|81294|P1|Overall Study|Ineligible|1
15858|NCT01894581|81301|P2|Overall Study|Screen Failure|4
15859|NCT01894581|81302|P1|Overall Study|Screen Failure|3
15860|NCT01894581|81301|P2|Overall Study|Withdrawal by Subject|3
15861|NCT01894581|81302|P1|Overall Study|Withdrawal by Subject|2
15862|NCT01894256|81315|P3|Part B|Lack of Efficacy|13
15863|NCT01894256|81316|P2|Part B|Lack of Efficacy|12
15864|NCT01894256|81317|P1|Part B|Lack of Efficacy|15
15865|NCT01894256|81315|P3|Part B|Withdrawal by Subject|0
15866|NCT01894256|81316|P2|Part B|Withdrawal by Subject|1
15867|NCT01894256|81317|P1|Part B|Withdrawal by Subject|0
15868|NCT01894256|81315|P3|Part B|Death|1
15869|NCT01894256|81316|P2|Part B|Death|1
15870|NCT01894256|81317|P1|Part B|Death|0
15871|NCT01894256|81315|P3|Part A|Adverse Event|0
15872|NCT01894256|81316|P2|Part A|Adverse Event|1
15873|NCT01894256|81317|P1|Part A|Adverse Event|0
15874|NCT01894230|81363|P2|Overall Study|Death|0
15875|NCT01894230|81364|P1|Overall Study|Death|1
15876|NCT01894230|81363|P2|Overall Study|Non-adherent|1
15877|NCT01894230|81364|P1|Overall Study|Non-adherent|0
15878|NCT01894230|81363|P2|Overall Study|Withdrawal by Subject|4
15879|NCT01894230|81364|P1|Overall Study|Withdrawal by Subject|4
15880|NCT01894230|81363|P2|Overall Study|Lost to Follow-up|2
15881|NCT01894230|81364|P1|Overall Study|Lost to Follow-up|2
15882|NCT01894100|81390|P2|Overall Study|Withdrawal by Subject|0
15883|NCT01894100|81391|P1|Overall Study|Withdrawal by Subject|3
15884|NCT01894100|81390|P2|Overall Study|Lost to Follow-up|1
15885|NCT01894100|81391|P1|Overall Study|Lost to Follow-up|0
15886|NCT01894022|81401|P2|Overall Study|Study Closed/terminated|10
15887|NCT01894022|81402|P1|Overall Study|Study Closed/terminated|7
15888|NCT01894022|81401|P2|Overall Study|Adverse Event, non-fatal|0
15889|NCT01894022|81402|P1|Overall Study|Adverse Event, non-fatal|1
15890|NCT01894022|81401|P2|Overall Study|Death|0
15891|NCT01894022|81402|P1|Overall Study|Death|1
15892|NCT01893905|81456|P2|Overall Study|Other reason|3
15893|NCT01893905|81457|P1|Overall Study|Other reason|1
15894|NCT01893905|81456|P2|Overall Study|Lack of adherence to treatment|0
15895|NCT01893905|81457|P1|Overall Study|Lack of adherence to treatment|2
15896|NCT01893905|81456|P2|Overall Study|Protocol Violation|1
15897|NCT01893905|81457|P1|Overall Study|Protocol Violation|6
15898|NCT01893905|81456|P2|Overall Study|Lost to Follow-up|0
15899|NCT01893905|81457|P1|Overall Study|Lost to Follow-up|1
15900|NCT01893905|81456|P2|Overall Study|Lack of Efficacy|7
15901|NCT01893905|81457|P1|Overall Study|Lack of Efficacy|5
15902|NCT01893905|81456|P2|Overall Study|Adverse Event|3
15903|NCT01893905|81457|P1|Overall Study|Adverse Event|9
15904|NCT01893905|81456|P2|Overall Study|Withdrawal by Subject|0
15905|NCT01893905|81457|P1|Overall Study|Withdrawal by Subject|1
15906|NCT01893411|81479|P3|Overall Study|Lost to Follow-up|1
15907|NCT01893411|81480|P2|Overall Study|Lost to Follow-up|0
15908|NCT01893411|81481|P1|Overall Study|Lost to Follow-up|2
15909|NCT01893411|81479|P3|Overall Study|Withdrawal by Subject|3
15910|NCT01893411|81480|P2|Overall Study|Withdrawal by Subject|4
15911|NCT01893411|81481|P1|Overall Study|Withdrawal by Subject|7
15912|NCT01893411|81479|P3|Overall Study|Adverse Event|0
15913|NCT01893411|81480|P2|Overall Study|Adverse Event|0
15914|NCT01893411|81481|P1|Overall Study|Adverse Event|1
15915|NCT01893411|81479|P3|Overall Study|Not Specified|3
15916|NCT01893411|81480|P2|Overall Study|Not Specified|1
15917|NCT01893411|81481|P1|Overall Study|Not Specified|3
15918|NCT01893411|81479|P3|Overall Study|Lack of Efficacy|0
15919|NCT01893411|81480|P2|Overall Study|Lack of Efficacy|1
15920|NCT01893411|81481|P1|Overall Study|Lack of Efficacy|2
15921|NCT01893411|81479|P3|Overall Study|Physician Decision|2
15922|NCT01893411|81480|P2|Overall Study|Physician Decision|1
15923|NCT01893411|81481|P1|Overall Study|Physician Decision|1
15924|NCT01893411|81479|P3|Overall Study|Protocol Violation|0
15925|NCT01893411|81480|P2|Overall Study|Protocol Violation|0
15926|NCT01893411|81481|P1|Overall Study|Protocol Violation|1
15927|NCT01893346|81563|P4|Overall Study|Withdrawal by Subject|0
15928|NCT01893346|81564|P3|Overall Study|Withdrawal by Subject|0
15929|NCT01893346|81565|P2|Overall Study|Withdrawal by Subject|0
15930|NCT01893346|81566|P1|Overall Study|Withdrawal by Subject|2
15931|NCT01893346|81563|P4|Overall Study|Protocol Violation|0
15932|NCT01893346|81564|P3|Overall Study|Protocol Violation|0
15933|NCT01893346|81565|P2|Overall Study|Protocol Violation|0
15934|NCT01893346|81566|P1|Overall Study|Protocol Violation|1
15935|NCT01893346|81563|P4|Overall Study|Lost to Follow-up|0
15936|NCT01893346|81564|P3|Overall Study|Lost to Follow-up|0
15937|NCT01893346|81565|P2|Overall Study|Lost to Follow-up|1
15938|NCT01893346|81566|P1|Overall Study|Lost to Follow-up|0
15939|NCT01893281|81580|P1|Overall Study|Withdrawal by Subject|1
15940|NCT01893281|81580|P1|Overall Study|Protocol Violation|1
15941|NCT01893281|81580|P1|Overall Study|Adverse Event|1
15942|NCT01893203|81587|P1|Overall Study|Withdrawal by Subject|1
15943|NCT01892657|81594|P1|Overall Study|Protocol Violation|12
15944|NCT01892657|81594|P1|Overall Study|Withdrawal by Subject|6
15945|NCT01892189|81671|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15946|NCT01892189|81672|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15947|NCT01892189|81673|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15948|NCT01892189|81674|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
15949|NCT01892189|81675|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15950|NCT01892189|81676|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15951|NCT01892189|81677|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15952|NCT01892189|81678|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15953|NCT01892189|81679|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
15954|NCT01892189|81671|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
15955|NCT01892189|81672|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
15956|NCT01892189|81673|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
15957|NCT01892189|81674|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
15958|NCT01892189|81675|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
15959|NCT01892189|81676|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
15960|NCT01892189|81677|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
15961|NCT01892189|81678|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
15962|NCT01892189|81679|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
15963|NCT01892189|81671|P9|Washout Period 1 (7 Days)|Adverse Event|1
15964|NCT01892189|81672|P8|Washout Period 1 (7 Days)|Adverse Event|0
15965|NCT01892189|81673|P7|Washout Period 1 (7 Days)|Adverse Event|0
15966|NCT01892189|81674|P6|Washout Period 1 (7 Days)|Adverse Event|0
15967|NCT01892189|81675|P5|Washout Period 1 (7 Days)|Adverse Event|0
15968|NCT01892189|81676|P4|Washout Period 1 (7 Days)|Adverse Event|0
15969|NCT01892189|81677|P3|Washout Period 1 (7 Days)|Adverse Event|0
15970|NCT01892189|81678|P2|Washout Period 1 (7 Days)|Adverse Event|0
15971|NCT01892189|81679|P1|Washout Period 1 (7 Days)|Adverse Event|0
15972|NCT01892163|81721|P2|Overall Study|Lost to Follow-up|0
15973|NCT01892163|81722|P1|Overall Study|Lost to Follow-up|1
15974|NCT01892163|81721|P2|Overall Study|Death|1
15975|NCT01892163|81722|P1|Overall Study|Death|1
15976|NCT01892020|81734|P2|Period 2|Protocol Violation|0
15977|NCT01892020|81735|P1|Period 2|Protocol Violation|1
15978|NCT01892020|81734|P2|Period 1|Unclassified|1
15979|NCT01892020|81735|P1|Period 1|Unclassified|0
15980|NCT01892020|81734|P2|Period 1|Protocol Violation|4
15981|NCT01892020|81735|P1|Period 1|Protocol Violation|2
15982|NCT01892020|81734|P2|Period 1|Adverse Event|1
15983|NCT01892020|81735|P1|Period 1|Adverse Event|1
15984|NCT01891864|81755|P6|Extension Period|Lost to Follow-up|0
15985|NCT01891864|81756|P5|Extension Period|Lost to Follow-up|0
15986|NCT01891864|81757|P4|Extension Period|Lost to Follow-up|0
15987|NCT01891864|81758|P3|Extension Period|Lost to Follow-up|2
15988|NCT01891864|81759|P2|Extension Period|Lost to Follow-up|0
15989|NCT01891864|81760|P1|Extension Period|Lost to Follow-up|0
15990|NCT01891864|81755|P6|Extension Period|Withdrawal by Subject|0
15991|NCT01891864|81756|P5|Extension Period|Withdrawal by Subject|4
15992|NCT01891864|81757|P4|Extension Period|Withdrawal by Subject|2
15993|NCT01891864|81758|P3|Extension Period|Withdrawal by Subject|1
15994|NCT01891864|81759|P2|Extension Period|Withdrawal by Subject|0
15995|NCT01891864|81760|P1|Extension Period|Withdrawal by Subject|0
15996|NCT01891864|81755|P6|Extension Period|Adverse Event|0
15997|NCT01891864|81756|P5|Extension Period|Adverse Event|2
15998|NCT01891864|81757|P4|Extension Period|Adverse Event|2
15999|NCT01891864|81758|P3|Extension Period|Adverse Event|4
16000|NCT01891864|81759|P2|Extension Period|Adverse Event|0
16001|NCT01891864|81760|P1|Extension Period|Adverse Event|0
16002|NCT01891864|81755|P6|Extension Period|Pregnancy|0
16003|NCT01891864|81756|P5|Extension Period|Pregnancy|0
16004|NCT01891864|81757|P4|Extension Period|Pregnancy|0
16005|NCT01891864|81758|P3|Extension Period|Pregnancy|1
16006|NCT01891864|81759|P2|Extension Period|Pregnancy|0
16007|NCT01891864|81760|P1|Extension Period|Pregnancy|0
16008|NCT01891864|81755|P6|Extension Period|Lack of Efficacy|0
16009|NCT01891864|81756|P5|Extension Period|Lack of Efficacy|1
16010|NCT01891864|81757|P4|Extension Period|Lack of Efficacy|1
16011|NCT01891864|81758|P3|Extension Period|Lack of Efficacy|0
16012|NCT01891864|81759|P2|Extension Period|Lack of Efficacy|0
16013|NCT01891864|81760|P1|Extension Period|Lack of Efficacy|0
16014|NCT01891864|81755|P6|Treatment Period 2|Withdrawal by Subject|1
16015|NCT01891864|81756|P5|Treatment Period 2|Withdrawal by Subject|1
16016|NCT01891864|81757|P4|Treatment Period 2|Withdrawal by Subject|4
16017|NCT01891864|81758|P3|Treatment Period 2|Withdrawal by Subject|3
16018|NCT01891864|81759|P2|Treatment Period 2|Withdrawal by Subject|0
16019|NCT01891864|81760|P1|Treatment Period 2|Withdrawal by Subject|0
16020|NCT01891864|81755|P6|Treatment Period 2|Termination of Site|0
16021|NCT01891864|81756|P5|Treatment Period 2|Termination of Site|2
16022|NCT01891864|81757|P4|Treatment Period 2|Termination of Site|0
16023|NCT01891864|81758|P3|Treatment Period 2|Termination of Site|0
16024|NCT01891864|81759|P2|Treatment Period 2|Termination of Site|0
16025|NCT01891864|81760|P1|Treatment Period 2|Termination of Site|0
16026|NCT01891864|81755|P6|Treatment Period 2|Adverse Event|4
16027|NCT01891864|81756|P5|Treatment Period 2|Adverse Event|0
16028|NCT01891864|81757|P4|Treatment Period 2|Adverse Event|2
16029|NCT01891864|81758|P3|Treatment Period 2|Adverse Event|1
16030|NCT01891864|81759|P2|Treatment Period 2|Adverse Event|0
16031|NCT01891864|81760|P1|Treatment Period 2|Adverse Event|0
16032|NCT01891864|81755|P6|Treatment Period 2|Lack of Efficacy|0
16033|NCT01891864|81756|P5|Treatment Period 2|Lack of Efficacy|1
16034|NCT01891864|81757|P4|Treatment Period 2|Lack of Efficacy|0
16035|NCT01891864|81758|P3|Treatment Period 2|Lack of Efficacy|1
16036|NCT01891864|81759|P2|Treatment Period 2|Lack of Efficacy|0
16037|NCT01891864|81760|P1|Treatment Period 2|Lack of Efficacy|0
16038|NCT01891864|81755|P6|Treatment Period 2|Site Termination|0
16039|NCT01891864|81756|P5|Treatment Period 2|Site Termination|0
16040|NCT01891864|81757|P4|Treatment Period 2|Site Termination|2
16041|NCT01891864|81758|P3|Treatment Period 2|Site Termination|1
16042|NCT01891864|81759|P2|Treatment Period 2|Site Termination|0
16043|NCT01891864|81760|P1|Treatment Period 2|Site Termination|0
16044|NCT01891864|81755|P6|Treatment Period 2|Physician Decision|0
16045|NCT01891864|81756|P5|Treatment Period 2|Physician Decision|0
16046|NCT01891864|81757|P4|Treatment Period 2|Physician Decision|0
16047|NCT01891864|81758|P3|Treatment Period 2|Physician Decision|1
16048|NCT01891864|81759|P2|Treatment Period 2|Physician Decision|0
16049|NCT01891864|81760|P1|Treatment Period 2|Physician Decision|0
16050|NCT01891864|81755|P6|Treatment Period 2|Protocol Violation|0
16051|NCT01891864|81756|P5|Treatment Period 2|Protocol Violation|0
16052|NCT01891864|81757|P4|Treatment Period 2|Protocol Violation|1
16053|NCT01891864|81758|P3|Treatment Period 2|Protocol Violation|0
16054|NCT01891864|81759|P2|Treatment Period 2|Protocol Violation|0
16055|NCT01891864|81760|P1|Treatment Period 2|Protocol Violation|0
16056|NCT01891864|81755|P6|Treatment Period 1|Lost to Follow-up|0
16057|NCT01891864|81756|P5|Treatment Period 1|Lost to Follow-up|0
16058|NCT01891864|81757|P4|Treatment Period 1|Lost to Follow-up|0
16059|NCT01891864|81758|P3|Treatment Period 1|Lost to Follow-up|0
16060|NCT01891864|81759|P2|Treatment Period 1|Lost to Follow-up|0
16061|NCT01891864|81760|P1|Treatment Period 1|Lost to Follow-up|1
16062|NCT01891864|81755|P6|Treatment Period 1|Withdrawal by Subject|0
16063|NCT01891864|81756|P5|Treatment Period 1|Withdrawal by Subject|0
16064|NCT01891864|81757|P4|Treatment Period 1|Withdrawal by Subject|0
16065|NCT01891864|81758|P3|Treatment Period 1|Withdrawal by Subject|0
16066|NCT01891864|81759|P2|Treatment Period 1|Withdrawal by Subject|5
16067|NCT01891864|81760|P1|Treatment Period 1|Withdrawal by Subject|2
16068|NCT01891864|81755|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
16069|NCT01891864|81756|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
16070|NCT01891864|81757|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
16071|NCT01891864|81758|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
16072|NCT01891864|81759|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
16073|NCT01891864|81760|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
16074|NCT01891864|81755|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
16075|NCT01891864|81756|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
16076|NCT01891864|81757|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
16077|NCT01891864|81758|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
16078|NCT01891864|81759|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
16079|NCT01891864|81760|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
16080|NCT01891864|81755|P6|Treatment Period 1|Physician Decision|0
16081|NCT01891864|81756|P5|Treatment Period 1|Physician Decision|0
16082|NCT01891864|81757|P4|Treatment Period 1|Physician Decision|0
16083|NCT01891864|81758|P3|Treatment Period 1|Physician Decision|0
16084|NCT01891864|81759|P2|Treatment Period 1|Physician Decision|1
16085|NCT01891864|81760|P1|Treatment Period 1|Physician Decision|0
16086|NCT01891864|81755|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
16087|NCT01891864|81756|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
16088|NCT01891864|81757|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
16089|NCT01891864|81758|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
16090|NCT01891864|81759|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
16091|NCT01891864|81760|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
16092|NCT01891669|81803|P10|Overall Study|Unspecified|0
16093|NCT01891669|81804|P9|Overall Study|Unspecified|0
16094|NCT01891669|81805|P8|Overall Study|Unspecified|1
16095|NCT01891669|81806|P7|Overall Study|Unspecified|0
16096|NCT01891669|81807|P6|Overall Study|Unspecified|0
16097|NCT01891669|81808|P5|Overall Study|Unspecified|0
16098|NCT01891669|81809|P4|Overall Study|Unspecified|0
16099|NCT01891669|81810|P3|Overall Study|Unspecified|0
16100|NCT01891669|81811|P2|Overall Study|Unspecified|0
16101|NCT01891669|81812|P1|Overall Study|Unspecified|1
16102|NCT01891669|81803|P10|Overall Study|Withdrawal by Subject|1
16103|NCT01891669|81804|P9|Overall Study|Withdrawal by Subject|1
16104|NCT01891669|81805|P8|Overall Study|Withdrawal by Subject|2
16105|NCT01891669|81806|P7|Overall Study|Withdrawal by Subject|1
16106|NCT01891669|81807|P6|Overall Study|Withdrawal by Subject|0
16107|NCT01891669|81808|P5|Overall Study|Withdrawal by Subject|0
16108|NCT01891669|81809|P4|Overall Study|Withdrawal by Subject|0
16109|NCT01891669|81810|P3|Overall Study|Withdrawal by Subject|0
16110|NCT01891669|81811|P2|Overall Study|Withdrawal by Subject|1
16111|NCT01891669|81812|P1|Overall Study|Withdrawal by Subject|1
16112|NCT01891669|81803|P10|Overall Study|Death|1
16113|NCT01891669|81804|P9|Overall Study|Death|0
16114|NCT01891669|81805|P8|Overall Study|Death|1
16115|NCT01891669|81806|P7|Overall Study|Death|0
16116|NCT01891669|81807|P6|Overall Study|Death|0
16117|NCT01891669|81808|P5|Overall Study|Death|0
16118|NCT01891669|81809|P4|Overall Study|Death|0
16119|NCT01891669|81810|P3|Overall Study|Death|0
16120|NCT01891669|81811|P2|Overall Study|Death|0
16121|NCT01891669|81812|P1|Overall Study|Death|0
16122|NCT01890967|81969|P6|Overall Study|Withdrawal by Subject|1
16123|NCT01890967|81970|P5|Overall Study|Withdrawal by Subject|3
16124|NCT01890967|81971|P4|Overall Study|Withdrawal by Subject|3
16125|NCT01890967|81972|P3|Overall Study|Withdrawal by Subject|2
16126|NCT01890967|81973|P2|Overall Study|Withdrawal by Subject|4
16127|NCT01890967|81974|P1|Overall Study|Withdrawal by Subject|3
16128|NCT01890967|81969|P6|Overall Study|Sponsor Decision|3
16129|NCT01890967|81970|P5|Overall Study|Sponsor Decision|2
16130|NCT01890967|81971|P4|Overall Study|Sponsor Decision|3
16131|NCT01890967|81972|P3|Overall Study|Sponsor Decision|1
16132|NCT01890967|81973|P2|Overall Study|Sponsor Decision|0
16133|NCT01890967|81974|P1|Overall Study|Sponsor Decision|2
16134|NCT01890967|81969|P6|Overall Study|Protocol Violation|1
16135|NCT01890967|81970|P5|Overall Study|Protocol Violation|4
16136|NCT01890967|81971|P4|Overall Study|Protocol Violation|2
16137|NCT01890967|81972|P3|Overall Study|Protocol Violation|3
16138|NCT01890967|81973|P2|Overall Study|Protocol Violation|3
16139|NCT01890967|81974|P1|Overall Study|Protocol Violation|0
16140|NCT01890967|81969|P6|Overall Study|Lost to Follow-up|1
16141|NCT01890967|81970|P5|Overall Study|Lost to Follow-up|0
16142|NCT01890967|81971|P4|Overall Study|Lost to Follow-up|1
16143|NCT01890967|81972|P3|Overall Study|Lost to Follow-up|1
16144|NCT01890967|81973|P2|Overall Study|Lost to Follow-up|1
16145|NCT01890967|81974|P1|Overall Study|Lost to Follow-up|1
16146|NCT01890967|81969|P6|Overall Study|Death|0
16147|NCT01890967|81970|P5|Overall Study|Death|0
16148|NCT01890967|81971|P4|Overall Study|Death|0
16149|NCT01890967|81972|P3|Overall Study|Death|0
16150|NCT01890967|81973|P2|Overall Study|Death|0
16151|NCT01890967|81974|P1|Overall Study|Death|1
16152|NCT01890967|81969|P6|Overall Study|Adverse Event|7
16153|NCT01890967|81970|P5|Overall Study|Adverse Event|1
16154|NCT01890967|81971|P4|Overall Study|Adverse Event|2
16155|NCT01890967|81972|P3|Overall Study|Adverse Event|3
16156|NCT01890967|81973|P2|Overall Study|Adverse Event|3
16157|NCT01890967|81974|P1|Overall Study|Adverse Event|3
16158|NCT01890915|82052|P2|Overall Study|Equipment Malfunction|1
16159|NCT01890915|82053|P1|Overall Study|Equipment Malfunction|0
16160|NCT01890915|82052|P2|Overall Study|Protocol Violation|0
16161|NCT01890915|82053|P1|Overall Study|Protocol Violation|2
16162|NCT01890915|82052|P2|Overall Study|Adverse Event|0
16163|NCT01890915|82053|P1|Overall Study|Adverse Event|1
16164|NCT01890785|82069|P6|Third Intervention|Withdrawal by Subject|0
16165|NCT01890785|82070|P5|Third Intervention|Withdrawal by Subject|0
16166|NCT01890785|82071|P4|Third Intervention|Withdrawal by Subject|0
16167|NCT01890785|82072|P3|Third Intervention|Withdrawal by Subject|0
16168|NCT01890785|82073|P2|Third Intervention|Withdrawal by Subject|1
16169|NCT01890785|82074|P1|Third Intervention|Withdrawal by Subject|0
16170|NCT01890759|82093|P2|Overall Study|Withdrawal by Subject|8
16171|NCT01890759|82094|P1|Overall Study|Withdrawal by Subject|2
16172|NCT01890759|82093|P2|Overall Study|Lost to Follow-up|2
16173|NCT01890759|82094|P1|Overall Study|Lost to Follow-up|0
16174|NCT01890759|82093|P2|Overall Study|Protocol Violation|2
16175|NCT01890759|82094|P1|Overall Study|Protocol Violation|0
16176|NCT01890746|82128|P2|Overall Study|Ongoing|50
16177|NCT01890746|82129|P1|Overall Study|Ongoing|44
16178|NCT01890746|82128|P2|Overall Study|Death|14
16179|NCT01890746|82129|P1|Overall Study|Death|23
16180|NCT01890746|82128|P2|Overall Study|Withdrawal by Subject|8
16181|NCT01890746|82129|P1|Overall Study|Withdrawal by Subject|4
16182|NCT01890746|82128|P2|Overall Study|Physician Decision|2
16183|NCT01890746|82129|P1|Overall Study|Physician Decision|2
16184|NCT01890746|82128|P2|Overall Study|Adverse Event|0
16185|NCT01890746|82129|P1|Overall Study|Adverse Event|1
16186|NCT01890512|82201|P1|Overall Study|Protocol Violation|1
16187|NCT01890512|82201|P1|Overall Study|Withdrawal by Subject|1
16188|NCT01890512|82201|P1|Overall Study|Physician Decision|1
16189|NCT01890473|82207|P2|Overall Study|Poor/non-compliance|0
16190|NCT01890473|82208|P1|Overall Study|Poor/non-compliance|1
16191|NCT01890473|82207|P2|Overall Study|Lost to Follow-up|0
16192|NCT01890473|82208|P1|Overall Study|Lost to Follow-up|1
16193|NCT01890148|82250|P1|Overall Study|Adverse Event|1
16194|NCT01890122|82270|P4|Overall Study|Randomized but not Treated|0
16195|NCT01890122|82271|P3|Overall Study|Randomized but not Treated|0
16196|NCT01890122|82272|P2|Overall Study|Randomized but not Treated|1
16197|NCT01890122|82273|P1|Overall Study|Randomized but not Treated|1
16198|NCT01890122|82270|P4|Overall Study|Reason not Specified|2
16199|NCT01890122|82271|P3|Overall Study|Reason not Specified|1
16200|NCT01890122|82272|P2|Overall Study|Reason not Specified|1
16201|NCT01890122|82273|P1|Overall Study|Reason not Specified|0
16202|NCT01890122|82270|P4|Overall Study|Lack of Efficacy|41
16203|NCT01890122|82271|P3|Overall Study|Lack of Efficacy|7
16204|NCT01890122|82272|P2|Overall Study|Lack of Efficacy|24
16205|NCT01890122|82273|P1|Overall Study|Lack of Efficacy|14
16206|NCT01890122|82270|P4|Overall Study|Voluntary Withdrawal|11
16207|NCT01890122|82271|P3|Overall Study|Voluntary Withdrawal|2
16208|NCT01890122|82272|P2|Overall Study|Voluntary Withdrawal|8
16209|NCT01890122|82273|P1|Overall Study|Voluntary Withdrawal|8
16210|NCT01890122|82270|P4|Overall Study|Lost to Follow-up|2
16211|NCT01890122|82271|P3|Overall Study|Lost to Follow-up|2
16212|NCT01890122|82272|P2|Overall Study|Lost to Follow-up|1
16213|NCT01890122|82273|P1|Overall Study|Lost to Follow-up|0
16214|NCT01890122|82270|P4|Overall Study|Major Protocol Deviation|1
16215|NCT01890122|82271|P3|Overall Study|Major Protocol Deviation|0
16216|NCT01890122|82272|P2|Overall Study|Major Protocol Deviation|1
16217|NCT01890122|82273|P1|Overall Study|Major Protocol Deviation|3
16218|NCT01890122|82270|P4|Overall Study|Adverse Event|2
16219|NCT01890122|82271|P3|Overall Study|Adverse Event|1
16220|NCT01890122|82272|P2|Overall Study|Adverse Event|1
16221|NCT01890122|82273|P1|Overall Study|Adverse Event|1
16222|NCT01889251|82420|P2|Overall Study|Adverse Event|0
16223|NCT01889251|82421|P1|Overall Study|Adverse Event|1
16224|NCT01888965|82427|P1|Overall Study|Lack of Efficacy|4
16225|NCT01888965|82427|P1|Overall Study|Adverse Event|5
16226|NCT01888900|82439|P2|Overall Study|failed treatment|2
16227|NCT01888900|82440|P1|Overall Study|failed treatment|0
16228|NCT01888367|82463|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
16229|NCT01888367|82464|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
16230|NCT01888367|82465|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
16231|NCT01888367|82463|P3|Overall Study|Protocol Violation|1
16232|NCT01888367|82464|P2|Overall Study|Protocol Violation|0
16233|NCT01888367|82465|P1|Overall Study|Protocol Violation|0
16234|NCT01888367|82463|P3|Overall Study|Lost to Follow-up|0
16235|NCT01888367|82464|P2|Overall Study|Lost to Follow-up|1
16236|NCT01888367|82465|P1|Overall Study|Lost to Follow-up|1
16237|NCT01888367|82463|P3|Overall Study|Withdrawal by Subject|1
16238|NCT01888367|82464|P2|Overall Study|Withdrawal by Subject|0
16239|NCT01888367|82465|P1|Overall Study|Withdrawal by Subject|1
16240|NCT01888367|82463|P3|Overall Study|Death|1
16241|NCT01888367|82464|P2|Overall Study|Death|0
16242|NCT01888367|82465|P1|Overall Study|Death|2
16243|NCT01888367|82463|P3|Overall Study|Physician Decision|2
16244|NCT01888367|82464|P2|Overall Study|Physician Decision|4
16245|NCT01888367|82465|P1|Overall Study|Physician Decision|3
16246|NCT01888003|82485|P3|Overall Study|Study Terminated|40
16247|NCT01888003|82486|P2|Overall Study|Study Terminated|6
16248|NCT01888003|82487|P1|Overall Study|Study Terminated|5
16249|NCT01887678|82527|P2|Overall Study|Specified|2
16250|NCT01887678|82528|P1|Overall Study|Specified|1
16251|NCT01887678|82527|P2|Overall Study|Non-compliance|3
16252|NCT01887678|82528|P1|Overall Study|Non-compliance|0
16253|NCT01887678|82527|P2|Overall Study|Lack of Efficacy|2
16254|NCT01887678|82528|P1|Overall Study|Lack of Efficacy|1
16255|NCT01887678|82527|P2|Overall Study|Deterioration of clinical condition|4
16256|NCT01887678|82528|P1|Overall Study|Deterioration of clinical condition|0
16257|NCT01887678|82527|P2|Overall Study|Lost to Follow-up|2
16258|NCT01887678|82528|P1|Overall Study|Lost to Follow-up|4
16259|NCT01887678|82527|P2|Overall Study|Withdrawal of consent|4
16260|NCT01887678|82528|P1|Overall Study|Withdrawal of consent|3
16261|NCT01887678|82527|P2|Overall Study|Exceeded rescue medication dosage|5
16262|NCT01887678|82528|P1|Overall Study|Exceeded rescue medication dosage|4
16263|NCT01887678|82527|P2|Overall Study|Adverse Event|6
16264|NCT01887678|82528|P1|Overall Study|Adverse Event|4
16265|NCT01887418|82596|P3|Overall Study|Travelling difficulties|1
16266|NCT01887418|82597|P2|Overall Study|Travelling difficulties|0
16267|NCT01887418|82598|P1|Overall Study|Travelling difficulties|0
16268|NCT01887353|82617|P2|Overall Study|Study stopped early|3
16269|NCT01887353|82618|P1|Overall Study|Study stopped early|4
16270|NCT01886781|82666|P2|Overall Study|Worsening of symptoms|1
16271|NCT01886781|82667|P1|Overall Study|Worsening of symptoms|1
16272|NCT01886781|82666|P2|Overall Study|Withdrawal by Subject|1
16273|NCT01886781|82667|P1|Overall Study|Withdrawal by Subject|2
16274|NCT01886781|82666|P2|Overall Study|Lost to Follow-up|0
16275|NCT01886781|82667|P1|Overall Study|Lost to Follow-up|5
16276|NCT01886781|82666|P2|Overall Study|Adverse Event|0
16277|NCT01886781|82667|P1|Overall Study|Adverse Event|1
16278|NCT01886781|82666|P2|Overall Study|Protocol Violation|0
16279|NCT01886781|82667|P1|Overall Study|Protocol Violation|5
16280|NCT01886716|82677|P4|Week 3|Lost to Follow-up|1
16281|NCT01886716|82678|P3|Week 3|Lost to Follow-up|0
16282|NCT01886716|82679|P2|Week 3|Lost to Follow-up|1
16283|NCT01886716|82680|P1|Week 3|Lost to Follow-up|1
16284|NCT01886716|82677|P4|Week 2|Lost to Follow-up|3
16285|NCT01886716|82678|P3|Week 2|Lost to Follow-up|1
16286|NCT01886716|82679|P2|Week 2|Lost to Follow-up|2
16287|NCT01886716|82680|P1|Week 2|Lost to Follow-up|3
16288|NCT01886716|82677|P4|Week 1|Lost to Follow-up|2
16289|NCT01886716|82678|P3|Week 1|Lost to Follow-up|2
16290|NCT01886716|82679|P2|Week 1|Lost to Follow-up|0
16291|NCT01886716|82680|P1|Week 1|Lost to Follow-up|0
16292|NCT01886690|82696|P2|Overall Study|Personal Reasons|1
16293|NCT01886690|82697|P1|Overall Study|Personal Reasons|0
16294|NCT01886690|82696|P2|Overall Study|Protocol Violation|1
16295|NCT01886690|82697|P1|Overall Study|Protocol Violation|0
16296|NCT01886313|82713|P2|Overall Study|Adverse Event|1
16297|NCT01886313|82714|P1|Overall Study|Adverse Event|1
16298|NCT01886300|82720|P1|Overall Study|Trial terminated by sponsor|16
16299|NCT01886287|82731|P1|Overall Study|Clinical progression due to disease|1
16300|NCT01886287|82731|P1|Overall Study|Radiographic disease progression|1
16301|NCT01885559|82771|P2|Overall Study|Protocol Violation|1
16302|NCT01885559|82772|P1|Overall Study|Protocol Violation|0
16303|NCT01885559|82771|P2|Overall Study|Less than full participation|19
16304|NCT01885559|82772|P1|Overall Study|Less than full participation|9
16305|NCT01885559|82771|P2|Overall Study|Lost to Follow-up|16
16306|NCT01885559|82772|P1|Overall Study|Lost to Follow-up|15
16307|NCT01885104|82817|P2|Overall Study|Physician Decision|0
16308|NCT01885104|82818|P1|Overall Study|Physician Decision|1
16309|NCT01885104|82817|P2|Overall Study|Lost to Follow-up|1
16310|NCT01885104|82818|P1|Overall Study|Lost to Follow-up|0
16311|NCT01885104|82817|P2|Overall Study|Withdrawal of Consent|0
16312|NCT01885104|82818|P1|Overall Study|Withdrawal of Consent|1
16313|NCT01885000|82828|P2|Overall Study|Protocol Violation|1
16314|NCT01885000|82829|P1|Overall Study|Protocol Violation|0
16315|NCT01885000|82828|P2|Overall Study|Withdrawal by Subject|1
16316|NCT01885000|82829|P1|Overall Study|Withdrawal by Subject|1
16317|NCT01885000|82828|P2|Overall Study|Adverse Event|0
16318|NCT01885000|82829|P1|Overall Study|Adverse Event|1
16319|NCT01884688|82841|P1|Overall Study|Screen Failure|2
16320|NCT01884675|82847|P2|Overall Study|Study closed/terminated|2
16321|NCT01884675|82848|P1|Overall Study|Study closed/terminated|3
16322|NCT01884571|82888|P1|Overall Study|Disease progression|3
16323|NCT01884571|82888|P1|Overall Study|Withdrawal by Subject|2
16324|NCT01884571|82888|P1|Overall Study|Death|2
16325|NCT01884571|82888|P1|Overall Study|Adverse Event|1
16326|NCT01883895|82978|P1|Overall Study|Lost to Follow-up|2
16327|NCT01883635|82985|P2|Overall Study|Withdrawal by Subject|0
16328|NCT01883635|82986|P1|Overall Study|Withdrawal by Subject|4
16329|NCT01883453|83000|P2|Overall Study|No episode of common cold|23
16330|NCT01883453|83001|P1|Overall Study|No episode of common cold|25
16331|NCT01882907|83029|P2|Overall Study|Withdrawal by Subject|6
16332|NCT01882907|83030|P1|Overall Study|Withdrawal by Subject|0
16333|NCT01882907|83029|P2|Overall Study|Protocol Violation|14
16334|NCT01882907|83030|P1|Overall Study|Protocol Violation|10
16335|NCT01882907|83029|P2|Overall Study|Lost to Follow-up|4
16336|NCT01882907|83030|P1|Overall Study|Lost to Follow-up|1
16337|NCT01882907|83029|P2|Overall Study|Lack of Efficacy|3
16338|NCT01882907|83030|P1|Overall Study|Lack of Efficacy|0
16339|NCT01882907|83029|P2|Overall Study|Adverse Event|1
16340|NCT01882907|83030|P1|Overall Study|Adverse Event|3
16341|NCT01882647|83073|P2|Overall Study|Withdrawal by Subject|4
16342|NCT01882647|83074|P1|Overall Study|Withdrawal by Subject|0
16343|NCT01882647|83073|P2|Overall Study|Lost to Follow-up|2
16344|NCT01882647|83074|P1|Overall Study|Lost to Follow-up|2
16345|NCT01882465|83090|P7|Period 2|Protocol Violation|0
16346|NCT01882465|83091|P6|Period 2|Protocol Violation|0
16347|NCT01882465|83092|P5|Period 2|Protocol Violation|1
16348|NCT01882465|83093|P4|Period 2|Protocol Violation|0
16349|NCT01882465|83094|P3|Period 2|Protocol Violation|0
16350|NCT01882465|83095|P2|Period 2|Protocol Violation|0
16351|NCT01882465|83096|P1|Period 2|Protocol Violation|0
16352|NCT01882465|83090|P7|Period 1|Withdrawal by Subject|1
16353|NCT01882465|83091|P6|Period 1|Withdrawal by Subject|0
16354|NCT01882465|83092|P5|Period 1|Withdrawal by Subject|0
16355|NCT01882465|83093|P4|Period 1|Withdrawal by Subject|0
16356|NCT01882465|83094|P3|Period 1|Withdrawal by Subject|0
16357|NCT01882465|83095|P2|Period 1|Withdrawal by Subject|0
16358|NCT01882465|83096|P1|Period 1|Withdrawal by Subject|0
16359|NCT01882465|83090|P7|Period 1|Lens Discomfort|0
16360|NCT01882465|83091|P6|Period 1|Lens Discomfort|0
16361|NCT01882465|83092|P5|Period 1|Lens Discomfort|0
16362|NCT01882465|83093|P4|Period 1|Lens Discomfort|1
16363|NCT01882465|83094|P3|Period 1|Lens Discomfort|0
16364|NCT01882465|83095|P2|Period 1|Lens Discomfort|0
16365|NCT01882465|83096|P1|Period 1|Lens Discomfort|0
16366|NCT01882257|83121|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
16367|NCT01882257|83122|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
16368|NCT01882257|83123|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
16369|NCT01882257|83121|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
16370|NCT01882257|83122|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
16371|NCT01882257|83123|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
16372|NCT01881776|83155|P3|Overall Study|Protocol Violation|1
16373|NCT01881776|83156|P2|Overall Study|Protocol Violation|2
16374|NCT01881776|83157|P1|Overall Study|Protocol Violation|0
16375|NCT01881776|83155|P3|Overall Study|Lost to Follow-up|1
16376|NCT01881776|83156|P2|Overall Study|Lost to Follow-up|2
16377|NCT01881776|83157|P1|Overall Study|Lost to Follow-up|1
16378|NCT01881737|83183|P1|Overall Study|Worsening of baseline behavior|1
16379|NCT01881737|83183|P1|Overall Study|Withdrawal by Subject|1
16380|NCT01881737|83183|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
16381|NCT01881126|83194|P2|Overall Study|Adverse Event|1
16382|NCT01881126|83195|P1|Overall Study|Adverse Event|0
16383|NCT01881126|83194|P2|Overall Study|Non-compliance|1
16384|NCT01881126|83195|P1|Overall Study|Non-compliance|1
16385|NCT01880736|83230|P4|Overall Study|Withdrawal Criteria|5
16386|NCT01880736|83231|P3|Overall Study|Withdrawal Criteria|1
16387|NCT01880736|83232|P2|Overall Study|Withdrawal Criteria|2
16388|NCT01880736|83233|P1|Overall Study|Withdrawal Criteria|1
16389|NCT01880736|83230|P4|Overall Study|Adverse Event|1
16390|NCT01880736|83231|P3|Overall Study|Adverse Event|0
16391|NCT01880736|83232|P2|Overall Study|Adverse Event|0
16392|NCT01880736|83233|P1|Overall Study|Adverse Event|0
16393|NCT01880515|83317|P2|Overall Study|Disease Progression|7
16394|NCT01880515|83318|P1|Overall Study|Disease Progression|5
16395|NCT01880515|83317|P2|Overall Study|Lost to Follow-up|2
16396|NCT01880515|83318|P1|Overall Study|Lost to Follow-up|3
16397|NCT01880437|83329|P3|Overall Study|Study terminated by Sponsor|2
16398|NCT01880437|83330|P2|Overall Study|Study terminated by Sponsor|0
16399|NCT01880437|83331|P1|Overall Study|Study terminated by Sponsor|3
16400|NCT01880437|83329|P3|Overall Study|Death|17
16401|NCT01880437|83330|P2|Overall Study|Death|4
16402|NCT01880437|83331|P1|Overall Study|Death|12
16403|NCT01880424|83357|P2|Overall Study|Not specified|0
16404|NCT01880424|83358|P1|Overall Study|Not specified|1
16405|NCT01880424|83357|P2|Overall Study|Withdrawal by Subject|30
16406|NCT01880424|83358|P1|Overall Study|Withdrawal by Subject|10
16407|NCT01880424|83357|P2|Overall Study|Protocol Violation|13
16408|NCT01880424|83358|P1|Overall Study|Protocol Violation|11
16409|NCT01880424|83357|P2|Overall Study|Lost to Follow-up|2
16410|NCT01880424|83358|P1|Overall Study|Lost to Follow-up|3
16411|NCT01880424|83357|P2|Overall Study|Lack of Efficacy|4
16412|NCT01880424|83358|P1|Overall Study|Lack of Efficacy|1
16413|NCT01880424|83357|P2|Overall Study|Adverse Event|6
16414|NCT01880424|83358|P1|Overall Study|Adverse Event|7
16415|NCT01880086|83401|P2|Overall Study|Lost to Follow-up|1
16416|NCT01880086|83402|P1|Overall Study|Lost to Follow-up|1
16417|NCT01879852|83422|P2|Overall Study|Withdrawal by Subject|0
16418|NCT01879852|83423|P1|Overall Study|Withdrawal by Subject|2
16419|NCT01879722|83467|P10|Overall Study|Voluntary Withdrawal|0
16420|NCT01879722|83468|P9|Overall Study|Voluntary Withdrawal|1
16421|NCT01879722|83469|P8|Overall Study|Voluntary Withdrawal|0
16422|NCT01879722|83470|P7|Overall Study|Voluntary Withdrawal|0
16423|NCT01879722|83471|P6|Overall Study|Voluntary Withdrawal|0
16424|NCT01879722|83472|P5|Overall Study|Voluntary Withdrawal|0
16425|NCT01879722|83473|P4|Overall Study|Voluntary Withdrawal|0
16426|NCT01879722|83474|P3|Overall Study|Voluntary Withdrawal|0
16427|NCT01879722|83475|P2|Overall Study|Voluntary Withdrawal|0
16428|NCT01879722|83476|P1|Overall Study|Voluntary Withdrawal|0
16429|NCT01879722|83467|P10|Overall Study|Pretreatment Event/Adverse Event|0
16430|NCT01879722|83468|P9|Overall Study|Pretreatment Event/Adverse Event|1
16431|NCT01879722|83469|P8|Overall Study|Pretreatment Event/Adverse Event|1
16432|NCT01879722|83470|P7|Overall Study|Pretreatment Event/Adverse Event|0
16433|NCT01879722|83471|P6|Overall Study|Pretreatment Event/Adverse Event|0
16434|NCT01879722|83472|P5|Overall Study|Pretreatment Event/Adverse Event|1
16435|NCT01879722|83473|P4|Overall Study|Pretreatment Event/Adverse Event|1
16436|NCT01879722|83474|P3|Overall Study|Pretreatment Event/Adverse Event|0
16437|NCT01879722|83475|P2|Overall Study|Pretreatment Event/Adverse Event|1
16438|NCT01879722|83476|P1|Overall Study|Pretreatment Event/Adverse Event|0
16439|NCT01879683|83624|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
16440|NCT01879618|83631|P1|Overall Study|Adverse Event|5
16441|NCT01879618|83631|P1|Overall Study|Protocol Violation|6
16442|NCT01879618|83631|P1|Overall Study|Surgery;changed schedule; not available|8
16443|NCT01879618|83631|P1|Overall Study|Withdrawal by Subject|1
16444|NCT01879618|83631|P1|Overall Study|Does not meet entrance criteria|1
16445|NCT01879579|83638|P2|Overall Study|Discontinued insulin - possible allergy|1
16446|NCT01879579|83639|P1|Overall Study|Discontinued insulin - possible allergy|0
16447|NCT01879579|83638|P2|Overall Study|Phenotypic type 1 diabetes|1
16448|NCT01879579|83639|P1|Overall Study|Phenotypic type 1 diabetes|0
16449|NCT01879579|83638|P2|Overall Study|Did not initiate insulin treatment|0
16450|NCT01879579|83639|P1|Overall Study|Did not initiate insulin treatment|1
16451|NCT01879579|83638|P2|Overall Study|Did not enroll in texting platform|0
16452|NCT01879579|83639|P1|Overall Study|Did not enroll in texting platform|1
16453|NCT01879579|83638|P2|Overall Study|Phone incompatible with texting platform|0
16454|NCT01879579|83639|P1|Overall Study|Phone incompatible with texting platform|3
16455|NCT01879553|83669|P2|Overall Study|Withdrawal by Subject|0
16456|NCT01879553|83670|P1|Overall Study|Withdrawal by Subject|1
16457|NCT01879410|83704|P2|Overall Study|Randomised in Error|2
16458|NCT01879410|83705|P1|Overall Study|Randomised in Error|1
16459|NCT01879410|83704|P2|Overall Study|Withdrawal by Subject|8
16460|NCT01879410|83705|P1|Overall Study|Withdrawal by Subject|7
16461|NCT01879410|83704|P2|Overall Study|Lost to Follow-up|1
16462|NCT01879410|83705|P1|Overall Study|Lost to Follow-up|2
16463|NCT01879410|83704|P2|Overall Study|Protocol Violation|7
16464|NCT01879410|83705|P1|Overall Study|Protocol Violation|1
16465|NCT01879410|83704|P2|Overall Study|Lack of Efficacy|6
16466|NCT01879410|83705|P1|Overall Study|Lack of Efficacy|4
16467|NCT01879410|83704|P2|Overall Study|Adverse Event|14
16468|NCT01879410|83705|P1|Overall Study|Adverse Event|9
16469|NCT01879319|83772|P2|Overall Study|Lost to Follow-up|5
16470|NCT01879319|83773|P1|Overall Study|Lost to Follow-up|1
16471|NCT01879319|83772|P2|Overall Study|Withdrawal by Subject|0
16472|NCT01879319|83773|P1|Overall Study|Withdrawal by Subject|1
16473|NCT01878214|83911|P2|Overall Study|Lost to Follow-up|36
16474|NCT01878214|83912|P1|Overall Study|Lost to Follow-up|35
16475|NCT01878214|83911|P2|Overall Study|Death|1
16476|NCT01878214|83912|P1|Overall Study|Death|0
16477|NCT01878214|83911|P2|Overall Study|Withdrawal by Subject|7
16478|NCT01878214|83912|P1|Overall Study|Withdrawal by Subject|18
16479|NCT01878175|83926|P1|Overall Study|Developed contraindicated health problem|2
16480|NCT01878149|83945|P2|Overall Study|Did Not Meet Eligibility Criteria|2
16481|NCT01878149|83946|P1|Overall Study|Did Not Meet Eligibility Criteria|2
16482|NCT01878097|83954|P2|Implementation Year 5|Surveys not fully completed|3007
16483|NCT01878097|83955|P1|Implementation Year 5|Surveys not fully completed|3604
16484|NCT01878097|83954|P2|Implementation Year 3|Surveys not fully completed|2980
16485|NCT01878097|83955|P1|Implementation Year 3|Surveys not fully completed|3494
16486|NCT01878097|83954|P2|Implementation Year 2|Surveys not fully completed|2841
16487|NCT01878097|83955|P1|Implementation Year 2|Surveys not fully completed|3281
16488|NCT01878097|83954|P2|Implementation Year 1|Surveys not fully completed|2549
16489|NCT01878097|83955|P1|Implementation Year 1|Surveys not fully completed|3202
16490|NCT01878097|83954|P2|Baseline|Surveys not fully completed|1800
16491|NCT01878097|83955|P1|Baseline|Surveys not fully completed|2497
16492|NCT01877720|83971|P2|Overall Study|Adverse Event|0
16493|NCT01877720|83972|P1|Overall Study|Adverse Event|1
16494|NCT01877668|84001|P5|Overall Study|Adverse event unrelated to study drug|1
16495|NCT01877668|84002|P4|Overall Study|Adverse event unrelated to study drug|0
16496|NCT01877668|84003|P3|Overall Study|Adverse event unrelated to study drug|2
16497|NCT01877668|84004|P2|Overall Study|Adverse event unrelated to study drug|1
16498|NCT01877668|84005|P1|Overall Study|Adverse event unrelated to study drug|4
16499|NCT01877668|84001|P5|Overall Study|Adverse event related to study drug|1
16500|NCT01877668|84002|P4|Overall Study|Adverse event related to study drug|2
16501|NCT01877668|84003|P3|Overall Study|Adverse event related to study drug|2
16502|NCT01877668|84004|P2|Overall Study|Adverse event related to study drug|2
16503|NCT01877668|84005|P1|Overall Study|Adverse event related to study drug|2
16504|NCT01877668|84001|P5|Overall Study|Protocol Violation|3
16505|NCT01877668|84002|P4|Overall Study|Protocol Violation|0
16506|NCT01877668|84003|P3|Overall Study|Protocol Violation|0
16507|NCT01877668|84004|P2|Overall Study|Protocol Violation|1
16508|NCT01877668|84005|P1|Overall Study|Protocol Violation|1
16509|NCT01877668|84001|P5|Overall Study|Not specified|3
16510|NCT01877668|84002|P4|Overall Study|Not specified|1
16511|NCT01877668|84003|P3|Overall Study|Not specified|1
16512|NCT01877668|84004|P2|Overall Study|Not specified|1
16513|NCT01877668|84005|P1|Overall Study|Not specified|1
16514|NCT01877668|84001|P5|Overall Study|Withdrawal by Subject|2
16515|NCT01877668|84002|P4|Overall Study|Withdrawal by Subject|2
16516|NCT01877668|84003|P3|Overall Study|Withdrawal by Subject|3
16517|NCT01877668|84004|P2|Overall Study|Withdrawal by Subject|0
16518|NCT01877668|84005|P1|Overall Study|Withdrawal by Subject|2
16519|NCT01877668|84001|P5|Overall Study|Lost to Follow-up|0
16520|NCT01877668|84002|P4|Overall Study|Lost to Follow-up|0
16521|NCT01877668|84003|P3|Overall Study|Lost to Follow-up|1
16522|NCT01877668|84004|P2|Overall Study|Lost to Follow-up|2
16523|NCT01877668|84005|P1|Overall Study|Lost to Follow-up|0
16524|NCT01877668|84001|P5|Overall Study|Insufficient clinical response|0
16525|NCT01877668|84002|P4|Overall Study|Insufficient clinical response|2
16526|NCT01877668|84003|P3|Overall Study|Insufficient clinical response|2
16527|NCT01877668|84004|P2|Overall Study|Insufficient clinical response|1
16528|NCT01877668|84005|P1|Overall Study|Insufficient clinical response|0
16529|NCT01877668|84001|P5|Overall Study|No longer met study criteria|0
16530|NCT01877668|84002|P4|Overall Study|No longer met study criteria|0
16531|NCT01877668|84003|P3|Overall Study|No longer met study criteria|1
16532|NCT01877668|84004|P2|Overall Study|No longer met study criteria|0
16533|NCT01877668|84005|P1|Overall Study|No longer met study criteria|1
16534|NCT01877668|84001|P5|Overall Study|Death|0
16535|NCT01877668|84002|P4|Overall Study|Death|1
16536|NCT01877668|84003|P3|Overall Study|Death|0
16537|NCT01877668|84004|P2|Overall Study|Death|0
16538|NCT01877668|84005|P1|Overall Study|Death|0
16539|NCT01877408|84241|P2|Overall Study|Lost to Follow-up|2
16540|NCT01877408|84242|P1|Overall Study|Lost to Follow-up|0
16541|NCT01876368|84261|P2|Overall Study|Subject/guardian decision|1
16542|NCT01876368|84262|P1|Overall Study|Subject/guardian decision|3
16543|NCT01876368|84261|P2|Overall Study|Protocol deviation|3
16544|NCT01876368|84262|P1|Overall Study|Protocol deviation|3
16545|NCT01876368|84261|P2|Overall Study|Physician Decision|2
16546|NCT01876368|84262|P1|Overall Study|Physician Decision|0
16547|NCT01876368|84261|P2|Overall Study|Non-compliance with study treatment|1
16548|NCT01876368|84262|P1|Overall Study|Non-compliance with study treatment|0
16549|NCT01876368|84261|P2|Overall Study|Lost to Follow-up|1
16550|NCT01876368|84262|P1|Overall Study|Lost to Follow-up|0
16551|NCT01876368|84261|P2|Overall Study|Lack of Efficacy|0
16552|NCT01876368|84262|P1|Overall Study|Lack of Efficacy|1
16553|NCT01876368|84261|P2|Overall Study|Adverse Event|5
16554|NCT01876368|84262|P1|Overall Study|Adverse Event|2
16555|NCT01877278|84320|P2|Overall Study|Lost to Follow-up|3
16556|NCT01877278|84321|P1|Overall Study|Lost to Follow-up|3
16557|NCT01876979|84369|P2|Overall Study|Physician Decision|3
16558|NCT01876979|84370|P1|Overall Study|Physician Decision|2
16559|NCT01876823|84376|P1|Overall Study|Patients moved|2
16560|NCT01876823|84376|P1|Overall Study|Physician Decision|2
16561|NCT01876823|84376|P1|Overall Study|Withdrawal by Subject|5
16562|NCT01876810|84389|P2|Overall Study|Physician Decision|1
16563|NCT01876810|84390|P1|Overall Study|Physician Decision|0
16564|NCT01876784|84402|P2|Overall Study|Ongoing|40
16565|NCT01876784|84403|P1|Overall Study|Ongoing|41
16566|NCT01876784|84402|P2|Overall Study|Other than specified above|6
16567|NCT01876784|84403|P1|Overall Study|Other than specified above|5
16568|NCT01876784|84402|P2|Overall Study|Randomized but not treated|1
16569|NCT01876784|84403|P1|Overall Study|Randomized but not treated|2
16570|NCT01876784|84402|P2|Overall Study|Death|0
16571|NCT01876784|84403|P1|Overall Study|Death|1
16572|NCT01876784|84402|P2|Overall Study|Lost to Follow-up|1
16573|NCT01876784|84403|P1|Overall Study|Lost to Follow-up|0
16574|NCT01876784|84402|P2|Overall Study|Disease progression|67
16575|NCT01876784|84403|P1|Overall Study|Disease progression|37
16576|NCT01876784|84402|P2|Overall Study|Protocol Violation|0
16577|NCT01876784|84403|P1|Overall Study|Protocol Violation|1
16578|NCT01876784|84402|P2|Overall Study|Adverse Event|2
16579|NCT01876784|84403|P1|Overall Study|Adverse Event|15
16580|NCT01876784|84402|P2|Overall Study|Withdrawal by Subject|2
16581|NCT01876784|84403|P1|Overall Study|Withdrawal by Subject|17
16582|NCT01876732|84409|P1|Overall Study|MMA was not over 800mg/dL|75
16583|NCT01876706|84414|P1|Overall Study|Lost to Follow-up|2
16584|NCT01876706|84414|P1|Overall Study|BPH Intervention|2
16585|NCT01875991|84433|P2|Overall Study|Sponsor Decision|0
16586|NCT01875991|84434|P1|Overall Study|Sponsor Decision|1
16587|NCT01875991|84433|P2|Overall Study|Withdrawal by Subject|6
16588|NCT01875991|84434|P1|Overall Study|Withdrawal by Subject|6
16589|NCT01875848|84472|P2|Overall Study|Withdrawal by Subject|0
16590|NCT01875848|84473|P1|Overall Study|Withdrawal by Subject|2
16591|NCT01875731|84483|P2|Overall Study|Fail to obtain lab sample|0
16592|NCT01875731|84484|P1|Overall Study|Fail to obtain lab sample|1
16593|NCT01875471|84503|P2|Overall Study|Unsatisfactory Lens Fitting|0
16594|NCT01875471|84504|P1|Overall Study|Unsatisfactory Lens Fitting|1
16595|NCT01875471|84503|P2|Overall Study|Adverse Event|1
16596|NCT01875471|84504|P1|Overall Study|Adverse Event|0
16597|NCT01875445|84512|P2|Overall Study|Withdrawal by Subject|0
16598|NCT01875445|84513|P1|Overall Study|Withdrawal by Subject|2
16599|NCT01875445|84512|P2|Overall Study|Lost to Follow-up|0
16600|NCT01875445|84513|P1|Overall Study|Lost to Follow-up|5
16601|NCT01874665|84557|P2|Overall Study|Treatment Ongoing|2
16602|NCT01874665|84558|P1|Overall Study|Treatment Ongoing|4
16603|NCT01874340|84567|P4|Overall Study|Withdrawal by Subject|1
16604|NCT01874340|84568|P3|Overall Study|Withdrawal by Subject|0
16605|NCT01874340|84569|P2|Overall Study|Withdrawal by Subject|0
16606|NCT01874340|84570|P1|Overall Study|Withdrawal by Subject|0
16607|NCT01874340|84567|P4|Overall Study|Study terminated by Sponsor|4
16608|NCT01874340|84568|P3|Overall Study|Study terminated by Sponsor|8
16609|NCT01874340|84569|P2|Overall Study|Study terminated by Sponsor|8
16610|NCT01874340|84570|P1|Overall Study|Study terminated by Sponsor|6
16611|NCT01874275|84598|P2|Overall Study|Lost to Follow-up|0
16612|NCT01874275|84599|P1|Overall Study|Lost to Follow-up|1
16613|NCT01874145|84622|P2|Extension Period|Lost to Follow-up|1
16614|NCT01874145|84623|P1|Extension Period|Lost to Follow-up|1
16615|NCT01874145|84622|P2|Extension Period|Withdrawal by Subject|1
16616|NCT01874145|84623|P1|Extension Period|Withdrawal by Subject|2
16617|NCT01874145|84622|P2|Extension Period|Adverse Event|2
16618|NCT01874145|84623|P1|Extension Period|Adverse Event|3
16619|NCT01874145|84622|P2|Core Period|Withdrawal by Subject|4
16620|NCT01874145|84623|P1|Core Period|Withdrawal by Subject|0
16621|NCT01874145|84622|P2|Core Period|Adverse Event|1
16622|NCT01874145|84623|P1|Core Period|Adverse Event|0
16623|NCT01874145|84622|P2|Core Period|Physician Decision|1
16624|NCT01874145|84623|P1|Core Period|Physician Decision|1
16625|NCT01874145|84622|P2|Core Period|Protocol Violation|1
16626|NCT01874145|84623|P1|Core Period|Protocol Violation|1
16627|NCT01874145|84622|P2|Core Period|Non-compliance|0
16628|NCT01874145|84623|P1|Core Period|Non-compliance|1
16629|NCT01874054|84675|P1|Follow-up Period|Continuing in Follow-up|48
16630|NCT01874054|84675|P1|Follow-up Period|Withdrawal by Subject|1
16631|NCT01874054|84675|P1|Treatment Period|Non-AE related|2
16632|NCT01874054|84675|P1|Treatment Period|Withdrawal by Subject|6
16633|NCT01874054|84675|P1|Treatment Period|Physician Decision|3
16634|NCT01874054|84675|P1|Treatment Period|Adverse Event|20
16635|NCT01874054|84675|P1|Treatment Period|Progressive Disease|7
16636|NCT01873950|84697|P5|Period 5|Withdrawal by Subject|0
16637|NCT01873950|84698|P4|Period 5|Withdrawal by Subject|1
16638|NCT01873950|84699|P3|Period 5|Withdrawal by Subject|0
16639|NCT01873950|84700|P2|Period 5|Withdrawal by Subject|0
16640|NCT01873950|84701|P1|Period 5|Withdrawal by Subject|0
16641|NCT01873859|84722|P2|Overall Study|Withdrawal by Subject|4
16642|NCT01873859|84723|P1|Overall Study|Withdrawal by Subject|0
16643|NCT01873729|84731|P1|Overall Study|Withdrawal by Subject|1
16644|NCT01873417|84736|P1|Overall Study|Physician Decision|3
16645|NCT01873417|84736|P1|Overall Study|Withdrawal by Subject|2
16646|NCT01873417|84736|P1|Overall Study|Lost to Follow-up|2
16647|NCT01873417|84736|P1|Overall Study|Adverse Event|24
16648|NCT01873417|84736|P1|Overall Study|Did Not Receive Any Study Drug|4
16649|NCT01872819|84747|P1|Overall Study|Withdrawal by Subject|1
16650|NCT01872819|84747|P1|Overall Study|Physician Decision|1
16651|NCT01872715|84751|P1|Overall Study|Withdrawal by Subject|2
16652|NCT01872715|84751|P1|Overall Study|Protocol Violation|1
16653|NCT01872715|84751|P1|Overall Study|Adverse Event|1
16654|NCT01872611|84768|P2|Overall Study|Reason not provided|6
16655|NCT01872611|84769|P1|Overall Study|Reason not provided|6
16656|NCT01872611|84768|P2|Overall Study|Withdrawal by Subject|1
16657|NCT01872611|84769|P1|Overall Study|Withdrawal by Subject|6
16658|NCT01872611|84768|P2|Overall Study|Physician Decision|0
16659|NCT01872611|84769|P1|Overall Study|Physician Decision|1
16660|NCT01872611|84768|P2|Overall Study|Lost to Follow-up|1
16661|NCT01872611|84769|P1|Overall Study|Lost to Follow-up|8
16662|NCT01872611|84768|P2|Overall Study|Death, prior to treatment|1
16663|NCT01872611|84769|P1|Overall Study|Death, prior to treatment|0
16664|NCT01872611|84768|P2|Overall Study|Death|1
16665|NCT01872611|84769|P1|Overall Study|Death|0
16666|NCT01872611|84768|P2|Overall Study|Adverse Event, prior to treatment|1
16667|NCT01872611|84769|P1|Overall Study|Adverse Event, prior to treatment|0
16668|NCT01872611|84768|P2|Overall Study|Adverse Event|1
16669|NCT01872611|84769|P1|Overall Study|Adverse Event|3
16670|NCT01872078|84791|P4|Overall Study|Patient met exclusion criterion 16.|1
16671|NCT01872078|84792|P3|Overall Study|Patient met exclusion criterion 16.|0
16672|NCT01872078|84793|P2|Overall Study|Patient met exclusion criterion 16.|0
16673|NCT01872078|84794|P1|Overall Study|Patient met exclusion criterion 16.|0
16674|NCT01872078|84791|P4|Overall Study|Withdrawal by Subject|0
16675|NCT01872078|84792|P3|Overall Study|Withdrawal by Subject|1
16676|NCT01872078|84793|P2|Overall Study|Withdrawal by Subject|0
16677|NCT01872078|84794|P1|Overall Study|Withdrawal by Subject|0
16678|NCT01872078|84791|P4|Overall Study|Protocol Violation|0
16679|NCT01872078|84792|P3|Overall Study|Protocol Violation|1
16680|NCT01872078|84793|P2|Overall Study|Protocol Violation|0
16681|NCT01872078|84794|P1|Overall Study|Protocol Violation|0
16682|NCT01872078|84791|P4|Overall Study|Dose administration non-compliance|1
16683|NCT01872078|84792|P3|Overall Study|Dose administration non-compliance|0
16684|NCT01872078|84793|P2|Overall Study|Dose administration non-compliance|0
16685|NCT01872078|84794|P1|Overall Study|Dose administration non-compliance|0
16686|NCT01872078|84791|P4|Overall Study|Adverse Event|0
16687|NCT01872078|84792|P3|Overall Study|Adverse Event|1
16688|NCT01872078|84793|P2|Overall Study|Adverse Event|0
16689|NCT01872078|84794|P1|Overall Study|Adverse Event|0
16690|NCT01871870|84804|P1|Overall Study|hyperglycemia|2
16691|NCT01871870|84804|P1|Overall Study|Hardware issues|7
16692|NCT01871805|84815|P6|Phase II|Lost to Follow-up|2
16693|NCT01871805|84816|P5|Phase II|Lost to Follow-up|0
16694|NCT01871805|84817|P4|Phase II|Lost to Follow-up|0
16695|NCT01871805|84818|P3|Phase II|Lost to Follow-up|0
16696|NCT01871805|84819|P2|Phase II|Lost to Follow-up|0
16697|NCT01871805|84820|P1|Phase II|Lost to Follow-up|0
16698|NCT01871805|84815|P6|Phase II|Alive in Survival Follow-up|17
16699|NCT01871805|84816|P5|Phase II|Alive in Survival Follow-up|0
16700|NCT01871805|84817|P4|Phase II|Alive in Survival Follow-up|0
16701|NCT01871805|84818|P3|Phase II|Alive in Survival Follow-up|0
16702|NCT01871805|84819|P2|Phase II|Alive in Survival Follow-up|0
16703|NCT01871805|84820|P1|Phase II|Alive in Survival Follow-up|0
16704|NCT01871805|84815|P6|Phase II|Alive on Treatment|56
16705|NCT01871805|84816|P5|Phase II|Alive on Treatment|0
16706|NCT01871805|84817|P4|Phase II|Alive on Treatment|0
16707|NCT01871805|84818|P3|Phase II|Alive on Treatment|0
16708|NCT01871805|84819|P2|Phase II|Alive on Treatment|0
16709|NCT01871805|84820|P1|Phase II|Alive on Treatment|0
16710|NCT01871805|84815|P6|Phase II|Death|12
16711|NCT01871805|84816|P5|Phase II|Death|0
16712|NCT01871805|84817|P4|Phase II|Death|0
16713|NCT01871805|84818|P3|Phase II|Death|0
16714|NCT01871805|84819|P2|Phase II|Death|0
16715|NCT01871805|84820|P1|Phase II|Death|0
16716|NCT01871805|84815|P6|Phase I|Lost to Follow-up|0
16717|NCT01871805|84816|P5|Phase I|Lost to Follow-up|0
16718|NCT01871805|84817|P4|Phase I|Lost to Follow-up|0
16719|NCT01871805|84818|P3|Phase I|Lost to Follow-up|0
16720|NCT01871805|84819|P2|Phase I|Lost to Follow-up|1
16721|NCT01871805|84820|P1|Phase I|Lost to Follow-up|0
16722|NCT01871805|84815|P6|Phase I|Alive in Survival Follow-up|0
16723|NCT01871805|84816|P5|Phase I|Alive in Survival Follow-up|4
16724|NCT01871805|84817|P4|Phase I|Alive in Survival Follow-up|1
16725|NCT01871805|84818|P3|Phase I|Alive in Survival Follow-up|3
16726|NCT01871805|84819|P2|Phase I|Alive in Survival Follow-up|0
16727|NCT01871805|84820|P1|Phase I|Alive in Survival Follow-up|1
16728|NCT01871805|84815|P6|Phase I|Alive on Treatment|0
16729|NCT01871805|84816|P5|Phase I|Alive on Treatment|3
16730|NCT01871805|84817|P4|Phase I|Alive on Treatment|4
16731|NCT01871805|84818|P3|Phase I|Alive on Treatment|5
16732|NCT01871805|84819|P2|Phase I|Alive on Treatment|3
16733|NCT01871805|84820|P1|Phase I|Alive on Treatment|0
16734|NCT01871805|84815|P6|Phase I|Death|0
16735|NCT01871805|84816|P5|Phase I|Death|6
16736|NCT01871805|84817|P4|Phase I|Death|2
16737|NCT01871805|84818|P3|Phase I|Death|5
16738|NCT01871805|84819|P2|Phase I|Death|3
16739|NCT01871805|84820|P1|Phase I|Death|6
16740|NCT01871558|84888|P2|Overall Study|Withdrawal by Subject|0
16741|NCT01871558|84889|P1|Overall Study|Withdrawal by Subject|2
16742|NCT01871558|84888|P2|Overall Study|antidiabetic drug prematurely stopped|1
16743|NCT01871558|84889|P1|Overall Study|antidiabetic drug prematurely stopped|1
16744|NCT01871558|84888|P2|Overall Study|Other reason|1
16745|NCT01871558|84889|P1|Overall Study|Other reason|0
16746|NCT01871532|84909|P2|Overall Study|Withdrawal by Subject|2
16747|NCT01871532|84910|P1|Overall Study|Withdrawal by Subject|1
16748|NCT01871519|84944|P1|Overall Study|Withdrawal by Subject|49
16749|NCT01871519|84944|P1|Overall Study|Lost to Follow-up|15
16750|NCT01871519|84944|P1|Overall Study|Death|26
16751|NCT01871402|84967|P2|Overall Study|Non-compliance|1
16752|NCT01871402|84968|P1|Overall Study|Non-compliance|0
16753|NCT01871402|84967|P2|Overall Study|Withdrawal by Subject|2
16754|NCT01871402|84968|P1|Overall Study|Withdrawal by Subject|0
16755|NCT01871402|84967|P2|Overall Study|Lost to Follow-up|0
16756|NCT01871402|84968|P1|Overall Study|Lost to Follow-up|1
16757|NCT01871285|84986|P4|First Intervention (1 Day)|Lost to Follow-up|0
16758|NCT01871285|84987|P3|First Intervention (1 Day)|Lost to Follow-up|1
16759|NCT01871285|84988|P2|First Intervention (1 Day)|Lost to Follow-up|1
16760|NCT01871285|84989|P1|First Intervention (1 Day)|Lost to Follow-up|0
16761|NCT01871285|84986|P4|First Intervention (1 Day)|Adverse Event|0
16762|NCT01871285|84987|P3|First Intervention (1 Day)|Adverse Event|0
16763|NCT01871285|84988|P2|First Intervention (1 Day)|Adverse Event|0
16764|NCT01871285|84989|P1|First Intervention (1 Day)|Adverse Event|1
16765|NCT01871142|85015|P1|Overall Study|Adverse Event|1
16766|NCT01871090|85031|P2|Overall Study|Subject Non-Compliance|1
16767|NCT01871090|85032|P1|Overall Study|Subject Non-Compliance|0
16768|NCT01871090|85031|P2|Overall Study|Interrogation not completed correctly|0
16769|NCT01871090|85032|P1|Overall Study|Interrogation not completed correctly|1
16770|NCT01871090|85031|P2|Overall Study|Interrogation not done in Emergency Room|22
16771|NCT01871090|85032|P1|Overall Study|Interrogation not done in Emergency Room|1
16772|NCT01870999|85045|P3|Overall Study|Protocol Violation|1
16773|NCT01870999|85046|P2|Overall Study|Protocol Violation|0
16774|NCT01870999|85047|P1|Overall Study|Protocol Violation|0
16775|NCT01870999|85045|P3|Overall Study|Withdrawal by Subject|5
16776|NCT01870999|85046|P2|Overall Study|Withdrawal by Subject|2
16777|NCT01870999|85047|P1|Overall Study|Withdrawal by Subject|0
16778|NCT01870999|85045|P3|Overall Study|Subject withdrawn by Investigator|0
16779|NCT01870999|85046|P2|Overall Study|Subject withdrawn by Investigator|0
16780|NCT01870999|85047|P1|Overall Study|Subject withdrawn by Investigator|1
16866|NCT01868009|85490|P2|Period 2 (5-9 Days)|Adverse Event|0
16781|NCT01870999|85045|P3|Overall Study|Subject met withdrawal criteria|0
16782|NCT01870999|85046|P2|Overall Study|Subject met withdrawal criteria|2
16783|NCT01870999|85047|P1|Overall Study|Subject met withdrawal criteria|3
16784|NCT01870999|85045|P3|Overall Study|Adverse Event|1
16785|NCT01870999|85046|P2|Overall Study|Adverse Event|4
16786|NCT01870999|85047|P1|Overall Study|Adverse Event|0
16787|NCT01870973|85105|P2|Overall Study|Lost to Follow-up|3
16788|NCT01870973|85106|P1|Overall Study|Lost to Follow-up|10
16789|NCT01870921|85112|P1|Overall Study|Other|1
16790|NCT01870921|85112|P1|Overall Study|Subject Lost to Follow up|2
16791|NCT01870921|85112|P1|Overall Study|Severe non-compliance to protocol|7
16792|NCT01870921|85112|P1|Overall Study|Subject decision|80
16793|NCT01870843|85131|P1|Overall Study|Withdrawal by Subject|18
16794|NCT01870843|85131|P1|Overall Study|Death|1
16795|NCT01870843|85131|P1|Overall Study|Lost to Follow-up|24
16796|NCT01870843|85131|P1|Overall Study|Adverse Event|10
16797|NCT01870739|85146|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
16798|NCT01870739|85147|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
16799|NCT01870739|85146|P2|Add-on Period (40 Weeks)|Protocol deviation|1
16800|NCT01870739|85147|P1|Add-on Period (40 Weeks)|Protocol deviation|1
16801|NCT01870739|85146|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
16802|NCT01870739|85147|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
16803|NCT01870739|85146|P2|Add-on Period (40 Weeks)|Adverse Event|1
16804|NCT01870739|85147|P1|Add-on Period (40 Weeks)|Adverse Event|0
16805|NCT01870739|85146|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
16806|NCT01870739|85147|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
16807|NCT01870739|85146|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
16808|NCT01870739|85147|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
16809|NCT01870739|85146|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
16810|NCT01870739|85147|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
16811|NCT01870583|85191|P3|Overall Study|Lost to Follow-up|5
16812|NCT01870583|85192|P2|Overall Study|Lost to Follow-up|13
16813|NCT01870583|85193|P1|Overall Study|Lost to Follow-up|11
16814|NCT01870583|85191|P3|Overall Study|Protocol Violation|3
16815|NCT01870583|85192|P2|Overall Study|Protocol Violation|5
16816|NCT01870583|85193|P1|Overall Study|Protocol Violation|0
16817|NCT01869959|85216|P5|Treatment Period|Withdrawal by Subject|0
16818|NCT01869959|85217|P4|Treatment Period|Withdrawal by Subject|0
16819|NCT01869959|85218|P3|Treatment Period|Withdrawal by Subject|0
16820|NCT01869959|85219|P2|Treatment Period|Withdrawal by Subject|1
16821|NCT01869959|85220|P1|Treatment Period|Withdrawal by Subject|0
16822|NCT01869959|85216|P5|Treatment Period|Sponsor decision|0
16823|NCT01869959|85217|P4|Treatment Period|Sponsor decision|1
16824|NCT01869959|85218|P3|Treatment Period|Sponsor decision|0
16825|NCT01869959|85219|P2|Treatment Period|Sponsor decision|1
16826|NCT01869959|85220|P1|Treatment Period|Sponsor decision|0
16827|NCT01869959|85216|P5|Treatment Period|Adverse Event|0
16828|NCT01869959|85217|P4|Treatment Period|Adverse Event|1
16829|NCT01869959|85218|P3|Treatment Period|Adverse Event|3
16830|NCT01869959|85219|P2|Treatment Period|Adverse Event|0
16831|NCT01869959|85220|P1|Treatment Period|Adverse Event|1
16832|NCT01869959|85216|P5|Randomization Period|Physician Decision|1
16833|NCT01869959|85217|P4|Randomization Period|Physician Decision|0
16834|NCT01869959|85218|P3|Randomization Period|Physician Decision|0
16835|NCT01869959|85219|P2|Randomization Period|Physician Decision|0
16836|NCT01869959|85220|P1|Randomization Period|Physician Decision|0
16837|NCT01869699|85290|P2|Overall Study|Withdrawal by Subject|0
16838|NCT01869699|85291|P1|Overall Study|Withdrawal by Subject|1
16839|NCT01868997|85375|P2|Overall Study|Not Specified|1
16840|NCT01868997|85376|P1|Overall Study|Not Specified|2
16841|NCT01868997|85375|P2|Overall Study|Lack of Efficacy|0
16842|NCT01868997|85376|P1|Overall Study|Lack of Efficacy|2
16843|NCT01868997|85375|P2|Overall Study|Adverse Event|5
16844|NCT01868997|85376|P1|Overall Study|Adverse Event|1
16845|NCT01868893|85392|P1|Overall Study|Neutropenia|1
16846|NCT01868893|85392|P1|Overall Study|Commercial availability of study drug|17
16847|NCT01868893|85392|P1|Overall Study|Adverse Event|2
16848|NCT01868542|85423|P2|Overall Study|Unclassified|1
16849|NCT01868542|85424|P1|Overall Study|Unclassified|0
16850|NCT01868542|85423|P2|Overall Study|Protocol Violation|1
16851|NCT01868542|85424|P1|Overall Study|Protocol Violation|0
16852|NCT01868503|85442|P1|Overall Study|Protocol Violation|1
16853|NCT01868503|85442|P1|Overall Study|Withdrawal by Subject|1
16854|NCT01868243|85452|P2|Overall Study|Death|1
16855|NCT01868243|85453|P1|Overall Study|Death|0
16856|NCT01868074|85463|P2|Overall Study|Withdrawal by Subject|2
16857|NCT01868074|85464|P1|Overall Study|Withdrawal by Subject|4
16858|NCT01868074|85463|P2|Overall Study|Lost to Follow-up|2
16859|NCT01868074|85464|P1|Overall Study|Lost to Follow-up|3
16860|NCT01868035|85474|P1|Overall Study|Non-compliance|1
16861|NCT01868035|85474|P1|Overall Study|Progressive Disease|2
16862|NCT01868035|85474|P1|Overall Study|Withdrawal by Subject|1
16863|NCT01868035|85474|P1|Overall Study|Lost to Follow-up|3
16864|NCT01868009|85490|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
16865|NCT01868009|85491|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
16867|NCT01868009|85491|P1|Period 2 (5-9 Days)|Adverse Event|1
16868|NCT01868009|85490|P2|Period 1 (5-9 Days)|Adverse Event|2
16869|NCT01868009|85491|P1|Period 1 (5-9 Days)|Adverse Event|0
16870|NCT01867710|85505|P4|Overall Study|Unspecified|0
16871|NCT01867710|85506|P3|Overall Study|Unspecified|0
16872|NCT01867710|85507|P2|Overall Study|Unspecified|1
16873|NCT01867710|85508|P1|Overall Study|Unspecified|0
16874|NCT01867710|85505|P4|Overall Study|Eligible Criteria Not Met|0
16875|NCT01867710|85506|P3|Overall Study|Eligible Criteria Not Met|1
16876|NCT01867710|85507|P2|Overall Study|Eligible Criteria Not Met|0
16877|NCT01867710|85508|P1|Overall Study|Eligible Criteria Not Met|0
16878|NCT01867710|85505|P4|Overall Study|Withdrawal by Subject|0
16879|NCT01867710|85506|P3|Overall Study|Withdrawal by Subject|0
16880|NCT01867710|85507|P2|Overall Study|Withdrawal by Subject|1
16881|NCT01867710|85508|P1|Overall Study|Withdrawal by Subject|0
16882|NCT01867710|85505|P4|Overall Study|Protocol Violation|1
16883|NCT01867710|85506|P3|Overall Study|Protocol Violation|0
16884|NCT01867710|85507|P2|Overall Study|Protocol Violation|0
16885|NCT01867710|85508|P1|Overall Study|Protocol Violation|1
16886|NCT01867710|85505|P4|Overall Study|Physician Decision|0
16887|NCT01867710|85506|P3|Overall Study|Physician Decision|1
16888|NCT01867710|85507|P2|Overall Study|Physician Decision|0
16889|NCT01867710|85508|P1|Overall Study|Physician Decision|0
16890|NCT01867710|85505|P4|Overall Study|Death|0
16891|NCT01867710|85506|P3|Overall Study|Death|1
16892|NCT01867710|85507|P2|Overall Study|Death|1
16893|NCT01867710|85508|P1|Overall Study|Death|0
16894|NCT01867710|85505|P4|Overall Study|Other Adverse Events|3
16895|NCT01867710|85506|P3|Overall Study|Other Adverse Events|1
16896|NCT01867710|85507|P2|Overall Study|Other Adverse Events|0
16897|NCT01867710|85508|P1|Overall Study|Other Adverse Events|1
16898|NCT01867710|85505|P4|Overall Study|Palliative Radiation Required|1
16899|NCT01867710|85506|P3|Overall Study|Palliative Radiation Required|1
16900|NCT01867710|85507|P2|Overall Study|Palliative Radiation Required|0
16901|NCT01867710|85508|P1|Overall Study|Palliative Radiation Required|0
16902|NCT01867710|85505|P4|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
16903|NCT01867710|85506|P3|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
16904|NCT01867710|85507|P2|Overall Study|Adverse Event Sustained Toxicity>Grade 1|0
16905|NCT01867710|85508|P1|Overall Study|Adverse Event Sustained Toxicity>Grade 1|1
16906|NCT01867710|85505|P4|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
16907|NCT01867710|85506|P3|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
16908|NCT01867710|85507|P2|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|2
16909|NCT01867710|85508|P1|Overall Study|Adverse Event Grade 3 or 4 Hypokalemia|0
16910|NCT01867710|85505|P4|Overall Study|Disease Progression|2
16911|NCT01867710|85506|P3|Overall Study|Disease Progression|4
16912|NCT01867710|85507|P2|Overall Study|Disease Progression|2
16913|NCT01867710|85508|P1|Overall Study|Disease Progression|5
16914|NCT01867658|85522|P1|Overall Study|Subject could not be contacted|1
16915|NCT01867658|85522|P1|Overall Study|Death|2
16916|NCT01867658|85522|P1|Overall Study|Withdrawal by Subject|6
16917|NCT01867307|85546|P2|Overall Study|Other Adverse Event|3
16918|NCT01867307|85547|P1|Overall Study|Other Adverse Event|1
16919|NCT01867307|85546|P2|Overall Study|Protocol Violation|0
16920|NCT01867307|85547|P1|Overall Study|Protocol Violation|2
16921|NCT01867021|85572|P2|Overall Study|Withdrawal by Subject|6
16922|NCT01867021|85573|P1|Overall Study|Withdrawal by Subject|1
16923|NCT01867021|85572|P2|Overall Study|Lost to Follow-up|2
16924|NCT01867021|85573|P1|Overall Study|Lost to Follow-up|0
16925|NCT01867021|85572|P2|Overall Study|Death|0
16926|NCT01867021|85573|P1|Overall Study|Death|1
16927|NCT01867021|85572|P2|Overall Study|Not Eligible|1
16928|NCT01867021|85573|P1|Overall Study|Not Eligible|0
16929|NCT01867021|85572|P2|Overall Study|Adverse Event|1
16930|NCT01867021|85573|P1|Overall Study|Adverse Event|0
16931|NCT01866709|85594|P2|Overall Study|Adverse Event|0
16932|NCT01866709|85595|P1|Overall Study|Adverse Event|1
16933|NCT01866423|85603|P1|Overall Study|Sponsor Decision|1
16934|NCT01866423|85603|P1|Overall Study|Lack of Efficacy|3
16935|NCT01866319|85616|P3|Overall Study|Remain on study|176
16936|NCT01866319|85617|P2|Overall Study|Remain on study|190
16937|NCT01866319|85618|P1|Overall Study|Remain on study|131
16938|NCT01866319|85616|P3|Overall Study|Withdrawal by Subject|6
16939|NCT01866319|85617|P2|Overall Study|Withdrawal by Subject|9
16940|NCT01866319|85618|P1|Overall Study|Withdrawal by Subject|31
16941|NCT01866319|85616|P3|Overall Study|Physician Decision|0
16942|NCT01866319|85617|P2|Overall Study|Physician Decision|0
16943|NCT01866319|85618|P1|Overall Study|Physician Decision|1
16944|NCT01866319|85616|P3|Overall Study|Lost to Follow-up|6
16945|NCT01866319|85617|P2|Overall Study|Lost to Follow-up|0
16946|NCT01866319|85618|P1|Overall Study|Lost to Follow-up|3
16947|NCT01866319|85616|P3|Overall Study|Death|77
16948|NCT01866319|85617|P2|Overall Study|Death|74
16949|NCT01866319|85618|P1|Overall Study|Death|97
16950|NCT01866319|85616|P3|Overall Study|Clinical progression|0
16951|NCT01866319|85617|P2|Overall Study|Clinical progression|0
16952|NCT01866319|85618|P1|Overall Study|Clinical progression|1
16953|NCT01866319|85616|P3|Overall Study|Adverse Event|12
16954|NCT01866319|85617|P2|Overall Study|Adverse Event|6
16955|NCT01866319|85618|P1|Overall Study|Adverse Event|13
16956|NCT01866293|85717|P1|Overall Study|Adverse Event|2
16957|NCT01865812|85759|P1|Overall Study|Adverse Event|2
16958|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Other|1
16959|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Other|0
16960|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
16961|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
16962|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
16963|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
16964|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Physician Decision|2
16965|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Physician Decision|4
16966|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
16967|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
16968|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
16969|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
16970|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
16971|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
16972|NCT01865747|85767|P2|Primary Intent to Treat (PITT)|Adverse Event|20
16973|NCT01865747|85768|P1|Primary Intent to Treat (PITT)|Adverse Event|21
16974|NCT01865747|85767|P2|Overall Study (ITT)|Reason Not Provided|1
16975|NCT01865747|85768|P1|Overall Study (ITT)|Reason Not Provided|0
16976|NCT01865747|85767|P2|Overall Study (ITT)|Progressive Disease|158
16977|NCT01865747|85768|P1|Overall Study (ITT)|Progressive Disease|122
16978|NCT01865747|85767|P2|Overall Study (ITT)|Sponsor Decision|1
16979|NCT01865747|85768|P1|Overall Study (ITT)|Sponsor Decision|0
16980|NCT01865747|85767|P2|Overall Study (ITT)|Withdrawal by Subject|11
16981|NCT01865747|85768|P1|Overall Study (ITT)|Withdrawal by Subject|6
16982|NCT01865747|85767|P2|Overall Study (ITT)|Physician Decision|2
16983|NCT01865747|85768|P1|Overall Study (ITT)|Physician Decision|5
16984|NCT01865747|85767|P2|Overall Study (ITT)|Protocol Violation|1
16985|NCT01865747|85768|P1|Overall Study (ITT)|Protocol Violation|1
16986|NCT01865747|85767|P2|Overall Study (ITT)|Lack of Efficacy|0
16987|NCT01865747|85768|P1|Overall Study (ITT)|Lack of Efficacy|3
16988|NCT01865747|85767|P2|Overall Study (ITT)|Clinical Deterioration|50
16989|NCT01865747|85768|P1|Overall Study (ITT)|Clinical Deterioration|29
16990|NCT01865747|85767|P2|Overall Study (ITT)|Adverse Event|31
16991|NCT01865747|85768|P1|Overall Study (ITT)|Adverse Event|32
16992|NCT01865084|85781|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
16993|NCT01865084|85782|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
16994|NCT01865084|85783|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
16995|NCT01865084|85781|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
16996|NCT01865084|85782|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
16997|NCT01865084|85783|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
16998|NCT01865084|85781|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
16999|NCT01865084|85782|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
17000|NCT01865084|85783|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
17001|NCT01865084|85781|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
17002|NCT01865084|85782|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
17003|NCT01865084|85783|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
17004|NCT01865084|85781|P3|Open Label Extension (OLE) Period|Adverse Event|1
17005|NCT01865084|85782|P2|Open Label Extension (OLE) Period|Adverse Event|0
17006|NCT01865084|85783|P1|Open Label Extension (OLE) Period|Adverse Event|0
17007|NCT01865084|85781|P3|Double Blind Period (DB)|Withdrawal by Subject|0
17008|NCT01865084|85782|P2|Double Blind Period (DB)|Withdrawal by Subject|0
17009|NCT01865084|85783|P1|Double Blind Period (DB)|Withdrawal by Subject|1
17010|NCT01865084|85781|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
17011|NCT01865084|85782|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
17012|NCT01865084|85783|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
17013|NCT01865084|85781|P3|Double Blind Period (DB)|Protocol Violation|1
17014|NCT01865084|85782|P2|Double Blind Period (DB)|Protocol Violation|0
17015|NCT01865084|85783|P1|Double Blind Period (DB)|Protocol Violation|0
17016|NCT01865084|85781|P3|Double Blind Period (DB)|Adverse Event|1
17017|NCT01865084|85782|P2|Double Blind Period (DB)|Adverse Event|2
17018|NCT01865084|85783|P1|Double Blind Period (DB)|Adverse Event|2
17019|NCT01864174|85828|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
17020|NCT01864174|85829|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
17021|NCT01864174|85828|P2|Off Treatment Follow-Up|Unspecified|0
17022|NCT01864174|85829|P1|Off Treatment Follow-Up|Unspecified|2
17023|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Unspecified|10
17024|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Unspecified|6
17025|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
17026|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
17027|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
17028|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
17029|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Death|0
17030|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Death|1
17031|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
17032|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
17033|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
17034|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
17035|NCT01864174|85828|P2|Double Blind - Compliant Randomized|Adverse Event|1
17036|NCT01864174|85829|P1|Double Blind - Compliant Randomized|Adverse Event|6
17037|NCT01864174|85828|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
17038|NCT01864174|85829|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
17039|NCT01864148|85848|P5|Overall Study|Not Dosed|0
17040|NCT01864148|85849|P4|Overall Study|Not Dosed|1
17041|NCT01864148|85850|P3|Overall Study|Not Dosed|0
17042|NCT01864148|85851|P2|Overall Study|Not Dosed|0
17043|NCT01864148|85852|P1|Overall Study|Not Dosed|0
17044|NCT01864148|85848|P5|Overall Study|Adverse Event|7
17045|NCT01864148|85849|P4|Overall Study|Adverse Event|7
17046|NCT01864148|85850|P3|Overall Study|Adverse Event|4
17047|NCT01864148|85851|P2|Overall Study|Adverse Event|2
17048|NCT01864148|85852|P1|Overall Study|Adverse Event|4
17049|NCT01864148|85848|P5|Overall Study|Lost to Follow-up|1
17050|NCT01864148|85849|P4|Overall Study|Lost to Follow-up|2
17051|NCT01864148|85850|P3|Overall Study|Lost to Follow-up|0
17052|NCT01864148|85851|P2|Overall Study|Lost to Follow-up|0
17053|NCT01864148|85852|P1|Overall Study|Lost to Follow-up|0
17054|NCT01864148|85848|P5|Overall Study|Withdrawal by Subject|8
17055|NCT01864148|85849|P4|Overall Study|Withdrawal by Subject|8
17056|NCT01864148|85850|P3|Overall Study|Withdrawal by Subject|6
17057|NCT01864148|85851|P2|Overall Study|Withdrawal by Subject|2
17058|NCT01864148|85852|P1|Overall Study|Withdrawal by Subject|9
17059|NCT01864148|85848|P5|Overall Study|Investigator Decision|6
17060|NCT01864148|85849|P4|Overall Study|Investigator Decision|4
17061|NCT01864148|85850|P3|Overall Study|Investigator Decision|0
17062|NCT01864148|85851|P2|Overall Study|Investigator Decision|0
17063|NCT01864148|85852|P1|Overall Study|Investigator Decision|5
17064|NCT01864148|85848|P5|Overall Study|Death|0
17065|NCT01864148|85849|P4|Overall Study|Death|1
17066|NCT01864148|85850|P3|Overall Study|Death|0
17067|NCT01864148|85851|P2|Overall Study|Death|0
17068|NCT01864148|85852|P1|Overall Study|Death|0
17069|NCT01864148|85848|P5|Overall Study|Not Specified|1
17070|NCT01864148|85849|P4|Overall Study|Not Specified|3
17071|NCT01864148|85850|P3|Overall Study|Not Specified|1
17072|NCT01864148|85851|P2|Overall Study|Not Specified|1
17073|NCT01864148|85852|P1|Overall Study|Not Specified|2
17074|NCT01864005|85881|P2|Overall Study|Need GP IIb/IIIa|3
17075|NCT01864005|85882|P1|Overall Study|Need GP IIb/IIIa|1
17076|NCT01864005|85881|P2|Overall Study|Disease need|1
17077|NCT01864005|85882|P1|Overall Study|Disease need|1
17078|NCT01864005|85881|P2|Overall Study|Incorrect enrolment|0
17079|NCT01864005|85882|P1|Overall Study|Incorrect enrolment|1
17080|NCT01864005|85881|P2|Overall Study|Withdrawal by Subject|1
17081|NCT01864005|85882|P1|Overall Study|Withdrawal by Subject|0
17082|NCT01864005|85881|P2|Overall Study|Protocol Violation|1
17083|NCT01864005|85882|P1|Overall Study|Protocol Violation|0
17084|NCT01863953|85899|P3|Overall Study|Adverse Event|1
17085|NCT01863953|85900|P2|Overall Study|Adverse Event|0
17086|NCT01863953|85901|P1|Overall Study|Adverse Event|0
17087|NCT01863771|85915|P4|Maintenance Phase|Withdrawal by Subject|3
17088|NCT01863771|85916|P3|Maintenance Phase|Withdrawal by Subject|2
17089|NCT01863771|85917|P2|Maintenance Phase|Withdrawal by Subject|1
17090|NCT01863771|85918|P1|Maintenance Phase|Withdrawal by Subject|0
17091|NCT01863771|85915|P4|Maintenance Phase|Pregnancy|0
17092|NCT01863771|85916|P3|Maintenance Phase|Pregnancy|0
17093|NCT01863771|85917|P2|Maintenance Phase|Pregnancy|1
17094|NCT01863771|85918|P1|Maintenance Phase|Pregnancy|0
17095|NCT01863771|85915|P4|Maintenance Phase|Physician Decision|1
17096|NCT01863771|85916|P3|Maintenance Phase|Physician Decision|2
17097|NCT01863771|85917|P2|Maintenance Phase|Physician Decision|0
17098|NCT01863771|85918|P1|Maintenance Phase|Physician Decision|0
17099|NCT01863771|85915|P4|Maintenance Phase|Lack of Efficacy|38
17100|NCT01863771|85916|P3|Maintenance Phase|Lack of Efficacy|7
17101|NCT01863771|85917|P2|Maintenance Phase|Lack of Efficacy|3
17102|NCT01863771|85918|P1|Maintenance Phase|Lack of Efficacy|0
17103|NCT01863771|85915|P4|Maintenance Phase|Adverse Event|1
17104|NCT01863771|85916|P3|Maintenance Phase|Adverse Event|1
17105|NCT01863771|85917|P2|Maintenance Phase|Adverse Event|0
17106|NCT01863771|85918|P1|Maintenance Phase|Adverse Event|0
17107|NCT01863771|85915|P4|Induction Phase|Withdrawal by Subject|0
17108|NCT01863771|85916|P3|Induction Phase|Withdrawal by Subject|0
17109|NCT01863771|85917|P2|Induction Phase|Withdrawal by Subject|0
17110|NCT01863771|85918|P1|Induction Phase|Withdrawal by Subject|2
17111|NCT01863771|85915|P4|Induction Phase|Lack of Efficacy|0
17112|NCT01863771|85916|P3|Induction Phase|Lack of Efficacy|0
17113|NCT01863771|85917|P2|Induction Phase|Lack of Efficacy|0
17114|NCT01863771|85918|P1|Induction Phase|Lack of Efficacy|10
17115|NCT01863771|85915|P4|Induction Phase|Adverse Event|0
17116|NCT01863771|85916|P3|Induction Phase|Adverse Event|0
17117|NCT01863771|85917|P2|Induction Phase|Adverse Event|0
17118|NCT01863771|85918|P1|Induction Phase|Adverse Event|9
17119|NCT01863680|85930|P1|Overall Study|Unspecified|6
17120|NCT01863680|85930|P1|Overall Study|Did not undergo IVF/ET|14
17121|NCT01863680|85930|P1|Overall Study|Withdrawal by Subject|1
17122|NCT01863680|85930|P1|Overall Study|Spontaneous pregnancy|2
17123|NCT01863680|85930|P1|Overall Study|Risk of OHSS|17
17124|NCT01863680|85930|P1|Overall Study|Adverse Event|17
17125|NCT01863667|85938|P2|Overall Study|Withdrawal by Subject|2
17126|NCT01863667|85939|P1|Overall Study|Withdrawal by Subject|2
17127|NCT01863667|85938|P2|Overall Study|Study terminated by Sponsor|30
17128|NCT01863667|85939|P1|Overall Study|Study terminated by Sponsor|30
17129|NCT01863667|85938|P2|Overall Study|Adverse Event|0
17130|NCT01863667|85939|P1|Overall Study|Adverse Event|1
17131|NCT01863433|85959|P1|Overall Study|Protocol Violation|1
17132|NCT01863368|85969|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
17133|NCT01863368|85970|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
17134|NCT01863368|85969|P2|Phase II, Day 35 to Day 90|Adverse Event|0
17135|NCT01863368|85970|P1|Phase II, Day 35 to Day 90|Adverse Event|1
17136|NCT01863368|85969|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
17137|NCT01863368|85970|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
17138|NCT01863368|85969|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
17139|NCT01863368|85970|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
17140|NCT01863368|85969|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
17141|NCT01863368|85970|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
17142|NCT01863368|85969|P2|Phase I, Day 0 to Day 35|Adverse Event|4
17143|NCT01863368|85970|P1|Phase I, Day 0 to Day 35|Adverse Event|2
17144|NCT01862991|85995|P3|Overall Study|Protocol Violation|0
17145|NCT01862991|85996|P2|Overall Study|Protocol Violation|0
17146|NCT01862991|85997|P1|Overall Study|Protocol Violation|1
17147|NCT01862991|85995|P3|Overall Study|Lost to Follow-up|1
17148|NCT01862991|85996|P2|Overall Study|Lost to Follow-up|1
17149|NCT01862991|85997|P1|Overall Study|Lost to Follow-up|2
17150|NCT01862484|86010|P2|Overall Study|Withdrawal by Subject|3
17151|NCT01862484|86011|P1|Overall Study|Withdrawal by Subject|0
17152|NCT01862484|86010|P2|Overall Study|Protocol Violation|2
17153|NCT01862484|86011|P1|Overall Study|Protocol Violation|0
17154|NCT01862484|86010|P2|Overall Study|Lost to Follow-up|2
17155|NCT01862484|86011|P1|Overall Study|Lost to Follow-up|1
17156|NCT01862484|86010|P2|Overall Study|Lack of Efficacy|1
17157|NCT01862484|86011|P1|Overall Study|Lack of Efficacy|1
17158|NCT01861522|86090|P2|Overall Study|Withdrawal by Subject|0
17159|NCT01861522|86091|P1|Overall Study|Withdrawal by Subject|2
17160|NCT01861522|86090|P2|Overall Study|Adverse Event|0
17161|NCT01861522|86091|P1|Overall Study|Adverse Event|1
17162|NCT01860989|86115|P1|Overall Study|Unsatisfactory therapeutic|5
17163|NCT01860976|86121|P2|Long Term Extension|Ongoing treatment at time of analysis|100
17164|NCT01860976|86122|P1|Long Term Extension|Ongoing treatment at time of analysis|106
17165|NCT01860976|86121|P2|Long Term Extension|Withdrawal by Subject|0
17166|NCT01860976|86122|P1|Long Term Extension|Withdrawal by Subject|1
17167|NCT01860976|86121|P2|Long Term Extension|Subject request to discontinue treatment|0
17168|NCT01860976|86122|P1|Long Term Extension|Subject request to discontinue treatment|2
17169|NCT01860976|86121|P2|Long Term Extension|Lack of Efficacy|7
17170|NCT01860976|86122|P1|Long Term Extension|Lack of Efficacy|3
17171|NCT01860976|86121|P2|Long Term Extension|Adverse Event|0
17172|NCT01860976|86122|P1|Long Term Extension|Adverse Event|1
17173|NCT01860976|86121|P2|Open-Label|Ongoing OL treatment at time of analysis|45
17174|NCT01860976|86122|P1|Open-Label|Ongoing OL treatment at time of analysis|46
17175|NCT01860976|86121|P2|Open-Label|Other Reasons|1
17176|NCT01860976|86122|P1|Open-Label|Other Reasons|1
17177|NCT01860976|86121|P2|Open-Label|Withdrawal by Subject|1
17178|NCT01860976|86122|P1|Open-Label|Withdrawal by Subject|4
17179|NCT01860976|86121|P2|Open-Label|Subject request discontinue treatment|3
17180|NCT01860976|86122|P1|Open-Label|Subject request discontinue treatment|4
17181|NCT01860976|86121|P2|Open-Label|Lost to Follow-up|2
17182|NCT01860976|86122|P1|Open-Label|Lost to Follow-up|1
17183|NCT01860976|86121|P2|Open-Label|Lack of Efficacy|8
17184|NCT01860976|86122|P1|Open-Label|Lack of Efficacy|16
17185|NCT01860976|86121|P2|Open-Label|Adverse Event|4
17186|NCT01860976|86122|P1|Open-Label|Adverse Event|2
17187|NCT01860976|86121|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
17188|NCT01860976|86122|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
17189|NCT01860976|86121|P2|Blinded Treatment|Entered Open-Label in error|1
17190|NCT01860976|86122|P1|Blinded Treatment|Entered Open-Label in error|0
17191|NCT01860976|86121|P2|Blinded Treatment|Subject no longer met criteria|0
17192|NCT01860976|86122|P1|Blinded Treatment|Subject no longer met criteria|1
17193|NCT01860976|86121|P2|Blinded Treatment|Withdrawal by Subject|5
17194|NCT01860976|86122|P1|Blinded Treatment|Withdrawal by Subject|3
17195|NCT01860976|86121|P2|Blinded Treatment|Subject request to discontinue treatment|3
17196|NCT01860976|86122|P1|Blinded Treatment|Subject request to discontinue treatment|2
17197|NCT01860976|86121|P2|Blinded Treatment|Lack of Efficacy|12
17198|NCT01860976|86122|P1|Blinded Treatment|Lack of Efficacy|5
17199|NCT01860976|86121|P2|Blinded Treatment|Adverse Event|3
17200|NCT01860976|86122|P1|Blinded Treatment|Adverse Event|1
17201|NCT01860846|86144|P1|Overall Study|Lost to Follow-up|33
17202|NCT01860703|86155|P4|Overall Study|Personal reason|0
17203|NCT01860703|86156|P3|Overall Study|Personal reason|1
17204|NCT01860703|86157|P2|Overall Study|Personal reason|0
17205|NCT01860703|86158|P1|Overall Study|Personal reason|1
17206|NCT01860703|86155|P4|Overall Study|Withdrawal by Subject|0
17207|NCT01860703|86156|P3|Overall Study|Withdrawal by Subject|0
17208|NCT01860703|86157|P2|Overall Study|Withdrawal by Subject|1
17209|NCT01860703|86158|P1|Overall Study|Withdrawal by Subject|0
17210|NCT01860703|86155|P4|Overall Study|Adverse Event|2
17211|NCT01860703|86156|P3|Overall Study|Adverse Event|0
17212|NCT01860703|86157|P2|Overall Study|Adverse Event|4
17213|NCT01860703|86158|P1|Overall Study|Adverse Event|1
17214|NCT01860677|86190|P2|Second Intervention (1 Day)|Lost to Follow-up|0
17215|NCT01860677|86191|P1|Second Intervention (1 Day)|Lost to Follow-up|7
17216|NCT01860534|86229|P2|ROP #2|discharged prior to ROP #2|0
17217|NCT01860534|86230|P1|ROP #2|discharged prior to ROP #2|1
17218|NCT01860534|86229|P2|ROP #1|Needed treatment for ROP|1
17219|NCT01860534|86230|P1|ROP #1|Needed treatment for ROP|0
17220|NCT01860079|86278|P2|Overall Study|Physician Decision|22
17221|NCT01860079|86279|P1|Overall Study|Physician Decision|14
17222|NCT01859988|86291|P6|Overall Study|Other than specified above|3
17223|NCT01859988|86292|P5|Overall Study|Other than specified above|5
17224|NCT01859988|86293|P4|Overall Study|Other than specified above|3
17225|NCT01859988|86294|P3|Overall Study|Other than specified above|11
17226|NCT01859988|86295|P2|Overall Study|Other than specified above|2
17227|NCT01859988|86296|P1|Overall Study|Other than specified above|0
17228|NCT01859988|86291|P6|Overall Study|Protocol Violation|0
17229|NCT01859988|86292|P5|Overall Study|Protocol Violation|0
17230|NCT01859988|86293|P4|Overall Study|Protocol Violation|0
17231|NCT01859988|86294|P3|Overall Study|Protocol Violation|1
17232|NCT01859988|86295|P2|Overall Study|Protocol Violation|0
17233|NCT01859988|86296|P1|Overall Study|Protocol Violation|0
17234|NCT01859988|86291|P6|Overall Study|Lost to Follow-up|2
17235|NCT01859988|86292|P5|Overall Study|Lost to Follow-up|3
17236|NCT01859988|86293|P4|Overall Study|Lost to Follow-up|0
17237|NCT01859988|86294|P3|Overall Study|Lost to Follow-up|3
17238|NCT01859988|86295|P2|Overall Study|Lost to Follow-up|2
17239|NCT01859988|86296|P1|Overall Study|Lost to Follow-up|1
17240|NCT01859988|86291|P6|Overall Study|Adverse Event|2
17241|NCT01859988|86292|P5|Overall Study|Adverse Event|2
17242|NCT01859988|86293|P4|Overall Study|Adverse Event|1
17243|NCT01859988|86294|P3|Overall Study|Adverse Event|3
17244|NCT01859988|86295|P2|Overall Study|Adverse Event|1
17245|NCT01859988|86296|P1|Overall Study|Adverse Event|2
17246|NCT01859988|86291|P6|Overall Study|Physician Decision|1
17247|NCT01859988|86292|P5|Overall Study|Physician Decision|4
17248|NCT01859988|86293|P4|Overall Study|Physician Decision|3
17249|NCT01859988|86294|P3|Overall Study|Physician Decision|1
17250|NCT01859988|86295|P2|Overall Study|Physician Decision|3
17251|NCT01859988|86296|P1|Overall Study|Physician Decision|1
17252|NCT01859988|86291|P6|Overall Study|Lack of Efficacy|9
17253|NCT01859988|86292|P5|Overall Study|Lack of Efficacy|7
17254|NCT01859988|86293|P4|Overall Study|Lack of Efficacy|0
17255|NCT01859988|86294|P3|Overall Study|Lack of Efficacy|5
17256|NCT01859988|86295|P2|Overall Study|Lack of Efficacy|1
17257|NCT01859988|86296|P1|Overall Study|Lack of Efficacy|1
17258|NCT01859988|86291|P6|Overall Study|Withdrawal by Subject|2
17259|NCT01859988|86292|P5|Overall Study|Withdrawal by Subject|2
17260|NCT01859988|86293|P4|Overall Study|Withdrawal by Subject|3
17261|NCT01859988|86294|P3|Overall Study|Withdrawal by Subject|4
17262|NCT01859988|86295|P2|Overall Study|Withdrawal by Subject|3
17263|NCT01859988|86296|P1|Overall Study|Withdrawal by Subject|6
17264|NCT01859949|86390|P2|Overall Study|Adverse Event|1
17265|NCT01859949|86391|P1|Overall Study|Adverse Event|0
17266|NCT01859949|86390|P2|Overall Study|Protocol Violation|1
17267|NCT01859949|86391|P1|Overall Study|Protocol Violation|1
17268|NCT01859949|86390|P2|Overall Study|Withdrawal by Subject|10
17269|NCT01859949|86391|P1|Overall Study|Withdrawal by Subject|11
17270|NCT01859949|86390|P2|Overall Study|Physician Decision|4
17271|NCT01859949|86391|P1|Overall Study|Physician Decision|2
17272|NCT01859949|86390|P2|Overall Study|Family Matters|1
17273|NCT01859949|86391|P1|Overall Study|Family Matters|0
17274|NCT01859793|86409|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
17275|NCT01859793|86410|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
17276|NCT01859793|86409|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
17277|NCT01859793|86410|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
17278|NCT01859793|86409|P2|First Intervention (8 Weeks)|Adverse Event|0
17279|NCT01859793|86410|P1|First Intervention (8 Weeks)|Adverse Event|1
17280|NCT01859793|86409|P2|First Intervention (8 Weeks)|Protocol Violation|0
17281|NCT01859793|86410|P1|First Intervention (8 Weeks)|Protocol Violation|2
17282|NCT01859715|86423|P3|Overall Study|No 2nd VAS|23
17283|NCT01859715|86424|P2|Overall Study|No 2nd VAS|8
17284|NCT01859715|86425|P1|Overall Study|No 2nd VAS|16
17285|NCT01859702|86436|P1|Overall Study|Adverse Event|2
17286|NCT01859702|86436|P1|Overall Study|Protocol deviation|3
17287|NCT01859598|86450|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
17288|NCT01859507|86458|P1|Overall Study|left the country|4
17289|NCT01859494|86463|P1|Overall Study|Adverse Event|1
17290|NCT01859390|86474|P2|Overall Study|Shipment Error|1
17291|NCT01859390|86475|P1|Overall Study|Shipment Error|0
17292|NCT01859390|86474|P2|Overall Study|Tube Cracked|2
17293|NCT01859390|86475|P1|Overall Study|Tube Cracked|0
17294|NCT01859390|86474|P2|Overall Study|Sample Missing Collection Date|1
17295|NCT01859390|86475|P1|Overall Study|Sample Missing Collection Date|0
17296|NCT01859390|86474|P2|Overall Study|Insufficient Sputum Collected|3
17297|NCT01859390|86475|P1|Overall Study|Insufficient Sputum Collected|1
17298|NCT01859143|86539|P2|Overall Study|Lost to Follow-up|0
17299|NCT01859143|86540|P1|Overall Study|Lost to Follow-up|2
17300|NCT01858766|86596|P19|Overall Study|Withdrew Consent|0
17301|NCT01858766|86597|P18|Overall Study|Withdrew Consent|0
17302|NCT01858766|86598|P17|Overall Study|Withdrew Consent|0
17303|NCT01858766|86599|P16|Overall Study|Withdrew Consent|0
17304|NCT01858766|86600|P15|Overall Study|Withdrew Consent|0
17305|NCT01858766|86601|P14|Overall Study|Withdrew Consent|0
17306|NCT01858766|86602|P13|Overall Study|Withdrew Consent|0
17307|NCT01858766|86603|P12|Overall Study|Withdrew Consent|1
17308|NCT01858766|86604|P11|Overall Study|Withdrew Consent|0
17309|NCT01858766|86605|P10|Overall Study|Withdrew Consent|0
17310|NCT01858766|86606|P9|Overall Study|Withdrew Consent|0
17311|NCT01858766|86607|P8|Overall Study|Withdrew Consent|0
17312|NCT01858766|86608|P7|Overall Study|Withdrew Consent|0
17313|NCT01858766|86609|P6|Overall Study|Withdrew Consent|0
17314|NCT01858766|86610|P5|Overall Study|Withdrew Consent|0
17315|NCT01858766|86611|P4|Overall Study|Withdrew Consent|0
17316|NCT01858766|86612|P3|Overall Study|Withdrew Consent|0
17317|NCT01858766|86613|P2|Overall Study|Withdrew Consent|0
17318|NCT01858766|86614|P1|Overall Study|Withdrew Consent|0
17319|NCT01858766|86596|P19|Overall Study|Lost to Follow-up|1
17320|NCT01858766|86597|P18|Overall Study|Lost to Follow-up|0
17321|NCT01858766|86598|P17|Overall Study|Lost to Follow-up|1
17322|NCT01858766|86599|P16|Overall Study|Lost to Follow-up|1
17323|NCT01858766|86600|P15|Overall Study|Lost to Follow-up|3
17324|NCT01858766|86601|P14|Overall Study|Lost to Follow-up|0
17325|NCT01858766|86602|P13|Overall Study|Lost to Follow-up|0
17326|NCT01858766|86603|P12|Overall Study|Lost to Follow-up|1
17327|NCT01858766|86604|P11|Overall Study|Lost to Follow-up|0
17328|NCT01858766|86605|P10|Overall Study|Lost to Follow-up|0
17329|NCT01858766|86606|P9|Overall Study|Lost to Follow-up|0
17330|NCT01858766|86607|P8|Overall Study|Lost to Follow-up|2
17331|NCT01858766|86608|P7|Overall Study|Lost to Follow-up|0
17332|NCT01858766|86609|P6|Overall Study|Lost to Follow-up|1
17333|NCT01858766|86610|P5|Overall Study|Lost to Follow-up|0
17334|NCT01858766|86611|P4|Overall Study|Lost to Follow-up|0
17335|NCT01858766|86612|P3|Overall Study|Lost to Follow-up|0
17336|NCT01858766|86613|P2|Overall Study|Lost to Follow-up|0
17337|NCT01858766|86614|P1|Overall Study|Lost to Follow-up|0
17338|NCT01858766|86596|P19|Overall Study|Lack of Efficacy|3
17339|NCT01858766|86597|P18|Overall Study|Lack of Efficacy|3
17340|NCT01858766|86598|P17|Overall Study|Lack of Efficacy|2
17341|NCT01858766|86599|P16|Overall Study|Lack of Efficacy|5
17342|NCT01858766|86600|P15|Overall Study|Lack of Efficacy|5
17343|NCT01858766|86601|P14|Overall Study|Lack of Efficacy|3
17344|NCT01858766|86602|P13|Overall Study|Lack of Efficacy|5
17345|NCT01858766|86603|P12|Overall Study|Lack of Efficacy|3
17346|NCT01858766|86604|P11|Overall Study|Lack of Efficacy|0
17347|NCT01858766|86605|P10|Overall Study|Lack of Efficacy|0
17348|NCT01858766|86606|P9|Overall Study|Lack of Efficacy|0
17349|NCT01858766|86607|P8|Overall Study|Lack of Efficacy|0
17350|NCT01858766|86608|P7|Overall Study|Lack of Efficacy|0
17351|NCT01858766|86609|P6|Overall Study|Lack of Efficacy|2
17352|NCT01858766|86610|P5|Overall Study|Lack of Efficacy|1
17353|NCT01858766|86611|P4|Overall Study|Lack of Efficacy|0
17354|NCT01858766|86612|P3|Overall Study|Lack of Efficacy|0
17355|NCT01858766|86613|P2|Overall Study|Lack of Efficacy|0
17356|NCT01858766|86614|P1|Overall Study|Lack of Efficacy|1
17357|NCT01858766|86596|P19|Overall Study|Death|0
17358|NCT01858766|86597|P18|Overall Study|Death|0
17359|NCT01858766|86598|P17|Overall Study|Death|0
17360|NCT01858766|86599|P16|Overall Study|Death|0
17361|NCT01858766|86600|P15|Overall Study|Death|0
17362|NCT01858766|86601|P14|Overall Study|Death|0
17363|NCT01858766|86602|P13|Overall Study|Death|0
17364|NCT01858766|86603|P12|Overall Study|Death|0
17365|NCT01858766|86604|P11|Overall Study|Death|0
17366|NCT01858766|86605|P10|Overall Study|Death|0
17367|NCT01858766|86606|P9|Overall Study|Death|0
17368|NCT01858766|86607|P8|Overall Study|Death|0
17369|NCT01858766|86608|P7|Overall Study|Death|0
17370|NCT01858766|86609|P6|Overall Study|Death|0
17371|NCT01858766|86610|P5|Overall Study|Death|0
17372|NCT01858766|86611|P4|Overall Study|Death|0
17373|NCT01858766|86612|P3|Overall Study|Death|1
17374|NCT01858766|86613|P2|Overall Study|Death|0
17375|NCT01858766|86614|P1|Overall Study|Death|0
17376|NCT01858766|86596|P19|Overall Study|Randomized but Never Treated|0
17377|NCT01858766|86597|P18|Overall Study|Randomized but Never Treated|1
17378|NCT01858766|86598|P17|Overall Study|Randomized but Never Treated|0
17379|NCT01858766|86599|P16|Overall Study|Randomized but Never Treated|0
17380|NCT01858766|86600|P15|Overall Study|Randomized but Never Treated|0
17381|NCT01858766|86601|P14|Overall Study|Randomized but Never Treated|0
17382|NCT01858766|86602|P13|Overall Study|Randomized but Never Treated|0
17383|NCT01858766|86603|P12|Overall Study|Randomized but Never Treated|0
17384|NCT01858766|86604|P11|Overall Study|Randomized but Never Treated|0
17385|NCT01858766|86605|P10|Overall Study|Randomized but Never Treated|0
17386|NCT01858766|86606|P9|Overall Study|Randomized but Never Treated|0
17387|NCT01858766|86607|P8|Overall Study|Randomized but Never Treated|0
17388|NCT01858766|86608|P7|Overall Study|Randomized but Never Treated|0
17389|NCT01858766|86609|P6|Overall Study|Randomized but Never Treated|1
17390|NCT01858766|86610|P5|Overall Study|Randomized but Never Treated|0
17391|NCT01858766|86611|P4|Overall Study|Randomized but Never Treated|0
17392|NCT01858766|86612|P3|Overall Study|Randomized but Never Treated|0
17393|NCT01858766|86613|P2|Overall Study|Randomized but Never Treated|0
17394|NCT01858766|86614|P1|Overall Study|Randomized but Never Treated|0
17395|NCT01858701|86685|P2|Period 2, Second 30 Days of Wear|Comfort|1
17396|NCT01858701|86686|P1|Period 2, Second 30 Days of Wear|Comfort|0
17397|NCT01858701|86685|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
17398|NCT01858701|86686|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
17399|NCT01858701|86685|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
17400|NCT01858701|86686|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
17401|NCT01858701|86685|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
17402|NCT01858701|86686|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
17403|NCT01858636|86692|P1|Overall Study|Withdrawal by Subject|1
17404|NCT01858636|86692|P1|Overall Study|Lost to Follow-up|1
17405|NCT01858636|86692|P1|Overall Study|Death|1
17406|NCT01858636|86692|P1|Overall Study|Physician Decision|1
17407|NCT01858636|86692|P1|Overall Study|No Device Deployment Attempted|24
17408|NCT01858389|86699|P2|Overall Study|Did not receive treatment|3
17409|NCT01858389|86700|P1|Overall Study|Did not receive treatment|0
17410|NCT01858389|86699|P2|Overall Study|Adverse Event|1
17411|NCT01858389|86700|P1|Overall Study|Adverse Event|3
17412|NCT01858389|86699|P2|Overall Study|Not specified|4
17413|NCT01858389|86700|P1|Overall Study|Not specified|2
17414|NCT01858389|86699|P2|Overall Study|Progressive disease|11
17415|NCT01858389|86700|P1|Overall Study|Progressive disease|10
17416|NCT01858389|86699|P2|Overall Study|Withdrawal by Subject|1
17417|NCT01858389|86700|P1|Overall Study|Withdrawal by Subject|0
17418|NCT01858389|86699|P2|Overall Study|Study terminated by sponsor|2
17419|NCT01858389|86700|P1|Overall Study|Study terminated by sponsor|0
17420|NCT01858389|86699|P2|Overall Study|Death|3
17421|NCT01858389|86700|P1|Overall Study|Death|1
17422|NCT01858376|86715|P1|Overall Study|Dropped d/t lab work not fitting criter|4
17423|NCT01857622|86753|P3|Overall Study|Withdrawal by Subject|0
17424|NCT01857622|86754|P2|Overall Study|Withdrawal by Subject|0
17425|NCT01857622|86755|P1|Overall Study|Withdrawal by Subject|1
17426|NCT01857622|86753|P3|Overall Study|Protocol Violation|0
17427|NCT01857622|86754|P2|Overall Study|Protocol Violation|1
17428|NCT01857622|86755|P1|Overall Study|Protocol Violation|4
17429|NCT01857622|86753|P3|Overall Study|Physician Decision|0
17430|NCT01857622|86754|P2|Overall Study|Physician Decision|0
17431|NCT01857622|86755|P1|Overall Study|Physician Decision|1
17432|NCT01857622|86753|P3|Overall Study|Adverse Event|2
17433|NCT01857622|86754|P2|Overall Study|Adverse Event|0
17434|NCT01857622|86755|P1|Overall Study|Adverse Event|5
17435|NCT01857583|86767|P4|Overall Study|Withdrawal by Subject|2
17436|NCT01857583|86768|P3|Overall Study|Withdrawal by Subject|1
17437|NCT01857583|86769|P2|Overall Study|Withdrawal by Subject|0
17438|NCT01857583|86770|P1|Overall Study|Withdrawal by Subject|1
17439|NCT01857583|86767|P4|Overall Study|Physician Decision|1
17440|NCT01857583|86768|P3|Overall Study|Physician Decision|0
17441|NCT01857583|86769|P2|Overall Study|Physician Decision|0
17442|NCT01857583|86770|P1|Overall Study|Physician Decision|0
17443|NCT01857583|86767|P4|Overall Study|Death|0
17444|NCT01857583|86768|P3|Overall Study|Death|1
17445|NCT01857583|86769|P2|Overall Study|Death|1
17446|NCT01857583|86770|P1|Overall Study|Death|0
17447|NCT01857583|86767|P4|Overall Study|Adverse Event|1
17448|NCT01857583|86768|P3|Overall Study|Adverse Event|1
17449|NCT01857583|86769|P2|Overall Study|Adverse Event|0
17450|NCT01857583|86770|P1|Overall Study|Adverse Event|0
17451|NCT01857531|86780|P1|Overall Study|Withdrawal by Subject|4
17452|NCT01857323|86798|P1|Overall Study|Did not complete 180 doses|48
17453|NCT01857323|86798|P1|Overall Study|Not specified|4
17454|NCT01857323|86798|P1|Overall Study|Lost to Follow-up|1
17455|NCT01857323|86798|P1|Overall Study|Protocol Violation|6
17456|NCT01857323|86798|P1|Overall Study|Non-compliance|1
17457|NCT01857323|86798|P1|Overall Study|Withdrawal by Subject|3
17458|NCT01857323|86798|P1|Overall Study|Adverse Event|1
17459|NCT01857206|86847|P2|Overall Study|Withdrawal by Subject|0
17460|NCT01857206|86848|P1|Overall Study|Withdrawal by Subject|1
17461|NCT01857206|86847|P2|Overall Study|Unclassified|3
17462|NCT01857206|86848|P1|Overall Study|Unclassified|3
17463|NCT01857206|86847|P2|Overall Study|Lost to Follow-up|6
17464|NCT01857206|86848|P1|Overall Study|Lost to Follow-up|9
17465|NCT01857206|86847|P2|Overall Study|ADMINISTRATIVE REASON|1
17466|NCT01857206|86848|P1|Overall Study|ADMINISTRATIVE REASON|0
17467|NCT01857102|86866|P2|Period 2|Unsatisfactory Lens Fit|0
17468|NCT01857102|86867|P1|Period 2|Unsatisfactory Lens Fit|1
17469|NCT01857102|86866|P2|Period 2|Lens Discomfort|0
17470|NCT01857102|86867|P1|Period 2|Lens Discomfort|1
17471|NCT01857102|86866|P2|Period 1|Physician Decision|0
17472|NCT01857102|86867|P1|Period 1|Physician Decision|1
17473|NCT01857102|86866|P2|Period 1|Unsatisfactory Visual Response|0
17474|NCT01857102|86867|P1|Period 1|Unsatisfactory Visual Response|1
17475|NCT01857102|86866|P2|Period 1|Unsatisfactory Lens Fit|0
17476|NCT01857102|86867|P1|Period 1|Unsatisfactory Lens Fit|1
17477|NCT01857102|86866|P2|Period 1|Lost to Follow-up|3
17478|NCT01857102|86867|P1|Period 1|Lost to Follow-up|0
17479|NCT01857102|86866|P2|Period 1|No longer meets Eligibility Criteria|2
17480|NCT01857102|86867|P1|Period 1|No longer meets Eligibility Criteria|0
17481|NCT01857063|86877|P2|Period 2 (7 Days)|Withdrawal by Subject|0
17482|NCT01857063|86878|P1|Period 2 (7 Days)|Withdrawal by Subject|1
17483|NCT01857063|86877|P2|Period 2 (7 Days)|Physician Decision|1
17484|NCT01857063|86878|P1|Period 2 (7 Days)|Physician Decision|1
17485|NCT01857063|86877|P2|Period 2 (7 Days)|Adverse Event|1
17486|NCT01857063|86878|P1|Period 2 (7 Days)|Adverse Event|2
17487|NCT01857063|86877|P2|Period 1 (7 Days)|Withdrawal by Subject|3
17488|NCT01857063|86878|P1|Period 1 (7 Days)|Withdrawal by Subject|1
17489|NCT01857063|86877|P2|Period 1 (7 Days)|Physician Decision|0
17490|NCT01857063|86878|P1|Period 1 (7 Days)|Physician Decision|1
17491|NCT01857063|86877|P2|Period 1 (7 Days)|Adverse Event|1
17492|NCT01857063|86878|P1|Period 1 (7 Days)|Adverse Event|0
17493|NCT01856686|86923|P2|Overall Study|Lost to Follow-up|11
17494|NCT01856686|86924|P1|Overall Study|Lost to Follow-up|5
17495|NCT01856673|86967|P3|Overall Study|Protocol Violation|1
17496|NCT01856673|86968|P2|Overall Study|Protocol Violation|0
17497|NCT01856673|86969|P1|Overall Study|Protocol Violation|1
17498|NCT01856673|86967|P3|Overall Study|Death|0
17499|NCT01856673|86968|P2|Overall Study|Death|1
17500|NCT01856673|86969|P1|Overall Study|Death|2
17501|NCT01856673|86967|P3|Overall Study|Paperwork errors|0
17502|NCT01856673|86968|P2|Overall Study|Paperwork errors|0
17503|NCT01856673|86969|P1|Overall Study|Paperwork errors|4
17504|NCT01856673|86967|P3|Overall Study|Psychologist decision|0
17505|NCT01856673|86968|P2|Overall Study|Psychologist decision|0
17506|NCT01856673|86969|P1|Overall Study|Psychologist decision|3
17507|NCT01856673|86967|P3|Overall Study|Unknown reasons|0
17508|NCT01856673|86968|P2|Overall Study|Unknown reasons|0
17509|NCT01856673|86969|P1|Overall Study|Unknown reasons|20
17510|NCT01856673|86967|P3|Overall Study|Lost to Follow-up|0
17511|NCT01856673|86968|P2|Overall Study|Lost to Follow-up|34
17512|NCT01856673|86969|P1|Overall Study|Lost to Follow-up|22
17513|NCT01856673|86967|P3|Overall Study|Withdrawal by Subject|33
17514|NCT01856673|86968|P2|Overall Study|Withdrawal by Subject|50
17515|NCT01856673|86969|P1|Overall Study|Withdrawal by Subject|46
17516|NCT01856569|86980|P1|Overall Study|Did not met inclusion criteria|8
17517|NCT01856569|86980|P1|Overall Study|Lost to Follow-up|3
17518|NCT01856569|86980|P1|Overall Study|Changed Site/Structure|1
17519|NCT01856569|86980|P1|Overall Study|Unspecified|1
17520|NCT01856322|87028|P3|Overall Study|off study due to lack of accrual|3
17521|NCT01856322|87029|P2|Overall Study|off study due to lack of accrual|0
17522|NCT01856322|87030|P1|Overall Study|off study due to lack of accrual|0
17523|NCT01856257|87040|P4|Overall Study|Donor complication|1
17524|NCT01856257|87041|P3|Overall Study|Donor complication|0
17525|NCT01856257|87042|P2|Overall Study|Donor complication|0
17526|NCT01856257|87043|P1|Overall Study|Donor complication|0
17527|NCT01856257|87040|P4|Overall Study|Withdrawal by Subject|0
17528|NCT01856257|87041|P3|Overall Study|Withdrawal by Subject|0
17529|NCT01856257|87042|P2|Overall Study|Withdrawal by Subject|1
17530|NCT01856257|87043|P1|Overall Study|Withdrawal by Subject|1
17531|NCT01856257|87040|P4|Overall Study|Physician Decision|1
17532|NCT01856257|87041|P3|Overall Study|Physician Decision|0
17533|NCT01856257|87042|P2|Overall Study|Physician Decision|0
17534|NCT01856257|87043|P1|Overall Study|Physician Decision|0
17535|NCT01856257|87040|P4|Overall Study|Death|0
17536|NCT01856257|87041|P3|Overall Study|Death|0
17537|NCT01856257|87042|P2|Overall Study|Death|0
17538|NCT01856257|87043|P1|Overall Study|Death|2
17539|NCT01855958|87197|P2|Overall Study|Withdrawal by Subject|0
17540|NCT01855958|87198|P1|Overall Study|Withdrawal by Subject|1
17541|NCT01855945|87228|P12|Overall Study|Withdrawal by Subject|1
17542|NCT01855945|87229|P11|Overall Study|Withdrawal by Subject|4
17543|NCT01855945|87230|P10|Overall Study|Withdrawal by Subject|2
17544|NCT01855945|87231|P9|Overall Study|Withdrawal by Subject|0
17545|NCT01855945|87232|P8|Overall Study|Withdrawal by Subject|0
17546|NCT01855945|87233|P7|Overall Study|Withdrawal by Subject|1
17547|NCT01855945|87234|P6|Overall Study|Withdrawal by Subject|0
17548|NCT01855945|87235|P5|Overall Study|Withdrawal by Subject|1
17549|NCT01855945|87236|P4|Overall Study|Withdrawal by Subject|1
17550|NCT01855945|87237|P3|Overall Study|Withdrawal by Subject|4
17551|NCT01855945|87238|P2|Overall Study|Withdrawal by Subject|0
17552|NCT01855945|87239|P1|Overall Study|Withdrawal by Subject|4
17553|NCT01855945|87228|P12|Overall Study|Other - Unclassified|0
17554|NCT01855945|87229|P11|Overall Study|Other - Unclassified|1
17555|NCT01855945|87230|P10|Overall Study|Other - Unclassified|0
17556|NCT01855945|87231|P9|Overall Study|Other - Unclassified|0
17557|NCT01855945|87232|P8|Overall Study|Other - Unclassified|1
17558|NCT01855945|87233|P7|Overall Study|Other - Unclassified|2
17559|NCT01855945|87234|P6|Overall Study|Other - Unclassified|0
17560|NCT01855945|87235|P5|Overall Study|Other - Unclassified|0
17561|NCT01855945|87236|P4|Overall Study|Other - Unclassified|0
17562|NCT01855945|87237|P3|Overall Study|Other - Unclassified|1
17563|NCT01855945|87238|P2|Overall Study|Other - Unclassified|1
17564|NCT01855945|87239|P1|Overall Study|Other - Unclassified|1
17565|NCT01855945|87228|P12|Overall Study|Lost to Follow-up|2
17566|NCT01855945|87229|P11|Overall Study|Lost to Follow-up|0
17567|NCT01855945|87230|P10|Overall Study|Lost to Follow-up|0
17568|NCT01855945|87231|P9|Overall Study|Lost to Follow-up|2
17569|NCT01855945|87232|P8|Overall Study|Lost to Follow-up|7
17570|NCT01855945|87233|P7|Overall Study|Lost to Follow-up|4
17571|NCT01855945|87234|P6|Overall Study|Lost to Follow-up|3
17572|NCT01855945|87235|P5|Overall Study|Lost to Follow-up|0
17573|NCT01855945|87236|P4|Overall Study|Lost to Follow-up|3
17574|NCT01855945|87237|P3|Overall Study|Lost to Follow-up|7
17575|NCT01855945|87238|P2|Overall Study|Lost to Follow-up|10
17576|NCT01855945|87239|P1|Overall Study|Lost to Follow-up|11
17577|NCT01855945|87228|P12|Overall Study|Death|0
17578|NCT01855945|87229|P11|Overall Study|Death|0
17579|NCT01855945|87230|P10|Overall Study|Death|0
17580|NCT01855945|87231|P9|Overall Study|Death|0
17581|NCT01855945|87232|P8|Overall Study|Death|0
17582|NCT01855945|87233|P7|Overall Study|Death|2
17583|NCT01855945|87234|P6|Overall Study|Death|0
17584|NCT01855945|87235|P5|Overall Study|Death|0
17585|NCT01855945|87236|P4|Overall Study|Death|0
17586|NCT01855945|87237|P3|Overall Study|Death|0
17587|NCT01855945|87238|P2|Overall Study|Death|0
17588|NCT01855945|87239|P1|Overall Study|Death|0
17589|NCT01855945|87228|P12|Overall Study|Adverse Event|0
17590|NCT01855945|87229|P11|Overall Study|Adverse Event|0
17591|NCT01855945|87230|P10|Overall Study|Adverse Event|0
17592|NCT01855945|87231|P9|Overall Study|Adverse Event|0
17593|NCT01855945|87232|P8|Overall Study|Adverse Event|0
17594|NCT01855945|87233|P7|Overall Study|Adverse Event|1
17595|NCT01855945|87234|P6|Overall Study|Adverse Event|0
17596|NCT01855945|87235|P5|Overall Study|Adverse Event|0
17597|NCT01855945|87236|P4|Overall Study|Adverse Event|0
17598|NCT01855945|87237|P3|Overall Study|Adverse Event|0
17599|NCT01855945|87238|P2|Overall Study|Adverse Event|0
17600|NCT01855945|87239|P1|Overall Study|Adverse Event|0
17601|NCT01855919|87375|P2|Overall Study|Protocol Violation|4
17602|NCT01855919|87376|P1|Overall Study|Protocol Violation|1
17603|NCT01855919|87375|P2|Overall Study|Entry Criteria Not Met|1
17604|NCT01855919|87376|P1|Overall Study|Entry Criteria Not Met|1
17605|NCT01855919|87375|P2|Overall Study|Withdrawal by Subject|10
17606|NCT01855919|87376|P1|Overall Study|Withdrawal by Subject|4
17607|NCT01855919|87375|P2|Overall Study|Lack of Efficacy|3
17608|NCT01855919|87376|P1|Overall Study|Lack of Efficacy|1
17609|NCT01855919|87375|P2|Overall Study|Adverse Event|8
17610|NCT01855919|87376|P1|Overall Study|Adverse Event|16
17611|NCT01855074|87408|P1|Overall Study|Started but not treated|1
17612|NCT01855074|87408|P1|Overall Study|Withdrawal by Subject|8
17613|NCT01855074|87408|P1|Overall Study|Lost to Follow-up|4
17614|NCT01855074|87408|P1|Overall Study|Adverse Event|1
17615|NCT01854944|87420|P3|Overall Study|Withdrawal by Subject|1
17616|NCT01854944|87421|P2|Overall Study|Withdrawal by Subject|0
17617|NCT01854944|87422|P1|Overall Study|Withdrawal by Subject|0
17618|NCT01853839|87476|P1|Overall Study|Lost to follow-up or no valid BP measure|336
17619|NCT01853839|87476|P1|Overall Study|End of treatment visit too early|33
17620|NCT01853839|87476|P1|Overall Study|Not meet ITT population definition|58
17621|NCT01853839|87476|P1|Overall Study|Violated inclusion criteria|2
17622|NCT01854697|87501|P5|Overall Study|Not Specified|0
17623|NCT01854697|87502|P4|Overall Study|Not Specified|0
17624|NCT01854697|87503|P3|Overall Study|Not Specified|1
17625|NCT01854697|87504|P2|Overall Study|Not Specified|1
17626|NCT01854697|87505|P1|Overall Study|Not Specified|0
17627|NCT01854697|87501|P5|Overall Study|Withdrew Consent|0
17628|NCT01854697|87502|P4|Overall Study|Withdrew Consent|1
17629|NCT01854697|87503|P3|Overall Study|Withdrew Consent|0
17630|NCT01854697|87504|P2|Overall Study|Withdrew Consent|1
17631|NCT01854697|87505|P1|Overall Study|Withdrew Consent|0
17632|NCT01854697|87501|P5|Overall Study|To enter another AbbVie study|1
17633|NCT01854697|87502|P4|Overall Study|To enter another AbbVie study|0
17634|NCT01854697|87503|P3|Overall Study|To enter another AbbVie study|0
17635|NCT01854697|87504|P2|Overall Study|To enter another AbbVie study|0
17636|NCT01854697|87505|P1|Overall Study|To enter another AbbVie study|1
17637|NCT01854697|87501|P5|Overall Study|Lost to Follow-up|0
17638|NCT01854697|87502|P4|Overall Study|Lost to Follow-up|2
17639|NCT01854697|87503|P3|Overall Study|Lost to Follow-up|1
17640|NCT01854697|87504|P2|Overall Study|Lost to Follow-up|1
17641|NCT01854697|87505|P1|Overall Study|Lost to Follow-up|4
17642|NCT01854697|87501|P5|Overall Study|Adverse Event|1
17643|NCT01854697|87502|P4|Overall Study|Adverse Event|0
17644|NCT01854697|87503|P3|Overall Study|Adverse Event|0
17645|NCT01854697|87504|P2|Overall Study|Adverse Event|0
17646|NCT01854697|87505|P1|Overall Study|Adverse Event|1
17647|NCT01854658|87549|P4|Overall Study|Administrative reasons|2
17648|NCT01854658|87550|P3|Overall Study|Administrative reasons|2
17649|NCT01854658|87551|P2|Overall Study|Administrative reasons|1
17650|NCT01854658|87552|P1|Overall Study|Administrative reasons|5
17651|NCT01854658|87549|P4|Overall Study|Adverse Event|19
17652|NCT01854658|87550|P3|Overall Study|Adverse Event|23
17653|NCT01854658|87551|P2|Overall Study|Adverse Event|14
17654|NCT01854658|87552|P1|Overall Study|Adverse Event|21
17655|NCT01854658|87549|P4|Overall Study|Lack of Efficacy|7
17656|NCT01854658|87550|P3|Overall Study|Lack of Efficacy|4
17657|NCT01854658|87551|P2|Overall Study|Lack of Efficacy|8
17658|NCT01854658|87552|P1|Overall Study|Lack of Efficacy|3
17659|NCT01854658|87549|P4|Overall Study|Protocol-specified criteria|7
17660|NCT01854658|87550|P3|Overall Study|Protocol-specified criteria|10
17661|NCT01854658|87551|P2|Overall Study|Protocol-specified criteria|15
17662|NCT01854658|87552|P1|Overall Study|Protocol-specified criteria|15
17663|NCT01854658|87549|P4|Overall Study|Withdrawal by Subject|15
17664|NCT01854658|87550|P3|Overall Study|Withdrawal by Subject|29
17665|NCT01854658|87551|P2|Overall Study|Withdrawal by Subject|21
17666|NCT01854658|87552|P1|Overall Study|Withdrawal by Subject|28
17667|NCT01854658|87549|P4|Overall Study|Lost to Follow-up|4
17668|NCT01854658|87550|P3|Overall Study|Lost to Follow-up|8
17669|NCT01854658|87551|P2|Overall Study|Lost to Follow-up|9
17670|NCT01854658|87552|P1|Overall Study|Lost to Follow-up|8
17671|NCT01854658|87549|P4|Overall Study|Physician Decision|4
17672|NCT01854658|87550|P3|Overall Study|Physician Decision|2
17673|NCT01854658|87551|P2|Overall Study|Physician Decision|5
17674|NCT01854658|87552|P1|Overall Study|Physician Decision|7
17675|NCT01854658|87549|P4|Overall Study|Protocol Violation|1
17676|NCT01854658|87550|P3|Overall Study|Protocol Violation|2
17677|NCT01854658|87551|P2|Overall Study|Protocol Violation|2
17678|NCT01854658|87552|P1|Overall Study|Protocol Violation|6
17679|NCT01854645|87587|P5|Overall Study|Adverse Event|11
17680|NCT01854645|87588|P4|Overall Study|Adverse Event|20
17681|NCT01854645|87589|P3|Overall Study|Adverse Event|19
17682|NCT01854645|87590|P2|Overall Study|Adverse Event|31
17683|NCT01854645|87591|P1|Overall Study|Adverse Event|33
17684|NCT01854645|87587|P5|Overall Study|Lack of Efficacy|9
17685|NCT01854645|87588|P4|Overall Study|Lack of Efficacy|3
17686|NCT01854645|87589|P3|Overall Study|Lack of Efficacy|9
17687|NCT01854645|87590|P2|Overall Study|Lack of Efficacy|12
17688|NCT01854645|87591|P1|Overall Study|Lack of Efficacy|7
17689|NCT01854645|87587|P5|Overall Study|Withdrawal by Subject|24
17690|NCT01854645|87588|P4|Overall Study|Withdrawal by Subject|21
17691|NCT01854645|87589|P3|Overall Study|Withdrawal by Subject|30
17692|NCT01854645|87590|P2|Overall Study|Withdrawal by Subject|41
17693|NCT01854645|87591|P1|Overall Study|Withdrawal by Subject|31
17694|NCT01854645|87587|P5|Overall Study|Physician Decision|7
17695|NCT01854645|87588|P4|Overall Study|Physician Decision|3
17696|NCT01854645|87589|P3|Overall Study|Physician Decision|3
17697|NCT01854645|87590|P2|Overall Study|Physician Decision|5
17698|NCT01854645|87591|P1|Overall Study|Physician Decision|1
17699|NCT01854645|87587|P5|Overall Study|Lost to Follow-up|0
17700|NCT01854645|87588|P4|Overall Study|Lost to Follow-up|5
17701|NCT01854645|87589|P3|Overall Study|Lost to Follow-up|8
17702|NCT01854645|87590|P2|Overall Study|Lost to Follow-up|7
17703|NCT01854645|87591|P1|Overall Study|Lost to Follow-up|10
17704|NCT01854645|87587|P5|Overall Study|Protocol Violation|1
17705|NCT01854645|87588|P4|Overall Study|Protocol Violation|4
17706|NCT01854645|87589|P3|Overall Study|Protocol Violation|5
17707|NCT01854645|87590|P2|Overall Study|Protocol Violation|0
17708|NCT01854645|87591|P1|Overall Study|Protocol Violation|3
17709|NCT01854645|87587|P5|Overall Study|Administrative Reasons / Missing|1
17710|NCT01854645|87588|P4|Overall Study|Administrative Reasons / Missing|1
17711|NCT01854645|87589|P3|Overall Study|Administrative Reasons / Missing|0
17712|NCT01854645|87590|P2|Overall Study|Administrative Reasons / Missing|0
17713|NCT01854645|87591|P1|Overall Study|Administrative Reasons / Missing|0
17714|NCT01854645|87587|P5|Overall Study|Protocol-Specified Criteria|7
17715|NCT01854645|87588|P4|Overall Study|Protocol-Specified Criteria|5
17716|NCT01854645|87589|P3|Overall Study|Protocol-Specified Criteria|8
17717|NCT01854645|87590|P2|Overall Study|Protocol-Specified Criteria|10
17718|NCT01854645|87591|P1|Overall Study|Protocol-Specified Criteria|13
17719|NCT01854528|87672|P2|Overall Study|Virologic Failure|9
17720|NCT01854528|87673|P1|Overall Study|Virologic Failure|0
17721|NCT01854528|87672|P2|Overall Study|Withdrawal by Subject|2
17722|NCT01854528|87673|P1|Overall Study|Withdrawal by Subject|0
17723|NCT01854528|87672|P2|Overall Study|Adverse Event|4
17724|NCT01854528|87673|P1|Overall Study|Adverse Event|0
17725|NCT01854047|87721|P5|Overall Study|Other than specified above|8
17726|NCT01854047|87722|P4|Overall Study|Other than specified above|5
17727|NCT01854047|87723|P3|Overall Study|Other than specified above|3
17728|NCT01854047|87724|P2|Overall Study|Other than specified above|3
17729|NCT01854047|87725|P1|Overall Study|Other than specified above|3
17730|NCT01854047|87721|P5|Overall Study|Randomized but not treated|4
17731|NCT01854047|87722|P4|Overall Study|Randomized but not treated|0
17732|NCT01854047|87723|P3|Overall Study|Randomized but not treated|2
17733|NCT01854047|87724|P2|Overall Study|Randomized but not treated|1
17734|NCT01854047|87725|P1|Overall Study|Randomized but not treated|0
17735|NCT01854047|87721|P5|Overall Study|Adverse Event|7
17736|NCT01854047|87722|P4|Overall Study|Adverse Event|10
17737|NCT01854047|87723|P3|Overall Study|Adverse Event|6
17738|NCT01854047|87724|P2|Overall Study|Adverse Event|4
17739|NCT01854047|87725|P1|Overall Study|Adverse Event|5
17740|NCT01854047|87721|P5|Overall Study|Poor compliance to protocol|0
17741|NCT01854047|87722|P4|Overall Study|Poor compliance to protocol|0
17742|NCT01854047|87723|P3|Overall Study|Poor compliance to protocol|2
17743|NCT01854047|87724|P2|Overall Study|Poor compliance to protocol|0
17744|NCT01854047|87725|P1|Overall Study|Poor compliance to protocol|3
17745|NCT01854047|87721|P5|Overall Study|Lack of Efficacy|0
17746|NCT01854047|87722|P4|Overall Study|Lack of Efficacy|0
17747|NCT01854047|87723|P3|Overall Study|Lack of Efficacy|0
17748|NCT01854047|87724|P2|Overall Study|Lack of Efficacy|0
17749|NCT01854047|87725|P1|Overall Study|Lack of Efficacy|1
17750|NCT01853982|87849|P2|Overall Study|Lost to Follow-up|1
17751|NCT01853982|87850|P1|Overall Study|Lost to Follow-up|0
17752|NCT01853982|87849|P2|Overall Study|Death|0
17753|NCT01853982|87850|P1|Overall Study|Death|1
17754|NCT01853982|87849|P2|Overall Study|Withdrawal by Subject|0
17755|NCT01853982|87850|P1|Overall Study|Withdrawal by Subject|1
17756|NCT01853696|87858|P2|Overall Study|Lost to Follow-up|4
17757|NCT01853696|87859|P1|Overall Study|Lost to Follow-up|5
17758|NCT01853696|87858|P2|Overall Study|Withdrawal by Subject|1
17759|NCT01853696|87859|P1|Overall Study|Withdrawal by Subject|1
17760|NCT01853475|87895|P3|Overall Study|Withdrawal by Subject|0
17761|NCT01853475|87896|P2|Overall Study|Withdrawal by Subject|1
17762|NCT01853475|87897|P1|Overall Study|Withdrawal by Subject|0
17763|NCT01853397|87918|P4|Overall Study|Subject Noncompliance|1
17764|NCT01853397|87919|P3|Overall Study|Subject Noncompliance|0
17765|NCT01853397|87920|P2|Overall Study|Subject Noncompliance|0
17766|NCT01853397|87921|P1|Overall Study|Subject Noncompliance|0
17767|NCT01853397|87918|P4|Overall Study|Withdrawal by Subject|1
17768|NCT01853397|87919|P3|Overall Study|Withdrawal by Subject|0
17769|NCT01853397|87920|P2|Overall Study|Withdrawal by Subject|0
17770|NCT01853397|87921|P1|Overall Study|Withdrawal by Subject|0
17771|NCT01853384|87949|P2|Completed Follow up Visit 2|Lost to Follow-up|1
17772|NCT01853384|87950|P1|Completed Follow up Visit 2|Lost to Follow-up|0
17773|NCT01853384|87949|P2|Completed Follow up Visit 2|Death|0
17774|NCT01853384|87950|P1|Completed Follow up Visit 2|Death|1
17775|NCT01853384|87949|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
17776|NCT01853384|87950|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
17777|NCT01853384|87949|P2|Completed Follow up Visit 2|Adverse Event|0
17778|NCT01853384|87950|P1|Completed Follow up Visit 2|Adverse Event|1
17779|NCT01853384|87949|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
17780|NCT01853384|87950|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
17781|NCT01853384|87949|P2|Completed Follow up Visit 1|Early Termination|9
17782|NCT01853384|87950|P1|Completed Follow up Visit 1|Early Termination|13
17783|NCT01853384|87949|P2|Randomized|Other|3
17784|NCT01853384|87950|P1|Randomized|Other|3
17785|NCT01853384|87949|P2|Randomized|Sponsor Decision|34
17786|NCT01853384|87950|P1|Randomized|Sponsor Decision|47
17787|NCT01853384|87949|P2|Randomized|Withdrawal by Subject|3
17788|NCT01853384|87950|P1|Randomized|Withdrawal by Subject|5
17789|NCT01853384|87949|P2|Randomized|Lost to Follow-up|1
17790|NCT01853384|87950|P1|Randomized|Lost to Follow-up|1
17791|NCT01853384|87949|P2|Randomized|Death|2
17792|NCT01853384|87950|P1|Randomized|Death|1
17793|NCT01853384|87949|P2|Randomized|Adverse Event|3
17794|NCT01853384|87950|P1|Randomized|Adverse Event|5
17795|NCT01853254|87988|P1|Overall Study|Administrative/Other|16
17796|NCT01853254|87988|P1|Overall Study|Withdrawal of Consent|16
17797|NCT01853254|87988|P1|Overall Study|Other Protocol Violation|1
17798|NCT01853254|87988|P1|Overall Study|Refusal of Treatment|1
17799|NCT01853254|87988|P1|Overall Study|Insufficient Therapeutic Response|22
17800|NCT01853254|87988|P1|Overall Study|Failure to Return|43
17801|NCT01853254|87988|P1|Overall Study|Death|1
17802|NCT01853254|87988|P1|Overall Study|Adverse Event/Intercurrent Illness|3
17803|NCT01853254|87988|P1|Overall Study|Abnormal Laboratory Test|1
17804|NCT01853176|88005|P2|Overall Study|Study terminated|0
17805|NCT01853176|88006|P1|Overall Study|Study terminated|4
17806|NCT01853072|88025|P2|Overall Study|Reason not specified|6
17807|NCT01853072|88026|P1|Overall Study|Reason not specified|9
17808|NCT01853072|88025|P2|Overall Study|Withdrawal by Subject|2
17809|NCT01853072|88026|P1|Overall Study|Withdrawal by Subject|1
17810|NCT01853072|88025|P2|Overall Study|Physician Decision|1
17811|NCT01853072|88026|P1|Overall Study|Physician Decision|1
17812|NCT01853072|88025|P2|Overall Study|Non-compliance with study drug|1
17813|NCT01853072|88026|P1|Overall Study|Non-compliance with study drug|0
17814|NCT01853072|88025|P2|Overall Study|Lost to Follow-up|3
17815|NCT01853072|88026|P1|Overall Study|Lost to Follow-up|0
17816|NCT01853072|88025|P2|Overall Study|Death|4
17817|NCT01853072|88026|P1|Overall Study|Death|1
17818|NCT01853072|88025|P2|Overall Study|Adverse Event|3
17819|NCT01853072|88026|P1|Overall Study|Adverse Event|0
17820|NCT01853072|88025|P2|Overall Study|Adverse event prior to treatment|1
17821|NCT01853072|88026|P1|Overall Study|Adverse event prior to treatment|0
17822|NCT01853046|88046|P2|Overall Study|Disease progression|3
17823|NCT01853046|88047|P1|Overall Study|Disease progression|13
17824|NCT01853046|88046|P2|Overall Study|Adverse Event|2
17825|NCT01853046|88047|P1|Overall Study|Adverse Event|4
17826|NCT01853046|88046|P2|Overall Study|Withdrawal by Subject|1
17827|NCT01853046|88047|P1|Overall Study|Withdrawal by Subject|1
17828|NCT01852825|88115|P3|Overall Study|Withdrawal by Subject|0
17829|NCT01852825|88116|P2|Overall Study|Withdrawal by Subject|0
17830|NCT01852825|88117|P1|Overall Study|Withdrawal by Subject|2
17831|NCT01852812|88143|P3|Overall Study|Non-compliance With Study Drug|0
17832|NCT01852812|88144|P2|Overall Study|Non-compliance With Study Drug|1
17833|NCT01852812|88145|P1|Overall Study|Non-compliance With Study Drug|0
17834|NCT01852812|88143|P3|Overall Study|Adverse Event|1
17835|NCT01852812|88144|P2|Overall Study|Adverse Event|0
17836|NCT01852812|88145|P1|Overall Study|Adverse Event|0
17837|NCT01851863|88178|P4|Overall Study|Lost to Follow-up|3
17838|NCT01851863|88179|P3|Overall Study|Lost to Follow-up|2
17839|NCT01851863|88180|P2|Overall Study|Lost to Follow-up|4
17840|NCT01851863|88181|P1|Overall Study|Lost to Follow-up|3
17841|NCT01851863|88178|P4|Overall Study|Did not receive study medication|0
17842|NCT01851863|88179|P3|Overall Study|Did not receive study medication|3
17843|NCT01851863|88180|P2|Overall Study|Did not receive study medication|5
17844|NCT01851863|88181|P1|Overall Study|Did not receive study medication|2
17845|NCT01852591|88217|P1|Overall Study|Not Evaluable at Time of Analysis|1
17846|NCT01852591|88217|P1|Overall Study|Withdrawal by Subject|2
17847|NCT01852214|88231|P2|Washout Period|Withdrawal by Subject|1
17848|NCT01852214|88232|P1|Washout Period|Withdrawal by Subject|0
17849|NCT01852214|88231|P2|Period 1|Withdrawal by Subject|1
17850|NCT01852214|88232|P1|Period 1|Withdrawal by Subject|0
17851|NCT01852214|88231|P2|Period 1|Adverse Event|2
17852|NCT01852214|88232|P1|Period 1|Adverse Event|1
17853|NCT01852162|88259|P2|Overall Study|Withdrawal by Subject|1
17854|NCT01852162|88260|P1|Overall Study|Withdrawal by Subject|3
17855|NCT01852162|88259|P2|Overall Study|Adverse Event|0
17856|NCT01852162|88260|P1|Overall Study|Adverse Event|1
17857|NCT01851720|88301|P2|Overall Study|Lost to Follow-up|1
17858|NCT01851720|88302|P1|Overall Study|Lost to Follow-up|0
17859|NCT01851590|88332|P3|Overall Study|Lack of Efficacy|0
17860|NCT01851590|88333|P2|Overall Study|Lack of Efficacy|1
17861|NCT01851590|88334|P1|Overall Study|Lack of Efficacy|0
17862|NCT01851590|88332|P3|Overall Study|Adverse Event|2
17863|NCT01851590|88333|P2|Overall Study|Adverse Event|0
17864|NCT01851590|88334|P1|Overall Study|Adverse Event|0
17865|NCT01851590|88332|P3|Overall Study|Withdrawal by Subject|1
17866|NCT01851590|88333|P2|Overall Study|Withdrawal by Subject|0
17867|NCT01851590|88334|P1|Overall Study|Withdrawal by Subject|0
17868|NCT01851330|88357|P3|Overall Study|Investigator’s Discretion|1
17869|NCT01851330|88358|P2|Overall Study|Investigator’s Discretion|0
17870|NCT01851330|88359|P1|Overall Study|Investigator’s Discretion|0
17871|NCT01851330|88357|P3|Overall Study|Withdrew Consent|0
17872|NCT01851330|88358|P2|Overall Study|Withdrew Consent|1
17873|NCT01851330|88359|P1|Overall Study|Withdrew Consent|2
17874|NCT01851330|88357|P3|Overall Study|Lost to Follow-up|9
17875|NCT01851330|88358|P2|Overall Study|Lost to Follow-up|6
17876|NCT01851330|88359|P1|Overall Study|Lost to Follow-up|1
17877|NCT01851330|88357|P3|Overall Study|Lack of Efficacy|2
17878|NCT01851330|88358|P2|Overall Study|Lack of Efficacy|9
17879|NCT01851330|88359|P1|Overall Study|Lack of Efficacy|10
17880|NCT01849588|88394|P1|Overall Study|Lack of Efficacy|3
17881|NCT01849562|88404|P3|Overall Study|Non-compliance with Study Drug|0
17882|NCT01849562|88405|P2|Overall Study|Non-compliance with Study Drug|0
17883|NCT01849562|88406|P1|Overall Study|Non-compliance with Study Drug|1
17884|NCT01849562|88404|P3|Overall Study|Lost to Follow-up|0
17885|NCT01849562|88405|P2|Overall Study|Lost to Follow-up|0
17886|NCT01849562|88406|P1|Overall Study|Lost to Follow-up|1
17887|NCT01849497|88419|P2|Overall Study|Lost to Follow-up|1
17888|NCT01849497|88420|P1|Overall Study|Lost to Follow-up|0
17889|NCT01849497|88419|P2|Overall Study|Sponsor Decision|1
17890|NCT01849497|88420|P1|Overall Study|Sponsor Decision|0
17891|NCT01849497|88419|P2|Overall Study|Withdrawal by Subject|2
17892|NCT01849497|88420|P1|Overall Study|Withdrawal by Subject|1
17893|NCT01850589|88430|P2|Overall Study|Withdrawal by Subject|0
17894|NCT01850589|88431|P1|Overall Study|Withdrawal by Subject|8
17895|NCT01849848|88494|P1|Overall Study|Progression of the primary disease|3
17896|NCT01849848|88494|P1|Overall Study|Physician Decision|1
17897|NCT01849458|88592|P1|Overall Study|Lost to Follow-up|4
17898|NCT01849289|88631|P2|Overall Study|Unclassified|18
17899|NCT01849289|88632|P1|Overall Study|Unclassified|25
17900|NCT01849289|88631|P2|Overall Study|Withdrawal criteria|0
17901|NCT01849289|88632|P1|Overall Study|Withdrawal criteria|1
17902|NCT01849289|88631|P2|Overall Study|Protocol Violation|3
17903|NCT01849289|88632|P1|Overall Study|Protocol Violation|3
17904|NCT01849289|88631|P2|Overall Study|Adverse Event|3
17905|NCT01849289|88632|P1|Overall Study|Adverse Event|3
17906|NCT01848990|88666|P3|Overall Study|Death|0
17907|NCT01848990|88667|P2|Overall Study|Death|0
17908|NCT01848990|88668|P1|Overall Study|Death|1
17909|NCT01848990|88666|P3|Overall Study|Non Compliance|0
17910|NCT01848990|88667|P2|Overall Study|Non Compliance|0
17911|NCT01848990|88668|P1|Overall Study|Non Compliance|1
17912|NCT01848990|88666|P3|Overall Study|Physician Decision|0
17913|NCT01848990|88667|P2|Overall Study|Physician Decision|0
17914|NCT01848990|88668|P1|Overall Study|Physician Decision|1
17915|NCT01848990|88666|P3|Overall Study|Withdrawal by Subject|9
17916|NCT01848990|88667|P2|Overall Study|Withdrawal by Subject|6
17917|NCT01848990|88668|P1|Overall Study|Withdrawal by Subject|20
17918|NCT01848990|88666|P3|Overall Study|Protocol Violation|0
17919|NCT01848990|88667|P2|Overall Study|Protocol Violation|1
17920|NCT01848990|88668|P1|Overall Study|Protocol Violation|0
17921|NCT01848990|88666|P3|Overall Study|Lost to Follow-up|2
17922|NCT01848990|88667|P2|Overall Study|Lost to Follow-up|1
17923|NCT01848990|88668|P1|Overall Study|Lost to Follow-up|6
17924|NCT01848990|88666|P3|Overall Study|Adverse Event|0
17925|NCT01848990|88667|P2|Overall Study|Adverse Event|1
17926|NCT01848990|88668|P1|Overall Study|Adverse Event|4
17927|NCT01848938|88694|P2|Overall Study|Lost to Follow-up|1
17928|NCT01848938|88695|P1|Overall Study|Lost to Follow-up|1
17929|NCT01848834|88744|P5|Overall Study|Not Treated|0
17930|NCT01848834|88745|P4|Overall Study|Not Treated|0
17931|NCT01848834|88746|P3|Overall Study|Not Treated|0
17932|NCT01848834|88747|P2|Overall Study|Not Treated|1
17933|NCT01848834|88748|P1|Overall Study|Not Treated|0
17934|NCT01848834|88744|P5|Overall Study|Withdrawal by Subject|7
17935|NCT01848834|88745|P4|Overall Study|Withdrawal by Subject|0
17936|NCT01848834|88746|P3|Overall Study|Withdrawal by Subject|3
17937|NCT01848834|88747|P2|Overall Study|Withdrawal by Subject|2
17938|NCT01848834|88748|P1|Overall Study|Withdrawal by Subject|0
17939|NCT01848834|88744|P5|Overall Study|Protocol Violation|2
17940|NCT01848834|88745|P4|Overall Study|Protocol Violation|0
17941|NCT01848834|88746|P3|Overall Study|Protocol Violation|1
17942|NCT01848834|88747|P2|Overall Study|Protocol Violation|0
17943|NCT01848834|88748|P1|Overall Study|Protocol Violation|0
17944|NCT01848834|88744|P5|Overall Study|Progressive Disease|78
17945|NCT01848834|88745|P4|Overall Study|Progressive Disease|36
17946|NCT01848834|88746|P3|Overall Study|Progressive Disease|21
17947|NCT01848834|88747|P2|Overall Study|Progressive Disease|41
17948|NCT01848834|88748|P1|Overall Study|Progressive Disease|27
17949|NCT01848834|88744|P5|Overall Study|Death|3
17950|NCT01848834|88745|P4|Overall Study|Death|0
17951|NCT01848834|88746|P3|Overall Study|Death|0
17952|NCT01848834|88747|P2|Overall Study|Death|1
17953|NCT01848834|88748|P1|Overall Study|Death|0
17954|NCT01848834|88744|P5|Overall Study|Complete Response|0
17955|NCT01848834|88745|P4|Overall Study|Complete Response|0
17956|NCT01848834|88746|P3|Overall Study|Complete Response|0
17957|NCT01848834|88747|P2|Overall Study|Complete Response|1
17958|NCT01848834|88748|P1|Overall Study|Complete Response|0
17959|NCT01848834|88744|P5|Overall Study|Adverse Event|15
17960|NCT01848834|88745|P4|Overall Study|Adverse Event|1
17961|NCT01848834|88746|P3|Overall Study|Adverse Event|6
17962|NCT01848834|88747|P2|Overall Study|Adverse Event|8
17963|NCT01848834|88748|P1|Overall Study|Adverse Event|3
17964|NCT01848834|88744|P5|Overall Study|Physician Decision|1
17965|NCT01848834|88745|P4|Overall Study|Physician Decision|0
17966|NCT01848834|88746|P3|Overall Study|Physician Decision|0
17967|NCT01848834|88747|P2|Overall Study|Physician Decision|0
17968|NCT01848834|88748|P1|Overall Study|Physician Decision|0
17969|NCT01848834|88744|P5|Overall Study|Ongoing in Study|26
17970|NCT01848834|88745|P4|Overall Study|Ongoing in Study|0
17971|NCT01848834|88746|P3|Overall Study|Ongoing in Study|1
17972|NCT01848834|88747|P2|Overall Study|Ongoing in Study|6
17973|NCT01848834|88748|P1|Overall Study|Ongoing in Study|0
17974|NCT01848756|88783|P1|Overall Study|Enrolled in Error|1
17975|NCT01848756|88783|P1|Overall Study|Withdrawal by Subject|1
17976|NCT01848756|88783|P1|Overall Study|Adverse Event|1
17977|NCT01848288|88797|P1|Overall Study|Withdrawal by Subject|1
17978|NCT01848288|88797|P1|Overall Study|Protocol Violation|1
17979|NCT01848288|88797|P1|Overall Study|Death|1
17980|NCT01848210|88808|P2|Overall Study|Administrative|0
17981|NCT01848210|88809|P1|Overall Study|Administrative|1
17982|NCT01848210|88808|P2|Overall Study|Chronic Venous Insufficiency Course|2
17983|NCT01848210|88809|P1|Overall Study|Chronic Venous Insufficiency Course|1
17984|NCT01848210|88808|P2|Overall Study|Hepatic Function Alteration|0
17985|NCT01848210|88809|P1|Overall Study|Hepatic Function Alteration|4
17986|NCT01848210|88808|P2|Overall Study|Hypesensitivity|0
17987|NCT01848210|88809|P1|Overall Study|Hypesensitivity|1
17988|NCT01848210|88808|P2|Overall Study|Discontinuation Criterion|7
17989|NCT01848210|88809|P1|Overall Study|Discontinuation Criterion|5
17990|NCT01848210|88808|P2|Overall Study|Adverse Event|9
17991|NCT01848210|88809|P1|Overall Study|Adverse Event|7
17992|NCT01848210|88808|P2|Overall Study|Impedition Condition|9
17993|NCT01848210|88809|P1|Overall Study|Impedition Condition|5
17994|NCT01848210|88808|P2|Overall Study|Use of Forbidden Drugs|10
17995|NCT01848210|88809|P1|Overall Study|Use of Forbidden Drugs|9
17996|NCT01848210|88808|P2|Overall Study|Protocol Violation|5
17997|NCT01848210|88809|P1|Overall Study|Protocol Violation|3
17998|NCT01848210|88808|P2|Overall Study|Lost to Follow-up|12
17999|NCT01848210|88809|P1|Overall Study|Lost to Follow-up|24
18000|NCT01848210|88808|P2|Overall Study|Informed Consent Form Withdrawal|24
18001|NCT01848210|88809|P1|Overall Study|Informed Consent Form Withdrawal|28
18002|NCT01848145|88821|P1|Subsequent Infusions: Weeks 3-8|Death|1
18003|NCT01848145|88821|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
18004|NCT01848145|88821|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
18005|NCT01848145|88821|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
18006|NCT01848145|88821|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
18007|NCT01848145|88821|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
18008|NCT01848145|88821|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
18009|NCT01847443|88898|P4|Washout Period Before Study Period 4|Positive alcohol test|0
18010|NCT01847443|88899|P3|Washout Period Before Study Period 4|Positive alcohol test|0
18011|NCT01847443|88900|P2|Washout Period Before Study Period 4|Positive alcohol test|0
18012|NCT01847443|88901|P1|Washout Period Before Study Period 4|Positive alcohol test|1
18013|NCT01847443|88898|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
18014|NCT01847443|88899|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
18015|NCT01847443|88900|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
18016|NCT01847443|88901|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
18017|NCT01847443|88898|P4|Washout Period Before Study Period 3|Other reason|0
18018|NCT01847443|88899|P3|Washout Period Before Study Period 3|Other reason|0
18019|NCT01847443|88900|P2|Washout Period Before Study Period 3|Other reason|0
18020|NCT01847443|88901|P1|Washout Period Before Study Period 3|Other reason|1
18021|NCT01847443|88898|P4|Washout Period Before Study Period 2|Other reason|0
18022|NCT01847443|88899|P3|Washout Period Before Study Period 2|Other reason|0
18023|NCT01847443|88900|P2|Washout Period Before Study Period 2|Other reason|0
18024|NCT01847443|88901|P1|Washout Period Before Study Period 2|Other reason|1
18025|NCT01847443|88898|P4|Washout Period Before Study Period 2|Adverse Event|0
18026|NCT01847443|88899|P3|Washout Period Before Study Period 2|Adverse Event|0
18027|NCT01847443|88900|P2|Washout Period Before Study Period 2|Adverse Event|1
18028|NCT01847443|88901|P1|Washout Period Before Study Period 2|Adverse Event|1
18029|NCT01847443|88898|P4|Study Period 1|Withdrawal by Subject|0
18030|NCT01847443|88899|P3|Study Period 1|Withdrawal by Subject|0
18031|NCT01847443|88900|P2|Study Period 1|Withdrawal by Subject|1
18032|NCT01847443|88901|P1|Study Period 1|Withdrawal by Subject|0
18033|NCT01846741|88958|P1|Baseline Visit|Subject did not meet entry criteria|2
18034|NCT01846442|89084|P4|Overall Study|Left the city/Lost medication|1
18035|NCT01846442|89085|P3|Overall Study|Left the city/Lost medication|1
18036|NCT01846442|89086|P2|Overall Study|Left the city/Lost medication|0
18037|NCT01846442|89087|P1|Overall Study|Left the city/Lost medication|1
18038|NCT01846442|89084|P4|Overall Study|Withdrawal by Subject|1
18039|NCT01846442|89085|P3|Overall Study|Withdrawal by Subject|0
18040|NCT01846442|89086|P2|Overall Study|Withdrawal by Subject|2
18041|NCT01846442|89087|P1|Overall Study|Withdrawal by Subject|3
18042|NCT01846442|89084|P4|Overall Study|Lost to Follow-up|0
18043|NCT01846442|89085|P3|Overall Study|Lost to Follow-up|1
18044|NCT01846442|89086|P2|Overall Study|Lost to Follow-up|0
18045|NCT01846442|89087|P1|Overall Study|Lost to Follow-up|0
18046|NCT01846442|89084|P4|Overall Study|Adverse Event|1
18047|NCT01846442|89085|P3|Overall Study|Adverse Event|2
18048|NCT01846442|89086|P2|Overall Study|Adverse Event|4
18049|NCT01846442|89087|P1|Overall Study|Adverse Event|2
18050|NCT01846416|89128|P3|Overall Study|Lost to Follow-up|1
18051|NCT01846416|89129|P2|Overall Study|Lost to Follow-up|2
18052|NCT01846416|89130|P1|Overall Study|Lost to Follow-up|0
18053|NCT01846416|89128|P3|Overall Study|Ongoing as of 7 January 2015|3
18054|NCT01846416|89129|P2|Overall Study|Ongoing as of 7 January 2015|41
18055|NCT01846416|89130|P1|Overall Study|Ongoing as of 7 January 2015|21
18056|NCT01846416|89128|P3|Overall Study|Unspecified|0
18057|NCT01846416|89129|P2|Overall Study|Unspecified|0
18058|NCT01846416|89130|P1|Overall Study|Unspecified|1
18059|NCT01846416|89128|P3|Overall Study|Withdrawal by Subject|0
18060|NCT01846416|89129|P2|Overall Study|Withdrawal by Subject|7
18061|NCT01846416|89130|P1|Overall Study|Withdrawal by Subject|1
18062|NCT01846416|89128|P3|Overall Study|Death|9
18063|NCT01846416|89129|P2|Overall Study|Death|43
18064|NCT01846416|89130|P1|Overall Study|Death|8
18065|NCT01846299|89175|P2|Overall Study|Adverse Event|0
18066|NCT01846299|89176|P1|Overall Study|Adverse Event|2
18067|NCT01846299|89175|P2|Overall Study|Withdrawal by Subject|6
18068|NCT01846299|89176|P1|Overall Study|Withdrawal by Subject|1
18069|NCT01846299|89175|P2|Overall Study|Lost to Follow-up|0
18070|NCT01846299|89176|P1|Overall Study|Lost to Follow-up|3
18071|NCT01846299|89175|P2|Overall Study|Death|2
18072|NCT01846299|89176|P1|Overall Study|Death|1
18073|NCT01846299|89175|P2|Overall Study|Protocol deviation|0
18074|NCT01846299|89176|P1|Overall Study|Protocol deviation|1
18075|NCT01846299|89175|P2|Overall Study|Physician Decision|2
18076|NCT01846299|89176|P1|Overall Study|Physician Decision|4
18077|NCT01846104|89212|P1|Overall Study|Withdrawal by Subject|1
18078|NCT01846039|89218|P1|Overall Study|Subject Withdrew Consent|1
18079|NCT01846039|89218|P1|Overall Study|Protocol Violation|1
18080|NCT01845831|89230|P5|Inpatient Phase|Withdrawal by Subject|0
18081|NCT01845831|89231|P4|Inpatient Phase|Withdrawal by Subject|0
18082|NCT01845831|89232|P3|Inpatient Phase|Withdrawal by Subject|0
18083|NCT01845831|89233|P2|Inpatient Phase|Withdrawal by Subject|1
18084|NCT01845831|89234|P1|Inpatient Phase|Withdrawal by Subject|1
18085|NCT01845077|89280|P6|Washout Period|Protocol Violation|0
18086|NCT01845077|89281|P5|Washout Period|Protocol Violation|1
18087|NCT01845077|89282|P4|Washout Period|Protocol Violation|1
18088|NCT01845077|89283|P3|Washout Period|Protocol Violation|0
18089|NCT01845077|89284|P2|Washout Period|Protocol Violation|0
18090|NCT01845077|89285|P1|Washout Period|Protocol Violation|0
18091|NCT01845077|89280|P6|Washout Period|elevated lab values (not clinic. sign.)|0
18092|NCT01845077|89281|P5|Washout Period|elevated lab values (not clinic. sign.)|0
18093|NCT01845077|89282|P4|Washout Period|elevated lab values (not clinic. sign.)|0
18094|NCT01845077|89283|P3|Washout Period|elevated lab values (not clinic. sign.)|1
18095|NCT01845077|89284|P2|Washout Period|elevated lab values (not clinic. sign.)|0
18096|NCT01845077|89285|P1|Washout Period|elevated lab values (not clinic. sign.)|0
18097|NCT01845077|89280|P6|Washout Period|Adverse Event|0
18098|NCT01845077|89281|P5|Washout Period|Adverse Event|0
18099|NCT01845077|89282|P4|Washout Period|Adverse Event|0
18100|NCT01845077|89283|P3|Washout Period|Adverse Event|0
18101|NCT01845077|89284|P2|Washout Period|Adverse Event|0
18102|NCT01845077|89285|P1|Washout Period|Adverse Event|1
18103|NCT01845077|89280|P6|Washout Period|Lost to Follow-up|1
18104|NCT01845077|89281|P5|Washout Period|Lost to Follow-up|0
18105|NCT01845077|89282|P4|Washout Period|Lost to Follow-up|1
18106|NCT01845077|89283|P3|Washout Period|Lost to Follow-up|0
18107|NCT01845077|89284|P2|Washout Period|Lost to Follow-up|1
18108|NCT01845077|89285|P1|Washout Period|Lost to Follow-up|0
18109|NCT01845025|89331|P2|Overall Study|Missing|1
18110|NCT01845025|89332|P1|Overall Study|Missing|1
18111|NCT01845025|89331|P2|Overall Study|Protocol deviation|6
18112|NCT01845025|89332|P1|Overall Study|Protocol deviation|3
18113|NCT01845025|89331|P2|Overall Study|Death|0
18114|NCT01845025|89332|P1|Overall Study|Death|2
18115|NCT01845025|89331|P2|Overall Study|Administrative problems|8
18116|NCT01845025|89332|P1|Overall Study|Administrative problems|8
18117|NCT01845025|89331|P2|Overall Study|Lost to Follow-up|13
18118|NCT01845025|89332|P1|Overall Study|Lost to Follow-up|13
18119|NCT01845025|89331|P2|Overall Study|Withdrawal by Subject|44
18120|NCT01845025|89332|P1|Overall Study|Withdrawal by Subject|48
18121|NCT01845025|89331|P2|Overall Study|Unsatisfactory therapeutic effect|2
18122|NCT01845025|89332|P1|Overall Study|Unsatisfactory therapeutic effect|4
18123|NCT01845025|89331|P2|Overall Study|Adverse Event|3
18124|NCT01845025|89332|P1|Overall Study|Adverse Event|6
18125|NCT01844895|89354|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
18126|NCT01844895|89354|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
18127|NCT01844895|89354|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
18128|NCT01844895|89354|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
18129|NCT01844895|89354|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
18130|NCT01844895|89354|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
18131|NCT01844895|89354|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
18132|NCT01844856|89372|P2|Overall Study|Randomized but was a Screen Failure|1
18133|NCT01844856|89373|P1|Overall Study|Randomized but was a Screen Failure|0
18134|NCT01844856|89372|P2|Overall Study|Inadvertently Not Scheduled|0
18135|NCT01844856|89373|P1|Overall Study|Inadvertently Not Scheduled|1
18136|NCT01844856|89372|P2|Overall Study|Enterococcus Resistant|1
18137|NCT01844856|89373|P1|Overall Study|Enterococcus Resistant|0
18138|NCT01844856|89372|P2|Overall Study|Noncompliance|3
18139|NCT01844856|89373|P1|Overall Study|Noncompliance|2
18140|NCT01844856|89372|P2|Overall Study|Withdrawal by Subject|2
18141|NCT01844856|89373|P1|Overall Study|Withdrawal by Subject|3
18142|NCT01844856|89372|P2|Overall Study|Adverse Event|6
18143|NCT01844856|89373|P1|Overall Study|Adverse Event|3
18144|NCT01844856|89372|P2|Overall Study|Lost to Follow-up|3
18145|NCT01844856|89373|P1|Overall Study|Lost to Follow-up|15
18146|NCT01844830|89385|P2|Overall Study|Withdrawal by Subject|0
18147|NCT01844830|89386|P1|Overall Study|Withdrawal by Subject|1
18148|NCT01844817|89416|P2|Treatment|Other|3
18149|NCT01844817|89417|P1|Treatment|Other|0
18150|NCT01844817|89416|P2|Treatment|Lost to Follow-up|1
18151|NCT01844817|89417|P1|Treatment|Lost to Follow-up|0
18152|NCT01844817|89416|P2|Treatment|Death|8
18153|NCT01844817|89417|P1|Treatment|Death|10
18154|NCT01844817|89416|P2|Treatment|Withdrawal by Subject|6
18155|NCT01844817|89417|P1|Treatment|Withdrawal by Subject|10
18156|NCT01844817|89416|P2|Treatment|Adverse Event|9
18157|NCT01844817|89417|P1|Treatment|Adverse Event|17
18158|NCT01844817|89416|P2|Treatment|Progressive Disease|36
18159|NCT01844817|89417|P1|Treatment|Progressive Disease|27
18160|NCT01844817|89416|P2|Enrolled and Randomized|Withdrawal by Subject|3
18161|NCT01844817|89417|P1|Enrolled and Randomized|Withdrawal by Subject|2
18162|NCT01844778|89430|P3|Overall Study|Adverse Event|2
18163|NCT01844778|89431|P2|Overall Study|Adverse Event|2
18164|NCT01844778|89432|P1|Overall Study|Adverse Event|0
18165|NCT01844778|89430|P3|Overall Study|Withdrawal by Subject|0
18166|NCT01844778|89431|P2|Overall Study|Withdrawal by Subject|0
18167|NCT01844778|89432|P1|Overall Study|Withdrawal by Subject|2
18168|NCT01844778|89430|P3|Overall Study|Protocol deviation|2
18169|NCT01844778|89431|P2|Overall Study|Protocol deviation|1
18170|NCT01844778|89432|P1|Overall Study|Protocol deviation|0
18171|NCT01844700|89458|P2|Overall Study|stopped taking meds|1
18172|NCT01844700|89459|P1|Overall Study|stopped taking meds|0
18173|NCT01844700|89458|P2|Overall Study|Withdrawal by Subject|0
18174|NCT01844700|89459|P1|Overall Study|Withdrawal by Subject|1
18175|NCT01844700|89458|P2|Overall Study|refused medication switch|0
18176|NCT01844700|89459|P1|Overall Study|refused medication switch|1
18177|NCT01844700|89458|P2|Overall Study|Lack of Efficacy|0
18178|NCT01844700|89459|P1|Overall Study|Lack of Efficacy|1
18179|NCT01844687|89471|P1|Visit 4|Withdrawal by Subject|2
18180|NCT01844687|89471|P1|Visit 4|Lost to Follow-up|1
18181|NCT01844687|89471|P1|Visit 4|Pregnancy|1
18182|NCT01844687|89471|P1|Visit 3|child care problems|1
18183|NCT01844687|89471|P1|Visit 3|Withdrawal by Subject|3
18184|NCT01844687|89471|P1|Visit 3|Lost to Follow-up|1
18185|NCT01844687|89471|P1|Visit 2|Protocol Violation|1
18186|NCT01844687|89471|P1|Visit 2|Withdrawal by Subject|1
18187|NCT01844687|89471|P1|Visit 1|Lost to Follow-up|5
18188|NCT01844687|89471|P1|Visit 1|Protocol Violation|3
18189|NCT01844531|89534|P4|Overall Study|Withdrawal by Subject|0
18190|NCT01844531|89535|P3|Overall Study|Withdrawal by Subject|0
18191|NCT01844531|89536|P2|Overall Study|Withdrawal by Subject|1
18192|NCT01844531|89537|P1|Overall Study|Withdrawal by Subject|0
18193|NCT01844518|89567|P1|Long-Term Extension|Still in On-Going Study|149
18194|NCT01844518|89567|P1|Long-Term Extension|No Longer Met Study Criteria|1
18195|NCT01844518|89567|P1|Long-Term Extension|Adverse Event|1
18196|NCT01844518|89567|P1|Long-Term Extension|Lack of Efficacy|6
18197|NCT01844518|89567|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
18198|NCT01844518|89567|P1|Short-Term (ST) Period|Withdrawal of Consent|2
18199|NCT01844518|89567|P1|Short-Term (ST) Period|Lack of Efficacy|3
18200|NCT01844518|89567|P1|Short-Term (ST) Period|Adverse Event|3
18201|NCT01843972|89642|P10|Overall Study|Withdrawal by Subject|0
18202|NCT01843972|89643|P9|Overall Study|Withdrawal by Subject|0
18203|NCT01843972|89644|P8|Overall Study|Withdrawal by Subject|0
18204|NCT01843972|89645|P7|Overall Study|Withdrawal by Subject|0
18205|NCT01843972|89646|P6|Overall Study|Withdrawal by Subject|0
18206|NCT01843972|89647|P5|Overall Study|Withdrawal by Subject|1
18207|NCT01843972|89648|P4|Overall Study|Withdrawal by Subject|0
18208|NCT01843972|89649|P3|Overall Study|Withdrawal by Subject|0
18209|NCT01843972|89650|P2|Overall Study|Withdrawal by Subject|0
18210|NCT01843972|89651|P1|Overall Study|Withdrawal by Subject|0
18211|NCT01843933|89721|P2|Overall Study|Data lost|4
18212|NCT01843933|89722|P1|Overall Study|Data lost|6
18213|NCT01843777|89739|P2|Overall Study|Withdrawal by Subject|0
18214|NCT01843777|89740|P1|Overall Study|Withdrawal by Subject|1
18215|NCT01843673|89748|P1|Overall Study|Withdrawal by Subject|4
18216|NCT01843673|89748|P1|Overall Study|Lack of Efficacy|2
18217|NCT01843660|89760|P1|Overall Study|Unspecified|30
18218|NCT01843374|89784|P2|Overall Study|Withdrawal by Subject|19
18219|NCT01843374|89785|P1|Overall Study|Withdrawal by Subject|14
18220|NCT01843374|89784|P2|Overall Study|Death|302
18221|NCT01843374|89785|P1|Overall Study|Death|150
18222|NCT01843348|89812|P3|Overall Study|Various reasons|6
18223|NCT01843348|89813|P2|Overall Study|Various reasons|9
18224|NCT01843348|89814|P1|Overall Study|Various reasons|4
18225|NCT01843348|89812|P3|Overall Study|Graft loss/retransplantation|11
18226|NCT01843348|89813|P2|Overall Study|Graft loss/retransplantation|8
18227|NCT01843348|89814|P1|Overall Study|Graft loss/retransplantation|5
18228|NCT01843348|89812|P3|Overall Study|Death|4
18229|NCT01843348|89813|P2|Overall Study|Death|3
18230|NCT01843348|89814|P1|Overall Study|Death|5
18231|NCT01843348|89812|P3|Overall Study|Lost to Follow-up|2
18232|NCT01843348|89813|P2|Overall Study|Lost to Follow-up|4
18233|NCT01843348|89814|P1|Overall Study|Lost to Follow-up|5
18234|NCT01843348|89812|P3|Overall Study|Withdrawal by Subject|18
18235|NCT01843348|89813|P2|Overall Study|Withdrawal by Subject|16
18236|NCT01843348|89814|P1|Overall Study|Withdrawal by Subject|4
18237|NCT01843192|89857|P3|Overall Study|Intra-operative exclusions per protocol|2
18238|NCT01843192|89858|P2|Overall Study|Intra-operative exclusions per protocol|6
18239|NCT01843192|89859|P1|Overall Study|Intra-operative exclusions per protocol|2
18240|NCT01842633|89943|P3|Overall Study|Technical issues|0
18241|NCT01842633|89944|P2|Overall Study|Technical issues|0
18242|NCT01842633|89945|P1|Overall Study|Technical issues|1
18243|NCT01842633|89943|P3|Overall Study|Withdrawal by Subject|0
18244|NCT01842633|89944|P2|Overall Study|Withdrawal by Subject|1
18245|NCT01842633|89945|P1|Overall Study|Withdrawal by Subject|0
18246|NCT01842633|89943|P3|Overall Study|Adverse Event|0
18247|NCT01842633|89944|P2|Overall Study|Adverse Event|1
18248|NCT01842633|89945|P1|Overall Study|Adverse Event|1
18249|NCT01842633|89943|P3|Overall Study|Screen Failure|0
18250|NCT01842633|89944|P2|Overall Study|Screen Failure|0
18251|NCT01842633|89945|P1|Overall Study|Screen Failure|1
18252|NCT01842607|89992|P1|Overall Study|Withdrawal by Subject|14
18253|NCT01842607|89992|P1|Overall Study|Physician Decision|9
18254|NCT01842607|89992|P1|Overall Study|Lost to Follow-up|3
18255|NCT01842607|89992|P1|Overall Study|Protocol defined stopping criteria|2
18256|NCT01842607|89992|P1|Overall Study|Protocol Violation|8
18257|NCT01842607|89992|P1|Overall Study|Lack of Efficacy|19
18258|NCT01842607|89992|P1|Overall Study|Adverse Event|11
18259|NCT01842438|90024|P2|T2: 6month Follow-up|Death|1
18260|NCT01842438|90025|P1|T2: 6month Follow-up|Death|0
18261|NCT01842438|90024|P2|T2: 6month Follow-up|Withdrawal by Subject|3
18262|NCT01842438|90025|P1|T2: 6month Follow-up|Withdrawal by Subject|4
18263|NCT01842438|90024|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
18264|NCT01842438|90025|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
18265|NCT01841970|90037|P1|Overall Study|Lost to Follow-up|8
18266|NCT01841970|90037|P1|Overall Study|Physician Decision|2
18267|NCT01841970|90037|P1|Overall Study|Withdrawal by Subject|1
18268|NCT01841697|90055|P2|Overall Study|Withdrawal by Subject|16
18269|NCT01841697|90056|P1|Overall Study|Withdrawal by Subject|16
18270|NCT01841697|90055|P2|Overall Study|Lost to Follow-up|1
18271|NCT01841697|90056|P1|Overall Study|Lost to Follow-up|4
18272|NCT01841697|90055|P2|Overall Study|Death|1
18273|NCT01841697|90056|P1|Overall Study|Death|0
18274|NCT01841593|90082|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
18275|NCT01841593|90083|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
18276|NCT01841593|90082|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
18277|NCT01841593|90083|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
18278|NCT01841567|90099|P1|Overall Study|Adverse Event|3
18279|NCT01840943|90127|P2|Overall Study|Lost to Follow-up|4
18280|NCT01840943|90128|P1|Overall Study|Lost to Follow-up|4
18281|NCT01840943|90127|P2|Overall Study|Physician Decision|2
18282|NCT01840943|90128|P1|Overall Study|Physician Decision|4
18283|NCT01840943|90127|P2|Overall Study|Withdrawal by Subject|6
18284|NCT01840943|90128|P1|Overall Study|Withdrawal by Subject|5
18285|NCT01840605|90164|P2|Overall Study|Physician Decision|1
18286|NCT01840605|90165|P1|Overall Study|Physician Decision|2
18287|NCT01840605|90164|P2|Overall Study|Adverse Event|1
18288|NCT01840605|90165|P1|Overall Study|Adverse Event|0
18289|NCT01840410|90173|P2|Overall Study|Adverse Event|1
18290|NCT01840410|90174|P1|Overall Study|Adverse Event|1
18291|NCT01840410|90173|P2|Overall Study|Withdrawal by Subject|1
18292|NCT01840410|90174|P1|Overall Study|Withdrawal by Subject|2
18293|NCT01840410|90173|P2|Overall Study|Lost to Follow-up|0
18294|NCT01840410|90174|P1|Overall Study|Lost to Follow-up|1
18295|NCT01840410|90173|P2|Overall Study|Protocol deviation|0
18296|NCT01840410|90174|P1|Overall Study|Protocol deviation|1
18297|NCT01840410|90173|P2|Overall Study|Pregnancy|0
18298|NCT01840410|90174|P1|Overall Study|Pregnancy|1
18299|NCT01840410|90173|P2|Overall Study|Physician Decision|2
18300|NCT01840410|90174|P1|Overall Study|Physician Decision|1
18301|NCT01839279|90299|P3|Overall Study|Classified as 'Other'|0
18302|NCT01839279|90300|P2|Overall Study|Classified as 'Other'|0
18303|NCT01839279|90301|P1|Overall Study|Classified as 'Other'|5
18304|NCT01839279|90299|P3|Overall Study|Withdrawal by Subject|1
18305|NCT01839279|90300|P2|Overall Study|Withdrawal by Subject|1
18306|NCT01839279|90301|P1|Overall Study|Withdrawal by Subject|4
18307|NCT01839279|90299|P3|Overall Study|Adverse Event|1
18308|NCT01839279|90300|P2|Overall Study|Adverse Event|1
18309|NCT01839279|90301|P1|Overall Study|Adverse Event|4
18310|NCT01838941|90333|P1|Overall Study|Withdrawal by Subject|1
18311|NCT01838941|90333|P1|Overall Study|Adverse Event|1
18312|NCT01838694|90340|P2|Overall Study|Adverse Event|1
18313|NCT01838694|90341|P1|Overall Study|Adverse Event|0
18314|NCT01838681|90350|P4|Period B/A+|Administrative or other reasons|28
18315|NCT01838681|90351|P3|Period B/A+|Administrative or other reasons|10
18316|NCT01838681|90352|P2|Period B/A+|Administrative or other reasons|6
18317|NCT01838681|90353|P1|Period B/A+|Administrative or other reasons|0
18318|NCT01838681|90350|P4|Period B/A+|Withdrawal before treatment|0
18319|NCT01838681|90351|P3|Period B/A+|Withdrawal before treatment|0
18320|NCT01838681|90352|P2|Period B/A+|Withdrawal before treatment|1
18321|NCT01838681|90353|P1|Period B/A+|Withdrawal before treatment|0
18322|NCT01838681|90350|P4|Period B/A+|Lost to Follow-up|11
18323|NCT01838681|90351|P3|Period B/A+|Lost to Follow-up|5
18324|NCT01838681|90352|P2|Period B/A+|Lost to Follow-up|2
18325|NCT01838681|90353|P1|Period B/A+|Lost to Follow-up|0
18326|NCT01838681|90350|P4|Period B/A+|Non-compliance with IMP|3
18327|NCT01838681|90351|P3|Period B/A+|Non-compliance with IMP|3
18328|NCT01838681|90352|P2|Period B/A+|Non-compliance with IMP|2
18329|NCT01838681|90353|P1|Period B/A+|Non-compliance with IMP|0
18330|NCT01838681|90350|P4|Period B/A+|Protocol Violation|6
18331|NCT01838681|90351|P3|Period B/A+|Protocol Violation|4
18332|NCT01838681|90352|P2|Period B/A+|Protocol Violation|1
18333|NCT01838681|90353|P1|Period B/A+|Protocol Violation|0
18334|NCT01838681|90350|P4|Period B/A+|Withdrawal by Subject|47
18335|NCT01838681|90351|P3|Period B/A+|Withdrawal by Subject|35
18336|NCT01838681|90352|P2|Period B/A+|Withdrawal by Subject|28
18337|NCT01838681|90353|P1|Period B/A+|Withdrawal by Subject|0
18338|NCT01838681|90350|P4|Period B/A+|Lack of Efficacy|6
18339|NCT01838681|90351|P3|Period B/A+|Lack of Efficacy|11
18340|NCT01838681|90352|P2|Period B/A+|Lack of Efficacy|9
18341|NCT01838681|90353|P1|Period B/A+|Lack of Efficacy|0
18342|NCT01838681|90350|P4|Period B/A+|Adverse Event|16
18343|NCT01838681|90351|P3|Period B/A+|Adverse Event|27
18344|NCT01838681|90352|P2|Period B/A+|Adverse Event|13
18345|NCT01838681|90353|P1|Period B/A+|Adverse Event|0
18346|NCT01838681|90350|P4|Period A|Administrative or other reasons|0
18347|NCT01838681|90351|P3|Period A|Administrative or other reasons|0
18348|NCT01838681|90352|P2|Period A|Administrative or other reasons|0
18349|NCT01838681|90353|P1|Period A|Administrative or other reasons|17
18350|NCT01838681|90350|P4|Period A|Withdrawal before treatment|0
18351|NCT01838681|90351|P3|Period A|Withdrawal before treatment|0
18352|NCT01838681|90352|P2|Period A|Withdrawal before treatment|0
18353|NCT01838681|90353|P1|Period A|Withdrawal before treatment|4
18354|NCT01838681|90350|P4|Period A|Lost to Follow-up|0
18355|NCT01838681|90351|P3|Period A|Lost to Follow-up|0
18356|NCT01838681|90352|P2|Period A|Lost to Follow-up|0
18357|NCT01838681|90353|P1|Period A|Lost to Follow-up|4
18358|NCT01838681|90350|P4|Period A|Non-compliance with IMP|0
18359|NCT01838681|90351|P3|Period A|Non-compliance with IMP|0
18360|NCT01838681|90352|P2|Period A|Non-compliance with IMP|0
18361|NCT01838681|90353|P1|Period A|Non-compliance with IMP|6
18362|NCT01838681|90350|P4|Period A|Protocol Violation|0
18363|NCT01838681|90351|P3|Period A|Protocol Violation|0
18364|NCT01838681|90352|P2|Period A|Protocol Violation|0
18365|NCT01838681|90353|P1|Period A|Protocol Violation|16
18366|NCT01838681|90350|P4|Period A|Withdrawal by Subject|0
18367|NCT01838681|90351|P3|Period A|Withdrawal by Subject|0
18368|NCT01838681|90352|P2|Period A|Withdrawal by Subject|0
18369|NCT01838681|90353|P1|Period A|Withdrawal by Subject|70
18370|NCT01838681|90350|P4|Period A|Early response|0
18371|NCT01838681|90351|P3|Period A|Early response|0
18372|NCT01838681|90352|P2|Period A|Early response|0
18373|NCT01838681|90353|P1|Period A|Early response|148
18374|NCT01838681|90350|P4|Period A|Lack of Efficacy|0
18375|NCT01838681|90351|P3|Period A|Lack of Efficacy|0
18376|NCT01838681|90352|P2|Period A|Lack of Efficacy|0
18377|NCT01838681|90353|P1|Period A|Lack of Efficacy|21
18378|NCT01838681|90350|P4|Period A|Adverse Event|0
18379|NCT01838681|90351|P3|Period A|Adverse Event|0
18380|NCT01838681|90352|P2|Period A|Adverse Event|0
18381|NCT01838681|90353|P1|Period A|Adverse Event|39
18382|NCT01838642|90393|P1|Overall Study|Died on study|1
18383|NCT01838616|90406|P2|Pick-up Arm|Technical problems|0
18384|NCT01838616|90407|P1|Pick-up Arm|Technical problems|1
18385|NCT01838616|90406|P2|Pick-up Arm|Withdrawal by Subject|0
18386|NCT01838616|90407|P1|Pick-up Arm|Withdrawal by Subject|1
18387|NCT01838616|90406|P2|Pick-up Arm|Adverse Event|0
18388|NCT01838616|90407|P1|Pick-up Arm|Adverse Event|9
18389|NCT01838616|90406|P2|Pick-up Arm|Lack of Efficacy|0
18390|NCT01838616|90407|P1|Pick-up Arm|Lack of Efficacy|4
18391|NCT01838616|90406|P2|Continuation Period|Technical problems|1
18392|NCT01838616|90407|P1|Continuation Period|Technical problems|0
18393|NCT01838616|90406|P2|Continuation Period|Withdrawal by Subject|4
18394|NCT01838616|90407|P1|Continuation Period|Withdrawal by Subject|0
18395|NCT01838616|90406|P2|Continuation Period|Lost to Follow-up|0
18396|NCT01838616|90407|P1|Continuation Period|Lost to Follow-up|1
18397|NCT01838616|90406|P2|Continuation Period|Protocol Violation|0
18398|NCT01838616|90407|P1|Continuation Period|Protocol Violation|2
18399|NCT01838616|90406|P2|Continuation Period|Adverse Event|4
18400|NCT01838616|90407|P1|Continuation Period|Adverse Event|8
18401|NCT01838616|90406|P2|Continuation Period|Lack of Efficacy|5
18402|NCT01838616|90407|P1|Continuation Period|Lack of Efficacy|3
18403|NCT01838616|90406|P2|Titration Period|Protocol Violation|1
18404|NCT01838616|90407|P1|Titration Period|Protocol Violation|0
18405|NCT01838616|90406|P2|Titration Period|Not specified|0
18406|NCT01838616|90407|P1|Titration Period|Not specified|1
18407|NCT01838616|90406|P2|Titration Period|Technical problems|0
18408|NCT01838616|90407|P1|Titration Period|Technical problems|1
18409|NCT01838616|90406|P2|Titration Period|Withdrawal by Subject|5
18410|NCT01838616|90407|P1|Titration Period|Withdrawal by Subject|5
18411|NCT01838616|90406|P2|Titration Period|Lack of Efficacy|12
18412|NCT01838616|90407|P1|Titration Period|Lack of Efficacy|5
18413|NCT01838616|90406|P2|Titration Period|Adverse Event|48
18414|NCT01838616|90407|P1|Titration Period|Adverse Event|18
18415|NCT01838590|90478|P2|Overall Study|Lost to Follow-up|1
18416|NCT01838590|90479|P1|Overall Study|Lost to Follow-up|0
18417|NCT01838590|90478|P2|Overall Study|Lack of Efficacy|4
18418|NCT01838590|90479|P1|Overall Study|Lack of Efficacy|12
18419|NCT01838499|90503|P2|Overall Study|Withdrawal by Subject|9
18420|NCT01838499|90504|P1|Overall Study|Withdrawal by Subject|19
18421|NCT01838499|90503|P2|Overall Study|Adverse Event|1
18422|NCT01838499|90504|P1|Overall Study|Adverse Event|2
18423|NCT01838499|90503|P2|Overall Study|Lack of Efficacy|2
18424|NCT01838499|90504|P1|Overall Study|Lack of Efficacy|1
18425|NCT01838499|90503|P2|Overall Study|Lost to Follow-up|4
18426|NCT01838499|90504|P1|Overall Study|Lost to Follow-up|2
18427|NCT01838499|90503|P2|Overall Study|Protocol Violation|1
18428|NCT01838499|90504|P1|Overall Study|Protocol Violation|0
18429|NCT01838213|90516|P2|Overall Study|Ineligible|191
18430|NCT01838213|90517|P1|Overall Study|Ineligible|166
18431|NCT01838044|90525|P2|Overall Study|Lost to Follow-up|2
18432|NCT01838044|90526|P1|Overall Study|Lost to Follow-up|0
18433|NCT01838044|90525|P2|Overall Study|Medication error without associated AE|1
18434|NCT01838044|90526|P1|Overall Study|Medication error without associated AE|0
18435|NCT01838044|90525|P2|Overall Study|Insufficient clinical response|2
18436|NCT01838044|90526|P1|Overall Study|Insufficient clinical response|1
18437|NCT01838044|90525|P2|Overall Study|Withdrawal by Subject|2
18438|NCT01838044|90526|P1|Overall Study|Withdrawal by Subject|0
18439|NCT01838044|90525|P2|Overall Study|Protocol Violation|3
18440|NCT01838044|90526|P1|Overall Study|Protocol Violation|3
18441|NCT01838044|90525|P2|Overall Study|Adverse Event|6
18442|NCT01838044|90526|P1|Overall Study|Adverse Event|4
18443|NCT01837966|90559|P2|Overall Study|Withdrawal by Subject|1
18444|NCT01837966|90560|P1|Overall Study|Withdrawal by Subject|2
18445|NCT01837797|90569|P5|Period 3|Other|2
18446|NCT01837797|90570|P4|Period 3|Other|0
18447|NCT01837797|90571|P3|Period 3|Other|0
18448|NCT01837797|90572|P2|Period 3|Other|0
18449|NCT01837797|90573|P1|Period 3|Other|0
18450|NCT01837797|90569|P5|Period 3|Administrative reasons|20
18451|NCT01837797|90570|P4|Period 3|Administrative reasons|0
18452|NCT01837797|90571|P3|Period 3|Administrative reasons|0
18453|NCT01837797|90572|P2|Period 3|Administrative reasons|0
18454|NCT01837797|90573|P1|Period 3|Administrative reasons|0
18455|NCT01837797|90569|P5|Period 3|Adverse Event|1
18456|NCT01837797|90570|P4|Period 3|Adverse Event|0
18457|NCT01837797|90571|P3|Period 3|Adverse Event|0
18458|NCT01837797|90572|P2|Period 3|Adverse Event|0
18459|NCT01837797|90573|P1|Period 3|Adverse Event|0
18460|NCT01837797|90569|P5|Period 2|Adverse Event|0
18461|NCT01837797|90570|P4|Period 2|Adverse Event|1
18462|NCT01837797|90571|P3|Period 2|Adverse Event|0
18463|NCT01837797|90572|P2|Period 2|Adverse Event|0
18464|NCT01837797|90573|P1|Period 2|Adverse Event|0
18465|NCT01837797|90569|P5|Period 2|Administrative or other reasons|0
18466|NCT01837797|90570|P4|Period 2|Administrative or other reasons|4
18467|NCT01837797|90571|P3|Period 2|Administrative or other reasons|2
18468|NCT01837797|90572|P2|Period 2|Administrative or other reasons|5
18469|NCT01837797|90573|P1|Period 2|Administrative or other reasons|0
18470|NCT01837797|90569|P5|Period 1|Other|0
18471|NCT01837797|90570|P4|Period 1|Other|0
18472|NCT01837797|90571|P3|Period 1|Other|0
18473|NCT01837797|90572|P2|Period 1|Other|0
18474|NCT01837797|90573|P1|Period 1|Other|10
18475|NCT01837797|90569|P5|Period 1|Withdrawal of consent before treatment|0
18476|NCT01837797|90570|P4|Period 1|Withdrawal of consent before treatment|0
18477|NCT01837797|90571|P3|Period 1|Withdrawal of consent before treatment|0
18478|NCT01837797|90572|P2|Period 1|Withdrawal of consent before treatment|0
18479|NCT01837797|90573|P1|Period 1|Withdrawal of consent before treatment|1
18480|NCT01837797|90569|P5|Period 1|Administrative reasons|0
18481|NCT01837797|90570|P4|Period 1|Administrative reasons|0
18482|NCT01837797|90571|P3|Period 1|Administrative reasons|0
18483|NCT01837797|90572|P2|Period 1|Administrative reasons|0
18484|NCT01837797|90573|P1|Period 1|Administrative reasons|76
18485|NCT01837797|90569|P5|Period 1|Withdrawal by Subject|0
18486|NCT01837797|90570|P4|Period 1|Withdrawal by Subject|0
18487|NCT01837797|90571|P3|Period 1|Withdrawal by Subject|0
18488|NCT01837797|90572|P2|Period 1|Withdrawal by Subject|0
18489|NCT01837797|90573|P1|Period 1|Withdrawal by Subject|6
18490|NCT01837797|90569|P5|Period 1|Adverse Event|0
18491|NCT01837797|90570|P4|Period 1|Adverse Event|0
18492|NCT01837797|90571|P3|Period 1|Adverse Event|0
18493|NCT01837797|90572|P2|Period 1|Adverse Event|0
18494|NCT01837797|90573|P1|Period 1|Adverse Event|9
18495|NCT01837719|90608|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
18496|NCT01837719|90608|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
18497|NCT01837680|90677|P2|Overall Study|switched to oral hypoglycemic or diet|4
18498|NCT01837680|90678|P1|Overall Study|switched to oral hypoglycemic or diet|2
18499|NCT01837680|90677|P2|Overall Study|allergic reaction|0
18500|NCT01837680|90678|P1|Overall Study|allergic reaction|6
18501|NCT01837680|90677|P2|Overall Study|lack of insurance|2
18502|NCT01837680|90678|P1|Overall Study|lack of insurance|0
18503|NCT01837680|90677|P2|Overall Study|Lost to Follow-up|2
18504|NCT01837680|90678|P1|Overall Study|Lost to Follow-up|2
18505|NCT01836523|90784|P4|Overall Study|Unclassified|29
18506|NCT01836523|90785|P3|Overall Study|Unclassified|19
18507|NCT01836523|90786|P2|Overall Study|Unclassified|28
18508|NCT01836523|90787|P1|Overall Study|Unclassified|17
18509|NCT01836523|90784|P4|Overall Study|Met Withdrawal Criteria|27
18510|NCT01836523|90785|P3|Overall Study|Met Withdrawal Criteria|21
18511|NCT01836523|90786|P2|Overall Study|Met Withdrawal Criteria|13
18512|NCT01836523|90787|P1|Overall Study|Met Withdrawal Criteria|13
18513|NCT01836523|90784|P4|Overall Study|Protocol Violation|4
18514|NCT01836523|90785|P3|Overall Study|Protocol Violation|2
18515|NCT01836523|90786|P2|Overall Study|Protocol Violation|3
18516|NCT01836523|90787|P1|Overall Study|Protocol Violation|6
18517|NCT01836523|90784|P4|Overall Study|Adverse Event|14
18518|NCT01836523|90785|P3|Overall Study|Adverse Event|49
18519|NCT01836523|90786|P2|Overall Study|Adverse Event|41
18520|NCT01836523|90787|P1|Overall Study|Adverse Event|15
18521|NCT01836471|90814|P5|Overall Study|Non compliance with tx|0
18522|NCT01836471|90815|P4|Overall Study|Non compliance with tx|0
18523|NCT01836471|90816|P3|Overall Study|Non compliance with tx|0
18524|NCT01836471|90817|P2|Overall Study|Non compliance with tx|1
18525|NCT01836471|90818|P1|Overall Study|Non compliance with tx|1
18526|NCT01836471|90814|P5|Overall Study|Adverse Event|2
18527|NCT01836471|90815|P4|Overall Study|Adverse Event|1
18528|NCT01836471|90816|P3|Overall Study|Adverse Event|1
18529|NCT01836471|90817|P2|Overall Study|Adverse Event|3
18530|NCT01836471|90818|P1|Overall Study|Adverse Event|6
18531|NCT01836471|90814|P5|Overall Study|Lost to Follow-up|1
18532|NCT01836471|90815|P4|Overall Study|Lost to Follow-up|1
18533|NCT01836471|90816|P3|Overall Study|Lost to Follow-up|0
18534|NCT01836471|90817|P2|Overall Study|Lost to Follow-up|0
18535|NCT01836471|90818|P1|Overall Study|Lost to Follow-up|0
18536|NCT01836471|90814|P5|Overall Study|Physician Decision|0
18537|NCT01836471|90815|P4|Overall Study|Physician Decision|0
18538|NCT01836471|90816|P3|Overall Study|Physician Decision|0
18539|NCT01836471|90817|P2|Overall Study|Physician Decision|1
18540|NCT01836471|90818|P1|Overall Study|Physician Decision|0
18541|NCT01836471|90814|P5|Overall Study|Withdrawal by Subject|2
18542|NCT01836471|90815|P4|Overall Study|Withdrawal by Subject|0
18543|NCT01836471|90816|P3|Overall Study|Withdrawal by Subject|1
18544|NCT01836471|90817|P2|Overall Study|Withdrawal by Subject|4
18545|NCT01836471|90818|P1|Overall Study|Withdrawal by Subject|3
18546|NCT01836471|90814|P5|Overall Study|Pregnancy|0
18547|NCT01836471|90815|P4|Overall Study|Pregnancy|0
18548|NCT01836471|90816|P3|Overall Study|Pregnancy|0
18549|NCT01836471|90817|P2|Overall Study|Pregnancy|0
18550|NCT01836471|90818|P1|Overall Study|Pregnancy|1
18551|NCT01836458|90847|P4|Overall Study|Unsatisfactory therapeutic effect|6
18552|NCT01836458|90848|P3|Overall Study|Unsatisfactory therapeutic effect|5
18553|NCT01836458|90849|P2|Overall Study|Unsatisfactory therapeutic effect|2
18554|NCT01836458|90850|P1|Overall Study|Unsatisfactory therapeutic effect|3
18555|NCT01835899|90912|P3|Overall Study|Other than stated above|0
18556|NCT01835899|90913|P2|Overall Study|Other than stated above|1
18557|NCT01835899|90914|P1|Overall Study|Other than stated above|0
18558|NCT01835899|90912|P3|Overall Study|Adverse Event|1
18559|NCT01835899|90913|P2|Overall Study|Adverse Event|0
18560|NCT01835899|90914|P1|Overall Study|Adverse Event|0
18561|NCT01835470|90965|P1|Long Term Treatment Period|Lack of Efficacy|1
18562|NCT01835470|90965|P1|Long Term Treatment Period|Subject Request to Discontinue|1
18563|NCT01835431|90977|P2|Overall Study|Protocol Violation|0
18564|NCT01835431|90978|P1|Overall Study|Protocol Violation|1
18565|NCT01835431|90977|P2|Overall Study|Withdrawal by Subject|10
18566|NCT01835431|90978|P1|Overall Study|Withdrawal by Subject|6
18567|NCT01835431|90977|P2|Overall Study|other|2
18568|NCT01835431|90978|P1|Overall Study|other|0
18569|NCT01835431|90977|P2|Overall Study|Adverse Event|0
18570|NCT01835431|90978|P1|Overall Study|Adverse Event|1
18571|NCT01835132|91016|P1|Initial Phase|Insufficient Therapeutic Response|2
18572|NCT01835015|91060|P5|Overall Study|Adverse Event|0
18573|NCT01835015|91061|P4|Overall Study|Adverse Event|0
18574|NCT01835015|91062|P3|Overall Study|Adverse Event|1
18575|NCT01835015|91063|P2|Overall Study|Adverse Event|0
18576|NCT01835015|91064|P1|Overall Study|Adverse Event|0
18577|NCT01834274|91172|P2|Overall Study|Other|1
18578|NCT01834274|91173|P1|Overall Study|Other|2
18579|NCT01834274|91172|P2|Overall Study|Lost to Follow-up|1
18580|NCT01834274|91173|P1|Overall Study|Lost to Follow-up|3
18581|NCT01834274|91172|P2|Overall Study|Withdrawal by Subject|1
18582|NCT01834274|91173|P1|Overall Study|Withdrawal by Subject|1
18583|NCT01834274|91172|P2|Overall Study|Study Termination|38
18584|NCT01834274|91173|P1|Overall Study|Study Termination|41
18585|NCT01834222|91196|P1|Overall Study|Not meet inclusion/exclusion criteria|1
18586|NCT01833897|91273|P1|Overall Study|Lack of Efficacy|1
18587|NCT01833533|91300|P2|Overall Study|Not Specified|7
18588|NCT01833533|91301|P1|Overall Study|Not Specified|2
18589|NCT01833533|91300|P2|Overall Study|To Enter an Extension Study|4
18590|NCT01833533|91301|P1|Overall Study|To Enter an Extension Study|0
18591|NCT01833533|91300|P2|Overall Study|Lost to Follow-up|9
18592|NCT01833533|91301|P1|Overall Study|Lost to Follow-up|4
18593|NCT01833533|91300|P2|Overall Study|Adverse Event|1
18594|NCT01833533|91301|P1|Overall Study|Adverse Event|0
18595|NCT01833065|91403|P5|Overall Study|Others|4
18596|NCT01833065|91404|P4|Overall Study|Others|1
18597|NCT01833065|91405|P3|Overall Study|Others|1
18598|NCT01833065|91406|P2|Overall Study|Others|1
18599|NCT01833065|91407|P1|Overall Study|Others|2
18600|NCT01833065|91403|P5|Overall Study|Trial terminated by sponsor|13
18601|NCT01833065|91404|P4|Overall Study|Trial terminated by sponsor|3
18602|NCT01833065|91405|P3|Overall Study|Trial terminated by sponsor|7
18603|NCT01833065|91406|P2|Overall Study|Trial terminated by sponsor|8
18604|NCT01833065|91407|P1|Overall Study|Trial terminated by sponsor|8
18605|NCT01833065|91403|P5|Overall Study|Subject's substantial non-compliance|0
18606|NCT01833065|91404|P4|Overall Study|Subject's substantial non-compliance|0
18607|NCT01833065|91405|P3|Overall Study|Subject's substantial non-compliance|0
18608|NCT01833065|91406|P2|Overall Study|Subject's substantial non-compliance|1
18609|NCT01833065|91407|P1|Overall Study|Subject's substantial non-compliance|0
18610|NCT01833065|91403|P5|Overall Study|Withdrawal by Subject|11
18611|NCT01833065|91404|P4|Overall Study|Withdrawal by Subject|3
18612|NCT01833065|91405|P3|Overall Study|Withdrawal by Subject|4
18613|NCT01833065|91406|P2|Overall Study|Withdrawal by Subject|2
18614|NCT01833065|91407|P1|Overall Study|Withdrawal by Subject|6
18615|NCT01833065|91403|P5|Overall Study|Lost to Follow-up|3
18616|NCT01833065|91404|P4|Overall Study|Lost to Follow-up|0
18617|NCT01833065|91405|P3|Overall Study|Lost to Follow-up|0
18618|NCT01833065|91406|P2|Overall Study|Lost to Follow-up|0
18619|NCT01833065|91407|P1|Overall Study|Lost to Follow-up|1
18620|NCT01833065|91403|P5|Overall Study|Protocol Violation|2
18621|NCT01833065|91404|P4|Overall Study|Protocol Violation|0
18622|NCT01833065|91405|P3|Overall Study|Protocol Violation|0
18623|NCT01833065|91406|P2|Overall Study|Protocol Violation|0
18624|NCT01833065|91407|P1|Overall Study|Protocol Violation|1
18625|NCT01833065|91403|P5|Overall Study|Adverse Event|3
18626|NCT01833065|91404|P4|Overall Study|Adverse Event|2
18627|NCT01833065|91405|P3|Overall Study|Adverse Event|0
18628|NCT01833065|91406|P2|Overall Study|Adverse Event|1
18629|NCT01833065|91407|P1|Overall Study|Adverse Event|6
18630|NCT01832766|91438|P2|Washout|Lost to Follow-up|1
18631|NCT01832766|91439|P1|Washout|Lost to Follow-up|0
18632|NCT01832493|91505|P1|Overall Study|Unable to place LV lead|2
18633|NCT01832493|91505|P1|Overall Study|Protocol Violation|4
18634|NCT01832493|91505|P1|Overall Study|Physician Decision|2
18635|NCT01832155|91514|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
18636|NCT01832155|91515|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
18637|NCT01832155|91514|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
18638|NCT01832155|91515|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
18639|NCT01831817|91549|P4|Overall Study|Withdrawl of Consent|0
18640|NCT01831817|91550|P3|Overall Study|Withdrawl of Consent|0
18641|NCT01831817|91551|P2|Overall Study|Withdrawl of Consent|0
18642|NCT01831817|91552|P1|Overall Study|Withdrawl of Consent|3
18643|NCT01831817|91549|P4|Overall Study|Lost to Follow-up|0
18644|NCT01831817|91550|P3|Overall Study|Lost to Follow-up|0
18645|NCT01831817|91551|P2|Overall Study|Lost to Follow-up|0
18646|NCT01831817|91552|P1|Overall Study|Lost to Follow-up|1
18647|NCT01831791|91590|P1|Overall Study|Withdrawal by Subject|10
18648|NCT01831726|91616|P1|Overall Study|Subject/guardian decision|7
18649|NCT01831726|91616|P1|Overall Study|Physician Decision|1
18650|NCT01831726|91616|P1|Overall Study|Disease Progression|49
18651|NCT01831726|91616|P1|Overall Study|Death|7
18652|NCT01831726|91616|P1|Overall Study|Adverse Event|16
18653|NCT01831466|91635|P12|Overall Study|Adverse Event|2
18654|NCT01831466|91636|P11|Overall Study|Adverse Event|0
18655|NCT01831466|91637|P10|Overall Study|Adverse Event|1
18656|NCT01831466|91638|P9|Overall Study|Adverse Event|1
18657|NCT01831466|91639|P8|Overall Study|Adverse Event|1
18658|NCT01831466|91640|P7|Overall Study|Adverse Event|0
18659|NCT01831466|91641|P6|Overall Study|Adverse Event|7
18660|NCT01831466|91642|P5|Overall Study|Adverse Event|3
18661|NCT01831466|91643|P4|Overall Study|Adverse Event|6
18662|NCT01831466|91644|P3|Overall Study|Adverse Event|4
18663|NCT01831466|91645|P2|Overall Study|Adverse Event|0
18664|NCT01831466|91646|P1|Overall Study|Adverse Event|0
18665|NCT01831466|91635|P12|Overall Study|Lack of Efficacy|0
18666|NCT01831466|91636|P11|Overall Study|Lack of Efficacy|2
18667|NCT01831466|91637|P10|Overall Study|Lack of Efficacy|2
18668|NCT01831466|91638|P9|Overall Study|Lack of Efficacy|2
18669|NCT01831466|91639|P8|Overall Study|Lack of Efficacy|1
18670|NCT01831466|91640|P7|Overall Study|Lack of Efficacy|1
18671|NCT01831466|91641|P6|Overall Study|Lack of Efficacy|8
18672|NCT01831466|91642|P5|Overall Study|Lack of Efficacy|9
18673|NCT01831466|91643|P4|Overall Study|Lack of Efficacy|6
18674|NCT01831466|91644|P3|Overall Study|Lack of Efficacy|7
18675|NCT01831466|91645|P2|Overall Study|Lack of Efficacy|8
18676|NCT01831466|91646|P1|Overall Study|Lack of Efficacy|5
18677|NCT01831466|91635|P12|Overall Study|Lost to Follow-up|1
18678|NCT01831466|91636|P11|Overall Study|Lost to Follow-up|0
18679|NCT01831466|91637|P10|Overall Study|Lost to Follow-up|1
18680|NCT01831466|91638|P9|Overall Study|Lost to Follow-up|0
18681|NCT01831466|91639|P8|Overall Study|Lost to Follow-up|0
18682|NCT01831466|91640|P7|Overall Study|Lost to Follow-up|0
18683|NCT01831466|91641|P6|Overall Study|Lost to Follow-up|3
18684|NCT01831466|91642|P5|Overall Study|Lost to Follow-up|0
18685|NCT01831466|91643|P4|Overall Study|Lost to Follow-up|2
18686|NCT01831466|91644|P3|Overall Study|Lost to Follow-up|4
18687|NCT01831466|91645|P2|Overall Study|Lost to Follow-up|1
18688|NCT01831466|91646|P1|Overall Study|Lost to Follow-up|0
18689|NCT01831466|91635|P12|Overall Study|Withdrawal by Subject|1
18690|NCT01831466|91636|P11|Overall Study|Withdrawal by Subject|0
18691|NCT01831466|91637|P10|Overall Study|Withdrawal by Subject|1
18692|NCT01831466|91638|P9|Overall Study|Withdrawal by Subject|0
18693|NCT01831466|91639|P8|Overall Study|Withdrawal by Subject|0
18694|NCT01831466|91640|P7|Overall Study|Withdrawal by Subject|0
18695|NCT01831466|91641|P6|Overall Study|Withdrawal by Subject|5
18696|NCT01831466|91642|P5|Overall Study|Withdrawal by Subject|3
18697|NCT01831466|91643|P4|Overall Study|Withdrawal by Subject|3
18698|NCT01831466|91644|P3|Overall Study|Withdrawal by Subject|3
18699|NCT01831466|91645|P2|Overall Study|Withdrawal by Subject|3
18700|NCT01831466|91646|P1|Overall Study|Withdrawal by Subject|6
18701|NCT01831466|91635|P12|Overall Study|Death|0
18702|NCT01831466|91636|P11|Overall Study|Death|0
18703|NCT01831466|91637|P10|Overall Study|Death|0
18704|NCT01831466|91638|P9|Overall Study|Death|0
18705|NCT01831466|91639|P8|Overall Study|Death|0
18706|NCT01831466|91640|P7|Overall Study|Death|0
18707|NCT01831466|91641|P6|Overall Study|Death|0
18708|NCT01831466|91642|P5|Overall Study|Death|0
18709|NCT01831466|91643|P4|Overall Study|Death|0
18710|NCT01831466|91644|P3|Overall Study|Death|0
18711|NCT01831466|91645|P2|Overall Study|Death|1
18712|NCT01831466|91646|P1|Overall Study|Death|0
18713|NCT01831466|91635|P12|Overall Study|Non-compliance with study treatment|0
18714|NCT01831466|91636|P11|Overall Study|Non-compliance with study treatment|0
18715|NCT01831466|91637|P10|Overall Study|Non-compliance with study treatment|0
18716|NCT01831466|91638|P9|Overall Study|Non-compliance with study treatment|0
18717|NCT01831466|91639|P8|Overall Study|Non-compliance with study treatment|0
18718|NCT01831466|91640|P7|Overall Study|Non-compliance with study treatment|0
18719|NCT01831466|91641|P6|Overall Study|Non-compliance with study treatment|1
18720|NCT01831466|91642|P5|Overall Study|Non-compliance with study treatment|0
18721|NCT01831466|91643|P4|Overall Study|Non-compliance with study treatment|0
18722|NCT01831466|91644|P3|Overall Study|Non-compliance with study treatment|1
18723|NCT01831466|91645|P2|Overall Study|Non-compliance with study treatment|1
18724|NCT01831466|91646|P1|Overall Study|Non-compliance with study treatment|2
18725|NCT01831466|91635|P12|Overall Study|Not specified|0
18726|NCT01831466|91636|P11|Overall Study|Not specified|0
18727|NCT01831466|91637|P10|Overall Study|Not specified|0
18728|NCT01831466|91638|P9|Overall Study|Not specified|0
18729|NCT01831466|91639|P8|Overall Study|Not specified|0
18730|NCT01831466|91640|P7|Overall Study|Not specified|0
18731|NCT01831466|91641|P6|Overall Study|Not specified|1
18732|NCT01831466|91642|P5|Overall Study|Not specified|2
18733|NCT01831466|91643|P4|Overall Study|Not specified|2
18734|NCT01831466|91644|P3|Overall Study|Not specified|2
18735|NCT01831466|91645|P2|Overall Study|Not specified|3
18736|NCT01831466|91646|P1|Overall Study|Not specified|2
18737|NCT01831466|91635|P12|Overall Study|Protocol Violation|0
18738|NCT01831466|91636|P11|Overall Study|Protocol Violation|0
18739|NCT01831466|91637|P10|Overall Study|Protocol Violation|0
18740|NCT01831466|91638|P9|Overall Study|Protocol Violation|0
18741|NCT01831466|91639|P8|Overall Study|Protocol Violation|0
18742|NCT01831466|91640|P7|Overall Study|Protocol Violation|0
18743|NCT01831466|91641|P6|Overall Study|Protocol Violation|1
18744|NCT01831466|91642|P5|Overall Study|Protocol Violation|0
18745|NCT01831466|91643|P4|Overall Study|Protocol Violation|0
18746|NCT01831466|91644|P3|Overall Study|Protocol Violation|2
18747|NCT01831466|91645|P2|Overall Study|Protocol Violation|1
18748|NCT01831466|91646|P1|Overall Study|Protocol Violation|1
18749|NCT01831258|91768|P2|Overall Study|Lost to Follow-up|2
18750|NCT01831258|91769|P1|Overall Study|Lost to Follow-up|3
18751|NCT01831258|91768|P2|Overall Study|Withdrawal by Subject|1
18752|NCT01831258|91769|P1|Overall Study|Withdrawal by Subject|2
18753|NCT01830920|91864|P5|Overall Study|Not specified|3
18754|NCT01830920|91865|P4|Overall Study|Not specified|5
18755|NCT01830920|91866|P3|Overall Study|Not specified|1
18756|NCT01830920|91867|P2|Overall Study|Not specified|1
18757|NCT01830920|91868|P1|Overall Study|Not specified|15
18758|NCT01830920|91864|P5|Overall Study|Death|4
18759|NCT01830920|91865|P4|Overall Study|Death|4
18760|NCT01830920|91866|P3|Overall Study|Death|5
18761|NCT01830920|91867|P2|Overall Study|Death|3
18762|NCT01830920|91868|P1|Overall Study|Death|3
18763|NCT01830920|91864|P5|Overall Study|Withdrawal by Subject|1
18764|NCT01830920|91865|P4|Overall Study|Withdrawal by Subject|7
18765|NCT01830920|91866|P3|Overall Study|Withdrawal by Subject|1
18766|NCT01830920|91867|P2|Overall Study|Withdrawal by Subject|2
18767|NCT01830920|91868|P1|Overall Study|Withdrawal by Subject|2
18768|NCT01830920|91864|P5|Overall Study|Adverse Event|0
18769|NCT01830920|91865|P4|Overall Study|Adverse Event|0
18770|NCT01830920|91866|P3|Overall Study|Adverse Event|1
18771|NCT01830920|91867|P2|Overall Study|Adverse Event|0
18772|NCT01830920|91868|P1|Overall Study|Adverse Event|1
18773|NCT01830881|91907|P2|Overall Study|Changed decision to have an abortion|1
18774|NCT01830881|91908|P1|Overall Study|Changed decision to have an abortion|0
18775|NCT01830855|91952|P4|Overall Study|Lost to Follow-up|33
18776|NCT01830855|91953|P3|Overall Study|Lost to Follow-up|23
18777|NCT01830855|91954|P2|Overall Study|Lost to Follow-up|20
18778|NCT01830855|91955|P1|Overall Study|Lost to Follow-up|47
18779|NCT01830855|91952|P4|Overall Study|No longer willing to participate|17
18780|NCT01830855|91953|P3|Overall Study|No longer willing to participate|12
18781|NCT01830855|91954|P2|Overall Study|No longer willing to participate|13
18782|NCT01830855|91955|P1|Overall Study|No longer willing to participate|32
18783|NCT01830855|91952|P4|Overall Study|Withdrawal by Subject|12
18784|NCT01830855|91953|P3|Overall Study|Withdrawal by Subject|10
18785|NCT01830855|91954|P2|Overall Study|Withdrawal by Subject|14
18786|NCT01830855|91955|P1|Overall Study|Withdrawal by Subject|33
18787|NCT01830855|91952|P4|Overall Study|Protocol deviation|6
18788|NCT01830855|91953|P3|Overall Study|Protocol deviation|6
18789|NCT01830855|91954|P2|Overall Study|Protocol deviation|5
18790|NCT01830855|91955|P1|Overall Study|Protocol deviation|10
18791|NCT01830855|91952|P4|Overall Study|Adverse Event|3
18792|NCT01830855|91953|P3|Overall Study|Adverse Event|6
18793|NCT01830855|91954|P2|Overall Study|Adverse Event|5
18794|NCT01830855|91955|P1|Overall Study|Adverse Event|11
18795|NCT01830855|91952|P4|Overall Study|No longer meets eligibility criteria|5
18796|NCT01830855|91953|P3|Overall Study|No longer meets eligibility criteria|3
18885|NCT01828112|92416|P2|Overall Study|Progressive disease|82
18797|NCT01830855|91954|P2|Overall Study|No longer meets eligibility criteria|2
18798|NCT01830855|91955|P1|Overall Study|No longer meets eligibility criteria|11
18799|NCT01830855|91952|P4|Overall Study|Pregnancy|1
18800|NCT01830855|91953|P3|Overall Study|Pregnancy|2
18801|NCT01830855|91954|P2|Overall Study|Pregnancy|1
18802|NCT01830855|91955|P1|Overall Study|Pregnancy|3
18803|NCT01830855|91952|P4|Overall Study|Medication error without associated AE|1
18804|NCT01830855|91953|P3|Overall Study|Medication error without associated AE|0
18805|NCT01830855|91954|P2|Overall Study|Medication error without associated AE|0
18806|NCT01830855|91955|P1|Overall Study|Medication error without associated AE|1
18807|NCT01830855|91952|P4|Overall Study|Unspecified|4
18808|NCT01830855|91953|P3|Overall Study|Unspecified|4
18809|NCT01830855|91954|P2|Overall Study|Unspecified|1
18810|NCT01830855|91955|P1|Overall Study|Unspecified|7
18811|NCT01830543|92086|P3|Overall Study|Unspecified|37
18812|NCT01830543|92087|P2|Overall Study|Unspecified|17
18813|NCT01830543|92088|P1|Overall Study|Unspecified|12
18814|NCT01830543|92086|P3|Overall Study|Withdrawal by consent|3
18815|NCT01830543|92087|P2|Overall Study|Withdrawal by consent|3
18816|NCT01830543|92088|P1|Overall Study|Withdrawal by consent|3
18817|NCT01830543|92086|P3|Overall Study|Physician Decision|12
18818|NCT01830543|92087|P2|Overall Study|Physician Decision|5
18819|NCT01830543|92088|P1|Overall Study|Physician Decision|11
18820|NCT01830543|92086|P3|Overall Study|Protocol Violation|7
18821|NCT01830543|92087|P2|Overall Study|Protocol Violation|7
18822|NCT01830543|92088|P1|Overall Study|Protocol Violation|3
18823|NCT01830543|92086|P3|Overall Study|Death|22
18824|NCT01830543|92087|P2|Overall Study|Death|22
18825|NCT01830543|92088|P1|Overall Study|Death|20
18826|NCT01830543|92086|P3|Overall Study|Adverse Event|76
18827|NCT01830543|92087|P2|Overall Study|Adverse Event|77
18828|NCT01830543|92088|P1|Overall Study|Adverse Event|91
18829|NCT01830543|92086|P3|Overall Study|Subject Decision|57
18830|NCT01830543|92087|P2|Overall Study|Subject Decision|21
18831|NCT01830543|92088|P1|Overall Study|Subject Decision|19
18832|NCT01830127|92220|P2|Overall Study|Other reason not defined above|2
18833|NCT01830127|92221|P1|Overall Study|Other reason not defined above|0
18834|NCT01830127|92220|P2|Overall Study|Withdrawal by Subject|1
18835|NCT01830127|92221|P1|Overall Study|Withdrawal by Subject|1
18836|NCT01830127|92220|P2|Overall Study|Lack of Efficacy|0
18837|NCT01830127|92221|P1|Overall Study|Lack of Efficacy|3
18838|NCT01830127|92220|P2|Overall Study|Adverse Event|6
18839|NCT01830127|92221|P1|Overall Study|Adverse Event|1
18840|NCT01829477|92256|P2|Overall Study|Withdrawal by Subject|0
18841|NCT01829477|92257|P1|Overall Study|Withdrawal by Subject|1
18842|NCT01829477|92256|P2|Overall Study|Study Terminated by Sponsor|15
18843|NCT01829477|92257|P1|Overall Study|Study Terminated by Sponsor|15
18844|NCT01829464|92270|P3|Overall Study|Lack of Efficacy|0
18845|NCT01829464|92271|P2|Overall Study|Lack of Efficacy|1
18846|NCT01829464|92272|P1|Overall Study|Lack of Efficacy|0
18847|NCT01829464|92270|P3|Overall Study|Study terminated by sponsor|25
18848|NCT01829464|92271|P2|Overall Study|Study terminated by sponsor|28
18849|NCT01829464|92272|P1|Overall Study|Study terminated by sponsor|25
18850|NCT01829464|92270|P3|Overall Study|Withdrawal by Subject|0
18851|NCT01829464|92271|P2|Overall Study|Withdrawal by Subject|0
18852|NCT01829464|92272|P1|Overall Study|Withdrawal by Subject|2
18853|NCT01829464|92270|P3|Overall Study|Lost to Follow-up|1
18854|NCT01829464|92271|P2|Overall Study|Lost to Follow-up|0
18855|NCT01829464|92272|P1|Overall Study|Lost to Follow-up|0
18856|NCT01829464|92270|P3|Overall Study|Adverse Event|0
18857|NCT01829464|92271|P2|Overall Study|Adverse Event|0
18858|NCT01829464|92272|P1|Overall Study|Adverse Event|1
18859|NCT01829243|92297|P2|First Intervention|Screen Failure|2
18860|NCT01829243|92298|P1|First Intervention|Screen Failure|4
18861|NCT01829230|92312|P2|Overall Study|Lost to Follow-up|1
18862|NCT01829230|92313|P1|Overall Study|Lost to Follow-up|1
18863|NCT01829230|92312|P2|Overall Study|Withdrawal by Subject|1
18864|NCT01829230|92313|P1|Overall Study|Withdrawal by Subject|0
18865|NCT01829230|92312|P2|Overall Study|Protocol Violation|2
18866|NCT01829230|92313|P1|Overall Study|Protocol Violation|0
18867|NCT01829191|92323|P2|Overall Study|Subject was fit for ortho - k|1
18868|NCT01829191|92324|P1|Overall Study|Subject was fit for ortho - k|0
18869|NCT01829191|92323|P2|Overall Study|Lost to Follow-up|1
18870|NCT01829191|92324|P1|Overall Study|Lost to Follow-up|0
18871|NCT01829191|92323|P2|Overall Study|Withdrawal by Subject|3
18872|NCT01829191|92324|P1|Overall Study|Withdrawal by Subject|2
18873|NCT01829191|92323|P2|Overall Study|Protocol Violation|1
18874|NCT01829191|92324|P1|Overall Study|Protocol Violation|4
18875|NCT01829191|92323|P2|Overall Study|Lens handling difficulty|4
18876|NCT01829191|92324|P1|Overall Study|Lens handling difficulty|1
18877|NCT01829191|92323|P2|Overall Study|Lens discomfort|3
18878|NCT01829191|92324|P1|Overall Study|Lens discomfort|0
18879|NCT01829191|92323|P2|Overall Study|Relocation|1
18880|NCT01829191|92324|P1|Overall Study|Relocation|0
18881|NCT01828281|92382|P2|Overall Study|Withdrawal by Subject|0
18882|NCT01828281|92383|P1|Overall Study|Withdrawal by Subject|1
18883|NCT01828112|92416|P2|Overall Study|Subject/guardian decision|8
18884|NCT01828112|92417|P1|Overall Study|Subject/guardian decision|6
18886|NCT01828112|92417|P1|Overall Study|Progressive disease|56
18887|NCT01828112|92416|P2|Overall Study|Physician Decision|5
18888|NCT01828112|92417|P1|Overall Study|Physician Decision|5
18889|NCT01828112|92416|P2|Overall Study|Death|5
18890|NCT01828112|92417|P1|Overall Study|Death|9
18891|NCT01828112|92416|P2|Overall Study|Adverse Event|8
18892|NCT01828112|92417|P1|Overall Study|Adverse Event|6
18893|NCT01827839|92423|P1|Overall Study|Consent Withdrawal|2
18894|NCT01827839|92423|P1|Overall Study|Adverse Event|1
18895|NCT01827670|92447|P2|Overall Study|Lost to Follow-up|1
18896|NCT01827670|92448|P1|Overall Study|Lost to Follow-up|0
18897|NCT01827670|92447|P2|Overall Study|Withdrawal of Consent|2
18898|NCT01827670|92448|P1|Overall Study|Withdrawal of Consent|3
18899|NCT01827592|92467|P3|Overall Study|Others|3
18900|NCT01827592|92468|P2|Overall Study|Others|1
18901|NCT01827592|92469|P1|Overall Study|Others|0
18902|NCT01827592|92467|P3|Overall Study|Trial terminated by Sponsor|51
18903|NCT01827592|92468|P2|Overall Study|Trial terminated by Sponsor|53
18904|NCT01827592|92469|P1|Overall Study|Trial terminated by Sponsor|47
18905|NCT01827592|92467|P3|Overall Study|Patient's substantial non-compliance|6
18906|NCT01827592|92468|P2|Overall Study|Patient's substantial non-compliance|1
18907|NCT01827592|92469|P1|Overall Study|Patient's substantial non-compliance|1
18908|NCT01827592|92467|P3|Overall Study|Withdrawal by Subject|11
18909|NCT01827592|92468|P2|Overall Study|Withdrawal by Subject|11
18910|NCT01827592|92469|P1|Overall Study|Withdrawal by Subject|12
18911|NCT01827592|92467|P3|Overall Study|Lost to Follow-up|2
18912|NCT01827592|92468|P2|Overall Study|Lost to Follow-up|2
18913|NCT01827592|92469|P1|Overall Study|Lost to Follow-up|1
18914|NCT01827592|92467|P3|Overall Study|Protocol Violation|0
18915|NCT01827592|92468|P2|Overall Study|Protocol Violation|1
18916|NCT01827592|92469|P1|Overall Study|Protocol Violation|2
18917|NCT01827592|92467|P3|Overall Study|Physician Decision|1
18918|NCT01827592|92468|P2|Overall Study|Physician Decision|2
18919|NCT01827592|92469|P1|Overall Study|Physician Decision|0
18920|NCT01827592|92467|P3|Overall Study|Adverse Event|2
18921|NCT01827592|92468|P2|Overall Study|Adverse Event|9
18922|NCT01827592|92469|P1|Overall Study|Adverse Event|11
18923|NCT01827371|92534|P4|Overall Study|Temporary study halt to vaccinations|13
18924|NCT01827371|92535|P3|Overall Study|Temporary study halt to vaccinations|5
18925|NCT01827371|92536|P2|Overall Study|Temporary study halt to vaccinations|2
18926|NCT01827371|92537|P1|Overall Study|Temporary study halt to vaccinations|11
18927|NCT01827371|92534|P4|Overall Study|Physician Decision|1
18928|NCT01827371|92535|P3|Overall Study|Physician Decision|0
18929|NCT01827371|92536|P2|Overall Study|Physician Decision|1
18930|NCT01827371|92537|P1|Overall Study|Physician Decision|0
18931|NCT01827371|92534|P4|Overall Study|Withdrawal by Subject|3
18932|NCT01827371|92535|P3|Overall Study|Withdrawal by Subject|2
18933|NCT01827371|92536|P2|Overall Study|Withdrawal by Subject|2
18934|NCT01827371|92537|P1|Overall Study|Withdrawal by Subject|1
18935|NCT01827371|92534|P4|Overall Study|Protocol Violation|0
18936|NCT01827371|92535|P3|Overall Study|Protocol Violation|0
18937|NCT01827371|92536|P2|Overall Study|Protocol Violation|0
18938|NCT01827371|92537|P1|Overall Study|Protocol Violation|1
18939|NCT01827371|92534|P4|Overall Study|Lost to Follow-up|4
18940|NCT01827371|92535|P3|Overall Study|Lost to Follow-up|0
18941|NCT01827371|92536|P2|Overall Study|Lost to Follow-up|2
18942|NCT01827371|92537|P1|Overall Study|Lost to Follow-up|0
18943|NCT01827371|92534|P4|Overall Study|Adverse Event|2
18944|NCT01827371|92535|P3|Overall Study|Adverse Event|4
18945|NCT01827371|92536|P2|Overall Study|Adverse Event|0
18946|NCT01827371|92537|P1|Overall Study|Adverse Event|0
18947|NCT01827332|92596|P2|Overall Study|Lost to Follow-up|1
18948|NCT01827332|92597|P1|Overall Study|Lost to Follow-up|2
18949|NCT01827319|92605|P1|Overall Study|Lost to Follow-up|3
18950|NCT01827254|92626|P1|Overall Study|Intolerance to treatment|4
18951|NCT01827254|92626|P1|Overall Study|Disease progression|36
18952|NCT01827254|92626|P1|Overall Study|Did not complete re-challenge|1
18953|NCT01827254|92626|P1|Overall Study|Discontinued prior initiation: sunitinib|1
18954|NCT01827254|92626|P1|Overall Study|Invalidated centre|3
18955|NCT01827254|92626|P1|Overall Study|Case report form not completed|4
18956|NCT01827254|92626|P1|Overall Study|Death|10
18957|NCT01826981|92651|P15|Overall Study|Enrolled/Randomized but Not Treated|0
18958|NCT01826981|92652|P14|Overall Study|Enrolled/Randomized but Not Treated|0
18959|NCT01826981|92653|P13|Overall Study|Enrolled/Randomized but Not Treated|0
18960|NCT01826981|92654|P12|Overall Study|Enrolled/Randomized but Not Treated|0
18961|NCT01826981|92655|P11|Overall Study|Enrolled/Randomized but Not Treated|0
18962|NCT01826981|92656|P10|Overall Study|Enrolled/Randomized but Not Treated|0
18963|NCT01826981|92657|P9|Overall Study|Enrolled/Randomized but Not Treated|0
18964|NCT01826981|92658|P8|Overall Study|Enrolled/Randomized but Not Treated|1
18965|NCT01826981|92659|P7|Overall Study|Enrolled/Randomized but Not Treated|0
18966|NCT01826981|92660|P6|Overall Study|Enrolled/Randomized but Not Treated|0
18967|NCT01826981|92661|P5|Overall Study|Enrolled/Randomized but Not Treated|0
18968|NCT01826981|92662|P4|Overall Study|Enrolled/Randomized but Not Treated|0
18969|NCT01826981|92663|P3|Overall Study|Enrolled/Randomized but Not Treated|0
18970|NCT01826981|92664|P2|Overall Study|Enrolled/Randomized but Not Treated|0
18971|NCT01826981|92665|P1|Overall Study|Enrolled/Randomized but Not Treated|0
18972|NCT01826981|92651|P15|Overall Study|Upper G-I Haemorrhage|0
18973|NCT01826981|92652|P14|Overall Study|Upper G-I Haemorrhage|1
18974|NCT01826981|92653|P13|Overall Study|Upper G-I Haemorrhage|0
18975|NCT01826981|92654|P12|Overall Study|Upper G-I Haemorrhage|0
18976|NCT01826981|92655|P11|Overall Study|Upper G-I Haemorrhage|0
18977|NCT01826981|92656|P10|Overall Study|Upper G-I Haemorrhage|0
18978|NCT01826981|92657|P9|Overall Study|Upper G-I Haemorrhage|0
18979|NCT01826981|92658|P8|Overall Study|Upper G-I Haemorrhage|0
18980|NCT01826981|92659|P7|Overall Study|Upper G-I Haemorrhage|0
18981|NCT01826981|92660|P6|Overall Study|Upper G-I Haemorrhage|0
18982|NCT01826981|92661|P5|Overall Study|Upper G-I Haemorrhage|0
18983|NCT01826981|92662|P4|Overall Study|Upper G-I Haemorrhage|0
18984|NCT01826981|92663|P3|Overall Study|Upper G-I Haemorrhage|0
18985|NCT01826981|92664|P2|Overall Study|Upper G-I Haemorrhage|0
18986|NCT01826981|92665|P1|Overall Study|Upper G-I Haemorrhage|0
18987|NCT01826981|92651|P15|Overall Study|Adverse Event|0
18988|NCT01826981|92652|P14|Overall Study|Adverse Event|0
18989|NCT01826981|92653|P13|Overall Study|Adverse Event|0
18990|NCT01826981|92654|P12|Overall Study|Adverse Event|0
18991|NCT01826981|92655|P11|Overall Study|Adverse Event|0
18992|NCT01826981|92656|P10|Overall Study|Adverse Event|0
18993|NCT01826981|92657|P9|Overall Study|Adverse Event|0
18994|NCT01826981|92658|P8|Overall Study|Adverse Event|0
18995|NCT01826981|92659|P7|Overall Study|Adverse Event|0
18996|NCT01826981|92660|P6|Overall Study|Adverse Event|0
18997|NCT01826981|92661|P5|Overall Study|Adverse Event|1
18998|NCT01826981|92662|P4|Overall Study|Adverse Event|0
18999|NCT01826981|92663|P3|Overall Study|Adverse Event|0
19000|NCT01826981|92664|P2|Overall Study|Adverse Event|0
19001|NCT01826981|92665|P1|Overall Study|Adverse Event|0
19002|NCT01826981|92651|P15|Overall Study|Withdrew Consent|0
19003|NCT01826981|92652|P14|Overall Study|Withdrew Consent|1
19004|NCT01826981|92653|P13|Overall Study|Withdrew Consent|0
19005|NCT01826981|92654|P12|Overall Study|Withdrew Consent|1
19006|NCT01826981|92655|P11|Overall Study|Withdrew Consent|0
19007|NCT01826981|92656|P10|Overall Study|Withdrew Consent|0
19008|NCT01826981|92657|P9|Overall Study|Withdrew Consent|0
19009|NCT01826981|92658|P8|Overall Study|Withdrew Consent|1
19010|NCT01826981|92659|P7|Overall Study|Withdrew Consent|1
19011|NCT01826981|92660|P6|Overall Study|Withdrew Consent|0
19012|NCT01826981|92661|P5|Overall Study|Withdrew Consent|0
19013|NCT01826981|92662|P4|Overall Study|Withdrew Consent|0
19014|NCT01826981|92663|P3|Overall Study|Withdrew Consent|0
19015|NCT01826981|92664|P2|Overall Study|Withdrew Consent|0
19016|NCT01826981|92665|P1|Overall Study|Withdrew Consent|0
19017|NCT01826981|92651|P15|Overall Study|Lost to Follow-up|0
19018|NCT01826981|92652|P14|Overall Study|Lost to Follow-up|0
19019|NCT01826981|92653|P13|Overall Study|Lost to Follow-up|1
19020|NCT01826981|92654|P12|Overall Study|Lost to Follow-up|1
19021|NCT01826981|92655|P11|Overall Study|Lost to Follow-up|1
19022|NCT01826981|92656|P10|Overall Study|Lost to Follow-up|1
19023|NCT01826981|92657|P9|Overall Study|Lost to Follow-up|0
19024|NCT01826981|92658|P8|Overall Study|Lost to Follow-up|1
19025|NCT01826981|92659|P7|Overall Study|Lost to Follow-up|0
19026|NCT01826981|92660|P6|Overall Study|Lost to Follow-up|1
19027|NCT01826981|92661|P5|Overall Study|Lost to Follow-up|1
19028|NCT01826981|92662|P4|Overall Study|Lost to Follow-up|0
19029|NCT01826981|92663|P3|Overall Study|Lost to Follow-up|0
19030|NCT01826981|92664|P2|Overall Study|Lost to Follow-up|0
19031|NCT01826981|92665|P1|Overall Study|Lost to Follow-up|0
19032|NCT01826981|92651|P15|Overall Study|Lack of Efficacy|0
19033|NCT01826981|92652|P14|Overall Study|Lack of Efficacy|3
19034|NCT01826981|92653|P13|Overall Study|Lack of Efficacy|0
19035|NCT01826981|92654|P12|Overall Study|Lack of Efficacy|0
19036|NCT01826981|92655|P11|Overall Study|Lack of Efficacy|1
19037|NCT01826981|92656|P10|Overall Study|Lack of Efficacy|0
19038|NCT01826981|92657|P9|Overall Study|Lack of Efficacy|7
19039|NCT01826981|92658|P8|Overall Study|Lack of Efficacy|8
19040|NCT01826981|92659|P7|Overall Study|Lack of Efficacy|0
19041|NCT01826981|92660|P6|Overall Study|Lack of Efficacy|0
19042|NCT01826981|92661|P5|Overall Study|Lack of Efficacy|5
19043|NCT01826981|92662|P4|Overall Study|Lack of Efficacy|0
19044|NCT01826981|92663|P3|Overall Study|Lack of Efficacy|0
19045|NCT01826981|92664|P2|Overall Study|Lack of Efficacy|1
19046|NCT01826981|92665|P1|Overall Study|Lack of Efficacy|0
19047|NCT01826604|92828|P2|Overall Study|Lost to Follow-up|9
19048|NCT01826604|92829|P1|Overall Study|Lost to Follow-up|8
19049|NCT01826370|92871|P1|Overall Study|Other reason not defined above|2
19050|NCT01826370|92871|P1|Overall Study|Lost to Follow-up|12
19051|NCT01826370|92871|P1|Overall Study|Protocol Violation|6
19052|NCT01826214|92879|P2|Overall Study|Subject/guardian decision|3
19053|NCT01826214|92880|P1|Overall Study|Subject/guardian decision|2
19054|NCT01826214|92879|P2|Overall Study|Study terminated by Sponsor|1
19055|NCT01826214|92880|P1|Overall Study|Study terminated by Sponsor|0
19056|NCT01826214|92879|P2|Overall Study|Progressive disease|21
19057|NCT01826214|92880|P1|Overall Study|Progressive disease|22
19058|NCT01826214|92879|P2|Overall Study|Physician Decision|2
19059|NCT01826214|92880|P1|Overall Study|Physician Decision|0
19060|NCT01826214|92879|P2|Overall Study|Lost to Follow-up|0
19061|NCT01826214|92880|P1|Overall Study|Lost to Follow-up|1
19062|NCT01826214|92879|P2|Overall Study|Death|1
19063|NCT01826214|92880|P1|Overall Study|Death|3
19064|NCT01826214|92879|P2|Overall Study|Adverse Event|6
19065|NCT01826214|92880|P1|Overall Study|Adverse Event|7
19066|NCT01826201|92898|P1|Overall Study|Non compliance with protocol|4
19067|NCT01825837|92908|P4|PART II|reason unspecified|0
19068|NCT01825837|92909|P3|PART II|reason unspecified|2
19069|NCT01825837|92910|P2|PART II|reason unspecified|2
19070|NCT01825837|92911|P1|PART II|reason unspecified|2
19071|NCT01825837|92908|P4|PART II|Treatment failure|0
19072|NCT01825837|92909|P3|PART II|Treatment failure|5
19073|NCT01825837|92910|P2|PART II|Treatment failure|4
19074|NCT01825837|92911|P1|PART II|Treatment failure|6
19075|NCT01825837|92908|P4|PART II|Adverse Event|0
19076|NCT01825837|92909|P3|PART II|Adverse Event|1
19077|NCT01825837|92910|P2|PART II|Adverse Event|3
19078|NCT01825837|92911|P1|PART II|Adverse Event|3
19079|NCT01825837|92908|P4|PART II|Patient non-compliance|0
19080|NCT01825837|92909|P3|PART II|Patient non-compliance|4
19081|NCT01825837|92910|P2|PART II|Patient non-compliance|2
19082|NCT01825837|92911|P1|PART II|Patient non-compliance|5
19083|NCT01825837|92908|P4|PART II|Withdrawal by Subject|0
19084|NCT01825837|92909|P3|PART II|Withdrawal by Subject|7
19085|NCT01825837|92910|P2|PART II|Withdrawal by Subject|3
19086|NCT01825837|92911|P1|PART II|Withdrawal by Subject|3
19087|NCT01825837|92908|P4|PART I|reason unspecified|3
19088|NCT01825837|92909|P3|PART I|reason unspecified|0
19089|NCT01825837|92910|P2|PART I|reason unspecified|0
19090|NCT01825837|92911|P1|PART I|reason unspecified|0
19091|NCT01825837|92908|P4|PART I|Treatment failure|7
19092|NCT01825837|92909|P3|PART I|Treatment failure|0
19093|NCT01825837|92910|P2|PART I|Treatment failure|0
19094|NCT01825837|92911|P1|PART I|Treatment failure|0
19095|NCT01825837|92908|P4|PART I|Patient non-compliance|1
19096|NCT01825837|92909|P3|PART I|Patient non-compliance|0
19097|NCT01825837|92910|P2|PART I|Patient non-compliance|0
19098|NCT01825837|92911|P1|PART I|Patient non-compliance|0
19099|NCT01825837|92908|P4|PART I|Withdrawal by Subject|6
19100|NCT01825837|92909|P3|PART I|Withdrawal by Subject|0
19101|NCT01825837|92910|P2|PART I|Withdrawal by Subject|0
19102|NCT01825837|92911|P1|PART I|Withdrawal by Subject|0
19103|NCT01825577|92919|P1|Overall Study|Lack of Efficacy|3
19104|NCT01825577|92919|P1|Overall Study|Withdrawn by family members|2
19105|NCT01825577|92919|P1|Overall Study|Withdrawal by Subject|1
19106|NCT01825577|92919|P1|Overall Study|Physician Decision|2
19107|NCT01825200|92943|P2|Overall Study|Withdrawal by Subject|1
19108|NCT01825200|92944|P1|Overall Study|Withdrawal by Subject|0
19109|NCT01825200|92943|P2|Overall Study|Lost to Follow-up|6
19110|NCT01825200|92944|P1|Overall Study|Lost to Follow-up|5
19111|NCT01824823|92974|P2|Overall Study|Off-treatment reason not submitted|0
19112|NCT01824823|92975|P1|Overall Study|Off-treatment reason not submitted|1
19113|NCT01824823|92974|P2|Overall Study|Lack of Efficacy|1
19114|NCT01824823|92975|P1|Overall Study|Lack of Efficacy|1
19115|NCT01823679|92981|P1|Overall Study|Death|1
19116|NCT01824602|93032|P4|Overall Study|Treatment failure|1
19117|NCT01824602|93033|P3|Overall Study|Treatment failure|0
19118|NCT01824602|93034|P2|Overall Study|Treatment failure|0
19119|NCT01824602|93035|P1|Overall Study|Treatment failure|0
19120|NCT01824602|93032|P4|Overall Study|Adverse Event|2
19121|NCT01824602|93033|P3|Overall Study|Adverse Event|2
19122|NCT01824602|93034|P2|Overall Study|Adverse Event|0
19123|NCT01824602|93035|P1|Overall Study|Adverse Event|1
19124|NCT01824602|93032|P4|Overall Study|Patient non-compliance|0
19125|NCT01824602|93033|P3|Overall Study|Patient non-compliance|1
19126|NCT01824602|93034|P2|Overall Study|Patient non-compliance|0
19127|NCT01824602|93035|P1|Overall Study|Patient non-compliance|0
19128|NCT01824602|93032|P4|Overall Study|Withdrawal by Subject|2
19129|NCT01824602|93033|P3|Overall Study|Withdrawal by Subject|1
19130|NCT01824602|93034|P2|Overall Study|Withdrawal by Subject|0
19131|NCT01824602|93035|P1|Overall Study|Withdrawal by Subject|0
19132|NCT01824498|93080|P6|Washout (8 Weeks)|Withdrawal by Subject|0
19133|NCT01824498|93081|P5|Washout (8 Weeks)|Withdrawal by Subject|1
19134|NCT01824498|93082|P4|Washout (8 Weeks)|Withdrawal by Subject|1
19135|NCT01824498|93083|P3|Washout (8 Weeks)|Withdrawal by Subject|2
19136|NCT01824498|93084|P2|Washout (8 Weeks)|Withdrawal by Subject|0
19137|NCT01824498|93085|P1|Washout (8 Weeks)|Withdrawal by Subject|2
19138|NCT01824355|93116|P1|Overall Study|unevaluable reference method results per|1
19139|NCT01824355|93116|P1|Overall Study|Adverse Event|2
19140|NCT01824342|93127|P2|Overall Study|Death|0
19141|NCT01824342|93128|P1|Overall Study|Death|2
19142|NCT01824342|93127|P2|Overall Study|Physician Decision|0
19143|NCT01824342|93128|P1|Overall Study|Physician Decision|5
19144|NCT01824342|93127|P2|Overall Study|Disease Progression|1
19145|NCT01824342|93128|P1|Overall Study|Disease Progression|1
19146|NCT01824342|93127|P2|Overall Study|Adverse Event|1
19147|NCT01824342|93128|P1|Overall Study|Adverse Event|1
19148|NCT01824342|93127|P2|Overall Study|Withdrawal by Subject|3
19149|NCT01824342|93128|P1|Overall Study|Withdrawal by Subject|0
19150|NCT01824303|93142|P2|Randomized Study|Other Miscellaneous Reasons|0
19151|NCT01824303|93143|P1|Randomized Study|Other Miscellaneous Reasons|1
19152|NCT01824303|93142|P2|Randomized Study|Withdrawal by Subject|1
19153|NCT01824303|93143|P1|Randomized Study|Withdrawal by Subject|1
19154|NCT01823536|93177|P6|Overall Study|Subject moved out of the state|0
19155|NCT01823536|93178|P5|Overall Study|Subject moved out of the state|1
19156|NCT01823536|93179|P4|Overall Study|Subject moved out of the state|0
19157|NCT01823536|93180|P3|Overall Study|Subject moved out of the state|0
19158|NCT01823536|93181|P2|Overall Study|Subject moved out of the state|0
19159|NCT01823536|93182|P1|Overall Study|Subject moved out of the state|0
19160|NCT01823536|93177|P6|Overall Study|Met exclusion criterion No 6|0
19161|NCT01823536|93178|P5|Overall Study|Met exclusion criterion No 6|0
19162|NCT01823536|93179|P4|Overall Study|Met exclusion criterion No 6|1
19163|NCT01823536|93180|P3|Overall Study|Met exclusion criterion No 6|0
19164|NCT01823536|93181|P2|Overall Study|Met exclusion criterion No 6|0
19165|NCT01823536|93182|P1|Overall Study|Met exclusion criterion No 6|0
19166|NCT01823536|93177|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
19167|NCT01823536|93178|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
19168|NCT01823536|93179|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
19169|NCT01823536|93180|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
19170|NCT01823536|93181|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
19171|NCT01823536|93182|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
19172|NCT01823536|93177|P6|Overall Study|Withdrawal by Subject|0
19173|NCT01823536|93178|P5|Overall Study|Withdrawal by Subject|0
19174|NCT01823536|93179|P4|Overall Study|Withdrawal by Subject|0
19175|NCT01823536|93180|P3|Overall Study|Withdrawal by Subject|0
19176|NCT01823536|93181|P2|Overall Study|Withdrawal by Subject|1
19177|NCT01823536|93182|P1|Overall Study|Withdrawal by Subject|1
19178|NCT01823536|93177|P6|Overall Study|Protocol Violation|0
19179|NCT01823536|93178|P5|Overall Study|Protocol Violation|0
19180|NCT01823536|93179|P4|Overall Study|Protocol Violation|0
19181|NCT01823536|93180|P3|Overall Study|Protocol Violation|0
19182|NCT01823536|93181|P2|Overall Study|Protocol Violation|1
19183|NCT01823536|93182|P1|Overall Study|Protocol Violation|0
19184|NCT01823536|93177|P6|Overall Study|Lost to Follow-up|0
19185|NCT01823536|93178|P5|Overall Study|Lost to Follow-up|1
19186|NCT01823536|93179|P4|Overall Study|Lost to Follow-up|1
19187|NCT01823536|93180|P3|Overall Study|Lost to Follow-up|0
19188|NCT01823536|93181|P2|Overall Study|Lost to Follow-up|0
19189|NCT01823536|93182|P1|Overall Study|Lost to Follow-up|1
19190|NCT01823341|93220|P1|Overall Study|Adverse Event|1
19191|NCT01823341|93220|P1|Overall Study|Withdrawal by Subject|7
19192|NCT01823341|93220|P1|Overall Study|Failed run-in|7
19193|NCT01823289|93263|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
19194|NCT01823289|93263|P1|Overall Study|Drug affected efficacy and safety|1
19195|NCT01823289|93263|P1|Overall Study|Transaminase increased more than 3 times|1
19196|NCT01823289|93263|P1|Overall Study|Administered contraindicated medicine|1
19197|NCT01823289|93263|P1|Overall Study|Physician Decision|9
19198|NCT01823289|93263|P1|Overall Study|Lack of Efficacy|1
19199|NCT01823289|93263|P1|Overall Study|Adverse Event|5
19200|NCT01823289|93263|P1|Overall Study|Lost to Follow-up|5
19201|NCT01823224|93271|P2|Overall Study|Withdrawal by Subject|1
19202|NCT01823224|93272|P1|Overall Study|Withdrawal by Subject|0
19203|NCT01823224|93271|P2|Overall Study|missed med dose|1
19204|NCT01823224|93272|P1|Overall Study|missed med dose|0
19205|NCT01823224|93271|P2|Overall Study|pharmacy error|1
19206|NCT01823224|93272|P1|Overall Study|pharmacy error|0
19207|NCT01823224|93271|P2|Overall Study|didn't qualify|2
19208|NCT01823224|93272|P1|Overall Study|didn't qualify|1
19209|NCT01823224|93271|P2|Overall Study|Lost to Follow-up|6
19210|NCT01823224|93272|P1|Overall Study|Lost to Follow-up|5
19211|NCT01823146|93282|P2|Overall Study|Lost to Follow-up|1
19212|NCT01823146|93283|P1|Overall Study|Lost to Follow-up|2
19213|NCT01823146|93282|P2|Overall Study|Withdrawal by Subject|1
19214|NCT01823146|93283|P1|Overall Study|Withdrawal by Subject|0
19215|NCT01822899|93295|P2|Overall Study|Withdrawal by Subject|7
19216|NCT01822899|93296|P1|Overall Study|Withdrawal by Subject|5
19217|NCT01822899|93295|P2|Overall Study|Lost to Follow-up|0
19218|NCT01822899|93296|P1|Overall Study|Lost to Follow-up|1
19219|NCT01822899|93295|P2|Overall Study|Protocol Violation|3
19220|NCT01822899|93296|P1|Overall Study|Protocol Violation|6
19221|NCT01822899|93295|P2|Overall Study|Lack of Efficacy|3
19222|NCT01822899|93296|P1|Overall Study|Lack of Efficacy|6
19223|NCT01822899|93295|P2|Overall Study|Adverse Event|5
19224|NCT01822899|93296|P1|Overall Study|Adverse Event|6
19225|NCT01822821|93306|P2|Overall Study|Other reasons|0
19226|NCT01822821|93307|P1|Overall Study|Other reasons|1
19227|NCT01822821|93306|P2|Overall Study|Eligible surgery cancelled|1
19228|NCT01822821|93307|P1|Overall Study|Eligible surgery cancelled|1
19229|NCT01822756|93336|P5|Overall Study|disease progression & patient preference|0
19230|NCT01822756|93337|P4|Overall Study|disease progression & patient preference|0
19231|NCT01822756|93338|P3|Overall Study|disease progression & patient preference|1
19232|NCT01822756|93339|P2|Overall Study|disease progression & patient preference|0
19233|NCT01822756|93340|P1|Overall Study|disease progression & patient preference|2
19234|NCT01822756|93336|P5|Overall Study|Physician Decision|0
19235|NCT01822756|93337|P4|Overall Study|Physician Decision|0
19236|NCT01822756|93338|P3|Overall Study|Physician Decision|0
19237|NCT01822756|93339|P2|Overall Study|Physician Decision|1
19238|NCT01822756|93340|P1|Overall Study|Physician Decision|0
19239|NCT01822756|93336|P5|Overall Study|Lost to Follow-up|1
19240|NCT01822756|93337|P4|Overall Study|Lost to Follow-up|0
19241|NCT01822756|93338|P3|Overall Study|Lost to Follow-up|1
19242|NCT01822756|93339|P2|Overall Study|Lost to Follow-up|0
19243|NCT01822756|93340|P1|Overall Study|Lost to Follow-up|1
19244|NCT01822756|93336|P5|Overall Study|Death|0
19245|NCT01822756|93337|P4|Overall Study|Death|0
19246|NCT01822756|93338|P3|Overall Study|Death|1
19247|NCT01822756|93339|P2|Overall Study|Death|2
19248|NCT01822756|93340|P1|Overall Study|Death|2
19249|NCT01822756|93336|P5|Overall Study|Disease progression|6
19250|NCT01822756|93337|P4|Overall Study|Disease progression|2
19251|NCT01822756|93338|P3|Overall Study|Disease progression|7
19252|NCT01822756|93339|P2|Overall Study|Disease progression|1
19253|NCT01822756|93340|P1|Overall Study|Disease progression|11
19254|NCT01822756|93336|P5|Overall Study|Adverse Event|0
19255|NCT01822756|93337|P4|Overall Study|Adverse Event|2
19256|NCT01822756|93338|P3|Overall Study|Adverse Event|0
19257|NCT01822756|93339|P2|Overall Study|Adverse Event|0
19258|NCT01822756|93340|P1|Overall Study|Adverse Event|0
19259|NCT01822691|93382|P1|Overall Study|Withdrawal by Subject|2
19260|NCT01822678|93393|P3|Overall Study|Lost to Follow-up|1
19261|NCT01822678|93394|P2|Overall Study|Lost to Follow-up|2
19262|NCT01822678|93395|P1|Overall Study|Lost to Follow-up|0
19263|NCT01822678|93393|P3|Overall Study|Lack of Efficacy|5
19264|NCT01822678|93394|P2|Overall Study|Lack of Efficacy|6
19265|NCT01822678|93395|P1|Overall Study|Lack of Efficacy|3
19266|NCT01822678|93393|P3|Overall Study|Adverse Event|1
19267|NCT01822678|93394|P2|Overall Study|Adverse Event|3
19268|NCT01822678|93395|P1|Overall Study|Adverse Event|4
19269|NCT01822678|93393|P3|Overall Study|Withdrawal by Subject|4
19270|NCT01822678|93394|P2|Overall Study|Withdrawal by Subject|4
19271|NCT01822678|93395|P1|Overall Study|Withdrawal by Subject|5
19272|NCT01822665|93403|P1|Overall Study|Other Reason|5
19273|NCT01822665|93403|P1|Overall Study|Adverse Event|3
19274|NCT01822535|93459|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
19275|NCT01822535|93460|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
19276|NCT01822535|93459|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
19277|NCT01822535|93460|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
19278|NCT01822535|93459|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
19279|NCT01822535|93460|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
19280|NCT01822223|93484|P2|Overall Study|Death|1
19281|NCT01822223|93485|P1|Overall Study|Death|0
19282|NCT01821963|93530|P1|Overall Study|Adverse Event|1
19283|NCT01821937|93536|P2|Overall Study|Adverse Event|3
19284|NCT01821937|93537|P1|Overall Study|Adverse Event|0
19285|NCT01821807|93561|P2|Overall Study|Lost to Follow-up|1
19286|NCT01821807|93562|P1|Overall Study|Lost to Follow-up|3
19287|NCT01821118|93650|P2|Overall Study|Death|1
19288|NCT01821118|93651|P1|Overall Study|Death|0
19289|NCT01820585|93694|P4|Overall Study|Pregnancy|0
19290|NCT01820585|93695|P3|Overall Study|Pregnancy|0
19291|NCT01820585|93696|P2|Overall Study|Pregnancy|1
19292|NCT01820585|93697|P1|Overall Study|Pregnancy|0
19293|NCT01820585|93694|P4|Overall Study|at sponsor request|0
19294|NCT01820585|93695|P3|Overall Study|at sponsor request|1
19295|NCT01820585|93696|P2|Overall Study|at sponsor request|0
19296|NCT01820585|93697|P1|Overall Study|at sponsor request|0
19297|NCT01820585|93694|P4|Overall Study|Subject non-compliance|2
19298|NCT01820585|93695|P3|Overall Study|Subject non-compliance|1
19299|NCT01820585|93696|P2|Overall Study|Subject non-compliance|0
19300|NCT01820585|93697|P1|Overall Study|Subject non-compliance|0
19301|NCT01820585|93694|P4|Overall Study|Protocol Violation|1
19302|NCT01820585|93695|P3|Overall Study|Protocol Violation|1
19303|NCT01820585|93696|P2|Overall Study|Protocol Violation|1
19304|NCT01820585|93697|P1|Overall Study|Protocol Violation|3
19305|NCT01820585|93694|P4|Overall Study|Lost to Follow-up|3
19306|NCT01820585|93695|P3|Overall Study|Lost to Follow-up|0
19307|NCT01820585|93696|P2|Overall Study|Lost to Follow-up|3
19308|NCT01820585|93697|P1|Overall Study|Lost to Follow-up|3
19309|NCT01820585|93694|P4|Overall Study|Withdrawal by Subject|8
19310|NCT01820585|93695|P3|Overall Study|Withdrawal by Subject|3
19311|NCT01820585|93696|P2|Overall Study|Withdrawal by Subject|7
19312|NCT01820585|93697|P1|Overall Study|Withdrawal by Subject|3
19313|NCT01820585|93694|P4|Overall Study|Lack of Efficacy|1
19314|NCT01820585|93695|P3|Overall Study|Lack of Efficacy|5
19315|NCT01820585|93696|P2|Overall Study|Lack of Efficacy|7
19316|NCT01820585|93697|P1|Overall Study|Lack of Efficacy|9
19317|NCT01820585|93694|P4|Overall Study|Adverse Event|34
19318|NCT01820585|93695|P3|Overall Study|Adverse Event|23
19319|NCT01820585|93696|P2|Overall Study|Adverse Event|13
19320|NCT01820585|93697|P1|Overall Study|Adverse Event|9
19321|NCT01820559|93710|P3|Overall Study|Lack of Efficacy|3
19322|NCT01820559|93711|P2|Overall Study|Lack of Efficacy|2
19323|NCT01820559|93712|P1|Overall Study|Lack of Efficacy|3
19324|NCT01820559|93710|P3|Overall Study|At sponsor request|1
19325|NCT01820559|93711|P2|Overall Study|At sponsor request|0
19326|NCT01820559|93712|P1|Overall Study|At sponsor request|0
19327|NCT01820559|93710|P3|Overall Study|Lost to Follow-up|2
19328|NCT01820559|93711|P2|Overall Study|Lost to Follow-up|2
19329|NCT01820559|93712|P1|Overall Study|Lost to Follow-up|3
19330|NCT01820559|93710|P3|Overall Study|Subject's non-compliance|2
19331|NCT01820559|93711|P2|Overall Study|Subject's non-compliance|0
19332|NCT01820559|93712|P1|Overall Study|Subject's non-compliance|1
19333|NCT01820559|93710|P3|Overall Study|Protocol Violation|3
19334|NCT01820559|93711|P2|Overall Study|Protocol Violation|1
19335|NCT01820559|93712|P1|Overall Study|Protocol Violation|2
19336|NCT01820559|93710|P3|Overall Study|Withdrawal by Subject|5
19337|NCT01820559|93711|P2|Overall Study|Withdrawal by Subject|2
19338|NCT01820559|93712|P1|Overall Study|Withdrawal by Subject|1
19339|NCT01820559|93710|P3|Overall Study|Adverse Event|13
19340|NCT01820559|93711|P2|Overall Study|Adverse Event|6
19341|NCT01820559|93712|P1|Overall Study|Adverse Event|4
19342|NCT01820364|93733|P2|Part II: LGX818 + MEK162|Study Termination|1
19343|NCT01820364|93734|P1|Part II: LGX818 + MEK162|Study Termination|0
19344|NCT01820364|93733|P2|Part I: LGX818|Disease Progression|0
19345|NCT01820364|93734|P1|Part I: LGX818|Disease Progression|4
19346|NCT01820364|93733|P2|Part I: LGX818|Adverse Event|0
19347|NCT01820364|93734|P1|Part I: LGX818|Adverse Event|6
19348|NCT01820364|93733|P2|Part I: LGX818|Administrative Problems|0
19349|NCT01820364|93734|P1|Part I: LGX818|Administrative Problems|3
19350|NCT01820364|93733|P2|Part I: LGX818|Death|0
19351|NCT01820364|93734|P1|Part I: LGX818|Death|1
19352|NCT01819272|93909|P6|Overall Study|Loss of Glucose Control|0
19353|NCT01819272|93910|P5|Overall Study|Loss of Glucose Control|2
19354|NCT01819272|93911|P4|Overall Study|Loss of Glucose Control|1
19355|NCT01819272|93912|P3|Overall Study|Loss of Glucose Control|0
19356|NCT01819272|93913|P2|Overall Study|Loss of Glucose Control|1
19357|NCT01819272|93914|P1|Overall Study|Loss of Glucose Control|2
19358|NCT01819272|93909|P6|Overall Study|Withdrawal of Consent|1
19359|NCT01819272|93910|P5|Overall Study|Withdrawal of Consent|0
19360|NCT01819272|93911|P4|Overall Study|Withdrawal of Consent|1
19361|NCT01819272|93912|P3|Overall Study|Withdrawal of Consent|2
19362|NCT01819272|93913|P2|Overall Study|Withdrawal of Consent|1
19363|NCT01819272|93914|P1|Overall Study|Withdrawal of Consent|0
19364|NCT01819272|93909|P6|Overall Study|Physician Decision|0
19365|NCT01819272|93910|P5|Overall Study|Physician Decision|0
19366|NCT01819272|93911|P4|Overall Study|Physician Decision|0
19367|NCT01819272|93912|P3|Overall Study|Physician Decision|0
19368|NCT01819272|93913|P2|Overall Study|Physician Decision|1
19369|NCT01819272|93914|P1|Overall Study|Physician Decision|0
19370|NCT01819272|93909|P6|Overall Study|Protocol Violation|3
19371|NCT01819272|93910|P5|Overall Study|Protocol Violation|2
19372|NCT01819272|93911|P4|Overall Study|Protocol Violation|1
19373|NCT01819272|93912|P3|Overall Study|Protocol Violation|0
19374|NCT01819272|93913|P2|Overall Study|Protocol Violation|0
19375|NCT01819272|93914|P1|Overall Study|Protocol Violation|0
19376|NCT01819272|93909|P6|Overall Study|Lost to Follow-up|3
19377|NCT01819272|93910|P5|Overall Study|Lost to Follow-up|0
19378|NCT01819272|93911|P4|Overall Study|Lost to Follow-up|0
19379|NCT01819272|93912|P3|Overall Study|Lost to Follow-up|1
19380|NCT01819272|93913|P2|Overall Study|Lost to Follow-up|0
19381|NCT01819272|93914|P1|Overall Study|Lost to Follow-up|3
19382|NCT01819272|93909|P6|Overall Study|Adverse Event|0
19383|NCT01819272|93910|P5|Overall Study|Adverse Event|0
19384|NCT01819272|93911|P4|Overall Study|Adverse Event|2
19385|NCT01819272|93912|P3|Overall Study|Adverse Event|0
19386|NCT01819272|93913|P2|Overall Study|Adverse Event|0
19387|NCT01819272|93914|P1|Overall Study|Adverse Event|1
19388|NCT01819194|93940|P1|Overall Study|Loss of study articles|2
19389|NCT01818752|93947|P2|Overall Study|Randomized but not Dosed|4
19390|NCT01818752|93948|P1|Overall Study|Randomized but not Dosed|7
19391|NCT01818752|93947|P2|Overall Study|Continuing Treatment|4
19392|NCT01818752|93948|P1|Overall Study|Continuing Treatment|1
19393|NCT01818752|93947|P2|Overall Study|Other|8
19394|NCT01818752|93948|P1|Overall Study|Other|7
19395|NCT01818752|93947|P2|Overall Study|Disease Progression|48
19396|NCT01818752|93948|P1|Overall Study|Disease Progression|54
19397|NCT01818752|93947|P2|Overall Study|Physician Decision|8
19398|NCT01818752|93948|P1|Overall Study|Physician Decision|9
19399|NCT01818752|93947|P2|Overall Study|Withdrawal by Subject|14
19400|NCT01818752|93948|P1|Overall Study|Withdrawal by Subject|15
19401|NCT01818752|93947|P2|Overall Study|Non-compliance|20
19402|NCT01818752|93948|P1|Overall Study|Non-compliance|16
19403|NCT01818752|93947|P2|Overall Study|Death|18
19404|NCT01818752|93948|P1|Overall Study|Death|14
19405|NCT01818752|93947|P2|Overall Study|Adverse Event|74
19406|NCT01818752|93948|P1|Overall Study|Adverse Event|64
19407|NCT01818700|93966|P1|Overall Study|Other|1
19408|NCT01818700|93966|P1|Overall Study|Protocol Violation|2
19409|NCT01818700|93966|P1|Overall Study|Withdrawal by Subject|27
19410|NCT01818700|93966|P1|Overall Study|Lost to Follow-up|5
19411|NCT01818700|93966|P1|Overall Study|Lack of Efficacy|2
19412|NCT01818700|93966|P1|Overall Study|Adverse Event|67
19413|NCT01818596|93977|P2|Overall Study|Still on Study|6
19414|NCT01818596|93978|P1|Overall Study|Still on Study|232
19415|NCT01818596|93977|P2|Overall Study|Lost to Follow-up|0
19416|NCT01818596|93978|P1|Overall Study|Lost to Follow-up|2
19417|NCT01818596|93977|P2|Overall Study|Protocol Violation|0
19418|NCT01818596|93978|P1|Overall Study|Protocol Violation|1
19419|NCT01818596|93977|P2|Overall Study|Withdrew Consent|0
19420|NCT01818596|93978|P1|Overall Study|Withdrew Consent|3
19421|NCT01818596|93977|P2|Overall Study|Adverse Event|0
19422|NCT01818596|93978|P1|Overall Study|Adverse Event|4
19423|NCT01818596|93977|P2|Overall Study|Enrolled but Not Treated|0
19424|NCT01818596|93978|P1|Overall Study|Enrolled but Not Treated|4
19425|NCT01818336|94026|P2|Overall Study|Lost to Follow-up|1
19426|NCT01818336|94027|P1|Overall Study|Lost to Follow-up|0
19427|NCT01818336|94026|P2|Overall Study|Declined retest visit|11
19428|NCT01818336|94027|P1|Overall Study|Declined retest visit|0
19429|NCT01818141|94035|P2|Overall Study|Lost to Follow-up|2
19430|NCT01818141|94036|P1|Overall Study|Lost to Follow-up|0
19431|NCT01818141|94035|P2|Overall Study|No baseline C.diff colonies|1
19432|NCT01818141|94036|P1|Overall Study|No baseline C.diff colonies|1
19433|NCT01818141|94035|P2|Overall Study|Withdrawal by Subject|0
19434|NCT01818141|94036|P1|Overall Study|Withdrawal by Subject|2
19435|NCT01817790|94092|P2|Overall Study|Other: Could not attend appointment|1
19436|NCT01817790|94093|P1|Overall Study|Other: Could not attend appointment|1
19437|NCT01817790|94092|P2|Overall Study|Withdrawal by Subject|3
19438|NCT01817790|94093|P1|Overall Study|Withdrawal by Subject|1
19439|NCT01817790|94092|P2|Overall Study|Protocol Violation|1
19440|NCT01817790|94093|P1|Overall Study|Protocol Violation|2
19441|NCT01817790|94092|P2|Overall Study|Lost to Follow-up|1
19442|NCT01817790|94093|P1|Overall Study|Lost to Follow-up|0
19443|NCT01817790|94092|P2|Overall Study|Adverse Event|2
19444|NCT01817790|94093|P1|Overall Study|Adverse Event|0
19445|NCT01817777|94137|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
19446|NCT01817777|94138|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
19447|NCT01817777|94139|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
19448|NCT01817777|94137|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
19449|NCT01817777|94138|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
19450|NCT01817777|94139|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
19451|NCT01817777|94137|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
19452|NCT01817777|94138|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
19453|NCT01817777|94139|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
19454|NCT01817777|94137|P3|Observational Phase (8 Weeks)|Early Study Termination|0
19455|NCT01817777|94138|P2|Observational Phase (8 Weeks)|Early Study Termination|0
19456|NCT01817777|94139|P1|Observational Phase (8 Weeks)|Early Study Termination|2
19457|NCT01817777|94137|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
19458|NCT01817777|94138|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
19459|NCT01817777|94139|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
19460|NCT01817764|94163|P2|Overall Study|Withdrawal by Subject|12
19461|NCT01817764|94164|P1|Overall Study|Withdrawal by Subject|10
19462|NCT01817764|94163|P2|Overall Study|Lost to Follow-up|4
19463|NCT01817764|94164|P1|Overall Study|Lost to Follow-up|1
19464|NCT01817764|94163|P2|Overall Study|Protocol Violation|5
19465|NCT01817764|94164|P1|Overall Study|Protocol Violation|7
19466|NCT01817764|94163|P2|Overall Study|Lack of Efficacy|7
19467|NCT01817764|94164|P1|Overall Study|Lack of Efficacy|9
19468|NCT01817764|94163|P2|Overall Study|Adverse Event|10
19469|NCT01817764|94164|P1|Overall Study|Adverse Event|7
19470|NCT01817725|94172|P1|Overall Study|Withdrawal by Subject|1
19471|NCT01816685|94202|P2|Overall Study|Surgery Cancelled|2
19472|NCT01816685|94203|P1|Overall Study|Surgery Cancelled|3
19473|NCT01816685|94202|P2|Overall Study|Lost to Follow-up|9
19474|NCT01816685|94203|P1|Overall Study|Lost to Follow-up|7
19475|NCT01816477|94213|P2|Overall Study|Unable to tolerate catheter placement|0
19476|NCT01816477|94214|P1|Overall Study|Unable to tolerate catheter placement|3
19477|NCT01816477|94213|P2|Overall Study|Withdrawal by Subject|1
19478|NCT01816477|94214|P1|Overall Study|Withdrawal by Subject|13
19479|NCT01816295|94268|P2|OLE Phase|Lack of Efficacy|7
19480|NCT01816295|94269|P1|OLE Phase|Lack of Efficacy|3
19481|NCT01816295|94268|P2|OLE Phase|Withdrawal by Subject|10
19482|NCT01816295|94269|P1|OLE Phase|Withdrawal by Subject|10
19483|NCT01816295|94268|P2|OLE Phase|Sponsor Decision|9
19484|NCT01816295|94269|P1|OLE Phase|Sponsor Decision|7
19485|NCT01816295|94268|P2|OLE Phase|Protocol Violation|4
19486|NCT01816295|94269|P1|OLE Phase|Protocol Violation|4
19487|NCT01816295|94268|P2|OLE Phase|Physician Decision|1
19488|NCT01816295|94269|P1|OLE Phase|Physician Decision|3
19489|NCT01816295|94268|P2|OLE Phase|Lost to Follow-up|5
19490|NCT01816295|94269|P1|OLE Phase|Lost to Follow-up|5
19491|NCT01816295|94268|P2|OLE Phase|Entry Criteria Not Met|5
19492|NCT01816295|94269|P1|OLE Phase|Entry Criteria Not Met|3
19493|NCT01816295|94268|P2|OLE Phase|Death|0
19494|NCT01816295|94269|P1|OLE Phase|Death|1
19495|NCT01816295|94268|P2|OLE Phase|Adverse Event|15
19496|NCT01816295|94269|P1|OLE Phase|Adverse Event|17
19497|NCT01816295|94268|P2|Double Blind Phase|Withdrawal by Subject|20
19498|NCT01816295|94269|P1|Double Blind Phase|Withdrawal by Subject|22
19499|NCT01816295|94268|P2|Double Blind Phase|Sponsor Decision|8
19500|NCT01816295|94269|P1|Double Blind Phase|Sponsor Decision|8
19501|NCT01816295|94268|P2|Double Blind Phase|Protocol Violation|11
19502|NCT01816295|94269|P1|Double Blind Phase|Protocol Violation|17
19503|NCT01816295|94268|P2|Double Blind Phase|Physician Decision|2
19504|NCT01816295|94269|P1|Double Blind Phase|Physician Decision|2
19505|NCT01816295|94268|P2|Double Blind Phase|Lost to Follow-up|5
19506|NCT01816295|94269|P1|Double Blind Phase|Lost to Follow-up|3
19507|NCT01816295|94268|P2|Double Blind Phase|Entry Criteria Not Met|2
19508|NCT01816295|94269|P1|Double Blind Phase|Entry Criteria Not Met|0
19509|NCT01816295|94268|P2|Double Blind Phase|Adverse Event|8
19510|NCT01816295|94269|P1|Double Blind Phase|Adverse Event|11
19511|NCT01816243|94284|P1|Overall Study|Amputation|3
19512|NCT01816243|94284|P1|Overall Study|Not eligible for the study|1
19513|NCT01816243|94284|P1|Overall Study|Lack of Efficacy|1
19514|NCT01816243|94284|P1|Overall Study|Lost to Follow-up|1
19515|NCT01816243|94284|P1|Overall Study|Adverse Event|6
19516|NCT01816048|94291|P1|Overall Study|Disease Progression|3
19517|NCT01816048|94291|P1|Overall Study|Withdrawal by Subject|1
19518|NCT01816048|94291|P1|Overall Study|Death|1
19519|NCT01816048|94291|P1|Overall Study|Adverse Event|1
19520|NCT01815918|94306|P2|Overall Study|Lack of Efficacy|15
19521|NCT01815918|94307|P1|Overall Study|Lack of Efficacy|15
19522|NCT01815918|94306|P2|Overall Study|Patient samples not analyzable|4
19523|NCT01815918|94307|P1|Overall Study|Patient samples not analyzable|3
19524|NCT01815840|94323|P2|Overall Study|Still on Study|64
19525|NCT01815840|94324|P1|Overall Study|Still on Study|73
19526|NCT01815840|94323|P2|Overall Study|Missing|1
19527|NCT01815840|94324|P1|Overall Study|Missing|1
19528|NCT01815840|94323|P2|Overall Study|Withdrew Consent|26
19529|NCT01815840|94324|P1|Overall Study|Withdrew Consent|26
19530|NCT01815840|94323|P2|Overall Study|Refused Treatment|1
19531|NCT01815840|94324|P1|Overall Study|Refused Treatment|3
19532|NCT01815840|94323|P2|Overall Study|Lost to Follow-up|2
19533|NCT01815840|94324|P1|Overall Study|Lost to Follow-up|1
19534|NCT01815840|94323|P2|Overall Study|Investigator Decision|3
19535|NCT01815840|94324|P1|Overall Study|Investigator Decision|1
19536|NCT01815840|94323|P2|Overall Study|Disease Progression|0
19537|NCT01815840|94324|P1|Overall Study|Disease Progression|1
19538|NCT01815840|94323|P2|Overall Study|Death|2
19539|NCT01815840|94324|P1|Overall Study|Death|2
19540|NCT01815840|94323|P2|Overall Study|Adverse Event|14
19541|NCT01815840|94324|P1|Overall Study|Adverse Event|8
19542|NCT01815736|94354|P2|Overall Study|Still on Study|449
19543|NCT01815736|94355|P1|Overall Study|Still on Study|929
19544|NCT01815736|94354|P2|Overall Study|Lost to Follow-up|7
19545|NCT01815736|94355|P1|Overall Study|Lost to Follow-up|6
19546|NCT01815736|94354|P2|Overall Study|Withdrew Consent|15
19547|NCT01815736|94355|P1|Overall Study|Withdrew Consent|7
19548|NCT01815736|94354|P2|Overall Study|Investigator's Discretion|0
19549|NCT01815736|94355|P1|Overall Study|Investigator's Discretion|4
19550|NCT01815736|94354|P2|Overall Study|Death|0
19551|NCT01815736|94355|P1|Overall Study|Death|4
19552|NCT01815736|94354|P2|Overall Study|Adverse Event|4
19553|NCT01815736|94355|P1|Overall Study|Adverse Event|7
19554|NCT01815736|94354|P2|Overall Study|Randomized but Not Treated|3
19555|NCT01815736|94355|P1|Overall Study|Randomized but Not Treated|4
19556|NCT01815099|94401|P1|Overall Study|unable to attend study visits|1
19557|NCT01815099|94401|P1|Overall Study|Lack of Efficacy|1
19558|NCT01814878|94415|P2|Overall Study|Unspecified|0
19559|NCT01814878|94416|P1|Overall Study|Unspecified|2
19560|NCT01814878|94415|P2|Overall Study|Screening failure (drop-out)|3
19561|NCT01814878|94416|P1|Overall Study|Screening failure (drop-out)|0
19562|NCT01814878|94415|P2|Overall Study|Physician Decision|1
19563|NCT01814878|94416|P1|Overall Study|Physician Decision|3
19564|NCT01814878|94415|P2|Overall Study|Protocol Violation|5
19565|NCT01814878|94416|P1|Overall Study|Protocol Violation|5
19566|NCT01814878|94415|P2|Overall Study|Withdrawal by Subject|16
19567|NCT01814878|94416|P1|Overall Study|Withdrawal by Subject|20
19568|NCT01814878|94415|P2|Overall Study|Adverse Event|5
19569|NCT01814878|94416|P1|Overall Study|Adverse Event|16
19570|NCT01814800|94436|P1|Overall Study|Subject relocation|1
19571|NCT01814800|94436|P1|Overall Study|Sponsor decision|1
19572|NCT01814800|94436|P1|Overall Study|Pregnancy|1
19573|NCT01814800|94436|P1|Overall Study|Adverse Event|2
19574|NCT01814761|94496|P2|Overall Study|Lost to Follow-up|5
19575|NCT01814761|94497|P1|Overall Study|Lost to Follow-up|1
19576|NCT01814761|94496|P2|Overall Study|Ocular Adverse Event|15
19577|NCT01814761|94497|P1|Overall Study|Ocular Adverse Event|6
19578|NCT01814761|94496|P2|Overall Study|Other Reasons|10
19579|NCT01814761|94497|P1|Overall Study|Other Reasons|1
19580|NCT01814748|94511|P2|Overall Study|Withdrawal by Subject|4
19581|NCT01814748|94512|P1|Overall Study|Withdrawal by Subject|6
19582|NCT01814748|94511|P2|Overall Study|Study site terminated by sponsor|1
19583|NCT01814748|94512|P1|Overall Study|Study site terminated by sponsor|1
19584|NCT01814748|94511|P2|Overall Study|Lost to Follow-up|2
19585|NCT01814748|94512|P1|Overall Study|Lost to Follow-up|1
19586|NCT01814696|94556|P2|Overall Study|Randomized to wrong group|0
19587|NCT01814696|94557|P1|Overall Study|Randomized to wrong group|1
19588|NCT01814696|94556|P2|Overall Study|Withdrawal by Subject|0
19589|NCT01814696|94557|P1|Overall Study|Withdrawal by Subject|1
19590|NCT01814670|94575|P1|Overall Study|Protocol Violation|12
19591|NCT01814553|94585|P2|Overall Study|Other than stated|8
19592|NCT01814553|94586|P1|Overall Study|Other than stated|7
19593|NCT01814553|94585|P2|Overall Study|Withdrawal by Subject|1
19594|NCT01814553|94586|P1|Overall Study|Withdrawal by Subject|1
19595|NCT01814553|94585|P2|Overall Study|Other Adverse Event|5
19596|NCT01814553|94586|P1|Overall Study|Other Adverse Event|4
19597|NCT01814553|94585|P2|Overall Study|PD per clinical progression|8
19598|NCT01814553|94586|P1|Overall Study|PD per clinical progression|6
19599|NCT01814397|94600|P1|Overall Study|Withdrawal by Subject|7
19600|NCT01814397|94600|P1|Overall Study|Adverse Event|7
19601|NCT01814332|94609|P2|Overall Study|Lost to Follow-up|1
19602|NCT01814332|94610|P1|Overall Study|Lost to Follow-up|5
19603|NCT01814332|94609|P2|Overall Study|Protocol Violation|4
19604|NCT01814332|94610|P1|Overall Study|Protocol Violation|0
19605|NCT01814332|94609|P2|Overall Study|Withdrawal by Subject|8
19606|NCT01814332|94610|P1|Overall Study|Withdrawal by Subject|3
19607|NCT01814332|94609|P2|Overall Study|Adverse Event|3
19608|NCT01814332|94610|P1|Overall Study|Adverse Event|8
19609|NCT01814137|94632|P2|Overall Study|Unclassified|1
19610|NCT01814137|94633|P1|Overall Study|Unclassified|2
19611|NCT01814137|94632|P2|Overall Study|Physician Decision|1
19612|NCT01814137|94633|P1|Overall Study|Physician Decision|1
19613|NCT01814137|94632|P2|Overall Study|Withdrawal by Subject|2
19614|NCT01814137|94633|P1|Overall Study|Withdrawal by Subject|2
19615|NCT01814137|94632|P2|Overall Study|Adverse Event|1
19616|NCT01814137|94633|P1|Overall Study|Adverse Event|0
19617|NCT01814046|94649|P3|Drug Administration|Death due to complications of RSV|0
19618|NCT01814046|94650|P2|Drug Administration|Death due to complications of RSV|0
19619|NCT01814046|94651|P1|Drug Administration|Death due to complications of RSV|1
19620|NCT01813890|94665|P3|Overall Study|Lack of Efficacy|2
19621|NCT01813890|94666|P2|Overall Study|Lack of Efficacy|1
19622|NCT01813890|94667|P1|Overall Study|Lack of Efficacy|9
19623|NCT01813890|94665|P3|Overall Study|Adverse Event|4
19624|NCT01813890|94666|P2|Overall Study|Adverse Event|3
19625|NCT01813890|94667|P1|Overall Study|Adverse Event|0
19626|NCT01813721|94696|P1|Overall Study|Withdrawal by Subject|1
19627|NCT01813721|94696|P1|Overall Study|Ineligibility determined|63
19628|NCT01813019|94757|P2|Overall Study|Protocol Deviation|1
19629|NCT01813019|94758|P1|Overall Study|Protocol Deviation|2
19630|NCT01813019|94757|P2|Overall Study|administrative problems|0
19631|NCT01813019|94758|P1|Overall Study|administrative problems|2
19632|NCT01813019|94757|P2|Overall Study|Withdrawal by Subject|2
19633|NCT01813019|94758|P1|Overall Study|Withdrawal by Subject|3
19634|NCT01813019|94757|P2|Overall Study|Adverse Event|3
19635|NCT01813019|94758|P1|Overall Study|Adverse Event|0
19636|NCT01812837|94769|P3|Overall Study|Protocol Violation|0
19637|NCT01812837|94770|P2|Overall Study|Protocol Violation|0
19638|NCT01812837|94771|P1|Overall Study|Protocol Violation|1
19639|NCT01812837|94769|P3|Overall Study|Lost to Follow-up|0
19640|NCT01812837|94770|P2|Overall Study|Lost to Follow-up|1
19641|NCT01812837|94771|P1|Overall Study|Lost to Follow-up|1
19642|NCT01812707|94783|P4|Overall Study|Consent withdrawn by participant|0
19643|NCT01812707|94784|P3|Overall Study|Consent withdrawn by participant|0
19644|NCT01812707|94785|P2|Overall Study|Consent withdrawn by participant|0
19645|NCT01812707|94786|P1|Overall Study|Consent withdrawn by participant|1
19646|NCT01812707|94783|P4|Overall Study|Poor compliance to protocol|0
19647|NCT01812707|94784|P3|Overall Study|Poor compliance to protocol|0
19648|NCT01812707|94785|P2|Overall Study|Poor compliance to protocol|0
19649|NCT01812707|94786|P1|Overall Study|Poor compliance to protocol|1
19650|NCT01812707|94783|P4|Overall Study|Adverse Event|2
19651|NCT01812707|94784|P3|Overall Study|Adverse Event|0
19652|NCT01812707|94785|P2|Overall Study|Adverse Event|0
19653|NCT01812707|94786|P1|Overall Study|Adverse Event|0
19654|NCT01812655|94834|P3|Overall Study|Protocol Violation|0
19655|NCT01812655|94835|P2|Overall Study|Protocol Violation|1
19656|NCT01812655|94836|P1|Overall Study|Protocol Violation|1
19657|NCT01812057|94861|P2|Overall Study|Physician Decision|0
19658|NCT01812057|94862|P1|Overall Study|Physician Decision|1
19659|NCT01812057|94861|P2|Overall Study|Protocol Violation|0
19660|NCT01812057|94862|P1|Overall Study|Protocol Violation|1
19661|NCT01811953|94940|P6|Overall Study|Protocol Violation|0
19662|NCT01811953|94941|P5|Overall Study|Protocol Violation|1
19663|NCT01811953|94942|P4|Overall Study|Protocol Violation|0
19664|NCT01811953|94943|P3|Overall Study|Protocol Violation|0
19665|NCT01811953|94944|P2|Overall Study|Protocol Violation|0
19666|NCT01811953|94945|P1|Overall Study|Protocol Violation|0
19667|NCT01811953|94940|P6|Overall Study|Adverse Event|1
19668|NCT01811953|94941|P5|Overall Study|Adverse Event|0
19669|NCT01811953|94942|P4|Overall Study|Adverse Event|1
19670|NCT01811953|94943|P3|Overall Study|Adverse Event|0
19671|NCT01811953|94944|P2|Overall Study|Adverse Event|0
19672|NCT01811953|94945|P1|Overall Study|Adverse Event|0
19673|NCT01811732|94991|P2|Overall Study|Correct study drug not available on site|0
19674|NCT01811732|94992|P1|Overall Study|Correct study drug not available on site|1
19675|NCT01811732|94991|P2|Overall Study|Admitted to another facility|0
19676|NCT01811732|94992|P1|Overall Study|Admitted to another facility|1
19677|NCT01811732|94991|P2|Overall Study|Subject incarcerated|2
19678|NCT01811732|94992|P1|Overall Study|Subject incarcerated|1
19679|NCT01811732|94991|P2|Overall Study|Protocol Violation|1
19680|NCT01811732|94992|P1|Overall Study|Protocol Violation|0
19681|NCT01811732|94991|P2|Overall Study|Insufficient venous access|1
19682|NCT01811732|94992|P1|Overall Study|Insufficient venous access|0
19683|NCT01811732|94991|P2|Overall Study|Death|1
19684|NCT01811732|94992|P1|Overall Study|Death|1
19685|NCT01811732|94991|P2|Overall Study|Physician Decision|0
19686|NCT01811732|94992|P1|Overall Study|Physician Decision|2
19687|NCT01811732|94991|P2|Overall Study|Non-compliance with study drug/procedure|3
19688|NCT01811732|94992|P1|Overall Study|Non-compliance with study drug/procedure|3
19689|NCT01811732|94991|P2|Overall Study|Lack of Efficacy|1
19690|NCT01811732|94992|P1|Overall Study|Lack of Efficacy|3
19691|NCT01811732|94991|P2|Overall Study|Adverse Event|9
19692|NCT01811732|94992|P1|Overall Study|Adverse Event|3
19693|NCT01811732|94991|P2|Overall Study|Withdrawal by Subject|10
19694|NCT01811732|94992|P1|Overall Study|Withdrawal by Subject|16
19695|NCT01811732|94991|P2|Overall Study|Lost to Follow-up|30
19696|NCT01811732|94992|P1|Overall Study|Lost to Follow-up|24
19697|NCT01811706|95002|P2|First Intervention ( 4 Weeks)|Adverse Event|0
19698|NCT01811706|95003|P1|First Intervention ( 4 Weeks)|Adverse Event|1
19699|NCT01811563|95020|P2|Overall Study|Incorrect Randomization procedure|1
19700|NCT01811563|95021|P1|Overall Study|Incorrect Randomization procedure|0
19701|NCT01811563|95020|P2|Overall Study|Lost to Follow-up|2
19702|NCT01811563|95021|P1|Overall Study|Lost to Follow-up|5
19703|NCT01811485|95050|P3|Overall Study|Protocol Deviation|0
19704|NCT01811485|95051|P2|Overall Study|Protocol Deviation|1
19705|NCT01811485|95052|P1|Overall Study|Protocol Deviation|0
19706|NCT01811485|95050|P3|Overall Study|Administrative problems|0
19707|NCT01811485|95051|P2|Overall Study|Administrative problems|0
19708|NCT01811485|95052|P1|Overall Study|Administrative problems|1
19709|NCT01811485|95050|P3|Overall Study|Unsatisfactory therapeutic effect|3
19710|NCT01811485|95051|P2|Overall Study|Unsatisfactory therapeutic effect|0
19711|NCT01811485|95052|P1|Overall Study|Unsatisfactory therapeutic effect|0
19712|NCT01811485|95050|P3|Overall Study|Adverse Event|2
19713|NCT01811485|95051|P2|Overall Study|Adverse Event|3
19714|NCT01811485|95052|P1|Overall Study|Adverse Event|1
19715|NCT01811472|95072|P3|Overall Study|Subject/guardian decision|0
19716|NCT01811472|95073|P2|Overall Study|Subject/guardian decision|0
19717|NCT01811472|95074|P1|Overall Study|Subject/guardian decision|1
19718|NCT01811472|95072|P3|Overall Study|Lost to Follow-up|1
19719|NCT01811472|95073|P2|Overall Study|Lost to Follow-up|0
19720|NCT01811472|95074|P1|Overall Study|Lost to Follow-up|0
19721|NCT01811472|95072|P3|Overall Study|Adverse Event|4
19722|NCT01811472|95073|P2|Overall Study|Adverse Event|0
19723|NCT01811472|95074|P1|Overall Study|Adverse Event|1
19724|NCT01811238|95139|P1|Overall Study|subject refused study medication|6
19725|NCT01811238|95139|P1|Overall Study|Lack of Efficacy|4
19726|NCT01811238|95139|P1|Overall Study|Protocol Violation|4
19727|NCT01811238|95139|P1|Overall Study|Adverse Event|25
19728|NCT01811238|95139|P1|Overall Study|Withdrawal by Subject|42
19729|NCT01811186|95150|P2|Overall Study|Lost to Follow-up|2
19730|NCT01811186|95151|P1|Overall Study|Lost to Follow-up|4
19731|NCT01811186|95150|P2|Overall Study|Lack of Efficacy|6
19732|NCT01811186|95151|P1|Overall Study|Lack of Efficacy|3
19733|NCT01811186|95150|P2|Overall Study|Withdrawal by Subject|10
19734|NCT01811186|95151|P1|Overall Study|Withdrawal by Subject|5
19735|NCT01811186|95150|P2|Overall Study|Protocol Violation|6
19736|NCT01811186|95151|P1|Overall Study|Protocol Violation|5
19737|NCT01811186|95150|P2|Overall Study|Adverse Event|38
19738|NCT01811186|95151|P1|Overall Study|Adverse Event|54
19739|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
19740|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
19741|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
19742|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
19743|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
19744|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
19745|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
19746|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
19747|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
19748|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
19749|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
19750|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
19751|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
19752|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
19753|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
19754|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
19755|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
19756|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
19757|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Death|1
19758|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Death|0
19759|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Death|0
19760|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
19761|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
19762|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
19763|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
19764|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
19765|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
19766|NCT01810939|95184|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
19767|NCT01810939|95185|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
19768|NCT01810939|95186|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
19769|NCT01810939|95184|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
19770|NCT01810939|95185|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
19771|NCT01810939|95186|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
19772|NCT01810939|95184|P3|Part A Treatment Period|Protocol-specified (High K+)|0
19773|NCT01810939|95185|P2|Part A Treatment Period|Protocol-specified (High K+)|0
19774|NCT01810939|95186|P1|Part A Treatment Period|Protocol-specified (High K+)|3
19775|NCT01810939|95184|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
19776|NCT01810939|95185|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
19777|NCT01810939|95186|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
19778|NCT01810939|95184|P3|Part A Treatment Period|Withdrawal by Subject|0
19779|NCT01810939|95185|P2|Part A Treatment Period|Withdrawal by Subject|0
19780|NCT01810939|95186|P1|Part A Treatment Period|Withdrawal by Subject|5
19781|NCT01810939|95184|P3|Part A Treatment Period|Adverse Event|0
19782|NCT01810939|95185|P2|Part A Treatment Period|Adverse Event|0
19783|NCT01810939|95186|P1|Part A Treatment Period|Adverse Event|10
19784|NCT01810939|95184|P3|Part A Treatment Period|Protocol Violation|0
19785|NCT01810939|95185|P2|Part A Treatment Period|Protocol Violation|0
19786|NCT01810939|95186|P1|Part A Treatment Period|Protocol Violation|2
19787|NCT01810939|95184|P3|Part A Treatment Period|Non-compliance with Study Drug|0
19788|NCT01810939|95185|P2|Part A Treatment Period|Non-compliance with Study Drug|0
19789|NCT01810939|95186|P1|Part A Treatment Period|Non-compliance with Study Drug|1
19790|NCT01810783|95199|P1|Overall Study|Enrolled, not treated|1
19791|NCT01810783|95199|P1|Overall Study|Adminstrative or other reason(s)|23
19792|NCT01810783|95199|P1|Overall Study|Non-compliance with IMP|4
19793|NCT01810783|95199|P1|Overall Study|Protocol Violation|5
19794|NCT01810783|95199|P1|Overall Study|Lost to Follow-up|10
19795|NCT01810783|95199|P1|Overall Study|Lack of Efficacy|12
19796|NCT01810783|95199|P1|Overall Study|Withdrawal by Subject|22
19797|NCT01810783|95199|P1|Overall Study|Adverse Event|32
19798|NCT01810380|95227|P3|Overall Study|Administrative or other reasons|9
19799|NCT01810380|95228|P2|Overall Study|Administrative or other reasons|13
19800|NCT01810380|95229|P1|Overall Study|Administrative or other reasons|11
19801|NCT01810380|95227|P3|Overall Study|Withdrawal by Subject|6
19802|NCT01810380|95228|P2|Overall Study|Withdrawal by Subject|0
19803|NCT01810380|95229|P1|Overall Study|Withdrawal by Subject|6
19804|NCT01810380|95227|P3|Overall Study|Protocol Violation|1
19805|NCT01810380|95228|P2|Overall Study|Protocol Violation|0
19806|NCT01810380|95229|P1|Overall Study|Protocol Violation|1
19807|NCT01810380|95227|P3|Overall Study|Lack of Efficacy|11
19808|NCT01810380|95228|P2|Overall Study|Lack of Efficacy|10
19809|NCT01810380|95229|P1|Overall Study|Lack of Efficacy|24
19810|NCT01810380|95227|P3|Overall Study|Adverse Event|4
19811|NCT01810380|95228|P2|Overall Study|Adverse Event|14
19812|NCT01810380|95229|P1|Overall Study|Adverse Event|11
19813|NCT01810380|95227|P3|Overall Study|Randomised not treated|1
19814|NCT01810380|95228|P2|Overall Study|Randomised not treated|1
19815|NCT01810380|95229|P1|Overall Study|Randomised not treated|2
19816|NCT01810302|95290|P2|Overall Study|Physician Decision|1
19817|NCT01810302|95291|P1|Overall Study|Physician Decision|0
19818|NCT01810302|95290|P2|Overall Study|Death|0
19819|NCT01810302|95291|P1|Overall Study|Death|1
19820|NCT01810263|95310|P2|Overall Study|Lost to Follow-up|7
19821|NCT01810263|95311|P1|Overall Study|Lost to Follow-up|8
19822|NCT01810042|95317|P1|Overall Study|Lost to Follow-up|10
19823|NCT01809327|95372|P5|Overall Study|Unspecified|9
19824|NCT01809327|95373|P4|Overall Study|Unspecified|4
19825|NCT01809327|95374|P3|Overall Study|Unspecified|7
19826|NCT01809327|95375|P2|Overall Study|Unspecified|15
19827|NCT01809327|95376|P1|Overall Study|Unspecified|14
19828|NCT01809327|95372|P5|Overall Study|Pregnancy|0
19829|NCT01809327|95373|P4|Overall Study|Pregnancy|0
19830|NCT01809327|95374|P3|Overall Study|Pregnancy|0
19831|NCT01809327|95375|P2|Overall Study|Pregnancy|0
19832|NCT01809327|95376|P1|Overall Study|Pregnancy|1
19833|NCT01809327|95372|P5|Overall Study|Physician Decision|0
19834|NCT01809327|95373|P4|Overall Study|Physician Decision|0
19835|NCT01809327|95374|P3|Overall Study|Physician Decision|0
19836|NCT01809327|95375|P2|Overall Study|Physician Decision|1
19837|NCT01809327|95376|P1|Overall Study|Physician Decision|1
19838|NCT01809327|95372|P5|Overall Study|Protocol Violation|0
19839|NCT01809327|95373|P4|Overall Study|Protocol Violation|0
19840|NCT01809327|95374|P3|Overall Study|Protocol Violation|0
19841|NCT01809327|95375|P2|Overall Study|Protocol Violation|1
19842|NCT01809327|95376|P1|Overall Study|Protocol Violation|0
19843|NCT01809327|95372|P5|Overall Study|Death|0
19844|NCT01809327|95373|P4|Overall Study|Death|0
19845|NCT01809327|95374|P3|Overall Study|Death|0
19846|NCT01809327|95375|P2|Overall Study|Death|0
19847|NCT01809327|95376|P1|Overall Study|Death|1
19848|NCT01809327|95372|P5|Overall Study|Adverse Event|8
19849|NCT01809327|95373|P4|Overall Study|Adverse Event|4
19850|NCT01809327|95374|P3|Overall Study|Adverse Event|7
19851|NCT01809327|95375|P2|Overall Study|Adverse Event|3
19852|NCT01809327|95376|P1|Overall Study|Adverse Event|4
19853|NCT01809327|95372|P5|Overall Study|Withdrawal by Subject|5
19854|NCT01809327|95373|P4|Overall Study|Withdrawal by Subject|2
19855|NCT01809327|95374|P3|Overall Study|Withdrawal by Subject|4
19856|NCT01809327|95375|P2|Overall Study|Withdrawal by Subject|4
19857|NCT01809327|95376|P1|Overall Study|Withdrawal by Subject|6
19858|NCT01809327|95372|P5|Overall Study|Lost to Follow-up|3
19859|NCT01809327|95373|P4|Overall Study|Lost to Follow-up|2
19860|NCT01809327|95374|P3|Overall Study|Lost to Follow-up|4
19861|NCT01809327|95375|P2|Overall Study|Lost to Follow-up|2
19862|NCT01809327|95376|P1|Overall Study|Lost to Follow-up|5
19863|NCT01809314|95418|P1|Overall Study|Lost to Follow-up|724
19864|NCT01809314|95418|P1|Overall Study|Insufficient Therapeutic Response|14
19865|NCT01809314|95418|P1|Overall Study|Adverse Event|6
19866|NCT01809314|95418|P1|Overall Study|Withdrawal Prior to Treatment|1
19867|NCT01809262|95424|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
19868|NCT01809262|95425|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
19869|NCT01809262|95426|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
19870|NCT01809262|95427|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
19871|NCT01809262|95428|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
19872|NCT01809262|95429|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
19873|NCT01809262|95430|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
19874|NCT01809262|95431|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
19875|NCT01809262|95432|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
19876|NCT01809262|95433|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
19877|NCT01809262|95424|P10|Period 1 (First Dose + Washout)|Adverse Event|0
19878|NCT01809262|95425|P9|Period 1 (First Dose + Washout)|Adverse Event|0
19879|NCT01809262|95426|P8|Period 1 (First Dose + Washout)|Adverse Event|0
19880|NCT01809262|95427|P7|Period 1 (First Dose + Washout)|Adverse Event|0
19881|NCT01809262|95428|P6|Period 1 (First Dose + Washout)|Adverse Event|0
19882|NCT01809262|95429|P5|Period 1 (First Dose + Washout)|Adverse Event|1
19883|NCT01809262|95430|P4|Period 1 (First Dose + Washout)|Adverse Event|0
19884|NCT01809262|95431|P3|Period 1 (First Dose + Washout)|Adverse Event|0
19885|NCT01809262|95432|P2|Period 1 (First Dose + Washout)|Adverse Event|0
19886|NCT01809262|95433|P1|Period 1 (First Dose + Washout)|Adverse Event|0
19887|NCT01809197|95502|P2|Overall Study|Product not available|1
19888|NCT01809197|95503|P1|Overall Study|Product not available|0
19889|NCT01809197|95502|P2|Overall Study|Withdrawal by Subject|1
19890|NCT01809197|95503|P1|Overall Study|Withdrawal by Subject|1
19891|NCT01809197|95502|P2|Overall Study|Decision Unrelated to an Adverse Event|0
19892|NCT01809197|95503|P1|Overall Study|Decision Unrelated to an Adverse Event|1
19893|NCT01809197|95502|P2|Overall Study|Non-Compliance|1
19894|NCT01809197|95503|P1|Overall Study|Non-Compliance|1
19895|NCT01809197|95502|P2|Overall Study|Failed slit lamp exam|0
19896|NCT01809197|95503|P1|Overall Study|Failed slit lamp exam|1
19897|NCT01809197|95502|P2|Overall Study|Adverse Event|3
19898|NCT01809197|95503|P1|Overall Study|Adverse Event|2
19899|NCT01809197|95502|P2|Overall Study|Lost to Follow-up|2
19900|NCT01809197|95503|P1|Overall Study|Lost to Follow-up|4
19901|NCT01808651|95574|P3|Study Period 1|Participant Decision|3
19902|NCT01808651|95575|P2|Study Period 1|Participant Decision|7
19903|NCT01808651|95576|P1|Study Period 1|Participant Decision|9
19904|NCT01808651|95574|P3|Study Period 1|Adverse Event|1
19905|NCT01808651|95575|P2|Study Period 1|Adverse Event|4
19906|NCT01808651|95576|P1|Study Period 1|Adverse Event|10
19907|NCT01808651|95574|P3|Study Period 1|Lack of Efficacy|0
19908|NCT01808651|95575|P2|Study Period 1|Lack of Efficacy|1
19909|NCT01808651|95576|P1|Study Period 1|Lack of Efficacy|2
19910|NCT01808651|95574|P3|Study Period 1|Physician Decision|0
19911|NCT01808651|95575|P2|Study Period 1|Physician Decision|2
19912|NCT01808651|95576|P1|Study Period 1|Physician Decision|3
19913|NCT01808651|95574|P3|Study Period 1|Protocol Violation|1
19914|NCT01808651|95575|P2|Study Period 1|Protocol Violation|0
19915|NCT01808651|95576|P1|Study Period 1|Protocol Violation|1
19916|NCT01808651|95574|P3|Study Period 1|Lost to Follow-up|0
19917|NCT01808651|95575|P2|Study Period 1|Lost to Follow-up|3
19918|NCT01808651|95576|P1|Study Period 1|Lost to Follow-up|1
19919|NCT01808612|95611|P3|Discontinuation Period|Lost to Follow-up|0
19920|NCT01808612|95612|P2|Discontinuation Period|Lost to Follow-up|1
19921|NCT01808612|95613|P1|Discontinuation Period|Lost to Follow-up|0
19922|NCT01808612|95611|P3|Discontinuation Period|Physician Decision|0
19923|NCT01808612|95612|P2|Discontinuation Period|Physician Decision|0
19924|NCT01808612|95613|P1|Discontinuation Period|Physician Decision|1
19925|NCT01808612|95611|P3|Discontinuation Period|Adverse Event|0
19926|NCT01808612|95612|P2|Discontinuation Period|Adverse Event|0
19927|NCT01808612|95613|P1|Discontinuation Period|Adverse Event|1
19928|NCT01808612|95611|P3|Treatment Period|Lack of Efficacy|2
19929|NCT01808612|95612|P2|Treatment Period|Lack of Efficacy|1
19930|NCT01808612|95613|P1|Treatment Period|Lack of Efficacy|1
19931|NCT01808612|95611|P3|Treatment Period|Sponsor Decision|0
19932|NCT01808612|95612|P2|Treatment Period|Sponsor Decision|0
19933|NCT01808612|95613|P1|Treatment Period|Sponsor Decision|1
19934|NCT01808612|95611|P3|Treatment Period|Physician Decision|4
19935|NCT01808612|95612|P2|Treatment Period|Physician Decision|0
19936|NCT01808612|95613|P1|Treatment Period|Physician Decision|1
19937|NCT01808612|95611|P3|Treatment Period|Withdrawal by Subject|4
19938|NCT01808612|95612|P2|Treatment Period|Withdrawal by Subject|0
19939|NCT01808612|95613|P1|Treatment Period|Withdrawal by Subject|1
19940|NCT01808612|95611|P3|Treatment Period|Protocol Violation|0
19941|NCT01808612|95612|P2|Treatment Period|Protocol Violation|0
19942|NCT01808612|95613|P1|Treatment Period|Protocol Violation|1
19943|NCT01808612|95611|P3|Treatment Period|Lost to Follow-up|1
19944|NCT01808612|95612|P2|Treatment Period|Lost to Follow-up|2
19945|NCT01808612|95613|P1|Treatment Period|Lost to Follow-up|2
19946|NCT01808612|95611|P3|Treatment Period|Adverse Event|3
19947|NCT01808612|95612|P2|Treatment Period|Adverse Event|4
19948|NCT01808612|95613|P1|Treatment Period|Adverse Event|8
19949|NCT01808534|95651|P1|Overall Study|Physician Decision|1
19950|NCT01808534|95651|P1|Overall Study|Disease progression|3
19951|NCT01808508|95662|P3|Overall Study|Lost to Follow-up|0
19952|NCT01808508|95663|P2|Overall Study|Lost to Follow-up|0
19953|NCT01808508|95664|P1|Overall Study|Lost to Follow-up|1
19954|NCT01808339|95681|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
19955|NCT01808339|95682|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
19956|NCT01808339|95683|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
19957|NCT01808339|95684|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
19958|NCT01808339|95685|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
19959|NCT01808339|95686|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
19960|NCT01808339|95681|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19961|NCT01808339|95682|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19962|NCT01808339|95683|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
19963|NCT01808339|95684|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19964|NCT01808339|95685|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
19965|NCT01808339|95686|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
19966|NCT01808339|95681|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
19967|NCT01808339|95682|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
19968|NCT01808339|95683|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
19969|NCT01808339|95684|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
19970|NCT01808339|95685|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
19971|NCT01808339|95686|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
19972|NCT01808313|95730|P1|Overall Study|Physician Decision|1
19973|NCT01808313|95730|P1|Overall Study|Lost to Follow-up|1
19974|NCT01808313|95730|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
19975|NCT01808313|95730|P1|Overall Study|Protocol Violation|2
19976|NCT01808313|95730|P1|Overall Study|Adverse Event|5
19977|NCT01808248|95760|P1|Overall Study|Lost to Follow-up|1
19978|NCT01808248|95760|P1|Overall Study|Withdrawal by Subject|1
19979|NCT01808248|95760|P1|Overall Study|Lack of Efficacy|3
19980|NCT01808209|95774|P2|Overall Study|Lost to Follow-up|1
19981|NCT01808209|95775|P1|Overall Study|Lost to Follow-up|0
19982|NCT01808092|95819|P2|Overall Study|Other Eligibility criteria|5
19983|NCT01808092|95820|P1|Overall Study|Other Eligibility criteria|3
19984|NCT01808092|95819|P2|Overall Study|Withdrawal by Subject|4
19985|NCT01808092|95820|P1|Overall Study|Withdrawal by Subject|9
19986|NCT01808092|95819|P2|Overall Study|Lost to Follow-up|7
19987|NCT01808092|95820|P1|Overall Study|Lost to Follow-up|3
19988|NCT01808092|95819|P2|Overall Study|Death|29
19989|NCT01808092|95820|P1|Overall Study|Death|39
19990|NCT01808066|95922|P1|Overall Study|Withdrawal by Subject|15
19991|NCT01807949|95929|P3|Overall Study|Randomized But Not Treated|2
19992|NCT01807949|95930|P2|Overall Study|Randomized But Not Treated|2
19993|NCT01807949|95931|P1|Overall Study|Randomized But Not Treated|0
19994|NCT01807949|95929|P3|Overall Study|Undefined|2
19995|NCT01807949|95930|P2|Overall Study|Undefined|1
19996|NCT01807949|95931|P1|Overall Study|Undefined|0
19997|NCT01807949|95929|P3|Overall Study|Non-Compliance|1
19998|NCT01807949|95930|P2|Overall Study|Non-Compliance|0
19999|NCT01807949|95931|P1|Overall Study|Non-Compliance|0
20000|NCT01807949|95929|P3|Overall Study|Withdrawal by Subject|2
20001|NCT01807949|95930|P2|Overall Study|Withdrawal by Subject|2
20002|NCT01807949|95931|P1|Overall Study|Withdrawal by Subject|1
20003|NCT01807949|95929|P3|Overall Study|Adverse Event|2
20004|NCT01807949|95930|P2|Overall Study|Adverse Event|2
20005|NCT01807949|95931|P1|Overall Study|Adverse Event|1
20006|NCT01807923|95983|P3|Overall Study|Randomized But Not Treated|5
20007|NCT01807923|95984|P2|Overall Study|Randomized But Not Treated|2
20008|NCT01807923|95985|P1|Overall Study|Randomized But Not Treated|3
20009|NCT01807923|95983|P3|Overall Study|Not Eligible (Genotype)|1
20010|NCT01807923|95984|P2|Overall Study|Not Eligible (Genotype)|0
20011|NCT01807923|95985|P1|Overall Study|Not Eligible (Genotype)|0
20012|NCT01807923|95983|P3|Overall Study|Physician Decision|1
20013|NCT01807923|95984|P2|Overall Study|Physician Decision|0
20014|NCT01807923|95985|P1|Overall Study|Physician Decision|0
20015|NCT01807923|95983|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
20016|NCT01807923|95984|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
20017|NCT01807923|95985|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
20018|NCT01807923|95983|P3|Overall Study|Adverse Event|2
20019|NCT01807923|95984|P2|Overall Study|Adverse Event|1
20020|NCT01807923|95985|P1|Overall Study|Adverse Event|2
20021|NCT01807234|96077|P6|Overall Study|Lack of Efficacy|1
20022|NCT01807234|96078|P5|Overall Study|Lack of Efficacy|1
20023|NCT01807234|96079|P4|Overall Study|Lack of Efficacy|0
20024|NCT01807234|96080|P3|Overall Study|Lack of Efficacy|0
20025|NCT01807234|96081|P2|Overall Study|Lack of Efficacy|0
20026|NCT01807234|96082|P1|Overall Study|Lack of Efficacy|0
20027|NCT01807234|96077|P6|Overall Study|Withdrawal by Subject|1
20028|NCT01807234|96078|P5|Overall Study|Withdrawal by Subject|2
20029|NCT01807234|96079|P4|Overall Study|Withdrawal by Subject|1
20030|NCT01807234|96080|P3|Overall Study|Withdrawal by Subject|1
20031|NCT01807234|96081|P2|Overall Study|Withdrawal by Subject|1
20032|NCT01807234|96082|P1|Overall Study|Withdrawal by Subject|3
20033|NCT01807234|96077|P6|Overall Study|Lost to Follow-up|2
20034|NCT01807234|96078|P5|Overall Study|Lost to Follow-up|1
20035|NCT01807234|96079|P4|Overall Study|Lost to Follow-up|1
20036|NCT01807234|96080|P3|Overall Study|Lost to Follow-up|1
20037|NCT01807234|96081|P2|Overall Study|Lost to Follow-up|5
20038|NCT01807234|96082|P1|Overall Study|Lost to Follow-up|2
20039|NCT01807156|96117|P1|Overall Study|Physician Decision|1
20040|NCT01806961|96141|P1|Overall Study|sponsor decision|16
20041|NCT01806779|96184|P3|Overall Study|Withdrawal by Subject|22
20042|NCT01806779|96185|P2|Overall Study|Withdrawal by Subject|23
20043|NCT01806779|96186|P1|Overall Study|Withdrawal by Subject|20
20044|NCT01806779|96184|P3|Overall Study|Lost to Follow-up|0
20045|NCT01806779|96185|P2|Overall Study|Lost to Follow-up|20
20046|NCT01806779|96186|P1|Overall Study|Lost to Follow-up|19
20047|NCT01806779|96184|P3|Overall Study|Lack of Efficacy|0
20048|NCT01806779|96185|P2|Overall Study|Lack of Efficacy|1
20049|NCT01806779|96186|P1|Overall Study|Lack of Efficacy|1
20050|NCT01806779|96184|P3|Overall Study|Physician Decision|1
20051|NCT01806779|96185|P2|Overall Study|Physician Decision|0
20052|NCT01806779|96186|P1|Overall Study|Physician Decision|2
20053|NCT01806714|96201|P2|Overall Study|No functioning phone number|170
20054|NCT01806714|96202|P1|Overall Study|No functioning phone number|200
20055|NCT01806623|96212|P1|Overall Study|Did not meet the inclusion criteria|56
20056|NCT01806623|96212|P1|Overall Study|Adverse Event|1
20057|NCT01806623|96212|P1|Overall Study|Withdrawal by Subject|1
20058|NCT01806584|96231|P2|Overall Study|Other unspecified|0
20059|NCT01806584|96232|P1|Overall Study|Other unspecified|1
20060|NCT01806584|96231|P2|Overall Study|Withdrawal by Subject|1
20061|NCT01806584|96232|P1|Overall Study|Withdrawal by Subject|1
20062|NCT01806584|96231|P2|Overall Study|Study terminated by sponsor|14
20063|NCT01806584|96232|P1|Overall Study|Study terminated by sponsor|9
20064|NCT01806584|96231|P2|Overall Study|Lost to Follow-up|2
20065|NCT01806584|96232|P1|Overall Study|Lost to Follow-up|0
20066|NCT01806584|96231|P2|Overall Study|Death|0
20067|NCT01806584|96232|P1|Overall Study|Death|1
20068|NCT01806584|96231|P2|Overall Study|Adverse Event|1
20069|NCT01806584|96232|P1|Overall Study|Adverse Event|2
20070|NCT01806545|96246|P2|Overall Study|Withdrawal by Subject|2
20071|NCT01806545|96247|P1|Overall Study|Withdrawal by Subject|3
20072|NCT01806545|96246|P2|Overall Study|Lost to Follow-up|0
20073|NCT01806545|96247|P1|Overall Study|Lost to Follow-up|1
20074|NCT01806545|96246|P2|Overall Study|Adverse Event|3
20075|NCT01806545|96247|P1|Overall Study|Adverse Event|2
20076|NCT01806389|96269|P1|Overall Study|Withdrawal by Subject|4
20077|NCT01806298|96283|P1|Overall Study|Other|5
20078|NCT01806298|96283|P1|Overall Study|Withdrawal by Subject|1
20079|NCT01806298|96283|P1|Overall Study|Protocol Non-compliance|1
20080|NCT01806298|96283|P1|Overall Study|Adverse Event|3
20081|NCT01806051|96293|P1|Overall Study|Withdrawal by Subject|6
20082|NCT01805180|96347|P3|Lead-in Donor Phase|screen failure|0
20083|NCT01805180|96348|P2|Lead-in Donor Phase|screen failure|0
20084|NCT01805180|96349|P1|Lead-in Donor Phase|screen failure|1
20085|NCT01804946|96387|P2|Overall Study|Do not meet inclusion criteria|2
20086|NCT01804946|96388|P1|Overall Study|Do not meet inclusion criteria|1
20087|NCT01804946|96387|P2|Overall Study|Insufficient data available|1
20088|NCT01804946|96388|P1|Overall Study|Insufficient data available|0
20089|NCT01804946|96387|P2|Overall Study|Adverse Event|1
20090|NCT01804946|96388|P1|Overall Study|Adverse Event|0
20091|NCT01804946|96387|P2|Overall Study|Protocol Violation|0
20092|NCT01804946|96388|P1|Overall Study|Protocol Violation|1
20093|NCT01804842|96426|P3|Overall Study|Personal Reason|1
20094|NCT01804842|96427|P2|Overall Study|Personal Reason|0
20095|NCT01804842|96428|P1|Overall Study|Personal Reason|0
20096|NCT01804842|96426|P3|Overall Study|Non-Compliance|0
20097|NCT01804842|96427|P2|Overall Study|Non-Compliance|1
20098|NCT01804842|96428|P1|Overall Study|Non-Compliance|1
20099|NCT01804842|96426|P3|Overall Study|Lost to Follow-up|0
20100|NCT01804842|96427|P2|Overall Study|Lost to Follow-up|0
20101|NCT01804842|96428|P1|Overall Study|Lost to Follow-up|1
20102|NCT01804842|96426|P3|Overall Study|Adverse Event|0
20103|NCT01804842|96427|P2|Overall Study|Adverse Event|1
20104|NCT01804842|96428|P1|Overall Study|Adverse Event|1
20105|NCT01804673|96445|P1|Overall Study|Unspecified|4
20106|NCT01804673|96445|P1|Overall Study|Use of Prohibited Medication|1
20107|NCT01804673|96445|P1|Overall Study|No Further Therapy Required|84
20108|NCT01804673|96445|P1|Overall Study|Change to Oral Therapy|37
20109|NCT01804673|96445|P1|Overall Study|Lack of Efficacy|9
20110|NCT01804673|96445|P1|Overall Study|Withdrawal by Subject|1
20111|NCT01804673|96445|P1|Overall Study|Adverse Event|4
20112|NCT01804140|96465|P1|Overall Study|No sampling or biopsy procedures done|114
20113|NCT01803737|96523|P2|Overall Study|Lost to Follow-up|2
20114|NCT01803737|96524|P1|Overall Study|Lost to Follow-up|0
20115|NCT01803737|96523|P2|Overall Study|Medical Reason|1
20116|NCT01803737|96524|P1|Overall Study|Medical Reason|0
20117|NCT01803737|96523|P2|Overall Study|Lack of Time|0
20118|NCT01803737|96524|P1|Overall Study|Lack of Time|1
20119|NCT01803607|96548|P2|Overall Study|Withdrawal by Subject|5
20120|NCT01803607|96549|P1|Overall Study|Withdrawal by Subject|6
20121|NCT01803607|96548|P2|Overall Study|Study terminated by sponsor|56
20122|NCT01803607|96549|P1|Overall Study|Study terminated by sponsor|54
20123|NCT01803607|96548|P2|Overall Study|Protocol Violation|2
20124|NCT01803607|96549|P1|Overall Study|Protocol Violation|3
20125|NCT01803607|96548|P2|Overall Study|Lack of Efficacy|1
20126|NCT01803607|96549|P1|Overall Study|Lack of Efficacy|0
20127|NCT01803607|96548|P2|Overall Study|Adverse Event|3
20128|NCT01803607|96549|P1|Overall Study|Adverse Event|5
20129|NCT01802632|96575|P6|Overall Study|Other (not specified)|1
20130|NCT01802632|96576|P5|Overall Study|Other (not specified)|0
20131|NCT01802632|96577|P4|Overall Study|Other (not specified)|1
20132|NCT01802632|96578|P3|Overall Study|Other (not specified)|7
20133|NCT01802632|96579|P2|Overall Study|Other (not specified)|0
20134|NCT01802632|96580|P1|Overall Study|Other (not specified)|0
20135|NCT01802632|96575|P6|Overall Study|Ongoing Study at Data Cut-off|22
20136|NCT01802632|96576|P5|Overall Study|Ongoing Study at Data Cut-off|6
20137|NCT01802632|96577|P4|Overall Study|Ongoing Study at Data Cut-off|50
20138|NCT01802632|96578|P3|Overall Study|Ongoing Study at Data Cut-off|115
20139|NCT01802632|96579|P2|Overall Study|Ongoing Study at Data Cut-off|16
20140|NCT01802632|96580|P1|Overall Study|Ongoing Study at Data Cut-off|168
20141|NCT01802632|96575|P6|Overall Study|Objective Disease Progression|4
20142|NCT01802632|96576|P5|Overall Study|Objective Disease Progression|4
20143|NCT01802632|96577|P4|Overall Study|Objective Disease Progression|6
20144|NCT01802632|96578|P3|Overall Study|Objective Disease Progression|104
20145|NCT01802632|96579|P2|Overall Study|Objective Disease Progression|12
20146|NCT01802632|96580|P1|Overall Study|Objective Disease Progression|1
20147|NCT01802632|96575|P6|Overall Study|Withdrawal by Subject|1
20148|NCT01802632|96576|P5|Overall Study|Withdrawal by Subject|0
20149|NCT01802632|96577|P4|Overall Study|Withdrawal by Subject|3
20150|NCT01802632|96578|P3|Overall Study|Withdrawal by Subject|7
20151|NCT01802632|96579|P2|Overall Study|Withdrawal by Subject|2
20152|NCT01802632|96580|P1|Overall Study|Withdrawal by Subject|4
20153|NCT01802632|96575|P6|Overall Study|Death|0
20154|NCT01802632|96576|P5|Overall Study|Death|2
20155|NCT01802632|96577|P4|Overall Study|Death|0
20156|NCT01802632|96578|P3|Overall Study|Death|38
20157|NCT01802632|96579|P2|Overall Study|Death|1
20158|NCT01802632|96580|P1|Overall Study|Death|28
20159|NCT01802515|96614|P3|Overall Study|Withdrawal by Subject|0
20160|NCT01802515|96615|P2|Overall Study|Withdrawal by Subject|0
20161|NCT01802515|96616|P1|Overall Study|Withdrawal by Subject|3
20162|NCT01802320|96627|P1|Overall Study|Withdrawal by Subject|1
20163|NCT01802320|96627|P1|Overall Study|Death|1
20164|NCT01801982|96701|P1|Overall Study|Lost to Follow-up|1
20165|NCT01801735|96711|P1|Overall Study|Other, including site closure|19
20166|NCT01801735|96711|P1|Overall Study|Death|1
20167|NCT01801735|96711|P1|Overall Study|Physician Decision|3
20168|NCT01801735|96711|P1|Overall Study|Non-compliance with Trial Drug|13
20169|NCT01801735|96711|P1|Overall Study|Lost to Follow-up|15
20170|NCT01801735|96711|P1|Overall Study|Protocol Violation|25
20171|NCT01801735|96711|P1|Overall Study|Withdrawal by Subject|27
20172|NCT01801735|96711|P1|Overall Study|Lack of Efficacy|28
20173|NCT01801735|96711|P1|Overall Study|Adverse Event|79
20174|NCT01801475|96718|P5|Overall Study|Withdrawal by Subject|1
20175|NCT01801475|96719|P4|Overall Study|Withdrawal by Subject|0
20176|NCT01801475|96720|P3|Overall Study|Withdrawal by Subject|0
20177|NCT01801475|96721|P2|Overall Study|Withdrawal by Subject|0
20178|NCT01801475|96722|P1|Overall Study|Withdrawal by Subject|0
20179|NCT01801436|96733|P1|Overall Study|Progressive disease|4
20180|NCT01801436|96733|P1|Overall Study|Adverse Event|2
20181|NCT01801436|96733|P1|Overall Study|Withdrawal by Subject|3
20182|NCT01801358|96771|P6|Overall Study|Withdrawal by Subject|2
20183|NCT01801358|96772|P5|Overall Study|Withdrawal by Subject|0
20184|NCT01801358|96773|P4|Overall Study|Withdrawal by Subject|1
20185|NCT01801358|96774|P3|Overall Study|Withdrawal by Subject|0
20186|NCT01801358|96775|P2|Overall Study|Withdrawal by Subject|0
20187|NCT01801358|96776|P1|Overall Study|Withdrawal by Subject|0
20188|NCT01801358|96771|P6|Overall Study|Progressive Disease|5
20189|NCT01801358|96772|P5|Overall Study|Progressive Disease|6
20190|NCT01801358|96773|P4|Overall Study|Progressive Disease|5
20191|NCT01801358|96774|P3|Overall Study|Progressive Disease|4
20192|NCT01801358|96775|P2|Overall Study|Progressive Disease|4
20193|NCT01801358|96776|P1|Overall Study|Progressive Disease|6
20194|NCT01801358|96771|P6|Overall Study|Physician Decision|0
20195|NCT01801358|96772|P5|Overall Study|Physician Decision|0
20196|NCT01801358|96773|P4|Overall Study|Physician Decision|0
20197|NCT01801358|96774|P3|Overall Study|Physician Decision|1
20198|NCT01801358|96775|P2|Overall Study|Physician Decision|0
20199|NCT01801358|96776|P1|Overall Study|Physician Decision|0
20200|NCT01801358|96771|P6|Overall Study|Adverse Event|1
20201|NCT01801358|96772|P5|Overall Study|Adverse Event|0
20202|NCT01801358|96773|P4|Overall Study|Adverse Event|0
20203|NCT01801358|96774|P3|Overall Study|Adverse Event|1
20204|NCT01801358|96775|P2|Overall Study|Adverse Event|2
20205|NCT01801358|96776|P1|Overall Study|Adverse Event|0
20206|NCT01801280|96898|P4|Period 4|Protocol Violation|0
20207|NCT01801280|96899|P3|Period 4|Protocol Violation|1
20208|NCT01801280|96900|P2|Period 4|Protocol Violation|0
20209|NCT01801280|96901|P1|Period 4|Protocol Violation|0
20210|NCT01801280|96898|P4|Period 2|Withdrawal by Subject|0
20211|NCT01801280|96899|P3|Period 2|Withdrawal by Subject|0
20212|NCT01801280|96900|P2|Period 2|Withdrawal by Subject|0
20213|NCT01801280|96901|P1|Period 2|Withdrawal by Subject|1
20214|NCT01801280|96898|P4|Period 1|Withdrawal by Subject|0
20215|NCT01801280|96899|P3|Period 1|Withdrawal by Subject|0
20216|NCT01801280|96900|P2|Period 1|Withdrawal by Subject|1
20217|NCT01801280|96901|P1|Period 1|Withdrawal by Subject|0
20218|NCT01801111|96916|P1|Overall Study|On-going Survival Follow up|25
20219|NCT01801111|96916|P1|Overall Study|Death|24
20220|NCT01801111|96916|P1|Overall Study|Treatment On-going|89
20221|NCT01800968|96941|P2|Overall Study|Physician Decision|0
20222|NCT01800968|96942|P1|Overall Study|Physician Decision|1
20223|NCT01800968|96941|P2|Overall Study|Withdrawal by Subject|9
20224|NCT01800968|96942|P1|Overall Study|Withdrawal by Subject|7
20225|NCT01800968|96941|P2|Overall Study|Lost to Follow-up|7
20226|NCT01800968|96942|P1|Overall Study|Lost to Follow-up|5
20227|NCT01800968|96941|P2|Overall Study|Death|16
20228|NCT01800968|96942|P1|Overall Study|Death|23
20229|NCT01800916|96984|P9|Test Period 1 (1 Week)|Adverse Event|0
20230|NCT01800916|96985|P8|Test Period 1 (1 Week)|Adverse Event|0
20231|NCT01800916|96986|P7|Test Period 1 (1 Week)|Adverse Event|0
20232|NCT01800916|96987|P6|Test Period 1 (1 Week)|Adverse Event|0
20233|NCT01800916|96988|P5|Test Period 1 (1 Week)|Adverse Event|1
20234|NCT01800916|96989|P4|Test Period 1 (1 Week)|Adverse Event|0
20235|NCT01800916|96990|P3|Test Period 1 (1 Week)|Adverse Event|0
20236|NCT01800916|96991|P2|Test Period 1 (1 Week)|Adverse Event|0
20237|NCT01800916|96992|P1|Test Period 1 (1 Week)|Adverse Event|0
20238|NCT01800916|96984|P9|Test Period 1 (1 Week)|Convex product user|0
20239|NCT01800916|96985|P8|Test Period 1 (1 Week)|Convex product user|0
20240|NCT01800916|96986|P7|Test Period 1 (1 Week)|Convex product user|0
20241|NCT01800916|96987|P6|Test Period 1 (1 Week)|Convex product user|0
20242|NCT01800916|96988|P5|Test Period 1 (1 Week)|Convex product user|0
20243|NCT01800916|96989|P4|Test Period 1 (1 Week)|Convex product user|1
20244|NCT01800916|96990|P3|Test Period 1 (1 Week)|Convex product user|0
20245|NCT01800916|96991|P2|Test Period 1 (1 Week)|Convex product user|0
20246|NCT01800916|96992|P1|Test Period 1 (1 Week)|Convex product user|0
20247|NCT01800903|97002|P6|Second Test Period|unable to catheterise|0
20248|NCT01800903|97003|P5|Second Test Period|unable to catheterise|0
20249|NCT01800903|97004|P4|Second Test Period|unable to catheterise|0
20250|NCT01800903|97005|P3|Second Test Period|unable to catheterise|0
20251|NCT01800903|97006|P2|Second Test Period|unable to catheterise|0
20252|NCT01800903|97007|P1|Second Test Period|unable to catheterise|1
20253|NCT01799941|97084|P1|Overall Study|Not Specified|15
20254|NCT01799941|97084|P1|Overall Study|Lost to Follow-up|17
20255|NCT01799941|97084|P1|Overall Study|Lack of Efficacy|3
20256|NCT01799941|97084|P1|Overall Study|Investigator Decision|4
20257|NCT01799941|97084|P1|Overall Study|Death|2
20258|NCT01799941|97084|P1|Overall Study|Withdrawal by Subject|21
20259|NCT01799941|97084|P1|Overall Study|Adverse Event|34
20260|NCT01799720|97141|P3|Overall Study|Pregnancy|1
20261|NCT01799720|97142|P2|Overall Study|Pregnancy|0
20262|NCT01799720|97143|P1|Overall Study|Pregnancy|0
20263|NCT01799720|97141|P3|Overall Study|Protocol Violation|0
20264|NCT01799720|97142|P2|Overall Study|Protocol Violation|1
20265|NCT01799720|97143|P1|Overall Study|Protocol Violation|0
20266|NCT01799720|97141|P3|Overall Study|Withdrawal by Subject|0
20267|NCT01799720|97142|P2|Overall Study|Withdrawal by Subject|0
20268|NCT01799720|97143|P1|Overall Study|Withdrawal by Subject|3
20269|NCT01799590|97181|P3|Overall Study|Unspecified|1
20270|NCT01799590|97182|P2|Overall Study|Unspecified|0
20271|NCT01799590|97183|P1|Overall Study|Unspecified|3
20272|NCT01799590|97181|P3|Overall Study|Use of prohibited concomitant drugs|0
20273|NCT01799590|97182|P2|Overall Study|Use of prohibited concomitant drugs|0
20274|NCT01799590|97183|P1|Overall Study|Use of prohibited concomitant drugs|1
20275|NCT01799590|97181|P3|Overall Study|Using drugs with restricted days of use|2
20276|NCT01799590|97182|P2|Overall Study|Using drugs with restricted days of use|3
20277|NCT01799590|97183|P1|Overall Study|Using drugs with restricted days of use|0
20278|NCT01799590|97181|P3|Overall Study|Aggravation of complications|1
20279|NCT01799590|97182|P2|Overall Study|Aggravation of complications|1
20280|NCT01799590|97183|P1|Overall Study|Aggravation of complications|0
20281|NCT01799590|97181|P3|Overall Study|Participants convenience|2
20282|NCT01799590|97182|P2|Overall Study|Participants convenience|4
20283|NCT01799590|97183|P1|Overall Study|Participants convenience|4
20284|NCT01799590|97181|P3|Overall Study|Lack of Efficacy|3
20285|NCT01799590|97182|P2|Overall Study|Lack of Efficacy|1
20286|NCT01799590|97183|P1|Overall Study|Lack of Efficacy|3
20287|NCT01799590|97181|P3|Overall Study|Pregnancy|0
20288|NCT01799590|97182|P2|Overall Study|Pregnancy|0
20289|NCT01799590|97183|P1|Overall Study|Pregnancy|2
20290|NCT01799590|97181|P3|Overall Study|Adverse Event|5
20291|NCT01799590|97182|P2|Overall Study|Adverse Event|7
20292|NCT01799590|97183|P1|Overall Study|Adverse Event|13
20293|NCT01799239|97218|P2|Period 2 (7 Days)|Protocol Violation|0
20294|NCT01799239|97219|P1|Period 2 (7 Days)|Protocol Violation|1
20295|NCT01799239|97218|P2|Period 2 (7 Days)|Withdrawal by Subject|1
20296|NCT01799239|97219|P1|Period 2 (7 Days)|Withdrawal by Subject|1
20297|NCT01799239|97218|P2|Period 1 (7 Days)|Protocol Violation|1
20298|NCT01799239|97219|P1|Period 1 (7 Days)|Protocol Violation|0
20299|NCT01799239|97218|P2|Period 1 (7 Days)|Withdrawal by Subject|0
20300|NCT01799239|97219|P1|Period 1 (7 Days)|Withdrawal by Subject|2
20301|NCT01799239|97218|P2|Period 1 (7 Days)|Lack of Efficacy|0
20302|NCT01799239|97219|P1|Period 1 (7 Days)|Lack of Efficacy|1
20303|NCT01799226|97227|P2|Overall Study|Disqualified at Day 14|0
20304|NCT01799226|97228|P1|Overall Study|Disqualified at Day 14|1
20305|NCT01799226|97227|P2|Overall Study|Withdrawal by Subject|0
20306|NCT01799226|97228|P1|Overall Study|Withdrawal by Subject|1
20307|NCT01798992|97240|P4|Overall Study|Insufficient biopsy tissue|0
20308|NCT01798992|97241|P3|Overall Study|Insufficient biopsy tissue|1
20309|NCT01798992|97242|P2|Overall Study|Insufficient biopsy tissue|0
20310|NCT01798992|97243|P1|Overall Study|Insufficient biopsy tissue|0
20311|NCT01798992|97240|P4|Overall Study|Lost to Follow-up|0
20312|NCT01798992|97241|P3|Overall Study|Lost to Follow-up|1
20313|NCT01798992|97242|P2|Overall Study|Lost to Follow-up|1
20314|NCT01798992|97243|P1|Overall Study|Lost to Follow-up|0
20315|NCT01798992|97240|P4|Overall Study|Administrative withdrawal|1
20316|NCT01798992|97241|P3|Overall Study|Administrative withdrawal|0
20317|NCT01798992|97242|P2|Overall Study|Administrative withdrawal|1
20318|NCT01798992|97243|P1|Overall Study|Administrative withdrawal|0
20319|NCT01798927|97263|P1|Overall Study|Withdrawal by Subject|1
20320|NCT01798706|97271|P2|Overall Study|Other than specified above|9
20321|NCT01798706|97272|P1|Overall Study|Other than specified above|5
20322|NCT01798706|97271|P2|Overall Study|Poor compliance to protocol|0
20323|NCT01798706|97272|P1|Overall Study|Poor compliance to protocol|1
20324|NCT01798706|97271|P2|Overall Study|Lack of Efficacy|2
20325|NCT01798706|97272|P1|Overall Study|Lack of Efficacy|0
20326|NCT01798706|97271|P2|Overall Study|Adverse Event|10
20327|NCT01798706|97272|P1|Overall Study|Adverse Event|15
20328|NCT01798485|97300|P2|Overall Study|Clinical Progression|24
20329|NCT01798485|97301|P1|Overall Study|Clinical Progression|35
20330|NCT01798485|97300|P2|Overall Study|Sponsor Decision|54
20331|NCT01798485|97301|P1|Overall Study|Sponsor Decision|61
20332|NCT01798485|97300|P2|Overall Study|Death|22
20333|NCT01798485|97301|P1|Overall Study|Death|25
20334|NCT01798485|97300|P2|Overall Study|Objective Disease Progression|106
20335|NCT01798485|97301|P1|Overall Study|Objective Disease Progression|152
20336|NCT01798485|97300|P2|Overall Study|Physician Decision|10
20337|NCT01798485|97301|P1|Overall Study|Physician Decision|14
20338|NCT01798485|97300|P2|Overall Study|Lost to Follow-up|3
20339|NCT01798485|97301|P1|Overall Study|Lost to Follow-up|0
20340|NCT01798485|97300|P2|Overall Study|Withdrawal by Subject|31
20341|NCT01798485|97301|P1|Overall Study|Withdrawal by Subject|27
20342|NCT01798485|97300|P2|Overall Study|Adverse Event|40
20343|NCT01798485|97301|P1|Overall Study|Adverse Event|32
20344|NCT01798134|97427|P1|Overall Study|Liver transplant/surgery|4
20345|NCT01798134|97427|P1|Overall Study|Physician Decision|3
20346|NCT01798134|97427|P1|Overall Study|Adverse Event|3
20347|NCT01798134|97427|P1|Overall Study|Death|2
20348|NCT01798134|97427|P1|Overall Study|Withdrawal by Subject|3
20349|NCT01798134|97427|P1|Overall Study|Lost to Follow-up|1
20350|NCT01798004|97434|P1|Overall Study|Enrollment another COG therapeutic trial|32
20351|NCT01798004|97434|P1|Overall Study|Initiation of other non-protocol therapy|5
20352|NCT01798004|97434|P1|Overall Study|Patient/parent refusal|7
20353|NCT01798004|97434|P1|Overall Study|Ineligible|4
20354|NCT01798004|97434|P1|Overall Study|Withdrawal by Subject|4
20355|NCT01798004|97434|P1|Overall Study|Physician Decision|25
20356|NCT01798004|97434|P1|Overall Study|Lack of Efficacy|8
20357|NCT01798004|97434|P1|Overall Study|Death|2
20358|NCT01797783|97440|P2|Overall Study|Withdrawal by Subject|0
20359|NCT01797783|97441|P1|Overall Study|Withdrawal by Subject|1
20360|NCT01797783|97440|P2|Overall Study|Adverse Event|1
20361|NCT01797783|97441|P1|Overall Study|Adverse Event|1
20362|NCT01797731|97465|P2|Overall Study|Didn't have proper radiographs required|3
20363|NCT01797731|97466|P1|Overall Study|Didn't have proper radiographs required|3
20364|NCT01797705|97474|P1|Overall Study|Withdrawal by Subject|1
20365|NCT01797705|97474|P1|Overall Study|Equipment anomalies during sleep studies|4
20366|NCT01797536|97482|P4|Overall Study|Adverse Event|0
20367|NCT01797536|97483|P3|Overall Study|Adverse Event|0
20368|NCT01797536|97484|P2|Overall Study|Adverse Event|1
20369|NCT01797536|97485|P1|Overall Study|Adverse Event|0
20370|NCT01797445|97517|P2|Overall Study|Still on Study|383
20371|NCT01797445|97518|P1|Overall Study|Still on Study|381
20372|NCT01797445|97517|P2|Overall Study|Lost to Follow-up|15
20373|NCT01797445|97518|P1|Overall Study|Lost to Follow-up|22
20374|NCT01797445|97517|P2|Overall Study|Withdrew Consent|19
20375|NCT01797445|97518|P1|Overall Study|Withdrew Consent|12
20376|NCT01797445|97517|P2|Overall Study|Protocol Violation|1
20377|NCT01797445|97518|P1|Overall Study|Protocol Violation|0
20378|NCT01797445|97517|P2|Overall Study|Noncompliance with Study Drug|1
20379|NCT01797445|97518|P1|Overall Study|Noncompliance with Study Drug|3
20380|NCT01797445|97517|P2|Overall Study|Investigator's Discretion|12
20381|NCT01797445|97518|P1|Overall Study|Investigator's Discretion|8
20382|NCT01797445|97517|P2|Overall Study|Lack of Efficacy|2
20383|NCT01797445|97518|P1|Overall Study|Lack of Efficacy|1
20384|NCT01797445|97517|P2|Overall Study|Death|2
20385|NCT01797445|97518|P1|Overall Study|Death|1
20386|NCT01797445|97517|P2|Overall Study|Adverse Event|0
20387|NCT01797445|97518|P1|Overall Study|Adverse Event|3
20388|NCT01797445|97517|P2|Overall Study|Randomized but Not Treated|2
20389|NCT01797445|97518|P1|Overall Study|Randomized but Not Treated|4
20390|NCT01797094|97576|P2|Overall Study|Other Miscellaneous Reasons|0
20391|NCT01797094|97577|P1|Overall Study|Other Miscellaneous Reasons|1
20392|NCT01797094|97576|P2|Overall Study|Protocol Violation|1
20393|NCT01797094|97577|P1|Overall Study|Protocol Violation|0
20394|NCT01797094|97576|P2|Overall Study|Personal Reasons|0
20395|NCT01797094|97577|P1|Overall Study|Personal Reasons|4
20396|NCT01797094|97576|P2|Overall Study|Adverse Event|1
20397|NCT01797094|97577|P1|Overall Study|Adverse Event|1
20398|NCT01797081|97599|P4|Overall Study|Protocol Violation|1
20399|NCT01797081|97600|P3|Overall Study|Protocol Violation|0
20400|NCT01797081|97601|P2|Overall Study|Protocol Violation|0
20401|NCT01797081|97602|P1|Overall Study|Protocol Violation|0
20402|NCT01797081|97599|P4|Overall Study|Personal Reasons|8
20403|NCT01797081|97600|P3|Overall Study|Personal Reasons|4
20404|NCT01797081|97601|P2|Overall Study|Personal Reasons|4
20405|NCT01797081|97602|P1|Overall Study|Personal Reasons|12
20406|NCT01797081|97599|P4|Overall Study|Pregnancy|0
20407|NCT01797081|97600|P3|Overall Study|Pregnancy|0
20408|NCT01797081|97601|P2|Overall Study|Pregnancy|0
20409|NCT01797081|97602|P1|Overall Study|Pregnancy|1
20410|NCT01797081|97599|P4|Overall Study|Adverse Event|0
20411|NCT01797081|97600|P3|Overall Study|Adverse Event|1
20412|NCT01797081|97601|P2|Overall Study|Adverse Event|0
20413|NCT01797081|97602|P1|Overall Study|Adverse Event|1
20414|NCT01796964|97643|P2|Overall Study|Withdrawal by Subject|1
20415|NCT01796964|97644|P1|Overall Study|Withdrawal by Subject|1
20416|NCT01796964|97643|P2|Overall Study|Protocol Violation|1
20417|NCT01796964|97644|P1|Overall Study|Protocol Violation|0
20418|NCT01796964|97643|P2|Overall Study|Death|0
20419|NCT01796964|97644|P1|Overall Study|Death|1
20420|NCT01796964|97643|P2|Overall Study|Adverse Event|1
20421|NCT01796964|97644|P1|Overall Study|Adverse Event|1
20422|NCT01796860|97666|P1|Overall Study|Withdrawal by Subject|3
20423|NCT01796548|97672|P1|Overall Study|unspecified|2
20424|NCT01796548|97672|P1|Overall Study|Lost to Follow-up|1
20425|NCT01795937|97706|P3|Overall Study|Physician Decision|0
20426|NCT01795937|97707|P2|Overall Study|Physician Decision|1
20427|NCT01795937|97708|P1|Overall Study|Physician Decision|0
20428|NCT01795937|97706|P3|Overall Study|Withdrawal by Subject|0
20429|NCT01795937|97707|P2|Overall Study|Withdrawal by Subject|0
20430|NCT01795937|97708|P1|Overall Study|Withdrawal by Subject|1
20431|NCT01795898|97737|P1|Overall Study|Physician Decision|1
20432|NCT01795898|97737|P1|Overall Study|Withdrew consent & had adverse events|3
20433|NCT01795898|97737|P1|Overall Study|Death|1
20434|NCT01795898|97737|P1|Overall Study|No pain|1
20435|NCT01795898|97737|P1|Overall Study|Diagnosed with metastasis|1
20436|NCT01795898|97737|P1|Overall Study|Withdrawal of consent|6
20437|NCT01795898|97737|P1|Overall Study|Lost to Follow-up|20
20438|NCT01795898|97737|P1|Overall Study|Adverse Event|27
20439|NCT01795547|97773|P2|Overall Study|Not stated|1
20440|NCT01795547|97774|P1|Overall Study|Not stated|0
20441|NCT01795547|97773|P2|Overall Study|Others|1
20442|NCT01795547|97774|P1|Overall Study|Others|4
20443|NCT01795547|97773|P2|Overall Study|Non-compliance with IMP|1
20444|NCT01795547|97774|P1|Overall Study|Non-compliance with IMP|1
20445|NCT01795547|97773|P2|Overall Study|Not Treated|10
20446|NCT01795547|97774|P1|Overall Study|Not Treated|4
20447|NCT01795547|97773|P2|Overall Study|Withdrawal of consent|12
20448|NCT01795547|97774|P1|Overall Study|Withdrawal of consent|7
20449|NCT01795547|97773|P2|Overall Study|Lost to Follow-up|5
20450|NCT01795547|97774|P1|Overall Study|Lost to Follow-up|2
20451|NCT01795547|97773|P2|Overall Study|Protocol Violation|4
20452|NCT01795547|97774|P1|Overall Study|Protocol Violation|6
20453|NCT01795547|97773|P2|Overall Study|Lack of Efficacy|3
20454|NCT01795547|97774|P1|Overall Study|Lack of Efficacy|8
20455|NCT01795547|97773|P2|Overall Study|Adverse Event|27
20456|NCT01795547|97774|P1|Overall Study|Adverse Event|16
20457|NCT01794949|97805|P2|Overall Study|Lost to Follow-up|0
20458|NCT01794949|97806|P1|Overall Study|Lost to Follow-up|1
20459|NCT01794845|97817|P1|Overall Study|Withdrawal by Subject|1
20460|NCT01794000|97867|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
20461|NCT01794000|97868|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
20462|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
20463|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
20464|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
20465|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
20466|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Physician Decision|0
20467|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Physician Decision|2
20468|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
20469|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
20470|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
20471|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
20472|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Death|2
20473|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Death|1
20474|NCT01794000|97867|P2|Double-Blind Phase (DBP)|Adverse Event|2
20475|NCT01794000|97868|P1|Double-Blind Phase (DBP)|Adverse Event|5
20476|NCT01793688|97899|P1|Overall Study|Protocol Violation|2
20477|NCT01792830|97941|P7|Overall Study|Adverse Event|0
20478|NCT01792830|97942|P6|Overall Study|Adverse Event|0
20479|NCT01792830|97943|P5|Overall Study|Adverse Event|1
20480|NCT01792830|97944|P4|Overall Study|Adverse Event|0
20481|NCT01792830|97945|P3|Overall Study|Adverse Event|0
20482|NCT01792830|97946|P2|Overall Study|Adverse Event|0
20483|NCT01792830|97947|P1|Overall Study|Adverse Event|0
20484|NCT01792830|97941|P7|Overall Study|Death|1
20485|NCT01792830|97942|P6|Overall Study|Death|0
20486|NCT01792830|97943|P5|Overall Study|Death|2
20487|NCT01792830|97944|P4|Overall Study|Death|1
20488|NCT01792830|97945|P3|Overall Study|Death|0
20489|NCT01792830|97946|P2|Overall Study|Death|0
20490|NCT01792830|97947|P1|Overall Study|Death|3
20491|NCT01792830|97941|P7|Overall Study|Withdrawal by Subject|2
20492|NCT01792830|97942|P6|Overall Study|Withdrawal by Subject|0
20493|NCT01792830|97943|P5|Overall Study|Withdrawal by Subject|9
20494|NCT01792830|97944|P4|Overall Study|Withdrawal by Subject|4
20495|NCT01792830|97945|P3|Overall Study|Withdrawal by Subject|0
20496|NCT01792830|97946|P2|Overall Study|Withdrawal by Subject|0
20497|NCT01792830|97947|P1|Overall Study|Withdrawal by Subject|22
20498|NCT01792635|97978|P3|Part B|Study terminated|3
20499|NCT01792635|97979|P2|Part B|Study terminated|4
20500|NCT01792635|97980|P1|Part B|Study terminated|0
20501|NCT01792635|97978|P3|Part B|Adverse Event|1
20502|NCT01792635|97979|P2|Part B|Adverse Event|0
20503|NCT01792635|97980|P1|Part B|Adverse Event|0
20504|NCT01792518|98008|P2|Overall Study|Other Reason|1
20505|NCT01792518|98009|P1|Overall Study|Other Reason|0
20506|NCT01792518|98008|P2|Overall Study|Withdrawal by Subject|0
20507|NCT01792518|98009|P1|Overall Study|Withdrawal by Subject|2
20508|NCT01792518|98008|P2|Overall Study|Lost to Follow-up|1
20509|NCT01792518|98009|P1|Overall Study|Lost to Follow-up|3
20510|NCT01792518|98008|P2|Overall Study|Protocol Violation|1
20511|NCT01792518|98009|P1|Overall Study|Protocol Violation|0
20512|NCT01792518|98008|P2|Overall Study|Adverse Event|4
20513|NCT01792518|98009|P1|Overall Study|Adverse Event|3
20514|NCT01791894|98032|P1|Overall Study|Adverse Event|1
20515|NCT01791803|98043|P4|Overall Study|Death|2
20516|NCT01791803|98044|P3|Overall Study|Death|2
20517|NCT01791803|98045|P2|Overall Study|Death|0
20518|NCT01791803|98046|P1|Overall Study|Death|0
20519|NCT01791803|98043|P4|Overall Study|Physician Decision|1
20520|NCT01791803|98044|P3|Overall Study|Physician Decision|0
20521|NCT01791803|98045|P2|Overall Study|Physician Decision|2
20522|NCT01791803|98046|P1|Overall Study|Physician Decision|0
20523|NCT01791803|98043|P4|Overall Study|Withdrawal by Subject|2
20524|NCT01791803|98044|P3|Overall Study|Withdrawal by Subject|0
20525|NCT01791803|98045|P2|Overall Study|Withdrawal by Subject|0
20526|NCT01791803|98046|P1|Overall Study|Withdrawal by Subject|0
20527|NCT01791725|98064|P3|Overall Study|Withdrawal by Subject|0
20528|NCT01791725|98065|P2|Overall Study|Withdrawal by Subject|1
20529|NCT01791725|98066|P1|Overall Study|Withdrawal by Subject|0
20530|NCT01791413|98124|P2|Overall Study|Lost to Follow-up|1
20531|NCT01791413|98125|P1|Overall Study|Lost to Follow-up|5
20532|NCT01791244|98134|P2|Overall Study|Laboratory Abnormality|1
20533|NCT01791244|98135|P1|Overall Study|Laboratory Abnormality|0
20534|NCT01791244|98134|P2|Overall Study|Insufficient clinical response|10
20535|NCT01791244|98135|P1|Overall Study|Insufficient clinical response|10
20536|NCT01791244|98134|P2|Overall Study|Adverse Event|7
20537|NCT01791244|98135|P1|Overall Study|Adverse Event|5
20538|NCT01791205|98171|P2|Phase II|Physician’s decision|0
20539|NCT01791205|98172|P1|Phase II|Physician’s decision|1
20540|NCT01791205|98171|P2|Phase II|Remission of disease|0
20541|NCT01791205|98172|P1|Phase II|Remission of disease|1
20542|NCT01791205|98171|P2|Phase II|Lost to Follow-up|0
20543|NCT01791205|98172|P1|Phase II|Lost to Follow-up|1
20544|NCT01791205|98171|P2|Phase II|Safety|0
20545|NCT01791205|98172|P1|Phase II|Safety|1
20546|NCT01791205|98171|P2|Phase II|Adverse Event|0
20547|NCT01791205|98172|P1|Phase II|Adverse Event|2
20548|NCT01791205|98171|P2|Phase II|Lack of Efficacy|0
20549|NCT01791205|98172|P1|Phase II|Lack of Efficacy|6
20550|NCT01791153|98256|P4|Overall Study|Withdrawal by Subject|1
20551|NCT01791153|98257|P3|Overall Study|Withdrawal by Subject|2
20552|NCT01791153|98258|P2|Overall Study|Withdrawal by Subject|2
20553|NCT01791153|98259|P1|Overall Study|Withdrawal by Subject|6
20554|NCT01791153|98256|P4|Overall Study|Protocol Violation|1
20555|NCT01791153|98257|P3|Overall Study|Protocol Violation|0
20556|NCT01791153|98258|P2|Overall Study|Protocol Violation|0
20557|NCT01791153|98259|P1|Overall Study|Protocol Violation|0
20558|NCT01791153|98256|P4|Overall Study|Physician Decision|1
20559|NCT01791153|98257|P3|Overall Study|Physician Decision|0
20560|NCT01791153|98258|P2|Overall Study|Physician Decision|0
20561|NCT01791153|98259|P1|Overall Study|Physician Decision|0
20562|NCT01791153|98256|P4|Overall Study|Non-Compliance|0
20563|NCT01791153|98257|P3|Overall Study|Non-Compliance|0
20564|NCT01791153|98258|P2|Overall Study|Non-Compliance|0
20565|NCT01791153|98259|P1|Overall Study|Non-Compliance|1
20566|NCT01791153|98256|P4|Overall Study|Lack of Efficacy|2
20567|NCT01791153|98257|P3|Overall Study|Lack of Efficacy|2
20568|NCT01791153|98258|P2|Overall Study|Lack of Efficacy|3
20569|NCT01791153|98259|P1|Overall Study|Lack of Efficacy|1
20570|NCT01791153|98256|P4|Overall Study|Adverse Event|0
20571|NCT01791153|98257|P3|Overall Study|Adverse Event|2
20572|NCT01791153|98258|P2|Overall Study|Adverse Event|3
20573|NCT01791153|98259|P1|Overall Study|Adverse Event|7
20574|NCT01790828|98315|P1|Overall Study|Not specified|34
20575|NCT01790633|98375|P2|Overall Study|RT failure and no follow-up ELISA|3
20576|NCT01790633|98376|P1|Overall Study|RT failure and no follow-up ELISA|0
20577|NCT01790633|98375|P2|Overall Study|Did not have serology performed|0
20578|NCT01790633|98376|P1|Overall Study|Did not have serology performed|47
20579|NCT01790633|98375|P2|Overall Study|Protocol Violation|2
20580|NCT01790633|98376|P1|Overall Study|Protocol Violation|1
20581|NCT01790516|98400|P2|Overall Study|Physician Decision|0
20582|NCT01790516|98401|P1|Overall Study|Physician Decision|1
20583|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
20584|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
20585|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
20586|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Not specified|3
20587|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
20588|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
20589|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
20590|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
20591|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
20592|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
20593|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
20594|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
20595|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
20596|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
20597|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
20598|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
20599|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
20600|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
20601|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
20602|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
20603|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
20604|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
20605|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
20606|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
20607|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
20608|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
20609|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
20610|NCT01789970|98442|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
20611|NCT01789970|98443|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
20612|NCT01789970|98444|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
20613|NCT01789970|98442|P3|Open-label Titration Period|Dropped out prior to dosing|0
20614|NCT01789970|98443|P2|Open-label Titration Period|Dropped out prior to dosing|0
20615|NCT01789970|98444|P1|Open-label Titration Period|Dropped out prior to dosing|2
20616|NCT01789970|98442|P3|Open-label Titration Period|Not specified|0
20617|NCT01789970|98443|P2|Open-label Titration Period|Not specified|0
20618|NCT01789970|98444|P1|Open-label Titration Period|Not specified|76
20619|NCT01789970|98442|P3|Open-label Titration Period|Pregnancy|0
20620|NCT01789970|98443|P2|Open-label Titration Period|Pregnancy|0
20621|NCT01789970|98444|P1|Open-label Titration Period|Pregnancy|2
20622|NCT01789970|98442|P3|Open-label Titration Period|Noncompliance with study procedures|0
20623|NCT01789970|98443|P2|Open-label Titration Period|Noncompliance with study procedures|0
20624|NCT01789970|98444|P1|Open-label Titration Period|Noncompliance with study procedures|8
20625|NCT01789970|98442|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
20626|NCT01789970|98443|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
20627|NCT01789970|98444|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
20628|NCT01789970|98442|P3|Open-label Titration Period|Noncompliance to study drug admin|0
20629|NCT01789970|98443|P2|Open-label Titration Period|Noncompliance to study drug admin|0
20630|NCT01789970|98444|P1|Open-label Titration Period|Noncompliance to study drug admin|11
20631|NCT01789970|98442|P3|Open-label Titration Period|Lost to Follow-up|0
20632|NCT01789970|98443|P2|Open-label Titration Period|Lost to Follow-up|0
20633|NCT01789970|98444|P1|Open-label Titration Period|Lost to Follow-up|5
20634|NCT01789970|98442|P3|Open-label Titration Period|Protocol Violation|0
20635|NCT01789970|98443|P2|Open-label Titration Period|Protocol Violation|0
20636|NCT01789970|98444|P1|Open-label Titration Period|Protocol Violation|18
20637|NCT01789970|98442|P3|Open-label Titration Period|Withdrawal by Subject|0
20638|NCT01789970|98443|P2|Open-label Titration Period|Withdrawal by Subject|0
20639|NCT01789970|98444|P1|Open-label Titration Period|Withdrawal by Subject|31
20640|NCT01789970|98442|P3|Open-label Titration Period|Lack of Efficacy|0
20641|NCT01789970|98443|P2|Open-label Titration Period|Lack of Efficacy|0
20642|NCT01789970|98444|P1|Open-label Titration Period|Lack of Efficacy|31
20643|NCT01789970|98442|P3|Open-label Titration Period|Adverse Event|0
20644|NCT01789970|98443|P2|Open-label Titration Period|Adverse Event|0
20645|NCT01789970|98444|P1|Open-label Titration Period|Adverse Event|68
20646|NCT01789606|98496|P2|Overall Study|Ineligible or not Willing to Continue|348
20647|NCT01789606|98497|P1|Overall Study|Ineligible or not Willing to Continue|0
20648|NCT01789606|98496|P2|Overall Study|Lost to Follow-up|14
20649|NCT01789606|98497|P1|Overall Study|Lost to Follow-up|0
20650|NCT01789606|98496|P2|Overall Study|Adverse Event|3
20651|NCT01789606|98497|P1|Overall Study|Adverse Event|0
20652|NCT01789606|98496|P2|Overall Study|Protocol Violation|55
20653|NCT01789606|98497|P1|Overall Study|Protocol Violation|0
20654|NCT01789606|98496|P2|Overall Study|No Study Medication Taken|1
20655|NCT01789606|98497|P1|Overall Study|No Study Medication Taken|0
20656|NCT01789606|98496|P2|Overall Study|Administrative Reasons|6
20657|NCT01789606|98497|P1|Overall Study|Administrative Reasons|17
20658|NCT01789606|98496|P2|Overall Study|Ineligible|2
20659|NCT01789606|98497|P1|Overall Study|Ineligible|6
20660|NCT01789606|98496|P2|Overall Study|Withdrawal by Subject|1
20661|NCT01789606|98497|P1|Overall Study|Withdrawal by Subject|0
20662|NCT01789606|98496|P2|Overall Study|Participant not Purchased the Product|20
20663|NCT01789606|98497|P1|Overall Study|Participant not Purchased the Product|0
20664|NCT01789476|98517|P2|Overall Study|Unable to get IV access|0
20665|NCT01789476|98518|P1|Overall Study|Unable to get IV access|1
20666|NCT01789476|98517|P2|Overall Study|Adverse Event|0
20667|NCT01789476|98518|P1|Overall Study|Adverse Event|1
20668|NCT01789476|98517|P2|Overall Study|Lack of Efficacy|2
20669|NCT01789476|98518|P1|Overall Study|Lack of Efficacy|6
20670|NCT01788566|98544|P1|Overall Study|Clinical Progressive Disease|3
20671|NCT01788566|98544|P1|Overall Study|Adverse Event|1
20672|NCT01788566|98544|P1|Overall Study|Death|4
20673|NCT01788358|98554|P1|Overall Study|Adverse Event|51
20674|NCT01788358|98554|P1|Overall Study|Lack of Efficacy|1
20675|NCT01788358|98554|P1|Overall Study|Withdrawal by Subject|26
20676|NCT01788358|98554|P1|Overall Study|Protocol Violation|3
20677|NCT01788358|98554|P1|Overall Study|Lost to Follow-up|5
20678|NCT01788358|98554|P1|Overall Study|Logistical difficulties|1
20679|NCT01788358|98554|P1|Overall Study|Unspecified|11
20680|NCT01788228|98568|P2|Overall Study|Migrated/moved from study area|0
20681|NCT01788228|98569|P1|Overall Study|Migrated/moved from study area|1
20682|NCT01788215|98588|P2|Overall Study|Lost to Follow-up|0
20683|NCT01788215|98589|P1|Overall Study|Lost to Follow-up|2
20684|NCT01788215|98588|P2|Overall Study|Withdrawal by Subject|1
20685|NCT01788215|98589|P1|Overall Study|Withdrawal by Subject|0
20686|NCT01788163|98618|P9|Overall Study|Withdrawal by Subject|1
20687|NCT01788163|98619|P8|Overall Study|Withdrawal by Subject|0
20688|NCT01788163|98620|P7|Overall Study|Withdrawal by Subject|0
20689|NCT01788163|98621|P6|Overall Study|Withdrawal by Subject|0
20690|NCT01788163|98622|P5|Overall Study|Withdrawal by Subject|0
20691|NCT01788163|98623|P4|Overall Study|Withdrawal by Subject|0
20692|NCT01788163|98624|P3|Overall Study|Withdrawal by Subject|0
20693|NCT01788163|98625|P2|Overall Study|Withdrawal by Subject|0
20694|NCT01788163|98626|P1|Overall Study|Withdrawal by Subject|2
20695|NCT01788163|98618|P9|Overall Study|Other|15
20696|NCT01788163|98619|P8|Overall Study|Other|48
20697|NCT01788163|98620|P7|Overall Study|Other|1
20698|NCT01788163|98621|P6|Overall Study|Other|7
20699|NCT01788163|98622|P5|Overall Study|Other|0
20700|NCT01788163|98623|P4|Overall Study|Other|0
20701|NCT01788163|98624|P3|Overall Study|Other|0
20702|NCT01788163|98625|P2|Overall Study|Other|0
20703|NCT01788163|98626|P1|Overall Study|Other|53
20704|NCT01788046|98789|P2|Overall Study|Protocol Specified Criteria|1
20705|NCT01788046|98790|P1|Overall Study|Protocol Specified Criteria|25
20706|NCT01788046|98789|P2|Overall Study|Death|5
20707|NCT01788046|98790|P1|Overall Study|Death|7
20708|NCT01788046|98789|P2|Overall Study|Lost to Follow-up|19
20709|NCT01788046|98790|P1|Overall Study|Lost to Follow-up|12
20710|NCT01788046|98789|P2|Overall Study|Withdrawal by Subject|12
20711|NCT01788046|98790|P1|Overall Study|Withdrawal by Subject|12
20712|NCT01787838|98806|P1|Overall Study|refused|1413
20713|NCT01787825|98810|P2|Overall Study|Data Not Analyzable|1
20714|NCT01787825|98811|P1|Overall Study|Data Not Analyzable|5
20715|NCT01787825|98810|P2|Overall Study|Subject Did Not Ingest Capsules|0
20716|NCT01787825|98811|P1|Overall Study|Subject Did Not Ingest Capsules|1
20717|NCT01787760|98829|P3|Overall Study|Near vision blur|0
20718|NCT01787760|98830|P2|Overall Study|Near vision blur|0
20719|NCT01787760|98831|P1|Overall Study|Near vision blur|1
20720|NCT01787760|98829|P3|Overall Study|Unsatisfactory visual response|0
20721|NCT01787760|98830|P2|Overall Study|Unsatisfactory visual response|1
20722|NCT01787760|98831|P1|Overall Study|Unsatisfactory visual response|1
20723|NCT01787760|98829|P3|Overall Study|Unsatisfactory physiological response|0
20724|NCT01787760|98830|P2|Overall Study|Unsatisfactory physiological response|4
20725|NCT01787760|98831|P1|Overall Study|Unsatisfactory physiological response|2
20726|NCT01787760|98829|P3|Overall Study|Unsatisfactory lens fitting performance|0
20727|NCT01787760|98830|P2|Overall Study|Unsatisfactory lens fitting performance|6
20728|NCT01787760|98831|P1|Overall Study|Unsatisfactory lens fitting performance|3
20729|NCT01787760|98829|P3|Overall Study|Stroke|0
20730|NCT01787760|98830|P2|Overall Study|Stroke|0
20731|NCT01787760|98831|P1|Overall Study|Stroke|1
20732|NCT01787760|98829|P3|Overall Study|Lost to Follow-up|1
20733|NCT01787760|98830|P2|Overall Study|Lost to Follow-up|0
20734|NCT01787760|98831|P1|Overall Study|Lost to Follow-up|1
20735|NCT01787760|98829|P3|Overall Study|Withdrawal by Subject|2
20736|NCT01787760|98830|P2|Overall Study|Withdrawal by Subject|1
20737|NCT01787760|98831|P1|Overall Study|Withdrawal by Subject|5
20738|NCT01787760|98829|P3|Overall Study|Protocol Violation|1
20739|NCT01787760|98830|P2|Overall Study|Protocol Violation|0
20740|NCT01787760|98831|P1|Overall Study|Protocol Violation|6
20741|NCT01787760|98829|P3|Overall Study|Lens handling difficulty|0
20742|NCT01787760|98830|P2|Overall Study|Lens handling difficulty|2
20743|NCT01787760|98831|P1|Overall Study|Lens handling difficulty|1
20744|NCT01787760|98829|P3|Overall Study|Lens discomfort|0
20745|NCT01787760|98830|P2|Overall Study|Lens discomfort|0
20746|NCT01787760|98831|P1|Overall Study|Lens discomfort|3
20747|NCT01787760|98829|P3|Overall Study|Relocation|0
20748|NCT01787760|98830|P2|Overall Study|Relocation|1
20749|NCT01787760|98831|P1|Overall Study|Relocation|1
20750|NCT01787760|98829|P3|Overall Study|Dryness|0
20751|NCT01787760|98830|P2|Overall Study|Dryness|1
20752|NCT01787760|98831|P1|Overall Study|Dryness|0
20753|NCT01787760|98829|P3|Overall Study|Decompensated on left exotropia|1
20754|NCT01787760|98830|P2|Overall Study|Decompensated on left exotropia|0
20755|NCT01787760|98831|P1|Overall Study|Decompensated on left exotropia|0
20756|NCT01787760|98829|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
20757|NCT01787760|98830|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
20758|NCT01787760|98831|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
20759|NCT01787591|98845|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
20760|NCT01787591|98846|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
20761|NCT01787591|98847|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
20762|NCT01787591|98848|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
20763|NCT01787461|98876|P2|Overall Study|Protocol Violation|0
20764|NCT01787461|98877|P1|Overall Study|Protocol Violation|3
20765|NCT01787461|98876|P2|Overall Study|Withdrawal by Subject|4
20766|NCT01787461|98877|P1|Overall Study|Withdrawal by Subject|3
20767|NCT01787461|98876|P2|Overall Study|No longer met eligibility criteria|0
20768|NCT01787461|98877|P1|Overall Study|No longer met eligibility criteria|1
20769|NCT01787461|98876|P2|Overall Study|Lost to Follow-up|2
20770|NCT01787461|98877|P1|Overall Study|Lost to Follow-up|3
20771|NCT01787461|98876|P2|Overall Study|Adverse Event|3
20772|NCT01787461|98877|P1|Overall Study|Adverse Event|4
20773|NCT01787279|98926|P1|Overall Study|Lack of Efficacy|1
20774|NCT01787279|98926|P1|Overall Study|Lost to Follow-up|2
20775|NCT01787188|98952|P3|Overall Study|Other, including patient moved|0
20776|NCT01787188|98953|P2|Overall Study|Other, including patient moved|3
20777|NCT01787188|98954|P1|Overall Study|Other, including patient moved|0
20778|NCT01787188|98952|P3|Overall Study|Lost to Follow-up|2
20779|NCT01787188|98953|P2|Overall Study|Lost to Follow-up|2
20780|NCT01787188|98954|P1|Overall Study|Lost to Follow-up|1
20781|NCT01787188|98952|P3|Overall Study|Protocol Violation|3
20782|NCT01787188|98953|P2|Overall Study|Protocol Violation|2
20783|NCT01787188|98954|P1|Overall Study|Protocol Violation|3
20784|NCT01787188|98952|P3|Overall Study|Withdrawal by Subject|2
20785|NCT01787188|98953|P2|Overall Study|Withdrawal by Subject|3
20786|NCT01787188|98954|P1|Overall Study|Withdrawal by Subject|4
20787|NCT01787188|98952|P3|Overall Study|Non-compliance with Study Drug|0
20788|NCT01787188|98953|P2|Overall Study|Non-compliance with Study Drug|1
20789|NCT01787188|98954|P1|Overall Study|Non-compliance with Study Drug|0
20790|NCT01787188|98952|P3|Overall Study|Lack of Efficacy|5
20791|NCT01787188|98953|P2|Overall Study|Lack of Efficacy|3
20792|NCT01787188|98954|P1|Overall Study|Lack of Efficacy|7
20793|NCT01787188|98952|P3|Overall Study|Adverse Event|6
20794|NCT01787188|98953|P2|Overall Study|Adverse Event|4
20795|NCT01787188|98954|P1|Overall Study|Adverse Event|2
20796|NCT01787032|99026|P6|Overall Study|Protocol Violation|1
20797|NCT01787032|99027|P5|Overall Study|Protocol Violation|1
20798|NCT01787032|99028|P4|Overall Study|Protocol Violation|0
20799|NCT01787032|99029|P3|Overall Study|Protocol Violation|0
20800|NCT01787032|99030|P2|Overall Study|Protocol Violation|0
20801|NCT01787032|99031|P1|Overall Study|Protocol Violation|0
20802|NCT01786993|99055|P2|Overall Study|Hospice Admission|0
20803|NCT01786993|99056|P1|Overall Study|Hospice Admission|1
20804|NCT01786993|99055|P2|Overall Study|System Explant|0
20805|NCT01786993|99056|P1|Overall Study|System Explant|1
20806|NCT01786993|99055|P2|Overall Study|Subject Non-Compliance|0
20807|NCT01786993|99056|P1|Overall Study|Subject Non-Compliance|1
20808|NCT01786993|99055|P2|Overall Study|Lost to Follow-up|1
20809|NCT01786993|99056|P1|Overall Study|Lost to Follow-up|0
20810|NCT01786993|99055|P2|Overall Study|Withdrawal by Subject|2
20811|NCT01786993|99056|P1|Overall Study|Withdrawal by Subject|3
20812|NCT01786993|99055|P2|Overall Study|Death|7
20813|NCT01786993|99056|P1|Overall Study|Death|6
20814|NCT01786707|99106|P2|Overall Study|Lost to Follow-up|1
20815|NCT01786707|99107|P1|Overall Study|Lost to Follow-up|1
20816|NCT01786668|99119|P4|Overall Study|Lost to Follow-up|0
20817|NCT01786668|99120|P3|Overall Study|Lost to Follow-up|1
20818|NCT01786668|99121|P2|Overall Study|Lost to Follow-up|0
20819|NCT01786668|99122|P1|Overall Study|Lost to Follow-up|1
20820|NCT01786668|99119|P4|Overall Study|Pregnancy|1
20821|NCT01786668|99120|P3|Overall Study|Pregnancy|0
20822|NCT01786668|99121|P2|Overall Study|Pregnancy|0
20823|NCT01786668|99122|P1|Overall Study|Pregnancy|0
20824|NCT01786668|99119|P4|Overall Study|Withdrawal by Subject|1
20825|NCT01786668|99120|P3|Overall Study|Withdrawal by Subject|3
20826|NCT01786668|99121|P2|Overall Study|Withdrawal by Subject|0
20827|NCT01786668|99122|P1|Overall Study|Withdrawal by Subject|0
20828|NCT01786668|99119|P4|Overall Study|Adverse Event|2
20829|NCT01786668|99120|P3|Overall Study|Adverse Event|1
20830|NCT01786668|99121|P2|Overall Study|Adverse Event|1
20831|NCT01786668|99122|P1|Overall Study|Adverse Event|0
20832|NCT01786629|99222|P2|Overall Study|Adverse Event|1
20833|NCT01786629|99223|P1|Overall Study|Adverse Event|0
20834|NCT01786629|99222|P2|Overall Study|Lack of Efficacy|4
20835|NCT01786629|99223|P1|Overall Study|Lack of Efficacy|0
20836|NCT01786551|99229|P1|Overall Study|Participant withdrew consent|2
20837|NCT01786330|99237|P2|Overall Study|Protocol Violation|0
20838|NCT01786330|99238|P1|Overall Study|Protocol Violation|1
20839|NCT01786330|99237|P2|Overall Study|Excluded intraoperatively|1
20840|NCT01786330|99238|P1|Overall Study|Excluded intraoperatively|0
20841|NCT01786330|99237|P2|Overall Study|Lost to Follow-up|1
20842|NCT01786330|99238|P1|Overall Study|Lost to Follow-up|0
20843|NCT01786330|99237|P2|Overall Study|Withdrawal by Subject|1
20844|NCT01786330|99238|P1|Overall Study|Withdrawal by Subject|0
20845|NCT01786174|99276|P2|Overall Study|Discontinued Study Drug|0
20846|NCT01786174|99277|P1|Overall Study|Discontinued Study Drug|2
20847|NCT01786109|99307|P3|Overall Study|adverse effects colon preparation|1
20848|NCT01786109|99308|P2|Overall Study|adverse effects colon preparation|0
20849|NCT01786109|99309|P1|Overall Study|adverse effects colon preparation|0
20850|NCT01786109|99307|P3|Overall Study|unrelated illness|1
20851|NCT01786109|99308|P2|Overall Study|unrelated illness|0
20852|NCT01786109|99309|P1|Overall Study|unrelated illness|0
20853|NCT01786109|99307|P3|Overall Study|fail manometry barostat tube placement|0
20854|NCT01786109|99308|P2|Overall Study|fail manometry barostat tube placement|0
20855|NCT01786109|99309|P1|Overall Study|fail manometry barostat tube placement|1
20856|NCT01785875|99338|P3|Overall Study|Missing|3
20857|NCT01785875|99339|P2|Overall Study|Missing|1
20858|NCT01785875|99340|P1|Overall Study|Missing|0
20859|NCT01785875|99338|P3|Overall Study|Protocol Specified Criteria|55
20860|NCT01785875|99339|P2|Overall Study|Protocol Specified Criteria|214
20861|NCT01785875|99340|P1|Overall Study|Protocol Specified Criteria|207
20862|NCT01785875|99338|P3|Overall Study|Sponsor Decision|0
20863|NCT01785875|99339|P2|Overall Study|Sponsor Decision|2
20864|NCT01785875|99340|P1|Overall Study|Sponsor Decision|0
20865|NCT01785875|99338|P3|Overall Study|Death|7
20866|NCT01785875|99339|P2|Overall Study|Death|16
20867|NCT01785875|99340|P1|Overall Study|Death|27
20868|NCT01785875|99338|P3|Overall Study|Lost to Follow-up|6
20869|NCT01785875|99339|P2|Overall Study|Lost to Follow-up|22
20870|NCT01785875|99340|P1|Overall Study|Lost to Follow-up|19
20871|NCT01785875|99338|P3|Overall Study|Withdrawal by Subject|36
20872|NCT01785875|99339|P2|Overall Study|Withdrawal by Subject|34
20873|NCT01785875|99340|P1|Overall Study|Withdrawal by Subject|41
20874|NCT01785849|99409|P2|Overall Study|Lost to Follow-up|11
20875|NCT01785849|99410|P1|Overall Study|Lost to Follow-up|10
20876|NCT01785849|99409|P2|Overall Study|Sponsor Decision|1
20877|NCT01785849|99410|P1|Overall Study|Sponsor Decision|0
20878|NCT01785849|99409|P2|Overall Study|Withdrawal by Subject|12
20879|NCT01785849|99410|P1|Overall Study|Withdrawal by Subject|15
20880|NCT01785849|99409|P2|Overall Study|Protocol Specified Criteria|1
20881|NCT01785849|99410|P1|Overall Study|Protocol Specified Criteria|29
20882|NCT01785849|99409|P2|Overall Study|Death|9
20883|NCT01785849|99410|P1|Overall Study|Death|7
20884|NCT01785628|99428|P2|Overall Study|Lost to Follow-up|3
20885|NCT01785628|99429|P1|Overall Study|Lost to Follow-up|2
20886|NCT01785615|99452|P4|Dietary Phase|Lost to Follow-up|24
20887|NCT01785615|99453|P3|Dietary Phase|Lost to Follow-up|0
20888|NCT01785615|99454|P2|Dietary Phase|Lost to Follow-up|0
20889|NCT01785615|99455|P1|Dietary Phase|Lost to Follow-up|0
20890|NCT01785602|99527|P2|Overall Study|Administrative problems|3
20891|NCT01785602|99528|P1|Overall Study|Administrative problems|7
20892|NCT01785602|99527|P2|Overall Study|Adverse Event|5
20893|NCT01785602|99528|P1|Overall Study|Adverse Event|3
20894|NCT01785602|99527|P2|Overall Study|Lost to Follow-up|1
20895|NCT01785602|99528|P1|Overall Study|Lost to Follow-up|1
20896|NCT01785602|99527|P2|Overall Study|Withdrawal by Subject|0
20897|NCT01785602|99528|P1|Overall Study|Withdrawal by Subject|2
20898|NCT01785524|99538|P2|Overall Study|Withdrawal by Subject|2
20899|NCT01785524|99539|P1|Overall Study|Withdrawal by Subject|2
20900|NCT01785472|99558|P3|Overall Study|Technical problems|1
20901|NCT01785472|99559|P2|Overall Study|Technical problems|0
20902|NCT01785472|99560|P1|Overall Study|Technical problems|0
20903|NCT01785472|99558|P3|Overall Study|Subject/guardian decision|11
20904|NCT01785472|99559|P2|Overall Study|Subject/guardian decision|10
20905|NCT01785472|99560|P1|Overall Study|Subject/guardian decision|15
20906|NCT01785472|99558|P3|Overall Study|Protocol deviation|2
20907|NCT01785472|99559|P2|Overall Study|Protocol deviation|2
20908|NCT01785472|99560|P1|Overall Study|Protocol deviation|0
20909|NCT01785472|99558|P3|Overall Study|Physician Decision|1
20910|NCT01785472|99559|P2|Overall Study|Physician Decision|1
20911|NCT01785472|99560|P1|Overall Study|Physician Decision|1
20912|NCT01785472|99558|P3|Overall Study|Lost to Follow-up|0
20913|NCT01785472|99559|P2|Overall Study|Lost to Follow-up|2
20914|NCT01785472|99560|P1|Overall Study|Lost to Follow-up|1
20915|NCT01785472|99558|P3|Overall Study|Lack of Efficacy|1
20916|NCT01785472|99559|P2|Overall Study|Lack of Efficacy|0
20917|NCT01785472|99560|P1|Overall Study|Lack of Efficacy|2
20918|NCT01785472|99558|P3|Overall Study|Adverse Event|6
20919|NCT01785472|99559|P2|Overall Study|Adverse Event|4
20920|NCT01785472|99560|P1|Overall Study|Adverse Event|5
20921|NCT01785160|99602|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
20922|NCT01785160|99602|P1|Treatment Period 1: Raltegravir|Not treated|1
20923|NCT01784965|99637|P2|Overall Study|Adverse Event|8
20924|NCT01784965|99638|P1|Overall Study|Adverse Event|0
20925|NCT01784965|99637|P2|Overall Study|Withdrawal by Subject|3
20926|NCT01784965|99638|P1|Overall Study|Withdrawal by Subject|6
20927|NCT01783938|99704|P2|Overall Study|Not Specified|0
20928|NCT01783938|99705|P1|Overall Study|Not Specified|1
20929|NCT01783938|99704|P2|Overall Study|Withdrew Consent|0
20930|NCT01783938|99705|P1|Overall Study|Withdrew Consent|3
20931|NCT01783938|99704|P2|Overall Study|Request to Discontinue Study Treatment|2
20932|NCT01783938|99705|P1|Overall Study|Request to Discontinue Study Treatment|1
20933|NCT01783938|99704|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
20934|NCT01783938|99705|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
20935|NCT01783938|99704|P2|Overall Study|Study Drug Toxicity|10
20936|NCT01783938|99705|P1|Overall Study|Study Drug Toxicity|22
20937|NCT01783938|99704|P2|Overall Study|Disease Progression|39
20938|NCT01783938|99705|P1|Overall Study|Disease Progression|18
20939|NCT01783886|99733|P3|Overall Study|Adverse Event|4
20940|NCT01783886|99734|P2|Overall Study|Adverse Event|5
20941|NCT01783886|99735|P1|Overall Study|Adverse Event|4
20942|NCT01783886|99733|P3|Overall Study|Withdrawal of consent by participant|4
20943|NCT01783886|99734|P2|Overall Study|Withdrawal of consent by participant|3
20944|NCT01783886|99735|P1|Overall Study|Withdrawal of consent by participant|1
20945|NCT01783886|99733|P3|Overall Study|Protocol deviation|2
20946|NCT01783886|99734|P2|Overall Study|Protocol deviation|0
20947|NCT01783886|99735|P1|Overall Study|Protocol deviation|0
20948|NCT01783886|99733|P3|Overall Study|Lost to Follow-up|0
20949|NCT01783886|99734|P2|Overall Study|Lost to Follow-up|3
20950|NCT01783886|99735|P1|Overall Study|Lost to Follow-up|0
20951|NCT01783821|99782|P2|Overall Study|Screen Failure|1
20952|NCT01783821|99783|P1|Overall Study|Screen Failure|1
20953|NCT01783730|99799|P1|Overall Study|Failed to meet inclusion criteria|6
20954|NCT01783678|99824|P6|Overall Study|Withdrew Consent|0
20955|NCT01783678|99825|P5|Overall Study|Withdrew Consent|0
20956|NCT01783678|99826|P4|Overall Study|Withdrew Consent|2
20957|NCT01783678|99827|P3|Overall Study|Withdrew Consent|0
20958|NCT01783678|99828|P2|Overall Study|Withdrew Consent|1
20959|NCT01783678|99829|P1|Overall Study|Withdrew Consent|1
20960|NCT01783678|99824|P6|Overall Study|Lost to Follow-up|0
20961|NCT01783678|99825|P5|Overall Study|Lost to Follow-up|1
20962|NCT01783678|99826|P4|Overall Study|Lost to Follow-up|2
20963|NCT01783678|99827|P3|Overall Study|Lost to Follow-up|0
20964|NCT01783678|99828|P2|Overall Study|Lost to Follow-up|4
20965|NCT01783678|99829|P1|Overall Study|Lost to Follow-up|0
20966|NCT01783678|99824|P6|Overall Study|Lack of Efficacy|5
20967|NCT01783678|99825|P5|Overall Study|Lack of Efficacy|6
20968|NCT01783678|99826|P4|Overall Study|Lack of Efficacy|3
20969|NCT01783678|99827|P3|Overall Study|Lack of Efficacy|1
20970|NCT01783678|99828|P2|Overall Study|Lack of Efficacy|13
20971|NCT01783678|99829|P1|Overall Study|Lack of Efficacy|1
20972|NCT01783678|99824|P6|Overall Study|Randomized but Not Treated|0
20973|NCT01783678|99825|P5|Overall Study|Randomized but Not Treated|0
20974|NCT01783678|99826|P4|Overall Study|Randomized but Not Treated|1
20975|NCT01783678|99827|P3|Overall Study|Randomized but Not Treated|0
20976|NCT01783678|99828|P2|Overall Study|Randomized but Not Treated|0
20977|NCT01783678|99829|P1|Overall Study|Randomized but Not Treated|0
20978|NCT01783548|99918|P2|Overall Study|Lack of Efficacy|1
20979|NCT01783548|99919|P1|Overall Study|Lack of Efficacy|1
20980|NCT01783548|99918|P2|Overall Study|Lost to Follow-up|3
20981|NCT01783548|99919|P1|Overall Study|Lost to Follow-up|8
20982|NCT01783548|99918|P2|Overall Study|Protocol Violation|2
20983|NCT01783548|99919|P1|Overall Study|Protocol Violation|2
20984|NCT01783548|99918|P2|Overall Study|Non-compliance|0
20985|NCT01783548|99919|P1|Overall Study|Non-compliance|4
20986|NCT01783548|99918|P2|Overall Study|Withdrawal by Subject|8
20987|NCT01783548|99919|P1|Overall Study|Withdrawal by Subject|11
20988|NCT01783548|99918|P2|Overall Study|Adverse Event|4
20989|NCT01783548|99919|P1|Overall Study|Adverse Event|8
20990|NCT01783496|99937|P6|Overall Study|Withdrawal by Subject|0
20991|NCT01783496|99938|P5|Overall Study|Withdrawal by Subject|0
20992|NCT01783496|99939|P4|Overall Study|Withdrawal by Subject|0
20993|NCT01783496|99940|P3|Overall Study|Withdrawal by Subject|0
20994|NCT01783496|99941|P2|Overall Study|Withdrawal by Subject|0
20995|NCT01783496|99942|P1|Overall Study|Withdrawal by Subject|1
20996|NCT01783496|99937|P6|Overall Study|Lost to Follow-up|1
20997|NCT01783496|99938|P5|Overall Study|Lost to Follow-up|0
20998|NCT01783496|99939|P4|Overall Study|Lost to Follow-up|2
20999|NCT01783496|99940|P3|Overall Study|Lost to Follow-up|0
21000|NCT01783496|99941|P2|Overall Study|Lost to Follow-up|0
21001|NCT01783496|99942|P1|Overall Study|Lost to Follow-up|0
21002|NCT01783418|99978|P2|Overall Study|Withdrawal by Subject|0
21003|NCT01783418|99979|P1|Overall Study|Withdrawal by Subject|1
21004|NCT01783015|100032|P3|Open Label Treatment|Study Terminated by Sponsor|6
21005|NCT01783015|100033|P2|Open Label Treatment|Study Terminated by Sponsor|0
21006|NCT01783015|100034|P1|Open Label Treatment|Study Terminated by Sponsor|0
21007|NCT01783015|100032|P3|Blinded Treatment|Study Terminated by Sponsor|0
21008|NCT01783015|100033|P2|Blinded Treatment|Study Terminated by Sponsor|0
21009|NCT01783015|100034|P1|Blinded Treatment|Study Terminated by Sponsor|2
21010|NCT01783015|100032|P3|Blinded Treatment|Withdrawal by Subject|0
21011|NCT01783015|100033|P2|Blinded Treatment|Withdrawal by Subject|1
21012|NCT01783015|100034|P1|Blinded Treatment|Withdrawal by Subject|0
21013|NCT01783015|100032|P3|Blinded Treatment|Protocol Violation|0
21014|NCT01783015|100033|P2|Blinded Treatment|Protocol Violation|1
21015|NCT01783015|100034|P1|Blinded Treatment|Protocol Violation|0
21016|NCT01783015|100032|P3|Blinded Treatment|Adverse Event|0
21017|NCT01783015|100033|P2|Blinded Treatment|Adverse Event|1
21018|NCT01783015|100034|P1|Blinded Treatment|Adverse Event|0
21019|NCT01782885|100134|P2|Overall Study|Lost to Follow-up|6
21020|NCT01782885|100135|P1|Overall Study|Lost to Follow-up|4
21021|NCT01782872|100161|P4|Overall Study|Withdrawal by Subject|0
21022|NCT01782872|100162|P3|Overall Study|Withdrawal by Subject|0
21023|NCT01782872|100163|P2|Overall Study|Withdrawal by Subject|1
21024|NCT01782872|100164|P1|Overall Study|Withdrawal by Subject|0
21025|NCT01782872|100161|P4|Overall Study|Protocol Violation|1
21026|NCT01782872|100162|P3|Overall Study|Protocol Violation|0
21027|NCT01782872|100163|P2|Overall Study|Protocol Violation|0
21028|NCT01782872|100164|P1|Overall Study|Protocol Violation|0
21029|NCT01782859|100188|P2|Overall Study|Withdrawal by Subject|1
21030|NCT01782859|100189|P1|Overall Study|Withdrawal by Subject|0
21031|NCT01782859|100188|P2|Overall Study|Protocol Violation|6
21032|NCT01782859|100189|P1|Overall Study|Protocol Violation|6
21033|NCT01782742|100205|P2|Double-blind Treatment Phase|Adverse Event|0
21034|NCT01782742|100206|P1|Double-blind Treatment Phase|Adverse Event|1
21035|NCT01782664|100245|P6|Overall Study|Withdrawal by Subject|0
21036|NCT01782664|100246|P5|Overall Study|Withdrawal by Subject|0
21037|NCT01782664|100247|P4|Overall Study|Withdrawal by Subject|0
21038|NCT01782664|100248|P3|Overall Study|Withdrawal by Subject|0
21039|NCT01782664|100249|P2|Overall Study|Withdrawal by Subject|2
21040|NCT01782664|100250|P1|Overall Study|Withdrawal by Subject|2
21041|NCT01782664|100245|P6|Overall Study|Protocol Violation|0
21042|NCT01782664|100246|P5|Overall Study|Protocol Violation|0
21043|NCT01782664|100247|P4|Overall Study|Protocol Violation|1
21044|NCT01782664|100248|P3|Overall Study|Protocol Violation|0
21045|NCT01782664|100249|P2|Overall Study|Protocol Violation|1
21046|NCT01782664|100250|P1|Overall Study|Protocol Violation|0
21047|NCT01782664|100245|P6|Overall Study|Lack of Efficacy|0
21048|NCT01782664|100246|P5|Overall Study|Lack of Efficacy|0
21049|NCT01782664|100247|P4|Overall Study|Lack of Efficacy|2
21050|NCT01782664|100248|P3|Overall Study|Lack of Efficacy|2
21051|NCT01782664|100249|P2|Overall Study|Lack of Efficacy|0
21052|NCT01782664|100250|P1|Overall Study|Lack of Efficacy|2
21053|NCT01782664|100245|P6|Overall Study|Adverse Event|0
21054|NCT01782664|100246|P5|Overall Study|Adverse Event|0
21055|NCT01782664|100247|P4|Overall Study|Adverse Event|2
21056|NCT01782664|100248|P3|Overall Study|Adverse Event|2
21057|NCT01782664|100249|P2|Overall Study|Adverse Event|2
21058|NCT01782664|100250|P1|Overall Study|Adverse Event|2
21059|NCT01782482|100398|P2|Overall Study|Habitually wearing toric lens OS|1
21060|NCT01782482|100399|P1|Overall Study|Habitually wearing toric lens OS|0
21061|NCT01782482|100398|P2|Overall Study|Randomized in Error|2
21062|NCT01782482|100399|P1|Overall Study|Randomized in Error|2
21063|NCT01782482|100398|P2|Overall Study|Withdrawal by Subject|3
21064|NCT01782482|100399|P1|Overall Study|Withdrawal by Subject|2
21065|NCT01782482|100398|P2|Overall Study|Protocol Violation|0
21066|NCT01782482|100399|P1|Overall Study|Protocol Violation|1
21067|NCT01782482|100398|P2|Overall Study|Physician Decision|0
21068|NCT01782482|100399|P1|Overall Study|Physician Decision|1
21069|NCT01782482|100398|P2|Overall Study|Lost to Follow-up|3
21070|NCT01782482|100399|P1|Overall Study|Lost to Follow-up|2
21071|NCT01782482|100398|P2|Overall Study|Adverse Event|1
21072|NCT01782482|100399|P1|Overall Study|Adverse Event|2
21073|NCT01782469|100407|P1|Overall Study|Lost to Follow-up|1
21074|NCT01782326|100417|P2|Double-blind Treatment|Technical problems|5
21075|NCT01782326|100418|P1|Double-blind Treatment|Technical problems|0
21076|NCT01782326|100417|P2|Double-blind Treatment|Protocol deviation|7
21077|NCT01782326|100418|P1|Double-blind Treatment|Protocol deviation|8
21078|NCT01782326|100417|P2|Double-blind Treatment|Physician Decision|16
21079|NCT01782326|100418|P1|Double-blind Treatment|Physician Decision|13
21080|NCT01782326|100417|P2|Double-blind Treatment|Lack of Efficacy|22
21081|NCT01782326|100418|P1|Double-blind Treatment|Lack of Efficacy|17
21082|NCT01782326|100417|P2|Double-blind Treatment|Subject/guardian decision|125
21083|NCT01782326|100418|P1|Double-blind Treatment|Subject/guardian decision|111
21084|NCT01782326|100417|P2|Double-blind Treatment|Adverse Event|145
21085|NCT01782326|100418|P1|Double-blind Treatment|Adverse Event|129
21086|NCT01782326|100417|P2|Planned Treatment Epoch|Technical problems|4
21087|NCT01782326|100418|P1|Planned Treatment Epoch|Technical problems|0
21088|NCT01782326|100417|P2|Planned Treatment Epoch|Lost to Follow-up|4
21089|NCT01782326|100418|P1|Planned Treatment Epoch|Lost to Follow-up|4
21090|NCT01782326|100417|P2|Planned Treatment Epoch|Protocol deviation|3
21091|NCT01782326|100418|P1|Planned Treatment Epoch|Protocol deviation|2
21092|NCT01782326|100417|P2|Planned Treatment Epoch|Physician Decision|16
21093|NCT01782326|100418|P1|Planned Treatment Epoch|Physician Decision|18
21094|NCT01782326|100417|P2|Planned Treatment Epoch|Death|30
21095|NCT01782326|100418|P1|Planned Treatment Epoch|Death|29
21096|NCT01782326|100417|P2|Planned Treatment Epoch|Subject/guardian decision|151
21097|NCT01782326|100418|P1|Planned Treatment Epoch|Subject/guardian decision|149
21098|NCT01782222|100481|P3|Overall Study|Moved to other state|0
21099|NCT01782222|100482|P2|Overall Study|Moved to other state|1
21100|NCT01782222|100483|P1|Overall Study|Moved to other state|0
21101|NCT01782222|100481|P3|Overall Study|Withdrawal by Subject|1
21102|NCT01782222|100482|P2|Overall Study|Withdrawal by Subject|4
21103|NCT01782222|100483|P1|Overall Study|Withdrawal by Subject|1
21104|NCT01782222|100481|P3|Overall Study|Protocol Violation|0
21105|NCT01782222|100482|P2|Overall Study|Protocol Violation|0
21106|NCT01782222|100483|P1|Overall Study|Protocol Violation|1
21107|NCT01782222|100481|P3|Overall Study|Lack of Efficacy|0
21108|NCT01782222|100482|P2|Overall Study|Lack of Efficacy|1
21109|NCT01782222|100483|P1|Overall Study|Lack of Efficacy|2
21110|NCT01782222|100481|P3|Overall Study|Adverse Event|3
21111|NCT01782222|100482|P2|Overall Study|Adverse Event|5
21112|NCT01782222|100483|P1|Overall Study|Adverse Event|4
21113|NCT01781962|100515|P1|Overall Study|Other Miscellaneous Reasons|5
21114|NCT01781637|100523|P2|Overall Study|Withdrawal by Subject|0
21115|NCT01781637|100524|P1|Overall Study|Withdrawal by Subject|1
21116|NCT01781637|100523|P2|Overall Study|Lack of Efficacy|6
21117|NCT01781637|100524|P1|Overall Study|Lack of Efficacy|2
21118|NCT01781637|100523|P2|Overall Study|Adverse Event|0
21119|NCT01781637|100524|P1|Overall Study|Adverse Event|1
21120|NCT01781299|100611|P2|Overall Study|Withdrawal by Subject|1
21121|NCT01781299|100612|P1|Overall Study|Withdrawal by Subject|0
21122|NCT01781026|100648|P1|Overall Study|Lack of Efficacy|2
21123|NCT01780987|100654|P2|Overall Study|Not Receiving any Study Medication|1
21124|NCT01780987|100655|P1|Overall Study|Not Receiving any Study Medication|0
21125|NCT01780987|100654|P2|Overall Study|Changing Residence|0
21126|NCT01780987|100655|P1|Overall Study|Changing Residence|1
21127|NCT01780987|100654|P2|Overall Study|Request of Changing Hospital|1
21128|NCT01780987|100655|P1|Overall Study|Request of Changing Hospital|0
21129|NCT01780987|100654|P2|Overall Study|Withdrawal by Subject|0
21130|NCT01780987|100655|P1|Overall Study|Withdrawal by Subject|2
21131|NCT01780987|100654|P2|Overall Study|Adverse Event|4
21132|NCT01780987|100655|P1|Overall Study|Adverse Event|0
21133|NCT01780974|100673|P2|Overall Study|Adverse Event|3
21134|NCT01780974|100674|P1|Overall Study|Adverse Event|1
21135|NCT01780974|100673|P2|Overall Study|Death|0
21136|NCT01780974|100674|P1|Overall Study|Death|1
21137|NCT01780935|100684|P2|Overall Study|Patient withdrew consent|9
21138|NCT01780935|100685|P1|Overall Study|Patient withdrew consent|8
21139|NCT01780935|100684|P2|Overall Study|Protocol deviation|1
21140|NCT01780935|100685|P1|Overall Study|Protocol deviation|0
21141|NCT01780935|100684|P2|Overall Study|Physician Decision|1
21142|NCT01780935|100685|P1|Overall Study|Physician Decision|1
21143|NCT01780935|100684|P2|Overall Study|Lost to Follow-up|6
21144|NCT01780935|100685|P1|Overall Study|Lost to Follow-up|2
21145|NCT01780935|100684|P2|Overall Study|Death|6
21146|NCT01780935|100685|P1|Overall Study|Death|1
21147|NCT01780935|100684|P2|Overall Study|Adverse Event|4
21148|NCT01780935|100685|P1|Overall Study|Adverse Event|2
21149|NCT01780935|100684|P2|Overall Study|Admin problems due to early termination|309
21150|NCT01780935|100685|P1|Overall Study|Admin problems due to early termination|321
21151|NCT01780584|100789|P3|Overall Study|Protocol Violation|1
21152|NCT01780584|100790|P2|Overall Study|Protocol Violation|0
21153|NCT01780584|100791|P1|Overall Study|Protocol Violation|0
21154|NCT01780584|100789|P3|Overall Study|Adverse Event|0
21155|NCT01780584|100790|P2|Overall Study|Adverse Event|1
21156|NCT01780584|100791|P1|Overall Study|Adverse Event|0
21157|NCT01780584|100789|P3|Overall Study|Death|1
21158|NCT01780584|100790|P2|Overall Study|Death|0
21159|NCT01780584|100791|P1|Overall Study|Death|1
21160|NCT01780506|100813|P2|Overall Study|Still on Study|388
21161|NCT01780506|100814|P1|Overall Study|Still on Study|401
21162|NCT01780506|100813|P2|Overall Study|Lost to Follow-up|14
21163|NCT01780506|100814|P1|Overall Study|Lost to Follow-up|10
21164|NCT01780506|100813|P2|Overall Study|Withdrew Consent|15
21165|NCT01780506|100814|P1|Overall Study|Withdrew Consent|13
21166|NCT01780506|100813|P2|Overall Study|Protocol Violation|3
21167|NCT01780506|100814|P1|Overall Study|Protocol Violation|3
21168|NCT01780506|100813|P2|Overall Study|Non-Compliance with Study Drug|1
21169|NCT01780506|100814|P1|Overall Study|Non-Compliance with Study Drug|1
21170|NCT01780506|100813|P2|Overall Study|Investigator's Discretion|1
21171|NCT01780506|100814|P1|Overall Study|Investigator's Discretion|2
21172|NCT01780506|100813|P2|Overall Study|Lack of Efficacy|1
21173|NCT01780506|100814|P1|Overall Study|Lack of Efficacy|1
21174|NCT01780506|100813|P2|Overall Study|Pregnancy|0
21175|NCT01780506|100814|P1|Overall Study|Pregnancy|1
21176|NCT01780506|100813|P2|Overall Study|Death|1
21177|NCT01780506|100814|P1|Overall Study|Death|0
21178|NCT01780506|100813|P2|Overall Study|Adverse Event|8
21179|NCT01780506|100814|P1|Overall Study|Adverse Event|3
21180|NCT01780506|100813|P2|Overall Study|Randomized but not Treated|2
21181|NCT01780506|100814|P1|Overall Study|Randomized but not Treated|3
21182|NCT01780389|100852|P1|Overall Study|Adverse Event|1
21183|NCT01779648|100892|P2|Overall Study|Protocol Violation|0
21184|NCT01779648|100893|P1|Overall Study|Protocol Violation|1
21185|NCT01778985|100943|P2|Overall Study|Protocol Violation|1
21186|NCT01778985|100944|P1|Overall Study|Protocol Violation|4
21187|NCT01778985|100943|P2|Overall Study|Physician Decision|2
21188|NCT01778985|100944|P1|Overall Study|Physician Decision|2
21189|NCT01778985|100943|P2|Overall Study|Lost to Follow-up|0
21190|NCT01778985|100944|P1|Overall Study|Lost to Follow-up|1
21191|NCT01778855|100990|P2|Overall Study|Death|1
21192|NCT01778855|100991|P1|Overall Study|Death|0
21193|NCT01778751|100999|P2|Overall Study|Transfered care|0
21194|NCT01778751|101000|P1|Overall Study|Transfered care|1
21195|NCT01778751|100999|P2|Overall Study|Withdrawal by Subject|2
21196|NCT01778751|101000|P1|Overall Study|Withdrawal by Subject|0
21197|NCT01778751|100999|P2|Overall Study|Lost to Follow-up|0
21198|NCT01778751|101000|P1|Overall Study|Lost to Follow-up|1
21199|NCT01778530|101012|P1|Overall Study|Adverse event/side effect|1
21200|NCT01778530|101012|P1|Overall Study|Progression on study|1
21201|NCT01778127|101024|P3|Overall Study|Withdrawal by Subject|4
21202|NCT01778127|101025|P2|Overall Study|Withdrawal by Subject|1
21203|NCT01778127|101026|P1|Overall Study|Withdrawal by Subject|3
21204|NCT01778127|101024|P3|Overall Study|Lost to Follow-up|2
21205|NCT01778127|101025|P2|Overall Study|Lost to Follow-up|1
21206|NCT01778127|101026|P1|Overall Study|Lost to Follow-up|5
21207|NCT01778062|101069|P2|Overall Study|major protocol deviation|3
21208|NCT01778062|101070|P1|Overall Study|major protocol deviation|4
21209|NCT01778062|101069|P2|Overall Study|Consent Withdrawal|5
21210|NCT01778062|101070|P1|Overall Study|Consent Withdrawal|1
21211|NCT01778062|101069|P2|Overall Study|Adverse Event|3
21212|NCT01778062|101070|P1|Overall Study|Adverse Event|1
21213|NCT01778049|101084|P6|Double Blind Treatment Period|Other reason not defined above|1
21214|NCT01778049|101085|P5|Double Blind Treatment Period|Other reason not defined above|2
21215|NCT01778049|101086|P4|Double Blind Treatment Period|Other reason not defined above|2
21216|NCT01778049|101087|P3|Double Blind Treatment Period|Other reason not defined above|4
21217|NCT01778049|101088|P2|Double Blind Treatment Period|Other reason not defined above|0
21218|NCT01778049|101089|P1|Double Blind Treatment Period|Other reason not defined above|0
21219|NCT01778049|101084|P6|Double Blind Treatment Period|Not treated|0
21220|NCT01778049|101085|P5|Double Blind Treatment Period|Not treated|2
21221|NCT01778049|101086|P4|Double Blind Treatment Period|Not treated|2
21222|NCT01778049|101087|P3|Double Blind Treatment Period|Not treated|0
21223|NCT01778049|101088|P2|Double Blind Treatment Period|Not treated|0
21224|NCT01778049|101089|P1|Double Blind Treatment Period|Not treated|0
21225|NCT01778049|101084|P6|Double Blind Treatment Period|Withdrawal by Subject|1
21226|NCT01778049|101085|P5|Double Blind Treatment Period|Withdrawal by Subject|0
21227|NCT01778049|101086|P4|Double Blind Treatment Period|Withdrawal by Subject|2
21228|NCT01778049|101087|P3|Double Blind Treatment Period|Withdrawal by Subject|1
21229|NCT01778049|101088|P2|Double Blind Treatment Period|Withdrawal by Subject|0
21230|NCT01778049|101089|P1|Double Blind Treatment Period|Withdrawal by Subject|0
21231|NCT01778049|101084|P6|Double Blind Treatment Period|Lost to Follow-up|2
21232|NCT01778049|101085|P5|Double Blind Treatment Period|Lost to Follow-up|5
21233|NCT01778049|101086|P4|Double Blind Treatment Period|Lost to Follow-up|1
21234|NCT01778049|101087|P3|Double Blind Treatment Period|Lost to Follow-up|4
21235|NCT01778049|101088|P2|Double Blind Treatment Period|Lost to Follow-up|0
21236|NCT01778049|101089|P1|Double Blind Treatment Period|Lost to Follow-up|0
21237|NCT01778049|101084|P6|Double Blind Treatment Period|Protocol Violation|0
21238|NCT01778049|101085|P5|Double Blind Treatment Period|Protocol Violation|0
21239|NCT01778049|101086|P4|Double Blind Treatment Period|Protocol Violation|0
21240|NCT01778049|101087|P3|Double Blind Treatment Period|Protocol Violation|2
21241|NCT01778049|101088|P2|Double Blind Treatment Period|Protocol Violation|0
21242|NCT01778049|101089|P1|Double Blind Treatment Period|Protocol Violation|0
21243|NCT01778049|101084|P6|Double Blind Treatment Period|Lack of Efficacy|1
21244|NCT01778049|101085|P5|Double Blind Treatment Period|Lack of Efficacy|0
21245|NCT01778049|101086|P4|Double Blind Treatment Period|Lack of Efficacy|0
21246|NCT01778049|101087|P3|Double Blind Treatment Period|Lack of Efficacy|0
21247|NCT01778049|101088|P2|Double Blind Treatment Period|Lack of Efficacy|0
21248|NCT01778049|101089|P1|Double Blind Treatment Period|Lack of Efficacy|0
21249|NCT01778049|101084|P6|Double Blind Treatment Period|Adverse Event|2
21250|NCT01778049|101085|P5|Double Blind Treatment Period|Adverse Event|3
21251|NCT01778049|101086|P4|Double Blind Treatment Period|Adverse Event|5
21252|NCT01778049|101087|P3|Double Blind Treatment Period|Adverse Event|4
21253|NCT01778049|101088|P2|Double Blind Treatment Period|Adverse Event|0
21254|NCT01778049|101089|P1|Double Blind Treatment Period|Adverse Event|0
21255|NCT01778049|101084|P6|Open Label Treatment Period|Other reason not defined above|0
21256|NCT01778049|101085|P5|Open Label Treatment Period|Other reason not defined above|0
21257|NCT01778049|101086|P4|Open Label Treatment Period|Other reason not defined above|0
21258|NCT01778049|101087|P3|Open Label Treatment Period|Other reason not defined above|0
21259|NCT01778049|101088|P2|Open Label Treatment Period|Other reason not defined above|94
21260|NCT01778049|101089|P1|Open Label Treatment Period|Other reason not defined above|77
21261|NCT01778049|101084|P6|Open Label Treatment Period|Not treated|0
21262|NCT01778049|101085|P5|Open Label Treatment Period|Not treated|0
21263|NCT01778049|101086|P4|Open Label Treatment Period|Not treated|0
21264|NCT01778049|101087|P3|Open Label Treatment Period|Not treated|0
21265|NCT01778049|101088|P2|Open Label Treatment Period|Not treated|1
21266|NCT01778049|101089|P1|Open Label Treatment Period|Not treated|2
21267|NCT01778049|101084|P6|Open Label Treatment Period|Withdrawal by Subject|0
21268|NCT01778049|101085|P5|Open Label Treatment Period|Withdrawal by Subject|0
21269|NCT01778049|101086|P4|Open Label Treatment Period|Withdrawal by Subject|0
21270|NCT01778049|101087|P3|Open Label Treatment Period|Withdrawal by Subject|0
21271|NCT01778049|101088|P2|Open Label Treatment Period|Withdrawal by Subject|10
21272|NCT01778049|101089|P1|Open Label Treatment Period|Withdrawal by Subject|4
21273|NCT01778049|101084|P6|Open Label Treatment Period|Lost to Follow-up|0
21274|NCT01778049|101085|P5|Open Label Treatment Period|Lost to Follow-up|0
21275|NCT01778049|101086|P4|Open Label Treatment Period|Lost to Follow-up|0
21276|NCT01778049|101087|P3|Open Label Treatment Period|Lost to Follow-up|0
21277|NCT01778049|101088|P2|Open Label Treatment Period|Lost to Follow-up|3
21278|NCT01778049|101089|P1|Open Label Treatment Period|Lost to Follow-up|4
21279|NCT01778049|101084|P6|Open Label Treatment Period|Protocol Violation|0
21280|NCT01778049|101085|P5|Open Label Treatment Period|Protocol Violation|0
21281|NCT01778049|101086|P4|Open Label Treatment Period|Protocol Violation|0
21282|NCT01778049|101087|P3|Open Label Treatment Period|Protocol Violation|0
21283|NCT01778049|101088|P2|Open Label Treatment Period|Protocol Violation|5
21284|NCT01778049|101089|P1|Open Label Treatment Period|Protocol Violation|5
21285|NCT01778049|101084|P6|Open Label Treatment Period|Lack of Efficacy|0
21286|NCT01778049|101085|P5|Open Label Treatment Period|Lack of Efficacy|0
21287|NCT01778049|101086|P4|Open Label Treatment Period|Lack of Efficacy|0
21288|NCT01778049|101087|P3|Open Label Treatment Period|Lack of Efficacy|0
21289|NCT01778049|101088|P2|Open Label Treatment Period|Lack of Efficacy|1
21290|NCT01778049|101089|P1|Open Label Treatment Period|Lack of Efficacy|1
21291|NCT01778049|101084|P6|Open Label Treatment Period|Adverse Event|0
21292|NCT01778049|101085|P5|Open Label Treatment Period|Adverse Event|0
21293|NCT01778049|101086|P4|Open Label Treatment Period|Adverse Event|0
21294|NCT01778049|101087|P3|Open Label Treatment Period|Adverse Event|0
21295|NCT01778049|101088|P2|Open Label Treatment Period|Adverse Event|15
21296|NCT01778049|101089|P1|Open Label Treatment Period|Adverse Event|5
21297|NCT01778023|101107|P2|Overall Study|Withdrawal by Subject|3
21298|NCT01778023|101108|P1|Overall Study|Withdrawal by Subject|0
21299|NCT01777932|101135|P1|Overall Study|Patient refused further treatment|10
21300|NCT01777932|101135|P1|Overall Study|Reimbursement limit|9
21301|NCT01777932|101135|P1|Overall Study|Investigator decision|10
21302|NCT01777932|101135|P1|Overall Study|Lost to Follow-up|3
21303|NCT01777932|101135|P1|Overall Study|Adverse Event|34
21304|NCT01777932|101135|P1|Overall Study|Death|3
21305|NCT01777932|101135|P1|Overall Study|Disease progression|136
21306|NCT01777776|101153|P4|Overall Study|Withdrawal by Subject|1
21307|NCT01777776|101154|P3|Overall Study|Withdrawal by Subject|0
21308|NCT01777776|101155|P2|Overall Study|Withdrawal by Subject|0
21309|NCT01777776|101156|P1|Overall Study|Withdrawal by Subject|0
21310|NCT01777776|101153|P4|Overall Study|Disease Progression|3
21311|NCT01777776|101154|P3|Overall Study|Disease Progression|6
21312|NCT01777776|101155|P2|Overall Study|Disease Progression|8
21313|NCT01777776|101156|P1|Overall Study|Disease Progression|4
21314|NCT01777776|101153|P4|Overall Study|Adverse Event|0
21315|NCT01777776|101154|P3|Overall Study|Adverse Event|0
21316|NCT01777776|101155|P2|Overall Study|Adverse Event|4
21317|NCT01777776|101156|P1|Overall Study|Adverse Event|2
21318|NCT01777763|101215|P2|Overall Study|Treatment Failure|6
21319|NCT01777763|101216|P1|Overall Study|Treatment Failure|1
21320|NCT01777763|101215|P2|Overall Study|Withdrawal by Subject|2
21321|NCT01777763|101216|P1|Overall Study|Withdrawal by Subject|0
21322|NCT01777763|101215|P2|Overall Study|Protocol Violation|7
21323|NCT01777763|101216|P1|Overall Study|Protocol Violation|1
21324|NCT01777763|101215|P2|Overall Study|Adverse Event|32
21325|NCT01777763|101216|P1|Overall Study|Adverse Event|2
21326|NCT01777620|101240|P2|Overall Study|Subject Withdrawal|0
21327|NCT01777620|101241|P1|Overall Study|Subject Withdrawal|1
21328|NCT01777581|101267|P2|Overall Study|Lack of Efficacy|1
21329|NCT01777581|101268|P1|Overall Study|Lack of Efficacy|0
21330|NCT01777581|101267|P2|Overall Study|Adverse Event|0
21331|NCT01777581|101268|P1|Overall Study|Adverse Event|2
21332|NCT01777581|101267|P2|Overall Study|Lost to Follow-up|1
21333|NCT01777581|101268|P1|Overall Study|Lost to Follow-up|1
21334|NCT01777334|101315|P2|Overall Study|Withdrawal by Subject|11
21335|NCT01777334|101316|P1|Overall Study|Withdrawal by Subject|14
21336|NCT01777334|101315|P2|Overall Study|Lost to Follow-up|2
21337|NCT01777334|101316|P1|Overall Study|Lost to Follow-up|3
21338|NCT01777334|101315|P2|Overall Study|Protocol Violation|7
21339|NCT01777334|101316|P1|Overall Study|Protocol Violation|3
21340|NCT01777334|101315|P2|Overall Study|Lack of Efficacy|29
21341|NCT01777334|101316|P1|Overall Study|Lack of Efficacy|15
21342|NCT01777334|101315|P2|Overall Study|Adverse Event|14
21343|NCT01777334|101316|P1|Overall Study|Adverse Event|18
21344|NCT01777321|101326|P2|Overall Study|Withdrawal by Subject|1
21345|NCT01777321|101327|P1|Overall Study|Withdrawal by Subject|0
21346|NCT01777282|101368|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
21347|NCT01777282|101369|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
21348|NCT01777282|101370|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
21349|NCT01777282|101371|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
21350|NCT01777282|101372|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
21351|NCT01777282|101368|P5|Overall Study|Protocol Violation|2
21352|NCT01777282|101369|P4|Overall Study|Protocol Violation|0
21353|NCT01777282|101370|P3|Overall Study|Protocol Violation|1
21354|NCT01777282|101371|P2|Overall Study|Protocol Violation|0
21355|NCT01777282|101372|P1|Overall Study|Protocol Violation|2
21356|NCT01777282|101368|P5|Overall Study|Withdrawal by Subject|2
21357|NCT01777282|101369|P4|Overall Study|Withdrawal by Subject|1
21358|NCT01777282|101370|P3|Overall Study|Withdrawal by Subject|0
21359|NCT01777282|101371|P2|Overall Study|Withdrawal by Subject|0
21360|NCT01777282|101372|P1|Overall Study|Withdrawal by Subject|4
21361|NCT01777282|101368|P5|Overall Study|Adverse Event|3
21362|NCT01777282|101369|P4|Overall Study|Adverse Event|1
21363|NCT01777282|101370|P3|Overall Study|Adverse Event|2
21364|NCT01777282|101371|P2|Overall Study|Adverse Event|4
21365|NCT01777282|101372|P1|Overall Study|Adverse Event|4
21366|NCT01777282|101368|P5|Overall Study|New Antidiabetic Medication|0
21367|NCT01777282|101369|P4|Overall Study|New Antidiabetic Medication|0
21368|NCT01777282|101370|P3|Overall Study|New Antidiabetic Medication|1
21369|NCT01777282|101371|P2|Overall Study|New Antidiabetic Medication|0
21370|NCT01777282|101372|P1|Overall Study|New Antidiabetic Medication|0
21371|NCT01777282|101368|P5|Overall Study|Persistent Hyperglycemia|0
21372|NCT01777282|101369|P4|Overall Study|Persistent Hyperglycemia|0
21373|NCT01777282|101370|P3|Overall Study|Persistent Hyperglycemia|1
21374|NCT01777282|101371|P2|Overall Study|Persistent Hyperglycemia|0
21375|NCT01777282|101372|P1|Overall Study|Persistent Hyperglycemia|0
21376|NCT01777269|101416|P2|Overall Study|Withdrawal by Subject|9
21377|NCT01777269|101417|P1|Overall Study|Withdrawal by Subject|9
21378|NCT01777269|101416|P2|Overall Study|Physician Decision|2
21379|NCT01777269|101417|P1|Overall Study|Physician Decision|5
21380|NCT01777269|101416|P2|Overall Study|Lost to Follow-up|0
21381|NCT01777269|101417|P1|Overall Study|Lost to Follow-up|4
21382|NCT01777269|101416|P2|Overall Study|Participants reached stopping criteria|1
21383|NCT01777269|101417|P1|Overall Study|Participants reached stopping criteria|1
21384|NCT01777269|101416|P2|Overall Study|Protocol Violation|4
21385|NCT01777269|101417|P1|Overall Study|Protocol Violation|4
21386|NCT01777269|101416|P2|Overall Study|Lack of Efficacy|10
21387|NCT01777269|101417|P1|Overall Study|Lack of Efficacy|8
21388|NCT01777269|101416|P2|Overall Study|Adverse Event|33
21389|NCT01777269|101417|P1|Overall Study|Adverse Event|24
21390|NCT01777191|101454|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
21391|NCT01777191|101455|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
21392|NCT01777191|101454|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
21393|NCT01777191|101455|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
21394|NCT01777191|101454|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
21395|NCT01777191|101455|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
21396|NCT01777191|101454|P2|Safety Extension Per (Week 12-Week 48)|Death|1
21397|NCT01777191|101455|P1|Safety Extension Per (Week 12-Week 48)|Death|0
21398|NCT01777191|101454|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
21399|NCT01777191|101455|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
21400|NCT01777191|101454|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
21401|NCT01777191|101455|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
21402|NCT01777191|101454|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
21403|NCT01777191|101455|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
21404|NCT01777191|101454|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
21405|NCT01777191|101455|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
21406|NCT01777191|101454|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
21407|NCT01777191|101455|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
21408|NCT01777191|101454|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
21409|NCT01777191|101455|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
21410|NCT01777191|101454|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
21411|NCT01777191|101455|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
21412|NCT01776554|101518|P2|Overall Study|Unclassified|1
21413|NCT01776554|101519|P1|Overall Study|Unclassified|4
21414|NCT01776554|101518|P2|Overall Study|Protocol Violation|0
21415|NCT01776554|101519|P1|Overall Study|Protocol Violation|1
21416|NCT01776554|101518|P2|Overall Study|Administrative Reason|5
21417|NCT01776554|101519|P1|Overall Study|Administrative Reason|2
21418|NCT01776554|101518|P2|Overall Study|Lost to Follow-up|9
21419|NCT01776554|101519|P1|Overall Study|Lost to Follow-up|6
21420|NCT01776554|101518|P2|Overall Study|Withdrawal by Subject|8
21421|NCT01776554|101519|P1|Overall Study|Withdrawal by Subject|3
21422|NCT01776554|101518|P2|Overall Study|Adverse Event|0
21423|NCT01776554|101519|P1|Overall Study|Adverse Event|1
21424|NCT01776541|101562|P2|Overall Study|Withdrawal by Subject|20
21425|NCT01776541|101563|P1|Overall Study|Withdrawal by Subject|12
21426|NCT01776541|101562|P2|Overall Study|Protocol Violation|1
21427|NCT01776541|101563|P1|Overall Study|Protocol Violation|2
21428|NCT01776541|101562|P2|Overall Study|Unclassified|4
21429|NCT01776541|101563|P1|Overall Study|Unclassified|5
21430|NCT01776541|101562|P2|Overall Study|Lost to Follow-up|48
21431|NCT01776541|101563|P1|Overall Study|Lost to Follow-up|27
21432|NCT01776541|101562|P2|Overall Study|Death|0
21433|NCT01776541|101563|P1|Overall Study|Death|4
21434|NCT01776541|101562|P2|Overall Study|Administrative Reason|2
21435|NCT01776541|101563|P1|Overall Study|Administrative Reason|6
21436|NCT01775995|101595|P2|Overall Study|Lost to Follow-up|1
21437|NCT01775995|101596|P1|Overall Study|Lost to Follow-up|1
21438|NCT01775670|101704|P2|Overall Study|Lost to Follow-up|1
21439|NCT01775670|101705|P1|Overall Study|Lost to Follow-up|1
21440|NCT01775553|101731|P1|Overall Study|Disease Progression|12
21441|NCT01775553|101731|P1|Overall Study|Adverse Event|1
21442|NCT01775189|101739|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
21443|NCT01775189|101740|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
21444|NCT01775189|101741|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
21445|NCT01775189|101742|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
21446|NCT01775189|101743|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
21447|NCT01775189|101744|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
21448|NCT01775189|101745|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
21449|NCT01775189|101739|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
21450|NCT01775189|101740|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
21451|NCT01775189|101741|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
21452|NCT01775189|101742|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
21453|NCT01775189|101743|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
21454|NCT01775189|101744|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
21455|NCT01775189|101745|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
21456|NCT01775189|101739|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
21457|NCT01775189|101740|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
21458|NCT01775189|101741|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
21459|NCT01775189|101742|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
21460|NCT01775189|101743|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
21461|NCT01775189|101744|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
21462|NCT01775189|101745|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
21463|NCT01775189|101739|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
21464|NCT01775189|101740|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
21465|NCT01775189|101741|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
21466|NCT01775189|101742|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
21467|NCT01775189|101743|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
21468|NCT01775189|101744|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
21469|NCT01775189|101745|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
21470|NCT01775189|101739|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
21471|NCT01775189|101740|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
21472|NCT01775189|101741|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
21473|NCT01775189|101742|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
21474|NCT01775189|101743|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
21475|NCT01775189|101744|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
21476|NCT01775189|101745|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
21477|NCT01775189|101739|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
21478|NCT01775189|101740|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
21479|NCT01775189|101741|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
21480|NCT01775189|101742|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
21481|NCT01775189|101743|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
21482|NCT01775189|101744|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
21483|NCT01775189|101745|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
21484|NCT01775137|101964|P1|Overall Study|Withdrawal by participants|5
21485|NCT01775137|101964|P1|Overall Study|Adverse Event|1
21486|NCT01775137|101964|P1|Overall Study|Unsatisfactory therapeutic effect|2
21487|NCT01775137|101964|P1|Overall Study|Protocol deviation|2
21488|NCT01775137|101964|P1|Overall Study|Death|1
21489|NCT01774981|101997|P8|Overall Study|Death|0
21490|NCT01774981|101998|P7|Overall Study|Death|0
21491|NCT01774981|101999|P6|Overall Study|Death|0
21492|NCT01774981|102000|P5|Overall Study|Death|1
21493|NCT01774981|102001|P4|Overall Study|Death|0
21494|NCT01774981|102002|P3|Overall Study|Death|0
21495|NCT01774981|102003|P2|Overall Study|Death|0
21496|NCT01774981|102004|P1|Overall Study|Death|0
21497|NCT01774981|101997|P8|Overall Study|Withdrawal by Subject|1
21498|NCT01774981|101998|P7|Overall Study|Withdrawal by Subject|0
21499|NCT01774981|101999|P6|Overall Study|Withdrawal by Subject|0
21500|NCT01774981|102000|P5|Overall Study|Withdrawal by Subject|0
21501|NCT01774981|102001|P4|Overall Study|Withdrawal by Subject|0
21502|NCT01774981|102002|P3|Overall Study|Withdrawal by Subject|0
21503|NCT01774981|102003|P2|Overall Study|Withdrawal by Subject|0
21504|NCT01774981|102004|P1|Overall Study|Withdrawal by Subject|0
21505|NCT01774981|101997|P8|Overall Study|Adverse Event|0
21506|NCT01774981|101998|P7|Overall Study|Adverse Event|0
21507|NCT01774981|101999|P6|Overall Study|Adverse Event|1
21508|NCT01774981|102000|P5|Overall Study|Adverse Event|0
21509|NCT01774981|102001|P4|Overall Study|Adverse Event|0
21510|NCT01774981|102002|P3|Overall Study|Adverse Event|0
21511|NCT01774981|102003|P2|Overall Study|Adverse Event|0
21512|NCT01774981|102004|P1|Overall Study|Adverse Event|0
21513|NCT01774968|102036|P2|Overall Study|Withdrawal by Subject|11
21514|NCT01774968|102037|P1|Overall Study|Withdrawal by Subject|6
21515|NCT01774968|102036|P2|Overall Study|Sponsor Decision|2
21516|NCT01774968|102037|P1|Overall Study|Sponsor Decision|0
21517|NCT01774968|102036|P2|Overall Study|Protocol Violation|13
21518|NCT01774968|102037|P1|Overall Study|Protocol Violation|14
21519|NCT01774968|102036|P2|Overall Study|Physician Decision|1
21520|NCT01774968|102037|P1|Overall Study|Physician Decision|5
21521|NCT01774968|102036|P2|Overall Study|Lost to Follow-up|3
21522|NCT01774968|102037|P1|Overall Study|Lost to Follow-up|1
21523|NCT01774968|102036|P2|Overall Study|Death|1
21524|NCT01774968|102037|P1|Overall Study|Death|0
21525|NCT01774968|102036|P2|Overall Study|Adverse Event|4
21526|NCT01774968|102037|P1|Overall Study|Adverse Event|4
21527|NCT01774929|102071|P1|Overall Study|Adverse Event|3
21528|NCT01774903|102077|P1|Overall Study|Ineligible to continue the trial|1
21529|NCT01774903|102077|P1|Overall Study|Lack of Efficacy|1
21530|NCT01774903|102077|P1|Overall Study|Withdrawal by Subject|2
21531|NCT01774903|102077|P1|Overall Study|Adverse Event|7
21532|NCT01774344|102116|P2|Overall Study|Non-compliance with study drug|2
21533|NCT01774344|102117|P1|Overall Study|Non-compliance with study drug|0
21534|NCT01774344|102116|P2|Overall Study|Physician Decision|1
21535|NCT01774344|102117|P1|Overall Study|Physician Decision|0
21536|NCT01774344|102116|P2|Overall Study|Adverse event (AE)|1
21537|NCT01774344|102117|P1|Overall Study|Adverse event (AE)|0
21538|NCT01774344|102116|P2|Overall Study|AE not related to disease progression|47
21539|NCT01774344|102117|P1|Overall Study|AE not related to disease progression|12
21540|NCT01774344|102116|P2|Overall Study|Ongoing with treatment|65
21541|NCT01774344|102117|P1|Overall Study|Ongoing with treatment|10
21542|NCT01774344|102116|P2|Overall Study|Unspecified|0
21543|NCT01774344|102117|P1|Overall Study|Unspecified|1
21544|NCT01774344|102116|P2|Overall Study|Study drug never administered|5
21545|NCT01774344|102117|P1|Overall Study|Study drug never administered|1
21546|NCT01774344|102116|P2|Overall Study|Withdrawal by Subject|26
21547|NCT01774344|102117|P1|Overall Study|Withdrawal by Subject|5
21548|NCT01774344|102116|P2|Overall Study|Protocol Violation|1
21549|NCT01774344|102117|P1|Overall Study|Protocol Violation|3
21550|NCT01774305|102133|P2|Overall Study|Physician Decision|0
21551|NCT01774305|102134|P1|Overall Study|Physician Decision|1
21552|NCT01774253|102142|P1|Overall Study|Death|1
21553|NCT01774253|102142|P1|Overall Study|Withdrawal by Subject|2
21554|NCT01774253|102142|P1|Overall Study|Physician Decision|2
21555|NCT01774253|102142|P1|Overall Study|Lack of Efficacy|4
21556|NCT01774110|102161|P1|Overall Study|Lost to Follow-up|7
21557|NCT01774097|102169|P2|Overall Study|Adverse Event|1
21558|NCT01774097|102170|P1|Overall Study|Adverse Event|1
21559|NCT01774097|102169|P2|Overall Study|Withdrawal by Subject|1
21560|NCT01774097|102170|P1|Overall Study|Withdrawal by Subject|1
21561|NCT01774084|102200|P2|Overall Study|Personal reasons|0
21562|NCT01774084|102201|P1|Overall Study|Personal reasons|1
21563|NCT01773889|102226|P1|Overall Study|lack of funding|2
21564|NCT01773473|102232|P2|Overall Study|Lost to Follow-up|0
21565|NCT01773473|102233|P1|Overall Study|Lost to Follow-up|2
21566|NCT01773473|102232|P2|Overall Study|Withdrawal by Subject|3
21567|NCT01773473|102233|P1|Overall Study|Withdrawal by Subject|5
21568|NCT01773473|102232|P2|Overall Study|Non-Compliance with study drug|4
21569|NCT01773473|102233|P1|Overall Study|Non-Compliance with study drug|1
21570|NCT01773473|102232|P2|Overall Study|Lack of Efficacy|1
21571|NCT01773473|102233|P1|Overall Study|Lack of Efficacy|0
21572|NCT01773473|102232|P2|Overall Study|Sponsor Decision|0
21573|NCT01773473|102233|P1|Overall Study|Sponsor Decision|2
21574|NCT01773473|102232|P2|Overall Study|Physician Decision|5
21575|NCT01773473|102233|P1|Overall Study|Physician Decision|3
21576|NCT01773473|102232|P2|Overall Study|Protocol Violation|4
21577|NCT01773473|102233|P1|Overall Study|Protocol Violation|0
21578|NCT01773473|102232|P2|Overall Study|Adverse Event|2
21579|NCT01773473|102233|P1|Overall Study|Adverse Event|3
21580|NCT01773291|102254|P3|Overall Study|Withdrawal by Subject|1
21581|NCT01773291|102255|P2|Overall Study|Withdrawal by Subject|0
21582|NCT01773291|102256|P1|Overall Study|Withdrawal by Subject|0
21583|NCT01773291|102254|P3|Overall Study|Protocol Violation|0
21584|NCT01773291|102255|P2|Overall Study|Protocol Violation|0
21585|NCT01773291|102256|P1|Overall Study|Protocol Violation|1
21586|NCT01773226|102267|P1|Overall Study|Withdrawal by Subject|1
21587|NCT01773122|102286|P4|Overall Study|Due to amended age eligibility criteria|1
21588|NCT01773122|102287|P3|Overall Study|Due to amended age eligibility criteria|0
21589|NCT01773122|102288|P2|Overall Study|Due to amended age eligibility criteria|1
21590|NCT01773122|102289|P1|Overall Study|Due to amended age eligibility criteria|3
21591|NCT01772576|102312|P1|Overall Study|Withdrawal by Subject|6
21592|NCT01772576|102312|P1|Overall Study|Adverse Event|6
21593|NCT01772576|102312|P1|Overall Study|Study device not used|3
21594|NCT01772576|102312|P1|Overall Study|Lost to Follow-up|3
21595|NCT01772576|102312|P1|Overall Study|Protocol Violation|1
21596|NCT01772576|102312|P1|Overall Study|Death|15
21597|NCT01772550|102324|P3|Overall Study|Adverse Event|1
21598|NCT01772550|102325|P2|Overall Study|Adverse Event|0
21599|NCT01772550|102326|P1|Overall Study|Adverse Event|0
21600|NCT01772550|102324|P3|Overall Study|Unable to insert IV in antecubital vein|5
21601|NCT01772550|102325|P2|Overall Study|Unable to insert IV in antecubital vein|1
21602|NCT01772550|102326|P1|Overall Study|Unable to insert IV in antecubital vein|1
21603|NCT01772537|102367|P3|Overall Study|unsuccessful lumbar drain placement|0
21604|NCT01772537|102368|P2|Overall Study|unsuccessful lumbar drain placement|0
21605|NCT01772537|102369|P1|Overall Study|unsuccessful lumbar drain placement|1
21606|NCT01772368|102383|P1|Overall Study|Not specified|1
21607|NCT01772368|102383|P1|Overall Study|Protocol Violation|2
21608|NCT01772368|102383|P1|Overall Study|Withdrawal by Subject|3
21609|NCT01772368|102383|P1|Overall Study|Adverse Event|1
21610|NCT01772316|102429|P1|Overall Study|Withdrawn by sponsor decision|5
21611|NCT01772316|102429|P1|Overall Study|Inform consent withdrawn|1
21612|NCT01772316|102429|P1|Overall Study|Serious adverse event|1
21613|NCT01772147|102450|P3|Overall Study|Lack of Efficacy|6
21614|NCT01772147|102451|P2|Overall Study|Lack of Efficacy|6
21615|NCT01772147|102452|P1|Overall Study|Lack of Efficacy|8
21616|NCT01772147|102450|P3|Overall Study|Protocol Deviation|1
21617|NCT01772147|102451|P2|Overall Study|Protocol Deviation|1
21618|NCT01772147|102452|P1|Overall Study|Protocol Deviation|2
21619|NCT01772147|102450|P3|Overall Study|Lost to Follow-up|1
21620|NCT01772147|102451|P2|Overall Study|Lost to Follow-up|0
21621|NCT01772147|102452|P1|Overall Study|Lost to Follow-up|1
21622|NCT01772147|102450|P3|Overall Study|Withdrew Consent|4
21623|NCT01772147|102451|P2|Overall Study|Withdrew Consent|8
21624|NCT01772147|102452|P1|Overall Study|Withdrew Consent|7
21625|NCT01772147|102450|P3|Overall Study|Adverse Event|6
21626|NCT01772147|102451|P2|Overall Study|Adverse Event|10
21627|NCT01772147|102452|P1|Overall Study|Adverse Event|13
21628|NCT01772134|102472|P3|Overall Study|Randomized Study Medication Not Received|1
21629|NCT01772134|102473|P2|Overall Study|Randomized Study Medication Not Received|0
21630|NCT01772134|102474|P1|Overall Study|Randomized Study Medication Not Received|2
21631|NCT01772134|102472|P3|Overall Study|Protocol-defined Stopping Criteria|0
21632|NCT01772134|102473|P2|Overall Study|Protocol-defined Stopping Criteria|0
21633|NCT01772134|102474|P1|Overall Study|Protocol-defined Stopping Criteria|1
21634|NCT01772134|102472|P3|Overall Study|Lack of Efficacy|3
21635|NCT01772134|102473|P2|Overall Study|Lack of Efficacy|5
21636|NCT01772134|102474|P1|Overall Study|Lack of Efficacy|11
21637|NCT01772134|102472|P3|Overall Study|Protocol Deviation|3
21638|NCT01772134|102473|P2|Overall Study|Protocol Deviation|3
21639|NCT01772134|102474|P1|Overall Study|Protocol Deviation|4
21640|NCT01772134|102472|P3|Overall Study|Lost to Follow-up|0
21641|NCT01772134|102473|P2|Overall Study|Lost to Follow-up|0
21642|NCT01772134|102474|P1|Overall Study|Lost to Follow-up|2
21643|NCT01772134|102472|P3|Overall Study|Withdrew Consent|5
21644|NCT01772134|102473|P2|Overall Study|Withdrew Consent|1
21645|NCT01772134|102474|P1|Overall Study|Withdrew Consent|3
21646|NCT01772134|102472|P3|Overall Study|Adverse Event|10
21647|NCT01772134|102473|P2|Overall Study|Adverse Event|5
21648|NCT01772134|102474|P1|Overall Study|Adverse Event|6
21649|NCT01771913|102511|P2|Overall Study|Withdrawal by Subject|0
21650|NCT01771913|102512|P1|Overall Study|Withdrawal by Subject|1
21651|NCT01770860|102526|P1|Overall Study|Administrative decision made by the PI|1
21652|NCT01770860|102526|P1|Overall Study|Lost to Follow-up|1
21653|NCT01770860|102526|P1|Overall Study|Withdrawal by Subject|4
21654|NCT01770743|102574|P5|Overall Study|Moving Out of State|0
21655|NCT01770743|102575|P4|Overall Study|Moving Out of State|0
21656|NCT01770743|102576|P3|Overall Study|Moving Out of State|0
21657|NCT01770743|102577|P2|Overall Study|Moving Out of State|1
21658|NCT01770743|102578|P1|Overall Study|Moving Out of State|0
21659|NCT01770743|102574|P5|Overall Study|Sponsor Terminated Subject|0
21660|NCT01770743|102575|P4|Overall Study|Sponsor Terminated Subject|1
21661|NCT01770743|102576|P3|Overall Study|Sponsor Terminated Subject|0
21662|NCT01770743|102577|P2|Overall Study|Sponsor Terminated Subject|0
21663|NCT01770743|102578|P1|Overall Study|Sponsor Terminated Subject|1
21664|NCT01770743|102574|P5|Overall Study|Lost to Follow-up|1
21665|NCT01770743|102575|P4|Overall Study|Lost to Follow-up|0
21666|NCT01770743|102576|P3|Overall Study|Lost to Follow-up|0
21667|NCT01770743|102577|P2|Overall Study|Lost to Follow-up|2
21668|NCT01770743|102578|P1|Overall Study|Lost to Follow-up|0
21669|NCT01770743|102574|P5|Overall Study|Withdrawal by Subject|1
21670|NCT01770743|102575|P4|Overall Study|Withdrawal by Subject|1
21671|NCT01770743|102576|P3|Overall Study|Withdrawal by Subject|1
21672|NCT01770743|102577|P2|Overall Study|Withdrawal by Subject|0
21673|NCT01770743|102578|P1|Overall Study|Withdrawal by Subject|0
21674|NCT01770743|102574|P5|Overall Study|Adverse Event|0
21675|NCT01770743|102575|P4|Overall Study|Adverse Event|0
21676|NCT01770743|102576|P3|Overall Study|Adverse Event|0
21677|NCT01770743|102577|P2|Overall Study|Adverse Event|0
21678|NCT01770743|102578|P1|Overall Study|Adverse Event|1
21679|NCT01770509|102680|P2|Overall Study|Lost to Follow-up|2
21680|NCT01770509|102681|P1|Overall Study|Lost to Follow-up|1
21681|NCT01770509|102680|P2|Overall Study|Injury|1
21682|NCT01770509|102681|P1|Overall Study|Injury|0
21683|NCT01770392|102706|P1|Washout Period of at Least 14 Days|Adverse Event|1
21684|NCT01770379|102721|P3|Overall Study|Adverse Event|2
21685|NCT01770379|102722|P2|Overall Study|Adverse Event|3
21686|NCT01770379|102723|P1|Overall Study|Adverse Event|1
21687|NCT01770379|102721|P3|Overall Study|Lack of Efficacy|6
21688|NCT01770379|102722|P2|Overall Study|Lack of Efficacy|6
21689|NCT01770379|102723|P1|Overall Study|Lack of Efficacy|8
21690|NCT01770379|102721|P3|Overall Study|Lost to Follow-up|2
21691|NCT01770379|102722|P2|Overall Study|Lost to Follow-up|0
21692|NCT01770379|102723|P1|Overall Study|Lost to Follow-up|0
21693|NCT01770379|102721|P3|Overall Study|Physician Decision|2
21694|NCT01770379|102722|P2|Overall Study|Physician Decision|1
21695|NCT01770379|102723|P1|Overall Study|Physician Decision|0
21696|NCT01770379|102721|P3|Overall Study|Protocol Violation|1
21697|NCT01770379|102722|P2|Overall Study|Protocol Violation|1
21698|NCT01770379|102723|P1|Overall Study|Protocol Violation|0
21699|NCT01770379|102721|P3|Overall Study|study terminated by sponsor|22
21700|NCT01770379|102722|P2|Overall Study|study terminated by sponsor|23
21701|NCT01770379|102723|P1|Overall Study|study terminated by sponsor|22
21702|NCT01770379|102721|P3|Overall Study|Withdrawal by Subject|7
21703|NCT01770379|102722|P2|Overall Study|Withdrawal by Subject|10
21704|NCT01770379|102723|P1|Overall Study|Withdrawal by Subject|7
21705|NCT01770379|102721|P3|Overall Study|Technical issues|0
21706|NCT01770379|102722|P2|Overall Study|Technical issues|0
21707|NCT01770379|102723|P1|Overall Study|Technical issues|1
21708|NCT01770145|102760|P1|Treatment|Withdrawal by Subject|1
21709|NCT01770145|102760|P1|Treatment|Adverse Event|3
21710|NCT01770145|102760|P1|Baseline|Unable to define optimal dose|4
21711|NCT01770145|102760|P1|Baseline|Lost to Follow-up|1
21712|NCT01770145|102760|P1|Baseline|Withdrawal by Subject|1
21713|NCT01770145|102760|P1|Baseline|Adverse Event|20
21714|NCT01769508|102780|P1|Overall Study|Lost to Follow-up|1
21715|NCT01769508|102780|P1|Overall Study|Adverse Event|1
21716|NCT01769508|102780|P1|Overall Study|Withdrawal by Subject|1
21717|NCT01769508|102780|P1|Overall Study|Death|3
21718|NCT01769443|102791|P2|Overall Study|Study closure|0
21719|NCT01769443|102792|P1|Overall Study|Study closure|1
21720|NCT01769391|102836|P2|Overall Study|On Treatment at Study Conclusion|0
21721|NCT01769391|102837|P1|Overall Study|On Treatment at Study Conclusion|3
21722|NCT01769391|102836|P2|Overall Study|Investigator Decision|0
21723|NCT01769391|102837|P1|Overall Study|Investigator Decision|2
21724|NCT01769391|102836|P2|Overall Study|Withdrawal by Subject|3
21725|NCT01769391|102837|P1|Overall Study|Withdrawal by Subject|4
21726|NCT01769391|102836|P2|Overall Study|Progressive Disease|2
21727|NCT01769391|102837|P1|Overall Study|Progressive Disease|1
21728|NCT01769391|102836|P2|Overall Study|Adverse Event|3
21729|NCT01769391|102837|P1|Overall Study|Adverse Event|0
21730|NCT01769391|102836|P2|Overall Study|Death|1
21731|NCT01769391|102837|P1|Overall Study|Death|10
21732|NCT01769378|102856|P2|Overall Study|Lost to Follow-up|0
21733|NCT01769378|102857|P1|Overall Study|Lost to Follow-up|2
21734|NCT01769378|102856|P2|Overall Study|Sponsor Decision|0
21735|NCT01769378|102857|P1|Overall Study|Sponsor Decision|1
21736|NCT01769378|102856|P2|Overall Study|Withdrawal by Subject|3
21737|NCT01769378|102857|P1|Overall Study|Withdrawal by Subject|10
21738|NCT01769378|102856|P2|Overall Study|Protocol Violation|1
21739|NCT01769378|102857|P1|Overall Study|Protocol Violation|1
21740|NCT01769378|102856|P2|Overall Study|Entry criteria not met|0
21741|NCT01769378|102857|P1|Overall Study|Entry criteria not met|1
21742|NCT01769378|102856|P2|Overall Study|Adverse Event|0
21743|NCT01769378|102857|P1|Overall Study|Adverse Event|10
21744|NCT01769339|102905|P1|Overall Study|Adverse Event|1
21745|NCT01769339|102905|P1|Overall Study|Lost to Follow-up|42
21746|NCT01769326|102916|P4|Overall Study|Got sick and could not complete study|0
21747|NCT01769326|102917|P3|Overall Study|Got sick and could not complete study|1
21748|NCT01769326|102918|P2|Overall Study|Got sick and could not complete study|0
21749|NCT01769326|102919|P1|Overall Study|Got sick and could not complete study|0
21750|NCT01769326|102916|P4|Overall Study|got a job|0
21751|NCT01769326|102917|P3|Overall Study|got a job|0
21752|NCT01769326|102918|P2|Overall Study|got a job|1
21753|NCT01769326|102919|P1|Overall Study|got a job|0
21754|NCT01769326|102916|P4|Overall Study|unrelated injry|0
21755|NCT01769326|102917|P3|Overall Study|unrelated injry|0
21756|NCT01769326|102918|P2|Overall Study|unrelated injry|1
21757|NCT01769326|102919|P1|Overall Study|unrelated injry|1
21758|NCT01769326|102916|P4|Overall Study|Lost to Follow-up|0
21759|NCT01769326|102917|P3|Overall Study|Lost to Follow-up|0
21760|NCT01769326|102918|P2|Overall Study|Lost to Follow-up|2
21761|NCT01769326|102919|P1|Overall Study|Lost to Follow-up|1
21762|NCT01769196|102957|P2|Overall Study|Withdrew consent|40
21763|NCT01769196|102958|P1|Overall Study|Withdrew consent|36
21764|NCT01769196|102957|P2|Overall Study|Participant never dosed with study drug|0
21765|NCT01769196|102958|P1|Overall Study|Participant never dosed with study drug|1
21766|NCT01769196|102957|P2|Overall Study|Study terminated by sponsor|161
21767|NCT01769196|102958|P1|Overall Study|Study terminated by sponsor|160
21768|NCT01769196|102957|P2|Overall Study|Protocol Violation|3
21769|NCT01769196|102958|P1|Overall Study|Protocol Violation|0
21770|NCT01769196|102957|P2|Overall Study|Protocol defined criteria for withdrawal|11
21771|NCT01769196|102958|P1|Overall Study|Protocol defined criteria for withdrawal|9
21772|NCT01769196|102957|P2|Overall Study|Progressive disease|6
21773|NCT01769196|102958|P1|Overall Study|Progressive disease|11
21774|NCT01769196|102957|P2|Overall Study|Lack of Efficacy|2
21775|NCT01769196|102958|P1|Overall Study|Lack of Efficacy|3
21776|NCT01769196|102957|P2|Overall Study|Investigator Discretion|3
21777|NCT01769196|102958|P1|Overall Study|Investigator Discretion|7
21778|NCT01769196|102957|P2|Overall Study|Death|26
21779|NCT01769196|102958|P1|Overall Study|Death|21
21780|NCT01769196|102957|P2|Overall Study|Adverse Event|20
21781|NCT01769196|102958|P1|Overall Study|Adverse Event|24
21782|NCT01769105|102988|P2|Cross-over|Lost to Follow-up|0
21783|NCT01769105|102989|P1|Cross-over|Lost to Follow-up|5
21784|NCT01769105|102988|P2|First Intervention|Protocol Violation|2
21785|NCT01769105|102989|P1|First Intervention|Protocol Violation|2
21786|NCT01768676|103010|P2|Overall Study|Withdrawal by Subject|10
21787|NCT01768676|103011|P1|Overall Study|Withdrawal by Subject|3
21788|NCT01768676|103010|P2|Overall Study|Physician Decision|1
21789|NCT01768676|103011|P1|Overall Study|Physician Decision|4
21790|NCT01768676|103010|P2|Overall Study|Protocol Violation|1
21791|NCT01768676|103011|P1|Overall Study|Protocol Violation|1
21792|NCT01768676|103010|P2|Overall Study|Lost to Follow-up|16
21793|NCT01768676|103011|P1|Overall Study|Lost to Follow-up|13
21794|NCT01768676|103010|P2|Overall Study|Adverse Event|3
21795|NCT01768676|103011|P1|Overall Study|Adverse Event|3
21796|NCT01768572|103028|P3|Overall Study|Other, Not due to an adverse event|1
21797|NCT01768572|103029|P2|Overall Study|Other, Not due to an adverse event|1
21798|NCT01768572|103030|P1|Overall Study|Other, Not due to an adverse event|1
21799|NCT01768572|103028|P3|Overall Study|Lack of Efficacy|1
21800|NCT01768572|103029|P2|Overall Study|Lack of Efficacy|3
21801|NCT01768572|103030|P1|Overall Study|Lack of Efficacy|1
21802|NCT01768572|103028|P3|Overall Study|Adverse Event|4
21803|NCT01768572|103029|P2|Overall Study|Adverse Event|8
21804|NCT01768572|103030|P1|Overall Study|Adverse Event|7
21805|NCT01768559|103041|P3|Overall Study|Other than specified|5
21806|NCT01768559|103042|P2|Overall Study|Other than specified|8
21807|NCT01768559|103043|P1|Overall Study|Other than specified|9
21808|NCT01768559|103041|P3|Overall Study|Poor compliance to protocol|2
21809|NCT01768559|103042|P2|Overall Study|Poor compliance to protocol|3
21810|NCT01768559|103043|P1|Overall Study|Poor compliance to protocol|0
21811|NCT01768559|103041|P3|Overall Study|Lack of Efficacy|0
21812|NCT01768559|103042|P2|Overall Study|Lack of Efficacy|4
21813|NCT01768559|103043|P1|Overall Study|Lack of Efficacy|6
21814|NCT01768559|103041|P3|Overall Study|Adverse Event|5
21815|NCT01768559|103042|P2|Overall Study|Adverse Event|2
21816|NCT01768559|103043|P1|Overall Study|Adverse Event|15
21817|NCT01768559|103041|P3|Overall Study|Randomized but not treated|1
21818|NCT01768559|103042|P2|Overall Study|Randomized but not treated|0
21819|NCT01768559|103043|P1|Overall Study|Randomized but not treated|0
21820|NCT01768286|103108|P4|Overall Study|Withdrew Consent|0
21821|NCT01768286|103109|P3|Overall Study|Withdrew Consent|1
21822|NCT01768286|103110|P2|Overall Study|Withdrew Consent|0
21823|NCT01768286|103111|P1|Overall Study|Withdrew Consent|0
21824|NCT01768286|103108|P4|Overall Study|Lack of Efficacy|1
21825|NCT01768286|103109|P3|Overall Study|Lack of Efficacy|0
21826|NCT01768286|103110|P2|Overall Study|Lack of Efficacy|4
21827|NCT01768286|103111|P1|Overall Study|Lack of Efficacy|7
21828|NCT01768286|103108|P4|Overall Study|Randomized But Not Treated|0
21829|NCT01768286|103109|P3|Overall Study|Randomized But Not Treated|1
21830|NCT01768286|103110|P2|Overall Study|Randomized But Not Treated|0
21831|NCT01768286|103111|P1|Overall Study|Randomized But Not Treated|0
21832|NCT01768117|103173|P1|Overall Study|Protocol Violation|3
21833|NCT01768117|103173|P1|Overall Study|Withdrawal by Subject|2
21834|NCT01768117|103173|P1|Overall Study|Lost to Follow-up|1
21835|NCT01767987|103237|P2|Overall Study|Physician Decision|1
21836|NCT01767987|103238|P1|Overall Study|Physician Decision|4
21837|NCT01767597|103296|P2|Overall Study|Withdrawal by Subject|0
21838|NCT01767597|103297|P1|Overall Study|Withdrawal by Subject|1
21839|NCT01767597|103296|P2|Overall Study|Incomplete intervention|1
21840|NCT01767597|103297|P1|Overall Study|Incomplete intervention|3
21841|NCT01767519|103306|P3|Overall Study|Adverse Event|1
21842|NCT01767519|103307|P2|Overall Study|Adverse Event|5
21843|NCT01767519|103308|P1|Overall Study|Adverse Event|5
21844|NCT01767519|103306|P3|Overall Study|Lack of Efficacy|0
21845|NCT01767519|103307|P2|Overall Study|Lack of Efficacy|0
21846|NCT01767519|103308|P1|Overall Study|Lack of Efficacy|1
21847|NCT01767519|103306|P3|Overall Study|Lost to Follow-up|2
21848|NCT01767519|103307|P2|Overall Study|Lost to Follow-up|1
21849|NCT01767519|103308|P1|Overall Study|Lost to Follow-up|3
21850|NCT01767519|103306|P3|Overall Study|Personal Reasons|0
21851|NCT01767519|103307|P2|Overall Study|Personal Reasons|0
21852|NCT01767519|103308|P1|Overall Study|Personal Reasons|1
21853|NCT01767519|103306|P3|Overall Study|Protocol Violation|0
21854|NCT01767519|103307|P2|Overall Study|Protocol Violation|3
21855|NCT01767519|103308|P1|Overall Study|Protocol Violation|0
21856|NCT01767519|103306|P3|Overall Study|Other Reasons|2
21857|NCT01767519|103307|P2|Overall Study|Other Reasons|4
21858|NCT01767519|103308|P1|Overall Study|Other Reasons|4
21859|NCT01767467|103336|P2|Overall Study|Subject unavailable|1
21860|NCT01767467|103337|P1|Overall Study|Subject unavailable|0
21861|NCT01767467|103336|P2|Overall Study|Physician Decision|0
21862|NCT01767467|103337|P1|Overall Study|Physician Decision|1
21863|NCT01767467|103336|P2|Overall Study|Suspected Herpes Zoster episode|1
21864|NCT01767467|103337|P1|Overall Study|Suspected Herpes Zoster episode|0
21865|NCT01767467|103336|P2|Overall Study|Withdrawal by Subject|10
21866|NCT01767467|103337|P1|Overall Study|Withdrawal by Subject|7
21867|NCT01767467|103336|P2|Overall Study|Protocol Violation|0
21868|NCT01767467|103337|P1|Overall Study|Protocol Violation|1
21869|NCT01767467|103336|P2|Overall Study|Adverse Event|8
21870|NCT01767467|103337|P1|Overall Study|Adverse Event|8
21871|NCT01767116|103386|P2|Overall Study|Lost to Follow-up|2
21872|NCT01767116|103387|P1|Overall Study|Lost to Follow-up|2
21873|NCT01766921|103445|P2|Overall Study|Withdrawal by Subject|5
21874|NCT01766921|103446|P1|Overall Study|Withdrawal by Subject|14
21875|NCT01766921|103445|P2|Overall Study|Protocol Violation|1
21876|NCT01766921|103446|P1|Overall Study|Protocol Violation|1
21877|NCT01766921|103445|P2|Overall Study|Unclassified|2
21878|NCT01766921|103446|P1|Overall Study|Unclassified|2
21879|NCT01766921|103445|P2|Overall Study|Lost to Follow-up|3
21880|NCT01766921|103446|P1|Overall Study|Lost to Follow-up|1
21881|NCT01766921|103445|P2|Overall Study|Death|1
21882|NCT01766921|103446|P1|Overall Study|Death|1
21883|NCT01766921|103445|P2|Overall Study|Administrative Reason|5
21884|NCT01766921|103446|P1|Overall Study|Administrative Reason|5
21885|NCT01766778|103467|P2|Overall Study|Withdrawal by Subject|0
21886|NCT01766778|103468|P1|Overall Study|Withdrawal by Subject|1
21887|NCT01766778|103467|P2|Overall Study|Adverse Event|4
21888|NCT01766778|103468|P1|Overall Study|Adverse Event|4
21889|NCT01766336|103522|P2|Overall Study|Withdrawal by Subject|15
21890|NCT01766336|103523|P1|Overall Study|Withdrawal by Subject|18
21891|NCT01766336|103522|P2|Overall Study|Sponsor Decision|43
21892|NCT01766336|103523|P1|Overall Study|Sponsor Decision|52
21893|NCT01766336|103522|P2|Overall Study|Protocol Violation|1
21894|NCT01766336|103523|P1|Overall Study|Protocol Violation|0
21895|NCT01766336|103522|P2|Overall Study|Physician Decision|2
21896|NCT01766336|103523|P1|Overall Study|Physician Decision|4
21897|NCT01766336|103522|P2|Overall Study|Lost to Follow-up|3
21898|NCT01766336|103523|P1|Overall Study|Lost to Follow-up|1
21899|NCT01766336|103522|P2|Overall Study|Death|3
21900|NCT01766336|103523|P1|Overall Study|Death|4
21901|NCT01766336|103522|P2|Overall Study|Adverse Event|8
21902|NCT01766336|103523|P1|Overall Study|Adverse Event|11
21903|NCT01766310|103531|P2|Overall Study|Lost to Follow-up|3
21904|NCT01766310|103532|P1|Overall Study|Lost to Follow-up|1
21905|NCT01766050|103560|P1|Overall Study|Withdrawal by Subject|2
21906|NCT01766050|103560|P1|Overall Study|Lost to Follow-up|1
21907|NCT01766050|103560|P1|Overall Study|Adverse Event|1
21908|NCT01766037|103695|P2|Overall Study|nausea / discomfort|0
21909|NCT01766037|103696|P1|Overall Study|nausea / discomfort|3
21910|NCT01766037|103695|P2|Overall Study|medical - unrelated|2
21911|NCT01766037|103696|P1|Overall Study|medical - unrelated|1
21912|NCT01766037|103695|P2|Overall Study|Moved from area|0
21913|NCT01766037|103696|P1|Overall Study|Moved from area|5
21914|NCT01766037|103695|P2|Overall Study|Withdrawal by Subject|16
21915|NCT01766037|103696|P1|Overall Study|Withdrawal by Subject|18
21916|NCT01766037|103695|P2|Overall Study|Physician Decision|1
21917|NCT01766037|103696|P1|Overall Study|Physician Decision|0
21918|NCT01766037|103695|P2|Overall Study|Lost to Follow-up|10
21919|NCT01766037|103696|P1|Overall Study|Lost to Follow-up|0
21920|NCT01766037|103695|P2|Overall Study|Lack of Efficacy|0
21921|NCT01766037|103696|P1|Overall Study|Lack of Efficacy|1
21922|NCT01766037|103695|P2|Overall Study|Adverse Event|0
21923|NCT01766037|103696|P1|Overall Study|Adverse Event|1
21924|NCT01764841|103761|P4|Overall Study|Lost to Follow-up|0
21925|NCT01764841|103762|P3|Overall Study|Lost to Follow-up|1
21926|NCT01764841|103763|P2|Overall Study|Lost to Follow-up|0
21927|NCT01764841|103764|P1|Overall Study|Lost to Follow-up|3
21928|NCT01764841|103761|P4|Overall Study|Withdrawal by Subject|15
21929|NCT01764841|103762|P3|Overall Study|Withdrawal by Subject|11
21930|NCT01764841|103763|P2|Overall Study|Withdrawal by Subject|24
21931|NCT01764841|103764|P1|Overall Study|Withdrawal by Subject|16
21932|NCT01764841|103761|P4|Overall Study|Protocol Violation|0
21933|NCT01764841|103762|P3|Overall Study|Protocol Violation|0
21934|NCT01764841|103763|P2|Overall Study|Protocol Violation|1
21935|NCT01764841|103764|P1|Overall Study|Protocol Violation|0
21936|NCT01764841|103761|P4|Overall Study|No Follow Up|0
21937|NCT01764841|103762|P3|Overall Study|No Follow Up|1
21938|NCT01764841|103763|P2|Overall Study|No Follow Up|0
21939|NCT01764841|103764|P1|Overall Study|No Follow Up|1
21940|NCT01764841|103761|P4|Overall Study|Death|4
21941|NCT01764841|103762|P3|Overall Study|Death|1
21942|NCT01764841|103763|P2|Overall Study|Death|0
21943|NCT01764841|103764|P1|Overall Study|Death|3
21944|NCT01764841|103761|P4|Overall Study|Logistical Difficulties|0
21945|NCT01764841|103762|P3|Overall Study|Logistical Difficulties|0
21946|NCT01764841|103763|P2|Overall Study|Logistical Difficulties|1
21947|NCT01764841|103764|P1|Overall Study|Logistical Difficulties|0
21948|NCT01765764|103813|P3|Treatment Period|Other Miscellaneous Reasons|2
21949|NCT01765764|103814|P2|Treatment Period|Other Miscellaneous Reasons|2
21950|NCT01765764|103815|P1|Treatment Period|Other Miscellaneous Reasons|1
21951|NCT01765764|103813|P3|Treatment Period|Personal Reasons|1
21952|NCT01765764|103814|P2|Treatment Period|Personal Reasons|2
21953|NCT01765764|103815|P1|Treatment Period|Personal Reasons|1
21954|NCT01765764|103813|P3|Treatment Period|Lost to Follow-up|2
21955|NCT01765764|103814|P2|Treatment Period|Lost to Follow-up|3
21956|NCT01765764|103815|P1|Treatment Period|Lost to Follow-up|0
21957|NCT01765764|103813|P3|Treatment Period|Adverse Event|1
21958|NCT01765764|103814|P2|Treatment Period|Adverse Event|2
21959|NCT01765764|103815|P1|Treatment Period|Adverse Event|1
21960|NCT01765569|103832|P1|Period C|Death|1
21961|NCT01765569|103832|P1|Period B|Withdrawal by Subject|1
21962|NCT01765543|103853|P1|Overall Study|Withdrawal by Subject|2
21963|NCT01765543|103853|P1|Overall Study|Death|1
21964|NCT01765426|103905|P4|Overall Study|Lost to Follow-up|0
21965|NCT01765426|103906|P3|Overall Study|Lost to Follow-up|0
21966|NCT01765426|103907|P2|Overall Study|Lost to Follow-up|1
21967|NCT01765426|103908|P1|Overall Study|Lost to Follow-up|0
21968|NCT01765270|103964|P2|Overall Study|Withdrawal by Subject|1
21969|NCT01765270|103965|P1|Overall Study|Withdrawal by Subject|0
21970|NCT01765270|103964|P2|Overall Study|Physician Decision|0
21971|NCT01765270|103965|P1|Overall Study|Physician Decision|1
21972|NCT01765192|103987|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
21973|NCT01765192|103988|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
21974|NCT01765192|103987|P2|Treatment Period 2|Reason not specified|2
21975|NCT01765192|103988|P1|Treatment Period 2|Reason not specified|0
21976|NCT01765192|103987|P2|Washout Period|Reason not specified|0
21977|NCT01765192|103988|P1|Washout Period|Reason not specified|1
21978|NCT01765192|103987|P2|Washout Period|Voluntary Withdrawal|1
21979|NCT01765192|103988|P1|Washout Period|Voluntary Withdrawal|1
21980|NCT01765192|103987|P2|Treatment Period 1|Adverse Event|1
21981|NCT01765192|103988|P1|Treatment Period 1|Adverse Event|0
21982|NCT01765153|104008|P2|Rest Phase 2|Lost to Follow-up|1
21983|NCT01765153|104009|P1|Rest Phase 2|Lost to Follow-up|2
21984|NCT01765153|104008|P2|Training Phase 2|Withdrawal by Subject|1
21985|NCT01765153|104009|P1|Training Phase 2|Withdrawal by Subject|0
21986|NCT01765153|104008|P2|Rest Phase 1|Withdrawal by Subject|1
21987|NCT01765153|104009|P1|Rest Phase 1|Withdrawal by Subject|0
21988|NCT01765153|104008|P2|Training Phase 1|Poor participation in intervention|1
21989|NCT01765153|104009|P1|Training Phase 1|Poor participation in intervention|0
21990|NCT01765153|104008|P2|Training Phase 1|Format of intervention differed|0
21991|NCT01765153|104009|P1|Training Phase 1|Format of intervention differed|1
21992|NCT01764997|104116|P5|Study Drug Treatment Period|Other than specified above|10
21993|NCT01764997|104117|P4|Study Drug Treatment Period|Other than specified above|0
21994|NCT01764997|104118|P3|Study Drug Treatment Period|Other than specified above|0
21995|NCT01764997|104119|P2|Study Drug Treatment Period|Other than specified above|0
21996|NCT01764997|104120|P1|Study Drug Treatment Period|Other than specified above|0
21997|NCT01764997|104116|P5|Study Drug Treatment Period|Lack of Efficacy|2
21998|NCT01764997|104117|P4|Study Drug Treatment Period|Lack of Efficacy|0
21999|NCT01764997|104118|P3|Study Drug Treatment Period|Lack of Efficacy|0
22000|NCT01764997|104119|P2|Study Drug Treatment Period|Lack of Efficacy|0
22001|NCT01764997|104120|P1|Study Drug Treatment Period|Lack of Efficacy|0
22002|NCT01764997|104116|P5|Study Drug Treatment Period|Adverse Event|24
22003|NCT01764997|104117|P4|Study Drug Treatment Period|Adverse Event|0
22004|NCT01764997|104118|P3|Study Drug Treatment Period|Adverse Event|0
22005|NCT01764997|104119|P2|Study Drug Treatment Period|Adverse Event|1
22006|NCT01764997|104120|P1|Study Drug Treatment Period|Adverse Event|0
22007|NCT01764997|104116|P5|Run-in Period|Other than specified above|0
22008|NCT01764997|104117|P4|Run-in Period|Other than specified above|0
22009|NCT01764997|104118|P3|Run-in Period|Other than specified above|0
22010|NCT01764997|104119|P2|Run-in Period|Other than specified above|0
22011|NCT01764997|104120|P1|Run-in Period|Other than specified above|17
22012|NCT01764997|104116|P5|Run-in Period|Poor compliance to protocol|0
22013|NCT01764997|104117|P4|Run-in Period|Poor compliance to protocol|0
22014|NCT01764997|104118|P3|Run-in Period|Poor compliance to protocol|0
22015|NCT01764997|104119|P2|Run-in Period|Poor compliance to protocol|0
22016|NCT01764997|104120|P1|Run-in Period|Poor compliance to protocol|1
22017|NCT01764997|104116|P5|Run-in Period|Lack of Efficacy|0
22018|NCT01764997|104117|P4|Run-in Period|Lack of Efficacy|0
22019|NCT01764997|104118|P3|Run-in Period|Lack of Efficacy|0
22020|NCT01764997|104119|P2|Run-in Period|Lack of Efficacy|0
22021|NCT01764997|104120|P1|Run-in Period|Lack of Efficacy|5
22022|NCT01764997|104116|P5|Run-in Period|Adverse Event|0
22023|NCT01764997|104117|P4|Run-in Period|Adverse Event|0
22024|NCT01764997|104118|P3|Run-in Period|Adverse Event|0
22025|NCT01764997|104119|P2|Run-in Period|Adverse Event|0
22026|NCT01764997|104120|P1|Run-in Period|Adverse Event|15
22027|NCT01764945|104147|P8|Overall Study|Adverse Event|0
22028|NCT01764945|104148|P7|Overall Study|Adverse Event|1
22029|NCT01764945|104149|P6|Overall Study|Adverse Event|0
22030|NCT01764945|104150|P5|Overall Study|Adverse Event|0
22031|NCT01764945|104151|P4|Overall Study|Adverse Event|0
22032|NCT01764945|104152|P3|Overall Study|Adverse Event|0
22033|NCT01764945|104153|P2|Overall Study|Adverse Event|1
22034|NCT01764945|104154|P1|Overall Study|Adverse Event|0
22035|NCT01764386|104203|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
22036|NCT01764386|104204|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
22037|NCT01764386|104203|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
22038|NCT01764386|104204|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
22039|NCT01764386|104203|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
22040|NCT01764386|104204|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
22041|NCT01764386|104203|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
22042|NCT01764386|104204|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
22043|NCT01764386|104203|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
22044|NCT01764386|104204|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
22045|NCT01764386|104203|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
22046|NCT01764386|104204|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
22047|NCT01764386|104203|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
22048|NCT01764386|104204|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
22049|NCT01764386|104203|P2|Controlled Treatment Period (CTP)|Adverse Event|0
22050|NCT01764386|104204|P1|Controlled Treatment Period (CTP)|Adverse Event|35
22051|NCT01764022|104247|P2|Overall Study|Protocol Violation|0
22052|NCT01764022|104248|P1|Overall Study|Protocol Violation|1
22053|NCT01764022|104247|P2|Overall Study|Physician Decision|2
22054|NCT01764022|104248|P1|Overall Study|Physician Decision|2
22055|NCT01764022|104247|P2|Overall Study|Lack of Efficacy|5
22056|NCT01764022|104248|P1|Overall Study|Lack of Efficacy|10
22057|NCT01764022|104247|P2|Overall Study|Withdrawal by Subject|4
22058|NCT01764022|104248|P1|Overall Study|Withdrawal by Subject|5
22059|NCT01764022|104247|P2|Overall Study|Death|1
22060|NCT01764022|104248|P1|Overall Study|Death|3
22061|NCT01763996|104276|P2|Treatment Period 2|Adverse Event|1
22062|NCT01763996|104277|P1|Treatment Period 2|Adverse Event|0
22063|NCT01763918|104307|P4|Overall Study|Sponsor Decision|0
22064|NCT01763918|104308|P3|Overall Study|Sponsor Decision|9
22065|NCT01763918|104309|P2|Overall Study|Sponsor Decision|0
22066|NCT01763918|104310|P1|Overall Study|Sponsor Decision|4
22067|NCT01763918|104307|P4|Overall Study|Withdrawal by Subject|2
22068|NCT01763918|104308|P3|Overall Study|Withdrawal by Subject|1
22069|NCT01763918|104309|P2|Overall Study|Withdrawal by Subject|1
22070|NCT01763918|104310|P1|Overall Study|Withdrawal by Subject|2
22071|NCT01763905|104408|P4|Overall Study|Lost to Follow-up|0
22072|NCT01763905|104409|P3|Overall Study|Lost to Follow-up|1
22073|NCT01763905|104410|P2|Overall Study|Lost to Follow-up|0
22074|NCT01763905|104411|P1|Overall Study|Lost to Follow-up|0
22075|NCT01763905|104408|P4|Overall Study|Decision by sponsor|0
22076|NCT01763905|104409|P3|Overall Study|Decision by sponsor|8
22077|NCT01763905|104410|P2|Overall Study|Decision by sponsor|0
22078|NCT01763905|104411|P1|Overall Study|Decision by sponsor|5
22079|NCT01763905|104408|P4|Overall Study|Withdrawal by Subject|1
22080|NCT01763905|104409|P3|Overall Study|Withdrawal by Subject|0
22081|NCT01763905|104410|P2|Overall Study|Withdrawal by Subject|1
22082|NCT01763905|104411|P1|Overall Study|Withdrawal by Subject|1
22083|NCT01763866|104529|P24|Overall Study|Death|0
22084|NCT01763866|104530|P23|Overall Study|Death|0
22085|NCT01763866|104531|P22|Overall Study|Death|0
22086|NCT01763866|104532|P21|Overall Study|Death|0
22087|NCT01763866|104533|P20|Overall Study|Death|0
22088|NCT01763866|104534|P19|Overall Study|Death|0
22089|NCT01763866|104535|P18|Overall Study|Death|0
22090|NCT01763866|104536|P17|Overall Study|Death|1
22091|NCT01763866|104537|P16|Overall Study|Death|0
22092|NCT01763866|104538|P15|Overall Study|Death|0
22093|NCT01763866|104539|P14|Overall Study|Death|0
22094|NCT01763866|104540|P13|Overall Study|Death|0
22095|NCT01763866|104541|P12|Overall Study|Death|0
22096|NCT01763866|104542|P11|Overall Study|Death|0
22097|NCT01763866|104543|P10|Overall Study|Death|0
22098|NCT01763866|104544|P9|Overall Study|Death|0
22099|NCT01763866|104545|P8|Overall Study|Death|0
22100|NCT01763866|104546|P7|Overall Study|Death|0
22101|NCT01763866|104547|P6|Overall Study|Death|0
22102|NCT01763866|104548|P5|Overall Study|Death|0
22103|NCT01763866|104549|P4|Overall Study|Death|0
22104|NCT01763866|104550|P3|Overall Study|Death|0
22105|NCT01763866|104551|P2|Overall Study|Death|0
22106|NCT01763866|104552|P1|Overall Study|Death|0
22107|NCT01763866|104529|P24|Overall Study|Lost to Follow-up|1
22108|NCT01763866|104530|P23|Overall Study|Lost to Follow-up|0
22109|NCT01763866|104531|P22|Overall Study|Lost to Follow-up|0
22110|NCT01763866|104532|P21|Overall Study|Lost to Follow-up|0
22111|NCT01763866|104533|P20|Overall Study|Lost to Follow-up|1
22112|NCT01763866|104534|P19|Overall Study|Lost to Follow-up|1
22113|NCT01763866|104535|P18|Overall Study|Lost to Follow-up|0
22114|NCT01763866|104536|P17|Overall Study|Lost to Follow-up|0
22115|NCT01763866|104537|P16|Overall Study|Lost to Follow-up|0
22116|NCT01763866|104538|P15|Overall Study|Lost to Follow-up|1
22117|NCT01763866|104539|P14|Overall Study|Lost to Follow-up|0
22118|NCT01763866|104540|P13|Overall Study|Lost to Follow-up|1
22119|NCT01763866|104541|P12|Overall Study|Lost to Follow-up|0
22120|NCT01763866|104542|P11|Overall Study|Lost to Follow-up|0
22121|NCT01763866|104543|P10|Overall Study|Lost to Follow-up|0
22122|NCT01763866|104544|P9|Overall Study|Lost to Follow-up|0
22123|NCT01763866|104545|P8|Overall Study|Lost to Follow-up|0
22124|NCT01763866|104546|P7|Overall Study|Lost to Follow-up|1
22125|NCT01763866|104547|P6|Overall Study|Lost to Follow-up|0
22126|NCT01763866|104548|P5|Overall Study|Lost to Follow-up|0
22127|NCT01763866|104549|P4|Overall Study|Lost to Follow-up|0
22128|NCT01763866|104550|P3|Overall Study|Lost to Follow-up|0
22129|NCT01763866|104551|P2|Overall Study|Lost to Follow-up|0
22130|NCT01763866|104552|P1|Overall Study|Lost to Follow-up|0
22131|NCT01763866|104529|P24|Overall Study|Decision by sponsor|0
22132|NCT01763866|104530|P23|Overall Study|Decision by sponsor|1
22133|NCT01763866|104531|P22|Overall Study|Decision by sponsor|0
22134|NCT01763866|104532|P21|Overall Study|Decision by sponsor|2
22135|NCT01763866|104533|P20|Overall Study|Decision by sponsor|0
22136|NCT01763866|104534|P19|Overall Study|Decision by sponsor|4
22137|NCT01763866|104535|P18|Overall Study|Decision by sponsor|0
22138|NCT01763866|104536|P17|Overall Study|Decision by sponsor|0
22139|NCT01763866|104537|P16|Overall Study|Decision by sponsor|0
22140|NCT01763866|104538|P15|Overall Study|Decision by sponsor|5
22141|NCT01763866|104539|P14|Overall Study|Decision by sponsor|0
22142|NCT01763866|104540|P13|Overall Study|Decision by sponsor|1
22143|NCT01763866|104541|P12|Overall Study|Decision by sponsor|0
22144|NCT01763866|104542|P11|Overall Study|Decision by sponsor|6
22145|NCT01763866|104543|P10|Overall Study|Decision by sponsor|0
22146|NCT01763866|104544|P9|Overall Study|Decision by sponsor|2
22147|NCT01763866|104545|P8|Overall Study|Decision by sponsor|0
22148|NCT01763866|104546|P7|Overall Study|Decision by sponsor|2
22149|NCT01763866|104547|P6|Overall Study|Decision by sponsor|0
22150|NCT01763866|104548|P5|Overall Study|Decision by sponsor|2
22151|NCT01763866|104549|P4|Overall Study|Decision by sponsor|0
22152|NCT01763866|104550|P3|Overall Study|Decision by sponsor|1
22153|NCT01763866|104551|P2|Overall Study|Decision by sponsor|0
22154|NCT01763866|104552|P1|Overall Study|Decision by sponsor|0
22155|NCT01763866|104529|P24|Overall Study|Withdrawal by Subject|1
22156|NCT01763866|104530|P23|Overall Study|Withdrawal by Subject|2
22157|NCT01763866|104531|P22|Overall Study|Withdrawal by Subject|1
22158|NCT01763866|104532|P21|Overall Study|Withdrawal by Subject|2
22159|NCT01763866|104533|P20|Overall Study|Withdrawal by Subject|1
22160|NCT01763866|104534|P19|Overall Study|Withdrawal by Subject|1
22161|NCT01763866|104535|P18|Overall Study|Withdrawal by Subject|1
22162|NCT01763866|104536|P17|Overall Study|Withdrawal by Subject|0
22163|NCT01763866|104537|P16|Overall Study|Withdrawal by Subject|3
22164|NCT01763866|104538|P15|Overall Study|Withdrawal by Subject|6
22165|NCT01763866|104539|P14|Overall Study|Withdrawal by Subject|0
22166|NCT01763866|104540|P13|Overall Study|Withdrawal by Subject|2
22167|NCT01763866|104541|P12|Overall Study|Withdrawal by Subject|2
22168|NCT01763866|104542|P11|Overall Study|Withdrawal by Subject|2
22169|NCT01763866|104543|P10|Overall Study|Withdrawal by Subject|1
22170|NCT01763866|104544|P9|Overall Study|Withdrawal by Subject|1
22171|NCT01763866|104545|P8|Overall Study|Withdrawal by Subject|0
22172|NCT01763866|104546|P7|Overall Study|Withdrawal by Subject|4
22173|NCT01763866|104547|P6|Overall Study|Withdrawal by Subject|3
22174|NCT01763866|104548|P5|Overall Study|Withdrawal by Subject|0
22175|NCT01763866|104549|P4|Overall Study|Withdrawal by Subject|0
22176|NCT01763866|104550|P3|Overall Study|Withdrawal by Subject|4
22177|NCT01763866|104551|P2|Overall Study|Withdrawal by Subject|1
22178|NCT01763866|104552|P1|Overall Study|Withdrawal by Subject|2
22179|NCT01763827|105112|P6|Overall Study|Lost to Follow-up|1
22180|NCT01763827|105113|P5|Overall Study|Lost to Follow-up|2
22181|NCT01763827|105114|P4|Overall Study|Lost to Follow-up|1
22182|NCT01763827|105115|P3|Overall Study|Lost to Follow-up|1
22183|NCT01763827|105116|P2|Overall Study|Lost to Follow-up|1
22184|NCT01763827|105117|P1|Overall Study|Lost to Follow-up|0
22185|NCT01763827|105112|P6|Overall Study|Decision by sponsor|1
22186|NCT01763827|105113|P5|Overall Study|Decision by sponsor|2
22187|NCT01763827|105114|P4|Overall Study|Decision by sponsor|0
22188|NCT01763827|105115|P3|Overall Study|Decision by sponsor|3
22189|NCT01763827|105116|P2|Overall Study|Decision by sponsor|0
22190|NCT01763827|105117|P1|Overall Study|Decision by sponsor|2
22191|NCT01763827|105112|P6|Overall Study|Withdrawal by Subject|0
22192|NCT01763827|105113|P5|Overall Study|Withdrawal by Subject|2
22193|NCT01763827|105114|P4|Overall Study|Withdrawal by Subject|0
22194|NCT01763827|105115|P3|Overall Study|Withdrawal by Subject|0
22195|NCT01763827|105116|P2|Overall Study|Withdrawal by Subject|0
22196|NCT01763827|105117|P1|Overall Study|Withdrawal by Subject|1
22197|NCT01763047|105288|P2|Period 2|Unsatisfactory lens Fitting|1
22198|NCT01763047|105289|P1|Period 2|Unsatisfactory lens Fitting|0
22199|NCT01763047|105288|P2|Period 2|Protocol Violation|2
22200|NCT01763047|105289|P1|Period 2|Protocol Violation|0
22201|NCT01763047|105288|P2|Period 2|Unsatisfactory Visual Response|1
22202|NCT01763047|105289|P1|Period 2|Unsatisfactory Visual Response|1
22203|NCT01763047|105288|P2|Period 2|Study Site office Closed|1
22204|NCT01763047|105289|P1|Period 2|Study Site office Closed|1
22205|NCT01763047|105288|P2|Period 2|No longer meets Eligibility Criteria|0
22206|NCT01763047|105289|P1|Period 2|No longer meets Eligibility Criteria|1
22207|NCT01763047|105288|P2|Period 2|Lens Discomfort|0
22208|NCT01763047|105289|P1|Period 2|Lens Discomfort|1
22209|NCT01763047|105288|P2|Period 1|Study Site office Closed|1
22210|NCT01763047|105289|P1|Period 1|Study Site office Closed|0
22211|NCT01763047|105288|P2|Period 1|Lens Power Not Available|1
22212|NCT01763047|105289|P1|Period 1|Lens Power Not Available|0
22213|NCT01763047|105288|P2|Period 1|Unsatisfactory Visual Response|3
22214|NCT01763047|105289|P1|Period 1|Unsatisfactory Visual Response|0
22215|NCT01763047|105288|P2|Period 1|Adverse Event|1
22216|NCT01763047|105289|P1|Period 1|Adverse Event|0
22217|NCT01763047|105288|P2|Period 1|No Longer Meets Eligibility criteria|0
22218|NCT01763047|105289|P1|Period 1|No Longer Meets Eligibility criteria|1
22219|NCT01763047|105288|P2|Period 1|Protocol Violation|4
22220|NCT01763047|105289|P1|Period 1|Protocol Violation|4
22221|NCT01763047|105288|P2|Period 1|Test Article Not Available|1
22222|NCT01763047|105289|P1|Period 1|Test Article Not Available|4
22223|NCT01762800|105335|P2|Overall Study|Withdrawal by Subject|4
22224|NCT01762800|105336|P1|Overall Study|Withdrawal by Subject|7
22225|NCT01762800|105335|P2|Overall Study|Physician Decision|1
22226|NCT01762800|105336|P1|Overall Study|Physician Decision|1
22227|NCT01762800|105335|P2|Overall Study|Study Closed/Terminated|1
22228|NCT01762800|105336|P1|Overall Study|Study Closed/Terminated|0
22229|NCT01762800|105335|P2|Overall Study|Lack of Efficacy|2
22230|NCT01762800|105336|P1|Overall Study|Lack of Efficacy|3
22231|NCT01762800|105335|P2|Overall Study|Adverse Event|13
22232|NCT01762800|105336|P1|Overall Study|Adverse Event|8
22233|NCT01762761|105410|P2|Overall Study|Physician Decision|1
22234|NCT01762761|105411|P1|Overall Study|Physician Decision|0
22235|NCT01762761|105410|P2|Overall Study|Protocol Violation|1
22236|NCT01762761|105411|P1|Overall Study|Protocol Violation|0
22237|NCT01762761|105410|P2|Overall Study|Lack of Efficacy|0
22238|NCT01762761|105411|P1|Overall Study|Lack of Efficacy|1
22239|NCT01762761|105410|P2|Overall Study|Adverse Event|2
22240|NCT01762761|105411|P1|Overall Study|Adverse Event|1
22241|NCT01762345|105489|P1|Overall Study|Protocol Violation|2
22242|NCT01762345|105489|P1|Overall Study|Adverse Event|5
22243|NCT01761565|105537|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
22244|NCT01761162|105590|P1|Overall Study|Withdrawal by Subject|3
22245|NCT01760876|105682|P1|Overall Study|Very poor baseline OCT quality|2
22246|NCT01760876|105682|P1|Overall Study|Major depression|1
22247|NCT01760876|105682|P1|Overall Study|Impaired renal function|1
22248|NCT01760876|105682|P1|Overall Study|Carcinoma of prostate|1
22249|NCT01760876|105682|P1|Overall Study|Non-cardiac death (head injury)|1
22250|NCT01759511|105716|P1|Overall Study|Withdrawal by Subject|3
22251|NCT01759511|105716|P1|Overall Study|Study Terminated by Sponsor|13
22252|NCT01759511|105716|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
22253|NCT01759511|105716|P1|Overall Study|Progressive Disease|5
22254|NCT01759511|105716|P1|Overall Study|Physician Decision|1
22255|NCT01759511|105716|P1|Overall Study|Lack of Efficacy|2
22256|NCT01759511|105716|P1|Overall Study|Death|2
22257|NCT01759511|105716|P1|Overall Study|Adverse Event|4
22342|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Protocol Violation|1
22258|NCT01759420|105724|P1|Overall Study|Inaccurate EKG machine readings|1
22259|NCT01759420|105724|P1|Overall Study|Screen failure|5
22260|NCT01759381|105731|P2|Overall Study|Death|0
22261|NCT01759381|105732|P1|Overall Study|Death|1
22262|NCT01759368|105740|P2|Overall Study|Lost to Follow-up|0
22263|NCT01759368|105741|P1|Overall Study|Lost to Follow-up|1
22264|NCT01759290|105759|P1|Overall Study|Unknown reason|4
22265|NCT01759290|105759|P1|Overall Study|Lost to Follow-up|53
22266|NCT01759290|105759|P1|Overall Study|Death|17
22267|NCT01759290|105759|P1|Overall Study|Physician Decision|2
22268|NCT01759290|105759|P1|Overall Study|Subjects withdrawn consent|5
22269|NCT01759264|105819|P1|Overall Study|Discontinued Humira Due to Business Trip|1
22270|NCT01759264|105819|P1|Overall Study|Withdrawal by Subject|3
22271|NCT01759264|105819|P1|Overall Study|Lost to Follow-up|2
22272|NCT01759264|105819|P1|Overall Study|Not Specified|2
22273|NCT01759264|105819|P1|Overall Study|Adverse Event|1
22274|NCT01759264|105819|P1|Overall Study|Serious Adverse Events (SAEs)|1
22275|NCT01758900|105847|P2|Overall Study|difficulty for further intubation|8
22276|NCT01758900|105848|P1|Overall Study|difficulty for further intubation|7
22277|NCT01758289|105866|P1|Overall Study|Adverse Event|9
22278|NCT01758289|105866|P1|Overall Study|Premature Study Termination|44
22279|NCT01757847|105892|P2|Overall Study|Withdrawal by Subject|4
22280|NCT01757847|105893|P1|Overall Study|Withdrawal by Subject|3
22281|NCT01757704|105903|P2|Overall Study|Protocol Violation|3
22282|NCT01757704|105904|P1|Overall Study|Protocol Violation|1
22283|NCT01757691|105922|P2|Overall Study|Administrative problems|0
22284|NCT01757691|105923|P1|Overall Study|Administrative problems|2
22285|NCT01757405|105959|P2|Overall Study|Withdrawal by Subject|1
22286|NCT01757405|105960|P1|Overall Study|Withdrawal by Subject|0
22287|NCT01757405|105959|P2|Overall Study|Lost to Follow-up|1
22288|NCT01757405|105960|P1|Overall Study|Lost to Follow-up|1
22289|NCT01757275|105978|P2|Overall Study|Not treated|4
22290|NCT01757275|105979|P1|Overall Study|Not treated|3
22291|NCT01757275|105978|P2|Overall Study|Withdrawal by Subject|4
22292|NCT01757275|105979|P1|Overall Study|Withdrawal by Subject|2
22293|NCT01757275|105978|P2|Overall Study|Adverse Event|3
22294|NCT01757275|105979|P1|Overall Study|Adverse Event|3
22295|NCT01757275|105978|P2|Overall Study|Lost to Follow-up|2
22296|NCT01757275|105979|P1|Overall Study|Lost to Follow-up|1
22297|NCT01757184|106003|P2|Double-Blind Period|Adverse Event|0
22298|NCT01757184|106004|P1|Double-Blind Period|Adverse Event|1
22299|NCT01756300|106048|P1|Overall Study|Withdrawal by Subject|1
22300|NCT01756300|106048|P1|Overall Study|Death|1
22301|NCT01756274|106070|P1|Overall Study|Laboratory error|1
22302|NCT01756274|106070|P1|Overall Study|Protocol Violation|2
22303|NCT01756235|106077|P1|Overall Study|Adalimumab Treatment was not Documented|2
22304|NCT01756157|106098|P2|First Intervention Period|Lost to Follow-up|2
22305|NCT01756157|106099|P1|First Intervention Period|Lost to Follow-up|0
22306|NCT01756157|106098|P2|First Intervention Period|Withdrawal by Subject|0
22307|NCT01756157|106099|P1|First Intervention Period|Withdrawal by Subject|1
22308|NCT01756079|106113|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
22309|NCT01756079|106113|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
22310|NCT01756079|106113|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
22311|NCT01756079|106113|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
22312|NCT01756079|106113|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
22313|NCT01756053|106119|P2|Period 2 (10 Days)|Protocol Violation|2
22314|NCT01756053|106120|P1|Period 2 (10 Days)|Protocol Violation|0
22315|NCT01756053|106119|P2|Period 1 (10 Days)|Protocol Violation|1
22316|NCT01756053|106120|P1|Period 1 (10 Days)|Protocol Violation|1
22317|NCT01755702|106140|P1|Washout Period II|Other Reason|5
22318|NCT01755702|106140|P1|Wash Out Period I|Other Reason|3
22319|NCT01755637|106182|P2|Period 1|Adverse Event|1
22320|NCT01755637|106183|P1|Period 1|Adverse Event|0
22321|NCT01755234|106216|P2|Overall Study|unblinded|0
22322|NCT01755234|106217|P1|Overall Study|unblinded|1
22323|NCT01755234|106216|P2|Overall Study|Withdrawal by Subject|1
22324|NCT01755234|106217|P1|Overall Study|Withdrawal by Subject|0
22325|NCT01755234|106216|P2|Overall Study|case cancelled|0
22326|NCT01755234|106217|P1|Overall Study|case cancelled|1
22327|NCT01755234|106216|P2|Overall Study|Change in surgical case|1
22328|NCT01755234|106217|P1|Overall Study|Change in surgical case|2
22329|NCT01755234|106216|P2|Overall Study|Lost to Follow-up|6
22330|NCT01755234|106217|P1|Overall Study|Lost to Follow-up|11
22331|NCT01755156|106248|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
22332|NCT01755156|106249|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
22333|NCT01755156|106248|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
22334|NCT01755156|106249|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
22335|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
22336|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
22337|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
22338|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
22339|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
22340|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
22341|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Protocol Violation|1
22343|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Physician Decision|1
22344|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Physician Decision|0
22345|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
22346|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
22347|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
22348|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
22349|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
22350|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
22351|NCT01755156|106248|P2|Phase A (Weeks 0-24)|Adverse Event|3
22352|NCT01755156|106249|P1|Phase A (Weeks 0-24)|Adverse Event|2
22353|NCT01755026|106312|P2|Overall Study|Withdrawal by Subject|1
22354|NCT01755026|106313|P1|Overall Study|Withdrawal by Subject|1
22355|NCT01755026|106312|P2|Overall Study|Adverse Event|0
22356|NCT01755026|106313|P1|Overall Study|Adverse Event|1
22357|NCT01754922|106321|P2|Overall Study|Adverse Event|1
22358|NCT01754922|106322|P1|Overall Study|Adverse Event|0
22359|NCT01754766|106335|P3|Overall Study|Personal reasons|0
22360|NCT01754766|106336|P2|Overall Study|Personal reasons|1
22361|NCT01754766|106337|P1|Overall Study|Personal reasons|1
22362|NCT01754727|106351|P1|Overall Study|Adalimumab Treatment was not Documented|2
22363|NCT01754493|106478|P1|Overall Study|Scheduling conflict|1
22364|NCT01754493|106478|P1|Overall Study|Moved out of town|1
22365|NCT01754493|106478|P1|Overall Study|Withdrawal by Subject|1
22366|NCT01754493|106478|P1|Overall Study|Lost to Follow-up|3
22367|NCT01754493|106478|P1|Overall Study|Adverse Event|1
22368|NCT01754467|106503|P1|Overall Study|Lost to Follow-up|1
22369|NCT01754402|106513|P3|Overall Study|Lack of Efficacy|1
22370|NCT01754402|106514|P2|Overall Study|Lack of Efficacy|0
22371|NCT01754402|106515|P1|Overall Study|Lack of Efficacy|0
22372|NCT01754402|106513|P3|Overall Study|Withdrawal by Subject|1
22373|NCT01754402|106514|P2|Overall Study|Withdrawal by Subject|0
22374|NCT01754402|106515|P1|Overall Study|Withdrawal by Subject|0
22375|NCT01754402|106513|P3|Overall Study|Adverse Event|1
22376|NCT01754402|106514|P2|Overall Study|Adverse Event|2
22377|NCT01754402|106515|P1|Overall Study|Adverse Event|2
22378|NCT01754402|106513|P3|Overall Study|Death|1
22379|NCT01754402|106514|P2|Overall Study|Death|0
22380|NCT01754402|106515|P1|Overall Study|Death|0
22381|NCT01754376|106549|P1|Overall Study|Lack of Efficacy|2
22382|NCT01754376|106549|P1|Overall Study|Adverse Event|1
22383|NCT01754259|106560|P2|Overall Study|Lost to Follow-up|1
22384|NCT01754259|106561|P1|Overall Study|Lost to Follow-up|0
22385|NCT01754259|106560|P2|Overall Study|Adverse Event|1
22386|NCT01754259|106561|P1|Overall Study|Adverse Event|3
22387|NCT01754259|106560|P2|Overall Study|Withdrawal by Subject|4
22388|NCT01754259|106561|P1|Overall Study|Withdrawal by Subject|2
22389|NCT01754194|106571|P2|Overall Study|Not Specified|8
22390|NCT01754194|106572|P1|Overall Study|Not Specified|9
22391|NCT01754194|106571|P2|Overall Study|Withdrawal by Subject|5
22392|NCT01754194|106572|P1|Overall Study|Withdrawal by Subject|4
22393|NCT01754194|106571|P2|Overall Study|Lost to Follow-up|14
22394|NCT01754194|106572|P1|Overall Study|Lost to Follow-up|39
22395|NCT01753856|106594|P2|Overall Study|Sponsor Decision|0
22396|NCT01753856|106595|P1|Overall Study|Sponsor Decision|2
22397|NCT01753856|106594|P2|Overall Study|Withdrawal by Subject|2
22398|NCT01753856|106595|P1|Overall Study|Withdrawal by Subject|0
22399|NCT01753856|106594|P2|Overall Study|Adverse Event|0
22400|NCT01753856|106595|P1|Overall Study|Adverse Event|1
22401|NCT01753518|106685|P2|Postpartum Follow-up|Lost to Follow-up|15
22402|NCT01753518|106686|P1|Postpartum Follow-up|Lost to Follow-up|22
22403|NCT01753518|106685|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
22404|NCT01753518|106686|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
22405|NCT01753518|106685|P2|Intention-to-Treat Analysis|Multifetal gestation|3
22406|NCT01753518|106686|P1|Intention-to-Treat Analysis|Multifetal gestation|2
22407|NCT01753518|106685|P2|Intention-to-Treat Analysis|Missing consent form|3
22408|NCT01753518|106686|P1|Intention-to-Treat Analysis|Missing consent form|5
22409|NCT01753336|106708|P1|Overall Study|Withdrawal by Subject|1
22410|NCT01753336|106708|P1|Overall Study|Sponsor's decision|2
22411|NCT01753336|106708|P1|Overall Study|Physician Decision|2
22412|NCT01753336|106708|P1|Overall Study|Lost to Follow-up|3
22413|NCT01753336|106708|P1|Overall Study|Patient decision|12
22414|NCT01753323|106720|P3|Overall Study|Adverse Event|1
22415|NCT01753323|106721|P2|Overall Study|Adverse Event|0
22416|NCT01753323|106722|P1|Overall Study|Adverse Event|0
22417|NCT01753323|106720|P3|Overall Study|Protocol deviation|0
22418|NCT01753323|106721|P2|Overall Study|Protocol deviation|0
22419|NCT01753323|106722|P1|Overall Study|Protocol deviation|1
22420|NCT01753323|106720|P3|Overall Study|Lack of Efficacy|8
22421|NCT01753323|106721|P2|Overall Study|Lack of Efficacy|0
22422|NCT01753323|106722|P1|Overall Study|Lack of Efficacy|0
22423|NCT01753310|106760|P2|Overall Study|Withdrawal by Subject|0
22424|NCT01753310|106761|P1|Overall Study|Withdrawal by Subject|1
22425|NCT01753310|106760|P2|Overall Study|Sponsor decision|0
22426|NCT01753310|106761|P1|Overall Study|Sponsor decision|1
22427|NCT01753310|106760|P2|Overall Study|Subject decision|2
22428|NCT01753310|106761|P1|Overall Study|Subject decision|2
22429|NCT01753310|106760|P2|Overall Study|Lost to Follow-up|0
22430|NCT01753310|106761|P1|Overall Study|Lost to Follow-up|2
22431|NCT01753310|106760|P2|Overall Study|Adverse Event|0
22432|NCT01753310|106761|P1|Overall Study|Adverse Event|1
22433|NCT01753310|106760|P2|Overall Study|Entered into open label extension study|22
22434|NCT01753310|106761|P1|Overall Study|Entered into open label extension study|25
22435|NCT01753115|106784|P3|Overall Study|Used excluded drug|0
22436|NCT01753115|106785|P2|Overall Study|Used excluded drug|1
22437|NCT01753115|106786|P1|Overall Study|Used excluded drug|0
22438|NCT01753115|106784|P3|Overall Study|Subject non-compliant|0
22439|NCT01753115|106785|P2|Overall Study|Subject non-compliant|3
22440|NCT01753115|106786|P1|Overall Study|Subject non-compliant|3
22441|NCT01753115|106784|P3|Overall Study|Withdrawal by Subject|6
22442|NCT01753115|106785|P2|Overall Study|Withdrawal by Subject|5
22443|NCT01753115|106786|P1|Overall Study|Withdrawal by Subject|6
22444|NCT01753115|106784|P3|Overall Study|Lost to Follow-up|8
22445|NCT01753115|106785|P2|Overall Study|Lost to Follow-up|6
22446|NCT01753115|106786|P1|Overall Study|Lost to Follow-up|3
22447|NCT01753076|106796|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
22448|NCT01753076|106797|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
22449|NCT01753076|106796|P2|Overall Study|Withdrawal by Subject|24
22450|NCT01753076|106797|P1|Overall Study|Withdrawal by Subject|14
22451|NCT01753076|106796|P2|Overall Study|Physician Decision|2
22452|NCT01753076|106797|P1|Overall Study|Physician Decision|4
22453|NCT01753076|106796|P2|Overall Study|Lost to Follow-up|1
22454|NCT01753076|106797|P1|Overall Study|Lost to Follow-up|2
22455|NCT01753076|106796|P2|Overall Study|Lack of Efficacy|1
22456|NCT01753076|106797|P1|Overall Study|Lack of Efficacy|3
22457|NCT01753076|106796|P2|Overall Study|Adverse Event|18
22458|NCT01753076|106797|P1|Overall Study|Adverse Event|17
22459|NCT01752907|106823|P2|Overall Study|Decision by Sponsor|9
22460|NCT01752907|106824|P1|Overall Study|Decision by Sponsor|6
22461|NCT01752907|106823|P2|Overall Study|Lost to Follow-up|1
22462|NCT01752907|106824|P1|Overall Study|Lost to Follow-up|2
22463|NCT01752907|106823|P2|Overall Study|Withdrawal by Subject|10
22464|NCT01752907|106824|P1|Overall Study|Withdrawal by Subject|4
22465|NCT01752855|106844|P2|Overall Study|Lack of Efficacy|2
22466|NCT01752855|106845|P1|Overall Study|Lack of Efficacy|0
22467|NCT01752855|106844|P2|Overall Study|Withdrew Consent|2
22468|NCT01752855|106845|P1|Overall Study|Withdrew Consent|0
22469|NCT01752855|106844|P2|Overall Study|Adverse Event|0
22470|NCT01752855|106845|P1|Overall Study|Adverse Event|1
22471|NCT01752023|106861|P2|Overall Study|Physician Decision|1
22472|NCT01752023|106862|P1|Overall Study|Physician Decision|2
22473|NCT01751867|106880|P2|Overall Study|Randomized but not treated.|1
22474|NCT01751867|106881|P1|Overall Study|Randomized but not treated.|2
22475|NCT01751867|106880|P2|Overall Study|Unspecified|37
22476|NCT01751867|106881|P1|Overall Study|Unspecified|11
22477|NCT01751867|106880|P2|Overall Study|Death|5
22478|NCT01751867|106881|P1|Overall Study|Death|0
22479|NCT01751867|106880|P2|Overall Study|Protocol Violation|2
22480|NCT01751867|106881|P1|Overall Study|Protocol Violation|0
22481|NCT01751867|106880|P2|Overall Study|Physician Decision|7
22482|NCT01751867|106881|P1|Overall Study|Physician Decision|4
22483|NCT01751867|106880|P2|Overall Study|Withdrawal by Subject|1
22484|NCT01751867|106881|P1|Overall Study|Withdrawal by Subject|3
22485|NCT01751867|106880|P2|Overall Study|Poor Compliance|5
22486|NCT01751867|106881|P1|Overall Study|Poor Compliance|0
22487|NCT01751867|106880|P2|Overall Study|Adverse Event|15
22488|NCT01751867|106881|P1|Overall Study|Adverse Event|8
22489|NCT01751867|106880|P2|Overall Study|Diease Progression|18
22490|NCT01751867|106881|P1|Overall Study|Diease Progression|4
22491|NCT01751867|106880|P2|Overall Study|Completed treatment,dropped in follow-up|8
22492|NCT01751867|106881|P1|Overall Study|Completed treatment,dropped in follow-up|4
22493|NCT01751802|106901|P2|Overall Study|Adverse Event|2
22494|NCT01751802|106902|P1|Overall Study|Adverse Event|4
22495|NCT01751724|106916|P2|Overall Study|withdrawn by parent|2
22496|NCT01751724|106917|P1|Overall Study|withdrawn by parent|0
22497|NCT01751724|106916|P2|Overall Study|extubated bef.start assigned treatment|0
22498|NCT01751724|106917|P1|Overall Study|extubated bef.start assigned treatment|1
22499|NCT01751178|107001|P3|Overall Study|Other Reason (unknown)|2
22500|NCT01751178|107002|P2|Overall Study|Other Reason (unknown)|0
22501|NCT01751178|107003|P1|Overall Study|Other Reason (unknown)|1
22502|NCT01751178|107001|P3|Overall Study|Adverse Event|0
22503|NCT01751178|107002|P2|Overall Study|Adverse Event|0
22504|NCT01751178|107003|P1|Overall Study|Adverse Event|2
22505|NCT01751165|107023|P3|Overall Study|Lost to Follow-up|1
22506|NCT01751165|107024|P2|Overall Study|Lost to Follow-up|1
22507|NCT01751165|107025|P1|Overall Study|Lost to Follow-up|1
22508|NCT01751165|107023|P3|Overall Study|Serious adverse event|0
22509|NCT01751165|107024|P2|Overall Study|Serious adverse event|2
22510|NCT01751165|107025|P1|Overall Study|Serious adverse event|0
22511|NCT01751165|107023|P3|Overall Study|Withdrawal by Subject|1
22512|NCT01751165|107024|P2|Overall Study|Withdrawal by Subject|0
22513|NCT01751165|107025|P1|Overall Study|Withdrawal by Subject|0
22514|NCT01751165|107023|P3|Overall Study|Adverse event, serious fatal|1
22515|NCT01751165|107024|P2|Overall Study|Adverse event, serious fatal|0
22516|NCT01751165|107025|P1|Overall Study|Adverse event, serious fatal|1
22517|NCT01751113|107065|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
22518|NCT01751113|107066|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
22519|NCT01751113|107067|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
22520|NCT01751113|107068|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
22521|NCT01751113|107069|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
22522|NCT01751113|107070|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
22523|NCT01751113|107065|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
22524|NCT01751113|107066|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
22525|NCT01751113|107067|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
22526|NCT01751113|107068|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
22527|NCT01751113|107069|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
22528|NCT01751113|107070|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
22529|NCT01751087|107111|P3|Overall Study|Physician Decision|1
22530|NCT01751087|107112|P2|Overall Study|Physician Decision|0
22531|NCT01751087|107113|P1|Overall Study|Physician Decision|0
22532|NCT01751087|107111|P3|Overall Study|Withdrawal by Subject|0
22533|NCT01751087|107112|P2|Overall Study|Withdrawal by Subject|0
22534|NCT01751087|107113|P1|Overall Study|Withdrawal by Subject|1
22535|NCT01750840|107201|P1|Overall Study|Lost to Follow-up|4
22536|NCT01750684|107208|P2|Overall Study|Protocol Violation|0
22537|NCT01750684|107209|P1|Overall Study|Protocol Violation|1
22538|NCT01750684|107208|P2|Overall Study|Withdrawn by Sponsor|1
22539|NCT01750684|107209|P1|Overall Study|Withdrawn by Sponsor|0
22540|NCT01750684|107208|P2|Overall Study|Non-compliance with Study Drug|1
22541|NCT01750684|107209|P1|Overall Study|Non-compliance with Study Drug|0
22542|NCT01750684|107208|P2|Overall Study|Death|0
22543|NCT01750684|107209|P1|Overall Study|Death|1
22544|NCT01750346|107244|P3|Overall Study|Adverse Event|0
22545|NCT01750346|107245|P2|Overall Study|Adverse Event|0
22546|NCT01750346|107246|P1|Overall Study|Adverse Event|1
22547|NCT01750294|107272|P1|Overall Study|Safety Endpoint|1
22548|NCT01750294|107272|P1|Overall Study|Withdrawal by Subject|1
22549|NCT01750281|107279|P3|Overall Study|Did not receive treatment|0
22550|NCT01750281|107280|P2|Overall Study|Did not receive treatment|1
22551|NCT01750281|107281|P1|Overall Study|Did not receive treatment|0
22552|NCT01750281|107279|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
22553|NCT01750281|107280|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
22554|NCT01750281|107281|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
22555|NCT01750281|107279|P3|Overall Study|Discontinued Selumetinib/Placebo|75
22556|NCT01750281|107280|P2|Overall Study|Discontinued Selumetinib/Placebo|77
22557|NCT01750281|107281|P1|Overall Study|Discontinued Selumetinib/Placebo|37
22558|NCT01750242|107311|P1|Overall Study|Unreadable Images|3
22559|NCT01749982|107329|P4|Overall Study|Withdrawal by Subject|1
22560|NCT01749982|107330|P3|Overall Study|Withdrawal by Subject|0
22561|NCT01749982|107331|P2|Overall Study|Withdrawal by Subject|0
22562|NCT01749982|107332|P1|Overall Study|Withdrawal by Subject|0
22563|NCT01749982|107329|P4|Overall Study|Lost to Follow-up|1
22564|NCT01749982|107330|P3|Overall Study|Lost to Follow-up|0
22565|NCT01749982|107331|P2|Overall Study|Lost to Follow-up|0
22566|NCT01749982|107332|P1|Overall Study|Lost to Follow-up|0
22567|NCT01749982|107329|P4|Overall Study|Physician Decision|1
22568|NCT01749982|107330|P3|Overall Study|Physician Decision|0
22569|NCT01749982|107331|P2|Overall Study|Physician Decision|0
22570|NCT01749982|107332|P1|Overall Study|Physician Decision|0
22571|NCT01748760|107411|P2|Overall Study|Lost to Follow-up|1
22572|NCT01748760|107412|P1|Overall Study|Lost to Follow-up|5
22573|NCT01748760|107411|P2|Overall Study|Withdrawal by Subject|1
22574|NCT01748760|107412|P1|Overall Study|Withdrawal by Subject|1
22575|NCT01749800|107421|P3|Overall Study|Withdrawal by Subject|0
22576|NCT01749800|107422|P2|Overall Study|Withdrawal by Subject|1
22577|NCT01749800|107423|P1|Overall Study|Withdrawal by Subject|0
22578|NCT01749800|107421|P3|Overall Study|not meeting inclusion criteria|0
22579|NCT01749800|107422|P2|Overall Study|not meeting inclusion criteria|0
22580|NCT01749800|107423|P1|Overall Study|not meeting inclusion criteria|3
22581|NCT01749735|107433|P2|Overall Study|Withdrawal by Subject|0
22582|NCT01749735|107434|P1|Overall Study|Withdrawal by Subject|1
22583|NCT01748890|107500|P1|Overall Study|Insufficient recruitment for analysis|4
22584|NCT01748071|107543|P3|Overall Study|Adverse Event|0
22585|NCT01748071|107544|P2|Overall Study|Adverse Event|2
22586|NCT01748071|107545|P1|Overall Study|Adverse Event|2
22587|NCT01747811|107807|P2|Overall Study|Lack of Efficacy|4
22588|NCT01747811|107808|P1|Overall Study|Lack of Efficacy|2
22589|NCT01747772|107824|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
22590|NCT01747655|107832|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
22591|NCT01747655|107833|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
22592|NCT01747655|107832|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
22593|NCT01747655|107833|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
22594|NCT01747655|107832|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
22595|NCT01747655|107833|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
22596|NCT01747629|107863|P2|Overall Study|Not specified|1
22597|NCT01747629|107864|P1|Overall Study|Not specified|2
22598|NCT01747629|107863|P2|Overall Study|Not treated|0
22599|NCT01747629|107864|P1|Overall Study|Not treated|1
22600|NCT01747629|107863|P2|Overall Study|Inclusion criteria not met|0
22601|NCT01747629|107864|P1|Overall Study|Inclusion criteria not met|1
22602|NCT01747629|107863|P2|Overall Study|Noncompliance|1
22603|NCT01747629|107864|P1|Overall Study|Noncompliance|1
22604|NCT01747629|107863|P2|Overall Study|Withdrawal by Subject|2
22605|NCT01747629|107864|P1|Overall Study|Withdrawal by Subject|2
22606|NCT01747629|107863|P2|Overall Study|Adverse Event|2
22607|NCT01747629|107864|P1|Overall Study|Adverse Event|1
22608|NCT01746862|107931|P2|Overall Study|Entered puberty during the study|0
22609|NCT01746862|107932|P1|Overall Study|Entered puberty during the study|1
22610|NCT01746862|107931|P2|Overall Study|Consent withdrawal by parent’s guardian|2
22611|NCT01746862|107932|P1|Overall Study|Consent withdrawal by parent’s guardian|5
22612|NCT01746862|107931|P2|Overall Study|Protocol Violation|0
22613|NCT01746862|107932|P1|Overall Study|Protocol Violation|1
22614|NCT01746862|107931|P2|Overall Study|Withdrawal by Subject|1
22615|NCT01746862|107932|P1|Overall Study|Withdrawal by Subject|1
22616|NCT01746368|108002|P2|Overall Study|Withdrawal by Subject|1
22617|NCT01746368|108003|P1|Overall Study|Withdrawal by Subject|0
22618|NCT01746368|108002|P2|Overall Study|Lost to Follow-up|0
22619|NCT01746368|108003|P1|Overall Study|Lost to Follow-up|2
22620|NCT01746173|108030|P1|Overall Study|Disease Progression|2
22621|NCT01746108|108038|P3|Overall Study|Lost to Follow-up|0
22622|NCT01746108|108039|P2|Overall Study|Lost to Follow-up|1
22623|NCT01746108|108040|P1|Overall Study|Lost to Follow-up|0
22624|NCT01746108|108038|P3|Overall Study|Withdrawal by Subject|0
22625|NCT01746108|108039|P2|Overall Study|Withdrawal by Subject|1
22626|NCT01746108|108040|P1|Overall Study|Withdrawal by Subject|0
22627|NCT01746108|108038|P3|Overall Study|Adverse event, non-fatal|0
22628|NCT01746108|108039|P2|Overall Study|Adverse event, non-fatal|1
22629|NCT01746108|108040|P1|Overall Study|Adverse event, non-fatal|0
22630|NCT01746108|108038|P3|Overall Study|Migrated /moved from study area|0
22631|NCT01746108|108039|P2|Overall Study|Migrated /moved from study area|1
22632|NCT01746108|108040|P1|Overall Study|Migrated /moved from study area|0
22633|NCT01745848|108113|P1|Overall Study|Adverse Event|6
22634|NCT01745380|108120|P2|Overall Study|Lack of Efficacy|1
22635|NCT01745380|108121|P1|Overall Study|Lack of Efficacy|0
22636|NCT01745380|108120|P2|Overall Study|Lost to Follow-up|0
22637|NCT01745380|108121|P1|Overall Study|Lost to Follow-up|1
22638|NCT01744977|108205|P2|Overall Study|No longer meets inclusion|0
22639|NCT01744977|108206|P1|Overall Study|No longer meets inclusion|6
22640|NCT01744977|108205|P2|Overall Study|Lost to Follow-up|0
22641|NCT01744977|108206|P1|Overall Study|Lost to Follow-up|2
22642|NCT01744977|108205|P2|Overall Study|Death|3
22643|NCT01744977|108206|P1|Overall Study|Death|2
22644|NCT01744977|108205|P2|Overall Study|Withdrawal by Subject|2
22645|NCT01744977|108206|P1|Overall Study|Withdrawal by Subject|1
22646|NCT01744691|108329|P1|Overall Study|Physician Decision|4
22647|NCT01744691|108329|P1|Overall Study|Withdrawal of consent for treatment|3
22648|NCT01744691|108329|P1|Overall Study|Unacceptable toxicity, AE or death|18
22649|NCT01744691|108329|P1|Overall Study|Progressive Disease|18
22650|NCT01744496|108336|P2|Maintenance Period|Subject left town|0
22651|NCT01744496|108337|P1|Maintenance Period|Subject left town|1
22652|NCT01744496|108336|P2|Maintenance Period|Withdrawal by Subject|1
22653|NCT01744496|108337|P1|Maintenance Period|Withdrawal by Subject|1
22654|NCT01744496|108336|P2|Maintenance Period|Protocol Violation|0
22655|NCT01744496|108337|P1|Maintenance Period|Protocol Violation|1
22656|NCT01744496|108336|P2|Maintenance Period|Adverse Event|3
22657|NCT01744496|108337|P1|Maintenance Period|Adverse Event|1
22658|NCT01744496|108336|P2|Titration Period|Personal reasons|1
22659|NCT01744496|108337|P1|Titration Period|Personal reasons|0
22660|NCT01744496|108336|P2|Titration Period|Adverse Event|1
22661|NCT01744496|108337|P1|Titration Period|Adverse Event|2
22662|NCT01744483|108358|P3|Overall Study|Routed to OSH|1
22663|NCT01744483|108359|P2|Overall Study|Routed to OSH|0
22664|NCT01744483|108360|P1|Overall Study|Routed to OSH|2
22665|NCT01744483|108358|P3|Overall Study|No ICU Admit|2
22666|NCT01744483|108359|P2|Overall Study|No ICU Admit|1
22667|NCT01744483|108360|P1|Overall Study|No ICU Admit|5
22668|NCT01744483|108358|P3|Overall Study|Withdrawal by Subject|2
22669|NCT01744483|108359|P2|Overall Study|Withdrawal by Subject|6
22670|NCT01744483|108360|P1|Overall Study|Withdrawal by Subject|4
22671|NCT01744483|108358|P3|Overall Study|Protocol Violation|1
22672|NCT01744483|108359|P2|Overall Study|Protocol Violation|2
22673|NCT01744483|108360|P1|Overall Study|Protocol Violation|1
22674|NCT01744483|108358|P3|Overall Study|Lost to Follow-up|11
22675|NCT01744483|108359|P2|Overall Study|Lost to Follow-up|9
22676|NCT01744483|108360|P1|Overall Study|Lost to Follow-up|8
22677|NCT01744483|108358|P3|Overall Study|Death|11
22678|NCT01744483|108359|P2|Overall Study|Death|4
22679|NCT01744483|108360|P1|Overall Study|Death|9
22680|NCT01744392|108368|P1|Overall Study|Physician Decision|1
22681|NCT01744197|108408|P2|Overall Study|No patch received|2
22682|NCT01744197|108409|P1|Overall Study|No patch received|2
22683|NCT01744197|108408|P2|Overall Study|Received 1 patch|1
22684|NCT01744197|108409|P1|Overall Study|Received 1 patch|2
22685|NCT01743092|108498|P2|Overall Study|Lost to Follow-up|15
22686|NCT01743092|108499|P1|Overall Study|Lost to Follow-up|14
22687|NCT01743027|108511|P4|Overall Study|Withdrawal by Subject|1
22688|NCT01743027|108512|P3|Overall Study|Withdrawal by Subject|3
22689|NCT01743027|108513|P2|Overall Study|Withdrawal by Subject|0
22690|NCT01743027|108514|P1|Overall Study|Withdrawal by Subject|1
22691|NCT01743027|108511|P4|Overall Study|Protocol Violation|0
22692|NCT01743027|108512|P3|Overall Study|Protocol Violation|1
22693|NCT01743027|108513|P2|Overall Study|Protocol Violation|1
22694|NCT01743027|108514|P1|Overall Study|Protocol Violation|1
22695|NCT01743027|108511|P4|Overall Study|Progressive Disease|0
22696|NCT01743027|108512|P3|Overall Study|Progressive Disease|3
22697|NCT01743027|108513|P2|Overall Study|Progressive Disease|4
22698|NCT01743027|108514|P1|Overall Study|Progressive Disease|1
22699|NCT01743027|108511|P4|Overall Study|Lost to Follow-up|0
22700|NCT01743027|108512|P3|Overall Study|Lost to Follow-up|2
22701|NCT01743027|108513|P2|Overall Study|Lost to Follow-up|0
22702|NCT01743027|108514|P1|Overall Study|Lost to Follow-up|0
22703|NCT01743027|108511|P4|Overall Study|Adverse Event|0
22704|NCT01743027|108512|P3|Overall Study|Adverse Event|0
22705|NCT01743027|108513|P2|Overall Study|Adverse Event|0
22706|NCT01743027|108514|P1|Overall Study|Adverse Event|2
22707|NCT01742897|108563|P1|Overall Study|Unspecified|1
22708|NCT01742897|108563|P1|Overall Study|Withdrawal by Subject|1
22709|NCT01742897|108563|P1|Overall Study|Adverse Event|3
22710|NCT01741792|108612|P3|Overall Study|Death|12
22711|NCT01741792|108613|P2|Overall Study|Death|1
22712|NCT01741792|108614|P1|Overall Study|Death|6
22713|NCT01741701|108681|P2|Overall Study|Withdrawal by Subject|1
22714|NCT01741701|108682|P1|Overall Study|Withdrawal by Subject|0
22715|NCT01741701|108681|P2|Overall Study|Adverse Event|1
22716|NCT01741701|108682|P1|Overall Study|Adverse Event|5
22717|NCT01741688|108698|P1|Overall Study|Withdrawal by Subject|1
22718|NCT01741688|108698|P1|Overall Study|Lack of insurance coverage|2
22719|NCT01740440|108918|P1|Overall Study|Lost to Follow-up|3
22720|NCT01740427|108926|P2|Overall Study|Study terminated by Sponsor|0
22721|NCT01740427|108927|P1|Overall Study|Study terminated by Sponsor|1
22722|NCT01740427|108926|P2|Overall Study|Lost to Follow-up|0
22723|NCT01740427|108927|P1|Overall Study|Lost to Follow-up|1
22724|NCT01740427|108926|P2|Overall Study|Protocol Violation|3
22725|NCT01740427|108927|P1|Overall Study|Protocol Violation|5
22726|NCT01740427|108926|P2|Overall Study|Death|2
22727|NCT01740427|108927|P1|Overall Study|Death|6
22728|NCT01740427|108926|P2|Overall Study|Unspecified reasons|4
22729|NCT01740427|108927|P1|Overall Study|Unspecified reasons|6
22730|NCT01740427|108926|P2|Overall Study|Subject refused continued treatment|9
22731|NCT01740427|108927|P1|Overall Study|Subject refused continued treatment|12
22732|NCT01740427|108926|P2|Overall Study|Global deterioration of health status|9
22733|NCT01740427|108927|P1|Overall Study|Global deterioration of health status|16
22734|NCT01740427|108926|P2|Overall Study|Adverse Event|9
22735|NCT01740427|108927|P1|Overall Study|Adverse Event|20
22736|NCT01740427|108926|P2|Overall Study|Objective progression or relapse|125
22737|NCT01740427|108927|P1|Overall Study|Objective progression or relapse|172
22738|NCT01740427|108926|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
22739|NCT01740427|108927|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
22740|NCT01740401|108979|P1|Overall Study|Did not reach primary endpoint|2
22741|NCT01740401|108979|P1|Overall Study|Adverse Event|2
22742|NCT01740401|108979|P1|Overall Study|Progression of disease|6
22743|NCT01740388|108988|P2|Overall Study|Subjects missing data, completed|36
22744|NCT01740388|108989|P1|Overall Study|Subjects missing data, completed|41
22745|NCT01740388|108988|P2|Overall Study|Physician Decision|6
22746|NCT01740388|108989|P1|Overall Study|Physician Decision|2
22747|NCT01740388|108988|P2|Overall Study|Lost to Follow-up|0
22748|NCT01740388|108989|P1|Overall Study|Lost to Follow-up|2
22749|NCT01740388|108988|P2|Overall Study|Withdrawal by Subject|2
22750|NCT01740388|108989|P1|Overall Study|Withdrawal by Subject|1
22751|NCT01740089|109041|P3|After 12 Weeks|Withdrawal by Subject|1
22752|NCT01740089|109042|P2|After 12 Weeks|Withdrawal by Subject|1
22753|NCT01740089|109043|P1|After 12 Weeks|Withdrawal by Subject|1
22754|NCT01740089|109041|P3|After 12 Weeks|Protocol Violation|1
22755|NCT01740089|109042|P2|After 12 Weeks|Protocol Violation|1
22756|NCT01740089|109043|P1|After 12 Weeks|Protocol Violation|1
22757|NCT01740089|109041|P3|After 12 Weeks|Adverse Event|5
22758|NCT01740089|109042|P2|After 12 Weeks|Adverse Event|0
22759|NCT01740089|109043|P1|After 12 Weeks|Adverse Event|2
22760|NCT01740089|109041|P3|After 12 Weeks|Lack of Efficacy|4
22761|NCT01740089|109042|P2|After 12 Weeks|Lack of Efficacy|1
22762|NCT01740089|109043|P1|After 12 Weeks|Lack of Efficacy|3
22763|NCT01740089|109041|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
22764|NCT01740089|109042|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
22765|NCT01740089|109043|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
22766|NCT01740089|109041|P3|First 12 Weeks of Treatment|Adverse Event|2
22767|NCT01740089|109042|P2|First 12 Weeks of Treatment|Adverse Event|1
22768|NCT01740089|109043|P1|First 12 Weeks of Treatment|Adverse Event|0
22769|NCT01739803|109061|P2|Overall Study|Lost to Follow-up|6
22770|NCT01739803|109062|P1|Overall Study|Lost to Follow-up|9
22771|NCT01739595|109075|P3|Overall Study|Drug discrepancy|0
22772|NCT01739595|109076|P2|Overall Study|Drug discrepancy|0
22773|NCT01739595|109077|P1|Overall Study|Drug discrepancy|1
22774|NCT01739595|109075|P3|Overall Study|Lab assessment|0
22775|NCT01739595|109076|P2|Overall Study|Lab assessment|0
22776|NCT01739595|109077|P1|Overall Study|Lab assessment|1
22777|NCT01739595|109075|P3|Overall Study|Protocol Violation|0
22778|NCT01739595|109076|P2|Overall Study|Protocol Violation|0
22779|NCT01739595|109077|P1|Overall Study|Protocol Violation|1
22780|NCT01739595|109075|P3|Overall Study|Eligibility issue|0
22781|NCT01739595|109076|P2|Overall Study|Eligibility issue|0
22782|NCT01739595|109077|P1|Overall Study|Eligibility issue|3
22783|NCT01739595|109075|P3|Overall Study|Withdrawal by Subject|2
22784|NCT01739595|109076|P2|Overall Study|Withdrawal by Subject|1
22785|NCT01739595|109077|P1|Overall Study|Withdrawal by Subject|2
22786|NCT01739595|109075|P3|Overall Study|Lost to Follow-up|0
22787|NCT01739595|109076|P2|Overall Study|Lost to Follow-up|0
22788|NCT01739595|109077|P1|Overall Study|Lost to Follow-up|2
22789|NCT01739595|109075|P3|Overall Study|Adverse Event|0
22790|NCT01739595|109076|P2|Overall Study|Adverse Event|0
22791|NCT01739595|109077|P1|Overall Study|Adverse Event|3
22792|NCT01738984|109096|P2|Overall Study|Lost to Follow-up|39
22793|NCT01738984|109097|P1|Overall Study|Lost to Follow-up|59
22794|NCT01738984|109096|P2|Overall Study|Withdrawal by Subject|0
22795|NCT01738984|109097|P1|Overall Study|Withdrawal by Subject|1
22796|NCT01738984|109096|P2|Overall Study|Pregnancy|0
22797|NCT01738984|109097|P1|Overall Study|Pregnancy|4
22798|NCT01738971|109110|P3|Overall Study|Lost to Follow-up|17
22799|NCT01738971|109111|P2|Overall Study|Lost to Follow-up|30
22800|NCT01738971|109112|P1|Overall Study|Lost to Follow-up|19
22801|NCT01738919|109128|P2|Overall Study|Not treated in accordance to guidelines|1
22802|NCT01738919|109129|P1|Overall Study|Not treated in accordance to guidelines|0
22803|NCT01738919|109128|P2|Overall Study|Withdrawal by Subject|1
22804|NCT01738919|109129|P1|Overall Study|Withdrawal by Subject|0
22805|NCT01738919|109128|P2|Overall Study|Immigrated|1
22806|NCT01738919|109129|P1|Overall Study|Immigrated|0
22807|NCT01738919|109128|P2|Overall Study|Lost to Follow-up|0
22808|NCT01738919|109129|P1|Overall Study|Lost to Follow-up|1
22809|NCT01738646|109270|P1|Overall Study|Still Receiving Treatment|2
22810|NCT01738581|109280|P2|Overall Study|Lost to Follow-up|0
22811|NCT01738581|109281|P1|Overall Study|Lost to Follow-up|1
22812|NCT01738438|109299|P1|Overall Study|Adverse Event|3
22813|NCT01738438|109299|P1|Overall Study|Disease Progression|32
22814|NCT01737996|109317|P3|Overall Study|Withdrawal by Subject|1
22815|NCT01737996|109318|P2|Overall Study|Withdrawal by Subject|0
22816|NCT01737996|109319|P1|Overall Study|Withdrawal by Subject|0
22817|NCT01737996|109317|P3|Overall Study|Adverse Event|1
22818|NCT01737996|109318|P2|Overall Study|Adverse Event|1
22819|NCT01737996|109319|P1|Overall Study|Adverse Event|0
22820|NCT01737931|109381|P3|Overall Study|Physician Decision|0
22821|NCT01737931|109382|P2|Overall Study|Physician Decision|1
22822|NCT01737931|109383|P1|Overall Study|Physician Decision|0
22823|NCT01737931|109381|P3|Overall Study|Withdrawal by Subject|1
22824|NCT01737931|109382|P2|Overall Study|Withdrawal by Subject|1
22825|NCT01737931|109383|P1|Overall Study|Withdrawal by Subject|0
22826|NCT01737879|109398|P1|Overall Study|Sponsor decision|40
22827|NCT01737879|109398|P1|Overall Study|Death|1
22828|NCT01737840|109407|P2|Overall Study|Diagnosed with an other pathology|2
22829|NCT01737840|109408|P1|Overall Study|Diagnosed with an other pathology|2
22830|NCT01737762|109418|P2|Overall Study|Trial termination|9
22831|NCT01737762|109419|P1|Overall Study|Trial termination|11
22832|NCT01737762|109418|P2|Overall Study|Moved from area|1
22833|NCT01737762|109419|P1|Overall Study|Moved from area|2
22834|NCT01737762|109418|P2|Overall Study|Physician Decision|1
22835|NCT01737762|109419|P1|Overall Study|Physician Decision|1
22836|NCT01737762|109418|P2|Overall Study|Progressive disease|2
22837|NCT01737762|109419|P1|Overall Study|Progressive disease|1
22838|NCT01737762|109418|P2|Overall Study|Withdrawal by Subject|2
22839|NCT01737762|109419|P1|Overall Study|Withdrawal by Subject|2
22840|NCT01737762|109418|P2|Overall Study|Lost to Follow-up|0
22841|NCT01737762|109419|P1|Overall Study|Lost to Follow-up|1
22842|NCT01737762|109418|P2|Overall Study|Adverse Event|2
22843|NCT01737762|109419|P1|Overall Study|Adverse Event|2
22844|NCT01737710|109432|P5|Overall Study|Vaccinated in Error/Ineligible|0
22845|NCT01737710|109433|P4|Overall Study|Vaccinated in Error/Ineligible|0
22846|NCT01737710|109434|P3|Overall Study|Vaccinated in Error/Ineligible|0
22847|NCT01737710|109435|P2|Overall Study|Vaccinated in Error/Ineligible|1
22848|NCT01737710|109436|P1|Overall Study|Vaccinated in Error/Ineligible|1
22849|NCT01737710|109432|P5|Overall Study|Withdrawal by Subject|0
22850|NCT01737710|109433|P4|Overall Study|Withdrawal by Subject|0
22851|NCT01737710|109434|P3|Overall Study|Withdrawal by Subject|1
22852|NCT01737710|109435|P2|Overall Study|Withdrawal by Subject|1
22853|NCT01737710|109436|P1|Overall Study|Withdrawal by Subject|1
22854|NCT01737710|109432|P5|Overall Study|Lost to Follow-up|0
22855|NCT01737710|109433|P4|Overall Study|Lost to Follow-up|0
22856|NCT01737710|109434|P3|Overall Study|Lost to Follow-up|2
22857|NCT01737710|109435|P2|Overall Study|Lost to Follow-up|2
22858|NCT01737710|109436|P1|Overall Study|Lost to Follow-up|0
22859|NCT01737021|109529|P2|Overall Study|Lost to Follow-up|3
22860|NCT01737021|109530|P1|Overall Study|Lost to Follow-up|5
22861|NCT01736917|109576|P1|Overall Study|Protocol Violation|10
22862|NCT01736917|109576|P1|Overall Study|Adverse Event|1
22863|NCT01736696|109590|P7|Overall Study|Withdrawal by Subject|0
22864|NCT01736696|109591|P6|Overall Study|Withdrawal by Subject|0
22865|NCT01736696|109592|P5|Overall Study|Withdrawal by Subject|0
22866|NCT01736696|109593|P4|Overall Study|Withdrawal by Subject|0
22867|NCT01736696|109594|P3|Overall Study|Withdrawal by Subject|1
22868|NCT01736696|109595|P2|Overall Study|Withdrawal by Subject|0
22869|NCT01736696|109596|P1|Overall Study|Withdrawal by Subject|0
22870|NCT01736657|109913|P1|Overall Study|insufficient vascular access|1
22871|NCT01736579|109922|P2|Overall Study|Termination of Study by Sponsor|2
22872|NCT01736579|109923|P1|Overall Study|Termination of Study by Sponsor|2
22873|NCT01736540|109957|P1|Overall Study|Unable to make MRI appointment|3
22874|NCT01736540|109957|P1|Overall Study|No show for MRI appointment|1
22875|NCT01736540|109957|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
22876|NCT01736540|109957|P1|Overall Study|Protocol Violation|1
22877|NCT01736540|109957|P1|Overall Study|Withdrawal by Subject|5
22878|NCT01736540|109957|P1|Overall Study|Abnormal test procedure|1
22879|NCT01736540|109957|P1|Overall Study|Death|1
22880|NCT01736540|109957|P1|Overall Study|Did not complete scan within 45 days|2
22881|NCT01736475|110023|P2|Overall Study|Other - Surgical procedure|0
22882|NCT01736475|110024|P1|Overall Study|Other - Surgical procedure|1
22883|NCT01736475|110023|P2|Overall Study|Other - Screen failure|0
22884|NCT01736475|110024|P1|Overall Study|Other - Screen failure|1
22885|NCT01736475|110023|P2|Overall Study|Protocol Violation|0
22886|NCT01736475|110024|P1|Overall Study|Protocol Violation|4
22887|NCT01736475|110023|P2|Overall Study|Withdrawal by Subject|0
22888|NCT01736475|110024|P1|Overall Study|Withdrawal by Subject|2
22889|NCT01736475|110023|P2|Overall Study|Adverse Event|0
22890|NCT01736475|110024|P1|Overall Study|Adverse Event|4
22891|NCT01736215|110077|P1|Overall Study|Insufficient data to perform analysis|8
22892|NCT01736215|110077|P1|Overall Study|Progressive disease stop chemotherapy|1
22893|NCT01736215|110077|P1|Overall Study|Adverse Event|4
22894|NCT01736215|110077|P1|Overall Study|Early termination of erythropoietin use|1
22895|NCT01736176|110089|P1|Overall Study|Unable to Complete PEG Placement|1
22896|NCT01736176|110089|P1|Overall Study|Lack of Efficacy|3
22897|NCT01736176|110089|P1|Overall Study|Withdrawal by Subject|4
22898|NCT01736176|110089|P1|Overall Study|Adverse Event|3
22899|NCT01735916|110136|P3|Overall Study|Withdrawal by Subject|0
22900|NCT01735916|110137|P2|Overall Study|Withdrawal by Subject|0
22901|NCT01735916|110138|P1|Overall Study|Withdrawal by Subject|3
22902|NCT01735916|110136|P3|Overall Study|Early termination of study by sponsor|7
22903|NCT01735916|110137|P2|Overall Study|Early termination of study by sponsor|19
22904|NCT01735916|110138|P1|Overall Study|Early termination of study by sponsor|4
22905|NCT01735916|110136|P3|Overall Study|Subject not eligible to be randomized|0
22906|NCT01735916|110137|P2|Overall Study|Subject not eligible to be randomized|0
22907|NCT01735916|110138|P1|Overall Study|Subject not eligible to be randomized|11
22908|NCT01735630|110176|P2|Overall Study|Withdrawal by Subject|9
22909|NCT01735630|110177|P1|Overall Study|Withdrawal by Subject|7
22910|NCT01735630|110176|P2|Overall Study|Sponsor Decision|1
22911|NCT01735630|110177|P1|Overall Study|Sponsor Decision|2
22912|NCT01735630|110176|P2|Overall Study|Physician Decision|1
22913|NCT01735630|110177|P1|Overall Study|Physician Decision|0
22914|NCT01735630|110176|P2|Overall Study|Lost to Follow-up|0
22915|NCT01735630|110177|P1|Overall Study|Lost to Follow-up|1
22916|NCT01735630|110176|P2|Overall Study|Adverse Event|7
22917|NCT01735630|110177|P1|Overall Study|Adverse Event|8
22918|NCT01735396|110204|P1|Overall Study|not evaluable|1
22919|NCT01735201|110233|P8|Overall Study|Other Miscellaneous Reasons|1
22920|NCT01735201|110234|P7|Overall Study|Other Miscellaneous Reasons|1
22921|NCT01735201|110235|P6|Overall Study|Other Miscellaneous Reasons|2
22922|NCT01735201|110236|P5|Overall Study|Other Miscellaneous Reasons|0
22923|NCT01735201|110237|P4|Overall Study|Other Miscellaneous Reasons|1
22924|NCT01735201|110238|P3|Overall Study|Other Miscellaneous Reasons|0
22925|NCT01735201|110239|P2|Overall Study|Other Miscellaneous Reasons|0
22926|NCT01735201|110240|P1|Overall Study|Other Miscellaneous Reasons|0
22927|NCT01735201|110233|P8|Overall Study|Protocol Violation|0
22928|NCT01735201|110234|P7|Overall Study|Protocol Violation|0
22929|NCT01735201|110235|P6|Overall Study|Protocol Violation|0
22930|NCT01735201|110236|P5|Overall Study|Protocol Violation|0
22931|NCT01735201|110237|P4|Overall Study|Protocol Violation|0
22932|NCT01735201|110238|P3|Overall Study|Protocol Violation|0
22933|NCT01735201|110239|P2|Overall Study|Protocol Violation|0
22934|NCT01735201|110240|P1|Overall Study|Protocol Violation|1
22935|NCT01735201|110233|P8|Overall Study|Personal Reasons|0
22936|NCT01735201|110234|P7|Overall Study|Personal Reasons|0
22937|NCT01735201|110235|P6|Overall Study|Personal Reasons|0
22938|NCT01735201|110236|P5|Overall Study|Personal Reasons|0
22939|NCT01735201|110237|P4|Overall Study|Personal Reasons|0
22940|NCT01735201|110238|P3|Overall Study|Personal Reasons|0
22941|NCT01735201|110239|P2|Overall Study|Personal Reasons|0
22942|NCT01735201|110240|P1|Overall Study|Personal Reasons|1
22943|NCT01735201|110233|P8|Overall Study|Adverse Event|1
22944|NCT01735201|110234|P7|Overall Study|Adverse Event|2
22945|NCT01735201|110235|P6|Overall Study|Adverse Event|3
22946|NCT01735201|110236|P5|Overall Study|Adverse Event|1
22947|NCT01735201|110237|P4|Overall Study|Adverse Event|1
22948|NCT01735201|110238|P3|Overall Study|Adverse Event|0
22949|NCT01735201|110239|P2|Overall Study|Adverse Event|1
22950|NCT01735201|110240|P1|Overall Study|Adverse Event|1
22951|NCT01735175|110276|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
22952|NCT01735175|110277|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
22953|NCT01735175|110276|P2|Overall Study|Death|2
22954|NCT01735175|110277|P1|Overall Study|Death|3
22955|NCT01735175|110276|P2|Overall Study|Lost to Follow-up|2
22956|NCT01735175|110277|P1|Overall Study|Lost to Follow-up|4
22957|NCT01735175|110276|P2|Overall Study|Withdrawal by Subject|2
22958|NCT01735175|110277|P1|Overall Study|Withdrawal by Subject|9
22959|NCT01734993|110297|P1|Overall Study|Lack of Efficacy|1
22960|NCT01734993|110297|P1|Overall Study|Adverse Event|1
22961|NCT01734785|110334|P4|Double−Blind Period|Not treated|0
22962|NCT01734785|110335|P3|Double−Blind Period|Not treated|0
22963|NCT01734785|110336|P2|Double−Blind Period|Not treated|0
22964|NCT01734785|110337|P1|Double−Blind Period|Not treated|1
22965|NCT01734785|110334|P4|Double−Blind Period|Withdrawal by Subject|0
22966|NCT01734785|110335|P3|Double−Blind Period|Withdrawal by Subject|0
22967|NCT01734785|110336|P2|Double−Blind Period|Withdrawal by Subject|0
22968|NCT01734785|110337|P1|Double−Blind Period|Withdrawal by Subject|2
22969|NCT01734785|110334|P4|Double−Blind Period|Lost to Follow-up|0
22970|NCT01734785|110335|P3|Double−Blind Period|Lost to Follow-up|2
22971|NCT01734785|110336|P2|Double−Blind Period|Lost to Follow-up|4
22972|NCT01734785|110337|P1|Double−Blind Period|Lost to Follow-up|2
22973|NCT01734785|110334|P4|Double−Blind Period|Protocol Violation|0
22974|NCT01734785|110335|P3|Double−Blind Period|Protocol Violation|1
22975|NCT01734785|110336|P2|Double−Blind Period|Protocol Violation|1
22976|NCT01734785|110337|P1|Double−Blind Period|Protocol Violation|0
22977|NCT01734785|110334|P4|Double−Blind Period|Lack of Efficacy|0
22978|NCT01734785|110335|P3|Double−Blind Period|Lack of Efficacy|0
22979|NCT01734785|110336|P2|Double−Blind Period|Lack of Efficacy|1
22980|NCT01734785|110337|P1|Double−Blind Period|Lack of Efficacy|0
22981|NCT01734785|110334|P4|Double−Blind Period|Adverse Event|0
22982|NCT01734785|110335|P3|Double−Blind Period|Adverse Event|2
22983|NCT01734785|110336|P2|Double−Blind Period|Adverse Event|3
22984|NCT01734785|110337|P1|Double−Blind Period|Adverse Event|0
22985|NCT01734785|110334|P4|Open−Label Period|Other Reasons|224
22986|NCT01734785|110335|P3|Open−Label Period|Other Reasons|0
22987|NCT01734785|110336|P2|Open−Label Period|Other Reasons|0
22988|NCT01734785|110337|P1|Open−Label Period|Other Reasons|0
22989|NCT01734785|110334|P4|Open−Label Period|Withdrawal by Subject|12
22990|NCT01734785|110335|P3|Open−Label Period|Withdrawal by Subject|0
22991|NCT01734785|110336|P2|Open−Label Period|Withdrawal by Subject|0
22992|NCT01734785|110337|P1|Open−Label Period|Withdrawal by Subject|0
22993|NCT01734785|110334|P4|Open−Label Period|Lost to Follow-up|14
22994|NCT01734785|110335|P3|Open−Label Period|Lost to Follow-up|0
22995|NCT01734785|110336|P2|Open−Label Period|Lost to Follow-up|0
22996|NCT01734785|110337|P1|Open−Label Period|Lost to Follow-up|0
22997|NCT01734785|110334|P4|Open−Label Period|Protocol Violation|13
22998|NCT01734785|110335|P3|Open−Label Period|Protocol Violation|0
22999|NCT01734785|110336|P2|Open−Label Period|Protocol Violation|0
23000|NCT01734785|110337|P1|Open−Label Period|Protocol Violation|0
23001|NCT01734785|110334|P4|Open−Label Period|Lack of Efficacy|1
23002|NCT01734785|110335|P3|Open−Label Period|Lack of Efficacy|0
23003|NCT01734785|110336|P2|Open−Label Period|Lack of Efficacy|0
23004|NCT01734785|110337|P1|Open−Label Period|Lack of Efficacy|0
23005|NCT01734785|110334|P4|Open−Label Period|Adverse Event|9
23006|NCT01734785|110335|P3|Open−Label Period|Adverse Event|0
23007|NCT01734785|110336|P2|Open−Label Period|Adverse Event|0
23008|NCT01734785|110337|P1|Open−Label Period|Adverse Event|0
23009|NCT01734772|110354|P2|Overall Study|Withdrawal by Subject|1
23010|NCT01734772|110355|P1|Overall Study|Withdrawal by Subject|0
23011|NCT01734772|110354|P2|Overall Study|Adverse Event|2
23012|NCT01734772|110355|P1|Overall Study|Adverse Event|1
23013|NCT01734395|110381|P1|Overall Study|Missing the reasons for not completed|3
23014|NCT01734395|110381|P1|Overall Study|Withdrawal by Subject|10
23015|NCT01734395|110381|P1|Overall Study|Adverse Event|40
23016|NCT01734395|110381|P1|Overall Study|Lack of Efficacy|5
23017|NCT01734395|110381|P1|Overall Study|Lost to Follow-up|287
23018|NCT01734395|110381|P1|Overall Study|Not specified|65
23019|NCT01733758|110439|P4|Overall Study|Inv Decision, HbA1c not controlled|1
23020|NCT01733758|110440|P3|Overall Study|Inv Decision, HbA1c not controlled|0
23021|NCT01733758|110441|P2|Overall Study|Inv Decision, HbA1c not controlled|1
23022|NCT01733758|110442|P1|Overall Study|Inv Decision, HbA1c not controlled|1
23023|NCT01733758|110439|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
23024|NCT01733758|110440|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
23025|NCT01733758|110441|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
23026|NCT01733758|110442|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
23027|NCT01733758|110439|P4|Overall Study|Non-compliance|0
23028|NCT01733758|110440|P3|Overall Study|Non-compliance|0
23029|NCT01733758|110441|P2|Overall Study|Non-compliance|0
23030|NCT01733758|110442|P1|Overall Study|Non-compliance|1
23031|NCT01733758|110439|P4|Overall Study|Protocol Violation|2
23032|NCT01733758|110440|P3|Overall Study|Protocol Violation|2
23033|NCT01733758|110441|P2|Overall Study|Protocol Violation|1
23034|NCT01733758|110442|P1|Overall Study|Protocol Violation|0
23035|NCT01733758|110439|P4|Overall Study|Persistent Hyperglycemia|0
23036|NCT01733758|110440|P3|Overall Study|Persistent Hyperglycemia|0
23037|NCT01733758|110441|P2|Overall Study|Persistent Hyperglycemia|2
23038|NCT01733758|110442|P1|Overall Study|Persistent Hyperglycemia|3
23039|NCT01733758|110439|P4|Overall Study|Withdrawal by Subject|3
23040|NCT01733758|110440|P3|Overall Study|Withdrawal by Subject|5
23041|NCT01733758|110441|P2|Overall Study|Withdrawal by Subject|1
23042|NCT01733758|110442|P1|Overall Study|Withdrawal by Subject|1
23043|NCT01733758|110439|P4|Overall Study|Adverse Event|1
23044|NCT01733758|110440|P3|Overall Study|Adverse Event|8
23045|NCT01733758|110441|P2|Overall Study|Adverse Event|7
23046|NCT01733758|110442|P1|Overall Study|Adverse Event|5
23047|NCT01733732|110508|P2|Overall Study|Did not attend all study visits|0
23048|NCT01733732|110509|P1|Overall Study|Did not attend all study visits|1
23049|NCT01733732|110508|P2|Overall Study|Adverse Event|0
23050|NCT01733732|110509|P1|Overall Study|Adverse Event|1
23051|NCT01733329|110545|P2|Overall Study|Uterine artery injury|0
23052|NCT01733329|110546|P1|Overall Study|Uterine artery injury|1
23053|NCT01733329|110545|P2|Overall Study|Protocol Violation|1
23054|NCT01733329|110546|P1|Overall Study|Protocol Violation|1
23055|NCT01733316|110558|P1|Overall Study|Withdrawal by Subject|1
23056|NCT01733316|110558|P1|Overall Study|Noncompliance|1
23057|NCT01733121|110638|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
23058|NCT01733121|110639|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
23059|NCT01733121|110638|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
23060|NCT01733121|110639|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
23061|NCT01733121|110638|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
23062|NCT01733121|110639|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
23063|NCT01733121|110638|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
23064|NCT01733121|110639|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
23065|NCT01732926|110681|P2|Overall Study|Blind Broken by Subject or Study Site|1
23066|NCT01732926|110682|P1|Overall Study|Blind Broken by Subject or Study Site|1
23067|NCT01732926|110681|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
23068|NCT01732926|110682|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
23069|NCT01732926|110681|P2|Overall Study|Other Reason|4
23070|NCT01732926|110682|P1|Overall Study|Other Reason|21
23071|NCT01732926|110681|P2|Overall Study|Physician Decision|11
23072|NCT01732926|110682|P1|Overall Study|Physician Decision|24
23073|NCT01732926|110681|P2|Overall Study|Withdrawal by Subject|8
23074|NCT01732926|110682|P1|Overall Study|Withdrawal by Subject|46
23075|NCT01732926|110681|P2|Overall Study|Study Terminated by Sponsor|80
23076|NCT01732926|110682|P1|Overall Study|Study Terminated by Sponsor|168
23077|NCT01732913|110698|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
23078|NCT01732913|110699|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
23079|NCT01732913|110698|P2|Overall Study|Other|1
23080|NCT01732913|110699|P1|Overall Study|Other|7
23081|NCT01732913|110698|P2|Overall Study|Physician Decision|7
23082|NCT01732913|110699|P1|Overall Study|Physician Decision|14
23083|NCT01732913|110698|P2|Overall Study|Withdrawal by Subject|4
23084|NCT01732913|110699|P1|Overall Study|Withdrawal by Subject|27
23085|NCT01732913|110698|P2|Overall Study|Study Terminated by Sponsor|55
23086|NCT01732913|110699|P1|Overall Study|Study Terminated by Sponsor|105
23087|NCT01732835|110713|P1|2-year Extended Follow-up|Death|1
23088|NCT01732835|110713|P1|2-year Extended Follow-up|Adverse Event|3
23089|NCT01732835|110713|P1|2-year Extended Follow-up|Withdrawal by Subject|1
23090|NCT01732835|110713|P1|6-month Primary Endpoint|Adverse Event|3
23091|NCT01732835|110713|P1|6-month Primary Endpoint|Withdrawal by Subject|2
23092|NCT01732835|110713|P1|6-month Primary Endpoint|Did not receive device|19
23093|NCT01732796|110747|P3|Overall Study|Other reason not defined above|2
23094|NCT01732796|110748|P2|Overall Study|Other reason not defined above|0
23095|NCT01732796|110749|P1|Overall Study|Other reason not defined above|1
23096|NCT01732796|110747|P3|Overall Study|Withdrawal by Subject|2
23097|NCT01732796|110748|P2|Overall Study|Withdrawal by Subject|8
23098|NCT01732796|110749|P1|Overall Study|Withdrawal by Subject|6
23099|NCT01732796|110747|P3|Overall Study|Lost to Follow-up|0
23100|NCT01732796|110748|P2|Overall Study|Lost to Follow-up|0
23101|NCT01732796|110749|P1|Overall Study|Lost to Follow-up|2
23102|NCT01732796|110747|P3|Overall Study|Lack of Efficacy|5
23103|NCT01732796|110748|P2|Overall Study|Lack of Efficacy|18
23104|NCT01732796|110749|P1|Overall Study|Lack of Efficacy|21
23105|NCT01732796|110747|P3|Overall Study|Adverse Event|4
23106|NCT01732796|110748|P2|Overall Study|Adverse Event|16
23107|NCT01732796|110749|P1|Overall Study|Adverse Event|16
23108|NCT01732770|110767|P2|Overall Study|Death|0
23109|NCT01732770|110768|P1|Overall Study|Death|1
23110|NCT01732770|110767|P2|Overall Study|Decision by Sponsor|2
23111|NCT01732770|110768|P1|Overall Study|Decision by Sponsor|2
23112|NCT01732770|110767|P2|Overall Study|Withdrawal by Subject|3
23113|NCT01732770|110768|P1|Overall Study|Withdrawal by Subject|5
23114|NCT01732770|110767|P2|Overall Study|Lost to Follow-up|3
23115|NCT01732770|110768|P1|Overall Study|Lost to Follow-up|2
23116|NCT01732757|110783|P3|Overall Study|Lost to Follow-up|0
23117|NCT01732757|110784|P2|Overall Study|Lost to Follow-up|0
23118|NCT01732757|110785|P1|Overall Study|Lost to Follow-up|1
23119|NCT01732692|110825|P2|Overall Study|Adverse Event|1
23120|NCT01732692|110826|P1|Overall Study|Adverse Event|0
23121|NCT01732588|110843|P3|First Intervention (7 Days)|Adverse Event|0
23122|NCT01732588|110844|P2|First Intervention (7 Days)|Adverse Event|1
23123|NCT01732588|110845|P1|First Intervention (7 Days)|Adverse Event|0
23124|NCT01732549|110861|P2|Overall Study|Not Specified|14
23125|NCT01732549|110862|P1|Overall Study|Not Specified|8
23126|NCT01732549|110861|P2|Overall Study|Disease progression|50
23127|NCT01732549|110862|P1|Overall Study|Disease progression|37
23128|NCT01732549|110861|P2|Overall Study|Consent withdrawn|6
23129|NCT01732549|110862|P1|Overall Study|Consent withdrawn|13
23130|NCT01732549|110861|P2|Overall Study|Adverse Event|3
23131|NCT01732549|110862|P1|Overall Study|Adverse Event|13
23132|NCT01732510|110889|P7|Overall Study|Study Terminated By Sponsor|6
23133|NCT01732510|110890|P6|Overall Study|Study Terminated By Sponsor|12
23134|NCT01732510|110891|P5|Overall Study|Study Terminated By Sponsor|0
23135|NCT01732510|110892|P4|Overall Study|Study Terminated By Sponsor|1
23136|NCT01732510|110893|P3|Overall Study|Study Terminated By Sponsor|0
23137|NCT01732510|110894|P2|Overall Study|Study Terminated By Sponsor|0
23138|NCT01732510|110895|P1|Overall Study|Study Terminated By Sponsor|0
23139|NCT01732510|110889|P7|Overall Study|Pregnancy|0
23140|NCT01732510|110890|P6|Overall Study|Pregnancy|0
23141|NCT01732510|110891|P5|Overall Study|Pregnancy|0
23142|NCT01732510|110892|P4|Overall Study|Pregnancy|1
23143|NCT01732510|110893|P3|Overall Study|Pregnancy|0
23144|NCT01732510|110894|P2|Overall Study|Pregnancy|0
23145|NCT01732510|110895|P1|Overall Study|Pregnancy|0
23146|NCT01732510|110889|P7|Overall Study|Physician Decision|0
23147|NCT01732510|110890|P6|Overall Study|Physician Decision|0
23148|NCT01732510|110891|P5|Overall Study|Physician Decision|0
23149|NCT01732510|110892|P4|Overall Study|Physician Decision|0
23150|NCT01732510|110893|P3|Overall Study|Physician Decision|0
23151|NCT01732510|110894|P2|Overall Study|Physician Decision|1
23152|NCT01732510|110895|P1|Overall Study|Physician Decision|0
23153|NCT01732510|110889|P7|Overall Study|Lost to Follow-up|0
23154|NCT01732510|110890|P6|Overall Study|Lost to Follow-up|1
23155|NCT01732510|110891|P5|Overall Study|Lost to Follow-up|0
23156|NCT01732510|110892|P4|Overall Study|Lost to Follow-up|1
23157|NCT01732510|110893|P3|Overall Study|Lost to Follow-up|1
23158|NCT01732510|110894|P2|Overall Study|Lost to Follow-up|0
23159|NCT01732510|110895|P1|Overall Study|Lost to Follow-up|0
23160|NCT01732510|110889|P7|Overall Study|Withdrawal by Subject|1
23161|NCT01732510|110890|P6|Overall Study|Withdrawal by Subject|0
23162|NCT01732510|110891|P5|Overall Study|Withdrawal by Subject|5
23163|NCT01732510|110892|P4|Overall Study|Withdrawal by Subject|1
23164|NCT01732510|110893|P3|Overall Study|Withdrawal by Subject|2
23165|NCT01732510|110894|P2|Overall Study|Withdrawal by Subject|3
23166|NCT01732510|110895|P1|Overall Study|Withdrawal by Subject|1
23167|NCT01732510|110889|P7|Overall Study|Protocol Violation|0
23168|NCT01732510|110890|P6|Overall Study|Protocol Violation|0
23169|NCT01732510|110891|P5|Overall Study|Protocol Violation|0
23170|NCT01732510|110892|P4|Overall Study|Protocol Violation|1
23171|NCT01732510|110893|P3|Overall Study|Protocol Violation|0
23172|NCT01732510|110894|P2|Overall Study|Protocol Violation|0
23173|NCT01732510|110895|P1|Overall Study|Protocol Violation|0
23174|NCT01732510|110889|P7|Overall Study|Adverse Event|1
23175|NCT01732510|110890|P6|Overall Study|Adverse Event|0
23176|NCT01732510|110891|P5|Overall Study|Adverse Event|0
23177|NCT01732510|110892|P4|Overall Study|Adverse Event|0
23178|NCT01732510|110893|P3|Overall Study|Adverse Event|1
23179|NCT01732510|110894|P2|Overall Study|Adverse Event|1
23180|NCT01732510|110895|P1|Overall Study|Adverse Event|0
23181|NCT01732484|110974|P1|Overall Study|chronical illness|5
23182|NCT01732484|110974|P1|Overall Study|Lost to Follow-up|14
23183|NCT01732484|110974|P1|Overall Study|Death|7
23184|NCT01732471|110982|P1|Overall Study|Withdrawal by Subject|1
23185|NCT01731990|110991|P2|Overall Study|Death|0
23186|NCT01731990|110992|P1|Overall Study|Death|1
23187|NCT01731990|110991|P2|Overall Study|Protocol deviation|2
23188|NCT01731990|110992|P1|Overall Study|Protocol deviation|1
23189|NCT01731990|110991|P2|Overall Study|Withdrawal by Subject|1
23190|NCT01731990|110992|P1|Overall Study|Withdrawal by Subject|1
23191|NCT01731990|110991|P2|Overall Study|Adverse Event|5
23192|NCT01731990|110992|P1|Overall Study|Adverse Event|1
23193|NCT01731938|111008|P2|Primary Part II|Missed Week 6 visit|3
23194|NCT01731938|111009|P1|Primary Part II|Missed Week 6 visit|2
23195|NCT01731938|111008|P2|Primary Part II|Death|1
23196|NCT01731938|111009|P1|Primary Part II|Death|2
23197|NCT01731938|111008|P2|Primary Part II|Lost to Follow-up|5
23198|NCT01731938|111009|P1|Primary Part II|Lost to Follow-up|4
23199|NCT01731938|111008|P2|Primary Part II|Withdrawal by Subject|4
23200|NCT01731938|111009|P1|Primary Part II|Withdrawal by Subject|5
23201|NCT01731938|111008|P2|Preliminary Part I|Missed Week 6 visit|3
23202|NCT01731938|111009|P1|Preliminary Part I|Missed Week 6 visit|0
23203|NCT01731938|111008|P2|Preliminary Part I|Lost to Follow-up|3
23204|NCT01731938|111009|P1|Preliminary Part I|Lost to Follow-up|0
23205|NCT01731938|111008|P2|Preliminary Part I|Physician Decision|0
23206|NCT01731938|111009|P1|Preliminary Part I|Physician Decision|1
23207|NCT01731938|111008|P2|Preliminary Part I|Withdrawal by Subject|2
23208|NCT01731938|111009|P1|Preliminary Part I|Withdrawal by Subject|2
23209|NCT01731470|111021|P1|Overall Study|Did not meet study criteria|1
23210|NCT01731470|111021|P1|Overall Study|Withdrawal by Subject|1
23211|NCT01730378|111047|P2|Overall Study|Lost to Follow-up|0
23212|NCT01730378|111048|P1|Overall Study|Lost to Follow-up|1
23213|NCT01730339|111079|P2|Overall Study|Un-specified|0
23214|NCT01730339|111080|P1|Overall Study|Un-specified|1
23215|NCT01730339|111079|P2|Overall Study|Lost to Follow-up|1
23216|NCT01730339|111080|P1|Overall Study|Lost to Follow-up|1
23217|NCT01730339|111079|P2|Overall Study|Withdrawal by Subject|2
23218|NCT01730339|111080|P1|Overall Study|Withdrawal by Subject|3
23219|NCT01730053|111120|P6|Overall Study|Other than specified|9
23220|NCT01730053|111121|P5|Overall Study|Other than specified|7
23221|NCT01730053|111122|P4|Overall Study|Other than specified|4
23222|NCT01730053|111123|P3|Overall Study|Other than specified|5
23223|NCT01730053|111124|P2|Overall Study|Other than specified|6
23224|NCT01730053|111125|P1|Overall Study|Other than specified|2
23225|NCT01730053|111120|P6|Overall Study|Poor compliance to protocol|2
23226|NCT01730053|111121|P5|Overall Study|Poor compliance to protocol|0
23227|NCT01730053|111122|P4|Overall Study|Poor compliance to protocol|0
23228|NCT01730053|111123|P3|Overall Study|Poor compliance to protocol|2
23229|NCT01730053|111124|P2|Overall Study|Poor compliance to protocol|2
23230|NCT01730053|111125|P1|Overall Study|Poor compliance to protocol|1
23231|NCT01730053|111120|P6|Overall Study|Adverse Event|2
23232|NCT01730053|111121|P5|Overall Study|Adverse Event|2
23233|NCT01730053|111122|P4|Overall Study|Adverse Event|3
23234|NCT01730053|111123|P3|Overall Study|Adverse Event|3
23235|NCT01730053|111124|P2|Overall Study|Adverse Event|6
23236|NCT01730053|111125|P1|Overall Study|Adverse Event|2
23237|NCT01730053|111120|P6|Overall Study|Physician Decision|0
23238|NCT01730053|111121|P5|Overall Study|Physician Decision|0
23239|NCT01730053|111122|P4|Overall Study|Physician Decision|1
23240|NCT01730053|111123|P3|Overall Study|Physician Decision|0
23241|NCT01730053|111124|P2|Overall Study|Physician Decision|0
23242|NCT01730053|111125|P1|Overall Study|Physician Decision|0
23243|NCT01730053|111120|P6|Overall Study|Participant moved|0
23244|NCT01730053|111121|P5|Overall Study|Participant moved|0
23245|NCT01730053|111122|P4|Overall Study|Participant moved|0
23246|NCT01730053|111123|P3|Overall Study|Participant moved|1
23247|NCT01730053|111124|P2|Overall Study|Participant moved|0
23248|NCT01730053|111125|P1|Overall Study|Participant moved|0
23249|NCT01730040|111284|P7|Overall Study|Poor compliance to protocol|1
23250|NCT01730040|111285|P6|Overall Study|Poor compliance to protocol|0
23251|NCT01730040|111286|P5|Overall Study|Poor compliance to protocol|0
23252|NCT01730040|111287|P4|Overall Study|Poor compliance to protocol|0
23253|NCT01730040|111288|P3|Overall Study|Poor compliance to protocol|0
23254|NCT01730040|111289|P2|Overall Study|Poor compliance to protocol|4
23255|NCT01730040|111290|P1|Overall Study|Poor compliance to protocol|2
23256|NCT01730040|111284|P7|Overall Study|Adverse Event|2
23257|NCT01730040|111285|P6|Overall Study|Adverse Event|1
23258|NCT01730040|111286|P5|Overall Study|Adverse Event|1
23259|NCT01730040|111287|P4|Overall Study|Adverse Event|3
23260|NCT01730040|111288|P3|Overall Study|Adverse Event|5
23261|NCT01730040|111289|P2|Overall Study|Adverse Event|3
23262|NCT01730040|111290|P1|Overall Study|Adverse Event|4
23263|NCT01730040|111284|P7|Overall Study|Other than specified|4
23264|NCT01730040|111285|P6|Overall Study|Other than specified|4
23265|NCT01730040|111286|P5|Overall Study|Other than specified|5
23266|NCT01730040|111287|P4|Overall Study|Other than specified|5
23267|NCT01730040|111288|P3|Overall Study|Other than specified|5
23268|NCT01730040|111289|P2|Overall Study|Other than specified|8
23269|NCT01730040|111290|P1|Overall Study|Other than specified|7
23270|NCT01730040|111284|P7|Overall Study|Physician Decision|1
23271|NCT01730040|111285|P6|Overall Study|Physician Decision|1
23272|NCT01730040|111286|P5|Overall Study|Physician Decision|0
23273|NCT01730040|111287|P4|Overall Study|Physician Decision|0
23274|NCT01730040|111288|P3|Overall Study|Physician Decision|0
23275|NCT01730040|111289|P2|Overall Study|Physician Decision|0
23276|NCT01730040|111290|P1|Overall Study|Physician Decision|0
23277|NCT01730040|111284|P7|Overall Study|Subject moved|1
23278|NCT01730040|111285|P6|Overall Study|Subject moved|0
23279|NCT01730040|111286|P5|Overall Study|Subject moved|0
23280|NCT01730040|111287|P4|Overall Study|Subject moved|0
23281|NCT01730040|111288|P3|Overall Study|Subject moved|1
23282|NCT01730040|111289|P2|Overall Study|Subject moved|0
23283|NCT01730040|111290|P1|Overall Study|Subject moved|0
23284|NCT01730040|111284|P7|Overall Study|Randomized but not treated|0
23285|NCT01730040|111285|P6|Overall Study|Randomized but not treated|1
23286|NCT01730040|111286|P5|Overall Study|Randomized but not treated|0
23287|NCT01730040|111287|P4|Overall Study|Randomized but not treated|0
23288|NCT01730040|111288|P3|Overall Study|Randomized but not treated|0
23289|NCT01730040|111289|P2|Overall Study|Randomized but not treated|0
23290|NCT01730040|111290|P1|Overall Study|Randomized but not treated|0
23291|NCT01729871|111469|P2|Overall Study|Unspecified|9
23292|NCT01729871|111470|P1|Overall Study|Unspecified|4
23293|NCT01729871|111469|P2|Overall Study|Withdrawal by Subject|3
23294|NCT01729871|111470|P1|Overall Study|Withdrawal by Subject|0
23295|NCT01729871|111469|P2|Overall Study|Protocol Violation|0
23296|NCT01729871|111470|P1|Overall Study|Protocol Violation|1
23297|NCT01729871|111469|P2|Overall Study|Physician Decision|2
23298|NCT01729871|111470|P1|Overall Study|Physician Decision|0
23299|NCT01729871|111469|P2|Overall Study|Lack of Efficacy|1
23300|NCT01729871|111470|P1|Overall Study|Lack of Efficacy|0
23301|NCT01729871|111469|P2|Overall Study|Death|1
23302|NCT01729871|111470|P1|Overall Study|Death|0
23303|NCT01729871|111469|P2|Overall Study|Adverse Event|7
23304|NCT01729871|111470|P1|Overall Study|Adverse Event|7
23305|NCT01729728|111489|P3|Overall Study|Protocol Violation|1
23306|NCT01729728|111490|P2|Overall Study|Protocol Violation|0
23307|NCT01729728|111491|P1|Overall Study|Protocol Violation|1
23308|NCT01729728|111489|P3|Overall Study|Adverse Event|0
23309|NCT01729728|111490|P2|Overall Study|Adverse Event|6
23310|NCT01729728|111491|P1|Overall Study|Adverse Event|0
23311|NCT01729559|111624|P2|Overall Study|Protocol Violation|28
23312|NCT01729559|111625|P1|Overall Study|Protocol Violation|31
23313|NCT01729026|111668|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
23314|NCT01729026|111669|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
23315|NCT01729026|111668|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
23316|NCT01729026|111669|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
23317|NCT01728792|111680|P5|Overall Study|Lost to Follow-up|0
23318|NCT01728792|111681|P4|Overall Study|Lost to Follow-up|2
23319|NCT01728792|111682|P3|Overall Study|Lost to Follow-up|4
23320|NCT01728792|111683|P2|Overall Study|Lost to Follow-up|1
23321|NCT01728792|111684|P1|Overall Study|Lost to Follow-up|2
23322|NCT01728792|111680|P5|Overall Study|Withdrawal of Consent|0
23323|NCT01728792|111681|P4|Overall Study|Withdrawal of Consent|1
23324|NCT01728792|111682|P3|Overall Study|Withdrawal of Consent|0
23325|NCT01728792|111683|P2|Overall Study|Withdrawal of Consent|1
23326|NCT01728792|111684|P1|Overall Study|Withdrawal of Consent|1
23327|NCT01728584|111735|P4|Overall Study|Other reason (not specified)|1
23328|NCT01728584|111736|P3|Overall Study|Other reason (not specified)|0
23329|NCT01728584|111737|P2|Overall Study|Other reason (not specified)|0
23330|NCT01728584|111738|P1|Overall Study|Other reason (not specified)|1
23331|NCT01728584|111735|P4|Overall Study|Screen failure|0
23332|NCT01728584|111736|P3|Overall Study|Screen failure|0
23333|NCT01728584|111737|P2|Overall Study|Screen failure|0
23334|NCT01728584|111738|P1|Overall Study|Screen failure|1
23335|NCT01728584|111735|P4|Overall Study|Withdrawal by Subject|0
23336|NCT01728584|111736|P3|Overall Study|Withdrawal by Subject|0
23337|NCT01728584|111737|P2|Overall Study|Withdrawal by Subject|0
23338|NCT01728584|111738|P1|Overall Study|Withdrawal by Subject|1
23339|NCT01728584|111735|P4|Overall Study|Physician Decision|0
23340|NCT01728584|111736|P3|Overall Study|Physician Decision|1
23341|NCT01728584|111737|P2|Overall Study|Physician Decision|0
23342|NCT01728584|111738|P1|Overall Study|Physician Decision|4
23343|NCT01728584|111735|P4|Overall Study|Adverse Event|0
23344|NCT01728584|111736|P3|Overall Study|Adverse Event|0
23345|NCT01728584|111737|P2|Overall Study|Adverse Event|0
23346|NCT01728584|111738|P1|Overall Study|Adverse Event|1
23347|NCT01728376|111796|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
23348|NCT01728376|111797|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
23349|NCT01728376|111798|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
23350|NCT01728376|111799|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
23351|NCT01728376|111800|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
23352|NCT01728376|111801|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
23353|NCT01728376|111796|P6|Overall Study|Did not receive treatment|0
23354|NCT01728376|111797|P5|Overall Study|Did not receive treatment|0
23355|NCT01728376|111798|P4|Overall Study|Did not receive treatment|0
23356|NCT01728376|111799|P3|Overall Study|Did not receive treatment|0
23357|NCT01728376|111800|P2|Overall Study|Did not receive treatment|1
23358|NCT01728376|111801|P1|Overall Study|Did not receive treatment|0
23359|NCT01728376|111796|P6|Overall Study|No relevant bacteria|1
23360|NCT01728376|111797|P5|Overall Study|No relevant bacteria|1
23361|NCT01728376|111798|P4|Overall Study|No relevant bacteria|0
23362|NCT01728376|111799|P3|Overall Study|No relevant bacteria|0
23363|NCT01728376|111800|P2|Overall Study|No relevant bacteria|0
23364|NCT01728376|111801|P1|Overall Study|No relevant bacteria|2
23365|NCT01728376|111796|P6|Overall Study|Persistent Positive Blood Cultures|0
23366|NCT01728376|111797|P5|Overall Study|Persistent Positive Blood Cultures|0
23367|NCT01728376|111798|P4|Overall Study|Persistent Positive Blood Cultures|0
23368|NCT01728376|111799|P3|Overall Study|Persistent Positive Blood Cultures|1
23369|NCT01728376|111800|P2|Overall Study|Persistent Positive Blood Cultures|0
23370|NCT01728376|111801|P1|Overall Study|Persistent Positive Blood Cultures|1
23371|NCT01728376|111796|P6|Overall Study|Adverse Event|0
23372|NCT01728376|111797|P5|Overall Study|Adverse Event|1
23373|NCT01728376|111798|P4|Overall Study|Adverse Event|1
23374|NCT01728376|111799|P3|Overall Study|Adverse Event|1
23375|NCT01728376|111800|P2|Overall Study|Adverse Event|1
23376|NCT01728376|111801|P1|Overall Study|Adverse Event|1
23377|NCT01728324|111874|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
23378|NCT01728324|111875|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
23379|NCT01728324|111876|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
23380|NCT01728324|111874|P3|Termination of RBV|Adverse Event (Placebo Period)|0
23381|NCT01728324|111875|P2|Termination of RBV|Adverse Event (Placebo Period)|1
23382|NCT01728324|111876|P1|Termination of RBV|Adverse Event (Placebo Period)|0
23383|NCT01728324|111874|P3|Termination of RBV|Other than stated|1
23384|NCT01728324|111875|P2|Termination of RBV|Other than stated|3
23385|NCT01728324|111876|P1|Termination of RBV|Other than stated|1
23386|NCT01728324|111874|P3|Termination of RBV|Withdrawal by Subject|2
23387|NCT01728324|111875|P2|Termination of RBV|Withdrawal by Subject|5
23388|NCT01728324|111876|P1|Termination of RBV|Withdrawal by Subject|9
23389|NCT01728324|111874|P3|Termination of RBV|Lack of Efficacy|7
23390|NCT01728324|111875|P2|Termination of RBV|Lack of Efficacy|11
23391|NCT01728324|111876|P1|Termination of RBV|Lack of Efficacy|14
23392|NCT01728324|111874|P3|Termination of RBV|Adverse Event|5
23393|NCT01728324|111875|P2|Termination of RBV|Adverse Event|16
23394|NCT01728324|111876|P1|Termination of RBV|Adverse Event|15
23395|NCT01728324|111874|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
23396|NCT01728324|111875|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
23397|NCT01728324|111876|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
23398|NCT01728324|111874|P3|Termination of FDV|Adverse Event (Placebo Period)|0
23399|NCT01728324|111875|P2|Termination of FDV|Adverse Event (Placebo Period)|1
23400|NCT01728324|111876|P1|Termination of FDV|Adverse Event (Placebo Period)|0
23401|NCT01728324|111874|P3|Termination of FDV|Other than stated|0
23402|NCT01728324|111875|P2|Termination of FDV|Other than stated|3
23403|NCT01728324|111876|P1|Termination of FDV|Other than stated|1
23404|NCT01728324|111874|P3|Termination of FDV|Withdrawal by Subject|2
23405|NCT01728324|111875|P2|Termination of FDV|Withdrawal by Subject|6
23406|NCT01728324|111876|P1|Termination of FDV|Withdrawal by Subject|9
23407|NCT01728324|111874|P3|Termination of FDV|Lack of Efficacy|8
23408|NCT01728324|111875|P2|Termination of FDV|Lack of Efficacy|12
23409|NCT01728324|111876|P1|Termination of FDV|Lack of Efficacy|14
23410|NCT01728324|111874|P3|Termination of FDV|Adverse Event|4
23411|NCT01728324|111875|P2|Termination of FDV|Adverse Event|13
23412|NCT01728324|111876|P1|Termination of FDV|Adverse Event|14
23413|NCT01728324|111874|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
23414|NCT01728324|111875|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
23415|NCT01728324|111876|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
23416|NCT01728324|111874|P3|Termination of DBV|Adverse Event (Placebo Period)|0
23417|NCT01728324|111875|P2|Termination of DBV|Adverse Event (Placebo Period)|1
23418|NCT01728324|111876|P1|Termination of DBV|Adverse Event (Placebo Period)|0
23419|NCT01728324|111874|P3|Termination of DBV|Other than stated|0
23420|NCT01728324|111875|P2|Termination of DBV|Other than stated|3
23421|NCT01728324|111876|P1|Termination of DBV|Other than stated|1
23422|NCT01728324|111874|P3|Termination of DBV|Withdrawal by Subject|2
23423|NCT01728324|111875|P2|Termination of DBV|Withdrawal by Subject|6
23424|NCT01728324|111876|P1|Termination of DBV|Withdrawal by Subject|9
23425|NCT01728324|111874|P3|Termination of DBV|Lack of Efficacy|8
23426|NCT01728324|111875|P2|Termination of DBV|Lack of Efficacy|12
23427|NCT01728324|111876|P1|Termination of DBV|Lack of Efficacy|14
23428|NCT01728324|111874|P3|Termination of DBV|Adverse Event|4
23429|NCT01728324|111875|P2|Termination of DBV|Adverse Event|13
23430|NCT01728324|111876|P1|Termination of DBV|Adverse Event|14
23431|NCT01728246|111897|P2|Overall Study|Adverse Event|5
23432|NCT01728246|111898|P1|Overall Study|Adverse Event|8
23433|NCT01728246|111897|P2|Overall Study|Lack of Efficacy|1
23434|NCT01728246|111898|P1|Overall Study|Lack of Efficacy|1
23435|NCT01728246|111897|P2|Overall Study|Lost to Follow-up|22
23436|NCT01728246|111898|P1|Overall Study|Lost to Follow-up|23
23437|NCT01728246|111897|P2|Overall Study|Withdrawal by Subject|3
23438|NCT01728246|111898|P1|Overall Study|Withdrawal by Subject|2
23439|NCT01728246|111897|P2|Overall Study|Protocol Violation|0
23440|NCT01728246|111898|P1|Overall Study|Protocol Violation|1
23441|NCT01728246|111897|P2|Overall Study|Participant needed rescue medication|5
23442|NCT01728246|111898|P1|Overall Study|Participant needed rescue medication|1
23443|NCT01728116|111916|P2|Overall Study|various not noted previously|0
23444|NCT01728116|111917|P1|Overall Study|various not noted previously|5
23445|NCT01728116|111916|P2|Overall Study|Incorrectly enrolled in Study|1
23446|NCT01728116|111917|P1|Overall Study|Incorrectly enrolled in Study|0
23447|NCT01728116|111916|P2|Overall Study|Inter-current finding at procedure|0
23448|NCT01728116|111917|P1|Overall Study|Inter-current finding at procedure|1
23449|NCT01728116|111916|P2|Overall Study|Subject Non-Compliance|0
23450|NCT01728116|111917|P1|Overall Study|Subject Non-Compliance|2
23451|NCT01728116|111916|P2|Overall Study|Physician Decision|0
23452|NCT01728116|111917|P1|Overall Study|Physician Decision|2
23453|NCT01728116|111916|P2|Overall Study|Lost to Follow-up|2
23454|NCT01728116|111917|P1|Overall Study|Lost to Follow-up|9
23455|NCT01728116|111916|P2|Overall Study|Procedure/device failure|0
23456|NCT01728116|111917|P1|Overall Study|Procedure/device failure|7
23457|NCT01728116|111916|P2|Overall Study|Adverse Event|0
23458|NCT01728116|111917|P1|Overall Study|Adverse Event|13
23459|NCT01728116|111916|P2|Overall Study|Withdrawal by Subject|9
23460|NCT01728116|111917|P1|Overall Study|Withdrawal by Subject|16
23461|NCT01728116|111916|P2|Overall Study|Sponsor Terminated Study|35
23462|NCT01728116|111917|P1|Overall Study|Sponsor Terminated Study|106
23463|NCT01728077|111942|P2|Overall Study|Non compliance|0
23464|NCT01728077|111943|P1|Overall Study|Non compliance|1
23465|NCT01728077|111942|P2|Overall Study|Patient moving|0
23466|NCT01728077|111943|P1|Overall Study|Patient moving|1
23467|NCT01728077|111942|P2|Overall Study|Death|1
23468|NCT01728077|111943|P1|Overall Study|Death|0
23469|NCT01728077|111942|P2|Overall Study|Subject choice|3
23470|NCT01728077|111943|P1|Overall Study|Subject choice|2
23471|NCT01728077|111942|P2|Overall Study|Lost to Follow-up|0
23472|NCT01728077|111943|P1|Overall Study|Lost to Follow-up|1
23473|NCT01728077|111942|P2|Overall Study|Lack of Efficacy|1
23474|NCT01728077|111943|P1|Overall Study|Lack of Efficacy|3
23475|NCT01727713|111995|P1|Overall Study|Protocol Deviation|2
23476|NCT01727713|111995|P1|Overall Study|Withdrawal by Subject|13
23477|NCT01727713|111995|P1|Overall Study|Participant Met Withdrawal Criteria|5
23478|NCT01727713|111995|P1|Overall Study|Adverse Event|10
23479|NCT01727713|111995|P1|Overall Study|Lost to Follow-up|5
23480|NCT01727700|112022|P3|Overall Study|Protocol Violation|0
23481|NCT01727700|112023|P2|Overall Study|Protocol Violation|0
23482|NCT01727700|112024|P1|Overall Study|Protocol Violation|2
23483|NCT01727700|112022|P3|Overall Study|Particpant withdrew consent|1
23484|NCT01727700|112023|P2|Overall Study|Particpant withdrew consent|3
23485|NCT01727700|112024|P1|Overall Study|Particpant withdrew consent|0
23486|NCT01727700|112022|P3|Overall Study|Adverse Event|1
23487|NCT01727700|112023|P2|Overall Study|Adverse Event|7
23488|NCT01727700|112024|P1|Overall Study|Adverse Event|0
23489|NCT01727505|112047|P2|Second 24 Hours|Missing data|1
23490|NCT01727505|112048|P1|Second 24 Hours|Missing data|0
23491|NCT01727505|112047|P2|First 24 Hours|Adverse Event|1
23492|NCT01727505|112048|P1|First 24 Hours|Adverse Event|0
23493|NCT01727258|112076|P3|Overall Study|Lost to Follow-up|0
23494|NCT01727258|112077|P2|Overall Study|Lost to Follow-up|0
23495|NCT01727258|112078|P1|Overall Study|Lost to Follow-up|1
23496|NCT01727258|112076|P3|Overall Study|Withdrawal by Subject|0
23497|NCT01727258|112077|P2|Overall Study|Withdrawal by Subject|1
23498|NCT01727258|112078|P1|Overall Study|Withdrawal by Subject|1
23499|NCT01727258|112076|P3|Overall Study|Noncompliance with Study Drug|1
23500|NCT01727258|112077|P2|Overall Study|Noncompliance with Study Drug|0
23501|NCT01727258|112078|P1|Overall Study|Noncompliance with Study Drug|0
23502|NCT01727258|112076|P3|Overall Study|Adverse Event|0
23503|NCT01727258|112077|P2|Overall Study|Adverse Event|2
23504|NCT01727258|112078|P1|Overall Study|Adverse Event|0
23505|NCT01727141|112120|P4|Overall Study|Withdrawal by Subject|11
23506|NCT01727141|112121|P3|Overall Study|Withdrawal by Subject|2
23507|NCT01727141|112122|P2|Overall Study|Withdrawal by Subject|4
23508|NCT01727141|112123|P1|Overall Study|Withdrawal by Subject|4
23509|NCT01727141|112120|P4|Overall Study|Protocol deviation|1
23510|NCT01727141|112121|P3|Overall Study|Protocol deviation|0
23511|NCT01727141|112122|P2|Overall Study|Protocol deviation|1
23512|NCT01727141|112123|P1|Overall Study|Protocol deviation|1
23513|NCT01727141|112120|P4|Overall Study|Death|1
23514|NCT01727141|112121|P3|Overall Study|Death|1
23515|NCT01727141|112122|P2|Overall Study|Death|1
23516|NCT01727141|112123|P1|Overall Study|Death|0
23517|NCT01727141|112120|P4|Overall Study|Lost to Follow-up|0
23518|NCT01727141|112121|P3|Overall Study|Lost to Follow-up|0
23519|NCT01727141|112122|P2|Overall Study|Lost to Follow-up|2
23520|NCT01727141|112123|P1|Overall Study|Lost to Follow-up|0
23521|NCT01727141|112120|P4|Overall Study|Physician Decision|2
23522|NCT01727141|112121|P3|Overall Study|Physician Decision|0
23523|NCT01727141|112122|P2|Overall Study|Physician Decision|1
23524|NCT01727141|112123|P1|Overall Study|Physician Decision|0
23525|NCT01727024|112173|P2|Period 1|Withdrawal by Subject|3
23526|NCT01727024|112174|P1|Period 1|Withdrawal by Subject|2
23527|NCT01727024|112173|P2|Period 1|Lost to Follow-up|1
23528|NCT01727024|112174|P1|Period 1|Lost to Follow-up|1
23529|NCT01726517|112196|P5|Overall Study|Withdrawal by Subject|0
23530|NCT01726517|112197|P4|Overall Study|Withdrawal by Subject|0
23531|NCT01726517|112198|P3|Overall Study|Withdrawal by Subject|1
23532|NCT01726517|112199|P2|Overall Study|Withdrawal by Subject|0
23533|NCT01726517|112200|P1|Overall Study|Withdrawal by Subject|0
23534|NCT01726335|112256|P1|Overall Study|Exacerbation of psychotic symptoms|1
23535|NCT01726335|112256|P1|Overall Study|Lost to Follow-up|2
23536|NCT01726335|112256|P1|Overall Study|Adverse Event|4
23537|NCT01726335|112256|P1|Overall Study|Withdrawal by Subject|15
23538|NCT01726335|112256|P1|Overall Study|Lost to Follow-up|2
23539|NCT01726049|112274|P2|Overall Study|refused second HC|2
23540|NCT01726049|112275|P1|Overall Study|refused second HC|0
23541|NCT01726049|112274|P2|Overall Study|Adverse Event|1
23542|NCT01726049|112275|P1|Overall Study|Adverse Event|4
23543|NCT01726049|112274|P2|Overall Study|Death|1
23544|NCT01726049|112275|P1|Overall Study|Death|1
23545|NCT01726023|112289|P2|Overall Study|Withdrawal by Subject|8
23546|NCT01726023|112290|P1|Overall Study|Withdrawal by Subject|16
23547|NCT01726023|112289|P2|Overall Study|Other Eligibility criteria|7
23548|NCT01726023|112290|P1|Overall Study|Other Eligibility criteria|7
23549|NCT01726023|112289|P2|Overall Study|Lost to Follow-up|10
23550|NCT01726023|112290|P1|Overall Study|Lost to Follow-up|5
23551|NCT01726023|112289|P2|Overall Study|Death|1
23552|NCT01726023|112290|P1|Overall Study|Death|1
23553|NCT01725529|112410|P3|Overall Study|Withdrawal by Subject|8
23554|NCT01725529|112411|P2|Overall Study|Withdrawal by Subject|14
23555|NCT01725529|112412|P1|Overall Study|Withdrawal by Subject|12
23556|NCT01725529|112410|P3|Overall Study|Protocol Violation|1
23557|NCT01725529|112411|P2|Overall Study|Protocol Violation|1
23558|NCT01725529|112412|P1|Overall Study|Protocol Violation|0
23559|NCT01725529|112410|P3|Overall Study|Lost to Follow-up|1
23560|NCT01725529|112411|P2|Overall Study|Lost to Follow-up|1
23561|NCT01725529|112412|P1|Overall Study|Lost to Follow-up|2
23562|NCT01725529|112410|P3|Overall Study|Adverse Event|0
23563|NCT01725529|112411|P2|Overall Study|Adverse Event|0
23564|NCT01725529|112412|P1|Overall Study|Adverse Event|1
23565|NCT01725451|112438|P4|Period 4|Adverse Event|0
23566|NCT01725451|112439|P3|Period 4|Adverse Event|1
23567|NCT01725451|112440|P2|Period 4|Adverse Event|0
23568|NCT01725451|112441|P1|Period 4|Adverse Event|0
23569|NCT01725451|112438|P4|Washout From Period 3|Adverse Event|0
23570|NCT01725451|112439|P3|Washout From Period 3|Adverse Event|0
23571|NCT01725451|112440|P2|Washout From Period 3|Adverse Event|1
23572|NCT01725451|112441|P1|Washout From Period 3|Adverse Event|0
23573|NCT01725451|112438|P4|Washout From Period 3|Protocol Violation|0
23574|NCT01725451|112439|P3|Washout From Period 3|Protocol Violation|1
23575|NCT01725451|112440|P2|Washout From Period 3|Protocol Violation|0
23576|NCT01725451|112441|P1|Washout From Period 3|Protocol Violation|0
23577|NCT01725451|112438|P4|Period 1|Withdrawal by Subject|0
23578|NCT01725451|112439|P3|Period 1|Withdrawal by Subject|0
23579|NCT01725451|112440|P2|Period 1|Withdrawal by Subject|0
23580|NCT01725451|112441|P1|Period 1|Withdrawal by Subject|1
23581|NCT01725386|112463|P2|Overall Study|Withdrawal by Subject|0
23582|NCT01725386|112464|P1|Overall Study|Withdrawal by Subject|10
23583|NCT01725386|112463|P2|Overall Study|Lost to Follow-up|6
23584|NCT01725386|112464|P1|Overall Study|Lost to Follow-up|81
23585|NCT01725386|112463|P2|Overall Study|Death|40
23586|NCT01725386|112464|P1|Overall Study|Death|84
23587|NCT01725308|112483|P3|Overall Study|Miscellaneous|3
23588|NCT01725308|112484|P2|Overall Study|Miscellaneous|0
23589|NCT01725308|112485|P1|Overall Study|Miscellaneous|2
23590|NCT01725308|112483|P3|Overall Study|Protocol Deviations|1
23591|NCT01725308|112484|P2|Overall Study|Protocol Deviations|1
23592|NCT01725308|112485|P1|Overall Study|Protocol Deviations|3
23593|NCT01725308|112483|P3|Overall Study|Lost to Follow-up|2
23594|NCT01725308|112484|P2|Overall Study|Lost to Follow-up|2
23595|NCT01725308|112485|P1|Overall Study|Lost to Follow-up|3
23596|NCT01725308|112483|P3|Overall Study|Subject Consent Withdrawal|5
23597|NCT01725308|112484|P2|Overall Study|Subject Consent Withdrawal|7
23598|NCT01725308|112485|P1|Overall Study|Subject Consent Withdrawal|12
23599|NCT01725308|112483|P3|Overall Study|Episode Change|2
23600|NCT01725308|112484|P2|Overall Study|Episode Change|0
23601|NCT01725308|112485|P1|Overall Study|Episode Change|3
23602|NCT01725308|112483|P3|Overall Study|Worsening of Underlying Disease|2
23603|NCT01725308|112484|P2|Overall Study|Worsening of Underlying Disease|0
23604|NCT01725308|112485|P1|Overall Study|Worsening of Underlying Disease|8
23605|NCT01725308|112483|P3|Overall Study|Lack of Efficacy|5
23606|NCT01725308|112484|P2|Overall Study|Lack of Efficacy|0
23607|NCT01725308|112485|P1|Overall Study|Lack of Efficacy|7
23608|NCT01725308|112483|P3|Overall Study|Adverse Event|21
23609|NCT01725308|112484|P2|Overall Study|Adverse Event|4
23610|NCT01725308|112485|P1|Overall Study|Adverse Event|5
23611|NCT01725308|112483|P3|Overall Study|Did Not Receive Drug|0
23612|NCT01725308|112484|P2|Overall Study|Did Not Receive Drug|0
23613|NCT01725308|112485|P1|Overall Study|Did Not Receive Drug|1
23614|NCT01725282|112539|P4|Overall Study|Lack of Efficacy|1
23615|NCT01725282|112540|P3|Overall Study|Lack of Efficacy|0
23616|NCT01725282|112541|P2|Overall Study|Lack of Efficacy|1
23617|NCT01725282|112542|P1|Overall Study|Lack of Efficacy|0
23618|NCT01725282|112539|P4|Overall Study|Withdrawal by Subject|1
23619|NCT01725282|112540|P3|Overall Study|Withdrawal by Subject|1
23620|NCT01725282|112541|P2|Overall Study|Withdrawal by Subject|0
23621|NCT01725282|112542|P1|Overall Study|Withdrawal by Subject|0
23622|NCT01725282|112539|P4|Overall Study|Study Site Withdrawal|0
23623|NCT01725282|112540|P3|Overall Study|Study Site Withdrawal|0
23624|NCT01725282|112541|P2|Overall Study|Study Site Withdrawal|1
23625|NCT01725282|112542|P1|Overall Study|Study Site Withdrawal|0
23626|NCT01725282|112539|P4|Overall Study|Met Exclusion Criteria|0
23627|NCT01725282|112540|P3|Overall Study|Met Exclusion Criteria|1
23628|NCT01725282|112541|P2|Overall Study|Met Exclusion Criteria|0
23629|NCT01725282|112542|P1|Overall Study|Met Exclusion Criteria|0
23630|NCT01725282|112539|P4|Overall Study|Exacerbation of Target Disease|1
23631|NCT01725282|112540|P3|Overall Study|Exacerbation of Target Disease|0
23632|NCT01725282|112541|P2|Overall Study|Exacerbation of Target Disease|0
23633|NCT01725282|112542|P1|Overall Study|Exacerbation of Target Disease|1
23634|NCT01725282|112539|P4|Overall Study|Adverse Event|4
23635|NCT01725282|112540|P3|Overall Study|Adverse Event|6
23636|NCT01725282|112541|P2|Overall Study|Adverse Event|3
23637|NCT01725282|112542|P1|Overall Study|Adverse Event|1
23638|NCT01725217|112575|P3|Overall Study|Withdrawal by Subject|0
23639|NCT01725217|112576|P2|Overall Study|Withdrawal by Subject|0
23640|NCT01725217|112577|P1|Overall Study|Withdrawal by Subject|1
23641|NCT01724528|112607|P2|Overall Study|Patient refused to attend last visit|0
23642|NCT01724528|112608|P1|Overall Study|Patient refused to attend last visit|1
23643|NCT01724528|112607|P2|Overall Study|Protocol Violation|1
23644|NCT01724528|112608|P1|Overall Study|Protocol Violation|0
23645|NCT01724528|112607|P2|Overall Study|Withdrawal by Subject|2
23646|NCT01724528|112608|P1|Overall Study|Withdrawal by Subject|0
23647|NCT01724528|112607|P2|Overall Study|Death|0
23648|NCT01724528|112608|P1|Overall Study|Death|3
23649|NCT01724359|112622|P1|Overall Study|Not specified|20
23650|NCT01724359|112622|P1|Overall Study|Death|1
23651|NCT01724359|112622|P1|Overall Study|Adverse Event|10
23652|NCT01724216|112635|P1|Overall Study|Scan was not completed|1
23653|NCT01724177|112639|P1|Overall Study|Unspecified|2
23654|NCT01724177|112639|P1|Overall Study|Progressive disease or Relapsed Disease|13
23655|NCT01724177|112639|P1|Overall Study|Adverse Event|6
23656|NCT01724021|112651|P2|Overall Study|Reason Not Specified|9
23657|NCT01724021|112652|P1|Overall Study|Reason Not Specified|6
23658|NCT01724021|112651|P2|Overall Study|Lack of Compliance|1
23659|NCT01724021|112652|P1|Overall Study|Lack of Compliance|0
23660|NCT01724021|112651|P2|Overall Study|Lost to Follow-up|7
23661|NCT01724021|112652|P1|Overall Study|Lost to Follow-up|0
23662|NCT01724021|112651|P2|Overall Study|Participant request/ Withdrew consent|10
23663|NCT01724021|112652|P1|Overall Study|Participant request/ Withdrew consent|13
23664|NCT01724021|112651|P2|Overall Study|Death|29
23665|NCT01724021|112652|P1|Overall Study|Death|24
23666|NCT01724021|112651|P2|Overall Study|Adverse Event|4
23667|NCT01724021|112652|P1|Overall Study|Adverse Event|5
23668|NCT01723904|112684|P1|Overall Study|Unable to follow protocol/ judged by inv|3
23669|NCT01723904|112684|P1|Overall Study|Adverse Event|5
23670|NCT01723904|112684|P1|Overall Study|Noncompliant|3
23671|NCT01723397|112705|P2|Study Period 2|Protocol Violation|1
23672|NCT01723397|112706|P1|Study Period 2|Protocol Violation|0
23673|NCT01723397|112705|P2|Study Period 1|Protocol Violation|1
23674|NCT01723397|112706|P1|Study Period 1|Protocol Violation|0
23675|NCT01723254|112720|P8|Overall Study|Withdrawal by Subject|2
23676|NCT01723254|112721|P7|Overall Study|Withdrawal by Subject|1
23677|NCT01723254|112722|P6|Overall Study|Withdrawal by Subject|1
23678|NCT01723254|112723|P5|Overall Study|Withdrawal by Subject|1
23679|NCT01723254|112724|P4|Overall Study|Withdrawal by Subject|0
23680|NCT01723254|112725|P3|Overall Study|Withdrawal by Subject|1
23681|NCT01723254|112726|P2|Overall Study|Withdrawal by Subject|2
23682|NCT01723254|112727|P1|Overall Study|Withdrawal by Subject|1
23683|NCT01723254|112720|P8|Overall Study|Protocol Violation|0
23684|NCT01723254|112721|P7|Overall Study|Protocol Violation|0
23685|NCT01723254|112722|P6|Overall Study|Protocol Violation|0
23686|NCT01723254|112723|P5|Overall Study|Protocol Violation|0
23687|NCT01723254|112724|P4|Overall Study|Protocol Violation|0
23688|NCT01723254|112725|P3|Overall Study|Protocol Violation|0
23689|NCT01723254|112726|P2|Overall Study|Protocol Violation|1
23690|NCT01723254|112727|P1|Overall Study|Protocol Violation|0
23691|NCT01723254|112720|P8|Overall Study|Move/Left to another country/city|0
23692|NCT01723254|112721|P7|Overall Study|Move/Left to another country/city|0
23693|NCT01723254|112722|P6|Overall Study|Move/Left to another country/city|0
23694|NCT01723254|112723|P5|Overall Study|Move/Left to another country/city|1
23695|NCT01723254|112724|P4|Overall Study|Move/Left to another country/city|1
23696|NCT01723254|112725|P3|Overall Study|Move/Left to another country/city|2
23697|NCT01723254|112726|P2|Overall Study|Move/Left to another country/city|0
23698|NCT01723254|112727|P1|Overall Study|Move/Left to another country/city|0
23699|NCT01723254|112720|P8|Overall Study|No longer have time to participate|0
23700|NCT01723254|112721|P7|Overall Study|No longer have time to participate|0
23701|NCT01723254|112722|P6|Overall Study|No longer have time to participate|0
23702|NCT01723254|112723|P5|Overall Study|No longer have time to participate|0
23703|NCT01723254|112724|P4|Overall Study|No longer have time to participate|1
23704|NCT01723254|112725|P3|Overall Study|No longer have time to participate|0
23705|NCT01723254|112726|P2|Overall Study|No longer have time to participate|0
23706|NCT01723254|112727|P1|Overall Study|No longer have time to participate|0
23707|NCT01723254|112720|P8|Overall Study|Personal issues|0
23708|NCT01723254|112721|P7|Overall Study|Personal issues|0
23709|NCT01723254|112722|P6|Overall Study|Personal issues|1
23710|NCT01723254|112723|P5|Overall Study|Personal issues|0
23711|NCT01723254|112724|P4|Overall Study|Personal issues|0
23712|NCT01723254|112725|P3|Overall Study|Personal issues|0
23713|NCT01723254|112726|P2|Overall Study|Personal issues|0
23714|NCT01723254|112727|P1|Overall Study|Personal issues|0
23715|NCT01723254|112720|P8|Overall Study|Conflict with work schedule|1
23716|NCT01723254|112721|P7|Overall Study|Conflict with work schedule|0
23717|NCT01723254|112722|P6|Overall Study|Conflict with work schedule|0
23718|NCT01723254|112723|P5|Overall Study|Conflict with work schedule|0
23719|NCT01723254|112724|P4|Overall Study|Conflict with work schedule|0
23720|NCT01723254|112725|P3|Overall Study|Conflict with work schedule|0
23721|NCT01723254|112726|P2|Overall Study|Conflict with work schedule|0
23722|NCT01723254|112727|P1|Overall Study|Conflict with work schedule|0
23723|NCT01723228|112779|P2|Overall Study|Not Specified|1
23724|NCT01723228|112780|P1|Overall Study|Not Specified|2
23725|NCT01723228|112779|P2|Overall Study|Lost to Follow-up|1
23726|NCT01723228|112780|P1|Overall Study|Lost to Follow-up|2
23727|NCT01723228|112779|P2|Overall Study|Protocol Violation|2
23728|NCT01723228|112780|P1|Overall Study|Protocol Violation|0
23729|NCT01723228|112779|P2|Overall Study|Withdrawal by Subject|1
23730|NCT01723228|112780|P1|Overall Study|Withdrawal by Subject|2
23731|NCT01723228|112779|P2|Overall Study|Adverse Event|6
23732|NCT01723228|112780|P1|Overall Study|Adverse Event|2
23733|NCT01722994|112798|P2|Overall Study|Missing data|17
23734|NCT01722994|112799|P1|Overall Study|Missing data|25
23735|NCT01722877|112813|P1|Overall Study|Lost to Follow-up|1
23736|NCT01722877|112813|P1|Overall Study|Death|1
23737|NCT01722266|112874|P4|Overall Study|Dropped out due to Nausea|0
23738|NCT01722266|112875|P3|Overall Study|Dropped out due to Nausea|2
23739|NCT01722266|112876|P2|Overall Study|Dropped out due to Nausea|0
23740|NCT01722266|112877|P1|Overall Study|Dropped out due to Nausea|0
23741|NCT01722266|112874|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
23742|NCT01722266|112875|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
23743|NCT01722266|112876|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
23744|NCT01722266|112877|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
23745|NCT01722266|112874|P4|Overall Study|Withdrawal by Subject|0
23746|NCT01722266|112875|P3|Overall Study|Withdrawal by Subject|0
23747|NCT01722266|112876|P2|Overall Study|Withdrawal by Subject|2
23748|NCT01722266|112877|P1|Overall Study|Withdrawal by Subject|1
23749|NCT01722162|112905|P2|Overall Study|Noncompliance|1
23750|NCT01722162|112906|P1|Overall Study|Noncompliance|0
23751|NCT01722162|112905|P2|Overall Study|Insurance denial post enrollment|1
23752|NCT01722162|112906|P1|Overall Study|Insurance denial post enrollment|0
23753|NCT01722162|112905|P2|Overall Study|Adverse Event|1
23754|NCT01722162|112906|P1|Overall Study|Adverse Event|1
23755|NCT01722162|112905|P2|Overall Study|Unrelated to study adverse event|2
23756|NCT01722162|112906|P1|Overall Study|Unrelated to study adverse event|2
23757|NCT01722162|112905|P2|Overall Study|Found ineligible|0
23758|NCT01722162|112906|P1|Overall Study|Found ineligible|1
23759|NCT01722162|112905|P2|Overall Study|Withdrawal by Subject|1
23760|NCT01722162|112906|P1|Overall Study|Withdrawal by Subject|1
23761|NCT01722097|112916|P2|Overall Study|Patient sheets not returned|5
23762|NCT01722097|112917|P1|Overall Study|Patient sheets not returned|6
23763|NCT01722071|112925|P2|Overall Study|Protocol Violation|0
23764|NCT01722071|112926|P1|Overall Study|Protocol Violation|1
23765|NCT01721772|112947|P2|Overall Study|Not specified|1
23766|NCT01721772|112948|P1|Overall Study|Not specified|0
23767|NCT01721772|112947|P2|Overall Study|Maximum clinical benefit|1
23768|NCT01721772|112948|P1|Overall Study|Maximum clinical benefit|1
23769|NCT01721772|112947|P2|Overall Study|Withdrawal by Subject|5
23770|NCT01721772|112948|P1|Overall Study|Withdrawal by Subject|7
23771|NCT01721772|112947|P2|Overall Study|Unrelated adverse event|3
23772|NCT01721772|112948|P1|Overall Study|Unrelated adverse event|2
23773|NCT01721772|112947|P2|Overall Study|Study drug toxicity|7
23774|NCT01721772|112948|P1|Overall Study|Study drug toxicity|5
23775|NCT01721772|112947|P2|Overall Study|Disease progression|175
23776|NCT01721772|112948|P1|Overall Study|Disease progression|96
23777|NCT01721759|112968|P1|Overall Study|Withdrawal by Subject|1
23778|NCT01721759|112968|P1|Overall Study|Adverse event unrelated to study drug|9
23779|NCT01721759|112968|P1|Overall Study|Study drug toxicity|14
23780|NCT01721759|112968|P1|Overall Study|Disease progression|78
23781|NCT01721746|112976|P3|Treatment Period|Unspecified|1
23782|NCT01721746|112977|P2|Treatment Period|Unspecified|1
23783|NCT01721746|112978|P1|Treatment Period|Unspecified|2
23784|NCT01721746|112976|P3|Treatment Period|Subject No Longer Met Study Criteria|0
23785|NCT01721746|112977|P2|Treatment Period|Subject No Longer Met Study Criteria|0
23786|NCT01721746|112978|P1|Treatment Period|Subject No Longer Met Study Criteria|4
23787|NCT01721746|112976|P3|Treatment Period|Poor/Non-compliance|0
23788|NCT01721746|112977|P2|Treatment Period|Poor/Non-compliance|0
23789|NCT01721746|112978|P1|Treatment Period|Poor/Non-compliance|1
23790|NCT01721746|112976|P3|Treatment Period|Maximum Clinical Benefit|3
23791|NCT01721746|112977|P2|Treatment Period|Maximum Clinical Benefit|0
23792|NCT01721746|112978|P1|Treatment Period|Maximum Clinical Benefit|1
23793|NCT01721746|112976|P3|Treatment Period|Subject Withdrew Consent|2
23794|NCT01721746|112977|P2|Treatment Period|Subject Withdrew Consent|0
23795|NCT01721746|112978|P1|Treatment Period|Subject Withdrew Consent|3
23796|NCT01721746|112976|P3|Treatment Period|Subject Request to Discontinue Treatment|6
23797|NCT01721746|112977|P2|Treatment Period|Subject Request to Discontinue Treatment|1
23798|NCT01721746|112978|P1|Treatment Period|Subject Request to Discontinue Treatment|19
23799|NCT01721746|112976|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
23800|NCT01721746|112977|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
23801|NCT01721746|112978|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
23802|NCT01721746|112976|P3|Treatment Period|Study Drug Toxicity|9
23803|NCT01721746|112977|P2|Treatment Period|Study Drug Toxicity|2
23804|NCT01721746|112978|P1|Treatment Period|Study Drug Toxicity|15
23805|NCT01721746|112976|P3|Treatment Period|Disease Progression|34
23806|NCT01721746|112977|P2|Treatment Period|Disease Progression|40
23807|NCT01721746|112978|P1|Treatment Period|Disease Progression|182
23808|NCT01721486|113001|P2|Overall Study|Physician Decision|1
23809|NCT01721486|113002|P1|Overall Study|Physician Decision|0
23810|NCT01721486|113001|P2|Overall Study|Protocol Violation|0
23811|NCT01721486|113002|P1|Overall Study|Protocol Violation|1
23812|NCT01721330|113016|P2|Overall Study|Withdrawal by Subject|1
23813|NCT01721330|113017|P1|Overall Study|Withdrawal by Subject|0
23814|NCT01721317|113025|P2|Overall Study|Withdrawal by Subject|1
23815|NCT01721317|113026|P1|Overall Study|Withdrawal by Subject|0
23816|NCT01721317|113025|P2|Overall Study|Physician Decision|1
23817|NCT01721317|113026|P1|Overall Study|Physician Decision|0
23818|NCT01721317|113025|P2|Overall Study|Study Closed / Terminated|2
23819|NCT01721317|113026|P1|Overall Study|Study Closed / Terminated|2
23820|NCT01721161|113105|P2|Overall Study|Not Specified|1
23821|NCT01721161|113106|P1|Overall Study|Not Specified|0
23822|NCT01721161|113105|P2|Overall Study|Withdrawal by Subject|1
23823|NCT01721161|113106|P1|Overall Study|Withdrawal by Subject|1
23824|NCT01721161|113105|P2|Overall Study|Lost to Follow-up|2
23825|NCT01721161|113106|P1|Overall Study|Lost to Follow-up|1
23826|NCT01721161|113105|P2|Overall Study|Adverse Event|3
23827|NCT01721161|113106|P1|Overall Study|Adverse Event|2
23828|NCT01721109|113129|P1|Extension Phase|Still on Study|35
23829|NCT01721109|113129|P1|Extension Phase|Non-Compliance with Study Drug|2
23830|NCT01721109|113129|P1|Main Phase|Non-Compliance with Study Drug|1
23831|NCT01721070|113235|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
23832|NCT01721057|113246|P7|Rescue Period|Lack of Efficacy|0
23833|NCT01721057|113247|P6|Rescue Period|Lack of Efficacy|0
23834|NCT01721057|113248|P5|Rescue Period|Lack of Efficacy|0
23835|NCT01721057|113249|P4|Rescue Period|Lack of Efficacy|2
23836|NCT01721057|113250|P3|Rescue Period|Lack of Efficacy|0
23837|NCT01721057|113251|P2|Rescue Period|Lack of Efficacy|0
23838|NCT01721057|113252|P1|Rescue Period|Lack of Efficacy|0
23839|NCT01721057|113246|P7|Rescue Period|Adverse Event|0
23840|NCT01721057|113247|P6|Rescue Period|Adverse Event|0
23841|NCT01721057|113248|P5|Rescue Period|Adverse Event|0
23842|NCT01721057|113249|P4|Rescue Period|Adverse Event|1
23843|NCT01721057|113250|P3|Rescue Period|Adverse Event|0
23844|NCT01721057|113251|P2|Rescue Period|Adverse Event|0
23845|NCT01721057|113252|P1|Rescue Period|Adverse Event|0
23846|NCT01721057|113246|P7|Treatment Period|Death|0
23847|NCT01721057|113247|P6|Treatment Period|Death|0
23848|NCT01721057|113248|P5|Treatment Period|Death|0
23849|NCT01721057|113249|P4|Treatment Period|Death|0
23850|NCT01721057|113250|P3|Treatment Period|Death|0
23851|NCT01721057|113251|P2|Treatment Period|Death|0
23852|NCT01721057|113252|P1|Treatment Period|Death|2
23853|NCT01721057|113246|P7|Treatment Period|Physician Decision|0
23854|NCT01721057|113247|P6|Treatment Period|Physician Decision|0
23855|NCT01721057|113248|P5|Treatment Period|Physician Decision|0
23856|NCT01721057|113249|P4|Treatment Period|Physician Decision|0
23857|NCT01721057|113250|P3|Treatment Period|Physician Decision|3
23858|NCT01721057|113251|P2|Treatment Period|Physician Decision|1
23859|NCT01721057|113252|P1|Treatment Period|Physician Decision|0
23860|NCT01721057|113246|P7|Treatment Period|Lost to Follow-up|0
23861|NCT01721057|113247|P6|Treatment Period|Lost to Follow-up|0
23862|NCT01721057|113248|P5|Treatment Period|Lost to Follow-up|0
23863|NCT01721057|113249|P4|Treatment Period|Lost to Follow-up|0
23864|NCT01721057|113250|P3|Treatment Period|Lost to Follow-up|0
23865|NCT01721057|113251|P2|Treatment Period|Lost to Follow-up|0
23866|NCT01721057|113252|P1|Treatment Period|Lost to Follow-up|1
23867|NCT01721057|113246|P7|Treatment Period|Lack of Efficacy|0
23868|NCT01721057|113247|P6|Treatment Period|Lack of Efficacy|0
23869|NCT01721057|113248|P5|Treatment Period|Lack of Efficacy|0
23870|NCT01721057|113249|P4|Treatment Period|Lack of Efficacy|0
23871|NCT01721057|113250|P3|Treatment Period|Lack of Efficacy|0
23872|NCT01721057|113251|P2|Treatment Period|Lack of Efficacy|3
23873|NCT01721057|113252|P1|Treatment Period|Lack of Efficacy|7
23874|NCT01721057|113246|P7|Treatment Period|Adverse Event|0
23875|NCT01721057|113247|P6|Treatment Period|Adverse Event|0
23876|NCT01721057|113248|P5|Treatment Period|Adverse Event|0
23877|NCT01721057|113249|P4|Treatment Period|Adverse Event|0
23878|NCT01721057|113250|P3|Treatment Period|Adverse Event|12
23879|NCT01721057|113251|P2|Treatment Period|Adverse Event|10
23880|NCT01721057|113252|P1|Treatment Period|Adverse Event|7
23881|NCT01721057|113246|P7|Treatment Period|Withdrawal by Subject|0
23882|NCT01721057|113247|P6|Treatment Period|Withdrawal by Subject|0
23883|NCT01721057|113248|P5|Treatment Period|Withdrawal by Subject|0
23884|NCT01721057|113249|P4|Treatment Period|Withdrawal by Subject|0
23885|NCT01721057|113250|P3|Treatment Period|Withdrawal by Subject|8
23886|NCT01721057|113251|P2|Treatment Period|Withdrawal by Subject|5
23887|NCT01721057|113252|P1|Treatment Period|Withdrawal by Subject|11
23888|NCT01720797|113324|P2|Overall Study|Withdrawal by Subject|0
23889|NCT01720797|113325|P1|Overall Study|Withdrawal by Subject|3
23890|NCT01720602|113331|P1|Overall Study|Progressive disease on therapy|2
23891|NCT01720602|113331|P1|Overall Study|Adverse Event|3
23892|NCT01720043|113399|P1|Overall Study|Withdrawal by Subject|1
23893|NCT01719861|113403|P1|Cycle 2|Death|1
23894|NCT01719861|113403|P1|Cycle 1|Death|4
23895|NCT01719757|113411|P1|Overall Study|well controlled pain|27
23896|NCT01719757|113411|P1|Overall Study|Protocol Violation|1
23897|NCT01719757|113411|P1|Overall Study|Lost to Follow-up|20
23898|NCT01719757|113411|P1|Overall Study|Withdrawal by Subject|15
23899|NCT01719757|113411|P1|Overall Study|Adverse Event|38
23900|NCT01719172|113450|P1|Overall Study|Death|1
23901|NCT01719172|113450|P1|Overall Study|Lost to Follow-up|1
23902|NCT01719003|113464|P9|Overall Study|Lack of Efficacy|0
23903|NCT01719003|113465|P8|Overall Study|Lack of Efficacy|0
23904|NCT01719003|113466|P7|Overall Study|Lack of Efficacy|1
23905|NCT01719003|113467|P6|Overall Study|Lack of Efficacy|0
23906|NCT01719003|113468|P5|Overall Study|Lack of Efficacy|0
23907|NCT01719003|113469|P4|Overall Study|Lack of Efficacy|0
23908|NCT01719003|113470|P3|Overall Study|Lack of Efficacy|0
23909|NCT01719003|113471|P2|Overall Study|Lack of Efficacy|0
23910|NCT01719003|113472|P1|Overall Study|Lack of Efficacy|0
23911|NCT01719003|113464|P9|Overall Study|Reason other than those specified|1
23912|NCT01719003|113465|P8|Overall Study|Reason other than those specified|3
23913|NCT01719003|113466|P7|Overall Study|Reason other than those specified|0
23914|NCT01719003|113467|P6|Overall Study|Reason other than those specified|1
23915|NCT01719003|113468|P5|Overall Study|Reason other than those specified|4
23916|NCT01719003|113469|P4|Overall Study|Reason other than those specified|3
23917|NCT01719003|113470|P3|Overall Study|Reason other than those specified|2
23918|NCT01719003|113471|P2|Overall Study|Reason other than those specified|0
23919|NCT01719003|113472|P1|Overall Study|Reason other than those specified|0
23920|NCT01719003|113464|P9|Overall Study|Refusal to continue, not due to AE|1
23921|NCT01719003|113465|P8|Overall Study|Refusal to continue, not due to AE|7
23922|NCT01719003|113466|P7|Overall Study|Refusal to continue, not due to AE|8
23923|NCT01719003|113467|P6|Overall Study|Refusal to continue, not due to AE|3
23924|NCT01719003|113468|P5|Overall Study|Refusal to continue, not due to AE|4
23925|NCT01719003|113469|P4|Overall Study|Refusal to continue, not due to AE|4
23926|NCT01719003|113470|P3|Overall Study|Refusal to continue, not due to AE|4
23927|NCT01719003|113471|P2|Overall Study|Refusal to continue, not due to AE|5
23928|NCT01719003|113472|P1|Overall Study|Refusal to continue, not due to AE|2
23929|NCT01719003|113464|P9|Overall Study|Lost to Follow-up|2
23930|NCT01719003|113465|P8|Overall Study|Lost to Follow-up|2
23931|NCT01719003|113466|P7|Overall Study|Lost to Follow-up|3
23932|NCT01719003|113467|P6|Overall Study|Lost to Follow-up|4
23933|NCT01719003|113468|P5|Overall Study|Lost to Follow-up|3
23934|NCT01719003|113469|P4|Overall Study|Lost to Follow-up|2
23935|NCT01719003|113470|P3|Overall Study|Lost to Follow-up|7
23936|NCT01719003|113471|P2|Overall Study|Lost to Follow-up|6
23937|NCT01719003|113472|P1|Overall Study|Lost to Follow-up|0
23938|NCT01719003|113464|P9|Overall Study|Adverse Event|0
23939|NCT01719003|113465|P8|Overall Study|Adverse Event|5
23940|NCT01719003|113466|P7|Overall Study|Adverse Event|6
23941|NCT01719003|113467|P6|Overall Study|Adverse Event|3
23942|NCT01719003|113468|P5|Overall Study|Adverse Event|4
23943|NCT01719003|113469|P4|Overall Study|Adverse Event|3
23944|NCT01719003|113470|P3|Overall Study|Adverse Event|4
23945|NCT01719003|113471|P2|Overall Study|Adverse Event|5
23946|NCT01719003|113472|P1|Overall Study|Adverse Event|6
23947|NCT01719003|113464|P9|Overall Study|Non compliant with protocol|0
23948|NCT01719003|113465|P8|Overall Study|Non compliant with protocol|3
23949|NCT01719003|113466|P7|Overall Study|Non compliant with protocol|2
23950|NCT01719003|113467|P6|Overall Study|Non compliant with protocol|1
23951|NCT01719003|113468|P5|Overall Study|Non compliant with protocol|2
23952|NCT01719003|113469|P4|Overall Study|Non compliant with protocol|1
23953|NCT01719003|113470|P3|Overall Study|Non compliant with protocol|0
23954|NCT01719003|113471|P2|Overall Study|Non compliant with protocol|1
23955|NCT01719003|113472|P1|Overall Study|Non compliant with protocol|1
23956|NCT01718535|113553|P10|Overall Study|Bidirectional Sequencing not possible|0
23957|NCT01718535|113554|P9|Overall Study|Bidirectional Sequencing not possible|0
23958|NCT01718535|113555|P8|Overall Study|Bidirectional Sequencing not possible|0
23959|NCT01718535|113556|P7|Overall Study|Bidirectional Sequencing not possible|0
23960|NCT01718535|113557|P6|Overall Study|Bidirectional Sequencing not possible|0
23961|NCT01718535|113558|P5|Overall Study|Bidirectional Sequencing not possible|0
23962|NCT01718535|113559|P4|Overall Study|Bidirectional Sequencing not possible|1
23963|NCT01718535|113560|P3|Overall Study|Bidirectional Sequencing not possible|0
23964|NCT01718535|113561|P2|Overall Study|Bidirectional Sequencing not possible|0
23965|NCT01718535|113562|P1|Overall Study|Bidirectional Sequencing not possible|1
23966|NCT01718509|113586|P2|Overall Study|Lack of Efficacy|0
23967|NCT01718509|113587|P1|Overall Study|Lack of Efficacy|1
23968|NCT01718509|113586|P2|Overall Study|Protocol Violation|2
23969|NCT01718509|113587|P1|Overall Study|Protocol Violation|4
23970|NCT01718509|113586|P2|Overall Study|Not specified|11
23971|NCT01718509|113587|P1|Overall Study|Not specified|13
23972|NCT01718509|113586|P2|Overall Study|Adverse Event|7
23973|NCT01718509|113587|P1|Overall Study|Adverse Event|5
23974|NCT01718509|113586|P2|Overall Study|Withdrawal by Subject|13
23975|NCT01718509|113587|P1|Overall Study|Withdrawal by Subject|7
23976|NCT01718509|113586|P2|Overall Study|Lost to Follow-up|15
23977|NCT01718509|113587|P1|Overall Study|Lost to Follow-up|18
23978|NCT01718483|113633|P2|Overall Study|Lack of Efficacy|0
23979|NCT01718483|113634|P1|Overall Study|Lack of Efficacy|1
23980|NCT01718483|113633|P2|Overall Study|Pregnancy|1
23981|NCT01718483|113634|P1|Overall Study|Pregnancy|1
23982|NCT01718483|113633|P2|Overall Study|Not specified|4
23983|NCT01718483|113634|P1|Overall Study|Not specified|1
23984|NCT01718483|113633|P2|Overall Study|Protocol Violation|2
23985|NCT01718483|113634|P1|Overall Study|Protocol Violation|4
23986|NCT01718483|113633|P2|Overall Study|Lost to Follow-up|3
23987|NCT01718483|113634|P1|Overall Study|Lost to Follow-up|8
23988|NCT01718483|113633|P2|Overall Study|Adverse Event|12
23989|NCT01718483|113634|P1|Overall Study|Adverse Event|5
23990|NCT01718483|113633|P2|Overall Study|Withdrawal by Subject|12
23991|NCT01718483|113634|P1|Overall Study|Withdrawal by Subject|14
23992|NCT01717989|113693|P1|Overall Study|Other|40
23993|NCT01717989|113693|P1|Overall Study|Protocol-specified criteria|551
23994|NCT01717989|113693|P1|Overall Study|Death|439
23995|NCT01717989|113693|P1|Overall Study|Lost to Follow-up|11
23996|NCT01717989|113693|P1|Overall Study|Physician Decision|2
23997|NCT01717989|113693|P1|Overall Study|Withdrawal by Subject|11
23998|NCT01717989|113693|P1|Overall Study|Protocol deviation|6
23999|NCT01717989|113693|P1|Overall Study|Ineligibility determined|6
24000|NCT01717976|113761|P2|Overall Study|Protocol Violation|1
24001|NCT01717976|113762|P1|Overall Study|Protocol Violation|0
24002|NCT01717768|113799|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24003|NCT01717768|113800|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24004|NCT01717768|113801|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
24005|NCT01717768|113802|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24006|NCT01717768|113803|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24007|NCT01717768|113804|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24008|NCT01717768|113805|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24009|NCT01717768|113806|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24010|NCT01717768|113807|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24011|NCT01717768|113808|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24012|NCT01717768|113809|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24013|NCT01717768|113810|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
24014|NCT01717768|113799|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24015|NCT01717768|113800|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24016|NCT01717768|113801|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24017|NCT01717768|113802|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24018|NCT01717768|113803|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
24019|NCT01717768|113804|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24020|NCT01717768|113805|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24021|NCT01717768|113806|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24022|NCT01717768|113807|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24023|NCT01717768|113808|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24024|NCT01717768|113809|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24025|NCT01717768|113810|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
24026|NCT01717768|113799|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
24027|NCT01717768|113800|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24028|NCT01717768|113801|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24029|NCT01717768|113802|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24030|NCT01717768|113803|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24031|NCT01717768|113804|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24032|NCT01717768|113805|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24033|NCT01717768|113806|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24034|NCT01717768|113807|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24035|NCT01717768|113808|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24036|NCT01717768|113809|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24037|NCT01717768|113810|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
24038|NCT01717768|113799|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24039|NCT01717768|113800|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24040|NCT01717768|113801|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24041|NCT01717768|113802|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24042|NCT01717768|113803|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24043|NCT01717768|113804|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24044|NCT01717768|113805|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24045|NCT01717768|113806|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24046|NCT01717768|113807|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24047|NCT01717768|113808|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24048|NCT01717768|113809|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
24049|NCT01717768|113810|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
24050|NCT01717638|113861|P13|Overall Study|Withdrawal by Subject|18
24051|NCT01717638|113862|P12|Overall Study|Withdrawal by Subject|0
24052|NCT01717638|113863|P11|Overall Study|Withdrawal by Subject|0
24053|NCT01717638|113864|P10|Overall Study|Withdrawal by Subject|1
24054|NCT01717638|113865|P9|Overall Study|Withdrawal by Subject|2
24055|NCT01717638|113866|P8|Overall Study|Withdrawal by Subject|1
24056|NCT01717638|113867|P7|Overall Study|Withdrawal by Subject|2
24057|NCT01717638|113868|P6|Overall Study|Withdrawal by Subject|0
24058|NCT01717638|113869|P5|Overall Study|Withdrawal by Subject|1
24059|NCT01717638|113870|P4|Overall Study|Withdrawal by Subject|0
24060|NCT01717638|113871|P3|Overall Study|Withdrawal by Subject|1
24061|NCT01717638|113872|P2|Overall Study|Withdrawal by Subject|1
24062|NCT01717638|113873|P1|Overall Study|Withdrawal by Subject|0
24063|NCT01717638|113861|P13|Overall Study|Father in hospital|1
24064|NCT01717638|113862|P12|Overall Study|Father in hospital|0
24065|NCT01717638|113863|P11|Overall Study|Father in hospital|0
24066|NCT01717638|113864|P10|Overall Study|Father in hospital|0
24067|NCT01717638|113865|P9|Overall Study|Father in hospital|0
24068|NCT01717638|113866|P8|Overall Study|Father in hospital|0
24069|NCT01717638|113867|P7|Overall Study|Father in hospital|0
24070|NCT01717638|113868|P6|Overall Study|Father in hospital|0
24071|NCT01717638|113869|P5|Overall Study|Father in hospital|0
24072|NCT01717638|113870|P4|Overall Study|Father in hospital|0
24073|NCT01717638|113871|P3|Overall Study|Father in hospital|0
24074|NCT01717638|113872|P2|Overall Study|Father in hospital|0
24075|NCT01717638|113873|P1|Overall Study|Father in hospital|0
24076|NCT01717638|113861|P13|Overall Study|Lost to Follow-up|0
24077|NCT01717638|113862|P12|Overall Study|Lost to Follow-up|0
24078|NCT01717638|113863|P11|Overall Study|Lost to Follow-up|0
24079|NCT01717638|113864|P10|Overall Study|Lost to Follow-up|0
24080|NCT01717638|113865|P9|Overall Study|Lost to Follow-up|0
24081|NCT01717638|113866|P8|Overall Study|Lost to Follow-up|0
24082|NCT01717638|113867|P7|Overall Study|Lost to Follow-up|0
24083|NCT01717638|113868|P6|Overall Study|Lost to Follow-up|1
24084|NCT01717638|113869|P5|Overall Study|Lost to Follow-up|0
24085|NCT01717638|113870|P4|Overall Study|Lost to Follow-up|0
24086|NCT01717638|113871|P3|Overall Study|Lost to Follow-up|0
24087|NCT01717638|113872|P2|Overall Study|Lost to Follow-up|0
24088|NCT01717638|113873|P1|Overall Study|Lost to Follow-up|0
24089|NCT01717456|114017|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
24090|NCT01717456|114018|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
24091|NCT01717456|114017|P2|End of Treatment|Lost to Follow-up|1
24092|NCT01717456|114018|P1|End of Treatment|Lost to Follow-up|0
24093|NCT01717456|114017|P2|End of Treatment|Physician Decision|1
24094|NCT01717456|114018|P1|End of Treatment|Physician Decision|0
24095|NCT01717326|114106|P20|Overall Study|Withdrawal by Subject|3
24096|NCT01717326|114107|P19|Overall Study|Withdrawal by Subject|2
24097|NCT01717326|114108|P18|Overall Study|Withdrawal by Subject|0
24098|NCT01717326|114109|P17|Overall Study|Withdrawal by Subject|0
24099|NCT01717326|114110|P16|Overall Study|Withdrawal by Subject|1
24100|NCT01717326|114111|P15|Overall Study|Withdrawal by Subject|0
24101|NCT01717326|114112|P14|Overall Study|Withdrawal by Subject|0
24102|NCT01717326|114113|P13|Overall Study|Withdrawal by Subject|1
24103|NCT01717326|114114|P12|Overall Study|Withdrawal by Subject|0
24104|NCT01717326|114115|P11|Overall Study|Withdrawal by Subject|0
24105|NCT01717326|114116|P10|Overall Study|Withdrawal by Subject|1
24106|NCT01717326|114117|P9|Overall Study|Withdrawal by Subject|0
24107|NCT01717326|114118|P8|Overall Study|Withdrawal by Subject|0
24108|NCT01717326|114119|P7|Overall Study|Withdrawal by Subject|0
24109|NCT01717326|114120|P6|Overall Study|Withdrawal by Subject|0
24110|NCT01717326|114121|P5|Overall Study|Withdrawal by Subject|0
24111|NCT01717326|114122|P4|Overall Study|Withdrawal by Subject|0
24112|NCT01717326|114123|P3|Overall Study|Withdrawal by Subject|0
24113|NCT01717326|114124|P2|Overall Study|Withdrawal by Subject|1
24114|NCT01717326|114125|P1|Overall Study|Withdrawal by Subject|0
24115|NCT01717326|114106|P20|Overall Study|Protocol Violation|0
24116|NCT01717326|114107|P19|Overall Study|Protocol Violation|0
24117|NCT01717326|114108|P18|Overall Study|Protocol Violation|0
24118|NCT01717326|114109|P17|Overall Study|Protocol Violation|0
24119|NCT01717326|114110|P16|Overall Study|Protocol Violation|0
24120|NCT01717326|114111|P15|Overall Study|Protocol Violation|0
24121|NCT01717326|114112|P14|Overall Study|Protocol Violation|0
24122|NCT01717326|114113|P13|Overall Study|Protocol Violation|0
24123|NCT01717326|114114|P12|Overall Study|Protocol Violation|0
24124|NCT01717326|114115|P11|Overall Study|Protocol Violation|0
24125|NCT01717326|114116|P10|Overall Study|Protocol Violation|0
24126|NCT01717326|114117|P9|Overall Study|Protocol Violation|0
24127|NCT01717326|114118|P8|Overall Study|Protocol Violation|0
24128|NCT01717326|114119|P7|Overall Study|Protocol Violation|0
24129|NCT01717326|114120|P6|Overall Study|Protocol Violation|0
24130|NCT01717326|114121|P5|Overall Study|Protocol Violation|1
24131|NCT01717326|114122|P4|Overall Study|Protocol Violation|0
24132|NCT01717326|114123|P3|Overall Study|Protocol Violation|0
24133|NCT01717326|114124|P2|Overall Study|Protocol Violation|0
24134|NCT01717326|114125|P1|Overall Study|Protocol Violation|0
24135|NCT01717326|114106|P20|Overall Study|Physician Decision|0
24136|NCT01717326|114107|P19|Overall Study|Physician Decision|0
24137|NCT01717326|114108|P18|Overall Study|Physician Decision|0
24138|NCT01717326|114109|P17|Overall Study|Physician Decision|0
24139|NCT01717326|114110|P16|Overall Study|Physician Decision|0
24140|NCT01717326|114111|P15|Overall Study|Physician Decision|0
24141|NCT01717326|114112|P14|Overall Study|Physician Decision|0
24142|NCT01717326|114113|P13|Overall Study|Physician Decision|0
24143|NCT01717326|114114|P12|Overall Study|Physician Decision|0
24144|NCT01717326|114115|P11|Overall Study|Physician Decision|0
24145|NCT01717326|114116|P10|Overall Study|Physician Decision|1
24146|NCT01717326|114117|P9|Overall Study|Physician Decision|0
24147|NCT01717326|114118|P8|Overall Study|Physician Decision|0
24148|NCT01717326|114119|P7|Overall Study|Physician Decision|0
24149|NCT01717326|114120|P6|Overall Study|Physician Decision|0
24150|NCT01717326|114121|P5|Overall Study|Physician Decision|0
24151|NCT01717326|114122|P4|Overall Study|Physician Decision|0
24152|NCT01717326|114123|P3|Overall Study|Physician Decision|0
24153|NCT01717326|114124|P2|Overall Study|Physician Decision|0
24154|NCT01717326|114125|P1|Overall Study|Physician Decision|0
24155|NCT01717326|114106|P20|Overall Study|Lost to Follow-up|3
24156|NCT01717326|114107|P19|Overall Study|Lost to Follow-up|2
24157|NCT01717326|114108|P18|Overall Study|Lost to Follow-up|0
24158|NCT01717326|114109|P17|Overall Study|Lost to Follow-up|1
24159|NCT01717326|114110|P16|Overall Study|Lost to Follow-up|2
24160|NCT01717326|114111|P15|Overall Study|Lost to Follow-up|0
24161|NCT01717326|114112|P14|Overall Study|Lost to Follow-up|0
24162|NCT01717326|114113|P13|Overall Study|Lost to Follow-up|0
24163|NCT01717326|114114|P12|Overall Study|Lost to Follow-up|0
24164|NCT01717326|114115|P11|Overall Study|Lost to Follow-up|1
24165|NCT01717326|114116|P10|Overall Study|Lost to Follow-up|0
24166|NCT01717326|114117|P9|Overall Study|Lost to Follow-up|0
24167|NCT01717326|114118|P8|Overall Study|Lost to Follow-up|0
24168|NCT01717326|114119|P7|Overall Study|Lost to Follow-up|1
24169|NCT01717326|114120|P6|Overall Study|Lost to Follow-up|0
24170|NCT01717326|114121|P5|Overall Study|Lost to Follow-up|1
24171|NCT01717326|114122|P4|Overall Study|Lost to Follow-up|2
24172|NCT01717326|114123|P3|Overall Study|Lost to Follow-up|0
24173|NCT01717326|114124|P2|Overall Study|Lost to Follow-up|0
24174|NCT01717326|114125|P1|Overall Study|Lost to Follow-up|3
24175|NCT01717326|114106|P20|Overall Study|Death|0
24176|NCT01717326|114107|P19|Overall Study|Death|0
24177|NCT01717326|114108|P18|Overall Study|Death|0
24178|NCT01717326|114109|P17|Overall Study|Death|0
24179|NCT01717326|114110|P16|Overall Study|Death|0
24180|NCT01717326|114111|P15|Overall Study|Death|0
24181|NCT01717326|114112|P14|Overall Study|Death|0
24182|NCT01717326|114113|P13|Overall Study|Death|0
24183|NCT01717326|114114|P12|Overall Study|Death|0
24184|NCT01717326|114115|P11|Overall Study|Death|1
24185|NCT01717326|114116|P10|Overall Study|Death|0
24186|NCT01717326|114117|P9|Overall Study|Death|0
24187|NCT01717326|114118|P8|Overall Study|Death|0
24188|NCT01717326|114119|P7|Overall Study|Death|0
24189|NCT01717326|114120|P6|Overall Study|Death|0
24190|NCT01717326|114121|P5|Overall Study|Death|0
24191|NCT01717326|114122|P4|Overall Study|Death|0
24192|NCT01717326|114123|P3|Overall Study|Death|0
24193|NCT01717326|114124|P2|Overall Study|Death|0
24194|NCT01717326|114125|P1|Overall Study|Death|0
24195|NCT01717313|114389|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
24196|NCT01717313|114390|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
24197|NCT01717313|114389|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
24198|NCT01717313|114390|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
24199|NCT01717313|114389|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
24200|NCT01717313|114390|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
24201|NCT01717313|114389|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
24202|NCT01717313|114390|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
24203|NCT01717313|114389|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
24204|NCT01717313|114390|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
24205|NCT01717313|114389|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
24206|NCT01717313|114390|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
24207|NCT01717313|114389|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
24208|NCT01717313|114390|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
24209|NCT01717313|114389|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
24210|NCT01717313|114390|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
24211|NCT01717313|114389|P2|Phase A (Weeks 0 to 24)|Death|1
24212|NCT01717313|114390|P1|Phase A (Weeks 0 to 24)|Death|0
24213|NCT01717287|114428|P2|Overall Study|Protocol Violation|1
24214|NCT01717287|114429|P1|Overall Study|Protocol Violation|0
24215|NCT01717287|114428|P2|Overall Study|Lost to Follow-up|2
24216|NCT01717287|114429|P1|Overall Study|Lost to Follow-up|0
24217|NCT01717040|114453|P2|Overall Study|New Substance Use Disorder|0
24218|NCT01717040|114454|P1|Overall Study|New Substance Use Disorder|1
24219|NCT01717040|114453|P2|Overall Study|Required Medication Change|1
24220|NCT01717040|114454|P1|Overall Study|Required Medication Change|0
24221|NCT01717040|114453|P2|Overall Study|Adverse Event|0
24222|NCT01717040|114454|P1|Overall Study|Adverse Event|1
24223|NCT01717040|114453|P2|Overall Study|Lack of Efficacy|1
24224|NCT01717040|114454|P1|Overall Study|Lack of Efficacy|1
24225|NCT01717040|114453|P2|Overall Study|Lost to Follow-up|3
24226|NCT01717040|114454|P1|Overall Study|Lost to Follow-up|2
24227|NCT01716754|114472|P4|Overall Study|Withdrawal by Subject|3
24228|NCT01716754|114473|P3|Overall Study|Withdrawal by Subject|4
24229|NCT01716754|114474|P2|Overall Study|Withdrawal by Subject|0
24230|NCT01716754|114475|P1|Overall Study|Withdrawal by Subject|5
24231|NCT01716754|114472|P4|Overall Study|Adverse Event|1
24232|NCT01716754|114473|P3|Overall Study|Adverse Event|2
24233|NCT01716754|114474|P2|Overall Study|Adverse Event|2
24234|NCT01716754|114475|P1|Overall Study|Adverse Event|4
24235|NCT01716754|114472|P4|Overall Study|Lost to Follow-up|1
24236|NCT01716754|114473|P3|Overall Study|Lost to Follow-up|0
24237|NCT01716754|114474|P2|Overall Study|Lost to Follow-up|0
24238|NCT01716754|114475|P1|Overall Study|Lost to Follow-up|1
24239|NCT01716754|114472|P4|Overall Study|Physician Decision|0
24240|NCT01716754|114473|P3|Overall Study|Physician Decision|0
24241|NCT01716754|114474|P2|Overall Study|Physician Decision|0
24242|NCT01716754|114475|P1|Overall Study|Physician Decision|1
24243|NCT01716754|114472|P4|Overall Study|Non-compliance with study treatment|0
24244|NCT01716754|114473|P3|Overall Study|Non-compliance with study treatment|1
24245|NCT01716754|114474|P2|Overall Study|Non-compliance with study treatment|0
24246|NCT01716754|114475|P1|Overall Study|Non-compliance with study treatment|0
24247|NCT01716754|114472|P4|Overall Study|Protocol deviation|2
24248|NCT01716754|114473|P3|Overall Study|Protocol deviation|7
24249|NCT01716754|114474|P2|Overall Study|Protocol deviation|2
24250|NCT01716754|114475|P1|Overall Study|Protocol deviation|0
24251|NCT01716754|114472|P4|Overall Study|Death|1
24252|NCT01716754|114473|P3|Overall Study|Death|0
24253|NCT01716754|114474|P2|Overall Study|Death|0
24254|NCT01716754|114475|P1|Overall Study|Death|0
24255|NCT01716663|114496|P1|Overall Study|Treated with non-study catheter|2
24256|NCT01716663|114496|P1|Overall Study|Withdrawn prior to procedure|4
24257|NCT01716585|114506|P2|Open-label Treatment|Withdrawal by Subject|3
24258|NCT01716585|114507|P1|Open-label Treatment|Withdrawal by Subject|0
24259|NCT01716585|114506|P2|Open-label Treatment|Virologic Failure|2
24260|NCT01716585|114507|P1|Open-label Treatment|Virologic Failure|0
24261|NCT01716585|114506|P2|Open-label Treatment|Adverse Event|2
24262|NCT01716585|114507|P1|Open-label Treatment|Adverse Event|0
24263|NCT01716585|114506|P2|Double-blind Treatment|Not Specified|0
24264|NCT01716585|114507|P1|Double-blind Treatment|Not Specified|1
24265|NCT01716585|114506|P2|Double-blind Treatment|Subject Noncompliant|0
24266|NCT01716585|114507|P1|Double-blind Treatment|Subject Noncompliant|1
24267|NCT01716585|114506|P2|Double-blind Treatment|Lost to Follow-up|0
24268|NCT01716585|114507|P1|Double-blind Treatment|Lost to Follow-up|2
24269|NCT01716585|114506|P2|Double-blind Treatment|Withdrawal by Subject|0
24270|NCT01716585|114507|P1|Double-blind Treatment|Withdrawal by Subject|3
24271|NCT01716585|114506|P2|Double-blind Treatment|Adverse Event|1
24272|NCT01716585|114507|P1|Double-blind Treatment|Adverse Event|2
24273|NCT01716585|114506|P2|Double-blind Treatment|Did Not Receive Study Drug|1
24274|NCT01716585|114507|P1|Double-blind Treatment|Did Not Receive Study Drug|4
24275|NCT01716559|114519|P1|Overall Study|Other withdrawal reason|75
24276|NCT01716559|114519|P1|Overall Study|Withdrawal by Subject|4
24277|NCT01716559|114519|P1|Overall Study|Death|21
24278|NCT01716559|114519|P1|Overall Study|Adverse Event|11
24279|NCT01716520|114527|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
24280|NCT01716520|114528|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
24281|NCT01716520|114529|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
24282|NCT01716520|114530|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
24283|NCT01716520|114531|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
24284|NCT01716520|114532|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
24285|NCT01716520|114527|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
24286|NCT01716520|114528|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
24287|NCT01716520|114529|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
24288|NCT01716520|114530|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
24289|NCT01716520|114531|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
24290|NCT01716520|114532|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
24291|NCT01716520|114527|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
24292|NCT01716520|114528|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
24293|NCT01716520|114529|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
24294|NCT01716520|114530|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
24295|NCT01716520|114531|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
24296|NCT01716520|114532|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
24297|NCT01716520|114527|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
24298|NCT01716520|114528|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
24299|NCT01716520|114529|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
24300|NCT01716520|114530|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
24301|NCT01716520|114531|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
24302|NCT01716520|114532|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
24303|NCT01716520|114527|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
24304|NCT01716520|114528|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
24305|NCT01716520|114529|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
24306|NCT01716520|114530|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
24307|NCT01716520|114531|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
24308|NCT01716520|114532|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
24309|NCT01716520|114527|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
24310|NCT01716520|114528|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
24311|NCT01716520|114529|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
24312|NCT01716520|114530|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
24313|NCT01716520|114531|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
24314|NCT01716520|114532|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
24315|NCT01716520|114527|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
24316|NCT01716520|114528|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
24317|NCT01716520|114529|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
24318|NCT01716520|114530|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
24319|NCT01716520|114531|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
24320|NCT01716520|114532|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
24321|NCT01716520|114527|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
24322|NCT01716520|114528|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
24323|NCT01716520|114529|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
24324|NCT01716520|114530|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
24325|NCT01716520|114531|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
24326|NCT01716520|114532|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
24327|NCT01716520|114527|P6|Treatment Period 2 (14 Days)|Adverse Event|0
24328|NCT01716520|114528|P5|Treatment Period 2 (14 Days)|Adverse Event|1
24329|NCT01716520|114529|P4|Treatment Period 2 (14 Days)|Adverse Event|0
24330|NCT01716520|114530|P3|Treatment Period 2 (14 Days)|Adverse Event|0
24331|NCT01716520|114531|P2|Treatment Period 2 (14 Days)|Adverse Event|0
24332|NCT01716520|114532|P1|Treatment Period 2 (14 Days)|Adverse Event|0
24333|NCT01716520|114527|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
24334|NCT01716520|114528|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
24335|NCT01716520|114529|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
24336|NCT01716520|114530|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
24337|NCT01716520|114531|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
24338|NCT01716520|114532|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
24339|NCT01716520|114527|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
24340|NCT01716520|114528|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
24341|NCT01716520|114529|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
24342|NCT01716520|114530|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
24343|NCT01716520|114531|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
24344|NCT01716520|114532|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
24345|NCT01716520|114527|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
24346|NCT01716520|114528|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
24347|NCT01716520|114529|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
24348|NCT01716520|114530|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
24349|NCT01716520|114531|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
24350|NCT01716520|114532|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
24351|NCT01716520|114527|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
24352|NCT01716520|114528|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
24353|NCT01716520|114529|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
24354|NCT01716520|114530|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
24355|NCT01716520|114531|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
24356|NCT01716520|114532|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
24357|NCT01716520|114527|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
24358|NCT01716520|114528|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
24359|NCT01716520|114529|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
24360|NCT01716520|114530|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
24361|NCT01716520|114531|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
24362|NCT01716520|114532|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
24363|NCT01716520|114527|P6|Treatment Period 1 (14 Days)|Adverse Event|0
24364|NCT01716520|114528|P5|Treatment Period 1 (14 Days)|Adverse Event|0
24365|NCT01716520|114529|P4|Treatment Period 1 (14 Days)|Adverse Event|0
24366|NCT01716520|114530|P3|Treatment Period 1 (14 Days)|Adverse Event|0
24367|NCT01716520|114531|P2|Treatment Period 1 (14 Days)|Adverse Event|0
24368|NCT01716520|114532|P1|Treatment Period 1 (14 Days)|Adverse Event|1
24369|NCT01716234|114587|P7|Overall Study|Withdrawal by Subject|0
24370|NCT01716234|114588|P6|Overall Study|Withdrawal by Subject|3
24371|NCT01716234|114589|P5|Overall Study|Withdrawal by Subject|1
24372|NCT01716234|114590|P4|Overall Study|Withdrawal by Subject|2
24373|NCT01716234|114591|P3|Overall Study|Withdrawal by Subject|2
24374|NCT01716234|114592|P2|Overall Study|Withdrawal by Subject|0
24375|NCT01716234|114593|P1|Overall Study|Withdrawal by Subject|3
24376|NCT01716234|114587|P7|Overall Study|Adverse Event|0
24377|NCT01716234|114588|P6|Overall Study|Adverse Event|6
24378|NCT01716234|114589|P5|Overall Study|Adverse Event|3
24379|NCT01716234|114590|P4|Overall Study|Adverse Event|8
24380|NCT01716234|114591|P3|Overall Study|Adverse Event|2
24381|NCT01716234|114592|P2|Overall Study|Adverse Event|10
24382|NCT01716234|114593|P1|Overall Study|Adverse Event|7
24383|NCT01716234|114587|P7|Overall Study|Did not meet protocol eligibility|0
24384|NCT01716234|114588|P6|Overall Study|Did not meet protocol eligibility|4
24385|NCT01716234|114589|P5|Overall Study|Did not meet protocol eligibility|0
24386|NCT01716234|114590|P4|Overall Study|Did not meet protocol eligibility|0
24387|NCT01716234|114591|P3|Overall Study|Did not meet protocol eligibility|1
24388|NCT01716234|114592|P2|Overall Study|Did not meet protocol eligibility|0
24389|NCT01716234|114593|P1|Overall Study|Did not meet protocol eligibility|0
24390|NCT01716234|114587|P7|Overall Study|Lack of Efficacy|0
24391|NCT01716234|114588|P6|Overall Study|Lack of Efficacy|0
24392|NCT01716234|114589|P5|Overall Study|Lack of Efficacy|0
24393|NCT01716234|114590|P4|Overall Study|Lack of Efficacy|1
24394|NCT01716234|114591|P3|Overall Study|Lack of Efficacy|0
24395|NCT01716234|114592|P2|Overall Study|Lack of Efficacy|0
24396|NCT01716234|114593|P1|Overall Study|Lack of Efficacy|0
24397|NCT01716234|114587|P7|Overall Study|Protocol Violation|0
24398|NCT01716234|114588|P6|Overall Study|Protocol Violation|1
24399|NCT01716234|114589|P5|Overall Study|Protocol Violation|1
24400|NCT01716234|114590|P4|Overall Study|Protocol Violation|1
24401|NCT01716234|114591|P3|Overall Study|Protocol Violation|0
24402|NCT01716234|114592|P2|Overall Study|Protocol Violation|0
24403|NCT01716234|114593|P1|Overall Study|Protocol Violation|0
24404|NCT01716169|114656|P1|Overall Study|inconsistent dressing application|1
24405|NCT01716169|114656|P1|Overall Study|Withdrawal by Subject|1
24406|NCT01716169|114656|P1|Overall Study|Lost to Follow-up|1
24407|NCT01716169|114656|P1|Overall Study|Adverse Event|1
24408|NCT01716156|114665|P3|Overall Study|Lost to Follow-up|0
24409|NCT01716156|114666|P2|Overall Study|Lost to Follow-up|0
24410|NCT01716156|114667|P1|Overall Study|Lost to Follow-up|1
24411|NCT01716156|114665|P3|Overall Study|Withdrawal by Subject|2
24412|NCT01716156|114666|P2|Overall Study|Withdrawal by Subject|1
24413|NCT01716156|114667|P1|Overall Study|Withdrawal by Subject|0
24414|NCT01716156|114665|P3|Overall Study|Protocol Violation|0
24415|NCT01716156|114666|P2|Overall Study|Protocol Violation|0
24416|NCT01716156|114667|P1|Overall Study|Protocol Violation|1
24417|NCT01716052|114693|P2|Overall Study|Withdrawal of funding|1
24418|NCT01716052|114694|P1|Overall Study|Withdrawal of funding|1
24419|NCT01715896|114736|P2|Overall Study|Unspecified|5
24420|NCT01715896|114737|P1|Overall Study|Unspecified|2
24421|NCT01715896|114736|P2|Overall Study|Withdrawal by Subject|4
24422|NCT01715896|114737|P1|Overall Study|Withdrawal by Subject|1
24423|NCT01715896|114736|P2|Overall Study|Lost to Follow-up|2
24424|NCT01715896|114737|P1|Overall Study|Lost to Follow-up|0
24425|NCT01715857|114800|P1|Overall Study|Did Not Meet Eligibility Criteria|96
24426|NCT01715831|114810|P1|Overall Study|Adverse Event|1
24427|NCT01715415|114828|P2|Open-label Treatment|Subject Noncompliant|1
24428|NCT01715415|114829|P1|Open-label Treatment|Subject Noncompliant|0
24429|NCT01715415|114828|P2|Open-label Treatment|Adverse Event|1
24430|NCT01715415|114829|P1|Open-label Treatment|Adverse Event|0
24431|NCT01715415|114828|P2|Double-blind Treatment|Not Specified|0
24432|NCT01715415|114829|P1|Double-blind Treatment|Not Specified|1
24433|NCT01715415|114828|P2|Double-blind Treatment|Withdrawal by Subject|1
24434|NCT01715415|114829|P1|Double-blind Treatment|Withdrawal by Subject|1
24435|NCT01715415|114828|P2|Double-blind Treatment|Adverse Event|0
24436|NCT01715415|114829|P1|Double-blind Treatment|Adverse Event|3
24437|NCT01715415|114828|P2|Double-blind Treatment|Did Not Receive Study Drug|1
24438|NCT01715415|114829|P1|Double-blind Treatment|Did Not Receive Study Drug|0
24439|NCT01715298|114843|P2|Overall Study|Patient/guardian decision|9
24440|NCT01715298|114844|P1|Overall Study|Patient/guardian decision|7
24441|NCT01715298|114843|P2|Overall Study|Lost to Follow-up|2
24442|NCT01715298|114844|P1|Overall Study|Lost to Follow-up|0
24443|NCT01715129|114891|P1|Overall Study|Unspecified|1
24444|NCT01715129|114891|P1|Overall Study|Lost to Follow-up|1
24445|NCT01715129|114891|P1|Overall Study|Consent Withdrawn|2
24446|NCT01715129|114891|P1|Overall Study|Protocol Violation|1
24447|NCT01715129|114891|P1|Overall Study|Lack of Efficacy|3
24448|NCT01715129|114891|P1|Overall Study|Adverse Event, fatal|1
24449|NCT01714635|114920|P3|Overall Study|Missed 6-month exam|0
24450|NCT01714635|114921|P2|Overall Study|Missed 6-month exam|0
24451|NCT01714635|114922|P1|Overall Study|Missed 6-month exam|1
24452|NCT01714635|114920|P3|Overall Study|Discontinued|2
24453|NCT01714635|114921|P2|Overall Study|Discontinued|0
24454|NCT01714635|114922|P1|Overall Study|Discontinued|1
24455|NCT01714609|114938|P2|Overall Study|Protocol Violation|0
24456|NCT01714609|114939|P1|Overall Study|Protocol Violation|1
24457|NCT01714544|114945|P1|Overall Study|Withdrawal by Subject|1
24458|NCT01714544|114945|P1|Overall Study|Physician Decision|1
24459|NCT01714544|114945|P1|Overall Study|Lost to Follow-up|1
24460|NCT01713998|115017|P3|Overall Study|Withdrawal by Subject|0
24461|NCT01713998|115018|P2|Overall Study|Withdrawal by Subject|0
24462|NCT01713998|115019|P1|Overall Study|Withdrawal by Subject|1
24463|NCT01713998|115017|P3|Overall Study|Lost to Follow-up|2
24464|NCT01713998|115018|P2|Overall Study|Lost to Follow-up|0
24465|NCT01713998|115019|P1|Overall Study|Lost to Follow-up|2
24466|NCT01713933|115037|P1|Overall Study|Excluded from analysis as a BMI outlier|1
24467|NCT01713933|115037|P1|Overall Study|Withdrawal by Subject|3
24468|NCT01713933|115037|P1|Overall Study|Lost to Follow-up|2
24469|NCT01713686|115049|P1|Overall Study|Withdrawal by Subject|6
24470|NCT01713686|115049|P1|Overall Study|Lost to Follow-up|9
24471|NCT01713530|115100|P2|Overall Study|Unclassified|2
24472|NCT01713530|115101|P1|Overall Study|Unclassified|4
24473|NCT01713530|115100|P2|Overall Study|Withdrawal criteria|12
24474|NCT01713530|115101|P1|Overall Study|Withdrawal criteria|21
24475|NCT01713530|115100|P2|Overall Study|Adverse Event|5
24476|NCT01713530|115101|P1|Overall Study|Adverse Event|0
24477|NCT01713348|115132|P4|Overall Study|Lost to Follow-up|0
24478|NCT01713348|115133|P3|Overall Study|Lost to Follow-up|0
24479|NCT01713348|115134|P2|Overall Study|Lost to Follow-up|0
24480|NCT01713348|115135|P1|Overall Study|Lost to Follow-up|1
24481|NCT01713348|115132|P4|Overall Study|Withdrawal by Subject|0
24482|NCT01713348|115133|P3|Overall Study|Withdrawal by Subject|2
24483|NCT01713348|115134|P2|Overall Study|Withdrawal by Subject|2
24484|NCT01713348|115135|P1|Overall Study|Withdrawal by Subject|3
24485|NCT01713283|115165|P2|Overall Study|Lost to Follow-up|1
24486|NCT01713283|115166|P1|Overall Study|Lost to Follow-up|1
24487|NCT01713283|115165|P2|Overall Study|Lack of Efficacy|2
24488|NCT01713283|115166|P1|Overall Study|Lack of Efficacy|10
24489|NCT01713036|115188|P1|Overall Study|Death|1
24490|NCT01712984|115228|P3|Overall Study|Withdrawal by Subject|7
24491|NCT01712984|115229|P2|Overall Study|Withdrawal by Subject|6
24492|NCT01712984|115230|P1|Overall Study|Withdrawal by Subject|6
24493|NCT01712984|115228|P3|Overall Study|Lost to Follow-up|1
24494|NCT01712984|115229|P2|Overall Study|Lost to Follow-up|10
24495|NCT01712984|115230|P1|Overall Study|Lost to Follow-up|8
24496|NCT01712984|115228|P3|Overall Study|Protocol Violation|1
24497|NCT01712984|115229|P2|Overall Study|Protocol Violation|0
24498|NCT01712984|115230|P1|Overall Study|Protocol Violation|2
24499|NCT01712984|115228|P3|Overall Study|Adverse Event|1
24500|NCT01712984|115229|P2|Overall Study|Adverse Event|0
24501|NCT01712984|115230|P1|Overall Study|Adverse Event|0
24502|NCT01712854|115250|P1|Overall Study|Physician Decision|1
24503|NCT01712685|115273|P1|Overall Study|pt declined to participate before trmt|1
24504|NCT01712516|115289|P4|Overall Study|Withdrawal by Subject|9
24505|NCT01712516|115290|P3|Overall Study|Withdrawal by Subject|3
24506|NCT01712516|115291|P2|Overall Study|Withdrawal by Subject|9
24507|NCT01712516|115292|P1|Overall Study|Withdrawal by Subject|3
24508|NCT01712516|115289|P4|Overall Study|Physician Decision|1
24509|NCT01712516|115290|P3|Overall Study|Physician Decision|0
24510|NCT01712516|115291|P2|Overall Study|Physician Decision|0
24511|NCT01712516|115292|P1|Overall Study|Physician Decision|2
24512|NCT01712516|115289|P4|Overall Study|Protocol deviation|0
24513|NCT01712516|115290|P3|Overall Study|Protocol deviation|1
24514|NCT01712516|115291|P2|Overall Study|Protocol deviation|0
24515|NCT01712516|115292|P1|Overall Study|Protocol deviation|1
24516|NCT01712516|115289|P4|Overall Study|Death|0
24517|NCT01712516|115290|P3|Overall Study|Death|0
24518|NCT01712516|115291|P2|Overall Study|Death|1
24519|NCT01712516|115292|P1|Overall Study|Death|0
24520|NCT01712516|115289|P4|Overall Study|Lost to Follow-up|1
24521|NCT01712516|115290|P3|Overall Study|Lost to Follow-up|2
24522|NCT01712516|115291|P2|Overall Study|Lost to Follow-up|0
24523|NCT01712516|115292|P1|Overall Study|Lost to Follow-up|0
24524|NCT01712516|115289|P4|Overall Study|Technical problems|2
24525|NCT01712516|115290|P3|Overall Study|Technical problems|0
24526|NCT01712516|115291|P2|Overall Study|Technical problems|0
24527|NCT01712516|115292|P1|Overall Study|Technical problems|0
24528|NCT01712399|115342|P1|Overall Study|Study closure|345
24529|NCT01712399|115342|P1|Overall Study|Adverse Event|11
24530|NCT01712399|115342|P1|Overall Study|Death|1
24531|NCT01712399|115342|P1|Overall Study|Withdrawal by Subject|39
24532|NCT01712399|115342|P1|Overall Study|Lost to Follow-up|1
24533|NCT01712334|115388|P2|Treatment Period 1|Randomized in Error|2
24534|NCT01712334|115389|P1|Treatment Period 1|Randomized in Error|0
24535|NCT01712256|115397|P1|Overall Study|Lost to Follow-up|1
24536|NCT01712204|115408|P2|Overall Study|Protocol Violation|1
24537|NCT01712204|115409|P1|Overall Study|Protocol Violation|1
24538|NCT01712204|115408|P2|Overall Study|Lost to Follow-up|0
24539|NCT01712204|115409|P1|Overall Study|Lost to Follow-up|1
24540|NCT01712204|115408|P2|Overall Study|Withdrawal by Subject|3
24541|NCT01712204|115409|P1|Overall Study|Withdrawal by Subject|3
24542|NCT01712204|115408|P2|Overall Study|Adverse Event|1
24543|NCT01712204|115409|P1|Overall Study|Adverse Event|3
24544|NCT01712178|115417|P2|Overall Study|Lost to Follow-up|1
24545|NCT01712178|115418|P1|Overall Study|Lost to Follow-up|0
24546|NCT01712178|115417|P2|Overall Study|Serious adverse event/withdrew consent|1
24547|NCT01712178|115418|P1|Overall Study|Serious adverse event/withdrew consent|0
24548|NCT01712178|115417|P2|Overall Study|Withdrew consent due to an adverse event|1
24549|NCT01712178|115418|P1|Overall Study|Withdrew consent due to an adverse event|1
24550|NCT01712074|115443|P3|Double Blind Period|No longer met eligibility criteria|0
24551|NCT01712074|115444|P2|Double Blind Period|No longer met eligibility criteria|3
24552|NCT01712074|115445|P1|Double Blind Period|No longer met eligibility criteria|0
24553|NCT01712074|115443|P3|Double Blind Period|Protocol Violation|1
24554|NCT01712074|115444|P2|Double Blind Period|Protocol Violation|0
24555|NCT01712074|115445|P1|Double Blind Period|Protocol Violation|0
24556|NCT01712074|115443|P3|Double Blind Period|Unspecified|1
24557|NCT01712074|115444|P2|Double Blind Period|Unspecified|4
24558|NCT01712074|115445|P1|Double Blind Period|Unspecified|0
24559|NCT01712074|115443|P3|Double Blind Period|Lost to Follow-up|1
24560|NCT01712074|115444|P2|Double Blind Period|Lost to Follow-up|2
24561|NCT01712074|115445|P1|Double Blind Period|Lost to Follow-up|0
24562|NCT01712074|115443|P3|Double Blind Period|Death|0
24563|NCT01712074|115444|P2|Double Blind Period|Death|1
24564|NCT01712074|115445|P1|Double Blind Period|Death|0
24565|NCT01712074|115443|P3|Double Blind Period|No longer willing to participate|4
24566|NCT01712074|115444|P2|Double Blind Period|No longer willing to participate|2
24567|NCT01712074|115445|P1|Double Blind Period|No longer willing to participate|0
24568|NCT01712074|115443|P3|Double Blind Period|Adverse Event|1
24569|NCT01712074|115444|P2|Double Blind Period|Adverse Event|2
24570|NCT01712074|115445|P1|Double Blind Period|Adverse Event|0
24571|NCT01712074|115443|P3|Placebo Run-in Period|No longer willing to participate|0
24572|NCT01712074|115444|P2|Placebo Run-in Period|No longer willing to participate|0
24573|NCT01712074|115445|P1|Placebo Run-in Period|No longer willing to participate|1
24574|NCT01712074|115443|P3|Placebo Run-in Period|Unspecified|0
24575|NCT01712074|115444|P2|Placebo Run-in Period|Unspecified|0
24576|NCT01712074|115445|P1|Placebo Run-in Period|Unspecified|1
24577|NCT01712074|115443|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
24578|NCT01712074|115444|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
24579|NCT01712074|115445|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
24580|NCT01712074|115443|P3|Placebo Run-in Period|Lost to Follow-up|0
24581|NCT01712074|115444|P2|Placebo Run-in Period|Lost to Follow-up|0
24582|NCT01712074|115445|P1|Placebo Run-in Period|Lost to Follow-up|1
24583|NCT01712074|115443|P3|Placebo Run-in Period|Adverse Event|0
24584|NCT01712074|115444|P2|Placebo Run-in Period|Adverse Event|0
24585|NCT01712074|115445|P1|Placebo Run-in Period|Adverse Event|2
24586|NCT01712061|115501|P3|Overall Study|Unspecified|0
24587|NCT01712061|115502|P2|Overall Study|Unspecified|3
24588|NCT01712061|115503|P1|Overall Study|Unspecified|0
24589|NCT01712061|115501|P3|Overall Study|Withdrawal by Subject|1
24590|NCT01712061|115502|P2|Overall Study|Withdrawal by Subject|7
24591|NCT01712061|115503|P1|Overall Study|Withdrawal by Subject|1
24592|NCT01712061|115501|P3|Overall Study|Medication Error Without Associated AE|0
24593|NCT01712061|115502|P2|Overall Study|Medication Error Without Associated AE|1
24594|NCT01712061|115503|P1|Overall Study|Medication Error Without Associated AE|0
24595|NCT01712061|115501|P3|Overall Study|Did Not Meet Entrance Criteria|3
24596|NCT01712061|115502|P2|Overall Study|Did Not Meet Entrance Criteria|6
24597|NCT01712061|115503|P1|Overall Study|Did Not Meet Entrance Criteria|4
24598|NCT01712061|115501|P3|Overall Study|Lost to Follow-up|1
24599|NCT01712061|115502|P2|Overall Study|Lost to Follow-up|0
24600|NCT01712061|115503|P1|Overall Study|Lost to Follow-up|1
24601|NCT01712061|115501|P3|Overall Study|Death|1
24602|NCT01712061|115502|P2|Overall Study|Death|0
24603|NCT01712061|115503|P1|Overall Study|Death|0
24604|NCT01712061|115501|P3|Overall Study|Adverse Event|5
24605|NCT01712061|115502|P2|Overall Study|Adverse Event|9
24606|NCT01712061|115503|P1|Overall Study|Adverse Event|4
24607|NCT01712009|115543|P3|Overall Study|Decision by Sponsor|12
24608|NCT01712009|115544|P2|Overall Study|Decision by Sponsor|14
24609|NCT01712009|115545|P1|Overall Study|Decision by Sponsor|12
24610|NCT01712009|115543|P3|Overall Study|Lost to Follow-up|1
24611|NCT01712009|115544|P2|Overall Study|Lost to Follow-up|0
24612|NCT01712009|115545|P1|Overall Study|Lost to Follow-up|2
24613|NCT01712009|115543|P3|Overall Study|Withdrawal by Subject|8
24614|NCT01712009|115544|P2|Overall Study|Withdrawal by Subject|15
24615|NCT01712009|115545|P1|Overall Study|Withdrawal by Subject|24
24616|NCT01711866|115579|P1|Overall Study|Adverse Event|2
24617|NCT01711866|115579|P1|Overall Study|Withdrawal by Subject|3
24618|NCT01711866|115579|P1|Overall Study|Noncompliant|3
24619|NCT01711853|115584|P1|Overall Study|Not treated|3
24620|NCT01711736|115591|P2|Overall Study|Migrated/moved from study area|1
24621|NCT01711736|115592|P1|Overall Study|Migrated/moved from study area|2
24622|NCT01711736|115591|P2|Overall Study|Withdrawal by Subject|6
24623|NCT01711736|115592|P1|Overall Study|Withdrawal by Subject|6
24624|NCT01711736|115591|P2|Overall Study|Lost to Follow-up|1
24625|NCT01711736|115592|P1|Overall Study|Lost to Follow-up|4
24626|NCT01711645|115620|P1|Overall Study|Physician Decision|5
24627|NCT01711645|115620|P1|Overall Study|Lost to Follow-up|6
24628|NCT01711645|115620|P1|Overall Study|Withdrawal by Subject|8
24629|NCT01711359|115665|P3|Treatment Period|Randomized, Not Treated|0
24630|NCT01711359|115666|P2|Treatment Period|Randomized, Not Treated|1
24631|NCT01711359|115667|P1|Treatment Period|Randomized, Not Treated|3
24632|NCT01711359|115665|P3|Treatment Period|Lost to Follow-up|1
24633|NCT01711359|115666|P2|Treatment Period|Lost to Follow-up|1
24634|NCT01711359|115667|P1|Treatment Period|Lost to Follow-up|1
24635|NCT01711359|115665|P3|Treatment Period|Sponsor Decision|0
24636|NCT01711359|115666|P2|Treatment Period|Sponsor Decision|0
24637|NCT01711359|115667|P1|Treatment Period|Sponsor Decision|1
24638|NCT01711359|115665|P3|Treatment Period|Entry Criteria Not Met|0
24639|NCT01711359|115666|P2|Treatment Period|Entry Criteria Not Met|0
24640|NCT01711359|115667|P1|Treatment Period|Entry Criteria Not Met|1
24641|NCT01711359|115665|P3|Treatment Period|Death|0
24642|NCT01711359|115666|P2|Treatment Period|Death|0
24643|NCT01711359|115667|P1|Treatment Period|Death|3
24644|NCT01711359|115665|P3|Treatment Period|Physician Decision|2
24645|NCT01711359|115666|P2|Treatment Period|Physician Decision|3
24646|NCT01711359|115667|P1|Treatment Period|Physician Decision|4
24647|NCT01711359|115665|P3|Treatment Period|Adverse Event|24
24648|NCT01711359|115666|P2|Treatment Period|Adverse Event|10
24649|NCT01711359|115667|P1|Treatment Period|Adverse Event|8
24650|NCT01711359|115665|P3|Treatment Period|Lack of Efficacy|2
24651|NCT01711359|115666|P2|Treatment Period|Lack of Efficacy|2
24652|NCT01711359|115667|P1|Treatment Period|Lack of Efficacy|13
24653|NCT01711359|115665|P3|Treatment Period|Withdrawal by Subject|13
24654|NCT01711359|115666|P2|Treatment Period|Withdrawal by Subject|7
24655|NCT01711359|115667|P1|Treatment Period|Withdrawal by Subject|18
24656|NCT01711216|115738|P1|Overall Study|no reason specified|22
24657|NCT01711216|115738|P1|Overall Study|variety of other minor reasons|83
24658|NCT01711216|115738|P1|Overall Study|Lost to Follow-up|46
24659|NCT01711216|115738|P1|Overall Study|Withdrawal by Subject|6
24660|NCT01711216|115738|P1|Overall Study|Pregnancy|56
24661|NCT01711216|115738|P1|Overall Study|Adverse Event|4
24662|NCT01710800|115791|P1|Overall Study|Protocol Violation|1
24663|NCT01710800|115791|P1|Overall Study|Withdrawal by Subject|21
24664|NCT01710657|115858|P3|Overall Study|Lack of Efficacy|1
24665|NCT01710657|115859|P2|Overall Study|Lack of Efficacy|1
24666|NCT01710657|115860|P1|Overall Study|Lack of Efficacy|0
24667|NCT01710657|115858|P3|Overall Study|Withdrawal by Subject|2
24668|NCT01710657|115859|P2|Overall Study|Withdrawal by Subject|1
24669|NCT01710657|115860|P1|Overall Study|Withdrawal by Subject|0
24670|NCT01710657|115858|P3|Overall Study|Adverse Event|28
24671|NCT01710657|115859|P2|Overall Study|Adverse Event|8
24672|NCT01710657|115860|P1|Overall Study|Adverse Event|14
24673|NCT01710657|115858|P3|Overall Study|Protocol Violation|0
24674|NCT01710657|115859|P2|Overall Study|Protocol Violation|2
24675|NCT01710657|115860|P1|Overall Study|Protocol Violation|2
24676|NCT01710657|115858|P3|Overall Study|Lost to Follow-up|1
24677|NCT01710657|115859|P2|Overall Study|Lost to Follow-up|0
24678|NCT01710657|115860|P1|Overall Study|Lost to Follow-up|2
24679|NCT01710527|115877|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
24680|NCT01710527|115878|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
24681|NCT01710514|115904|P2|Overall Study|Withdrawal by Subject|0
24682|NCT01710514|115905|P1|Overall Study|Withdrawal by Subject|1
24683|NCT01710514|115904|P2|Overall Study|Adverse Event|7
24684|NCT01710514|115905|P1|Overall Study|Adverse Event|6
24685|NCT01710501|115926|P3|Overall Study|Lost to Follow-up|0
24686|NCT01710501|115927|P2|Overall Study|Lost to Follow-up|0
24687|NCT01710501|115928|P1|Overall Study|Lost to Follow-up|2
24688|NCT01710358|115960|P3|Rescue Period|Withdrawal by Subject|0
24689|NCT01710358|115961|P2|Rescue Period|Withdrawal by Subject|8
24690|NCT01710358|115962|P1|Rescue Period|Withdrawal by Subject|0
24691|NCT01710358|115960|P3|Rescue Period|Lack of Efficacy|0
24692|NCT01710358|115961|P2|Rescue Period|Lack of Efficacy|7
24693|NCT01710358|115962|P1|Rescue Period|Lack of Efficacy|0
24694|NCT01710358|115960|P3|Rescue Period|Death|0
24695|NCT01710358|115961|P2|Rescue Period|Death|1
24696|NCT01710358|115962|P1|Rescue Period|Death|0
24697|NCT01710358|115960|P3|Rescue Period|Adverse Event|0
24698|NCT01710358|115961|P2|Rescue Period|Adverse Event|15
24699|NCT01710358|115962|P1|Rescue Period|Adverse Event|0
24700|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
24701|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
24702|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
24703|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
24704|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
24705|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
24706|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
24707|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
24708|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
24709|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
24710|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
24711|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
24712|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
24713|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
24714|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
24715|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
24716|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
24717|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
24718|NCT01710358|115960|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
24719|NCT01710358|115961|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
24720|NCT01710358|115962|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
24721|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
24722|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
24723|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
24724|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
24725|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
24726|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
24727|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
24728|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
24729|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
24730|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
24731|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
24732|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
24733|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
24734|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
24735|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
24736|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
24737|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
24738|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
24739|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
24740|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
24741|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
24742|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
24743|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
24744|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
24745|NCT01710358|115960|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
24746|NCT01710358|115961|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
24747|NCT01710358|115962|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
24748|NCT01710345|116033|P3|Overall Study|Drug Dosing Error|0
24749|NCT01710345|116034|P2|Overall Study|Drug Dosing Error|0
24750|NCT01710345|116035|P1|Overall Study|Drug Dosing Error|1
24751|NCT01710345|116033|P3|Overall Study|Lack of Efficacy|1
24752|NCT01710345|116034|P2|Overall Study|Lack of Efficacy|3
24753|NCT01710345|116035|P1|Overall Study|Lack of Efficacy|2
24754|NCT01710345|116033|P3|Overall Study|Adverse Event|0
24755|NCT01710345|116034|P2|Overall Study|Adverse Event|2
24756|NCT01710345|116035|P1|Overall Study|Adverse Event|0
24757|NCT01710046|116056|P2|Overall Study|Lost to Follow-up|0
24758|NCT01710046|116057|P1|Overall Study|Lost to Follow-up|1
24759|NCT01710033|116097|P5|Stage 2|Adverse Event|1
24760|NCT01710033|116098|P4|Stage 2|Adverse Event|0
24761|NCT01710033|116099|P3|Stage 2|Adverse Event|0
24762|NCT01710033|116100|P2|Stage 2|Adverse Event|0
24763|NCT01710033|116101|P1|Stage 2|Adverse Event|0
24764|NCT01710020|116182|P1|Period 1|Protocol Violation|1
24765|NCT01709903|116201|P2|Overall Study|Adverse Event|18
24766|NCT01709903|116202|P1|Overall Study|Adverse Event|11
24767|NCT01709903|116201|P2|Overall Study|Withdrawal by Subject|6
24768|NCT01709903|116202|P1|Overall Study|Withdrawal by Subject|6
24769|NCT01709903|116201|P2|Overall Study|Lack of Efficacy|3
24770|NCT01709903|116202|P1|Overall Study|Lack of Efficacy|3
24771|NCT01709903|116201|P2|Overall Study|Protocol Violation|2
24772|NCT01709903|116202|P1|Overall Study|Protocol Violation|3
24773|NCT01709903|116201|P2|Overall Study|Death|0
24774|NCT01709903|116202|P1|Overall Study|Death|2
24775|NCT01709903|116201|P2|Overall Study|Lost to Follow-up|2
24776|NCT01709903|116202|P1|Overall Study|Lost to Follow-up|0
24777|NCT01709903|116201|P2|Overall Study|no longer needed study drug|1
24778|NCT01709903|116202|P1|Overall Study|no longer needed study drug|0
24779|NCT01709903|116201|P2|Overall Study|In ability to use device|1
24780|NCT01709903|116202|P1|Overall Study|In ability to use device|1
24781|NCT01709903|116201|P2|Overall Study|Abnormal test procedure results|0
24782|NCT01709903|116202|P1|Overall Study|Abnormal test procedure results|1
24783|NCT01709903|116201|P2|Overall Study|administrative problems|6
24784|NCT01709903|116202|P1|Overall Study|administrative problems|2
24785|NCT01709864|116226|P2|Overall Study|Death|1
24786|NCT01709864|116227|P1|Overall Study|Death|0
24787|NCT01709864|116226|P2|Overall Study|Adverse Event|2
24788|NCT01709864|116227|P1|Overall Study|Adverse Event|0
24789|NCT01709864|116226|P2|Overall Study|non-compliance with study treatment|1
24790|NCT01709864|116227|P1|Overall Study|non-compliance with study treatment|1
24791|NCT01709864|116226|P2|Overall Study|Lost to Follow-up|0
24792|NCT01709864|116227|P1|Overall Study|Lost to Follow-up|1
24793|NCT01709864|116226|P2|Overall Study|subject/guardian decision|6
24794|NCT01709864|116227|P1|Overall Study|subject/guardian decision|5
24795|NCT01709864|116226|P2|Overall Study|Physician Decision|1
24796|NCT01709864|116227|P1|Overall Study|Physician Decision|0
24797|NCT01709708|116298|P2|Overall Study|Protocol Violation|2
24798|NCT01709708|116299|P1|Overall Study|Protocol Violation|1
24799|NCT01709578|116308|P3|Overall Study|Other, not related to safety or efficacy|5
24800|NCT01709578|116309|P2|Overall Study|Other, not related to safety or efficacy|7
24801|NCT01709578|116310|P1|Overall Study|Other, not related to safety or efficacy|2
24802|NCT01709578|116308|P3|Overall Study|Poor compliance to protocol|1
24803|NCT01709578|116309|P2|Overall Study|Poor compliance to protocol|2
24804|NCT01709578|116310|P1|Overall Study|Poor compliance to protocol|1
24805|NCT01709578|116308|P3|Overall Study|Lack of Efficacy|2
24806|NCT01709578|116309|P2|Overall Study|Lack of Efficacy|4
24807|NCT01709578|116310|P1|Overall Study|Lack of Efficacy|5
24808|NCT01709578|116308|P3|Overall Study|Adverse Event|17
24809|NCT01709578|116309|P2|Overall Study|Adverse Event|18
24810|NCT01709578|116310|P1|Overall Study|Adverse Event|9
24811|NCT01709578|116308|P3|Overall Study|Rescued and entered in long term safety|26
24812|NCT01709578|116309|P2|Overall Study|Rescued and entered in long term safety|25
24813|NCT01709578|116310|P1|Overall Study|Rescued and entered in long term safety|63
24814|NCT01709513|116441|P3|Overall Study|Unspecified|7
24815|NCT01709513|116442|P2|Overall Study|Unspecified|11
24816|NCT01709513|116443|P1|Overall Study|Unspecified|3
24817|NCT01709513|116441|P3|Overall Study|Poor compliance to protocol|0
24818|NCT01709513|116442|P2|Overall Study|Poor compliance to protocol|0
24819|NCT01709513|116443|P1|Overall Study|Poor compliance to protocol|2
24820|NCT01709513|116441|P3|Overall Study|Adverse Event|23
24821|NCT01709513|116442|P2|Overall Study|Adverse Event|31
24822|NCT01709513|116443|P1|Overall Study|Adverse Event|16
24823|NCT01709513|116441|P3|Overall Study|Randomized but not treated|0
24824|NCT01709513|116442|P2|Overall Study|Randomized but not treated|1
24825|NCT01709513|116443|P1|Overall Study|Randomized but not treated|0
24826|NCT01709500|116504|P2|Overall Study|Treatment ongoing|78
24827|NCT01709500|116505|P1|Overall Study|Treatment ongoing|156
24828|NCT01709500|116504|P2|Overall Study|Related to IMP administration|0
24829|NCT01709500|116505|P1|Overall Study|Related to IMP administration|1
24830|NCT01709500|116504|P2|Overall Study|Unspecified|1
24831|NCT01709500|116505|P1|Overall Study|Unspecified|3
24832|NCT01709500|116504|P2|Overall Study|Poor compliance to protocol|1
24833|NCT01709500|116505|P1|Overall Study|Poor compliance to protocol|2
24834|NCT01709500|116504|P2|Overall Study|Adverse Event|1
24835|NCT01709500|116505|P1|Overall Study|Adverse Event|5
24836|NCT01709500|116504|P2|Overall Study|Randomized but not treated|1
24837|NCT01709500|116505|P1|Overall Study|Randomized but not treated|0
24838|NCT01709383|116583|P2|Overall Study|Lost to Follow-up|0
24839|NCT01709383|116584|P1|Overall Study|Lost to Follow-up|1
24840|NCT01709331|116602|P1|Overall Study|Adverse Event|1
24841|NCT01709305|116608|P5|Phase 2|Withdrawal by Subject|12
24842|NCT01709305|116609|P4|Phase 2|Withdrawal by Subject|15
24843|NCT01709305|116610|P3|Phase 2|Withdrawal by Subject|6
24844|NCT01709305|116611|P2|Phase 2|Withdrawal by Subject|8
24845|NCT01709305|116612|P1|Phase 2|Withdrawal by Subject|0
24846|NCT01709305|116608|P5|Phase 2|Protocol Violation|9
24847|NCT01709305|116609|P4|Phase 2|Protocol Violation|13
24848|NCT01709305|116610|P3|Phase 2|Protocol Violation|19
24849|NCT01709305|116611|P2|Phase 2|Protocol Violation|19
24850|NCT01709305|116612|P1|Phase 2|Protocol Violation|0
24851|NCT01709305|116608|P5|Phase 2|Physician Decision|2
24852|NCT01709305|116609|P4|Phase 2|Physician Decision|1
24853|NCT01709305|116610|P3|Phase 2|Physician Decision|0
24854|NCT01709305|116611|P2|Phase 2|Physician Decision|2
24855|NCT01709305|116612|P1|Phase 2|Physician Decision|0
24856|NCT01709305|116608|P5|Phase 2|Travel, moving, etc.|5
24857|NCT01709305|116609|P4|Phase 2|Travel, moving, etc.|3
24858|NCT01709305|116610|P3|Phase 2|Travel, moving, etc.|3
24859|NCT01709305|116611|P2|Phase 2|Travel, moving, etc.|2
24860|NCT01709305|116612|P1|Phase 2|Travel, moving, etc.|0
24861|NCT01709305|116608|P5|Phase 2|Lost to Follow-up|5
24862|NCT01709305|116609|P4|Phase 2|Lost to Follow-up|9
24863|NCT01709305|116610|P3|Phase 2|Lost to Follow-up|6
24864|NCT01709305|116611|P2|Phase 2|Lost to Follow-up|10
24865|NCT01709305|116612|P1|Phase 2|Lost to Follow-up|0
24866|NCT01709305|116608|P5|Phase 2|Laboratory Adverse Event|1
24867|NCT01709305|116609|P4|Phase 2|Laboratory Adverse Event|1
24868|NCT01709305|116610|P3|Phase 2|Laboratory Adverse Event|0
24869|NCT01709305|116611|P2|Phase 2|Laboratory Adverse Event|1
24870|NCT01709305|116612|P1|Phase 2|Laboratory Adverse Event|0
24871|NCT01709305|116608|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
24872|NCT01709305|116609|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
24873|NCT01709305|116610|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
24874|NCT01709305|116611|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
24875|NCT01709305|116612|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
24876|NCT01709305|116608|P5|Phase 2|Death|0
24877|NCT01709305|116609|P4|Phase 2|Death|0
24878|NCT01709305|116610|P3|Phase 2|Death|1
24879|NCT01709305|116611|P2|Phase 2|Death|0
24880|NCT01709305|116612|P1|Phase 2|Death|0
24881|NCT01709305|116608|P5|Phase 2|Clinical Adverse Event|11
24882|NCT01709305|116609|P4|Phase 2|Clinical Adverse Event|6
24883|NCT01709305|116610|P3|Phase 2|Clinical Adverse Event|10
24884|NCT01709305|116611|P2|Phase 2|Clinical Adverse Event|10
24885|NCT01709305|116612|P1|Phase 2|Clinical Adverse Event|0
24886|NCT01709305|116608|P5|Phase 1|Withdrawal by Subject|0
24887|NCT01709305|116609|P4|Phase 1|Withdrawal by Subject|0
24888|NCT01709305|116610|P3|Phase 1|Withdrawal by Subject|0
24889|NCT01709305|116611|P2|Phase 1|Withdrawal by Subject|0
24890|NCT01709305|116612|P1|Phase 1|Withdrawal by Subject|218
24891|NCT01709305|116608|P5|Phase 1|Protocol Violation|0
24892|NCT01709305|116609|P4|Phase 1|Protocol Violation|0
24893|NCT01709305|116610|P3|Phase 1|Protocol Violation|0
24894|NCT01709305|116611|P2|Phase 1|Protocol Violation|0
24895|NCT01709305|116612|P1|Phase 1|Protocol Violation|118
24896|NCT01709305|116608|P5|Phase 1|Physician Decision|0
24897|NCT01709305|116609|P4|Phase 1|Physician Decision|0
24898|NCT01709305|116610|P3|Phase 1|Physician Decision|0
24899|NCT01709305|116611|P2|Phase 1|Physician Decision|0
24900|NCT01709305|116612|P1|Phase 1|Physician Decision|13
24901|NCT01709305|116608|P5|Phase 1|Travel, moving, etc.|0
24902|NCT01709305|116609|P4|Phase 1|Travel, moving, etc.|0
24903|NCT01709305|116610|P3|Phase 1|Travel, moving, etc.|0
24904|NCT01709305|116611|P2|Phase 1|Travel, moving, etc.|0
24905|NCT01709305|116612|P1|Phase 1|Travel, moving, etc.|30
24906|NCT01709305|116608|P5|Phase 1|Lost to Follow-up|0
24907|NCT01709305|116609|P4|Phase 1|Lost to Follow-up|0
24908|NCT01709305|116610|P3|Phase 1|Lost to Follow-up|0
24909|NCT01709305|116611|P2|Phase 1|Lost to Follow-up|0
24910|NCT01709305|116612|P1|Phase 1|Lost to Follow-up|147
24911|NCT01709305|116608|P5|Phase 1|Laboratory Adverse Event|0
24912|NCT01709305|116609|P4|Phase 1|Laboratory Adverse Event|0
24913|NCT01709305|116610|P3|Phase 1|Laboratory Adverse Event|0
24914|NCT01709305|116611|P2|Phase 1|Laboratory Adverse Event|0
24915|NCT01709305|116612|P1|Phase 1|Laboratory Adverse Event|16
24916|NCT01709305|116608|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
24917|NCT01709305|116609|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
24918|NCT01709305|116610|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
24919|NCT01709305|116611|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
24920|NCT01709305|116612|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
24921|NCT01709305|116608|P5|Phase 1|Death|0
24922|NCT01709305|116609|P4|Phase 1|Death|0
24923|NCT01709305|116610|P3|Phase 1|Death|0
24924|NCT01709305|116611|P2|Phase 1|Death|0
24925|NCT01709305|116612|P1|Phase 1|Death|2
24926|NCT01709305|116608|P5|Phase 1|Clinical Adverse Event|0
24927|NCT01709305|116609|P4|Phase 1|Clinical Adverse Event|0
24928|NCT01709305|116610|P3|Phase 1|Clinical Adverse Event|0
24929|NCT01709305|116611|P2|Phase 1|Clinical Adverse Event|0
24930|NCT01709305|116612|P1|Phase 1|Clinical Adverse Event|80
24931|NCT01709227|116649|P2|Overall Study|Pleural Peritoneal communication|9
24932|NCT01709227|116650|P1|Overall Study|Pleural Peritoneal communication|0
24933|NCT01709227|116649|P2|Overall Study|Physician Decision|0
24934|NCT01709227|116650|P1|Overall Study|Physician Decision|1
24935|NCT01709162|116676|P2|Overall Study|Withdrawal by Subject|1
24936|NCT01709162|116677|P1|Overall Study|Withdrawal by Subject|0
24937|NCT01709162|116676|P2|Overall Study|Not specified|0
24938|NCT01709162|116677|P1|Overall Study|Not specified|1
24939|NCT01709162|116676|P2|Overall Study|Administrative reason by sponsor|1
24940|NCT01709162|116677|P1|Overall Study|Administrative reason by sponsor|0
24941|NCT01709162|116676|P2|Overall Study|Study drug toxicity|0
24942|NCT01709162|116677|P1|Overall Study|Study drug toxicity|2
24943|NCT01709162|116676|P2|Overall Study|Disease progression|3
24944|NCT01709162|116677|P1|Overall Study|Disease progression|3
24945|NCT01709084|116698|P2|Overall Study|Not Treated|2
24946|NCT01709084|116699|P1|Overall Study|Not Treated|0
24947|NCT01709084|116698|P2|Overall Study|Participant Reached a Virologic Endpoint|1
24948|NCT01709084|116699|P1|Overall Study|Participant Reached a Virologic Endpoint|0
24949|NCT01709084|116698|P2|Overall Study|unspecified|3
24950|NCT01709084|116699|P1|Overall Study|unspecified|5
24951|NCT01709084|116698|P2|Overall Study|Adverse Event|0
24952|NCT01709084|116699|P1|Overall Study|Adverse Event|5
24953|NCT01709084|116698|P2|Overall Study|Withdrawal by Subject|2
24954|NCT01709084|116699|P1|Overall Study|Withdrawal by Subject|2
24955|NCT01709084|116698|P2|Overall Study|Lost to Follow-up|7
24956|NCT01709084|116699|P1|Overall Study|Lost to Follow-up|4
24957|NCT01708954|116727|P3|Step 2|Withdrawal by Subject|0
24958|NCT01708954|116728|P2|Step 2|Withdrawal by Subject|1
24959|NCT01708954|116729|P1|Step 2|Withdrawal by Subject|1
24960|NCT01708954|116727|P3|Step 2|Adverse Event|0
24961|NCT01708954|116728|P2|Step 2|Adverse Event|2
24962|NCT01708954|116729|P1|Step 2|Adverse Event|3
24963|NCT01708954|116727|P3|Step 2|Disease progression|0
24964|NCT01708954|116728|P2|Step 2|Disease progression|4
24965|NCT01708954|116729|P1|Step 2|Disease progression|9
24966|NCT01708954|116727|P3|Step 1|Ineligible or never received treatment|8
24967|NCT01708954|116728|P2|Step 1|Ineligible or never received treatment|2
24968|NCT01708954|116729|P1|Step 1|Ineligible or never received treatment|4
24969|NCT01708954|116727|P3|Step 1|Off-treatment reason not submitted|1
24970|NCT01708954|116728|P2|Step 1|Off-treatment reason not submitted|1
24971|NCT01708954|116729|P1|Step 1|Off-treatment reason not submitted|1
24972|NCT01708954|116727|P3|Step 1|Symptomatic deterioration|1
24973|NCT01708954|116728|P2|Step 1|Symptomatic deterioration|0
24974|NCT01708954|116729|P1|Step 1|Symptomatic deterioration|1
24975|NCT01708954|116727|P3|Step 1|Crossed over to Step 2|0
24976|NCT01708954|116728|P2|Step 1|Crossed over to Step 2|0
24977|NCT01708954|116729|P1|Step 1|Crossed over to Step 2|2
24978|NCT01708954|116727|P3|Step 1|Other complicating disease|0
24979|NCT01708954|116728|P2|Step 1|Other complicating disease|2
24980|NCT01708954|116729|P1|Step 1|Other complicating disease|0
24981|NCT01708954|116727|P3|Step 1|Withdrawal by Subject|3
24982|NCT01708954|116728|P2|Step 1|Withdrawal by Subject|5
24983|NCT01708954|116729|P1|Step 1|Withdrawal by Subject|2
24984|NCT01708954|116727|P3|Step 1|Death|3
24985|NCT01708954|116728|P2|Step 1|Death|2
24986|NCT01708954|116729|P1|Step 1|Death|3
24987|NCT01708954|116727|P3|Step 1|Adverse Event|13
24988|NCT01708954|116728|P2|Step 1|Adverse Event|11
24989|NCT01708954|116729|P1|Step 1|Adverse Event|3
24990|NCT01708954|116727|P3|Step 1|Disease progression|14
24991|NCT01708954|116728|P2|Step 1|Disease progression|17
24992|NCT01708954|116729|P1|Step 1|Disease progression|26
24993|NCT01708915|116754|P4|Overall Study|Other reasons than stated above|2
24994|NCT01708915|116755|P3|Overall Study|Other reasons than stated above|0
24995|NCT01708915|116756|P2|Overall Study|Other reasons than stated above|1
24996|NCT01708915|116757|P1|Overall Study|Other reasons than stated above|1
24997|NCT01708915|116754|P4|Overall Study|Withdrawal by Subject|2
24998|NCT01708915|116755|P3|Overall Study|Withdrawal by Subject|2
24999|NCT01708915|116756|P2|Overall Study|Withdrawal by Subject|1
25000|NCT01708915|116757|P1|Overall Study|Withdrawal by Subject|0
25001|NCT01708915|116754|P4|Overall Study|Protocol Violation|1
25002|NCT01708915|116755|P3|Overall Study|Protocol Violation|0
25003|NCT01708915|116756|P2|Overall Study|Protocol Violation|0
25004|NCT01708915|116757|P1|Overall Study|Protocol Violation|0
25005|NCT01708915|116754|P4|Overall Study|Lack of Efficacy|15
25006|NCT01708915|116755|P3|Overall Study|Lack of Efficacy|35
25007|NCT01708915|116756|P2|Overall Study|Lack of Efficacy|60
25008|NCT01708915|116757|P1|Overall Study|Lack of Efficacy|84
25009|NCT01708915|116754|P4|Overall Study|Adverse Event|13
25010|NCT01708915|116755|P3|Overall Study|Adverse Event|9
25011|NCT01708915|116756|P2|Overall Study|Adverse Event|0
25012|NCT01708915|116757|P1|Overall Study|Adverse Event|1
25013|NCT01708902|116786|P7|Overall Study|Other Reason|0
25014|NCT01708902|116787|P6|Overall Study|Other Reason|2
25015|NCT01708902|116788|P5|Overall Study|Other Reason|1
25016|NCT01708902|116789|P4|Overall Study|Other Reason|1
25017|NCT01708902|116790|P3|Overall Study|Other Reason|1
25018|NCT01708902|116791|P2|Overall Study|Other Reason|0
25019|NCT01708902|116792|P1|Overall Study|Other Reason|1
25020|NCT01708902|116786|P7|Overall Study|Refused to continue trial medication|1
25021|NCT01708902|116787|P6|Overall Study|Refused to continue trial medication|1
25022|NCT01708902|116788|P5|Overall Study|Refused to continue trial medication|8
25023|NCT01708902|116789|P4|Overall Study|Refused to continue trial medication|2
25024|NCT01708902|116790|P3|Overall Study|Refused to continue trial medication|4
25025|NCT01708902|116791|P2|Overall Study|Refused to continue trial medication|0
25026|NCT01708902|116792|P1|Overall Study|Refused to continue trial medication|8
25027|NCT01708902|116786|P7|Overall Study|Lost to Follow-up|1
25028|NCT01708902|116787|P6|Overall Study|Lost to Follow-up|0
25029|NCT01708902|116788|P5|Overall Study|Lost to Follow-up|0
25030|NCT01708902|116789|P4|Overall Study|Lost to Follow-up|2
25031|NCT01708902|116790|P3|Overall Study|Lost to Follow-up|2
25032|NCT01708902|116791|P2|Overall Study|Lost to Follow-up|1
25033|NCT01708902|116792|P1|Overall Study|Lost to Follow-up|2
25034|NCT01708902|116786|P7|Overall Study|Non compliance with protocol|0
25035|NCT01708902|116787|P6|Overall Study|Non compliance with protocol|0
25036|NCT01708902|116788|P5|Overall Study|Non compliance with protocol|0
25037|NCT01708902|116789|P4|Overall Study|Non compliance with protocol|3
25038|NCT01708902|116790|P3|Overall Study|Non compliance with protocol|1
25039|NCT01708902|116791|P2|Overall Study|Non compliance with protocol|2
25040|NCT01708902|116792|P1|Overall Study|Non compliance with protocol|0
25041|NCT01708902|116786|P7|Overall Study|Lack of Efficacy|0
25042|NCT01708902|116787|P6|Overall Study|Lack of Efficacy|1
25043|NCT01708902|116788|P5|Overall Study|Lack of Efficacy|0
25044|NCT01708902|116789|P4|Overall Study|Lack of Efficacy|0
25045|NCT01708902|116790|P3|Overall Study|Lack of Efficacy|0
25046|NCT01708902|116791|P2|Overall Study|Lack of Efficacy|1
25047|NCT01708902|116792|P1|Overall Study|Lack of Efficacy|3
25048|NCT01708902|116786|P7|Overall Study|Adverse Event|5
25049|NCT01708902|116787|P6|Overall Study|Adverse Event|3
25050|NCT01708902|116788|P5|Overall Study|Adverse Event|7
25051|NCT01708902|116789|P4|Overall Study|Adverse Event|2
25052|NCT01708902|116790|P3|Overall Study|Adverse Event|9
25053|NCT01708902|116791|P2|Overall Study|Adverse Event|4
25054|NCT01708902|116792|P1|Overall Study|Adverse Event|3
25055|NCT01708291|116865|P2|Overall Study|fighting|1
25056|NCT01708291|116866|P1|Overall Study|fighting|2
25057|NCT01708187|116905|P2|Overall Study|Lost to Follow-up|1
25058|NCT01708187|116906|P1|Overall Study|Lost to Follow-up|0
25059|NCT01708174|116915|P3|Treatment Period|Adverse Event|0
25060|NCT01708174|116916|P2|Treatment Period|Adverse Event|1
25061|NCT01708174|116917|P1|Treatment Period|Adverse Event|0
25062|NCT01708174|116915|P3|Treatment Period|Death|1
25063|NCT01708174|116916|P2|Treatment Period|Death|0
25064|NCT01708174|116917|P1|Treatment Period|Death|0
25065|NCT01708174|116915|P3|Treatment Period|Progressive disease|0
25066|NCT01708174|116916|P2|Treatment Period|Progressive disease|1
25067|NCT01708174|116917|P1|Treatment Period|Progressive disease|0
25068|NCT01708174|116915|P3|Treatment Period|Withdrawal by Subject|0
25069|NCT01708174|116916|P2|Treatment Period|Withdrawal by Subject|0
25070|NCT01708174|116917|P1|Treatment Period|Withdrawal by Subject|1
25071|NCT01708057|116954|P3|Overall Study|Withdrawal due to study termination.|1
25072|NCT01708057|116955|P2|Overall Study|Withdrawal due to study termination.|1
25073|NCT01708057|116956|P1|Overall Study|Withdrawal due to study termination.|1
25074|NCT01707667|117014|P2|Period 1|expulsion of colonic sensor catheter|0
25075|NCT01707667|117015|P1|Period 1|expulsion of colonic sensor catheter|1
25076|NCT01707290|117039|P2|Overall Study|Other unspecified|0
25077|NCT01707290|117040|P1|Overall Study|Other unspecified|17
25078|NCT01707290|117039|P2|Overall Study|Commercial drug available|1
25079|NCT01707290|117040|P1|Overall Study|Commercial drug available|60
25080|NCT01707290|117039|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
25081|NCT01707290|117040|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
25082|NCT01707290|117039|P2|Overall Study|Lost to Follow-up|0
25083|NCT01707290|117040|P1|Overall Study|Lost to Follow-up|3
25084|NCT01707290|117039|P2|Overall Study|Physician Decision|0
25085|NCT01707290|117040|P1|Overall Study|Physician Decision|1
25086|NCT01707290|117039|P2|Overall Study|Adverse event (AE)|0
25087|NCT01707290|117040|P1|Overall Study|Adverse event (AE)|1
25088|NCT01706926|117123|P4|Overall Study|Unspecified|3
25089|NCT01706926|117124|P3|Overall Study|Unspecified|4
25090|NCT01706926|117125|P2|Overall Study|Unspecified|4
25091|NCT01706926|117126|P1|Overall Study|Unspecified|4
25092|NCT01706926|117123|P4|Overall Study|Withdrawal by Subject|2
25093|NCT01706926|117124|P3|Overall Study|Withdrawal by Subject|1
25094|NCT01706926|117125|P2|Overall Study|Withdrawal by Subject|0
25095|NCT01706926|117126|P1|Overall Study|Withdrawal by Subject|2
25096|NCT01706926|117123|P4|Overall Study|Lost to Follow-up|0
25097|NCT01706926|117124|P3|Overall Study|Lost to Follow-up|1
25098|NCT01706926|117125|P2|Overall Study|Lost to Follow-up|0
25099|NCT01706926|117126|P1|Overall Study|Lost to Follow-up|0
25100|NCT01706770|117245|P2|Overall Study|Physician Decision|0
25101|NCT01706770|117246|P1|Overall Study|Physician Decision|1
25102|NCT01706770|117245|P2|Overall Study|Lost to Follow-up|0
25103|NCT01706770|117246|P1|Overall Study|Lost to Follow-up|1
25104|NCT01706575|117294|P1|Overall Study|Started but not Treated|6
25105|NCT01706575|117294|P1|Overall Study|Lost to Follow-up|2
25106|NCT01706575|117294|P1|Overall Study|Participant Withdrew Consent|4
25107|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
25108|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
25109|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
25110|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Physician Decision|2
25111|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Physician Decision|2
25112|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Physician Decision|0
25113|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
25114|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
25115|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
25116|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
25117|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
25118|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
25119|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Protocol Violation|2
25120|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Protocol Violation|4
25121|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Protocol Violation|0
25122|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
25123|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
25124|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
25210|NCT01704495|117591|P3|Optional Safety Extension|Adverse Event|0
25125|NCT01706328|117312|P3|12-week Double-blind Treatment Period|Adverse Event|16
25126|NCT01706328|117313|P2|12-week Double-blind Treatment Period|Adverse Event|14
25127|NCT01706328|117314|P1|12-week Double-blind Treatment Period|Adverse Event|0
25128|NCT01706328|117312|P3|2-week Run-in Period|Lost to Follow-up|0
25129|NCT01706328|117313|P2|2-week Run-in Period|Lost to Follow-up|0
25130|NCT01706328|117314|P1|2-week Run-in Period|Lost to Follow-up|2
25131|NCT01706328|117312|P3|2-week Run-in Period|Adverse Event|0
25132|NCT01706328|117313|P2|2-week Run-in Period|Adverse Event|0
25133|NCT01706328|117314|P1|2-week Run-in Period|Adverse Event|4
25134|NCT01706328|117312|P3|2-week Run-in Period|Physician Decision|0
25135|NCT01706328|117313|P2|2-week Run-in Period|Physician Decision|0
25136|NCT01706328|117314|P1|2-week Run-in Period|Physician Decision|4
25137|NCT01706328|117312|P3|2-week Run-in Period|Withdrawal by Subject|0
25138|NCT01706328|117313|P2|2-week Run-in Period|Withdrawal by Subject|0
25139|NCT01706328|117314|P1|2-week Run-in Period|Withdrawal by Subject|15
25140|NCT01706328|117312|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
25141|NCT01706328|117313|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
25142|NCT01706328|117314|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
25143|NCT01706250|117324|P1|Overall Study|Lost to Follow-up|2
25144|NCT01706159|117355|P2|Overall Study|Unclassified|1
25145|NCT01706159|117356|P1|Overall Study|Unclassified|6
25146|NCT01706159|117355|P2|Overall Study|Withdrawal Criteria|1
25147|NCT01706159|117356|P1|Overall Study|Withdrawal Criteria|2
25148|NCT01706146|117370|P1|Overall Study|Developed AF and need for antiplatelets|2
25149|NCT01706146|117370|P1|Overall Study|Adverse Event|3
25150|NCT01706146|117370|P1|Overall Study|Withdrawal by Subject|1
25151|NCT01705717|117377|P2|Overall Study|Not Specified|2
25152|NCT01705717|117378|P1|Overall Study|Not Specified|0
25153|NCT01705717|117377|P2|Overall Study|Lack of Efficacy|1
25154|NCT01705717|117378|P1|Overall Study|Lack of Efficacy|0
25155|NCT01705717|117377|P2|Overall Study|Adverse Event|2
25156|NCT01705717|117378|P1|Overall Study|Adverse Event|2
25157|NCT01705652|117395|P2|Overall Study|non-compliance|1
25158|NCT01705652|117396|P1|Overall Study|non-compliance|1
25159|NCT01705652|117395|P2|Overall Study|Withdrawal by Subject|2
25160|NCT01705652|117396|P1|Overall Study|Withdrawal by Subject|1
25161|NCT01705652|117395|P2|Overall Study|Adverse Event|0
25162|NCT01705652|117396|P1|Overall Study|Adverse Event|1
25163|NCT01705574|117404|P2|Overall Study|Still on Study|125
25164|NCT01705574|117405|P1|Overall Study|Still on Study|135
25165|NCT01705574|117404|P2|Overall Study|Lost to Follow-up|15
25166|NCT01705574|117405|P1|Overall Study|Lost to Follow-up|11
25167|NCT01705574|117404|P2|Overall Study|Withdrew Consent|5
25168|NCT01705574|117405|P1|Overall Study|Withdrew Consent|8
25169|NCT01705574|117404|P2|Overall Study|Protocol Violation|0
25170|NCT01705574|117405|P1|Overall Study|Protocol Violation|1
25171|NCT01705574|117404|P2|Overall Study|Non-Compliance with Study Drug|4
25172|NCT01705574|117405|P1|Overall Study|Non-Compliance with Study Drug|4
25173|NCT01705574|117404|P2|Overall Study|Pregnancy|1
25174|NCT01705574|117405|P1|Overall Study|Pregnancy|1
25175|NCT01705574|117404|P2|Overall Study|Adverse Event|9
25176|NCT01705574|117405|P1|Overall Study|Adverse Event|3
25177|NCT01705574|117404|P2|Overall Study|Randomized but Not Treated|4
25178|NCT01705574|117405|P1|Overall Study|Randomized but Not Treated|4
25179|NCT01705145|117423|P1|Part B|Adverse Event|1
25180|NCT01704846|117470|P2|Treatment Period 2|Withdrawal by Subject|1
25181|NCT01704846|117471|P1|Treatment Period 2|Withdrawal by Subject|0
25182|NCT01704755|117526|P2|Overall Study|Withdrew consent and personal issues|0
25183|NCT01704755|117527|P1|Overall Study|Withdrew consent and personal issues|1
25184|NCT01704755|117526|P2|Overall Study|Other (not specified)|1
25185|NCT01704755|117527|P1|Overall Study|Other (not specified)|3
25186|NCT01704755|117526|P2|Overall Study|Withdrew consent|1
25187|NCT01704755|117527|P1|Overall Study|Withdrew consent|1
25188|NCT01704755|117526|P2|Overall Study|Lost to Follow-up|4
25189|NCT01704755|117527|P1|Overall Study|Lost to Follow-up|3
25190|NCT01704755|117526|P2|Overall Study|Adverse Event|1
25191|NCT01704755|117527|P1|Overall Study|Adverse Event|4
25192|NCT01704651|117541|P2|Overall Study|Post-op did not have laparotomy|1
25193|NCT01704651|117542|P1|Overall Study|Post-op did not have laparotomy|2
25194|NCT01704651|117541|P2|Overall Study|Nasogastric tube placement in surgery|1
25195|NCT01704651|117542|P1|Overall Study|Nasogastric tube placement in surgery|1
25196|NCT01704651|117541|P2|Overall Study|Pre-op change in treatment plan|4
25197|NCT01704651|117542|P1|Overall Study|Pre-op change in treatment plan|1
25198|NCT01704651|117541|P2|Overall Study|Pre-op withdrawal by subject|1
25199|NCT01704651|117542|P1|Overall Study|Pre-op withdrawal by subject|1
25200|NCT01704599|117550|P1|Overall Study|Adverse Event|1
25201|NCT01704495|117590|P4|Optional Safety Extension|Withdrawal by Subject|2
25202|NCT01704495|117591|P3|Optional Safety Extension|Withdrawal by Subject|1
25203|NCT01704495|117592|P2|Optional Safety Extension|Withdrawal by Subject|0
25204|NCT01704495|117593|P1|Optional Safety Extension|Withdrawal by Subject|2
25205|NCT01704495|117590|P4|Optional Safety Extension|Other reason|28
25206|NCT01704495|117591|P3|Optional Safety Extension|Other reason|30
25207|NCT01704495|117592|P2|Optional Safety Extension|Other reason|29
25208|NCT01704495|117593|P1|Optional Safety Extension|Other reason|27
25209|NCT01704495|117590|P4|Optional Safety Extension|Adverse Event|1
25211|NCT01704495|117592|P2|Optional Safety Extension|Adverse Event|4
25212|NCT01704495|117593|P1|Optional Safety Extension|Adverse Event|0
25213|NCT01704495|117590|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
25214|NCT01704495|117591|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
25215|NCT01704495|117592|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
25216|NCT01704495|117593|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
25217|NCT01704495|117590|P4|Subjects Randomized|Protocol Violation|0
25218|NCT01704495|117591|P3|Subjects Randomized|Protocol Violation|2
25219|NCT01704495|117592|P2|Subjects Randomized|Protocol Violation|1
25220|NCT01704495|117593|P1|Subjects Randomized|Protocol Violation|1
25221|NCT01704495|117590|P4|Subjects Randomized|Withdrawal by Subject|5
25222|NCT01704495|117591|P3|Subjects Randomized|Withdrawal by Subject|5
25223|NCT01704495|117592|P2|Subjects Randomized|Withdrawal by Subject|5
25224|NCT01704495|117593|P1|Subjects Randomized|Withdrawal by Subject|5
25225|NCT01704495|117590|P4|Subjects Randomized|Adverse Event|7
25226|NCT01704495|117591|P3|Subjects Randomized|Adverse Event|0
25227|NCT01704495|117592|P2|Subjects Randomized|Adverse Event|2
25228|NCT01704495|117593|P1|Subjects Randomized|Adverse Event|8
25229|NCT01704495|117590|P4|Subjects Randomized|Discontinuation criteria met|0
25230|NCT01704495|117591|P3|Subjects Randomized|Discontinuation criteria met|2
25231|NCT01704495|117592|P2|Subjects Randomized|Discontinuation criteria met|2
25232|NCT01704495|117593|P1|Subjects Randomized|Discontinuation criteria met|4
25233|NCT01704495|117590|P4|Subjects Randomized|Other Reason|2
25234|NCT01704495|117591|P3|Subjects Randomized|Other Reason|3
25235|NCT01704495|117592|P2|Subjects Randomized|Other Reason|2
25236|NCT01704495|117593|P1|Subjects Randomized|Other Reason|3
25237|NCT01704287|117809|P5|Switch to Pembrolizumab Treatment Period|Ongoing in Study|16
25238|NCT01704287|117810|P4|Switch to Pembrolizumab Treatment Period|Ongoing in Study|21
25239|NCT01704287|117811|P3|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
25240|NCT01704287|117812|P2|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
25241|NCT01704287|117813|P1|Switch to Pembrolizumab Treatment Period|Ongoing in Study|0
25242|NCT01704287|117809|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
25243|NCT01704287|117810|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
25244|NCT01704287|117811|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
25245|NCT01704287|117812|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
25246|NCT01704287|117813|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
25247|NCT01704287|117809|P5|Switch to Pembrolizumab Treatment Period|Death|28
25248|NCT01704287|117810|P4|Switch to Pembrolizumab Treatment Period|Death|29
25249|NCT01704287|117811|P3|Switch to Pembrolizumab Treatment Period|Death|0
25250|NCT01704287|117812|P2|Switch to Pembrolizumab Treatment Period|Death|0
25251|NCT01704287|117813|P1|Switch to Pembrolizumab Treatment Period|Death|0
25252|NCT01704287|117809|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
25253|NCT01704287|117810|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
25337|NCT01703260|118110|P3|Overall Study|Withdrawal by Subject|1
25254|NCT01704287|117811|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
25255|NCT01704287|117812|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
25256|NCT01704287|117813|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
25257|NCT01704287|117809|P5|Initial Treatment Period|Switched to Pembrolizumab|0
25258|NCT01704287|117810|P4|Initial Treatment Period|Switched to Pembrolizumab|0
25259|NCT01704287|117811|P3|Initial Treatment Period|Switched to Pembrolizumab|98
25260|NCT01704287|117812|P2|Initial Treatment Period|Switched to Pembrolizumab|0
25261|NCT01704287|117813|P1|Initial Treatment Period|Switched to Pembrolizumab|0
25262|NCT01704287|117809|P5|Initial Treatment Period|Lost to Follow-up|0
25263|NCT01704287|117810|P4|Initial Treatment Period|Lost to Follow-up|0
25264|NCT01704287|117811|P3|Initial Treatment Period|Lost to Follow-up|3
25265|NCT01704287|117812|P2|Initial Treatment Period|Lost to Follow-up|1
25266|NCT01704287|117813|P1|Initial Treatment Period|Lost to Follow-up|3
25267|NCT01704287|117809|P5|Initial Treatment Period|Ongoing in Study|0
25268|NCT01704287|117810|P4|Initial Treatment Period|Ongoing in Study|0
25269|NCT01704287|117811|P3|Initial Treatment Period|Ongoing in Study|44
25270|NCT01704287|117812|P2|Initial Treatment Period|Ongoing in Study|62
25271|NCT01704287|117813|P1|Initial Treatment Period|Ongoing in Study|52
25272|NCT01704287|117809|P5|Initial Treatment Period|Unspecified|0
25273|NCT01704287|117810|P4|Initial Treatment Period|Unspecified|0
25274|NCT01704287|117811|P3|Initial Treatment Period|Unspecified|0
25275|NCT01704287|117812|P2|Initial Treatment Period|Unspecified|0
25276|NCT01704287|117813|P1|Initial Treatment Period|Unspecified|1
25277|NCT01704287|117809|P5|Initial Treatment Period|Withdrawal by Subject|0
25278|NCT01704287|117810|P4|Initial Treatment Period|Withdrawal by Subject|0
25279|NCT01704287|117811|P3|Initial Treatment Period|Withdrawal by Subject|4
25280|NCT01704287|117812|P2|Initial Treatment Period|Withdrawal by Subject|1
25281|NCT01704287|117813|P1|Initial Treatment Period|Withdrawal by Subject|1
25282|NCT01704287|117809|P5|Initial Treatment Period|Death|0
25283|NCT01704287|117810|P4|Initial Treatment Period|Death|0
25284|NCT01704287|117811|P3|Initial Treatment Period|Death|30
25285|NCT01704287|117812|P2|Initial Treatment Period|Death|117
25286|NCT01704287|117813|P1|Initial Treatment Period|Death|123
25287|NCT01704261|117848|P2|Overall Study|Lost to Follow-up|0
25288|NCT01704261|117849|P1|Overall Study|Lost to Follow-up|1
25289|NCT01704261|117848|P2|Overall Study|Withdrawal by Subject|15
25290|NCT01704261|117849|P1|Overall Study|Withdrawal by Subject|12
25291|NCT01704079|117876|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
25292|NCT01704079|117877|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
25293|NCT01704079|117876|P2|Overall Study|Subject noncompliance|3
25294|NCT01704079|117877|P1|Overall Study|Subject noncompliance|2
25295|NCT01704079|117876|P2|Overall Study|Protocol Violation|0
25296|NCT01704079|117877|P1|Overall Study|Protocol Violation|1
25297|NCT01704079|117876|P2|Overall Study|Adverse Event|7
25298|NCT01704079|117877|P1|Overall Study|Adverse Event|4
25299|NCT01704079|117876|P2|Overall Study|Lost to Follow-up|5
25300|NCT01704079|117877|P1|Overall Study|Lost to Follow-up|2
25301|NCT01704079|117876|P2|Overall Study|Withdrawal by Subject|7
25302|NCT01704079|117877|P1|Overall Study|Withdrawal by Subject|5
25303|NCT01703988|117893|P4|Overall Study|Investigator Judgment|1
25304|NCT01703988|117894|P3|Overall Study|Investigator Judgment|0
25305|NCT01703988|117895|P2|Overall Study|Investigator Judgment|0
25306|NCT01703988|117896|P1|Overall Study|Investigator Judgment|0
25307|NCT01703858|117926|P3|Overall Study|Withdrawal by Subject|0
25308|NCT01703858|117927|P2|Overall Study|Withdrawal by Subject|1
25309|NCT01703858|117928|P1|Overall Study|Withdrawal by Subject|0
25310|NCT01703845|117953|P2|Overall Study|other than stated above|0
25311|NCT01703845|117954|P1|Overall Study|other than stated above|1
25312|NCT01703845|117953|P2|Overall Study|Protocol Violation|0
25313|NCT01703845|117954|P1|Overall Study|Protocol Violation|1
25314|NCT01703845|117953|P2|Overall Study|Adverse Event|0
25315|NCT01703845|117954|P1|Overall Study|Adverse Event|1
25316|NCT01703832|117991|P2|Overall Study|Withdrawal by Subject|0
25317|NCT01703832|117992|P1|Overall Study|Withdrawal by Subject|1
25318|NCT01703819|118024|P2|Overall Study|Withdrawal by Subject|1
25319|NCT01703819|118025|P1|Overall Study|Withdrawal by Subject|0
25320|NCT01703819|118024|P2|Overall Study|Adverse Event|1
25321|NCT01703819|118025|P1|Overall Study|Adverse Event|0
25322|NCT01703286|118082|P6|Period 2 Including Washout|Adverse Event|0
25323|NCT01703286|118083|P5|Period 2 Including Washout|Adverse Event|0
25324|NCT01703286|118084|P4|Period 2 Including Washout|Adverse Event|1
25325|NCT01703286|118085|P3|Period 2 Including Washout|Adverse Event|0
25326|NCT01703286|118086|P2|Period 2 Including Washout|Adverse Event|0
25327|NCT01703286|118087|P1|Period 2 Including Washout|Adverse Event|0
25328|NCT01703286|118082|P6|Period 1 Including Washout|Withdrawal by Subject|1
25329|NCT01703286|118083|P5|Period 1 Including Washout|Withdrawal by Subject|0
25330|NCT01703286|118084|P4|Period 1 Including Washout|Withdrawal by Subject|1
25331|NCT01703286|118085|P3|Period 1 Including Washout|Withdrawal by Subject|0
25332|NCT01703286|118086|P2|Period 1 Including Washout|Withdrawal by Subject|0
25333|NCT01703286|118087|P1|Period 1 Including Washout|Withdrawal by Subject|0
25334|NCT01703260|118110|P3|Overall Study|Study Termination|0
25335|NCT01703260|118111|P2|Overall Study|Study Termination|2
25336|NCT01703260|118112|P1|Overall Study|Study Termination|1
25338|NCT01703260|118111|P2|Overall Study|Withdrawal by Subject|0
25339|NCT01703260|118112|P1|Overall Study|Withdrawal by Subject|0
25340|NCT01703260|118110|P3|Overall Study|Lost to Follow-up|0
25341|NCT01703260|118111|P2|Overall Study|Lost to Follow-up|0
25342|NCT01703260|118112|P1|Overall Study|Lost to Follow-up|1
25343|NCT01703260|118110|P3|Overall Study|Adverse Event|2
25344|NCT01703260|118111|P2|Overall Study|Adverse Event|2
25345|NCT01703260|118112|P1|Overall Study|Adverse Event|1
25346|NCT01703221|118138|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
25347|NCT01703221|118139|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
25348|NCT01703221|118140|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
25349|NCT01703221|118138|P3|Phase B - (Week 25 to 52)|Adverse Event|2
25350|NCT01703221|118139|P2|Phase B - (Week 25 to 52)|Adverse Event|3
25351|NCT01703221|118140|P1|Phase B - (Week 25 to 52)|Adverse Event|2
25352|NCT01703221|118138|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
25353|NCT01703221|118139|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
25354|NCT01703221|118140|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
25355|NCT01703221|118138|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
25356|NCT01703221|118139|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
25357|NCT01703221|118140|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
25358|NCT01703221|118138|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
25359|NCT01703221|118139|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25360|NCT01703221|118140|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
25361|NCT01703221|118138|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
25362|NCT01703221|118139|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
25363|NCT01703221|118140|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
25364|NCT01703221|118138|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
25365|NCT01703221|118139|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
25366|NCT01703221|118140|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
25367|NCT01703221|118138|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
25368|NCT01703221|118139|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
25369|NCT01703221|118140|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
25370|NCT01703091|118171|P2|Overall Study|Sponsor Decision|0
25371|NCT01703091|118172|P1|Overall Study|Sponsor Decision|1
25372|NCT01703091|118171|P2|Overall Study|Withdrawal by Subject|0
25373|NCT01703091|118172|P1|Overall Study|Withdrawal by Subject|1
25374|NCT01703091|118171|P2|Overall Study|Physician Decision|1
25375|NCT01703091|118172|P1|Overall Study|Physician Decision|2
25376|NCT01703091|118171|P2|Overall Study|Adverse Event|3
25377|NCT01703091|118172|P1|Overall Study|Adverse Event|5
25378|NCT01703000|118188|P1|Overall Study|Death|1
25379|NCT01702987|118221|P2|Overall Study|Withdrawal by Subject|0
25380|NCT01702987|118222|P1|Overall Study|Withdrawal by Subject|1
25381|NCT01702961|118228|P1|Overall Study|Ongoing|11
25382|NCT01702961|118228|P1|Overall Study|Lost to Follow-up|2
25383|NCT01702961|118228|P1|Overall Study|Death|6
25384|NCT01702961|118228|P1|Overall Study|Relapse|20
25385|NCT01702961|118228|P1|Overall Study|Progressive disease|5
25386|NCT01702961|118228|P1|Overall Study|Additional treatment|3
25387|NCT01702532|118236|P2|Overall Study|Adverse Event|1
25388|NCT01702532|118237|P1|Overall Study|Adverse Event|0
25389|NCT01702519|118247|P2|Washout Period|Withdrawal by Subject|2
25390|NCT01702519|118248|P1|Washout Period|Withdrawal by Subject|0
25391|NCT01702519|118247|P2|Washout Period|Lost to Follow-up|0
25392|NCT01702519|118248|P1|Washout Period|Lost to Follow-up|1
25393|NCT01702454|118266|P2|Overall Study|Lost to Follow-up|6
25394|NCT01702454|118267|P1|Overall Study|Lost to Follow-up|3
25395|NCT01702454|118266|P2|Overall Study|Migrated/moved from study area|1
25396|NCT01702454|118267|P1|Overall Study|Migrated/moved from study area|0
25397|NCT01702454|118266|P2|Overall Study|Consent withdrawal|1
25398|NCT01702454|118267|P1|Overall Study|Consent withdrawal|0
25399|NCT01702363|118345|P1|Overall Study|Withdrawal by Subject|2
25400|NCT01702363|118345|P1|Overall Study|Lack of Efficacy|4
25401|NCT01702363|118345|P1|Overall Study|Adverse Event|14
25402|NCT01702311|118362|P2|Overall Study|Physician Decision|4
25403|NCT01702311|118363|P1|Overall Study|Physician Decision|3
25404|NCT01702311|118362|P2|Overall Study|Discharge less than 24 hours|7
25405|NCT01702311|118363|P1|Overall Study|Discharge less than 24 hours|10
25406|NCT01702311|118362|P2|Overall Study|Withdrawal by Subject|2
25407|NCT01702311|118363|P1|Overall Study|Withdrawal by Subject|3
25408|NCT01702298|118369|P1|Overall Study|Withdrawal by Subject|1
25409|NCT01702246|118397|P1|Overall Study|Physician Decision|1
25410|NCT01702246|118397|P1|Overall Study|Withdrawal by Subject|2
25411|NCT01702246|118397|P1|Overall Study|Lost to Follow-up|2
25412|NCT01702025|118451|P4|Overall Study|Adverse Event|0
25413|NCT01702025|118452|P3|Overall Study|Adverse Event|1
25414|NCT01702025|118453|P2|Overall Study|Adverse Event|1
25415|NCT01702025|118454|P1|Overall Study|Adverse Event|1
25416|NCT01702025|118451|P4|Overall Study|Equipment failure|0
25417|NCT01702025|118452|P3|Overall Study|Equipment failure|0
25418|NCT01702025|118453|P2|Overall Study|Equipment failure|0
25419|NCT01702025|118454|P1|Overall Study|Equipment failure|1
25420|NCT01701674|118483|P1|Overall Study|Unable to safely complete treatment|1
25421|NCT01701401|118567|P4|Overall Study|Protocol Violation|0
25422|NCT01701401|118568|P3|Overall Study|Protocol Violation|1
25423|NCT01701401|118569|P2|Overall Study|Protocol Violation|0
25424|NCT01701401|118570|P1|Overall Study|Protocol Violation|0
25425|NCT01701401|118567|P4|Overall Study|Adverse Event|0
25426|NCT01701401|118568|P3|Overall Study|Adverse Event|0
25427|NCT01701401|118569|P2|Overall Study|Adverse Event|0
25428|NCT01701401|118570|P1|Overall Study|Adverse Event|1
25429|NCT01701401|118567|P4|Overall Study|Lack of Efficacy|0
25430|NCT01701401|118568|P3|Overall Study|Lack of Efficacy|2
25431|NCT01701401|118569|P2|Overall Study|Lack of Efficacy|0
25432|NCT01701401|118570|P1|Overall Study|Lack of Efficacy|1
25433|NCT01701401|118567|P4|Overall Study|Withdrew Consent|2
25434|NCT01701401|118568|P3|Overall Study|Withdrew Consent|1
25435|NCT01701401|118569|P2|Overall Study|Withdrew Consent|3
25436|NCT01701401|118570|P1|Overall Study|Withdrew Consent|0
25437|NCT01701401|118567|P4|Overall Study|Lost to Follow-up|3
25438|NCT01701401|118568|P3|Overall Study|Lost to Follow-up|1
25439|NCT01701401|118569|P2|Overall Study|Lost to Follow-up|5
25440|NCT01701401|118570|P1|Overall Study|Lost to Follow-up|5
25441|NCT01701401|118567|P4|Overall Study|Randomized But Not Treated|1
25442|NCT01701401|118568|P3|Overall Study|Randomized But Not Treated|0
25443|NCT01701401|118569|P2|Overall Study|Randomized But Not Treated|1
25444|NCT01701401|118570|P1|Overall Study|Randomized But Not Treated|3
25445|NCT01701362|118622|P2|Overall Study|Reasons other than those mentioned above|5
25446|NCT01701362|118623|P1|Overall Study|Reasons other than those mentioned above|3
25447|NCT01701362|118622|P2|Overall Study|Randomized but not treated|2
25448|NCT01701362|118623|P1|Overall Study|Randomized but not treated|1
25449|NCT01701362|118622|P2|Overall Study|Death|1
25450|NCT01701362|118623|P1|Overall Study|Death|0
25451|NCT01701362|118622|P2|Overall Study|Insufficient clinical response|6
25452|NCT01701362|118623|P1|Overall Study|Insufficient clinical response|6
25453|NCT01701362|118622|P2|Overall Study|Lost to Follow-up|9
25454|NCT01701362|118623|P1|Overall Study|Lost to Follow-up|6
25455|NCT01701362|118622|P2|Overall Study|No longer willing to participate|14
25456|NCT01701362|118623|P1|Overall Study|No longer willing to participate|8
25457|NCT01701362|118622|P2|Overall Study|Protocol Violation|3
25458|NCT01701362|118623|P1|Overall Study|Protocol Violation|5
25459|NCT01701362|118622|P2|Overall Study|Adverse events related to study drug|10
25460|NCT01701362|118623|P1|Overall Study|Adverse events related to study drug|12
25461|NCT01701362|118622|P2|Overall Study|Adverse events not related to study drug|6
25462|NCT01701362|118623|P1|Overall Study|Adverse events not related to study drug|1
25463|NCT01701245|118659|P2|Overall Study|Did not complete the open label period|12
25464|NCT01701245|118660|P1|Overall Study|Did not complete the open label period|11
25465|NCT01701245|118659|P2|Overall Study|Protocol Violation|3
25466|NCT01701245|118660|P1|Overall Study|Protocol Violation|1
25467|NCT01701063|118692|P3|Overall Study|Unspecified|1
25468|NCT01701063|118693|P2|Overall Study|Unspecified|0
25469|NCT01701063|118694|P1|Overall Study|Unspecified|0
25470|NCT01701063|118692|P3|Overall Study|Withdrawal by Subject|1
25471|NCT01701063|118693|P2|Overall Study|Withdrawal by Subject|0
25472|NCT01701063|118694|P1|Overall Study|Withdrawal by Subject|0
25473|NCT01701063|118692|P3|Overall Study|Lost to Follow-up|0
25474|NCT01701063|118693|P2|Overall Study|Lost to Follow-up|1
25475|NCT01701063|118694|P1|Overall Study|Lost to Follow-up|0
25476|NCT01700530|118836|P3|Overall Study|Withdrawal by Subject|1
25477|NCT01700530|118837|P2|Overall Study|Withdrawal by Subject|3
25478|NCT01700530|118838|P1|Overall Study|Withdrawal by Subject|0
25479|NCT01700387|118864|P2|Overall Study|Lost to Follow-up|1
25480|NCT01700387|118865|P1|Overall Study|Lost to Follow-up|2
25481|NCT01700387|118864|P2|Overall Study|Adverse Event|1
25482|NCT01700387|118865|P1|Overall Study|Adverse Event|1
25483|NCT01700387|118864|P2|Overall Study|Withdrawal by Subject|2
25484|NCT01700387|118865|P1|Overall Study|Withdrawal by Subject|1
25485|NCT01700348|118875|P1|Overall Study|Lost to Follow-up|1
25486|NCT01700348|118875|P1|Overall Study|Withdrawal by Subject|22
25487|NCT01700192|118893|P2|Overall Study|Never received study drug|0
25488|NCT01700192|118894|P1|Overall Study|Never received study drug|1
25489|NCT01700192|118893|P2|Overall Study|Withdrawal by Subject|64
25490|NCT01700192|118894|P1|Overall Study|Withdrawal by Subject|56
25491|NCT01700192|118893|P2|Overall Study|Technical problems|1
25492|NCT01700192|118894|P1|Overall Study|Technical problems|0
25493|NCT01700192|118893|P2|Overall Study|Protocol Violation|4
25494|NCT01700192|118894|P1|Overall Study|Protocol Violation|3
25495|NCT01700192|118893|P2|Overall Study|Progressive disease|0
25496|NCT01700192|118894|P1|Overall Study|Progressive disease|1
25497|NCT01700192|118893|P2|Overall Study|Pregnancy|4
25498|NCT01700192|118894|P1|Overall Study|Pregnancy|1
25499|NCT01700192|118893|P2|Overall Study|Physician Decision|3
25500|NCT01700192|118894|P1|Overall Study|Physician Decision|2
25501|NCT01700192|118893|P2|Overall Study|Noncompliance with study drug|5
25502|NCT01700192|118894|P1|Overall Study|Noncompliance with study drug|0
25503|NCT01700192|118893|P2|Overall Study|Lost to Follow-up|29
25504|NCT01700192|118894|P1|Overall Study|Lost to Follow-up|42
25505|NCT01700192|118893|P2|Overall Study|Lack of Efficacy|0
25506|NCT01700192|118894|P1|Overall Study|Lack of Efficacy|1
25507|NCT01700192|118893|P2|Overall Study|Adverse Event|18
25508|NCT01700192|118894|P1|Overall Study|Adverse Event|73
25509|NCT01700179|118912|P1|Overall Study|Physician Decision|2
25510|NCT01700140|118919|P3|Overall Study|Inclusion/exclusion criteria deviation|0
25511|NCT01700140|118920|P2|Overall Study|Inclusion/exclusion criteria deviation|4
25512|NCT01700140|118921|P1|Overall Study|Inclusion/exclusion criteria deviation|1
25513|NCT01700140|118919|P3|Overall Study|Adverse Event|0
25514|NCT01700140|118920|P2|Overall Study|Adverse Event|1
25515|NCT01700140|118921|P1|Overall Study|Adverse Event|0
25516|NCT01700140|118919|P3|Overall Study|Aggravation of symptoms|0
25517|NCT01700140|118920|P2|Overall Study|Aggravation of symptoms|0
25518|NCT01700140|118921|P1|Overall Study|Aggravation of symptoms|1
25519|NCT01700140|118919|P3|Overall Study|Use of chemotherapy or surgical therapy|0
25520|NCT01700140|118920|P2|Overall Study|Use of chemotherapy or surgical therapy|1
25521|NCT01700140|118921|P1|Overall Study|Use of chemotherapy or surgical therapy|0
25522|NCT01700140|118919|P3|Overall Study|Discontinuation of radiotherapy|0
25523|NCT01700140|118920|P2|Overall Study|Discontinuation of radiotherapy|0
25524|NCT01700140|118921|P1|Overall Study|Discontinuation of radiotherapy|1
25525|NCT01700140|118919|P3|Overall Study|Use of rescue drugs|1
25526|NCT01700140|118920|P2|Overall Study|Use of rescue drugs|3
25527|NCT01700140|118921|P1|Overall Study|Use of rescue drugs|3
25528|NCT01699867|118953|P1|Overall Study|Screening Failure|3
25529|NCT01699815|118960|P2|Overall Study|Adverse Event|1
25530|NCT01699815|118961|P1|Overall Study|Adverse Event|0
25531|NCT01699815|118960|P2|Overall Study|record could not be located|0
25532|NCT01699815|118961|P1|Overall Study|record could not be located|1
25533|NCT01699815|118960|P2|Overall Study|Protocol Violation|7
25534|NCT01699815|118961|P1|Overall Study|Protocol Violation|4
25535|NCT01699789|118973|P2|Overall Study|Lost to Follow-up|101
25536|NCT01699789|118974|P1|Overall Study|Lost to Follow-up|83
25537|NCT01699789|118973|P2|Overall Study|Death|2
25538|NCT01699789|118974|P1|Overall Study|Death|1
25539|NCT01699789|118973|P2|Overall Study|Withdrawal by Subject|23
25540|NCT01699789|118974|P1|Overall Study|Withdrawal by Subject|18
25541|NCT01699750|119044|P2|Overall Study|Other|2
25542|NCT01699750|119045|P1|Overall Study|Other|0
25543|NCT01699750|119044|P2|Overall Study|Withdrew Consent|1
25544|NCT01699750|119045|P1|Overall Study|Withdrew Consent|0
25545|NCT01699685|119069|P2|Period 2|Lost to Follow-up|0
25546|NCT01699685|119070|P1|Period 2|Lost to Follow-up|1
25547|NCT01699685|119069|P2|Period 1|Patient request|1
25548|NCT01699685|119070|P1|Period 1|Patient request|0
25549|NCT01699685|119069|P2|Period 1|Other|1
25550|NCT01699685|119070|P1|Period 1|Other|0
25551|NCT01699685|119069|P2|Period 1|Medical or ethical, noncompliance|0
25552|NCT01699685|119070|P1|Period 1|Medical or ethical, noncompliance|2
25553|NCT01699685|119069|P2|Period 1|Adverse Event|1
25554|NCT01699685|119070|P1|Period 1|Adverse Event|1
25555|NCT01699087|119103|P1|Overall Study|Unable to make future visits|2
25556|NCT01699087|119103|P1|Overall Study|Screen failure (prior to treatment)|15
25557|NCT01699087|119103|P1|Overall Study|Lost to Follow-up|7
25558|NCT01699022|119117|P1|Overall Study|Early discontinuation from the study|3
25559|NCT01698814|119132|P2|Overall Study|Randomized in error|0
25560|NCT01698814|119133|P1|Overall Study|Randomized in error|1
25561|NCT01698814|119132|P2|Overall Study|Pregnancy|0
25562|NCT01698814|119133|P1|Overall Study|Pregnancy|1
25563|NCT01698814|119132|P2|Overall Study|Lost to Follow-up|1
25564|NCT01698814|119133|P1|Overall Study|Lost to Follow-up|0
25565|NCT01698814|119132|P2|Overall Study|Adverse Event|2
25566|NCT01698814|119133|P1|Overall Study|Adverse Event|0
25567|NCT01698801|119139|P1|Follow Up Phase|Death|4
25568|NCT01698801|119139|P1|Follow Up Phase|Withdrawal by Subject|1
25569|NCT01698801|119139|P1|Treatment Phase|Disease progression|1
25570|NCT01698801|119139|P1|Treatment Phase|Withdrawal by Subject|1
25571|NCT01698801|119139|P1|Treatment Phase|Not specified|4
25572|NCT01698801|119139|P1|Treatment Phase|Protocol Violation|1
25573|NCT01698801|119139|P1|Treatment Phase|Adverse Event|4
25574|NCT01698775|119150|P2|Phase B|Withdrawal by Subject|2
25575|NCT01698775|119151|P1|Phase B|Withdrawal by Subject|6
25576|NCT01698775|119150|P2|Phase B|Protocol Violation|1
25577|NCT01698775|119151|P1|Phase B|Protocol Violation|1
25578|NCT01698775|119150|P2|Phase B|Physician Decision|1
25579|NCT01698775|119151|P1|Phase B|Physician Decision|1
25580|NCT01698775|119150|P2|Phase B|Lost to Follow-up|1
25581|NCT01698775|119151|P1|Phase B|Lost to Follow-up|0
25582|NCT01698775|119150|P2|Phase B|Lack of Efficacy|1
25583|NCT01698775|119151|P1|Phase B|Lack of Efficacy|0
25584|NCT01698775|119150|P2|Phase B|Death|1
25585|NCT01698775|119151|P1|Phase B|Death|0
25586|NCT01698775|119150|P2|Phase B|Adverse Event|3
25587|NCT01698775|119151|P1|Phase B|Adverse Event|6
25588|NCT01698775|119150|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
25589|NCT01698775|119151|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
25590|NCT01698775|119150|P2|Phase A|Kidney [transplant]|1
25591|NCT01698775|119151|P1|Phase A|Kidney [transplant]|0
25592|NCT01698775|119150|P2|Phase A|Withdrawal by Subject|4
25593|NCT01698775|119151|P1|Phase A|Withdrawal by Subject|3
25594|NCT01698775|119150|P2|Phase A|Protocol Violation|0
25595|NCT01698775|119151|P1|Phase A|Protocol Violation|1
25596|NCT01698775|119150|P2|Phase A|Lost to Follow-up|2
25597|NCT01698775|119151|P1|Phase A|Lost to Follow-up|1
25598|NCT01698775|119150|P2|Phase A|Lack of Efficacy|0
25599|NCT01698775|119151|P1|Phase A|Lack of Efficacy|1
25600|NCT01698775|119150|P2|Phase A|Death|1
25601|NCT01698775|119151|P1|Phase A|Death|1
25602|NCT01698775|119150|P2|Phase A|Adverse Event|1
25603|NCT01698775|119151|P1|Phase A|Adverse Event|2
25604|NCT01698554|119200|P4|Overall Study|Other Miscellaneous Reasons|0
25605|NCT01698554|119201|P3|Overall Study|Other Miscellaneous Reasons|0
25606|NCT01698554|119202|P2|Overall Study|Other Miscellaneous Reasons|0
25607|NCT01698554|119203|P1|Overall Study|Other Miscellaneous Reasons|1
25608|NCT01698554|119200|P4|Overall Study|Protocol Violation|0
25609|NCT01698554|119201|P3|Overall Study|Protocol Violation|1
25610|NCT01698554|119202|P2|Overall Study|Protocol Violation|0
25611|NCT01698554|119203|P1|Overall Study|Protocol Violation|2
25612|NCT01698554|119200|P4|Overall Study|Personal Reasons|1
25613|NCT01698554|119201|P3|Overall Study|Personal Reasons|1
25614|NCT01698554|119202|P2|Overall Study|Personal Reasons|5
25615|NCT01698554|119203|P1|Overall Study|Personal Reasons|0
25616|NCT01698554|119200|P4|Overall Study|Lost to Follow-up|0
25617|NCT01698554|119201|P3|Overall Study|Lost to Follow-up|0
25618|NCT01698554|119202|P2|Overall Study|Lost to Follow-up|0
25619|NCT01698554|119203|P1|Overall Study|Lost to Follow-up|1
25620|NCT01698554|119200|P4|Overall Study|Adverse Event|1
25621|NCT01698554|119201|P3|Overall Study|Adverse Event|0
25622|NCT01698554|119202|P2|Overall Study|Adverse Event|5
25623|NCT01698554|119203|P1|Overall Study|Adverse Event|2
25624|NCT01698320|119242|P3|40-Week Open-Label Period|Lost to Follow-up|0
25625|NCT01698320|119243|P2|40-Week Open-Label Period|Lost to Follow-up|2
25626|NCT01698320|119244|P1|40-Week Open-Label Period|Lost to Follow-up|0
25627|NCT01698320|119242|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
25628|NCT01698320|119243|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
25629|NCT01698320|119244|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
25630|NCT01698320|119242|P3|40-Week Open-Label Period|Pregnancy|1
25631|NCT01698320|119243|P2|40-Week Open-Label Period|Pregnancy|2
25632|NCT01698320|119244|P1|40-Week Open-Label Period|Pregnancy|0
25633|NCT01698320|119242|P3|40-Week Open-Label Period|Withdrawal by Subject|7
25634|NCT01698320|119243|P2|40-Week Open-Label Period|Withdrawal by Subject|11
25635|NCT01698320|119244|P1|40-Week Open-Label Period|Withdrawal by Subject|0
25636|NCT01698320|119242|P3|40-Week Open-Label Period|Adverse Event|2
25637|NCT01698320|119243|P2|40-Week Open-Label Period|Adverse Event|3
25638|NCT01698320|119244|P1|40-Week Open-Label Period|Adverse Event|0
25639|NCT01698320|119242|P3|12-Week Double-Blind Period|Lost to Follow-up|4
25640|NCT01698320|119243|P2|12-Week Double-Blind Period|Lost to Follow-up|0
25641|NCT01698320|119244|P1|12-Week Double-Blind Period|Lost to Follow-up|0
25642|NCT01698320|119242|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
25643|NCT01698320|119243|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
25644|NCT01698320|119244|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
25645|NCT01698320|119242|P3|12-Week Double-Blind Period|Pregnancy|1
25646|NCT01698320|119243|P2|12-Week Double-Blind Period|Pregnancy|1
25647|NCT01698320|119244|P1|12-Week Double-Blind Period|Pregnancy|0
25648|NCT01698320|119242|P3|12-Week Double-Blind Period|Protocol Violation|2
25649|NCT01698320|119243|P2|12-Week Double-Blind Period|Protocol Violation|0
25650|NCT01698320|119244|P1|12-Week Double-Blind Period|Protocol Violation|0
25651|NCT01698320|119242|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
25652|NCT01698320|119243|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
25653|NCT01698320|119244|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
25654|NCT01698320|119242|P3|12-Week Double-Blind Period|Adverse Event|1
25655|NCT01698320|119243|P2|12-Week Double-Blind Period|Adverse Event|1
25656|NCT01698320|119244|P1|12-Week Double-Blind Period|Adverse Event|0
25657|NCT01698320|119242|P3|Run-In Period (Week -1 to Day 0)|Not specified|0
25658|NCT01698320|119243|P2|Run-In Period (Week -1 to Day 0)|Not specified|0
25659|NCT01698320|119244|P1|Run-In Period (Week -1 to Day 0)|Not specified|1
25660|NCT01698320|119242|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
25661|NCT01698320|119243|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
25662|NCT01698320|119244|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
25663|NCT01698320|119242|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
25664|NCT01698320|119243|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
25665|NCT01698320|119244|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
25666|NCT01698320|119242|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
25667|NCT01698320|119243|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
25668|NCT01698320|119244|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
25669|NCT01698268|119264|P2|Overall Study|Physician Decision|1
25670|NCT01698268|119265|P1|Overall Study|Physician Decision|2
25671|NCT01697969|119271|P1|Overall Study|Did not meet inc/exc criteria|3
25672|NCT01697956|119278|P2|Overall Study|Protocol Violation|1
25673|NCT01697956|119279|P1|Overall Study|Protocol Violation|1
25674|NCT01697696|119309|P2|Overall Study|Subject/guardian decision|35
25675|NCT01697696|119310|P1|Overall Study|Subject/guardian decision|31
25676|NCT01697696|119309|P2|Overall Study|Lost to Follow-up|7
25677|NCT01697696|119310|P1|Overall Study|Lost to Follow-up|10
25678|NCT01697696|119309|P2|Overall Study|Death|2
25679|NCT01697696|119310|P1|Overall Study|Death|4
25680|NCT01697696|119309|P2|Overall Study|Physician Decision|0
25681|NCT01697696|119310|P1|Overall Study|Physician Decision|1
25682|NCT01697696|119309|P2|Overall Study|Protocol deviation|0
25683|NCT01697696|119310|P1|Overall Study|Protocol deviation|1
25684|NCT01697696|119309|P2|Overall Study|Study terminated by sponsor|3
25685|NCT01697696|119310|P1|Overall Study|Study terminated by sponsor|0
25686|NCT01697592|119342|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
25687|NCT01697592|119343|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
25688|NCT01697592|119344|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
25689|NCT01697592|119345|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
25690|NCT01697592|119346|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
25691|NCT01697592|119347|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
25692|NCT01697592|119348|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
25693|NCT01697592|119349|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
25694|NCT01697592|119350|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
25695|NCT01697592|119351|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
25696|NCT01697592|119342|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25697|NCT01697592|119343|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25698|NCT01697592|119344|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
25699|NCT01697592|119345|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25700|NCT01697592|119346|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
25701|NCT01697592|119347|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25702|NCT01697592|119348|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25703|NCT01697592|119349|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25704|NCT01697592|119350|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
25705|NCT01697592|119351|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
25706|NCT01697592|119342|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
25707|NCT01697592|119343|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
25708|NCT01697592|119344|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
25709|NCT01697592|119345|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
25710|NCT01697592|119346|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
25711|NCT01697592|119347|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
25712|NCT01697592|119348|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
25713|NCT01697592|119349|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
25714|NCT01697592|119350|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
25715|NCT01697592|119351|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
25716|NCT01697592|119342|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
25717|NCT01697592|119343|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
25718|NCT01697592|119344|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
25719|NCT01697592|119345|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
25720|NCT01697592|119346|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
25721|NCT01697592|119347|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
25722|NCT01697592|119348|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
25723|NCT01697592|119349|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
25724|NCT01697592|119350|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
25725|NCT01697592|119351|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
25726|NCT01697592|119342|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
25727|NCT01697592|119343|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25728|NCT01697592|119344|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25729|NCT01697592|119345|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
25730|NCT01697592|119346|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25731|NCT01697592|119347|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25732|NCT01697592|119348|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25733|NCT01697592|119349|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
25734|NCT01697592|119350|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
25735|NCT01697592|119351|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
25736|NCT01697592|119342|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
25737|NCT01697592|119343|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
25738|NCT01697592|119344|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
25739|NCT01697592|119345|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
25740|NCT01697592|119346|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
25741|NCT01697592|119347|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
25742|NCT01697592|119348|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
25743|NCT01697592|119349|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
25744|NCT01697592|119350|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
25745|NCT01697592|119351|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
25746|NCT01697592|119342|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
25747|NCT01697592|119343|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
25748|NCT01697592|119344|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
25749|NCT01697592|119345|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
25750|NCT01697592|119346|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
25751|NCT01697592|119347|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
25752|NCT01697592|119348|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
25753|NCT01697592|119349|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
25754|NCT01697592|119350|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
25755|NCT01697592|119351|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
25756|NCT01697592|119342|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25757|NCT01697592|119343|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25758|NCT01697592|119344|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25759|NCT01697592|119345|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25760|NCT01697592|119346|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25761|NCT01697592|119347|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25762|NCT01697592|119348|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25763|NCT01697592|119349|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25764|NCT01697592|119350|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
25765|NCT01697592|119351|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
25766|NCT01697501|119415|P1|Overall Study|Protocol Violation|2
25767|NCT01697462|119458|P1|Overall Study|Missing|5
25768|NCT01697462|119458|P1|Overall Study|Unspecified|10
25769|NCT01697462|119458|P1|Overall Study|Death|1
25770|NCT01697462|119458|P1|Overall Study|Investigator Decision|21
25771|NCT01697462|119458|P1|Overall Study|Withdrawal by Subject|12
25772|NCT01697462|119458|P1|Overall Study|Lost to Follow-up|21
25773|NCT01697462|119458|P1|Overall Study|Adverse Event|6
25774|NCT01697462|119458|P1|Overall Study|Disease Progression|1
25775|NCT01697449|119465|P1|Overall Study|Missing|25
25776|NCT01697449|119465|P1|Overall Study|Unspecified|1
25777|NCT01697449|119465|P1|Overall Study|Death|2
25778|NCT01697449|119465|P1|Overall Study|Physician Decision|1
25779|NCT01697449|119465|P1|Overall Study|Withdrawal by Subject|2
25780|NCT01697449|119465|P1|Overall Study|Lost to Follow-up|5
25781|NCT01697449|119465|P1|Overall Study|Adverse Event|7
25782|NCT01697449|119465|P1|Overall Study|Disease progression|47
25783|NCT01697358|119476|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
25784|NCT01697358|119477|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
25785|NCT01697358|119476|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
25786|NCT01697358|119477|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
25787|NCT01697358|119476|P2|Period II: 6-24M Long-term Follow-up|Death|1
25788|NCT01697358|119477|P1|Period II: 6-24M Long-term Follow-up|Death|1
25789|NCT01697358|119476|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
25790|NCT01697358|119477|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
25791|NCT01697358|119476|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
25792|NCT01697358|119477|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
25793|NCT01697358|119476|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
25794|NCT01697358|119477|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
25795|NCT01697358|119476|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
25796|NCT01697358|119477|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
25797|NCT01697358|119476|P2|Period I: Randomization to 6 Months|Adverse Event|1
25798|NCT01697358|119477|P1|Period I: Randomization to 6 Months|Adverse Event|1
25799|NCT01697358|119476|P2|Period I: Randomization to 6 Months|Physician Decision|0
25800|NCT01697358|119477|P1|Period I: Randomization to 6 Months|Physician Decision|4
25801|NCT01697358|119476|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
25802|NCT01697358|119477|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
25803|NCT01697345|119493|P1|Overall Study|Withdrawal by Subject|1
25804|NCT01697319|119512|P1|Extension Phase|Terminated by Sponsor|15
25805|NCT01697319|119512|P1|Primary Phase|Withdrawal by Subject|1
25806|NCT01696994|119521|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
25807|NCT01696994|119522|P1|Overall Study|Refused Screen (Ovarian Screening)|0
25808|NCT01696994|119521|P2|Overall Study|Refused ASU (Control)|0
25809|NCT01696994|119522|P1|Overall Study|Refused ASU (Control)|311
25810|NCT01696994|119521|P2|Overall Study|No Ovaries at Baseline|4851
25811|NCT01696994|119522|P1|Overall Study|No Ovaries at Baseline|4807
25812|NCT01696994|119521|P2|Overall Study|Died Before ASU (Control)|0
25813|NCT01696994|119522|P1|Overall Study|Died Before ASU (Control)|73
25814|NCT01696994|119521|P2|Overall Study|Died Before Randomization|2
25815|NCT01696994|119522|P1|Overall Study|Died Before Randomization|1
25816|NCT01696994|119521|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
25817|NCT01696994|119522|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
25818|NCT01696981|119550|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
25819|NCT01696981|119551|P1|Overall Study|Refused Screen (Colorectal Screening)|0
25820|NCT01696981|119550|P2|Overall Study|Refused ASU (Control)|0
25821|NCT01696981|119551|P1|Overall Study|Refused ASU (Control)|920
25822|NCT01696981|119550|P2|Overall Study|Died Before ASU (Control)|0
25823|NCT01696981|119551|P1|Overall Study|Died Before ASU (Control)|278
25824|NCT01696981|119550|P2|Overall Study|Died Before Randomization|8
25825|NCT01696981|119551|P1|Overall Study|Died Before Randomization|3
25826|NCT01696981|119550|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
25827|NCT01696981|119551|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
25828|NCT01696968|119571|P2|Overall Study|Refused Screen (Lung Screening)|6796
25829|NCT01696968|119572|P1|Overall Study|Refused Screen (Lung Screening)|0
25830|NCT01696968|119571|P2|Overall Study|Refused ASU (Control)|0
25831|NCT01696968|119572|P1|Overall Study|Refused ASU (Control)|920
25832|NCT01696968|119571|P2|Overall Study|Died Before ASU (Control)|0
25833|NCT01696968|119572|P1|Overall Study|Died Before ASU (Control)|278
25834|NCT01696968|119571|P2|Overall Study|Died Before Randomization|8
25835|NCT01696968|119572|P1|Overall Study|Died Before Randomization|3
25836|NCT01696968|119571|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
25837|NCT01696968|119572|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
25838|NCT01696929|119592|P1|Overall Study|Physician Decision|1
25839|NCT01696773|119599|P2|Days 15-27, Washout|Adverse Event|0
25840|NCT01696773|119600|P1|Days 15-27, Washout|Adverse Event|1
25841|NCT01696695|119627|P1|Overall Study|Major Protocol Violation|192
25842|NCT01696695|119627|P1|Overall Study|Unspecified|74
25843|NCT01696695|119627|P1|Overall Study|Lost to Follow-up|48
25844|NCT01696695|119627|P1|Overall Study|Withdrawal by Subject|92
25845|NCT01696695|119627|P1|Overall Study|Adverse Event|74
25846|NCT01696695|119627|P1|Overall Study|Death|29
25847|NCT01696695|119627|P1|Overall Study|Disease progression|373
25848|NCT01696643|119639|P2|Overall Study|Participant Did Not Receive Study Drug|2
25849|NCT01696643|119640|P1|Overall Study|Participant Did Not Receive Study Drug|2
25850|NCT01696643|119639|P2|Overall Study|Medical Monitor Decision|2
25851|NCT01696643|119640|P1|Overall Study|Medical Monitor Decision|0
25852|NCT01696643|119639|P2|Overall Study|Participant Incarcerated|1
25853|NCT01696643|119640|P1|Overall Study|Participant Incarcerated|0
25854|NCT01696643|119639|P2|Overall Study|Site Error|1
25855|NCT01696643|119640|P1|Overall Study|Site Error|2
25856|NCT01696643|119639|P2|Overall Study|Participant on Restricted Bed Rest|0
25857|NCT01696643|119640|P1|Overall Study|Participant on Restricted Bed Rest|1
25858|NCT01696643|119639|P2|Overall Study|Withdrawal by Subject|149
25859|NCT01696643|119640|P1|Overall Study|Withdrawal by Subject|142
25860|NCT01696643|119639|P2|Overall Study|Study Terminated by Sponsor|294
25861|NCT01696643|119640|P1|Overall Study|Study Terminated by Sponsor|286
25862|NCT01696643|119639|P2|Overall Study|Protocol Violation|7
25863|NCT01696643|119640|P1|Overall Study|Protocol Violation|7
25864|NCT01696643|119639|P2|Overall Study|Pregnancy|1
25865|NCT01696643|119640|P1|Overall Study|Pregnancy|0
25866|NCT01696643|119639|P2|Overall Study|Physician Decision|2
25867|NCT01696643|119640|P1|Overall Study|Physician Decision|3
25868|NCT01696643|119639|P2|Overall Study|Lost to Follow-up|67
25869|NCT01696643|119640|P1|Overall Study|Lost to Follow-up|67
25870|NCT01696643|119639|P2|Overall Study|Lack of Efficacy|0
25871|NCT01696643|119640|P1|Overall Study|Lack of Efficacy|3
25872|NCT01696643|119639|P2|Overall Study|Death|2
25873|NCT01696643|119640|P1|Overall Study|Death|1
25874|NCT01696643|119639|P2|Overall Study|Adverse Event|7
25875|NCT01696643|119640|P1|Overall Study|Adverse Event|15
25876|NCT01696214|119668|P4|Overall Study|Lost to Follow-up|0
25877|NCT01696214|119669|P3|Overall Study|Lost to Follow-up|0
25878|NCT01696214|119670|P2|Overall Study|Lost to Follow-up|1
25879|NCT01696214|119671|P1|Overall Study|Lost to Follow-up|0
25880|NCT01696188|119683|P2|Overall Study|Protocol Violation|1
25881|NCT01696188|119684|P1|Overall Study|Protocol Violation|1
25882|NCT01696071|119696|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
25883|NCT01696071|119697|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
25884|NCT01696058|119725|P2|Overall Study|Other reason prematurely discontinued|3
25885|NCT01696058|119726|P1|Overall Study|Other reason prematurely discontinued|5
25886|NCT01696058|119725|P2|Overall Study|Withdrawal by Subject|6
25887|NCT01696058|119726|P1|Overall Study|Withdrawal by Subject|4
25888|NCT01696058|119725|P2|Overall Study|Lost to Follow-up|5
25889|NCT01696058|119726|P1|Overall Study|Lost to Follow-up|2
25890|NCT01696058|119725|P2|Overall Study|Protocol Violation|3
25891|NCT01696058|119726|P1|Overall Study|Protocol Violation|9
25892|NCT01696058|119725|P2|Overall Study|Lack of Efficacy|3
25893|NCT01696058|119726|P1|Overall Study|Lack of Efficacy|2
25894|NCT01696058|119725|P2|Overall Study|Adverse Event|11
25895|NCT01696058|119726|P1|Overall Study|Adverse Event|21
25896|NCT01696045|119754|P2|Overall Study|Disease progression|2
25897|NCT01696045|119755|P1|Overall Study|Disease progression|2
25898|NCT01696045|119754|P2|Overall Study|Study drug toxicity|5
25899|NCT01696045|119755|P1|Overall Study|Study drug toxicity|1
25900|NCT01695772|119771|P1|Overall Study|Unspecified Reason|1
25901|NCT01695772|119771|P1|Overall Study|Protocol Violation|2
25902|NCT01695772|119771|P1|Overall Study|Lost to Follow-up|4
25903|NCT01695772|119771|P1|Overall Study|Investigator Decision|5
25904|NCT01695772|119771|P1|Overall Study|Progressive Disease|8
25905|NCT01695772|119771|P1|Overall Study|Withdrawal by Subject|18
25906|NCT01695746|119783|P1|Overall Study|Participant not willing to participate|3
25907|NCT01695746|119783|P1|Overall Study|Protocol Violation|5
25908|NCT01695746|119783|P1|Overall Study|Non-compliance by the participant|3
25909|NCT01695746|119783|P1|Overall Study|Adverse Event|1
25910|NCT01695239|119832|P4|Overall Study|Protocol Violation|0
25911|NCT01695239|119833|P3|Overall Study|Protocol Violation|0
25912|NCT01695239|119834|P2|Overall Study|Protocol Violation|0
25913|NCT01695239|119835|P1|Overall Study|Protocol Violation|1
25914|NCT01695239|119832|P4|Overall Study|Lost to Follow-up|0
25915|NCT01695239|119833|P3|Overall Study|Lost to Follow-up|0
25916|NCT01695239|119834|P2|Overall Study|Lost to Follow-up|0
25917|NCT01695239|119835|P1|Overall Study|Lost to Follow-up|1
25918|NCT01695239|119832|P4|Overall Study|Sponsor Decision|0
25919|NCT01695239|119833|P3|Overall Study|Sponsor Decision|1
25920|NCT01695239|119834|P2|Overall Study|Sponsor Decision|0
25921|NCT01695239|119835|P1|Overall Study|Sponsor Decision|3
25922|NCT01695239|119832|P4|Overall Study|Withdrawal by Subject|0
25923|NCT01695239|119833|P3|Overall Study|Withdrawal by Subject|1
25924|NCT01695239|119834|P2|Overall Study|Withdrawal by Subject|1
25925|NCT01695239|119835|P1|Overall Study|Withdrawal by Subject|3
25926|NCT01695239|119832|P4|Overall Study|Lack of Efficacy|0
25927|NCT01695239|119833|P3|Overall Study|Lack of Efficacy|2
25928|NCT01695239|119834|P2|Overall Study|Lack of Efficacy|0
25929|NCT01695239|119835|P1|Overall Study|Lack of Efficacy|4
25930|NCT01695239|119832|P4|Overall Study|Adverse Event|3
25931|NCT01695239|119833|P3|Overall Study|Adverse Event|2
25932|NCT01695239|119834|P2|Overall Study|Adverse Event|2
25933|NCT01695239|119835|P1|Overall Study|Adverse Event|2
25934|NCT01695239|119832|P4|Overall Study|Entry Criteria Not Met|3
25935|NCT01695239|119833|P3|Overall Study|Entry Criteria Not Met|3
25936|NCT01695239|119834|P2|Overall Study|Entry Criteria Not Met|1
25937|NCT01695239|119835|P1|Overall Study|Entry Criteria Not Met|1
25938|NCT01695239|119832|P4|Overall Study|On Study Treatment|0
25939|NCT01695239|119833|P3|Overall Study|On Study Treatment|1
25940|NCT01695239|119834|P2|Overall Study|On Study Treatment|0
25941|NCT01695239|119835|P1|Overall Study|On Study Treatment|0
25942|NCT01694771|119938|P2|Overall Study|Other reasons|6
25943|NCT01694771|119939|P1|Overall Study|Other reasons|5
25944|NCT01694771|119938|P2|Overall Study|Consent withdrawn|9
25945|NCT01694771|119939|P1|Overall Study|Consent withdrawn|7
25946|NCT01694771|119938|P2|Overall Study|Lost to Follow-up|3
25947|NCT01694771|119939|P1|Overall Study|Lost to Follow-up|2
25948|NCT01694771|119938|P2|Overall Study|Non compliance protocol|6
25949|NCT01694771|119939|P1|Overall Study|Non compliance protocol|7
25950|NCT01694771|119938|P2|Overall Study|Lack of Efficacy|0
25951|NCT01694771|119939|P1|Overall Study|Lack of Efficacy|1
25952|NCT01694771|119938|P2|Overall Study|Adverse Event|16
25953|NCT01694771|119939|P1|Overall Study|Adverse Event|18
25954|NCT01694706|119963|P3|Overall Study|other reason not defined above|0
25955|NCT01694706|119964|P2|Overall Study|other reason not defined above|0
25956|NCT01694706|119965|P1|Overall Study|other reason not defined above|1
25957|NCT01694706|119963|P3|Overall Study|Adverse Event|0
25958|NCT01694706|119964|P2|Overall Study|Adverse Event|1
25959|NCT01694706|119965|P1|Overall Study|Adverse Event|0
25960|NCT01694420|120008|P1|Overall Study|Lost to Follow-up|3
25961|NCT01693367|120121|P2|Overall Study|Physician Decision|1
25962|NCT01693367|120122|P1|Overall Study|Physician Decision|0
25963|NCT01693367|120121|P2|Overall Study|Withdrawal by Subject|1
25964|NCT01693367|120122|P1|Overall Study|Withdrawal by Subject|1
25965|NCT01693185|120140|P2|Overall Study|diagnostic procedure after colonoscopy|6
25966|NCT01693185|120141|P1|Overall Study|diagnostic procedure after colonoscopy|0
25967|NCT01693029|120159|P2|Overall Study|Non-compliance|1
25968|NCT01693029|120160|P1|Overall Study|Non-compliance|2
25969|NCT01693029|120159|P2|Overall Study|Death|8
25970|NCT01693029|120160|P1|Overall Study|Death|5
25971|NCT01693029|120159|P2|Overall Study|Adverse Event|6
25972|NCT01693029|120160|P1|Overall Study|Adverse Event|1
25973|NCT01693029|120159|P2|Overall Study|Lost to Follow-up|1
25974|NCT01693029|120160|P1|Overall Study|Lost to Follow-up|0
25975|NCT01693029|120159|P2|Overall Study|Physician Decision|2
25976|NCT01693029|120160|P1|Overall Study|Physician Decision|0
25977|NCT01693029|120159|P2|Overall Study|Change in dialysis modality|1
25978|NCT01693029|120160|P1|Overall Study|Change in dialysis modality|2
25979|NCT01693029|120159|P2|Overall Study|Protocol Violation|7
25980|NCT01693029|120160|P1|Overall Study|Protocol Violation|6
25981|NCT01693029|120159|P2|Overall Study|Bindinging anti-EPO antibodies|2
25982|NCT01693029|120160|P1|Overall Study|Bindinging anti-EPO antibodies|6
25983|NCT01693029|120159|P2|Overall Study|Kidney transplantation|7
25984|NCT01693029|120160|P1|Overall Study|Kidney transplantation|7
25985|NCT01693029|120159|P2|Overall Study|Withdrawal by Subject|22
25986|NCT01693029|120160|P1|Overall Study|Withdrawal by Subject|15
25987|NCT01691885|120172|P2|Washout Period (7-9 Days)|Adverse Event|1
25988|NCT01691885|120173|P1|Washout Period (7-9 Days)|Adverse Event|0
25989|NCT01691885|120172|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
25990|NCT01691885|120173|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
25991|NCT01692938|120198|P2|Overall Study|Study completed prior to site completion|3
25992|NCT01692938|120199|P1|Overall Study|Study completed prior to site completion|3
25993|NCT01692938|120198|P2|Overall Study|Protocol Deviation|1
25994|NCT01692938|120199|P1|Overall Study|Protocol Deviation|1
25995|NCT01692782|120210|P3|Overall Study|Withdrawal by Subject|3
25996|NCT01692782|120211|P2|Overall Study|Withdrawal by Subject|10
25997|NCT01692782|120212|P1|Overall Study|Withdrawal by Subject|3
25998|NCT01692782|120210|P3|Overall Study|SAE not related to study drug|0
25999|NCT01692782|120211|P2|Overall Study|SAE not related to study drug|1
26000|NCT01692782|120212|P1|Overall Study|SAE not related to study drug|0
26001|NCT01692782|120210|P3|Overall Study|Non-compliant with study visits|1
26002|NCT01692782|120211|P2|Overall Study|Non-compliant with study visits|0
26003|NCT01692782|120212|P1|Overall Study|Non-compliant with study visits|0
26004|NCT01692782|120210|P3|Overall Study|Non-complance with study drug|1
26005|NCT01692782|120211|P2|Overall Study|Non-complance with study drug|4
26006|NCT01692782|120212|P1|Overall Study|Non-complance with study drug|0
26007|NCT01692782|120210|P3|Overall Study|Protocol Violation|2
26008|NCT01692782|120211|P2|Overall Study|Protocol Violation|0
26009|NCT01692782|120212|P1|Overall Study|Protocol Violation|1
26010|NCT01692782|120210|P3|Overall Study|Pregnancy|0
26011|NCT01692782|120211|P2|Overall Study|Pregnancy|0
26012|NCT01692782|120212|P1|Overall Study|Pregnancy|1
26013|NCT01692782|120210|P3|Overall Study|Lost to Follow-up|1
26014|NCT01692782|120211|P2|Overall Study|Lost to Follow-up|7
26015|NCT01692782|120212|P1|Overall Study|Lost to Follow-up|2
26016|NCT01692782|120210|P3|Overall Study|Lack of Efficacy|0
26017|NCT01692782|120211|P2|Overall Study|Lack of Efficacy|2
26018|NCT01692782|120212|P1|Overall Study|Lack of Efficacy|1
26019|NCT01692782|120210|P3|Overall Study|Adverse Event|2
26020|NCT01692782|120211|P2|Overall Study|Adverse Event|32
26021|NCT01692782|120212|P1|Overall Study|Adverse Event|12
26022|NCT01692626|120240|P2|Overall Study|Withdrawal by Subject|0
26023|NCT01692626|120241|P1|Overall Study|Withdrawal by Subject|1
26024|NCT01692626|120240|P2|Overall Study|Protocol Violation|2
26025|NCT01692626|120241|P1|Overall Study|Protocol Violation|1
26026|NCT01692626|120240|P2|Overall Study|Adverse Event|3
26027|NCT01692626|120241|P1|Overall Study|Adverse Event|2
26028|NCT01692626|120240|P2|Overall Study|Death|1
26029|NCT01692626|120241|P1|Overall Study|Death|0
26030|NCT01692301|120270|P2|Overall Study|Lost to Follow-up|1
26031|NCT01692301|120271|P1|Overall Study|Lost to Follow-up|1
26032|NCT01692301|120270|P2|Overall Study|Physician Decision|2
26033|NCT01692301|120271|P1|Overall Study|Physician Decision|2
26034|NCT01692301|120270|P2|Overall Study|Technical problems|1
26035|NCT01692301|120271|P1|Overall Study|Technical problems|0
26036|NCT01692301|120270|P2|Overall Study|Patient/guardian decision|15
26037|NCT01692301|120271|P1|Overall Study|Patient/guardian decision|16
26038|NCT01692301|120270|P2|Overall Study|Protocol deviation|2
26039|NCT01692301|120271|P1|Overall Study|Protocol deviation|9
26040|NCT01692301|120270|P2|Overall Study|Non-compliance with study treatment|2
26041|NCT01692301|120271|P1|Overall Study|Non-compliance with study treatment|1
26042|NCT01692301|120270|P2|Overall Study|Lack of Efficacy|5
26043|NCT01692301|120271|P1|Overall Study|Lack of Efficacy|0
26044|NCT01692301|120270|P2|Overall Study|Death|2
26045|NCT01692301|120271|P1|Overall Study|Death|1
26046|NCT01692301|120270|P2|Overall Study|Adverse Event|12
26047|NCT01692301|120271|P1|Overall Study|Adverse Event|15
26048|NCT01691794|120300|P3|Overall Study|Poor compliance/noncompliance|1
26049|NCT01691794|120301|P2|Overall Study|Poor compliance/noncompliance|0
26050|NCT01691794|120302|P1|Overall Study|Poor compliance/noncompliance|0
26051|NCT01691794|120300|P3|Overall Study|Lack of Efficacy|1
26052|NCT01691794|120301|P2|Overall Study|Lack of Efficacy|1
26053|NCT01691794|120302|P1|Overall Study|Lack of Efficacy|0
26054|NCT01691794|120300|P3|Overall Study|No longer meets study criteria|0
26055|NCT01691794|120301|P2|Overall Study|No longer meets study criteria|2
26056|NCT01691794|120302|P1|Overall Study|No longer meets study criteria|0
26057|NCT01691794|120300|P3|Overall Study|Adverse Event|1
26058|NCT01691794|120301|P2|Overall Study|Adverse Event|0
26059|NCT01691794|120302|P1|Overall Study|Adverse Event|0
26060|NCT01691781|120318|P2|Overall Study|Adverse Event|1
26061|NCT01691781|120319|P1|Overall Study|Adverse Event|0
26062|NCT01691781|120318|P2|Overall Study|Protocol Violation|2
26063|NCT01691781|120319|P1|Overall Study|Protocol Violation|2
26064|NCT01691781|120318|P2|Overall Study|Physician Decision|1
26065|NCT01691781|120319|P1|Overall Study|Physician Decision|1
26066|NCT01691781|120318|P2|Overall Study|Withdrawal by Subject|3
26067|NCT01691781|120319|P1|Overall Study|Withdrawal by Subject|4
26068|NCT01691612|120342|P1|Overall Study|Adverse Event|1
26069|NCT01691612|120342|P1|Overall Study|deemed ineligible after 1st visit|6
26070|NCT01691521|120453|P3|Overall Study|Withdrawal by Subject|4
26071|NCT01691521|120454|P2|Overall Study|Withdrawal by Subject|9
26072|NCT01691521|120455|P1|Overall Study|Withdrawal by Subject|5
26073|NCT01691521|120453|P3|Overall Study|Physician Decision|0
26074|NCT01691521|120454|P2|Overall Study|Physician Decision|1
26075|NCT01691521|120455|P1|Overall Study|Physician Decision|2
26076|NCT01691521|120453|P3|Overall Study|Lost to Follow-up|2
26077|NCT01691521|120454|P2|Overall Study|Lost to Follow-up|2
26078|NCT01691521|120455|P1|Overall Study|Lost to Follow-up|0
26079|NCT01691521|120453|P3|Overall Study|Protocol Violation|0
26080|NCT01691521|120454|P2|Overall Study|Protocol Violation|3
26081|NCT01691521|120455|P1|Overall Study|Protocol Violation|0
26082|NCT01691521|120453|P3|Overall Study|Lack of Efficacy|2
26083|NCT01691521|120454|P2|Overall Study|Lack of Efficacy|1
26084|NCT01691521|120455|P1|Overall Study|Lack of Efficacy|1
26085|NCT01691521|120453|P3|Overall Study|Adverse Event|1
26086|NCT01691521|120454|P2|Overall Study|Adverse Event|0
26087|NCT01691521|120455|P1|Overall Study|Adverse Event|4
26088|NCT01691508|120477|P2|Overall Study|Withdrawal by Subject|0
26089|NCT01691508|120478|P1|Overall Study|Withdrawal by Subject|1
26090|NCT01691508|120477|P2|Overall Study|Adverse Event|3
26091|NCT01691508|120478|P1|Overall Study|Adverse Event|3
26092|NCT01691482|120492|P2|Treatment Period 2|Protocol Violation|1
26093|NCT01691482|120493|P1|Treatment Period 2|Protocol Violation|1
26094|NCT01691482|120492|P2|Treatment Period 2|Adverse Event|1
26095|NCT01691482|120493|P1|Treatment Period 2|Adverse Event|0
26096|NCT01691248|120582|P2|Overall Study|Not Treated|7
26097|NCT01691248|120583|P1|Overall Study|Not Treated|4
26098|NCT01691248|120582|P2|Overall Study|Reason not provided|4
26099|NCT01691248|120583|P1|Overall Study|Reason not provided|4
26100|NCT01691248|120582|P2|Overall Study|Lost to Follow-up|5
26101|NCT01691248|120583|P1|Overall Study|Lost to Follow-up|2
26102|NCT01691248|120582|P2|Overall Study|Confirmed CDAD|31
26103|NCT01691248|120583|P1|Overall Study|Confirmed CDAD|14
26104|NCT01691248|120582|P2|Overall Study|Withdrawal by Subject|18
26105|NCT01691248|120583|P1|Overall Study|Withdrawal by Subject|20
26106|NCT01691248|120582|P2|Overall Study|Adverse Event|22
26107|NCT01691248|120583|P1|Overall Study|Adverse Event|24
26108|NCT01691248|120582|P2|Overall Study|Protocol Violation|27
26109|NCT01691248|120583|P1|Overall Study|Protocol Violation|43
26110|NCT01691092|120593|P1|Overall Study|screen fail|19
26111|NCT01691092|120593|P1|Overall Study|used for different study|2
26112|NCT01691092|120593|P1|Overall Study|non-compliance|3
26113|NCT01691092|120593|P1|Overall Study|Withdrawal by Subject|3
26114|NCT01691092|120593|P1|Overall Study|Physician Decision|4
26115|NCT01691092|120593|P1|Overall Study|Lost to Follow-up|10
26116|NCT01691014|120601|P4|Overall Study|Lack of Efficacy|0
26117|NCT01691014|120602|P3|Overall Study|Lack of Efficacy|7
26118|NCT01691014|120603|P2|Overall Study|Lack of Efficacy|3
26119|NCT01691014|120604|P1|Overall Study|Lack of Efficacy|2
26120|NCT01691014|120601|P4|Overall Study|Adverse Event|1
26121|NCT01691014|120602|P3|Overall Study|Adverse Event|1
26122|NCT01691014|120603|P2|Overall Study|Adverse Event|5
26123|NCT01691014|120604|P1|Overall Study|Adverse Event|0
26124|NCT01691014|120601|P4|Overall Study|Withdrawal by Subject|1
26125|NCT01691014|120602|P3|Overall Study|Withdrawal by Subject|1
26126|NCT01691014|120603|P2|Overall Study|Withdrawal by Subject|1
26127|NCT01691014|120604|P1|Overall Study|Withdrawal by Subject|0
26128|NCT01691014|120601|P4|Overall Study|Unspecified|0
26129|NCT01691014|120602|P3|Overall Study|Unspecified|2
26130|NCT01691014|120603|P2|Overall Study|Unspecified|0
26131|NCT01691014|120604|P1|Overall Study|Unspecified|0
26132|NCT01691014|120601|P4|Overall Study|Premature Termination|3
26133|NCT01691014|120602|P3|Overall Study|Premature Termination|0
26134|NCT01691014|120603|P2|Overall Study|Premature Termination|6
26135|NCT01691014|120604|P1|Overall Study|Premature Termination|1
26136|NCT01690299|120689|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
26137|NCT01690299|120690|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
26138|NCT01690299|120691|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
26139|NCT01690299|120692|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
26140|NCT01690299|120693|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
26141|NCT01690299|120694|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
26142|NCT01690299|120689|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
26143|NCT01690299|120690|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
26144|NCT01690299|120691|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
26145|NCT01690299|120692|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
26146|NCT01690299|120693|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
26147|NCT01690299|120694|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
26148|NCT01690299|120689|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
26149|NCT01690299|120690|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
26150|NCT01690299|120691|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
26151|NCT01690299|120692|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
26152|NCT01690299|120693|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
26153|NCT01690299|120694|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
26154|NCT01690299|120689|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
26155|NCT01690299|120690|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
26156|NCT01690299|120691|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
26157|NCT01690299|120692|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
26158|NCT01690299|120693|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
26159|NCT01690299|120694|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
26160|NCT01690299|120689|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
26161|NCT01690299|120690|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
26162|NCT01690299|120691|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
26163|NCT01690299|120692|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
26164|NCT01690299|120693|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
26165|NCT01690299|120694|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
26166|NCT01690299|120689|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
26167|NCT01690299|120690|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
26168|NCT01690299|120691|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
26169|NCT01690299|120692|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
26170|NCT01690299|120693|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
26171|NCT01690299|120694|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
26172|NCT01690299|120689|P6|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
26173|NCT01690299|120690|P5|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
26174|NCT01690299|120691|P4|Placebo-controlled Phase (Weeks 0-16)|Unspecified|0
26175|NCT01690299|120692|P3|Placebo-controlled Phase (Weeks 0-16)|Unspecified|1
26176|NCT01690299|120693|P2|Placebo-controlled Phase (Weeks 0-16)|Unspecified|1
26177|NCT01690299|120694|P1|Placebo-controlled Phase (Weeks 0-16)|Unspecified|2
26178|NCT01690299|120689|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
26179|NCT01690299|120690|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
26180|NCT01690299|120691|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
26181|NCT01690299|120692|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
26182|NCT01690299|120693|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
26183|NCT01690299|120694|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
26184|NCT01690299|120689|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
26185|NCT01690299|120690|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
26186|NCT01690299|120691|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
26187|NCT01690299|120692|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
26188|NCT01690299|120693|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
26189|NCT01690299|120694|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
26190|NCT01690299|120689|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
26191|NCT01690299|120690|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
26192|NCT01690299|120691|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
26193|NCT01690299|120692|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
26194|NCT01690299|120693|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
26195|NCT01690299|120694|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
26196|NCT01690052|120830|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
26197|NCT01690052|120831|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
26198|NCT01689857|120848|P2|Overall Study|Lost to Follow-up|2
26199|NCT01689857|120849|P1|Overall Study|Lost to Follow-up|5
26200|NCT01689649|120855|P1|Overall Study|Lost to Follow-up|5
26201|NCT01689649|120855|P1|Overall Study|Protocol Violation|3
26202|NCT01689649|120855|P1|Overall Study|Non-compliance|11
26203|NCT01689649|120855|P1|Overall Study|Lack of Efficacy|3
26204|NCT01689532|120867|P2|Overall Study|Physician Decision|0
26205|NCT01689532|120868|P1|Overall Study|Physician Decision|2
26206|NCT01689532|120867|P2|Overall Study|Withdrawal by Subject|2
26207|NCT01689532|120868|P1|Overall Study|Withdrawal by Subject|1
26208|NCT01689532|120867|P2|Overall Study|Lack of Efficacy|2
26209|NCT01689532|120868|P1|Overall Study|Lack of Efficacy|2
26210|NCT01689532|120867|P2|Overall Study|Adverse Event|5
26211|NCT01689532|120868|P1|Overall Study|Adverse Event|9
26212|NCT01689519|120932|P2|Overall Study|Physician Decision|3
26213|NCT01689519|120933|P1|Overall Study|Physician Decision|0
26214|NCT01689519|120932|P2|Overall Study|Withdrawal by Subject|17
26215|NCT01689519|120933|P1|Overall Study|Withdrawal by Subject|17
26216|NCT01689519|120932|P2|Overall Study|Lost to Follow-up|2
26217|NCT01689519|120933|P1|Overall Study|Lost to Follow-up|6
26218|NCT01689519|120932|P2|Overall Study|Death|116
26219|NCT01689519|120933|P1|Overall Study|Death|143
26220|NCT01689363|120960|P8|Overall Study|Protocol Violation|0
26221|NCT01689363|120961|P7|Overall Study|Protocol Violation|0
26222|NCT01689363|120962|P6|Overall Study|Protocol Violation|0
26223|NCT01689363|120963|P5|Overall Study|Protocol Violation|0
26224|NCT01689363|120964|P4|Overall Study|Protocol Violation|0
26225|NCT01689363|120965|P3|Overall Study|Protocol Violation|0
26226|NCT01689363|120966|P2|Overall Study|Protocol Violation|1
26227|NCT01689363|120967|P1|Overall Study|Protocol Violation|0
26228|NCT01689337|121022|P1|Overall Study|Study Discontinuation|1
26229|NCT01689207|121061|P11|Overall Study|Adverse Event|0
26230|NCT01689207|121062|P10|Overall Study|Adverse Event|0
26231|NCT01689207|121063|P9|Overall Study|Adverse Event|1
26232|NCT01689207|121064|P8|Overall Study|Adverse Event|0
26233|NCT01689207|121065|P7|Overall Study|Adverse Event|0
26234|NCT01689207|121066|P6|Overall Study|Adverse Event|1
26235|NCT01689207|121067|P5|Overall Study|Adverse Event|2
26236|NCT01689207|121068|P4|Overall Study|Adverse Event|0
26237|NCT01689207|121069|P3|Overall Study|Adverse Event|0
26238|NCT01689207|121070|P2|Overall Study|Adverse Event|1
26239|NCT01689207|121071|P1|Overall Study|Adverse Event|0
26240|NCT01688921|121178|P2|Overall Study|informed consent|0
26241|NCT01688921|121179|P1|Overall Study|informed consent|3
26242|NCT01688921|121178|P2|Overall Study|Protocol Violation|1
26243|NCT01688921|121179|P1|Overall Study|Protocol Violation|0
26244|NCT01688921|121178|P2|Overall Study|Physician Decision|1
26245|NCT01688921|121179|P1|Overall Study|Physician Decision|6
26246|NCT01688921|121178|P2|Overall Study|Lost to Follow-up|13
26247|NCT01688921|121179|P1|Overall Study|Lost to Follow-up|7
26248|NCT01688882|121204|P2|Overall Study|Administrative problems|0
26249|NCT01688882|121205|P1|Overall Study|Administrative problems|1
26250|NCT01688882|121204|P2|Overall Study|Unsatisfactory therapeutic effect|1
26251|NCT01688882|121205|P1|Overall Study|Unsatisfactory therapeutic effect|1
26252|NCT01688882|121204|P2|Overall Study|Adverse Event|0
26253|NCT01688882|121205|P1|Overall Study|Adverse Event|1
26254|NCT01688830|121240|P21|Overall Study|Lost to Follow-up|0
26255|NCT01688830|121241|P20|Overall Study|Lost to Follow-up|0
26256|NCT01688830|121242|P19|Overall Study|Lost to Follow-up|0
26257|NCT01688830|121243|P18|Overall Study|Lost to Follow-up|0
26258|NCT01688830|121244|P17|Overall Study|Lost to Follow-up|0
26259|NCT01688830|121245|P16|Overall Study|Lost to Follow-up|0
26260|NCT01688830|121246|P15|Overall Study|Lost to Follow-up|0
26261|NCT01688830|121247|P14|Overall Study|Lost to Follow-up|0
26262|NCT01688830|121248|P13|Overall Study|Lost to Follow-up|0
26263|NCT01688830|121249|P12|Overall Study|Lost to Follow-up|0
26264|NCT01688830|121250|P11|Overall Study|Lost to Follow-up|1
26265|NCT01688830|121251|P10|Overall Study|Lost to Follow-up|0
26266|NCT01688830|121252|P9|Overall Study|Lost to Follow-up|0
26267|NCT01688830|121253|P8|Overall Study|Lost to Follow-up|0
26268|NCT01688830|121254|P7|Overall Study|Lost to Follow-up|0
26269|NCT01688830|121255|P6|Overall Study|Lost to Follow-up|0
26270|NCT01688830|121256|P5|Overall Study|Lost to Follow-up|0
26271|NCT01688830|121257|P4|Overall Study|Lost to Follow-up|0
26272|NCT01688830|121258|P3|Overall Study|Lost to Follow-up|0
26273|NCT01688830|121259|P2|Overall Study|Lost to Follow-up|0
26274|NCT01688830|121260|P1|Overall Study|Lost to Follow-up|0
26275|NCT01688726|121406|P2|Overall Study|Relocated abroad|1
26276|NCT01688726|121407|P1|Overall Study|Relocated abroad|0
26277|NCT01688726|121406|P2|Overall Study|Adverse Event|0
26278|NCT01688726|121407|P1|Overall Study|Adverse Event|1
26279|NCT01688635|121419|P2|Washout 3|Withdrawal by Subject|0
26280|NCT01688635|121420|P1|Washout 3|Withdrawal by Subject|1
26281|NCT01688635|121419|P2|Washout 2|Sponsor Decision|2
26282|NCT01688635|121420|P1|Washout 2|Sponsor Decision|1
26283|NCT01688635|121419|P2|Washout 2|Withdrawal by Subject|0
26284|NCT01688635|121420|P1|Washout 2|Withdrawal by Subject|1
26285|NCT01688635|121419|P2|Washout 2|Physician Decision|0
26286|NCT01688635|121420|P1|Washout 2|Physician Decision|1
26287|NCT01688635|121419|P2|Washout 1|Physician Decision|1
26288|NCT01688635|121420|P1|Washout 1|Physician Decision|0
26289|NCT01688635|121419|P2|Washout 1|Adverse Event|1
26290|NCT01688635|121420|P1|Washout 1|Adverse Event|0
26291|NCT01688635|121419|P2|Washout 1|Withdrawal by Subject|0
26292|NCT01688635|121420|P1|Washout 1|Withdrawal by Subject|1
26293|NCT01688050|121471|P1|Overall Study|Still be eligible for follow-up|37
26294|NCT01688050|121471|P1|Overall Study|Withdrawal by Subject|2
26295|NCT01688050|121471|P1|Overall Study|Lost to Follow-up|5
26296|NCT01688050|121471|P1|Overall Study|Conversion to open repair|1
26297|NCT01688050|121471|P1|Overall Study|Death|5
26298|NCT01687478|121484|P2|Overall Study|Entry Criteria Not Met|2
26299|NCT01687478|121485|P1|Overall Study|Entry Criteria Not Met|6
26300|NCT01687478|121484|P2|Overall Study|Physician Decision|3
26301|NCT01687478|121485|P1|Overall Study|Physician Decision|1
26302|NCT01687478|121484|P2|Overall Study|Withdrawal by Subject|19
26303|NCT01687478|121485|P1|Overall Study|Withdrawal by Subject|21
26304|NCT01687478|121484|P2|Overall Study|Protocol Violation|2
26305|NCT01687478|121485|P1|Overall Study|Protocol Violation|0
26306|NCT01687478|121484|P2|Overall Study|Lost to Follow-up|3
26307|NCT01687478|121485|P1|Overall Study|Lost to Follow-up|1
26308|NCT01687478|121484|P2|Overall Study|Adverse Event|10
26309|NCT01687478|121485|P1|Overall Study|Adverse Event|3
26310|NCT01687283|121509|P2|Overall Study|Withdrawal by Subject|8
26311|NCT01687283|121510|P1|Overall Study|Withdrawal by Subject|9
26312|NCT01687283|121509|P2|Overall Study|Investigator discretion|0
26313|NCT01687283|121510|P1|Overall Study|Investigator discretion|2
26314|NCT01687283|121509|P2|Overall Study|Lost to Follow-up|1
26315|NCT01687283|121510|P1|Overall Study|Lost to Follow-up|1
26316|NCT01687283|121509|P2|Overall Study|protocol defined stopping criteria|10
26317|NCT01687283|121510|P1|Overall Study|protocol defined stopping criteria|8
26318|NCT01687283|121509|P2|Overall Study|Protocol Violation|3
26319|NCT01687283|121510|P1|Overall Study|Protocol Violation|1
26320|NCT01687283|121509|P2|Overall Study|Lack of Efficacy|1
26321|NCT01687283|121510|P1|Overall Study|Lack of Efficacy|3
26322|NCT01687283|121509|P2|Overall Study|Adverse Event|4
26323|NCT01687283|121510|P1|Overall Study|Adverse Event|11
26324|NCT01687270|121533|P1|Overall Study|Lost to Follow-up|1
26325|NCT01687270|121533|P1|Overall Study|Lack of Efficacy|11
26326|NCT01687257|121544|P3|Overall Study|Investigator's Discretion|0
26327|NCT01687257|121545|P2|Overall Study|Investigator's Discretion|3
26328|NCT01687257|121546|P1|Overall Study|Investigator's Discretion|0
26329|NCT01687257|121544|P3|Overall Study|Adverse Event|0
26330|NCT01687257|121545|P2|Overall Study|Adverse Event|0
26331|NCT01687257|121546|P1|Overall Study|Adverse Event|1
26332|NCT01687257|121544|P3|Overall Study|Subject Withdrew Consent|1
26333|NCT01687257|121545|P2|Overall Study|Subject Withdrew Consent|1
26334|NCT01687257|121546|P1|Overall Study|Subject Withdrew Consent|1
26335|NCT01687257|121544|P3|Overall Study|Efficacy Failure|5
26336|NCT01687257|121545|P2|Overall Study|Efficacy Failure|0
26337|NCT01687257|121546|P1|Overall Study|Efficacy Failure|6
26338|NCT01687218|121611|P6|Overall Study|Relocated, no follow-up planned|0
26339|NCT01687218|121612|P5|Overall Study|Relocated, no follow-up planned|0
26340|NCT01687218|121613|P4|Overall Study|Relocated, no follow-up planned|1
26341|NCT01687218|121614|P3|Overall Study|Relocated, no follow-up planned|1
26342|NCT01687218|121615|P2|Overall Study|Relocated, no follow-up planned|0
26343|NCT01687218|121616|P1|Overall Study|Relocated, no follow-up planned|1
26344|NCT01687218|121611|P6|Overall Study|Withdrawal by Subject|0
26345|NCT01687218|121612|P5|Overall Study|Withdrawal by Subject|1
26346|NCT01687218|121613|P4|Overall Study|Withdrawal by Subject|1
26347|NCT01687218|121614|P3|Overall Study|Withdrawal by Subject|0
26348|NCT01687218|121615|P2|Overall Study|Withdrawal by Subject|3
26349|NCT01687218|121616|P1|Overall Study|Withdrawal by Subject|2
26350|NCT01687101|121640|P1|Overall Study|Lost to Follow-up|7
26351|NCT01686932|121667|P2|Period 1|Adverse Event|1
26352|NCT01686932|121668|P1|Period 1|Adverse Event|1
26353|NCT01686828|121698|P4|Overall Study|Weight Loss|0
26354|NCT01686828|121699|P3|Overall Study|Weight Loss|1
26355|NCT01686828|121700|P2|Overall Study|Weight Loss|0
26356|NCT01686828|121701|P1|Overall Study|Weight Loss|0
26357|NCT01686828|121698|P4|Overall Study|New Job|0
26358|NCT01686828|121699|P3|Overall Study|New Job|0
26359|NCT01686828|121700|P2|Overall Study|New Job|1
26360|NCT01686828|121701|P1|Overall Study|New Job|0
26361|NCT01686828|121698|P4|Overall Study|Physician Decision|0
26362|NCT01686828|121699|P3|Overall Study|Physician Decision|0
26363|NCT01686828|121700|P2|Overall Study|Physician Decision|0
26364|NCT01686828|121701|P1|Overall Study|Physician Decision|1
26365|NCT01686633|121775|P3|Overall Study|Lost to Follow-up|1
26366|NCT01686633|121776|P2|Overall Study|Lost to Follow-up|1
26367|NCT01686633|121777|P1|Overall Study|Lost to Follow-up|0
26368|NCT01686633|121775|P3|Overall Study|Protocol-defined Stopping Criteria|1
26369|NCT01686633|121776|P2|Overall Study|Protocol-defined Stopping Criteria|0
26370|NCT01686633|121777|P1|Overall Study|Protocol-defined Stopping Criteria|1
26371|NCT01686633|121775|P3|Overall Study|Protocol Violation|0
26372|NCT01686633|121776|P2|Overall Study|Protocol Violation|3
26373|NCT01686633|121777|P1|Overall Study|Protocol Violation|2
26374|NCT01686633|121775|P3|Overall Study|Adverse Event|3
26375|NCT01686633|121776|P2|Overall Study|Adverse Event|3
26376|NCT01686633|121777|P1|Overall Study|Adverse Event|4
26377|NCT01686633|121775|P3|Overall Study|Physician Decision|4
26378|NCT01686633|121776|P2|Overall Study|Physician Decision|4
26379|NCT01686633|121777|P1|Overall Study|Physician Decision|3
26380|NCT01686633|121775|P3|Overall Study|Withdrawal by Subject|5
26381|NCT01686633|121776|P2|Overall Study|Withdrawal by Subject|8
26382|NCT01686633|121777|P1|Overall Study|Withdrawal by Subject|8
26383|NCT01686633|121775|P3|Overall Study|Lack of Efficacy|11
26384|NCT01686633|121776|P2|Overall Study|Lack of Efficacy|13
26385|NCT01686633|121777|P1|Overall Study|Lack of Efficacy|33
26386|NCT01686568|121802|P2|Sub-Study|Not consented for sub-study|2
26387|NCT01686568|121803|P1|Sub-Study|Not consented for sub-study|2
26388|NCT01686568|121802|P2|Main Study|Liver enzymes above range of exclusion|0
26389|NCT01686568|121803|P1|Main Study|Liver enzymes above range of exclusion|1
26390|NCT01686568|121802|P2|Main Study|Noncompliance with protocol|1
26391|NCT01686568|121803|P1|Main Study|Noncompliance with protocol|0
26392|NCT01686568|121802|P2|Main Study|Withdrawal by Subject|3
26393|NCT01686568|121803|P1|Main Study|Withdrawal by Subject|1
26394|NCT01685983|121888|P1|Overall Study|Unspecified|7
26395|NCT01685983|121888|P1|Overall Study|Noncompliance with Study Drug|1
26396|NCT01685983|121888|P1|Overall Study|Physician Decision|13
26397|NCT01685983|121888|P1|Overall Study|Progressive Disease|32
26398|NCT01685983|121888|P1|Overall Study|Protocol Violation|2
26399|NCT01685983|121888|P1|Overall Study|Withdrawal by Subject|19
26400|NCT01685983|121888|P1|Overall Study|Death|1
26401|NCT01685983|121888|P1|Overall Study|Adverse Event|7
26402|NCT01685801|121902|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
26403|NCT01685801|121903|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
26404|NCT01685801|121904|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
26405|NCT01685801|121905|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
26406|NCT01685801|121902|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
26407|NCT01685801|121903|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
26408|NCT01685801|121904|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
26409|NCT01685801|121905|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
26410|NCT01685606|121953|P1|Overall Study|Withdrawal by Subject|1
26411|NCT01685437|121966|P1|Overall Study|Unable to make visits due to work|1
26412|NCT01685437|121966|P1|Overall Study|Protocol Violation|4
26413|NCT01685437|121966|P1|Overall Study|Adverse Event|1
26414|NCT01685437|121966|P1|Overall Study|Lost to Follow-up|3
26415|NCT01685437|121966|P1|Overall Study|Withdrawal by Subject|22
26416|NCT01685216|121989|P1|Overall Study|Did not receive study drug|1
26417|NCT01685203|122006|P7|Overall Study|Patient's decision|0
26418|NCT01685203|122007|P6|Overall Study|Patient's decision|1
26419|NCT01685203|122008|P5|Overall Study|Patient's decision|0
26420|NCT01685203|122009|P4|Overall Study|Patient's decision|0
26421|NCT01685203|122010|P3|Overall Study|Patient's decision|0
26422|NCT01685203|122011|P2|Overall Study|Patient's decision|0
26423|NCT01685203|122012|P1|Overall Study|Patient's decision|0
26424|NCT01685203|122006|P7|Overall Study|Adverse event and withdrew consent|0
26425|NCT01685203|122007|P6|Overall Study|Adverse event and withdrew consent|0
26426|NCT01685203|122008|P5|Overall Study|Adverse event and withdrew consent|0
26427|NCT01685203|122009|P4|Overall Study|Adverse event and withdrew consent|0
26428|NCT01685203|122010|P3|Overall Study|Adverse event and withdrew consent|0
26429|NCT01685203|122011|P2|Overall Study|Adverse event and withdrew consent|0
26430|NCT01685203|122012|P1|Overall Study|Adverse event and withdrew consent|1
26431|NCT01685203|122006|P7|Overall Study|Adverse Event|0
26432|NCT01685203|122007|P6|Overall Study|Adverse Event|2
26433|NCT01685203|122008|P5|Overall Study|Adverse Event|0
26434|NCT01685203|122009|P4|Overall Study|Adverse Event|0
26435|NCT01685203|122010|P3|Overall Study|Adverse Event|0
26436|NCT01685203|122011|P2|Overall Study|Adverse Event|0
26437|NCT01685203|122012|P1|Overall Study|Adverse Event|0
26438|NCT01685203|122006|P7|Overall Study|Lost to Follow-up|0
26439|NCT01685203|122007|P6|Overall Study|Lost to Follow-up|0
26440|NCT01685203|122008|P5|Overall Study|Lost to Follow-up|0
26441|NCT01685203|122009|P4|Overall Study|Lost to Follow-up|1
26442|NCT01685203|122010|P3|Overall Study|Lost to Follow-up|0
26443|NCT01685203|122011|P2|Overall Study|Lost to Follow-up|3
26444|NCT01685203|122012|P1|Overall Study|Lost to Follow-up|3
26445|NCT01685060|122056|P1|Overall Study|Death|8
26446|NCT01685060|122056|P1|Overall Study|Lost to Follow-up|1
26447|NCT01685060|122056|P1|Overall Study|Subject/guardian decision|20
26448|NCT01685060|122056|P1|Overall Study|Physician Decision|14
26449|NCT01685060|122056|P1|Overall Study|Progressive disease|69
26450|NCT01685060|122056|P1|Overall Study|Adverse Event|12
26451|NCT01685060|122056|P1|Overall Study|Rollover patients|16
26452|NCT01684930|122073|P2|Overall Study|Withdrawal by Subject|1
26453|NCT01684930|122074|P1|Overall Study|Withdrawal by Subject|3
26454|NCT01684878|122094|P4|Part 2: Randomized Phase|Participant noncompliance|1
26455|NCT01684878|122095|P3|Part 2: Randomized Phase|Participant noncompliance|0
26456|NCT01684878|122096|P2|Part 2: Randomized Phase|Participant noncompliance|0
26457|NCT01684878|122097|P1|Part 2: Randomized Phase|Participant noncompliance|0
26458|NCT01684878|122094|P4|Part 2: Randomized Phase|Alive at data-cut|7
26459|NCT01684878|122095|P3|Part 2: Randomized Phase|Alive at data-cut|13
26460|NCT01684878|122096|P2|Part 2: Randomized Phase|Alive at data-cut|0
26461|NCT01684878|122097|P1|Part 2: Randomized Phase|Alive at data-cut|0
26462|NCT01684878|122094|P4|Part 2: Randomized Phase|Death|68
26463|NCT01684878|122095|P3|Part 2: Randomized Phase|Death|62
26464|NCT01684878|122096|P2|Part 2: Randomized Phase|Death|0
26465|NCT01684878|122097|P1|Part 2: Randomized Phase|Death|0
26466|NCT01684878|122094|P4|Part 2: Randomized Phase|Lost to Follow-up|0
26467|NCT01684878|122095|P3|Part 2: Randomized Phase|Lost to Follow-up|2
26468|NCT01684878|122096|P2|Part 2: Randomized Phase|Lost to Follow-up|0
26469|NCT01684878|122097|P1|Part 2: Randomized Phase|Lost to Follow-up|0
26470|NCT01684878|122094|P4|Part 2: Randomized Phase|Participant withdrew consent|2
26471|NCT01684878|122095|P3|Part 2: Randomized Phase|Participant withdrew consent|1
26472|NCT01684878|122096|P2|Part 2: Randomized Phase|Participant withdrew consent|0
26473|NCT01684878|122097|P1|Part 2: Randomized Phase|Participant withdrew consent|0
26474|NCT01684878|122094|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
26475|NCT01684878|122095|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
26476|NCT01684878|122096|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
26477|NCT01684878|122097|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
26478|NCT01684878|122094|P4|Part 1: Safety Run in Phase|Death|0
26479|NCT01684878|122095|P3|Part 1: Safety Run in Phase|Death|0
26480|NCT01684878|122096|P2|Part 1: Safety Run in Phase|Death|20
26481|NCT01684878|122097|P1|Part 1: Safety Run in Phase|Death|15
26482|NCT01684878|122094|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
26483|NCT01684878|122095|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
26484|NCT01684878|122096|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
26485|NCT01684878|122097|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
26486|NCT01684215|122197|P4|Overall Study|Ongoing at date of cut-off|38
26487|NCT01684215|122198|P3|Overall Study|Ongoing at date of cut-off|4
26488|NCT01684215|122199|P2|Overall Study|Ongoing at date of cut-off|0
26489|NCT01684215|122200|P1|Overall Study|Ongoing at date of cut-off|0
26490|NCT01684215|122197|P4|Overall Study|Death|1
26491|NCT01684215|122198|P3|Overall Study|Death|0
26492|NCT01684215|122199|P2|Overall Study|Death|0
26493|NCT01684215|122200|P1|Overall Study|Death|0
26494|NCT01684215|122197|P4|Overall Study|Unspecified|0
26495|NCT01684215|122198|P3|Overall Study|Unspecified|1
26496|NCT01684215|122199|P2|Overall Study|Unspecified|0
26497|NCT01684215|122200|P1|Overall Study|Unspecified|0
26498|NCT01684215|122197|P4|Overall Study|Objective progression or relapse|0
26499|NCT01684215|122198|P3|Overall Study|Objective progression or relapse|0
26500|NCT01684215|122199|P2|Overall Study|Objective progression or relapse|6
26501|NCT01684215|122200|P1|Overall Study|Objective progression or relapse|5
26502|NCT01684215|122197|P4|Overall Study|Adverse Event|4
26503|NCT01684215|122198|P3|Overall Study|Adverse Event|1
26504|NCT01684215|122199|P2|Overall Study|Adverse Event|0
26505|NCT01684215|122200|P1|Overall Study|Adverse Event|1
26506|NCT01684046|122274|P2|Period 1, First 30 Days|Adverse Event|2
26507|NCT01684046|122275|P1|Period 1, First 30 Days|Adverse Event|0
26508|NCT01684033|122281|P2|Period 2, Second 30 Days|Adverse Event|0
26509|NCT01684033|122282|P1|Period 2, Second 30 Days|Adverse Event|1
26510|NCT01684033|122281|P2|Period 1, First 30 Days|Lost to Follow-up|0
26511|NCT01684033|122282|P1|Period 1, First 30 Days|Lost to Follow-up|1
26512|NCT01684033|122281|P2|Period 1, First 30 Days|Withdrawal by Subject|0
26513|NCT01684033|122282|P1|Period 1, First 30 Days|Withdrawal by Subject|1
26514|NCT01684033|122281|P2|Period 1, First 30 Days|Noncompliance|0
26515|NCT01684033|122282|P1|Period 1, First 30 Days|Noncompliance|1
26516|NCT01684033|122281|P2|Period 1, First 30 Days|Adverse Event|1
26517|NCT01684033|122282|P1|Period 1, First 30 Days|Adverse Event|1
26518|NCT01682876|122316|P4|Overall Study|Other|1
26519|NCT01682876|122317|P3|Overall Study|Other|1
26520|NCT01682876|122318|P2|Overall Study|Other|0
26521|NCT01682876|122319|P1|Overall Study|Other|1
26522|NCT01682876|122316|P4|Overall Study|Withdrawal by Subject|2
26523|NCT01682876|122317|P3|Overall Study|Withdrawal by Subject|0
26524|NCT01682876|122318|P2|Overall Study|Withdrawal by Subject|0
26525|NCT01682876|122319|P1|Overall Study|Withdrawal by Subject|4
26526|NCT01682876|122316|P4|Overall Study|Protocol Violation|1
26527|NCT01682876|122317|P3|Overall Study|Protocol Violation|1
26528|NCT01682876|122318|P2|Overall Study|Protocol Violation|1
26529|NCT01682876|122319|P1|Overall Study|Protocol Violation|1
26530|NCT01682876|122316|P4|Overall Study|Lost to Follow-up|11
26531|NCT01682876|122317|P3|Overall Study|Lost to Follow-up|9
26532|NCT01682876|122318|P2|Overall Study|Lost to Follow-up|15
26533|NCT01682876|122319|P1|Overall Study|Lost to Follow-up|11
26534|NCT01682876|122316|P4|Overall Study|Adverse Event|1
26535|NCT01682876|122317|P3|Overall Study|Adverse Event|0
26536|NCT01682876|122318|P2|Overall Study|Adverse Event|0
26537|NCT01682876|122319|P1|Overall Study|Adverse Event|0
26538|NCT01682876|122316|P4|Overall Study|Administrative reason|3
26539|NCT01682876|122317|P3|Overall Study|Administrative reason|0
26540|NCT01682876|122318|P2|Overall Study|Administrative reason|4
26541|NCT01682876|122319|P1|Overall Study|Administrative reason|4
26542|NCT01682863|122365|P3|Overall Study|Physician Decision|1
26543|NCT01682863|122366|P2|Overall Study|Physician Decision|0
26544|NCT01682863|122367|P1|Overall Study|Physician Decision|0
26545|NCT01682863|122365|P3|Overall Study|Adverse Event|2
26546|NCT01682863|122366|P2|Overall Study|Adverse Event|1
26547|NCT01682863|122367|P1|Overall Study|Adverse Event|0
26548|NCT01682863|122365|P3|Overall Study|Technical problems|0
26549|NCT01682863|122366|P2|Overall Study|Technical problems|0
26550|NCT01682863|122367|P1|Overall Study|Technical problems|1
26551|NCT01682863|122365|P3|Overall Study|Protocol deviation|1
26552|NCT01682863|122366|P2|Overall Study|Protocol deviation|0
26553|NCT01682863|122367|P1|Overall Study|Protocol deviation|1
26554|NCT01682863|122365|P3|Overall Study|Death|4
26555|NCT01682863|122366|P2|Overall Study|Death|3
26556|NCT01682863|122367|P1|Overall Study|Death|1
26557|NCT01682863|122365|P3|Overall Study|Lost to Follow-up|6
26558|NCT01682863|122366|P2|Overall Study|Lost to Follow-up|1
26559|NCT01682863|122367|P1|Overall Study|Lost to Follow-up|5
26560|NCT01682863|122365|P3|Overall Study|Subject/guardian decision|10
26561|NCT01682863|122366|P2|Overall Study|Subject/guardian decision|12
26562|NCT01682863|122367|P1|Overall Study|Subject/guardian decision|19
26563|NCT01683838|122398|P2|Overall Study|not specified|3
26564|NCT01683838|122399|P1|Overall Study|not specified|4
26565|NCT01683838|122398|P2|Overall Study|Lost to Follow-up|1
26566|NCT01683838|122399|P1|Overall Study|Lost to Follow-up|1
26567|NCT01683838|122398|P2|Overall Study|Withdrawal by Subject|5
26568|NCT01683838|122399|P1|Overall Study|Withdrawal by Subject|6
26569|NCT01683838|122398|P2|Overall Study|Protocol Violation|1
26570|NCT01683838|122399|P1|Overall Study|Protocol Violation|3
26571|NCT01683838|122398|P2|Overall Study|Adverse Event|2
26572|NCT01683838|122399|P1|Overall Study|Adverse Event|12
26573|NCT01683604|122439|P1|Overall Study|Unspecified|2
26574|NCT01683604|122439|P1|Overall Study|Lack of Efficacy|1
26575|NCT01683604|122439|P1|Overall Study|Adverse Event|2
26576|NCT01683409|122624|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
26577|NCT01683409|122625|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
26578|NCT01683409|122626|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
26579|NCT01683409|122627|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
26580|NCT01683409|122628|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
26581|NCT01683409|122624|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
26582|NCT01683409|122625|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
26583|NCT01683409|122626|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
26584|NCT01683409|122627|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
26585|NCT01683409|122628|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
26586|NCT01683409|122624|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
26587|NCT01683409|122625|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
26588|NCT01683409|122626|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
26589|NCT01683409|122627|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
26590|NCT01683409|122628|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
26591|NCT01683409|122624|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
26592|NCT01683409|122625|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
26593|NCT01683409|122626|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
26594|NCT01683409|122627|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
26595|NCT01683409|122628|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
26596|NCT01683409|122624|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
26597|NCT01683409|122625|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
26598|NCT01683409|122626|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
26599|NCT01683409|122627|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
26600|NCT01683409|122628|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
26601|NCT01683409|122624|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
26602|NCT01683409|122625|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
26603|NCT01683409|122626|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
26604|NCT01683409|122627|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
26605|NCT01683409|122628|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
26606|NCT01683409|122624|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
26607|NCT01683409|122625|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
26608|NCT01683409|122626|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
26609|NCT01683409|122627|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
26693|NCT01682720|122828|P3|Overall Study|Randomized but Not Treated|1
26610|NCT01683409|122628|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
26611|NCT01683409|122624|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
26612|NCT01683409|122625|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
26613|NCT01683409|122626|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
26614|NCT01683409|122627|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
26615|NCT01683409|122628|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
26616|NCT01683409|122624|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
26617|NCT01683409|122625|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
26618|NCT01683409|122626|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
26619|NCT01683409|122627|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
26620|NCT01683409|122628|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
26621|NCT01683409|122624|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
26622|NCT01683409|122625|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
26623|NCT01683409|122626|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
26624|NCT01683409|122627|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
26625|NCT01683409|122628|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
26626|NCT01683409|122624|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
26627|NCT01683409|122625|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
26628|NCT01683409|122626|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
26629|NCT01683409|122627|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
26630|NCT01683409|122628|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
26631|NCT01683383|122671|P2|Overall Study|Infant was not transported|0
26632|NCT01683383|122672|P1|Overall Study|Infant was not transported|1
26633|NCT01683266|122688|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
26634|NCT01683266|122689|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
26635|NCT01683266|122688|P2|Overall Study|Possibly Hypoglycemia|0
26636|NCT01683266|122689|P1|Overall Study|Possibly Hypoglycemia|1
26637|NCT01683266|122688|P2|Overall Study|Perceived Lack of Efficacy|1
26638|NCT01683266|122689|P1|Overall Study|Perceived Lack of Efficacy|1
26639|NCT01683266|122688|P2|Overall Study|Nonserious Hypoglycemia|3
26640|NCT01683266|122689|P1|Overall Study|Nonserious Hypoglycemia|0
26641|NCT01683266|122688|P2|Overall Study|Site Closure / Site Withdrawal|3
26642|NCT01683266|122689|P1|Overall Study|Site Closure / Site Withdrawal|1
26643|NCT01683266|122688|P2|Overall Study|Lost to Follow-up|0
26644|NCT01683266|122689|P1|Overall Study|Lost to Follow-up|5
26645|NCT01683266|122688|P2|Overall Study|Selection Criterion / Protocol Violation|5
26646|NCT01683266|122689|P1|Overall Study|Selection Criterion / Protocol Violation|7
26647|NCT01683266|122688|P2|Overall Study|Personal Reason|25
26648|NCT01683266|122689|P1|Overall Study|Personal Reason|17
26649|NCT01683266|122688|P2|Overall Study|Protocol Violation|6
26650|NCT01683266|122689|P1|Overall Study|Protocol Violation|13
26651|NCT01683266|122688|P2|Overall Study|Lack of Efficacy|2
26652|NCT01683266|122689|P1|Overall Study|Lack of Efficacy|5
26653|NCT01683266|122688|P2|Overall Study|Adverse Event|4
26654|NCT01683266|122689|P1|Overall Study|Adverse Event|5
26655|NCT01683058|122717|P1|Overall Study|Lack of Efficacy|2
26656|NCT01683058|122717|P1|Overall Study|Withdrawal by Subject|7
26657|NCT01683058|122717|P1|Overall Study|Subject Met Withdrawal Criteria|5
26658|NCT01683058|122717|P1|Overall Study|Adverse Event|6
26659|NCT01683058|122717|P1|Overall Study|Lost to Follow-up|9
26660|NCT01683019|122748|P3|Overall Study|Withdrawal by Subject|4
26661|NCT01683019|122749|P2|Overall Study|Withdrawal by Subject|1
26662|NCT01683019|122750|P1|Overall Study|Withdrawal by Subject|2
26663|NCT01682837|122758|P1|Baseline|Withdrawal by Subject|5
26664|NCT01682759|122802|P2|Overall Study|Withdrawal by Subject|55
26665|NCT01682759|122803|P1|Overall Study|Withdrawal by Subject|56
26666|NCT01682759|122802|P2|Overall Study|Physician Decision|1
26667|NCT01682759|122803|P1|Overall Study|Physician Decision|1
26668|NCT01682759|122802|P2|Overall Study|Lost to Follow-up|13
26669|NCT01682759|122803|P1|Overall Study|Lost to Follow-up|10
26670|NCT01682759|122802|P2|Overall Study|Death|1
26671|NCT01682759|122803|P1|Overall Study|Death|2
26672|NCT01682720|122827|P4|Overall Study|Adverse Event|1
26673|NCT01682720|122828|P3|Overall Study|Adverse Event|1
26674|NCT01682720|122829|P2|Overall Study|Adverse Event|0
26675|NCT01682720|122830|P1|Overall Study|Adverse Event|1
26676|NCT01682720|122827|P4|Overall Study|Subject Withdrew Consent|2
26677|NCT01682720|122828|P3|Overall Study|Subject Withdrew Consent|2
26678|NCT01682720|122829|P2|Overall Study|Subject Withdrew Consent|0
26679|NCT01682720|122830|P1|Overall Study|Subject Withdrew Consent|0
26680|NCT01682720|122827|P4|Overall Study|Lost to Follow-up|6
26681|NCT01682720|122828|P3|Overall Study|Lost to Follow-up|0
26682|NCT01682720|122829|P2|Overall Study|Lost to Follow-up|1
26683|NCT01682720|122830|P1|Overall Study|Lost to Follow-up|1
26684|NCT01682720|122827|P4|Overall Study|Efficacy Failure|30
26685|NCT01682720|122828|P3|Overall Study|Efficacy Failure|3
26686|NCT01682720|122829|P2|Overall Study|Efficacy Failure|3
26687|NCT01682720|122830|P1|Overall Study|Efficacy Failure|0
26688|NCT01682720|122827|P4|Overall Study|Terminated by Sponsor|0
26689|NCT01682720|122828|P3|Overall Study|Terminated by Sponsor|0
26690|NCT01682720|122829|P2|Overall Study|Terminated by Sponsor|0
26691|NCT01682720|122830|P1|Overall Study|Terminated by Sponsor|83
26692|NCT01682720|122827|P4|Overall Study|Randomized but Not Treated|0
26694|NCT01682720|122829|P2|Overall Study|Randomized but Not Treated|1
26695|NCT01682720|122830|P1|Overall Study|Randomized but Not Treated|0
26696|NCT01682681|122847|P1|Overall Study|Low compliance|13
26697|NCT01682681|122847|P1|Overall Study|unspecified|21
26698|NCT01682681|122847|P1|Overall Study|tapering of topiramate|5
26699|NCT01682681|122847|P1|Overall Study|Adverse Event|46
26700|NCT01682681|122847|P1|Overall Study|Lost to Follow-up|174
26701|NCT01682681|122847|P1|Overall Study|Moved to other hospital|10
26702|NCT01682681|122847|P1|Overall Study|Withdrawal by Subject|1
26703|NCT01682681|122847|P1|Overall Study|Lack of Efficacy|62
26704|NCT01682603|122876|P1|Overall Study|Lost to Follow-up|3
26705|NCT01682460|122918|P1|Overall Study|Did not meet inclusion criteria|2
26706|NCT01682460|122918|P1|Overall Study|Withdrawal by Subject|2
26707|NCT01682031|122972|P2|Overall Study|Patient stopped selenium on his own|1
26708|NCT01682031|122973|P1|Overall Study|Patient stopped selenium on his own|0
26709|NCT01682031|122972|P2|Overall Study|Patient could not swallow tablets|0
26710|NCT01682031|122973|P1|Overall Study|Patient could not swallow tablets|1
26711|NCT01682031|122972|P2|Overall Study|MRI results indicate increased nodul|1
26712|NCT01682031|122973|P1|Overall Study|MRI results indicate increased nodul|0
26713|NCT01682031|122972|P2|Overall Study|Adverse Event|2
26714|NCT01682031|122973|P1|Overall Study|Adverse Event|0
26715|NCT01682031|122972|P2|Overall Study|Withdrawal by Subject|1
26716|NCT01682031|122973|P1|Overall Study|Withdrawal by Subject|0
26717|NCT01681849|122996|P3|Overall Study|Lost to Follow-up|6
26718|NCT01681849|122997|P2|Overall Study|Lost to Follow-up|2
26719|NCT01681849|122998|P1|Overall Study|Lost to Follow-up|3
26720|NCT01681849|122996|P3|Overall Study|Withdrawal by Subject|33
26721|NCT01681849|122997|P2|Overall Study|Withdrawal by Subject|5
26722|NCT01681849|122998|P1|Overall Study|Withdrawal by Subject|3
26723|NCT01681849|122996|P3|Overall Study|Protocol Violation|0
26724|NCT01681849|122997|P2|Overall Study|Protocol Violation|0
26725|NCT01681849|122998|P1|Overall Study|Protocol Violation|2
26726|NCT01681628|123009|P2|19 Months Follow-up|Lost to Follow-up|43
26727|NCT01681628|123010|P1|19 Months Follow-up|Lost to Follow-up|61
26728|NCT01681628|123009|P2|19 Months Follow-up|Death|0
26729|NCT01681628|123010|P1|19 Months Follow-up|Death|1
26730|NCT01681628|123009|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
26731|NCT01681628|123010|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
26732|NCT01681628|123009|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
26733|NCT01681628|123010|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
26734|NCT01681576|123023|P2|Period 2|Non-compliance with study treatment|0
26735|NCT01681576|123024|P1|Period 2|Non-compliance with study treatment|1
26736|NCT01681576|123023|P2|Period 2|subject/guardian decision|1
26737|NCT01681576|123024|P1|Period 2|subject/guardian decision|3
26738|NCT01681576|123023|P2|Period 1|Protocol Deviation|0
26739|NCT01681576|123024|P1|Period 1|Protocol Deviation|1
26740|NCT01681576|123023|P2|Period 1|Adverse Event|0
26741|NCT01681576|123024|P1|Period 1|Adverse Event|1
26742|NCT01681511|123040|P2|Overall Study|No post-catheter sample collected|4
26743|NCT01681511|123041|P1|Overall Study|No post-catheter sample collected|11
26744|NCT01681511|123040|P2|Overall Study|No Daily Urine Sample Collected|1
26745|NCT01681511|123041|P1|Overall Study|No Daily Urine Sample Collected|0
26746|NCT01681511|123040|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
26747|NCT01681511|123041|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
26748|NCT01681511|123040|P2|Overall Study|Failed Inclusion/Exclusion|0
26749|NCT01681511|123041|P1|Overall Study|Failed Inclusion/Exclusion|3
26750|NCT01681511|123040|P2|Overall Study|No Treatment Received|3
26751|NCT01681511|123041|P1|Overall Study|No Treatment Received|1
26752|NCT01681472|123059|P4|Overall Study|Adverse Event|0
26753|NCT01681472|123060|P3|Overall Study|Adverse Event|0
26754|NCT01681472|123061|P2|Overall Study|Adverse Event|1
26755|NCT01681472|123062|P1|Overall Study|Adverse Event|0
26756|NCT01681368|123072|P1|Overall Study|Refused further follow up|1
26757|NCT01681368|123072|P1|Overall Study|Refused further treatment|1
26758|NCT01681277|123089|P5|Overall Study|Adverse Event|0
26759|NCT01681277|123090|P4|Overall Study|Adverse Event|0
26760|NCT01681277|123091|P3|Overall Study|Adverse Event|0
26761|NCT01681277|123092|P2|Overall Study|Adverse Event|0
26762|NCT01681277|123093|P1|Overall Study|Adverse Event|1
26763|NCT01681212|123134|P1|Overall Study|Administrative reason by sponsor|1
26764|NCT01681212|123134|P1|Overall Study|No longer met study criteria|5
26765|NCT01681069|123192|P2|Overall Study|Adverse Event|1
26766|NCT01681069|123193|P1|Overall Study|Adverse Event|0
26767|NCT01681069|123192|P2|Overall Study|Protocol Violation|1
26768|NCT01681069|123193|P1|Overall Study|Protocol Violation|1
26769|NCT01681069|123192|P2|Overall Study|Withdrawal by Subject|5
26770|NCT01681069|123193|P1|Overall Study|Withdrawal by Subject|4
26771|NCT01681004|123205|P2|Study Completion|Death|1
26772|NCT01681004|123206|P1|Study Completion|Death|1
26773|NCT01681004|123205|P2|Study Completion|Site Termination|1
26774|NCT01681004|123206|P1|Study Completion|Site Termination|2
26775|NCT01681004|123205|P2|Study Completion|Physician Decision|3
26776|NCT01681004|123206|P1|Study Completion|Physician Decision|1
26777|NCT01681004|123205|P2|Study Completion|Lost to Follow-up|3
26778|NCT01681004|123206|P1|Study Completion|Lost to Follow-up|8
26779|NCT01681004|123205|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
26780|NCT01681004|123206|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
26781|NCT01680991|123263|P3|Overall Study|PD confirmed in other hospital|0
26782|NCT01680991|123264|P2|Overall Study|PD confirmed in other hospital|0
26783|NCT01680991|123265|P1|Overall Study|PD confirmed in other hospital|1
26784|NCT01680991|123263|P3|Overall Study|Bad physical condition|1
26785|NCT01680991|123264|P2|Overall Study|Bad physical condition|0
26786|NCT01680991|123265|P1|Overall Study|Bad physical condition|0
26787|NCT01680991|123263|P3|Overall Study|Physician Decision|2
26788|NCT01680991|123264|P2|Overall Study|Physician Decision|7
26789|NCT01680991|123265|P1|Overall Study|Physician Decision|0
26790|NCT01680991|123263|P3|Overall Study|Progressive disease (PD)|0
26791|NCT01680991|123264|P2|Overall Study|Progressive disease (PD)|10
26792|NCT01680991|123265|P1|Overall Study|Progressive disease (PD)|0
26793|NCT01680991|123263|P3|Overall Study|Withdrawal by Subject|0
26794|NCT01680991|123264|P2|Overall Study|Withdrawal by Subject|1
26795|NCT01680991|123265|P1|Overall Study|Withdrawal by Subject|5
26796|NCT01680991|123263|P3|Overall Study|Protocol Violation|0
26797|NCT01680991|123264|P2|Overall Study|Protocol Violation|1
26798|NCT01680991|123265|P1|Overall Study|Protocol Violation|0
26799|NCT01680991|123263|P3|Overall Study|Death|1
26800|NCT01680991|123264|P2|Overall Study|Death|0
26801|NCT01680991|123265|P1|Overall Study|Death|1
26802|NCT01680991|123263|P3|Overall Study|Adverse Event|0
26803|NCT01680991|123264|P2|Overall Study|Adverse Event|0
26804|NCT01680991|123265|P1|Overall Study|Adverse Event|1
26805|NCT01680861|123345|P2|Early Post-transplant Period|Protocol Violation|1
26806|NCT01680861|123346|P1|Early Post-transplant Period|Protocol Violation|1
26807|NCT01680497|123401|P1|Overall Study|Lost to Follow-up|2
26808|NCT01680458|123411|P1|Overall Study|Protocol Violation|3
26809|NCT01680341|123422|P2|Overall Study|Unclassified|15
26810|NCT01680341|123423|P1|Overall Study|Unclassified|18
26811|NCT01680341|123422|P2|Overall Study|Adverse Event|2
26812|NCT01680341|123423|P1|Overall Study|Adverse Event|3
26813|NCT01680159|123494|P1|Increased Dose Period|Withdrawal by Subject|2
26814|NCT01680159|123494|P1|Increased Dose Period|Adverse Event|6
26815|NCT01680159|123494|P1|Screening Period|Not meet criteria for dose-up period|7
26816|NCT01680016|123521|P4|Overall Study|Withdrawal by Subject|1
26817|NCT01680016|123522|P3|Overall Study|Withdrawal by Subject|1
26818|NCT01680016|123523|P2|Overall Study|Withdrawal by Subject|7
26819|NCT01680016|123524|P1|Overall Study|Withdrawal by Subject|5
26820|NCT01680016|123521|P4|Overall Study|Protocol Violation|0
26821|NCT01680016|123522|P3|Overall Study|Protocol Violation|0
26822|NCT01680016|123523|P2|Overall Study|Protocol Violation|1
26823|NCT01680016|123524|P1|Overall Study|Protocol Violation|0
26824|NCT01680016|123521|P4|Overall Study|The Subject went out of The Trial|0
26825|NCT01680016|123522|P3|Overall Study|The Subject went out of The Trial|3
26826|NCT01680016|123523|P2|Overall Study|The Subject went out of The Trial|0
26827|NCT01680016|123524|P1|Overall Study|The Subject went out of The Trial|1
26828|NCT01680016|123521|P4|Overall Study|Adverse Event|4
26829|NCT01680016|123522|P3|Overall Study|Adverse Event|1
26830|NCT01680016|123523|P2|Overall Study|Adverse Event|0
26831|NCT01680016|123524|P1|Overall Study|Adverse Event|0
26832|NCT01679613|123586|P4|Overall Study|other than stated above|2
26833|NCT01679613|123587|P3|Overall Study|other than stated above|2
26834|NCT01679613|123588|P2|Overall Study|other than stated above|1
26835|NCT01679613|123589|P1|Overall Study|other than stated above|0
26836|NCT01679236|123632|P2|Overall Study|Lost to Follow-up|15
26837|NCT01679236|123633|P1|Overall Study|Lost to Follow-up|15
26838|NCT01679002|123680|P3|Overall Study|Adverse Event|0
26839|NCT01679002|123681|P2|Overall Study|Adverse Event|1
26840|NCT01679002|123682|P1|Overall Study|Adverse Event|1
26841|NCT01678911|123709|P2|Second Intervention|Lost to Follow-up|0
26842|NCT01678911|123710|P1|Second Intervention|Lost to Follow-up|2
26843|NCT01678820|123756|P3|Overall Study|Not treated with double-blind study drug|2
26844|NCT01678820|123757|P2|Overall Study|Not treated with double-blind study drug|2
26845|NCT01678820|123758|P1|Overall Study|Not treated with double-blind study drug|0
26846|NCT01678820|123756|P3|Overall Study|Protocol Violation|4
26847|NCT01678820|123757|P2|Overall Study|Protocol Violation|5
26848|NCT01678820|123758|P1|Overall Study|Protocol Violation|4
26849|NCT01678820|123756|P3|Overall Study|Physician Decision|1
26850|NCT01678820|123757|P2|Overall Study|Physician Decision|0
26851|NCT01678820|123758|P1|Overall Study|Physician Decision|0
26852|NCT01678820|123756|P3|Overall Study|Non-compliance with study drug|0
26853|NCT01678820|123757|P2|Overall Study|Non-compliance with study drug|1
26854|NCT01678820|123758|P1|Overall Study|Non-compliance with study drug|0
26855|NCT01678820|123756|P3|Overall Study|Lost to Follow-up|2
26856|NCT01678820|123757|P2|Overall Study|Lost to Follow-up|2
26857|NCT01678820|123758|P1|Overall Study|Lost to Follow-up|7
26858|NCT01678820|123756|P3|Overall Study|Adverse Event|2
26859|NCT01678820|123757|P2|Overall Study|Adverse Event|2
26860|NCT01678820|123758|P1|Overall Study|Adverse Event|2
26861|NCT01678820|123756|P3|Overall Study|Protocol Specified Criteria|1
26862|NCT01678820|123757|P2|Overall Study|Protocol Specified Criteria|3
26863|NCT01678820|123758|P1|Overall Study|Protocol Specified Criteria|2
26864|NCT01678820|123756|P3|Overall Study|Withdrawal by Subject|2
26865|NCT01678820|123757|P2|Overall Study|Withdrawal by Subject|5
26866|NCT01678820|123758|P1|Overall Study|Withdrawal by Subject|2
26867|NCT01678820|123756|P3|Overall Study|Study Terminated by Sponsor|43
26868|NCT01678820|123757|P2|Overall Study|Study Terminated by Sponsor|43
26869|NCT01678820|123758|P1|Overall Study|Study Terminated by Sponsor|45
26870|NCT01678807|123803|P3|Overall Study|Withdrawn by Parent/Guardian|0
26871|NCT01678807|123804|P2|Overall Study|Withdrawn by Parent/Guardian|1
26872|NCT01678807|123805|P1|Overall Study|Withdrawn by Parent/Guardian|0
26873|NCT01678807|123803|P3|Overall Study|Adverse Event|0
26874|NCT01678807|123804|P2|Overall Study|Adverse Event|4
26875|NCT01678807|123805|P1|Overall Study|Adverse Event|4
26876|NCT01678313|123818|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
26877|NCT01678313|123819|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
26878|NCT01678313|123818|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
26879|NCT01678313|123819|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
26880|NCT01678313|123818|P2|Completed the 3-month Therapy|Physician Decision|4
26881|NCT01678313|123819|P1|Completed the 3-month Therapy|Physician Decision|3
26882|NCT01678313|123818|P2|Completed the 3-month Therapy|Lost to Follow-up|8
26883|NCT01678313|123819|P1|Completed the 3-month Therapy|Lost to Follow-up|3
26884|NCT01678131|123853|P3|Overall Study|Withdrawal by Subject|2
26885|NCT01678131|123854|P2|Overall Study|Withdrawal by Subject|0
26886|NCT01678131|123855|P1|Overall Study|Withdrawal by Subject|0
26887|NCT01678131|123853|P3|Overall Study|Adverse Event|0
26888|NCT01678131|123854|P2|Overall Study|Adverse Event|1
26889|NCT01678131|123855|P1|Overall Study|Adverse Event|0
26890|NCT01677988|123863|P1|Overall Study|Lack of Efficacy|2
26891|NCT01677936|123876|P2|Overall Study|Protocol Violation|4
26892|NCT01677936|123877|P1|Overall Study|Protocol Violation|0
26893|NCT01677936|123876|P2|Overall Study|Lost to Follow-up|0
26894|NCT01677936|123877|P1|Overall Study|Lost to Follow-up|1
26895|NCT01677936|123876|P2|Overall Study|Adverse Event|0
26896|NCT01677936|123877|P1|Overall Study|Adverse Event|1
26897|NCT01677936|123876|P2|Overall Study|Protocol Violation|0
26898|NCT01677936|123877|P1|Overall Study|Protocol Violation|3
26899|NCT01677936|123876|P2|Overall Study|Lost to Follow-up|1
26900|NCT01677936|123877|P1|Overall Study|Lost to Follow-up|4
26901|NCT01677858|123890|P5|Overall Study|Lost to Follow-up|1
26902|NCT01677858|123891|P4|Overall Study|Lost to Follow-up|0
26903|NCT01677858|123892|P3|Overall Study|Lost to Follow-up|0
26904|NCT01677858|123893|P2|Overall Study|Lost to Follow-up|0
26905|NCT01677858|123894|P1|Overall Study|Lost to Follow-up|0
26906|NCT01677858|123890|P5|Overall Study|Withdrawal by Subject|15
26907|NCT01677858|123891|P4|Overall Study|Withdrawal by Subject|0
26908|NCT01677858|123892|P3|Overall Study|Withdrawal by Subject|1
26909|NCT01677858|123893|P2|Overall Study|Withdrawal by Subject|1
26910|NCT01677858|123894|P1|Overall Study|Withdrawal by Subject|0
26911|NCT01677858|123890|P5|Overall Study|Progressive Disease|43
26912|NCT01677858|123891|P4|Overall Study|Progressive Disease|3
26913|NCT01677858|123892|P3|Overall Study|Progressive Disease|9
26914|NCT01677858|123893|P2|Overall Study|Progressive Disease|1
26915|NCT01677858|123894|P1|Overall Study|Progressive Disease|2
26916|NCT01677858|123890|P5|Overall Study|Physician Decision|12
26917|NCT01677858|123891|P4|Overall Study|Physician Decision|0
26918|NCT01677858|123892|P3|Overall Study|Physician Decision|2
26919|NCT01677858|123893|P2|Overall Study|Physician Decision|0
26920|NCT01677858|123894|P1|Overall Study|Physician Decision|1
26921|NCT01677858|123890|P5|Overall Study|Death|1
26922|NCT01677858|123891|P4|Overall Study|Death|0
26923|NCT01677858|123892|P3|Overall Study|Death|0
26924|NCT01677858|123893|P2|Overall Study|Death|0
26925|NCT01677858|123894|P1|Overall Study|Death|0
26926|NCT01677858|123890|P5|Overall Study|Adverse Event|13
26927|NCT01677858|123891|P4|Overall Study|Adverse Event|3
26928|NCT01677858|123892|P3|Overall Study|Adverse Event|2
26929|NCT01677858|123893|P2|Overall Study|Adverse Event|0
26930|NCT01677858|123894|P1|Overall Study|Adverse Event|0
26931|NCT01677767|123967|P1|Overall Study|Non-compliance by the participants|3
26932|NCT01677767|123967|P1|Overall Study|Withdrawal by Subject|10
26933|NCT01677767|123967|P1|Overall Study|Protocol Violation|4
26934|NCT01677767|123967|P1|Overall Study|Death|4
26935|NCT01677767|123967|P1|Overall Study|Adverse Event|1
26936|NCT01677624|123981|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
26937|NCT01677299|123990|P4|Overall Study|Withdrawal by Subject|1
26938|NCT01677299|123991|P3|Overall Study|Withdrawal by Subject|0
26939|NCT01677299|123992|P2|Overall Study|Withdrawal by Subject|1
26940|NCT01677299|123993|P1|Overall Study|Withdrawal by Subject|0
26941|NCT01677299|123990|P4|Overall Study|Adverse Event|0
26942|NCT01677299|123991|P3|Overall Study|Adverse Event|1
26943|NCT01677299|123992|P2|Overall Study|Adverse Event|2
26944|NCT01677299|123993|P1|Overall Study|Adverse Event|0
26945|NCT01677195|124025|P3|Overall Study|Protocol Violation|4
26946|NCT01677195|124026|P2|Overall Study|Protocol Violation|3
26947|NCT01677195|124027|P1|Overall Study|Protocol Violation|7
26948|NCT01677195|124025|P3|Overall Study|Pregnancy|0
26949|NCT01677195|124026|P2|Overall Study|Pregnancy|1
26950|NCT01677195|124027|P1|Overall Study|Pregnancy|0
26951|NCT01677195|124025|P3|Overall Study|Physician Decision|2
26952|NCT01677195|124026|P2|Overall Study|Physician Decision|2
26953|NCT01677195|124027|P1|Overall Study|Physician Decision|1
26954|NCT01677195|124025|P3|Overall Study|Adverse Event|1
26955|NCT01677195|124026|P2|Overall Study|Adverse Event|4
26956|NCT01677195|124027|P1|Overall Study|Adverse Event|6
26957|NCT01677195|124025|P3|Overall Study|Withdrawal by Subject|1
26958|NCT01677195|124026|P2|Overall Study|Withdrawal by Subject|0
26959|NCT01677195|124027|P1|Overall Study|Withdrawal by Subject|1
26960|NCT01677195|124025|P3|Overall Study|Lost to Follow-up|22
26961|NCT01677195|124026|P2|Overall Study|Lost to Follow-up|22
26962|NCT01677195|124027|P1|Overall Study|Lost to Follow-up|14
26963|NCT01677182|124038|P3|Overall Study|Other reasons|2
26964|NCT01677182|124039|P2|Overall Study|Other reasons|5
26965|NCT01677182|124040|P1|Overall Study|Other reasons|1
26966|NCT01677182|124038|P3|Overall Study|Lack of Efficacy|1
26967|NCT01677182|124039|P2|Overall Study|Lack of Efficacy|0
26968|NCT01677182|124040|P1|Overall Study|Lack of Efficacy|3
26969|NCT01677182|124038|P3|Overall Study|Study termination|11
26970|NCT01677182|124039|P2|Overall Study|Study termination|9
26971|NCT01677182|124040|P1|Overall Study|Study termination|12
26972|NCT01677182|124038|P3|Overall Study|Withdrawal by Subject|10
26973|NCT01677182|124039|P2|Overall Study|Withdrawal by Subject|12
26974|NCT01677182|124040|P1|Overall Study|Withdrawal by Subject|7
26975|NCT01677182|124038|P3|Overall Study|Lost to Follow-up|3
26976|NCT01677182|124039|P2|Overall Study|Lost to Follow-up|0
26977|NCT01677182|124040|P1|Overall Study|Lost to Follow-up|4
26978|NCT01677182|124038|P3|Overall Study|Protocol Violation|4
26979|NCT01677182|124039|P2|Overall Study|Protocol Violation|1
26980|NCT01677182|124040|P1|Overall Study|Protocol Violation|5
26981|NCT01677182|124038|P3|Overall Study|Adverse Event|8
26982|NCT01677182|124039|P2|Overall Study|Adverse Event|1
26983|NCT01677182|124040|P1|Overall Study|Adverse Event|2
26984|NCT01676896|124075|P3|Overall Study|Withdrawal by Subject|19
26985|NCT01676896|124076|P2|Overall Study|Withdrawal by Subject|7
26986|NCT01676896|124077|P1|Overall Study|Withdrawal by Subject|12
26987|NCT01676220|124238|P2|Overall Study|No More Need of Insulin|0
26988|NCT01676220|124239|P1|Overall Study|No More Need of Insulin|1
26989|NCT01676220|124238|P2|Overall Study|Non Serious Hypoglycemia|0
26990|NCT01676220|124239|P1|Overall Study|Non Serious Hypoglycemia|2
26991|NCT01676220|124238|P2|Overall Study|Perceived Lack of Efficacy|1
26992|NCT01676220|124239|P1|Overall Study|Perceived Lack of Efficacy|3
26993|NCT01676220|124238|P2|Overall Study|Site Closure/Site Withdrawal|4
26994|NCT01676220|124239|P1|Overall Study|Site Closure/Site Withdrawal|1
26995|NCT01676220|124238|P2|Overall Study|Selection Criterion/Protocol Violation|9
26996|NCT01676220|124239|P1|Overall Study|Selection Criterion/Protocol Violation|9
26997|NCT01676220|124238|P2|Overall Study|Lost to Follow-up|18
26998|NCT01676220|124239|P1|Overall Study|Lost to Follow-up|11
26999|NCT01676220|124238|P2|Overall Study|Personal Reason|45
27000|NCT01676220|124239|P1|Overall Study|Personal Reason|34
27001|NCT01676220|124238|P2|Overall Study|Received Rescue Therapy|22
27002|NCT01676220|124239|P1|Overall Study|Received Rescue Therapy|14
27003|NCT01676220|124238|P2|Overall Study|Protocol Violation|12
27004|NCT01676220|124239|P1|Overall Study|Protocol Violation|11
27005|NCT01676220|124238|P2|Overall Study|Lack of Efficacy|5
27006|NCT01676220|124239|P1|Overall Study|Lack of Efficacy|2
27007|NCT01676220|124238|P2|Overall Study|Adverse Event|8
27008|NCT01676220|124239|P1|Overall Study|Adverse Event|10
27009|NCT01676220|124238|P2|Overall Study|Randomized But Not Treated|1
27010|NCT01676220|124239|P1|Overall Study|Randomized But Not Treated|4
27011|NCT01676012|124269|P1|Overall Study|incomplete set of videos|1
27012|NCT01676012|124269|P1|Overall Study|Adverse Event|2
27013|NCT01675661|124280|P2|Overall Study|Other reason|2
27014|NCT01675661|124281|P1|Overall Study|Other reason|1
27015|NCT01675661|124280|P2|Overall Study|Death|1
27016|NCT01675661|124281|P1|Overall Study|Death|0
27017|NCT01675661|124280|P2|Overall Study|Physician Decision|2
27018|NCT01675661|124281|P1|Overall Study|Physician Decision|0
27019|NCT01675661|124280|P2|Overall Study|Withdrawal by Subject|7
27020|NCT01675661|124281|P1|Overall Study|Withdrawal by Subject|3
27021|NCT01675661|124280|P2|Overall Study|Moved away|6
27022|NCT01675661|124281|P1|Overall Study|Moved away|5
27023|NCT01675661|124280|P2|Overall Study|Practical problems|5
27024|NCT01675661|124281|P1|Overall Study|Practical problems|9
27025|NCT01675661|124280|P2|Overall Study|Lost to Follow-up|23
27026|NCT01675661|124281|P1|Overall Study|Lost to Follow-up|22
27027|NCT01675544|124293|P1|Overall Study|Withdrawal by Subject|2
27028|NCT01675531|124298|P1|Overall Study|Protocol Violation|8
27029|NCT01675531|124298|P1|Overall Study|Lack of Efficacy|1
27030|NCT01675531|124298|P1|Overall Study|Withdrawal by Subject|7
27031|NCT01675531|124298|P1|Overall Study|Adverse Event|9
27032|NCT01675492|124305|P1|Overall Study|study completed early - product approval|42
27033|NCT01675427|124319|P1|Overall Study|Not Specified|2
27034|NCT01675427|124319|P1|Overall Study|Lost to Follow-up|5
27035|NCT01675427|124319|P1|Overall Study|Sample not Collected by Mistake|2
27036|NCT01675427|124319|P1|Overall Study|Participant Refused Sample Collection|18
27037|NCT01675427|124319|P1|Overall Study|Withdrawal by Subject|7
27038|NCT01675167|124606|P3|Double-blind Treatment Phase|Not specified|5
27039|NCT01675167|124607|P2|Double-blind Treatment Phase|Not specified|7
27040|NCT01675167|124608|P1|Double-blind Treatment Phase|Not specified|0
27041|NCT01675167|124606|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
27042|NCT01675167|124607|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
27043|NCT01675167|124608|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
27044|NCT01675167|124606|P3|Double-blind Treatment Phase|Lost to Follow-up|5
27045|NCT01675167|124607|P2|Double-blind Treatment Phase|Lost to Follow-up|1
27046|NCT01675167|124608|P1|Double-blind Treatment Phase|Lost to Follow-up|0
27047|NCT01675167|124606|P3|Double-blind Treatment Phase|Protocol Violation|11
27048|NCT01675167|124607|P2|Double-blind Treatment Phase|Protocol Violation|4
27049|NCT01675167|124608|P1|Double-blind Treatment Phase|Protocol Violation|0
27050|NCT01675167|124606|P3|Double-blind Treatment Phase|Adverse Event|13
27051|NCT01675167|124607|P2|Double-blind Treatment Phase|Adverse Event|5
27052|NCT01675167|124608|P1|Double-blind Treatment Phase|Adverse Event|0
27053|NCT01675167|124606|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
27054|NCT01675167|124607|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
27055|NCT01675167|124608|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
27056|NCT01675167|124606|P3|Double-blind Treatment Phase|Lack of Efficacy|61
27057|NCT01675167|124607|P2|Double-blind Treatment Phase|Lack of Efficacy|19
27058|NCT01675167|124608|P1|Double-blind Treatment Phase|Lack of Efficacy|0
27059|NCT01675167|124606|P3|Open-label Titration Phase|Not specified|0
27060|NCT01675167|124607|P2|Open-label Titration Phase|Not specified|0
27061|NCT01675167|124608|P1|Open-label Titration Phase|Not specified|55
27062|NCT01675167|124606|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
27063|NCT01675167|124607|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
27064|NCT01675167|124608|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
27065|NCT01675167|124606|P3|Open-label Titration Phase|Lost to Follow-up|0
27066|NCT01675167|124607|P2|Open-label Titration Phase|Lost to Follow-up|0
27067|NCT01675167|124608|P1|Open-label Titration Phase|Lost to Follow-up|15
27068|NCT01675167|124606|P3|Open-label Titration Phase|Protocol Violation|0
27069|NCT01675167|124607|P2|Open-label Titration Phase|Protocol Violation|0
27070|NCT01675167|124608|P1|Open-label Titration Phase|Protocol Violation|43
27071|NCT01675167|124606|P3|Open-label Titration Phase|Withdrawal by Subject|0
27072|NCT01675167|124607|P2|Open-label Titration Phase|Withdrawal by Subject|0
27073|NCT01675167|124608|P1|Open-label Titration Phase|Withdrawal by Subject|46
27074|NCT01675167|124606|P3|Open-label Titration Phase|Lack of Efficacy|0
27075|NCT01675167|124607|P2|Open-label Titration Phase|Lack of Efficacy|0
27076|NCT01675167|124608|P1|Open-label Titration Phase|Lack of Efficacy|63
27077|NCT01675167|124606|P3|Open-label Titration Phase|Adverse Event|0
27078|NCT01675167|124607|P2|Open-label Titration Phase|Adverse Event|0
27079|NCT01675167|124608|P1|Open-label Titration Phase|Adverse Event|81
27080|NCT01675141|124630|P1|Overall Study|No treatment, per protocol|1
27081|NCT01675141|124630|P1|Overall Study|Physician Decision|4
27082|NCT01675141|124630|P1|Overall Study|Withdrawal by Subject|3
27083|NCT01675141|124630|P1|Overall Study|Lenalidomide outside NIH|3
27084|NCT01675128|124643|P3|Overall Study|Pulmonary complication; off study|0
27085|NCT01675128|124644|P2|Overall Study|Pulmonary complication; off study|1
27086|NCT01675128|124645|P1|Overall Study|Pulmonary complication; off study|0
27087|NCT01675128|124643|P3|Overall Study|Refused further treatment|0
27088|NCT01675128|124644|P2|Overall Study|Refused further treatment|0
27089|NCT01675128|124645|P1|Overall Study|Refused further treatment|1
27090|NCT01675128|124643|P3|Overall Study|Disease progression on study|1
27091|NCT01675128|124644|P2|Overall Study|Disease progression on study|1
27092|NCT01675128|124645|P1|Overall Study|Disease progression on study|1
27093|NCT01675050|124673|P2|Period One Treatment|Withdrawal by Subject|0
27094|NCT01675050|124674|P1|Period One Treatment|Withdrawal by Subject|1
27095|NCT01675011|124684|P2|Overall Study|Trial terminated by Sponsor|1
27096|NCT01675011|124685|P1|Overall Study|Trial terminated by Sponsor|3
27097|NCT01674725|124693|P2|Overall Study|Lost to Follow-up|1
27098|NCT01674725|124694|P1|Overall Study|Lost to Follow-up|0
27099|NCT01674725|124693|P2|Overall Study|Withdrawal by Subject|0
27100|NCT01674725|124694|P1|Overall Study|Withdrawal by Subject|1
27101|NCT01674725|124693|P2|Overall Study|Did not receive study drug|0
27102|NCT01674725|124694|P1|Overall Study|Did not receive study drug|1
27103|NCT01674725|124693|P2|Overall Study|Adverse Event|0
27104|NCT01674725|124694|P1|Overall Study|Adverse Event|1
27105|NCT01674712|124713|P5|Overall Study|Lack of Efficacy|1
27106|NCT01674712|124714|P4|Overall Study|Lack of Efficacy|0
27107|NCT01674712|124715|P3|Overall Study|Lack of Efficacy|1
27108|NCT01674712|124716|P2|Overall Study|Lack of Efficacy|0
27109|NCT01674712|124717|P1|Overall Study|Lack of Efficacy|0
27110|NCT01674712|124713|P5|Overall Study|Administrative|1
27111|NCT01674712|124714|P4|Overall Study|Administrative|0
27112|NCT01674712|124715|P3|Overall Study|Administrative|0
27113|NCT01674712|124716|P2|Overall Study|Administrative|1
27114|NCT01674712|124717|P1|Overall Study|Administrative|0
27115|NCT01674712|124713|P5|Overall Study|Withdrawal by Subject|3
27116|NCT01674712|124714|P4|Overall Study|Withdrawal by Subject|4
27117|NCT01674712|124715|P3|Overall Study|Withdrawal by Subject|5
27118|NCT01674712|124716|P2|Overall Study|Withdrawal by Subject|2
27119|NCT01674712|124717|P1|Overall Study|Withdrawal by Subject|2
27120|NCT01674712|124713|P5|Overall Study|Protocol Violation|0
27121|NCT01674712|124714|P4|Overall Study|Protocol Violation|0
27122|NCT01674712|124715|P3|Overall Study|Protocol Violation|0
27123|NCT01674712|124716|P2|Overall Study|Protocol Violation|0
27124|NCT01674712|124717|P1|Overall Study|Protocol Violation|2
27125|NCT01674712|124713|P5|Overall Study|Lost to Follow-up|0
27126|NCT01674712|124714|P4|Overall Study|Lost to Follow-up|0
27127|NCT01674712|124715|P3|Overall Study|Lost to Follow-up|0
27128|NCT01674712|124716|P2|Overall Study|Lost to Follow-up|0
27129|NCT01674712|124717|P1|Overall Study|Lost to Follow-up|1
27130|NCT01674712|124713|P5|Overall Study|Adverse Event|6
27131|NCT01674712|124714|P4|Overall Study|Adverse Event|4
27132|NCT01674712|124715|P3|Overall Study|Adverse Event|3
27133|NCT01674712|124716|P2|Overall Study|Adverse Event|6
27134|NCT01674712|124717|P1|Overall Study|Adverse Event|5
27135|NCT01674647|124741|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
27136|NCT01674647|124742|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
27137|NCT01674647|124741|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
27138|NCT01674647|124742|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
27139|NCT01674647|124741|P2|30-day Safety Follow-up Period|Logistical difficulties|3
27140|NCT01674647|124742|P1|30-day Safety Follow-up Period|Logistical difficulties|1
27141|NCT01674647|124741|P2|30-day Safety Follow-up Period|Protocol Violation|22
27142|NCT01674647|124742|P1|30-day Safety Follow-up Period|Protocol Violation|39
27143|NCT01674647|124741|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
27144|NCT01674647|124742|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
27145|NCT01674647|124741|P2|30-day Safety Follow-up Period|Death|2
27146|NCT01674647|124742|P1|30-day Safety Follow-up Period|Death|3
27147|NCT01674647|124741|P2|Treatment Period|Protocol Violation|36
27148|NCT01674647|124742|P1|Treatment Period|Protocol Violation|56
27149|NCT01674647|124741|P2|Treatment Period|Treatment failure|14
27150|NCT01674647|124742|P1|Treatment Period|Treatment failure|0
27151|NCT01674647|124741|P2|Treatment Period|Logistical difficulties|8
27152|NCT01674647|124742|P1|Treatment Period|Logistical difficulties|5
27153|NCT01674647|124741|P2|Treatment Period|Switching to other therapy|2
27154|NCT01674647|124742|P1|Treatment Period|Switching to other therapy|5
27155|NCT01674647|124741|P2|Treatment Period|Withdrawal by Subject|16
27156|NCT01674647|124742|P1|Treatment Period|Withdrawal by Subject|19
27157|NCT01674647|124741|P2|Treatment Period|Lost to Follow-up|1
27158|NCT01674647|124742|P1|Treatment Period|Lost to Follow-up|1
27159|NCT01674647|124741|P2|Treatment Period|Non-compliance with study drug|0
27160|NCT01674647|124742|P1|Treatment Period|Non-compliance with study drug|3
27161|NCT01674647|124741|P2|Treatment Period|Adverse Event|22
27162|NCT01674647|124742|P1|Treatment Period|Adverse Event|60
27163|NCT01674647|124741|P2|Treatment Period|Physician Decision|1
27164|NCT01674647|124742|P1|Treatment Period|Physician Decision|3
27165|NCT01674647|124741|P2|Treatment Period|Efficacy outcome reached|1
27166|NCT01674647|124742|P1|Treatment Period|Efficacy outcome reached|0
27167|NCT01674647|124741|P2|Treatment Period|Death|1
27168|NCT01674647|124742|P1|Treatment Period|Death|4
27169|NCT01674634|124768|P1|Overall Study|Lost to Follow-up|3
27170|NCT01674634|124768|P1|Overall Study|Withdrawal by Subject|3
27171|NCT01674062|124816|P2|Overall Study|Programming Error|0
27172|NCT01674062|124817|P1|Overall Study|Programming Error|1
27173|NCT01674062|124816|P2|Overall Study|Death|1
27174|NCT01674062|124817|P1|Overall Study|Death|0
27175|NCT01674062|124816|P2|Overall Study|Adverse Event|1
27176|NCT01674062|124817|P1|Overall Study|Adverse Event|1
27177|NCT01674062|124816|P2|Overall Study|Not Specified|1
27178|NCT01674062|124817|P1|Overall Study|Not Specified|8
27179|NCT01674062|124816|P2|Overall Study|Insufficient Therapeutic Response|26
27180|NCT01674062|124817|P1|Overall Study|Insufficient Therapeutic Response|56
27181|NCT01674010|124832|P3|Randomization Phase 2|Withdrawal by Subject|7
27182|NCT01674010|124833|P2|Randomization Phase 2|Withdrawal by Subject|8
27183|NCT01674010|124834|P1|Randomization Phase 2|Withdrawal by Subject|0
27184|NCT01674010|124832|P3|Randomization Phase 2|Sponsor Decision|45
27185|NCT01674010|124833|P2|Randomization Phase 2|Sponsor Decision|42
27186|NCT01674010|124834|P1|Randomization Phase 2|Sponsor Decision|0
27187|NCT01674010|124832|P3|Randomization Phase 2|Protocol Violation|1
27188|NCT01674010|124833|P2|Randomization Phase 2|Protocol Violation|1
27189|NCT01674010|124834|P1|Randomization Phase 2|Protocol Violation|0
27190|NCT01674010|124832|P3|Randomization Phase 2|Pregnancy|1
27191|NCT01674010|124833|P2|Randomization Phase 2|Pregnancy|1
27192|NCT01674010|124834|P1|Randomization Phase 2|Pregnancy|0
27193|NCT01674010|124832|P3|Randomization Phase 2|Physician Decision|2
27194|NCT01674010|124833|P2|Randomization Phase 2|Physician Decision|0
27195|NCT01674010|124834|P1|Randomization Phase 2|Physician Decision|0
27196|NCT01674010|124832|P3|Randomization Phase 2|Mood episode recurrence|2
27197|NCT01674010|124833|P2|Randomization Phase 2|Mood episode recurrence|8
27198|NCT01674010|124834|P1|Randomization Phase 2|Mood episode recurrence|0
27199|NCT01674010|124832|P3|Randomization Phase 2|Lost to Follow-up|2
27200|NCT01674010|124833|P2|Randomization Phase 2|Lost to Follow-up|1
27201|NCT01674010|124834|P1|Randomization Phase 2|Lost to Follow-up|0
27202|NCT01674010|124832|P3|Randomization Phase 2|Adverse Event|1
27203|NCT01674010|124833|P2|Randomization Phase 2|Adverse Event|1
27204|NCT01674010|124834|P1|Randomization Phase 2|Adverse Event|0
27205|NCT01674010|124832|P3|Open Treatment Phase 1|Withdrawal by Subject|0
27206|NCT01674010|124833|P2|Open Treatment Phase 1|Withdrawal by Subject|0
27207|NCT01674010|124834|P1|Open Treatment Phase 1|Withdrawal by Subject|25
27208|NCT01674010|124832|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
27209|NCT01674010|124833|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
27210|NCT01674010|124834|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
27211|NCT01674010|124832|P3|Open Treatment Phase 1|Sponsor Decision|0
27212|NCT01674010|124833|P2|Open Treatment Phase 1|Sponsor Decision|0
27213|NCT01674010|124834|P1|Open Treatment Phase 1|Sponsor Decision|79
27214|NCT01674010|124832|P3|Open Treatment Phase 1|Protocol Violation|0
27215|NCT01674010|124833|P2|Open Treatment Phase 1|Protocol Violation|0
27216|NCT01674010|124834|P1|Open Treatment Phase 1|Protocol Violation|7
27217|NCT01674010|124832|P3|Open Treatment Phase 1|Physician Decision|0
27218|NCT01674010|124833|P2|Open Treatment Phase 1|Physician Decision|0
27219|NCT01674010|124834|P1|Open Treatment Phase 1|Physician Decision|9
27220|NCT01674010|124832|P3|Open Treatment Phase 1|Lost to Follow-up|0
27221|NCT01674010|124833|P2|Open Treatment Phase 1|Lost to Follow-up|0
27222|NCT01674010|124834|P1|Open Treatment Phase 1|Lost to Follow-up|19
27223|NCT01674010|124832|P3|Open Treatment Phase 1|Death|0
27224|NCT01674010|124833|P2|Open Treatment Phase 1|Death|0
27225|NCT01674010|124834|P1|Open Treatment Phase 1|Death|1
27226|NCT01674010|124832|P3|Open Treatment Phase 1|Adverse Event|0
27227|NCT01674010|124833|P2|Open Treatment Phase 1|Adverse Event|0
27228|NCT01674010|124834|P1|Open Treatment Phase 1|Adverse Event|10
27229|NCT01673984|124853|P2|Overall Study|Study termination|6
27230|NCT01673984|124854|P1|Overall Study|Study termination|9
27231|NCT01673984|124853|P2|Overall Study|Adverse Event|0
27232|NCT01673984|124854|P1|Overall Study|Adverse Event|1
27233|NCT01673867|124896|P2|Treatment|Physician Decision|1
27234|NCT01673867|124897|P1|Treatment|Physician Decision|0
27235|NCT01673867|124896|P2|Treatment|Symptomatic deterioration|1
27236|NCT01673867|124897|P1|Treatment|Symptomatic deterioration|0
27237|NCT01673867|124896|P2|Treatment|Required prolonged hospitalization|1
27238|NCT01673867|124897|P1|Treatment|Required prolonged hospitalization|0
27239|NCT01673867|124896|P2|Treatment|Health status not improved|0
27240|NCT01673867|124897|P1|Treatment|Health status not improved|1
27241|NCT01673867|124896|P2|Treatment|Required steroid therapy|0
27242|NCT01673867|124897|P1|Treatment|Required steroid therapy|1
27243|NCT01673867|124896|P2|Treatment|No longer meets criteria|0
27244|NCT01673867|124897|P1|Treatment|No longer meets criteria|2
27245|NCT01673867|124896|P2|Treatment|Maximum clinical benefit|10
27246|NCT01673867|124897|P1|Treatment|Maximum clinical benefit|0
27247|NCT01673867|124896|P2|Treatment|Withdrawal by Subject|6
27248|NCT01673867|124897|P1|Treatment|Withdrawal by Subject|4
27249|NCT01673867|124896|P2|Treatment|Requested treatment discontinuation|16
27250|NCT01673867|124897|P1|Treatment|Requested treatment discontinuation|5
27251|NCT01673867|124896|P2|Treatment|AE unrelated to study drug|11
27252|NCT01673867|124897|P1|Treatment|AE unrelated to study drug|19
27253|NCT01673867|124896|P2|Treatment|Death|1
27254|NCT01673867|124897|P1|Treatment|Death|1
27255|NCT01673867|124896|P2|Treatment|Study Drug Toxicity|42
27256|NCT01673867|124897|P1|Treatment|Study Drug Toxicity|17
27257|NCT01673867|124896|P2|Treatment|Disease Progression|179
27258|NCT01673867|124897|P1|Treatment|Disease Progression|194
27259|NCT01673867|124896|P2|Randomization|No longer meets criteria|5
27260|NCT01673867|124897|P1|Randomization|No longer meets criteria|4
27261|NCT01673867|124896|P2|Randomization|Lost to Follow-up|1
27262|NCT01673867|124897|P1|Randomization|Lost to Follow-up|0
27263|NCT01673867|124896|P2|Randomization|Withdrawal by Subject|12
27264|NCT01673867|124897|P1|Randomization|Withdrawal by Subject|0
27265|NCT01673867|124896|P2|Randomization|Requested treatment discontinuation|4
27266|NCT01673867|124897|P1|Randomization|Requested treatment discontinuation|0
27267|NCT01673867|124896|P2|Randomization|AE unrelated to study drug|0
27268|NCT01673867|124897|P1|Randomization|AE unrelated to study drug|1
27269|NCT01673854|124923|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
27270|NCT01673854|124923|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
27271|NCT01673854|124923|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
27272|NCT01673854|124923|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
27273|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
27274|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
27275|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
27276|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
27277|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
27278|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
27279|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
27280|NCT01673854|124923|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
27281|NCT01673698|124946|P2|Overall Study|Lost to Follow-up|13
27282|NCT01673698|124947|P1|Overall Study|Lost to Follow-up|51
27283|NCT01673620|124957|P2|Overall Study|Adverse Event|0
27284|NCT01673620|124958|P1|Overall Study|Adverse Event|1
27285|NCT01673594|124968|P2|Overall Study|Withdrawal by Subject|1
27286|NCT01673594|124969|P1|Overall Study|Withdrawal by Subject|0
27287|NCT01673594|124968|P2|Overall Study|Physician Decision|4
27288|NCT01673594|124969|P1|Overall Study|Physician Decision|2
27289|NCT01673594|124968|P2|Overall Study|Lost to Follow-up|0
27290|NCT01673594|124969|P1|Overall Study|Lost to Follow-up|1
27291|NCT01673594|124968|P2|Overall Study|Adverse Event|1
27292|NCT01673594|124969|P1|Overall Study|Adverse Event|3
27293|NCT01673490|124988|P1|Overall Study|Withdrawal by Subject|3
27294|NCT01673490|124988|P1|Overall Study|Adverse Event|3
27295|NCT01673490|124988|P1|Overall Study|Lost to Follow-up|1
27296|NCT01673347|125005|P1|Overall Study|failure of allograft|7
27297|NCT01673282|125014|P2|Overall Study|unspecified|6
27298|NCT01673282|125015|P1|Overall Study|unspecified|1
27299|NCT01673282|125014|P2|Overall Study|Withdrawal by Subject|3
27300|NCT01673282|125015|P1|Overall Study|Withdrawal by Subject|3
27301|NCT01673282|125014|P2|Overall Study|Lost to Follow-up|10
27302|NCT01673282|125015|P1|Overall Study|Lost to Follow-up|11
27303|NCT01673282|125014|P2|Overall Study|Lack of Efficacy|2
27304|NCT01673282|125015|P1|Overall Study|Lack of Efficacy|9
27305|NCT01673282|125014|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
27306|NCT01673282|125015|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
27307|NCT01673178|125051|P5|Overall Study|Unspecified|0
27308|NCT01673178|125052|P4|Overall Study|Unspecified|1
27309|NCT01673178|125053|P3|Overall Study|Unspecified|2
27310|NCT01673178|125054|P2|Overall Study|Unspecified|0
27311|NCT01673178|125055|P1|Overall Study|Unspecified|1
27312|NCT01673178|125051|P5|Overall Study|Adverse Event|0
27313|NCT01673178|125052|P4|Overall Study|Adverse Event|2
27314|NCT01673178|125053|P3|Overall Study|Adverse Event|0
27315|NCT01673178|125054|P2|Overall Study|Adverse Event|0
27316|NCT01673178|125055|P1|Overall Study|Adverse Event|1
27317|NCT01673178|125051|P5|Overall Study|Protocol Violation|0
27318|NCT01673178|125052|P4|Overall Study|Protocol Violation|1
27319|NCT01673178|125053|P3|Overall Study|Protocol Violation|0
27320|NCT01673178|125054|P2|Overall Study|Protocol Violation|1
27321|NCT01673178|125055|P1|Overall Study|Protocol Violation|1
27322|NCT01673178|125051|P5|Overall Study|Withdrawal by Subject|2
27323|NCT01673178|125052|P4|Overall Study|Withdrawal by Subject|4
27324|NCT01673178|125053|P3|Overall Study|Withdrawal by Subject|1
27325|NCT01673178|125054|P2|Overall Study|Withdrawal by Subject|0
27326|NCT01673178|125055|P1|Overall Study|Withdrawal by Subject|0
27327|NCT01673178|125051|P5|Overall Study|Lost to Follow-up|0
27328|NCT01673178|125052|P4|Overall Study|Lost to Follow-up|0
27329|NCT01673178|125053|P3|Overall Study|Lost to Follow-up|0
27330|NCT01673178|125054|P2|Overall Study|Lost to Follow-up|1
27331|NCT01673178|125055|P1|Overall Study|Lost to Follow-up|0
27332|NCT01673126|125294|P2|Overall Study|change of diagnosis|3
27333|NCT01673126|125295|P1|Overall Study|change of diagnosis|4
27334|NCT01673009|125311|P1|Overall Study|Withdrawal by Subject|8
27335|NCT01673009|125311|P1|Overall Study|Physician Decision|5
27336|NCT01672970|125396|P1|Overall Study|Enrolled but not treated|1
27337|NCT01672970|125396|P1|Overall Study|Unspecified|9
27338|NCT01672970|125396|P1|Overall Study|Lost to Follow-up|5
27339|NCT01672970|125396|P1|Overall Study|Withdrawal by Subject|2
27340|NCT01672970|125396|P1|Overall Study|Adverse Event|18
27341|NCT01672970|125396|P1|Overall Study|Lack of Efficacy|12
27342|NCT01672957|125432|P1|Overall Study|ICF Signed After Transplantation|5
27343|NCT01672957|125432|P1|Overall Study|Death|2
27344|NCT01672957|125432|P1|Overall Study|Protocol Violation|48
27345|NCT01672788|125451|P4|Washout Period 2 (7 Days)|Adverse Event|1
27346|NCT01672788|125452|P3|Washout Period 2 (7 Days)|Adverse Event|0
27347|NCT01672788|125453|P2|Washout Period 2 (7 Days)|Adverse Event|0
27348|NCT01672788|125454|P1|Washout Period 2 (7 Days)|Adverse Event|0
27349|NCT01672723|125484|P2|First Intervention|Adverse Event|0
27350|NCT01672723|125485|P1|First Intervention|Adverse Event|3
27351|NCT01672294|125522|P4|Overall Study|Lost to Follow-up|9
27352|NCT01672294|125523|P3|Overall Study|Lost to Follow-up|7
27353|NCT01672294|125524|P2|Overall Study|Lost to Follow-up|16
27354|NCT01672294|125525|P1|Overall Study|Lost to Follow-up|1
27355|NCT01672294|125522|P4|Overall Study|Excluded by study|0
27356|NCT01672294|125523|P3|Overall Study|Excluded by study|0
27357|NCT01672294|125524|P2|Overall Study|Excluded by study|1
27358|NCT01672294|125525|P1|Overall Study|Excluded by study|1
27359|NCT01672294|125522|P4|Overall Study|Withdrawal by Subject|4
27360|NCT01672294|125523|P3|Overall Study|Withdrawal by Subject|4
27361|NCT01672294|125524|P2|Overall Study|Withdrawal by Subject|4
27362|NCT01672294|125525|P1|Overall Study|Withdrawal by Subject|4
27363|NCT01671748|125558|P2|4 Week run-in Phase|Not eligible|0
27364|NCT01671748|125559|P1|4 Week run-in Phase|Not eligible|9
27365|NCT01671748|125558|P2|4 Week run-in Phase|Adverse Event|0
27366|NCT01671748|125559|P1|4 Week run-in Phase|Adverse Event|1
27367|NCT01671748|125558|P2|4 Week run-in Phase|Withdrawal by Subject|0
27368|NCT01671748|125559|P1|4 Week run-in Phase|Withdrawal by Subject|1
27369|NCT01671488|125586|P1|Overall Study|Withdrawal by Subject|1
27370|NCT01671280|125601|P1|Overall Study|Withdrawal by Subject|2
27371|NCT01671111|125607|P1|Overall Study|Unspecified|24
27372|NCT01671111|125607|P1|Overall Study|Physician Decision|1
27373|NCT01671111|125607|P1|Overall Study|Withdrawal by Subject|2
27374|NCT01671111|125607|P1|Overall Study|Lack of Efficacy|1
27375|NCT01671111|125607|P1|Overall Study|Adverse Event|2
27376|NCT01671059|125617|P1|Overall Study|Lack of Efficacy|1
27377|NCT01671059|125617|P1|Overall Study|Adverse Event|4
27378|NCT01670721|125709|P1|Overall Study|Other than specified above|38
27379|NCT01670721|125709|P1|Overall Study|Participant's decision|15
27380|NCT01670656|125721|P5|Overall Study|Subject moved|0
27381|NCT01670656|125722|P4|Overall Study|Subject moved|1
27382|NCT01670656|125723|P3|Overall Study|Subject moved|0
27383|NCT01670656|125724|P2|Overall Study|Subject moved|0
27384|NCT01670656|125725|P1|Overall Study|Subject moved|0
27385|NCT01670656|125721|P5|Overall Study|Lost to Follow-up|3
27386|NCT01670656|125722|P4|Overall Study|Lost to Follow-up|0
27387|NCT01670656|125723|P3|Overall Study|Lost to Follow-up|0
27388|NCT01670656|125724|P2|Overall Study|Lost to Follow-up|0
27389|NCT01670656|125725|P1|Overall Study|Lost to Follow-up|0
27390|NCT01670656|125721|P5|Overall Study|Subject withdrew consent|1
27391|NCT01670656|125722|P4|Overall Study|Subject withdrew consent|1
27392|NCT01670656|125723|P3|Overall Study|Subject withdrew consent|2
27393|NCT01670656|125724|P2|Overall Study|Subject withdrew consent|1
27394|NCT01670656|125725|P1|Overall Study|Subject withdrew consent|0
27395|NCT01670656|125721|P5|Overall Study|Adverse Event|3
27396|NCT01670656|125722|P4|Overall Study|Adverse Event|3
27397|NCT01670656|125723|P3|Overall Study|Adverse Event|2
27398|NCT01670656|125724|P2|Overall Study|Adverse Event|2
27399|NCT01670656|125725|P1|Overall Study|Adverse Event|2
27400|NCT01670656|125721|P5|Overall Study|Non-compliance with protocol|2
27401|NCT01670656|125722|P4|Overall Study|Non-compliance with protocol|1
27402|NCT01670656|125723|P3|Overall Study|Non-compliance with protocol|1
27403|NCT01670656|125724|P2|Overall Study|Non-compliance with protocol|3
27404|NCT01670656|125725|P1|Overall Study|Non-compliance with protocol|0
27405|NCT01670656|125721|P5|Overall Study|Withdrawal by Subject|0
27406|NCT01670656|125722|P4|Overall Study|Withdrawal by Subject|0
27407|NCT01670656|125723|P3|Overall Study|Withdrawal by Subject|0
27408|NCT01670656|125724|P2|Overall Study|Withdrawal by Subject|1
27409|NCT01670656|125725|P1|Overall Study|Withdrawal by Subject|1
27410|NCT01670656|125721|P5|Overall Study|Pregnancy|1
27411|NCT01670656|125722|P4|Overall Study|Pregnancy|0
27412|NCT01670656|125723|P3|Overall Study|Pregnancy|0
27413|NCT01670656|125724|P2|Overall Study|Pregnancy|0
27414|NCT01670656|125725|P1|Overall Study|Pregnancy|0
27415|NCT01670656|125721|P5|Overall Study|Non-compliance with study drug|1
27416|NCT01670656|125722|P4|Overall Study|Non-compliance with study drug|0
27417|NCT01670656|125723|P3|Overall Study|Non-compliance with study drug|3
27418|NCT01670656|125724|P2|Overall Study|Non-compliance with study drug|0
27419|NCT01670656|125725|P1|Overall Study|Non-compliance with study drug|0
27420|NCT01670526|125754|P2|Overall Study|Lost to Follow-up|5
27421|NCT01670526|125755|P1|Overall Study|Lost to Follow-up|9
27422|NCT01670526|125754|P2|Overall Study|Withdrawal by Subject|1
27423|NCT01670526|125755|P1|Overall Study|Withdrawal by Subject|3
27424|NCT01670279|125779|P4|Overall Study|Participant met withdrawal criteria|1
27425|NCT01670279|125780|P3|Overall Study|Participant met withdrawal criteria|0
27426|NCT01670279|125781|P2|Overall Study|Participant met withdrawal criteria|0
27427|NCT01670279|125782|P1|Overall Study|Participant met withdrawal criteria|0
27428|NCT01670279|125779|P4|Overall Study|Physician Decision|0
27429|NCT01670279|125780|P3|Overall Study|Physician Decision|0
27430|NCT01670279|125781|P2|Overall Study|Physician Decision|1
27431|NCT01670279|125782|P1|Overall Study|Physician Decision|0
27432|NCT01670279|125779|P4|Overall Study|Adverse Event|0
27433|NCT01670279|125780|P3|Overall Study|Adverse Event|0
27434|NCT01670279|125781|P2|Overall Study|Adverse Event|1
27435|NCT01670279|125782|P1|Overall Study|Adverse Event|0
27436|NCT01670045|125822|P1|Overall Study|Lost to Follow-up|11
27437|NCT01670045|125822|P1|Overall Study|Death|1
27438|NCT01670045|125822|P1|Overall Study|Adverse Event|1
27439|NCT01670045|125822|P1|Overall Study|Withdrawal by Subject|3
27440|NCT01670019|125840|P2|Overall Study|Withdrawal by Subject|0
27441|NCT01670019|125841|P1|Overall Study|Withdrawal by Subject|6
27442|NCT01670019|125840|P2|Overall Study|Adverse Event|0
27443|NCT01670019|125841|P1|Overall Study|Adverse Event|3
27444|NCT01669902|125855|P1|Overall Study|Unspecified|8
27445|NCT01669902|125855|P1|Overall Study|Lack of Efficacy|10
27446|NCT01669902|125855|P1|Overall Study|Adverse Event|11
27447|NCT01669811|125890|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
27448|NCT01669811|125891|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
27449|NCT01669811|125890|P2|Overall Study|Adverse Event|6
27450|NCT01669811|125891|P1|Overall Study|Adverse Event|2
27451|NCT01669811|125890|P2|Overall Study|Withdrawal by Subject|2
27452|NCT01669811|125891|P1|Overall Study|Withdrawal by Subject|1
27453|NCT01669811|125890|P2|Overall Study|Investigator decision|1
27454|NCT01669811|125891|P1|Overall Study|Investigator decision|0
27455|NCT01669629|125958|P2|Period 1|protocol deviation|2
27456|NCT01669629|125959|P1|Period 1|protocol deviation|1
27457|NCT01669577|125982|P1|Overall Study|Physician Decision|34
27458|NCT01669577|125982|P1|Overall Study|Lost to Follow-up|78
27459|NCT01669577|125982|P1|Overall Study|Death|22
27460|NCT01669174|125988|P2|Overall Study|Administrative problems|2
27461|NCT01669174|125989|P1|Overall Study|Administrative problems|1
27462|NCT01669174|125988|P2|Overall Study|Adverse Event|2
27463|NCT01669174|125989|P1|Overall Study|Adverse Event|2
27464|NCT01669174|125988|P2|Overall Study|Lost to Follow-up|0
27465|NCT01669174|125989|P1|Overall Study|Lost to Follow-up|1
27466|NCT01669174|125988|P2|Overall Study|Subject withdrew consent|2
27467|NCT01669174|125989|P1|Overall Study|Subject withdrew consent|2
27468|NCT01669122|126005|P1|Washout Period II|Protocol Violation|2
27469|NCT01669122|126005|P1|Period I|Lost to Follow-up|1
27470|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
27471|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
27472|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
27473|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
27474|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
27475|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
27476|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
27477|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
27478|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
27479|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
27480|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
27481|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
27482|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
27483|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
27484|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
27485|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
27486|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
27487|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
27488|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
27489|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
27490|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
27491|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
27492|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
27493|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
27494|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
27495|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
27496|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
27497|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
27498|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
27499|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
27500|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
27501|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
27502|NCT01668797|126098|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
27503|NCT01668797|126099|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
27504|NCT01668797|126100|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
27505|NCT01668797|126101|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
27506|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
27507|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
27508|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
27509|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
27510|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
27511|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
27512|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
27513|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
27514|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
27515|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
27516|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
27517|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
27518|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Protocol Violation|0
27519|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Protocol Violation|0
27520|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Protocol Violation|3
27521|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Protocol Violation|0
27522|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
27523|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
27524|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
27525|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
27526|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Physician Decision|0
27527|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Physician Decision|0
27528|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Physician Decision|11
27529|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Physician Decision|0
27530|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
27531|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
27532|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
27533|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
27534|NCT01668797|126098|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
27535|NCT01668797|126099|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
27536|NCT01668797|126100|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
27537|NCT01668797|126101|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
27538|NCT01668797|126098|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
27539|NCT01668797|126099|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
27540|NCT01668797|126100|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
27541|NCT01668797|126101|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
27542|NCT01668797|126098|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
27543|NCT01668797|126099|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
27544|NCT01668797|126100|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
27545|NCT01668797|126101|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
27546|NCT01668797|126098|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
27547|NCT01668797|126099|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
27548|NCT01668797|126100|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
27549|NCT01668797|126101|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
27550|NCT01668797|126098|P4|Phase A (Conversion Phase)|Protocol Violation|0
27551|NCT01668797|126099|P3|Phase A (Conversion Phase)|Protocol Violation|0
27552|NCT01668797|126100|P2|Phase A (Conversion Phase)|Protocol Violation|0
27553|NCT01668797|126101|P1|Phase A (Conversion Phase)|Protocol Violation|2
27554|NCT01668797|126098|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
27555|NCT01668797|126099|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
27556|NCT01668797|126100|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
27557|NCT01668797|126101|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
27558|NCT01668797|126098|P4|Phase A (Conversion Phase)|Physician Decision|0
27559|NCT01668797|126099|P3|Phase A (Conversion Phase)|Physician Decision|0
27560|NCT01668797|126100|P2|Phase A (Conversion Phase)|Physician Decision|0
27561|NCT01668797|126101|P1|Phase A (Conversion Phase)|Physician Decision|2
27562|NCT01668797|126098|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
27563|NCT01668797|126099|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
27564|NCT01668797|126100|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
27565|NCT01668797|126101|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
27566|NCT01668797|126098|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
27567|NCT01668797|126099|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
27568|NCT01668797|126100|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
27569|NCT01668797|126101|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
27570|NCT01668784|126166|P2|Treated (Overall)|Not Specified|4
27571|NCT01668784|126167|P1|Treated (Overall)|Not Specified|0
27572|NCT01668784|126166|P2|Treated (Overall)|Maximal Clinical Benefit|3
27573|NCT01668784|126167|P1|Treated (Overall)|Maximal Clinical Benefit|2
27574|NCT01668784|126166|P2|Treated (Overall)|Withdrawal by Subject|3
27575|NCT01668784|126167|P1|Treated (Overall)|Withdrawal by Subject|2
27576|NCT01668784|126166|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
27577|NCT01668784|126167|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
27578|NCT01668784|126166|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
27579|NCT01668784|126167|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
27580|NCT01668784|126166|P2|Treated (Overall)|Death|1
27581|NCT01668784|126167|P1|Treated (Overall)|Death|1
27582|NCT01668784|126166|P2|Treated (Overall)|Study Drug Toxicity|53
27583|NCT01668784|126167|P1|Treated (Overall)|Study Drug Toxicity|35
27584|NCT01668784|126166|P2|Treated (Overall)|Disease Progression|273
27585|NCT01668784|126167|P1|Treated (Overall)|Disease Progression|285
27586|NCT01668784|126166|P2|Randomized (Pre-treatment)|Not Specified|1
27587|NCT01668784|126167|P1|Randomized (Pre-treatment)|Not Specified|0
27588|NCT01668784|126166|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
27589|NCT01668784|126167|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
27590|NCT01668784|126166|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
27591|NCT01668784|126167|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
27592|NCT01668784|126166|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
27593|NCT01668784|126167|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
27594|NCT01668784|126166|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
27595|NCT01668784|126167|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
27596|NCT01668784|126166|P2|Randomized (Pre-treatment)|Disease Progression|1
27597|NCT01668784|126167|P1|Randomized (Pre-treatment)|Disease Progression|0
27598|NCT01668667|126195|P4|Overall Study|Withdrawal by Subject|5
27599|NCT01668667|126196|P3|Overall Study|Withdrawal by Subject|5
27600|NCT01668667|126197|P2|Overall Study|Withdrawal by Subject|4
27601|NCT01668667|126198|P1|Overall Study|Withdrawal by Subject|7
27602|NCT01668667|126195|P4|Overall Study|Physician Decision|0
27603|NCT01668667|126196|P3|Overall Study|Physician Decision|1
27604|NCT01668667|126197|P2|Overall Study|Physician Decision|0
27605|NCT01668667|126198|P1|Overall Study|Physician Decision|3
27606|NCT01668667|126195|P4|Overall Study|Lost to Follow-up|6
27607|NCT01668667|126196|P3|Overall Study|Lost to Follow-up|7
27608|NCT01668667|126197|P2|Overall Study|Lost to Follow-up|4
27609|NCT01668667|126198|P1|Overall Study|Lost to Follow-up|9
27610|NCT01668667|126195|P4|Overall Study|Protocol Violation|5
27611|NCT01668667|126196|P3|Overall Study|Protocol Violation|12
27612|NCT01668667|126197|P2|Overall Study|Protocol Violation|10
27613|NCT01668667|126198|P1|Overall Study|Protocol Violation|6
27614|NCT01668667|126195|P4|Overall Study|Lack of Efficacy|3
27615|NCT01668667|126196|P3|Overall Study|Lack of Efficacy|2
27616|NCT01668667|126197|P2|Overall Study|Lack of Efficacy|2
27617|NCT01668667|126198|P1|Overall Study|Lack of Efficacy|3
27618|NCT01668667|126195|P4|Overall Study|Adverse Event|4
27619|NCT01668667|126196|P3|Overall Study|Adverse Event|4
27620|NCT01668667|126197|P2|Overall Study|Adverse Event|6
27621|NCT01668667|126198|P1|Overall Study|Adverse Event|3
27622|NCT01668654|126220|P1|Overall Study|Withdrawal by Subject|1
27623|NCT01668654|126220|P1|Overall Study|Study Closed/Terminated|3
27624|NCT01668589|126281|P4|Overall Study|Other|15
27625|NCT01668589|126282|P3|Overall Study|Other|7
27626|NCT01668589|126283|P2|Overall Study|Other|10
27627|NCT01668589|126284|P1|Overall Study|Other|44
27628|NCT01668589|126281|P4|Overall Study|Death|11
27629|NCT01668589|126282|P3|Overall Study|Death|2
27630|NCT01668589|126283|P2|Overall Study|Death|3
27631|NCT01668589|126284|P1|Overall Study|Death|12
27632|NCT01668589|126281|P4|Overall Study|Full Consent/Agreement Withdrawn|4
27633|NCT01668589|126282|P3|Overall Study|Full Consent/Agreement Withdrawn|11
27634|NCT01668589|126283|P2|Overall Study|Full Consent/Agreement Withdrawn|8
27635|NCT01668589|126284|P1|Overall Study|Full Consent/Agreement Withdrawn|54
27636|NCT01668589|126281|P4|Overall Study|Lost to Follow-up|5
27637|NCT01668589|126282|P3|Overall Study|Lost to Follow-up|15
27638|NCT01668589|126283|P2|Overall Study|Lost to Follow-up|37
27639|NCT01668589|126284|P1|Overall Study|Lost to Follow-up|29
27640|NCT01668173|126322|P1|Overall Study|Trial suspension|4
27641|NCT01668173|126322|P1|Overall Study|Adverse Event|3
27642|NCT01668004|126448|P1|Overall Study|Non-compliance with treatment|2
27643|NCT01668004|126448|P1|Overall Study|Lack of Efficacy|9
27644|NCT01668004|126448|P1|Overall Study|Lost to Follow-up|5
27645|NCT01668004|126448|P1|Overall Study|Withdrawal by Subject|2
27646|NCT01668004|126448|P1|Overall Study|Adverse Event|7
27647|NCT01667926|126470|P3|Overall Study|Side effects|0
27648|NCT01667926|126471|P2|Overall Study|Side effects|0
27649|NCT01667926|126472|P1|Overall Study|Side effects|3
27650|NCT01667926|126470|P3|Overall Study|Lost to Follow-up|1
27651|NCT01667926|126471|P2|Overall Study|Lost to Follow-up|2
27652|NCT01667926|126472|P1|Overall Study|Lost to Follow-up|1
27653|NCT01667926|126470|P3|Overall Study|Inclusion/Exclusion Criteria|5
27654|NCT01667926|126471|P2|Overall Study|Inclusion/Exclusion Criteria|0
27655|NCT01667926|126472|P1|Overall Study|Inclusion/Exclusion Criteria|0
27656|NCT01667926|126470|P3|Overall Study|Time committment|2
27657|NCT01667926|126471|P2|Overall Study|Time committment|0
27658|NCT01667926|126472|P1|Overall Study|Time committment|0
27659|NCT01667926|126470|P3|Overall Study|Physician Decision|1
27660|NCT01667926|126471|P2|Overall Study|Physician Decision|0
27661|NCT01667926|126472|P1|Overall Study|Physician Decision|0
27662|NCT01667926|126470|P3|Overall Study|Withdrawal by Subject|2
27663|NCT01667926|126471|P2|Overall Study|Withdrawal by Subject|2
27664|NCT01667926|126472|P1|Overall Study|Withdrawal by Subject|1
27665|NCT01667900|126485|P20|Part B|Death|0
27666|NCT01667900|126486|P19|Part B|Death|0
27667|NCT01667900|126487|P18|Part B|Death|0
27668|NCT01667900|126488|P17|Part B|Death|1
27669|NCT01667900|126489|P16|Part B|Death|0
27670|NCT01667900|126490|P15|Part B|Death|0
27671|NCT01667900|126491|P14|Part B|Death|0
27672|NCT01667900|126492|P13|Part B|Death|0
27673|NCT01667900|126493|P12|Part B|Death|0
27674|NCT01667900|126494|P11|Part B|Death|0
27675|NCT01667900|126495|P10|Part B|Death|0
27676|NCT01667900|126496|P9|Part B|Death|0
27677|NCT01667900|126497|P8|Part B|Death|0
27678|NCT01667900|126498|P7|Part B|Death|0
27679|NCT01667900|126499|P6|Part B|Death|0
27680|NCT01667900|126500|P5|Part B|Death|0
27681|NCT01667900|126501|P4|Part B|Death|0
27682|NCT01667900|126502|P3|Part B|Death|0
27683|NCT01667900|126503|P2|Part B|Death|0
27684|NCT01667900|126504|P1|Part B|Death|0
27685|NCT01667731|126567|P5|Overall Study|Death|0
27686|NCT01667731|126568|P4|Overall Study|Death|0
27687|NCT01667731|126569|P3|Overall Study|Death|0
27688|NCT01667731|126570|P2|Overall Study|Death|1
27689|NCT01667731|126571|P1|Overall Study|Death|0
27690|NCT01667731|126567|P5|Overall Study|Subject Withdrew Consent|1
27691|NCT01667731|126568|P4|Overall Study|Subject Withdrew Consent|0
27692|NCT01667731|126569|P3|Overall Study|Subject Withdrew Consent|1
27693|NCT01667731|126570|P2|Overall Study|Subject Withdrew Consent|0
27694|NCT01667731|126571|P1|Overall Study|Subject Withdrew Consent|2
27695|NCT01667731|126567|P5|Overall Study|Lost to Follow-up|2
27696|NCT01667731|126568|P4|Overall Study|Lost to Follow-up|1
27697|NCT01667731|126569|P3|Overall Study|Lost to Follow-up|1
27698|NCT01667731|126570|P2|Overall Study|Lost to Follow-up|3
27699|NCT01667731|126571|P1|Overall Study|Lost to Follow-up|2
27700|NCT01667731|126567|P5|Overall Study|Efficacy Failure|24
27701|NCT01667731|126568|P4|Overall Study|Efficacy Failure|1
27702|NCT01667731|126569|P3|Overall Study|Efficacy Failure|0
27703|NCT01667731|126570|P2|Overall Study|Efficacy Failure|12
27704|NCT01667731|126571|P1|Overall Study|Efficacy Failure|1
27705|NCT01667731|126567|P5|Overall Study|Enrolled but not treated|1
27706|NCT01667731|126568|P4|Overall Study|Enrolled but not treated|0
27707|NCT01667731|126569|P3|Overall Study|Enrolled but not treated|0
27708|NCT01667731|126570|P2|Overall Study|Enrolled but not treated|0
27709|NCT01667731|126571|P1|Overall Study|Enrolled but not treated|0
27710|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
27711|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
27712|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
27713|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
27714|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
27715|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
27716|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
27717|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
27718|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
27719|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
27720|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
27721|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
27722|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
27723|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
27724|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
27725|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
27726|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
27727|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
27728|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
27729|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
27730|NCT01667679|126626|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
27731|NCT01667679|126627|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
27732|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
27733|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
27734|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
27735|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
27736|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
27737|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
27738|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
27739|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
27740|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
27741|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
27742|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
27743|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
27744|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
27745|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
27746|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
27747|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
27748|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
27749|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
27750|NCT01667679|126626|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
27751|NCT01667679|126627|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
27752|NCT01667432|126712|P1|Overall Study|Missing Information|4
27753|NCT01667432|126712|P1|Overall Study|Reason Not Specified|2
27754|NCT01667432|126712|P1|Overall Study|Principal Investigator Decision|1
27755|NCT01667432|126712|P1|Overall Study|Protocol Deviation|2
27756|NCT01667432|126712|P1|Overall Study|Adverse Event|1
27757|NCT01667432|126712|P1|Overall Study|Insufficient Therapeutic Response|4
27758|NCT01667432|126712|P1|Overall Study|Refused Treatment/Withdrew Consent|1
27759|NCT01667432|126712|P1|Overall Study|Lost to Follow-up|3
27760|NCT01667432|126712|P1|Overall Study|Moved to Another Center|3
27761|NCT01667432|126712|P1|Overall Study|Failure to Return|10
27762|NCT01667432|126712|P1|Overall Study|Premature Study Termination|26
27763|NCT01667224|126719|P2|Overall Study|Protocol Violation|1
27764|NCT01667224|126720|P1|Overall Study|Protocol Violation|1
27765|NCT01667224|126719|P2|Overall Study|Withdrawal by Subject|1
27766|NCT01667224|126720|P1|Overall Study|Withdrawal by Subject|3
27767|NCT01667107|126734|P2|Overall Study|Lack of Efficacy|1
27768|NCT01667107|126735|P1|Overall Study|Lack of Efficacy|0
27769|NCT01667107|126734|P2|Overall Study|Protocol Violation|1
27770|NCT01667107|126735|P1|Overall Study|Protocol Violation|0
27771|NCT01667107|126734|P2|Overall Study|Tolerability issues|2
27772|NCT01667107|126735|P1|Overall Study|Tolerability issues|0
27773|NCT01667107|126734|P2|Overall Study|Adverse Event|3
27774|NCT01667107|126735|P1|Overall Study|Adverse Event|4
27775|NCT01666951|126753|P2|Overall Study|Not dosed|1
27776|NCT01666951|126754|P1|Overall Study|Not dosed|1
27777|NCT01666782|126805|P2|Overall Study|Enrolled both years; year 1 data used|0
27778|NCT01666782|126806|P1|Overall Study|Enrolled both years; year 1 data used|4
27779|NCT01666782|126805|P2|Overall Study|Received 2 doses of vaccine|1
27780|NCT01666782|126806|P1|Overall Study|Received 2 doses of vaccine|0
27781|NCT01666119|126844|P1|Overall Study|Subject experiencing withdrawal symptoms|5
27782|NCT01666119|126844|P1|Overall Study|non compliance with study medication, pa|18
27783|NCT01666119|126844|P1|Overall Study|Lost to Follow-up|7
27784|NCT01666119|126844|P1|Overall Study|Withdrawal by Subject|16
27785|NCT01666119|126844|P1|Overall Study|Adverse Event|6
27786|NCT01666002|126851|P2|Overall Study|Lost to Follow-up|0
27787|NCT01666002|126852|P1|Overall Study|Lost to Follow-up|5
27788|NCT01665911|126873|P1|Overall Study|Adverse Event|1
27789|NCT01665911|126873|P1|Overall Study|Withdrawal by Subject|1
27790|NCT01665911|126873|P1|Overall Study|Protocol Violation|4
27791|NCT01665807|126882|P3|Overall Study|Withdrawal by Subject|1
27792|NCT01665807|126883|P2|Overall Study|Withdrawal by Subject|0
27793|NCT01665807|126884|P1|Overall Study|Withdrawal by Subject|2
27794|NCT01664949|127045|P2|Overall Study|Other Miscellaneous Reasons|1
27795|NCT01664949|127046|P1|Overall Study|Other Miscellaneous Reasons|3
27796|NCT01664949|127045|P2|Overall Study|Protocol Violation|5
27797|NCT01664949|127046|P1|Overall Study|Protocol Violation|5
27798|NCT01664949|127045|P2|Overall Study|Personal Reasons|4
27799|NCT01664949|127046|P1|Overall Study|Personal Reasons|3
27800|NCT01664949|127045|P2|Overall Study|Lost to Follow-up|2
27801|NCT01664949|127046|P1|Overall Study|Lost to Follow-up|1
27802|NCT01664949|127045|P2|Overall Study|Lack of Efficacy|1
27803|NCT01664949|127046|P1|Overall Study|Lack of Efficacy|1
27804|NCT01664949|127045|P2|Overall Study|Adverse Event|12
27805|NCT01664949|127046|P1|Overall Study|Adverse Event|11
27806|NCT01664923|127062|P2|Overall Study|Miscellaneous|1
27807|NCT01664923|127063|P1|Overall Study|Miscellaneous|5
27808|NCT01664923|127062|P2|Overall Study|Adverse Event|12
27809|NCT01664923|127063|P1|Overall Study|Adverse Event|16
27810|NCT01664923|127062|P2|Overall Study|Disease Progression|139
27811|NCT01664923|127063|P1|Overall Study|Disease Progression|58
27812|NCT01664923|127062|P2|Overall Study|Withdrawal by Subject|5
27813|NCT01664923|127063|P1|Overall Study|Withdrawal by Subject|11
27814|NCT01664923|127062|P2|Overall Study|Protocol Violation|0
27815|NCT01664923|127063|P1|Overall Study|Protocol Violation|2
27816|NCT01664923|127062|P2|Overall Study|Lost to Follow-up|1
27817|NCT01664923|127063|P1|Overall Study|Lost to Follow-up|0
27818|NCT01664923|127062|P2|Overall Study|Death|0
27819|NCT01664923|127063|P1|Overall Study|Death|1
27820|NCT01664624|127107|P4|Overall Study|Adverse Event|0
27821|NCT01664624|127108|P3|Overall Study|Adverse Event|0
27822|NCT01664624|127109|P2|Overall Study|Adverse Event|1
27823|NCT01664624|127110|P1|Overall Study|Adverse Event|0
27824|NCT01664533|127157|P1|Overall Study|Protocol Violation|3
27825|NCT01664533|127157|P1|Overall Study|Study termination|9
27826|NCT01664533|127157|P1|Overall Study|Lost to Follow-up|3
27827|NCT01664533|127157|P1|Overall Study|Death|42
27828|NCT01664494|127165|P1|Overall Study|Lost to Follow-up|99
27829|NCT01664494|127165|P1|Overall Study|Not specified|49
27830|NCT01664494|127165|P1|Overall Study|Death|18
27831|NCT01664494|127165|P1|Overall Study|Withdrawal by Subject|27
27832|NCT01664247|127172|P2|Overall Study|Unclassified|29
27833|NCT01664247|127173|P1|Overall Study|Unclassified|5
27834|NCT01664247|127172|P2|Overall Study|Withdrawal Criteria|4
27835|NCT01664247|127173|P1|Overall Study|Withdrawal Criteria|1
27836|NCT01664247|127172|P2|Overall Study|Protocol Violation|5
27837|NCT01664247|127173|P1|Overall Study|Protocol Violation|3
27838|NCT01664247|127172|P2|Overall Study|Adverse Event|3
27839|NCT01664247|127173|P1|Overall Study|Adverse Event|5
27840|NCT01664104|127250|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
27841|NCT01664104|127250|P1|Overall Study|Other|1
27842|NCT01664104|127250|P1|Overall Study|Lost to Follow-up|4
27843|NCT01664104|127250|P1|Overall Study|Withdrawal by Subject|1
27844|NCT01664104|127250|P1|Overall Study|Lack of Efficacy|2
27845|NCT01664104|127250|P1|Overall Study|Adverse Event|6
27846|NCT01664052|127319|P2|Phase 2|No device placement|4
27847|NCT01664052|127320|P1|Phase 2|No device placement|0
27848|NCT01664052|127319|P2|Phase 1|No HSG 1 hr post placement|0
27849|NCT01664052|127320|P1|Phase 1|No HSG 1 hr post placement|1
27850|NCT01664052|127319|P2|Phase 1|No device placement|0
27851|NCT01664052|127320|P1|Phase 1|No device placement|6
27852|NCT01664039|127338|P2|Overall Study|Noncompliance|1
27853|NCT01664039|127339|P1|Overall Study|Noncompliance|1
27854|NCT01664039|127338|P2|Overall Study|Withdrawal by Subject|3
27855|NCT01664039|127339|P1|Overall Study|Withdrawal by Subject|1
27856|NCT01664039|127338|P2|Overall Study|Lost to Follow-up|1
27857|NCT01664039|127339|P1|Overall Study|Lost to Follow-up|1
27858|NCT01664039|127338|P2|Overall Study|Adverse Event|4
27859|NCT01664039|127339|P1|Overall Study|Adverse Event|3
27860|NCT01663987|127361|P2|Overall Study|Other reason not defined above|0
27861|NCT01663987|127362|P1|Overall Study|Other reason not defined above|3
27862|NCT01663987|127361|P2|Overall Study|Withdrawal by Subject|3
27863|NCT01663987|127362|P1|Overall Study|Withdrawal by Subject|2
27864|NCT01663987|127361|P2|Overall Study|Lost to Follow-up|1
27865|NCT01663987|127362|P1|Overall Study|Lost to Follow-up|1
27866|NCT01663987|127361|P2|Overall Study|Adverse Event|2
27867|NCT01663987|127362|P1|Overall Study|Adverse Event|7
27868|NCT01663727|127405|P2|Overall Study|Lost to Follow-up|3
27869|NCT01663727|127406|P1|Overall Study|Lost to Follow-up|8
27870|NCT01663727|127405|P2|Overall Study|Alive in Follow-Up|132
27871|NCT01663727|127406|P1|Overall Study|Alive in Follow-Up|143
27872|NCT01663727|127405|P2|Overall Study|Alive on Treatment|39
27873|NCT01663727|127406|P1|Overall Study|Alive on Treatment|31
27874|NCT01663727|127405|P2|Overall Study|Death|65
27875|NCT01663727|127406|P1|Overall Study|Death|60
27876|NCT01663714|127434|P1|Long-Term Follow-Up|Non-compliance|1
27877|NCT01663714|127434|P1|Long-Term Follow-Up|Death|4
27878|NCT01663714|127434|P1|Long-Term Follow-Up|Lost to Follow-up|1
27879|NCT01663714|127434|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
27880|NCT01663714|127434|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
27881|NCT01663714|127434|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
27882|NCT01663532|127463|P2|Overall Study|Lack of Efficacy|60
27883|NCT01663532|127464|P1|Overall Study|Lack of Efficacy|15
27884|NCT01663532|127463|P2|Overall Study|Withdrawal by Subject|17
27885|NCT01663532|127464|P1|Overall Study|Withdrawal by Subject|35
27886|NCT01663532|127463|P2|Overall Study|Physician Decision|1
27887|NCT01663532|127464|P1|Overall Study|Physician Decision|1
27888|NCT01663532|127463|P2|Overall Study|Met Withdrawal Criteria|6
27889|NCT01663532|127464|P1|Overall Study|Met Withdrawal Criteria|7
27890|NCT01663532|127463|P2|Overall Study|Adverse Event|13
27891|NCT01663532|127464|P1|Overall Study|Adverse Event|7
27892|NCT01663532|127463|P2|Overall Study|Lost to Follow-up|10
27893|NCT01663532|127464|P1|Overall Study|Lost to Follow-up|9
27894|NCT01663506|127482|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
27895|NCT01663506|127482|P1|Overall Study|Adverse Event|1
27896|NCT01663506|127482|P1|Overall Study|Lost to Follow-up|1
27897|NCT01663506|127482|P1|Overall Study|Consent Withdrawal by Subject|1
27898|NCT01663506|127482|P1|Overall Study|Lack of Efficacy|3
27899|NCT01663233|127524|P2|Overall Study|Lost to Follow-up|1
27900|NCT01663233|127525|P1|Overall Study|Lost to Follow-up|0
27901|NCT01663233|127524|P2|Overall Study|Protocol Deviation|4
27902|NCT01663233|127525|P1|Overall Study|Protocol Deviation|1
27903|NCT01663233|127524|P2|Overall Study|Withdrawal by Subject|2
27904|NCT01663233|127525|P1|Overall Study|Withdrawal by Subject|3
27905|NCT01663103|127549|P2|Overall Study|dog bite|0
27906|NCT01663103|127550|P1|Overall Study|dog bite|1
27907|NCT01663103|127549|P2|Overall Study|Adverse Event|0
27908|NCT01663103|127550|P1|Overall Study|Adverse Event|1
27909|NCT01663103|127549|P2|Overall Study|Withdrawal by Subject|2
27910|NCT01663103|127550|P1|Overall Study|Withdrawal by Subject|1
27911|NCT01662999|127578|P6|Period 3|Withdrawal by Subject|0
27912|NCT01662999|127579|P5|Period 3|Withdrawal by Subject|0
27913|NCT01662999|127580|P4|Period 3|Withdrawal by Subject|0
27914|NCT01662999|127581|P3|Period 3|Withdrawal by Subject|0
27915|NCT01662999|127582|P2|Period 3|Withdrawal by Subject|1
27916|NCT01662999|127583|P1|Period 3|Withdrawal by Subject|0
27917|NCT01662986|127654|P2|Overall Study|Other than stated above|0
27918|NCT01662986|127655|P1|Overall Study|Other than stated above|3
27919|NCT01662986|127654|P2|Overall Study|Not Treated|0
27920|NCT01662986|127655|P1|Overall Study|Not Treated|1
27921|NCT01662986|127654|P2|Overall Study|Withdrawal by Subject|2
27922|NCT01662986|127655|P1|Overall Study|Withdrawal by Subject|2
27923|NCT01662986|127654|P2|Overall Study|Lost to Follow-up|4
27924|NCT01662986|127655|P1|Overall Study|Lost to Follow-up|5
27925|NCT01662986|127654|P2|Overall Study|Protocol Violation|3
27926|NCT01662986|127655|P1|Overall Study|Protocol Violation|2
27927|NCT01662986|127654|P2|Overall Study|Adverse Event|4
27928|NCT01662986|127655|P1|Overall Study|Adverse Event|5
27929|NCT01662648|127775|P2|Overall Study|LOE and Participant non-compliant|1
27930|NCT01662648|127776|P1|Overall Study|LOE and Participant non-compliant|0
27931|NCT01662648|127775|P2|Overall Study|LOE and other reason unspecified|0
27932|NCT01662648|127776|P1|Overall Study|LOE and other reason unspecified|1
27933|NCT01662648|127775|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
27934|NCT01662648|127776|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
27935|NCT01662648|127775|P2|Overall Study|Unspecified|11
27936|NCT01662648|127776|P1|Overall Study|Unspecified|8
27937|NCT01662648|127775|P2|Overall Study|Participant non-compliant|20
27938|NCT01662648|127776|P1|Overall Study|Participant non-compliant|16
27939|NCT01662648|127775|P2|Overall Study|Withdrawal by Subject|53
27940|NCT01662648|127776|P1|Overall Study|Withdrawal by Subject|36
27941|NCT01662648|127775|P2|Overall Study|Lost to Follow-up|36
27942|NCT01662648|127776|P1|Overall Study|Lost to Follow-up|24
27943|NCT01662648|127775|P2|Overall Study|Participant ineligible to continue trial|1
27944|NCT01662648|127776|P1|Overall Study|Participant ineligible to continue trial|1
27945|NCT01662648|127775|P2|Overall Study|Lack of Efficacy|16
27946|NCT01662648|127776|P1|Overall Study|Lack of Efficacy|17
27947|NCT01662648|127775|P2|Overall Study|Adverse Event|37
27948|NCT01662648|127776|P1|Overall Study|Adverse Event|40
27949|NCT01662648|127775|P2|Overall Study|Death|3
27950|NCT01662648|127776|P1|Overall Study|Death|1
27951|NCT01662635|127798|P1|Overall Study|scarce samples for evaluation|30
27952|NCT01662440|127850|P4|Overall Study|Withdrawal by Subject|2
27953|NCT01662440|127851|P3|Overall Study|Withdrawal by Subject|2
27954|NCT01662440|127852|P2|Overall Study|Withdrawal by Subject|2
27955|NCT01662440|127853|P1|Overall Study|Withdrawal by Subject|5
27956|NCT01662440|127850|P4|Overall Study|Protocol Violation|0
27957|NCT01662440|127851|P3|Overall Study|Protocol Violation|0
27958|NCT01662440|127852|P2|Overall Study|Protocol Violation|0
27959|NCT01662440|127853|P1|Overall Study|Protocol Violation|1
27960|NCT01662440|127850|P4|Overall Study|Subject moved to another country.|0
27961|NCT01662440|127851|P3|Overall Study|Subject moved to another country.|0
27962|NCT01662440|127852|P2|Overall Study|Subject moved to another country.|1
27963|NCT01662440|127853|P1|Overall Study|Subject moved to another country.|0
27964|NCT01662440|127850|P4|Overall Study|Lost to Follow-up|1
27965|NCT01662440|127851|P3|Overall Study|Lost to Follow-up|4
27966|NCT01662440|127852|P2|Overall Study|Lost to Follow-up|2
27967|NCT01662440|127853|P1|Overall Study|Lost to Follow-up|2
27968|NCT01662440|127850|P4|Overall Study|Death|0
27969|NCT01662440|127851|P3|Overall Study|Death|0
27970|NCT01662440|127852|P2|Overall Study|Death|1
27971|NCT01662440|127853|P1|Overall Study|Death|0
27972|NCT01662440|127850|P4|Overall Study|Adverse Event|1
27973|NCT01662440|127851|P3|Overall Study|Adverse Event|0
27974|NCT01662440|127852|P2|Overall Study|Adverse Event|0
27975|NCT01662440|127853|P1|Overall Study|Adverse Event|1
27976|NCT01662362|127901|P1|Overall Study|Lost to Follow-up|38
27977|NCT01662310|127906|P5|Open-Label Extension Phase|Withdrawal by Subject|7
27978|NCT01662310|127907|P4|Open-Label Extension Phase|Withdrawal by Subject|2
27979|NCT01662310|127908|P3|Open-Label Extension Phase|Withdrawal by Subject|0
27980|NCT01662310|127909|P2|Open-Label Extension Phase|Withdrawal by Subject|0
27981|NCT01662310|127910|P1|Open-Label Extension Phase|Withdrawal by Subject|0
27982|NCT01662310|127906|P5|Open-Label Extension Phase|Pregnancy|0
27983|NCT01662310|127907|P4|Open-Label Extension Phase|Pregnancy|1
27984|NCT01662310|127908|P3|Open-Label Extension Phase|Pregnancy|0
27985|NCT01662310|127909|P2|Open-Label Extension Phase|Pregnancy|0
27986|NCT01662310|127910|P1|Open-Label Extension Phase|Pregnancy|0
27987|NCT01662310|127906|P5|Open-Label Extension Phase|Lost to Follow-up|1
27988|NCT01662310|127907|P4|Open-Label Extension Phase|Lost to Follow-up|2
27989|NCT01662310|127908|P3|Open-Label Extension Phase|Lost to Follow-up|0
27990|NCT01662310|127909|P2|Open-Label Extension Phase|Lost to Follow-up|0
27991|NCT01662310|127910|P1|Open-Label Extension Phase|Lost to Follow-up|0
27992|NCT01662310|127906|P5|Open-Label Extension Phase|Lack of Efficacy|2
27993|NCT01662310|127907|P4|Open-Label Extension Phase|Lack of Efficacy|2
27994|NCT01662310|127908|P3|Open-Label Extension Phase|Lack of Efficacy|0
27995|NCT01662310|127909|P2|Open-Label Extension Phase|Lack of Efficacy|0
27996|NCT01662310|127910|P1|Open-Label Extension Phase|Lack of Efficacy|0
27997|NCT01662310|127906|P5|Open-Label Extension Phase|Death|0
27998|NCT01662310|127907|P4|Open-Label Extension Phase|Death|1
27999|NCT01662310|127908|P3|Open-Label Extension Phase|Death|0
28000|NCT01662310|127909|P2|Open-Label Extension Phase|Death|0
28001|NCT01662310|127910|P1|Open-Label Extension Phase|Death|0
28002|NCT01662310|127906|P5|Open-Label Extension Phase|Adverse Event|0
28003|NCT01662310|127907|P4|Open-Label Extension Phase|Adverse Event|3
28004|NCT01662310|127908|P3|Open-Label Extension Phase|Adverse Event|0
28005|NCT01662310|127909|P2|Open-Label Extension Phase|Adverse Event|0
28006|NCT01662310|127910|P1|Open-Label Extension Phase|Adverse Event|0
28007|NCT01662310|127906|P5|Double-Blind Phase|Randomized but not treated|0
28008|NCT01662310|127907|P4|Double-Blind Phase|Randomized but not treated|0
28009|NCT01662310|127908|P3|Double-Blind Phase|Randomized but not treated|0
28010|NCT01662310|127909|P2|Double-Blind Phase|Randomized but not treated|1
28011|NCT01662310|127910|P1|Double-Blind Phase|Randomized but not treated|0
28012|NCT01662310|127906|P5|Double-Blind Phase|unspecified|0
28013|NCT01662310|127907|P4|Double-Blind Phase|unspecified|0
28014|NCT01662310|127908|P3|Double-Blind Phase|unspecified|1
28015|NCT01662310|127909|P2|Double-Blind Phase|unspecified|0
28016|NCT01662310|127910|P1|Double-Blind Phase|unspecified|0
28017|NCT01662310|127906|P5|Double-Blind Phase|Withdrawal by Subject|0
28018|NCT01662310|127907|P4|Double-Blind Phase|Withdrawal by Subject|0
28019|NCT01662310|127908|P3|Double-Blind Phase|Withdrawal by Subject|3
28020|NCT01662310|127909|P2|Double-Blind Phase|Withdrawal by Subject|9
28021|NCT01662310|127910|P1|Double-Blind Phase|Withdrawal by Subject|0
28022|NCT01662310|127906|P5|Double-Blind Phase|Pregnancy|0
28023|NCT01662310|127907|P4|Double-Blind Phase|Pregnancy|0
28024|NCT01662310|127908|P3|Double-Blind Phase|Pregnancy|0
28025|NCT01662310|127909|P2|Double-Blind Phase|Pregnancy|2
28026|NCT01662310|127910|P1|Double-Blind Phase|Pregnancy|0
28027|NCT01662310|127906|P5|Double-Blind Phase|Lost to Follow-up|0
28028|NCT01662310|127907|P4|Double-Blind Phase|Lost to Follow-up|0
28029|NCT01662310|127908|P3|Double-Blind Phase|Lost to Follow-up|0
28030|NCT01662310|127909|P2|Double-Blind Phase|Lost to Follow-up|3
28031|NCT01662310|127910|P1|Double-Blind Phase|Lost to Follow-up|0
28032|NCT01662310|127906|P5|Double-Blind Phase|Adverse Event|0
28033|NCT01662310|127907|P4|Double-Blind Phase|Adverse Event|0
28034|NCT01662310|127908|P3|Double-Blind Phase|Adverse Event|1
28035|NCT01662310|127909|P2|Double-Blind Phase|Adverse Event|0
28036|NCT01662310|127910|P1|Double-Blind Phase|Adverse Event|0
28037|NCT01662310|127906|P5|Run-In or Stabilization Phase|unspecified|0
28038|NCT01662310|127907|P4|Run-In or Stabilization Phase|unspecified|0
28039|NCT01662310|127908|P3|Run-In or Stabilization Phase|unspecified|0
28040|NCT01662310|127909|P2|Run-In or Stabilization Phase|unspecified|0
28041|NCT01662310|127910|P1|Run-In or Stabilization Phase|unspecified|1
28042|NCT01662310|127906|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
28043|NCT01662310|127907|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
28044|NCT01662310|127908|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
28045|NCT01662310|127909|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
28046|NCT01662310|127910|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
28047|NCT01662310|127906|P5|Run-In or Stabilization Phase|Protocol Violation|0
28048|NCT01662310|127907|P4|Run-In or Stabilization Phase|Protocol Violation|0
28049|NCT01662310|127908|P3|Run-In or Stabilization Phase|Protocol Violation|0
28050|NCT01662310|127909|P2|Run-In or Stabilization Phase|Protocol Violation|0
28051|NCT01662310|127910|P1|Run-In or Stabilization Phase|Protocol Violation|15
28052|NCT01662310|127906|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
28053|NCT01662310|127907|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
28054|NCT01662310|127908|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
28055|NCT01662310|127909|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
28056|NCT01662310|127910|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
28057|NCT01662310|127906|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
28058|NCT01662310|127907|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
28059|NCT01662310|127908|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
28060|NCT01662310|127909|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
28061|NCT01662310|127910|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
28062|NCT01662310|127906|P5|Run-In or Stabilization Phase|Adverse Event|0
28063|NCT01662310|127907|P4|Run-In or Stabilization Phase|Adverse Event|0
28064|NCT01662310|127908|P3|Run-In or Stabilization Phase|Adverse Event|0
28065|NCT01662310|127909|P2|Run-In or Stabilization Phase|Adverse Event|0
28066|NCT01662310|127910|P1|Run-In or Stabilization Phase|Adverse Event|11
28067|NCT01662102|127966|P2|Overall Study|Sponsor's decision|0
28068|NCT01662102|127967|P1|Overall Study|Sponsor's decision|1
28069|NCT01662063|127975|P3|Overall Study|Not Specified|0
28070|NCT01662063|127976|P2|Overall Study|Not Specified|1
28071|NCT01662063|127977|P1|Overall Study|Not Specified|0
28072|NCT01662063|127975|P3|Overall Study|Physician Decision|0
28073|NCT01662063|127976|P2|Overall Study|Physician Decision|2
28074|NCT01662063|127977|P1|Overall Study|Physician Decision|0
28075|NCT01662063|127975|P3|Overall Study|Withdrawal by Subject|1
28076|NCT01662063|127976|P2|Overall Study|Withdrawal by Subject|4
28077|NCT01662063|127977|P1|Overall Study|Withdrawal by Subject|2
28078|NCT01662063|127975|P3|Overall Study|Protocol Violation|0
28079|NCT01662063|127976|P2|Overall Study|Protocol Violation|0
28080|NCT01662063|127977|P1|Overall Study|Protocol Violation|1
28081|NCT01662063|127975|P3|Overall Study|Lost to Follow-up|0
28082|NCT01662063|127976|P2|Overall Study|Lost to Follow-up|4
28083|NCT01662063|127977|P1|Overall Study|Lost to Follow-up|0
28084|NCT01662063|127975|P3|Overall Study|Lack of Efficacy|0
28085|NCT01662063|127976|P2|Overall Study|Lack of Efficacy|6
28086|NCT01662063|127977|P1|Overall Study|Lack of Efficacy|1
28087|NCT01662063|127975|P3|Overall Study|Adverse Event or Intercurrent Illness|0
28088|NCT01662063|127976|P2|Overall Study|Adverse Event or Intercurrent Illness|12
28089|NCT01662063|127977|P1|Overall Study|Adverse Event or Intercurrent Illness|1
28090|NCT01662024|128056|P1|Overall Study|Withdrawal by Subject|3
28091|NCT01662024|128056|P1|Overall Study|Pregnancy|2
28092|NCT01661972|128068|P2|Overall Study|Withdrawal by Subject|1
28093|NCT01661972|128069|P1|Overall Study|Withdrawal by Subject|0
28094|NCT01661972|128068|P2|Overall Study|Death during Treatment period|1
28095|NCT01661972|128069|P1|Overall Study|Death during Treatment period|1
28096|NCT01661972|128068|P2|Overall Study|Adverse Event|2
28097|NCT01661972|128069|P1|Overall Study|Adverse Event|1
28098|NCT01661933|128079|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
28099|NCT01661933|128079|P1|Low-dose Gluten Challenge|Physician Decision|2
28100|NCT01661790|128094|P2|Overall Study|Lost to Follow-up|2
28101|NCT01661790|128095|P1|Overall Study|Lost to Follow-up|0
28102|NCT01661205|128138|P1|Overall Study|Physician Decision|2
28103|NCT01661179|128149|P1|Overall Study|Other Eligibility criteria|4
28104|NCT01661179|128149|P1|Overall Study|Withdrawal by Subject|1
28105|NCT01661179|128149|P1|Overall Study|Death|1
28106|NCT01661140|128153|P3|Double-Blind Period|Administrative/Other|6
28107|NCT01661140|128154|P2|Double-Blind Period|Administrative/Other|7
28108|NCT01661140|128155|P1|Double-Blind Period|Administrative/Other|0
28109|NCT01661140|128153|P3|Double-Blind Period|Sponsor Termination|17
28110|NCT01661140|128154|P2|Double-Blind Period|Sponsor Termination|14
28111|NCT01661140|128155|P1|Double-Blind Period|Sponsor Termination|0
28112|NCT01661140|128153|P3|Double-Blind Period|Investigator's Decision|2
28113|NCT01661140|128154|P2|Double-Blind Period|Investigator's Decision|1
28114|NCT01661140|128155|P1|Double-Blind Period|Investigator's Decision|0
28115|NCT01661140|128153|P3|Double-Blind Period|Withdrawal by Subject|3
28116|NCT01661140|128154|P2|Double-Blind Period|Withdrawal by Subject|1
28117|NCT01661140|128155|P1|Double-Blind Period|Withdrawal by Subject|0
28118|NCT01661140|128153|P3|Double-Blind Period|Protocol Violation|3
28119|NCT01661140|128154|P2|Double-Blind Period|Protocol Violation|2
28120|NCT01661140|128155|P1|Double-Blind Period|Protocol Violation|0
28121|NCT01661140|128153|P3|Double-Blind Period|Adverse Event|18
28122|NCT01661140|128154|P2|Double-Blind Period|Adverse Event|16
28123|NCT01661140|128155|P1|Double-Blind Period|Adverse Event|0
28124|NCT01661140|128153|P3|Double-Blind Period|Refused Treatment|1
28125|NCT01661140|128154|P2|Double-Blind Period|Refused Treatment|0
28126|NCT01661140|128155|P1|Double-Blind Period|Refused Treatment|0
28127|NCT01661140|128153|P3|Open-Label Period|Lost to Follow-up|0
28128|NCT01661140|128154|P2|Open-Label Period|Lost to Follow-up|0
28129|NCT01661140|128155|P1|Open-Label Period|Lost to Follow-up|2
28130|NCT01661140|128153|P3|Open-Label Period|Did not meet EULAR criteria|0
28131|NCT01661140|128154|P2|Open-Label Period|Did not meet EULAR criteria|0
28132|NCT01661140|128155|P1|Open-Label Period|Did not meet EULAR criteria|1
28133|NCT01661140|128153|P3|Open-Label Period|Sponsor termination|0
28134|NCT01661140|128154|P2|Open-Label Period|Sponsor termination|0
28135|NCT01661140|128155|P1|Open-Label Period|Sponsor termination|16
28136|NCT01661140|128153|P3|Open-Label Period|Administrative/Other|0
28137|NCT01661140|128154|P2|Open-Label Period|Administrative/Other|0
28138|NCT01661140|128155|P1|Open-Label Period|Administrative/Other|1
28139|NCT01661140|128153|P3|Open-Label Period|Death|0
28140|NCT01661140|128154|P2|Open-Label Period|Death|0
28141|NCT01661140|128155|P1|Open-Label Period|Death|1
28142|NCT01661140|128153|P3|Open-Label Period|Investigator Decision|0
28143|NCT01661140|128154|P2|Open-Label Period|Investigator Decision|0
28144|NCT01661140|128155|P1|Open-Label Period|Investigator Decision|3
28145|NCT01661140|128153|P3|Open-Label Period|Withdrawal by Subject|0
28146|NCT01661140|128154|P2|Open-Label Period|Withdrawal by Subject|0
28147|NCT01661140|128155|P1|Open-Label Period|Withdrawal by Subject|5
28148|NCT01661140|128153|P3|Open-Label Period|Protocol Violation|0
28149|NCT01661140|128154|P2|Open-Label Period|Protocol Violation|0
28150|NCT01661140|128155|P1|Open-Label Period|Protocol Violation|3
28151|NCT01661140|128153|P3|Open-Label Period|Adverse Event|0
28152|NCT01661140|128154|P2|Open-Label Period|Adverse Event|0
28153|NCT01661140|128155|P1|Open-Label Period|Adverse Event|44
28154|NCT01661062|128201|P1|Overall Study|Withdrawal by Subject|2
28155|NCT01661062|128201|P1|Overall Study|Completed Treatment Off Study|3
28156|NCT01660906|128206|P1|Overall Study|Discontinued due to study drug toxicity|3
28157|NCT01660763|128237|P2|Overall Study|Patient ready for early discharge|4
28158|NCT01660763|128238|P1|Overall Study|Patient ready for early discharge|28
28159|NCT01660763|128237|P2|Overall Study|Withdrawal by Subject|0
28160|NCT01660763|128238|P1|Overall Study|Withdrawal by Subject|4
28161|NCT01660763|128237|P2|Overall Study|Protocol Violation|0
28162|NCT01660763|128238|P1|Overall Study|Protocol Violation|1
28163|NCT01660763|128237|P2|Overall Study|Adverse Event|7
28164|NCT01660763|128238|P1|Overall Study|Adverse Event|22
28165|NCT01660763|128237|P2|Overall Study|Lack of Efficacy|50
28166|NCT01660763|128238|P1|Overall Study|Lack of Efficacy|45
28167|NCT01659736|128285|P2|3-month Follow-up|Lost to Follow-up|1
28168|NCT01659736|128286|P1|3-month Follow-up|Lost to Follow-up|0
28169|NCT01659736|128285|P2|Treatment Period|Withdrawal by Subject|0
28170|NCT01659736|128286|P1|Treatment Period|Withdrawal by Subject|1
28171|NCT01659736|128285|P2|Treatment Period|Protocol Violation|1
28172|NCT01659736|128286|P1|Treatment Period|Protocol Violation|3
28173|NCT01659736|128285|P2|Treatment Period|Adverse Event|1
28174|NCT01659736|128286|P1|Treatment Period|Adverse Event|1
28175|NCT01660334|128300|P1|Overall Study|Lost to Follow-up|1
28176|NCT01660022|128543|P6|First Sequence (7 Days)|Protocol Violation|1
28177|NCT01660022|128544|P5|First Sequence (7 Days)|Protocol Violation|0
28178|NCT01660022|128545|P4|First Sequence (7 Days)|Protocol Violation|0
28179|NCT01660022|128546|P3|First Sequence (7 Days)|Protocol Violation|0
28180|NCT01660022|128547|P2|First Sequence (7 Days)|Protocol Violation|0
28181|NCT01660022|128548|P1|First Sequence (7 Days)|Protocol Violation|0
28182|NCT01660022|128543|P6|First Sequence (7 Days)|Adverse Event|3
28183|NCT01660022|128544|P5|First Sequence (7 Days)|Adverse Event|1
28184|NCT01660022|128545|P4|First Sequence (7 Days)|Adverse Event|0
28185|NCT01660022|128546|P3|First Sequence (7 Days)|Adverse Event|0
28186|NCT01660022|128547|P2|First Sequence (7 Days)|Adverse Event|0
28187|NCT01660022|128548|P1|First Sequence (7 Days)|Adverse Event|0
28188|NCT01660022|128543|P6|First Sequence (7 Days)|Withdrawal by Subject|0
28189|NCT01660022|128544|P5|First Sequence (7 Days)|Withdrawal by Subject|0
28190|NCT01660022|128545|P4|First Sequence (7 Days)|Withdrawal by Subject|1
28191|NCT01660022|128546|P3|First Sequence (7 Days)|Withdrawal by Subject|0
28192|NCT01660022|128547|P2|First Sequence (7 Days)|Withdrawal by Subject|1
28193|NCT01660022|128548|P1|First Sequence (7 Days)|Withdrawal by Subject|0
28194|NCT01659996|128607|P3|Overall Study|Withdrawal by Subject|5
28195|NCT01659996|128608|P2|Overall Study|Withdrawal by Subject|1
28196|NCT01659996|128609|P1|Overall Study|Withdrawal by Subject|4
28197|NCT01659996|128607|P3|Overall Study|Adverse Event|1
28198|NCT01659996|128608|P2|Overall Study|Adverse Event|0
28199|NCT01659996|128609|P1|Overall Study|Adverse Event|0
28200|NCT01659996|128607|P3|Overall Study|Lost to Follow-up|2
28201|NCT01659996|128608|P2|Overall Study|Lost to Follow-up|3
28202|NCT01659996|128609|P1|Overall Study|Lost to Follow-up|1
28203|NCT01659996|128607|P3|Overall Study|Protocol Violation|3
28204|NCT01659996|128608|P2|Overall Study|Protocol Violation|3
28205|NCT01659996|128609|P1|Overall Study|Protocol Violation|3
28206|NCT01659853|128641|P2|Washout , 3 to 7 Days|Protocol Violation|0
28207|NCT01659853|128642|P1|Washout , 3 to 7 Days|Protocol Violation|1
28208|NCT01659853|128641|P2|Washout , 3 to 7 Days|Adverse Event|0
28209|NCT01659853|128642|P1|Washout , 3 to 7 Days|Adverse Event|1
28210|NCT01659554|128650|P1|Overall Study|Study Termination|4
28211|NCT01659320|128657|P1|Overall Study|Physician Decision|1
28212|NCT01659320|128657|P1|Overall Study|Withdrawal by Subject|2
28213|NCT01659125|128676|P1|Overall Study|Failed to Start Treatment|2
28214|NCT01659125|128676|P1|Overall Study|Time Constraints|2
28215|NCT01659125|128676|P1|Overall Study|Technical Problem|1
28216|NCT01659125|128676|P1|Overall Study|Lost to Follow-up|7
28217|NCT01659125|128676|P1|Overall Study|Withdrawal by Subject|2
28218|NCT01659021|128683|P2|Overall Study|Still on Study|1
28219|NCT01659021|128684|P1|Overall Study|Still on Study|34
28220|NCT01659021|128683|P2|Overall Study|Withdrawal by Subject|16
28221|NCT01659021|128684|P1|Overall Study|Withdrawal by Subject|18
28222|NCT01659021|128683|P2|Overall Study|Physician Decision|16
28223|NCT01659021|128684|P1|Overall Study|Physician Decision|32
28224|NCT01659021|128683|P2|Overall Study|Other?|1
28225|NCT01659021|128684|P1|Overall Study|Other?|1
28226|NCT01659021|128683|P2|Overall Study|Lost to Follow-up|0
28227|NCT01659021|128684|P1|Overall Study|Lost to Follow-up|1
28228|NCT01659021|128683|P2|Overall Study|Adverse Event|3
28229|NCT01659021|128684|P1|Overall Study|Adverse Event|2
28230|NCT01658943|128702|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
28231|NCT01658943|128703|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
28232|NCT01658943|128702|P2|Overall Study|Not eligible|9
28233|NCT01658943|128703|P1|Overall Study|Not eligible|7
28234|NCT01658943|128702|P2|Overall Study|not protocol specified|1
28235|NCT01658943|128703|P1|Overall Study|not protocol specified|4
28236|NCT01658943|128702|P2|Overall Study|Death|2
28237|NCT01658943|128703|P1|Overall Study|Death|4
28238|NCT01658943|128702|P2|Overall Study|Progression/Relapse|40
28239|NCT01658943|128703|P1|Overall Study|Progression/Relapse|39
28240|NCT01658943|128702|P2|Overall Study|Withdrawal by Subject|2
28241|NCT01658943|128703|P1|Overall Study|Withdrawal by Subject|9
28242|NCT01658943|128702|P2|Overall Study|Adverse Event|13
28243|NCT01658943|128703|P1|Overall Study|Adverse Event|6
28244|NCT01658904|128718|P3|Overall Study|Principal Investigator discretion|0
28245|NCT01658904|128719|P2|Overall Study|Principal Investigator discretion|0
28246|NCT01658904|128720|P1|Overall Study|Principal Investigator discretion|2
28247|NCT01658813|128746|P1|Overall Study|Disease progression|3
28248|NCT01658735|128757|P3|Overall Study|Withdrawal by Subject|3
28249|NCT01658735|128758|P2|Overall Study|Withdrawal by Subject|5
28250|NCT01658735|128759|P1|Overall Study|Withdrawal by Subject|3
28251|NCT01658735|128757|P3|Overall Study|Protocol Violation|0
28252|NCT01658735|128758|P2|Overall Study|Protocol Violation|1
28253|NCT01658735|128759|P1|Overall Study|Protocol Violation|0
28254|NCT01658735|128757|P3|Overall Study|Lost to Follow-up|0
28255|NCT01658735|128758|P2|Overall Study|Lost to Follow-up|1
28256|NCT01658735|128759|P1|Overall Study|Lost to Follow-up|1
28257|NCT01658735|128757|P3|Overall Study|Lack of Efficacy|1
28258|NCT01658735|128758|P2|Overall Study|Lack of Efficacy|0
28259|NCT01658735|128759|P1|Overall Study|Lack of Efficacy|1
28260|NCT01658579|128801|P4|Treatment Period B|Unspecified|1
28261|NCT01658579|128802|P3|Treatment Period B|Unspecified|0
28262|NCT01658579|128803|P2|Treatment Period B|Unspecified|0
28263|NCT01658579|128804|P1|Treatment Period B|Unspecified|0
28264|NCT01658579|128801|P4|Treatment Period A|Adverse Event|0
28265|NCT01658579|128802|P3|Treatment Period A|Adverse Event|0
28266|NCT01658579|128803|P2|Treatment Period A|Adverse Event|0
28267|NCT01658579|128804|P1|Treatment Period A|Adverse Event|1
28268|NCT01658579|128801|P4|Treatment Period A|Unspecified|1
28269|NCT01658579|128802|P3|Treatment Period A|Unspecified|1
28270|NCT01658579|128803|P2|Treatment Period A|Unspecified|0
28271|NCT01658579|128804|P1|Treatment Period A|Unspecified|0
28272|NCT01658514|128832|P3|Overall Study|Protocol Violation|2
28273|NCT01658514|128833|P2|Overall Study|Protocol Violation|0
28274|NCT01658514|128834|P1|Overall Study|Protocol Violation|1
28275|NCT01658436|128845|P2|Overall Study|Death|0
28276|NCT01658436|128846|P1|Overall Study|Death|1
28277|NCT01658436|128845|P2|Overall Study|Subject/guardian decision|1
28278|NCT01658436|128846|P1|Overall Study|Subject/guardian decision|0
28279|NCT01658436|128845|P2|Overall Study|Study terminated by sponsor|1
28280|NCT01658436|128846|P1|Overall Study|Study terminated by sponsor|0
28281|NCT01658436|128845|P2|Overall Study|Progressive disease|4
28282|NCT01658436|128846|P1|Overall Study|Progressive disease|12
28283|NCT01658436|128845|P2|Overall Study|Physician Decision|0
28284|NCT01658436|128846|P1|Overall Study|Physician Decision|1
28285|NCT01658436|128845|P2|Overall Study|Adverse Event|5
28286|NCT01658436|128846|P1|Overall Study|Adverse Event|6
28287|NCT01658072|128855|P2|Overall Study|Protocol Violation|2
28288|NCT01658072|128856|P1|Overall Study|Protocol Violation|4
28289|NCT01658020|128864|P2|Overall Study|Protocol Violation|1
28290|NCT01658020|128865|P1|Overall Study|Protocol Violation|0
28291|NCT01658020|128864|P2|Overall Study|Withdrawal by Subject|5
28292|NCT01658020|128865|P1|Overall Study|Withdrawal by Subject|4
28293|NCT01658020|128864|P2|Overall Study|Lost to Follow-up|0
28294|NCT01658020|128865|P1|Overall Study|Lost to Follow-up|1
28295|NCT01658020|128864|P2|Overall Study|Adverse Event|3
28296|NCT01658020|128865|P1|Overall Study|Adverse Event|3
28297|NCT01657903|128881|P1|Overall Study|Withdrawal by Subject|1
28298|NCT01657903|128881|P1|Overall Study|Lost to Follow-up|1
28299|NCT01657877|128903|P1|Overall Study|Other Reason|2
28300|NCT01657877|128903|P1|Overall Study|Adverse Event|2
28301|NCT01657877|128903|P1|Overall Study|Protocol Violation|6
28302|NCT01657877|128903|P1|Overall Study|Withdrawal by Subject|4
28303|NCT01657461|128922|P2|Overall Study|Withdrawal by Subject|3
28304|NCT01657461|128923|P1|Overall Study|Withdrawal by Subject|1
28305|NCT01657461|128922|P2|Overall Study|Physician Decision|2
28306|NCT01657461|128923|P1|Overall Study|Physician Decision|0
28307|NCT01657461|128922|P2|Overall Study|Lost to Follow-up|3
28308|NCT01657461|128923|P1|Overall Study|Lost to Follow-up|0
28309|NCT01657461|128922|P2|Overall Study|Death|12
28310|NCT01657461|128923|P1|Overall Study|Death|9
28311|NCT01657370|128953|P6|Overall Study|Lost to Follow-up|1
28312|NCT01657370|128954|P5|Overall Study|Lost to Follow-up|0
28313|NCT01657370|128955|P4|Overall Study|Lost to Follow-up|0
28314|NCT01657370|128956|P3|Overall Study|Lost to Follow-up|1
28315|NCT01657370|128957|P2|Overall Study|Lost to Follow-up|0
28316|NCT01657370|128958|P1|Overall Study|Lost to Follow-up|2
28317|NCT01657370|128953|P6|Overall Study|Protocol Violation|0
28318|NCT01657370|128954|P5|Overall Study|Protocol Violation|0
28319|NCT01657370|128955|P4|Overall Study|Protocol Violation|1
28320|NCT01657370|128956|P3|Overall Study|Protocol Violation|1
28321|NCT01657370|128957|P2|Overall Study|Protocol Violation|1
28322|NCT01657370|128958|P1|Overall Study|Protocol Violation|1
28323|NCT01657370|128953|P6|Overall Study|Adverse Event|0
28324|NCT01657370|128954|P5|Overall Study|Adverse Event|1
28325|NCT01657370|128955|P4|Overall Study|Adverse Event|0
28326|NCT01657370|128956|P3|Overall Study|Adverse Event|0
28327|NCT01657370|128957|P2|Overall Study|Adverse Event|0
28328|NCT01657370|128958|P1|Overall Study|Adverse Event|0
28329|NCT01657370|128953|P6|Overall Study|Lack of Qualifying Event|2
28330|NCT01657370|128954|P5|Overall Study|Lack of Qualifying Event|1
28331|NCT01657370|128955|P4|Overall Study|Lack of Qualifying Event|2
28332|NCT01657370|128956|P3|Overall Study|Lack of Qualifying Event|3
28333|NCT01657370|128957|P2|Overall Study|Lack of Qualifying Event|0
28334|NCT01657370|128958|P1|Overall Study|Lack of Qualifying Event|1
28335|NCT01657370|128953|P6|Overall Study|Physician Decision|0
28336|NCT01657370|128954|P5|Overall Study|Physician Decision|5
28337|NCT01657370|128955|P4|Overall Study|Physician Decision|2
28338|NCT01657370|128956|P3|Overall Study|Physician Decision|1
28339|NCT01657370|128957|P2|Overall Study|Physician Decision|3
28340|NCT01657370|128958|P1|Overall Study|Physician Decision|2
28341|NCT01657370|128953|P6|Overall Study|Withdrawal by Subject|1
28342|NCT01657370|128954|P5|Overall Study|Withdrawal by Subject|0
28343|NCT01657370|128955|P4|Overall Study|Withdrawal by Subject|0
28344|NCT01657370|128956|P3|Overall Study|Withdrawal by Subject|1
28345|NCT01657370|128957|P2|Overall Study|Withdrawal by Subject|0
28346|NCT01657370|128958|P1|Overall Study|Withdrawal by Subject|0
28347|NCT01657292|129040|P1|Overall Study|Change of therapy|1
28348|NCT01657292|129040|P1|Overall Study|Violation of eligibility criteria|1
28349|NCT01657292|129040|P1|Overall Study|Withdrawal by Subject|2
28350|NCT01657292|129040|P1|Overall Study|Adverse Event|6
28351|NCT01657032|129049|P2|Overall Study|Lost to Follow-up|7
28352|NCT01657032|129050|P1|Overall Study|Lost to Follow-up|0
28353|NCT01657019|129076|P1|Overall Study|Not Specified|58
28354|NCT01657019|129076|P1|Overall Study|Lack of Efficacy|3
28355|NCT01657019|129076|P1|Overall Study|Protocol Violation|6
28356|NCT01657019|129076|P1|Overall Study|Lost to Follow-up|48
28357|NCT01657019|129076|P1|Overall Study|Adverse Event|55
28358|NCT01657019|129076|P1|Overall Study|Withdrawal by Subject|65
28359|NCT01656967|129090|P2|Overall Study|unsuccessful ETT insertion|2
28360|NCT01656967|129091|P1|Overall Study|unsuccessful ETT insertion|3
28361|NCT01656967|129090|P2|Overall Study|faulty monitor|0
28362|NCT01656967|129091|P1|Overall Study|faulty monitor|1
28363|NCT01656889|129113|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
28364|NCT01656889|129114|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
28365|NCT01656889|129113|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
28366|NCT01656889|129114|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
28367|NCT01656889|129113|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
28368|NCT01656889|129114|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
28369|NCT01656889|129113|P2|Post Treatment Follow-Up, 3 Months|Death|5
28370|NCT01656889|129114|P1|Post Treatment Follow-Up, 3 Months|Death|1
28371|NCT01656889|129113|P2|Treatment Period, 12 Weeks|Moved out of the area|2
28372|NCT01656889|129114|P1|Treatment Period, 12 Weeks|Moved out of the area|0
28373|NCT01656889|129113|P2|Treatment Period, 12 Weeks|Protocol Violation|1
28374|NCT01656889|129114|P1|Treatment Period, 12 Weeks|Protocol Violation|0
28375|NCT01656889|129113|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
28376|NCT01656889|129114|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
28377|NCT01656889|129113|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
28378|NCT01656889|129114|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
28379|NCT01656889|129113|P2|Treatment Period, 12 Weeks|Death|1
28380|NCT01656889|129114|P1|Treatment Period, 12 Weeks|Death|0
28381|NCT01656889|129113|P2|Treatment Period, 12 Weeks|Adverse Event|4
28382|NCT01656889|129114|P1|Treatment Period, 12 Weeks|Adverse Event|10
28383|NCT01656850|129134|P2|First Intervention (3 Months)|Withdrawal by Subject|4
28384|NCT01656850|129135|P1|First Intervention (3 Months)|Withdrawal by Subject|3
28385|NCT01656759|129226|P2|Overall Study|Protocol Violation|3
28386|NCT01656759|129227|P1|Overall Study|Protocol Violation|2
28387|NCT01656434|129258|P2|Overall Study|Withdrawal by Subject|7
28388|NCT01656434|129259|P1|Overall Study|Withdrawal by Subject|64
28389|NCT01656434|129258|P2|Overall Study|Participant withdrew consent|9
28390|NCT01656434|129259|P1|Overall Study|Participant withdrew consent|28
28391|NCT01656434|129258|P2|Overall Study|Participant moved|12
28392|NCT01656434|129259|P1|Overall Study|Participant moved|40
28393|NCT01656434|129258|P2|Overall Study|Non-compliance with protocol|15
28394|NCT01656434|129259|P1|Overall Study|Non-compliance with protocol|39
28395|NCT01656434|129258|P2|Overall Study|Part. discontinued; unrelated to drug|10
28396|NCT01656434|129259|P1|Overall Study|Part. discontinued; unrelated to drug|55
28397|NCT01656434|129258|P2|Overall Study|Participant discontinued; drug related|4
28398|NCT01656434|129259|P1|Overall Study|Participant discontinued; drug related|13
28399|NCT01656434|129258|P2|Overall Study|Study terminated by sponsor|348
28400|NCT01656434|129259|P1|Overall Study|Study terminated by sponsor|1501
28401|NCT01656434|129258|P2|Overall Study|Non-compliance with study drug|9
28402|NCT01656434|129259|P1|Overall Study|Non-compliance with study drug|48
28403|NCT01656434|129258|P2|Overall Study|Physician Decision|2
28404|NCT01656434|129259|P1|Overall Study|Physician Decision|7
28405|NCT01656434|129258|P2|Overall Study|Pregnancy|10
28406|NCT01656434|129259|P1|Overall Study|Pregnancy|45
28407|NCT01656434|129258|P2|Overall Study|Pregnancy wish|6
28408|NCT01656434|129259|P1|Overall Study|Pregnancy wish|18
28409|NCT01656434|129258|P2|Overall Study|Protocol Violation|0
28410|NCT01656434|129259|P1|Overall Study|Protocol Violation|7
28411|NCT01656434|129258|P2|Overall Study|Screen failure|0
28412|NCT01656434|129259|P1|Overall Study|Screen failure|2
28413|NCT01656434|129258|P2|Overall Study|Site discontinued study participation|9
28414|NCT01656434|129259|P1|Overall Study|Site discontinued study participation|24
28415|NCT01656434|129258|P2|Overall Study|Lost to Follow-up|76
28416|NCT01656434|129259|P1|Overall Study|Lost to Follow-up|309
28417|NCT01656434|129258|P2|Overall Study|Enrollment terminated at trial site|0
28418|NCT01656434|129259|P1|Overall Study|Enrollment terminated at trial site|2
28419|NCT01656434|129258|P2|Overall Study|Adverse Event|63
28420|NCT01656434|129259|P1|Overall Study|Adverse Event|199
28421|NCT01656408|129285|P10|Overall Study|Physician Decision|3
28422|NCT01656408|129286|P9|Overall Study|Physician Decision|1
28423|NCT01656408|129287|P8|Overall Study|Physician Decision|1
28424|NCT01656408|129288|P7|Overall Study|Physician Decision|0
28425|NCT01656408|129289|P6|Overall Study|Physician Decision|1
28426|NCT01656408|129290|P5|Overall Study|Physician Decision|1
28427|NCT01656408|129291|P4|Overall Study|Physician Decision|0
28428|NCT01656408|129292|P3|Overall Study|Physician Decision|1
28429|NCT01656408|129293|P2|Overall Study|Physician Decision|0
28430|NCT01656408|129294|P1|Overall Study|Physician Decision|1
28431|NCT01656408|129285|P10|Overall Study|Adverse Event|0
28432|NCT01656408|129286|P9|Overall Study|Adverse Event|1
28433|NCT01656408|129287|P8|Overall Study|Adverse Event|0
28434|NCT01656408|129288|P7|Overall Study|Adverse Event|1
28435|NCT01656408|129289|P6|Overall Study|Adverse Event|1
28436|NCT01656408|129290|P5|Overall Study|Adverse Event|0
28437|NCT01656408|129291|P4|Overall Study|Adverse Event|0
28438|NCT01656408|129292|P3|Overall Study|Adverse Event|1
28439|NCT01656408|129293|P2|Overall Study|Adverse Event|0
28440|NCT01656408|129294|P1|Overall Study|Adverse Event|0
28441|NCT01656304|129483|P1|Overall Study|Ineligible, uncontrolled hypertension|1
28442|NCT01656161|129521|P1|Overall Study|Withdrawal by Subject|1
28443|NCT01656161|129521|P1|Overall Study|Protocol Violation|1
28444|NCT01656161|129521|P1|Overall Study|Adverse Event|2
28445|NCT01656161|129521|P1|Overall Study|Death|3
28446|NCT01655498|129539|P1|Overall Study|Withdrawal by Subject|1
28447|NCT01655498|129539|P1|Overall Study|Protocol Violation|2
28448|NCT01655498|129539|P1|Overall Study|Unrelated health issue|2
28449|NCT01655381|129546|P1|Overall Study|Insufficient Treatment Response|1
28450|NCT01655381|129546|P1|Overall Study|Moved to Another City|1
28451|NCT01655381|129546|P1|Overall Study|Investigator Decision|1
28452|NCT01654666|129627|P3|Overall Study|Withdrawal by Subject|1
28453|NCT01654666|129628|P2|Overall Study|Withdrawal by Subject|4
28454|NCT01654666|129629|P1|Overall Study|Withdrawal by Subject|4
28455|NCT01654666|129627|P3|Overall Study|Lost to Follow-up|5
28456|NCT01654666|129628|P2|Overall Study|Lost to Follow-up|5
28457|NCT01654666|129629|P1|Overall Study|Lost to Follow-up|4
28458|NCT01654666|129627|P3|Overall Study|Protocol Violation|8
28459|NCT01654666|129628|P2|Overall Study|Protocol Violation|4
28460|NCT01654666|129629|P1|Overall Study|Protocol Violation|7
28461|NCT01654601|129654|P2|2nd Administration|Protocol Violation|1
28462|NCT01654601|129655|P1|2nd Administration|Protocol Violation|0
28463|NCT01654601|129654|P2|2nd Administration|Adverse Event|0
28464|NCT01654601|129655|P1|2nd Administration|Adverse Event|1
28465|NCT01654601|129654|P2|1st Administration|Protocol Violation|2
28466|NCT01654601|129655|P1|1st Administration|Protocol Violation|0
28467|NCT01654601|129654|P2|1st Administration|Withdrawal by Subject|0
28468|NCT01654601|129655|P1|1st Administration|Withdrawal by Subject|2
28469|NCT01654549|129669|P2|Overall Study|H.pylori eradication not successful|1
28470|NCT01654549|129670|P1|Overall Study|H.pylori eradication not successful|0
28471|NCT01654536|129682|P2|Overall Study|Withdrawal by Subject|25
28472|NCT01654536|129683|P1|Overall Study|Withdrawal by Subject|27
28473|NCT01654536|129682|P2|Overall Study|Physician Decision|8
28474|NCT01654536|129683|P1|Overall Study|Physician Decision|12
28475|NCT01654536|129682|P2|Overall Study|Lost to Follow-up|5
28476|NCT01654536|129683|P1|Overall Study|Lost to Follow-up|5
28477|NCT01654523|129719|P1|Overall Study|Withdrawal by Subject|1
28478|NCT01654302|129725|P2|Second Intervention (Day 7)|Lost to Follow-up|1
28479|NCT01654302|129726|P1|Second Intervention (Day 7)|Lost to Follow-up|1
28480|NCT01654276|129732|P1|Overall Study|Withdrawal by Subject|1
28481|NCT01654276|129732|P1|Overall Study|Lost to Follow-up|4
28482|NCT01654276|129732|P1|Overall Study|Lack of Efficacy|1
28483|NCT01654250|129786|P2|Overall Study|Lost to Follow-up|0
28484|NCT01654250|129787|P1|Overall Study|Lost to Follow-up|1
28485|NCT01654224|129804|P2|Overall Study|Insufficient blood sample|2
28486|NCT01654224|129805|P1|Overall Study|Insufficient blood sample|3
28487|NCT01654224|129804|P2|Overall Study|Did not receive allocation|8
28488|NCT01654224|129805|P1|Overall Study|Did not receive allocation|1
28489|NCT01654224|129804|P2|Overall Study|Lost to Follow-up|2
28490|NCT01654224|129805|P1|Overall Study|Lost to Follow-up|2
28491|NCT01653782|129827|P3|Overall Study|Lost to Follow-up|2
28492|NCT01653782|129828|P2|Overall Study|Lost to Follow-up|3
28493|NCT01653782|129829|P1|Overall Study|Lost to Follow-up|7
28494|NCT01653782|129827|P3|Overall Study|Withdrawal by Subject|4
28495|NCT01653782|129828|P2|Overall Study|Withdrawal by Subject|15
28496|NCT01653782|129829|P1|Overall Study|Withdrawal by Subject|9
28497|NCT01653743|129839|P2|Overall Study|Investigator discretion|0
28498|NCT01653743|129840|P1|Overall Study|Investigator discretion|3
28499|NCT01653743|129839|P2|Overall Study|Withdrawal by Subject|0
28500|NCT01653743|129840|P1|Overall Study|Withdrawal by Subject|1
28501|NCT01653262|129887|P1|Overall Study|AE, non-serious non-fatal|1
28502|NCT01653262|129887|P1|Overall Study|SAE, non-fatal|1
28503|NCT01653262|129887|P1|Overall Study|Lack of Efficacy|1
28504|NCT01653158|129900|P8|Overall Study|Withdrawal by Subject|0
28505|NCT01653158|129901|P7|Overall Study|Withdrawal by Subject|0
28506|NCT01653158|129902|P6|Overall Study|Withdrawal by Subject|0
28507|NCT01653158|129903|P5|Overall Study|Withdrawal by Subject|0
28508|NCT01653158|129904|P4|Overall Study|Withdrawal by Subject|0
28509|NCT01653158|129905|P3|Overall Study|Withdrawal by Subject|0
28510|NCT01653158|129906|P2|Overall Study|Withdrawal by Subject|0
28511|NCT01653158|129907|P1|Overall Study|Withdrawal by Subject|1
28512|NCT01653158|129900|P8|Overall Study|Progressive disease|9
28513|NCT01653158|129901|P7|Overall Study|Progressive disease|2
28514|NCT01653158|129902|P6|Overall Study|Progressive disease|1
28515|NCT01653158|129903|P5|Overall Study|Progressive disease|1
28516|NCT01653158|129904|P4|Overall Study|Progressive disease|0
28517|NCT01653158|129905|P3|Overall Study|Progressive disease|0
28518|NCT01653158|129906|P2|Overall Study|Progressive disease|0
28519|NCT01653158|129907|P1|Overall Study|Progressive disease|0
28520|NCT01653158|129900|P8|Overall Study|Unspecified|1
28521|NCT01653158|129901|P7|Overall Study|Unspecified|0
28522|NCT01653158|129902|P6|Overall Study|Unspecified|0
28523|NCT01653158|129903|P5|Overall Study|Unspecified|0
28524|NCT01653158|129904|P4|Overall Study|Unspecified|0
28525|NCT01653158|129905|P3|Overall Study|Unspecified|0
28526|NCT01653158|129906|P2|Overall Study|Unspecified|0
28527|NCT01653158|129907|P1|Overall Study|Unspecified|0
28528|NCT01653158|129900|P8|Overall Study|Adverse Event|3
28529|NCT01653158|129901|P7|Overall Study|Adverse Event|0
28530|NCT01653158|129902|P6|Overall Study|Adverse Event|0
28531|NCT01653158|129903|P5|Overall Study|Adverse Event|0
28532|NCT01653158|129904|P4|Overall Study|Adverse Event|1
28533|NCT01653158|129905|P3|Overall Study|Adverse Event|0
28534|NCT01653158|129906|P2|Overall Study|Adverse Event|0
28535|NCT01653158|129907|P1|Overall Study|Adverse Event|0
28536|NCT01653158|129900|P8|Overall Study|Death|2
28537|NCT01653158|129901|P7|Overall Study|Death|0
28538|NCT01653158|129902|P6|Overall Study|Death|0
28539|NCT01653158|129903|P5|Overall Study|Death|0
28540|NCT01653158|129904|P4|Overall Study|Death|1
28541|NCT01653158|129905|P3|Overall Study|Death|0
28542|NCT01653158|129906|P2|Overall Study|Death|0
28543|NCT01653158|129907|P1|Overall Study|Death|0
28544|NCT01653132|130179|P2|First Intervention|Protocol Violation|0
28545|NCT01653132|130180|P1|First Intervention|Protocol Violation|1
28546|NCT01652885|130230|P1|Overall Study|Adverse Event|1
28547|NCT01652729|130258|P3|Overall Study|Administrative|0
28548|NCT01652729|130259|P2|Overall Study|Administrative|0
28549|NCT01652729|130260|P1|Overall Study|Administrative|1
28550|NCT01652729|130258|P3|Overall Study|Lost to Follow-up|3
28551|NCT01652729|130259|P2|Overall Study|Lost to Follow-up|6
28552|NCT01652729|130260|P1|Overall Study|Lost to Follow-up|6
28553|NCT01652729|130258|P3|Overall Study|Protocol Violation|0
28554|NCT01652729|130259|P2|Overall Study|Protocol Violation|0
28555|NCT01652729|130260|P1|Overall Study|Protocol Violation|1
28556|NCT01652729|130258|P3|Overall Study|Physician Decision|1
28557|NCT01652729|130259|P2|Overall Study|Physician Decision|0
28558|NCT01652729|130260|P1|Overall Study|Physician Decision|1
28559|NCT01652729|130258|P3|Overall Study|Adverse Event|3
28560|NCT01652729|130259|P2|Overall Study|Adverse Event|0
28561|NCT01652729|130260|P1|Overall Study|Adverse Event|4
28562|NCT01652729|130258|P3|Overall Study|Withdrawal by Subject|7
28563|NCT01652729|130259|P2|Overall Study|Withdrawal by Subject|7
28564|NCT01652729|130260|P1|Overall Study|Withdrawal by Subject|14
28565|NCT01652716|130282|P2|Overall Study|Withdrawal by Subject|18
28566|NCT01652716|130283|P1|Overall Study|Withdrawal by Subject|33
28567|NCT01652716|130282|P2|Overall Study|Adverse Event|10
28568|NCT01652716|130283|P1|Overall Study|Adverse Event|7
28569|NCT01652716|130282|P2|Overall Study|Protocol Violation|1
28570|NCT01652716|130283|P1|Overall Study|Protocol Violation|2
28571|NCT01652716|130282|P2|Overall Study|Lost to Follow-up|11
28572|NCT01652716|130283|P1|Overall Study|Lost to Follow-up|12
28573|NCT01652716|130282|P2|Overall Study|Investigator decision|4
28574|NCT01652716|130283|P1|Overall Study|Investigator decision|1
28575|NCT01652716|130282|P2|Overall Study|Administrative|2
28576|NCT01652716|130283|P1|Overall Study|Administrative|0
28577|NCT01652716|130282|P2|Overall Study|Loss of glucose control|0
28578|NCT01652716|130283|P1|Overall Study|Loss of glucose control|1
28579|NCT01652703|130303|P6|Overall Study|Other|1
28580|NCT01652703|130304|P5|Overall Study|Other|1
28581|NCT01652703|130305|P4|Overall Study|Other|1
28582|NCT01652703|130306|P3|Overall Study|Other|0
28583|NCT01652703|130307|P2|Overall Study|Other|0
28584|NCT01652703|130308|P1|Overall Study|Other|0
28585|NCT01652703|130303|P6|Overall Study|Withdrawal by Subject|1
28586|NCT01652703|130304|P5|Overall Study|Withdrawal by Subject|0
28587|NCT01652703|130305|P4|Overall Study|Withdrawal by Subject|1
28588|NCT01652703|130306|P3|Overall Study|Withdrawal by Subject|3
28589|NCT01652703|130307|P2|Overall Study|Withdrawal by Subject|1
28590|NCT01652703|130308|P1|Overall Study|Withdrawal by Subject|0
28591|NCT01652690|130366|P2|Overall Study|Death|2
28592|NCT01652690|130367|P1|Overall Study|Death|5
28593|NCT01652690|130366|P2|Overall Study|Lost to Follow-up|6
28594|NCT01652690|130367|P1|Overall Study|Lost to Follow-up|6
28595|NCT01652690|130366|P2|Overall Study|Other|9
28596|NCT01652690|130367|P1|Overall Study|Other|8
28597|NCT01652690|130366|P2|Overall Study|Withdrawal by Subject|4
28598|NCT01652690|130367|P1|Overall Study|Withdrawal by Subject|16
28599|NCT01652664|130401|P2|Overall Study|Inadequate IOP control|0
28600|NCT01652664|130402|P1|Overall Study|Inadequate IOP control|1
28601|NCT01652664|130401|P2|Overall Study|Treatment Failure|1
28602|NCT01652664|130402|P1|Overall Study|Treatment Failure|5
28603|NCT01652573|130411|P2|Overall Study|Adverse Event|1
28604|NCT01652573|130412|P1|Overall Study|Adverse Event|0
28605|NCT01652287|130467|P2|Overall Study|Withdrawal by Subject|0
28606|NCT01652287|130468|P1|Overall Study|Withdrawal by Subject|2
28607|NCT01651949|130488|P3|Overall Study|Withdrawal by Subject|9
28608|NCT01651949|130489|P2|Overall Study|Withdrawal by Subject|18
28609|NCT01651949|130490|P1|Overall Study|Withdrawal by Subject|17
28610|NCT01651949|130488|P3|Overall Study|Screen failure|0
28611|NCT01651949|130489|P2|Overall Study|Screen failure|2
28612|NCT01651949|130490|P1|Overall Study|Screen failure|2
28613|NCT01651949|130488|P3|Overall Study|Adverse Event|1
28614|NCT01651949|130489|P2|Overall Study|Adverse Event|2
28615|NCT01651949|130490|P1|Overall Study|Adverse Event|0
28616|NCT01651949|130488|P3|Overall Study|Physician Decision|0
28617|NCT01651949|130489|P2|Overall Study|Physician Decision|2
28618|NCT01651949|130490|P1|Overall Study|Physician Decision|0
28619|NCT01651949|130488|P3|Overall Study|Protocol Violation|1
28620|NCT01651949|130489|P2|Overall Study|Protocol Violation|2
28621|NCT01651949|130490|P1|Overall Study|Protocol Violation|0
28622|NCT01651949|130488|P3|Overall Study|Lost to Follow-up|20
28623|NCT01651949|130489|P2|Overall Study|Lost to Follow-up|56
28624|NCT01651949|130490|P1|Overall Study|Lost to Follow-up|30
28625|NCT01651949|130488|P3|Overall Study|Unknown status|0
28626|NCT01651949|130489|P2|Overall Study|Unknown status|4
28627|NCT01651949|130490|P1|Overall Study|Unknown status|4
28628|NCT01651936|130510|P3|Extension Study|Study terminated by sponsor|13
28629|NCT01651936|130511|P2|Extension Study|Study terminated by sponsor|0
28630|NCT01651936|130512|P1|Extension Study|Study terminated by sponsor|0
28631|NCT01651936|130510|P3|Extension Study|Lack of Efficacy|1
28632|NCT01651936|130511|P2|Extension Study|Lack of Efficacy|0
28633|NCT01651936|130512|P1|Extension Study|Lack of Efficacy|0
28634|NCT01651936|130510|P3|Base Study|Study terminated by sponsor|0
28635|NCT01651936|130511|P2|Base Study|Study terminated by sponsor|16
28636|NCT01651936|130512|P1|Base Study|Study terminated by sponsor|21
28637|NCT01651936|130510|P3|Base Study|Early Escape|0
28638|NCT01651936|130511|P2|Base Study|Early Escape|8
28639|NCT01651936|130512|P1|Base Study|Early Escape|2
28640|NCT01651936|130510|P3|Base Study|Withdrawal by Subject|0
28641|NCT01651936|130511|P2|Base Study|Withdrawal by Subject|1
28642|NCT01651936|130512|P1|Base Study|Withdrawal by Subject|1
28643|NCT01651936|130510|P3|Base Study|Adverse Event|0
28644|NCT01651936|130511|P2|Base Study|Adverse Event|0
28645|NCT01651936|130512|P1|Base Study|Adverse Event|3
28646|NCT01651780|130535|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
28647|NCT01651780|130536|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
28648|NCT01651780|130535|P2|Overall Study|Lost to Follow-up|2
28649|NCT01651780|130536|P1|Overall Study|Lost to Follow-up|1
28650|NCT01651780|130535|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
28651|NCT01651780|130536|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
28652|NCT01651780|130535|P2|Overall Study|Withdrawal by Subject|0
28653|NCT01651780|130536|P1|Overall Study|Withdrawal by Subject|2
28654|NCT01651780|130535|P2|Overall Study|Reason Not Specified: No 30-day visit|2
28655|NCT01651780|130536|P1|Overall Study|Reason Not Specified: No 30-day visit|2
28656|NCT01651780|130535|P2|Overall Study|Physician decision: No 30-day visit|1
28657|NCT01651780|130536|P1|Overall Study|Physician decision: No 30-day visit|2
28658|NCT01651260|130586|P1|Overall Study|unable to apply product|3
28659|NCT01651208|130593|P2|Overall Study|Lost to Follow-up|16
28660|NCT01651208|130594|P1|Overall Study|Lost to Follow-up|14
28661|NCT01651000|130611|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
28662|NCT01651000|130612|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
28663|NCT01651000|130611|P2|Overall Study|Administrative reason|0
28664|NCT01651000|130612|P1|Overall Study|Administrative reason|1
28665|NCT01651000|130611|P2|Overall Study|Physician Decision|0
28666|NCT01651000|130612|P1|Overall Study|Physician Decision|1
28667|NCT01651000|130611|P2|Overall Study|Lack of Efficacy|1
28668|NCT01651000|130612|P1|Overall Study|Lack of Efficacy|1
28669|NCT01651000|130611|P2|Overall Study|Subject noncompliance|3
28670|NCT01651000|130612|P1|Overall Study|Subject noncompliance|0
28671|NCT01651000|130611|P2|Overall Study|Withdrawal by Subject|10
28672|NCT01651000|130612|P1|Overall Study|Withdrawal by Subject|2
28673|NCT01651000|130611|P2|Overall Study|Protocol Violation|3
28674|NCT01651000|130612|P1|Overall Study|Protocol Violation|0
28675|NCT01651000|130611|P2|Overall Study|Lost to Follow-up|2
28676|NCT01651000|130612|P1|Overall Study|Lost to Follow-up|3
28677|NCT01651000|130611|P2|Overall Study|Adverse Event|8
28678|NCT01651000|130612|P1|Overall Study|Adverse Event|2
28679|NCT01650831|130624|P1|Overall Study|Screen failure|1
28680|NCT01650805|130634|P2|Overall Study|Withdrawal by Subject|0
28681|NCT01650805|130635|P1|Overall Study|Withdrawal by Subject|1
28682|NCT01650779|130645|P1|Overall Study|Withdrawal by Subject|1
28683|NCT01650519|130654|P2|Overall Study|Withdrawal by Subject|0
28684|NCT01650519|130655|P1|Overall Study|Withdrawal by Subject|1
28685|NCT01650285|130715|P1|Overall Study|Adverse Event|1
28686|NCT01650246|130719|P1|Overall Study|Lack of Efficacy|30
28687|NCT01650246|130719|P1|Overall Study|Death|1
28688|NCT01650246|130719|P1|Overall Study|Withdrawal by Subject|26
28689|NCT01650246|130719|P1|Overall Study|Lost to Follow-up|5
28690|NCT01650246|130719|P1|Overall Study|Sponsor terminated study|53
28691|NCT01650246|130719|P1|Overall Study|Protocol Violation|5
28692|NCT01650246|130719|P1|Overall Study|Adverse Event|23
28693|NCT01649856|130726|P2|Overall Study|Ongoing in Follow-Up|152
28694|NCT01649856|130727|P1|Overall Study|Ongoing in Follow-Up|303
28695|NCT01649856|130726|P2|Overall Study|Not Specified|0
28696|NCT01649856|130727|P1|Overall Study|Not Specified|1
28697|NCT01649856|130726|P2|Overall Study|Lack of Compliance|1
28698|NCT01649856|130727|P1|Overall Study|Lack of Compliance|0
28699|NCT01649856|130726|P2|Overall Study|Lost to Follow-up|7
28700|NCT01649856|130727|P1|Overall Study|Lost to Follow-up|9
28701|NCT01649856|130726|P2|Overall Study|Stable or Progressed Disease|3
28702|NCT01649856|130727|P1|Overall Study|Stable or Progressed Disease|5
28703|NCT01649856|130726|P2|Overall Study|Death|26
28704|NCT01649856|130727|P1|Overall Study|Death|37
28705|NCT01649856|130726|P2|Overall Study|Treatment Failure|1
28706|NCT01649856|130727|P1|Overall Study|Treatment Failure|4
28707|NCT01649856|130726|P2|Overall Study|Protocol Violation|4
28708|NCT01649856|130727|P1|Overall Study|Protocol Violation|4
28709|NCT01649856|130726|P2|Overall Study|Withdrawal by Subject|9
28710|NCT01649856|130727|P1|Overall Study|Withdrawal by Subject|6
28711|NCT01649804|130759|P1|Overall Study|Administrative/Other|8
28712|NCT01649791|130771|P1|Overall Study|Adverse Event|1
28713|NCT01649791|130771|P1|Overall Study|Disease Progression|2
28714|NCT01649557|130781|P3|Overall Study|Lack of Efficacy|0
28715|NCT01649557|130782|P2|Overall Study|Lack of Efficacy|0
28716|NCT01649557|130783|P1|Overall Study|Lack of Efficacy|5
28717|NCT01649557|130781|P3|Overall Study|Protocol deviation|0
28718|NCT01649557|130782|P2|Overall Study|Protocol deviation|2
28719|NCT01649557|130783|P1|Overall Study|Protocol deviation|0
28720|NCT01649557|130781|P3|Overall Study|Withdrawal by Subject|4
28721|NCT01649557|130782|P2|Overall Study|Withdrawal by Subject|5
28722|NCT01649557|130783|P1|Overall Study|Withdrawal by Subject|15
28723|NCT01649557|130781|P3|Overall Study|Physician Decision|1
28724|NCT01649557|130782|P2|Overall Study|Physician Decision|2
28725|NCT01649557|130783|P1|Overall Study|Physician Decision|8
28726|NCT01649557|130781|P3|Overall Study|Met withdrawal criteria|0
28727|NCT01649557|130782|P2|Overall Study|Met withdrawal criteria|0
28728|NCT01649557|130783|P1|Overall Study|Met withdrawal criteria|4
28729|NCT01649557|130781|P3|Overall Study|Adverse Event|1
28730|NCT01649557|130782|P2|Overall Study|Adverse Event|5
28731|NCT01649557|130783|P1|Overall Study|Adverse Event|7
28732|NCT01649557|130781|P3|Overall Study|Lost to Follow-up|3
28733|NCT01649557|130782|P2|Overall Study|Lost to Follow-up|0
28734|NCT01649557|130783|P1|Overall Study|Lost to Follow-up|5
28735|NCT01649297|130845|P5|Overall Study|For other reason|0
28736|NCT01649297|130846|P4|Overall Study|For other reason|0
28737|NCT01649297|130847|P3|Overall Study|For other reason|2
28738|NCT01649297|130848|P2|Overall Study|For other reason|1
28739|NCT01649297|130849|P1|Overall Study|For other reason|4
28740|NCT01649297|130845|P5|Overall Study|Patient withdrawal (not due to AE)|1
28741|NCT01649297|130846|P4|Overall Study|Patient withdrawal (not due to AE)|1
28742|NCT01649297|130847|P3|Overall Study|Patient withdrawal (not due to AE)|4
28743|NCT01649297|130848|P2|Overall Study|Patient withdrawal (not due to AE)|6
28744|NCT01649297|130849|P1|Overall Study|Patient withdrawal (not due to AE)|3
28745|NCT01649297|130845|P5|Overall Study|Lost to Follow-up|0
28746|NCT01649297|130846|P4|Overall Study|Lost to Follow-up|3
28747|NCT01649297|130847|P3|Overall Study|Lost to Follow-up|4
28748|NCT01649297|130848|P2|Overall Study|Lost to Follow-up|1
28749|NCT01649297|130849|P1|Overall Study|Lost to Follow-up|1
28750|NCT01649297|130845|P5|Overall Study|Non compliant with Protocol|1
28751|NCT01649297|130846|P4|Overall Study|Non compliant with Protocol|2
28752|NCT01649297|130847|P3|Overall Study|Non compliant with Protocol|3
28753|NCT01649297|130848|P2|Overall Study|Non compliant with Protocol|0
28754|NCT01649297|130849|P1|Overall Study|Non compliant with Protocol|1
28755|NCT01649297|130845|P5|Overall Study|Lack of Efficacy|1
28756|NCT01649297|130846|P4|Overall Study|Lack of Efficacy|0
28757|NCT01649297|130847|P3|Overall Study|Lack of Efficacy|0
28758|NCT01649297|130848|P2|Overall Study|Lack of Efficacy|0
28759|NCT01649297|130849|P1|Overall Study|Lack of Efficacy|0
28760|NCT01649297|130845|P5|Overall Study|Adverse Event|1
28761|NCT01649297|130846|P4|Overall Study|Adverse Event|13
28762|NCT01649297|130847|P3|Overall Study|Adverse Event|4
28763|NCT01649297|130848|P2|Overall Study|Adverse Event|5
28764|NCT01649297|130849|P1|Overall Study|Adverse Event|5
28765|NCT01649232|130868|P2|Overall Study|Physician Decision|0
28766|NCT01649232|130869|P1|Overall Study|Physician Decision|2
28767|NCT01648790|130921|P5|Treatment 3|Withdrawal by Subject|0
28768|NCT01648790|130922|P4|Treatment 3|Withdrawal by Subject|1
28769|NCT01648790|130923|P3|Treatment 3|Withdrawal by Subject|0
28770|NCT01648790|130924|P2|Treatment 3|Withdrawal by Subject|0
28771|NCT01648790|130925|P1|Treatment 3|Withdrawal by Subject|0
28772|NCT01648699|130946|P1|Overall Study|Unspecified/unable to complete 4 visits|2
28773|NCT01648699|130946|P1|Overall Study|Lost to Follow-up|2
28774|NCT01648699|130946|P1|Overall Study|Death|1
28775|NCT01647542|130975|P3|Overall Study|Death|1
28776|NCT01647542|130976|P2|Overall Study|Death|0
28777|NCT01647542|130977|P1|Overall Study|Death|0
28778|NCT01647542|130975|P3|Overall Study|Lack of Efficacy|0
28779|NCT01647542|130976|P2|Overall Study|Lack of Efficacy|1
28780|NCT01647542|130977|P1|Overall Study|Lack of Efficacy|1
28781|NCT01647542|130975|P3|Overall Study|Study Termination|65
28782|NCT01647542|130976|P2|Overall Study|Study Termination|61
28783|NCT01647542|130977|P1|Overall Study|Study Termination|64
28784|NCT01647542|130975|P3|Overall Study|Withdrawal by Subject|0
28785|NCT01647542|130976|P2|Overall Study|Withdrawal by Subject|4
28786|NCT01647542|130977|P1|Overall Study|Withdrawal by Subject|6
28787|NCT01647542|130975|P3|Overall Study|Lost to Follow-up|2
28788|NCT01647542|130976|P2|Overall Study|Lost to Follow-up|2
28789|NCT01647542|130977|P1|Overall Study|Lost to Follow-up|0
28790|NCT01647542|130975|P3|Overall Study|Adverse Event|4
28791|NCT01647542|130976|P2|Overall Study|Adverse Event|5
28792|NCT01647542|130977|P1|Overall Study|Adverse Event|4
28793|NCT01647542|130975|P3|Overall Study|Major Protocol Deviation|0
28794|NCT01647542|130976|P2|Overall Study|Major Protocol Deviation|0
28795|NCT01647542|130977|P1|Overall Study|Major Protocol Deviation|1
28796|NCT01648582|130997|P3|Overall Study|Sponsor Decision|1
28797|NCT01648582|130998|P2|Overall Study|Sponsor Decision|1
28798|NCT01648582|130999|P1|Overall Study|Sponsor Decision|0
28799|NCT01648582|130997|P3|Overall Study|Death|0
28800|NCT01648582|130998|P2|Overall Study|Death|0
28801|NCT01648582|130999|P1|Overall Study|Death|1
28802|NCT01648582|130997|P3|Overall Study|Physician Decision|3
28803|NCT01648582|130998|P2|Overall Study|Physician Decision|1
28804|NCT01648582|130999|P1|Overall Study|Physician Decision|0
28805|NCT01648582|130997|P3|Overall Study|Withdrawal by Subject|17
28806|NCT01648582|130998|P2|Overall Study|Withdrawal by Subject|17
28807|NCT01648582|130999|P1|Overall Study|Withdrawal by Subject|15
28808|NCT01648582|130997|P3|Overall Study|Protocol Violation|1
28809|NCT01648582|130998|P2|Overall Study|Protocol Violation|2
28810|NCT01648582|130999|P1|Overall Study|Protocol Violation|1
28811|NCT01648582|130997|P3|Overall Study|Lost to Follow-up|8
28812|NCT01648582|130998|P2|Overall Study|Lost to Follow-up|6
28813|NCT01648582|130999|P1|Overall Study|Lost to Follow-up|9
28814|NCT01648582|130997|P3|Overall Study|Adverse Event|2
28815|NCT01648582|130998|P2|Overall Study|Adverse Event|11
28816|NCT01648582|130999|P1|Overall Study|Adverse Event|6
28817|NCT01648140|131103|P4|Overall Study|Lost to Follow-up|0
28818|NCT01648140|131104|P3|Overall Study|Lost to Follow-up|2
28819|NCT01648140|131105|P2|Overall Study|Lost to Follow-up|1
28820|NCT01648140|131106|P1|Overall Study|Lost to Follow-up|2
28821|NCT01648140|131103|P4|Overall Study|Withdrawal by Subject|2
28822|NCT01648140|131104|P3|Overall Study|Withdrawal by Subject|3
28823|NCT01648140|131105|P2|Overall Study|Withdrawal by Subject|3
28824|NCT01648140|131106|P1|Overall Study|Withdrawal by Subject|2
28825|NCT01648140|131103|P4|Overall Study|Adverse Event|0
28826|NCT01648140|131104|P3|Overall Study|Adverse Event|2
28827|NCT01648140|131105|P2|Overall Study|Adverse Event|1
28828|NCT01648140|131106|P1|Overall Study|Adverse Event|3
28829|NCT01648140|131103|P4|Overall Study|Lack of Efficacy|0
28830|NCT01648140|131104|P3|Overall Study|Lack of Efficacy|1
28831|NCT01648140|131105|P2|Overall Study|Lack of Efficacy|7
28832|NCT01648140|131106|P1|Overall Study|Lack of Efficacy|4
28833|NCT01648140|131103|P4|Overall Study|Physician Decision|0
28834|NCT01648140|131104|P3|Overall Study|Physician Decision|0
28835|NCT01648140|131105|P2|Overall Study|Physician Decision|0
28836|NCT01648140|131106|P1|Overall Study|Physician Decision|1
28837|NCT01648101|131271|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
28838|NCT01648101|131272|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
28839|NCT01648101|131273|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
28840|NCT01648101|131271|P3|Transition Phase (4 Weeks)|Study Terminated|0
28841|NCT01648101|131272|P2|Transition Phase (4 Weeks)|Study Terminated|0
28842|NCT01648101|131273|P1|Transition Phase (4 Weeks)|Study Terminated|1
28843|NCT01648101|131271|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
28844|NCT01648101|131272|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
28845|NCT01648101|131273|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
28846|NCT01648101|131271|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
28847|NCT01648101|131272|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
28848|NCT01648101|131273|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
28849|NCT01648101|131271|P3|Transition Phase (4 Weeks)|Adverse Event|2
28850|NCT01648101|131272|P2|Transition Phase (4 Weeks)|Adverse Event|3
28851|NCT01648101|131273|P1|Transition Phase (4 Weeks)|Adverse Event|4
28852|NCT01648101|131271|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
28853|NCT01648101|131272|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
28854|NCT01648101|131273|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
28855|NCT01648101|131271|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
28856|NCT01648101|131272|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
28857|NCT01648101|131273|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
28858|NCT01648101|131271|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
28859|NCT01648101|131272|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
28860|NCT01648101|131273|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
28861|NCT01648101|131271|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
28862|NCT01648101|131272|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
28863|NCT01648101|131273|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
28864|NCT01648101|131271|P3|Titration Phase (4 Weeks)|Adverse Event|3
28865|NCT01648101|131272|P2|Titration Phase (4 Weeks)|Adverse Event|2
28866|NCT01648101|131273|P1|Titration Phase (4 Weeks)|Adverse Event|0
28867|NCT01648101|131271|P3|Titration Phase (4 Weeks)|Protocol Violation|2
28868|NCT01648101|131272|P2|Titration Phase (4 Weeks)|Protocol Violation|1
28869|NCT01648101|131273|P1|Titration Phase (4 Weeks)|Protocol Violation|2
28870|NCT01647711|131360|P5|Overall Study|Other reason not defined|0
28871|NCT01647711|131361|P4|Overall Study|Other reason not defined|1
28872|NCT01647711|131362|P3|Overall Study|Other reason not defined|1
28873|NCT01647711|131363|P2|Overall Study|Other reason not defined|1
28874|NCT01647711|131364|P1|Overall Study|Other reason not defined|0
28875|NCT01647711|131360|P5|Overall Study|Refused to continue taking medication|1
28876|NCT01647711|131361|P4|Overall Study|Refused to continue taking medication|2
28877|NCT01647711|131362|P3|Overall Study|Refused to continue taking medication|0
28878|NCT01647711|131363|P2|Overall Study|Refused to continue taking medication|0
28879|NCT01647711|131364|P1|Overall Study|Refused to continue taking medication|0
28880|NCT01647711|131360|P5|Overall Study|Protocol Violation|1
28881|NCT01647711|131361|P4|Overall Study|Protocol Violation|0
28882|NCT01647711|131362|P3|Overall Study|Protocol Violation|0
28883|NCT01647711|131363|P2|Overall Study|Protocol Violation|0
28884|NCT01647711|131364|P1|Overall Study|Protocol Violation|0
28885|NCT01647711|131360|P5|Overall Study|Other adverse event|2
28886|NCT01647711|131361|P4|Overall Study|Other adverse event|0
28887|NCT01647711|131362|P3|Overall Study|Other adverse event|2
28888|NCT01647711|131363|P2|Overall Study|Other adverse event|0
28889|NCT01647711|131364|P1|Overall Study|Other adverse event|0
28890|NCT01647711|131360|P5|Overall Study|Progressive disease|2
28891|NCT01647711|131361|P4|Overall Study|Progressive disease|8
28892|NCT01647711|131362|P3|Overall Study|Progressive disease|6
28893|NCT01647711|131363|P2|Overall Study|Progressive disease|2
28894|NCT01647711|131364|P1|Overall Study|Progressive disease|6
28895|NCT01646827|131417|P2|Overall Study|Withdrawal by Subject|0
28896|NCT01646827|131418|P1|Overall Study|Withdrawal by Subject|1
28897|NCT01646827|131417|P2|Overall Study|Physician Decision|2
28898|NCT01646827|131418|P1|Overall Study|Physician Decision|1
28899|NCT01646827|131417|P2|Overall Study|Lost to Follow-up|3
28900|NCT01646827|131418|P1|Overall Study|Lost to Follow-up|0
28901|NCT01646398|131496|P2|Overall Study|Withdrawal by Subject|0
28902|NCT01646398|131497|P1|Overall Study|Withdrawal by Subject|1
28903|NCT01646385|131513|P2|Overall Study|Switched to alternate biologic|649
28904|NCT01646385|131514|P1|Overall Study|Switched to alternate biologic|636
28905|NCT01646385|131513|P2|Overall Study|Death|222
28906|NCT01646385|131514|P1|Overall Study|Death|202
28907|NCT01646320|131547|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
28908|NCT01646320|131548|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
28909|NCT01646320|131547|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
28910|NCT01646320|131548|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
28911|NCT01646320|131547|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
28912|NCT01646320|131548|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
28913|NCT01646320|131547|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
28914|NCT01646320|131548|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
28915|NCT01646320|131547|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
28916|NCT01646320|131548|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
28917|NCT01646320|131547|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
28918|NCT01646320|131548|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
28919|NCT01646320|131547|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
28920|NCT01646320|131548|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
28921|NCT01646320|131547|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
28922|NCT01646320|131548|P1|Short-term Period (Day 1 to Week 24)|Not specified|1
28923|NCT01646320|131547|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
28924|NCT01646320|131548|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
28925|NCT01646320|131547|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
28926|NCT01646320|131548|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
28927|NCT01646320|131547|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
28928|NCT01646320|131548|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
28929|NCT01646268|131564|P2|Overall Study|Other|0
28930|NCT01646268|131565|P1|Overall Study|Other|2
28931|NCT01646268|131564|P2|Overall Study|Withdrawal by Subject|5
28932|NCT01646268|131565|P1|Overall Study|Withdrawal by Subject|2
28933|NCT01646268|131564|P2|Overall Study|Protocol Violation|1
28934|NCT01646268|131565|P1|Overall Study|Protocol Violation|0
28935|NCT01646268|131564|P2|Overall Study|Lack of Efficacy|3
28936|NCT01646268|131565|P1|Overall Study|Lack of Efficacy|1
28937|NCT01646268|131564|P2|Overall Study|Adverse Event|7
28938|NCT01646268|131565|P1|Overall Study|Adverse Event|6
28939|NCT01646255|131579|P2|Overall Study|Inclusion Criteria Deviation|0
28940|NCT01646255|131580|P1|Overall Study|Inclusion Criteria Deviation|1
28941|NCT01646255|131579|P2|Overall Study|Compliance is not well|0
28942|NCT01646255|131580|P1|Overall Study|Compliance is not well|1
28943|NCT01646255|131579|P2|Overall Study|Withdrawal by Subject|6
28944|NCT01646255|131580|P1|Overall Study|Withdrawal by Subject|10
28945|NCT01646255|131579|P2|Overall Study|Lack of Efficacy|0
28946|NCT01646255|131580|P1|Overall Study|Lack of Efficacy|2
28947|NCT01646255|131579|P2|Overall Study|Adverse Event|8
28948|NCT01646255|131580|P1|Overall Study|Adverse Event|7
28949|NCT01646177|131614|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
28950|NCT01646177|131615|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
28951|NCT01646177|131616|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
28952|NCT01646177|131617|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
28953|NCT01646177|131614|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
28954|NCT01646177|131615|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
28955|NCT01646177|131616|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
28956|NCT01646177|131617|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
28957|NCT01646177|131614|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
28958|NCT01646177|131615|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
28959|NCT01646177|131616|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
28960|NCT01646177|131617|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
28961|NCT01646177|131614|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
28962|NCT01646177|131615|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
28963|NCT01646177|131616|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
28964|NCT01646177|131617|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
28965|NCT01646177|131614|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
28966|NCT01646177|131615|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
28967|NCT01646177|131616|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
28968|NCT01646177|131617|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
28969|NCT01646177|131614|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
28970|NCT01646177|131615|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
28971|NCT01646177|131616|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
28972|NCT01646177|131617|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
28973|NCT01646138|131711|P5|Overall Study|Lost to Follow-up|2
28974|NCT01646138|131712|P4|Overall Study|Lost to Follow-up|0
28975|NCT01646138|131713|P3|Overall Study|Lost to Follow-up|0
28976|NCT01646138|131714|P2|Overall Study|Lost to Follow-up|0
28977|NCT01646138|131715|P1|Overall Study|Lost to Follow-up|0
28978|NCT01646125|131729|P2|Overall Study|Subject/Guardian decision|1
28979|NCT01646125|131730|P1|Overall Study|Subject/Guardian decision|1
28980|NCT01646125|131729|P2|Overall Study|Study terminated by sponsor|1
28981|NCT01646125|131730|P1|Overall Study|Study terminated by sponsor|2
28982|NCT01646125|131729|P2|Overall Study|Progressive disease|16
28983|NCT01646125|131730|P1|Overall Study|Progressive disease|22
28984|NCT01646125|131729|P2|Overall Study|Physician Decision|3
28985|NCT01646125|131730|P1|Overall Study|Physician Decision|1
28986|NCT01646125|131729|P2|Overall Study|Death|1
28987|NCT01646125|131730|P1|Overall Study|Death|1
28988|NCT01646125|131729|P2|Overall Study|Adverse Event|1
28989|NCT01646125|131730|P1|Overall Study|Adverse Event|2
28990|NCT01646125|131729|P2|Overall Study|Untreated|5
28991|NCT01646125|131730|P1|Overall Study|Untreated|2
28992|NCT01646073|131755|P2|Period B (12 Weeks)|Lost to Follow-up|1
28993|NCT01646073|131756|P1|Period B (12 Weeks)|Lost to Follow-up|0
28994|NCT01646073|131755|P2|Period B (12 Weeks)|Withdrawal by Subject|5
28995|NCT01646073|131756|P1|Period B (12 Weeks)|Withdrawal by Subject|1
28996|NCT01646073|131755|P2|Period B (12 Weeks)|Adverse Event|7
28997|NCT01646073|131756|P1|Period B (12 Weeks)|Adverse Event|0
28998|NCT01646073|131755|P2|Period A (12 Weeks)|Not Specified|1
28999|NCT01646073|131756|P1|Period A (12 Weeks)|Not Specified|0
29000|NCT01646073|131755|P2|Period A (12 Weeks)|Protocol Violation|1
29001|NCT01646073|131756|P1|Period A (12 Weeks)|Protocol Violation|0
29002|NCT01646073|131755|P2|Period A (12 Weeks)|Lack of Efficacy|0
29003|NCT01646073|131756|P1|Period A (12 Weeks)|Lack of Efficacy|1
29004|NCT01646073|131755|P2|Period A (12 Weeks)|Withdrawal by Subject|1
29005|NCT01646073|131756|P1|Period A (12 Weeks)|Withdrawal by Subject|1
29006|NCT01646073|131755|P2|Period A (12 Weeks)|Adverse Event|2
29007|NCT01646073|131756|P1|Period A (12 Weeks)|Adverse Event|0
29008|NCT01646021|131797|P2|Overall Study|Withdrawal by Subject|13
29009|NCT01646021|131798|P1|Overall Study|Withdrawal by Subject|6
29010|NCT01646021|131797|P2|Overall Study|Lost to Follow-up|2
29011|NCT01646021|131798|P1|Overall Study|Lost to Follow-up|1
29012|NCT01646021|131797|P2|Overall Study|Death|63
29013|NCT01646021|131798|P1|Overall Study|Death|59
29014|NCT01645735|131831|P2|Overall Study|Adverse Event|1
29015|NCT01645735|131832|P1|Overall Study|Adverse Event|0
29016|NCT01645735|131831|P2|Overall Study|Protocol Violation|0
29017|NCT01645735|131832|P1|Overall Study|Protocol Violation|1
29018|NCT01645735|131831|P2|Overall Study|Withdrawal by Subject|0
29019|NCT01645735|131832|P1|Overall Study|Withdrawal by Subject|1
29020|NCT01645735|131831|P2|Overall Study|Physician Decision|0
29021|NCT01645735|131832|P1|Overall Study|Physician Decision|2
29022|NCT01645280|131874|P5|Overall Study|Treatment not completed/Completed f/u|2
29023|NCT01645280|131875|P4|Overall Study|Treatment not completed/Completed f/u|0
29024|NCT01645280|131876|P3|Overall Study|Treatment not completed/Completed f/u|2
29025|NCT01645280|131877|P2|Overall Study|Treatment not completed/Completed f/u|1
29026|NCT01645280|131878|P1|Overall Study|Treatment not completed/Completed f/u|1
29027|NCT01645280|131874|P5|Overall Study|Unspecified|0
29028|NCT01645280|131875|P4|Overall Study|Unspecified|0
29029|NCT01645280|131876|P3|Overall Study|Unspecified|2
29030|NCT01645280|131877|P2|Overall Study|Unspecified|1
29031|NCT01645280|131878|P1|Overall Study|Unspecified|1
29032|NCT01645280|131874|P5|Overall Study|Lost to Follow-up|1
29033|NCT01645280|131875|P4|Overall Study|Lost to Follow-up|2
29034|NCT01645280|131876|P3|Overall Study|Lost to Follow-up|0
29035|NCT01645280|131877|P2|Overall Study|Lost to Follow-up|0
29036|NCT01645280|131878|P1|Overall Study|Lost to Follow-up|0
29037|NCT01645280|131874|P5|Overall Study|Withdrawal by Subject|5
29038|NCT01645280|131875|P4|Overall Study|Withdrawal by Subject|4
29039|NCT01645280|131876|P3|Overall Study|Withdrawal by Subject|2
29040|NCT01645280|131877|P2|Overall Study|Withdrawal by Subject|0
29041|NCT01645280|131878|P1|Overall Study|Withdrawal by Subject|4
29042|NCT01645280|131874|P5|Overall Study|Death|0
29043|NCT01645280|131875|P4|Overall Study|Death|0
29044|NCT01645280|131876|P3|Overall Study|Death|0
29045|NCT01645280|131877|P2|Overall Study|Death|1
29046|NCT01645280|131878|P1|Overall Study|Death|0
29047|NCT01645176|131906|P1|Overall Study|did not complete final MRI|1
29048|NCT01645176|131906|P1|Overall Study|Lack of Efficacy|4
29049|NCT01645111|131910|P1|Overall Study|Did not require Clevidipine|15
29050|NCT01644734|131949|P1|Overall Study|Missing documentation|238
29051|NCT01644734|131949|P1|Overall Study|Reasons other than stated above|7
29052|NCT01644734|131949|P1|Overall Study|Lost to Follow-up|17
29053|NCT01644734|131949|P1|Overall Study|Adverse Event|4
29054|NCT01644643|131963|P4|Overall Study|Other Eligibility criteria|2
29055|NCT01644643|131964|P3|Overall Study|Other Eligibility criteria|0
29056|NCT01644643|131965|P2|Overall Study|Other Eligibility criteria|0
29057|NCT01644643|131966|P1|Overall Study|Other Eligibility criteria|0
29058|NCT01644643|131963|P4|Overall Study|Withdrawal by Subject|1
29059|NCT01644643|131964|P3|Overall Study|Withdrawal by Subject|2
29060|NCT01644643|131965|P2|Overall Study|Withdrawal by Subject|0
29061|NCT01644643|131966|P1|Overall Study|Withdrawal by Subject|1
29062|NCT01644643|131963|P4|Overall Study|Lost to Follow-up|4
29063|NCT01644643|131964|P3|Overall Study|Lost to Follow-up|0
29064|NCT01644643|131965|P2|Overall Study|Lost to Follow-up|0
29065|NCT01644643|131966|P1|Overall Study|Lost to Follow-up|0
29066|NCT01644643|131963|P4|Overall Study|Death|3
29067|NCT01644643|131964|P3|Overall Study|Death|3
29068|NCT01644643|131965|P2|Overall Study|Death|0
29069|NCT01644643|131966|P1|Overall Study|Death|1
29070|NCT01644617|132131|P3|Overall Study|Adverse Event|6
29071|NCT01644617|132132|P2|Overall Study|Adverse Event|0
29072|NCT01644617|132133|P1|Overall Study|Adverse Event|3
29073|NCT01644617|132131|P3|Overall Study|Lost to Follow-up|0
29074|NCT01644617|132132|P2|Overall Study|Lost to Follow-up|1
29075|NCT01644617|132133|P1|Overall Study|Lost to Follow-up|0
29076|NCT01644617|132131|P3|Overall Study|Withdrawal by Subject|1
29077|NCT01644617|132132|P2|Overall Study|Withdrawal by Subject|4
29078|NCT01644617|132133|P1|Overall Study|Withdrawal by Subject|3
29079|NCT01644500|132190|P3|Overall Study|Lost to Follow-up|2
29080|NCT01644500|132191|P2|Overall Study|Lost to Follow-up|11
29081|NCT01644500|132192|P1|Overall Study|Lost to Follow-up|4
29082|NCT01644500|132190|P3|Overall Study|Sponsor Decision|1
29083|NCT01644500|132191|P2|Overall Study|Sponsor Decision|0
29084|NCT01644500|132192|P1|Overall Study|Sponsor Decision|0
29085|NCT01644500|132190|P3|Overall Study|Physician Decision|1
29086|NCT01644500|132191|P2|Overall Study|Physician Decision|1
29087|NCT01644500|132192|P1|Overall Study|Physician Decision|1
29088|NCT01644500|132190|P3|Overall Study|Withdrawal by Subject|12
29089|NCT01644500|132191|P2|Overall Study|Withdrawal by Subject|13
29090|NCT01644500|132192|P1|Overall Study|Withdrawal by Subject|11
29091|NCT01644500|132190|P3|Overall Study|Protocol Violation|0
29092|NCT01644500|132191|P2|Overall Study|Protocol Violation|1
29093|NCT01644500|132192|P1|Overall Study|Protocol Violation|1
29094|NCT01644500|132190|P3|Overall Study|Death|0
29095|NCT01644500|132191|P2|Overall Study|Death|1
29096|NCT01644500|132192|P1|Overall Study|Death|0
29097|NCT01644500|132190|P3|Overall Study|Adverse Event|2
29098|NCT01644500|132191|P2|Overall Study|Adverse Event|1
29099|NCT01644500|132192|P1|Overall Study|Adverse Event|7
29100|NCT01644474|132262|P2|Overall Study|Protocol Violation|0
29101|NCT01644474|132263|P1|Overall Study|Protocol Violation|1
29102|NCT01644474|132262|P2|Overall Study|Site scheduling error|1
29103|NCT01644474|132263|P1|Overall Study|Site scheduling error|1
29104|NCT01644474|132262|P2|Overall Study|Adverse Event|5
29105|NCT01644474|132263|P1|Overall Study|Adverse Event|4
29106|NCT01644474|132262|P2|Overall Study|Participant moved|1
29107|NCT01644474|132263|P1|Overall Study|Participant moved|0
29108|NCT01644474|132262|P2|Overall Study|Consent withdrawn by participant|1
29109|NCT01644474|132263|P1|Overall Study|Consent withdrawn by participant|0
29110|NCT01644474|132262|P2|Overall Study|Poor compliance to protocol|0
29111|NCT01644474|132263|P1|Overall Study|Poor compliance to protocol|1
29112|NCT01644188|132447|P2|Overall Study|Other than specified above|7
29113|NCT01644188|132448|P1|Overall Study|Other than specified above|6
29114|NCT01644188|132447|P2|Overall Study|Site closure|1
29115|NCT01644188|132448|P1|Overall Study|Site closure|1
29116|NCT01644188|132447|P2|Overall Study|Last visit outside protocol visit window|16
29117|NCT01644188|132448|P1|Overall Study|Last visit outside protocol visit window|14
29118|NCT01644188|132447|P2|Overall Study|Death|3
29119|NCT01644188|132448|P1|Overall Study|Death|4
29120|NCT01644188|132447|P2|Overall Study|Lost to Follow-up|0
29121|NCT01644188|132448|P1|Overall Study|Lost to Follow-up|1
29122|NCT01644188|132447|P2|Overall Study|Selection criteria finally not met|0
29123|NCT01644188|132448|P1|Overall Study|Selection criteria finally not met|2
29124|NCT01644188|132447|P2|Overall Study|Consent withdrawn by participant|7
29125|NCT01644188|132448|P1|Overall Study|Consent withdrawn by participant|14
29126|NCT01644188|132447|P2|Overall Study|Related to auto-injector administration|2
29127|NCT01644188|132448|P1|Overall Study|Related to auto-injector administration|2
29128|NCT01644188|132447|P2|Overall Study|Participant moved|2
29129|NCT01644188|132448|P1|Overall Study|Participant moved|7
29130|NCT01644188|132447|P2|Overall Study|Physician Decision|3
29131|NCT01644188|132448|P1|Overall Study|Physician Decision|1
29132|NCT01644188|132447|P2|Overall Study|Poor compliance to protocol|14
29133|NCT01644188|132448|P1|Overall Study|Poor compliance to protocol|26
29134|NCT01644188|132447|P2|Overall Study|Adverse Event|20
29135|NCT01644188|132448|P1|Overall Study|Adverse Event|44
29136|NCT01644175|132506|P2|Overall Study|Other than specified above|3
29137|NCT01644175|132507|P1|Overall Study|Other than specified above|0
29138|NCT01644175|132506|P2|Overall Study|Lost to Follow-up|0
29139|NCT01644175|132507|P1|Overall Study|Lost to Follow-up|1
29140|NCT01644175|132506|P2|Overall Study|Site closure|2
29141|NCT01644175|132507|P1|Overall Study|Site closure|2
29142|NCT01644175|132506|P2|Overall Study|Selection criteria finally not met|1
29143|NCT01644175|132507|P1|Overall Study|Selection criteria finally not met|0
29144|NCT01644175|132506|P2|Overall Study|Last visit outside protocol visit window|11
29145|NCT01644175|132507|P1|Overall Study|Last visit outside protocol visit window|4
29146|NCT01644175|132506|P2|Overall Study|Related to Autoinjector Administration|1
29147|NCT01644175|132507|P1|Overall Study|Related to Autoinjector Administration|2
29148|NCT01644175|132506|P2|Overall Study|Consent withdrawn by participant|4
29149|NCT01644175|132507|P1|Overall Study|Consent withdrawn by participant|3
29150|NCT01644175|132506|P2|Overall Study|Participant Moved|2
29151|NCT01644175|132507|P1|Overall Study|Participant Moved|1
29152|NCT01644175|132506|P2|Overall Study|Physician Decision|2
29153|NCT01644175|132507|P1|Overall Study|Physician Decision|1
29154|NCT01644175|132506|P2|Overall Study|Poor compliance to protocol|10
29155|NCT01644175|132507|P1|Overall Study|Poor compliance to protocol|9
29156|NCT01644175|132506|P2|Overall Study|Death|2
29157|NCT01644175|132507|P1|Overall Study|Death|1
29158|NCT01644175|132506|P2|Overall Study|Adverse Event|13
29159|NCT01644175|132507|P1|Overall Study|Adverse Event|8
29160|NCT01644175|132506|P2|Overall Study|Randomized But Not Treated|2
29161|NCT01644175|132507|P1|Overall Study|Randomized But Not Treated|0
29162|NCT01643928|132567|P5|Overall Study|Adverse Event|2
29163|NCT01643928|132568|P4|Overall Study|Adverse Event|1
29164|NCT01643928|132569|P3|Overall Study|Adverse Event|0
29165|NCT01643928|132570|P2|Overall Study|Adverse Event|1
29166|NCT01643928|132571|P1|Overall Study|Adverse Event|2
29167|NCT01643928|132567|P5|Overall Study|Unspecified|0
29168|NCT01643928|132568|P4|Overall Study|Unspecified|0
29169|NCT01643928|132569|P3|Overall Study|Unspecified|1
29170|NCT01643928|132570|P2|Overall Study|Unspecified|1
29171|NCT01643928|132571|P1|Overall Study|Unspecified|5
29172|NCT01643928|132567|P5|Overall Study|Pregnancy|0
29173|NCT01643928|132568|P4|Overall Study|Pregnancy|1
29174|NCT01643928|132569|P3|Overall Study|Pregnancy|0
29175|NCT01643928|132570|P2|Overall Study|Pregnancy|0
29176|NCT01643928|132571|P1|Overall Study|Pregnancy|0
29177|NCT01643928|132567|P5|Overall Study|Withdrawal by Subject|0
29178|NCT01643928|132568|P4|Overall Study|Withdrawal by Subject|1
29179|NCT01643928|132569|P3|Overall Study|Withdrawal by Subject|0
29180|NCT01643928|132570|P2|Overall Study|Withdrawal by Subject|0
29181|NCT01643928|132571|P1|Overall Study|Withdrawal by Subject|2
29182|NCT01643928|132567|P5|Overall Study|Lost to Follow-up|0
29183|NCT01643928|132568|P4|Overall Study|Lost to Follow-up|0
29184|NCT01643928|132569|P3|Overall Study|Lost to Follow-up|2
29185|NCT01643928|132570|P2|Overall Study|Lost to Follow-up|0
29186|NCT01643928|132571|P1|Overall Study|Lost to Follow-up|1
29187|NCT01643798|132866|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
29188|NCT01643798|132867|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
29189|NCT01643668|132878|P1|Overall Study|Death|1
29190|NCT01643044|132914|P2|Overall Study|Delivered outside of hospital|2
29191|NCT01643044|132915|P1|Overall Study|Delivered outside of hospital|1
29192|NCT01643044|132914|P2|Overall Study|Miscarried baby|2
29193|NCT01643044|132915|P1|Overall Study|Miscarried baby|2
29194|NCT01643044|132914|P2|Overall Study|Lost to Follow-up|1
29195|NCT01643044|132915|P1|Overall Study|Lost to Follow-up|1
29196|NCT01642914|132924|P3|Overall Study|Other Reason|0
29197|NCT01642914|132925|P2|Overall Study|Other Reason|0
29198|NCT01642914|132926|P1|Overall Study|Other Reason|1
29199|NCT01642914|132924|P3|Overall Study|Lost to Follow-up|7
29200|NCT01642914|132925|P2|Overall Study|Lost to Follow-up|3
29201|NCT01642914|132926|P1|Overall Study|Lost to Follow-up|5
29202|NCT01642914|132924|P3|Overall Study|Withdrawal by Subject|10
29203|NCT01642914|132925|P2|Overall Study|Withdrawal by Subject|5
29204|NCT01642914|132926|P1|Overall Study|Withdrawal by Subject|5
29205|NCT01642914|132924|P3|Overall Study|Protocol Violation|6
29206|NCT01642914|132925|P2|Overall Study|Protocol Violation|13
29207|NCT01642914|132926|P1|Overall Study|Protocol Violation|15
29208|NCT01642914|132924|P3|Overall Study|Lack of Efficacy|2
29209|NCT01642914|132925|P2|Overall Study|Lack of Efficacy|4
29210|NCT01642914|132926|P1|Overall Study|Lack of Efficacy|9
29211|NCT01642914|132924|P3|Overall Study|Adverse Event|15
29212|NCT01642914|132925|P2|Overall Study|Adverse Event|7
29213|NCT01642914|132926|P1|Overall Study|Adverse Event|11
29214|NCT01642732|133001|P1|Overall Study|Withdrawal by Subject|1
29215|NCT01642615|133006|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
29216|NCT01642615|133007|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
29217|NCT01642615|133008|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
29218|NCT01642615|133006|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
29219|NCT01642615|133007|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
29220|NCT01642615|133008|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
29221|NCT01642615|133006|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
29222|NCT01642615|133007|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
29223|NCT01642615|133008|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
29224|NCT01642615|133006|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
29225|NCT01642615|133007|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
29226|NCT01642615|133008|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
29227|NCT01642615|133006|P3|Open Label Maintenance Phase|Did not receive treatment|0
29228|NCT01642615|133007|P2|Open Label Maintenance Phase|Did not receive treatment|0
29229|NCT01642615|133008|P1|Open Label Maintenance Phase|Did not receive treatment|1
29230|NCT01642615|133006|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
29231|NCT01642615|133007|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
29232|NCT01642615|133008|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
29233|NCT01642615|133006|P3|Open Label Maintenance Phase|Lost to Follow-up|0
29234|NCT01642615|133007|P2|Open Label Maintenance Phase|Lost to Follow-up|0
29235|NCT01642615|133008|P1|Open Label Maintenance Phase|Lost to Follow-up|1
29236|NCT01642615|133006|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
29237|NCT01642615|133007|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
29238|NCT01642615|133008|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
29239|NCT01642615|133006|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
29240|NCT01642615|133007|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
29241|NCT01642615|133008|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
29242|NCT01642602|133022|P1|Overall Study|Adverse Event|2
29243|NCT01642589|133029|P2|Overall Study|Withdrawal by Subject|1
29244|NCT01642589|133030|P1|Overall Study|Withdrawal by Subject|1
29245|NCT01642407|133069|P1|Overall Study|Insufficient clinical response|2
29246|NCT01642277|133113|P2|Overall Study|Withdrawal by Subject|0
29247|NCT01642277|133114|P1|Overall Study|Withdrawal by Subject|11
29248|NCT01642277|133113|P2|Overall Study|Protocol Violation|0
29249|NCT01642277|133114|P1|Overall Study|Protocol Violation|1
29250|NCT01642277|133113|P2|Overall Study|Physician Decision|0
29251|NCT01642277|133114|P1|Overall Study|Physician Decision|2
29252|NCT01642277|133113|P2|Overall Study|Adverse Event|0
29253|NCT01642277|133114|P1|Overall Study|Adverse Event|10
29254|NCT01642212|133146|P5|Open-label Extension|Not Specified|1
29255|NCT01642212|133147|P4|Open-label Extension|Not Specified|0
29256|NCT01642212|133148|P3|Open-label Extension|Not Specified|0
29257|NCT01642212|133149|P2|Open-label Extension|Not Specified|0
29258|NCT01642212|133150|P1|Open-label Extension|Not Specified|0
29259|NCT01642212|133146|P5|Open-label Extension|Lost to Follow-up|1
29260|NCT01642212|133147|P4|Open-label Extension|Lost to Follow-up|0
29261|NCT01642212|133148|P3|Open-label Extension|Lost to Follow-up|0
29262|NCT01642212|133149|P2|Open-label Extension|Lost to Follow-up|0
29263|NCT01642212|133150|P1|Open-label Extension|Lost to Follow-up|0
29264|NCT01642212|133146|P5|Open-label Extension|Consent Withdrawn|2
29265|NCT01642212|133147|P4|Open-label Extension|Consent Withdrawn|0
29266|NCT01642212|133148|P3|Open-label Extension|Consent Withdrawn|0
29267|NCT01642212|133149|P2|Open-label Extension|Consent Withdrawn|0
29268|NCT01642212|133150|P1|Open-label Extension|Consent Withdrawn|0
29269|NCT01642212|133146|P5|Open-label Extension|Sponsor Decision|4
29270|NCT01642212|133147|P4|Open-label Extension|Sponsor Decision|7
29271|NCT01642212|133148|P3|Open-label Extension|Sponsor Decision|0
29272|NCT01642212|133149|P2|Open-label Extension|Sponsor Decision|0
29273|NCT01642212|133150|P1|Open-label Extension|Sponsor Decision|0
29274|NCT01642212|133146|P5|Open-label Extension|Adverse Event|0
29275|NCT01642212|133147|P4|Open-label Extension|Adverse Event|3
29276|NCT01642212|133148|P3|Open-label Extension|Adverse Event|0
29277|NCT01642212|133149|P2|Open-label Extension|Adverse Event|0
29278|NCT01642212|133150|P1|Open-label Extension|Adverse Event|0
29279|NCT01642212|133146|P5|Double-blind Treatment|Adverse Event|0
29280|NCT01642212|133147|P4|Double-blind Treatment|Adverse Event|0
29281|NCT01642212|133148|P3|Double-blind Treatment|Adverse Event|1
29282|NCT01642212|133149|P2|Double-blind Treatment|Adverse Event|0
29283|NCT01642212|133150|P1|Double-blind Treatment|Adverse Event|0
29284|NCT01642212|133146|P5|Double-blind Treatment|Non-compliance|0
29285|NCT01642212|133147|P4|Double-blind Treatment|Non-compliance|0
29286|NCT01642212|133148|P3|Double-blind Treatment|Non-compliance|0
29287|NCT01642212|133149|P2|Double-blind Treatment|Non-compliance|1
29288|NCT01642212|133150|P1|Double-blind Treatment|Non-compliance|0
29289|NCT01642212|133146|P5|Double-blind Treatment|Not Specified|0
29290|NCT01642212|133147|P4|Double-blind Treatment|Not Specified|0
29291|NCT01642212|133148|P3|Double-blind Treatment|Not Specified|1
29292|NCT01642212|133149|P2|Double-blind Treatment|Not Specified|2
29293|NCT01642212|133150|P1|Double-blind Treatment|Not Specified|0
29294|NCT01642212|133146|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
29295|NCT01642212|133147|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
29296|NCT01642212|133148|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
29297|NCT01642212|133149|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
29298|NCT01642212|133150|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
29299|NCT01642004|133239|P2|Treatment|Missing from data|1
29300|NCT01642004|133240|P1|Treatment|Missing from data|0
29301|NCT01642004|133239|P2|Treatment|Unspecified|2
29302|NCT01642004|133240|P1|Treatment|Unspecified|1
29303|NCT01642004|133239|P2|Treatment|No longer meets study criteria|2
29304|NCT01642004|133240|P1|Treatment|No longer meets study criteria|1
29305|NCT01642004|133239|P2|Treatment|Poor/non-compliance|0
29306|NCT01642004|133240|P1|Treatment|Poor/non-compliance|1
29307|NCT01642004|133239|P2|Treatment|Maximum clinical benefit|7
29308|NCT01642004|133240|P1|Treatment|Maximum clinical benefit|2
29309|NCT01642004|133239|P2|Treatment|Withdrawal by Subject|9
29310|NCT01642004|133240|P1|Treatment|Withdrawal by Subject|5
29311|NCT01642004|133239|P2|Treatment|Adverse event unrelated to study drug|13
29312|NCT01642004|133240|P1|Treatment|Adverse event unrelated to study drug|6
29313|NCT01642004|133239|P2|Treatment|Death|0
29314|NCT01642004|133240|P1|Treatment|Death|1
29315|NCT01642004|133239|P2|Treatment|Study drug toxicity|13
29316|NCT01642004|133240|P1|Treatment|Study drug toxicity|5
29317|NCT01642004|133239|P2|Treatment|Disease progression|80
29318|NCT01642004|133240|P1|Treatment|Disease progression|88
29319|NCT01642004|133239|P2|Randomization|No longer meets study criteria|2
29320|NCT01642004|133240|P1|Randomization|No longer meets study criteria|2
29321|NCT01642004|133239|P2|Randomization|Withdrawal by Subject|6
29322|NCT01642004|133240|P1|Randomization|Withdrawal by Subject|1
29323|NCT01642004|133239|P2|Randomization|Adverse Event unrelated to study drug|0
29324|NCT01642004|133240|P1|Randomization|Adverse Event unrelated to study drug|1
29325|NCT01641991|133274|P4|Overall Study|no longer eligible|4
29326|NCT01641991|133275|P3|Overall Study|no longer eligible|0
29327|NCT01641991|133276|P2|Overall Study|no longer eligible|1
29328|NCT01641991|133277|P1|Overall Study|no longer eligible|2
29329|NCT01641991|133274|P4|Overall Study|Pregnancy|0
29330|NCT01641991|133275|P3|Overall Study|Pregnancy|1
29331|NCT01641991|133276|P2|Overall Study|Pregnancy|0
29332|NCT01641991|133277|P1|Overall Study|Pregnancy|0
29333|NCT01641991|133274|P4|Overall Study|Protocol Violation|0
29334|NCT01641991|133275|P3|Overall Study|Protocol Violation|3
29335|NCT01641991|133276|P2|Overall Study|Protocol Violation|1
29336|NCT01641991|133277|P1|Overall Study|Protocol Violation|1
29337|NCT01641991|133274|P4|Overall Study|Lost to Follow-up|1
29338|NCT01641991|133275|P3|Overall Study|Lost to Follow-up|3
29339|NCT01641991|133276|P2|Overall Study|Lost to Follow-up|2
29340|NCT01641991|133277|P1|Overall Study|Lost to Follow-up|0
29341|NCT01641991|133274|P4|Overall Study|Adverse Event|1
29342|NCT01641991|133275|P3|Overall Study|Adverse Event|2
29343|NCT01641991|133276|P2|Overall Study|Adverse Event|1
29344|NCT01641991|133277|P1|Overall Study|Adverse Event|2
29345|NCT01641991|133274|P4|Overall Study|Withdrawal by Subject|5
29346|NCT01641991|133275|P3|Overall Study|Withdrawal by Subject|1
29347|NCT01641991|133276|P2|Overall Study|Withdrawal by Subject|2
29348|NCT01641991|133277|P1|Overall Study|Withdrawal by Subject|4
29349|NCT01641991|133274|P4|Overall Study|Physician Decision|5
29350|NCT01641991|133275|P3|Overall Study|Physician Decision|7
29351|NCT01641991|133276|P2|Overall Study|Physician Decision|1
29352|NCT01641991|133277|P1|Overall Study|Physician Decision|0
29353|NCT01641952|133361|P1|Overall Study|Adverse Event|6
29354|NCT01641952|133361|P1|Overall Study|Lost to Follow-up|28
29355|NCT01641939|133377|P3|Overall Study|Study Terminated by Sponsor|3
29356|NCT01641939|133378|P2|Overall Study|Study Terminated by Sponsor|28
29357|NCT01641939|133379|P1|Overall Study|Study Terminated by Sponsor|10
29358|NCT01641939|133377|P3|Overall Study|Withdrawal by Subject|5
29359|NCT01641939|133378|P2|Overall Study|Withdrawal by Subject|11
29360|NCT01641939|133379|P1|Overall Study|Withdrawal by Subject|14
29361|NCT01641939|133377|P3|Overall Study|Lost to Follow-up|1
29362|NCT01641939|133378|P2|Overall Study|Lost to Follow-up|2
29363|NCT01641939|133379|P1|Overall Study|Lost to Follow-up|3
29364|NCT01641939|133377|P3|Overall Study|Death|61
29365|NCT01641939|133378|P2|Overall Study|Death|187
29366|NCT01641939|133379|P1|Overall Study|Death|90
29367|NCT01641926|133422|P4|Overall Study|Not Treated|0
29368|NCT01641926|133423|P3|Overall Study|Not Treated|1
29369|NCT01641926|133424|P2|Overall Study|Not Treated|1
29370|NCT01641926|133425|P1|Overall Study|Not Treated|1
29371|NCT01641926|133422|P4|Overall Study|Withdrawal by Subject|1
29372|NCT01641926|133423|P3|Overall Study|Withdrawal by Subject|6
29373|NCT01641926|133424|P2|Overall Study|Withdrawal by Subject|5
29374|NCT01641926|133425|P1|Overall Study|Withdrawal by Subject|13
29375|NCT01641926|133422|P4|Overall Study|Protocol Violation|1
29376|NCT01641926|133423|P3|Overall Study|Protocol Violation|0
29377|NCT01641926|133424|P2|Overall Study|Protocol Violation|0
29378|NCT01641926|133425|P1|Overall Study|Protocol Violation|1
29379|NCT01641926|133422|P4|Overall Study|Physician Decision|1
29380|NCT01641926|133423|P3|Overall Study|Physician Decision|0
29381|NCT01641926|133424|P2|Overall Study|Physician Decision|5
29382|NCT01641926|133425|P1|Overall Study|Physician Decision|6
29383|NCT01641926|133422|P4|Overall Study|Lost to Follow-up|0
29384|NCT01641926|133423|P3|Overall Study|Lost to Follow-up|1
29385|NCT01641926|133424|P2|Overall Study|Lost to Follow-up|2
29386|NCT01641926|133425|P1|Overall Study|Lost to Follow-up|2
29387|NCT01641926|133422|P4|Overall Study|Adverse Event|1
29388|NCT01641926|133423|P3|Overall Study|Adverse Event|3
29389|NCT01641926|133424|P2|Overall Study|Adverse Event|2
29390|NCT01641926|133425|P1|Overall Study|Adverse Event|5
29391|NCT01641900|133453|P2|Overall Study|Withdrawal by Subject|2
29392|NCT01641900|133454|P1|Overall Study|Withdrawal by Subject|2
29393|NCT01641861|133466|P2|Overall Study|Died due to drowning|1
29394|NCT01641861|133467|P1|Overall Study|Died due to drowning|0
29395|NCT01641861|133466|P2|Overall Study|Lost the tooth due to normal exfoliation|8
29396|NCT01641861|133467|P1|Overall Study|Lost the tooth due to normal exfoliation|14
29397|NCT01641861|133466|P2|Overall Study|Lost to Follow-up|16
29398|NCT01641861|133467|P1|Overall Study|Lost to Follow-up|21
29399|NCT01641822|133488|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
29400|NCT01641822|133489|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
29401|NCT01641822|133490|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
29402|NCT01641822|133488|P3|Comparative Phase|Withdrew consent|7
29403|NCT01641822|133489|P2|Comparative Phase|Withdrew consent|3
29404|NCT01641822|133490|P1|Comparative Phase|Withdrew consent|0
29405|NCT01641822|133488|P3|Comparative Phase|Adverse event, serious fatal|0
29406|NCT01641822|133489|P2|Comparative Phase|Adverse event, serious fatal|1
29407|NCT01641822|133490|P1|Comparative Phase|Adverse event, serious fatal|0
29408|NCT01641822|133488|P3|Comparative Phase|Pregnancy|1
29409|NCT01641822|133489|P2|Comparative Phase|Pregnancy|0
29410|NCT01641822|133490|P1|Comparative Phase|Pregnancy|0
29411|NCT01641822|133488|P3|Comparative Phase|Investigator's discretion|1
29412|NCT01641822|133489|P2|Comparative Phase|Investigator's discretion|0
29413|NCT01641822|133490|P1|Comparative Phase|Investigator's discretion|0
29414|NCT01641822|133488|P3|Comparative Phase|Noncompliance with study drug|0
29415|NCT01641822|133489|P2|Comparative Phase|Noncompliance with study drug|1
29416|NCT01641822|133490|P1|Comparative Phase|Noncompliance with study drug|0
29417|NCT01641822|133488|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
29418|NCT01641822|133489|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
29419|NCT01641822|133490|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
29420|NCT01641822|133488|P3|Run-in Phase|Withdrew consent|0
29421|NCT01641822|133489|P2|Run-in Phase|Withdrew consent|0
29422|NCT01641822|133490|P1|Run-in Phase|Withdrew consent|1
29423|NCT01641822|133488|P3|Run-in Phase|Adverse Event|0
29424|NCT01641822|133489|P2|Run-in Phase|Adverse Event|0
29425|NCT01641822|133490|P1|Run-in Phase|Adverse Event|3
29426|NCT01641822|133488|P3|Run-in Phase|Noncompliance with study drug|0
29427|NCT01641822|133489|P2|Run-in Phase|Noncompliance with study drug|0
29428|NCT01641822|133490|P1|Run-in Phase|Noncompliance with study drug|1
29429|NCT01641692|133507|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
29430|NCT01641692|133508|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
29431|NCT01641692|133509|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
29432|NCT01641692|133510|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
29433|NCT01641692|133511|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
29434|NCT01641692|133512|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
29435|NCT01641692|133513|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
29436|NCT01641692|133514|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
29437|NCT01641692|133507|P8|Washout Period 3 or Follow-up|Protocol Violation|0
29438|NCT01641692|133508|P7|Washout Period 3 or Follow-up|Protocol Violation|0
29439|NCT01641692|133509|P6|Washout Period 3 or Follow-up|Protocol Violation|1
29440|NCT01641692|133510|P5|Washout Period 3 or Follow-up|Protocol Violation|0
29441|NCT01641692|133511|P4|Washout Period 3 or Follow-up|Protocol Violation|0
29442|NCT01641692|133512|P3|Washout Period 3 or Follow-up|Protocol Violation|0
29443|NCT01641692|133513|P2|Washout Period 3 or Follow-up|Protocol Violation|0
29444|NCT01641692|133514|P1|Washout Period 3 or Follow-up|Protocol Violation|0
29445|NCT01641692|133507|P8|Treatment Period 3|Lost to Follow-up|0
29446|NCT01641692|133508|P7|Treatment Period 3|Lost to Follow-up|0
29447|NCT01641692|133509|P6|Treatment Period 3|Lost to Follow-up|0
29448|NCT01641692|133510|P5|Treatment Period 3|Lost to Follow-up|0
29449|NCT01641692|133511|P4|Treatment Period 3|Lost to Follow-up|0
29450|NCT01641692|133512|P3|Treatment Period 3|Lost to Follow-up|0
29451|NCT01641692|133513|P2|Treatment Period 3|Lost to Follow-up|1
29452|NCT01641692|133514|P1|Treatment Period 3|Lost to Follow-up|0
29453|NCT01641692|133507|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
29454|NCT01641692|133508|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
29455|NCT01641692|133509|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
29456|NCT01641692|133510|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
29457|NCT01641692|133511|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
29458|NCT01641692|133512|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
29459|NCT01641692|133513|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
29460|NCT01641692|133514|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
29461|NCT01641692|133507|P8|Treatment Period 3|Protocol Violation|0
29462|NCT01641692|133508|P7|Treatment Period 3|Protocol Violation|0
29463|NCT01641692|133509|P6|Treatment Period 3|Protocol Violation|0
29464|NCT01641692|133510|P5|Treatment Period 3|Protocol Violation|0
29465|NCT01641692|133511|P4|Treatment Period 3|Protocol Violation|0
29466|NCT01641692|133512|P3|Treatment Period 3|Protocol Violation|1
29467|NCT01641692|133513|P2|Treatment Period 3|Protocol Violation|0
29468|NCT01641692|133514|P1|Treatment Period 3|Protocol Violation|0
29469|NCT01641692|133507|P8|Treatment Period 3|Adverse Event|0
29470|NCT01641692|133508|P7|Treatment Period 3|Adverse Event|1
29471|NCT01641692|133509|P6|Treatment Period 3|Adverse Event|0
29472|NCT01641692|133510|P5|Treatment Period 3|Adverse Event|0
29473|NCT01641692|133511|P4|Treatment Period 3|Adverse Event|0
29474|NCT01641692|133512|P3|Treatment Period 3|Adverse Event|0
29475|NCT01641692|133513|P2|Treatment Period 3|Adverse Event|0
29476|NCT01641692|133514|P1|Treatment Period 3|Adverse Event|0
29477|NCT01641692|133507|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
29478|NCT01641692|133508|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
29479|NCT01641692|133509|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
29480|NCT01641692|133510|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
29481|NCT01641692|133511|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
29482|NCT01641692|133512|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
29483|NCT01641692|133513|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
29484|NCT01641692|133514|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
29485|NCT01641692|133507|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
29486|NCT01641692|133508|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
29487|NCT01641692|133509|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
29488|NCT01641692|133510|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
29489|NCT01641692|133511|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
29490|NCT01641692|133512|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
29491|NCT01641692|133513|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
29492|NCT01641692|133514|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
29493|NCT01641692|133507|P8|Treatment Period 2|Withdrawal by Subject|1
29494|NCT01641692|133508|P7|Treatment Period 2|Withdrawal by Subject|0
29495|NCT01641692|133509|P6|Treatment Period 2|Withdrawal by Subject|1
29496|NCT01641692|133510|P5|Treatment Period 2|Withdrawal by Subject|0
29497|NCT01641692|133511|P4|Treatment Period 2|Withdrawal by Subject|0
29498|NCT01641692|133512|P3|Treatment Period 2|Withdrawal by Subject|0
29499|NCT01641692|133513|P2|Treatment Period 2|Withdrawal by Subject|0
29500|NCT01641692|133514|P1|Treatment Period 2|Withdrawal by Subject|1
29501|NCT01641692|133507|P8|Treatment Period 2|Lost to Follow-up|0
29502|NCT01641692|133508|P7|Treatment Period 2|Lost to Follow-up|0
29503|NCT01641692|133509|P6|Treatment Period 2|Lost to Follow-up|1
29504|NCT01641692|133510|P5|Treatment Period 2|Lost to Follow-up|0
29505|NCT01641692|133511|P4|Treatment Period 2|Lost to Follow-up|0
29506|NCT01641692|133512|P3|Treatment Period 2|Lost to Follow-up|0
29507|NCT01641692|133513|P2|Treatment Period 2|Lost to Follow-up|0
29508|NCT01641692|133514|P1|Treatment Period 2|Lost to Follow-up|0
29509|NCT01641692|133507|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
29510|NCT01641692|133508|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
29511|NCT01641692|133509|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
29512|NCT01641692|133510|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
29513|NCT01641692|133511|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
29514|NCT01641692|133512|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
29515|NCT01641692|133513|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
29516|NCT01641692|133514|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
29517|NCT01641692|133507|P8|Treatment Period 2|Lack of Efficacy|0
29518|NCT01641692|133508|P7|Treatment Period 2|Lack of Efficacy|0
29519|NCT01641692|133509|P6|Treatment Period 2|Lack of Efficacy|0
29520|NCT01641692|133510|P5|Treatment Period 2|Lack of Efficacy|0
29521|NCT01641692|133511|P4|Treatment Period 2|Lack of Efficacy|0
29522|NCT01641692|133512|P3|Treatment Period 2|Lack of Efficacy|0
29523|NCT01641692|133513|P2|Treatment Period 2|Lack of Efficacy|0
29524|NCT01641692|133514|P1|Treatment Period 2|Lack of Efficacy|1
29525|NCT01641692|133507|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
29526|NCT01641692|133508|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
29527|NCT01641692|133509|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
29528|NCT01641692|133510|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
29529|NCT01641692|133511|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
29530|NCT01641692|133512|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
29531|NCT01641692|133513|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
29532|NCT01641692|133514|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
29533|NCT01641692|133507|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
29534|NCT01641692|133508|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
29535|NCT01641692|133509|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
29536|NCT01641692|133510|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
29537|NCT01641692|133511|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
29538|NCT01641692|133512|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
29539|NCT01641692|133513|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
29540|NCT01641692|133514|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
29541|NCT01641692|133507|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
29542|NCT01641692|133508|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
29543|NCT01641692|133509|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
29544|NCT01641692|133510|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
29545|NCT01641692|133511|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
29546|NCT01641692|133512|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
29547|NCT01641692|133513|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
29548|NCT01641692|133514|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
29549|NCT01641692|133507|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
29550|NCT01641692|133508|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
29551|NCT01641692|133509|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
29552|NCT01641692|133510|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
29553|NCT01641692|133511|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
29554|NCT01641692|133512|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
29555|NCT01641692|133513|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
29556|NCT01641692|133514|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
29557|NCT01641692|133507|P8|Treatment Period 1|Withdrawal by Subject|1
29558|NCT01641692|133508|P7|Treatment Period 1|Withdrawal by Subject|0
29559|NCT01641692|133509|P6|Treatment Period 1|Withdrawal by Subject|2
29560|NCT01641692|133510|P5|Treatment Period 1|Withdrawal by Subject|0
29561|NCT01641692|133511|P4|Treatment Period 1|Withdrawal by Subject|0
29562|NCT01641692|133512|P3|Treatment Period 1|Withdrawal by Subject|0
29563|NCT01641692|133513|P2|Treatment Period 1|Withdrawal by Subject|0
29564|NCT01641692|133514|P1|Treatment Period 1|Withdrawal by Subject|0
29565|NCT01641692|133507|P8|Treatment Period 1|Physician Decision|0
29566|NCT01641692|133508|P7|Treatment Period 1|Physician Decision|0
29567|NCT01641692|133509|P6|Treatment Period 1|Physician Decision|0
29568|NCT01641692|133510|P5|Treatment Period 1|Physician Decision|1
29569|NCT01641692|133511|P4|Treatment Period 1|Physician Decision|0
29570|NCT01641692|133512|P3|Treatment Period 1|Physician Decision|0
29571|NCT01641692|133513|P2|Treatment Period 1|Physician Decision|0
29572|NCT01641692|133514|P1|Treatment Period 1|Physician Decision|0
29573|NCT01641692|133507|P8|Treatment Period 1|Lost to Follow-up|0
29574|NCT01641692|133508|P7|Treatment Period 1|Lost to Follow-up|0
29575|NCT01641692|133509|P6|Treatment Period 1|Lost to Follow-up|0
29576|NCT01641692|133510|P5|Treatment Period 1|Lost to Follow-up|0
29577|NCT01641692|133511|P4|Treatment Period 1|Lost to Follow-up|0
29578|NCT01641692|133512|P3|Treatment Period 1|Lost to Follow-up|1
29579|NCT01641692|133513|P2|Treatment Period 1|Lost to Follow-up|0
29580|NCT01641692|133514|P1|Treatment Period 1|Lost to Follow-up|0
29581|NCT01641692|133507|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
29582|NCT01641692|133508|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
29583|NCT01641692|133509|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
29584|NCT01641692|133510|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
29585|NCT01641692|133511|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
29586|NCT01641692|133512|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
29587|NCT01641692|133513|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
29588|NCT01641692|133514|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
29589|NCT01641692|133507|P8|Treatment Period 1|Protocol Violation|0
29590|NCT01641692|133508|P7|Treatment Period 1|Protocol Violation|0
29591|NCT01641692|133509|P6|Treatment Period 1|Protocol Violation|0
29592|NCT01641692|133510|P5|Treatment Period 1|Protocol Violation|2
29593|NCT01641692|133511|P4|Treatment Period 1|Protocol Violation|0
29594|NCT01641692|133512|P3|Treatment Period 1|Protocol Violation|0
29595|NCT01641692|133513|P2|Treatment Period 1|Protocol Violation|0
29596|NCT01641692|133514|P1|Treatment Period 1|Protocol Violation|1
29597|NCT01641692|133507|P8|Treatment Period 1|Lack of Efficacy|1
29598|NCT01641692|133508|P7|Treatment Period 1|Lack of Efficacy|0
29599|NCT01641692|133509|P6|Treatment Period 1|Lack of Efficacy|0
29600|NCT01641692|133510|P5|Treatment Period 1|Lack of Efficacy|0
29601|NCT01641692|133511|P4|Treatment Period 1|Lack of Efficacy|0
29602|NCT01641692|133512|P3|Treatment Period 1|Lack of Efficacy|0
29603|NCT01641692|133513|P2|Treatment Period 1|Lack of Efficacy|0
29604|NCT01641692|133514|P1|Treatment Period 1|Lack of Efficacy|0
29605|NCT01641692|133507|P8|Treatment Period 1|Adverse Event|0
29606|NCT01641692|133508|P7|Treatment Period 1|Adverse Event|0
29607|NCT01641692|133509|P6|Treatment Period 1|Adverse Event|0
29608|NCT01641692|133510|P5|Treatment Period 1|Adverse Event|0
29609|NCT01641692|133511|P4|Treatment Period 1|Adverse Event|0
29610|NCT01641692|133512|P3|Treatment Period 1|Adverse Event|0
29611|NCT01641692|133513|P2|Treatment Period 1|Adverse Event|0
29612|NCT01641692|133514|P1|Treatment Period 1|Adverse Event|1
29613|NCT01641640|133714|P1|Overall Study|Adverse Event|1
29614|NCT01641640|133714|P1|Overall Study|Withdrawal by Subject|2
29615|NCT01641640|133714|P1|Overall Study|Lost to Follow-up|3
29616|NCT01641640|133714|P1|Overall Study|Efficacy failure|29
29617|NCT01641640|133714|P1|Overall Study|Enrolled but not treated|1
29618|NCT01641471|133725|P2|Overall Study|Protocol Violation|4
29619|NCT01641471|133726|P1|Overall Study|Protocol Violation|2
29620|NCT01641471|133725|P2|Overall Study|Lost to Follow-up|4
29621|NCT01641471|133726|P1|Overall Study|Lost to Follow-up|2
29622|NCT01641471|133725|P2|Overall Study|Withdrawal by Subject|19
29623|NCT01641471|133726|P1|Overall Study|Withdrawal by Subject|19
29624|NCT01641237|133732|P4|Period III|Lost to Follow-up|0
29625|NCT01641237|133733|P3|Period III|Lost to Follow-up|0
29626|NCT01641237|133734|P2|Period III|Lost to Follow-up|0
29627|NCT01641237|133735|P1|Period III|Lost to Follow-up|1
29628|NCT01641237|133732|P4|Period II|Withdrawal by Subject|0
29629|NCT01641237|133733|P3|Period II|Withdrawal by Subject|0
29630|NCT01641237|133734|P2|Period II|Withdrawal by Subject|0
29631|NCT01641237|133735|P1|Period II|Withdrawal by Subject|1
29632|NCT01641159|133759|P2|Overall Study|Withdrawal by Subject|1
29633|NCT01641159|133760|P1|Overall Study|Withdrawal by Subject|0
29634|NCT01641159|133759|P2|Overall Study|Lost to Follow-up|1
29635|NCT01641159|133760|P1|Overall Study|Lost to Follow-up|2
29636|NCT01641133|133771|P3|Overall Study|Lost to Follow-up|2
29637|NCT01641133|133772|P2|Overall Study|Lost to Follow-up|2
29638|NCT01641133|133773|P1|Overall Study|Lost to Follow-up|0
29639|NCT01641133|133771|P3|Overall Study|Withdrawal by Subject|3
29640|NCT01641133|133772|P2|Overall Study|Withdrawal by Subject|3
29641|NCT01641133|133773|P1|Overall Study|Withdrawal by Subject|5
29642|NCT01641133|133771|P3|Overall Study|Adverse Event|1
29643|NCT01641133|133772|P2|Overall Study|Adverse Event|0
29644|NCT01641133|133773|P1|Overall Study|Adverse Event|0
29645|NCT01641133|133771|P3|Overall Study|Migrated/moved from study area|1
29646|NCT01641133|133772|P2|Overall Study|Migrated/moved from study area|3
29647|NCT01641133|133773|P1|Overall Study|Migrated/moved from study area|5
29648|NCT01641133|133771|P3|Overall Study|Protocol Violation|1
29649|NCT01641133|133772|P2|Overall Study|Protocol Violation|1
29650|NCT01641133|133773|P1|Overall Study|Protocol Violation|0
29651|NCT01641081|133823|P10|Period 5|Adverse Event|0
29652|NCT01641081|133824|P9|Period 5|Adverse Event|0
29653|NCT01641081|133825|P8|Period 5|Adverse Event|0
29654|NCT01641081|133826|P7|Period 5|Adverse Event|0
29655|NCT01641081|133827|P6|Period 5|Adverse Event|0
29656|NCT01641081|133828|P5|Period 5|Adverse Event|0
29657|NCT01641081|133829|P4|Period 5|Adverse Event|0
29658|NCT01641081|133830|P3|Period 5|Adverse Event|2
29659|NCT01641081|133831|P2|Period 5|Adverse Event|0
29660|NCT01641081|133832|P1|Period 5|Adverse Event|0
29661|NCT01641081|133823|P10|Period 4|Adverse Event|0
29662|NCT01641081|133824|P9|Period 4|Adverse Event|0
29663|NCT01641081|133825|P8|Period 4|Adverse Event|0
29664|NCT01641081|133826|P7|Period 4|Adverse Event|0
29665|NCT01641081|133827|P6|Period 4|Adverse Event|0
29666|NCT01641081|133828|P5|Period 4|Adverse Event|0
29667|NCT01641081|133829|P4|Period 4|Adverse Event|1
29668|NCT01641081|133830|P3|Period 4|Adverse Event|0
29669|NCT01641081|133831|P2|Period 4|Adverse Event|1
29670|NCT01641081|133832|P1|Period 4|Adverse Event|0
29671|NCT01641081|133823|P10|Period 3|Withdrawal by Subject|0
29672|NCT01641081|133824|P9|Period 3|Withdrawal by Subject|1
29673|NCT01641081|133825|P8|Period 3|Withdrawal by Subject|0
29674|NCT01641081|133826|P7|Period 3|Withdrawal by Subject|0
29675|NCT01641081|133827|P6|Period 3|Withdrawal by Subject|0
29676|NCT01641081|133828|P5|Period 3|Withdrawal by Subject|0
29677|NCT01641081|133829|P4|Period 3|Withdrawal by Subject|0
29678|NCT01641081|133830|P3|Period 3|Withdrawal by Subject|0
29679|NCT01641081|133831|P2|Period 3|Withdrawal by Subject|0
29680|NCT01641081|133832|P1|Period 3|Withdrawal by Subject|0
29681|NCT01641081|133823|P10|Period 3|Adverse Event|0
29682|NCT01641081|133824|P9|Period 3|Adverse Event|0
29683|NCT01641081|133825|P8|Period 3|Adverse Event|0
29684|NCT01641081|133826|P7|Period 3|Adverse Event|0
29685|NCT01641081|133827|P6|Period 3|Adverse Event|0
29686|NCT01641081|133828|P5|Period 3|Adverse Event|0
29687|NCT01641081|133829|P4|Period 3|Adverse Event|0
29688|NCT01641081|133830|P3|Period 3|Adverse Event|1
29689|NCT01641081|133831|P2|Period 3|Adverse Event|0
29690|NCT01641081|133832|P1|Period 3|Adverse Event|0
29691|NCT01641081|133823|P10|Period 2|Protocol Violation|0
29692|NCT01641081|133824|P9|Period 2|Protocol Violation|0
29693|NCT01641081|133825|P8|Period 2|Protocol Violation|0
29694|NCT01641081|133826|P7|Period 2|Protocol Violation|0
29695|NCT01641081|133827|P6|Period 2|Protocol Violation|0
29696|NCT01641081|133828|P5|Period 2|Protocol Violation|0
29697|NCT01641081|133829|P4|Period 2|Protocol Violation|0
29698|NCT01641081|133830|P3|Period 2|Protocol Violation|0
29699|NCT01641081|133831|P2|Period 2|Protocol Violation|0
29700|NCT01641081|133832|P1|Period 2|Protocol Violation|1
29701|NCT01641081|133823|P10|Period 2|Withdrawal by Subject|0
29702|NCT01641081|133824|P9|Period 2|Withdrawal by Subject|0
29703|NCT01641081|133825|P8|Period 2|Withdrawal by Subject|0
29704|NCT01641081|133826|P7|Period 2|Withdrawal by Subject|2
29705|NCT01641081|133827|P6|Period 2|Withdrawal by Subject|0
29706|NCT01641081|133828|P5|Period 2|Withdrawal by Subject|0
29707|NCT01641081|133829|P4|Period 2|Withdrawal by Subject|1
29708|NCT01641081|133830|P3|Period 2|Withdrawal by Subject|0
29709|NCT01641081|133831|P2|Period 2|Withdrawal by Subject|0
29710|NCT01641081|133832|P1|Period 2|Withdrawal by Subject|0
29711|NCT01641081|133823|P10|Period 2|Adverse Event|0
29712|NCT01641081|133824|P9|Period 2|Adverse Event|0
29713|NCT01641081|133825|P8|Period 2|Adverse Event|0
29714|NCT01641081|133826|P7|Period 2|Adverse Event|0
29715|NCT01641081|133827|P6|Period 2|Adverse Event|1
29716|NCT01641081|133828|P5|Period 2|Adverse Event|0
29717|NCT01641081|133829|P4|Period 2|Adverse Event|0
29718|NCT01641081|133830|P3|Period 2|Adverse Event|0
29719|NCT01641081|133831|P2|Period 2|Adverse Event|0
29720|NCT01641081|133832|P1|Period 2|Adverse Event|0
29721|NCT01641081|133823|P10|Period 1|Adverse Event|0
29722|NCT01641081|133824|P9|Period 1|Adverse Event|0
29723|NCT01641081|133825|P8|Period 1|Adverse Event|2
29724|NCT01641081|133826|P7|Period 1|Adverse Event|0
29725|NCT01641081|133827|P6|Period 1|Adverse Event|0
29726|NCT01641081|133828|P5|Period 1|Adverse Event|0
29727|NCT01641081|133829|P4|Period 1|Adverse Event|0
29728|NCT01641081|133830|P3|Period 1|Adverse Event|0
29729|NCT01641081|133831|P2|Period 1|Adverse Event|0
29730|NCT01641081|133832|P1|Period 1|Adverse Event|1
29731|NCT01641081|133823|P10|Period 1|Protocol Violation|0
29732|NCT01641081|133824|P9|Period 1|Protocol Violation|0
29733|NCT01641081|133825|P8|Period 1|Protocol Violation|1
29734|NCT01641081|133826|P7|Period 1|Protocol Violation|0
29735|NCT01641081|133827|P6|Period 1|Protocol Violation|0
29736|NCT01641081|133828|P5|Period 1|Protocol Violation|1
29737|NCT01641081|133829|P4|Period 1|Protocol Violation|0
29738|NCT01641081|133830|P3|Period 1|Protocol Violation|0
29739|NCT01641081|133831|P2|Period 1|Protocol Violation|0
29740|NCT01641081|133832|P1|Period 1|Protocol Violation|0
29741|NCT01641081|133823|P10|Period 1|Sponsor request (potential unblinding)|0
29742|NCT01641081|133824|P9|Period 1|Sponsor request (potential unblinding)|0
29743|NCT01641081|133825|P8|Period 1|Sponsor request (potential unblinding)|0
29744|NCT01641081|133826|P7|Period 1|Sponsor request (potential unblinding)|1
29745|NCT01641081|133827|P6|Period 1|Sponsor request (potential unblinding)|0
29746|NCT01641081|133828|P5|Period 1|Sponsor request (potential unblinding)|0
29747|NCT01641081|133829|P4|Period 1|Sponsor request (potential unblinding)|0
29748|NCT01641081|133830|P3|Period 1|Sponsor request (potential unblinding)|0
29749|NCT01641081|133831|P2|Period 1|Sponsor request (potential unblinding)|0
29750|NCT01641081|133832|P1|Period 1|Sponsor request (potential unblinding)|0
29751|NCT01640964|133852|P3|Overall Study|Protocol Deviation|2
29752|NCT01640964|133853|P2|Overall Study|Protocol Deviation|1
29753|NCT01640964|133854|P1|Overall Study|Protocol Deviation|1
29754|NCT01640964|133852|P3|Overall Study|Lost to Follow-up|1
29755|NCT01640964|133853|P2|Overall Study|Lost to Follow-up|0
29756|NCT01640964|133854|P1|Overall Study|Lost to Follow-up|0
29757|NCT01640925|133871|P2|Overall Study|Previously enrolled in this trial|11
29758|NCT01640925|133872|P1|Overall Study|Previously enrolled in this trial|13
29759|NCT01640925|133871|P2|Overall Study|Withdrawal by Subject|0
29760|NCT01640925|133872|P1|Overall Study|Withdrawal by Subject|1
29761|NCT01640353|133892|P1|Overall Study|Physician Decision|1
29762|NCT01640353|133892|P1|Overall Study|Lost to Follow-up|12
29763|NCT01640353|133892|P1|Overall Study|Early site termination|3
29764|NCT01640353|133892|P1|Overall Study|Death|2
29765|NCT01640353|133892|P1|Overall Study|Withdrawal by Subject|5
29766|NCT01640353|133892|P1|Overall Study|Withdrawn from analysis at term site|12
29767|NCT01640353|133892|P1|Overall Study|Withdrew prior to treatment|10
29768|NCT01640314|133940|P2|Overall Study|Protocol Violation|1
29769|NCT01640314|133941|P1|Overall Study|Protocol Violation|0
29770|NCT01640184|133979|P3|Overall Study|Protocol Violation|1
29771|NCT01640184|133980|P2|Overall Study|Protocol Violation|0
29772|NCT01640184|133981|P1|Overall Study|Protocol Violation|0
29773|NCT01640184|133979|P3|Overall Study|Withdrawal by Subject|1
29774|NCT01640184|133980|P2|Overall Study|Withdrawal by Subject|1
29775|NCT01640184|133981|P1|Overall Study|Withdrawal by Subject|0
29776|NCT01640184|133979|P3|Overall Study|Physician Decision|0
29777|NCT01640184|133980|P2|Overall Study|Physician Decision|0
29778|NCT01640184|133981|P1|Overall Study|Physician Decision|3
29779|NCT01640184|133979|P3|Overall Study|Lost to Follow-up|0
29780|NCT01640184|133980|P2|Overall Study|Lost to Follow-up|1
29781|NCT01640184|133981|P1|Overall Study|Lost to Follow-up|4
29782|NCT01640184|133979|P3|Overall Study|Death|0
29783|NCT01640184|133980|P2|Overall Study|Death|0
29784|NCT01640184|133981|P1|Overall Study|Death|1
29785|NCT01640054|134010|P1|Overall Study|Adverse Event|2
29786|NCT01640054|134010|P1|Overall Study|Lack of Efficacy|3
29787|NCT01640054|134010|P1|Overall Study|Study-specific disc criteria|1
29788|NCT01639833|134020|P2|Overall Study|Withdrawal by Subject|2
29789|NCT01639833|134021|P1|Overall Study|Withdrawal by Subject|2
29790|NCT01639833|134020|P2|Overall Study|Death|2
29791|NCT01639833|134021|P1|Overall Study|Death|4
29792|NCT01639755|134029|P1|Overall Study|Patient had device explantation|4
29793|NCT01639755|134029|P1|Overall Study|Study Ongoing|15
29794|NCT01639742|134037|P1|Overall Study|Lost to Follow-up|1
29795|NCT01639742|134037|P1|Overall Study|Study Ongoing|17
29796|NCT01639729|134045|P6|Overall Study|Withdrawal by Subject|0
29797|NCT01639729|134046|P5|Overall Study|Withdrawal by Subject|0
29798|NCT01639729|134047|P4|Overall Study|Withdrawal by Subject|1
29799|NCT01639729|134048|P3|Overall Study|Withdrawal by Subject|1
29800|NCT01639729|134049|P2|Overall Study|Withdrawal by Subject|0
29801|NCT01639729|134050|P1|Overall Study|Withdrawal by Subject|1
29802|NCT01639703|134072|P1|Overall Study|Other reason|7
29803|NCT01639703|134072|P1|Overall Study|Withdrawal by Subject|5
29804|NCT01639560|134115|P2|Overall Study|Adverse Event|2
29805|NCT01639560|134116|P1|Overall Study|Adverse Event|0
29806|NCT01639560|134115|P2|Overall Study|Lost to Follow-up|11
29807|NCT01639560|134116|P1|Overall Study|Lost to Follow-up|9
29808|NCT01639560|134115|P2|Overall Study|Lack of Efficacy|2
29809|NCT01639560|134116|P1|Overall Study|Lack of Efficacy|1
29810|NCT01639560|134115|P2|Overall Study|Withdrawal by Subject|14
29811|NCT01639560|134116|P1|Overall Study|Withdrawal by Subject|9
29812|NCT01639469|134130|P2|Overall Study|Lost to Follow-up|1
29813|NCT01639469|134131|P1|Overall Study|Lost to Follow-up|1
29814|NCT01639469|134130|P2|Overall Study|Death|2
29815|NCT01639469|134131|P1|Overall Study|Death|4
29816|NCT01639144|134236|P2|Overall Study|Met postoperative exclusion criteria|3
29817|NCT01639144|134237|P1|Overall Study|Met postoperative exclusion criteria|4
29818|NCT01639144|134236|P2|Overall Study|Physician Decision|0
29819|NCT01639144|134237|P1|Overall Study|Physician Decision|2
29820|NCT01639144|134236|P2|Overall Study|Withdrawal by Subject|2
29821|NCT01639144|134237|P1|Overall Study|Withdrawal by Subject|4
29822|NCT01639001|134245|P2|Overall Study|Death|35
29823|NCT01639001|134246|P1|Overall Study|Death|35
29824|NCT01639001|134245|P2|Overall Study|Lost to Follow-up|0
29825|NCT01639001|134246|P1|Overall Study|Lost to Follow-up|1
29826|NCT01639001|134245|P2|Overall Study|Refused further follow-up|6
29827|NCT01639001|134246|P1|Overall Study|Refused further follow-up|3
29828|NCT01639001|134245|P2|Overall Study|Ongoing at date of cutoff|60
29829|NCT01639001|134246|P1|Overall Study|Ongoing at date of cutoff|65
29830|NCT01639001|134245|P2|Overall Study|Randomized but not treated|2
29831|NCT01639001|134246|P1|Overall Study|Randomized but not treated|0
29832|NCT01638000|134332|P2|Overall Study|Miscellaneous|2
29833|NCT01638000|134333|P1|Overall Study|Miscellaneous|2
29834|NCT01638000|134332|P2|Overall Study|Withdrawal by Subject|24
29835|NCT01638000|134333|P1|Overall Study|Withdrawal by Subject|21
29836|NCT01638000|134332|P2|Overall Study|Protocol Violation|13
29837|NCT01638000|134333|P1|Overall Study|Protocol Violation|11
29838|NCT01638000|134332|P2|Overall Study|Lack of Efficacy|6
29839|NCT01638000|134333|P1|Overall Study|Lack of Efficacy|5
29840|NCT01638000|134332|P2|Overall Study|Adverse Event|16
29841|NCT01638000|134333|P1|Overall Study|Adverse Event|14
29842|NCT01638000|134332|P2|Overall Study|Randomized but Never Received Drug|10
29843|NCT01638000|134333|P1|Overall Study|Randomized but Never Received Drug|7
29844|NCT01637961|134431|P1|Overall Study|Ineligible: inadequate pathology|1
29845|NCT01637961|134431|P1|Overall Study|Ineligible: wrong primary|1
29846|NCT01637922|134456|P2|Overall Study|Lost to Follow-up|0
29847|NCT01637922|134457|P1|Overall Study|Lost to Follow-up|2
29848|NCT01637922|134456|P2|Overall Study|Withdrawal by Subject|3
29849|NCT01637922|134457|P1|Overall Study|Withdrawal by Subject|0
29850|NCT01637922|134456|P2|Overall Study|Protocol Violation|1
29851|NCT01637922|134457|P1|Overall Study|Protocol Violation|0
29852|NCT01637922|134456|P2|Overall Study|Adverse Event|1
29853|NCT01637922|134457|P1|Overall Study|Adverse Event|0
29854|NCT01637584|134482|P2|Overall Study|Withdrawal by Subject|3
29855|NCT01637584|134483|P1|Overall Study|Withdrawal by Subject|1
29856|NCT01637272|134490|P1|Overall Study|Protocol Violation|2
29857|NCT01637272|134490|P1|Overall Study|Administrative problems|1
29858|NCT01637272|134490|P1|Overall Study|completed core, did not enter ext. phase|4
29859|NCT01637272|134490|P1|Overall Study|Lost to Follow-up|2
29860|NCT01637272|134490|P1|Overall Study|Withdrawal by Subject|3
29861|NCT01637272|134490|P1|Overall Study|Unsatisfactory therapeutic effect|2
29862|NCT01637272|134490|P1|Overall Study|Adverse Event|6
29863|NCT01636986|134570|P2|Overall Study|Corneal Staining|1
29864|NCT01636986|134571|P1|Overall Study|Corneal Staining|0
29865|NCT01636986|134570|P2|Overall Study|Withdrawal by Subject|1
29866|NCT01636986|134571|P1|Overall Study|Withdrawal by Subject|0
29867|NCT01636960|134577|P1|Maintenance Phase|Progressive disease|1
29868|NCT01636960|134577|P1|Maintenance Phase|Adverse Event|3
29869|NCT01636960|134577|P1|Maintenance Phase|Continued drug after regulatory approval|3
29870|NCT01636960|134577|P1|Induction Phase|Adverse Event|2
29871|NCT01636947|134585|P2|Overall Study|Did Not Meet Eligibility Criteria|4
29872|NCT01636947|134586|P1|Overall Study|Did Not Meet Eligibility Criteria|1
29873|NCT01636947|134585|P2|Overall Study|Adverse Event|1
29874|NCT01636947|134586|P1|Overall Study|Adverse Event|1
29875|NCT01636947|134585|P2|Overall Study|Withdrawal by Subject|3
29876|NCT01636947|134586|P1|Overall Study|Withdrawal by Subject|3
29877|NCT01636947|134585|P2|Overall Study|Protocol Violation|1
29878|NCT01636947|134586|P1|Overall Study|Protocol Violation|1
29879|NCT01636947|134585|P2|Overall Study|Lost to Follow-up|0
29880|NCT01636947|134586|P1|Overall Study|Lost to Follow-up|4
29881|NCT01636947|134585|P2|Overall Study|Not Treated|2
29882|NCT01636947|134586|P1|Overall Study|Not Treated|2
29883|NCT01636778|134606|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
29884|NCT01636778|134607|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
29885|NCT01636778|134608|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
29886|NCT01636778|134606|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
29887|NCT01636778|134607|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
29888|NCT01636778|134608|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
29889|NCT01636778|134606|P3|Follow-up Period After Part 2|Other|1
29890|NCT01636778|134607|P2|Follow-up Period After Part 2|Other|0
29891|NCT01636778|134608|P1|Follow-up Period After Part 2|Other|0
29892|NCT01636778|134606|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
29893|NCT01636778|134607|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
29894|NCT01636778|134608|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
29895|NCT01636778|134606|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
29896|NCT01636778|134607|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
29897|NCT01636778|134608|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
29898|NCT01636778|134606|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
29899|NCT01636778|134607|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
29900|NCT01636778|134608|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
29901|NCT01636778|134606|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
29902|NCT01636778|134607|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
29903|NCT01636778|134608|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
29904|NCT01636778|134606|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
29905|NCT01636778|134607|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
29906|NCT01636778|134608|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
29907|NCT01636713|134679|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
29908|NCT01636713|134680|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
29909|NCT01636713|134681|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
29910|NCT01636713|134679|P3|Overall Study|Withdrawal by Subject|8
29911|NCT01636713|134680|P2|Overall Study|Withdrawal by Subject|4
29912|NCT01636713|134681|P1|Overall Study|Withdrawal by Subject|5
29913|NCT01636713|134679|P3|Overall Study|Lost to Follow-up|1
29914|NCT01636713|134680|P2|Overall Study|Lost to Follow-up|0
29915|NCT01636713|134681|P1|Overall Study|Lost to Follow-up|0
29916|NCT01636713|134679|P3|Overall Study|Protocol Violation|1
29917|NCT01636713|134680|P2|Overall Study|Protocol Violation|0
29918|NCT01636713|134681|P1|Overall Study|Protocol Violation|3
29919|NCT01636713|134679|P3|Overall Study|Lack of Efficacy|2
29920|NCT01636713|134680|P2|Overall Study|Lack of Efficacy|6
29921|NCT01636713|134681|P1|Overall Study|Lack of Efficacy|6
29922|NCT01636713|134679|P3|Overall Study|Adverse Event|7
29923|NCT01636713|134680|P2|Overall Study|Adverse Event|16
29924|NCT01636713|134681|P1|Overall Study|Adverse Event|16
29925|NCT01636362|134731|P1|Overall Study|Withdrawal by Subject|1
29926|NCT01636362|134731|P1|Overall Study|Subject healed, not returning|1
29927|NCT01636362|134731|P1|Overall Study|Physician Decision|6
29928|NCT01636258|134739|P2|Overall Study|Lost to Follow-up|0
29929|NCT01636258|134740|P1|Overall Study|Lost to Follow-up|1
29930|NCT01636076|134780|P2|Overall Study|Withdrawal by Subject|10
29931|NCT01636076|134781|P1|Overall Study|Withdrawal by Subject|7
29932|NCT01636076|134780|P2|Overall Study|Adverse Event|11
29933|NCT01636076|134781|P1|Overall Study|Adverse Event|6
29934|NCT01636076|134780|P2|Overall Study|Non-compliance with study treatment|1
29935|NCT01636076|134781|P1|Overall Study|Non-compliance with study treatment|1
29936|NCT01636076|134780|P2|Overall Study|Physician Decision|1
29937|NCT01636076|134781|P1|Overall Study|Physician Decision|1
29938|NCT01636076|134780|P2|Overall Study|Lost to Follow-up|0
29939|NCT01636076|134781|P1|Overall Study|Lost to Follow-up|1
29940|NCT01636076|134780|P2|Overall Study|Lack of Efficacy|1
29941|NCT01636076|134781|P1|Overall Study|Lack of Efficacy|0
29942|NCT01636076|134780|P2|Overall Study|Terminated by sponsor|1
29943|NCT01636076|134781|P1|Overall Study|Terminated by sponsor|1
29944|NCT01635933|134852|P2|Overall Study|No longer had transportation|1
29945|NCT01635933|134853|P1|Overall Study|No longer had transportation|0
29946|NCT01635933|134852|P2|Overall Study|Noncompliance|1
29947|NCT01635933|134853|P1|Overall Study|Noncompliance|0
29948|NCT01635933|134852|P2|Overall Study|Subject decision|1
29949|NCT01635933|134853|P1|Overall Study|Subject decision|1
29950|NCT01635933|134852|P2|Overall Study|Lost to Follow-up|5
29951|NCT01635933|134853|P1|Overall Study|Lost to Follow-up|0
29952|NCT01635933|134852|P2|Overall Study|Adverse Event|0
29953|NCT01635933|134853|P1|Overall Study|Adverse Event|1
29954|NCT01635920|134865|P2|Overall Study|Subject decision|0
29955|NCT01635920|134866|P1|Overall Study|Subject decision|2
29956|NCT01635920|134865|P2|Overall Study|Lost to Follow-up|1
29957|NCT01635920|134866|P1|Overall Study|Lost to Follow-up|0
29958|NCT01635920|134865|P2|Overall Study|Adverse Event|0
29959|NCT01635920|134866|P1|Overall Study|Adverse Event|1
29960|NCT01635855|134879|P1|Overall Study|Withdrawal by Subject|4
29961|NCT01635218|134921|P3|Overall Study|Lost to Follow-up|6
29962|NCT01635218|134922|P2|Overall Study|Lost to Follow-up|7
29963|NCT01635218|134923|P1|Overall Study|Lost to Follow-up|3
29964|NCT01634854|134958|P2|Overall Study|Cesarean delivery|7
29965|NCT01634854|134959|P1|Overall Study|Cesarean delivery|2
29966|NCT01634659|134979|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
29967|NCT01634659|134980|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
29968|NCT01634659|134979|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
29969|NCT01634659|134980|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
29970|NCT01634555|135010|P1|Overall Study|Ongoing receiving treatment|13
29971|NCT01634555|135010|P1|Overall Study|Physician Decision|1
29972|NCT01634555|135010|P1|Overall Study|Adverse Event|3
29973|NCT01634360|135020|P2|Overall Study|Study termination by sponsor|44
29974|NCT01634360|135021|P1|Overall Study|Study termination by sponsor|18
29975|NCT01634360|135020|P2|Overall Study|Not specified|20
29976|NCT01634360|135021|P1|Overall Study|Not specified|3
29977|NCT01634360|135020|P2|Overall Study|Lack of Efficacy|14
29978|NCT01634360|135021|P1|Overall Study|Lack of Efficacy|4
29979|NCT01634360|135020|P2|Overall Study|Protocol Violation|1
29980|NCT01634360|135021|P1|Overall Study|Protocol Violation|1
29981|NCT01634360|135020|P2|Overall Study|subject withdrew consent|23
29982|NCT01634360|135021|P1|Overall Study|subject withdrew consent|13
29983|NCT01634360|135020|P2|Overall Study|Adverse Event|34
29984|NCT01634360|135021|P1|Overall Study|Adverse Event|10
29985|NCT01634243|135050|P2|Overall Study|Lack of Efficacy|0
29986|NCT01634243|135051|P1|Overall Study|Lack of Efficacy|1
29987|NCT01634243|135050|P2|Overall Study|Adverse Event|5
29988|NCT01634243|135051|P1|Overall Study|Adverse Event|5
29989|NCT01634165|135077|P4|Period 2|Adverse Event|0
29990|NCT01634165|135078|P3|Period 2|Adverse Event|0
29991|NCT01634165|135079|P2|Period 2|Adverse Event|1
29992|NCT01634165|135080|P1|Period 2|Adverse Event|0
29993|NCT01634152|135113|P3|Overall Study|Other reason not defined above|1
29994|NCT01634152|135114|P2|Overall Study|Other reason not defined above|0
29995|NCT01634152|135115|P1|Overall Study|Other reason not defined above|1
29996|NCT01634152|135113|P3|Overall Study|Not treated|0
29997|NCT01634152|135114|P2|Overall Study|Not treated|1
29998|NCT01634152|135115|P1|Overall Study|Not treated|0
29999|NCT01634152|135113|P3|Overall Study|Consent withdrawn not due to AE|1
30000|NCT01634152|135114|P2|Overall Study|Consent withdrawn not due to AE|0
30001|NCT01634152|135115|P1|Overall Study|Consent withdrawn not due to AE|1
30002|NCT01634152|135113|P3|Overall Study|Adverse Event|2
30003|NCT01634152|135114|P2|Overall Study|Adverse Event|0
30004|NCT01634152|135115|P1|Overall Study|Adverse Event|2
30005|NCT01634139|135198|P3|Overall Study|Not treated|0
30006|NCT01634139|135199|P2|Overall Study|Not treated|1
30007|NCT01634139|135200|P1|Overall Study|Not treated|1
30008|NCT01634139|135198|P3|Overall Study|Lost to Follow-up|0
30009|NCT01634139|135199|P2|Overall Study|Lost to Follow-up|2
30010|NCT01634139|135200|P1|Overall Study|Lost to Follow-up|0
30011|NCT01634139|135198|P3|Overall Study|Other|3
30012|NCT01634139|135199|P2|Overall Study|Other|0
30013|NCT01634139|135200|P1|Overall Study|Other|4
30014|NCT01634139|135198|P3|Overall Study|Consent withdrawn not due to AE|2
30015|NCT01634139|135199|P2|Overall Study|Consent withdrawn not due to AE|3
30016|NCT01634139|135200|P1|Overall Study|Consent withdrawn not due to AE|4
30017|NCT01634139|135198|P3|Overall Study|Non compliant with protocol|0
30018|NCT01634139|135199|P2|Overall Study|Non compliant with protocol|0
30019|NCT01634139|135200|P1|Overall Study|Non compliant with protocol|1
30020|NCT01634113|135301|P3|Overall Study|Not treated|1
30021|NCT01634113|135302|P2|Overall Study|Not treated|0
30022|NCT01634113|135303|P1|Overall Study|Not treated|0
30023|NCT01634100|135347|P6|Overall Study|Withdrawal by Subject|0
30024|NCT01634100|135348|P5|Overall Study|Withdrawal by Subject|0
30025|NCT01634100|135349|P4|Overall Study|Withdrawal by Subject|0
30026|NCT01634100|135350|P3|Overall Study|Withdrawal by Subject|1
30027|NCT01634100|135351|P2|Overall Study|Withdrawal by Subject|0
30028|NCT01634100|135352|P1|Overall Study|Withdrawal by Subject|1
30029|NCT01633944|135368|P3|Double-blind Treatment Phase|Not specified|0
30030|NCT01633944|135369|P2|Double-blind Treatment Phase|Not specified|7
30031|NCT01633944|135370|P1|Double-blind Treatment Phase|Not specified|0
30032|NCT01633944|135368|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
30033|NCT01633944|135369|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
30034|NCT01633944|135370|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
30035|NCT01633944|135368|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
30036|NCT01633944|135369|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
30037|NCT01633944|135370|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
30038|NCT01633944|135368|P3|Double-blind Treatment Phase|Lost to Follow-up|9
30039|NCT01633944|135369|P2|Double-blind Treatment Phase|Lost to Follow-up|4
30040|NCT01633944|135370|P1|Double-blind Treatment Phase|Lost to Follow-up|0
30041|NCT01633944|135368|P3|Double-blind Treatment Phase|Protocol Violation|10
30042|NCT01633944|135369|P2|Double-blind Treatment Phase|Protocol Violation|7
30043|NCT01633944|135370|P1|Double-blind Treatment Phase|Protocol Violation|0
30044|NCT01633944|135368|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
30045|NCT01633944|135369|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
30046|NCT01633944|135370|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
30047|NCT01633944|135368|P3|Double-blind Treatment Phase|Lack of Efficacy|23
30048|NCT01633944|135369|P2|Double-blind Treatment Phase|Lack of Efficacy|8
30049|NCT01633944|135370|P1|Double-blind Treatment Phase|Lack of Efficacy|0
30050|NCT01633944|135368|P3|Double-blind Treatment Phase|Adverse Event|7
30051|NCT01633944|135369|P2|Double-blind Treatment Phase|Adverse Event|13
30052|NCT01633944|135370|P1|Double-blind Treatment Phase|Adverse Event|0
30053|NCT01633944|135368|P3|Open-label Titration Phase|Not specified|0
30054|NCT01633944|135369|P2|Open-label Titration Phase|Not specified|0
30055|NCT01633944|135370|P1|Open-label Titration Phase|Not specified|68
30056|NCT01633944|135368|P3|Open-label Titration Phase|Lost to Follow-up|0
30057|NCT01633944|135369|P2|Open-label Titration Phase|Lost to Follow-up|0
30058|NCT01633944|135370|P1|Open-label Titration Phase|Lost to Follow-up|22
30059|NCT01633944|135368|P3|Open-label Titration Phase|Protocol Violation|0
30060|NCT01633944|135369|P2|Open-label Titration Phase|Protocol Violation|0
30061|NCT01633944|135370|P1|Open-label Titration Phase|Protocol Violation|24
30062|NCT01633944|135368|P3|Open-label Titration Phase|Withdrawal by Subject|0
30063|NCT01633944|135369|P2|Open-label Titration Phase|Withdrawal by Subject|0
30064|NCT01633944|135370|P1|Open-label Titration Phase|Withdrawal by Subject|34
30065|NCT01633944|135368|P3|Open-label Titration Phase|Lack of Efficacy|0
30066|NCT01633944|135369|P2|Open-label Titration Phase|Lack of Efficacy|0
30067|NCT01633944|135370|P1|Open-label Titration Phase|Lack of Efficacy|33
30068|NCT01633944|135368|P3|Open-label Titration Phase|Adverse Event|0
30069|NCT01633944|135369|P2|Open-label Titration Phase|Adverse Event|0
30070|NCT01633944|135370|P1|Open-label Titration Phase|Adverse Event|109
30071|NCT01632904|135460|P2|Overall Study|Reason for discontinuation not available|1
30072|NCT01632904|135461|P1|Overall Study|Reason for discontinuation not available|0
30073|NCT01632904|135460|P2|Overall Study|Disease Progression|1
30074|NCT01632904|135461|P1|Overall Study|Disease Progression|0
30075|NCT01632904|135460|P2|Overall Study|Subject decision|2
30076|NCT01632904|135461|P1|Overall Study|Subject decision|3
30077|NCT01632904|135460|P2|Overall Study|Physician Decision|1
30078|NCT01632904|135461|P1|Overall Study|Physician Decision|0
30079|NCT01632904|135460|P2|Overall Study|Adverse Event|1
30080|NCT01632904|135461|P1|Overall Study|Adverse Event|4
30081|NCT01632878|135471|P1|Treatment|no information on study completion|43
30082|NCT01632878|135471|P1|Treatment|missing information|4
30083|NCT01632878|135471|P1|Treatment|Physician Decision|34
30084|NCT01632878|135471|P1|Treatment|Withdrawal by Subject|36
30085|NCT01632878|135471|P1|Treatment|Lost to Follow-up|41
30086|NCT01632878|135471|P1|Screening|Physician Decision|268
30087|NCT01632800|135475|P1|Overall Study|Subject did not fit in apparatus|1
30088|NCT01632150|135555|P1|Overall Study|Moved to compassionate program|2
30089|NCT01632150|135555|P1|Overall Study|Patient underwent autologous transplant|1
30090|NCT01632150|135555|P1|Overall Study|Withdrawal by Subject|2
30091|NCT01632150|135555|P1|Overall Study|Unrelated adverse event|7
30092|NCT01632150|135555|P1|Overall Study|Study drug toxicity|1
30093|NCT01632150|135555|P1|Overall Study|Disease progression|27
30094|NCT01632020|135564|P2|Overall Study|Adverse Event|0
30095|NCT01632020|135565|P1|Overall Study|Adverse Event|1
30096|NCT01632020|135564|P2|Overall Study|Withdrawal by Subject|0
30097|NCT01632020|135565|P1|Overall Study|Withdrawal by Subject|1
30098|NCT01631864|135584|P2|Overall Study|Adverse Event|3
30099|NCT01631864|135585|P1|Overall Study|Adverse Event|2
30100|NCT01631864|135584|P2|Overall Study|Withdrawal by Subject|1
30101|NCT01631864|135585|P1|Overall Study|Withdrawal by Subject|0
30102|NCT01631825|135597|P1|Overall Study|Physician Decision|2
30103|NCT01631825|135597|P1|Overall Study|Discontinuation criteria|1
30104|NCT01631825|135597|P1|Overall Study|Protocol Violation|4
30105|NCT01631825|135597|P1|Overall Study|Withdrawal by Subject|9
30106|NCT01631825|135597|P1|Overall Study|Lack of Efficacy|7
30107|NCT01631825|135597|P1|Overall Study|Adverse Event|42
30108|NCT01631812|135617|P1|Overall Study|Physician Decision|3
30109|NCT01631812|135617|P1|Overall Study|Withdrawal by Subject|4
30110|NCT01631812|135617|P1|Overall Study|Lack of Efficacy|5
30111|NCT01631812|135617|P1|Overall Study|Adverse Event|25
30112|NCT01631435|135755|P1|Overall Study|incomplete study procedure|5
30113|NCT01631435|135755|P1|Overall Study|Withdrawal by Subject|2
30114|NCT01631435|135755|P1|Overall Study|Adverse Event|2
30115|NCT01631227|135762|P2|Overall Study|administrative|1
30116|NCT01631227|135763|P1|Overall Study|administrative|2
30117|NCT01631227|135762|P2|Overall Study|Adverse Event|0
30118|NCT01631227|135763|P1|Overall Study|Adverse Event|1
30119|NCT01631227|135762|P2|Overall Study|withdrawn consent|21
30120|NCT01631227|135763|P1|Overall Study|withdrawn consent|27
30121|NCT01630135|135829|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
30122|NCT01630135|135830|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
30123|NCT01629823|135894|P3|Washout Period|Protocol Violation|0
30124|NCT01629823|135895|P2|Washout Period|Protocol Violation|1
30125|NCT01629823|135896|P1|Washout Period|Protocol Violation|0
30126|NCT01629823|135894|P3|Washout Period|Pregnancy|0
30127|NCT01629823|135895|P2|Washout Period|Pregnancy|0
30128|NCT01629823|135896|P1|Washout Period|Pregnancy|1
30129|NCT01629823|135894|P3|Washout Period|Safety|0
30130|NCT01629823|135895|P2|Washout Period|Safety|5
30131|NCT01629823|135896|P1|Washout Period|Safety|2
30132|NCT01629823|135894|P3|Trial Period|Failed to hold medication|1
30133|NCT01629823|135895|P2|Trial Period|Failed to hold medication|0
30134|NCT01629823|135896|P1|Trial Period|Failed to hold medication|0
30135|NCT01629823|135894|P3|Trial Period|Out-of-window visit|0
30136|NCT01629823|135895|P2|Trial Period|Out-of-window visit|2
30137|NCT01629823|135896|P1|Trial Period|Out-of-window visit|0
30138|NCT01629823|135894|P3|Trial Period|Adverse Event|0
30139|NCT01629823|135895|P2|Trial Period|Adverse Event|1
30140|NCT01629823|135896|P1|Trial Period|Adverse Event|0
30141|NCT01629823|135894|P3|Trial Period|Pregnancy|0
30142|NCT01629823|135895|P2|Trial Period|Pregnancy|0
30143|NCT01629823|135896|P1|Trial Period|Pregnancy|1
30144|NCT01629823|135894|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
30145|NCT01629823|135895|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
30146|NCT01629823|135896|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
30147|NCT01629823|135894|P3|Trial Period|Missed visit|8
30148|NCT01629823|135895|P2|Trial Period|Missed visit|9
30149|NCT01629823|135896|P1|Trial Period|Missed visit|11
30150|NCT01629706|135931|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
30151|NCT01629706|135931|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
30152|NCT01629706|135931|P1|Phase 2 Habitual|Relocation prior to Dispense|1
30153|NCT01629706|135931|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
30154|NCT01629706|135931|P1|Phase 2 Habitual|Screen Failure|6
30155|NCT01629706|135931|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
30156|NCT01629706|135931|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
30157|NCT01629706|135931|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
30158|NCT01629706|135931|P1|Phase 1 PureVision|Screen Failure|4
30159|NCT01629693|135959|P2|Overall Study|Subject decision unrelated to AE|1
30160|NCT01629693|135960|P1|Overall Study|Subject decision unrelated to AE|0
30161|NCT01629693|135959|P2|Overall Study|Poor comfort of study lenses|2
30162|NCT01629693|135960|P1|Overall Study|Poor comfort of study lenses|0
30163|NCT01629693|135959|P2|Overall Study|Investigator decision|1
30164|NCT01629693|135960|P1|Overall Study|Investigator decision|0
30165|NCT01629693|135959|P2|Overall Study|Adverse Event|0
30166|NCT01629693|135960|P1|Overall Study|Adverse Event|1
30167|NCT01629693|135959|P2|Overall Study|Withdrawal by Subject|2
30168|NCT01629693|135960|P1|Overall Study|Withdrawal by Subject|2
30169|NCT01629693|135959|P2|Overall Study|Lost to Follow-up|4
30170|NCT01629693|135960|P1|Overall Study|Lost to Follow-up|2
30171|NCT01629667|135969|P3|Overall Study|Code break|0
30172|NCT01629667|135970|P2|Overall Study|Code break|0
30173|NCT01629667|135971|P1|Overall Study|Code break|1
30174|NCT01629667|135969|P3|Overall Study|Enrolled in another clinical study|0
30175|NCT01629667|135970|P2|Overall Study|Enrolled in another clinical study|1
30176|NCT01629667|135971|P1|Overall Study|Enrolled in another clinical study|0
30177|NCT01629667|135969|P3|Overall Study|Site error in safety follow-up|1
30178|NCT01629667|135970|P2|Overall Study|Site error in safety follow-up|0
30179|NCT01629667|135971|P1|Overall Study|Site error in safety follow-up|0
30180|NCT01629667|135969|P3|Overall Study|Started other medicine|1
30181|NCT01629667|135970|P2|Overall Study|Started other medicine|0
30182|NCT01629667|135971|P1|Overall Study|Started other medicine|1
30183|NCT01629667|135969|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
30184|NCT01629667|135970|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
30185|NCT01629667|135971|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
30186|NCT01629667|135969|P3|Overall Study|Requiring lung transplant|3
30187|NCT01629667|135970|P2|Overall Study|Requiring lung transplant|1
30188|NCT01629667|135971|P1|Overall Study|Requiring lung transplant|2
30189|NCT01629667|135969|P3|Overall Study|Ongoing AE worsening right heart failure|0
30190|NCT01629667|135970|P2|Overall Study|Ongoing AE worsening right heart failure|1
30191|NCT01629667|135971|P1|Overall Study|Ongoing AE worsening right heart failure|0
30192|NCT01629667|135969|P3|Overall Study|Randomized, not treated|0
30193|NCT01629667|135970|P2|Overall Study|Randomized, not treated|1
30194|NCT01629667|135971|P1|Overall Study|Randomized, not treated|2
30195|NCT01629667|135969|P3|Overall Study|Death|3
30196|NCT01629667|135970|P2|Overall Study|Death|5
30197|NCT01629667|135971|P1|Overall Study|Death|1
30198|NCT01629667|135969|P3|Overall Study|Withdrawal by Subject|28
30199|NCT01629667|135970|P2|Overall Study|Withdrawal by Subject|20
30200|NCT01629667|135971|P1|Overall Study|Withdrawal by Subject|31
30201|NCT01629667|135969|P3|Overall Study|Lost to Follow-up|1
30202|NCT01629667|135970|P2|Overall Study|Lost to Follow-up|1
30203|NCT01629667|135971|P1|Overall Study|Lost to Follow-up|0
30204|NCT01629589|136055|P2|Overall Study|Did not receive study vaccine|1
30205|NCT01629589|136056|P1|Overall Study|Did not receive study vaccine|0
30206|NCT01629589|136055|P2|Overall Study|Withdrawal by Subject|3
30207|NCT01629589|136056|P1|Overall Study|Withdrawal by Subject|2
30208|NCT01629589|136055|P2|Overall Study|Lost to Follow-up|1
30209|NCT01629589|136056|P1|Overall Study|Lost to Follow-up|2
30210|NCT01629589|136055|P2|Overall Study|Protocol Violation|2
30211|NCT01629589|136056|P1|Overall Study|Protocol Violation|4
30212|NCT01628965|136095|P1|Overall Study|Discontinuation criteria|8
30213|NCT01628965|136095|P1|Overall Study|Lost to Follow-up|1
30214|NCT01628965|136095|P1|Overall Study|Withdrawal by Subject|3
30215|NCT01628965|136095|P1|Overall Study|Lack of Efficacy|7
30216|NCT01628965|136095|P1|Overall Study|Adverse Event|30
30217|NCT01628926|136104|P3|Overall Study|Physician Decision|1
30218|NCT01628926|136105|P2|Overall Study|Physician Decision|2
30219|NCT01628926|136106|P1|Overall Study|Physician Decision|2
30220|NCT01628926|136104|P3|Overall Study|Discontinuation criteria|0
30221|NCT01628926|136105|P2|Overall Study|Discontinuation criteria|4
30222|NCT01628926|136106|P1|Overall Study|Discontinuation criteria|3
30223|NCT01628926|136104|P3|Overall Study|Protocol Violation|0
30224|NCT01628926|136105|P2|Overall Study|Protocol Violation|1
30225|NCT01628926|136106|P1|Overall Study|Protocol Violation|0
30226|NCT01628926|136104|P3|Overall Study|Withdrawal by Subject|2
30227|NCT01628926|136105|P2|Overall Study|Withdrawal by Subject|4
30228|NCT01628926|136106|P1|Overall Study|Withdrawal by Subject|6
30229|NCT01628926|136104|P3|Overall Study|Lack of Efficacy|5
30230|NCT01628926|136105|P2|Overall Study|Lack of Efficacy|1
30231|NCT01628926|136106|P1|Overall Study|Lack of Efficacy|2
30232|NCT01628926|136104|P3|Overall Study|Adverse Event|9
30233|NCT01628926|136105|P2|Overall Study|Adverse Event|11
30234|NCT01628926|136106|P1|Overall Study|Adverse Event|13
30235|NCT01628913|136155|P2|Overall Study|Physician Decision|3
30236|NCT01628913|136156|P1|Overall Study|Physician Decision|1
30237|NCT01628913|136155|P2|Overall Study|Withdrawal by Subject|0
30238|NCT01628913|136156|P1|Overall Study|Withdrawal by Subject|1
30239|NCT01628913|136155|P2|Overall Study|study terminated by Sponsor|9
30240|NCT01628913|136156|P1|Overall Study|study terminated by Sponsor|4
30241|NCT01628913|136155|P2|Overall Study|Death|0
30242|NCT01628913|136156|P1|Overall Study|Death|1
30243|NCT01628913|136155|P2|Overall Study|Protocol Violation|0
30244|NCT01628913|136156|P1|Overall Study|Protocol Violation|1
30245|NCT01628913|136155|P2|Overall Study|Disease Progression|14
30246|NCT01628913|136156|P1|Overall Study|Disease Progression|11
30247|NCT01628913|136155|P2|Overall Study|Adverse Event|5
30248|NCT01628913|136156|P1|Overall Study|Adverse Event|12
30249|NCT01628848|136170|P2|Overall Study|Physician Decision|1
30250|NCT01628848|136171|P1|Overall Study|Physician Decision|3
30251|NCT01628848|136170|P2|Overall Study|Withdrawal by Subject|2
30252|NCT01628848|136171|P1|Overall Study|Withdrawal by Subject|0
30253|NCT01628848|136170|P2|Overall Study|Lack of Efficacy|4
30254|NCT01628848|136171|P1|Overall Study|Lack of Efficacy|0
30255|NCT01628848|136170|P2|Overall Study|Adverse Event|7
30256|NCT01628848|136171|P1|Overall Study|Adverse Event|9
30257|NCT01628692|136205|P6|Overall Study|Completed 12 Week only|1
30258|NCT01628692|136206|P5|Overall Study|Completed 12 Week only|0
30259|NCT01628692|136207|P4|Overall Study|Completed 12 Week only|0
30260|NCT01628692|136208|P3|Overall Study|Completed 12 Week only|0
30261|NCT01628692|136209|P2|Overall Study|Completed 12 Week only|0
30262|NCT01628692|136210|P1|Overall Study|Completed 12 Week only|0
30263|NCT01628692|136205|P6|Overall Study|Administrative reason by sponsor|1
30264|NCT01628692|136206|P5|Overall Study|Administrative reason by sponsor|0
30265|NCT01628692|136207|P4|Overall Study|Administrative reason by sponsor|0
30266|NCT01628692|136208|P3|Overall Study|Administrative reason by sponsor|0
30267|NCT01628692|136209|P2|Overall Study|Administrative reason by sponsor|0
30268|NCT01628692|136210|P1|Overall Study|Administrative reason by sponsor|0
30269|NCT01628692|136205|P6|Overall Study|Poor compliance/noncompliance|0
30270|NCT01628692|136206|P5|Overall Study|Poor compliance/noncompliance|0
30271|NCT01628692|136207|P4|Overall Study|Poor compliance/noncompliance|0
30272|NCT01628692|136208|P3|Overall Study|Poor compliance/noncompliance|0
30273|NCT01628692|136209|P2|Overall Study|Poor compliance/noncompliance|0
30274|NCT01628692|136210|P1|Overall Study|Poor compliance/noncompliance|1
30275|NCT01628692|136205|P6|Overall Study|Death|0
30276|NCT01628692|136206|P5|Overall Study|Death|0
30277|NCT01628692|136207|P4|Overall Study|Death|0
30278|NCT01628692|136208|P3|Overall Study|Death|0
30279|NCT01628692|136209|P2|Overall Study|Death|1
30280|NCT01628692|136210|P1|Overall Study|Death|0
30281|NCT01628692|136205|P6|Overall Study|Withdrawal by Subject|0
30282|NCT01628692|136206|P5|Overall Study|Withdrawal by Subject|0
30283|NCT01628692|136207|P4|Overall Study|Withdrawal by Subject|0
30284|NCT01628692|136208|P3|Overall Study|Withdrawal by Subject|1
30285|NCT01628692|136209|P2|Overall Study|Withdrawal by Subject|1
30286|NCT01628692|136210|P1|Overall Study|Withdrawal by Subject|0
30287|NCT01628692|136205|P6|Overall Study|Adverse Event|0
30288|NCT01628692|136206|P5|Overall Study|Adverse Event|0
30289|NCT01628692|136207|P4|Overall Study|Adverse Event|0
30290|NCT01628692|136208|P3|Overall Study|Adverse Event|2
30291|NCT01628692|136209|P2|Overall Study|Adverse Event|0
30292|NCT01628692|136210|P1|Overall Study|Adverse Event|2
30293|NCT01628692|136205|P6|Overall Study|Lack of Efficacy|7
30294|NCT01628692|136206|P5|Overall Study|Lack of Efficacy|4
30295|NCT01628692|136207|P4|Overall Study|Lack of Efficacy|1
30296|NCT01628692|136208|P3|Overall Study|Lack of Efficacy|5
30297|NCT01628692|136209|P2|Overall Study|Lack of Efficacy|4
30298|NCT01628692|136210|P1|Overall Study|Lack of Efficacy|4
30299|NCT01628510|136278|P2|Overall Study|Death|1
30300|NCT01628510|136279|P1|Overall Study|Death|3
30301|NCT01628510|136278|P2|Overall Study|Withdrawal by Subject|4
30302|NCT01628510|136279|P1|Overall Study|Withdrawal by Subject|0
30303|NCT01628367|136287|P2|Overall Study|Adverse Event|0
30304|NCT01628367|136288|P1|Overall Study|Adverse Event|1
30305|NCT01627860|136334|P2|Overall Study|Protocol Violation|0
30306|NCT01627860|136335|P1|Overall Study|Protocol Violation|1
30307|NCT01627860|136334|P2|Overall Study|Seizure frequency doubled|1
30308|NCT01627860|136335|P1|Overall Study|Seizure frequency doubled|0
30309|NCT01627860|136334|P2|Overall Study|Withdrawal by Subject|1
30310|NCT01627860|136335|P1|Overall Study|Withdrawal by Subject|2
30311|NCT01627860|136334|P2|Overall Study|Adverse Event|4
30312|NCT01627860|136335|P1|Overall Study|Adverse Event|9
30313|NCT01627782|136349|P4|Overall Study|Randomized But Not Treated|0
30314|NCT01627782|136350|P3|Overall Study|Randomized But Not Treated|0
30315|NCT01627782|136351|P2|Overall Study|Randomized But Not Treated|0
30316|NCT01627782|136352|P1|Overall Study|Randomized But Not Treated|1
30317|NCT01627782|136349|P4|Overall Study|Unspecified|3
30318|NCT01627782|136350|P3|Overall Study|Unspecified|0
30319|NCT01627782|136351|P2|Overall Study|Unspecified|2
30320|NCT01627782|136352|P1|Overall Study|Unspecified|0
30321|NCT01627782|136349|P4|Overall Study|Withdrawal by Subject|0
30322|NCT01627782|136350|P3|Overall Study|Withdrawal by Subject|0
30323|NCT01627782|136351|P2|Overall Study|Withdrawal by Subject|1
30324|NCT01627782|136352|P1|Overall Study|Withdrawal by Subject|2
30325|NCT01627782|136349|P4|Overall Study|Protocol Violation|0
30326|NCT01627782|136350|P3|Overall Study|Protocol Violation|0
30327|NCT01627782|136351|P2|Overall Study|Protocol Violation|0
30328|NCT01627782|136352|P1|Overall Study|Protocol Violation|1
30329|NCT01627782|136349|P4|Overall Study|Lack of Efficacy|2
30330|NCT01627782|136350|P3|Overall Study|Lack of Efficacy|15
30331|NCT01627782|136351|P2|Overall Study|Lack of Efficacy|1
30332|NCT01627782|136352|P1|Overall Study|Lack of Efficacy|11
30333|NCT01627782|136349|P4|Overall Study|Adverse Event|1
30334|NCT01627782|136350|P3|Overall Study|Adverse Event|0
30335|NCT01627782|136351|P2|Overall Study|Adverse Event|2
30336|NCT01627782|136352|P1|Overall Study|Adverse Event|1
30337|NCT01627561|136410|P2|Overall Study|Withdrawal by Subject|2
30338|NCT01627561|136411|P1|Overall Study|Withdrawal by Subject|0
30339|NCT01627561|136410|P2|Overall Study|Migrated/moved from study area|1
30340|NCT01627561|136411|P1|Overall Study|Migrated/moved from study area|0
30341|NCT01627340|136459|P2|Overall Study|Withdrawal by Subject|0
30342|NCT01627340|136460|P1|Overall Study|Withdrawal by Subject|2
30343|NCT01627340|136459|P2|Overall Study|Pregnancy|0
30344|NCT01627340|136460|P1|Overall Study|Pregnancy|1
30345|NCT01627340|136459|P2|Overall Study|Lost to Follow-up|4
30346|NCT01627340|136460|P1|Overall Study|Lost to Follow-up|8
30347|NCT01627340|136459|P2|Overall Study|Adverse Event|0
30348|NCT01627340|136460|P1|Overall Study|Adverse Event|1
30349|NCT01627327|136478|P2|Overall Study|Withdrawal by Subject|3
30350|NCT01627327|136479|P1|Overall Study|Withdrawal by Subject|3
30351|NCT01627327|136478|P2|Overall Study|Physician Decision|0
30352|NCT01627327|136479|P1|Overall Study|Physician Decision|1
30353|NCT01627327|136478|P2|Overall Study|Lost to Follow-up|3
30354|NCT01627327|136479|P1|Overall Study|Lost to Follow-up|1
30355|NCT01627327|136478|P2|Overall Study|Protocol Violation|10
30356|NCT01627327|136479|P1|Overall Study|Protocol Violation|4
30357|NCT01627327|136478|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
30358|NCT01627327|136479|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
30359|NCT01627327|136478|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
30360|NCT01627327|136479|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
30361|NCT01627327|136478|P2|Overall Study|Adverse Event|12
30362|NCT01627327|136479|P1|Overall Study|Adverse Event|6
30363|NCT01627249|136492|P3|Overall Study|Missed Visit|0
30364|NCT01627249|136493|P2|Overall Study|Missed Visit|1
30365|NCT01627249|136494|P1|Overall Study|Missed Visit|1
30366|NCT01627249|136492|P3|Overall Study|Withdrawal by Subject|9
30367|NCT01627249|136493|P2|Overall Study|Withdrawal by Subject|6
30368|NCT01627249|136494|P1|Overall Study|Withdrawal by Subject|12
30369|NCT01627249|136492|P3|Overall Study|Death|3
30370|NCT01627249|136493|P2|Overall Study|Death|5
30371|NCT01627249|136494|P1|Overall Study|Death|3
30372|NCT01626690|136615|P2|Overall Study|Adverse Event|0
30373|NCT01626690|136616|P1|Overall Study|Adverse Event|1
30374|NCT01626690|136615|P2|Overall Study|Protocol Violation|0
30375|NCT01626690|136616|P1|Overall Study|Protocol Violation|1
30376|NCT01626456|136638|P2|Overall Study|Incarceration|2
30377|NCT01626456|136639|P1|Overall Study|Incarceration|0
30378|NCT01626456|136638|P2|Overall Study|Site Closure|3
30379|NCT01626456|136639|P1|Overall Study|Site Closure|2
30380|NCT01626456|136638|P2|Overall Study|Protocol Violation|1
30381|NCT01626456|136639|P1|Overall Study|Protocol Violation|1
30382|NCT01626456|136638|P2|Overall Study|Physician Decision|4
30383|NCT01626456|136639|P1|Overall Study|Physician Decision|1
30384|NCT01626456|136638|P2|Overall Study|Lack of Efficacy|7
30385|NCT01626456|136639|P1|Overall Study|Lack of Efficacy|6
30386|NCT01626456|136638|P2|Overall Study|Lost to Follow-up|27
30387|NCT01626456|136639|P1|Overall Study|Lost to Follow-up|2
30388|NCT01626456|136638|P2|Overall Study|Adverse Event|27
30389|NCT01626456|136639|P1|Overall Study|Adverse Event|2
30390|NCT01626456|136638|P2|Overall Study|Withdrawal by Subject|46
30391|NCT01626456|136639|P1|Overall Study|Withdrawal by Subject|21
30392|NCT01626391|136669|P2|Overall Study|Withdrawal by Subject|0
30393|NCT01626391|136670|P1|Overall Study|Withdrawal by Subject|1
30394|NCT01626391|136669|P2|Overall Study|Physician Decision|0
30395|NCT01626391|136670|P1|Overall Study|Physician Decision|1
30396|NCT01626118|136680|P4|Overall Study|Investigator Decision|0
30397|NCT01626118|136681|P3|Overall Study|Investigator Decision|0
30398|NCT01626118|136682|P2|Overall Study|Investigator Decision|1
30399|NCT01626118|136683|P1|Overall Study|Investigator Decision|0
30400|NCT01626118|136680|P4|Overall Study|Adverse Event|0
30401|NCT01626118|136681|P3|Overall Study|Adverse Event|1
30402|NCT01626118|136682|P2|Overall Study|Adverse Event|1
30403|NCT01626118|136683|P1|Overall Study|Adverse Event|0
30404|NCT01626118|136680|P4|Overall Study|Lost to Follow-up|0
30405|NCT01626118|136681|P3|Overall Study|Lost to Follow-up|0
30406|NCT01626118|136682|P2|Overall Study|Lost to Follow-up|0
30407|NCT01626118|136683|P1|Overall Study|Lost to Follow-up|1
30408|NCT01626118|136680|P4|Overall Study|Lack of Efficacy|3
30409|NCT01626118|136681|P3|Overall Study|Lack of Efficacy|1
30410|NCT01626118|136682|P2|Overall Study|Lack of Efficacy|0
30411|NCT01626118|136683|P1|Overall Study|Lack of Efficacy|1
30412|NCT01625910|136729|P2|Overall Study|Lost to Follow-up|4
30413|NCT01625910|136730|P1|Overall Study|Lost to Follow-up|3
30414|NCT01625845|136740|P2|Overall Study|Withdrawal by Subject|0
30415|NCT01625845|136741|P1|Overall Study|Withdrawal by Subject|2
30416|NCT01625845|136740|P2|Overall Study|Lost to Follow-up|1
30417|NCT01625845|136741|P1|Overall Study|Lost to Follow-up|2
30418|NCT01625845|136740|P2|Overall Study|Adverse Event|2
30419|NCT01625845|136741|P1|Overall Study|Adverse Event|1
30420|NCT01625689|136761|P2|Overall Study|Migration|1
30421|NCT01625689|136762|P1|Overall Study|Migration|2
30422|NCT01625377|136798|P2|Overall Study|Abnormal laboratory values|0
30423|NCT01625377|136799|P1|Overall Study|Abnormal laboratory values|1
30424|NCT01625377|136798|P2|Overall Study|Unsatisfactory therapeutic effect|1
30425|NCT01625377|136799|P1|Overall Study|Unsatisfactory therapeutic effect|0
30426|NCT01625377|136798|P2|Overall Study|Graft loss|0
30427|NCT01625377|136799|P1|Overall Study|Graft loss|1
30428|NCT01625377|136798|P2|Overall Study|Adverse Event|16
30429|NCT01625377|136799|P1|Overall Study|Adverse Event|3
30430|NCT01625377|136798|P2|Overall Study|Protocol Violation|3
30431|NCT01625377|136799|P1|Overall Study|Protocol Violation|0
30432|NCT01625377|136798|P2|Overall Study|Administrative Problem|1
30433|NCT01625377|136799|P1|Overall Study|Administrative Problem|1
30434|NCT01625377|136798|P2|Overall Study|Death|1
30435|NCT01625377|136799|P1|Overall Study|Death|1
30436|NCT01625338|136832|P3|Overall Study|Study Discontinued by Sponsor|1
30437|NCT01625338|136833|P2|Overall Study|Study Discontinued by Sponsor|0
30438|NCT01625338|136834|P1|Overall Study|Study Discontinued by Sponsor|0
30439|NCT01625338|136832|P3|Overall Study|Adverse Event|1
30440|NCT01625338|136833|P2|Overall Study|Adverse Event|0
30441|NCT01625338|136834|P1|Overall Study|Adverse Event|1
30442|NCT01625338|136832|P3|Overall Study|Subject Withdrew Consent|2
30443|NCT01625338|136833|P2|Overall Study|Subject Withdrew Consent|0
30444|NCT01625338|136834|P1|Overall Study|Subject Withdrew Consent|1
30445|NCT01625338|136832|P3|Overall Study|Investigator Decision|1
30446|NCT01625338|136833|P2|Overall Study|Investigator Decision|2
30447|NCT01625338|136834|P1|Overall Study|Investigator Decision|0
30448|NCT01625338|136832|P3|Overall Study|Lost to Follow-up|2
30449|NCT01625338|136833|P2|Overall Study|Lost to Follow-up|3
30450|NCT01625338|136834|P1|Overall Study|Lost to Follow-up|3
30451|NCT01625338|136832|P3|Overall Study|Efficacy Failure|31
30452|NCT01625338|136833|P2|Overall Study|Efficacy Failure|39
30453|NCT01625338|136834|P1|Overall Study|Efficacy Failure|27
30454|NCT01625338|136832|P3|Overall Study|Enrolled but not Treated|1
30455|NCT01625338|136833|P2|Overall Study|Enrolled but not Treated|0
30456|NCT01625338|136834|P1|Overall Study|Enrolled but not Treated|0
30457|NCT01625091|136873|P2|Post-intervention|Study termination|1
30458|NCT01625091|136874|P1|Post-intervention|Study termination|2
30459|NCT01625091|136873|P2|Post-intervention|Lost to Follow-up|0
30460|NCT01625091|136874|P1|Post-intervention|Lost to Follow-up|2
30461|NCT01625091|136873|P2|Post-intervention|Death|1
30462|NCT01625091|136874|P1|Post-intervention|Death|0
30463|NCT01625091|136873|P2|Intervention|Study termination|3
30464|NCT01625091|136874|P1|Intervention|Study termination|2
30465|NCT01625091|136873|P2|Intervention|Lost to Follow-up|4
30466|NCT01625091|136874|P1|Intervention|Lost to Follow-up|4
30467|NCT01625091|136873|P2|Intervention|Adverse Event|2
30468|NCT01625091|136874|P1|Intervention|Adverse Event|0
30469|NCT01625091|136873|P2|Intervention|Withdrawal by Subject|1
30470|NCT01625091|136874|P1|Intervention|Withdrawal by Subject|4
30471|NCT01625091|136873|P2|Intervention|Death|1
30472|NCT01625091|136874|P1|Intervention|Death|1
30473|NCT01624467|136915|P1|Overall Study|Subject Withdrew from Treatment|1
30474|NCT01624467|136915|P1|Overall Study|Per Sponsor Requirement|1
30475|NCT01624467|136915|P1|Overall Study|Progressive Disease|19
30476|NCT01624467|136915|P1|Overall Study|Adverse Event|7
30477|NCT01624467|136915|P1|Overall Study|Lost to Follow-up|1
30478|NCT01624467|136915|P1|Overall Study|Withdrawal by Subject|2
30479|NCT01624259|136954|P2|Overall Study|Abnormal laboratory measure|0
30480|NCT01624259|136955|P1|Overall Study|Abnormal laboratory measure|3
30481|NCT01624259|136954|P2|Overall Study|Lost to Follow-up|3
30482|NCT01624259|136955|P1|Overall Study|Lost to Follow-up|2
30483|NCT01624259|136954|P2|Overall Study|Physician Decision|1
30484|NCT01624259|136955|P1|Overall Study|Physician Decision|1
30485|NCT01624259|136954|P2|Overall Study|Withdrawal by Subject|7
30486|NCT01624259|136955|P1|Overall Study|Withdrawal by Subject|5
30487|NCT01624259|136954|P2|Overall Study|Protocol Violation|2
30488|NCT01624259|136955|P1|Overall Study|Protocol Violation|1
30489|NCT01624259|136954|P2|Overall Study|Adverse Event|18
30490|NCT01624259|136955|P1|Overall Study|Adverse Event|18
30491|NCT01624233|137004|P1|Period 3 - Maintenance|Withdrawal by Subject|2
30492|NCT01624233|137004|P1|Period 3 - Maintenance|Physician Decision|2
30493|NCT01624233|137004|P1|Period 3 - Maintenance|Lack of Efficacy|1
30494|NCT01624233|137004|P1|Period 3 - Maintenance|Adverse Event|2
30495|NCT01624233|137004|P1|Period 2 - Induction|Adverse Event|1
30496|NCT01623830|137057|P2|Overall Study|Exclusion from Study|2
30497|NCT01623830|137058|P1|Overall Study|Exclusion from Study|1
30498|NCT01623830|137057|P2|Overall Study|Withdrawal by Subject|7
30499|NCT01623830|137058|P1|Overall Study|Withdrawal by Subject|6
30500|NCT01623271|137099|P1|Overall Study|Withdrawal by Subject|2
30501|NCT01623154|137103|P1|Overall Study|Did not drink Pranactin Citric|4
30502|NCT01623115|137111|P2|Overall Study|Other than specified above|3
30503|NCT01623115|137112|P1|Overall Study|Other than specified above|0
30504|NCT01623115|137111|P2|Overall Study|Death|4
30505|NCT01623115|137112|P1|Overall Study|Death|0
30506|NCT01623115|137111|P2|Overall Study|Site closure|7
30507|NCT01623115|137112|P1|Overall Study|Site closure|1
30508|NCT01623115|137111|P2|Overall Study|Last visit outside protocol visit window|26
30509|NCT01623115|137112|P1|Overall Study|Last visit outside protocol visit window|14
30510|NCT01623115|137111|P2|Overall Study|Related to study drug administration|2
30511|NCT01623115|137112|P1|Overall Study|Related to study drug administration|0
30512|NCT01623115|137111|P2|Overall Study|Consent withdrawn by participant|6
30513|NCT01623115|137112|P1|Overall Study|Consent withdrawn by participant|2
30514|NCT01623115|137111|P2|Overall Study|Poor compliance to protocol|10
30515|NCT01623115|137112|P1|Overall Study|Poor compliance to protocol|4
30516|NCT01623115|137111|P2|Overall Study|Adverse Event|13
30517|NCT01623115|137112|P1|Overall Study|Adverse Event|10
30518|NCT01623115|137111|P2|Overall Study|Participants moved|5
30519|NCT01623115|137112|P1|Overall Study|Participants moved|1
30520|NCT01623115|137111|P2|Overall Study|Physician Decision|0
30521|NCT01623115|137112|P1|Overall Study|Physician Decision|1
30522|NCT01623115|137111|P2|Overall Study|Randomized but not treated|1
30523|NCT01623115|137112|P1|Overall Study|Randomized but not treated|0
30524|NCT01623050|137172|P1|Overall Study|Lost to Follow-up|9
30525|NCT01622673|137186|P6|Treatment Period 3|Protocol Violation|0
30526|NCT01622673|137187|P5|Treatment Period 3|Protocol Violation|0
30527|NCT01622673|137188|P4|Treatment Period 3|Protocol Violation|0
30528|NCT01622673|137189|P3|Treatment Period 3|Protocol Violation|0
30529|NCT01622673|137190|P2|Treatment Period 3|Protocol Violation|1
30530|NCT01622673|137191|P1|Treatment Period 3|Protocol Violation|0
30531|NCT01622673|137186|P6|Treatment Period 2|Withdrawal by Subject|0
30532|NCT01622673|137187|P5|Treatment Period 2|Withdrawal by Subject|0
30533|NCT01622673|137188|P4|Treatment Period 2|Withdrawal by Subject|1
30534|NCT01622673|137189|P3|Treatment Period 2|Withdrawal by Subject|0
30535|NCT01622673|137190|P2|Treatment Period 2|Withdrawal by Subject|0
30536|NCT01622673|137191|P1|Treatment Period 2|Withdrawal by Subject|0
30537|NCT01622673|137186|P6|Treatment Period 1|Protocol Violation|0
30538|NCT01622673|137187|P5|Treatment Period 1|Protocol Violation|0
30539|NCT01622673|137188|P4|Treatment Period 1|Protocol Violation|0
30540|NCT01622673|137189|P3|Treatment Period 1|Protocol Violation|0
30541|NCT01622673|137190|P2|Treatment Period 1|Protocol Violation|1
30542|NCT01622673|137191|P1|Treatment Period 1|Protocol Violation|0
30543|NCT01622673|137186|P6|Treatment Period 1|Withdrawal by Subject|0
30544|NCT01622673|137187|P5|Treatment Period 1|Withdrawal by Subject|0
30545|NCT01622673|137188|P4|Treatment Period 1|Withdrawal by Subject|1
30546|NCT01622673|137189|P3|Treatment Period 1|Withdrawal by Subject|0
30547|NCT01622673|137190|P2|Treatment Period 1|Withdrawal by Subject|0
30548|NCT01622673|137191|P1|Treatment Period 1|Withdrawal by Subject|0
30549|NCT01622660|137226|P1|Overall Study|Adverse Event|1
30550|NCT01622231|137261|P1|Overall Study|Withdrawal by Subject|1
30551|NCT01622231|137261|P1|Overall Study|Physician Decision|1
30552|NCT01621191|137356|P1|Overall Study|Site Removed From Study|1
30553|NCT01621191|137356|P1|Overall Study|Lost to Follow-up|1
30554|NCT01621191|137356|P1|Overall Study|Lack of Efficacy|6
30555|NCT01621191|137356|P1|Overall Study|Withdrawal by Subject|8
30556|NCT01621191|137356|P1|Overall Study|Adverse Event|9
30557|NCT01621178|137370|P3|Overall Study|Physician Decision|5
30558|NCT01621178|137371|P2|Overall Study|Physician Decision|2
30559|NCT01621178|137372|P1|Overall Study|Physician Decision|3
30560|NCT01621178|137370|P3|Overall Study|Withdrawal by Subject|17
30561|NCT01621178|137371|P2|Overall Study|Withdrawal by Subject|14
30562|NCT01621178|137372|P1|Overall Study|Withdrawal by Subject|8
30563|NCT01621178|137370|P3|Overall Study|Lost to Follow-up|1
30564|NCT01621178|137371|P2|Overall Study|Lost to Follow-up|1
30565|NCT01621178|137372|P1|Overall Study|Lost to Follow-up|1
30566|NCT01621178|137370|P3|Overall Study|Death|1
30567|NCT01621178|137371|P2|Overall Study|Death|4
30568|NCT01621178|137372|P1|Overall Study|Death|2
30569|NCT01621178|137370|P3|Overall Study|Adverse Event|7
30570|NCT01621178|137371|P2|Overall Study|Adverse Event|1
30571|NCT01621178|137372|P1|Overall Study|Adverse Event|1
30572|NCT01621126|137419|P1|Overall Study|Physician Decision|6
30573|NCT01620489|137440|P2|Overall Study|Unclassified|2
30574|NCT01620489|137441|P1|Overall Study|Unclassified|1
30575|NCT01620489|137440|P2|Overall Study|Withdrawal Criteria|25
30576|NCT01620489|137441|P1|Overall Study|Withdrawal Criteria|17
30577|NCT01620489|137440|P2|Overall Study|Protocol Violation|3
30578|NCT01620489|137441|P1|Overall Study|Protocol Violation|0
30579|NCT01620489|137440|P2|Overall Study|Adverse Event|4
30580|NCT01620489|137441|P1|Overall Study|Adverse Event|17
30581|NCT01620255|137462|P5|Overall Study|Withdrawn at discretion of investigator|1
30582|NCT01620255|137463|P4|Overall Study|Withdrawn at discretion of investigator|0
30583|NCT01620255|137464|P3|Overall Study|Withdrawn at discretion of investigator|0
30584|NCT01620255|137465|P2|Overall Study|Withdrawn at discretion of investigator|0
30585|NCT01620255|137466|P1|Overall Study|Withdrawn at discretion of investigator|0
30586|NCT01620255|137462|P5|Overall Study|Adverse Event|1
30587|NCT01620255|137463|P4|Overall Study|Adverse Event|1
30588|NCT01620255|137464|P3|Overall Study|Adverse Event|0
30589|NCT01620255|137465|P2|Overall Study|Adverse Event|4
30590|NCT01620255|137466|P1|Overall Study|Adverse Event|0
30591|NCT01620255|137462|P5|Overall Study|Non-compliance|0
30592|NCT01620255|137463|P4|Overall Study|Non-compliance|0
30593|NCT01620255|137464|P3|Overall Study|Non-compliance|0
30594|NCT01620255|137465|P2|Overall Study|Non-compliance|1
30595|NCT01620255|137466|P1|Overall Study|Non-compliance|0
30596|NCT01620255|137462|P5|Overall Study|Participant underwent fecal transplant|0
30597|NCT01620255|137463|P4|Overall Study|Participant underwent fecal transplant|0
30598|NCT01620255|137464|P3|Overall Study|Participant underwent fecal transplant|1
30599|NCT01620255|137465|P2|Overall Study|Participant underwent fecal transplant|0
30600|NCT01620255|137466|P1|Overall Study|Participant underwent fecal transplant|0
30601|NCT01620255|137462|P5|Overall Study|Withdrawal by Subject|4
30602|NCT01620255|137463|P4|Overall Study|Withdrawal by Subject|2
30603|NCT01620255|137464|P3|Overall Study|Withdrawal by Subject|1
30604|NCT01620255|137465|P2|Overall Study|Withdrawal by Subject|1
30605|NCT01620255|137466|P1|Overall Study|Withdrawal by Subject|4
30606|NCT01620177|137543|P1|Overall Study|Randomized, Not Active due to Scheduling|1
30607|NCT01620177|137543|P1|Overall Study|Physician Decision|2
30608|NCT01620177|137543|P1|Overall Study|Lost to Follow-up|7
30609|NCT01620177|137543|P1|Overall Study|Withdrawal by Subject|26
30610|NCT01620177|137543|P1|Overall Study|Failure at Screening Visit|43
30611|NCT01620138|137568|P2|Overall Study|Adverse Event|0
30612|NCT01620138|137569|P1|Overall Study|Adverse Event|2
30613|NCT01620138|137568|P2|Overall Study|Lack of Efficacy|0
30614|NCT01620138|137569|P1|Overall Study|Lack of Efficacy|1
30615|NCT01620138|137568|P2|Overall Study|Withdrawal by Subject|0
30616|NCT01620138|137569|P1|Overall Study|Withdrawal by Subject|3
30617|NCT01620086|137577|P3|Overall Study|Physician Decision|0
30618|NCT01620086|137578|P2|Overall Study|Physician Decision|0
30619|NCT01620086|137579|P1|Overall Study|Physician Decision|1
30620|NCT01620086|137577|P3|Overall Study|failed study criteria|0
30621|NCT01620086|137578|P2|Overall Study|failed study criteria|4
30622|NCT01620086|137579|P1|Overall Study|failed study criteria|1
30623|NCT01620086|137577|P3|Overall Study|Withdrawal by Subject|0
30624|NCT01620086|137578|P2|Overall Study|Withdrawal by Subject|3
30625|NCT01620086|137579|P1|Overall Study|Withdrawal by Subject|3
30626|NCT01620060|137598|P1|Overall Study|Per Sponsor Decision|2
30627|NCT01620060|137598|P1|Overall Study|Family emergency|1
30628|NCT01620060|137598|P1|Overall Study|Did not comply with Study Produre|1
30629|NCT01620060|137598|P1|Overall Study|Withdrawal by Subject|1
30630|NCT01620060|137598|P1|Overall Study|Protocol Violation|1
30631|NCT01620060|137598|P1|Overall Study|Adverse Event|9
30632|NCT01619878|137617|P1|Follow-up at 12 Months of Age|Death|2
30633|NCT01619878|137617|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
30634|NCT01619878|137617|P1|6 Week Follow-up Phase|Adverse Event|1
30635|NCT01619800|137631|P2|Overall Study|study terminated|0
30636|NCT01619800|137632|P1|Overall Study|study terminated|2
30637|NCT01619787|137640|P1|Overall Study|Lost to Follow-up|5
30638|NCT01619579|137657|P2|Overall Study|Withdrawal by Subject|3
30639|NCT01619579|137658|P1|Overall Study|Withdrawal by Subject|0
30640|NCT01619059|137670|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
30641|NCT01619059|137671|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
30642|NCT01619059|137670|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
30643|NCT01619059|137671|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
30644|NCT01619059|137670|P2|Long-Term (LT) Treatment Period|Death|0
30645|NCT01619059|137671|P1|Long-Term (LT) Treatment Period|Death|1
30646|NCT01619059|137670|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
30647|NCT01619059|137671|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
30648|NCT01619059|137670|P2|Long-Term (LT) Treatment Period|Adverse Event|3
30649|NCT01619059|137671|P1|Long-Term (LT) Treatment Period|Adverse Event|2
30650|NCT01619059|137670|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
30651|NCT01619059|137671|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
30652|NCT01619059|137670|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
30653|NCT01619059|137671|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
30654|NCT01619059|137670|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
30655|NCT01619059|137671|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
30656|NCT01619059|137670|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
30657|NCT01619059|137671|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
30658|NCT01619059|137670|P2|Short-Term (ST) Treatment Period|Adverse Event|0
30659|NCT01619059|137671|P1|Short-Term (ST) Treatment Period|Adverse Event|1
30660|NCT01618968|137687|P4|Overall Study|Death|1
30661|NCT01618968|137688|P3|Overall Study|Death|0
30662|NCT01618968|137689|P2|Overall Study|Death|0
30663|NCT01618968|137690|P1|Overall Study|Death|0
30664|NCT01618968|137687|P4|Overall Study|Adverse Event|0
30665|NCT01618968|137688|P3|Overall Study|Adverse Event|0
30666|NCT01618968|137689|P2|Overall Study|Adverse Event|0
30667|NCT01618968|137690|P1|Overall Study|Adverse Event|1
30668|NCT01618864|137757|P1|Overall Study|Lost to Follow-up|2
30669|NCT01618864|137757|P1|Overall Study|Withdrawal by Subject|2
30670|NCT01618838|137766|P1|Overall Study|slow accrual, trial closed prematurely.|4
30671|NCT01618708|137772|P2|Overall Study|Randomized but not treated|2
30672|NCT01618708|137773|P1|Overall Study|Randomized but not treated|3
30673|NCT01618708|137772|P2|Overall Study|Other than specified above|1
30674|NCT01618708|137773|P1|Overall Study|Other than specified above|1
30675|NCT01618708|137772|P2|Overall Study|Technical problems|0
30676|NCT01618708|137773|P1|Overall Study|Technical problems|2
30677|NCT01618708|137772|P2|Overall Study|Lack of Efficacy|8
30678|NCT01618708|137773|P1|Overall Study|Lack of Efficacy|8
30679|NCT01618708|137772|P2|Overall Study|Withdrawal by Subject|22
30680|NCT01618708|137773|P1|Overall Study|Withdrawal by Subject|17
30681|NCT01618708|137772|P2|Overall Study|Lost to Follow-up|3
30682|NCT01618708|137773|P1|Overall Study|Lost to Follow-up|3
30683|NCT01618708|137772|P2|Overall Study|Adverse Event|10
30684|NCT01618708|137773|P1|Overall Study|Adverse Event|10
30685|NCT01618669|137787|P2|Overall Study|Miscellaneous Reason|1
30686|NCT01618669|137788|P1|Overall Study|Miscellaneous Reason|0
30687|NCT01618669|137787|P2|Overall Study|Withdrawal by Subject|9
30688|NCT01618669|137788|P1|Overall Study|Withdrawal by Subject|9
30689|NCT01618669|137787|P2|Overall Study|Protocol Violation|3
30690|NCT01618669|137788|P1|Overall Study|Protocol Violation|5
30691|NCT01618669|137787|P2|Overall Study|Adverse Event|7
30692|NCT01618669|137788|P1|Overall Study|Adverse Event|16
30693|NCT01618669|137787|P2|Overall Study|Randomized but Never Received Study Drug|2
30694|NCT01618669|137788|P1|Overall Study|Randomized but Never Received Study Drug|3
30695|NCT01618669|137787|P2|Overall Study|Lost to Follow-up|1
30696|NCT01618669|137788|P1|Overall Study|Lost to Follow-up|1
30697|NCT01618266|137841|P1|Overall Study|Protocol Violation|43
30698|NCT01618266|137841|P1|Overall Study|Lack of Efficacy|23
30699|NCT01618266|137841|P1|Overall Study|Other reasons|11
30700|NCT01618266|137841|P1|Overall Study|Treatment satisfaction|10
30701|NCT01618266|137841|P1|Overall Study|Lost to Follow-up|9
30702|NCT01618214|137878|P2|Overall Study|Unclassified|5
30703|NCT01618214|137879|P1|Overall Study|Unclassified|4
30704|NCT01618214|137878|P2|Overall Study|Withdrawal Criteria|2
30705|NCT01618214|137879|P1|Overall Study|Withdrawal Criteria|1
30706|NCT01618214|137878|P2|Overall Study|Protocol Violation|4
30707|NCT01618214|137879|P1|Overall Study|Protocol Violation|1
30708|NCT01618214|137878|P2|Overall Study|Lack of Efficacy|1
30709|NCT01618214|137879|P1|Overall Study|Lack of Efficacy|1
30710|NCT01618214|137878|P2|Overall Study|Adverse Event|1
30711|NCT01618214|137879|P1|Overall Study|Adverse Event|3
30712|NCT01618162|137895|P2|Overall Study|Unclassified|13
30713|NCT01618162|137896|P1|Overall Study|Unclassified|14
30714|NCT01618162|137895|P2|Overall Study|Withdrawal Criteria|10
30715|NCT01618162|137896|P1|Overall Study|Withdrawal Criteria|2
30716|NCT01618162|137895|P2|Overall Study|Adverse Event|2
30717|NCT01618162|137896|P1|Overall Study|Adverse Event|9
30718|NCT01618162|137895|P2|Overall Study|Protocol Violation|10
30719|NCT01618162|137896|P1|Overall Study|Protocol Violation|13
30720|NCT01618019|137916|P2|Overall Study|Withdrawal by Subject|14
30721|NCT01618019|137917|P1|Overall Study|Withdrawal by Subject|14
30722|NCT01617668|137939|P4|Overall Study|Subject/guardian decision|1
30723|NCT01617668|137940|P3|Overall Study|Subject/guardian decision|2
30724|NCT01617668|137941|P2|Overall Study|Subject/guardian decision|3
30725|NCT01617668|137942|P1|Overall Study|Subject/guardian decision|1
30726|NCT01617668|137939|P4|Overall Study|Progressive Disease|9
30727|NCT01617668|137940|P3|Overall Study|Progressive Disease|6
30728|NCT01617668|137941|P2|Overall Study|Progressive Disease|4
30729|NCT01617668|137942|P1|Overall Study|Progressive Disease|4
30730|NCT01617668|137939|P4|Overall Study|Physician Decision|0
30731|NCT01617668|137940|P3|Overall Study|Physician Decision|3
30732|NCT01617668|137941|P2|Overall Study|Physician Decision|2
30733|NCT01617668|137942|P1|Overall Study|Physician Decision|1
30734|NCT01617668|137939|P4|Overall Study|Adverse Event|5
30735|NCT01617668|137940|P3|Overall Study|Adverse Event|12
30736|NCT01617668|137941|P2|Overall Study|Adverse Event|0
30737|NCT01617668|137942|P1|Overall Study|Adverse Event|7
30738|NCT01617655|137983|P2|Overall Study|Other than specified above|2
30739|NCT01617655|137984|P1|Overall Study|Other than specified above|1
30740|NCT01617655|137983|P2|Overall Study|Site closure|5
30741|NCT01617655|137984|P1|Overall Study|Site closure|3
30742|NCT01617655|137983|P2|Overall Study|Last visit outside protocol visit window|10
30743|NCT01617655|137984|P1|Overall Study|Last visit outside protocol visit window|1
30744|NCT01617655|137983|P2|Overall Study|Consent withdrawn by participant|1
30745|NCT01617655|137984|P1|Overall Study|Consent withdrawn by participant|1
30746|NCT01617655|137983|P2|Overall Study|Participants moved|4
30747|NCT01617655|137984|P1|Overall Study|Participants moved|0
30748|NCT01617655|137983|P2|Overall Study|Poor compliance to protocol|4
30749|NCT01617655|137984|P1|Overall Study|Poor compliance to protocol|1
30750|NCT01617655|137983|P2|Overall Study|Adverse Event|3
30751|NCT01617655|137984|P1|Overall Study|Adverse Event|2
30752|NCT01617447|138069|P2|Overall Study|Physician Decision|2
30753|NCT01617447|138070|P1|Overall Study|Physician Decision|0
30754|NCT01617447|138069|P2|Overall Study|Adverse Event|1
30755|NCT01617447|138070|P1|Overall Study|Adverse Event|0
30756|NCT01617434|138078|P2|Overall Study|Unclassified|4
30757|NCT01617434|138079|P1|Overall Study|Unclassified|3
30758|NCT01617434|138078|P2|Overall Study|Withdrawal Criteria|37
30759|NCT01617434|138079|P1|Overall Study|Withdrawal Criteria|12
30760|NCT01617434|138078|P2|Overall Study|Protocol Violation|7
30761|NCT01617434|138079|P1|Overall Study|Protocol Violation|8
30762|NCT01617434|138078|P2|Overall Study|Adverse Event|3
30763|NCT01617434|138079|P1|Overall Study|Adverse Event|12
30764|NCT01617187|138111|P4|Treatment Through Study Completion|Protocol Violation|1
30765|NCT01617187|138112|P3|Treatment Through Study Completion|Protocol Violation|0
30766|NCT01617187|138113|P2|Treatment Through Study Completion|Protocol Violation|0
30767|NCT01617187|138114|P1|Treatment Through Study Completion|Protocol Violation|1
30768|NCT01617187|138111|P4|Treatment Through Study Completion|Withdrawal by Subject|6
30769|NCT01617187|138112|P3|Treatment Through Study Completion|Withdrawal by Subject|3
30770|NCT01617187|138113|P2|Treatment Through Study Completion|Withdrawal by Subject|8
30771|NCT01617187|138114|P1|Treatment Through Study Completion|Withdrawal by Subject|5
30772|NCT01617187|138111|P4|Treatment Through Study Completion|Lost to Follow-up|2
30773|NCT01617187|138112|P3|Treatment Through Study Completion|Lost to Follow-up|2
30774|NCT01617187|138113|P2|Treatment Through Study Completion|Lost to Follow-up|2
30775|NCT01617187|138114|P1|Treatment Through Study Completion|Lost to Follow-up|4
30776|NCT01617187|138111|P4|Treatment Through Study Completion|Adverse Event|1
30777|NCT01617187|138112|P3|Treatment Through Study Completion|Adverse Event|0
30778|NCT01617187|138113|P2|Treatment Through Study Completion|Adverse Event|1
30779|NCT01617187|138114|P1|Treatment Through Study Completion|Adverse Event|1
30780|NCT01617187|138111|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
30781|NCT01617187|138112|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
30782|NCT01617187|138113|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
30783|NCT01617187|138114|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
30784|NCT01617187|138111|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
30785|NCT01617187|138112|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
30786|NCT01617187|138113|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
30787|NCT01617187|138114|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
30788|NCT01617187|138111|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
30789|NCT01617187|138112|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
30790|NCT01617187|138113|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
30791|NCT01617187|138114|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
30792|NCT01617070|138184|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
30793|NCT01617005|138202|P1|Overall Study|Lack of motivation for treatment|1
30794|NCT01617005|138202|P1|Overall Study|Pregnancy|1
30795|NCT01616953|138211|P2|Overall Study|lack of bone and soft tissue|0
30796|NCT01616953|138212|P1|Overall Study|lack of bone and soft tissue|1
30797|NCT01616953|138211|P2|Overall Study|Lost to Follow-up|0
30798|NCT01616953|138212|P1|Overall Study|Lost to Follow-up|1
30799|NCT01616771|138220|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
30800|NCT01616459|138245|P4|Overall Study|Other reason|0
30801|NCT01616459|138246|P3|Overall Study|Other reason|1
30802|NCT01616459|138247|P2|Overall Study|Other reason|1
30803|NCT01616459|138248|P1|Overall Study|Other reason|0
30804|NCT01616459|138245|P4|Overall Study|Withdrawal by Subject|4
30805|NCT01616459|138246|P3|Overall Study|Withdrawal by Subject|4
30806|NCT01616459|138247|P2|Overall Study|Withdrawal by Subject|4
30807|NCT01616459|138248|P1|Overall Study|Withdrawal by Subject|2
30808|NCT01616459|138245|P4|Overall Study|Protocol Violation|2
30809|NCT01616459|138246|P3|Overall Study|Protocol Violation|0
30810|NCT01616459|138247|P2|Overall Study|Protocol Violation|0
30811|NCT01616459|138248|P1|Overall Study|Protocol Violation|0
30812|NCT01616459|138245|P4|Overall Study|Lost to Follow-up|2
30813|NCT01616459|138246|P3|Overall Study|Lost to Follow-up|3
30814|NCT01616459|138247|P2|Overall Study|Lost to Follow-up|11
30815|NCT01616459|138248|P1|Overall Study|Lost to Follow-up|1
30816|NCT01616459|138245|P4|Overall Study|Adverse Event|0
30817|NCT01616459|138246|P3|Overall Study|Adverse Event|2
30818|NCT01616459|138247|P2|Overall Study|Adverse Event|1
30819|NCT01616459|138248|P1|Overall Study|Adverse Event|1
30820|NCT01616173|138337|P3|Overall Study|Lost to Follow-up|0
30821|NCT01616173|138338|P2|Overall Study|Lost to Follow-up|2
30822|NCT01616173|138339|P1|Overall Study|Lost to Follow-up|0
30823|NCT01615939|138367|P2|Overall Study|Lost to Follow-up|0
30824|NCT01615939|138368|P1|Overall Study|Lost to Follow-up|5
30825|NCT01615822|138381|P3|Period 2|Lost to Follow-up|2
30826|NCT01615822|138382|P2|Period 2|Lost to Follow-up|1
30827|NCT01615822|138383|P1|Period 2|Lost to Follow-up|0
30828|NCT01615822|138381|P3|Period 1|Adverse Event|0
30829|NCT01615822|138382|P2|Period 1|Adverse Event|1
30830|NCT01615822|138383|P1|Period 1|Adverse Event|1
30831|NCT01615822|138381|P3|Period 1|Withdrawal by Subject|0
30832|NCT01615822|138382|P2|Period 1|Withdrawal by Subject|1
30833|NCT01615822|138383|P1|Period 1|Withdrawal by Subject|0
30834|NCT01615328|138429|P2|Overall Study|Lost to Follow-up|5
30835|NCT01615328|138430|P1|Overall Study|Lost to Follow-up|3
30836|NCT01615263|138442|P2|Overall Study|Post-randomization exclusion|2
30837|NCT01615263|138443|P1|Overall Study|Post-randomization exclusion|0
30838|NCT01615198|138457|P2|Overall Study|Adverse Event|5
30839|NCT01615198|138458|P1|Overall Study|Adverse Event|11
30840|NCT01615198|138457|P2|Overall Study|Lack of Efficacy|6
30841|NCT01615198|138458|P1|Overall Study|Lack of Efficacy|1
30842|NCT01615198|138457|P2|Overall Study|Lost to Follow-up|1
30843|NCT01615198|138458|P1|Overall Study|Lost to Follow-up|1
30844|NCT01615198|138457|P2|Overall Study|Physician Decision|1
30845|NCT01615198|138458|P1|Overall Study|Physician Decision|5
30846|NCT01615198|138457|P2|Overall Study|Protocol deviation|1
30847|NCT01615198|138458|P1|Overall Study|Protocol deviation|1
30848|NCT01615198|138457|P2|Overall Study|Withdrawal by Subject|5
30849|NCT01615198|138458|P1|Overall Study|Withdrawal by Subject|5
30850|NCT01615029|138491|P5|Overall Study|Ongoing|23
30851|NCT01615029|138492|P4|Overall Study|Ongoing|2
30852|NCT01615029|138493|P3|Overall Study|Ongoing|3
30853|NCT01615029|138494|P2|Overall Study|Ongoing|2
30854|NCT01615029|138495|P1|Overall Study|Ongoing|1
30855|NCT01615029|138491|P5|Overall Study|Physician Decision|1
30856|NCT01615029|138492|P4|Overall Study|Physician Decision|0
30857|NCT01615029|138493|P3|Overall Study|Physician Decision|0
30858|NCT01615029|138494|P2|Overall Study|Physician Decision|0
30859|NCT01615029|138495|P1|Overall Study|Physician Decision|0
30860|NCT01615029|138491|P5|Overall Study|Progressive disease|5
30861|NCT01615029|138492|P4|Overall Study|Progressive disease|1
30862|NCT01615029|138493|P3|Overall Study|Progressive disease|1
30863|NCT01615029|138494|P2|Overall Study|Progressive disease|1
30864|NCT01615029|138495|P1|Overall Study|Progressive disease|2
30865|NCT01615029|138491|P5|Overall Study|Lost to Follow-up|1
30866|NCT01615029|138492|P4|Overall Study|Lost to Follow-up|0
30867|NCT01615029|138493|P3|Overall Study|Lost to Follow-up|0
30868|NCT01615029|138494|P2|Overall Study|Lost to Follow-up|0
30869|NCT01615029|138495|P1|Overall Study|Lost to Follow-up|0
30870|NCT01615029|138491|P5|Overall Study|Death|1
30871|NCT01615029|138492|P4|Overall Study|Death|0
30872|NCT01615029|138493|P3|Overall Study|Death|0
30873|NCT01615029|138494|P2|Overall Study|Death|0
30874|NCT01615029|138495|P1|Overall Study|Death|0
30875|NCT01615029|138491|P5|Overall Study|Adverse Event|1
30876|NCT01615029|138492|P4|Overall Study|Adverse Event|0
30877|NCT01615029|138493|P3|Overall Study|Adverse Event|0
30878|NCT01615029|138494|P2|Overall Study|Adverse Event|0
30879|NCT01615029|138495|P1|Overall Study|Adverse Event|0
30880|NCT01614886|138518|P2|Overall Study|Protocol deviation|2
30881|NCT01614886|138519|P1|Overall Study|Protocol deviation|0
30882|NCT01614886|138518|P2|Overall Study|Death|0
30883|NCT01614886|138519|P1|Overall Study|Death|1
30884|NCT01614886|138518|P2|Overall Study|Withdrawal by Subject|4
30885|NCT01614886|138519|P1|Overall Study|Withdrawal by Subject|4
30886|NCT01614886|138518|P2|Overall Study|Adverse Event|20
30887|NCT01614886|138519|P1|Overall Study|Adverse Event|15
30888|NCT01614795|138537|P4|Overall Study|Ineligible|0
30889|NCT01614795|138538|P3|Overall Study|Ineligible|0
30890|NCT01614795|138539|P2|Overall Study|Ineligible|1
30891|NCT01614795|138540|P1|Overall Study|Ineligible|0
30892|NCT01614795|138537|P4|Overall Study|Withdrawal by Subject|2
30893|NCT01614795|138538|P3|Overall Study|Withdrawal by Subject|0
30894|NCT01614795|138539|P2|Overall Study|Withdrawal by Subject|1
30895|NCT01614795|138540|P1|Overall Study|Withdrawal by Subject|0
30896|NCT01614795|138537|P4|Overall Study|Physician Decision|1
30897|NCT01614795|138538|P3|Overall Study|Physician Decision|1
30898|NCT01614795|138539|P2|Overall Study|Physician Decision|0
30899|NCT01614795|138540|P1|Overall Study|Physician Decision|1
30900|NCT01614795|138537|P4|Overall Study|Lack of Efficacy|8
30901|NCT01614795|138538|P3|Overall Study|Lack of Efficacy|9
30902|NCT01614795|138539|P2|Overall Study|Lack of Efficacy|10
30903|NCT01614795|138540|P1|Overall Study|Lack of Efficacy|10
30904|NCT01614795|138537|P4|Overall Study|Adverse Event|1
30905|NCT01614795|138538|P3|Overall Study|Adverse Event|1
30906|NCT01614795|138539|P2|Overall Study|Adverse Event|0
30907|NCT01614795|138540|P1|Overall Study|Adverse Event|0
30908|NCT01614769|138550|P6|Period 3|Withdrawal by Subject|0
30909|NCT01614769|138551|P5|Period 3|Withdrawal by Subject|0
30910|NCT01614769|138552|P4|Period 3|Withdrawal by Subject|0
30911|NCT01614769|138553|P3|Period 3|Withdrawal by Subject|1
30912|NCT01614769|138554|P2|Period 3|Withdrawal by Subject|0
30913|NCT01614769|138555|P1|Period 3|Withdrawal by Subject|0
30914|NCT01614769|138550|P6|Period 1|Withdrawal by Subject|0
30915|NCT01614769|138551|P5|Period 1|Withdrawal by Subject|0
30916|NCT01614769|138552|P4|Period 1|Withdrawal by Subject|0
30917|NCT01614769|138553|P3|Period 1|Withdrawal by Subject|0
30918|NCT01614769|138554|P2|Period 1|Withdrawal by Subject|0
30919|NCT01614769|138555|P1|Period 1|Withdrawal by Subject|1
30920|NCT01614769|138550|P6|Period 1|Protocol Violation|0
30921|NCT01614769|138551|P5|Period 1|Protocol Violation|0
30922|NCT01614769|138552|P4|Period 1|Protocol Violation|1
30923|NCT01614769|138553|P3|Period 1|Protocol Violation|0
30924|NCT01614769|138554|P2|Period 1|Protocol Violation|0
30925|NCT01614769|138555|P1|Period 1|Protocol Violation|0
30926|NCT01614769|138550|P6|Period 1|Discontinued due to Hypoglycemia|1
30927|NCT01614769|138551|P5|Period 1|Discontinued due to Hypoglycemia|0
30928|NCT01614769|138552|P4|Period 1|Discontinued due to Hypoglycemia|1
30929|NCT01614769|138553|P3|Period 1|Discontinued due to Hypoglycemia|0
30930|NCT01614769|138554|P2|Period 1|Discontinued due to Hypoglycemia|0
30931|NCT01614769|138555|P1|Period 1|Discontinued due to Hypoglycemia|0
30932|NCT01614600|138577|P1|Overall Study|Protocol deviation|1
30933|NCT01614600|138577|P1|Overall Study|Unable to remove lens at the end of day|1
30934|NCT01614600|138577|P1|Overall Study|Discomfort|1
30935|NCT01614600|138577|P1|Overall Study|Unacceptable fit|1
30936|NCT01614470|138608|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
30937|NCT01614470|138609|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
30938|NCT01614470|138610|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
30939|NCT01614470|138608|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
30940|NCT01614470|138609|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
30941|NCT01614470|138610|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
30942|NCT01614457|138632|P2|Overall Study|Pregnancy (Self or Partner)|0
30943|NCT01614457|138633|P1|Overall Study|Pregnancy (Self or Partner)|1
30944|NCT01614457|138632|P2|Overall Study|Non-Compliance|0
30945|NCT01614457|138633|P1|Overall Study|Non-Compliance|1
30946|NCT01614249|138651|P2|Overall Study|Lost to Follow-up|23
30947|NCT01614249|138652|P1|Overall Study|Lost to Follow-up|11
30948|NCT01613599|138658|P1|Overall Study|Ongoing|81
30949|NCT01613599|138658|P1|Overall Study|Reason not specified|2
30950|NCT01613599|138658|P1|Overall Study|Withdrawal by Subject|6
30951|NCT01613599|138658|P1|Overall Study|Lost to Follow-up|2
30952|NCT01613599|138658|P1|Overall Study|Death|6
30953|NCT01613417|138673|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
30954|NCT01613417|138674|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
30955|NCT01613378|138711|P1|Overall Study|Other Reason|4
30956|NCT01613378|138711|P1|Overall Study|Lost to Follow-up|1
30957|NCT01613378|138711|P1|Overall Study|Death|2
30958|NCT01613378|138711|P1|Overall Study|Withdrawal by Subject|8
30959|NCT01613378|138711|P1|Overall Study|Adverse Event|11
30960|NCT01613378|138711|P1|Overall Study|Lack of Efficacy|13
30961|NCT01613326|138741|P2|Overall Study|Protocol Violation|1
30962|NCT01613326|138742|P1|Overall Study|Protocol Violation|0
30963|NCT01613326|138741|P2|Overall Study|Administrative|2
30964|NCT01613326|138742|P1|Overall Study|Administrative|0
30965|NCT01613326|138741|P2|Overall Study|Lost to Follow-up|1
30966|NCT01613326|138742|P1|Overall Study|Lost to Follow-up|0
30967|NCT01613326|138741|P2|Overall Study|Lack of Efficacy|1
30968|NCT01613326|138742|P1|Overall Study|Lack of Efficacy|0
30969|NCT01613326|138741|P2|Overall Study|inability to use device|0
30970|NCT01613326|138742|P1|Overall Study|inability to use device|1
30971|NCT01613326|138741|P2|Overall Study|Abnormal test procedure result(s)|0
30972|NCT01613326|138742|P1|Overall Study|Abnormal test procedure result(s)|2
30973|NCT01613326|138741|P2|Overall Study|Withdrawal by Subject|4
30974|NCT01613326|138742|P1|Overall Study|Withdrawal by Subject|3
30975|NCT01613326|138741|P2|Overall Study|Adverse Event|5
30976|NCT01613326|138742|P1|Overall Study|Adverse Event|7
30977|NCT01613248|138799|P6|Overall Study|Pregnancy|0
30978|NCT01613248|138800|P5|Overall Study|Pregnancy|0
30979|NCT01613248|138801|P4|Overall Study|Pregnancy|1
30980|NCT01613248|138802|P3|Overall Study|Pregnancy|0
30981|NCT01613248|138803|P2|Overall Study|Pregnancy|0
30982|NCT01613248|138804|P1|Overall Study|Pregnancy|0
30983|NCT01613248|138799|P6|Overall Study|Lack of Qualifying Event|18
30984|NCT01613248|138800|P5|Overall Study|Lack of Qualifying Event|15
30985|NCT01613248|138801|P4|Overall Study|Lack of Qualifying Event|11
30986|NCT01613248|138802|P3|Overall Study|Lack of Qualifying Event|10
30987|NCT01613248|138803|P2|Overall Study|Lack of Qualifying Event|11
30988|NCT01613248|138804|P1|Overall Study|Lack of Qualifying Event|9
30989|NCT01613248|138799|P6|Overall Study|Physician Decision|6
30990|NCT01613248|138800|P5|Overall Study|Physician Decision|7
30991|NCT01613248|138801|P4|Overall Study|Physician Decision|4
30992|NCT01613248|138802|P3|Overall Study|Physician Decision|9
30993|NCT01613248|138803|P2|Overall Study|Physician Decision|8
30994|NCT01613248|138804|P1|Overall Study|Physician Decision|8
30995|NCT01613248|138799|P6|Overall Study|Study Terminated by Sponsor|11
30996|NCT01613248|138800|P5|Overall Study|Study Terminated by Sponsor|9
30997|NCT01613248|138801|P4|Overall Study|Study Terminated by Sponsor|8
30998|NCT01613248|138802|P3|Overall Study|Study Terminated by Sponsor|8
30999|NCT01613248|138803|P2|Overall Study|Study Terminated by Sponsor|6
31000|NCT01613248|138804|P1|Overall Study|Study Terminated by Sponsor|4
31001|NCT01613248|138799|P6|Overall Study|Lost to Follow-up|2
31002|NCT01613248|138800|P5|Overall Study|Lost to Follow-up|4
31003|NCT01613248|138801|P4|Overall Study|Lost to Follow-up|8
31004|NCT01613248|138802|P3|Overall Study|Lost to Follow-up|4
31005|NCT01613248|138803|P2|Overall Study|Lost to Follow-up|7
31006|NCT01613248|138804|P1|Overall Study|Lost to Follow-up|5
31007|NCT01613248|138799|P6|Overall Study|Withdrawal by Subject|1
31008|NCT01613248|138800|P5|Overall Study|Withdrawal by Subject|0
31009|NCT01613248|138801|P4|Overall Study|Withdrawal by Subject|5
31010|NCT01613248|138802|P3|Overall Study|Withdrawal by Subject|2
31011|NCT01613248|138803|P2|Overall Study|Withdrawal by Subject|2
31012|NCT01613248|138804|P1|Overall Study|Withdrawal by Subject|3
31013|NCT01613248|138799|P6|Overall Study|Adverse Event|0
31014|NCT01613248|138800|P5|Overall Study|Adverse Event|0
31015|NCT01613248|138801|P4|Overall Study|Adverse Event|1
31016|NCT01613248|138802|P3|Overall Study|Adverse Event|0
31017|NCT01613248|138803|P2|Overall Study|Adverse Event|0
31018|NCT01613248|138804|P1|Overall Study|Adverse Event|0
31019|NCT01613131|138904|P2|Overall Study|Withdrawal by Subject|5
31020|NCT01613131|138905|P1|Overall Study|Withdrawal by Subject|3
31021|NCT01613027|138933|P1|Overall Study|Patient’s Decision Due to Adverse Event|1
31022|NCT01613027|138933|P1|Overall Study|Lack of Efficacy|1
31023|NCT01613027|138933|P1|Overall Study|Switched Physician|1
31024|NCT01613027|138933|P1|Overall Study|Lost to Follow-up|5
31025|NCT01612858|138963|P2|Overall Study|Withdrawal by Subject|1
31026|NCT01612858|138964|P1|Overall Study|Withdrawal by Subject|5
31027|NCT01612702|139001|P2|Overall Study|Protocol Violation|11
31028|NCT01612702|139002|P1|Overall Study|Protocol Violation|11
31029|NCT01612676|139016|P4|Overall Study|Protocol Violation|0
31030|NCT01612676|139017|P3|Overall Study|Protocol Violation|0
31031|NCT01612676|139018|P2|Overall Study|Protocol Violation|1
31032|NCT01612676|139019|P1|Overall Study|Protocol Violation|0
31033|NCT01612676|139016|P4|Overall Study|Adverse Event|3
31034|NCT01612676|139017|P3|Overall Study|Adverse Event|1
31035|NCT01612676|139018|P2|Overall Study|Adverse Event|3
31036|NCT01612676|139019|P1|Overall Study|Adverse Event|2
31037|NCT01612156|139097|P2|Overall Study|Protocol Violation|0
31038|NCT01612156|139098|P1|Overall Study|Protocol Violation|2
31039|NCT01612000|139110|P4|Overall Study|Withdrawal by Subject|2
31040|NCT01612000|139111|P3|Overall Study|Withdrawal by Subject|2
31041|NCT01612000|139112|P2|Overall Study|Withdrawal by Subject|1
31042|NCT01612000|139113|P1|Overall Study|Withdrawal by Subject|3
31043|NCT01612000|139110|P4|Overall Study|Physician Decision|0
31044|NCT01612000|139111|P3|Overall Study|Physician Decision|1
31045|NCT01612000|139112|P2|Overall Study|Physician Decision|0
31046|NCT01612000|139113|P1|Overall Study|Physician Decision|0
31047|NCT01612000|139110|P4|Overall Study|Lost to Follow-up|8
31048|NCT01612000|139111|P3|Overall Study|Lost to Follow-up|4
31049|NCT01612000|139112|P2|Overall Study|Lost to Follow-up|4
31050|NCT01612000|139113|P1|Overall Study|Lost to Follow-up|6
31051|NCT01611974|139138|P3|Overall Study|Withdrawal by Subject|4
31052|NCT01611974|139139|P2|Overall Study|Withdrawal by Subject|1
31053|NCT01611974|139140|P1|Overall Study|Withdrawal by Subject|0
31054|NCT01611974|139138|P3|Overall Study|Physician Decision|2
31055|NCT01611974|139139|P2|Overall Study|Physician Decision|1
31056|NCT01611974|139140|P1|Overall Study|Physician Decision|5
31057|NCT01611974|139138|P3|Overall Study|Lost to Follow-up|0
31058|NCT01611974|139139|P2|Overall Study|Lost to Follow-up|1
31059|NCT01611974|139140|P1|Overall Study|Lost to Follow-up|0
31060|NCT01611974|139138|P3|Overall Study|Death|10
31061|NCT01611974|139139|P2|Overall Study|Death|12
31062|NCT01611974|139140|P1|Overall Study|Death|10
31063|NCT01611883|139186|P2|Overall Study|Adverse Event|1
31064|NCT01611883|139187|P1|Overall Study|Adverse Event|1
31065|NCT01611857|139213|P2|Overall Study|Withdrawal by Subject|2
31066|NCT01611857|139214|P1|Overall Study|Withdrawal by Subject|0
31067|NCT01611792|139226|P2|Followup: at 6 Months|Lost to Follow-up|13
31068|NCT01611792|139227|P1|Followup: at 6 Months|Lost to Follow-up|6
31069|NCT01611792|139226|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
31070|NCT01611792|139227|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
31071|NCT01611558|139281|P1|Maintenance Phase|Study drug toxicity|1
31072|NCT01611558|139281|P1|Maintenance Phase|Withdrawal by Subject|1
31073|NCT01611558|139281|P1|Induction Phase|Death|1
31074|NCT01611558|139281|P1|Induction Phase|Adverse event unrelated to study drug|1
31075|NCT01611558|139281|P1|Induction Phase|Not reported|5
31076|NCT01611558|139281|P1|Induction Phase|Disease progression|14
31077|NCT01611558|139281|P1|Induction Phase|Study drug toxicity|17
31078|NCT01610791|139287|P1|Overall Study|Not determined|5
31079|NCT01610791|139287|P1|Overall Study|Death|1
31080|NCT01610791|139287|P1|Overall Study|Adverse event and Investigator decision|1
31081|NCT01610791|139287|P1|Overall Study|Physician Decision|1
31082|NCT01610791|139287|P1|Overall Study|Adverse Event|6
31083|NCT01610791|139287|P1|Overall Study|Lost to Follow-up|7
31084|NCT01610713|139310|P2|Overall Study|Lost to Follow-up|1
31085|NCT01610713|139311|P1|Overall Study|Lost to Follow-up|0
31086|NCT01610713|139310|P2|Overall Study|adv. to use original dose/amitriptyline|0
31087|NCT01610713|139311|P1|Overall Study|adv. to use original dose/amitriptyline|1
31088|NCT01610713|139310|P2|Overall Study|low mood and poor motivation|0
31089|NCT01610713|139311|P1|Overall Study|low mood and poor motivation|1
31090|NCT01610713|139310|P2|Overall Study|Lack of Efficacy|0
31091|NCT01610713|139311|P1|Overall Study|Lack of Efficacy|1
31092|NCT01610713|139310|P2|Overall Study|Adverse Event|0
31093|NCT01610713|139311|P1|Overall Study|Adverse Event|3
31094|NCT01610700|139369|P2|Overall Study|subject took one dose of street cannabis|1
31095|NCT01610700|139370|P1|Overall Study|subject took one dose of street cannabis|0
31096|NCT01610700|139369|P2|Overall Study|Withdrawal by Subject|1
31097|NCT01610700|139370|P1|Overall Study|Withdrawal by Subject|0
31098|NCT01610700|139369|P2|Overall Study|Adverse Event|1
31099|NCT01610700|139370|P1|Overall Study|Adverse Event|3
31100|NCT01610687|139424|P1|Overall Study|Felt more alter without study medication|1
31101|NCT01610687|139424|P1|Overall Study|Cannabis affecting job|1
31102|NCT01610687|139424|P1|Overall Study|Death|1
31103|NCT01610687|139424|P1|Overall Study|Unable to make journey|1
31104|NCT01610687|139424|P1|Overall Study|Symptom control without study medication|2
31105|NCT01610687|139424|P1|Overall Study|Lost to Follow-up|4
31106|NCT01610687|139424|P1|Overall Study|Withdrawal by Subject|7
31107|NCT01610687|139424|P1|Overall Study|Moved out of area|6
31108|NCT01610687|139424|P1|Overall Study|Adverse Event|18
31109|NCT01610687|139424|P1|Overall Study|Lack of Efficacy|26
31110|NCT01610596|139437|P2|Overall Study|Lost to Follow-up|1
31111|NCT01610596|139438|P1|Overall Study|Lost to Follow-up|0
31112|NCT01610557|139475|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
31113|NCT01610557|139476|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
31114|NCT01610557|139477|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
31115|NCT01610557|139478|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
31116|NCT01610557|139479|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
31117|NCT01610557|139475|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
31118|NCT01610557|139476|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
31119|NCT01610557|139477|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
31120|NCT01610557|139478|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
31121|NCT01610557|139479|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
31122|NCT01610492|139492|P1|Overall Study|Physician Decision|1
31123|NCT01610492|139492|P1|Overall Study|Lack of Efficacy|2
31124|NCT01610297|139504|P1|Overall Study|Lost to Follow-up|1
31125|NCT01610167|139515|P3|Overall Study|Scheduling conflict.|2
31126|NCT01610167|139516|P2|Overall Study|Scheduling conflict.|0
31127|NCT01610167|139517|P1|Overall Study|Scheduling conflict.|0
31128|NCT01610076|139554|P2|Overall Study|Lost to Follow-up|4
31129|NCT01610076|139555|P1|Overall Study|Lost to Follow-up|3
31130|NCT01610076|139554|P2|Overall Study|Technical issue with video|1
31131|NCT01610076|139555|P1|Overall Study|Technical issue with video|0
31132|NCT01610063|139566|P2|Overall Study|Lost to Follow-up|20
31133|NCT01610063|139567|P1|Overall Study|Lost to Follow-up|42
31134|NCT01610037|139590|P3|Treatment and Follow up Period|Lost to Follow-up|4
31135|NCT01610037|139591|P2|Treatment and Follow up Period|Lost to Follow-up|6
31136|NCT01610037|139592|P1|Treatment and Follow up Period|Lost to Follow-up|1
31137|NCT01610037|139590|P3|Treatment and Follow up Period|Administrative problems|2
31138|NCT01610037|139591|P2|Treatment and Follow up Period|Administrative problems|3
31139|NCT01610037|139592|P1|Treatment and Follow up Period|Administrative problems|1
31140|NCT01610037|139590|P3|Treatment and Follow up Period|Death|4
31141|NCT01610037|139591|P2|Treatment and Follow up Period|Death|5
31142|NCT01610037|139592|P1|Treatment and Follow up Period|Death|10
31143|NCT01610037|139590|P3|Treatment and Follow up Period|Subject withdrew consent|16
31144|NCT01610037|139591|P2|Treatment and Follow up Period|Subject withdrew consent|14
31145|NCT01610037|139592|P1|Treatment and Follow up Period|Subject withdrew consent|13
31146|NCT01610037|139590|P3|All Patients|Abnormal test procedure result(s)|3
31147|NCT01610037|139591|P2|All Patients|Abnormal test procedure result(s)|1
31148|NCT01610037|139592|P1|All Patients|Abnormal test procedure result(s)|0
31149|NCT01610037|139590|P3|All Patients|Lost to Follow-up|0
31150|NCT01610037|139591|P2|All Patients|Lost to Follow-up|0
31151|NCT01610037|139592|P1|All Patients|Lost to Follow-up|1
31152|NCT01610037|139590|P3|All Patients|Administrative problems|4
31153|NCT01610037|139591|P2|All Patients|Administrative problems|4
31154|NCT01610037|139592|P1|All Patients|Administrative problems|1
31155|NCT01610037|139590|P3|All Patients|Abnormal laboratory value|0
31156|NCT01610037|139591|P2|All Patients|Abnormal laboratory value|1
31157|NCT01610037|139592|P1|All Patients|Abnormal laboratory value|1
31158|NCT01610037|139590|P3|All Patients|Protocol deviation|3
31159|NCT01610037|139591|P2|All Patients|Protocol deviation|3
31160|NCT01610037|139592|P1|All Patients|Protocol deviation|4
31161|NCT01610037|139590|P3|All Patients|Death|1
31162|NCT01610037|139591|P2|All Patients|Death|2
31163|NCT01610037|139592|P1|All Patients|Death|4
31164|NCT01610037|139590|P3|All Patients|Unsatisfactory therapeutic effect|27
31165|NCT01610037|139591|P2|All Patients|Unsatisfactory therapeutic effect|8
31166|NCT01610037|139592|P1|All Patients|Unsatisfactory therapeutic effect|9
31167|NCT01610037|139590|P3|All Patients|Withdrawal by Subject|20
31168|NCT01610037|139591|P2|All Patients|Withdrawal by Subject|10
31169|NCT01610037|139592|P1|All Patients|Withdrawal by Subject|12
31170|NCT01610037|139590|P3|All Patients|Adverse Event|26
31171|NCT01610037|139591|P2|All Patients|Adverse Event|22
31172|NCT01610037|139592|P1|All Patients|Adverse Event|27
31173|NCT01609790|139645|P3|Overall Study|Protocol Violation|8
31174|NCT01609790|139646|P2|Overall Study|Protocol Violation|7
31175|NCT01609790|139647|P1|Overall Study|Protocol Violation|1
31176|NCT01609582|139665|P2|Overall Study|Randomized, but not treated|3
31177|NCT01609582|139666|P1|Overall Study|Randomized, but not treated|0
31178|NCT01609582|139665|P2|Overall Study|Other|10
31179|NCT01609582|139666|P1|Overall Study|Other|9
31180|NCT01609582|139665|P2|Overall Study|Study Terminated by Sponsor|1548
31181|NCT01609582|139666|P1|Overall Study|Study Terminated by Sponsor|1543
31182|NCT01609582|139665|P2|Overall Study|Withdrawal by Subject|15
31183|NCT01609582|139666|P1|Overall Study|Withdrawal by Subject|21
31184|NCT01609582|139665|P2|Overall Study|Lost to Follow-up|10
31185|NCT01609582|139666|P1|Overall Study|Lost to Follow-up|10
31186|NCT01609582|139665|P2|Overall Study|Adverse Event|18
31187|NCT01609582|139666|P1|Overall Study|Adverse Event|20
31188|NCT01609543|139674|P1|Overall Study|Death|7
31189|NCT01609543|139674|P1|Overall Study|Protocol Violation|1
31190|NCT01609543|139674|P1|Overall Study|Withdrawal by Subject|1
31191|NCT01609543|139674|P1|Overall Study|Adverse Event|5
31192|NCT01609543|139674|P1|Overall Study|Disease Progression|28
31193|NCT01609478|139683|P3|Overall Study|Withdrawal by Subject|2
31194|NCT01609478|139684|P2|Overall Study|Withdrawal by Subject|0
31195|NCT01609478|139685|P1|Overall Study|Withdrawal by Subject|2
31196|NCT01609478|139683|P3|Overall Study|Physician Decision|1
31197|NCT01609478|139684|P2|Overall Study|Physician Decision|0
31198|NCT01609478|139685|P1|Overall Study|Physician Decision|1
31199|NCT01609478|139683|P3|Overall Study|Non-Compliance with study treatment|0
31200|NCT01609478|139684|P2|Overall Study|Non-Compliance with study treatment|0
31201|NCT01609478|139685|P1|Overall Study|Non-Compliance with study treatment|1
31202|NCT01609478|139683|P3|Overall Study|Protocol Deviation|1
31203|NCT01609478|139684|P2|Overall Study|Protocol Deviation|1
31204|NCT01609478|139685|P1|Overall Study|Protocol Deviation|0
31205|NCT01609478|139683|P3|Overall Study|Adverse Event|5
31206|NCT01609478|139684|P2|Overall Study|Adverse Event|1
31207|NCT01609478|139685|P1|Overall Study|Adverse Event|3
31208|NCT01609257|139751|P2|Overall Study|Non-compliance/Protocol deviation|6
31209|NCT01609257|139752|P1|Overall Study|Non-compliance/Protocol deviation|4
31210|NCT01609257|139751|P2|Overall Study|Voluntary Withdrawal by Subject|1
31211|NCT01609257|139752|P1|Overall Study|Voluntary Withdrawal by Subject|0
31212|NCT01609257|139751|P2|Overall Study|Lost to Follow-up|1
31213|NCT01609257|139752|P1|Overall Study|Lost to Follow-up|2
31214|NCT01609062|139824|P2|Extension Phase|Anticipated surgery & transition to EAP|1
31215|NCT01609062|139825|P1|Extension Phase|Anticipated surgery & transition to EAP|0
31216|NCT01609062|139824|P2|Extension Phase|Discontinued drug and then was pregnant|0
31217|NCT01609062|139825|P1|Extension Phase|Discontinued drug and then was pregnant|1
31218|NCT01609062|139824|P2|Extension Phase|Terminated by Sponsor|9
31219|NCT01609062|139825|P1|Extension Phase|Terminated by Sponsor|14
31220|NCT01609023|139868|P1|Overall Study|Personal reasons|1
31221|NCT01609023|139868|P1|Overall Study|Death|2
31222|NCT01609023|139868|P1|Overall Study|Physician Decision|2
31223|NCT01609023|139868|P1|Overall Study|Disease progression|10
31224|NCT01609023|139868|P1|Overall Study|Toxicity|3
31225|NCT01609023|139868|P1|Overall Study|Lost to Follow-up|8
31226|NCT01609023|139868|P1|Overall Study|Withdrawal by Subject|4
31227|NCT01609023|139868|P1|Overall Study|Lack of Efficacy|3
31228|NCT01609010|139880|P2|Overall Study|Lost to Follow-up|1
31229|NCT01609010|139881|P1|Overall Study|Lost to Follow-up|1
31230|NCT01609010|139880|P2|Overall Study|New cancer|0
31231|NCT01609010|139881|P1|Overall Study|New cancer|1
31232|NCT01609010|139880|P2|Overall Study|Protocol Violation|1
31233|NCT01609010|139881|P1|Overall Study|Protocol Violation|1
31234|NCT01609010|139880|P2|Overall Study|Pathology review|1
31235|NCT01609010|139881|P1|Overall Study|Pathology review|2
31236|NCT01609010|139880|P2|Overall Study|Other malignancy|0
31237|NCT01609010|139881|P1|Overall Study|Other malignancy|1
31238|NCT01609010|139880|P2|Overall Study|Not specified|0
31239|NCT01609010|139881|P1|Overall Study|Not specified|2
31240|NCT01609010|139880|P2|Overall Study|Withdrawal by Subject|2
31241|NCT01609010|139881|P1|Overall Study|Withdrawal by Subject|2
31242|NCT01609010|139880|P2|Overall Study|Adverse Event|6
31243|NCT01609010|139881|P1|Overall Study|Adverse Event|3
31244|NCT01609010|139880|P2|Overall Study|Progressive disease (PD)|10
31245|NCT01609010|139881|P1|Overall Study|Progressive disease (PD)|8
31246|NCT01609010|139880|P2|Overall Study|Stable disease (SD)|16
31247|NCT01609010|139881|P1|Overall Study|Stable disease (SD)|22
31248|NCT01608724|139942|P1|Overall Study|Safety reasons|1
31249|NCT01608724|139942|P1|Overall Study|bood sugar too high, etc.|3
31250|NCT01608724|139942|P1|Overall Study|Protocol Violation|6
31251|NCT01608724|139942|P1|Overall Study|Adverse Event|29
31252|NCT01608724|139942|P1|Overall Study|Study-specific discontinuation criteria|32
31253|NCT01608724|139942|P1|Overall Study|Lost to Follow-up|41
31254|NCT01608724|139942|P1|Overall Study|Withdrawal by Subject|131
31255|NCT01608321|139974|P2|Overall Study|Withdrawal by Subject|0
31256|NCT01608321|139975|P1|Overall Study|Withdrawal by Subject|1
31257|NCT01608308|139983|P2|Overall Study|pretreatment medical and billing reasons|2
31258|NCT01608308|139984|P1|Overall Study|pretreatment medical and billing reasons|0
31259|NCT01607593|140183|P1|Overall Study|Unspecified|4
31260|NCT01607593|140183|P1|Overall Study|Continuation|33
31261|NCT01607593|140183|P1|Overall Study|Lost to Follow-up|25
31262|NCT01607593|140183|P1|Overall Study|Lack of Efficacy|16
31263|NCT01607593|140183|P1|Overall Study|Adverse Event|15
31264|NCT01607476|140192|P3|Overall Study|Lost to Follow-up|2
31265|NCT01607476|140193|P2|Overall Study|Lost to Follow-up|0
31266|NCT01607476|140194|P1|Overall Study|Lost to Follow-up|0
31267|NCT01607476|140192|P3|Overall Study|Withdrawal by Subject|1
31268|NCT01607476|140193|P2|Overall Study|Withdrawal by Subject|0
31269|NCT01607476|140194|P1|Overall Study|Withdrawal by Subject|1
31270|NCT01607398|140288|P2|Overall Study|Severe COPD|0
31271|NCT01607398|140289|P1|Overall Study|Severe COPD|2
31272|NCT01607398|140288|P2|Overall Study|Adverse Event|2
31273|NCT01607398|140289|P1|Overall Study|Adverse Event|0
31274|NCT01606800|140390|P2|Overall Study|Missing completion status|0
31275|NCT01606800|140391|P1|Overall Study|Missing completion status|2
31276|NCT01606800|140390|P2|Overall Study|Participant withdrew consent|1
31277|NCT01606800|140391|P1|Overall Study|Participant withdrew consent|0
31278|NCT01606800|140390|P2|Overall Study|Adverse Event|1
31279|NCT01606800|140391|P1|Overall Study|Adverse Event|3
31280|NCT01606748|140399|P2|Overall Study|Withdrawal by Subject|0
31281|NCT01606748|140400|P1|Overall Study|Withdrawal by Subject|1
31282|NCT01606748|140399|P2|Overall Study|Progressive Disease|0
31283|NCT01606748|140400|P1|Overall Study|Progressive Disease|1
31284|NCT01606748|140399|P2|Overall Study|Adverse Event|0
31285|NCT01606748|140400|P1|Overall Study|Adverse Event|1
31286|NCT01606670|140441|P1|Overall Study|Other Reason|2
31287|NCT01606670|140441|P1|Overall Study|Withdrawal by Subject|3
31288|NCT01606670|140441|P1|Overall Study|Lost to Follow-up|3
31289|NCT01606670|140441|P1|Overall Study|Lack of Efficacy|2
31290|NCT01606670|140441|P1|Overall Study|Adverse Event|6
31291|NCT01606319|140451|P2|Overall Study|Adverse Event|4
31292|NCT01606319|140452|P1|Overall Study|Adverse Event|1
31293|NCT01606319|140451|P2|Overall Study|Lack of Efficacy|8
31294|NCT01606319|140452|P1|Overall Study|Lack of Efficacy|6
31295|NCT01606319|140451|P2|Overall Study|Physician Decision|2
31296|NCT01606319|140452|P1|Overall Study|Physician Decision|1
31297|NCT01606319|140451|P2|Overall Study|Withdrawal by Subject|12
31298|NCT01606319|140452|P1|Overall Study|Withdrawal by Subject|9
31299|NCT01606319|140451|P2|Overall Study|Lost to Follow-up|14
31300|NCT01606319|140452|P1|Overall Study|Lost to Follow-up|17
31301|NCT01606306|140470|P6|Overall Study|Physician Decision|0
31302|NCT01606306|140471|P5|Overall Study|Physician Decision|0
31303|NCT01606306|140472|P4|Overall Study|Physician Decision|0
31304|NCT01606306|140473|P3|Overall Study|Physician Decision|0
31305|NCT01606306|140474|P2|Overall Study|Physician Decision|2
31306|NCT01606306|140475|P1|Overall Study|Physician Decision|1
31307|NCT01606306|140470|P6|Overall Study|Withdrawal by Subject|4
31308|NCT01606306|140471|P5|Overall Study|Withdrawal by Subject|5
31309|NCT01606306|140472|P4|Overall Study|Withdrawal by Subject|4
31310|NCT01606306|140473|P3|Overall Study|Withdrawal by Subject|4
31311|NCT01606306|140474|P2|Overall Study|Withdrawal by Subject|3
31312|NCT01606306|140475|P1|Overall Study|Withdrawal by Subject|4
31313|NCT01606306|140470|P6|Overall Study|Lost to Follow-up|5
31314|NCT01606306|140471|P5|Overall Study|Lost to Follow-up|3
31315|NCT01606306|140472|P4|Overall Study|Lost to Follow-up|4
31316|NCT01606306|140473|P3|Overall Study|Lost to Follow-up|5
31317|NCT01606306|140474|P2|Overall Study|Lost to Follow-up|4
31318|NCT01606306|140475|P1|Overall Study|Lost to Follow-up|7
31319|NCT01606306|140470|P6|Overall Study|Adverse Event|0
31320|NCT01606306|140471|P5|Overall Study|Adverse Event|2
31321|NCT01606306|140472|P4|Overall Study|Adverse Event|1
31322|NCT01606306|140473|P3|Overall Study|Adverse Event|1
31323|NCT01606306|140474|P2|Overall Study|Adverse Event|0
31324|NCT01606306|140475|P1|Overall Study|Adverse Event|1
31325|NCT01606306|140470|P6|Overall Study|Lack of Efficacy|2
31326|NCT01606306|140471|P5|Overall Study|Lack of Efficacy|1
31327|NCT01606306|140472|P4|Overall Study|Lack of Efficacy|4
31328|NCT01606306|140473|P3|Overall Study|Lack of Efficacy|4
31329|NCT01606306|140474|P2|Overall Study|Lack of Efficacy|1
31330|NCT01606306|140475|P1|Overall Study|Lack of Efficacy|2
31331|NCT01606254|140485|P4|Overall Study|Adverse Event|1
31332|NCT01606254|140486|P3|Overall Study|Adverse Event|0
31333|NCT01606254|140487|P2|Overall Study|Adverse Event|1
31334|NCT01606254|140488|P1|Overall Study|Adverse Event|1
31335|NCT01606254|140485|P4|Overall Study|Withdrawal by Subject|2
31336|NCT01606254|140486|P3|Overall Study|Withdrawal by Subject|0
31337|NCT01606254|140487|P2|Overall Study|Withdrawal by Subject|3
31338|NCT01606254|140488|P1|Overall Study|Withdrawal by Subject|1
31339|NCT01606228|140570|P1|Overall Study|Adverse Event|1
31340|NCT01606228|140570|P1|Overall Study|Lack of Efficacy|2
31341|NCT01606228|140570|P1|Overall Study|Non-compliant|3
31342|NCT01606228|140570|P1|Overall Study|Withdrawal by Subject|3
31343|NCT01606228|140570|P1|Overall Study|Lost to Follow-up|20
31344|NCT01606202|140587|P2|Overall Study|Problems with administration|1
31345|NCT01606202|140588|P1|Overall Study|Problems with administration|0
31346|NCT01606202|140587|P2|Overall Study|Personal problems|1
31347|NCT01606202|140588|P1|Overall Study|Personal problems|0
31348|NCT01606202|140587|P2|Overall Study|Withdrawal by Subject|1
31349|NCT01606202|140588|P1|Overall Study|Withdrawal by Subject|2
31350|NCT01606202|140587|P2|Overall Study|Adverse Event|0
31351|NCT01606202|140588|P1|Overall Study|Adverse Event|5
31352|NCT01606189|140620|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
31353|NCT01606189|140621|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
31354|NCT01606189|140622|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
31355|NCT01606189|140623|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
31356|NCT01606189|140624|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
31357|NCT01606189|140625|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
31358|NCT01606189|140620|P6|Second Intenvention (14-20 Days)|Adverse Event|1
31359|NCT01606189|140621|P5|Second Intenvention (14-20 Days)|Adverse Event|0
31360|NCT01606189|140622|P4|Second Intenvention (14-20 Days)|Adverse Event|0
31361|NCT01606189|140623|P3|Second Intenvention (14-20 Days)|Adverse Event|0
31362|NCT01606189|140624|P2|Second Intenvention (14-20 Days)|Adverse Event|0
31363|NCT01606189|140625|P1|Second Intenvention (14-20 Days)|Adverse Event|0
31364|NCT01606176|140659|P2|Overall Study|Withdrawal by Subject|0
31365|NCT01606176|140660|P1|Overall Study|Withdrawal by Subject|1
31366|NCT01606176|140659|P2|Overall Study|Disease progression|0
31367|NCT01606176|140660|P1|Overall Study|Disease progression|1
31368|NCT01606176|140659|P2|Overall Study|Adverse Event|3
31369|NCT01606176|140660|P1|Overall Study|Adverse Event|2
31370|NCT01606137|140705|P1|Overall Study|Unable to collect consistent data|1
31371|NCT01606137|140705|P1|Overall Study|Patient moving|1
31372|NCT01606137|140705|P1|Overall Study|Unable to tolerate study med. taste|1
31373|NCT01606137|140705|P1|Overall Study|Personal reasons|1
31374|NCT01606137|140705|P1|Overall Study|Patient leaving country|1
31375|NCT01606137|140705|P1|Overall Study|Wanted to try another treatment|1
31376|NCT01606137|140705|P1|Overall Study|Not enough improvement|4
31377|NCT01606137|140705|P1|Overall Study|Spray causes nausea|1
31378|NCT01606137|140705|P1|Overall Study|Increased bilirubin|1
31379|NCT01606137|140705|P1|Overall Study|multiple sclerosis less stable|1
31380|NCT01606137|140705|P1|Overall Study|Issues with driving|4
31381|NCT01606137|140705|P1|Overall Study|Decreased/no pain|4
31382|NCT01606137|140705|P1|Overall Study|Death|1
31383|NCT01606137|140705|P1|Overall Study|Patient non-compliance|9
31384|NCT01606137|140705|P1|Overall Study|Protocol Violation|1
31385|NCT01606137|140705|P1|Overall Study|Lost to Follow-up|15
31386|NCT01606137|140705|P1|Overall Study|Lack of Efficacy|56
31387|NCT01606137|140705|P1|Overall Study|Withdrawal by Subject|74
31388|NCT01606137|140705|P1|Overall Study|Adverse Event|85
31389|NCT01606007|140728|P3|Overall Study|Poor/Non-compliance|0
31390|NCT01606007|140729|P2|Overall Study|Poor/Non-compliance|0
31391|NCT01606007|140730|P1|Overall Study|Poor/Non-compliance|1
31392|NCT01606007|140728|P3|Overall Study|Lost to Follow-up|5
31393|NCT01606007|140729|P2|Overall Study|Lost to Follow-up|8
31394|NCT01606007|140730|P1|Overall Study|Lost to Follow-up|6
31395|NCT01606007|140728|P3|Overall Study|discontinue study treatment|1
31396|NCT01606007|140729|P2|Overall Study|discontinue study treatment|2
31397|NCT01606007|140730|P1|Overall Study|discontinue study treatment|0
31398|NCT01606007|140728|P3|Overall Study|Adverse Event|1
31399|NCT01606007|140729|P2|Overall Study|Adverse Event|1
31400|NCT01606007|140730|P1|Overall Study|Adverse Event|0
31401|NCT01606007|140728|P3|Overall Study|Withdrawal by Subject|1
31402|NCT01606007|140729|P2|Overall Study|Withdrawal by Subject|6
31403|NCT01606007|140730|P1|Overall Study|Withdrawal by Subject|8
31404|NCT01606007|140728|P3|Overall Study|Pregnancy|1
31405|NCT01606007|140729|P2|Overall Study|Pregnancy|1
31406|NCT01606007|140730|P1|Overall Study|Pregnancy|0
31407|NCT01606007|140728|P3|Overall Study|Reason 'Other' in the protocol|1
31408|NCT01606007|140729|P2|Overall Study|Reason 'Other' in the protocol|1
31409|NCT01606007|140730|P1|Overall Study|Reason 'Other' in the protocol|0
31410|NCT01605916|140765|P5|Overall Study|Withdrawal by Subject|2
31411|NCT01605916|140766|P4|Overall Study|Withdrawal by Subject|0
31412|NCT01605916|140767|P3|Overall Study|Withdrawal by Subject|0
31413|NCT01605916|140768|P2|Overall Study|Withdrawal by Subject|1
31414|NCT01605916|140769|P1|Overall Study|Withdrawal by Subject|1
31415|NCT01605916|140765|P5|Overall Study|Lack of Efficacy|4
31416|NCT01605916|140766|P4|Overall Study|Lack of Efficacy|5
31417|NCT01605916|140767|P3|Overall Study|Lack of Efficacy|3
31418|NCT01605916|140768|P2|Overall Study|Lack of Efficacy|3
31419|NCT01605916|140769|P1|Overall Study|Lack of Efficacy|2
31420|NCT01605916|140765|P5|Overall Study|Adverse Event|0
31421|NCT01605916|140766|P4|Overall Study|Adverse Event|1
31422|NCT01605916|140767|P3|Overall Study|Adverse Event|0
31423|NCT01605916|140768|P2|Overall Study|Adverse Event|0
31424|NCT01605916|140769|P1|Overall Study|Adverse Event|1
31425|NCT01605877|140842|P1|Overall Study|Withdrawal by Subject|1
31426|NCT01605825|140906|P2|Overall Study|Non-Compliance with Protocol|0
31427|NCT01605825|140907|P1|Overall Study|Non-Compliance with Protocol|3
31428|NCT01605825|140906|P2|Overall Study|Non-Compliance -Investigational Drug|0
31429|NCT01605825|140907|P1|Overall Study|Non-Compliance -Investigational Drug|3
31430|NCT01605825|140906|P2|Overall Study|Withdrawal by Subject|1
31431|NCT01605825|140907|P1|Overall Study|Withdrawal by Subject|0
31432|NCT01605825|140906|P2|Overall Study|Adverse Event|2
31433|NCT01605825|140907|P1|Overall Study|Adverse Event|4
31434|NCT01605799|140915|P2|Overall Study|Withdrawal by Subject|1
31435|NCT01605799|140916|P1|Overall Study|Withdrawal by Subject|2
31436|NCT01605617|140931|P2|Washout Period of 4 Weeks|Study Terminated|1
31437|NCT01605617|140932|P1|Washout Period of 4 Weeks|Study Terminated|2
31438|NCT01605617|140931|P2|First Intervention|Adverse Event|1
31439|NCT01605617|140932|P1|First Intervention|Adverse Event|0
31440|NCT01605461|140991|P1|Overall Study|Withdrawal by Subject|1
31441|NCT01605461|140991|P1|Overall Study|Lost to Follow-up|3
31442|NCT01605370|141002|P2|Overall Study|Adverse Event|0
31443|NCT01605370|141003|P1|Overall Study|Adverse Event|1
31444|NCT01604941|141038|P6|Overall Study|Early Study Termination|0
31445|NCT01604941|141039|P5|Overall Study|Early Study Termination|0
31446|NCT01604941|141040|P4|Overall Study|Early Study Termination|3
31447|NCT01604941|141041|P3|Overall Study|Early Study Termination|3
31448|NCT01604941|141042|P2|Overall Study|Early Study Termination|2
31449|NCT01604941|141043|P1|Overall Study|Early Study Termination|9
31450|NCT01604941|141038|P6|Overall Study|Participant Decision|2
31451|NCT01604941|141039|P5|Overall Study|Participant Decision|0
31452|NCT01604941|141040|P4|Overall Study|Participant Decision|0
31453|NCT01604941|141041|P3|Overall Study|Participant Decision|0
31454|NCT01604941|141042|P2|Overall Study|Participant Decision|0
31455|NCT01604941|141043|P1|Overall Study|Participant Decision|0
31456|NCT01604941|141038|P6|Overall Study|Non-compliance|0
31457|NCT01604941|141039|P5|Overall Study|Non-compliance|0
31458|NCT01604941|141040|P4|Overall Study|Non-compliance|0
31459|NCT01604941|141041|P3|Overall Study|Non-compliance|0
31460|NCT01604941|141042|P2|Overall Study|Non-compliance|0
31461|NCT01604941|141043|P1|Overall Study|Non-compliance|1
31462|NCT01604941|141038|P6|Overall Study|Adverse Event|5
31463|NCT01604941|141039|P5|Overall Study|Adverse Event|1
31464|NCT01604941|141040|P4|Overall Study|Adverse Event|0
31465|NCT01604941|141041|P3|Overall Study|Adverse Event|0
31466|NCT01604941|141042|P2|Overall Study|Adverse Event|2
31467|NCT01604941|141043|P1|Overall Study|Adverse Event|1
31468|NCT01604850|141071|P2|Overall Study|Subject withdrew consent|0
31469|NCT01604850|141072|P1|Overall Study|Subject withdrew consent|1
31470|NCT01604850|141071|P2|Overall Study|Lost to Follow-up|0
31471|NCT01604850|141072|P1|Overall Study|Lost to Follow-up|1
31472|NCT01604850|141071|P2|Overall Study|Efficacy Failure|29
31473|NCT01604850|141072|P1|Overall Study|Efficacy Failure|50
31474|NCT01604850|141071|P2|Overall Study|Enrolled but never treated|1
31475|NCT01604850|141072|P1|Overall Study|Enrolled but never treated|0
31476|NCT01604278|141096|P2|Overall Study|Protocol Deviation|3
31477|NCT01604278|141097|P1|Overall Study|Protocol Deviation|5
31478|NCT01604278|141096|P2|Overall Study|Adverse Event|5
31479|NCT01604278|141097|P1|Overall Study|Adverse Event|3
31480|NCT01604278|141096|P2|Overall Study|Withdrawal by Subject|3
31481|NCT01604278|141097|P1|Overall Study|Withdrawal by Subject|3
31482|NCT01604278|141096|P2|Overall Study|Administrative problems|1
31483|NCT01604278|141097|P1|Overall Study|Administrative problems|2
31484|NCT01604278|141096|P2|Overall Study|Lost to Follow-up|0
31485|NCT01604278|141097|P1|Overall Study|Lost to Follow-up|1
31486|NCT01604278|141096|P2|Overall Study|Lack of Efficacy|1
31487|NCT01604278|141097|P1|Overall Study|Lack of Efficacy|0
31488|NCT01604265|141123|P2|Overall Study|Withdrawal by Subject|0
31489|NCT01604265|141124|P1|Overall Study|Withdrawal by Subject|1
31490|NCT01604265|141123|P2|Overall Study|Adverse Event|0
31491|NCT01604265|141124|P1|Overall Study|Adverse Event|1
31492|NCT01603875|141235|P3|Overall Study|Protocol Violation|0
31493|NCT01603875|141236|P2|Overall Study|Protocol Violation|1
31494|NCT01603875|141237|P1|Overall Study|Protocol Violation|0
31495|NCT01603875|141235|P3|Overall Study|Lost to Follow-up|6
31496|NCT01603875|141236|P2|Overall Study|Lost to Follow-up|3
31497|NCT01603875|141237|P1|Overall Study|Lost to Follow-up|4
31498|NCT01603875|141235|P3|Overall Study|Preexisting rabies antibody|3
31499|NCT01603875|141236|P2|Overall Study|Preexisting rabies antibody|4
31500|NCT01603875|141237|P1|Overall Study|Preexisting rabies antibody|3
31501|NCT01603459|141257|P1|Overall Study|Administrative reason|1
31502|NCT01603459|141257|P1|Overall Study|Non-compliance|1
31503|NCT01603459|141257|P1|Overall Study|Predefined discontinuation criteria|3
31504|NCT01603459|141257|P1|Overall Study|Lost to Follow-up|3
31505|NCT01603459|141257|P1|Overall Study|Withdrawal by Subject|5
31506|NCT01603459|141257|P1|Overall Study|Adverse Event|5
31507|NCT01603394|141408|P1|Overall Study|Adverse Event|1
31508|NCT01603277|141425|P2|Overall Study|Non-Compliance|1
31509|NCT01603277|141426|P1|Overall Study|Non-Compliance|2
31510|NCT01603277|141425|P2|Overall Study|Withdrawal by Subject|4
31511|NCT01603277|141426|P1|Overall Study|Withdrawal by Subject|5
31512|NCT01603277|141425|P2|Overall Study|Protocol Violation|10
31513|NCT01603277|141426|P1|Overall Study|Protocol Violation|6
31514|NCT01603277|141425|P2|Overall Study|Physician Decision|1
31515|NCT01603277|141426|P1|Overall Study|Physician Decision|0
31516|NCT01603277|141425|P2|Overall Study|Adverse Event|2
31517|NCT01603277|141426|P1|Overall Study|Adverse Event|1
31518|NCT01603121|141432|P2|Second Intervention, 10 Hours|Adverse Event|0
31519|NCT01603121|141433|P1|Second Intervention, 10 Hours|Adverse Event|1
31520|NCT01603082|141445|P2|Overall Study|Failed inclusion criterion after dosed|0
31521|NCT01603082|141446|P1|Overall Study|Failed inclusion criterion after dosed|1
31522|NCT01603082|141445|P2|Overall Study|Withdrawal by Subject|0
31523|NCT01603082|141446|P1|Overall Study|Withdrawal by Subject|1
31524|NCT01603082|141445|P2|Overall Study|Adverse Event|1
31525|NCT01603082|141446|P1|Overall Study|Adverse Event|0
31526|NCT01603043|141487|P2|Overall Study|Study Futility|3
31527|NCT01603043|141488|P1|Overall Study|Study Futility|7
31528|NCT01602965|141500|P2|Overall Study|Lost to Follow-up|2
31529|NCT01602965|141501|P1|Overall Study|Lost to Follow-up|4
31530|NCT01602744|141509|P2|Overall Study|Lost to Follow-up|8
31531|NCT01602744|141510|P1|Overall Study|Lost to Follow-up|13
31532|NCT01602744|141509|P2|Overall Study|Death|15
31533|NCT01602744|141510|P1|Overall Study|Death|17
31534|NCT01602562|141534|P2|Overall Study|Withdrawal by Subject|1
31535|NCT01602562|141535|P1|Overall Study|Withdrawal by Subject|1
31536|NCT01602562|141534|P2|Overall Study|Physician Decision|1
31537|NCT01602562|141535|P1|Overall Study|Physician Decision|1
31538|NCT01602562|141534|P2|Overall Study|Adverse Event|1
31539|NCT01602562|141535|P1|Overall Study|Adverse Event|3
31540|NCT01602549|141571|P2|Overall Study|Withdrawal by Subject|0
31541|NCT01602549|141572|P1|Overall Study|Withdrawal by Subject|1
31542|NCT01602549|141571|P2|Overall Study|Protocol Violation|1
31543|NCT01602549|141572|P1|Overall Study|Protocol Violation|0
31544|NCT01602510|141651|P3|Randomized Phase|Withdrawal by Subject|7
31545|NCT01602510|141652|P2|Randomized Phase|Withdrawal by Subject|6
31546|NCT01602510|141653|P1|Randomized Phase|Withdrawal by Subject|0
31547|NCT01602510|141651|P3|Randomized Phase|Physician Decision|2
31548|NCT01602510|141652|P2|Randomized Phase|Physician Decision|0
31549|NCT01602510|141653|P1|Randomized Phase|Physician Decision|0
31550|NCT01602510|141651|P3|Randomized Phase|Lost to Follow-up|3
31551|NCT01602510|141652|P2|Randomized Phase|Lost to Follow-up|1
31552|NCT01602510|141653|P1|Randomized Phase|Lost to Follow-up|0
31553|NCT01602510|141651|P3|Randomized Phase|Met protocol-defined stopping criteria|48
31554|NCT01602510|141652|P2|Randomized Phase|Met protocol-defined stopping criteria|58
31555|NCT01602510|141653|P1|Randomized Phase|Met protocol-defined stopping criteria|0
31556|NCT01602510|141651|P3|Randomized Phase|Protocol Violation|3
31557|NCT01602510|141652|P2|Randomized Phase|Protocol Violation|3
31558|NCT01602510|141653|P1|Randomized Phase|Protocol Violation|0
31559|NCT01602510|141651|P3|Randomized Phase|Lack of Efficacy|4
31560|NCT01602510|141652|P2|Randomized Phase|Lack of Efficacy|4
31561|NCT01602510|141653|P1|Randomized Phase|Lack of Efficacy|0
31562|NCT01602510|141651|P3|Randomized Phase|Adverse Event|6
31563|NCT01602510|141652|P2|Randomized Phase|Adverse Event|2
31564|NCT01602510|141653|P1|Randomized Phase|Adverse Event|0
31565|NCT01602510|141651|P3|Open Label Phase|Withdrawal by Subject|0
31566|NCT01602510|141652|P2|Open Label Phase|Withdrawal by Subject|0
31567|NCT01602510|141653|P1|Open Label Phase|Withdrawal by Subject|57
31568|NCT01602510|141651|P3|Open Label Phase|Physician Decision|0
31569|NCT01602510|141652|P2|Open Label Phase|Physician Decision|0
31570|NCT01602510|141653|P1|Open Label Phase|Physician Decision|19
31571|NCT01602510|141651|P3|Open Label Phase|Lost to Follow-up|0
31572|NCT01602510|141652|P2|Open Label Phase|Lost to Follow-up|0
31573|NCT01602510|141653|P1|Open Label Phase|Lost to Follow-up|22
31574|NCT01602510|141651|P3|Open Label Phase|Met protocol-defined stopping criteria|0
31575|NCT01602510|141652|P2|Open Label Phase|Met protocol-defined stopping criteria|0
31576|NCT01602510|141653|P1|Open Label Phase|Met protocol-defined stopping criteria|122
31577|NCT01602510|141651|P3|Open Label Phase|Protocol Violation|0
31578|NCT01602510|141652|P2|Open Label Phase|Protocol Violation|0
31579|NCT01602510|141653|P1|Open Label Phase|Protocol Violation|15
31580|NCT01602510|141651|P3|Open Label Phase|Lack of Efficacy|0
31581|NCT01602510|141652|P2|Open Label Phase|Lack of Efficacy|0
31582|NCT01602510|141653|P1|Open Label Phase|Lack of Efficacy|22
31583|NCT01602510|141651|P3|Open Label Phase|Adverse Event|0
31584|NCT01602510|141652|P2|Open Label Phase|Adverse Event|0
31585|NCT01602510|141653|P1|Open Label Phase|Adverse Event|46
31586|NCT01602484|141679|P2|Overall Study|Airway issues unrelated to study|1
31587|NCT01602484|141680|P1|Overall Study|Airway issues unrelated to study|0
31588|NCT01602380|141698|P2|Overall Study|Eligibility criteria not fulfilled|3
31589|NCT01602380|141699|P1|Overall Study|Eligibility criteria not fulfilled|2
31590|NCT01602380|141698|P2|Overall Study|Lost to Follow-up|1
31591|NCT01602380|141699|P1|Overall Study|Lost to Follow-up|6
31592|NCT01602380|141698|P2|Overall Study|Withdrawal by Subject|29
31593|NCT01602380|141699|P1|Overall Study|Withdrawal by Subject|22
31594|NCT01602380|141698|P2|Overall Study|Death|68
31595|NCT01602380|141699|P1|Overall Study|Death|63
31596|NCT01602341|141723|P2|Overall Study|Adverse Event|1
31597|NCT01602341|141724|P1|Overall Study|Adverse Event|0
31598|NCT01601821|141791|P2|Overall Study|Unspecified|1
31599|NCT01601821|141792|P1|Overall Study|Unspecified|5
31600|NCT01601821|141791|P2|Overall Study|Study Events|1
31601|NCT01601821|141792|P1|Overall Study|Study Events|7
31602|NCT01601821|141791|P2|Overall Study|Graft Loss|6
31603|NCT01601821|141792|P1|Overall Study|Graft Loss|6
31604|NCT01601821|141791|P2|Overall Study|Withdrawal by Subject|0
31605|NCT01601821|141792|P1|Overall Study|Withdrawal by Subject|1
31606|NCT01601821|141791|P2|Overall Study|Lost to Follow-up|14
31607|NCT01601821|141792|P1|Overall Study|Lost to Follow-up|6
31608|NCT01601821|141791|P2|Overall Study|Protocol Violation|2
31609|NCT01601821|141792|P1|Overall Study|Protocol Violation|2
31610|NCT01601821|141791|P2|Overall Study|Death|5
31611|NCT01601821|141792|P1|Overall Study|Death|2
31612|NCT01601704|141828|P2|Overall Study|Randomized but not dispensed study med|4
31613|NCT01601704|141829|P1|Overall Study|Randomized but not dispensed study med|1
31614|NCT01601470|141847|P1|Period 2 - LCZ696|Physician Decision|1
31615|NCT01601132|141909|P1|Overall Study|Protocol deviation|1
31616|NCT01601132|141909|P1|Overall Study|Patient withdrew consent|1
31617|NCT01600885|141943|P2|First Period|moved out of area|0
31618|NCT01600885|141944|P1|First Period|moved out of area|1
31619|NCT01600885|141943|P2|First Period|Adverse Event|1
31620|NCT01600885|141944|P1|First Period|Adverse Event|1
31621|NCT01600716|141961|P2|Overall Study|Adverse Event|1
31622|NCT01600716|141962|P1|Overall Study|Adverse Event|1
31623|NCT01600716|141961|P2|Overall Study|Lack of Efficacy|1
31624|NCT01600716|141962|P1|Overall Study|Lack of Efficacy|2
31625|NCT01600716|141961|P2|Overall Study|Pregnancy|0
31626|NCT01600716|141962|P1|Overall Study|Pregnancy|1
31627|NCT01600716|141961|P2|Overall Study|Lost to Follow-up|2
31628|NCT01600716|141962|P1|Overall Study|Lost to Follow-up|0
31629|NCT01600716|141961|P2|Overall Study|Personal Reasons|2
31630|NCT01600716|141962|P1|Overall Study|Personal Reasons|0
31631|NCT01600716|141961|P2|Overall Study|Other Reasons|1
31632|NCT01600716|141962|P1|Overall Study|Other Reasons|3
31633|NCT01600326|142038|P2|Overall Study|Lost to Follow-up|1
31634|NCT01600326|142039|P1|Overall Study|Lost to Follow-up|1
31635|NCT01600092|142115|P2|Overall Study|Randomized but not vaccinated|3
31636|NCT01600092|142116|P1|Overall Study|Randomized but not vaccinated|3
31637|NCT01600092|142115|P2|Overall Study|Physician Decision|1
31638|NCT01600092|142116|P1|Overall Study|Physician Decision|1
31639|NCT01600092|142115|P2|Overall Study|Withdrawal by parent/guardian|6
31640|NCT01600092|142116|P1|Overall Study|Withdrawal by parent/guardian|8
31641|NCT01600092|142115|P2|Overall Study|Lost to Follow-up|6
31642|NCT01600092|142116|P1|Overall Study|Lost to Follow-up|4
31643|NCT01600092|142115|P2|Overall Study|Adverse Event|0
31644|NCT01600092|142116|P1|Overall Study|Adverse Event|2
31645|NCT01600053|142130|P1|Overall Study|trial will not meet the interim endpoint|9
31646|NCT01600053|142130|P1|Overall Study|Adverse Event|2
31647|NCT01600014|142135|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
31648|NCT01600014|142136|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
31649|NCT01600014|142135|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
31650|NCT01600014|142136|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
31651|NCT01600014|142135|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
31652|NCT01600014|142136|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
31653|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
31654|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
31655|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
31656|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
31657|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
31658|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
31659|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
31660|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
31661|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
31662|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
31663|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
31664|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
31665|NCT01600014|142135|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
31666|NCT01600014|142136|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
31667|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
31668|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
31669|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
31670|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
31671|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
31672|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
31673|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Other|0
31674|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Other|27
31675|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
31676|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
31677|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
31678|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
31679|NCT01600014|142135|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
31680|NCT01600014|142136|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
31681|NCT01599806|142164|P2|Overall Study|Other Eligibility criteria|9
31682|NCT01599806|142165|P1|Overall Study|Other Eligibility criteria|11
31683|NCT01599806|142164|P2|Overall Study|Withdrawal by Subject|12
31684|NCT01599806|142165|P1|Overall Study|Withdrawal by Subject|12
31685|NCT01599806|142164|P2|Overall Study|Lost to Follow-up|20
31686|NCT01599806|142165|P1|Overall Study|Lost to Follow-up|20
31687|NCT01599650|142298|P3|Overall Study|Adverse Event|4
31688|NCT01599650|142299|P2|Overall Study|Adverse Event|8
31689|NCT01599650|142300|P1|Overall Study|Adverse Event|3
31690|NCT01599650|142298|P3|Overall Study|Withdrawal by Subject|10
31691|NCT01599650|142299|P2|Overall Study|Withdrawal by Subject|11
31692|NCT01599650|142300|P1|Overall Study|Withdrawal by Subject|11
31693|NCT01599650|142298|P3|Overall Study|Lost to Follow-up|3
31694|NCT01599650|142299|P2|Overall Study|Lost to Follow-up|3
31695|NCT01599650|142300|P1|Overall Study|Lost to Follow-up|3
31696|NCT01599650|142298|P3|Overall Study|Death|2
31697|NCT01599650|142299|P2|Overall Study|Death|1
31698|NCT01599650|142300|P1|Overall Study|Death|2
31699|NCT01599650|142298|P3|Overall Study|Protocol Violation|0
31700|NCT01599650|142299|P2|Overall Study|Protocol Violation|3
31701|NCT01599650|142300|P1|Overall Study|Protocol Violation|0
31702|NCT01599650|142298|P3|Overall Study|Physician Decision|7
31703|NCT01599650|142299|P2|Overall Study|Physician Decision|0
31704|NCT01599650|142300|P1|Overall Study|Physician Decision|2
31705|NCT01599650|142298|P3|Overall Study|Administrative issue|1
31706|NCT01599650|142299|P2|Overall Study|Administrative issue|0
31707|NCT01599650|142300|P1|Overall Study|Administrative issue|1
31708|NCT01599637|142339|P3|Overall Study|Adverse Event|0
31709|NCT01599637|142340|P2|Overall Study|Adverse Event|0
31710|NCT01599637|142341|P1|Overall Study|Adverse Event|1
31711|NCT01599637|142339|P3|Overall Study|administrative problems|0
31712|NCT01599637|142340|P2|Overall Study|administrative problems|2
31713|NCT01599637|142341|P1|Overall Study|administrative problems|0
31714|NCT01599585|142388|P2|Overall Study|randomized did not start treatment|3
31715|NCT01599585|142389|P1|Overall Study|randomized did not start treatment|3
31716|NCT01599585|142388|P2|Overall Study|Lost to Follow-up|5
31717|NCT01599585|142389|P1|Overall Study|Lost to Follow-up|3
31718|NCT01599585|142388|P2|Overall Study|Withdrawal by Subject|9
31719|NCT01599585|142389|P1|Overall Study|Withdrawal by Subject|16
31720|NCT01599325|142427|P1|Overall Study|Unspecified|2
31721|NCT01599325|142427|P1|Overall Study|Lack of Therapeutic Effect|9
31722|NCT01599325|142427|P1|Overall Study|Protocol Violation|1
31723|NCT01599325|142427|P1|Overall Study|Death|13
31724|NCT01599325|142427|P1|Overall Study|Withdrawal by Subject|20
31725|NCT01599325|142427|P1|Overall Study|Disease Progression|7
31726|NCT01599325|142427|P1|Overall Study|Adverse Event|5
31727|NCT01599234|142449|P2|Overall Study|Pregnancy|1
31728|NCT01599234|142450|P1|Overall Study|Pregnancy|0
31729|NCT01599234|142449|P2|Overall Study|Contra-indication discovered|1
31730|NCT01599234|142450|P1|Overall Study|Contra-indication discovered|0
31731|NCT01599234|142449|P2|Overall Study|Patient would not stop driving|0
31732|NCT01599234|142450|P1|Overall Study|Patient would not stop driving|1
31733|NCT01599234|142449|P2|Overall Study|Death|0
31734|NCT01599234|142450|P1|Overall Study|Death|1
31735|NCT01599234|142449|P2|Overall Study|Sponsor request as creatinine levels <50|1
31736|NCT01599234|142450|P1|Overall Study|Sponsor request as creatinine levels <50|0
31737|NCT01599234|142449|P2|Overall Study|Unable to operate spray|0
31738|NCT01599234|142450|P1|Overall Study|Unable to operate spray|1
31739|NCT01599234|142449|P2|Overall Study|Lack of Efficacy|4
31740|NCT01599234|142450|P1|Overall Study|Lack of Efficacy|2
31741|NCT01599234|142449|P2|Overall Study|Lost to Follow-up|2
31742|NCT01599234|142450|P1|Overall Study|Lost to Follow-up|1
31743|NCT01599234|142449|P2|Overall Study|Withdrawal by Subject|1
31744|NCT01599234|142450|P1|Overall Study|Withdrawal by Subject|2
31745|NCT01599234|142449|P2|Overall Study|Adverse Event|5
31746|NCT01599234|142450|P1|Overall Study|Adverse Event|9
31747|NCT01599104|142475|P3|Overall Study|Adverse Event|12
31748|NCT01599104|142476|P2|Overall Study|Adverse Event|6
31749|NCT01599104|142477|P1|Overall Study|Adverse Event|7
31750|NCT01599104|142475|P3|Overall Study|Lack of Efficacy|10
31751|NCT01599104|142476|P2|Overall Study|Lack of Efficacy|4
31752|NCT01599104|142477|P1|Overall Study|Lack of Efficacy|4
31753|NCT01599104|142475|P3|Overall Study|Non-compliance with study treatment|0
31754|NCT01599104|142476|P2|Overall Study|Non-compliance with study treatment|1
31755|NCT01599104|142477|P1|Overall Study|Non-compliance with study treatment|0
31756|NCT01599104|142475|P3|Overall Study|Physician Decision|2
31757|NCT01599104|142476|P2|Overall Study|Physician Decision|2
31758|NCT01599104|142477|P1|Overall Study|Physician Decision|3
31759|NCT01599104|142475|P3|Overall Study|Technical Problems|0
31760|NCT01599104|142476|P2|Overall Study|Technical Problems|0
31761|NCT01599104|142477|P1|Overall Study|Technical Problems|1
31762|NCT01599104|142475|P3|Overall Study|Withdrawal by Subject|2
31763|NCT01599104|142476|P2|Overall Study|Withdrawal by Subject|1
31764|NCT01599104|142477|P1|Overall Study|Withdrawal by Subject|1
31765|NCT01598987|142515|P1|Baseline to 24 Month|Lost to Follow-up|1
31766|NCT01598987|142515|P1|Baseline to 24 Month|Administrative problems|2
31767|NCT01598987|142515|P1|Baseline to 24 Month|Withdrawal by Subject|5
31768|NCT01598987|142515|P1|Baseline to Month 12|Withdrawal by Subject|4
31769|NCT01598987|142515|P1|Baseline to Month 12|Administrative problems|2
31770|NCT01598610|142564|P1|Overall Study|Adverse Event|1
31771|NCT01598532|142581|P1|Overall Study|Did not meet inclusion criteria|8
31772|NCT01598532|142581|P1|Overall Study|Lost to Follow-up|3
31773|NCT01598506|142590|P1|Overall Study|Withdrawal by Subject|2
31774|NCT01598129|142630|P1|Overall Study|Withdrawal by Subject|1
31775|NCT01598129|142630|P1|Overall Study|Deterioration of WHO status to WHO 4|2
31776|NCT01598129|142630|P1|Overall Study|Disease progression|6
31777|NCT01597908|142652|P2|Overall Study|Ongoing|202
31778|NCT01597908|142653|P1|Overall Study|Ongoing|236
31779|NCT01597908|142652|P2|Overall Study|Withdrawal by Subject|18
31780|NCT01597908|142653|P1|Overall Study|Withdrawal by Subject|10
31781|NCT01597908|142652|P2|Overall Study|Physician Decision|1
31782|NCT01597908|142653|P1|Overall Study|Physician Decision|2
31783|NCT01597908|142652|P2|Overall Study|Lost to Follow-up|9
31784|NCT01597908|142653|P1|Overall Study|Lost to Follow-up|4
31785|NCT01597908|142652|P2|Overall Study|Death|122
31786|NCT01597908|142653|P1|Overall Study|Death|100
31787|NCT01597596|142680|P2|Overall Study|Physician Decision|1
31788|NCT01597596|142681|P1|Overall Study|Physician Decision|0
31789|NCT01597596|142680|P2|Overall Study|Study terminated by sponsor|0
31790|NCT01597596|142681|P1|Overall Study|Study terminated by sponsor|1
31791|NCT01597492|142695|P2|Overall Study|Other Reason|0
31792|NCT01597492|142696|P1|Overall Study|Other Reason|2
31793|NCT01597492|142695|P2|Overall Study|Lost to Follow-up|2
31794|NCT01597492|142696|P1|Overall Study|Lost to Follow-up|0
31795|NCT01597492|142695|P2|Overall Study|Adverse Event|0
31796|NCT01597492|142696|P1|Overall Study|Adverse Event|3
31797|NCT01597492|142695|P2|Overall Study|Withdrawal by Subject|2
31798|NCT01597492|142696|P1|Overall Study|Withdrawal by Subject|1
31799|NCT01597479|142704|P2|Overall Study|Lost to Follow-up|0
31800|NCT01597479|142705|P1|Overall Study|Lost to Follow-up|1
31801|NCT01597479|142704|P2|Overall Study|Protocol Violation|0
31802|NCT01597479|142705|P1|Overall Study|Protocol Violation|1
31803|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31804|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31805|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
31806|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31807|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31808|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31809|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31810|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31811|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31812|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31813|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31814|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31815|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
31816|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31817|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
31818|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
31819|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
31820|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
31821|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31822|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
31823|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31824|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31825|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31826|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31827|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31828|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
31829|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
31830|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
31831|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
31832|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
31833|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
31834|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
31835|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
31836|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
31837|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
31838|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
31839|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
31840|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
31841|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
31842|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
31843|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31844|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
31845|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
31846|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
31847|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31848|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31849|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31850|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
31851|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31852|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31853|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31854|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
31855|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
31856|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
31857|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
31858|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
31859|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
31860|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
31861|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
31862|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
31863|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
31864|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
31865|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
31866|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
31867|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
31868|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
31869|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
31870|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
31871|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
31872|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
31873|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
31874|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
31875|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
31876|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
31877|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
31878|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
31879|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
31880|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
31881|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
31882|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
31883|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
31884|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31885|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
31886|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31887|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
31888|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31889|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31890|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31891|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31892|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31893|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
31894|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31895|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31896|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31897|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|111
31898|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31899|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
31900|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|21
31901|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|80
31902|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|148
31903|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31904|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31905|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31906|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
31907|NCT01597245|142727|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31908|NCT01597245|142728|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31909|NCT01597245|142729|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31910|NCT01597245|142730|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31911|NCT01597245|142731|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31912|NCT01597245|142732|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31913|NCT01597245|142733|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
31914|NCT01597245|142734|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
31915|NCT01597245|142735|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31916|NCT01597245|142736|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31917|NCT01597245|142737|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31918|NCT01597245|142738|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31919|NCT01597245|142739|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
31920|NCT01597245|142727|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31921|NCT01597245|142728|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31922|NCT01597245|142729|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31923|NCT01597245|142730|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31924|NCT01597245|142731|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31925|NCT01597245|142732|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31926|NCT01597245|142733|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31927|NCT01597245|142734|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31928|NCT01597245|142735|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31929|NCT01597245|142736|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
31930|NCT01597245|142737|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
31931|NCT01597245|142738|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
31932|NCT01597245|142739|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
31933|NCT01597245|142727|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
31934|NCT01597245|142728|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
31935|NCT01597245|142729|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
31936|NCT01597245|142730|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
31937|NCT01597245|142731|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
31938|NCT01597245|142732|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
31939|NCT01597245|142733|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
31940|NCT01597245|142734|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
31941|NCT01597245|142735|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
31942|NCT01597245|142736|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
31943|NCT01597245|142737|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
31944|NCT01597245|142738|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
31945|NCT01597245|142739|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
31946|NCT01597245|142727|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31947|NCT01597245|142728|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31948|NCT01597245|142729|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31949|NCT01597245|142730|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31950|NCT01597245|142731|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31951|NCT01597245|142732|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31952|NCT01597245|142733|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31953|NCT01597245|142734|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31954|NCT01597245|142735|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31955|NCT01597245|142736|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
31956|NCT01597245|142737|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
31957|NCT01597245|142738|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
31958|NCT01597245|142739|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
31959|NCT01597245|142727|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31960|NCT01597245|142728|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31961|NCT01597245|142729|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31962|NCT01597245|142730|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31963|NCT01597245|142731|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
32044|NCT01594749|143266|P2|Overall Study|Lost Source Documentation|0
31964|NCT01597245|142732|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31965|NCT01597245|142733|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31966|NCT01597245|142734|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31967|NCT01597245|142735|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
31968|NCT01597245|142736|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
31969|NCT01597245|142737|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
31970|NCT01597245|142738|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
31971|NCT01597245|142739|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
31972|NCT01597245|142727|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31973|NCT01597245|142728|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31974|NCT01597245|142729|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31975|NCT01597245|142730|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31976|NCT01597245|142731|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31977|NCT01597245|142732|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31978|NCT01597245|142733|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31979|NCT01597245|142734|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31980|NCT01597245|142735|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
31981|NCT01597245|142736|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
31982|NCT01597245|142737|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
31983|NCT01597245|142738|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
31984|NCT01597245|142739|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
31985|NCT01597245|142727|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
31986|NCT01597245|142728|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
31987|NCT01597245|142729|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
31988|NCT01597245|142730|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
31989|NCT01597245|142731|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
31990|NCT01597245|142732|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
31991|NCT01597245|142733|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
31992|NCT01597245|142734|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
31993|NCT01597245|142735|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
31994|NCT01597245|142736|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
31995|NCT01597245|142737|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
31996|NCT01597245|142738|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
31997|NCT01597245|142739|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
31998|NCT01597050|142862|P2|Overall Study|Withdrawal by Subject|0
31999|NCT01597050|142863|P1|Overall Study|Withdrawal by Subject|1
32000|NCT01596972|142871|P2|Overall Study|Withdrawal by Subject|1
32001|NCT01596972|142872|P1|Overall Study|Withdrawal by Subject|0
32002|NCT01596972|142871|P2|Overall Study|Lost to Follow-up|4
32003|NCT01596972|142872|P1|Overall Study|Lost to Follow-up|0
32004|NCT01596972|142871|P2|Overall Study|Physician Decision|9
32005|NCT01596972|142872|P1|Overall Study|Physician Decision|1
32006|NCT01596582|142895|P2|Overall Study|Missing all outcome data|1
32007|NCT01596582|142896|P1|Overall Study|Missing all outcome data|1
32008|NCT01596582|142895|P2|Overall Study|Deemed ineligible after study visit|6
32009|NCT01596582|142896|P1|Overall Study|Deemed ineligible after study visit|3
32010|NCT01596504|142923|P3|Overall Study|Withdrawal by Subject|0
32011|NCT01596504|142924|P2|Overall Study|Withdrawal by Subject|0
32012|NCT01596504|142925|P1|Overall Study|Withdrawal by Subject|1
32013|NCT01596504|142923|P3|Overall Study|Adverse Event|1
32014|NCT01596504|142924|P2|Overall Study|Adverse Event|2
32015|NCT01596504|142925|P1|Overall Study|Adverse Event|1
32016|NCT01596504|142923|P3|Overall Study|Participant's Private Reason|0
32017|NCT01596504|142924|P2|Overall Study|Participant's Private Reason|1
32018|NCT01596504|142925|P1|Overall Study|Participant's Private Reason|0
32019|NCT01596062|142997|P3|Overall Study|Lack of Efficacy|1
32020|NCT01596062|142998|P2|Overall Study|Lack of Efficacy|0
32021|NCT01596062|142999|P1|Overall Study|Lack of Efficacy|0
32022|NCT01596062|142997|P3|Overall Study|Adverse Event|2
32023|NCT01596062|142998|P2|Overall Study|Adverse Event|0
32024|NCT01596062|142999|P1|Overall Study|Adverse Event|1
32025|NCT01595438|143062|P2|Overall Study|Other Eligibility criteria|9
32026|NCT01595438|143063|P1|Overall Study|Other Eligibility criteria|11
32027|NCT01595438|143062|P2|Overall Study|Withdrawal by Subject|12
32028|NCT01595438|143063|P1|Overall Study|Withdrawal by Subject|12
32029|NCT01595438|143062|P2|Overall Study|Lost to Follow-up|20
32030|NCT01595438|143063|P1|Overall Study|Lost to Follow-up|20
32031|NCT01594970|143232|P3|Overall Study|Lost to Follow-up|37
32032|NCT01594970|143233|P2|Overall Study|Lost to Follow-up|54
32033|NCT01594970|143234|P1|Overall Study|Lost to Follow-up|54
32034|NCT01594970|143232|P3|Overall Study|Adverse Event|23
32035|NCT01594970|143233|P2|Overall Study|Adverse Event|23
32036|NCT01594970|143234|P1|Overall Study|Adverse Event|17
32037|NCT01594970|143232|P3|Overall Study|Non-Adverse Event Related|6
32038|NCT01594970|143233|P2|Overall Study|Non-Adverse Event Related|5
32039|NCT01594970|143234|P1|Overall Study|Non-Adverse Event Related|4
32040|NCT01594762|143253|P2|Overall Study|Lost to Follow-up|10
32041|NCT01594762|143254|P1|Overall Study|Lost to Follow-up|10
32042|NCT01594762|143253|P2|Overall Study|Withdrawal by Subject|0
32043|NCT01594762|143254|P1|Overall Study|Withdrawal by Subject|1
32045|NCT01594749|143267|P1|Overall Study|Lost Source Documentation|1
32046|NCT01594749|143266|P2|Overall Study|Not Treated|10
32047|NCT01594749|143267|P1|Overall Study|Not Treated|4
32048|NCT01594749|143266|P2|Overall Study|Death|3
32049|NCT01594749|143267|P1|Overall Study|Death|9
32050|NCT01594749|143266|P2|Overall Study|Lost to Follow-up|0
32051|NCT01594749|143267|P1|Overall Study|Lost to Follow-up|1
32052|NCT01594749|143266|P2|Overall Study|Non-compliance with Protocol|1
32053|NCT01594749|143267|P1|Overall Study|Non-compliance with Protocol|0
32054|NCT01594749|143266|P2|Overall Study|Physician Decision|1
32055|NCT01594749|143267|P1|Overall Study|Physician Decision|1
32056|NCT01594749|143266|P2|Overall Study|Protocol Violation|0
32057|NCT01594749|143267|P1|Overall Study|Protocol Violation|2
32058|NCT01594749|143266|P2|Overall Study|Withdrawal by Subject|2
32059|NCT01594749|143267|P1|Overall Study|Withdrawal by Subject|2
32060|NCT01594749|143266|P2|Overall Study|Adverse Event|1
32061|NCT01594749|143267|P1|Overall Study|Adverse Event|2
32062|NCT01594411|143396|P1|Overall Study|Lost to Follow-up|2
32063|NCT01594125|143434|P5|Overall Study|Progressive Disease|7
32064|NCT01594125|143435|P4|Overall Study|Progressive Disease|3
32065|NCT01594125|143436|P3|Overall Study|Progressive Disease|3
32066|NCT01594125|143437|P2|Overall Study|Progressive Disease|12
32067|NCT01594125|143438|P1|Overall Study|Progressive Disease|3
32068|NCT01594125|143434|P5|Overall Study|Withdrawal by Subject|0
32069|NCT01594125|143435|P4|Overall Study|Withdrawal by Subject|1
32070|NCT01594125|143436|P3|Overall Study|Withdrawal by Subject|0
32071|NCT01594125|143437|P2|Overall Study|Withdrawal by Subject|0
32072|NCT01594125|143438|P1|Overall Study|Withdrawal by Subject|1
32073|NCT01593787|143498|P3|Overall Study|Adverse Event|0
32074|NCT01593787|143499|P2|Overall Study|Adverse Event|0
32075|NCT01593787|143500|P1|Overall Study|Adverse Event|1
32076|NCT01592864|143587|P2|Overall Study|Withdrawal by Subject|1
32077|NCT01592864|143588|P1|Overall Study|Withdrawal by Subject|0
32078|NCT01592786|143619|P1|Overall Study|Other|3
32079|NCT01592786|143619|P1|Overall Study|Lost to Follow-up|19
32080|NCT01592786|143619|P1|Overall Study|Withdrawal by Subject|23
32081|NCT01592786|143619|P1|Overall Study|Protocol Violation|14
32082|NCT01592786|143619|P1|Overall Study|Lack of Efficacy|19
32083|NCT01592786|143619|P1|Overall Study|Adverse Event|60
32084|NCT01592773|143623|P1|Overall Study|Other Reason|1
32085|NCT01592773|143623|P1|Overall Study|Inclusion/exclusion not meet|1
32086|NCT01592773|143623|P1|Overall Study|Protocol Violation|2
32087|NCT01592773|143623|P1|Overall Study|Lack of Efficacy|9
32088|NCT01592773|143623|P1|Overall Study|Adverse Event|17
32089|NCT01592773|143623|P1|Overall Study|Lost to Follow-up|19
32090|NCT01592773|143623|P1|Overall Study|Withdrawal by Subject|35
32091|NCT01592773|143623|P1|Overall Study|Study Terminated by Sponsor|582
32092|NCT01592760|143630|P3|24-hour Follow-Up|Lost to Follow-up|2
32093|NCT01592760|143631|P2|24-hour Follow-Up|Lost to Follow-up|3
32094|NCT01592760|143632|P1|24-hour Follow-Up|Lost to Follow-up|4
32095|NCT01592708|143675|P2|Overall Study|Protocol Violation|0
32096|NCT01592708|143676|P1|Overall Study|Protocol Violation|3
32097|NCT01592695|143692|P2|Overall Study|Lost to Follow-up|4
32098|NCT01592695|143693|P1|Overall Study|Lost to Follow-up|8
32099|NCT01592344|143737|P2|Overall Study|not available at primary outcome visit|4
32100|NCT01592344|143738|P1|Overall Study|not available at primary outcome visit|2
32101|NCT01592344|143737|P2|Overall Study|Lack of Efficacy|0
32102|NCT01592344|143738|P1|Overall Study|Lack of Efficacy|1
32103|NCT01592344|143737|P2|Overall Study|Adverse Event|1
32104|NCT01592344|143738|P1|Overall Study|Adverse Event|1
32105|NCT01592292|143752|P4|Overall Study|Not specified|1
32106|NCT01592292|143753|P3|Overall Study|Not specified|2
32107|NCT01592292|143754|P2|Overall Study|Not specified|1
32108|NCT01592292|143755|P1|Overall Study|Not specified|1
32109|NCT01592292|143752|P4|Overall Study|Withdrew consent|0
32110|NCT01592292|143753|P3|Overall Study|Withdrew consent|0
32111|NCT01592292|143754|P2|Overall Study|Withdrew consent|1
32112|NCT01592292|143755|P1|Overall Study|Withdrew consent|2
32113|NCT01592292|143752|P4|Overall Study|Follow-up loss|0
32114|NCT01592292|143753|P3|Overall Study|Follow-up loss|1
32115|NCT01592292|143754|P2|Overall Study|Follow-up loss|3
32116|NCT01592292|143755|P1|Overall Study|Follow-up loss|3
32117|NCT01592045|143800|P2|Overall Study|Moved out of country|0
32118|NCT01592045|143801|P1|Overall Study|Moved out of country|2
32119|NCT01592045|143800|P2|Overall Study|Withdrawal by Subject|0
32120|NCT01592045|143801|P1|Overall Study|Withdrawal by Subject|1
32121|NCT01592045|143800|P2|Overall Study|Adverse Event|1
32122|NCT01592045|143801|P1|Overall Study|Adverse Event|1
32123|NCT01592045|143800|P2|Overall Study|Disease Progression|1
32124|NCT01592045|143801|P1|Overall Study|Disease Progression|1
32125|NCT01591863|143819|P1|Overall Study|Lack of Efficacy|1
32126|NCT01591863|143819|P1|Overall Study|recurrence|9
32127|NCT01591863|143819|P1|Overall Study|Withdrawal by Subject|1
32128|NCT01591863|143819|P1|Overall Study|Adverse Event|3
32129|NCT01591681|143846|P1|Overall Study|Failed to use system during run-in|1
32130|NCT01591681|143846|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
32131|NCT01591616|143872|P1|Overall Study|Withdrawal by Subject|1
32132|NCT01591499|144013|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
32133|NCT01591499|144014|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
32134|NCT01591499|144015|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
32135|NCT01591499|144016|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
32136|NCT01591499|144013|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
32137|NCT01591499|144014|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
32138|NCT01591499|144015|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
32139|NCT01591499|144016|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
32140|NCT01591499|144013|P4|Baseline Visit|Withdrawal by Subject|2
32141|NCT01591499|144014|P3|Baseline Visit|Withdrawal by Subject|0
32142|NCT01591499|144015|P2|Baseline Visit|Withdrawal by Subject|2
32143|NCT01591499|144016|P1|Baseline Visit|Withdrawal by Subject|0
32144|NCT01591460|144082|P1|Overall Study|Protocol Violation|1
32145|NCT01591460|144082|P1|Overall Study|Withdrawal by Subject|1
32146|NCT01591460|144082|P1|Overall Study|Participant Refusal|3
32147|NCT01591460|144082|P1|Overall Study|Noncompliance|1
32148|NCT01591460|144082|P1|Overall Study|Lost to Follow-up|1
32149|NCT01591460|144082|P1|Overall Study|Treatment Discontinued by Error|1
32150|NCT01591460|144082|P1|Overall Study|Rebound or Breakthrough|3
32151|NCT01591460|144082|P1|Overall Study|Futility Rule (Week 24)|3
32152|NCT01591460|144082|P1|Overall Study|Futility Rule (Week 12)|7
32153|NCT01591460|144082|P1|Overall Study|Adverse Event or Intercurrent Illness|5
32154|NCT01591382|144173|P2|Overall Study|Participant Opted for Morphine PCA|1
32155|NCT01591382|144174|P1|Overall Study|Participant Opted for Morphine PCA|1
32156|NCT01591382|144173|P2|Overall Study|Discharged Prior to Study Completion|1
32157|NCT01591382|144174|P1|Overall Study|Discharged Prior to Study Completion|2
32158|NCT01590888|144298|P3|Overall Study|Lost to Follow-up|0
32159|NCT01590888|144299|P2|Overall Study|Lost to Follow-up|0
32160|NCT01590888|144300|P1|Overall Study|Lost to Follow-up|1
32161|NCT01590888|144298|P3|Overall Study|Adverse Event|1
32162|NCT01590888|144299|P2|Overall Study|Adverse Event|0
32163|NCT01590888|144300|P1|Overall Study|Adverse Event|3
32164|NCT01590810|144364|P5|Overall Study|Physician Decision|0
32165|NCT01590810|144365|P4|Overall Study|Physician Decision|0
32166|NCT01590810|144366|P3|Overall Study|Physician Decision|1
32167|NCT01590810|144367|P2|Overall Study|Physician Decision|1
32168|NCT01590810|144368|P1|Overall Study|Physician Decision|0
32169|NCT01590797|144513|P2|Overall Study|Other Protocol Specified Criteria|4
32170|NCT01590797|144514|P1|Overall Study|Other Protocol Specified Criteria|2
32171|NCT01590797|144513|P2|Overall Study|Withdrawal by Subject|5
32172|NCT01590797|144514|P1|Overall Study|Withdrawal by Subject|7
32173|NCT01590797|144513|P2|Overall Study|Protocol Violation|1
32174|NCT01590797|144514|P1|Overall Study|Protocol Violation|4
32175|NCT01590797|144513|P2|Overall Study|Lost to Follow-up|1
32176|NCT01590797|144514|P1|Overall Study|Lost to Follow-up|0
32177|NCT01590797|144513|P2|Overall Study|Lack of Efficacy|2
32178|NCT01590797|144514|P1|Overall Study|Lack of Efficacy|0
32179|NCT01590797|144513|P2|Overall Study|Adverse Event|3
32180|NCT01590797|144514|P1|Overall Study|Adverse Event|4
32181|NCT01590771|144530|P2|Overall Study|Adverse Event|7
32182|NCT01590771|144531|P1|Overall Study|Adverse Event|3
32183|NCT01590771|144530|P2|Overall Study|Lack of Efficacy|0
32184|NCT01590771|144531|P1|Overall Study|Lack of Efficacy|1
32185|NCT01590771|144530|P2|Overall Study|Lost to Follow-up|1
32186|NCT01590771|144531|P1|Overall Study|Lost to Follow-up|1
32187|NCT01590771|144530|P2|Overall Study|Protocol Violation|2
32188|NCT01590771|144531|P1|Overall Study|Protocol Violation|1
32189|NCT01590771|144530|P2|Overall Study|Withdrawal by Subject|15
32190|NCT01590771|144531|P1|Overall Study|Withdrawal by Subject|8
32191|NCT01590771|144530|P2|Overall Study|Other Protocol Specified Criteria|14
32192|NCT01590771|144531|P1|Overall Study|Other Protocol Specified Criteria|5
32193|NCT01590758|144559|P2|Overall Study|Lost to Follow-up|2
32194|NCT01590758|144560|P1|Overall Study|Lost to Follow-up|4
32195|NCT01590758|144559|P2|Overall Study|Physician Decision|2
32196|NCT01590758|144560|P1|Overall Study|Physician Decision|1
32197|NCT01590758|144559|P2|Overall Study|Withdrawal by Subject|3
32198|NCT01590758|144560|P1|Overall Study|Withdrawal by Subject|0
32199|NCT01590563|144570|P1|Overall Study|simple uterine hyperplasia - not related|1
32200|NCT01590212|144594|P3|Overall Study|Lost to Follow-up|3
32201|NCT01590212|144595|P2|Overall Study|Lost to Follow-up|2
32202|NCT01590212|144596|P1|Overall Study|Lost to Follow-up|1
32203|NCT01590212|144594|P3|Overall Study|Withdrawal by Subject|2
32204|NCT01590212|144595|P2|Overall Study|Withdrawal by Subject|2
32205|NCT01590212|144596|P1|Overall Study|Withdrawal by Subject|2
32206|NCT01589822|144640|P3|Overall Study|Missed 90 day visit|1
32207|NCT01589822|144641|P2|Overall Study|Missed 90 day visit|1
32208|NCT01589822|144642|P1|Overall Study|Missed 90 day visit|2
32209|NCT01589822|144640|P3|Overall Study|Death|0
32210|NCT01589822|144641|P2|Overall Study|Death|0
32211|NCT01589822|144642|P1|Overall Study|Death|1
32212|NCT01589822|144640|P3|Overall Study|Withdrawal by Subject|0
32213|NCT01589822|144641|P2|Overall Study|Withdrawal by Subject|2
32214|NCT01589822|144642|P1|Overall Study|Withdrawal by Subject|1
32215|NCT01589653|144661|P2|Overall Study|Unclassified|3
32216|NCT01589653|144662|P1|Overall Study|Unclassified|0
32217|NCT01589653|144661|P2|Overall Study|Withdrawal criteria|7
32218|NCT01589653|144662|P1|Overall Study|Withdrawal criteria|4
32219|NCT01589653|144661|P2|Overall Study|Protocol Violation|1
32220|NCT01589653|144662|P1|Overall Study|Protocol Violation|3
32221|NCT01589497|144710|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
32222|NCT01589497|144711|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
32223|NCT01589497|144712|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
32224|NCT01589497|144713|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
32225|NCT01589497|144710|P4|Overall Study|Death|0
32226|NCT01589497|144711|P3|Overall Study|Death|0
32227|NCT01589497|144712|P2|Overall Study|Death|0
32228|NCT01589497|144713|P1|Overall Study|Death|1
32229|NCT01589497|144710|P4|Overall Study|Withdrawal by Subject|1
32230|NCT01589497|144711|P3|Overall Study|Withdrawal by Subject|0
32231|NCT01589497|144712|P2|Overall Study|Withdrawal by Subject|1
32232|NCT01589497|144713|P1|Overall Study|Withdrawal by Subject|0
32233|NCT01589445|144751|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
32234|NCT01589445|144751|P1|002 (Metformin)-3 Months|Adverse Event|2
32235|NCT01589445|144751|P1|002 (Metformin)-3 Months|Protocol Violation|2
32236|NCT01589445|144751|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
32237|NCT01589445|144751|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
32238|NCT01589445|144751|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
32239|NCT01589445|144751|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
32240|NCT01589445|144751|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
32241|NCT01589445|144751|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
32242|NCT01589445|144751|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
32243|NCT01589237|144771|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
32244|NCT01589237|144772|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
32245|NCT01589237|144773|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
32246|NCT01589237|144774|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
32247|NCT01589237|144771|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
32248|NCT01589237|144772|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
32249|NCT01589237|144773|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
32250|NCT01589237|144774|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
32251|NCT01589237|144771|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
32426|NCT01585246|145813|P3|Overall Study|Withdrawal by Subject|1
32252|NCT01589237|144772|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
32253|NCT01589237|144773|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
32254|NCT01589237|144774|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
32255|NCT01589237|144771|P4|Part A (52 Weeks)|Subject/guardian decision|0
32256|NCT01589237|144772|P3|Part A (52 Weeks)|Subject/guardian decision|2
32257|NCT01589237|144773|P2|Part A (52 Weeks)|Subject/guardian decision|3
32258|NCT01589237|144774|P1|Part A (52 Weeks)|Subject/guardian decision|2
32259|NCT01588951|144823|P3|Overall Study|Ineligible in retrospect|1
32260|NCT01588951|144824|P2|Overall Study|Ineligible in retrospect|0
32261|NCT01588951|144825|P1|Overall Study|Ineligible in retrospect|0
32262|NCT01588548|144851|P6|Overall Study|Condition Under Investigation Worsened|3
32263|NCT01588548|144852|P5|Overall Study|Condition Under Investigation Worsened|3
32264|NCT01588548|144853|P4|Overall Study|Condition Under Investigation Worsened|4
32265|NCT01588548|144854|P3|Overall Study|Condition Under Investigation Worsened|4
32266|NCT01588548|144855|P2|Overall Study|Condition Under Investigation Worsened|6
32267|NCT01588548|144856|P1|Overall Study|Condition Under Investigation Worsened|3
32268|NCT01588548|144851|P6|Overall Study|Adverse Event|0
32269|NCT01588548|144852|P5|Overall Study|Adverse Event|1
32270|NCT01588548|144853|P4|Overall Study|Adverse Event|2
32271|NCT01588548|144854|P3|Overall Study|Adverse Event|1
32272|NCT01588548|144855|P2|Overall Study|Adverse Event|0
32273|NCT01588548|144856|P1|Overall Study|Adverse Event|0
32274|NCT01588548|144851|P6|Overall Study|Withdrawal by Subject|3
32275|NCT01588548|144852|P5|Overall Study|Withdrawal by Subject|2
32276|NCT01588548|144853|P4|Overall Study|Withdrawal by Subject|1
32277|NCT01588548|144854|P3|Overall Study|Withdrawal by Subject|1
32278|NCT01588548|144855|P2|Overall Study|Withdrawal by Subject|1
32279|NCT01588548|144856|P1|Overall Study|Withdrawal by Subject|0
32280|NCT01588496|144873|P3|Overall Study|Withdrawal by Subject|0
32281|NCT01588496|144874|P2|Overall Study|Withdrawal by Subject|1
32282|NCT01588496|144875|P1|Overall Study|Withdrawal by Subject|0
32283|NCT01588405|144914|P1|Overall Study|Clinical Worsening|1
32284|NCT01588405|144914|P1|Overall Study|Adverse Event|1
32285|NCT01588353|144941|P3|Step3|Adverse Event|2
32286|NCT01588353|144942|P2|Step3|Adverse Event|0
32287|NCT01588353|144943|P1|Step3|Adverse Event|0
32288|NCT01588353|144941|P3|Step2|Withdrawal by Subject|0
32289|NCT01588353|144942|P2|Step2|Withdrawal by Subject|1
32290|NCT01588353|144943|P1|Step2|Withdrawal by Subject|0
32291|NCT01588106|144986|P2|Overall Study|Withdrawal by Subject|4
32292|NCT01588106|144987|P1|Overall Study|Withdrawal by Subject|5
32293|NCT01587989|144995|P3|Randomized Study Treatment|Physician Decision|1
32294|NCT01587989|144996|P2|Randomized Study Treatment|Physician Decision|0
32295|NCT01587989|144997|P1|Randomized Study Treatment|Physician Decision|0
32296|NCT01587989|144995|P3|Randomized Study Treatment|Screening failure|0
32297|NCT01587989|144996|P2|Randomized Study Treatment|Screening failure|1
32298|NCT01587989|144997|P1|Randomized Study Treatment|Screening failure|0
32299|NCT01587989|144995|P3|Randomized Study Treatment|Withdrawal by Subject|0
32300|NCT01587989|144996|P2|Randomized Study Treatment|Withdrawal by Subject|1
32301|NCT01587989|144997|P1|Randomized Study Treatment|Withdrawal by Subject|0
32302|NCT01587989|144995|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
32303|NCT01587989|144996|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
32304|NCT01587989|144997|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
32305|NCT01587989|144995|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
32306|NCT01587989|144996|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
32307|NCT01587989|144997|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
32308|NCT01587989|144995|P3|12-Week Open-Label Run-In Period|Physician Decision|0
32309|NCT01587989|144996|P2|12-Week Open-Label Run-In Period|Physician Decision|0
32310|NCT01587989|144997|P1|12-Week Open-Label Run-In Period|Physician Decision|7
32311|NCT01587885|145058|P2|Treatment Period 1|Protocol Violation|2
32312|NCT01587885|145059|P1|Treatment Period 1|Protocol Violation|0
32313|NCT01587885|145058|P2|Treatment Period 1|Failure to Return|1
32314|NCT01587885|145059|P1|Treatment Period 1|Failure to Return|0
32315|NCT01587651|145075|P3|Overall Study|Withdrawal by Subject|0
32316|NCT01587651|145076|P2|Overall Study|Withdrawal by Subject|1
32317|NCT01587651|145077|P1|Overall Study|Withdrawal by Subject|0
32318|NCT01587651|145075|P3|Overall Study|Protocol Violation|1
32319|NCT01587651|145076|P2|Overall Study|Protocol Violation|1
32320|NCT01587651|145077|P1|Overall Study|Protocol Violation|0
32321|NCT01587651|145075|P3|Overall Study|Adverse Event|0
32322|NCT01587651|145076|P2|Overall Study|Adverse Event|1
32323|NCT01587651|145077|P1|Overall Study|Adverse Event|0
32324|NCT01587118|145104|P1|Overall Study|nonresponse|1
32325|NCT01587118|145104|P1|Overall Study|Relocation|1
32326|NCT01587118|145104|P1|Overall Study|Lost to Follow-up|2
32327|NCT01587118|145104|P1|Overall Study|Adverse Event|3
32328|NCT01587079|145128|P1|Overall Study|Adverse Event|14
32329|NCT01587079|145128|P1|Overall Study|Withdrawal by Subject|7
32330|NCT01587079|145128|P1|Overall Study|Physician Decision|2
32331|NCT01587079|145128|P1|Overall Study|Lost to Follow-up|2
32332|NCT01587079|145128|P1|Overall Study|Protocol Violation|5
32333|NCT01587079|145128|P1|Overall Study|Protocol-specified criteria|9
32334|NCT01587014|145259|P1|Overall Study|Death|2
32335|NCT01587001|145266|P2|Overall Study|Insufficient samples to complete testing|1
32336|NCT01587001|145267|P1|Overall Study|Insufficient samples to complete testing|4
32337|NCT01587001|145266|P2|Overall Study|Lost to Follow-up|0
32338|NCT01587001|145267|P1|Overall Study|Lost to Follow-up|2
32339|NCT01586806|145316|P3|Overall Study|Lost to Follow-up|2
32340|NCT01586806|145317|P2|Overall Study|Lost to Follow-up|3
32341|NCT01586806|145318|P1|Overall Study|Lost to Follow-up|2
32342|NCT01586806|145316|P3|Overall Study|Withdrawal by Subject|0
32343|NCT01586806|145317|P2|Overall Study|Withdrawal by Subject|0
32344|NCT01586806|145318|P1|Overall Study|Withdrawal by Subject|1
32345|NCT01586806|145316|P3|Overall Study|Protocol Violation|0
32346|NCT01586806|145317|P2|Overall Study|Protocol Violation|1
32347|NCT01586806|145318|P1|Overall Study|Protocol Violation|0
32348|NCT01586364|145338|P1|Overall Study|Other-Not specified|1
32349|NCT01586364|145338|P1|Overall Study|Other-PI discretion, site closing|2
32350|NCT01586364|145338|P1|Overall Study|Other-Site closure due to PI illness|1
32351|NCT01586364|145338|P1|Overall Study|Other-Subject wasn't getting much relief|1
32352|NCT01586364|145338|P1|Overall Study|Other-Did not feel better post-treatment|1
32353|NCT01586364|145338|P1|Overall Study|Lack of Efficacy|1
32354|NCT01586364|145338|P1|Overall Study|Protocol Violation|16
32355|NCT01586364|145338|P1|Overall Study|Lost to Follow-up|17
32356|NCT01586364|145338|P1|Overall Study|Adverse Event|37
32357|NCT01586364|145338|P1|Overall Study|Withdrawal by Subject|40
32358|NCT01586338|145391|P1|Overall Study|Unspecified|1
32359|NCT01586338|145391|P1|Overall Study|Withdrawal by participant|3
32360|NCT01586338|145391|P1|Overall Study|Lost to Follow-up|1
32361|NCT01586338|145391|P1|Overall Study|Adverse Event|3
32362|NCT01586195|145414|P1|Overall Study|Reason not specified|9
32363|NCT01586195|145414|P1|Overall Study|Started new anti-melanoma therapy|1
32364|NCT01586195|145414|P1|Overall Study|Withdrawal of Consent|5
32365|NCT01586195|145414|P1|Overall Study|Death|11
32366|NCT01585987|145437|P2|Treated|Poor/Non-Compliance|1
32367|NCT01585987|145438|P1|Treated|Poor/Non-Compliance|0
32368|NCT01585987|145437|P2|Treated|Subject Request|1
32369|NCT01585987|145438|P1|Treated|Subject Request|0
32370|NCT01585987|145437|P2|Treated|Non-Specified|2
32371|NCT01585987|145438|P1|Treated|Non-Specified|1
32372|NCT01585987|145437|P2|Treated|Maximum Clinical Benefit|1
32373|NCT01585987|145438|P1|Treated|Maximum Clinical Benefit|0
32374|NCT01585987|145437|P2|Treated|Lost to Follow-up|1
32375|NCT01585987|145438|P1|Treated|Lost to Follow-up|0
32376|NCT01585987|145437|P2|Treated|Death|0
32377|NCT01585987|145438|P1|Treated|Death|1
32378|NCT01585987|145437|P2|Treated|Withdrawal by Subject|2
32379|NCT01585987|145438|P1|Treated|Withdrawal by Subject|1
32380|NCT01585987|145437|P2|Treated|Adverse Event|0
32381|NCT01585987|145438|P1|Treated|Adverse Event|3
32382|NCT01585987|145437|P2|Treated|Study Drug Toxicity|5
32383|NCT01585987|145438|P1|Treated|Study Drug Toxicity|9
32384|NCT01585987|145437|P2|Treated|Disease Progression|36
32385|NCT01585987|145438|P1|Treated|Disease Progression|39
32386|NCT01585987|145437|P2|Randomized|No longer met criteria|2
32387|NCT01585987|145438|P1|Randomized|No longer met criteria|0
32388|NCT01585987|145437|P2|Randomized|Withdrawal by Subject|4
32389|NCT01585987|145438|P1|Randomized|Withdrawal by Subject|0
32390|NCT01585961|145453|P1|Overall Study|Ablation cancelled for slow-heal wound|1
32391|NCT01585961|145453|P1|Overall Study|Lost to Follow-up|23
32392|NCT01585961|145453|P1|Overall Study|Withdrawal by Subject|1
32393|NCT01585961|145453|P1|Overall Study|Decision to use non-study catheter|1
32394|NCT01585961|145453|P1|Overall Study|Physician Decision|1
32395|NCT01585961|145453|P1|Overall Study|Death|6
32396|NCT01585584|145530|P1|Overall Study|Physician Decision|2
32397|NCT01585584|145530|P1|Overall Study|Withdrawal by Subject|1
32398|NCT01585584|145530|P1|Overall Study|Lack of Efficacy|1
32399|NCT01585558|145537|P3|Overall Study|Lack of Efficacy|1
32400|NCT01585558|145538|P2|Overall Study|Lack of Efficacy|0
32401|NCT01585558|145539|P1|Overall Study|Lack of Efficacy|0
32402|NCT01585558|145537|P3|Overall Study|Protocol Violation|2
32403|NCT01585558|145538|P2|Overall Study|Protocol Violation|3
32404|NCT01585558|145539|P1|Overall Study|Protocol Violation|4
32405|NCT01585558|145537|P3|Overall Study|Adverse Event|1
32406|NCT01585558|145538|P2|Overall Study|Adverse Event|4
32407|NCT01585558|145539|P1|Overall Study|Adverse Event|3
32408|NCT01585558|145537|P3|Overall Study|Lost to Follow-up|3
32409|NCT01585558|145538|P2|Overall Study|Lost to Follow-up|0
32410|NCT01585558|145539|P1|Overall Study|Lost to Follow-up|2
32411|NCT01585558|145537|P3|Overall Study|Withdrawal by Subject|8
32412|NCT01585558|145538|P2|Overall Study|Withdrawal by Subject|5
32413|NCT01585558|145539|P1|Overall Study|Withdrawal by Subject|4
32414|NCT01585428|145773|P2|Overall Study|Death during treatment|0
32415|NCT01585428|145774|P1|Overall Study|Death during treatment|1
32416|NCT01585272|145798|P1|Overall Study|Withdrawal by Subject|10
32417|NCT01585272|145798|P1|Overall Study|Protocol Violation|7
32418|NCT01585272|145798|P1|Overall Study|Adverse Event|22
32419|NCT01585246|145811|P5|Overall Study|Other|0
32420|NCT01585246|145812|P4|Overall Study|Other|1
32421|NCT01585246|145813|P3|Overall Study|Other|1
32422|NCT01585246|145814|P2|Overall Study|Other|1
32423|NCT01585246|145815|P1|Overall Study|Other|0
32424|NCT01585246|145811|P5|Overall Study|Withdrawal by Subject|1
32425|NCT01585246|145812|P4|Overall Study|Withdrawal by Subject|2
32427|NCT01585246|145814|P2|Overall Study|Withdrawal by Subject|0
32428|NCT01585246|145815|P1|Overall Study|Withdrawal by Subject|0
32429|NCT01585246|145811|P5|Overall Study|Protocol Violation|1
32430|NCT01585246|145812|P4|Overall Study|Protocol Violation|0
32431|NCT01585246|145813|P3|Overall Study|Protocol Violation|0
32432|NCT01585246|145814|P2|Overall Study|Protocol Violation|0
32433|NCT01585246|145815|P1|Overall Study|Protocol Violation|0
32434|NCT01585246|145811|P5|Overall Study|Lost to Follow-up|0
32435|NCT01585246|145812|P4|Overall Study|Lost to Follow-up|1
32436|NCT01585246|145813|P3|Overall Study|Lost to Follow-up|2
32437|NCT01585246|145814|P2|Overall Study|Lost to Follow-up|0
32438|NCT01585246|145815|P1|Overall Study|Lost to Follow-up|0
32439|NCT01585038|145832|P2|Overall Study|Adverse Event|2
32440|NCT01585038|145833|P1|Overall Study|Adverse Event|2
32441|NCT01584843|145849|P6|Second Treatment Period|Withdrawal by Subject|1
32442|NCT01584843|145850|P5|Second Treatment Period|Withdrawal by Subject|0
32443|NCT01584843|145851|P4|Second Treatment Period|Withdrawal by Subject|0
32444|NCT01584843|145852|P3|Second Treatment Period|Withdrawal by Subject|0
32445|NCT01584843|145853|P2|Second Treatment Period|Withdrawal by Subject|0
32446|NCT01584843|145854|P1|Second Treatment Period|Withdrawal by Subject|0
32447|NCT01584843|145849|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
32448|NCT01584843|145850|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
32449|NCT01584843|145851|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
32450|NCT01584843|145852|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
32451|NCT01584843|145853|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
32452|NCT01584843|145854|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
32453|NCT01584843|145849|P6|First Treatment Period|Protocol Violation|1
32454|NCT01584843|145850|P5|First Treatment Period|Protocol Violation|0
32455|NCT01584843|145851|P4|First Treatment Period|Protocol Violation|0
32456|NCT01584843|145852|P3|First Treatment Period|Protocol Violation|0
32457|NCT01584843|145853|P2|First Treatment Period|Protocol Violation|0
32458|NCT01584843|145854|P1|First Treatment Period|Protocol Violation|0
32459|NCT01584843|145849|P6|First Treatment Period|Adverse Event|0
32460|NCT01584843|145850|P5|First Treatment Period|Adverse Event|0
32461|NCT01584843|145851|P4|First Treatment Period|Adverse Event|0
32462|NCT01584843|145852|P3|First Treatment Period|Adverse Event|1
32463|NCT01584843|145853|P2|First Treatment Period|Adverse Event|0
32464|NCT01584843|145854|P1|First Treatment Period|Adverse Event|0
32465|NCT01584648|145965|P2|Overall Study|Ongoing|147
32466|NCT01584648|145966|P1|Overall Study|Ongoing|154
32467|NCT01584648|145965|P2|Overall Study|Death|55
32468|NCT01584648|145966|P1|Overall Study|Death|40
32469|NCT01584648|145965|P2|Overall Study|Withdrawal by Subject|5
32470|NCT01584648|145966|P1|Overall Study|Withdrawal by Subject|11
32471|NCT01584648|145965|P2|Overall Study|Physician Decision|2
32472|NCT01584648|145966|P1|Overall Study|Physician Decision|2
32473|NCT01584648|145965|P2|Overall Study|Lost to Follow-up|3
32474|NCT01584648|145966|P1|Overall Study|Lost to Follow-up|4
32475|NCT01584232|146071|P2|Overall Study|Lost to Follow-up|0
32476|NCT01584232|146072|P1|Overall Study|Lost to Follow-up|1
32477|NCT01584232|146071|P2|Overall Study|Physician Decision|1
32478|NCT01584232|146072|P1|Overall Study|Physician Decision|2
32479|NCT01584232|146071|P2|Overall Study|Withdrawal by Subject|1
32480|NCT01584232|146072|P1|Overall Study|Withdrawal by Subject|2
32481|NCT01584232|146071|P2|Overall Study|Adverse Event|1
32482|NCT01584232|146072|P1|Overall Study|Adverse Event|3
32483|NCT01582789|146092|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
32484|NCT01582789|146093|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
32485|NCT01583530|146135|P6|Overall Study|Lack of compliance|0
32486|NCT01583530|146136|P5|Overall Study|Lack of compliance|1
32487|NCT01583530|146137|P4|Overall Study|Lack of compliance|0
32488|NCT01583530|146138|P3|Overall Study|Lack of compliance|0
32489|NCT01583530|146139|P2|Overall Study|Lack of compliance|0
32490|NCT01583530|146140|P1|Overall Study|Lack of compliance|0
32491|NCT01583530|146135|P6|Overall Study|Lost to Follow-up|0
32492|NCT01583530|146136|P5|Overall Study|Lost to Follow-up|3
32493|NCT01583530|146137|P4|Overall Study|Lost to Follow-up|0
32494|NCT01583530|146138|P3|Overall Study|Lost to Follow-up|0
32495|NCT01583530|146139|P2|Overall Study|Lost to Follow-up|0
32496|NCT01583530|146140|P1|Overall Study|Lost to Follow-up|0
32497|NCT01583530|146135|P6|Overall Study|Withdrawal by Subject|2
32498|NCT01583530|146136|P5|Overall Study|Withdrawal by Subject|1
32499|NCT01583530|146137|P4|Overall Study|Withdrawal by Subject|1
32500|NCT01583530|146138|P3|Overall Study|Withdrawal by Subject|0
32501|NCT01583530|146139|P2|Overall Study|Withdrawal by Subject|3
32502|NCT01583530|146140|P1|Overall Study|Withdrawal by Subject|0
32503|NCT01583530|146135|P6|Overall Study|Adverse Event|1
32504|NCT01583530|146136|P5|Overall Study|Adverse Event|0
32505|NCT01583530|146137|P4|Overall Study|Adverse Event|0
32506|NCT01583530|146138|P3|Overall Study|Adverse Event|0
32507|NCT01583530|146139|P2|Overall Study|Adverse Event|0
32508|NCT01583530|146140|P1|Overall Study|Adverse Event|0
32509|NCT01583374|146202|P3|Overall Study|Unspecified|0
32510|NCT01583374|146203|P2|Overall Study|Unspecified|1
32511|NCT01583374|146204|P1|Overall Study|Unspecified|0
32512|NCT01583374|146202|P3|Overall Study|Protocol Violation|3
32513|NCT01583374|146203|P2|Overall Study|Protocol Violation|0
32514|NCT01583374|146204|P1|Overall Study|Protocol Violation|0
32515|NCT01583374|146202|P3|Overall Study|Lost to Follow-up|0
32516|NCT01583374|146203|P2|Overall Study|Lost to Follow-up|2
32517|NCT01583374|146204|P1|Overall Study|Lost to Follow-up|1
32518|NCT01583374|146202|P3|Overall Study|Withdrawal by Subject|5
32519|NCT01583374|146203|P2|Overall Study|Withdrawal by Subject|3
32520|NCT01583374|146204|P1|Overall Study|Withdrawal by Subject|8
32521|NCT01583374|146202|P3|Overall Study|Non-compliance with study drug|0
32522|NCT01583374|146203|P2|Overall Study|Non-compliance with study drug|1
32523|NCT01583374|146204|P1|Overall Study|Non-compliance with study drug|1
32524|NCT01583374|146202|P3|Overall Study|Lack of Efficacy|5
32525|NCT01583374|146203|P2|Overall Study|Lack of Efficacy|2
32526|NCT01583374|146204|P1|Overall Study|Lack of Efficacy|3
32527|NCT01583374|146202|P3|Overall Study|Adverse Event|12
32528|NCT01583374|146203|P2|Overall Study|Adverse Event|7
32529|NCT01583374|146204|P1|Overall Study|Adverse Event|6
32530|NCT01582945|146223|P1|Overall Study|Scheduling conflicts|1
32531|NCT01582945|146223|P1|Overall Study|Intolerable side-effects|1
32532|NCT01582854|146237|P2|Overall Study|Other Miscellaneous Reason|0
32533|NCT01582854|146238|P1|Overall Study|Other Miscellaneous Reason|1
32534|NCT01582854|146237|P2|Overall Study|General Anaesthesia|1
32535|NCT01582854|146238|P1|Overall Study|General Anaesthesia|0
32536|NCT01582854|146237|P2|Overall Study|Carotid or Neurosurgery|1
32537|NCT01582854|146238|P1|Overall Study|Carotid or Neurosurgery|0
32538|NCT01582854|146237|P2|Overall Study|Disallowed Concomitant Medication|2
32539|NCT01582854|146238|P1|Overall Study|Disallowed Concomitant Medication|3
32540|NCT01582854|146237|P2|Overall Study|Recurrent Stroke|8
32541|NCT01582854|146238|P1|Overall Study|Recurrent Stroke|13
32542|NCT01582854|146237|P2|Overall Study|Physician Decision|1
32543|NCT01582854|146238|P1|Overall Study|Physician Decision|0
32544|NCT01582854|146237|P2|Overall Study|Lost to Follow-up|2
32545|NCT01582854|146238|P1|Overall Study|Lost to Follow-up|1
32546|NCT01582854|146237|P2|Overall Study|Withdrawal by Participant|11
32547|NCT01582854|146238|P1|Overall Study|Withdrawal by Participant|8
32548|NCT01582854|146237|P2|Overall Study|Adverse Event|3
32549|NCT01582854|146238|P1|Overall Study|Adverse Event|2
32550|NCT01582854|146237|P2|Overall Study|Death|5
32551|NCT01582854|146238|P1|Overall Study|Death|8
32552|NCT01582308|146308|P10|Period 4|Physician Decision|1
32553|NCT01582308|146309|P9|Period 4|Physician Decision|0
32554|NCT01582308|146310|P8|Period 4|Physician Decision|0
32555|NCT01582308|146311|P7|Period 4|Physician Decision|0
32556|NCT01582308|146312|P6|Period 4|Physician Decision|1
32557|NCT01582308|146313|P5|Period 4|Physician Decision|0
32558|NCT01582308|146314|P4|Period 4|Physician Decision|0
32559|NCT01582308|146315|P3|Period 4|Physician Decision|0
32560|NCT01582308|146316|P2|Period 4|Physician Decision|0
32561|NCT01582308|146317|P1|Period 4|Physician Decision|1
32562|NCT01582308|146308|P10|10-day Washout Following Period 1|Physician Decision|0
32563|NCT01582308|146309|P9|10-day Washout Following Period 1|Physician Decision|0
32564|NCT01582308|146310|P8|10-day Washout Following Period 1|Physician Decision|0
32565|NCT01582308|146311|P7|10-day Washout Following Period 1|Physician Decision|0
32566|NCT01582308|146312|P6|10-day Washout Following Period 1|Physician Decision|0
32567|NCT01582308|146313|P5|10-day Washout Following Period 1|Physician Decision|1
32568|NCT01582308|146314|P4|10-day Washout Following Period 1|Physician Decision|0
32569|NCT01582308|146315|P3|10-day Washout Following Period 1|Physician Decision|0
32570|NCT01582308|146316|P2|10-day Washout Following Period 1|Physician Decision|0
32571|NCT01582308|146317|P1|10-day Washout Following Period 1|Physician Decision|0
32572|NCT01582308|146308|P10|Period 1|Withdrawal by Subject|0
32573|NCT01582308|146309|P9|Period 1|Withdrawal by Subject|0
32574|NCT01582308|146310|P8|Period 1|Withdrawal by Subject|0
32575|NCT01582308|146311|P7|Period 1|Withdrawal by Subject|1
32576|NCT01582308|146312|P6|Period 1|Withdrawal by Subject|0
32577|NCT01582308|146313|P5|Period 1|Withdrawal by Subject|0
32578|NCT01582308|146314|P4|Period 1|Withdrawal by Subject|0
32579|NCT01582308|146315|P3|Period 1|Withdrawal by Subject|0
32580|NCT01582308|146316|P2|Period 1|Withdrawal by Subject|0
32581|NCT01582308|146317|P1|Period 1|Withdrawal by Subject|0
32582|NCT01582282|146345|P3|Overall Study|fasting blood glucose outside Protocol|0
32583|NCT01582282|146346|P2|Overall Study|fasting blood glucose outside Protocol|1
32584|NCT01582282|146347|P1|Overall Study|fasting blood glucose outside Protocol|0
32585|NCT01582282|146345|P3|Overall Study|Lost to Follow-up|0
32586|NCT01582282|146346|P2|Overall Study|Lost to Follow-up|0
32587|NCT01582282|146347|P1|Overall Study|Lost to Follow-up|1
32588|NCT01582282|146345|P3|Overall Study|Adverse Event|0
32589|NCT01582282|146346|P2|Overall Study|Adverse Event|1
32590|NCT01582282|146347|P1|Overall Study|Adverse Event|1
32591|NCT01582243|146370|P1|Overall Study|Lost to Follow-up|1
32592|NCT01582243|146370|P1|Overall Study|Adverse Event|1
32593|NCT01582243|146370|P1|Overall Study|Withdrawal by Subject|1
32594|NCT01582178|146381|P2|Overall Study|Physician Decision|5
32595|NCT01582178|146382|P1|Overall Study|Physician Decision|6
32596|NCT01582100|146403|P1|Overall Study|Withdrawal by Subject|1
32597|NCT01582100|146403|P1|Overall Study|Adverse Event|1
32598|NCT01582009|146407|P1|Overall Study|Physician Decision|1
32599|NCT01582009|146407|P1|Overall Study|Withdrawal by Subject|1
32600|NCT01581931|146415|P2|Washout|Adverse Event|1
32601|NCT01581931|146416|P1|Washout|Adverse Event|0
32602|NCT01581684|146440|P10|Overall Study|Other reason not defined|0
32603|NCT01581684|146441|P9|Overall Study|Other reason not defined|1
32604|NCT01581684|146442|P8|Overall Study|Other reason not defined|0
32605|NCT01581684|146443|P7|Overall Study|Other reason not defined|0
32606|NCT01581684|146444|P6|Overall Study|Other reason not defined|0
32607|NCT01581684|146445|P5|Overall Study|Other reason not defined|0
32608|NCT01581684|146446|P4|Overall Study|Other reason not defined|0
32609|NCT01581684|146447|P3|Overall Study|Other reason not defined|0
32610|NCT01581684|146448|P2|Overall Study|Other reason not defined|0
32611|NCT01581684|146449|P1|Overall Study|Other reason not defined|0
32612|NCT01581307|146556|P1|Overall Study|Withdrawal by Subject|1
32613|NCT01581281|146565|P3|Overall Study|Early Study Closure|12
32614|NCT01581281|146566|P2|Overall Study|Early Study Closure|6
32615|NCT01581281|146567|P1|Overall Study|Early Study Closure|15
32616|NCT01581021|146589|P2|Overall Study|Lack of Efficacy|1
32617|NCT01581021|146590|P1|Overall Study|Lack of Efficacy|0
32618|NCT01581021|146589|P2|Overall Study|Lenke 6 Classification|1
32619|NCT01581021|146590|P1|Overall Study|Lenke 6 Classification|0
32620|NCT01581021|146589|P2|Overall Study|Not Randomized|2
32621|NCT01581021|146590|P1|Overall Study|Not Randomized|1
32622|NCT01581021|146589|P2|Overall Study|Neuromuscular|1
32623|NCT01581021|146590|P1|Overall Study|Neuromuscular|2
32624|NCT01581021|146589|P2|Overall Study|More than 2 hooks in thoracic|0
32625|NCT01581021|146590|P1|Overall Study|More than 2 hooks in thoracic|3
32626|NCT01581021|146589|P2|Overall Study|Lost to Follow-up|6
32627|NCT01581021|146590|P1|Overall Study|Lost to Follow-up|4
32628|NCT01580995|146616|P2|Overall Study|Lost to Follow-up|2
32629|NCT01580995|146617|P1|Overall Study|Lost to Follow-up|2
32630|NCT01580488|146670|P1|Overall Study|Withdrawal by Subject|1
32631|NCT01580020|146811|P4|Overall Study|Lost to Follow-up|0
32632|NCT01580020|146812|P3|Overall Study|Lost to Follow-up|1
32633|NCT01580020|146813|P2|Overall Study|Lost to Follow-up|0
32634|NCT01580020|146814|P1|Overall Study|Lost to Follow-up|0
32635|NCT01580020|146811|P4|Overall Study|Administrative Problems|0
32636|NCT01580020|146812|P3|Overall Study|Administrative Problems|1
32637|NCT01580020|146813|P2|Overall Study|Administrative Problems|0
32638|NCT01580020|146814|P1|Overall Study|Administrative Problems|0
32639|NCT01580020|146811|P4|Overall Study|Adverse Event|1
32640|NCT01580020|146812|P3|Overall Study|Adverse Event|1
32641|NCT01580020|146813|P2|Overall Study|Adverse Event|1
32642|NCT01580020|146814|P1|Overall Study|Adverse Event|1
32643|NCT01580020|146811|P4|Overall Study|Withdrawal by Subject|0
32644|NCT01580020|146812|P3|Overall Study|Withdrawal by Subject|1
32645|NCT01580020|146813|P2|Overall Study|Withdrawal by Subject|1
32646|NCT01580020|146814|P1|Overall Study|Withdrawal by Subject|0
32647|NCT01580020|146811|P4|Overall Study|Lack of Efficacy|1
32648|NCT01580020|146812|P3|Overall Study|Lack of Efficacy|0
32649|NCT01580020|146813|P2|Overall Study|Lack of Efficacy|5
32650|NCT01580020|146814|P1|Overall Study|Lack of Efficacy|0
32651|NCT01579916|146858|P2|Overall Study|Death|0
32652|NCT01579916|146859|P1|Overall Study|Death|1
32653|NCT01579916|146858|P2|Overall Study|Withdrawal by Subject|1
32654|NCT01579916|146859|P1|Overall Study|Withdrawal by Subject|1
32655|NCT01579916|146858|P2|Overall Study|Lost to Follow-up|1
32656|NCT01579916|146859|P1|Overall Study|Lost to Follow-up|6
32657|NCT01579578|146911|P2|Overall Study|Ongoing|0
32658|NCT01579578|146912|P1|Overall Study|Ongoing|3
32659|NCT01579578|146911|P2|Overall Study|Eligibility criteria|9
32660|NCT01579578|146912|P1|Overall Study|Eligibility criteria|3
32661|NCT01579578|146911|P2|Overall Study|Withdrawal by Subject|1
32662|NCT01579578|146912|P1|Overall Study|Withdrawal by Subject|2
32663|NCT01579578|146911|P2|Overall Study|Lost to Follow-up|1
32664|NCT01579578|146912|P1|Overall Study|Lost to Follow-up|1
32665|NCT01579578|146911|P2|Overall Study|Death|1
32666|NCT01579578|146912|P1|Overall Study|Death|4
32667|NCT01579565|146924|P2|Treated|declined to return for final visit|1
32668|NCT01579565|146925|P1|Treated|declined to return for final visit|0
32669|NCT01579565|146924|P2|Treated|Lost to Follow-up|1
32670|NCT01579565|146925|P1|Treated|Lost to Follow-up|2
32671|NCT01579565|146924|P2|Treated|Physician Decision|1
32672|NCT01579565|146925|P1|Treated|Physician Decision|0
32673|NCT01579565|146924|P2|Randomized|prohibited preoperative medication|1
32674|NCT01579565|146925|P1|Randomized|prohibited preoperative medication|0
32675|NCT01579565|146924|P2|Randomized|prohibited preoperative eating|0
32676|NCT01579565|146925|P1|Randomized|prohibited preoperative eating|1
32677|NCT01579565|146924|P2|Randomized|inadequate preoperative pupil dilation|1
32678|NCT01579565|146925|P1|Randomized|inadequate preoperative pupil dilation|0
32679|NCT01579565|146924|P2|Randomized|Withdrawal by Subject|0
32680|NCT01579565|146925|P1|Randomized|Withdrawal by Subject|3
32681|NCT01579565|146924|P2|Randomized|Adverse Event|3
32682|NCT01579565|146925|P1|Randomized|Adverse Event|1
32683|NCT01579474|146959|P6|Overall Study|Withdrawal by Subject|0
32684|NCT01579474|146960|P5|Overall Study|Withdrawal by Subject|0
32685|NCT01579474|146961|P4|Overall Study|Withdrawal by Subject|0
32686|NCT01579474|146962|P3|Overall Study|Withdrawal by Subject|0
32687|NCT01579474|146963|P2|Overall Study|Withdrawal by Subject|0
32688|NCT01579474|146964|P1|Overall Study|Withdrawal by Subject|1
32689|NCT01579474|146959|P6|Overall Study|Lack of Efficacy|0
32690|NCT01579474|146960|P5|Overall Study|Lack of Efficacy|1
32691|NCT01579474|146961|P4|Overall Study|Lack of Efficacy|0
32692|NCT01579474|146962|P3|Overall Study|Lack of Efficacy|0
32693|NCT01579474|146963|P2|Overall Study|Lack of Efficacy|0
32694|NCT01579474|146964|P1|Overall Study|Lack of Efficacy|1
32695|NCT01579474|146959|P6|Overall Study|Adverse Event|1
32696|NCT01579474|146960|P5|Overall Study|Adverse Event|0
32697|NCT01579474|146961|P4|Overall Study|Adverse Event|0
32698|NCT01579474|146962|P3|Overall Study|Adverse Event|2
32699|NCT01579474|146963|P2|Overall Study|Adverse Event|13
32700|NCT01579474|146964|P1|Overall Study|Adverse Event|1
32701|NCT01579006|147111|P1|Overall Study|Scheduled surgery|1
32702|NCT01579006|147111|P1|Overall Study|Due to participant's health fund|1
32703|NCT01579006|147111|P1|Overall Study|Non-compliance|3
32704|NCT01579006|147111|P1|Overall Study|Withdrawal by Subject|5
32705|NCT01579006|147111|P1|Overall Study|Adverse Event|13
32706|NCT01579006|147111|P1|Overall Study|Lack of Efficacy|10
32707|NCT01578850|147161|P3|Period 2|Unspecified Reasons|0
32708|NCT01578850|147162|P2|Period 2|Unspecified Reasons|1
32709|NCT01578850|147163|P1|Period 2|Unspecified Reasons|0
32710|NCT01578850|147161|P3|Period 2|Study Terminated by Sponsor|4
32711|NCT01578850|147162|P2|Period 2|Study Terminated by Sponsor|5
32712|NCT01578850|147163|P1|Period 2|Study Terminated by Sponsor|0
32713|NCT01578850|147161|P3|Period 2|Withdrawal by Subject|2
32714|NCT01578850|147162|P2|Period 2|Withdrawal by Subject|2
32715|NCT01578850|147163|P1|Period 2|Withdrawal by Subject|0
32716|NCT01578850|147161|P3|Period 2|Lost to Follow-up|2
32717|NCT01578850|147162|P2|Period 2|Lost to Follow-up|1
32718|NCT01578850|147163|P1|Period 2|Lost to Follow-up|0
32719|NCT01578850|147161|P3|Period 2|Adverse Event|6
32720|NCT01578850|147162|P2|Period 2|Adverse Event|3
32721|NCT01578850|147163|P1|Period 2|Adverse Event|0
32722|NCT01578850|147161|P3|Period 2|Insufficient Clinical Response|0
32723|NCT01578850|147162|P2|Period 2|Insufficient Clinical Response|1
32724|NCT01578850|147163|P1|Period 2|Insufficient Clinical Response|0
32725|NCT01578850|147161|P3|Period 1|Study Terminated by Sponsor|0
32726|NCT01578850|147162|P2|Period 1|Study Terminated by Sponsor|0
32727|NCT01578850|147163|P1|Period 1|Study Terminated by Sponsor|3
32728|NCT01578850|147161|P3|Period 1|Withdrawal by Subject|0
32729|NCT01578850|147162|P2|Period 1|Withdrawal by Subject|0
32730|NCT01578850|147163|P1|Period 1|Withdrawal by Subject|9
32731|NCT01578850|147161|P3|Period 1|Does Not Meet Entrance Criteria|0
32732|NCT01578850|147162|P2|Period 1|Does Not Meet Entrance Criteria|0
32733|NCT01578850|147163|P1|Period 1|Does Not Meet Entrance Criteria|12
32734|NCT01578850|147161|P3|Period 1|Death|0
32735|NCT01578850|147162|P2|Period 1|Death|0
32736|NCT01578850|147163|P1|Period 1|Death|1
32737|NCT01578850|147161|P3|Period 1|Adverse Event|0
32738|NCT01578850|147162|P2|Period 1|Adverse Event|0
32739|NCT01578850|147163|P1|Period 1|Adverse Event|11
32740|NCT01578850|147161|P3|Period 1|Insufficient Clinical Response|0
32741|NCT01578850|147162|P2|Period 1|Insufficient Clinical Response|0
32742|NCT01578850|147163|P1|Period 1|Insufficient Clinical Response|1
32743|NCT01578785|147215|P2|Overall Study|Study terminated by sponsor|118
32744|NCT01578785|147216|P1|Overall Study|Study terminated by sponsor|59
32745|NCT01578785|147215|P2|Overall Study|Withdrawal by Subject|1
32746|NCT01578785|147216|P1|Overall Study|Withdrawal by Subject|0
32747|NCT01578330|147246|P1|Overall Study|Protocol Violation|5
32748|NCT01578330|147246|P1|Overall Study|Adverse Event|2
32749|NCT01578187|147253|P1|Usability Phase|Withdrawal by Subject|1
32750|NCT01577758|147287|P8|mCRC Expansion Phase|Progression Disease|19
32751|NCT01577758|147288|P7|mCRC Expansion Phase|Progression Disease|0
32752|NCT01577758|147289|P6|mCRC Expansion Phase|Progression Disease|0
32753|NCT01577758|147290|P5|mCRC Expansion Phase|Progression Disease|0
32754|NCT01577758|147291|P4|mCRC Expansion Phase|Progression Disease|0
32755|NCT01577758|147292|P3|mCRC Expansion Phase|Progression Disease|0
32756|NCT01577758|147293|P2|mCRC Expansion Phase|Progression Disease|0
32757|NCT01577758|147294|P1|mCRC Expansion Phase|Progression Disease|0
32758|NCT01577758|147287|P8|mCRC Expansion Phase|Withdrawal by Subject|2
32759|NCT01577758|147288|P7|mCRC Expansion Phase|Withdrawal by Subject|0
32760|NCT01577758|147289|P6|mCRC Expansion Phase|Withdrawal by Subject|0
32761|NCT01577758|147290|P5|mCRC Expansion Phase|Withdrawal by Subject|0
32762|NCT01577758|147291|P4|mCRC Expansion Phase|Withdrawal by Subject|0
32763|NCT01577758|147292|P3|mCRC Expansion Phase|Withdrawal by Subject|0
32764|NCT01577758|147293|P2|mCRC Expansion Phase|Withdrawal by Subject|0
32765|NCT01577758|147294|P1|mCRC Expansion Phase|Withdrawal by Subject|0
32766|NCT01577758|147287|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
32767|NCT01577758|147288|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
32768|NCT01577758|147289|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
32769|NCT01577758|147290|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
32770|NCT01577758|147291|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
32771|NCT01577758|147292|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
32772|NCT01577758|147293|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
32773|NCT01577758|147294|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
32774|NCT01577758|147287|P8|Dose Escalation Phase|Progression Disease|0
32775|NCT01577758|147288|P7|Dose Escalation Phase|Progression Disease|0
32776|NCT01577758|147289|P6|Dose Escalation Phase|Progression Disease|0
32777|NCT01577758|147290|P5|Dose Escalation Phase|Progression Disease|5
32778|NCT01577758|147291|P4|Dose Escalation Phase|Progression Disease|2
32779|NCT01577758|147292|P3|Dose Escalation Phase|Progression Disease|1
32780|NCT01577758|147293|P2|Dose Escalation Phase|Progression Disease|2
32781|NCT01577758|147294|P1|Dose Escalation Phase|Progression Disease|2
32782|NCT01577758|147287|P8|Dose Escalation Phase|Withdrawal by Subject|0
32783|NCT01577758|147288|P7|Dose Escalation Phase|Withdrawal by Subject|0
32784|NCT01577758|147289|P6|Dose Escalation Phase|Withdrawal by Subject|1
32785|NCT01577758|147290|P5|Dose Escalation Phase|Withdrawal by Subject|0
32786|NCT01577758|147291|P4|Dose Escalation Phase|Withdrawal by Subject|0
32787|NCT01577758|147292|P3|Dose Escalation Phase|Withdrawal by Subject|0
32788|NCT01577758|147293|P2|Dose Escalation Phase|Withdrawal by Subject|0
32789|NCT01577758|147294|P1|Dose Escalation Phase|Withdrawal by Subject|0
32790|NCT01577758|147287|P8|Dose Escalation Phase|Symptomatic Deterioration|0
32791|NCT01577758|147288|P7|Dose Escalation Phase|Symptomatic Deterioration|0
32792|NCT01577758|147289|P6|Dose Escalation Phase|Symptomatic Deterioration|1
32793|NCT01577758|147290|P5|Dose Escalation Phase|Symptomatic Deterioration|1
32794|NCT01577758|147291|P4|Dose Escalation Phase|Symptomatic Deterioration|0
32795|NCT01577758|147292|P3|Dose Escalation Phase|Symptomatic Deterioration|1
32796|NCT01577758|147293|P2|Dose Escalation Phase|Symptomatic Deterioration|0
32797|NCT01577758|147294|P1|Dose Escalation Phase|Symptomatic Deterioration|0
32798|NCT01577758|147287|P8|Dose Escalation Phase|Adverse Event|0
32799|NCT01577758|147288|P7|Dose Escalation Phase|Adverse Event|1
32800|NCT01577758|147289|P6|Dose Escalation Phase|Adverse Event|2
32801|NCT01577758|147290|P5|Dose Escalation Phase|Adverse Event|0
32802|NCT01577758|147291|P4|Dose Escalation Phase|Adverse Event|0
32803|NCT01577758|147292|P3|Dose Escalation Phase|Adverse Event|0
32804|NCT01577758|147293|P2|Dose Escalation Phase|Adverse Event|0
32805|NCT01577758|147294|P1|Dose Escalation Phase|Adverse Event|0
32806|NCT01577745|147333|P6|Overall Study|Alternative Therapy|0
32807|NCT01577745|147334|P5|Overall Study|Alternative Therapy|1
32808|NCT01577745|147335|P4|Overall Study|Alternative Therapy|1
32809|NCT01577745|147336|P3|Overall Study|Alternative Therapy|0
32810|NCT01577745|147337|P2|Overall Study|Alternative Therapy|0
32811|NCT01577745|147338|P1|Overall Study|Alternative Therapy|0
32812|NCT01577745|147333|P6|Overall Study|Lost to Follow-up|1
32813|NCT01577745|147334|P5|Overall Study|Lost to Follow-up|0
32814|NCT01577745|147335|P4|Overall Study|Lost to Follow-up|0
32815|NCT01577745|147336|P3|Overall Study|Lost to Follow-up|0
32816|NCT01577745|147337|P2|Overall Study|Lost to Follow-up|0
32817|NCT01577745|147338|P1|Overall Study|Lost to Follow-up|0
32818|NCT01577745|147333|P6|Overall Study|Physician Decision|0
32819|NCT01577745|147334|P5|Overall Study|Physician Decision|1
32820|NCT01577745|147335|P4|Overall Study|Physician Decision|1
32821|NCT01577745|147336|P3|Overall Study|Physician Decision|0
32822|NCT01577745|147337|P2|Overall Study|Physician Decision|0
32823|NCT01577745|147338|P1|Overall Study|Physician Decision|0
32824|NCT01577745|147333|P6|Overall Study|Death|3
32825|NCT01577745|147334|P5|Overall Study|Death|1
32826|NCT01577745|147335|P4|Overall Study|Death|1
32827|NCT01577745|147336|P3|Overall Study|Death|2
32828|NCT01577745|147337|P2|Overall Study|Death|2
32829|NCT01577745|147338|P1|Overall Study|Death|3
32830|NCT01577745|147333|P6|Overall Study|Withdrawal by Subject|0
32831|NCT01577745|147334|P5|Overall Study|Withdrawal by Subject|2
32832|NCT01577745|147335|P4|Overall Study|Withdrawal by Subject|3
32833|NCT01577745|147336|P3|Overall Study|Withdrawal by Subject|0
32834|NCT01577745|147337|P2|Overall Study|Withdrawal by Subject|1
32835|NCT01577745|147338|P1|Overall Study|Withdrawal by Subject|0
32836|NCT01577381|147522|P4|Overall Study|Ongoing at Date of Cut-Off|0
32837|NCT01577381|147523|P3|Overall Study|Ongoing at Date of Cut-Off|1
32838|NCT01577381|147524|P2|Overall Study|Ongoing at Date of Cut-Off|2
32839|NCT01577381|147525|P1|Overall Study|Ongoing at Date of Cut-Off|0
32840|NCT01577381|147522|P4|Overall Study|Discontinued|2
32841|NCT01577381|147523|P3|Overall Study|Discontinued|2
32842|NCT01577381|147524|P2|Overall Study|Discontinued|1
32843|NCT01577381|147525|P1|Overall Study|Discontinued|2
32844|NCT01577186|147663|P1|Overall Study|Unspecified|2
32845|NCT01577186|147663|P1|Overall Study|Non-Compliant|8
32846|NCT01577186|147663|P1|Overall Study|Ineligible to Continue|15
32847|NCT01577186|147663|P1|Overall Study|Insufficient Response|18
32848|NCT01577186|147663|P1|Overall Study|Withdrawal by Subject|35
32849|NCT01577186|147663|P1|Overall Study|Lost to Follow-up|28
32850|NCT01577186|147663|P1|Overall Study|Death|1
32851|NCT01577186|147663|P1|Overall Study|Adverse Event|23
32852|NCT01577160|147671|P1|Overall Study|Unspecified|9
32853|NCT01577160|147671|P1|Overall Study|Subject Uncooperative|7
32854|NCT01577160|147671|P1|Overall Study|Withdrawal by Subject|18
32855|NCT01577160|147671|P1|Overall Study|Lost to Follow-up|40
32856|NCT01577160|147671|P1|Overall Study|Lack of Efficacy|15
32857|NCT01577160|147671|P1|Overall Study|Adverse Event|9
32858|NCT01576718|147717|P7|Treatment Period|Noncompliance to study medication|1
32859|NCT01576718|147718|P6|Treatment Period|Noncompliance to study medication|1
32860|NCT01576718|147719|P5|Treatment Period|Noncompliance to study medication|0
32861|NCT01576718|147720|P4|Treatment Period|Noncompliance to study medication|0
32862|NCT01576718|147721|P3|Treatment Period|Noncompliance to study medication|0
32863|NCT01576718|147722|P2|Treatment Period|Noncompliance to study medication|0
32864|NCT01576718|147723|P1|Treatment Period|Noncompliance to study medication|0
32865|NCT01576718|147717|P7|Treatment Period|Lost to Follow-up|0
32866|NCT01576718|147718|P6|Treatment Period|Lost to Follow-up|0
32867|NCT01576718|147719|P5|Treatment Period|Lost to Follow-up|1
32868|NCT01576718|147720|P4|Treatment Period|Lost to Follow-up|0
32869|NCT01576718|147721|P3|Treatment Period|Lost to Follow-up|0
32870|NCT01576718|147722|P2|Treatment Period|Lost to Follow-up|0
32871|NCT01576718|147723|P1|Treatment Period|Lost to Follow-up|0
32872|NCT01576718|147717|P7|Treatment Period|Met stopping criteria|15
32873|NCT01576718|147718|P6|Treatment Period|Met stopping criteria|33
32874|NCT01576718|147719|P5|Treatment Period|Met stopping criteria|16
32875|NCT01576718|147720|P4|Treatment Period|Met stopping criteria|19
32876|NCT01576718|147721|P3|Treatment Period|Met stopping criteria|13
32877|NCT01576718|147722|P2|Treatment Period|Met stopping criteria|16
32878|NCT01576718|147723|P1|Treatment Period|Met stopping criteria|0
32879|NCT01576718|147717|P7|Treatment Period|Sponsor request|0
32880|NCT01576718|147718|P6|Treatment Period|Sponsor request|1
32881|NCT01576718|147719|P5|Treatment Period|Sponsor request|0
32882|NCT01576718|147720|P4|Treatment Period|Sponsor request|0
32883|NCT01576718|147721|P3|Treatment Period|Sponsor request|0
32884|NCT01576718|147722|P2|Treatment Period|Sponsor request|1
32885|NCT01576718|147723|P1|Treatment Period|Sponsor request|0
32886|NCT01576718|147717|P7|Treatment Period|Protocol Violation|12
32887|NCT01576718|147718|P6|Treatment Period|Protocol Violation|8
32888|NCT01576718|147719|P5|Treatment Period|Protocol Violation|6
32889|NCT01576718|147720|P4|Treatment Period|Protocol Violation|10
32890|NCT01576718|147721|P3|Treatment Period|Protocol Violation|4
32891|NCT01576718|147722|P2|Treatment Period|Protocol Violation|5
32892|NCT01576718|147723|P1|Treatment Period|Protocol Violation|0
32893|NCT01576718|147717|P7|Treatment Period|Physician Decision|0
32894|NCT01576718|147718|P6|Treatment Period|Physician Decision|0
32895|NCT01576718|147719|P5|Treatment Period|Physician Decision|1
32896|NCT01576718|147720|P4|Treatment Period|Physician Decision|1
32897|NCT01576718|147721|P3|Treatment Period|Physician Decision|1
32898|NCT01576718|147722|P2|Treatment Period|Physician Decision|1
32899|NCT01576718|147723|P1|Treatment Period|Physician Decision|0
32900|NCT01576718|147717|P7|Treatment Period|Withdrawal by Subject|2
32901|NCT01576718|147718|P6|Treatment Period|Withdrawal by Subject|4
32902|NCT01576718|147719|P5|Treatment Period|Withdrawal by Subject|2
32903|NCT01576718|147720|P4|Treatment Period|Withdrawal by Subject|0
32904|NCT01576718|147721|P3|Treatment Period|Withdrawal by Subject|1
32905|NCT01576718|147722|P2|Treatment Period|Withdrawal by Subject|1
32906|NCT01576718|147723|P1|Treatment Period|Withdrawal by Subject|0
32907|NCT01576718|147717|P7|Treatment Period|Adverse Event|0
32908|NCT01576718|147718|P6|Treatment Period|Adverse Event|1
32909|NCT01576718|147719|P5|Treatment Period|Adverse Event|1
32910|NCT01576718|147720|P4|Treatment Period|Adverse Event|1
32911|NCT01576718|147721|P3|Treatment Period|Adverse Event|1
32912|NCT01576718|147722|P2|Treatment Period|Adverse Event|1
32913|NCT01576718|147723|P1|Treatment Period|Adverse Event|0
32914|NCT01576718|147717|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
32915|NCT01576718|147718|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
32916|NCT01576718|147719|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
32917|NCT01576718|147720|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
32918|NCT01576718|147721|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
32919|NCT01576718|147722|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
32920|NCT01576718|147723|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
32921|NCT01576718|147717|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
32922|NCT01576718|147718|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
32923|NCT01576718|147719|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
32924|NCT01576718|147720|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
32925|NCT01576718|147721|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
32926|NCT01576718|147722|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
32927|NCT01576718|147723|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
32928|NCT01576718|147717|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
32929|NCT01576718|147718|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
32930|NCT01576718|147719|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
32931|NCT01576718|147720|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
32932|NCT01576718|147721|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
32933|NCT01576718|147722|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
32934|NCT01576718|147723|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
32935|NCT01576718|147717|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
32936|NCT01576718|147718|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
32937|NCT01576718|147719|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
32938|NCT01576718|147720|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
32939|NCT01576718|147721|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
32940|NCT01576718|147722|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
32941|NCT01576718|147723|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
32942|NCT01576718|147717|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
32943|NCT01576718|147718|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
32944|NCT01576718|147719|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
32945|NCT01576718|147720|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
32946|NCT01576718|147721|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
32947|NCT01576718|147722|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
32948|NCT01576718|147723|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
32949|NCT01576367|147824|P1|Overall Study|Moved to commercial use after 6 months|1
32950|NCT01576367|147824|P1|Overall Study|Unsatisfactory therapeutic effect|2
32951|NCT01576341|147832|P1|Overall Study|Other|12
32952|NCT01576341|147832|P1|Overall Study|Protocol Violation|12
32953|NCT01576341|147832|P1|Overall Study|Kidney transplantation|10
32954|NCT01576341|147832|P1|Overall Study|Lost to Follow-up|2
32955|NCT01576341|147832|P1|Overall Study|Physician Decision|2
32956|NCT01576341|147832|P1|Overall Study|Death|21
32957|NCT01576341|147832|P1|Overall Study|Adverse Event|10
32958|NCT01576341|147832|P1|Overall Study|Withdrawal by Subject|24
32959|NCT01576159|147843|P4|Overall Study|Protocol Violation|0
32960|NCT01576159|147844|P3|Overall Study|Protocol Violation|0
32961|NCT01576159|147845|P2|Overall Study|Protocol Violation|0
32962|NCT01576159|147846|P1|Overall Study|Protocol Violation|1
32963|NCT01576159|147843|P4|Overall Study|Lost to Follow-up|1
32964|NCT01576159|147844|P3|Overall Study|Lost to Follow-up|0
32965|NCT01576159|147845|P2|Overall Study|Lost to Follow-up|0
32966|NCT01576159|147846|P1|Overall Study|Lost to Follow-up|0
32967|NCT01576159|147843|P4|Overall Study|Physician Decision|0
32968|NCT01576159|147844|P3|Overall Study|Physician Decision|1
32969|NCT01576159|147845|P2|Overall Study|Physician Decision|0
32970|NCT01576159|147846|P1|Overall Study|Physician Decision|0
32971|NCT01576159|147843|P4|Overall Study|Withdrawal by Subject|0
32972|NCT01576159|147844|P3|Overall Study|Withdrawal by Subject|0
32973|NCT01576159|147845|P2|Overall Study|Withdrawal by Subject|1
32974|NCT01576159|147846|P1|Overall Study|Withdrawal by Subject|0
32975|NCT01576146|147864|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
32976|NCT01576146|147864|P1|Extension Period 2|Renal Transplant|1
32977|NCT01576146|147864|P1|Extension Period 2|Adverse Event|1
32978|NCT01576146|147864|P1|Extension Period 2|Death|1
32979|NCT01576146|147864|P1|Extension Period 2|Sponsor Decision|13
32980|NCT01576146|147864|P1|Extension Period 1|Renal Transplant|1
32981|NCT01576146|147864|P1|Extension Period 1|Parathyroidectomy|1
32982|NCT01576146|147864|P1|Extension Period 1|Lost to Follow-up|1
32983|NCT01576146|147864|P1|Extension Period 1|Withdrawal by Subject|1
32984|NCT01576146|147864|P1|Extension Period 1|Physician Decision|2
32985|NCT01576146|147864|P1|Extension Period 1|Death|2
32986|NCT01576146|147864|P1|Extension Period 1|Adverse Event|2
32987|NCT01576042|147897|P2|Overall Study|Physician Decision|0
32988|NCT01576042|147898|P1|Overall Study|Physician Decision|2
32989|NCT01575899|147934|P3|Overall Study|Protocol Violation|0
32990|NCT01575899|147935|P2|Overall Study|Protocol Violation|1
32991|NCT01575899|147936|P1|Overall Study|Protocol Violation|2
32992|NCT01575899|147934|P3|Overall Study|Lost to Follow-up|2
32993|NCT01575899|147935|P2|Overall Study|Lost to Follow-up|4
32994|NCT01575899|147936|P1|Overall Study|Lost to Follow-up|3
32995|NCT01575769|147946|P1|Overall Study|Study terminated by sponsor|40
32996|NCT01575769|147946|P1|Overall Study|Adverse Event|1
32997|NCT01575561|147989|P1|Overall Study|administration|1
32998|NCT01575561|147989|P1|Overall Study|Withdrawal by Subject|11
32999|NCT01575561|147989|P1|Overall Study|Protocol Violation|4
33000|NCT01575561|147989|P1|Overall Study|Lost to Follow-up|6
33001|NCT01575561|147989|P1|Overall Study|Lack of Efficacy|8
33002|NCT01575561|147989|P1|Overall Study|Adverse Event|9
33003|NCT01575197|148012|P3|Overall Study|Protocol Violation|1
33004|NCT01575197|148013|P2|Overall Study|Protocol Violation|1
33005|NCT01575197|148014|P1|Overall Study|Protocol Violation|2
33006|NCT01575197|148012|P3|Overall Study|Withdrawal by Subject|1
33007|NCT01575197|148013|P2|Overall Study|Withdrawal by Subject|1
33008|NCT01575197|148014|P1|Overall Study|Withdrawal by Subject|0
33009|NCT01575197|148012|P3|Overall Study|Lost to Follow-up|0
33010|NCT01575197|148013|P2|Overall Study|Lost to Follow-up|1
33011|NCT01575197|148014|P1|Overall Study|Lost to Follow-up|0
33012|NCT01575197|148012|P3|Overall Study|SAE|0
33013|NCT01575197|148013|P2|Overall Study|SAE|1
33014|NCT01575197|148014|P1|Overall Study|SAE|0
33015|NCT01575197|148012|P3|Overall Study|Migration out of study area|4
33016|NCT01575197|148013|P2|Overall Study|Migration out of study area|5
33017|NCT01575197|148014|P1|Overall Study|Migration out of study area|1
33018|NCT01573910|148036|P2|Overall Study|Patient decision unrelated to Advs Event|11
33019|NCT01573910|148037|P1|Overall Study|Patient decision unrelated to Advs Event|11
33020|NCT01573910|148036|P2|Overall Study|Protocol Violation|0
33021|NCT01573910|148037|P1|Overall Study|Protocol Violation|3
33022|NCT01573910|148036|P2|Overall Study|Withdrawal by Subject|1
33023|NCT01573910|148037|P1|Overall Study|Withdrawal by Subject|0
33024|NCT01573910|148036|P2|Overall Study|Lost to Follow-up|1
33025|NCT01573910|148037|P1|Overall Study|Lost to Follow-up|2
33026|NCT01573910|148036|P2|Overall Study|Adverse Event|4
33027|NCT01573910|148037|P1|Overall Study|Adverse Event|4
33028|NCT01575054|148047|P2|Overall Study|Adverse Event|8
33029|NCT01575054|148048|P1|Overall Study|Adverse Event|9
33030|NCT01575054|148047|P2|Overall Study|Lost to Follow-up|3
33031|NCT01575054|148048|P1|Overall Study|Lost to Follow-up|3
33032|NCT01575054|148047|P2|Overall Study|Personal Reasons|11
33033|NCT01575054|148048|P1|Overall Study|Personal Reasons|10
33034|NCT01575054|148047|P2|Overall Study|Protocol Violation|1
33035|NCT01575054|148048|P1|Overall Study|Protocol Violation|2
33036|NCT01575054|148047|P2|Overall Study|Other Reasons|3
33037|NCT01575054|148048|P1|Overall Study|Other Reasons|5
33038|NCT01575028|148064|P2|Overall Study|Physician Decision|1
33039|NCT01575028|148065|P1|Overall Study|Physician Decision|0
33040|NCT01574703|148075|P4|Overall Study|Death|0
33041|NCT01574703|148076|P3|Overall Study|Death|1
33042|NCT01574703|148077|P2|Overall Study|Death|1
33043|NCT01574703|148078|P1|Overall Study|Death|2
33044|NCT01574703|148075|P4|Overall Study|Lost to Follow-up|35
33045|NCT01574703|148076|P3|Overall Study|Lost to Follow-up|46
33046|NCT01574703|148077|P2|Overall Study|Lost to Follow-up|41
33047|NCT01574703|148078|P1|Overall Study|Lost to Follow-up|43
33048|NCT01574703|148075|P4|Overall Study|Met Withdrawal Criteria|0
33049|NCT01574703|148076|P3|Overall Study|Met Withdrawal Criteria|1
33050|NCT01574703|148077|P2|Overall Study|Met Withdrawal Criteria|1
33051|NCT01574703|148078|P1|Overall Study|Met Withdrawal Criteria|0
33052|NCT01574703|148075|P4|Overall Study|Withdrawal by Subject|61
33053|NCT01574703|148076|P3|Overall Study|Withdrawal by Subject|36
33054|NCT01574703|148077|P2|Overall Study|Withdrawal by Subject|52
33055|NCT01574703|148078|P1|Overall Study|Withdrawal by Subject|53
33056|NCT01574703|148075|P4|Overall Study|Unspecified Reason|16
33057|NCT01574703|148076|P3|Overall Study|Unspecified Reason|20
33058|NCT01574703|148077|P2|Overall Study|Unspecified Reason|15
33059|NCT01574703|148078|P1|Overall Study|Unspecified Reason|27
33060|NCT01574703|148075|P4|Overall Study|Protocol Violation|1
33061|NCT01574703|148076|P3|Overall Study|Protocol Violation|0
33062|NCT01574703|148077|P2|Overall Study|Protocol Violation|0
33063|NCT01574703|148078|P1|Overall Study|Protocol Violation|0
33064|NCT01574703|148075|P4|Overall Study|Adverse Event|1
33065|NCT01574703|148076|P3|Overall Study|Adverse Event|1
33066|NCT01574703|148077|P2|Overall Study|Adverse Event|2
33067|NCT01574703|148078|P1|Overall Study|Adverse Event|0
33068|NCT01574651|148122|P2|Overall Study|Withdrawal by Subject|10
33069|NCT01574651|148123|P1|Overall Study|Withdrawal by Subject|9
33070|NCT01574651|148122|P2|Overall Study|Protocol Violation|5
33071|NCT01574651|148123|P1|Overall Study|Protocol Violation|3
33072|NCT01574651|148122|P2|Overall Study|Unsatisfactory therapeutic effect|0
33073|NCT01574651|148123|P1|Overall Study|Unsatisfactory therapeutic effect|6
33074|NCT01574651|148122|P2|Overall Study|Abnormal test procedure result(s)|1
33075|NCT01574651|148123|P1|Overall Study|Abnormal test procedure result(s)|1
33076|NCT01574651|148122|P2|Overall Study|Abnormal laboratory value(s)|0
33077|NCT01574651|148123|P1|Overall Study|Abnormal laboratory value(s)|1
33078|NCT01574651|148122|P2|Overall Study|Adverse Event|27
33079|NCT01574651|148123|P1|Overall Study|Adverse Event|36
33080|NCT01574651|148122|P2|Overall Study|Patient's inability to use the device|1
33081|NCT01574651|148123|P1|Overall Study|Patient's inability to use the device|0
33082|NCT01574651|148122|P2|Overall Study|Death|3
33083|NCT01574651|148123|P1|Overall Study|Death|3
33084|NCT01574651|148122|P2|Overall Study|Administrative problems|1
33085|NCT01574651|148123|P1|Overall Study|Administrative problems|0
33086|NCT01574651|148122|P2|Overall Study|Lost to Follow-up|4
33087|NCT01574651|148123|P1|Overall Study|Lost to Follow-up|2
33088|NCT01574612|148145|P1|Overall Study|Lost to Follow-up|2
33089|NCT01574612|148145|P1|Overall Study|Withdrawal by Subject|1
33090|NCT01574612|148145|P1|Overall Study|non compliant with drug|2
33091|NCT01574612|148145|P1|Overall Study|Adverse Event|3
33092|NCT01574326|148151|P2|Overall Study|Other: Mainly kidney transplant|8
33093|NCT01574326|148152|P1|Overall Study|Other: Mainly kidney transplant|8
33094|NCT01574326|148151|P2|Overall Study|Adverse Event|3
33095|NCT01574326|148152|P1|Overall Study|Adverse Event|1
33096|NCT01574326|148151|P2|Overall Study|Physician Decision|3
33097|NCT01574326|148152|P1|Overall Study|Physician Decision|5
33098|NCT01574326|148151|P2|Overall Study|Withdrawal by Participant|4
33099|NCT01574326|148152|P1|Overall Study|Withdrawal by Participant|2
33100|NCT01574326|148151|P2|Overall Study|Randomized but not treated|1
33101|NCT01574326|148152|P1|Overall Study|Randomized but not treated|0
33102|NCT01574248|148165|P2|Overall Study|Missing primary endpoint data|0
33103|NCT01574248|148166|P1|Overall Study|Missing primary endpoint data|1
33104|NCT01574248|148165|P2|Overall Study|Withdrawal by Subject|0
33105|NCT01574248|148166|P1|Overall Study|Withdrawal by Subject|2
33106|NCT01574079|148210|P2|Overall Study|Lost to Follow-up|0
33107|NCT01574079|148211|P1|Overall Study|Lost to Follow-up|1
33108|NCT01574079|148210|P2|Overall Study|Physician Decision|2
33109|NCT01574079|148211|P1|Overall Study|Physician Decision|0
33110|NCT01573767|148225|P4|Overall Study|Withdrawal by Subject|0
33111|NCT01573767|148226|P3|Overall Study|Withdrawal by Subject|0
33112|NCT01573767|148227|P2|Overall Study|Withdrawal by Subject|1
33113|NCT01573767|148228|P1|Overall Study|Withdrawal by Subject|0
33114|NCT01573767|148225|P4|Overall Study|Physician Decision|2
33115|NCT01573767|148226|P3|Overall Study|Physician Decision|0
33116|NCT01573767|148227|P2|Overall Study|Physician Decision|2
33117|NCT01573767|148228|P1|Overall Study|Physician Decision|1
33118|NCT01573767|148225|P4|Overall Study|Lost to Follow-up|1
33119|NCT01573767|148226|P3|Overall Study|Lost to Follow-up|1
33120|NCT01573767|148227|P2|Overall Study|Lost to Follow-up|1
33121|NCT01573767|148228|P1|Overall Study|Lost to Follow-up|0
33122|NCT01573767|148225|P4|Overall Study|Protocol Violation|3
33123|NCT01573767|148226|P3|Overall Study|Protocol Violation|1
33124|NCT01573767|148227|P2|Overall Study|Protocol Violation|1
33125|NCT01573767|148228|P1|Overall Study|Protocol Violation|3
33126|NCT01573767|148225|P4|Overall Study|Lack of Efficacy|17
33127|NCT01573767|148226|P3|Overall Study|Lack of Efficacy|12
33128|NCT01573767|148227|P2|Overall Study|Lack of Efficacy|15
33129|NCT01573767|148228|P1|Overall Study|Lack of Efficacy|18
33130|NCT01573767|148225|P4|Overall Study|Adverse Event|1
33131|NCT01573767|148226|P3|Overall Study|Adverse Event|0
33132|NCT01573767|148227|P2|Overall Study|Adverse Event|1
33133|NCT01573767|148228|P1|Overall Study|Adverse Event|0
33134|NCT01573624|148262|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
33135|NCT01573624|148263|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
33136|NCT01573624|148264|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
33137|NCT01573624|148265|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
33138|NCT01573624|148266|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
33139|NCT01573624|148267|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
33140|NCT01573624|148268|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
33141|NCT01573624|148262|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
33142|NCT01573624|148263|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
33143|NCT01573624|148264|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
33144|NCT01573624|148265|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
33145|NCT01573624|148266|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
33146|NCT01573624|148267|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
33147|NCT01573624|148268|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
33148|NCT01573624|148262|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
33149|NCT01573624|148263|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
33150|NCT01573624|148264|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
33151|NCT01573624|148265|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
33152|NCT01573624|148266|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
33153|NCT01573624|148267|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
33154|NCT01573624|148268|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
33155|NCT01573624|148262|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
33156|NCT01573624|148263|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
33157|NCT01573624|148264|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
33158|NCT01573624|148265|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
33159|NCT01573624|148266|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
33160|NCT01573624|148267|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
33161|NCT01573624|148268|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
33162|NCT01573624|148262|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
33163|NCT01573624|148263|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
33164|NCT01573624|148264|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
33165|NCT01573624|148265|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
33166|NCT01573624|148266|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
33167|NCT01573624|148267|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
33168|NCT01573624|148268|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
33169|NCT01573624|148262|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
33170|NCT01573624|148263|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
33171|NCT01573624|148264|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
33172|NCT01573624|148265|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
33173|NCT01573624|148266|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
33174|NCT01573624|148267|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
33175|NCT01573624|148268|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
33176|NCT01573624|148262|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
33177|NCT01573624|148263|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
33178|NCT01573624|148264|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
33179|NCT01573624|148265|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
33180|NCT01573624|148266|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
33181|NCT01573624|148267|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
33182|NCT01573624|148268|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
33183|NCT01573624|148262|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
33184|NCT01573624|148263|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
33185|NCT01573624|148264|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
33186|NCT01573624|148265|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
33405|NCT01572792|148479|P2|Lead-in Study|Lost to Follow-up|9
33187|NCT01573624|148266|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
33188|NCT01573624|148267|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
33189|NCT01573624|148268|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
33190|NCT01573624|148262|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
33191|NCT01573624|148263|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
33192|NCT01573624|148264|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
33193|NCT01573624|148265|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
33194|NCT01573624|148266|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
33195|NCT01573624|148267|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
33196|NCT01573624|148268|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
33197|NCT01573624|148262|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
33198|NCT01573624|148263|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
33199|NCT01573624|148264|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
33200|NCT01573624|148265|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
33201|NCT01573624|148266|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
33202|NCT01573624|148267|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
33203|NCT01573624|148268|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
33204|NCT01573624|148262|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
33205|NCT01573624|148263|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
33206|NCT01573624|148264|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
33207|NCT01573624|148265|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
33208|NCT01573624|148266|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
33209|NCT01573624|148267|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
33210|NCT01573624|148268|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
33211|NCT01573624|148262|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
33212|NCT01573624|148263|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
33213|NCT01573624|148264|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
33214|NCT01573624|148265|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
33215|NCT01573624|148266|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
33216|NCT01573624|148267|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
33217|NCT01573624|148268|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
33218|NCT01573624|148262|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
33219|NCT01573624|148263|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
33220|NCT01573624|148264|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
33221|NCT01573624|148265|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
33222|NCT01573624|148266|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
33223|NCT01573624|148267|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
33224|NCT01573624|148268|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
33225|NCT01573624|148262|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
33226|NCT01573624|148263|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
33227|NCT01573624|148264|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
33228|NCT01573624|148265|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
33229|NCT01573624|148266|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
33230|NCT01573624|148267|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
33231|NCT01573624|148268|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
33232|NCT01573624|148262|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
33233|NCT01573624|148263|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
33234|NCT01573624|148264|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
33235|NCT01573624|148265|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
33236|NCT01573624|148266|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
33237|NCT01573624|148267|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
33238|NCT01573624|148268|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
33239|NCT01573624|148262|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
33240|NCT01573624|148263|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
33241|NCT01573624|148264|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
33242|NCT01573624|148265|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
33243|NCT01573624|148266|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
33244|NCT01573624|148267|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
33245|NCT01573624|148268|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
33246|NCT01573624|148262|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
33247|NCT01573624|148263|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
33248|NCT01573624|148264|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
33249|NCT01573624|148265|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
33250|NCT01573624|148266|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
33251|NCT01573624|148267|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
33252|NCT01573624|148268|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
33253|NCT01573624|148262|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
33406|NCT01572792|148480|P1|Lead-in Study|Lost to Follow-up|5
33254|NCT01573624|148263|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
33255|NCT01573624|148264|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
33256|NCT01573624|148265|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
33257|NCT01573624|148266|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
33258|NCT01573624|148267|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
33259|NCT01573624|148268|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
33260|NCT01573624|148262|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
33261|NCT01573624|148263|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
33262|NCT01573624|148264|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
33263|NCT01573624|148265|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
33264|NCT01573624|148266|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
33265|NCT01573624|148267|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
33266|NCT01573624|148268|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
33267|NCT01573624|148262|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
33268|NCT01573624|148263|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
33269|NCT01573624|148264|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
33270|NCT01573624|148265|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
33271|NCT01573624|148266|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
33272|NCT01573624|148267|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
33273|NCT01573624|148268|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
33274|NCT01573624|148262|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
33275|NCT01573624|148263|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
33276|NCT01573624|148264|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
33277|NCT01573624|148265|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
33278|NCT01573624|148266|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
33279|NCT01573624|148267|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
33280|NCT01573624|148268|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
33281|NCT01573624|148262|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
33282|NCT01573624|148263|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
33283|NCT01573624|148264|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
33284|NCT01573624|148265|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
33285|NCT01573624|148266|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
33286|NCT01573624|148267|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
33287|NCT01573624|148268|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
33288|NCT01573624|148262|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
33289|NCT01573624|148263|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
33290|NCT01573624|148264|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
33291|NCT01573624|148265|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
33292|NCT01573624|148266|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
33293|NCT01573624|148267|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
33294|NCT01573624|148268|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
33295|NCT01573624|148262|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
33296|NCT01573624|148263|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
33297|NCT01573624|148264|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
33298|NCT01573624|148265|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
33299|NCT01573624|148266|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
33300|NCT01573624|148267|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
33301|NCT01573624|148268|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
33302|NCT01573624|148262|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
33303|NCT01573624|148263|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
33304|NCT01573624|148264|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
33305|NCT01573624|148265|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
33306|NCT01573624|148266|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
33307|NCT01573624|148267|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
33308|NCT01573624|148268|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
33309|NCT01573624|148262|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
33310|NCT01573624|148263|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
33311|NCT01573624|148264|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
33312|NCT01573624|148265|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
33313|NCT01573624|148266|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
33314|NCT01573624|148267|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
33315|NCT01573624|148268|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
33316|NCT01573624|148262|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
33317|NCT01573624|148263|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
33318|NCT01573624|148264|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
33319|NCT01573624|148265|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
33320|NCT01573624|148266|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
33321|NCT01573624|148267|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
33322|NCT01573624|148268|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
33323|NCT01573000|148357|P2|Long-Term Follow-Up|Lost to Follow-up|1
33324|NCT01573000|148358|P1|Long-Term Follow-Up|Lost to Follow-up|0
33325|NCT01573000|148357|P2|Long-Term Follow-Up|Death|0
33326|NCT01573000|148358|P1|Long-Term Follow-Up|Death|3
33327|NCT01573000|148357|P2|Crossover Phase|Death|3
33328|NCT01573000|148358|P1|Crossover Phase|Death|0
33329|NCT01573000|148357|P2|Crossover Phase|Lost to Follow-up|2
33330|NCT01573000|148358|P1|Crossover Phase|Lost to Follow-up|0
33331|NCT01573000|148357|P2|Crossover Phase|Lack of Efficacy|13
33332|NCT01573000|148358|P1|Crossover Phase|Lack of Efficacy|0
33333|NCT01573000|148357|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
33334|NCT01573000|148358|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
33335|NCT01573000|148357|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
33336|NCT01573000|148358|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
33337|NCT01573000|148357|P2|Dosimetric and Therapeutic Treatment|Death|1
33338|NCT01573000|148358|P1|Dosimetric and Therapeutic Treatment|Death|0
33339|NCT01573000|148357|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
33340|NCT01573000|148358|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
33341|NCT01573000|148357|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
33342|NCT01573000|148358|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
33343|NCT01572948|148454|P2|Overall Study|unable to contact|1
33344|NCT01572948|148455|P1|Overall Study|unable to contact|0
33345|NCT01572948|148454|P2|Overall Study|Lost to Follow-up|0
33346|NCT01572948|148455|P1|Overall Study|Lost to Follow-up|1
33347|NCT01572792|148476|P5|Extension Study|Site termination/COPD exacerbation/other|6
33348|NCT01572792|148477|P4|Extension Study|Site termination/COPD exacerbation/other|6
33349|NCT01572792|148478|P3|Extension Study|Site termination/COPD exacerbation/other|4
33350|NCT01572792|148479|P2|Extension Study|Site termination/COPD exacerbation/other|8
33351|NCT01572792|148480|P1|Extension Study|Site termination/COPD exacerbation/other|3
33352|NCT01572792|148476|P5|Extension Study|Adverse Event|4
33353|NCT01572792|148477|P4|Extension Study|Adverse Event|6
33354|NCT01572792|148478|P3|Extension Study|Adverse Event|5
33355|NCT01572792|148479|P2|Extension Study|Adverse Event|6
33356|NCT01572792|148480|P1|Extension Study|Adverse Event|7
33357|NCT01572792|148476|P5|Extension Study|Lack of Efficacy|2
33358|NCT01572792|148477|P4|Extension Study|Lack of Efficacy|2
33359|NCT01572792|148478|P3|Extension Study|Lack of Efficacy|3
33360|NCT01572792|148479|P2|Extension Study|Lack of Efficacy|3
33361|NCT01572792|148480|P1|Extension Study|Lack of Efficacy|2
33362|NCT01572792|148476|P5|Extension Study|Protocol Violation|3
33363|NCT01572792|148477|P4|Extension Study|Protocol Violation|4
33364|NCT01572792|148478|P3|Extension Study|Protocol Violation|3
33365|NCT01572792|148479|P2|Extension Study|Protocol Violation|4
33366|NCT01572792|148480|P1|Extension Study|Protocol Violation|0
33367|NCT01572792|148476|P5|Extension Study|Withdrawal by Subject|14
33368|NCT01572792|148477|P4|Extension Study|Withdrawal by Subject|8
33369|NCT01572792|148478|P3|Extension Study|Withdrawal by Subject|11
33370|NCT01572792|148479|P2|Extension Study|Withdrawal by Subject|6
33371|NCT01572792|148480|P1|Extension Study|Withdrawal by Subject|7
33372|NCT01572792|148476|P5|Extension Study|Lost to Follow-up|3
33373|NCT01572792|148477|P4|Extension Study|Lost to Follow-up|3
33374|NCT01572792|148478|P3|Extension Study|Lost to Follow-up|0
33375|NCT01572792|148479|P2|Extension Study|Lost to Follow-up|2
33376|NCT01572792|148480|P1|Extension Study|Lost to Follow-up|6
33377|NCT01572792|148476|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
33378|NCT01572792|148477|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
33379|NCT01572792|148478|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
33380|NCT01572792|148479|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
33381|NCT01572792|148480|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
33382|NCT01572792|148476|P5|Lead-in Study|Adverse Event|14
33383|NCT01572792|148477|P4|Lead-in Study|Adverse Event|16
33384|NCT01572792|148478|P3|Lead-in Study|Adverse Event|22
33385|NCT01572792|148479|P2|Lead-in Study|Adverse Event|21
33386|NCT01572792|148480|P1|Lead-in Study|Adverse Event|21
33387|NCT01572792|148476|P5|Lead-in Study|Lack of Efficacy|10
33388|NCT01572792|148477|P4|Lead-in Study|Lack of Efficacy|8
33389|NCT01572792|148478|P3|Lead-in Study|Lack of Efficacy|4
33390|NCT01572792|148479|P2|Lead-in Study|Lack of Efficacy|5
33391|NCT01572792|148480|P1|Lead-in Study|Lack of Efficacy|20
33392|NCT01572792|148476|P5|Lead-in Study|Protocol Violation|21
33393|NCT01572792|148477|P4|Lead-in Study|Protocol Violation|13
33394|NCT01572792|148478|P3|Lead-in Study|Protocol Violation|12
33395|NCT01572792|148479|P2|Lead-in Study|Protocol Violation|10
33396|NCT01572792|148480|P1|Lead-in Study|Protocol Violation|19
33397|NCT01572792|148476|P5|Lead-in Study|Withdrawal by Subject|11
33398|NCT01572792|148477|P4|Lead-in Study|Withdrawal by Subject|24
33399|NCT01572792|148478|P3|Lead-in Study|Withdrawal by Subject|12
33400|NCT01572792|148479|P2|Lead-in Study|Withdrawal by Subject|11
33401|NCT01572792|148480|P1|Lead-in Study|Withdrawal by Subject|22
33402|NCT01572792|148476|P5|Lead-in Study|Lost to Follow-up|4
33403|NCT01572792|148477|P4|Lead-in Study|Lost to Follow-up|2
33404|NCT01572792|148478|P3|Lead-in Study|Lost to Follow-up|4
33407|NCT01572740|148529|P2|Overall Study|unclassified|3
33408|NCT01572740|148530|P1|Overall Study|unclassified|4
33409|NCT01572740|148529|P2|Overall Study|Withdrawal by Subject|1
33410|NCT01572740|148530|P1|Overall Study|Withdrawal by Subject|1
33411|NCT01572740|148529|P2|Overall Study|Adverse Event|1
33412|NCT01572740|148530|P1|Overall Study|Adverse Event|1
33413|NCT01572727|148560|P2|Overall Study|Untreated|7
33414|NCT01572727|148561|P1|Overall Study|Untreated|4
33415|NCT01572727|148560|P2|Overall Study|Death|2
33416|NCT01572727|148561|P1|Overall Study|Death|2
33417|NCT01572727|148560|P2|Overall Study|Parent/guardian decision|9
33418|NCT01572727|148561|P1|Overall Study|Parent/guardian decision|14
33419|NCT01572727|148560|P2|Overall Study|Study terminated by sponsor|83
33420|NCT01572727|148561|P1|Overall Study|Study terminated by sponsor|61
33421|NCT01572727|148560|P2|Overall Study|Protocol Violation|1
33422|NCT01572727|148561|P1|Overall Study|Protocol Violation|0
33423|NCT01572727|148560|P2|Overall Study|Progressive disease|82
33424|NCT01572727|148561|P1|Overall Study|Progressive disease|59
33425|NCT01572727|148560|P2|Overall Study|Physician Decision|9
33426|NCT01572727|148561|P1|Overall Study|Physician Decision|23
33427|NCT01572727|148560|P2|Overall Study|Lost to Follow-up|1
33428|NCT01572727|148561|P1|Overall Study|Lost to Follow-up|1
33429|NCT01572727|148560|P2|Overall Study|Adverse Event|15
33430|NCT01572727|148561|P1|Overall Study|Adverse Event|43
33431|NCT01572675|148583|P2|Overall Study|Lost to Follow-up|27
33432|NCT01572675|148584|P1|Overall Study|Lost to Follow-up|22
33433|NCT01572675|148583|P2|Overall Study|Missing data|4
33434|NCT01572675|148584|P1|Overall Study|Missing data|1
33435|NCT01572675|148583|P2|Overall Study|Rheumatologist new evaluation|1
33436|NCT01572675|148584|P1|Overall Study|Rheumatologist new evaluation|0
33437|NCT01572675|148583|P2|Overall Study|Unknown reason|1
33438|NCT01572675|148584|P1|Overall Study|Unknown reason|1
33439|NCT01572675|148583|P2|Overall Study|Other disease detected|1
33440|NCT01572675|148584|P1|Overall Study|Other disease detected|1
33441|NCT01572675|148583|P2|Overall Study|Death unrelated to coxibs|1
33442|NCT01572675|148584|P1|Overall Study|Death unrelated to coxibs|1
33443|NCT01572675|148583|P2|Overall Study|Physician Decision|2
33444|NCT01572675|148584|P1|Overall Study|Physician Decision|2
33445|NCT01572675|148583|P2|Overall Study|Withdrawal by Subject|1
33446|NCT01572675|148584|P1|Overall Study|Withdrawal by Subject|5
33447|NCT01572675|148583|P2|Overall Study|Surgical intervention|6
33448|NCT01572675|148584|P1|Overall Study|Surgical intervention|3
33449|NCT01572675|148583|P2|Overall Study|Improved symptoms|2
33450|NCT01572675|148584|P1|Overall Study|Improved symptoms|8
33451|NCT01572675|148583|P2|Overall Study|Intolerance|5
33452|NCT01572675|148584|P1|Overall Study|Intolerance|6
33453|NCT01572675|148583|P2|Overall Study|Lack of Efficacy|31
33454|NCT01572675|148584|P1|Overall Study|Lack of Efficacy|31
33455|NCT01572675|148583|P2|Overall Study|Recovery|23
33456|NCT01572675|148584|P1|Overall Study|Recovery|16
33457|NCT01572675|148583|P2|Overall Study|End of prescribed treatment|118
33458|NCT01572675|148584|P1|Overall Study|End of prescribed treatment|140
33459|NCT01571453|148712|P2|Overall Study|Administrative or other reason(s)|3
33460|NCT01571453|148713|P1|Overall Study|Administrative or other reason(s)|4
33461|NCT01571453|148712|P2|Overall Study|Lost to Follow-up|2
33462|NCT01571453|148713|P1|Overall Study|Lost to Follow-up|4
33463|NCT01571453|148712|P2|Overall Study|Withdrawal of consent|13
33464|NCT01571453|148713|P1|Overall Study|Withdrawal of consent|5
33465|NCT01571453|148712|P2|Overall Study|Protocol Violation|5
33466|NCT01571453|148713|P1|Overall Study|Protocol Violation|1
33467|NCT01571453|148712|P2|Overall Study|Non-compliance|4
33468|NCT01571453|148713|P1|Overall Study|Non-compliance|2
33469|NCT01571453|148712|P2|Overall Study|Lack of Efficacy|3
33470|NCT01571453|148713|P1|Overall Study|Lack of Efficacy|8
33471|NCT01571453|148712|P2|Overall Study|Adverse Event|32
33472|NCT01571453|148713|P1|Overall Study|Adverse Event|14
33473|NCT01571362|148729|P3|Double-Blind Treatment Period|Other - unspecified|1
33474|NCT01571362|148730|P2|Double-Blind Treatment Period|Other - unspecified|6
33475|NCT01571362|148731|P1|Double-Blind Treatment Period|Other - unspecified|0
33476|NCT01571362|148729|P3|Double-Blind Treatment Period|Insufficient clinical response|4
33477|NCT01571362|148730|P2|Double-Blind Treatment Period|Insufficient clinical response|16
33478|NCT01571362|148731|P1|Double-Blind Treatment Period|Insufficient clinical response|0
33479|NCT01571362|148729|P3|Double-Blind Treatment Period|Lost to Follow-up|6
33480|NCT01571362|148730|P2|Double-Blind Treatment Period|Lost to Follow-up|3
33481|NCT01571362|148731|P1|Double-Blind Treatment Period|Lost to Follow-up|0
33482|NCT01571362|148729|P3|Double-Blind Treatment Period|Adverse Event|14
33483|NCT01571362|148730|P2|Double-Blind Treatment Period|Adverse Event|9
33484|NCT01571362|148731|P1|Double-Blind Treatment Period|Adverse Event|0
33485|NCT01571362|148729|P3|Double-Blind Treatment Period|Protocol Violation|9
33486|NCT01571362|148730|P2|Double-Blind Treatment Period|Protocol Violation|8
33487|NCT01571362|148731|P1|Double-Blind Treatment Period|Protocol Violation|0
33488|NCT01571362|148729|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
33489|NCT01571362|148730|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
33490|NCT01571362|148731|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
33491|NCT01571362|148729|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
33492|NCT01571362|148730|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
33493|NCT01571362|148731|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
33494|NCT01571362|148729|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
33495|NCT01571362|148730|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
33496|NCT01571362|148731|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
33497|NCT01571362|148729|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
33498|NCT01571362|148730|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
33499|NCT01571362|148731|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
33500|NCT01571362|148729|P3|Open-Label Conversion + Titration Period|Adverse Event|0
33501|NCT01571362|148730|P2|Open-Label Conversion + Titration Period|Adverse Event|0
33502|NCT01571362|148731|P1|Open-Label Conversion + Titration Period|Adverse Event|57
33503|NCT01571362|148729|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
33504|NCT01571362|148730|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
33505|NCT01571362|148731|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
33506|NCT01571362|148729|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
33507|NCT01571362|148730|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
33508|NCT01571362|148731|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
33509|NCT01571232|148903|P2|Overall Study|Withdrawal by Subject|0
33510|NCT01571232|148904|P1|Overall Study|Withdrawal by Subject|1
33511|NCT01571232|148903|P2|Overall Study|Lost to Follow-up|1
33512|NCT01571232|148904|P1|Overall Study|Lost to Follow-up|0
33513|NCT01570751|148916|P2|Period B (16 Weeks)|Protocol Violation|1
33514|NCT01570751|148917|P1|Period B (16 Weeks)|Protocol Violation|0
33515|NCT01570751|148916|P2|Period B (16 Weeks)|Adverse Event|0
33516|NCT01570751|148917|P1|Period B (16 Weeks)|Adverse Event|1
33517|NCT01570751|148916|P2|Period A (16 Weeks)|Unclassified|3
33518|NCT01570751|148917|P1|Period A (16 Weeks)|Unclassified|2
33519|NCT01570751|148916|P2|Period A (16 Weeks)|Withdrawal criteria|1
33520|NCT01570751|148917|P1|Period A (16 Weeks)|Withdrawal criteria|0
33521|NCT01570751|148916|P2|Period A (16 Weeks)|Protocol Violation|1
33522|NCT01570751|148917|P1|Period A (16 Weeks)|Protocol Violation|1
33523|NCT01570686|148935|P2|Overall Study|Unsatisfactory therapeutic effect|1
33524|NCT01570686|148936|P1|Overall Study|Unsatisfactory therapeutic effect|2
33525|NCT01570686|148935|P2|Overall Study|Withdrawal by Subject|4
33526|NCT01570686|148936|P1|Overall Study|Withdrawal by Subject|4
33527|NCT01570686|148935|P2|Overall Study|Protocol Deviation|0
33528|NCT01570686|148936|P1|Overall Study|Protocol Deviation|3
33529|NCT01570686|148935|P2|Overall Study|Lost to Follow-up|3
33530|NCT01570686|148936|P1|Overall Study|Lost to Follow-up|4
33531|NCT01570686|148935|P2|Overall Study|Adverse Event|6
33532|NCT01570686|148936|P1|Overall Study|Adverse Event|8
33533|NCT01570686|148935|P2|Overall Study|Administrative problems|1
33534|NCT01570686|148936|P1|Overall Study|Administrative problems|0
33707|NCT01566721|149864|P2|Overall Study|Death|3
33535|NCT01570686|148935|P2|Overall Study|Abnormal test procedure result(s)|1
33536|NCT01570686|148936|P1|Overall Study|Abnormal test procedure result(s)|1
33537|NCT01570309|148972|P2|Overall Study|Withdrawal by Subject|3
33538|NCT01570309|148973|P1|Overall Study|Withdrawal by Subject|3
33539|NCT01570244|148987|P1|Microgynon+Faldaprevir|Adverse Event|1
33540|NCT01570192|149009|P2|Overall Study|Physician Decision|1
33541|NCT01570192|149010|P1|Overall Study|Physician Decision|0
33542|NCT01570192|149009|P2|Overall Study|changed to palliative care|0
33543|NCT01570192|149010|P1|Overall Study|changed to palliative care|1
33544|NCT01570192|149009|P2|Overall Study|no qualifying organism|12
33545|NCT01570192|149010|P1|Overall Study|no qualifying organism|6
33546|NCT01569841|149016|P2|Period A (6 Weeks)|Withdrawal by Subject|1
33547|NCT01569841|149017|P1|Period A (6 Weeks)|Withdrawal by Subject|0
33548|NCT01569763|149106|P2|Overall Study|Adverse Event|0
33549|NCT01569763|149107|P1|Overall Study|Adverse Event|1
33550|NCT01569763|149106|P2|Overall Study|Lack of Efficacy|7
33551|NCT01569763|149107|P1|Overall Study|Lack of Efficacy|2
33552|NCT01569568|149119|P2|Overall Study|Physician Decision|2
33553|NCT01569568|149120|P1|Overall Study|Physician Decision|0
33554|NCT01569464|149143|P2|Overall Study|Other|1
33555|NCT01569464|149144|P1|Overall Study|Other|1
33556|NCT01569464|149143|P2|Overall Study|Withdrawal by Subject|1
33557|NCT01569464|149144|P1|Overall Study|Withdrawal by Subject|1
33558|NCT01569464|149143|P2|Overall Study|Lost to Follow-up|3
33559|NCT01569464|149144|P1|Overall Study|Lost to Follow-up|2
33560|NCT01569464|149143|P2|Overall Study|Protocol Violation|0
33561|NCT01569464|149144|P1|Overall Study|Protocol Violation|1
33562|NCT01569464|149143|P2|Overall Study|Lack of Efficacy|0
33563|NCT01569464|149144|P1|Overall Study|Lack of Efficacy|1
33564|NCT01569464|149143|P2|Overall Study|Adverse Event|0
33565|NCT01569464|149144|P1|Overall Study|Adverse Event|4
33566|NCT01569438|149182|P2|Overall Study|Protocol Violation|0
33567|NCT01569438|149183|P1|Overall Study|Protocol Violation|1
33568|NCT01569438|149182|P2|Overall Study|Withdrawal by Subject|1
33569|NCT01569438|149183|P1|Overall Study|Withdrawal by Subject|0
33570|NCT01569438|149182|P2|Overall Study|Lack of Efficacy|1
33571|NCT01569438|149183|P1|Overall Study|Lack of Efficacy|1
33572|NCT01569438|149182|P2|Overall Study|Adverse Event|7
33573|NCT01569438|149183|P1|Overall Study|Adverse Event|0
33574|NCT01569152|149197|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
33575|NCT01569152|149198|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
33576|NCT01569152|149199|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
33577|NCT01569152|149197|P3|Safety Extension, Period 3|Physician Decision|2
33578|NCT01569152|149198|P2|Safety Extension, Period 3|Physician Decision|0
33579|NCT01569152|149199|P1|Safety Extension, Period 3|Physician Decision|0
33580|NCT01569152|149197|P3|Safety Extension, Period 3|Withdrawal by Subject|2
33581|NCT01569152|149198|P2|Safety Extension, Period 3|Withdrawal by Subject|0
33582|NCT01569152|149199|P1|Safety Extension, Period 3|Withdrawal by Subject|0
33583|NCT01569152|149197|P3|Safety Extension, Period 3|Adverse Event|4
33584|NCT01569152|149198|P2|Safety Extension, Period 3|Adverse Event|0
33585|NCT01569152|149199|P1|Safety Extension, Period 3|Adverse Event|0
33586|NCT01569152|149197|P3|Phase IIa, Period 1|Withdrawal by Subject|0
33587|NCT01569152|149198|P2|Phase IIa, Period 1|Withdrawal by Subject|1
33588|NCT01569152|149199|P1|Phase IIa, Period 1|Withdrawal by Subject|2
33589|NCT01569152|149197|P3|Phase IIa, Period 1|Protocol Violation|0
33590|NCT01569152|149198|P2|Phase IIa, Period 1|Protocol Violation|1
33591|NCT01569152|149199|P1|Phase IIa, Period 1|Protocol Violation|0
33592|NCT01569152|149197|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
33593|NCT01569152|149198|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
33594|NCT01569152|149199|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
33595|NCT01569152|149197|P3|Phase IIa, Period 1|Lost to Follow-up|0
33596|NCT01569152|149198|P2|Phase IIa, Period 1|Lost to Follow-up|0
33597|NCT01569152|149199|P1|Phase IIa, Period 1|Lost to Follow-up|1
33598|NCT01569152|149197|P3|Phase IIa, Period 1|Adverse Event|0
33599|NCT01569152|149198|P2|Phase IIa, Period 1|Adverse Event|0
33600|NCT01569152|149199|P1|Phase IIa, Period 1|Adverse Event|4
33601|NCT01569152|149197|P3|Phase IIa, Period 1|Early Escape|0
33602|NCT01569152|149198|P2|Phase IIa, Period 1|Early Escape|22
33603|NCT01569152|149199|P1|Phase IIa, Period 1|Early Escape|5
33604|NCT01569074|149335|P5|Overall Study|Adverse Event|0
33605|NCT01569074|149336|P4|Overall Study|Adverse Event|0
33606|NCT01569074|149337|P3|Overall Study|Adverse Event|3
33607|NCT01569074|149338|P2|Overall Study|Adverse Event|0
33608|NCT01569074|149339|P1|Overall Study|Adverse Event|1
33609|NCT01569074|149335|P5|Overall Study|eg change in circumstances|1
33610|NCT01569074|149336|P4|Overall Study|eg change in circumstances|1
33611|NCT01569074|149337|P3|Overall Study|eg change in circumstances|0
33612|NCT01569074|149338|P2|Overall Study|eg change in circumstances|2
33613|NCT01569074|149339|P1|Overall Study|eg change in circumstances|0
33614|NCT01569074|149335|P5|Overall Study|Severe non-compliance to protocol|0
33615|NCT01569074|149336|P4|Overall Study|Severe non-compliance to protocol|0
33616|NCT01569074|149337|P3|Overall Study|Severe non-compliance to protocol|1
33617|NCT01569074|149338|P2|Overall Study|Severe non-compliance to protocol|0
33618|NCT01569074|149339|P1|Overall Study|Severe non-compliance to protocol|0
33619|NCT01569074|149335|P5|Overall Study|Study-specific discontinuation criteria|0
33620|NCT01569074|149336|P4|Overall Study|Study-specific discontinuation criteria|0
33621|NCT01569074|149337|P3|Overall Study|Study-specific discontinuation criteria|0
33622|NCT01569074|149338|P2|Overall Study|Study-specific discontinuation criteria|1
33623|NCT01569074|149339|P1|Overall Study|Study-specific discontinuation criteria|0
33624|NCT01569074|149335|P5|Overall Study|Study stopped|7
33625|NCT01569074|149336|P4|Overall Study|Study stopped|7
33626|NCT01569074|149337|P3|Overall Study|Study stopped|8
33627|NCT01569074|149338|P2|Overall Study|Study stopped|6
33628|NCT01569074|149339|P1|Overall Study|Study stopped|6
33629|NCT01568892|149419|P2|Open-label Phase|Ongoing|15
33630|NCT01568892|149420|P1|Open-label Phase|Ongoing|12
33631|NCT01568892|149419|P2|Open-label Phase|Lack of Efficacy|1
33632|NCT01568892|149420|P1|Open-label Phase|Lack of Efficacy|0
33633|NCT01568892|149419|P2|Open-label Phase|Adverse Event|0
33634|NCT01568892|149420|P1|Open-label Phase|Adverse Event|1
33635|NCT01568866|149458|P2|Overall Study|Randomized but Not Dosed|1
33636|NCT01568866|149459|P1|Overall Study|Randomized but Not Dosed|9
33637|NCT01568866|149458|P2|Overall Study|Lost to Follow-up|0
33638|NCT01568866|149459|P1|Overall Study|Lost to Follow-up|1
33639|NCT01568866|149458|P2|Overall Study|Protocol Non-compliance|4
33640|NCT01568866|149459|P1|Overall Study|Protocol Non-compliance|1
33641|NCT01568866|149458|P2|Overall Study|Death|13
33642|NCT01568866|149459|P1|Overall Study|Death|9
33643|NCT01568866|149458|P2|Overall Study|Withdrawal by Subject|6
33644|NCT01568866|149459|P1|Overall Study|Withdrawal by Subject|19
33645|NCT01568866|149458|P2|Overall Study|Physician Decision|18
33646|NCT01568866|149459|P1|Overall Study|Physician Decision|35
33647|NCT01568866|149458|P2|Overall Study|Patient Request|40
33648|NCT01568866|149459|P1|Overall Study|Patient Request|45
33649|NCT01568866|149458|P2|Overall Study|Adverse Event|65
33650|NCT01568866|149459|P1|Overall Study|Adverse Event|73
33651|NCT01568866|149458|P2|Overall Study|Disease Progression|117
33652|NCT01568866|149459|P1|Overall Study|Disease Progression|168
33653|NCT01568593|149490|P2|Overall Study|Adverse Event|2
33654|NCT01568593|149491|P1|Overall Study|Adverse Event|3
33655|NCT01568593|149490|P2|Overall Study|Lack of Efficacy|1
33656|NCT01568593|149491|P1|Overall Study|Lack of Efficacy|4
33657|NCT01568112|149511|P4|Overall Study|Withdrawal by Physician|1
33658|NCT01568112|149512|P3|Overall Study|Withdrawal by Physician|1
33659|NCT01568112|149513|P2|Overall Study|Withdrawal by Physician|0
33660|NCT01568112|149514|P1|Overall Study|Withdrawal by Physician|1
33661|NCT01568112|149511|P4|Overall Study|Withdrawal by Subject|7
33662|NCT01568112|149512|P3|Overall Study|Withdrawal by Subject|0
33663|NCT01568112|149513|P2|Overall Study|Withdrawal by Subject|3
33664|NCT01568112|149514|P1|Overall Study|Withdrawal by Subject|2
33665|NCT01568112|149511|P4|Overall Study|Lost to Follow-up|1
33666|NCT01568112|149512|P3|Overall Study|Lost to Follow-up|0
33667|NCT01568112|149513|P2|Overall Study|Lost to Follow-up|0
33668|NCT01568112|149514|P1|Overall Study|Lost to Follow-up|0
33669|NCT01568112|149511|P4|Overall Study|Withdrew due to Adverse Event|3
33670|NCT01568112|149512|P3|Overall Study|Withdrew due to Adverse Event|6
33671|NCT01568112|149513|P2|Overall Study|Withdrew due to Adverse Event|4
33672|NCT01568112|149514|P1|Overall Study|Withdrew due to Adverse Event|2
33673|NCT01568112|149511|P4|Overall Study|Randomized But Not Treated|0
33674|NCT01568112|149512|P3|Overall Study|Randomized But Not Treated|0
33675|NCT01568112|149513|P2|Overall Study|Randomized But Not Treated|1
33676|NCT01568112|149514|P1|Overall Study|Randomized But Not Treated|0
33677|NCT01568047|149672|P4|Overall Study|Adverse Event|1
33678|NCT01568047|149673|P3|Overall Study|Adverse Event|1
33679|NCT01568047|149674|P2|Overall Study|Adverse Event|0
33680|NCT01568047|149675|P1|Overall Study|Adverse Event|0
33681|NCT01568047|149672|P4|Overall Study|Withdrawal by Subject|0
33682|NCT01568047|149673|P3|Overall Study|Withdrawal by Subject|0
33683|NCT01568047|149674|P2|Overall Study|Withdrawal by Subject|1
33684|NCT01568047|149675|P1|Overall Study|Withdrawal by Subject|0
33685|NCT01568047|149672|P4|Overall Study|Ineligibility|0
33686|NCT01568047|149673|P3|Overall Study|Ineligibility|0
33687|NCT01568047|149674|P2|Overall Study|Ineligibility|0
33688|NCT01568047|149675|P1|Overall Study|Ineligibility|1
33689|NCT01568034|149693|P4|Overall Study|Withdrawal by Subject|0
33690|NCT01568034|149694|P3|Overall Study|Withdrawal by Subject|0
33691|NCT01568034|149695|P2|Overall Study|Withdrawal by Subject|0
33692|NCT01568034|149696|P1|Overall Study|Withdrawal by Subject|1
33693|NCT01567852|149743|P2|Overall Study|ECT discontinued|1
33694|NCT01567852|149744|P1|Overall Study|ECT discontinued|1
33695|NCT01567852|149743|P2|Overall Study|Withdrawal by Subject|6
33696|NCT01567852|149744|P1|Overall Study|Withdrawal by Subject|3
33697|NCT01567826|149762|P2|Overall Study|Lost to Follow-up|2
33698|NCT01567826|149763|P1|Overall Study|Lost to Follow-up|3
33699|NCT01567163|149792|P1|Overall Study|Lost to Follow-up|2
33700|NCT01567163|149792|P1|Overall Study|Progressive Disease|2
33701|NCT01566981|149832|P2|Overall Study|Lost to Follow-up|8
33702|NCT01566981|149833|P1|Overall Study|Lost to Follow-up|5
33703|NCT01566721|149864|P2|Overall Study|Withdrew Prior to Treatment|1
33704|NCT01566721|149865|P1|Overall Study|Withdrew Prior to Treatment|3
33705|NCT01566721|149864|P2|Overall Study|Not Specified|4
33706|NCT01566721|149865|P1|Overall Study|Not Specified|10
33708|NCT01566721|149865|P1|Overall Study|Death|6
33709|NCT01566721|149864|P2|Overall Study|Lost to Follow-up|0
33710|NCT01566721|149865|P1|Overall Study|Lost to Follow-up|18
33711|NCT01566721|149864|P2|Overall Study|Disease Progression/Recurrence|28
33712|NCT01566721|149865|P1|Overall Study|Disease Progression/Recurrence|123
33713|NCT01566721|149864|P2|Overall Study|Withdrawal by Subject|15
33714|NCT01566721|149865|P1|Overall Study|Withdrawal by Subject|58
33715|NCT01566721|149864|P2|Overall Study|Ongoing Study|659
33716|NCT01566721|149865|P1|Overall Study|Ongoing Study|1649
33717|NCT01566604|149947|P2|Overall Study|Withdrawal by Subject|6
33718|NCT01566604|149948|P1|Overall Study|Withdrawal by Subject|9
33719|NCT01566604|149947|P2|Overall Study|Adverse Event|2
33720|NCT01566604|149948|P1|Overall Study|Adverse Event|4
33721|NCT01566604|149947|P2|Overall Study|Death|1
33722|NCT01566604|149948|P1|Overall Study|Death|4
33723|NCT01566604|149947|P2|Overall Study|Abnormal laboratory value|0
33724|NCT01566604|149948|P1|Overall Study|Abnormal laboratory value|2
33725|NCT01566604|149947|P2|Overall Study|Protocol deviation|0
33726|NCT01566604|149948|P1|Overall Study|Protocol deviation|2
33727|NCT01566604|149947|P2|Overall Study|Lack of Efficacy|2
33728|NCT01566604|149948|P1|Overall Study|Lack of Efficacy|1
33729|NCT01566604|149947|P2|Overall Study|Administrative problems|0
33730|NCT01566604|149948|P1|Overall Study|Administrative problems|1
33731|NCT01566604|149947|P2|Overall Study|Patient's inability to use the device|0
33732|NCT01566604|149948|P1|Overall Study|Patient's inability to use the device|1
33733|NCT01566435|150035|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
33734|NCT01566149|150108|P2|Overall Study|Withdrawal by Subject|0
33735|NCT01566149|150109|P1|Overall Study|Withdrawal by Subject|1
33736|NCT01566149|150108|P2|Overall Study|Protocol Violation|1
33737|NCT01566149|150109|P1|Overall Study|Protocol Violation|0
33738|NCT01566149|150108|P2|Overall Study|Non-compliance with study medication|0
33739|NCT01566149|150109|P1|Overall Study|Non-compliance with study medication|2
33740|NCT01566149|150108|P2|Overall Study|Adverse Event|1
33741|NCT01566149|150109|P1|Overall Study|Adverse Event|0
33742|NCT01565993|150142|P2|Overall Study|Physician Decision|3
33743|NCT01565993|150143|P1|Overall Study|Physician Decision|0
33744|NCT01565980|150151|P2|Overall Study|Withdrawal by Subject|3
33745|NCT01565980|150152|P1|Overall Study|Withdrawal by Subject|0
33746|NCT01565980|150151|P2|Overall Study|stopped medical treatment|0
33747|NCT01565980|150152|P1|Overall Study|stopped medical treatment|1
33748|NCT01565980|150151|P2|Overall Study|health complications|1
33749|NCT01565980|150152|P1|Overall Study|health complications|1
33750|NCT01565980|150151|P2|Overall Study|Lost to Follow-up|0
33751|NCT01565980|150152|P1|Overall Study|Lost to Follow-up|1
33752|NCT01565980|150151|P2|Overall Study|Death|0
33753|NCT01565980|150152|P1|Overall Study|Death|1
33754|NCT01565889|150211|P6|Part B|Lost to Follow-up|1
33755|NCT01565889|150212|P5|Part B|Lost to Follow-up|0
33756|NCT01565889|150213|P4|Part B|Lost to Follow-up|0
33757|NCT01565889|150214|P3|Part B|Lost to Follow-up|0
33758|NCT01565889|150215|P2|Part B|Lost to Follow-up|0
33759|NCT01565889|150216|P1|Part B|Lost to Follow-up|0
33760|NCT01565889|150211|P6|Part B|Lack of Efficacy|2
33761|NCT01565889|150212|P5|Part B|Lack of Efficacy|0
33762|NCT01565889|150213|P4|Part B|Lack of Efficacy|0
33763|NCT01565889|150214|P3|Part B|Lack of Efficacy|0
33764|NCT01565889|150215|P2|Part B|Lack of Efficacy|0
33765|NCT01565889|150216|P1|Part B|Lack of Efficacy|0
33766|NCT01565889|150211|P6|Part B|Withdrawal by Subject|1
33767|NCT01565889|150212|P5|Part B|Withdrawal by Subject|0
33768|NCT01565889|150213|P4|Part B|Withdrawal by Subject|0
33769|NCT01565889|150214|P3|Part B|Withdrawal by Subject|0
33770|NCT01565889|150215|P2|Part B|Withdrawal by Subject|0
33771|NCT01565889|150216|P1|Part B|Withdrawal by Subject|0
33772|NCT01565889|150211|P6|Part A|Withdrawal by Subject|0
33773|NCT01565889|150212|P5|Part A|Withdrawal by Subject|0
33774|NCT01565889|150213|P4|Part A|Withdrawal by Subject|0
33775|NCT01565889|150214|P3|Part A|Withdrawal by Subject|0
33776|NCT01565889|150215|P2|Part A|Withdrawal by Subject|0
33777|NCT01565889|150216|P1|Part A|Withdrawal by Subject|1
33778|NCT01565850|150247|P2|Overall Study|Withdrew Consent|2
33779|NCT01565850|150248|P1|Overall Study|Withdrew Consent|4
33780|NCT01565850|150247|P2|Overall Study|Participant noncompliance|0
33781|NCT01565850|150248|P1|Overall Study|Participant noncompliance|2
33782|NCT01565850|150247|P2|Overall Study|Investigator’s Discretion|1
33783|NCT01565850|150248|P1|Overall Study|Investigator’s Discretion|2
33784|NCT01565850|150247|P2|Overall Study|Lost to Follow-up|4
33785|NCT01565850|150248|P1|Overall Study|Lost to Follow-up|12
33786|NCT01565850|150247|P2|Overall Study|Adverse Event|1
33787|NCT01565850|150248|P1|Overall Study|Adverse Event|0
33788|NCT01565707|150268|P4|Overall Study|Miscellaneous|2
33789|NCT01565707|150269|P3|Overall Study|Miscellaneous|0
33790|NCT01565707|150270|P2|Overall Study|Miscellaneous|1
33791|NCT01565707|150271|P1|Overall Study|Miscellaneous|1
33792|NCT01565707|150268|P4|Overall Study|Randomized but not evaluable|0
33793|NCT01565707|150269|P3|Overall Study|Randomized but not evaluable|0
33794|NCT01565707|150270|P2|Overall Study|Randomized but not evaluable|0
33795|NCT01565707|150271|P1|Overall Study|Randomized but not evaluable|2
33796|NCT01565707|150268|P4|Overall Study|Withdrawal by Subject|1
33797|NCT01565707|150269|P3|Overall Study|Withdrawal by Subject|1
33798|NCT01565707|150270|P2|Overall Study|Withdrawal by Subject|1
33799|NCT01565707|150271|P1|Overall Study|Withdrawal by Subject|3
33800|NCT01565707|150268|P4|Overall Study|Protocol Violation|1
33801|NCT01565707|150269|P3|Overall Study|Protocol Violation|0
33802|NCT01565707|150270|P2|Overall Study|Protocol Violation|0
33803|NCT01565707|150271|P1|Overall Study|Protocol Violation|1
33804|NCT01565707|150268|P4|Overall Study|Lost to Follow-up|0
33805|NCT01565707|150269|P3|Overall Study|Lost to Follow-up|0
33806|NCT01565707|150270|P2|Overall Study|Lost to Follow-up|0
33807|NCT01565707|150271|P1|Overall Study|Lost to Follow-up|1
33808|NCT01565707|150268|P4|Overall Study|Adverse Event|1
33809|NCT01565707|150269|P3|Overall Study|Adverse Event|2
33810|NCT01565707|150270|P2|Overall Study|Adverse Event|6
33811|NCT01565707|150271|P1|Overall Study|Adverse Event|1
33812|NCT01565564|150364|P2|Overall Study|Lost to Follow-up|1
33813|NCT01565564|150365|P1|Overall Study|Lost to Follow-up|5
33814|NCT01565343|150440|P3|Overall Study|Administrative decision/technical issues|0
33815|NCT01565343|150441|P2|Overall Study|Administrative decision/technical issues|0
33816|NCT01565343|150442|P1|Overall Study|Administrative decision/technical issues|1
33817|NCT01565291|150472|P2|Overall Study|Withdrawal by Subject|0
33818|NCT01565291|150473|P1|Overall Study|Withdrawal by Subject|1
33819|NCT01565148|150485|P4|Overall Study|Physician Decision|0
33820|NCT01565148|150486|P3|Overall Study|Physician Decision|0
33821|NCT01565148|150487|P2|Overall Study|Physician Decision|5
33822|NCT01565148|150488|P1|Overall Study|Physician Decision|2
33823|NCT01565148|150485|P4|Overall Study|Death|0
33824|NCT01565148|150486|P3|Overall Study|Death|1
33825|NCT01565148|150487|P2|Overall Study|Death|0
33826|NCT01565148|150488|P1|Overall Study|Death|0
33827|NCT01565148|150485|P4|Overall Study|Rescue Therapy|8
33828|NCT01565148|150486|P3|Overall Study|Rescue Therapy|5
33829|NCT01565148|150487|P2|Overall Study|Rescue Therapy|5
33830|NCT01565148|150488|P1|Overall Study|Rescue Therapy|8
33831|NCT01565148|150485|P4|Overall Study|Lost to Follow-up|3
33832|NCT01565148|150486|P3|Overall Study|Lost to Follow-up|0
33833|NCT01565148|150487|P2|Overall Study|Lost to Follow-up|4
33834|NCT01565148|150488|P1|Overall Study|Lost to Follow-up|4
33835|NCT01565148|150485|P4|Overall Study|Withdrawal by Subject|2
33836|NCT01565148|150486|P3|Overall Study|Withdrawal by Subject|1
33837|NCT01565148|150487|P2|Overall Study|Withdrawal by Subject|1
33838|NCT01565148|150488|P1|Overall Study|Withdrawal by Subject|1
33839|NCT01565083|150524|P2|Overall Study|Unspecified|5
33840|NCT01565083|150525|P1|Overall Study|Unspecified|3
33841|NCT01565083|150524|P2|Overall Study|Death|23
33842|NCT01565083|150525|P1|Overall Study|Death|22
33843|NCT01565083|150524|P2|Overall Study|Lost to Follow-up|7
33844|NCT01565083|150525|P1|Overall Study|Lost to Follow-up|2
33845|NCT01565083|150524|P2|Overall Study|Withdrawal by Subject|4
33846|NCT01565083|150525|P1|Overall Study|Withdrawal by Subject|6
33847|NCT01564862|150562|P3|Overall Study|Other reason(s)|0
33848|NCT01564862|150563|P2|Overall Study|Other reason(s)|0
33849|NCT01564862|150564|P1|Overall Study|Other reason(s)|1
33850|NCT01564862|150562|P3|Overall Study|Lack of Efficacy|6
33851|NCT01564862|150563|P2|Overall Study|Lack of Efficacy|5
33852|NCT01564862|150564|P1|Overall Study|Lack of Efficacy|1
33853|NCT01564862|150562|P3|Overall Study|Voluntary Withdrawal|8
33854|NCT01564862|150563|P2|Overall Study|Voluntary Withdrawal|6
33855|NCT01564862|150564|P1|Overall Study|Voluntary Withdrawal|9
33856|NCT01564862|150562|P3|Overall Study|Lost to Follow-up|6
33857|NCT01564862|150563|P2|Overall Study|Lost to Follow-up|8
33858|NCT01564862|150564|P1|Overall Study|Lost to Follow-up|10
33859|NCT01564862|150562|P3|Overall Study|Major Protocol Deviation|4
33860|NCT01564862|150563|P2|Overall Study|Major Protocol Deviation|3
33861|NCT01564862|150564|P1|Overall Study|Major Protocol Deviation|3
33862|NCT01564862|150562|P3|Overall Study|Pretreatment Event or Adverse Event|6
33863|NCT01564862|150563|P2|Overall Study|Pretreatment Event or Adverse Event|12
33864|NCT01564862|150564|P1|Overall Study|Pretreatment Event or Adverse Event|6
33865|NCT01564758|150613|P1|Overall Study|Unspecified|3
33866|NCT01564758|150613|P1|Overall Study|Adverse Event|3
33867|NCT01564758|150613|P1|Overall Study|Death|8
33868|NCT01564732|150620|P2|Overall Study|Early termination by the study sponsor|5
33869|NCT01564732|150621|P1|Overall Study|Early termination by the study sponsor|6
33870|NCT01564537|150656|P2|Overall Study|Other Miscellaneous Reasons|2
33871|NCT01564537|150657|P1|Overall Study|Other Miscellaneous Reasons|1
33872|NCT01564537|150656|P2|Overall Study|Lost to Follow-up|0
33873|NCT01564537|150657|P1|Overall Study|Lost to Follow-up|1
33874|NCT01564537|150656|P2|Overall Study|Withdrawal by Participant|4
33875|NCT01564537|150657|P1|Overall Study|Withdrawal by Participant|4
33876|NCT01564459|150680|P3|Double-blind Treatment|Adverse Event|1
33877|NCT01564459|150681|P2|Double-blind Treatment|Adverse Event|0
33878|NCT01564459|150682|P1|Double-blind Treatment|Adverse Event|0
33879|NCT01564459|150680|P3|Run-In|Withdrawal by Subject|0
33880|NCT01564459|150681|P2|Run-In|Withdrawal by Subject|0
33881|NCT01564459|150682|P1|Run-In|Withdrawal by Subject|1
33882|NCT01564459|150680|P3|Run-In|Protocol Violation|0
33883|NCT01564459|150681|P2|Run-In|Protocol Violation|0
33884|NCT01564459|150682|P1|Run-In|Protocol Violation|1
33885|NCT01564459|150680|P3|Run-In|Non-compliance with study drug|0
33886|NCT01564459|150681|P2|Run-In|Non-compliance with study drug|0
33887|NCT01564459|150682|P1|Run-In|Non-compliance with study drug|2
33888|NCT01564459|150680|P3|Run-In|Lost to Follow-up|0
33889|NCT01564459|150681|P2|Run-In|Lost to Follow-up|0
33890|NCT01564459|150682|P1|Run-In|Lost to Follow-up|1
33891|NCT01564459|150680|P3|Run-In|Adverse Event|0
33892|NCT01564459|150681|P2|Run-In|Adverse Event|0
33893|NCT01564459|150682|P1|Run-In|Adverse Event|7
33894|NCT01564407|150706|P5|Overall Study|funding lost, study ended|0
33895|NCT01564407|150707|P4|Overall Study|funding lost, study ended|1
33896|NCT01564407|150708|P3|Overall Study|funding lost, study ended|0
33897|NCT01564407|150709|P2|Overall Study|funding lost, study ended|0
33898|NCT01564407|150710|P1|Overall Study|funding lost, study ended|0
33899|NCT01564407|150706|P5|Overall Study|Withdrawal by Subject|0
33900|NCT01564407|150707|P4|Overall Study|Withdrawal by Subject|0
33901|NCT01564407|150708|P3|Overall Study|Withdrawal by Subject|0
33902|NCT01564407|150709|P2|Overall Study|Withdrawal by Subject|1
33903|NCT01564407|150710|P1|Overall Study|Withdrawal by Subject|0
33904|NCT01564407|150706|P5|Overall Study|Lost to Follow-up|0
33905|NCT01564407|150707|P4|Overall Study|Lost to Follow-up|0
33906|NCT01564407|150708|P3|Overall Study|Lost to Follow-up|0
33907|NCT01564407|150709|P2|Overall Study|Lost to Follow-up|1
33908|NCT01564407|150710|P1|Overall Study|Lost to Follow-up|0
33909|NCT01564394|150751|P2|Overall Study|Withdrawal by Subject|10
33910|NCT01564394|150752|P1|Overall Study|Withdrawal by Subject|6
33911|NCT01563978|150766|P2|Overall Study|Adverse Event|2
33912|NCT01563978|150767|P1|Overall Study|Adverse Event|1
33913|NCT01563978|150766|P2|Overall Study|Dev. of study specific discont. criteria|0
33914|NCT01563978|150767|P1|Overall Study|Dev. of study specific discont. criteria|1
33915|NCT01563978|150766|P2|Overall Study|Lost to Follow-up|0
33916|NCT01563978|150767|P1|Overall Study|Lost to Follow-up|1
33917|NCT01563978|150766|P2|Overall Study|Physician Decision|0
33918|NCT01563978|150767|P1|Overall Study|Physician Decision|1
33919|NCT01563536|150793|P2|Overall Study|Lost to Follow-up|0
33920|NCT01563536|150794|P1|Overall Study|Lost to Follow-up|1
33921|NCT01563536|150793|P2|Overall Study|Withdrawal by Subject|2
33922|NCT01563536|150794|P1|Overall Study|Withdrawal by Subject|0
33923|NCT01563185|150828|P1|Overall Study|Non-Compliance with study drug|1
33924|NCT01563185|150828|P1|Overall Study|Withdrawal by Subject|1
33925|NCT01563172|150842|P1|Overall Study|Other (Not specified)|1
33926|NCT01563172|150842|P1|Overall Study|Other (Protocol deviation)|5
33927|NCT01563172|150842|P1|Overall Study|Lost to Follow-up|2
33928|NCT01563172|150842|P1|Overall Study|Adverse Event|5
33929|NCT01563029|150948|P5|Overall Study|Withdrawal by Subject|3
33930|NCT01563029|150949|P4|Overall Study|Withdrawal by Subject|4
33931|NCT01563029|150950|P3|Overall Study|Withdrawal by Subject|3
33932|NCT01563029|150951|P2|Overall Study|Withdrawal by Subject|1
33933|NCT01563029|150952|P1|Overall Study|Withdrawal by Subject|4
33934|NCT01563029|150948|P5|Overall Study|Physician Decision|2
33935|NCT01563029|150949|P4|Overall Study|Physician Decision|4
33936|NCT01563029|150950|P3|Overall Study|Physician Decision|2
33937|NCT01563029|150951|P2|Overall Study|Physician Decision|5
33938|NCT01563029|150952|P1|Overall Study|Physician Decision|3
33939|NCT01563029|150948|P5|Overall Study|Lost to Follow-up|1
33940|NCT01563029|150949|P4|Overall Study|Lost to Follow-up|1
33941|NCT01563029|150950|P3|Overall Study|Lost to Follow-up|1
33942|NCT01563029|150951|P2|Overall Study|Lost to Follow-up|0
33943|NCT01563029|150952|P1|Overall Study|Lost to Follow-up|1
33944|NCT01563029|150948|P5|Overall Study|Protocol defined stopping criteria|0
33945|NCT01563029|150949|P4|Overall Study|Protocol defined stopping criteria|0
33946|NCT01563029|150950|P3|Overall Study|Protocol defined stopping criteria|0
33947|NCT01563029|150951|P2|Overall Study|Protocol defined stopping criteria|0
33948|NCT01563029|150952|P1|Overall Study|Protocol defined stopping criteria|1
33949|NCT01563029|150948|P5|Overall Study|Protocol Violation|3
33950|NCT01563029|150949|P4|Overall Study|Protocol Violation|1
33951|NCT01563029|150950|P3|Overall Study|Protocol Violation|3
33952|NCT01563029|150951|P2|Overall Study|Protocol Violation|2
33953|NCT01563029|150952|P1|Overall Study|Protocol Violation|1
33954|NCT01563029|150948|P5|Overall Study|Lack of Efficacy|19
33955|NCT01563029|150949|P4|Overall Study|Lack of Efficacy|21
33956|NCT01563029|150950|P3|Overall Study|Lack of Efficacy|23
33957|NCT01563029|150951|P2|Overall Study|Lack of Efficacy|16
33958|NCT01563029|150952|P1|Overall Study|Lack of Efficacy|42
33959|NCT01563029|150948|P5|Overall Study|Adverse Event|1
33960|NCT01563029|150949|P4|Overall Study|Adverse Event|2
33961|NCT01563029|150950|P3|Overall Study|Adverse Event|1
33962|NCT01563029|150951|P2|Overall Study|Adverse Event|0
33963|NCT01563029|150952|P1|Overall Study|Adverse Event|1
33964|NCT01562873|151018|P2|Overall Study|Clinical PD and adverse event|0
33965|NCT01562873|151019|P1|Overall Study|Clinical PD and adverse event|1
33966|NCT01562873|151018|P2|Overall Study|Clinical Disease Progression|0
33967|NCT01562873|151019|P1|Overall Study|Clinical Disease Progression|9
33968|NCT01562873|151018|P2|Overall Study|Adverse Event|0
33969|NCT01562873|151019|P1|Overall Study|Adverse Event|1
33970|NCT01562873|151018|P2|Overall Study|Disease Progression per RECIST|0
33971|NCT01562873|151019|P1|Overall Study|Disease Progression per RECIST|10
33972|NCT01562743|151031|P1|Overall Study|Physician Decision|2
33973|NCT01562743|151031|P1|Overall Study|Lost to Follow-up|2
33974|NCT01562743|151031|P1|Overall Study|Discontinuation criteria|2
33975|NCT01562743|151031|P1|Overall Study|Protocol Violation|1
33976|NCT01562743|151031|P1|Overall Study|Withdrawal by Subject|13
33977|NCT01562743|151031|P1|Overall Study|Lack of Efficacy|3
33978|NCT01562743|151031|P1|Overall Study|Adverse Event|29
33979|NCT01562613|151050|P1|Overall Study|Withdrawal by Subject|2
33980|NCT01562613|151050|P1|Overall Study|Lost to Follow-up|2
33981|NCT01562548|151060|P4|Overall Study|Lost to Follow-up|0
33982|NCT01562548|151061|P3|Overall Study|Lost to Follow-up|1
33983|NCT01562548|151062|P2|Overall Study|Lost to Follow-up|0
33984|NCT01562548|151063|P1|Overall Study|Lost to Follow-up|0
33985|NCT01562327|151113|P1|Overall Study|Infusion not received at 6 month window|4
33986|NCT01562327|151113|P1|Overall Study|Participant drop-out|1
33987|NCT01562327|151113|P1|Overall Study|Lack of Efficacy|1
33988|NCT01562327|151113|P1|Overall Study|Adverse Event|2
33989|NCT01562314|151143|P2|Overall Study|Withdrawal by Subject|1
33990|NCT01562314|151144|P1|Overall Study|Withdrawal by Subject|0
33991|NCT01562314|151143|P2|Overall Study|Met Withdrawal Criteria|2
33992|NCT01562314|151144|P1|Overall Study|Met Withdrawal Criteria|3
33993|NCT01562314|151143|P2|Overall Study|Adverse Event|5
33994|NCT01562314|151144|P1|Overall Study|Adverse Event|10
33995|NCT01562275|151231|P13|Stage 2|Progression of Disease|4
33996|NCT01562275|151232|P12|Stage 2|Progression of Disease|12
33997|NCT01562275|151233|P11|Stage 2|Progression of Disease|0
33998|NCT01562275|151234|P10|Stage 2|Progression of Disease|0
33999|NCT01562275|151235|P9|Stage 2|Progression of Disease|0
34000|NCT01562275|151236|P8|Stage 2|Progression of Disease|0
34001|NCT01562275|151237|P7|Stage 2|Progression of Disease|0
34002|NCT01562275|151238|P6|Stage 2|Progression of Disease|0
34003|NCT01562275|151239|P5|Stage 2|Progression of Disease|0
34004|NCT01562275|151240|P4|Stage 2|Progression of Disease|0
34005|NCT01562275|151241|P3|Stage 2|Progression of Disease|0
34006|NCT01562275|151242|P2|Stage 2|Progression of Disease|0
34007|NCT01562275|151243|P1|Stage 2|Progression of Disease|0
34008|NCT01562275|151231|P13|Stage 2|Death|1
34009|NCT01562275|151232|P12|Stage 2|Death|2
34010|NCT01562275|151233|P11|Stage 2|Death|0
34011|NCT01562275|151234|P10|Stage 2|Death|0
34012|NCT01562275|151235|P9|Stage 2|Death|0
34013|NCT01562275|151236|P8|Stage 2|Death|0
34014|NCT01562275|151237|P7|Stage 2|Death|0
34015|NCT01562275|151238|P6|Stage 2|Death|0
34016|NCT01562275|151239|P5|Stage 2|Death|0
34017|NCT01562275|151240|P4|Stage 2|Death|0
34018|NCT01562275|151241|P3|Stage 2|Death|0
34019|NCT01562275|151242|P2|Stage 2|Death|0
34020|NCT01562275|151243|P1|Stage 2|Death|0
34021|NCT01562275|151231|P13|Stage 1|Withdrawal by Subject|0
34022|NCT01562275|151232|P12|Stage 1|Withdrawal by Subject|0
34023|NCT01562275|151233|P11|Stage 1|Withdrawal by Subject|0
34024|NCT01562275|151234|P10|Stage 1|Withdrawal by Subject|1
34025|NCT01562275|151235|P9|Stage 1|Withdrawal by Subject|0
34026|NCT01562275|151236|P8|Stage 1|Withdrawal by Subject|0
34027|NCT01562275|151237|P7|Stage 1|Withdrawal by Subject|1
34028|NCT01562275|151238|P6|Stage 1|Withdrawal by Subject|0
34029|NCT01562275|151239|P5|Stage 1|Withdrawal by Subject|0
34030|NCT01562275|151240|P4|Stage 1|Withdrawal by Subject|2
34031|NCT01562275|151241|P3|Stage 1|Withdrawal by Subject|0
34032|NCT01562275|151242|P2|Stage 1|Withdrawal by Subject|1
34033|NCT01562275|151243|P1|Stage 1|Withdrawal by Subject|0
34034|NCT01562275|151231|P13|Stage 1|Progression of Disease|0
34035|NCT01562275|151232|P12|Stage 1|Progression of Disease|0
34036|NCT01562275|151233|P11|Stage 1|Progression of Disease|3
34037|NCT01562275|151234|P10|Stage 1|Progression of Disease|5
34038|NCT01562275|151235|P9|Stage 1|Progression of Disease|2
34039|NCT01562275|151236|P8|Stage 1|Progression of Disease|7
34040|NCT01562275|151237|P7|Stage 1|Progression of Disease|1
34041|NCT01562275|151238|P6|Stage 1|Progression of Disease|4
34042|NCT01562275|151239|P5|Stage 1|Progression of Disease|2
34043|NCT01562275|151240|P4|Stage 1|Progression of Disease|1
34044|NCT01562275|151241|P3|Stage 1|Progression of Disease|2
34045|NCT01562275|151242|P2|Stage 1|Progression of Disease|6
34046|NCT01562275|151243|P1|Stage 1|Progression of Disease|2
34047|NCT01562275|151231|P13|Stage 1|Physician Decision|0
34048|NCT01562275|151232|P12|Stage 1|Physician Decision|0
34049|NCT01562275|151233|P11|Stage 1|Physician Decision|0
34050|NCT01562275|151234|P10|Stage 1|Physician Decision|0
34051|NCT01562275|151235|P9|Stage 1|Physician Decision|1
34052|NCT01562275|151236|P8|Stage 1|Physician Decision|0
34053|NCT01562275|151237|P7|Stage 1|Physician Decision|1
34054|NCT01562275|151238|P6|Stage 1|Physician Decision|0
34055|NCT01562275|151239|P5|Stage 1|Physician Decision|1
34056|NCT01562275|151240|P4|Stage 1|Physician Decision|0
34057|NCT01562275|151241|P3|Stage 1|Physician Decision|0
34058|NCT01562275|151242|P2|Stage 1|Physician Decision|0
34059|NCT01562275|151243|P1|Stage 1|Physician Decision|0
34060|NCT01562275|151231|P13|Stage 1|Non Compliance|0
34061|NCT01562275|151232|P12|Stage 1|Non Compliance|0
34062|NCT01562275|151233|P11|Stage 1|Non Compliance|0
34063|NCT01562275|151234|P10|Stage 1|Non Compliance|0
34064|NCT01562275|151235|P9|Stage 1|Non Compliance|0
34065|NCT01562275|151236|P8|Stage 1|Non Compliance|0
34066|NCT01562275|151237|P7|Stage 1|Non Compliance|0
34067|NCT01562275|151238|P6|Stage 1|Non Compliance|0
34068|NCT01562275|151239|P5|Stage 1|Non Compliance|0
34069|NCT01562275|151240|P4|Stage 1|Non Compliance|0
34070|NCT01562275|151241|P3|Stage 1|Non Compliance|1
34071|NCT01562275|151242|P2|Stage 1|Non Compliance|0
34072|NCT01562275|151243|P1|Stage 1|Non Compliance|0
34073|NCT01562275|151231|P13|Stage 1|Death|0
34074|NCT01562275|151232|P12|Stage 1|Death|0
34075|NCT01562275|151233|P11|Stage 1|Death|0
34076|NCT01562275|151234|P10|Stage 1|Death|0
34077|NCT01562275|151235|P9|Stage 1|Death|0
34078|NCT01562275|151236|P8|Stage 1|Death|0
34079|NCT01562275|151237|P7|Stage 1|Death|0
34080|NCT01562275|151238|P6|Stage 1|Death|0
34081|NCT01562275|151239|P5|Stage 1|Death|0
34082|NCT01562275|151240|P4|Stage 1|Death|0
34083|NCT01562275|151241|P3|Stage 1|Death|0
34084|NCT01562275|151242|P2|Stage 1|Death|0
34085|NCT01562275|151243|P1|Stage 1|Death|1
34086|NCT01562275|151231|P13|Stage 1|Adverse Event|0
34087|NCT01562275|151232|P12|Stage 1|Adverse Event|0
34088|NCT01562275|151233|P11|Stage 1|Adverse Event|0
34089|NCT01562275|151234|P10|Stage 1|Adverse Event|1
34090|NCT01562275|151235|P9|Stage 1|Adverse Event|0
34091|NCT01562275|151236|P8|Stage 1|Adverse Event|0
34092|NCT01562275|151237|P7|Stage 1|Adverse Event|0
34093|NCT01562275|151238|P6|Stage 1|Adverse Event|0
34094|NCT01562275|151239|P5|Stage 1|Adverse Event|1
34095|NCT01562275|151240|P4|Stage 1|Adverse Event|1
34096|NCT01562275|151241|P3|Stage 1|Adverse Event|0
34097|NCT01562275|151242|P2|Stage 1|Adverse Event|0
34098|NCT01562275|151243|P1|Stage 1|Adverse Event|0
34099|NCT01561898|151386|P4|Overall Study|Physician Decision|1
34100|NCT01561898|151387|P3|Overall Study|Physician Decision|7
34101|NCT01561898|151388|P2|Overall Study|Physician Decision|5
34102|NCT01561898|151389|P1|Overall Study|Physician Decision|1
34103|NCT01561898|151386|P4|Overall Study|Adverse Event|9
34104|NCT01561898|151387|P3|Overall Study|Adverse Event|14
34105|NCT01561898|151388|P2|Overall Study|Adverse Event|19
34106|NCT01561898|151389|P1|Overall Study|Adverse Event|1
34107|NCT01561898|151386|P4|Overall Study|Lost to Follow-up|0
34108|NCT01561898|151387|P3|Overall Study|Lost to Follow-up|1
34109|NCT01561898|151388|P2|Overall Study|Lost to Follow-up|0
34110|NCT01561898|151389|P1|Overall Study|Lost to Follow-up|0
34111|NCT01561898|151386|P4|Overall Study|Worsening of complications|0
34112|NCT01561898|151387|P3|Overall Study|Worsening of complications|0
34113|NCT01561898|151388|P2|Overall Study|Worsening of complications|1
34114|NCT01561898|151389|P1|Overall Study|Worsening of complications|0
34115|NCT01561898|151386|P4|Overall Study|Lack of Efficacy|5
34116|NCT01561898|151387|P3|Overall Study|Lack of Efficacy|10
34117|NCT01561898|151388|P2|Overall Study|Lack of Efficacy|8
34118|NCT01561898|151389|P1|Overall Study|Lack of Efficacy|0
34119|NCT01561898|151386|P4|Overall Study|Withdrawal by Subject|5
34120|NCT01561898|151387|P3|Overall Study|Withdrawal by Subject|12
34121|NCT01561898|151388|P2|Overall Study|Withdrawal by Subject|8
34122|NCT01561898|151389|P1|Overall Study|Withdrawal by Subject|0
34123|NCT01561560|151435|P2|Second Two Weeks of Wear|Adverse Event|1
34124|NCT01561560|151436|P1|Second Two Weeks of Wear|Adverse Event|0
34125|NCT01561560|151435|P2|First Two Weeks of Wear|Adverse Event|1
34126|NCT01561560|151436|P1|First Two Weeks of Wear|Adverse Event|0
34127|NCT01561560|151435|P2|First Two Weeks of Wear|Time/job conflict|1
34128|NCT01561560|151436|P1|First Two Weeks of Wear|Time/job conflict|0
34129|NCT01561313|151465|P2|Overall Study|Adverse event and withdrawal by subject|0
34130|NCT01561313|151466|P1|Overall Study|Adverse event and withdrawal by subject|1
34131|NCT01561313|151465|P2|Overall Study|Withdrawal by Subject|0
34132|NCT01561313|151466|P1|Overall Study|Withdrawal by Subject|1
34133|NCT01561300|151484|P2|Run in on Placebo|Adverse Event|0
34134|NCT01561300|151485|P1|Run in on Placebo|Adverse Event|1
34135|NCT01561079|151496|P1|Overall Study|Protocol Violation|2
34136|NCT01561079|151496|P1|Overall Study|Withdrawal by Subject|59
34137|NCT01561079|151496|P1|Overall Study|Physician Decision|17
34138|NCT01560988|151539|P2|Washout (Six Weeks)|Lost to Follow-up|2
34139|NCT01560988|151540|P1|Washout (Six Weeks)|Lost to Follow-up|2
34140|NCT01560988|151539|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
34141|NCT01560988|151540|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
34142|NCT01560988|151539|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
34143|NCT01560988|151540|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
34144|NCT01560819|151573|P2|Overall Study|Physician Decision|0
34145|NCT01560819|151574|P1|Overall Study|Physician Decision|1
34146|NCT01560507|151581|P3|Overall Study|Withdrawal by Subject|0
34147|NCT01560507|151582|P2|Overall Study|Withdrawal by Subject|1
34148|NCT01560507|151583|P1|Overall Study|Withdrawal by Subject|1
34149|NCT01560507|151581|P3|Overall Study|Lost to Follow-up|2
34150|NCT01560507|151582|P2|Overall Study|Lost to Follow-up|1
34151|NCT01560507|151583|P1|Overall Study|Lost to Follow-up|3
34152|NCT01560429|151596|P2|Overall Study|Protocol Violation|6
34153|NCT01560429|151597|P1|Overall Study|Protocol Violation|3
34154|NCT01560403|151607|P2|Overall Study|Lost to Follow-up|1
34155|NCT01560403|151608|P1|Overall Study|Lost to Follow-up|0
34156|NCT01560234|151626|P8|Overall Study|Lost to Follow-up|2
34157|NCT01560234|151627|P7|Overall Study|Lost to Follow-up|0
34158|NCT01560234|151628|P6|Overall Study|Lost to Follow-up|2
34159|NCT01560234|151629|P5|Overall Study|Lost to Follow-up|0
34160|NCT01560234|151630|P4|Overall Study|Lost to Follow-up|0
34161|NCT01560234|151631|P3|Overall Study|Lost to Follow-up|1
34162|NCT01560234|151632|P2|Overall Study|Lost to Follow-up|0
34163|NCT01560234|151633|P1|Overall Study|Lost to Follow-up|3
34164|NCT01559935|151711|P1|Maintenance Phase|Non-compliance|2
34165|NCT01559935|151711|P1|Maintenance Phase|Withdrawal by Subject|5
34166|NCT01559935|151711|P1|Maintenance Phase|Lack of Efficacy|18
34167|NCT01559935|151711|P1|Maintenance Phase|Toxicity|1
34168|NCT01559935|151711|P1|Maintenance Phase|Remains on study|28
34169|NCT01559935|151711|P1|BiRD Phase|Withdrawal by Subject|2
34170|NCT01559935|151711|P1|BiRD Phase|Lack of Efficacy|1
34171|NCT01559935|151711|P1|BiRD Phase|Toxicity|1
34172|NCT01559935|151711|P1|Car Phase|non-compliance|1
34173|NCT01559935|151711|P1|Car Phase|Insurance|1
34174|NCT01559935|151711|P1|Car Phase|Per protocol|1
34175|NCT01559935|151711|P1|Car Phase|Withdrawal by Subject|2
34176|NCT01559935|151711|P1|Car Phase|Physician Decision|1
34177|NCT01559935|151711|P1|Car Phase|Lost to Follow-up|1
34178|NCT01559935|151711|P1|Car Phase|Lack of Efficacy|2
34179|NCT01559935|151711|P1|Car Phase|Death|1
34180|NCT01559935|151711|P1|Car Phase|Toxicity|4
34181|NCT01559844|151747|P1|Overall Study|No Longer A Transplant Candidate|3
34182|NCT01559844|151747|P1|Overall Study|Efficacy Failure|10
34183|NCT01559844|151747|P1|Overall Study|Death|5
34184|NCT01559844|151747|P1|Overall Study|Consent Withdrawn|7
34185|NCT01559675|151760|P2|Overall Study|2nd operation on same patient excluded|12
34186|NCT01559675|151761|P1|Overall Study|2nd operation on same patient excluded|14
34187|NCT01559675|151760|P2|Overall Study|Protocol Violation|2
34188|NCT01559675|151761|P1|Overall Study|Protocol Violation|1
34189|NCT01559454|151792|P2|Overall Study|Lack of Efficacy|1
34190|NCT01559454|151793|P1|Overall Study|Lack of Efficacy|0
34191|NCT01559454|151792|P2|Overall Study|Protocol Violation|1
34192|NCT01559454|151793|P1|Overall Study|Protocol Violation|0
34193|NCT01559454|151792|P2|Overall Study|Physician Decision|1
34194|NCT01559454|151793|P1|Overall Study|Physician Decision|0
34195|NCT01559454|151792|P2|Overall Study|Withdrawal by Subject|1
34196|NCT01559454|151793|P1|Overall Study|Withdrawal by Subject|0
34197|NCT01559454|151792|P2|Overall Study|Lost to Follow-up|2
34198|NCT01559454|151793|P1|Overall Study|Lost to Follow-up|3
34199|NCT01559311|151812|P3|Overall Study|Adverse Event|1
34200|NCT01559311|151813|P2|Overall Study|Adverse Event|0
34201|NCT01559311|151814|P1|Overall Study|Adverse Event|0
34202|NCT01559311|151812|P3|Overall Study|Lost to Follow-up|2
34203|NCT01559311|151813|P2|Overall Study|Lost to Follow-up|3
34204|NCT01559311|151814|P1|Overall Study|Lost to Follow-up|0
34205|NCT01559311|151812|P3|Overall Study|Death|3
34206|NCT01559311|151813|P2|Overall Study|Death|2
34207|NCT01559311|151814|P1|Overall Study|Death|0
34208|NCT01559311|151812|P3|Overall Study|Withdrawal by Subject|0
34209|NCT01559311|151813|P2|Overall Study|Withdrawal by Subject|1
34210|NCT01559311|151814|P1|Overall Study|Withdrawal by Subject|2
34211|NCT01559311|151812|P3|Overall Study|Difficulty in cannulating the lateral ve|0
34212|NCT01559311|151813|P2|Overall Study|Difficulty in cannulating the lateral ve|0
34213|NCT01559311|151814|P1|Overall Study|Difficulty in cannulating the lateral ve|1
34214|NCT01559311|151812|P3|Overall Study|Protocol Violation|2
34215|NCT01559311|151813|P2|Overall Study|Protocol Violation|0
34216|NCT01559311|151814|P1|Overall Study|Protocol Violation|0
34217|NCT01559116|151825|P1|Overall Study|other than stated above|9
34218|NCT01559116|151825|P1|Overall Study|Withdrawal by Subject|4
34219|NCT01559116|151825|P1|Overall Study|Protocol Violation|1
34220|NCT01559116|151825|P1|Overall Study|Lost to Follow-up|1
34221|NCT01559116|151825|P1|Overall Study|Lack of Efficacy|1
34222|NCT01559116|151825|P1|Overall Study|Adverse Event|10
34223|NCT01559012|151908|P2|Overall Study|Withdrawal by Subject|1
34224|NCT01559012|151909|P1|Overall Study|Withdrawal by Subject|0
34225|NCT01558739|151945|P1|Overall Study|Protocol Violation|1
34226|NCT01558739|151945|P1|Overall Study|Disease Progression|4
34227|NCT01558739|151945|P1|Overall Study|Death|3
34228|NCT01558739|151945|P1|Overall Study|Withdrawal by Subject|2
34229|NCT01558739|151945|P1|Overall Study|Adverse Event|7
34230|NCT01558674|151970|P2|Part 1|Withdrawal by Subject|0
34231|NCT01558674|151971|P1|Part 1|Withdrawal by Subject|1
34232|NCT01558674|151970|P2|Part 1|Study Terminated by Sponsor|0
34233|NCT01558674|151971|P1|Part 1|Study Terminated by Sponsor|10
34234|NCT01558596|152038|P2|Overall Study|Protocol Violation|0
34235|NCT01558596|152039|P1|Overall Study|Protocol Violation|1
34236|NCT01558596|152038|P2|Overall Study|surgery elsewhere or cancelled|1
34237|NCT01558596|152039|P1|Overall Study|surgery elsewhere or cancelled|1
34238|NCT01558596|152038|P2|Overall Study|Withdrawal by Subject|0
34239|NCT01558596|152039|P1|Overall Study|Withdrawal by Subject|1
34240|NCT01558297|152054|P3|Overall Study|Withdrawal by Subject|1
34241|NCT01558297|152055|P2|Overall Study|Withdrawal by Subject|2
34242|NCT01558297|152056|P1|Overall Study|Withdrawal by Subject|2
34243|NCT01558271|152073|P3|Overall Study|Physician Decision|1
34244|NCT01558271|152074|P2|Overall Study|Physician Decision|2
34245|NCT01558271|152075|P1|Overall Study|Physician Decision|0
34246|NCT01558271|152073|P3|Overall Study|Withdrawal by Subject|12
34247|NCT01558271|152074|P2|Overall Study|Withdrawal by Subject|6
34248|NCT01558271|152075|P1|Overall Study|Withdrawal by Subject|10
34249|NCT01558271|152073|P3|Overall Study|Protocol Violation|0
34250|NCT01558271|152074|P2|Overall Study|Protocol Violation|0
34251|NCT01558271|152075|P1|Overall Study|Protocol Violation|1
34252|NCT01558271|152073|P3|Overall Study|Lost to Follow-up|0
34253|NCT01558271|152074|P2|Overall Study|Lost to Follow-up|0
34254|NCT01558271|152075|P1|Overall Study|Lost to Follow-up|1
34255|NCT01558271|152073|P3|Overall Study|Adverse Event|4
34256|NCT01558271|152074|P2|Overall Study|Adverse Event|3
34257|NCT01558271|152075|P1|Overall Study|Adverse Event|6
34258|NCT01558089|152141|P1|Overall Study|Withdrawal by Subject|6
34259|NCT01558089|152141|P1|Overall Study|Lost to Follow-up|5
34260|NCT01558089|152141|P1|Overall Study|Lack of Efficacy|1
34261|NCT01558089|152141|P1|Overall Study|Adverse Event|1
34262|NCT01557920|152156|P2|Overall Study|Lack of Efficacy|0
34263|NCT01557920|152157|P1|Overall Study|Lack of Efficacy|1
34264|NCT01557920|152156|P2|Overall Study|Withdrawal by Subject|3
34265|NCT01557920|152157|P1|Overall Study|Withdrawal by Subject|2
34266|NCT01557842|152220|P2|Overall Study|Not Ablated|0
34267|NCT01557842|152221|P1|Overall Study|Not Ablated|2
34268|NCT01557842|152220|P2|Overall Study|Study Terminated by Sponsor|4
34269|NCT01557842|152221|P1|Overall Study|Study Terminated by Sponsor|3
34270|NCT01557842|152220|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
34271|NCT01557842|152221|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
34272|NCT01557842|152220|P2|Overall Study|Lack of Efficacy|1
34273|NCT01557842|152221|P1|Overall Study|Lack of Efficacy|0
34274|NCT01557842|152220|P2|Overall Study|Death|0
34275|NCT01557842|152221|P1|Overall Study|Death|1
34276|NCT01557842|152220|P2|Overall Study|Lost to Follow-up|1
34277|NCT01557842|152221|P1|Overall Study|Lost to Follow-up|0
34278|NCT01555463|152268|P2|Follow up|Other reason|3
34279|NCT01555463|152269|P1|Follow up|Other reason|3
34280|NCT01555463|152268|P2|Follow up|Protocol Violation|4
34281|NCT01555463|152269|P1|Follow up|Protocol Violation|2
34282|NCT01555463|152268|P2|Follow up|Lost to Follow-up|10
34283|NCT01555463|152269|P1|Follow up|Lost to Follow-up|9
34284|NCT01555463|152268|P2|Follow up|Withdrawal by Subject|22
34285|NCT01555463|152269|P1|Follow up|Withdrawal by Subject|22
34286|NCT01555463|152268|P2|Follow up|Death|1
34287|NCT01555463|152269|P1|Follow up|Death|0
34288|NCT01555463|152268|P2|Follow up|Adverse Event|5
34289|NCT01555463|152269|P1|Follow up|Adverse Event|2
34290|NCT01555463|152268|P2|Treatment|Other reason|3
34291|NCT01555463|152269|P1|Treatment|Other reason|2
34292|NCT01555463|152268|P2|Treatment|Protocol Violation|5
34293|NCT01555463|152269|P1|Treatment|Protocol Violation|4
34294|NCT01555463|152268|P2|Treatment|Lost to Follow-up|23
34295|NCT01555463|152269|P1|Treatment|Lost to Follow-up|28
34296|NCT01555463|152268|P2|Treatment|Withdrawal by Subject|36
34297|NCT01555463|152269|P1|Treatment|Withdrawal by Subject|24
34298|NCT01555463|152268|P2|Treatment|Adverse Event|12
34299|NCT01555463|152269|P1|Treatment|Adverse Event|6
34300|NCT01557582|152313|P1|Overall Study|Operator error|2
34301|NCT01557582|152313|P1|Overall Study|Protocol Violation|4
34302|NCT01557569|152321|P2|Overall Study|noncompliance with rules of residential|1
34303|NCT01557569|152322|P1|Overall Study|noncompliance with rules of residential|0
34304|NCT01557569|152321|P2|Overall Study|Withdrawal by Subject|5
34305|NCT01557569|152322|P1|Overall Study|Withdrawal by Subject|3
34306|NCT01557569|152321|P2|Overall Study|high blood pressure|1
34307|NCT01557569|152322|P1|Overall Study|high blood pressure|0
34308|NCT01557569|152321|P2|Overall Study|Adverse Event|0
34309|NCT01557569|152322|P1|Overall Study|Adverse Event|2
34310|NCT01557504|152330|P2|Overall Study|Physician Decision|0
34311|NCT01557504|152331|P1|Overall Study|Physician Decision|1
34312|NCT01557348|152356|P2|Overall Study|Administrative|11
34313|NCT01557348|152357|P1|Overall Study|Administrative|18
34314|NCT01557348|152356|P2|Overall Study|Lost to Follow-up|22
34315|NCT01557348|152357|P1|Overall Study|Lost to Follow-up|26
34316|NCT01557348|152356|P2|Overall Study|Withdrawal by Subject|4
34317|NCT01557348|152357|P1|Overall Study|Withdrawal by Subject|5
34318|NCT01557348|152356|P2|Overall Study|Insufficient Therapeutic Response|28
34319|NCT01557348|152357|P1|Overall Study|Insufficient Therapeutic Response|13
34320|NCT01557348|152356|P2|Overall Study|Death|4
34321|NCT01557348|152357|P1|Overall Study|Death|7
34322|NCT01557348|152356|P2|Overall Study|Infusion reaction event|5
34323|NCT01557348|152357|P1|Overall Study|Infusion reaction event|5
34324|NCT01557348|152356|P2|Overall Study|Adverse Event|16
34325|NCT01557348|152357|P1|Overall Study|Adverse Event|6
34326|NCT01557283|152474|P1|Overall Study|Unspecified|6
34327|NCT01557283|152474|P1|Overall Study|Worsening of psoriasis|1
34328|NCT01557283|152474|P1|Overall Study|Participant’s weight too high for dose|1
34329|NCT01557283|152474|P1|Overall Study|Withdrawal by Subject|1
34330|NCT01557283|152474|P1|Overall Study|Non-compliance|1
34331|NCT01557283|152474|P1|Overall Study|Lack of Efficacy|1
34332|NCT01557283|152474|P1|Overall Study|Adverse Event|7
34333|NCT01557283|152474|P1|Overall Study|Non-responder|19
34334|NCT01557283|152474|P1|Overall Study|Lost to Follow-up|7
34335|NCT01557166|152486|P2|Overall Study|Unclassified|5
34336|NCT01557166|152487|P1|Overall Study|Unclassified|2
34337|NCT01557166|152486|P2|Overall Study|Psychiatric disorder|0
34338|NCT01557166|152487|P1|Overall Study|Psychiatric disorder|1
34339|NCT01557166|152486|P2|Overall Study|Target dose not tolerated|0
34340|NCT01557166|152487|P1|Overall Study|Target dose not tolerated|1
34341|NCT01557166|152486|P2|Overall Study|Withdrawn consent|20
34342|NCT01557166|152487|P1|Overall Study|Withdrawn consent|12
34343|NCT01557166|152486|P2|Overall Study|Protocol Violation|5
34344|NCT01557166|152487|P1|Overall Study|Protocol Violation|8
34345|NCT01557166|152486|P2|Overall Study|Lack of Efficacy|1
34346|NCT01557166|152487|P1|Overall Study|Lack of Efficacy|2
34347|NCT01557166|152486|P2|Overall Study|Adverse Event|6
34348|NCT01557166|152487|P1|Overall Study|Adverse Event|20
34349|NCT01556997|152502|P3|Overall Study|Not specified|7
34350|NCT01556997|152503|P2|Overall Study|Not specified|3
34351|NCT01556997|152504|P1|Overall Study|Not specified|2
34352|NCT01556997|152502|P3|Overall Study|Withdrawal by Subject|8
34353|NCT01556997|152503|P2|Overall Study|Withdrawal by Subject|6
34354|NCT01556997|152504|P1|Overall Study|Withdrawal by Subject|7
34355|NCT01556997|152502|P3|Overall Study|Physician Decision|1
34356|NCT01556997|152503|P2|Overall Study|Physician Decision|1
34357|NCT01556997|152504|P1|Overall Study|Physician Decision|1
34358|NCT01556997|152502|P3|Overall Study|Lost to Follow-up|4
34359|NCT01556997|152503|P2|Overall Study|Lost to Follow-up|6
34360|NCT01556997|152504|P1|Overall Study|Lost to Follow-up|6
34361|NCT01556997|152502|P3|Overall Study|Adverse Event|12
34362|NCT01556997|152503|P2|Overall Study|Adverse Event|12
34363|NCT01556997|152504|P1|Overall Study|Adverse Event|10
34364|NCT01556932|152515|P2|Time Point 60 Minutes|Withdrawal by Subject|1
34365|NCT01556932|152516|P1|Time Point 60 Minutes|Withdrawal by Subject|1
34366|NCT01556763|152542|P3|Overall Study|Withdrawal by Subject|0
34367|NCT01556763|152543|P2|Overall Study|Withdrawal by Subject|1
34368|NCT01556763|152544|P1|Overall Study|Withdrawal by Subject|0
34369|NCT01556165|152657|P2|Overall Study|Withdrawal of Consent|1
34370|NCT01556165|152658|P1|Overall Study|Withdrawal of Consent|7
34371|NCT01556165|152657|P2|Overall Study|Protocol Violation|3
34372|NCT01556165|152658|P1|Overall Study|Protocol Violation|0
34373|NCT01556165|152657|P2|Overall Study|Adverse Event|3
34374|NCT01556165|152658|P1|Overall Study|Adverse Event|5
34375|NCT01555983|152683|P6|Overall Study|Withdrawal by Subject|1
34376|NCT01555983|152684|P5|Overall Study|Withdrawal by Subject|1
34377|NCT01555983|152685|P4|Overall Study|Withdrawal by Subject|0
34378|NCT01555983|152686|P3|Overall Study|Withdrawal by Subject|0
34379|NCT01555983|152687|P2|Overall Study|Withdrawal by Subject|0
34380|NCT01555983|152688|P1|Overall Study|Withdrawal by Subject|1
34381|NCT01555931|152698|P2|Overall Study|Lost to Follow-up|5
34382|NCT01555931|152699|P1|Overall Study|Lost to Follow-up|2
34383|NCT01555164|152709|P2|Overall Study|Subject Withdrew Consent|11
34384|NCT01555164|152710|P1|Overall Study|Subject Withdrew Consent|6
34385|NCT01555164|152709|P2|Overall Study|Subject Non-compliance|6
34386|NCT01555164|152710|P1|Overall Study|Subject Non-compliance|14
34387|NCT01555164|152709|P2|Overall Study|Protocol Violation|5
34388|NCT01555164|152710|P1|Overall Study|Protocol Violation|9
34389|NCT01555164|152709|P2|Overall Study|Lost to Follow-up|3
34390|NCT01555164|152710|P1|Overall Study|Lost to Follow-up|4
34391|NCT01555164|152709|P2|Overall Study|Investigator's Discretion|2
34392|NCT01555164|152710|P1|Overall Study|Investigator's Discretion|2
34393|NCT01555164|152709|P2|Overall Study|Hyperglycemia|1
34394|NCT01555164|152710|P1|Overall Study|Hyperglycemia|0
34395|NCT01555164|152709|P2|Overall Study|Adverse Event|7
34396|NCT01555164|152710|P1|Overall Study|Adverse Event|5
34397|NCT01555151|152724|P4|Overall Study|Lost to Follow-up|1
34398|NCT01555151|152725|P3|Overall Study|Lost to Follow-up|0
34399|NCT01555151|152726|P2|Overall Study|Lost to Follow-up|0
34400|NCT01555151|152727|P1|Overall Study|Lost to Follow-up|0
34401|NCT01555151|152724|P4|Overall Study|Adverse Event|2
34402|NCT01555151|152725|P3|Overall Study|Adverse Event|1
34403|NCT01555151|152726|P2|Overall Study|Adverse Event|2
34404|NCT01555151|152727|P1|Overall Study|Adverse Event|1
34405|NCT01555151|152724|P4|Overall Study|Protocol Violation|5
34406|NCT01555151|152725|P3|Overall Study|Protocol Violation|3
34407|NCT01555151|152726|P2|Overall Study|Protocol Violation|3
34408|NCT01555151|152727|P1|Overall Study|Protocol Violation|3
34409|NCT01555151|152724|P4|Overall Study|Administrative|0
34410|NCT01555151|152725|P3|Overall Study|Administrative|2
34411|NCT01555151|152726|P2|Overall Study|Administrative|1
34412|NCT01555151|152727|P1|Overall Study|Administrative|3
34413|NCT01555151|152724|P4|Overall Study|Withdrawal by Subject|2
34414|NCT01555151|152725|P3|Overall Study|Withdrawal by Subject|0
34415|NCT01555151|152726|P2|Overall Study|Withdrawal by Subject|2
34416|NCT01555151|152727|P1|Overall Study|Withdrawal by Subject|6
34417|NCT01555138|152780|P2|Overall Study|Adverse Event|14
34418|NCT01555138|152781|P1|Overall Study|Adverse Event|14
34419|NCT01555138|152780|P2|Overall Study|Withdrawal by Subject|15
34420|NCT01555138|152781|P1|Overall Study|Withdrawal by Subject|16
34421|NCT01555138|152780|P2|Overall Study|Administrative problems|0
34422|NCT01555138|152781|P1|Overall Study|Administrative problems|8
34423|NCT01555138|152780|P2|Overall Study|Protocol Violation|3
34424|NCT01555138|152781|P1|Overall Study|Protocol Violation|5
34425|NCT01555138|152780|P2|Overall Study|Lack of Efficacy|2
34426|NCT01555138|152781|P1|Overall Study|Lack of Efficacy|2
34427|NCT01555138|152780|P2|Overall Study|Abnormal Lab reults|3
34428|NCT01555138|152781|P1|Overall Study|Abnormal Lab reults|1
34429|NCT01555138|152780|P2|Overall Study|Lost to Follow-up|0
34430|NCT01555138|152781|P1|Overall Study|Lost to Follow-up|1
34431|NCT01555138|152780|P2|Overall Study|Death|1
34432|NCT01555138|152781|P1|Overall Study|Death|0
34433|NCT01555073|152811|P4|Overall Study|Lost to Follow-up|5
34434|NCT01555073|152812|P3|Overall Study|Lost to Follow-up|0
34435|NCT01555073|152813|P2|Overall Study|Lost to Follow-up|2
34436|NCT01555073|152814|P1|Overall Study|Lost to Follow-up|1
34437|NCT01554904|152841|P1|Overall Study|Had sleep apnea on Home Study 1|1
34438|NCT01554904|152841|P1|Overall Study|Withdrawal by Subject|3
34439|NCT01554579|152861|P2|Overall Study|Withdrawal by Subject|1
34440|NCT01554579|152862|P1|Overall Study|Withdrawal by Subject|2
34441|NCT01554579|152861|P2|Overall Study|Lack of Efficacy|1
34442|NCT01554579|152862|P1|Overall Study|Lack of Efficacy|2
34443|NCT01554579|152861|P2|Overall Study|Adverse Event|25
34444|NCT01554579|152862|P1|Overall Study|Adverse Event|6
34445|NCT01554241|152876|P4|Overall Study|Withdrawal by Subject|0
34446|NCT01554241|152877|P3|Overall Study|Withdrawal by Subject|2
34447|NCT01554241|152878|P2|Overall Study|Withdrawal by Subject|0
34448|NCT01554241|152879|P1|Overall Study|Withdrawal by Subject|0
34449|NCT01554241|152876|P4|Overall Study|protocol specified change in eGFR|0
34450|NCT01554241|152877|P3|Overall Study|protocol specified change in eGFR|1
34451|NCT01554241|152878|P2|Overall Study|protocol specified change in eGFR|0
34452|NCT01554241|152879|P1|Overall Study|protocol specified change in eGFR|0
34453|NCT01554241|152876|P4|Overall Study|protocol specified renal stone|1
34454|NCT01554241|152877|P3|Overall Study|protocol specified renal stone|0
34455|NCT01554241|152878|P2|Overall Study|protocol specified renal stone|0
34456|NCT01554241|152879|P1|Overall Study|protocol specified renal stone|0
34457|NCT01554241|152876|P4|Overall Study|Death|0
34458|NCT01554241|152877|P3|Overall Study|Death|1
34459|NCT01554241|152878|P2|Overall Study|Death|1
34460|NCT01554241|152879|P1|Overall Study|Death|3
34461|NCT01554176|152895|P5|Run-out Phase|Protocol Violation|0
34462|NCT01554176|152896|P4|Run-out Phase|Protocol Violation|1
34463|NCT01554176|152897|P3|Run-out Phase|Protocol Violation|0
34464|NCT01554176|152898|P2|Run-out Phase|Protocol Violation|0
34465|NCT01554176|152899|P1|Run-out Phase|Protocol Violation|0
34466|NCT01554176|152895|P5|Treatment Phase|Lost to Follow-up|0
34467|NCT01554176|152896|P4|Treatment Phase|Lost to Follow-up|0
34468|NCT01554176|152897|P3|Treatment Phase|Lost to Follow-up|0
34469|NCT01554176|152898|P2|Treatment Phase|Lost to Follow-up|0
34470|NCT01554176|152899|P1|Treatment Phase|Lost to Follow-up|3
34471|NCT01554176|152895|P5|Treatment Phase|Withdrawal by Subject|0
34472|NCT01554176|152896|P4|Treatment Phase|Withdrawal by Subject|0
34473|NCT01554176|152897|P3|Treatment Phase|Withdrawal by Subject|0
34474|NCT01554176|152898|P2|Treatment Phase|Withdrawal by Subject|0
34475|NCT01554176|152899|P1|Treatment Phase|Withdrawal by Subject|1
34476|NCT01554176|152895|P5|Treatment Phase|Non-compliance with study drug|0
34477|NCT01554176|152896|P4|Treatment Phase|Non-compliance with study drug|0
34478|NCT01554176|152897|P3|Treatment Phase|Non-compliance with study drug|0
34479|NCT01554176|152898|P2|Treatment Phase|Non-compliance with study drug|0
34480|NCT01554176|152899|P1|Treatment Phase|Non-compliance with study drug|1
34481|NCT01554176|152895|P5|Treatment Phase|Adverse event, non-fatal|0
34482|NCT01554176|152896|P4|Treatment Phase|Adverse event, non-fatal|0
34483|NCT01554176|152897|P3|Treatment Phase|Adverse event, non-fatal|0
34484|NCT01554176|152898|P2|Treatment Phase|Adverse event, non-fatal|1
34485|NCT01554176|152899|P1|Treatment Phase|Adverse event, non-fatal|1
34486|NCT01554176|152895|P5|Treatment Phase|Lack of Efficacy|0
34487|NCT01554176|152896|P4|Treatment Phase|Lack of Efficacy|0
34488|NCT01554176|152897|P3|Treatment Phase|Lack of Efficacy|0
34489|NCT01554176|152898|P2|Treatment Phase|Lack of Efficacy|1
34490|NCT01554176|152899|P1|Treatment Phase|Lack of Efficacy|0
34491|NCT01554176|152895|P5|Treatment Phase|Physician Decision|0
34492|NCT01554176|152896|P4|Treatment Phase|Physician Decision|0
34493|NCT01554176|152897|P3|Treatment Phase|Physician Decision|0
34494|NCT01554176|152898|P2|Treatment Phase|Physician Decision|1
34495|NCT01554176|152899|P1|Treatment Phase|Physician Decision|1
34496|NCT01554176|152895|P5|Treatment Phase|Protocol Violation|0
34497|NCT01554176|152896|P4|Treatment Phase|Protocol Violation|0
34498|NCT01554176|152897|P3|Treatment Phase|Protocol Violation|0
34499|NCT01554176|152898|P2|Treatment Phase|Protocol Violation|2
34500|NCT01554176|152899|P1|Treatment Phase|Protocol Violation|1
34501|NCT01554163|152926|P2|Overall Study|Not Treated|0
34502|NCT01554163|152927|P1|Overall Study|Not Treated|1
34503|NCT01554163|152926|P2|Overall Study|Withdrawal by Subject|5
34504|NCT01554163|152927|P1|Overall Study|Withdrawal by Subject|1
34505|NCT01554163|152926|P2|Overall Study|Protocol Violation|4
34506|NCT01554163|152927|P1|Overall Study|Protocol Violation|0
34507|NCT01554163|152926|P2|Overall Study|Non-Compliance With Study Drug|1
34508|NCT01554163|152927|P1|Overall Study|Non-Compliance With Study Drug|1
34509|NCT01554163|152926|P2|Overall Study|Lost to Follow-up|0
34510|NCT01554163|152927|P1|Overall Study|Lost to Follow-up|1
34511|NCT01554163|152926|P2|Overall Study|Lack of Efficacy|0
34512|NCT01554163|152927|P1|Overall Study|Lack of Efficacy|1
34513|NCT01554163|152926|P2|Overall Study|Adverse Event|0
34514|NCT01554163|152927|P1|Overall Study|Adverse Event|3
34515|NCT01553851|152945|P1|Overall Study|constipation|1
34516|NCT01553851|152945|P1|Overall Study|Adverse Event|2
34517|NCT01553318|152973|P2|Overall Study|Protocol Violation|2
34518|NCT01553318|152974|P1|Overall Study|Protocol Violation|3
34519|NCT01552954|153009|P2|Overall Study|diagnosed DM|0
34520|NCT01552954|153010|P1|Overall Study|diagnosed DM|1
34521|NCT01552954|153009|P2|Overall Study|Protocol Violation|2
34522|NCT01552954|153010|P1|Overall Study|Protocol Violation|1
34523|NCT01552954|153009|P2|Overall Study|Withdrawal by Subject|1
34524|NCT01552954|153010|P1|Overall Study|Withdrawal by Subject|1
34525|NCT01552954|153009|P2|Overall Study|Lost to Follow-up|1
34526|NCT01552954|153010|P1|Overall Study|Lost to Follow-up|1
34527|NCT01552954|153009|P2|Overall Study|Adverse Event|2
34528|NCT01552954|153010|P1|Overall Study|Adverse Event|1
34529|NCT01552928|153026|P4|Period 3|Adverse Event|0
34530|NCT01552928|153027|P3|Period 3|Adverse Event|1
34531|NCT01552928|153028|P2|Period 3|Adverse Event|0
34532|NCT01552928|153029|P1|Period 3|Adverse Event|0
34533|NCT01552915|153076|P3|Overall Study|Not specified|6
34534|NCT01552915|153077|P2|Overall Study|Not specified|0
34535|NCT01552915|153078|P1|Overall Study|Not specified|2
34536|NCT01552915|153076|P3|Overall Study|Lack of Efficacy|4
34537|NCT01552915|153077|P2|Overall Study|Lack of Efficacy|1
34538|NCT01552915|153078|P1|Overall Study|Lack of Efficacy|8
34539|NCT01552915|153076|P3|Overall Study|Protocol Violation|4
34540|NCT01552915|153077|P2|Overall Study|Protocol Violation|4
34541|NCT01552915|153078|P1|Overall Study|Protocol Violation|0
34542|NCT01552915|153076|P3|Overall Study|Withdrawal by Subject|5
34543|NCT01552915|153077|P2|Overall Study|Withdrawal by Subject|4
34544|NCT01552915|153078|P1|Overall Study|Withdrawal by Subject|6
34545|NCT01552915|153076|P3|Overall Study|Lost to Follow-up|5
34546|NCT01552915|153077|P2|Overall Study|Lost to Follow-up|6
34547|NCT01552915|153078|P1|Overall Study|Lost to Follow-up|4
34548|NCT01552915|153076|P3|Overall Study|Adverse Event|3
34549|NCT01552915|153077|P2|Overall Study|Adverse Event|14
34550|NCT01552915|153078|P1|Overall Study|Adverse Event|3
34551|NCT01552902|153101|P3|Overall Study|Unspecified|3
34552|NCT01552902|153102|P2|Overall Study|Unspecified|4
34553|NCT01552902|153103|P1|Overall Study|Unspecified|3
34554|NCT01552902|153101|P3|Overall Study|Lost to Follow-up|6
34555|NCT01552902|153102|P2|Overall Study|Lost to Follow-up|3
34556|NCT01552902|153103|P1|Overall Study|Lost to Follow-up|1
34557|NCT01552902|153101|P3|Overall Study|Withdrawal by Subject|6
34558|NCT01552902|153102|P2|Overall Study|Withdrawal by Subject|9
34559|NCT01552902|153103|P1|Overall Study|Withdrawal by Subject|1
34560|NCT01552902|153101|P3|Overall Study|Lack of Efficacy|1
34561|NCT01552902|153102|P2|Overall Study|Lack of Efficacy|3
34562|NCT01552902|153103|P1|Overall Study|Lack of Efficacy|4
34563|NCT01552902|153101|P3|Overall Study|Protocol Violation|3
34564|NCT01552902|153102|P2|Overall Study|Protocol Violation|3
34565|NCT01552902|153103|P1|Overall Study|Protocol Violation|3
34566|NCT01552902|153101|P3|Overall Study|Adverse Event|14
34567|NCT01552902|153102|P2|Overall Study|Adverse Event|15
34568|NCT01552902|153103|P1|Overall Study|Adverse Event|1
34569|NCT01552772|153153|P1|Overall Study|Protocol Deviation|1
34570|NCT01552772|153153|P1|Overall Study|Adverse Event|1
34571|NCT01552772|153153|P1|Overall Study|Lost to Follow-up|2
34572|NCT01552694|153169|P2|Overall Study|Protocol Violation|1
34573|NCT01552694|153170|P1|Overall Study|Protocol Violation|0
34574|NCT01552694|153169|P2|Overall Study|Lost to Follow-up|1
34575|NCT01552694|153170|P1|Overall Study|Lost to Follow-up|0
34576|NCT01552681|153182|P2|Overall Study|Subject moved away|1
34577|NCT01552681|153183|P1|Overall Study|Subject moved away|0
34578|NCT01552681|153182|P2|Overall Study|Physician Decision|0
34579|NCT01552681|153183|P1|Overall Study|Physician Decision|1
34580|NCT01552681|153182|P2|Overall Study|Withdrawal by Subject|0
34581|NCT01552681|153183|P1|Overall Study|Withdrawal by Subject|4
34582|NCT01552603|153231|P1|Overall Study|Physician Decision|1
34583|NCT01552057|153262|P2|Overall Study|Physician Decision|0
34584|NCT01552057|153263|P1|Overall Study|Physician Decision|1
34585|NCT01552057|153262|P2|Overall Study|Entry Criteria Not Met|2
34586|NCT01552057|153263|P1|Overall Study|Entry Criteria Not Met|2
34587|NCT01552057|153262|P2|Overall Study|Withdrawal by Subject|8
34588|NCT01552057|153263|P1|Overall Study|Withdrawal by Subject|5
34589|NCT01552057|153262|P2|Overall Study|Lack of Efficacy|23
34590|NCT01552057|153263|P1|Overall Study|Lack of Efficacy|8
34591|NCT01552057|153262|P2|Overall Study|Adverse Event|15
34592|NCT01552057|153263|P1|Overall Study|Adverse Event|14
34593|NCT01551758|153329|P2|Overall Study|Withdrawal by Subject|17
34594|NCT01551758|153330|P1|Overall Study|Withdrawal by Subject|14
34595|NCT01551758|153329|P2|Overall Study|Physician Decision|3
34596|NCT01551758|153330|P1|Overall Study|Physician Decision|9
34597|NCT01551758|153329|P2|Overall Study|Lost to Follow-up|25
34598|NCT01551758|153330|P1|Overall Study|Lost to Follow-up|29
34599|NCT01551758|153329|P2|Overall Study|Met Protocol-defined stopping criteria|10
34600|NCT01551758|153330|P1|Overall Study|Met Protocol-defined stopping criteria|8
34601|NCT01551758|153329|P2|Overall Study|Protocol Violation|6
34602|NCT01551758|153330|P1|Overall Study|Protocol Violation|5
34603|NCT01551758|153329|P2|Overall Study|Lack of Efficacy|1
34604|NCT01551758|153330|P1|Overall Study|Lack of Efficacy|0
34605|NCT01551758|153329|P2|Overall Study|Adverse Event|43
34606|NCT01551758|153330|P1|Overall Study|Adverse Event|29
34607|NCT01551693|153370|P2|Overall Study|Withdrawal by Subject|1
34608|NCT01551693|153371|P1|Overall Study|Withdrawal by Subject|0
34609|NCT01551693|153370|P2|Overall Study|Adverse Event|1
34610|NCT01551693|153371|P1|Overall Study|Adverse Event|0
34611|NCT01551693|153370|P2|Overall Study|Disease Progression|0
34612|NCT01551693|153371|P1|Overall Study|Disease Progression|1
34613|NCT01551355|153387|P6|Overall Study|Lost to Follow-up|6
34614|NCT01551355|153388|P5|Overall Study|Lost to Follow-up|9
34615|NCT01551355|153389|P4|Overall Study|Lost to Follow-up|24
34616|NCT01551355|153390|P3|Overall Study|Lost to Follow-up|34
34617|NCT01551355|153391|P2|Overall Study|Lost to Follow-up|49
34618|NCT01551355|153392|P1|Overall Study|Lost to Follow-up|51
34619|NCT01551303|153406|P2|Overall Study|failed awareness check on vision test|7
34620|NCT01551303|153407|P1|Overall Study|failed awareness check on vision test|4
34621|NCT01551173|153421|P2|Overall Study|Not specified|3
34622|NCT01551173|153422|P1|Overall Study|Not specified|5
34623|NCT01551173|153421|P2|Overall Study|Lost to Follow-up|7
34624|NCT01551173|153422|P1|Overall Study|Lost to Follow-up|5
34625|NCT01551173|153421|P2|Overall Study|Adverse Event|6
34626|NCT01551173|153422|P1|Overall Study|Adverse Event|7
34627|NCT01551173|153421|P2|Overall Study|Withdrawal by Subject|16
34628|NCT01551173|153422|P1|Overall Study|Withdrawal by Subject|11
34629|NCT01550965|153442|P1|Overall Study|Not Specified|13
34630|NCT01550965|153442|P1|Overall Study|Lack of Efficacy|59
34631|NCT01550965|153442|P1|Overall Study|Lost to Follow-up|2
34632|NCT01550965|153442|P1|Overall Study|Withdrawal by Subject|10
34633|NCT01550965|153442|P1|Overall Study|Adverse Event|26
34634|NCT01550744|153482|P3|Double-Blind|unspecified|10
34635|NCT01550744|153483|P2|Double-Blind|unspecified|2
34636|NCT01550744|153484|P1|Double-Blind|unspecified|0
34637|NCT01550744|153482|P3|Double-Blind|Pregnancy|3
34638|NCT01550744|153483|P2|Double-Blind|Pregnancy|0
34639|NCT01550744|153484|P1|Double-Blind|Pregnancy|0
34640|NCT01550744|153482|P3|Double-Blind|Protocol Violation|4
34641|NCT01550744|153483|P2|Double-Blind|Protocol Violation|0
34642|NCT01550744|153484|P1|Double-Blind|Protocol Violation|0
34643|NCT01550744|153482|P3|Double-Blind|Lack of Efficacy|8
34644|NCT01550744|153483|P2|Double-Blind|Lack of Efficacy|2
34645|NCT01550744|153484|P1|Double-Blind|Lack of Efficacy|0
34646|NCT01550744|153482|P3|Double-Blind|Death|0
34647|NCT01550744|153483|P2|Double-Blind|Death|1
34648|NCT01550744|153484|P1|Double-Blind|Death|0
34649|NCT01550744|153482|P3|Double-Blind|Adverse Event|15
34650|NCT01550744|153483|P2|Double-Blind|Adverse Event|4
34651|NCT01550744|153484|P1|Double-Blind|Adverse Event|0
34652|NCT01550744|153482|P3|Double-Blind|Withdrawal by Subject|15
34653|NCT01550744|153483|P2|Double-Blind|Withdrawal by Subject|2
34654|NCT01550744|153484|P1|Double-Blind|Withdrawal by Subject|0
34655|NCT01550744|153482|P3|Double-Blind|Lost to Follow-up|12
34656|NCT01550744|153483|P2|Double-Blind|Lost to Follow-up|6
34657|NCT01550744|153484|P1|Double-Blind|Lost to Follow-up|0
34658|NCT01550744|153482|P3|Open-Label|unspecified|0
34659|NCT01550744|153483|P2|Open-Label|unspecified|0
34660|NCT01550744|153484|P1|Open-Label|unspecified|1
34661|NCT01550744|153482|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
34662|NCT01550744|153483|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
34663|NCT01550744|153484|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
34664|NCT01550744|153482|P3|Open-Label|Not all 3 study drug injections received|0
34665|NCT01550744|153483|P2|Open-Label|Not all 3 study drug injections received|0
34666|NCT01550744|153484|P1|Open-Label|Not all 3 study drug injections received|2
34667|NCT01550744|153482|P3|Open-Label|Protocol Violation|0
34668|NCT01550744|153483|P2|Open-Label|Protocol Violation|0
34669|NCT01550744|153484|P1|Open-Label|Protocol Violation|4
34670|NCT01550744|153482|P3|Open-Label|Lack of Efficacy|0
34671|NCT01550744|153483|P2|Open-Label|Lack of Efficacy|0
34672|NCT01550744|153484|P1|Open-Label|Lack of Efficacy|4
34673|NCT01550744|153482|P3|Open-Label|Adverse Event|0
34674|NCT01550744|153483|P2|Open-Label|Adverse Event|0
34675|NCT01550744|153484|P1|Open-Label|Adverse Event|11
34676|NCT01550744|153482|P3|Open-Label|Withdrawal by Subject|0
34677|NCT01550744|153483|P2|Open-Label|Withdrawal by Subject|0
34678|NCT01550744|153484|P1|Open-Label|Withdrawal by Subject|13
34679|NCT01550744|153482|P3|Open-Label|Lost to Follow-up|0
34680|NCT01550744|153483|P2|Open-Label|Lost to Follow-up|0
34681|NCT01550744|153484|P1|Open-Label|Lost to Follow-up|7
34682|NCT01550289|153537|P2|Overall Study|Withdrawal by Subject|3
34683|NCT01550289|153538|P1|Overall Study|Withdrawal by Subject|11
34684|NCT01550289|153537|P2|Overall Study|Lost to Follow-up|1
34685|NCT01550289|153538|P1|Overall Study|Lost to Follow-up|1
34686|NCT01550289|153537|P2|Overall Study|Protocol Violation|0
34687|NCT01550289|153538|P1|Overall Study|Protocol Violation|1
34688|NCT01549964|153589|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
34689|NCT01549964|153590|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
34690|NCT01549964|153591|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
34691|NCT01549964|153592|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
34692|NCT01549964|153589|P4|80-Week Extension Period|Lost to Follow-up|1
34693|NCT01549964|153590|P3|80-Week Extension Period|Lost to Follow-up|2
34694|NCT01549964|153591|P2|80-Week Extension Period|Lost to Follow-up|0
34695|NCT01549964|153592|P1|80-Week Extension Period|Lost to Follow-up|1
34696|NCT01549964|153589|P4|80-Week Extension Period|Voluntary Withdrawal|2
34697|NCT01549964|153590|P3|80-Week Extension Period|Voluntary Withdrawal|4
34698|NCT01549964|153591|P2|80-Week Extension Period|Voluntary Withdrawal|1
34699|NCT01549964|153592|P1|80-Week Extension Period|Voluntary Withdrawal|0
34700|NCT01549964|153589|P4|80-Week Extension Period|Study Terminated by Sponsor|132
34701|NCT01549964|153590|P3|80-Week Extension Period|Study Terminated by Sponsor|132
34702|NCT01549964|153591|P2|80-Week Extension Period|Study Terminated by Sponsor|137
34703|NCT01549964|153592|P1|80-Week Extension Period|Study Terminated by Sponsor|65
34704|NCT01549964|153589|P4|80-Week Extension Period|Pregnancy|0
34705|NCT01549964|153590|P3|80-Week Extension Period|Pregnancy|1
34706|NCT01549964|153591|P2|80-Week Extension Period|Pregnancy|0
34707|NCT01549964|153592|P1|80-Week Extension Period|Pregnancy|0
34708|NCT01549964|153589|P4|24-Week Treatment Period|Completion Status Unknown|0
34709|NCT01549964|153590|P3|24-Week Treatment Period|Completion Status Unknown|1
34710|NCT01549964|153591|P2|24-Week Treatment Period|Completion Status Unknown|0
34711|NCT01549964|153592|P1|24-Week Treatment Period|Completion Status Unknown|1
34712|NCT01549964|153589|P4|24-Week Treatment Period|Randomized but Not Treated|1
34713|NCT01549964|153590|P3|24-Week Treatment Period|Randomized but Not Treated|0
34714|NCT01549964|153591|P2|24-Week Treatment Period|Randomized but Not Treated|0
34715|NCT01549964|153592|P1|24-Week Treatment Period|Randomized but Not Treated|0
34716|NCT01549964|153589|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
34717|NCT01549964|153590|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
34718|NCT01549964|153591|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
34719|NCT01549964|153592|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
34720|NCT01549964|153589|P4|24-Week Treatment Period|Other|0
34721|NCT01549964|153590|P3|24-Week Treatment Period|Other|1
34722|NCT01549964|153591|P2|24-Week Treatment Period|Other|0
34723|NCT01549964|153592|P1|24-Week Treatment Period|Other|1
34724|NCT01549964|153589|P4|24-Week Treatment Period|Lack of Efficacy|1
34725|NCT01549964|153590|P3|24-Week Treatment Period|Lack of Efficacy|1
34726|NCT01549964|153591|P2|24-Week Treatment Period|Lack of Efficacy|0
34727|NCT01549964|153592|P1|24-Week Treatment Period|Lack of Efficacy|1
34728|NCT01549964|153589|P4|24-Week Treatment Period|Lost to Follow-up|2
34729|NCT01549964|153590|P3|24-Week Treatment Period|Lost to Follow-up|1
34730|NCT01549964|153591|P2|24-Week Treatment Period|Lost to Follow-up|0
34731|NCT01549964|153592|P1|24-Week Treatment Period|Lost to Follow-up|1
34732|NCT01549964|153589|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
34733|NCT01549964|153590|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
34734|NCT01549964|153591|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
34735|NCT01549964|153592|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
34736|NCT01549964|153589|P4|24-Week Treatment Period|Voluntary Withdrawal|8
34737|NCT01549964|153590|P3|24-Week Treatment Period|Voluntary Withdrawal|3
34738|NCT01549964|153591|P2|24-Week Treatment Period|Voluntary Withdrawal|3
34739|NCT01549964|153592|P1|24-Week Treatment Period|Voluntary Withdrawal|6
34740|NCT01549964|153589|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
34741|NCT01549964|153590|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
34742|NCT01549964|153591|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
34743|NCT01549964|153592|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
34744|NCT01549951|153610|P1|Overall Study|Other|2
34745|NCT01549951|153610|P1|Overall Study|Symptomatic deterioration|1
34746|NCT01549951|153610|P1|Overall Study|Progressive disease|29
34747|NCT01549951|153610|P1|Overall Study|Unsatisfactory therapeutic response|1
34748|NCT01549951|153610|P1|Overall Study|Withdrawal by Subject|2
34749|NCT01549951|153610|P1|Overall Study|Adverse Event|15
34750|NCT01549873|153637|P2|Overall Study|Physician Decision|1
34751|NCT01549873|153638|P1|Overall Study|Physician Decision|0
34752|NCT01549860|153650|P2|Overall Study|Physician Decision|1
34753|NCT01549860|153651|P1|Overall Study|Physician Decision|1
34754|NCT01549860|153650|P2|Overall Study|Withdrawal by Subject|0
34755|NCT01549860|153651|P1|Overall Study|Withdrawal by Subject|1
34756|NCT01549613|153663|P2|Overall Study|Lost to Follow-up|11
34757|NCT01549613|153664|P1|Overall Study|Lost to Follow-up|11
34758|NCT01549392|153683|P2|Overall Study|Withdrawal by Subject|0
34759|NCT01549392|153684|P1|Overall Study|Withdrawal by Subject|1
34760|NCT01549275|153703|P2|Overall Study|Lost to Follow-up|0
34761|NCT01549275|153704|P1|Overall Study|Lost to Follow-up|1
34762|NCT01549041|153727|P2|Overall Study|Adverse Event|4
34763|NCT01549041|153728|P1|Overall Study|Adverse Event|0
34764|NCT01549041|153727|P2|Overall Study|Lack of Efficacy|4
34765|NCT01549041|153728|P1|Overall Study|Lack of Efficacy|2
34766|NCT01548638|153775|P1|Overall Study|Withdrawal by Subject|1
34767|NCT01548638|153775|P1|Overall Study|Protocol Violation|3
34768|NCT01548573|153782|P1|Overall Study|Withdrawal by Subject|2
34769|NCT01548573|153782|P1|Overall Study|Death|3
34770|NCT01548417|153791|P2|Overall Study|Withdrawal by Subject|2
34771|NCT01548417|153792|P1|Overall Study|Withdrawal by Subject|0
34772|NCT01548287|153804|P5|Randomized Period|Adverse Event|0
34773|NCT01548287|153805|P4|Randomized Period|Adverse Event|0
34774|NCT01548287|153806|P3|Randomized Period|Adverse Event|5
34775|NCT01548287|153807|P2|Randomized Period|Adverse Event|2
34776|NCT01548287|153808|P1|Randomized Period|Adverse Event|0
34777|NCT01548287|153804|P5|Randomized Period|Did not meet inclusion criteria|0
34778|NCT01548287|153805|P4|Randomized Period|Did not meet inclusion criteria|0
34779|NCT01548287|153806|P3|Randomized Period|Did not meet inclusion criteria|2
34780|NCT01548287|153807|P2|Randomized Period|Did not meet inclusion criteria|0
34781|NCT01548287|153808|P1|Randomized Period|Did not meet inclusion criteria|0
34782|NCT01548287|153804|P5|Screening|Did not meet eligibility criteria|74
34783|NCT01548287|153805|P4|Screening|Did not meet eligibility criteria|0
34784|NCT01548287|153806|P3|Screening|Did not meet eligibility criteria|0
34785|NCT01548287|153807|P2|Screening|Did not meet eligibility criteria|0
34786|NCT01548287|153808|P1|Screening|Did not meet eligibility criteria|0
34787|NCT01548287|153804|P5|Screening|No reason provided|9
34788|NCT01548287|153805|P4|Screening|No reason provided|0
34789|NCT01548287|153806|P3|Screening|No reason provided|0
34790|NCT01548287|153807|P2|Screening|No reason provided|0
34791|NCT01548287|153808|P1|Screening|No reason provided|0
34792|NCT01547728|153854|P1|Overall Study|Screen failure|39
34793|NCT01547728|153854|P1|Overall Study|Drug not ready for subject|1
34794|NCT01547728|153854|P1|Overall Study|Change in procedure and equipment|1
34795|NCT01547598|153963|P2|Overall Study|Other Miscellaneous Reasons|1
34796|NCT01547598|153964|P1|Overall Study|Other Miscellaneous Reasons|2
34797|NCT01547598|153963|P2|Overall Study|Protocol Violation|1
34798|NCT01547598|153964|P1|Overall Study|Protocol Violation|1
34799|NCT01547598|153963|P2|Overall Study|Adverse Event|1
34800|NCT01547598|153964|P1|Overall Study|Adverse Event|1
34801|NCT01547598|153963|P2|Overall Study|Lost to Follow-up|1
34802|NCT01547598|153964|P1|Overall Study|Lost to Follow-up|1
34803|NCT01547598|153963|P2|Overall Study|Withdrew consent|1
34804|NCT01547598|153964|P1|Overall Study|Withdrew consent|1
34805|NCT01547286|154042|P1|Overall Study|Physician Decision|1
34806|NCT01547286|154042|P1|Overall Study|Did not meet all eligibility criteria|1
34807|NCT01547130|154060|P2|Overall Study|Lost to Follow-up|5
34808|NCT01547130|154061|P1|Overall Study|Lost to Follow-up|9
34809|NCT01546922|154075|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
34810|NCT01546922|154076|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
34811|NCT01546922|154075|P2|Second Period of 10 Weeks|Protocol Violation|1
34812|NCT01546922|154076|P1|Second Period of 10 Weeks|Protocol Violation|3
34813|NCT01546922|154075|P2|First Period of 10 Weeks|Investigator's judgment|0
34814|NCT01546922|154076|P1|First Period of 10 Weeks|Investigator's judgment|1
34815|NCT01546922|154075|P2|First Period of 10 Weeks|Withdrawal by Subject|1
34816|NCT01546922|154076|P1|First Period of 10 Weeks|Withdrawal by Subject|1
34817|NCT01546922|154075|P2|First Period of 10 Weeks|Protocol Violation|1
34818|NCT01546922|154076|P1|First Period of 10 Weeks|Protocol Violation|3
34819|NCT01546883|154082|P1|Overall Study|other unrelated illness|1
34820|NCT01546883|154082|P1|Overall Study|early closure of study|2
34821|NCT01546883|154082|P1|Overall Study|Lost to Follow-up|2
34822|NCT01546883|154082|P1|Overall Study|Adverse Event|4
34823|NCT01546883|154082|P1|Overall Study|Withdrawal by Subject|3
34824|NCT01546688|154088|P2|Overall Study|Lack of Efficacy|0
34825|NCT01546688|154089|P1|Overall Study|Lack of Efficacy|1
34826|NCT01546688|154088|P2|Overall Study|Withdrawal by Subject|1
34827|NCT01546688|154089|P1|Overall Study|Withdrawal by Subject|2
34828|NCT01546688|154088|P2|Overall Study|Adverse Event|4
34829|NCT01546688|154089|P1|Overall Study|Adverse Event|0
34830|NCT01546649|154121|P2|Overall Study|Withdrawal by Subject|2
34831|NCT01546649|154122|P1|Overall Study|Withdrawal by Subject|1
34832|NCT01546649|154121|P2|Overall Study|Discovery of secondary cancer|1
34833|NCT01546649|154122|P1|Overall Study|Discovery of secondary cancer|0
34834|NCT01546649|154121|P2|Overall Study|Recurrence|1
34835|NCT01546649|154122|P1|Overall Study|Recurrence|1
34836|NCT01546649|154121|P2|Overall Study|Lack of Efficacy|0
34837|NCT01546649|154122|P1|Overall Study|Lack of Efficacy|1
34838|NCT01546649|154121|P2|Overall Study|Protocol Violation|0
34839|NCT01546649|154122|P1|Overall Study|Protocol Violation|1
34840|NCT01546649|154121|P2|Overall Study|Adverse Event|5
34841|NCT01546649|154122|P1|Overall Study|Adverse Event|4
34842|NCT01546623|154157|P2|Overall Study|Did Not Receive Study Drug|1
34843|NCT01546623|154158|P1|Overall Study|Did Not Receive Study Drug|1
34844|NCT01546623|154157|P2|Overall Study|High Prostate specific antigen|1
34845|NCT01546623|154158|P1|Overall Study|High Prostate specific antigen|2
34846|NCT01546623|154157|P2|Overall Study|Major Protocol Deviation|1
34847|NCT01546623|154158|P1|Overall Study|Major Protocol Deviation|1
34848|NCT01546623|154157|P2|Overall Study|Adverse Event|3
34849|NCT01546623|154158|P1|Overall Study|Adverse Event|2
34850|NCT01546519|154188|P4|Overall Study|Withdrawal by Subject|0
34851|NCT01546519|154189|P3|Overall Study|Withdrawal by Subject|0
34852|NCT01546519|154190|P2|Overall Study|Withdrawal by Subject|0
34853|NCT01546519|154191|P1|Overall Study|Withdrawal by Subject|1
34854|NCT01546519|154188|P4|Overall Study|Physician Decision|3
34855|NCT01546519|154189|P3|Overall Study|Physician Decision|2
34856|NCT01546519|154190|P2|Overall Study|Physician Decision|5
34857|NCT01546519|154191|P1|Overall Study|Physician Decision|6
34858|NCT01546519|154188|P4|Overall Study|related to disease progression|1
34859|NCT01546519|154189|P3|Overall Study|related to disease progression|2
34860|NCT01546519|154190|P2|Overall Study|related to disease progression|2
34861|NCT01546519|154191|P1|Overall Study|related to disease progression|2
34862|NCT01546519|154188|P4|Overall Study|Death|1
34863|NCT01546519|154189|P3|Overall Study|Death|3
34864|NCT01546519|154190|P2|Overall Study|Death|1
34865|NCT01546519|154191|P1|Overall Study|Death|0
34866|NCT01546519|154188|P4|Overall Study|Adverse Event|1
34867|NCT01546519|154189|P3|Overall Study|Adverse Event|1
34868|NCT01546519|154190|P2|Overall Study|Adverse Event|0
34869|NCT01546519|154191|P1|Overall Study|Adverse Event|0
34870|NCT01546207|154256|P1|Overall Study|Death|1
34871|NCT01546155|154269|P1|Overall Study|could not tolerate long scan duration|3
34872|NCT01546142|154275|P2|Overall Study|Subject Randomized but Not Treated|0
34873|NCT01546142|154276|P1|Overall Study|Subject Randomized but Not Treated|1
34874|NCT01546142|154275|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
34875|NCT01546142|154276|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
34876|NCT01546142|154275|P2|Overall Study|Lost to Follow-up|15
34877|NCT01546142|154276|P1|Overall Study|Lost to Follow-up|20
34878|NCT01546142|154275|P2|Overall Study|Adverse Event|3
34879|NCT01546142|154276|P1|Overall Study|Adverse Event|6
34880|NCT01546142|154275|P2|Overall Study|Subject Noncompliance|1
34881|NCT01546142|154276|P1|Overall Study|Subject Noncompliance|1
34882|NCT01546142|154275|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
34883|NCT01546142|154276|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
34884|NCT01545388|154367|P3|Overall Study|Not specified|0
34885|NCT01545388|154368|P2|Overall Study|Not specified|1
34886|NCT01545388|154369|P1|Overall Study|Not specified|1
34887|NCT01545388|154367|P3|Overall Study|Withdrawal by Subject|2
34888|NCT01545388|154368|P2|Overall Study|Withdrawal by Subject|4
34889|NCT01545388|154369|P1|Overall Study|Withdrawal by Subject|1
34890|NCT01545388|154367|P3|Overall Study|Participant moved or relocated|0
34891|NCT01545388|154368|P2|Overall Study|Participant moved or relocated|0
34892|NCT01545388|154369|P1|Overall Study|Participant moved or relocated|1
34893|NCT01545388|154367|P3|Overall Study|Lack of Efficacy|5
34894|NCT01545388|154368|P2|Overall Study|Lack of Efficacy|2
34895|NCT01545388|154369|P1|Overall Study|Lack of Efficacy|3
34896|NCT01545388|154367|P3|Overall Study|Adverse Event|1
34897|NCT01545388|154368|P2|Overall Study|Adverse Event|4
34898|NCT01545388|154369|P1|Overall Study|Adverse Event|2
34899|NCT01544153|154449|P4|Overall Study|Non-smoker|0
34900|NCT01544153|154450|P3|Overall Study|Non-smoker|1
34901|NCT01544153|154451|P2|Overall Study|Non-smoker|0
34902|NCT01544153|154452|P1|Overall Study|Non-smoker|0
34903|NCT01544153|154449|P4|Overall Study|Under 18|0
34904|NCT01544153|154450|P3|Overall Study|Under 18|0
34905|NCT01544153|154451|P2|Overall Study|Under 18|1
34906|NCT01544153|154452|P1|Overall Study|Under 18|0
34907|NCT01543958|154520|P1|Overall Study|ART initiation|1
34908|NCT01543958|154520|P1|Overall Study|Loss to follow-up|3
34909|NCT01544920|154586|P2|Overall Study|Withdrawal by Subject|4
34910|NCT01544920|154587|P1|Overall Study|Withdrawal by Subject|4
34911|NCT01544920|154586|P2|Overall Study|Physician Decision|1
34912|NCT01544920|154587|P1|Overall Study|Physician Decision|4
34913|NCT01544920|154586|P2|Overall Study|Protocol Violation|2
34914|NCT01544920|154587|P1|Overall Study|Protocol Violation|0
34915|NCT01544920|154586|P2|Overall Study|Lost to Follow-up|12
34916|NCT01544920|154587|P1|Overall Study|Lost to Follow-up|11
34917|NCT01544920|154586|P2|Overall Study|Death|1
34918|NCT01544920|154587|P1|Overall Study|Death|0
34919|NCT01544920|154586|P2|Overall Study|Adverse Event|3
34920|NCT01544920|154587|P1|Overall Study|Adverse Event|0
34921|NCT01544582|154598|P4|Analysis Population|Participant in Jail|0
34922|NCT01544582|154599|P3|Analysis Population|Participant in Jail|1
34923|NCT01544582|154600|P2|Analysis Population|Participant in Jail|0
34924|NCT01544582|154601|P1|Analysis Population|Participant in Jail|0
34925|NCT01544582|154598|P4|Analysis Population|Programmed Surgery|0
34926|NCT01544582|154599|P3|Analysis Population|Programmed Surgery|0
34927|NCT01544582|154600|P2|Analysis Population|Programmed Surgery|1
34928|NCT01544582|154601|P1|Analysis Population|Programmed Surgery|0
34929|NCT01544582|154598|P4|Analysis Population|Poor Participant Compliance|0
34930|NCT01544582|154599|P3|Analysis Population|Poor Participant Compliance|0
34931|NCT01544582|154600|P2|Analysis Population|Poor Participant Compliance|1
34932|NCT01544582|154601|P1|Analysis Population|Poor Participant Compliance|0
34933|NCT01544582|154598|P4|Analysis Population|Poor Adherence|0
34934|NCT01544582|154599|P3|Analysis Population|Poor Adherence|1
34935|NCT01544582|154600|P2|Analysis Population|Poor Adherence|0
34936|NCT01544582|154601|P1|Analysis Population|Poor Adherence|0
34937|NCT01544582|154598|P4|Analysis Population|No Social Insurance|0
34938|NCT01544582|154599|P3|Analysis Population|No Social Insurance|1
34939|NCT01544582|154600|P2|Analysis Population|No Social Insurance|0
34940|NCT01544582|154601|P1|Analysis Population|No Social Insurance|0
34941|NCT01544582|154598|P4|Analysis Population|Liver Transplantation|0
34942|NCT01544582|154599|P3|Analysis Population|Liver Transplantation|1
34943|NCT01544582|154600|P2|Analysis Population|Liver Transplantation|0
34944|NCT01544582|154601|P1|Analysis Population|Liver Transplantation|0
34945|NCT01544582|154598|P4|Analysis Population|Intolerance|0
34946|NCT01544582|154599|P3|Analysis Population|Intolerance|0
34947|NCT01544582|154600|P2|Analysis Population|Intolerance|1
34948|NCT01544582|154601|P1|Analysis Population|Intolerance|0
34949|NCT01544582|154598|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
34950|NCT01544582|154599|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
34951|NCT01544582|154600|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
34952|NCT01544582|154601|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
34953|NCT01544582|154598|P4|Analysis Population|Bad Tolerance to Treatment|0
34954|NCT01544582|154599|P3|Analysis Population|Bad Tolerance to Treatment|2
34955|NCT01544582|154600|P2|Analysis Population|Bad Tolerance to Treatment|0
34956|NCT01544582|154601|P1|Analysis Population|Bad Tolerance to Treatment|0
34957|NCT01544582|154598|P4|Analysis Population|Lost to Follow-up|5
34958|NCT01544582|154599|P3|Analysis Population|Lost to Follow-up|6
34959|NCT01544582|154600|P2|Analysis Population|Lost to Follow-up|6
34960|NCT01544582|154601|P1|Analysis Population|Lost to Follow-up|0
34961|NCT01544582|154598|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
34962|NCT01544582|154599|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
34963|NCT01544582|154600|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
34964|NCT01544582|154601|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
34965|NCT01544582|154598|P4|Analysis Population|Effectiveness Reason|12
34966|NCT01544582|154599|P3|Analysis Population|Effectiveness Reason|29
34967|NCT01544582|154600|P2|Analysis Population|Effectiveness Reason|48
34968|NCT01544582|154601|P1|Analysis Population|Effectiveness Reason|0
34969|NCT01544582|154598|P4|Analysis Population|Safety Reason|8
34970|NCT01544582|154599|P3|Analysis Population|Safety Reason|31
34971|NCT01544582|154600|P2|Analysis Population|Safety Reason|33
34972|NCT01544582|154601|P1|Analysis Population|Safety Reason|0
34973|NCT01544582|154598|P4|Analysis Population|Physician Decision|9
34974|NCT01544582|154599|P3|Analysis Population|Physician Decision|10
34975|NCT01544582|154600|P2|Analysis Population|Physician Decision|13
34976|NCT01544582|154601|P1|Analysis Population|Physician Decision|0
34977|NCT01544582|154598|P4|Analysis Population|Participant Refuses to Continue Study|4
34978|NCT01544582|154599|P3|Analysis Population|Participant Refuses to Continue Study|17
34979|NCT01544582|154600|P2|Analysis Population|Participant Refuses to Continue Study|15
34980|NCT01544582|154601|P1|Analysis Population|Participant Refuses to Continue Study|0
34981|NCT01544582|154598|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
34982|NCT01544582|154599|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
34983|NCT01544582|154600|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
34984|NCT01544582|154601|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
34985|NCT01544582|154598|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
34986|NCT01544582|154599|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
34987|NCT01544582|154600|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
34988|NCT01544582|154601|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
34989|NCT01544478|154659|P1|Overall Study|Withdrawal by Subject|52
34990|NCT01544478|154659|P1|Overall Study|Pregnancy|1
34991|NCT01544478|154659|P1|Overall Study|Physician Decision|15
34992|NCT01544478|154659|P1|Overall Study|Lost to Follow-up|48
34993|NCT01544478|154659|P1|Overall Study|Death|1
34994|NCT01544478|154659|P1|Overall Study|Adverse Event|1
34995|NCT01544348|154702|P8|Overall Study|Physician Decision|0
34996|NCT01544348|154703|P7|Overall Study|Physician Decision|0
34997|NCT01544348|154704|P6|Overall Study|Physician Decision|1
34998|NCT01544348|154705|P5|Overall Study|Physician Decision|0
34999|NCT01544348|154706|P4|Overall Study|Physician Decision|0
35000|NCT01544348|154707|P3|Overall Study|Physician Decision|0
35001|NCT01544348|154708|P2|Overall Study|Physician Decision|0
35002|NCT01544348|154709|P1|Overall Study|Physician Decision|0
35003|NCT01544348|154702|P8|Overall Study|Withdrawal by Subject|0
35004|NCT01544348|154703|P7|Overall Study|Withdrawal by Subject|1
35005|NCT01544348|154704|P6|Overall Study|Withdrawal by Subject|2
35006|NCT01544348|154705|P5|Overall Study|Withdrawal by Subject|1
35007|NCT01544348|154706|P4|Overall Study|Withdrawal by Subject|0
35008|NCT01544348|154707|P3|Overall Study|Withdrawal by Subject|0
35009|NCT01544348|154708|P2|Overall Study|Withdrawal by Subject|0
35010|NCT01544348|154709|P1|Overall Study|Withdrawal by Subject|1
35011|NCT01544348|154702|P8|Overall Study|Lost to Follow-up|0
35012|NCT01544348|154703|P7|Overall Study|Lost to Follow-up|1
35013|NCT01544348|154704|P6|Overall Study|Lost to Follow-up|0
35014|NCT01544348|154705|P5|Overall Study|Lost to Follow-up|0
35015|NCT01544348|154706|P4|Overall Study|Lost to Follow-up|0
35016|NCT01544348|154707|P3|Overall Study|Lost to Follow-up|0
35017|NCT01544348|154708|P2|Overall Study|Lost to Follow-up|0
35018|NCT01544348|154709|P1|Overall Study|Lost to Follow-up|1
35019|NCT01544309|154751|P2|Overall Study|Administered prohibit prior medication|0
35020|NCT01544309|154752|P1|Overall Study|Administered prohibit prior medication|1
35021|NCT01544309|154751|P2|Overall Study|Not performed pre-dose examination|2
35022|NCT01544309|154752|P1|Overall Study|Not performed pre-dose examination|1
35023|NCT01544309|154751|P2|Overall Study|Physician Decision|1
35024|NCT01544309|154752|P1|Overall Study|Physician Decision|4
35025|NCT01544309|154751|P2|Overall Study|Protocol Violation|1
35026|NCT01544309|154752|P1|Overall Study|Protocol Violation|2
35027|NCT01544309|154751|P2|Overall Study|Withdrawal by Subject|7
35028|NCT01544309|154752|P1|Overall Study|Withdrawal by Subject|12
35029|NCT01544179|154790|P2|Overall Study|Eligibility criteria not fulfilled|0
35030|NCT01544179|154791|P1|Overall Study|Eligibility criteria not fulfilled|1
35031|NCT01544179|154790|P2|Overall Study|Withdrawal by Subject|7
35032|NCT01544179|154791|P1|Overall Study|Withdrawal by Subject|12
35033|NCT01544179|154790|P2|Overall Study|Adverse Event|1
35034|NCT01544179|154791|P1|Overall Study|Adverse Event|0
35035|NCT01544179|154790|P2|Overall Study|Lost to Follow-up|1
35036|NCT01544179|154791|P1|Overall Study|Lost to Follow-up|0
35037|NCT01544179|154790|P2|Overall Study|Death|37
35038|NCT01544179|154791|P1|Overall Study|Death|50
35039|NCT01543828|154882|P2|Treatment 2|Lost to Follow-up|0
35040|NCT01543828|154883|P1|Treatment 2|Lost to Follow-up|1
35041|NCT01543685|154896|P5|Overall Study|Adverse Event|2
35042|NCT01543685|154897|P4|Overall Study|Adverse Event|0
35043|NCT01543685|154898|P3|Overall Study|Adverse Event|0
35044|NCT01543685|154899|P2|Overall Study|Adverse Event|1
35045|NCT01543685|154900|P1|Overall Study|Adverse Event|2
35046|NCT01543685|154896|P5|Overall Study|Lack of Efficacy|2
35047|NCT01543685|154897|P4|Overall Study|Lack of Efficacy|0
35048|NCT01543685|154898|P3|Overall Study|Lack of Efficacy|2
35049|NCT01543685|154899|P2|Overall Study|Lack of Efficacy|2
35050|NCT01543685|154900|P1|Overall Study|Lack of Efficacy|1
35051|NCT01543503|154972|P2|Overall Study|Screen failure|0
35052|NCT01543503|154973|P1|Overall Study|Screen failure|1
35053|NCT01543503|154972|P2|Overall Study|Participant went to United States|0
35054|NCT01543503|154973|P1|Overall Study|Participant went to United States|1
35055|NCT01543503|154972|P2|Overall Study|Participant consented to another study|2
35056|NCT01543503|154973|P1|Overall Study|Participant consented to another study|0
35057|NCT01543503|154972|P2|Overall Study|Moved to other rheumatologic site|1
35058|NCT01543503|154973|P1|Overall Study|Moved to other rheumatologic site|0
35059|NCT01543503|154972|P2|Overall Study|Participant did not attend a visit|0
35060|NCT01543503|154973|P1|Overall Study|Participant did not attend a visit|1
35061|NCT01543503|154972|P2|Overall Study|Site stopped participation|1
35062|NCT01543503|154973|P1|Overall Study|Site stopped participation|5
35063|NCT01543503|154972|P2|Overall Study|Participant recruited after closing date|1
35064|NCT01543503|154973|P1|Overall Study|Participant recruited after closing date|0
35065|NCT01543503|154972|P2|Overall Study|Investigator did not wish to participate|1
35066|NCT01543503|154973|P1|Overall Study|Investigator did not wish to participate|1
35067|NCT01543503|154972|P2|Overall Study|Participant decision to stop treatment|0
35068|NCT01543503|154973|P1|Overall Study|Participant decision to stop treatment|1
35069|NCT01543503|154972|P2|Overall Study|Participant moved to Scotland|0
35070|NCT01543503|154973|P1|Overall Study|Participant moved to Scotland|1
35071|NCT01543503|154972|P2|Overall Study|Participant transferred to another city|0
35072|NCT01543503|154973|P1|Overall Study|Participant transferred to another city|1
35073|NCT01543503|154972|P2|Overall Study|Participant will not return for visits|2
35074|NCT01543503|154973|P1|Overall Study|Participant will not return for visits|0
35075|NCT01543503|154972|P2|Overall Study|Participant moved to another city|0
35076|NCT01543503|154973|P1|Overall Study|Participant moved to another city|2
35077|NCT01543503|154972|P2|Overall Study|Incorrect medication received|0
35078|NCT01543503|154973|P1|Overall Study|Incorrect medication received|1
35079|NCT01543503|154972|P2|Overall Study|Refused to continue treatment|0
35080|NCT01543503|154973|P1|Overall Study|Refused to continue treatment|7
35081|NCT01543503|154972|P2|Overall Study|Participant did not complete last visit|2
35082|NCT01543503|154973|P1|Overall Study|Participant did not complete last visit|0
35083|NCT01543503|154972|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
35084|NCT01543503|154973|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
35085|NCT01543503|154972|P2|Overall Study|Intolerance to the biologic treatment|1
35086|NCT01543503|154973|P1|Overall Study|Intolerance to the biologic treatment|0
35087|NCT01543503|154972|P2|Overall Study|Change of jobs|1
35088|NCT01543503|154973|P1|Overall Study|Change of jobs|0
35089|NCT01543503|154972|P2|Overall Study|Participant withdrew informed consent|10
35090|NCT01543503|154973|P1|Overall Study|Participant withdrew informed consent|8
35091|NCT01543503|154972|P2|Overall Study|Lack of Efficacy|16
35092|NCT01543503|154973|P1|Overall Study|Lack of Efficacy|4
35093|NCT01543503|154972|P2|Overall Study|Adverse Event|13
35094|NCT01543503|154973|P1|Overall Study|Adverse Event|9
35095|NCT01543503|154972|P2|Overall Study|Lost to Follow-up|36
35096|NCT01543503|154973|P1|Overall Study|Lost to Follow-up|32
35097|NCT01543204|155017|P1|Overall Study|Lost to Follow-up|1
35098|NCT01543204|155017|P1|Overall Study|Requirement for Alternative Therapy|1
35099|NCT01543204|155017|P1|Overall Study|Withdrawal by Subject|4
35100|NCT01543204|155017|P1|Overall Study|Adverse Event|1
35101|NCT01543204|155017|P1|Overall Study|Non-compliance|1
35102|NCT01542788|155109|P2|Overall Study|Withdrawal by Subject|0
35103|NCT01542788|155110|P1|Overall Study|Withdrawal by Subject|1
35104|NCT01542788|155109|P2|Overall Study|Physician Decision|0
35105|NCT01542788|155110|P1|Overall Study|Physician Decision|1
35106|NCT01542788|155109|P2|Overall Study|Protocol Violation|0
35107|NCT01542788|155110|P1|Overall Study|Protocol Violation|2
35108|NCT01542788|155109|P2|Overall Study|Death|0
35109|NCT01542788|155110|P1|Overall Study|Death|3
35110|NCT01542788|155109|P2|Overall Study|Lost to Follow-up|0
35111|NCT01542788|155110|P1|Overall Study|Lost to Follow-up|5
35112|NCT01542788|155109|P2|Overall Study|Lack of Efficacy|71
35113|NCT01542788|155110|P1|Overall Study|Lack of Efficacy|41
35114|NCT01542788|155109|P2|Overall Study|Randomized but Not Treated|0
35115|NCT01542788|155110|P1|Overall Study|Randomized but Not Treated|2
35116|NCT01542632|155149|P6|Overall Study|Sponsor/Investigator Decision|0
35117|NCT01542632|155150|P5|Overall Study|Sponsor/Investigator Decision|1
35118|NCT01542632|155151|P4|Overall Study|Sponsor/Investigator Decision|0
35119|NCT01542632|155152|P3|Overall Study|Sponsor/Investigator Decision|0
35120|NCT01542632|155153|P2|Overall Study|Sponsor/Investigator Decision|0
35121|NCT01542632|155154|P1|Overall Study|Sponsor/Investigator Decision|0
35122|NCT01542632|155149|P6|Overall Study|Lost to Follow-up|0
35123|NCT01542632|155150|P5|Overall Study|Lost to Follow-up|0
35124|NCT01542632|155151|P4|Overall Study|Lost to Follow-up|0
35125|NCT01542632|155152|P3|Overall Study|Lost to Follow-up|0
35126|NCT01542632|155153|P2|Overall Study|Lost to Follow-up|1
35127|NCT01542632|155154|P1|Overall Study|Lost to Follow-up|0
35128|NCT01542632|155149|P6|Overall Study|Adverse Event|0
35129|NCT01542632|155150|P5|Overall Study|Adverse Event|0
35130|NCT01542632|155151|P4|Overall Study|Adverse Event|0
35131|NCT01542632|155152|P3|Overall Study|Adverse Event|1
35132|NCT01542632|155153|P2|Overall Study|Adverse Event|0
35133|NCT01542632|155154|P1|Overall Study|Adverse Event|0
35134|NCT01542632|155149|P6|Overall Study|Withdrawal of Consent|0
35135|NCT01542632|155150|P5|Overall Study|Withdrawal of Consent|3
35136|NCT01542632|155151|P4|Overall Study|Withdrawal of Consent|2
35137|NCT01542632|155152|P3|Overall Study|Withdrawal of Consent|0
35138|NCT01542632|155153|P2|Overall Study|Withdrawal of Consent|0
35139|NCT01542632|155154|P1|Overall Study|Withdrawal of Consent|0
35140|NCT01542034|155268|P2|Overall Study|Lost to Follow-up|6
35141|NCT01542034|155269|P1|Overall Study|Lost to Follow-up|7
35142|NCT01542034|155268|P2|Overall Study|Adverse Event|2
35143|NCT01542034|155269|P1|Overall Study|Adverse Event|2
35144|NCT01542034|155268|P2|Overall Study|Subject Noncompliance|0
35145|NCT01542034|155269|P1|Overall Study|Subject Noncompliance|1
35146|NCT01542034|155268|P2|Overall Study|Administrative decision|3
35147|NCT01542034|155269|P1|Overall Study|Administrative decision|0
35148|NCT01542034|155268|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
35149|NCT01542034|155269|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
35150|NCT01541969|155283|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
35151|NCT01541969|155284|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
35152|NCT01541969|155283|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
35153|NCT01541969|155284|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
35154|NCT01541969|155283|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
35155|NCT01541969|155284|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
35156|NCT01541969|155283|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
35157|NCT01541969|155284|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
35158|NCT01541969|155283|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
35159|NCT01541969|155284|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
35160|NCT01541969|155283|P2|Double-blind (0-12 Weeks)|Adverse Event|0
35161|NCT01541969|155284|P1|Double-blind (0-12 Weeks)|Adverse Event|2
35162|NCT01541969|155283|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
35163|NCT01541969|155284|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
35164|NCT01541969|155283|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
35165|NCT01541969|155284|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
35166|NCT01541969|155283|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
35167|NCT01541969|155284|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
35168|NCT01541969|155283|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
35169|NCT01541969|155284|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
35170|NCT01541930|155300|P1|Overall Study|Withdrawal by Subject|1
35171|NCT01541917|155322|P2|Overall Study|Withdrawal by Subject|7
35172|NCT01541917|155323|P1|Overall Study|Withdrawal by Subject|13
35173|NCT01541917|155322|P2|Overall Study|Lost to Follow-up|2
35174|NCT01541917|155323|P1|Overall Study|Lost to Follow-up|2
35175|NCT01541865|155339|P1|Overall Study|Protocol Violation|1
35176|NCT01541865|155339|P1|Overall Study|Adverse Event|1
35177|NCT01541865|155339|P1|Overall Study|Withdrawal by Subject|9
35178|NCT01541865|155339|P1|Overall Study|Lost to Follow-up|11
35179|NCT01541826|155357|P3|Overall Study|Withdrawal by Subject|0
35180|NCT01541826|155358|P2|Overall Study|Withdrawal by Subject|0
35181|NCT01541826|155359|P1|Overall Study|Withdrawal by Subject|2
35182|NCT01541826|155357|P3|Overall Study|Lost to Follow-up|0
35183|NCT01541826|155358|P2|Overall Study|Lost to Follow-up|3
35184|NCT01541826|155359|P1|Overall Study|Lost to Follow-up|2
35185|NCT01541644|155441|P1|Overall Study|Withdrawal by Subject|3
35186|NCT01541397|155460|P2|Overall Study|Study ended prior to data collection|2
35187|NCT01541397|155461|P1|Overall Study|Study ended prior to data collection|4
35188|NCT01541371|155486|P1|Overall Study|Unspecified|6
35189|NCT01541371|155486|P1|Overall Study|Study medication non-compliance|3
35190|NCT01541371|155486|P1|Overall Study|Protocol Violation|6
35191|NCT01541371|155486|P1|Overall Study|Lack of Efficacy|12
35192|NCT01541371|155486|P1|Overall Study|Adverse Event|15
35193|NCT01541371|155486|P1|Overall Study|Lost to Follow-up|21
35194|NCT01541371|155486|P1|Overall Study|Withdrawal by Subject|14
35195|NCT01541254|155515|P1|Overall Study|alternate stent used|1
35196|NCT01541254|155515|P1|Overall Study|stent not required|1
35197|NCT01541254|155515|P1|Overall Study|GI bleed prior to procedure|1
35198|NCT01541254|155515|P1|Overall Study|enrolled after study closed|1
35199|NCT01541254|155515|P1|Overall Study|excluded - metal allergy|1
35200|NCT01541254|155515|P1|Overall Study|Withdrawal by Subject|1
35201|NCT01540981|155522|P2|Overall Study|Withdrawal by Subject|0
35202|NCT01540981|155523|P1|Overall Study|Withdrawal by Subject|1
35203|NCT01540851|155533|P2|Overall Study|Withdrawal by Subject|3
35204|NCT01540851|155534|P1|Overall Study|Withdrawal by Subject|7
35205|NCT01540851|155533|P2|Overall Study|Lost to Follow-up|15
35206|NCT01540851|155534|P1|Overall Study|Lost to Follow-up|14
35207|NCT01540487|155674|P2|Overall Study|Protocol Violation|0
35208|NCT01540487|155675|P1|Overall Study|Protocol Violation|1
35209|NCT01539759|155810|P2|Overall Study|Lost to Follow-up|8
35210|NCT01539759|155811|P1|Overall Study|Lost to Follow-up|6
35211|NCT01539642|155821|P2|Overall Study|Withdrawal by Subject|2
35212|NCT01539642|155822|P1|Overall Study|Withdrawal by Subject|2
35213|NCT01539642|155821|P2|Overall Study|Adverse Event|4
35214|NCT01539642|155822|P1|Overall Study|Adverse Event|6
35215|NCT01539642|155821|P2|Overall Study|Patient ready for early discharge|7
35216|NCT01539642|155822|P1|Overall Study|Patient ready for early discharge|8
35217|NCT01539642|155821|P2|Overall Study|Lack of Efficacy|18
35218|NCT01539642|155822|P1|Overall Study|Lack of Efficacy|20
35219|NCT01539538|155839|P2|Overall Study|PCA no longer required or PCA problem|7
35220|NCT01539538|155840|P1|Overall Study|PCA no longer required or PCA problem|3
35221|NCT01539538|155839|P2|Overall Study|Withdrawal by Subject|3
35222|NCT01539538|155840|P1|Overall Study|Withdrawal by Subject|2
35223|NCT01539538|155839|P2|Overall Study|Lack of Efficacy|16
35224|NCT01539538|155840|P1|Overall Study|Lack of Efficacy|13
35225|NCT01539538|155839|P2|Overall Study|Adverse Event|18
35226|NCT01539538|155840|P1|Overall Study|Adverse Event|13
35227|NCT01539525|155849|P3|Overall Study|Protocol Violation|4
35228|NCT01539525|155850|P2|Overall Study|Protocol Violation|1
35229|NCT01539525|155851|P1|Overall Study|Protocol Violation|1
35230|NCT01539525|155849|P3|Overall Study|Withdrawal by Subject|2
35231|NCT01539525|155850|P2|Overall Study|Withdrawal by Subject|3
35232|NCT01539525|155851|P1|Overall Study|Withdrawal by Subject|0
35233|NCT01539525|155849|P3|Overall Study|Lost to Follow-up|11
35234|NCT01539525|155850|P2|Overall Study|Lost to Follow-up|12
35235|NCT01539525|155851|P1|Overall Study|Lost to Follow-up|19
35236|NCT01539512|155870|P2|Overall Study|Richter's Transformation|0
35237|NCT01539512|155871|P1|Overall Study|Richter's Transformation|1
35238|NCT01539512|155870|P2|Overall Study|Withdrawal by Subject|5
35239|NCT01539512|155871|P1|Overall Study|Withdrawal by Subject|12
35240|NCT01539512|155870|P2|Overall Study|Physician Decision|1
35241|NCT01539512|155871|P1|Overall Study|Physician Decision|1
35242|NCT01539512|155870|P2|Overall Study|Adverse Event|7
35243|NCT01539512|155871|P1|Overall Study|Adverse Event|9
35244|NCT01539317|155887|P2|Overall Study|Screening Error. Deleted from analysis.|0
35245|NCT01539317|155888|P1|Overall Study|Screening Error. Deleted from analysis.|1
35246|NCT01539083|155918|P3|After Randomization (TP and VTP)|Progressive Disease|2
35247|NCT01539083|155919|P2|After Randomization (TP and VTP)|Progressive Disease|3
35248|NCT01539083|155920|P1|After Randomization (TP and VTP)|Progressive Disease|0
35249|NCT01539083|155918|P3|After Randomization (TP and VTP)|Death|6
35250|NCT01539083|155919|P2|After Randomization (TP and VTP)|Death|4
35251|NCT01539083|155920|P1|After Randomization (TP and VTP)|Death|0
35252|NCT01539083|155918|P3|After Randomization (TP and VTP)|Adverse Event|0
35253|NCT01539083|155919|P2|After Randomization (TP and VTP)|Adverse Event|1
35254|NCT01539083|155920|P1|After Randomization (TP and VTP)|Adverse Event|0
35255|NCT01539083|155918|P3|After Randomization (TP and VTP)|Withdrawal by Subject|1
35256|NCT01539083|155919|P2|After Randomization (TP and VTP)|Withdrawal by Subject|3
35257|NCT01539083|155920|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
35258|NCT01539083|155918|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
35259|NCT01539083|155919|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
35260|NCT01539083|155920|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
35261|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Unspecified|0
35262|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Unspecified|0
35263|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Unspecified|5
35264|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Progressive Disease|0
35265|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Progressive Disease|0
35266|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Progressive Disease|8
35267|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Physician Decision|0
35268|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Physician Decision|0
35269|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Physician Decision|14
35270|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Protocol Violation|0
35271|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Protocol Violation|0
35272|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Protocol Violation|2
35273|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Death|0
35274|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Death|0
35275|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Death|6
35276|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Adverse Event|0
35277|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Adverse Event|0
35278|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Adverse Event|14
35279|NCT01539083|155918|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
35280|NCT01539083|155919|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
35281|NCT01539083|155920|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
35282|NCT01538472|155962|P1|Overall Study|Death|1
35283|NCT01538472|155962|P1|Overall Study|Disease Progression|3
35284|NCT01537783|155996|P2|Overall Study|Lost to Follow-up|2
35285|NCT01537783|155997|P1|Overall Study|Lost to Follow-up|11
35286|NCT01537549|156048|P1|Overall Study|Withdrawal by Subject|2
35287|NCT01537549|156048|P1|Overall Study|Lost to Follow-up|1
35288|NCT01537432|156056|P2|Overall Study|Unsatisfactory therapeutic effect|0
35289|NCT01537432|156057|P1|Overall Study|Unsatisfactory therapeutic effect|1
35290|NCT01537432|156056|P2|Overall Study|Adverse Event|0
35291|NCT01537432|156057|P1|Overall Study|Adverse Event|1
35292|NCT01537432|156056|P2|Overall Study|Administrative problems|0
35293|NCT01537432|156057|P1|Overall Study|Administrative problems|1
35294|NCT01537432|156056|P2|Overall Study|Withdrawal by Subject|1
35295|NCT01537432|156057|P1|Overall Study|Withdrawal by Subject|0
35296|NCT01537432|156056|P2|Overall Study|Lost to Follow-up|1
35297|NCT01537432|156057|P1|Overall Study|Lost to Follow-up|3
35298|NCT01537302|156093|P1|Overall Study|Withdrawal by Subject|1
35299|NCT01537302|156093|P1|Overall Study|Lost to Follow-up|1
35300|NCT01537198|156100|P1|Overall Study|Not Specified|111
35301|NCT01537198|156100|P1|Overall Study|No Further Visits to the Clinic|37
35302|NCT01537198|156100|P1|Overall Study|Adverse Event|4
35303|NCT01537198|156100|P1|Overall Study|RSV infection|2
35304|NCT01537133|156129|P4|Overall Study|Lost to Follow-up|0
35305|NCT01537133|156130|P3|Overall Study|Lost to Follow-up|0
35306|NCT01537133|156131|P2|Overall Study|Lost to Follow-up|0
35307|NCT01537133|156132|P1|Overall Study|Lost to Follow-up|1
35308|NCT01537133|156129|P4|Overall Study|Withdrawal by Subject|0
35309|NCT01537133|156130|P3|Overall Study|Withdrawal by Subject|0
35310|NCT01537133|156131|P2|Overall Study|Withdrawal by Subject|0
35311|NCT01537133|156132|P1|Overall Study|Withdrawal by Subject|2
35312|NCT01537120|156148|P1|3 Weeks Placebo|Withdrawal by Subject|1
35313|NCT01537120|156148|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
35314|NCT01537081|156161|P3|Overall Study|Assigned but never dosed|0
35315|NCT01537081|156162|P2|Overall Study|Assigned but never dosed|0
35316|NCT01537081|156163|P1|Overall Study|Assigned but never dosed|1
35317|NCT01537081|156161|P3|Overall Study|Sponsor decision|0
35318|NCT01537081|156162|P2|Overall Study|Sponsor decision|1
35319|NCT01537081|156163|P1|Overall Study|Sponsor decision|0
35320|NCT01537081|156161|P3|Overall Study|Physician Decision|0
35321|NCT01537081|156162|P2|Overall Study|Physician Decision|6
35322|NCT01537081|156163|P1|Overall Study|Physician Decision|5
35323|NCT01537081|156161|P3|Overall Study|Withdrawal by Subject|3
35324|NCT01537081|156162|P2|Overall Study|Withdrawal by Subject|11
35325|NCT01537081|156163|P1|Overall Study|Withdrawal by Subject|6
35326|NCT01537081|156161|P3|Overall Study|Protocol Violation|2
35327|NCT01537081|156162|P2|Overall Study|Protocol Violation|2
35328|NCT01537081|156163|P1|Overall Study|Protocol Violation|3
35329|NCT01537081|156161|P3|Overall Study|Lost to Follow-up|9
35330|NCT01537081|156162|P2|Overall Study|Lost to Follow-up|15
35331|NCT01537081|156163|P1|Overall Study|Lost to Follow-up|17
35332|NCT01537081|156161|P3|Overall Study|Lack of Efficacy|0
35333|NCT01537081|156162|P2|Overall Study|Lack of Efficacy|1
35334|NCT01537081|156163|P1|Overall Study|Lack of Efficacy|2
35335|NCT01537081|156161|P3|Overall Study|Adverse Event|2
35336|NCT01537081|156162|P2|Overall Study|Adverse Event|2
35337|NCT01537081|156163|P1|Overall Study|Adverse Event|5
35338|NCT01537042|156176|P2|Overall Study|Other|1
35339|NCT01537042|156177|P1|Overall Study|Other|0
35340|NCT01537042|156176|P2|Overall Study|Protocol Violation|1
35341|NCT01537042|156177|P1|Overall Study|Protocol Violation|0
35342|NCT01537042|156176|P2|Overall Study|Lack of Efficacy|1
35343|NCT01537042|156177|P1|Overall Study|Lack of Efficacy|0
35344|NCT01537042|156176|P2|Overall Study|Adverse Event|2
35345|NCT01537042|156177|P1|Overall Study|Adverse Event|0
35346|NCT01536951|156215|P9|Second Intervention and Washout Period 2|Adverse Event|0
35347|NCT01536951|156216|P8|Second Intervention and Washout Period 2|Adverse Event|1
35348|NCT01536951|156217|P7|Second Intervention and Washout Period 2|Adverse Event|0
35349|NCT01536951|156218|P6|Second Intervention and Washout Period 2|Adverse Event|0
35350|NCT01536951|156219|P5|Second Intervention and Washout Period 2|Adverse Event|0
35351|NCT01536951|156220|P4|Second Intervention and Washout Period 2|Adverse Event|0
35352|NCT01536951|156221|P3|Second Intervention and Washout Period 2|Adverse Event|0
35353|NCT01536951|156222|P2|Second Intervention and Washout Period 2|Adverse Event|0
35354|NCT01536951|156223|P1|Second Intervention and Washout Period 2|Adverse Event|0
35355|NCT01536951|156215|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
35356|NCT01536951|156216|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
35357|NCT01536951|156217|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
35529|NCT01535807|156863|P1|Overall Study|Withdrawal by Subject|1
35358|NCT01536951|156218|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
35359|NCT01536951|156219|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
35360|NCT01536951|156220|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
35361|NCT01536951|156221|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
35362|NCT01536951|156222|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
35363|NCT01536951|156223|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
35364|NCT01536860|156280|P3|Washout Period (3 Days)|Lost to Follow-up|0
35365|NCT01536860|156281|P2|Washout Period (3 Days)|Lost to Follow-up|0
35366|NCT01536860|156282|P1|Washout Period (3 Days)|Lost to Follow-up|1
35367|NCT01536704|156290|P4|Washout Period 3|Adverse Event|0
35368|NCT01536704|156291|P3|Washout Period 3|Adverse Event|1
35369|NCT01536704|156292|P2|Washout Period 3|Adverse Event|0
35370|NCT01536704|156293|P1|Washout Period 3|Adverse Event|0
35371|NCT01536704|156290|P4|Period 3|Adverse Event|1
35372|NCT01536704|156291|P3|Period 3|Adverse Event|0
35373|NCT01536704|156292|P2|Period 3|Adverse Event|0
35374|NCT01536704|156293|P1|Period 3|Adverse Event|0
35375|NCT01536704|156290|P4|Washout Period 2|Withdrawal by Subject|1
35376|NCT01536704|156291|P3|Washout Period 2|Withdrawal by Subject|0
35377|NCT01536704|156292|P2|Washout Period 2|Withdrawal by Subject|0
35378|NCT01536704|156293|P1|Washout Period 2|Withdrawal by Subject|0
35379|NCT01536704|156290|P4|Washout Period 2|Adverse Event|0
35380|NCT01536704|156291|P3|Washout Period 2|Adverse Event|0
35381|NCT01536704|156292|P2|Washout Period 2|Adverse Event|0
35382|NCT01536704|156293|P1|Washout Period 2|Adverse Event|1
35383|NCT01536704|156290|P4|Washout Period 1|Withdrawal by Subject|0
35384|NCT01536704|156291|P3|Washout Period 1|Withdrawal by Subject|0
35385|NCT01536704|156292|P2|Washout Period 1|Withdrawal by Subject|2
35386|NCT01536704|156293|P1|Washout Period 1|Withdrawal by Subject|1
35387|NCT01536587|156323|P1|Overall Study|Adverse Event|2
35388|NCT01536574|156362|P2|Overall Study|Lack of Efficacy|0
35389|NCT01536574|156363|P1|Overall Study|Lack of Efficacy|1
35390|NCT01536574|156362|P2|Overall Study|Withdrawal by Subject|2
35391|NCT01536574|156363|P1|Overall Study|Withdrawal by Subject|1
35392|NCT01536574|156362|P2|Overall Study|Adverse Event|5
35393|NCT01536574|156363|P1|Overall Study|Adverse Event|4
35478|NCT01536145|156662|P9|Overall Study|Unspecified|0
35394|NCT01536561|156381|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
35395|NCT01536561|156381|P1|Dosimetric and Therapeutic Treatment|Death|2
35396|NCT01536561|156381|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
35397|NCT01536561|156381|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
35398|NCT01536561|156381|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
35399|NCT01536561|156381|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
35400|NCT01536418|156458|P2|Overall Study|Withdrawal by Subject|3
35401|NCT01536418|156459|P1|Overall Study|Withdrawal by Subject|5
35402|NCT01536418|156458|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
35403|NCT01536418|156459|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
35404|NCT01536418|156458|P2|Overall Study|Adverse Event|4
35405|NCT01536418|156459|P1|Overall Study|Adverse Event|9
35406|NCT01536418|156458|P2|Overall Study|Lack of Efficacy|16
35407|NCT01536418|156459|P1|Overall Study|Lack of Efficacy|10
35408|NCT01536418|156458|P2|Overall Study|Study closed/terminated|37
35409|NCT01536418|156459|P1|Overall Study|Study closed/terminated|41
35410|NCT01536418|156458|P2|Overall Study|Physician Decision|3
35411|NCT01536418|156459|P1|Overall Study|Physician Decision|1
35412|NCT01536418|156458|P2|Overall Study|Protocol Violation|3
35413|NCT01536418|156459|P1|Overall Study|Protocol Violation|2
35414|NCT01536405|156479|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
35415|NCT01536405|156480|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
35416|NCT01536405|156479|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
35417|NCT01536405|156480|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
35418|NCT01536405|156479|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
35419|NCT01536405|156480|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
35420|NCT01536405|156479|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
35421|NCT01536405|156480|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
35422|NCT01536405|156479|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
35423|NCT01536405|156480|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
35424|NCT01536405|156479|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
35425|NCT01536405|156480|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
35426|NCT01536405|156479|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
35427|NCT01536405|156480|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
35428|NCT01536405|156479|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
35429|NCT01536405|156480|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
35430|NCT01536405|156479|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
35431|NCT01536405|156480|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
35432|NCT01536405|156479|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
35433|NCT01536405|156480|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
35434|NCT01536405|156479|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
35435|NCT01536405|156480|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
35436|NCT01536405|156479|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
35437|NCT01536405|156480|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
35438|NCT01536405|156479|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
35439|NCT01536405|156480|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
35440|NCT01536379|156518|P2|Overall Study|Withdrawal by Subject|1
35441|NCT01536379|156519|P1|Overall Study|Withdrawal by Subject|1
35442|NCT01536379|156518|P2|Overall Study|Adverse Event|2
35443|NCT01536379|156519|P1|Overall Study|Adverse Event|1
35444|NCT01536262|156611|P3|Overall Study|Other than stated above|0
35445|NCT01536262|156612|P2|Overall Study|Other than stated above|0
35446|NCT01536262|156613|P1|Overall Study|Other than stated above|1
35447|NCT01536262|156611|P3|Overall Study|Withdrawal by Subject|0
35448|NCT01536262|156612|P2|Overall Study|Withdrawal by Subject|1
35449|NCT01536262|156613|P1|Overall Study|Withdrawal by Subject|1
35450|NCT01536262|156611|P3|Overall Study|Adverse Event|2
35451|NCT01536262|156612|P2|Overall Study|Adverse Event|1
35452|NCT01536262|156613|P1|Overall Study|Adverse Event|6
35453|NCT01536171|156655|P1|Overall Study|Withdrawal by Subject|1
35454|NCT01536145|156660|P11|Overall Study|Adverse Event|3
35455|NCT01536145|156661|P10|Overall Study|Adverse Event|0
35456|NCT01536145|156662|P9|Overall Study|Adverse Event|0
35457|NCT01536145|156663|P8|Overall Study|Adverse Event|2
35458|NCT01536145|156664|P7|Overall Study|Adverse Event|0
35459|NCT01536145|156665|P6|Overall Study|Adverse Event|0
35460|NCT01536145|156666|P5|Overall Study|Adverse Event|0
35461|NCT01536145|156667|P4|Overall Study|Adverse Event|0
35462|NCT01536145|156668|P3|Overall Study|Adverse Event|0
35463|NCT01536145|156669|P2|Overall Study|Adverse Event|0
35464|NCT01536145|156670|P1|Overall Study|Adverse Event|0
35465|NCT01536145|156660|P11|Overall Study|Death|0
35466|NCT01536145|156661|P10|Overall Study|Death|0
35467|NCT01536145|156662|P9|Overall Study|Death|0
35468|NCT01536145|156663|P8|Overall Study|Death|0
35469|NCT01536145|156664|P7|Overall Study|Death|1
35470|NCT01536145|156665|P6|Overall Study|Death|0
35471|NCT01536145|156666|P5|Overall Study|Death|0
35472|NCT01536145|156667|P4|Overall Study|Death|0
35473|NCT01536145|156668|P3|Overall Study|Death|0
35474|NCT01536145|156669|P2|Overall Study|Death|0
35475|NCT01536145|156670|P1|Overall Study|Death|0
35476|NCT01536145|156660|P11|Overall Study|Unspecified|2
35477|NCT01536145|156661|P10|Overall Study|Unspecified|3
35479|NCT01536145|156663|P8|Overall Study|Unspecified|0
35480|NCT01536145|156664|P7|Overall Study|Unspecified|0
35481|NCT01536145|156665|P6|Overall Study|Unspecified|0
35482|NCT01536145|156666|P5|Overall Study|Unspecified|1
35483|NCT01536145|156667|P4|Overall Study|Unspecified|0
35484|NCT01536145|156668|P3|Overall Study|Unspecified|0
35485|NCT01536145|156669|P2|Overall Study|Unspecified|0
35486|NCT01536145|156670|P1|Overall Study|Unspecified|0
35487|NCT01536145|156660|P11|Overall Study|Withdrawal by Subject|2
35488|NCT01536145|156661|P10|Overall Study|Withdrawal by Subject|0
35489|NCT01536145|156662|P9|Overall Study|Withdrawal by Subject|2
35490|NCT01536145|156663|P8|Overall Study|Withdrawal by Subject|0
35491|NCT01536145|156664|P7|Overall Study|Withdrawal by Subject|0
35492|NCT01536145|156665|P6|Overall Study|Withdrawal by Subject|1
35493|NCT01536145|156666|P5|Overall Study|Withdrawal by Subject|0
35494|NCT01536145|156667|P4|Overall Study|Withdrawal by Subject|0
35495|NCT01536145|156668|P3|Overall Study|Withdrawal by Subject|1
35496|NCT01536145|156669|P2|Overall Study|Withdrawal by Subject|0
35497|NCT01536145|156670|P1|Overall Study|Withdrawal by Subject|0
35498|NCT01536145|156660|P11|Overall Study|Progressive disease|3
35499|NCT01536145|156661|P10|Overall Study|Progressive disease|3
35500|NCT01536145|156662|P9|Overall Study|Progressive disease|1
35501|NCT01536145|156663|P8|Overall Study|Progressive disease|2
35502|NCT01536145|156664|P7|Overall Study|Progressive disease|1
35503|NCT01536145|156665|P6|Overall Study|Progressive disease|2
35504|NCT01536145|156666|P5|Overall Study|Progressive disease|1
35505|NCT01536145|156667|P4|Overall Study|Progressive disease|2
35506|NCT01536145|156668|P3|Overall Study|Progressive disease|1
35507|NCT01536145|156669|P2|Overall Study|Progressive disease|4
35508|NCT01536145|156670|P1|Overall Study|Progressive disease|3
35509|NCT01536119|156777|P2|Overall Study|Lost to Follow-up|14
35510|NCT01536119|156778|P1|Overall Study|Lost to Follow-up|17
35511|NCT01536093|156804|P2|Overall Study|Withdrawal by Subject|1
35512|NCT01536093|156805|P1|Overall Study|Withdrawal by Subject|0
35513|NCT01536093|156804|P2|Overall Study|absence of maternal colostrum|0
35514|NCT01536093|156805|P1|Overall Study|absence of maternal colostrum|2
35515|NCT01536093|156804|P2|Overall Study|Death|2
35516|NCT01536093|156805|P1|Overall Study|Death|1
35517|NCT01536067|156821|P1|Overall Study|Disease Progression|1
35518|NCT01536015|156834|P2|Overall Study|Study closure|5
35519|NCT01536015|156835|P1|Overall Study|Study closure|5
35520|NCT01536015|156834|P2|Overall Study|Inclusion Criterion not met|0
35521|NCT01536015|156835|P1|Overall Study|Inclusion Criterion not met|2
35522|NCT01536015|156834|P2|Overall Study|Lost to Follow-up|1
35523|NCT01536015|156835|P1|Overall Study|Lost to Follow-up|0
35524|NCT01536015|156834|P2|Overall Study|Adverse Event|4
35525|NCT01536015|156835|P1|Overall Study|Adverse Event|1
35526|NCT01535807|156862|P2|Overall Study|Data collection error|1
35527|NCT01535807|156863|P1|Overall Study|Data collection error|1
35528|NCT01535807|156862|P2|Overall Study|Withdrawal by Subject|1
35530|NCT01535729|156869|P1|Overall Study|No participant record available|5
35531|NCT01535729|156869|P1|Overall Study|Not treated|9
35532|NCT01535729|156869|P1|Overall Study|Screening failure|1
35533|NCT01535729|156869|P1|Overall Study|Protocol Violation|11
35534|NCT01535729|156869|P1|Overall Study|NSCLC grade IV histology not confirmed|20
35535|NCT01535729|156869|P1|Overall Study|No previous chemotherapy|33
35536|NCT01535729|156869|P1|Overall Study|Did not sign informed consent|1
35537|NCT01535729|156869|P1|Overall Study|Unspecified|19
35538|NCT01535729|156869|P1|Overall Study|Death|52
35539|NCT01535729|156869|P1|Overall Study|Lost to Follow-up|8
35540|NCT01535729|156869|P1|Overall Study|Discontinued treatment|25
35541|NCT01535729|156869|P1|Overall Study|Disease progression|230
35542|NCT01535729|156869|P1|Overall Study|Withdrawal by Subject|2
35543|NCT01535638|156910|P6|Treatment 3 (Single Dose)|Protocol Violation|0
35544|NCT01535638|156911|P5|Treatment 3 (Single Dose)|Protocol Violation|0
35545|NCT01535638|156912|P4|Treatment 3 (Single Dose)|Protocol Violation|1
35546|NCT01535638|156913|P3|Treatment 3 (Single Dose)|Protocol Violation|0
35547|NCT01535638|156914|P2|Treatment 3 (Single Dose)|Protocol Violation|0
35548|NCT01535638|156915|P1|Treatment 3 (Single Dose)|Protocol Violation|0
35549|NCT01535638|156910|P6|Treatment 1 (Single Dose)|Protocol Violation|1
35550|NCT01535638|156911|P5|Treatment 1 (Single Dose)|Protocol Violation|0
35551|NCT01535638|156912|P4|Treatment 1 (Single Dose)|Protocol Violation|0
35552|NCT01535638|156913|P3|Treatment 1 (Single Dose)|Protocol Violation|0
35553|NCT01535638|156914|P2|Treatment 1 (Single Dose)|Protocol Violation|0
35554|NCT01535638|156915|P1|Treatment 1 (Single Dose)|Protocol Violation|0
35555|NCT01535599|156929|P2|Overall Study|Noncompliance|1
35556|NCT01535599|156930|P1|Overall Study|Noncompliance|0
35557|NCT01535599|156929|P2|Overall Study|Stopped medication|1
35558|NCT01535599|156930|P1|Overall Study|Stopped medication|0
35559|NCT01535599|156929|P2|Overall Study|Unspecified|0
35560|NCT01535599|156930|P1|Overall Study|Unspecified|1
35561|NCT01535599|156929|P2|Overall Study|Did not use product|0
35562|NCT01535599|156930|P1|Overall Study|Did not use product|1
35563|NCT01535599|156929|P2|Overall Study|Randomized in Error|4
35564|NCT01535599|156930|P1|Overall Study|Randomized in Error|2
35565|NCT01535599|156929|P2|Overall Study|BL Culture + for Yeast//Fungi|1
35566|NCT01535599|156930|P1|Overall Study|BL Culture + for Yeast//Fungi|0
35567|NCT01535599|156929|P2|Overall Study|BL Culture + for Group A Strep|1
35568|NCT01535599|156930|P1|Overall Study|BL Culture + for Group A Strep|0
35569|NCT01535599|156929|P2|Overall Study|Treatment Failure|66
35570|NCT01535599|156930|P1|Overall Study|Treatment Failure|33
35571|NCT01535599|156929|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
35572|NCT01535599|156930|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
35573|NCT01535599|156929|P2|Overall Study|Lost to Follow-up|4
35574|NCT01535599|156930|P1|Overall Study|Lost to Follow-up|3
35575|NCT01535599|156929|P2|Overall Study|Adverse Event|15
35576|NCT01535599|156930|P1|Overall Study|Adverse Event|6
35577|NCT01535560|156942|P2|Overall Study|Randomized in Error|1
35578|NCT01535560|156943|P1|Overall Study|Randomized in Error|0
35579|NCT01535560|156942|P2|Overall Study|Other|1
35580|NCT01535560|156943|P1|Overall Study|Other|0
35581|NCT01535560|156942|P2|Overall Study|Treatment Failure|83
35582|NCT01535560|156943|P1|Overall Study|Treatment Failure|21
35583|NCT01535560|156942|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
35584|NCT01535560|156943|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
35585|NCT01535560|156942|P2|Overall Study|Lost to Follow-up|3
35586|NCT01535560|156943|P1|Overall Study|Lost to Follow-up|1
35587|NCT01535560|156942|P2|Overall Study|Adverse Event|7
35588|NCT01535560|156943|P1|Overall Study|Adverse Event|12
35589|NCT01535261|156986|P1|Overall Study|Adverse Event|12
35590|NCT01535261|156986|P1|Overall Study|Withdrawal by Subject|14
35591|NCT01535261|156986|P1|Overall Study|Lost to Follow-up|8
35592|NCT01535261|156986|P1|Overall Study|Death|5
35593|NCT01535261|156986|P1|Overall Study|Protocol Violation|3
35594|NCT01535261|156986|P1|Overall Study|Physician Decision|8
35595|NCT01535235|156999|P2|Overall Study|Adverse Event|0
35596|NCT01535235|157000|P1|Overall Study|Adverse Event|1
35597|NCT01535222|157014|P6|Overall Study|Inclusion/exclusion|0
35598|NCT01535222|157015|P5|Overall Study|Inclusion/exclusion|0
35599|NCT01535222|157016|P4|Overall Study|Inclusion/exclusion|0
35600|NCT01535222|157017|P3|Overall Study|Inclusion/exclusion|1
35601|NCT01535222|157018|P2|Overall Study|Inclusion/exclusion|0
35602|NCT01535222|157019|P1|Overall Study|Inclusion/exclusion|0
35603|NCT01535040|157050|P2|Overall Study|Multiple Reasons|1
35604|NCT01535040|157051|P1|Overall Study|Multiple Reasons|1
35605|NCT01535040|157050|P2|Overall Study|Toxicity|5
35606|NCT01535040|157051|P1|Overall Study|Toxicity|7
35607|NCT01535040|157050|P2|Overall Study|Never Started|4
35608|NCT01535040|157051|P1|Overall Study|Never Started|9
35609|NCT01535040|157050|P2|Overall Study|Withdrawal by Subject|10
35610|NCT01535040|157051|P1|Overall Study|Withdrawal by Subject|13
35611|NCT01535040|157050|P2|Overall Study|Physician Decision|1
35612|NCT01535040|157051|P1|Overall Study|Physician Decision|0
35613|NCT01534962|157092|P4|Overall Study|Discontinued at AF recurrence|31
35614|NCT01534962|157093|P3|Overall Study|Discontinued at AF recurrence|24
35615|NCT01534962|157094|P2|Overall Study|Discontinued at AF recurrence|26
35616|NCT01534962|157095|P1|Overall Study|Discontinued at AF recurrence|35
35617|NCT01534962|157092|P4|Overall Study|Randomized but did not start treatment|1
35618|NCT01534962|157093|P3|Overall Study|Randomized but did not start treatment|0
35619|NCT01534962|157094|P2|Overall Study|Randomized but did not start treatment|0
35620|NCT01534962|157095|P1|Overall Study|Randomized but did not start treatment|2
35621|NCT01534676|157152|P2|Overall Study|Study closed due to poor enrollment|1
35622|NCT01534676|157153|P1|Overall Study|Study closed due to poor enrollment|2
35623|NCT01534637|157159|P1|Overall Study|Liver Mets before treatment|1
35624|NCT01534637|157159|P1|Overall Study|Adverse Event|1
35625|NCT01534637|157159|P1|Overall Study|Withdrawal by Subject|1
35626|NCT01534637|157159|P1|Overall Study|Lack of Efficacy|3
35627|NCT01534637|157159|P1|Overall Study|Physician Decision|3
35628|NCT01534533|157169|P4|Overall Study|Withdrawal by Subject|1
35629|NCT01534533|157170|P3|Overall Study|Withdrawal by Subject|4
35630|NCT01534533|157171|P2|Overall Study|Withdrawal by Subject|3
35631|NCT01534533|157172|P1|Overall Study|Withdrawal by Subject|5
35632|NCT01534533|157169|P4|Overall Study|Lost to Follow-up|3
35633|NCT01534533|157170|P3|Overall Study|Lost to Follow-up|4
35634|NCT01534533|157171|P2|Overall Study|Lost to Follow-up|0
35635|NCT01534533|157172|P1|Overall Study|Lost to Follow-up|3
35636|NCT01534520|157200|P2|Overall Study|Adverse Event|1
35637|NCT01534520|157201|P1|Overall Study|Adverse Event|0
35638|NCT01534351|157216|P3|Overall Study|Study Terminated Early|0
35639|NCT01534351|157217|P2|Overall Study|Study Terminated Early|0
35640|NCT01534351|157218|P1|Overall Study|Study Terminated Early|1
35641|NCT01534208|157237|P2|Overall Study|Needed prohibited meds|0
35642|NCT01534208|157238|P1|Overall Study|Needed prohibited meds|1
35643|NCT01534208|157237|P2|Overall Study|PCP decision|0
35644|NCT01534208|157238|P1|Overall Study|PCP decision|1
35645|NCT01534208|157237|P2|Overall Study|Eligibility error|0
35646|NCT01534208|157238|P1|Overall Study|Eligibility error|3
35647|NCT01534208|157237|P2|Overall Study|Lab assessment|1
35648|NCT01534208|157238|P1|Overall Study|Lab assessment|2
35649|NCT01534208|157237|P2|Overall Study|Subject relocation|0
35650|NCT01534208|157238|P1|Overall Study|Subject relocation|2
35651|NCT01534208|157237|P2|Overall Study|Sponsor decision|1
35652|NCT01534208|157238|P1|Overall Study|Sponsor decision|4
35653|NCT01534208|157237|P2|Overall Study|Protocol Violation|2
35654|NCT01534208|157238|P1|Overall Study|Protocol Violation|2
35655|NCT01534208|157237|P2|Overall Study|Lack of Efficacy|3
35656|NCT01534208|157238|P1|Overall Study|Lack of Efficacy|0
35657|NCT01534208|157237|P2|Overall Study|Physician Decision|0
35658|NCT01534208|157238|P1|Overall Study|Physician Decision|2
35659|NCT01534208|157237|P2|Overall Study|Adverse Event|8
35660|NCT01534208|157238|P1|Overall Study|Adverse Event|15
35661|NCT01534208|157237|P2|Overall Study|Withdrawal by Subject|20
35662|NCT01534208|157238|P1|Overall Study|Withdrawal by Subject|6
35663|NCT01534208|157237|P2|Overall Study|Lost to Follow-up|14
35664|NCT01534208|157238|P1|Overall Study|Lost to Follow-up|19
35665|NCT01534182|157256|P2|Overall Study|Adverse Event|3
35666|NCT01534182|157257|P1|Overall Study|Adverse Event|7
35667|NCT01534182|157256|P2|Overall Study|Withdrawal by Subject|7
35668|NCT01534182|157257|P1|Overall Study|Withdrawal by Subject|4
35669|NCT01534182|157256|P2|Overall Study|Administrative problems|0
35670|NCT01534182|157257|P1|Overall Study|Administrative problems|1
35671|NCT01534078|157288|P1|Overall Study|Withdrawal by Subject|1
35672|NCT01534078|157288|P1|Overall Study|Death|1
35673|NCT01533935|157304|P5|Overall Study|Other reason not defined above|1
35674|NCT01533935|157305|P4|Overall Study|Other reason not defined above|0
35675|NCT01533935|157306|P3|Overall Study|Other reason not defined above|1
35676|NCT01533935|157307|P2|Overall Study|Other reason not defined above|0
35677|NCT01533935|157308|P1|Overall Study|Other reason not defined above|1
35678|NCT01533935|157304|P5|Overall Study|Withdrawal by Subject|4
35679|NCT01533935|157305|P4|Overall Study|Withdrawal by Subject|2
35680|NCT01533935|157306|P3|Overall Study|Withdrawal by Subject|5
35681|NCT01533935|157307|P2|Overall Study|Withdrawal by Subject|4
35682|NCT01533935|157308|P1|Overall Study|Withdrawal by Subject|0
35683|NCT01533935|157304|P5|Overall Study|Lost to Follow-up|0
35684|NCT01533935|157305|P4|Overall Study|Lost to Follow-up|0
35685|NCT01533935|157306|P3|Overall Study|Lost to Follow-up|1
35686|NCT01533935|157307|P2|Overall Study|Lost to Follow-up|0
35687|NCT01533935|157308|P1|Overall Study|Lost to Follow-up|0
35688|NCT01533935|157304|P5|Overall Study|Protocol Violation|0
35689|NCT01533935|157305|P4|Overall Study|Protocol Violation|0
35690|NCT01533935|157306|P3|Overall Study|Protocol Violation|0
35691|NCT01533935|157307|P2|Overall Study|Protocol Violation|2
35692|NCT01533935|157308|P1|Overall Study|Protocol Violation|0
35693|NCT01533935|157304|P5|Overall Study|Adverse Event|3
35694|NCT01533935|157305|P4|Overall Study|Adverse Event|5
35695|NCT01533935|157306|P3|Overall Study|Adverse Event|1
35696|NCT01533935|157307|P2|Overall Study|Adverse Event|7
35697|NCT01533935|157308|P1|Overall Study|Adverse Event|5
35698|NCT01533922|157335|P5|Overall Study|Other reason not defined above|0
35699|NCT01533922|157336|P4|Overall Study|Other reason not defined above|0
35700|NCT01533922|157337|P3|Overall Study|Other reason not defined above|1
35701|NCT01533922|157338|P2|Overall Study|Other reason not defined above|0
35702|NCT01533922|157339|P1|Overall Study|Other reason not defined above|2
35703|NCT01533922|157335|P5|Overall Study|Withdrawal by Subject|1
35704|NCT01533922|157336|P4|Overall Study|Withdrawal by Subject|2
35705|NCT01533922|157337|P3|Overall Study|Withdrawal by Subject|2
35706|NCT01533922|157338|P2|Overall Study|Withdrawal by Subject|1
35707|NCT01533922|157339|P1|Overall Study|Withdrawal by Subject|3
35708|NCT01533922|157335|P5|Overall Study|Protocol Violation|1
35709|NCT01533922|157336|P4|Overall Study|Protocol Violation|0
35710|NCT01533922|157337|P3|Overall Study|Protocol Violation|0
35711|NCT01533922|157338|P2|Overall Study|Protocol Violation|3
35712|NCT01533922|157339|P1|Overall Study|Protocol Violation|0
35713|NCT01533922|157335|P5|Overall Study|Lack of Efficacy|0
35714|NCT01533922|157336|P4|Overall Study|Lack of Efficacy|0
35715|NCT01533922|157337|P3|Overall Study|Lack of Efficacy|1
35716|NCT01533922|157338|P2|Overall Study|Lack of Efficacy|0
35717|NCT01533922|157339|P1|Overall Study|Lack of Efficacy|0
35718|NCT01533922|157335|P5|Overall Study|Adverse Event|4
35719|NCT01533922|157336|P4|Overall Study|Adverse Event|3
35720|NCT01533922|157337|P3|Overall Study|Adverse Event|6
35721|NCT01533922|157338|P2|Overall Study|Adverse Event|8
35722|NCT01533922|157339|P1|Overall Study|Adverse Event|5
35723|NCT01533493|157402|P2|Overall Study|Lost to Follow-up|0
35724|NCT01533493|157403|P1|Overall Study|Lost to Follow-up|2
35725|NCT01533493|157402|P2|Overall Study|Withdrawal by Subject|2
35726|NCT01533493|157403|P1|Overall Study|Withdrawal by Subject|1
35727|NCT01533493|157402|P2|Overall Study|Adverse Event|1
35728|NCT01533493|157403|P1|Overall Study|Adverse Event|2
35729|NCT01533428|157411|P2|Overall Study|Withdrawal by Subject|6
35730|NCT01533428|157412|P1|Overall Study|Withdrawal by Subject|7
35731|NCT01533428|157411|P2|Overall Study|Lost to Follow-up|1
35732|NCT01533428|157412|P1|Overall Study|Lost to Follow-up|2
35733|NCT01533428|157411|P2|Overall Study|Adverse Event|1
35734|NCT01533428|157412|P1|Overall Study|Adverse Event|0
35735|NCT01533246|157458|P1|Overall Study|Withdrawal by Subject|1
35736|NCT01533246|157458|P1|Overall Study|Adverse Event|1
35737|NCT01533181|157469|P2|Overall Study|Patient withdrawal pre-active treatment|0
35738|NCT01533181|157470|P1|Overall Study|Patient withdrawal pre-active treatment|1
35739|NCT01533181|157469|P2|Overall Study|Disease progression pre-active treatment|1
35740|NCT01533181|157470|P1|Overall Study|Disease progression pre-active treatment|0
35741|NCT01532999|157587|P2|Overall Study|New job|2
35742|NCT01532999|157588|P1|Overall Study|New job|0
35743|NCT01532999|157587|P2|Overall Study|incarcerated|1
35744|NCT01532999|157588|P1|Overall Study|incarcerated|0
35745|NCT01532999|157587|P2|Overall Study|Adverse Event|1
35746|NCT01532999|157588|P1|Overall Study|Adverse Event|0
35747|NCT01532999|157587|P2|Overall Study|no show for week 9 assessments|4
35748|NCT01532999|157588|P1|Overall Study|no show for week 9 assessments|6
35749|NCT01532999|157587|P2|Overall Study|substantial noncompliance|0
35750|NCT01532999|157588|P1|Overall Study|substantial noncompliance|2
35751|NCT01532999|157587|P2|Overall Study|should not have been randomized|0
35752|NCT01532999|157588|P1|Overall Study|should not have been randomized|1
35753|NCT01532999|157587|P2|Overall Study|Relocated|0
35754|NCT01532999|157588|P1|Overall Study|Relocated|2
35755|NCT01532999|157587|P2|Overall Study|Withdrawal by Subject|0
35756|NCT01532999|157588|P1|Overall Study|Withdrawal by Subject|5
35757|NCT01532999|157587|P2|Overall Study|Physician Decision|2
35758|NCT01532999|157588|P1|Overall Study|Physician Decision|1
35759|NCT01532999|157587|P2|Overall Study|Lost to Follow-up|8
35760|NCT01532999|157588|P1|Overall Study|Lost to Follow-up|14
35761|NCT01532934|157670|P2|Overall Study|In controlled environment|2
35762|NCT01532934|157671|P1|Overall Study|In controlled environment|3
35763|NCT01532934|157670|P2|Overall Study|Lost to Follow-up|11
35764|NCT01532934|157671|P1|Overall Study|Lost to Follow-up|11
35765|NCT01532869|157683|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
35766|NCT01532869|157684|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
35767|NCT01532869|157683|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
35768|NCT01532869|157684|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
35769|NCT01532869|157683|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
35770|NCT01532869|157684|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
35771|NCT01532869|157683|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
35772|NCT01532869|157684|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
35773|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
35774|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
35775|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
35776|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
35777|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
35778|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
35779|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
35780|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
35781|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
35782|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
35783|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
35784|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
35785|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
35786|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
35787|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
35788|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
35789|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
35790|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
35791|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
35792|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
35793|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
35794|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
35795|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
35796|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
35797|NCT01532869|157683|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
35798|NCT01532869|157684|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
35799|NCT01532570|157737|P4|Overall Study|Withdrawal by Subject|0
35800|NCT01532570|157738|P3|Overall Study|Withdrawal by Subject|0
35801|NCT01532570|157739|P2|Overall Study|Withdrawal by Subject|1
35802|NCT01532570|157740|P1|Overall Study|Withdrawal by Subject|0
35803|NCT01532570|157737|P4|Overall Study|Lack of Efficacy|0
35804|NCT01532570|157738|P3|Overall Study|Lack of Efficacy|0
35805|NCT01532570|157739|P2|Overall Study|Lack of Efficacy|0
35806|NCT01532570|157740|P1|Overall Study|Lack of Efficacy|1
35807|NCT01532414|157785|P3|Overall Study|Withdrawn by sponsor|0
35808|NCT01532414|157786|P2|Overall Study|Withdrawn by sponsor|0
35809|NCT01532414|157787|P1|Overall Study|Withdrawn by sponsor|1
35810|NCT01532414|157785|P3|Overall Study|Unable to complete 24 hour PK|1
35811|NCT01532414|157786|P2|Overall Study|Unable to complete 24 hour PK|0
35812|NCT01532414|157787|P1|Overall Study|Unable to complete 24 hour PK|0
35813|NCT01532414|157785|P3|Overall Study|Adverse Event|1
35814|NCT01532414|157786|P2|Overall Study|Adverse Event|1
35815|NCT01532414|157787|P1|Overall Study|Adverse Event|0
35816|NCT01532414|157785|P3|Overall Study|No V6 semen sample|0
35817|NCT01532414|157786|P2|Overall Study|No V6 semen sample|1
35818|NCT01532414|157787|P1|Overall Study|No V6 semen sample|0
35819|NCT01532414|157785|P3|Overall Study|Withdrawal by Subject|0
35820|NCT01532414|157786|P2|Overall Study|Withdrawal by Subject|0
35821|NCT01532414|157787|P1|Overall Study|Withdrawal by Subject|3
35822|NCT01532414|157785|P3|Overall Study|Lost to Follow-up|1
35823|NCT01532414|157786|P2|Overall Study|Lost to Follow-up|0
35824|NCT01532414|157787|P1|Overall Study|Lost to Follow-up|3
35825|NCT01531998|157853|P1|Overall Study|Withdrawal by Subject|3
35826|NCT01531725|157858|P1|Overall Study|Protocol Violation|5
35827|NCT01531387|157865|P2|Overall Study|Early termination of study|11
35828|NCT01531387|157866|P1|Overall Study|Early termination of study|11
35829|NCT01531205|157958|P1|Overall Study|Did not proceed to surgery|1
35830|NCT01530997|157967|P1|Overall Study|Withdrawal by Subject|1
35831|NCT01530997|157967|P1|Overall Study|Physician Decision|1
35832|NCT01530464|158011|P2|Washout (24h)|Withdrawal by Subject|1
35833|NCT01530464|158012|P1|Washout (24h)|Withdrawal by Subject|0
35834|NCT01530464|158011|P2|Washout (24h)|Withdrawal by Subject|0
35835|NCT01530464|158012|P1|Washout (24h)|Withdrawal by Subject|1
35836|NCT01530334|158064|P1|Overall Study|Progressive disease|47
35837|NCT01530334|158064|P1|Overall Study|unknown reason|1
35838|NCT01530334|158064|P1|Overall Study|Adverse Event|3
35839|NCT01530087|158098|P1|Overall Study|Physician Decision|2
35840|NCT01529645|158120|P10|Overall Study|Withdrawal by Subject|0
35841|NCT01529645|158121|P9|Overall Study|Withdrawal by Subject|0
35842|NCT01529645|158122|P8|Overall Study|Withdrawal by Subject|0
35843|NCT01529645|158123|P7|Overall Study|Withdrawal by Subject|0
35844|NCT01529645|158124|P6|Overall Study|Withdrawal by Subject|1
35845|NCT01529645|158125|P5|Overall Study|Withdrawal by Subject|1
35846|NCT01529645|158126|P4|Overall Study|Withdrawal by Subject|1
35847|NCT01529645|158127|P3|Overall Study|Withdrawal by Subject|0
35848|NCT01529645|158128|P2|Overall Study|Withdrawal by Subject|0
35849|NCT01529645|158129|P1|Overall Study|Withdrawal by Subject|2
35850|NCT01529645|158120|P10|Overall Study|SAE - Premature contractions|0
35851|NCT01529645|158121|P9|Overall Study|SAE - Premature contractions|0
35852|NCT01529645|158122|P8|Overall Study|SAE - Premature contractions|0
35853|NCT01529645|158123|P7|Overall Study|SAE - Premature contractions|0
35854|NCT01529645|158124|P6|Overall Study|SAE - Premature contractions|0
35855|NCT01529645|158125|P5|Overall Study|SAE - Premature contractions|0
35856|NCT01529645|158126|P4|Overall Study|SAE - Premature contractions|0
35857|NCT01529645|158127|P3|Overall Study|SAE - Premature contractions|1
35858|NCT01529645|158128|P2|Overall Study|SAE - Premature contractions|0
35859|NCT01529645|158129|P1|Overall Study|SAE - Premature contractions|0
35860|NCT01529645|158120|P10|Overall Study|Lost to Follow-up|0
35861|NCT01529645|158121|P9|Overall Study|Lost to Follow-up|1
35862|NCT01529645|158122|P8|Overall Study|Lost to Follow-up|0
35863|NCT01529645|158123|P7|Overall Study|Lost to Follow-up|2
35864|NCT01529645|158124|P6|Overall Study|Lost to Follow-up|0
35865|NCT01529645|158125|P5|Overall Study|Lost to Follow-up|1
35866|NCT01529645|158126|P4|Overall Study|Lost to Follow-up|1
35867|NCT01529645|158127|P3|Overall Study|Lost to Follow-up|1
35868|NCT01529645|158128|P2|Overall Study|Lost to Follow-up|1
35869|NCT01529645|158129|P1|Overall Study|Lost to Follow-up|0
35870|NCT01529632|158227|P2|Overall Study|Adverse Event|1
35871|NCT01529632|158228|P1|Overall Study|Adverse Event|1
35872|NCT01529632|158227|P2|Overall Study|Protocol Violation|1
35873|NCT01529632|158228|P1|Overall Study|Protocol Violation|0
35874|NCT01529632|158227|P2|Overall Study|Administrative problem|1
35875|NCT01529632|158228|P1|Overall Study|Administrative problem|2
35876|NCT01529515|158248|P4|DOUBLE BLIND PHASE|Unspecified|2
35877|NCT01529515|158249|P3|DOUBLE BLIND PHASE|Unspecified|9
35878|NCT01529515|158250|P2|DOUBLE BLIND PHASE|Unspecified|0
35879|NCT01529515|158251|P1|DOUBLE BLIND PHASE|Unspecified|0
35880|NCT01529515|158248|P4|DOUBLE BLIND PHASE|Protocol Violation|0
35881|NCT01529515|158249|P3|DOUBLE BLIND PHASE|Protocol Violation|1
35882|NCT01529515|158250|P2|DOUBLE BLIND PHASE|Protocol Violation|0
35883|NCT01529515|158251|P1|DOUBLE BLIND PHASE|Protocol Violation|0
35884|NCT01529515|158248|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
35885|NCT01529515|158249|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
35886|NCT01529515|158250|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
35887|NCT01529515|158251|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
35888|NCT01529515|158248|P4|DOUBLE BLIND PHASE|Pregnancy|0
35889|NCT01529515|158249|P3|DOUBLE BLIND PHASE|Pregnancy|1
35890|NCT01529515|158250|P2|DOUBLE BLIND PHASE|Pregnancy|0
35891|NCT01529515|158251|P1|DOUBLE BLIND PHASE|Pregnancy|0
35892|NCT01529515|158248|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
35893|NCT01529515|158249|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
35894|NCT01529515|158250|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
35895|NCT01529515|158251|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
35896|NCT01529515|158248|P4|DOUBLE BLIND PHASE|Adverse Event|0
35897|NCT01529515|158249|P3|DOUBLE BLIND PHASE|Adverse Event|1
35898|NCT01529515|158250|P2|DOUBLE BLIND PHASE|Adverse Event|0
35899|NCT01529515|158251|P1|DOUBLE BLIND PHASE|Adverse Event|0
35900|NCT01529515|158248|P4|MAINTENANCE PHASE|Unspecified|0
35901|NCT01529515|158249|P3|MAINTENANCE PHASE|Unspecified|0
35902|NCT01529515|158250|P2|MAINTENANCE PHASE|Unspecified|10
35903|NCT01529515|158251|P1|MAINTENANCE PHASE|Unspecified|0
35904|NCT01529515|158248|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
35905|NCT01529515|158249|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
35906|NCT01529515|158250|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
35907|NCT01529515|158251|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
35908|NCT01529515|158248|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
35909|NCT01529515|158249|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
35910|NCT01529515|158250|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
35911|NCT01529515|158251|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
35912|NCT01529515|158248|P4|MAINTENANCE PHASE|Protocol Violation|0
35913|NCT01529515|158249|P3|MAINTENANCE PHASE|Protocol Violation|0
35914|NCT01529515|158250|P2|MAINTENANCE PHASE|Protocol Violation|12
35915|NCT01529515|158251|P1|MAINTENANCE PHASE|Protocol Violation|0
35916|NCT01529515|158248|P4|MAINTENANCE PHASE|Lost to Follow-up|0
35917|NCT01529515|158249|P3|MAINTENANCE PHASE|Lost to Follow-up|0
35918|NCT01529515|158250|P2|MAINTENANCE PHASE|Lost to Follow-up|5
35919|NCT01529515|158251|P1|MAINTENANCE PHASE|Lost to Follow-up|0
35920|NCT01529515|158248|P4|MAINTENANCE PHASE|Lack of Efficacy|0
35921|NCT01529515|158249|P3|MAINTENANCE PHASE|Lack of Efficacy|0
35922|NCT01529515|158250|P2|MAINTENANCE PHASE|Lack of Efficacy|9
35923|NCT01529515|158251|P1|MAINTENANCE PHASE|Lack of Efficacy|0
35924|NCT01529515|158248|P4|MAINTENANCE PHASE|Adverse Event|0
35925|NCT01529515|158249|P3|MAINTENANCE PHASE|Adverse Event|0
35926|NCT01529515|158250|P2|MAINTENANCE PHASE|Adverse Event|10
35927|NCT01529515|158251|P1|MAINTENANCE PHASE|Adverse Event|0
35928|NCT01529515|158248|P4|TRANSITION PHASE|Unspecified|0
35929|NCT01529515|158249|P3|TRANSITION PHASE|Unspecified|0
35930|NCT01529515|158250|P2|TRANSITION PHASE|Unspecified|0
35931|NCT01529515|158251|P1|TRANSITION PHASE|Unspecified|9
35932|NCT01529515|158248|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
35933|NCT01529515|158249|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
35934|NCT01529515|158250|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
35935|NCT01529515|158251|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
35936|NCT01529515|158248|P4|TRANSITION PHASE|Withdrawal by Subject|0
35937|NCT01529515|158249|P3|TRANSITION PHASE|Withdrawal by Subject|0
35938|NCT01529515|158250|P2|TRANSITION PHASE|Withdrawal by Subject|0
35939|NCT01529515|158251|P1|TRANSITION PHASE|Withdrawal by Subject|51
35940|NCT01529515|158248|P4|TRANSITION PHASE|Protocol Violation|0
35941|NCT01529515|158249|P3|TRANSITION PHASE|Protocol Violation|0
35942|NCT01529515|158250|P2|TRANSITION PHASE|Protocol Violation|0
35943|NCT01529515|158251|P1|TRANSITION PHASE|Protocol Violation|4
35944|NCT01529515|158248|P4|TRANSITION PHASE|Lost to Follow-up|0
35945|NCT01529515|158249|P3|TRANSITION PHASE|Lost to Follow-up|0
35946|NCT01529515|158250|P2|TRANSITION PHASE|Lost to Follow-up|0
35947|NCT01529515|158251|P1|TRANSITION PHASE|Lost to Follow-up|19
35948|NCT01529515|158248|P4|TRANSITION PHASE|Lack of Efficacy|0
35949|NCT01529515|158249|P3|TRANSITION PHASE|Lack of Efficacy|0
35950|NCT01529515|158250|P2|TRANSITION PHASE|Lack of Efficacy|0
35951|NCT01529515|158251|P1|TRANSITION PHASE|Lack of Efficacy|19
35952|NCT01529515|158248|P4|TRANSITION PHASE|Death|0
35953|NCT01529515|158249|P3|TRANSITION PHASE|Death|0
35954|NCT01529515|158250|P2|TRANSITION PHASE|Death|0
35955|NCT01529515|158251|P1|TRANSITION PHASE|Death|1
35956|NCT01529515|158248|P4|TRANSITION PHASE|Adverse Event|0
35957|NCT01529515|158249|P3|TRANSITION PHASE|Adverse Event|0
35958|NCT01529515|158250|P2|TRANSITION PHASE|Adverse Event|0
35959|NCT01529515|158251|P1|TRANSITION PHASE|Adverse Event|16
35960|NCT01529385|158298|P2|Overall Study|Lost to Follow-up|1
35961|NCT01529385|158299|P1|Overall Study|Lost to Follow-up|2
35962|NCT01529112|158331|P2|Overall Study|Withdrawal by Subject|3
35963|NCT01529112|158332|P1|Overall Study|Withdrawal by Subject|7
35964|NCT01529112|158331|P2|Overall Study|Protocol Violation|0
35965|NCT01529112|158332|P1|Overall Study|Protocol Violation|1
35966|NCT01529112|158331|P2|Overall Study|Death|38
35967|NCT01529112|158332|P1|Overall Study|Death|59
35968|NCT01529112|158331|P2|Overall Study|Adverse Event|0
35969|NCT01529112|158332|P1|Overall Study|Adverse Event|2
35970|NCT01528969|158359|P2|Overall Study|absent from the school at baseline|0
35971|NCT01528969|158360|P1|Overall Study|absent from the school at baseline|2
35972|NCT01528735|158383|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
35973|NCT01528735|158384|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
35974|NCT01528735|158383|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
35975|NCT01528735|158384|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
35976|NCT01528696|158486|P2|Overall Study|See detailed description|19
35977|NCT01528696|158487|P1|Overall Study|See detailed description|18
35978|NCT01528605|158503|P6|Overall Study|Death|0
35979|NCT01528605|158504|P5|Overall Study|Death|0
35980|NCT01528605|158505|P4|Overall Study|Death|0
35981|NCT01528605|158506|P3|Overall Study|Death|0
35982|NCT01528605|158507|P2|Overall Study|Death|0
35983|NCT01528605|158508|P1|Overall Study|Death|1
35984|NCT01528605|158503|P6|Overall Study|Lost to Follow-up|0
35985|NCT01528605|158504|P5|Overall Study|Lost to Follow-up|0
35986|NCT01528605|158505|P4|Overall Study|Lost to Follow-up|1
35987|NCT01528605|158506|P3|Overall Study|Lost to Follow-up|1
35988|NCT01528605|158507|P2|Overall Study|Lost to Follow-up|0
35989|NCT01528605|158508|P1|Overall Study|Lost to Follow-up|1
35990|NCT01528345|158538|P2|Overall Study|Subject/Guardian Decision|0
35991|NCT01528345|158539|P1|Overall Study|Subject/Guardian Decision|5
35992|NCT01528345|158538|P2|Overall Study|Study Terminated by Sponsor|8
35993|NCT01528345|158539|P1|Overall Study|Study Terminated by Sponsor|4
35994|NCT01528345|158538|P2|Overall Study|Progressive Disease|40
35995|NCT01528345|158539|P1|Overall Study|Progressive Disease|26
35996|NCT01528345|158538|P2|Overall Study|Non-compliance with study treatment|0
35997|NCT01528345|158539|P1|Overall Study|Non-compliance with study treatment|1
35998|NCT01528345|158538|P2|Overall Study|Death|1
35999|NCT01528345|158539|P1|Overall Study|Death|1
36000|NCT01528345|158538|P2|Overall Study|Adverse Event|1
36001|NCT01528345|158539|P1|Overall Study|Adverse Event|10
36002|NCT01527487|158629|P2|Overall Study|Death|1
36003|NCT01527487|158630|P1|Overall Study|Death|0
36004|NCT01527487|158629|P2|Overall Study|Adverse Event|1
36005|NCT01527487|158630|P1|Overall Study|Adverse Event|1
36006|NCT01527487|158629|P2|Overall Study|Disease Progression|1
36007|NCT01527487|158630|P1|Overall Study|Disease Progression|4
36008|NCT01527487|158629|P2|Overall Study|MD Discretion/Lack of Efficacy|4
36009|NCT01527487|158630|P1|Overall Study|MD Discretion/Lack of Efficacy|3
36010|NCT01527370|158642|P1|Overall Study|Death|1
36011|NCT01527370|158642|P1|Overall Study|Physician Decision|1
36012|NCT01527370|158642|P1|Overall Study|Withdrawal by Subject|4
36013|NCT01527006|158661|P2|Extension Phase|Not Specified|3
36014|NCT01527006|158662|P1|Extension Phase|Not Specified|0
36015|NCT01527006|158661|P2|Extension Phase|Inadequate therapeutic effect|1
36016|NCT01527006|158662|P1|Extension Phase|Inadequate therapeutic effect|1
36017|NCT01527006|158661|P2|Extension Phase|Subject Choice|1
36018|NCT01527006|158662|P1|Extension Phase|Subject Choice|1
36019|NCT01527006|158661|P2|Extension Phase|Lost to Follow-up|1
36020|NCT01527006|158662|P1|Extension Phase|Lost to Follow-up|0
36021|NCT01527006|158661|P2|Extension Phase|Adverse Event|2
36022|NCT01527006|158662|P1|Extension Phase|Adverse Event|4
36023|NCT01527006|158661|P2|Core Study|Not Specified|2
36024|NCT01527006|158662|P1|Core Study|Not Specified|0
36025|NCT01527006|158661|P2|Core Study|Withdrawal by Subject|1
36026|NCT01527006|158662|P1|Core Study|Withdrawal by Subject|0
36027|NCT01527006|158661|P2|Core Study|Inadequate Therapeutic Effect|0
36028|NCT01527006|158662|P1|Core Study|Inadequate Therapeutic Effect|1
36029|NCT01527006|158661|P2|Core Study|Subject Choice|0
36030|NCT01527006|158662|P1|Core Study|Subject Choice|1
36031|NCT01527006|158661|P2|Core Study|Lost to Follow-up|1
36032|NCT01527006|158662|P1|Core Study|Lost to Follow-up|0
36033|NCT01527006|158661|P2|Core Study|Adverse Event|2
36034|NCT01527006|158662|P1|Core Study|Adverse Event|0
36035|NCT01526785|158729|P1|Overall Study|Withdrawal by Subject|2
36036|NCT01526785|158729|P1|Overall Study|Physician Decision|1
36037|NCT01526785|158729|P1|Overall Study|Death|2
36038|NCT01526785|158729|P1|Overall Study|Study Terminated by Sponsor|8
36039|NCT01526733|158739|P2|Phase 1|Withdrawal by Subject|1
36040|NCT01526733|158740|P1|Phase 1|Withdrawal by Subject|1
36041|NCT01526733|158739|P2|Phase 1|Protocol Violation|0
36042|NCT01526733|158740|P1|Phase 1|Protocol Violation|1
36043|NCT01526551|158762|P1|Overall Study|Lack of returned parental consent form|424
36044|NCT01526148|158809|P2|Overall Study|Incarcerated|2
36045|NCT01526148|158810|P1|Overall Study|Incarcerated|0
36046|NCT01526148|158809|P2|Overall Study|Moved out of state|0
36047|NCT01526148|158810|P1|Overall Study|Moved out of state|1
36048|NCT01526148|158809|P2|Overall Study|Unable to discontinue concomitant med|0
36049|NCT01526148|158810|P1|Overall Study|Unable to discontinue concomitant med|1
36050|NCT01526148|158809|P2|Overall Study|Unstable Medical Condition|0
36051|NCT01526148|158810|P1|Overall Study|Unstable Medical Condition|1
36052|NCT01526148|158809|P2|Overall Study|Withdrawal by Subject|0
36053|NCT01526148|158810|P1|Overall Study|Withdrawal by Subject|2
36054|NCT01526148|158809|P2|Overall Study|Lost to Follow-up|6
36055|NCT01526148|158810|P1|Overall Study|Lost to Follow-up|3
36056|NCT01526148|158809|P2|Overall Study|Adverse Event|5
36057|NCT01526148|158810|P1|Overall Study|Adverse Event|6
36058|NCT01525849|158827|P2|Overall Study|Anatomic exclusion criteria identified|3
36059|NCT01525849|158828|P1|Overall Study|Anatomic exclusion criteria identified|0
36060|NCT01525849|158827|P2|Overall Study|Unrelated medical issue (not treated)|2
36061|NCT01525849|158828|P1|Overall Study|Unrelated medical issue (not treated)|1
36062|NCT01525849|158827|P2|Overall Study|Withdrawal by Subject|9
36063|NCT01525849|158828|P1|Overall Study|Withdrawal by Subject|1
36064|NCT01525849|158827|P2|Overall Study|Lost to Follow-up|2
36065|NCT01525849|158828|P1|Overall Study|Lost to Follow-up|3
36066|NCT01525641|158884|P1|Overall Study|Other than stated above|7
36067|NCT01525641|158884|P1|Overall Study|Lost to follow-up (Changing hospital)|19
36068|NCT01525641|158884|P1|Overall Study|Lost to follow-up (Unknown reason)|10
36069|NCT01525641|158884|P1|Overall Study|Lost to follow-up (relocation)|1
36070|NCT01525641|158884|P1|Overall Study|Improvement|5
36071|NCT01525641|158884|P1|Overall Study|Lack of Efficacy|24
36072|NCT01525641|158884|P1|Overall Study|Adverse Event|73
36073|NCT01525641|158884|P1|Overall Study|No visit since the first visit|16
36074|NCT01525641|158884|P1|Overall Study|Case report form not collected|25
36075|NCT01525628|158898|P5|Overall Study|Other reason not defined above|0
36076|NCT01525628|158899|P4|Overall Study|Other reason not defined above|3
36077|NCT01525628|158900|P3|Overall Study|Other reason not defined above|0
36078|NCT01525628|158901|P2|Overall Study|Other reason not defined above|0
36079|NCT01525628|158902|P1|Overall Study|Other reason not defined above|0
36080|NCT01525628|158898|P5|Overall Study|Withdrawal by Subject|0
36081|NCT01525628|158899|P4|Overall Study|Withdrawal by Subject|0
36082|NCT01525628|158900|P3|Overall Study|Withdrawal by Subject|0
36083|NCT01525628|158901|P2|Overall Study|Withdrawal by Subject|1
36084|NCT01525628|158902|P1|Overall Study|Withdrawal by Subject|0
36085|NCT01525628|158898|P5|Overall Study|Lost to Follow-up|0
36086|NCT01525628|158899|P4|Overall Study|Lost to Follow-up|0
36087|NCT01525628|158900|P3|Overall Study|Lost to Follow-up|0
36088|NCT01525628|158901|P2|Overall Study|Lost to Follow-up|1
36089|NCT01525628|158902|P1|Overall Study|Lost to Follow-up|1
36090|NCT01525628|158898|P5|Overall Study|Protocol Violation|0
36091|NCT01525628|158899|P4|Overall Study|Protocol Violation|0
36092|NCT01525628|158900|P3|Overall Study|Protocol Violation|1
36093|NCT01525628|158901|P2|Overall Study|Protocol Violation|0
36094|NCT01525628|158902|P1|Overall Study|Protocol Violation|0
36095|NCT01525628|158898|P5|Overall Study|Lack of Efficacy|2
36096|NCT01525628|158899|P4|Overall Study|Lack of Efficacy|1
36097|NCT01525628|158900|P3|Overall Study|Lack of Efficacy|2
36098|NCT01525628|158901|P2|Overall Study|Lack of Efficacy|2
36099|NCT01525628|158902|P1|Overall Study|Lack of Efficacy|0
36100|NCT01525628|158898|P5|Overall Study|Adverse Event|1
36101|NCT01525628|158899|P4|Overall Study|Adverse Event|0
36102|NCT01525628|158900|P3|Overall Study|Adverse Event|2
36103|NCT01525628|158901|P2|Overall Study|Adverse Event|1
36104|NCT01525628|158902|P1|Overall Study|Adverse Event|1
36105|NCT01525615|158969|P3|Overall Study|Other reason not described above|1
36106|NCT01525615|158970|P2|Overall Study|Other reason not described above|0
36107|NCT01525615|158971|P1|Overall Study|Other reason not described above|1
36108|NCT01525615|158969|P3|Overall Study|Withdrawal by Subject|0
36109|NCT01525615|158970|P2|Overall Study|Withdrawal by Subject|0
36110|NCT01525615|158971|P1|Overall Study|Withdrawal by Subject|1
36111|NCT01525615|158969|P3|Overall Study|Lost to Follow-up|0
36112|NCT01525615|158970|P2|Overall Study|Lost to Follow-up|0
36113|NCT01525615|158971|P1|Overall Study|Lost to Follow-up|1
36114|NCT01525615|158969|P3|Overall Study|Adverse Event|5
36115|NCT01525615|158970|P2|Overall Study|Adverse Event|7
36116|NCT01525615|158971|P1|Overall Study|Adverse Event|11
36117|NCT01525550|159027|P2|Overall Study|Ongoing|23
36118|NCT01525550|159028|P1|Overall Study|Ongoing|45
36119|NCT01525550|159027|P2|Overall Study|Other Unspecified|2
36120|NCT01525550|159028|P1|Overall Study|Other Unspecified|0
36121|NCT01525550|159027|P2|Overall Study|Death|19
36122|NCT01525550|159028|P1|Overall Study|Death|10
36123|NCT01525550|159027|P2|Overall Study|Lost to Follow-up|1
36124|NCT01525550|159028|P1|Overall Study|Lost to Follow-up|4
36125|NCT01525550|159027|P2|Overall Study|Withdrawal by Subject|0
36126|NCT01525550|159028|P1|Overall Study|Withdrawal by Subject|2
36127|NCT01525407|159099|P2|Overall Study|Delay in Transplant|0
36128|NCT01525407|159100|P1|Overall Study|Delay in Transplant|1
36129|NCT01525407|159099|P2|Overall Study|Transplant was delayed|1
36130|NCT01525407|159100|P1|Overall Study|Transplant was delayed|0
36131|NCT01525407|159099|P2|Overall Study|Withdrawal by Subject|1
36132|NCT01525407|159100|P1|Overall Study|Withdrawal by Subject|0
36133|NCT01525407|159099|P2|Overall Study|Change in recipient treatment plan|2
36134|NCT01525407|159100|P1|Overall Study|Change in recipient treatment plan|2
36135|NCT01525238|159117|P3|Overall Study|Withdrawal by Subject|0
36136|NCT01525238|159118|P2|Overall Study|Withdrawal by Subject|0
36137|NCT01525238|159119|P1|Overall Study|Withdrawal by Subject|1
36138|NCT01525225|159184|P1|Enrollment|Not Specified|1
36139|NCT01525225|159184|P1|Enrollment|No longer met study criteria|1
36140|NCT01524913|159201|P3|Overall Study|Lost to Follow-up|0
36141|NCT01524913|159202|P2|Overall Study|Lost to Follow-up|0
36142|NCT01524913|159203|P1|Overall Study|Lost to Follow-up|4
36143|NCT01524900|159225|P5|Overall Study|No reason documented|0
36144|NCT01524900|159226|P4|Overall Study|No reason documented|1
36145|NCT01524900|159227|P3|Overall Study|No reason documented|0
36146|NCT01524900|159228|P2|Overall Study|No reason documented|1
36147|NCT01524900|159229|P1|Overall Study|No reason documented|2
36148|NCT01524900|159225|P5|Overall Study|Other reason than stated above|0
36149|NCT01524900|159226|P4|Overall Study|Other reason than stated above|0
36150|NCT01524900|159227|P3|Overall Study|Other reason than stated above|0
36151|NCT01524900|159228|P2|Overall Study|Other reason than stated above|1
36152|NCT01524900|159229|P1|Overall Study|Other reason than stated above|1
36153|NCT01524900|159225|P5|Overall Study|Lost to Follow-up|0
36154|NCT01524900|159226|P4|Overall Study|Lost to Follow-up|0
36155|NCT01524900|159227|P3|Overall Study|Lost to Follow-up|1
36156|NCT01524900|159228|P2|Overall Study|Lost to Follow-up|12
36157|NCT01524900|159229|P1|Overall Study|Lost to Follow-up|3
36158|NCT01524887|159274|P3|Overall Study|Use of prohibited medication|0
36159|NCT01524887|159275|P2|Overall Study|Use of prohibited medication|0
36160|NCT01524887|159276|P1|Overall Study|Use of prohibited medication|1
36161|NCT01524887|159274|P3|Overall Study|Withdrawal by Caregiver|2
36162|NCT01524887|159275|P2|Overall Study|Withdrawal by Caregiver|0
36163|NCT01524887|159276|P1|Overall Study|Withdrawal by Caregiver|0
36164|NCT01524887|159274|P3|Overall Study|Study termination|79
36165|NCT01524887|159275|P2|Overall Study|Study termination|87
36166|NCT01524887|159276|P1|Overall Study|Study termination|73
36167|NCT01524887|159274|P3|Overall Study|Protocol Violation|1
36168|NCT01524887|159275|P2|Overall Study|Protocol Violation|0
36169|NCT01524887|159276|P1|Overall Study|Protocol Violation|0
36170|NCT01524887|159274|P3|Overall Study|Adverse Event|1
36171|NCT01524887|159275|P2|Overall Study|Adverse Event|1
36172|NCT01524887|159276|P1|Overall Study|Adverse Event|5
36173|NCT01524887|159274|P3|Overall Study|Withdrawal by Subject|3
36174|NCT01524887|159275|P2|Overall Study|Withdrawal by Subject|2
36175|NCT01524887|159276|P1|Overall Study|Withdrawal by Subject|6
36176|NCT01524796|159320|P1|Overall Study|Adverse Event and Lack of Efficacy|1
36177|NCT01524796|159320|P1|Overall Study|Switch to carbamazapine|1
36178|NCT01524796|159320|P1|Overall Study|Nervous about confidentiality|1
36179|NCT01524796|159320|P1|Overall Study|Gall stone surgery|1
36180|NCT01524796|159320|P1|Overall Study|Deterioration of pains|1
36181|NCT01524796|159320|P1|Overall Study|Move|1
36182|NCT01524796|159320|P1|Overall Study|Withdrawal by Subject|4
36183|NCT01524796|159320|P1|Overall Study|The price|1
36184|NCT01524796|159320|P1|Overall Study|Lost to Follow-up|1
36185|NCT01524796|159320|P1|Overall Study|Lack of Efficacy|3
36186|NCT01524796|159320|P1|Overall Study|Adverse Event|13
36187|NCT01524783|159335|P2|Randomized and Treated|Death|1
36188|NCT01524783|159336|P1|Randomized and Treated|Death|4
36189|NCT01524783|159335|P2|Randomized and Treated|Protocol Violation|1
36190|NCT01524783|159336|P1|Randomized and Treated|Protocol Violation|1
36191|NCT01524783|159335|P2|Randomized and Treated|Withdrawal by Subject|5
36192|NCT01524783|159336|P1|Randomized and Treated|Withdrawal by Subject|15
36193|NCT01524783|159335|P2|Randomized and Treated|Disease Progression|70
36194|NCT01524783|159336|P1|Randomized and Treated|Disease Progression|76
36195|NCT01524783|159335|P2|Randomized and Treated|Adverse Event|7
36196|NCT01524783|159336|P1|Randomized and Treated|Adverse Event|59
36197|NCT01524783|159335|P2|Randomized But Not Treated|Randomized, did not receive drug|0
36198|NCT01524783|159336|P1|Randomized But Not Treated|Randomized, did not receive drug|2
36199|NCT01524770|159358|P2|First Intervention|Protocol Violation|0
36200|NCT01524770|159359|P1|First Intervention|Protocol Violation|1
36201|NCT01524770|159358|P2|First Intervention|Adverse Event|1
36202|NCT01524770|159359|P1|First Intervention|Adverse Event|1
36203|NCT01524770|159358|P2|First Intervention|Withdrawal by Subject|0
36204|NCT01524770|159359|P1|First Intervention|Withdrawal by Subject|1
36205|NCT01524627|159371|P2|Overall Study|Lost to Follow-up|1
36206|NCT01524627|159372|P1|Overall Study|Lost to Follow-up|1
36207|NCT01524627|159371|P2|Overall Study|Physician Decision|1
36208|NCT01524627|159372|P1|Overall Study|Physician Decision|0
36209|NCT01524198|159399|P2|Overall Study|Withdrawal by Subject|10
36210|NCT01524198|159400|P1|Overall Study|Withdrawal by Subject|15
36211|NCT01524198|159399|P2|Overall Study|Protocol Violation|6
36212|NCT01524198|159400|P1|Overall Study|Protocol Violation|8
36213|NCT01523886|159427|P2|Overall Study|surgery cancelled|1
36214|NCT01523886|159428|P1|Overall Study|surgery cancelled|0
36215|NCT01523873|159434|P1|Overall Study|Protocol Violation|422
36216|NCT01523756|159441|P2|Test Period 2|Withdrawal by Subject|1
36217|NCT01523756|159442|P1|Test Period 2|Withdrawal by Subject|0
36218|NCT01523756|159441|P2|Test Period 1|Adverse Event|0
36219|NCT01523756|159442|P1|Test Period 1|Adverse Event|1
36220|NCT01523756|159441|P2|Baseline Period|Adverse Event|1
36221|NCT01523756|159442|P1|Baseline Period|Adverse Event|0
36222|NCT01523743|159450|P2|Period 2|Adverse Event|0
36223|NCT01523743|159451|P1|Period 2|Adverse Event|1
36224|NCT01523743|159450|P2|Period 2|Withdrawal by Subject|2
36225|NCT01523743|159451|P1|Period 2|Withdrawal by Subject|0
36226|NCT01523743|159450|P2|Period 1|Felt unable to empty bladder|0
36227|NCT01523743|159451|P1|Period 1|Felt unable to empty bladder|1
36228|NCT01523743|159450|P2|Period 1|Lack of Efficacy|0
36229|NCT01523743|159451|P1|Period 1|Lack of Efficacy|1
36230|NCT01523743|159450|P2|Period 1|Lost to Follow-up|0
36231|NCT01523743|159451|P1|Period 1|Lost to Follow-up|1
36232|NCT01523743|159450|P2|Period 1|Withdrawal by Subject|2
36233|NCT01523743|159451|P1|Period 1|Withdrawal by Subject|6
36234|NCT01523743|159450|P2|Period 1|Adverse Event|0
36235|NCT01523743|159451|P1|Period 1|Adverse Event|1
36236|NCT01523587|159459|P2|Overall Study|Randomised but not treated|2
36237|NCT01523587|159460|P1|Overall Study|Randomised but not treated|6
36238|NCT01523587|159459|P2|Overall Study|no reason given|3
36239|NCT01523587|159460|P1|Overall Study|no reason given|2
36240|NCT01523587|159459|P2|Overall Study|Withdrawal by Subject|12
36241|NCT01523587|159460|P1|Overall Study|Withdrawal by Subject|23
36242|NCT01523587|159459|P2|Overall Study|Lost to Follow-up|2
36243|NCT01523587|159460|P1|Overall Study|Lost to Follow-up|2
36244|NCT01523587|159459|P2|Overall Study|Non Compliance with protocol|1
36245|NCT01523587|159460|P1|Overall Study|Non Compliance with protocol|2
36246|NCT01523587|159459|P2|Overall Study|Adverse Event|34
36247|NCT01523587|159460|P1|Overall Study|Adverse Event|52
36248|NCT01523457|159480|P2|Overall Study|Withdrawal by Subject|2
36249|NCT01523457|159481|P1|Overall Study|Withdrawal by Subject|7
36250|NCT01523392|159499|P2|Washout Period - 10 to 14 Days|Adverse Event|0
36251|NCT01523392|159500|P1|Washout Period - 10 to 14 Days|Adverse Event|1
36252|NCT01523392|159499|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
36253|NCT01523392|159500|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
36254|NCT01523392|159499|P2|Treatment Period 1|Withdrawal by Subject|0
36255|NCT01523392|159500|P1|Treatment Period 1|Withdrawal by Subject|2
36256|NCT01523366|159516|P2|Treatment Period 2|Not completed at least 7 days treatment|0
36345|NCT01521884|159869|P1|Overall Study|Physician Decision|2
36257|NCT01523366|159517|P1|Treatment Period 2|Not completed at least 7 days treatment|1
36258|NCT01523366|159516|P2|Treatment Period 1|Withdrawal by Subject|0
36259|NCT01523366|159517|P1|Treatment Period 1|Withdrawal by Subject|1
36260|NCT01523301|159533|P2|Overall Study|Other Reason|2
36261|NCT01523301|159534|P1|Overall Study|Other Reason|0
36262|NCT01523301|159533|P2|Overall Study|Withdrawal by Subject|8
36263|NCT01523301|159534|P1|Overall Study|Withdrawal by Subject|6
36264|NCT01523301|159533|P2|Overall Study|Lost to Follow-up|0
36265|NCT01523301|159534|P1|Overall Study|Lost to Follow-up|1
36266|NCT01523301|159533|P2|Overall Study|Protocol Violation|4
36267|NCT01523301|159534|P1|Overall Study|Protocol Violation|3
36268|NCT01523301|159533|P2|Overall Study|Lack of Efficacy|2
36269|NCT01523301|159534|P1|Overall Study|Lack of Efficacy|0
36270|NCT01523301|159533|P2|Overall Study|Adverse Event|16
36271|NCT01523301|159534|P1|Overall Study|Adverse Event|25
36272|NCT01522976|159555|P3|Overall Study|Not protocol specified|27
36273|NCT01522976|159556|P2|Overall Study|Not protocol specified|27
36274|NCT01522976|159557|P1|Overall Study|Not protocol specified|22
36275|NCT01522976|159555|P3|Overall Study|Refusal unrelated to adverse event|14
36276|NCT01522976|159556|P2|Overall Study|Refusal unrelated to adverse event|13
36277|NCT01522976|159557|P1|Overall Study|Refusal unrelated to adverse event|10
36278|NCT01522976|159555|P3|Overall Study|Adverse Event|18
36279|NCT01522976|159556|P2|Overall Study|Adverse Event|7
36280|NCT01522976|159557|P1|Overall Study|Adverse Event|17
36281|NCT01522976|159555|P3|Overall Study|Disease progression|25
36282|NCT01522976|159556|P2|Overall Study|Disease progression|30
36283|NCT01522976|159557|P1|Overall Study|Disease progression|28
36284|NCT01522976|159555|P3|Overall Study|Still on treatment|6
36285|NCT01522976|159556|P2|Overall Study|Still on treatment|9
36286|NCT01522976|159557|P1|Overall Study|Still on treatment|9
36287|NCT01522976|159555|P3|Overall Study|Death|2
36288|NCT01522976|159556|P2|Overall Study|Death|6
36289|NCT01522976|159557|P1|Overall Study|Death|7
36290|NCT01522976|159555|P3|Overall Study|Ineligible|1
36291|NCT01522976|159556|P2|Overall Study|Ineligible|0
36292|NCT01522976|159557|P1|Overall Study|Ineligible|4
36293|NCT01522456|159634|P1|Overall Study|Tolerability Assessment|1
36294|NCT01522456|159634|P1|Overall Study|Pregnancy|1
36295|NCT01522456|159634|P1|Overall Study|Withdrawal by Subject|2
36296|NCT01522456|159634|P1|Overall Study|Lost to Follow-up|2
36297|NCT01522456|159634|P1|Overall Study|Adverse Event|2
36298|NCT01522235|159702|P2|Overall Study|Physician Decision|1
36299|NCT01522235|159703|P1|Overall Study|Physician Decision|1
36300|NCT01521923|159734|P4|Overall Study|AE, captured in Period 1|1
36301|NCT01521923|159735|P3|Overall Study|AE, captured in Period 1|0
36302|NCT01521923|159736|P2|Overall Study|AE, captured in Period 1|1
36303|NCT01521923|159737|P1|Overall Study|AE, captured in Period 1|0
36304|NCT01521923|159734|P4|Overall Study|Other|6
36305|NCT01521923|159735|P3|Overall Study|Other|3
36306|NCT01521923|159736|P2|Overall Study|Other|1
36307|NCT01521923|159737|P1|Overall Study|Other|2
36308|NCT01521923|159734|P4|Overall Study|Withdrawal by Subject|2
36309|NCT01521923|159735|P3|Overall Study|Withdrawal by Subject|1
36310|NCT01521923|159736|P2|Overall Study|Withdrawal by Subject|1
36311|NCT01521923|159737|P1|Overall Study|Withdrawal by Subject|1
36312|NCT01521923|159734|P4|Overall Study|Lost to Follow-up|1
36313|NCT01521923|159735|P3|Overall Study|Lost to Follow-up|2
36314|NCT01521923|159736|P2|Overall Study|Lost to Follow-up|0
36315|NCT01521923|159737|P1|Overall Study|Lost to Follow-up|1
36316|NCT01521923|159734|P4|Overall Study|Protocol Violation|0
36317|NCT01521923|159735|P3|Overall Study|Protocol Violation|1
36318|NCT01521923|159736|P2|Overall Study|Protocol Violation|0
36319|NCT01521923|159737|P1|Overall Study|Protocol Violation|0
36320|NCT01521923|159734|P4|Overall Study|Lack of Efficacy|0
36321|NCT01521923|159735|P3|Overall Study|Lack of Efficacy|0
36322|NCT01521923|159736|P2|Overall Study|Lack of Efficacy|1
36323|NCT01521923|159737|P1|Overall Study|Lack of Efficacy|1
36324|NCT01521923|159734|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
36325|NCT01521923|159735|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
36326|NCT01521923|159736|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
36327|NCT01521923|159737|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
36328|NCT01521923|159734|P4|Overall Study|AE, non-serious, non-fatal|2
36329|NCT01521923|159735|P3|Overall Study|AE, non-serious, non-fatal|6
36330|NCT01521923|159736|P2|Overall Study|AE, non-serious, non-fatal|3
36331|NCT01521923|159737|P1|Overall Study|AE, non-serious, non-fatal|1
36332|NCT01521923|159734|P4|Overall Study|SAE, non-fatal|0
36333|NCT01521923|159735|P3|Overall Study|SAE, non-fatal|2
36334|NCT01521923|159736|P2|Overall Study|SAE, non-fatal|2
36335|NCT01521923|159737|P1|Overall Study|SAE, non-fatal|0
36336|NCT01521923|159734|P4|Overall Study|AE, serious fatal|0
36337|NCT01521923|159735|P3|Overall Study|AE, serious fatal|0
36338|NCT01521923|159736|P2|Overall Study|AE, serious fatal|0
36339|NCT01521923|159737|P1|Overall Study|AE, serious fatal|1
36340|NCT01521897|159857|P1|Overall Study|Lost to Follow-up|5
36341|NCT01521897|159857|P1|Overall Study|Protocol Violation|18
36342|NCT01521884|159869|P1|Overall Study|Lost to Follow-up|4
36343|NCT01521884|159869|P1|Overall Study|Participant non-eligible|1
36344|NCT01521884|159869|P1|Overall Study|Protocol Violation|3
36346|NCT01521884|159869|P1|Overall Study|Withdrawal by Subject|1
36347|NCT01521884|159869|P1|Overall Study|Pregnancy|1
36348|NCT01521884|159869|P1|Overall Study|Adverse Event|5
36349|NCT01521884|159869|P1|Overall Study|Non Responders|10
36350|NCT01521559|159966|P2|Overall Study|Other|2
36351|NCT01521559|159967|P1|Overall Study|Other|1
36352|NCT01521559|159966|P2|Overall Study|Protocol Violation|0
36353|NCT01521559|159967|P1|Overall Study|Protocol Violation|1
36354|NCT01521559|159966|P2|Overall Study|Lost to Follow-up|1
36355|NCT01521559|159967|P1|Overall Study|Lost to Follow-up|3
36356|NCT01521559|159966|P2|Overall Study|Withdrawal by Subject|11
36357|NCT01521559|159967|P1|Overall Study|Withdrawal by Subject|9
36358|NCT01521559|159966|P2|Overall Study|Death|0
36359|NCT01521559|159967|P1|Overall Study|Death|1
36360|NCT01521559|159966|P2|Overall Study|Adverse Event|4
36361|NCT01521559|159967|P1|Overall Study|Adverse Event|0
36362|NCT01521507|159990|P2|Stage 2: Observational Design|Physician Decision|0
36363|NCT01521507|159991|P1|Stage 2: Observational Design|Physician Decision|1
36364|NCT01521507|159990|P2|Stage 2: Observational Design|Withdrawal by Subject|1
36365|NCT01521507|159991|P1|Stage 2: Observational Design|Withdrawal by Subject|3
36366|NCT01521507|159990|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
36367|NCT01521507|159991|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
36368|NCT01521507|159990|P2|Stage 1: Randomized Design|Lost to Follow-up|2
36369|NCT01521507|159991|P1|Stage 1: Randomized Design|Lost to Follow-up|0
36370|NCT01521507|159990|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
36371|NCT01521507|159991|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
36372|NCT01521507|159990|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
36373|NCT01521507|159991|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
36374|NCT01521364|160008|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
36375|NCT01521364|160008|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
36376|NCT01520987|160084|P8|Overall Study|Withdrawal by Subject|0
36377|NCT01520987|160085|P7|Overall Study|Withdrawal by Subject|0
36378|NCT01520987|160086|P6|Overall Study|Withdrawal by Subject|1
36379|NCT01520987|160087|P5|Overall Study|Withdrawal by Subject|0
36380|NCT01520987|160088|P4|Overall Study|Withdrawal by Subject|0
36381|NCT01520987|160089|P3|Overall Study|Withdrawal by Subject|0
36382|NCT01520987|160090|P2|Overall Study|Withdrawal by Subject|0
36383|NCT01520987|160091|P1|Overall Study|Withdrawal by Subject|1
36384|NCT01520922|160151|P2|Survival Follow-up|Withdrawal by Subject|0
36385|NCT01520922|160152|P1|Survival Follow-up|Withdrawal by Subject|1
36386|NCT01520922|160151|P2|Follow up|Lost to Follow-up|1
36387|NCT01520922|160152|P1|Follow up|Lost to Follow-up|0
36388|NCT01520922|160151|P2|Treatment Phase|Adverse Event|5
36389|NCT01520922|160152|P1|Treatment Phase|Adverse Event|3
36390|NCT01520922|160151|P2|Treatment Phase|Progression|2
36391|NCT01520922|160152|P1|Treatment Phase|Progression|0
36392|NCT01520922|160151|P2|Treatment Phase|Physician Decision|1
36393|NCT01520922|160152|P1|Treatment Phase|Physician Decision|2
36394|NCT01520909|160214|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
36395|NCT01520909|160215|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
36396|NCT01520909|160216|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
36397|NCT01520909|160214|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
36398|NCT01520909|160215|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
36399|NCT01520909|160216|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
36400|NCT01520909|160214|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
36401|NCT01520909|160215|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
36402|NCT01520909|160216|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
36403|NCT01520909|160214|P3|Part 1 (Randomized Period)|Adverse Event|0
36404|NCT01520909|160215|P2|Part 1 (Randomized Period)|Adverse Event|2
36405|NCT01520909|160216|P1|Part 1 (Randomized Period)|Adverse Event|1
36406|NCT01520714|160333|P2|Overall Study|Lack of Efficacy|1
36407|NCT01520714|160334|P1|Overall Study|Lack of Efficacy|0
36408|NCT01520714|160333|P2|Overall Study|Adverse Event|2
36409|NCT01520714|160334|P1|Overall Study|Adverse Event|0
36410|NCT01520714|160333|P2|Overall Study|Protocol Violation|3
36411|NCT01520714|160334|P1|Overall Study|Protocol Violation|0
36412|NCT01520506|160359|P1|Overall Study|Withdrawal by Subject|1
36413|NCT01520506|160359|P1|Overall Study|Lost to Follow-up|1
36414|NCT01520506|160359|P1|Overall Study|Missed Visit|4
36415|NCT01520402|160410|P1|Overall Study|Physician Decision|3
36416|NCT01520402|160410|P1|Overall Study|Withdrawal by Subject|2
36417|NCT01519960|160424|P3|Overall Study|Lost to Follow-up|0
36418|NCT01519960|160425|P2|Overall Study|Lost to Follow-up|1
36419|NCT01519960|160426|P1|Overall Study|Lost to Follow-up|0
36420|NCT01519960|160424|P3|Overall Study|Withdrawal by Subject|0
36421|NCT01519960|160425|P2|Overall Study|Withdrawal by Subject|4
36422|NCT01519960|160426|P1|Overall Study|Withdrawal by Subject|0
36423|NCT01519960|160424|P3|Overall Study|Adverse Event|0
36424|NCT01519960|160425|P2|Overall Study|Adverse Event|1
36425|NCT01519960|160426|P1|Overall Study|Adverse Event|0
36426|NCT01519960|160424|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
36427|NCT01519960|160425|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
36428|NCT01519960|160426|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
36429|NCT01519960|160424|P3|Overall Study|Ongoing in Follow-Up|10
36430|NCT01519960|160425|P2|Overall Study|Ongoing in Follow-Up|11
36431|NCT01519960|160426|P1|Overall Study|Ongoing in Follow-Up|101
36432|NCT01519934|160532|P1|Overall Study|Lost to Follow-up|3
36433|NCT01519921|160541|P2|Overall Study|High alanine aminotransferase (ALT)|1
36434|NCT01519921|160542|P1|Overall Study|High alanine aminotransferase (ALT)|0
36435|NCT01519921|160541|P2|Overall Study|Treatment refusal|1
36436|NCT01519921|160542|P1|Overall Study|Treatment refusal|2
36437|NCT01519921|160541|P2|Overall Study|Lost to Follow-up|1
36438|NCT01519921|160542|P1|Overall Study|Lost to Follow-up|2
36439|NCT01519921|160541|P2|Overall Study|Withdrawal by Subject|0
36440|NCT01519921|160542|P1|Overall Study|Withdrawal by Subject|3
36441|NCT01519921|160541|P2|Overall Study|Lack of Efficacy|3
36442|NCT01519921|160542|P1|Overall Study|Lack of Efficacy|4
36443|NCT01519921|160541|P2|Overall Study|Adverse Event|9
36444|NCT01519921|160542|P1|Overall Study|Adverse Event|10
36445|NCT01519817|160591|P4|Overall Study|Off study due to infection|1
36446|NCT01519817|160592|P3|Overall Study|Off study due to infection|0
36447|NCT01519817|160593|P2|Overall Study|Off study due to infection|0
36448|NCT01519817|160594|P1|Overall Study|Off study due to infection|0
36449|NCT01519817|160591|P4|Overall Study|Withdrawal by Subject|0
36450|NCT01519817|160592|P3|Overall Study|Withdrawal by Subject|0
36451|NCT01519817|160593|P2|Overall Study|Withdrawal by Subject|0
36452|NCT01519817|160594|P1|Overall Study|Withdrawal by Subject|1
36453|NCT01519791|160634|P2|Overall Study|Lost to Follow-up|14
36454|NCT01519791|160635|P1|Overall Study|Lost to Follow-up|6
36455|NCT01519791|160634|P2|Overall Study|Withdrawal by Subject|37
36456|NCT01519791|160635|P1|Overall Study|Withdrawal by Subject|15
36457|NCT01519791|160634|P2|Overall Study|AE, non-serious non-fatal|31
36458|NCT01519791|160635|P1|Overall Study|AE, non-serious non-fatal|12
36459|NCT01519791|160634|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
36460|NCT01519791|160635|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
36461|NCT01519791|160634|P2|Overall Study|AE, serious fatal|1
36462|NCT01519791|160635|P1|Overall Study|AE, serious fatal|0
36463|NCT01519791|160634|P2|Overall Study|SAE, non-fatal|22
36464|NCT01519791|160635|P1|Overall Study|SAE, non-fatal|6
36465|NCT01519791|160634|P2|Overall Study|Lack of Efficacy|20
36466|NCT01519791|160635|P1|Overall Study|Lack of Efficacy|16
36467|NCT01519791|160634|P2|Overall Study|subjects randomized in error|0
36468|NCT01519791|160635|P1|Overall Study|subjects randomized in error|2
36469|NCT01519791|160634|P2|Overall Study|Other Reason|222
36470|NCT01519791|160635|P1|Overall Study|Other Reason|87
36471|NCT01519791|160634|P2|Overall Study|Protocol Violation|19
36472|NCT01519791|160635|P1|Overall Study|Protocol Violation|6
36473|NCT01519791|160634|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
36474|NCT01519791|160635|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
36475|NCT01519778|160699|P1|Overall Study|Physician Decision|1
36476|NCT01519778|160699|P1|Overall Study|Lost to Follow-up|10
36477|NCT01519778|160699|P1|Overall Study|Withdrawal by Subject|3
36478|NCT01519765|160705|P2|Overall Study|Withdrawal by Subject|1
36479|NCT01519765|160706|P1|Overall Study|Withdrawal by Subject|0
36480|NCT01519765|160705|P2|Overall Study|Protocol Violation|0
36481|NCT01519765|160706|P1|Overall Study|Protocol Violation|1
36482|NCT01519765|160705|P2|Overall Study|Lack of Efficacy|0
36483|NCT01519765|160706|P1|Overall Study|Lack of Efficacy|2
36484|NCT01519765|160705|P2|Overall Study|Adverse Event|1
36485|NCT01519765|160706|P1|Overall Study|Adverse Event|0
36486|NCT01519700|160784|P4|Overall Study|Other Reason|4
36487|NCT01519700|160785|P3|Overall Study|Other Reason|0
36488|NCT01519700|160786|P2|Overall Study|Other Reason|2
36489|NCT01519700|160787|P1|Overall Study|Other Reason|2
36490|NCT01519700|160784|P4|Overall Study|Withdrawal by Subject|2
36491|NCT01519700|160785|P3|Overall Study|Withdrawal by Subject|3
36492|NCT01519700|160786|P2|Overall Study|Withdrawal by Subject|3
36493|NCT01519700|160787|P1|Overall Study|Withdrawal by Subject|5
36494|NCT01519700|160784|P4|Overall Study|Physician Decision|0
36495|NCT01519700|160785|P3|Overall Study|Physician Decision|3
36496|NCT01519700|160786|P2|Overall Study|Physician Decision|1
36497|NCT01519700|160787|P1|Overall Study|Physician Decision|1
36498|NCT01519700|160784|P4|Overall Study|Lost to Follow-up|1
36499|NCT01519700|160785|P3|Overall Study|Lost to Follow-up|1
36500|NCT01519700|160786|P2|Overall Study|Lost to Follow-up|0
36501|NCT01519700|160787|P1|Overall Study|Lost to Follow-up|0
36502|NCT01519700|160784|P4|Overall Study|Death|0
36503|NCT01519700|160785|P3|Overall Study|Death|0
36504|NCT01519700|160786|P2|Overall Study|Death|0
36505|NCT01519700|160787|P1|Overall Study|Death|1
36506|NCT01519674|160822|P3|Overall Study|Unsclassified|3
36507|NCT01519674|160823|P2|Overall Study|Unsclassified|4
36508|NCT01519674|160824|P1|Overall Study|Unsclassified|10
36509|NCT01519674|160822|P3|Overall Study|Withdrawal Criteria|7
36510|NCT01519674|160823|P2|Overall Study|Withdrawal Criteria|2
36511|NCT01519674|160824|P1|Overall Study|Withdrawal Criteria|7
36512|NCT01519674|160822|P3|Overall Study|Protocol Violation|1
36513|NCT01519674|160823|P2|Overall Study|Protocol Violation|3
36514|NCT01519674|160824|P1|Overall Study|Protocol Violation|0
36515|NCT01519674|160822|P3|Overall Study|Lack of Efficacy|1
36516|NCT01519674|160823|P2|Overall Study|Lack of Efficacy|1
36517|NCT01519674|160824|P1|Overall Study|Lack of Efficacy|1
36518|NCT01519674|160822|P3|Overall Study|Adverse Event|0
36519|NCT01519674|160823|P2|Overall Study|Adverse Event|3
36520|NCT01519674|160824|P1|Overall Study|Adverse Event|3
36521|NCT01519661|160862|P1|Overall Study|Adverse Event|29
36522|NCT01519661|160862|P1|Overall Study|Lack of Efficacy|6
36523|NCT01519661|160862|P1|Overall Study|Withdrawal by Subject|17
36524|NCT01519661|160862|P1|Overall Study|Lost to Follow-up|3
36525|NCT01519661|160862|P1|Overall Study|Protocol deviation|6
36526|NCT01519518|160888|P2|Overall Study|Consent not available|10
36527|NCT01519518|160889|P1|Overall Study|Consent not available|7
36528|NCT01519427|160914|P1|Overall Study|disease progression|2
36529|NCT01519323|160921|P2|Overall Study|Study terminated by sponsor|1
36530|NCT01519323|160922|P1|Overall Study|Study terminated by sponsor|0
36531|NCT01519323|160921|P2|Overall Study|Death|2
36532|NCT01519323|160922|P1|Overall Study|Death|3
36533|NCT01519245|160982|P2|Overall Study|Met exclusion criteria, not analysed|2
36534|NCT01519245|160983|P1|Overall Study|Met exclusion criteria, not analysed|1
36535|NCT01519206|160995|P1|Overall Study|Missed Visit|2
36536|NCT01519206|160995|P1|Overall Study|Lost to Follow-up|3
36537|NCT01519167|161009|P2|Overall Study|Physician Decision|1
36538|NCT01519167|161010|P1|Overall Study|Physician Decision|0
36539|NCT01519167|161009|P2|Overall Study|Medical condition changes&deep sedation|2
36540|NCT01519167|161010|P1|Overall Study|Medical condition changes&deep sedation|0
36541|NCT01519167|161009|P2|Overall Study|Lack of Efficacy|1
36542|NCT01519167|161010|P1|Overall Study|Lack of Efficacy|0
36543|NCT01519167|161009|P2|Overall Study|Adverse Event|1
36544|NCT01519167|161010|P1|Overall Study|Adverse Event|0
36545|NCT01519167|161009|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
36546|NCT01519167|161010|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
36547|NCT01519089|161036|P2|Overall Study|Not received study drug|1
36548|NCT01519089|161037|P1|Overall Study|Not received study drug|0
36549|NCT01519089|161036|P2|Overall Study|Unspecified|6
36550|NCT01519089|161037|P1|Overall Study|Unspecified|2
36551|NCT01519089|161036|P2|Overall Study|Withdrawal by Subject|2
36552|NCT01519089|161037|P1|Overall Study|Withdrawal by Subject|0
36553|NCT01519089|161036|P2|Overall Study|Lost to Follow-up|0
36554|NCT01519089|161037|P1|Overall Study|Lost to Follow-up|1
36555|NCT01519089|161036|P2|Overall Study|Lack of Efficacy|2
36556|NCT01519089|161037|P1|Overall Study|Lack of Efficacy|0
36557|NCT01519089|161036|P2|Overall Study|Adverse Event|4
36558|NCT01519089|161037|P1|Overall Study|Adverse Event|4
36559|NCT01518946|161158|P3|Randomized Phase (First Intervention)|Not specified|0
36560|NCT01518946|161159|P2|Randomized Phase (First Intervention)|Not specified|1
36561|NCT01518946|161160|P1|Randomized Phase (First Intervention)|Not specified|0
36562|NCT01518946|161158|P3|Open-label Phase|Not specified|0
36563|NCT01518946|161159|P2|Open-label Phase|Not specified|0
36564|NCT01518946|161160|P1|Open-label Phase|Not specified|4
36565|NCT01518322|161171|P1|Overall Study|FeNO measurement was missing|13
36566|NCT01518257|161192|P2|Overall Study|Other Miscellaneous Reason|0
36567|NCT01518257|161193|P1|Overall Study|Other Miscellaneous Reason|1
36568|NCT01518257|161192|P2|Overall Study|Lost to Follow-up|0
36569|NCT01518257|161193|P1|Overall Study|Lost to Follow-up|1
36570|NCT01518244|161215|P1|Overall Study|Adverse Event|3
36571|NCT01518192|161223|P3|Overall Study|Lost to Follow-up|35
36572|NCT01518192|161224|P2|Overall Study|Lost to Follow-up|26
36573|NCT01518192|161225|P1|Overall Study|Lost to Follow-up|29
36574|NCT01518153|161246|P3|Donor Lymphocyte Infusion|Death|1
36575|NCT01518153|161247|P2|Donor Lymphocyte Infusion|Death|2
36576|NCT01518153|161248|P1|Donor Lymphocyte Infusion|Death|0
36577|NCT01518153|161246|P3|Stem Cell Transplant|Adverse Event|0
36578|NCT01518153|161247|P2|Stem Cell Transplant|Adverse Event|0
36579|NCT01518153|161248|P1|Stem Cell Transplant|Adverse Event|1
36580|NCT01518153|161246|P3|Stem Cell Transplant|Secondary graft failure|0
36581|NCT01518153|161247|P2|Stem Cell Transplant|Secondary graft failure|0
36582|NCT01518153|161248|P1|Stem Cell Transplant|Secondary graft failure|1
36583|NCT01518153|161246|P3|Stem Cell Transplant|Death|0
36584|NCT01518153|161247|P2|Stem Cell Transplant|Death|0
36585|NCT01518153|161248|P1|Stem Cell Transplant|Death|2
36586|NCT01518153|161246|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
36587|NCT01518153|161247|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
36588|NCT01518153|161248|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
36589|NCT01517984|161259|P4|Overall Study|Ineligible for randomization|0
36590|NCT01517984|161260|P3|Overall Study|Ineligible for randomization|0
36591|NCT01517984|161261|P2|Overall Study|Ineligible for randomization|14
36592|NCT01517984|161262|P1|Overall Study|Ineligible for randomization|0
36593|NCT01517984|161259|P4|Overall Study|Screen Failure|0
36594|NCT01517984|161260|P3|Overall Study|Screen Failure|0
36595|NCT01517984|161261|P2|Overall Study|Screen Failure|0
36596|NCT01517984|161262|P1|Overall Study|Screen Failure|4
36597|NCT01517984|161259|P4|Overall Study|Withdrawal by Subject|1
36598|NCT01517984|161260|P3|Overall Study|Withdrawal by Subject|4
36599|NCT01517984|161261|P2|Overall Study|Withdrawal by Subject|8
36600|NCT01517984|161262|P1|Overall Study|Withdrawal by Subject|1
36601|NCT01517984|161259|P4|Overall Study|Lost to Follow-up|0
36602|NCT01517984|161260|P3|Overall Study|Lost to Follow-up|0
36603|NCT01517984|161261|P2|Overall Study|Lost to Follow-up|1
36604|NCT01517984|161262|P1|Overall Study|Lost to Follow-up|0
36605|NCT01517750|161299|P4|Overall Study|Lost to Follow-up|1
36606|NCT01517750|161300|P3|Overall Study|Lost to Follow-up|4
36607|NCT01517750|161301|P2|Overall Study|Lost to Follow-up|2
36608|NCT01517750|161302|P1|Overall Study|Lost to Follow-up|1
36609|NCT01517412|161339|P2|Overall Study|Other than specified above|5
36610|NCT01517412|161340|P1|Overall Study|Other than specified above|8
36611|NCT01517412|161339|P2|Overall Study|Poor compliance to protocol|3
36612|NCT01517412|161340|P1|Overall Study|Poor compliance to protocol|8
36613|NCT01517412|161339|P2|Overall Study|Lack of Efficacy|5
36614|NCT01517412|161340|P1|Overall Study|Lack of Efficacy|10
36615|NCT01517412|161339|P2|Overall Study|Adverse Event|11
36616|NCT01517412|161340|P1|Overall Study|Adverse Event|10
36617|NCT01517373|161369|P6|Treatment Period|Medication error without AEs|2
36618|NCT01517373|161370|P5|Treatment Period|Medication error without AEs|0
36619|NCT01517373|161371|P4|Treatment Period|Medication error without AEs|1
36620|NCT01517373|161372|P3|Treatment Period|Medication error without AEs|2
36621|NCT01517373|161373|P2|Treatment Period|Medication error without AEs|0
36622|NCT01517373|161374|P1|Treatment Period|Medication error without AEs|0
36623|NCT01517373|161369|P6|Treatment Period|Lack of Efficacy|0
36624|NCT01517373|161370|P5|Treatment Period|Lack of Efficacy|2
36625|NCT01517373|161371|P4|Treatment Period|Lack of Efficacy|3
36626|NCT01517373|161372|P3|Treatment Period|Lack of Efficacy|1
36627|NCT01517373|161373|P2|Treatment Period|Lack of Efficacy|1
36628|NCT01517373|161374|P1|Treatment Period|Lack of Efficacy|0
36629|NCT01517373|161369|P6|Treatment Period|Protocol Violation|0
36630|NCT01517373|161370|P5|Treatment Period|Protocol Violation|1
36631|NCT01517373|161371|P4|Treatment Period|Protocol Violation|0
36632|NCT01517373|161372|P3|Treatment Period|Protocol Violation|0
36633|NCT01517373|161373|P2|Treatment Period|Protocol Violation|0
36634|NCT01517373|161374|P1|Treatment Period|Protocol Violation|0
36635|NCT01517373|161369|P6|Treatment Period|Unspecified|0
36636|NCT01517373|161370|P5|Treatment Period|Unspecified|1
36637|NCT01517373|161371|P4|Treatment Period|Unspecified|0
36638|NCT01517373|161372|P3|Treatment Period|Unspecified|0
36639|NCT01517373|161373|P2|Treatment Period|Unspecified|0
36640|NCT01517373|161374|P1|Treatment Period|Unspecified|0
36641|NCT01517373|161369|P6|Treatment Period|Withdrawal by Subject|3
36642|NCT01517373|161370|P5|Treatment Period|Withdrawal by Subject|2
36643|NCT01517373|161371|P4|Treatment Period|Withdrawal by Subject|2
36644|NCT01517373|161372|P3|Treatment Period|Withdrawal by Subject|2
36645|NCT01517373|161373|P2|Treatment Period|Withdrawal by Subject|3
36646|NCT01517373|161374|P1|Treatment Period|Withdrawal by Subject|0
36647|NCT01517373|161369|P6|Treatment Period|Lost to Follow-up|0
36648|NCT01517373|161370|P5|Treatment Period|Lost to Follow-up|0
36649|NCT01517373|161371|P4|Treatment Period|Lost to Follow-up|1
36650|NCT01517373|161372|P3|Treatment Period|Lost to Follow-up|1
36651|NCT01517373|161373|P2|Treatment Period|Lost to Follow-up|0
36652|NCT01517373|161374|P1|Treatment Period|Lost to Follow-up|0
36653|NCT01517373|161369|P6|Treatment Period|Adverse Event|2
36654|NCT01517373|161370|P5|Treatment Period|Adverse Event|0
36655|NCT01517373|161371|P4|Treatment Period|Adverse Event|0
36656|NCT01517373|161372|P3|Treatment Period|Adverse Event|0
36657|NCT01517373|161373|P2|Treatment Period|Adverse Event|0
36658|NCT01517373|161374|P1|Treatment Period|Adverse Event|0
36659|NCT01517373|161369|P6|Run-in Period|Unspecified|0
36660|NCT01517373|161370|P5|Run-in Period|Unspecified|0
36661|NCT01517373|161371|P4|Run-in Period|Unspecified|0
36662|NCT01517373|161372|P3|Run-in Period|Unspecified|0
36663|NCT01517373|161373|P2|Run-in Period|Unspecified|0
36664|NCT01517373|161374|P1|Run-in Period|Unspecified|1
36665|NCT01517373|161369|P6|Run-in Period|Sponsor Decision|0
36666|NCT01517373|161370|P5|Run-in Period|Sponsor Decision|0
36667|NCT01517373|161371|P4|Run-in Period|Sponsor Decision|0
36668|NCT01517373|161372|P3|Run-in Period|Sponsor Decision|0
36669|NCT01517373|161373|P2|Run-in Period|Sponsor Decision|0
36670|NCT01517373|161374|P1|Run-in Period|Sponsor Decision|3
36671|NCT01517373|161369|P6|Run-in Period|Withdrawal by Subject|0
36672|NCT01517373|161370|P5|Run-in Period|Withdrawal by Subject|0
36673|NCT01517373|161371|P4|Run-in Period|Withdrawal by Subject|0
36674|NCT01517373|161372|P3|Run-in Period|Withdrawal by Subject|0
36675|NCT01517373|161373|P2|Run-in Period|Withdrawal by Subject|0
36676|NCT01517373|161374|P1|Run-in Period|Withdrawal by Subject|12
36677|NCT01517373|161369|P6|Run-in Period|Lost to Follow-up|0
36678|NCT01517373|161370|P5|Run-in Period|Lost to Follow-up|0
36679|NCT01517373|161371|P4|Run-in Period|Lost to Follow-up|0
36680|NCT01517373|161372|P3|Run-in Period|Lost to Follow-up|0
36681|NCT01517373|161373|P2|Run-in Period|Lost to Follow-up|0
36682|NCT01517373|161374|P1|Run-in Period|Lost to Follow-up|1
36683|NCT01517373|161369|P6|Run-in Period|Did not meet eligibility criteria|0
36684|NCT01517373|161370|P5|Run-in Period|Did not meet eligibility criteria|0
36685|NCT01517373|161371|P4|Run-in Period|Did not meet eligibility criteria|0
36686|NCT01517373|161372|P3|Run-in Period|Did not meet eligibility criteria|0
36687|NCT01517373|161373|P2|Run-in Period|Did not meet eligibility criteria|0
36688|NCT01517373|161374|P1|Run-in Period|Did not meet eligibility criteria|34
36689|NCT01517373|161369|P6|Run-in Period|Adverse Event|0
36690|NCT01517373|161370|P5|Run-in Period|Adverse Event|0
36691|NCT01517373|161371|P4|Run-in Period|Adverse Event|0
36692|NCT01517373|161372|P3|Run-in Period|Adverse Event|0
36693|NCT01517373|161373|P2|Run-in Period|Adverse Event|0
36694|NCT01517373|161374|P1|Run-in Period|Adverse Event|5
36695|NCT01517373|161369|P6|Run-in Period|Death|0
36696|NCT01517373|161370|P5|Run-in Period|Death|0
36697|NCT01517373|161371|P4|Run-in Period|Death|0
36698|NCT01517373|161372|P3|Run-in Period|Death|0
36699|NCT01517373|161373|P2|Run-in Period|Death|0
36700|NCT01517373|161374|P1|Run-in Period|Death|1
36701|NCT01517295|161444|P2|Overall Study|Physician Decision|0
36702|NCT01517295|161445|P1|Overall Study|Physician Decision|1
36703|NCT01517282|161459|P4|Overall Study|Physician Decision|0
36704|NCT01517282|161460|P3|Overall Study|Physician Decision|0
36705|NCT01517282|161461|P2|Overall Study|Physician Decision|0
36706|NCT01517282|161462|P1|Overall Study|Physician Decision|1
36707|NCT01517282|161459|P4|Overall Study|Consent withdrawn|1
36708|NCT01517282|161460|P3|Overall Study|Consent withdrawn|1
36709|NCT01517282|161461|P2|Overall Study|Consent withdrawn|1
36710|NCT01517282|161462|P1|Overall Study|Consent withdrawn|0
36711|NCT01517178|161496|P2|Period 2|E.g. study termination|2
36712|NCT01517178|161497|P1|Period 2|E.g. study termination|2
36713|NCT01517178|161496|P2|Period 2|Withdrawal by Subject|0
36714|NCT01517178|161497|P1|Period 2|Withdrawal by Subject|3
36715|NCT01517178|161496|P2|Period 2|Adverse Event|0
36716|NCT01517178|161497|P1|Period 2|Adverse Event|1
36717|NCT01517178|161496|P2|Period 1|Withdrawal by Subject|1
36718|NCT01517178|161497|P1|Period 1|Withdrawal by Subject|0
36719|NCT01517178|161496|P2|Period 1|E.g. study termination|1
36720|NCT01517178|161497|P1|Period 1|E.g. study termination|3
36721|NCT01517178|161496|P2|Period 1|Lack of Efficacy|1
36722|NCT01517178|161497|P1|Period 1|Lack of Efficacy|0
36723|NCT01517178|161496|P2|Period 1|Adverse Event|2
36724|NCT01517178|161497|P1|Period 1|Adverse Event|1
36725|NCT01516970|161516|P2|Overall Study|Unspecified|7
36726|NCT01516970|161517|P1|Overall Study|Unspecified|9
36727|NCT01516970|161516|P2|Overall Study|Withdrawal by Subject|1
36728|NCT01516970|161517|P1|Overall Study|Withdrawal by Subject|1
36729|NCT01516970|161516|P2|Overall Study|Adverse Event|5
36730|NCT01516970|161517|P1|Overall Study|Adverse Event|1
36731|NCT01516970|161516|P2|Overall Study|Lost to Follow-up|8
36732|NCT01516970|161517|P1|Overall Study|Lost to Follow-up|7
36733|NCT01516892|161529|P1|Overall Study|Missing|1
36734|NCT01516892|161529|P1|Overall Study|Other Miscellaneous Reasons|43
36735|NCT01516892|161529|P1|Overall Study|Protocol Violation|60
36736|NCT01516892|161529|P1|Overall Study|Subject Withdrew Consent|92
36737|NCT01516892|161529|P1|Overall Study|Lost to Follow-up|82
36738|NCT01516892|161529|P1|Overall Study|Pregnancy|5
36739|NCT01516892|161529|P1|Overall Study|Lack of Efficacy|35
36740|NCT01516892|161529|P1|Overall Study|Adverse Event|25
36741|NCT01516879|161537|P2|Overall Study|Other|10
36742|NCT01516879|161538|P1|Overall Study|Other|5
36743|NCT01516879|161537|P2|Overall Study|Lost to Follow-up|11
36744|NCT01516879|161538|P1|Overall Study|Lost to Follow-up|2
36745|NCT01516879|161537|P2|Overall Study|Death|2
36746|NCT01516879|161538|P1|Overall Study|Death|0
36747|NCT01516879|161537|P2|Overall Study|Withdrawal by Subject|11
36748|NCT01516879|161538|P1|Overall Study|Withdrawal by Subject|9
36749|NCT01516749|161572|P1|Follow-up Off Therapy|Lost to Follow-up|1
36750|NCT01516749|161572|P1|Active Therapy|Lost to Follow-up|1
36751|NCT01516736|161581|P2|Overall Study|Other (not specified)|1
36752|NCT01516736|161582|P1|Overall Study|Other (not specified)|0
36753|NCT01516736|161581|P2|Overall Study|Protocol Violation|1
36754|NCT01516736|161582|P1|Overall Study|Protocol Violation|0
36755|NCT01516736|161581|P2|Overall Study|Lack of Efficacy|0
36756|NCT01516736|161582|P1|Overall Study|Lack of Efficacy|1
36757|NCT01516736|161581|P2|Overall Study|Physician Decision|1
36758|NCT01516736|161582|P1|Overall Study|Physician Decision|2
36759|NCT01516736|161581|P2|Overall Study|Death|1
36760|NCT01516736|161582|P1|Overall Study|Death|3
36761|NCT01516736|161581|P2|Overall Study|Adverse Event|5
36762|NCT01516736|161582|P1|Overall Study|Adverse Event|4
36763|NCT01516736|161581|P2|Overall Study|Withdrawal by Subject|4
36764|NCT01516736|161582|P1|Overall Study|Withdrawal by Subject|10
36765|NCT01516437|161619|P4|Overall Study|Reason not specified|1
36766|NCT01516437|161620|P3|Overall Study|Reason not specified|1
36767|NCT01516437|161621|P2|Overall Study|Reason not specified|0
36768|NCT01516437|161622|P1|Overall Study|Reason not specified|0
36769|NCT01516034|161685|P1|Overall Study|Lack of Efficacy|7
36770|NCT01516034|161685|P1|Overall Study|Physician Decision|1
36771|NCT01516008|161692|P3|Overall Study|Reason not specified|1
36772|NCT01516008|161693|P2|Overall Study|Reason not specified|0
36773|NCT01516008|161694|P1|Overall Study|Reason not specified|0
36774|NCT01516008|161692|P3|Overall Study|Protocol Violation|0
36775|NCT01516008|161693|P2|Overall Study|Protocol Violation|0
36776|NCT01516008|161694|P1|Overall Study|Protocol Violation|1
36777|NCT01516008|161692|P3|Overall Study|Lack of Efficacy|10
36778|NCT01516008|161693|P2|Overall Study|Lack of Efficacy|14
36779|NCT01516008|161694|P1|Overall Study|Lack of Efficacy|44
36780|NCT01516008|161692|P3|Overall Study|Adverse Event|7
36781|NCT01516008|161693|P2|Overall Study|Adverse Event|2
36782|NCT01516008|161694|P1|Overall Study|Adverse Event|0
36783|NCT01515865|161790|P3|Part B (Open-label)|Not Specified|0
36784|NCT01515865|161791|P2|Part B (Open-label)|Not Specified|0
36785|NCT01515865|161792|P1|Part B (Open-label)|Not Specified|1
36786|NCT01515865|161790|P3|Part B (Open-label)|Withdrawal by Subject|0
36787|NCT01515865|161791|P2|Part B (Open-label)|Withdrawal by Subject|0
36788|NCT01515865|161792|P1|Part B (Open-label)|Withdrawal by Subject|1
36789|NCT01515865|161790|P3|Part A (Open-label)|Not Specified|0
36790|NCT01515865|161791|P2|Part A (Open-label)|Not Specified|0
36791|NCT01515865|161792|P1|Part A (Open-label)|Not Specified|3
36792|NCT01515423|161860|P3|DOUBLE BLIND|Blind broken by investigator|0
36793|NCT01515423|161861|P2|DOUBLE BLIND|Blind broken by investigator|1
36794|NCT01515423|161862|P1|DOUBLE BLIND|Blind broken by investigator|0
36795|NCT01515423|161860|P3|DOUBLE BLIND|Unspecified|12
36796|NCT01515423|161861|P2|DOUBLE BLIND|Unspecified|6
36797|NCT01515423|161862|P1|DOUBLE BLIND|Unspecified|0
36798|NCT01515423|161860|P3|DOUBLE BLIND|Withdrawal by Subject|53
36799|NCT01515423|161861|P2|DOUBLE BLIND|Withdrawal by Subject|50
36800|NCT01515423|161862|P1|DOUBLE BLIND|Withdrawal by Subject|0
36801|NCT01515423|161860|P3|DOUBLE BLIND|Pregnancy|0
36802|NCT01515423|161861|P2|DOUBLE BLIND|Pregnancy|2
36803|NCT01515423|161862|P1|DOUBLE BLIND|Pregnancy|0
36804|NCT01515423|161860|P3|DOUBLE BLIND|Lost to Follow-up|12
36805|NCT01515423|161861|P2|DOUBLE BLIND|Lost to Follow-up|7
36806|NCT01515423|161862|P1|DOUBLE BLIND|Lost to Follow-up|0
36807|NCT01515423|161860|P3|DOUBLE BLIND|Death|2
36808|NCT01515423|161861|P2|DOUBLE BLIND|Death|1
36809|NCT01515423|161862|P1|DOUBLE BLIND|Death|0
36810|NCT01515423|161860|P3|DOUBLE BLIND|Adverse Event|13
36811|NCT01515423|161861|P2|DOUBLE BLIND|Adverse Event|15
36812|NCT01515423|161862|P1|DOUBLE BLIND|Adverse Event|0
36813|NCT01515423|161860|P3|Open Label Phase|Unspecified|0
36814|NCT01515423|161861|P2|Open Label Phase|Unspecified|0
36815|NCT01515423|161862|P1|Open Label Phase|Unspecified|28
36816|NCT01515423|161860|P3|Open Label Phase|excluded from DB Phase|0
36817|NCT01515423|161861|P2|Open Label Phase|excluded from DB Phase|0
36818|NCT01515423|161862|P1|Open Label Phase|excluded from DB Phase|70
36819|NCT01515423|161860|P3|Open Label Phase|Withdrawal by Subject|0
36820|NCT01515423|161861|P2|Open Label Phase|Withdrawal by Subject|0
36821|NCT01515423|161862|P1|Open Label Phase|Withdrawal by Subject|118
36822|NCT01515423|161860|P3|Open Label Phase|Lost to Follow-up|0
36823|NCT01515423|161861|P2|Open Label Phase|Lost to Follow-up|0
36824|NCT01515423|161862|P1|Open Label Phase|Lost to Follow-up|21
36825|NCT01515423|161860|P3|Open Label Phase|Lack of Efficacy|0
36826|NCT01515423|161861|P2|Open Label Phase|Lack of Efficacy|0
36827|NCT01515423|161862|P1|Open Label Phase|Lack of Efficacy|117
36828|NCT01515423|161860|P3|Open Label Phase|Death|0
36829|NCT01515423|161861|P2|Open Label Phase|Death|0
36830|NCT01515423|161862|P1|Open Label Phase|Death|2
36831|NCT01515423|161860|P3|Open Label Phase|Adverse Event|0
36832|NCT01515423|161861|P2|Open Label Phase|Adverse Event|0
36833|NCT01515423|161862|P1|Open Label Phase|Adverse Event|57
36834|NCT01515306|161903|P2|Overall Study|Ongoing receiving treatment|14
36835|NCT01515306|161904|P1|Overall Study|Ongoing receiving treatment|9
36836|NCT01515306|161903|P2|Overall Study|Progressive Disease|0
36837|NCT01515306|161904|P1|Overall Study|Progressive Disease|1
36838|NCT01515306|161903|P2|Overall Study|Adverse Event|0
36839|NCT01515306|161904|P1|Overall Study|Adverse Event|2
36840|NCT01515189|161917|P2|First Re-Induction Phase|Unspecified|0
36841|NCT01515189|161918|P1|First Re-Induction Phase|Unspecified|1
36842|NCT01515189|161917|P2|First Re-Induction Phase|No longer meets study criteria|0
36843|NCT01515189|161918|P1|First Re-Induction Phase|No longer meets study criteria|1
36844|NCT01515189|161917|P2|First Re-Induction Phase|Withdrawal by Subject|1
36845|NCT01515189|161918|P1|First Re-Induction Phase|Withdrawal by Subject|1
36846|NCT01515189|161917|P2|First Re-Induction Phase|Study drug toxicity|0
36847|NCT01515189|161918|P1|First Re-Induction Phase|Study drug toxicity|5
36848|NCT01515189|161917|P2|First Re-Induction Phase|Disease progression|14
36849|NCT01515189|161918|P1|First Re-Induction Phase|Disease progression|6
36850|NCT01515189|161917|P2|Induction|Unspecified|4
36851|NCT01515189|161918|P1|Induction|Unspecified|0
36852|NCT01515189|161917|P2|Induction|Lost to Follow-up|0
36853|NCT01515189|161918|P1|Induction|Lost to Follow-up|1
36854|NCT01515189|161917|P2|Induction|No longer meets study criteria|2
36855|NCT01515189|161918|P1|Induction|No longer meets study criteria|0
36856|NCT01515189|161917|P2|Induction|Withdrawal by Subject|9
36857|NCT01515189|161918|P1|Induction|Withdrawal by Subject|3
36858|NCT01515189|161917|P2|Induction|Adverse Event|9
36859|NCT01515189|161918|P1|Induction|Adverse Event|14
36860|NCT01515189|161917|P2|Induction|Death|17
36861|NCT01515189|161918|P1|Induction|Death|24
36862|NCT01515189|161917|P2|Induction|Study drug toxicity|36
36863|NCT01515189|161918|P1|Induction|Study drug toxicity|86
36864|NCT01515189|161917|P2|Induction|Disease Progression|155
36865|NCT01515189|161918|P1|Induction|Disease Progression|109
36866|NCT01514864|161991|P2|Overall Study|Study drug toxicity|0
36867|NCT01514864|161992|P1|Overall Study|Study drug toxicity|2
36868|NCT01514864|161991|P2|Overall Study|Disease progression|5
36869|NCT01514864|161992|P1|Overall Study|Disease progression|7
36870|NCT01514760|162008|P1|Overall Study|Lost to Follow-up|2
36871|NCT01514461|162037|P3|Overall Study|Death|0
36872|NCT01514461|162038|P2|Overall Study|Death|0
36873|NCT01514461|162039|P1|Overall Study|Death|1
36874|NCT01514461|162037|P3|Overall Study|Patient/guardian decision|1
36875|NCT01514461|162038|P2|Overall Study|Patient/guardian decision|1
36876|NCT01514461|162039|P1|Overall Study|Patient/guardian decision|1
36877|NCT01514461|162037|P3|Overall Study|Physician Decision|0
36878|NCT01514461|162038|P2|Overall Study|Physician Decision|1
36879|NCT01514461|162039|P1|Overall Study|Physician Decision|1
36880|NCT01514461|162037|P3|Overall Study|Adverse Event|3
36881|NCT01514461|162038|P2|Overall Study|Adverse Event|1
36882|NCT01514461|162039|P1|Overall Study|Adverse Event|2
36883|NCT01514448|162078|P2|Overall Study|New Cancer Therapy|0
36884|NCT01514448|162079|P1|Overall Study|New Cancer Therapy|1
36885|NCT01514448|162078|P2|Overall Study|Lost to Follow-up|0
36886|NCT01514448|162079|P1|Overall Study|Lost to Follow-up|2
36887|NCT01514448|162078|P2|Overall Study|Withdrawal by Subject|0
36888|NCT01514448|162079|P1|Overall Study|Withdrawal by Subject|2
36889|NCT01514448|162078|P2|Overall Study|Death|8
36890|NCT01514448|162079|P1|Overall Study|Death|7
36891|NCT01514422|162094|P1|Overall Study|Lost to Follow-up|1
36892|NCT01514240|162112|P2|Overall Study|Subject Decision|7
36893|NCT01514240|162113|P1|Overall Study|Subject Decision|2
36894|NCT01514240|162112|P2|Overall Study|Adverse Event|4
36895|NCT01514240|162113|P1|Overall Study|Adverse Event|4
36896|NCT01514136|162226|P8|Test Period 2; Test C*|Protocol Violation|0
36897|NCT01514136|162227|P7|Test Period 2; Test C*|Protocol Violation|1
36898|NCT01514136|162228|P6|Test Period 2; Test C*|Protocol Violation|0
36899|NCT01514136|162229|P5|Test Period 2; Test C*|Protocol Violation|0
36900|NCT01514136|162230|P4|Test Period 2; Test C*|Protocol Violation|0
36901|NCT01514136|162231|P3|Test Period 2; Test C*|Protocol Violation|0
36902|NCT01514136|162232|P2|Test Period 2; Test C*|Protocol Violation|0
36903|NCT01514136|162233|P1|Test Period 2; Test C*|Protocol Violation|0
36904|NCT01514136|162226|P8|Test Period 2; Test C*|holiday|0
36905|NCT01514136|162227|P7|Test Period 2; Test C*|holiday|1
36906|NCT01514136|162228|P6|Test Period 2; Test C*|holiday|0
36907|NCT01514136|162229|P5|Test Period 2; Test C*|holiday|0
36908|NCT01514136|162230|P4|Test Period 2; Test C*|holiday|0
36909|NCT01514136|162231|P3|Test Period 2; Test C*|holiday|0
36910|NCT01514136|162232|P2|Test Period 2; Test C*|holiday|0
36911|NCT01514136|162233|P1|Test Period 2; Test C*|holiday|0
36912|NCT01514136|162226|P8|Test Period 2; Test C*|Withdrawal by Subject|0
36913|NCT01514136|162227|P7|Test Period 2; Test C*|Withdrawal by Subject|1
36914|NCT01514136|162228|P6|Test Period 2; Test C*|Withdrawal by Subject|0
36915|NCT01514136|162229|P5|Test Period 2; Test C*|Withdrawal by Subject|0
36916|NCT01514136|162230|P4|Test Period 2; Test C*|Withdrawal by Subject|0
36917|NCT01514136|162231|P3|Test Period 2; Test C*|Withdrawal by Subject|0
36918|NCT01514136|162232|P2|Test Period 2; Test C*|Withdrawal by Subject|0
36919|NCT01514136|162233|P1|Test Period 2; Test C*|Withdrawal by Subject|0
36920|NCT01514136|162226|P8|Test Period 2; Test B*|Withdrawal by Subject|0
36921|NCT01514136|162227|P7|Test Period 2; Test B*|Withdrawal by Subject|0
36922|NCT01514136|162228|P6|Test Period 2; Test B*|Withdrawal by Subject|2
36923|NCT01514136|162229|P5|Test Period 2; Test B*|Withdrawal by Subject|0
36924|NCT01514136|162230|P4|Test Period 2; Test B*|Withdrawal by Subject|0
36925|NCT01514136|162231|P3|Test Period 2; Test B*|Withdrawal by Subject|0
36926|NCT01514136|162232|P2|Test Period 2; Test B*|Withdrawal by Subject|0
36927|NCT01514136|162233|P1|Test Period 2; Test B*|Withdrawal by Subject|0
36928|NCT01514136|162226|P8|Test Period 2; Test A*|Holiday|0
36929|NCT01514136|162227|P7|Test Period 2; Test A*|Holiday|0
36930|NCT01514136|162228|P6|Test Period 2; Test A*|Holiday|0
36931|NCT01514136|162229|P5|Test Period 2; Test A*|Holiday|1
36932|NCT01514136|162230|P4|Test Period 2; Test A*|Holiday|0
36933|NCT01514136|162231|P3|Test Period 2; Test A*|Holiday|0
36934|NCT01514136|162232|P2|Test Period 2; Test A*|Holiday|0
36935|NCT01514136|162233|P1|Test Period 2; Test A*|Holiday|0
36936|NCT01514136|162226|P8|Test Period 2; Test A*|Adverse Event|0
36937|NCT01514136|162227|P7|Test Period 2; Test A*|Adverse Event|0
36938|NCT01514136|162228|P6|Test Period 2; Test A*|Adverse Event|0
36939|NCT01514136|162229|P5|Test Period 2; Test A*|Adverse Event|1
36940|NCT01514136|162230|P4|Test Period 2; Test A*|Adverse Event|0
36941|NCT01514136|162231|P3|Test Period 2; Test A*|Adverse Event|0
36942|NCT01514136|162232|P2|Test Period 2; Test A*|Adverse Event|0
36943|NCT01514136|162233|P1|Test Period 2; Test A*|Adverse Event|0
36944|NCT01514136|162226|P8|Test Period 1; Test D|Subject took a break due to holiday|0
36945|NCT01514136|162227|P7|Test Period 1; Test D|Subject took a break due to holiday|0
36946|NCT01514136|162228|P6|Test Period 1; Test D|Subject took a break due to holiday|0
36947|NCT01514136|162229|P5|Test Period 1; Test D|Subject took a break due to holiday|0
36948|NCT01514136|162230|P4|Test Period 1; Test D|Subject took a break due to holiday|2
36949|NCT01514136|162231|P3|Test Period 1; Test D|Subject took a break due to holiday|0
36950|NCT01514136|162232|P2|Test Period 1; Test D|Subject took a break due to holiday|0
36951|NCT01514136|162233|P1|Test Period 1; Test D|Subject took a break due to holiday|0
36952|NCT01514136|162226|P8|Test Period 1; Test B|Withdrawal by Subject|0
36953|NCT01514136|162227|P7|Test Period 1; Test B|Withdrawal by Subject|0
36954|NCT01514136|162228|P6|Test Period 1; Test B|Withdrawal by Subject|0
36955|NCT01514136|162229|P5|Test Period 1; Test B|Withdrawal by Subject|0
36956|NCT01514136|162230|P4|Test Period 1; Test B|Withdrawal by Subject|0
36957|NCT01514136|162231|P3|Test Period 1; Test B|Withdrawal by Subject|0
36958|NCT01514136|162232|P2|Test Period 1; Test B|Withdrawal by Subject|1
36959|NCT01514136|162233|P1|Test Period 1; Test B|Withdrawal by Subject|0
36960|NCT01514136|162226|P8|Test Period 1; Test A|Break from study holiday|0
36961|NCT01514136|162227|P7|Test Period 1; Test A|Break from study holiday|0
36962|NCT01514136|162228|P6|Test Period 1; Test A|Break from study holiday|0
36963|NCT01514136|162229|P5|Test Period 1; Test A|Break from study holiday|0
36964|NCT01514136|162230|P4|Test Period 1; Test A|Break from study holiday|0
36965|NCT01514136|162231|P3|Test Period 1; Test A|Break from study holiday|0
36966|NCT01514136|162232|P2|Test Period 1; Test A|Break from study holiday|0
36967|NCT01514136|162233|P1|Test Period 1; Test A|Break from study holiday|2
36968|NCT01514136|162226|P8|Test Period 1; Test A|Protocol Violation|0
36969|NCT01514136|162227|P7|Test Period 1; Test A|Protocol Violation|0
36970|NCT01514136|162228|P6|Test Period 1; Test A|Protocol Violation|0
36971|NCT01514136|162229|P5|Test Period 1; Test A|Protocol Violation|0
36972|NCT01514136|162230|P4|Test Period 1; Test A|Protocol Violation|0
36973|NCT01514136|162231|P3|Test Period 1; Test A|Protocol Violation|0
36974|NCT01514136|162232|P2|Test Period 1; Test A|Protocol Violation|0
36975|NCT01514136|162233|P1|Test Period 1; Test A|Protocol Violation|1
36976|NCT01513590|162301|P2|Overall Study|Unclassified|10
36977|NCT01513590|162302|P1|Overall Study|Unclassified|5
36978|NCT01513590|162301|P2|Overall Study|Withdrawal Criteria|0
36979|NCT01513590|162302|P1|Overall Study|Withdrawal Criteria|3
36980|NCT01513590|162301|P2|Overall Study|Adverse Event|3
36981|NCT01513590|162302|P1|Overall Study|Adverse Event|2
36982|NCT01513473|162322|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
36983|NCT01513473|162323|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
36984|NCT01513473|162322|P2|Extension Trial (26 Weeks)|Adverse Event|1
36985|NCT01513473|162323|P1|Extension Trial (26 Weeks)|Adverse Event|0
36986|NCT01513473|162322|P2|Main Trial (26 Weeks)|Unclassified|2
36987|NCT01513473|162323|P1|Main Trial (26 Weeks)|Unclassified|0
36988|NCT01513473|162322|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
36989|NCT01513473|162323|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
36990|NCT01513473|162322|P2|Main Trial (26 Weeks)|Adverse Event|2
36991|NCT01513473|162323|P1|Main Trial (26 Weeks)|Adverse Event|0
36992|NCT01513460|162350|P3|Overall Study|Abnormal test procedure|0
36993|NCT01513460|162351|P2|Overall Study|Abnormal test procedure|0
36994|NCT01513460|162352|P1|Overall Study|Abnormal test procedure|1
36995|NCT01513460|162350|P3|Overall Study|Adverse Event|23
36996|NCT01513460|162351|P2|Overall Study|Adverse Event|18
36997|NCT01513460|162352|P1|Overall Study|Adverse Event|16
36998|NCT01513460|162350|P3|Overall Study|Withdrawal by Subject|21
36999|NCT01513460|162351|P2|Overall Study|Withdrawal by Subject|8
37000|NCT01513460|162352|P1|Overall Study|Withdrawal by Subject|7
37001|NCT01513460|162350|P3|Overall Study|Protocol deviations|3
37002|NCT01513460|162351|P2|Overall Study|Protocol deviations|4
37003|NCT01513460|162352|P1|Overall Study|Protocol deviations|3
37004|NCT01513460|162350|P3|Overall Study|Lack of Efficacy|5
37005|NCT01513460|162351|P2|Overall Study|Lack of Efficacy|2
37006|NCT01513460|162352|P1|Overall Study|Lack of Efficacy|1
37007|NCT01513460|162350|P3|Overall Study|Abnormal laboratory value|1
37008|NCT01513460|162351|P2|Overall Study|Abnormal laboratory value|0
37009|NCT01513460|162352|P1|Overall Study|Abnormal laboratory value|1
37010|NCT01513460|162350|P3|Overall Study|Lost to Follow-up|2
37011|NCT01513460|162351|P2|Overall Study|Lost to Follow-up|0
37012|NCT01513460|162352|P1|Overall Study|Lost to Follow-up|0
37013|NCT01513460|162350|P3|Overall Study|Death|1
37014|NCT01513460|162351|P2|Overall Study|Death|0
37015|NCT01513460|162352|P1|Overall Study|Death|0
37016|NCT01513330|162387|P2|Standard Care First,|not known|0
37017|NCT01513330|162388|P1|Standard Care First,|not known|1
37018|NCT01513330|162387|P2|Standard Care First,|Withdrawal by Subject|2
37019|NCT01513330|162388|P1|Standard Care First,|Withdrawal by Subject|1
37020|NCT01513330|162387|P2|Standard Care First,|Lack of Efficacy|2
37021|NCT01513330|162388|P1|Standard Care First,|Lack of Efficacy|2
37022|NCT01513330|162387|P2|SenSura Mio First,|not known|0
37023|NCT01513330|162388|P1|SenSura Mio First,|not known|1
37024|NCT01513330|162387|P2|SenSura Mio First,|Withdrawal by Subject|1
37025|NCT01513330|162388|P1|SenSura Mio First,|Withdrawal by Subject|1
37026|NCT01513330|162387|P2|SenSura Mio First,|Lack of Efficacy|1
37027|NCT01513330|162388|P1|SenSura Mio First,|Lack of Efficacy|0
37028|NCT01513330|162387|P2|SenSura Mio First,|Adverse Event|0
37029|NCT01513330|162388|P1|SenSura Mio First,|Adverse Event|2
37030|NCT01513317|162396|P2|Overall Study|Not specified|1
37031|NCT01513317|162397|P1|Overall Study|Not specified|0
37032|NCT01513317|162396|P2|Overall Study|Study terminated by sponsor|18
37033|NCT01513317|162397|P1|Overall Study|Study terminated by sponsor|18
37034|NCT01513317|162396|P2|Overall Study|Death|1
37035|NCT01513317|162397|P1|Overall Study|Death|1
37036|NCT01513317|162396|P2|Overall Study|Withdrawal by Subject|4
37037|NCT01513317|162397|P1|Overall Study|Withdrawal by Subject|15
37038|NCT01513291|162415|P5|Run-out Period|Withdrawal by Subject|0
37039|NCT01513291|162416|P4|Run-out Period|Withdrawal by Subject|1
37040|NCT01513291|162417|P3|Run-out Period|Withdrawal by Subject|0
37041|NCT01513291|162418|P2|Run-out Period|Withdrawal by Subject|0
37042|NCT01513291|162419|P1|Run-out Period|Withdrawal by Subject|0
37043|NCT01513291|162415|P5|Run-out Period|Lost to Follow-up|0
37044|NCT01513291|162416|P4|Run-out Period|Lost to Follow-up|1
37045|NCT01513291|162417|P3|Run-out Period|Lost to Follow-up|0
37046|NCT01513291|162418|P2|Run-out Period|Lost to Follow-up|0
37047|NCT01513291|162419|P1|Run-out Period|Lost to Follow-up|0
37048|NCT01513291|162415|P5|Treatment Period|Randomized not treated|0
37049|NCT01513291|162416|P4|Treatment Period|Randomized not treated|0
37050|NCT01513291|162417|P3|Treatment Period|Randomized not treated|0
37051|NCT01513291|162418|P2|Treatment Period|Randomized not treated|2
37052|NCT01513291|162419|P1|Treatment Period|Randomized not treated|0
37053|NCT01513291|162415|P5|Treatment Period|Withdrawal by Subject|0
37054|NCT01513291|162416|P4|Treatment Period|Withdrawal by Subject|0
37055|NCT01513291|162417|P3|Treatment Period|Withdrawal by Subject|0
37056|NCT01513291|162418|P2|Treatment Period|Withdrawal by Subject|5
37057|NCT01513291|162419|P1|Treatment Period|Withdrawal by Subject|8
37058|NCT01513291|162415|P5|Treatment Period|Protocol Violation|0
37059|NCT01513291|162416|P4|Treatment Period|Protocol Violation|0
37060|NCT01513291|162417|P3|Treatment Period|Protocol Violation|0
37061|NCT01513291|162418|P2|Treatment Period|Protocol Violation|2
37062|NCT01513291|162419|P1|Treatment Period|Protocol Violation|1
37063|NCT01513291|162415|P5|Treatment Period|Physician Decision|0
37064|NCT01513291|162416|P4|Treatment Period|Physician Decision|0
37065|NCT01513291|162417|P3|Treatment Period|Physician Decision|0
37066|NCT01513291|162418|P2|Treatment Period|Physician Decision|0
37067|NCT01513291|162419|P1|Treatment Period|Physician Decision|1
37068|NCT01513291|162415|P5|Treatment Period|Lost to Follow-up|0
37069|NCT01513291|162416|P4|Treatment Period|Lost to Follow-up|0
37070|NCT01513291|162417|P3|Treatment Period|Lost to Follow-up|0
37071|NCT01513291|162418|P2|Treatment Period|Lost to Follow-up|3
37072|NCT01513291|162419|P1|Treatment Period|Lost to Follow-up|2
37073|NCT01513291|162415|P5|Treatment Period|Lack of Efficacy|0
37074|NCT01513291|162416|P4|Treatment Period|Lack of Efficacy|0
37075|NCT01513291|162417|P3|Treatment Period|Lack of Efficacy|0
37076|NCT01513291|162418|P2|Treatment Period|Lack of Efficacy|0
37077|NCT01513291|162419|P1|Treatment Period|Lack of Efficacy|3
37078|NCT01513291|162415|P5|Treatment Period|Adverse Event|0
37079|NCT01513291|162416|P4|Treatment Period|Adverse Event|0
37080|NCT01513291|162417|P3|Treatment Period|Adverse Event|0
37081|NCT01513291|162418|P2|Treatment Period|Adverse Event|4
37082|NCT01513291|162419|P1|Treatment Period|Adverse Event|8
37083|NCT01513239|162447|P3|Overall Study|Withdrawal by Subject|42
37084|NCT01513239|162448|P2|Overall Study|Withdrawal by Subject|29
37085|NCT01513239|162449|P1|Overall Study|Withdrawal by Subject|27
37086|NCT01513239|162447|P3|Overall Study|Technical Problems|0
37087|NCT01513239|162448|P2|Overall Study|Technical Problems|2
37088|NCT01513239|162449|P1|Overall Study|Technical Problems|1
37089|NCT01513239|162447|P3|Overall Study|Protocol Violation|2
37090|NCT01513239|162448|P2|Overall Study|Protocol Violation|2
37091|NCT01513239|162449|P1|Overall Study|Protocol Violation|2
37092|NCT01513239|162447|P3|Overall Study|Physician Decision|4
37093|NCT01513239|162448|P2|Overall Study|Physician Decision|4
37094|NCT01513239|162449|P1|Overall Study|Physician Decision|4
37095|NCT01513239|162447|P3|Overall Study|Lost to Follow-up|6
37096|NCT01513239|162448|P2|Overall Study|Lost to Follow-up|10
37097|NCT01513239|162449|P1|Overall Study|Lost to Follow-up|11
37098|NCT01513239|162447|P3|Overall Study|Death|32
37099|NCT01513239|162448|P2|Overall Study|Death|22
37100|NCT01513239|162449|P1|Overall Study|Death|29
37101|NCT01513239|162447|P3|Overall Study|Adverse Event|2
37102|NCT01513239|162448|P2|Overall Study|Adverse Event|1
37103|NCT01513239|162449|P1|Overall Study|Adverse Event|1
37104|NCT01513148|162499|P2|Overall Study|Protocol Violation|2
37105|NCT01513148|162500|P1|Overall Study|Protocol Violation|2
37106|NCT01512979|162567|P2|Overall Study|Reason other than stated above|9
37107|NCT01512979|162568|P1|Overall Study|Reason other than stated above|13
37108|NCT01512979|162567|P2|Overall Study|Withdrawal by Subject|2
37109|NCT01512979|162568|P1|Overall Study|Withdrawal by Subject|1
37110|NCT01512979|162567|P2|Overall Study|Lost to Follow-up|5
37111|NCT01512979|162568|P1|Overall Study|Lost to Follow-up|2
37112|NCT01512979|162567|P2|Overall Study|Protocol Violation|4
37113|NCT01512979|162568|P1|Overall Study|Protocol Violation|1
37114|NCT01512979|162567|P2|Overall Study|Adverse Event|2
37115|NCT01512979|162568|P1|Overall Study|Adverse Event|2
37116|NCT01512745|162615|P2|Overall Study|Protocol Violation|0
37117|NCT01512745|162616|P1|Overall Study|Protocol Violation|1
37118|NCT01512745|162615|P2|Overall Study|Lack of Efficacy|2
37119|NCT01512745|162616|P1|Overall Study|Lack of Efficacy|2
37120|NCT01512745|162615|P2|Overall Study|Lost to Follow-up|0
37121|NCT01512745|162616|P1|Overall Study|Lost to Follow-up|4
37122|NCT01512745|162615|P2|Overall Study|Withdrawal by Subject|2
37123|NCT01512745|162616|P1|Overall Study|Withdrawal by Subject|2
37124|NCT01512745|162615|P2|Overall Study|Death|13
37125|NCT01512745|162616|P1|Overall Study|Death|9
37126|NCT01512745|162615|P2|Overall Study|Adverse Event|3
37127|NCT01512745|162616|P1|Overall Study|Adverse Event|22
37128|NCT01512368|162630|P1|Overall Study|Protocol Violation|3
37129|NCT01512160|162666|P4|Overall Study|Withdrawal by Subject|1
37130|NCT01512160|162667|P3|Overall Study|Withdrawal by Subject|0
37131|NCT01512160|162668|P2|Overall Study|Withdrawal by Subject|0
37132|NCT01512160|162669|P1|Overall Study|Withdrawal by Subject|1
37133|NCT01512160|162666|P4|Overall Study|Lost to Follow-up|0
37134|NCT01512160|162667|P3|Overall Study|Lost to Follow-up|0
37135|NCT01512160|162668|P2|Overall Study|Lost to Follow-up|0
37136|NCT01512160|162669|P1|Overall Study|Lost to Follow-up|1
37137|NCT01512108|162761|P2|Overall Study|Unclassified|3
37138|NCT01512108|162762|P1|Overall Study|Unclassified|11
37139|NCT01512108|162761|P2|Overall Study|Withdrawal Criteria|0
37140|NCT01512108|162762|P1|Overall Study|Withdrawal Criteria|1
37141|NCT01512108|162761|P2|Overall Study|Protocol Violation|2
37142|NCT01512108|162762|P1|Overall Study|Protocol Violation|1
37143|NCT01512108|162761|P2|Overall Study|Adverse Event|4
37144|NCT01512108|162762|P1|Overall Study|Adverse Event|9
37145|NCT01511939|162788|P3|Overall Study|Withdrawal by Subject|0
37146|NCT01511939|162789|P2|Overall Study|Withdrawal by Subject|1
37147|NCT01511939|162790|P1|Overall Study|Withdrawal by Subject|2
37148|NCT01511536|162819|P3|Phase 2|Unspecified|9
37149|NCT01511536|162820|P2|Phase 2|Unspecified|0
37150|NCT01511536|162821|P1|Phase 2|Unspecified|0
37151|NCT01511536|162819|P3|Phase 1|Unspecified|0
37152|NCT01511536|162820|P2|Phase 1|Unspecified|1
37153|NCT01511536|162821|P1|Phase 1|Unspecified|0
37154|NCT01511445|162843|P2|Overall Study|Protocol Violation|0
37155|NCT01511445|162844|P1|Overall Study|Protocol Violation|1
37156|NCT01511445|162843|P2|Overall Study|Protocol Violation|3
37157|NCT01511445|162844|P1|Overall Study|Protocol Violation|1
37158|NCT01511445|162843|P2|Overall Study|Lost to Follow-up|1
37159|NCT01511445|162844|P1|Overall Study|Lost to Follow-up|3
37160|NCT01511107|162864|P2|Overall Study|Withdrawal by Subject|20
37161|NCT01511107|162865|P1|Overall Study|Withdrawal by Subject|9
37162|NCT01511107|162864|P2|Overall Study|Lost to Follow-up|19
37163|NCT01511107|162865|P1|Overall Study|Lost to Follow-up|10
37164|NCT01511107|162864|P2|Overall Study|Ineligible|2
37165|NCT01511107|162865|P1|Overall Study|Ineligible|3
37166|NCT01510912|162932|P1|Overall Study|Other, including joint replacement|5
37167|NCT01510912|162932|P1|Overall Study|Lost to Follow-up|26
37168|NCT01510912|162932|P1|Overall Study|Protocol Violation|27
37169|NCT01510912|162932|P1|Overall Study|Physician Decision|1
37170|NCT01510912|162932|P1|Overall Study|Withdrawal by Subject|49
37171|NCT01510912|162932|P1|Overall Study|Non-compliance with trial drug|23
37172|NCT01510912|162932|P1|Overall Study|Lack of Efficacy|12
37173|NCT01510912|162932|P1|Overall Study|Adverse Event|99
37174|NCT01510769|162948|P3|Overall Study|Death|0
37175|NCT01510769|162949|P2|Overall Study|Death|1
37176|NCT01510769|162950|P1|Overall Study|Death|1
37177|NCT01510769|162948|P3|Overall Study|Withdrawal by Subject|3
37178|NCT01510769|162949|P2|Overall Study|Withdrawal by Subject|4
37179|NCT01510769|162950|P1|Overall Study|Withdrawal by Subject|3
37180|NCT01510769|162948|P3|Overall Study|Lost to Follow-up|5
37181|NCT01510769|162949|P2|Overall Study|Lost to Follow-up|1
37182|NCT01510769|162950|P1|Overall Study|Lost to Follow-up|5
37183|NCT01510769|162948|P3|Overall Study|Protocol Violation|9
37184|NCT01510769|162949|P2|Overall Study|Protocol Violation|10
37185|NCT01510769|162950|P1|Overall Study|Protocol Violation|11
37186|NCT01510769|162948|P3|Overall Study|Gout Flare|1
37187|NCT01510769|162949|P2|Overall Study|Gout Flare|3
37188|NCT01510769|162950|P1|Overall Study|Gout Flare|0
37189|NCT01510769|162948|P3|Overall Study|Adverse Event|4
37190|NCT01510769|162949|P2|Overall Study|Adverse Event|6
37191|NCT01510769|162950|P1|Overall Study|Adverse Event|7
37192|NCT01510756|162967|P1|Overall Study|Physician Decision|1
37193|NCT01510756|162967|P1|Overall Study|Lack of Efficacy|2
37194|NCT01510756|162967|P1|Overall Study|Death|1
37195|NCT01510717|162975|P2|Overall Study|Withdrawal by Subject|2
37196|NCT01510717|162976|P1|Overall Study|Withdrawal by Subject|0
37197|NCT01510717|162975|P2|Overall Study|Lost to Follow-up|1
37198|NCT01510717|162976|P1|Overall Study|Lost to Follow-up|0
37199|NCT01510717|162975|P2|Overall Study|Death|0
37200|NCT01510717|162976|P1|Overall Study|Death|1
37201|NCT01510717|162975|P2|Overall Study|Adverse Event|2
37202|NCT01510717|162976|P1|Overall Study|Adverse Event|1
37203|NCT01510158|163096|P3|Overall Study|Death|0
37204|NCT01510158|163097|P2|Overall Study|Death|0
37205|NCT01510158|163098|P1|Overall Study|Death|1
37206|NCT01510158|163096|P3|Overall Study|Withdrawal by Subject|10
37207|NCT01510158|163097|P2|Overall Study|Withdrawal by Subject|13
37208|NCT01510158|163098|P1|Overall Study|Withdrawal by Subject|10
37209|NCT01510158|163096|P3|Overall Study|Lost to Follow-up|9
37210|NCT01510158|163097|P2|Overall Study|Lost to Follow-up|16
37211|NCT01510158|163098|P1|Overall Study|Lost to Follow-up|13
37212|NCT01510158|163096|P3|Overall Study|Sponsor terminated study.|2
37213|NCT01510158|163097|P2|Overall Study|Sponsor terminated study.|0
37214|NCT01510158|163098|P1|Overall Study|Sponsor terminated study.|2
37215|NCT01510158|163096|P3|Overall Study|Protocol Violation|24
37216|NCT01510158|163097|P2|Overall Study|Protocol Violation|16
37217|NCT01510158|163098|P1|Overall Study|Protocol Violation|17
37218|NCT01510158|163096|P3|Overall Study|Gout flare|0
37219|NCT01510158|163097|P2|Overall Study|Gout flare|0
37220|NCT01510158|163098|P1|Overall Study|Gout flare|1
37221|NCT01510158|163096|P3|Overall Study|Adverse Event|5
37222|NCT01510158|163097|P2|Overall Study|Adverse Event|8
37223|NCT01510158|163098|P1|Overall Study|Adverse Event|7
37224|NCT01510145|163112|P1|Overall Study|Relative reported subject withdrew|1
37225|NCT01510145|163112|P1|Overall Study|Withdrawal by Subject|6
37226|NCT01510145|163112|P1|Overall Study|Lost to Follow-up|5
37227|NCT01510145|163112|P1|Overall Study|Adverse Event|6
37228|NCT01509664|163146|P2|Overall Study|Lost to Follow-up|21
37229|NCT01509664|163147|P1|Overall Study|Lost to Follow-up|15
37230|NCT01509079|163222|P2|Overall Study|started an excluded medication|1
37231|NCT01509079|163223|P1|Overall Study|started an excluded medication|0
37232|NCT01509079|163222|P2|Overall Study|Lack of Efficacy|2
37233|NCT01509079|163223|P1|Overall Study|Lack of Efficacy|0
37234|NCT01509053|163239|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
37235|NCT01509053|163239|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
37236|NCT01509053|163239|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
37237|NCT01509053|163239|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
37238|NCT01509053|163239|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
37239|NCT01509053|163239|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
37240|NCT01508936|163301|P2|Overall Study|Data from 2 sites deemed invalid|11
37241|NCT01508936|163302|P1|Overall Study|Data from 2 sites deemed invalid|4
37242|NCT01508936|163301|P2|Overall Study|Not specified|5
37243|NCT01508936|163302|P1|Overall Study|Not specified|0
37244|NCT01508936|163301|P2|Overall Study|Lost to Follow-up|9
37245|NCT01508936|163302|P1|Overall Study|Lost to Follow-up|2
37246|NCT01508936|163301|P2|Overall Study|Protocol Violation|3
37247|NCT01508936|163302|P1|Overall Study|Protocol Violation|2
37248|NCT01508936|163301|P2|Overall Study|Withdrawal by Subject|18
37249|NCT01508936|163302|P1|Overall Study|Withdrawal by Subject|4
37250|NCT01508936|163301|P2|Overall Study|Lack of Efficacy|1
37251|NCT01508936|163302|P1|Overall Study|Lack of Efficacy|0
37252|NCT01508936|163301|P2|Overall Study|Adverse Event|32
37253|NCT01508936|163302|P1|Overall Study|Adverse Event|11
37254|NCT01508910|163341|P4|Treatment|Sponsor Decision|1
37255|NCT01508910|163342|P3|Treatment|Sponsor Decision|0
37256|NCT01508910|163343|P2|Treatment|Sponsor Decision|0
37257|NCT01508910|163344|P1|Treatment|Sponsor Decision|0
37258|NCT01508910|163341|P4|Treatment|Withdrawal by Subject|1
37259|NCT01508910|163342|P3|Treatment|Withdrawal by Subject|6
37260|NCT01508910|163343|P2|Treatment|Withdrawal by Subject|1
37261|NCT01508910|163344|P1|Treatment|Withdrawal by Subject|0
37262|NCT01508910|163341|P4|Treatment|Lost to Follow-up|1
37263|NCT01508910|163342|P3|Treatment|Lost to Follow-up|2
37264|NCT01508910|163343|P2|Treatment|Lost to Follow-up|0
37265|NCT01508910|163344|P1|Treatment|Lost to Follow-up|0
37266|NCT01508910|163341|P4|Treatment|Death|0
37267|NCT01508910|163342|P3|Treatment|Death|2
37268|NCT01508910|163343|P2|Treatment|Death|3
37269|NCT01508910|163344|P1|Treatment|Death|2
37270|NCT01508702|163377|P2|Overall Study|Withdrawal by Subject|7
37271|NCT01508702|163378|P1|Overall Study|Withdrawal by Subject|11
37272|NCT01508702|163377|P2|Overall Study|Lost to Follow-up|2
37273|NCT01508702|163378|P1|Overall Study|Lost to Follow-up|1
37274|NCT01508702|163377|P2|Overall Study|Protocol Violation|1
37275|NCT01508702|163378|P1|Overall Study|Protocol Violation|2
37276|NCT01508702|163377|P2|Overall Study|Gout flare|0
37277|NCT01508702|163378|P1|Overall Study|Gout flare|2
37278|NCT01508702|163377|P2|Overall Study|Adverse Event|3
37279|NCT01508702|163378|P1|Overall Study|Adverse Event|7
37280|NCT01508676|163386|P2|Phase II (2 Weeks)|Medication Exclusion|0
37281|NCT01508676|163387|P1|Phase II (2 Weeks)|Medication Exclusion|1
37282|NCT01508676|163386|P2|Phase II (2 Weeks)|Skin Sensitivity|1
37283|NCT01508676|163387|P1|Phase II (2 Weeks)|Skin Sensitivity|0
37284|NCT01508676|163386|P2|Phase I (2 Weeks)|Positive Drug Screen|2
37285|NCT01508676|163387|P1|Phase I (2 Weeks)|Positive Drug Screen|0
37286|NCT01508676|163386|P2|Phase I (2 Weeks)|Wrong Pain Type|0
37287|NCT01508676|163387|P1|Phase I (2 Weeks)|Wrong Pain Type|1
37288|NCT01508676|163386|P2|Phase I (2 Weeks)|Medication Exclusion|1
37289|NCT01508676|163387|P1|Phase I (2 Weeks)|Medication Exclusion|1
37290|NCT01508325|163408|P2|Overall Study|Unspecified|2
37291|NCT01508325|163409|P1|Overall Study|Unspecified|2
37292|NCT01508325|163408|P2|Overall Study|Lost to Follow-up|6
37293|NCT01508325|163409|P1|Overall Study|Lost to Follow-up|5
37294|NCT01508325|163408|P2|Overall Study|Adverse Event|0
37295|NCT01508325|163409|P1|Overall Study|Adverse Event|1
37296|NCT01508325|163408|P2|Overall Study|Physician Decision|1
37297|NCT01508325|163409|P1|Overall Study|Physician Decision|2
37298|NCT01508325|163408|P2|Overall Study|Protocol Violation|3
37299|NCT01508325|163409|P1|Overall Study|Protocol Violation|0
37300|NCT01508325|163408|P2|Overall Study|Withdrawal by Subject|9
37301|NCT01508325|163409|P1|Overall Study|Withdrawal by Subject|8
37302|NCT01508169|163439|P2|Overall Study|Lost to Follow-up|2
37303|NCT01508169|163440|P1|Overall Study|Lost to Follow-up|1
37304|NCT01508169|163439|P2|Overall Study|Withdrawal by Subject|0
37305|NCT01508169|163440|P1|Overall Study|Withdrawal by Subject|1
37306|NCT01508169|163439|P2|Overall Study|Adverse Event|0
37307|NCT01508169|163440|P1|Overall Study|Adverse Event|1
37308|NCT01508130|163454|P2|Overall Study|Administrative|3
37309|NCT01508130|163455|P1|Overall Study|Administrative|14
37310|NCT01508130|163454|P2|Overall Study|Insufficient therapeutic response|23
37311|NCT01508130|163455|P1|Overall Study|Insufficient therapeutic response|74
37312|NCT01508130|163454|P2|Overall Study|Subject’s substantial non-compliance|9
37313|NCT01508130|163455|P1|Overall Study|Subject’s substantial non-compliance|25
37314|NCT01508130|163454|P2|Overall Study|Withdrawal by Subject|3
37315|NCT01508130|163455|P1|Overall Study|Withdrawal by Subject|3
37316|NCT01508130|163454|P2|Overall Study|Lost to Follow-up|2
37317|NCT01508130|163455|P1|Overall Study|Lost to Follow-up|25
37318|NCT01508130|163454|P2|Overall Study|Protocol Violation|0
37319|NCT01508130|163455|P1|Overall Study|Protocol Violation|2
37320|NCT01508130|163454|P2|Overall Study|Death|1
37321|NCT01508130|163455|P1|Overall Study|Death|3
37322|NCT01508130|163454|P2|Overall Study|Adverse Event|28
37323|NCT01508130|163455|P1|Overall Study|Adverse Event|81
37324|NCT01507896|163519|P1|Overall Study|The surgery was denied by the sponsor.|1
37325|NCT01507896|163519|P1|Overall Study|Withdrawal by Subject|1
37326|NCT01507831|163562|P2|Overall Study|Unspecified|6
37327|NCT01507831|163563|P1|Overall Study|Unspecified|3
37328|NCT01507831|163562|P2|Overall Study|Potential lost to follow-up|0
37329|NCT01507831|163563|P1|Overall Study|Potential lost to follow-up|3
37330|NCT01507831|163562|P2|Overall Study|Site closure|3
37331|NCT01507831|163563|P1|Overall Study|Site closure|0
37332|NCT01507831|163562|P2|Overall Study|Selection criteria finally not met|1
37333|NCT01507831|163563|P1|Overall Study|Selection criteria finally not met|0
37334|NCT01507831|163562|P2|Overall Study|Last visit outside protocol visit window|143
37335|NCT01507831|163563|P1|Overall Study|Last visit outside protocol visit window|51
37336|NCT01507831|163562|P2|Overall Study|Related to study drug administration|14
37337|NCT01507831|163563|P1|Overall Study|Related to study drug administration|5
37338|NCT01507831|163562|P2|Overall Study|Consent withdrawn by participant|72
37339|NCT01507831|163563|P1|Overall Study|Consent withdrawn by participant|34
37340|NCT01507831|163562|P2|Overall Study|Participant moved|19
37341|NCT01507831|163563|P1|Overall Study|Participant moved|5
37342|NCT01507831|163562|P2|Overall Study|Physician Decision|4
37343|NCT01507831|163563|P1|Overall Study|Physician Decision|0
37344|NCT01507831|163562|P2|Overall Study|Poor compliance to protocol|60
37345|NCT01507831|163563|P1|Overall Study|Poor compliance to protocol|38
37346|NCT01507831|163562|P2|Overall Study|Death|2
37347|NCT01507831|163563|P1|Overall Study|Death|6
37348|NCT01507831|163562|P2|Overall Study|Adverse Event|113
37349|NCT01507831|163563|P1|Overall Study|Adverse Event|48
37350|NCT01507831|163562|P2|Overall Study|Randomized but not treated|3
37351|NCT01507831|163563|P1|Overall Study|Randomized but not treated|0
37352|NCT01507662|163633|P2|Overall Study|Proxy interview done|3
37353|NCT01507662|163634|P1|Overall Study|Proxy interview done|2
37354|NCT01507662|163633|P2|Overall Study|Lost to Follow-up|523
37355|NCT01507662|163634|P1|Overall Study|Lost to Follow-up|498
37356|NCT01507662|163633|P2|Overall Study|Withdrawal by Subject|287
37357|NCT01507662|163634|P1|Overall Study|Withdrawal by Subject|290
37358|NCT01507662|163633|P2|Overall Study|Death|18
37359|NCT01507662|163634|P1|Overall Study|Death|26
37360|NCT01507246|163659|P2|Overall Study|Required different surgical procedures|1
37361|NCT01507246|163660|P1|Overall Study|Required different surgical procedures|2
37362|NCT01507090|163758|P1|Overall Study|incomplete dataset|18
37363|NCT01507051|163797|P4|Overall Study|Adverse Event|0
37364|NCT01507051|163798|P3|Overall Study|Adverse Event|0
37365|NCT01507051|163799|P2|Overall Study|Adverse Event|0
37366|NCT01507051|163800|P1|Overall Study|Adverse Event|1
37367|NCT01507051|163797|P4|Overall Study|Physician Decision|1
37368|NCT01507051|163798|P3|Overall Study|Physician Decision|0
37369|NCT01507051|163799|P2|Overall Study|Physician Decision|0
37370|NCT01507051|163800|P1|Overall Study|Physician Decision|0
37371|NCT01507051|163797|P4|Overall Study|Withdrawal by Subject|6
37372|NCT01507051|163798|P3|Overall Study|Withdrawal by Subject|1
37373|NCT01507051|163799|P2|Overall Study|Withdrawal by Subject|3
37374|NCT01507051|163800|P1|Overall Study|Withdrawal by Subject|1
37375|NCT01506960|163918|P1|Overall Study|Did not meet angiographic criteria|47
37376|NCT01506947|163924|P1|Overall Study|Did Not Meet Eligibility Criteria|3
37377|NCT01506947|163924|P1|Overall Study|Death|1
37378|NCT01506947|163924|P1|Overall Study|Adverse Event|5
37379|NCT01506947|163924|P1|Overall Study|Lost to Follow-up|7
37380|NCT01506908|163942|P2|Overall Study|Adverse Event|0
37381|NCT01506908|163943|P1|Overall Study|Adverse Event|1
37382|NCT01506882|163961|P2|Overall Study|Other Reason|0
37383|NCT01506882|163962|P1|Overall Study|Other Reason|2
37384|NCT01506882|163961|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
37385|NCT01506882|163962|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
37386|NCT01506882|163961|P2|Overall Study|AE, non-serious non-fatal|1
37387|NCT01506882|163962|P1|Overall Study|AE, non-serious non-fatal|3
37388|NCT01506882|163961|P2|Overall Study|SAE, non-fatal|0
37389|NCT01506882|163962|P1|Overall Study|SAE, non-fatal|2
37390|NCT01506882|163961|P2|Overall Study|Withdrawal by Subject|3
37391|NCT01506882|163962|P1|Overall Study|Withdrawal by Subject|9
37392|NCT01506882|163961|P2|Overall Study|Lost to Follow-up|0
37393|NCT01506882|163962|P1|Overall Study|Lost to Follow-up|1
37394|NCT01506882|163961|P2|Overall Study|Lack of Efficacy|3
37395|NCT01506882|163962|P1|Overall Study|Lack of Efficacy|4
37396|NCT01506726|163976|P2|Overall Study|Adverse Event|2
37397|NCT01506726|163977|P1|Overall Study|Adverse Event|1
37398|NCT01506596|164017|P1|Overall Study|ineligible pathology|1
37399|NCT01506323|164031|P2|Overall Study|Started another treatment|0
37400|NCT01506323|164032|P1|Overall Study|Started another treatment|1
37401|NCT01506323|164031|P2|Overall Study|Schedule or Transportation conflict|0
37402|NCT01506323|164032|P1|Overall Study|Schedule or Transportation conflict|8
37403|NCT01506323|164031|P2|Overall Study|Moved out of area|2
37404|NCT01506323|164032|P1|Overall Study|Moved out of area|5
37405|NCT01506323|164031|P2|Overall Study|Lack of Efficacy|3
37406|NCT01506323|164032|P1|Overall Study|Lack of Efficacy|1
37407|NCT01506323|164031|P2|Overall Study|Withdrawal by Subject|4
37408|NCT01506323|164032|P1|Overall Study|Withdrawal by Subject|4
37409|NCT01506323|164031|P2|Overall Study|Lost to Follow-up|4
37410|NCT01506323|164032|P1|Overall Study|Lost to Follow-up|5
37411|NCT01506193|164061|P3|Overall Study|Lost to Follow-up|3
37412|NCT01506193|164062|P2|Overall Study|Lost to Follow-up|3
37413|NCT01506193|164063|P1|Overall Study|Lost to Follow-up|8
37414|NCT01506193|164061|P3|Overall Study|Withdrawal by Subject|8
37415|NCT01506193|164062|P2|Overall Study|Withdrawal by Subject|1
37416|NCT01506193|164063|P1|Overall Study|Withdrawal by Subject|5
37417|NCT01506193|164061|P3|Overall Study|Adverse event, non-fatal|1
37418|NCT01506193|164062|P2|Overall Study|Adverse event, non-fatal|0
37419|NCT01506193|164063|P1|Overall Study|Adverse event, non-fatal|0
37420|NCT01506193|164061|P3|Overall Study|Migrated/moved from study area|1
37421|NCT01506193|164062|P2|Overall Study|Migrated/moved from study area|0
37422|NCT01506193|164063|P1|Overall Study|Migrated/moved from study area|0
37423|NCT01506193|164061|P3|Overall Study|Protocol Violation|1
37424|NCT01506193|164062|P2|Overall Study|Protocol Violation|0
37425|NCT01506193|164063|P1|Overall Study|Protocol Violation|1
37426|NCT01505881|164096|P2|Overall Study|Withdrawal by Subject|0
37427|NCT01505881|164097|P1|Overall Study|Withdrawal by Subject|2
37428|NCT01505881|164096|P2|Overall Study|Lost to Follow-up|0
37429|NCT01505881|164097|P1|Overall Study|Lost to Follow-up|2
37430|NCT01505881|164096|P2|Overall Study|Adverse Event|1
37431|NCT01505881|164097|P1|Overall Study|Adverse Event|0
37432|NCT01505647|164120|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
37433|NCT01505647|164121|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
37434|NCT01505647|164120|P2|Day 43 Through Day 182 Follow-up|Death|1
37435|NCT01505647|164121|P1|Day 43 Through Day 182 Follow-up|Death|0
37436|NCT01505647|164120|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
37437|NCT01505647|164121|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
37438|NCT01505647|164120|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
37439|NCT01505647|164121|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
37440|NCT01505647|164120|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
37441|NCT01505647|164121|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
37442|NCT01505608|164137|P2|Phase II|Protocol Violation|1
37443|NCT01505608|164138|P1|Phase II|Protocol Violation|0
37444|NCT01505608|164137|P2|Phase II|Lack of Efficacy|1
37445|NCT01505608|164138|P1|Phase II|Lack of Efficacy|2
37446|NCT01505608|164137|P2|Phase I|Withdrawal by Subject|1
37447|NCT01505608|164138|P1|Phase I|Withdrawal by Subject|0
37448|NCT01505608|164137|P2|Phase I|Adverse Event|1
37449|NCT01505608|164138|P1|Phase I|Adverse Event|0
37450|NCT01505608|164137|P2|Phase I|Lack of Efficacy|4
37451|NCT01505608|164138|P1|Phase I|Lack of Efficacy|0
37452|NCT01505387|164173|P2|Overall Study|Withdrawal by Subject|1
37453|NCT01505387|164174|P1|Overall Study|Withdrawal by Subject|1
37454|NCT01505387|164173|P2|Overall Study|Protocol Violation|0
37455|NCT01505387|164174|P1|Overall Study|Protocol Violation|1
37456|NCT01505374|164180|P2|Overall Study|Lost to Follow-up|0
37457|NCT01505374|164181|P1|Overall Study|Lost to Follow-up|1
37458|NCT01505114|164199|P4|Overall Study|investigator decision|0
37459|NCT01505114|164200|P3|Overall Study|investigator decision|1
37460|NCT01505114|164201|P2|Overall Study|investigator decision|0
37461|NCT01505114|164202|P1|Overall Study|investigator decision|1
37462|NCT01505114|164199|P4|Overall Study|staff safety concerns|1
37463|NCT01505114|164200|P3|Overall Study|staff safety concerns|0
37464|NCT01505114|164201|P2|Overall Study|staff safety concerns|0
37465|NCT01505114|164202|P1|Overall Study|staff safety concerns|0
37466|NCT01505114|164199|P4|Overall Study|inadvertent enrollment due to peanut all|1
37467|NCT01505114|164200|P3|Overall Study|inadvertent enrollment due to peanut all|0
37468|NCT01505114|164201|P2|Overall Study|inadvertent enrollment due to peanut all|0
37469|NCT01505114|164202|P1|Overall Study|inadvertent enrollment due to peanut all|0
37470|NCT01505114|164199|P4|Overall Study|relocated|3
37471|NCT01505114|164200|P3|Overall Study|relocated|2
37472|NCT01505114|164201|P2|Overall Study|relocated|2
37473|NCT01505114|164202|P1|Overall Study|relocated|4
37474|NCT01505114|164199|P4|Overall Study|Lost to Follow-up|7
37475|NCT01505114|164200|P3|Overall Study|Lost to Follow-up|8
37476|NCT01505114|164201|P2|Overall Study|Lost to Follow-up|5
37477|NCT01505114|164202|P1|Overall Study|Lost to Follow-up|11
37478|NCT01505114|164199|P4|Overall Study|unable to adhere to visit schedule|3
37479|NCT01505114|164200|P3|Overall Study|unable to adhere to visit schedule|3
37480|NCT01505114|164201|P2|Overall Study|unable to adhere to visit schedule|2
37481|NCT01505114|164202|P1|Overall Study|unable to adhere to visit schedule|3
37482|NCT01505114|164199|P4|Overall Study|Death|1
37483|NCT01505114|164200|P3|Overall Study|Death|0
37484|NCT01505114|164201|P2|Overall Study|Death|0
37485|NCT01505114|164202|P1|Overall Study|Death|1
37486|NCT01505114|164199|P4|Overall Study|Withdrawal by Subject|7
37487|NCT01505114|164200|P3|Overall Study|Withdrawal by Subject|4
37488|NCT01505114|164201|P2|Overall Study|Withdrawal by Subject|4
37489|NCT01505114|164202|P1|Overall Study|Withdrawal by Subject|5
37490|NCT01504971|164216|P1|Overall Study|Physician Decision|13
37491|NCT01504867|164245|P2|Overall Study|Consent revoked|1
37492|NCT01504867|164246|P1|Overall Study|Consent revoked|5
37493|NCT01504867|164245|P2|Overall Study|Inclusion criteria not met|2
37494|NCT01504867|164246|P1|Overall Study|Inclusion criteria not met|2
37495|NCT01503021|164299|P2|Overall Study|Moved, received transplant, etc.|7
37496|NCT01503021|164300|P1|Overall Study|Moved, received transplant, etc.|5
37497|NCT01503021|164299|P2|Overall Study|Withdrawal by Subject|8
37498|NCT01503021|164300|P1|Overall Study|Withdrawal by Subject|9
37499|NCT01503021|164299|P2|Overall Study|Protocol Violation|3
37500|NCT01503021|164300|P1|Overall Study|Protocol Violation|1
37501|NCT01503021|164299|P2|Overall Study|Physician Decision|0
37502|NCT01503021|164300|P1|Overall Study|Physician Decision|3
37503|NCT01503021|164299|P2|Overall Study|Lost to Follow-up|0
37504|NCT01503021|164300|P1|Overall Study|Lost to Follow-up|2
37505|NCT01503021|164299|P2|Overall Study|Death|2
37506|NCT01503021|164300|P1|Overall Study|Death|0
37507|NCT01503021|164299|P2|Overall Study|Adverse Event|6
37508|NCT01503021|164300|P1|Overall Study|Adverse Event|7
37509|NCT01502709|164377|P2|Overall Study|Lost to Follow-up|0
37510|NCT01502709|164378|P1|Overall Study|Lost to Follow-up|4
37511|NCT01502644|164391|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
37512|NCT01502644|164392|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
37513|NCT01502644|164393|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
37514|NCT01502644|164394|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
37515|NCT01502644|164391|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
37516|NCT01502644|164392|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
37517|NCT01502644|164393|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
37518|NCT01502644|164394|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
37519|NCT01502644|164391|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
37520|NCT01502644|164392|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
37521|NCT01502644|164393|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
37522|NCT01502644|164394|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
37523|NCT01502644|164391|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
37524|NCT01502644|164392|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
37525|NCT01502644|164393|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
37526|NCT01502644|164394|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
37527|NCT01502644|164391|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
37528|NCT01502644|164392|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
37529|NCT01502644|164393|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
37530|NCT01502644|164394|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
37531|NCT01502423|164404|P2|Overall Study|Withdrawal by Subject|1
37532|NCT01502423|164405|P1|Overall Study|Withdrawal by Subject|0
37533|NCT01502410|164427|P4|Overall Study|Withdrawal by Subject|0
37534|NCT01502410|164428|P3|Overall Study|Withdrawal by Subject|0
37535|NCT01502410|164429|P2|Overall Study|Withdrawal by Subject|0
37536|NCT01502410|164430|P1|Overall Study|Withdrawal by Subject|2
37537|NCT01502410|164427|P4|Overall Study|Physician Decision|0
37538|NCT01502410|164428|P3|Overall Study|Physician Decision|0
37539|NCT01502410|164429|P2|Overall Study|Physician Decision|1
37540|NCT01502410|164430|P1|Overall Study|Physician Decision|0
37541|NCT01502410|164427|P4|Overall Study|Lack of Efficacy|0
37542|NCT01502410|164428|P3|Overall Study|Lack of Efficacy|0
37543|NCT01502410|164429|P2|Overall Study|Lack of Efficacy|7
37544|NCT01502410|164430|P1|Overall Study|Lack of Efficacy|7
37545|NCT01502410|164427|P4|Overall Study|Adverse Event|0
37546|NCT01502410|164428|P3|Overall Study|Adverse Event|0
37547|NCT01502410|164429|P2|Overall Study|Adverse Event|2
37548|NCT01502410|164430|P1|Overall Study|Adverse Event|1
37549|NCT01502371|164443|P5|Overall Study|Excluded Medication|1
37550|NCT01502371|164444|P4|Overall Study|Excluded Medication|0
37551|NCT01502371|164445|P3|Overall Study|Excluded Medication|1
37552|NCT01502371|164446|P2|Overall Study|Excluded Medication|1
37553|NCT01502371|164447|P1|Overall Study|Excluded Medication|0
37554|NCT01502371|164443|P5|Overall Study|Protocol Violation|10
37555|NCT01502371|164444|P4|Overall Study|Protocol Violation|5
37556|NCT01502371|164445|P3|Overall Study|Protocol Violation|6
37557|NCT01502371|164446|P2|Overall Study|Protocol Violation|5
37558|NCT01502371|164447|P1|Overall Study|Protocol Violation|9
37559|NCT01502371|164443|P5|Overall Study|Technical Problems|1
37560|NCT01502371|164444|P4|Overall Study|Technical Problems|4
37561|NCT01502371|164445|P3|Overall Study|Technical Problems|2
37562|NCT01502371|164446|P2|Overall Study|Technical Problems|0
37563|NCT01502371|164447|P1|Overall Study|Technical Problems|1
37564|NCT01502371|164443|P5|Overall Study|Noncompliance with Study Drug|1
37565|NCT01502371|164444|P4|Overall Study|Noncompliance with Study Drug|2
37566|NCT01502371|164445|P3|Overall Study|Noncompliance with Study Drug|1
37567|NCT01502371|164446|P2|Overall Study|Noncompliance with Study Drug|0
37568|NCT01502371|164447|P1|Overall Study|Noncompliance with Study Drug|0
37569|NCT01502371|164443|P5|Overall Study|Physician Decision|1
37570|NCT01502371|164444|P4|Overall Study|Physician Decision|0
37571|NCT01502371|164445|P3|Overall Study|Physician Decision|0
37572|NCT01502371|164446|P2|Overall Study|Physician Decision|0
37573|NCT01502371|164447|P1|Overall Study|Physician Decision|3
37574|NCT01502371|164443|P5|Overall Study|Lack of Efficacy|4
37575|NCT01502371|164444|P4|Overall Study|Lack of Efficacy|2
37576|NCT01502371|164445|P3|Overall Study|Lack of Efficacy|2
37577|NCT01502371|164446|P2|Overall Study|Lack of Efficacy|3
37578|NCT01502371|164447|P1|Overall Study|Lack of Efficacy|3
37579|NCT01502371|164443|P5|Overall Study|Treatment Failure|30
37580|NCT01502371|164444|P4|Overall Study|Treatment Failure|19
37581|NCT01502371|164445|P3|Overall Study|Treatment Failure|12
37582|NCT01502371|164446|P2|Overall Study|Treatment Failure|20
37583|NCT01502371|164447|P1|Overall Study|Treatment Failure|22
37584|NCT01502371|164443|P5|Overall Study|Adverse Event|3
37585|NCT01502371|164444|P4|Overall Study|Adverse Event|4
37586|NCT01502371|164445|P3|Overall Study|Adverse Event|0
37587|NCT01502371|164446|P2|Overall Study|Adverse Event|1
37588|NCT01502371|164447|P1|Overall Study|Adverse Event|2
37589|NCT01502371|164443|P5|Overall Study|Withdrawal by Subject|1
37590|NCT01502371|164444|P4|Overall Study|Withdrawal by Subject|1
37591|NCT01502371|164445|P3|Overall Study|Withdrawal by Subject|1
37592|NCT01502371|164446|P2|Overall Study|Withdrawal by Subject|2
37593|NCT01502371|164447|P1|Overall Study|Withdrawal by Subject|1
37594|NCT01502228|164487|P1|Overall Study|Death|1
37595|NCT01502033|164492|P1|Overall Study|1 participant went back to school|1
37596|NCT01502033|164492|P1|Overall Study|1 participant had worsening depression|1
37597|NCT01502033|164492|P1|Overall Study|1 participant had scalp discomfort|1
37598|NCT01501110|164511|P2|Overall Study|Death|1
37599|NCT01501110|164512|P1|Overall Study|Death|0
37600|NCT01500720|164536|P2|Overall Study|Unspecified|8
37601|NCT01500720|164537|P1|Overall Study|Unspecified|4
37602|NCT01500720|164536|P2|Overall Study|Randomized But Not Treated|1
37603|NCT01500720|164537|P1|Overall Study|Randomized But Not Treated|1
37604|NCT01500694|164551|P2|Overall Study|Unspecified|3
37605|NCT01500694|164552|P1|Overall Study|Unspecified|9
37606|NCT01500694|164551|P2|Overall Study|Lack of Efficacy|5
37607|NCT01500694|164552|P1|Overall Study|Lack of Efficacy|14
37608|NCT01500694|164551|P2|Overall Study|Lost to Follow-up|3
37609|NCT01500694|164552|P1|Overall Study|Lost to Follow-up|2
37610|NCT01500694|164551|P2|Overall Study|Withdrawal by Subject|14
37611|NCT01500694|164552|P1|Overall Study|Withdrawal by Subject|23
37612|NCT01500694|164551|P2|Overall Study|Protocol Violation|1
37613|NCT01500694|164552|P1|Overall Study|Protocol Violation|0
37614|NCT01500694|164551|P2|Overall Study|Adverse Event|3
37615|NCT01500694|164552|P1|Overall Study|Adverse Event|4
37616|NCT01500629|164578|P2|Washout Period of 14 to 30 Days|Pregnancy|0
37617|NCT01500629|164579|P1|Washout Period of 14 to 30 Days|Pregnancy|1
37618|NCT01500434|164663|P1|Overall Study|Missed 12-month follow-up|5
37619|NCT01500434|164663|P1|Overall Study|Withdrawal by Subject|1
37620|NCT01500434|164663|P1|Overall Study|Death|1
37621|NCT01500382|164696|P4|Washout Period|Study site went out of business|0
37622|NCT01500382|164697|P3|Washout Period|Study site went out of business|1
37623|NCT01500382|164698|P2|Washout Period|Study site went out of business|0
37624|NCT01500382|164699|P1|Washout Period|Study site went out of business|0
37625|NCT01500317|164724|P3|Overall Study|Withdrawal by Subject|0
37626|NCT01500317|164725|P2|Overall Study|Withdrawal by Subject|2
37627|NCT01500317|164726|P1|Overall Study|Withdrawal by Subject|3
37628|NCT01500278|164748|P2|Week 13 - Week 104|Adverse Event|54
37629|NCT01500278|164749|P1|Week 13 - Week 104|Adverse Event|54
37630|NCT01500278|164748|P2|Week 13 - Week 104|Death|4
37631|NCT01500278|164749|P1|Week 13 - Week 104|Death|2
37632|NCT01500278|164748|P2|Week 13 - Week 104|Not completed|1
37633|NCT01500278|164749|P1|Week 13 - Week 104|Not completed|0
37634|NCT01500278|164748|P2|Week 13 - Week 104|Personal reason|1
37635|NCT01500278|164749|P1|Week 13 - Week 104|Personal reason|0
37636|NCT01500278|164748|P2|Week 13 - Week 104|Medical monitor decision|2
37637|NCT01500278|164749|P1|Week 13 - Week 104|Medical monitor decision|0
37638|NCT01500278|164748|P2|Week 13 - Week 104|Sponsor decision|2
37639|NCT01500278|164749|P1|Week 13 - Week 104|Sponsor decision|0
37640|NCT01500278|164748|P2|Week 13 - Week 104|Relocation|1
37641|NCT01500278|164749|P1|Week 13 - Week 104|Relocation|0
37642|NCT01500278|164748|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
37643|NCT01500278|164749|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
37644|NCT01500278|164748|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
37645|NCT01500278|164749|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
37646|NCT01500278|164748|P2|Week 13 - Week 104|Principal investigator retiring|0
37647|NCT01500278|164749|P1|Week 13 - Week 104|Principal investigator retiring|1
37648|NCT01500278|164748|P2|Week 13 - Week 104|Protocol deviation|0
37649|NCT01500278|164749|P1|Week 13 - Week 104|Protocol deviation|1
37650|NCT01500278|164748|P2|Week 13 - Week 104|Exclusion criteria not met|0
37651|NCT01500278|164749|P1|Week 13 - Week 104|Exclusion criteria not met|1
37652|NCT01500278|164748|P2|Week 13 - Week 104|Withdrawn in error|0
37653|NCT01500278|164749|P1|Week 13 - Week 104|Withdrawn in error|1
37654|NCT01500278|164748|P2|Week 13 - Week 104|Sponsor request|0
37655|NCT01500278|164749|P1|Week 13 - Week 104|Sponsor request|4
37656|NCT01500278|164748|P2|Week 13 - Week 104|False positive test|2
37657|NCT01500278|164749|P1|Week 13 - Week 104|False positive test|1
37658|NCT01500278|164748|P2|Week 13 - Week 104|Recurrent infections|0
37659|NCT01500278|164749|P1|Week 13 - Week 104|Recurrent infections|1
37660|NCT01500278|164748|P2|Week 13 - Week 104|Non/bad compliance|5
37661|NCT01500278|164749|P1|Week 13 - Week 104|Non/bad compliance|7
37662|NCT01500278|164748|P2|Week 13 - Week 104|Week 24 Non-Responder|16
37663|NCT01500278|164749|P1|Week 13 - Week 104|Week 24 Non-Responder|20
37664|NCT01500278|164748|P2|Week 13 - Week 104|Withdrawal by Subject|13
37665|NCT01500278|164749|P1|Week 13 - Week 104|Withdrawal by Subject|22
37666|NCT01500278|164748|P2|Week 13 - Week 104|Lost to Follow-up|5
37667|NCT01500278|164749|P1|Week 13 - Week 104|Lost to Follow-up|6
37668|NCT01500278|164748|P2|Week 13 - Week 104|Protocol Violation|6
37669|NCT01500278|164749|P1|Week 13 - Week 104|Protocol Violation|6
37670|NCT01500278|164748|P2|Week 13 - Week 104|Lack of Efficacy|12
37671|NCT01500278|164749|P1|Week 13 - Week 104|Lack of Efficacy|11
37672|NCT01500278|164748|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
37673|NCT01500278|164749|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
37674|NCT01500278|164748|P2|Week 0 - Week 12|Other serious disease|1
37675|NCT01500278|164749|P1|Week 0 - Week 12|Other serious disease|0
37676|NCT01500278|164748|P2|Week 0 - Week 12|Personal reason|1
37677|NCT01500278|164749|P1|Week 0 - Week 12|Personal reason|0
37678|NCT01500278|164748|P2|Week 0 - Week 12|Sponsor decision|0
37679|NCT01500278|164749|P1|Week 0 - Week 12|Sponsor decision|1
37680|NCT01500278|164748|P2|Week 0 - Week 12|Prior history of serious disease|0
37681|NCT01500278|164749|P1|Week 0 - Week 12|Prior history of serious disease|1
37682|NCT01500278|164748|P2|Week 0 - Week 12|Investigator decision|0
37683|NCT01500278|164749|P1|Week 0 - Week 12|Investigator decision|1
37684|NCT01500278|164748|P2|Week 0 - Week 12|Exclusion criteria not met|0
37685|NCT01500278|164749|P1|Week 0 - Week 12|Exclusion criteria not met|1
37686|NCT01500278|164748|P2|Week 0 - Week 12|Patient decision|0
37687|NCT01500278|164749|P1|Week 0 - Week 12|Patient decision|1
37688|NCT01500278|164748|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
37689|NCT01500278|164749|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
37690|NCT01500278|164748|P2|Week 0 - Week 12|Withdrawal by Subject|2
37691|NCT01500278|164749|P1|Week 0 - Week 12|Withdrawal by Subject|7
37692|NCT01500278|164748|P2|Week 0 - Week 12|Lost to Follow-up|1
37693|NCT01500278|164749|P1|Week 0 - Week 12|Lost to Follow-up|1
37694|NCT01500278|164748|P2|Week 0 - Week 12|Protocol Violation|16
37695|NCT01500278|164749|P1|Week 0 - Week 12|Protocol Violation|10
37696|NCT01500278|164748|P2|Week 0 - Week 12|Lack of Efficacy|1
37697|NCT01500278|164749|P1|Week 0 - Week 12|Lack of Efficacy|0
37698|NCT01500252|164773|P2|Overall Study|Lost to Follow-up|4
37699|NCT01500252|164774|P1|Overall Study|Lost to Follow-up|5
37700|NCT01500252|164773|P2|Overall Study|Death|2
37701|NCT01500252|164774|P1|Overall Study|Death|4
37702|NCT01500226|164800|P2|Overall Study|Other Reasons|16
37703|NCT01500226|164801|P1|Overall Study|Other Reasons|19
37704|NCT01500226|164800|P2|Overall Study|Lost to Follow-up|5
37705|NCT01500226|164801|P1|Overall Study|Lost to Follow-up|9
37706|NCT01500226|164800|P2|Overall Study|Lack of Efficacy|30
37707|NCT01500226|164801|P1|Overall Study|Lack of Efficacy|14
37708|NCT01500226|164800|P2|Overall Study|Physician Decision|15
37709|NCT01500226|164801|P1|Overall Study|Physician Decision|17
37710|NCT01500226|164800|P2|Overall Study|Protocol Violation|39
37711|NCT01500226|164801|P1|Overall Study|Protocol Violation|53
37712|NCT01500226|164800|P2|Overall Study|Disease Progression|14
37713|NCT01500226|164801|P1|Overall Study|Disease Progression|16
37714|NCT01500226|164800|P2|Overall Study|Death|4
37715|NCT01500226|164801|P1|Overall Study|Death|12
37716|NCT01500226|164800|P2|Overall Study|Withdrawal by Subject|96
37717|NCT01500226|164801|P1|Overall Study|Withdrawal by Subject|93
37718|NCT01500226|164800|P2|Overall Study|Chemo Completed or Change in Therapy|237
37719|NCT01500226|164801|P1|Overall Study|Chemo Completed or Change in Therapy|235
37720|NCT01500226|164800|P2|Overall Study|Adverse Event|38
37721|NCT01500226|164801|P1|Overall Study|Adverse Event|31
37722|NCT01500213|164813|P2|Overall Study|Other Reasons|5
37723|NCT01500213|164814|P1|Overall Study|Other Reasons|7
37724|NCT01500213|164813|P2|Overall Study|Lost to Follow-up|6
37725|NCT01500213|164814|P1|Overall Study|Lost to Follow-up|3
37726|NCT01500213|164813|P2|Overall Study|Lack of Efficacy|7
37727|NCT01500213|164814|P1|Overall Study|Lack of Efficacy|9
37728|NCT01500213|164813|P2|Overall Study|Physician Decision|10
37729|NCT01500213|164814|P1|Overall Study|Physician Decision|12
37730|NCT01500213|164813|P2|Overall Study|Protocol Violation|19
37731|NCT01500213|164814|P1|Overall Study|Protocol Violation|19
37732|NCT01500213|164813|P2|Overall Study|Disease Progression|21
37733|NCT01500213|164814|P1|Overall Study|Disease Progression|13
37734|NCT01500213|164813|P2|Overall Study|Death|3
37735|NCT01500213|164814|P1|Overall Study|Death|7
37736|NCT01500213|164813|P2|Overall Study|Withdrawal by Subject|37
37737|NCT01500213|164814|P1|Overall Study|Withdrawal by Subject|28
37738|NCT01500213|164813|P2|Overall Study|Chemo Completed or Change in Therapy|81
37739|NCT01500213|164814|P1|Overall Study|Chemo Completed or Change in Therapy|84
37740|NCT01500213|164813|P2|Overall Study|Adverse Event|35
37741|NCT01500213|164814|P1|Overall Study|Adverse Event|35
37742|NCT01500135|164826|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
37743|NCT01500135|164827|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
37744|NCT01500135|164826|P2|Overall Study|Participant was a Safety Concern|0
37745|NCT01500135|164827|P1|Overall Study|Participant was a Safety Concern|1
37746|NCT01500135|164826|P2|Overall Study|Patient Missed Scheduled Appointments|1
37747|NCT01500135|164827|P1|Overall Study|Patient Missed Scheduled Appointments|0
37748|NCT01500135|164826|P2|Overall Study|Principal Investigator (PI) Discretion|0
37749|NCT01500135|164827|P1|Overall Study|Principal Investigator (PI) Discretion|1
37750|NCT01500135|164826|P2|Overall Study|Fatal Adverse Event (AE)|5
37751|NCT01500135|164827|P1|Overall Study|Fatal Adverse Event (AE)|5
37752|NCT01500135|164826|P2|Overall Study|Lost to Follow-up|4
37753|NCT01500135|164827|P1|Overall Study|Lost to Follow-up|6
37754|NCT01500135|164826|P2|Overall Study|Withdrawal of Consent|0
37755|NCT01500135|164827|P1|Overall Study|Withdrawal of Consent|4
37756|NCT01500083|164852|P2|Overall Study|Other Reasons|5
37757|NCT01500083|164853|P1|Overall Study|Other Reasons|2
37758|NCT01500083|164852|P2|Overall Study|Investigator Discretion|8
37759|NCT01500083|164853|P1|Overall Study|Investigator Discretion|3
37760|NCT01500083|164852|P2|Overall Study|Disease Progression|10
37761|NCT01500083|164853|P1|Overall Study|Disease Progression|2
37762|NCT01500083|164852|P2|Overall Study|Withdrawal of Consent|1
37763|NCT01500083|164853|P1|Overall Study|Withdrawal of Consent|0
37764|NCT01500083|164852|P2|Overall Study|Lost to Follow-up|0
37765|NCT01500083|164853|P1|Overall Study|Lost to Follow-up|1
37766|NCT01500083|164852|P2|Overall Study|Death|2
37767|NCT01500083|164853|P1|Overall Study|Death|0
37768|NCT01500083|164852|P2|Overall Study|Adverse Event|17
37769|NCT01500083|164853|P1|Overall Study|Adverse Event|4
37770|NCT01500031|164859|P1|Overall Study|Withdrawal by Subject|4
37771|NCT01500031|164859|P1|Overall Study|Death|1
37772|NCT01499849|164894|P2|Overall Study|Other Reasons|30
37773|NCT01499849|164895|P1|Overall Study|Other Reasons|27
37774|NCT01499849|164894|P2|Overall Study|Lost to Follow-up|3
37775|NCT01499849|164895|P1|Overall Study|Lost to Follow-up|6
37776|NCT01499849|164894|P2|Overall Study|Lack of Efficacy|4
37777|NCT01499849|164895|P1|Overall Study|Lack of Efficacy|3
37778|NCT01499849|164894|P2|Overall Study|Physician Decision|19
37779|NCT01499849|164895|P1|Overall Study|Physician Decision|20
37780|NCT01499849|164894|P2|Overall Study|Protocol Violation|11
37781|NCT01499849|164895|P1|Overall Study|Protocol Violation|11
37782|NCT01499849|164894|P2|Overall Study|Disease Progression|10
37783|NCT01499849|164895|P1|Overall Study|Disease Progression|11
37784|NCT01499849|164894|P2|Overall Study|Death|7
37785|NCT01499849|164895|P1|Overall Study|Death|5
37786|NCT01499849|164894|P2|Overall Study|Withdrawal by Subject|43
37787|NCT01499849|164895|P1|Overall Study|Withdrawal by Subject|43
37788|NCT01499849|164894|P2|Overall Study|Chemo completed or Change in Therapy|67
37789|NCT01499849|164895|P1|Overall Study|Chemo completed or Change in Therapy|70
37790|NCT01499849|164894|P2|Overall Study|Adverse Event|32
37791|NCT01499849|164895|P1|Overall Study|Adverse Event|28
37792|NCT01499810|164905|P1|Overall Study|Withdrawal by Subject|1
37793|NCT01499810|164905|P1|Overall Study|Protocol Violation|1
37794|NCT01499810|164905|P1|Overall Study|Lost to Follow-up|10
37795|NCT01499667|164955|P3|Overall Study|Lack of Efficacy|0
37796|NCT01499667|164956|P2|Overall Study|Lack of Efficacy|0
37797|NCT01499667|164957|P1|Overall Study|Lack of Efficacy|2
37798|NCT01499667|164955|P3|Overall Study|Withdrawal by Subject|1
37799|NCT01499667|164956|P2|Overall Study|Withdrawal by Subject|1
37800|NCT01499667|164957|P1|Overall Study|Withdrawal by Subject|2
37801|NCT01499667|164955|P3|Overall Study|Adverse Event|2
37802|NCT01499667|164956|P2|Overall Study|Adverse Event|2
37803|NCT01499667|164957|P1|Overall Study|Adverse Event|0
37804|NCT01499667|164955|P3|Overall Study|Protocol Violation|2
37805|NCT01499667|164956|P2|Overall Study|Protocol Violation|3
37806|NCT01499667|164957|P1|Overall Study|Protocol Violation|1
37807|NCT01499667|164955|P3|Overall Study|administrative problems|5
37808|NCT01499667|164956|P2|Overall Study|administrative problems|5
37809|NCT01499667|164957|P1|Overall Study|administrative problems|4
37810|NCT01499576|165005|P1|Overall Study|Withdrawal by Subject|9
37811|NCT01499576|165005|P1|Overall Study|Physician Decision|12
37812|NCT01499355|165019|P4|Double-Blind Period|Lost to Follow-up|0
37813|NCT01499355|165020|P3|Double-Blind Period|Lost to Follow-up|0
37814|NCT01499355|165021|P2|Double-Blind Period|Lost to Follow-up|1
37815|NCT01499355|165022|P1|Double-Blind Period|Lost to Follow-up|0
37816|NCT01499355|165019|P4|Double-Blind Period|Consent Withdrawn|2
37817|NCT01499355|165020|P3|Double-Blind Period|Consent Withdrawn|1
37818|NCT01499355|165021|P2|Double-Blind Period|Consent Withdrawn|0
37819|NCT01499355|165022|P1|Double-Blind Period|Consent Withdrawn|0
37820|NCT01499355|165019|P4|Double-Blind Period|Investigator Decision|3
37821|NCT01499355|165020|P3|Double-Blind Period|Investigator Decision|3
37822|NCT01499355|165021|P2|Double-Blind Period|Investigator Decision|0
37823|NCT01499355|165022|P1|Double-Blind Period|Investigator Decision|0
37824|NCT01499355|165019|P4|Double-Blind Period|Death|0
37825|NCT01499355|165020|P3|Double-Blind Period|Death|0
37826|NCT01499355|165021|P2|Double-Blind Period|Death|1
37827|NCT01499355|165022|P1|Double-Blind Period|Death|0
37828|NCT01499355|165019|P4|Double-Blind Period|Not Specified|2
37829|NCT01499355|165020|P3|Double-Blind Period|Not Specified|2
37830|NCT01499355|165021|P2|Double-Blind Period|Not Specified|1
37831|NCT01499355|165022|P1|Double-Blind Period|Not Specified|0
37832|NCT01499355|165019|P4|Double-Blind Period|Study Termination|14
37833|NCT01499355|165020|P3|Double-Blind Period|Study Termination|16
37834|NCT01499355|165021|P2|Double-Blind Period|Study Termination|18
37835|NCT01499355|165022|P1|Double-Blind Period|Study Termination|0
37836|NCT01499355|165019|P4|Double-Blind Period|Adverse Event|2
37837|NCT01499355|165020|P3|Double-Blind Period|Adverse Event|3
37838|NCT01499355|165021|P2|Double-Blind Period|Adverse Event|2
37839|NCT01499355|165022|P1|Double-Blind Period|Adverse Event|0
37840|NCT01499355|165019|P4|Run-In Period|Adverse Event|0
37841|NCT01499355|165020|P3|Run-In Period|Adverse Event|0
37842|NCT01499355|165021|P2|Run-In Period|Adverse Event|0
37843|NCT01499355|165022|P1|Run-In Period|Adverse Event|8
37844|NCT01499355|165019|P4|Run-In Period|Consent Withdrawn|0
37845|NCT01499355|165020|P3|Run-In Period|Consent Withdrawn|0
37846|NCT01499355|165021|P2|Run-In Period|Consent Withdrawn|0
37847|NCT01499355|165022|P1|Run-In Period|Consent Withdrawn|1
37848|NCT01499355|165019|P4|Run-In Period|Investigator Decision|0
37849|NCT01499355|165020|P3|Run-In Period|Investigator Decision|0
37850|NCT01499355|165021|P2|Run-In Period|Investigator Decision|0
37851|NCT01499355|165022|P1|Run-In Period|Investigator Decision|2
37852|NCT01499355|165019|P4|Run-In Period|Death|0
37853|NCT01499355|165020|P3|Run-In Period|Death|0
37854|NCT01499355|165021|P2|Run-In Period|Death|0
37855|NCT01499355|165022|P1|Run-In Period|Death|2
37856|NCT01499355|165019|P4|Run-In Period|Not Specified|0
37857|NCT01499355|165020|P3|Run-In Period|Not Specified|0
37858|NCT01499355|165021|P2|Run-In Period|Not Specified|0
37859|NCT01499355|165022|P1|Run-In Period|Not Specified|3
37860|NCT01499355|165019|P4|Run-In Period|Study Termination|0
37861|NCT01499355|165020|P3|Run-In Period|Study Termination|0
37862|NCT01499355|165021|P2|Run-In Period|Study Termination|0
37863|NCT01499355|165022|P1|Run-In Period|Study Termination|15
37864|NCT01499303|165055|P2|Overall Study|Other|1
37865|NCT01499303|165056|P1|Overall Study|Other|0
37866|NCT01499303|165055|P2|Overall Study|Adverse Event|4
37867|NCT01499303|165056|P1|Overall Study|Adverse Event|1
37868|NCT01499303|165055|P2|Overall Study|Withdrawal by Subject|1
37869|NCT01499303|165056|P1|Overall Study|Withdrawal by Subject|0
37870|NCT01499303|165055|P2|Overall Study|Ongoing|1
37871|NCT01499303|165056|P1|Overall Study|Ongoing|2
37872|NCT01499290|165064|P2|Overall Study|Adverse Event|7
37873|NCT01499290|165065|P1|Overall Study|Adverse Event|14
37874|NCT01499290|165064|P2|Overall Study|Lack of Efficacy|8
37875|NCT01499290|165065|P1|Overall Study|Lack of Efficacy|7
37876|NCT01499290|165064|P2|Overall Study|Condition improved/subject recovered|0
37877|NCT01499290|165065|P1|Overall Study|Condition improved/subject recovered|1
37878|NCT01499290|165064|P2|Overall Study|Not specified in study report|5
37879|NCT01499290|165065|P1|Overall Study|Not specified in study report|11
37880|NCT01499290|165064|P2|Overall Study|Withdrawal by Subject|15
37881|NCT01499290|165065|P1|Overall Study|Withdrawal by Subject|22
37882|NCT01499277|165115|P2|Overall Study|Lack of therapeutic response and other|7
37883|NCT01499277|165116|P1|Overall Study|Lack of therapeutic response and other|8
37884|NCT01499277|165115|P2|Overall Study|Withdrawal by Subject|6
37885|NCT01499277|165116|P1|Overall Study|Withdrawal by Subject|16
37886|NCT01499277|165115|P2|Overall Study|Protocol Violation|3
37887|NCT01499277|165116|P1|Overall Study|Protocol Violation|2
37888|NCT01499277|165115|P2|Overall Study|Lost to Follow-up|8
37889|NCT01499277|165116|P1|Overall Study|Lost to Follow-up|15
37890|NCT01499277|165115|P2|Overall Study|Death|2
37891|NCT01499277|165116|P1|Overall Study|Death|3
37892|NCT01499277|165115|P2|Overall Study|Adverse Event|6
37893|NCT01499277|165116|P1|Overall Study|Adverse Event|3
37894|NCT01499199|165138|P1|Overall Study|Lack of Efficacy|1
37895|NCT01499199|165138|P1|Overall Study|Adverse Event|1
37896|NCT01499134|165175|P2|Overall Study|Withdrawal by Subject|1
37897|NCT01499134|165176|P1|Overall Study|Withdrawal by Subject|0
37898|NCT01499095|165198|P2|Overall Study|Perceived Lack of Efficacy|1
37899|NCT01499095|165199|P1|Overall Study|Perceived Lack of Efficacy|1
37900|NCT01499095|165198|P2|Overall Study|Change in Injection Schedule|0
37901|NCT01499095|165199|P1|Overall Study|Change in Injection Schedule|2
37902|NCT01499095|165198|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
37903|NCT01499095|165199|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
37904|NCT01499095|165198|P2|Overall Study|Hypoglycemia|1
37905|NCT01499095|165199|P1|Overall Study|Hypoglycemia|3
37906|NCT01499095|165198|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
37907|NCT01499095|165199|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
37908|NCT01499095|165198|P2|Overall Study|Lost to Follow-up|4
37909|NCT01499095|165199|P1|Overall Study|Lost to Follow-up|6
37910|NCT01499095|165198|P2|Overall Study|Diverse Reasons|25
37911|NCT01499095|165199|P1|Overall Study|Diverse Reasons|22
37912|NCT01499095|165198|P2|Overall Study|Received Rescue Therapy|40
37913|NCT01499095|165199|P1|Overall Study|Received Rescue Therapy|32
37914|NCT01499095|165198|P2|Overall Study|Protocol Violation|7
37915|NCT01499095|165199|P1|Overall Study|Protocol Violation|6
37916|NCT01499095|165198|P2|Overall Study|Lack of Efficacy|1
37917|NCT01499095|165199|P1|Overall Study|Lack of Efficacy|2
37918|NCT01499095|165198|P2|Overall Study|Adverse Event|7
37919|NCT01499095|165199|P1|Overall Study|Adverse Event|12
37920|NCT01499095|165198|P2|Overall Study|Randomized But Not Treated|1
37921|NCT01499095|165199|P1|Overall Study|Randomized But Not Treated|1
37922|NCT01499082|165229|P2|Overall Study|Lost to Follow-up|3
37923|NCT01499082|165230|P1|Overall Study|Lost to Follow-up|1
37924|NCT01499082|165229|P2|Overall Study|Hypoglycemia|3
37925|NCT01499082|165230|P1|Overall Study|Hypoglycemia|2
37926|NCT01499082|165229|P2|Overall Study|Site Closure for Noncompliance|2
37927|NCT01499082|165230|P1|Overall Study|Site Closure for Noncompliance|5
37928|NCT01499082|165229|P2|Overall Study|Diverse Reasons|14
37929|NCT01499082|165230|P1|Overall Study|Diverse Reasons|18
37930|NCT01499082|165229|P2|Overall Study|Protocol Violation|8
37931|NCT01499082|165230|P1|Overall Study|Protocol Violation|6
37932|NCT01499082|165229|P2|Overall Study|Lack of Efficacy|1
37933|NCT01499082|165230|P1|Overall Study|Lack of Efficacy|1
37934|NCT01499082|165229|P2|Overall Study|Adverse Event|16
37935|NCT01499082|165230|P1|Overall Study|Adverse Event|12
37936|NCT01499082|165229|P2|Overall Study|Randomized but not Treated|1
37937|NCT01499082|165230|P1|Overall Study|Randomized but not Treated|0
37938|NCT01498822|165260|P2|Overall Study|Lost to Follow-up|3
37939|NCT01498822|165261|P1|Overall Study|Lost to Follow-up|8
37940|NCT01498822|165260|P2|Overall Study|Withdrawal by Subject|25
37941|NCT01498822|165261|P1|Overall Study|Withdrawal by Subject|15
37942|NCT01498822|165260|P2|Overall Study|Adverse Event, serious fatal|1
37943|NCT01498822|165261|P1|Overall Study|Adverse Event, serious fatal|1
37944|NCT01498822|165260|P2|Overall Study|SAE, non-fatal|2
37945|NCT01498822|165261|P1|Overall Study|SAE, non-fatal|2
37946|NCT01498822|165260|P2|Overall Study|AE, non-serious non-fatal|17
37947|NCT01498822|165261|P1|Overall Study|AE, non-serious non-fatal|8
37948|NCT01498822|165260|P2|Overall Study|Lack of Efficacy|2
37949|NCT01498822|165261|P1|Overall Study|Lack of Efficacy|7
37950|NCT01498822|165260|P2|Overall Study|Other Reason|2
37951|NCT01498822|165261|P1|Overall Study|Other Reason|5
37952|NCT01498822|165260|P2|Overall Study|Protocol Violation|4
37953|NCT01498822|165261|P1|Overall Study|Protocol Violation|8
37954|NCT01498692|165288|P1|Overall Study|Missed 12-month visit|3
37955|NCT01498692|165288|P1|Overall Study|Withdrawal by Subject|1
37956|NCT01498692|165288|P1|Overall Study|Death|4
37957|NCT01498679|165319|P2|Overall Study|Withdrawal by Subject|4
37958|NCT01498679|165320|P1|Overall Study|Withdrawal by Subject|12
37959|NCT01498679|165319|P2|Overall Study|Physician Decision|2
37960|NCT01498679|165320|P1|Overall Study|Physician Decision|0
37961|NCT01498679|165319|P2|Overall Study|Protocol Violation|0
37962|NCT01498679|165320|P1|Overall Study|Protocol Violation|4
37963|NCT01498679|165319|P2|Overall Study|Lack of Efficacy|12
37964|NCT01498679|165320|P1|Overall Study|Lack of Efficacy|72
37965|NCT01498679|165319|P2|Overall Study|Adverse Event|4
37966|NCT01498679|165320|P1|Overall Study|Adverse Event|1
37967|NCT01498653|165336|P2|Overall Study|Withdrawal by Subject|3
37968|NCT01498653|165337|P1|Overall Study|Withdrawal by Subject|2
37969|NCT01498653|165336|P2|Overall Study|Physician Decision|0
37970|NCT01498653|165337|P1|Overall Study|Physician Decision|2
37971|NCT01498653|165336|P2|Overall Study|Lost to Follow-up|0
37972|NCT01498653|165337|P1|Overall Study|Lost to Follow-up|1
37973|NCT01498653|165336|P2|Overall Study|Protocol Violation|4
37974|NCT01498653|165337|P1|Overall Study|Protocol Violation|0
37975|NCT01498653|165336|P2|Overall Study|Lack of Efficacy|26
37976|NCT01498653|165337|P1|Overall Study|Lack of Efficacy|12
37977|NCT01498653|165336|P2|Overall Study|Adverse Event|2
37978|NCT01498653|165337|P1|Overall Study|Adverse Event|2
37979|NCT01498640|165351|P1|Overall Study|not specified|3
37980|NCT01498640|165351|P1|Overall Study|Death|1
37981|NCT01498640|165351|P1|Overall Study|Lost to Follow-up|1
37982|NCT01498575|165381|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
37983|NCT01498575|165382|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
37984|NCT01498575|165381|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
37985|NCT01498575|165382|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
37986|NCT01498575|165381|P2|Overall Sample|Withdrawal by Subject|14
37987|NCT01498575|165382|P1|Overall Sample|Withdrawal by Subject|60
37988|NCT01498458|165399|P1|Overall Study|Physician Decision|3
37989|NCT01498458|165399|P1|Overall Study|Adverse Event|4
37990|NCT01498185|165454|P5|Overall Study|No longer met criteria, etc|2
37991|NCT01498185|165455|P4|Overall Study|No longer met criteria, etc|0
37992|NCT01498185|165456|P3|Overall Study|No longer met criteria, etc|0
37993|NCT01498185|165457|P2|Overall Study|No longer met criteria, etc|0
37994|NCT01498185|165458|P1|Overall Study|No longer met criteria, etc|0
37995|NCT01498185|165454|P5|Overall Study|Withdrawal by Subject|1
37996|NCT01498185|165455|P4|Overall Study|Withdrawal by Subject|2
37997|NCT01498185|165456|P3|Overall Study|Withdrawal by Subject|0
37998|NCT01498185|165457|P2|Overall Study|Withdrawal by Subject|1
37999|NCT01498185|165458|P1|Overall Study|Withdrawal by Subject|1
38000|NCT01498185|165454|P5|Overall Study|Adverse Event|0
38001|NCT01498185|165455|P4|Overall Study|Adverse Event|1
38002|NCT01498185|165456|P3|Overall Study|Adverse Event|0
38003|NCT01498185|165457|P2|Overall Study|Adverse Event|0
38004|NCT01498185|165458|P1|Overall Study|Adverse Event|0
38005|NCT01498120|165498|P1|Overall Study|Unspecified|4
38006|NCT01498120|165498|P1|Overall Study|AE, non-serious non-fatal|3
38007|NCT01498120|165498|P1|Overall Study|Withdrawal by Subject|5
38008|NCT01498120|165498|P1|Overall Study|Lost to Follow-up|1
38009|NCT01498068|165505|P2|Overall Study|Withdrawal by Subject|1
38010|NCT01498068|165506|P1|Overall Study|Withdrawal by Subject|1
38011|NCT01497938|165524|P2|Overall Study|Device Violation|0
38012|NCT01497938|165525|P1|Overall Study|Device Violation|1
38013|NCT01497938|165524|P2|Overall Study|Withdrawal by Subject|0
38014|NCT01497938|165525|P1|Overall Study|Withdrawal by Subject|4
38015|NCT01497938|165524|P2|Overall Study|Physician Decision|1
38016|NCT01497938|165525|P1|Overall Study|Physician Decision|0
38017|NCT01497938|165524|P2|Overall Study|Adverse Event|1
38018|NCT01497938|165525|P1|Overall Study|Adverse Event|0
38019|NCT01497899|165537|P4|Open-Label Extension Phase|Still in the Open-Label Extension Phase|38
38020|NCT01497899|165538|P3|Open-Label Extension Phase|Still in the Open-Label Extension Phase|69
38021|NCT01497899|165539|P2|Open-Label Extension Phase|Still in the Open-Label Extension Phase|53
38022|NCT01497899|165540|P1|Open-Label Extension Phase|Still in the Open-Label Extension Phase|104
38023|NCT01497899|165537|P4|Open-Label Extension Phase|Lost to Follow-up|0
38024|NCT01497899|165538|P3|Open-Label Extension Phase|Lost to Follow-up|1
38025|NCT01497899|165539|P2|Open-Label Extension Phase|Lost to Follow-up|0
38026|NCT01497899|165540|P1|Open-Label Extension Phase|Lost to Follow-up|1
38027|NCT01497899|165537|P4|Double-Blind Phase|Subject Non-Compliance|0
38028|NCT01497899|165538|P3|Double-Blind Phase|Subject Non-Compliance|0
38029|NCT01497899|165539|P2|Double-Blind Phase|Subject Non-Compliance|1
38030|NCT01497899|165540|P1|Double-Blind Phase|Subject Non-Compliance|0
38031|NCT01497899|165537|P4|Double-Blind Phase|Lost to Follow-up|0
38032|NCT01497899|165538|P3|Double-Blind Phase|Lost to Follow-up|0
38033|NCT01497899|165539|P2|Double-Blind Phase|Lost to Follow-up|2
38034|NCT01497899|165540|P1|Double-Blind Phase|Lost to Follow-up|3
38035|NCT01497899|165537|P4|Double-Blind Phase|Withdrew Consent|0
38036|NCT01497899|165538|P3|Double-Blind Phase|Withdrew Consent|0
38037|NCT01497899|165539|P2|Double-Blind Phase|Withdrew Consent|1
38038|NCT01497899|165540|P1|Double-Blind Phase|Withdrew Consent|0
38039|NCT01497899|165537|P4|Double-Blind Phase|Investigator's Discretion|0
38040|NCT01497899|165538|P3|Double-Blind Phase|Investigator's Discretion|0
38041|NCT01497899|165539|P2|Double-Blind Phase|Investigator's Discretion|0
38042|NCT01497899|165540|P1|Double-Blind Phase|Investigator's Discretion|1
38043|NCT01497899|165537|P4|Double-Blind Phase|Lack of Efficacy|0
38044|NCT01497899|165538|P3|Double-Blind Phase|Lack of Efficacy|0
38045|NCT01497899|165539|P2|Double-Blind Phase|Lack of Efficacy|1
38046|NCT01497899|165540|P1|Double-Blind Phase|Lack of Efficacy|0
38047|NCT01497899|165537|P4|Double-Blind Phase|Adverse Event|0
38048|NCT01497899|165538|P3|Double-Blind Phase|Adverse Event|0
38049|NCT01497899|165539|P2|Double-Blind Phase|Adverse Event|0
38050|NCT01497899|165540|P1|Double-Blind Phase|Adverse Event|1
38051|NCT01497899|165537|P4|Double-Blind Phase|Randomized but not Treated|0
38052|NCT01497899|165538|P3|Double-Blind Phase|Randomized but not Treated|0
38053|NCT01497899|165539|P2|Double-Blind Phase|Randomized but not Treated|0
38054|NCT01497899|165540|P1|Double-Blind Phase|Randomized but not Treated|1
38055|NCT01497366|165568|P2|Overall Study|Randomized but not treated|21
38056|NCT01497366|165569|P1|Overall Study|Randomized but not treated|7
38057|NCT01497366|165568|P2|Overall Study|Death|1
38058|NCT01497366|165569|P1|Overall Study|Death|1
38059|NCT01497366|165568|P2|Overall Study|Other|0
38060|NCT01497366|165569|P1|Overall Study|Other|5
38061|NCT01497366|165568|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
38062|NCT01497366|165569|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
38063|NCT01497366|165568|P2|Overall Study|Withdrawal by Subject|6
38064|NCT01497366|165569|P1|Overall Study|Withdrawal by Subject|6
38065|NCT01497366|165568|P2|Overall Study|Lost to Follow-up|10
38066|NCT01497366|165569|P1|Overall Study|Lost to Follow-up|11
38067|NCT01497366|165568|P2|Overall Study|Virologic failure|50
38068|NCT01497366|165569|P1|Overall Study|Virologic failure|2
38069|NCT01497275|165587|P1|Overall Study|Adverse Event|1
38070|NCT01497275|165587|P1|Overall Study|Death|1
38071|NCT01497262|165594|P1|Overall Study|Protocol Violation|1
38072|NCT01497262|165594|P1|Overall Study|Adverse Event|2
38073|NCT01497262|165594|P1|Overall Study|Withdrawal by Subject|2
38074|NCT01497262|165594|P1|Overall Study|Physician Decision|1
38075|NCT01497262|165594|P1|Overall Study|Abnormal Test Procedure Result|1
38076|NCT01497262|165594|P1|Overall Study|Abnormal Lab Values|4
38077|NCT01497197|165601|P2|Overall Study|Unspecified|1
38078|NCT01497197|165602|P1|Overall Study|Unspecified|3
38079|NCT01497197|165601|P2|Overall Study|All embryos discarded|3
38080|NCT01497197|165602|P1|Overall Study|All embryos discarded|0
38081|NCT01497197|165601|P2|Overall Study|Intention to freeze all embryos|1
38082|NCT01497197|165602|P1|Overall Study|Intention to freeze all embryos|0
38083|NCT01497197|165601|P2|Overall Study|No fertilisation|5
38084|NCT01497197|165602|P1|Overall Study|No fertilisation|6
38085|NCT01497197|165601|P2|Overall Study|No oocytes retrieved|2
38086|NCT01497197|165602|P1|Overall Study|No oocytes retrieved|3
38087|NCT01497197|165601|P2|Overall Study|Risk of OHSS|0
38088|NCT01497197|165602|P1|Overall Study|Risk of OHSS|1
38089|NCT01497197|165601|P2|Overall Study|Excessive/lack of response to treatment|0
38090|NCT01497197|165602|P1|Overall Study|Excessive/lack of response to treatment|1
38091|NCT01497197|165601|P2|Overall Study|Withdrawal by Subject|1
38092|NCT01497197|165602|P1|Overall Study|Withdrawal by Subject|2
38093|NCT01497197|165601|P2|Overall Study|Protocol Violation|2
38094|NCT01497197|165602|P1|Overall Study|Protocol Violation|0
38095|NCT01497197|165601|P2|Overall Study|Lost to Follow-up|0
38096|NCT01497197|165602|P1|Overall Study|Lost to Follow-up|1
38097|NCT01496807|165637|P1|Overall Study|Change in diagnosis|1
38098|NCT01496807|165637|P1|Overall Study|Participant preference/toxicity|8
38099|NCT01496807|165637|P1|Overall Study|Progressive Disease|21
38100|NCT01496469|165649|P2|Overall Study|Other|1
38101|NCT01496469|165650|P1|Overall Study|Other|1
38102|NCT01496469|165649|P2|Overall Study|BP exceeds protocol limits|2
38103|NCT01496469|165650|P1|Overall Study|BP exceeds protocol limits|1
38104|NCT01496469|165649|P2|Overall Study|Withdrawal by Subject|4
38105|NCT01496469|165650|P1|Overall Study|Withdrawal by Subject|4
38106|NCT01496469|165649|P2|Overall Study|Lost to Follow-up|1
38107|NCT01496469|165650|P1|Overall Study|Lost to Follow-up|1
38108|NCT01496469|165649|P2|Overall Study|Protocol Violation|0
38109|NCT01496469|165650|P1|Overall Study|Protocol Violation|2
38110|NCT01496469|165649|P2|Overall Study|Adverse Event|0
38111|NCT01496469|165650|P1|Overall Study|Adverse Event|1
38112|NCT01496456|165660|P1|Overall Study|Lost to Follow-up|7
38113|NCT01496456|165660|P1|Overall Study|Protocol Violation|1
38114|NCT01496430|165673|P3|Overall Study|Other|0
38115|NCT01496430|165674|P2|Overall Study|Other|0
38116|NCT01496430|165675|P1|Overall Study|Other|2
38117|NCT01496430|165673|P3|Overall Study|Principal Investigator Discretion|1
38118|NCT01496430|165674|P2|Overall Study|Principal Investigator Discretion|1
38119|NCT01496430|165675|P1|Overall Study|Principal Investigator Discretion|0
38120|NCT01496430|165673|P3|Overall Study|Voluntary Withdrawal|6
38121|NCT01496430|165674|P2|Overall Study|Voluntary Withdrawal|1
38122|NCT01496430|165675|P1|Overall Study|Voluntary Withdrawal|2
38123|NCT01496430|165673|P3|Overall Study|Lost to Follow-up|1
38124|NCT01496430|165674|P2|Overall Study|Lost to Follow-up|3
38125|NCT01496430|165675|P1|Overall Study|Lost to Follow-up|2
38126|NCT01496430|165673|P3|Overall Study|Major Protocol Deviation|1
38127|NCT01496430|165674|P2|Overall Study|Major Protocol Deviation|0
38128|NCT01496430|165675|P1|Overall Study|Major Protocol Deviation|0
38129|NCT01496430|165673|P3|Overall Study|Adverse Event|1
38130|NCT01496430|165674|P2|Overall Study|Adverse Event|0
38131|NCT01496430|165675|P1|Overall Study|Adverse Event|0
38132|NCT01496287|165787|P1|Overall Study|Incomplete anesthesia|5
38133|NCT01496287|165787|P1|Overall Study|Lost to Follow-up|1
38134|NCT01496274|165797|P2|Overall Study|Lost to Follow-up|3
38135|NCT01496274|165798|P1|Overall Study|Lost to Follow-up|0
38136|NCT01496274|165797|P2|Overall Study|Withdrawal by Subject|0
38137|NCT01496274|165798|P1|Overall Study|Withdrawal by Subject|2
38138|NCT01496274|165797|P2|Overall Study|Adverse Event|1
38139|NCT01496274|165798|P1|Overall Study|Adverse Event|1
38140|NCT01496274|165797|P2|Overall Study|Protocol Violation|1
38141|NCT01496274|165798|P1|Overall Study|Protocol Violation|0
38142|NCT01496183|165843|P2|Overall Study|Withdrawal by Subject|1
38143|NCT01496183|165844|P1|Overall Study|Withdrawal by Subject|0
38144|NCT01496183|165843|P2|Overall Study|Physician Decision|1
38145|NCT01496183|165844|P1|Overall Study|Physician Decision|3
38146|NCT01495975|165893|P2|Overall Study|Lost to Follow-up|0
38147|NCT01495975|165894|P1|Overall Study|Lost to Follow-up|1
38148|NCT01495793|166018|P1|Overall Study|Violation of inclusion criteria|1
38149|NCT01495793|166018|P1|Overall Study|Lost to Follow-up|1
38150|NCT01495702|166031|P2|Randomized Phase|Protocol Violation|1
38151|NCT01495702|166032|P1|Randomized Phase|Protocol Violation|3
38152|NCT01495702|166031|P2|Randomized Phase|Participant Noncompliance|0
38153|NCT01495702|166032|P1|Randomized Phase|Participant Noncompliance|1
38154|NCT01495702|166031|P2|Randomized Phase|Lost to Follow-up|3
38155|NCT01495702|166032|P1|Randomized Phase|Lost to Follow-up|4
38156|NCT01495702|166031|P2|Randomized Phase|Withdrew Consent|18
38157|NCT01495702|166032|P1|Randomized Phase|Withdrew Consent|10
38158|NCT01495702|166031|P2|Randomized Phase|Investigators Discretion|0
38159|NCT01495702|166032|P1|Randomized Phase|Investigators Discretion|2
38160|NCT01495702|166031|P2|Randomized Phase|Lack of Efficacy|0
38161|NCT01495702|166032|P1|Randomized Phase|Lack of Efficacy|2
38162|NCT01495702|166031|P2|Randomized Phase|Death|0
38163|NCT01495702|166032|P1|Randomized Phase|Death|1
38164|NCT01495702|166031|P2|Randomized Phase|Adverse Event|2
38165|NCT01495702|166032|P1|Randomized Phase|Adverse Event|2
38166|NCT01495702|166031|P2|Randomized Phase|Randomized But Not Treated|4
38167|NCT01495702|166032|P1|Randomized Phase|Randomized But Not Treated|1
38168|NCT01495000|166103|P2|Overall Study|Withdrawal by Subject|10
38169|NCT01495000|166104|P1|Overall Study|Withdrawal by Subject|10
38170|NCT01495000|166103|P2|Overall Study|Protocol Violation|0
38171|NCT01495000|166104|P1|Overall Study|Protocol Violation|1
38172|NCT01495000|166103|P2|Overall Study|Lost to Follow-up|2
38173|NCT01495000|166104|P1|Overall Study|Lost to Follow-up|2
38174|NCT01494987|166146|P2|Overall Study|Subject Withdrew Consent|3
38175|NCT01494987|166147|P1|Overall Study|Subject Withdrew Consent|2
38176|NCT01494987|166146|P2|Overall Study|Subject Non-Compliance|10
38177|NCT01494987|166147|P1|Overall Study|Subject Non-Compliance|9
38178|NCT01494987|166146|P2|Overall Study|Protocol Violation|3
38179|NCT01494987|166147|P1|Overall Study|Protocol Violation|3
38180|NCT01494987|166146|P2|Overall Study|Lost to Follow-up|1
38181|NCT01494987|166147|P1|Overall Study|Lost to Follow-up|1
38182|NCT01494987|166146|P2|Overall Study|Investigator's Discretion|2
38183|NCT01494987|166147|P1|Overall Study|Investigator's Discretion|1
38184|NCT01494987|166146|P2|Overall Study|Hyperglycemia|4
38185|NCT01494987|166147|P1|Overall Study|Hyperglycemia|6
38186|NCT01494987|166146|P2|Overall Study|Adverse Event|5
38187|NCT01494987|166147|P1|Overall Study|Adverse Event|6
38188|NCT01494818|166161|P2|Overall Study|Lost to Follow-up|0
38189|NCT01494818|166162|P1|Overall Study|Lost to Follow-up|1
38190|NCT01494818|166161|P2|Overall Study|Relocation|2
38191|NCT01494818|166162|P1|Overall Study|Relocation|1
38192|NCT01494649|166193|P2|Overall Study|Lost to Follow-up|1
38193|NCT01494649|166194|P1|Overall Study|Lost to Follow-up|0
38194|NCT01494610|166210|P2|Period 4|Protocol Violation|0
38195|NCT01494610|166211|P1|Period 4|Protocol Violation|1
38196|NCT01494610|166210|P2|Period 3|Withdrawal by Subject|0
38197|NCT01494610|166211|P1|Period 3|Withdrawal by Subject|1
38198|NCT01494610|166210|P2|Period 3|Adverse Event|0
38199|NCT01494610|166211|P1|Period 3|Adverse Event|1
38200|NCT01494610|166210|P2|Period 1|Withdrawal by Subject|1
38201|NCT01494610|166211|P1|Period 1|Withdrawal by Subject|1
38202|NCT01494584|166279|P1|Overall Study|Study Closed/Terminated|1
38203|NCT01494532|166411|P6|Overall Study|Withdrawal by Subject|0
38204|NCT01494532|166412|P5|Overall Study|Withdrawal by Subject|2
38205|NCT01494532|166413|P4|Overall Study|Withdrawal by Subject|3
38206|NCT01494532|166414|P3|Overall Study|Withdrawal by Subject|4
38207|NCT01494532|166415|P2|Overall Study|Withdrawal by Subject|1
38208|NCT01494532|166416|P1|Overall Study|Withdrawal by Subject|3
38209|NCT01494532|166411|P6|Overall Study|Physician Decision|0
38210|NCT01494532|166412|P5|Overall Study|Physician Decision|0
38211|NCT01494532|166413|P4|Overall Study|Physician Decision|2
38212|NCT01494532|166414|P3|Overall Study|Physician Decision|1
38213|NCT01494532|166415|P2|Overall Study|Physician Decision|1
38214|NCT01494532|166416|P1|Overall Study|Physician Decision|0
38215|NCT01494532|166411|P6|Overall Study|Lost to Follow-up|0
38216|NCT01494532|166412|P5|Overall Study|Lost to Follow-up|0
38217|NCT01494532|166413|P4|Overall Study|Lost to Follow-up|2
38218|NCT01494532|166414|P3|Overall Study|Lost to Follow-up|0
38219|NCT01494532|166415|P2|Overall Study|Lost to Follow-up|0
38220|NCT01494532|166416|P1|Overall Study|Lost to Follow-up|1
38221|NCT01494532|166411|P6|Overall Study|Protocol-defined stopping criteria|0
38222|NCT01494532|166412|P5|Overall Study|Protocol-defined stopping criteria|0
38223|NCT01494532|166413|P4|Overall Study|Protocol-defined stopping criteria|0
38224|NCT01494532|166414|P3|Overall Study|Protocol-defined stopping criteria|1
38225|NCT01494532|166415|P2|Overall Study|Protocol-defined stopping criteria|0
38226|NCT01494532|166416|P1|Overall Study|Protocol-defined stopping criteria|0
38227|NCT01494532|166411|P6|Overall Study|Protocol deviation|0
38228|NCT01494532|166412|P5|Overall Study|Protocol deviation|3
38229|NCT01494532|166413|P4|Overall Study|Protocol deviation|2
38230|NCT01494532|166414|P3|Overall Study|Protocol deviation|3
38231|NCT01494532|166415|P2|Overall Study|Protocol deviation|1
38232|NCT01494532|166416|P1|Overall Study|Protocol deviation|2
38233|NCT01494532|166411|P6|Overall Study|Lack of Efficacy|0
38234|NCT01494532|166412|P5|Overall Study|Lack of Efficacy|2
38235|NCT01494532|166413|P4|Overall Study|Lack of Efficacy|0
38236|NCT01494532|166414|P3|Overall Study|Lack of Efficacy|0
38237|NCT01494532|166415|P2|Overall Study|Lack of Efficacy|0
38238|NCT01494532|166416|P1|Overall Study|Lack of Efficacy|0
38239|NCT01494532|166411|P6|Overall Study|Adverse Event|0
38240|NCT01494532|166412|P5|Overall Study|Adverse Event|5
38241|NCT01494532|166413|P4|Overall Study|Adverse Event|6
38242|NCT01494532|166414|P3|Overall Study|Adverse Event|8
38243|NCT01494532|166415|P2|Overall Study|Adverse Event|1
38244|NCT01494532|166416|P1|Overall Study|Adverse Event|4
38245|NCT01494506|166571|P3|Overall Study|Other|1
38246|NCT01494506|166572|P2|Overall Study|Other|3
38247|NCT01494506|166573|P1|Overall Study|Other|0
38248|NCT01494506|166571|P3|Overall Study|Sponsor Decision|1
38249|NCT01494506|166572|P2|Overall Study|Sponsor Decision|0
38250|NCT01494506|166573|P1|Overall Study|Sponsor Decision|0
38251|NCT01494506|166571|P3|Overall Study|Clinical Deterioration|13
38252|NCT01494506|166572|P2|Overall Study|Clinical Deterioration|17
38253|NCT01494506|166573|P1|Overall Study|Clinical Deterioration|21
38254|NCT01494506|166571|P3|Overall Study|Withdrawal by Subject|14
38255|NCT01494506|166572|P2|Overall Study|Withdrawal by Subject|20
38256|NCT01494506|166573|P1|Overall Study|Withdrawal by Subject|17
38257|NCT01494506|166571|P3|Overall Study|Physician Decision|4
38258|NCT01494506|166572|P2|Overall Study|Physician Decision|5
38259|NCT01494506|166573|P1|Overall Study|Physician Decision|7
38260|NCT01494506|166571|P3|Overall Study|Death|2
38261|NCT01494506|166572|P2|Overall Study|Death|5
38262|NCT01494506|166573|P1|Overall Study|Death|9
38263|NCT01494506|166571|P3|Overall Study|Adverse Event|11
38264|NCT01494506|166572|P2|Overall Study|Adverse Event|10
38265|NCT01494506|166573|P1|Overall Study|Adverse Event|17
38266|NCT01494506|166571|P3|Overall Study|Lack of Efficacy|57
38267|NCT01494506|166572|P2|Overall Study|Lack of Efficacy|83
38268|NCT01494506|166573|P1|Overall Study|Lack of Efficacy|77
38269|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
38270|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
38271|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
38272|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
38273|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
38274|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
38275|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
38276|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
38277|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
38278|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
38279|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
38280|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
38281|NCT01494467|166610|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
38282|NCT01494467|166611|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
38283|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
38284|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
38285|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Other|1
38286|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Other|1
38287|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
38288|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
38289|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
38290|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
38291|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
38292|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
38293|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
38294|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
38295|NCT01494467|166610|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
38296|NCT01494467|166611|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
38297|NCT01494350|166627|P1|Overall Study|Worsening of lesion|1
38298|NCT01494298|166637|P2|Overall Study|Protocol Violation|8
38299|NCT01494298|166638|P1|Overall Study|Protocol Violation|2
38300|NCT01493687|166663|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
38301|NCT01493687|166664|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
38302|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
38303|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
38304|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
38305|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
38306|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
38307|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
38308|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
38309|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
38310|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
38311|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
38312|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
38313|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
38314|NCT01493687|166663|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
38315|NCT01493687|166664|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
38316|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
38317|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
38318|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
38319|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
38320|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
38321|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
38322|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
38323|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
38324|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
38325|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
38326|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
38327|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
38328|NCT01493687|166663|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
38329|NCT01493687|166664|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
38330|NCT01493557|166683|P3|Adding the Second Strategy|Withdrawal by Subject|0
38331|NCT01493557|166684|P2|Adding the Second Strategy|Withdrawal by Subject|1
38332|NCT01493557|166685|P1|Adding the Second Strategy|Withdrawal by Subject|0
38333|NCT01493557|166683|P3|Adding the Second Strategy|Other adverse event|0
38334|NCT01493557|166684|P2|Adding the Second Strategy|Other adverse event|2
38335|NCT01493557|166685|P1|Adding the Second Strategy|Other adverse event|1
38336|NCT01493557|166683|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
38337|NCT01493557|166684|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
38338|NCT01493557|166685|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
38339|NCT01493557|166683|P3|Randomized to Management Strategies|Other than stated above|0
38340|NCT01493557|166684|P2|Randomized to Management Strategies|Other than stated above|3
38341|NCT01493557|166685|P1|Randomized to Management Strategies|Other than stated above|1
38342|NCT01493557|166683|P3|Randomized to Management Strategies|Withdrawal by Subject|0
38343|NCT01493557|166684|P2|Randomized to Management Strategies|Withdrawal by Subject|1
38344|NCT01493557|166685|P1|Randomized to Management Strategies|Withdrawal by Subject|0
38345|NCT01493557|166683|P3|Randomized to Management Strategies|Protocol Violation|0
38346|NCT01493557|166684|P2|Randomized to Management Strategies|Protocol Violation|0
38347|NCT01493557|166685|P1|Randomized to Management Strategies|Protocol Violation|3
38348|NCT01493557|166683|P3|Randomized to Management Strategies|Other adverse event|0
38349|NCT01493557|166684|P2|Randomized to Management Strategies|Other adverse event|5
38350|NCT01493557|166685|P1|Randomized to Management Strategies|Other adverse event|8
38351|NCT01493557|166683|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
38352|NCT01493557|166684|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
38353|NCT01493557|166685|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
38354|NCT01493557|166683|P3|Not Randomized to Management Strategies|Other than stated above|21
38355|NCT01493557|166684|P2|Not Randomized to Management Strategies|Other than stated above|0
38356|NCT01493557|166685|P1|Not Randomized to Management Strategies|Other than stated above|0
38357|NCT01493557|166683|P3|Not Randomized to Management Strategies|Early termination|34
38358|NCT01493557|166684|P2|Not Randomized to Management Strategies|Early termination|0
38359|NCT01493557|166685|P1|Not Randomized to Management Strategies|Early termination|0
38360|NCT01493557|166683|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
38361|NCT01493557|166684|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
38362|NCT01493557|166685|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
38363|NCT01493557|166683|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
38364|NCT01493557|166684|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
38365|NCT01493557|166685|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
38366|NCT01493557|166683|P3|Not Randomized to Management Strategies|Protocol Violation|1
38367|NCT01493557|166684|P2|Not Randomized to Management Strategies|Protocol Violation|0
38368|NCT01493557|166685|P1|Not Randomized to Management Strategies|Protocol Violation|0
38369|NCT01493557|166683|P3|Not Randomized to Management Strategies|Other adverse event|54
38370|NCT01493557|166684|P2|Not Randomized to Management Strategies|Other adverse event|0
38371|NCT01493557|166685|P1|Not Randomized to Management Strategies|Other adverse event|0
38372|NCT01493557|166683|P3|Not Randomized to Management Strategies|Worsening of other pre−existing disease|9
38373|NCT01493557|166684|P2|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
38374|NCT01493557|166685|P1|Not Randomized to Management Strategies|Worsening of other pre−existing disease|0
38464|NCT01491802|166970|P2|Overall Study|Withdrawal by Subject|1
38375|NCT01493557|166683|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
38376|NCT01493557|166684|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
38377|NCT01493557|166685|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
38378|NCT01493531|166713|P3|Overall Study|Death|0
38379|NCT01493531|166714|P2|Overall Study|Death|1
38380|NCT01493531|166715|P1|Overall Study|Death|0
38381|NCT01493531|166713|P3|Overall Study|Withdrawal by Subject|11
38382|NCT01493531|166714|P2|Overall Study|Withdrawal by Subject|13
38383|NCT01493531|166715|P1|Overall Study|Withdrawal by Subject|16
38384|NCT01493531|166713|P3|Overall Study|Lost to Follow-up|11
38385|NCT01493531|166714|P2|Overall Study|Lost to Follow-up|7
38386|NCT01493531|166715|P1|Overall Study|Lost to Follow-up|5
38387|NCT01493531|166713|P3|Overall Study|Sponsor terminated study|3
38388|NCT01493531|166714|P2|Overall Study|Sponsor terminated study|2
38389|NCT01493531|166715|P1|Overall Study|Sponsor terminated study|5
38390|NCT01493531|166713|P3|Overall Study|Protocol Violation|12
38391|NCT01493531|166714|P2|Overall Study|Protocol Violation|15
38392|NCT01493531|166715|P1|Overall Study|Protocol Violation|8
38393|NCT01493531|166713|P3|Overall Study|Gout flare|2
38394|NCT01493531|166714|P2|Overall Study|Gout flare|0
38395|NCT01493531|166715|P1|Overall Study|Gout flare|3
38396|NCT01493531|166713|P3|Overall Study|Adverse Event|9
38397|NCT01493531|166714|P2|Overall Study|Adverse Event|12
38398|NCT01493531|166715|P1|Overall Study|Adverse Event|4
38399|NCT01493427|166729|P1|Overall Study|Other|2
38400|NCT01493427|166729|P1|Overall Study|Inability to Follow Instructions|2
38401|NCT01493427|166729|P1|Overall Study|Lost to Follow-up|2
38402|NCT01493427|166729|P1|Overall Study|Personal Reasons|4
38403|NCT01493427|166729|P1|Overall Study|Adverse Event|10
38404|NCT01493089|166749|P2|Overall Study|Physician Decision|1
38405|NCT01493089|166750|P1|Overall Study|Physician Decision|0
38406|NCT01493089|166749|P2|Overall Study|Withdrawal by Subject|0
38407|NCT01493089|166750|P1|Overall Study|Withdrawal by Subject|1
38408|NCT01493089|166749|P2|Overall Study|Protocol Violation|2
38409|NCT01493089|166750|P1|Overall Study|Protocol Violation|2
38410|NCT01492439|166768|P2|Overall Study|Withdrew from RTE|9
38411|NCT01492439|166769|P1|Overall Study|Withdrew from RTE|4
38412|NCT01492426|166817|P2|Follow-Up|Lost to Follow-up|6
38413|NCT01492426|166818|P1|Follow-Up|Lost to Follow-up|12
38414|NCT01492426|166817|P2|Follow-Up|Participant Withdrew Consent|1
38415|NCT01492426|166818|P1|Follow-Up|Participant Withdrew Consent|6
38416|NCT01492426|166817|P2|Follow-Up|Unspecified|2
38417|NCT01492426|166818|P1|Follow-Up|Unspecified|4
38418|NCT01492426|166817|P2|Follow-Up|Death|0
38419|NCT01492426|166818|P1|Follow-Up|Death|1
38420|NCT01492426|166817|P2|Follow-Up|Protocol Requires no Follow-Up|1
38421|NCT01492426|166818|P1|Follow-Up|Protocol Requires no Follow-Up|2
38422|NCT01492426|166817|P2|Treatment|Participant does not meet study criteria|0
38423|NCT01492426|166818|P1|Treatment|Participant does not meet study criteria|1
38424|NCT01492426|166817|P2|Treatment|Lost to Follow-up|4
38425|NCT01492426|166818|P1|Treatment|Lost to Follow-up|9
38426|NCT01492426|166817|P2|Treatment|Subject requested discontinue study drug|3
38427|NCT01492426|166818|P1|Treatment|Subject requested discontinue study drug|7
38428|NCT01492426|166817|P2|Treatment|Poor compliance/noncompliance|0
38429|NCT01492426|166818|P1|Treatment|Poor compliance/noncompliance|1
38430|NCT01492426|166817|P2|Treatment|Participant withdrew consent|2
38431|NCT01492426|166818|P1|Treatment|Participant withdrew consent|1
38432|NCT01492426|166817|P2|Treatment|Lack of Efficacy|5
38433|NCT01492426|166818|P1|Treatment|Lack of Efficacy|38
38434|NCT01492426|166817|P2|Treatment|Adverse Event|25
38435|NCT01492426|166818|P1|Treatment|Adverse Event|25
38436|NCT01492426|166817|P2|Treatment|Unspecified|0
38437|NCT01492426|166818|P1|Treatment|Unspecified|1
38438|NCT01492426|166817|P2|Treatment|Death|1
38439|NCT01492426|166818|P1|Treatment|Death|0
38440|NCT01492400|166836|P2|Overall Study|Adverse Event|5
38441|NCT01492400|166837|P1|Overall Study|Adverse Event|10
38442|NCT01492400|166836|P2|Overall Study|Lack of Efficacy|1
38443|NCT01492400|166837|P1|Overall Study|Lack of Efficacy|1
38444|NCT01492400|166836|P2|Overall Study|Pregnancy|1
38445|NCT01492400|166837|P1|Overall Study|Pregnancy|0
38446|NCT01492400|166836|P2|Overall Study|Lost to Follow-up|1
38447|NCT01492400|166837|P1|Overall Study|Lost to Follow-up|3
38448|NCT01492400|166836|P2|Overall Study|Personal Reasons|5
38449|NCT01492400|166837|P1|Overall Study|Personal Reasons|0
38450|NCT01492400|166836|P2|Overall Study|Miscellaneous Reasons|3
38451|NCT01492400|166837|P1|Overall Study|Miscellaneous Reasons|2
38452|NCT01492088|166850|P3|Overall Study|Reason Not Specified|12
38453|NCT01492088|166851|P2|Overall Study|Reason Not Specified|6
38454|NCT01492088|166852|P1|Overall Study|Reason Not Specified|2
38455|NCT01492088|166850|P3|Overall Study|Death|1
38456|NCT01492088|166851|P2|Overall Study|Death|6
38457|NCT01492088|166852|P1|Overall Study|Death|1
38458|NCT01492088|166850|P3|Overall Study|Withdrawal by Patient|0
38459|NCT01492088|166851|P2|Overall Study|Withdrawal by Patient|2
38460|NCT01492088|166852|P1|Overall Study|Withdrawal by Patient|0
38461|NCT01491919|166922|P3|Overall Study|Insufficient PK sampling|1
38462|NCT01491919|166923|P2|Overall Study|Insufficient PK sampling|2
38463|NCT01491919|166924|P1|Overall Study|Insufficient PK sampling|1
38465|NCT01491802|166971|P1|Overall Study|Withdrawal by Subject|0
38466|NCT01491802|166970|P2|Overall Study|Adverse Event|1
38467|NCT01491802|166971|P1|Overall Study|Adverse Event|1
38468|NCT01491737|166998|P2|Overall Study|Reason not specified|3
38469|NCT01491737|166999|P1|Overall Study|Reason not specified|2
38470|NCT01491737|166998|P2|Overall Study|Death|28
38471|NCT01491737|166999|P1|Overall Study|Death|33
38472|NCT01491737|166998|P2|Overall Study|Lost to Follow-up|6
38473|NCT01491737|166999|P1|Overall Study|Lost to Follow-up|1
38474|NCT01491737|166998|P2|Overall Study|Withdrawal of consent|13
38475|NCT01491737|166999|P1|Overall Study|Withdrawal of consent|13
38476|NCT01491672|167022|P3|Overall Study|Death|0
38477|NCT01491672|167023|P2|Overall Study|Death|4
38478|NCT01491672|167024|P1|Overall Study|Death|0
38479|NCT01491672|167022|P3|Overall Study|Protocol deviation|0
38480|NCT01491672|167023|P2|Overall Study|Protocol deviation|1
38481|NCT01491672|167024|P1|Overall Study|Protocol deviation|0
38482|NCT01491672|167022|P3|Overall Study|Disease progression|6
38483|NCT01491672|167023|P2|Overall Study|Disease progression|34
38484|NCT01491672|167024|P1|Overall Study|Disease progression|42
38485|NCT01491672|167022|P3|Overall Study|Adverse Event|4
38486|NCT01491672|167023|P2|Overall Study|Adverse Event|10
38487|NCT01491672|167024|P1|Overall Study|Adverse Event|8
38488|NCT01491672|167022|P3|Overall Study|Withdrawal by Subject|0
38489|NCT01491672|167023|P2|Overall Study|Withdrawal by Subject|7
38490|NCT01491672|167024|P1|Overall Study|Withdrawal by Subject|6
38491|NCT01491672|167022|P3|Overall Study|Lost to Follow-up|1
38492|NCT01491672|167023|P2|Overall Study|Lost to Follow-up|4
38493|NCT01491672|167024|P1|Overall Study|Lost to Follow-up|0
38494|NCT01491607|167061|P1|Overall Study|Withdrawal by Subject|3
38495|NCT01491607|167061|P1|Overall Study|Lost to Follow-up|7
38496|NCT01491035|167270|P8|Overall Study|Lost to Follow-up|0
38497|NCT01491035|167271|P7|Overall Study|Lost to Follow-up|0
38498|NCT01491035|167272|P6|Overall Study|Lost to Follow-up|0
38499|NCT01491035|167273|P5|Overall Study|Lost to Follow-up|1
38500|NCT01491035|167274|P4|Overall Study|Lost to Follow-up|0
38501|NCT01491035|167275|P3|Overall Study|Lost to Follow-up|0
38502|NCT01491035|167276|P2|Overall Study|Lost to Follow-up|0
38503|NCT01491035|167277|P1|Overall Study|Lost to Follow-up|0
38504|NCT01490866|167378|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
38505|NCT01490866|167378|P1|Axitinib Maintenance Therapy|Protocol Violation|2
38506|NCT01490866|167378|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
38507|NCT01490866|167378|P1|Axitinib Maintenance Therapy|Adverse Event|12
38508|NCT01490866|167378|P1|Axitinib Maintenance Therapy|Disease Progression|30
38509|NCT01490866|167378|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
38510|NCT01490866|167378|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
38511|NCT01490866|167378|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
38512|NCT01490866|167378|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
38513|NCT01490866|167378|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
38514|NCT01490866|167378|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
38515|NCT01490840|167389|P2|Phase 2|Adverse Event|1
38516|NCT01490840|167390|P1|Phase 2|Adverse Event|1
38517|NCT01490840|167389|P2|Phase 2|Lost to Follow-up|1
38518|NCT01490840|167390|P1|Phase 2|Lost to Follow-up|1
38519|NCT01490840|167389|P2|Phase 2|Permanent interruption of fingolimod|1
38520|NCT01490840|167390|P1|Phase 2|Permanent interruption of fingolimod|0
38521|NCT01490840|167389|P2|Phase 2|Withdrawal by Subject|3
38522|NCT01490840|167390|P1|Phase 2|Withdrawal by Subject|4
38523|NCT01490840|167389|P2|Phase 1|Visit 6a omitted|0
38524|NCT01490840|167390|P1|Phase 1|Visit 6a omitted|1
38525|NCT01490840|167389|P2|Phase 1|Withdrawal by Subject|5
38526|NCT01490840|167390|P1|Phase 1|Withdrawal by Subject|6
38527|NCT01490840|167389|P2|Phase 1|Adverse Event|1
38528|NCT01490840|167390|P1|Phase 1|Adverse Event|2
38529|NCT01490840|167389|P2|Phase 1|Lost to Follow-up|0
38530|NCT01490840|167390|P1|Phase 1|Lost to Follow-up|1
38531|NCT01490697|167414|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
38532|NCT01490697|167415|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
38533|NCT01490632|167428|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
38534|NCT01490632|167429|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
38535|NCT01490632|167430|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
38536|NCT01490632|167431|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
38537|NCT01490632|167432|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
38538|NCT01490632|167433|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
38539|NCT01490632|167434|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
38540|NCT01490632|167435|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
38541|NCT01490632|167436|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
38542|NCT01490632|167437|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
38543|NCT01490632|167438|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
38544|NCT01490632|167439|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
38545|NCT01490632|167440|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
38546|NCT01490632|167441|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
38547|NCT01490632|167442|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
38548|NCT01490632|167443|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
38549|NCT01490632|167444|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
38550|NCT01490632|167445|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
38551|NCT01490632|167446|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
38552|NCT01490632|167447|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
38553|NCT01490632|167428|P20|Part D: Re-Treatment Period|Protocol Violation|0
38554|NCT01490632|167429|P19|Part D: Re-Treatment Period|Protocol Violation|1
38555|NCT01490632|167430|P18|Part D: Re-Treatment Period|Protocol Violation|0
38556|NCT01490632|167431|P17|Part D: Re-Treatment Period|Protocol Violation|0
38557|NCT01490632|167432|P16|Part D: Re-Treatment Period|Protocol Violation|0
38558|NCT01490632|167433|P15|Part D: Re-Treatment Period|Protocol Violation|0
38559|NCT01490632|167434|P14|Part D: Re-Treatment Period|Protocol Violation|0
38560|NCT01490632|167435|P13|Part D: Re-Treatment Period|Protocol Violation|0
38561|NCT01490632|167436|P12|Part D: Re-Treatment Period|Protocol Violation|0
38562|NCT01490632|167437|P11|Part D: Re-Treatment Period|Protocol Violation|0
38563|NCT01490632|167438|P10|Part D: Re-Treatment Period|Protocol Violation|0
38564|NCT01490632|167439|P9|Part D: Re-Treatment Period|Protocol Violation|0
38565|NCT01490632|167440|P8|Part D: Re-Treatment Period|Protocol Violation|0
38566|NCT01490632|167441|P7|Part D: Re-Treatment Period|Protocol Violation|0
38567|NCT01490632|167442|P6|Part D: Re-Treatment Period|Protocol Violation|0
38568|NCT01490632|167443|P5|Part D: Re-Treatment Period|Protocol Violation|0
38569|NCT01490632|167444|P4|Part D: Re-Treatment Period|Protocol Violation|0
38570|NCT01490632|167445|P3|Part D: Re-Treatment Period|Protocol Violation|0
38571|NCT01490632|167446|P2|Part D: Re-Treatment Period|Protocol Violation|0
38572|NCT01490632|167447|P1|Part D: Re-Treatment Period|Protocol Violation|0
38573|NCT01490632|167428|P20|Part D: Re-Treatment Period|Physician Decision|1
38574|NCT01490632|167429|P19|Part D: Re-Treatment Period|Physician Decision|1
38575|NCT01490632|167430|P18|Part D: Re-Treatment Period|Physician Decision|0
38576|NCT01490632|167431|P17|Part D: Re-Treatment Period|Physician Decision|0
38577|NCT01490632|167432|P16|Part D: Re-Treatment Period|Physician Decision|0
38578|NCT01490632|167433|P15|Part D: Re-Treatment Period|Physician Decision|0
38579|NCT01490632|167434|P14|Part D: Re-Treatment Period|Physician Decision|0
38580|NCT01490632|167435|P13|Part D: Re-Treatment Period|Physician Decision|0
38581|NCT01490632|167436|P12|Part D: Re-Treatment Period|Physician Decision|0
38582|NCT01490632|167437|P11|Part D: Re-Treatment Period|Physician Decision|0
38583|NCT01490632|167438|P10|Part D: Re-Treatment Period|Physician Decision|0
38584|NCT01490632|167439|P9|Part D: Re-Treatment Period|Physician Decision|0
38585|NCT01490632|167440|P8|Part D: Re-Treatment Period|Physician Decision|0
38586|NCT01490632|167441|P7|Part D: Re-Treatment Period|Physician Decision|0
38587|NCT01490632|167442|P6|Part D: Re-Treatment Period|Physician Decision|0
38588|NCT01490632|167443|P5|Part D: Re-Treatment Period|Physician Decision|0
38589|NCT01490632|167444|P4|Part D: Re-Treatment Period|Physician Decision|0
38590|NCT01490632|167445|P3|Part D: Re-Treatment Period|Physician Decision|0
38591|NCT01490632|167446|P2|Part D: Re-Treatment Period|Physician Decision|0
38592|NCT01490632|167447|P1|Part D: Re-Treatment Period|Physician Decision|0
38593|NCT01490632|167428|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
38594|NCT01490632|167429|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
38595|NCT01490632|167430|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
38596|NCT01490632|167431|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
38597|NCT01490632|167432|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
38598|NCT01490632|167433|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
38599|NCT01490632|167434|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
38600|NCT01490632|167435|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
38601|NCT01490632|167436|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
38602|NCT01490632|167437|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
38603|NCT01490632|167438|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
38604|NCT01490632|167439|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
38605|NCT01490632|167440|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
38606|NCT01490632|167441|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
38607|NCT01490632|167442|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
38608|NCT01490632|167443|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
38609|NCT01490632|167444|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
38610|NCT01490632|167445|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
38611|NCT01490632|167446|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
38612|NCT01490632|167447|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
38613|NCT01490632|167428|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
38614|NCT01490632|167429|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
38615|NCT01490632|167430|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
38616|NCT01490632|167431|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
38617|NCT01490632|167432|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
38618|NCT01490632|167433|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
38619|NCT01490632|167434|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
38620|NCT01490632|167435|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
38621|NCT01490632|167436|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
38622|NCT01490632|167437|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
38623|NCT01490632|167438|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
38624|NCT01490632|167439|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
38625|NCT01490632|167440|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
38626|NCT01490632|167441|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
38627|NCT01490632|167442|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
38628|NCT01490632|167443|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
38629|NCT01490632|167444|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
38630|NCT01490632|167445|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
38631|NCT01490632|167446|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
38632|NCT01490632|167447|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
38633|NCT01490632|167428|P20|Part D: Re-Treatment Period|Death|0
38634|NCT01490632|167429|P19|Part D: Re-Treatment Period|Death|1
38635|NCT01490632|167430|P18|Part D: Re-Treatment Period|Death|0
38636|NCT01490632|167431|P17|Part D: Re-Treatment Period|Death|0
38637|NCT01490632|167432|P16|Part D: Re-Treatment Period|Death|0
38638|NCT01490632|167433|P15|Part D: Re-Treatment Period|Death|0
38639|NCT01490632|167434|P14|Part D: Re-Treatment Period|Death|0
38640|NCT01490632|167435|P13|Part D: Re-Treatment Period|Death|0
38641|NCT01490632|167436|P12|Part D: Re-Treatment Period|Death|0
38642|NCT01490632|167437|P11|Part D: Re-Treatment Period|Death|0
38643|NCT01490632|167438|P10|Part D: Re-Treatment Period|Death|0
38644|NCT01490632|167439|P9|Part D: Re-Treatment Period|Death|0
38645|NCT01490632|167440|P8|Part D: Re-Treatment Period|Death|0
38646|NCT01490632|167441|P7|Part D: Re-Treatment Period|Death|0
38647|NCT01490632|167442|P6|Part D: Re-Treatment Period|Death|0
38648|NCT01490632|167443|P5|Part D: Re-Treatment Period|Death|0
38649|NCT01490632|167444|P4|Part D: Re-Treatment Period|Death|0
38650|NCT01490632|167445|P3|Part D: Re-Treatment Period|Death|0
38651|NCT01490632|167446|P2|Part D: Re-Treatment Period|Death|0
38652|NCT01490632|167447|P1|Part D: Re-Treatment Period|Death|0
38653|NCT01490632|167428|P20|Part D: Re-Treatment Period|Adverse Event|3
38654|NCT01490632|167429|P19|Part D: Re-Treatment Period|Adverse Event|1
38655|NCT01490632|167430|P18|Part D: Re-Treatment Period|Adverse Event|1
38656|NCT01490632|167431|P17|Part D: Re-Treatment Period|Adverse Event|0
38657|NCT01490632|167432|P16|Part D: Re-Treatment Period|Adverse Event|0
38658|NCT01490632|167433|P15|Part D: Re-Treatment Period|Adverse Event|0
38659|NCT01490632|167434|P14|Part D: Re-Treatment Period|Adverse Event|0
38660|NCT01490632|167435|P13|Part D: Re-Treatment Period|Adverse Event|0
38661|NCT01490632|167436|P12|Part D: Re-Treatment Period|Adverse Event|0
38662|NCT01490632|167437|P11|Part D: Re-Treatment Period|Adverse Event|0
38663|NCT01490632|167438|P10|Part D: Re-Treatment Period|Adverse Event|0
38664|NCT01490632|167439|P9|Part D: Re-Treatment Period|Adverse Event|0
38665|NCT01490632|167440|P8|Part D: Re-Treatment Period|Adverse Event|0
38666|NCT01490632|167441|P7|Part D: Re-Treatment Period|Adverse Event|0
38667|NCT01490632|167442|P6|Part D: Re-Treatment Period|Adverse Event|0
38668|NCT01490632|167443|P5|Part D: Re-Treatment Period|Adverse Event|0
38669|NCT01490632|167444|P4|Part D: Re-Treatment Period|Adverse Event|0
38670|NCT01490632|167445|P3|Part D: Re-Treatment Period|Adverse Event|0
38671|NCT01490632|167446|P2|Part D: Re-Treatment Period|Adverse Event|0
38672|NCT01490632|167447|P1|Part D: Re-Treatment Period|Adverse Event|0
38673|NCT01490632|167428|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38674|NCT01490632|167429|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38675|NCT01490632|167430|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38676|NCT01490632|167431|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38677|NCT01490632|167432|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
38678|NCT01490632|167433|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
38679|NCT01490632|167434|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
38680|NCT01490632|167435|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
38681|NCT01490632|167436|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38682|NCT01490632|167437|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38683|NCT01490632|167438|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38684|NCT01490632|167439|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38685|NCT01490632|167440|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38686|NCT01490632|167441|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38687|NCT01490632|167442|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38688|NCT01490632|167443|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38689|NCT01490632|167444|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38690|NCT01490632|167445|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38691|NCT01490632|167446|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38692|NCT01490632|167447|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
38693|NCT01490632|167428|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38694|NCT01490632|167429|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38695|NCT01490632|167430|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38696|NCT01490632|167431|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38697|NCT01490632|167432|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
38698|NCT01490632|167433|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
38699|NCT01490632|167434|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38700|NCT01490632|167435|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38701|NCT01490632|167436|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38702|NCT01490632|167437|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38703|NCT01490632|167438|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38704|NCT01490632|167439|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38705|NCT01490632|167440|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38706|NCT01490632|167441|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38707|NCT01490632|167442|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38708|NCT01490632|167443|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38709|NCT01490632|167444|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38710|NCT01490632|167445|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38711|NCT01490632|167446|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38712|NCT01490632|167447|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
38713|NCT01490632|167428|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38714|NCT01490632|167429|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38715|NCT01490632|167430|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38716|NCT01490632|167431|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38717|NCT01490632|167432|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38718|NCT01490632|167433|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38719|NCT01490632|167434|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
38720|NCT01490632|167435|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38721|NCT01490632|167436|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38722|NCT01490632|167437|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38723|NCT01490632|167438|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38724|NCT01490632|167439|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38725|NCT01490632|167440|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38726|NCT01490632|167441|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38727|NCT01490632|167442|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38728|NCT01490632|167443|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38729|NCT01490632|167444|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38730|NCT01490632|167445|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38731|NCT01490632|167446|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38732|NCT01490632|167447|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
38733|NCT01490632|167428|P20|Part C: Washout or Step-Down Period|Adverse Event|0
38734|NCT01490632|167429|P19|Part C: Washout or Step-Down Period|Adverse Event|0
38735|NCT01490632|167430|P18|Part C: Washout or Step-Down Period|Adverse Event|0
38736|NCT01490632|167431|P17|Part C: Washout or Step-Down Period|Adverse Event|0
38737|NCT01490632|167432|P16|Part C: Washout or Step-Down Period|Adverse Event|2
38738|NCT01490632|167433|P15|Part C: Washout or Step-Down Period|Adverse Event|2
38739|NCT01490632|167434|P14|Part C: Washout or Step-Down Period|Adverse Event|0
38740|NCT01490632|167435|P13|Part C: Washout or Step-Down Period|Adverse Event|0
38741|NCT01490632|167436|P12|Part C: Washout or Step-Down Period|Adverse Event|0
38742|NCT01490632|167437|P11|Part C: Washout or Step-Down Period|Adverse Event|0
38743|NCT01490632|167438|P10|Part C: Washout or Step-Down Period|Adverse Event|0
38744|NCT01490632|167439|P9|Part C: Washout or Step-Down Period|Adverse Event|0
38745|NCT01490632|167440|P8|Part C: Washout or Step-Down Period|Adverse Event|0
38746|NCT01490632|167441|P7|Part C: Washout or Step-Down Period|Adverse Event|0
38747|NCT01490632|167442|P6|Part C: Washout or Step-Down Period|Adverse Event|0
38748|NCT01490632|167443|P5|Part C: Washout or Step-Down Period|Adverse Event|0
38749|NCT01490632|167444|P4|Part C: Washout or Step-Down Period|Adverse Event|0
38750|NCT01490632|167445|P3|Part C: Washout or Step-Down Period|Adverse Event|0
38751|NCT01490632|167446|P2|Part C: Washout or Step-Down Period|Adverse Event|0
38752|NCT01490632|167447|P1|Part C: Washout or Step-Down Period|Adverse Event|0
38753|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38754|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38755|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38756|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38757|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38758|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38759|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38760|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38761|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
38762|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
38763|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
38764|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
38765|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
38766|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
38767|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
39062|NCT01490125|167839|P4|Period III|Adverse Event|1
38768|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38769|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38770|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38771|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38772|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
38773|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38774|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38775|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38776|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38777|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38778|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38779|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38780|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38781|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
38782|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
38783|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38784|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
38785|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38786|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
38787|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38788|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38789|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38790|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38791|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38792|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
38793|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
38794|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
38795|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
38796|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
38797|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
38798|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
38799|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
38800|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
38801|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
38802|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
38803|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
38804|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
38805|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
38806|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
38807|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
38808|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
38809|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
38810|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
38811|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
38812|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
38813|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Physician Decision|0
38814|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Physician Decision|0
38815|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Physician Decision|0
38816|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Physician Decision|0
38817|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Physician Decision|0
38818|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Physician Decision|0
38819|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Physician Decision|0
38820|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Physician Decision|0
38821|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Physician Decision|0
38822|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Physician Decision|0
38823|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Physician Decision|0
38824|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Physician Decision|0
38825|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Physician Decision|0
38826|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Physician Decision|1
38827|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Physician Decision|0
38828|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Physician Decision|0
38829|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Physician Decision|0
38830|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Physician Decision|0
38831|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Physician Decision|0
38832|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Physician Decision|0
38833|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38834|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38835|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38836|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38837|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38838|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38839|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38840|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38841|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38842|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38843|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
38844|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38845|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38846|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
38847|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38848|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38849|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38850|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38851|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38852|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
38853|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38854|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38855|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38856|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38857|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38858|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38859|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38860|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38861|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38862|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
38863|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
38864|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
38865|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38866|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
38867|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38868|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38869|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38870|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38871|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38872|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
38873|NCT01490632|167428|P20|Part B: Extension or Step-Up Period|Adverse Event|0
38874|NCT01490632|167429|P19|Part B: Extension or Step-Up Period|Adverse Event|0
38875|NCT01490632|167430|P18|Part B: Extension or Step-Up Period|Adverse Event|0
38876|NCT01490632|167431|P17|Part B: Extension or Step-Up Period|Adverse Event|0
38877|NCT01490632|167432|P16|Part B: Extension or Step-Up Period|Adverse Event|0
38878|NCT01490632|167433|P15|Part B: Extension or Step-Up Period|Adverse Event|0
38879|NCT01490632|167434|P14|Part B: Extension or Step-Up Period|Adverse Event|0
38880|NCT01490632|167435|P13|Part B: Extension or Step-Up Period|Adverse Event|0
38881|NCT01490632|167436|P12|Part B: Extension or Step-Up Period|Adverse Event|1
38882|NCT01490632|167437|P11|Part B: Extension or Step-Up Period|Adverse Event|3
38883|NCT01490632|167438|P10|Part B: Extension or Step-Up Period|Adverse Event|2
38884|NCT01490632|167439|P9|Part B: Extension or Step-Up Period|Adverse Event|0
38885|NCT01490632|167440|P8|Part B: Extension or Step-Up Period|Adverse Event|0
38886|NCT01490632|167441|P7|Part B: Extension or Step-Up Period|Adverse Event|2
38887|NCT01490632|167442|P6|Part B: Extension or Step-Up Period|Adverse Event|2
38888|NCT01490632|167443|P5|Part B: Extension or Step-Up Period|Adverse Event|0
38889|NCT01490632|167444|P4|Part B: Extension or Step-Up Period|Adverse Event|0
38890|NCT01490632|167445|P3|Part B: Extension or Step-Up Period|Adverse Event|0
38891|NCT01490632|167446|P2|Part B: Extension or Step-Up Period|Adverse Event|0
38892|NCT01490632|167447|P1|Part B: Extension or Step-Up Period|Adverse Event|0
38893|NCT01490632|167428|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38894|NCT01490632|167429|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38895|NCT01490632|167430|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38896|NCT01490632|167431|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38897|NCT01490632|167432|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38898|NCT01490632|167433|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38899|NCT01490632|167434|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38900|NCT01490632|167435|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38901|NCT01490632|167436|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38902|NCT01490632|167437|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38903|NCT01490632|167438|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38904|NCT01490632|167439|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38905|NCT01490632|167440|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38906|NCT01490632|167441|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38907|NCT01490632|167442|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38908|NCT01490632|167443|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
38909|NCT01490632|167444|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38910|NCT01490632|167445|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38911|NCT01490632|167446|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38912|NCT01490632|167447|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
38913|NCT01490632|167428|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
38914|NCT01490632|167429|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
38915|NCT01490632|167430|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
38916|NCT01490632|167431|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
38917|NCT01490632|167432|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
38918|NCT01490632|167433|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
38919|NCT01490632|167434|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
38920|NCT01490632|167435|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
38921|NCT01490632|167436|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
38922|NCT01490632|167437|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
38923|NCT01490632|167438|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
38924|NCT01490632|167439|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
38925|NCT01490632|167440|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
38926|NCT01490632|167441|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
38927|NCT01490632|167442|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
38928|NCT01490632|167443|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
38929|NCT01490632|167444|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
38930|NCT01490632|167445|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
38931|NCT01490632|167446|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
38932|NCT01490632|167447|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
38933|NCT01490632|167428|P20|Part A: Initial Treatment Period|Sponsor Decision|0
38934|NCT01490632|167429|P19|Part A: Initial Treatment Period|Sponsor Decision|0
38935|NCT01490632|167430|P18|Part A: Initial Treatment Period|Sponsor Decision|0
38936|NCT01490632|167431|P17|Part A: Initial Treatment Period|Sponsor Decision|0
38937|NCT01490632|167432|P16|Part A: Initial Treatment Period|Sponsor Decision|0
38938|NCT01490632|167433|P15|Part A: Initial Treatment Period|Sponsor Decision|0
38939|NCT01490632|167434|P14|Part A: Initial Treatment Period|Sponsor Decision|0
38940|NCT01490632|167435|P13|Part A: Initial Treatment Period|Sponsor Decision|0
38941|NCT01490632|167436|P12|Part A: Initial Treatment Period|Sponsor Decision|0
38942|NCT01490632|167437|P11|Part A: Initial Treatment Period|Sponsor Decision|0
38943|NCT01490632|167438|P10|Part A: Initial Treatment Period|Sponsor Decision|0
38944|NCT01490632|167439|P9|Part A: Initial Treatment Period|Sponsor Decision|0
38945|NCT01490632|167440|P8|Part A: Initial Treatment Period|Sponsor Decision|0
38946|NCT01490632|167441|P7|Part A: Initial Treatment Period|Sponsor Decision|0
38947|NCT01490632|167442|P6|Part A: Initial Treatment Period|Sponsor Decision|0
38948|NCT01490632|167443|P5|Part A: Initial Treatment Period|Sponsor Decision|0
38949|NCT01490632|167444|P4|Part A: Initial Treatment Period|Sponsor Decision|0
38950|NCT01490632|167445|P3|Part A: Initial Treatment Period|Sponsor Decision|0
38951|NCT01490632|167446|P2|Part A: Initial Treatment Period|Sponsor Decision|0
38952|NCT01490632|167447|P1|Part A: Initial Treatment Period|Sponsor Decision|2
38953|NCT01490632|167428|P20|Part A: Initial Treatment Period|Physician Decision|0
38954|NCT01490632|167429|P19|Part A: Initial Treatment Period|Physician Decision|0
38955|NCT01490632|167430|P18|Part A: Initial Treatment Period|Physician Decision|0
38956|NCT01490632|167431|P17|Part A: Initial Treatment Period|Physician Decision|0
38957|NCT01490632|167432|P16|Part A: Initial Treatment Period|Physician Decision|0
38958|NCT01490632|167433|P15|Part A: Initial Treatment Period|Physician Decision|0
38959|NCT01490632|167434|P14|Part A: Initial Treatment Period|Physician Decision|0
38960|NCT01490632|167435|P13|Part A: Initial Treatment Period|Physician Decision|0
38961|NCT01490632|167436|P12|Part A: Initial Treatment Period|Physician Decision|0
38962|NCT01490632|167437|P11|Part A: Initial Treatment Period|Physician Decision|0
38963|NCT01490632|167438|P10|Part A: Initial Treatment Period|Physician Decision|0
38964|NCT01490632|167439|P9|Part A: Initial Treatment Period|Physician Decision|0
38965|NCT01490632|167440|P8|Part A: Initial Treatment Period|Physician Decision|0
38966|NCT01490632|167441|P7|Part A: Initial Treatment Period|Physician Decision|0
38967|NCT01490632|167442|P6|Part A: Initial Treatment Period|Physician Decision|0
38968|NCT01490632|167443|P5|Part A: Initial Treatment Period|Physician Decision|0
38969|NCT01490632|167444|P4|Part A: Initial Treatment Period|Physician Decision|1
38970|NCT01490632|167445|P3|Part A: Initial Treatment Period|Physician Decision|0
38971|NCT01490632|167446|P2|Part A: Initial Treatment Period|Physician Decision|1
38972|NCT01490632|167447|P1|Part A: Initial Treatment Period|Physician Decision|0
38973|NCT01490632|167428|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
38974|NCT01490632|167429|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
38975|NCT01490632|167430|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
38976|NCT01490632|167431|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
38977|NCT01490632|167432|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
38978|NCT01490632|167433|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
38979|NCT01490632|167434|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
38980|NCT01490632|167435|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
38981|NCT01490632|167436|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
38982|NCT01490632|167437|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
38983|NCT01490632|167438|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
38984|NCT01490632|167439|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
38985|NCT01490632|167440|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
38986|NCT01490632|167441|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
38987|NCT01490632|167442|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
38988|NCT01490632|167443|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
38989|NCT01490632|167444|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
38990|NCT01490632|167445|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
38991|NCT01490632|167446|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
38992|NCT01490632|167447|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
38993|NCT01490632|167428|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
38994|NCT01490632|167429|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
38995|NCT01490632|167430|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
38996|NCT01490632|167431|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
38997|NCT01490632|167432|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
38998|NCT01490632|167433|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
38999|NCT01490632|167434|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
39000|NCT01490632|167435|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
39001|NCT01490632|167436|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
39002|NCT01490632|167437|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
39003|NCT01490632|167438|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
39004|NCT01490632|167439|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
39005|NCT01490632|167440|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
39006|NCT01490632|167441|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
39007|NCT01490632|167442|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
39008|NCT01490632|167443|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
39009|NCT01490632|167444|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
39010|NCT01490632|167445|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
39011|NCT01490632|167446|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
39012|NCT01490632|167447|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
39013|NCT01490632|167428|P20|Part A: Initial Treatment Period|Adverse Event|0
39014|NCT01490632|167429|P19|Part A: Initial Treatment Period|Adverse Event|0
39015|NCT01490632|167430|P18|Part A: Initial Treatment Period|Adverse Event|0
39016|NCT01490632|167431|P17|Part A: Initial Treatment Period|Adverse Event|0
39017|NCT01490632|167432|P16|Part A: Initial Treatment Period|Adverse Event|0
39018|NCT01490632|167433|P15|Part A: Initial Treatment Period|Adverse Event|0
39019|NCT01490632|167434|P14|Part A: Initial Treatment Period|Adverse Event|0
39020|NCT01490632|167435|P13|Part A: Initial Treatment Period|Adverse Event|0
39021|NCT01490632|167436|P12|Part A: Initial Treatment Period|Adverse Event|0
39022|NCT01490632|167437|P11|Part A: Initial Treatment Period|Adverse Event|0
39023|NCT01490632|167438|P10|Part A: Initial Treatment Period|Adverse Event|0
39024|NCT01490632|167439|P9|Part A: Initial Treatment Period|Adverse Event|0
39025|NCT01490632|167440|P8|Part A: Initial Treatment Period|Adverse Event|0
39026|NCT01490632|167441|P7|Part A: Initial Treatment Period|Adverse Event|0
39027|NCT01490632|167442|P6|Part A: Initial Treatment Period|Adverse Event|0
39028|NCT01490632|167443|P5|Part A: Initial Treatment Period|Adverse Event|4
39029|NCT01490632|167444|P4|Part A: Initial Treatment Period|Adverse Event|4
39030|NCT01490632|167445|P3|Part A: Initial Treatment Period|Adverse Event|2
39031|NCT01490632|167446|P2|Part A: Initial Treatment Period|Adverse Event|0
39032|NCT01490632|167447|P1|Part A: Initial Treatment Period|Adverse Event|0
39033|NCT01490294|167579|P4|Overall Study|Adverse Event|0
39034|NCT01490294|167580|P3|Overall Study|Adverse Event|0
39035|NCT01490294|167581|P2|Overall Study|Adverse Event|0
39036|NCT01490294|167582|P1|Overall Study|Adverse Event|1
39037|NCT01490294|167579|P4|Overall Study|Prematurely discontinuation|1
39038|NCT01490294|167580|P3|Overall Study|Prematurely discontinuation|1
39039|NCT01490294|167581|P2|Overall Study|Prematurely discontinuation|0
39040|NCT01490294|167582|P1|Overall Study|Prematurely discontinuation|4
39041|NCT01490190|167816|P1|Overall Study|Ring expulsion|2
39042|NCT01490190|167816|P1|Overall Study|Inconvenience|1
39043|NCT01490190|167816|P1|Overall Study|Relocation|1
39044|NCT01490190|167816|P1|Overall Study|Lost to Follow-up|13
39045|NCT01490190|167816|P1|Overall Study|Protocol Violation|5
39046|NCT01490190|167816|P1|Overall Study|Adverse Event|17
39047|NCT01490190|167816|P1|Overall Study|Withdrawal by Subject|9
39048|NCT01490125|167837|P6|Period III|Lack of Efficacy|0
39049|NCT01490125|167838|P5|Period III|Lack of Efficacy|1
39050|NCT01490125|167839|P4|Period III|Lack of Efficacy|0
39051|NCT01490125|167840|P3|Period III|Lack of Efficacy|0
39052|NCT01490125|167841|P2|Period III|Lack of Efficacy|0
39053|NCT01490125|167842|P1|Period III|Lack of Efficacy|0
39054|NCT01490125|167837|P6|Period III|Death|0
39055|NCT01490125|167838|P5|Period III|Death|0
39056|NCT01490125|167839|P4|Period III|Death|1
39057|NCT01490125|167840|P3|Period III|Death|0
39058|NCT01490125|167841|P2|Period III|Death|0
39059|NCT01490125|167842|P1|Period III|Death|0
39060|NCT01490125|167837|P6|Period III|Adverse Event|0
39061|NCT01490125|167838|P5|Period III|Adverse Event|0
39063|NCT01490125|167840|P3|Period III|Adverse Event|0
39064|NCT01490125|167841|P2|Period III|Adverse Event|1
39065|NCT01490125|167842|P1|Period III|Adverse Event|3
39066|NCT01490125|167837|P6|Period II|Withdrawal by Subject|0
39067|NCT01490125|167838|P5|Period II|Withdrawal by Subject|0
39068|NCT01490125|167839|P4|Period II|Withdrawal by Subject|0
39069|NCT01490125|167840|P3|Period II|Withdrawal by Subject|0
39070|NCT01490125|167841|P2|Period II|Withdrawal by Subject|0
39071|NCT01490125|167842|P1|Period II|Withdrawal by Subject|1
39072|NCT01490125|167837|P6|Period II|Lost to Follow-up|0
39073|NCT01490125|167838|P5|Period II|Lost to Follow-up|0
39074|NCT01490125|167839|P4|Period II|Lost to Follow-up|0
39075|NCT01490125|167840|P3|Period II|Lost to Follow-up|0
39076|NCT01490125|167841|P2|Period II|Lost to Follow-up|1
39077|NCT01490125|167842|P1|Period II|Lost to Follow-up|0
39078|NCT01490125|167837|P6|Period II|Protocol Violation|0
39079|NCT01490125|167838|P5|Period II|Protocol Violation|0
39080|NCT01490125|167839|P4|Period II|Protocol Violation|1
39081|NCT01490125|167840|P3|Period II|Protocol Violation|1
39082|NCT01490125|167841|P2|Period II|Protocol Violation|0
39083|NCT01490125|167842|P1|Period II|Protocol Violation|0
39084|NCT01490125|167837|P6|Period II|Adverse Event|2
39085|NCT01490125|167838|P5|Period II|Adverse Event|4
39086|NCT01490125|167839|P4|Period II|Adverse Event|2
39087|NCT01490125|167840|P3|Period II|Adverse Event|2
39088|NCT01490125|167841|P2|Period II|Adverse Event|3
39089|NCT01490125|167842|P1|Period II|Adverse Event|2
39090|NCT01490125|167837|P6|Period I|Withdrawal by Subject|1
39091|NCT01490125|167838|P5|Period I|Withdrawal by Subject|2
39092|NCT01490125|167839|P4|Period I|Withdrawal by Subject|1
39093|NCT01490125|167840|P3|Period I|Withdrawal by Subject|2
39094|NCT01490125|167841|P2|Period I|Withdrawal by Subject|3
39095|NCT01490125|167842|P1|Period I|Withdrawal by Subject|1
39096|NCT01490125|167837|P6|Period I|Protocol Violation|0
39097|NCT01490125|167838|P5|Period I|Protocol Violation|0
39098|NCT01490125|167839|P4|Period I|Protocol Violation|1
39099|NCT01490125|167840|P3|Period I|Protocol Violation|1
39100|NCT01490125|167841|P2|Period I|Protocol Violation|1
39101|NCT01490125|167842|P1|Period I|Protocol Violation|1
39102|NCT01490125|167837|P6|Period I|Adverse Event|4
39103|NCT01490125|167838|P5|Period I|Adverse Event|2
39104|NCT01490125|167839|P4|Period I|Adverse Event|3
39105|NCT01490125|167840|P3|Period I|Adverse Event|1
39106|NCT01490125|167841|P2|Period I|Adverse Event|1
39107|NCT01490125|167842|P1|Period I|Adverse Event|4
39108|NCT01490086|167870|P5|Overall Study|Subject left hospital|0
39109|NCT01490086|167871|P4|Overall Study|Subject left hospital|1
39110|NCT01490086|167872|P3|Overall Study|Subject left hospital|0
39111|NCT01490086|167873|P2|Overall Study|Subject left hospital|1
39112|NCT01490086|167874|P1|Overall Study|Subject left hospital|0
39113|NCT01490086|167870|P5|Overall Study|Subject uncontrollable and abusive|0
39114|NCT01490086|167871|P4|Overall Study|Subject uncontrollable and abusive|0
39115|NCT01490086|167872|P3|Overall Study|Subject uncontrollable and abusive|0
39116|NCT01490086|167873|P2|Overall Study|Subject uncontrollable and abusive|1
39117|NCT01490086|167874|P1|Overall Study|Subject uncontrollable and abusive|0
39118|NCT01490086|167870|P5|Overall Study|Worsening of symptoms|0
39119|NCT01490086|167871|P4|Overall Study|Worsening of symptoms|1
39120|NCT01490086|167872|P3|Overall Study|Worsening of symptoms|0
39121|NCT01490086|167873|P2|Overall Study|Worsening of symptoms|1
39122|NCT01490086|167874|P1|Overall Study|Worsening of symptoms|0
39123|NCT01490086|167870|P5|Overall Study|Lack of Efficacy|8
39124|NCT01490086|167871|P4|Overall Study|Lack of Efficacy|0
39125|NCT01490086|167872|P3|Overall Study|Lack of Efficacy|1
39126|NCT01490086|167873|P2|Overall Study|Lack of Efficacy|3
39127|NCT01490086|167874|P1|Overall Study|Lack of Efficacy|0
39128|NCT01490086|167870|P5|Overall Study|Adverse Event|0
39129|NCT01490086|167871|P4|Overall Study|Adverse Event|2
39130|NCT01490086|167872|P3|Overall Study|Adverse Event|1
39131|NCT01490086|167873|P2|Overall Study|Adverse Event|0
39132|NCT01490086|167874|P1|Overall Study|Adverse Event|0
39133|NCT01490086|167870|P5|Overall Study|Physician Decision|1
39134|NCT01490086|167871|P4|Overall Study|Physician Decision|3
39135|NCT01490086|167872|P3|Overall Study|Physician Decision|2
39136|NCT01490086|167873|P2|Overall Study|Physician Decision|4
39137|NCT01490086|167874|P1|Overall Study|Physician Decision|3
39138|NCT01490086|167870|P5|Overall Study|Lost to Follow-up|1
39139|NCT01490086|167871|P4|Overall Study|Lost to Follow-up|0
39140|NCT01490086|167872|P3|Overall Study|Lost to Follow-up|0
39141|NCT01490086|167873|P2|Overall Study|Lost to Follow-up|0
39142|NCT01490086|167874|P1|Overall Study|Lost to Follow-up|0
39143|NCT01490086|167870|P5|Overall Study|Abnormal laboratory findings|0
39144|NCT01490086|167871|P4|Overall Study|Abnormal laboratory findings|0
39145|NCT01490086|167872|P3|Overall Study|Abnormal laboratory findings|0
39146|NCT01490086|167873|P2|Overall Study|Abnormal laboratory findings|0
39147|NCT01490086|167874|P1|Overall Study|Abnormal laboratory findings|1
39148|NCT01490086|167870|P5|Overall Study|Non-compliance|0
39149|NCT01490086|167871|P4|Overall Study|Non-compliance|0
39150|NCT01490086|167872|P3|Overall Study|Non-compliance|0
39151|NCT01490086|167873|P2|Overall Study|Non-compliance|1
39152|NCT01490086|167874|P1|Overall Study|Non-compliance|0
39153|NCT01490086|167870|P5|Overall Study|Consent withdrawn|1
39154|NCT01490086|167871|P4|Overall Study|Consent withdrawn|0
39155|NCT01490086|167872|P3|Overall Study|Consent withdrawn|3
39156|NCT01490086|167873|P2|Overall Study|Consent withdrawn|4
39157|NCT01490086|167874|P1|Overall Study|Consent withdrawn|4
39158|NCT01490060|167908|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
39159|NCT01490060|167909|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
39160|NCT01490060|167910|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
39161|NCT01490060|167911|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
39162|NCT01490060|167908|P4|Cycle 2|Non-Compliance|0
39163|NCT01490060|167909|P3|Cycle 2|Non-Compliance|1
39164|NCT01490060|167910|P2|Cycle 2|Non-Compliance|0
39165|NCT01490060|167911|P1|Cycle 2|Non-Compliance|0
39166|NCT01490060|167908|P4|Cycle 2|Change of Treatment|0
39167|NCT01490060|167909|P3|Cycle 2|Change of Treatment|0
39168|NCT01490060|167910|P2|Cycle 2|Change of Treatment|1
39169|NCT01490060|167911|P1|Cycle 2|Change of Treatment|1
39170|NCT01490060|167908|P4|Cycle 1|Treatment at Another Facility|1
39171|NCT01490060|167909|P3|Cycle 1|Treatment at Another Facility|0
39172|NCT01490060|167910|P2|Cycle 1|Treatment at Another Facility|0
39173|NCT01490060|167911|P1|Cycle 1|Treatment at Another Facility|0
39174|NCT01490060|167908|P4|Cycle 1|Withdrawal by Subject|1
39175|NCT01490060|167909|P3|Cycle 1|Withdrawal by Subject|0
39176|NCT01490060|167910|P2|Cycle 1|Withdrawal by Subject|0
39177|NCT01490060|167911|P1|Cycle 1|Withdrawal by Subject|0
39178|NCT01490060|167908|P4|Cycle 1|Insurance Denied|0
39179|NCT01490060|167909|P3|Cycle 1|Insurance Denied|2
39180|NCT01490060|167910|P2|Cycle 1|Insurance Denied|0
39181|NCT01490060|167911|P1|Cycle 1|Insurance Denied|0
39182|NCT01490060|167908|P4|Cycle 1|Change of Treatment|1
39183|NCT01490060|167909|P3|Cycle 1|Change of Treatment|1
39184|NCT01490060|167910|P2|Cycle 1|Change of Treatment|1
39185|NCT01490060|167911|P1|Cycle 1|Change of Treatment|0
39186|NCT01489956|167921|P3|Overall Study|Withdrawal by Subject|1
39187|NCT01489956|167922|P2|Overall Study|Withdrawal by Subject|0
39188|NCT01489956|167923|P1|Overall Study|Withdrawal by Subject|0
39189|NCT01489956|167921|P3|Overall Study|Lost to Follow-up|0
39190|NCT01489956|167922|P2|Overall Study|Lost to Follow-up|0
39191|NCT01489956|167923|P1|Overall Study|Lost to Follow-up|1
39192|NCT01489891|167960|P2|Overall Study|Endoscopy failure|0
39193|NCT01489891|167961|P1|Overall Study|Endoscopy failure|1
39194|NCT01489527|168099|P2|Overall Study|Not compliant|0
39195|NCT01489527|168100|P1|Overall Study|Not compliant|1
39196|NCT01489527|168099|P2|Overall Study|Procedures|0
39197|NCT01489527|168100|P1|Overall Study|Procedures|1
39198|NCT01489527|168099|P2|Overall Study|Lost to Follow-up|1
39199|NCT01489527|168100|P1|Overall Study|Lost to Follow-up|5
39200|NCT01489527|168099|P2|Overall Study|Withdrawal by Subject|4
39201|NCT01489527|168100|P1|Overall Study|Withdrawal by Subject|0
39202|NCT01489527|168099|P2|Overall Study|Participant moved|7
39203|NCT01489527|168100|P1|Overall Study|Participant moved|6
39204|NCT01489527|168099|P2|Overall Study|Pregnancy|14
39205|NCT01489527|168100|P1|Overall Study|Pregnancy|9
39206|NCT01489358|168117|P3|Overall Study|Lost to Follow-up|2
39207|NCT01489358|168118|P2|Overall Study|Lost to Follow-up|0
39208|NCT01489358|168119|P1|Overall Study|Lost to Follow-up|0
39209|NCT01489254|168169|P4|Open-label Extension Part|Other reasons for not completing study|5
39210|NCT01489254|168170|P3|Open-label Extension Part|Other reasons for not completing study|0
39211|NCT01489254|168171|P2|Open-label Extension Part|Other reasons for not completing study|0
39212|NCT01489254|168172|P1|Open-label Extension Part|Other reasons for not completing study|0
39213|NCT01489254|168169|P4|Open-label Extension Part|Lost to Follow-up|9
39214|NCT01489254|168170|P3|Open-label Extension Part|Lost to Follow-up|0
39215|NCT01489254|168171|P2|Open-label Extension Part|Lost to Follow-up|0
39216|NCT01489254|168172|P1|Open-label Extension Part|Lost to Follow-up|0
39217|NCT01489254|168169|P4|Open-label Extension Part|Protocol Violation|1
39218|NCT01489254|168170|P3|Open-label Extension Part|Protocol Violation|0
39219|NCT01489254|168171|P2|Open-label Extension Part|Protocol Violation|0
39220|NCT01489254|168172|P1|Open-label Extension Part|Protocol Violation|0
39221|NCT01489254|168169|P4|Open-label Extension Part|Withdrawal by Subject|30
39222|NCT01489254|168170|P3|Open-label Extension Part|Withdrawal by Subject|0
39223|NCT01489254|168171|P2|Open-label Extension Part|Withdrawal by Subject|0
39224|NCT01489254|168172|P1|Open-label Extension Part|Withdrawal by Subject|0
39225|NCT01489254|168169|P4|Open-label Extension Part|Pregnancy|3
39226|NCT01489254|168170|P3|Open-label Extension Part|Pregnancy|0
39227|NCT01489254|168171|P2|Open-label Extension Part|Pregnancy|0
39228|NCT01489254|168172|P1|Open-label Extension Part|Pregnancy|0
39229|NCT01489254|168169|P4|Open-label Extension Part|Adverse Event|10
39230|NCT01489254|168170|P3|Open-label Extension Part|Adverse Event|0
39231|NCT01489254|168171|P2|Open-label Extension Part|Adverse Event|0
39232|NCT01489254|168172|P1|Open-label Extension Part|Adverse Event|0
39233|NCT01489254|168169|P4|Double-blind Part|Other reasons for not completing study|0
39234|NCT01489254|168170|P3|Double-blind Part|Other reasons for not completing study|0
39235|NCT01489254|168171|P2|Double-blind Part|Other reasons for not completing study|6
39236|NCT01489254|168172|P1|Double-blind Part|Other reasons for not completing study|4
39237|NCT01489254|168169|P4|Double-blind Part|Lost to Follow-up|0
39238|NCT01489254|168170|P3|Double-blind Part|Lost to Follow-up|0
39239|NCT01489254|168171|P2|Double-blind Part|Lost to Follow-up|2
39240|NCT01489254|168172|P1|Double-blind Part|Lost to Follow-up|1
39241|NCT01489254|168169|P4|Double-blind Part|Withdrawal by Subject|0
39242|NCT01489254|168170|P3|Double-blind Part|Withdrawal by Subject|1
39243|NCT01489254|168171|P2|Double-blind Part|Withdrawal by Subject|20
39244|NCT01489254|168172|P1|Double-blind Part|Withdrawal by Subject|12
39245|NCT01489254|168169|P4|Double-blind Part|Pregnancy|0
39246|NCT01489254|168170|P3|Double-blind Part|Pregnancy|0
39247|NCT01489254|168171|P2|Double-blind Part|Pregnancy|3
39248|NCT01489254|168172|P1|Double-blind Part|Pregnancy|1
39249|NCT01489254|168169|P4|Double-blind Part|Adverse Event|0
39250|NCT01489254|168170|P3|Double-blind Part|Adverse Event|2
39251|NCT01489254|168171|P2|Double-blind Part|Adverse Event|2
39252|NCT01489254|168172|P1|Double-blind Part|Adverse Event|7
39253|NCT01489189|168183|P2|Overall Study|Missed Visit|4
39254|NCT01489189|168184|P1|Overall Study|Missed Visit|1
39255|NCT01489189|168183|P2|Overall Study|Death|8
39256|NCT01489189|168184|P1|Overall Study|Death|10
39257|NCT01489189|168183|P2|Overall Study|Withdrawal by Subject|23
39258|NCT01489189|168184|P1|Overall Study|Withdrawal by Subject|20
39259|NCT01488994|168211|P2|Overall Study|Withdrawal by Subject|1
39260|NCT01488994|168212|P1|Overall Study|Withdrawal by Subject|0
39261|NCT01488578|168316|P1|Overall Study|Protocol Violation|1836
39262|NCT01488487|168350|P1|Overall Study|Withdrawal by Subject|2
39263|NCT01488487|168350|P1|Overall Study|Death|1
39264|NCT01488487|168350|P1|Overall Study|Adverse Event|6
39265|NCT01488448|168359|P2|Overall Study|Protocol Violation|3
39266|NCT01488448|168360|P1|Overall Study|Protocol Violation|4
39267|NCT01488448|168359|P2|Overall Study|Physician Decision|9
39268|NCT01488448|168360|P1|Overall Study|Physician Decision|4
39269|NCT01488448|168359|P2|Overall Study|Adverse Event|4
39270|NCT01488448|168360|P1|Overall Study|Adverse Event|9
39271|NCT01488448|168359|P2|Overall Study|Withdrawal by Subject|1
39272|NCT01488448|168360|P1|Overall Study|Withdrawal by Subject|3
39273|NCT01488370|168402|P3|Overall Study|Protocol Violation|1
39274|NCT01488370|168403|P2|Overall Study|Protocol Violation|1
39275|NCT01488370|168404|P1|Overall Study|Protocol Violation|0
39276|NCT01488071|168451|P2|Overall Study|Administrative or Other Reason(s)|4
39277|NCT01488071|168452|P1|Overall Study|Administrative or Other Reason(s)|5
39278|NCT01488071|168451|P2|Overall Study|Lost to Follow-up|0
39279|NCT01488071|168452|P1|Overall Study|Lost to Follow-up|1
39280|NCT01488071|168451|P2|Overall Study|Withdrawal of Consent|12
39281|NCT01488071|168452|P1|Overall Study|Withdrawal of Consent|14
39282|NCT01488071|168451|P2|Overall Study|Protocol Violation|7
39283|NCT01488071|168452|P1|Overall Study|Protocol Violation|5
39284|NCT01488071|168451|P2|Overall Study|Non-compliance with study drug|0
39285|NCT01488071|168452|P1|Overall Study|Non-compliance with study drug|2
39286|NCT01488071|168451|P2|Overall Study|Lack of Efficacy|17
39287|NCT01488071|168452|P1|Overall Study|Lack of Efficacy|11
39288|NCT01488071|168451|P2|Overall Study|Adverse Event|23
39289|NCT01488071|168452|P1|Overall Study|Adverse Event|15
39290|NCT01487863|168532|P2|Overall Study|Death|19
39291|NCT01487863|168533|P1|Overall Study|Death|19
39292|NCT01487577|168550|P1|Overall Study|Became ineligible after signing consent|1
39293|NCT01487525|168564|P2|Overall Study|Withdrawal by Subject|1
39294|NCT01487525|168565|P1|Overall Study|Withdrawal by Subject|0
39295|NCT01486966|168583|P2|Overall Study|Withdrawal by Subject|1
39296|NCT01486966|168584|P1|Overall Study|Withdrawal by Subject|0
39297|NCT01486966|168583|P2|Overall Study|Adverse Event|1
39298|NCT01486966|168584|P1|Overall Study|Adverse Event|0
39299|NCT01486927|168608|P1|Overall Study|Subject did not reach 6 mo of treatment|1
39300|NCT01486927|168608|P1|Overall Study|Withdrawal by Subject|8
39301|NCT01486927|168608|P1|Overall Study|50 Exposure days not reached|2
39302|NCT01486927|168608|P1|Overall Study|Physician Decision|1
39303|NCT01486927|168608|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
39304|NCT01486758|168641|P2|Overall Study|Lost to Follow-up|1
39305|NCT01486758|168642|P1|Overall Study|Lost to Follow-up|0
39306|NCT01486446|168709|P2|Overall Study|Adverse Event|0
39307|NCT01486446|168710|P1|Overall Study|Adverse Event|1
39308|NCT01486238|168732|P2|Overall Study|Lost to Follow-up|3
39309|NCT01486238|168733|P1|Overall Study|Lost to Follow-up|0
39310|NCT01486238|168732|P2|Overall Study|Withdrawal by Subject|1
39311|NCT01486238|168733|P1|Overall Study|Withdrawal by Subject|2
39312|NCT01486238|168732|P2|Overall Study|Death|2
39313|NCT01486238|168733|P1|Overall Study|Death|0
39314|NCT01485991|168747|P2|Overall Study|randomized but not treated|2
39315|NCT01485991|168748|P1|Overall Study|randomized but not treated|6
39316|NCT01485991|168747|P2|Overall Study|Withdrawal by Subject|20
39317|NCT01485991|168748|P1|Overall Study|Withdrawal by Subject|13
39318|NCT01485991|168747|P2|Overall Study|Lost to Follow-up|10
39319|NCT01485991|168748|P1|Overall Study|Lost to Follow-up|13
39320|NCT01485991|168747|P2|Overall Study|Adverse Event|4
39321|NCT01485991|168748|P1|Overall Study|Adverse Event|0
39322|NCT01485887|168758|P1|Overall Study|Primary disease markedly improved|1
39323|NCT01485887|168758|P1|Overall Study|Deterioration of primary disease|1
39324|NCT01485887|168758|P1|Overall Study|Adverse Event|8
39325|NCT01485887|168758|P1|Overall Study|Withdrawal by Subject|2
39326|NCT01485796|168770|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
39327|NCT01485796|168770|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
39328|NCT01485796|168770|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
39329|NCT01485796|168770|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
39330|NCT01485796|168770|P1|Period 2: Epoch 2|Switch to safety follow-up|26
39331|NCT01485796|168770|P1|Period 2: Epoch 2|Adverse Event|3
39332|NCT01485796|168770|P1|Period 2: Epoch 2|Withdrawal by Subject|6
39333|NCT01485796|168770|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
39334|NCT01485640|168792|P1|Overall Study|Terminated by Sponsor|95
39335|NCT01485640|168792|P1|Overall Study|Withdrawal by Subject|14
39336|NCT01485640|168792|P1|Overall Study|Protocol Violation|1
39337|NCT01485640|168792|P1|Overall Study|Lack of Efficacy|2
39338|NCT01485640|168792|P1|Overall Study|Adverse Event|10
39339|NCT01485536|168797|P1|Overall Study|Adverse Event|1
39340|NCT01485536|168797|P1|Overall Study|Withdrawal by Subject|3
39341|NCT01485354|168806|P1|Overall Study|Withdrawal by Subject|5
39342|NCT01485172|168820|P6|Overall Study|Withdrawal by Subject|1
39343|NCT01485172|168821|P5|Overall Study|Withdrawal by Subject|1
39344|NCT01485172|168822|P4|Overall Study|Withdrawal by Subject|1
39345|NCT01485172|168823|P3|Overall Study|Withdrawal by Subject|0
39346|NCT01485172|168824|P2|Overall Study|Withdrawal by Subject|0
39347|NCT01485172|168825|P1|Overall Study|Withdrawal by Subject|2
39348|NCT01485172|168820|P6|Overall Study|Physician Decision|0
39349|NCT01485172|168821|P5|Overall Study|Physician Decision|1
39350|NCT01485172|168822|P4|Overall Study|Physician Decision|0
39351|NCT01485172|168823|P3|Overall Study|Physician Decision|0
39352|NCT01485172|168824|P2|Overall Study|Physician Decision|0
39353|NCT01485172|168825|P1|Overall Study|Physician Decision|0
39354|NCT01485172|168820|P6|Overall Study|Lost to Follow-up|1
39355|NCT01485172|168821|P5|Overall Study|Lost to Follow-up|0
39356|NCT01485172|168822|P4|Overall Study|Lost to Follow-up|0
39357|NCT01485172|168823|P3|Overall Study|Lost to Follow-up|1
39358|NCT01485172|168824|P2|Overall Study|Lost to Follow-up|0
39359|NCT01485172|168825|P1|Overall Study|Lost to Follow-up|0
39360|NCT01485172|168820|P6|Overall Study|Protocol defined stopping criteria|0
39361|NCT01485172|168821|P5|Overall Study|Protocol defined stopping criteria|1
39362|NCT01485172|168822|P4|Overall Study|Protocol defined stopping criteria|0
39363|NCT01485172|168823|P3|Overall Study|Protocol defined stopping criteria|0
39364|NCT01485172|168824|P2|Overall Study|Protocol defined stopping criteria|0
39365|NCT01485172|168825|P1|Overall Study|Protocol defined stopping criteria|1
39366|NCT01485172|168820|P6|Overall Study|Protocol Violation|0
39367|NCT01485172|168821|P5|Overall Study|Protocol Violation|1
39368|NCT01485172|168822|P4|Overall Study|Protocol Violation|5
39369|NCT01485172|168823|P3|Overall Study|Protocol Violation|4
39370|NCT01485172|168824|P2|Overall Study|Protocol Violation|0
39371|NCT01485172|168825|P1|Overall Study|Protocol Violation|0
39372|NCT01485172|168820|P6|Overall Study|Lack of Efficacy|0
39373|NCT01485172|168821|P5|Overall Study|Lack of Efficacy|0
39374|NCT01485172|168822|P4|Overall Study|Lack of Efficacy|0
39375|NCT01485172|168823|P3|Overall Study|Lack of Efficacy|0
39376|NCT01485172|168824|P2|Overall Study|Lack of Efficacy|0
39377|NCT01485172|168825|P1|Overall Study|Lack of Efficacy|2
39378|NCT01485172|168820|P6|Overall Study|Adverse Event|2
39379|NCT01485172|168821|P5|Overall Study|Adverse Event|1
39380|NCT01485172|168822|P4|Overall Study|Adverse Event|2
39381|NCT01485172|168823|P3|Overall Study|Adverse Event|2
39382|NCT01485172|168824|P2|Overall Study|Adverse Event|1
39383|NCT01485172|168825|P1|Overall Study|Adverse Event|2
39384|NCT01485094|168902|P3|Overall Study|Withdrawal by Subject|0
39385|NCT01485094|168903|P2|Overall Study|Withdrawal by Subject|1
39386|NCT01485094|168904|P1|Overall Study|Withdrawal by Subject|1
39387|NCT01485094|168902|P3|Overall Study|Lost to Follow-up|0
39388|NCT01485094|168903|P2|Overall Study|Lost to Follow-up|0
39389|NCT01485094|168904|P1|Overall Study|Lost to Follow-up|1
39390|NCT01485094|168902|P3|Overall Study|Adverse Event|1
39391|NCT01485094|168903|P2|Overall Study|Adverse Event|1
39392|NCT01485094|168904|P1|Overall Study|Adverse Event|1
39393|NCT01484977|168945|P1|Overall Study|Lack of Compliance|1
39394|NCT01484977|168945|P1|Overall Study|Low White Blood Cell Count|1
39395|NCT01484977|168945|P1|Overall Study|Moving Overseas|1
39396|NCT01484977|168945|P1|Overall Study|Subject Protocol Non-compliant|1
39397|NCT01484977|168945|P1|Overall Study|Withdrawal by Subject|4
39398|NCT01484977|168945|P1|Overall Study|Lost to Follow-up|1
39399|NCT01484977|168945|P1|Overall Study|Protocol Violation|6
39400|NCT01484977|168945|P1|Overall Study|Lack of Efficacy|4
39401|NCT01484977|168945|P1|Overall Study|Adverse Event|8
39402|NCT01484951|168949|P1|Overall Study|Non-Compliance|1
39403|NCT01484951|168949|P1|Overall Study|Personal Reasons|1
39404|NCT01484951|168949|P1|Overall Study|Adverse Event|3
39405|NCT01484938|168954|P1|Overall Study|Noncompliance|1
39406|NCT01484938|168954|P1|Overall Study|Lost to Follow-up|1
39407|NCT01484938|168954|P1|Overall Study|Adverse Event|2
39408|NCT01484912|168961|P2|Overall Study|Physician Decision|1
39409|NCT01484912|168962|P1|Overall Study|Physician Decision|0
39410|NCT01484912|168961|P2|Overall Study|Withdrawal by Subject|0
39411|NCT01484912|168962|P1|Overall Study|Withdrawal by Subject|1
39412|NCT01484873|168972|P1|Overall Study|Withdrawal by Subject|2
39413|NCT01484834|168984|P4|Overall Study|Lost to Follow-up|4
39414|NCT01484834|168985|P3|Overall Study|Lost to Follow-up|1
39415|NCT01484834|168986|P2|Overall Study|Lost to Follow-up|8
39416|NCT01484834|168987|P1|Overall Study|Lost to Follow-up|5
39417|NCT01484561|169024|P2|Overall Study|Adverse Event|4
39418|NCT01484561|169025|P1|Overall Study|Adverse Event|1
39419|NCT01484561|169024|P2|Overall Study|Not specified|1
39420|NCT01484561|169025|P1|Overall Study|Not specified|1
39421|NCT01484561|169024|P2|Overall Study|Withdrawal by Subject|0
39422|NCT01484561|169025|P1|Overall Study|Withdrawal by Subject|3
39423|NCT01484561|169024|P2|Overall Study|Lost to Follow-up|0
39424|NCT01484561|169025|P1|Overall Study|Lost to Follow-up|1
39425|NCT01484561|169024|P2|Overall Study|Lack of Efficacy|1
39426|NCT01484561|169025|P1|Overall Study|Lack of Efficacy|3
39427|NCT01484496|169115|P4|Period 2|Other|6
39428|NCT01484496|169116|P3|Period 2|Other|9
39429|NCT01484496|169117|P2|Period 2|Other|0
39430|NCT01484496|169118|P1|Period 2|Other|0
39431|NCT01484496|169115|P4|Period 2|Adverse Event|13
39432|NCT01484496|169116|P3|Period 2|Adverse Event|5
39433|NCT01484496|169117|P2|Period 2|Adverse Event|0
39434|NCT01484496|169118|P1|Period 2|Adverse Event|0
39435|NCT01484496|169115|P4|Period 2|Lack of Efficacy|3
39436|NCT01484496|169116|P3|Period 2|Lack of Efficacy|1
39437|NCT01484496|169117|P2|Period 2|Lack of Efficacy|0
39438|NCT01484496|169118|P1|Period 2|Lack of Efficacy|0
39439|NCT01484496|169115|P4|Period 1|Unable to Visit Site|0
39440|NCT01484496|169116|P3|Period 1|Unable to Visit Site|0
39441|NCT01484496|169117|P2|Period 1|Unable to Visit Site|2
39442|NCT01484496|169118|P1|Period 1|Unable to Visit Site|0
39443|NCT01484496|169115|P4|Period 1|Lack of Compliance|0
39444|NCT01484496|169116|P3|Period 1|Lack of Compliance|0
39445|NCT01484496|169117|P2|Period 1|Lack of Compliance|1
39446|NCT01484496|169118|P1|Period 1|Lack of Compliance|2
39447|NCT01484496|169115|P4|Period 1|Treatment Failure|0
39448|NCT01484496|169116|P3|Period 1|Treatment Failure|0
39449|NCT01484496|169117|P2|Period 1|Treatment Failure|6
39450|NCT01484496|169118|P1|Period 1|Treatment Failure|3
39451|NCT01484496|169115|P4|Period 1|Positive Pregnancy|0
39452|NCT01484496|169116|P3|Period 1|Positive Pregnancy|0
39453|NCT01484496|169117|P2|Period 1|Positive Pregnancy|6
39454|NCT01484496|169118|P1|Period 1|Positive Pregnancy|1
39455|NCT01484496|169115|P4|Period 1|Lost to Follow-up|0
39456|NCT01484496|169116|P3|Period 1|Lost to Follow-up|0
39457|NCT01484496|169117|P2|Period 1|Lost to Follow-up|6
39458|NCT01484496|169118|P1|Period 1|Lost to Follow-up|2
39459|NCT01484496|169115|P4|Period 1|Withdrawal by Subject|0
39460|NCT01484496|169116|P3|Period 1|Withdrawal by Subject|0
39461|NCT01484496|169117|P2|Period 1|Withdrawal by Subject|12
39462|NCT01484496|169118|P1|Period 1|Withdrawal by Subject|15
39463|NCT01484496|169115|P4|Period 1|Adverse Event|0
39464|NCT01484496|169116|P3|Period 1|Adverse Event|0
39465|NCT01484496|169117|P2|Period 1|Adverse Event|40
39466|NCT01484496|169118|P1|Period 1|Adverse Event|25
39467|NCT01484496|169115|P4|Period 1|Lack of Efficacy|0
39468|NCT01484496|169116|P3|Period 1|Lack of Efficacy|0
39469|NCT01484496|169117|P2|Period 1|Lack of Efficacy|15
39470|NCT01484496|169118|P1|Period 1|Lack of Efficacy|10
39471|NCT01484496|169115|P4|Period 1|Physician Decision|0
39472|NCT01484496|169116|P3|Period 1|Physician Decision|0
39473|NCT01484496|169117|P2|Period 1|Physician Decision|1
39474|NCT01484496|169118|P1|Period 1|Physician Decision|5
39475|NCT01484496|169115|P4|Period 1|Protocol Violation|0
39476|NCT01484496|169116|P3|Period 1|Protocol Violation|0
39477|NCT01484496|169117|P2|Period 1|Protocol Violation|4
39478|NCT01484496|169118|P1|Period 1|Protocol Violation|3
39479|NCT01484197|169136|P4|Treatment Period 2|Subject withdrew consent|1
39480|NCT01484197|169137|P3|Treatment Period 2|Subject withdrew consent|0
39481|NCT01484197|169138|P2|Treatment Period 2|Subject withdrew consent|0
39482|NCT01484197|169139|P1|Treatment Period 2|Subject withdrew consent|0
39483|NCT01484197|169136|P4|Treatment Period 1|Adverse Event|0
39484|NCT01484197|169137|P3|Treatment Period 1|Adverse Event|0
39485|NCT01484197|169138|P2|Treatment Period 1|Adverse Event|0
39486|NCT01484197|169139|P1|Treatment Period 1|Adverse Event|1
39487|NCT01484132|169222|P1|Overall Study|No post-treatment urine sample collected|10
39488|NCT01484132|169222|P1|Overall Study|No pre-treatment urine sample collected|1
39489|NCT01484132|169222|P1|Overall Study|Ineligible|1
39490|NCT01484132|169222|P1|Overall Study|Difficulty with time commitment|2
39491|NCT01484132|169222|P1|Overall Study|Lost to Follow-up|8
39492|NCT01484054|169230|P2|Period 1|Withdrawal by Subject|1
39493|NCT01484054|169231|P1|Period 1|Withdrawal by Subject|0
39494|NCT01484028|169249|P4|Period 1|Lens Discomfort|0
39495|NCT01484028|169250|P3|Period 1|Lens Discomfort|0
39496|NCT01484028|169251|P2|Period 1|Lens Discomfort|1
39497|NCT01484028|169252|P1|Period 1|Lens Discomfort|0
39498|NCT01484028|169249|P4|Period 1|Non-Compliance to Protocol|1
39499|NCT01484028|169250|P3|Period 1|Non-Compliance to Protocol|0
39500|NCT01484028|169251|P2|Period 1|Non-Compliance to Protocol|1
39501|NCT01484028|169252|P1|Period 1|Non-Compliance to Protocol|0
39502|NCT01484028|169249|P4|Period 1|Lost to Follow-up|0
39503|NCT01484028|169250|P3|Period 1|Lost to Follow-up|0
39504|NCT01484028|169251|P2|Period 1|Lost to Follow-up|1
39505|NCT01484028|169252|P1|Period 1|Lost to Follow-up|0
39506|NCT01483937|169345|P2|Overall Study|Withdrawal by Subject|3
39507|NCT01483937|169346|P1|Overall Study|Withdrawal by Subject|4
39508|NCT01483924|169373|P5|Overall Study|Sponsor concern over ECG result|0
39509|NCT01483924|169374|P4|Overall Study|Sponsor concern over ECG result|1
39510|NCT01483924|169375|P3|Overall Study|Sponsor concern over ECG result|0
39511|NCT01483924|169376|P2|Overall Study|Sponsor concern over ECG result|0
39512|NCT01483924|169377|P1|Overall Study|Sponsor concern over ECG result|0
39513|NCT01483924|169373|P5|Overall Study|Non-compliance|1
39514|NCT01483924|169374|P4|Overall Study|Non-compliance|1
39515|NCT01483924|169375|P3|Overall Study|Non-compliance|0
39516|NCT01483924|169376|P2|Overall Study|Non-compliance|0
39517|NCT01483924|169377|P1|Overall Study|Non-compliance|0
39518|NCT01483924|169373|P5|Overall Study|Adverse Event|0
39519|NCT01483924|169374|P4|Overall Study|Adverse Event|1
39520|NCT01483924|169375|P3|Overall Study|Adverse Event|1
39521|NCT01483924|169376|P2|Overall Study|Adverse Event|0
39522|NCT01483924|169377|P1|Overall Study|Adverse Event|0
39523|NCT01483924|169373|P5|Overall Study|Withdrawal by Subject|1
39524|NCT01483924|169374|P4|Overall Study|Withdrawal by Subject|1
39525|NCT01483924|169375|P3|Overall Study|Withdrawal by Subject|0
39526|NCT01483924|169376|P2|Overall Study|Withdrawal by Subject|0
39527|NCT01483924|169377|P1|Overall Study|Withdrawal by Subject|2
39528|NCT01483820|169425|P1|Overall Study|Death|1
39529|NCT01483820|169425|P1|Overall Study|Adverse Event|1
39530|NCT01483820|169425|P1|Overall Study|Lack of Efficacy|6
39531|NCT01483651|169434|P6|Overall Study|Withdrawal by Subject|1
39532|NCT01483651|169435|P5|Overall Study|Withdrawal by Subject|0
39533|NCT01483651|169436|P4|Overall Study|Withdrawal by Subject|0
39534|NCT01483651|169437|P3|Overall Study|Withdrawal by Subject|1
39535|NCT01483651|169438|P2|Overall Study|Withdrawal by Subject|1
39536|NCT01483651|169439|P1|Overall Study|Withdrawal by Subject|0
39537|NCT01483625|169449|P2|Overall Study|Due to other reason|0
39538|NCT01483625|169450|P1|Overall Study|Due to other reason|1
39539|NCT01483625|169449|P2|Overall Study|Refused to continue medication|1
39540|NCT01483625|169450|P1|Overall Study|Refused to continue medication|2
39541|NCT01483625|169449|P2|Overall Study|Adverse Event|1
39542|NCT01483625|169450|P1|Overall Study|Adverse Event|1
39543|NCT01483599|169473|P14|After Controlled Period(Week 16-Week 40)|Unspecified|0
39544|NCT01483599|169474|P13|After Controlled Period(Week 16-Week 40)|Unspecified|1
39545|NCT01483599|169475|P12|After Controlled Period(Week 16-Week 40)|Unspecified|0
39546|NCT01483599|169476|P11|After Controlled Period(Week 16-Week 40)|Unspecified|0
39547|NCT01483599|169477|P10|After Controlled Period(Week 16-Week 40)|Unspecified|4
39548|NCT01483599|169478|P9|After Controlled Period(Week 16-Week 40)|Unspecified|0
39549|NCT01483599|169479|P8|After Controlled Period(Week 16-Week 40)|Unspecified|1
39550|NCT01483599|169480|P7|After Controlled Period(Week 16-Week 40)|Unspecified|0
39551|NCT01483599|169481|P6|After Controlled Period(Week 16-Week 40)|Unspecified|0
39552|NCT01483599|169482|P5|After Controlled Period(Week 16-Week 40)|Unspecified|0
39553|NCT01483599|169483|P4|After Controlled Period(Week 16-Week 40)|Unspecified|0
39554|NCT01483599|169484|P3|After Controlled Period(Week 16-Week 40)|Unspecified|0
39555|NCT01483599|169485|P2|After Controlled Period(Week 16-Week 40)|Unspecified|0
39556|NCT01483599|169486|P1|After Controlled Period(Week 16-Week 40)|Unspecified|0
39557|NCT01483599|169473|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
39558|NCT01483599|169474|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
39559|NCT01483599|169475|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39560|NCT01483599|169476|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39561|NCT01483599|169477|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39562|NCT01483599|169478|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
39563|NCT01483599|169479|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39564|NCT01483599|169480|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39565|NCT01483599|169481|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39566|NCT01483599|169482|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39567|NCT01483599|169483|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39568|NCT01483599|169484|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39569|NCT01483599|169485|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39570|NCT01483599|169486|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
39571|NCT01483599|169473|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
39572|NCT01483599|169474|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39573|NCT01483599|169475|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39574|NCT01483599|169476|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
39575|NCT01483599|169477|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39576|NCT01483599|169478|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
39577|NCT01483599|169479|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39578|NCT01483599|169480|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39579|NCT01483599|169481|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39580|NCT01483599|169482|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39581|NCT01483599|169483|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39582|NCT01483599|169484|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39583|NCT01483599|169485|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39584|NCT01483599|169486|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
39585|NCT01483599|169473|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
39586|NCT01483599|169474|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39587|NCT01483599|169475|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
39588|NCT01483599|169476|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39589|NCT01483599|169477|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39590|NCT01483599|169478|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
39591|NCT01483599|169479|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39592|NCT01483599|169480|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39593|NCT01483599|169481|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39594|NCT01483599|169482|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39595|NCT01483599|169483|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39596|NCT01483599|169484|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39597|NCT01483599|169485|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39598|NCT01483599|169486|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
39599|NCT01483599|169473|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
39600|NCT01483599|169474|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
39601|NCT01483599|169475|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39602|NCT01483599|169476|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39603|NCT01483599|169477|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39604|NCT01483599|169478|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
39605|NCT01483599|169479|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
39606|NCT01483599|169480|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39607|NCT01483599|169481|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39608|NCT01483599|169482|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39609|NCT01483599|169483|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39610|NCT01483599|169484|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39611|NCT01483599|169485|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39612|NCT01483599|169486|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
39613|NCT01483599|169473|P14|After Controlled Period(Week 16-Week 40)|Death|0
39614|NCT01483599|169474|P13|After Controlled Period(Week 16-Week 40)|Death|0
39615|NCT01483599|169475|P12|After Controlled Period(Week 16-Week 40)|Death|0
39616|NCT01483599|169476|P11|After Controlled Period(Week 16-Week 40)|Death|0
39617|NCT01483599|169477|P10|After Controlled Period(Week 16-Week 40)|Death|0
39618|NCT01483599|169478|P9|After Controlled Period(Week 16-Week 40)|Death|1
39619|NCT01483599|169479|P8|After Controlled Period(Week 16-Week 40)|Death|0
39620|NCT01483599|169480|P7|After Controlled Period(Week 16-Week 40)|Death|0
39621|NCT01483599|169481|P6|After Controlled Period(Week 16-Week 40)|Death|0
39622|NCT01483599|169482|P5|After Controlled Period(Week 16-Week 40)|Death|0
39623|NCT01483599|169483|P4|After Controlled Period(Week 16-Week 40)|Death|0
39624|NCT01483599|169484|P3|After Controlled Period(Week 16-Week 40)|Death|0
39625|NCT01483599|169485|P2|After Controlled Period(Week 16-Week 40)|Death|0
39626|NCT01483599|169486|P1|After Controlled Period(Week 16-Week 40)|Death|0
39627|NCT01483599|169473|P14|Controlled Period (CP) (up to Week 16)|Unspecified|0
39628|NCT01483599|169474|P13|Controlled Period (CP) (up to Week 16)|Unspecified|0
39629|NCT01483599|169475|P12|Controlled Period (CP) (up to Week 16)|Unspecified|0
39630|NCT01483599|169476|P11|Controlled Period (CP) (up to Week 16)|Unspecified|0
39631|NCT01483599|169477|P10|Controlled Period (CP) (up to Week 16)|Unspecified|0
39632|NCT01483599|169478|P9|Controlled Period (CP) (up to Week 16)|Unspecified|0
39633|NCT01483599|169479|P8|Controlled Period (CP) (up to Week 16)|Unspecified|0
39634|NCT01483599|169480|P7|Controlled Period (CP) (up to Week 16)|Unspecified|0
39635|NCT01483599|169481|P6|Controlled Period (CP) (up to Week 16)|Unspecified|0
39636|NCT01483599|169482|P5|Controlled Period (CP) (up to Week 16)|Unspecified|1
39637|NCT01483599|169483|P4|Controlled Period (CP) (up to Week 16)|Unspecified|1
39638|NCT01483599|169484|P3|Controlled Period (CP) (up to Week 16)|Unspecified|0
39639|NCT01483599|169485|P2|Controlled Period (CP) (up to Week 16)|Unspecified|2
39640|NCT01483599|169486|P1|Controlled Period (CP) (up to Week 16)|Unspecified|0
39641|NCT01483599|169473|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39642|NCT01483599|169474|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39643|NCT01483599|169475|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39644|NCT01483599|169476|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39645|NCT01483599|169477|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39646|NCT01483599|169478|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39647|NCT01483599|169479|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39648|NCT01483599|169480|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39649|NCT01483599|169481|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39650|NCT01483599|169482|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39651|NCT01483599|169483|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39652|NCT01483599|169484|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39653|NCT01483599|169485|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
39654|NCT01483599|169486|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
39655|NCT01483599|169473|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39656|NCT01483599|169474|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39657|NCT01483599|169475|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39658|NCT01483599|169476|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39659|NCT01483599|169477|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39660|NCT01483599|169478|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39661|NCT01483599|169479|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39662|NCT01483599|169480|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
39663|NCT01483599|169481|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39664|NCT01483599|169482|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39665|NCT01483599|169483|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
39666|NCT01483599|169484|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39667|NCT01483599|169485|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
39668|NCT01483599|169486|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
39669|NCT01483599|169473|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39670|NCT01483599|169474|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39671|NCT01483599|169475|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39672|NCT01483599|169476|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39673|NCT01483599|169477|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39674|NCT01483599|169478|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39675|NCT01483599|169479|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39676|NCT01483599|169480|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
39677|NCT01483599|169481|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
39678|NCT01483599|169482|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
39679|NCT01483599|169483|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
39680|NCT01483599|169484|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39681|NCT01483599|169485|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
39682|NCT01483599|169486|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
39683|NCT01483183|169576|P10|Overall Study|Withdrawal by Subject|1
39684|NCT01483183|169577|P9|Overall Study|Withdrawal by Subject|0
39685|NCT01483183|169578|P8|Overall Study|Withdrawal by Subject|0
39686|NCT01483183|169579|P7|Overall Study|Withdrawal by Subject|0
39687|NCT01483183|169580|P6|Overall Study|Withdrawal by Subject|0
39688|NCT01483183|169581|P5|Overall Study|Withdrawal by Subject|0
39689|NCT01483183|169582|P4|Overall Study|Withdrawal by Subject|0
39690|NCT01483183|169583|P3|Overall Study|Withdrawal by Subject|0
39691|NCT01483183|169584|P2|Overall Study|Withdrawal by Subject|0
39692|NCT01483183|169585|P1|Overall Study|Withdrawal by Subject|0
39693|NCT01483183|169576|P10|Overall Study|Physician Decision|0
39694|NCT01483183|169577|P9|Overall Study|Physician Decision|0
39695|NCT01483183|169578|P8|Overall Study|Physician Decision|0
39696|NCT01483183|169579|P7|Overall Study|Physician Decision|2
39697|NCT01483183|169580|P6|Overall Study|Physician Decision|0
39698|NCT01483183|169581|P5|Overall Study|Physician Decision|0
39699|NCT01483183|169582|P4|Overall Study|Physician Decision|0
39700|NCT01483183|169583|P3|Overall Study|Physician Decision|0
39701|NCT01483183|169584|P2|Overall Study|Physician Decision|0
39702|NCT01483183|169585|P1|Overall Study|Physician Decision|0
39703|NCT01483118|169655|P2|Overall Study|Lost to Follow-up|16
39704|NCT01483118|169656|P1|Overall Study|Lost to Follow-up|12
39705|NCT01482910|169668|P2|Overall Study|Death|0
39706|NCT01482910|169669|P1|Overall Study|Death|1
39707|NCT01482910|169668|P2|Overall Study|Withdrawal by Subject|2
39708|NCT01482910|169669|P1|Overall Study|Withdrawal by Subject|7
39709|NCT01482910|169668|P2|Overall Study|Protocol Violation|1
39710|NCT01482910|169669|P1|Overall Study|Protocol Violation|1
39711|NCT01482910|169668|P2|Overall Study|Lost to Follow-up|1
39712|NCT01482910|169669|P1|Overall Study|Lost to Follow-up|0
39713|NCT01482910|169668|P2|Overall Study|Adverse Event|5
39714|NCT01482910|169669|P1|Overall Study|Adverse Event|6
39715|NCT01482884|169681|P2|Overall Study|Withdrawal by Subject|13
39716|NCT01482884|169682|P1|Overall Study|Withdrawal by Subject|8
39717|NCT01482884|169681|P2|Overall Study|Adverse Event|1
39718|NCT01482884|169682|P1|Overall Study|Adverse Event|2
39719|NCT01482884|169681|P2|Overall Study|Lack of Efficacy|1
39720|NCT01482884|169682|P1|Overall Study|Lack of Efficacy|0
39721|NCT01482884|169681|P2|Overall Study|Lost to Follow-up|2
39722|NCT01482884|169682|P1|Overall Study|Lost to Follow-up|2
39723|NCT01482884|169681|P2|Overall Study|Protocol Violation|0
39724|NCT01482884|169682|P1|Overall Study|Protocol Violation|1
39725|NCT01482884|169681|P2|Overall Study|Medical decision due to lack of efficacy|1
39726|NCT01482884|169682|P1|Overall Study|Medical decision due to lack of efficacy|0
39727|NCT01482819|169708|P1|Overall Study|Lost to Follow-up|2
39728|NCT01482767|169728|P2|Overall Study|Nurse error|0
39729|NCT01482767|169729|P1|Overall Study|Nurse error|1
39730|NCT01482767|169728|P2|Overall Study|Ineligible|5
39731|NCT01482767|169729|P1|Overall Study|Ineligible|0
39732|NCT01482767|169728|P2|Overall Study|Alternate HCV treatment|8
39733|NCT01482767|169729|P1|Overall Study|Alternate HCV treatment|7
39734|NCT01482767|169728|P2|Overall Study|Non-adherence to study requirements|7
39735|NCT01482767|169729|P1|Overall Study|Non-adherence to study requirements|4
39736|NCT01482767|169728|P2|Overall Study|Site closure|14
39737|NCT01482767|169729|P1|Overall Study|Site closure|22
39738|NCT01482767|169728|P2|Overall Study|Adverse Event|3
39739|NCT01482767|169729|P1|Overall Study|Adverse Event|0
39740|NCT01482767|169728|P2|Overall Study|Lost to Follow-up|6
39741|NCT01482767|169729|P1|Overall Study|Lost to Follow-up|12
39742|NCT01482767|169728|P2|Overall Study|Withdrawal by Subject|5
39743|NCT01482767|169729|P1|Overall Study|Withdrawal by Subject|7
39744|NCT01482767|169728|P2|Overall Study|Death|1
39745|NCT01482767|169729|P1|Overall Study|Death|1
39746|NCT01482429|169751|P2|Protocol|Protocol Violation|0
39747|NCT01482429|169752|P1|Protocol|Protocol Violation|275
39748|NCT01482429|169751|P2|Care Usual|Lost to Follow-up|1
39749|NCT01482429|169752|P1|Care Usual|Lost to Follow-up|0
39750|NCT01482429|169751|P2|Care Usual|Protocol Violation|172
39751|NCT01482429|169752|P1|Care Usual|Protocol Violation|0
39752|NCT01482312|169764|P3|Period 2, 90 Minutes of Wear|Unspecified|0
39753|NCT01482312|169765|P2|Period 2, 90 Minutes of Wear|Unspecified|0
39754|NCT01482312|169766|P1|Period 2, 90 Minutes of Wear|Unspecified|1
39755|NCT01482312|169764|P3|Period 1, 90 Minutes of Wear|Unspecified|0
39756|NCT01482312|169765|P2|Period 1, 90 Minutes of Wear|Unspecified|0
39757|NCT01482312|169766|P1|Period 1, 90 Minutes of Wear|Unspecified|1
39758|NCT01482221|169780|P3|Overall Study|Physician Decision|0
39759|NCT01482221|169781|P2|Overall Study|Physician Decision|1
39760|NCT01482221|169782|P1|Overall Study|Physician Decision|0
39761|NCT01482221|169780|P3|Overall Study|Incorrect randomization|0
39762|NCT01482221|169781|P2|Overall Study|Incorrect randomization|1
39763|NCT01482221|169782|P1|Overall Study|Incorrect randomization|0
39764|NCT01482221|169780|P3|Overall Study|Withdrawal by Subject|12
39765|NCT01482221|169781|P2|Overall Study|Withdrawal by Subject|7
39766|NCT01482221|169782|P1|Overall Study|Withdrawal by Subject|10
39767|NCT01482221|169780|P3|Overall Study|Adverse Event|3
39768|NCT01482221|169781|P2|Overall Study|Adverse Event|7
39769|NCT01482221|169782|P1|Overall Study|Adverse Event|1
39770|NCT01482221|169780|P3|Overall Study|Severe Non-Compliance to Protocol|1
39771|NCT01482221|169781|P2|Overall Study|Severe Non-Compliance to Protocol|0
39772|NCT01482221|169782|P1|Overall Study|Severe Non-Compliance to Protocol|1
39773|NCT01482221|169780|P3|Overall Study|Condition under Investigation Worsened|4
39774|NCT01482221|169781|P2|Overall Study|Condition under Investigation Worsened|2
39775|NCT01482221|169782|P1|Overall Study|Condition under Investigation Worsened|3
39776|NCT01482221|169780|P3|Overall Study|Study-Specific Withdrawal Criteria|1
39777|NCT01482221|169781|P2|Overall Study|Study-Specific Withdrawal Criteria|0
39778|NCT01482221|169782|P1|Overall Study|Study-Specific Withdrawal Criteria|2
39779|NCT01482221|169780|P3|Overall Study|Lost to Follow-up|1
39780|NCT01482221|169781|P2|Overall Study|Lost to Follow-up|2
39781|NCT01482221|169782|P1|Overall Study|Lost to Follow-up|3
39782|NCT01482221|169780|P3|Overall Study|Lack of Efficacy|1
39783|NCT01482221|169781|P2|Overall Study|Lack of Efficacy|0
39784|NCT01482221|169782|P1|Overall Study|Lack of Efficacy|1
39785|NCT01482065|169858|P2|Overall Study|Withdrawal by Subject|1
39786|NCT01482065|169859|P1|Overall Study|Withdrawal by Subject|0
39787|NCT01481896|169880|P1|Overall Study|Lost to Follow-up|12
39788|NCT01481324|169933|P3|Overall Study|Missing Data|2
39789|NCT01481324|169934|P2|Overall Study|Missing Data|2
39790|NCT01481324|169935|P1|Overall Study|Missing Data|0
39791|NCT01481116|169954|P3|Overall Study|Hypoglycemic Event|0
39792|NCT01481116|169955|P2|Overall Study|Hypoglycemic Event|0
39793|NCT01481116|169956|P1|Overall Study|Hypoglycemic Event|4
39794|NCT01481116|169954|P3|Overall Study|Death|0
39795|NCT01481116|169955|P2|Overall Study|Death|1
39796|NCT01481116|169956|P1|Overall Study|Death|2
39797|NCT01481116|169954|P3|Overall Study|Investigator's Discretion|0
39798|NCT01481116|169955|P2|Overall Study|Investigator's Discretion|0
39799|NCT01481116|169956|P1|Overall Study|Investigator's Discretion|2
39800|NCT01481116|169954|P3|Overall Study|Non-Compliant With Study Drug|1
39801|NCT01481116|169955|P2|Overall Study|Non-Compliant With Study Drug|1
39802|NCT01481116|169956|P1|Overall Study|Non-Compliant With Study Drug|0
39803|NCT01481116|169954|P3|Overall Study|Sponsor Decision|3
39804|NCT01481116|169955|P2|Overall Study|Sponsor Decision|1
39805|NCT01481116|169956|P1|Overall Study|Sponsor Decision|0
39806|NCT01481116|169954|P3|Overall Study|Investigator Decision|1
39807|NCT01481116|169955|P2|Overall Study|Investigator Decision|2
39808|NCT01481116|169956|P1|Overall Study|Investigator Decision|3
39809|NCT01481116|169954|P3|Overall Study|Participant Moved Out of Country|1
39810|NCT01481116|169955|P2|Overall Study|Participant Moved Out of Country|0
39811|NCT01481116|169956|P1|Overall Study|Participant Moved Out of Country|1
39812|NCT01481116|169954|P3|Overall Study|Participant Moved Out of Area|1
39813|NCT01481116|169955|P2|Overall Study|Participant Moved Out of Area|0
39814|NCT01481116|169956|P1|Overall Study|Participant Moved Out of Area|2
39815|NCT01481116|169954|P3|Overall Study|Participant Started Taking Glipizide|0
39816|NCT01481116|169955|P2|Overall Study|Participant Started Taking Glipizide|0
39817|NCT01481116|169956|P1|Overall Study|Participant Started Taking Glipizide|1
39818|NCT01481116|169954|P3|Overall Study|Unspecified|0
39819|NCT01481116|169955|P2|Overall Study|Unspecified|1
39820|NCT01481116|169956|P1|Overall Study|Unspecified|1
39821|NCT01481116|169954|P3|Overall Study|Contraindications|0
39822|NCT01481116|169955|P2|Overall Study|Contraindications|1
39823|NCT01481116|169956|P1|Overall Study|Contraindications|1
39824|NCT01481116|169954|P3|Overall Study|Lack of Efficacy|1
39825|NCT01481116|169955|P2|Overall Study|Lack of Efficacy|3
39826|NCT01481116|169956|P1|Overall Study|Lack of Efficacy|3
39827|NCT01481116|169954|P3|Overall Study|Pregnancy|1
39828|NCT01481116|169955|P2|Overall Study|Pregnancy|0
39829|NCT01481116|169956|P1|Overall Study|Pregnancy|0
39830|NCT01481116|169954|P3|Overall Study|Study Termination|713
39831|NCT01481116|169955|P2|Overall Study|Study Termination|729
39832|NCT01481116|169956|P1|Overall Study|Study Termination|730
39833|NCT01481116|169954|P3|Overall Study|Withdrawal by Subject|37
39834|NCT01481116|169955|P2|Overall Study|Withdrawal by Subject|33
39835|NCT01481116|169956|P1|Overall Study|Withdrawal by Subject|37
39836|NCT01481116|169954|P3|Overall Study|Lost to Follow-up|11
39837|NCT01481116|169955|P2|Overall Study|Lost to Follow-up|12
39838|NCT01481116|169956|P1|Overall Study|Lost to Follow-up|8
39839|NCT01481116|169954|P3|Overall Study|Major Protocol Deviation|1
39840|NCT01481116|169955|P2|Overall Study|Major Protocol Deviation|7
39841|NCT01481116|169956|P1|Overall Study|Major Protocol Deviation|3
39842|NCT01481116|169954|P3|Overall Study|Adverse Event|42
39843|NCT01481116|169955|P2|Overall Study|Adverse Event|26
39844|NCT01481116|169956|P1|Overall Study|Adverse Event|26
39845|NCT01480674|169982|P1|Overall Study|visit not done|10
39846|NCT01480674|169982|P1|Overall Study|Lost to Follow-up|2
39847|NCT01480674|169982|P1|Overall Study|Death|23
39848|NCT01480596|169996|P2|Overall Study|MG exacerbation or change in medication|2
39849|NCT01480596|169997|P1|Overall Study|MG exacerbation or change in medication|2
39850|NCT01480596|169996|P2|Overall Study|Adverse Event|0
39851|NCT01480596|169997|P1|Overall Study|Adverse Event|3
39852|NCT01480284|170045|P2|Overall Study|Physician Decision|0
39853|NCT01480284|170046|P1|Overall Study|Physician Decision|1
39854|NCT01480284|170045|P2|Overall Study|Lost to Follow-up|0
39855|NCT01480284|170046|P1|Overall Study|Lost to Follow-up|1
39856|NCT01480284|170045|P2|Overall Study|Study closed/terminated|0
39857|NCT01480284|170046|P1|Overall Study|Study closed/terminated|3
39858|NCT01480284|170045|P2|Overall Study|Adverse Event|0
39859|NCT01480284|170046|P1|Overall Study|Adverse Event|1
39860|NCT01480284|170045|P2|Overall Study|Withdrawal by Subject|0
39861|NCT01480284|170046|P1|Overall Study|Withdrawal by Subject|2
39862|NCT01480076|170129|P1|Overall Study|Not Specified|52
39863|NCT01480076|170129|P1|Overall Study|Investigator Decision|13
39864|NCT01480076|170129|P1|Overall Study|Lost to Follow-up|7
39865|NCT01480076|170129|P1|Overall Study|Withdrawal by Subject|105
39866|NCT01480076|170129|P1|Overall Study|Non-compliance With Study Protocol|15
39867|NCT01480076|170129|P1|Overall Study|Disease Progression|5
39868|NCT01480076|170129|P1|Overall Study|Death|2
39869|NCT01480076|170129|P1|Overall Study|Adverse Event|39
39870|NCT01480076|170129|P1|Overall Study|Run-in Failure|52
39871|NCT01479868|170248|P1|Overall Study|Initiation of new HCV Therapy|1
39872|NCT01479868|170248|P1|Overall Study|Sponsor's Decision|1
39873|NCT01479868|170248|P1|Overall Study|Withdrawal by Subject|1
39874|NCT01479868|170248|P1|Overall Study|Protocol Violation|1
39875|NCT01479868|170248|P1|Overall Study|Lost to Follow-up|4
39876|NCT01479868|170248|P1|Overall Study|Adverse Event|1
39877|NCT01479777|170263|P1|Overall Study|Physician Decision|2
39878|NCT01479764|170275|P2|Treated|Lost to Follow-up|2
39879|NCT01479764|170276|P1|Treated|Lost to Follow-up|0
39880|NCT01479764|170275|P2|Randomized|Withdrawal by Subject|0
39881|NCT01479764|170276|P1|Randomized|Withdrawal by Subject|1
39882|NCT01479764|170275|P2|Randomized|Adverse Event|1
39883|NCT01479764|170276|P1|Randomized|Adverse Event|1
39884|NCT01479621|170299|P7|Treatment Period|Met stopping criteria|6
39885|NCT01479621|170300|P6|Treatment Period|Met stopping criteria|20
39886|NCT01479621|170301|P5|Treatment Period|Met stopping criteria|9
39887|NCT01479621|170302|P4|Treatment Period|Met stopping criteria|4
39888|NCT01479621|170303|P3|Treatment Period|Met stopping criteria|7
39889|NCT01479621|170304|P2|Treatment Period|Met stopping criteria|8
39890|NCT01479621|170305|P1|Treatment Period|Met stopping criteria|0
39891|NCT01479621|170299|P7|Treatment Period|Lost to Follow-up|1
39892|NCT01479621|170300|P6|Treatment Period|Lost to Follow-up|2
39893|NCT01479621|170301|P5|Treatment Period|Lost to Follow-up|2
39894|NCT01479621|170302|P4|Treatment Period|Lost to Follow-up|0
39895|NCT01479621|170303|P3|Treatment Period|Lost to Follow-up|1
39896|NCT01479621|170304|P2|Treatment Period|Lost to Follow-up|0
39897|NCT01479621|170305|P1|Treatment Period|Lost to Follow-up|0
39898|NCT01479621|170299|P7|Treatment Period|Sponsor request subject to be withdrawn|3
39899|NCT01479621|170300|P6|Treatment Period|Sponsor request subject to be withdrawn|1
39900|NCT01479621|170301|P5|Treatment Period|Sponsor request subject to be withdrawn|1
39901|NCT01479621|170302|P4|Treatment Period|Sponsor request subject to be withdrawn|1
39902|NCT01479621|170303|P3|Treatment Period|Sponsor request subject to be withdrawn|3
39903|NCT01479621|170304|P2|Treatment Period|Sponsor request subject to be withdrawn|2
39904|NCT01479621|170305|P1|Treatment Period|Sponsor request subject to be withdrawn|0
39905|NCT01479621|170299|P7|Treatment Period|Pregnancy|0
39906|NCT01479621|170300|P6|Treatment Period|Pregnancy|0
39907|NCT01479621|170301|P5|Treatment Period|Pregnancy|0
39908|NCT01479621|170302|P4|Treatment Period|Pregnancy|0
39909|NCT01479621|170303|P3|Treatment Period|Pregnancy|2
39910|NCT01479621|170304|P2|Treatment Period|Pregnancy|0
39911|NCT01479621|170305|P1|Treatment Period|Pregnancy|0
39912|NCT01479621|170299|P7|Treatment Period|Protocol Violation|6
39913|NCT01479621|170300|P6|Treatment Period|Protocol Violation|10
39914|NCT01479621|170301|P5|Treatment Period|Protocol Violation|2
39915|NCT01479621|170302|P4|Treatment Period|Protocol Violation|5
39916|NCT01479621|170303|P3|Treatment Period|Protocol Violation|6
39917|NCT01479621|170304|P2|Treatment Period|Protocol Violation|9
39918|NCT01479621|170305|P1|Treatment Period|Protocol Violation|0
39919|NCT01479621|170299|P7|Treatment Period|Non-compliance to study drug|1
39920|NCT01479621|170300|P6|Treatment Period|Non-compliance to study drug|0
39921|NCT01479621|170301|P5|Treatment Period|Non-compliance to study drug|0
39922|NCT01479621|170302|P4|Treatment Period|Non-compliance to study drug|0
39923|NCT01479621|170303|P3|Treatment Period|Non-compliance to study drug|0
39924|NCT01479621|170304|P2|Treatment Period|Non-compliance to study drug|1
39925|NCT01479621|170305|P1|Treatment Period|Non-compliance to study drug|0
39926|NCT01479621|170299|P7|Treatment Period|Physician Decision|0
39927|NCT01479621|170300|P6|Treatment Period|Physician Decision|1
39928|NCT01479621|170301|P5|Treatment Period|Physician Decision|1
39929|NCT01479621|170302|P4|Treatment Period|Physician Decision|0
39930|NCT01479621|170303|P3|Treatment Period|Physician Decision|0
39931|NCT01479621|170304|P2|Treatment Period|Physician Decision|0
39932|NCT01479621|170305|P1|Treatment Period|Physician Decision|0
39933|NCT01479621|170299|P7|Treatment Period|Withdrawal by Subject|1
39934|NCT01479621|170300|P6|Treatment Period|Withdrawal by Subject|5
39935|NCT01479621|170301|P5|Treatment Period|Withdrawal by Subject|5
39936|NCT01479621|170302|P4|Treatment Period|Withdrawal by Subject|2
39937|NCT01479621|170303|P3|Treatment Period|Withdrawal by Subject|2
39938|NCT01479621|170304|P2|Treatment Period|Withdrawal by Subject|4
39939|NCT01479621|170305|P1|Treatment Period|Withdrawal by Subject|0
39940|NCT01479621|170299|P7|Treatment Period|Adverse Event|2
39941|NCT01479621|170300|P6|Treatment Period|Adverse Event|2
39942|NCT01479621|170301|P5|Treatment Period|Adverse Event|1
39943|NCT01479621|170302|P4|Treatment Period|Adverse Event|0
39944|NCT01479621|170303|P3|Treatment Period|Adverse Event|0
39945|NCT01479621|170304|P2|Treatment Period|Adverse Event|0
39946|NCT01479621|170305|P1|Treatment Period|Adverse Event|0
39947|NCT01479621|170299|P7|Pre-Assignment Period (Run-In Placebo)|Not specified|0
39948|NCT01479621|170300|P6|Pre-Assignment Period (Run-In Placebo)|Not specified|0
39949|NCT01479621|170301|P5|Pre-Assignment Period (Run-In Placebo)|Not specified|0
39950|NCT01479621|170302|P4|Pre-Assignment Period (Run-In Placebo)|Not specified|0
39951|NCT01479621|170303|P3|Pre-Assignment Period (Run-In Placebo)|Not specified|0
39952|NCT01479621|170304|P2|Pre-Assignment Period (Run-In Placebo)|Not specified|0
39953|NCT01479621|170305|P1|Pre-Assignment Period (Run-In Placebo)|Not specified|15
39954|NCT01479621|170299|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
39955|NCT01479621|170300|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
39956|NCT01479621|170301|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
39957|NCT01479621|170302|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
39958|NCT01479621|170303|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
39959|NCT01479621|170304|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
39960|NCT01479621|170305|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
39961|NCT01479621|170299|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
39962|NCT01479621|170300|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
39963|NCT01479621|170301|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
39964|NCT01479621|170302|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
39965|NCT01479621|170303|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
39966|NCT01479621|170304|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
39967|NCT01479621|170305|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
39968|NCT01479621|170299|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
39969|NCT01479621|170300|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
39970|NCT01479621|170301|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
39971|NCT01479621|170302|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
39972|NCT01479621|170303|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
39973|NCT01479621|170304|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
39974|NCT01479621|170305|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
39975|NCT01479621|170299|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
39976|NCT01479621|170300|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
39977|NCT01479621|170301|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
39978|NCT01479621|170302|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
39979|NCT01479621|170303|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
39980|NCT01479621|170304|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
39981|NCT01479621|170305|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
39982|NCT01479595|170393|P2|Overall Study|Adverse Event|1
39983|NCT01479595|170394|P1|Overall Study|Adverse Event|2
39984|NCT01479595|170393|P2|Overall Study|Protocol deviation|1
39985|NCT01479595|170394|P1|Overall Study|Protocol deviation|0
39986|NCT01479530|170439|P2|Overall Study|Withdrawal of Consent|2
39987|NCT01479530|170440|P1|Overall Study|Withdrawal of Consent|3
39988|NCT01479530|170439|P2|Overall Study|Protocol Violation|3
39989|NCT01479530|170440|P1|Overall Study|Protocol Violation|2
39990|NCT01479530|170439|P2|Overall Study|Lack of Efficacy|1
39991|NCT01479530|170440|P1|Overall Study|Lack of Efficacy|0
39992|NCT01479530|170439|P2|Overall Study|Adverse Event|6
39993|NCT01479530|170440|P1|Overall Study|Adverse Event|5
39994|NCT01479374|170477|P3|Overall Study|Other|5
39995|NCT01479374|170478|P2|Overall Study|Other|4
39996|NCT01479374|170479|P1|Overall Study|Other|0
39997|NCT01479374|170477|P3|Overall Study|Decision Unrelated to Adverse Event|0
39998|NCT01479374|170478|P2|Overall Study|Decision Unrelated to Adverse Event|1
39999|NCT01479374|170479|P1|Overall Study|Decision Unrelated to Adverse Event|0
40000|NCT01479374|170477|P3|Overall Study|Lost to Follow-up|0
40001|NCT01479374|170478|P2|Overall Study|Lost to Follow-up|2
40002|NCT01479374|170479|P1|Overall Study|Lost to Follow-up|1
40003|NCT01479374|170477|P3|Overall Study|Adverse Event|0
40004|NCT01479374|170478|P2|Overall Study|Adverse Event|1
40005|NCT01479374|170479|P1|Overall Study|Adverse Event|2
40006|NCT01478971|170544|P1|Peginesatide Treatment Period|Other|4
40007|NCT01478971|170544|P1|Peginesatide Treatment Period|Lost to Follow-up|4
40008|NCT01478971|170544|P1|Peginesatide Treatment Period|Death|4
40009|NCT01478971|170544|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
40010|NCT01478971|170544|P1|Peginesatide Treatment Period|Adverse Event|1
40011|NCT01478971|170544|P1|Standard of Care Period|Other|4
40012|NCT01478971|170544|P1|Standard of Care Period|Lost to Follow-up|9
40013|NCT01478971|170544|P1|Standard of Care Period|Death|8
40014|NCT01478971|170544|P1|Standard of Care Period|Withdrawal by Subject|3
40015|NCT01478971|170544|P1|Standard of Care Period|Adverse Event|1
40016|NCT01478958|170561|P3|Overall Study|Unable to comply|2
40017|NCT01478958|170562|P2|Overall Study|Unable to comply|0
40018|NCT01478958|170563|P1|Overall Study|Unable to comply|0
40019|NCT01478958|170561|P3|Overall Study|Re-located|0
40020|NCT01478958|170562|P2|Overall Study|Re-located|1
40021|NCT01478958|170563|P1|Overall Study|Re-located|0
40022|NCT01478958|170561|P3|Overall Study|Weight loss|0
40023|NCT01478958|170562|P2|Overall Study|Weight loss|0
40024|NCT01478958|170563|P1|Overall Study|Weight loss|1
40025|NCT01478958|170561|P3|Overall Study|Withdrawal by Subject|1
40026|NCT01478958|170562|P2|Overall Study|Withdrawal by Subject|1
40027|NCT01478958|170563|P1|Overall Study|Withdrawal by Subject|1
40028|NCT01478828|170571|P1|Overall Study|Adverse Event|1
40029|NCT01478620|170576|P1|Overall Study|Lost to Follow-up|6
40030|NCT01478594|170582|P2|Overall Study|Study Closed by Sponsor|5
40031|NCT01478594|170583|P1|Overall Study|Study Closed by Sponsor|8
40032|NCT01478594|170582|P2|Overall Study|Withdrawal by Subject|3
40033|NCT01478594|170583|P1|Overall Study|Withdrawal by Subject|9
40034|NCT01478594|170582|P2|Overall Study|Lost to Follow-up|1
40035|NCT01478594|170583|P1|Overall Study|Lost to Follow-up|3
40036|NCT01478594|170582|P2|Overall Study|Death|18
40037|NCT01478594|170583|P1|Overall Study|Death|45
40038|NCT01478594|170582|P2|Overall Study|Randomized but Never Received Study Drug|1
40039|NCT01478594|170583|P1|Overall Study|Randomized but Never Received Study Drug|0
40040|NCT01478373|170655|P1|Survival Phase|Progressive Disease|27
40041|NCT01478373|170655|P1|Survival Phase|crossover to another study|2
40042|NCT01478373|170655|P1|Survival Phase|Protocol Violation|1
40043|NCT01478373|170655|P1|Survival Phase|Adverse Event|8
40044|NCT01478373|170655|P1|Treatment Phase|Protocol Violation|1
40045|NCT01478360|170668|P2|Overall Study|Administrative problems|2
40046|NCT01478360|170669|P1|Overall Study|Administrative problems|1
40047|NCT01478360|170668|P2|Overall Study|Adverse Event|1
40048|NCT01478360|170669|P1|Overall Study|Adverse Event|0
40049|NCT01478360|170668|P2|Overall Study|Lost to Follow-up|0
40050|NCT01478360|170669|P1|Overall Study|Lost to Follow-up|1
40051|NCT01478347|170675|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
40052|NCT01478347|170675|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
40053|NCT01478347|170675|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
40054|NCT01478113|170693|P2|Overall Study|Physician Decision|0
40055|NCT01478113|170694|P1|Overall Study|Physician Decision|1
40056|NCT01478113|170693|P2|Overall Study|Withdrawal by Subject|1
40057|NCT01478113|170694|P1|Overall Study|Withdrawal by Subject|0
40058|NCT01478087|170712|P1|Overall Study|due to sponsor closing study|1
40059|NCT01478048|170719|P2|Overall Study|Physician Decision|0
40060|NCT01478048|170720|P1|Overall Study|Physician Decision|1
40061|NCT01478048|170719|P2|Overall Study|Not reported|0
40062|NCT01478048|170720|P1|Overall Study|Not reported|1
40063|NCT01478048|170719|P2|Overall Study|no longer meets study criteria|0
40064|NCT01478048|170720|P1|Overall Study|no longer meets study criteria|1
40065|NCT01478048|170719|P2|Overall Study|poor/non-compliance|1
40066|NCT01478048|170720|P1|Overall Study|poor/non-compliance|1
40067|NCT01478048|170719|P2|Overall Study|non-specified|3
40068|NCT01478048|170720|P1|Overall Study|non-specified|1
40069|NCT01478048|170719|P2|Overall Study|Withdrawal by Subject|5
40070|NCT01478048|170720|P1|Overall Study|Withdrawal by Subject|2
40071|NCT01478048|170719|P2|Overall Study|subject request to discontinue treatment|5
40072|NCT01478048|170720|P1|Overall Study|subject request to discontinue treatment|1
40073|NCT01478048|170719|P2|Overall Study|Adverse Event|9
40074|NCT01478048|170720|P1|Overall Study|Adverse Event|1
40075|NCT01478048|170719|P2|Overall Study|study drug toxicity|13
40076|NCT01478048|170720|P1|Overall Study|study drug toxicity|8
40077|NCT01478048|170719|P2|Overall Study|Disease Progression|32
40078|NCT01478048|170720|P1|Overall Study|Disease Progression|46
40079|NCT01477892|170749|P2|Overall Study|Withdrawal by Subject|2
40080|NCT01477892|170750|P1|Overall Study|Withdrawal by Subject|0
40081|NCT01477853|170761|P3|Phase B|Study terminated by sponsor|11
40082|NCT01477853|170762|P2|Phase B|Study terminated by sponsor|10
40083|NCT01477853|170763|P1|Phase B|Study terminated by sponsor|12
40084|NCT01477853|170761|P3|Phase B|Lost to Follow-up|0
40085|NCT01477853|170762|P2|Phase B|Lost to Follow-up|1
40086|NCT01477853|170763|P1|Phase B|Lost to Follow-up|0
40087|NCT01477853|170761|P3|Phase A|Study terminated by sponsor|39
40088|NCT01477853|170762|P2|Phase A|Study terminated by sponsor|40
40089|NCT01477853|170763|P1|Phase A|Study terminated by sponsor|37
40090|NCT01477853|170761|P3|Phase A|Physician Decision|1
40091|NCT01477853|170762|P2|Phase A|Physician Decision|0
40092|NCT01477853|170763|P1|Phase A|Physician Decision|1
40093|NCT01477853|170761|P3|Phase A|Lost to Follow-up|2
40094|NCT01477853|170762|P2|Phase A|Lost to Follow-up|3
40095|NCT01477853|170763|P1|Phase A|Lost to Follow-up|4
40096|NCT01477853|170761|P3|Phase A|Adverse Event|2
40097|NCT01477853|170762|P2|Phase A|Adverse Event|2
40098|NCT01477853|170763|P1|Phase A|Adverse Event|1
40099|NCT01477749|170830|P1|Overall Study|Physician Decision|4
40100|NCT01477333|170938|P1|Overall Study|Clinical Deterioration|1
40101|NCT01477333|170938|P1|Overall Study|Withdrawal by Subject|1
40102|NCT01477333|170938|P1|Overall Study|Adverse Event|1
40103|NCT01475734|170956|P2|Overall Study|Physician Decision|1
40104|NCT01475734|170957|P1|Overall Study|Physician Decision|0
40105|NCT01475734|170956|P2|Overall Study|Protocol Violation|0
40106|NCT01475734|170957|P1|Overall Study|Protocol Violation|1
40107|NCT01475734|170956|P2|Overall Study|Withdrawal by Subject|0
40108|NCT01475734|170957|P1|Overall Study|Withdrawal by Subject|1
40109|NCT01475721|170985|P2|Overall Study|Withdrawal by Subject|8
40110|NCT01475721|170986|P1|Overall Study|Withdrawal by Subject|8
40111|NCT01475721|170985|P2|Overall Study|Death|6
40112|NCT01475721|170986|P1|Overall Study|Death|3
40113|NCT01476722|171016|P1|Overall Study|Adverse Event|1
40114|NCT01476696|171023|P3|Overall Study|Withdrawal by Subject|0
40115|NCT01476696|171024|P2|Overall Study|Withdrawal by Subject|0
40116|NCT01476696|171025|P1|Overall Study|Withdrawal by Subject|1
40117|NCT01476696|171023|P3|Overall Study|Sponsor decision|0
40118|NCT01476696|171024|P2|Overall Study|Sponsor decision|1
40119|NCT01476696|171025|P1|Overall Study|Sponsor decision|2
40120|NCT01476475|171041|P2|Overall Study|Other reasons|2
40121|NCT01476475|171042|P1|Overall Study|Other reasons|4
40122|NCT01476475|171041|P2|Overall Study|Poor compliance to protocol|1
40123|NCT01476475|171042|P1|Overall Study|Poor compliance to protocol|1
40124|NCT01476475|171041|P2|Overall Study|Adverse Event|0
40125|NCT01476475|171042|P1|Overall Study|Adverse Event|6
40126|NCT01475851|171471|P2|Overall Study|Protocol defined stopping criteria|0
40127|NCT01475851|171472|P1|Overall Study|Protocol defined stopping criteria|1
40128|NCT01475838|171500|P2|Extension Phase|Participant Noncompliance|0
40129|NCT01475838|171501|P1|Extension Phase|Participant Noncompliance|1
40130|NCT01475838|171500|P2|Randomized Phase|Protocol Violation|4
40131|NCT01475838|171501|P1|Randomized Phase|Protocol Violation|9
40132|NCT01475838|171500|P2|Randomized Phase|Participant Noncompliance|5
40133|NCT01475838|171501|P1|Randomized Phase|Participant Noncompliance|1
40134|NCT01475838|171500|P2|Randomized Phase|Lost to Follow-up|4
40135|NCT01475838|171501|P1|Randomized Phase|Lost to Follow-up|3
40136|NCT01475838|171500|P2|Randomized Phase|Withdrew Consent|14
40137|NCT01475838|171501|P1|Randomized Phase|Withdrew Consent|10
40138|NCT01475838|171500|P2|Randomized Phase|Investigators Discretion|2
40139|NCT01475838|171501|P1|Randomized Phase|Investigators Discretion|1
40140|NCT01475838|171500|P2|Randomized Phase|Pregnancy|1
40141|NCT01475838|171501|P1|Randomized Phase|Pregnancy|0
40142|NCT01475838|171500|P2|Randomized Phase|Adverse Event|1
40143|NCT01475838|171501|P1|Randomized Phase|Adverse Event|6
40144|NCT01475838|171500|P2|Randomized Phase|Randomized but Not Treated|5
40145|NCT01475838|171501|P1|Randomized Phase|Randomized but Not Treated|0
40146|NCT01475487|171516|P2|Overall Study|had to leave early for personal reasons|1
40147|NCT01475487|171517|P1|Overall Study|had to leave early for personal reasons|2
40148|NCT01475474|171529|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
40149|NCT01475474|171529|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
40150|NCT01475461|171540|P7|Treatment Period|Adverse Event|0
40151|NCT01475461|171541|P6|Treatment Period|Adverse Event|0
40152|NCT01475461|171542|P5|Treatment Period|Adverse Event|0
40153|NCT01475461|171543|P4|Treatment Period|Adverse Event|1
40154|NCT01475461|171544|P3|Treatment Period|Adverse Event|0
40155|NCT01475461|171545|P2|Treatment Period|Adverse Event|0
40156|NCT01475461|171546|P1|Treatment Period|Adverse Event|0
40157|NCT01475461|171540|P7|Treatment Period|Medication Error|0
40158|NCT01475461|171541|P6|Treatment Period|Medication Error|0
40159|NCT01475461|171542|P5|Treatment Period|Medication Error|0
40160|NCT01475461|171543|P4|Treatment Period|Medication Error|1
40161|NCT01475461|171544|P3|Treatment Period|Medication Error|0
40162|NCT01475461|171545|P2|Treatment Period|Medication Error|0
40163|NCT01475461|171546|P1|Treatment Period|Medication Error|0
40164|NCT01475461|171540|P7|Treatment Period|Lack of Efficacy|0
40165|NCT01475461|171541|P6|Treatment Period|Lack of Efficacy|1
40166|NCT01475461|171542|P5|Treatment Period|Lack of Efficacy|1
40167|NCT01475461|171543|P4|Treatment Period|Lack of Efficacy|2
40168|NCT01475461|171544|P3|Treatment Period|Lack of Efficacy|0
40169|NCT01475461|171545|P2|Treatment Period|Lack of Efficacy|2
40170|NCT01475461|171546|P1|Treatment Period|Lack of Efficacy|0
40171|NCT01475461|171540|P7|Treatment Period|Protocol Violation|1
40172|NCT01475461|171541|P6|Treatment Period|Protocol Violation|0
40173|NCT01475461|171542|P5|Treatment Period|Protocol Violation|0
40174|NCT01475461|171543|P4|Treatment Period|Protocol Violation|0
40175|NCT01475461|171544|P3|Treatment Period|Protocol Violation|0
40176|NCT01475461|171545|P2|Treatment Period|Protocol Violation|1
40177|NCT01475461|171546|P1|Treatment Period|Protocol Violation|0
40178|NCT01475461|171540|P7|Treatment Period|Unspecified|0
40179|NCT01475461|171541|P6|Treatment Period|Unspecified|0
40180|NCT01475461|171542|P5|Treatment Period|Unspecified|0
40181|NCT01475461|171543|P4|Treatment Period|Unspecified|0
40182|NCT01475461|171544|P3|Treatment Period|Unspecified|0
40183|NCT01475461|171545|P2|Treatment Period|Unspecified|1
40184|NCT01475461|171546|P1|Treatment Period|Unspecified|0
40185|NCT01475461|171540|P7|Treatment Period|Withdrawal by Subject|0
40186|NCT01475461|171541|P6|Treatment Period|Withdrawal by Subject|2
40187|NCT01475461|171542|P5|Treatment Period|Withdrawal by Subject|2
40188|NCT01475461|171543|P4|Treatment Period|Withdrawal by Subject|0
40189|NCT01475461|171544|P3|Treatment Period|Withdrawal by Subject|2
40190|NCT01475461|171545|P2|Treatment Period|Withdrawal by Subject|2
40191|NCT01475461|171546|P1|Treatment Period|Withdrawal by Subject|0
40192|NCT01475461|171540|P7|Treatment Period|Lost to Follow-up|1
40193|NCT01475461|171541|P6|Treatment Period|Lost to Follow-up|2
40194|NCT01475461|171542|P5|Treatment Period|Lost to Follow-up|1
40195|NCT01475461|171543|P4|Treatment Period|Lost to Follow-up|3
40196|NCT01475461|171544|P3|Treatment Period|Lost to Follow-up|2
40197|NCT01475461|171545|P2|Treatment Period|Lost to Follow-up|3
40198|NCT01475461|171546|P1|Treatment Period|Lost to Follow-up|0
40199|NCT01475461|171540|P7|Treatment Period|Death|0
40200|NCT01475461|171541|P6|Treatment Period|Death|0
40201|NCT01475461|171542|P5|Treatment Period|Death|0
40202|NCT01475461|171543|P4|Treatment Period|Death|1
40203|NCT01475461|171544|P3|Treatment Period|Death|0
40204|NCT01475461|171545|P2|Treatment Period|Death|0
40205|NCT01475461|171546|P1|Treatment Period|Death|0
40206|NCT01475461|171540|P7|Run-in Period|Protocol Violation|0
40207|NCT01475461|171541|P6|Run-in Period|Protocol Violation|0
40208|NCT01475461|171542|P5|Run-in Period|Protocol Violation|0
40209|NCT01475461|171543|P4|Run-in Period|Protocol Violation|0
40210|NCT01475461|171544|P3|Run-in Period|Protocol Violation|0
40211|NCT01475461|171545|P2|Run-in Period|Protocol Violation|0
40212|NCT01475461|171546|P1|Run-in Period|Protocol Violation|4
40213|NCT01475461|171540|P7|Run-in Period|Unspecified|0
40214|NCT01475461|171541|P6|Run-in Period|Unspecified|0
40215|NCT01475461|171542|P5|Run-in Period|Unspecified|0
40216|NCT01475461|171543|P4|Run-in Period|Unspecified|0
40217|NCT01475461|171544|P3|Run-in Period|Unspecified|0
40218|NCT01475461|171545|P2|Run-in Period|Unspecified|0
40219|NCT01475461|171546|P1|Run-in Period|Unspecified|3
40220|NCT01475461|171540|P7|Run-in Period|Withdrawal by Subject|0
40221|NCT01475461|171541|P6|Run-in Period|Withdrawal by Subject|0
40222|NCT01475461|171542|P5|Run-in Period|Withdrawal by Subject|0
40223|NCT01475461|171543|P4|Run-in Period|Withdrawal by Subject|0
40224|NCT01475461|171544|P3|Run-in Period|Withdrawal by Subject|0
40225|NCT01475461|171545|P2|Run-in Period|Withdrawal by Subject|0
40226|NCT01475461|171546|P1|Run-in Period|Withdrawal by Subject|11
40227|NCT01475461|171540|P7|Run-in Period|Lost to Follow-up|0
40228|NCT01475461|171541|P6|Run-in Period|Lost to Follow-up|0
40229|NCT01475461|171542|P5|Run-in Period|Lost to Follow-up|0
40230|NCT01475461|171543|P4|Run-in Period|Lost to Follow-up|0
40231|NCT01475461|171544|P3|Run-in Period|Lost to Follow-up|0
40232|NCT01475461|171545|P2|Run-in Period|Lost to Follow-up|0
40233|NCT01475461|171546|P1|Run-in Period|Lost to Follow-up|7
40234|NCT01475461|171540|P7|Run-in Period|Not meet eligibility criteria|0
40235|NCT01475461|171541|P6|Run-in Period|Not meet eligibility criteria|0
40236|NCT01475461|171542|P5|Run-in Period|Not meet eligibility criteria|0
40237|NCT01475461|171543|P4|Run-in Period|Not meet eligibility criteria|0
40238|NCT01475461|171544|P3|Run-in Period|Not meet eligibility criteria|0
40239|NCT01475461|171545|P2|Run-in Period|Not meet eligibility criteria|0
40240|NCT01475461|171546|P1|Run-in Period|Not meet eligibility criteria|16
40241|NCT01475253|171670|P4|Randomized, Blinded Study|Lost to Follow-up|0
40242|NCT01475253|171671|P3|Randomized, Blinded Study|Lost to Follow-up|0
40243|NCT01475253|171672|P2|Randomized, Blinded Study|Lost to Follow-up|0
40244|NCT01475253|171673|P1|Randomized, Blinded Study|Lost to Follow-up|1
40245|NCT01475253|171670|P4|Randomized, Blinded Study|Withdrawal by Subject|0
40246|NCT01475253|171671|P3|Randomized, Blinded Study|Withdrawal by Subject|0
40247|NCT01475253|171672|P2|Randomized, Blinded Study|Withdrawal by Subject|1
40248|NCT01475253|171673|P1|Randomized, Blinded Study|Withdrawal by Subject|1
40249|NCT01475214|171702|P3|Overall Study|Withdrawal by Subject|1
40250|NCT01475214|171703|P2|Overall Study|Withdrawal by Subject|4
40251|NCT01475214|171704|P1|Overall Study|Withdrawal by Subject|2
40252|NCT01475214|171702|P3|Overall Study|Physician Decision|0
40253|NCT01475214|171703|P2|Overall Study|Physician Decision|0
40254|NCT01475214|171704|P1|Overall Study|Physician Decision|2
40255|NCT01475214|171702|P3|Overall Study|Lost to Follow-up|1
40256|NCT01475214|171703|P2|Overall Study|Lost to Follow-up|0
40257|NCT01475214|171704|P1|Overall Study|Lost to Follow-up|1
40258|NCT01475097|171729|P2|Overall Study|Protocol Violation|1
40259|NCT01475097|171730|P1|Overall Study|Protocol Violation|1
40260|NCT01475071|171738|P1|Overall Study|Lost to Follow-up|1
40261|NCT01475071|171738|P1|Overall Study|Withdrawal by Subject|6
40262|NCT01475071|171738|P1|Overall Study|Physician Decision|1
40263|NCT01474993|171748|P2|Overall Study|Adverse Event|1
40264|NCT01474993|171749|P1|Overall Study|Adverse Event|0
40265|NCT01474993|171748|P2|Overall Study|Lost to Follow-up|2
40266|NCT01474993|171749|P1|Overall Study|Lost to Follow-up|1
40267|NCT01474876|171787|P3|Overall Study|Investigator's decision and pt request|0
40268|NCT01474876|171788|P2|Overall Study|Investigator's decision and pt request|0
40269|NCT01474876|171789|P1|Overall Study|Investigator's decision and pt request|1
40270|NCT01474876|171787|P3|Overall Study|Patient's request|0
40271|NCT01474876|171788|P2|Overall Study|Patient's request|5
40272|NCT01474876|171789|P1|Overall Study|Patient's request|19
40273|NCT01474876|171787|P3|Overall Study|Investigator's decision|0
40274|NCT01474876|171788|P2|Overall Study|Investigator's decision|6
40275|NCT01474876|171789|P1|Overall Study|Investigator's decision|28
40276|NCT01474876|171787|P3|Overall Study|Lost to Follow-up|0
40277|NCT01474876|171788|P2|Overall Study|Lost to Follow-up|4
40278|NCT01474876|171789|P1|Overall Study|Lost to Follow-up|5
40279|NCT01474876|171787|P3|Overall Study|Serious Adverse Event|0
40280|NCT01474876|171788|P2|Overall Study|Serious Adverse Event|3
40281|NCT01474876|171789|P1|Overall Study|Serious Adverse Event|2
40282|NCT01474876|171787|P3|Overall Study|Adverse Event|0
40283|NCT01474876|171788|P2|Overall Study|Adverse Event|5
40284|NCT01474876|171789|P1|Overall Study|Adverse Event|11
40285|NCT01474772|171835|P2|Follow-up|AE not Related to Study Drug|1
40286|NCT01474772|171836|P1|Follow-up|AE not Related to Study Drug|0
40287|NCT01474772|171835|P2|Period 2|Reason not Specified|2
40288|NCT01474772|171836|P1|Period 2|Reason not Specified|0
40289|NCT01474772|171835|P2|Period 2|Lost to Follow-up|1
40290|NCT01474772|171836|P1|Period 2|Lost to Follow-up|1
40291|NCT01474772|171835|P2|Period 2|Withdrawal by Subject|4
40292|NCT01474772|171836|P1|Period 2|Withdrawal by Subject|3
40293|NCT01474772|171835|P2|Period 2|Lack of Efficacy|0
40294|NCT01474772|171836|P1|Period 2|Lack of Efficacy|1
40295|NCT01474772|171835|P2|Period 2|AE not Related to Study Drug|1
40296|NCT01474772|171836|P1|Period 2|AE not Related to Study Drug|4
40297|NCT01474772|171835|P2|Period 2|AE Related to Study Drug|1
40298|NCT01474772|171836|P1|Period 2|AE Related to Study Drug|0
40299|NCT01474772|171835|P2|Period 2|Death|1
40300|NCT01474772|171836|P1|Period 2|Death|0
40301|NCT01474772|171835|P2|Washout|Reason not Specified|1
40302|NCT01474772|171836|P1|Washout|Reason not Specified|0
40303|NCT01474772|171835|P2|Washout|Lost to Follow-up|1
40304|NCT01474772|171836|P1|Washout|Lost to Follow-up|0
40305|NCT01474772|171835|P2|Washout|Withdrawal by Subject|0
40306|NCT01474772|171836|P1|Washout|Withdrawal by Subject|1
40307|NCT01474772|171835|P2|Washout|AE not Related to Study Drug|0
40308|NCT01474772|171836|P1|Washout|AE not Related to Study Drug|2
40309|NCT01474772|171835|P2|Period 1|Reason not Specified|1
40310|NCT01474772|171836|P1|Period 1|Reason not Specified|1
40311|NCT01474772|171835|P2|Period 1|Lost to Follow-up|0
40312|NCT01474772|171836|P1|Period 1|Lost to Follow-up|1
40313|NCT01474772|171835|P2|Period 1|Withdrawal by Subject|1
40314|NCT01474772|171836|P1|Period 1|Withdrawal by Subject|3
40315|NCT01474772|171835|P2|Period 1|AE not Related to Study Drug|0
40316|NCT01474772|171836|P1|Period 1|AE not Related to Study Drug|1
40317|NCT01474772|171835|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
40318|NCT01474772|171836|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
40319|NCT01474681|171886|P4|Overall Study|Death|6
40320|NCT01474681|171887|P3|Overall Study|Death|2
40321|NCT01474681|171888|P2|Overall Study|Death|3
40322|NCT01474681|171889|P1|Overall Study|Death|0
40323|NCT01474551|171940|P1|Overall Study|Death|1
40324|NCT01474538|171946|P2|Treatment Period 2|Protocol Violation|0
40325|NCT01474538|171947|P1|Treatment Period 2|Protocol Violation|1
40326|NCT01474538|171946|P2|Treatment Period 2|Physician Decision|1
40327|NCT01474538|171947|P1|Treatment Period 2|Physician Decision|0
40328|NCT01474538|171946|P2|Treatment Period 2|Sponsor decision|0
40329|NCT01474538|171947|P1|Treatment Period 2|Sponsor decision|1
40330|NCT01474538|171946|P2|Treatment Period 2|Withdrawal by Subject|0
40331|NCT01474538|171947|P1|Treatment Period 2|Withdrawal by Subject|2
40332|NCT01474538|171946|P2|Treatment Period 2|Adverse Event|1
40333|NCT01474538|171947|P1|Treatment Period 2|Adverse Event|1
40334|NCT01474538|171946|P2|Treatment Period 2|Death|0
40335|NCT01474538|171947|P1|Treatment Period 2|Death|1
40336|NCT01474538|171946|P2|Treatment Period 1|Protocol Violation|1
40337|NCT01474538|171947|P1|Treatment Period 1|Protocol Violation|0
40338|NCT01474538|171946|P2|Treatment Period 1|Withdrawal by Subject|3
40339|NCT01474538|171947|P1|Treatment Period 1|Withdrawal by Subject|1
40340|NCT01474538|171946|P2|Treatment Period 1|Physician Decision|0
40341|NCT01474538|171947|P1|Treatment Period 1|Physician Decision|1
40342|NCT01474538|171946|P2|Treatment Period 1|Death|0
40343|NCT01474538|171947|P1|Treatment Period 1|Death|1
40344|NCT01474512|171964|P10|Maintenance Period|Treated but Discontinued in Induction|0
40345|NCT01474512|171965|P9|Maintenance Period|Treated but Discontinued in Induction|0
40346|NCT01474512|171966|P8|Maintenance Period|Treated but Discontinued in Induction|0
40347|NCT01474512|171967|P7|Maintenance Period|Treated but Discontinued in Induction|0
40348|NCT01474512|171968|P6|Maintenance Period|Treated but Discontinued in Induction|0
40349|NCT01474512|171969|P5|Maintenance Period|Treated but Discontinued in Induction|1
40350|NCT01474512|171970|P4|Maintenance Period|Treated but Discontinued in Induction|0
40351|NCT01474512|171971|P3|Maintenance Period|Treated but Discontinued in Induction|0
40352|NCT01474512|171972|P2|Maintenance Period|Treated but Discontinued in Induction|0
40353|NCT01474512|171973|P1|Maintenance Period|Treated but Discontinued in Induction|0
40354|NCT01474512|171964|P10|Maintenance Period|Protocol Violation|1
40355|NCT01474512|171965|P9|Maintenance Period|Protocol Violation|0
40356|NCT01474512|171966|P8|Maintenance Period|Protocol Violation|1
40357|NCT01474512|171967|P7|Maintenance Period|Protocol Violation|0
40358|NCT01474512|171968|P6|Maintenance Period|Protocol Violation|0
40359|NCT01474512|171969|P5|Maintenance Period|Protocol Violation|0
40360|NCT01474512|171970|P4|Maintenance Period|Protocol Violation|1
40361|NCT01474512|171971|P3|Maintenance Period|Protocol Violation|0
40362|NCT01474512|171972|P2|Maintenance Period|Protocol Violation|0
40363|NCT01474512|171973|P1|Maintenance Period|Protocol Violation|0
40364|NCT01474512|171964|P10|Maintenance Period|Lack of Efficacy|12
40365|NCT01474512|171965|P9|Maintenance Period|Lack of Efficacy|11
40366|NCT01474512|171966|P8|Maintenance Period|Lack of Efficacy|11
40367|NCT01474512|171967|P7|Maintenance Period|Lack of Efficacy|0
40368|NCT01474512|171968|P6|Maintenance Period|Lack of Efficacy|0
40369|NCT01474512|171969|P5|Maintenance Period|Lack of Efficacy|0
40370|NCT01474512|171970|P4|Maintenance Period|Lack of Efficacy|1
40371|NCT01474512|171971|P3|Maintenance Period|Lack of Efficacy|0
40372|NCT01474512|171972|P2|Maintenance Period|Lack of Efficacy|0
40373|NCT01474512|171973|P1|Maintenance Period|Lack of Efficacy|0
40374|NCT01474512|171964|P10|Maintenance Period|Clinical Relapse|0
40375|NCT01474512|171965|P9|Maintenance Period|Clinical Relapse|0
40376|NCT01474512|171966|P8|Maintenance Period|Clinical Relapse|0
40377|NCT01474512|171967|P7|Maintenance Period|Clinical Relapse|0
40378|NCT01474512|171968|P6|Maintenance Period|Clinical Relapse|0
40379|NCT01474512|171969|P5|Maintenance Period|Clinical Relapse|0
40380|NCT01474512|171970|P4|Maintenance Period|Clinical Relapse|1
40381|NCT01474512|171971|P3|Maintenance Period|Clinical Relapse|0
40382|NCT01474512|171972|P2|Maintenance Period|Clinical Relapse|0
40383|NCT01474512|171973|P1|Maintenance Period|Clinical Relapse|0
40384|NCT01474512|171964|P10|Maintenance Period|Investigator Decision|0
40385|NCT01474512|171965|P9|Maintenance Period|Investigator Decision|0
40386|NCT01474512|171966|P8|Maintenance Period|Investigator Decision|2
40387|NCT01474512|171967|P7|Maintenance Period|Investigator Decision|0
40388|NCT01474512|171968|P6|Maintenance Period|Investigator Decision|1
40389|NCT01474512|171969|P5|Maintenance Period|Investigator Decision|0
40390|NCT01474512|171970|P4|Maintenance Period|Investigator Decision|0
40391|NCT01474512|171971|P3|Maintenance Period|Investigator Decision|0
40392|NCT01474512|171972|P2|Maintenance Period|Investigator Decision|0
40393|NCT01474512|171973|P1|Maintenance Period|Investigator Decision|0
40394|NCT01474512|171964|P10|Maintenance Period|Death|0
40395|NCT01474512|171965|P9|Maintenance Period|Death|0
40396|NCT01474512|171966|P8|Maintenance Period|Death|0
40397|NCT01474512|171967|P7|Maintenance Period|Death|0
40398|NCT01474512|171968|P6|Maintenance Period|Death|2
40399|NCT01474512|171969|P5|Maintenance Period|Death|0
40400|NCT01474512|171970|P4|Maintenance Period|Death|0
40401|NCT01474512|171971|P3|Maintenance Period|Death|0
40402|NCT01474512|171972|P2|Maintenance Period|Death|0
40403|NCT01474512|171973|P1|Maintenance Period|Death|0
40404|NCT01474512|171964|P10|Maintenance Period|Lost to Follow-up|1
40405|NCT01474512|171965|P9|Maintenance Period|Lost to Follow-up|1
40406|NCT01474512|171966|P8|Maintenance Period|Lost to Follow-up|2
40407|NCT01474512|171967|P7|Maintenance Period|Lost to Follow-up|0
40408|NCT01474512|171968|P6|Maintenance Period|Lost to Follow-up|0
40409|NCT01474512|171969|P5|Maintenance Period|Lost to Follow-up|3
40410|NCT01474512|171970|P4|Maintenance Period|Lost to Follow-up|3
40411|NCT01474512|171971|P3|Maintenance Period|Lost to Follow-up|0
40412|NCT01474512|171972|P2|Maintenance Period|Lost to Follow-up|0
40413|NCT01474512|171973|P1|Maintenance Period|Lost to Follow-up|0
40414|NCT01474512|171964|P10|Maintenance Period|Withdrawal by Subject|1
40415|NCT01474512|171965|P9|Maintenance Period|Withdrawal by Subject|3
40416|NCT01474512|171966|P8|Maintenance Period|Withdrawal by Subject|6
40417|NCT01474512|171967|P7|Maintenance Period|Withdrawal by Subject|1
40418|NCT01474512|171968|P6|Maintenance Period|Withdrawal by Subject|3
40419|NCT01474512|171969|P5|Maintenance Period|Withdrawal by Subject|2
40420|NCT01474512|171970|P4|Maintenance Period|Withdrawal by Subject|6
40421|NCT01474512|171971|P3|Maintenance Period|Withdrawal by Subject|0
40422|NCT01474512|171972|P2|Maintenance Period|Withdrawal by Subject|0
40423|NCT01474512|171973|P1|Maintenance Period|Withdrawal by Subject|0
40424|NCT01474512|171964|P10|Maintenance Period|Adverse Event|3
40425|NCT01474512|171965|P9|Maintenance Period|Adverse Event|1
40426|NCT01474512|171966|P8|Maintenance Period|Adverse Event|19
40427|NCT01474512|171967|P7|Maintenance Period|Adverse Event|0
40428|NCT01474512|171968|P6|Maintenance Period|Adverse Event|7
40429|NCT01474512|171969|P5|Maintenance Period|Adverse Event|2
40430|NCT01474512|171970|P4|Maintenance Period|Adverse Event|4
40431|NCT01474512|171971|P3|Maintenance Period|Adverse Event|0
40432|NCT01474512|171972|P2|Maintenance Period|Adverse Event|0
40433|NCT01474512|171973|P1|Maintenance Period|Adverse Event|0
40434|NCT01474512|171964|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
40435|NCT01474512|171965|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
40436|NCT01474512|171966|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
40437|NCT01474512|171967|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
40438|NCT01474512|171968|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
40439|NCT01474512|171969|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
40440|NCT01474512|171970|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
40441|NCT01474512|171971|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
40442|NCT01474512|171972|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
40443|NCT01474512|171973|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
40444|NCT01474512|171964|P10|Induction Period|Lost to Follow-up|0
40445|NCT01474512|171965|P9|Induction Period|Lost to Follow-up|0
40446|NCT01474512|171966|P8|Induction Period|Lost to Follow-up|0
40447|NCT01474512|171967|P7|Induction Period|Lost to Follow-up|0
40448|NCT01474512|171968|P6|Induction Period|Lost to Follow-up|0
40449|NCT01474512|171969|P5|Induction Period|Lost to Follow-up|0
40450|NCT01474512|171970|P4|Induction Period|Lost to Follow-up|0
40451|NCT01474512|171971|P3|Induction Period|Lost to Follow-up|2
40452|NCT01474512|171972|P2|Induction Period|Lost to Follow-up|0
40453|NCT01474512|171973|P1|Induction Period|Lost to Follow-up|1
40454|NCT01474512|171964|P10|Induction Period|Sponsor Decision|0
40455|NCT01474512|171965|P9|Induction Period|Sponsor Decision|0
40456|NCT01474512|171966|P8|Induction Period|Sponsor Decision|0
40457|NCT01474512|171967|P7|Induction Period|Sponsor Decision|0
40458|NCT01474512|171968|P6|Induction Period|Sponsor Decision|0
40459|NCT01474512|171969|P5|Induction Period|Sponsor Decision|0
40460|NCT01474512|171970|P4|Induction Period|Sponsor Decision|0
40461|NCT01474512|171971|P3|Induction Period|Sponsor Decision|1
40462|NCT01474512|171972|P2|Induction Period|Sponsor Decision|1
40463|NCT01474512|171973|P1|Induction Period|Sponsor Decision|1
40464|NCT01474512|171964|P10|Induction Period|Protocol Violation|0
40465|NCT01474512|171965|P9|Induction Period|Protocol Violation|0
40466|NCT01474512|171966|P8|Induction Period|Protocol Violation|0
40467|NCT01474512|171967|P7|Induction Period|Protocol Violation|0
40468|NCT01474512|171968|P6|Induction Period|Protocol Violation|0
40469|NCT01474512|171969|P5|Induction Period|Protocol Violation|0
40470|NCT01474512|171970|P4|Induction Period|Protocol Violation|0
40471|NCT01474512|171971|P3|Induction Period|Protocol Violation|0
40472|NCT01474512|171972|P2|Induction Period|Protocol Violation|6
40473|NCT01474512|171973|P1|Induction Period|Protocol Violation|3
40474|NCT01474512|171964|P10|Induction Period|Withdrawal by Subject|0
40475|NCT01474512|171965|P9|Induction Period|Withdrawal by Subject|0
40476|NCT01474512|171966|P8|Induction Period|Withdrawal by Subject|0
40477|NCT01474512|171967|P7|Induction Period|Withdrawal by Subject|0
40478|NCT01474512|171968|P6|Induction Period|Withdrawal by Subject|0
40479|NCT01474512|171969|P5|Induction Period|Withdrawal by Subject|0
40480|NCT01474512|171970|P4|Induction Period|Withdrawal by Subject|0
40481|NCT01474512|171971|P3|Induction Period|Withdrawal by Subject|5
40482|NCT01474512|171972|P2|Induction Period|Withdrawal by Subject|6
40483|NCT01474512|171973|P1|Induction Period|Withdrawal by Subject|6
40484|NCT01474512|171964|P10|Induction Period|Lack of Efficacy|0
40485|NCT01474512|171965|P9|Induction Period|Lack of Efficacy|0
40486|NCT01474512|171966|P8|Induction Period|Lack of Efficacy|0
40487|NCT01474512|171967|P7|Induction Period|Lack of Efficacy|0
40488|NCT01474512|171968|P6|Induction Period|Lack of Efficacy|0
40489|NCT01474512|171969|P5|Induction Period|Lack of Efficacy|0
40490|NCT01474512|171970|P4|Induction Period|Lack of Efficacy|0
40491|NCT01474512|171971|P3|Induction Period|Lack of Efficacy|0
40492|NCT01474512|171972|P2|Induction Period|Lack of Efficacy|1
40493|NCT01474512|171973|P1|Induction Period|Lack of Efficacy|7
40494|NCT01474512|171964|P10|Induction Period|Adverse Event|0
40495|NCT01474512|171965|P9|Induction Period|Adverse Event|0
40496|NCT01474512|171966|P8|Induction Period|Adverse Event|0
40497|NCT01474512|171967|P7|Induction Period|Adverse Event|0
40498|NCT01474512|171968|P6|Induction Period|Adverse Event|0
40499|NCT01474512|171969|P5|Induction Period|Adverse Event|0
40500|NCT01474512|171970|P4|Induction Period|Adverse Event|0
40501|NCT01474512|171971|P3|Induction Period|Adverse Event|10
40502|NCT01474512|171972|P2|Induction Period|Adverse Event|10
40503|NCT01474512|171973|P1|Induction Period|Adverse Event|6
40504|NCT01474434|172042|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
40505|NCT01474434|172043|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
40506|NCT01474434|172044|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
40507|NCT01474434|172045|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
40508|NCT01474434|172042|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
40509|NCT01474434|172043|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
40510|NCT01474434|172044|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
40511|NCT01474434|172045|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
40512|NCT01474434|172042|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
40513|NCT01474434|172043|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
40514|NCT01474434|172044|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
40515|NCT01474434|172045|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
40516|NCT01474317|172087|P1|Overall Study|Subject ineligible for study|1
40517|NCT01474317|172087|P1|Overall Study|Adverse Event|1
40518|NCT01474291|172096|P1|Overall Study|Death|2
40519|NCT01474291|172096|P1|Overall Study|No Reason Reported|10
40520|NCT01474291|172096|P1|Overall Study|Patient No Longer Wanted to Participate|12
40521|NCT01474291|172096|P1|Overall Study|Lost to Follow-up|29
40522|NCT01474291|172096|P1|Overall Study|Adverse Event|53
40523|NCT01474291|172096|P1|Overall Study|Lack of Treatment Efficacy|88
40524|NCT01474291|172096|P1|Overall Study|Not Evaluable for Efficacy|26
40525|NCT01474239|172140|P2|Overall Study|Withdrawal for Economic Reason|0
40526|NCT01474239|172141|P1|Overall Study|Withdrawal for Economic Reason|1
40527|NCT01474239|172140|P2|Overall Study|Clinical Disease Progression|1
40528|NCT01474239|172141|P1|Overall Study|Clinical Disease Progression|7
40529|NCT01474239|172140|P2|Overall Study|Death|1
40530|NCT01474239|172141|P1|Overall Study|Death|1
40531|NCT01474239|172140|P2|Overall Study|Withdrawal by Subject|2
40532|NCT01474239|172141|P1|Overall Study|Withdrawal by Subject|1
40533|NCT01474239|172140|P2|Overall Study|Adverse Event|3
40534|NCT01474239|172141|P1|Overall Study|Adverse Event|12
40535|NCT01474239|172140|P2|Overall Study|Disease Progression|25
40536|NCT01474239|172141|P1|Overall Study|Disease Progression|37
40537|NCT01473953|172335|P5|Overall Study|Unspecified|0
40538|NCT01473953|172336|P4|Overall Study|Unspecified|0
40539|NCT01473953|172337|P3|Overall Study|Unspecified|0
40540|NCT01473953|172338|P2|Overall Study|Unspecified|0
40541|NCT01473953|172339|P1|Overall Study|Unspecified|1
40542|NCT01473836|172381|P1|Overall Study|Does not meet entrance criteria|1
40543|NCT01473836|172381|P1|Overall Study|Lack of Efficacy|1
40544|NCT01473836|172381|P1|Overall Study|Adverse Event|4
40545|NCT01473758|172392|P4|Cycle 2|Adverse Event|0
40546|NCT01473758|172393|P3|Cycle 2|Adverse Event|5
40547|NCT01473758|172394|P2|Cycle 2|Adverse Event|0
40548|NCT01473758|172395|P1|Cycle 2|Adverse Event|0
40549|NCT01473758|172392|P4|Cycle 1|Withdrawal by Subject|0
40550|NCT01473758|172393|P3|Cycle 1|Withdrawal by Subject|0
40551|NCT01473758|172394|P2|Cycle 1|Withdrawal by Subject|1
40552|NCT01473758|172395|P1|Cycle 1|Withdrawal by Subject|1
40553|NCT01473758|172392|P4|Cycle 1|Adverse Event|0
40554|NCT01473758|172393|P3|Cycle 1|Adverse Event|0
40555|NCT01473758|172394|P2|Cycle 1|Adverse Event|2
40556|NCT01473758|172395|P1|Cycle 1|Adverse Event|10
40557|NCT01473602|172532|P2|Overall Study|Physician Decision|0
40558|NCT01473602|172533|P1|Overall Study|Physician Decision|1
40559|NCT01473602|172532|P2|Overall Study|Withdrawal by Subject|4
40560|NCT01473602|172533|P1|Overall Study|Withdrawal by Subject|5
40561|NCT01473602|172532|P2|Overall Study|Lost to Follow-up|1
40562|NCT01473602|172533|P1|Overall Study|Lost to Follow-up|1
40563|NCT01473602|172532|P2|Overall Study|Death|1
40564|NCT01473602|172533|P1|Overall Study|Death|0
40565|NCT01473602|172532|P2|Overall Study|Adverse Event|2
40566|NCT01473602|172533|P1|Overall Study|Adverse Event|1
40567|NCT01473589|172569|P2|Overall Study|Entry criteria not met|1
40568|NCT01473589|172570|P1|Overall Study|Entry criteria not met|0
40569|NCT01473589|172569|P2|Overall Study|Physician Decision|1
40570|NCT01473589|172570|P1|Overall Study|Physician Decision|0
40571|NCT01473589|172569|P2|Overall Study|Withdrawal by Subject|11
40572|NCT01473589|172570|P1|Overall Study|Withdrawal by Subject|5
40573|NCT01473589|172569|P2|Overall Study|Protocol Violation|0
40574|NCT01473589|172570|P1|Overall Study|Protocol Violation|1
40575|NCT01473589|172569|P2|Overall Study|Lost to Follow-up|2
40576|NCT01473589|172570|P1|Overall Study|Lost to Follow-up|2
40577|NCT01473589|172569|P2|Overall Study|Death|0
40578|NCT01473589|172570|P1|Overall Study|Death|2
40579|NCT01473589|172569|P2|Overall Study|Adverse Event|1
40580|NCT01473589|172570|P1|Overall Study|Adverse Event|1
40581|NCT01473563|172604|P1|Overall Study|Lost to FU post tx discontinuation|1
40582|NCT01473524|172626|P3|Overall Study|Withdrawal by Subject|1
40583|NCT01473524|172627|P2|Overall Study|Withdrawal by Subject|1
40584|NCT01473524|172628|P1|Overall Study|Withdrawal by Subject|2
40585|NCT01473524|172626|P3|Overall Study|Death|0
40586|NCT01473524|172627|P2|Overall Study|Death|0
40587|NCT01473524|172628|P1|Overall Study|Death|1
40588|NCT01473524|172626|P3|Overall Study|Adverse Event|2
40589|NCT01473524|172627|P2|Overall Study|Adverse Event|8
40590|NCT01473524|172628|P1|Overall Study|Adverse Event|4
40591|NCT01473394|172661|P2|Overall Study|Lost to Follow-up|11
40592|NCT01473394|172662|P1|Overall Study|Lost to Follow-up|9
40593|NCT01473394|172661|P2|Overall Study|Withdrew Consent|10
40594|NCT01473394|172662|P1|Overall Study|Withdrew Consent|12
40595|NCT01473394|172661|P2|Overall Study|Protocol Violation|5
40596|NCT01473394|172662|P1|Overall Study|Protocol Violation|7
40597|NCT01473394|172661|P2|Overall Study|Insufficient Therapeutic Response|1
40598|NCT01473394|172662|P1|Overall Study|Insufficient Therapeutic Response|4
40599|NCT01473394|172661|P2|Overall Study|Adverse Event|16
40600|NCT01473394|172662|P1|Overall Study|Adverse Event|13
40601|NCT01473381|172676|P4|Overall Study|Other Reasons|3
40602|NCT01473381|172677|P3|Overall Study|Other Reasons|1
40603|NCT01473381|172678|P2|Overall Study|Other Reasons|0
40604|NCT01473381|172679|P1|Overall Study|Other Reasons|0
40605|NCT01473381|172676|P4|Overall Study|Lost to Follow-up|23
40606|NCT01473381|172677|P3|Overall Study|Lost to Follow-up|35
40607|NCT01473381|172678|P2|Overall Study|Lost to Follow-up|28
40608|NCT01473381|172679|P1|Overall Study|Lost to Follow-up|25
40609|NCT01473381|172676|P4|Overall Study|Withdrawal of Consent|26
40610|NCT01473381|172677|P3|Overall Study|Withdrawal of Consent|20
40611|NCT01473381|172678|P2|Overall Study|Withdrawal of Consent|21
40612|NCT01473381|172679|P1|Overall Study|Withdrawal of Consent|20
40613|NCT01473381|172676|P4|Overall Study|Protocol Violation|17
40614|NCT01473381|172677|P3|Overall Study|Protocol Violation|19
40615|NCT01473381|172678|P2|Overall Study|Protocol Violation|23
40616|NCT01473381|172679|P1|Overall Study|Protocol Violation|17
40617|NCT01473381|172676|P4|Overall Study|Insufficient Therapeutic Response|3
40618|NCT01473381|172677|P3|Overall Study|Insufficient Therapeutic Response|2
40619|NCT01473381|172678|P2|Overall Study|Insufficient Therapeutic Response|1
40620|NCT01473381|172679|P1|Overall Study|Insufficient Therapeutic Response|10
40621|NCT01473381|172676|P4|Overall Study|Adverse Event|17
40622|NCT01473381|172677|P3|Overall Study|Adverse Event|25
40623|NCT01473381|172678|P2|Overall Study|Adverse Event|20
40624|NCT01473381|172679|P1|Overall Study|Adverse Event|8
40625|NCT01472939|172763|P4|Overall Study|Withdrawal by Subject|4
40626|NCT01472939|172764|P3|Overall Study|Withdrawal by Subject|1
40627|NCT01472939|172765|P2|Overall Study|Withdrawal by Subject|3
40628|NCT01472939|172766|P1|Overall Study|Withdrawal by Subject|9
40629|NCT01472939|172763|P4|Overall Study|Protocol Violation|1
40630|NCT01472939|172764|P3|Overall Study|Protocol Violation|0
40631|NCT01472939|172765|P2|Overall Study|Protocol Violation|3
40632|NCT01472939|172766|P1|Overall Study|Protocol Violation|3
40633|NCT01472939|172763|P4|Overall Study|Withdrawal By PI|0
40634|NCT01472939|172764|P3|Overall Study|Withdrawal By PI|0
40635|NCT01472939|172765|P2|Overall Study|Withdrawal By PI|0
40636|NCT01472939|172766|P1|Overall Study|Withdrawal By PI|1
40637|NCT01472939|172763|P4|Overall Study|Prohibited Medication|0
40638|NCT01472939|172764|P3|Overall Study|Prohibited Medication|0
40639|NCT01472939|172765|P2|Overall Study|Prohibited Medication|1
40640|NCT01472939|172766|P1|Overall Study|Prohibited Medication|0
40641|NCT01472939|172763|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
40642|NCT01472939|172764|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
40643|NCT01472939|172765|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
40644|NCT01472939|172766|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
40645|NCT01472939|172763|P4|Overall Study|Lost to Follow-up|0
40646|NCT01472939|172764|P3|Overall Study|Lost to Follow-up|2
40647|NCT01472939|172765|P2|Overall Study|Lost to Follow-up|0
40648|NCT01472939|172766|P1|Overall Study|Lost to Follow-up|3
40649|NCT01472939|172763|P4|Overall Study|Lack of Efficacy|1
40650|NCT01472939|172764|P3|Overall Study|Lack of Efficacy|0
40651|NCT01472939|172765|P2|Overall Study|Lack of Efficacy|0
40652|NCT01472939|172766|P1|Overall Study|Lack of Efficacy|1
40653|NCT01472939|172763|P4|Overall Study|Adverse Event|14
40654|NCT01472939|172764|P3|Overall Study|Adverse Event|7
40655|NCT01472939|172765|P2|Overall Study|Adverse Event|7
40656|NCT01472939|172766|P1|Overall Study|Adverse Event|3
40657|NCT01472835|172810|P2|Overall Study|Lost to Follow-up|0
40658|NCT01472835|172811|P1|Overall Study|Lost to Follow-up|2
40659|NCT01472380|172866|P1|1 Day Period Between Dosing|Protocol Violation|1
40660|NCT01472380|172866|P1|Efavirenz Alone|Withdrawal by Subject|1
40661|NCT01472341|172877|P1|Overall Study|Death|9
40662|NCT01472341|172877|P1|Overall Study|Laboratory parameters unavailable|25
40663|NCT01472341|172877|P1|Overall Study|Lost to Follow-up|52
40664|NCT01472341|172877|P1|Overall Study|Withdrawal by Subject|39
40665|NCT01472341|172877|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
40666|NCT01472341|172877|P1|Overall Study|Started insulin therapy|55
40667|NCT01472289|172883|P1|Overall Study|Death|2
40668|NCT01472185|172895|P2|Overall Study|Subject Withdrew Consent|3
40669|NCT01472185|172896|P1|Overall Study|Subject Withdrew Consent|6
40670|NCT01472185|172895|P2|Overall Study|Subject Noncompliance|15
40671|NCT01472185|172896|P1|Overall Study|Subject Noncompliance|8
40672|NCT01472185|172895|P2|Overall Study|Protocol Violation|1
40673|NCT01472185|172896|P1|Overall Study|Protocol Violation|5
40674|NCT01472185|172895|P2|Overall Study|Lost to Follow-up|1
40675|NCT01472185|172896|P1|Overall Study|Lost to Follow-up|4
40676|NCT01472185|172895|P2|Overall Study|Investigator’s Discretion|1
40677|NCT01472185|172896|P1|Overall Study|Investigator’s Discretion|3
40678|NCT01472185|172895|P2|Overall Study|Hyperglycemia|2
40679|NCT01472185|172896|P1|Overall Study|Hyperglycemia|5
40680|NCT01472185|172895|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
40681|NCT01472185|172896|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
40682|NCT01472185|172895|P2|Overall Study|Randomized but Not Treated|1
40683|NCT01472185|172896|P1|Overall Study|Randomized but Not Treated|0
40684|NCT01471782|172916|P6|Overall Study|Death|1
40685|NCT01471782|172917|P5|Overall Study|Death|0
40686|NCT01471782|172918|P4|Overall Study|Death|0
40687|NCT01471782|172919|P3|Overall Study|Death|0
40688|NCT01471782|172920|P2|Overall Study|Death|0
40689|NCT01471782|172921|P1|Overall Study|Death|0
40690|NCT01471782|172916|P6|Overall Study|Withdrawal by Parent/Guardian|0
40691|NCT01471782|172917|P5|Overall Study|Withdrawal by Parent/Guardian|1
40692|NCT01471782|172918|P4|Overall Study|Withdrawal by Parent/Guardian|0
40693|NCT01471782|172919|P3|Overall Study|Withdrawal by Parent/Guardian|0
40694|NCT01471782|172920|P2|Overall Study|Withdrawal by Parent/Guardian|0
40695|NCT01471782|172921|P1|Overall Study|Withdrawal by Parent/Guardian|0
40696|NCT01471782|172916|P6|Overall Study|Physician Decision|8
40697|NCT01471782|172917|P5|Overall Study|Physician Decision|3
40698|NCT01471782|172918|P4|Overall Study|Physician Decision|0
40699|NCT01471782|172919|P3|Overall Study|Physician Decision|0
40700|NCT01471782|172920|P2|Overall Study|Physician Decision|0
40701|NCT01471782|172921|P1|Overall Study|Physician Decision|0
40702|NCT01471782|172916|P6|Overall Study|Disease Relapse|1
40703|NCT01471782|172917|P5|Overall Study|Disease Relapse|2
40704|NCT01471782|172918|P4|Overall Study|Disease Relapse|1
40705|NCT01471782|172919|P3|Overall Study|Disease Relapse|0
40706|NCT01471782|172920|P2|Overall Study|Disease Relapse|0
40707|NCT01471782|172921|P1|Overall Study|Disease Relapse|0
40708|NCT01471782|172916|P6|Overall Study|Change of Chemotherapy|4
40709|NCT01471782|172917|P5|Overall Study|Change of Chemotherapy|1
40710|NCT01471782|172918|P4|Overall Study|Change of Chemotherapy|0
40711|NCT01471782|172919|P3|Overall Study|Change of Chemotherapy|0
40712|NCT01471782|172920|P2|Overall Study|Change of Chemotherapy|1
40713|NCT01471782|172921|P1|Overall Study|Change of Chemotherapy|1
40714|NCT01471782|172916|P6|Overall Study|Other|5
40715|NCT01471782|172917|P5|Overall Study|Other|6
40716|NCT01471782|172918|P4|Overall Study|Other|1
40717|NCT01471782|172919|P3|Overall Study|Other|1
40718|NCT01471782|172920|P2|Overall Study|Other|0
40719|NCT01471782|172921|P1|Overall Study|Other|0
40720|NCT01471782|172916|P6|Overall Study|Adverse Event|1
40721|NCT01471782|172917|P5|Overall Study|Adverse Event|3
40722|NCT01471782|172918|P4|Overall Study|Adverse Event|2
40723|NCT01471782|172919|P3|Overall Study|Adverse Event|2
40724|NCT01471782|172920|P2|Overall Study|Adverse Event|1
40725|NCT01471782|172921|P1|Overall Study|Adverse Event|1
40726|NCT01471782|172916|P6|Overall Study|Lack of Efficacy|18
40727|NCT01471782|172917|P5|Overall Study|Lack of Efficacy|5
40728|NCT01471782|172918|P4|Overall Study|Lack of Efficacy|1
40729|NCT01471782|172919|P3|Overall Study|Lack of Efficacy|1
40730|NCT01471782|172920|P2|Overall Study|Lack of Efficacy|2
40731|NCT01471782|172921|P1|Overall Study|Lack of Efficacy|1
40732|NCT01471782|172916|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
40733|NCT01471782|172917|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
40734|NCT01471782|172918|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
40735|NCT01471782|172919|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
40736|NCT01471782|172920|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
40737|NCT01471782|172921|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
40738|NCT01471691|172975|P2|Overall Study|Lack of Efficacy|1
40739|NCT01471691|172976|P1|Overall Study|Lack of Efficacy|0
40740|NCT01471574|172990|P4|Follow-up Period|Follow-up no longer required|0
40741|NCT01471574|172991|P3|Follow-up Period|Follow-up no longer required|0
40742|NCT01471574|172992|P2|Follow-up Period|Follow-up no longer required|1
40743|NCT01471574|172993|P1|Follow-up Period|Follow-up no longer required|0
40744|NCT01471574|172990|P4|Follow-up Period|Death|0
40745|NCT01471574|172991|P3|Follow-up Period|Death|1
40746|NCT01471574|172992|P2|Follow-up Period|Death|0
40747|NCT01471574|172993|P1|Follow-up Period|Death|0
40748|NCT01471574|172990|P4|Follow-up Period|Lost to Follow-up|2
40749|NCT01471574|172991|P3|Follow-up Period|Lost to Follow-up|3
40750|NCT01471574|172992|P2|Follow-up Period|Lost to Follow-up|1
40751|NCT01471574|172993|P1|Follow-up Period|Lost to Follow-up|4
40752|NCT01471574|172990|P4|Follow-up Period|Withdrawal by Subject|1
40753|NCT01471574|172991|P3|Follow-up Period|Withdrawal by Subject|3
40754|NCT01471574|172992|P2|Follow-up Period|Withdrawal by Subject|0
40755|NCT01471574|172993|P1|Follow-up Period|Withdrawal by Subject|3
40756|NCT01471574|172990|P4|Treatment Period|Not specified|0
40757|NCT01471574|172991|P3|Treatment Period|Not specified|0
40758|NCT01471574|172992|P2|Treatment Period|Not specified|0
40759|NCT01471574|172993|P1|Treatment Period|Not specified|1
40760|NCT01471574|172990|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
40761|NCT01471574|172991|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
40762|NCT01471574|172992|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
40763|NCT01471574|172993|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
40764|NCT01471574|172990|P4|Treatment Period|Lost to Follow-up|0
40765|NCT01471574|172991|P3|Treatment Period|Lost to Follow-up|2
40766|NCT01471574|172992|P2|Treatment Period|Lost to Follow-up|2
40767|NCT01471574|172993|P1|Treatment Period|Lost to Follow-up|1
40768|NCT01471574|172990|P4|Treatment Period|Patient Requested Discontinue Study drug|1
40769|NCT01471574|172991|P3|Treatment Period|Patient Requested Discontinue Study drug|1
40770|NCT01471574|172992|P2|Treatment Period|Patient Requested Discontinue Study drug|0
40771|NCT01471574|172993|P1|Treatment Period|Patient Requested Discontinue Study drug|4
40772|NCT01471574|172990|P4|Treatment Period|Withdrawal by Subject|0
40773|NCT01471574|172991|P3|Treatment Period|Withdrawal by Subject|1
40774|NCT01471574|172992|P2|Treatment Period|Withdrawal by Subject|1
40775|NCT01471574|172993|P1|Treatment Period|Withdrawal by Subject|5
40776|NCT01471574|172990|P4|Treatment Period|Adverse Event|1
40777|NCT01471574|172991|P3|Treatment Period|Adverse Event|6
40778|NCT01471574|172992|P2|Treatment Period|Adverse Event|3
40779|NCT01471574|172993|P1|Treatment Period|Adverse Event|7
40780|NCT01471574|172990|P4|Treatment Period|Lack of Efficacy|1
40781|NCT01471574|172991|P3|Treatment Period|Lack of Efficacy|14
40782|NCT01471574|172992|P2|Treatment Period|Lack of Efficacy|4
40783|NCT01471574|172993|P1|Treatment Period|Lack of Efficacy|12
40784|NCT01471379|173025|P3|Overall Study|Study terminated|0
40785|NCT01471379|173026|P2|Overall Study|Study terminated|1
40786|NCT01471379|173027|P1|Overall Study|Study terminated|0
40787|NCT01471379|173025|P3|Overall Study|Adverse Event|0
40788|NCT01471379|173026|P2|Overall Study|Adverse Event|0
40789|NCT01471379|173027|P1|Overall Study|Adverse Event|1
40790|NCT01471353|173047|P1|Overall Study|remain on study|3
40791|NCT01471197|173055|P2|Overall Study|Study Drug Toxicity|0
40792|NCT01471197|173056|P1|Overall Study|Study Drug Toxicity|1
40793|NCT01471197|173055|P2|Overall Study|Death|0
40794|NCT01471197|173056|P1|Overall Study|Death|1
40795|NCT01471197|173055|P2|Overall Study|Disease Progression|2
40796|NCT01471197|173056|P1|Overall Study|Disease Progression|4
40797|NCT01471171|173066|P2|Treatment Period 2|Adverse Event|0
40798|NCT01471171|173067|P1|Treatment Period 2|Adverse Event|1
40799|NCT01471171|173066|P2|Treatment Period 1|Adverse Event|1
40800|NCT01471171|173067|P1|Treatment Period 1|Adverse Event|4
40801|NCT01471015|173085|P3|Overall Study|Death|1
40802|NCT01471015|173086|P2|Overall Study|Death|1
40803|NCT01471015|173087|P1|Overall Study|Death|0
40804|NCT01470469|173129|P2|Overall Study|Not specified|1
40805|NCT01470469|173130|P1|Overall Study|Not specified|2
40806|NCT01470469|173129|P2|Overall Study|Protocol Violation|1
40807|NCT01470469|173130|P1|Overall Study|Protocol Violation|1
40808|NCT01470469|173129|P2|Overall Study|Lost to Follow-up|2
40809|NCT01470469|173130|P1|Overall Study|Lost to Follow-up|2
40810|NCT01470469|173129|P2|Overall Study|Adverse Event|7
40811|NCT01470469|173130|P1|Overall Study|Adverse Event|0
40812|NCT01470469|173129|P2|Overall Study|Lack of Efficacy|7
40813|NCT01470469|173130|P1|Overall Study|Lack of Efficacy|1
40814|NCT01470469|173129|P2|Overall Study|Withdrawal by Subject|6
40815|NCT01470469|173130|P1|Overall Study|Withdrawal by Subject|4
40816|NCT01470417|173150|P2|Overall Study|Disease progression|2
40817|NCT01470417|173151|P1|Overall Study|Disease progression|0
40818|NCT01470248|173163|P1|Overall Study|Withdrawal by Subject|1
40819|NCT01470144|173219|P1|Overall Study|Patient’s and investigator’s decision|1
40820|NCT01470144|173219|P1|Overall Study|Lung transplant|6
40821|NCT01470144|173219|P1|Overall Study|Death|1
40822|NCT01470144|173219|P1|Overall Study|Adverse Event|2
40823|NCT01470001|173260|P2|Overall Study|Withdrawal by Subject|1
40824|NCT01470001|173261|P1|Overall Study|Withdrawal by Subject|2
40825|NCT01470001|173260|P2|Overall Study|Physician Decision|0
40826|NCT01470001|173261|P1|Overall Study|Physician Decision|2
40827|NCT01470001|173260|P2|Overall Study|Lost to Follow-up|1
40828|NCT01470001|173261|P1|Overall Study|Lost to Follow-up|1
40829|NCT01469819|173271|P1|Overall Study|Technical malfunction of SmartPill data|3
40830|NCT01469819|173271|P1|Overall Study|Could not swallow SmartPill|2
40831|NCT01469819|173271|P1|Overall Study|Did not meet inclusionary criteria|2
40832|NCT01469819|173271|P1|Overall Study|Withdrawal by Subject|1
40833|NCT01469637|173295|P2|Second Intervention|Incarcerated|0
40834|NCT01469637|173296|P1|Second Intervention|Incarcerated|1
40835|NCT01469637|173295|P2|First Intervention|Unacceptable behavior|1
40836|NCT01469637|173296|P1|First Intervention|Unacceptable behavior|0
40837|NCT01469546|173304|P1|Received 5 mg Dose|Physician Decision|3
40838|NCT01469546|173304|P1|Received 5 mg Dose|Progressive Disease|3
40839|NCT01469546|173304|P1|Received 5 mg Dose|Protocol Violation|2
40840|NCT01469546|173304|P1|Received 5 mg Dose|Death|2
40841|NCT01469546|173304|P1|Received 5 mg Dose|Adverse Event|13
40842|NCT01469364|173311|P1|Overall Study|Withdrawal by Subject|1
40843|NCT01469364|173311|P1|Overall Study|Adverse Event|1
40844|NCT01469182|173362|P2|Overall Study|Did not meet Protocol Eligibility|0
40845|NCT01469182|173363|P1|Overall Study|Did not meet Protocol Eligibility|3
40846|NCT01469182|173362|P2|Overall Study|Protocol Violation|2
40847|NCT01469182|173363|P1|Overall Study|Protocol Violation|4
40848|NCT01469182|173362|P2|Overall Study|Withdrawal by Subject|1
40849|NCT01469182|173363|P1|Overall Study|Withdrawal by Subject|4
40850|NCT01469182|173362|P2|Overall Study|Lost to Follow-up|0
40851|NCT01469182|173363|P1|Overall Study|Lost to Follow-up|3
40852|NCT01469182|173362|P2|Overall Study|Adverse Event|3
40853|NCT01469182|173363|P1|Overall Study|Adverse Event|21
40854|NCT01469065|173390|P5|Overall Study|Not specified|0
40855|NCT01469065|173391|P4|Overall Study|Not specified|0
40856|NCT01469065|173392|P3|Overall Study|Not specified|0
40857|NCT01469065|173393|P2|Overall Study|Not specified|1
40858|NCT01469065|173394|P1|Overall Study|Not specified|0
40859|NCT01469065|173390|P5|Overall Study|Lack of Efficacy|1
40860|NCT01469065|173391|P4|Overall Study|Lack of Efficacy|0
40861|NCT01469065|173392|P3|Overall Study|Lack of Efficacy|0
40862|NCT01469065|173393|P2|Overall Study|Lack of Efficacy|0
40863|NCT01469065|173394|P1|Overall Study|Lack of Efficacy|0
40864|NCT01469052|173490|P6|Overall Study|Unspecified|0
40865|NCT01469052|173491|P5|Overall Study|Unspecified|1
40866|NCT01469052|173492|P4|Overall Study|Unspecified|0
40867|NCT01469052|173493|P3|Overall Study|Unspecified|0
40868|NCT01469052|173494|P2|Overall Study|Unspecified|1
40869|NCT01469052|173495|P1|Overall Study|Unspecified|0
40870|NCT01469052|173490|P6|Overall Study|Moved to rollover protocol|1
40871|NCT01469052|173491|P5|Overall Study|Moved to rollover protocol|0
40872|NCT01469052|173492|P4|Overall Study|Moved to rollover protocol|0
40873|NCT01469052|173493|P3|Overall Study|Moved to rollover protocol|1
40874|NCT01469052|173494|P2|Overall Study|Moved to rollover protocol|0
40875|NCT01469052|173495|P1|Overall Study|Moved to rollover protocol|1
40876|NCT01469052|173490|P6|Overall Study|Lack of Efficacy|2
40877|NCT01469052|173491|P5|Overall Study|Lack of Efficacy|0
40878|NCT01469052|173492|P4|Overall Study|Lack of Efficacy|0
40879|NCT01469052|173493|P3|Overall Study|Lack of Efficacy|0
40880|NCT01469052|173494|P2|Overall Study|Lack of Efficacy|0
40881|NCT01469052|173495|P1|Overall Study|Lack of Efficacy|0
40882|NCT01469052|173490|P6|Overall Study|Progressive disease|2
40883|NCT01469052|173491|P5|Overall Study|Progressive disease|7
40884|NCT01469052|173492|P4|Overall Study|Progressive disease|3
40885|NCT01469052|173493|P3|Overall Study|Progressive disease|5
40886|NCT01469052|173494|P2|Overall Study|Progressive disease|0
40887|NCT01469052|173495|P1|Overall Study|Progressive disease|3
40888|NCT01469052|173490|P6|Overall Study|Adverse Event|1
40889|NCT01469052|173491|P5|Overall Study|Adverse Event|0
40890|NCT01469052|173492|P4|Overall Study|Adverse Event|2
40891|NCT01469052|173493|P3|Overall Study|Adverse Event|0
40892|NCT01469052|173494|P2|Overall Study|Adverse Event|3
40893|NCT01469052|173495|P1|Overall Study|Adverse Event|2
40894|NCT01469000|173557|P2|Overall Study|On treatment, not yet died or PD|7
40895|NCT01469000|173558|P1|Overall Study|On treatment, not yet died or PD|23
40896|NCT01469000|173557|P2|Overall Study|Entry Criteria Not Met|0
40897|NCT01469000|173558|P1|Overall Study|Entry Criteria Not Met|1
40898|NCT01469000|173557|P2|Overall Study|Physician Decision|1
40899|NCT01469000|173558|P1|Overall Study|Physician Decision|0
40900|NCT01469000|173557|P2|Overall Study|Withdrawal by Subject|1
40901|NCT01469000|173558|P1|Overall Study|Withdrawal by Subject|9
40902|NCT01468818|173591|P1|Overall Study|Death during treatment|2
40903|NCT01468311|173649|P1|Overall Study|Withdrawal by Subject|1
40904|NCT01468311|173649|P1|Overall Study|mobilization failure|1
40905|NCT01468233|173661|P6|Treatment Period 2|Not specified|0
40906|NCT01468233|173662|P5|Treatment Period 2|Not specified|1
40907|NCT01468233|173663|P4|Treatment Period 2|Not specified|0
40908|NCT01468233|173664|P3|Treatment Period 2|Not specified|3
40909|NCT01468233|173665|P2|Treatment Period 2|Not specified|0
40910|NCT01468233|173666|P1|Treatment Period 2|Not specified|0
40911|NCT01468233|173661|P6|Treatment Period 2|Lost to Follow-up|0
40912|NCT01468233|173662|P5|Treatment Period 2|Lost to Follow-up|2
40913|NCT01468233|173663|P4|Treatment Period 2|Lost to Follow-up|0
40914|NCT01468233|173664|P3|Treatment Period 2|Lost to Follow-up|3
40915|NCT01468233|173665|P2|Treatment Period 2|Lost to Follow-up|0
40916|NCT01468233|173666|P1|Treatment Period 2|Lost to Follow-up|0
40917|NCT01468233|173661|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
40918|NCT01468233|173662|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
40919|NCT01468233|173663|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
40920|NCT01468233|173664|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
40921|NCT01468233|173665|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
40922|NCT01468233|173666|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
40923|NCT01468233|173661|P6|Treatment Period 2|Withdrawal by Subject|1
40924|NCT01468233|173662|P5|Treatment Period 2|Withdrawal by Subject|1
40925|NCT01468233|173663|P4|Treatment Period 2|Withdrawal by Subject|1
40926|NCT01468233|173664|P3|Treatment Period 2|Withdrawal by Subject|9
40927|NCT01468233|173665|P2|Treatment Period 2|Withdrawal by Subject|0
40928|NCT01468233|173666|P1|Treatment Period 2|Withdrawal by Subject|0
40929|NCT01468233|173661|P6|Treatment Period 2|Lack of Efficacy|1
40930|NCT01468233|173662|P5|Treatment Period 2|Lack of Efficacy|0
40931|NCT01468233|173663|P4|Treatment Period 2|Lack of Efficacy|2
40932|NCT01468233|173664|P3|Treatment Period 2|Lack of Efficacy|9
40933|NCT01468233|173665|P2|Treatment Period 2|Lack of Efficacy|0
40934|NCT01468233|173666|P1|Treatment Period 2|Lack of Efficacy|0
40935|NCT01468233|173661|P6|Treatment Period 2|Adverse Event|1
40936|NCT01468233|173662|P5|Treatment Period 2|Adverse Event|2
40937|NCT01468233|173663|P4|Treatment Period 2|Adverse Event|0
40938|NCT01468233|173664|P3|Treatment Period 2|Adverse Event|3
40939|NCT01468233|173665|P2|Treatment Period 2|Adverse Event|0
40940|NCT01468233|173666|P1|Treatment Period 2|Adverse Event|0
40941|NCT01468233|173661|P6|Treatment Period 1|Not specified|0
40942|NCT01468233|173662|P5|Treatment Period 1|Not specified|0
40943|NCT01468233|173663|P4|Treatment Period 1|Not specified|0
40944|NCT01468233|173664|P3|Treatment Period 1|Not specified|0
40945|NCT01468233|173665|P2|Treatment Period 1|Not specified|1
40946|NCT01468233|173666|P1|Treatment Period 1|Not specified|1
40947|NCT01468233|173661|P6|Treatment Period 1|Lost to Follow-up|0
40948|NCT01468233|173662|P5|Treatment Period 1|Lost to Follow-up|0
40949|NCT01468233|173663|P4|Treatment Period 1|Lost to Follow-up|0
40950|NCT01468233|173664|P3|Treatment Period 1|Lost to Follow-up|0
40951|NCT01468233|173665|P2|Treatment Period 1|Lost to Follow-up|0
40952|NCT01468233|173666|P1|Treatment Period 1|Lost to Follow-up|3
40953|NCT01468233|173661|P6|Treatment Period 1|Withdrawal by Subject|0
40954|NCT01468233|173662|P5|Treatment Period 1|Withdrawal by Subject|0
40955|NCT01468233|173663|P4|Treatment Period 1|Withdrawal by Subject|0
40956|NCT01468233|173664|P3|Treatment Period 1|Withdrawal by Subject|0
40957|NCT01468233|173665|P2|Treatment Period 1|Withdrawal by Subject|4
40958|NCT01468233|173666|P1|Treatment Period 1|Withdrawal by Subject|3
40959|NCT01468233|173661|P6|Treatment Period 1|Adverse Event|0
40960|NCT01468233|173662|P5|Treatment Period 1|Adverse Event|0
40961|NCT01468233|173663|P4|Treatment Period 1|Adverse Event|0
40962|NCT01468233|173664|P3|Treatment Period 1|Adverse Event|0
40963|NCT01468233|173665|P2|Treatment Period 1|Adverse Event|3
40964|NCT01468233|173666|P1|Treatment Period 1|Adverse Event|5
40965|NCT01468207|173688|P6|Treatment Period 2|Not specified|2
40966|NCT01468207|173689|P5|Treatment Period 2|Not specified|1
40967|NCT01468207|173690|P4|Treatment Period 2|Not specified|1
40968|NCT01468207|173691|P3|Treatment Period 2|Not specified|5
40969|NCT01468207|173692|P2|Treatment Period 2|Not specified|0
40970|NCT01468207|173693|P1|Treatment Period 2|Not specified|0
40971|NCT01468207|173688|P6|Treatment Period 2|Lost to Follow-up|0
40972|NCT01468207|173689|P5|Treatment Period 2|Lost to Follow-up|0
40973|NCT01468207|173690|P4|Treatment Period 2|Lost to Follow-up|1
40974|NCT01468207|173691|P3|Treatment Period 2|Lost to Follow-up|5
40975|NCT01468207|173692|P2|Treatment Period 2|Lost to Follow-up|0
40976|NCT01468207|173693|P1|Treatment Period 2|Lost to Follow-up|0
40977|NCT01468207|173688|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
40978|NCT01468207|173689|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
40979|NCT01468207|173690|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
40980|NCT01468207|173691|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
41154|NCT01467492|174098|P1|Overall Study|Enrolled But Not Treated|1
40981|NCT01468207|173692|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
40982|NCT01468207|173693|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
40983|NCT01468207|173688|P6|Treatment Period 2|Withdrawal by Subject|2
40984|NCT01468207|173689|P5|Treatment Period 2|Withdrawal by Subject|0
40985|NCT01468207|173690|P4|Treatment Period 2|Withdrawal by Subject|0
40986|NCT01468207|173691|P3|Treatment Period 2|Withdrawal by Subject|5
40987|NCT01468207|173692|P2|Treatment Period 2|Withdrawal by Subject|0
40988|NCT01468207|173693|P1|Treatment Period 2|Withdrawal by Subject|0
40989|NCT01468207|173688|P6|Treatment Period 2|Lack of Efficacy|2
40990|NCT01468207|173689|P5|Treatment Period 2|Lack of Efficacy|0
40991|NCT01468207|173690|P4|Treatment Period 2|Lack of Efficacy|1
40992|NCT01468207|173691|P3|Treatment Period 2|Lack of Efficacy|1
40993|NCT01468207|173692|P2|Treatment Period 2|Lack of Efficacy|0
40994|NCT01468207|173693|P1|Treatment Period 2|Lack of Efficacy|0
40995|NCT01468207|173688|P6|Treatment Period 2|Adverse Event|1
40996|NCT01468207|173689|P5|Treatment Period 2|Adverse Event|2
40997|NCT01468207|173690|P4|Treatment Period 2|Adverse Event|1
40998|NCT01468207|173691|P3|Treatment Period 2|Adverse Event|6
40999|NCT01468207|173692|P2|Treatment Period 2|Adverse Event|0
41000|NCT01468207|173693|P1|Treatment Period 2|Adverse Event|0
41001|NCT01468207|173688|P6|Treatment Period 1|Not specified|0
41002|NCT01468207|173689|P5|Treatment Period 1|Not specified|0
41003|NCT01468207|173690|P4|Treatment Period 1|Not specified|0
41004|NCT01468207|173691|P3|Treatment Period 1|Not specified|0
41005|NCT01468207|173692|P2|Treatment Period 1|Not specified|2
41006|NCT01468207|173693|P1|Treatment Period 1|Not specified|0
41007|NCT01468207|173688|P6|Treatment Period 1|Lost to Follow-up|0
41008|NCT01468207|173689|P5|Treatment Period 1|Lost to Follow-up|0
41009|NCT01468207|173690|P4|Treatment Period 1|Lost to Follow-up|0
41010|NCT01468207|173691|P3|Treatment Period 1|Lost to Follow-up|0
41011|NCT01468207|173692|P2|Treatment Period 1|Lost to Follow-up|1
41012|NCT01468207|173693|P1|Treatment Period 1|Lost to Follow-up|2
41013|NCT01468207|173688|P6|Treatment Period 1|Withdrawal by Subject|0
41014|NCT01468207|173689|P5|Treatment Period 1|Withdrawal by Subject|0
41015|NCT01468207|173690|P4|Treatment Period 1|Withdrawal by Subject|0
41016|NCT01468207|173691|P3|Treatment Period 1|Withdrawal by Subject|0
41017|NCT01468207|173692|P2|Treatment Period 1|Withdrawal by Subject|4
41018|NCT01468207|173693|P1|Treatment Period 1|Withdrawal by Subject|5
41019|NCT01468207|173688|P6|Treatment Period 1|Protocol Violation|0
41020|NCT01468207|173689|P5|Treatment Period 1|Protocol Violation|0
41021|NCT01468207|173690|P4|Treatment Period 1|Protocol Violation|0
41022|NCT01468207|173691|P3|Treatment Period 1|Protocol Violation|0
41023|NCT01468207|173692|P2|Treatment Period 1|Protocol Violation|1
41024|NCT01468207|173693|P1|Treatment Period 1|Protocol Violation|1
41025|NCT01468207|173688|P6|Treatment Period 1|Adverse Event|0
41026|NCT01468207|173689|P5|Treatment Period 1|Adverse Event|0
41027|NCT01468207|173690|P4|Treatment Period 1|Adverse Event|0
41028|NCT01468207|173691|P3|Treatment Period 1|Adverse Event|0
41029|NCT01468207|173692|P2|Treatment Period 1|Adverse Event|0
41030|NCT01468207|173693|P1|Treatment Period 1|Adverse Event|1
41031|NCT01468181|173718|P5|Overall Study|Withdrawal by Subject|0
41032|NCT01468181|173719|P4|Overall Study|Withdrawal by Subject|0
41033|NCT01468181|173720|P3|Overall Study|Withdrawal by Subject|0
41034|NCT01468181|173721|P2|Overall Study|Withdrawal by Subject|1
41035|NCT01468181|173722|P1|Overall Study|Withdrawal by Subject|0
41036|NCT01468181|173718|P5|Overall Study|Lost to Follow-up|1
41037|NCT01468181|173719|P4|Overall Study|Lost to Follow-up|0
41038|NCT01468181|173720|P3|Overall Study|Lost to Follow-up|1
41039|NCT01468181|173721|P2|Overall Study|Lost to Follow-up|0
41040|NCT01468181|173722|P1|Overall Study|Lost to Follow-up|0
41041|NCT01468181|173718|P5|Overall Study|Physician Decision|1
41042|NCT01468181|173719|P4|Overall Study|Physician Decision|1
41043|NCT01468181|173720|P3|Overall Study|Physician Decision|0
41044|NCT01468181|173721|P2|Overall Study|Physician Decision|0
41045|NCT01468181|173722|P1|Overall Study|Physician Decision|0
41046|NCT01468181|173718|P5|Overall Study|Protocol Violation|1
41047|NCT01468181|173719|P4|Overall Study|Protocol Violation|0
41048|NCT01468181|173720|P3|Overall Study|Protocol Violation|1
41049|NCT01468181|173721|P2|Overall Study|Protocol Violation|0
41050|NCT01468181|173722|P1|Overall Study|Protocol Violation|2
41051|NCT01468181|173718|P5|Overall Study|Adverse Event|2
41052|NCT01468181|173719|P4|Overall Study|Adverse Event|2
41053|NCT01468181|173720|P3|Overall Study|Adverse Event|6
41054|NCT01468181|173721|P2|Overall Study|Adverse Event|1
41055|NCT01468181|173722|P1|Overall Study|Adverse Event|8
41056|NCT01468077|173771|P2|Overall Study|Physician Decision|0
41057|NCT01468077|173772|P1|Overall Study|Physician Decision|1
41058|NCT01468077|173771|P2|Overall Study|Lack of Efficacy|1
41059|NCT01468077|173772|P1|Overall Study|Lack of Efficacy|1
41060|NCT01468077|173771|P2|Overall Study|Adverse Event|2
41061|NCT01468077|173772|P1|Overall Study|Adverse Event|2
41062|NCT01467960|173825|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
41063|NCT01467960|173826|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
41064|NCT01467960|173827|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
41065|NCT01467960|173828|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
41066|NCT01467960|173829|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
41067|NCT01467960|173830|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
41068|NCT01467713|173889|P4|Overall Study|Reason not Specified|7
41069|NCT01467713|173890|P3|Overall Study|Reason not Specified|8
41070|NCT01467713|173891|P2|Overall Study|Reason not Specified|11
41071|NCT01467713|173892|P1|Overall Study|Reason not Specified|6
41072|NCT01467713|173889|P4|Overall Study|Relapse|35
41073|NCT01467713|173890|P3|Overall Study|Relapse|28
41074|NCT01467713|173891|P2|Overall Study|Relapse|25
41075|NCT01467713|173892|P1|Overall Study|Relapse|35
41076|NCT01467713|173889|P4|Overall Study|Pregnancy|3
41077|NCT01467713|173890|P3|Overall Study|Pregnancy|1
41078|NCT01467713|173891|P2|Overall Study|Pregnancy|1
41079|NCT01467713|173892|P1|Overall Study|Pregnancy|0
41080|NCT01467713|173889|P4|Overall Study|Study Termination|29
41081|NCT01467713|173890|P3|Overall Study|Study Termination|28
41082|NCT01467713|173891|P2|Overall Study|Study Termination|33
41083|NCT01467713|173892|P1|Overall Study|Study Termination|23
41084|NCT01467713|173889|P4|Overall Study|Voluntary Withdrawal|20
41085|NCT01467713|173890|P3|Overall Study|Voluntary Withdrawal|21
41086|NCT01467713|173891|P2|Overall Study|Voluntary Withdrawal|14
41087|NCT01467713|173892|P1|Overall Study|Voluntary Withdrawal|18
41088|NCT01467713|173889|P4|Overall Study|Lost to Follow-up|9
41089|NCT01467713|173890|P3|Overall Study|Lost to Follow-up|6
41090|NCT01467713|173891|P2|Overall Study|Lost to Follow-up|12
41091|NCT01467713|173892|P1|Overall Study|Lost to Follow-up|9
41092|NCT01467713|173889|P4|Overall Study|Major Protocol Deviation|1
41093|NCT01467713|173890|P3|Overall Study|Major Protocol Deviation|4
41094|NCT01467713|173891|P2|Overall Study|Major Protocol Deviation|4
41095|NCT01467713|173892|P1|Overall Study|Major Protocol Deviation|2
41096|NCT01467713|173889|P4|Overall Study|Pretreatment Event or Adverse Event|5
41097|NCT01467713|173890|P3|Overall Study|Pretreatment Event or Adverse Event|6
41098|NCT01467713|173891|P2|Overall Study|Pretreatment Event or Adverse Event|4
41099|NCT01467713|173892|P1|Overall Study|Pretreatment Event or Adverse Event|9
41100|NCT01467700|173946|P4|Overall Study|Reason not Specified|8
41101|NCT01467700|173947|P3|Overall Study|Reason not Specified|2
41102|NCT01467700|173948|P2|Overall Study|Reason not Specified|3
41103|NCT01467700|173949|P1|Overall Study|Reason not Specified|1
41104|NCT01467700|173946|P4|Overall Study|Lack of Efficacy|1
41105|NCT01467700|173947|P3|Overall Study|Lack of Efficacy|2
41106|NCT01467700|173948|P2|Overall Study|Lack of Efficacy|0
41107|NCT01467700|173949|P1|Overall Study|Lack of Efficacy|2
41108|NCT01467700|173946|P4|Overall Study|Pregnancy|0
41109|NCT01467700|173947|P3|Overall Study|Pregnancy|1
41110|NCT01467700|173948|P2|Overall Study|Pregnancy|1
41111|NCT01467700|173949|P1|Overall Study|Pregnancy|0
41112|NCT01467700|173946|P4|Overall Study|Study Termination|7
41113|NCT01467700|173947|P3|Overall Study|Study Termination|10
41114|NCT01467700|173948|P2|Overall Study|Study Termination|5
41115|NCT01467700|173949|P1|Overall Study|Study Termination|6
41116|NCT01467700|173946|P4|Overall Study|Voluntary Withdrawal|2
41117|NCT01467700|173947|P3|Overall Study|Voluntary Withdrawal|6
41118|NCT01467700|173948|P2|Overall Study|Voluntary Withdrawal|7
41119|NCT01467700|173949|P1|Overall Study|Voluntary Withdrawal|5
41120|NCT01467700|173946|P4|Overall Study|Lost to Follow-up|3
41121|NCT01467700|173947|P3|Overall Study|Lost to Follow-up|2
41122|NCT01467700|173948|P2|Overall Study|Lost to Follow-up|5
41123|NCT01467700|173949|P1|Overall Study|Lost to Follow-up|6
41124|NCT01467700|173946|P4|Overall Study|Major Protocol Deviation|3
41125|NCT01467700|173947|P3|Overall Study|Major Protocol Deviation|2
41126|NCT01467700|173948|P2|Overall Study|Major Protocol Deviation|3
41127|NCT01467700|173949|P1|Overall Study|Major Protocol Deviation|3
41128|NCT01467700|173946|P4|Overall Study|Pretreatment Event or Adverse Event|3
41129|NCT01467700|173947|P3|Overall Study|Pretreatment Event or Adverse Event|2
41130|NCT01467700|173948|P2|Overall Study|Pretreatment Event or Adverse Event|4
41131|NCT01467700|173949|P1|Overall Study|Pretreatment Event or Adverse Event|6
41132|NCT01467661|173991|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
41133|NCT01467661|173991|P1|Overall Study|Lack of Efficacy|3
41134|NCT01467661|173991|P1|Overall Study|Withdrawal by Subject|1
41135|NCT01467661|173991|P1|Overall Study|Adverse Event|16
41136|NCT01467583|174011|P3|Overall Study|Protocol Violation|2
41137|NCT01467583|174012|P2|Overall Study|Protocol Violation|0
41138|NCT01467583|174013|P1|Overall Study|Protocol Violation|0
41139|NCT01467583|174011|P3|Overall Study|Withdrawal by Subject|0
41140|NCT01467583|174012|P2|Overall Study|Withdrawal by Subject|0
41141|NCT01467583|174013|P1|Overall Study|Withdrawal by Subject|1
41142|NCT01467583|174011|P3|Overall Study|Death|0
41143|NCT01467583|174012|P2|Overall Study|Death|1
41144|NCT01467583|174013|P1|Overall Study|Death|1
41145|NCT01467570|174026|P2|Overall Study|Lost to Follow-up|9
41146|NCT01467570|174027|P1|Overall Study|Lost to Follow-up|8
41147|NCT01467505|174064|P2|Overall Study|Study Terminated by Sponsor|3
41148|NCT01467505|174065|P1|Overall Study|Study Terminated by Sponsor|28
41149|NCT01467505|174064|P2|Overall Study|Withdrawal by Subject|0
41150|NCT01467505|174065|P1|Overall Study|Withdrawal by Subject|4
41151|NCT01467505|174064|P2|Overall Study|Adverse Event|0
41152|NCT01467505|174065|P1|Overall Study|Adverse Event|1
41153|NCT01467492|174097|P2|Overall Study|Enrolled But Not Treated|0
41155|NCT01467492|174097|P2|Overall Study|Undefined|0
41156|NCT01467492|174098|P1|Overall Study|Undefined|2
41157|NCT01467492|174097|P2|Overall Study|Lost to Follow-up|2
41158|NCT01467492|174098|P1|Overall Study|Lost to Follow-up|3
41159|NCT01467492|174097|P2|Overall Study|Adverse Event|3
41160|NCT01467492|174098|P1|Overall Study|Adverse Event|4
41161|NCT01467492|174097|P2|Overall Study|Study Terminated by Sponsor|4
41162|NCT01467492|174098|P1|Overall Study|Study Terminated by Sponsor|6
41163|NCT01467492|174097|P2|Overall Study|Withdrawal by Subject|4
41164|NCT01467492|174098|P1|Overall Study|Withdrawal by Subject|6
41165|NCT01467479|174122|P3|Overall Study|Unspecified|0
41166|NCT01467479|174123|P2|Overall Study|Unspecified|0
41167|NCT01467479|174124|P1|Overall Study|Unspecified|1
41168|NCT01467479|174122|P3|Overall Study|Study Terminated by Sponsor|3
41169|NCT01467479|174123|P2|Overall Study|Study Terminated by Sponsor|3
41170|NCT01467479|174124|P1|Overall Study|Study Terminated by Sponsor|1
41171|NCT01467479|174122|P3|Overall Study|Withdrawal of Consent|7
41172|NCT01467479|174123|P2|Overall Study|Withdrawal of Consent|7
41173|NCT01467479|174124|P1|Overall Study|Withdrawal of Consent|3
41174|NCT01467479|174122|P3|Overall Study|Lost to Follow-up|3
41175|NCT01467479|174123|P2|Overall Study|Lost to Follow-up|5
41176|NCT01467479|174124|P1|Overall Study|Lost to Follow-up|2
41177|NCT01467479|174122|P3|Overall Study|Death|1
41178|NCT01467479|174123|P2|Overall Study|Death|0
41179|NCT01467479|174124|P1|Overall Study|Death|0
41180|NCT01467479|174122|P3|Overall Study|Adverse Event|0
41181|NCT01467479|174123|P2|Overall Study|Adverse Event|2
41182|NCT01467479|174124|P1|Overall Study|Adverse Event|1
41183|NCT01467479|174122|P3|Overall Study|No Study Medication|2
41184|NCT01467479|174123|P2|Overall Study|No Study Medication|0
41185|NCT01467479|174124|P1|Overall Study|No Study Medication|1
41186|NCT01467076|174154|P3|Overall Study|Lost to Follow-up|0
41187|NCT01467076|174155|P2|Overall Study|Lost to Follow-up|0
41188|NCT01467076|174156|P1|Overall Study|Lost to Follow-up|1
41189|NCT01466881|174173|P1|Overall Study|Other reason not protocol specified|5
41190|NCT01466881|174173|P1|Overall Study|Death|4
41191|NCT01466881|174173|P1|Overall Study|Progression/relapse|20
41192|NCT01466881|174173|P1|Overall Study|Adverse Event|6
41193|NCT01466881|174173|P1|Overall Study|Ineligible|5
41194|NCT01466790|174190|P8|Overall Study|Withdrawal by Subject|1
41195|NCT01466790|174191|P7|Overall Study|Withdrawal by Subject|1
41196|NCT01466790|174192|P6|Overall Study|Withdrawal by Subject|0
41197|NCT01466790|174193|P5|Overall Study|Withdrawal by Subject|1
41198|NCT01466790|174194|P4|Overall Study|Withdrawal by Subject|0
41199|NCT01466790|174195|P3|Overall Study|Withdrawal by Subject|0
41200|NCT01466790|174196|P2|Overall Study|Withdrawal by Subject|1
41201|NCT01466790|174197|P1|Overall Study|Withdrawal by Subject|1
41202|NCT01466790|174190|P8|Overall Study|Lost to Follow-up|0
41203|NCT01466790|174191|P7|Overall Study|Lost to Follow-up|0
41204|NCT01466790|174192|P6|Overall Study|Lost to Follow-up|0
41205|NCT01466790|174193|P5|Overall Study|Lost to Follow-up|0
41206|NCT01466790|174194|P4|Overall Study|Lost to Follow-up|0
41207|NCT01466790|174195|P3|Overall Study|Lost to Follow-up|0
41208|NCT01466790|174196|P2|Overall Study|Lost to Follow-up|0
41209|NCT01466790|174197|P1|Overall Study|Lost to Follow-up|2
41210|NCT01466790|174190|P8|Overall Study|Adverse Event|0
41211|NCT01466790|174191|P7|Overall Study|Adverse Event|0
41212|NCT01466790|174192|P6|Overall Study|Adverse Event|0
41213|NCT01466790|174193|P5|Overall Study|Adverse Event|2
41214|NCT01466790|174194|P4|Overall Study|Adverse Event|0
41215|NCT01466790|174195|P3|Overall Study|Adverse Event|0
41216|NCT01466790|174196|P2|Overall Study|Adverse Event|0
41217|NCT01466790|174197|P1|Overall Study|Adverse Event|1
41218|NCT01466673|174282|P2|Overall Study|Adverse Event|1
41219|NCT01466673|174283|P1|Overall Study|Adverse Event|2
41220|NCT01466673|174282|P2|Overall Study|Lost to Follow-up|5
41221|NCT01466673|174283|P1|Overall Study|Lost to Follow-up|3
41222|NCT01466673|174282|P2|Overall Study|Non-compliance with study treatment|0
41223|NCT01466673|174283|P1|Overall Study|Non-compliance with study treatment|2
41224|NCT01466660|174309|P2|Overall Study|Other reason not defined above|6
41225|NCT01466660|174310|P1|Overall Study|Other reason not defined above|3
41226|NCT01466660|174309|P2|Overall Study|Refused continuation of trial medication|3
41227|NCT01466660|174310|P1|Overall Study|Refused continuation of trial medication|4
41228|NCT01466660|174309|P2|Overall Study|Protocol Violation|1
41229|NCT01466660|174310|P1|Overall Study|Protocol Violation|1
41230|NCT01466660|174309|P2|Overall Study|Other adverse event|17
41231|NCT01466660|174310|P1|Overall Study|Other adverse event|18
41232|NCT01466660|174309|P2|Overall Study|Worsening of underlying cancer disease|2
41233|NCT01466660|174310|P1|Overall Study|Worsening of underlying cancer disease|5
41234|NCT01466660|174309|P2|Overall Study|Progressive Disease (RECIST 1.1)|122
41235|NCT01466660|174310|P1|Overall Study|Progressive Disease (RECIST 1.1)|115
41236|NCT01466595|174336|P2|Overall Study|Withdrawal by Subject|1
41237|NCT01466595|174337|P1|Overall Study|Withdrawal by Subject|0
41238|NCT01466491|174431|P4|Overall Study|Missing Data|0
41239|NCT01466491|174432|P3|Overall Study|Missing Data|1
41240|NCT01466491|174433|P2|Overall Study|Missing Data|0
41241|NCT01466491|174434|P1|Overall Study|Missing Data|0
41242|NCT01466491|174431|P4|Overall Study|Protocol Violation|0
41243|NCT01466491|174432|P3|Overall Study|Protocol Violation|2
41244|NCT01466491|174433|P2|Overall Study|Protocol Violation|3
41245|NCT01466491|174434|P1|Overall Study|Protocol Violation|0
41246|NCT01466387|174454|P6|Overall Study|Protocol Violation|0
41247|NCT01466387|174455|P5|Overall Study|Protocol Violation|0
41248|NCT01466387|174456|P4|Overall Study|Protocol Violation|1
41249|NCT01466387|174457|P3|Overall Study|Protocol Violation|0
41250|NCT01466387|174458|P2|Overall Study|Protocol Violation|0
41251|NCT01466387|174459|P1|Overall Study|Protocol Violation|1
41252|NCT01466387|174454|P6|Overall Study|Lost to Follow-up|1
41253|NCT01466387|174455|P5|Overall Study|Lost to Follow-up|0
41254|NCT01466387|174456|P4|Overall Study|Lost to Follow-up|0
41255|NCT01466387|174457|P3|Overall Study|Lost to Follow-up|0
41256|NCT01466387|174458|P2|Overall Study|Lost to Follow-up|0
41257|NCT01466387|174459|P1|Overall Study|Lost to Follow-up|0
41258|NCT01466387|174454|P6|Overall Study|Adverse Event|0
41259|NCT01466387|174455|P5|Overall Study|Adverse Event|0
41260|NCT01466387|174456|P4|Overall Study|Adverse Event|1
41261|NCT01466387|174457|P3|Overall Study|Adverse Event|1
41262|NCT01466387|174458|P2|Overall Study|Adverse Event|0
41263|NCT01466387|174459|P1|Overall Study|Adverse Event|0
41264|NCT01466348|174520|P2|Period I - First Intervention|Withdrawal by Subject|1
41265|NCT01466348|174521|P1|Period I - First Intervention|Withdrawal by Subject|0
41266|NCT01466270|174549|P2|Overall Study|Multiple|1
41267|NCT01466270|174550|P1|Overall Study|Multiple|1
41268|NCT01466270|174549|P2|Overall Study|Toxicity|1
41269|NCT01466270|174550|P1|Overall Study|Toxicity|4
41270|NCT01466270|174549|P2|Overall Study|Progression|0
41271|NCT01466270|174550|P1|Overall Study|Progression|1
41272|NCT01466270|174549|P2|Overall Study|Lost to Follow-up|3
41273|NCT01466270|174550|P1|Overall Study|Lost to Follow-up|1
41274|NCT01466270|174549|P2|Overall Study|Physician Decision|0
41275|NCT01466270|174550|P1|Overall Study|Physician Decision|1
41276|NCT01466270|174549|P2|Overall Study|Withdrawal by Subject|1
41277|NCT01466270|174550|P1|Overall Study|Withdrawal by Subject|4
41278|NCT01466192|174562|P1|Overall Study|Withdrawal by Subject|3
41279|NCT01466192|174562|P1|Overall Study|Physician Decision|1
41280|NCT01466179|174566|P1|Overall Study|Other|3
41281|NCT01466179|174566|P1|Overall Study|Protocol Violation|2
41282|NCT01466179|174566|P1|Overall Study|Withdrawal by Subject|7
41283|NCT01466179|174566|P1|Overall Study|Death|7
41284|NCT01466179|174566|P1|Overall Study|Lack of Efficacy|14
41285|NCT01466179|174566|P1|Overall Study|Disease relapse|23
41286|NCT01466179|174566|P1|Overall Study|Adverse Event|32
41287|NCT01466179|174566|P1|Overall Study|Progressive disease|43
41288|NCT01466179|174566|P1|Overall Study|Physician Decision|46
41289|NCT01466179|174566|P1|Overall Study|Ongoing in core study|2
41290|NCT01466153|174589|P3|Overall Study|Other-Unspecified|2
41291|NCT01466153|174590|P2|Overall Study|Other-Unspecified|4
41292|NCT01466153|174591|P1|Overall Study|Other-Unspecified|6
41293|NCT01466153|174589|P3|Overall Study|Randomized-Not Treated|4
41294|NCT01466153|174590|P2|Overall Study|Randomized-Not Treated|3
41295|NCT01466153|174591|P1|Overall Study|Randomized-Not Treated|2
41296|NCT01466153|174589|P3|Overall Study|Investigator Discretion|2
41297|NCT01466153|174590|P2|Overall Study|Investigator Discretion|2
41298|NCT01466153|174591|P1|Overall Study|Investigator Discretion|3
41299|NCT01466153|174589|P3|Overall Study|Withdrawal of Consent|0
41300|NCT01466153|174590|P2|Overall Study|Withdrawal of Consent|0
41301|NCT01466153|174591|P1|Overall Study|Withdrawal of Consent|2
41302|NCT01466153|174589|P3|Overall Study|Adverse Event|17
41303|NCT01466153|174590|P2|Overall Study|Adverse Event|13
41304|NCT01466153|174591|P1|Overall Study|Adverse Event|14
41305|NCT01466153|174589|P3|Overall Study|Disease Progression|0
41306|NCT01466153|174590|P2|Overall Study|Disease Progression|2
41307|NCT01466153|174591|P1|Overall Study|Disease Progression|2
41308|NCT01466062|174646|P1|Overall Study|Withdrawal by Subject|1
41309|NCT01466062|174646|P1|Overall Study|Adverse Event|1
41310|NCT01465997|174669|P2|Overall Study|subject left participation SP0993|1
41311|NCT01465997|174670|P1|Overall Study|subject left participation SP0993|0
41312|NCT01465997|174669|P2|Overall Study|decision by site staff|1
41313|NCT01465997|174670|P1|Overall Study|decision by site staff|0
41314|NCT01465997|174669|P2|Overall Study|withdrew before follow-up|13
41315|NCT01465997|174670|P1|Overall Study|withdrew before follow-up|0
41316|NCT01465997|174669|P2|Overall Study|local lab unblinded site|0
41317|NCT01465997|174670|P1|Overall Study|local lab unblinded site|1
41318|NCT01465997|174669|P2|Overall Study|subject withdrew consent|0
41319|NCT01465997|174670|P1|Overall Study|subject withdrew consent|1
41320|NCT01465997|174669|P2|Overall Study|sponsor's decision|1
41321|NCT01465997|174670|P1|Overall Study|sponsor's decision|1
41322|NCT01465997|174669|P2|Overall Study|Death|1
41323|NCT01465997|174670|P1|Overall Study|Death|0
41324|NCT01465997|174669|P2|Overall Study|investigator's decision|1
41325|NCT01465997|174670|P1|Overall Study|investigator's decision|1
41326|NCT01465997|174669|P2|Overall Study|Withdrawal by Subject|35
41327|NCT01465997|174670|P1|Overall Study|Withdrawal by Subject|32
41328|NCT01465997|174669|P2|Overall Study|Lost to Follow-up|9
41329|NCT01465997|174670|P1|Overall Study|Lost to Follow-up|6
41330|NCT01465997|174669|P2|Overall Study|Protocol Violation|4
41331|NCT01465997|174670|P1|Overall Study|Protocol Violation|1
41332|NCT01465997|174669|P2|Overall Study|Lack of Efficacy|1
41333|NCT01465997|174670|P1|Overall Study|Lack of Efficacy|13
41334|NCT01465997|174669|P2|Overall Study|Adverse Event|22
41335|NCT01465997|174670|P1|Overall Study|Adverse Event|12
41336|NCT01465958|174680|P2|Subcutaneous (SC) Phase|Adverse Event|1
41337|NCT01465958|174681|P1|Subcutaneous (SC) Phase|Adverse Event|0
41338|NCT01465958|174680|P2|Run-in Phase|Protocol Violation|0
41339|NCT01465958|174681|P1|Run-in Phase|Protocol Violation|1
41340|NCT01465802|174694|P5|Overall Study|Death|2
41341|NCT01465802|174695|P4|Overall Study|Death|10
41342|NCT01465802|174696|P3|Overall Study|Death|0
41343|NCT01465802|174697|P2|Overall Study|Death|12
41344|NCT01465802|174698|P1|Overall Study|Death|15
41345|NCT01465802|174694|P5|Overall Study|Reason not specified|2
41346|NCT01465802|174695|P4|Overall Study|Reason not specified|10
41347|NCT01465802|174696|P3|Overall Study|Reason not specified|0
41348|NCT01465802|174697|P2|Overall Study|Reason not specified|4
41349|NCT01465802|174698|P1|Overall Study|Reason not specified|9
41350|NCT01465802|174694|P5|Overall Study|Lost to Follow-up|0
41351|NCT01465802|174695|P4|Overall Study|Lost to Follow-up|0
41352|NCT01465802|174696|P3|Overall Study|Lost to Follow-up|0
41353|NCT01465802|174697|P2|Overall Study|Lost to Follow-up|1
41354|NCT01465802|174698|P1|Overall Study|Lost to Follow-up|1
41355|NCT01465802|174694|P5|Overall Study|Withdrawal by Subject|1
41356|NCT01465802|174695|P4|Overall Study|Withdrawal by Subject|8
41357|NCT01465802|174696|P3|Overall Study|Withdrawal by Subject|0
41358|NCT01465802|174697|P2|Overall Study|Withdrawal by Subject|7
41359|NCT01465802|174698|P1|Overall Study|Withdrawal by Subject|7
41360|NCT01465802|174694|P5|Overall Study|Study terminated by sponsor|7
41361|NCT01465802|174695|P4|Overall Study|Study terminated by sponsor|1
41362|NCT01465802|174696|P3|Overall Study|Study terminated by sponsor|0
41363|NCT01465802|174697|P2|Overall Study|Study terminated by sponsor|0
41364|NCT01465802|174698|P1|Overall Study|Study terminated by sponsor|1
41365|NCT01465763|174750|P3|Overall Study|Death|0
41366|NCT01465763|174751|P2|Overall Study|Death|0
41367|NCT01465763|174752|P1|Overall Study|Death|1
41368|NCT01465763|174750|P3|Overall Study|Protocol Violation|1
41369|NCT01465763|174751|P2|Overall Study|Protocol Violation|1
41370|NCT01465763|174752|P1|Overall Study|Protocol Violation|4
41371|NCT01465763|174750|P3|Overall Study|Unspecified|0
41372|NCT01465763|174751|P2|Overall Study|Unspecified|0
41373|NCT01465763|174752|P1|Overall Study|Unspecified|2
41374|NCT01465763|174750|P3|Overall Study|Adverse Event|1
41375|NCT01465763|174751|P2|Overall Study|Adverse Event|0
41376|NCT01465763|174752|P1|Overall Study|Adverse Event|9
41377|NCT01465763|174750|P3|Overall Study|Insufficient Clinical Response|1
41378|NCT01465763|174751|P2|Overall Study|Insufficient Clinical Response|0
41379|NCT01465763|174752|P1|Overall Study|Insufficient Clinical Response|11
41380|NCT01465763|174750|P3|Overall Study|Withdrawal by Subject|1
41381|NCT01465763|174751|P2|Overall Study|Withdrawal by Subject|0
41382|NCT01465763|174752|P1|Overall Study|Withdrawal by Subject|4
41383|NCT01465386|174822|P1|Overall Study|Adverse Event|1
41384|NCT01465386|174822|P1|Overall Study|Lack of Efficacy|3
41385|NCT01465347|174826|P2|Overall Study|Admitted to hospice|1
41386|NCT01465347|174827|P1|Overall Study|Admitted to hospice|0
41387|NCT01465347|174826|P2|Overall Study|Physician Decision|1
41388|NCT01465347|174827|P1|Overall Study|Physician Decision|0
41389|NCT01465347|174826|P2|Overall Study|Withdrawal by Subject|1
41390|NCT01465347|174827|P1|Overall Study|Withdrawal by Subject|1
41391|NCT01465230|174837|P1|Overall Study|Withdrawal by Subject|2
41392|NCT01465178|174843|P2|Overall Study|Withdrawal by Subject|0
41393|NCT01465178|174844|P1|Overall Study|Withdrawal by Subject|1
41394|NCT01465022|174868|P3|Overall Study|Not Randomized|70
41395|NCT01465022|174869|P2|Overall Study|Not Randomized|0
41396|NCT01465022|174870|P1|Overall Study|Not Randomized|0
41397|NCT01465022|174868|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
41398|NCT01465022|174869|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
41399|NCT01465022|174870|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
41400|NCT01465022|174868|P3|Overall Study|Lost to Follow-up|0
41401|NCT01465022|174869|P2|Overall Study|Lost to Follow-up|14
41402|NCT01465022|174870|P1|Overall Study|Lost to Follow-up|15
41403|NCT01464931|174904|P2|Overall Study|Withdrawal by Subject|0
41404|NCT01464931|174905|P1|Overall Study|Withdrawal by Subject|1
41405|NCT01464879|174942|P1|Overall Study|Non-compliance|1
41406|NCT01464879|174942|P1|Overall Study|Physician Decision|1
41407|NCT01464827|175003|P14|Overall Study|Not Treated|2
41408|NCT01464827|175004|P13|Overall Study|Not Treated|0
41409|NCT01464827|175005|P12|Overall Study|Not Treated|1
41410|NCT01464827|175006|P11|Overall Study|Not Treated|0
41411|NCT01464827|175007|P10|Overall Study|Not Treated|2
41412|NCT01464827|175008|P9|Overall Study|Not Treated|0
41413|NCT01464827|175009|P8|Overall Study|Not Treated|0
41414|NCT01464827|175010|P7|Overall Study|Not Treated|1
41415|NCT01464827|175011|P6|Overall Study|Not Treated|0
41416|NCT01464827|175012|P5|Overall Study|Not Treated|1
41417|NCT01464827|175013|P4|Overall Study|Not Treated|0
41418|NCT01464827|175014|P3|Overall Study|Not Treated|0
41419|NCT01464827|175015|P2|Overall Study|Not Treated|2
41420|NCT01464827|175016|P1|Overall Study|Not Treated|0
41421|NCT01464827|175003|P14|Overall Study|Other|0
41422|NCT01464827|175004|P13|Overall Study|Other|1
41423|NCT01464827|175005|P12|Overall Study|Other|0
41424|NCT01464827|175006|P11|Overall Study|Other|2
41425|NCT01464827|175007|P10|Overall Study|Other|1
41426|NCT01464827|175008|P9|Overall Study|Other|3
41427|NCT01464827|175009|P8|Overall Study|Other|0
41428|NCT01464827|175010|P7|Overall Study|Other|1
41429|NCT01464827|175011|P6|Overall Study|Other|0
41430|NCT01464827|175012|P5|Overall Study|Other|3
41431|NCT01464827|175013|P4|Overall Study|Other|2
41432|NCT01464827|175014|P3|Overall Study|Other|0
41433|NCT01464827|175015|P2|Overall Study|Other|3
41434|NCT01464827|175016|P1|Overall Study|Other|2
41435|NCT01464827|175003|P14|Overall Study|Lost to Follow-up|1
41436|NCT01464827|175004|P13|Overall Study|Lost to Follow-up|0
41437|NCT01464827|175005|P12|Overall Study|Lost to Follow-up|1
41438|NCT01464827|175006|P11|Overall Study|Lost to Follow-up|0
41439|NCT01464827|175007|P10|Overall Study|Lost to Follow-up|0
41440|NCT01464827|175008|P9|Overall Study|Lost to Follow-up|0
41441|NCT01464827|175009|P8|Overall Study|Lost to Follow-up|2
41442|NCT01464827|175010|P7|Overall Study|Lost to Follow-up|2
41443|NCT01464827|175011|P6|Overall Study|Lost to Follow-up|1
41444|NCT01464827|175012|P5|Overall Study|Lost to Follow-up|3
41445|NCT01464827|175013|P4|Overall Study|Lost to Follow-up|2
41446|NCT01464827|175014|P3|Overall Study|Lost to Follow-up|0
41447|NCT01464827|175015|P2|Overall Study|Lost to Follow-up|2
41448|NCT01464827|175016|P1|Overall Study|Lost to Follow-up|0
41449|NCT01464827|175003|P14|Overall Study|Withdrawal by Subject|0
41450|NCT01464827|175004|P13|Overall Study|Withdrawal by Subject|0
41451|NCT01464827|175005|P12|Overall Study|Withdrawal by Subject|0
41452|NCT01464827|175006|P11|Overall Study|Withdrawal by Subject|0
41453|NCT01464827|175007|P10|Overall Study|Withdrawal by Subject|0
41454|NCT01464827|175008|P9|Overall Study|Withdrawal by Subject|0
41455|NCT01464827|175009|P8|Overall Study|Withdrawal by Subject|1
41456|NCT01464827|175010|P7|Overall Study|Withdrawal by Subject|0
41457|NCT01464827|175011|P6|Overall Study|Withdrawal by Subject|0
41458|NCT01464827|175012|P5|Overall Study|Withdrawal by Subject|1
41459|NCT01464827|175013|P4|Overall Study|Withdrawal by Subject|0
41460|NCT01464827|175014|P3|Overall Study|Withdrawal by Subject|0
41461|NCT01464827|175015|P2|Overall Study|Withdrawal by Subject|0
41462|NCT01464827|175016|P1|Overall Study|Withdrawal by Subject|1
41463|NCT01464827|175003|P14|Overall Study|Adverse Event|0
41464|NCT01464827|175004|P13|Overall Study|Adverse Event|1
41465|NCT01464827|175005|P12|Overall Study|Adverse Event|0
41466|NCT01464827|175006|P11|Overall Study|Adverse Event|0
41467|NCT01464827|175007|P10|Overall Study|Adverse Event|0
41468|NCT01464827|175008|P9|Overall Study|Adverse Event|0
41469|NCT01464827|175009|P8|Overall Study|Adverse Event|0
41470|NCT01464827|175010|P7|Overall Study|Adverse Event|0
41471|NCT01464827|175011|P6|Overall Study|Adverse Event|0
41472|NCT01464827|175012|P5|Overall Study|Adverse Event|0
41473|NCT01464827|175013|P4|Overall Study|Adverse Event|0
41474|NCT01464827|175014|P3|Overall Study|Adverse Event|0
41475|NCT01464827|175015|P2|Overall Study|Adverse Event|0
41476|NCT01464827|175016|P1|Overall Study|Adverse Event|0
41477|NCT01464788|175063|P3|Overall Study|Patient had hemorrhage after tPA started|0
41478|NCT01464788|175064|P2|Overall Study|Patient had hemorrhage after tPA started|1
41479|NCT01464788|175065|P1|Overall Study|Patient had hemorrhage after tPA started|0
41480|NCT01464788|175063|P3|Overall Study|Lost to Follow-up|0
41481|NCT01464788|175064|P2|Overall Study|Lost to Follow-up|1
41482|NCT01464788|175065|P1|Overall Study|Lost to Follow-up|0
41483|NCT01464619|175078|P2|Overall Study|Lost to Follow-up|4
41484|NCT01464619|175079|P1|Overall Study|Lost to Follow-up|3
41485|NCT01464424|175099|P2|Period 1, First 6 Weeks|Adverse Event|1
41486|NCT01464424|175100|P1|Period 1, First 6 Weeks|Adverse Event|0
41487|NCT01464307|175122|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
41488|NCT01464307|175123|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
41489|NCT01464307|175122|P2|Open-Label Extension Period|Non-compliance|0
41490|NCT01464307|175123|P1|Open-Label Extension Period|Non-compliance|9
41491|NCT01464307|175122|P2|Open-Label Extension Period|Lost to Follow-up|0
41492|NCT01464307|175123|P1|Open-Label Extension Period|Lost to Follow-up|1
41493|NCT01464307|175122|P2|Open-Label Extension Period|Death|0
41494|NCT01464307|175123|P1|Open-Label Extension Period|Death|1
41495|NCT01464307|175122|P2|Open-Label Extension Period|Lack of Efficacy|0
41496|NCT01464307|175123|P1|Open-Label Extension Period|Lack of Efficacy|5
41497|NCT01464307|175122|P2|Open-Label Extension Period|Withdrawal by Subject|0
41498|NCT01464307|175123|P1|Open-Label Extension Period|Withdrawal by Subject|14
41499|NCT01464307|175122|P2|Open-Label Extension Period|Adverse Event|0
41500|NCT01464307|175123|P1|Open-Label Extension Period|Adverse Event|15
41501|NCT01464307|175122|P2|Main Period|Predefined discontinuation criteria|1
41502|NCT01464307|175123|P1|Main Period|Predefined discontinuation criteria|2
41503|NCT01464307|175122|P2|Main Period|Withdrawal by Subject|2
41504|NCT01464307|175123|P1|Main Period|Withdrawal by Subject|5
41505|NCT01464307|175122|P2|Main Period|Lack of Efficacy|0
41506|NCT01464307|175123|P1|Main Period|Lack of Efficacy|2
41507|NCT01464307|175122|P2|Main Period|Adverse Event|1
41508|NCT01464307|175123|P1|Main Period|Adverse Event|6
41509|NCT01464307|175122|P2|Main Period|Death|1
41510|NCT01464307|175123|P1|Main Period|Death|0
41511|NCT01464255|175138|P2|Overall Study|unresolve corneal staining|1
41512|NCT01464255|175139|P1|Overall Study|unresolve corneal staining|0
41513|NCT01464021|175184|P1|Overall Study|various|11
41514|NCT01464021|175184|P1|Overall Study|Lack of Efficacy|1
41515|NCT01464021|175184|P1|Overall Study|Lost to Follow-up|1
41516|NCT01464021|175184|P1|Overall Study|Withdrawal by Subject|13
41517|NCT01463982|175200|P4|Overall Study|Treatment delay over 5 week|0
41518|NCT01463982|175201|P3|Overall Study|Treatment delay over 5 week|1
41519|NCT01463982|175202|P2|Overall Study|Treatment delay over 5 week|0
41520|NCT01463982|175203|P1|Overall Study|Treatment delay over 5 week|0
41521|NCT01463982|175200|P4|Overall Study|Withdrawal by Subject|0
41522|NCT01463982|175201|P3|Overall Study|Withdrawal by Subject|1
41523|NCT01463982|175202|P2|Overall Study|Withdrawal by Subject|1
41524|NCT01463982|175203|P1|Overall Study|Withdrawal by Subject|0
41525|NCT01463878|175219|P2|Overall Study|no longer met criteria for tube feed|2
41526|NCT01463878|175220|P1|Overall Study|no longer met criteria for tube feed|2
41527|NCT01463696|175234|P8|Overall Study|Not Treated|0
41528|NCT01463696|175235|P7|Overall Study|Not Treated|1
41529|NCT01463696|175236|P6|Overall Study|Not Treated|0
41530|NCT01463696|175237|P5|Overall Study|Not Treated|0
41531|NCT01463696|175238|P4|Overall Study|Not Treated|0
41532|NCT01463696|175239|P3|Overall Study|Not Treated|0
41533|NCT01463696|175240|P2|Overall Study|Not Treated|0
41534|NCT01463696|175241|P1|Overall Study|Not Treated|0
41535|NCT01463696|175234|P8|Overall Study|Withdrawal by Subject|0
41536|NCT01463696|175235|P7|Overall Study|Withdrawal by Subject|2
41537|NCT01463696|175236|P6|Overall Study|Withdrawal by Subject|1
41538|NCT01463696|175237|P5|Overall Study|Withdrawal by Subject|1
41539|NCT01463696|175238|P4|Overall Study|Withdrawal by Subject|1
41540|NCT01463696|175239|P3|Overall Study|Withdrawal by Subject|0
41541|NCT01463696|175240|P2|Overall Study|Withdrawal by Subject|0
41542|NCT01463696|175241|P1|Overall Study|Withdrawal by Subject|0
41543|NCT01463696|175234|P8|Overall Study|Progressive Disease|2
41544|NCT01463696|175235|P7|Overall Study|Progressive Disease|4
41545|NCT01463696|175236|P6|Overall Study|Progressive Disease|1
41546|NCT01463696|175237|P5|Overall Study|Progressive Disease|0
41547|NCT01463696|175238|P4|Overall Study|Progressive Disease|1
41548|NCT01463696|175239|P3|Overall Study|Progressive Disease|0
41549|NCT01463696|175240|P2|Overall Study|Progressive Disease|1
41550|NCT01463696|175241|P1|Overall Study|Progressive Disease|0
41551|NCT01463696|175234|P8|Overall Study|Lost to Follow-up|0
41552|NCT01463696|175235|P7|Overall Study|Lost to Follow-up|0
41553|NCT01463696|175236|P6|Overall Study|Lost to Follow-up|0
41554|NCT01463696|175237|P5|Overall Study|Lost to Follow-up|0
41555|NCT01463696|175238|P4|Overall Study|Lost to Follow-up|0
41556|NCT01463696|175239|P3|Overall Study|Lost to Follow-up|1
41557|NCT01463696|175240|P2|Overall Study|Lost to Follow-up|0
41558|NCT01463696|175241|P1|Overall Study|Lost to Follow-up|0
41559|NCT01463696|175234|P8|Overall Study|Adverse Event|2
41560|NCT01463696|175235|P7|Overall Study|Adverse Event|3
41561|NCT01463696|175236|P6|Overall Study|Adverse Event|1
41562|NCT01463696|175237|P5|Overall Study|Adverse Event|0
41563|NCT01463696|175238|P4|Overall Study|Adverse Event|2
41564|NCT01463696|175239|P3|Overall Study|Adverse Event|0
41565|NCT01463696|175240|P2|Overall Study|Adverse Event|1
41566|NCT01463696|175241|P1|Overall Study|Adverse Event|0
41567|NCT01463683|175294|P3|Overall Study|Withdrawal by Subject|2
41568|NCT01463683|175295|P2|Overall Study|Withdrawal by Subject|17
41569|NCT01463683|175296|P1|Overall Study|Withdrawal by Subject|5
41570|NCT01463683|175294|P3|Overall Study|Pregnancy|1
41571|NCT01463683|175295|P2|Overall Study|Pregnancy|2
41572|NCT01463683|175296|P1|Overall Study|Pregnancy|2
41573|NCT01463683|175294|P3|Overall Study|Physician Decision|1
41574|NCT01463683|175295|P2|Overall Study|Physician Decision|3
41575|NCT01463683|175296|P1|Overall Study|Physician Decision|0
41576|NCT01463683|175294|P3|Overall Study|Lost to Follow-up|7
41577|NCT01463683|175295|P2|Overall Study|Lost to Follow-up|9
41578|NCT01463683|175296|P1|Overall Study|Lost to Follow-up|10
41579|NCT01463683|175294|P3|Overall Study|Adverse Event|0
41580|NCT01463683|175295|P2|Overall Study|Adverse Event|0
41581|NCT01463683|175296|P1|Overall Study|Adverse Event|2
41582|NCT01463527|175316|P2|Overall Study|Crying >20% of sedation|6
41583|NCT01463527|175317|P1|Overall Study|Crying >20% of sedation|5
41584|NCT01463527|175316|P2|Overall Study|Protocol Violation|1
41585|NCT01463527|175317|P1|Overall Study|Protocol Violation|1
41586|NCT01463293|175338|P3|Overall Study|Other|2
41587|NCT01463293|175339|P2|Overall Study|Other|0
41588|NCT01463293|175340|P1|Overall Study|Other|0
41589|NCT01463293|175338|P3|Overall Study|Withdrawal by Subject|5
41590|NCT01463293|175339|P2|Overall Study|Withdrawal by Subject|10
41591|NCT01463293|175340|P1|Overall Study|Withdrawal by Subject|4
41592|NCT01463293|175338|P3|Overall Study|Adverse Event|0
41593|NCT01463293|175339|P2|Overall Study|Adverse Event|2
41594|NCT01463293|175340|P1|Overall Study|Adverse Event|1
41595|NCT01463293|175338|P3|Overall Study|Lost to Follow-up|5
41596|NCT01463293|175339|P2|Overall Study|Lost to Follow-up|4
41597|NCT01463293|175340|P1|Overall Study|Lost to Follow-up|1
41598|NCT01463111|175348|P1|Overall Study|Physician Decision|2
41599|NCT01463111|175348|P1|Overall Study|Lost to Follow-up|5
41600|NCT01463111|175348|P1|Overall Study|Withdrawal by Subject|2
41601|NCT01463033|175358|P2|Overall Study|Death|2
41602|NCT01463033|175359|P1|Overall Study|Death|3
41603|NCT01463033|175358|P2|Overall Study|Lost to Follow-up|4
41604|NCT01463033|175359|P1|Overall Study|Lost to Follow-up|4
41605|NCT01463007|175366|P1|Overall Study|Physician Decision|1
41606|NCT01462942|175377|P5|Overall Study|Protocol Violation|6
41607|NCT01462942|175378|P4|Overall Study|Protocol Violation|9
41608|NCT01462942|175379|P3|Overall Study|Protocol Violation|9
41609|NCT01462942|175380|P2|Overall Study|Protocol Violation|6
41610|NCT01462942|175381|P1|Overall Study|Protocol Violation|4
41611|NCT01462942|175377|P5|Overall Study|Lost to Follow-up|1
41612|NCT01462942|175378|P4|Overall Study|Lost to Follow-up|1
41613|NCT01462942|175379|P3|Overall Study|Lost to Follow-up|1
41614|NCT01462942|175380|P2|Overall Study|Lost to Follow-up|1
41615|NCT01462942|175381|P1|Overall Study|Lost to Follow-up|0
41616|NCT01462942|175377|P5|Overall Study|Lack of Efficacy|3
41617|NCT01462942|175378|P4|Overall Study|Lack of Efficacy|5
41618|NCT01462942|175379|P3|Overall Study|Lack of Efficacy|4
41619|NCT01462942|175380|P2|Overall Study|Lack of Efficacy|0
41620|NCT01462942|175381|P1|Overall Study|Lack of Efficacy|6
41621|NCT01462942|175377|P5|Overall Study|Withdrawal by Subject|19
41622|NCT01462942|175378|P4|Overall Study|Withdrawal by Subject|16
41623|NCT01462942|175379|P3|Overall Study|Withdrawal by Subject|14
41624|NCT01462942|175380|P2|Overall Study|Withdrawal by Subject|10
41625|NCT01462942|175381|P1|Overall Study|Withdrawal by Subject|14
41626|NCT01462942|175377|P5|Overall Study|Other, including COPD exacerbation|5
41627|NCT01462942|175378|P4|Overall Study|Other, including COPD exacerbation|8
41628|NCT01462942|175379|P3|Overall Study|Other, including COPD exacerbation|2
41629|NCT01462942|175380|P2|Overall Study|Other, including COPD exacerbation|5
41630|NCT01462942|175381|P1|Overall Study|Other, including COPD exacerbation|3
41631|NCT01462942|175377|P5|Overall Study|Adverse Event|11
41632|NCT01462942|175378|P4|Overall Study|Adverse Event|11
41633|NCT01462942|175379|P3|Overall Study|Adverse Event|10
41634|NCT01462942|175380|P2|Overall Study|Adverse Event|12
41635|NCT01462942|175381|P1|Overall Study|Adverse Event|7
41636|NCT01462929|175411|P3|Overall Study|Lack of Efficacy|1
41637|NCT01462929|175412|P2|Overall Study|Lack of Efficacy|0
41638|NCT01462929|175413|P1|Overall Study|Lack of Efficacy|0
41639|NCT01462929|175411|P3|Overall Study|Withdrawal by Subject|0
41640|NCT01462929|175412|P2|Overall Study|Withdrawal by Subject|1
41641|NCT01462929|175413|P1|Overall Study|Withdrawal by Subject|2
41642|NCT01462929|175411|P3|Overall Study|Adverse Event|4
41643|NCT01462929|175412|P2|Overall Study|Adverse Event|3
41644|NCT01462929|175413|P1|Overall Study|Adverse Event|3
41645|NCT01462695|175449|P2|Overall Study|Inevaluable (did not receive study drug)|0
41646|NCT01462695|175450|P1|Overall Study|Inevaluable (did not receive study drug)|1
41647|NCT01462695|175449|P2|Overall Study|Withdrawal by Subject|0
41648|NCT01462695|175450|P1|Overall Study|Withdrawal by Subject|2
41649|NCT01462695|175449|P2|Overall Study|Physician Decision|0
41650|NCT01462695|175450|P1|Overall Study|Physician Decision|5
41651|NCT01462695|175449|P2|Overall Study|Lack of Efficacy|12
41652|NCT01462695|175450|P1|Overall Study|Lack of Efficacy|6
41653|NCT01462695|175449|P2|Overall Study|Death|0
41654|NCT01462695|175450|P1|Overall Study|Death|2
41655|NCT01462695|175449|P2|Overall Study|Adverse Event|1
41656|NCT01462695|175450|P1|Overall Study|Adverse Event|1
41657|NCT01462435|175460|P4|Overall Study|Lost to Follow-up|1
41658|NCT01462435|175461|P3|Overall Study|Lost to Follow-up|0
41659|NCT01462435|175462|P2|Overall Study|Lost to Follow-up|0
41660|NCT01462435|175463|P1|Overall Study|Lost to Follow-up|0
41661|NCT01462435|175460|P4|Overall Study|Withdrawal by Subject|1
41662|NCT01462435|175461|P3|Overall Study|Withdrawal by Subject|0
41663|NCT01462435|175462|P2|Overall Study|Withdrawal by Subject|0
41664|NCT01462435|175463|P1|Overall Study|Withdrawal by Subject|0
41665|NCT01462435|175460|P4|Overall Study|Physician Decision|0
41666|NCT01462435|175461|P3|Overall Study|Physician Decision|1
41667|NCT01462435|175462|P2|Overall Study|Physician Decision|0
41668|NCT01462435|175463|P1|Overall Study|Physician Decision|0
41669|NCT01462435|175460|P4|Overall Study|Lack of Efficacy|3
41670|NCT01462435|175461|P3|Overall Study|Lack of Efficacy|0
41671|NCT01462435|175462|P2|Overall Study|Lack of Efficacy|0
41672|NCT01462435|175463|P1|Overall Study|Lack of Efficacy|1
41673|NCT01462370|175501|P2|Overall Study|Withdrawal by Subject|3
41674|NCT01462370|175502|P1|Overall Study|Withdrawal by Subject|0
41675|NCT01462370|175501|P2|Overall Study|Physician Decision|1
41676|NCT01462370|175502|P1|Overall Study|Physician Decision|0
41677|NCT01462370|175501|P2|Overall Study|Lack of Qualifying Event|1
41678|NCT01462370|175502|P1|Overall Study|Lack of Qualifying Event|1
41679|NCT01462357|175537|P3|Month 24|Migrated/moved from study area|0
41680|NCT01462357|175538|P2|Month 24|Migrated/moved from study area|2
41681|NCT01462357|175539|P1|Month 24|Migrated/moved from study area|0
41682|NCT01462357|175537|P3|Month 24|Lost to Follow-up|6
41683|NCT01462357|175538|P2|Month 24|Lost to Follow-up|4
41684|NCT01462357|175539|P1|Month 24|Lost to Follow-up|2
41685|NCT01462357|175537|P3|Month 24|Withdrawal by Subject|3
41686|NCT01462357|175538|P2|Month 24|Withdrawal by Subject|8
41687|NCT01462357|175539|P1|Month 24|Withdrawal by Subject|2
41688|NCT01462357|175537|P3|Month 18|Unspecified|1
41689|NCT01462357|175538|P2|Month 18|Unspecified|1
41690|NCT01462357|175539|P1|Month 18|Unspecified|0
41691|NCT01462357|175537|P3|Month 18|Lost to Follow-up|5
41692|NCT01462357|175538|P2|Month 18|Lost to Follow-up|4
41693|NCT01462357|175539|P1|Month 18|Lost to Follow-up|1
41694|NCT01462357|175537|P3|Month 18|Withdrawal by Subject|3
41695|NCT01462357|175538|P2|Month 18|Withdrawal by Subject|6
41696|NCT01462357|175539|P1|Month 18|Withdrawal by Subject|2
41697|NCT01462357|175537|P3|Month 12|Lost to Follow-up|5
41698|NCT01462357|175538|P2|Month 12|Lost to Follow-up|4
41699|NCT01462357|175539|P1|Month 12|Lost to Follow-up|1
41700|NCT01462357|175537|P3|Month 12|Withdrawal by Subject|3
41701|NCT01462357|175538|P2|Month 12|Withdrawal by Subject|6
41702|NCT01462357|175539|P1|Month 12|Withdrawal by Subject|2
41703|NCT01462357|175537|P3|Month 7|Withdrawal by Subject|6
41704|NCT01462357|175538|P2|Month 7|Withdrawal by Subject|5
41705|NCT01462357|175539|P1|Month 7|Withdrawal by Subject|1
41706|NCT01462344|175612|P2|Overall Study|Lost to Follow-up|7
41707|NCT01462344|175613|P1|Overall Study|Lost to Follow-up|7
41708|NCT01462344|175612|P2|Overall Study|Protocol Violation|53
41709|NCT01462344|175613|P1|Overall Study|Protocol Violation|68
41710|NCT01462344|175612|P2|Overall Study|Lack of Efficacy|6
41711|NCT01462344|175613|P1|Overall Study|Lack of Efficacy|5
41712|NCT01462344|175612|P2|Overall Study|Asthma Exacerbation|35
41713|NCT01462344|175613|P1|Overall Study|Asthma Exacerbation|34
41714|NCT01462344|175612|P2|Overall Study|Adverse Event|23
41715|NCT01462344|175613|P1|Overall Study|Adverse Event|24
41716|NCT01462344|175612|P2|Overall Study|Withdrawal by Subject|226
41717|NCT01462344|175613|P1|Overall Study|Withdrawal by Subject|245
41718|NCT01462318|175635|P3|Extension Phase|Adverse Event|22
41719|NCT01462318|175636|P2|Extension Phase|Adverse Event|0
41720|NCT01462318|175637|P1|Extension Phase|Adverse Event|0
41721|NCT01462318|175635|P3|Extension Phase|Investigator Decision|5
41722|NCT01462318|175636|P2|Extension Phase|Investigator Decision|0
41723|NCT01462318|175637|P1|Extension Phase|Investigator Decision|0
41724|NCT01462318|175635|P3|Extension Phase|Withdrawal by Subject|15
41725|NCT01462318|175636|P2|Extension Phase|Withdrawal by Subject|0
41726|NCT01462318|175637|P1|Extension Phase|Withdrawal by Subject|0
41727|NCT01462318|175635|P3|Extension Phase|Disease Progression|1
41728|NCT01462318|175636|P2|Extension Phase|Disease Progression|0
41729|NCT01462318|175637|P1|Extension Phase|Disease Progression|0
41730|NCT01462318|175635|P3|Extension Phase|Not Specified|1
41731|NCT01462318|175636|P2|Extension Phase|Not Specified|0
41732|NCT01462318|175637|P1|Extension Phase|Not Specified|0
41733|NCT01462318|175635|P3|Extension Phase|Lost to Follow-up|1
41734|NCT01462318|175636|P2|Extension Phase|Lost to Follow-up|0
41735|NCT01462318|175637|P1|Extension Phase|Lost to Follow-up|0
41736|NCT01462318|175635|P3|Main Study / TP-DI Study|Adverse Event|0
41737|NCT01462318|175636|P2|Main Study / TP-DI Study|Adverse Event|0
41738|NCT01462318|175637|P1|Main Study / TP-DI Study|Adverse Event|4
41739|NCT01462318|175635|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
41740|NCT01462318|175636|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
41741|NCT01462318|175637|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
41742|NCT01462318|175635|P3|Main Study / TP-DI Study|Not Specified|0
41743|NCT01462318|175636|P2|Main Study / TP-DI Study|Not Specified|0
41744|NCT01462318|175637|P1|Main Study / TP-DI Study|Not Specified|2
41745|NCT01462266|175660|P2|Overall Study|Screen failure|1
41746|NCT01462266|175661|P1|Overall Study|Screen failure|1
41747|NCT01462266|175660|P2|Overall Study|Withdrawal by Subject|2
41748|NCT01462266|175661|P1|Overall Study|Withdrawal by Subject|7
41749|NCT01462266|175660|P2|Overall Study|Protocol Violation|3
41750|NCT01462266|175661|P1|Overall Study|Protocol Violation|1
41751|NCT01462266|175660|P2|Overall Study|Physician Decision|5
41752|NCT01462266|175661|P1|Overall Study|Physician Decision|2
41753|NCT01462266|175660|P2|Overall Study|Creatinine and eGFR, excluded medication|4
41754|NCT01462266|175661|P1|Overall Study|Creatinine and eGFR, excluded medication|8
41755|NCT01462266|175660|P2|Overall Study|Non-compliance with study drug|0
41756|NCT01462266|175661|P1|Overall Study|Non-compliance with study drug|3
41757|NCT01462266|175660|P2|Overall Study|Lost to Follow-up|3
41758|NCT01462266|175661|P1|Overall Study|Lost to Follow-up|4
41759|NCT01462266|175660|P2|Overall Study|Lack of Efficacy|2
41760|NCT01462266|175661|P1|Overall Study|Lack of Efficacy|0
41761|NCT01462266|175660|P2|Overall Study|Death|1
41762|NCT01462266|175661|P1|Overall Study|Death|2
41763|NCT01462266|175660|P2|Overall Study|Adverse Event|6
41764|NCT01462266|175661|P1|Overall Study|Adverse Event|7
41765|NCT01462227|175677|P4|Second Assignment|Protocol Violation|0
41766|NCT01462227|175678|P3|Second Assignment|Protocol Violation|1
41767|NCT01462227|175679|P2|Second Assignment|Protocol Violation|1
41768|NCT01462227|175680|P1|Second Assignment|Protocol Violation|0
41769|NCT01462227|175677|P4|Second Assignment|Lost to Follow-up|0
41770|NCT01462227|175678|P3|Second Assignment|Lost to Follow-up|0
41771|NCT01462227|175679|P2|Second Assignment|Lost to Follow-up|0
41772|NCT01462227|175680|P1|Second Assignment|Lost to Follow-up|1
41773|NCT01462162|175698|P1|Overall Study|Unspecified|2
41774|NCT01462162|175698|P1|Overall Study|Abnormal laboratory parameters|1
41775|NCT01462162|175698|P1|Overall Study|Lack of Efficacy|4
41776|NCT01462162|175698|P1|Overall Study|Adverse Event|5
41777|NCT01462084|175723|P2|Overall Study|Protocol Violation|1
41778|NCT01462084|175724|P1|Overall Study|Protocol Violation|1
41779|NCT01462084|175723|P2|Overall Study|Withdrawal by Subject|0
41780|NCT01462084|175724|P1|Overall Study|Withdrawal by Subject|1
41781|NCT01462045|175735|P3|Overall Study|Family matter|0
41782|NCT01462045|175736|P2|Overall Study|Family matter|1
41783|NCT01462045|175737|P1|Overall Study|Family matter|0
41784|NCT01461993|175751|P3|Overall Study|Unspecified|6
41785|NCT01461993|175752|P2|Overall Study|Unspecified|15
41786|NCT01461993|175753|P1|Overall Study|Unspecified|13
41787|NCT01461993|175751|P3|Overall Study|Did not meet entrance criteria|0
41788|NCT01461993|175752|P2|Overall Study|Did not meet entrance criteria|3
41789|NCT01461993|175753|P1|Overall Study|Did not meet entrance criteria|2
41790|NCT01461993|175751|P3|Overall Study|No longer met eligibility criteria|10
41791|NCT01461993|175752|P2|Overall Study|No longer met eligibility criteria|18
41792|NCT01461993|175753|P1|Overall Study|No longer met eligibility criteria|13
41793|NCT01461993|175751|P3|Overall Study|Adverse Event|3
41794|NCT01461993|175752|P2|Overall Study|Adverse Event|11
41795|NCT01461993|175753|P1|Overall Study|Adverse Event|9
41796|NCT01461993|175751|P3|Overall Study|Protocol Violation|7
41797|NCT01461993|175752|P2|Overall Study|Protocol Violation|9
41798|NCT01461993|175753|P1|Overall Study|Protocol Violation|10
41799|NCT01461993|175751|P3|Overall Study|Lost to Follow-up|22
41800|NCT01461993|175752|P2|Overall Study|Lost to Follow-up|48
41801|NCT01461993|175753|P1|Overall Study|Lost to Follow-up|44
41802|NCT01461993|175751|P3|Overall Study|Withdrawal by Subject|16
41803|NCT01461993|175752|P2|Overall Study|Withdrawal by Subject|53
41804|NCT01461993|175753|P1|Overall Study|Withdrawal by Subject|60
41805|NCT01461980|175778|P3|Overall Study|Randomized but not vaccinated|7
41806|NCT01461980|175779|P2|Overall Study|Randomized but not vaccinated|8
41807|NCT01461980|175780|P1|Overall Study|Randomized but not vaccinated|4
41808|NCT01461980|175778|P3|Overall Study|No longer willing to participate|54
41809|NCT01461980|175779|P2|Overall Study|No longer willing to participate|38
41810|NCT01461980|175780|P1|Overall Study|No longer willing to participate|52
41811|NCT01461980|175778|P3|Overall Study|Lost to Follow-up|51
41812|NCT01461980|175779|P2|Overall Study|Lost to Follow-up|53
41813|NCT01461980|175780|P1|Overall Study|Lost to Follow-up|52
41814|NCT01461980|175778|P3|Overall Study|No longer meets eligibility criteria|19
41815|NCT01461980|175779|P2|Overall Study|No longer meets eligibility criteria|9
41816|NCT01461980|175780|P1|Overall Study|No longer meets eligibility criteria|18
41817|NCT01461980|175778|P3|Overall Study|Protocol Violation|16
41818|NCT01461980|175779|P2|Overall Study|Protocol Violation|19
41819|NCT01461980|175780|P1|Overall Study|Protocol Violation|12
41820|NCT01461980|175778|P3|Overall Study|Adverse Event|6
41821|NCT01461980|175779|P2|Overall Study|Adverse Event|5
41822|NCT01461980|175780|P1|Overall Study|Adverse Event|12
41823|NCT01461980|175778|P3|Overall Study|Medication error|6
41824|NCT01461980|175779|P2|Overall Study|Medication error|5
41825|NCT01461980|175780|P1|Overall Study|Medication error|7
41826|NCT01461980|175778|P3|Overall Study|Unspecified|6
41827|NCT01461980|175779|P2|Overall Study|Unspecified|8
41828|NCT01461980|175780|P1|Overall Study|Unspecified|9
41829|NCT01461811|175812|P2|Overall Study|Noncompliance|1
41830|NCT01461811|175813|P1|Overall Study|Noncompliance|1
41831|NCT01461811|175812|P2|Overall Study|Subject decision unrelated to an AE|1
41832|NCT01461811|175813|P1|Overall Study|Subject decision unrelated to an AE|1
41833|NCT01461811|175812|P2|Overall Study|Adverse Event|1
41834|NCT01461811|175813|P1|Overall Study|Adverse Event|2
41835|NCT01461707|175852|P2|Overall Study|Withdrawal by Subject|0
41836|NCT01461707|175853|P1|Overall Study|Withdrawal by Subject|1
41837|NCT01461551|175881|P3|Overall Study|Physician Decision|2
41838|NCT01461551|175882|P2|Overall Study|Physician Decision|1
41839|NCT01461551|175883|P1|Overall Study|Physician Decision|2
41840|NCT01461538|175894|P3|Overall Study|Withdrawal by Subject|0
41841|NCT01461538|175895|P2|Overall Study|Withdrawal by Subject|1
41842|NCT01461538|175896|P1|Overall Study|Withdrawal by Subject|1
41843|NCT01461538|175894|P3|Overall Study|Study Stopped by Sponsor|0
41844|NCT01461538|175895|P2|Overall Study|Study Stopped by Sponsor|1
41845|NCT01461538|175896|P1|Overall Study|Study Stopped by Sponsor|2
41846|NCT01461538|175894|P3|Overall Study|Death|2
41847|NCT01461538|175895|P2|Overall Study|Death|6
41848|NCT01461538|175896|P1|Overall Study|Death|15
41849|NCT01461369|175954|P3|Overall Study|Withdrawal by Subject|2
41850|NCT01461369|175955|P2|Overall Study|Withdrawal by Subject|3
41851|NCT01461369|175956|P1|Overall Study|Withdrawal by Subject|1
41852|NCT01461369|175954|P3|Overall Study|Protocol Violation|2
41853|NCT01461369|175955|P2|Overall Study|Protocol Violation|2
41854|NCT01461369|175956|P1|Overall Study|Protocol Violation|1
41855|NCT01461369|175954|P3|Overall Study|Adverse Event|4
41856|NCT01461369|175955|P2|Overall Study|Adverse Event|12
41857|NCT01461369|175956|P1|Overall Study|Adverse Event|9
41858|NCT01461369|175954|P3|Overall Study|Lost to Follow-up|3
41859|NCT01461369|175955|P2|Overall Study|Lost to Follow-up|0
41860|NCT01461369|175956|P1|Overall Study|Lost to Follow-up|0
41861|NCT01461369|175954|P3|Overall Study|Lack of Efficacy|6
41862|NCT01461369|175955|P2|Overall Study|Lack of Efficacy|0
41863|NCT01461369|175956|P1|Overall Study|Lack of Efficacy|2
41864|NCT01461096|175981|P2|Overall Study|Lost to Follow-up|4
41865|NCT01461096|175982|P1|Overall Study|Lost to Follow-up|8
41866|NCT01461096|175981|P2|Overall Study|Subj not willing to adhere to reqs|4
41867|NCT01461096|175982|P1|Overall Study|Subj not willing to adhere to reqs|3
41868|NCT01461096|175981|P2|Overall Study|Withdrawal by Subject|3
41869|NCT01461096|175982|P1|Overall Study|Withdrawal by Subject|5
41870|NCT01461096|175981|P2|Overall Study|Site is closing|30
41871|NCT01461096|175982|P1|Overall Study|Site is closing|27
41872|NCT01461096|175981|P2|Overall Study|Subj not able to get to clinic|13
41873|NCT01461096|175982|P1|Overall Study|Subj not able to get to clinic|15
41874|NCT01461096|175981|P2|Overall Study|Severe debilitation, unable to continue|1
41875|NCT01461096|175982|P1|Overall Study|Severe debilitation, unable to continue|1
41876|NCT01461096|175981|P2|Overall Study|Death|6
41877|NCT01461096|175982|P1|Overall Study|Death|3
41878|NCT01461057|175998|P2|Overall Study|Physician Decision|1
41879|NCT01461057|175999|P1|Overall Study|Physician Decision|0
41880|NCT01461057|175998|P2|Overall Study|Withdrawal by Subject|3
41881|NCT01461057|175999|P1|Overall Study|Withdrawal by Subject|2
41882|NCT01461057|175998|P2|Overall Study|Death|8
41883|NCT01461057|175999|P1|Overall Study|Death|7
41884|NCT01461057|175998|P2|Overall Study|Currently in safety follow up|3
41885|NCT01461057|175999|P1|Overall Study|Currently in safety follow up|4
41886|NCT01461057|175998|P2|Overall Study|Currently in treatment|0
41887|NCT01461057|175999|P1|Overall Study|Currently in treatment|2
41888|NCT01461044|176009|P2|Overall Study|Lost to Follow-up|5
41889|NCT01461044|176010|P1|Overall Study|Lost to Follow-up|12
41890|NCT01461044|176009|P2|Overall Study|Death|35
41891|NCT01461044|176010|P1|Overall Study|Death|58
41892|NCT01460628|176110|P1|Overall Study|Withdrawal by Subject|2
41893|NCT01460628|176110|P1|Overall Study|Adverse Event|3
41894|NCT01460446|176122|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
41895|NCT01460446|176123|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
41896|NCT01460446|176122|P2|Overall Study|Pregnancy|0
41897|NCT01460446|176123|P1|Overall Study|Pregnancy|1
41898|NCT01460446|176122|P2|Overall Study|Surgery/Illness|1
41899|NCT01460446|176123|P1|Overall Study|Surgery/Illness|1
41900|NCT01460446|176122|P2|Overall Study|Non-compliance & Consent Withdrawn|3
41901|NCT01460446|176123|P1|Overall Study|Non-compliance & Consent Withdrawn|1
41902|NCT01460446|176122|P2|Overall Study|Consent Withdrawn|4
41903|NCT01460446|176123|P1|Overall Study|Consent Withdrawn|0
41904|NCT01460446|176122|P2|Overall Study|Non-compliance|9
41905|NCT01460446|176123|P1|Overall Study|Non-compliance|2
41906|NCT01460342|176152|P2|Overall Study|Lack of Efficacy|0
41907|NCT01460342|176153|P1|Overall Study|Lack of Efficacy|1
41908|NCT01460342|176152|P2|Overall Study|Physician Decision|3
41909|NCT01460342|176153|P1|Overall Study|Physician Decision|1
41910|NCT01460342|176152|P2|Overall Study|Withdrawal by Subject|4
41911|NCT01460342|176153|P1|Overall Study|Withdrawal by Subject|3
41912|NCT01460342|176152|P2|Overall Study|Protocol Violation|1
41913|NCT01460342|176153|P1|Overall Study|Protocol Violation|0
41914|NCT01460342|176152|P2|Overall Study|Lost to Follow-up|2
41915|NCT01460342|176153|P1|Overall Study|Lost to Follow-up|1
41916|NCT01460342|176152|P2|Overall Study|Adverse Event|4
41917|NCT01460342|176153|P1|Overall Study|Adverse Event|5
41918|NCT01460290|176173|P1|Overall Study|Elevated liver function|1
41919|NCT01460290|176173|P1|Overall Study|Adverse Event|3
41920|NCT01459913|176197|P4|Overall Study|Did Not Meet Inclusion Criteria|1
41921|NCT01459913|176198|P3|Overall Study|Did Not Meet Inclusion Criteria|0
41922|NCT01459913|176199|P2|Overall Study|Did Not Meet Inclusion Criteria|0
41923|NCT01459913|176200|P1|Overall Study|Did Not Meet Inclusion Criteria|0
41924|NCT01459913|176197|P4|Overall Study|Unspecified|1
41925|NCT01459913|176198|P3|Overall Study|Unspecified|3
41926|NCT01459913|176199|P2|Overall Study|Unspecified|0
41927|NCT01459913|176200|P1|Overall Study|Unspecified|0
41928|NCT01459913|176197|P4|Overall Study|Study Terminated by Sponsor|11
41929|NCT01459913|176198|P3|Overall Study|Study Terminated by Sponsor|9
41930|NCT01459913|176199|P2|Overall Study|Study Terminated by Sponsor|15
41931|NCT01459913|176200|P1|Overall Study|Study Terminated by Sponsor|30
41932|NCT01459913|176197|P4|Overall Study|Physician Decision|0
41933|NCT01459913|176198|P3|Overall Study|Physician Decision|0
41934|NCT01459913|176199|P2|Overall Study|Physician Decision|1
41935|NCT01459913|176200|P1|Overall Study|Physician Decision|0
41936|NCT01459913|176197|P4|Overall Study|Non- Compliance|3
41937|NCT01459913|176198|P3|Overall Study|Non- Compliance|0
41938|NCT01459913|176199|P2|Overall Study|Non- Compliance|0
41939|NCT01459913|176200|P1|Overall Study|Non- Compliance|0
41940|NCT01459913|176197|P4|Overall Study|Death|1
41941|NCT01459913|176198|P3|Overall Study|Death|0
41942|NCT01459913|176199|P2|Overall Study|Death|0
41943|NCT01459913|176200|P1|Overall Study|Death|0
41944|NCT01459913|176197|P4|Overall Study|Lost to Follow-up|8
41945|NCT01459913|176198|P3|Overall Study|Lost to Follow-up|1
41946|NCT01459913|176199|P2|Overall Study|Lost to Follow-up|4
41947|NCT01459913|176200|P1|Overall Study|Lost to Follow-up|7
41948|NCT01459913|176197|P4|Overall Study|Withdrawal by Subject|5
41949|NCT01459913|176198|P3|Overall Study|Withdrawal by Subject|0
41950|NCT01459913|176199|P2|Overall Study|Withdrawal by Subject|0
41951|NCT01459913|176200|P1|Overall Study|Withdrawal by Subject|4
41952|NCT01459913|176197|P4|Overall Study|Adverse Event|3
41953|NCT01459913|176198|P3|Overall Study|Adverse Event|0
41954|NCT01459913|176199|P2|Overall Study|Adverse Event|0
41955|NCT01459913|176200|P1|Overall Study|Adverse Event|0
41956|NCT01459796|176231|P2|Overall Study|Decision by the sponsor|108
41957|NCT01459796|176232|P1|Overall Study|Decision by the sponsor|75
41958|NCT01459796|176231|P2|Overall Study|Reason unspecified|2
41959|NCT01459796|176232|P1|Overall Study|Reason unspecified|1
41960|NCT01459796|176231|P2|Overall Study|Lost to Follow-up|4
41961|NCT01459796|176232|P1|Overall Study|Lost to Follow-up|5
41962|NCT01459796|176231|P2|Overall Study|Withdrawal by Subject|3
41963|NCT01459796|176232|P1|Overall Study|Withdrawal by Subject|6
41964|NCT01459796|176231|P2|Overall Study|Adverse Event|5
41965|NCT01459796|176232|P1|Overall Study|Adverse Event|5
41966|NCT01459796|176231|P2|Overall Study|Non compliance with protocol|4
41967|NCT01459796|176232|P1|Overall Study|Non compliance with protocol|2
41968|NCT01459783|176250|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
41969|NCT01459783|176251|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
41970|NCT01459783|176250|P2|6 Months to 12 Months|Lost to Follow-up|7
41971|NCT01459783|176251|P1|6 Months to 12 Months|Lost to Follow-up|2
41972|NCT01459783|176250|P2|6 Months to 12 Months|Withdrawal by Subject|5
41973|NCT01459783|176251|P1|6 Months to 12 Months|Withdrawal by Subject|6
41974|NCT01459783|176250|P2|6 Months to 12 Months|Death|1
41975|NCT01459783|176251|P1|6 Months to 12 Months|Death|0
41976|NCT01459783|176250|P2|Baseline to 6 Months|Lost to Follow-up|14
41977|NCT01459783|176251|P1|Baseline to 6 Months|Lost to Follow-up|19
41978|NCT01459783|176250|P2|Baseline to 6 Months|Withdrawal by Subject|6
41979|NCT01459783|176251|P1|Baseline to 6 Months|Withdrawal by Subject|12
41980|NCT01459783|176250|P2|Baseline to 6 Months|Death|0
41981|NCT01459783|176251|P1|Baseline to 6 Months|Death|1
41982|NCT01459068|176463|P2|Overall Study|Death|1
41983|NCT01459068|176464|P1|Overall Study|Death|0
41984|NCT01459068|176463|P2|Overall Study|Lost to Follow-up|15
41985|NCT01459068|176464|P1|Overall Study|Lost to Follow-up|31
41986|NCT01459068|176463|P2|Overall Study|Withdrawal by Subject|18
41987|NCT01459068|176464|P1|Overall Study|Withdrawal by Subject|8
41988|NCT01459016|176480|P1|Overall Study|Amendment Discontinuation Criteria|4
41989|NCT01459016|176480|P1|Overall Study|Withdrawal by Subject|11
41990|NCT01458951|176497|P3|Overall Study|Insufficient Clinical Response|11
41991|NCT01458951|176498|P2|Overall Study|Insufficient Clinical Response|0
41992|NCT01458951|176499|P1|Overall Study|Insufficient Clinical Response|17
41993|NCT01458951|176497|P3|Overall Study|Adverse Event|2
41994|NCT01458951|176498|P2|Overall Study|Adverse Event|0
41995|NCT01458951|176499|P1|Overall Study|Adverse Event|7
41996|NCT01458951|176497|P3|Overall Study|Withdrawal by Subject|2
41997|NCT01458951|176498|P2|Overall Study|Withdrawal by Subject|0
41998|NCT01458951|176499|P1|Overall Study|Withdrawal by Subject|2
41999|NCT01458951|176497|P3|Overall Study|Protocol Violation|0
42000|NCT01458951|176498|P2|Overall Study|Protocol Violation|1
42001|NCT01458951|176499|P1|Overall Study|Protocol Violation|5
42002|NCT01458951|176497|P3|Overall Study|Unspecified|0
42003|NCT01458951|176498|P2|Overall Study|Unspecified|0
42004|NCT01458951|176499|P1|Overall Study|Unspecified|1
42005|NCT01458639|176524|P1|Overall Study|Inability to obtain subject blood sample|1
42006|NCT01458639|176524|P1|Overall Study|Equipment issue|1
42007|NCT01458639|176524|P1|Overall Study|Physician Decision|4
42008|NCT01458587|176536|P2|Overall Study|Withdrawal by Subject|0
42009|NCT01458587|176537|P1|Overall Study|Withdrawal by Subject|1
42010|NCT01458574|176700|P3|Overall Study|Randomized but not treated|0
42011|NCT01458574|176701|P2|Overall Study|Randomized but not treated|1
42012|NCT01458574|176702|P1|Overall Study|Randomized but not treated|0
42013|NCT01458574|176700|P3|Overall Study|Unspecified|0
42014|NCT01458574|176701|P2|Overall Study|Unspecified|1
42015|NCT01458574|176702|P1|Overall Study|Unspecified|2
42016|NCT01458574|176700|P3|Overall Study|Withdrawal by Subject|5
42017|NCT01458574|176701|P2|Overall Study|Withdrawal by Subject|3
42018|NCT01458574|176702|P1|Overall Study|Withdrawal by Subject|6
42019|NCT01458574|176700|P3|Overall Study|Protocol Violation|0
42020|NCT01458574|176701|P2|Overall Study|Protocol Violation|1
42021|NCT01458574|176702|P1|Overall Study|Protocol Violation|0
42022|NCT01458574|176700|P3|Overall Study|Pregnancy|0
42023|NCT01458574|176701|P2|Overall Study|Pregnancy|1
42024|NCT01458574|176702|P1|Overall Study|Pregnancy|1
42025|NCT01458574|176700|P3|Overall Study|Lost to Follow-up|1
42026|NCT01458574|176701|P2|Overall Study|Lost to Follow-up|2
42027|NCT01458574|176702|P1|Overall Study|Lost to Follow-up|3
42028|NCT01458574|176700|P3|Overall Study|Lack of Efficacy|132
42029|NCT01458574|176701|P2|Overall Study|Lack of Efficacy|53
42030|NCT01458574|176702|P1|Overall Study|Lack of Efficacy|70
42031|NCT01458574|176700|P3|Overall Study|Adverse Event|7
42032|NCT01458574|176701|P2|Overall Study|Adverse Event|9
42033|NCT01458574|176702|P1|Overall Study|Adverse Event|5
42034|NCT01458535|176832|P6|Overall Study|Adverse Event|0
42035|NCT01458535|176833|P5|Overall Study|Adverse Event|0
42036|NCT01458535|176834|P4|Overall Study|Adverse Event|1
42037|NCT01458535|176835|P3|Overall Study|Adverse Event|0
42038|NCT01458535|176836|P2|Overall Study|Adverse Event|0
42039|NCT01458535|176837|P1|Overall Study|Adverse Event|0
42040|NCT01458535|176832|P6|Overall Study|Lost to Follow-up|2
42041|NCT01458535|176833|P5|Overall Study|Lost to Follow-up|2
42042|NCT01458535|176834|P4|Overall Study|Lost to Follow-up|3
42043|NCT01458535|176835|P3|Overall Study|Lost to Follow-up|0
42044|NCT01458535|176836|P2|Overall Study|Lost to Follow-up|2
42045|NCT01458535|176837|P1|Overall Study|Lost to Follow-up|0
42046|NCT01458535|176832|P6|Overall Study|Withdrawal by Subject|1
42047|NCT01458535|176833|P5|Overall Study|Withdrawal by Subject|1
42048|NCT01458535|176834|P4|Overall Study|Withdrawal by Subject|0
42049|NCT01458535|176835|P3|Overall Study|Withdrawal by Subject|2
42050|NCT01458535|176836|P2|Overall Study|Withdrawal by Subject|0
42051|NCT01458535|176837|P1|Overall Study|Withdrawal by Subject|0
42052|NCT01458535|176832|P6|Overall Study|Other|1
42053|NCT01458535|176833|P5|Overall Study|Other|1
42054|NCT01458535|176834|P4|Overall Study|Other|0
42055|NCT01458535|176835|P3|Overall Study|Other|0
42056|NCT01458535|176836|P2|Overall Study|Other|0
42057|NCT01458535|176837|P1|Overall Study|Other|0
42058|NCT01458392|176890|P3|Overall Study|Patient unwilling to comply with protoco|2
42059|NCT01458392|176891|P2|Overall Study|Patient unwilling to comply with protoco|0
42060|NCT01458392|176892|P1|Overall Study|Patient unwilling to comply with protoco|0
42061|NCT01458392|176890|P3|Overall Study|At the discretion of the sponsor|7
42062|NCT01458392|176891|P2|Overall Study|At the discretion of the sponsor|2
42063|NCT01458392|176892|P1|Overall Study|At the discretion of the sponsor|0
42064|NCT01458392|176890|P3|Overall Study|Death|22
42065|NCT01458392|176891|P2|Overall Study|Death|11
42066|NCT01458392|176892|P1|Overall Study|Death|2
42067|NCT01458275|176920|P3|Overall Study|Withdrawal by Subject|1
42068|NCT01458275|176921|P2|Overall Study|Withdrawal by Subject|2
42069|NCT01458275|176922|P1|Overall Study|Withdrawal by Subject|3
42070|NCT01458275|176920|P3|Overall Study|Protocol Violation|2
42071|NCT01458275|176921|P2|Overall Study|Protocol Violation|5
42072|NCT01458275|176922|P1|Overall Study|Protocol Violation|5
42073|NCT01458275|176920|P3|Overall Study|Lost to Follow-up|5
42074|NCT01458275|176921|P2|Overall Study|Lost to Follow-up|2
42075|NCT01458275|176922|P1|Overall Study|Lost to Follow-up|3
42076|NCT01458275|176920|P3|Overall Study|Adverse Event|1
42077|NCT01458275|176921|P2|Overall Study|Adverse Event|4
42078|NCT01458275|176922|P1|Overall Study|Adverse Event|3
42079|NCT01458249|176964|P1|Overall Study|Ongoing|1
42080|NCT01458249|176964|P1|Overall Study|Not specified|2
42081|NCT01458249|176964|P1|Overall Study|Adverse Event|4
42082|NCT01458249|176964|P1|Overall Study|Not treated|1
42083|NCT01458210|176983|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
42084|NCT01458210|176983|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
42085|NCT01458210|176983|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
42086|NCT01458210|176983|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
42087|NCT01458171|177000|P1|Overall Study|Adverse Event|1
42088|NCT01458106|177023|P2|Overall Study|Withdrawn Per Protocol|1
42089|NCT01458106|177024|P1|Overall Study|Withdrawn Per Protocol|0
42090|NCT01458106|177023|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
42091|NCT01458106|177024|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
42092|NCT01458106|177023|P2|Overall Study|Withdrawal by Subject|0
42093|NCT01458106|177024|P1|Overall Study|Withdrawal by Subject|2
42094|NCT01457950|177101|P4|Open-Label Phase|Withdrawal by Subject|0
42095|NCT01457950|177102|P3|Open-Label Phase|Withdrawal by Subject|2
42096|NCT01457950|177103|P2|Open-Label Phase|Withdrawal by Subject|0
42097|NCT01457950|177104|P1|Open-Label Phase|Withdrawal by Subject|0
42098|NCT01457950|177101|P4|Open-Label Phase|Protocol Violation|1
42099|NCT01457950|177102|P3|Open-Label Phase|Protocol Violation|0
42100|NCT01457950|177103|P2|Open-Label Phase|Protocol Violation|0
42101|NCT01457950|177104|P1|Open-Label Phase|Protocol Violation|0
42102|NCT01457950|177101|P4|Open-Label Phase|Adverse Event|1
42103|NCT01457950|177102|P3|Open-Label Phase|Adverse Event|0
42104|NCT01457950|177103|P2|Open-Label Phase|Adverse Event|0
42105|NCT01457950|177104|P1|Open-Label Phase|Adverse Event|0
42106|NCT01457950|177101|P4|Double-Blind Phase|Withdrawal by Subject|0
42107|NCT01457950|177102|P3|Double-Blind Phase|Withdrawal by Subject|0
42108|NCT01457950|177103|P2|Double-Blind Phase|Withdrawal by Subject|2
42109|NCT01457950|177104|P1|Double-Blind Phase|Withdrawal by Subject|6
42110|NCT01457950|177101|P4|Double-Blind Phase|Protocol Violation|0
42111|NCT01457950|177102|P3|Double-Blind Phase|Protocol Violation|0
42112|NCT01457950|177103|P2|Double-Blind Phase|Protocol Violation|1
42113|NCT01457950|177104|P1|Double-Blind Phase|Protocol Violation|2
42114|NCT01457950|177101|P4|Double-Blind Phase|Continuation Criteria Not Met|0
42115|NCT01457950|177102|P3|Double-Blind Phase|Continuation Criteria Not Met|0
42116|NCT01457950|177103|P2|Double-Blind Phase|Continuation Criteria Not Met|0
42117|NCT01457950|177104|P1|Double-Blind Phase|Continuation Criteria Not Met|1
42118|NCT01457846|177186|P2|Overall Study|Lost to Follow-up|0
42119|NCT01457846|177187|P1|Overall Study|Lost to Follow-up|1
42120|NCT01457846|177186|P2|Overall Study|Withdrawal by Subject|1
42121|NCT01457846|177187|P1|Overall Study|Withdrawal by Subject|1
42122|NCT01457846|177186|P2|Overall Study|Unclassified reason for not completed|10
42123|NCT01457846|177187|P1|Overall Study|Unclassified reason for not completed|11
42124|NCT01457846|177186|P2|Overall Study|Death|16
42125|NCT01457846|177187|P1|Overall Study|Death|27
42126|NCT01457846|177186|P2|Overall Study|Did not receive treatment|1
42127|NCT01457846|177187|P1|Overall Study|Did not receive treatment|0
42128|NCT01457846|177186|P2|Overall Study|Death before treatment|2
42129|NCT01457846|177187|P1|Overall Study|Death before treatment|1
42130|NCT01457703|177203|P2|Overall Study|Withdrawal by Subject|4
42131|NCT01457703|177204|P1|Overall Study|Withdrawal by Subject|1
42132|NCT01457703|177203|P2|Overall Study|Screen Failure|7
42133|NCT01457703|177204|P1|Overall Study|Screen Failure|5
42134|NCT01457339|177301|P2|Period 6 (250 mg)|Personal appointment|1
42135|NCT01457339|177302|P1|Period 6 (250 mg)|Personal appointment|0
42136|NCT01457339|177301|P2|Period 6 (250 mg)|Family Emergency|0
42137|NCT01457339|177302|P1|Period 6 (250 mg)|Family Emergency|1
42138|NCT01457339|177301|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
42139|NCT01457339|177302|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
42140|NCT01457339|177301|P2|Period 3 (100 mg)|Adverse Event|1
42141|NCT01457339|177302|P1|Period 3 (100 mg)|Adverse Event|0
42142|NCT01457053|177468|P2|Overall Study|Unable to undergo selected treatment|1
42143|NCT01457053|177469|P1|Overall Study|Unable to undergo selected treatment|1
42144|NCT01457014|177475|P4|First Night|Withdrawal by Subject|0
42145|NCT01457014|177476|P3|First Night|Withdrawal by Subject|0
42146|NCT01457014|177477|P2|First Night|Withdrawal by Subject|0
42147|NCT01457014|177478|P1|First Night|Withdrawal by Subject|3
42148|NCT01457014|177475|P4|First Night|Didn't meet inclusion/exclusion criteria|0
42149|NCT01457014|177476|P3|First Night|Didn't meet inclusion/exclusion criteria|0
42150|NCT01457014|177477|P2|First Night|Didn't meet inclusion/exclusion criteria|0
42151|NCT01457014|177478|P1|First Night|Didn't meet inclusion/exclusion criteria|37
42152|NCT01456962|177495|P2|Overall Study|Lost to Follow-up|1
42153|NCT01456962|177496|P1|Overall Study|Lost to Follow-up|2
42154|NCT01456936|177506|P4|Overall Study|Randomized but not treated|21
42155|NCT01456936|177507|P3|Overall Study|Randomized but not treated|16
42156|NCT01456936|177508|P2|Overall Study|Randomized but not treated|28
42157|NCT01456936|177509|P1|Overall Study|Randomized but not treated|21
42158|NCT01456936|177506|P4|Overall Study|Death|3
42159|NCT01456936|177507|P3|Overall Study|Death|1
42160|NCT01456936|177508|P2|Overall Study|Death|3
42161|NCT01456936|177509|P1|Overall Study|Death|0
42162|NCT01456936|177506|P4|Overall Study|Adverse event (study drug unrelated)|9
42163|NCT01456936|177507|P3|Overall Study|Adverse event (study drug unrelated)|9
42164|NCT01456936|177508|P2|Overall Study|Adverse event (study drug unrelated)|7
42165|NCT01456936|177509|P1|Overall Study|Adverse event (study drug unrelated)|9
42166|NCT01456936|177506|P4|Overall Study|Adverse event (study drug)|17
42167|NCT01456936|177507|P3|Overall Study|Adverse event (study drug)|26
42168|NCT01456936|177508|P2|Overall Study|Adverse event (study drug)|21
42169|NCT01456936|177509|P1|Overall Study|Adverse event (study drug)|25
42170|NCT01456936|177506|P4|Overall Study|Medication error|1
42171|NCT01456936|177507|P3|Overall Study|Medication error|0
42172|NCT01456936|177508|P2|Overall Study|Medication error|1
42173|NCT01456936|177509|P1|Overall Study|Medication error|0
42174|NCT01456936|177506|P4|Overall Study|Lost to Follow-up|127
42175|NCT01456936|177507|P3|Overall Study|Lost to Follow-up|144
42176|NCT01456936|177508|P2|Overall Study|Lost to Follow-up|126
42177|NCT01456936|177509|P1|Overall Study|Lost to Follow-up|135
42178|NCT01456936|177506|P4|Overall Study|No longer willing to participate|248
42179|NCT01456936|177507|P3|Overall Study|No longer willing to participate|224
42180|NCT01456936|177508|P2|Overall Study|No longer willing to participate|218
42181|NCT01456936|177509|P1|Overall Study|No longer willing to participate|195
42182|NCT01456936|177506|P4|Overall Study|Insufficient clinical response|13
42183|NCT01456936|177507|P3|Overall Study|Insufficient clinical response|14
42184|NCT01456936|177508|P2|Overall Study|Insufficient clinical response|4
42185|NCT01456936|177509|P1|Overall Study|Insufficient clinical response|4
42186|NCT01456936|177506|P4|Overall Study|Pregnancy|1
42187|NCT01456936|177507|P3|Overall Study|Pregnancy|0
42188|NCT01456936|177508|P2|Overall Study|Pregnancy|0
42189|NCT01456936|177509|P1|Overall Study|Pregnancy|1
42190|NCT01456936|177506|P4|Overall Study|Protocol Violation|5
42191|NCT01456936|177507|P3|Overall Study|Protocol Violation|5
42192|NCT01456936|177508|P2|Overall Study|Protocol Violation|2
42193|NCT01456936|177509|P1|Overall Study|Protocol Violation|4
42194|NCT01456936|177506|P4|Overall Study|No longer meets eligibility criteria|5
42195|NCT01456936|177507|P3|Overall Study|No longer meets eligibility criteria|6
42196|NCT01456936|177508|P2|Overall Study|No longer meets eligibility criteria|8
42197|NCT01456936|177509|P1|Overall Study|No longer meets eligibility criteria|4
42198|NCT01456936|177506|P4|Overall Study|Other reason|33
42199|NCT01456936|177507|P3|Overall Study|Other reason|36
42200|NCT01456936|177508|P2|Overall Study|Other reason|30
42201|NCT01456936|177509|P1|Overall Study|Other reason|41
42202|NCT01456780|177618|P3|Overall Study|Lost to Follow-up|0
42203|NCT01456780|177619|P2|Overall Study|Lost to Follow-up|3
42204|NCT01456780|177620|P1|Overall Study|Lost to Follow-up|3
42205|NCT01456195|177653|P3|Overall Study|Other Reasons|3
42206|NCT01456195|177654|P2|Overall Study|Other Reasons|1
42207|NCT01456195|177655|P1|Overall Study|Other Reasons|2
42208|NCT01456195|177653|P3|Overall Study|Lack of Efficacy|0
42209|NCT01456195|177654|P2|Overall Study|Lack of Efficacy|1
42210|NCT01456195|177655|P1|Overall Study|Lack of Efficacy|0
42211|NCT01456195|177653|P3|Overall Study|Voluntary Withdrawal|7
42212|NCT01456195|177654|P2|Overall Study|Voluntary Withdrawal|3
42213|NCT01456195|177655|P1|Overall Study|Voluntary Withdrawal|5
42214|NCT01456195|177653|P3|Overall Study|Lost to Follow-up|3
42215|NCT01456195|177654|P2|Overall Study|Lost to Follow-up|1
42216|NCT01456195|177655|P1|Overall Study|Lost to Follow-up|3
42217|NCT01456195|177653|P3|Overall Study|Pretreatment Event/Adverse Event|1
42218|NCT01456195|177654|P2|Overall Study|Pretreatment Event/Adverse Event|4
42219|NCT01456195|177655|P1|Overall Study|Pretreatment Event/Adverse Event|1
42220|NCT01456169|177675|P3|Overall Study|Other|0
42221|NCT01456169|177676|P2|Overall Study|Other|1
42222|NCT01456169|177677|P1|Overall Study|Other|1
42223|NCT01456169|177675|P3|Overall Study|Lack of Efficacy|0
42224|NCT01456169|177676|P2|Overall Study|Lack of Efficacy|0
42225|NCT01456169|177677|P1|Overall Study|Lack of Efficacy|2
42226|NCT01456169|177675|P3|Overall Study|Voluntary Withdrawal|2
42227|NCT01456169|177676|P2|Overall Study|Voluntary Withdrawal|0
42228|NCT01456169|177677|P1|Overall Study|Voluntary Withdrawal|3
42229|NCT01456169|177675|P3|Overall Study|Major Protocol Deviation|3
42230|NCT01456169|177676|P2|Overall Study|Major Protocol Deviation|2
42231|NCT01456169|177677|P1|Overall Study|Major Protocol Deviation|3
42232|NCT01456169|177675|P3|Overall Study|Adverse Event|7
42233|NCT01456169|177676|P2|Overall Study|Adverse Event|2
42234|NCT01456169|177677|P1|Overall Study|Adverse Event|1
42235|NCT01456130|177737|P1|Overall Study|Other|1
42236|NCT01456130|177737|P1|Overall Study|Lack of Efficacy|4
42237|NCT01456130|177737|P1|Overall Study|Voluntary Withdrawal|1
42238|NCT01456130|177737|P1|Overall Study|Adverse Event|4
42239|NCT01456052|177747|P3|Overall Study|Treatment Failure|1
42240|NCT01456052|177748|P2|Overall Study|Treatment Failure|1
42241|NCT01456052|177749|P1|Overall Study|Treatment Failure|0
42242|NCT01456052|177747|P3|Overall Study|Physician Decision|1
42243|NCT01456052|177748|P2|Overall Study|Physician Decision|0
42244|NCT01456052|177749|P1|Overall Study|Physician Decision|1
42245|NCT01456052|177747|P3|Overall Study|Protocol Violation|0
42246|NCT01456052|177748|P2|Overall Study|Protocol Violation|1
42247|NCT01456052|177749|P1|Overall Study|Protocol Violation|0
42248|NCT01456052|177747|P3|Overall Study|Consent withdrawn|1
42249|NCT01456052|177748|P2|Overall Study|Consent withdrawn|2
42250|NCT01456052|177749|P1|Overall Study|Consent withdrawn|0
42251|NCT01456052|177747|P3|Overall Study|Adverse Event|2
42252|NCT01456052|177748|P2|Overall Study|Adverse Event|1
42253|NCT01456052|177749|P1|Overall Study|Adverse Event|1
42254|NCT01456039|177769|P3|Phase 2 (Second Step)|Unspecified|1
42255|NCT01456039|177770|P2|Phase 2 (Second Step)|Unspecified|0
42256|NCT01456039|177771|P1|Phase 2 (Second Step)|Unspecified|0
42257|NCT01456039|177769|P3|Phase 2 (Second Step)|Protocol Violation|1
42258|NCT01456039|177770|P2|Phase 2 (Second Step)|Protocol Violation|0
42259|NCT01456039|177771|P1|Phase 2 (Second Step)|Protocol Violation|0
42260|NCT01456039|177769|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
42261|NCT01456039|177770|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
42262|NCT01456039|177771|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
42263|NCT01456039|177769|P3|Phase 2 (Second Step)|Adverse Event|10
42264|NCT01456039|177770|P2|Phase 2 (Second Step)|Adverse Event|0
42265|NCT01456039|177771|P1|Phase 2 (Second Step)|Adverse Event|0
42266|NCT01456039|177769|P3|Phase 2 (Second Step)|Disease Progression|17
42267|NCT01456039|177770|P2|Phase 2 (Second Step)|Disease Progression|0
42268|NCT01456039|177771|P1|Phase 2 (Second Step)|Disease Progression|0
42269|NCT01456039|177769|P3|Phase 1 (First Step)|Not specified|0
42270|NCT01456039|177770|P2|Phase 1 (First Step)|Not specified|1
42271|NCT01456039|177771|P1|Phase 1 (First Step)|Not specified|0
42272|NCT01456039|177769|P3|Phase 1 (First Step)|Adverse Event|0
42273|NCT01456039|177770|P2|Phase 1 (First Step)|Adverse Event|3
42274|NCT01456039|177771|P1|Phase 1 (First Step)|Adverse Event|0
42275|NCT01456039|177769|P3|Phase 1 (First Step)|Withdrawal by Subject|0
42276|NCT01456039|177770|P2|Phase 1 (First Step)|Withdrawal by Subject|2
42277|NCT01456039|177771|P1|Phase 1 (First Step)|Withdrawal by Subject|1
42278|NCT01456039|177769|P3|Phase 1 (First Step)|Disease Progression|0
42279|NCT01456039|177770|P2|Phase 1 (First Step)|Disease Progression|1
42280|NCT01456039|177771|P1|Phase 1 (First Step)|Disease Progression|1
42281|NCT01455428|177914|P2|Overall Study|Unspecified|4
42282|NCT01455428|177915|P1|Overall Study|Unspecified|2
42283|NCT01455428|177914|P2|Overall Study|Did not receive treatment|1
42284|NCT01455428|177915|P1|Overall Study|Did not receive treatment|1
42285|NCT01455428|177914|P2|Overall Study|Insufficient clinical response|2
42286|NCT01455428|177915|P1|Overall Study|Insufficient clinical response|0
42287|NCT01455428|177914|P2|Overall Study|Did not meet entrance criteria|2
42288|NCT01455428|177915|P1|Overall Study|Did not meet entrance criteria|0
42289|NCT01455428|177914|P2|Overall Study|Withdrawal by Subject|5
42290|NCT01455428|177915|P1|Overall Study|Withdrawal by Subject|2
42291|NCT01455428|177914|P2|Overall Study|Lost to Follow-up|1
42292|NCT01455428|177915|P1|Overall Study|Lost to Follow-up|1
42293|NCT01455428|177914|P2|Overall Study|Adverse Event|2
42294|NCT01455428|177915|P1|Overall Study|Adverse Event|6
42295|NCT01455428|177914|P2|Overall Study|Protocol Violation|1
42296|NCT01455428|177915|P1|Overall Study|Protocol Violation|2
42297|NCT01455415|177971|P2|Follow-up|Unspecified Reason|0
42298|NCT01455415|177972|P1|Follow-up|Unspecified Reason|1
42299|NCT01455415|177971|P2|Follow-up|Withdrawal by Subject|0
42300|NCT01455415|177972|P1|Follow-up|Withdrawal by Subject|2
42301|NCT01455415|177971|P2|Follow-up|Lack of Efficacy|1
42302|NCT01455415|177972|P1|Follow-up|Lack of Efficacy|0
42303|NCT01455415|177971|P2|Follow-up|AE Related to Study Drug|1
42304|NCT01455415|177972|P1|Follow-up|AE Related to Study Drug|0
42305|NCT01455415|177971|P2|Period 2|Protocol Violation|0
42306|NCT01455415|177972|P1|Period 2|Protocol Violation|2
42307|NCT01455415|177971|P2|Period 2|Unspecified Reason|3
42308|NCT01455415|177972|P1|Period 2|Unspecified Reason|2
42309|NCT01455415|177971|P2|Period 2|Withdrawal by Subject|3
42310|NCT01455415|177972|P1|Period 2|Withdrawal by Subject|2
42311|NCT01455415|177971|P2|Period 2|Lack of Efficacy|0
42312|NCT01455415|177972|P1|Period 2|Lack of Efficacy|2
42313|NCT01455415|177971|P2|Period 2|AE Not Related to Study Drug|1
42314|NCT01455415|177972|P1|Period 2|AE Not Related to Study Drug|2
42315|NCT01455415|177971|P2|Period 2|Lost to Follow-up|1
42316|NCT01455415|177972|P1|Period 2|Lost to Follow-up|2
42317|NCT01455415|177971|P2|Period 2|AE Related to Study Drug|2
42318|NCT01455415|177972|P1|Period 2|AE Related to Study Drug|1
42319|NCT01455415|177971|P2|Washout|Protocol Violation|1
42320|NCT01455415|177972|P1|Washout|Protocol Violation|0
42321|NCT01455415|177971|P2|Washout|Unspecified Reason|2
42322|NCT01455415|177972|P1|Washout|Unspecified Reason|1
42323|NCT01455415|177971|P2|Washout|AE Not Related to Study Drug|3
42324|NCT01455415|177972|P1|Washout|AE Not Related to Study Drug|2
42325|NCT01455415|177971|P2|Washout|Drug Error not Associated to AE|1
42326|NCT01455415|177972|P1|Washout|Drug Error not Associated to AE|2
42327|NCT01455415|177971|P2|Washout|Lost to Follow-up|0
42328|NCT01455415|177972|P1|Washout|Lost to Follow-up|1
42329|NCT01455415|177971|P2|Washout|AE Related to Study Drug|0
42330|NCT01455415|177972|P1|Washout|AE Related to Study Drug|2
42331|NCT01455415|177971|P2|Period 1|Protocol Violation|2
42332|NCT01455415|177972|P1|Period 1|Protocol Violation|0
42333|NCT01455415|177971|P2|Period 1|Unspecified Reason|1
42334|NCT01455415|177972|P1|Period 1|Unspecified Reason|1
42335|NCT01455415|177971|P2|Period 1|Withdrawal by Subject|5
42336|NCT01455415|177972|P1|Period 1|Withdrawal by Subject|4
42337|NCT01455415|177971|P2|Period 1|AE Not Related to Study Drug|6
42338|NCT01455415|177972|P1|Period 1|AE Not Related to Study Drug|2
42339|NCT01455415|177971|P2|Period 1|Drug Error not Associated to AE|1
42340|NCT01455415|177972|P1|Period 1|Drug Error not Associated to AE|0
42341|NCT01455415|177971|P2|Period 1|Lost To Follow-up Related to Study Drug|3
42342|NCT01455415|177972|P1|Period 1|Lost To Follow-up Related to Study Drug|3
42343|NCT01455415|177971|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
42344|NCT01455415|177972|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
42345|NCT01455220|178022|P1|Overall Study|screen fail|30
42346|NCT01455194|178032|P4|Overall Study|Miscellaneous|4
42347|NCT01455194|178033|P3|Overall Study|Miscellaneous|1
42348|NCT01455194|178034|P2|Overall Study|Miscellaneous|5
42349|NCT01455194|178035|P1|Overall Study|Miscellaneous|4
42350|NCT01455194|178032|P4|Overall Study|Discontinuation criterion fulfilled|2
42351|NCT01455194|178033|P3|Overall Study|Discontinuation criterion fulfilled|0
42352|NCT01455194|178034|P2|Overall Study|Discontinuation criterion fulfilled|2
42353|NCT01455194|178035|P1|Overall Study|Discontinuation criterion fulfilled|3
42354|NCT01455194|178032|P4|Overall Study|Pregnancy|0
42355|NCT01455194|178033|P3|Overall Study|Pregnancy|1
42356|NCT01455194|178034|P2|Overall Study|Pregnancy|1
42357|NCT01455194|178035|P1|Overall Study|Pregnancy|0
42358|NCT01455194|178032|P4|Overall Study|Lost to Follow-up|1
42359|NCT01455194|178033|P3|Overall Study|Lost to Follow-up|1
42360|NCT01455194|178034|P2|Overall Study|Lost to Follow-up|0
42361|NCT01455194|178035|P1|Overall Study|Lost to Follow-up|2
42362|NCT01455194|178032|P4|Overall Study|Withdrawal by Subject|9
42363|NCT01455194|178033|P3|Overall Study|Withdrawal by Subject|12
42364|NCT01455194|178034|P2|Overall Study|Withdrawal by Subject|16
42365|NCT01455194|178035|P1|Overall Study|Withdrawal by Subject|21
42366|NCT01455194|178032|P4|Overall Study|Adverse Event|3
42367|NCT01455194|178033|P3|Overall Study|Adverse Event|1
42368|NCT01455194|178034|P2|Overall Study|Adverse Event|1
42369|NCT01455194|178035|P1|Overall Study|Adverse Event|1
42370|NCT01455194|178032|P4|Overall Study|Deterioration in asthma|9
42371|NCT01455194|178033|P3|Overall Study|Deterioration in asthma|14
42372|NCT01455194|178034|P2|Overall Study|Deterioration in asthma|6
42373|NCT01455194|178035|P1|Overall Study|Deterioration in asthma|12
42374|NCT01455194|178032|P4|Overall Study|Randomisation Failure|0
42375|NCT01455194|178033|P3|Overall Study|Randomisation Failure|0
42376|NCT01455194|178034|P2|Overall Study|Randomisation Failure|0
42377|NCT01455194|178035|P1|Overall Study|Randomisation Failure|90
42378|NCT01455194|178032|P4|Overall Study|Screen Failure|0
42379|NCT01455194|178033|P3|Overall Study|Screen Failure|0
42380|NCT01455194|178034|P2|Overall Study|Screen Failure|0
42381|NCT01455194|178035|P1|Overall Study|Screen Failure|20
42382|NCT01455012|178098|P2|Overall Study|Unknown reason|0
42383|NCT01455012|178099|P1|Overall Study|Unknown reason|2
42384|NCT01455012|178098|P2|Overall Study|Withdrawal by Subject|1
42385|NCT01455012|178099|P1|Overall Study|Withdrawal by Subject|3
42386|NCT01455012|178098|P2|Overall Study|Lack of Efficacy|1
42387|NCT01455012|178099|P1|Overall Study|Lack of Efficacy|6
42388|NCT01455012|178098|P2|Overall Study|Adverse Event|2
42389|NCT01455012|178099|P1|Overall Study|Adverse Event|0
42390|NCT01454934|178166|P2|Overall Study|Ongoing, survival follow-up|2
42391|NCT01454934|178167|P1|Overall Study|Ongoing, survival follow-up|1
42392|NCT01454934|178166|P2|Overall Study|Not treated|2
42393|NCT01454934|178167|P1|Overall Study|Not treated|1
42394|NCT01454934|178166|P2|Overall Study|Not specified|16
42395|NCT01454934|178167|P1|Overall Study|Not specified|5
42396|NCT01454934|178166|P2|Overall Study|Clinical progression|25
42397|NCT01454934|178167|P1|Overall Study|Clinical progression|28
42398|NCT01454934|178166|P2|Overall Study|Withdrawn consent|5
42399|NCT01454934|178167|P1|Overall Study|Withdrawn consent|2
42400|NCT01454934|178166|P2|Overall Study|Lost to Follow-up|1
42401|NCT01454934|178167|P1|Overall Study|Lost to Follow-up|0
42402|NCT01454934|178166|P2|Overall Study|Withdrawal by Subject|15
42403|NCT01454934|178167|P1|Overall Study|Withdrawal by Subject|11
42404|NCT01454934|178166|P2|Overall Study|Adverse Event|24
42405|NCT01454934|178167|P1|Overall Study|Adverse Event|28
42406|NCT01454934|178166|P2|Overall Study|Disease progression|180
42407|NCT01454934|178167|P1|Overall Study|Disease progression|194
42408|NCT01454830|178179|P2|Overall Study|Withdrawal - no polysomnography|2
42409|NCT01454830|178180|P1|Overall Study|Withdrawal - no polysomnography|3
42410|NCT01454830|178179|P2|Overall Study|Post-allocation Exclude-other treatment|7
42411|NCT01454830|178180|P1|Overall Study|Post-allocation Exclude-other treatment|6
42412|NCT01454830|178179|P2|Overall Study|Post-allocation Exclude-refused PAP|2
42413|NCT01454830|178180|P1|Overall Study|Post-allocation Exclude-refused PAP|0
42414|NCT01454830|178179|P2|Overall Study|Post-allocation Exclude- AHI<10|12
42415|NCT01454830|178180|P1|Overall Study|Post-allocation Exclude- AHI<10|18
42416|NCT01454830|178179|P2|Overall Study|Withdrawal by Subject|4
42417|NCT01454830|178180|P1|Overall Study|Withdrawal by Subject|4
42418|NCT01454778|178211|P1|Overall Study|Death|1
42419|NCT01454778|178211|P1|Overall Study|Lost to Follow-up|2
42420|NCT01454726|178222|P2|Overall Study|Withdrawal by Subject|1
42421|NCT01454726|178223|P1|Overall Study|Withdrawal by Subject|0
42422|NCT01454583|178232|P3|3rd Year|Lost to Follow-up|297
42423|NCT01454583|178233|P2|3rd Year|Lost to Follow-up|512
42424|NCT01454583|178234|P1|3rd Year|Lost to Follow-up|1959
42425|NCT01454583|178232|P3|2nd Year|Lost to Follow-up|737
42426|NCT01454583|178233|P2|2nd Year|Lost to Follow-up|1049
42427|NCT01454583|178234|P1|2nd Year|Lost to Follow-up|3965
42428|NCT01454583|178232|P3|1st Year|Lost to Follow-up|180
42429|NCT01454583|178233|P2|1st Year|Lost to Follow-up|318
42430|NCT01454583|178234|P1|1st Year|Lost to Follow-up|1057
42431|NCT01454531|178302|P1|Overall Study|Other|1
42432|NCT01454531|178302|P1|Overall Study|Delay in IMP administration|1
42433|NCT01454531|178302|P1|Overall Study|Physician Decision|1
42434|NCT01454531|178302|P1|Overall Study|Lost to Follow-up|1
42435|NCT01454531|178302|P1|Overall Study|Withdrawal by Subject|5
42436|NCT01454531|178302|P1|Overall Study|Adverse Event|14
42437|NCT01454401|178338|P1|Overall Study|non-adherence|1
42438|NCT01454401|178338|P1|Overall Study|osteomyelitis|2
42439|NCT01454401|178338|P1|Overall Study|hospitalised|1
42440|NCT01454401|178338|P1|Overall Study|Death|1
42441|NCT01454063|178351|P2|Randomized|Protocol Violation|1
42442|NCT01454063|178352|P1|Randomized|Protocol Violation|0
42443|NCT01454063|178351|P2|Randomized|Adverse Event|1
42444|NCT01454063|178352|P1|Randomized|Adverse Event|1
42445|NCT01453998|178373|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
42446|NCT01453998|178374|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
42447|NCT01453998|178375|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
42448|NCT01453946|178440|P1|Overall Study|Adverse Event|3
42449|NCT01453946|178440|P1|Overall Study|Lack of Efficacy|3
42450|NCT01453946|178440|P1|Overall Study|Protocol Violation|2
42451|NCT01453946|178440|P1|Overall Study|Did not receive drug for the taper phase|1
42452|NCT01453855|178457|P2|Overall Study|Other|1
42453|NCT01453855|178458|P1|Overall Study|Other|0
42454|NCT01453855|178457|P2|Overall Study|Inadequate Control of IOP|5
42455|NCT01453855|178458|P1|Overall Study|Inadequate Control of IOP|1
42456|NCT01453855|178457|P2|Overall Study|Noncompliance|0
42457|NCT01453855|178458|P1|Overall Study|Noncompliance|1
42458|NCT01453855|178457|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
42459|NCT01453855|178458|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
42460|NCT01453855|178457|P2|Overall Study|Lost to Follow-up|1
42461|NCT01453855|178458|P1|Overall Study|Lost to Follow-up|2
42462|NCT01453855|178457|P2|Overall Study|Adverse Event|4
42463|NCT01453855|178458|P1|Overall Study|Adverse Event|3
42464|NCT01453725|178466|P2|Overall Study|Physician Decision|1
42465|NCT01453725|178467|P1|Overall Study|Physician Decision|1
42466|NCT01453725|178466|P2|Overall Study|Pregnancy|0
42467|NCT01453725|178467|P1|Overall Study|Pregnancy|1
42468|NCT01453725|178466|P2|Overall Study|Pregnancy Wish|2
42469|NCT01453725|178467|P1|Overall Study|Pregnancy Wish|0
42470|NCT01453725|178466|P2|Overall Study|Withdrawal by Subject|3
42471|NCT01453725|178467|P1|Overall Study|Withdrawal by Subject|2
42472|NCT01453725|178466|P2|Overall Study|Protocol Violation|0
42473|NCT01453725|178467|P1|Overall Study|Protocol Violation|1
42474|NCT01453725|178466|P2|Overall Study|Non-compliance With Protocol|2
42475|NCT01453725|178467|P1|Overall Study|Non-compliance With Protocol|1
42476|NCT01453725|178466|P2|Overall Study|Lost to Follow-up|0
42477|NCT01453725|178467|P1|Overall Study|Lost to Follow-up|4
42478|NCT01453725|178466|P2|Overall Study|Adverse Event|3
42479|NCT01453725|178467|P1|Overall Study|Adverse Event|3
42480|NCT01452529|178489|P3|Double-blind (DB) Period|Administrative|7
42481|NCT01452529|178490|P2|Double-blind (DB) Period|Administrative|11
42482|NCT01452529|178491|P1|Double-blind (DB) Period|Administrative|0
42483|NCT01452529|178489|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
42484|NCT01452529|178490|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
42485|NCT01452529|178491|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
42486|NCT01452529|178489|P3|Double-blind (DB) Period|Lack of Efficacy|44
42487|NCT01452529|178490|P2|Double-blind (DB) Period|Lack of Efficacy|16
42488|NCT01452529|178491|P1|Double-blind (DB) Period|Lack of Efficacy|0
42489|NCT01452529|178489|P3|Double-blind (DB) Period|Lost to Follow-up|3
42490|NCT01452529|178490|P2|Double-blind (DB) Period|Lost to Follow-up|5
42491|NCT01452529|178491|P1|Double-blind (DB) Period|Lost to Follow-up|0
42492|NCT01452529|178489|P3|Double-blind (DB) Period|Withdrawal by Subject|14
42493|NCT01452529|178490|P2|Double-blind (DB) Period|Withdrawal by Subject|15
42494|NCT01452529|178491|P1|Double-blind (DB) Period|Withdrawal by Subject|0
42495|NCT01452529|178489|P3|Double-blind (DB) Period|Adverse Event|11
42496|NCT01452529|178490|P2|Double-blind (DB) Period|Adverse Event|18
42497|NCT01452529|178491|P1|Double-blind (DB) Period|Adverse Event|0
42498|NCT01452529|178489|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
42499|NCT01452529|178490|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
42500|NCT01452529|178491|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
42501|NCT01452529|178489|P3|Run-in Period|Administrative|0
42502|NCT01452529|178490|P2|Run-in Period|Administrative|0
42503|NCT01452529|178491|P1|Run-in Period|Administrative|21
42504|NCT01452529|178489|P3|Run-in Period|Confirmed or suspected diversion|0
42505|NCT01452529|178490|P2|Run-in Period|Confirmed or suspected diversion|0
42506|NCT01452529|178491|P1|Run-in Period|Confirmed or suspected diversion|23
42507|NCT01452529|178489|P3|Run-in Period|Lack of Efficacy|0
42508|NCT01452529|178490|P2|Run-in Period|Lack of Efficacy|0
42509|NCT01452529|178491|P1|Run-in Period|Lack of Efficacy|46
42510|NCT01452529|178489|P3|Run-in Period|Lost to Follow-up|0
42511|NCT01452529|178490|P2|Run-in Period|Lost to Follow-up|0
42512|NCT01452529|178491|P1|Run-in Period|Lost to Follow-up|19
42513|NCT01452529|178489|P3|Run-in Period|Withdrawal by Subject|0
42514|NCT01452529|178490|P2|Run-in Period|Withdrawal by Subject|0
42515|NCT01452529|178491|P1|Run-in Period|Withdrawal by Subject|49
42516|NCT01452529|178489|P3|Run-in Period|Adverse Event|0
42517|NCT01452529|178490|P2|Run-in Period|Adverse Event|0
42518|NCT01452529|178491|P1|Run-in Period|Adverse Event|96
42519|NCT01453595|178506|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
42520|NCT01453595|178507|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
42521|NCT01453595|178508|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
42522|NCT01453374|178627|P1|Overall Study|Incarcerated|2
42523|NCT01453374|178627|P1|Overall Study|Withdrawal by Subject|5
42524|NCT01453374|178627|P1|Overall Study|Lost to Follow-up|3
42525|NCT01453374|178627|P1|Overall Study|Lack of Efficacy|1
42526|NCT01453374|178627|P1|Overall Study|Adverse Event|7
42527|NCT01453348|178646|P3|Overall Study|Protocol Violation|0
42528|NCT01453348|178647|P2|Overall Study|Protocol Violation|0
42529|NCT01453348|178648|P1|Overall Study|Protocol Violation|1
42530|NCT01453348|178646|P3|Overall Study|Withdrawal by Subject|0
42531|NCT01453348|178647|P2|Overall Study|Withdrawal by Subject|1
42532|NCT01453348|178648|P1|Overall Study|Withdrawal by Subject|0
42533|NCT01453348|178646|P3|Overall Study|Death|1
42534|NCT01453348|178647|P2|Overall Study|Death|0
42535|NCT01453348|178648|P1|Overall Study|Death|0
42536|NCT01453296|178664|P2|Treatment Period 2|Withdrawal by Subject|0
42537|NCT01453296|178665|P1|Treatment Period 2|Withdrawal by Subject|1
42538|NCT01453296|178664|P2|Treatment Period 2|Adverse Event|0
42539|NCT01453296|178665|P1|Treatment Period 2|Adverse Event|1
42540|NCT01453296|178664|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
42541|NCT01453296|178665|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
42542|NCT01453296|178664|P2|Treatment Period 1|Adverse Event|1
42543|NCT01453296|178665|P1|Treatment Period 1|Adverse Event|0
42544|NCT01453049|178765|P2|Overall Study|Randomized in Error|0
42545|NCT01453049|178766|P1|Overall Study|Randomized in Error|1
42546|NCT01453049|178765|P2|Overall Study|Withdrawal by Subject|0
42547|NCT01453049|178766|P1|Overall Study|Withdrawal by Subject|1
42548|NCT01453049|178765|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
42549|NCT01453049|178766|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
42550|NCT01453049|178765|P2|Overall Study|Lost to Follow-up|1
42551|NCT01453049|178766|P1|Overall Study|Lost to Follow-up|2
42552|NCT01453049|178765|P2|Overall Study|Protocol Violation|5
42553|NCT01453049|178766|P1|Overall Study|Protocol Violation|2
42554|NCT01453036|178839|P3|Overall Study|Lost to Follow-up|31
42555|NCT01453036|178840|P2|Overall Study|Lost to Follow-up|115
42556|NCT01453036|178841|P1|Overall Study|Lost to Follow-up|26
42557|NCT01453023|178849|P2|Treatment Period 2|Protocol Violation|1
42558|NCT01453023|178850|P1|Treatment Period 2|Protocol Violation|0
42559|NCT01453023|178849|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
42560|NCT01453023|178850|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
42561|NCT01453023|178849|P2|Treatment Period (TP) 1|Protocol Violation|0
42562|NCT01453023|178850|P1|Treatment Period (TP) 1|Protocol Violation|1
42563|NCT01452347|178924|P2|Overall Study|Other reason not defined above|0
42564|NCT01452347|178925|P1|Overall Study|Other reason not defined above|2
42565|NCT01452347|178924|P2|Overall Study|Not treated|3
42566|NCT01452347|178925|P1|Overall Study|Not treated|6
42567|NCT01452347|178924|P2|Overall Study|Withdrawal by Subject|3
42568|NCT01452347|178925|P1|Overall Study|Withdrawal by Subject|3
42569|NCT01452347|178924|P2|Overall Study|Lost to Follow-up|0
42570|NCT01452347|178925|P1|Overall Study|Lost to Follow-up|2
42571|NCT01452347|178924|P2|Overall Study|Non compliance protocol|0
42572|NCT01452347|178925|P1|Overall Study|Non compliance protocol|2
42573|NCT01452347|178924|P2|Overall Study|Adverse Event|1
42574|NCT01452347|178925|P1|Overall Study|Adverse Event|2
42575|NCT01452152|178957|P3|Overall Study|Study termination by sponsor|4
42576|NCT01452152|178958|P2|Overall Study|Study termination by sponsor|0
42577|NCT01452152|178959|P1|Overall Study|Study termination by sponsor|5
42578|NCT01451931|178995|P3|Overall Study|Withdrawal by Subject|22
42579|NCT01451931|178996|P2|Overall Study|Withdrawal by Subject|22
42580|NCT01451931|178997|P1|Overall Study|Withdrawal by Subject|16
42581|NCT01451931|178995|P3|Overall Study|Lost to Follow-up|21
42582|NCT01451931|178996|P2|Overall Study|Lost to Follow-up|36
42583|NCT01451931|178997|P1|Overall Study|Lost to Follow-up|17
42584|NCT01451814|179019|P2|Overall Study|Lost to Follow-up|4
42585|NCT01451814|179020|P1|Overall Study|Lost to Follow-up|5
42586|NCT01451814|179019|P2|Overall Study|Withdrawal by Subject|1
42587|NCT01451814|179020|P1|Overall Study|Withdrawal by Subject|1
42588|NCT01451762|179052|P3|Overall Study|Lost to Follow-up|6
42589|NCT01451762|179053|P2|Overall Study|Lost to Follow-up|6
42590|NCT01451762|179054|P1|Overall Study|Lost to Follow-up|3
42591|NCT01451749|179064|P2|Overall Study|Withdrawal by Subject|1
42592|NCT01451749|179065|P1|Overall Study|Withdrawal by Subject|0
42593|NCT01451749|179064|P2|Overall Study|Adverse Event|0
42594|NCT01451749|179065|P1|Overall Study|Adverse Event|2
42595|NCT01451749|179064|P2|Overall Study|Meet the exclusion criteria,and|1
42596|NCT01451749|179065|P1|Overall Study|Meet the exclusion criteria,and|1
42597|NCT01451749|179064|P2|Overall Study|Lost to Follow-up|5
42598|NCT01451749|179065|P1|Overall Study|Lost to Follow-up|15
42599|NCT01451749|179064|P2|Overall Study|Protocol Violation|7
42600|NCT01451749|179065|P1|Overall Study|Protocol Violation|14
42601|NCT01451723|179077|P2|Overall Study|study halted|5
42602|NCT01451723|179078|P1|Overall Study|study halted|6
42603|NCT01451645|179088|P2|Overall Study|Lost to Follow-up|3
42604|NCT01451645|179089|P1|Overall Study|Lost to Follow-up|4
42605|NCT01451645|179088|P2|Overall Study|Withdrawal by Subject|2
42606|NCT01451645|179089|P1|Overall Study|Withdrawal by Subject|4
42607|NCT01451645|179088|P2|Overall Study|Adverse Event|3
42608|NCT01451645|179089|P1|Overall Study|Adverse Event|0
42609|NCT01451645|179088|P2|Overall Study|Protocol Violation|0
42610|NCT01451645|179089|P1|Overall Study|Protocol Violation|1
42611|NCT01451554|179160|P2|Overall Study|Withdrawal by Subject|9
42612|NCT01451554|179161|P1|Overall Study|Withdrawal by Subject|14
42613|NCT01451541|179172|P3|Overall Study|randomization error, noncompliance|8
42614|NCT01451541|179173|P2|Overall Study|randomization error, noncompliance|10
42615|NCT01451541|179174|P1|Overall Study|randomization error, noncompliance|11
42616|NCT01451541|179172|P3|Overall Study|Withdrawal by Subject|6
42617|NCT01451541|179173|P2|Overall Study|Withdrawal by Subject|8
42618|NCT01451541|179174|P1|Overall Study|Withdrawal by Subject|15
42619|NCT01451541|179172|P3|Overall Study|Lost to Follow-up|7
42620|NCT01451541|179173|P2|Overall Study|Lost to Follow-up|4
42621|NCT01451541|179174|P1|Overall Study|Lost to Follow-up|4
42622|NCT01451541|179172|P3|Overall Study|Lack of Efficacy|0
42623|NCT01451541|179173|P2|Overall Study|Lack of Efficacy|0
42624|NCT01451541|179174|P1|Overall Study|Lack of Efficacy|2
42625|NCT01451541|179172|P3|Overall Study|Adverse Event|6
42626|NCT01451541|179173|P2|Overall Study|Adverse Event|3
42627|NCT01451541|179174|P1|Overall Study|Adverse Event|4
42628|NCT01451437|179223|P9|Overall Study|Withdrawal by Subject|0
42629|NCT01451437|179224|P8|Overall Study|Withdrawal by Subject|0
42630|NCT01451437|179225|P7|Overall Study|Withdrawal by Subject|1
42631|NCT01451437|179226|P6|Overall Study|Withdrawal by Subject|0
42632|NCT01451437|179227|P5|Overall Study|Withdrawal by Subject|1
42633|NCT01451437|179228|P4|Overall Study|Withdrawal by Subject|0
42634|NCT01451437|179229|P3|Overall Study|Withdrawal by Subject|0
42635|NCT01451437|179230|P2|Overall Study|Withdrawal by Subject|0
42636|NCT01451437|179231|P1|Overall Study|Withdrawal by Subject|0
42637|NCT01451437|179223|P9|Overall Study|Protocol Violation|0
42638|NCT01451437|179224|P8|Overall Study|Protocol Violation|0
42639|NCT01451437|179225|P7|Overall Study|Protocol Violation|1
42640|NCT01451437|179226|P6|Overall Study|Protocol Violation|0
42641|NCT01451437|179227|P5|Overall Study|Protocol Violation|0
42642|NCT01451437|179228|P4|Overall Study|Protocol Violation|0
42643|NCT01451437|179229|P3|Overall Study|Protocol Violation|0
42644|NCT01451437|179230|P2|Overall Study|Protocol Violation|0
42645|NCT01451437|179231|P1|Overall Study|Protocol Violation|0
42646|NCT01451437|179223|P9|Overall Study|Disease Progression|3
42647|NCT01451437|179224|P8|Overall Study|Disease Progression|1
42648|NCT01451437|179225|P7|Overall Study|Disease Progression|3
42649|NCT01451437|179226|P6|Overall Study|Disease Progression|2
42650|NCT01451437|179227|P5|Overall Study|Disease Progression|3
42651|NCT01451437|179228|P4|Overall Study|Disease Progression|1
42652|NCT01451437|179229|P3|Overall Study|Disease Progression|1
42653|NCT01451437|179230|P2|Overall Study|Disease Progression|0
42654|NCT01451437|179231|P1|Overall Study|Disease Progression|0
42655|NCT01451437|179223|P9|Overall Study|Physician Decision|0
42656|NCT01451437|179224|P8|Overall Study|Physician Decision|0
42657|NCT01451437|179225|P7|Overall Study|Physician Decision|0
42658|NCT01451437|179226|P6|Overall Study|Physician Decision|0
42659|NCT01451437|179227|P5|Overall Study|Physician Decision|0
42660|NCT01451437|179228|P4|Overall Study|Physician Decision|0
42661|NCT01451437|179229|P3|Overall Study|Physician Decision|2
42662|NCT01451437|179230|P2|Overall Study|Physician Decision|1
42663|NCT01451437|179231|P1|Overall Study|Physician Decision|1
42664|NCT01451437|179223|P9|Overall Study|Adverse Event|1
42665|NCT01451437|179224|P8|Overall Study|Adverse Event|2
42666|NCT01451437|179225|P7|Overall Study|Adverse Event|1
42667|NCT01451437|179226|P6|Overall Study|Adverse Event|1
42668|NCT01451437|179227|P5|Overall Study|Adverse Event|0
42669|NCT01451437|179228|P4|Overall Study|Adverse Event|0
42670|NCT01451437|179229|P3|Overall Study|Adverse Event|0
42671|NCT01451437|179230|P2|Overall Study|Adverse Event|0
42672|NCT01451437|179231|P1|Overall Study|Adverse Event|0
42673|NCT01451424|179363|P4|Overall Study|Adverse Event|1
42674|NCT01451424|179364|P3|Overall Study|Adverse Event|0
42675|NCT01451424|179365|P2|Overall Study|Adverse Event|0
42676|NCT01451424|179366|P1|Overall Study|Adverse Event|0
42677|NCT01451424|179363|P4|Overall Study|Physician Decision|1
42678|NCT01451424|179364|P3|Overall Study|Physician Decision|1
42679|NCT01451424|179365|P2|Overall Study|Physician Decision|0
42680|NCT01451424|179366|P1|Overall Study|Physician Decision|0
42681|NCT01451424|179363|P4|Overall Study|Lost to Follow-up|1
42682|NCT01451424|179364|P3|Overall Study|Lost to Follow-up|0
42683|NCT01451424|179365|P2|Overall Study|Lost to Follow-up|1
42684|NCT01451424|179366|P1|Overall Study|Lost to Follow-up|0
42685|NCT01451424|179363|P4|Overall Study|Withdrawal by Subject|2
42686|NCT01451424|179364|P3|Overall Study|Withdrawal by Subject|0
42687|NCT01451424|179365|P2|Overall Study|Withdrawal by Subject|1
42688|NCT01451424|179366|P1|Overall Study|Withdrawal by Subject|1
42689|NCT01451398|179424|P2|Overall Study|Lack of Efficacy|1
42690|NCT01451398|179425|P1|Overall Study|Lack of Efficacy|0
42691|NCT01451398|179424|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
42692|NCT01451398|179425|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
42693|NCT01451398|179424|P2|Overall Study|Moved out of country|1
42694|NCT01451398|179425|P1|Overall Study|Moved out of country|0
42695|NCT01451398|179424|P2|Overall Study|Non-compliance with protocol|1
42696|NCT01451398|179425|P1|Overall Study|Non-compliance with protocol|1
42697|NCT01451398|179424|P2|Overall Study|Non-compliance with study drug|3
42698|NCT01451398|179425|P1|Overall Study|Non-compliance with study drug|1
42699|NCT01451398|179424|P2|Overall Study|Lost to Follow-up|4
42700|NCT01451398|179425|P1|Overall Study|Lost to Follow-up|6
42701|NCT01451398|179424|P2|Overall Study|Withdrawal by Subject|14
42702|NCT01451398|179425|P1|Overall Study|Withdrawal by Subject|10
42703|NCT01451398|179424|P2|Overall Study|Physician Decision|1
42704|NCT01451398|179425|P1|Overall Study|Physician Decision|1
42705|NCT01451398|179424|P2|Overall Study|Protocol Violation|2
42706|NCT01451398|179425|P1|Overall Study|Protocol Violation|1
42707|NCT01451398|179424|P2|Overall Study|Adverse Event|9
42708|NCT01451398|179425|P1|Overall Study|Adverse Event|7
42709|NCT01451203|179459|P2|Post-treatment Period|Investigator decision|1
42710|NCT01451203|179460|P1|Post-treatment Period|Investigator decision|0
42711|NCT01451203|179459|P2|Post-treatment Period|Adverse Event|1
42712|NCT01451203|179460|P1|Post-treatment Period|Adverse Event|0
42713|NCT01451203|179459|P2|Post-treatment Period|Lack of Efficacy|28
42714|NCT01451203|179460|P1|Post-treatment Period|Lack of Efficacy|12
42715|NCT01451203|179459|P2|Post-treatment Period|Consent withdrawn|4
42716|NCT01451203|179460|P1|Post-treatment Period|Consent withdrawn|2
42717|NCT01451203|179459|P2|Double-blind Treatment Period|Investigator decision|0
42718|NCT01451203|179460|P1|Double-blind Treatment Period|Investigator decision|2
42719|NCT01451203|179459|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
42720|NCT01451203|179460|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
42721|NCT01451203|179459|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
42722|NCT01451203|179460|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
42723|NCT01451203|179459|P2|Double-blind Treatment Period|Adverse Event|9
42724|NCT01451203|179460|P1|Double-blind Treatment Period|Adverse Event|6
42725|NCT01451203|179459|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
42726|NCT01451203|179460|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
42727|NCT01451203|179459|P2|Double-blind Treatment Period|Lack of Efficacy|36
42728|NCT01451203|179460|P1|Double-blind Treatment Period|Lack of Efficacy|71
42729|NCT01451203|179459|P2|Double-blind Treatment Period|Consent Withdrawn|2
42730|NCT01451203|179460|P1|Double-blind Treatment Period|Consent Withdrawn|3
42731|NCT01451203|179459|P2|Double-blind Treatment Period|Did not receive treatment|2
42732|NCT01451203|179460|P1|Double-blind Treatment Period|Did not receive treatment|1
42733|NCT01450813|179478|P4|Overall Study|Physician Decision|3
42734|NCT01450813|179479|P3|Overall Study|Physician Decision|0
42735|NCT01450813|179480|P2|Overall Study|Physician Decision|1
42736|NCT01450813|179481|P1|Overall Study|Physician Decision|1
42737|NCT01450800|179495|P2|Overall Study|Protocol Violation|3
42738|NCT01450800|179496|P1|Overall Study|Protocol Violation|1
42739|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
42740|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
42741|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Not reported|1
42742|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Not reported|0
42743|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
42744|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
42745|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
42746|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
42747|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
42748|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
42749|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
42750|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
42751|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Death|6
42752|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Death|5
42753|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
42754|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|11
42755|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
42756|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|14
42757|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
42758|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|25
42759|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
42760|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Study drug toxicity|85
42761|NCT01450761|179531|P2|Treatment With Blinded Study Therapy|Disease progression|409
42762|NCT01450761|179532|P1|Treatment With Blinded Study Therapy|Disease progression|314
42763|NCT01450761|179531|P2|Lead-in Chemotherapy|Lost to Follow-up|0
42764|NCT01450761|179532|P1|Lead-in Chemotherapy|Lost to Follow-up|2
42765|NCT01450761|179531|P2|Lead-in Chemotherapy|Unspecified|2
42766|NCT01450761|179532|P1|Lead-in Chemotherapy|Unspecified|2
42767|NCT01450761|179531|P2|Lead-in Chemotherapy|Death|3
42768|NCT01450761|179532|P1|Lead-in Chemotherapy|Death|3
42769|NCT01450761|179531|P2|Lead-in Chemotherapy|No longer meets study criteria|7
42770|NCT01450761|179532|P1|Lead-in Chemotherapy|No longer meets study criteria|3
42771|NCT01450761|179531|P2|Lead-in Chemotherapy|Study drug toxicity|10
42772|NCT01450761|179532|P1|Lead-in Chemotherapy|Study drug toxicity|6
42773|NCT01450761|179531|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
42774|NCT01450761|179532|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
42775|NCT01450761|179531|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
42776|NCT01450761|179532|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
42777|NCT01450761|179531|P2|Lead-in Chemotherapy|Disease progression|32
42778|NCT01450761|179532|P1|Lead-in Chemotherapy|Disease progression|33
42779|NCT01450761|179531|P2|Randomization|Unspecified|1
42780|NCT01450761|179532|P1|Randomization|Unspecified|0
42781|NCT01450761|179531|P2|Randomization|Adverse Event unrelated to study drug|0
42782|NCT01450761|179532|P1|Randomization|Adverse Event unrelated to study drug|1
42783|NCT01450761|179531|P2|Randomization|Disease progression|2
42784|NCT01450761|179532|P1|Randomization|Disease progression|0
42785|NCT01450761|179531|P2|Randomization|Withdrawal by Subject|0
42786|NCT01450761|179532|P1|Randomization|Withdrawal by Subject|2
42787|NCT01450761|179531|P2|Randomization|Subject no longer meets study criteria|2
42788|NCT01450761|179532|P1|Randomization|Subject no longer meets study criteria|1
42789|NCT01450696|179544|P2|Overall Study|Study Terminated by Sponsor|58
42790|NCT01450696|179545|P1|Overall Study|Study Terminated by Sponsor|53
42791|NCT01450696|179544|P2|Overall Study|Withdrawal by Subject|2
42792|NCT01450696|179545|P1|Overall Study|Withdrawal by Subject|13
42793|NCT01450696|179544|P2|Overall Study|Non-Compliance|0
42794|NCT01450696|179545|P1|Overall Study|Non-Compliance|1
42795|NCT01450696|179544|P2|Overall Study|Lost to Follow-up|3
42796|NCT01450696|179545|P1|Overall Study|Lost to Follow-up|3
42797|NCT01450696|179544|P2|Overall Study|Death|84
42798|NCT01450696|179545|P1|Overall Study|Death|77
42799|NCT01450696|179544|P2|Overall Study|Never Treated|1
42800|NCT01450696|179545|P1|Overall Study|Never Treated|1
42801|NCT01450683|179567|P1|Overall Study|Adverse Event|2
42802|NCT01450631|179573|P2|Overall Study|Withdrawal by Subject|0
42803|NCT01450631|179574|P1|Overall Study|Withdrawal by Subject|1
42804|NCT01450631|179573|P2|Overall Study|Lost to Follow-up|4
42805|NCT01450631|179574|P1|Overall Study|Lost to Follow-up|2
42806|NCT01450007|179705|P3|Overall Study|Adverse Event|0
42807|NCT01450007|179706|P2|Overall Study|Adverse Event|1
42808|NCT01450007|179707|P1|Overall Study|Adverse Event|0
42809|NCT01450007|179705|P3|Overall Study|Protocol Violation|1
42810|NCT01450007|179706|P2|Overall Study|Protocol Violation|1
42811|NCT01450007|179707|P1|Overall Study|Protocol Violation|0
42812|NCT01450007|179705|P3|Overall Study|Late exclusion before treatment|2
42813|NCT01450007|179706|P2|Overall Study|Late exclusion before treatment|3
42814|NCT01450007|179707|P1|Overall Study|Late exclusion before treatment|2
42815|NCT01449955|179726|P2|Overall Study|Withdrawal by Subject|2
42816|NCT01449955|179727|P1|Overall Study|Withdrawal by Subject|1
42817|NCT01449929|179735|P2|Overall Study|Ongoing|213
42818|NCT01449929|179736|P1|Overall Study|Ongoing|224
42819|NCT01449929|179735|P2|Overall Study|Physician Decision|3
42820|NCT01449929|179736|P1|Overall Study|Physician Decision|2
42821|NCT01449929|179735|P2|Overall Study|Withdrawal by Subject|1
42822|NCT01449929|179736|P1|Overall Study|Withdrawal by Subject|1
42823|NCT01449929|179735|P2|Overall Study|Lost to Follow-up|10
42824|NCT01449929|179736|P1|Overall Study|Lost to Follow-up|6
42825|NCT01449929|179735|P2|Overall Study|Protocol-defined Stopping Criteria|1
42826|NCT01449929|179736|P1|Overall Study|Protocol-defined Stopping Criteria|1
42827|NCT01449929|179735|P2|Overall Study|Protocol Violation|3
42828|NCT01449929|179736|P1|Overall Study|Protocol Violation|3
42829|NCT01449929|179735|P2|Overall Study|Lack of Efficacy|2
42830|NCT01449929|179736|P1|Overall Study|Lack of Efficacy|2
42831|NCT01449929|179735|P2|Overall Study|Adverse Event|9
42832|NCT01449929|179736|P1|Overall Study|Adverse Event|3
42833|NCT01449812|179775|P3|Overall Study|Lost to Follow-up|0
42834|NCT01449812|179776|P2|Overall Study|Lost to Follow-up|0
42835|NCT01449812|179777|P1|Overall Study|Lost to Follow-up|1
42836|NCT01449812|179775|P3|Overall Study|Withdrawal by Subject|1
42837|NCT01449812|179776|P2|Overall Study|Withdrawal by Subject|0
42838|NCT01449812|179777|P1|Overall Study|Withdrawal by Subject|0
42839|NCT01449812|179775|P3|Overall Study|Migrated/moved from study area|0
42840|NCT01449812|179776|P2|Overall Study|Migrated/moved from study area|0
42841|NCT01449812|179777|P1|Overall Study|Migrated/moved from study area|1
42842|NCT01449708|179892|P2|Overall Study|respiratory failure|0
42843|NCT01449708|179893|P1|Overall Study|respiratory failure|1
42844|NCT01449708|179892|P2|Overall Study|surgical complication|2
42845|NCT01449708|179893|P1|Overall Study|surgical complication|1
42846|NCT01449708|179892|P2|Overall Study|Protocol Violation|1
42847|NCT01449708|179893|P1|Overall Study|Protocol Violation|0
42848|NCT01449682|179904|P2|Overall Study|Adverse Event|0
42849|NCT01449682|179905|P1|Overall Study|Adverse Event|1
42850|NCT01449682|179904|P2|Overall Study|Death|1
42851|NCT01449682|179905|P1|Overall Study|Death|0
42852|NCT01449539|179917|P1|Overall Study|Toxicity not study related|1
42853|NCT01449539|179917|P1|Overall Study|Withdrawal by Subject|3
42854|NCT01449526|179923|P2|Overall Study|Cannot maintain visits|1
42855|NCT01449526|179924|P1|Overall Study|Cannot maintain visits|0
42856|NCT01449526|179923|P2|Overall Study|Lack of Motivation|1
42857|NCT01449526|179924|P1|Overall Study|Lack of Motivation|0
42858|NCT01449526|179923|P2|Overall Study|Symptoms/complaints|1
42859|NCT01449526|179924|P1|Overall Study|Symptoms/complaints|0
42860|NCT01449526|179923|P2|Overall Study|Withdrawal by Subject|1
42861|NCT01449526|179924|P1|Overall Study|Withdrawal by Subject|1
42862|NCT01449526|179923|P2|Overall Study|Lost to Follow-up|2
42863|NCT01449526|179924|P1|Overall Study|Lost to Follow-up|1
42864|NCT01449461|179993|P6|Overall Study|Reason not specified|1
42865|NCT01449461|179994|P5|Overall Study|Reason not specified|0
42866|NCT01449461|179995|P4|Overall Study|Reason not specified|3
42867|NCT01449461|179996|P3|Overall Study|Reason not specified|0
42868|NCT01449461|179997|P2|Overall Study|Reason not specified|1
42869|NCT01449461|179998|P1|Overall Study|Reason not specified|0
42870|NCT01449461|179993|P6|Overall Study|Clinical progressive disease|3
42871|NCT01449461|179994|P5|Overall Study|Clinical progressive disease|3
42872|NCT01449461|179995|P4|Overall Study|Clinical progressive disease|0
42873|NCT01449461|179996|P3|Overall Study|Clinical progressive disease|0
42874|NCT01449461|179997|P2|Overall Study|Clinical progressive disease|1
42875|NCT01449461|179998|P1|Overall Study|Clinical progressive disease|2
42876|NCT01449461|179993|P6|Overall Study|Documented progressive disease|5
42877|NCT01449461|179994|P5|Overall Study|Documented progressive disease|21
42878|NCT01449461|179995|P4|Overall Study|Documented progressive disease|11
42879|NCT01449461|179996|P3|Overall Study|Documented progressive disease|14
42880|NCT01449461|179997|P2|Overall Study|Documented progressive disease|6
42881|NCT01449461|179998|P1|Overall Study|Documented progressive disease|4
42882|NCT01449461|179993|P6|Overall Study|Death|1
42883|NCT01449461|179994|P5|Overall Study|Death|4
42884|NCT01449461|179995|P4|Overall Study|Death|0
42885|NCT01449461|179996|P3|Overall Study|Death|0
42886|NCT01449461|179997|P2|Overall Study|Death|1
42887|NCT01449461|179998|P1|Overall Study|Death|0
42888|NCT01449461|179993|P6|Overall Study|Adverse Event|3
42889|NCT01449461|179994|P5|Overall Study|Adverse Event|3
42890|NCT01449461|179995|P4|Overall Study|Adverse Event|3
42891|NCT01449461|179996|P3|Overall Study|Adverse Event|2
42892|NCT01449461|179997|P2|Overall Study|Adverse Event|3
42893|NCT01449461|179998|P1|Overall Study|Adverse Event|0
42894|NCT01449461|179993|P6|Overall Study|Ongoing|2
42895|NCT01449461|179994|P5|Overall Study|Ongoing|17
42896|NCT01449461|179995|P4|Overall Study|Ongoing|15
42897|NCT01449461|179996|P3|Overall Study|Ongoing|2
42898|NCT01449461|179997|P2|Overall Study|Ongoing|6
42899|NCT01449461|179998|P1|Overall Study|Ongoing|0
42900|NCT01449370|180135|P25|Overall Study|Death|1
42901|NCT01449370|180136|P24|Overall Study|Death|0
42902|NCT01449370|180137|P23|Overall Study|Death|0
42903|NCT01449370|180138|P22|Overall Study|Death|0
42904|NCT01449370|180139|P21|Overall Study|Death|0
42905|NCT01449370|180140|P20|Overall Study|Death|0
42906|NCT01449370|180141|P19|Overall Study|Death|0
42907|NCT01449370|180142|P18|Overall Study|Death|0
42908|NCT01449370|180143|P17|Overall Study|Death|0
42909|NCT01449370|180144|P16|Overall Study|Death|0
42910|NCT01449370|180145|P15|Overall Study|Death|0
42911|NCT01449370|180146|P14|Overall Study|Death|0
42912|NCT01449370|180147|P13|Overall Study|Death|0
42913|NCT01449370|180148|P12|Overall Study|Death|0
42914|NCT01449370|180149|P11|Overall Study|Death|0
42915|NCT01449370|180150|P10|Overall Study|Death|0
42916|NCT01449370|180151|P9|Overall Study|Death|0
42917|NCT01449370|180152|P8|Overall Study|Death|0
42918|NCT01449370|180153|P7|Overall Study|Death|0
42919|NCT01449370|180154|P6|Overall Study|Death|0
42920|NCT01449370|180155|P5|Overall Study|Death|0
42921|NCT01449370|180156|P4|Overall Study|Death|0
42922|NCT01449370|180157|P3|Overall Study|Death|0
42923|NCT01449370|180158|P2|Overall Study|Death|0
42924|NCT01449370|180159|P1|Overall Study|Death|0
42925|NCT01449370|180135|P25|Overall Study|Medication Prohibited by Protocol|0
42926|NCT01449370|180136|P24|Overall Study|Medication Prohibited by Protocol|1
42927|NCT01449370|180137|P23|Overall Study|Medication Prohibited by Protocol|0
42928|NCT01449370|180138|P22|Overall Study|Medication Prohibited by Protocol|0
42929|NCT01449370|180139|P21|Overall Study|Medication Prohibited by Protocol|0
42930|NCT01449370|180140|P20|Overall Study|Medication Prohibited by Protocol|0
42931|NCT01449370|180141|P19|Overall Study|Medication Prohibited by Protocol|0
42932|NCT01449370|180142|P18|Overall Study|Medication Prohibited by Protocol|0
42933|NCT01449370|180143|P17|Overall Study|Medication Prohibited by Protocol|0
42934|NCT01449370|180144|P16|Overall Study|Medication Prohibited by Protocol|0
42935|NCT01449370|180145|P15|Overall Study|Medication Prohibited by Protocol|0
42936|NCT01449370|180146|P14|Overall Study|Medication Prohibited by Protocol|0
42937|NCT01449370|180147|P13|Overall Study|Medication Prohibited by Protocol|0
42938|NCT01449370|180148|P12|Overall Study|Medication Prohibited by Protocol|0
42939|NCT01449370|180149|P11|Overall Study|Medication Prohibited by Protocol|0
42940|NCT01449370|180150|P10|Overall Study|Medication Prohibited by Protocol|0
42941|NCT01449370|180151|P9|Overall Study|Medication Prohibited by Protocol|0
42942|NCT01449370|180152|P8|Overall Study|Medication Prohibited by Protocol|0
42943|NCT01449370|180153|P7|Overall Study|Medication Prohibited by Protocol|0
42944|NCT01449370|180154|P6|Overall Study|Medication Prohibited by Protocol|0
42945|NCT01449370|180155|P5|Overall Study|Medication Prohibited by Protocol|0
42946|NCT01449370|180156|P4|Overall Study|Medication Prohibited by Protocol|0
42947|NCT01449370|180157|P3|Overall Study|Medication Prohibited by Protocol|0
42948|NCT01449370|180158|P2|Overall Study|Medication Prohibited by Protocol|0
42949|NCT01449370|180159|P1|Overall Study|Medication Prohibited by Protocol|0
42950|NCT01449370|180135|P25|Overall Study|Other|0
42951|NCT01449370|180136|P24|Overall Study|Other|1
42952|NCT01449370|180137|P23|Overall Study|Other|1
42953|NCT01449370|180138|P22|Overall Study|Other|0
42954|NCT01449370|180139|P21|Overall Study|Other|0
42955|NCT01449370|180140|P20|Overall Study|Other|0
42956|NCT01449370|180141|P19|Overall Study|Other|0
42957|NCT01449370|180142|P18|Overall Study|Other|0
42958|NCT01449370|180143|P17|Overall Study|Other|0
42959|NCT01449370|180144|P16|Overall Study|Other|0
42960|NCT01449370|180145|P15|Overall Study|Other|0
42961|NCT01449370|180146|P14|Overall Study|Other|0
42962|NCT01449370|180147|P13|Overall Study|Other|0
42963|NCT01449370|180148|P12|Overall Study|Other|0
42964|NCT01449370|180149|P11|Overall Study|Other|0
42965|NCT01449370|180150|P10|Overall Study|Other|1
42966|NCT01449370|180151|P9|Overall Study|Other|1
42967|NCT01449370|180152|P8|Overall Study|Other|0
42968|NCT01449370|180153|P7|Overall Study|Other|0
42969|NCT01449370|180154|P6|Overall Study|Other|0
42970|NCT01449370|180155|P5|Overall Study|Other|0
42971|NCT01449370|180156|P4|Overall Study|Other|0
42972|NCT01449370|180157|P3|Overall Study|Other|0
42973|NCT01449370|180158|P2|Overall Study|Other|0
42974|NCT01449370|180159|P1|Overall Study|Other|0
42975|NCT01449370|180135|P25|Overall Study|Lost to Follow-up|0
42976|NCT01449370|180136|P24|Overall Study|Lost to Follow-up|0
42977|NCT01449370|180137|P23|Overall Study|Lost to Follow-up|0
42978|NCT01449370|180138|P22|Overall Study|Lost to Follow-up|0
42979|NCT01449370|180139|P21|Overall Study|Lost to Follow-up|1
42980|NCT01449370|180140|P20|Overall Study|Lost to Follow-up|0
42981|NCT01449370|180141|P19|Overall Study|Lost to Follow-up|0
42982|NCT01449370|180142|P18|Overall Study|Lost to Follow-up|0
42983|NCT01449370|180143|P17|Overall Study|Lost to Follow-up|0
42984|NCT01449370|180144|P16|Overall Study|Lost to Follow-up|0
42985|NCT01449370|180145|P15|Overall Study|Lost to Follow-up|0
42986|NCT01449370|180146|P14|Overall Study|Lost to Follow-up|0
42987|NCT01449370|180147|P13|Overall Study|Lost to Follow-up|0
42988|NCT01449370|180148|P12|Overall Study|Lost to Follow-up|0
42989|NCT01449370|180149|P11|Overall Study|Lost to Follow-up|0
42990|NCT01449370|180150|P10|Overall Study|Lost to Follow-up|0
42991|NCT01449370|180151|P9|Overall Study|Lost to Follow-up|0
42992|NCT01449370|180152|P8|Overall Study|Lost to Follow-up|0
42993|NCT01449370|180153|P7|Overall Study|Lost to Follow-up|0
42994|NCT01449370|180154|P6|Overall Study|Lost to Follow-up|0
42995|NCT01449370|180155|P5|Overall Study|Lost to Follow-up|0
42996|NCT01449370|180156|P4|Overall Study|Lost to Follow-up|0
42997|NCT01449370|180157|P3|Overall Study|Lost to Follow-up|0
42998|NCT01449370|180158|P2|Overall Study|Lost to Follow-up|0
42999|NCT01449370|180159|P1|Overall Study|Lost to Follow-up|0
43000|NCT01449370|180135|P25|Overall Study|Participant Decision|1
43001|NCT01449370|180136|P24|Overall Study|Participant Decision|0
43002|NCT01449370|180137|P23|Overall Study|Participant Decision|0
43003|NCT01449370|180138|P22|Overall Study|Participant Decision|1
43004|NCT01449370|180139|P21|Overall Study|Participant Decision|0
43005|NCT01449370|180140|P20|Overall Study|Participant Decision|0
43006|NCT01449370|180141|P19|Overall Study|Participant Decision|1
43007|NCT01449370|180142|P18|Overall Study|Participant Decision|0
43008|NCT01449370|180143|P17|Overall Study|Participant Decision|3
43009|NCT01449370|180144|P16|Overall Study|Participant Decision|1
43010|NCT01449370|180145|P15|Overall Study|Participant Decision|0
43011|NCT01449370|180146|P14|Overall Study|Participant Decision|1
43012|NCT01449370|180147|P13|Overall Study|Participant Decision|1
43013|NCT01449370|180148|P12|Overall Study|Participant Decision|0
43014|NCT01449370|180149|P11|Overall Study|Participant Decision|0
43015|NCT01449370|180150|P10|Overall Study|Participant Decision|0
43016|NCT01449370|180151|P9|Overall Study|Participant Decision|1
43017|NCT01449370|180152|P8|Overall Study|Participant Decision|1
43018|NCT01449370|180153|P7|Overall Study|Participant Decision|0
43019|NCT01449370|180154|P6|Overall Study|Participant Decision|0
43020|NCT01449370|180155|P5|Overall Study|Participant Decision|0
43021|NCT01449370|180156|P4|Overall Study|Participant Decision|0
43022|NCT01449370|180157|P3|Overall Study|Participant Decision|0
43023|NCT01449370|180158|P2|Overall Study|Participant Decision|0
43024|NCT01449370|180159|P1|Overall Study|Participant Decision|0
43025|NCT01449370|180135|P25|Overall Study|Adverse Event|3
43026|NCT01449370|180136|P24|Overall Study|Adverse Event|1
43027|NCT01449370|180137|P23|Overall Study|Adverse Event|0
43028|NCT01449370|180138|P22|Overall Study|Adverse Event|1
43029|NCT01449370|180139|P21|Overall Study|Adverse Event|0
43030|NCT01449370|180140|P20|Overall Study|Adverse Event|1
43031|NCT01449370|180141|P19|Overall Study|Adverse Event|1
43032|NCT01449370|180142|P18|Overall Study|Adverse Event|0
43033|NCT01449370|180143|P17|Overall Study|Adverse Event|0
43034|NCT01449370|180144|P16|Overall Study|Adverse Event|1
43035|NCT01449370|180145|P15|Overall Study|Adverse Event|0
43036|NCT01449370|180146|P14|Overall Study|Adverse Event|2
43037|NCT01449370|180147|P13|Overall Study|Adverse Event|0
43038|NCT01449370|180148|P12|Overall Study|Adverse Event|0
43039|NCT01449370|180149|P11|Overall Study|Adverse Event|0
43040|NCT01449370|180150|P10|Overall Study|Adverse Event|1
43041|NCT01449370|180151|P9|Overall Study|Adverse Event|1
43042|NCT01449370|180152|P8|Overall Study|Adverse Event|0
43043|NCT01449370|180153|P7|Overall Study|Adverse Event|0
43044|NCT01449370|180154|P6|Overall Study|Adverse Event|0
43045|NCT01449370|180155|P5|Overall Study|Adverse Event|0
43046|NCT01449370|180156|P4|Overall Study|Adverse Event|1
43047|NCT01449370|180157|P3|Overall Study|Adverse Event|0
43048|NCT01449370|180158|P2|Overall Study|Adverse Event|2
43049|NCT01449370|180159|P1|Overall Study|Adverse Event|1
43050|NCT01449370|180135|P25|Overall Study|Disease Progression|3
43051|NCT01449370|180136|P24|Overall Study|Disease Progression|7
43052|NCT01449370|180137|P23|Overall Study|Disease Progression|3
43053|NCT01449370|180138|P22|Overall Study|Disease Progression|2
43054|NCT01449370|180139|P21|Overall Study|Disease Progression|5
43055|NCT01449370|180140|P20|Overall Study|Disease Progression|2
43056|NCT01449370|180141|P19|Overall Study|Disease Progression|1
43057|NCT01449370|180142|P18|Overall Study|Disease Progression|3
43058|NCT01449370|180143|P17|Overall Study|Disease Progression|4
43059|NCT01449370|180144|P16|Overall Study|Disease Progression|1
43060|NCT01449370|180145|P15|Overall Study|Disease Progression|3
43061|NCT01449370|180146|P14|Overall Study|Disease Progression|8
43062|NCT01449370|180147|P13|Overall Study|Disease Progression|2
43063|NCT01449370|180148|P12|Overall Study|Disease Progression|3
43064|NCT01449370|180149|P11|Overall Study|Disease Progression|3
43065|NCT01449370|180150|P10|Overall Study|Disease Progression|1
43066|NCT01449370|180151|P9|Overall Study|Disease Progression|9
43067|NCT01449370|180152|P8|Overall Study|Disease Progression|2
43068|NCT01449370|180153|P7|Overall Study|Disease Progression|3
43069|NCT01449370|180154|P6|Overall Study|Disease Progression|3
43070|NCT01449370|180155|P5|Overall Study|Disease Progression|3
43071|NCT01449370|180156|P4|Overall Study|Disease Progression|3
43072|NCT01449370|180157|P3|Overall Study|Disease Progression|8
43073|NCT01449370|180158|P2|Overall Study|Disease Progression|4
43074|NCT01449370|180159|P1|Overall Study|Disease Progression|5
43075|NCT01449279|180537|P1|Overall Study|Toxicity|2
43076|NCT01449279|180537|P1|Overall Study|Lack of Efficacy|5
43077|NCT01449006|180562|P2|Overall Study|Protocol Violation|0
43078|NCT01449006|180563|P1|Overall Study|Protocol Violation|1
43079|NCT01449006|180562|P2|Overall Study|Withdrawal by Subject|0
43080|NCT01449006|180563|P1|Overall Study|Withdrawal by Subject|1
43081|NCT01449006|180562|P2|Overall Study|Lost to Follow-up|0
43082|NCT01449006|180563|P1|Overall Study|Lost to Follow-up|1
43083|NCT01448850|180577|P2|Overall Study|Unspecified|12
43084|NCT01448850|180578|P1|Overall Study|Unspecified|15
43085|NCT01448850|180577|P2|Overall Study|Lost to Follow-up|1
43086|NCT01448850|180578|P1|Overall Study|Lost to Follow-up|3
43087|NCT01448850|180577|P2|Overall Study|Withdrawal by Subject|21
43088|NCT01448850|180578|P1|Overall Study|Withdrawal by Subject|13
43089|NCT01448850|180577|P2|Overall Study|Death|6
43090|NCT01448850|180578|P1|Overall Study|Death|3
43091|NCT01448707|180603|P2|Overall Study|Unspecified|4
43092|NCT01448707|180604|P1|Overall Study|Unspecified|7
43093|NCT01448707|180603|P2|Overall Study|Withdrawal by Subject|7
43094|NCT01448707|180604|P1|Overall Study|Withdrawal by Subject|6
43095|NCT01448707|180603|P2|Overall Study|Lost to Follow-up|6
43096|NCT01448707|180604|P1|Overall Study|Lost to Follow-up|2
43097|NCT01448707|180603|P2|Overall Study|Adverse Event|1
43098|NCT01448707|180604|P1|Overall Study|Adverse Event|3
43099|NCT01448616|180625|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
43100|NCT01448616|180626|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
43101|NCT01448616|180627|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
43102|NCT01448616|180628|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
43103|NCT01448616|180625|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
43104|NCT01448616|180626|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
43105|NCT01448616|180627|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
43106|NCT01448616|180628|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
43107|NCT01448616|180625|P4|Study Drug (Treatment Phase)|Adverse Event|0
43108|NCT01448616|180626|P3|Study Drug (Treatment Phase)|Adverse Event|1
43109|NCT01448616|180627|P2|Study Drug (Treatment Phase)|Adverse Event|1
43110|NCT01448616|180628|P1|Study Drug (Treatment Phase)|Adverse Event|0
43111|NCT01448616|180625|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
43112|NCT01448616|180626|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
43113|NCT01448616|180627|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
43114|NCT01448616|180628|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
43115|NCT01448616|180625|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
43116|NCT01448616|180626|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
43117|NCT01448616|180627|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
43118|NCT01448616|180628|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
43119|NCT01448213|180675|P2|Overall Study|Protocol Violation|2
43120|NCT01448213|180676|P1|Overall Study|Protocol Violation|1
43121|NCT01448213|180675|P2|Overall Study|Adverse Event|10
43122|NCT01448213|180676|P1|Overall Study|Adverse Event|4
43123|NCT01448213|180675|P2|Overall Study|Lost to Follow-up|10
43124|NCT01448213|180676|P1|Overall Study|Lost to Follow-up|12
43125|NCT01448057|180686|P2|Overall Study|Withdrawal by Subject|0
43126|NCT01448057|180687|P1|Overall Study|Withdrawal by Subject|2
43127|NCT01448057|180686|P2|Overall Study|Adverse Event|2
43128|NCT01448057|180687|P1|Overall Study|Adverse Event|0
43129|NCT01448057|180686|P2|Overall Study|Lost to Follow-up|0
43130|NCT01448057|180687|P1|Overall Study|Lost to Follow-up|3
43131|NCT01448057|180686|P2|Overall Study|Protocol Violation|2
43132|NCT01448057|180687|P1|Overall Study|Protocol Violation|3
43133|NCT01448044|180697|P2|Follow Up Period|not specified|11
43134|NCT01448044|180698|P1|Follow Up Period|not specified|5
43135|NCT01448044|180697|P2|Follow Up Period|Lost to Follow-up|2
43136|NCT01448044|180698|P1|Follow Up Period|Lost to Follow-up|6
43137|NCT01448044|180697|P2|Follow Up Period|Withdrawal by Subject|1
43138|NCT01448044|180698|P1|Follow Up Period|Withdrawal by Subject|1
43139|NCT01448044|180697|P2|Treatment Period|Other reason|0
43140|NCT01448044|180698|P1|Treatment Period|Other reason|2
43141|NCT01448044|180697|P2|Treatment Period|Lost to Follow-up|1
43142|NCT01448044|180698|P1|Treatment Period|Lost to Follow-up|2
43143|NCT01448044|180697|P2|Treatment Period|Participant does not meet study criteria|0
43144|NCT01448044|180698|P1|Treatment Period|Participant does not meet study criteria|1
43145|NCT01448044|180697|P2|Treatment Period|Completed 24 weeks treatment period only|0
43146|NCT01448044|180698|P1|Treatment Period|Completed 24 weeks treatment period only|8
43147|NCT01448044|180697|P2|Treatment Period|Subject requested discontinue study drug|0
43148|NCT01448044|180698|P1|Treatment Period|Subject requested discontinue study drug|1
43149|NCT01448044|180697|P2|Treatment Period|Lack of Efficacy|12
43150|NCT01448044|180698|P1|Treatment Period|Lack of Efficacy|5
43151|NCT01448044|180697|P2|Treatment Period|Adverse Event|3
43152|NCT01448044|180698|P1|Treatment Period|Adverse Event|4
43153|NCT01447927|180714|P2|Overall Study|Withdrawal by Subject|0
43154|NCT01447927|180715|P1|Overall Study|Withdrawal by Subject|1
43155|NCT01447927|180714|P2|Overall Study|Adverse Event|3
43156|NCT01447927|180715|P1|Overall Study|Adverse Event|4
43157|NCT01447719|180745|P1|Overall Study|Family withdrew autopsy consent|7
43158|NCT01447719|180745|P1|Overall Study|Withdrawal by Subject|2
43159|NCT01447719|180745|P1|Overall Study|Subject still living at end of study|79
43160|NCT01447719|180745|P1|Overall Study|Invalid image or not imaged|3
43161|NCT01447719|180745|P1|Overall Study|Image acquisition failure|2
43162|NCT01447576|180771|P1|Overall Study|Physician Decision|6
43163|NCT01447576|180771|P1|Overall Study|Lack of Efficacy|68
43164|NCT01447576|180771|P1|Overall Study|Protocol deviation|83
43165|NCT01447576|180771|P1|Overall Study|Withdrawal by Subject|100
43166|NCT01447576|180771|P1|Overall Study|Participant met withdrawal criteria|40
43167|NCT01447576|180771|P1|Overall Study|Adverse Event|127
43168|NCT01447576|180771|P1|Overall Study|Lost to Follow-up|52
43169|NCT01447446|180804|P6|Overall Study|Reason not Specified|0
43170|NCT01447446|180805|P5|Overall Study|Reason not Specified|1
43171|NCT01447446|180806|P4|Overall Study|Reason not Specified|1
43172|NCT01447446|180807|P3|Overall Study|Reason not Specified|1
43173|NCT01447446|180808|P2|Overall Study|Reason not Specified|1
43174|NCT01447446|180809|P1|Overall Study|Reason not Specified|1
43175|NCT01447446|180804|P6|Overall Study|New Treatment Started|0
43176|NCT01447446|180805|P5|Overall Study|New Treatment Started|2
43177|NCT01447446|180806|P4|Overall Study|New Treatment Started|0
43178|NCT01447446|180807|P3|Overall Study|New Treatment Started|1
43179|NCT01447446|180808|P2|Overall Study|New Treatment Started|2
43180|NCT01447446|180809|P1|Overall Study|New Treatment Started|8
43181|NCT01447446|180804|P6|Overall Study|SVR12 Assessment|5
43182|NCT01447446|180805|P5|Overall Study|SVR12 Assessment|5
43183|NCT01447446|180806|P4|Overall Study|SVR12 Assessment|1
43184|NCT01447446|180807|P3|Overall Study|SVR12 Assessment|2
43185|NCT01447446|180808|P2|Overall Study|SVR12 Assessment|1
43186|NCT01447446|180809|P1|Overall Study|SVR12 Assessment|13
43187|NCT01447446|180804|P6|Overall Study|Administrative/Other|4
43188|NCT01447446|180805|P5|Overall Study|Administrative/Other|33
43189|NCT01447446|180806|P4|Overall Study|Administrative/Other|2
43190|NCT01447446|180807|P3|Overall Study|Administrative/Other|10
43191|NCT01447446|180808|P2|Overall Study|Administrative/Other|9
43192|NCT01447446|180809|P1|Overall Study|Administrative/Other|34
43193|NCT01447446|180804|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
43194|NCT01447446|180805|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
43195|NCT01447446|180806|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
43196|NCT01447446|180807|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
43197|NCT01447446|180808|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
43198|NCT01447446|180809|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
43199|NCT01447446|180804|P6|Overall Study|Failure to Return/Consent Withdrawn|9
43200|NCT01447446|180805|P5|Overall Study|Failure to Return/Consent Withdrawn|69
43201|NCT01447446|180806|P4|Overall Study|Failure to Return/Consent Withdrawn|7
43202|NCT01447446|180807|P3|Overall Study|Failure to Return/Consent Withdrawn|31
43203|NCT01447446|180808|P2|Overall Study|Failure to Return/Consent Withdrawn|78
43204|NCT01447446|180809|P1|Overall Study|Failure to Return/Consent Withdrawn|357
43205|NCT01447446|180804|P6|Overall Study|Adverse Event|0
43206|NCT01447446|180805|P5|Overall Study|Adverse Event|2
43207|NCT01447446|180806|P4|Overall Study|Adverse Event|0
43208|NCT01447446|180807|P3|Overall Study|Adverse Event|1
43209|NCT01447446|180808|P2|Overall Study|Adverse Event|0
43210|NCT01447446|180809|P1|Overall Study|Adverse Event|3
43211|NCT01447446|180804|P6|Overall Study|Death|0
43212|NCT01447446|180805|P5|Overall Study|Death|7
43213|NCT01447446|180806|P4|Overall Study|Death|1
43214|NCT01447446|180807|P3|Overall Study|Death|2
43215|NCT01447446|180808|P2|Overall Study|Death|3
43216|NCT01447446|180809|P1|Overall Study|Death|6
43217|NCT01447433|180899|P2|Overall Study|Protocol Violation|1
43218|NCT01447433|180900|P1|Overall Study|Protocol Violation|1
43219|NCT01447433|180899|P2|Overall Study|Withdrawal by Subject|3
43220|NCT01447433|180900|P1|Overall Study|Withdrawal by Subject|3
43221|NCT01447433|180899|P2|Overall Study|Lost to Follow-up|2
43222|NCT01447433|180900|P1|Overall Study|Lost to Follow-up|0
43223|NCT01447420|180927|P3|Overall Study|Lack of Efficacy|8
43224|NCT01447420|180928|P2|Overall Study|Lack of Efficacy|19
43225|NCT01447420|180929|P1|Overall Study|Lack of Efficacy|1
43226|NCT01447420|180927|P3|Overall Study|Withdrawal by Subject|0
43227|NCT01447420|180928|P2|Overall Study|Withdrawal by Subject|1
43228|NCT01447420|180929|P1|Overall Study|Withdrawal by Subject|4
43229|NCT01447420|180927|P3|Overall Study|Protocol Violation|0
43230|NCT01447420|180928|P2|Overall Study|Protocol Violation|3
43231|NCT01447420|180929|P1|Overall Study|Protocol Violation|3
43232|NCT01447420|180927|P3|Overall Study|Adverse Event|2
43233|NCT01447420|180928|P2|Overall Study|Adverse Event|4
43234|NCT01447420|180929|P1|Overall Study|Adverse Event|2
43235|NCT01446796|181042|P2|Overall Study|Withdrawal by Subject|0
43236|NCT01446796|181043|P1|Overall Study|Withdrawal by Subject|1
43237|NCT01446419|181068|P2|Overall Study|Terminated per protocol|0
43238|NCT01446419|181069|P1|Overall Study|Terminated per protocol|3
43239|NCT01446419|181068|P2|Overall Study|Withdrawal by Subject|1
43240|NCT01446419|181069|P1|Overall Study|Withdrawal by Subject|1
43241|NCT01446419|181068|P2|Overall Study|Death|0
43242|NCT01446419|181069|P1|Overall Study|Death|1
43243|NCT01446289|181083|P4|Overall Study|Withdrawal by Subject|0
43244|NCT01446289|181084|P3|Overall Study|Withdrawal by Subject|1
43245|NCT01446289|181085|P2|Overall Study|Withdrawal by Subject|0
43246|NCT01446289|181086|P1|Overall Study|Withdrawal by Subject|1
43247|NCT01446237|181129|P1|Overall Study|Withdrawal by Subject|7
43248|NCT01446237|181129|P1|Overall Study|Lost to Follow-up|2
43249|NCT01446237|181129|P1|Overall Study|Adverse Event|1
43250|NCT01446003|181137|P2|Period 2|Adverse Event|0
43251|NCT01446003|181138|P1|Period 2|Adverse Event|1
43252|NCT01446003|181137|P2|Period 1|Protocol Violation|0
43253|NCT01446003|181138|P1|Period 1|Protocol Violation|2
43254|NCT01445951|181159|P3|Overall Study|Cough|0
43255|NCT01445951|181160|P2|Overall Study|Cough|1
43256|NCT01445951|181161|P1|Overall Study|Cough|0
43257|NCT01445951|181159|P3|Overall Study|Sponsor decision - subject travel|0
43258|NCT01445951|181160|P2|Overall Study|Sponsor decision - subject travel|1
43259|NCT01445951|181161|P1|Overall Study|Sponsor decision - subject travel|0
43260|NCT01445951|181159|P3|Overall Study|Non-compliance with protocol|0
43261|NCT01445951|181160|P2|Overall Study|Non-compliance with protocol|1
43262|NCT01445951|181161|P1|Overall Study|Non-compliance with protocol|0
43263|NCT01445951|181159|P3|Overall Study|Non-compliance with study drug|0
43264|NCT01445951|181160|P2|Overall Study|Non-compliance with study drug|2
43265|NCT01445951|181161|P1|Overall Study|Non-compliance with study drug|1
43266|NCT01445951|181159|P3|Overall Study|Death|1
43267|NCT01445951|181160|P2|Overall Study|Death|0
43268|NCT01445951|181161|P1|Overall Study|Death|0
43269|NCT01445951|181159|P3|Overall Study|Pregnancy|4
43270|NCT01445951|181160|P2|Overall Study|Pregnancy|1
43271|NCT01445951|181161|P1|Overall Study|Pregnancy|0
43272|NCT01445951|181159|P3|Overall Study|Lost to Follow-up|4
43273|NCT01445951|181160|P2|Overall Study|Lost to Follow-up|2
43274|NCT01445951|181161|P1|Overall Study|Lost to Follow-up|1
43275|NCT01445951|181159|P3|Overall Study|Physician Decision|0
43276|NCT01445951|181160|P2|Overall Study|Physician Decision|1
43277|NCT01445951|181161|P1|Overall Study|Physician Decision|3
43278|NCT01445951|181159|P3|Overall Study|Withdrawal by Subject|8
43279|NCT01445951|181160|P2|Overall Study|Withdrawal by Subject|16
43280|NCT01445951|181161|P1|Overall Study|Withdrawal by Subject|21
43281|NCT01445951|181159|P3|Overall Study|Protocol Violation|2
43282|NCT01445951|181160|P2|Overall Study|Protocol Violation|2
43283|NCT01445951|181161|P1|Overall Study|Protocol Violation|2
43284|NCT01445951|181159|P3|Overall Study|Adverse Event|0
43285|NCT01445951|181160|P2|Overall Study|Adverse Event|9
43286|NCT01445951|181161|P1|Overall Study|Adverse Event|16
43287|NCT01445847|181229|P2|Overall Study|Missed Data|0
43288|NCT01445847|181230|P1|Overall Study|Missed Data|1
43289|NCT01445847|181229|P2|Overall Study|Protocol Violation|14
43290|NCT01445847|181230|P1|Overall Study|Protocol Violation|13
43291|NCT01445769|181236|P1|Overall Study|Lost to Follow-up|5
43292|NCT01445769|181236|P1|Overall Study|Disease Progression|1
43293|NCT01445769|181236|P1|Overall Study|Consent Withdrawn|2
43294|NCT01445678|181256|P2|Overall Study|Withdrawal by Subject|5
43295|NCT01445678|181257|P1|Overall Study|Withdrawal by Subject|9
43296|NCT01445678|181256|P2|Overall Study|Protocol Violation|1
43297|NCT01445678|181257|P1|Overall Study|Protocol Violation|1
43298|NCT01445678|181256|P2|Overall Study|Lost to Follow-up|5
43299|NCT01445678|181257|P1|Overall Study|Lost to Follow-up|8
43300|NCT01445678|181256|P2|Overall Study|Lack of Efficacy|2
43301|NCT01445678|181257|P1|Overall Study|Lack of Efficacy|0
43302|NCT01445678|181256|P2|Overall Study|Adverse Event|8
43303|NCT01445678|181257|P1|Overall Study|Adverse Event|12
43304|NCT01445652|181275|P2|Overall Study|Adverse Event|0
43305|NCT01445652|181276|P1|Overall Study|Adverse Event|1
43306|NCT01445652|181275|P2|Overall Study|Failed teach session|0
43307|NCT01445652|181276|P1|Overall Study|Failed teach session|2
43308|NCT01445652|181275|P2|Overall Study|Failed to attend scheduled visit|3
43309|NCT01445652|181276|P1|Overall Study|Failed to attend scheduled visit|2
43310|NCT01445652|181275|P2|Overall Study|Not comfortable in lenses|0
43311|NCT01445652|181276|P1|Overall Study|Not comfortable in lenses|5
43312|NCT01445613|181294|P1|1-year Follow-up|Received a non-study stent|2
43313|NCT01445613|181294|P1|1-year Follow-up|Physician Decision|2
43314|NCT01445613|181294|P1|1-year Follow-up|Death|30
43315|NCT01445613|181294|P1|1-year Follow-up|Lost to Follow-up|2
43316|NCT01445613|181294|P1|1-year Follow-up|Missed visit|29
43317|NCT01445613|181294|P1|1-year Follow-up|Withdrawal by Subject|12
43318|NCT01445613|181294|P1|30-day Follow-up|Death|3
43319|NCT01445613|181294|P1|30-day Follow-up|Missed visit|23
43320|NCT01445613|181294|P1|30-day Follow-up|Physician Decision|3
43321|NCT01445613|181294|P1|30-day Follow-up|Withdrawal by Subject|6
43322|NCT01445548|181312|P1|Overall Study|Adverse Event|1
43323|NCT01444898|181366|P1|Overall Study|Withdrawal by Subject|1
43324|NCT01444781|181381|P3|Overall Study|Withdrawal by Subject|2
43325|NCT01444781|181382|P2|Overall Study|Withdrawal by Subject|1
43326|NCT01444781|181383|P1|Overall Study|Withdrawal by Subject|3
43327|NCT01444781|181381|P3|Overall Study|Lost to Follow-up|1
43328|NCT01444781|181382|P2|Overall Study|Lost to Follow-up|3
43329|NCT01444781|181383|P1|Overall Study|Lost to Follow-up|0
43330|NCT01444651|181423|P2|Overall Study|Missing data|1
43331|NCT01444651|181424|P1|Overall Study|Missing data|1
43332|NCT01444651|181423|P2|Overall Study|Non-fasting|1
43333|NCT01444651|181424|P1|Overall Study|Non-fasting|2
43334|NCT01444651|181423|P2|Overall Study|Lost to Follow-up|5
43335|NCT01444651|181424|P1|Overall Study|Lost to Follow-up|5
43336|NCT01444651|181423|P2|Overall Study|Adverse Event|2
43337|NCT01444651|181424|P1|Overall Study|Adverse Event|3
43338|NCT01444456|181440|P1|Overall Study|Not treated|104
43339|NCT01444456|181440|P1|Overall Study|Other|18
43340|NCT01444456|181440|P1|Overall Study|Ineligibility determined|23
43341|NCT01444456|181440|P1|Overall Study|Death|73
43342|NCT01444456|181440|P1|Overall Study|Lost to Follow-up|37
43343|NCT01444456|181440|P1|Overall Study|Physician Decision|9
43344|NCT01444456|181440|P1|Overall Study|Withdrawal by Subject|21
43345|NCT01444430|181451|P2|Overall Study|CRF termination module not completed.|1
43346|NCT01444430|181452|P1|Overall Study|CRF termination module not completed.|0
43347|NCT01444430|181451|P2|Overall Study|Lost to Follow-up|0
43348|NCT01444430|181452|P1|Overall Study|Lost to Follow-up|2
43349|NCT01444430|181451|P2|Overall Study|Death|8
43350|NCT01444430|181452|P1|Overall Study|Death|6
43351|NCT01444430|181451|P2|Overall Study|Withdrawal by Subject|72
43352|NCT01444430|181452|P1|Overall Study|Withdrawal by Subject|53
43353|NCT01444417|181474|P2|Overall Study|Withdrawal by Subject|0
43354|NCT01444417|181475|P1|Overall Study|Withdrawal by Subject|2
43355|NCT01444417|181474|P2|Overall Study|Ineligibility Determined|1
43356|NCT01444417|181475|P1|Overall Study|Ineligibility Determined|0
43357|NCT01444391|181491|P1|Overall Study|Death|1
43358|NCT01444378|181499|P1|Overall Study|Missed Visits|10
43359|NCT01444378|181499|P1|Overall Study|Administrative Closure Of The Study|2
43360|NCT01444378|181499|P1|Overall Study|Death|3
43361|NCT01444378|181499|P1|Overall Study|Withdrawal by Subject|1
43362|NCT01444378|181499|P1|Overall Study|Lost to Follow-up|1
43363|NCT01444300|181611|P2|Overall Study|Adverse Event|0
43364|NCT01444300|181612|P1|Overall Study|Adverse Event|4
43365|NCT01444092|181644|P1|Overall Study|Other Eligibility criteria|7
43366|NCT01444092|181644|P1|Overall Study|Withdrawal by Subject|1
43367|NCT01444092|181644|P1|Overall Study|Protocol Violation|1
43368|NCT01444092|181644|P1|Overall Study|Adverse Event|8
43369|NCT01443923|181652|P2|Overall Study|Adverse Event|0
43370|NCT01443923|181653|P1|Overall Study|Adverse Event|1
43371|NCT01443858|181670|P3|Overall Study|Lost to Follow-up|2
43372|NCT01443858|181671|P2|Overall Study|Lost to Follow-up|5
43373|NCT01443858|181672|P1|Overall Study|Lost to Follow-up|5
43374|NCT01443858|181670|P3|Overall Study|Lack of Efficacy|0
43375|NCT01443858|181671|P2|Overall Study|Lack of Efficacy|0
43376|NCT01443858|181672|P1|Overall Study|Lack of Efficacy|1
43377|NCT01443858|181670|P3|Overall Study|Withdrawal by Subject|5
43378|NCT01443858|181671|P2|Overall Study|Withdrawal by Subject|8
43379|NCT01443858|181672|P1|Overall Study|Withdrawal by Subject|9
43380|NCT01443845|181694|P2|Overall Study|Lost to Follow-up|13
43381|NCT01443845|181695|P1|Overall Study|Lost to Follow-up|9
43382|NCT01443845|181694|P2|Overall Study|Military Conflict - Site Terminated|21
43383|NCT01443845|181695|P1|Overall Study|Military Conflict - Site Terminated|20
43384|NCT01443845|181694|P2|Overall Study|Withdrawal by Subject|67
43385|NCT01443845|181695|P1|Overall Study|Withdrawal by Subject|63
43386|NCT01443845|181694|P2|Overall Study|Adverse Event|138
43387|NCT01443845|181695|P1|Overall Study|Adverse Event|64
43388|NCT01443845|181694|P2|Overall Study|Lack of Efficacy|5
43389|NCT01443845|181695|P1|Overall Study|Lack of Efficacy|10
43390|NCT01443845|181694|P2|Overall Study|Deterioration in pulmonary function|4
43391|NCT01443845|181695|P1|Overall Study|Deterioration in pulmonary function|1
43392|NCT01443845|181694|P2|Overall Study|Other reasons, such as COPD exacerbation|44
43393|NCT01443845|181695|P1|Overall Study|Other reasons, such as COPD exacerbation|44
43394|NCT01443845|181694|P2|Overall Study|Protocol Violation|45
43395|NCT01443845|181695|P1|Overall Study|Protocol Violation|43
43396|NCT01443403|181716|P4|Overall Study|Other - Miscellaneous|1
43397|NCT01443403|181717|P3|Overall Study|Other - Miscellaneous|0
43398|NCT01443403|181718|P2|Overall Study|Other - Miscellaneous|0
43399|NCT01443403|181719|P1|Overall Study|Other - Miscellaneous|1
43400|NCT01443403|181716|P4|Overall Study|Use of Prohibited Treatment|0
43401|NCT01443403|181717|P3|Overall Study|Use of Prohibited Treatment|0
43402|NCT01443403|181718|P2|Overall Study|Use of Prohibited Treatment|3
43403|NCT01443403|181719|P1|Overall Study|Use of Prohibited Treatment|2
43404|NCT01443403|181716|P4|Overall Study|Protocol Violation|1
43405|NCT01443403|181717|P3|Overall Study|Protocol Violation|1
43406|NCT01443403|181718|P2|Overall Study|Protocol Violation|1
43407|NCT01443403|181719|P1|Overall Study|Protocol Violation|2
43408|NCT01443403|181716|P4|Overall Study|Lost to Follow-up|1
43409|NCT01443403|181717|P3|Overall Study|Lost to Follow-up|0
43410|NCT01443403|181718|P2|Overall Study|Lost to Follow-up|0
43411|NCT01443403|181719|P1|Overall Study|Lost to Follow-up|0
43412|NCT01443403|181716|P4|Overall Study|Withdrawal by Subject|1
43413|NCT01443403|181717|P3|Overall Study|Withdrawal by Subject|2
43414|NCT01443403|181718|P2|Overall Study|Withdrawal by Subject|1
43415|NCT01443403|181719|P1|Overall Study|Withdrawal by Subject|0
43416|NCT01443403|181716|P4|Overall Study|Adverse Event|5
43417|NCT01443403|181717|P3|Overall Study|Adverse Event|4
43418|NCT01443403|181718|P2|Overall Study|Adverse Event|1
43419|NCT01443403|181719|P1|Overall Study|Adverse Event|1
43420|NCT01443364|181866|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
43421|NCT01443364|181866|P1|Overall Study|AE, non-serious non-fatal|8
43422|NCT01443364|181866|P1|Overall Study|SAE, non-fatal|6
43423|NCT01443364|181866|P1|Overall Study|Other Reason|4
43424|NCT01443364|181866|P1|Overall Study|Withdrawal by Subject|5
43425|NCT01443364|181866|P1|Overall Study|Lost to Follow-up|3
43426|NCT01443364|181866|P1|Overall Study|Lack of Efficacy|14
43427|NCT01443130|181995|P6|Overall Study|Death of Subject's Infant|0
43428|NCT01443130|181996|P5|Overall Study|Death of Subject's Infant|0
43429|NCT01443130|181997|P4|Overall Study|Death of Subject's Infant|0
43430|NCT01443130|181998|P3|Overall Study|Death of Subject's Infant|11
43431|NCT01443130|181999|P2|Overall Study|Death of Subject's Infant|10
43432|NCT01443130|182000|P1|Overall Study|Death of Subject's Infant|5
43433|NCT01443130|181995|P6|Overall Study|Withdrawal by Subject|2
43434|NCT01443130|181996|P5|Overall Study|Withdrawal by Subject|7
43435|NCT01443130|181997|P4|Overall Study|Withdrawal by Subject|7
43436|NCT01443130|181998|P3|Overall Study|Withdrawal by Subject|12
43437|NCT01443130|181999|P2|Overall Study|Withdrawal by Subject|14
43438|NCT01443130|182000|P1|Overall Study|Withdrawal by Subject|15
43439|NCT01443130|181995|P6|Overall Study|Protocol Violation|3
43440|NCT01443130|181996|P5|Overall Study|Protocol Violation|2
43441|NCT01443130|181997|P4|Overall Study|Protocol Violation|2
43442|NCT01443130|181998|P3|Overall Study|Protocol Violation|3
43443|NCT01443130|181999|P2|Overall Study|Protocol Violation|1
43444|NCT01443130|182000|P1|Overall Study|Protocol Violation|2
43445|NCT01443130|181995|P6|Overall Study|Adverse Event|0
43446|NCT01443130|181996|P5|Overall Study|Adverse Event|0
43447|NCT01443130|181997|P4|Overall Study|Adverse Event|0
43448|NCT01443130|181998|P3|Overall Study|Adverse Event|1
43449|NCT01443130|181999|P2|Overall Study|Adverse Event|1
43450|NCT01443130|182000|P1|Overall Study|Adverse Event|2
43451|NCT01443130|181995|P6|Overall Study|Death|8
43452|NCT01443130|181996|P5|Overall Study|Death|10
43453|NCT01443130|181997|P4|Overall Study|Death|7
43454|NCT01443130|181998|P3|Overall Study|Death|0
43455|NCT01443130|181999|P2|Overall Study|Death|1
43456|NCT01443130|182000|P1|Overall Study|Death|0
43457|NCT01443130|181995|P6|Overall Study|Lost to Follow-up|21
43458|NCT01443130|181996|P5|Overall Study|Lost to Follow-up|25
43459|NCT01443130|181997|P4|Overall Study|Lost to Follow-up|23
43460|NCT01443130|181998|P3|Overall Study|Lost to Follow-up|50
43461|NCT01443130|181999|P2|Overall Study|Lost to Follow-up|42
43462|NCT01443130|182000|P1|Overall Study|Lost to Follow-up|44
43463|NCT01443078|182050|P1|Overall Study|Patient had brain mets|1
43464|NCT01443078|182050|P1|Overall Study|Withdrawal by Subject|1
43465|NCT01443078|182050|P1|Overall Study|Responded to neoadjuvant platinum txt|27
43466|NCT01443026|182056|P2|Overall Study|Lost to Follow-up|1
43467|NCT01443026|182057|P1|Overall Study|Lost to Follow-up|2
43468|NCT01443026|182056|P2|Overall Study|Withdrawal by Subject|3
43469|NCT01443026|182057|P1|Overall Study|Withdrawal by Subject|0
43470|NCT01443026|182056|P2|Overall Study|Death|1
43471|NCT01443026|182057|P1|Overall Study|Death|0
43472|NCT01443026|182056|P2|Overall Study|Physician Decision|0
43473|NCT01443026|182057|P1|Overall Study|Physician Decision|1
43474|NCT01442779|182072|P1|Overall Study|Non-compliance|1
43475|NCT01442779|182072|P1|Overall Study|Death|3
43476|NCT01442779|182072|P1|Overall Study|Withdrawal by Subject|3
43477|NCT01442688|182080|P2|Second Intervention|Adverse Event|0
43478|NCT01442688|182081|P1|Second Intervention|Adverse Event|1
43479|NCT01442688|182080|P2|First Intervention|subject incarcerated|0
43480|NCT01442688|182081|P1|First Intervention|subject incarcerated|1
43481|NCT01442688|182080|P2|First Intervention|Withdrawal by Subject|0
43482|NCT01442688|182081|P1|First Intervention|Withdrawal by Subject|1
43483|NCT01442675|182089|P1|Overall Study|Withdrawal by Subject|4
43484|NCT01442675|182089|P1|Overall Study|Lost to Follow-up|2
43485|NCT01442675|182089|P1|Overall Study|Protocol Violation|6
43486|NCT01442376|182102|P3|Overall Study|Not eligible for subsequent cycles|0
43487|NCT01442376|182103|P2|Overall Study|Not eligible for subsequent cycles|2
43488|NCT01442376|182104|P1|Overall Study|Not eligible for subsequent cycles|1
43489|NCT01442376|182102|P3|Overall Study|Patients not treated|1
43490|NCT01442376|182103|P2|Overall Study|Patients not treated|3
43491|NCT01442376|182104|P1|Overall Study|Patients not treated|2
43492|NCT01442376|182102|P3|Overall Study|Withdrawal of consent|1
43493|NCT01442376|182103|P2|Overall Study|Withdrawal of consent|0
43494|NCT01442376|182104|P1|Overall Study|Withdrawal of consent|0
43495|NCT01442376|182102|P3|Overall Study|Death|1
43496|NCT01442376|182103|P2|Overall Study|Death|1
43497|NCT01442376|182104|P1|Overall Study|Death|0
43498|NCT01442376|182102|P3|Overall Study|Adverse Event|2
43499|NCT01442376|182103|P2|Overall Study|Adverse Event|3
43500|NCT01442376|182104|P1|Overall Study|Adverse Event|0
43501|NCT01442181|182117|P2|Overall Study|atrial fibrillation not noted|1
43502|NCT01442181|182118|P1|Overall Study|atrial fibrillation not noted|0
43503|NCT01442181|182117|P2|Overall Study|patient in an additional study|0
43504|NCT01442181|182118|P1|Overall Study|patient in an additional study|1
43505|NCT01442181|182117|P2|Overall Study|Lost to Follow-up|1
43506|NCT01442181|182118|P1|Overall Study|Lost to Follow-up|1
43507|NCT01442181|182117|P2|Overall Study|low ejection factor|1
43508|NCT01442181|182118|P1|Overall Study|low ejection factor|0
43509|NCT01442181|182117|P2|Overall Study|no insurance for surgery|0
43510|NCT01442181|182118|P1|Overall Study|no insurance for surgery|1
43511|NCT01442181|182117|P2|Overall Study|patient refused surgery|0
43512|NCT01442181|182118|P1|Overall Study|patient refused surgery|1
43513|NCT01442155|182142|P1|Overall Study|Lost to Follow-up|2
43514|NCT01442155|182142|P1|Overall Study|Adverse Event|2
43515|NCT01442155|182142|P1|Overall Study|Recurrence|26
43516|NCT01442155|182142|P1|Overall Study|Complete remission|35
43517|NCT01442103|182158|P1|Overall Study|Lost to Follow-up|2
43518|NCT01442064|182168|P6|Overall Study|Condition mandated other intervention|2
43519|NCT01442064|182169|P5|Overall Study|Condition mandated other intervention|0
43520|NCT01442064|182170|P4|Overall Study|Condition mandated other intervention|0
43521|NCT01442064|182171|P3|Overall Study|Condition mandated other intervention|2
43522|NCT01442064|182172|P2|Overall Study|Condition mandated other intervention|1
43523|NCT01442064|182173|P1|Overall Study|Condition mandated other intervention|1
43524|NCT01442064|182168|P6|Overall Study|Subject non-compliance|2
43525|NCT01442064|182169|P5|Overall Study|Subject non-compliance|0
43526|NCT01442064|182170|P4|Overall Study|Subject non-compliance|0
43527|NCT01442064|182171|P3|Overall Study|Subject non-compliance|0
43528|NCT01442064|182172|P2|Overall Study|Subject non-compliance|0
43529|NCT01442064|182173|P1|Overall Study|Subject non-compliance|0
43530|NCT01442064|182168|P6|Overall Study|Sponsor decision|87
43531|NCT01442064|182169|P5|Overall Study|Sponsor decision|95
43532|NCT01442064|182170|P4|Overall Study|Sponsor decision|88
43533|NCT01442064|182171|P3|Overall Study|Sponsor decision|92
43534|NCT01442064|182172|P2|Overall Study|Sponsor decision|88
43535|NCT01442064|182173|P1|Overall Study|Sponsor decision|82
43536|NCT01442064|182168|P6|Overall Study|Withdrawal by Subject|1
43537|NCT01442064|182169|P5|Overall Study|Withdrawal by Subject|2
43538|NCT01442064|182170|P4|Overall Study|Withdrawal by Subject|2
43539|NCT01442064|182171|P3|Overall Study|Withdrawal by Subject|2
43540|NCT01442064|182172|P2|Overall Study|Withdrawal by Subject|3
43541|NCT01442064|182173|P1|Overall Study|Withdrawal by Subject|6
43542|NCT01442064|182168|P6|Overall Study|Physician Decision|1
43543|NCT01442064|182169|P5|Overall Study|Physician Decision|3
43544|NCT01442064|182170|P4|Overall Study|Physician Decision|3
43545|NCT01442064|182171|P3|Overall Study|Physician Decision|2
43546|NCT01442064|182172|P2|Overall Study|Physician Decision|1
43547|NCT01442064|182173|P1|Overall Study|Physician Decision|1
43548|NCT01442064|182168|P6|Overall Study|Lost to Follow-up|3
43549|NCT01442064|182169|P5|Overall Study|Lost to Follow-up|3
43550|NCT01442064|182170|P4|Overall Study|Lost to Follow-up|1
43551|NCT01442064|182171|P3|Overall Study|Lost to Follow-up|1
43552|NCT01442064|182172|P2|Overall Study|Lost to Follow-up|5
43553|NCT01442064|182173|P1|Overall Study|Lost to Follow-up|5
43554|NCT01442064|182168|P6|Overall Study|Death|3
43555|NCT01442064|182169|P5|Overall Study|Death|1
43556|NCT01442064|182170|P4|Overall Study|Death|3
43557|NCT01442064|182171|P3|Overall Study|Death|3
43558|NCT01442064|182172|P2|Overall Study|Death|1
43559|NCT01442064|182173|P1|Overall Study|Death|0
43560|NCT01442064|182168|P6|Overall Study|Adverse Event|0
43561|NCT01442064|182169|P5|Overall Study|Adverse Event|2
43562|NCT01442064|182170|P4|Overall Study|Adverse Event|1
43563|NCT01442064|182171|P3|Overall Study|Adverse Event|2
43564|NCT01442064|182172|P2|Overall Study|Adverse Event|2
43565|NCT01442064|182173|P1|Overall Study|Adverse Event|2
43566|NCT01442038|182210|P2|Overall Study|Study Terminated By Sponsor|3
43567|NCT01442038|182211|P1|Overall Study|Study Terminated By Sponsor|2
43568|NCT01442038|182210|P2|Overall Study|Investigator's Discretion|16
43569|NCT01442038|182211|P1|Overall Study|Investigator's Discretion|13
43570|NCT01442038|182210|P2|Overall Study|Protocol Deviation|20
43571|NCT01442038|182211|P1|Overall Study|Protocol Deviation|9
43572|NCT01442038|182210|P2|Overall Study|Adverse Event|15
43573|NCT01442038|182211|P1|Overall Study|Adverse Event|26
43574|NCT01442038|182210|P2|Overall Study|Lost to Follow-up|51
43575|NCT01442038|182211|P1|Overall Study|Lost to Follow-up|37
43576|NCT01442038|182210|P2|Overall Study|Participant Withdrew Consent|102
43577|NCT01442038|182211|P1|Overall Study|Participant Withdrew Consent|137
43578|NCT01442038|182210|P2|Overall Study|Investigator-Initiated Early Closure|43
43579|NCT01442038|182211|P1|Overall Study|Investigator-Initiated Early Closure|44
43580|NCT01442038|182210|P2|Overall Study|Death|29
43581|NCT01442038|182211|P1|Overall Study|Death|35
43582|NCT01441973|182225|P2|Overall Study|Nonrelated cardiac amyloidosis|1
43583|NCT01441973|182226|P1|Overall Study|Nonrelated cardiac amyloidosis|0
43584|NCT01441973|182225|P2|Overall Study|Poor compliance/noncompliance|1
43585|NCT01441973|182226|P1|Overall Study|Poor compliance/noncompliance|0
43586|NCT01441973|182225|P2|Overall Study|Patient request to discontinue treatment|1
43587|NCT01441973|182226|P1|Overall Study|Patient request to discontinue treatment|1
43588|NCT01441973|182225|P2|Overall Study|Adverse event unrelated to study drug|0
43589|NCT01441973|182226|P1|Overall Study|Adverse event unrelated to study drug|3
43590|NCT01441973|182225|P2|Overall Study|Disease progression|2
43591|NCT01441973|182226|P1|Overall Study|Disease progression|4
43592|NCT01441960|182240|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
43593|NCT01441960|182241|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
43594|NCT01441960|182240|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
43595|NCT01441960|182241|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
43596|NCT01441960|182240|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
43597|NCT01441960|182241|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
43598|NCT01441765|182262|P2|Overall Study|Death|0
43599|NCT01441765|182263|P1|Overall Study|Death|1
43600|NCT01441596|182280|P3|Overall Study|Not treated|1
43601|NCT01441596|182281|P2|Overall Study|Not treated|1
43602|NCT01441596|182282|P1|Overall Study|Not treated|0
43603|NCT01441596|182280|P3|Overall Study|Withdrawal by Subject|2
43604|NCT01441596|182281|P2|Overall Study|Withdrawal by Subject|0
43605|NCT01441596|182282|P1|Overall Study|Withdrawal by Subject|4
43606|NCT01441596|182280|P3|Overall Study|Other reason not defined below|1
43607|NCT01441596|182281|P2|Overall Study|Other reason not defined below|2
43608|NCT01441596|182282|P1|Overall Study|Other reason not defined below|0
43609|NCT01441440|182329|P3|Overall Study|Difficllty in keeping the schedule|0
43610|NCT01441440|182330|P2|Overall Study|Difficllty in keeping the schedule|1
43611|NCT01441440|182331|P1|Overall Study|Difficllty in keeping the schedule|1
43612|NCT01441440|182329|P3|Overall Study|Work-related matter|0
43613|NCT01441440|182330|P2|Overall Study|Work-related matter|1
43614|NCT01441440|182331|P1|Overall Study|Work-related matter|0
43615|NCT01441440|182329|P3|Overall Study|Moving|1
43616|NCT01441440|182330|P2|Overall Study|Moving|1
43617|NCT01441440|182331|P1|Overall Study|Moving|0
43618|NCT01441440|182329|P3|Overall Study|Lack of Efficacy|1
43619|NCT01441440|182330|P2|Overall Study|Lack of Efficacy|0
43620|NCT01441440|182331|P1|Overall Study|Lack of Efficacy|1
43621|NCT01441440|182329|P3|Overall Study|Pregnancy|0
43622|NCT01441440|182330|P2|Overall Study|Pregnancy|0
43623|NCT01441440|182331|P1|Overall Study|Pregnancy|1
43624|NCT01441440|182329|P3|Overall Study|Withdrawal by Subject|9
43625|NCT01441440|182330|P2|Overall Study|Withdrawal by Subject|9
43626|NCT01441440|182331|P1|Overall Study|Withdrawal by Subject|11
43627|NCT01441440|182329|P3|Overall Study|Lost to Follow-up|1
43628|NCT01441440|182330|P2|Overall Study|Lost to Follow-up|2
43629|NCT01441440|182331|P1|Overall Study|Lost to Follow-up|0
43630|NCT01441440|182329|P3|Overall Study|Adverse Event|9
43631|NCT01441440|182330|P2|Overall Study|Adverse Event|9
43632|NCT01441440|182331|P1|Overall Study|Adverse Event|2
43633|NCT01441440|182329|P3|Overall Study|Death|1
43634|NCT01441440|182330|P2|Overall Study|Death|0
43635|NCT01441440|182331|P1|Overall Study|Death|1
43636|NCT01441414|182354|P1|Overall Study|Subject refused further follow-up|1
43637|NCT01441414|182354|P1|Overall Study|Study terminated by sponsor|2
43638|NCT01441414|182354|P1|Overall Study|Other reasons|3
43639|NCT01441414|182354|P1|Overall Study|Participant died|9
43640|NCT01441180|182433|P3|Overall Study|Discontinued|2
43641|NCT01441180|182434|P2|Overall Study|Discontinued|0
43642|NCT01441180|182435|P1|Overall Study|Discontinued|0
43643|NCT01441180|182433|P3|Overall Study|Lost to Follow-up|1
43644|NCT01441180|182434|P2|Overall Study|Lost to Follow-up|1
43645|NCT01441180|182435|P1|Overall Study|Lost to Follow-up|1
43646|NCT01441102|182446|P1|Overall Study|Withdrawal by Subject|2
43647|NCT01441102|182446|P1|Overall Study|Adverse Event|1
43648|NCT01440972|182486|P2|Overall Study|Withdrawal by Subject|2
43649|NCT01440972|182487|P1|Overall Study|Withdrawal by Subject|3
43650|NCT01440946|182511|P2|Overall Study|Physician Decision|0
43651|NCT01440946|182512|P1|Overall Study|Physician Decision|1
43652|NCT01440946|182511|P2|Overall Study|Lost to Follow-up|1
43653|NCT01440946|182512|P1|Overall Study|Lost to Follow-up|1
43654|NCT01440881|182551|P2|Overall Study|Death|1
43655|NCT01440881|182552|P1|Overall Study|Death|0
43656|NCT01440647|182593|P2|Overall Study|Death|3
43657|NCT01440647|182594|P1|Overall Study|Death|2
43658|NCT01440595|182613|P3|Overall Study|Study terminated by sponsor.|1
43659|NCT01440595|182614|P2|Overall Study|Study terminated by sponsor.|2
43660|NCT01440595|182615|P1|Overall Study|Study terminated by sponsor.|1
43661|NCT01440595|182613|P3|Overall Study|Lost to Follow-up|0
43662|NCT01440595|182614|P2|Overall Study|Lost to Follow-up|1
43663|NCT01440595|182615|P1|Overall Study|Lost to Follow-up|0
43664|NCT01440569|182635|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
43665|NCT01440569|182636|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
43666|NCT01440569|182635|P2|Open-Label Rollover Phase|Lost to Follow-up|3
43667|NCT01440569|182636|P1|Open-Label Rollover Phase|Lost to Follow-up|26
43668|NCT01440569|182635|P2|Open-Label Rollover Phase|Withdrew Consent|1
43669|NCT01440569|182636|P1|Open-Label Rollover Phase|Withdrew Consent|11
43670|NCT01440569|182635|P2|Open-Label Rollover Phase|Investigator’s Discretion|1
43671|NCT01440569|182636|P1|Open-Label Rollover Phase|Investigator’s Discretion|3
43672|NCT01440569|182635|P2|Open-Label Rollover Phase|Lack of Efficacy|0
43673|NCT01440569|182636|P1|Open-Label Rollover Phase|Lack of Efficacy|2
43674|NCT01440569|182635|P2|Open-Label Rollover Phase|Pregnancy|0
43675|NCT01440569|182636|P1|Open-Label Rollover Phase|Pregnancy|1
43676|NCT01440569|182635|P2|Open-Label Rollover Phase|Adverse Event|0
43677|NCT01440569|182636|P1|Open-Label Rollover Phase|Adverse Event|3
43678|NCT01440569|182635|P2|Main Study|Protocol Violation|0
43679|NCT01440569|182636|P1|Main Study|Protocol Violation|1
43680|NCT01440569|182635|P2|Main Study|Subject Non-Compliance|0
43681|NCT01440569|182636|P1|Main Study|Subject Non-Compliance|3
43682|NCT01440569|182635|P2|Main Study|Lost to Follow-up|2
43683|NCT01440569|182636|P1|Main Study|Lost to Follow-up|13
43684|NCT01440569|182635|P2|Main Study|Withdrew Consent|1
43685|NCT01440569|182636|P1|Main Study|Withdrew Consent|7
43686|NCT01440569|182635|P2|Main Study|Investigator's Discretion|1
43687|NCT01440569|182636|P1|Main Study|Investigator's Discretion|1
43688|NCT01440569|182635|P2|Main Study|Pregnancy|0
43689|NCT01440569|182636|P1|Main Study|Pregnancy|1
43690|NCT01440569|182635|P2|Main Study|Adverse Event|0
43691|NCT01440569|182636|P1|Main Study|Adverse Event|9
43692|NCT01440569|182635|P2|Main Study|Enrolled but not treated|0
43693|NCT01440569|182636|P1|Main Study|Enrolled but not treated|1
43694|NCT01440517|182671|P1|Overall Study|Subject withdrawn prior to dosing|1
43695|NCT01440374|182702|P4|Part 3: Extension|Physician Decision|14
43696|NCT01440374|182703|P3|Part 3: Extension|Physician Decision|0
43697|NCT01440374|182704|P2|Part 3: Extension|Physician Decision|0
43698|NCT01440374|182705|P1|Part 3: Extension|Physician Decision|0
43699|NCT01440374|182702|P4|Part 3: Extension|Adverse Event|13
43700|NCT01440374|182703|P3|Part 3: Extension|Adverse Event|0
43701|NCT01440374|182704|P2|Part 3: Extension|Adverse Event|0
43702|NCT01440374|182705|P1|Part 3: Extension|Adverse Event|0
43703|NCT01440374|182702|P4|Part 3: Extension|Withdrawal by Subject|5
43704|NCT01440374|182703|P3|Part 3: Extension|Withdrawal by Subject|0
43705|NCT01440374|182704|P2|Part 3: Extension|Withdrawal by Subject|0
43706|NCT01440374|182705|P1|Part 3: Extension|Withdrawal by Subject|0
43707|NCT01440374|182702|P4|Part 2; Double-blind Phase|Not treated|0
43708|NCT01440374|182703|P3|Part 2; Double-blind Phase|Not treated|1
43709|NCT01440374|182704|P2|Part 2; Double-blind Phase|Not treated|0
43710|NCT01440374|182705|P1|Part 2; Double-blind Phase|Not treated|0
43711|NCT01440374|182702|P4|Part 2; Double-blind Phase|Adverse Event|0
43712|NCT01440374|182703|P3|Part 2; Double-blind Phase|Adverse Event|31
43713|NCT01440374|182704|P2|Part 2; Double-blind Phase|Adverse Event|7
43714|NCT01440374|182705|P1|Part 2; Double-blind Phase|Adverse Event|0
43715|NCT01440374|182702|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
43716|NCT01440374|182703|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
43717|NCT01440374|182704|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
43718|NCT01440374|182705|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
43719|NCT01440374|182702|P4|Part 2; Double-blind Phase|Protocol Violation|0
43720|NCT01440374|182703|P3|Part 2; Double-blind Phase|Protocol Violation|1
43721|NCT01440374|182704|P2|Part 2; Double-blind Phase|Protocol Violation|0
43722|NCT01440374|182705|P1|Part 2; Double-blind Phase|Protocol Violation|0
43723|NCT01440374|182702|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
43724|NCT01440374|182703|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
43725|NCT01440374|182704|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
43726|NCT01440374|182705|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
43727|NCT01440374|182702|P4|Part 2; Double-blind Phase|Physician Decision|0
43728|NCT01440374|182703|P3|Part 2; Double-blind Phase|Physician Decision|17
43729|NCT01440374|182704|P2|Part 2; Double-blind Phase|Physician Decision|8
43730|NCT01440374|182705|P1|Part 2; Double-blind Phase|Physician Decision|0
43731|NCT01440374|182702|P4|Part 1: Open-label Phase|Physician Decision|0
43732|NCT01440374|182703|P3|Part 1: Open-label Phase|Physician Decision|0
43733|NCT01440374|182704|P2|Part 1: Open-label Phase|Physician Decision|0
43734|NCT01440374|182705|P1|Part 1: Open-label Phase|Physician Decision|1
43735|NCT01440374|182702|P4|Part 1: Open-label Phase|Adverse Event|0
43736|NCT01440374|182703|P3|Part 1: Open-label Phase|Adverse Event|0
43737|NCT01440374|182704|P2|Part 1: Open-label Phase|Adverse Event|0
43738|NCT01440374|182705|P1|Part 1: Open-label Phase|Adverse Event|5
43739|NCT01440322|182740|P2|Overall Study|Other Non-Product Related|0
43740|NCT01440322|182741|P1|Overall Study|Other Non-Product Related|1
43741|NCT01440322|182740|P2|Overall Study|Unrelated Medical Problem|1
43742|NCT01440322|182741|P1|Overall Study|Unrelated Medical Problem|0
43743|NCT01440322|182740|P2|Overall Study|Other Product Related|0
43744|NCT01440322|182741|P1|Overall Study|Other Product Related|1
43745|NCT01440322|182740|P2|Overall Study|Unacceptable Subjective Vision|0
43746|NCT01440322|182741|P1|Overall Study|Unacceptable Subjective Vision|1
43747|NCT01440322|182740|P2|Overall Study|Symptoms and Problems|0
43748|NCT01440322|182741|P1|Overall Study|Symptoms and Problems|1
43749|NCT01440322|182740|P2|Overall Study|Biomicroscopy|0
43750|NCT01440322|182741|P1|Overall Study|Biomicroscopy|1
43751|NCT01440322|182740|P2|Overall Study|Discomfort|0
43752|NCT01440322|182741|P1|Overall Study|Discomfort|2
43753|NCT01440283|182763|P1|Overall Study|Physician Decision|3
43754|NCT01440283|182763|P1|Overall Study|Withdrawal by Subject|4
43755|NCT01440283|182763|P1|Overall Study|Death|3
43756|NCT01440101|182778|P3|Overall Study|Not Specified|0
43757|NCT01440101|182779|P2|Overall Study|Not Specified|1
43758|NCT01440101|182780|P1|Overall Study|Not Specified|0
43759|NCT01440101|182778|P3|Overall Study|Withdrawal by Subject|1
43760|NCT01440101|182779|P2|Overall Study|Withdrawal by Subject|3
43761|NCT01440101|182780|P1|Overall Study|Withdrawal by Subject|0
43762|NCT01440101|182778|P3|Overall Study|Adverse Event|0
43763|NCT01440101|182779|P2|Overall Study|Adverse Event|0
43764|NCT01440101|182780|P1|Overall Study|Adverse Event|2
43765|NCT01440049|182813|P1|Overall Study|Adverse Event|5
43766|NCT01439971|182845|P5|Overall Study|Required number in cohort dosed|1
43767|NCT01439971|182846|P4|Overall Study|Required number in cohort dosed|0
43768|NCT01439971|182847|P3|Overall Study|Required number in cohort dosed|2
43769|NCT01439971|182848|P2|Overall Study|Required number in cohort dosed|1
43770|NCT01439971|182849|P1|Overall Study|Required number in cohort dosed|0
43771|NCT01439945|183029|P4|Double-Blind Treatment Phase|Ineligible|1
43772|NCT01439945|183030|P3|Double-Blind Treatment Phase|Ineligible|0
43773|NCT01439945|183031|P2|Double-Blind Treatment Phase|Ineligible|2
43774|NCT01439945|183032|P1|Double-Blind Treatment Phase|Ineligible|1
43775|NCT01439945|183029|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
43776|NCT01439945|183030|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
43777|NCT01439945|183031|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
43778|NCT01439945|183032|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
43779|NCT01439867|183057|P2|Overall Study|Protocol-specified Criteria|0
43780|NCT01439867|183058|P1|Overall Study|Protocol-specified Criteria|1
43781|NCT01439867|183057|P2|Overall Study|Administrative Decision|5
43782|NCT01439867|183058|P1|Overall Study|Administrative Decision|4
43783|NCT01439867|183057|P2|Overall Study|Withdrawal by Subject|2
43784|NCT01439867|183058|P1|Overall Study|Withdrawal by Subject|1
43785|NCT01439867|183057|P2|Overall Study|Non-compliance|1
43786|NCT01439867|183058|P1|Overall Study|Non-compliance|0
43787|NCT01439724|183099|P2|Overall Study|missing consultation|8
43788|NCT01439724|183100|P1|Overall Study|missing consultation|9
43789|NCT01439360|183112|P2|Overall Study|Withdrawal by Subject|129
43790|NCT01439360|183113|P1|Overall Study|Withdrawal by Subject|140
43791|NCT01439360|183112|P2|Overall Study|Protocol Violation|0
43792|NCT01439360|183113|P1|Overall Study|Protocol Violation|1
43793|NCT01439360|183112|P2|Overall Study|Others|5
43794|NCT01439360|183113|P1|Overall Study|Others|10
43795|NCT01439360|183112|P2|Overall Study|Lost to Follow-up|58
43796|NCT01439360|183113|P1|Overall Study|Lost to Follow-up|43
43797|NCT01439360|183112|P2|Overall Study|Adverse Event|16
43798|NCT01439360|183113|P1|Overall Study|Adverse Event|4
43799|NCT01439282|183163|P2|Overall Study|Not specified|1
43800|NCT01439282|183164|P1|Overall Study|Not specified|1
43801|NCT01439282|183163|P2|Overall Study|Withdrawal by Subject|0
43802|NCT01439282|183164|P1|Overall Study|Withdrawal by Subject|2
43803|NCT01439282|183163|P2|Overall Study|Adverse Event|0
43804|NCT01439282|183164|P1|Overall Study|Adverse Event|5
43805|NCT01439204|183174|P2|Overall Study|poor/non-compliance|0
43806|NCT01439204|183175|P1|Overall Study|poor/non-compliance|3
43807|NCT01439204|183174|P2|Overall Study|No longer meets study criteria|0
43808|NCT01439204|183175|P1|Overall Study|No longer meets study criteria|1
43809|NCT01439204|183174|P2|Overall Study|Lost to Follow-up|2
43810|NCT01439204|183175|P1|Overall Study|Lost to Follow-up|0
43811|NCT01439204|183174|P2|Overall Study|Withdrawal by Subject|1
43812|NCT01439204|183175|P1|Overall Study|Withdrawal by Subject|0
43813|NCT01439126|183209|P2|Overall Study|Other-Miscellaneous|12
43814|NCT01439126|183210|P1|Overall Study|Other-Miscellaneous|12
43815|NCT01439126|183209|P2|Overall Study|Other-Use of prohibited treatment|2
43816|NCT01439126|183210|P1|Overall Study|Other-Use of prohibited treatment|0
43817|NCT01439126|183209|P2|Overall Study|Lost to Follow-up|3
43818|NCT01439126|183210|P1|Overall Study|Lost to Follow-up|6
43819|NCT01439126|183209|P2|Overall Study|Protocol Violation|4
43820|NCT01439126|183210|P1|Overall Study|Protocol Violation|6
43821|NCT01439126|183209|P2|Overall Study|Withdrawal by Subject|21
43822|NCT01439126|183210|P1|Overall Study|Withdrawal by Subject|5
43823|NCT01439126|183209|P2|Overall Study|Adverse Event|0
43824|NCT01439126|183210|P1|Overall Study|Adverse Event|2
43825|NCT01438996|183248|P3|Overall Study|Not meeting Inclusion Criteria|0
43826|NCT01438996|183249|P2|Overall Study|Not meeting Inclusion Criteria|1
43827|NCT01438996|183250|P1|Overall Study|Not meeting Inclusion Criteria|4
43828|NCT01438814|183284|P2|Overall Study|Not specified|4
43829|NCT01438814|183285|P1|Overall Study|Not specified|2
43830|NCT01438814|183284|P2|Overall Study|Withdrawal by Subject|2
43831|NCT01438814|183285|P1|Overall Study|Withdrawal by Subject|4
43832|NCT01438814|183284|P2|Overall Study|Lost to Follow-up|3
43833|NCT01438814|183285|P1|Overall Study|Lost to Follow-up|4
43834|NCT01438814|183284|P2|Overall Study|Protocol Violation|2
43835|NCT01438814|183285|P1|Overall Study|Protocol Violation|1
43836|NCT01438814|183284|P2|Overall Study|Adverse Event|3
43837|NCT01438814|183285|P1|Overall Study|Adverse Event|3
43838|NCT01438541|183321|P1|Overall Study|discharge from the hospital|5
43839|NCT01438541|183321|P1|Overall Study|Withdrawal by Subject|1
43840|NCT01438541|183321|P1|Overall Study|Physician Decision|1
43841|NCT01438489|183330|P3|Overall Study|Inadequate venous access|0
43842|NCT01438489|183331|P2|Overall Study|Inadequate venous access|2
43843|NCT01438489|183332|P1|Overall Study|Inadequate venous access|0
43844|NCT01438489|183330|P3|Overall Study|Did not complete all 3 follow-up visits|2
43845|NCT01438489|183331|P2|Overall Study|Did not complete all 3 follow-up visits|5
43846|NCT01438489|183332|P1|Overall Study|Did not complete all 3 follow-up visits|2
43847|NCT01438489|183330|P3|Overall Study|Received prohibited medication|0
43848|NCT01438489|183331|P2|Overall Study|Received prohibited medication|0
43849|NCT01438489|183332|P1|Overall Study|Received prohibited medication|1
43850|NCT01438489|183330|P3|Overall Study|AE/SAEs|1
43851|NCT01438489|183331|P2|Overall Study|AE/SAEs|1
43852|NCT01438489|183332|P1|Overall Study|AE/SAEs|2
43853|NCT01438489|183330|P3|Overall Study|Investigator decision|0
43854|NCT01438489|183331|P2|Overall Study|Investigator decision|1
43855|NCT01438489|183332|P1|Overall Study|Investigator decision|0
43856|NCT01438489|183330|P3|Overall Study|Subject choice/Subject moved|1
43857|NCT01438489|183331|P2|Overall Study|Subject choice/Subject moved|1
43858|NCT01438489|183332|P1|Overall Study|Subject choice/Subject moved|2
43859|NCT01438489|183330|P3|Overall Study|Sponsor decision|4
43860|NCT01438489|183331|P2|Overall Study|Sponsor decision|1
43861|NCT01438489|183332|P1|Overall Study|Sponsor decision|4
43862|NCT01438489|183330|P3|Overall Study|Death|1
43863|NCT01438489|183331|P2|Overall Study|Death|0
43864|NCT01438489|183332|P1|Overall Study|Death|0
43865|NCT01438489|183330|P3|Overall Study|Withdrawal by Subject|8
43866|NCT01438489|183331|P2|Overall Study|Withdrawal by Subject|3
43867|NCT01438489|183332|P1|Overall Study|Withdrawal by Subject|11
43868|NCT01438489|183330|P3|Overall Study|Lost to Follow-up|2
43869|NCT01438489|183331|P2|Overall Study|Lost to Follow-up|2
43870|NCT01438489|183332|P1|Overall Study|Lost to Follow-up|4
43871|NCT01438424|183375|P1|Overall Study|Participant noncompliance|20
43872|NCT01438424|183375|P1|Overall Study|No longer met inclusion criteria|1
43873|NCT01438424|183375|P1|Overall Study|Pregnancy|7
43874|NCT01438424|183375|P1|Overall Study|Need for drug prohibited by protocol|14
43875|NCT01438424|183375|P1|Overall Study|Abnormal laboratory test result|14
43876|NCT01438424|183375|P1|Overall Study|Lost to Follow-up|17
43877|NCT01438424|183375|P1|Overall Study|Adverse Event|17
43878|NCT01438424|183375|P1|Overall Study|Death|22
43879|NCT01438424|183375|P1|Overall Study|Progression of chronic hepatitis B|22
43880|NCT01438424|183375|P1|Overall Study|Withdrawal by Subject|104
43881|NCT01438424|183375|P1|Overall Study|Not identified|55
43882|NCT01438424|183375|P1|Overall Study|Minimal virologic response|95
43883|NCT01438424|183375|P1|Overall Study|Continuing treatment|29
43884|NCT01438307|183413|P2|Overall Study|Death|1
43885|NCT01438307|183414|P1|Overall Study|Death|1
43886|NCT01438294|183428|P2|Overall Study|Lost to Follow-up|7
43887|NCT01438294|183429|P1|Overall Study|Lost to Follow-up|3
43888|NCT01438177|183472|P1|Overall Study|Initiation of new therapy|1
43889|NCT01438177|183472|P1|Overall Study|Withdrawal by Subject|1
43890|NCT01438151|183478|P1|Overall Study|study terminated|8
43891|NCT01438060|183484|P2|On Study Beyond Week 140|Other Reason|3
43892|NCT01438060|183485|P1|On Study Beyond Week 140|Other Reason|0
43893|NCT01438060|183484|P2|On Study Beyond Week 140|Death|1
43894|NCT01438060|183485|P1|On Study Beyond Week 140|Death|0
43895|NCT01438060|183484|P2|On Study Beyond Week 140|Withdrawal by Subject|1
43896|NCT01438060|183485|P1|On Study Beyond Week 140|Withdrawal by Subject|0
43897|NCT01438060|183484|P2|On Study Beyond Week 140|Lack of Efficacy|1
43898|NCT01438060|183485|P1|On Study Beyond Week 140|Lack of Efficacy|0
43899|NCT01438060|183484|P2|On Study Beyond Week 140|Adverse Event|2
43900|NCT01438060|183485|P1|On Study Beyond Week 140|Adverse Event|0
43901|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
43902|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
43903|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Death|12
43904|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Death|22
43905|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
43906|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
43907|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
43908|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
43909|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
43910|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
43911|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
43912|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
43913|NCT01438060|183484|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
43914|NCT01438060|183485|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
43915|NCT01438060|183484|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
43916|NCT01438060|183485|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
43917|NCT01438060|183484|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
43918|NCT01438060|183485|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
43919|NCT01438060|183484|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
43920|NCT01438060|183485|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
43921|NCT01438060|183484|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
43922|NCT01438060|183485|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
43923|NCT01438060|183484|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
43924|NCT01438060|183485|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
43925|NCT01438060|183484|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
43926|NCT01438060|183485|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
43927|NCT01437995|183566|P3|Overall Study|Lost to Follow-up|20
43928|NCT01437995|183567|P2|Overall Study|Lost to Follow-up|18
43929|NCT01437995|183568|P1|Overall Study|Lost to Follow-up|11
43930|NCT01437943|183590|P2|Overall Study|Adverse Event|0
43931|NCT01437943|183591|P1|Overall Study|Adverse Event|2
43932|NCT01437943|183590|P2|Overall Study|Subject expressed pregnancy plans|0
43933|NCT01437943|183591|P1|Overall Study|Subject expressed pregnancy plans|1
43934|NCT01437943|183590|P2|Overall Study|Aliskiren trials terminated by Novartis|2
43935|NCT01437943|183591|P1|Overall Study|Aliskiren trials terminated by Novartis|4
43936|NCT01437878|183599|P2|Overall Study|Withdrawal by Subject|0
43937|NCT01437878|183600|P1|Overall Study|Withdrawal by Subject|1
43938|NCT01437540|183642|P2|Overall Study|Withdrawal by Subject|15
43939|NCT01437540|183643|P1|Overall Study|Withdrawal by Subject|31
43940|NCT01437540|183642|P2|Overall Study|Adverse Event|13
43941|NCT01437540|183643|P1|Overall Study|Adverse Event|26
43942|NCT01437540|183642|P2|Overall Study|Protocol Violation|12
43943|NCT01437540|183643|P1|Overall Study|Protocol Violation|24
43944|NCT01437540|183642|P2|Overall Study|Lack of Efficacy|11
43945|NCT01437540|183643|P1|Overall Study|Lack of Efficacy|23
43946|NCT01437540|183642|P2|Overall Study|Lost to Follow-up|5
43947|NCT01437540|183643|P1|Overall Study|Lost to Follow-up|3
43948|NCT01437540|183642|P2|Overall Study|COPD exacerbation|3
43949|NCT01437540|183643|P1|Overall Study|COPD exacerbation|13
43950|NCT01437540|183642|P2|Overall Study|Not listed below|6
43951|NCT01437540|183643|P1|Overall Study|Not listed below|7
43952|NCT01437423|183670|P1|Overall Study|Off label usage|3
43953|NCT01437423|183670|P1|Overall Study|Lost to Follow-up|12
43954|NCT01437397|183682|P5|Overall Study|Site termination/COPD exacerbation/other|14
43955|NCT01437397|183683|P4|Overall Study|Site termination/COPD exacerbation/other|9
43956|NCT01437397|183684|P3|Overall Study|Site termination/COPD exacerbation/other|9
43957|NCT01437397|183685|P2|Overall Study|Site termination/COPD exacerbation/other|8
43958|NCT01437397|183686|P1|Overall Study|Site termination/COPD exacerbation/other|10
43959|NCT01437397|183682|P5|Overall Study|Adverse Event|21
43960|NCT01437397|183683|P4|Overall Study|Adverse Event|14
43961|NCT01437397|183684|P3|Overall Study|Adverse Event|16
43962|NCT01437397|183685|P2|Overall Study|Adverse Event|22
43963|NCT01437397|183686|P1|Overall Study|Adverse Event|21
43964|NCT01437397|183682|P5|Overall Study|Lack of Efficacy|20
43965|NCT01437397|183683|P4|Overall Study|Lack of Efficacy|10
43966|NCT01437397|183684|P3|Overall Study|Lack of Efficacy|8
43967|NCT01437397|183685|P2|Overall Study|Lack of Efficacy|4
43968|NCT01437397|183686|P1|Overall Study|Lack of Efficacy|5
43969|NCT01437397|183682|P5|Overall Study|Protocol Violation|19
43970|NCT01437397|183683|P4|Overall Study|Protocol Violation|21
43971|NCT01437397|183684|P3|Overall Study|Protocol Violation|13
43972|NCT01437397|183685|P2|Overall Study|Protocol Violation|12
43973|NCT01437397|183686|P1|Overall Study|Protocol Violation|10
43974|NCT01437397|183682|P5|Overall Study|Withdrawal by Subject|22
43975|NCT01437397|183683|P4|Overall Study|Withdrawal by Subject|11
43976|NCT01437397|183684|P3|Overall Study|Withdrawal by Subject|24
43977|NCT01437397|183685|P2|Overall Study|Withdrawal by Subject|12
43978|NCT01437397|183686|P1|Overall Study|Withdrawal by Subject|11
43979|NCT01437397|183682|P5|Overall Study|Lost to Follow-up|5
43980|NCT01437397|183683|P4|Overall Study|Lost to Follow-up|4
43981|NCT01437397|183684|P3|Overall Study|Lost to Follow-up|2
43982|NCT01437397|183685|P2|Overall Study|Lost to Follow-up|4
43983|NCT01437397|183686|P1|Overall Study|Lost to Follow-up|9
43984|NCT01437319|183713|P3|Phase II|Protocol Violation|0
43985|NCT01437319|183714|P2|Phase II|Protocol Violation|1
43986|NCT01437319|183715|P1|Phase II|Protocol Violation|0
43987|NCT01437319|183713|P3|Phase II|Study related symptoms/complaints|19
43988|NCT01437319|183714|P2|Phase II|Study related symptoms/complaints|28
43989|NCT01437319|183715|P1|Phase II|Study related symptoms/complaints|0
43990|NCT01437319|183713|P3|Phase II|Lost to Follow-up|2
43991|NCT01437319|183714|P2|Phase II|Lost to Follow-up|7
43992|NCT01437319|183715|P1|Phase II|Lost to Follow-up|0
43993|NCT01437319|183713|P3|Phase II|Withdrawal by Subject|16
43994|NCT01437319|183714|P2|Phase II|Withdrawal by Subject|8
43995|NCT01437319|183715|P1|Phase II|Withdrawal by Subject|0
43996|NCT01437319|183713|P3|Phase I|Withdrawal by Subject|0
43997|NCT01437319|183714|P2|Phase I|Withdrawal by Subject|0
43998|NCT01437319|183715|P1|Phase I|Withdrawal by Subject|25
43999|NCT01437319|183713|P3|Phase I|Study related symptoms/complaints|0
44000|NCT01437319|183714|P2|Phase I|Study related symptoms/complaints|0
44001|NCT01437319|183715|P1|Phase I|Study related symptoms/complaints|27
44002|NCT01437319|183713|P3|Phase I|Protocol Violation|0
44003|NCT01437319|183714|P2|Phase I|Protocol Violation|0
44004|NCT01437319|183715|P1|Phase I|Protocol Violation|1
44005|NCT01437319|183713|P3|Phase I|Lost to Follow-up|0
44006|NCT01437319|183714|P2|Phase I|Lost to Follow-up|0
44007|NCT01437319|183715|P1|Phase I|Lost to Follow-up|2
44008|NCT01437267|183730|P6|Overall Study|Protocol Violation|0
44009|NCT01437267|183731|P5|Overall Study|Protocol Violation|0
44010|NCT01437267|183732|P4|Overall Study|Protocol Violation|0
44011|NCT01437267|183733|P3|Overall Study|Protocol Violation|0
44012|NCT01437267|183734|P2|Overall Study|Protocol Violation|1
44013|NCT01437267|183735|P1|Overall Study|Protocol Violation|0
44014|NCT01437267|183730|P6|Overall Study|Withdrawal by Subject|0
44015|NCT01437267|183731|P5|Overall Study|Withdrawal by Subject|0
44016|NCT01437267|183732|P4|Overall Study|Withdrawal by Subject|1
44017|NCT01437267|183733|P3|Overall Study|Withdrawal by Subject|0
44018|NCT01437267|183734|P2|Overall Study|Withdrawal by Subject|0
44019|NCT01437267|183735|P1|Overall Study|Withdrawal by Subject|0
44020|NCT01437111|183778|P1|Overall Study|Protocol Violation|1
44021|NCT01437111|183778|P1|Overall Study|Lost to Follow-up|5
44022|NCT01437111|183778|P1|Overall Study|Physician Decision|1
44023|NCT01437111|183778|P1|Overall Study|Not reported|5
44024|NCT01437111|183778|P1|Overall Study|Withdrawal by Subject|4
44025|NCT01437111|183778|P1|Overall Study|Adverse Event|2
44026|NCT01436643|183856|P4|Core Phase (16 Weeks)|Protocol Violation|0
44027|NCT01436643|183857|P3|Core Phase (16 Weeks)|Protocol Violation|1
44028|NCT01436643|183858|P2|Core Phase (16 Weeks)|Protocol Violation|1
44029|NCT01436643|183859|P1|Core Phase (16 Weeks)|Protocol Violation|1
44030|NCT01436643|183856|P4|Core Phase (16 Weeks)|Abnormal Test result|0
44031|NCT01436643|183857|P3|Core Phase (16 Weeks)|Abnormal Test result|1
44032|NCT01436643|183858|P2|Core Phase (16 Weeks)|Abnormal Test result|0
44033|NCT01436643|183859|P1|Core Phase (16 Weeks)|Abnormal Test result|0
44034|NCT01436643|183856|P4|Core Phase (16 Weeks)|Adverse Event|0
44035|NCT01436643|183857|P3|Core Phase (16 Weeks)|Adverse Event|1
44036|NCT01436643|183858|P2|Core Phase (16 Weeks)|Adverse Event|3
44037|NCT01436643|183859|P1|Core Phase (16 Weeks)|Adverse Event|0
44038|NCT01436643|183856|P4|2-week Pre-treatment|Protocol Violation|4
44039|NCT01436643|183857|P3|2-week Pre-treatment|Protocol Violation|0
44040|NCT01436643|183858|P2|2-week Pre-treatment|Protocol Violation|0
44041|NCT01436643|183859|P1|2-week Pre-treatment|Protocol Violation|0
44042|NCT01436643|183856|P4|2-week Pre-treatment|Adverse Event|5
44043|NCT01436643|183857|P3|2-week Pre-treatment|Adverse Event|0
44044|NCT01436643|183858|P2|2-week Pre-treatment|Adverse Event|0
44045|NCT01436643|183859|P1|2-week Pre-treatment|Adverse Event|0
44046|NCT01436643|183856|P4|2-week Pre-treatment|Abnormal test result|1
44047|NCT01436643|183857|P3|2-week Pre-treatment|Abnormal test result|0
44048|NCT01436643|183858|P2|2-week Pre-treatment|Abnormal test result|0
44049|NCT01436643|183859|P1|2-week Pre-treatment|Abnormal test result|0
44050|NCT01436500|183894|P5|Overall Study|not specified|0
44051|NCT01436500|183895|P4|Overall Study|not specified|1
44052|NCT01436500|183896|P3|Overall Study|not specified|0
44053|NCT01436500|183897|P2|Overall Study|not specified|1
44054|NCT01436500|183898|P1|Overall Study|not specified|0
44055|NCT01436500|183894|P5|Overall Study|discontinued study drug|0
44056|NCT01436500|183895|P4|Overall Study|discontinued study drug|0
44057|NCT01436500|183896|P3|Overall Study|discontinued study drug|0
44058|NCT01436500|183897|P2|Overall Study|discontinued study drug|0
44059|NCT01436500|183898|P1|Overall Study|discontinued study drug|1
44060|NCT01436500|183894|P5|Overall Study|initiation of dialysis|1
44061|NCT01436500|183895|P4|Overall Study|initiation of dialysis|0
44062|NCT01436500|183896|P3|Overall Study|initiation of dialysis|0
44063|NCT01436500|183897|P2|Overall Study|initiation of dialysis|0
44064|NCT01436500|183898|P1|Overall Study|initiation of dialysis|0
44065|NCT01436500|183894|P5|Overall Study|liver transplant|0
44066|NCT01436500|183895|P4|Overall Study|liver transplant|0
44067|NCT01436500|183896|P3|Overall Study|liver transplant|0
44068|NCT01436500|183897|P2|Overall Study|liver transplant|0
44069|NCT01436500|183898|P1|Overall Study|liver transplant|1
44070|NCT01436500|183894|P5|Overall Study|Physician Decision|0
44071|NCT01436500|183895|P4|Overall Study|Physician Decision|0
44072|NCT01436500|183896|P3|Overall Study|Physician Decision|1
44073|NCT01436500|183897|P2|Overall Study|Physician Decision|0
44074|NCT01436500|183898|P1|Overall Study|Physician Decision|0
44075|NCT01436500|183894|P5|Overall Study|Withdrawal by Subject|2
44076|NCT01436500|183895|P4|Overall Study|Withdrawal by Subject|0
44077|NCT01436500|183896|P3|Overall Study|Withdrawal by Subject|2
44078|NCT01436500|183897|P2|Overall Study|Withdrawal by Subject|0
44079|NCT01436500|183898|P1|Overall Study|Withdrawal by Subject|0
44080|NCT01436500|183894|P5|Overall Study|Adverse Event|1
44081|NCT01436500|183895|P4|Overall Study|Adverse Event|0
44082|NCT01436500|183896|P3|Overall Study|Adverse Event|2
44083|NCT01436500|183897|P2|Overall Study|Adverse Event|2
44084|NCT01436500|183898|P1|Overall Study|Adverse Event|0
44085|NCT01436500|183894|P5|Overall Study|Death|0
44086|NCT01436500|183895|P4|Overall Study|Death|0
44087|NCT01436500|183896|P3|Overall Study|Death|0
44088|NCT01436500|183897|P2|Overall Study|Death|0
44089|NCT01436500|183898|P1|Overall Study|Death|1
44090|NCT01436370|183948|P8|Overall Study|Lost to Follow-up|0
44091|NCT01436370|183949|P7|Overall Study|Lost to Follow-up|0
44092|NCT01436370|183950|P6|Overall Study|Lost to Follow-up|0
44093|NCT01436370|183951|P5|Overall Study|Lost to Follow-up|1
44094|NCT01436370|183952|P4|Overall Study|Lost to Follow-up|0
44095|NCT01436370|183953|P3|Overall Study|Lost to Follow-up|0
44096|NCT01436370|183954|P2|Overall Study|Lost to Follow-up|0
44097|NCT01436370|183955|P1|Overall Study|Lost to Follow-up|0
44098|NCT01436305|184036|P3|Overall Study|Withdrawal by Subject|0
44099|NCT01436305|184037|P2|Overall Study|Withdrawal by Subject|3
44100|NCT01436305|184038|P1|Overall Study|Withdrawal by Subject|1
44101|NCT01436305|184036|P3|Overall Study|Lost to Follow-up|0
44102|NCT01436305|184037|P2|Overall Study|Lost to Follow-up|1
44103|NCT01436305|184038|P1|Overall Study|Lost to Follow-up|0
44104|NCT01436305|184036|P3|Overall Study|Death|0
44105|NCT01436305|184037|P2|Overall Study|Death|0
44106|NCT01436305|184038|P1|Overall Study|Death|1
44107|NCT01436253|184165|P1|Overall Study|Not meeting all eligibility criteria|117
44108|NCT01436253|184165|P1|Overall Study|Lost to Follow-up|182
44109|NCT01436201|184170|P1|Overall Study|Protocol Violation|1
44110|NCT01436201|184170|P1|Overall Study|Withdrawal by Subject|1
44111|NCT01436201|184170|P1|Overall Study|Adverse Event|2
44112|NCT01436175|184180|P1|Overall Study|Unspecified|826
44113|NCT01436175|184180|P1|Overall Study|Met blood pressure or pulse withdrawal|63
44114|NCT01436175|184180|P1|Overall Study|Lack of Efficacy|24
44115|NCT01436175|184180|P1|Overall Study|Lost to Follow-up|89
44116|NCT01436175|184180|P1|Overall Study|Withdrawal by Subject|108
44117|NCT01436175|184180|P1|Overall Study|Protocol Violation|49
44118|NCT01436175|184180|P1|Overall Study|Adverse Event|111
44119|NCT01436162|184207|P3|Randomized Phase|Not Specified|4
44120|NCT01436162|184208|P2|Randomized Phase|Not Specified|5
44121|NCT01436162|184209|P1|Randomized Phase|Not Specified|2
44122|NCT01436162|184207|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
44123|NCT01436162|184208|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
44124|NCT01436162|184209|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
44125|NCT01436162|184207|P3|Randomized Phase|Lack of Efficacy|1
44126|NCT01436162|184208|P2|Randomized Phase|Lack of Efficacy|1
44127|NCT01436162|184209|P1|Randomized Phase|Lack of Efficacy|0
44128|NCT01436162|184207|P3|Randomized Phase|Lost to Follow-up|4
44129|NCT01436162|184208|P2|Randomized Phase|Lost to Follow-up|5
44130|NCT01436162|184209|P1|Randomized Phase|Lost to Follow-up|17
44131|NCT01436162|184207|P3|Randomized Phase|Withdrawal by Subject|8
44132|NCT01436162|184208|P2|Randomized Phase|Withdrawal by Subject|9
44133|NCT01436162|184209|P1|Randomized Phase|Withdrawal by Subject|16
44134|NCT01436162|184207|P3|Randomized Phase|Protocol Violation|2
44135|NCT01436162|184208|P2|Randomized Phase|Protocol Violation|4
44136|NCT01436162|184209|P1|Randomized Phase|Protocol Violation|4
44137|NCT01436162|184207|P3|Randomized Phase|Adverse Event|6
44138|NCT01436162|184208|P2|Randomized Phase|Adverse Event|5
44139|NCT01436162|184209|P1|Randomized Phase|Adverse Event|1
44140|NCT01436162|184207|P3|Single-blind Lead-in Phase|Not Specified|0
44141|NCT01436162|184208|P2|Single-blind Lead-in Phase|Not Specified|0
44142|NCT01436162|184209|P1|Single-blind Lead-in Phase|Not Specified|107
44143|NCT01436162|184207|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44144|NCT01436162|184208|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44145|NCT01436162|184209|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
44146|NCT01436162|184207|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
44147|NCT01436162|184208|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
44148|NCT01436162|184209|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
44149|NCT01436162|184207|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
44150|NCT01436162|184208|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
44151|NCT01436162|184209|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
44152|NCT01436162|184207|P3|Single-blind Lead-in Phase|Protocol Violation|0
44153|NCT01436162|184208|P2|Single-blind Lead-in Phase|Protocol Violation|0
44154|NCT01436162|184209|P1|Single-blind Lead-in Phase|Protocol Violation|24
44155|NCT01436162|184207|P3|Single-blind Lead-in Phase|Adverse Event|0
44156|NCT01436162|184208|P2|Single-blind Lead-in Phase|Adverse Event|0
44157|NCT01436162|184209|P1|Single-blind Lead-in Phase|Adverse Event|26
44158|NCT01436149|184243|P3|Randomized Phase|Not Specified|11
44159|NCT01436149|184244|P2|Randomized Phase|Not Specified|5
44160|NCT01436149|184245|P1|Randomized Phase|Not Specified|12
44161|NCT01436149|184243|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
44162|NCT01436149|184244|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
44163|NCT01436149|184245|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
44164|NCT01436149|184243|P3|Randomized Phase|Lack of Efficacy|1
44165|NCT01436149|184244|P2|Randomized Phase|Lack of Efficacy|0
44166|NCT01436149|184245|P1|Randomized Phase|Lack of Efficacy|0
44167|NCT01436149|184243|P3|Randomized Phase|Lost to Follow-up|6
44168|NCT01436149|184244|P2|Randomized Phase|Lost to Follow-up|5
44169|NCT01436149|184245|P1|Randomized Phase|Lost to Follow-up|34
44170|NCT01436149|184243|P3|Randomized Phase|Withdrawal by Subject|10
44171|NCT01436149|184244|P2|Randomized Phase|Withdrawal by Subject|10
44172|NCT01436149|184245|P1|Randomized Phase|Withdrawal by Subject|16
44173|NCT01436149|184243|P3|Randomized Phase|Protocol Violation|0
44174|NCT01436149|184244|P2|Randomized Phase|Protocol Violation|5
44175|NCT01436149|184245|P1|Randomized Phase|Protocol Violation|4
44176|NCT01436149|184243|P3|Randomized Phase|Adverse Event|11
44177|NCT01436149|184244|P2|Randomized Phase|Adverse Event|10
44178|NCT01436149|184245|P1|Randomized Phase|Adverse Event|9
44179|NCT01436149|184243|P3|Antidepressant Lead-in Phase|Not Specified|0
44180|NCT01436149|184244|P2|Antidepressant Lead-in Phase|Not Specified|0
44181|NCT01436149|184245|P1|Antidepressant Lead-in Phase|Not Specified|119
44182|NCT01436149|184243|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
44183|NCT01436149|184244|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
44184|NCT01436149|184245|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
44185|NCT01436149|184243|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
44186|NCT01436149|184244|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
44187|NCT01436149|184245|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
44188|NCT01436149|184243|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44189|NCT01436149|184244|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44190|NCT01436149|184245|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
44191|NCT01436149|184243|P3|Antidepressant Lead-in Phase|Protocol Violation|0
44192|NCT01436149|184244|P2|Antidepressant Lead-in Phase|Protocol Violation|0
44193|NCT01436149|184245|P1|Antidepressant Lead-in Phase|Protocol Violation|29
44194|NCT01436149|184243|P3|Antidepressant Lead-in Phase|Adverse Event|0
44195|NCT01436149|184244|P2|Antidepressant Lead-in Phase|Adverse Event|0
44196|NCT01436149|184245|P1|Antidepressant Lead-in Phase|Adverse Event|39
44197|NCT01436110|184276|P3|Overall Study|Did Not Receive Trial Medication|3
44198|NCT01436110|184277|P2|Overall Study|Did Not Receive Trial Medication|0
44199|NCT01436110|184278|P1|Overall Study|Did Not Receive Trial Medication|1
44200|NCT01436110|184276|P3|Overall Study|Protocol Violation|1
44201|NCT01436110|184277|P2|Overall Study|Protocol Violation|1
44202|NCT01436110|184278|P1|Overall Study|Protocol Violation|3
44203|NCT01436110|184276|P3|Overall Study|Lost to Follow-up|3
44204|NCT01436110|184277|P2|Overall Study|Lost to Follow-up|1
44205|NCT01436110|184278|P1|Overall Study|Lost to Follow-up|1
44206|NCT01436110|184276|P3|Overall Study|Physician Decision|1
44207|NCT01436110|184277|P2|Overall Study|Physician Decision|1
44208|NCT01436110|184278|P1|Overall Study|Physician Decision|3
44209|NCT01436110|184276|P3|Overall Study|Adverse Event|2
44210|NCT01436110|184277|P2|Overall Study|Adverse Event|1
44211|NCT01436110|184278|P1|Overall Study|Adverse Event|2
44212|NCT01436110|184276|P3|Overall Study|Withdrawal by Subject|4
44213|NCT01436110|184277|P2|Overall Study|Withdrawal by Subject|8
44214|NCT01436110|184278|P1|Overall Study|Withdrawal by Subject|6
44215|NCT01436110|184276|P3|Overall Study|Lack of Efficacy|9
44216|NCT01436110|184277|P2|Overall Study|Lack of Efficacy|14
44217|NCT01436110|184278|P1|Overall Study|Lack of Efficacy|23
44218|NCT01436084|184301|P1|Overall Study|Early Closure of Study|1
44219|NCT01436084|184301|P1|Overall Study|Withdrawal by Subject|1
44220|NCT01436084|184301|P1|Overall Study|Disease Progression|2
44221|NCT01436071|184307|P2|Overall Study|Did Not Receive Trial Medication|3
44222|NCT01436071|184308|P1|Overall Study|Did Not Receive Trial Medication|3
44223|NCT01436071|184307|P2|Overall Study|Withdrawal by Subject|2
44224|NCT01436071|184308|P1|Overall Study|Withdrawal by Subject|2
44225|NCT01436071|184307|P2|Overall Study|Physician Decision|0
44226|NCT01436071|184308|P1|Overall Study|Physician Decision|1
44227|NCT01436071|184307|P2|Overall Study|Lost to Follow-up|1
44228|NCT01436071|184308|P1|Overall Study|Lost to Follow-up|3
44229|NCT01436071|184307|P2|Overall Study|Protocol Violation|1
44230|NCT01436071|184308|P1|Overall Study|Protocol Violation|0
44231|NCT01436071|184307|P2|Overall Study|Lack of Efficacy|7
44232|NCT01436071|184308|P1|Overall Study|Lack of Efficacy|16
44233|NCT01436071|184307|P2|Overall Study|Adverse Event|0
44234|NCT01436071|184308|P1|Overall Study|Adverse Event|1
44235|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Administrative|2
44236|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Administrative|5
44237|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Administrative|0
44238|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
44239|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
44240|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
44241|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
44242|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
44243|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
44244|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
44245|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
44246|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
44247|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
44248|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
44249|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
44250|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
44251|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
44252|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
44253|NCT01435928|184350|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
44254|NCT01435928|184351|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
44255|NCT01435928|184352|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
44256|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Administrative|0
44257|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Administrative|0
44258|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Administrative|14
44421|NCT01433354|184795|P1|Overall Study|Protocol Violation|2
44259|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
44260|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
44261|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
44262|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
44263|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
44264|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
44265|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
44266|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
44267|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
44268|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
44269|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
44270|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
44271|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
44272|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
44273|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
44274|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
44275|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
44276|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
44277|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Death|0
44278|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Death|0
44279|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Death|1
44280|NCT01435928|184350|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
44281|NCT01435928|184351|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
44282|NCT01435928|184352|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
44283|NCT01435798|184379|P1|Overall Study|Withdrawal by Subject|1
44284|NCT01435759|184398|P6|Double-blind Phase|Not Specified|0
44285|NCT01435759|184399|P5|Double-blind Phase|Not Specified|0
44286|NCT01435759|184400|P4|Double-blind Phase|Not Specified|2
44287|NCT01435759|184401|P3|Double-blind Phase|Not Specified|0
44288|NCT01435759|184402|P2|Double-blind Phase|Not Specified|2
44289|NCT01435759|184403|P1|Double-blind Phase|Not Specified|8
44290|NCT01435759|184398|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
44291|NCT01435759|184399|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
44292|NCT01435759|184400|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
44293|NCT01435759|184401|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
44294|NCT01435759|184402|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
44295|NCT01435759|184403|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
44296|NCT01435759|184398|P6|Double-blind Phase|Lost to Follow-up|3
44297|NCT01435759|184399|P5|Double-blind Phase|Lost to Follow-up|3
44298|NCT01435759|184400|P4|Double-blind Phase|Lost to Follow-up|0
44299|NCT01435759|184401|P3|Double-blind Phase|Lost to Follow-up|2
44300|NCT01435759|184402|P2|Double-blind Phase|Lost to Follow-up|1
44301|NCT01435759|184403|P1|Double-blind Phase|Lost to Follow-up|31
44302|NCT01435759|184398|P6|Double-blind Phase|Withdrawal by Subject|2
44303|NCT01435759|184399|P5|Double-blind Phase|Withdrawal by Subject|2
44304|NCT01435759|184400|P4|Double-blind Phase|Withdrawal by Subject|4
44305|NCT01435759|184401|P3|Double-blind Phase|Withdrawal by Subject|3
44306|NCT01435759|184402|P2|Double-blind Phase|Withdrawal by Subject|4
44307|NCT01435759|184403|P1|Double-blind Phase|Withdrawal by Subject|17
44308|NCT01435759|184398|P6|Double-blind Phase|Protocol Violation|1
44309|NCT01435759|184399|P5|Double-blind Phase|Protocol Violation|0
44310|NCT01435759|184400|P4|Double-blind Phase|Protocol Violation|2
44311|NCT01435759|184401|P3|Double-blind Phase|Protocol Violation|1
44312|NCT01435759|184402|P2|Double-blind Phase|Protocol Violation|0
44313|NCT01435759|184403|P1|Double-blind Phase|Protocol Violation|2
44314|NCT01435759|184398|P6|Double-blind Phase|Adverse Event|3
44315|NCT01435759|184399|P5|Double-blind Phase|Adverse Event|1
44316|NCT01435759|184400|P4|Double-blind Phase|Adverse Event|1
44317|NCT01435759|184401|P3|Double-blind Phase|Adverse Event|1
44318|NCT01435759|184402|P2|Double-blind Phase|Adverse Event|0
44319|NCT01435759|184403|P1|Double-blind Phase|Adverse Event|7
44320|NCT01435759|184398|P6|Antidepressant Lead-in Phase|Not Specified|0
44321|NCT01435759|184399|P5|Antidepressant Lead-in Phase|Not Specified|0
44322|NCT01435759|184400|P4|Antidepressant Lead-in Phase|Not Specified|0
44323|NCT01435759|184401|P3|Antidepressant Lead-in Phase|Not Specified|0
44324|NCT01435759|184402|P2|Antidepressant Lead-in Phase|Not Specified|0
44325|NCT01435759|184403|P1|Antidepressant Lead-in Phase|Not Specified|119
44326|NCT01435759|184398|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44327|NCT01435759|184399|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44328|NCT01435759|184400|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44329|NCT01435759|184401|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44330|NCT01435759|184402|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
44331|NCT01435759|184403|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
44332|NCT01435759|184398|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
44333|NCT01435759|184399|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
44334|NCT01435759|184400|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
44335|NCT01435759|184401|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
44336|NCT01435759|184402|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
44337|NCT01435759|184403|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
44338|NCT01435759|184398|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44339|NCT01435759|184399|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44340|NCT01435759|184400|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44341|NCT01435759|184401|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44342|NCT01435759|184402|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
44343|NCT01435759|184403|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
44344|NCT01435759|184398|P6|Antidepressant Lead-in Phase|Protocol Violation|0
44345|NCT01435759|184399|P5|Antidepressant Lead-in Phase|Protocol Violation|0
44346|NCT01435759|184400|P4|Antidepressant Lead-in Phase|Protocol Violation|0
44347|NCT01435759|184401|P3|Antidepressant Lead-in Phase|Protocol Violation|0
44348|NCT01435759|184402|P2|Antidepressant Lead-in Phase|Protocol Violation|0
44349|NCT01435759|184403|P1|Antidepressant Lead-in Phase|Protocol Violation|16
44350|NCT01435759|184398|P6|Antidepressant Lead-in Phase|Adverse Event|0
44351|NCT01435759|184399|P5|Antidepressant Lead-in Phase|Adverse Event|0
44352|NCT01435759|184400|P4|Antidepressant Lead-in Phase|Adverse Event|0
44353|NCT01435759|184401|P3|Antidepressant Lead-in Phase|Adverse Event|0
44354|NCT01435759|184402|P2|Antidepressant Lead-in Phase|Adverse Event|0
44355|NCT01435759|184403|P1|Antidepressant Lead-in Phase|Adverse Event|40
44356|NCT01435655|184430|P1|Overall Study|Unspecified|1
44357|NCT01435655|184430|P1|Overall Study|Death|2
44358|NCT01435577|184444|P2|Overall Study|Alternative treatment started|1
44359|NCT01435577|184445|P1|Overall Study|Alternative treatment started|0
44360|NCT01435577|184444|P2|Overall Study|Lack of Efficacy|51
44361|NCT01435577|184445|P1|Overall Study|Lack of Efficacy|7
44362|NCT01435577|184444|P2|Overall Study|Adverse Event|0
44363|NCT01435577|184445|P1|Overall Study|Adverse Event|10
44364|NCT01435460|184495|P2|Overall Study|Did not meet eligibility criteria|0
44365|NCT01435460|184496|P1|Overall Study|Did not meet eligibility criteria|2
44366|NCT01435460|184495|P2|Overall Study|Protocol Violation|1
44367|NCT01435460|184496|P1|Overall Study|Protocol Violation|0
44368|NCT01435460|184495|P2|Overall Study|Withdrawal by Subject|3
44369|NCT01435460|184496|P1|Overall Study|Withdrawal by Subject|1
44370|NCT01435460|184495|P2|Overall Study|Lost to Follow-up|1
44371|NCT01435460|184496|P1|Overall Study|Lost to Follow-up|6
44372|NCT01435460|184495|P2|Overall Study|Adverse Event|1
44373|NCT01435460|184496|P1|Overall Study|Adverse Event|2
44374|NCT01435265|184510|P2|Overall Study|Lost to Follow-up|1
44375|NCT01435265|184511|P1|Overall Study|Lost to Follow-up|0
44376|NCT01435122|184525|P1|Overall Study|Early withdrawal due to toxicity|8
44377|NCT01435031|184534|P1|ITT at 1 Year|Lost to Follow-up|5
44378|NCT01435031|184534|P1|ITT at 1 Year|Withdrawal by Subject|2
44379|NCT01435031|184534|P1|ITT at 1 Year|Death|1
44380|NCT01435031|184534|P1|ITT at 6 Months|Lost to Follow-up|3
44381|NCT01435031|184534|P1|ITT at 6 Months|Death|2
44382|NCT01435031|184534|P1|ITT at 1 Month|Lost to Follow-up|4
44383|NCT01435031|184534|P1|ITT at 1 Month|Death|1
44384|NCT01435031|184534|P1|ITT at 1 Month|Withdrawal by Subject|1
44385|NCT01434823|184614|P2|Overall Study|Incomplete data in medical record|7
44386|NCT01434823|184615|P1|Overall Study|Incomplete data in medical record|4
44387|NCT01434693|184633|P4|Overall Study|Lost to Follow-up|0
44388|NCT01434693|184634|P3|Overall Study|Lost to Follow-up|0
44389|NCT01434693|184635|P2|Overall Study|Lost to Follow-up|0
44390|NCT01434693|184636|P1|Overall Study|Lost to Follow-up|1
44391|NCT01434693|184633|P4|Overall Study|Withdrawal by Subject|1
44392|NCT01434693|184634|P3|Overall Study|Withdrawal by Subject|1
44393|NCT01434693|184635|P2|Overall Study|Withdrawal by Subject|0
44394|NCT01434693|184636|P1|Overall Study|Withdrawal by Subject|1
44395|NCT01434693|184633|P4|Overall Study|Adverse Event|0
44396|NCT01434693|184634|P3|Overall Study|Adverse Event|0
44397|NCT01434693|184635|P2|Overall Study|Adverse Event|0
44398|NCT01434693|184636|P1|Overall Study|Adverse Event|1
44399|NCT01434680|184650|P4|Overall Study|Protocol Violation|0
44400|NCT01434680|184651|P3|Overall Study|Protocol Violation|0
44401|NCT01434680|184652|P2|Overall Study|Protocol Violation|1
44402|NCT01434680|184653|P1|Overall Study|Protocol Violation|1
44403|NCT01434680|184650|P4|Overall Study|Lost to Follow-up|0
44404|NCT01434680|184651|P3|Overall Study|Lost to Follow-up|0
44405|NCT01434680|184652|P2|Overall Study|Lost to Follow-up|1
44406|NCT01434680|184653|P1|Overall Study|Lost to Follow-up|1
44407|NCT01434680|184650|P4|Overall Study|Withdrawal by Subject|0
44408|NCT01434680|184651|P3|Overall Study|Withdrawal by Subject|2
44409|NCT01434680|184652|P2|Overall Study|Withdrawal by Subject|0
44410|NCT01434680|184653|P1|Overall Study|Withdrawal by Subject|1
44411|NCT01434654|184670|P2|Overall Study|Lost to Follow-up|0
44412|NCT01434654|184671|P1|Overall Study|Lost to Follow-up|1
44413|NCT01434654|184670|P2|Overall Study|Withdrawal by Subject|0
44414|NCT01434654|184671|P1|Overall Study|Withdrawal by Subject|1
44415|NCT01433549|184767|P2|Phase 2: Second Study Product|Adverse Event|1
44416|NCT01433549|184768|P1|Phase 2: Second Study Product|Adverse Event|0
44417|NCT01433471|184778|P2|Overall Study|Withdrawal by Subject|1
44418|NCT01433471|184779|P1|Overall Study|Withdrawal by Subject|0
44419|NCT01433354|184795|P1|Overall Study|Subject Withdrew Consent|3
44420|NCT01433354|184795|P1|Overall Study|Lack of Efficacy|17
44422|NCT01433354|184795|P1|Overall Study|Administrative problems|90
44423|NCT01433354|184795|P1|Overall Study|Lost to Follow-up|1
44424|NCT01433354|184795|P1|Overall Study|Adverse Event|6
44425|NCT01433263|184811|P2|Overall Study|Withdrawal by Subject|7
44426|NCT01433263|184812|P1|Overall Study|Withdrawal by Subject|10
44427|NCT01433263|184811|P2|Overall Study|Protocol Deviation|0
44428|NCT01433263|184812|P1|Overall Study|Protocol Deviation|1
44429|NCT01433263|184811|P2|Overall Study|Lost to Follow-up|1
44430|NCT01433263|184812|P1|Overall Study|Lost to Follow-up|0
44431|NCT01433263|184811|P2|Overall Study|Death|3
44432|NCT01433263|184812|P1|Overall Study|Death|5
44433|NCT01433263|184811|P2|Overall Study|Adverse Event|1
44434|NCT01433263|184812|P1|Overall Study|Adverse Event|3
44435|NCT01433250|184841|P2|Overall Study|Withdrawal by Subject|2
44436|NCT01433250|184842|P1|Overall Study|Withdrawal by Subject|3
44437|NCT01433250|184841|P2|Overall Study|Protocol Violation|1
44438|NCT01433250|184842|P1|Overall Study|Protocol Violation|0
44439|NCT01433172|184861|P3|Overall Study|Death|0
44440|NCT01433172|184862|P2|Overall Study|Death|2
44441|NCT01433172|184863|P1|Overall Study|Death|0
44442|NCT01433172|184861|P3|Overall Study|Disease Progression|1
44443|NCT01433172|184862|P2|Overall Study|Disease Progression|0
44444|NCT01433172|184863|P1|Overall Study|Disease Progression|0
44445|NCT01433172|184861|P3|Overall Study|Withdrawal by Subject|0
44446|NCT01433172|184862|P2|Overall Study|Withdrawal by Subject|1
44447|NCT01433172|184863|P1|Overall Study|Withdrawal by Subject|0
44448|NCT01433159|184875|P2|Overall Study|Protocol Violation|1
44449|NCT01433159|184876|P1|Overall Study|Protocol Violation|0
44450|NCT01433159|184875|P2|Overall Study|Physician Decision|0
44451|NCT01433159|184876|P1|Overall Study|Physician Decision|1
44452|NCT01433159|184875|P2|Overall Study|Adverse Event|0
44453|NCT01433159|184876|P1|Overall Study|Adverse Event|1
44454|NCT01433055|184908|P2|Overall Study|Severely elevated triglycerides at entry|0
44455|NCT01433055|184909|P1|Overall Study|Severely elevated triglycerides at entry|1
44456|NCT01433055|184908|P2|Overall Study|Diagnosed with cancer unrelated to study|0
44457|NCT01433055|184909|P1|Overall Study|Diagnosed with cancer unrelated to study|1
44458|NCT01432938|184931|P2|Second Intervention|Adverse Event|0
44459|NCT01432938|184932|P1|Second Intervention|Adverse Event|1
44460|NCT01432938|184931|P2|First Intervention|Physician Decision|0
44461|NCT01432938|184932|P1|First Intervention|Physician Decision|1
44462|NCT01432938|184931|P2|First Intervention|Protocol Violation|0
44463|NCT01432938|184932|P1|First Intervention|Protocol Violation|1
44464|NCT01432756|184962|P4|Overall Study|Lost to Follow-up|1
44465|NCT01432756|184963|P3|Overall Study|Lost to Follow-up|2
44466|NCT01432756|184964|P2|Overall Study|Lost to Follow-up|0
44467|NCT01432756|184965|P1|Overall Study|Lost to Follow-up|1
44468|NCT01432626|184973|P1|Overall Study|Imaging agent not available|1
44469|NCT01432626|184973|P1|Overall Study|Only 1 image competed|2
44470|NCT01432626|184973|P1|Overall Study|Withdrawal by Subject|2
44471|NCT01432626|184973|P1|Overall Study|LV function recovered|2
44472|NCT01432600|184980|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
44473|NCT01432600|184981|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
44474|NCT01432600|184982|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
44475|NCT01432574|184998|P1|Overall Study|Not interested|1
44476|NCT01432574|184998|P1|Overall Study|Moved|2
44477|NCT01432457|185044|P3|Overall Study|Did not take study drug|3
44478|NCT01432457|185045|P2|Overall Study|Did not take study drug|6
44479|NCT01432457|185046|P1|Overall Study|Did not take study drug|6
44480|NCT01432457|185044|P3|Overall Study|Reasons not defined|4
44481|NCT01432457|185045|P2|Overall Study|Reasons not defined|3
44482|NCT01432457|185046|P1|Overall Study|Reasons not defined|2
44483|NCT01432457|185044|P3|Overall Study|Withdrawal by Subject|9
44484|NCT01432457|185045|P2|Overall Study|Withdrawal by Subject|11
44485|NCT01432457|185046|P1|Overall Study|Withdrawal by Subject|6
44486|NCT01432457|185044|P3|Overall Study|Protocol Violation|6
44487|NCT01432457|185045|P2|Overall Study|Protocol Violation|2
44488|NCT01432457|185046|P1|Overall Study|Protocol Violation|3
44489|NCT01432457|185044|P3|Overall Study|Lost to Follow-up|20
44490|NCT01432457|185045|P2|Overall Study|Lost to Follow-up|15
44491|NCT01432457|185046|P1|Overall Study|Lost to Follow-up|11
44492|NCT01432457|185044|P3|Overall Study|Lack of Efficacy|1
44493|NCT01432457|185045|P2|Overall Study|Lack of Efficacy|1
44494|NCT01432457|185046|P1|Overall Study|Lack of Efficacy|2
44495|NCT01432457|185044|P3|Overall Study|Adverse Event|16
44496|NCT01432457|185045|P2|Overall Study|Adverse Event|10
44497|NCT01432457|185046|P1|Overall Study|Adverse Event|7
44498|NCT01432444|185075|P3|Extension Phase|Withdrawal by Subject|13
44499|NCT01432444|185076|P2|Extension Phase|Withdrawal by Subject|0
44500|NCT01432444|185077|P1|Extension Phase|Withdrawal by Subject|0
44501|NCT01432444|185075|P3|Extension Phase|Physician Decision|1
44502|NCT01432444|185076|P2|Extension Phase|Physician Decision|0
44503|NCT01432444|185077|P1|Extension Phase|Physician Decision|0
44504|NCT01432444|185075|P3|Extension Phase|Met Withdrawal Criteria|144
44505|NCT01432444|185076|P2|Extension Phase|Met Withdrawal Criteria|0
44506|NCT01432444|185077|P1|Extension Phase|Met Withdrawal Criteria|0
44507|NCT01432444|185075|P3|Extension Phase|Sponsor Discontinued Trial|7
44508|NCT01432444|185076|P2|Extension Phase|Sponsor Discontinued Trial|0
44509|NCT01432444|185077|P1|Extension Phase|Sponsor Discontinued Trial|0
44510|NCT01432444|185075|P3|Extension Phase|Adverse Event|10
44511|NCT01432444|185076|P2|Extension Phase|Adverse Event|0
44512|NCT01432444|185077|P1|Extension Phase|Adverse Event|0
44513|NCT01432444|185075|P3|Extension Phase|Lost to Follow-up|17
44514|NCT01432444|185076|P2|Extension Phase|Lost to Follow-up|0
44515|NCT01432444|185077|P1|Extension Phase|Lost to Follow-up|0
44516|NCT01432444|185075|P3|Treatment Phase|Lack of Efficacy|0
44517|NCT01432444|185076|P2|Treatment Phase|Lack of Efficacy|10
44518|NCT01432444|185077|P1|Treatment Phase|Lack of Efficacy|0
44519|NCT01432444|185075|P3|Treatment Phase|Protocol Deviation|0
44520|NCT01432444|185076|P2|Treatment Phase|Protocol Deviation|3
44521|NCT01432444|185077|P1|Treatment Phase|Protocol Deviation|0
44522|NCT01432444|185075|P3|Treatment Phase|Withdrawal by Subject|0
44523|NCT01432444|185076|P2|Treatment Phase|Withdrawal by Subject|41
44524|NCT01432444|185077|P1|Treatment Phase|Withdrawal by Subject|0
44525|NCT01432444|185075|P3|Treatment Phase|Physician Decision|0
44526|NCT01432444|185076|P2|Treatment Phase|Physician Decision|5
44527|NCT01432444|185077|P1|Treatment Phase|Physician Decision|0
44528|NCT01432444|185075|P3|Treatment Phase|Met Withdrawal Criteria|0
44529|NCT01432444|185076|P2|Treatment Phase|Met Withdrawal Criteria|11
44530|NCT01432444|185077|P1|Treatment Phase|Met Withdrawal Criteria|0
44531|NCT01432444|185075|P3|Treatment Phase|Adverse Event|0
44532|NCT01432444|185076|P2|Treatment Phase|Adverse Event|37
44533|NCT01432444|185077|P1|Treatment Phase|Adverse Event|0
44534|NCT01432444|185075|P3|Treatment Phase|Lost to Follow-up|0
44535|NCT01432444|185076|P2|Treatment Phase|Lost to Follow-up|33
44536|NCT01432444|185077|P1|Treatment Phase|Lost to Follow-up|0
44537|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
44538|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
44539|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
44540|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
44541|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
44542|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
44543|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
44544|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
44545|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
44546|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Physician Decision|0
44547|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Physician Decision|0
44548|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Physician Decision|8
44549|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
44550|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
44551|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
44552|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Adverse Event|0
44553|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Adverse Event|0
44554|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Adverse Event|16
44555|NCT01432444|185075|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
44556|NCT01432444|185076|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
44557|NCT01432444|185077|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
44558|NCT01432366|185103|P1|Overall Study|Unspecified|14
44559|NCT01432366|185103|P1|Overall Study|Investigator Forget to Complete Visits|1
44560|NCT01432366|185103|P1|Overall Study|Site Closed|20
44561|NCT01432366|185103|P1|Overall Study|Lack of Efficacy|1
44562|NCT01432366|185103|P1|Overall Study|Lost to Follow-up|13
44563|NCT01432366|185103|P1|Overall Study|Pregnancy|1
44564|NCT01432366|185103|P1|Overall Study|Withdrawal Due to Non-Compliance|3
44565|NCT01432366|185103|P1|Overall Study|Adverse Event|8
44566|NCT01432366|185103|P1|Overall Study|Non-Responder|7
44567|NCT01432327|185125|P4|Posttest 1 Year|Allergic reaction|1
44568|NCT01432327|185126|P3|Posttest 1 Year|Allergic reaction|1
44569|NCT01432327|185127|P2|Posttest 1 Year|Allergic reaction|0
44570|NCT01432327|185128|P1|Posttest 1 Year|Allergic reaction|0
44571|NCT01432327|185125|P4|Posttest 1 Year|Lost to Follow-up|2
44572|NCT01432327|185126|P3|Posttest 1 Year|Lost to Follow-up|4
44573|NCT01432327|185127|P2|Posttest 1 Year|Lost to Follow-up|0
44574|NCT01432327|185128|P1|Posttest 1 Year|Lost to Follow-up|0
44575|NCT01432327|185125|P4|Posttest 1 Year|Measurement have to take place in future|20
44576|NCT01432327|185126|P3|Posttest 1 Year|Measurement have to take place in future|15
44577|NCT01432327|185127|P2|Posttest 1 Year|Measurement have to take place in future|28
44578|NCT01432327|185128|P1|Posttest 1 Year|Measurement have to take place in future|24
44579|NCT01432327|185125|P4|Posttest 6 Months|Withdrawal by Subject|0
44580|NCT01432327|185126|P3|Posttest 6 Months|Withdrawal by Subject|1
44581|NCT01432327|185127|P2|Posttest 6 Months|Withdrawal by Subject|0
44582|NCT01432327|185128|P1|Posttest 6 Months|Withdrawal by Subject|0
44583|NCT01432327|185125|P4|Posttest 6 Months|Allergic reaction|0
44584|NCT01432327|185126|P3|Posttest 6 Months|Allergic reaction|1
44585|NCT01432327|185127|P2|Posttest 6 Months|Allergic reaction|0
44586|NCT01432327|185128|P1|Posttest 6 Months|Allergic reaction|0
44587|NCT01432327|185125|P4|Posttest 6 Months|Lost to Follow-up|2
44588|NCT01432327|185126|P3|Posttest 6 Months|Lost to Follow-up|3
44589|NCT01432327|185127|P2|Posttest 6 Months|Lost to Follow-up|0
44590|NCT01432327|185128|P1|Posttest 6 Months|Lost to Follow-up|0
44591|NCT01432327|185125|P4|Posttest 3 Months|Allergic reaction|0
44592|NCT01432327|185126|P3|Posttest 3 Months|Allergic reaction|0
44593|NCT01432327|185127|P2|Posttest 3 Months|Allergic reaction|2
44594|NCT01432327|185128|P1|Posttest 3 Months|Allergic reaction|0
44595|NCT01432327|185125|P4|Posttest 3 Months|Lost to Follow-up|1
44596|NCT01432327|185126|P3|Posttest 3 Months|Lost to Follow-up|2
44597|NCT01432327|185127|P2|Posttest 3 Months|Lost to Follow-up|0
44598|NCT01432327|185128|P1|Posttest 3 Months|Lost to Follow-up|1
44599|NCT01432327|185125|P4|Posttest 3 Months|depression|0
44600|NCT01432327|185126|P3|Posttest 3 Months|depression|0
44601|NCT01432327|185127|P2|Posttest 3 Months|depression|0
44602|NCT01432327|185128|P1|Posttest 3 Months|depression|3
44603|NCT01432275|185138|P2|ADC With Calculator (10 Days)|Protocol Violation|1
44604|NCT01432275|185139|P1|ADC With Calculator (10 Days)|Protocol Violation|0
44605|NCT01432275|185138|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
44606|NCT01432275|185139|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
44607|NCT01432275|185138|P2|ADC With Calculator (10 Days)|Physician Decision|1
44608|NCT01432275|185139|P1|ADC With Calculator (10 Days)|Physician Decision|1
44609|NCT01432275|185138|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
44610|NCT01432275|185139|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
44611|NCT01432275|185138|P2|Second BG Meter System (7 Days)|Physician Decision|1
44612|NCT01432275|185139|P1|Second BG Meter System (7 Days)|Physician Decision|0
44613|NCT01432275|185138|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
44614|NCT01432275|185139|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
44615|NCT01432275|185138|P2|Second BG Meter System (7 Days)|Adverse Event|1
44616|NCT01432275|185139|P1|Second BG Meter System (7 Days)|Adverse Event|1
44617|NCT01432275|185138|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
44618|NCT01432275|185139|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
44619|NCT01432275|185138|P2|First BG Meter System (7 Days)|Adverse Event|2
44620|NCT01432275|185139|P1|First BG Meter System (7 Days)|Adverse Event|0
44621|NCT01432262|185148|P2|Overall Study|Withdrawal by Subject|1
44622|NCT01432262|185149|P1|Overall Study|Withdrawal by Subject|2
44623|NCT01431976|185243|P1|Overall Study|Withdrawal by Subject|1
44624|NCT01431976|185243|P1|Overall Study|Physician Decision|1
44625|NCT01431976|185243|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
44626|NCT01431976|185243|P1|Overall Study|Lack of Efficacy|2
44627|NCT01431976|185243|P1|Overall Study|Adverse Event|6
44628|NCT01431963|185254|P1|Overall Study|Withdrawal by Subject|3
44629|NCT01431963|185254|P1|Overall Study|Physician Decision|4
44630|NCT01431963|185254|P1|Overall Study|Protocol-defined Stopping Criteria|2
44631|NCT01431963|185254|P1|Overall Study|Protocol Violation|1
44632|NCT01431963|185254|P1|Overall Study|Lack of Efficacy|7
44633|NCT01431963|185254|P1|Overall Study|Adverse Event|18
44634|NCT01431950|185262|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
44635|NCT01431950|185263|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
44636|NCT01431950|185262|P2|Overall Study|Lost to Follow-up|1
44637|NCT01431950|185263|P1|Overall Study|Lost to Follow-up|0
44638|NCT01431950|185262|P2|Overall Study|Lack of Efficacy|1
44639|NCT01431950|185263|P1|Overall Study|Lack of Efficacy|2
44640|NCT01431950|185262|P2|Overall Study|Physician Decision|1
44641|NCT01431950|185263|P1|Overall Study|Physician Decision|2
44642|NCT01431950|185262|P2|Overall Study|Adverse Event|2
44643|NCT01431950|185263|P1|Overall Study|Adverse Event|2
44644|NCT01431950|185262|P2|Overall Study|Protocol Violation|3
44645|NCT01431950|185263|P1|Overall Study|Protocol Violation|2
44646|NCT01431950|185262|P2|Overall Study|Withdrawal by Subject|3
44647|NCT01431950|185263|P1|Overall Study|Withdrawal by Subject|4
44648|NCT01431950|185262|P2|Overall Study|Study Site Closed/Terminated|3
44649|NCT01431950|185263|P1|Overall Study|Study Site Closed/Terminated|7
44650|NCT01431716|185301|P1|Overall Study|Withdrawal of consent|1
44651|NCT01431521|185326|P4|Overall Study|Withdrawal by Subject|0
44652|NCT01431521|185327|P3|Overall Study|Withdrawal by Subject|1
44653|NCT01431521|185328|P2|Overall Study|Withdrawal by Subject|0
44654|NCT01431521|185329|P1|Overall Study|Withdrawal by Subject|0
44655|NCT01431508|185350|P1|Overall Study|Unable to Follow Protocol Procedures|1
44656|NCT01431508|185350|P1|Overall Study|Lack of Efficacy|1
44657|NCT01431287|185401|P5|Overall Study|not stated above|1
44658|NCT01431287|185402|P4|Overall Study|not stated above|2
44659|NCT01431287|185403|P3|Overall Study|not stated above|2
44660|NCT01431287|185404|P2|Overall Study|not stated above|2
44661|NCT01431287|185405|P1|Overall Study|not stated above|4
44662|NCT01431287|185401|P5|Overall Study|Consent withdrawn not due to AE|29
44663|NCT01431287|185402|P4|Overall Study|Consent withdrawn not due to AE|19
44664|NCT01431287|185403|P3|Overall Study|Consent withdrawn not due to AE|34
44665|NCT01431287|185404|P2|Overall Study|Consent withdrawn not due to AE|30
44666|NCT01431287|185405|P1|Overall Study|Consent withdrawn not due to AE|29
44667|NCT01431287|185401|P5|Overall Study|Lost to Follow-up|1
44668|NCT01431287|185402|P4|Overall Study|Lost to Follow-up|3
44669|NCT01431287|185403|P3|Overall Study|Lost to Follow-up|2
44670|NCT01431287|185404|P2|Overall Study|Lost to Follow-up|3
44671|NCT01431287|185405|P1|Overall Study|Lost to Follow-up|0
44672|NCT01431287|185401|P5|Overall Study|Non compliant with protocol|5
44673|NCT01431287|185402|P4|Overall Study|Non compliant with protocol|6
44674|NCT01431287|185403|P3|Overall Study|Non compliant with protocol|5
44675|NCT01431287|185404|P2|Overall Study|Non compliant with protocol|6
44676|NCT01431287|185405|P1|Overall Study|Non compliant with protocol|6
44677|NCT01431287|185401|P5|Overall Study|Adverse Event|41
44678|NCT01431287|185402|P4|Overall Study|Adverse Event|33
44679|NCT01431287|185403|P3|Overall Study|Adverse Event|53
44680|NCT01431287|185404|P2|Overall Study|Adverse Event|57
44681|NCT01431287|185405|P1|Overall Study|Adverse Event|59
44682|NCT01431287|185401|P5|Overall Study|not treated|0
44683|NCT01431287|185402|P4|Overall Study|not treated|0
44684|NCT01431287|185403|P3|Overall Study|not treated|1
44685|NCT01431287|185404|P2|Overall Study|not treated|0
44686|NCT01431287|185405|P1|Overall Study|not treated|0
44687|NCT01431274|185567|P5|Overall Study|Other reason not stated above|4
44688|NCT01431274|185568|P4|Overall Study|Other reason not stated above|2
44689|NCT01431274|185569|P3|Overall Study|Other reason not stated above|7
44690|NCT01431274|185570|P2|Overall Study|Other reason not stated above|5
44691|NCT01431274|185571|P1|Overall Study|Other reason not stated above|6
44692|NCT01431274|185567|P5|Overall Study|Lost to Follow-up|0
44693|NCT01431274|185568|P4|Overall Study|Lost to Follow-up|4
44694|NCT01431274|185569|P3|Overall Study|Lost to Follow-up|1
44695|NCT01431274|185570|P2|Overall Study|Lost to Follow-up|7
44696|NCT01431274|185571|P1|Overall Study|Lost to Follow-up|6
44697|NCT01431274|185567|P5|Overall Study|Non compliant with protocol|4
44698|NCT01431274|185568|P4|Overall Study|Non compliant with protocol|4
44699|NCT01431274|185569|P3|Overall Study|Non compliant with protocol|4
44700|NCT01431274|185570|P2|Overall Study|Non compliant with protocol|8
44701|NCT01431274|185571|P1|Overall Study|Non compliant with protocol|5
44702|NCT01431274|185567|P5|Overall Study|Consent withdrawn not due to AE|11
44703|NCT01431274|185568|P4|Overall Study|Consent withdrawn not due to AE|20
44704|NCT01431274|185569|P3|Overall Study|Consent withdrawn not due to AE|17
44705|NCT01431274|185570|P2|Overall Study|Consent withdrawn not due to AE|20
44706|NCT01431274|185571|P1|Overall Study|Consent withdrawn not due to AE|29
44707|NCT01431274|185567|P5|Overall Study|Adverse Event|37
44708|NCT01431274|185568|P4|Overall Study|Adverse Event|30
44709|NCT01431274|185569|P3|Overall Study|Adverse Event|43
44710|NCT01431274|185570|P2|Overall Study|Adverse Event|37
44711|NCT01431274|185571|P1|Overall Study|Adverse Event|51
44712|NCT01431144|185749|P2|Overall Study|Implant mobility and removal|0
44713|NCT01431144|185750|P1|Overall Study|Implant mobility and removal|2
44714|NCT01431079|185769|P2|Overall Study|Lost to Follow-up|39
44715|NCT01431079|185770|P1|Overall Study|Lost to Follow-up|35
44716|NCT01430754|185849|P2|Run-In Phase|Lost to Follow-up|0
44717|NCT01430754|185850|P1|Run-In Phase|Lost to Follow-up|1
44718|NCT01430754|185849|P2|Run-In Phase|Withdrawal by Subject|0
44719|NCT01430754|185850|P1|Run-In Phase|Withdrawal by Subject|2
44720|NCT01430754|185849|P2|Run-In Phase|Other|0
44721|NCT01430754|185850|P1|Run-In Phase|Other|2
44722|NCT01430754|185849|P2|Run-In Phase|Adverse Event|0
44723|NCT01430754|185850|P1|Run-In Phase|Adverse Event|2
44724|NCT01430754|185849|P2|Run-In Phase|Protocol Violation|0
44725|NCT01430754|185850|P1|Run-In Phase|Protocol Violation|6
44726|NCT01430754|185849|P2|Run-In Phase|Circadian Period Ineligible|0
44727|NCT01430754|185850|P1|Run-In Phase|Circadian Period Ineligible|24
44728|NCT01430624|185908|P3|Overall Study|technical or eligibility|2
44729|NCT01430624|185909|P2|Overall Study|technical or eligibility|5
44730|NCT01430624|185910|P1|Overall Study|technical or eligibility|5
44731|NCT01430624|185908|P3|Overall Study|Lost to Follow-up|27
44732|NCT01430624|185909|P2|Overall Study|Lost to Follow-up|29
44733|NCT01430624|185910|P1|Overall Study|Lost to Follow-up|23
44734|NCT01430611|185941|P2|Overall Study|Withdrawal by Subject|14
44735|NCT01430611|185942|P1|Overall Study|Withdrawal by Subject|15
44736|NCT01430611|185941|P2|Overall Study|Lost to Follow-up|0
44737|NCT01430611|185942|P1|Overall Study|Lost to Follow-up|1
44738|NCT01430611|185941|P2|Overall Study|Protocol Violation|0
44739|NCT01430611|185942|P1|Overall Study|Protocol Violation|1
44740|NCT01430611|185941|P2|Overall Study|Adverse Event|1
44741|NCT01430611|185942|P1|Overall Study|Adverse Event|0
44742|NCT01430585|185960|P1|Overall Study|Unspecified|7
44743|NCT01430585|185960|P1|Overall Study|Study Terminated by Sponsor|3
44744|NCT01430585|185960|P1|Overall Study|Objective Progression or Relapse|3
44745|NCT01430585|185960|P1|Overall Study|Death|1
44746|NCT01430468|185995|P2|Overall Study|Withdrawal by Subject|1
44747|NCT01430468|185996|P1|Overall Study|Withdrawal by Subject|1
44748|NCT01430468|185995|P2|Overall Study|Physician Decision|1
44749|NCT01430468|185996|P1|Overall Study|Physician Decision|2
44750|NCT01430403|186005|P3|Overall Study|Withdrawal by Subject|3
44751|NCT01430403|186006|P2|Overall Study|Withdrawal by Subject|1
44752|NCT01430403|186007|P1|Overall Study|Withdrawal by Subject|9
44753|NCT01430403|186005|P3|Overall Study|Protocol Violation|2
44754|NCT01430403|186006|P2|Overall Study|Protocol Violation|3
44755|NCT01430403|186007|P1|Overall Study|Protocol Violation|2
44756|NCT01430403|186005|P3|Overall Study|Physician Decision|0
44757|NCT01430403|186006|P2|Overall Study|Physician Decision|0
44758|NCT01430403|186007|P1|Overall Study|Physician Decision|1
44759|NCT01430403|186005|P3|Overall Study|Lost to Follow-up|3
44760|NCT01430403|186006|P2|Overall Study|Lost to Follow-up|5
44761|NCT01430403|186007|P1|Overall Study|Lost to Follow-up|5
44762|NCT01430130|186105|P1|Overall Study|Infection on Control Side of Incision|1
44763|NCT01430130|186105|P1|Overall Study|Lost to Follow-up|1
44764|NCT01430104|186111|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
44765|NCT01429623|186147|P2|Overall Study|No post baseline data|4
44766|NCT01429623|186148|P1|Overall Study|No post baseline data|4
44767|NCT01429623|186147|P2|Overall Study|Conversion to Alzheimer's disease|21
44768|NCT01429623|186148|P1|Overall Study|Conversion to Alzheimer's disease|14
44769|NCT01429623|186147|P2|Overall Study|Assorted|2
44770|NCT01429623|186148|P1|Overall Study|Assorted|1
44771|NCT01429623|186147|P2|Overall Study|Protocol Violation|2
44772|NCT01429623|186148|P1|Overall Study|Protocol Violation|3
44773|NCT01429623|186147|P2|Overall Study|Physician Decision|3
44774|NCT01429623|186148|P1|Overall Study|Physician Decision|2
44775|NCT01429623|186147|P2|Overall Study|Withdrawal by Subject|13
44776|NCT01429623|186148|P1|Overall Study|Withdrawal by Subject|19
44777|NCT01429623|186147|P2|Overall Study|Adverse Event|14
44778|NCT01429623|186148|P1|Overall Study|Adverse Event|7
44779|NCT01429623|186147|P2|Overall Study|Death|0
44780|NCT01429623|186148|P1|Overall Study|Death|1
44781|NCT01429584|186162|P2|Overall Study|Protocol Violation|1
44782|NCT01429584|186163|P1|Overall Study|Protocol Violation|0
44783|NCT01429584|186162|P2|Overall Study|Withdrawal by Subject|0
44784|NCT01429584|186163|P1|Overall Study|Withdrawal by Subject|1
44785|NCT01429441|186194|P2|Overall Study|Withdrawal by Subject|18
44786|NCT01429441|186195|P1|Overall Study|Withdrawal by Subject|27
44787|NCT01429441|186194|P2|Overall Study|Physician Decision|0
44788|NCT01429441|186195|P1|Overall Study|Physician Decision|1
44789|NCT01429441|186194|P2|Overall Study|Lost to Follow-up|2
44790|NCT01429441|186195|P1|Overall Study|Lost to Follow-up|5
44791|NCT01429441|186194|P2|Overall Study|Death|2
44792|NCT01429441|186195|P1|Overall Study|Death|0
44793|NCT01429441|186194|P2|Overall Study|Adverse Event|1
44794|NCT01429441|186195|P1|Overall Study|Adverse Event|5
44795|NCT01429077|186210|P2|Overall Study|Lost to Follow-up|3
44796|NCT01429077|186211|P1|Overall Study|Lost to Follow-up|0
44797|NCT01429051|186234|P1|Tolerability Phase|Other|2
44798|NCT01429051|186234|P1|Tolerability Phase|Physician Decision|1
44799|NCT01429051|186234|P1|Tolerability Phase|Withdrawal by Subject|5
44800|NCT01429051|186234|P1|Tolerability Phase|Adverse Event|2
44801|NCT01429051|186234|P1|Tolerability Phase|Death|5
44802|NCT01429051|186234|P1|Efficacy Phase|Death|1
44803|NCT01429051|186234|P1|Efficacy Phase|Adverse Event|1
44804|NCT01429051|186234|P1|Titration Phase|Less than 3 BTP episodes per week|2
44805|NCT01429051|186234|P1|Titration Phase|Unsuccessful titration at any dose|1
44806|NCT01429051|186234|P1|Titration Phase|Physician Decision|1
44807|NCT01429051|186234|P1|Titration Phase|Withdrawal by Subject|7
44808|NCT01429051|186234|P1|Titration Phase|Death|1
44809|NCT01428882|186257|P2|Overall Study|Protocol Violation|3
44810|NCT01428882|186258|P1|Overall Study|Protocol Violation|4
44811|NCT01428882|186257|P2|Overall Study|Lack of Efficacy|7
44812|NCT01428882|186258|P1|Overall Study|Lack of Efficacy|2
44813|NCT01428713|186281|P2|Overall Study|Adverse Event|2
44814|NCT01428713|186282|P1|Overall Study|Adverse Event|0
44815|NCT01428713|186281|P2|Overall Study|Withdrawal by Subject|1
44816|NCT01428713|186282|P1|Overall Study|Withdrawal by Subject|1
44817|NCT01428713|186281|P2|Overall Study|Non-compliance|2
44818|NCT01428713|186282|P1|Overall Study|Non-compliance|2
44819|NCT01428661|186291|P3|Open Label Extension|**Various|185
44820|NCT01428661|186292|P2|Open Label Extension|**Various|0
44821|NCT01428661|186293|P1|Open Label Extension|**Various|0
44822|NCT01428661|186291|P3|Open Label Extension|Lack of Efficacy|24
44823|NCT01428661|186292|P2|Open Label Extension|Lack of Efficacy|0
44824|NCT01428661|186293|P1|Open Label Extension|Lack of Efficacy|0
44825|NCT01428661|186291|P3|Open Label Extension|Withdrawal by Subject|49
44826|NCT01428661|186292|P2|Open Label Extension|Withdrawal by Subject|0
44827|NCT01428661|186293|P1|Open Label Extension|Withdrawal by Subject|0
44828|NCT01428661|186291|P3|Open Label Extension|Lost to Follow-up|38
44829|NCT01428661|186292|P2|Open Label Extension|Lost to Follow-up|0
44830|NCT01428661|186293|P1|Open Label Extension|Lost to Follow-up|0
44831|NCT01428661|186291|P3|Open Label Extension|Adverse Event|15
44832|NCT01428661|186292|P2|Open Label Extension|Adverse Event|0
44833|NCT01428661|186293|P1|Open Label Extension|Adverse Event|0
44834|NCT01428661|186291|P3|Open Label Extension|Protocol Violation|9
44835|NCT01428661|186292|P2|Open Label Extension|Protocol Violation|0
44836|NCT01428661|186293|P1|Open Label Extension|Protocol Violation|0
44837|NCT01428661|186291|P3|Double-Masked Phase|*Various|0
44838|NCT01428661|186292|P2|Double-Masked Phase|*Various|6
44839|NCT01428661|186293|P1|Double-Masked Phase|*Various|1
44840|NCT01428661|186291|P3|Double-Masked Phase|Lack of Efficacy|0
44841|NCT01428661|186292|P2|Double-Masked Phase|Lack of Efficacy|1
44842|NCT01428661|186293|P1|Double-Masked Phase|Lack of Efficacy|2
44843|NCT01428661|186291|P3|Double-Masked Phase|Withdrawal by Subject|0
44844|NCT01428661|186292|P2|Double-Masked Phase|Withdrawal by Subject|20
44845|NCT01428661|186293|P1|Double-Masked Phase|Withdrawal by Subject|18
44846|NCT01428661|186291|P3|Double-Masked Phase|Lost to Follow-up|0
44847|NCT01428661|186292|P2|Double-Masked Phase|Lost to Follow-up|14
44848|NCT01428661|186293|P1|Double-Masked Phase|Lost to Follow-up|14
44849|NCT01428661|186291|P3|Double-Masked Phase|Adverse Event|0
44850|NCT01428661|186292|P2|Double-Masked Phase|Adverse Event|4
44851|NCT01428661|186293|P1|Double-Masked Phase|Adverse Event|13
44852|NCT01428661|186291|P3|Double-Masked Phase|Protocol Violation|0
44853|NCT01428661|186292|P2|Double-Masked Phase|Protocol Violation|4
44854|NCT01428661|186293|P1|Double-Masked Phase|Protocol Violation|9
44855|NCT01428583|186301|P1|Overall Study|Unspecified|6
44856|NCT01428583|186301|P1|Overall Study|Sponsor’s request|3
44857|NCT01428583|186301|P1|Overall Study|Confirmed positive urine drug test|8
44858|NCT01428583|186301|P1|Overall Study|Non-compliant|25
44859|NCT01428583|186301|P1|Overall Study|Physician Decision|12
44860|NCT01428583|186301|P1|Overall Study|Protocol Violation|1
44861|NCT01428583|186301|P1|Overall Study|Pregnancy|1
44862|NCT01428583|186301|P1|Overall Study|Death|1
44863|NCT01428583|186301|P1|Overall Study|Lost to Follow-up|17
44864|NCT01428583|186301|P1|Overall Study|Lack of Efficacy|37
44865|NCT01428583|186301|P1|Overall Study|Withdrawal by Subject|51
44866|NCT01428583|186301|P1|Overall Study|Adverse Event|75
44867|NCT01428258|186338|P2|Intervention 1|Withdrawal by Subject|0
44868|NCT01428258|186339|P1|Intervention 1|Withdrawal by Subject|2
44869|NCT01428128|186361|P1|Overall Study|Adverse Event|1
44870|NCT01428128|186361|P1|Overall Study|Received Neulasta in one cycle|2
44871|NCT01428128|186361|P1|Overall Study|Screen failure by p53|10
44872|NCT01428128|186361|P1|Overall Study|Withdrawal by Subject|4
44873|NCT01428115|186365|P1|Overall Study|Withdrawal by Subject|4
44874|NCT01428115|186365|P1|Overall Study|Protocol Violation|3
44875|NCT01428115|186365|P1|Overall Study|Pregnancy|1
44876|NCT01428115|186365|P1|Overall Study|Lost to Follow-up|10
44877|NCT01428115|186365|P1|Overall Study|Lack of Efficacy|3
44878|NCT01428076|186380|P2|Overall Study|Adverse Event|1
44879|NCT01428076|186381|P1|Overall Study|Adverse Event|0
44880|NCT01428063|186392|P3|Overall Study|No longer meets study criteria|0
44881|NCT01428063|186393|P2|Overall Study|No longer meets study criteria|1
44882|NCT01428063|186394|P1|Overall Study|No longer meets study criteria|0
44883|NCT01428063|186392|P3|Overall Study|Lost to Follow-up|0
44884|NCT01428063|186393|P2|Overall Study|Lost to Follow-up|2
44885|NCT01428063|186394|P1|Overall Study|Lost to Follow-up|0
44886|NCT01428063|186392|P3|Overall Study|Adverse Event|0
44887|NCT01428063|186393|P2|Overall Study|Adverse Event|3
44888|NCT01428063|186394|P1|Overall Study|Adverse Event|2
44889|NCT01428063|186392|P3|Overall Study|Lack of Efficacy|1
44890|NCT01428063|186393|P2|Overall Study|Lack of Efficacy|4
44891|NCT01428063|186394|P1|Overall Study|Lack of Efficacy|8
44892|NCT01427933|186465|P2|Overall Study|Investigator's Decision|0
44893|NCT01427933|186466|P1|Overall Study|Investigator's Decision|1
44894|NCT01427933|186465|P2|Overall Study|Not Specified|0
44895|NCT01427933|186466|P1|Overall Study|Not Specified|1
44896|NCT01427933|186465|P2|Overall Study|Lost to Follow-up|5
44897|NCT01427933|186466|P1|Overall Study|Lost to Follow-up|1
44898|NCT01427933|186465|P2|Overall Study|Withdrawal by Subject|8
44899|NCT01427933|186466|P1|Overall Study|Withdrawal by Subject|5
44900|NCT01427920|186486|P2|Overall Study|Unclassified|8
44901|NCT01427920|186487|P1|Overall Study|Unclassified|2
44902|NCT01427920|186486|P2|Overall Study|Withdrawal Criteria|4
44903|NCT01427920|186487|P1|Overall Study|Withdrawal Criteria|4
44904|NCT01427920|186486|P2|Overall Study|Protocol Violation|3
44905|NCT01427920|186487|P1|Overall Study|Protocol Violation|1
44906|NCT01427920|186486|P2|Overall Study|Lack of Efficacy|0
44907|NCT01427920|186487|P1|Overall Study|Lack of Efficacy|1
44908|NCT01427920|186486|P2|Overall Study|Adverse Event|2
44909|NCT01427920|186487|P1|Overall Study|Adverse Event|1
44910|NCT01427907|186507|P2|Overall Study|Withdrawal by Subject|4
44911|NCT01427907|186508|P1|Overall Study|Withdrawal by Subject|3
44912|NCT01427803|186529|P2|Overall Study|did not take product|0
44913|NCT01427803|186530|P1|Overall Study|did not take product|1
44914|NCT01427803|186529|P2|Overall Study|Physician Decision|0
44915|NCT01427803|186530|P1|Overall Study|Physician Decision|3
44916|NCT01427803|186529|P2|Overall Study|Protocol Violation|0
44917|NCT01427803|186530|P1|Overall Study|Protocol Violation|1
44918|NCT01427803|186529|P2|Overall Study|Unable to complete full treatment period|0
44919|NCT01427803|186530|P1|Overall Study|Unable to complete full treatment period|6
44920|NCT01427803|186529|P2|Overall Study|Withdrawal by Subject|0
44921|NCT01427803|186530|P1|Overall Study|Withdrawal by Subject|20
44922|NCT01427803|186529|P2|Overall Study|Lost to Follow-up|26
44923|NCT01427803|186530|P1|Overall Study|Lost to Follow-up|32
44924|NCT01427751|186544|P2|Overall Study|Other miscellaneous reasons|4
44925|NCT01427751|186545|P1|Overall Study|Other miscellaneous reasons|6
44926|NCT01427751|186544|P2|Overall Study|Death|0
44927|NCT01427751|186545|P1|Overall Study|Death|2
44928|NCT01427751|186544|P2|Overall Study|Protocol Violation|4
44929|NCT01427751|186545|P1|Overall Study|Protocol Violation|6
44930|NCT01427751|186544|P2|Overall Study|Withdrawal of consent|2
44931|NCT01427751|186545|P1|Overall Study|Withdrawal of consent|2
44932|NCT01427751|186544|P2|Overall Study|Lost to Follow-up|1
44933|NCT01427751|186545|P1|Overall Study|Lost to Follow-up|3
44934|NCT01427751|186544|P2|Overall Study|No further treatment benefit expected|1
44935|NCT01427751|186545|P1|Overall Study|No further treatment benefit expected|5
44936|NCT01427751|186544|P2|Overall Study|Adverse Event|2
44937|NCT01427751|186545|P1|Overall Study|Adverse Event|18
44938|NCT01427738|186565|P2|Overall Study|Lost to Follow-up|5
44939|NCT01427738|186566|P1|Overall Study|Lost to Follow-up|1
44940|NCT01427738|186565|P2|Overall Study|Subject not willing to adhere to reqs|2
44941|NCT01427738|186566|P1|Overall Study|Subject not willing to adhere to reqs|1
44942|NCT01427738|186565|P2|Overall Study|Withdrawal by Subject|2
44943|NCT01427738|186566|P1|Overall Study|Withdrawal by Subject|0
44944|NCT01427738|186565|P2|Overall Study|Subject unable to get to clinic|2
44945|NCT01427738|186566|P1|Overall Study|Subject unable to get to clinic|5
44946|NCT01427738|186565|P2|Overall Study|Severe debilitation, unable to continue|1
44947|NCT01427738|186566|P1|Overall Study|Severe debilitation, unable to continue|0
44948|NCT01427738|186565|P2|Overall Study|Death|9
44949|NCT01427738|186566|P1|Overall Study|Death|12
44950|NCT01427309|186629|P4|Overall Study|Withdrawal by Subject|55
44951|NCT01427309|186630|P3|Overall Study|Withdrawal by Subject|61
44952|NCT01427309|186631|P2|Overall Study|Withdrawal by Subject|148
44953|NCT01427309|186632|P1|Overall Study|Withdrawal by Subject|148
44954|NCT01427309|186629|P4|Overall Study|Serious adverse event|61
44955|NCT01427309|186630|P3|Overall Study|Serious adverse event|50
44956|NCT01427309|186631|P2|Overall Study|Serious adverse event|45
44957|NCT01427309|186632|P1|Overall Study|Serious adverse event|52
44958|NCT01427309|186629|P4|Overall Study|Adverse Event|1
44959|NCT01427309|186630|P3|Overall Study|Adverse Event|3
44960|NCT01427309|186631|P2|Overall Study|Adverse Event|0
44961|NCT01427309|186632|P1|Overall Study|Adverse Event|0
44962|NCT01427309|186629|P4|Overall Study|Protocol Violation|124
44963|NCT01427309|186630|P3|Overall Study|Protocol Violation|125
44964|NCT01427309|186631|P2|Overall Study|Protocol Violation|69
44965|NCT01427309|186632|P1|Overall Study|Protocol Violation|42
44966|NCT01427309|186629|P4|Overall Study|Lost to Follow-up|135
44967|NCT01427309|186630|P3|Overall Study|Lost to Follow-up|122
44968|NCT01427309|186631|P2|Overall Study|Lost to Follow-up|145
44969|NCT01427309|186632|P1|Overall Study|Lost to Follow-up|130
44970|NCT01426958|186670|P1|Overall Study|Adverse Event|2
44971|NCT01426854|186699|P2|Overall Study|Other|2
44972|NCT01426854|186700|P1|Overall Study|Other|3
44973|NCT01426854|186699|P2|Overall Study|Protocol Deviation|1
44974|NCT01426854|186700|P1|Overall Study|Protocol Deviation|0
44975|NCT01426854|186699|P2|Overall Study|Treatment Failure|16
44976|NCT01426854|186700|P1|Overall Study|Treatment Failure|0
44977|NCT01426854|186699|P2|Overall Study|Noncompliance|1
44978|NCT01426854|186700|P1|Overall Study|Noncompliance|0
44979|NCT01426854|186699|P2|Overall Study|Lost to Follow-up|0
44980|NCT01426854|186700|P1|Overall Study|Lost to Follow-up|3
44981|NCT01426854|186699|P2|Overall Study|Subject Decision Unrelated to AE|6
44982|NCT01426854|186700|P1|Overall Study|Subject Decision Unrelated to AE|5
44983|NCT01426854|186699|P2|Overall Study|Adverse Event|5
44984|NCT01426854|186700|P1|Overall Study|Adverse Event|1
44985|NCT01426789|186710|P6|Part 2|Adverse Event|0
44986|NCT01426789|186711|P5|Part 2|Adverse Event|1
44987|NCT01426789|186712|P4|Part 2|Adverse Event|0
44988|NCT01426789|186713|P3|Part 2|Adverse Event|2
44989|NCT01426789|186714|P2|Part 2|Adverse Event|0
44990|NCT01426789|186715|P1|Part 2|Adverse Event|0
44991|NCT01426789|186710|P6|Part 2|Lack of Efficacy|0
44992|NCT01426789|186711|P5|Part 2|Lack of Efficacy|2
44993|NCT01426789|186712|P4|Part 2|Lack of Efficacy|0
44994|NCT01426789|186713|P3|Part 2|Lack of Efficacy|5
44995|NCT01426789|186714|P2|Part 2|Lack of Efficacy|0
44996|NCT01426789|186715|P1|Part 2|Lack of Efficacy|0
44997|NCT01426789|186710|P6|Part 2|Withdrawal by Subject|0
44998|NCT01426789|186711|P5|Part 2|Withdrawal by Subject|2
44999|NCT01426789|186712|P4|Part 2|Withdrawal by Subject|1
45000|NCT01426789|186713|P3|Part 2|Withdrawal by Subject|0
45001|NCT01426789|186714|P2|Part 2|Withdrawal by Subject|0
45002|NCT01426789|186715|P1|Part 2|Withdrawal by Subject|0
45003|NCT01426789|186710|P6|Part 2|Lost to Follow-up|0
45004|NCT01426789|186711|P5|Part 2|Lost to Follow-up|1
45005|NCT01426789|186712|P4|Part 2|Lost to Follow-up|0
45006|NCT01426789|186713|P3|Part 2|Lost to Follow-up|4
45007|NCT01426789|186714|P2|Part 2|Lost to Follow-up|0
45008|NCT01426789|186715|P1|Part 2|Lost to Follow-up|0
45009|NCT01426789|186710|P6|Part 2|Administrative problems|0
45010|NCT01426789|186711|P5|Part 2|Administrative problems|1
45011|NCT01426789|186712|P4|Part 2|Administrative problems|0
45012|NCT01426789|186713|P3|Part 2|Administrative problems|2
45013|NCT01426789|186714|P2|Part 2|Administrative problems|0
45014|NCT01426789|186715|P1|Part 2|Administrative problems|0
45015|NCT01426789|186710|P6|Part 2|Death|0
45016|NCT01426789|186711|P5|Part 2|Death|1
45017|NCT01426789|186712|P4|Part 2|Death|0
45018|NCT01426789|186713|P3|Part 2|Death|1
45019|NCT01426789|186714|P2|Part 2|Death|0
45020|NCT01426789|186715|P1|Part 2|Death|0
45021|NCT01426789|186710|P6|Part 2|Protocol deviation|0
45022|NCT01426789|186711|P5|Part 2|Protocol deviation|0
45023|NCT01426789|186712|P4|Part 2|Protocol deviation|0
45024|NCT01426789|186713|P3|Part 2|Protocol deviation|1
45025|NCT01426789|186714|P2|Part 2|Protocol deviation|0
45026|NCT01426789|186715|P1|Part 2|Protocol deviation|0
45027|NCT01426789|186710|P6|Part 1|Adverse Event|0
45028|NCT01426789|186711|P5|Part 1|Adverse Event|0
45029|NCT01426789|186712|P4|Part 1|Adverse Event|0
45030|NCT01426789|186713|P3|Part 1|Adverse Event|0
45031|NCT01426789|186714|P2|Part 1|Adverse Event|0
45032|NCT01426789|186715|P1|Part 1|Adverse Event|3
45033|NCT01426789|186710|P6|Part 1|Lack of Efficacy|0
45034|NCT01426789|186711|P5|Part 1|Lack of Efficacy|0
45035|NCT01426789|186712|P4|Part 1|Lack of Efficacy|0
45036|NCT01426789|186713|P3|Part 1|Lack of Efficacy|0
45037|NCT01426789|186714|P2|Part 1|Lack of Efficacy|1
45038|NCT01426789|186715|P1|Part 1|Lack of Efficacy|2
45039|NCT01426789|186710|P6|Part 1|Lost to Follow-up|0
45040|NCT01426789|186711|P5|Part 1|Lost to Follow-up|0
45041|NCT01426789|186712|P4|Part 1|Lost to Follow-up|0
45042|NCT01426789|186713|P3|Part 1|Lost to Follow-up|0
45043|NCT01426789|186714|P2|Part 1|Lost to Follow-up|2
45044|NCT01426789|186715|P1|Part 1|Lost to Follow-up|1
45045|NCT01426789|186710|P6|Part 1|Protocol deviation|0
45046|NCT01426789|186711|P5|Part 1|Protocol deviation|0
45047|NCT01426789|186712|P4|Part 1|Protocol deviation|0
45048|NCT01426789|186713|P3|Part 1|Protocol deviation|0
45049|NCT01426789|186714|P2|Part 1|Protocol deviation|1
45050|NCT01426789|186715|P1|Part 1|Protocol deviation|0
45051|NCT01426438|186760|P2|Overall Study|Missed Scan|2
45052|NCT01426438|186761|P1|Overall Study|Missed Scan|2
45053|NCT01426438|186760|P2|Overall Study|Poor scan quality|2
45054|NCT01426438|186761|P1|Overall Study|Poor scan quality|3
45055|NCT01426438|186760|P2|Overall Study|Off study Treatment|3
45056|NCT01426438|186761|P1|Overall Study|Off study Treatment|9
45057|NCT01426438|186760|P2|Overall Study|Lost to Follow-up|3
45058|NCT01426438|186761|P1|Overall Study|Lost to Follow-up|1
45059|NCT01426425|186793|P1|Overall Study|Met inclusion/exclusion, not treated|2
45060|NCT01426425|186793|P1|Overall Study|Inclusion/exclusion criteria not met|151
45061|NCT01426425|186793|P1|Overall Study|Exited prior to EP study|22
45062|NCT01426373|186799|P1|Overall Study|Miscellaneous Reasons|4
45063|NCT01426373|186799|P1|Overall Study|Participant Convenience|10
45064|NCT01426373|186799|P1|Overall Study|Lost to Follow-up|14
45065|NCT01426373|186799|P1|Overall Study|Adverse Event|6
45066|NCT01426347|186832|P2|Overall Study|Withdrawal by Subject|0
45067|NCT01426347|186833|P1|Overall Study|Withdrawal by Subject|5
45068|NCT01426347|186832|P2|Overall Study|Protocol Violation|0
45069|NCT01426347|186833|P1|Overall Study|Protocol Violation|2
45070|NCT01426347|186832|P2|Overall Study|Lost to Follow-up|3
45071|NCT01426347|186833|P1|Overall Study|Lost to Follow-up|0
45072|NCT01426269|186841|P3|Period 2: 40 Weeks|Relapsed|18
45073|NCT01426269|186842|P2|Period 2: 40 Weeks|Relapsed|9
45074|NCT01426269|186843|P1|Period 2: 40 Weeks|Relapsed|0
45075|NCT01426269|186841|P3|Period 2: 40 Weeks|Site closed|5
45076|NCT01426269|186842|P2|Period 2: 40 Weeks|Site closed|6
45077|NCT01426269|186843|P1|Period 2: 40 Weeks|Site closed|0
45078|NCT01426269|186841|P3|Period 2: 40 Weeks|Lost to Follow-up|6
45079|NCT01426269|186842|P2|Period 2: 40 Weeks|Lost to Follow-up|8
45080|NCT01426269|186843|P1|Period 2: 40 Weeks|Lost to Follow-up|0
45081|NCT01426269|186841|P3|Period 2: 40 Weeks|Protocol Violation|5
45082|NCT01426269|186842|P2|Period 2: 40 Weeks|Protocol Violation|5
45083|NCT01426269|186843|P1|Period 2: 40 Weeks|Protocol Violation|0
45084|NCT01426269|186841|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
45085|NCT01426269|186842|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
45086|NCT01426269|186843|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
45087|NCT01426269|186841|P3|Period 2: 40 Weeks|Adverse Event|2
45088|NCT01426269|186842|P2|Period 2: 40 Weeks|Adverse Event|1
45089|NCT01426269|186843|P1|Period 2: 40 Weeks|Adverse Event|0
45090|NCT01426269|186841|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
45091|NCT01426269|186842|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
45092|NCT01426269|186843|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
45093|NCT01426269|186841|P3|Eligibility for Period 2, Randomization|Did not qualify|0
45094|NCT01426269|186842|P2|Eligibility for Period 2, Randomization|Did not qualify|0
45095|NCT01426269|186843|P1|Eligibility for Period 2, Randomization|Did not qualify|42
45096|NCT01426269|186841|P3|Period 1: 12 Weeks|Pregnancy|0
45097|NCT01426269|186842|P2|Period 1: 12 Weeks|Pregnancy|0
45098|NCT01426269|186843|P1|Period 1: 12 Weeks|Pregnancy|1
45099|NCT01426269|186841|P3|Period 1: 12 Weeks|Lost to Follow-up|0
45100|NCT01426269|186842|P2|Period 1: 12 Weeks|Lost to Follow-up|0
45101|NCT01426269|186843|P1|Period 1: 12 Weeks|Lost to Follow-up|22
45102|NCT01426269|186841|P3|Period 1: 12 Weeks|Protocol Violation|0
45103|NCT01426269|186842|P2|Period 1: 12 Weeks|Protocol Violation|0
45104|NCT01426269|186843|P1|Period 1: 12 Weeks|Protocol Violation|5
45105|NCT01426269|186841|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
45106|NCT01426269|186842|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
45107|NCT01426269|186843|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
45108|NCT01426269|186841|P3|Period 1: 12 Weeks|Adverse Event|0
45109|NCT01426269|186842|P2|Period 1: 12 Weeks|Adverse Event|0
45110|NCT01426269|186843|P1|Period 1: 12 Weeks|Adverse Event|5
45111|NCT01426113|186878|P2|Overall Study|Adverse Event|1
45112|NCT01426113|186879|P1|Overall Study|Adverse Event|0
45113|NCT01426113|186878|P2|Overall Study|Study Discontinued|1
45114|NCT01426113|186879|P1|Overall Study|Study Discontinued|1
45115|NCT01425814|186925|P6|Period 5|Stability criteria not fulfilled|1
45116|NCT01425814|186926|P5|Period 5|Stability criteria not fulfilled|0
45117|NCT01425814|186927|P4|Period 5|Stability criteria not fulfilled|0
45118|NCT01425814|186928|P3|Period 5|Stability criteria not fulfilled|1
45119|NCT01425814|186929|P2|Period 5|Stability criteria not fulfilled|0
45120|NCT01425814|186930|P1|Period 5|Stability criteria not fulfilled|0
45121|NCT01425814|186925|P6|Period 4|Adverse Event|0
45122|NCT01425814|186926|P5|Period 4|Adverse Event|0
45123|NCT01425814|186927|P4|Period 4|Adverse Event|0
45124|NCT01425814|186928|P3|Period 4|Adverse Event|1
45125|NCT01425814|186929|P2|Period 4|Adverse Event|0
45126|NCT01425814|186930|P1|Period 4|Adverse Event|1
45127|NCT01425814|186925|P6|Period 3|Adverse Event|1
45128|NCT01425814|186926|P5|Period 3|Adverse Event|0
45129|NCT01425814|186927|P4|Period 3|Adverse Event|0
45130|NCT01425814|186928|P3|Period 3|Adverse Event|0
45131|NCT01425814|186929|P2|Period 3|Adverse Event|0
45132|NCT01425814|186930|P1|Period 3|Adverse Event|0
45133|NCT01425814|186925|P6|Period 2|Stability criteria not fulfilled|0
45134|NCT01425814|186926|P5|Period 2|Stability criteria not fulfilled|0
45135|NCT01425814|186927|P4|Period 2|Stability criteria not fulfilled|0
45136|NCT01425814|186928|P3|Period 2|Stability criteria not fulfilled|0
45137|NCT01425814|186929|P2|Period 2|Stability criteria not fulfilled|1
45138|NCT01425814|186930|P1|Period 2|Stability criteria not fulfilled|0
45139|NCT01425814|186925|P6|Period 1|Stability criteria not fulfilled|0
45140|NCT01425814|186926|P5|Period 1|Stability criteria not fulfilled|0
45141|NCT01425814|186927|P4|Period 1|Stability criteria not fulfilled|0
45142|NCT01425814|186928|P3|Period 1|Stability criteria not fulfilled|0
45143|NCT01425814|186929|P2|Period 1|Stability criteria not fulfilled|1
45144|NCT01425814|186930|P1|Period 1|Stability criteria not fulfilled|0
45145|NCT01425749|187024|P2|Overall Study|progression of melanoma|1
45146|NCT01425749|187025|P1|Overall Study|progression of melanoma|0
45147|NCT01425632|187043|P3|Overall Study|Withdrawal by Subject|1
45148|NCT01425632|187044|P2|Overall Study|Withdrawal by Subject|0
45149|NCT01425632|187045|P1|Overall Study|Withdrawal by Subject|0
45150|NCT01425632|187043|P3|Overall Study|Protocol Violation|2
45151|NCT01425632|187044|P2|Overall Study|Protocol Violation|0
45152|NCT01425632|187045|P1|Overall Study|Protocol Violation|0
45153|NCT01425632|187043|P3|Overall Study|Physician Decision|0
45154|NCT01425632|187044|P2|Overall Study|Physician Decision|0
45155|NCT01425632|187045|P1|Overall Study|Physician Decision|1
45156|NCT01425632|187043|P3|Overall Study|Adverse Event|1
45157|NCT01425632|187044|P2|Overall Study|Adverse Event|1
45158|NCT01425632|187045|P1|Overall Study|Adverse Event|0
45159|NCT01425528|187055|P2|Overall Study|Withdrawal by Subject|1
45160|NCT01425528|187056|P1|Overall Study|Withdrawal by Subject|1
45161|NCT01425463|187064|P2|Overall Study|Unknown Reason|7
45162|NCT01425463|187065|P1|Overall Study|Unknown Reason|4
45163|NCT01425463|187064|P2|Overall Study|Withdrawal by Subject|5
45164|NCT01425463|187065|P1|Overall Study|Withdrawal by Subject|7
45165|NCT01425463|187064|P2|Overall Study|Lost to Follow-up|2
45166|NCT01425463|187065|P1|Overall Study|Lost to Follow-up|5
45167|NCT01425463|187064|P2|Overall Study|Protocol Violation|2
45168|NCT01425463|187065|P1|Overall Study|Protocol Violation|2
45169|NCT01425463|187064|P2|Overall Study|Lack of Efficacy|1
45170|NCT01425463|187065|P1|Overall Study|Lack of Efficacy|1
45171|NCT01425463|187064|P2|Overall Study|Adverse Event|7
45172|NCT01425463|187065|P1|Overall Study|Adverse Event|5
45173|NCT01425359|187081|P2|Overall Study|Did Not Meet Qualifying Criteria|5
45174|NCT01425359|187082|P1|Overall Study|Did Not Meet Qualifying Criteria|3
45175|NCT01425359|187081|P2|Overall Study|Investigator’s Discretion|0
45176|NCT01425359|187082|P1|Overall Study|Investigator’s Discretion|2
45177|NCT01425359|187081|P2|Overall Study|Subject Withdrew Consent|2
45178|NCT01425359|187082|P1|Overall Study|Subject Withdrew Consent|1
45179|NCT01425359|187081|P2|Overall Study|Protocol Violation|2
45180|NCT01425359|187082|P1|Overall Study|Protocol Violation|1
45181|NCT01425359|187081|P2|Overall Study|Unsatisfactory Response|0
45182|NCT01425359|187082|P1|Overall Study|Unsatisfactory Response|1
45183|NCT01425359|187081|P2|Overall Study|Death|1
45184|NCT01425359|187082|P1|Overall Study|Death|0
45185|NCT01425359|187081|P2|Overall Study|Revascularization|1
45186|NCT01425359|187082|P1|Overall Study|Revascularization|0
45187|NCT01425359|187081|P2|Overall Study|Adverse Event|8
45188|NCT01425359|187082|P1|Overall Study|Adverse Event|9
45189|NCT01425359|187081|P2|Overall Study|Randomized but Not Treated|3
45190|NCT01425359|187082|P1|Overall Study|Randomized but Not Treated|2
45191|NCT01425268|187113|P2|Overall Study|Physician Decision|0
45192|NCT01425268|187114|P1|Overall Study|Physician Decision|1
45193|NCT01425268|187113|P2|Overall Study|Sponsor Decision|0
45194|NCT01425268|187114|P1|Overall Study|Sponsor Decision|5
45195|NCT01425268|187113|P2|Overall Study|Withdrawal by Subject|0
45196|NCT01425268|187114|P1|Overall Study|Withdrawal by Subject|2
45197|NCT01425203|187135|P3|Crossover Phase|Other virologic failure criteria|3
45198|NCT01425203|187136|P2|Crossover Phase|Other virologic failure criteria|0
45199|NCT01425203|187137|P1|Crossover Phase|Other virologic failure criteria|0
45200|NCT01425203|187135|P3|Crossover Phase|Failure at futility timepoint|3
45201|NCT01425203|187136|P2|Crossover Phase|Failure at futility timepoint|0
45202|NCT01425203|187137|P1|Crossover Phase|Failure at futility timepoint|0
45203|NCT01425203|187135|P3|Treatment Phase|Did not receive treatment|0
45204|NCT01425203|187136|P2|Treatment Phase|Did not receive treatment|1
45205|NCT01425203|187137|P1|Treatment Phase|Did not receive treatment|0
45206|NCT01425203|187135|P3|Treatment Phase|Unidentified reasons|0
45207|NCT01425203|187136|P2|Treatment Phase|Unidentified reasons|5
45208|NCT01425203|187137|P1|Treatment Phase|Unidentified reasons|11
45209|NCT01425203|187135|P3|Treatment Phase|Other virologic failure criteria|0
45210|NCT01425203|187136|P2|Treatment Phase|Other virologic failure criteria|3
45211|NCT01425203|187137|P1|Treatment Phase|Other virologic failure criteria|5
45212|NCT01425203|187135|P3|Treatment Phase|Failure at futility timepoint|0
45213|NCT01425203|187136|P2|Treatment Phase|Failure at futility timepoint|27
45214|NCT01425203|187137|P1|Treatment Phase|Failure at futility timepoint|8
45215|NCT01425203|187135|P3|Treatment Phase|DC during PR Lead-in Phase|0
45216|NCT01425203|187136|P2|Treatment Phase|DC during PR Lead-in Phase|1
45217|NCT01425203|187137|P1|Treatment Phase|DC during PR Lead-in Phase|3
45218|NCT01425190|187154|P3|Overall Study|Full dose not consumed.|0
45219|NCT01425190|187155|P2|Overall Study|Full dose not consumed.|0
45220|NCT01425190|187156|P1|Overall Study|Full dose not consumed.|1
45221|NCT01424930|187192|P2|Overall Study|Reason not specified|6
45222|NCT01424930|187193|P1|Overall Study|Reason not specified|0
45223|NCT01424930|187192|P2|Overall Study|Screen Failure|1
45224|NCT01424930|187193|P1|Overall Study|Screen Failure|0
45225|NCT01424930|187192|P2|Overall Study|Progressive Disease|6
45226|NCT01424930|187193|P1|Overall Study|Progressive Disease|3
45227|NCT01424930|187192|P2|Overall Study|Death|0
45228|NCT01424930|187193|P1|Overall Study|Death|1
45229|NCT01424930|187192|P2|Overall Study|Adverse Event|1
45230|NCT01424930|187193|P1|Overall Study|Adverse Event|0
45231|NCT01424813|187207|P2|Overall Study|not specified|2
45232|NCT01424813|187208|P1|Overall Study|not specified|1
45233|NCT01424813|187207|P2|Overall Study|Protocol Violation|0
45234|NCT01424813|187208|P1|Overall Study|Protocol Violation|1
45235|NCT01424813|187207|P2|Overall Study|Withdrawal by Subject|0
45236|NCT01424813|187208|P1|Overall Study|Withdrawal by Subject|3
45237|NCT01424644|187228|P2|Overall Study|Unable to Classify|0
45238|NCT01424644|187229|P1|Overall Study|Unable to Classify|1
45239|NCT01424644|187228|P2|Overall Study|Administrative Reason|0
45240|NCT01424644|187229|P1|Overall Study|Administrative Reason|1
45241|NCT01424644|187228|P2|Overall Study|Protocol Violation|3
45242|NCT01424644|187229|P1|Overall Study|Protocol Violation|4
45243|NCT01424644|187228|P2|Overall Study|Lost to Follow-up|12
45244|NCT01424644|187229|P1|Overall Study|Lost to Follow-up|16
45245|NCT01424644|187228|P2|Overall Study|Withdrawal by Subject|12
45246|NCT01424644|187229|P1|Overall Study|Withdrawal by Subject|9
45247|NCT01424644|187228|P2|Overall Study|Adverse Event|0
45248|NCT01424644|187229|P1|Overall Study|Adverse Event|2
45249|NCT01424501|187249|P6|Overall Study|Lost to Follow-up|0
45250|NCT01424501|187250|P5|Overall Study|Lost to Follow-up|0
45251|NCT01424501|187251|P4|Overall Study|Lost to Follow-up|0
45252|NCT01424501|187252|P3|Overall Study|Lost to Follow-up|1
45253|NCT01424501|187253|P2|Overall Study|Lost to Follow-up|0
45254|NCT01424501|187254|P1|Overall Study|Lost to Follow-up|0
45255|NCT01424501|187249|P6|Overall Study|Withdrawal by Subject|0
45256|NCT01424501|187250|P5|Overall Study|Withdrawal by Subject|0
45257|NCT01424501|187251|P4|Overall Study|Withdrawal by Subject|0
45258|NCT01424501|187252|P3|Overall Study|Withdrawal by Subject|1
45259|NCT01424501|187253|P2|Overall Study|Withdrawal by Subject|1
45260|NCT01424501|187254|P1|Overall Study|Withdrawal by Subject|1
45261|NCT01424306|187418|P6|Overall Study|Protocol Violation|0
45262|NCT01424306|187419|P5|Overall Study|Protocol Violation|1
45263|NCT01424306|187420|P4|Overall Study|Protocol Violation|0
45264|NCT01424306|187421|P3|Overall Study|Protocol Violation|0
45265|NCT01424306|187422|P2|Overall Study|Protocol Violation|0
45266|NCT01424306|187423|P1|Overall Study|Protocol Violation|0
45267|NCT01424228|187472|P2|Overall Study|Unplanned journey|1
45268|NCT01424228|187473|P1|Overall Study|Unplanned journey|0
45269|NCT01424228|187472|P2|Overall Study|Worsening of symptoms|0
45270|NCT01424228|187473|P1|Overall Study|Worsening of symptoms|1
45271|NCT01424228|187472|P2|Overall Study|Non-compliance|0
45272|NCT01424228|187473|P1|Overall Study|Non-compliance|2
45273|NCT01424228|187472|P2|Overall Study|inclusion/exclusion criteria not met|2
45274|NCT01424228|187473|P1|Overall Study|inclusion/exclusion criteria not met|2
45275|NCT01424228|187472|P2|Overall Study|Lack of Efficacy|7
45276|NCT01424228|187473|P1|Overall Study|Lack of Efficacy|5
45277|NCT01424228|187472|P2|Overall Study|Sponsor's decision|12
45278|NCT01424228|187473|P1|Overall Study|Sponsor's decision|9
45279|NCT01424228|187472|P2|Overall Study|Adverse Event|14
45280|NCT01424228|187473|P1|Overall Study|Adverse Event|10
45281|NCT01424228|187472|P2|Overall Study|Withdrawal by Subject|11
45282|NCT01424228|187473|P1|Overall Study|Withdrawal by Subject|27
45283|NCT01424189|187513|P2|Overall Study|Death|1
45284|NCT01424189|187514|P1|Overall Study|Death|3
45285|NCT01424189|187513|P2|Overall Study|Subject moved|0
45286|NCT01424189|187514|P1|Overall Study|Subject moved|1
45287|NCT01424189|187513|P2|Overall Study|Withdrawal by Subject|4
45288|NCT01424189|187514|P1|Overall Study|Withdrawal by Subject|4
45289|NCT01424189|187513|P2|Overall Study|Lost to Follow-up|1
45290|NCT01424189|187514|P1|Overall Study|Lost to Follow-up|4
45291|NCT01424189|187513|P2|Overall Study|Adverse Event|0
45292|NCT01424189|187514|P1|Overall Study|Adverse Event|1
45293|NCT01423916|187555|P3|Overall Study|Protocol Deviation|0
45294|NCT01423916|187556|P2|Overall Study|Protocol Deviation|0
45295|NCT01423916|187557|P1|Overall Study|Protocol Deviation|1
45296|NCT01423916|187555|P3|Overall Study|Withdrawal by Subject|3
45297|NCT01423916|187556|P2|Overall Study|Withdrawal by Subject|10
45298|NCT01423916|187557|P1|Overall Study|Withdrawal by Subject|3
45299|NCT01423916|187555|P3|Overall Study|Physician Decision|1
45300|NCT01423916|187556|P2|Overall Study|Physician Decision|0
45301|NCT01423916|187557|P1|Overall Study|Physician Decision|1
45302|NCT01423916|187555|P3|Overall Study|Met Withdrawal Criteria|1
45303|NCT01423916|187556|P2|Overall Study|Met Withdrawal Criteria|1
45304|NCT01423916|187557|P1|Overall Study|Met Withdrawal Criteria|1
45305|NCT01423916|187555|P3|Overall Study|Adverse Event|2
45306|NCT01423916|187556|P2|Overall Study|Adverse Event|9
45307|NCT01423916|187557|P1|Overall Study|Adverse Event|5
45308|NCT01423617|187631|P2|Overall Study|Lost to Follow-up|1
45309|NCT01423617|187632|P1|Overall Study|Lost to Follow-up|0
45310|NCT01423604|187649|P2|Randomized|Patient decision|9
45311|NCT01423604|187650|P1|Randomized|Patient decision|5
45312|NCT01423604|187649|P2|Randomized|Other - unspecified|31
45313|NCT01423604|187650|P1|Randomized|Other - unspecified|37
45314|NCT01423604|187649|P2|Randomized|Physician Decision|13
45315|NCT01423604|187650|P1|Randomized|Physician Decision|16
45316|NCT01423604|187649|P2|Randomized|Death|0
45317|NCT01423604|187650|P1|Randomized|Death|1
45318|NCT01423604|187649|P2|Randomized|Adverse Event|10
45319|NCT01423604|187650|P1|Randomized|Adverse Event|4
45320|NCT01423604|187649|P2|Safety Run-In|Patient decision|0
45321|NCT01423604|187650|P1|Safety Run-In|Patient decision|1
45322|NCT01423604|187649|P2|Safety Run-In|Disease progression|0
45323|NCT01423604|187650|P1|Safety Run-In|Disease progression|3
45324|NCT01423604|187649|P2|Safety Run-In|Physician Decision|0
45325|NCT01423604|187650|P1|Safety Run-In|Physician Decision|1
45326|NCT01423604|187649|P2|Safety Run-In|Death|0
45327|NCT01423604|187650|P1|Safety Run-In|Death|1
45328|NCT01423604|187649|P2|Safety Run-In|Adverse Event|0
45329|NCT01423604|187650|P1|Safety Run-In|Adverse Event|3
45330|NCT01423253|187665|P1|Overall Study|Withdrawal by Subject|2
45331|NCT01423253|187665|P1|Overall Study|Protocol Violation|2
45332|NCT01423253|187665|P1|Overall Study|Lost to Follow-up|1
45333|NCT01423253|187665|P1|Overall Study|Lack of Efficacy|2
45334|NCT01423253|187665|P1|Overall Study|Adverse Event|2
45335|NCT01423084|187687|P2|Overall Study|Withdrawal by Subject|3
45336|NCT01423084|187688|P1|Overall Study|Withdrawal by Subject|2
45337|NCT01423084|187687|P2|Overall Study|Adverse Event|1
45338|NCT01423084|187688|P1|Overall Study|Adverse Event|0
45339|NCT01422915|187718|P1|Overall Study|Adverse Event|1
45340|NCT01422889|187723|P1|Overall Study|No Data Entered for Study Stent|9
45341|NCT01422876|187738|P10|Week 52|Death|0
45342|NCT01422876|187739|P9|Week 52|Death|1
45343|NCT01422876|187740|P8|Week 52|Death|3
45344|NCT01422876|187741|P7|Week 52|Death|1
45345|NCT01422876|187742|P6|Week 52|Death|0
45346|NCT01422876|187743|P5|Week 52|Death|0
45347|NCT01422876|187744|P4|Week 52|Death|1
45348|NCT01422876|187745|P3|Week 52|Death|0
45349|NCT01422876|187746|P2|Week 52|Death|1
45350|NCT01422876|187747|P1|Week 52|Death|0
45351|NCT01422876|187738|P10|Week 52|Consent withdrawn|9
45352|NCT01422876|187739|P9|Week 52|Consent withdrawn|13
45353|NCT01422876|187740|P8|Week 52|Consent withdrawn|12
45354|NCT01422876|187741|P7|Week 52|Consent withdrawn|10
45355|NCT01422876|187742|P6|Week 52|Consent withdrawn|12
45356|NCT01422876|187743|P5|Week 52|Consent withdrawn|7
45357|NCT01422876|187744|P4|Week 52|Consent withdrawn|12
45358|NCT01422876|187745|P3|Week 52|Consent withdrawn|6
45359|NCT01422876|187746|P2|Week 52|Consent withdrawn|4
45360|NCT01422876|187747|P1|Week 52|Consent withdrawn|9
45361|NCT01422876|187738|P10|Week 52|Lost to Follow-up|8
45362|NCT01422876|187739|P9|Week 52|Lost to Follow-up|7
45363|NCT01422876|187740|P8|Week 52|Lost to Follow-up|8
45364|NCT01422876|187741|P7|Week 52|Lost to Follow-up|5
45365|NCT01422876|187742|P6|Week 52|Lost to Follow-up|5
45366|NCT01422876|187743|P5|Week 52|Lost to Follow-up|8
45367|NCT01422876|187744|P4|Week 52|Lost to Follow-up|5
45368|NCT01422876|187745|P3|Week 52|Lost to Follow-up|7
45369|NCT01422876|187746|P2|Week 52|Lost to Follow-up|5
45370|NCT01422876|187747|P1|Week 52|Lost to Follow-up|3
45371|NCT01422876|187738|P10|Week 24|Death|0
45372|NCT01422876|187739|P9|Week 24|Death|0
45373|NCT01422876|187740|P8|Week 24|Death|0
45374|NCT01422876|187741|P7|Week 24|Death|0
45375|NCT01422876|187742|P6|Week 24|Death|0
45376|NCT01422876|187743|P5|Week 24|Death|0
45377|NCT01422876|187744|P4|Week 24|Death|0
45378|NCT01422876|187745|P3|Week 24|Death|0
45379|NCT01422876|187746|P2|Week 24|Death|1
45380|NCT01422876|187747|P1|Week 24|Death|0
45381|NCT01422876|187738|P10|Week 24|Consent withdrawn|6
45382|NCT01422876|187739|P9|Week 24|Consent withdrawn|3
45383|NCT01422876|187740|P8|Week 24|Consent withdrawn|4
45384|NCT01422876|187741|P7|Week 24|Consent withdrawn|5
45385|NCT01422876|187742|P6|Week 24|Consent withdrawn|6
45386|NCT01422876|187743|P5|Week 24|Consent withdrawn|5
45387|NCT01422876|187744|P4|Week 24|Consent withdrawn|4
45388|NCT01422876|187745|P3|Week 24|Consent withdrawn|3
45389|NCT01422876|187746|P2|Week 24|Consent withdrawn|1
45390|NCT01422876|187747|P1|Week 24|Consent withdrawn|5
45391|NCT01422876|187738|P10|Week 24|Lost to Follow-up|4
45392|NCT01422876|187739|P9|Week 24|Lost to Follow-up|3
45393|NCT01422876|187740|P8|Week 24|Lost to Follow-up|3
45394|NCT01422876|187741|P7|Week 24|Lost to Follow-up|1
45395|NCT01422876|187742|P6|Week 24|Lost to Follow-up|0
45396|NCT01422876|187743|P5|Week 24|Lost to Follow-up|2
45397|NCT01422876|187744|P4|Week 24|Lost to Follow-up|4
45398|NCT01422876|187745|P3|Week 24|Lost to Follow-up|2
45399|NCT01422876|187746|P2|Week 24|Lost to Follow-up|1
45400|NCT01422876|187747|P1|Week 24|Lost to Follow-up|1
45401|NCT01422850|187794|P1|Overall Study|Physician Decision|3
45402|NCT01422824|187800|P1|Overall Study|Lost to Follow-up|37
45403|NCT01422824|187800|P1|Overall Study|Case record form not evaluated|1
45404|NCT01422720|187805|P1|Overall Study|Ineligibility|1
45405|NCT01422720|187805|P1|Overall Study|Withdrawal by Subject|4
45406|NCT01422720|187805|P1|Overall Study|Lack of Efficacy|1
45407|NCT01422720|187805|P1|Overall Study|Adverse Event|16
45408|NCT01422538|187816|P3|Overall Study|Missed visit|1
45409|NCT01422538|187817|P2|Overall Study|Missed visit|1
45410|NCT01422538|187818|P1|Overall Study|Missed visit|0
45411|NCT01422538|187816|P3|Overall Study|Lost to Follow-up|1
45412|NCT01422538|187817|P2|Overall Study|Lost to Follow-up|1
45413|NCT01422538|187818|P1|Overall Study|Lost to Follow-up|0
45414|NCT01422408|187862|P1|Overall Study|Withdrawal by Subject|3
45415|NCT01422408|187862|P1|Overall Study|Adverse Event|1
45416|NCT01422382|187891|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
45417|NCT01422304|187907|P2|Overall Study|Not Treated|11
45418|NCT01422304|187908|P1|Overall Study|Not Treated|3
45419|NCT01422304|187907|P2|Overall Study|Did Not Meet Protocol Eligibility|2
45420|NCT01422304|187908|P1|Overall Study|Did Not Meet Protocol Eligibility|0
45421|NCT01422304|187907|P2|Overall Study|Withdrawal by Subject|2
45422|NCT01422304|187908|P1|Overall Study|Withdrawal by Subject|4
45423|NCT01422304|187907|P2|Overall Study|Protocol Violation|0
45424|NCT01422304|187908|P1|Overall Study|Protocol Violation|1
45425|NCT01422304|187907|P2|Overall Study|Never Entered Follow-up|1
45426|NCT01422304|187908|P1|Overall Study|Never Entered Follow-up|2
45427|NCT01422304|187907|P2|Overall Study|Lost to Follow-up|20
45428|NCT01422304|187908|P1|Overall Study|Lost to Follow-up|14
45429|NCT01422304|187907|P2|Overall Study|Adverse Event|1
45430|NCT01422304|187908|P1|Overall Study|Adverse Event|0
45431|NCT01422239|187940|P2|Overall Study|Lost to Follow-up|3
45432|NCT01422239|187941|P1|Overall Study|Lost to Follow-up|4
45433|NCT01422213|187963|P3|Overall Study|Administrative or Other Reason(s)|2
45434|NCT01422213|187964|P2|Overall Study|Administrative or Other Reason(s)|4
45435|NCT01422213|187965|P1|Overall Study|Administrative or Other Reason(s)|5
45436|NCT01422213|187963|P3|Overall Study|Lost to Follow-up|5
45437|NCT01422213|187964|P2|Overall Study|Lost to Follow-up|3
45438|NCT01422213|187965|P1|Overall Study|Lost to Follow-up|3
45439|NCT01422213|187963|P3|Overall Study|Withdrawal of Consent|5
45440|NCT01422213|187964|P2|Overall Study|Withdrawal of Consent|3
45441|NCT01422213|187965|P1|Overall Study|Withdrawal of Consent|7
45442|NCT01422213|187963|P3|Overall Study|Protocol Violation|4
45443|NCT01422213|187964|P2|Overall Study|Protocol Violation|2
45444|NCT01422213|187965|P1|Overall Study|Protocol Violation|0
45445|NCT01422213|187963|P3|Overall Study|Non-compliance with study drug|0
45446|NCT01422213|187964|P2|Overall Study|Non-compliance with study drug|1
45447|NCT01422213|187965|P1|Overall Study|Non-compliance with study drug|0
45448|NCT01422213|187963|P3|Overall Study|Lack of Efficacy|2
45449|NCT01422213|187964|P2|Overall Study|Lack of Efficacy|2
45450|NCT01422213|187965|P1|Overall Study|Lack of Efficacy|10
45451|NCT01422213|187963|P3|Overall Study|Adverse Event|11
45452|NCT01422213|187964|P2|Overall Study|Adverse Event|7
45453|NCT01422213|187965|P1|Overall Study|Adverse Event|8
45454|NCT01422187|188026|P3|Overall Study|Lost to Follow-up|0
45455|NCT01422187|188027|P2|Overall Study|Lost to Follow-up|1
45456|NCT01422187|188028|P1|Overall Study|Lost to Follow-up|0
45457|NCT01422187|188026|P3|Overall Study|Personal reason|0
45458|NCT01422187|188027|P2|Overall Study|Personal reason|0
45459|NCT01422187|188028|P1|Overall Study|Personal reason|1
45460|NCT01421719|188059|P1|Overall Study|Withdrawal by Subject|4
45461|NCT01421667|188068|P4|Overall Study|Lost to Follow-up|0
45462|NCT01421667|188069|P3|Overall Study|Lost to Follow-up|0
45463|NCT01421667|188070|P2|Overall Study|Lost to Follow-up|1
45464|NCT01421667|188071|P1|Overall Study|Lost to Follow-up|0
45465|NCT01421667|188068|P4|Overall Study|Withdrawal by Subject|1
45466|NCT01421667|188069|P3|Overall Study|Withdrawal by Subject|2
45467|NCT01421667|188070|P2|Overall Study|Withdrawal by Subject|1
45468|NCT01421667|188071|P1|Overall Study|Withdrawal by Subject|0
45469|NCT01421641|188132|P2|Overall Study|Protocol Violation|2
45470|NCT01421641|188133|P1|Overall Study|Protocol Violation|2
45471|NCT01421511|188155|P2|Overall Study|Death|1
45472|NCT01421511|188156|P1|Overall Study|Death|1
45473|NCT01421511|188155|P2|Overall Study|Withdrawal by Subject|5
45474|NCT01421511|188156|P1|Overall Study|Withdrawal by Subject|6
45475|NCT01421511|188155|P2|Overall Study|Physician Decision|1
45476|NCT01421511|188156|P1|Overall Study|Physician Decision|0
45477|NCT01421511|188155|P2|Overall Study|Randomized but didn't receive study drug|7
45478|NCT01421511|188156|P1|Overall Study|Randomized but didn't receive study drug|1
45479|NCT01421511|188155|P2|Overall Study|Lost to Follow-up|14
45480|NCT01421511|188156|P1|Overall Study|Lost to Follow-up|11
45481|NCT01421459|188206|P2|Overall Study|Withdrawal by Subject|16
45482|NCT01421459|188207|P1|Overall Study|Withdrawal by Subject|12
45483|NCT01421459|188206|P2|Overall Study|Protocol Violation|5
45484|NCT01421459|188207|P1|Overall Study|Protocol Violation|8
45485|NCT01421459|188206|P2|Overall Study|Physician Decision|9
45486|NCT01421459|188207|P1|Overall Study|Physician Decision|9
45487|NCT01421459|188206|P2|Overall Study|Lost to Follow-up|9
45488|NCT01421459|188207|P1|Overall Study|Lost to Follow-up|8
45489|NCT01421459|188206|P2|Overall Study|Lack of Efficacy|2
45490|NCT01421459|188207|P1|Overall Study|Lack of Efficacy|1
45491|NCT01421459|188206|P2|Overall Study|Death|1
45492|NCT01421459|188207|P1|Overall Study|Death|1
45493|NCT01421459|188206|P2|Overall Study|Adverse Event|10
45494|NCT01421459|188207|P1|Overall Study|Adverse Event|6
45495|NCT01421303|188245|P1|Overall Study|Withdrawal by Subject|1
45496|NCT01421303|188245|P1|Overall Study|Unspecified|7
45497|NCT01421303|188245|P1|Overall Study|Non compliance with study procedure|1
45498|NCT01421303|188245|P1|Overall Study|Lost to Follow-up|13
45499|NCT01421277|188272|P2|Overall Study|Incomplete baseline data|31
45500|NCT01421277|188273|P1|Overall Study|Incomplete baseline data|0
45501|NCT01421277|188272|P2|Overall Study|Lack of qualifying event|61
45502|NCT01421277|188273|P1|Overall Study|Lack of qualifying event|0
45503|NCT01421147|188285|P2|Extension Period|Withdrawal by Subject|3
45504|NCT01421147|188286|P1|Extension Period|Withdrawal by Subject|5
45505|NCT01421147|188285|P2|Extension Period|Physician Decision|0
45506|NCT01421147|188286|P1|Extension Period|Physician Decision|1
45507|NCT01421147|188285|P2|Extension Period|Lost to Follow-up|5
45508|NCT01421147|188286|P1|Extension Period|Lost to Follow-up|2
45509|NCT01421147|188285|P2|Extension Period|Death|1
45510|NCT01421147|188286|P1|Extension Period|Death|0
45511|NCT01421147|188285|P2|Extension Period|Adverse Event|2
45512|NCT01421147|188286|P1|Extension Period|Adverse Event|0
45513|NCT01421147|188285|P2|Treatment Period|Withdrawal by Subject|5
45514|NCT01421147|188286|P1|Treatment Period|Withdrawal by Subject|10
45515|NCT01421147|188285|P2|Treatment Period|Physician Decision|2
45516|NCT01421147|188286|P1|Treatment Period|Physician Decision|2
45517|NCT01421147|188285|P2|Treatment Period|Lost to Follow-up|1
45518|NCT01421147|188286|P1|Treatment Period|Lost to Follow-up|2
45519|NCT01421147|188285|P2|Treatment Period|Adverse Event|3
45520|NCT01421147|188286|P1|Treatment Period|Adverse Event|2
45521|NCT01421134|188318|P2|Overall Study|Lost to Follow-up|1
45522|NCT01421134|188319|P1|Overall Study|Lost to Follow-up|1
45523|NCT01421134|188318|P2|Overall Study|Administrative|1
45524|NCT01421134|188319|P1|Overall Study|Administrative|0
45525|NCT01421134|188318|P2|Overall Study|Withdrawal by Subject|1
45526|NCT01421134|188319|P1|Overall Study|Withdrawal by Subject|1
45527|NCT01421134|188318|P2|Overall Study|Protocol Violation|3
45528|NCT01421134|188319|P1|Overall Study|Protocol Violation|0
45529|NCT01421134|188318|P2|Overall Study|Lack of Efficacy|4
45530|NCT01421134|188319|P1|Overall Study|Lack of Efficacy|2
45531|NCT01421134|188318|P2|Overall Study|Adverse Event|5
45532|NCT01421134|188319|P1|Overall Study|Adverse Event|3
45533|NCT01420926|188339|P2|Overall Study|Continues on active treatment|3
45534|NCT01420926|188340|P1|Overall Study|Continues on active treatment|1
45535|NCT01420926|188339|P2|Overall Study|Physician Decision|5
45536|NCT01420926|188340|P1|Overall Study|Physician Decision|7
45537|NCT01420926|188339|P2|Overall Study|Non-protocol treatment|20
45538|NCT01420926|188340|P1|Overall Study|Non-protocol treatment|17
45539|NCT01420926|188339|P2|Overall Study|Withdrawal by Subject|16
45540|NCT01420926|188340|P1|Overall Study|Withdrawal by Subject|11
45541|NCT01420926|188339|P2|Overall Study|Death|17
45542|NCT01420926|188340|P1|Overall Study|Death|18
45543|NCT01420926|188339|P2|Overall Study|Adverse Event|4
45544|NCT01420926|188340|P1|Overall Study|Adverse Event|6
45545|NCT01420081|188398|P9|Overall Study|Other Reasons|0
45546|NCT01420081|188399|P8|Overall Study|Other Reasons|0
45547|NCT01420081|188400|P7|Overall Study|Other Reasons|0
45548|NCT01420081|188401|P6|Overall Study|Other Reasons|0
45549|NCT01420081|188402|P5|Overall Study|Other Reasons|0
45550|NCT01420081|188403|P4|Overall Study|Other Reasons|0
45551|NCT01420081|188404|P3|Overall Study|Other Reasons|1
45552|NCT01420081|188405|P2|Overall Study|Other Reasons|0
45553|NCT01420081|188406|P1|Overall Study|Other Reasons|0
45554|NCT01420081|188398|P9|Overall Study|Subject Refused Futher Follow-up|0
45555|NCT01420081|188399|P8|Overall Study|Subject Refused Futher Follow-up|0
45556|NCT01420081|188400|P7|Overall Study|Subject Refused Futher Follow-up|0
45557|NCT01420081|188401|P6|Overall Study|Subject Refused Futher Follow-up|0
45558|NCT01420081|188402|P5|Overall Study|Subject Refused Futher Follow-up|1
45559|NCT01420081|188403|P4|Overall Study|Subject Refused Futher Follow-up|0
45560|NCT01420081|188404|P3|Overall Study|Subject Refused Futher Follow-up|1
45561|NCT01420081|188405|P2|Overall Study|Subject Refused Futher Follow-up|0
45562|NCT01420081|188406|P1|Overall Study|Subject Refused Futher Follow-up|0
45563|NCT01420081|188398|P9|Overall Study|Study Terminated by Sponsor|2
45564|NCT01420081|188399|P8|Overall Study|Study Terminated by Sponsor|2
45565|NCT01420081|188400|P7|Overall Study|Study Terminated by Sponsor|3
45566|NCT01420081|188401|P6|Overall Study|Study Terminated by Sponsor|7
45567|NCT01420081|188402|P5|Overall Study|Study Terminated by Sponsor|11
45568|NCT01420081|188403|P4|Overall Study|Study Terminated by Sponsor|3
45569|NCT01420081|188404|P3|Overall Study|Study Terminated by Sponsor|1
45570|NCT01420081|188405|P2|Overall Study|Study Terminated by Sponsor|1
45571|NCT01420081|188406|P1|Overall Study|Study Terminated by Sponsor|2
45572|NCT01420081|188398|P9|Overall Study|Lost to Follow-up|0
45573|NCT01420081|188399|P8|Overall Study|Lost to Follow-up|0
45574|NCT01420081|188400|P7|Overall Study|Lost to Follow-up|0
45575|NCT01420081|188401|P6|Overall Study|Lost to Follow-up|1
45576|NCT01420081|188402|P5|Overall Study|Lost to Follow-up|1
45577|NCT01420081|188403|P4|Overall Study|Lost to Follow-up|0
45578|NCT01420081|188404|P3|Overall Study|Lost to Follow-up|0
45579|NCT01420081|188405|P2|Overall Study|Lost to Follow-up|0
45580|NCT01420081|188406|P1|Overall Study|Lost to Follow-up|0
45581|NCT01420081|188398|P9|Overall Study|Death|1
45582|NCT01420081|188399|P8|Overall Study|Death|1
45583|NCT01420081|188400|P7|Overall Study|Death|0
45584|NCT01420081|188401|P6|Overall Study|Death|12
45585|NCT01420081|188402|P5|Overall Study|Death|7
45586|NCT01420081|188403|P4|Overall Study|Death|0
45587|NCT01420081|188404|P3|Overall Study|Death|8
45588|NCT01420081|188405|P2|Overall Study|Death|0
45589|NCT01420081|188406|P1|Overall Study|Death|1
45590|NCT01419769|188525|P1|Overall Study|Not evaluable due to pigtail stents|1
45591|NCT01419769|188525|P1|Overall Study|Did not receive the AXIOS stent|3
45592|NCT01419314|188546|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
45593|NCT01419314|188547|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
45594|NCT01419314|188546|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
45595|NCT01419314|188547|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
45596|NCT01419314|188546|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
45597|NCT01419314|188547|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
45598|NCT01419236|188588|P2|Overall Study|Entry Criteria Not Met|0
45599|NCT01419236|188589|P1|Overall Study|Entry Criteria Not Met|1
45600|NCT01419236|188588|P2|Overall Study|Withdrawal by Subject|4
45601|NCT01419236|188589|P1|Overall Study|Withdrawal by Subject|1
45602|NCT01419236|188588|P2|Overall Study|Physician Decision|0
45603|NCT01419236|188589|P1|Overall Study|Physician Decision|1
45604|NCT01419236|188588|P2|Overall Study|Lost to Follow-up|0
45605|NCT01419236|188589|P1|Overall Study|Lost to Follow-up|1
45606|NCT01419236|188588|P2|Overall Study|Lack of Efficacy|1
45607|NCT01419236|188589|P1|Overall Study|Lack of Efficacy|0
45608|NCT01419236|188588|P2|Overall Study|Adverse Event|0
45609|NCT01419236|188589|P1|Overall Study|Adverse Event|1
45610|NCT01419197|188613|P2|Overall Study|Lost to Follow-up|4
45611|NCT01419197|188614|P1|Overall Study|Lost to Follow-up|14
45612|NCT01419197|188613|P2|Overall Study|Reason Not Specified|1
45613|NCT01419197|188614|P1|Overall Study|Reason Not Specified|0
45614|NCT01419197|188613|P2|Overall Study|Study Completed by Sponsor|34
45615|NCT01419197|188614|P1|Overall Study|Study Completed by Sponsor|103
45616|NCT01419197|188613|P2|Overall Study|Withdrawal by Subject|32
45617|NCT01419197|188614|P1|Overall Study|Withdrawal by Subject|33
45618|NCT01419197|188613|P2|Overall Study|Non-compliance|1
45619|NCT01419197|188614|P1|Overall Study|Non-compliance|3
45620|NCT01419197|188613|P2|Overall Study|Physician Decision|4
45621|NCT01419197|188614|P1|Overall Study|Physician Decision|4
45622|NCT01419197|188613|P2|Overall Study|Death|122
45623|NCT01419197|188614|P1|Overall Study|Death|247
45624|NCT01419184|188639|P2|Overall Study|Participant randomized, not treated|0
45625|NCT01419184|188640|P1|Overall Study|Participant randomized, not treated|1
45626|NCT01419184|188639|P2|Overall Study|No IRLOS-No adverse event treatment date|1
45627|NCT01419184|188640|P1|Overall Study|No IRLOS-No adverse event treatment date|0
45628|NCT01419184|188639|P2|Overall Study|No IRLOS-non trial antibiotic used|2
45629|NCT01419184|188640|P1|Overall Study|No IRLOS-non trial antibiotic used|1
45630|NCT01419184|188639|P2|Overall Study|No IRLOS-randomized, not treated|4
45631|NCT01419184|188640|P1|Overall Study|No IRLOS-randomized, not treated|2
45632|NCT01419184|188639|P2|Overall Study|No IRLOS-No in-patient end date reported|6
45633|NCT01419184|188640|P1|Overall Study|No IRLOS-No in-patient end date reported|3
45634|NCT01419184|188639|P2|Overall Study|Site data not available|2
45635|NCT01419184|188640|P1|Overall Study|Site data not available|3
45636|NCT01418937|188678|P1|Overall Study|Withdrawal by Subject|1
45637|NCT01418937|188678|P1|Overall Study|Pregnancy|1
45638|NCT01418937|188678|P1|Overall Study|Protocol Violation|1
45639|NCT01418937|188678|P1|Overall Study|Lost to Follow-up|5
45640|NCT01418365|188709|P2|Second Intervention|Withdrawal by Subject|1
45641|NCT01418365|188710|P1|Second Intervention|Withdrawal by Subject|0
45642|NCT01418365|188709|P2|First Intervention|Non-compliance|0
45643|NCT01418365|188710|P1|First Intervention|Non-compliance|1
45644|NCT01418365|188709|P2|First Intervention|Withdrawal by Subject|1
45645|NCT01418365|188710|P1|First Intervention|Withdrawal by Subject|0
45646|NCT01418209|188721|P3|Overall Study|Did not provide hot flash diary data|3
45647|NCT01418209|188722|P2|Overall Study|Did not provide hot flash diary data|3
45648|NCT01418209|188723|P1|Overall Study|Did not provide hot flash diary data|1
45649|NCT01418209|188721|P3|Overall Study|Withdrawal by Subject|1
45650|NCT01418209|188722|P2|Overall Study|Withdrawal by Subject|0
45651|NCT01418209|188723|P1|Overall Study|Withdrawal by Subject|1
45652|NCT01417481|188777|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
45653|NCT01417481|188778|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
45654|NCT01417377|188843|P1|Overall Study|Enrolled, but not treated|1
45655|NCT01417377|188843|P1|Overall Study|Lost to Follow-up|12
45656|NCT01417195|188852|P2|Overall Study|No transfer due to elevated progesterone|0
45657|NCT01417195|188853|P1|Overall Study|No transfer due to elevated progesterone|1
45658|NCT01417195|188852|P2|Overall Study|No transfer due to risk of OHSS|0
45659|NCT01417195|188853|P1|Overall Study|No transfer due to risk of OHSS|1
45660|NCT01417195|188852|P2|Overall Study|No embryos for transfer|1
45661|NCT01417195|188853|P1|Overall Study|No embryos for transfer|0
45662|NCT01417195|188852|P2|Overall Study|Stimulation failure|0
45663|NCT01417195|188853|P1|Overall Study|Stimulation failure|1
45664|NCT01417156|188869|P1|Overall Study|Protocol Violation|2
45665|NCT01417156|188869|P1|Overall Study|Adverse Event|12
45666|NCT01417104|188879|P2|Overall Study|Adverse Event|0
45667|NCT01417104|188880|P1|Overall Study|Adverse Event|1
45668|NCT01417104|188879|P2|Overall Study|Failure to make contact|1
45669|NCT01417104|188880|P1|Overall Study|Failure to make contact|0
45670|NCT01417104|188879|P2|Overall Study|Withdrawal by Subject|1
45671|NCT01417104|188880|P1|Overall Study|Withdrawal by Subject|5
45672|NCT01417078|188890|P1|Overall Study|Withdrawal by Subject|1
45673|NCT01416610|188913|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
45674|NCT01416610|188913|P1|Overall Study|Lost to Follow-up|7
45675|NCT01416610|188913|P1|Overall Study|Withdrawal by Subject|13
45676|NCT01416610|188913|P1|Overall Study|No reason given|5
45677|NCT01416610|188913|P1|Overall Study|Lack of Efficacy|4
45678|NCT01416610|188913|P1|Overall Study|Adverse Event -Patient decision|3
45679|NCT01416610|188913|P1|Overall Study|Adverse Event|4
45680|NCT01416571|188927|P1|Overall Study|Lost to Follow-up|2
45681|NCT01416272|188954|P1|Overall Study|Study related complaints|1
45682|NCT01416272|188954|P1|Overall Study|Lost to Follow-up|1
45683|NCT01416272|188954|P1|Overall Study|Unacceptable distance visual acuity|2
45684|NCT01416181|188962|P2|Part 2|Lost to Follow-up|2
45685|NCT01416181|188963|P1|Part 2|Lost to Follow-up|2
45686|NCT01416181|188962|P2|Part 2|Lack of Efficacy|1
45687|NCT01416181|188963|P1|Part 2|Lack of Efficacy|4
45688|NCT01416181|188962|P2|Part 2|Withdrawal by Subject|5
45689|NCT01416181|188963|P1|Part 2|Withdrawal by Subject|14
45690|NCT01416181|188962|P2|Part 2|Investigator Decision|7
45691|NCT01416181|188963|P1|Part 2|Investigator Decision|6
45692|NCT01416181|188962|P2|Part 2|Not Specified|267
45693|NCT01416181|188963|P1|Part 2|Not Specified|234
45694|NCT01416181|188962|P2|Part 2|Adverse Event|4
45695|NCT01416181|188963|P1|Part 2|Adverse Event|11
45696|NCT01416181|188962|P2|Part 1|Ongoing in Follow-Up|8
45697|NCT01416181|188963|P1|Part 1|Ongoing in Follow-Up|14
45698|NCT01416181|188962|P2|Part 1|Adverse Event|18
45699|NCT01416181|188963|P1|Part 1|Adverse Event|15
45700|NCT01416181|188962|P2|Part 1|Lost to Follow-up|1
45701|NCT01416181|188963|P1|Part 1|Lost to Follow-up|1
45702|NCT01416181|188962|P2|Part 1|Lack of Efficacy|8
45703|NCT01416181|188963|P1|Part 1|Lack of Efficacy|16
45704|NCT01416181|188962|P2|Part 1|Withdrawal by Subject|48
45705|NCT01416181|188963|P1|Part 1|Withdrawal by Subject|74
45706|NCT01416181|188962|P2|Part 1|Investigator Decision|6
45707|NCT01416181|188963|P1|Part 1|Investigator Decision|7
45708|NCT01416181|188962|P2|Part 1|Death|1
45709|NCT01416181|188963|P1|Part 1|Death|0
45710|NCT01416181|188962|P2|Part 1|Not Specified|24
45711|NCT01416181|188963|P1|Part 1|Not Specified|10
45712|NCT01416155|189025|P1|Overall Study|Not specified|7
45713|NCT01416155|189025|P1|Overall Study|Investigator decision|8
45714|NCT01416155|189025|P1|Overall Study|Withdrawal by Subject|33
45715|NCT01416155|189025|P1|Overall Study|Positive for anti-BG00002 antibodies|2
45716|NCT01416155|189025|P1|Overall Study|Adverse Event|8
45717|NCT01416142|189032|P3|PureVision2 HD|Inability to maintain lens wear|1
45718|NCT01416142|189033|P2|PureVision2 HD|Inability to maintain lens wear|0
45719|NCT01416142|189034|P1|PureVision2 HD|Inability to maintain lens wear|0
45720|NCT01415986|189061|P1|Overall Study|Lost to Follow-up|1
45721|NCT01415921|189078|P2|Overall Study|Other|0
45722|NCT01415921|189079|P1|Overall Study|Other|2
45723|NCT01415921|189078|P2|Overall Study|Withdrawal by Subject|1
45724|NCT01415921|189079|P1|Overall Study|Withdrawal by Subject|0
45725|NCT01415921|189078|P2|Overall Study|Physician Decision|1
45726|NCT01415921|189079|P1|Overall Study|Physician Decision|1
45727|NCT01415921|189078|P2|Overall Study|Adverse Event|1
45728|NCT01415921|189079|P1|Overall Study|Adverse Event|0
45729|NCT01415908|189089|P2|Overall Study|Withdrawal by Subject|0
45730|NCT01415908|189090|P1|Overall Study|Withdrawal by Subject|1
45731|NCT01415531|189127|P2|Overall Study|Other Reasons|2
45732|NCT01415531|189128|P1|Overall Study|Other Reasons|3
45733|NCT01415531|189127|P2|Overall Study|Lack of Compliance|4
45734|NCT01415531|189128|P1|Overall Study|Lack of Compliance|1
45735|NCT01415531|189127|P2|Overall Study|Lost to Follow-up|14
45736|NCT01415531|189128|P1|Overall Study|Lost to Follow-up|6
45737|NCT01415531|189127|P2|Overall Study|Withdrawal by Subject|4
45738|NCT01415531|189128|P1|Overall Study|Withdrawal by Subject|5
45739|NCT01415531|189127|P2|Overall Study|Protocol Violation|1
45740|NCT01415531|189128|P1|Overall Study|Protocol Violation|0
45741|NCT01415531|189127|P2|Overall Study|Lack of Efficacy|2
45742|NCT01415531|189128|P1|Overall Study|Lack of Efficacy|3
45743|NCT01415531|189127|P2|Overall Study|Adverse Event|10
45744|NCT01415531|189128|P1|Overall Study|Adverse Event|7
45745|NCT01415518|189138|P2|Overall Study|Condition under Investigation Worsened|1
45746|NCT01415518|189139|P1|Overall Study|Condition under Investigation Worsened|1
45747|NCT01415518|189138|P2|Overall Study|Death|1
45748|NCT01415518|189139|P1|Overall Study|Death|1
45749|NCT01415518|189138|P2|Overall Study|Adverse Event|4
45750|NCT01415518|189139|P1|Overall Study|Adverse Event|3
45751|NCT01415518|189138|P2|Overall Study|Lost to Follow-up|5
45752|NCT01415518|189139|P1|Overall Study|Lost to Follow-up|3
45753|NCT01415518|189138|P2|Overall Study|Protocol Violation|8
45754|NCT01415518|189139|P1|Overall Study|Protocol Violation|6
45755|NCT01415518|189138|P2|Overall Study|Withdrawal by Subject|12
45756|NCT01415518|189139|P1|Overall Study|Withdrawal by Subject|2
45757|NCT01415401|189239|P1|Overall Study|Terminated by Sponsor|1
45758|NCT01415401|189239|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
45759|NCT01415401|189239|P1|Overall Study|Adverse Event|5
45760|NCT01415349|189244|P2|Treatment Period 1|Withdrawal by Subject|1
45761|NCT01415349|189245|P1|Treatment Period 1|Withdrawal by Subject|0
45762|NCT01415349|189244|P2|Treatment Period 1|Adverse Event|1
45763|NCT01415349|189245|P1|Treatment Period 1|Adverse Event|0
45764|NCT01414855|189257|P1|Overall Study|Withdrawal by Subject|1
45765|NCT01414855|189257|P1|Overall Study|Physician Decision|1
45766|NCT01414855|189257|P1|Overall Study|Other Reasons- Unspecified|1
45767|NCT01414855|189257|P1|Overall Study|Disease progression,|2
45768|NCT01414855|189257|P1|Overall Study|Adverse Event|8
45769|NCT01414205|189323|P2|Overall Study|Randomized but not Treated|1
45770|NCT01414205|189324|P1|Overall Study|Randomized but not Treated|1
45771|NCT01414205|189323|P2|Overall Study|Physician Decision|1
45772|NCT01414205|189324|P1|Overall Study|Physician Decision|0
45773|NCT01414205|189323|P2|Overall Study|Lost to Follow-up|4
45774|NCT01414205|189324|P1|Overall Study|Lost to Follow-up|1
45775|NCT01414205|189323|P2|Overall Study|Death|1
45776|NCT01414205|189324|P1|Overall Study|Death|5
45777|NCT01414166|189393|P2|Overall Study|Withdrawal by Subject|5
45778|NCT01414166|189394|P1|Overall Study|Withdrawal by Subject|3
45779|NCT01414166|189393|P2|Overall Study|Study terminated by Sponsor|75
45780|NCT01414166|189394|P1|Overall Study|Study terminated by Sponsor|68
45781|NCT01414166|189393|P2|Overall Study|Protocol Violation|0
45782|NCT01414166|189394|P1|Overall Study|Protocol Violation|2
45783|NCT01414166|189393|P2|Overall Study|Physician Decision|0
45784|NCT01414166|189394|P1|Overall Study|Physician Decision|2
45785|NCT01414166|189393|P2|Overall Study|Non-compliance with study drug|0
45786|NCT01414166|189394|P1|Overall Study|Non-compliance with study drug|2
45787|NCT01414166|189393|P2|Overall Study|Lost to Follow-up|1
45788|NCT01414166|189394|P1|Overall Study|Lost to Follow-up|4
45789|NCT01414166|189393|P2|Overall Study|Adverse Event|2
45790|NCT01414166|189394|P1|Overall Study|Adverse Event|10
45791|NCT01414114|189457|P1|Overall Study|Other|2
45792|NCT01414114|189457|P1|Overall Study|Withdrawal by Subject|1
45793|NCT01414114|189457|P1|Overall Study|Adverse Event|2
45794|NCT01413958|189513|P2|Overall Study|Lost to Follow-up|1
45795|NCT01413958|189514|P1|Overall Study|Lost to Follow-up|0
45796|NCT01413542|189565|P4|Overall Study|Adverse Event|1
45797|NCT01413542|189566|P3|Overall Study|Adverse Event|0
45798|NCT01413542|189567|P2|Overall Study|Adverse Event|0
45799|NCT01413542|189568|P1|Overall Study|Adverse Event|0
45800|NCT01413542|189565|P4|Overall Study|Physician Decision|0
45801|NCT01413542|189566|P3|Overall Study|Physician Decision|3
45802|NCT01413542|189567|P2|Overall Study|Physician Decision|0
45803|NCT01413542|189568|P1|Overall Study|Physician Decision|1
45804|NCT01413360|189590|P1|Overall Study|Adverse Event|1
45805|NCT01413360|189590|P1|Overall Study|Lost to Follow-up|2
45806|NCT01413204|189598|P3|Overall Study|Fasting plasma glucose level increased|10
45807|NCT01413204|189599|P2|Overall Study|Fasting plasma glucose level increased|0
45808|NCT01413204|189600|P1|Overall Study|Fasting plasma glucose level increased|1
45809|NCT01413204|189598|P3|Overall Study|Clearly not eligible for the study|1
45810|NCT01413204|189599|P2|Overall Study|Clearly not eligible for the study|0
45811|NCT01413204|189600|P1|Overall Study|Clearly not eligible for the study|0
45812|NCT01413204|189598|P3|Overall Study|Withdrawal by Subject|4
45813|NCT01413204|189599|P2|Overall Study|Withdrawal by Subject|4
45814|NCT01413204|189600|P1|Overall Study|Withdrawal by Subject|1
45815|NCT01413204|189598|P3|Overall Study|Physician Decision|2
45816|NCT01413204|189599|P2|Overall Study|Physician Decision|0
45817|NCT01413204|189600|P1|Overall Study|Physician Decision|3
45818|NCT01413204|189598|P3|Overall Study|Adverse Event|2
45819|NCT01413204|189599|P2|Overall Study|Adverse Event|2
45820|NCT01413204|189600|P1|Overall Study|Adverse Event|1
45821|NCT01413191|189608|P1|Overall Study|Death|1
45822|NCT01413191|189608|P1|Overall Study|Disease Progression|5
45823|NCT01413191|189608|P1|Overall Study|Lost to Follow-up|5
45824|NCT01412983|189612|P2|1st Period|Inability to maintain wear|1
45825|NCT01412983|189613|P1|1st Period|Inability to maintain wear|0
45826|NCT01412983|189612|P2|1st Period|Unacceptable lens movement|1
45827|NCT01412983|189613|P1|1st Period|Unacceptable lens movement|0
45828|NCT01412983|189612|P2|1st Period|Positive slit lamp finding|1
45829|NCT01412983|189613|P1|1st Period|Positive slit lamp finding|0
45830|NCT01412983|189612|P2|1st Period|Ineligible|1
45831|NCT01412983|189613|P1|1st Period|Ineligible|0
45832|NCT01412957|189623|P2|Overall Study|Death|133
45833|NCT01412957|189624|P1|Overall Study|Death|136
45834|NCT01412957|189623|P2|Overall Study|Lost to Follow-up|2
45835|NCT01412957|189624|P1|Overall Study|Lost to Follow-up|7
45836|NCT01412957|189623|P2|Overall Study|Withdrawal by Subject|22
45837|NCT01412957|189624|P1|Overall Study|Withdrawal by Subject|6
45838|NCT01412944|189646|P6|Entire: IV + Maintenance|Adverse Event|0
45839|NCT01412944|189647|P5|Entire: IV + Maintenance|Adverse Event|0
45840|NCT01412944|189648|P4|Entire: IV + Maintenance|Adverse Event|0
45841|NCT01412944|189649|P3|Entire: IV + Maintenance|Adverse Event|0
45842|NCT01412944|189650|P2|Entire: IV + Maintenance|Adverse Event|1
45843|NCT01412944|189651|P1|Entire: IV + Maintenance|Adverse Event|0
45844|NCT01412944|189646|P6|Entire: IV + Maintenance|Lack of Efficacy|0
45845|NCT01412944|189647|P5|Entire: IV + Maintenance|Lack of Efficacy|0
45846|NCT01412944|189648|P4|Entire: IV + Maintenance|Lack of Efficacy|0
45847|NCT01412944|189649|P3|Entire: IV + Maintenance|Lack of Efficacy|0
45848|NCT01412944|189650|P2|Entire: IV + Maintenance|Lack of Efficacy|1
45849|NCT01412944|189651|P1|Entire: IV + Maintenance|Lack of Efficacy|0
45850|NCT01412944|189646|P6|Entire: IV + Maintenance|Lost to Follow-up|0
45851|NCT01412944|189647|P5|Entire: IV + Maintenance|Lost to Follow-up|0
45852|NCT01412944|189648|P4|Entire: IV + Maintenance|Lost to Follow-up|0
45853|NCT01412944|189649|P3|Entire: IV + Maintenance|Lost to Follow-up|0
45854|NCT01412944|189650|P2|Entire: IV + Maintenance|Lost to Follow-up|1
45855|NCT01412944|189651|P1|Entire: IV + Maintenance|Lost to Follow-up|0
45856|NCT01412944|189646|P6|Entire: IV + Maintenance|Protocol deviation|0
45857|NCT01412944|189647|P5|Entire: IV + Maintenance|Protocol deviation|0
45858|NCT01412944|189648|P4|Entire: IV + Maintenance|Protocol deviation|0
45859|NCT01412944|189649|P3|Entire: IV + Maintenance|Protocol deviation|0
45860|NCT01412944|189650|P2|Entire: IV + Maintenance|Protocol deviation|1
45861|NCT01412944|189651|P1|Entire: IV + Maintenance|Protocol deviation|0
45862|NCT01412944|189646|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
45863|NCT01412944|189647|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
45864|NCT01412944|189648|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
45865|NCT01412944|189649|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
45866|NCT01412944|189650|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
45867|NCT01412944|189651|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
45868|NCT01412944|189646|P6|Entire: IV + Maintenance|Lack of Efficacy|0
45869|NCT01412944|189647|P5|Entire: IV + Maintenance|Lack of Efficacy|1
45870|NCT01412944|189648|P4|Entire: IV + Maintenance|Lack of Efficacy|0
45871|NCT01412944|189649|P3|Entire: IV + Maintenance|Lack of Efficacy|0
45872|NCT01412944|189650|P2|Entire: IV + Maintenance|Lack of Efficacy|0
45873|NCT01412944|189651|P1|Entire: IV + Maintenance|Lack of Efficacy|0
45874|NCT01412944|189646|P6|Entire: IV + Maintenance|Lost to Follow-up|1
45875|NCT01412944|189647|P5|Entire: IV + Maintenance|Lost to Follow-up|0
45876|NCT01412944|189648|P4|Entire: IV + Maintenance|Lost to Follow-up|0
45877|NCT01412944|189649|P3|Entire: IV + Maintenance|Lost to Follow-up|0
45878|NCT01412944|189650|P2|Entire: IV + Maintenance|Lost to Follow-up|0
45879|NCT01412944|189651|P1|Entire: IV + Maintenance|Lost to Follow-up|0
45880|NCT01412944|189646|P6|Entire: IV + Maintenance|Protocol deviation|1
45881|NCT01412944|189647|P5|Entire: IV + Maintenance|Protocol deviation|0
45882|NCT01412944|189648|P4|Entire: IV + Maintenance|Protocol deviation|0
45883|NCT01412944|189649|P3|Entire: IV + Maintenance|Protocol deviation|0
45884|NCT01412944|189650|P2|Entire: IV + Maintenance|Protocol deviation|0
45885|NCT01412944|189651|P1|Entire: IV + Maintenance|Protocol deviation|0
45886|NCT01412944|189646|P6|Entire: IV + Maintenance|Adverse Event|0
45887|NCT01412944|189647|P5|Entire: IV + Maintenance|Adverse Event|1
45888|NCT01412944|189648|P4|Entire: IV + Maintenance|Adverse Event|0
45889|NCT01412944|189649|P3|Entire: IV + Maintenance|Adverse Event|0
45890|NCT01412944|189650|P2|Entire: IV + Maintenance|Adverse Event|0
45891|NCT01412944|189651|P1|Entire: IV + Maintenance|Adverse Event|0
45892|NCT01412944|189646|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
45893|NCT01412944|189647|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
45894|NCT01412944|189648|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
45895|NCT01412944|189649|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
45896|NCT01412944|189650|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
45897|NCT01412944|189651|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
45898|NCT01412944|189646|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
45899|NCT01412944|189647|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
45900|NCT01412944|189648|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
45901|NCT01412944|189649|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
45902|NCT01412944|189650|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
45903|NCT01412944|189651|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
45904|NCT01412944|189646|P6|IV: Per CAIN457A2307|Protocol deviation|0
45905|NCT01412944|189647|P5|IV: Per CAIN457A2307|Protocol deviation|0
45906|NCT01412944|189648|P4|IV: Per CAIN457A2307|Protocol deviation|0
45907|NCT01412944|189649|P3|IV: Per CAIN457A2307|Protocol deviation|0
45908|NCT01412944|189650|P2|IV: Per CAIN457A2307|Protocol deviation|1
45909|NCT01412944|189651|P1|IV: Per CAIN457A2307|Protocol deviation|0
45910|NCT01412944|189646|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
45911|NCT01412944|189647|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
45912|NCT01412944|189648|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
45913|NCT01412944|189649|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
45914|NCT01412944|189650|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
45915|NCT01412944|189651|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
45916|NCT01412944|189646|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
45917|NCT01412944|189647|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
45918|NCT01412944|189648|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
45919|NCT01412944|189649|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
45920|NCT01412944|189650|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
45921|NCT01412944|189651|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
45922|NCT01412944|189646|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
45923|NCT01412944|189647|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
45924|NCT01412944|189648|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
45925|NCT01412944|189649|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
45926|NCT01412944|189650|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
45927|NCT01412944|189651|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
45928|NCT01412944|189646|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
45929|NCT01412944|189647|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
45930|NCT01412944|189648|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
45931|NCT01412944|189649|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
45932|NCT01412944|189650|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
45933|NCT01412944|189651|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
45934|NCT01412879|189697|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
45935|NCT01412879|189698|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
45936|NCT01412879|189699|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
45937|NCT01412879|189697|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
45938|NCT01412879|189698|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
45939|NCT01412879|189699|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
45940|NCT01412879|189697|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
45941|NCT01412879|189698|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
45942|NCT01412879|189699|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
45943|NCT01412879|189697|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
45944|NCT01412879|189698|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
45945|NCT01412879|189699|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
45946|NCT01412879|189697|P3|Initial Registration (Induction Therapy)|Adverse Event|0
45947|NCT01412879|189698|P2|Initial Registration (Induction Therapy)|Adverse Event|3
45948|NCT01412879|189699|P1|Initial Registration (Induction Therapy)|Adverse Event|5
45949|NCT01412801|189719|P6|Overall Study|Relocated to another area|0
45950|NCT01412801|189720|P5|Overall Study|Relocated to another area|0
45951|NCT01412801|189721|P4|Overall Study|Relocated to another area|0
45952|NCT01412801|189722|P3|Overall Study|Relocated to another area|2
45953|NCT01412801|189723|P2|Overall Study|Relocated to another area|0
45954|NCT01412801|189724|P1|Overall Study|Relocated to another area|0
45955|NCT01412801|189719|P6|Overall Study|Withdrawal by Subject|0
45956|NCT01412801|189720|P5|Overall Study|Withdrawal by Subject|0
45957|NCT01412801|189721|P4|Overall Study|Withdrawal by Subject|0
45958|NCT01412801|189722|P3|Overall Study|Withdrawal by Subject|1
45959|NCT01412801|189723|P2|Overall Study|Withdrawal by Subject|2
45960|NCT01412801|189724|P1|Overall Study|Withdrawal by Subject|3
45961|NCT01412801|189719|P6|Overall Study|Lost to Follow-up|1
45962|NCT01412801|189720|P5|Overall Study|Lost to Follow-up|1
45963|NCT01412801|189721|P4|Overall Study|Lost to Follow-up|0
45964|NCT01412801|189722|P3|Overall Study|Lost to Follow-up|4
45965|NCT01412801|189723|P2|Overall Study|Lost to Follow-up|2
45966|NCT01412801|189724|P1|Overall Study|Lost to Follow-up|1
45967|NCT01412801|189719|P6|Overall Study|Death|2
45968|NCT01412801|189720|P5|Overall Study|Death|2
45969|NCT01412801|189721|P4|Overall Study|Death|4
45970|NCT01412801|189722|P3|Overall Study|Death|0
45971|NCT01412801|189723|P2|Overall Study|Death|1
45972|NCT01412801|189724|P1|Overall Study|Death|0
45973|NCT01412424|189872|P1|Extension Treatment Period|Patient Request|2
45974|NCT01412424|189872|P1|Extension Treatment Period|Treatment Failure|2
45975|NCT01412424|189872|P1|Extension Treatment Period|Adverse Event|2
45976|NCT01412424|189872|P1|Core Treatment Period|Sponsor Request|1
45977|NCT01412424|189872|P1|Core Treatment Period|Lost to Follow-up|2
45978|NCT01412424|189872|P1|Core Treatment Period|Patient Request|5
45979|NCT01412424|189872|P1|Core Treatment Period|Adverse Event|21
45980|NCT01412424|189872|P1|Core Treatment Period|Treatment Failure|24
45981|NCT01412333|189890|P2|Overall Study|Lost to Follow-up|6
45982|NCT01412333|189891|P1|Overall Study|Lost to Follow-up|10
45983|NCT01412333|189890|P2|Overall Study|Adverse Event|16
45984|NCT01412333|189891|P1|Overall Study|Adverse Event|25
45985|NCT01412333|189890|P2|Overall Study|Consent withdrawn by participant|12
45986|NCT01412333|189891|P1|Overall Study|Consent withdrawn by participant|25
45987|NCT01412333|189890|P2|Overall Study|Pregnancy|0
45988|NCT01412333|189891|P1|Overall Study|Pregnancy|3
45989|NCT01412333|189890|P2|Overall Study|Lack of Efficacy|6
45990|NCT01412333|189891|P1|Overall Study|Lack of Efficacy|15
45991|NCT01412333|189890|P2|Overall Study|Non-compliance|3
45992|NCT01412333|189891|P1|Overall Study|Non-compliance|1
45993|NCT01412333|189890|P2|Overall Study|Protocol Violation|1
45994|NCT01412333|189891|P1|Overall Study|Protocol Violation|1
45995|NCT01412333|189890|P2|Overall Study|Non-compliance with study drug|1
45996|NCT01412333|189891|P1|Overall Study|Non-compliance with study drug|1
45997|NCT01412333|189890|P2|Overall Study|Reason not specified|10
45998|NCT01412333|189891|P1|Overall Study|Reason not specified|16
45999|NCT01412333|189890|P2|Overall Study|Physician Decision|1
46000|NCT01412333|189891|P1|Overall Study|Physician Decision|0
46001|NCT01412333|189890|P2|Overall Study|Death|1
46002|NCT01412333|189891|P1|Overall Study|Death|1
46003|NCT01412229|189951|P1|Overall Study|Physician Decision|1
46004|NCT01412151|189967|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
46005|NCT01412151|189967|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
46006|NCT01412151|189967|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
46007|NCT01412151|189967|P1|Week 0 - 306 - Treatment Period|Death|1
46008|NCT01411891|189978|P2|Overall Study|Catheter dislodgement or loss to follow-|2
46009|NCT01411891|189979|P1|Overall Study|Catheter dislodgement or loss to follow-|3
46010|NCT01411852|189987|P2|Hospital Intervention Phase|Vascular access failed|0
46011|NCT01411852|189988|P1|Hospital Intervention Phase|Vascular access failed|1
46012|NCT01411852|189987|P2|Hospital Intervention Phase|Withdrawal by Subject|0
46013|NCT01411852|189988|P1|Hospital Intervention Phase|Withdrawal by Subject|1
46014|NCT01411852|189987|P2|Hospital Intervention Phase|Spinal cord injury|0
46015|NCT01411852|189988|P1|Hospital Intervention Phase|Spinal cord injury|2
46016|NCT01411852|189987|P2|Hospital Intervention Phase|Other ineligible|2
46017|NCT01411852|189988|P1|Hospital Intervention Phase|Other ineligible|2
46018|NCT01411852|189987|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
46019|NCT01411852|189988|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
46020|NCT01411852|189987|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
46021|NCT01411852|189988|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
46022|NCT01411852|189987|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
46023|NCT01411852|189988|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
46024|NCT01411852|189987|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
46025|NCT01411852|189988|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
46026|NCT01411852|189987|P2|Hospital Intervention Phase|CPR administered|1
46027|NCT01411852|189988|P1|Hospital Intervention Phase|CPR administered|3
46028|NCT01411852|189987|P2|Hospital Intervention Phase|Miscommunication error|2
46029|NCT01411852|189988|P1|Hospital Intervention Phase|Miscommunication error|1
46030|NCT01411852|189987|P2|Hospital Intervention Phase|No qualifying SBP|1
46031|NCT01411852|189988|P1|Hospital Intervention Phase|No qualifying SBP|5
46032|NCT01411852|189987|P2|Hospital Intervention Phase|Severe head injury|4
46033|NCT01411852|189988|P1|Hospital Intervention Phase|Severe head injury|5
46034|NCT01411852|189987|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
46035|NCT01411852|189988|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
46036|NCT01411852|189987|P2|Prehospital Intervention Phase|Found to be under age|1
46037|NCT01411852|189988|P1|Prehospital Intervention Phase|Found to be under age|0
46038|NCT01411852|189987|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
46039|NCT01411852|189988|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
46040|NCT01411852|189987|P2|Prehospital Intervention Phase|No qualifying SBP|4
46041|NCT01411852|189988|P1|Prehospital Intervention Phase|No qualifying SBP|5
46042|NCT01411228|190089|P3|Overall Study|Withdrawal by Subject|0
46043|NCT01411228|190090|P2|Overall Study|Withdrawal by Subject|0
46044|NCT01411228|190091|P1|Overall Study|Withdrawal by Subject|1
46045|NCT01411228|190089|P3|Overall Study|Lost to Follow-up|1
46046|NCT01411228|190090|P2|Overall Study|Lost to Follow-up|0
46047|NCT01411228|190091|P1|Overall Study|Lost to Follow-up|0
46048|NCT01411215|190113|P2|Overall Study|Screen failure|1
46049|NCT01411215|190114|P1|Overall Study|Screen failure|0
46050|NCT01411215|190113|P2|Overall Study|Unspecified|17
46051|NCT01411215|190114|P1|Overall Study|Unspecified|12
46052|NCT01411215|190113|P2|Overall Study|Withdrawal by Subject|21
46053|NCT01411215|190114|P1|Overall Study|Withdrawal by Subject|34
46054|NCT01411215|190113|P2|Overall Study|Protocol Violation|5
46055|NCT01411215|190114|P1|Overall Study|Protocol Violation|3
46056|NCT01411215|190113|P2|Overall Study|Study terminated by sponsor|15
46057|NCT01411215|190114|P1|Overall Study|Study terminated by sponsor|2
46058|NCT01411215|190113|P2|Overall Study|Did not meet entrance criteria|1
46059|NCT01411215|190114|P1|Overall Study|Did not meet entrance criteria|0
46060|NCT01411215|190113|P2|Overall Study|Lost to Follow-up|18
46061|NCT01411215|190114|P1|Overall Study|Lost to Follow-up|12
46062|NCT01411215|190113|P2|Overall Study|Lack of Efficacy|4
46063|NCT01411215|190114|P1|Overall Study|Lack of Efficacy|2
46064|NCT01411215|190113|P2|Overall Study|Adverse Event|2
46065|NCT01411215|190114|P1|Overall Study|Adverse Event|1
46066|NCT01410604|190173|P2|Overall Study|Physician Decision|1
46067|NCT01410604|190174|P1|Overall Study|Physician Decision|0
46068|NCT01410604|190173|P2|Overall Study|Lost to Follow-up|0
46069|NCT01410604|190174|P1|Overall Study|Lost to Follow-up|1
46070|NCT01410604|190173|P2|Overall Study|Adverse Event|1
46071|NCT01410604|190174|P1|Overall Study|Adverse Event|2
46072|NCT01410474|190210|P2|Overall Study|Withdrawal by Subject|1
46073|NCT01410474|190211|P1|Overall Study|Withdrawal by Subject|0
46074|NCT01410448|190234|P2|Overall Study|Death|3
46075|NCT01410448|190235|P1|Overall Study|Death|2
46076|NCT01410448|190234|P2|Overall Study|Protocol Violation|4
46077|NCT01410448|190235|P1|Overall Study|Protocol Violation|0
46078|NCT01410448|190234|P2|Overall Study|Withdrawal by Subject|2
46079|NCT01410448|190235|P1|Overall Study|Withdrawal by Subject|3
46080|NCT01410448|190234|P2|Overall Study|Lost to Follow-up|0
46081|NCT01410448|190235|P1|Overall Study|Lost to Follow-up|1
46082|NCT01410448|190234|P2|Overall Study|Administrative issues|1
46083|NCT01410448|190235|P1|Overall Study|Administrative issues|2
46084|NCT01410448|190234|P2|Overall Study|Graft loss|1
46085|NCT01410448|190235|P1|Overall Study|Graft loss|4
46086|NCT01410448|190234|P2|Overall Study|No conversion to everolimus|24
46087|NCT01410448|190235|P1|Overall Study|No conversion to everolimus|0
46088|NCT01410240|190301|P3|Overall Study|Missed week 6 assessments|1
46089|NCT01410240|190302|P2|Overall Study|Missed week 6 assessments|1
46090|NCT01410240|190303|P1|Overall Study|Missed week 6 assessments|1
46091|NCT01410240|190301|P3|Overall Study|Physician Decision|1
46092|NCT01410240|190302|P2|Overall Study|Physician Decision|0
46093|NCT01410240|190303|P1|Overall Study|Physician Decision|0
46094|NCT01410227|190374|P4|Overall Study|Met Excl. Criteria After Starting Study|0
46095|NCT01410227|190375|P3|Overall Study|Met Excl. Criteria After Starting Study|1
46096|NCT01410227|190376|P2|Overall Study|Met Excl. Criteria After Starting Study|0
46097|NCT01410227|190377|P1|Overall Study|Met Excl. Criteria After Starting Study|0
46098|NCT01410227|190374|P4|Overall Study|Pregnancy|1
46099|NCT01410227|190375|P3|Overall Study|Pregnancy|0
46100|NCT01410227|190376|P2|Overall Study|Pregnancy|0
46101|NCT01410227|190377|P1|Overall Study|Pregnancy|0
46102|NCT01410227|190374|P4|Overall Study|Withdrawal by Subject|0
46103|NCT01410227|190375|P3|Overall Study|Withdrawal by Subject|1
46104|NCT01410227|190376|P2|Overall Study|Withdrawal by Subject|0
46105|NCT01410227|190377|P1|Overall Study|Withdrawal by Subject|3
46106|NCT01410227|190374|P4|Overall Study|Adverse Event|0
46107|NCT01410227|190375|P3|Overall Study|Adverse Event|0
46108|NCT01410227|190376|P2|Overall Study|Adverse Event|0
46109|NCT01410227|190377|P1|Overall Study|Adverse Event|1
46110|NCT01410110|190449|P2|Overall Study|Withdrawal by Subject|2
46111|NCT01410110|190450|P1|Overall Study|Withdrawal by Subject|4
46112|NCT01409993|190474|P4|Overall Study|Lost to Follow-up|0
46113|NCT01409993|190475|P3|Overall Study|Lost to Follow-up|0
46114|NCT01409993|190476|P2|Overall Study|Lost to Follow-up|1
46115|NCT01409993|190477|P1|Overall Study|Lost to Follow-up|0
46116|NCT01409993|190474|P4|Overall Study|Withdrawal by Subject|4
46117|NCT01409993|190475|P3|Overall Study|Withdrawal by Subject|0
46118|NCT01409993|190476|P2|Overall Study|Withdrawal by Subject|0
46119|NCT01409993|190477|P1|Overall Study|Withdrawal by Subject|0
46120|NCT01409993|190474|P4|Overall Study|Adverse Event|1
46121|NCT01409993|190475|P3|Overall Study|Adverse Event|3
46122|NCT01409993|190476|P2|Overall Study|Adverse Event|4
46123|NCT01409993|190477|P1|Overall Study|Adverse Event|4
46124|NCT01409837|190497|P2|Overall Study|Physician Decision|1
46125|NCT01409837|190498|P1|Overall Study|Physician Decision|0
46126|NCT01409837|190497|P2|Overall Study|Lost to Follow-up|0
46127|NCT01409837|190498|P1|Overall Study|Lost to Follow-up|1
46128|NCT01409837|190497|P2|Overall Study|Withdrawal by Subject|1
46129|NCT01409837|190498|P1|Overall Study|Withdrawal by Subject|2
46130|NCT01409707|190523|P3|Overall Study|Withdrawal by Subject|16
46131|NCT01409707|190524|P2|Overall Study|Withdrawal by Subject|17
46132|NCT01409707|190525|P1|Overall Study|Withdrawal by Subject|5
46133|NCT01409564|190537|P2|Overall Study|brain abnormalities found in T1 MR|2
46134|NCT01409564|190538|P1|Overall Study|brain abnormalities found in T1 MR|1
46135|NCT01409564|190537|P2|Overall Study|low medication compliance|3
46136|NCT01409564|190538|P1|Overall Study|low medication compliance|4
46137|NCT01409434|190556|P1|Overall Study|Protocol Violation|4
46138|NCT01409382|190566|P2|Overall Study|Had a 2nd trimester loss after accident|0
46139|NCT01409382|190567|P1|Overall Study|Had a 2nd trimester loss after accident|1
46140|NCT01409382|190566|P2|Overall Study|Did not manage to get pregnant|70
46141|NCT01409382|190567|P1|Overall Study|Did not manage to get pregnant|64
46142|NCT01409382|190566|P2|Overall Study|Still pregnant when study ended|2
46143|NCT01409382|190567|P1|Overall Study|Still pregnant when study ended|13
46144|NCT01409382|190566|P2|Overall Study|Multiple pregnancy|4
46145|NCT01409382|190567|P1|Overall Study|Multiple pregnancy|2
46146|NCT01409382|190566|P2|Overall Study|Protocol Violation|3
46147|NCT01409382|190567|P1|Overall Study|Protocol Violation|0
46148|NCT01409382|190566|P2|Overall Study|Lost to Follow-up|1
46149|NCT01409382|190567|P1|Overall Study|Lost to Follow-up|1
46150|NCT01408914|190634|P3|Overall Study|Change in local TB/HIV norms|1
46151|NCT01408914|190635|P2|Overall Study|Change in local TB/HIV norms|1
46152|NCT01408914|190636|P1|Overall Study|Change in local TB/HIV norms|0
46153|NCT01408914|190634|P3|Overall Study|Late exclusion|3
46154|NCT01408914|190635|P2|Overall Study|Late exclusion|3
46155|NCT01408914|190636|P1|Overall Study|Late exclusion|0
46156|NCT01408914|190634|P3|Overall Study|Moved out of study jurisdiction|0
46157|NCT01408914|190635|P2|Overall Study|Moved out of study jurisdiction|1
46158|NCT01408914|190636|P1|Overall Study|Moved out of study jurisdiction|1
46159|NCT01408914|190634|P3|Overall Study|Withdrawal by Subject|1
46160|NCT01408914|190635|P2|Overall Study|Withdrawal by Subject|0
46161|NCT01408914|190636|P1|Overall Study|Withdrawal by Subject|1
46162|NCT01408914|190634|P3|Overall Study|Physician Decision|0
46163|NCT01408914|190635|P2|Overall Study|Physician Decision|1
46164|NCT01408914|190636|P1|Overall Study|Physician Decision|1
46165|NCT01408914|190634|P3|Overall Study|Lost to Follow-up|2
46166|NCT01408914|190635|P2|Overall Study|Lost to Follow-up|1
46167|NCT01408914|190636|P1|Overall Study|Lost to Follow-up|4
46168|NCT01408914|190634|P3|Overall Study|Could not complete tx in protocol period|6
46169|NCT01408914|190635|P2|Overall Study|Could not complete tx in protocol period|5
46170|NCT01408914|190636|P1|Overall Study|Could not complete tx in protocol period|5
46171|NCT01408888|190650|P2|Second Intervention|Adverse Event|0
46172|NCT01408888|190651|P1|Second Intervention|Adverse Event|1
46173|NCT01408888|190650|P2|Second Intervention|Withdrawal by Subject|0
46174|NCT01408888|190651|P1|Second Intervention|Withdrawal by Subject|1
46175|NCT01408888|190650|P2|First Intervention|Withdrawal by Subject|2
46176|NCT01408888|190651|P1|First Intervention|Withdrawal by Subject|0
46177|NCT01408888|190650|P2|First Intervention|Adverse Event|1
46178|NCT01408888|190651|P1|First Intervention|Adverse Event|0
46179|NCT01408706|190730|P2|Overall Study|Physician Decision|0
46180|NCT01408706|190731|P1|Overall Study|Physician Decision|1
46181|NCT01408628|190741|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
46182|NCT01408628|190741|P1|Completed 6 Month Follow-Up|Protocol Violation|6
46183|NCT01408628|190741|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
46184|NCT01408628|190741|P1|Consented|Withdrawal by Subject|12
46185|NCT01408537|190747|P1|Overall Study|Lost to Follow-up|3
46186|NCT01408537|190747|P1|Overall Study|Protocol Violation|3
46187|NCT01408537|190747|P1|Overall Study|Withdrawal by Subject|2
46188|NCT01408485|190763|P1|Overall Study|Withdrawal by Subject|21
46189|NCT01408303|190781|P3|Overall Study|Noncompliance|1
46190|NCT01408303|190782|P2|Overall Study|Noncompliance|0
46191|NCT01408303|190783|P1|Overall Study|Noncompliance|1
46192|NCT01408303|190781|P3|Overall Study|Protocol Violation|0
46193|NCT01408303|190782|P2|Overall Study|Protocol Violation|1
46194|NCT01408303|190783|P1|Overall Study|Protocol Violation|0
46195|NCT01408303|190781|P3|Overall Study|Withdrawal by Subject|1
46196|NCT01408303|190782|P2|Overall Study|Withdrawal by Subject|3
46197|NCT01408303|190783|P1|Overall Study|Withdrawal by Subject|2
46198|NCT01408303|190781|P3|Overall Study|Lost to Follow-up|2
46199|NCT01408303|190782|P2|Overall Study|Lost to Follow-up|1
46200|NCT01408303|190783|P1|Overall Study|Lost to Follow-up|0
46201|NCT01408303|190781|P3|Overall Study|Adverse Event|2
46202|NCT01408303|190782|P2|Overall Study|Adverse Event|7
46203|NCT01408303|190783|P1|Overall Study|Adverse Event|3
46204|NCT01408277|190793|P2|Overall Study|Protocol Violation|0
46205|NCT01408277|190794|P1|Overall Study|Protocol Violation|2
46206|NCT01408277|190793|P2|Overall Study|Withdrawal by Subject|0
46207|NCT01408277|190794|P1|Overall Study|Withdrawal by Subject|2
46208|NCT01408277|190793|P2|Overall Study|Lost to Follow-up|0
46209|NCT01408277|190794|P1|Overall Study|Lost to Follow-up|1
46210|NCT01408277|190793|P2|Overall Study|Adverse Event|4
46211|NCT01408277|190794|P1|Overall Study|Adverse Event|3
46212|NCT01407354|190831|P2|First Intervention|Physician Decision|0
46213|NCT01407354|190832|P1|First Intervention|Physician Decision|1
46214|NCT01407354|190831|P2|First Intervention|Adverse Event|0
46215|NCT01407354|190832|P1|First Intervention|Adverse Event|1
46216|NCT01407354|190831|P2|First Intervention|Withdrawal by Subject|2
46217|NCT01407354|190832|P1|First Intervention|Withdrawal by Subject|0
46218|NCT01407276|190848|P8|Overall Study|Withdrawal by Subject|1
46219|NCT01407276|190849|P7|Overall Study|Withdrawal by Subject|0
46220|NCT01407276|190850|P6|Overall Study|Withdrawal by Subject|0
46221|NCT01407276|190851|P5|Overall Study|Withdrawal by Subject|0
46222|NCT01407276|190852|P4|Overall Study|Withdrawal by Subject|0
46223|NCT01407276|190853|P3|Overall Study|Withdrawal by Subject|0
46224|NCT01407276|190854|P2|Overall Study|Withdrawal by Subject|0
46225|NCT01407276|190855|P1|Overall Study|Withdrawal by Subject|0
46226|NCT01406938|190994|P6|Follow up|Lost to Follow-up|1
46227|NCT01406938|190995|P5|Follow up|Lost to Follow-up|2
46228|NCT01406938|190996|P4|Follow up|Lost to Follow-up|1
46229|NCT01406938|190997|P3|Follow up|Lost to Follow-up|0
46230|NCT01406938|190998|P2|Follow up|Lost to Follow-up|1
46231|NCT01406938|190999|P1|Follow up|Lost to Follow-up|1
46232|NCT01406938|190994|P6|Follow up|Physician Decision|1
46233|NCT01406938|190995|P5|Follow up|Physician Decision|3
46234|NCT01406938|190996|P4|Follow up|Physician Decision|0
46235|NCT01406938|190997|P3|Follow up|Physician Decision|2
46236|NCT01406938|190998|P2|Follow up|Physician Decision|0
46237|NCT01406938|190999|P1|Follow up|Physician Decision|0
46238|NCT01406938|190994|P6|Follow up|Protocol Violation|0
46239|NCT01406938|190995|P5|Follow up|Protocol Violation|0
46240|NCT01406938|190996|P4|Follow up|Protocol Violation|0
46241|NCT01406938|190997|P3|Follow up|Protocol Violation|1
46242|NCT01406938|190998|P2|Follow up|Protocol Violation|0
46243|NCT01406938|190999|P1|Follow up|Protocol Violation|0
46244|NCT01406938|190994|P6|Follow up|Patient/guardian decision|1
46245|NCT01406938|190995|P5|Follow up|Patient/guardian decision|4
46246|NCT01406938|190996|P4|Follow up|Patient/guardian decision|2
46247|NCT01406938|190997|P3|Follow up|Patient/guardian decision|4
46248|NCT01406938|190998|P2|Follow up|Patient/guardian decision|2
46249|NCT01406938|190999|P1|Follow up|Patient/guardian decision|4
46250|NCT01406938|190994|P6|Follow up|Lack of Efficacy|0
46251|NCT01406938|190995|P5|Follow up|Lack of Efficacy|0
46252|NCT01406938|190996|P4|Follow up|Lack of Efficacy|0
46253|NCT01406938|190997|P3|Follow up|Lack of Efficacy|1
46254|NCT01406938|190998|P2|Follow up|Lack of Efficacy|2
46255|NCT01406938|190999|P1|Follow up|Lack of Efficacy|3
46256|NCT01406938|190994|P6|Maintenance Period|Lack of Efficacy|5
46257|NCT01406938|190995|P5|Maintenance Period|Lack of Efficacy|3
46258|NCT01406938|190996|P4|Maintenance Period|Lack of Efficacy|1
46259|NCT01406938|190997|P3|Maintenance Period|Lack of Efficacy|2
46260|NCT01406938|190998|P2|Maintenance Period|Lack of Efficacy|0
46261|NCT01406938|190999|P1|Maintenance Period|Lack of Efficacy|0
46262|NCT01406938|190994|P6|Maintenance Period|Lost to Follow-up|0
46263|NCT01406938|190995|P5|Maintenance Period|Lost to Follow-up|4
46264|NCT01406938|190996|P4|Maintenance Period|Lost to Follow-up|0
46265|NCT01406938|190997|P3|Maintenance Period|Lost to Follow-up|0
46266|NCT01406938|190998|P2|Maintenance Period|Lost to Follow-up|0
46267|NCT01406938|190999|P1|Maintenance Period|Lost to Follow-up|0
46268|NCT01406938|190994|P6|Maintenance Period|Pregnancy|0
46269|NCT01406938|190995|P5|Maintenance Period|Pregnancy|1
46270|NCT01406938|190996|P4|Maintenance Period|Pregnancy|0
46271|NCT01406938|190997|P3|Maintenance Period|Pregnancy|0
46272|NCT01406938|190998|P2|Maintenance Period|Pregnancy|0
46273|NCT01406938|190999|P1|Maintenance Period|Pregnancy|0
46274|NCT01406938|190994|P6|Maintenance Period|Protocol Violation|2
46275|NCT01406938|190995|P5|Maintenance Period|Protocol Violation|2
46276|NCT01406938|190996|P4|Maintenance Period|Protocol Violation|2
46277|NCT01406938|190997|P3|Maintenance Period|Protocol Violation|2
46278|NCT01406938|190998|P2|Maintenance Period|Protocol Violation|0
46279|NCT01406938|190999|P1|Maintenance Period|Protocol Violation|0
46280|NCT01406938|190994|P6|Maintenance Period|Subject/guardian decision|7
46281|NCT01406938|190995|P5|Maintenance Period|Subject/guardian decision|10
46282|NCT01406938|190996|P4|Maintenance Period|Subject/guardian decision|7
46283|NCT01406938|190997|P3|Maintenance Period|Subject/guardian decision|11
46284|NCT01406938|190998|P2|Maintenance Period|Subject/guardian decision|0
46285|NCT01406938|190999|P1|Maintenance Period|Subject/guardian decision|0
46286|NCT01406938|190994|P6|Maintenance Period|Death|0
46287|NCT01406938|190995|P5|Maintenance Period|Death|1
46288|NCT01406938|190996|P4|Maintenance Period|Death|0
46289|NCT01406938|190997|P3|Maintenance Period|Death|0
46290|NCT01406938|190998|P2|Maintenance Period|Death|0
46291|NCT01406938|190999|P1|Maintenance Period|Death|0
46292|NCT01406938|190994|P6|Maintenance Period|Adverse Event|2
46293|NCT01406938|190995|P5|Maintenance Period|Adverse Event|4
46294|NCT01406938|190996|P4|Maintenance Period|Adverse Event|8
46295|NCT01406938|190997|P3|Maintenance Period|Adverse Event|2
46296|NCT01406938|190998|P2|Maintenance Period|Adverse Event|0
46297|NCT01406938|190999|P1|Maintenance Period|Adverse Event|0
46298|NCT01406938|190994|P6|Induction Period|Lost to Follow-up|0
46299|NCT01406938|190995|P5|Induction Period|Lost to Follow-up|0
46300|NCT01406938|190996|P4|Induction Period|Lost to Follow-up|0
46301|NCT01406938|190997|P3|Induction Period|Lost to Follow-up|0
46302|NCT01406938|190998|P2|Induction Period|Lost to Follow-up|3
46303|NCT01406938|190999|P1|Induction Period|Lost to Follow-up|2
46304|NCT01406938|190994|P6|Induction Period|Lack of Efficacy|0
46305|NCT01406938|190995|P5|Induction Period|Lack of Efficacy|0
46306|NCT01406938|190996|P4|Induction Period|Lack of Efficacy|0
46307|NCT01406938|190997|P3|Induction Period|Lack of Efficacy|0
46308|NCT01406938|190998|P2|Induction Period|Lack of Efficacy|0
46309|NCT01406938|190999|P1|Induction Period|Lack of Efficacy|1
46310|NCT01406938|190994|P6|Induction Period|Adverse Event|0
46311|NCT01406938|190995|P5|Induction Period|Adverse Event|0
46312|NCT01406938|190996|P4|Induction Period|Adverse Event|0
46313|NCT01406938|190997|P3|Induction Period|Adverse Event|0
46314|NCT01406938|190998|P2|Induction Period|Adverse Event|9
46315|NCT01406938|190999|P1|Induction Period|Adverse Event|8
46316|NCT01406938|190994|P6|Induction Period|Protocol deviation|0
46317|NCT01406938|190995|P5|Induction Period|Protocol deviation|0
46318|NCT01406938|190996|P4|Induction Period|Protocol deviation|0
46319|NCT01406938|190997|P3|Induction Period|Protocol deviation|0
46320|NCT01406938|190998|P2|Induction Period|Protocol deviation|0
46321|NCT01406938|190999|P1|Induction Period|Protocol deviation|1
46322|NCT01406938|190994|P6|Induction Period|Subject/guardian decision|0
46323|NCT01406938|190995|P5|Induction Period|Subject/guardian decision|0
46324|NCT01406938|190996|P4|Induction Period|Subject/guardian decision|0
46325|NCT01406938|190997|P3|Induction Period|Subject/guardian decision|0
46326|NCT01406938|190998|P2|Induction Period|Subject/guardian decision|8
46327|NCT01406938|190999|P1|Induction Period|Subject/guardian decision|6
46328|NCT01406795|191115|P1|Overall Study|Withdrawal by Subject|1
46329|NCT01406574|191129|P4|Overall Study|Definite progression of primary disease|0
46330|NCT01406574|191130|P3|Overall Study|Definite progression of primary disease|0
46331|NCT01406574|191131|P2|Overall Study|Definite progression of primary disease|0
46332|NCT01406574|191132|P1|Overall Study|Definite progression of primary disease|1
46333|NCT01406574|191129|P4|Overall Study|Withdrawal by Subject|0
46334|NCT01406574|191130|P3|Overall Study|Withdrawal by Subject|0
46335|NCT01406574|191131|P2|Overall Study|Withdrawal by Subject|1
46336|NCT01406574|191132|P1|Overall Study|Withdrawal by Subject|0
46337|NCT01406574|191129|P4|Overall Study|Physician Decision|1
46338|NCT01406574|191130|P3|Overall Study|Physician Decision|0
46339|NCT01406574|191131|P2|Overall Study|Physician Decision|0
46340|NCT01406574|191132|P1|Overall Study|Physician Decision|0
46341|NCT01406574|191129|P4|Overall Study|Adverse Event|3
46342|NCT01406574|191130|P3|Overall Study|Adverse Event|1
46343|NCT01406574|191131|P2|Overall Study|Adverse Event|0
46344|NCT01406574|191132|P1|Overall Study|Adverse Event|0
46345|NCT01406015|191167|P2|Overall Study|Withdrawal by Subject|3
46346|NCT01406015|191168|P1|Overall Study|Withdrawal by Subject|3
46347|NCT01405950|191184|P4|Overall Study|Withdrawal by Subject|0
46348|NCT01405950|191185|P3|Overall Study|Withdrawal by Subject|0
46349|NCT01405950|191186|P2|Overall Study|Withdrawal by Subject|0
46350|NCT01405950|191187|P1|Overall Study|Withdrawal by Subject|1
46351|NCT01405924|191222|P1|Overall Study|Missing/Incomplete Data|2
46352|NCT01405924|191222|P1|Overall Study|Protocol Violation|8
46353|NCT01405898|191234|P2|Overall Study|Withdrawal by Subject|2
46354|NCT01405898|191235|P1|Overall Study|Withdrawal by Subject|2
46355|NCT01405820|191259|P6|Open-Label Treatment Period|Adverse Event|0
46356|NCT01405820|191260|P5|Open-Label Treatment Period|Adverse Event|0
46357|NCT01405820|191261|P4|Open-Label Treatment Period|Adverse Event|1
46358|NCT01405820|191262|P3|Open-Label Treatment Period|Adverse Event|0
46359|NCT01405820|191263|P2|Open-Label Treatment Period|Adverse Event|0
46360|NCT01405820|191264|P1|Open-Label Treatment Period|Adverse Event|0
46361|NCT01405820|191259|P6|Open-Label Treatment Period|Physician Decision|0
46362|NCT01405820|191260|P5|Open-Label Treatment Period|Physician Decision|1
46363|NCT01405820|191261|P4|Open-Label Treatment Period|Physician Decision|2
46364|NCT01405820|191262|P3|Open-Label Treatment Period|Physician Decision|1
46365|NCT01405820|191263|P2|Open-Label Treatment Period|Physician Decision|0
46366|NCT01405820|191264|P1|Open-Label Treatment Period|Physician Decision|0
46367|NCT01405820|191259|P6|Open-Label Treatment Period|Not Specified|1
46368|NCT01405820|191260|P5|Open-Label Treatment Period|Not Specified|1
46369|NCT01405820|191261|P4|Open-Label Treatment Period|Not Specified|1
46370|NCT01405820|191262|P3|Open-Label Treatment Period|Not Specified|1
46371|NCT01405820|191263|P2|Open-Label Treatment Period|Not Specified|1
46372|NCT01405820|191264|P1|Open-Label Treatment Period|Not Specified|1
46373|NCT01405820|191259|P6|Open-Label Treatment Period|Withdrawal by Subject|1
46374|NCT01405820|191260|P5|Open-Label Treatment Period|Withdrawal by Subject|0
46375|NCT01405820|191261|P4|Open-Label Treatment Period|Withdrawal by Subject|1
46376|NCT01405820|191262|P3|Open-Label Treatment Period|Withdrawal by Subject|1
46377|NCT01405820|191263|P2|Open-Label Treatment Period|Withdrawal by Subject|1
46378|NCT01405820|191264|P1|Open-Label Treatment Period|Withdrawal by Subject|3
46379|NCT01405820|191259|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
46380|NCT01405820|191260|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
46381|NCT01405820|191261|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
46382|NCT01405820|191262|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
46383|NCT01405820|191263|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
46384|NCT01405820|191264|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
46385|NCT01405820|191259|P6|Randomized Treatment Period|Death|0
46386|NCT01405820|191260|P5|Randomized Treatment Period|Death|0
46387|NCT01405820|191261|P4|Randomized Treatment Period|Death|1
46388|NCT01405820|191262|P3|Randomized Treatment Period|Death|0
46389|NCT01405820|191263|P2|Randomized Treatment Period|Death|0
46390|NCT01405820|191264|P1|Randomized Treatment Period|Death|0
46391|NCT01405820|191259|P6|Randomized Treatment Period|Treatment Arm Closed|28
46392|NCT01405820|191260|P5|Randomized Treatment Period|Treatment Arm Closed|33
46393|NCT01405820|191261|P4|Randomized Treatment Period|Treatment Arm Closed|36
46394|NCT01405820|191262|P3|Randomized Treatment Period|Treatment Arm Closed|20
46395|NCT01405820|191263|P2|Randomized Treatment Period|Treatment Arm Closed|0
46396|NCT01405820|191264|P1|Randomized Treatment Period|Treatment Arm Closed|0
46397|NCT01405820|191259|P6|Randomized Treatment Period|Incorrect Study Treatment|0
46398|NCT01405820|191260|P5|Randomized Treatment Period|Incorrect Study Treatment|2
46399|NCT01405820|191261|P4|Randomized Treatment Period|Incorrect Study Treatment|0
46400|NCT01405820|191262|P3|Randomized Treatment Period|Incorrect Study Treatment|3
46401|NCT01405820|191263|P2|Randomized Treatment Period|Incorrect Study Treatment|0
46402|NCT01405820|191264|P1|Randomized Treatment Period|Incorrect Study Treatment|0
46403|NCT01405820|191259|P6|Randomized Treatment Period|Rescue|8
46404|NCT01405820|191260|P5|Randomized Treatment Period|Rescue|8
46405|NCT01405820|191261|P4|Randomized Treatment Period|Rescue|10
46406|NCT01405820|191262|P3|Randomized Treatment Period|Rescue|13
46407|NCT01405820|191263|P2|Randomized Treatment Period|Rescue|1
46408|NCT01405820|191264|P1|Randomized Treatment Period|Rescue|0
46409|NCT01405820|191259|P6|Randomized Treatment Period|Physician Decision|0
46410|NCT01405820|191260|P5|Randomized Treatment Period|Physician Decision|0
46411|NCT01405820|191261|P4|Randomized Treatment Period|Physician Decision|0
46412|NCT01405820|191262|P3|Randomized Treatment Period|Physician Decision|1
46413|NCT01405820|191263|P2|Randomized Treatment Period|Physician Decision|2
46414|NCT01405820|191264|P1|Randomized Treatment Period|Physician Decision|0
46415|NCT01405820|191259|P6|Randomized Treatment Period|Not Specified|0
46416|NCT01405820|191260|P5|Randomized Treatment Period|Not Specified|0
46417|NCT01405820|191261|P4|Randomized Treatment Period|Not Specified|1
46418|NCT01405820|191262|P3|Randomized Treatment Period|Not Specified|1
46419|NCT01405820|191263|P2|Randomized Treatment Period|Not Specified|2
46420|NCT01405820|191264|P1|Randomized Treatment Period|Not Specified|2
46421|NCT01405820|191259|P6|Randomized Treatment Period|Withdrawal by Subject|0
46422|NCT01405820|191260|P5|Randomized Treatment Period|Withdrawal by Subject|0
46423|NCT01405820|191261|P4|Randomized Treatment Period|Withdrawal by Subject|2
46424|NCT01405820|191262|P3|Randomized Treatment Period|Withdrawal by Subject|2
46425|NCT01405820|191263|P2|Randomized Treatment Period|Withdrawal by Subject|2
46426|NCT01405820|191264|P1|Randomized Treatment Period|Withdrawal by Subject|6
46427|NCT01405820|191259|P6|Randomized Treatment Period|Adverse Event|1
46428|NCT01405820|191260|P5|Randomized Treatment Period|Adverse Event|2
46429|NCT01405820|191261|P4|Randomized Treatment Period|Adverse Event|0
46430|NCT01405820|191262|P3|Randomized Treatment Period|Adverse Event|3
46431|NCT01405820|191263|P2|Randomized Treatment Period|Adverse Event|3
46432|NCT01405820|191264|P1|Randomized Treatment Period|Adverse Event|3
46433|NCT01405768|191360|P2|Overall Study|Didn't complete questionnaire correctly|0
46434|NCT01405768|191361|P1|Overall Study|Didn't complete questionnaire correctly|4
46435|NCT01405742|191373|P2|Overall Study|Lost to Follow-up|0
46436|NCT01405742|191374|P1|Overall Study|Lost to Follow-up|1
46437|NCT01405560|191384|P1|Overall Study|Physician Decision|1
46438|NCT01405508|191399|P4|Overall Study|AE, non-serious non-fatal|0
46439|NCT01405508|191400|P3|Overall Study|AE, non-serious non-fatal|0
46440|NCT01405508|191401|P2|Overall Study|AE, non-serious non-fatal|1
46441|NCT01405508|191402|P1|Overall Study|AE, non-serious non-fatal|1
46442|NCT01405027|191442|P2|Overall Study|Other or Unknown|25
46443|NCT01405027|191443|P1|Overall Study|Other or Unknown|12
46444|NCT01405027|191442|P2|Overall Study|Death|0
46445|NCT01405027|191443|P1|Overall Study|Death|1
46446|NCT01405027|191442|P2|Overall Study|Investigator judgement|2
46447|NCT01405027|191443|P1|Overall Study|Investigator judgement|0
46448|NCT01405027|191442|P2|Overall Study|Lost to Follow-up|24
46449|NCT01405027|191443|P1|Overall Study|Lost to Follow-up|16
46450|NCT01405027|191442|P2|Overall Study|Withdrawn consent|0
46451|NCT01405027|191443|P1|Overall Study|Withdrawn consent|3
46452|NCT01404988|191460|P3|Overall Study|Lost to Follow-up|1
46453|NCT01404988|191461|P2|Overall Study|Lost to Follow-up|2
46454|NCT01404988|191462|P1|Overall Study|Lost to Follow-up|1
46455|NCT01404988|191460|P3|Overall Study|Withdrawal by Subject|0
46456|NCT01404988|191461|P2|Overall Study|Withdrawal by Subject|2
46457|NCT01404988|191462|P1|Overall Study|Withdrawal by Subject|2
46458|NCT01404988|191460|P3|Overall Study|Adverse Event|0
46459|NCT01404988|191461|P2|Overall Study|Adverse Event|0
46460|NCT01404988|191462|P1|Overall Study|Adverse Event|1
46461|NCT01404988|191460|P3|Overall Study|Death|2
46462|NCT01404988|191461|P2|Overall Study|Death|0
46463|NCT01404988|191462|P1|Overall Study|Death|2
46464|NCT01404234|191590|P1|Overall Study|Withdrawal by Subject|2
46465|NCT01404208|191606|P2|Overall Study|Discontinued|0
46466|NCT01404208|191607|P1|Overall Study|Discontinued|3
46467|NCT01403987|191672|P3|Overall Study|Residents forgot their secret PIN|18
46468|NCT01403987|191673|P2|Overall Study|Residents forgot their secret PIN|17
46469|NCT01403987|191674|P1|Overall Study|Residents forgot their secret PIN|18
46470|NCT01403805|191690|P2|Overall Study|Death|1
46471|NCT01403805|191691|P1|Overall Study|Death|0
46472|NCT01403805|191690|P2|Overall Study|Lost to Follow-up|2
46473|NCT01403805|191691|P1|Overall Study|Lost to Follow-up|0
46474|NCT01403805|191690|P2|Overall Study|Withdrawal by Subject|4
46475|NCT01403805|191691|P1|Overall Study|Withdrawal by Subject|0
46476|NCT01403194|191749|P1|Overall Study|Lost to Follow-up|8
46477|NCT01403194|191749|P1|Overall Study|Screen Failure|2
46478|NCT01403051|191761|P2|Overall Study|Lost to Follow-up|5
46479|NCT01403051|191762|P1|Overall Study|Lost to Follow-up|5
46480|NCT01403051|191761|P2|Overall Study|Withdrawal by Subject|1
46481|NCT01403051|191762|P1|Overall Study|Withdrawal by Subject|2
46482|NCT01403051|191761|P2|Overall Study|Death|0
46483|NCT01403051|191762|P1|Overall Study|Death|1
46484|NCT01403051|191761|P2|Overall Study|Protocol Violation|0
46485|NCT01403051|191762|P1|Overall Study|Protocol Violation|2
46486|NCT01402986|191798|P4|Overall Study|Unspecified|6
46487|NCT01402986|191799|P3|Overall Study|Unspecified|1
46488|NCT01402986|191800|P2|Overall Study|Unspecified|5
46489|NCT01402986|191801|P1|Overall Study|Unspecified|2
46490|NCT01402986|191798|P4|Overall Study|Lost to Follow-up|1
46491|NCT01402986|191799|P3|Overall Study|Lost to Follow-up|0
46492|NCT01402986|191800|P2|Overall Study|Lost to Follow-up|0
46493|NCT01402986|191801|P1|Overall Study|Lost to Follow-up|0
46494|NCT01402986|191798|P4|Overall Study|Death|2
46495|NCT01402986|191799|P3|Overall Study|Death|0
46496|NCT01402986|191800|P2|Overall Study|Death|0
46497|NCT01402986|191801|P1|Overall Study|Death|0
46498|NCT01402986|191798|P4|Overall Study|Withdrawal by Subject|13
46499|NCT01402986|191799|P3|Overall Study|Withdrawal by Subject|7
46500|NCT01402986|191800|P2|Overall Study|Withdrawal by Subject|10
46501|NCT01402986|191801|P1|Overall Study|Withdrawal by Subject|7
46502|NCT01402947|191936|P2|First Intervention|Adverse Event|1
46503|NCT01402947|191937|P1|First Intervention|Adverse Event|0
46504|NCT01402869|191948|P3|Overall Study|Required Tooth Extraction|1
46505|NCT01402869|191949|P2|Overall Study|Required Tooth Extraction|0
46506|NCT01402869|191950|P1|Overall Study|Required Tooth Extraction|0
46507|NCT01402817|191964|P1|Overall Study|Study Suspended by FDA|8
46508|NCT01402817|191964|P1|Overall Study|Withdrawal by Subject|3
46509|NCT01402700|191969|P1|Overall Study|Missed Visit|1
46510|NCT01402700|191969|P1|Overall Study|Withdrawal by Subject|3
46511|NCT01402700|191969|P1|Overall Study|Death|3
46512|NCT01402570|191973|P1|Overall Study|Adverse Event|1
46513|NCT01402284|191980|P1|Overall Study|Non compliance|2
46514|NCT01402284|191980|P1|Overall Study|Disease progression on study|9
46515|NCT01402284|191980|P1|Overall Study|Physician Decision|1
46516|NCT01402284|191980|P1|Overall Study|Follows up at Memorial Sloan Kettering|2
46517|NCT01402284|191980|P1|Overall Study|Withdrawal consent|1
46518|NCT01402102|192062|P2|Overall Study|Withdrawal by Subject|2
46519|NCT01402102|192063|P1|Overall Study|Withdrawal by Subject|0
46520|NCT01402102|192062|P2|Overall Study|Insufficiency of compliance|1
46521|NCT01402102|192063|P1|Overall Study|Insufficiency of compliance|1
46522|NCT01402102|192062|P2|Overall Study|Protocol Violation|0
46523|NCT01402102|192063|P1|Overall Study|Protocol Violation|1
46524|NCT01402063|192083|P2|Overall Study|Withdrawal by Subject|3
46525|NCT01402063|192084|P1|Overall Study|Withdrawal by Subject|3
46526|NCT01401842|192113|P2|Overall Study|other/unknown|17
46527|NCT01401842|192114|P1|Overall Study|other/unknown|28
46528|NCT01401842|192113|P2|Overall Study|on profile|5
46529|NCT01401842|192114|P1|Overall Study|on profile|9
46530|NCT01401842|192113|P2|Overall Study|invalid follow-up strength data|4
46531|NCT01401842|192114|P1|Overall Study|invalid follow-up strength data|1
46532|NCT01401842|192113|P2|Overall Study|discharged from US Army|4
46533|NCT01401842|192114|P1|Overall Study|discharged from US Army|3
46534|NCT01401842|192113|P2|Overall Study|changed companies|34
46535|NCT01401842|192114|P1|Overall Study|changed companies|20
46536|NCT01401842|192113|P2|Overall Study|academic reason|1
46537|NCT01401842|192114|P1|Overall Study|academic reason|4
46538|NCT01401842|192113|P2|Overall Study|Withdrawal by Subject|2
46539|NCT01401842|192114|P1|Overall Study|Withdrawal by Subject|3
46540|NCT01401647|192127|P3|Overall Study|Lost to Follow-up|1
46541|NCT01401647|192128|P2|Overall Study|Lost to Follow-up|3
46542|NCT01401647|192129|P1|Overall Study|Lost to Follow-up|3
46543|NCT01401647|192127|P3|Overall Study|Withdrawal by Subject|2
46544|NCT01401647|192128|P2|Overall Study|Withdrawal by Subject|5
46545|NCT01401647|192129|P1|Overall Study|Withdrawal by Subject|1
46546|NCT01401478|192184|P1|Overall Study|Serious adverse event|1
46547|NCT01401478|192184|P1|Overall Study|Low intact parathyroid hormone|1
46548|NCT01401478|192184|P1|Overall Study|Hyperphosphatemia and adverse event|1
46549|NCT01401478|192184|P1|Overall Study|Blood samples not available|1
46550|NCT01401478|192184|P1|Overall Study|Withdrawal by Subject|3
46551|NCT01401478|192184|P1|Overall Study|Kidney transplantation|3
46552|NCT01401478|192184|P1|Overall Study|Lost to Follow-up|5
46553|NCT01401478|192184|P1|Overall Study|Hyperphosphatemia|5
46554|NCT01401478|192184|P1|Overall Study|Adverse Event|5
46555|NCT01401478|192184|P1|Overall Study|Study drug not available|6
46556|NCT01401465|192197|P2|Treatment Period 2|Withdrawal by Subject|1
46557|NCT01401465|192198|P1|Treatment Period 2|Withdrawal by Subject|0
46558|NCT01401465|192197|P2|Treatment Period 2|Lost to Follow-up|1
46559|NCT01401465|192198|P1|Treatment Period 2|Lost to Follow-up|0
46560|NCT01401465|192197|P2|Treatment Period 1|Scheduling Difficulties|1
46561|NCT01401465|192198|P1|Treatment Period 1|Scheduling Difficulties|1
46562|NCT01401465|192197|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
46563|NCT01401465|192198|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
46564|NCT01401465|192197|P2|Treatment Period 1|Non-Compliance to Study Drug|0
46565|NCT01401465|192198|P1|Treatment Period 1|Non-Compliance to Study Drug|1
46566|NCT01401465|192197|P2|Treatment Period 1|Withdrawal by Subject|4
46567|NCT01401465|192198|P1|Treatment Period 1|Withdrawal by Subject|1
46568|NCT01401465|192197|P2|Treatment Period 1|Protocol Violation|0
46569|NCT01401465|192198|P1|Treatment Period 1|Protocol Violation|5
46570|NCT01401465|192197|P2|Treatment Period 1|Pregnancy|1
46571|NCT01401465|192198|P1|Treatment Period 1|Pregnancy|0
46572|NCT01401465|192197|P2|Treatment Period 1|Adverse Event|1
46573|NCT01401465|192198|P1|Treatment Period 1|Adverse Event|4
46574|NCT01401361|192261|P1|Overall Study|Subject/family decision post procedure|2
46575|NCT01401361|192261|P1|Overall Study|Lost to Follow-up|3
46576|NCT01401361|192261|P1|Overall Study|Physician Decision|1
46577|NCT01401361|192261|P1|Overall Study|Lack of Efficacy|6
46578|NCT01401361|192261|P1|Overall Study|Withdrawal by Subject|16
46579|NCT01401322|192267|P1|Overall Study|Physician Decision|1
46580|NCT01401322|192267|P1|Overall Study|Withdrawal by Subject|1
46581|NCT01401283|192273|P2|Overall Study|suspicion of malignant hyperthermia|1
46582|NCT01401283|192274|P1|Overall Study|suspicion of malignant hyperthermia|0
46583|NCT01401283|192273|P2|Overall Study|no central venous access|1
46584|NCT01401283|192274|P1|Overall Study|no central venous access|0
46585|NCT01401283|192273|P2|Overall Study|preoperative arrhythmia|0
46586|NCT01401283|192274|P1|Overall Study|preoperative arrhythmia|5
46587|NCT01401283|192273|P2|Overall Study|surgery cancelled|8
46588|NCT01401283|192274|P1|Overall Study|surgery cancelled|5
46589|NCT01401153|192340|P2|Second Test Day|illness|5
46590|NCT01401153|192341|P1|Second Test Day|illness|0
46591|NCT01401153|192340|P2|First Test Day|Learning disabilities; illness|10
46592|NCT01401153|192341|P1|First Test Day|Learning disabilities; illness|1
46593|NCT01401062|192388|P2|Overall Study|Withdrawal by Subject|1
46594|NCT01401062|192389|P1|Overall Study|Withdrawal by Subject|1
46595|NCT01401062|192388|P2|Overall Study|Physician Decision|0
46596|NCT01401062|192389|P1|Overall Study|Physician Decision|1
46597|NCT01401062|192388|P2|Overall Study|Death|7
46598|NCT01401062|192389|P1|Overall Study|Death|9
46599|NCT01401010|192412|P2|Overall Study|Could not interpret assay results|0
46600|NCT01401010|192413|P1|Overall Study|Could not interpret assay results|1
46601|NCT01400958|192438|P2|Overall Study|Adverse Event|0
46602|NCT01400958|192439|P1|Overall Study|Adverse Event|1
46603|NCT01400958|192438|P2|Overall Study|Withdrawal by Subject|1
46604|NCT01400958|192439|P1|Overall Study|Withdrawal by Subject|0
46605|NCT01400958|192438|P2|Overall Study|Physician Decision|1
46606|NCT01400958|192439|P1|Overall Study|Physician Decision|0
46607|NCT01400932|192449|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
46608|NCT01400932|192450|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
46609|NCT01400932|192449|P2|Overall Study|Protocol Deviation|1
46610|NCT01400932|192450|P1|Overall Study|Protocol Deviation|0
46611|NCT01400932|192449|P2|Overall Study|Lost to Follow-up|0
46612|NCT01400932|192450|P1|Overall Study|Lost to Follow-up|1
46613|NCT01400932|192449|P2|Overall Study|Withdrawal by Subject|6
46614|NCT01400932|192450|P1|Overall Study|Withdrawal by Subject|2
46615|NCT01400932|192449|P2|Overall Study|Lack of Efficacy|3
46616|NCT01400932|192450|P1|Overall Study|Lack of Efficacy|0
46617|NCT01400932|192449|P2|Overall Study|Adverse Event|5
46618|NCT01400932|192450|P1|Overall Study|Adverse Event|10
46619|NCT01400919|192472|P1|Overall Study|Missed visit|2
46620|NCT01400919|192472|P1|Overall Study|Lost to Follow-up|2
46621|NCT01400919|192472|P1|Overall Study|Withdrawal by Subject|4
46622|NCT01400893|192515|P2|Overall Study|Lost to Follow-up|6
46623|NCT01400893|192516|P1|Overall Study|Lost to Follow-up|0
46624|NCT01400893|192515|P2|Overall Study|Death|21
46625|NCT01400893|192516|P1|Overall Study|Death|27
46626|NCT01400841|192528|P1|Extended Study Phase (2 Years)|Adverse Event|2
46627|NCT01400841|192528|P1|Initial Study Phase (6 Months)|Death|1
46628|NCT01400698|192566|P6|Overall Study|Unspecified|0
46629|NCT01400698|192567|P5|Overall Study|Unspecified|1
46630|NCT01400698|192568|P4|Overall Study|Unspecified|2
46631|NCT01400698|192569|P3|Overall Study|Unspecified|0
46632|NCT01400698|192570|P2|Overall Study|Unspecified|2
46633|NCT01400698|192571|P1|Overall Study|Unspecified|4
46634|NCT01400698|192566|P6|Overall Study|Adverse Event|0
46635|NCT01400698|192567|P5|Overall Study|Adverse Event|0
46636|NCT01400698|192568|P4|Overall Study|Adverse Event|0
46637|NCT01400698|192569|P3|Overall Study|Adverse Event|0
46638|NCT01400698|192570|P2|Overall Study|Adverse Event|0
46639|NCT01400698|192571|P1|Overall Study|Adverse Event|1
46640|NCT01400698|192566|P6|Overall Study|Non-compliance|0
46641|NCT01400698|192567|P5|Overall Study|Non-compliance|0
46642|NCT01400698|192568|P4|Overall Study|Non-compliance|1
46643|NCT01400698|192569|P3|Overall Study|Non-compliance|0
46644|NCT01400698|192570|P2|Overall Study|Non-compliance|1
46645|NCT01400698|192571|P1|Overall Study|Non-compliance|0
46646|NCT01400698|192566|P6|Overall Study|Protocol Violation|0
46647|NCT01400698|192567|P5|Overall Study|Protocol Violation|1
46648|NCT01400698|192568|P4|Overall Study|Protocol Violation|0
46649|NCT01400698|192569|P3|Overall Study|Protocol Violation|0
46650|NCT01400698|192570|P2|Overall Study|Protocol Violation|1
46651|NCT01400698|192571|P1|Overall Study|Protocol Violation|0
46652|NCT01400698|192566|P6|Overall Study|Withdrawal by Subject|3
46653|NCT01400698|192567|P5|Overall Study|Withdrawal by Subject|1
46654|NCT01400698|192568|P4|Overall Study|Withdrawal by Subject|4
46655|NCT01400698|192569|P3|Overall Study|Withdrawal by Subject|0
46656|NCT01400698|192570|P2|Overall Study|Withdrawal by Subject|2
46657|NCT01400698|192571|P1|Overall Study|Withdrawal by Subject|8
46658|NCT01400698|192566|P6|Overall Study|Lost to Follow-up|3
46659|NCT01400698|192567|P5|Overall Study|Lost to Follow-up|4
46660|NCT01400698|192568|P4|Overall Study|Lost to Follow-up|1
46661|NCT01400698|192569|P3|Overall Study|Lost to Follow-up|2
46662|NCT01400698|192570|P2|Overall Study|Lost to Follow-up|5
46663|NCT01400698|192571|P1|Overall Study|Lost to Follow-up|2
46664|NCT01400516|192595|P2|Primary Trial|Withdrawal by Subject|2
46665|NCT01400516|192596|P1|Primary Trial|Withdrawal by Subject|0
46666|NCT01400451|192609|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
46667|NCT01400451|192610|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
46668|NCT01400451|192611|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
46669|NCT01400451|192609|P3|Combination Treatment (or Intended)|Disease Progression|1
46670|NCT01400451|192610|P2|Combination Treatment (or Intended)|Disease Progression|1
46671|NCT01400451|192611|P1|Combination Treatment (or Intended)|Disease Progression|3
46672|NCT01400451|192609|P3|Combination Treatment (or Intended)|Adverse Event|0
46673|NCT01400451|192610|P2|Combination Treatment (or Intended)|Adverse Event|0
46674|NCT01400451|192611|P1|Combination Treatment (or Intended)|Adverse Event|1
46675|NCT01400451|192609|P3|Combination Treatment (or Intended)|Drug Toxicity|0
46676|NCT01400451|192610|P2|Combination Treatment (or Intended)|Drug Toxicity|1
46677|NCT01400451|192611|P1|Combination Treatment (or Intended)|Drug Toxicity|0
46678|NCT01400451|192609|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
46679|NCT01400451|192610|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
46680|NCT01400451|192611|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
46681|NCT01400425|192625|P1|Overall Study|Withdrawal by Subject|10
46682|NCT01400412|192638|P2|Overall Study|Never started study treatment|3
46683|NCT01400412|192639|P1|Overall Study|Never started study treatment|0
46684|NCT01400412|192638|P2|Overall Study|Unable to complete|3
46685|NCT01400412|192639|P1|Overall Study|Unable to complete|3
46686|NCT01400412|192638|P2|Overall Study|Withdrawal by Subject|4
46687|NCT01400412|192639|P1|Overall Study|Withdrawal by Subject|3
46688|NCT01400412|192638|P2|Overall Study|Lost to Follow-up|7
46689|NCT01400412|192639|P1|Overall Study|Lost to Follow-up|4
46690|NCT01400243|192685|P2|Overall Study|Protocol Violation|11
46691|NCT01400243|192686|P1|Overall Study|Protocol Violation|8
46692|NCT01400139|192708|P1|HYD Extension Period|Administrative|10
46693|NCT01400139|192708|P1|HYD Extension Period|Withdrawal by Subject|5
46694|NCT01400139|192708|P1|HYD Extension Period|Adverse Event|8
46695|NCT01400139|192708|P1|HYD Core Study|Did not qualify for Maintenance Period|14
46696|NCT01400139|192708|P1|HYD Core Study|Administrative|56
46697|NCT01400139|192708|P1|HYD Core Study|Confirmed or suspected diversion|20
46698|NCT01400139|192708|P1|HYD Core Study|Lost to Follow-up|39
46699|NCT01400139|192708|P1|HYD Core Study|Withdrawal by Subject|114
46700|NCT01400139|192708|P1|HYD Core Study|Lack of Efficacy|59
46701|NCT01400139|192708|P1|HYD Core Study|Adverse Event|210
46702|NCT01400113|192718|P2|Overall Study|Withdrawal by Subject|1
46703|NCT01400113|192719|P1|Overall Study|Withdrawal by Subject|1
46704|NCT01399788|192734|P2|First Intervention Period|Adverse Event|0
46705|NCT01399788|192735|P1|First Intervention Period|Adverse Event|1
46706|NCT01399723|192757|P2|Overall Study|Lost to Follow-up|1
46707|NCT01399723|192758|P1|Overall Study|Lost to Follow-up|0
46708|NCT01399697|192771|P3|Overall Study|Sponsor Decision|0
46709|NCT01399697|192772|P2|Overall Study|Sponsor Decision|0
46710|NCT01399697|192773|P1|Overall Study|Sponsor Decision|1
46711|NCT01399697|192771|P3|Overall Study|Clinical RA remission|0
46712|NCT01399697|192772|P2|Overall Study|Clinical RA remission|0
46713|NCT01399697|192773|P1|Overall Study|Clinical RA remission|1
46714|NCT01399697|192771|P3|Overall Study|Positive result for hepatitis B|0
46715|NCT01399697|192772|P2|Overall Study|Positive result for hepatitis B|0
46716|NCT01399697|192773|P1|Overall Study|Positive result for hepatitis B|1
46717|NCT01399697|192771|P3|Overall Study|Inclusion Error|0
46718|NCT01399697|192772|P2|Overall Study|Inclusion Error|0
46719|NCT01399697|192773|P1|Overall Study|Inclusion Error|2
46720|NCT01399697|192771|P3|Overall Study|Non-Compliant|0
46721|NCT01399697|192772|P2|Overall Study|Non-Compliant|0
46722|NCT01399697|192773|P1|Overall Study|Non-Compliant|1
46723|NCT01399697|192771|P3|Overall Study|Protocol Violation|0
46724|NCT01399697|192772|P2|Overall Study|Protocol Violation|0
46725|NCT01399697|192773|P1|Overall Study|Protocol Violation|2
46726|NCT01399697|192771|P3|Overall Study|Lack of Efficacy|1
46727|NCT01399697|192772|P2|Overall Study|Lack of Efficacy|0
46728|NCT01399697|192773|P1|Overall Study|Lack of Efficacy|9
46729|NCT01399697|192771|P3|Overall Study|Investigator Decisión|2
46730|NCT01399697|192772|P2|Overall Study|Investigator Decisión|0
46731|NCT01399697|192773|P1|Overall Study|Investigator Decisión|1
46732|NCT01399697|192771|P3|Overall Study|Withdrawal by Subject|0
46733|NCT01399697|192772|P2|Overall Study|Withdrawal by Subject|0
46734|NCT01399697|192773|P1|Overall Study|Withdrawal by Subject|8
46735|NCT01399697|192771|P3|Overall Study|Lost to Follow-up|0
46736|NCT01399697|192772|P2|Overall Study|Lost to Follow-up|0
46737|NCT01399697|192773|P1|Overall Study|Lost to Follow-up|2
46738|NCT01399697|192771|P3|Overall Study|Adverse Event|1
46739|NCT01399697|192772|P2|Overall Study|Adverse Event|3
46740|NCT01399697|192773|P1|Overall Study|Adverse Event|13
46741|NCT01399619|192800|P4|Overall Study|Not treated|2
46742|NCT01399619|192801|P3|Overall Study|Not treated|0
46743|NCT01399619|192802|P2|Overall Study|Not treated|0
46744|NCT01399619|192803|P1|Overall Study|Not treated|0
46745|NCT01399619|192800|P4|Overall Study|Protocol Violation|1
46746|NCT01399619|192801|P3|Overall Study|Protocol Violation|0
46747|NCT01399619|192802|P2|Overall Study|Protocol Violation|0
46748|NCT01399619|192803|P1|Overall Study|Protocol Violation|0
46749|NCT01399619|192800|P4|Overall Study|Withdrawal by Subject|4
46750|NCT01399619|192801|P3|Overall Study|Withdrawal by Subject|3
46751|NCT01399619|192802|P2|Overall Study|Withdrawal by Subject|0
46752|NCT01399619|192803|P1|Overall Study|Withdrawal by Subject|6
46753|NCT01399619|192800|P4|Overall Study|Lack of Efficacy|0
46754|NCT01399619|192801|P3|Overall Study|Lack of Efficacy|5
46755|NCT01399619|192802|P2|Overall Study|Lack of Efficacy|0
46756|NCT01399619|192803|P1|Overall Study|Lack of Efficacy|9
46757|NCT01399619|192800|P4|Overall Study|Adverse Event|10
46758|NCT01399619|192801|P3|Overall Study|Adverse Event|4
46759|NCT01399619|192802|P2|Overall Study|Adverse Event|0
46760|NCT01399619|192803|P1|Overall Study|Adverse Event|10
46761|NCT01399593|192866|P2|Overall Study|Transplantectomy|1
46762|NCT01399593|192867|P1|Overall Study|Transplantectomy|0
46763|NCT01399593|192866|P2|Overall Study|Death|1
46764|NCT01399593|192867|P1|Overall Study|Death|1
46765|NCT01399593|192866|P2|Overall Study|Adverse Event|0
46766|NCT01399593|192867|P1|Overall Study|Adverse Event|1
46767|NCT01399593|192866|P2|Overall Study|Physician Decision|0
46768|NCT01399593|192867|P1|Overall Study|Physician Decision|1
46769|NCT01399190|192900|P1|Overall Study|Physician Decision|2
46770|NCT01399190|192900|P1|Overall Study|Participant's Request|5
46771|NCT01399190|192900|P1|Overall Study|Adverse Event|8
46772|NCT01399190|192900|P1|Overall Study|Not Eligible for Final Analysis|5
46773|NCT01399125|192908|P2|Overall Study|Protocol Deviation|2
46774|NCT01399125|192909|P1|Overall Study|Protocol Deviation|5
46775|NCT01399125|192908|P2|Overall Study|Death|1
46776|NCT01399125|192909|P1|Overall Study|Death|0
46777|NCT01399125|192908|P2|Overall Study|Administrative Problems|11
46778|NCT01399125|192909|P1|Overall Study|Administrative Problems|7
46779|NCT01399125|192908|P2|Overall Study|Lost to Follow-up|3
46780|NCT01399125|192909|P1|Overall Study|Lost to Follow-up|2
46781|NCT01399125|192908|P2|Overall Study|Withdrawal by Subject|8
46782|NCT01399125|192909|P1|Overall Study|Withdrawal by Subject|5
46783|NCT01399125|192908|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
46784|NCT01399125|192909|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
46785|NCT01399125|192908|P2|Overall Study|Abnormal Lab values|1
46786|NCT01399125|192909|P1|Overall Study|Abnormal Lab values|0
46787|NCT01399125|192908|P2|Overall Study|Adverse Event|30
46788|NCT01399125|192909|P1|Overall Study|Adverse Event|32
46789|NCT01399099|192923|P1|Overall Study|Miscellaneous|4
46790|NCT01399099|192923|P1|Overall Study|Infection|1
46791|NCT01399099|192923|P1|Overall Study|Skin Irritation|13
46792|NCT01399099|192923|P1|Overall Study|Protocol Violation|1
46793|NCT01399099|192923|P1|Overall Study|Physician Decision|1
46794|NCT01399099|192923|P1|Overall Study|Lost to Follow-up|11
46795|NCT01399047|192930|P2|Overall Study|Withdrawal by Subject|1
46796|NCT01399047|192931|P1|Overall Study|Withdrawal by Subject|0
46797|NCT01398956|192959|P1|Overall Study|Subject moved a long distance|1
46798|NCT01398956|192959|P1|Overall Study|Withdrawal Criteria No.3|1
46799|NCT01398956|192959|P1|Overall Study|AE, non-serious non-fatal|4
46800|NCT01398956|192959|P1|Overall Study|Withdrawal by Subject|4
46801|NCT01398787|192991|P1|Overall Study|Adverse Event|1
46802|NCT01398514|193009|P2|Overall Study|Failure to show a conditioned response|3
46803|NCT01398514|193010|P1|Overall Study|Failure to show a conditioned response|4
46804|NCT01398514|193009|P2|Overall Study|Physiologic non-responsiveness|3
46805|NCT01398514|193010|P1|Overall Study|Physiologic non-responsiveness|1
46806|NCT01398514|193009|P2|Overall Study|Non-compliance with study procedures|0
46807|NCT01398514|193010|P1|Overall Study|Non-compliance with study procedures|2
46808|NCT01398514|193009|P2|Overall Study|Adverse Event|0
46809|NCT01398514|193010|P1|Overall Study|Adverse Event|1
46810|NCT01398410|193045|P2|Overall Study|Not Specified|29
46811|NCT01398410|193046|P1|Overall Study|Not Specified|36
46812|NCT01398410|193045|P2|Overall Study|Inadequate Therapeutic Effect|0
46813|NCT01398410|193046|P1|Overall Study|Inadequate Therapeutic Effect|2
46814|NCT01398410|193045|P2|Overall Study|Participants Choice|11
46815|NCT01398410|193046|P1|Overall Study|Participants Choice|8
46816|NCT01398410|193045|P2|Overall Study|Adverse Event|16
46817|NCT01398410|193046|P1|Overall Study|Adverse Event|12
46818|NCT01398176|193056|P2|Overall Study|Physician Decision|3
46819|NCT01398176|193057|P1|Overall Study|Physician Decision|2
46820|NCT01398176|193056|P2|Overall Study|Lost to Follow-up|3
46821|NCT01398176|193057|P1|Overall Study|Lost to Follow-up|1
46822|NCT01397890|193065|P2|Overall Study|Others|1
46823|NCT01397890|193066|P1|Overall Study|Others|2
46824|NCT01397890|193065|P2|Overall Study|Severe Non-Compliance to Protocol|1
46825|NCT01397890|193066|P1|Overall Study|Severe Non-Compliance to Protocol|2
46826|NCT01397890|193065|P2|Overall Study|Adverse Event|2
46827|NCT01397890|193066|P1|Overall Study|Adverse Event|1
46828|NCT01397890|193065|P2|Overall Study|Condition under Investigation Worsened|3
46829|NCT01397890|193066|P1|Overall Study|Condition under Investigation Worsened|1
46830|NCT01397890|193065|P2|Overall Study|Lost to Follow-up|4
46831|NCT01397890|193066|P1|Overall Study|Lost to Follow-up|1
46832|NCT01397890|193065|P2|Overall Study|Death|3
46833|NCT01397890|193066|P1|Overall Study|Death|2
46834|NCT01397890|193065|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
46835|NCT01397890|193066|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
46836|NCT01397890|193065|P2|Overall Study|Withdrawal by Subject|11
46837|NCT01397890|193066|P1|Overall Study|Withdrawal by Subject|7
46838|NCT01397786|193136|P3|Phase B|Lack of Efficacy|14
46839|NCT01397786|193137|P2|Phase B|Lack of Efficacy|7
46840|NCT01397786|193138|P1|Phase B|Lack of Efficacy|22
46841|NCT01397786|193136|P3|Phase B|Protocol Deviation|4
46842|NCT01397786|193137|P2|Phase B|Protocol Deviation|2
46843|NCT01397786|193138|P1|Phase B|Protocol Deviation|1
46844|NCT01397786|193136|P3|Phase B|Withdrawal by Subject|30
46845|NCT01397786|193137|P2|Phase B|Withdrawal by Subject|45
46846|NCT01397786|193138|P1|Phase B|Withdrawal by Subject|102
46847|NCT01397786|193136|P3|Phase B|Physician Decision|3
46848|NCT01397786|193137|P2|Phase B|Physician Decision|1
46849|NCT01397786|193138|P1|Phase B|Physician Decision|9
46850|NCT01397786|193136|P3|Phase B|Subject Met Withdrawal Criteria|38
46851|NCT01397786|193137|P2|Phase B|Subject Met Withdrawal Criteria|5
46852|NCT01397786|193138|P1|Phase B|Subject Met Withdrawal Criteria|38
46853|NCT01397786|193136|P3|Phase B|Adverse Event|27
46854|NCT01397786|193137|P2|Phase B|Adverse Event|23
46855|NCT01397786|193138|P1|Phase B|Adverse Event|109
46856|NCT01397786|193136|P3|Phase B|Lost to Follow-up|22
46857|NCT01397786|193137|P2|Phase B|Lost to Follow-up|12
46858|NCT01397786|193138|P1|Phase B|Lost to Follow-up|22
46859|NCT01397786|193136|P3|Phase A|Lack of Efficacy|1
46860|NCT01397786|193137|P2|Phase A|Lack of Efficacy|0
46861|NCT01397786|193138|P1|Phase A|Lack of Efficacy|0
46862|NCT01397786|193136|P3|Phase A|Withdrawal by Subject|5
46863|NCT01397786|193137|P2|Phase A|Withdrawal by Subject|0
46864|NCT01397786|193138|P1|Phase A|Withdrawal by Subject|0
46865|NCT01397786|193136|P3|Phase A|Physician Decision|1
46866|NCT01397786|193137|P2|Phase A|Physician Decision|0
46867|NCT01397786|193138|P1|Phase A|Physician Decision|0
46868|NCT01397786|193136|P3|Phase A|Subject Met Withdrawal Criteria|7
46869|NCT01397786|193137|P2|Phase A|Subject Met Withdrawal Criteria|0
46870|NCT01397786|193138|P1|Phase A|Subject Met Withdrawal Criteria|0
46871|NCT01397786|193136|P3|Phase A|Adverse Event|8
46872|NCT01397786|193137|P2|Phase A|Adverse Event|0
46873|NCT01397786|193138|P1|Phase A|Adverse Event|0
46874|NCT01397786|193136|P3|Phase A|Lost to Follow-up|6
46875|NCT01397786|193137|P2|Phase A|Lost to Follow-up|0
46876|NCT01397786|193138|P1|Phase A|Lost to Follow-up|0
46877|NCT01397747|193204|P1|Overall Study|FIT excluded|34
46878|NCT01397747|193204|P1|Overall Study|Colonoscopy excluded|304
46879|NCT01397747|193204|P1|Overall Study|Multitarget DNA test excluded|689
46880|NCT01397461|193236|P3|Overall Study|Not treated|1
46881|NCT01397461|193237|P2|Overall Study|Not treated|0
46882|NCT01397461|193238|P1|Overall Study|Not treated|0
46883|NCT01397461|193236|P3|Overall Study|Lack of Efficacy|0
46884|NCT01397461|193237|P2|Overall Study|Lack of Efficacy|3
46885|NCT01397461|193238|P1|Overall Study|Lack of Efficacy|0
46886|NCT01397461|193236|P3|Overall Study|Lost to Follow-up|1
46887|NCT01397461|193237|P2|Overall Study|Lost to Follow-up|2
46888|NCT01397461|193238|P1|Overall Study|Lost to Follow-up|0
46889|NCT01397461|193236|P3|Overall Study|Withdrawal by Subject|0
46890|NCT01397461|193237|P2|Overall Study|Withdrawal by Subject|1
46891|NCT01397461|193238|P1|Overall Study|Withdrawal by Subject|2
46892|NCT01397448|193249|P3|Overall Study|Not specified|4
46893|NCT01397448|193250|P2|Overall Study|Not specified|7
46894|NCT01397448|193251|P1|Overall Study|Not specified|8
46895|NCT01397448|193249|P3|Overall Study|Lack of Efficacy|5
46896|NCT01397448|193250|P2|Overall Study|Lack of Efficacy|0
46897|NCT01397448|193251|P1|Overall Study|Lack of Efficacy|2
46898|NCT01397448|193249|P3|Overall Study|Withdrawal by Subject|3
46899|NCT01397448|193250|P2|Overall Study|Withdrawal by Subject|4
46900|NCT01397448|193251|P1|Overall Study|Withdrawal by Subject|4
46901|NCT01397448|193249|P3|Overall Study|Adverse Event|6
46902|NCT01397448|193250|P2|Overall Study|Adverse Event|4
46903|NCT01397448|193251|P1|Overall Study|Adverse Event|4
46904|NCT01397409|193272|P10|Stage 3|Other Miscellaneous Reasons|0
46905|NCT01397409|193273|P9|Stage 3|Other Miscellaneous Reasons|0
46906|NCT01397409|193274|P8|Stage 3|Other Miscellaneous Reasons|1
46907|NCT01397409|193275|P7|Stage 3|Other Miscellaneous Reasons|0
46908|NCT01397409|193276|P6|Stage 3|Other Miscellaneous Reasons|0
46909|NCT01397409|193277|P5|Stage 3|Other Miscellaneous Reasons|0
46910|NCT01397409|193278|P4|Stage 3|Other Miscellaneous Reasons|0
46911|NCT01397409|193279|P3|Stage 3|Other Miscellaneous Reasons|0
46912|NCT01397409|193280|P2|Stage 3|Other Miscellaneous Reasons|0
46913|NCT01397409|193281|P1|Stage 3|Other Miscellaneous Reasons|0
46914|NCT01397409|193272|P10|Stage 3|Adverse Event|0
46915|NCT01397409|193273|P9|Stage 3|Adverse Event|0
46916|NCT01397409|193274|P8|Stage 3|Adverse Event|1
46917|NCT01397409|193275|P7|Stage 3|Adverse Event|0
46918|NCT01397409|193276|P6|Stage 3|Adverse Event|0
46919|NCT01397409|193277|P5|Stage 3|Adverse Event|0
46920|NCT01397409|193278|P4|Stage 3|Adverse Event|0
46921|NCT01397409|193279|P3|Stage 3|Adverse Event|0
46922|NCT01397409|193280|P2|Stage 3|Adverse Event|0
46923|NCT01397409|193281|P1|Stage 3|Adverse Event|0
46924|NCT01397409|193272|P10|Stage 2|Other Miscellaneous Reasons|0
46925|NCT01397409|193273|P9|Stage 2|Other Miscellaneous Reasons|0
46926|NCT01397409|193274|P8|Stage 2|Other Miscellaneous Reasons|0
46927|NCT01397409|193275|P7|Stage 2|Other Miscellaneous Reasons|0
46928|NCT01397409|193276|P6|Stage 2|Other Miscellaneous Reasons|1
46929|NCT01397409|193277|P5|Stage 2|Other Miscellaneous Reasons|1
46930|NCT01397409|193278|P4|Stage 2|Other Miscellaneous Reasons|0
46931|NCT01397409|193279|P3|Stage 2|Other Miscellaneous Reasons|0
46932|NCT01397409|193280|P2|Stage 2|Other Miscellaneous Reasons|0
46933|NCT01397409|193281|P1|Stage 2|Other Miscellaneous Reasons|0
46934|NCT01397409|193272|P10|Stage 2|Personal Reasons|0
46935|NCT01397409|193273|P9|Stage 2|Personal Reasons|0
46936|NCT01397409|193274|P8|Stage 2|Personal Reasons|0
46937|NCT01397409|193275|P7|Stage 2|Personal Reasons|0
46938|NCT01397409|193276|P6|Stage 2|Personal Reasons|0
46939|NCT01397409|193277|P5|Stage 2|Personal Reasons|1
46940|NCT01397409|193278|P4|Stage 2|Personal Reasons|0
46941|NCT01397409|193279|P3|Stage 2|Personal Reasons|0
46942|NCT01397409|193280|P2|Stage 2|Personal Reasons|0
46943|NCT01397409|193281|P1|Stage 2|Personal Reasons|0
46944|NCT01397409|193272|P10|Stage 2|Adverse Event|0
46945|NCT01397409|193273|P9|Stage 2|Adverse Event|0
46946|NCT01397409|193274|P8|Stage 2|Adverse Event|0
46947|NCT01397409|193275|P7|Stage 2|Adverse Event|0
46948|NCT01397409|193276|P6|Stage 2|Adverse Event|3
46949|NCT01397409|193277|P5|Stage 2|Adverse Event|6
46950|NCT01397409|193278|P4|Stage 2|Adverse Event|0
46951|NCT01397409|193279|P3|Stage 2|Adverse Event|0
46952|NCT01397409|193280|P2|Stage 2|Adverse Event|0
46953|NCT01397409|193281|P1|Stage 2|Adverse Event|0
46954|NCT01397253|193321|P2|Overall Study|Reviewed by only 1 pharmacist|149
46955|NCT01397253|193322|P1|Overall Study|Reviewed by only 1 pharmacist|126
46956|NCT01397084|193328|P1|Overall Study|Used other proton pump inhibitor|1
46957|NCT01397084|193328|P1|Overall Study|Lost to Follow-up|1
46958|NCT01397084|193328|P1|Overall Study|Withdrawal by Subject|1
46959|NCT01397084|193328|P1|Overall Study|Adverse Event|2
46960|NCT01397084|193328|P1|Overall Study|Protocol Violation|2
46961|NCT01397084|193328|P1|Overall Study|Severe Non-Compliance to Protocol|1
46962|NCT01396525|193335|P1|Overall Study|Lost to Follow-up|4
46963|NCT01396525|193335|P1|Overall Study|Death|14
46964|NCT01396525|193335|P1|Overall Study|Withdrawal by Subject|8
46965|NCT01396512|193435|P2|Overall Study|Withdrawal by Subject|1
46966|NCT01396512|193436|P1|Overall Study|Withdrawal by Subject|0
46967|NCT01396434|193451|P3|Overall Study|Unspecified|0
46968|NCT01396434|193452|P2|Overall Study|Unspecified|0
46969|NCT01396434|193453|P1|Overall Study|Unspecified|10
46970|NCT01396434|193451|P3|Overall Study|Lost to Follow-up|0
46971|NCT01396434|193452|P2|Overall Study|Lost to Follow-up|0
46972|NCT01396434|193453|P1|Overall Study|Lost to Follow-up|1
46973|NCT01396421|193465|P4|Overall Study|Lack of Efficacy|18
46974|NCT01396421|193466|P3|Overall Study|Lack of Efficacy|7
46975|NCT01396421|193467|P2|Overall Study|Lack of Efficacy|17
46976|NCT01396421|193468|P1|Overall Study|Lack of Efficacy|7
46977|NCT01396421|193465|P4|Overall Study|Protocol Deviation|0
46978|NCT01396421|193466|P3|Overall Study|Protocol Deviation|1
46979|NCT01396421|193467|P2|Overall Study|Protocol Deviation|1
46980|NCT01396421|193468|P1|Overall Study|Protocol Deviation|2
46981|NCT01396421|193465|P4|Overall Study|Withdrawal by Subject|21
46982|NCT01396421|193466|P3|Overall Study|Withdrawal by Subject|13
46983|NCT01396421|193467|P2|Overall Study|Withdrawal by Subject|24
46984|NCT01396421|193468|P1|Overall Study|Withdrawal by Subject|31
46985|NCT01396421|193465|P4|Overall Study|Physician Decision|3
46986|NCT01396421|193466|P3|Overall Study|Physician Decision|0
46987|NCT01396421|193467|P2|Overall Study|Physician Decision|1
46988|NCT01396421|193468|P1|Overall Study|Physician Decision|1
46989|NCT01396421|193465|P4|Overall Study|Participant Met Withdrawal Criteria|0
46990|NCT01396421|193466|P3|Overall Study|Participant Met Withdrawal Criteria|1
46991|NCT01396421|193467|P2|Overall Study|Participant Met Withdrawal Criteria|0
46992|NCT01396421|193468|P1|Overall Study|Participant Met Withdrawal Criteria|1
46993|NCT01396421|193465|P4|Overall Study|Adverse Event|32
46994|NCT01396421|193466|P3|Overall Study|Adverse Event|12
46995|NCT01396421|193467|P2|Overall Study|Adverse Event|15
46996|NCT01396421|193468|P1|Overall Study|Adverse Event|17
46997|NCT01396421|193465|P4|Overall Study|Lost to Follow-up|1
46998|NCT01396421|193466|P3|Overall Study|Lost to Follow-up|0
46999|NCT01396421|193467|P2|Overall Study|Lost to Follow-up|0
47000|NCT01396421|193468|P1|Overall Study|Lost to Follow-up|0
47001|NCT01396395|193540|P2|Overall Study|Unspecified|1
47002|NCT01396395|193541|P1|Overall Study|Unspecified|0
47003|NCT01396395|193540|P2|Overall Study|Lost to Follow-up|11
47004|NCT01396395|193541|P1|Overall Study|Lost to Follow-up|17
47005|NCT01396395|193540|P2|Overall Study|Adverse Event|2
47006|NCT01396395|193541|P1|Overall Study|Adverse Event|10
47007|NCT01396395|193540|P2|Overall Study|Protocol Violation|1
47008|NCT01396395|193541|P1|Overall Study|Protocol Violation|3
47009|NCT01396395|193540|P2|Overall Study|Withdrawal by Subject|12
47010|NCT01396395|193541|P1|Overall Study|Withdrawal by Subject|10
47011|NCT01396265|193581|P1|Rifa+Afatinib|Withdrawal by Subject|1
47012|NCT01396187|193670|P5|Overall Study|Unspecified|1
47013|NCT01396187|193671|P4|Overall Study|Unspecified|0
47014|NCT01396187|193672|P3|Overall Study|Unspecified|0
47015|NCT01396187|193673|P2|Overall Study|Unspecified|1
47016|NCT01396187|193674|P1|Overall Study|Unspecified|1
47017|NCT01396187|193670|P5|Overall Study|Withdrawal by Subject|0
47018|NCT01396187|193671|P4|Overall Study|Withdrawal by Subject|0
47019|NCT01396187|193672|P3|Overall Study|Withdrawal by Subject|1
47020|NCT01396187|193673|P2|Overall Study|Withdrawal by Subject|1
47021|NCT01396187|193674|P1|Overall Study|Withdrawal by Subject|0
47022|NCT01396187|193670|P5|Overall Study|Adverse Event|0
47023|NCT01396187|193671|P4|Overall Study|Adverse Event|0
47024|NCT01396187|193672|P3|Overall Study|Adverse Event|0
47025|NCT01396187|193673|P2|Overall Study|Adverse Event|1
47026|NCT01396187|193674|P1|Overall Study|Adverse Event|0
47027|NCT01396161|193774|P7|Overall Study|unspecified|1
47028|NCT01396161|193775|P6|Overall Study|unspecified|0
47029|NCT01396161|193776|P5|Overall Study|unspecified|0
47030|NCT01396161|193777|P4|Overall Study|unspecified|0
47031|NCT01396161|193778|P3|Overall Study|unspecified|0
47032|NCT01396161|193779|P2|Overall Study|unspecified|0
47033|NCT01396161|193780|P1|Overall Study|unspecified|0
47034|NCT01396161|193774|P7|Overall Study|Withdrawal by Subject|0
47035|NCT01396161|193775|P6|Overall Study|Withdrawal by Subject|0
47036|NCT01396161|193776|P5|Overall Study|Withdrawal by Subject|1
47037|NCT01396161|193777|P4|Overall Study|Withdrawal by Subject|0
47038|NCT01396161|193778|P3|Overall Study|Withdrawal by Subject|0
47039|NCT01396161|193779|P2|Overall Study|Withdrawal by Subject|0
47040|NCT01396161|193780|P1|Overall Study|Withdrawal by Subject|0
47041|NCT01396083|193835|P2|Overall Study|Lost to Follow-up|0
47042|NCT01396083|193836|P1|Overall Study|Lost to Follow-up|1
47043|NCT01396083|193835|P2|Overall Study|Administrative problems|0
47044|NCT01396083|193836|P1|Overall Study|Administrative problems|1
47045|NCT01396083|193835|P2|Overall Study|Abnormal laboratory value(s)|0
47046|NCT01396083|193836|P1|Overall Study|Abnormal laboratory value(s)|1
47047|NCT01396083|193835|P2|Overall Study|Protocol deviation(s)|1
47048|NCT01396083|193836|P1|Overall Study|Protocol deviation(s)|0
47049|NCT01396083|193835|P2|Overall Study|Consent withdrawn|5
47050|NCT01396083|193836|P1|Overall Study|Consent withdrawn|4
47051|NCT01396083|193835|P2|Overall Study|Unsatisfactory therapeutic effect|13
47052|NCT01396083|193836|P1|Overall Study|Unsatisfactory therapeutic effect|2
47053|NCT01396083|193835|P2|Overall Study|Adverse Event|28
47054|NCT01396083|193836|P1|Overall Study|Adverse Event|2
47055|NCT01396070|193860|P1|Overall Study|Lack of Efficacy|4
47056|NCT01396070|193860|P1|Overall Study|Physician Decision|3
47057|NCT01396070|193860|P1|Overall Study|Adverse Event|8
47058|NCT01396070|193860|P1|Overall Study|Death|2
47059|NCT01396070|193860|P1|Overall Study|Withdrawal by Subject|2
47060|NCT01396057|193869|P2|Overall Study|Consent withdrawn|2
47061|NCT01396057|193870|P1|Overall Study|Consent withdrawn|3
47062|NCT01396057|193869|P2|Overall Study|Protocol deviation|4
47063|NCT01396057|193870|P1|Overall Study|Protocol deviation|4
47064|NCT01396057|193869|P2|Overall Study|Unsatisfactory therapeutic effect|6
47065|NCT01396057|193870|P1|Overall Study|Unsatisfactory therapeutic effect|2
47066|NCT01396057|193869|P2|Overall Study|Adverse Event|6
47067|NCT01396057|193870|P1|Overall Study|Adverse Event|2
47068|NCT01396005|193919|P2|Overall Study|Non-compliance with protocol|1
47069|NCT01396005|193920|P1|Overall Study|Non-compliance with protocol|0
47070|NCT01396005|193919|P2|Overall Study|Withdrawal by Subject|1
47071|NCT01396005|193920|P1|Overall Study|Withdrawal by Subject|0
47072|NCT01395914|193951|P2|Overall Study|Lost to Follow-up|2
47073|NCT01395914|193952|P1|Overall Study|Lost to Follow-up|6
47074|NCT01395914|193951|P2|Overall Study|Study drug-related AE|0
47075|NCT01395914|193952|P1|Overall Study|Study drug-related AE|1
47076|NCT01395914|193951|P2|Overall Study|Withdrawal by patient|14
47077|NCT01395914|193952|P1|Overall Study|Withdrawal by patient|27
47078|NCT01395914|193951|P2|Overall Study|Other|3
47079|NCT01395914|193952|P1|Overall Study|Other|9
47080|NCT01395914|193951|P2|Overall Study|Death|17
47081|NCT01395914|193952|P1|Overall Study|Death|23
47082|NCT01395914|193951|P2|Overall Study|Unrelated to study drug AE|1
47083|NCT01395914|193952|P1|Overall Study|Unrelated to study drug AE|6
47084|NCT01395901|193966|P2|Overall Study|Withdrawal of consent|0
47085|NCT01395901|193967|P1|Overall Study|Withdrawal of consent|1
47086|NCT01395901|193966|P2|Overall Study|Adverse Event|1
47087|NCT01395901|193967|P1|Overall Study|Adverse Event|0
47088|NCT01395901|193966|P2|Overall Study|Randomized but not received study drug|4
47089|NCT01395901|193967|P1|Overall Study|Randomized but not received study drug|5
47090|NCT01395901|193966|P2|Overall Study|Lost to Follow-up|0
47091|NCT01395901|193967|P1|Overall Study|Lost to Follow-up|4
47092|NCT01395888|193983|P3|Treatment Period (TP)|Withdrawal by Subject|3
47093|NCT01395888|193984|P2|Treatment Period (TP)|Withdrawal by Subject|2
47094|NCT01395888|193985|P1|Treatment Period (TP)|Withdrawal by Subject|0
47095|NCT01395888|193983|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
47096|NCT01395888|193984|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
47097|NCT01395888|193985|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
47098|NCT01395888|193983|P3|Treatment Period (TP)|Protocol Violation|5
47099|NCT01395888|193984|P2|Treatment Period (TP)|Protocol Violation|1
47100|NCT01395888|193985|P1|Treatment Period (TP)|Protocol Violation|0
47101|NCT01395888|193983|P3|Treatment Period (TP)|Lack of Efficacy|3
47102|NCT01395888|193984|P2|Treatment Period (TP)|Lack of Efficacy|4
47103|NCT01395888|193985|P1|Treatment Period (TP)|Lack of Efficacy|0
47104|NCT01395888|193983|P3|Treatment Period (TP)|Adverse Event|6
47105|NCT01395888|193984|P2|Treatment Period (TP)|Adverse Event|7
47106|NCT01395888|193985|P1|Treatment Period (TP)|Adverse Event|0
47107|NCT01395888|193983|P3|2-week Run-in Period|Withdrawal by Subject|0
47108|NCT01395888|193984|P2|2-week Run-in Period|Withdrawal by Subject|0
47109|NCT01395888|193985|P1|2-week Run-in Period|Withdrawal by Subject|4
47110|NCT01395888|193983|P3|2-week Run-in Period|Protocol Violation|0
47111|NCT01395888|193984|P2|2-week Run-in Period|Protocol Violation|0
47112|NCT01395888|193985|P1|2-week Run-in Period|Protocol Violation|2
47113|NCT01395888|193983|P3|2-week Run-in Period|Lost to Follow-up|0
47114|NCT01395888|193984|P2|2-week Run-in Period|Lost to Follow-up|0
47115|NCT01395888|193985|P1|2-week Run-in Period|Lost to Follow-up|1
47116|NCT01395888|193983|P3|2-week Run-in Period|Continuation Criteria Not Met|0
47117|NCT01395888|193984|P2|2-week Run-in Period|Continuation Criteria Not Met|0
47118|NCT01395888|193985|P1|2-week Run-in Period|Continuation Criteria Not Met|13
47119|NCT01395888|193983|P3|2-week Run-in Period|Adverse Event|0
47120|NCT01395888|193984|P2|2-week Run-in Period|Adverse Event|0
47121|NCT01395888|193985|P1|2-week Run-in Period|Adverse Event|2
47122|NCT01395823|193993|P2|Overall Study|Withdrawal by Subject|4
47123|NCT01395823|193994|P1|Overall Study|Withdrawal by Subject|5
47124|NCT01395823|193993|P2|Overall Study|GI symptoms|0
47125|NCT01395823|193994|P1|Overall Study|GI symptoms|1
47126|NCT01395823|193993|P2|Overall Study|Transplant|0
47127|NCT01395823|193994|P1|Overall Study|Transplant|1
47128|NCT01395823|193993|P2|Overall Study|Lost to Follow-up|0
47129|NCT01395823|193994|P1|Overall Study|Lost to Follow-up|1
47130|NCT01395823|193993|P2|Overall Study|Physician Decision|1
47131|NCT01395823|193994|P1|Overall Study|Physician Decision|3
47132|NCT01395823|193993|P2|Overall Study|Death|4
47133|NCT01395823|193994|P1|Overall Study|Death|4
47134|NCT01395784|194031|P1|Overall Study|Physician Decision|5
47135|NCT01395784|194031|P1|Overall Study|Withdrawal by Subject|3
47136|NCT01395784|194031|P1|Overall Study|Lost to Follow-up|7
47137|NCT01395524|194039|P3|Overall Study|Subject had spinal surgery|1
47138|NCT01395524|194040|P2|Overall Study|Subject had spinal surgery|0
47139|NCT01395524|194041|P1|Overall Study|Subject had spinal surgery|0
47140|NCT01395524|194039|P3|Overall Study|Did not receive treatment|3
47141|NCT01395524|194040|P2|Overall Study|Did not receive treatment|1
47142|NCT01395524|194041|P1|Overall Study|Did not receive treatment|1
47143|NCT01395524|194039|P3|Overall Study|Withdrawal by Subject|8
47144|NCT01395524|194040|P2|Overall Study|Withdrawal by Subject|8
47145|NCT01395524|194041|P1|Overall Study|Withdrawal by Subject|4
47146|NCT01395524|194039|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
47147|NCT01395524|194040|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
47148|NCT01395524|194041|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
47149|NCT01395524|194039|P3|Overall Study|Death|0
47150|NCT01395524|194040|P2|Overall Study|Death|0
47151|NCT01395524|194041|P1|Overall Study|Death|1
47152|NCT01395524|194039|P3|Overall Study|Adverse Event|3
47153|NCT01395524|194040|P2|Overall Study|Adverse Event|4
47154|NCT01395524|194041|P1|Overall Study|Adverse Event|4
47155|NCT01395524|194039|P3|Overall Study|Severe noncompliance with protocol|0
47156|NCT01395524|194040|P2|Overall Study|Severe noncompliance with protocol|0
47157|NCT01395524|194041|P1|Overall Study|Severe noncompliance with protocol|1
47158|NCT01395524|194039|P3|Overall Study|Study-Specific Withdrawal Criteria|0
47159|NCT01395524|194040|P2|Overall Study|Study-Specific Withdrawal Criteria|2
47160|NCT01395524|194041|P1|Overall Study|Study-Specific Withdrawal Criteria|1
47161|NCT01395524|194039|P3|Overall Study|Lost to Follow-up|1
47162|NCT01395524|194040|P2|Overall Study|Lost to Follow-up|1
47163|NCT01395524|194041|P1|Overall Study|Lost to Follow-up|3
47164|NCT01395524|194039|P3|Overall Study|Non-compliance with study schedule|1
47165|NCT01395524|194040|P2|Overall Study|Non-compliance with study schedule|0
47166|NCT01395524|194041|P1|Overall Study|Non-compliance with study schedule|1
47167|NCT01395394|194064|P3|Baseline Study Visit|Protocol Violation|0
47168|NCT01395394|194065|P2|Baseline Study Visit|Protocol Violation|0
47169|NCT01395394|194066|P1|Baseline Study Visit|Protocol Violation|1
47170|NCT01395368|194077|P1|Overall Study|Withdrawal by Subject|2
47171|NCT01395368|194077|P1|Overall Study|Physician Decision|14
47172|NCT01395017|194099|P2|Overall Study|Sponsor discontinued study|4
47173|NCT01395017|194100|P1|Overall Study|Sponsor discontinued study|1
47174|NCT01395017|194099|P2|Overall Study|Disease progression|58
47175|NCT01395017|194100|P1|Overall Study|Disease progression|42
47176|NCT01395017|194099|P2|Overall Study|Death|3
47177|NCT01395017|194100|P1|Overall Study|Death|4
47178|NCT01395017|194099|P2|Overall Study|Protocol deviation|2
47179|NCT01395017|194100|P1|Overall Study|Protocol deviation|1
47180|NCT01395017|194099|P2|Overall Study|Withdrawal by Subject|8
47181|NCT01395017|194100|P1|Overall Study|Withdrawal by Subject|14
47182|NCT01395017|194099|P2|Overall Study|Physician Decision|15
47183|NCT01395017|194100|P1|Overall Study|Physician Decision|11
47184|NCT01395017|194099|P2|Overall Study|Adverse Event|12
47185|NCT01395017|194100|P1|Overall Study|Adverse Event|26
47186|NCT01395017|194099|P2|Overall Study|Lost to Follow-up|0
47187|NCT01395017|194100|P1|Overall Study|Lost to Follow-up|1
47188|NCT01394991|194110|P2|Overall Study|Prematurely Termination of Trial|10
47189|NCT01394991|194111|P1|Overall Study|Prematurely Termination of Trial|9
47190|NCT01394991|194110|P2|Overall Study|Disease Progression|7
47191|NCT01394991|194111|P1|Overall Study|Disease Progression|7
47192|NCT01394991|194110|P2|Overall Study|Chemotherapy Termination|15
47193|NCT01394991|194111|P1|Overall Study|Chemotherapy Termination|10
47194|NCT01394991|194110|P2|Overall Study|Withdrawal by Subject|17
47195|NCT01394991|194111|P1|Overall Study|Withdrawal by Subject|20
47196|NCT01394991|194110|P2|Overall Study|Protocol Violation|1
47197|NCT01394991|194111|P1|Overall Study|Protocol Violation|1
47198|NCT01394991|194110|P2|Overall Study|Physician Decision|3
47199|NCT01394991|194111|P1|Overall Study|Physician Decision|1
47200|NCT01394991|194110|P2|Overall Study|Lost to Follow-up|8
47201|NCT01394991|194111|P1|Overall Study|Lost to Follow-up|6
47202|NCT01394991|194110|P2|Overall Study|Lack of Efficacy|7
47203|NCT01394991|194111|P1|Overall Study|Lack of Efficacy|5
47204|NCT01394991|194110|P2|Overall Study|Adverse Event|4
47205|NCT01394991|194111|P1|Overall Study|Adverse Event|0
47206|NCT01394978|194133|P2|Overall Study|Death|7
47207|NCT01394978|194134|P1|Overall Study|Death|6
47208|NCT01394978|194133|P2|Overall Study|Lost to Follow-up|20
47209|NCT01394978|194134|P1|Overall Study|Lost to Follow-up|13
47210|NCT01394978|194133|P2|Overall Study|Withdrawal by Subject|4
47211|NCT01394978|194134|P1|Overall Study|Withdrawal by Subject|2
47212|NCT01394718|194151|P2|Overall Study|Met protocol-specific stopping criteria|1
47213|NCT01394718|194152|P1|Overall Study|Met protocol-specific stopping criteria|2
47214|NCT01394276|194188|P1|Overall Study|Symptoms of concurrent diseases|1
47215|NCT01394276|194188|P1|Overall Study|unavailability of drug at the Hospital|2
47216|NCT01394276|194188|P1|Overall Study|Pregnancy|1
47217|NCT01394276|194188|P1|Overall Study|Participant moved to another site|1
47218|NCT01394276|194188|P1|Overall Study|Lost to Follow-up|5
47219|NCT01394276|194188|P1|Overall Study|Insufficient compliance|9
47220|NCT01394276|194188|P1|Overall Study|Insufficient therapeutic effect|17
47221|NCT01394276|194188|P1|Overall Study|Remission of disease|2
47222|NCT01394276|194188|P1|Overall Study|Not related AEs|9
47223|NCT01394276|194188|P1|Overall Study|Related Adverse event (AEs)|15
47224|NCT01394250|194212|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
47225|NCT01394250|194213|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
47226|NCT01394250|194212|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
47227|NCT01394250|194213|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
47228|NCT01394185|194221|P6|Overall Study|Protocol Violation|1
47229|NCT01394185|194222|P5|Overall Study|Protocol Violation|0
47230|NCT01394185|194223|P4|Overall Study|Protocol Violation|1
47231|NCT01394185|194224|P3|Overall Study|Protocol Violation|0
47232|NCT01394185|194225|P2|Overall Study|Protocol Violation|0
47233|NCT01394185|194226|P1|Overall Study|Protocol Violation|1
47234|NCT01394185|194221|P6|Overall Study|Change in protocol|0
47235|NCT01394185|194222|P5|Overall Study|Change in protocol|3
47236|NCT01394185|194223|P4|Overall Study|Change in protocol|0
47237|NCT01394185|194224|P3|Overall Study|Change in protocol|0
47238|NCT01394185|194225|P2|Overall Study|Change in protocol|0
47239|NCT01394185|194226|P1|Overall Study|Change in protocol|3
47240|NCT01394185|194221|P6|Overall Study|Withdrawal by Subject|0
47241|NCT01394185|194222|P5|Overall Study|Withdrawal by Subject|1
47242|NCT01394185|194223|P4|Overall Study|Withdrawal by Subject|0
47243|NCT01394185|194224|P3|Overall Study|Withdrawal by Subject|0
47244|NCT01394185|194225|P2|Overall Study|Withdrawal by Subject|0
47245|NCT01394185|194226|P1|Overall Study|Withdrawal by Subject|2
47246|NCT01393964|194253|P3|Overall Study|Subject to receive non-protocol therapy|1
47247|NCT01393964|194254|P2|Overall Study|Subject to receive non-protocol therapy|0
47248|NCT01393964|194255|P1|Overall Study|Subject to receive non-protocol therapy|0
47249|NCT01393964|194253|P3|Overall Study|Subject converted to roll-over study|0
47250|NCT01393964|194254|P2|Overall Study|Subject converted to roll-over study|1
47251|NCT01393964|194255|P1|Overall Study|Subject converted to roll-over study|0
47252|NCT01393964|194253|P3|Overall Study|Investigator removed subject from study|0
47253|NCT01393964|194254|P2|Overall Study|Investigator removed subject from study|1
47254|NCT01393964|194255|P1|Overall Study|Investigator removed subject from study|0
47255|NCT01393964|194253|P3|Overall Study|Subject plateaued in terms of effect|0
47256|NCT01393964|194254|P2|Overall Study|Subject plateaued in terms of effect|0
47257|NCT01393964|194255|P1|Overall Study|Subject plateaued in terms of effect|1
47258|NCT01393964|194253|P3|Overall Study|Subject switched to commercial supply|2
47259|NCT01393964|194254|P2|Overall Study|Subject switched to commercial supply|0
47260|NCT01393964|194255|P1|Overall Study|Subject switched to commercial supply|1
47261|NCT01393964|194253|P3|Overall Study|Subject decided to move to transplant|0
47262|NCT01393964|194254|P2|Overall Study|Subject decided to move to transplant|0
47263|NCT01393964|194255|P1|Overall Study|Subject decided to move to transplant|1
47264|NCT01393964|194253|P3|Overall Study|Subject request stop study treatment|0
47265|NCT01393964|194254|P2|Overall Study|Subject request stop study treatment|1
47266|NCT01393964|194255|P1|Overall Study|Subject request stop study treatment|0
47267|NCT01393964|194253|P3|Overall Study|Adverse event unrelated to study drug|0
47268|NCT01393964|194254|P2|Overall Study|Adverse event unrelated to study drug|3
47269|NCT01393964|194255|P1|Overall Study|Adverse event unrelated to study drug|0
47270|NCT01393964|194253|P3|Overall Study|Withdrawal by Subject|1
47271|NCT01393964|194254|P2|Overall Study|Withdrawal by Subject|0
47272|NCT01393964|194255|P1|Overall Study|Withdrawal by Subject|0
47273|NCT01393964|194253|P3|Overall Study|Study drug toxicity|0
47274|NCT01393964|194254|P2|Overall Study|Study drug toxicity|0
47275|NCT01393964|194255|P1|Overall Study|Study drug toxicity|1
47276|NCT01393964|194253|P3|Overall Study|Disease Progression|5
47277|NCT01393964|194254|P2|Overall Study|Disease Progression|3
47278|NCT01393964|194255|P1|Overall Study|Disease Progression|4
47279|NCT01393899|194296|P3|Overall Study|Adverse Event|3
47280|NCT01393899|194297|P2|Overall Study|Adverse Event|5
47281|NCT01393899|194298|P1|Overall Study|Adverse Event|1
47282|NCT01393899|194296|P3|Overall Study|Lack of Efficacy|16
47283|NCT01393899|194297|P2|Overall Study|Lack of Efficacy|21
47284|NCT01393899|194298|P1|Overall Study|Lack of Efficacy|26
47285|NCT01393899|194296|P3|Overall Study|Does not meet entrance criteria|1
47286|NCT01393899|194297|P2|Overall Study|Does not meet entrance criteria|0
47287|NCT01393899|194298|P1|Overall Study|Does not meet entrance criteria|1
47288|NCT01393899|194296|P3|Overall Study|Lost to Follow-up|1
47289|NCT01393899|194297|P2|Overall Study|Lost to Follow-up|0
47290|NCT01393899|194298|P1|Overall Study|Lost to Follow-up|0
47291|NCT01393899|194296|P3|Overall Study|Withdrawal by Subject|1
47292|NCT01393899|194297|P2|Overall Study|Withdrawal by Subject|2
47293|NCT01393899|194298|P1|Overall Study|Withdrawal by Subject|2
47294|NCT01393899|194296|P3|Overall Study|Unspecified|0
47295|NCT01393899|194297|P2|Overall Study|Unspecified|0
47296|NCT01393899|194298|P1|Overall Study|Unspecified|1
47297|NCT01393899|194296|P3|Overall Study|Study terminated by sponsor|1
47298|NCT01393899|194297|P2|Overall Study|Study terminated by sponsor|0
47299|NCT01393899|194298|P1|Overall Study|Study terminated by sponsor|1
47300|NCT01393743|194352|P3|Extension Phase|Not specified|14
47301|NCT01393743|194353|P2|Extension Phase|Not specified|0
47302|NCT01393743|194354|P1|Extension Phase|Not specified|0
47303|NCT01393743|194352|P3|Extension Phase|Pregnancy|1
47304|NCT01393743|194353|P2|Extension Phase|Pregnancy|0
47305|NCT01393743|194354|P1|Extension Phase|Pregnancy|0
47306|NCT01393743|194352|P3|Extension Phase|Withdrawal by Subject|8
47307|NCT01393743|194353|P2|Extension Phase|Withdrawal by Subject|0
47308|NCT01393743|194354|P1|Extension Phase|Withdrawal by Subject|0
47309|NCT01393743|194352|P3|Extension Phase|Inadequate therapeutic effect|7
47310|NCT01393743|194353|P2|Extension Phase|Inadequate therapeutic effect|0
47311|NCT01393743|194354|P1|Extension Phase|Inadequate therapeutic effect|0
47312|NCT01393743|194352|P3|Extension Phase|Participant choice|16
47313|NCT01393743|194353|P2|Extension Phase|Participant choice|0
47314|NCT01393743|194354|P1|Extension Phase|Participant choice|0
47315|NCT01393743|194352|P3|Extension Phase|Lost to Follow-up|2
47316|NCT01393743|194353|P2|Extension Phase|Lost to Follow-up|0
47317|NCT01393743|194354|P1|Extension Phase|Lost to Follow-up|0
47318|NCT01393743|194352|P3|Extension Phase|Adverse Event|12
47319|NCT01393743|194353|P2|Extension Phase|Adverse Event|0
47320|NCT01393743|194354|P1|Extension Phase|Adverse Event|0
47321|NCT01393743|194352|P3|Core Study|Inadequate therapeutic effect|0
47322|NCT01393743|194353|P2|Core Study|Inadequate therapeutic effect|0
47323|NCT01393743|194354|P1|Core Study|Inadequate therapeutic effect|2
47324|NCT01393743|194352|P3|Core Study|Participant's Choice|0
47325|NCT01393743|194353|P2|Core Study|Participant's Choice|3
47326|NCT01393743|194354|P1|Core Study|Participant's Choice|2
47327|NCT01393743|194352|P3|Core Study|Lost to Follow-up|0
47328|NCT01393743|194353|P2|Core Study|Lost to Follow-up|1
47329|NCT01393743|194354|P1|Core Study|Lost to Follow-up|1
47330|NCT01393743|194352|P3|Core Study|Adverse Event|0
47331|NCT01393743|194353|P2|Core Study|Adverse Event|9
47332|NCT01393743|194354|P1|Core Study|Adverse Event|5
47333|NCT01393730|194377|P1|Overall Study|Adverse Event|1
47334|NCT01393730|194377|P1|Overall Study|Other|2
47335|NCT01393730|194377|P1|Overall Study|Withdrawal by Subject|3
47336|NCT01393626|194410|P4|Overall Study|Protocol Violation|0
47337|NCT01393626|194411|P3|Overall Study|Protocol Violation|2
47338|NCT01393626|194412|P2|Overall Study|Protocol Violation|0
47339|NCT01393626|194413|P1|Overall Study|Protocol Violation|1
47340|NCT01393626|194410|P4|Overall Study|Unspecified|0
47341|NCT01393626|194411|P3|Overall Study|Unspecified|0
47342|NCT01393626|194412|P2|Overall Study|Unspecified|0
47343|NCT01393626|194413|P1|Overall Study|Unspecified|1
47344|NCT01393626|194410|P4|Overall Study|Withdrawal by Subject|0
47345|NCT01393626|194411|P3|Overall Study|Withdrawal by Subject|0
47346|NCT01393626|194412|P2|Overall Study|Withdrawal by Subject|4
47347|NCT01393626|194413|P1|Overall Study|Withdrawal by Subject|6
47348|NCT01393626|194410|P4|Overall Study|Lost to Follow-up|0
47349|NCT01393626|194411|P3|Overall Study|Lost to Follow-up|1
47350|NCT01393626|194412|P2|Overall Study|Lost to Follow-up|1
47351|NCT01393626|194413|P1|Overall Study|Lost to Follow-up|1
47352|NCT01393626|194410|P4|Overall Study|Lack of Efficacy|1
47353|NCT01393626|194411|P3|Overall Study|Lack of Efficacy|4
47354|NCT01393626|194412|P2|Overall Study|Lack of Efficacy|6
47355|NCT01393626|194413|P1|Overall Study|Lack of Efficacy|6
47356|NCT01393626|194410|P4|Overall Study|Did not meet entrance criteria|0
47357|NCT01393626|194411|P3|Overall Study|Did not meet entrance criteria|0
47358|NCT01393626|194412|P2|Overall Study|Did not meet entrance criteria|0
47359|NCT01393626|194413|P1|Overall Study|Did not meet entrance criteria|1
47360|NCT01393626|194410|P4|Overall Study|Adverse Event|0
47361|NCT01393626|194411|P3|Overall Study|Adverse Event|5
47362|NCT01393626|194412|P2|Overall Study|Adverse Event|1
47363|NCT01393626|194413|P1|Overall Study|Adverse Event|2
47364|NCT01393613|194493|P4|Overall Study|Lack of Efficacy|21
47365|NCT01393613|194494|P3|Overall Study|Lack of Efficacy|16
47366|NCT01393613|194495|P2|Overall Study|Lack of Efficacy|20
47367|NCT01393613|194496|P1|Overall Study|Lack of Efficacy|9
47368|NCT01393613|194493|P4|Overall Study|Protocol Deviation|0
47369|NCT01393613|194494|P3|Overall Study|Protocol Deviation|0
47370|NCT01393613|194495|P2|Overall Study|Protocol Deviation|1
47371|NCT01393613|194496|P1|Overall Study|Protocol Deviation|2
47372|NCT01393613|194493|P4|Overall Study|Withdrawal by Subject|21
47373|NCT01393613|194494|P3|Overall Study|Withdrawal by Subject|23
47374|NCT01393613|194495|P2|Overall Study|Withdrawal by Subject|25
47375|NCT01393613|194496|P1|Overall Study|Withdrawal by Subject|15
47376|NCT01393613|194493|P4|Overall Study|Physician Decision|1
47377|NCT01393613|194494|P3|Overall Study|Physician Decision|0
47378|NCT01393613|194495|P2|Overall Study|Physician Decision|0
47379|NCT01393613|194496|P1|Overall Study|Physician Decision|2
47380|NCT01393613|194493|P4|Overall Study|Participant Met Withdrawal Criteria|1
47381|NCT01393613|194494|P3|Overall Study|Participant Met Withdrawal Criteria|2
47382|NCT01393613|194495|P2|Overall Study|Participant Met Withdrawal Criteria|0
47383|NCT01393613|194496|P1|Overall Study|Participant Met Withdrawal Criteria|0
47384|NCT01393613|194493|P4|Overall Study|Adverse Event|22
47385|NCT01393613|194494|P3|Overall Study|Adverse Event|13
47386|NCT01393613|194495|P2|Overall Study|Adverse Event|11
47387|NCT01393613|194496|P1|Overall Study|Adverse Event|11
47388|NCT01393600|194558|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
47389|NCT01393600|194559|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
47390|NCT01393600|194560|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
47391|NCT01393600|194561|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
47392|NCT01393600|194558|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
47393|NCT01393600|194559|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
47394|NCT01393600|194560|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
47395|NCT01393600|194561|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
47396|NCT01393600|194558|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
47397|NCT01393600|194559|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
47398|NCT01393600|194560|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
47399|NCT01393600|194561|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
47400|NCT01393600|194558|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
47401|NCT01393600|194559|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
47402|NCT01393600|194560|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
47403|NCT01393600|194561|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
47404|NCT01393600|194558|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
47405|NCT01393600|194559|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
47406|NCT01393600|194560|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
47407|NCT01393600|194561|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
47408|NCT01393600|194558|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
47409|NCT01393600|194559|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
47410|NCT01393600|194560|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
47411|NCT01393600|194561|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
47412|NCT01393600|194558|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
47413|NCT01393600|194559|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
47414|NCT01393600|194560|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
47415|NCT01393600|194561|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
47416|NCT01393444|194576|P1|Overall Study|Determined ineligible during screening.|2
47417|NCT01393444|194576|P1|Overall Study|Withdrawal by Subject|1
47418|NCT01393106|194596|P1|Overall Study|Lack of Efficacy|1
47419|NCT01393106|194596|P1|Overall Study|Withdrawal by Subject|1
47420|NCT01393106|194596|P1|Overall Study|Adverse Event|3
47421|NCT01392742|194613|P1|Overall Study|Missing information|13
47422|NCT01392742|194613|P1|Overall Study|Unspecified|3
47423|NCT01392742|194613|P1|Overall Study|Protocol Violation|14
47424|NCT01392742|194613|P1|Overall Study|Adverse event/intercurrent illness|17
47425|NCT01392742|194613|P1|Overall Study|ITR and Protocol deviation|1
47426|NCT01392742|194613|P1|Overall Study|Insufficient therapeutic response (ITR)|30
47427|NCT01392742|194613|P1|Overall Study|Lost to Follow-up|34
47428|NCT01392742|194613|P1|Overall Study|No treatment/no cooperation/withdrew|12
47429|NCT01392742|194613|P1|Overall Study|Failure to return|35
47430|NCT01392742|194613|P1|Overall Study|Premature study termination|42
47431|NCT01392677|194659|P2|Overall Study|Other reason|2
47432|NCT01392677|194660|P1|Overall Study|Other reason|3
47433|NCT01392677|194659|P2|Overall Study|Incorrect enrollment|3
47434|NCT01392677|194660|P1|Overall Study|Incorrect enrollment|2
47435|NCT01392677|194659|P2|Overall Study|Withdrawal by Subject|2
47436|NCT01392677|194660|P1|Overall Study|Withdrawal by Subject|0
47437|NCT01392677|194659|P2|Overall Study|Adverse Event|1
47438|NCT01392677|194660|P1|Overall Study|Adverse Event|3
47439|NCT01392573|194676|P2|Overall Study|Unclassified|6
47440|NCT01392573|194677|P1|Overall Study|Unclassified|9
47441|NCT01392573|194676|P2|Overall Study|Site closure|7
47442|NCT01392573|194677|P1|Overall Study|Site closure|8
47443|NCT01392573|194676|P2|Overall Study|Withdrawal Criteria|15
47444|NCT01392573|194677|P1|Overall Study|Withdrawal Criteria|13
47445|NCT01392573|194676|P2|Overall Study|Protocol Violation|2
47446|NCT01392573|194677|P1|Overall Study|Protocol Violation|0
47447|NCT01392573|194676|P2|Overall Study|Lack of Efficacy|2
47448|NCT01392573|194677|P1|Overall Study|Lack of Efficacy|1
47449|NCT01392573|194676|P2|Overall Study|Adverse Event|3
47450|NCT01392573|194677|P1|Overall Study|Adverse Event|1
47451|NCT01392560|194685|P1|Overall Study|discontinued during placebo run-in|2
47452|NCT01392560|194685|P1|Overall Study|not entered|8
47453|NCT01392560|194685|P1|Overall Study|Adverse Event|2
47454|NCT01392547|194691|P1|Overall Study|Unclassified|1
47455|NCT01392547|194691|P1|Overall Study|Withdrawal criteria|3
47456|NCT01392547|194691|P1|Overall Study|Non-compliance|2
47457|NCT01392547|194691|P1|Overall Study|Adverse Event|2
47458|NCT01392495|194705|P1|Overall Study|Adverse Event|3
47459|NCT01392495|194705|P1|Overall Study|Withdrawal by Subject|2
47460|NCT01392495|194705|P1|Overall Study|Administrative problems|8
47461|NCT01392495|194705|P1|Overall Study|Death|3
47462|NCT01392378|194722|P5|Toddler Dose|Withdrawal by Parent|1
47463|NCT01392378|194723|P4|Toddler Dose|Withdrawal by Parent|1
47464|NCT01392378|194724|P3|Toddler Dose|Withdrawal by Parent|0
47465|NCT01392378|194725|P2|Toddler Dose|Withdrawal by Parent|1
47466|NCT01392378|194726|P1|Toddler Dose|Withdrawal by Parent|0
47467|NCT01392378|194722|P5|Toddler Dose|Lost to Follow-up|0
47468|NCT01392378|194723|P4|Toddler Dose|Lost to Follow-up|1
47469|NCT01392378|194724|P3|Toddler Dose|Lost to Follow-up|0
47470|NCT01392378|194725|P2|Toddler Dose|Lost to Follow-up|0
47471|NCT01392378|194726|P1|Toddler Dose|Lost to Follow-up|0
47472|NCT01392378|194722|P5|After Infant Series|Withdrawal by Parent|1
47473|NCT01392378|194723|P4|After Infant Series|Withdrawal by Parent|0
47474|NCT01392378|194724|P3|After Infant Series|Withdrawal by Parent|1
47475|NCT01392378|194725|P2|After Infant Series|Withdrawal by Parent|1
47476|NCT01392378|194726|P1|After Infant Series|Withdrawal by Parent|0
47477|NCT01392378|194722|P5|After Infant Series|Lost to Follow-up|0
47478|NCT01392378|194723|P4|After Infant Series|Lost to Follow-up|0
47479|NCT01392378|194724|P3|After Infant Series|Lost to Follow-up|1
47480|NCT01392378|194725|P2|After Infant Series|Lost to Follow-up|0
47481|NCT01392378|194726|P1|After Infant Series|Lost to Follow-up|0
47482|NCT01392378|194722|P5|Infant Series|Withdrawal by Parent|0
47483|NCT01392378|194723|P4|Infant Series|Withdrawal by Parent|0
47484|NCT01392378|194724|P3|Infant Series|Withdrawal by Parent|0
47485|NCT01392378|194725|P2|Infant Series|Withdrawal by Parent|1
47486|NCT01392378|194726|P1|Infant Series|Withdrawal by Parent|4
47487|NCT01392378|194722|P5|Infant Series|Protocol Violation|0
47488|NCT01392378|194723|P4|Infant Series|Protocol Violation|0
47489|NCT01392378|194724|P3|Infant Series|Protocol Violation|0
47490|NCT01392378|194725|P2|Infant Series|Protocol Violation|1
47491|NCT01392378|194726|P1|Infant Series|Protocol Violation|0
47492|NCT01392378|194722|P5|Infant Series|Lost to Follow-up|0
47493|NCT01392378|194723|P4|Infant Series|Lost to Follow-up|1
47494|NCT01392378|194724|P3|Infant Series|Lost to Follow-up|0
47495|NCT01392378|194725|P2|Infant Series|Lost to Follow-up|0
47496|NCT01392378|194726|P1|Infant Series|Lost to Follow-up|0
47497|NCT01392378|194722|P5|Infant Series|Adverse Event|0
47498|NCT01392378|194723|P4|Infant Series|Adverse Event|1
47499|NCT01392378|194724|P3|Infant Series|Adverse Event|0
47500|NCT01392378|194725|P2|Infant Series|Adverse Event|0
47501|NCT01392378|194726|P1|Infant Series|Adverse Event|0
47502|NCT01392326|194866|P3|Overall Study|Adverse Event|11
47503|NCT01392326|194867|P2|Overall Study|Adverse Event|6
47504|NCT01392326|194868|P1|Overall Study|Adverse Event|9
47505|NCT01392326|194866|P3|Overall Study|Lack of Efficacy|15
47506|NCT01392326|194867|P2|Overall Study|Lack of Efficacy|10
47507|NCT01392326|194868|P1|Overall Study|Lack of Efficacy|14
47508|NCT01392326|194866|P3|Overall Study|Lost to Follow-up|4
47509|NCT01392326|194867|P2|Overall Study|Lost to Follow-up|3
47510|NCT01392326|194868|P1|Overall Study|Lost to Follow-up|1
47511|NCT01392326|194866|P3|Overall Study|Physician Decision|2
47512|NCT01392326|194867|P2|Overall Study|Physician Decision|5
47513|NCT01392326|194868|P1|Overall Study|Physician Decision|7
47514|NCT01392326|194866|P3|Overall Study|Pregnancy|1
47515|NCT01392326|194867|P2|Overall Study|Pregnancy|0
47516|NCT01392326|194868|P1|Overall Study|Pregnancy|0
47517|NCT01392326|194866|P3|Overall Study|Protocol Violation|0
47518|NCT01392326|194867|P2|Overall Study|Protocol Violation|0
47519|NCT01392326|194868|P1|Overall Study|Protocol Violation|2
47520|NCT01392326|194866|P3|Overall Study|Withdrawal by Subject|15
47521|NCT01392326|194867|P2|Overall Study|Withdrawal by Subject|11
47522|NCT01392326|194868|P1|Overall Study|Withdrawal by Subject|12
47523|NCT01392326|194866|P3|Overall Study|Death|0
47524|NCT01392326|194867|P2|Overall Study|Death|0
47525|NCT01392326|194868|P1|Overall Study|Death|2
47526|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
47527|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
47528|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
47529|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
47530|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
47531|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
47532|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Adverse Event|7
47533|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Adverse Event|0
47534|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Adverse Event|0
47535|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Death|4
47536|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Death|0
47537|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Death|0
47538|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Non-compliance|1
47539|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Non-compliance|0
47540|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Non-compliance|0
47541|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
47542|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
47543|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
47544|NCT01392300|194905|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
47545|NCT01392300|194906|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
47546|NCT01392300|194907|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
47547|NCT01392300|194905|P3|Main Period (MP)|Non-compliance|0
47548|NCT01392300|194906|P2|Main Period (MP)|Non-compliance|0
47549|NCT01392300|194907|P1|Main Period (MP)|Non-compliance|1
47550|NCT01392300|194905|P3|Main Period (MP)|Lost to Follow-up|0
47551|NCT01392300|194906|P2|Main Period (MP)|Lost to Follow-up|3
47552|NCT01392300|194907|P1|Main Period (MP)|Lost to Follow-up|3
47553|NCT01392300|194905|P3|Main Period (MP)|Withdrawal by Subject|0
47554|NCT01392300|194906|P2|Main Period (MP)|Withdrawal by Subject|1
47555|NCT01392300|194907|P1|Main Period (MP)|Withdrawal by Subject|5
47556|NCT01392300|194905|P3|Main Period (MP)|Predefined discontinuation criteria|0
47557|NCT01392300|194906|P2|Main Period (MP)|Predefined discontinuation criteria|3
47558|NCT01392300|194907|P1|Main Period (MP)|Predefined discontinuation criteria|2
47559|NCT01392170|195012|P1|Overall Study|Ineligible|1
47560|NCT01392170|195012|P1|Overall Study|Withdrawal by Subject|1
47561|NCT01391819|195060|P1|Overall Study|Unspecified|9
47562|NCT01391819|195060|P1|Overall Study|Death|3
47563|NCT01391819|195060|P1|Overall Study|Lost to Follow-up|252
47564|NCT01391819|195060|P1|Overall Study|Migrated/moved from study area|82
47565|NCT01391819|195060|P1|Overall Study|Withdrawal by Subject|56
47566|NCT01391663|195091|P4|Overall Study|Withdrawal by Subject|0
47567|NCT01391663|195092|P3|Overall Study|Withdrawal by Subject|1
47568|NCT01391663|195093|P2|Overall Study|Withdrawal by Subject|0
47569|NCT01391663|195094|P1|Overall Study|Withdrawal by Subject|0
47570|NCT01391507|195140|P4|Overall Study|Protocol Violation|2
47571|NCT01391507|195141|P3|Overall Study|Protocol Violation|1
47572|NCT01391507|195142|P2|Overall Study|Protocol Violation|1
47573|NCT01391507|195143|P1|Overall Study|Protocol Violation|2
47574|NCT01391507|195140|P4|Overall Study|Lack of Efficacy|1
47575|NCT01391507|195141|P3|Overall Study|Lack of Efficacy|0
47576|NCT01391507|195142|P2|Overall Study|Lack of Efficacy|0
47577|NCT01391507|195143|P1|Overall Study|Lack of Efficacy|0
47578|NCT01391507|195140|P4|Overall Study|Withdrawal by Subject|1
47579|NCT01391507|195141|P3|Overall Study|Withdrawal by Subject|1
47580|NCT01391507|195142|P2|Overall Study|Withdrawal by Subject|2
47581|NCT01391507|195143|P1|Overall Study|Withdrawal by Subject|1
47582|NCT01391507|195140|P4|Overall Study|Adverse Event|2
47583|NCT01391507|195141|P3|Overall Study|Adverse Event|2
47584|NCT01391507|195142|P2|Overall Study|Adverse Event|1
47585|NCT01391507|195143|P1|Overall Study|Adverse Event|1
47586|NCT01391507|195140|P4|Overall Study|Death|1
47587|NCT01391507|195141|P3|Overall Study|Death|0
47588|NCT01391507|195142|P2|Overall Study|Death|0
47589|NCT01391507|195143|P1|Overall Study|Death|0
47590|NCT01391000|195322|P2|Overall Study|Lost to Follow-up|0
47591|NCT01391000|195323|P1|Overall Study|Lost to Follow-up|2
47592|NCT01390948|195336|P3|Overall Study|Withdrew consent from survival follow-up|0
47593|NCT01390948|195337|P2|Overall Study|Withdrew consent from survival follow-up|5
47594|NCT01390948|195338|P1|Overall Study|Withdrew consent from survival follow-up|3
47595|NCT01390948|195336|P3|Overall Study|Ongoing|0
47596|NCT01390948|195337|P2|Overall Study|Ongoing|6
47597|NCT01390948|195338|P1|Overall Study|Ongoing|6
47598|NCT01390948|195336|P3|Overall Study|Death|2
47599|NCT01390948|195337|P2|Overall Study|Death|34
47600|NCT01390948|195338|P1|Overall Study|Death|30
47601|NCT01390948|195336|P3|Overall Study|Alive in follow-up|1
47602|NCT01390948|195337|P2|Overall Study|Alive in follow-up|17
47603|NCT01390948|195338|P1|Overall Study|Alive in follow-up|20
47604|NCT01390857|195404|P1|Overall Study|No Visit after the First Visit|7
47605|NCT01390857|195404|P1|Overall Study|Lost to Follow-up|1
47606|NCT01390857|195404|P1|Overall Study|Protocol Violation|2
47607|NCT01390844|195415|P4|Follow-Up Phase|Non-Medical Reasons|0
47608|NCT01390844|195416|P3|Follow-Up Phase|Non-Medical Reasons|1
47609|NCT01390844|195417|P2|Follow-Up Phase|Non-Medical Reasons|1
47610|NCT01390844|195418|P1|Follow-Up Phase|Non-Medical Reasons|1
47611|NCT01390844|195415|P4|Treatment Phase|Non-GCP Compliant|3
47612|NCT01390844|195416|P3|Treatment Phase|Non-GCP Compliant|10
47613|NCT01390844|195417|P2|Treatment Phase|Non-GCP Compliant|0
47614|NCT01390844|195418|P1|Treatment Phase|Non-GCP Compliant|0
47615|NCT01390844|195415|P4|Treatment Phase|Non-Medical Reasons|1
47616|NCT01390844|195416|P3|Treatment Phase|Non-Medical Reasons|8
47617|NCT01390844|195417|P2|Treatment Phase|Non-Medical Reasons|1
47618|NCT01390844|195418|P1|Treatment Phase|Non-Medical Reasons|5
47619|NCT01390844|195415|P4|Treatment Phase|Treatment Failure|13
47620|NCT01390844|195416|P3|Treatment Phase|Treatment Failure|10
47621|NCT01390844|195417|P2|Treatment Phase|Treatment Failure|25
47622|NCT01390844|195418|P1|Treatment Phase|Treatment Failure|23
47623|NCT01390844|195415|P4|Treatment Phase|Adverse Event|2
47624|NCT01390844|195416|P3|Treatment Phase|Adverse Event|3
47625|NCT01390844|195417|P2|Treatment Phase|Adverse Event|2
47626|NCT01390844|195418|P1|Treatment Phase|Adverse Event|12
47627|NCT01390779|195745|P1|Overall Study|Physician Decision|1
47628|NCT01390649|195750|P1|Overall Study|Physician Decision|1
47629|NCT01390441|195760|P5|Extension Period|Protocol Violation|0
47630|NCT01390441|195761|P4|Extension Period|Protocol Violation|1
47631|NCT01390441|195762|P3|Extension Period|Protocol Violation|0
47632|NCT01390441|195763|P2|Extension Period|Protocol Violation|1
47633|NCT01390441|195764|P1|Extension Period|Protocol Violation|3
47634|NCT01390441|195760|P5|Treatment Period|Lost to Follow-up|0
47635|NCT01390441|195761|P4|Treatment Period|Lost to Follow-up|0
47636|NCT01390441|195762|P3|Treatment Period|Lost to Follow-up|0
47637|NCT01390441|195763|P2|Treatment Period|Lost to Follow-up|0
47638|NCT01390441|195764|P1|Treatment Period|Lost to Follow-up|1
47639|NCT01390441|195760|P5|Treatment Period|Withdrawal by Subject|1
47640|NCT01390441|195761|P4|Treatment Period|Withdrawal by Subject|0
47641|NCT01390441|195762|P3|Treatment Period|Withdrawal by Subject|1
47642|NCT01390441|195763|P2|Treatment Period|Withdrawal by Subject|0
47643|NCT01390441|195764|P1|Treatment Period|Withdrawal by Subject|0
47644|NCT01390441|195760|P5|Treatment Period|Adverse Event|2
47645|NCT01390441|195761|P4|Treatment Period|Adverse Event|1
47646|NCT01390441|195762|P3|Treatment Period|Adverse Event|1
47647|NCT01390441|195763|P2|Treatment Period|Adverse Event|0
47648|NCT01390441|195764|P1|Treatment Period|Adverse Event|0
47649|NCT01390441|195760|P5|Treatment Period|Unknown due to early stopping of study|7
47650|NCT01390441|195761|P4|Treatment Period|Unknown due to early stopping of study|11
47651|NCT01390441|195762|P3|Treatment Period|Unknown due to early stopping of study|8
47652|NCT01390441|195763|P2|Treatment Period|Unknown due to early stopping of study|0
47653|NCT01390441|195764|P1|Treatment Period|Unknown due to early stopping of study|0
47654|NCT01390441|195760|P5|Treatment Period|Lack of Efficacy|1
47655|NCT01390441|195761|P4|Treatment Period|Lack of Efficacy|0
47656|NCT01390441|195762|P3|Treatment Period|Lack of Efficacy|0
47657|NCT01390441|195763|P2|Treatment Period|Lack of Efficacy|0
47658|NCT01390441|195764|P1|Treatment Period|Lack of Efficacy|0
47659|NCT01390441|195760|P5|Treatment Period|Physician Decision|0
47660|NCT01390441|195761|P4|Treatment Period|Physician Decision|1
47661|NCT01390441|195762|P3|Treatment Period|Physician Decision|0
47662|NCT01390441|195763|P2|Treatment Period|Physician Decision|0
47663|NCT01390441|195764|P1|Treatment Period|Physician Decision|0
47664|NCT01390441|195760|P5|Treatment Period|Protocol Violation|0
47665|NCT01390441|195761|P4|Treatment Period|Protocol Violation|0
47666|NCT01390441|195762|P3|Treatment Period|Protocol Violation|0
47667|NCT01390441|195763|P2|Treatment Period|Protocol Violation|1
47668|NCT01390441|195764|P1|Treatment Period|Protocol Violation|0
47669|NCT01390428|195829|P6|Overall Study|Withdrawal by Subject|0
47670|NCT01390428|195830|P5|Overall Study|Withdrawal by Subject|0
47671|NCT01390428|195831|P4|Overall Study|Withdrawal by Subject|0
47672|NCT01390428|195832|P3|Overall Study|Withdrawal by Subject|1
47673|NCT01390428|195833|P2|Overall Study|Withdrawal by Subject|0
47674|NCT01390428|195834|P1|Overall Study|Withdrawal by Subject|0
47675|NCT01390428|195829|P6|Overall Study|Elective Surgery|0
47676|NCT01390428|195830|P5|Overall Study|Elective Surgery|1
47677|NCT01390428|195831|P4|Overall Study|Elective Surgery|0
47678|NCT01390428|195832|P3|Overall Study|Elective Surgery|0
47679|NCT01390428|195833|P2|Overall Study|Elective Surgery|0
47680|NCT01390428|195834|P1|Overall Study|Elective Surgery|0
47681|NCT01390402|195897|P1|Overall Study|Disease Progression|4
47682|NCT01390402|195897|P1|Overall Study|Death|1
47683|NCT01390389|195903|P2|Overall Study|Screen Fail|1
47684|NCT01390389|195904|P1|Overall Study|Screen Fail|2
47685|NCT01390389|195903|P2|Overall Study|Withdrawal by Subject|0
47686|NCT01390389|195904|P1|Overall Study|Withdrawal by Subject|2
47687|NCT01390181|195933|P1|Overall Study|Study Terminated due to Low Accrual|3
47688|NCT01390181|195933|P1|Overall Study|Lost to Follow-up|1
47689|NCT01390038|195937|P1|Overall Study|Simpliciti System Removal|2
47690|NCT01390038|195937|P1|Overall Study|Withdrawal by Subject|4
47691|NCT01390038|195937|P1|Overall Study|Lost to Follow-up|1
47692|NCT01390038|195937|P1|Overall Study|Death|1
47693|NCT01389973|195947|P1|Overall Study|Unspecified|10
47694|NCT01389973|195947|P1|Overall Study|Trial Stopped by Sponsor|9
47695|NCT01389973|195947|P1|Overall Study|Lost to Follow-up|1
47696|NCT01389882|195957|P2|Overall Study|Withdrawal by Subject|1
47697|NCT01389882|195958|P1|Overall Study|Withdrawal by Subject|0
47698|NCT01389882|195957|P2|Overall Study|Respiratory rate > 80/min during study|3
47699|NCT01389882|195958|P1|Overall Study|Respiratory rate > 80/min during study|1
47700|NCT01389817|196046|P2|Overall Study|Withdrawal by Subject|0
47701|NCT01389817|196047|P1|Overall Study|Withdrawal by Subject|2
47702|NCT01389817|196046|P2|Overall Study|Lost to Follow-up|0
47703|NCT01389817|196047|P1|Overall Study|Lost to Follow-up|1
47704|NCT01389817|196046|P2|Overall Study|Physician Decision|0
47705|NCT01389817|196047|P1|Overall Study|Physician Decision|1
47706|NCT01389596|196056|P3|Overall Study|Other Unspecified|0
47707|NCT01389596|196057|P2|Overall Study|Other Unspecified|1
47708|NCT01389596|196058|P1|Overall Study|Other Unspecified|2
47709|NCT01389596|196056|P3|Overall Study|Death|0
47710|NCT01389596|196057|P2|Overall Study|Death|1
47711|NCT01389596|196058|P1|Overall Study|Death|0
47712|NCT01389596|196056|P3|Overall Study|Adverse Event|0
47713|NCT01389596|196057|P2|Overall Study|Adverse Event|4
47714|NCT01389596|196058|P1|Overall Study|Adverse Event|1
47715|NCT01389596|196056|P3|Overall Study|Insufficient Clinical Response|5
47716|NCT01389596|196057|P2|Overall Study|Insufficient Clinical Response|4
47717|NCT01389596|196058|P1|Overall Study|Insufficient Clinical Response|3
47718|NCT01389596|196056|P3|Overall Study|Withdrawal by Subject|2
47719|NCT01389596|196057|P2|Overall Study|Withdrawal by Subject|2
47720|NCT01389596|196058|P1|Overall Study|Withdrawal by Subject|1
47721|NCT01389596|196056|P3|Overall Study|Protocol Violation|3
47722|NCT01389596|196057|P2|Overall Study|Protocol Violation|4
47723|NCT01389596|196058|P1|Overall Study|Protocol Violation|3
47724|NCT01389323|196117|P1|Follow-up Period (up to 48 Weeks)|Unspecified|3
47725|NCT01389323|196117|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
47726|NCT01389323|196117|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
47727|NCT01389323|196117|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
47728|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
47729|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
47730|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
47731|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
47732|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
47733|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
47734|NCT01389323|196117|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
47735|NCT01389102|196180|P6|Overall Study|Investigator Judgement|0
47736|NCT01389102|196181|P5|Overall Study|Investigator Judgement|0
47737|NCT01389102|196182|P4|Overall Study|Investigator Judgement|0
47738|NCT01389102|196183|P3|Overall Study|Investigator Judgement|0
47739|NCT01389102|196184|P2|Overall Study|Investigator Judgement|1
47740|NCT01389102|196185|P1|Overall Study|Investigator Judgement|0
47741|NCT01389102|196180|P6|Overall Study|Unavailable due to husband's illness|0
47742|NCT01389102|196181|P5|Overall Study|Unavailable due to husband's illness|0
47743|NCT01389102|196182|P4|Overall Study|Unavailable due to husband's illness|0
47744|NCT01389102|196183|P3|Overall Study|Unavailable due to husband's illness|0
47745|NCT01389102|196184|P2|Overall Study|Unavailable due to husband's illness|1
47746|NCT01389102|196185|P1|Overall Study|Unavailable due to husband's illness|0
47747|NCT01389102|196180|P6|Overall Study|Subject Moved|0
47748|NCT01389102|196181|P5|Overall Study|Subject Moved|0
47749|NCT01389102|196182|P4|Overall Study|Subject Moved|0
47750|NCT01389102|196183|P3|Overall Study|Subject Moved|1
47751|NCT01389102|196184|P2|Overall Study|Subject Moved|0
47752|NCT01389102|196185|P1|Overall Study|Subject Moved|2
47753|NCT01389102|196180|P6|Overall Study|Subject Traveling Out of Country|0
47754|NCT01389102|196181|P5|Overall Study|Subject Traveling Out of Country|0
47755|NCT01389102|196182|P4|Overall Study|Subject Traveling Out of Country|1
47756|NCT01389102|196183|P3|Overall Study|Subject Traveling Out of Country|0
47757|NCT01389102|196184|P2|Overall Study|Subject Traveling Out of Country|0
47758|NCT01389102|196185|P1|Overall Study|Subject Traveling Out of Country|0
47759|NCT01389102|196180|P6|Overall Study|Withdrawal by Subject|3
47760|NCT01389102|196181|P5|Overall Study|Withdrawal by Subject|3
47761|NCT01389102|196182|P4|Overall Study|Withdrawal by Subject|2
47762|NCT01389102|196183|P3|Overall Study|Withdrawal by Subject|9
47763|NCT01389102|196184|P2|Overall Study|Withdrawal by Subject|4
47764|NCT01389102|196185|P1|Overall Study|Withdrawal by Subject|7
47765|NCT01389102|196180|P6|Overall Study|Protocol Violation|1
47766|NCT01389102|196181|P5|Overall Study|Protocol Violation|1
47767|NCT01389102|196182|P4|Overall Study|Protocol Violation|0
47768|NCT01389102|196183|P3|Overall Study|Protocol Violation|3
47769|NCT01389102|196184|P2|Overall Study|Protocol Violation|0
47770|NCT01389102|196185|P1|Overall Study|Protocol Violation|0
47771|NCT01389102|196180|P6|Overall Study|Lost to Follow-up|1
47772|NCT01389102|196181|P5|Overall Study|Lost to Follow-up|4
47773|NCT01389102|196182|P4|Overall Study|Lost to Follow-up|2
47774|NCT01389102|196183|P3|Overall Study|Lost to Follow-up|1
47775|NCT01389102|196184|P2|Overall Study|Lost to Follow-up|1
47776|NCT01389102|196185|P1|Overall Study|Lost to Follow-up|4
47777|NCT01389102|196180|P6|Overall Study|Hurricane Katrina|1
47778|NCT01389102|196181|P5|Overall Study|Hurricane Katrina|3
47779|NCT01389102|196182|P4|Overall Study|Hurricane Katrina|0
47780|NCT01389102|196183|P3|Overall Study|Hurricane Katrina|3
47781|NCT01389102|196184|P2|Overall Study|Hurricane Katrina|2
47782|NCT01389102|196185|P1|Overall Study|Hurricane Katrina|4
47783|NCT01389102|196180|P6|Overall Study|Adverse Event|2
47784|NCT01389102|196181|P5|Overall Study|Adverse Event|2
47785|NCT01389102|196182|P4|Overall Study|Adverse Event|2
47786|NCT01389102|196183|P3|Overall Study|Adverse Event|2
47787|NCT01389102|196184|P2|Overall Study|Adverse Event|3
47788|NCT01389102|196185|P1|Overall Study|Adverse Event|1
47789|NCT01388907|196263|P2|Overall Study|Adverse Event|0
47790|NCT01388907|196264|P1|Overall Study|Adverse Event|2
47791|NCT01388816|196280|P4|Overall Study|Protocol Violation|0
47792|NCT01388816|196281|P3|Overall Study|Protocol Violation|2
47793|NCT01388816|196282|P2|Overall Study|Protocol Violation|0
47794|NCT01388816|196283|P1|Overall Study|Protocol Violation|0
47795|NCT01388816|196280|P4|Overall Study|Withdrawal by Subject|0
47796|NCT01388816|196281|P3|Overall Study|Withdrawal by Subject|1
47797|NCT01388816|196282|P2|Overall Study|Withdrawal by Subject|1
47798|NCT01388816|196283|P1|Overall Study|Withdrawal by Subject|2
47799|NCT01388816|196280|P4|Overall Study|Lost to Follow-up|0
47800|NCT01388816|196281|P3|Overall Study|Lost to Follow-up|0
47801|NCT01388816|196282|P2|Overall Study|Lost to Follow-up|1
47802|NCT01388816|196283|P1|Overall Study|Lost to Follow-up|0
47803|NCT01388816|196280|P4|Overall Study|Adverse Event|0
47804|NCT01388816|196281|P3|Overall Study|Adverse Event|0
47805|NCT01388816|196282|P2|Overall Study|Adverse Event|2
47806|NCT01388816|196283|P1|Overall Study|Adverse Event|0
47807|NCT01388790|196312|P1|Overall Study|Ongoing at data cut−off date|8
47808|NCT01388647|196319|P2|Overall Study|Adverse Event|2
47809|NCT01388647|196320|P1|Overall Study|Adverse Event|1
47810|NCT01388530|196331|P1|Overall Study|Lost to Follow-up|5
47811|NCT01388491|196340|P2|Overall Study|Pregnancy|0
47812|NCT01388491|196341|P1|Overall Study|Pregnancy|1
47813|NCT01388491|196340|P2|Overall Study|Noncompliance|0
47814|NCT01388491|196341|P1|Overall Study|Noncompliance|2
47815|NCT01388491|196340|P2|Overall Study|Protocol Violation|0
47816|NCT01388491|196341|P1|Overall Study|Protocol Violation|2
47817|NCT01388491|196340|P2|Overall Study|Lost to Follow-up|3
47818|NCT01388491|196341|P1|Overall Study|Lost to Follow-up|4
47819|NCT01388491|196340|P2|Overall Study|Withdrawal by Subject|10
47820|NCT01388491|196341|P1|Overall Study|Withdrawal by Subject|6
47821|NCT01388491|196340|P2|Overall Study|Sponsor Request|7
47822|NCT01388491|196341|P1|Overall Study|Sponsor Request|9
47823|NCT01388491|196340|P2|Overall Study|Adverse Event|9
47824|NCT01388491|196341|P1|Overall Study|Adverse Event|10
47825|NCT01388361|196376|P3|Overall Study|Unclassified|1
47826|NCT01388361|196377|P2|Overall Study|Unclassified|0
47827|NCT01388361|196378|P1|Overall Study|Unclassified|0
47828|NCT01388361|196376|P3|Overall Study|Withdrawal criteria|10
47829|NCT01388361|196377|P2|Overall Study|Withdrawal criteria|7
47830|NCT01388361|196378|P1|Overall Study|Withdrawal criteria|12
47831|NCT01388361|196376|P3|Overall Study|Protocol Violation|2
47832|NCT01388361|196377|P2|Overall Study|Protocol Violation|0
47833|NCT01388361|196378|P1|Overall Study|Protocol Violation|0
47834|NCT01388361|196376|P3|Overall Study|Adverse Event|1
47835|NCT01388361|196377|P2|Overall Study|Adverse Event|5
47836|NCT01388361|196378|P1|Overall Study|Adverse Event|0
47837|NCT01388166|196395|P1|Overall Study|Others than specified above|13
47838|NCT01388166|196395|P1|Overall Study|Lost to Follow-up|30
47839|NCT01388166|196395|P1|Overall Study|Adverse Event|16
47840|NCT01387789|196401|P1|Overall Study|Lost to Follow-up|1
47841|NCT01387789|196401|P1|Overall Study|Lack of Efficacy|2
47842|NCT01387789|196401|P1|Overall Study|Adverse Event|5
47843|NCT01387737|196415|P2|Overall Study|Clearly not eligible for the study|3
47844|NCT01387737|196416|P1|Overall Study|Clearly not eligible for the study|1
47845|NCT01387737|196415|P2|Overall Study|Withdrawal by Subject|31
47846|NCT01387737|196416|P1|Overall Study|Withdrawal by Subject|27
47847|NCT01387737|196415|P2|Overall Study|Physician Decision|10
47848|NCT01387737|196416|P1|Overall Study|Physician Decision|3
47849|NCT01387737|196415|P2|Overall Study|Lack of Efficacy|0
47850|NCT01387737|196416|P1|Overall Study|Lack of Efficacy|1
47851|NCT01387737|196415|P2|Overall Study|Adverse Event|30
47852|NCT01387737|196416|P1|Overall Study|Adverse Event|20
47853|NCT01387594|196450|P2|Overall Study|Lost to Follow-up|1
47854|NCT01387594|196451|P1|Overall Study|Lost to Follow-up|0
47855|NCT01387594|196450|P2|Overall Study|Withdrawal by Subject|2
47856|NCT01387594|196451|P1|Overall Study|Withdrawal by Subject|0
47857|NCT01387542|196479|P1|Overall Study|Lost to Follow-up|1
47858|NCT01387542|196479|P1|Overall Study|Non-compliant|1
47859|NCT01387542|196479|P1|Overall Study|Insufficient response|1
47860|NCT01387542|196479|P1|Overall Study|Changed diagnosis|1
47861|NCT01387542|196479|P1|Overall Study|Withdrawal by Subject|1
47862|NCT01387542|196479|P1|Overall Study|Adverse Event|3
47863|NCT01387347|196497|P2|Overall Study|Lost to Follow-up|1
47864|NCT01387347|196498|P1|Overall Study|Lost to Follow-up|2
47865|NCT01387282|196510|P2|Overall Study|Lost to Follow-up|1
47866|NCT01387282|196511|P1|Overall Study|Lost to Follow-up|4
47867|NCT01387282|196510|P2|Overall Study|Study drug-related AE|2
47868|NCT01387282|196511|P1|Overall Study|Study drug-related AE|2
47869|NCT01387282|196510|P2|Overall Study|Withdrawal by patient|23
47870|NCT01387282|196511|P1|Overall Study|Withdrawal by patient|33
47871|NCT01387282|196510|P2|Overall Study|Unrelated AE|4
47872|NCT01387282|196511|P1|Overall Study|Unrelated AE|6
47873|NCT01387282|196510|P2|Overall Study|Other|1
47874|NCT01387282|196511|P1|Overall Study|Other|5
47875|NCT01387282|196510|P2|Overall Study|Death|16
47876|NCT01387282|196511|P1|Overall Study|Death|47
47877|NCT01387269|196527|P2|Overall Study|Lost to Follow-up|0
47878|NCT01387269|196528|P1|Overall Study|Lost to Follow-up|1
47879|NCT01387269|196527|P2|Overall Study|Study drug-related AE|0
47880|NCT01387269|196528|P1|Overall Study|Study drug-related AE|1
47881|NCT01387269|196527|P2|Overall Study|Withdrawal by patient|10
47882|NCT01387269|196528|P1|Overall Study|Withdrawal by patient|32
47883|NCT01387269|196527|P2|Overall Study|Unrelated AE|3
47884|NCT01387269|196528|P1|Overall Study|Unrelated AE|12
47885|NCT01387269|196527|P2|Overall Study|Other|7
47886|NCT01387269|196528|P1|Overall Study|Other|8
47887|NCT01387269|196527|P2|Overall Study|Death|20
47888|NCT01387269|196528|P1|Overall Study|Death|38
47889|NCT01387230|196545|P3|Overall Study|Withdrawal by Subject|0
47890|NCT01387230|196546|P2|Overall Study|Withdrawal by Subject|1
47891|NCT01387230|196547|P1|Overall Study|Withdrawal by Subject|4
47892|NCT01387230|196545|P3|Overall Study|Lost to Follow-up|1
47893|NCT01387230|196546|P2|Overall Study|Lost to Follow-up|0
47894|NCT01387230|196547|P1|Overall Study|Lost to Follow-up|0
47895|NCT01387230|196545|P3|Overall Study|Protocol-defined Stopping Criteria|5
47896|NCT01387230|196546|P2|Overall Study|Protocol-defined Stopping Criteria|0
47897|NCT01387230|196547|P1|Overall Study|Protocol-defined Stopping Criteria|6
47898|NCT01387230|196545|P3|Overall Study|Lack of Efficacy|4
47899|NCT01387230|196546|P2|Overall Study|Lack of Efficacy|5
47900|NCT01387230|196547|P1|Overall Study|Lack of Efficacy|8
47901|NCT01387230|196545|P3|Overall Study|Adverse Event|3
47902|NCT01387230|196546|P2|Overall Study|Adverse Event|1
47903|NCT01387230|196547|P1|Overall Study|Adverse Event|0
47904|NCT01387074|196593|P1|Overall Study|Lack of Efficacy|1
47905|NCT01387074|196593|P1|Overall Study|Lost to Follow-up|7
47906|NCT01387022|196606|P2|Overall Study|Lost to Follow-up|3
47907|NCT01387022|196607|P1|Overall Study|Lost to Follow-up|0
47908|NCT01387022|196606|P2|Overall Study|Death|1
47909|NCT01387022|196607|P1|Overall Study|Death|1
47910|NCT01386944|196634|P1|Overall Study|Unspecified reason|8
47911|NCT01386944|196634|P1|Overall Study|Lost to Follow-up|8
47912|NCT01386944|196634|P1|Overall Study|Lack of Efficacy|14
47913|NCT01386944|196634|P1|Overall Study|Adverse Event|26
47914|NCT01386788|196644|P1|Overall Study|Lost to Follow-up|2
47915|NCT01386606|196664|P4|Overall Study|T levels too high|0
47916|NCT01386606|196665|P3|Overall Study|T levels too high|1
47917|NCT01386606|196666|P2|Overall Study|T levels too high|1
47918|NCT01386606|196667|P1|Overall Study|T levels too high|0
47919|NCT01386606|196664|P4|Overall Study|Unable to draw PK|0
47920|NCT01386606|196665|P3|Overall Study|Unable to draw PK|0
47921|NCT01386606|196666|P2|Overall Study|Unable to draw PK|0
47922|NCT01386606|196667|P1|Overall Study|Unable to draw PK|1
47923|NCT01386606|196664|P4|Overall Study|Subject incarcerated|0
47924|NCT01386606|196665|P3|Overall Study|Subject incarcerated|0
47925|NCT01386606|196666|P2|Overall Study|Subject incarcerated|1
47926|NCT01386606|196667|P1|Overall Study|Subject incarcerated|0
47927|NCT01386606|196664|P4|Overall Study|Lost to Follow-up|0
47928|NCT01386606|196665|P3|Overall Study|Lost to Follow-up|0
47929|NCT01386606|196666|P2|Overall Study|Lost to Follow-up|0
47930|NCT01386606|196667|P1|Overall Study|Lost to Follow-up|2
47931|NCT01386606|196664|P4|Overall Study|Protocol Violation|1
47932|NCT01386606|196665|P3|Overall Study|Protocol Violation|1
47933|NCT01386606|196666|P2|Overall Study|Protocol Violation|0
47934|NCT01386606|196667|P1|Overall Study|Protocol Violation|1
47935|NCT01386606|196664|P4|Overall Study|Withdrawal by Subject|0
47936|NCT01386606|196665|P3|Overall Study|Withdrawal by Subject|1
47937|NCT01386606|196666|P2|Overall Study|Withdrawal by Subject|1
47938|NCT01386606|196667|P1|Overall Study|Withdrawal by Subject|0
47939|NCT01386606|196664|P4|Overall Study|Adverse Event|0
47940|NCT01386606|196665|P3|Overall Study|Adverse Event|0
47941|NCT01386606|196666|P2|Overall Study|Adverse Event|1
47942|NCT01386606|196667|P1|Overall Study|Adverse Event|0
47943|NCT01386125|196707|P2|Overall Study|Participant Leaving Country|0
47944|NCT01386125|196708|P1|Overall Study|Participant Leaving Country|1
47945|NCT01386125|196707|P2|Overall Study|Lack of Efficacy|1
47946|NCT01386125|196708|P1|Overall Study|Lack of Efficacy|0
47947|NCT01386125|196707|P2|Overall Study|Adverse Event|5
47948|NCT01386125|196708|P1|Overall Study|Adverse Event|2
47949|NCT01386125|196707|P2|Overall Study|Withdrawal by Subject|12
47950|NCT01386125|196708|P1|Overall Study|Withdrawal by Subject|13
47951|NCT01386125|196707|P2|Overall Study|Disease Progress|2
47952|NCT01386125|196708|P1|Overall Study|Disease Progress|1
47953|NCT01386125|196707|P2|Overall Study|Protocol Violation|7
47954|NCT01386125|196708|P1|Overall Study|Protocol Violation|5
47955|NCT01386125|196707|P2|Overall Study|Physician Decision|1
47956|NCT01386125|196708|P1|Overall Study|Physician Decision|0
47957|NCT01386125|196707|P2|Overall Study|Lost to Follow-up|9
47958|NCT01386125|196708|P1|Overall Study|Lost to Follow-up|3
47959|NCT01386008|196716|P1|Overall Study|Adverse Event|3
47960|NCT01386008|196716|P1|Overall Study|exited w/o incident /study discontinued|17
47961|NCT01385995|196725|P2|Period 1, 2 Months|Physician Decision|0
47962|NCT01385995|196726|P1|Period 1, 2 Months|Physician Decision|1
47963|NCT01385748|196743|P3|Overall Study|Adverse Event|1
47964|NCT01385748|196744|P2|Overall Study|Adverse Event|2
47965|NCT01385748|196745|P1|Overall Study|Adverse Event|4
47966|NCT01385748|196743|P3|Overall Study|Not specified|1
47967|NCT01385748|196744|P2|Overall Study|Not specified|7
47968|NCT01385748|196745|P1|Overall Study|Not specified|1
47969|NCT01385748|196743|P3|Overall Study|Noncompliance|6
47970|NCT01385748|196744|P2|Overall Study|Noncompliance|1
47971|NCT01385748|196745|P1|Overall Study|Noncompliance|3
47972|NCT01385748|196743|P3|Overall Study|Withdrawal by Subject|5
47973|NCT01385748|196744|P2|Overall Study|Withdrawal by Subject|4
47974|NCT01385748|196745|P1|Overall Study|Withdrawal by Subject|7
47975|NCT01385566|196826|P6|Overall Study|Withdrawal by Subject|0
47976|NCT01385566|196827|P5|Overall Study|Withdrawal by Subject|0
47977|NCT01385566|196828|P4|Overall Study|Withdrawal by Subject|1
47978|NCT01385566|196829|P3|Overall Study|Withdrawal by Subject|0
47979|NCT01385566|196830|P2|Overall Study|Withdrawal by Subject|0
47980|NCT01385566|196831|P1|Overall Study|Withdrawal by Subject|0
47981|NCT01385566|196826|P6|Overall Study|Lost to Follow-up|0
47982|NCT01385566|196827|P5|Overall Study|Lost to Follow-up|0
47983|NCT01385566|196828|P4|Overall Study|Lost to Follow-up|0
47984|NCT01385566|196829|P3|Overall Study|Lost to Follow-up|0
47985|NCT01385566|196830|P2|Overall Study|Lost to Follow-up|0
47986|NCT01385566|196831|P1|Overall Study|Lost to Follow-up|1
47987|NCT01385371|196885|P2|Overall Study|Administrative|2
47988|NCT01385371|196886|P1|Overall Study|Administrative|2
47989|NCT01385371|196885|P2|Overall Study|Protocol Violation|21
47990|NCT01385371|196886|P1|Overall Study|Protocol Violation|25
47991|NCT01385371|196885|P2|Overall Study|Withdrawal by Subject|39
47992|NCT01385371|196886|P1|Overall Study|Withdrawal by Subject|52
47993|NCT01385371|196885|P2|Overall Study|Lost to Follow-up|16
47994|NCT01385371|196886|P1|Overall Study|Lost to Follow-up|16
47995|NCT01385371|196885|P2|Overall Study|Adverse Event|19
47996|NCT01385371|196886|P1|Overall Study|Adverse Event|54
47997|NCT01385202|196916|P1|Overall Study|Withdrawn|1
47998|NCT01385202|196916|P1|Overall Study|Not Eligible|11
47999|NCT01385202|196916|P1|Overall Study|Lost to Follow-up|6
48000|NCT01384760|196984|P2|Overall Study|Protocol Violation|0
48001|NCT01384760|196985|P1|Overall Study|Protocol Violation|16
48002|NCT01384760|196984|P2|Overall Study|Lost to Follow-up|6
48003|NCT01384760|196985|P1|Overall Study|Lost to Follow-up|0
48004|NCT01384292|197005|P3|Part B|Severe non-compliance to protocol|0
48005|NCT01384292|197006|P2|Part B|Severe non-compliance to protocol|0
48006|NCT01384292|197007|P1|Part B|Severe non-compliance to protocol|1
48007|NCT01384019|197019|P2|Overall Study|MRI refusal|6
48008|NCT01384019|197020|P1|Overall Study|MRI refusal|6
48009|NCT01384019|197019|P2|Overall Study|Death|0
48010|NCT01384019|197020|P1|Overall Study|Death|1
48011|NCT01384019|197019|P2|Overall Study|Withdrawal by Subject|0
48012|NCT01384019|197020|P1|Overall Study|Withdrawal by Subject|3
48013|NCT01383993|197029|P3|Overall Study|Marketed voriconazole in post-therapy|0
48014|NCT01383993|197030|P2|Overall Study|Marketed voriconazole in post-therapy|0
48015|NCT01383993|197031|P1|Overall Study|Marketed voriconazole in post-therapy|2
48016|NCT01383993|197029|P3|Overall Study|Withdrawal by Subject|1
48017|NCT01383993|197030|P2|Overall Study|Withdrawal by Subject|0
48018|NCT01383993|197031|P1|Overall Study|Withdrawal by Subject|0
48019|NCT01383993|197029|P3|Overall Study|Adverse Event|0
48020|NCT01383993|197030|P2|Overall Study|Adverse Event|1
48021|NCT01383993|197031|P1|Overall Study|Adverse Event|1
48022|NCT01383954|197078|P1|Overall Study|Reason Not Specified|9
48023|NCT01383954|197078|P1|Overall Study|Adverse Event|1
48024|NCT01383954|197078|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
48025|NCT01383954|197078|P1|Overall Study|Lack of Efficacy|2
48026|NCT01383928|197086|P3|Phase 2|Unsatisfactory therapeutic response|1
48027|NCT01383928|197087|P2|Phase 2|Unsatisfactory therapeutic response|0
48028|NCT01383928|197088|P1|Phase 2|Unsatisfactory therapeutic response|0
48029|NCT01383928|197086|P3|Phase 2|Withdrawal by Subject|4
48030|NCT01383928|197087|P2|Phase 2|Withdrawal by Subject|0
48031|NCT01383928|197088|P1|Phase 2|Withdrawal by Subject|0
48032|NCT01383928|197086|P3|Phase 2|Progressive Disease|5
48033|NCT01383928|197087|P2|Phase 2|Progressive Disease|0
48034|NCT01383928|197088|P1|Phase 2|Progressive Disease|0
48035|NCT01383928|197086|P3|Phase 2|Other|4
48036|NCT01383928|197087|P2|Phase 2|Other|0
48037|NCT01383928|197088|P1|Phase 2|Other|0
48038|NCT01383928|197086|P3|Phase 2|Adverse Event|8
48039|NCT01383928|197087|P2|Phase 2|Adverse Event|0
48040|NCT01383928|197088|P1|Phase 2|Adverse Event|0
48041|NCT01383928|197086|P3|Phase 2|Autologous Stem Cell Transplantation|18
48042|NCT01383928|197087|P2|Phase 2|Autologous Stem Cell Transplantation|0
48043|NCT01383928|197088|P1|Phase 2|Autologous Stem Cell Transplantation|0
48044|NCT01383928|197086|P3|Phase 1|Progressive Disease|0
48045|NCT01383928|197087|P2|Phase 1|Progressive Disease|1
48046|NCT01383928|197088|P1|Phase 1|Progressive Disease|1
48047|NCT01383928|197086|P3|Phase 1|Other|0
48048|NCT01383928|197087|P2|Phase 1|Other|3
48049|NCT01383928|197088|P1|Phase 1|Other|1
48050|NCT01383928|197086|P3|Phase 1|Adverse Event|0
48051|NCT01383928|197087|P2|Phase 1|Adverse Event|2
48052|NCT01383928|197088|P1|Phase 1|Adverse Event|1
48053|NCT01383928|197086|P3|Phase 1|Autologous Stem Cell Transplantation|0
48054|NCT01383928|197087|P2|Phase 1|Autologous Stem Cell Transplantation|1
48055|NCT01383928|197088|P1|Phase 1|Autologous Stem Cell Transplantation|2
48056|NCT01383707|197152|P1|Overall Study|Progressive disease|23
48057|NCT01383707|197152|P1|Overall Study|Adverse Event|14
48058|NCT01383707|197152|P1|Overall Study|Sponsor's decision|2
48059|NCT01383707|197152|P1|Overall Study|Not specified|8
48060|NCT01383707|197152|P1|Overall Study|Death|19
48061|NCT01383707|197152|P1|Overall Study|Consent withdrawal|6
48062|NCT01383499|197192|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
48063|NCT01383499|197193|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
48064|NCT01383499|197194|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
48065|NCT01383499|197195|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
48066|NCT01383486|197245|P1|Overall Study|Did not take any product|6
48067|NCT01383486|197245|P1|Overall Study|Incomplete information for analysis|2
48068|NCT01383486|197245|P1|Overall Study|Lost to Follow-up|10
48069|NCT01383356|197322|P2|Period 1|Personal|2
48070|NCT01383356|197323|P1|Period 1|Personal|0
48071|NCT01383356|197322|P2|Period 1|Out of Range Mid-study-Test|1
48072|NCT01383356|197323|P1|Period 1|Out of Range Mid-study-Test|0
48073|NCT01383356|197322|P2|Period 1|Non-compliance|0
48074|NCT01383356|197323|P1|Period 1|Non-compliance|3
48075|NCT01383356|197322|P2|Period 1|Adverse Event|3
48076|NCT01383356|197323|P1|Period 1|Adverse Event|5
48077|NCT01383174|197353|P2|6 Month Assessment|Refused to complete|0
48078|NCT01383174|197354|P1|6 Month Assessment|Refused to complete|4
48079|NCT01383174|197353|P2|6 Month Assessment|Lost to Follow-up|1
48080|NCT01383174|197354|P1|6 Month Assessment|Lost to Follow-up|1
48081|NCT01383174|197353|P2|3 Month Assessment|Refused to complete|0
48082|NCT01383174|197354|P1|3 Month Assessment|Refused to complete|4
48083|NCT01383174|197353|P2|3 Month Assessment|Lost to Follow-up|0
48084|NCT01383174|197354|P1|3 Month Assessment|Lost to Follow-up|2
48085|NCT01383174|197353|P2|3 Month Assessment|Death|1
48086|NCT01383174|197354|P1|3 Month Assessment|Death|0
48087|NCT01383096|197381|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
48088|NCT01383096|197382|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
48089|NCT01383096|197383|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
48090|NCT01383096|197381|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
48091|NCT01383096|197382|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
48092|NCT01383096|197383|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
48093|NCT01383096|197381|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
48094|NCT01383096|197382|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
48095|NCT01383096|197383|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
48096|NCT01383096|197381|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
48097|NCT01383096|197382|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
48098|NCT01383096|197383|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
48099|NCT01383096|197381|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
48100|NCT01383096|197382|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
48101|NCT01383096|197383|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
48102|NCT01383096|197381|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
48103|NCT01383096|197382|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
48104|NCT01383096|197383|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
48105|NCT01383096|197381|P3|Third Intervention (8 Days)|Adverse Event|0
48106|NCT01383096|197382|P2|Third Intervention (8 Days)|Adverse Event|0
48107|NCT01383096|197383|P1|Third Intervention (8 Days)|Adverse Event|1
48108|NCT01383096|197381|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
48109|NCT01383096|197382|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
48110|NCT01383096|197383|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
48111|NCT01383096|197381|P3|Third Intervention (8 Days)|Elevated AST|0
48112|NCT01383096|197382|P2|Third Intervention (8 Days)|Elevated AST|1
48113|NCT01383096|197383|P1|Third Intervention (8 Days)|Elevated AST|0
48114|NCT01383096|197381|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
48115|NCT01383096|197382|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
48116|NCT01383096|197383|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
48117|NCT01383096|197381|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
48118|NCT01383096|197382|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
48119|NCT01383096|197383|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
48120|NCT01382940|197451|P1|Overall Study|Protocol Violation|20
48121|NCT01382940|197451|P1|Overall Study|Withdrawal by Subject|23
48122|NCT01382940|197451|P1|Overall Study|Physician Decision|7
48123|NCT01382940|197451|P1|Overall Study|Lost to Follow-up|4
48124|NCT01382940|197451|P1|Overall Study|Adverse Event|19
48125|NCT01382446|197513|P2|Overall Study|Removal from Mechanical Ventilation|3
48126|NCT01382446|197514|P1|Overall Study|Removal from Mechanical Ventilation|3
48127|NCT01382446|197513|P2|Overall Study|Withdrawal by Subject|1
48128|NCT01382446|197514|P1|Overall Study|Withdrawal by Subject|0
48129|NCT01382251|197541|P2|Overall Study|Contacted after study closed|1
48130|NCT01382251|197542|P1|Overall Study|Contacted after study closed|1
48131|NCT01382251|197541|P2|Overall Study|Lost to Follow-up|4
48132|NCT01382251|197542|P1|Overall Study|Lost to Follow-up|4
48133|NCT01382251|197541|P2|Overall Study|Surgeries cancelled or delayed|16
48134|NCT01382251|197542|P1|Overall Study|Surgeries cancelled or delayed|16
48135|NCT01382225|197555|P2|Overall Study|Other|2
48136|NCT01382225|197556|P1|Overall Study|Other|4
48137|NCT01382225|197555|P2|Overall Study|Subject Withdrew Consent|2
48138|NCT01382225|197556|P1|Overall Study|Subject Withdrew Consent|5
48139|NCT01382225|197555|P2|Overall Study|Protocol Violation|1
48140|NCT01382225|197556|P1|Overall Study|Protocol Violation|2
48141|NCT01382225|197555|P2|Overall Study|Adverse Event|2
48142|NCT01382225|197556|P1|Overall Study|Adverse Event|3
48143|NCT01382212|197578|P1|Overall Study|Withdrew consent|1
48144|NCT01382212|197578|P1|Overall Study|Kidney transplant|1
48145|NCT01381926|197641|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
48146|NCT01381926|197642|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
48147|NCT01381926|197641|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
48148|NCT01381926|197642|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
48149|NCT01381900|197655|P3|Overall Study|Early withdraw|1
48150|NCT01381900|197656|P2|Overall Study|Early withdraw|1
48151|NCT01381900|197657|P1|Overall Study|Early withdraw|3
48152|NCT01381900|197655|P3|Overall Study|Withdrawal by Subject|1
48153|NCT01381900|197656|P2|Overall Study|Withdrawal by Subject|0
48154|NCT01381900|197657|P1|Overall Study|Withdrawal by Subject|0
48155|NCT01381900|197655|P3|Overall Study|Protocol Violation|1
48156|NCT01381900|197656|P2|Overall Study|Protocol Violation|1
48157|NCT01381900|197657|P1|Overall Study|Protocol Violation|0
48158|NCT01381900|197655|P3|Overall Study|Physician Decision|1
48159|NCT01381900|197656|P2|Overall Study|Physician Decision|1
48160|NCT01381900|197657|P1|Overall Study|Physician Decision|0
48161|NCT01381900|197655|P3|Overall Study|Noncompliance with study drug|1
48162|NCT01381900|197656|P2|Overall Study|Noncompliance with study drug|0
48163|NCT01381900|197657|P1|Overall Study|Noncompliance with study drug|0
48164|NCT01381900|197655|P3|Overall Study|Adverse Event|7
48165|NCT01381900|197656|P2|Overall Study|Adverse Event|6
48166|NCT01381900|197657|P1|Overall Study|Adverse Event|4
48167|NCT01381900|197655|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
48168|NCT01381900|197656|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
48169|NCT01381900|197657|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
48170|NCT01380782|197679|P4|Overall Study|Withdrawal by Subject|1
48171|NCT01380782|197680|P3|Overall Study|Withdrawal by Subject|1
48172|NCT01380782|197681|P2|Overall Study|Withdrawal by Subject|0
48173|NCT01380782|197682|P1|Overall Study|Withdrawal by Subject|0
48174|NCT01380782|197679|P4|Overall Study|Physician Decision|0
48175|NCT01380782|197680|P3|Overall Study|Physician Decision|0
48176|NCT01380782|197681|P2|Overall Study|Physician Decision|0
48177|NCT01380782|197682|P1|Overall Study|Physician Decision|1
48178|NCT01380782|197679|P4|Overall Study|Lack of Efficacy|3
48179|NCT01380782|197680|P3|Overall Study|Lack of Efficacy|10
48180|NCT01380782|197681|P2|Overall Study|Lack of Efficacy|9
48181|NCT01380782|197682|P1|Overall Study|Lack of Efficacy|10
48182|NCT01380782|197679|P4|Overall Study|Death|0
48183|NCT01380782|197680|P3|Overall Study|Death|0
48184|NCT01380782|197681|P2|Overall Study|Death|0
48185|NCT01380782|197682|P1|Overall Study|Death|1
48186|NCT01380782|197679|P4|Overall Study|Adverse Event|0
48187|NCT01380782|197680|P3|Overall Study|Adverse Event|0
48188|NCT01380782|197681|P2|Overall Study|Adverse Event|1
48189|NCT01380782|197682|P1|Overall Study|Adverse Event|0
48190|NCT01380769|197705|P2|Overall Study|Protocol Violation|1
48191|NCT01380769|197706|P1|Overall Study|Protocol Violation|0
48192|NCT01380769|197705|P2|Overall Study|Adverse Event|1
48193|NCT01380769|197706|P1|Overall Study|Adverse Event|1
48194|NCT01380769|197705|P2|Overall Study|Physician Decision|1
48195|NCT01380769|197706|P1|Overall Study|Physician Decision|1
48196|NCT01380769|197705|P2|Overall Study|Withdrawal by Subject|11
48197|NCT01380769|197706|P1|Overall Study|Withdrawal by Subject|7
48198|NCT01380730|197722|P8|Overall Study|Death|0
48199|NCT01380730|197723|P7|Overall Study|Death|0
48200|NCT01380730|197724|P6|Overall Study|Death|0
48201|NCT01380730|197725|P5|Overall Study|Death|1
48202|NCT01380730|197726|P4|Overall Study|Death|0
48203|NCT01380730|197727|P3|Overall Study|Death|0
48204|NCT01380730|197728|P2|Overall Study|Death|0
48205|NCT01380730|197729|P1|Overall Study|Death|0
48206|NCT01381679|197787|P1|Overall Study|Lost to Follow-up|885
48207|NCT01381679|197787|P1|Overall Study|Adverse Event|3
48208|NCT01381575|197802|P3|Overall Study|Withdrawal by Subject|4
48209|NCT01381575|197803|P2|Overall Study|Withdrawal by Subject|0
48210|NCT01381575|197804|P1|Overall Study|Withdrawal by Subject|0
48211|NCT01381575|197802|P3|Overall Study|Protocol Violation|1
48212|NCT01381575|197803|P2|Overall Study|Protocol Violation|0
48213|NCT01381575|197804|P1|Overall Study|Protocol Violation|0
48214|NCT01381575|197802|P3|Overall Study|Lost to Follow-up|1
48215|NCT01381575|197803|P2|Overall Study|Lost to Follow-up|0
48216|NCT01381575|197804|P1|Overall Study|Lost to Follow-up|0
48217|NCT01381575|197802|P3|Overall Study|Adverse Event|1
48218|NCT01381575|197803|P2|Overall Study|Adverse Event|0
48219|NCT01381575|197804|P1|Overall Study|Adverse Event|0
48220|NCT01381575|197802|P3|Overall Study|Unspecified|0
48221|NCT01381575|197803|P2|Overall Study|Unspecified|10
48222|NCT01381575|197804|P1|Overall Study|Unspecified|2
48223|NCT01381016|197889|P2|Overall Study|Physician Decision|2
48224|NCT01381016|197890|P1|Overall Study|Physician Decision|0
48225|NCT01381016|197889|P2|Overall Study|Withdrawal by Subject|1
48226|NCT01381016|197890|P1|Overall Study|Withdrawal by Subject|0
48227|NCT01381016|197889|P2|Overall Study|Screen Failure|2
48228|NCT01381016|197890|P1|Overall Study|Screen Failure|2
48229|NCT01381016|197889|P2|Overall Study|Lost to Follow-up|1
48230|NCT01381016|197890|P1|Overall Study|Lost to Follow-up|1
48231|NCT01380834|197900|P2|Overall Study|Physician Decision|0
48232|NCT01380834|197901|P1|Overall Study|Physician Decision|1
48233|NCT01380379|197920|P1|Overall Study|Pregnancy|1
48234|NCT01380327|197933|P3|Overall Study|Questionable onset of epilepsy|1
48235|NCT01380327|197934|P2|Overall Study|Questionable onset of epilepsy|0
48236|NCT01380327|197935|P1|Overall Study|Questionable onset of epilepsy|0
48237|NCT01380327|197933|P3|Overall Study|Housing situation precluded ability to k|1
48238|NCT01380327|197934|P2|Overall Study|Housing situation precluded ability to k|0
48239|NCT01380327|197935|P1|Overall Study|Housing situation precluded ability to k|0
48240|NCT01380327|197933|P3|Overall Study|Withdrawal by Subject|1
48241|NCT01380327|197934|P2|Overall Study|Withdrawal by Subject|0
48242|NCT01380327|197935|P1|Overall Study|Withdrawal by Subject|0
48243|NCT01380327|197933|P3|Overall Study|Protocol Violation|3
48244|NCT01380327|197934|P2|Overall Study|Protocol Violation|2
48245|NCT01380327|197935|P1|Overall Study|Protocol Violation|3
48246|NCT01380327|197933|P3|Overall Study|Lost to Follow-up|1
48247|NCT01380327|197934|P2|Overall Study|Lost to Follow-up|1
48248|NCT01380327|197935|P1|Overall Study|Lost to Follow-up|0
48249|NCT01380145|197966|P1|Overall Study|Progressive disease|4
48250|NCT01380093|197974|P9|Treatment Phase: Third Intervention|Unspecified|1
48251|NCT01380093|197975|P8|Treatment Phase: Third Intervention|Unspecified|0
48252|NCT01380093|197976|P7|Treatment Phase: Third Intervention|Unspecified|0
48253|NCT01380093|197977|P6|Treatment Phase: Third Intervention|Unspecified|0
48254|NCT01380093|197978|P5|Treatment Phase: Third Intervention|Unspecified|0
48255|NCT01380093|197979|P4|Treatment Phase: Third Intervention|Unspecified|0
48256|NCT01380093|197980|P3|Treatment Phase: Third Intervention|Unspecified|0
48257|NCT01380093|197981|P2|Treatment Phase: Third Intervention|Unspecified|0
48258|NCT01380093|197982|P1|Treatment Phase: Third Intervention|Unspecified|0
48259|NCT01380093|197974|P9|Treatment Phase: Third Intervention|Non-compliance|1
48260|NCT01380093|197975|P8|Treatment Phase: Third Intervention|Non-compliance|0
48261|NCT01380093|197976|P7|Treatment Phase: Third Intervention|Non-compliance|0
48262|NCT01380093|197977|P6|Treatment Phase: Third Intervention|Non-compliance|0
48263|NCT01380093|197978|P5|Treatment Phase: Third Intervention|Non-compliance|0
48264|NCT01380093|197979|P4|Treatment Phase: Third Intervention|Non-compliance|0
48265|NCT01380093|197980|P3|Treatment Phase: Third Intervention|Non-compliance|0
48266|NCT01380093|197981|P2|Treatment Phase: Third Intervention|Non-compliance|0
48267|NCT01380093|197982|P1|Treatment Phase: Third Intervention|Non-compliance|0
48268|NCT01380093|197974|P9|Treatment Phase: Second Intervention|Unspecified|0
48269|NCT01380093|197975|P8|Treatment Phase: Second Intervention|Unspecified|0
48270|NCT01380093|197976|P7|Treatment Phase: Second Intervention|Unspecified|0
48271|NCT01380093|197977|P6|Treatment Phase: Second Intervention|Unspecified|0
48272|NCT01380093|197978|P5|Treatment Phase: Second Intervention|Unspecified|0
48273|NCT01380093|197979|P4|Treatment Phase: Second Intervention|Unspecified|1
48274|NCT01380093|197980|P3|Treatment Phase: Second Intervention|Unspecified|0
48275|NCT01380093|197981|P2|Treatment Phase: Second Intervention|Unspecified|0
48276|NCT01380093|197982|P1|Treatment Phase: Second Intervention|Unspecified|0
48277|NCT01380093|197974|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
48278|NCT01380093|197975|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
48279|NCT01380093|197976|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
48280|NCT01380093|197977|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
48281|NCT01380093|197978|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
48282|NCT01380093|197979|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
48283|NCT01380093|197980|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
48284|NCT01380093|197981|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
48285|NCT01380093|197982|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
48286|NCT01380093|197974|P9|Drug Discrimination Phase: Day 2|Backup participant|0
48287|NCT01380093|197975|P8|Drug Discrimination Phase: Day 2|Backup participant|0
48288|NCT01380093|197976|P7|Drug Discrimination Phase: Day 2|Backup participant|0
48289|NCT01380093|197977|P6|Drug Discrimination Phase: Day 2|Backup participant|0
48290|NCT01380093|197978|P5|Drug Discrimination Phase: Day 2|Backup participant|0
48291|NCT01380093|197979|P4|Drug Discrimination Phase: Day 2|Backup participant|0
48292|NCT01380093|197980|P3|Drug Discrimination Phase: Day 2|Backup participant|1
48293|NCT01380093|197981|P2|Drug Discrimination Phase: Day 2|Backup participant|0
48294|NCT01380093|197982|P1|Drug Discrimination Phase: Day 2|Backup participant|0
48295|NCT01380093|197974|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48296|NCT01380093|197975|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48297|NCT01380093|197976|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48298|NCT01380093|197977|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48299|NCT01380093|197978|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48300|NCT01380093|197979|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48301|NCT01380093|197980|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
48302|NCT01380093|197981|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
48303|NCT01380093|197982|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
48304|NCT01380093|197974|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
48305|NCT01380093|197975|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
48306|NCT01380093|197976|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
48307|NCT01380093|197977|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
48308|NCT01380093|197978|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
48309|NCT01380093|197979|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
48310|NCT01380093|197980|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
48311|NCT01380093|197981|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
48312|NCT01380093|197982|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
48313|NCT01380093|197974|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48314|NCT01380093|197975|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48315|NCT01380093|197976|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48316|NCT01380093|197977|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48317|NCT01380093|197978|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48318|NCT01380093|197979|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48319|NCT01380093|197980|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48320|NCT01380093|197981|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
48321|NCT01380093|197982|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
48322|NCT01380093|197974|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
48323|NCT01380093|197975|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
48324|NCT01380093|197976|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
48325|NCT01380093|197977|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
48326|NCT01380093|197978|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
48327|NCT01380093|197979|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
48328|NCT01380093|197980|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
48329|NCT01380093|197981|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
48330|NCT01380093|197982|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
48331|NCT01380093|197974|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
48332|NCT01380093|197975|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
48333|NCT01380093|197976|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
48334|NCT01380093|197977|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
48335|NCT01380093|197978|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
48336|NCT01380093|197979|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
48337|NCT01380093|197980|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
48338|NCT01380093|197981|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
48339|NCT01380093|197982|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
48340|NCT01380093|197974|P9|Naloxone Challenge Phase|Screen failures|0
48341|NCT01380093|197975|P8|Naloxone Challenge Phase|Screen failures|0
48342|NCT01380093|197976|P7|Naloxone Challenge Phase|Screen failures|0
48343|NCT01380093|197977|P6|Naloxone Challenge Phase|Screen failures|0
48344|NCT01380093|197978|P5|Naloxone Challenge Phase|Screen failures|0
48345|NCT01380093|197979|P4|Naloxone Challenge Phase|Screen failures|0
48346|NCT01380093|197980|P3|Naloxone Challenge Phase|Screen failures|0
48347|NCT01380093|197981|P2|Naloxone Challenge Phase|Screen failures|0
48348|NCT01380093|197982|P1|Naloxone Challenge Phase|Screen failures|21
48349|NCT01380080|198274|P2|Overall Study|Lost to Follow-up|0
48350|NCT01380080|198275|P1|Overall Study|Lost to Follow-up|2
48351|NCT01380080|198274|P2|Overall Study|Not willing to adhere to requirements|1
48352|NCT01380080|198275|P1|Overall Study|Not willing to adhere to requirements|3
48353|NCT01380080|198274|P2|Overall Study|Not able to get to clinic|0
48354|NCT01380080|198275|P1|Overall Study|Not able to get to clinic|4
48355|NCT01380080|198274|P2|Overall Study|Withdrawal by Subject|0
48356|NCT01380080|198275|P1|Overall Study|Withdrawal by Subject|4
48357|NCT01380080|198274|P2|Overall Study|Death|22
48358|NCT01380080|198275|P1|Overall Study|Death|20
48359|NCT01379937|198300|P4|Overall Study|Lost to Follow-up|0
48360|NCT01379937|198301|P3|Overall Study|Lost to Follow-up|2
48361|NCT01379937|198302|P2|Overall Study|Lost to Follow-up|2
48362|NCT01379937|198303|P1|Overall Study|Lost to Follow-up|1
48363|NCT01379937|198300|P4|Overall Study|Consent withdrawal|0
48364|NCT01379937|198301|P3|Overall Study|Consent withdrawal|0
48365|NCT01379937|198302|P2|Overall Study|Consent withdrawal|1
48366|NCT01379937|198303|P1|Overall Study|Consent withdrawal|0
48367|NCT01379937|198300|P4|Overall Study|Protocol Violation|1
48368|NCT01379937|198301|P3|Overall Study|Protocol Violation|0
48369|NCT01379937|198302|P2|Overall Study|Protocol Violation|0
48370|NCT01379937|198303|P1|Overall Study|Protocol Violation|0
48371|NCT01379781|198385|P2|Overall Study|Lost to Follow-up|8
48372|NCT01379781|198386|P1|Overall Study|Lost to Follow-up|11
48373|NCT01379768|198395|P3|Overall Study|Lost to Follow-up|0
48374|NCT01379768|198396|P2|Overall Study|Lost to Follow-up|0
48375|NCT01379768|198397|P1|Overall Study|Lost to Follow-up|2
48376|NCT01379768|198395|P3|Overall Study|Adverse Event|0
48377|NCT01379768|198396|P2|Overall Study|Adverse Event|1
48378|NCT01379768|198397|P1|Overall Study|Adverse Event|1
48379|NCT01379703|198420|P3|9 Months Through 18 Months|Reason Unknown|0
48380|NCT01379703|198421|P2|9 Months Through 18 Months|Reason Unknown|23
48381|NCT01379703|198422|P1|9 Months Through 18 Months|Reason Unknown|0
48382|NCT01379703|198420|P3|9 Months Through 18 Months|Fatigue|0
48383|NCT01379703|198421|P2|9 Months Through 18 Months|Fatigue|1
48384|NCT01379703|198422|P1|9 Months Through 18 Months|Fatigue|0
48385|NCT01379703|198420|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
48386|NCT01379703|198421|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
48387|NCT01379703|198422|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
48388|NCT01379703|198420|P3|9 Months Through 18 Months|Patient Noncompliance|0
48389|NCT01379703|198421|P2|9 Months Through 18 Months|Patient Noncompliance|4
48390|NCT01379703|198422|P1|9 Months Through 18 Months|Patient Noncompliance|0
48391|NCT01379703|198420|P3|9 Months Through 18 Months|Treatment failure|0
48392|NCT01379703|198421|P2|9 Months Through 18 Months|Treatment failure|5
48393|NCT01379703|198422|P1|9 Months Through 18 Months|Treatment failure|0
48394|NCT01379703|198420|P3|9 Months Through 18 Months|Adverse Event|0
48395|NCT01379703|198421|P2|9 Months Through 18 Months|Adverse Event|6
48396|NCT01379703|198422|P1|9 Months Through 18 Months|Adverse Event|0
48397|NCT01379703|198420|P3|9 Months Through 18 Months|Withdrawal by Subject|0
48398|NCT01379703|198421|P2|9 Months Through 18 Months|Withdrawal by Subject|11
48399|NCT01379703|198422|P1|9 Months Through 18 Months|Withdrawal by Subject|0
48400|NCT01379703|198420|P3|9 Months Through 18 Months|Lost to Follow-up|0
48401|NCT01379703|198421|P2|9 Months Through 18 Months|Lost to Follow-up|178
48402|NCT01379703|198422|P1|9 Months Through 18 Months|Lost to Follow-up|0
48403|NCT01379703|198420|P3|Study Start Through 9 Months|Reason unknown|24
48404|NCT01379703|198421|P2|Study Start Through 9 Months|Reason unknown|31
48405|NCT01379703|198422|P1|Study Start Through 9 Months|Reason unknown|2
48406|NCT01379703|198420|P3|Study Start Through 9 Months|Increased triglycerides|0
48407|NCT01379703|198421|P2|Study Start Through 9 Months|Increased triglycerides|1
48408|NCT01379703|198422|P1|Study Start Through 9 Months|Increased triglycerides|0
48409|NCT01379703|198420|P3|Study Start Through 9 Months|Poor general condition|0
48410|NCT01379703|198421|P2|Study Start Through 9 Months|Poor general condition|1
48411|NCT01379703|198422|P1|Study Start Through 9 Months|Poor general condition|0
48412|NCT01379703|198420|P3|Study Start Through 9 Months|Medication not available|1
48413|NCT01379703|198421|P2|Study Start Through 9 Months|Medication not available|2
48414|NCT01379703|198422|P1|Study Start Through 9 Months|Medication not available|0
48415|NCT01379703|198420|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
48416|NCT01379703|198421|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
48417|NCT01379703|198422|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
48418|NCT01379703|198420|P3|Study Start Through 9 Months|Patient Noncompliance|1
48419|NCT01379703|198421|P2|Study Start Through 9 Months|Patient Noncompliance|0
48420|NCT01379703|198422|P1|Study Start Through 9 Months|Patient Noncompliance|0
48421|NCT01379703|198420|P3|Study Start Through 9 Months|Treatment Failure|2
48422|NCT01379703|198421|P2|Study Start Through 9 Months|Treatment Failure|2
48423|NCT01379703|198422|P1|Study Start Through 9 Months|Treatment Failure|0
48424|NCT01379703|198420|P3|Study Start Through 9 Months|Withdrawal by Subject|1
48425|NCT01379703|198421|P2|Study Start Through 9 Months|Withdrawal by Subject|6
48426|NCT01379703|198422|P1|Study Start Through 9 Months|Withdrawal by Subject|0
48427|NCT01379703|198420|P3|Study Start Through 9 Months|Adverse Event|10
48428|NCT01379703|198421|P2|Study Start Through 9 Months|Adverse Event|14
48429|NCT01379703|198422|P1|Study Start Through 9 Months|Adverse Event|0
48430|NCT01379703|198420|P3|Study Start Through 9 Months|Lost to Follow-up|104
48431|NCT01379703|198421|P2|Study Start Through 9 Months|Lost to Follow-up|61
48432|NCT01379703|198422|P1|Study Start Through 9 Months|Lost to Follow-up|2
48433|NCT01379534|198522|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
48434|NCT01379534|198523|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
48435|NCT01379534|198522|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
48436|NCT01379534|198523|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
48437|NCT01379534|198522|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
48438|NCT01379534|198523|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
48439|NCT01379534|198522|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
48440|NCT01379534|198523|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
48441|NCT01379534|198522|P2|Treatment Phase|Adverse Event|7
48442|NCT01379534|198523|P1|Treatment Phase|Adverse Event|7
48443|NCT01379534|198522|P2|Treatment Phase|Progressive disease|22
48444|NCT01379534|198523|P1|Treatment Phase|Progressive disease|13
48445|NCT01379534|198522|P2|Treatment Phase|Withdrawal by Subject|2
48446|NCT01379534|198523|P1|Treatment Phase|Withdrawal by Subject|2
48447|NCT01379521|198543|P2|Post-Treatment Evaluations|Death|0
48448|NCT01379521|198544|P1|Post-Treatment Evaluations|Death|1
48449|NCT01379521|198543|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
48450|NCT01379521|198544|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
48451|NCT01379521|198543|P2|Post-Treatment Evaluations|Disease Progression|20
48452|NCT01379521|198544|P1|Post-Treatment Evaluations|Disease Progression|22
48453|NCT01379521|198543|P2|Overall Study -Treatment Period|Death|1
48454|NCT01379521|198544|P1|Overall Study -Treatment Period|Death|2
48455|NCT01379521|198543|P2|Overall Study -Treatment Period|Administrative Problems|0
48456|NCT01379521|198544|P1|Overall Study -Treatment Period|Administrative Problems|1
48457|NCT01379521|198543|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
48458|NCT01379521|198544|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
48459|NCT01379521|198543|P2|Overall Study -Treatment Period|Protocol Deviation|2
48460|NCT01379521|198544|P1|Overall Study -Treatment Period|Protocol Deviation|0
48461|NCT01379521|198543|P2|Overall Study -Treatment Period|New Cancer Therapy|0
48462|NCT01379521|198544|P1|Overall Study -Treatment Period|New Cancer Therapy|1
48463|NCT01379521|198543|P2|Overall Study -Treatment Period|Disease Progression|22
48464|NCT01379521|198544|P1|Overall Study -Treatment Period|Disease Progression|23
48465|NCT01379521|198543|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
48466|NCT01379521|198544|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
48467|NCT01379521|198543|P2|Overall Study -Treatment Period|Adverse Event|0
48468|NCT01379521|198544|P1|Overall Study -Treatment Period|Adverse Event|3
48469|NCT01378975|198614|P2|Overall Study|Withdrew Consent|3
48470|NCT01378975|198615|P1|Overall Study|Withdrew Consent|4
48471|NCT01378975|198614|P2|Overall Study|Lost to Follow-up|1
48472|NCT01378975|198615|P1|Overall Study|Lost to Follow-up|4
48473|NCT01378975|198614|P2|Overall Study|Investigator Request|0
48474|NCT01378975|198615|P1|Overall Study|Investigator Request|1
48475|NCT01378975|198614|P2|Overall Study|Death|46
48476|NCT01378975|198615|P1|Overall Study|Death|77
48477|NCT01378962|198641|P1|Overall Study|Unspecified|2
48478|NCT01378962|198641|P1|Overall Study|Lost to Follow-up|1
48479|NCT01378962|198641|P1|Overall Study|Death|14
48480|NCT01378429|198667|P2|Overall Study|Noncompliance with study drug|0
48481|NCT01378429|198668|P1|Overall Study|Noncompliance with study drug|1
48482|NCT01378325|198710|P2|Overall Study|Protocol Violation|1
48483|NCT01378325|198711|P1|Overall Study|Protocol Violation|0
48484|NCT01378195|198728|P2|Overall Study|Lost to Follow-up|18
48485|NCT01378195|198729|P1|Overall Study|Lost to Follow-up|29
48486|NCT01378117|198742|P3|Overall Study|discharged before med given|1
48487|NCT01378117|198743|P2|Overall Study|discharged before med given|0
48488|NCT01378117|198744|P1|Overall Study|discharged before med given|2
48489|NCT01378117|198742|P3|Overall Study|withdrawal|2
48490|NCT01378117|198743|P2|Overall Study|withdrawal|1
48491|NCT01378117|198744|P1|Overall Study|withdrawal|2
48492|NCT01378104|198754|P2|Overall Study|Withdrawal by Subject|13
48493|NCT01378104|198755|P1|Overall Study|Withdrawal by Subject|12
48494|NCT01378104|198754|P2|Overall Study|Lack of Efficacy|5
48495|NCT01378104|198755|P1|Overall Study|Lack of Efficacy|7
48496|NCT01378104|198754|P2|Overall Study|Adverse Event|8
48497|NCT01378104|198755|P1|Overall Study|Adverse Event|8
48498|NCT01377480|198833|P4|Overall Study|Not specified|6
48499|NCT01377480|198834|P3|Overall Study|Not specified|7
48500|NCT01377480|198835|P2|Overall Study|Not specified|0
48501|NCT01377480|198836|P1|Overall Study|Not specified|0
48502|NCT01377480|198833|P4|Overall Study|Serious adverse event|1
48503|NCT01377480|198834|P3|Overall Study|Serious adverse event|1
48504|NCT01377480|198835|P2|Overall Study|Serious adverse event|0
48505|NCT01377480|198836|P1|Overall Study|Serious adverse event|0
48506|NCT01377480|198833|P4|Overall Study|Withdrawal by Subject|0
48507|NCT01377480|198834|P3|Overall Study|Withdrawal by Subject|1
48508|NCT01377480|198835|P2|Overall Study|Withdrawal by Subject|0
48509|NCT01377480|198836|P1|Overall Study|Withdrawal by Subject|0
48510|NCT01377480|198833|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
48511|NCT01377480|198834|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
48512|NCT01377480|198835|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
48513|NCT01377480|198836|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
48514|NCT01377480|198833|P4|Overall Study|Protocol Violation|4
48515|NCT01377480|198834|P3|Overall Study|Protocol Violation|0
48516|NCT01377480|198835|P2|Overall Study|Protocol Violation|0
48517|NCT01377480|198836|P1|Overall Study|Protocol Violation|0
48518|NCT01377233|198915|P5|Double-blind|Administrative or other|1
48519|NCT01377233|198916|P4|Double-blind|Administrative or other|1
48520|NCT01377233|198917|P3|Double-blind|Administrative or other|0
48521|NCT01377233|198918|P2|Double-blind|Administrative or other|0
48522|NCT01377233|198919|P1|Double-blind|Administrative or other|0
48523|NCT01377233|198915|P5|Double-blind|Withdrawal by Subject|0
48524|NCT01377233|198916|P4|Double-blind|Withdrawal by Subject|1
48525|NCT01377233|198917|P3|Double-blind|Withdrawal by Subject|0
48526|NCT01377233|198918|P2|Double-blind|Withdrawal by Subject|0
48527|NCT01377233|198919|P1|Double-blind|Withdrawal by Subject|0
48528|NCT01377233|198915|P5|Double-blind|Protocol Violation|1
48529|NCT01377233|198916|P4|Double-blind|Protocol Violation|0
48530|NCT01377233|198917|P3|Double-blind|Protocol Violation|0
48531|NCT01377233|198918|P2|Double-blind|Protocol Violation|0
48532|NCT01377233|198919|P1|Double-blind|Protocol Violation|0
48533|NCT01377233|198915|P5|Double-blind|Adverse Event|0
48534|NCT01377233|198916|P4|Double-blind|Adverse Event|2
48535|NCT01377233|198917|P3|Double-blind|Adverse Event|2
48536|NCT01377233|198918|P2|Double-blind|Adverse Event|1
48537|NCT01377233|198919|P1|Double-blind|Adverse Event|0
48538|NCT01377233|198915|P5|Open-label|Withdrawal by Subject|0
48539|NCT01377233|198916|P4|Open-label|Withdrawal by Subject|0
48540|NCT01377233|198917|P3|Open-label|Withdrawal by Subject|0
48541|NCT01377233|198918|P2|Open-label|Withdrawal by Subject|0
48542|NCT01377233|198919|P1|Open-label|Withdrawal by Subject|3
48543|NCT01377233|198915|P5|Open-label|Adverse Event|0
48544|NCT01377233|198916|P4|Open-label|Adverse Event|0
48545|NCT01377233|198917|P3|Open-label|Adverse Event|0
48546|NCT01377233|198918|P2|Open-label|Adverse Event|0
48547|NCT01377233|198919|P1|Open-label|Adverse Event|1
48548|NCT01377194|198946|P3|Overall Study|Lost to Follow-up|11
48549|NCT01377194|198947|P2|Overall Study|Lost to Follow-up|8
48550|NCT01377194|198948|P1|Overall Study|Lost to Follow-up|14
48551|NCT01377194|198946|P3|Overall Study|Withdrawal by Subject|7
48552|NCT01377194|198947|P2|Overall Study|Withdrawal by Subject|10
48553|NCT01377194|198948|P1|Overall Study|Withdrawal by Subject|8
48554|NCT01377194|198946|P3|Overall Study|Protocol Violation|6
48555|NCT01377194|198947|P2|Overall Study|Protocol Violation|10
48556|NCT01377194|198948|P1|Overall Study|Protocol Violation|4
48557|NCT01377194|198946|P3|Overall Study|Lack of Efficacy|3
48558|NCT01377194|198947|P2|Overall Study|Lack of Efficacy|3
48559|NCT01377194|198948|P1|Overall Study|Lack of Efficacy|3
48560|NCT01377194|198946|P3|Overall Study|Adverse Event|19
48561|NCT01377194|198947|P2|Overall Study|Adverse Event|12
48562|NCT01377194|198948|P1|Overall Study|Adverse Event|3
48563|NCT01377012|198962|P3|Extension Study, Weeks 104-260|Adverse Event|1
48564|NCT01377012|198963|P2|Extension Study, Weeks 104-260|Adverse Event|2
48565|NCT01377012|198964|P1|Extension Study, Weeks 104-260|Adverse Event|0
48566|NCT01377012|198962|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
48567|NCT01377012|198963|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
48568|NCT01377012|198964|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
48569|NCT01377012|198962|P3|Extension Study, Weeks 104-260|Physician Decision|0
48570|NCT01377012|198963|P2|Extension Study, Weeks 104-260|Physician Decision|0
48571|NCT01377012|198964|P1|Extension Study, Weeks 104-260|Physician Decision|1
48572|NCT01377012|198962|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
48573|NCT01377012|198963|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
48574|NCT01377012|198964|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
48575|NCT01377012|198962|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
48576|NCT01377012|198963|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
48577|NCT01377012|198964|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
48578|NCT01377012|198962|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
48579|NCT01377012|198963|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
48580|NCT01377012|198964|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
48581|NCT01377012|198962|P3|Core Study|Adverse Event|13
48582|NCT01377012|198963|P2|Core Study|Adverse Event|14
48583|NCT01377012|198964|P1|Core Study|Adverse Event|10
48584|NCT01377012|198962|P3|Core Study|Death|1
48585|NCT01377012|198963|P2|Core Study|Death|1
48586|NCT01377012|198964|P1|Core Study|Death|1
48587|NCT01377012|198962|P3|Core Study|Lack of Efficacy|37
48588|NCT01377012|198963|P2|Core Study|Lack of Efficacy|28
48589|NCT01377012|198964|P1|Core Study|Lack of Efficacy|41
48590|NCT01377012|198962|P3|Core Study|Lost to Follow-up|4
48591|NCT01377012|198963|P2|Core Study|Lost to Follow-up|5
48592|NCT01377012|198964|P1|Core Study|Lost to Follow-up|7
48593|NCT01377012|198962|P3|Core Study|No Longer require treatment|1
48594|NCT01377012|198963|P2|Core Study|No Longer require treatment|0
48595|NCT01377012|198964|P1|Core Study|No Longer require treatment|0
48596|NCT01377012|198962|P3|Core Study|Non-Compliant with study treatment|1
48597|NCT01377012|198963|P2|Core Study|Non-Compliant with study treatment|0
48598|NCT01377012|198964|P1|Core Study|Non-Compliant with study treatment|0
48599|NCT01377012|198962|P3|Core Study|Physician Decision|10
48600|NCT01377012|198963|P2|Core Study|Physician Decision|4
48601|NCT01377012|198964|P1|Core Study|Physician Decision|5
48602|NCT01377012|198962|P3|Core Study|Pregnancy|1
48603|NCT01377012|198963|P2|Core Study|Pregnancy|0
48604|NCT01377012|198964|P1|Core Study|Pregnancy|0
48605|NCT01377012|198962|P3|Core Study|Protocol Violation|2
48606|NCT01377012|198963|P2|Core Study|Protocol Violation|3
48607|NCT01377012|198964|P1|Core Study|Protocol Violation|7
48608|NCT01377012|198962|P3|Core Study|Withdrawal by Subject|18
48609|NCT01377012|198963|P2|Core Study|Withdrawal by Subject|23
48610|NCT01377012|198964|P1|Core Study|Withdrawal by Subject|15
48611|NCT01377012|198962|P3|Core Study|Technical problems|0
48612|NCT01377012|198963|P2|Core Study|Technical problems|0
48613|NCT01377012|198964|P1|Core Study|Technical problems|1
48614|NCT01377012|198962|P3|Core Study|Study terminated by Sponsor|46
48615|NCT01377012|198963|P2|Core Study|Study terminated by Sponsor|54
48616|NCT01377012|198964|P1|Core Study|Study terminated by Sponsor|47
48617|NCT01376908|199001|P2|Overall Study|Withdrawal by Subject|2
48618|NCT01376908|199002|P1|Overall Study|Withdrawal by Subject|1
48619|NCT01376908|199001|P2|Overall Study|Protocol Violation|1
48620|NCT01376908|199002|P1|Overall Study|Protocol Violation|1
48621|NCT01376804|199035|P1|Treatment Period|Patient did not receive study drug|1
48622|NCT01376804|199035|P1|Treatment Period|Adverse Event|6
48623|NCT01376804|199035|P1|Treatment Period|Withdrawal by Subject|1
48624|NCT01376700|199046|P1|Overall Study|Low or high titer inhibitor|8
48625|NCT01376700|199046|P1|Overall Study|Sponsor terminated study early|8
48626|NCT01376388|199108|P1|Overall Study|Withdrawal by Subject|3
48627|NCT01376388|199108|P1|Overall Study|Lack of Efficacy|2
48628|NCT01376388|199108|P1|Overall Study|Adverse Event|13
48629|NCT01376349|199146|P3|Raondomized Treatment|Alternative Treatment|1
48630|NCT01376349|199147|P2|Raondomized Treatment|Alternative Treatment|0
48631|NCT01376349|199148|P1|Raondomized Treatment|Alternative Treatment|0
48632|NCT01376349|199146|P3|Raondomized Treatment|Unkown|1
48633|NCT01376349|199147|P2|Raondomized Treatment|Unkown|2
48634|NCT01376349|199148|P1|Raondomized Treatment|Unkown|1
48635|NCT01376349|199146|P3|Raondomized Treatment|Adverse Event|14
48636|NCT01376349|199147|P2|Raondomized Treatment|Adverse Event|17
48637|NCT01376349|199148|P1|Raondomized Treatment|Adverse Event|13
48638|NCT01376349|199146|P3|Raondomized Treatment|Withdrawal by Subject|13
48639|NCT01376349|199147|P2|Raondomized Treatment|Withdrawal by Subject|16
48640|NCT01376349|199148|P1|Raondomized Treatment|Withdrawal by Subject|10
48641|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
48642|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
48643|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
48644|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
48645|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
48646|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Physician Decision|0
48647|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Physician Decision|1
48648|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Physician Decision|1
48649|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Physician Decision|0
48650|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Physician Decision|0
48651|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
48652|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
48653|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
48654|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
48655|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
48656|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
48657|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
48658|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
48659|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
48660|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
48661|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
48662|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
48663|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
48664|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
48665|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
48666|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
48667|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
48668|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
48669|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
48670|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
48671|NCT01376245|199170|P5|24-week, Double-blind Treatment Period|Adverse Event|18
48672|NCT01376245|199171|P4|24-week, Double-blind Treatment Period|Adverse Event|8
48673|NCT01376245|199172|P3|24-week, Double-blind Treatment Period|Adverse Event|7
48674|NCT01376245|199173|P2|24-week, Double-blind Treatment Period|Adverse Event|16
48675|NCT01376245|199174|P1|24-week, Double-blind Treatment Period|Adverse Event|0
48676|NCT01376245|199170|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
48677|NCT01376245|199171|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
48678|NCT01376245|199172|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
48679|NCT01376245|199173|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
48680|NCT01376245|199174|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
48681|NCT01376245|199170|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
48682|NCT01376245|199171|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
48683|NCT01376245|199172|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
48684|NCT01376245|199173|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
48685|NCT01376245|199174|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
48686|NCT01376245|199170|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
48687|NCT01376245|199171|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
48688|NCT01376245|199172|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
48689|NCT01376245|199173|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
48690|NCT01376245|199174|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
48691|NCT01376245|199170|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
48692|NCT01376245|199171|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
48693|NCT01376245|199172|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
48694|NCT01376245|199173|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
48695|NCT01376245|199174|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
48696|NCT01376245|199170|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
48697|NCT01376245|199171|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
48698|NCT01376245|199172|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
48699|NCT01376245|199173|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
48700|NCT01376245|199174|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
48701|NCT01376089|199190|P2|Overall Study|Patient received no contrast media|4
48702|NCT01376089|199191|P1|Overall Study|Patient received no contrast media|3
48703|NCT01376037|199214|P2|Overall Study|Lost to Follow-up|2
48704|NCT01376037|199215|P1|Overall Study|Lost to Follow-up|0
48705|NCT01375777|199230|P9|Overall Study|Other|1
48706|NCT01375777|199231|P8|Overall Study|Other|0
48707|NCT01375777|199232|P7|Overall Study|Other|0
48708|NCT01375777|199233|P6|Overall Study|Other|0
48709|NCT01375777|199234|P5|Overall Study|Other|0
48710|NCT01375777|199235|P4|Overall Study|Other|0
48711|NCT01375777|199236|P3|Overall Study|Other|0
48712|NCT01375777|199237|P2|Overall Study|Other|1
48713|NCT01375777|199238|P1|Overall Study|Other|1
48714|NCT01375777|199230|P9|Overall Study|Lost to Follow-up|0
48715|NCT01375777|199231|P8|Overall Study|Lost to Follow-up|0
48716|NCT01375777|199232|P7|Overall Study|Lost to Follow-up|1
48717|NCT01375777|199233|P6|Overall Study|Lost to Follow-up|0
48718|NCT01375777|199234|P5|Overall Study|Lost to Follow-up|0
48719|NCT01375777|199235|P4|Overall Study|Lost to Follow-up|0
48720|NCT01375777|199236|P3|Overall Study|Lost to Follow-up|0
48721|NCT01375777|199237|P2|Overall Study|Lost to Follow-up|0
48722|NCT01375777|199238|P1|Overall Study|Lost to Follow-up|1
48723|NCT01375777|199230|P9|Overall Study|Withdrawal by Subject|1
48724|NCT01375777|199231|P8|Overall Study|Withdrawal by Subject|2
48725|NCT01375777|199232|P7|Overall Study|Withdrawal by Subject|1
48726|NCT01375777|199233|P6|Overall Study|Withdrawal by Subject|1
48727|NCT01375777|199234|P5|Overall Study|Withdrawal by Subject|1
48728|NCT01375777|199235|P4|Overall Study|Withdrawal by Subject|0
48729|NCT01375777|199236|P3|Overall Study|Withdrawal by Subject|1
48730|NCT01375777|199237|P2|Overall Study|Withdrawal by Subject|2
48731|NCT01375777|199238|P1|Overall Study|Withdrawal by Subject|0
48732|NCT01375764|199308|P5|Overall Study|Other|0
48733|NCT01375764|199309|P4|Overall Study|Other|1
48734|NCT01375764|199310|P3|Overall Study|Other|0
48735|NCT01375764|199311|P2|Overall Study|Other|0
48736|NCT01375764|199312|P1|Overall Study|Other|0
48737|NCT01375764|199308|P5|Overall Study|Withdrawal by Subject|1
48738|NCT01375764|199309|P4|Overall Study|Withdrawal by Subject|0
48739|NCT01375764|199310|P3|Overall Study|Withdrawal by Subject|0
48740|NCT01375764|199311|P2|Overall Study|Withdrawal by Subject|0
48741|NCT01375764|199312|P1|Overall Study|Withdrawal by Subject|2
48742|NCT01375764|199308|P5|Overall Study|Lost to Follow-up|0
48743|NCT01375764|199309|P4|Overall Study|Lost to Follow-up|0
48744|NCT01375764|199310|P3|Overall Study|Lost to Follow-up|0
48745|NCT01375764|199311|P2|Overall Study|Lost to Follow-up|1
48746|NCT01375764|199312|P1|Overall Study|Lost to Follow-up|0
48747|NCT01375751|199358|P3|Overall Study|Other|0
48748|NCT01375751|199359|P2|Overall Study|Other|1
48749|NCT01375751|199360|P1|Overall Study|Other|0
48750|NCT01375608|199404|P1|Overall Study|Withdrawal by Subject|2
48751|NCT01375374|199413|P1|Overall Study|Adverse Event|1
48752|NCT01375049|199463|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
48753|NCT01375049|199463|P1|Overall Study|Withdrawal by Subject|2
48754|NCT01375049|199463|P1|Overall Study|Lost to Follow-up|1
48755|NCT01375049|199463|P1|Overall Study|Adverse Event|2
48756|NCT01374971|199478|P1|Overall Study|Withdrawal by Subject|1
48757|NCT01374919|199483|P1|Overall Study|Withdrawal by Subject|2
48758|NCT01374568|199502|P2|Overall Study|Lab unable to analyze BTM|2
48759|NCT01374568|199503|P1|Overall Study|Lab unable to analyze BTM|0
48760|NCT01374451|199513|P2|Overall Study|Administrative problems|0
48761|NCT01374451|199514|P1|Overall Study|Administrative problems|1
48762|NCT01374425|199560|P2|Overall Study|Not Specified|43
48763|NCT01374425|199561|P1|Overall Study|Not Specified|41
48764|NCT01374425|199560|P2|Overall Study|Lost to Follow-up|1
48765|NCT01374425|199561|P1|Overall Study|Lost to Follow-up|2
48766|NCT01374425|199560|P2|Overall Study|Sponsor Decision|1
48767|NCT01374425|199561|P1|Overall Study|Sponsor Decision|0
48768|NCT01374425|199560|P2|Overall Study|Protocol Violation|3
48769|NCT01374425|199561|P1|Overall Study|Protocol Violation|2
48770|NCT01374425|199560|P2|Overall Study|Refused Treatment|24
48771|NCT01374425|199561|P1|Overall Study|Refused Treatment|10
48772|NCT01374425|199560|P2|Overall Study|Withdrawal by Subject|7
48773|NCT01374425|199561|P1|Overall Study|Withdrawal by Subject|6
48774|NCT01374425|199560|P2|Overall Study|Death (Adverse Event)|4
48775|NCT01374425|199561|P1|Overall Study|Death (Adverse Event)|2
48776|NCT01374425|199560|P2|Overall Study|Death (Progression of Disease)|0
48777|NCT01374425|199561|P1|Overall Study|Death (Progression of Disease)|1
48778|NCT01374425|199560|P2|Overall Study|Adverse Event|18
48779|NCT01374425|199561|P1|Overall Study|Adverse Event|29
48780|NCT01374425|199560|P2|Overall Study|Clinical Disease Progression|6
48781|NCT01374425|199561|P1|Overall Study|Clinical Disease Progression|9
48782|NCT01374425|199560|P2|Overall Study|Radiographic Disease Progression|81
48783|NCT01374425|199561|P1|Overall Study|Radiographic Disease Progression|86
48784|NCT01374269|199646|P2|Overall Study|closed research|2
48785|NCT01374269|199647|P1|Overall Study|closed research|1
48786|NCT01374269|199646|P2|Overall Study|Lost to Follow-up|3
48787|NCT01374269|199647|P1|Overall Study|Lost to Follow-up|1
48788|NCT01374269|199646|P2|Overall Study|Withdrawal by Subject|0
48789|NCT01374269|199647|P1|Overall Study|Withdrawal by Subject|4
48790|NCT01374178|199775|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
48791|NCT01374178|199776|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
48792|NCT01374178|199775|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
48793|NCT01374178|199776|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
48794|NCT01374087|199794|P2|Overall Study|Not provided|13
48795|NCT01374087|199795|P1|Overall Study|Not provided|13
48796|NCT01374087|199794|P2|Overall Study|Disease progression|2
48797|NCT01374087|199795|P1|Overall Study|Disease progression|2
48798|NCT01374087|199794|P2|Overall Study|Adverse Event|1
48799|NCT01374087|199795|P1|Overall Study|Adverse Event|0
48800|NCT01373918|199805|P2|Overall Study|Physician Decision|1
48801|NCT01373918|199806|P1|Overall Study|Physician Decision|0
48802|NCT01373346|199845|P1|Overall Study|Death|1
48803|NCT01373294|199868|P2|Overall Study|Adverse Event|0
48804|NCT01373294|199869|P1|Overall Study|Adverse Event|1
48805|NCT01373281|199878|P2|Overall Study|Serious adverse event|5
48806|NCT01373281|199879|P1|Overall Study|Serious adverse event|6
48807|NCT01373281|199878|P2|Overall Study|Adverse Event|4
48808|NCT01373281|199879|P1|Overall Study|Adverse Event|4
48809|NCT01373281|199878|P2|Overall Study|Lost to Follow-up|1
48810|NCT01373281|199879|P1|Overall Study|Lost to Follow-up|4
48811|NCT01373281|199878|P2|Overall Study|Protocol Violation|4
48812|NCT01373281|199879|P1|Overall Study|Protocol Violation|13
48813|NCT01373281|199878|P2|Overall Study|Withdrawal by Subject|31
48814|NCT01373281|199879|P1|Overall Study|Withdrawal by Subject|52
48815|NCT01372995|199898|P3|Overall Study|Physician Decision|1
48816|NCT01372995|199899|P2|Overall Study|Physician Decision|0
48817|NCT01372995|199900|P1|Overall Study|Physician Decision|0
48818|NCT01372995|199898|P3|Overall Study|Spouse withdrew participant from study|0
48819|NCT01372995|199899|P2|Overall Study|Spouse withdrew participant from study|1
48820|NCT01372995|199900|P1|Overall Study|Spouse withdrew participant from study|0
48821|NCT01372878|199947|P1|Overall Study|incomplete study procedure|104
48822|NCT01372878|199947|P1|Overall Study|Protocol Violation|17
48823|NCT01372878|199947|P1|Overall Study|Withdrawal by Subject|63
48824|NCT01372748|199967|P2|Overall Study|Withdrawal by Subject|5
48825|NCT01372748|199968|P1|Overall Study|Withdrawal by Subject|7
48826|NCT01372748|199967|P2|Overall Study|Lost to Follow-up|34
48827|NCT01372748|199968|P1|Overall Study|Lost to Follow-up|16
48828|NCT01372605|199978|P2|Overall Study|Changed medical home|0
48829|NCT01372605|199979|P1|Overall Study|Changed medical home|2
48830|NCT01372605|199978|P2|Overall Study|Moved|0
48831|NCT01372605|199979|P1|Overall Study|Moved|3
48832|NCT01372605|199978|P2|Overall Study|Withdrawal by Subject|7
48833|NCT01372605|199979|P1|Overall Study|Withdrawal by Subject|4
48834|NCT01372605|199978|P2|Overall Study|Lost to Follow-up|1
48835|NCT01372605|199979|P1|Overall Study|Lost to Follow-up|2
48836|NCT01372605|199978|P2|Overall Study|Death|2
48837|NCT01372605|199979|P1|Overall Study|Death|1
48838|NCT01372501|200005|P1|Overall Study|Device migration|1
48839|NCT01372501|200005|P1|Overall Study|Adverse Event|4
48840|NCT01372410|200028|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
48841|NCT01372410|200029|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
48842|NCT01372410|200030|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
48843|NCT01372410|200031|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
48844|NCT01372410|200032|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
48845|NCT01372410|200033|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
48846|NCT01372410|200034|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
48847|NCT01372410|200035|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
48848|NCT01372410|200028|P8|Treatment Period 3 (7 Days)|Adverse Event|0
48849|NCT01372410|200029|P7|Treatment Period 3 (7 Days)|Adverse Event|0
48850|NCT01372410|200030|P6|Treatment Period 3 (7 Days)|Adverse Event|0
48851|NCT01372410|200031|P5|Treatment Period 3 (7 Days)|Adverse Event|0
48852|NCT01372410|200032|P4|Treatment Period 3 (7 Days)|Adverse Event|0
48853|NCT01372410|200033|P3|Treatment Period 3 (7 Days)|Adverse Event|1
48854|NCT01372410|200034|P2|Treatment Period 3 (7 Days)|Adverse Event|0
48855|NCT01372410|200035|P1|Treatment Period 3 (7 Days)|Adverse Event|0
48856|NCT01372410|200028|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
48857|NCT01372410|200029|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48858|NCT01372410|200030|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48859|NCT01372410|200031|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48860|NCT01372410|200032|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48861|NCT01372410|200033|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48862|NCT01372410|200034|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48863|NCT01372410|200035|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
48864|NCT01372410|200028|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
48865|NCT01372410|200029|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
48866|NCT01372410|200030|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
48867|NCT01372410|200031|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
48868|NCT01372410|200032|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
48869|NCT01372410|200033|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
48870|NCT01372410|200034|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
48871|NCT01372410|200035|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
48872|NCT01372410|200028|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
48873|NCT01372410|200029|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
48874|NCT01372410|200030|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
48875|NCT01372410|200031|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
48876|NCT01372410|200032|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
48877|NCT01372410|200033|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
48878|NCT01372410|200034|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
48879|NCT01372410|200035|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
48880|NCT01372410|200028|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
48881|NCT01372410|200029|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
48882|NCT01372410|200030|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
48883|NCT01372410|200031|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
48884|NCT01372410|200032|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
48885|NCT01372410|200033|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
48886|NCT01372410|200034|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
48887|NCT01372410|200035|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
48888|NCT01372410|200028|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48889|NCT01372410|200029|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
48890|NCT01372410|200030|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48891|NCT01372410|200031|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48892|NCT01372410|200032|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48893|NCT01372410|200033|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48894|NCT01372410|200034|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48895|NCT01372410|200035|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
48896|NCT01372410|200028|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48897|NCT01372410|200029|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48898|NCT01372410|200030|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48899|NCT01372410|200031|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
48900|NCT01372410|200032|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48901|NCT01372410|200033|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48902|NCT01372410|200034|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48903|NCT01372410|200035|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
48904|NCT01372410|200028|P8|Treatment Period 1 (7 Days)|Adverse Event|0
48905|NCT01372410|200029|P7|Treatment Period 1 (7 Days)|Adverse Event|1
48906|NCT01372410|200030|P6|Treatment Period 1 (7 Days)|Adverse Event|0
48907|NCT01372410|200031|P5|Treatment Period 1 (7 Days)|Adverse Event|0
48908|NCT01372410|200032|P4|Treatment Period 1 (7 Days)|Adverse Event|0
48909|NCT01372410|200033|P3|Treatment Period 1 (7 Days)|Adverse Event|0
48910|NCT01372410|200034|P2|Treatment Period 1 (7 Days)|Adverse Event|1
48911|NCT01372410|200035|P1|Treatment Period 1 (7 Days)|Adverse Event|0
48912|NCT01372410|200028|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
48913|NCT01372410|200029|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
48914|NCT01372410|200030|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
48915|NCT01372410|200031|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
48916|NCT01372410|200032|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
48917|NCT01372410|200033|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
48918|NCT01372410|200034|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
48919|NCT01372410|200035|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
48920|NCT01372384|200072|P1|Overall Study|Progression of disease|3
48921|NCT01372150|200095|P3|Overall Study|Randomized but not treated|0
48922|NCT01372150|200096|P2|Overall Study|Randomized but not treated|1
48923|NCT01372150|200097|P1|Overall Study|Randomized but not treated|0
48924|NCT01372150|200095|P3|Overall Study|Adverse Event|2
48925|NCT01372150|200096|P2|Overall Study|Adverse Event|1
48926|NCT01372150|200097|P1|Overall Study|Adverse Event|2
48927|NCT01372150|200095|P3|Overall Study|Other|2
48928|NCT01372150|200096|P2|Overall Study|Other|0
48929|NCT01372150|200097|P1|Overall Study|Other|1
48930|NCT01372150|200095|P3|Overall Study|Withdrawal by Subject|2
48931|NCT01372150|200096|P2|Overall Study|Withdrawal by Subject|7
48932|NCT01372150|200097|P1|Overall Study|Withdrawal by Subject|2
48933|NCT01372150|200095|P3|Overall Study|Protocol Violation|3
48934|NCT01372150|200096|P2|Overall Study|Protocol Violation|0
48935|NCT01372150|200097|P1|Overall Study|Protocol Violation|1
48936|NCT01372150|200095|P3|Overall Study|Lost to Follow-up|6
48937|NCT01372150|200096|P2|Overall Study|Lost to Follow-up|5
48938|NCT01372150|200097|P1|Overall Study|Lost to Follow-up|4
48939|NCT01372150|200095|P3|Overall Study|Lack of Efficacy|1
48940|NCT01372150|200096|P2|Overall Study|Lack of Efficacy|0
48941|NCT01372150|200097|P1|Overall Study|Lack of Efficacy|3
48942|NCT01371994|200116|P2|Overall Study|Miscellaneous Reasons|4
48943|NCT01371994|200117|P1|Overall Study|Miscellaneous Reasons|6
48944|NCT01371994|200116|P2|Overall Study|Physician Decision|1
48945|NCT01371994|200117|P1|Overall Study|Physician Decision|1
48946|NCT01371994|200116|P2|Overall Study|Randomized but Never Received Study Drug|6
48947|NCT01371994|200117|P1|Overall Study|Randomized but Never Received Study Drug|6
48948|NCT01371994|200116|P2|Overall Study|Protocol Violation|17
48949|NCT01371994|200117|P1|Overall Study|Protocol Violation|24
48950|NCT01371994|200116|P2|Overall Study|Lost to Follow-up|1
48951|NCT01371994|200117|P1|Overall Study|Lost to Follow-up|1
48952|NCT01371994|200116|P2|Overall Study|Withdrawal by Subject|7
48953|NCT01371994|200117|P1|Overall Study|Withdrawal by Subject|13
48954|NCT01371994|200116|P2|Overall Study|Lack of Efficacy|0
48955|NCT01371994|200117|P1|Overall Study|Lack of Efficacy|3
48956|NCT01371994|200116|P2|Overall Study|Adverse Event|6
48957|NCT01371994|200117|P1|Overall Study|Adverse Event|3
48958|NCT01371877|200161|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
48959|NCT01371877|200162|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
48960|NCT01371851|200174|P2|Overall Study|Blood Pressure outside study parameters|0
48961|NCT01371851|200175|P1|Overall Study|Blood Pressure outside study parameters|2
48962|NCT01371851|200174|P2|Overall Study|non study related adverse event|0
48963|NCT01371851|200175|P1|Overall Study|non study related adverse event|1
48964|NCT01371851|200174|P2|Overall Study|was arrested and put in jail|1
48965|NCT01371851|200175|P1|Overall Study|was arrested and put in jail|0
48966|NCT01371851|200174|P2|Overall Study|Lost to Follow-up|8
48967|NCT01371851|200175|P1|Overall Study|Lost to Follow-up|5
48968|NCT01371838|200183|P2|Overall Study|Surgery|0
48969|NCT01371838|200184|P1|Overall Study|Surgery|1
48970|NCT01371838|200183|P2|Overall Study|Lack of therapeutic response|1
48971|NCT01371838|200184|P1|Overall Study|Lack of therapeutic response|0
48972|NCT01371838|200183|P2|Overall Study|Last follow-up visit not conducted|0
48973|NCT01371838|200184|P1|Overall Study|Last follow-up visit not conducted|2
48974|NCT01371838|200183|P2|Overall Study|Investigator Decision|8
48975|NCT01371838|200184|P1|Overall Study|Investigator Decision|3
48976|NCT01371838|200183|P2|Overall Study|Protocol Violation|0
48977|NCT01371838|200184|P1|Overall Study|Protocol Violation|3
48978|NCT01371838|200183|P2|Overall Study|Death|4
48979|NCT01371838|200184|P1|Overall Study|Death|3
48980|NCT01371838|200183|P2|Overall Study|Lost to Follow-up|20
48981|NCT01371838|200184|P1|Overall Study|Lost to Follow-up|10
48982|NCT01371838|200183|P2|Overall Study|Withdrawal by Subject|33
48983|NCT01371838|200184|P1|Overall Study|Withdrawal by Subject|27
48984|NCT01371825|200220|P1|Primary Efficacy Analysis Period|Death|3
48985|NCT01371747|200255|P6|Overall Study|Other Reasons|1
48986|NCT01371747|200256|P5|Overall Study|Other Reasons|0
48987|NCT01371747|200257|P4|Overall Study|Other Reasons|0
48988|NCT01371747|200258|P3|Overall Study|Other Reasons|2
48989|NCT01371747|200259|P2|Overall Study|Other Reasons|1
48990|NCT01371747|200260|P1|Overall Study|Other Reasons|2
48991|NCT01371747|200255|P6|Overall Study|Withdrawal by Subject|4
48992|NCT01371747|200256|P5|Overall Study|Withdrawal by Subject|2
48993|NCT01371747|200257|P4|Overall Study|Withdrawal by Subject|2
48994|NCT01371747|200258|P3|Overall Study|Withdrawal by Subject|5
48995|NCT01371747|200259|P2|Overall Study|Withdrawal by Subject|12
48996|NCT01371747|200260|P1|Overall Study|Withdrawal by Subject|6
48997|NCT01371747|200255|P6|Overall Study|Physician Decision|0
48998|NCT01371747|200256|P5|Overall Study|Physician Decision|1
48999|NCT01371747|200257|P4|Overall Study|Physician Decision|0
49000|NCT01371747|200258|P3|Overall Study|Physician Decision|0
49001|NCT01371747|200259|P2|Overall Study|Physician Decision|0
49002|NCT01371747|200260|P1|Overall Study|Physician Decision|0
49003|NCT01371747|200255|P6|Overall Study|Non-Compliance|1
49004|NCT01371747|200256|P5|Overall Study|Non-Compliance|0
49005|NCT01371747|200257|P4|Overall Study|Non-Compliance|0
49006|NCT01371747|200258|P3|Overall Study|Non-Compliance|3
49007|NCT01371747|200259|P2|Overall Study|Non-Compliance|4
49008|NCT01371747|200260|P1|Overall Study|Non-Compliance|3
49009|NCT01371747|200255|P6|Overall Study|Protocol Violation|0
49010|NCT01371747|200256|P5|Overall Study|Protocol Violation|0
49011|NCT01371747|200257|P4|Overall Study|Protocol Violation|0
49012|NCT01371747|200258|P3|Overall Study|Protocol Violation|1
49013|NCT01371747|200259|P2|Overall Study|Protocol Violation|0
49014|NCT01371747|200260|P1|Overall Study|Protocol Violation|0
49015|NCT01371747|200255|P6|Overall Study|Low Serum Potassium Results|3
49016|NCT01371747|200256|P5|Overall Study|Low Serum Potassium Results|0
49017|NCT01371747|200257|P4|Overall Study|Low Serum Potassium Results|1
49018|NCT01371747|200258|P3|Overall Study|Low Serum Potassium Results|1
49019|NCT01371747|200259|P2|Overall Study|Low Serum Potassium Results|1
49020|NCT01371747|200260|P1|Overall Study|Low Serum Potassium Results|1
49021|NCT01371747|200255|P6|Overall Study|High Serum Potassium Results|2
49022|NCT01371747|200256|P5|Overall Study|High Serum Potassium Results|0
49023|NCT01371747|200257|P4|Overall Study|High Serum Potassium Results|2
49024|NCT01371747|200258|P3|Overall Study|High Serum Potassium Results|1
49025|NCT01371747|200259|P2|Overall Study|High Serum Potassium Results|1
49026|NCT01371747|200260|P1|Overall Study|High Serum Potassium Results|1
49027|NCT01371747|200255|P6|Overall Study|Abnormal Renal Function|1
49028|NCT01371747|200256|P5|Overall Study|Abnormal Renal Function|0
49029|NCT01371747|200257|P4|Overall Study|Abnormal Renal Function|1
49030|NCT01371747|200258|P3|Overall Study|Abnormal Renal Function|0
49031|NCT01371747|200259|P2|Overall Study|Abnormal Renal Function|2
49032|NCT01371747|200260|P1|Overall Study|Abnormal Renal Function|0
49033|NCT01371747|200255|P6|Overall Study|Death|0
49034|NCT01371747|200256|P5|Overall Study|Death|2
49035|NCT01371747|200257|P4|Overall Study|Death|1
49036|NCT01371747|200258|P3|Overall Study|Death|4
49037|NCT01371747|200259|P2|Overall Study|Death|0
49038|NCT01371747|200260|P1|Overall Study|Death|1
49039|NCT01371747|200255|P6|Overall Study|Adverse Event|2
49040|NCT01371747|200256|P5|Overall Study|Adverse Event|2
49041|NCT01371747|200257|P4|Overall Study|Adverse Event|2
49042|NCT01371747|200258|P3|Overall Study|Adverse Event|7
49043|NCT01371747|200259|P2|Overall Study|Adverse Event|2
49044|NCT01371747|200260|P1|Overall Study|Adverse Event|4
49045|NCT01371734|200325|P3|Overall Study|Lack of Efficacy|0
49046|NCT01371734|200326|P2|Overall Study|Lack of Efficacy|2
49047|NCT01371734|200327|P1|Overall Study|Lack of Efficacy|2
49048|NCT01371734|200325|P3|Overall Study|Adverse Event|3
49049|NCT01371734|200326|P2|Overall Study|Adverse Event|8
49050|NCT01371734|200327|P1|Overall Study|Adverse Event|8
49051|NCT01371734|200325|P3|Overall Study|Protocol Violation|2
49052|NCT01371734|200326|P2|Overall Study|Protocol Violation|1
49053|NCT01371734|200327|P1|Overall Study|Protocol Violation|3
49054|NCT01371734|200325|P3|Overall Study|Lost to Follow-up|1
49055|NCT01371734|200326|P2|Overall Study|Lost to Follow-up|3
49056|NCT01371734|200327|P1|Overall Study|Lost to Follow-up|5
49057|NCT01371734|200325|P3|Overall Study|Withdrawal by Subject|9
49058|NCT01371734|200326|P2|Overall Study|Withdrawal by Subject|4
49059|NCT01371734|200327|P1|Overall Study|Withdrawal by Subject|3
49060|NCT01371734|200325|P3|Overall Study|Not specified|2
49061|NCT01371734|200326|P2|Overall Study|Not specified|1
49062|NCT01371734|200327|P1|Overall Study|Not specified|2
49063|NCT01371721|200347|P3|Overall Study|Randomized but not treated|0
49064|NCT01371721|200348|P2|Overall Study|Randomized but not treated|0
49065|NCT01371721|200349|P1|Overall Study|Randomized but not treated|1
49066|NCT01371721|200347|P3|Overall Study|Lack of Efficacy|3
49067|NCT01371721|200348|P2|Overall Study|Lack of Efficacy|4
49068|NCT01371721|200349|P1|Overall Study|Lack of Efficacy|2
49069|NCT01371721|200347|P3|Overall Study|Not specified|0
49070|NCT01371721|200348|P2|Overall Study|Not specified|3
49071|NCT01371721|200349|P1|Overall Study|Not specified|2
49072|NCT01371721|200347|P3|Overall Study|Withdrawal by Subject|11
49073|NCT01371721|200348|P2|Overall Study|Withdrawal by Subject|7
49074|NCT01371721|200349|P1|Overall Study|Withdrawal by Subject|5
49075|NCT01371721|200347|P3|Overall Study|Lost to Follow-up|6
49076|NCT01371721|200348|P2|Overall Study|Lost to Follow-up|2
49077|NCT01371721|200349|P1|Overall Study|Lost to Follow-up|8
49078|NCT01371721|200347|P3|Overall Study|Protocol Violation|5
49079|NCT01371721|200348|P2|Overall Study|Protocol Violation|4
49080|NCT01371721|200349|P1|Overall Study|Protocol Violation|6
49081|NCT01371721|200347|P3|Overall Study|Adverse Event|5
49082|NCT01371721|200348|P2|Overall Study|Adverse Event|4
49083|NCT01371721|200349|P1|Overall Study|Adverse Event|5
49084|NCT01371708|200382|P3|Overall Study|Started but did not receive treatment|1
49085|NCT01371708|200383|P2|Overall Study|Started but did not receive treatment|0
49086|NCT01371708|200384|P1|Overall Study|Started but did not receive treatment|1
49087|NCT01371708|200382|P3|Overall Study|Adverse Event|12
49088|NCT01371708|200383|P2|Overall Study|Adverse Event|8
49089|NCT01371708|200384|P1|Overall Study|Adverse Event|5
49090|NCT01371708|200382|P3|Overall Study|Not specified|4
49091|NCT01371708|200383|P2|Overall Study|Not specified|2
49092|NCT01371708|200384|P1|Overall Study|Not specified|3
49093|NCT01371708|200382|P3|Overall Study|Medication error/not related to AE|0
49094|NCT01371708|200383|P2|Overall Study|Medication error/not related to AE|1
49095|NCT01371708|200384|P1|Overall Study|Medication error/not related to AE|0
49096|NCT01371708|200382|P3|Overall Study|No longer willing to participate|13
49097|NCT01371708|200383|P2|Overall Study|No longer willing to participate|7
49098|NCT01371708|200384|P1|Overall Study|No longer willing to participate|7
49099|NCT01371708|200382|P3|Overall Study|Protocol Violation|2
49100|NCT01371708|200383|P2|Overall Study|Protocol Violation|1
49101|NCT01371708|200384|P1|Overall Study|Protocol Violation|2
49102|NCT01371708|200382|P3|Overall Study|Lost to Follow-up|7
49103|NCT01371708|200383|P2|Overall Study|Lost to Follow-up|9
49104|NCT01371708|200384|P1|Overall Study|Lost to Follow-up|5
49105|NCT01371708|200382|P3|Overall Study|Insufficient clinical response|0
49106|NCT01371708|200383|P2|Overall Study|Insufficient clinical response|2
49107|NCT01371708|200384|P1|Overall Study|Insufficient clinical response|3
49108|NCT01371643|200416|P2|Overall Study|Withdrawal by Subject|0
49109|NCT01371643|200417|P1|Overall Study|Withdrawal by Subject|3
49110|NCT01371565|200427|P1|Overall Study|Resection of neuroendocrine tumor|1
49111|NCT01371565|200427|P1|Overall Study|Death|1
49112|NCT01371565|200427|P1|Overall Study|Withdrawal by Subject|1
49113|NCT01371552|200431|P6|Part 1, First 3 Days|Inconvenience|0
49114|NCT01371552|200432|P5|Part 1, First 3 Days|Inconvenience|0
49115|NCT01371552|200433|P4|Part 1, First 3 Days|Inconvenience|0
49116|NCT01371552|200434|P3|Part 1, First 3 Days|Inconvenience|1
49117|NCT01371552|200435|P2|Part 1, First 3 Days|Inconvenience|0
49118|NCT01371552|200436|P1|Part 1, First 3 Days|Inconvenience|0
49119|NCT01371539|200463|P2|Period Two: One Week|Time/job conflict|1
49120|NCT01371539|200464|P1|Period Two: One Week|Time/job conflict|0
49121|NCT01371539|200463|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
49122|NCT01371539|200464|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
49123|NCT01371539|200463|P2|Period Two: One Week|Lost to Follow-up|1
49124|NCT01371539|200464|P1|Period Two: One Week|Lost to Follow-up|0
49125|NCT01371539|200463|P2|Period One: One Week|Lost to Follow-up|1
49126|NCT01371539|200464|P1|Period One: One Week|Lost to Follow-up|0
49127|NCT01371006|200474|P2|Overall Study|Adverse Event|0
49128|NCT01371006|200475|P1|Overall Study|Adverse Event|1
49129|NCT01370863|200516|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
49130|NCT01370863|200517|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
49131|NCT01370863|200516|P2|Overall Study|Did not want second pH/MII monitoring|1
49132|NCT01370863|200517|P1|Overall Study|Did not want second pH/MII monitoring|1
49133|NCT01370863|200516|P2|Overall Study|Adverse Event|1
49134|NCT01370863|200517|P1|Overall Study|Adverse Event|1
49135|NCT01370733|200542|P2|Overall Study|Protocol Violation|3
49136|NCT01370733|200543|P1|Overall Study|Protocol Violation|1
49137|NCT01370733|200542|P2|Overall Study|Physician Decision|2
49138|NCT01370733|200543|P1|Overall Study|Physician Decision|0
49139|NCT01370733|200542|P2|Overall Study|Lack of Efficacy|5
49140|NCT01370733|200543|P1|Overall Study|Lack of Efficacy|3
49141|NCT01370733|200542|P2|Overall Study|Adverse Event|4
49142|NCT01370733|200543|P1|Overall Study|Adverse Event|2
49143|NCT01370733|200542|P2|Overall Study|Lost to Follow-up|0
49144|NCT01370733|200543|P1|Overall Study|Lost to Follow-up|3
49145|NCT01370733|200542|P2|Overall Study|Withdrawal by Subject|8
49146|NCT01370733|200543|P1|Overall Study|Withdrawal by Subject|8
49147|NCT01370694|200565|P1|Overall Study|Progressive disease|2
49148|NCT01370694|200565|P1|Overall Study|Switched to rituximab|4
49149|NCT01370655|200587|P12|Period 2|Withdrawal by Subject|0
49150|NCT01370655|200588|P11|Period 2|Withdrawal by Subject|0
49151|NCT01370655|200589|P10|Period 2|Withdrawal by Subject|0
49152|NCT01370655|200590|P9|Period 2|Withdrawal by Subject|1
49153|NCT01370655|200591|P8|Period 2|Withdrawal by Subject|0
49154|NCT01370655|200592|P7|Period 2|Withdrawal by Subject|0
49155|NCT01370655|200593|P6|Period 2|Withdrawal by Subject|0
49156|NCT01370655|200594|P5|Period 2|Withdrawal by Subject|0
49157|NCT01370655|200595|P4|Period 2|Withdrawal by Subject|0
49158|NCT01370655|200596|P3|Period 2|Withdrawal by Subject|0
49159|NCT01370655|200597|P2|Period 2|Withdrawal by Subject|0
49160|NCT01370655|200598|P1|Period 2|Withdrawal by Subject|0
49161|NCT01370655|200587|P12|Period 2|met protocol specified stopping criteria|0
49162|NCT01370655|200588|P11|Period 2|met protocol specified stopping criteria|1
49163|NCT01370655|200589|P10|Period 2|met protocol specified stopping criteria|0
49164|NCT01370655|200590|P9|Period 2|met protocol specified stopping criteria|1
49165|NCT01370655|200591|P8|Period 2|met protocol specified stopping criteria|0
49166|NCT01370655|200592|P7|Period 2|met protocol specified stopping criteria|1
49167|NCT01370655|200593|P6|Period 2|met protocol specified stopping criteria|0
49168|NCT01370655|200594|P5|Period 2|met protocol specified stopping criteria|0
49169|NCT01370655|200595|P4|Period 2|met protocol specified stopping criteria|0
49170|NCT01370655|200596|P3|Period 2|met protocol specified stopping criteria|1
49171|NCT01370655|200597|P2|Period 2|met protocol specified stopping criteria|0
49172|NCT01370655|200598|P1|Period 2|met protocol specified stopping criteria|0
49173|NCT01370655|200587|P12|Period 2|Adverse Event|0
49174|NCT01370655|200588|P11|Period 2|Adverse Event|0
49175|NCT01370655|200589|P10|Period 2|Adverse Event|0
49176|NCT01370655|200590|P9|Period 2|Adverse Event|0
49177|NCT01370655|200591|P8|Period 2|Adverse Event|1
49178|NCT01370655|200592|P7|Period 2|Adverse Event|0
49179|NCT01370655|200593|P6|Period 2|Adverse Event|0
49180|NCT01370655|200594|P5|Period 2|Adverse Event|1
49181|NCT01370655|200595|P4|Period 2|Adverse Event|0
49182|NCT01370655|200596|P3|Period 2|Adverse Event|1
49183|NCT01370655|200597|P2|Period 2|Adverse Event|0
49184|NCT01370655|200598|P1|Period 2|Adverse Event|0
49185|NCT01370655|200587|P12|Period 1|Adverse Event|0
49186|NCT01370655|200588|P11|Period 1|Adverse Event|0
49187|NCT01370655|200589|P10|Period 1|Adverse Event|0
49188|NCT01370655|200590|P9|Period 1|Adverse Event|0
49189|NCT01370655|200591|P8|Period 1|Adverse Event|0
49190|NCT01370655|200592|P7|Period 1|Adverse Event|1
49191|NCT01370655|200593|P6|Period 1|Adverse Event|0
49192|NCT01370655|200594|P5|Period 1|Adverse Event|0
49193|NCT01370655|200595|P4|Period 1|Adverse Event|0
49194|NCT01370655|200596|P3|Period 1|Adverse Event|0
49195|NCT01370655|200597|P2|Period 1|Adverse Event|0
49196|NCT01370655|200598|P1|Period 1|Adverse Event|2
49197|NCT01370642|200635|P3|Overall Study|Withdrawal by Subject|3
49198|NCT01370642|200636|P2|Overall Study|Withdrawal by Subject|4
49199|NCT01370642|200637|P1|Overall Study|Withdrawal by Subject|2
49200|NCT01370642|200635|P3|Overall Study|Physician Decision|2
49201|NCT01370642|200636|P2|Overall Study|Physician Decision|1
49202|NCT01370642|200637|P1|Overall Study|Physician Decision|4
49203|NCT01370642|200635|P3|Overall Study|Lost to Follow-up|1
49204|NCT01370642|200636|P2|Overall Study|Lost to Follow-up|0
49205|NCT01370642|200637|P1|Overall Study|Lost to Follow-up|0
49206|NCT01370642|200635|P3|Overall Study|Detectable HCV RNA|22
49207|NCT01370642|200636|P2|Overall Study|Detectable HCV RNA|0
49208|NCT01370642|200637|P1|Overall Study|Detectable HCV RNA|0
49209|NCT01370642|200635|P3|Overall Study|Adverse Event|1
49210|NCT01370642|200636|P2|Overall Study|Adverse Event|1
49211|NCT01370642|200637|P1|Overall Study|Adverse Event|2
49212|NCT01370616|200668|P2|Overall Study|Withdrawal by Subject|34
49213|NCT01370616|200669|P1|Overall Study|Withdrawal by Subject|34
49214|NCT01370616|200668|P2|Overall Study|Technical Problems|5
49215|NCT01370616|200669|P1|Overall Study|Technical Problems|3
49216|NCT01370616|200668|P2|Overall Study|Recovery|0
49217|NCT01370616|200669|P1|Overall Study|Recovery|1
49218|NCT01370616|200668|P2|Overall Study|Progressive Disease|1
49219|NCT01370616|200669|P1|Overall Study|Progressive Disease|0
49220|NCT01370616|200668|P2|Overall Study|Physician Decision|6
49221|NCT01370616|200669|P1|Overall Study|Physician Decision|6
49222|NCT01370616|200668|P2|Overall Study|Lost to Follow-up|3
49223|NCT01370616|200669|P1|Overall Study|Lost to Follow-up|0
49224|NCT01370616|200668|P2|Overall Study|Lack of Efficacy|2
49225|NCT01370616|200669|P1|Overall Study|Lack of Efficacy|6
49226|NCT01370616|200668|P2|Overall Study|Death|0
49227|NCT01370616|200669|P1|Overall Study|Death|1
49228|NCT01370616|200668|P2|Overall Study|Adverse Event|16
49229|NCT01370616|200669|P1|Overall Study|Adverse Event|11
49230|NCT01370603|200693|P2|Period 2|Withdrawal by Subject|0
49231|NCT01370603|200694|P1|Period 2|Withdrawal by Subject|1
49232|NCT01370603|200693|P2|Period 2|Lost to Follow-up|0
49233|NCT01370603|200694|P1|Period 2|Lost to Follow-up|1
49234|NCT01370603|200693|P2|Period 2|Adverse Event|4
49235|NCT01370603|200694|P1|Period 2|Adverse Event|1
49236|NCT01370603|200693|P2|Crossover Washout|Non-compliance with Study Drug|2
49237|NCT01370603|200694|P1|Crossover Washout|Non-compliance with Study Drug|0
49238|NCT01370603|200693|P2|Crossover Washout|Withdrawal by Subject|1
49239|NCT01370603|200694|P1|Crossover Washout|Withdrawal by Subject|4
49240|NCT01370603|200693|P2|Crossover Washout|Protocol Violation|0
49241|NCT01370603|200694|P1|Crossover Washout|Protocol Violation|1
49242|NCT01370603|200693|P2|Crossover Washout|Lost to Follow-up|0
49243|NCT01370603|200694|P1|Crossover Washout|Lost to Follow-up|2
49244|NCT01370603|200693|P2|Crossover Washout|Adverse Event|1
49245|NCT01370603|200694|P1|Crossover Washout|Adverse Event|2
49246|NCT01370603|200693|P2|Period 1|Withdrawal by Subject|5
49247|NCT01370603|200694|P1|Period 1|Withdrawal by Subject|5
49248|NCT01370603|200693|P2|Period 1|Protocol Violation|2
49249|NCT01370603|200694|P1|Period 1|Protocol Violation|2
49250|NCT01370603|200693|P2|Period 1|Lost to Follow-up|0
49251|NCT01370603|200694|P1|Period 1|Lost to Follow-up|2
49252|NCT01370603|200693|P2|Period 1|Adverse Event|3
49253|NCT01370603|200694|P1|Period 1|Adverse Event|5
49254|NCT01370590|200712|P2|Period 2|Withdrawal by Subject|1
49255|NCT01370590|200713|P1|Period 2|Withdrawal by Subject|1
49256|NCT01370590|200712|P2|Period 2|Adverse Event|1
49257|NCT01370590|200713|P1|Period 2|Adverse Event|0
49258|NCT01370590|200712|P2|Crossover Washout Period|Withdrawal by Subject|2
49259|NCT01370590|200713|P1|Crossover Washout Period|Withdrawal by Subject|2
49260|NCT01370590|200712|P2|Crossover Washout Period|Non-compliance with Study Drug|0
49261|NCT01370590|200713|P1|Crossover Washout Period|Non-compliance with Study Drug|1
49262|NCT01370590|200712|P2|Crossover Washout Period|Lost to Follow-up|0
49263|NCT01370590|200713|P1|Crossover Washout Period|Lost to Follow-up|2
49264|NCT01370590|200712|P2|Crossover Washout Period|Adverse Event|4
49265|NCT01370590|200713|P1|Crossover Washout Period|Adverse Event|1
49266|NCT01370590|200712|P2|Period 1|Could not access randomization system|1
49267|NCT01370590|200713|P1|Period 1|Could not access randomization system|0
49268|NCT01370590|200712|P2|Period 1|Withdrawal by Subject|2
49269|NCT01370590|200713|P1|Period 1|Withdrawal by Subject|4
49270|NCT01370590|200712|P2|Period 1|Protocol Violation|2
49271|NCT01370590|200713|P1|Period 1|Protocol Violation|2
49272|NCT01370590|200712|P2|Period 1|Lost to Follow-up|2
49273|NCT01370590|200713|P1|Period 1|Lost to Follow-up|2
49274|NCT01370590|200712|P2|Period 1|Adverse Event|4
49275|NCT01370590|200713|P1|Period 1|Adverse Event|8
49276|NCT01370538|200731|P2|Overall Study|Lost to follow up|10
49277|NCT01370538|200732|P1|Overall Study|Lost to follow up|6
49278|NCT01370538|200731|P2|Overall Study|Development of study specific withdrawal|1
49279|NCT01370538|200732|P1|Overall Study|Development of study specific withdrawal|1
49280|NCT01370538|200731|P2|Overall Study|Protocol Violation|5
49281|NCT01370538|200732|P1|Overall Study|Protocol Violation|8
49282|NCT01370538|200731|P2|Overall Study|Adverse Event|0
49283|NCT01370538|200732|P1|Overall Study|Adverse Event|1
49284|NCT01370538|200731|P2|Overall Study|Eligibility criteria not fulfilled|1
49285|NCT01370538|200732|P1|Overall Study|Eligibility criteria not fulfilled|0
49286|NCT01370538|200731|P2|Overall Study|Voluntary Discontinuation by Subject|2
49287|NCT01370538|200732|P1|Overall Study|Voluntary Discontinuation by Subject|3
49288|NCT01370525|200748|P2|Overall Study|Lost to follow up|6
49289|NCT01370525|200749|P1|Overall Study|Lost to follow up|2
49290|NCT01370525|200748|P2|Overall Study|Protocol Violation|1
49291|NCT01370525|200749|P1|Overall Study|Protocol Violation|2
49292|NCT01370525|200748|P2|Overall Study|Adverse Event|1
49293|NCT01370525|200749|P1|Overall Study|Adverse Event|0
49294|NCT01370525|200748|P2|Overall Study|Eligibility criteria not fulfilled|0
49295|NCT01370525|200749|P1|Overall Study|Eligibility criteria not fulfilled|2
49296|NCT01370525|200748|P2|Overall Study|Voluntary Discontinuation by Subject|3
49297|NCT01370525|200749|P1|Overall Study|Voluntary Discontinuation by Subject|2
49298|NCT01370408|200773|P1|Overall Study|treatment failure|9
49299|NCT01370356|200833|P2|Overall Study|AE Not Related to Study Drug|4
49300|NCT01370356|200834|P1|Overall Study|AE Not Related to Study Drug|1
49301|NCT01370356|200833|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
49302|NCT01370356|200834|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
49303|NCT01370356|200833|P2|Overall Study|Protocol Violation|3
49304|NCT01370356|200834|P1|Overall Study|Protocol Violation|3
49305|NCT01370356|200833|P2|Overall Study|Reason not specified|43
49306|NCT01370356|200834|P1|Overall Study|Reason not specified|39
49307|NCT01370356|200833|P2|Overall Study|Withdrawal by Subject|59
49308|NCT01370356|200834|P1|Overall Study|Withdrawal by Subject|54
49309|NCT01370356|200833|P2|Overall Study|Lost to Follow-up|81
49310|NCT01370356|200834|P1|Overall Study|Lost to Follow-up|76
49311|NCT01370356|200833|P2|Overall Study|Lack of Efficacy|28
49312|NCT01370356|200834|P1|Overall Study|Lack of Efficacy|6
49313|NCT01370356|200833|P2|Overall Study|Death|0
49314|NCT01370356|200834|P1|Overall Study|Death|1
49315|NCT01370265|200848|P2|First Intervention|Adverse Event|1
49316|NCT01370265|200849|P1|First Intervention|Adverse Event|1
49317|NCT01370083|200868|P2|Overall Study|Adverse Event|1
49318|NCT01370083|200869|P1|Overall Study|Adverse Event|0
49319|NCT01370083|200868|P2|Overall Study|Lost to Follow-up|0
49320|NCT01370083|200869|P1|Overall Study|Lost to Follow-up|2
49321|NCT01370005|200882|P3|Overall Study|Other reason not defined above|2
49322|NCT01370005|200883|P2|Overall Study|Other reason not defined above|0
49323|NCT01370005|200884|P1|Overall Study|Other reason not defined above|3
49324|NCT01370005|200882|P3|Overall Study|Patient refusal to continue,not due toAE|0
49325|NCT01370005|200883|P2|Overall Study|Patient refusal to continue,not due toAE|4
49326|NCT01370005|200884|P1|Overall Study|Patient refusal to continue,not due toAE|5
49327|NCT01370005|200882|P3|Overall Study|Lost to Follow-up|1
49328|NCT01370005|200883|P2|Overall Study|Lost to Follow-up|1
49329|NCT01370005|200884|P1|Overall Study|Lost to Follow-up|1
49330|NCT01370005|200882|P3|Overall Study|Non compliant with protocol|2
49331|NCT01370005|200883|P2|Overall Study|Non compliant with protocol|1
49332|NCT01370005|200884|P1|Overall Study|Non compliant with protocol|0
49333|NCT01370005|200882|P3|Overall Study|Lack of Efficacy|0
49334|NCT01370005|200883|P2|Overall Study|Lack of Efficacy|0
49335|NCT01370005|200884|P1|Overall Study|Lack of Efficacy|1
49336|NCT01370005|200882|P3|Overall Study|Adverse Event|6
49337|NCT01370005|200883|P2|Overall Study|Adverse Event|5
49338|NCT01370005|200884|P1|Overall Study|Adverse Event|5
49339|NCT01370005|200882|P3|Overall Study|Not treated|0
49340|NCT01370005|200883|P2|Overall Study|Not treated|0
49341|NCT01370005|200884|P1|Overall Study|Not treated|1
49342|NCT01369849|200966|P3|Overall Study|Ineligible prior to treatment|1
49343|NCT01369849|200967|P2|Overall Study|Ineligible prior to treatment|0
49344|NCT01369849|200968|P1|Overall Study|Ineligible prior to treatment|0
49345|NCT01369784|200977|P1|Overall Study|Protocol Violation|12
49346|NCT01369680|201060|P4|Overall Study|Lost to Follow-up|2
49347|NCT01369680|201061|P3|Overall Study|Lost to Follow-up|1
49348|NCT01369680|201062|P2|Overall Study|Lost to Follow-up|0
49349|NCT01369680|201063|P1|Overall Study|Lost to Follow-up|0
49350|NCT01369641|201084|P1|Overall Study|Withdrawal by Subject|1
49351|NCT01369615|201090|P2|Overall Study|Lost to Follow-up|1
49352|NCT01369615|201091|P1|Overall Study|Lost to Follow-up|0
49353|NCT01369615|201090|P2|Overall Study|Withdrawal by Subject|1
49354|NCT01369615|201091|P1|Overall Study|Withdrawal by Subject|0
49355|NCT01369485|201099|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
49356|NCT01369485|201100|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
49357|NCT01369485|201099|P2|Open Label Phase (Week 12 to Month 12)|Death|1
49358|NCT01369485|201100|P1|Open Label Phase (Week 12 to Month 12)|Death|0
49359|NCT01369485|201099|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
49360|NCT01369485|201100|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
49361|NCT01369485|201099|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
49362|NCT01369485|201100|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
49363|NCT01369485|201099|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
49364|NCT01369485|201100|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
49365|NCT01369485|201099|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
49366|NCT01369485|201100|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
49367|NCT01369485|201099|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
49368|NCT01369485|201100|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
49369|NCT01369485|201099|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
49370|NCT01369485|201100|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
49371|NCT01369485|201099|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
49372|NCT01369485|201100|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
49373|NCT01369485|201099|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
49374|NCT01369485|201100|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
49375|NCT01369355|201146|P6|Overall Study|Not Treated|0
49376|NCT01369355|201147|P5|Overall Study|Not Treated|0
49377|NCT01369355|201148|P4|Overall Study|Not Treated|0
49378|NCT01369355|201149|P3|Overall Study|Not Treated|1
49379|NCT01369355|201150|P2|Overall Study|Not Treated|0
49380|NCT01369355|201151|P1|Overall Study|Not Treated|0
49381|NCT01369355|201146|P6|Overall Study|unspecified|0
49382|NCT01369355|201147|P5|Overall Study|unspecified|1
49383|NCT01369355|201148|P4|Overall Study|unspecified|0
49384|NCT01369355|201149|P3|Overall Study|unspecified|0
49385|NCT01369355|201150|P2|Overall Study|unspecified|0
49386|NCT01369355|201151|P1|Overall Study|unspecified|0
49387|NCT01369355|201146|P6|Overall Study|Withdrawal by Subject|22
49388|NCT01369355|201147|P5|Overall Study|Withdrawal by Subject|8
49389|NCT01369355|201148|P4|Overall Study|Withdrawal by Subject|6
49390|NCT01369355|201149|P3|Overall Study|Withdrawal by Subject|7
49391|NCT01369355|201150|P2|Overall Study|Withdrawal by Subject|2
49392|NCT01369355|201151|P1|Overall Study|Withdrawal by Subject|6
49393|NCT01369355|201146|P6|Overall Study|Lost to Follow-up|6
49394|NCT01369355|201147|P5|Overall Study|Lost to Follow-up|5
49395|NCT01369355|201148|P4|Overall Study|Lost to Follow-up|2
49396|NCT01369355|201149|P3|Overall Study|Lost to Follow-up|1
49397|NCT01369355|201150|P2|Overall Study|Lost to Follow-up|0
49398|NCT01369355|201151|P1|Overall Study|Lost to Follow-up|1
49399|NCT01369355|201146|P6|Overall Study|Protocol Violation|2
49400|NCT01369355|201147|P5|Overall Study|Protocol Violation|0
49401|NCT01369355|201148|P4|Overall Study|Protocol Violation|0
49402|NCT01369355|201149|P3|Overall Study|Protocol Violation|1
49403|NCT01369355|201150|P2|Overall Study|Protocol Violation|1
49404|NCT01369355|201151|P1|Overall Study|Protocol Violation|0
49405|NCT01369355|201146|P6|Overall Study|Lack of Efficacy|217
49406|NCT01369355|201147|P5|Overall Study|Lack of Efficacy|126
49407|NCT01369355|201148|P4|Overall Study|Lack of Efficacy|15
49408|NCT01369355|201149|P3|Overall Study|Lack of Efficacy|15
49409|NCT01369355|201150|P2|Overall Study|Lack of Efficacy|14
49410|NCT01369355|201151|P1|Overall Study|Lack of Efficacy|15
49411|NCT01369355|201146|P6|Overall Study|Adverse Event|25
49412|NCT01369355|201147|P5|Overall Study|Adverse Event|14
49413|NCT01369355|201148|P4|Overall Study|Adverse Event|7
49414|NCT01369355|201149|P3|Overall Study|Adverse Event|6
49415|NCT01369355|201150|P2|Overall Study|Adverse Event|12
49416|NCT01369355|201151|P1|Overall Study|Adverse Event|9
49417|NCT01369342|201180|P3|Overall Study|Not Treated|0
49418|NCT01369342|201181|P2|Overall Study|Not Treated|0
49419|NCT01369342|201182|P1|Overall Study|Not Treated|1
49420|NCT01369342|201180|P3|Overall Study|Lost to Follow-up|1
49421|NCT01369342|201181|P2|Overall Study|Lost to Follow-up|2
49422|NCT01369342|201182|P1|Overall Study|Lost to Follow-up|5
49423|NCT01369342|201180|P3|Overall Study|Withdrawal by Subject|2
49424|NCT01369342|201181|P2|Overall Study|Withdrawal by Subject|7
49425|NCT01369342|201182|P1|Overall Study|Withdrawal by Subject|7
49426|NCT01369329|201205|P3|Overall Study|Unspecified|2
49427|NCT01369329|201206|P2|Overall Study|Unspecified|3
49428|NCT01369329|201207|P1|Overall Study|Unspecified|2
49429|NCT01369329|201205|P3|Overall Study|Lost to Follow-up|2
49430|NCT01369329|201206|P2|Overall Study|Lost to Follow-up|2
49431|NCT01369329|201207|P1|Overall Study|Lost to Follow-up|2
49432|NCT01369329|201205|P3|Overall Study|Withdrawal by Subject|10
49433|NCT01369329|201206|P2|Overall Study|Withdrawal by Subject|6
49434|NCT01369329|201207|P1|Overall Study|Withdrawal by Subject|8
49435|NCT01369225|201233|P6|Overall Study|Adverse Event|0
49436|NCT01369225|201234|P5|Overall Study|Adverse Event|1
49437|NCT01369225|201235|P4|Overall Study|Adverse Event|1
49438|NCT01369225|201236|P3|Overall Study|Adverse Event|0
49439|NCT01369225|201237|P2|Overall Study|Adverse Event|0
49440|NCT01369225|201238|P1|Overall Study|Adverse Event|0
49441|NCT01369225|201233|P6|Overall Study|Unspecified|0
49442|NCT01369225|201234|P5|Overall Study|Unspecified|1
49443|NCT01369225|201235|P4|Overall Study|Unspecified|0
49444|NCT01369225|201236|P3|Overall Study|Unspecified|0
49445|NCT01369225|201237|P2|Overall Study|Unspecified|0
49446|NCT01369225|201238|P1|Overall Study|Unspecified|1
49447|NCT01369225|201233|P6|Overall Study|Does Not Meet Entrance Criteria|0
49448|NCT01369225|201234|P5|Overall Study|Does Not Meet Entrance Criteria|0
49449|NCT01369225|201235|P4|Overall Study|Does Not Meet Entrance Criteria|0
49450|NCT01369225|201236|P3|Overall Study|Does Not Meet Entrance Criteria|1
49451|NCT01369225|201237|P2|Overall Study|Does Not Meet Entrance Criteria|0
49452|NCT01369225|201238|P1|Overall Study|Does Not Meet Entrance Criteria|0
49453|NCT01369225|201233|P6|Overall Study|Withdrawal by Subject|0
49454|NCT01369225|201234|P5|Overall Study|Withdrawal by Subject|0
49455|NCT01369225|201235|P4|Overall Study|Withdrawal by Subject|1
49456|NCT01369225|201236|P3|Overall Study|Withdrawal by Subject|2
49457|NCT01369225|201237|P2|Overall Study|Withdrawal by Subject|0
49458|NCT01369225|201238|P1|Overall Study|Withdrawal by Subject|1
49459|NCT01368965|201336|P1|Overall Study|Lost to Follow-up|12
49460|NCT01368900|201345|P1|Overall Study|Lost to Follow-up|7
49461|NCT01368835|201420|P1|Overall Study|Lost to Follow-up|11
49462|NCT01368835|201420|P1|Overall Study|Inclusion criteria/photography quality|22
49463|NCT01368536|201462|P3|Overall Study|Protocol deviation|1
49464|NCT01368536|201463|P2|Overall Study|Protocol deviation|3
49465|NCT01368536|201464|P1|Overall Study|Protocol deviation|0
49466|NCT01368536|201462|P3|Overall Study|Administrative problems|35
49467|NCT01368536|201463|P2|Overall Study|Administrative problems|39
49468|NCT01368536|201464|P1|Overall Study|Administrative problems|34
49469|NCT01368536|201462|P3|Overall Study|Lost to Follow-up|5
49470|NCT01368536|201463|P2|Overall Study|Lost to Follow-up|3
49471|NCT01368536|201464|P1|Overall Study|Lost to Follow-up|3
49472|NCT01368536|201462|P3|Overall Study|Withdrawal by Subject|4
49473|NCT01368536|201463|P2|Overall Study|Withdrawal by Subject|5
49474|NCT01368536|201464|P1|Overall Study|Withdrawal by Subject|2
49475|NCT01368536|201462|P3|Overall Study|No longer required study medication|1
49476|NCT01368536|201463|P2|Overall Study|No longer required study medication|0
49477|NCT01368536|201464|P1|Overall Study|No longer required study medication|0
49478|NCT01368536|201462|P3|Overall Study|Unsatisfactory therapeutic effect|2
49479|NCT01368536|201463|P2|Overall Study|Unsatisfactory therapeutic effect|2
49480|NCT01368536|201464|P1|Overall Study|Unsatisfactory therapeutic effect|7
49481|NCT01368536|201462|P3|Overall Study|Abnormal test procedure result(s)|1
49482|NCT01368536|201463|P2|Overall Study|Abnormal test procedure result(s)|0
49483|NCT01368536|201464|P1|Overall Study|Abnormal test procedure result(s)|0
49484|NCT01368536|201462|P3|Overall Study|Abnormal laboratory value(s)|2
49485|NCT01368536|201463|P2|Overall Study|Abnormal laboratory value(s)|1
49486|NCT01368536|201464|P1|Overall Study|Abnormal laboratory value(s)|0
49487|NCT01368536|201462|P3|Overall Study|Adverse Event|8
49488|NCT01368536|201463|P2|Overall Study|Adverse Event|6
49489|NCT01368536|201464|P1|Overall Study|Adverse Event|5
49490|NCT01368432|201487|P2|Overall Study|Lost to Follow-up|1
49491|NCT01368432|201488|P1|Overall Study|Lost to Follow-up|0
49492|NCT01368406|201522|P2|Overall Study|started working|3
49493|NCT01368406|201523|P1|Overall Study|started working|2
49494|NCT01368406|201522|P2|Overall Study|relapse of the disease|2
49495|NCT01368406|201523|P1|Overall Study|relapse of the disease|3
49496|NCT01368406|201522|P2|Overall Study|Withdrawal by Subject|4
49497|NCT01368406|201523|P1|Overall Study|Withdrawal by Subject|8
49498|NCT01368406|201522|P2|Overall Study|Lost to Follow-up|4
49499|NCT01368406|201523|P1|Overall Study|Lost to Follow-up|8
49500|NCT01368276|201531|P2|Overall Study|Death|10
49501|NCT01368276|201532|P1|Overall Study|Death|1
49502|NCT01368211|201569|P2|Second Platelets Transfusion|No need for additional transfusion|2
49503|NCT01368211|201570|P1|Second Platelets Transfusion|No need for additional transfusion|1
49504|NCT01368081|201598|P13|Overall Study|Other reason not defined above|3
49505|NCT01368081|201599|P12|Overall Study|Other reason not defined above|0
49506|NCT01368081|201600|P11|Overall Study|Other reason not defined above|0
49507|NCT01368081|201601|P10|Overall Study|Other reason not defined above|1
49508|NCT01368081|201602|P9|Overall Study|Other reason not defined above|0
49509|NCT01368081|201603|P8|Overall Study|Other reason not defined above|0
49510|NCT01368081|201604|P7|Overall Study|Other reason not defined above|2
49511|NCT01368081|201605|P6|Overall Study|Other reason not defined above|1
49512|NCT01368081|201606|P5|Overall Study|Other reason not defined above|0
49513|NCT01368081|201607|P4|Overall Study|Other reason not defined above|1
49514|NCT01368081|201608|P3|Overall Study|Other reason not defined above|0
49515|NCT01368081|201609|P2|Overall Study|Other reason not defined above|0
49516|NCT01368081|201610|P1|Overall Study|Other reason not defined above|2
49517|NCT01368081|201598|P13|Overall Study|Withdrawal by Subject|0
49518|NCT01368081|201599|P12|Overall Study|Withdrawal by Subject|2
49519|NCT01368081|201600|P11|Overall Study|Withdrawal by Subject|3
49520|NCT01368081|201601|P10|Overall Study|Withdrawal by Subject|4
49521|NCT01368081|201602|P9|Overall Study|Withdrawal by Subject|5
49522|NCT01368081|201603|P8|Overall Study|Withdrawal by Subject|2
49523|NCT01368081|201604|P7|Overall Study|Withdrawal by Subject|4
49524|NCT01368081|201605|P6|Overall Study|Withdrawal by Subject|3
49525|NCT01368081|201606|P5|Overall Study|Withdrawal by Subject|0
49526|NCT01368081|201607|P4|Overall Study|Withdrawal by Subject|1
49527|NCT01368081|201608|P3|Overall Study|Withdrawal by Subject|1
49528|NCT01368081|201609|P2|Overall Study|Withdrawal by Subject|4
49529|NCT01368081|201610|P1|Overall Study|Withdrawal by Subject|4
49530|NCT01368081|201598|P13|Overall Study|Lost to Follow-up|1
49531|NCT01368081|201599|P12|Overall Study|Lost to Follow-up|0
49532|NCT01368081|201600|P11|Overall Study|Lost to Follow-up|0
49533|NCT01368081|201601|P10|Overall Study|Lost to Follow-up|0
49534|NCT01368081|201602|P9|Overall Study|Lost to Follow-up|0
49535|NCT01368081|201603|P8|Overall Study|Lost to Follow-up|0
49536|NCT01368081|201604|P7|Overall Study|Lost to Follow-up|0
49537|NCT01368081|201605|P6|Overall Study|Lost to Follow-up|0
49538|NCT01368081|201606|P5|Overall Study|Lost to Follow-up|0
49539|NCT01368081|201607|P4|Overall Study|Lost to Follow-up|0
49540|NCT01368081|201608|P3|Overall Study|Lost to Follow-up|0
49541|NCT01368081|201609|P2|Overall Study|Lost to Follow-up|0
49542|NCT01368081|201610|P1|Overall Study|Lost to Follow-up|0
49543|NCT01368081|201598|P13|Overall Study|Protocol Violation|0
49544|NCT01368081|201599|P12|Overall Study|Protocol Violation|0
49545|NCT01368081|201600|P11|Overall Study|Protocol Violation|0
49546|NCT01368081|201601|P10|Overall Study|Protocol Violation|0
49547|NCT01368081|201602|P9|Overall Study|Protocol Violation|0
49548|NCT01368081|201603|P8|Overall Study|Protocol Violation|1
49549|NCT01368081|201604|P7|Overall Study|Protocol Violation|0
49550|NCT01368081|201605|P6|Overall Study|Protocol Violation|1
49551|NCT01368081|201606|P5|Overall Study|Protocol Violation|0
49552|NCT01368081|201607|P4|Overall Study|Protocol Violation|0
49553|NCT01368081|201608|P3|Overall Study|Protocol Violation|0
49554|NCT01368081|201609|P2|Overall Study|Protocol Violation|0
49555|NCT01368081|201610|P1|Overall Study|Protocol Violation|0
49556|NCT01368081|201598|P13|Overall Study|Lack of Efficacy|0
49557|NCT01368081|201599|P12|Overall Study|Lack of Efficacy|0
49558|NCT01368081|201600|P11|Overall Study|Lack of Efficacy|0
49559|NCT01368081|201601|P10|Overall Study|Lack of Efficacy|0
49560|NCT01368081|201602|P9|Overall Study|Lack of Efficacy|0
49561|NCT01368081|201603|P8|Overall Study|Lack of Efficacy|2
49562|NCT01368081|201604|P7|Overall Study|Lack of Efficacy|0
49563|NCT01368081|201605|P6|Overall Study|Lack of Efficacy|0
49564|NCT01368081|201606|P5|Overall Study|Lack of Efficacy|0
49565|NCT01368081|201607|P4|Overall Study|Lack of Efficacy|1
49566|NCT01368081|201608|P3|Overall Study|Lack of Efficacy|0
49567|NCT01368081|201609|P2|Overall Study|Lack of Efficacy|1
49568|NCT01368081|201610|P1|Overall Study|Lack of Efficacy|0
49569|NCT01368081|201598|P13|Overall Study|Adverse Event|3
49570|NCT01368081|201599|P12|Overall Study|Adverse Event|1
49571|NCT01368081|201600|P11|Overall Study|Adverse Event|6
49572|NCT01368081|201601|P10|Overall Study|Adverse Event|5
49573|NCT01368081|201602|P9|Overall Study|Adverse Event|3
49574|NCT01368081|201603|P8|Overall Study|Adverse Event|2
49575|NCT01368081|201604|P7|Overall Study|Adverse Event|6
49576|NCT01368081|201605|P6|Overall Study|Adverse Event|5
49577|NCT01368081|201606|P5|Overall Study|Adverse Event|2
49578|NCT01368081|201607|P4|Overall Study|Adverse Event|2
49579|NCT01368081|201608|P3|Overall Study|Adverse Event|3
49580|NCT01368081|201609|P2|Overall Study|Adverse Event|4
49581|NCT01368081|201610|P1|Overall Study|Adverse Event|4
49582|NCT01368042|201664|P1|Overall Study|Transplanted|1
49583|NCT01368042|201664|P1|Overall Study|Lost to Follow-up|4
49584|NCT01368042|201664|P1|Overall Study|Protocol Violation|11
49585|NCT01368042|201664|P1|Overall Study|Death|14
49586|NCT01367886|201684|P1|Overall Study|Death|1
49587|NCT01367886|201684|P1|Overall Study|Lack of Efficacy|2
49588|NCT01367886|201684|P1|Overall Study|Lost to Follow-up|4
49589|NCT01367834|201734|P2|Overall Study|Study was ended.|1
49590|NCT01367834|201735|P1|Overall Study|Study was ended.|0
49591|NCT01367834|201734|P2|Overall Study|Withdrawal by Subject|2
49592|NCT01367834|201735|P1|Overall Study|Withdrawal by Subject|2
49593|NCT01367704|201759|P2|Overall Study|Lost to Follow-up|161
49594|NCT01367704|201760|P1|Overall Study|Lost to Follow-up|47
49595|NCT01367457|201773|P3|Overall Study|Suspected DP/suspected active infection|0
49596|NCT01367457|201774|P2|Overall Study|Suspected DP/suspected active infection|0
49597|NCT01367457|201775|P1|Overall Study|Suspected DP/suspected active infection|1
49598|NCT01367457|201773|P3|Overall Study|Palliative. Overall decline|0
49599|NCT01367457|201774|P2|Overall Study|Palliative. Overall decline|0
49600|NCT01367457|201775|P1|Overall Study|Palliative. Overall decline|1
49601|NCT01367457|201773|P3|Overall Study|Patient's Wish|0
49602|NCT01367457|201774|P2|Overall Study|Patient's Wish|0
49603|NCT01367457|201775|P1|Overall Study|Patient's Wish|1
49604|NCT01367457|201773|P3|Overall Study|CD, Suspected disease progression (DP)|0
49605|NCT01367457|201774|P2|Overall Study|CD, Suspected disease progression (DP)|0
49606|NCT01367457|201775|P1|Overall Study|CD, Suspected disease progression (DP)|1
49607|NCT01367457|201773|P3|Overall Study|Death from septic shock|0
49608|NCT01367457|201774|P2|Overall Study|Death from septic shock|0
49609|NCT01367457|201775|P1|Overall Study|Death from septic shock|1
49610|NCT01367457|201773|P3|Overall Study|Lost to Follow-up|0
49611|NCT01367457|201774|P2|Overall Study|Lost to Follow-up|0
49612|NCT01367457|201775|P1|Overall Study|Lost to Follow-up|1
49613|NCT01367457|201773|P3|Overall Study|Rejection of treatment|0
49614|NCT01367457|201774|P2|Overall Study|Rejection of treatment|0
49615|NCT01367457|201775|P1|Overall Study|Rejection of treatment|1
49616|NCT01367457|201773|P3|Overall Study|Overall decline|0
49617|NCT01367457|201774|P2|Overall Study|Overall decline|0
49618|NCT01367457|201775|P1|Overall Study|Overall decline|1
49619|NCT01367457|201773|P3|Overall Study|Intestinal obstruction with necrosis|0
49620|NCT01367457|201774|P2|Overall Study|Intestinal obstruction with necrosis|0
49621|NCT01367457|201775|P1|Overall Study|Intestinal obstruction with necrosis|1
49622|NCT01367457|201773|P3|Overall Study|No clinical benefit|0
49623|NCT01367457|201774|P2|Overall Study|No clinical benefit|0
49624|NCT01367457|201775|P1|Overall Study|No clinical benefit|1
49625|NCT01367457|201773|P3|Overall Study|Stabilisation + frequent infections|0
49626|NCT01367457|201774|P2|Overall Study|Stabilisation + frequent infections|0
49627|NCT01367457|201775|P1|Overall Study|Stabilisation + frequent infections|1
49628|NCT01367457|201773|P3|Overall Study|Overall status worsens to grade 4|0
49629|NCT01367457|201774|P2|Overall Study|Overall status worsens to grade 4|0
49630|NCT01367457|201775|P1|Overall Study|Overall status worsens to grade 4|1
49631|NCT01367457|201773|P3|Overall Study|Uncontrolled pain|0
49632|NCT01367457|201774|P2|Overall Study|Uncontrolled pain|0
49633|NCT01367457|201775|P1|Overall Study|Uncontrolled pain|1
49634|NCT01367457|201773|P3|Overall Study|CD, associated leukaemia|0
49635|NCT01367457|201774|P2|Overall Study|CD, associated leukaemia|0
49636|NCT01367457|201775|P1|Overall Study|CD, associated leukaemia|1
49637|NCT01367457|201773|P3|Overall Study|Withdrawal by Subject|0
49638|NCT01367457|201774|P2|Overall Study|Withdrawal by Subject|0
49639|NCT01367457|201775|P1|Overall Study|Withdrawal by Subject|1
49640|NCT01367457|201773|P3|Overall Study|Choledocolithiasis and pancreatitis|0
49641|NCT01367457|201774|P2|Overall Study|Choledocolithiasis and pancreatitis|0
49642|NCT01367457|201775|P1|Overall Study|Choledocolithiasis and pancreatitis|1
49643|NCT01367457|201773|P3|Overall Study|low grade toxicities + stable disease|0
49644|NCT01367457|201774|P2|Overall Study|low grade toxicities + stable disease|0
49645|NCT01367457|201775|P1|Overall Study|low grade toxicities + stable disease|1
49646|NCT01367457|201773|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
49647|NCT01367457|201774|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
49648|NCT01367457|201775|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
49649|NCT01367457|201773|P3|Overall Study|Bleeding from cavernous haemangioma|0
49650|NCT01367457|201774|P2|Overall Study|Bleeding from cavernous haemangioma|0
49651|NCT01367457|201775|P1|Overall Study|Bleeding from cavernous haemangioma|1
49652|NCT01367457|201773|P3|Overall Study|Investigator's opinion, stable disease|0
49653|NCT01367457|201774|P2|Overall Study|Investigator's opinion, stable disease|0
49654|NCT01367457|201775|P1|Overall Study|Investigator's opinion, stable disease|1
49655|NCT01367457|201773|P3|Overall Study|Patient asks for rest + slow progression|0
49656|NCT01367457|201774|P2|Overall Study|Patient asks for rest + slow progression|0
49657|NCT01367457|201775|P1|Overall Study|Patient asks for rest + slow progression|1
49658|NCT01367457|201773|P3|Overall Study|Progression|0
49659|NCT01367457|201774|P2|Overall Study|Progression|0
49660|NCT01367457|201775|P1|Overall Study|Progression|137
49661|NCT01367457|201773|P3|Overall Study|Toxicity|0
49662|NCT01367457|201774|P2|Overall Study|Toxicity|0
49663|NCT01367457|201775|P1|Overall Study|Toxicity|16
49664|NCT01367457|201773|P3|Overall Study|Progression and death|0
49665|NCT01367457|201774|P2|Overall Study|Progression and death|0
49666|NCT01367457|201775|P1|Overall Study|Progression and death|8
49667|NCT01367457|201773|P3|Overall Study|Clinical decline (CD)|0
49668|NCT01367457|201774|P2|Overall Study|Clinical decline (CD)|0
49669|NCT01367457|201775|P1|Overall Study|Clinical decline (CD)|2
49670|NCT01367457|201773|P3|Overall Study|Investigator's decision|0
49671|NCT01367457|201774|P2|Overall Study|Investigator's decision|0
49672|NCT01367457|201775|P1|Overall Study|Investigator's decision|2
49673|NCT01367457|201773|P3|Overall Study|Death|0
49674|NCT01367457|201774|P2|Overall Study|Death|0
49675|NCT01367457|201775|P1|Overall Study|Death|2
49676|NCT01367249|201797|P2|Overall Study|Not Specified|10
49677|NCT01367249|201798|P1|Overall Study|Not Specified|3
49678|NCT01367249|201797|P2|Overall Study|Withdrawal by Subject|6
49679|NCT01367249|201798|P1|Overall Study|Withdrawal by Subject|6
49680|NCT01367158|201817|P11|Overall Study|Protocol Violation|0
49681|NCT01367158|201818|P10|Overall Study|Protocol Violation|0
49682|NCT01367158|201819|P9|Overall Study|Protocol Violation|0
49683|NCT01367158|201820|P8|Overall Study|Protocol Violation|0
49684|NCT01367158|201821|P7|Overall Study|Protocol Violation|0
49685|NCT01367158|201822|P6|Overall Study|Protocol Violation|0
49686|NCT01367158|201823|P5|Overall Study|Protocol Violation|0
49687|NCT01367158|201824|P4|Overall Study|Protocol Violation|0
49688|NCT01367158|201825|P3|Overall Study|Protocol Violation|0
49689|NCT01367158|201826|P2|Overall Study|Protocol Violation|1
49690|NCT01367158|201827|P1|Overall Study|Protocol Violation|0
49691|NCT01367158|201817|P11|Overall Study|Lost to Follow-up|1
49692|NCT01367158|201818|P10|Overall Study|Lost to Follow-up|0
49693|NCT01367158|201819|P9|Overall Study|Lost to Follow-up|0
49694|NCT01367158|201820|P8|Overall Study|Lost to Follow-up|1
49695|NCT01367158|201821|P7|Overall Study|Lost to Follow-up|0
49696|NCT01367158|201822|P6|Overall Study|Lost to Follow-up|2
49697|NCT01367158|201823|P5|Overall Study|Lost to Follow-up|0
49698|NCT01367158|201824|P4|Overall Study|Lost to Follow-up|1
49699|NCT01367158|201825|P3|Overall Study|Lost to Follow-up|0
49700|NCT01367158|201826|P2|Overall Study|Lost to Follow-up|0
49701|NCT01367158|201827|P1|Overall Study|Lost to Follow-up|0
49702|NCT01367158|201817|P11|Overall Study|Withdrew consent|0
49703|NCT01367158|201818|P10|Overall Study|Withdrew consent|0
49704|NCT01367158|201819|P9|Overall Study|Withdrew consent|0
49705|NCT01367158|201820|P8|Overall Study|Withdrew consent|1
49706|NCT01367158|201821|P7|Overall Study|Withdrew consent|0
49707|NCT01367158|201822|P6|Overall Study|Withdrew consent|0
49708|NCT01367158|201823|P5|Overall Study|Withdrew consent|2
49709|NCT01367158|201824|P4|Overall Study|Withdrew consent|0
49710|NCT01367158|201825|P3|Overall Study|Withdrew consent|1
49711|NCT01367158|201826|P2|Overall Study|Withdrew consent|2
49712|NCT01367158|201827|P1|Overall Study|Withdrew consent|0
49713|NCT01367119|201971|P2|Overall Study|Withdrawal by Subject|1
49714|NCT01367119|201972|P1|Overall Study|Withdrawal by Subject|1
49715|NCT01367119|201971|P2|Overall Study|Adverse Event|0
49716|NCT01367119|201972|P1|Overall Study|Adverse Event|1
49717|NCT01366846|202027|P4|Overall Study|Scheduling Conflicts|0
49718|NCT01366846|202028|P3|Overall Study|Scheduling Conflicts|1
49719|NCT01366846|202029|P2|Overall Study|Scheduling Conflicts|0
49720|NCT01366846|202030|P1|Overall Study|Scheduling Conflicts|0
49721|NCT01366846|202027|P4|Overall Study|Communication Difficulties|1
49722|NCT01366846|202028|P3|Overall Study|Communication Difficulties|0
49723|NCT01366846|202029|P2|Overall Study|Communication Difficulties|4
49724|NCT01366846|202030|P1|Overall Study|Communication Difficulties|1
49725|NCT01366846|202027|P4|Overall Study|Withdrawal by Subject|0
49726|NCT01366846|202028|P3|Overall Study|Withdrawal by Subject|0
49727|NCT01366846|202029|P2|Overall Study|Withdrawal by Subject|0
49728|NCT01366846|202030|P1|Overall Study|Withdrawal by Subject|2
49729|NCT01366638|202053|P3|Overall Study|Not specified|0
49730|NCT01366638|202054|P2|Overall Study|Not specified|0
49731|NCT01366638|202055|P1|Overall Study|Not specified|1
49732|NCT01366638|202053|P3|Overall Study|Withdrawal by Subject|6
49733|NCT01366638|202054|P2|Overall Study|Withdrawal by Subject|0
49734|NCT01366638|202055|P1|Overall Study|Withdrawal by Subject|0
49735|NCT01366534|202092|P3|Overall Study|Declined challenged|0
49736|NCT01366534|202093|P2|Overall Study|Declined challenged|1
49737|NCT01366534|202094|P1|Overall Study|Declined challenged|0
49738|NCT01366534|202092|P3|Overall Study|Migrated|0
49739|NCT01366534|202093|P2|Overall Study|Migrated|1
49740|NCT01366534|202094|P1|Overall Study|Migrated|1
49741|NCT01366534|202092|P3|Overall Study|Lost to Follow-up|0
49742|NCT01366534|202093|P2|Overall Study|Lost to Follow-up|0
49743|NCT01366534|202094|P1|Overall Study|Lost to Follow-up|1
49744|NCT01366521|202144|P4|Overall Study|Withdrawal by Subject|0
49745|NCT01366521|202145|P3|Overall Study|Withdrawal by Subject|0
49746|NCT01366521|202146|P2|Overall Study|Withdrawal by Subject|1
49747|NCT01366521|202147|P1|Overall Study|Withdrawal by Subject|0
49748|NCT01366521|202144|P4|Overall Study|Physician Decision|0
49749|NCT01366521|202145|P3|Overall Study|Physician Decision|1
49750|NCT01366521|202146|P2|Overall Study|Physician Decision|0
49751|NCT01366521|202147|P1|Overall Study|Physician Decision|0
49752|NCT01366521|202144|P4|Overall Study|Protocol Violation|0
49753|NCT01366521|202145|P3|Overall Study|Protocol Violation|1
49754|NCT01366521|202146|P2|Overall Study|Protocol Violation|0
49755|NCT01366521|202147|P1|Overall Study|Protocol Violation|0
49756|NCT01366521|202144|P4|Overall Study|Adverse Event|0
49757|NCT01366521|202145|P3|Overall Study|Adverse Event|0
49758|NCT01366521|202146|P2|Overall Study|Adverse Event|0
49759|NCT01366521|202147|P1|Overall Study|Adverse Event|1
49760|NCT01366443|202222|P1|Overall Study|Under 18 yo|1
49761|NCT01366443|202222|P1|Overall Study|Lost to Follow-up|2
49762|NCT01366209|202236|P2|Overall Study|Withdrew consent|3
49763|NCT01366209|202237|P1|Overall Study|Withdrew consent|4
49764|NCT01366209|202236|P2|Overall Study|Sponsors decision|1
49765|NCT01366209|202237|P1|Overall Study|Sponsors decision|0
49766|NCT01366209|202236|P2|Overall Study|Physician Decision|0
49767|NCT01366209|202237|P1|Overall Study|Physician Decision|1
49768|NCT01366209|202236|P2|Overall Study|Lost to Follow-up|1
49769|NCT01366209|202237|P1|Overall Study|Lost to Follow-up|2
49770|NCT01366209|202236|P2|Overall Study|Lung transplantation|1
49771|NCT01366209|202237|P1|Overall Study|Lung transplantation|6
49772|NCT01366209|202236|P2|Overall Study|Death|19
49773|NCT01366209|202237|P1|Overall Study|Death|12
49774|NCT01366209|202236|P2|Overall Study|Withdrawal by Subject|4
49775|NCT01366209|202237|P1|Overall Study|Withdrawal by Subject|4
49776|NCT01366209|202236|P2|Overall Study|Adverse Event|7
49777|NCT01366209|202237|P1|Overall Study|Adverse Event|6
49778|NCT01366092|202254|P1|Overall Study|Withdrawal by Subject|1
49779|NCT01366092|202254|P1|Overall Study|Physician Decision|1
49780|NCT01366092|202254|P1|Overall Study|Progressive cGVHD|2
49781|NCT01365910|202263|P1|Overall Study|pt did not get tx, nausea/vomiting|1
49782|NCT01365910|202263|P1|Overall Study|other complicating disease|1
49783|NCT01365910|202263|P1|Overall Study|Adverse Event|3
49784|NCT01365910|202263|P1|Overall Study|disease progression|18
49785|NCT01365910|202263|P1|Overall Study|Withdrawal by Subject|7
49786|NCT01365546|202358|P1|Overall Study|Study termination|1
49787|NCT01365546|202358|P1|Overall Study|Screen failure|9
49788|NCT01365546|202358|P1|Overall Study|Withdrawal by Subject|1
49789|NCT01365507|202368|P2|Overall Study|Unclassified|4
49790|NCT01365507|202369|P1|Overall Study|Unclassified|1
49791|NCT01365507|202368|P2|Overall Study|Withdrawal Criteria|5
49792|NCT01365507|202369|P1|Overall Study|Withdrawal Criteria|8
49793|NCT01365494|202385|P2|Overall Study|Lost to Follow-up|2
49794|NCT01365494|202386|P1|Overall Study|Lost to Follow-up|1
49795|NCT01365494|202385|P2|Overall Study|Withdrawal by Subject|1
49796|NCT01365494|202386|P1|Overall Study|Withdrawal by Subject|0
49797|NCT01365494|202385|P2|Overall Study|Adverse Event|0
49798|NCT01365494|202386|P1|Overall Study|Adverse Event|1
49799|NCT01365481|202402|P4|Overall Study|Unsatisfactory therapeutic effect|0
49800|NCT01365481|202403|P3|Overall Study|Unsatisfactory therapeutic effect|1
49801|NCT01365481|202404|P2|Overall Study|Unsatisfactory therapeutic effect|0
49802|NCT01365481|202405|P1|Overall Study|Unsatisfactory therapeutic effect|0
49803|NCT01365481|202402|P4|Overall Study|Protocol deviation|1
49804|NCT01365481|202403|P3|Overall Study|Protocol deviation|0
49805|NCT01365481|202404|P2|Overall Study|Protocol deviation|1
49806|NCT01365481|202405|P1|Overall Study|Protocol deviation|0
49807|NCT01365481|202402|P4|Overall Study|Administrative problems|0
49808|NCT01365481|202403|P3|Overall Study|Administrative problems|0
49809|NCT01365481|202404|P2|Overall Study|Administrative problems|1
49810|NCT01365481|202405|P1|Overall Study|Administrative problems|0
49811|NCT01365481|202402|P4|Overall Study|Abnormal laboratory value(s)|0
49812|NCT01365481|202403|P3|Overall Study|Abnormal laboratory value(s)|0
49813|NCT01365481|202404|P2|Overall Study|Abnormal laboratory value(s)|1
49814|NCT01365481|202405|P1|Overall Study|Abnormal laboratory value(s)|0
49815|NCT01365481|202402|P4|Overall Study|Lost to Follow-up|3
49816|NCT01365481|202403|P3|Overall Study|Lost to Follow-up|2
49817|NCT01365481|202404|P2|Overall Study|Lost to Follow-up|1
49818|NCT01365481|202405|P1|Overall Study|Lost to Follow-up|1
49819|NCT01365481|202402|P4|Overall Study|Withdrawal by Subject|1
49820|NCT01365481|202403|P3|Overall Study|Withdrawal by Subject|1
49821|NCT01365481|202404|P2|Overall Study|Withdrawal by Subject|2
49822|NCT01365481|202405|P1|Overall Study|Withdrawal by Subject|0
49823|NCT01365481|202402|P4|Overall Study|Adverse Event|2
49824|NCT01365481|202403|P3|Overall Study|Adverse Event|0
49825|NCT01365481|202404|P2|Overall Study|Adverse Event|9
49826|NCT01365481|202405|P1|Overall Study|Adverse Event|6
49827|NCT01365468|202425|P2|Overall Study|Lost to Follow-up|0
49828|NCT01365468|202426|P1|Overall Study|Lost to Follow-up|2
49829|NCT01365468|202425|P2|Overall Study|Disease progression|0
49830|NCT01365468|202426|P1|Overall Study|Disease progression|1
49831|NCT01365468|202425|P2|Overall Study|Physician Decision|0
49832|NCT01365468|202426|P1|Overall Study|Physician Decision|1
49833|NCT01365455|202441|P5|Maintenance Period|Subject/guardian decision|1
49834|NCT01365455|202442|P4|Maintenance Period|Subject/guardian decision|4
49835|NCT01365455|202443|P3|Maintenance Period|Subject/guardian decision|2
49836|NCT01365455|202444|P2|Maintenance Period|Subject/guardian decision|6
49837|NCT01365455|202445|P1|Maintenance Period|Subject/guardian decision|4
49838|NCT01365455|202441|P5|Maintenance Period|Protocol deviation|0
49839|NCT01365455|202442|P4|Maintenance Period|Protocol deviation|0
49840|NCT01365455|202443|P3|Maintenance Period|Protocol deviation|0
49841|NCT01365455|202444|P2|Maintenance Period|Protocol deviation|1
49842|NCT01365455|202445|P1|Maintenance Period|Protocol deviation|1
49843|NCT01365455|202441|P5|Maintenance Period|Pregnancy|2
49844|NCT01365455|202442|P4|Maintenance Period|Pregnancy|0
49845|NCT01365455|202443|P3|Maintenance Period|Pregnancy|0
49846|NCT01365455|202444|P2|Maintenance Period|Pregnancy|4
49847|NCT01365455|202445|P1|Maintenance Period|Pregnancy|0
49848|NCT01365455|202441|P5|Maintenance Period|Physician Decision|1
49849|NCT01365455|202442|P4|Maintenance Period|Physician Decision|0
49850|NCT01365455|202443|P3|Maintenance Period|Physician Decision|0
49851|NCT01365455|202444|P2|Maintenance Period|Physician Decision|1
49852|NCT01365455|202445|P1|Maintenance Period|Physician Decision|0
49853|NCT01365455|202441|P5|Maintenance Period|Non-compliance with study treatment|0
49854|NCT01365455|202442|P4|Maintenance Period|Non-compliance with study treatment|1
49855|NCT01365455|202443|P3|Maintenance Period|Non-compliance with study treatment|0
49856|NCT01365455|202444|P2|Maintenance Period|Non-compliance with study treatment|0
49857|NCT01365455|202445|P1|Maintenance Period|Non-compliance with study treatment|0
49858|NCT01365455|202441|P5|Maintenance Period|Lost to Follow-up|3
49859|NCT01365455|202442|P4|Maintenance Period|Lost to Follow-up|0
49860|NCT01365455|202443|P3|Maintenance Period|Lost to Follow-up|0
49861|NCT01365455|202444|P2|Maintenance Period|Lost to Follow-up|4
49862|NCT01365455|202445|P1|Maintenance Period|Lost to Follow-up|2
49863|NCT01365455|202441|P5|Maintenance Period|Lack of Efficacy|2
49864|NCT01365455|202442|P4|Maintenance Period|Lack of Efficacy|2
49865|NCT01365455|202443|P3|Maintenance Period|Lack of Efficacy|0
49866|NCT01365455|202444|P2|Maintenance Period|Lack of Efficacy|2
49867|NCT01365455|202445|P1|Maintenance Period|Lack of Efficacy|10
49868|NCT01365455|202441|P5|Maintenance Period|Adverse Event|4
49869|NCT01365455|202442|P4|Maintenance Period|Adverse Event|2
49870|NCT01365455|202443|P3|Maintenance Period|Adverse Event|1
49871|NCT01365455|202444|P2|Maintenance Period|Adverse Event|5
49872|NCT01365455|202445|P1|Maintenance Period|Adverse Event|12
49873|NCT01365455|202441|P5|Induction Period|Lost to Follow-up|0
49874|NCT01365455|202442|P4|Induction Period|Lost to Follow-up|0
49875|NCT01365455|202443|P3|Induction Period|Lost to Follow-up|3
49876|NCT01365455|202444|P2|Induction Period|Lost to Follow-up|0
49877|NCT01365455|202445|P1|Induction Period|Lost to Follow-up|0
49878|NCT01365455|202441|P5|Induction Period|Subject/guardian decision|0
49879|NCT01365455|202442|P4|Induction Period|Subject/guardian decision|0
49880|NCT01365455|202443|P3|Induction Period|Subject/guardian decision|8
49881|NCT01365455|202444|P2|Induction Period|Subject/guardian decision|1
49882|NCT01365455|202445|P1|Induction Period|Subject/guardian decision|9
49883|NCT01365455|202441|P5|Induction Period|Protocol deviation|0
49884|NCT01365455|202442|P4|Induction Period|Protocol deviation|0
49885|NCT01365455|202443|P3|Induction Period|Protocol deviation|1
49886|NCT01365455|202444|P2|Induction Period|Protocol deviation|1
49887|NCT01365455|202445|P1|Induction Period|Protocol deviation|0
49888|NCT01365455|202441|P5|Induction Period|Pregnancy|0
49889|NCT01365455|202442|P4|Induction Period|Pregnancy|0
49890|NCT01365455|202443|P3|Induction Period|Pregnancy|0
49891|NCT01365455|202444|P2|Induction Period|Pregnancy|1
49892|NCT01365455|202445|P1|Induction Period|Pregnancy|0
49893|NCT01365455|202441|P5|Induction Period|Lack of Efficacy|0
49894|NCT01365455|202442|P4|Induction Period|Lack of Efficacy|0
49895|NCT01365455|202443|P3|Induction Period|Lack of Efficacy|0
49896|NCT01365455|202444|P2|Induction Period|Lack of Efficacy|1
49897|NCT01365455|202445|P1|Induction Period|Lack of Efficacy|1
49898|NCT01365455|202441|P5|Induction Period|Adverse Event|0
49899|NCT01365455|202442|P4|Induction Period|Adverse Event|0
49900|NCT01365455|202443|P3|Induction Period|Adverse Event|4
49901|NCT01365455|202444|P2|Induction Period|Adverse Event|3
49902|NCT01365455|202445|P1|Induction Period|Adverse Event|5
49903|NCT01365273|202535|P2|Overall Study|Physician Decision|0
49904|NCT01365273|202536|P1|Overall Study|Physician Decision|1
49905|NCT01365273|202535|P2|Overall Study|Protocol Violation|1
49906|NCT01365273|202536|P1|Overall Study|Protocol Violation|0
49907|NCT01365273|202535|P2|Overall Study|Lost to Follow-up|0
49908|NCT01365273|202536|P1|Overall Study|Lost to Follow-up|1
49909|NCT01365130|202546|P1|Overall Study|Progression/worsening of Dx prior to txt|2
49910|NCT01365091|202554|P4|Period 2|Adverse Event|0
49911|NCT01365091|202555|P3|Period 2|Adverse Event|1
49912|NCT01365091|202556|P2|Period 2|Adverse Event|0
49913|NCT01365091|202557|P1|Period 2|Adverse Event|0
49914|NCT01365091|202554|P4|Period 2|Withdrawal by Subject|0
49915|NCT01365091|202555|P3|Period 2|Withdrawal by Subject|0
49916|NCT01365091|202556|P2|Period 2|Withdrawal by Subject|0
49917|NCT01365091|202557|P1|Period 2|Withdrawal by Subject|1
49918|NCT01365091|202554|P4|Period 1|Personal reasons|0
49919|NCT01365091|202555|P3|Period 1|Personal reasons|1
49920|NCT01365091|202556|P2|Period 1|Personal reasons|0
49921|NCT01365091|202557|P1|Period 1|Personal reasons|0
49922|NCT01365091|202554|P4|Period 1|Withdrawal by Subject|0
49923|NCT01365091|202555|P3|Period 1|Withdrawal by Subject|0
49924|NCT01365091|202556|P2|Period 1|Withdrawal by Subject|1
49925|NCT01365091|202557|P1|Period 1|Withdrawal by Subject|0
49926|NCT01365091|202554|P4|Period 1|No longer met study criteria|0
49927|NCT01365091|202555|P3|Period 1|No longer met study criteria|0
49928|NCT01365091|202556|P2|Period 1|No longer met study criteria|1
49929|NCT01365091|202557|P1|Period 1|No longer met study criteria|0
49930|NCT01365091|202554|P4|Period 1|Positive test result for drugs of abuse|0
49931|NCT01365091|202555|P3|Period 1|Positive test result for drugs of abuse|0
49932|NCT01365091|202556|P2|Period 1|Positive test result for drugs of abuse|0
49933|NCT01365091|202557|P1|Period 1|Positive test result for drugs of abuse|1
49934|NCT01365091|202554|P4|Period 1|Adverse Event|3
49935|NCT01365091|202555|P3|Period 1|Adverse Event|2
49936|NCT01365091|202556|P2|Period 1|Adverse Event|0
49937|NCT01365091|202557|P1|Period 1|Adverse Event|1
49938|NCT01365052|202585|P2|Overall Study|Adverse Event|4
49939|NCT01365052|202586|P1|Overall Study|Adverse Event|4
49940|NCT01365039|202602|P2|Overall Study|Study related symptoms and complaints|0
49941|NCT01365039|202603|P1|Overall Study|Study related symptoms and complaints|1
49942|NCT01364922|202614|P3|Double-Blind (DB) Period|Other, Unspecified|0
49943|NCT01364922|202615|P2|Double-Blind (DB) Period|Other, Unspecified|1
49944|NCT01364922|202616|P1|Double-Blind (DB) Period|Other, Unspecified|0
49945|NCT01364922|202614|P3|Double-Blind (DB) Period|Adverse Event|1
49946|NCT01364922|202615|P2|Double-Blind (DB) Period|Adverse Event|0
49947|NCT01364922|202616|P1|Double-Blind (DB) Period|Adverse Event|0
49948|NCT01364922|202614|P3|Double-Blind (DB) Period|Subject Noncompliant|0
49949|NCT01364922|202615|P2|Double-Blind (DB) Period|Subject Noncompliant|1
49950|NCT01364922|202616|P1|Double-Blind (DB) Period|Subject Noncompliant|0
49951|NCT01364922|202614|P3|Double-Blind (DB) Period|Lack of Efficacy|4
49952|NCT01364922|202615|P2|Double-Blind (DB) Period|Lack of Efficacy|3
49953|NCT01364922|202616|P1|Double-Blind (DB) Period|Lack of Efficacy|0
49954|NCT01364922|202614|P3|Open-label (OL) Period|Other, Unspecified|0
49955|NCT01364922|202615|P2|Open-label (OL) Period|Other, Unspecified|0
49956|NCT01364922|202616|P1|Open-label (OL) Period|Other, Unspecified|1
49957|NCT01364922|202614|P3|Open-label (OL) Period|Lost to Follow-up|0
49958|NCT01364922|202615|P2|Open-label (OL) Period|Lost to Follow-up|0
49959|NCT01364922|202616|P1|Open-label (OL) Period|Lost to Follow-up|1
49960|NCT01364922|202614|P3|Open-label (OL) Period|Lack of Efficacy|0
49961|NCT01364922|202615|P2|Open-label (OL) Period|Lack of Efficacy|0
49962|NCT01364922|202616|P1|Open-label (OL) Period|Lack of Efficacy|3
49963|NCT01364922|202614|P3|Open-label (OL) Period|Withdrawal by Subject|0
49964|NCT01364922|202615|P2|Open-label (OL) Period|Withdrawal by Subject|0
49965|NCT01364922|202616|P1|Open-label (OL) Period|Withdrawal by Subject|4
49966|NCT01364922|202614|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
49967|NCT01364922|202615|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
49968|NCT01364922|202616|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
49969|NCT01364922|202614|P3|Open-label (OL) Period|Adverse Event|0
49970|NCT01364922|202615|P2|Open-label (OL) Period|Adverse Event|0
49971|NCT01364922|202616|P1|Open-label (OL) Period|Adverse Event|7
49972|NCT01364727|202643|P1|Overall Study|Not Eligible|2
49973|NCT01364649|202651|P2|Overall Study|Other|1
49974|NCT01364649|202652|P1|Overall Study|Other|4
49975|NCT01364649|202651|P2|Overall Study|Lost to Follow-up|13
49976|NCT01364649|202652|P1|Overall Study|Lost to Follow-up|12
49977|NCT01364649|202651|P2|Overall Study|Withdrawal of Consent|7
49978|NCT01364649|202652|P1|Overall Study|Withdrawal of Consent|9
49979|NCT01364649|202651|P2|Overall Study|Protocol Deviations|8
49980|NCT01364649|202652|P1|Overall Study|Protocol Deviations|4
49981|NCT01364649|202651|P2|Overall Study|Non-compliance with Investigational Drug|0
49982|NCT01364649|202652|P1|Overall Study|Non-compliance with Investigational Drug|1
49983|NCT01364649|202651|P2|Overall Study|Lack of Efficacy|0
49984|NCT01364649|202652|P1|Overall Study|Lack of Efficacy|6
49985|NCT01364649|202651|P2|Overall Study|Pretreatment Event or Adverse Event|14
49986|NCT01364649|202652|P1|Overall Study|Pretreatment Event or Adverse Event|20
49987|NCT01364428|202674|P2|Overall Study|Other|3
49988|NCT01364428|202675|P1|Overall Study|Other|3
49989|NCT01364428|202674|P2|Overall Study|Withdrawal Criteria|10
49990|NCT01364428|202675|P1|Overall Study|Withdrawal Criteria|14
49991|NCT01364428|202674|P2|Overall Study|Protocol Violation|0
49992|NCT01364428|202675|P1|Overall Study|Protocol Violation|2
49993|NCT01364428|202674|P2|Overall Study|Adverse Event|2
49994|NCT01364428|202675|P1|Overall Study|Adverse Event|1
49995|NCT01364389|202692|P3|Overall Study|Adverse Event|0
49996|NCT01364389|202693|P2|Overall Study|Adverse Event|0
49997|NCT01364389|202694|P1|Overall Study|Adverse Event|1
49998|NCT01364389|202692|P3|Overall Study|Administrative problems|0
49999|NCT01364389|202693|P2|Overall Study|Administrative problems|0
50000|NCT01364389|202694|P1|Overall Study|Administrative problems|1
50001|NCT01364389|202692|P3|Overall Study|Protocol deviation|1
50002|NCT01364389|202693|P2|Overall Study|Protocol deviation|0
50003|NCT01364389|202694|P1|Overall Study|Protocol deviation|0
50004|NCT01364389|202692|P3|Overall Study|Withdrawal by Subject|0
50005|NCT01364389|202693|P2|Overall Study|Withdrawal by Subject|1
50006|NCT01364389|202694|P1|Overall Study|Withdrawal by Subject|0
50007|NCT01364298|202713|P2|Overall Study|Unspecified|3
50008|NCT01364298|202714|P1|Overall Study|Unspecified|1
50009|NCT01364298|202713|P2|Overall Study|Withdrawal by Subject|3
50010|NCT01364298|202714|P1|Overall Study|Withdrawal by Subject|3
50011|NCT01364298|202713|P2|Overall Study|Lost to Follow-up|10
50012|NCT01364298|202714|P1|Overall Study|Lost to Follow-up|5
50013|NCT01364298|202713|P2|Overall Study|Lack of Efficacy|0
50014|NCT01364298|202714|P1|Overall Study|Lack of Efficacy|1
50015|NCT01364298|202713|P2|Overall Study|Lack of adherence to treatment|3
50016|NCT01364298|202714|P1|Overall Study|Lack of adherence to treatment|1
50017|NCT01364298|202713|P2|Overall Study|Adverse Event|4
50018|NCT01364298|202714|P1|Overall Study|Adverse Event|3
50019|NCT01363986|202756|P1|Overall Study|Disease progression|1
50020|NCT01363908|202766|P2|Chronic Dosing (CD) Phase|Early study termination|3
50021|NCT01363908|202767|P1|Chronic Dosing (CD) Phase|Early study termination|9
50022|NCT01363908|202766|P2|Chronic Dosing (CD) Phase|Physician Decision|1
50023|NCT01363908|202767|P1|Chronic Dosing (CD) Phase|Physician Decision|0
50024|NCT01363908|202766|P2|Chronic Dosing (CD) Phase|Patient decision|1
50025|NCT01363908|202767|P1|Chronic Dosing (CD) Phase|Patient decision|0
50026|NCT01363908|202766|P2|Chronic Dosing (CD) Phase|Adverse Event|1
50027|NCT01363908|202767|P1|Chronic Dosing (CD) Phase|Adverse Event|1
50028|NCT01363765|202803|P2|Overall Study|smear during intervention|0
50029|NCT01363765|202804|P1|Overall Study|smear during intervention|2170
50030|NCT01363765|202803|P2|Overall Study|age not recorded (used for cross-linkage|354
50031|NCT01363765|202804|P1|Overall Study|age not recorded (used for cross-linkage|117
50032|NCT01363765|202803|P2|Overall Study|non-resident|76
50033|NCT01363765|202804|P1|Overall Study|non-resident|156
50034|NCT01363765|202803|P2|Overall Study|duplicate records|3177
50035|NCT01363765|202804|P1|Overall Study|duplicate records|736
50036|NCT01363765|202803|P2|Overall Study|non-diagnostic|1124
50037|NCT01363765|202804|P1|Overall Study|non-diagnostic|2621
50038|NCT01363713|202816|P1|Overall Study|Withdrawal by Subject|2
50039|NCT01363713|202816|P1|Overall Study|Protocol Violation|3
50040|NCT01363713|202816|P1|Overall Study|Adverse Event|1
50041|NCT01363700|202825|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
50042|NCT01363700|202826|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
50043|NCT01363700|202827|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
50044|NCT01363700|202828|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
50045|NCT01363700|202829|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
50046|NCT01363661|202848|P2|Overall Study|Lost to Follow-up|1
50047|NCT01363661|202849|P1|Overall Study|Lost to Follow-up|3
50048|NCT01363661|202848|P2|Overall Study|Protocol Violation|0
50049|NCT01363661|202849|P1|Overall Study|Protocol Violation|1
50050|NCT01363661|202848|P2|Overall Study|Withdrawal by Subject|1
50051|NCT01363661|202849|P1|Overall Study|Withdrawal by Subject|1
50052|NCT01363661|202848|P2|Overall Study|Adverse Event|2
50053|NCT01363661|202849|P1|Overall Study|Adverse Event|9
50054|NCT01363440|202890|P3|Overall Study|Other|2
50055|NCT01363440|202891|P2|Overall Study|Other|5
50056|NCT01363440|202892|P1|Overall Study|Other|4
50057|NCT01363440|202890|P3|Overall Study|Lost to Follow-up|5
50058|NCT01363440|202891|P2|Overall Study|Lost to Follow-up|4
50059|NCT01363440|202892|P1|Overall Study|Lost to Follow-up|2
50060|NCT01363440|202890|P3|Overall Study|Withdrawal by Subject|11
50061|NCT01363440|202891|P2|Overall Study|Withdrawal by Subject|11
50062|NCT01363440|202892|P1|Overall Study|Withdrawal by Subject|9
50063|NCT01363440|202890|P3|Overall Study|Death|5
50064|NCT01363440|202891|P2|Overall Study|Death|7
50065|NCT01363440|202892|P1|Overall Study|Death|3
50066|NCT01363440|202890|P3|Overall Study|Adverse Event|4
50067|NCT01363440|202891|P2|Overall Study|Adverse Event|4
50068|NCT01363440|202892|P1|Overall Study|Adverse Event|5
50069|NCT01363349|202938|P2|Overall Study|missing|2
50070|NCT01363349|202939|P1|Overall Study|missing|1
50071|NCT01363349|202938|P2|Overall Study|Not reported|37
50072|NCT01363349|202939|P1|Overall Study|Not reported|36
50073|NCT01363349|202938|P2|Overall Study|Lost to Follow-up|6
50074|NCT01363349|202939|P1|Overall Study|Lost to Follow-up|5
50075|NCT01363349|202938|P2|Overall Study|Withdrawal by Subject|6
50076|NCT01363349|202939|P1|Overall Study|Withdrawal by Subject|14
50077|NCT01363349|202938|P2|Overall Study|Non compliance/Protocol deviations|2
50078|NCT01363349|202939|P1|Overall Study|Non compliance/Protocol deviations|2
50079|NCT01363349|202938|P2|Overall Study|Lack of Efficacy|10
50080|NCT01363349|202939|P1|Overall Study|Lack of Efficacy|3
50081|NCT01363349|202938|P2|Overall Study|Adverse Event|7
50082|NCT01363349|202939|P1|Overall Study|Adverse Event|6
50083|NCT01363297|202950|P5|Overall Study|Death|30
50084|NCT01363297|202951|P4|Overall Study|Death|10
50085|NCT01363297|202952|P3|Overall Study|Death|6
50086|NCT01363297|202953|P2|Overall Study|Death|6
50087|NCT01363297|202954|P1|Overall Study|Death|3
50088|NCT01363297|202950|P5|Overall Study|Not specified|1
50089|NCT01363297|202951|P4|Overall Study|Not specified|0
50090|NCT01363297|202952|P3|Overall Study|Not specified|0
50091|NCT01363297|202953|P2|Overall Study|Not specified|0
50092|NCT01363297|202954|P1|Overall Study|Not specified|0
50093|NCT01363076|203046|P2|Overall Study|Withdrawal by Subject|1
50094|NCT01363076|203047|P1|Overall Study|Withdrawal by Subject|0
50095|NCT01363011|203079|P2|Extension Phase|Rolled Over to Another Gilead Study|1
50096|NCT01363011|203080|P1|Extension Phase|Rolled Over to Another Gilead Study|2
50097|NCT01363011|203079|P2|Extension Phase|Lost to Follow-up|2
50098|NCT01363011|203080|P1|Extension Phase|Lost to Follow-up|0
50099|NCT01363011|203079|P2|Extension Phase|Withdrew Consent|1
50100|NCT01363011|203080|P1|Extension Phase|Withdrew Consent|0
50101|NCT01363011|203079|P2|Extension Phase|Investigator's Discretion|2
50102|NCT01363011|203080|P1|Extension Phase|Investigator's Discretion|2
50103|NCT01363011|203079|P2|Extension Phase|Lack of Efficacy|1
50104|NCT01363011|203080|P1|Extension Phase|Lack of Efficacy|0
50105|NCT01363011|203079|P2|Extension Phase|Adverse Event|1
50106|NCT01363011|203080|P1|Extension Phase|Adverse Event|1
50107|NCT01363011|203079|P2|Main Study|Protocol Violation|1
50108|NCT01363011|203080|P1|Main Study|Protocol Violation|0
50109|NCT01363011|203079|P2|Main Study|Withdrew Consent|4
50110|NCT01363011|203080|P1|Main Study|Withdrew Consent|1
50111|NCT01363011|203079|P2|Main Study|Investigator's Discretion|1
50112|NCT01363011|203080|P1|Main Study|Investigator's Discretion|1
50113|NCT01363011|203079|P2|Main Study|Adverse Event|3
50114|NCT01363011|203080|P1|Main Study|Adverse Event|2
50115|NCT01362608|203205|P2|Overall Study|Adverse Event|2
50116|NCT01362608|203206|P1|Overall Study|Adverse Event|0
50117|NCT01362608|203205|P2|Overall Study|Lack of Efficacy|2
50118|NCT01362608|203206|P1|Overall Study|Lack of Efficacy|0
50119|NCT01362608|203205|P2|Overall Study|Withdrawal by Subject|2
50120|NCT01362608|203206|P1|Overall Study|Withdrawal by Subject|1
50121|NCT01362608|203205|P2|Overall Study|Lost to Follow-up|1
50122|NCT01362608|203206|P1|Overall Study|Lost to Follow-up|3
50123|NCT01362608|203205|P2|Overall Study|Protocol Violation|1
50124|NCT01362608|203206|P1|Overall Study|Protocol Violation|0
50125|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
50126|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
50127|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
50128|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
50129|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
50130|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
50131|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
50132|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
50133|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
50134|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
50135|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
50136|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
50137|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
50138|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
50139|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
50140|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
50141|NCT01362530|203244|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
50142|NCT01362530|203245|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
50143|NCT01362530|203244|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
50144|NCT01362530|203245|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
50145|NCT01362530|203244|P2|Base Study (Cycle 1)|Protocol Violation|0
50146|NCT01362530|203245|P1|Base Study (Cycle 1)|Protocol Violation|2
50147|NCT01362530|203244|P2|Base Study (Cycle 1)|Physician Decision|1
50148|NCT01362530|203245|P1|Base Study (Cycle 1)|Physician Decision|0
50149|NCT01362530|203244|P2|Base Study (Cycle 1)|Adverse Event|0
50150|NCT01362530|203245|P1|Base Study (Cycle 1)|Adverse Event|2
50151|NCT01362517|203258|P1|Overall Study|Lost to Follow-up|1
50152|NCT01362517|203258|P1|Overall Study|Protocol Violation|1
50153|NCT01362491|203269|P3|Overall Study|Ineligible|0
50154|NCT01362491|203270|P2|Overall Study|Ineligible|0
50155|NCT01362491|203271|P1|Overall Study|Ineligible|1
50156|NCT01362439|203319|P1|Overall Study|Participant who withdrew consent|8
50157|NCT01362439|203319|P1|Overall Study|Study medication non-compliant|1
50158|NCT01362439|203319|P1|Overall Study|Lost to Follow-up|2
50159|NCT01362439|203319|P1|Overall Study|Lack of Efficacy|3
50160|NCT01362439|203319|P1|Overall Study|Adverse Event|1
50161|NCT01362348|203334|P1|Overall Study|Study closed/terminated|5
50162|NCT01362348|203334|P1|Overall Study|Protocol-defined stopping criteria|9
50163|NCT01362296|203353|P4|Crossover Phase|Study Closed/Terminated|0
50164|NCT01362296|203354|P3|Crossover Phase|Study Closed/Terminated|1
50165|NCT01362296|203355|P2|Crossover Phase|Study Closed/Terminated|0
50166|NCT01362296|203356|P1|Crossover Phase|Study Closed/Terminated|0
50167|NCT01362296|203353|P4|Crossover Phase|Adverse Event|0
50168|NCT01362296|203354|P3|Crossover Phase|Adverse Event|4
50169|NCT01362296|203355|P2|Crossover Phase|Adverse Event|0
50170|NCT01362296|203356|P1|Crossover Phase|Adverse Event|0
50171|NCT01362296|203353|P4|Crossover Phase|Withdrawal by Subject|1
50172|NCT01362296|203354|P3|Crossover Phase|Withdrawal by Subject|2
50173|NCT01362296|203355|P2|Crossover Phase|Withdrawal by Subject|0
50174|NCT01362296|203356|P1|Crossover Phase|Withdrawal by Subject|0
50175|NCT01362296|203353|P4|Crossover Phase|PD including Death due to PD|1
50176|NCT01362296|203354|P3|Crossover Phase|PD including Death due to PD|16
50177|NCT01362296|203355|P2|Crossover Phase|PD including Death due to PD|0
50178|NCT01362296|203356|P1|Crossover Phase|PD including Death due to PD|0
50179|NCT01362296|203353|P4|Randomized Phase (RP)|Study Closed/Terminated|0
50180|NCT01362296|203354|P3|Randomized Phase (RP)|Study Closed/Terminated|0
50181|NCT01362296|203355|P2|Randomized Phase (RP)|Study Closed/Terminated|1
50182|NCT01362296|203356|P1|Randomized Phase (RP)|Study Closed/Terminated|8
50183|NCT01362296|203353|P4|Randomized Phase (RP)|Adverse Event|0
50184|NCT01362296|203354|P3|Randomized Phase (RP)|Adverse Event|0
50185|NCT01362296|203355|P2|Randomized Phase (RP)|Adverse Event|4
50186|NCT01362296|203356|P1|Randomized Phase (RP)|Adverse Event|20
50187|NCT01362296|203353|P4|Randomized Phase (RP)|Withdrawal by Subject|0
50188|NCT01362296|203354|P3|Randomized Phase (RP)|Withdrawal by Subject|0
50189|NCT01362296|203355|P2|Randomized Phase (RP)|Withdrawal by Subject|1
50190|NCT01362296|203356|P1|Randomized Phase (RP)|Withdrawal by Subject|2
50191|NCT01362296|203353|P4|Randomized Phase (RP)|Physician Decision|0
50192|NCT01362296|203354|P3|Randomized Phase (RP)|Physician Decision|0
50193|NCT01362296|203355|P2|Randomized Phase (RP)|Physician Decision|9
50194|NCT01362296|203356|P1|Randomized Phase (RP)|Physician Decision|1
50195|NCT01362296|203353|P4|Randomized Phase (RP)|PD including Death due to PD|0
50196|NCT01362296|203354|P3|Randomized Phase (RP)|PD including Death due to PD|0
50197|NCT01362296|203355|P2|Randomized Phase (RP)|PD including Death due to PD|28
50198|NCT01362296|203356|P1|Randomized Phase (RP)|PD including Death due to PD|56
50199|NCT01362244|203404|P2|Overall Study|Protocol Defined Stopping Criteria|1
50200|NCT01362244|203405|P1|Overall Study|Protocol Defined Stopping Criteria|0
50201|NCT01362244|203404|P2|Overall Study|Did not Meet Continuation Criteria|11
50202|NCT01362244|203405|P1|Overall Study|Did not Meet Continuation Criteria|17
50203|NCT01362244|203404|P2|Overall Study|Withdrawal by Subject|1
50204|NCT01362244|203405|P1|Overall Study|Withdrawal by Subject|2
50205|NCT01362244|203404|P2|Overall Study|Protocol Violation|1
50206|NCT01362244|203405|P1|Overall Study|Protocol Violation|5
50207|NCT01362244|203404|P2|Overall Study|Lost to Follow-up|2
50208|NCT01362244|203405|P1|Overall Study|Lost to Follow-up|0
50209|NCT01362244|203404|P2|Overall Study|Lack of Efficacy|11
50210|NCT01362244|203405|P1|Overall Study|Lack of Efficacy|5
50211|NCT01362244|203404|P2|Overall Study|Adverse Event|5
50212|NCT01362244|203405|P1|Overall Study|Adverse Event|3
50213|NCT01362140|203517|P2|Overall Study|Discontinued Without Receiving Treatment|1
50214|NCT01362140|203518|P1|Overall Study|Discontinued Without Receiving Treatment|0
50215|NCT01362140|203517|P2|Overall Study|Protocol-specified Criteria|2
50216|NCT01362140|203518|P1|Overall Study|Protocol-specified Criteria|1
50217|NCT01362140|203517|P2|Overall Study|Other|1
50218|NCT01362140|203518|P1|Overall Study|Other|1
50219|NCT01362140|203517|P2|Overall Study|Death|1
50220|NCT01362140|203518|P1|Overall Study|Death|2
50221|NCT01362140|203517|P2|Overall Study|Administrative Decision|1
50222|NCT01362140|203518|P1|Overall Study|Administrative Decision|0
50223|NCT01362140|203517|P2|Overall Study|Withdrawal by Subject|3
50224|NCT01362140|203518|P1|Overall Study|Withdrawal by Subject|3
50225|NCT01362140|203517|P2|Overall Study|Adverse Event|2
50226|NCT01362140|203518|P1|Overall Study|Adverse Event|2
50227|NCT01362140|203517|P2|Overall Study|Noncompliance|0
50228|NCT01362140|203518|P1|Overall Study|Noncompliance|1
50229|NCT01362062|203542|P2|Overall Study|Had significant improvement|0
50230|NCT01362062|203543|P1|Overall Study|Had significant improvement|9
50231|NCT01362062|203542|P2|Overall Study|Detected with Spondylo-arthritis|0
50232|NCT01362062|203543|P1|Overall Study|Detected with Spondylo-arthritis|1
50233|NCT01362062|203542|P2|Overall Study|Non-compliant participant|0
50234|NCT01362062|203543|P1|Overall Study|Non-compliant participant|2
50235|NCT01362062|203542|P2|Overall Study|Withdrawal by Subject|0
50236|NCT01362062|203543|P1|Overall Study|Withdrawal by Subject|2
50237|NCT01362062|203542|P2|Overall Study|Lost to Follow-up|0
50238|NCT01362062|203543|P1|Overall Study|Lost to Follow-up|11
50239|NCT01362062|203542|P2|Overall Study|Adverse Event|0
50240|NCT01362062|203543|P1|Overall Study|Adverse Event|1
50241|NCT01362049|203564|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
50242|NCT01362049|203565|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
50243|NCT01362049|203566|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
50244|NCT01362049|203567|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
50245|NCT01362049|203564|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
50246|NCT01362049|203565|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
50247|NCT01362049|203566|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
50248|NCT01362049|203567|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
50249|NCT01360645|203619|P4|Phase A+|Protocol Deviation|4
50250|NCT01360645|203620|P3|Phase A+|Protocol Deviation|0
50251|NCT01360645|203621|P2|Phase A+|Protocol Deviation|0
50252|NCT01360645|203622|P1|Phase A+|Protocol Deviation|0
50253|NCT01360645|203619|P4|Phase A+|Withdrawal by Subject|5
50254|NCT01360645|203620|P3|Phase A+|Withdrawal by Subject|0
50255|NCT01360645|203621|P2|Phase A+|Withdrawal by Subject|0
50256|NCT01360645|203622|P1|Phase A+|Withdrawal by Subject|0
50257|NCT01360645|203619|P4|Phase A+|Physician Decision|2
50258|NCT01360645|203620|P3|Phase A+|Physician Decision|0
50259|NCT01360645|203621|P2|Phase A+|Physician Decision|0
50260|NCT01360645|203622|P1|Phase A+|Physician Decision|0
50261|NCT01360645|203619|P4|Phase A+|Met Withdrawal Criteria|4
50262|NCT01360645|203620|P3|Phase A+|Met Withdrawal Criteria|0
50263|NCT01360645|203621|P2|Phase A+|Met Withdrawal Criteria|0
50264|NCT01360645|203622|P1|Phase A+|Met Withdrawal Criteria|0
50265|NCT01360645|203619|P4|Phase A+|Adverse Event|2
50266|NCT01360645|203620|P3|Phase A+|Adverse Event|0
50267|NCT01360645|203621|P2|Phase A+|Adverse Event|0
50268|NCT01360645|203622|P1|Phase A+|Adverse Event|0
50269|NCT01360645|203619|P4|Phase A+|Lost to Follow-up|7
50270|NCT01360645|203620|P3|Phase A+|Lost to Follow-up|0
50271|NCT01360645|203621|P2|Phase A+|Lost to Follow-up|0
50272|NCT01360645|203622|P1|Phase A+|Lost to Follow-up|0
50273|NCT01360645|203619|P4|Phase B (6 Weeks)|Protocol Deviation|0
50274|NCT01360645|203620|P3|Phase B (6 Weeks)|Protocol Deviation|3
50275|NCT01360645|203621|P2|Phase B (6 Weeks)|Protocol Deviation|1
50276|NCT01360645|203622|P1|Phase B (6 Weeks)|Protocol Deviation|0
50277|NCT01360645|203619|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
50278|NCT01360645|203620|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
50279|NCT01360645|203621|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
50280|NCT01360645|203622|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
50281|NCT01360645|203619|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
50282|NCT01360645|203620|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
50283|NCT01360645|203621|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
50284|NCT01360645|203622|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
50285|NCT01360645|203619|P4|Phase B (6 Weeks)|Adverse Event|0
50286|NCT01360645|203620|P3|Phase B (6 Weeks)|Adverse Event|0
50287|NCT01360645|203621|P2|Phase B (6 Weeks)|Adverse Event|6
50288|NCT01360645|203622|P1|Phase B (6 Weeks)|Adverse Event|0
50289|NCT01360645|203619|P4|Phase B (6 Weeks)|Lost to Follow-up|0
50290|NCT01360645|203620|P3|Phase B (6 Weeks)|Lost to Follow-up|0
50291|NCT01360645|203621|P2|Phase B (6 Weeks)|Lost to Follow-up|1
50292|NCT01360645|203622|P1|Phase B (6 Weeks)|Lost to Follow-up|0
50293|NCT01360645|203619|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
50294|NCT01360645|203620|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
50295|NCT01360645|203621|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
50296|NCT01360645|203622|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
50297|NCT01360645|203619|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
50298|NCT01360645|203620|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
50299|NCT01360645|203621|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
50300|NCT01360645|203622|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
50301|NCT01360645|203619|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
50302|NCT01360645|203620|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
50303|NCT01360645|203621|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
50304|NCT01360645|203622|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
50305|NCT01360645|203619|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
50306|NCT01360645|203620|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
50307|NCT01360645|203621|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
50308|NCT01360645|203622|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
50309|NCT01360645|203619|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
50310|NCT01360645|203620|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
50311|NCT01360645|203621|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
50312|NCT01360645|203622|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
50313|NCT01360645|203619|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
50314|NCT01360645|203620|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
50315|NCT01360645|203621|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
50316|NCT01360645|203622|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
50317|NCT01360632|203677|P5|Phase A+|Protocol Deviation|3
50318|NCT01360632|203678|P4|Phase A+|Protocol Deviation|0
50319|NCT01360632|203679|P3|Phase A+|Protocol Deviation|0
50320|NCT01360632|203680|P2|Phase A+|Protocol Deviation|0
50321|NCT01360632|203681|P1|Phase A+|Protocol Deviation|0
50322|NCT01360632|203677|P5|Phase A+|Withdrawal by Subject|8
50323|NCT01360632|203678|P4|Phase A+|Withdrawal by Subject|0
50324|NCT01360632|203679|P3|Phase A+|Withdrawal by Subject|0
50325|NCT01360632|203680|P2|Phase A+|Withdrawal by Subject|0
50326|NCT01360632|203681|P1|Phase A+|Withdrawal by Subject|0
50327|NCT01360632|203677|P5|Phase A+|Physician Decision|3
50328|NCT01360632|203678|P4|Phase A+|Physician Decision|0
50329|NCT01360632|203679|P3|Phase A+|Physician Decision|0
50330|NCT01360632|203680|P2|Phase A+|Physician Decision|0
50331|NCT01360632|203681|P1|Phase A+|Physician Decision|0
50332|NCT01360632|203677|P5|Phase A+|Met Withdrawal Criteria|7
50333|NCT01360632|203678|P4|Phase A+|Met Withdrawal Criteria|0
50334|NCT01360632|203679|P3|Phase A+|Met Withdrawal Criteria|0
50335|NCT01360632|203680|P2|Phase A+|Met Withdrawal Criteria|0
50336|NCT01360632|203681|P1|Phase A+|Met Withdrawal Criteria|0
50337|NCT01360632|203677|P5|Phase A+|Adverse Event|2
50338|NCT01360632|203678|P4|Phase A+|Adverse Event|0
50339|NCT01360632|203679|P3|Phase A+|Adverse Event|0
50340|NCT01360632|203680|P2|Phase A+|Adverse Event|0
50341|NCT01360632|203681|P1|Phase A+|Adverse Event|0
50342|NCT01360632|203677|P5|Phase A+|Lost to Follow-up|2
50343|NCT01360632|203678|P4|Phase A+|Lost to Follow-up|0
50344|NCT01360632|203679|P3|Phase A+|Lost to Follow-up|0
50345|NCT01360632|203680|P2|Phase A+|Lost to Follow-up|0
50346|NCT01360632|203681|P1|Phase A+|Lost to Follow-up|0
50347|NCT01360632|203677|P5|Phase B (6 Weeks)|Lack of Efficacy|0
50348|NCT01360632|203678|P4|Phase B (6 Weeks)|Lack of Efficacy|0
50349|NCT01360632|203679|P3|Phase B (6 Weeks)|Lack of Efficacy|0
50350|NCT01360632|203680|P2|Phase B (6 Weeks)|Lack of Efficacy|1
50351|NCT01360632|203681|P1|Phase B (6 Weeks)|Lack of Efficacy|0
50352|NCT01360632|203677|P5|Phase B (6 Weeks)|Protocol Deviation|0
50353|NCT01360632|203678|P4|Phase B (6 Weeks)|Protocol Deviation|1
50354|NCT01360632|203679|P3|Phase B (6 Weeks)|Protocol Deviation|4
50355|NCT01360632|203680|P2|Phase B (6 Weeks)|Protocol Deviation|1
50356|NCT01360632|203681|P1|Phase B (6 Weeks)|Protocol Deviation|0
50357|NCT01360632|203677|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
50358|NCT01360632|203678|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
50359|NCT01360632|203679|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
50360|NCT01360632|203680|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
50361|NCT01360632|203681|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
50362|NCT01360632|203677|P5|Phase B (6 Weeks)|Physician Decision|0
50363|NCT01360632|203678|P4|Phase B (6 Weeks)|Physician Decision|1
50364|NCT01360632|203679|P3|Phase B (6 Weeks)|Physician Decision|0
50365|NCT01360632|203680|P2|Phase B (6 Weeks)|Physician Decision|0
50366|NCT01360632|203681|P1|Phase B (6 Weeks)|Physician Decision|0
50367|NCT01360632|203677|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
50368|NCT01360632|203678|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
50369|NCT01360632|203679|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
50370|NCT01360632|203680|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
50371|NCT01360632|203681|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
50372|NCT01360632|203677|P5|Phase B (6 Weeks)|Adverse Event|0
50373|NCT01360632|203678|P4|Phase B (6 Weeks)|Adverse Event|3
50374|NCT01360632|203679|P3|Phase B (6 Weeks)|Adverse Event|9
50375|NCT01360632|203680|P2|Phase B (6 Weeks)|Adverse Event|3
50376|NCT01360632|203681|P1|Phase B (6 Weeks)|Adverse Event|0
50377|NCT01360632|203677|P5|Phase B (6 Weeks)|Lost to Follow-up|0
50378|NCT01360632|203678|P4|Phase B (6 Weeks)|Lost to Follow-up|0
50379|NCT01360632|203679|P3|Phase B (6 Weeks)|Lost to Follow-up|1
50380|NCT01360632|203680|P2|Phase B (6 Weeks)|Lost to Follow-up|1
50381|NCT01360632|203681|P1|Phase B (6 Weeks)|Lost to Follow-up|0
50382|NCT01360632|203677|P5|Phase A (8 Weeks)|Protocol Deviation|0
50383|NCT01360632|203678|P4|Phase A (8 Weeks)|Protocol Deviation|0
50384|NCT01360632|203679|P3|Phase A (8 Weeks)|Protocol Deviation|0
50385|NCT01360632|203680|P2|Phase A (8 Weeks)|Protocol Deviation|0
50386|NCT01360632|203681|P1|Phase A (8 Weeks)|Protocol Deviation|39
50387|NCT01360632|203677|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
50388|NCT01360632|203678|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
50389|NCT01360632|203679|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
50390|NCT01360632|203680|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
50391|NCT01360632|203681|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
50392|NCT01360632|203677|P5|Phase A (8 Weeks)|Physician Decision|0
50393|NCT01360632|203678|P4|Phase A (8 Weeks)|Physician Decision|0
50394|NCT01360632|203679|P3|Phase A (8 Weeks)|Physician Decision|0
50395|NCT01360632|203680|P2|Phase A (8 Weeks)|Physician Decision|0
50396|NCT01360632|203681|P1|Phase A (8 Weeks)|Physician Decision|10
50397|NCT01360632|203677|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
50398|NCT01360632|203678|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
50399|NCT01360632|203679|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
50400|NCT01360632|203680|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
50401|NCT01360632|203681|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
50402|NCT01360632|203677|P5|Phase A (8 Weeks)|Adverse Event|0
50403|NCT01360632|203678|P4|Phase A (8 Weeks)|Adverse Event|0
50404|NCT01360632|203679|P3|Phase A (8 Weeks)|Adverse Event|0
50405|NCT01360632|203680|P2|Phase A (8 Weeks)|Adverse Event|0
50406|NCT01360632|203681|P1|Phase A (8 Weeks)|Adverse Event|60
50407|NCT01360632|203677|P5|Phase A (8 Weeks)|Lost to Follow-up|0
50408|NCT01360632|203678|P4|Phase A (8 Weeks)|Lost to Follow-up|0
50409|NCT01360632|203679|P3|Phase A (8 Weeks)|Lost to Follow-up|0
50410|NCT01360632|203680|P2|Phase A (8 Weeks)|Lost to Follow-up|0
50411|NCT01360632|203681|P1|Phase A (8 Weeks)|Lost to Follow-up|27
50412|NCT01360554|203760|P2|Overall Study|Randomized but not treated.|3
50413|NCT01360554|203761|P1|Overall Study|Randomized but not treated.|3
50414|NCT01360554|203760|P2|Overall Study|Other, not specified|0
50415|NCT01360554|203761|P1|Overall Study|Other, not specified|1
50416|NCT01360554|203760|P2|Overall Study|Study terminated by sponsor|37
50417|NCT01360554|203761|P1|Overall Study|Study terminated by sponsor|49
50418|NCT01360554|203760|P2|Overall Study|Withdrawal by Subject|24
50419|NCT01360554|203761|P1|Overall Study|Withdrawal by Subject|23
50420|NCT01360554|203760|P2|Overall Study|Lost to Follow-up|4
50421|NCT01360554|203761|P1|Overall Study|Lost to Follow-up|4
50422|NCT01360554|203760|P2|Overall Study|Death|371
50423|NCT01360554|203761|P1|Overall Study|Death|359
50424|NCT01361594|203812|P2|Overall Study|Withdrawal by Subject|2
50425|NCT01361594|203813|P1|Overall Study|Withdrawal by Subject|1
50426|NCT01361568|203827|P6|Overall Study|Withdrawal by Subject|1
50427|NCT01361568|203828|P5|Overall Study|Withdrawal by Subject|0
50428|NCT01361568|203829|P4|Overall Study|Withdrawal by Subject|0
50429|NCT01361568|203830|P3|Overall Study|Withdrawal by Subject|0
50430|NCT01361568|203831|P2|Overall Study|Withdrawal by Subject|1
50431|NCT01361568|203832|P1|Overall Study|Withdrawal by Subject|2
50432|NCT01361568|203827|P6|Overall Study|Physician Decision|1
50433|NCT01361568|203828|P5|Overall Study|Physician Decision|0
50434|NCT01361568|203829|P4|Overall Study|Physician Decision|0
50435|NCT01361568|203830|P3|Overall Study|Physician Decision|0
50436|NCT01361568|203831|P2|Overall Study|Physician Decision|0
50437|NCT01361568|203832|P1|Overall Study|Physician Decision|0
50438|NCT01361568|203827|P6|Overall Study|Adverse Event|0
50439|NCT01361568|203828|P5|Overall Study|Adverse Event|1
50440|NCT01361568|203829|P4|Overall Study|Adverse Event|0
50441|NCT01361568|203830|P3|Overall Study|Adverse Event|0
50442|NCT01361568|203831|P2|Overall Study|Adverse Event|0
50443|NCT01361568|203832|P1|Overall Study|Adverse Event|0
50444|NCT01361464|203862|P1|Overall Study|Withdrawal by Subject|2
50445|NCT01361464|203862|P1|Overall Study|Death|1
50446|NCT01361308|203871|P2|Overall Study|Not Specified|1
50447|NCT01361308|203872|P1|Overall Study|Not Specified|0
50448|NCT01361308|203871|P2|Overall Study|Failed C-SSRS|2
50449|NCT01361308|203872|P1|Overall Study|Failed C-SSRS|5
50450|NCT01361308|203871|P2|Overall Study|Eligibility Criteria Not Met|3
50451|NCT01361308|203872|P1|Overall Study|Eligibility Criteria Not Met|2
50452|NCT01361308|203871|P2|Overall Study|Adverse Event|4
50453|NCT01361308|203872|P1|Overall Study|Adverse Event|8
50454|NCT01361308|203871|P2|Overall Study|Lost to Follow-up|4
50455|NCT01361308|203872|P1|Overall Study|Lost to Follow-up|5
50456|NCT01361308|203871|P2|Overall Study|Protocol Violation|0
50457|NCT01361308|203872|P1|Overall Study|Protocol Violation|1
50458|NCT01361308|203871|P2|Overall Study|Lack of Efficacy|0
50459|NCT01361308|203872|P1|Overall Study|Lack of Efficacy|2
50460|NCT01361308|203871|P2|Overall Study|Physician Decision|3
50461|NCT01361308|203872|P1|Overall Study|Physician Decision|3
50462|NCT01361308|203871|P2|Overall Study|Withdrawal by Subject|13
50463|NCT01361308|203872|P1|Overall Study|Withdrawal by Subject|9
50464|NCT01361178|203914|P2|Overall Study|Death|0
50465|NCT01361178|203915|P1|Overall Study|Death|13
50466|NCT01361126|203923|P2|Overall Study|Sponsor decision|2
50467|NCT01361126|203924|P1|Overall Study|Sponsor decision|0
50468|NCT01361009|203957|P1|Overall Study|Protocol Violation|116
50469|NCT01360996|203967|P3|Overall Study|Noncompliant|0
50470|NCT01360996|203968|P2|Overall Study|Noncompliant|0
50471|NCT01360996|203969|P1|Overall Study|Noncompliant|2
50472|NCT01360996|203967|P3|Overall Study|Withdrawal by Subject|2
50473|NCT01360996|203968|P2|Overall Study|Withdrawal by Subject|3
50474|NCT01360996|203969|P1|Overall Study|Withdrawal by Subject|4
50475|NCT01360840|203991|P3|Overall Study|Ongoing at data cut-off|9
50476|NCT01360840|203992|P2|Overall Study|Ongoing at data cut-off|10
50477|NCT01360840|203993|P1|Overall Study|Ongoing at data cut-off|10
50478|NCT01360021|204046|P3|Overall Study|Adverse Event|3
50479|NCT01360021|204047|P2|Overall Study|Adverse Event|3
50480|NCT01360021|204048|P1|Overall Study|Adverse Event|2
50481|NCT01360021|204046|P3|Overall Study|Withdrawal by Subject|2
50482|NCT01360021|204047|P2|Overall Study|Withdrawal by Subject|0
50483|NCT01360021|204048|P1|Overall Study|Withdrawal by Subject|4
50484|NCT01360021|204046|P3|Overall Study|Protocol Violation|1
50485|NCT01360021|204047|P2|Overall Study|Protocol Violation|0
50486|NCT01360021|204048|P1|Overall Study|Protocol Violation|0
50487|NCT01360021|204046|P3|Overall Study|Eligibility criteria + other|1
50488|NCT01360021|204047|P2|Overall Study|Eligibility criteria + other|1
50489|NCT01360021|204048|P1|Overall Study|Eligibility criteria + other|2
50490|NCT01359943|204074|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
50491|NCT01359943|204075|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
50492|NCT01359943|204076|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
50493|NCT01359943|204074|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
50494|NCT01359943|204075|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
50495|NCT01359943|204076|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
50496|NCT01359943|204074|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
50497|NCT01359943|204075|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
50498|NCT01359943|204076|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
50499|NCT01359943|204074|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
50500|NCT01359943|204075|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
50501|NCT01359943|204076|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
50502|NCT01359943|204074|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
50503|NCT01359943|204075|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
50504|NCT01359943|204076|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
50505|NCT01359943|204074|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
50506|NCT01359943|204075|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
50507|NCT01359943|204076|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
50508|NCT01359943|204074|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
50509|NCT01359943|204075|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
50510|NCT01359943|204076|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
50511|NCT01359943|204074|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
50512|NCT01359943|204075|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
50513|NCT01359943|204076|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
50514|NCT01359943|204074|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
50515|NCT01359943|204075|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
50516|NCT01359943|204076|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
50517|NCT01359943|204074|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
50518|NCT01359943|204075|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
50519|NCT01359943|204076|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
50520|NCT01359943|204074|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
50521|NCT01359943|204075|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
50522|NCT01359943|204076|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
50523|NCT01359943|204074|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
50524|NCT01359943|204075|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
50525|NCT01359943|204076|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
50526|NCT01359943|204074|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
50527|NCT01359943|204075|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
50528|NCT01359943|204076|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
50529|NCT01359943|204074|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
50530|NCT01359943|204075|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
50531|NCT01359943|204076|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
50532|NCT01359943|204074|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
50533|NCT01359943|204075|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
50534|NCT01359943|204076|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
50535|NCT01359904|204124|P2|Overall Study|Withdrawal by Subject|0
50536|NCT01359904|204125|P1|Overall Study|Withdrawal by Subject|1
50537|NCT01359644|204179|P10|Follow-up Period|Lost to Follow-up|0
50538|NCT01359644|204180|P9|Follow-up Period|Lost to Follow-up|0
50539|NCT01359644|204181|P8|Follow-up Period|Lost to Follow-up|2
50540|NCT01359644|204182|P7|Follow-up Period|Lost to Follow-up|1
50541|NCT01359644|204183|P6|Follow-up Period|Lost to Follow-up|0
50542|NCT01359644|204184|P5|Follow-up Period|Lost to Follow-up|0
50543|NCT01359644|204185|P4|Follow-up Period|Lost to Follow-up|0
50544|NCT01359644|204186|P3|Follow-up Period|Lost to Follow-up|0
50545|NCT01359644|204187|P2|Follow-up Period|Lost to Follow-up|0
50546|NCT01359644|204188|P1|Follow-up Period|Lost to Follow-up|0
50547|NCT01359644|204179|P10|Follow-up Period|Withdrawal by Subject|0
50548|NCT01359644|204180|P9|Follow-up Period|Withdrawal by Subject|0
50549|NCT01359644|204181|P8|Follow-up Period|Withdrawal by Subject|0
50550|NCT01359644|204182|P7|Follow-up Period|Withdrawal by Subject|0
50551|NCT01359644|204183|P6|Follow-up Period|Withdrawal by Subject|1
50552|NCT01359644|204184|P5|Follow-up Period|Withdrawal by Subject|0
50553|NCT01359644|204185|P4|Follow-up Period|Withdrawal by Subject|0
50554|NCT01359644|204186|P3|Follow-up Period|Withdrawal by Subject|0
50555|NCT01359644|204187|P2|Follow-up Period|Withdrawal by Subject|0
50556|NCT01359644|204188|P1|Follow-up Period|Withdrawal by Subject|0
50557|NCT01359644|204179|P10|Treatment Period|Lost to Follow-up|0
50558|NCT01359644|204180|P9|Treatment Period|Lost to Follow-up|0
50559|NCT01359644|204181|P8|Treatment Period|Lost to Follow-up|0
50560|NCT01359644|204182|P7|Treatment Period|Lost to Follow-up|0
50561|NCT01359644|204183|P6|Treatment Period|Lost to Follow-up|1
50562|NCT01359644|204184|P5|Treatment Period|Lost to Follow-up|0
50563|NCT01359644|204185|P4|Treatment Period|Lost to Follow-up|0
50564|NCT01359644|204186|P3|Treatment Period|Lost to Follow-up|0
50565|NCT01359644|204187|P2|Treatment Period|Lost to Follow-up|0
50566|NCT01359644|204188|P1|Treatment Period|Lost to Follow-up|0
50567|NCT01359644|204179|P10|Treatment Period|Adverse Event|0
50568|NCT01359644|204180|P9|Treatment Period|Adverse Event|0
50569|NCT01359644|204181|P8|Treatment Period|Adverse Event|0
50570|NCT01359644|204182|P7|Treatment Period|Adverse Event|0
50571|NCT01359644|204183|P6|Treatment Period|Adverse Event|1
50572|NCT01359644|204184|P5|Treatment Period|Adverse Event|0
50573|NCT01359644|204185|P4|Treatment Period|Adverse Event|0
50574|NCT01359644|204186|P3|Treatment Period|Adverse Event|1
50575|NCT01359644|204187|P2|Treatment Period|Adverse Event|0
50576|NCT01359644|204188|P1|Treatment Period|Adverse Event|0
50577|NCT01359644|204179|P10|Treatment Period|Lack of Efficacy|0
50578|NCT01359644|204180|P9|Treatment Period|Lack of Efficacy|0
50579|NCT01359644|204181|P8|Treatment Period|Lack of Efficacy|0
50580|NCT01359644|204182|P7|Treatment Period|Lack of Efficacy|0
50581|NCT01359644|204183|P6|Treatment Period|Lack of Efficacy|0
50582|NCT01359644|204184|P5|Treatment Period|Lack of Efficacy|0
50583|NCT01359644|204185|P4|Treatment Period|Lack of Efficacy|0
50584|NCT01359644|204186|P3|Treatment Period|Lack of Efficacy|0
50585|NCT01359644|204187|P2|Treatment Period|Lack of Efficacy|1
50586|NCT01359644|204188|P1|Treatment Period|Lack of Efficacy|0
50587|NCT01359449|204232|P2|Overall Study|Withdrawal by Subject|2
50588|NCT01359449|204233|P1|Overall Study|Withdrawal by Subject|3
50589|NCT01359449|204232|P2|Overall Study|Protocol Violation|2
50590|NCT01359449|204233|P1|Overall Study|Protocol Violation|0
50591|NCT01359449|204232|P2|Overall Study|Lost to Follow-up|0
50592|NCT01359449|204233|P1|Overall Study|Lost to Follow-up|1
50593|NCT01359254|204279|P2|Overall Study|Death|0
50594|NCT01359254|204280|P1|Overall Study|Death|1
50595|NCT01359150|204290|P2|Overall Study|Unspecified|0
50596|NCT01359150|204291|P1|Overall Study|Unspecified|1
50597|NCT01359150|204290|P2|Overall Study|Adverse Event|3
50598|NCT01359150|204291|P1|Overall Study|Adverse Event|4
50599|NCT01359150|204290|P2|Overall Study|Withdrawal by Subject|1
50600|NCT01359150|204291|P1|Overall Study|Withdrawal by Subject|1
50601|NCT01359150|204290|P2|Overall Study|Lack of Efficacy|1
50602|NCT01359150|204291|P1|Overall Study|Lack of Efficacy|1
50603|NCT01358864|204328|P8|Overall Study|Not treated|0
50604|NCT01358864|204329|P7|Overall Study|Not treated|1
50605|NCT01358864|204330|P6|Overall Study|Not treated|0
50606|NCT01358864|204331|P5|Overall Study|Not treated|0
50607|NCT01358864|204332|P4|Overall Study|Not treated|0
50608|NCT01358864|204333|P3|Overall Study|Not treated|0
50609|NCT01358864|204334|P2|Overall Study|Not treated|0
50610|NCT01358864|204335|P1|Overall Study|Not treated|0
50611|NCT01358864|204328|P8|Overall Study|Other reason not defined above|0
50612|NCT01358864|204329|P7|Overall Study|Other reason not defined above|2
50613|NCT01358864|204330|P6|Overall Study|Other reason not defined above|0
50614|NCT01358864|204331|P5|Overall Study|Other reason not defined above|0
50615|NCT01358864|204332|P4|Overall Study|Other reason not defined above|0
50616|NCT01358864|204333|P3|Overall Study|Other reason not defined above|0
50617|NCT01358864|204334|P2|Overall Study|Other reason not defined above|0
50618|NCT01358864|204335|P1|Overall Study|Other reason not defined above|2
50619|NCT01358864|204328|P8|Overall Study|Withdrawal by Subject|3
50620|NCT01358864|204329|P7|Overall Study|Withdrawal by Subject|1
50621|NCT01358864|204330|P6|Overall Study|Withdrawal by Subject|1
50622|NCT01358864|204331|P5|Overall Study|Withdrawal by Subject|0
50623|NCT01358864|204332|P4|Overall Study|Withdrawal by Subject|0
50624|NCT01358864|204333|P3|Overall Study|Withdrawal by Subject|2
50625|NCT01358864|204334|P2|Overall Study|Withdrawal by Subject|4
50626|NCT01358864|204335|P1|Overall Study|Withdrawal by Subject|3
50627|NCT01358864|204328|P8|Overall Study|Lost to Follow-up|1
50628|NCT01358864|204329|P7|Overall Study|Lost to Follow-up|0
50629|NCT01358864|204330|P6|Overall Study|Lost to Follow-up|0
50630|NCT01358864|204331|P5|Overall Study|Lost to Follow-up|0
50631|NCT01358864|204332|P4|Overall Study|Lost to Follow-up|0
50632|NCT01358864|204333|P3|Overall Study|Lost to Follow-up|1
50633|NCT01358864|204334|P2|Overall Study|Lost to Follow-up|0
50634|NCT01358864|204335|P1|Overall Study|Lost to Follow-up|0
50635|NCT01358864|204328|P8|Overall Study|Lack of Efficacy|44
50636|NCT01358864|204329|P7|Overall Study|Lack of Efficacy|49
50637|NCT01358864|204330|P6|Overall Study|Lack of Efficacy|4
50638|NCT01358864|204331|P5|Overall Study|Lack of Efficacy|7
50639|NCT01358864|204332|P4|Overall Study|Lack of Efficacy|19
50640|NCT01358864|204333|P3|Overall Study|Lack of Efficacy|4
50641|NCT01358864|204334|P2|Overall Study|Lack of Efficacy|3
50642|NCT01358864|204335|P1|Overall Study|Lack of Efficacy|26
50643|NCT01358864|204328|P8|Overall Study|Adverse Event|7
50644|NCT01358864|204329|P7|Overall Study|Adverse Event|12
50645|NCT01358864|204330|P6|Overall Study|Adverse Event|8
50646|NCT01358864|204331|P5|Overall Study|Adverse Event|4
50647|NCT01358864|204332|P4|Overall Study|Adverse Event|0
50648|NCT01358864|204333|P3|Overall Study|Adverse Event|9
50649|NCT01358864|204334|P2|Overall Study|Adverse Event|6
50650|NCT01358864|204335|P1|Overall Study|Adverse Event|0
50651|NCT01358825|204426|P2|Overall Study|Blood sample not drawn|1
50652|NCT01358825|204427|P1|Overall Study|Blood sample not drawn|0
50653|NCT01358760|204451|P3|Overall Study|Entry criteria not met/Non-compliance|16
50654|NCT01358760|204452|P2|Overall Study|Entry criteria not met/Non-compliance|12
50655|NCT01358760|204453|P1|Overall Study|Entry criteria not met/Non-compliance|12
50656|NCT01358760|204451|P3|Overall Study|Physician Decision|1
50657|NCT01358760|204452|P2|Overall Study|Physician Decision|0
50658|NCT01358760|204453|P1|Overall Study|Physician Decision|1
50659|NCT01358760|204451|P3|Overall Study|Withdrawal by Subject|2
50660|NCT01358760|204452|P2|Overall Study|Withdrawal by Subject|3
50661|NCT01358760|204453|P1|Overall Study|Withdrawal by Subject|5
50662|NCT01358760|204451|P3|Overall Study|Lost to Follow-up|3
50663|NCT01358760|204452|P2|Overall Study|Lost to Follow-up|1
50664|NCT01358760|204453|P1|Overall Study|Lost to Follow-up|1
50665|NCT01358760|204451|P3|Overall Study|Adverse Event|3
50666|NCT01358760|204452|P2|Overall Study|Adverse Event|4
50667|NCT01358760|204453|P1|Overall Study|Adverse Event|3
50668|NCT01358734|204488|P3|Overall Study|Not Specified|4
50669|NCT01358734|204489|P2|Overall Study|Not Specified|5
50670|NCT01358734|204490|P1|Overall Study|Not Specified|2
50671|NCT01358734|204488|P3|Overall Study|Non-compliance with study drug|1
50672|NCT01358734|204489|P2|Overall Study|Non-compliance with study drug|0
50673|NCT01358734|204490|P1|Overall Study|Non-compliance with study drug|0
50674|NCT01358734|204488|P3|Overall Study|Progressive Disease|13
50675|NCT01358734|204489|P2|Overall Study|Progressive Disease|11
50676|NCT01358734|204490|P1|Overall Study|Progressive Disease|5
50677|NCT01358734|204488|P3|Overall Study|Death|2
50678|NCT01358734|204489|P2|Overall Study|Death|7
50679|NCT01358734|204490|P1|Overall Study|Death|3
50680|NCT01358734|204488|P3|Overall Study|Withdrawal by Subject|3
50681|NCT01358734|204489|P2|Overall Study|Withdrawal by Subject|6
50682|NCT01358734|204490|P1|Overall Study|Withdrawal by Subject|1
50683|NCT01358734|204488|P3|Overall Study|Lack of Efficacy|3
50684|NCT01358734|204489|P2|Overall Study|Lack of Efficacy|1
50685|NCT01358734|204490|P1|Overall Study|Lack of Efficacy|0
50686|NCT01358734|204488|P3|Overall Study|Adverse Event|3
50687|NCT01358734|204489|P2|Overall Study|Adverse Event|7
50688|NCT01358734|204490|P1|Overall Study|Adverse Event|4
50689|NCT01358708|204509|P2|Double-Blind Treatment Phase|Protocol Violation|0
50690|NCT01358708|204510|P1|Double-Blind Treatment Phase|Protocol Violation|1
50691|NCT01358708|204509|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
50692|NCT01358708|204510|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
50693|NCT01358578|204533|P6|Follow-up Period|Physician Decision|0
50694|NCT01358578|204534|P5|Follow-up Period|Physician Decision|0
50695|NCT01358578|204535|P4|Follow-up Period|Physician Decision|2
50696|NCT01358578|204536|P3|Follow-up Period|Physician Decision|0
50697|NCT01358578|204537|P2|Follow-up Period|Physician Decision|1
50698|NCT01358578|204538|P1|Follow-up Period|Physician Decision|1
50699|NCT01358578|204533|P6|Follow-up Period|Withdrawal by Subject|0
50700|NCT01358578|204534|P5|Follow-up Period|Withdrawal by Subject|0
50701|NCT01358578|204535|P4|Follow-up Period|Withdrawal by Subject|12
50702|NCT01358578|204536|P3|Follow-up Period|Withdrawal by Subject|1
50703|NCT01358578|204537|P2|Follow-up Period|Withdrawal by Subject|3
50704|NCT01358578|204538|P1|Follow-up Period|Withdrawal by Subject|3
50705|NCT01358578|204533|P6|Follow-up Period|Pregnancy|0
50706|NCT01358578|204534|P5|Follow-up Period|Pregnancy|0
50707|NCT01358578|204535|P4|Follow-up Period|Pregnancy|0
50708|NCT01358578|204536|P3|Follow-up Period|Pregnancy|0
50709|NCT01358578|204537|P2|Follow-up Period|Pregnancy|0
50710|NCT01358578|204538|P1|Follow-up Period|Pregnancy|1
50711|NCT01358578|204533|P6|Follow-up Period|non- compliance with study treatment|0
50712|NCT01358578|204534|P5|Follow-up Period|non- compliance with study treatment|0
50713|NCT01358578|204535|P4|Follow-up Period|non- compliance with study treatment|0
50714|NCT01358578|204536|P3|Follow-up Period|non- compliance with study treatment|0
50715|NCT01358578|204537|P2|Follow-up Period|non- compliance with study treatment|0
50716|NCT01358578|204538|P1|Follow-up Period|non- compliance with study treatment|1
50717|NCT01358578|204533|P6|Follow-up Period|Lost to Follow-up|0
50718|NCT01358578|204534|P5|Follow-up Period|Lost to Follow-up|0
50719|NCT01358578|204535|P4|Follow-up Period|Lost to Follow-up|4
50720|NCT01358578|204536|P3|Follow-up Period|Lost to Follow-up|0
50721|NCT01358578|204537|P2|Follow-up Period|Lost to Follow-up|1
50722|NCT01358578|204538|P1|Follow-up Period|Lost to Follow-up|0
50723|NCT01358578|204533|P6|Follow-up Period|Lack of Efficacy|0
50724|NCT01358578|204534|P5|Follow-up Period|Lack of Efficacy|0
50725|NCT01358578|204535|P4|Follow-up Period|Lack of Efficacy|1
50726|NCT01358578|204536|P3|Follow-up Period|Lack of Efficacy|4
50727|NCT01358578|204537|P2|Follow-up Period|Lack of Efficacy|0
50728|NCT01358578|204538|P1|Follow-up Period|Lack of Efficacy|3
50729|NCT01358578|204533|P6|Follow-up Period|Adverse Event|0
50730|NCT01358578|204534|P5|Follow-up Period|Adverse Event|0
50731|NCT01358578|204535|P4|Follow-up Period|Adverse Event|0
50732|NCT01358578|204536|P3|Follow-up Period|Adverse Event|0
50733|NCT01358578|204537|P2|Follow-up Period|Adverse Event|1
50734|NCT01358578|204538|P1|Follow-up Period|Adverse Event|1
50735|NCT01358578|204533|P6|Maintenance Period|Withdrawal by Subject|3
50736|NCT01358578|204534|P5|Maintenance Period|Withdrawal by Subject|6
50737|NCT01358578|204535|P4|Maintenance Period|Withdrawal by Subject|15
50738|NCT01358578|204536|P3|Maintenance Period|Withdrawal by Subject|2
50739|NCT01358578|204537|P2|Maintenance Period|Withdrawal by Subject|7
50740|NCT01358578|204538|P1|Maintenance Period|Withdrawal by Subject|12
50741|NCT01358578|204533|P6|Maintenance Period|Protocol deviation|2
50742|NCT01358578|204534|P5|Maintenance Period|Protocol deviation|2
50743|NCT01358578|204535|P4|Maintenance Period|Protocol deviation|2
50744|NCT01358578|204536|P3|Maintenance Period|Protocol deviation|0
50745|NCT01358578|204537|P2|Maintenance Period|Protocol deviation|4
50746|NCT01358578|204538|P1|Maintenance Period|Protocol deviation|7
50747|NCT01358578|204533|P6|Maintenance Period|Pregnancy|0
50748|NCT01358578|204534|P5|Maintenance Period|Pregnancy|0
50749|NCT01358578|204535|P4|Maintenance Period|Pregnancy|0
50750|NCT01358578|204536|P3|Maintenance Period|Pregnancy|0
50751|NCT01358578|204537|P2|Maintenance Period|Pregnancy|0
50752|NCT01358578|204538|P1|Maintenance Period|Pregnancy|1
50753|NCT01358578|204533|P6|Maintenance Period|Physician Decision|0
50754|NCT01358578|204534|P5|Maintenance Period|Physician Decision|0
50755|NCT01358578|204535|P4|Maintenance Period|Physician Decision|1
50756|NCT01358578|204536|P3|Maintenance Period|Physician Decision|0
50757|NCT01358578|204537|P2|Maintenance Period|Physician Decision|1
50758|NCT01358578|204538|P1|Maintenance Period|Physician Decision|0
50759|NCT01358578|204533|P6|Maintenance Period|Non-compliance with study treatment|2
50760|NCT01358578|204534|P5|Maintenance Period|Non-compliance with study treatment|1
50761|NCT01358578|204535|P4|Maintenance Period|Non-compliance with study treatment|2
50762|NCT01358578|204536|P3|Maintenance Period|Non-compliance with study treatment|0
50763|NCT01358578|204537|P2|Maintenance Period|Non-compliance with study treatment|1
50764|NCT01358578|204538|P1|Maintenance Period|Non-compliance with study treatment|3
50765|NCT01358578|204533|P6|Maintenance Period|Lost to Follow-up|1
50766|NCT01358578|204534|P5|Maintenance Period|Lost to Follow-up|1
50767|NCT01358578|204535|P4|Maintenance Period|Lost to Follow-up|5
50768|NCT01358578|204536|P3|Maintenance Period|Lost to Follow-up|0
50769|NCT01358578|204537|P2|Maintenance Period|Lost to Follow-up|0
50770|NCT01358578|204538|P1|Maintenance Period|Lost to Follow-up|4
50771|NCT01358578|204533|P6|Maintenance Period|Lack of Efficacy|0
50772|NCT01358578|204534|P5|Maintenance Period|Lack of Efficacy|3
50773|NCT01358578|204535|P4|Maintenance Period|Lack of Efficacy|11
50774|NCT01358578|204536|P3|Maintenance Period|Lack of Efficacy|0
50775|NCT01358578|204537|P2|Maintenance Period|Lack of Efficacy|2
50776|NCT01358578|204538|P1|Maintenance Period|Lack of Efficacy|10
50777|NCT01358578|204533|P6|Maintenance Period|Adverse Event|3
50778|NCT01358578|204534|P5|Maintenance Period|Adverse Event|4
50779|NCT01358578|204535|P4|Maintenance Period|Adverse Event|6
50780|NCT01358578|204536|P3|Maintenance Period|Adverse Event|0
50781|NCT01358578|204537|P2|Maintenance Period|Adverse Event|7
50782|NCT01358578|204538|P1|Maintenance Period|Adverse Event|2
50783|NCT01358578|204533|P6|Induction Period|Withdrawal by Subject|0
50784|NCT01358578|204534|P5|Induction Period|Withdrawal by Subject|0
50785|NCT01358578|204535|P4|Induction Period|Withdrawal by Subject|6
50786|NCT01358578|204536|P3|Induction Period|Withdrawal by Subject|10
50787|NCT01358578|204537|P2|Induction Period|Withdrawal by Subject|5
50788|NCT01358578|204538|P1|Induction Period|Withdrawal by Subject|5
50789|NCT01358578|204533|P6|Induction Period|technical problems|0
50790|NCT01358578|204534|P5|Induction Period|technical problems|0
50791|NCT01358578|204535|P4|Induction Period|technical problems|1
50792|NCT01358578|204536|P3|Induction Period|technical problems|1
50793|NCT01358578|204537|P2|Induction Period|technical problems|0
50794|NCT01358578|204538|P1|Induction Period|technical problems|0
50795|NCT01358578|204533|P6|Induction Period|Protocol Deviation|0
50796|NCT01358578|204534|P5|Induction Period|Protocol Deviation|0
50797|NCT01358578|204535|P4|Induction Period|Protocol Deviation|3
50798|NCT01358578|204536|P3|Induction Period|Protocol Deviation|0
50799|NCT01358578|204537|P2|Induction Period|Protocol Deviation|5
50800|NCT01358578|204538|P1|Induction Period|Protocol Deviation|3
50801|NCT01358578|204533|P6|Induction Period|Physician Decision|0
50802|NCT01358578|204534|P5|Induction Period|Physician Decision|0
50803|NCT01358578|204535|P4|Induction Period|Physician Decision|0
50804|NCT01358578|204536|P3|Induction Period|Physician Decision|2
50805|NCT01358578|204537|P2|Induction Period|Physician Decision|1
50806|NCT01358578|204538|P1|Induction Period|Physician Decision|2
50807|NCT01358578|204533|P6|Induction Period|Lost to Follow-up|0
50808|NCT01358578|204534|P5|Induction Period|Lost to Follow-up|0
50809|NCT01358578|204535|P4|Induction Period|Lost to Follow-up|4
50810|NCT01358578|204536|P3|Induction Period|Lost to Follow-up|1
50811|NCT01358578|204537|P2|Induction Period|Lost to Follow-up|0
50812|NCT01358578|204538|P1|Induction Period|Lost to Follow-up|0
50813|NCT01358578|204533|P6|Induction Period|Lack of Efficacy|0
50814|NCT01358578|204534|P5|Induction Period|Lack of Efficacy|0
50815|NCT01358578|204535|P4|Induction Period|Lack of Efficacy|1
50816|NCT01358578|204536|P3|Induction Period|Lack of Efficacy|9
50817|NCT01358578|204537|P2|Induction Period|Lack of Efficacy|0
50818|NCT01358578|204538|P1|Induction Period|Lack of Efficacy|0
50819|NCT01358578|204533|P6|Induction Period|Adverse Event|0
50820|NCT01358578|204534|P5|Induction Period|Adverse Event|0
50821|NCT01358578|204535|P4|Induction Period|Adverse Event|6
50822|NCT01358578|204536|P3|Induction Period|Adverse Event|2
50823|NCT01358578|204537|P2|Induction Period|Adverse Event|4
50824|NCT01358578|204538|P1|Induction Period|Adverse Event|2
50825|NCT01358526|204590|P3|Double-blind Phase|Administrative|10
50826|NCT01358526|204591|P2|Double-blind Phase|Administrative|6
50827|NCT01358526|204592|P1|Double-blind Phase|Administrative|0
50828|NCT01358526|204590|P3|Double-blind Phase|Confirmed or suspected diversion|6
50829|NCT01358526|204591|P2|Double-blind Phase|Confirmed or suspected diversion|5
50830|NCT01358526|204592|P1|Double-blind Phase|Confirmed or suspected diversion|0
50831|NCT01358526|204590|P3|Double-blind Phase|Lack of Efficacy|73
50832|NCT01358526|204591|P2|Double-blind Phase|Lack of Efficacy|31
50833|NCT01358526|204592|P1|Double-blind Phase|Lack of Efficacy|0
50834|NCT01358526|204590|P3|Double-blind Phase|Lost to Follow-up|1
50835|NCT01358526|204591|P2|Double-blind Phase|Lost to Follow-up|4
50836|NCT01358526|204592|P1|Double-blind Phase|Lost to Follow-up|0
50837|NCT01358526|204590|P3|Double-blind Phase|Withdrawal by Subject|8
50838|NCT01358526|204591|P2|Double-blind Phase|Withdrawal by Subject|10
50839|NCT01358526|204592|P1|Double-blind Phase|Withdrawal by Subject|0
50840|NCT01358526|204590|P3|Double-blind Phase|Adverse Event|23
50841|NCT01358526|204591|P2|Double-blind Phase|Adverse Event|24
50842|NCT01358526|204592|P1|Double-blind Phase|Adverse Event|0
50843|NCT01358526|204590|P3|Open-label Titration Period|Did not qualify|0
50844|NCT01358526|204591|P2|Open-label Titration Period|Did not qualify|0
50845|NCT01358526|204592|P1|Open-label Titration Period|Did not qualify|178
50846|NCT01358526|204590|P3|Open-label Titration Period|Administrative|0
50847|NCT01358526|204591|P2|Open-label Titration Period|Administrative|0
50848|NCT01358526|204592|P1|Open-label Titration Period|Administrative|8
50849|NCT01358526|204590|P3|Open-label Titration Period|Confirmed or suspected diversion|0
50850|NCT01358526|204591|P2|Open-label Titration Period|Confirmed or suspected diversion|0
50851|NCT01358526|204592|P1|Open-label Titration Period|Confirmed or suspected diversion|16
50852|NCT01358526|204590|P3|Open-label Titration Period|Lack of Efficacy|0
50853|NCT01358526|204591|P2|Open-label Titration Period|Lack of Efficacy|0
50854|NCT01358526|204592|P1|Open-label Titration Period|Lack of Efficacy|107
50855|NCT01358526|204590|P3|Open-label Titration Period|Lost to Follow-up|0
50856|NCT01358526|204591|P2|Open-label Titration Period|Lost to Follow-up|0
50857|NCT01358526|204592|P1|Open-label Titration Period|Lost to Follow-up|25
50858|NCT01358526|204590|P3|Open-label Titration Period|Withdrawal by Subject|0
50859|NCT01358526|204591|P2|Open-label Titration Period|Withdrawal by Subject|0
50860|NCT01358526|204592|P1|Open-label Titration Period|Withdrawal by Subject|65
50861|NCT01358526|204590|P3|Open-label Titration Period|Adverse Event|0
50862|NCT01358526|204591|P2|Open-label Titration Period|Adverse Event|0
50863|NCT01358526|204592|P1|Open-label Titration Period|Adverse Event|95
50864|NCT01358357|204609|P3|Double-Blind Phase|Administrative|0
50865|NCT01358357|204610|P2|Double-Blind Phase|Administrative|1
50866|NCT01358357|204611|P1|Double-Blind Phase|Administrative|0
50867|NCT01358357|204609|P3|Double-Blind Phase|Recurrence of mood event|0
50868|NCT01358357|204610|P2|Double-Blind Phase|Recurrence of mood event|64
50869|NCT01358357|204611|P1|Double-Blind Phase|Recurrence of mood event|48
50870|NCT01358357|204609|P3|Double-Blind Phase|Terminated at study completion|0
50871|NCT01358357|204610|P2|Double-Blind Phase|Terminated at study completion|0
50872|NCT01358357|204611|P1|Double-Blind Phase|Terminated at study completion|2
50873|NCT01358357|204609|P3|Double-Blind Phase|Protocol Violation|0
50874|NCT01358357|204610|P2|Double-Blind Phase|Protocol Violation|12
50875|NCT01358357|204611|P1|Double-Blind Phase|Protocol Violation|16
50876|NCT01358357|204609|P3|Double-Blind Phase|Protocol Violation|0
50877|NCT01358357|204610|P2|Double-Blind Phase|Protocol Violation|11
50878|NCT01358357|204611|P1|Double-Blind Phase|Protocol Violation|1
50879|NCT01358357|204609|P3|Double-Blind Phase|Lost to Follow-up|0
50880|NCT01358357|204610|P2|Double-Blind Phase|Lost to Follow-up|7
50881|NCT01358357|204611|P1|Double-Blind Phase|Lost to Follow-up|5
50882|NCT01358357|204609|P3|Double-Blind Phase|Adverse Event|0
50883|NCT01358357|204610|P2|Double-Blind Phase|Adverse Event|5
50884|NCT01358357|204611|P1|Double-Blind Phase|Adverse Event|8
50885|NCT01358357|204609|P3|Open Label Phase|Mood episode|42
50886|NCT01358357|204610|P2|Open Label Phase|Mood episode|0
50887|NCT01358357|204611|P1|Open Label Phase|Mood episode|0
50888|NCT01358357|204609|P3|Open Label Phase|Terminated at study completion|5
50889|NCT01358357|204610|P2|Open Label Phase|Terminated at study completion|0
50890|NCT01358357|204611|P1|Open Label Phase|Terminated at study completion|0
50891|NCT01358357|204609|P3|Open Label Phase|Did not meet criteria for DB phase|16
50892|NCT01358357|204610|P2|Open Label Phase|Did not meet criteria for DB phase|0
50893|NCT01358357|204611|P1|Open Label Phase|Did not meet criteria for DB phase|0
50894|NCT01358357|204609|P3|Open Label Phase|Withdrawal by Subject|112
50895|NCT01358357|204610|P2|Open Label Phase|Withdrawal by Subject|0
50896|NCT01358357|204611|P1|Open Label Phase|Withdrawal by Subject|0
50897|NCT01358357|204609|P3|Open Label Phase|Protocol Violation|45
50898|NCT01358357|204610|P2|Open Label Phase|Protocol Violation|0
50899|NCT01358357|204611|P1|Open Label Phase|Protocol Violation|0
50900|NCT01358357|204609|P3|Open Label Phase|Lost to Follow-up|76
50901|NCT01358357|204610|P2|Open Label Phase|Lost to Follow-up|0
50902|NCT01358357|204611|P1|Open Label Phase|Lost to Follow-up|0
50903|NCT01358357|204609|P3|Open Label Phase|Lack of Efficacy|107
50904|NCT01358357|204610|P2|Open Label Phase|Lack of Efficacy|0
50905|NCT01358357|204611|P1|Open Label Phase|Lack of Efficacy|0
50906|NCT01358357|204609|P3|Open Label Phase|Adverse Event|59
50907|NCT01358357|204610|P2|Open Label Phase|Adverse Event|0
50908|NCT01358357|204611|P1|Open Label Phase|Adverse Event|0
50909|NCT01358175|204647|P3|Overall Study|Adverse Event|11
50910|NCT01358175|204648|P2|Overall Study|Adverse Event|11
50911|NCT01358175|204649|P1|Overall Study|Adverse Event|6
50912|NCT01358175|204647|P3|Overall Study|Lack of Efficacy|6
50913|NCT01358175|204648|P2|Overall Study|Lack of Efficacy|8
50914|NCT01358175|204649|P1|Overall Study|Lack of Efficacy|3
50915|NCT01358175|204647|P3|Overall Study|Lost to Follow-up|3
50916|NCT01358175|204648|P2|Overall Study|Lost to Follow-up|1
50917|NCT01358175|204649|P1|Overall Study|Lost to Follow-up|1
50918|NCT01358175|204647|P3|Overall Study|Non Compliance with Study Treatment|1
50919|NCT01358175|204648|P2|Overall Study|Non Compliance with Study Treatment|1
50920|NCT01358175|204649|P1|Overall Study|Non Compliance with Study Treatment|0
50921|NCT01358175|204647|P3|Overall Study|Physician Decision|0
50922|NCT01358175|204648|P2|Overall Study|Physician Decision|0
50923|NCT01358175|204649|P1|Overall Study|Physician Decision|1
50924|NCT01358175|204647|P3|Overall Study|Pregnancy|0
50925|NCT01358175|204648|P2|Overall Study|Pregnancy|1
50926|NCT01358175|204649|P1|Overall Study|Pregnancy|0
50927|NCT01358175|204647|P3|Overall Study|Technical issues|0
50928|NCT01358175|204648|P2|Overall Study|Technical issues|1
50929|NCT01358175|204649|P1|Overall Study|Technical issues|0
50930|NCT01358175|204647|P3|Overall Study|Withdrawal by Subject|10
50931|NCT01358175|204648|P2|Overall Study|Withdrawal by Subject|5
50932|NCT01358175|204649|P1|Overall Study|Withdrawal by Subject|9
50933|NCT01358175|204647|P3|Overall Study|Death|1
50934|NCT01358175|204648|P2|Overall Study|Death|0
50935|NCT01358175|204649|P1|Overall Study|Death|1
50936|NCT01357980|204686|P4|Overall Study|Consent withdrawn|0
50937|NCT01357980|204687|P3|Overall Study|Consent withdrawn|1
50938|NCT01357980|204688|P2|Overall Study|Consent withdrawn|0
50939|NCT01357980|204689|P1|Overall Study|Consent withdrawn|0
50940|NCT01357980|204686|P4|Overall Study|Lack of Efficacy|0
50941|NCT01357980|204687|P3|Overall Study|Lack of Efficacy|0
50942|NCT01357980|204688|P2|Overall Study|Lack of Efficacy|1
50943|NCT01357980|204689|P1|Overall Study|Lack of Efficacy|0
50944|NCT01357889|204733|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
51109|NCT01354938|205425|P1|Overall Study|Lost to Follow-up|1
50945|NCT01357889|204734|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
50946|NCT01357889|204733|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
50947|NCT01357889|204734|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
50948|NCT01357889|204733|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
50949|NCT01357889|204734|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
50950|NCT01357889|204733|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
50951|NCT01357889|204734|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
50952|NCT01357889|204733|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
50953|NCT01357889|204734|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
50954|NCT01357889|204733|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
50955|NCT01357889|204734|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
50956|NCT01357889|204733|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
50957|NCT01357889|204734|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
50958|NCT01357889|204733|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
50959|NCT01357889|204734|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
50960|NCT01357889|204733|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
50961|NCT01357889|204734|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
50962|NCT01357889|204733|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
50963|NCT01357889|204734|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
50964|NCT01357889|204733|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
50965|NCT01357889|204734|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
50966|NCT01357889|204733|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
50967|NCT01357889|204734|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
50968|NCT01357889|204733|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
50969|NCT01357889|204734|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
50970|NCT01357850|204778|P4|Overall Study|Lost to Follow-up|0
50971|NCT01357850|204779|P3|Overall Study|Lost to Follow-up|0
50972|NCT01357850|204780|P2|Overall Study|Lost to Follow-up|0
50973|NCT01357850|204781|P1|Overall Study|Lost to Follow-up|1
50974|NCT01357655|204872|P2|Overall Study|Subject Withdrew Consent|0
50975|NCT01357655|204873|P1|Overall Study|Subject Withdrew Consent|1
50976|NCT01357655|204872|P2|Overall Study|Study Drug Toxicity|0
50977|NCT01357655|204873|P1|Overall Study|Study Drug Toxicity|11
50978|NCT01357655|204872|P2|Overall Study|Reason Unspecified|0
50979|NCT01357655|204873|P1|Overall Study|Reason Unspecified|1
50980|NCT01357655|204872|P2|Overall Study|Maximum Clinical Benefit|0
50981|NCT01357655|204873|P1|Overall Study|Maximum Clinical Benefit|2
50982|NCT01357655|204872|P2|Overall Study|Lost to Follow-up|0
50983|NCT01357655|204873|P1|Overall Study|Lost to Follow-up|2
50984|NCT01357655|204872|P2|Overall Study|Disease Progression|0
50985|NCT01357655|204873|P1|Overall Study|Disease Progression|1
50986|NCT01357655|204872|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
50987|NCT01357655|204873|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
50988|NCT01357655|204872|P2|Overall Study|Administrative Reason by Sponsor|0
50989|NCT01357655|204873|P1|Overall Study|Administrative Reason by Sponsor|45
50990|NCT01357616|204890|P2|Overall Study|Withdrawal by Subject|0
50991|NCT01357616|204891|P1|Overall Study|Withdrawal by Subject|1
50992|NCT01357616|204890|P2|Overall Study|Decision Unrelated to Adverse Event|1
50993|NCT01357616|204891|P1|Overall Study|Decision Unrelated to Adverse Event|3
50994|NCT01357616|204890|P2|Overall Study|Inadequate Control of IOP|2
50995|NCT01357616|204891|P1|Overall Study|Inadequate Control of IOP|1
50996|NCT01357616|204890|P2|Overall Study|Protocol Violation|2
50997|NCT01357616|204891|P1|Overall Study|Protocol Violation|0
50998|NCT01357616|204890|P2|Overall Study|Lost to Follow-up|3
50999|NCT01357616|204891|P1|Overall Study|Lost to Follow-up|4
51000|NCT01357616|204890|P2|Overall Study|Adverse Event|1
51001|NCT01357616|204891|P1|Overall Study|Adverse Event|1
51002|NCT01357551|204905|P2|Overall Study|Lost to Follow-up|6
51003|NCT01357551|204906|P1|Overall Study|Lost to Follow-up|16
51004|NCT01357551|204905|P2|Overall Study|Death|1
51005|NCT01357551|204906|P1|Overall Study|Death|0
51006|NCT01357551|204905|P2|Overall Study|Withdrawal by Subject|4
51007|NCT01357551|204906|P1|Overall Study|Withdrawal by Subject|6
51008|NCT01357239|204933|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
51009|NCT01357239|204934|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
51010|NCT01357239|204935|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
51011|NCT01357239|204936|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
51012|NCT01357239|204933|P4|Stratum II: Partially-Methylated|Adverse Event|1
51013|NCT01357239|204934|P3|Stratum II: Partially-Methylated|Adverse Event|0
51014|NCT01357239|204935|P2|Stratum II: Partially-Methylated|Adverse Event|0
51015|NCT01357239|204936|P1|Stratum II: Partially-Methylated|Adverse Event|0
51016|NCT01357239|204933|P4|Stratum I: Fully-Methylated|Adverse Event|0
51017|NCT01357239|204934|P3|Stratum I: Fully-Methylated|Adverse Event|1
51018|NCT01357239|204935|P2|Stratum I: Fully-Methylated|Adverse Event|0
51019|NCT01357239|204936|P1|Stratum I: Fully-Methylated|Adverse Event|0
51020|NCT01357239|204933|P4|Stratum: All Patients|Subject withdrew consent|1
51021|NCT01357239|204934|P3|Stratum: All Patients|Subject withdrew consent|1
51022|NCT01357239|204935|P2|Stratum: All Patients|Subject withdrew consent|0
51023|NCT01357239|204936|P1|Stratum: All Patients|Subject withdrew consent|0
51024|NCT01357239|204933|P4|Stratum: All Patients|Adverse Event|1
51025|NCT01357239|204934|P3|Stratum: All Patients|Adverse Event|1
51026|NCT01357239|204935|P2|Stratum: All Patients|Adverse Event|0
51027|NCT01357239|204936|P1|Stratum: All Patients|Adverse Event|0
51028|NCT01356966|205014|P2|Overall Study|Physician Decision|0
51029|NCT01356966|205015|P1|Overall Study|Physician Decision|1
51030|NCT01356966|205014|P2|Overall Study|Withdrawal by Subject|2
51031|NCT01356966|205015|P1|Overall Study|Withdrawal by Subject|1
51032|NCT01356940|205027|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
51033|NCT01356940|205028|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
51034|NCT01356940|205027|P2|First Intervention (28 Days)|Adverse Event|0
51035|NCT01356940|205028|P1|First Intervention (28 Days)|Adverse Event|1
51036|NCT01356602|205050|P3|Overall Study|Adverse Event|1
51037|NCT01356602|205051|P2|Overall Study|Adverse Event|1
51038|NCT01356602|205052|P1|Overall Study|Adverse Event|0
51039|NCT01356602|205050|P3|Overall Study|Lack of Efficacy|4
51040|NCT01356602|205051|P2|Overall Study|Lack of Efficacy|1
51041|NCT01356602|205052|P1|Overall Study|Lack of Efficacy|0
51042|NCT01356602|205050|P3|Overall Study|Withdrawal by Subject|7
51043|NCT01356602|205051|P2|Overall Study|Withdrawal by Subject|3
51044|NCT01356602|205052|P1|Overall Study|Withdrawal by Subject|4
51045|NCT01356602|205050|P3|Overall Study|Lost to Follow-up|6
51046|NCT01356602|205051|P2|Overall Study|Lost to Follow-up|5
51047|NCT01356602|205052|P1|Overall Study|Lost to Follow-up|4
51048|NCT01356602|205050|P3|Overall Study|Administrative Problems|5
51049|NCT01356602|205051|P2|Overall Study|Administrative Problems|4
51050|NCT01356602|205052|P1|Overall Study|Administrative Problems|1
51051|NCT01356602|205050|P3|Overall Study|Protocol Deviation|1
51052|NCT01356602|205051|P2|Overall Study|Protocol Deviation|1
51053|NCT01356602|205052|P1|Overall Study|Protocol Deviation|0
51054|NCT01356589|205111|P1|Overall Study|Dose data not recorded|2
51055|NCT01356589|205111|P1|Overall Study|Enrolled, but not treated|3
51056|NCT01356407|205168|P2|Overall Study|Not complete Endoscopy|2
51057|NCT01356407|205169|P1|Overall Study|Not complete Endoscopy|2
51058|NCT01356407|205168|P2|Overall Study|Could not afford IMP administration|1
51059|NCT01356407|205169|P1|Overall Study|Could not afford IMP administration|0
51060|NCT01356407|205168|P2|Overall Study|Patient Withdrew Consent|1
51061|NCT01356407|205169|P1|Overall Study|Patient Withdrew Consent|2
51062|NCT01356407|205168|P2|Overall Study|Lost to Follow-up|0
51063|NCT01356407|205169|P1|Overall Study|Lost to Follow-up|2
51150|NCT01354314|205479|P3|Overall Study|Lost to Follow-up|1
51064|NCT01355679|205207|P1|Overall Study|benign tumor types found at biopsy|2
51065|NCT01355627|205216|P2|Overall Study|Other|1
51066|NCT01355627|205217|P1|Overall Study|Other|1
51067|NCT01355627|205216|P2|Overall Study|Fatal Adverse Event|23
51068|NCT01355627|205217|P1|Overall Study|Fatal Adverse Event|19
51069|NCT01355627|205216|P2|Overall Study|Lost to Follow-up|7
51070|NCT01355627|205217|P1|Overall Study|Lost to Follow-up|8
51071|NCT01355627|205216|P2|Overall Study|Request By the Patient to Discontinue|7
51072|NCT01355627|205217|P1|Overall Study|Request By the Patient to Discontinue|5
51073|NCT01355523|205256|P2|Overall Study|Adverse Event|2
51074|NCT01355523|205257|P1|Overall Study|Adverse Event|0
51075|NCT01355523|205256|P2|Overall Study|Protocol Violation|2
51076|NCT01355523|205257|P1|Overall Study|Protocol Violation|0
51077|NCT01355523|205256|P2|Overall Study|Lost to Follow-up|2
51078|NCT01355523|205257|P1|Overall Study|Lost to Follow-up|0
51079|NCT01355523|205256|P2|Overall Study|Withdrawal by Subject|4
51080|NCT01355523|205257|P1|Overall Study|Withdrawal by Subject|1
51081|NCT01355302|205333|P3|Phase 1b|Study terminated by sponsor|0
51082|NCT01355302|205334|P2|Phase 1b|Study terminated by sponsor|0
51083|NCT01355302|205335|P1|Phase 1b|Study terminated by sponsor|2
51084|NCT01355302|205333|P3|Phase 1b|Death|0
51085|NCT01355302|205334|P2|Phase 1b|Death|0
51086|NCT01355302|205335|P1|Phase 1b|Death|4
51087|NCT01355081|205376|P3|Overall Study|Non Compliance with Study Medication|0
51088|NCT01355081|205377|P2|Overall Study|Non Compliance with Study Medication|1
51089|NCT01355081|205378|P1|Overall Study|Non Compliance with Study Medication|0
51090|NCT01355081|205376|P3|Overall Study|Lack of Efficacy|1
51091|NCT01355081|205377|P2|Overall Study|Lack of Efficacy|1
51092|NCT01355081|205378|P1|Overall Study|Lack of Efficacy|2
51093|NCT01355081|205376|P3|Overall Study|Withdrawal of Consent|3
51094|NCT01355081|205377|P2|Overall Study|Withdrawal of Consent|3
51095|NCT01355081|205378|P1|Overall Study|Withdrawal of Consent|2
51096|NCT01355081|205376|P3|Overall Study|Lost to Follow-up|1
51097|NCT01355081|205377|P2|Overall Study|Lost to Follow-up|0
51098|NCT01355081|205378|P1|Overall Study|Lost to Follow-up|0
51099|NCT01355081|205376|P3|Overall Study|Major Protocol Deviation|0
51100|NCT01355081|205377|P2|Overall Study|Major Protocol Deviation|1
51101|NCT01355081|205378|P1|Overall Study|Major Protocol Deviation|0
51102|NCT01355081|205376|P3|Overall Study|Pretreatment Event or Adverse Event|6
51103|NCT01355081|205377|P2|Overall Study|Pretreatment Event or Adverse Event|4
51104|NCT01355081|205378|P1|Overall Study|Pretreatment Event or Adverse Event|3
51105|NCT01355068|205401|P2|First Intervention Period|Withdrawal by Subject|1
51106|NCT01355068|205402|P1|First Intervention Period|Withdrawal by Subject|0
51107|NCT01355068|205401|P2|First Intervention Period|Adverse Event|1
51108|NCT01355068|205402|P1|First Intervention Period|Adverse Event|0
51110|NCT01354899|205431|P1|Overall Study|Protocol Violation|1
51111|NCT01354899|205431|P1|Overall Study|discharge from the hospital|2
51112|NCT01354431|205452|P3|Participants Treated|Withdrawal by Subject|1
51113|NCT01354431|205453|P2|Participants Treated|Withdrawal by Subject|2
51114|NCT01354431|205454|P1|Participants Treated|Withdrawal by Subject|1
51115|NCT01354431|205452|P3|Participants Treated|Adverse Event|4
51116|NCT01354431|205453|P2|Participants Treated|Adverse Event|2
51117|NCT01354431|205454|P1|Participants Treated|Adverse Event|1
51118|NCT01354431|205452|P3|Participants Treated|Death|0
51119|NCT01354431|205453|P2|Participants Treated|Death|1
51120|NCT01354431|205454|P1|Participants Treated|Death|0
51121|NCT01354431|205452|P3|Participants Treated|Study Drug Toxicity|4
51122|NCT01354431|205453|P2|Participants Treated|Study Drug Toxicity|7
51123|NCT01354431|205454|P1|Participants Treated|Study Drug Toxicity|2
51124|NCT01354431|205452|P3|Participants Treated|Disease Progression|41
51125|NCT01354431|205453|P2|Participants Treated|Disease Progression|40
51126|NCT01354431|205454|P1|Participants Treated|Disease Progression|49
51127|NCT01354431|205452|P3|Participants Treated|Continuing Treatment|4
51128|NCT01354431|205453|P2|Participants Treated|Continuing Treatment|2
51129|NCT01354431|205454|P1|Participants Treated|Continuing Treatment|6
51130|NCT01354431|205452|P3|Randomized to Enter Treatment Period|No longer met criteria|0
51131|NCT01354431|205453|P2|Randomized to Enter Treatment Period|No longer met criteria|0
51132|NCT01354431|205454|P1|Randomized to Enter Treatment Period|No longer met criteria|1
51133|NCT01354314|205478|P4|Overall Study|Less than 90% Adherence|4
51134|NCT01354314|205479|P3|Overall Study|Less than 90% Adherence|6
51135|NCT01354314|205480|P2|Overall Study|Less than 90% Adherence|2
51136|NCT01354314|205481|P1|Overall Study|Less than 90% Adherence|4
51137|NCT01354314|205478|P4|Overall Study|Protocol Violation|0
51138|NCT01354314|205479|P3|Overall Study|Protocol Violation|0
51139|NCT01354314|205480|P2|Overall Study|Protocol Violation|1
51140|NCT01354314|205481|P1|Overall Study|Protocol Violation|1
51141|NCT01354314|205478|P4|Overall Study|Adverse Event|1
51142|NCT01354314|205479|P3|Overall Study|Adverse Event|0
51143|NCT01354314|205480|P2|Overall Study|Adverse Event|0
51144|NCT01354314|205481|P1|Overall Study|Adverse Event|0
51145|NCT01354314|205478|P4|Overall Study|Withdrawal by Subject|0
51146|NCT01354314|205479|P3|Overall Study|Withdrawal by Subject|1
51147|NCT01354314|205480|P2|Overall Study|Withdrawal by Subject|0
51148|NCT01354314|205481|P1|Overall Study|Withdrawal by Subject|0
51149|NCT01354314|205478|P4|Overall Study|Lost to Follow-up|1
51151|NCT01354314|205480|P2|Overall Study|Lost to Follow-up|0
51152|NCT01354314|205481|P1|Overall Study|Lost to Follow-up|1
51153|NCT01354223|205617|P2|Overall Study|Withdrawal by Subject|1
51154|NCT01354223|205618|P1|Overall Study|Withdrawal by Subject|3
51155|NCT01354132|205677|P2|1 Month Post Study Medication|Withdrawal by Subject|3
51156|NCT01354132|205678|P1|1 Month Post Study Medication|Withdrawal by Subject|1
51157|NCT01354132|205677|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
51158|NCT01354132|205678|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
51159|NCT01354132|205677|P2|Double Blind (Visits 1-7)|Adverse Event|0
51160|NCT01354132|205678|P1|Double Blind (Visits 1-7)|Adverse Event|1
51161|NCT01354132|205677|P2|Randomization|Withdrawal by Subject|1
51162|NCT01354132|205678|P1|Randomization|Withdrawal by Subject|0
51163|NCT01354132|205677|P2|Randomization|Physician Decision|0
51164|NCT01354132|205678|P1|Randomization|Physician Decision|1
51165|NCT01354106|205716|P1|Overall Study|Withdrawal by Subject|2
51166|NCT01354028|205722|P2|Overall Study|No quiet alert state|1
51167|NCT01354028|205723|P1|Overall Study|No quiet alert state|0
51168|NCT01354028|205722|P2|Overall Study|Discharged before study start|2
51169|NCT01354028|205723|P1|Overall Study|Discharged before study start|2
51170|NCT01354028|205722|P2|Overall Study|Physician Decision|2
51171|NCT01354028|205723|P1|Overall Study|Physician Decision|0
51172|NCT01353963|205759|P1|Overall Study|Adverse Event|2
51173|NCT01353911|205777|P8|Overall Study|Status Not Recorded|0
51174|NCT01353911|205778|P7|Overall Study|Status Not Recorded|0
51175|NCT01353911|205779|P6|Overall Study|Status Not Recorded|0
51176|NCT01353911|205780|P5|Overall Study|Status Not Recorded|0
51177|NCT01353911|205781|P4|Overall Study|Status Not Recorded|0
51178|NCT01353911|205782|P3|Overall Study|Status Not Recorded|1
51179|NCT01353911|205783|P2|Overall Study|Status Not Recorded|0
51180|NCT01353911|205784|P1|Overall Study|Status Not Recorded|4
51181|NCT01353911|205777|P8|Overall Study|Withdrawal by Subject|9
51182|NCT01353911|205778|P7|Overall Study|Withdrawal by Subject|3
51183|NCT01353911|205779|P6|Overall Study|Withdrawal by Subject|3
51184|NCT01353911|205780|P5|Overall Study|Withdrawal by Subject|2
51185|NCT01353911|205781|P4|Overall Study|Withdrawal by Subject|2
51186|NCT01353911|205782|P3|Overall Study|Withdrawal by Subject|4
51187|NCT01353911|205783|P2|Overall Study|Withdrawal by Subject|3
51188|NCT01353911|205784|P1|Overall Study|Withdrawal by Subject|2
51189|NCT01353911|205777|P8|Overall Study|Lost to Follow-up|6
51190|NCT01353911|205778|P7|Overall Study|Lost to Follow-up|3
51191|NCT01353911|205779|P6|Overall Study|Lost to Follow-up|4
51192|NCT01353911|205780|P5|Overall Study|Lost to Follow-up|4
51193|NCT01353911|205781|P4|Overall Study|Lost to Follow-up|0
51194|NCT01353911|205782|P3|Overall Study|Lost to Follow-up|4
51195|NCT01353911|205783|P2|Overall Study|Lost to Follow-up|6
51196|NCT01353911|205784|P1|Overall Study|Lost to Follow-up|2
51197|NCT01353898|205864|P6|Overall Study|Study site terminated|1
51198|NCT01353898|205865|P5|Overall Study|Study site terminated|0
51199|NCT01353898|205866|P4|Overall Study|Study site terminated|0
51200|NCT01353898|205867|P3|Overall Study|Study site terminated|0
51201|NCT01353898|205868|P2|Overall Study|Study site terminated|0
51202|NCT01353898|205869|P1|Overall Study|Study site terminated|0
51203|NCT01353859|205895|P1|Overall Study|Lack of Efficacy|1
51204|NCT01353859|205895|P1|Overall Study|Adverse Event|3
51205|NCT01353664|205908|P1|Overall Study|Disease Progression|16
51206|NCT01353664|205908|P1|Overall Study|Unspecified|3
51207|NCT01353586|205914|P2|Overall Study|Neurological exam not done|1
51208|NCT01353586|205915|P1|Overall Study|Neurological exam not done|0
51209|NCT01353586|205914|P2|Overall Study|Never had insertion of study catheter|1
51210|NCT01353586|205915|P1|Overall Study|Never had insertion of study catheter|4
51211|NCT01353586|205914|P2|Overall Study|Procedure terminated prior to ablation|0
51212|NCT01353586|205915|P1|Overall Study|Procedure terminated prior to ablation|3
51213|NCT01353508|205933|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
51214|NCT01353508|205934|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
51215|NCT01353508|205935|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
51216|NCT01353508|205936|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
51217|NCT01353508|205933|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
51218|NCT01353508|205934|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
51219|NCT01353508|205935|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
51220|NCT01353508|205936|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
51221|NCT01353274|206014|P1|Overall Study|No case report form (CRF) collected|28
51222|NCT01353222|206024|P2|Overall Study|Site closed research department|0
51223|NCT01353222|206025|P1|Overall Study|Site closed research department|1
51224|NCT01353222|206024|P2|Overall Study|Study Terminated|37
51225|NCT01353222|206025|P1|Overall Study|Study Terminated|31
51226|NCT01353222|206024|P2|Overall Study|Withdrawal by Subject|5
51227|NCT01353222|206025|P1|Overall Study|Withdrawal by Subject|8
51228|NCT01353222|206024|P2|Overall Study|Death|30
51229|NCT01353222|206025|P1|Overall Study|Death|30
51230|NCT01352845|206059|P2|Overall Study|Death|0
51231|NCT01352845|206060|P1|Overall Study|Death|3
51232|NCT01352845|206059|P2|Overall Study|Protocol Violation|6
51233|NCT01352845|206060|P1|Overall Study|Protocol Violation|12
51234|NCT01352845|206059|P2|Overall Study|Unspecified|7
51235|NCT01352845|206060|P1|Overall Study|Unspecified|17
51236|NCT01352845|206059|P2|Overall Study|Adverse Event|6
51237|NCT01352845|206060|P1|Overall Study|Adverse Event|22
51238|NCT01352845|206059|P2|Overall Study|Pregnancy|7
51239|NCT01352845|206060|P1|Overall Study|Pregnancy|27
51240|NCT01352845|206059|P2|Overall Study|No Longer Meets Eligibility Criteria|11
51241|NCT01352845|206060|P1|Overall Study|No Longer Meets Eligibility Criteria|24
51242|NCT01352845|206059|P2|Overall Study|Withdrawal by Subject|16
51243|NCT01352845|206060|P1|Overall Study|Withdrawal by Subject|48
51244|NCT01352845|206059|P2|Overall Study|No Longer Willing to Participate|58
51245|NCT01352845|206060|P1|Overall Study|No Longer Willing to Participate|205
51246|NCT01352845|206059|P2|Overall Study|Lost to Follow-up|92
51247|NCT01352845|206060|P1|Overall Study|Lost to Follow-up|313
51248|NCT01352793|206149|P2|Overall Study|No longer meets eligibility criteria|15
51249|NCT01352793|206150|P1|Overall Study|No longer meets eligibility criteria|25
51250|NCT01352793|206149|P2|Overall Study|Randomized but not vaccinated|0
51251|NCT01352793|206150|P1|Overall Study|Randomized but not vaccinated|8
51252|NCT01352793|206149|P2|Overall Study|Death|0
51253|NCT01352793|206150|P1|Overall Study|Death|1
51254|NCT01352793|206149|P2|Overall Study|Medication error|2
51255|NCT01352793|206150|P1|Overall Study|Medication error|2
51256|NCT01352793|206149|P2|Overall Study|Unspecified|7
51257|NCT01352793|206150|P1|Overall Study|Unspecified|25
51258|NCT01352793|206149|P2|Overall Study|Pregnancy|8
51259|NCT01352793|206150|P1|Overall Study|Pregnancy|26
51260|NCT01352793|206149|P2|Overall Study|Physician Decision|0
51261|NCT01352793|206150|P1|Overall Study|Physician Decision|1
51262|NCT01352793|206149|P2|Overall Study|Adverse Event|10
51263|NCT01352793|206150|P1|Overall Study|Adverse Event|44
51264|NCT01352793|206149|P2|Overall Study|Protocol Violation|23
51265|NCT01352793|206150|P1|Overall Study|Protocol Violation|44
51266|NCT01352793|206149|P2|Overall Study|Withdrawal by Subject|55
51267|NCT01352793|206150|P1|Overall Study|Withdrawal by Subject|120
51268|NCT01352793|206149|P2|Overall Study|Lost to Follow-up|125
51269|NCT01352793|206150|P1|Overall Study|Lost to Follow-up|289
51270|NCT01352741|206174|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
51271|NCT01352741|206175|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
51272|NCT01352741|206174|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
51273|NCT01352741|206175|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
51274|NCT01352741|206174|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
51275|NCT01352741|206175|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
51276|NCT01352741|206174|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
51277|NCT01352741|206175|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
51278|NCT01352741|206174|P2|Double-blind Comparative Period|Not Specified|2
51279|NCT01352741|206175|P1|Double-blind Comparative Period|Not Specified|1
51280|NCT01352741|206174|P2|Double-blind Comparative Period|Withdrawal of consent|3
51281|NCT01352741|206175|P1|Double-blind Comparative Period|Withdrawal of consent|8
51282|NCT01352741|206174|P2|Double-blind Comparative Period|Death|1
51283|NCT01352741|206175|P1|Double-blind Comparative Period|Death|0
51284|NCT01352741|206174|P2|Double-blind Comparative Period|Lost to Follow-up|0
51285|NCT01352741|206175|P1|Double-blind Comparative Period|Lost to Follow-up|1
51286|NCT01352741|206174|P2|Double-blind Comparative Period|Adverse Event|17
51287|NCT01352741|206175|P1|Double-blind Comparative Period|Adverse Event|16
51288|NCT01352741|206174|P2|Double-blind Comparative Period|Lack of Efficacy|3
51289|NCT01352741|206175|P1|Double-blind Comparative Period|Lack of Efficacy|0
51290|NCT01352741|206174|P2|Double-blind Comparative Period|Protocol Violation|0
51291|NCT01352741|206175|P1|Double-blind Comparative Period|Protocol Violation|2
51292|NCT01352741|206174|P2|Open-label Tapentadol Titration Period|Not Specified|0
51293|NCT01352741|206175|P1|Open-label Tapentadol Titration Period|Not Specified|4
51294|NCT01352741|206174|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
51295|NCT01352741|206175|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
51296|NCT01352741|206174|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
51297|NCT01352741|206175|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
51298|NCT01352741|206174|P2|Open-label Tapentadol Titration Period|Adverse Event|0
51299|NCT01352741|206175|P1|Open-label Tapentadol Titration Period|Adverse Event|34
51300|NCT01352741|206174|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
51301|NCT01352741|206175|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
51302|NCT01352741|206174|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
51303|NCT01352741|206175|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
51304|NCT01352715|206269|P2|Overall Study|major ineligibility|1
51305|NCT01352715|206270|P1|Overall Study|major ineligibility|2
51306|NCT01352715|206269|P2|Overall Study|no final visit in closeout period|12
51307|NCT01352715|206270|P1|Overall Study|no final visit in closeout period|15
51308|NCT01352715|206269|P2|Overall Study|site closure|15
51309|NCT01352715|206270|P1|Overall Study|site closure|16
51310|NCT01352715|206269|P2|Overall Study|Withdrawal by Subject|8
51311|NCT01352715|206270|P1|Overall Study|Withdrawal by Subject|4
51312|NCT01352715|206269|P2|Overall Study|Lost to Follow-up|7
51313|NCT01352715|206270|P1|Overall Study|Lost to Follow-up|5
51314|NCT01352715|206269|P2|Overall Study|Death|3
51315|NCT01352715|206270|P1|Overall Study|Death|3
51316|NCT01352585|206292|P1|Overall Study|Not specified|7
51317|NCT01352585|206292|P1|Overall Study|Lost to Follow-up|1
51318|NCT01352585|206292|P1|Overall Study|Adverse Event|3
51319|NCT01352507|206309|P2|Treatment Period 2|Lack of Efficacy|0
51320|NCT01352507|206310|P1|Treatment Period 2|Lack of Efficacy|1
51321|NCT01352507|206309|P2|Treatment Period 2|Withdrawal by Subject|3
51322|NCT01352507|206310|P1|Treatment Period 2|Withdrawal by Subject|4
51323|NCT01352507|206309|P2|Treatment Period 2|Entry Criteria Not Met|0
51324|NCT01352507|206310|P1|Treatment Period 2|Entry Criteria Not Met|1
51325|NCT01352507|206309|P2|Washout Period|Withdrawal by Subject|1
51326|NCT01352507|206310|P1|Washout Period|Withdrawal by Subject|0
51327|NCT01352507|206309|P2|Treatment Period 1|Physician Decision|0
51328|NCT01352507|206310|P1|Treatment Period 1|Physician Decision|1
51329|NCT01352507|206309|P2|Treatment Period 1|Withdrawal by Subject|5
51330|NCT01352507|206310|P1|Treatment Period 1|Withdrawal by Subject|7
51331|NCT01352507|206309|P2|Treatment Period 1|Lost to Follow-up|4
51332|NCT01352507|206310|P1|Treatment Period 1|Lost to Follow-up|3
51333|NCT01352507|206309|P2|Treatment Period 1|Adverse Event|0
51334|NCT01352507|206310|P1|Treatment Period 1|Adverse Event|3
51335|NCT01352416|206363|P4|Overall Study|Physician Decision|1
51336|NCT01352416|206364|P3|Overall Study|Physician Decision|2
51337|NCT01352416|206365|P2|Overall Study|Physician Decision|2
51338|NCT01352416|206366|P1|Overall Study|Physician Decision|1
51339|NCT01352117|206378|P2|Overall Study|Ineligible (no KS diagnosis)|0
51340|NCT01352117|206379|P1|Overall Study|Ineligible (no KS diagnosis)|1
51341|NCT01352117|206378|P2|Overall Study|Did not initiate study treatment|0
51342|NCT01352117|206379|P1|Overall Study|Did not initiate study treatment|1
51343|NCT01352117|206378|P2|Overall Study|Non-adherent to study requirements|0
51344|NCT01352117|206379|P1|Overall Study|Non-adherent to study requirements|1
51345|NCT01352117|206378|P2|Overall Study|Lost to Follow-up|4
51346|NCT01352117|206379|P1|Overall Study|Lost to Follow-up|2
51347|NCT01352117|206378|P2|Overall Study|Withdrawal by Subject|0
51348|NCT01352117|206379|P1|Overall Study|Withdrawal by Subject|1
51349|NCT01352117|206378|P2|Overall Study|Death|12
51350|NCT01352117|206379|P1|Overall Study|Death|13
51351|NCT01352117|206378|P2|Overall Study|On study|80
51352|NCT01352117|206379|P1|Overall Study|On study|49
51353|NCT01351623|206431|P1|Overall Study|Death|2
51354|NCT01351623|206431|P1|Overall Study|Withdrawal by Subject|1
51355|NCT01351623|206431|P1|Overall Study|Adverse Event|4
51356|NCT01351623|206431|P1|Overall Study|Protocol Violation|2
51357|NCT01351025|206513|P2|Week 24 - 44|unable to get to clinic|1
51358|NCT01351025|206514|P1|Week 24 - 44|unable to get to clinic|1
51359|NCT01351025|206513|P2|Week 24 - 44|Site closed|1
51360|NCT01351025|206514|P1|Week 24 - 44|Site closed|0
51361|NCT01351025|206513|P2|Week 24 - 44|Lost to Follow-up|2
51362|NCT01351025|206514|P1|Week 24 - 44|Lost to Follow-up|0
51363|NCT01351025|206513|P2|Week 0 - 20|Withdrawal by Subject|0
51364|NCT01351025|206514|P1|Week 0 - 20|Withdrawal by Subject|1
51365|NCT01351025|206513|P2|Week 0 - 20|Lost to Follow-up|1
51366|NCT01351025|206514|P1|Week 0 - 20|Lost to Follow-up|2
51367|NCT01350999|206547|P3|Overall Study|Difficulty Making it to Study Visit|5
51368|NCT01350999|206548|P2|Overall Study|Difficulty Making it to Study Visit|1
51369|NCT01350999|206549|P1|Overall Study|Difficulty Making it to Study Visit|1
51370|NCT01350999|206547|P3|Overall Study|Voluntary withdrawal|6
51371|NCT01350999|206548|P2|Overall Study|Voluntary withdrawal|4
51372|NCT01350999|206549|P1|Overall Study|Voluntary withdrawal|3
51373|NCT01350999|206547|P3|Overall Study|Adverse Event|10
51374|NCT01350999|206548|P2|Overall Study|Adverse Event|9
51375|NCT01350999|206549|P1|Overall Study|Adverse Event|4
51376|NCT01350973|206587|P3|Overall Study|Voluntary Withdrawal|1
51377|NCT01350973|206588|P2|Overall Study|Voluntary Withdrawal|1
51378|NCT01350973|206589|P1|Overall Study|Voluntary Withdrawal|2
51379|NCT01350973|206587|P3|Overall Study|Adverse Event|7
51380|NCT01350973|206588|P2|Overall Study|Adverse Event|7
51381|NCT01350973|206589|P1|Overall Study|Adverse Event|4
51382|NCT01350934|206630|P2|Extension Study|Withdrawal by Subject|1
51383|NCT01350934|206631|P1|Extension Study|Withdrawal by Subject|0
51384|NCT01350934|206630|P2|Extension Study|Lack of Efficacy|1
51385|NCT01350934|206631|P1|Extension Study|Lack of Efficacy|0
51386|NCT01350934|206630|P2|Extension Study|Protocol Violation|1
51387|NCT01350934|206631|P1|Extension Study|Protocol Violation|1
51388|NCT01350934|206630|P2|Extension Study|Lost to Follow-up|0
51389|NCT01350934|206631|P1|Extension Study|Lost to Follow-up|2
51390|NCT01350934|206630|P2|Extension Study|Adverse Event|1
51391|NCT01350934|206631|P1|Extension Study|Adverse Event|2
51392|NCT01350934|206630|P2|Base Study|Non-Compliance With Study Drug|0
51393|NCT01350934|206631|P1|Base Study|Non-Compliance With Study Drug|2
51394|NCT01350934|206630|P2|Base Study|Withdrawal by Subject|2
51395|NCT01350934|206631|P1|Base Study|Withdrawal by Subject|1
51396|NCT01350934|206630|P2|Base Study|Protocol Violation|1
51397|NCT01350934|206631|P1|Base Study|Protocol Violation|1
51398|NCT01350934|206630|P2|Base Study|Lost to Follow-up|0
51399|NCT01350934|206631|P1|Base Study|Lost to Follow-up|1
51400|NCT01350934|206630|P2|Base Study|Adverse Event|0
51401|NCT01350934|206631|P1|Base Study|Adverse Event|6
51402|NCT01350804|206653|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
51403|NCT01350804|206654|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
51404|NCT01350804|206655|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
51405|NCT01350804|206656|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
51406|NCT01350804|206653|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
51407|NCT01350804|206654|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
51408|NCT01350804|206655|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
51409|NCT01350804|206656|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
51410|NCT01350804|206653|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
51411|NCT01350804|206654|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
51412|NCT01350804|206655|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
51413|NCT01350804|206656|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
51414|NCT01350804|206653|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
51415|NCT01350804|206654|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
51416|NCT01350804|206655|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
51417|NCT01350804|206656|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
51418|NCT01350804|206653|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
51419|NCT01350804|206654|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
51420|NCT01350804|206655|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
51421|NCT01350804|206656|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
51422|NCT01350804|206653|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
51423|NCT01350804|206654|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
51424|NCT01350804|206655|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
51425|NCT01350804|206656|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
51426|NCT01350804|206653|P4|Core Study|Adverse Event|8
51427|NCT01350804|206654|P3|Core Study|Adverse Event|8
51428|NCT01350804|206655|P2|Core Study|Adverse Event|10
51429|NCT01350804|206656|P1|Core Study|Adverse Event|8
51430|NCT01350804|206653|P4|Core Study|Death|0
51431|NCT01350804|206654|P3|Core Study|Death|1
51432|NCT01350804|206655|P2|Core Study|Death|1
51433|NCT01350804|206656|P1|Core Study|Death|1
51434|NCT01350804|206653|P4|Core Study|Lack of Efficacy|5
51435|NCT01350804|206654|P3|Core Study|Lack of Efficacy|18
51436|NCT01350804|206655|P2|Core Study|Lack of Efficacy|19
51437|NCT01350804|206656|P1|Core Study|Lack of Efficacy|16
51438|NCT01350804|206653|P4|Core Study|Lost to Follow-up|1
51439|NCT01350804|206654|P3|Core Study|Lost to Follow-up|2
51440|NCT01350804|206655|P2|Core Study|Lost to Follow-up|0
51441|NCT01350804|206656|P1|Core Study|Lost to Follow-up|3
51442|NCT01350804|206653|P4|Core Study|Physician Decision|3
51443|NCT01350804|206654|P3|Core Study|Physician Decision|1
51444|NCT01350804|206655|P2|Core Study|Physician Decision|0
51445|NCT01350804|206656|P1|Core Study|Physician Decision|1
51446|NCT01350804|206653|P4|Core Study|Protocol deviation|0
51447|NCT01350804|206654|P3|Core Study|Protocol deviation|1
51448|NCT01350804|206655|P2|Core Study|Protocol deviation|0
51449|NCT01350804|206656|P1|Core Study|Protocol deviation|1
51450|NCT01350804|206653|P4|Core Study|Study terminated by Sponsor|2
51451|NCT01350804|206654|P3|Core Study|Study terminated by Sponsor|0
51452|NCT01350804|206655|P2|Core Study|Study terminated by Sponsor|0
51453|NCT01350804|206656|P1|Core Study|Study terminated by Sponsor|0
51454|NCT01350804|206653|P4|Core Study|Withdrawal by Subject|7
51455|NCT01350804|206654|P3|Core Study|Withdrawal by Subject|16
51456|NCT01350804|206655|P2|Core Study|Withdrawal by Subject|17
51457|NCT01350804|206656|P1|Core Study|Withdrawal by Subject|11
51458|NCT01350544|206753|P2|Overall Study|Lost to Follow-up|15
51459|NCT01350544|206754|P1|Overall Study|Lost to Follow-up|18
51460|NCT01350544|206753|P2|Overall Study|Incarceration|0
51461|NCT01350544|206754|P1|Overall Study|Incarceration|1
51462|NCT01350544|206753|P2|Overall Study|Withdrawal by Subject|1
51463|NCT01350544|206754|P1|Overall Study|Withdrawal by Subject|0
51464|NCT01350544|206753|P2|Overall Study|Medical Issues|1
51465|NCT01350544|206754|P1|Overall Study|Medical Issues|1
51466|NCT01350544|206753|P2|Overall Study|Moved out of LA County|2
51467|NCT01350544|206754|P1|Overall Study|Moved out of LA County|2
51468|NCT01350544|206753|P2|Overall Study|Death|2
51469|NCT01350544|206754|P1|Overall Study|Death|1
51470|NCT01350544|206753|P2|Overall Study|Administrative Withdrawal|1
51471|NCT01350544|206754|P1|Overall Study|Administrative Withdrawal|0
51472|NCT01350414|206769|P1|Overall Study|Physician Decision|2
51473|NCT01350414|206769|P1|Overall Study|Withdrawal by Subject|4
51474|NCT01350414|206769|P1|Overall Study|Lost to Follow-up|13
51475|NCT01350271|206808|P3|Overall Study|Lost to Follow-up|26
51476|NCT01350271|206809|P2|Overall Study|Lost to Follow-up|17
51477|NCT01350271|206810|P1|Overall Study|Lost to Follow-up|21
51478|NCT01350128|206849|P1|Overall Study|Lost to Follow-up|2
51479|NCT01350128|206849|P1|Overall Study|Physician Decision|1
51480|NCT01350128|206849|P1|Overall Study|Protocol discontinuation criteria|8
51481|NCT01350128|206849|P1|Overall Study|Withdrawal by Subject|3
51482|NCT01350115|206913|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
51483|NCT01350115|206914|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
51484|NCT01350115|206913|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
51485|NCT01350115|206914|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
51486|NCT01350115|206913|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
51487|NCT01350115|206914|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
51488|NCT01349959|206945|P1|Overall Study|Patients are followed for survival|7
51489|NCT01349907|206976|P2|Overall Study|Administrative|1
51490|NCT01349907|206977|P1|Overall Study|Administrative|1
51491|NCT01349907|206976|P2|Overall Study|Protocol Violation|13
51492|NCT01349907|206977|P1|Overall Study|Protocol Violation|33
51493|NCT01349907|206976|P2|Overall Study|Withdrawal by Subject|8
51494|NCT01349907|206977|P1|Overall Study|Withdrawal by Subject|30
51495|NCT01349907|206976|P2|Overall Study|Lost to Follow-up|6
51496|NCT01349907|206977|P1|Overall Study|Lost to Follow-up|25
51497|NCT01349907|206976|P2|Overall Study|Treatment failure|4
51498|NCT01349907|206977|P1|Overall Study|Treatment failure|13
51499|NCT01349907|206976|P2|Overall Study|Adverse Event|11
51500|NCT01349907|206977|P1|Overall Study|Adverse Event|37
51501|NCT01349829|207015|P2|Overall Study|Migrated/moved|7
51502|NCT01349829|207016|P1|Overall Study|Migrated/moved|2
51503|NCT01349829|207015|P2|Overall Study|Consent withdrawal|8
51504|NCT01349829|207016|P1|Overall Study|Consent withdrawal|3
51505|NCT01349829|207015|P2|Overall Study|Lost to Follow-up|8
51506|NCT01349829|207016|P1|Overall Study|Lost to Follow-up|4
51507|NCT01349816|207034|P1|Overall Study|Protocol-specified criteria|8
51508|NCT01349816|207034|P1|Overall Study|Protocol Violation|1
51509|NCT01349816|207034|P1|Overall Study|Lost to Follow-up|2
51510|NCT01349816|207034|P1|Overall Study|Adverse Event|14
51511|NCT01349816|207034|P1|Overall Study|Physician Decision|1
51512|NCT01349816|207034|P1|Overall Study|Withdrawal by Subject|4
51513|NCT01349803|207100|P4|Overall Study|Protocol-specified criteria|0
51514|NCT01349803|207101|P3|Overall Study|Protocol-specified criteria|3
51515|NCT01349803|207102|P2|Overall Study|Protocol-specified criteria|1
51516|NCT01349803|207103|P1|Overall Study|Protocol-specified criteria|0
51517|NCT01349803|207100|P4|Overall Study|Withdrawal by Subject|0
51518|NCT01349803|207101|P3|Overall Study|Withdrawal by Subject|0
51519|NCT01349803|207102|P2|Overall Study|Withdrawal by Subject|0
51520|NCT01349803|207103|P1|Overall Study|Withdrawal by Subject|1
51521|NCT01349803|207100|P4|Overall Study|Adverse Event|2
51522|NCT01349803|207101|P3|Overall Study|Adverse Event|0
51523|NCT01349803|207102|P2|Overall Study|Adverse Event|0
51524|NCT01349803|207103|P1|Overall Study|Adverse Event|0
51525|NCT01349790|207173|P1|Overall Study|Lost to Follow-up|1
51526|NCT01349790|207173|P1|Overall Study|Adverse Event|1
51527|NCT01349790|207173|P1|Overall Study|Withdrawal by Patient|2
51528|NCT01349790|207173|P1|Overall Study|Death|2
51529|NCT01349790|207173|P1|Overall Study|Investigator Judgement|3
51530|NCT01349595|207194|P2|Overall Study|Lack of funding|2
51531|NCT01349595|207195|P1|Overall Study|Lack of funding|2
51532|NCT01349465|207212|P2|Overall Study|Subject Ineligible To Continue The Trial|19
51533|NCT01349465|207213|P1|Overall Study|Subject Ineligible To Continue The Trial|0
51534|NCT01349465|207212|P2|Overall Study|Withdrawal by Subject|2
51535|NCT01349465|207213|P1|Overall Study|Withdrawal by Subject|4
51536|NCT01349465|207212|P2|Overall Study|Lost to Follow-up|1
51537|NCT01349465|207213|P1|Overall Study|Lost to Follow-up|10
51538|NCT01349465|207212|P2|Overall Study|Death|0
51539|NCT01349465|207213|P1|Overall Study|Death|3
51540|NCT01349465|207212|P2|Overall Study|Adverse Event|0
51541|NCT01349465|207213|P1|Overall Study|Adverse Event|1
51542|NCT01349192|207234|P2|Overall Study|Failure to adhere to Protocol|0
51543|NCT01349192|207235|P1|Overall Study|Failure to adhere to Protocol|2
51544|NCT01349192|207234|P2|Overall Study|Lost to Follow-up|3
51545|NCT01349192|207235|P1|Overall Study|Lost to Follow-up|1
51546|NCT01349192|207234|P2|Overall Study|Withdrawal by Subject|2
51547|NCT01349192|207235|P1|Overall Study|Withdrawal by Subject|0
51548|NCT01349192|207234|P2|Overall Study|Protocol Violation|1
51549|NCT01349192|207235|P1|Overall Study|Protocol Violation|0
51550|NCT01348854|207260|P2|Overall Study|Withdrawal by Subject|0
51551|NCT01348854|207261|P1|Overall Study|Withdrawal by Subject|1
51552|NCT01348854|207260|P2|Overall Study|Lost to Follow-up|1
51553|NCT01348854|207261|P1|Overall Study|Lost to Follow-up|2
51554|NCT01348789|207269|P1|Overall Study|Withdrawal by Subject|2
51555|NCT01348789|207269|P1|Overall Study|Protocol Violation|2
51556|NCT01348776|207280|P1|Overall Study|Lost to Follow-up|3
51557|NCT01348425|207311|P2|Overall Study|Imaging was not taken.|1
51558|NCT01348425|207312|P1|Overall Study|Imaging was not taken.|1
51559|NCT01348165|207324|P7|Overall Study|Adverse Event|1
51560|NCT01348165|207325|P6|Overall Study|Adverse Event|0
51561|NCT01348165|207326|P5|Overall Study|Adverse Event|0
51562|NCT01348165|207327|P4|Overall Study|Adverse Event|0
51563|NCT01348165|207328|P3|Overall Study|Adverse Event|0
51564|NCT01348165|207329|P2|Overall Study|Adverse Event|0
51565|NCT01348165|207330|P1|Overall Study|Adverse Event|0
51566|NCT01348139|207459|P6|Period 1|Adverse Event|0
51567|NCT01348139|207460|P5|Period 1|Adverse Event|0
51568|NCT01348139|207461|P4|Period 1|Adverse Event|0
51569|NCT01348139|207462|P3|Period 1|Adverse Event|0
51570|NCT01348139|207463|P2|Period 1|Adverse Event|0
51571|NCT01348139|207464|P1|Period 1|Adverse Event|1
51572|NCT01348100|207545|P7|Overall Study|Administrative Problems|1
51573|NCT01348100|207546|P6|Overall Study|Administrative Problems|1
51574|NCT01348100|207547|P5|Overall Study|Administrative Problems|0
51575|NCT01348100|207548|P4|Overall Study|Administrative Problems|0
51576|NCT01348100|207549|P3|Overall Study|Administrative Problems|0
51577|NCT01348100|207550|P2|Overall Study|Administrative Problems|0
51578|NCT01348100|207551|P1|Overall Study|Administrative Problems|0
51579|NCT01348100|207545|P7|Overall Study|Lost to Follow-up|1
51580|NCT01348100|207546|P6|Overall Study|Lost to Follow-up|0
51581|NCT01348100|207547|P5|Overall Study|Lost to Follow-up|0
51582|NCT01348100|207548|P4|Overall Study|Lost to Follow-up|0
51583|NCT01348100|207549|P3|Overall Study|Lost to Follow-up|0
51584|NCT01348100|207550|P2|Overall Study|Lost to Follow-up|0
51585|NCT01348100|207551|P1|Overall Study|Lost to Follow-up|0
51586|NCT01348100|207545|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
51587|NCT01348100|207546|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
51588|NCT01348100|207547|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
51589|NCT01348100|207548|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
51590|NCT01348100|207549|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
51591|NCT01348100|207550|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
51592|NCT01348100|207551|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
51593|NCT01348100|207545|P7|Overall Study|Protocol Deviation|0
51594|NCT01348100|207546|P6|Overall Study|Protocol Deviation|0
51595|NCT01348100|207547|P5|Overall Study|Protocol Deviation|0
51596|NCT01348100|207548|P4|Overall Study|Protocol Deviation|1
51597|NCT01348100|207549|P3|Overall Study|Protocol Deviation|0
51598|NCT01348100|207550|P2|Overall Study|Protocol Deviation|0
51599|NCT01348100|207551|P1|Overall Study|Protocol Deviation|0
51600|NCT01348100|207545|P7|Overall Study|Subject Withdrew Consent|1
51601|NCT01348100|207546|P6|Overall Study|Subject Withdrew Consent|0
51602|NCT01348100|207547|P5|Overall Study|Subject Withdrew Consent|1
51603|NCT01348100|207548|P4|Overall Study|Subject Withdrew Consent|0
51604|NCT01348100|207549|P3|Overall Study|Subject Withdrew Consent|2
51605|NCT01348100|207550|P2|Overall Study|Subject Withdrew Consent|0
51606|NCT01348100|207551|P1|Overall Study|Subject Withdrew Consent|0
51607|NCT01348087|207596|P1|Overall Study|Adverse Event|25
51608|NCT01348087|207596|P1|Overall Study|Subject withdrew consent|7
51609|NCT01348087|207596|P1|Overall Study|Lost to Follow-up|1
51610|NCT01348087|207596|P1|Overall Study|protocol deviation|1
51611|NCT01348087|207596|P1|Overall Study|Administrative problems|79
51612|NCT01348087|207596|P1|Overall Study|Unsatisfactory therapeutic effect|35
51613|NCT01347931|207610|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
51614|NCT01347879|207622|P2|Overall Study|Not known|3
51615|NCT01347879|207623|P1|Overall Study|Not known|2
51616|NCT01347879|207622|P2|Overall Study|Withdrawal by Subject|2
51617|NCT01347879|207623|P1|Overall Study|Withdrawal by Subject|3
51618|NCT01347879|207622|P2|Overall Study|Lost to Follow-up|0
51619|NCT01347879|207623|P1|Overall Study|Lost to Follow-up|2
51620|NCT01347879|207622|P2|Overall Study|Adverse Event|12
51621|NCT01347879|207623|P1|Overall Study|Adverse Event|0
51622|NCT01347840|207655|P1|Overall Study|Withdrawal by Subject|1
51623|NCT01347710|207678|P1|Overall Study|Other|3
51624|NCT01347710|207678|P1|Overall Study|Physician Decision|2
51625|NCT01347710|207678|P1|Overall Study|Lost to Follow-up|1
51626|NCT01347710|207678|P1|Overall Study|issue with vitals prior to dosing|1
51627|NCT01347710|207678|P1|Overall Study|Angio or SPECT not completed|18
51628|NCT01347710|207678|P1|Overall Study|Adverse Event|4
51629|NCT01347710|207678|P1|Overall Study|Withdrawal by Subject|2
51630|NCT01347580|207699|P2|Overall Study|Had other reason|6
51631|NCT01347580|207700|P1|Overall Study|Had other reason|9
51632|NCT01347580|207699|P2|Overall Study|Lost to Follow-up|1
51633|NCT01347580|207700|P1|Overall Study|Lost to Follow-up|3
51634|NCT01347580|207699|P2|Overall Study|Protocol Violation|7
51635|NCT01347580|207700|P1|Overall Study|Protocol Violation|10
51636|NCT01347580|207699|P2|Overall Study|Death|19
51637|NCT01347580|207700|P1|Overall Study|Death|30
51638|NCT01347580|207699|P2|Overall Study|Withdrawal by Subject|23
51639|NCT01347580|207700|P1|Overall Study|Withdrawal by Subject|13
51640|NCT01347554|207730|P2|Overall Study|Lack of Efficacy|11
51641|NCT01347554|207731|P1|Overall Study|Lack of Efficacy|7
51642|NCT01347112|207768|P2|Overall Study|Lost to Follow-up|5
51643|NCT01347112|207769|P1|Overall Study|Lost to Follow-up|3
51644|NCT01347112|207768|P2|Overall Study|Withdrawal by Subject|7
51645|NCT01347112|207769|P1|Overall Study|Withdrawal by Subject|1
51646|NCT01347086|207789|P10|Overall Study|failed screening visit|1
51647|NCT01347086|207790|P9|Overall Study|failed screening visit|0
51648|NCT01347086|207791|P8|Overall Study|failed screening visit|1
51649|NCT01347086|207792|P7|Overall Study|failed screening visit|1
51650|NCT01347086|207793|P6|Overall Study|failed screening visit|0
51651|NCT01347086|207794|P5|Overall Study|failed screening visit|0
51652|NCT01347086|207795|P4|Overall Study|failed screening visit|0
51653|NCT01347086|207796|P3|Overall Study|failed screening visit|1
51654|NCT01347086|207797|P2|Overall Study|failed screening visit|0
51655|NCT01347086|207798|P1|Overall Study|failed screening visit|0
51656|NCT01347073|207897|P1|Overall Study|Liver Transplant|1
51657|NCT01347073|207897|P1|Overall Study|Adverse Event|1
51658|NCT01346774|207976|P2|Overall Study|Adverse Event|2
51659|NCT01346774|207977|P1|Overall Study|Adverse Event|1
51660|NCT01346774|207976|P2|Overall Study|Protocol Violation|3
51661|NCT01346774|207977|P1|Overall Study|Protocol Violation|2
51662|NCT01346774|207976|P2|Overall Study|Withdrawal by Subject|4
51663|NCT01346774|207977|P1|Overall Study|Withdrawal by Subject|1
51664|NCT01346774|207976|P2|Overall Study|Lost to Follow-up|4
51665|NCT01346774|207977|P1|Overall Study|Lost to Follow-up|3
51666|NCT01346774|207976|P2|Overall Study|Did not take a single dose|4
51667|NCT01346774|207977|P1|Overall Study|Did not take a single dose|6
51668|NCT01346592|207986|P3|Overall Study|Unable to Classify|6
51669|NCT01346592|207987|P2|Overall Study|Unable to Classify|3
51670|NCT01346592|207988|P1|Overall Study|Unable to Classify|7
51671|NCT01346592|207986|P3|Overall Study|Administrative reason|0
51672|NCT01346592|207987|P2|Overall Study|Administrative reason|0
51673|NCT01346592|207988|P1|Overall Study|Administrative reason|1
51674|NCT01346592|207986|P3|Overall Study|Inappropriate enrollment|1
51675|NCT01346592|207987|P2|Overall Study|Inappropriate enrollment|1
51676|NCT01346592|207988|P1|Overall Study|Inappropriate enrollment|3
51677|NCT01346592|207986|P3|Overall Study|Withdrawal by Subject|38
51678|NCT01346592|207987|P2|Overall Study|Withdrawal by Subject|51
51679|NCT01346592|207988|P1|Overall Study|Withdrawal by Subject|77
51680|NCT01346592|207986|P3|Overall Study|Adverse Event|0
51681|NCT01346592|207987|P2|Overall Study|Adverse Event|1
51682|NCT01346592|207988|P1|Overall Study|Adverse Event|0
51683|NCT01346592|207986|P3|Overall Study|Death|4
51684|NCT01346592|207987|P2|Overall Study|Death|3
51685|NCT01346592|207988|P1|Overall Study|Death|1
51686|NCT01346592|207986|P3|Overall Study|Protocol Violation|0
51687|NCT01346592|207987|P2|Overall Study|Protocol Violation|1
51688|NCT01346592|207988|P1|Overall Study|Protocol Violation|2
51689|NCT01346592|207986|P3|Overall Study|Lost to Follow-up|29
51690|NCT01346592|207987|P2|Overall Study|Lost to Follow-up|29
51691|NCT01346592|207988|P1|Overall Study|Lost to Follow-up|62
51692|NCT01346514|208080|P2|Overall Study|Death|4
51693|NCT01346514|208081|P1|Overall Study|Death|3
51694|NCT01346514|208080|P2|Overall Study|Withdrawal by Subject|3
51695|NCT01346514|208081|P1|Overall Study|Withdrawal by Subject|7
51696|NCT01346514|208080|P2|Overall Study|Lost to Follow-up|30
51697|NCT01346514|208081|P1|Overall Study|Lost to Follow-up|19
51698|NCT01346501|208101|P2|Overall Study|Not Specified|12
51699|NCT01346501|208102|P1|Overall Study|Not Specified|8
51700|NCT01346501|208101|P2|Overall Study|Initiated Other Biological Agents|1
51701|NCT01346501|208102|P1|Overall Study|Initiated Other Biological Agents|3
51702|NCT01346475|208135|P2|First Intervention|Lost to Follow-up|3
51703|NCT01346475|208136|P1|First Intervention|Lost to Follow-up|4
51704|NCT01346293|208161|P2|Overall Study|Other|0
51705|NCT01346293|208162|P1|Overall Study|Other|1
51706|NCT01346293|208161|P2|Overall Study|Withdrawal by Subject|4
51707|NCT01346293|208162|P1|Overall Study|Withdrawal by Subject|15
51708|NCT01346293|208161|P2|Overall Study|Lost to Follow-up|8
51709|NCT01346293|208162|P1|Overall Study|Lost to Follow-up|21
51710|NCT01346293|208161|P2|Overall Study|Protocol Violation|9
51711|NCT01346293|208162|P1|Overall Study|Protocol Violation|30
51712|NCT01346176|208191|P3|Completed Satisfaction Survey|Lost to Follow-up|4
51713|NCT01346176|208192|P2|Completed Satisfaction Survey|Lost to Follow-up|4
51714|NCT01346176|208193|P1|Completed Satisfaction Survey|Lost to Follow-up|3
51715|NCT01346176|208191|P3|Completed Satisfaction Survey|Death|2
51716|NCT01346176|208192|P2|Completed Satisfaction Survey|Death|0
51717|NCT01346176|208193|P1|Completed Satisfaction Survey|Death|3
51718|NCT01346176|208191|P3|Completed Advance Directive|Other reason did not complete AD|7
51719|NCT01346176|208192|P2|Completed Advance Directive|Other reason did not complete AD|12
51720|NCT01346176|208193|P1|Completed Advance Directive|Other reason did not complete AD|7
51721|NCT01346176|208191|P3|Completed Advance Directive|Became Ineligible|1
51722|NCT01346176|208192|P2|Completed Advance Directive|Became Ineligible|0
51723|NCT01346176|208193|P1|Completed Advance Directive|Became Ineligible|3
51724|NCT01346176|208191|P3|Completed Advance Directive|Death|2
51725|NCT01346176|208192|P2|Completed Advance Directive|Death|2
51726|NCT01346176|208193|P1|Completed Advance Directive|Death|3
51727|NCT01346176|208191|P3|Recruited|Protocol Violation|0
51728|NCT01346176|208192|P2|Recruited|Protocol Violation|0
51729|NCT01346176|208193|P1|Recruited|Protocol Violation|1
51730|NCT01346059|208222|P2|Overall Study|Withdrawal by Subject|0
51731|NCT01346059|208223|P1|Overall Study|Withdrawal by Subject|1
51732|NCT01345929|208235|P2|Overall Study|Patient withdrawal|1
51733|NCT01345929|208236|P1|Overall Study|Patient withdrawal|0
51734|NCT01345929|208235|P2|Overall Study|40,000 CFU/ML|0
51735|NCT01345929|208236|P1|Overall Study|40,000 CFU/ML|1
51736|NCT01345929|208235|P2|Overall Study|Didn't meet eligibility criteria|0
51737|NCT01345929|208236|P1|Overall Study|Didn't meet eligibility criteria|2
51738|NCT01345929|208235|P2|Overall Study|Adverse Event|1
51739|NCT01345929|208236|P1|Overall Study|Adverse Event|0
51740|NCT01345929|208235|P2|Overall Study|Lost to Follow-up|9
51741|NCT01345929|208236|P1|Overall Study|Lost to Follow-up|9
51742|NCT01345929|208235|P2|Overall Study|Withdrawal by Subject|8
51743|NCT01345929|208236|P1|Overall Study|Withdrawal by Subject|9
51744|NCT01345786|208248|P4|Overall Study|Lost to Follow-up|2
51745|NCT01345786|208249|P3|Overall Study|Lost to Follow-up|0
51746|NCT01345786|208250|P2|Overall Study|Lost to Follow-up|0
51747|NCT01345786|208251|P1|Overall Study|Lost to Follow-up|0
51748|NCT01345786|208248|P4|Overall Study|Administrative|0
51749|NCT01345786|208249|P3|Overall Study|Administrative|0
51750|NCT01345786|208250|P2|Overall Study|Administrative|5
51751|NCT01345786|208251|P1|Overall Study|Administrative|3
51752|NCT01345786|208248|P4|Overall Study|Noncompliance with protocol|0
51753|NCT01345786|208249|P3|Overall Study|Noncompliance with protocol|1
51754|NCT01345786|208250|P2|Overall Study|Noncompliance with protocol|0
51755|NCT01345786|208251|P1|Overall Study|Noncompliance with protocol|1
51756|NCT01345786|208248|P4|Overall Study|Subject withdrew consent|0
51757|NCT01345786|208249|P3|Overall Study|Subject withdrew consent|1
51758|NCT01345786|208250|P2|Overall Study|Subject withdrew consent|2
51759|NCT01345786|208251|P1|Overall Study|Subject withdrew consent|2
51760|NCT01345786|208248|P4|Overall Study|Adverse Event|1
51761|NCT01345786|208249|P3|Overall Study|Adverse Event|3
51762|NCT01345786|208250|P2|Overall Study|Adverse Event|1
51763|NCT01345786|208251|P1|Overall Study|Adverse Event|0
51764|NCT01345682|208331|P2|Overall Study|Reason other than those specified above|2
51765|NCT01345682|208332|P1|Overall Study|Reason other than those specified above|3
51766|NCT01345682|208331|P2|Overall Study|Not treated|1
51767|NCT01345682|208332|P1|Overall Study|Not treated|2
51768|NCT01345682|208331|P2|Overall Study|Refused to continue trial medication|9
51769|NCT01345682|208332|P1|Overall Study|Refused to continue trial medication|16
51770|NCT01345682|208331|P2|Overall Study|Lost to Follow-up|1
51771|NCT01345682|208332|P1|Overall Study|Lost to Follow-up|0
51772|NCT01345682|208331|P2|Overall Study|Non-compliance with protocol|1
51773|NCT01345682|208332|P1|Overall Study|Non-compliance with protocol|0
51774|NCT01345682|208331|P2|Overall Study|Adverse Event|41
51775|NCT01345682|208332|P1|Overall Study|Adverse Event|49
51776|NCT01345682|208331|P2|Overall Study|Worsening of underlying cancer disease|13
51777|NCT01345682|208332|P1|Overall Study|Worsening of underlying cancer disease|21
51778|NCT01345682|208331|P2|Overall Study|Progressive disease per RECIST|89
51779|NCT01345682|208332|P1|Overall Study|Progressive disease per RECIST|215
51780|NCT01345630|208366|P2|Overall Study|Insufficient clinical response|11
51781|NCT01345630|208367|P1|Overall Study|Insufficient clinical response|48
51782|NCT01345630|208366|P2|Overall Study|No longer willing to participate|12
51783|NCT01345630|208367|P1|Overall Study|No longer willing to participate|9
51784|NCT01345630|208366|P2|Overall Study|Withdrawn due to pregnancy|2
51785|NCT01345630|208367|P1|Overall Study|Withdrawn due to pregnancy|1
51786|NCT01345630|208366|P2|Overall Study|Other reasons|8
51787|NCT01345630|208367|P1|Overall Study|Other reasons|6
51788|NCT01345630|208366|P2|Overall Study|Study terminated by sponsor|285
51789|NCT01345630|208367|P1|Overall Study|Study terminated by sponsor|254
51790|NCT01345630|208366|P2|Overall Study|Medication error without associated AE|1
51791|NCT01345630|208367|P1|Overall Study|Medication error without associated AE|0
51792|NCT01345630|208366|P2|Overall Study|Protocol Violation|1
51793|NCT01345630|208367|P1|Overall Study|Protocol Violation|4
51794|NCT01345630|208366|P2|Overall Study|Lost to Follow-up|16
51795|NCT01345630|208367|P1|Overall Study|Lost to Follow-up|17
51796|NCT01345630|208366|P2|Overall Study|Adverse Event|23
51797|NCT01345630|208367|P1|Overall Study|Adverse Event|22
51798|NCT01345591|208423|P1|Overall Study|Lost to Follow-up|1
51799|NCT01345318|208432|P1|Overall Study|Unspecified|3
51800|NCT01345318|208432|P1|Overall Study|Withdrawal by Subject|41
51801|NCT01345318|208432|P1|Overall Study|Protocol Violation|1
51802|NCT01345318|208432|P1|Overall Study|Lost to Follow-up|2
51803|NCT01345318|208432|P1|Overall Study|Lack of Efficacy|17
51804|NCT01345318|208432|P1|Overall Study|Adverse Event|16
51805|NCT01345292|208440|P3|Overall Study|Withdrawal by Subject|1
51806|NCT01345292|208441|P2|Overall Study|Withdrawal by Subject|0
51807|NCT01345292|208442|P1|Overall Study|Withdrawal by Subject|2
51808|NCT01345253|208473|P2|Overall Study|Withdrawal by Subject|19
51809|NCT01345253|208474|P1|Overall Study|Withdrawal by Subject|9
51810|NCT01345253|208473|P2|Overall Study|Physician Decision|12
51811|NCT01345253|208474|P1|Overall Study|Physician Decision|4
51812|NCT01345253|208473|P2|Overall Study|Lost to Follow-up|8
51813|NCT01345253|208474|P1|Overall Study|Lost to Follow-up|3
51814|NCT01345253|208473|P2|Overall Study|Met Protocol Defined Stopping Criteria|1
51815|NCT01345253|208474|P1|Overall Study|Met Protocol Defined Stopping Criteria|6
51816|NCT01345253|208473|P2|Overall Study|Protocol Violation|5
51817|NCT01345253|208474|P1|Overall Study|Protocol Violation|1
51818|NCT01345253|208473|P2|Overall Study|Lack of Efficacy|7
51819|NCT01345253|208474|P1|Overall Study|Lack of Efficacy|11
51820|NCT01345253|208473|P2|Overall Study|Adverse Event|27
51821|NCT01345253|208474|P1|Overall Study|Adverse Event|22
51822|NCT01345240|208493|P5|Overall Study|Serious Adverse Event|1
51823|NCT01345240|208494|P4|Overall Study|Serious Adverse Event|2
51824|NCT01345240|208495|P3|Overall Study|Serious Adverse Event|2
51825|NCT01345240|208496|P2|Overall Study|Serious Adverse Event|2
51826|NCT01345240|208497|P1|Overall Study|Serious Adverse Event|1
51827|NCT01345240|208493|P5|Overall Study|Lost to Follow-up|6
51828|NCT01345240|208494|P4|Overall Study|Lost to Follow-up|8
51829|NCT01345240|208495|P3|Overall Study|Lost to Follow-up|8
51830|NCT01345240|208496|P2|Overall Study|Lost to Follow-up|12
51831|NCT01345240|208497|P1|Overall Study|Lost to Follow-up|1
51832|NCT01345162|208592|P2|Overall Study|Protocol Violation|4
51833|NCT01345162|208593|P1|Overall Study|Protocol Violation|2
51834|NCT01345123|208602|P3|Overall Study|participants no longer with health plan|88
51835|NCT01345123|208603|P2|Overall Study|participants no longer with health plan|85
51836|NCT01345123|208604|P1|Overall Study|participants no longer with health plan|79
51837|NCT01345058|208626|P2|Overall Study|Participant No-Show at Multiple Visits|0
51838|NCT01345058|208627|P1|Overall Study|Participant No-Show at Multiple Visits|1
51839|NCT01345058|208626|P2|Overall Study|Participant Stopped Taking Study Drug|0
51840|NCT01345058|208627|P1|Overall Study|Participant Stopped Taking Study Drug|1
51841|NCT01345058|208626|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
51842|NCT01345058|208627|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
51843|NCT01345058|208626|P2|Overall Study|Participant Reported Increase in Events|0
51844|NCT01345058|208627|P1|Overall Study|Participant Reported Increase in Events|1
51845|NCT01345058|208626|P2|Overall Study|Withdrawal by Subject|0
51846|NCT01345058|208627|P1|Overall Study|Withdrawal by Subject|1
51847|NCT01344876|208641|P5|Overall Study|Definite progression of primary disease|0
51848|NCT01344876|208642|P4|Overall Study|Definite progression of primary disease|3
51849|NCT01344876|208643|P3|Overall Study|Definite progression of primary disease|0
51850|NCT01344876|208644|P2|Overall Study|Definite progression of primary disease|0
51851|NCT01344876|208645|P1|Overall Study|Definite progression of primary disease|1
51852|NCT01344876|208641|P5|Overall Study|Withdrawal by Subject|0
51853|NCT01344876|208642|P4|Overall Study|Withdrawal by Subject|0
51854|NCT01344876|208643|P3|Overall Study|Withdrawal by Subject|1
51855|NCT01344876|208644|P2|Overall Study|Withdrawal by Subject|0
51856|NCT01344876|208645|P1|Overall Study|Withdrawal by Subject|0
51857|NCT01344876|208641|P5|Overall Study|Adverse Event|1
51858|NCT01344876|208642|P4|Overall Study|Adverse Event|0
51859|NCT01344876|208643|P3|Overall Study|Adverse Event|0
51860|NCT01344876|208644|P2|Overall Study|Adverse Event|0
51861|NCT01344876|208645|P1|Overall Study|Adverse Event|0
51862|NCT01344824|208659|P1|Overall Study|Progression|15
51863|NCT01344824|208659|P1|Overall Study|Other complicating disease|1
51864|NCT01344824|208659|P1|Overall Study|Withdrawal by Subject|6
51865|NCT01344824|208659|P1|Overall Study|Adverse Event|15
51866|NCT01344759|208667|P2|Overall Study|Patients failed to reach sedation level|2
51867|NCT01344759|208668|P1|Overall Study|Patients failed to reach sedation level|0
51868|NCT01344629|208700|P2|Crossover Period 2|Withdrawal by Subject|1
51869|NCT01344629|208701|P1|Crossover Period 2|Withdrawal by Subject|0
51870|NCT01344538|208730|P2|Overall Study|Lost to Follow-up|0
51871|NCT01344538|208731|P1|Overall Study|Lost to Follow-up|1
51872|NCT01344538|208730|P2|Overall Study|Adverse Event|1
51873|NCT01344538|208731|P1|Overall Study|Adverse Event|1
51874|NCT01344460|208737|P1|Overall Study|Lost to Follow-up|2
51875|NCT01344460|208737|P1|Overall Study|Withdrawal by Subject|1
51876|NCT01344447|208782|P1|Overall Study|Error of power injector|1
51877|NCT01344447|208782|P1|Overall Study|Bolus tracking failed|1
51878|NCT01344447|208782|P1|Overall Study|MRA unsuccessful|1
51879|NCT01344447|208782|P1|Overall Study|Physician Decision|1
51880|NCT01344447|208782|P1|Overall Study|The contrast was not seen|1
51881|NCT01344447|208782|P1|Overall Study|Withdrawal by Subject|1
51882|NCT01344447|208782|P1|Overall Study|Protocol Violation|1
51883|NCT01344447|208782|P1|Overall Study|Adverse Event|1
51884|NCT01344369|208826|P2|Second Intervention|Emesis within 2 x Tmax|1
51885|NCT01344369|208827|P1|Second Intervention|Emesis within 2 x Tmax|0
51886|NCT01344369|208826|P2|Washout of 28 Days|Physician Decision|1
51887|NCT01344369|208827|P1|Washout of 28 Days|Physician Decision|0
51888|NCT01344369|208826|P2|Washout of 28 Days|Withdrawal by Subject|0
51889|NCT01344369|208827|P1|Washout of 28 Days|Withdrawal by Subject|1
51890|NCT01344161|208845|P2|Overall Study|Protocol Violation|1
51891|NCT01344161|208846|P1|Overall Study|Protocol Violation|1
51892|NCT01344161|208845|P2|Overall Study|Pregnancy|1
51893|NCT01344161|208846|P1|Overall Study|Pregnancy|0
51894|NCT01344161|208845|P2|Overall Study|Lost to Follow-up|1
51895|NCT01344161|208846|P1|Overall Study|Lost to Follow-up|4
51896|NCT01344057|208858|P1|Overall Study|Premature Withdrawal|1
51897|NCT01343901|208865|P1|Overall Study|Participant decision|1
51898|NCT01343901|208865|P1|Overall Study|Management by another medical team|11
51899|NCT01343901|208865|P1|Overall Study|Lost to Follow-up|12
51900|NCT01343901|208865|P1|Overall Study|Physician Decision|4
51901|NCT01343901|208865|P1|Overall Study|Death|85
51902|NCT01343888|208889|P3|Overall Study|other than stated above|1
51903|NCT01343888|208890|P2|Overall Study|other than stated above|0
51904|NCT01343888|208891|P1|Overall Study|other than stated above|0
51905|NCT01343888|208889|P3|Overall Study|Withdrawal by Subject|2
51906|NCT01343888|208890|P2|Overall Study|Withdrawal by Subject|4
51907|NCT01343888|208891|P1|Overall Study|Withdrawal by Subject|4
51908|NCT01343888|208889|P3|Overall Study|Protocol Violation|0
51909|NCT01343888|208890|P2|Overall Study|Protocol Violation|2
51910|NCT01343888|208891|P1|Overall Study|Protocol Violation|0
51911|NCT01343888|208889|P3|Overall Study|Lost to Follow-up|1
51912|NCT01343888|208890|P2|Overall Study|Lost to Follow-up|2
51913|NCT01343888|208891|P1|Overall Study|Lost to Follow-up|0
51914|NCT01343888|208889|P3|Overall Study|Lack of Efficacy|13
51915|NCT01343888|208890|P2|Overall Study|Lack of Efficacy|9
51916|NCT01343888|208891|P1|Overall Study|Lack of Efficacy|9
51917|NCT01343888|208889|P3|Overall Study|Adverse Event|5
51918|NCT01343888|208890|P2|Overall Study|Adverse Event|22
51919|NCT01343888|208891|P1|Overall Study|Adverse Event|12
51920|NCT01343823|208933|P4|Overall Study|Withdrawal by Subject|0
51921|NCT01343823|208934|P3|Overall Study|Withdrawal by Subject|0
51922|NCT01343823|208935|P2|Overall Study|Withdrawal by Subject|0
51923|NCT01343823|208936|P1|Overall Study|Withdrawal by Subject|1
51924|NCT01343823|208933|P4|Overall Study|Study Terminated|1
51925|NCT01343823|208934|P3|Overall Study|Study Terminated|0
51926|NCT01343823|208935|P2|Overall Study|Study Terminated|0
51927|NCT01343823|208936|P1|Overall Study|Study Terminated|1
51928|NCT01343368|208970|P2|Overall Study|Lost to Follow-up|0
51929|NCT01343368|208971|P1|Overall Study|Lost to Follow-up|1
51930|NCT01343368|208970|P2|Overall Study|Death|0
51931|NCT01343368|208971|P1|Overall Study|Death|1
51932|NCT01343277|209007|P2|Overall Study|Subsequent anticancer therapy|0
51933|NCT01343277|209008|P1|Overall Study|Subsequent anticancer therapy|1
51934|NCT01343277|209007|P2|Overall Study|Treatment ongoing|2
51935|NCT01343277|209008|P1|Overall Study|Treatment ongoing|8
51936|NCT01343277|209007|P2|Overall Study|Randomized not treated|21
51937|NCT01343277|209008|P1|Overall Study|Randomized not treated|6
51938|NCT01343277|209007|P2|Overall Study|Disease progression|138
51939|NCT01343277|209008|P1|Overall Study|Disease progression|270
51940|NCT01343277|209007|P2|Overall Study|Adverse Event|13
51941|NCT01343277|209008|P1|Overall Study|Adverse Event|67
51942|NCT01343277|209007|P2|Overall Study|Death|1
51943|NCT01343277|209008|P1|Overall Study|Death|10
51944|NCT01343277|209007|P2|Overall Study|Physician Decision|2
51945|NCT01343277|209008|P1|Overall Study|Physician Decision|1
51946|NCT01343277|209007|P2|Overall Study|Withdrawal by Subject|13
51947|NCT01343277|209008|P1|Overall Study|Withdrawal by Subject|18
51948|NCT01343277|209007|P2|Overall Study|Unspecified|3
51949|NCT01343277|209008|P1|Overall Study|Unspecified|3
51950|NCT01343082|209041|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
51951|NCT01343082|209042|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
51952|NCT01343082|209043|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
51953|NCT01343082|209041|P3|Treatment Period , Switched to DE-111|Physician Decision|2
51954|NCT01343082|209042|P2|Treatment Period , Switched to DE-111|Physician Decision|2
51955|NCT01343082|209043|P1|Treatment Period , Switched to DE-111|Physician Decision|0
51956|NCT01343082|209041|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
51957|NCT01343082|209042|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
51958|NCT01343082|209043|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
51959|NCT01343082|209041|P3|Treatment Period , Switched to DE-111|Adverse Event|3
51960|NCT01343082|209042|P2|Treatment Period , Switched to DE-111|Adverse Event|4
51961|NCT01343082|209043|P1|Treatment Period , Switched to DE-111|Adverse Event|1
51962|NCT01343082|209041|P3|The run-in Period|Not meeting criteria|5
51963|NCT01343082|209042|P2|The run-in Period|Not meeting criteria|4
51964|NCT01343082|209043|P1|The run-in Period|Not meeting criteria|3
51965|NCT01343056|209051|P4|Overall Study|Lost to Follow-up|9
51966|NCT01343056|209052|P3|Overall Study|Lost to Follow-up|3
51967|NCT01343056|209053|P2|Overall Study|Lost to Follow-up|5
51968|NCT01343056|209054|P1|Overall Study|Lost to Follow-up|7
51969|NCT01342965|209122|P2|Overall Study|Withdrawal by Subject|9
51970|NCT01342965|209123|P1|Overall Study|Withdrawal by Subject|2
51971|NCT01342965|209122|P2|Overall Study|Other Reasons- Unspecified|38
51972|NCT01342965|209123|P1|Overall Study|Other Reasons- Unspecified|44
51973|NCT01342965|209122|P2|Overall Study|Lost to Follow-up|3
51974|NCT01342965|209123|P1|Overall Study|Lost to Follow-up|5
51975|NCT01342965|209122|P2|Overall Study|Death|57
51976|NCT01342965|209123|P1|Overall Study|Death|58
51977|NCT01342926|209141|P4|Overall Study|Withdrawal by Subject|5
51978|NCT01342926|209142|P3|Overall Study|Withdrawal by Subject|3
51979|NCT01342926|209143|P2|Overall Study|Withdrawal by Subject|4
51980|NCT01342926|209144|P1|Overall Study|Withdrawal by Subject|2
51981|NCT01342926|209141|P4|Overall Study|Investigator Discretion|0
51982|NCT01342926|209142|P3|Overall Study|Investigator Discretion|0
51983|NCT01342926|209143|P2|Overall Study|Investigator Discretion|2
51984|NCT01342926|209144|P1|Overall Study|Investigator Discretion|2
51985|NCT01342926|209141|P4|Overall Study|Lost to Follow-up|0
51986|NCT01342926|209142|P3|Overall Study|Lost to Follow-up|1
51987|NCT01342926|209143|P2|Overall Study|Lost to Follow-up|1
51988|NCT01342926|209144|P1|Overall Study|Lost to Follow-up|0
51989|NCT01342926|209141|P4|Overall Study|Adverse Event|7
51990|NCT01342926|209142|P3|Overall Study|Adverse Event|10
51991|NCT01342926|209143|P2|Overall Study|Adverse Event|8
51992|NCT01342926|209144|P1|Overall Study|Adverse Event|5
51993|NCT01342913|209224|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
51994|NCT01342913|209225|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
51995|NCT01342913|209226|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
51996|NCT01342913|209224|P3|Double-Blind Treatment Period|Physician Decision|0
51997|NCT01342913|209225|P2|Double-Blind Treatment Period|Physician Decision|2
51998|NCT01342913|209226|P1|Double-Blind Treatment Period|Physician Decision|0
51999|NCT01342913|209224|P3|Double-Blind Treatment Period|Lost to Follow-up|3
52000|NCT01342913|209225|P2|Double-Blind Treatment Period|Lost to Follow-up|1
52001|NCT01342913|209226|P1|Double-Blind Treatment Period|Lost to Follow-up|0
52002|NCT01342913|209224|P3|Double-Blind Treatment Period|Protocol Violation|9
52003|NCT01342913|209225|P2|Double-Blind Treatment Period|Protocol Violation|6
52004|NCT01342913|209226|P1|Double-Blind Treatment Period|Protocol Violation|0
52005|NCT01342913|209224|P3|Double-Blind Treatment Period|Lack of Efficacy|3
52006|NCT01342913|209225|P2|Double-Blind Treatment Period|Lack of Efficacy|2
52007|NCT01342913|209226|P1|Double-Blind Treatment Period|Lack of Efficacy|0
52008|NCT01342913|209224|P3|Double-Blind Treatment Period|Adverse Event|6
52009|NCT01342913|209225|P2|Double-Blind Treatment Period|Adverse Event|3
52010|NCT01342913|209226|P1|Double-Blind Treatment Period|Adverse Event|0
52011|NCT01342913|209224|P3|2-week Run-in Period|Continuation Criteria Not Met|0
52012|NCT01342913|209225|P2|2-week Run-in Period|Continuation Criteria Not Met|0
52013|NCT01342913|209226|P1|2-week Run-in Period|Continuation Criteria Not Met|88
52014|NCT01342913|209224|P3|2-week Run-in Period|Protocol Violation|0
52015|NCT01342913|209225|P2|2-week Run-in Period|Protocol Violation|0
52016|NCT01342913|209226|P1|2-week Run-in Period|Protocol Violation|5
52017|NCT01342913|209224|P3|2-week Run-in Period|Adverse Event|0
52018|NCT01342913|209225|P2|2-week Run-in Period|Adverse Event|0
52019|NCT01342913|209226|P1|2-week Run-in Period|Adverse Event|2
52020|NCT01342913|209224|P3|2-week Run-in Period|Withdrawal by Subject|0
52021|NCT01342913|209225|P2|2-week Run-in Period|Withdrawal by Subject|0
52022|NCT01342913|209226|P1|2-week Run-in Period|Withdrawal by Subject|7
52023|NCT01342913|209224|P3|2-week Run-in Period|Physician Decision|0
52024|NCT01342913|209225|P2|2-week Run-in Period|Physician Decision|0
52025|NCT01342913|209226|P1|2-week Run-in Period|Physician Decision|6
52026|NCT01342913|209224|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
52027|NCT01342913|209225|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
52028|NCT01342913|209226|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
52029|NCT01342887|209236|P1|Overall Study|Death|2
52030|NCT01342640|209270|P1|Overall Study|Unspecified|1
52031|NCT01342640|209270|P1|Overall Study|Lost to Follow-up|21
52032|NCT01342640|209270|P1|Overall Study|Protocol Violation|16
52033|NCT01342640|209270|P1|Overall Study|Adverse Event|3
52034|NCT01342510|209365|P4|Overall Study|Protocol Violation|11
52035|NCT01342510|209366|P3|Overall Study|Protocol Violation|13
52036|NCT01342510|209367|P2|Overall Study|Protocol Violation|6
52037|NCT01342510|209368|P1|Overall Study|Protocol Violation|12
52038|NCT01342484|209381|P3|Overall Study|Withdrawal by Subject|0
52039|NCT01342484|209382|P2|Overall Study|Withdrawal by Subject|0
52040|NCT01342484|209383|P1|Overall Study|Withdrawal by Subject|1
52041|NCT01342484|209381|P3|Overall Study|Protocol Violation|1
52042|NCT01342484|209382|P2|Overall Study|Protocol Violation|0
52043|NCT01342484|209383|P1|Overall Study|Protocol Violation|0
52044|NCT01342484|209381|P3|Overall Study|Other Reasons|0
52045|NCT01342484|209382|P2|Overall Study|Other Reasons|0
52046|NCT01342484|209383|P1|Overall Study|Other Reasons|1
52047|NCT01342445|209439|P2|Overall Study|Experienced side effects|2
52048|NCT01342445|209440|P1|Overall Study|Experienced side effects|0
52049|NCT01342341|209456|P2|Overall Study|Lost to Follow-up|4
52050|NCT01342341|209457|P1|Overall Study|Lost to Follow-up|4
52051|NCT01342094|209478|P2|Overall Study|Withdrawal by Subject|2
52052|NCT01342094|209479|P1|Overall Study|Withdrawal by Subject|0
52053|NCT01342094|209478|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
52054|NCT01342094|209479|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
52055|NCT01342094|209478|P2|Overall Study|Adverse Event|0
52056|NCT01342094|209479|P1|Overall Study|Adverse Event|5
52057|NCT01342081|209488|P3|Overall Study|Withdrawal by Subject|0
52058|NCT01342081|209489|P2|Overall Study|Withdrawal by Subject|1
52059|NCT01342081|209490|P1|Overall Study|Withdrawal by Subject|1
52060|NCT01342081|209488|P3|Overall Study|Physician Decision|0
52061|NCT01342081|209489|P2|Overall Study|Physician Decision|1
52062|NCT01342081|209490|P1|Overall Study|Physician Decision|0
52063|NCT01342081|209488|P3|Overall Study|Adverse Event|0
52064|NCT01342081|209489|P2|Overall Study|Adverse Event|0
52065|NCT01342081|209490|P1|Overall Study|Adverse Event|1
52066|NCT01342081|209488|P3|Overall Study|Did not receive allocated intervention|1
52067|NCT01342081|209489|P2|Overall Study|Did not receive allocated intervention|0
52068|NCT01342081|209490|P1|Overall Study|Did not receive allocated intervention|0
52069|NCT01341990|209500|P2|Overall Study|Withdrawal by Subject|0
52070|NCT01341990|209501|P1|Overall Study|Withdrawal by Subject|2
52071|NCT01341990|209500|P2|Overall Study|Torn Study Lens|0
52072|NCT01341990|209501|P1|Overall Study|Torn Study Lens|1
52073|NCT01341990|209500|P2|Overall Study|Adverse Event|1
52074|NCT01341990|209501|P1|Overall Study|Adverse Event|0
52075|NCT01341782|209525|P2|Overall Study|Other|0
52076|NCT01341782|209526|P1|Overall Study|Other|5
52077|NCT01341782|209525|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
52078|NCT01341782|209526|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
52079|NCT01341782|209525|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
52080|NCT01341782|209526|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
52081|NCT01341782|209525|P2|Overall Study|Missed 3 consecutive doses|4
52082|NCT01341782|209526|P1|Overall Study|Missed 3 consecutive doses|0
52083|NCT01341782|209525|P2|Overall Study|Withdrawal by Subject|5
52084|NCT01341782|209526|P1|Overall Study|Withdrawal by Subject|6
52085|NCT01341782|209525|P2|Overall Study|Adverse Event|1
52086|NCT01341782|209526|P1|Overall Study|Adverse Event|1
52087|NCT01340937|209593|P4|Period 3: Toddler Vaccinations|Technical problem|0
52088|NCT01340937|209594|P3|Period 3: Toddler Vaccinations|Technical problem|1
52089|NCT01340937|209595|P2|Period 3: Toddler Vaccinations|Technical problem|1
52090|NCT01340937|209596|P1|Period 3: Toddler Vaccinations|Technical problem|1
52091|NCT01340937|209593|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
52092|NCT01340937|209594|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
52093|NCT01340937|209595|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
52094|NCT01340937|209596|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
52095|NCT01340937|209593|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
52096|NCT01340937|209594|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
52097|NCT01340937|209595|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
52098|NCT01340937|209596|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
52099|NCT01340937|209593|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
52100|NCT01340937|209594|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
52101|NCT01340937|209595|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
52102|NCT01340937|209596|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
52103|NCT01340937|209593|P4|Period 2: Interim Period|Technical problems|3
52104|NCT01340937|209594|P3|Period 2: Interim Period|Technical problems|6
52105|NCT01340937|209595|P2|Period 2: Interim Period|Technical problems|4
52106|NCT01340937|209596|P1|Period 2: Interim Period|Technical problems|4
52107|NCT01340937|209593|P4|Period 2: Interim Period|Protocol Violation|3
52108|NCT01340937|209594|P3|Period 2: Interim Period|Protocol Violation|6
52109|NCT01340937|209595|P2|Period 2: Interim Period|Protocol Violation|3
52110|NCT01340937|209596|P1|Period 2: Interim Period|Protocol Violation|5
52111|NCT01340937|209593|P4|Period 2: Interim Period|Physician Decision|0
52112|NCT01340937|209594|P3|Period 2: Interim Period|Physician Decision|1
52113|NCT01340937|209595|P2|Period 2: Interim Period|Physician Decision|1
52114|NCT01340937|209596|P1|Period 2: Interim Period|Physician Decision|0
52115|NCT01340937|209593|P4|Period 2: Interim Period|Lost to Follow-up|23
52116|NCT01340937|209594|P3|Period 2: Interim Period|Lost to Follow-up|53
52117|NCT01340937|209595|P2|Period 2: Interim Period|Lost to Follow-up|48
52118|NCT01340937|209596|P1|Period 2: Interim Period|Lost to Follow-up|29
52119|NCT01340937|209593|P4|Period 2: Interim Period|Adverse Event|0
52120|NCT01340937|209594|P3|Period 2: Interim Period|Adverse Event|1
52121|NCT01340937|209595|P2|Period 2: Interim Period|Adverse Event|0
52122|NCT01340937|209596|P1|Period 2: Interim Period|Adverse Event|1
52123|NCT01340937|209593|P4|Period 2: Interim Period|Withdrawal by Subject|12
52124|NCT01340937|209594|P3|Period 2: Interim Period|Withdrawal by Subject|17
52125|NCT01340937|209595|P2|Period 2: Interim Period|Withdrawal by Subject|23
52126|NCT01340937|209596|P1|Period 2: Interim Period|Withdrawal by Subject|28
52127|NCT01340937|209593|P4|Period 1: Infant Series|Randomized but not vaccinated|1
52128|NCT01340937|209594|P3|Period 1: Infant Series|Randomized but not vaccinated|2
52129|NCT01340937|209595|P2|Period 1: Infant Series|Randomized but not vaccinated|5
52130|NCT01340937|209596|P1|Period 1: Infant Series|Randomized but not vaccinated|0
52131|NCT01340937|209593|P4|Period 1: Infant Series|Withdrawal by Subject|15
52132|NCT01340937|209594|P3|Period 1: Infant Series|Withdrawal by Subject|30
52133|NCT01340937|209595|P2|Period 1: Infant Series|Withdrawal by Subject|32
52134|NCT01340937|209596|P1|Period 1: Infant Series|Withdrawal by Subject|33
52135|NCT01340937|209593|P4|Period 1: Infant Series|Protocol Violation|3
52136|NCT01340937|209594|P3|Period 1: Infant Series|Protocol Violation|4
52137|NCT01340937|209595|P2|Period 1: Infant Series|Protocol Violation|4
52138|NCT01340937|209596|P1|Period 1: Infant Series|Protocol Violation|1
52139|NCT01340937|209593|P4|Period 1: Infant Series|Physician Decision|0
52140|NCT01340937|209594|P3|Period 1: Infant Series|Physician Decision|1
52141|NCT01340937|209595|P2|Period 1: Infant Series|Physician Decision|3
52142|NCT01340937|209596|P1|Period 1: Infant Series|Physician Decision|2
52143|NCT01340937|209593|P4|Period 1: Infant Series|Lost to Follow-up|13
52144|NCT01340937|209594|P3|Period 1: Infant Series|Lost to Follow-up|12
52145|NCT01340937|209595|P2|Period 1: Infant Series|Lost to Follow-up|14
52146|NCT01340937|209596|P1|Period 1: Infant Series|Lost to Follow-up|20
52147|NCT01340937|209593|P4|Period 1: Infant Series|Death|0
52148|NCT01340937|209594|P3|Period 1: Infant Series|Death|2
52149|NCT01340937|209595|P2|Period 1: Infant Series|Death|0
52150|NCT01340937|209596|P1|Period 1: Infant Series|Death|2
52151|NCT01340937|209593|P4|Period 1: Infant Series|Adverse Event|0
52152|NCT01340937|209594|P3|Period 1: Infant Series|Adverse Event|4
52153|NCT01340937|209595|P2|Period 1: Infant Series|Adverse Event|1
52154|NCT01340937|209596|P1|Period 1: Infant Series|Adverse Event|0
52155|NCT01340937|209593|P4|Period 1: Infant Series|Other protocol criterion not met|0
52156|NCT01340937|209594|P3|Period 1: Infant Series|Other protocol criterion not met|1
52157|NCT01340937|209595|P2|Period 1: Infant Series|Other protocol criterion not met|1
52158|NCT01340937|209596|P1|Period 1: Infant Series|Other protocol criterion not met|0
52159|NCT01340794|209755|P2|Overall Study|Withdrawal by Subject|1
52160|NCT01340794|209756|P1|Overall Study|Withdrawal by Subject|0
52161|NCT01340768|209772|P2|Overall Study|Other|0
52162|NCT01340768|209773|P1|Overall Study|Other|2
52163|NCT01340768|209772|P2|Overall Study|Withdrawal by Subject|1
52164|NCT01340768|209773|P1|Overall Study|Withdrawal by Subject|5
52165|NCT01340768|209772|P2|Overall Study|Lost to Follow-up|4
52166|NCT01340768|209773|P1|Overall Study|Lost to Follow-up|10
52167|NCT01340664|209784|P3|Overall Study|Not specified|2
52168|NCT01340664|209785|P2|Overall Study|Not specified|2
52169|NCT01340664|209786|P1|Overall Study|Not specified|1
52170|NCT01340664|209784|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
52171|NCT01340664|209785|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
52172|NCT01340664|209786|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
52173|NCT01340664|209784|P3|Overall Study|Glycemic withdrawal criteria|0
52174|NCT01340664|209785|P2|Overall Study|Glycemic withdrawal criteria|0
52175|NCT01340664|209786|P1|Overall Study|Glycemic withdrawal criteria|2
52176|NCT01340664|209784|P3|Overall Study|Withdrawal by Subject|0
52177|NCT01340664|209785|P2|Overall Study|Withdrawal by Subject|4
52178|NCT01340664|209786|P1|Overall Study|Withdrawal by Subject|2
52179|NCT01340664|209784|P3|Overall Study|Lost to Follow-up|2
52180|NCT01340664|209785|P2|Overall Study|Lost to Follow-up|0
52181|NCT01340664|209786|P1|Overall Study|Lost to Follow-up|2
52182|NCT01340664|209784|P3|Overall Study|Adverse Event|7
52183|NCT01340664|209785|P2|Overall Study|Adverse Event|1
52184|NCT01340664|209786|P1|Overall Study|Adverse Event|0
52185|NCT01340651|209803|P1|Overall Study|Commercial Supply per Sponsor|12
52186|NCT01340651|209803|P1|Overall Study|Consent Withdrawn|2
52187|NCT01340651|209803|P1|Overall Study|Adverse Event|3
52188|NCT01340625|209819|P2|Washout Period of 28 Days|Withdrawal by Subject|0
52189|NCT01340625|209820|P1|Washout Period of 28 Days|Withdrawal by Subject|1
52190|NCT01340625|209819|P2|First Intervention|Adverse Event|0
52191|NCT01340625|209820|P1|First Intervention|Adverse Event|1
52192|NCT01340209|209928|P3|Overall Study|Other reason not defined above|4
52193|NCT01340209|209929|P2|Overall Study|Other reason not defined above|5
52194|NCT01340209|209930|P1|Overall Study|Other reason not defined above|3
52195|NCT01340209|209928|P3|Overall Study|Withdrawal by Subject|1
52196|NCT01340209|209929|P2|Overall Study|Withdrawal by Subject|0
52197|NCT01340209|209930|P1|Overall Study|Withdrawal by Subject|0
52198|NCT01340209|209928|P3|Overall Study|Protocol Violation|1
52199|NCT01340209|209929|P2|Overall Study|Protocol Violation|2
52200|NCT01340209|209930|P1|Overall Study|Protocol Violation|1
52201|NCT01340209|209928|P3|Overall Study|Adverse Event|2
52202|NCT01340209|209929|P2|Overall Study|Adverse Event|1
52203|NCT01340209|209930|P1|Overall Study|Adverse Event|1
52204|NCT01340196|209965|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
52205|NCT01340066|209996|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
52206|NCT01340066|209997|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
52207|NCT01340066|209998|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
52208|NCT01340066|209996|P3|5 Week Double Blind Randomization Period|Physician Decision|0
52209|NCT01340066|209997|P2|5 Week Double Blind Randomization Period|Physician Decision|1
52210|NCT01340066|209998|P1|5 Week Double Blind Randomization Period|Physician Decision|0
52211|NCT01340066|209996|P3|5 Week Double Blind Randomization Period|Adverse Event|2
52212|NCT01340066|209997|P2|5 Week Double Blind Randomization Period|Adverse Event|2
52213|NCT01340066|209998|P1|5 Week Double Blind Randomization Period|Adverse Event|0
52214|NCT01340066|209996|P3|Placebo Run in Period|Screen Failures|0
52215|NCT01340066|209997|P2|Placebo Run in Period|Screen Failures|0
52216|NCT01340066|209998|P1|Placebo Run in Period|Screen Failures|27
52217|NCT01340027|210017|P12|Overall Study|Miscellaneous|0
52218|NCT01340027|210018|P11|Overall Study|Miscellaneous|1
52219|NCT01340027|210019|P10|Overall Study|Miscellaneous|0
52220|NCT01340027|210020|P9|Overall Study|Miscellaneous|0
52221|NCT01340027|210021|P8|Overall Study|Miscellaneous|0
52222|NCT01340027|210022|P7|Overall Study|Miscellaneous|0
52223|NCT01340027|210023|P6|Overall Study|Miscellaneous|0
52224|NCT01340027|210024|P5|Overall Study|Miscellaneous|0
52225|NCT01340027|210025|P4|Overall Study|Miscellaneous|1
52226|NCT01340027|210026|P3|Overall Study|Miscellaneous|0
52227|NCT01340027|210027|P2|Overall Study|Miscellaneous|0
52228|NCT01340027|210028|P1|Overall Study|Miscellaneous|0
52229|NCT01340027|210017|P12|Overall Study|Withdrawal by Subject|1
52230|NCT01340027|210018|P11|Overall Study|Withdrawal by Subject|0
52231|NCT01340027|210019|P10|Overall Study|Withdrawal by Subject|2
52232|NCT01340027|210020|P9|Overall Study|Withdrawal by Subject|1
52233|NCT01340027|210021|P8|Overall Study|Withdrawal by Subject|4
52234|NCT01340027|210022|P7|Overall Study|Withdrawal by Subject|3
52235|NCT01340027|210023|P6|Overall Study|Withdrawal by Subject|2
52236|NCT01340027|210024|P5|Overall Study|Withdrawal by Subject|3
52237|NCT01340027|210025|P4|Overall Study|Withdrawal by Subject|3
52238|NCT01340027|210026|P3|Overall Study|Withdrawal by Subject|1
52239|NCT01340027|210027|P2|Overall Study|Withdrawal by Subject|3
52240|NCT01340027|210028|P1|Overall Study|Withdrawal by Subject|4
52241|NCT01340027|210017|P12|Overall Study|Protocol Violation|0
52242|NCT01340027|210018|P11|Overall Study|Protocol Violation|0
52243|NCT01340027|210019|P10|Overall Study|Protocol Violation|2
52244|NCT01340027|210020|P9|Overall Study|Protocol Violation|2
52245|NCT01340027|210021|P8|Overall Study|Protocol Violation|1
52246|NCT01340027|210022|P7|Overall Study|Protocol Violation|0
52247|NCT01340027|210023|P6|Overall Study|Protocol Violation|0
52248|NCT01340027|210024|P5|Overall Study|Protocol Violation|6
52249|NCT01340027|210025|P4|Overall Study|Protocol Violation|0
52250|NCT01340027|210026|P3|Overall Study|Protocol Violation|0
52251|NCT01340027|210027|P2|Overall Study|Protocol Violation|2
52252|NCT01340027|210028|P1|Overall Study|Protocol Violation|1
52253|NCT01340027|210017|P12|Overall Study|Lost to Follow-up|0
52254|NCT01340027|210018|P11|Overall Study|Lost to Follow-up|0
52255|NCT01340027|210019|P10|Overall Study|Lost to Follow-up|1
52256|NCT01340027|210020|P9|Overall Study|Lost to Follow-up|0
52257|NCT01340027|210021|P8|Overall Study|Lost to Follow-up|0
52258|NCT01340027|210022|P7|Overall Study|Lost to Follow-up|1
52259|NCT01340027|210023|P6|Overall Study|Lost to Follow-up|0
52260|NCT01340027|210024|P5|Overall Study|Lost to Follow-up|0
52261|NCT01340027|210025|P4|Overall Study|Lost to Follow-up|0
52262|NCT01340027|210026|P3|Overall Study|Lost to Follow-up|0
52263|NCT01340027|210027|P2|Overall Study|Lost to Follow-up|1
52264|NCT01340027|210028|P1|Overall Study|Lost to Follow-up|0
52265|NCT01340027|210017|P12|Overall Study|Lack of Efficacy|0
52266|NCT01340027|210018|P11|Overall Study|Lack of Efficacy|0
52267|NCT01340027|210019|P10|Overall Study|Lack of Efficacy|0
52268|NCT01340027|210020|P9|Overall Study|Lack of Efficacy|1
52269|NCT01340027|210021|P8|Overall Study|Lack of Efficacy|1
52270|NCT01340027|210022|P7|Overall Study|Lack of Efficacy|1
52271|NCT01340027|210023|P6|Overall Study|Lack of Efficacy|0
52272|NCT01340027|210024|P5|Overall Study|Lack of Efficacy|0
52273|NCT01340027|210025|P4|Overall Study|Lack of Efficacy|0
52274|NCT01340027|210026|P3|Overall Study|Lack of Efficacy|0
52275|NCT01340027|210027|P2|Overall Study|Lack of Efficacy|0
52276|NCT01340027|210028|P1|Overall Study|Lack of Efficacy|0
52277|NCT01340027|210017|P12|Overall Study|Adverse Event|3
52278|NCT01340027|210018|P11|Overall Study|Adverse Event|1
52279|NCT01340027|210019|P10|Overall Study|Adverse Event|1
52280|NCT01340027|210020|P9|Overall Study|Adverse Event|4
52281|NCT01340027|210021|P8|Overall Study|Adverse Event|1
52282|NCT01340027|210022|P7|Overall Study|Adverse Event|2
52283|NCT01340027|210023|P6|Overall Study|Adverse Event|2
52284|NCT01340027|210024|P5|Overall Study|Adverse Event|1
52285|NCT01340027|210025|P4|Overall Study|Adverse Event|0
52286|NCT01340027|210026|P3|Overall Study|Adverse Event|2
52287|NCT01340027|210027|P2|Overall Study|Adverse Event|1
52288|NCT01340027|210028|P1|Overall Study|Adverse Event|0
52289|NCT01340027|210017|P12|Overall Study|Randomized but Never Received Study Drug|0
52290|NCT01340027|210018|P11|Overall Study|Randomized but Never Received Study Drug|0
52291|NCT01340027|210019|P10|Overall Study|Randomized but Never Received Study Drug|0
52292|NCT01340027|210020|P9|Overall Study|Randomized but Never Received Study Drug|0
52293|NCT01340027|210021|P8|Overall Study|Randomized but Never Received Study Drug|0
52294|NCT01340027|210022|P7|Overall Study|Randomized but Never Received Study Drug|0
52295|NCT01340027|210023|P6|Overall Study|Randomized but Never Received Study Drug|0
52296|NCT01340027|210024|P5|Overall Study|Randomized but Never Received Study Drug|0
52297|NCT01340027|210025|P4|Overall Study|Randomized but Never Received Study Drug|0
52298|NCT01340027|210026|P3|Overall Study|Randomized but Never Received Study Drug|1
52299|NCT01340027|210027|P2|Overall Study|Randomized but Never Received Study Drug|0
52300|NCT01340027|210028|P1|Overall Study|Randomized but Never Received Study Drug|0
52301|NCT01340014|210404|P2|Period 2, Second 7 Days|Adverse Event|1
52302|NCT01340014|210405|P1|Period 2, Second 7 Days|Adverse Event|0
52303|NCT01340014|210404|P2|Period 1, First 7 Days|Personal Reasons|0
52304|NCT01340014|210405|P1|Period 1, First 7 Days|Personal Reasons|1
52305|NCT01340014|210404|P2|Period 1, First 7 Days|Adverse Event|0
52306|NCT01340014|210405|P1|Period 1, First 7 Days|Adverse Event|1
52307|NCT01339923|210426|P7|Overall Study|Withdrawal by Subject|2
52308|NCT01339923|210427|P6|Overall Study|Withdrawal by Subject|3
52309|NCT01339923|210428|P5|Overall Study|Withdrawal by Subject|4
52310|NCT01339923|210429|P4|Overall Study|Withdrawal by Subject|1
52311|NCT01339923|210430|P3|Overall Study|Withdrawal by Subject|6
52312|NCT01339923|210431|P2|Overall Study|Withdrawal by Subject|11
52313|NCT01339923|210432|P1|Overall Study|Withdrawal by Subject|7
52314|NCT01339923|210426|P7|Overall Study|Unable to Classify|5
52315|NCT01339923|210427|P6|Overall Study|Unable to Classify|1
52316|NCT01339923|210428|P5|Overall Study|Unable to Classify|0
52317|NCT01339923|210429|P4|Overall Study|Unable to Classify|0
52318|NCT01339923|210430|P3|Overall Study|Unable to Classify|1
52319|NCT01339923|210431|P2|Overall Study|Unable to Classify|0
52320|NCT01339923|210432|P1|Overall Study|Unable to Classify|1
52321|NCT01339923|210426|P7|Overall Study|Protocol Violation|1
52322|NCT01339923|210427|P6|Overall Study|Protocol Violation|3
52323|NCT01339923|210428|P5|Overall Study|Protocol Violation|0
52324|NCT01339923|210429|P4|Overall Study|Protocol Violation|0
52325|NCT01339923|210430|P3|Overall Study|Protocol Violation|0
52326|NCT01339923|210431|P2|Overall Study|Protocol Violation|0
52327|NCT01339923|210432|P1|Overall Study|Protocol Violation|0
52328|NCT01339923|210426|P7|Overall Study|Lost to Follow-up|5
52329|NCT01339923|210427|P6|Overall Study|Lost to Follow-up|1
52330|NCT01339923|210428|P5|Overall Study|Lost to Follow-up|1
52331|NCT01339923|210429|P4|Overall Study|Lost to Follow-up|3
52332|NCT01339923|210430|P3|Overall Study|Lost to Follow-up|0
52333|NCT01339923|210431|P2|Overall Study|Lost to Follow-up|4
52334|NCT01339923|210432|P1|Overall Study|Lost to Follow-up|4
52335|NCT01339923|210426|P7|Overall Study|Inappropriate Enrollment|0
52336|NCT01339923|210427|P6|Overall Study|Inappropriate Enrollment|1
52337|NCT01339923|210428|P5|Overall Study|Inappropriate Enrollment|0
52338|NCT01339923|210429|P4|Overall Study|Inappropriate Enrollment|0
52339|NCT01339923|210430|P3|Overall Study|Inappropriate Enrollment|0
52340|NCT01339923|210431|P2|Overall Study|Inappropriate Enrollment|0
52341|NCT01339923|210432|P1|Overall Study|Inappropriate Enrollment|1
52342|NCT01339923|210426|P7|Overall Study|Adverse Event|1
52343|NCT01339923|210427|P6|Overall Study|Adverse Event|0
52344|NCT01339923|210428|P5|Overall Study|Adverse Event|0
52345|NCT01339923|210429|P4|Overall Study|Adverse Event|0
52346|NCT01339923|210430|P3|Overall Study|Adverse Event|1
52347|NCT01339923|210431|P2|Overall Study|Adverse Event|1
52348|NCT01339923|210432|P1|Overall Study|Adverse Event|1
52349|NCT01339897|210505|P4|Overall Study|Adverse Event|1
52350|NCT01339897|210506|P3|Overall Study|Adverse Event|0
52351|NCT01339897|210507|P2|Overall Study|Adverse Event|0
52352|NCT01339897|210508|P1|Overall Study|Adverse Event|1
52353|NCT01339832|210534|P1|Overall Study|Death|11
52354|NCT01339832|210534|P1|Overall Study|Lost to Follow-up|3
52355|NCT01339429|210545|P1|Overall Study|Physician Decision|3
52356|NCT01339429|210545|P1|Overall Study|Withdrawal by Subject|1
52357|NCT01339390|210585|P2|Overall Study|Lost to Follow-up|127
52358|NCT01339390|210586|P1|Overall Study|Lost to Follow-up|125
52359|NCT01339390|210585|P2|Overall Study|Death|29
52360|NCT01339390|210586|P1|Overall Study|Death|32
52361|NCT01339052|210644|P2|Overall Study|Physician Decision|0
52362|NCT01339052|210645|P1|Overall Study|Physician Decision|1
52363|NCT01339052|210644|P2|Overall Study|Withdrawal by Subject|3
52364|NCT01339052|210645|P1|Overall Study|Withdrawal by Subject|0
52365|NCT01339052|210644|P2|Overall Study|Adverse Event|1
52366|NCT01339052|210645|P1|Overall Study|Adverse Event|1
52367|NCT01339052|210644|P2|Overall Study|Disease progression|46
52368|NCT01339052|210645|P1|Overall Study|Disease progression|13
52369|NCT01339000|210671|P2|Overall Study|study closed due to lack of drug supply|0
52370|NCT01339000|210672|P1|Overall Study|study closed due to lack of drug supply|1
52371|NCT01338870|210692|P6|Overall Study|Adverse Event|1
52372|NCT01338870|210693|P5|Overall Study|Adverse Event|4
52373|NCT01338870|210694|P4|Overall Study|Adverse Event|5
52374|NCT01338870|210695|P3|Overall Study|Adverse Event|1
52375|NCT01338870|210696|P2|Overall Study|Adverse Event|4
52376|NCT01338870|210697|P1|Overall Study|Adverse Event|4
52377|NCT01338870|210692|P6|Overall Study|Protocol Violation|1
52378|NCT01338870|210693|P5|Overall Study|Protocol Violation|1
52379|NCT01338870|210694|P4|Overall Study|Protocol Violation|2
52380|NCT01338870|210695|P3|Overall Study|Protocol Violation|2
52381|NCT01338870|210696|P2|Overall Study|Protocol Violation|2
52382|NCT01338870|210697|P1|Overall Study|Protocol Violation|0
52383|NCT01338870|210692|P6|Overall Study|Unspecified|2
52384|NCT01338870|210693|P5|Overall Study|Unspecified|0
52385|NCT01338870|210694|P4|Overall Study|Unspecified|2
52386|NCT01338870|210695|P3|Overall Study|Unspecified|3
52387|NCT01338870|210696|P2|Overall Study|Unspecified|3
52388|NCT01338870|210697|P1|Overall Study|Unspecified|3
52389|NCT01338870|210692|P6|Overall Study|Withdrawal by Subject|2
52390|NCT01338870|210693|P5|Overall Study|Withdrawal by Subject|0
52391|NCT01338870|210694|P4|Overall Study|Withdrawal by Subject|0
52392|NCT01338870|210695|P3|Overall Study|Withdrawal by Subject|4
52393|NCT01338870|210696|P2|Overall Study|Withdrawal by Subject|3
52394|NCT01338870|210697|P1|Overall Study|Withdrawal by Subject|2
52395|NCT01338870|210692|P6|Overall Study|Lost to Follow-up|0
52396|NCT01338870|210693|P5|Overall Study|Lost to Follow-up|1
52397|NCT01338870|210694|P4|Overall Study|Lost to Follow-up|0
52398|NCT01338870|210695|P3|Overall Study|Lost to Follow-up|1
52399|NCT01338870|210696|P2|Overall Study|Lost to Follow-up|0
52400|NCT01338870|210697|P1|Overall Study|Lost to Follow-up|0
52401|NCT01338818|210752|P1|Overall Study|Protocol Deviation|4
52402|NCT01338818|210752|P1|Overall Study|Administrative problems|3
52403|NCT01338818|210752|P1|Overall Study|Lost to Follow-up|4
52404|NCT01338818|210752|P1|Overall Study|Withdrawal by Subject|11
52405|NCT01338818|210752|P1|Overall Study|no longer require study drug|1
52406|NCT01338818|210752|P1|Overall Study|Lack of Efficacy|5
52407|NCT01338818|210752|P1|Overall Study|Adverse Event|8
52408|NCT01338792|210758|P1|Overall Study|Withdrawal by Subject|1
52409|NCT01338792|210758|P1|Overall Study|Death|1
52410|NCT01338792|210758|P1|Overall Study|Adverse Event|2
52411|NCT01338636|210773|P1|Overall Study|Withdrawn due to lack of improvement|8
52412|NCT01338610|210787|P3|Overall Study|Adverse Event|0
52413|NCT01338610|210788|P2|Overall Study|Adverse Event|0
52414|NCT01338610|210789|P1|Overall Study|Adverse Event|3
52415|NCT01338610|210787|P3|Overall Study|Protocol Violation|1
52416|NCT01338610|210788|P2|Overall Study|Protocol Violation|0
52417|NCT01338610|210789|P1|Overall Study|Protocol Violation|1
52418|NCT01338610|210787|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
52419|NCT01338610|210788|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
52420|NCT01338610|210789|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
52421|NCT01338493|210796|P1|12 Months Follow up|Lost to Follow-up|9
52422|NCT01338493|210796|P1|6 Months Follow up|Missed visit|8
52423|NCT01338493|210796|P1|6 Months Follow up|Lost to Follow-up|11
52424|NCT01338493|210796|P1|Discharge|Missed visit|1
52425|NCT01338493|210796|P1|Discharge|Death|1
52426|NCT01338493|210796|P1|Enrolled|Patient not implanted|4
52427|NCT01338493|210796|P1|Enrolled|Withdrawal by Subject|1
52428|NCT01338025|210803|P2|Overall Study|Found ineligible after starting|0
52429|NCT01338025|210804|P1|Overall Study|Found ineligible after starting|1
52430|NCT01338025|210803|P2|Overall Study|Withdrawal by Subject|2
52431|NCT01338025|210804|P1|Overall Study|Withdrawal by Subject|0
52432|NCT01338025|210803|P2|Overall Study|Unexpected closure of study|9
52433|NCT01338025|210804|P1|Overall Study|Unexpected closure of study|10
52434|NCT01338012|210816|P1|Overall Study|Study terminated|4
52435|NCT01338012|210816|P1|Overall Study|Death|4
52436|NCT01337960|210823|P3|Overall Study|Withdrawal by Subject|0
52437|NCT01337960|210824|P2|Overall Study|Withdrawal by Subject|0
52438|NCT01337960|210825|P1|Overall Study|Withdrawal by Subject|1
52439|NCT01337960|210823|P3|Overall Study|Lost to Follow-up|0
52440|NCT01337960|210824|P2|Overall Study|Lost to Follow-up|0
52441|NCT01337960|210825|P1|Overall Study|Lost to Follow-up|1
52442|NCT01337674|210858|P4|Treatment Period 2|Withdrawal by Subject|0
52443|NCT01337674|210859|P3|Treatment Period 2|Withdrawal by Subject|1
52444|NCT01337674|210860|P2|Treatment Period 2|Withdrawal by Subject|0
52445|NCT01337674|210861|P1|Treatment Period 2|Withdrawal by Subject|0
52446|NCT01337674|210858|P4|Treatment Period 1|Discontinued due to blood draws|1
52447|NCT01337674|210859|P3|Treatment Period 1|Discontinued due to blood draws|0
52448|NCT01337674|210860|P2|Treatment Period 1|Discontinued due to blood draws|0
52449|NCT01337674|210861|P1|Treatment Period 1|Discontinued due to blood draws|0
52450|NCT01337674|210858|P4|Treatment Period 1|Adverse Event|0
52451|NCT01337674|210859|P3|Treatment Period 1|Adverse Event|0
52452|NCT01337674|210860|P2|Treatment Period 1|Adverse Event|1
52453|NCT01337674|210861|P1|Treatment Period 1|Adverse Event|0
52454|NCT01337635|210879|P2|Overall Study|Lost to Follow-up|1
52455|NCT01337635|210880|P1|Overall Study|Lost to Follow-up|0
52456|NCT01337297|210928|P2|Overall Study|Lost to Follow-up|3
52457|NCT01337297|210929|P1|Overall Study|Lost to Follow-up|1
52458|NCT01337297|210928|P2|Overall Study|They entered to single anodal tDCS|3
52459|NCT01337297|210929|P1|Overall Study|They entered to single anodal tDCS|4
52460|NCT01337167|210937|P2|Toddler Vaccinations|Withdrawal by Subject|0
52461|NCT01337167|210938|P1|Toddler Vaccinations|Withdrawal by Subject|3
52462|NCT01337167|210937|P2|Toddler Vaccinations|Protocol Violation|1
52463|NCT01337167|210938|P1|Toddler Vaccinations|Protocol Violation|0
52464|NCT01337167|210937|P2|Toddler Vaccinations|Lost to Follow-up|12
52465|NCT01337167|210938|P1|Toddler Vaccinations|Lost to Follow-up|11
52466|NCT01337167|210937|P2|Interim Period|Other protocol criterion not met|1
52467|NCT01337167|210938|P1|Interim Period|Other protocol criterion not met|0
52468|NCT01337167|210937|P2|Interim Period|Withdrawal by Subject|10
52469|NCT01337167|210938|P1|Interim Period|Withdrawal by Subject|18
52470|NCT01337167|210937|P2|Interim Period|Protocol Violation|3
52471|NCT01337167|210938|P1|Interim Period|Protocol Violation|5
52472|NCT01337167|210937|P2|Interim Period|Physician Decision|3
52473|NCT01337167|210938|P1|Interim Period|Physician Decision|6
52474|NCT01337167|210937|P2|Interim Period|Non-compliance with study drug|0
52475|NCT01337167|210938|P1|Interim Period|Non-compliance with study drug|1
52476|NCT01337167|210937|P2|Interim Period|Lost to Follow-up|23
52477|NCT01337167|210938|P1|Interim Period|Lost to Follow-up|51
52478|NCT01337167|210937|P2|Infant Series|Randomized but not vaccinated|3
52479|NCT01337167|210938|P1|Infant Series|Randomized but not vaccinated|5
52480|NCT01337167|210937|P2|Infant Series|Withdrawal by Subject|4
52481|NCT01337167|210938|P1|Infant Series|Withdrawal by Subject|15
52482|NCT01337167|210937|P2|Infant Series|Protocol Violation|9
52483|NCT01337167|210938|P1|Infant Series|Protocol Violation|22
52484|NCT01337167|210937|P2|Infant Series|Physician Decision|1
52485|NCT01337167|210938|P1|Infant Series|Physician Decision|3
52486|NCT01337167|210937|P2|Infant Series|Non-compliance with study drug|1
52487|NCT01337167|210938|P1|Infant Series|Non-compliance with study drug|2
52488|NCT01337167|210937|P2|Infant Series|Lost to Follow-up|7
52489|NCT01337167|210938|P1|Infant Series|Lost to Follow-up|13
52490|NCT01337167|210937|P2|Infant Series|Death|1
52491|NCT01337167|210938|P1|Infant Series|Death|1
52492|NCT01337167|210937|P2|Infant Series|Adverse Event|1
52493|NCT01337167|210938|P1|Infant Series|Adverse Event|1
52494|NCT01337115|211006|P2|Overall Study|Protocol Violation|0
52495|NCT01337115|211007|P1|Overall Study|Protocol Violation|2
52496|NCT01337050|211026|P3|Overall Study|Participants refused further follow-up|7
52497|NCT01337050|211027|P2|Overall Study|Participants refused further follow-up|7
52498|NCT01337050|211028|P1|Overall Study|Participants refused further follow-up|0
52499|NCT01337050|211026|P3|Overall Study|Unspecified|8
52500|NCT01337050|211027|P2|Overall Study|Unspecified|6
52501|NCT01337050|211028|P1|Overall Study|Unspecified|4
52502|NCT01337050|211026|P3|Overall Study|Death|4
52503|NCT01337050|211027|P2|Overall Study|Death|0
52504|NCT01337050|211028|P1|Overall Study|Death|0
52505|NCT01336972|211089|P3|Overall Study|Adverse Event|0
52506|NCT01336972|211090|P2|Overall Study|Adverse Event|1
52507|NCT01336972|211091|P1|Overall Study|Adverse Event|1
52508|NCT01336894|211128|P2|Follow-up|Study terminated prematurely|7
52509|NCT01336894|211129|P1|Follow-up|Study terminated prematurely|2
52510|NCT01336764|211149|P2|Overall Study|Withdrawal by Subject|5
52511|NCT01336764|211150|P1|Overall Study|Withdrawal by Subject|5
52512|NCT01336738|211161|P5|Overall Study|Unspecified|4
52513|NCT01336738|211162|P4|Overall Study|Unspecified|3
52514|NCT01336738|211163|P3|Overall Study|Unspecified|2
52515|NCT01336738|211164|P2|Overall Study|Unspecified|3
52516|NCT01336738|211165|P1|Overall Study|Unspecified|3
52517|NCT01336738|211161|P5|Overall Study|Withdrawal by Subject|1
52518|NCT01336738|211162|P4|Overall Study|Withdrawal by Subject|1
52519|NCT01336738|211163|P3|Overall Study|Withdrawal by Subject|2
52520|NCT01336738|211164|P2|Overall Study|Withdrawal by Subject|0
52521|NCT01336738|211165|P1|Overall Study|Withdrawal by Subject|2
52522|NCT01336738|211161|P5|Overall Study|Protocol Violation|0
52523|NCT01336738|211162|P4|Overall Study|Protocol Violation|0
52524|NCT01336738|211163|P3|Overall Study|Protocol Violation|0
52525|NCT01336738|211164|P2|Overall Study|Protocol Violation|1
52526|NCT01336738|211165|P1|Overall Study|Protocol Violation|0
52527|NCT01336738|211161|P5|Overall Study|Did not meet entrance criteria|0
52528|NCT01336738|211162|P4|Overall Study|Did not meet entrance criteria|0
52529|NCT01336738|211163|P3|Overall Study|Did not meet entrance criteria|0
52530|NCT01336738|211164|P2|Overall Study|Did not meet entrance criteria|1
52531|NCT01336738|211165|P1|Overall Study|Did not meet entrance criteria|0
52532|NCT01336738|211161|P5|Overall Study|Lost to Follow-up|2
52533|NCT01336738|211162|P4|Overall Study|Lost to Follow-up|2
52534|NCT01336738|211163|P3|Overall Study|Lost to Follow-up|2
52535|NCT01336738|211164|P2|Overall Study|Lost to Follow-up|1
52536|NCT01336738|211165|P1|Overall Study|Lost to Follow-up|2
52537|NCT01336738|211161|P5|Overall Study|Adverse Event|3
52538|NCT01336738|211162|P4|Overall Study|Adverse Event|1
52539|NCT01336738|211163|P3|Overall Study|Adverse Event|2
52540|NCT01336738|211164|P2|Overall Study|Adverse Event|3
52541|NCT01336738|211165|P1|Overall Study|Adverse Event|0
52542|NCT01336712|211207|P1|Overall Study|Lack of Efficacy|1
52543|NCT01336712|211207|P1|Overall Study|Death|2
52544|NCT01336647|211220|P3|Overall Study|Lost to Follow-up|3
52545|NCT01336647|211221|P2|Overall Study|Lost to Follow-up|1
52546|NCT01336647|211222|P1|Overall Study|Lost to Follow-up|4
52547|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
52548|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
52549|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
52550|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
52551|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Physician Decision|1
52552|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Physician Decision|1
52553|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Physician Decision|3
52554|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Physician Decision|0
52555|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
52556|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
52557|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
52558|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
52559|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
52560|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
52561|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
52562|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
52563|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
52564|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
52565|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
52566|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
52567|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
52568|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
52569|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
52570|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
52571|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
52572|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
52573|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
52574|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
52575|NCT01336608|211236|P4|24-week, Double-blind Treatment Period|Adverse Event|7
52576|NCT01336608|211237|P3|24-week, Double-blind Treatment Period|Adverse Event|6
52577|NCT01336608|211238|P2|24-week, Double-blind Treatment Period|Adverse Event|8
52578|NCT01336608|211239|P1|24-week, Double-blind Treatment Period|Adverse Event|0
52579|NCT01336608|211236|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
52580|NCT01336608|211237|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
52581|NCT01336608|211238|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
52582|NCT01336608|211239|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
52583|NCT01336608|211236|P4|2-week, Single-blind Run-In Period|Physician Decision|0
52584|NCT01336608|211237|P3|2-week, Single-blind Run-In Period|Physician Decision|0
52585|NCT01336608|211238|P2|2-week, Single-blind Run-In Period|Physician Decision|0
52586|NCT01336608|211239|P1|2-week, Single-blind Run-In Period|Physician Decision|1
52587|NCT01336608|211236|P4|2-week, Single-blind Run-In Period|Adverse Event|0
52588|NCT01336608|211237|P3|2-week, Single-blind Run-In Period|Adverse Event|0
52589|NCT01336608|211238|P2|2-week, Single-blind Run-In Period|Adverse Event|0
52590|NCT01336608|211239|P1|2-week, Single-blind Run-In Period|Adverse Event|1
52591|NCT01336608|211236|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
52592|NCT01336608|211237|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
52593|NCT01336608|211238|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
52594|NCT01336608|211239|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
52595|NCT01336608|211236|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
52596|NCT01336608|211237|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
52597|NCT01336608|211238|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
52598|NCT01336608|211239|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
52599|NCT01336569|211253|P1|Overall Study|Lost to Follow-up|4
52600|NCT01336205|211276|P2|Overall Study|Did not receive treatment|0
52601|NCT01336205|211277|P1|Overall Study|Did not receive treatment|4
52602|NCT01336205|211276|P2|Overall Study|Withdrawal by Subject|38
52603|NCT01336205|211277|P1|Overall Study|Withdrawal by Subject|72
52604|NCT01336205|211276|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
52605|NCT01336205|211277|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
52606|NCT01336205|211276|P2|Overall Study|Death|1
52607|NCT01336205|211277|P1|Overall Study|Death|1
52608|NCT01336205|211276|P2|Overall Study|Adverse Event|6
52609|NCT01336205|211277|P1|Overall Study|Adverse Event|56
52610|NCT01336205|211276|P2|Overall Study|Severe noncompliance with protocol|2
52611|NCT01336205|211277|P1|Overall Study|Severe noncompliance with protocol|9
52612|NCT01336205|211276|P2|Overall Study|Lack of Efficacy|0
52613|NCT01336205|211277|P1|Overall Study|Lack of Efficacy|4
52614|NCT01336205|211276|P2|Overall Study|Study-Specific Withdrawal Criteria|7
52615|NCT01336205|211277|P1|Overall Study|Study-Specific Withdrawal Criteria|16
52616|NCT01336205|211276|P2|Overall Study|Lost to Follow-up|20
52617|NCT01336205|211277|P1|Overall Study|Lost to Follow-up|40
52618|NCT01336205|211276|P2|Overall Study|Other|9
52619|NCT01336205|211277|P1|Overall Study|Other|22
52620|NCT01336023|211305|P3|Week 27 to 52|Unclassified|9
52621|NCT01336023|211306|P2|Week 27 to 52|Unclassified|18
52622|NCT01336023|211307|P1|Week 27 to 52|Unclassified|13
52623|NCT01336023|211305|P3|Week 27 to 52|Withdrawal Criteria|16
52624|NCT01336023|211306|P2|Week 27 to 52|Withdrawal Criteria|19
52625|NCT01336023|211307|P1|Week 27 to 52|Withdrawal Criteria|14
52626|NCT01336023|211305|P3|Week 27 to 52|Protocol Violation|1
52627|NCT01336023|211306|P2|Week 27 to 52|Protocol Violation|2
52628|NCT01336023|211307|P1|Week 27 to 52|Protocol Violation|0
52629|NCT01336023|211305|P3|Week 27 to 52|Adverse Event|2
52630|NCT01336023|211306|P2|Week 27 to 52|Adverse Event|5
52631|NCT01336023|211307|P1|Week 27 to 52|Adverse Event|1
52632|NCT01336023|211305|P3|Week 0 to Week 26|Unclassified|9
52633|NCT01336023|211306|P2|Week 0 to Week 26|Unclassified|16
52634|NCT01336023|211307|P1|Week 0 to Week 26|Unclassified|5
52635|NCT01336023|211305|P3|Week 0 to Week 26|Withdrawal Criteria|40
52636|NCT01336023|211306|P2|Week 0 to Week 26|Withdrawal Criteria|69
52637|NCT01336023|211307|P1|Week 0 to Week 26|Withdrawal Criteria|34
52638|NCT01336023|211305|P3|Week 0 to Week 26|Protocol Violation|0
52639|NCT01336023|211306|P2|Week 0 to Week 26|Protocol Violation|2
52640|NCT01336023|211307|P1|Week 0 to Week 26|Protocol Violation|1
52641|NCT01336023|211305|P3|Week 0 to Week 26|Lack of Efficacy|0
52642|NCT01336023|211306|P2|Week 0 to Week 26|Lack of Efficacy|1
52643|NCT01336023|211307|P1|Week 0 to Week 26|Lack of Efficacy|0
52644|NCT01336023|211305|P3|Week 0 to Week 26|Adverse Event|24
52645|NCT01336023|211306|P2|Week 0 to Week 26|Adverse Event|10
52646|NCT01336023|211307|P1|Week 0 to Week 26|Adverse Event|8
52647|NCT01335997|211328|P2|Period III|Lost to Follow-up|0
52648|NCT01335997|211329|P1|Period III|Lost to Follow-up|1
52649|NCT01335997|211328|P2|Period III|Protocol Violation|1
52650|NCT01335997|211329|P1|Period III|Protocol Violation|0
52651|NCT01335997|211328|P2|Period III|Study Terminated by Sponsor|76
52652|NCT01335997|211329|P1|Period III|Study Terminated by Sponsor|77
52653|NCT01335997|211328|P2|Period III|Adverse Event|2
52654|NCT01335997|211329|P1|Period III|Adverse Event|0
52655|NCT01335997|211328|P2|Period I and II|Physician Decision|1
52656|NCT01335997|211329|P1|Period I and II|Physician Decision|2
52657|NCT01335997|211328|P2|Period I and II|Protocol Violation|10
52658|NCT01335997|211329|P1|Period I and II|Protocol Violation|9
52659|NCT01335997|211328|P2|Period I and II|Study Terminated by Sponsor|415
52660|NCT01335997|211329|P1|Period I and II|Study Terminated by Sponsor|406
52661|NCT01335997|211328|P2|Period I and II|Withdrawal by Subject|4
52662|NCT01335997|211329|P1|Period I and II|Withdrawal by Subject|9
52663|NCT01335997|211328|P2|Period I and II|Lost to Follow-up|5
52664|NCT01335997|211329|P1|Period I and II|Lost to Follow-up|3
52665|NCT01335997|211328|P2|Period I and II|Noncompliance with Study Drug|1
52666|NCT01335997|211329|P1|Period I and II|Noncompliance with Study Drug|1
52667|NCT01335997|211328|P2|Period I and II|Adverse Event|43
52668|NCT01335997|211329|P1|Period I and II|Adverse Event|63
52669|NCT01335971|211342|P3|Overall Study|Did not complete bronchoscopy|1
52670|NCT01335971|211343|P2|Overall Study|Did not complete bronchoscopy|1
52671|NCT01335971|211344|P1|Overall Study|Did not complete bronchoscopy|1
52672|NCT01335971|211342|P3|Overall Study|Withdrawal by Subject|0
52673|NCT01335971|211343|P2|Overall Study|Withdrawal by Subject|0
52674|NCT01335971|211344|P1|Overall Study|Withdrawal by Subject|1
52675|NCT01335698|211440|P5|Treatment Stage 2|Continuing treatment|6
52676|NCT01335698|211441|P4|Treatment Stage 2|Continuing treatment|19
52677|NCT01335698|211442|P3|Treatment Stage 2|Continuing treatment|13
52678|NCT01335698|211443|P2|Treatment Stage 2|Continuing treatment|3
52679|NCT01335698|211444|P1|Treatment Stage 2|Continuing treatment|11
52680|NCT01335698|211440|P5|Treatment Stage 2|Poor compliance/noncompliance|0
52681|NCT01335698|211441|P4|Treatment Stage 2|Poor compliance/noncompliance|3
52682|NCT01335698|211442|P3|Treatment Stage 2|Poor compliance/noncompliance|0
52683|NCT01335698|211443|P2|Treatment Stage 2|Poor compliance/noncompliance|0
52684|NCT01335698|211444|P1|Treatment Stage 2|Poor compliance/noncompliance|1
52685|NCT01335698|211440|P5|Treatment Stage 2|Withdrawal by Subject|0
52686|NCT01335698|211441|P4|Treatment Stage 2|Withdrawal by Subject|0
52687|NCT01335698|211442|P3|Treatment Stage 2|Withdrawal by Subject|0
52688|NCT01335698|211443|P2|Treatment Stage 2|Withdrawal by Subject|0
52689|NCT01335698|211444|P1|Treatment Stage 2|Withdrawal by Subject|1
52690|NCT01335698|211440|P5|Treatment Stage 2|Adverse Event|0
52691|NCT01335698|211441|P4|Treatment Stage 2|Adverse Event|1
52692|NCT01335698|211442|P3|Treatment Stage 2|Adverse Event|0
52693|NCT01335698|211443|P2|Treatment Stage 2|Adverse Event|0
52694|NCT01335698|211444|P1|Treatment Stage 2|Adverse Event|0
52695|NCT01335698|211440|P5|Treatment Stage 2|Lack of Efficacy|0
52696|NCT01335698|211441|P4|Treatment Stage 2|Lack of Efficacy|1
52697|NCT01335698|211442|P3|Treatment Stage 2|Lack of Efficacy|3
52698|NCT01335698|211443|P2|Treatment Stage 2|Lack of Efficacy|1
52699|NCT01335698|211444|P1|Treatment Stage 2|Lack of Efficacy|2
52700|NCT01335698|211440|P5|Treatment Stage 1|Not specified|0
52701|NCT01335698|211441|P4|Treatment Stage 1|Not specified|1
52702|NCT01335698|211442|P3|Treatment Stage 1|Not specified|0
52703|NCT01335698|211443|P2|Treatment Stage 1|Not specified|0
52704|NCT01335698|211444|P1|Treatment Stage 1|Not specified|1
52705|NCT01335698|211440|P5|Treatment Stage 1|No longer meets study criteria|0
52706|NCT01335698|211441|P4|Treatment Stage 1|No longer meets study criteria|1
52707|NCT01335698|211442|P3|Treatment Stage 1|No longer meets study criteria|0
52708|NCT01335698|211443|P2|Treatment Stage 1|No longer meets study criteria|1
52709|NCT01335698|211444|P1|Treatment Stage 1|No longer meets study criteria|1
52710|NCT01335698|211440|P5|Treatment Stage 1|Poor compliance/noncompliance|0
52711|NCT01335698|211441|P4|Treatment Stage 1|Poor compliance/noncompliance|2
52712|NCT01335698|211442|P3|Treatment Stage 1|Poor compliance/noncompliance|0
52713|NCT01335698|211443|P2|Treatment Stage 1|Poor compliance/noncompliance|1
52714|NCT01335698|211444|P1|Treatment Stage 1|Poor compliance/noncompliance|0
52715|NCT01335698|211440|P5|Treatment Stage 1|Lost to Follow-up|0
52716|NCT01335698|211441|P4|Treatment Stage 1|Lost to Follow-up|0
52717|NCT01335698|211442|P3|Treatment Stage 1|Lost to Follow-up|0
52718|NCT01335698|211443|P2|Treatment Stage 1|Lost to Follow-up|1
52719|NCT01335698|211444|P1|Treatment Stage 1|Lost to Follow-up|1
52720|NCT01335698|211440|P5|Treatment Stage 1|Withdrawal by Subject|0
52721|NCT01335698|211441|P4|Treatment Stage 1|Withdrawal by Subject|1
52722|NCT01335698|211442|P3|Treatment Stage 1|Withdrawal by Subject|0
52723|NCT01335698|211443|P2|Treatment Stage 1|Withdrawal by Subject|2
52724|NCT01335698|211444|P1|Treatment Stage 1|Withdrawal by Subject|1
52725|NCT01335698|211440|P5|Treatment Stage 1|Adverse Event|1
52726|NCT01335698|211441|P4|Treatment Stage 1|Adverse Event|1
52727|NCT01335698|211442|P3|Treatment Stage 1|Adverse Event|2
52728|NCT01335698|211443|P2|Treatment Stage 1|Adverse Event|2
52729|NCT01335698|211444|P1|Treatment Stage 1|Adverse Event|1
52730|NCT01335698|211440|P5|Treatment Stage 1|Lack of Efficacy|1
52731|NCT01335698|211441|P4|Treatment Stage 1|Lack of Efficacy|3
52732|NCT01335698|211442|P3|Treatment Stage 1|Lack of Efficacy|3
52733|NCT01335698|211443|P2|Treatment Stage 1|Lack of Efficacy|1
52734|NCT01335698|211444|P1|Treatment Stage 1|Lack of Efficacy|3
52735|NCT01335477|211502|P2|Overall Study|Reason other than those stated above|2
52736|NCT01335477|211503|P1|Overall Study|Reason other than those stated above|2
52737|NCT01335477|211502|P2|Overall Study|Not treated|2
52738|NCT01335477|211503|P1|Overall Study|Not treated|1
52739|NCT01335477|211502|P2|Overall Study|Consent withdrawn, not due to AE|9
52740|NCT01335477|211503|P1|Overall Study|Consent withdrawn, not due to AE|7
52741|NCT01335477|211502|P2|Overall Study|Lost to Follow-up|2
52742|NCT01335477|211503|P1|Overall Study|Lost to Follow-up|1
52743|NCT01335477|211502|P2|Overall Study|Non compliant with protocol|2
52744|NCT01335477|211503|P1|Overall Study|Non compliant with protocol|0
52745|NCT01335477|211502|P2|Overall Study|Adverse Event|42
52746|NCT01335477|211503|P1|Overall Study|Adverse Event|30
52747|NCT01335464|211567|P2|Overall Study|Reason other than those stated above|1
52748|NCT01335464|211568|P1|Overall Study|Reason other than those stated above|1
52749|NCT01335464|211567|P2|Overall Study|Not treated|0
52750|NCT01335464|211568|P1|Overall Study|Not treated|2
52751|NCT01335464|211567|P2|Overall Study|Consent withdrawn, not due to AE|23
52752|NCT01335464|211568|P1|Overall Study|Consent withdrawn, not due to AE|12
52753|NCT01335464|211567|P2|Overall Study|Non compliant with protocol|0
52754|NCT01335464|211568|P1|Overall Study|Non compliant with protocol|2
52755|NCT01335464|211567|P2|Overall Study|Adverse Event|25
52756|NCT01335464|211568|P1|Overall Study|Adverse Event|15
52757|NCT01334918|211728|P2|Overall Study|Withdrawal by Subject|1
52758|NCT01334918|211729|P1|Overall Study|Withdrawal by Subject|0
52759|NCT01334918|211728|P2|Overall Study|Adverse Event|0
52760|NCT01334918|211729|P1|Overall Study|Adverse Event|2
52761|NCT01334918|211728|P2|Overall Study|Did not receive study drug|0
52762|NCT01334918|211729|P1|Overall Study|Did not receive study drug|6
52763|NCT01334866|211755|P1|Overall Study|medically necessary post-procedure|1
52764|NCT01334866|211755|P1|Overall Study|medically necessary prior to procedure|2
52765|NCT01334866|211755|P1|Overall Study|Physician Decision|3
52766|NCT01334866|211755|P1|Overall Study|Lost to Follow-up|3
52767|NCT01334866|211755|P1|Overall Study|Withdrawal by Subject|10
52768|NCT01334710|211792|P1|Overall Study|Trial was terminated|3
52769|NCT01334606|211796|P1|Overall Study|Study Terminated due to slow enrolment|18
52770|NCT01334554|211804|P2|Overall Study|Adverse Event|2
52771|NCT01334554|211805|P1|Overall Study|Adverse Event|4
52772|NCT01334515|211815|P2|Overall Study|Withdrawal by Subject|1
52773|NCT01334515|211816|P1|Overall Study|Withdrawal by Subject|1
52774|NCT01334515|211815|P2|Overall Study|Physician Decision|1
52775|NCT01334515|211816|P1|Overall Study|Physician Decision|1
52776|NCT01334515|211815|P2|Overall Study|Lack of Efficacy|21
52777|NCT01334515|211816|P1|Overall Study|Lack of Efficacy|8
52778|NCT01334515|211815|P2|Overall Study|Death|0
52779|NCT01334515|211816|P1|Overall Study|Death|1
52780|NCT01334515|211815|P2|Overall Study|Adverse Event|6
52781|NCT01334515|211816|P1|Overall Study|Adverse Event|1
52782|NCT01334125|211854|P2|Overall Study|Lost to Follow-up|3
52783|NCT01334125|211855|P1|Overall Study|Lost to Follow-up|3
52784|NCT01333956|211871|P4|Overall Study|Withdrawal by Subject|0
52785|NCT01333956|211872|P3|Overall Study|Withdrawal by Subject|1
52786|NCT01333956|211873|P2|Overall Study|Withdrawal by Subject|2
52787|NCT01333956|211874|P1|Overall Study|Withdrawal by Subject|0
52788|NCT01333956|211871|P4|Overall Study|Unable to complete study procedure|1
52789|NCT01333956|211872|P3|Overall Study|Unable to complete study procedure|0
52790|NCT01333956|211873|P2|Overall Study|Unable to complete study procedure|0
52791|NCT01333956|211874|P1|Overall Study|Unable to complete study procedure|1
52792|NCT01333956|211871|P4|Overall Study|Lost to Follow-up|1
52793|NCT01333956|211872|P3|Overall Study|Lost to Follow-up|0
52794|NCT01333956|211873|P2|Overall Study|Lost to Follow-up|2
52795|NCT01333956|211874|P1|Overall Study|Lost to Follow-up|1
52796|NCT01333865|211908|P1|Overall Study|Adverse Event|2
52797|NCT01333722|211928|P2|Overall Study|Withdrawal by Subject|1
52798|NCT01333722|211929|P1|Overall Study|Withdrawal by Subject|0
52799|NCT01333722|211928|P2|Overall Study|Lack of Efficacy|2
52800|NCT01333722|211929|P1|Overall Study|Lack of Efficacy|0
52801|NCT01333501|211954|P2|Overall Study|Withdrawn consent|12
52802|NCT01333501|211955|P1|Overall Study|Withdrawn consent|3
52803|NCT01333501|211954|P2|Overall Study|Unsatisfactory therapeutic effect|7
52804|NCT01333501|211955|P1|Overall Study|Unsatisfactory therapeutic effect|1
52805|NCT01333501|211954|P2|Overall Study|Abnormal laboratory value|1
52806|NCT01333501|211955|P1|Overall Study|Abnormal laboratory value|2
52807|NCT01333501|211954|P2|Overall Study|Adverse Event|1
52808|NCT01333501|211955|P1|Overall Study|Adverse Event|3
52809|NCT01333475|212022|P2|Overall Study|Toxicity|3
52810|NCT01333475|212023|P1|Overall Study|Toxicity|1
52811|NCT01333475|212022|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
52812|NCT01333475|212023|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
52813|NCT01333397|212049|P5|Overall Study|Lost to Follow-up|0
52814|NCT01333397|212050|P4|Overall Study|Lost to Follow-up|1
52815|NCT01333397|212051|P3|Overall Study|Lost to Follow-up|0
52816|NCT01333397|212052|P2|Overall Study|Lost to Follow-up|0
52817|NCT01333397|212053|P1|Overall Study|Lost to Follow-up|1
52818|NCT01333189|212127|P2|Overall Study|Moved from region|1
52819|NCT01333189|212128|P1|Overall Study|Moved from region|0
52820|NCT01333189|212127|P2|Overall Study|Transportation difficulties|1
52821|NCT01333189|212128|P1|Overall Study|Transportation difficulties|0
52822|NCT01333189|212127|P2|Overall Study|Adverse Event|0
52823|NCT01333189|212128|P1|Overall Study|Adverse Event|1
52824|NCT01333189|212127|P2|Overall Study|Time constraints|0
52825|NCT01333189|212128|P1|Overall Study|Time constraints|1
52826|NCT01333111|212159|P3|Overall Study|Ineffective therapy|1
52827|NCT01333111|212160|P2|Overall Study|Ineffective therapy|0
52828|NCT01333111|212161|P1|Overall Study|Ineffective therapy|0
52829|NCT01333111|212159|P3|Overall Study|Non-compliance|0
52830|NCT01333111|212160|P2|Overall Study|Non-compliance|0
52831|NCT01333111|212161|P1|Overall Study|Non-compliance|1
52832|NCT01333111|212159|P3|Overall Study|withdrawal criteria|0
52833|NCT01333111|212160|P2|Overall Study|withdrawal criteria|1
52834|NCT01333111|212161|P1|Overall Study|withdrawal criteria|0
52835|NCT01333111|212159|P3|Overall Study|unclassified|0
52836|NCT01333111|212160|P2|Overall Study|unclassified|0
52837|NCT01333111|212161|P1|Overall Study|unclassified|1
52838|NCT01333111|212159|P3|Overall Study|personal reasons|1
52839|NCT01333111|212160|P2|Overall Study|personal reasons|0
52840|NCT01333111|212161|P1|Overall Study|personal reasons|0
52841|NCT01333111|212159|P3|Overall Study|patient undergoing major surgery|0
52842|NCT01333111|212160|P2|Overall Study|patient undergoing major surgery|2
52843|NCT01333111|212161|P1|Overall Study|patient undergoing major surgery|0
52844|NCT01332994|212185|P1|Overall Study|Not Specified|8
52845|NCT01332994|212185|P1|Overall Study|Administrative Problem|2
52846|NCT01332994|212185|P1|Overall Study|Withdrawal by Subject|15
52847|NCT01332994|212185|P1|Overall Study|Protocol Violation|6
52848|NCT01332994|212185|P1|Overall Study|Lost to Follow-up|4
52849|NCT01332994|212185|P1|Overall Study|Lack of Efficacy|1
52850|NCT01332994|212185|P1|Overall Study|Death|1
52851|NCT01332994|212185|P1|Overall Study|Adverse Event|34
52852|NCT01332968|212254|P8|Follow-Up Period|Lost to Follow-up|2
52853|NCT01332968|212255|P7|Follow-Up Period|Lost to Follow-up|1
52854|NCT01332968|212256|P6|Follow-Up Period|Lost to Follow-up|0
52855|NCT01332968|212257|P5|Follow-Up Period|Lost to Follow-up|0
52856|NCT01332968|212258|P4|Follow-Up Period|Lost to Follow-up|0
52857|NCT01332968|212259|P3|Follow-Up Period|Lost to Follow-up|0
52858|NCT01332968|212260|P2|Follow-Up Period|Lost to Follow-up|0
52859|NCT01332968|212261|P1|Follow-Up Period|Lost to Follow-up|0
52860|NCT01332968|212254|P8|Follow-Up Period|Withdrawal by Subject|2
52861|NCT01332968|212255|P7|Follow-Up Period|Withdrawal by Subject|1
52862|NCT01332968|212256|P6|Follow-Up Period|Withdrawal by Subject|0
52863|NCT01332968|212257|P5|Follow-Up Period|Withdrawal by Subject|0
52864|NCT01332968|212258|P4|Follow-Up Period|Withdrawal by Subject|0
52865|NCT01332968|212259|P3|Follow-Up Period|Withdrawal by Subject|0
52866|NCT01332968|212260|P2|Follow-Up Period|Withdrawal by Subject|0
52867|NCT01332968|212261|P1|Follow-Up Period|Withdrawal by Subject|0
52868|NCT01332968|212254|P8|Follow-Up Period|Follow-up ongoing|505
52869|NCT01332968|212255|P7|Follow-Up Period|Follow-up ongoing|502
52870|NCT01332968|212256|P6|Follow-Up Period|Follow-up ongoing|0
52871|NCT01332968|212257|P5|Follow-Up Period|Follow-up ongoing|0
52872|NCT01332968|212258|P4|Follow-Up Period|Follow-up ongoing|0
52873|NCT01332968|212259|P3|Follow-Up Period|Follow-up ongoing|0
52874|NCT01332968|212260|P2|Follow-Up Period|Follow-up ongoing|0
52875|NCT01332968|212261|P1|Follow-Up Period|Follow-up ongoing|0
52876|NCT01332968|212254|P8|Follow-Up Period|Death|22
52877|NCT01332968|212255|P7|Follow-Up Period|Death|38
52878|NCT01332968|212256|P6|Follow-Up Period|Death|0
52879|NCT01332968|212257|P5|Follow-Up Period|Death|0
52880|NCT01332968|212258|P4|Follow-Up Period|Death|0
52881|NCT01332968|212259|P3|Follow-Up Period|Death|0
52882|NCT01332968|212260|P2|Follow-Up Period|Death|0
52883|NCT01332968|212261|P1|Follow-Up Period|Death|0
52884|NCT01332968|212254|P8|Maintenance/Observation Period|Treatment ongoing|0
52885|NCT01332968|212255|P7|Maintenance/Observation Period|Treatment ongoing|0
52886|NCT01332968|212256|P6|Maintenance/Observation Period|Treatment ongoing|8
52887|NCT01332968|212257|P5|Maintenance/Observation Period|Treatment ongoing|10
52888|NCT01332968|212258|P4|Maintenance/Observation Period|Treatment ongoing|62
52889|NCT01332968|212259|P3|Maintenance/Observation Period|Treatment ongoing|54
52890|NCT01332968|212260|P2|Maintenance/Observation Period|Treatment ongoing|0
52891|NCT01332968|212261|P1|Maintenance/Observation Period|Treatment ongoing|0
52892|NCT01332968|212254|P8|Maintenance/Observation Period|Adverse Event|0
52893|NCT01332968|212255|P7|Maintenance/Observation Period|Adverse Event|0
52894|NCT01332968|212256|P6|Maintenance/Observation Period|Adverse Event|0
52895|NCT01332968|212257|P5|Maintenance/Observation Period|Adverse Event|0
52896|NCT01332968|212258|P4|Maintenance/Observation Period|Adverse Event|65
52897|NCT01332968|212259|P3|Maintenance/Observation Period|Adverse Event|50
52898|NCT01332968|212260|P2|Maintenance/Observation Period|Adverse Event|0
52899|NCT01332968|212261|P1|Maintenance/Observation Period|Adverse Event|0
52900|NCT01332968|212254|P8|Maintenance/Observation Period|Death|0
52901|NCT01332968|212255|P7|Maintenance/Observation Period|Death|0
52902|NCT01332968|212256|P6|Maintenance/Observation Period|Death|0
52903|NCT01332968|212257|P5|Maintenance/Observation Period|Death|0
52904|NCT01332968|212258|P4|Maintenance/Observation Period|Death|6
52905|NCT01332968|212259|P3|Maintenance/Observation Period|Death|5
52906|NCT01332968|212260|P2|Maintenance/Observation Period|Death|0
52907|NCT01332968|212261|P1|Maintenance/Observation Period|Death|0
52908|NCT01332968|212254|P8|Maintenance/Observation Period|Lost to Follow-up|0
52909|NCT01332968|212255|P7|Maintenance/Observation Period|Lost to Follow-up|0
52910|NCT01332968|212256|P6|Maintenance/Observation Period|Lost to Follow-up|0
52911|NCT01332968|212257|P5|Maintenance/Observation Period|Lost to Follow-up|0
52912|NCT01332968|212258|P4|Maintenance/Observation Period|Lost to Follow-up|2
52913|NCT01332968|212259|P3|Maintenance/Observation Period|Lost to Follow-up|1
52914|NCT01332968|212260|P2|Maintenance/Observation Period|Lost to Follow-up|0
52915|NCT01332968|212261|P1|Maintenance/Observation Period|Lost to Follow-up|0
52916|NCT01332968|212254|P8|Maintenance/Observation Period|Non-compliance|0
52917|NCT01332968|212255|P7|Maintenance/Observation Period|Non-compliance|0
52918|NCT01332968|212256|P6|Maintenance/Observation Period|Non-compliance|1
52919|NCT01332968|212257|P5|Maintenance/Observation Period|Non-compliance|0
52920|NCT01332968|212258|P4|Maintenance/Observation Period|Non-compliance|3
52921|NCT01332968|212259|P3|Maintenance/Observation Period|Non-compliance|2
52922|NCT01332968|212260|P2|Maintenance/Observation Period|Non-compliance|0
52923|NCT01332968|212261|P1|Maintenance/Observation Period|Non-compliance|0
52924|NCT01332968|212254|P8|Maintenance/Observation Period|Other|0
52925|NCT01332968|212255|P7|Maintenance/Observation Period|Other|0
52926|NCT01332968|212256|P6|Maintenance/Observation Period|Other|0
52927|NCT01332968|212257|P5|Maintenance/Observation Period|Other|0
52928|NCT01332968|212258|P4|Maintenance/Observation Period|Other|5
52929|NCT01332968|212259|P3|Maintenance/Observation Period|Other|4
52930|NCT01332968|212260|P2|Maintenance/Observation Period|Other|0
52931|NCT01332968|212261|P1|Maintenance/Observation Period|Other|0
52932|NCT01332968|212254|P8|Maintenance/Observation Period|Physician Decision|0
52933|NCT01332968|212255|P7|Maintenance/Observation Period|Physician Decision|0
52934|NCT01332968|212256|P6|Maintenance/Observation Period|Physician Decision|0
52935|NCT01332968|212257|P5|Maintenance/Observation Period|Physician Decision|0
52936|NCT01332968|212258|P4|Maintenance/Observation Period|Physician Decision|19
52937|NCT01332968|212259|P3|Maintenance/Observation Period|Physician Decision|14
52938|NCT01332968|212260|P2|Maintenance/Observation Period|Physician Decision|0
52939|NCT01332968|212261|P1|Maintenance/Observation Period|Physician Decision|0
52940|NCT01332968|212254|P8|Maintenance/Observation Period|Progressive disease|0
52941|NCT01332968|212255|P7|Maintenance/Observation Period|Progressive disease|0
52942|NCT01332968|212256|P6|Maintenance/Observation Period|Progressive disease|0
52943|NCT01332968|212257|P5|Maintenance/Observation Period|Progressive disease|0
52944|NCT01332968|212258|P4|Maintenance/Observation Period|Progressive disease|39
52945|NCT01332968|212259|P3|Maintenance/Observation Period|Progressive disease|72
52946|NCT01332968|212260|P2|Maintenance/Observation Period|Progressive disease|0
52947|NCT01332968|212261|P1|Maintenance/Observation Period|Progressive disease|0
52948|NCT01332968|212254|P8|Maintenance/Observation Period|Protocol Violation|0
52949|NCT01332968|212255|P7|Maintenance/Observation Period|Protocol Violation|0
52950|NCT01332968|212256|P6|Maintenance/Observation Period|Protocol Violation|0
52951|NCT01332968|212257|P5|Maintenance/Observation Period|Protocol Violation|0
52952|NCT01332968|212258|P4|Maintenance/Observation Period|Protocol Violation|1
52953|NCT01332968|212259|P3|Maintenance/Observation Period|Protocol Violation|1
52954|NCT01332968|212260|P2|Maintenance/Observation Period|Protocol Violation|0
52955|NCT01332968|212261|P1|Maintenance/Observation Period|Protocol Violation|0
52956|NCT01332968|212254|P8|Maintenance/Observation Period|Withdrawal by Subject|0
52957|NCT01332968|212255|P7|Maintenance/Observation Period|Withdrawal by Subject|0
52958|NCT01332968|212256|P6|Maintenance/Observation Period|Withdrawal by Subject|0
52959|NCT01332968|212257|P5|Maintenance/Observation Period|Withdrawal by Subject|0
52960|NCT01332968|212258|P4|Maintenance/Observation Period|Withdrawal by Subject|5
52961|NCT01332968|212259|P3|Maintenance/Observation Period|Withdrawal by Subject|10
52962|NCT01332968|212260|P2|Maintenance/Observation Period|Withdrawal by Subject|0
52963|NCT01332968|212261|P1|Maintenance/Observation Period|Withdrawal by Subject|0
52964|NCT01332968|212254|P8|Induction Period|Randomized, but not treated|0
52965|NCT01332968|212255|P7|Induction Period|Randomized, but not treated|0
52966|NCT01332968|212256|P6|Induction Period|Randomized, but not treated|0
52967|NCT01332968|212257|P5|Induction Period|Randomized, but not treated|0
52968|NCT01332968|212258|P4|Induction Period|Randomized, but not treated|0
52969|NCT01332968|212259|P3|Induction Period|Randomized, but not treated|0
52970|NCT01332968|212260|P2|Induction Period|Randomized, but not treated|7
52971|NCT01332968|212261|P1|Induction Period|Randomized, but not treated|4
52972|NCT01332968|212254|P8|Induction Period|Adverse Event|0
52973|NCT01332968|212255|P7|Induction Period|Adverse Event|0
52974|NCT01332968|212256|P6|Induction Period|Adverse Event|0
52975|NCT01332968|212257|P5|Induction Period|Adverse Event|0
52976|NCT01332968|212258|P4|Induction Period|Adverse Event|0
52977|NCT01332968|212259|P3|Induction Period|Adverse Event|0
52978|NCT01332968|212260|P2|Induction Period|Adverse Event|26
52979|NCT01332968|212261|P1|Induction Period|Adverse Event|23
52980|NCT01332968|212254|P8|Induction Period|Death|0
52981|NCT01332968|212255|P7|Induction Period|Death|0
52982|NCT01332968|212256|P6|Induction Period|Death|0
52983|NCT01332968|212257|P5|Induction Period|Death|0
52984|NCT01332968|212258|P4|Induction Period|Death|0
52985|NCT01332968|212259|P3|Induction Period|Death|0
52986|NCT01332968|212260|P2|Induction Period|Death|4
52987|NCT01332968|212261|P1|Induction Period|Death|1
52988|NCT01332968|212254|P8|Induction Period|Non-compliance|0
52989|NCT01332968|212255|P7|Induction Period|Non-compliance|0
52990|NCT01332968|212256|P6|Induction Period|Non-compliance|0
52991|NCT01332968|212257|P5|Induction Period|Non-compliance|0
52992|NCT01332968|212258|P4|Induction Period|Non-compliance|0
52993|NCT01332968|212259|P3|Induction Period|Non-compliance|0
52994|NCT01332968|212260|P2|Induction Period|Non-compliance|0
52995|NCT01332968|212261|P1|Induction Period|Non-compliance|1
52996|NCT01332968|212254|P8|Induction Period|Other|0
52997|NCT01332968|212255|P7|Induction Period|Other|0
52998|NCT01332968|212256|P6|Induction Period|Other|0
52999|NCT01332968|212257|P5|Induction Period|Other|0
53000|NCT01332968|212258|P4|Induction Period|Other|0
53001|NCT01332968|212259|P3|Induction Period|Other|0
53002|NCT01332968|212260|P2|Induction Period|Other|2
53003|NCT01332968|212261|P1|Induction Period|Other|2
53004|NCT01332968|212254|P8|Induction Period|Physician Decision|0
53005|NCT01332968|212255|P7|Induction Period|Physician Decision|0
53006|NCT01332968|212256|P6|Induction Period|Physician Decision|0
53007|NCT01332968|212257|P5|Induction Period|Physician Decision|0
53008|NCT01332968|212258|P4|Induction Period|Physician Decision|0
53009|NCT01332968|212259|P3|Induction Period|Physician Decision|0
53010|NCT01332968|212260|P2|Induction Period|Physician Decision|1
53011|NCT01332968|212261|P1|Induction Period|Physician Decision|6
53012|NCT01332968|212254|P8|Induction Period|Progressive disease|0
53013|NCT01332968|212255|P7|Induction Period|Progressive disease|0
53014|NCT01332968|212256|P6|Induction Period|Progressive disease|0
53015|NCT01332968|212257|P5|Induction Period|Progressive disease|0
53016|NCT01332968|212258|P4|Induction Period|Progressive disease|0
53017|NCT01332968|212259|P3|Induction Period|Progressive disease|0
53018|NCT01332968|212260|P2|Induction Period|Progressive disease|7
53019|NCT01332968|212261|P1|Induction Period|Progressive disease|15
53020|NCT01332968|212254|P8|Induction Period|Protocol Violation|0
53021|NCT01332968|212255|P7|Induction Period|Protocol Violation|0
53022|NCT01332968|212256|P6|Induction Period|Protocol Violation|0
53023|NCT01332968|212257|P5|Induction Period|Protocol Violation|0
53024|NCT01332968|212258|P4|Induction Period|Protocol Violation|0
53025|NCT01332968|212259|P3|Induction Period|Protocol Violation|0
53026|NCT01332968|212260|P2|Induction Period|Protocol Violation|4
53027|NCT01332968|212261|P1|Induction Period|Protocol Violation|3
53028|NCT01332968|212254|P8|Induction Period|Withdrawal by Subject|0
53029|NCT01332968|212255|P7|Induction Period|Withdrawal by Subject|0
53030|NCT01332968|212256|P6|Induction Period|Withdrawal by Subject|0
53031|NCT01332968|212257|P5|Induction Period|Withdrawal by Subject|0
53032|NCT01332968|212258|P4|Induction Period|Withdrawal by Subject|0
53033|NCT01332968|212259|P3|Induction Period|Withdrawal by Subject|0
53034|NCT01332968|212260|P2|Induction Period|Withdrawal by Subject|5
53035|NCT01332968|212261|P1|Induction Period|Withdrawal by Subject|3
53036|NCT01332318|212445|P4|Overall Study|Protocol Violation|1
53037|NCT01332318|212446|P3|Overall Study|Protocol Violation|1
53038|NCT01332318|212447|P2|Overall Study|Protocol Violation|0
53039|NCT01332318|212448|P1|Overall Study|Protocol Violation|1
53040|NCT01332318|212445|P4|Overall Study|Withdrawal by Subject|1
53041|NCT01332318|212446|P3|Overall Study|Withdrawal by Subject|0
53042|NCT01332318|212447|P2|Overall Study|Withdrawal by Subject|1
53043|NCT01332318|212448|P1|Overall Study|Withdrawal by Subject|1
53044|NCT01332318|212445|P4|Overall Study|Adverse Event|0
53045|NCT01332318|212446|P3|Overall Study|Adverse Event|0
53046|NCT01332318|212447|P2|Overall Study|Adverse Event|3
53047|NCT01332318|212448|P1|Overall Study|Adverse Event|0
53048|NCT01332305|212559|P5|Overall Study|Physician Decision|0
53049|NCT01332305|212560|P4|Overall Study|Physician Decision|1
53050|NCT01332305|212561|P3|Overall Study|Physician Decision|0
53051|NCT01332305|212562|P2|Overall Study|Physician Decision|0
53052|NCT01332305|212563|P1|Overall Study|Physician Decision|0
53053|NCT01332305|212559|P5|Overall Study|Treatment Failure|0
53054|NCT01332305|212560|P4|Overall Study|Treatment Failure|0
53055|NCT01332305|212561|P3|Overall Study|Treatment Failure|0
53056|NCT01332305|212562|P2|Overall Study|Treatment Failure|1
53057|NCT01332305|212563|P1|Overall Study|Treatment Failure|1
53058|NCT01332305|212559|P5|Overall Study|Withdrawal by Sponsor|1
53059|NCT01332305|212560|P4|Overall Study|Withdrawal by Sponsor|1
53060|NCT01332305|212561|P3|Overall Study|Withdrawal by Sponsor|0
53061|NCT01332305|212562|P2|Overall Study|Withdrawal by Sponsor|0
53062|NCT01332305|212563|P1|Overall Study|Withdrawal by Sponsor|1
53063|NCT01332305|212559|P5|Overall Study|Protocol Violation|3
53064|NCT01332305|212560|P4|Overall Study|Protocol Violation|0
53065|NCT01332305|212561|P3|Overall Study|Protocol Violation|1
53066|NCT01332305|212562|P2|Overall Study|Protocol Violation|2
53067|NCT01332305|212563|P1|Overall Study|Protocol Violation|1
53068|NCT01332305|212559|P5|Overall Study|Lost to Follow-up|3
53069|NCT01332305|212560|P4|Overall Study|Lost to Follow-up|2
53070|NCT01332305|212561|P3|Overall Study|Lost to Follow-up|3
53071|NCT01332305|212562|P2|Overall Study|Lost to Follow-up|2
53072|NCT01332305|212563|P1|Overall Study|Lost to Follow-up|0
53073|NCT01332305|212559|P5|Overall Study|Withdrawal by Subject|0
53074|NCT01332305|212560|P4|Overall Study|Withdrawal by Subject|1
53075|NCT01332305|212561|P3|Overall Study|Withdrawal by Subject|4
53076|NCT01332305|212562|P2|Overall Study|Withdrawal by Subject|5
53077|NCT01332305|212563|P1|Overall Study|Withdrawal by Subject|6
53078|NCT01332305|212559|P5|Overall Study|Adverse Event|5
53079|NCT01332305|212560|P4|Overall Study|Adverse Event|3
53080|NCT01332305|212561|P3|Overall Study|Adverse Event|6
53081|NCT01332305|212562|P2|Overall Study|Adverse Event|4
53082|NCT01332305|212563|P1|Overall Study|Adverse Event|1
53083|NCT01332292|212585|P2|Treatment Period 2 (14 Days)|Physician Decision|1
53084|NCT01332292|212586|P1|Treatment Period 2 (14 Days)|Physician Decision|1
53085|NCT01332292|212585|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
53086|NCT01332292|212586|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
53087|NCT01332292|212585|P2|Treatment Period 1 (14 Days)|Adverse Event|0
53088|NCT01332292|212586|P1|Treatment Period 1 (14 Days)|Adverse Event|1
53089|NCT01332227|212677|P2|Overall Study|Patient began prohibited medication|1
53090|NCT01332227|212678|P1|Overall Study|Patient began prohibited medication|0
53091|NCT01332227|212677|P2|Overall Study|Patient moved from area|0
53092|NCT01332227|212678|P1|Overall Study|Patient moved from area|1
53093|NCT01332227|212677|P2|Overall Study|Poor compliance/noncompliance|1
53094|NCT01332227|212678|P1|Overall Study|Poor compliance/noncompliance|1
53095|NCT01332227|212677|P2|Overall Study|Lack of Efficacy|1
53096|NCT01332227|212678|P1|Overall Study|Lack of Efficacy|3
53097|NCT01332227|212677|P2|Overall Study|Lost to Follow-up|0
53098|NCT01332227|212678|P1|Overall Study|Lost to Follow-up|2
53099|NCT01332227|212677|P2|Overall Study|Withdrawal by Subject|1
53100|NCT01332227|212678|P1|Overall Study|Withdrawal by Subject|5
53101|NCT01332227|212677|P2|Overall Study|Adverse Event|1
53102|NCT01332227|212678|P1|Overall Study|Adverse Event|4
53103|NCT01332149|212859|P2|Overall Study|Randomized but not treated|2
53104|NCT01332149|212860|P1|Overall Study|Randomized but not treated|1
53105|NCT01332149|212859|P2|Overall Study|Did not meet entrance criteria|4
53106|NCT01332149|212860|P1|Overall Study|Did not meet entrance criteria|3
53107|NCT01332149|212859|P2|Overall Study|Insufficient clinical response|7
53108|NCT01332149|212860|P1|Overall Study|Insufficient clinical response|4
53109|NCT01332149|212859|P2|Overall Study|Lost to Follow-up|1
53110|NCT01332149|212860|P1|Overall Study|Lost to Follow-up|1
53111|NCT01332149|212859|P2|Overall Study|Withdrawal by Subject|5
53112|NCT01332149|212860|P1|Overall Study|Withdrawal by Subject|4
53113|NCT01332149|212859|P2|Overall Study|Protocol Violation|3
53114|NCT01332149|212860|P1|Overall Study|Protocol Violation|1
53115|NCT01332149|212859|P2|Overall Study|Other unspecified|7
53116|NCT01332149|212860|P1|Overall Study|Other unspecified|5
53117|NCT01332149|212859|P2|Overall Study|Adverse Event|9
53118|NCT01332149|212860|P1|Overall Study|Adverse Event|11
53119|NCT01332019|212938|P2|Overall Study|Adverse Event|22
53120|NCT01332019|212939|P1|Overall Study|Adverse Event|13
53121|NCT01332019|212938|P2|Overall Study|Lost to Follow-up|7
53122|NCT01332019|212939|P1|Overall Study|Lost to Follow-up|4
53123|NCT01332019|212938|P2|Overall Study|Withdrawal by Subject|71
53124|NCT01332019|212939|P1|Overall Study|Withdrawal by Subject|73
53125|NCT01332019|212938|P2|Overall Study|Physician Decision|3
53126|NCT01332019|212939|P1|Overall Study|Physician Decision|4
53127|NCT01332019|212938|P2|Overall Study|Death|1
53128|NCT01332019|212939|P1|Overall Study|Death|2
53129|NCT01332019|212938|P2|Overall Study|Not Specified|18
53130|NCT01332019|212939|P1|Overall Study|Not Specified|16
53131|NCT01332019|212938|P2|Overall Study|Was Not Dosed|0
53132|NCT01332019|212939|P1|Overall Study|Was Not Dosed|1
53133|NCT01331837|213023|P2|Overall Study|Withdrawal by Subject|16
53134|NCT01331837|213024|P1|Overall Study|Withdrawal by Subject|13
53135|NCT01331837|213023|P2|Overall Study|Info not recorded|16
53136|NCT01331837|213024|P1|Overall Study|Info not recorded|10
53137|NCT01331837|213023|P2|Overall Study|Lost to Follow-up|1
53138|NCT01331837|213024|P1|Overall Study|Lost to Follow-up|3
53139|NCT01331837|213023|P2|Overall Study|Death|34
53140|NCT01331837|213024|P1|Overall Study|Death|30
53141|NCT01331824|213064|P1|Overall Study|Withdrawal by Subject|1
53142|NCT01331824|213064|P1|Overall Study|Disease Progression|9
53143|NCT01331824|213064|P1|Overall Study|Death|1
53144|NCT01331824|213064|P1|Overall Study|Adverse Event|2
53145|NCT01331681|213098|P3|Overall Study|Not Received Study Treatment|2
53146|NCT01331681|213099|P2|Overall Study|Not Received Study Treatment|0
53147|NCT01331681|213100|P1|Overall Study|Not Received Study Treatment|0
53148|NCT01331681|213098|P3|Overall Study|Switching to other therapy|1
53149|NCT01331681|213099|P2|Overall Study|Switching to other therapy|0
53150|NCT01331681|213100|P1|Overall Study|Switching to other therapy|0
53151|NCT01331681|213098|P3|Overall Study|Sponsor decision|0
53152|NCT01331681|213099|P2|Overall Study|Sponsor decision|1
53153|NCT01331681|213100|P1|Overall Study|Sponsor decision|1
53154|NCT01331681|213098|P3|Overall Study|Therapeutic procedure required|0
53155|NCT01331681|213099|P2|Overall Study|Therapeutic procedure required|0
53156|NCT01331681|213100|P1|Overall Study|Therapeutic procedure required|1
53157|NCT01331681|213098|P3|Overall Study|Physician Decision|4
53158|NCT01331681|213099|P2|Overall Study|Physician Decision|0
53159|NCT01331681|213100|P1|Overall Study|Physician Decision|2
53160|NCT01331681|213098|P3|Overall Study|Lost to Follow-up|1
53161|NCT01331681|213099|P2|Overall Study|Lost to Follow-up|4
53162|NCT01331681|213100|P1|Overall Study|Lost to Follow-up|2
53163|NCT01331681|213098|P3|Overall Study|Protocol Violation|0
53164|NCT01331681|213099|P2|Overall Study|Protocol Violation|1
53165|NCT01331681|213100|P1|Overall Study|Protocol Violation|1
53166|NCT01331681|213098|P3|Overall Study|Withdrawal by Subject|15
53167|NCT01331681|213099|P2|Overall Study|Withdrawal by Subject|8
53168|NCT01331681|213100|P1|Overall Study|Withdrawal by Subject|12
53169|NCT01331681|213098|P3|Overall Study|Lack of Efficacy|0
53170|NCT01331681|213099|P2|Overall Study|Lack of Efficacy|1
53171|NCT01331681|213100|P1|Overall Study|Lack of Efficacy|0
53172|NCT01331681|213098|P3|Overall Study|Death|2
53173|NCT01331681|213099|P2|Overall Study|Death|6
53174|NCT01331681|213100|P1|Overall Study|Death|6
53175|NCT01331681|213098|P3|Overall Study|Adverse Event|10
53176|NCT01331681|213099|P2|Overall Study|Adverse Event|13
53177|NCT01331681|213100|P1|Overall Study|Adverse Event|10
53178|NCT01331291|213139|P2|Overall Study|Death|1
53179|NCT01331291|213140|P1|Overall Study|Death|0
53180|NCT01331291|213139|P2|Overall Study|Lack of Efficacy|8
53181|NCT01331291|213140|P1|Overall Study|Lack of Efficacy|2
53182|NCT01331161|213174|P2|Overall Study|Pregnancy|1
53183|NCT01331161|213175|P1|Overall Study|Pregnancy|0
53184|NCT01331161|213174|P2|Overall Study|Lost to Follow-up|1
53185|NCT01331161|213175|P1|Overall Study|Lost to Follow-up|0
53186|NCT01331161|213174|P2|Overall Study|Physician Decision|0
53187|NCT01331161|213175|P1|Overall Study|Physician Decision|1
53188|NCT01331109|213183|P1|Overall Study|Study Terminated by Sponsor|38
53189|NCT01331109|213183|P1|Overall Study|Lost to Follow-up|1
53190|NCT01331109|213183|P1|Overall Study|Withdrawal by Subject|7
53191|NCT01331109|213183|P1|Overall Study|Protocol Violation|3
53192|NCT01331109|213183|P1|Overall Study|Lack of Efficacy|2
53193|NCT01331109|213183|P1|Overall Study|Adverse Event|6
53194|NCT01331005|213195|P2|Overall Study|Withdrawal by Subject|3
53195|NCT01331005|213196|P1|Overall Study|Withdrawal by Subject|2
53196|NCT01331005|213195|P2|Overall Study|Lost to Follow-up|1
53197|NCT01331005|213196|P1|Overall Study|Lost to Follow-up|2
53198|NCT01330914|213202|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
53199|NCT01330914|213202|P1|Overall Study|Withdrawal by Subject|4
53200|NCT01330628|213208|P2|Overall Study|Didn't receive study treatment|0
53201|NCT01330628|213209|P1|Overall Study|Didn't receive study treatment|1
53202|NCT01330628|213208|P2|Overall Study|Withdrawn|6
53203|NCT01330628|213209|P1|Overall Study|Withdrawn|18
53204|NCT01330628|213208|P2|Overall Study|Adverse Event|25
53205|NCT01330628|213209|P1|Overall Study|Adverse Event|44
53206|NCT01330628|213208|P2|Overall Study|Lost to Follow-up|6
53207|NCT01330628|213209|P1|Overall Study|Lost to Follow-up|5
53208|NCT01330628|213208|P2|Overall Study|Death|3
53209|NCT01330628|213209|P1|Overall Study|Death|2
53210|NCT01330433|213219|P2|Overall Study|Lost to Follow-up|0
53211|NCT01330433|213220|P1|Overall Study|Lost to Follow-up|1
53212|NCT01330433|213219|P2|Overall Study|Death|3
53213|NCT01330433|213220|P1|Overall Study|Death|1
53214|NCT01330381|213259|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
53215|NCT01330381|213260|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
53216|NCT01330381|213261|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
53217|NCT01330381|213259|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
53218|NCT01330381|213260|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
53219|NCT01330381|213261|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
53220|NCT01330381|213259|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
53221|NCT01330381|213260|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
53222|NCT01330381|213261|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
53223|NCT01330381|213259|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
53224|NCT01330381|213260|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
53225|NCT01330381|213261|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
53226|NCT01330381|213259|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
53227|NCT01330381|213260|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
53228|NCT01330381|213261|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
53229|NCT01330381|213259|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
53230|NCT01330381|213260|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
53231|NCT01330381|213261|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
53232|NCT01330381|213259|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
53233|NCT01330381|213260|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
53234|NCT01330381|213261|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
53235|NCT01330381|213259|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
53236|NCT01330381|213260|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
53237|NCT01330381|213261|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
53238|NCT01330381|213259|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
53239|NCT01330381|213260|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
53240|NCT01330381|213261|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
53241|NCT01330381|213259|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
53242|NCT01330381|213260|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
53243|NCT01330381|213261|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
53244|NCT01330316|213322|P2|Overall Study|other than above|1
53245|NCT01330316|213323|P1|Overall Study|other than above|0
53246|NCT01330316|213322|P2|Overall Study|Withdrawal by Subject|1
53247|NCT01330316|213323|P1|Overall Study|Withdrawal by Subject|0
53248|NCT01330316|213322|P2|Overall Study|Lost to Follow-up|1
53249|NCT01330316|213323|P1|Overall Study|Lost to Follow-up|0
53250|NCT01330316|213322|P2|Overall Study|Lack of Efficacy|10
53251|NCT01330316|213323|P1|Overall Study|Lack of Efficacy|0
53252|NCT01330316|213322|P2|Overall Study|Adverse Event|2
53253|NCT01330316|213323|P1|Overall Study|Adverse Event|2
53254|NCT01330303|213359|P2|Period 1|Withdrawal by Subject|1
53255|NCT01330303|213360|P1|Period 1|Withdrawal by Subject|0
53256|NCT01330303|213359|P2|Period 1|Protocol Violation|1
53257|NCT01330303|213360|P1|Period 1|Protocol Violation|0
53258|NCT01330303|213359|P2|Period 1|Adverse Event|0
53259|NCT01330303|213360|P1|Period 1|Adverse Event|1
53260|NCT01330108|213394|P1|Overall Study|Withdrawal by Subject|4
53261|NCT01330030|213412|P2|Overall Study|Lost to Follow-up|17
53262|NCT01330030|213413|P1|Overall Study|Lost to Follow-up|16
53263|NCT01330017|213424|P5|Overall Study|Unknown Reason|2
53264|NCT01330017|213425|P4|Overall Study|Unknown Reason|7
53265|NCT01330017|213426|P3|Overall Study|Unknown Reason|5
53266|NCT01330017|213427|P2|Overall Study|Unknown Reason|3
53267|NCT01330017|213428|P1|Overall Study|Unknown Reason|5
53268|NCT01330017|213424|P5|Overall Study|Protocol Violation|0
53269|NCT01330017|213425|P4|Overall Study|Protocol Violation|1
53270|NCT01330017|213426|P3|Overall Study|Protocol Violation|0
53271|NCT01330017|213427|P2|Overall Study|Protocol Violation|0
53272|NCT01330017|213428|P1|Overall Study|Protocol Violation|0
53273|NCT01330017|213424|P5|Overall Study|Lost to Follow-up|0
53274|NCT01330017|213425|P4|Overall Study|Lost to Follow-up|0
53275|NCT01330017|213426|P3|Overall Study|Lost to Follow-up|1
53276|NCT01330017|213427|P2|Overall Study|Lost to Follow-up|0
53277|NCT01330017|213428|P1|Overall Study|Lost to Follow-up|0
53278|NCT01330017|213424|P5|Overall Study|Withdrawal by Subject|1
53279|NCT01330017|213425|P4|Overall Study|Withdrawal by Subject|0
53280|NCT01330017|213426|P3|Overall Study|Withdrawal by Subject|1
53281|NCT01330017|213427|P2|Overall Study|Withdrawal by Subject|0
53282|NCT01330017|213428|P1|Overall Study|Withdrawal by Subject|0
53283|NCT01330017|213424|P5|Overall Study|Adverse Event|0
53284|NCT01330017|213425|P4|Overall Study|Adverse Event|4
53285|NCT01330017|213426|P3|Overall Study|Adverse Event|1
53286|NCT01330017|213427|P2|Overall Study|Adverse Event|1
53287|NCT01330017|213428|P1|Overall Study|Adverse Event|0
53288|NCT01329978|213477|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
53289|NCT01329978|213478|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
53290|NCT01329978|213479|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
53291|NCT01329978|213480|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
53292|NCT01329978|213481|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
53293|NCT01329978|213477|P5|Rerandomization Treatment Period|Lost to Follow-up|3
53294|NCT01329978|213478|P4|Rerandomization Treatment Period|Lost to Follow-up|5
53295|NCT01329978|213479|P3|Rerandomization Treatment Period|Lost to Follow-up|0
53296|NCT01329978|213480|P2|Rerandomization Treatment Period|Lost to Follow-up|0
53297|NCT01329978|213481|P1|Rerandomization Treatment Period|Lost to Follow-up|0
53298|NCT01329978|213477|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
53299|NCT01329978|213478|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
53300|NCT01329978|213479|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
53301|NCT01329978|213480|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
53302|NCT01329978|213481|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
53303|NCT01329978|213477|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
53304|NCT01329978|213478|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
53305|NCT01329978|213479|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
53306|NCT01329978|213480|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
53307|NCT01329978|213481|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
53308|NCT01329978|213477|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
53309|NCT01329978|213478|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
53310|NCT01329978|213479|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
53311|NCT01329978|213480|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
53312|NCT01329978|213481|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
53313|NCT01329978|213477|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
53314|NCT01329978|213478|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
53315|NCT01329978|213479|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
53316|NCT01329978|213480|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
53317|NCT01329978|213481|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
53318|NCT01329978|213477|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
53319|NCT01329978|213478|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
53320|NCT01329978|213479|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
53321|NCT01329978|213480|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
53322|NCT01329978|213481|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
53323|NCT01329939|213555|P4|Overall Study|Adverse Event|3
53324|NCT01329939|213556|P3|Overall Study|Adverse Event|0
53325|NCT01329939|213557|P2|Overall Study|Adverse Event|0
53326|NCT01329939|213558|P1|Overall Study|Adverse Event|0
53327|NCT01329939|213555|P4|Overall Study|Withdrawal by Subject|0
53328|NCT01329939|213556|P3|Overall Study|Withdrawal by Subject|0
53329|NCT01329939|213557|P2|Overall Study|Withdrawal by Subject|1
53330|NCT01329939|213558|P1|Overall Study|Withdrawal by Subject|0
53331|NCT01329939|213555|P4|Overall Study|Lost to Follow-up|2
53332|NCT01329939|213556|P3|Overall Study|Lost to Follow-up|1
53333|NCT01329939|213557|P2|Overall Study|Lost to Follow-up|0
53334|NCT01329939|213558|P1|Overall Study|Lost to Follow-up|3
53335|NCT01329562|213622|P2|Overall Study|Physician Decision|1
53336|NCT01329562|213623|P1|Overall Study|Physician Decision|0
53337|NCT01329562|213622|P2|Overall Study|Subject withdrew due to personal issues.|2
53338|NCT01329562|213623|P1|Overall Study|Subject withdrew due to personal issues.|3
53339|NCT01329562|213622|P2|Overall Study|Lost to Follow-up|1
53340|NCT01329562|213623|P1|Overall Study|Lost to Follow-up|1
53341|NCT01329562|213622|P2|Overall Study|Protocol Violation|3
53342|NCT01329562|213623|P1|Overall Study|Protocol Violation|5
53343|NCT01329549|213672|P1|Overall Study|Adverse Event|1
53344|NCT01329549|213672|P1|Overall Study|Withdrawal by Subject|1
53345|NCT01329419|213683|P1|Overall Study|Protocol Violation|235
53346|NCT01329263|213691|P2|Overall Study|Withdrawal by Subject|2
53347|NCT01329263|213692|P1|Overall Study|Withdrawal by Subject|1
53348|NCT01329263|213691|P2|Overall Study|Lost to Follow-up|21
53349|NCT01329263|213692|P1|Overall Study|Lost to Follow-up|4
53350|NCT01329029|213729|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
53351|NCT01329029|213730|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
53352|NCT01329029|213729|P2|Overall Study|Lost to Follow-up|5
53353|NCT01329029|213730|P1|Overall Study|Lost to Follow-up|8
53354|NCT01329029|213729|P2|Overall Study|Physician Decision|13
53355|NCT01329029|213730|P1|Overall Study|Physician Decision|16
53356|NCT01329029|213729|P2|Overall Study|COPD Exacerbation|18
53357|NCT01329029|213730|P1|Overall Study|COPD Exacerbation|11
53358|NCT01329029|213729|P2|Overall Study|Other|20
53359|NCT01329029|213730|P1|Overall Study|Other|14
53360|NCT01329029|213729|P2|Overall Study|Death|19
53361|NCT01329029|213730|P1|Overall Study|Death|16
53362|NCT01329029|213729|P2|Overall Study|Adverse Event|29
53363|NCT01329029|213730|P1|Overall Study|Adverse Event|82
53364|NCT01329029|213729|P2|Overall Study|Withdrawal by Subject|87
53365|NCT01329029|213730|P1|Overall Study|Withdrawal by Subject|117
53366|NCT01328951|213820|P2|Overall Study|Not Specified|6
53367|NCT01328951|213821|P1|Overall Study|Not Specified|11
53368|NCT01328951|213820|P2|Overall Study|Study Closed by the Sponsor|31
53369|NCT01328951|213821|P1|Overall Study|Study Closed by the Sponsor|36
53370|NCT01328951|213820|P2|Overall Study|Withdrawal by Subject|6
53371|NCT01328951|213821|P1|Overall Study|Withdrawal by Subject|6
53372|NCT01328951|213820|P2|Overall Study|Lost to Follow-up|7
53373|NCT01328951|213821|P1|Overall Study|Lost to Follow-up|6
53374|NCT01328951|213820|P2|Overall Study|Death|258
53375|NCT01328951|213821|P1|Overall Study|Death|243
53376|NCT01328951|213820|P2|Overall Study|Adverse Event|0
53377|NCT01328951|213821|P1|Overall Study|Adverse Event|2
53378|NCT01328951|213820|P2|Overall Study|Disease Progression|14
53379|NCT01328951|213821|P1|Overall Study|Disease Progression|17
53380|NCT01328756|213890|P1|Overall Study|Unspecified|29
53381|NCT01328756|213890|P1|Overall Study|Lost to Follow-up|5
53382|NCT01328756|213890|P1|Overall Study|Withdrawal by Subject|41
53383|NCT01328756|213890|P1|Overall Study|Lack of Efficacy|5
53384|NCT01328756|213890|P1|Overall Study|Adverse Event|39
53385|NCT01328756|213890|P1|Overall Study|Protocol Violation|4
53386|NCT01328717|213907|P1|Overall Study|Adverse Event|1
53387|NCT01328574|213912|P1|Overall Study|Refused further treatment|1
53388|NCT01328548|213926|P2|Overall Study|Protocol Violation|0
53389|NCT01328548|213927|P1|Overall Study|Protocol Violation|1
53390|NCT01328548|213926|P2|Overall Study|Death|0
53391|NCT01328548|213927|P1|Overall Study|Death|3
53392|NCT01328496|213947|P2|Overall Study|Significant Change in Health Status|0
53393|NCT01328496|213948|P1|Overall Study|Significant Change in Health Status|1
53394|NCT01328444|213966|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
53395|NCT01328444|213967|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
53396|NCT01328444|213968|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53397|NCT01328444|213969|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53398|NCT01328444|213970|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53399|NCT01328444|213971|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53400|NCT01328444|213966|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
53401|NCT01328444|213967|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
53402|NCT01328444|213968|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
53403|NCT01328444|213969|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
53404|NCT01328444|213970|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
53405|NCT01328444|213971|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
53406|NCT01328444|213966|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
53407|NCT01328444|213967|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
53408|NCT01328444|213968|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
53409|NCT01328444|213969|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
53410|NCT01328444|213970|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
53411|NCT01328444|213971|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
53412|NCT01328444|213966|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
53413|NCT01328444|213967|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
53414|NCT01328444|213968|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
53415|NCT01328444|213969|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
53416|NCT01328444|213970|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
53417|NCT01328444|213971|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
53418|NCT01328444|213966|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
53419|NCT01328444|213967|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
53420|NCT01328444|213968|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
53421|NCT01328444|213969|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
53422|NCT01328444|213970|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
53423|NCT01328444|213971|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
53424|NCT01328444|213966|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
53425|NCT01328444|213967|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
53426|NCT01328444|213968|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
53427|NCT01328444|213969|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
53428|NCT01328444|213970|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
53429|NCT01328444|213971|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
53430|NCT01328444|213966|P6|Washout Period (14 Days)|Withdrawal by Subject|1
53431|NCT01328444|213967|P5|Washout Period (14 Days)|Withdrawal by Subject|0
53432|NCT01328444|213968|P4|Washout Period (14 Days)|Withdrawal by Subject|0
53433|NCT01328444|213969|P3|Washout Period (14 Days)|Withdrawal by Subject|0
53434|NCT01328444|213970|P2|Washout Period (14 Days)|Withdrawal by Subject|0
53435|NCT01328444|213971|P1|Washout Period (14 Days)|Withdrawal by Subject|0
53436|NCT01328444|213966|P6|Washout Period (14 Days)|Lack of Efficacy|1
53437|NCT01328444|213967|P5|Washout Period (14 Days)|Lack of Efficacy|0
53438|NCT01328444|213968|P4|Washout Period (14 Days)|Lack of Efficacy|0
53439|NCT01328444|213969|P3|Washout Period (14 Days)|Lack of Efficacy|0
53440|NCT01328444|213970|P2|Washout Period (14 Days)|Lack of Efficacy|0
53441|NCT01328444|213971|P1|Washout Period (14 Days)|Lack of Efficacy|0
53442|NCT01328444|213966|P6|Washout Period (14 Days)|Adverse Event|2
53443|NCT01328444|213967|P5|Washout Period (14 Days)|Adverse Event|1
53444|NCT01328444|213968|P4|Washout Period (14 Days)|Adverse Event|1
53445|NCT01328444|213969|P3|Washout Period (14 Days)|Adverse Event|0
53446|NCT01328444|213970|P2|Washout Period (14 Days)|Adverse Event|1
53447|NCT01328444|213971|P1|Washout Period (14 Days)|Adverse Event|1
53448|NCT01328444|213966|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
53449|NCT01328444|213967|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
53450|NCT01328444|213968|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
53451|NCT01328444|213969|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
53452|NCT01328444|213970|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
53453|NCT01328444|213971|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
53454|NCT01328444|213966|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
53455|NCT01328444|213967|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53456|NCT01328444|213968|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
53457|NCT01328444|213969|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53458|NCT01328444|213970|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53459|NCT01328444|213971|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
53460|NCT01328444|213966|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
53461|NCT01328444|213967|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
53462|NCT01328444|213968|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
53463|NCT01328444|213969|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
53464|NCT01328444|213970|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
53465|NCT01328444|213971|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
53466|NCT01328444|213966|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
53467|NCT01328444|213967|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
53468|NCT01328444|213968|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
53469|NCT01328444|213969|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
53470|NCT01328444|213970|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
53471|NCT01328444|213971|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
53472|NCT01328444|213966|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
53473|NCT01328444|213967|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
53474|NCT01328444|213968|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
53475|NCT01328444|213969|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
53476|NCT01328444|213970|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
53477|NCT01328444|213971|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
53478|NCT01328444|213966|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
53479|NCT01328444|213967|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
53480|NCT01328444|213968|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
53481|NCT01328444|213969|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
53482|NCT01328444|213970|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
53483|NCT01328444|213971|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
53484|NCT01328431|214017|P2|12 Month (12M)|Lost to Follow-up|91
53485|NCT01328431|214018|P1|12 Month (12M)|Lost to Follow-up|82
53486|NCT01328431|214017|P2|12 Month (12M)|Death|6
53487|NCT01328431|214018|P1|12 Month (12M)|Death|2
53488|NCT01328431|214017|P2|3 Month (3M)|Lost to Follow-up|70
53489|NCT01328431|214018|P1|3 Month (3M)|Lost to Follow-up|75
53490|NCT01328431|214017|P2|3 Month (3M)|Death|2
53491|NCT01328431|214018|P1|3 Month (3M)|Death|2
53492|NCT01328431|214017|P2|1 Month (1M)|Lost to Follow-up|58
53493|NCT01328431|214018|P1|1 Month (1M)|Lost to Follow-up|55
53494|NCT01328431|214017|P2|Baseline|Protocol Violation|2
53495|NCT01328431|214018|P1|Baseline|Protocol Violation|0
53496|NCT01328366|214074|P1|Overall Study|Lost to Follow-up|7
53497|NCT01328366|214074|P1|Overall Study|Withdrawal by Subject|2
53498|NCT01328366|214074|P1|Overall Study|Death|1
53499|NCT01328080|214170|P1|Overall Study|Lost to Follow-up|5
53500|NCT01328054|214174|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
53501|NCT01328054|214175|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
53502|NCT01328054|214174|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
53503|NCT01328054|214175|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
53504|NCT01328054|214174|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
53505|NCT01328054|214175|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
53506|NCT01328041|214200|P1|Overall Study|Withdrawal by Subject|7
53507|NCT01328041|214200|P1|Overall Study|Physician Decision|2
53508|NCT01328041|214200|P1|Overall Study|Lost to Follow-up|7
53509|NCT01328041|214200|P1|Overall Study|Protocol Violation|7
53510|NCT01328041|214200|P1|Overall Study|Lack of Efficacy|27
53511|NCT01328041|214200|P1|Overall Study|Adverse Event|7
53512|NCT01327885|214249|P2|Overall Study|Ongoing|1
53513|NCT01327885|214250|P1|Overall Study|Ongoing|1
53514|NCT01327885|214249|P2|Overall Study|Not treated|1
53515|NCT01327885|214250|P1|Overall Study|Not treated|1
53516|NCT01327885|214249|P2|Overall Study|Withdrawal of consent from study|4
53517|NCT01327885|214250|P1|Overall Study|Withdrawal of consent from study|2
53518|NCT01327885|214249|P2|Overall Study|Not specified|6
53519|NCT01327885|214250|P1|Overall Study|Not specified|8
53520|NCT01327885|214249|P2|Overall Study|Subject choice|10
53521|NCT01327885|214250|P1|Overall Study|Subject choice|5
53522|NCT01327885|214249|P2|Overall Study|Adverse Event|10
53523|NCT01327885|214250|P1|Overall Study|Adverse Event|14
53524|NCT01327885|214249|P2|Overall Study|Clinical progression|27
53525|NCT01327885|214250|P1|Overall Study|Clinical progression|24
53526|NCT01327885|214249|P2|Overall Study|Disease progression-according to RECIST|165
53527|NCT01327885|214250|P1|Overall Study|Disease progression-according to RECIST|173
53528|NCT01327703|214262|P2|Second Treatment Period|Protocol Violation|1
53529|NCT01327703|214263|P1|Second Treatment Period|Protocol Violation|0
53530|NCT01327703|214262|P2|Second Treatment Period|Adverse Event|1
53531|NCT01327703|214263|P1|Second Treatment Period|Adverse Event|1
53532|NCT01327651|214319|P9|Post Study Follow-up|Lost to Follow-up|2
53533|NCT01327651|214320|P8|Post Study Follow-up|Lost to Follow-up|1
53534|NCT01327651|214321|P7|Post Study Follow-up|Lost to Follow-up|4
53535|NCT01327651|214322|P6|Post Study Follow-up|Lost to Follow-up|0
53536|NCT01327651|214323|P5|Post Study Follow-up|Lost to Follow-up|0
53537|NCT01327651|214324|P4|Post Study Follow-up|Lost to Follow-up|0
53538|NCT01327651|214325|P3|Post Study Follow-up|Lost to Follow-up|1
53539|NCT01327651|214326|P2|Post Study Follow-up|Lost to Follow-up|1
53540|NCT01327651|214327|P1|Post Study Follow-up|Lost to Follow-up|0
53541|NCT01327651|214319|P9|Self-administered Dosing Period|Withdrawal by Subject|1
53542|NCT01327651|214320|P8|Self-administered Dosing Period|Withdrawal by Subject|1
53543|NCT01327651|214321|P7|Self-administered Dosing Period|Withdrawal by Subject|2
53544|NCT01327651|214322|P6|Self-administered Dosing Period|Withdrawal by Subject|0
53545|NCT01327651|214323|P5|Self-administered Dosing Period|Withdrawal by Subject|0
53546|NCT01327651|214324|P4|Self-administered Dosing Period|Withdrawal by Subject|1
53547|NCT01327651|214325|P3|Self-administered Dosing Period|Withdrawal by Subject|0
53548|NCT01327651|214326|P2|Self-administered Dosing Period|Withdrawal by Subject|1
53549|NCT01327651|214327|P1|Self-administered Dosing Period|Withdrawal by Subject|0
53550|NCT01327651|214319|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
53551|NCT01327651|214320|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
53552|NCT01327651|214321|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
53553|NCT01327651|214322|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
53554|NCT01327651|214323|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
53555|NCT01327651|214324|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
53556|NCT01327651|214325|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
53557|NCT01327651|214326|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
53558|NCT01327651|214327|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
53559|NCT01327651|214319|P9|Self-administered Dosing Period|Lost to Follow-up|10
53560|NCT01327651|214320|P8|Self-administered Dosing Period|Lost to Follow-up|9
53561|NCT01327651|214321|P7|Self-administered Dosing Period|Lost to Follow-up|8
53562|NCT01327651|214322|P6|Self-administered Dosing Period|Lost to Follow-up|0
53563|NCT01327651|214323|P5|Self-administered Dosing Period|Lost to Follow-up|3
53564|NCT01327651|214324|P4|Self-administered Dosing Period|Lost to Follow-up|2
53565|NCT01327651|214325|P3|Self-administered Dosing Period|Lost to Follow-up|4
53566|NCT01327651|214326|P2|Self-administered Dosing Period|Lost to Follow-up|2
53567|NCT01327651|214327|P1|Self-administered Dosing Period|Lost to Follow-up|3
53568|NCT01327599|214446|P1|Overall Study|Withdrawal of Consent|1
53569|NCT01327599|214446|P1|Overall Study|Could Not Attend Visit|1
53570|NCT01327599|214446|P1|Overall Study|Adverse Event|1
53571|NCT01327547|214456|P2|Overall Study|Continuing in the study|56
53572|NCT01327547|214457|P1|Overall Study|Continuing in the study|56
53573|NCT01327547|214456|P2|Overall Study|Non-compliance with study procedures|0
53574|NCT01327547|214457|P1|Overall Study|Non-compliance with study procedures|1
53575|NCT01327547|214456|P2|Overall Study|Requirement for prohibited medication|0
53576|NCT01327547|214457|P1|Overall Study|Requirement for prohibited medication|2
53577|NCT01327547|214456|P2|Overall Study|Non-compliance - alcohol consumption|1
53578|NCT01327547|214457|P1|Overall Study|Non-compliance - alcohol consumption|0
53579|NCT01327547|214456|P2|Overall Study|Does Not Meet Entrance Criteria|2
53580|NCT01327547|214457|P1|Overall Study|Does Not Meet Entrance Criteria|2
53581|NCT01327547|214456|P2|Overall Study|Withdrawal by Subject|4
53582|NCT01327547|214457|P1|Overall Study|Withdrawal by Subject|2
53583|NCT01327547|214456|P2|Overall Study|Non-Compliance With Study Treatment|1
53584|NCT01327547|214457|P1|Overall Study|Non-Compliance With Study Treatment|0
53585|NCT01327547|214456|P2|Overall Study|Lost to Follow-up|1
53586|NCT01327547|214457|P1|Overall Study|Lost to Follow-up|3
53587|NCT01327547|214456|P2|Overall Study|Death|1
53588|NCT01327547|214457|P1|Overall Study|Death|0
53589|NCT01327547|214456|P2|Overall Study|Adverse Event|1
53590|NCT01327547|214457|P1|Overall Study|Adverse Event|4
53591|NCT01327482|214502|P1|Overall Study|Adverse Event|1
53592|NCT01327339|214507|P1|Overall Study|Protocol Violation|8
53593|NCT01327300|214642|P2|Washout (3 Weeks)|Withdrawal by Subject|0
53594|NCT01327300|214643|P1|Washout (3 Weeks)|Withdrawal by Subject|1
53595|NCT01327053|214661|P2|Overall Study|Untreated|1
53596|NCT01327053|214662|P1|Overall Study|Untreated|0
53597|NCT01327053|214661|P2|Overall Study|Withdrawal by Subject|28
53598|NCT01327053|214662|P1|Overall Study|Withdrawal by Subject|5
53599|NCT01327053|214661|P2|Overall Study|Protocol Violation|1
53600|NCT01327053|214662|P1|Overall Study|Protocol Violation|0
53601|NCT01327053|214661|P2|Overall Study|Progressive Disease|6
53602|NCT01327053|214662|P1|Overall Study|Progressive Disease|15
53603|NCT01327053|214661|P2|Overall Study|Physician Decision|10
53604|NCT01327053|214662|P1|Overall Study|Physician Decision|3
53605|NCT01327053|214661|P2|Overall Study|Non-compliance with study treatment|3
53606|NCT01327053|214662|P1|Overall Study|Non-compliance with study treatment|0
53607|NCT01327053|214661|P2|Overall Study|Lost to Follow-up|4
53608|NCT01327053|214662|P1|Overall Study|Lost to Follow-up|1
53609|NCT01327053|214661|P2|Overall Study|Death|4
53610|NCT01327053|214662|P1|Overall Study|Death|0
53611|NCT01327053|214661|P2|Overall Study|Adverse Event|48
53612|NCT01327053|214662|P1|Overall Study|Adverse Event|16
53613|NCT01326962|214690|P1|Overall Study|Not Specified|2
53614|NCT01326962|214690|P1|Overall Study|Lost to Follow-up|3
53615|NCT01326962|214690|P1|Overall Study|Withdrawal by Subject|1
53616|NCT01326962|214690|P1|Overall Study|Adverse Event|1
53617|NCT01326910|214708|P2|Overall Study|Protocol Violation|1
53618|NCT01326910|214709|P1|Overall Study|Protocol Violation|1
53619|NCT01326910|214708|P2|Overall Study|Withdrawal by Subject|2
53620|NCT01326910|214709|P1|Overall Study|Withdrawal by Subject|3
53621|NCT01326845|214723|P2|Overall Study|Misisng|3
53622|NCT01326845|214724|P1|Overall Study|Misisng|1
53623|NCT01326845|214723|P2|Overall Study|Adverse Event|0
53624|NCT01326845|214724|P1|Overall Study|Adverse Event|1
53625|NCT01326845|214723|P2|Overall Study|Administrative Problems|2
53626|NCT01326845|214724|P1|Overall Study|Administrative Problems|5
53627|NCT01326533|214748|P2|Overall Study|Adverse Event|0
53628|NCT01326533|214749|P1|Overall Study|Adverse Event|1
53629|NCT01326533|214748|P2|Overall Study|Withdrawal by Subject|0
53630|NCT01326533|214749|P1|Overall Study|Withdrawal by Subject|1
53631|NCT01326533|214748|P2|Overall Study|Lost to Follow-up|0
53632|NCT01326533|214749|P1|Overall Study|Lost to Follow-up|2
53633|NCT01326026|214759|P2|Overall Study|Other|3
53634|NCT01326026|214760|P1|Overall Study|Other|3
53635|NCT01326026|214759|P2|Overall Study|Withdrawal Criteria|7
53636|NCT01326026|214760|P1|Overall Study|Withdrawal Criteria|5
53637|NCT01326026|214759|P2|Overall Study|Adverse Event|3
53638|NCT01326026|214760|P1|Overall Study|Adverse Event|4
53639|NCT01325701|214825|P2|Overall Study|Rollerover Extension Study|0
53640|NCT01325701|214826|P1|Overall Study|Rollerover Extension Study|4
53641|NCT01325701|214825|P2|Overall Study|Withdrawal by Subject|1
53642|NCT01325701|214826|P1|Overall Study|Withdrawal by Subject|2
53643|NCT01325701|214825|P2|Overall Study|Physician Decision|2
53644|NCT01325701|214826|P1|Overall Study|Physician Decision|2
53645|NCT01325701|214825|P2|Overall Study|Protocol Violation|0
53646|NCT01325701|214826|P1|Overall Study|Protocol Violation|1
53647|NCT01325701|214825|P2|Overall Study|Adverse Event|0
53648|NCT01325701|214826|P1|Overall Study|Adverse Event|12
53649|NCT01325623|214836|P1|Overall Study|Withdrawal by Subject|3
53650|NCT01325532|214880|P2|Overall Study|Withdrawal by Subject|0
53651|NCT01325532|214881|P1|Overall Study|Withdrawal by Subject|2
53652|NCT01325493|214893|P2|Overall Study|Allergy|0
53653|NCT01325493|214894|P1|Overall Study|Allergy|1
53654|NCT01325493|214893|P2|Overall Study|loss of neuromonitoring signals|2
53655|NCT01325493|214894|P1|Overall Study|loss of neuromonitoring signals|0
53656|NCT01325493|214893|P2|Overall Study|Protocol Violation|1
53657|NCT01325493|214894|P1|Overall Study|Protocol Violation|0
53658|NCT01325428|214906|P1|Part B|Other reason not defined above|1
53659|NCT01325428|214906|P1|Part B|Refused continue taking trial medication|2
53660|NCT01325428|214906|P1|Part A|Other reason not defined above|2
53661|NCT01325428|214906|P1|Part A|Refused continue taking trial medication|2
53662|NCT01325428|214906|P1|Part A|Other adverse event|1
53663|NCT01325428|214906|P1|Part A|Clinical signs, symptoms of progression|2
53664|NCT01325428|214906|P1|Part A|Progressive disease according to RECIST|9
53665|NCT01325350|214926|P5|Overall Study|Did Not Receive Treatment|1
53666|NCT01325350|214927|P4|Overall Study|Did Not Receive Treatment|0
53667|NCT01325350|214928|P3|Overall Study|Did Not Receive Treatment|1
53668|NCT01325350|214929|P2|Overall Study|Did Not Receive Treatment|1
53669|NCT01325350|214930|P1|Overall Study|Did Not Receive Treatment|0
53670|NCT01325350|214926|P5|Overall Study|Withdrawal by Subject|0
53671|NCT01325350|214927|P4|Overall Study|Withdrawal by Subject|1
53672|NCT01325350|214928|P3|Overall Study|Withdrawal by Subject|1
53673|NCT01325350|214929|P2|Overall Study|Withdrawal by Subject|0
53674|NCT01325350|214930|P1|Overall Study|Withdrawal by Subject|0
53675|NCT01325350|214926|P5|Overall Study|Protocol Violation|0
53676|NCT01325350|214927|P4|Overall Study|Protocol Violation|1
53677|NCT01325350|214928|P3|Overall Study|Protocol Violation|0
53678|NCT01325350|214929|P2|Overall Study|Protocol Violation|0
53679|NCT01325350|214930|P1|Overall Study|Protocol Violation|0
53680|NCT01325350|214926|P5|Overall Study|Personal Reasons|3
53681|NCT01325350|214927|P4|Overall Study|Personal Reasons|5
53682|NCT01325350|214928|P3|Overall Study|Personal Reasons|6
53683|NCT01325350|214929|P2|Overall Study|Personal Reasons|1
53684|NCT01325350|214930|P1|Overall Study|Personal Reasons|2
53685|NCT01325350|214926|P5|Overall Study|Lost to Follow-up|5
53686|NCT01325350|214927|P4|Overall Study|Lost to Follow-up|1
53687|NCT01325350|214928|P3|Overall Study|Lost to Follow-up|5
53688|NCT01325350|214929|P2|Overall Study|Lost to Follow-up|0
53689|NCT01325350|214930|P1|Overall Study|Lost to Follow-up|1
53690|NCT01325350|214926|P5|Overall Study|Pregnancy|1
53691|NCT01325350|214927|P4|Overall Study|Pregnancy|0
53692|NCT01325350|214928|P3|Overall Study|Pregnancy|1
53693|NCT01325350|214929|P2|Overall Study|Pregnancy|0
53694|NCT01325350|214930|P1|Overall Study|Pregnancy|0
53695|NCT01325350|214926|P5|Overall Study|Adverse Event|2
53696|NCT01325350|214927|P4|Overall Study|Adverse Event|1
53697|NCT01325350|214928|P3|Overall Study|Adverse Event|3
53698|NCT01325350|214929|P2|Overall Study|Adverse Event|3
53699|NCT01325350|214930|P1|Overall Study|Adverse Event|3
53700|NCT01325337|214972|P5|Overall Study|Withdrawal by Subject|1
53701|NCT01325337|214973|P4|Overall Study|Withdrawal by Subject|0
53702|NCT01325337|214974|P3|Overall Study|Withdrawal by Subject|1
53703|NCT01325337|214975|P2|Overall Study|Withdrawal by Subject|0
53704|NCT01325337|214976|P1|Overall Study|Withdrawal by Subject|1
53705|NCT01325337|214972|P5|Overall Study|Personal Reasons|3
53706|NCT01325337|214973|P4|Overall Study|Personal Reasons|8
53707|NCT01325337|214974|P3|Overall Study|Personal Reasons|4
53708|NCT01325337|214975|P2|Overall Study|Personal Reasons|5
53709|NCT01325337|214976|P1|Overall Study|Personal Reasons|2
53710|NCT01325337|214972|P5|Overall Study|Lost to Follow-up|2
53711|NCT01325337|214973|P4|Overall Study|Lost to Follow-up|1
53712|NCT01325337|214974|P3|Overall Study|Lost to Follow-up|2
53713|NCT01325337|214975|P2|Overall Study|Lost to Follow-up|2
53714|NCT01325337|214976|P1|Overall Study|Lost to Follow-up|2
53715|NCT01325337|214972|P5|Overall Study|Adverse Event|2
53716|NCT01325337|214973|P4|Overall Study|Adverse Event|1
53717|NCT01325337|214974|P3|Overall Study|Adverse Event|2
53718|NCT01325337|214975|P2|Overall Study|Adverse Event|2
53719|NCT01325337|214976|P1|Overall Study|Adverse Event|0
53720|NCT01324999|215059|P1|Overall Study|Withdrawal by Subject|2
53721|NCT01324999|215059|P1|Overall Study|Adverse Event|3
53722|NCT01324947|215070|P1|Overall Study|1 discontinued before starting drug|1
53723|NCT01324947|215070|P1|Overall Study|Withdrawal by Subject|3
53724|NCT01324947|215070|P1|Overall Study|Progressive Disease|50
53725|NCT01324947|215070|P1|Overall Study|Unspecified|3
53726|NCT01324947|215070|P1|Overall Study|Death|10
53727|NCT01324947|215070|P1|Overall Study|Adverse Event|7
53728|NCT01324622|215103|P2|Overall Study|Lack of Efficacy|0
53729|NCT01324622|215104|P1|Overall Study|Lack of Efficacy|1
53730|NCT01324622|215103|P2|Overall Study|Death|0
53731|NCT01324622|215104|P1|Overall Study|Death|1
53732|NCT01324622|215103|P2|Overall Study|Lost to Follow-up|7
53733|NCT01324622|215104|P1|Overall Study|Lost to Follow-up|7
53734|NCT01324570|215134|P2|Overall Study|Administrative|2
53735|NCT01324570|215135|P1|Overall Study|Administrative|0
53736|NCT01324570|215134|P2|Overall Study|Confirmed or suspected diversion|1
53737|NCT01324570|215135|P1|Overall Study|Confirmed or suspected diversion|0
53738|NCT01324570|215134|P2|Overall Study|Lack of Efficacy|1
53739|NCT01324570|215135|P1|Overall Study|Lack of Efficacy|0
53740|NCT01324570|215134|P2|Overall Study|Withdrawal by Subject|3
53741|NCT01324570|215135|P1|Overall Study|Withdrawal by Subject|0
53742|NCT01324570|215134|P2|Overall Study|Adverse Event|7
53743|NCT01324570|215135|P1|Overall Study|Adverse Event|4
53744|NCT01324440|215149|P2|Overall Study|Subject moved|1
53745|NCT01324440|215150|P1|Overall Study|Subject moved|0
53746|NCT01324401|215164|P2|Overall Study|Adverse Event|3
53747|NCT01324401|215165|P1|Overall Study|Adverse Event|1
53748|NCT01324401|215164|P2|Overall Study|Withdrawn before any treatment|3
53749|NCT01324401|215165|P1|Overall Study|Withdrawn before any treatment|0
53750|NCT01324388|215176|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
53751|NCT01324388|215177|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
53752|NCT01324388|215178|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
53753|NCT01324388|215179|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
53754|NCT01324388|215176|P4|Part 2 of Study: First Intervention|Protocol Violation|1
53755|NCT01324388|215177|P3|Part 2 of Study: First Intervention|Protocol Violation|0
53756|NCT01324388|215178|P2|Part 2 of Study: First Intervention|Protocol Violation|0
53757|NCT01324388|215179|P1|Part 2 of Study: First Intervention|Protocol Violation|0
53758|NCT01324388|215176|P4|Part 1 of Study|Physician Decision|0
53759|NCT01324388|215177|P3|Part 1 of Study|Physician Decision|0
53760|NCT01324388|215178|P2|Part 1 of Study|Physician Decision|0
53761|NCT01324388|215179|P1|Part 1 of Study|Physician Decision|1
53762|NCT01324388|215176|P4|Part 1 of Study|Protocol Violation|0
53763|NCT01324388|215177|P3|Part 1 of Study|Protocol Violation|0
53764|NCT01324388|215178|P2|Part 1 of Study|Protocol Violation|2
53765|NCT01324388|215179|P1|Part 1 of Study|Protocol Violation|1
53766|NCT01324388|215176|P4|Part 1 of Study|Adverse Event|0
53767|NCT01324388|215177|P3|Part 1 of Study|Adverse Event|0
53768|NCT01324388|215178|P2|Part 1 of Study|Adverse Event|0
53769|NCT01324388|215179|P1|Part 1 of Study|Adverse Event|2
53770|NCT01324349|215200|P2|Overall Study|Withdrawal by Subject|1
53771|NCT01324349|215201|P1|Overall Study|Withdrawal by Subject|0
53772|NCT01324349|215200|P2|Overall Study|Death|1
53773|NCT01324349|215201|P1|Overall Study|Death|1
53774|NCT01324323|215211|P1|Overall Study|Withdrawal by Subject|1
53775|NCT01324310|215231|P1|Overall Study|Disease Progression|1
53776|NCT01324310|215231|P1|Overall Study|Adverse Event|1
53777|NCT01324271|215251|P2|Overall Study|Physician Decision|0
53778|NCT01324271|215252|P1|Overall Study|Physician Decision|1
53779|NCT01324271|215251|P2|Overall Study|Lost to Follow-up|0
53780|NCT01324271|215252|P1|Overall Study|Lost to Follow-up|3
53781|NCT01324102|215275|P2|Overall Study|illness|6
53782|NCT01324102|215276|P1|Overall Study|illness|1
53783|NCT01324024|215283|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
53784|NCT01324024|215284|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
53785|NCT01323972|215322|P4|Overall Study|Lost to Follow-up|1
53786|NCT01323972|215323|P3|Overall Study|Lost to Follow-up|1
53787|NCT01323972|215324|P2|Overall Study|Lost to Follow-up|1
53788|NCT01323972|215325|P1|Overall Study|Lost to Follow-up|0
53789|NCT01323972|215322|P4|Overall Study|Migrated/moved from study area|0
53790|NCT01323972|215323|P3|Overall Study|Migrated/moved from study area|0
53791|NCT01323972|215324|P2|Overall Study|Migrated/moved from study area|2
53792|NCT01323972|215325|P1|Overall Study|Migrated/moved from study area|1
53793|NCT01323972|215322|P4|Overall Study|Withdrawal by Subject|0
53794|NCT01323972|215323|P3|Overall Study|Withdrawal by Subject|1
53795|NCT01323972|215324|P2|Overall Study|Withdrawal by Subject|0
53796|NCT01323972|215325|P1|Overall Study|Withdrawal by Subject|1
53797|NCT01323920|215418|P1|Overall Study|Withdrawal by Subject|1
53798|NCT01323920|215418|P1|Overall Study|Death|5
53799|NCT01323790|215459|P3|Overall Study|Severe non-compliance with protocol|2
53800|NCT01323790|215460|P2|Overall Study|Severe non-compliance with protocol|2
53801|NCT01323790|215461|P1|Overall Study|Severe non-compliance with protocol|2
53802|NCT01323790|215459|P3|Overall Study|Did Not Receive Treatment|1
53803|NCT01323790|215460|P2|Overall Study|Did Not Receive Treatment|0
53804|NCT01323790|215461|P1|Overall Study|Did Not Receive Treatment|2
53805|NCT01323790|215459|P3|Overall Study|Withdrawal by Subject|13
53806|NCT01323790|215460|P2|Overall Study|Withdrawal by Subject|20
53807|NCT01323790|215461|P1|Overall Study|Withdrawal by Subject|23
53808|NCT01323790|215459|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
53809|NCT01323790|215460|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
53810|NCT01323790|215461|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
53811|NCT01323790|215459|P3|Overall Study|Adverse Event|12
53812|NCT01323790|215460|P2|Overall Study|Adverse Event|24
53813|NCT01323790|215461|P1|Overall Study|Adverse Event|11
53814|NCT01323790|215459|P3|Overall Study|Lack of Efficacy|3
53815|NCT01323790|215460|P2|Overall Study|Lack of Efficacy|0
53816|NCT01323790|215461|P1|Overall Study|Lack of Efficacy|3
53817|NCT01323790|215459|P3|Overall Study|Study-Specific Withdrawal Criteria|3
53818|NCT01323790|215460|P2|Overall Study|Study-Specific Withdrawal Criteria|3
53819|NCT01323790|215461|P1|Overall Study|Study-Specific Withdrawal Criteria|0
53820|NCT01323790|215459|P3|Overall Study|Lost to Follow-up|9
53821|NCT01323790|215460|P2|Overall Study|Lost to Follow-up|9
53822|NCT01323790|215461|P1|Overall Study|Lost to Follow-up|11
53823|NCT01323790|215459|P3|Overall Study|Other|1
53824|NCT01323790|215460|P2|Overall Study|Other|2
53825|NCT01323790|215461|P1|Overall Study|Other|3
53826|NCT01323673|215512|P2|Overall Study|Withdrawal by Subject|3
53827|NCT01323673|215513|P1|Overall Study|Withdrawal by Subject|2
53828|NCT01323673|215512|P2|Overall Study|Protocol Violation|0
53829|NCT01323673|215513|P1|Overall Study|Protocol Violation|1
53830|NCT01323673|215512|P2|Overall Study|Lost to Follow-up|1
53831|NCT01323673|215513|P1|Overall Study|Lost to Follow-up|0
53832|NCT01323673|215512|P2|Overall Study|Adverse Event|1
53833|NCT01323673|215513|P1|Overall Study|Adverse Event|0
53834|NCT01323660|215533|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53835|NCT01323660|215534|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
53836|NCT01323660|215535|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
53837|NCT01323660|215536|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
53838|NCT01323660|215537|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
53839|NCT01323660|215538|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
53840|NCT01323660|215533|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
53841|NCT01323660|215534|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
53842|NCT01323660|215535|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
53843|NCT01323660|215536|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
53844|NCT01323660|215537|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
53845|NCT01323660|215538|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
53846|NCT01323660|215533|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
53847|NCT01323660|215534|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
53848|NCT01323660|215535|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
53849|NCT01323660|215536|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
53850|NCT01323660|215537|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
53851|NCT01323660|215538|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
53852|NCT01323660|215533|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
53853|NCT01323660|215534|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
53854|NCT01323660|215535|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
53855|NCT01323660|215536|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
53856|NCT01323660|215537|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
53857|NCT01323660|215538|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
53858|NCT01323660|215533|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
53859|NCT01323660|215534|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
53860|NCT01323660|215535|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
53861|NCT01323660|215536|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
53862|NCT01323660|215537|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
53863|NCT01323660|215538|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
53864|NCT01323660|215533|P6|Washout Period (14 Days)|Lack of Efficacy|2
53865|NCT01323660|215534|P5|Washout Period (14 Days)|Lack of Efficacy|2
53866|NCT01323660|215535|P4|Washout Period (14 Days)|Lack of Efficacy|3
53867|NCT01323660|215536|P3|Washout Period (14 Days)|Lack of Efficacy|1
53868|NCT01323660|215537|P2|Washout Period (14 Days)|Lack of Efficacy|0
53869|NCT01323660|215538|P1|Washout Period (14 Days)|Lack of Efficacy|0
53870|NCT01323660|215533|P6|Washout Period (14 Days)|Adverse Event|0
53871|NCT01323660|215534|P5|Washout Period (14 Days)|Adverse Event|1
53872|NCT01323660|215535|P4|Washout Period (14 Days)|Adverse Event|0
53873|NCT01323660|215536|P3|Washout Period (14 Days)|Adverse Event|0
53874|NCT01323660|215537|P2|Washout Period (14 Days)|Adverse Event|0
53875|NCT01323660|215538|P1|Washout Period (14 Days)|Adverse Event|0
53876|NCT01323660|215533|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
53877|NCT01323660|215534|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
53878|NCT01323660|215535|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
53879|NCT01323660|215536|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
53880|NCT01323660|215537|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
53881|NCT01323660|215538|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
53882|NCT01323660|215533|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53883|NCT01323660|215534|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
53884|NCT01323660|215535|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53885|NCT01323660|215536|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53886|NCT01323660|215537|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53887|NCT01323660|215538|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
53888|NCT01323660|215533|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
53889|NCT01323660|215534|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
53890|NCT01323660|215535|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
53891|NCT01323660|215536|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
53892|NCT01323660|215537|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
53893|NCT01323660|215538|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
53894|NCT01323660|215533|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
53895|NCT01323660|215534|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
53896|NCT01323660|215535|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
53897|NCT01323660|215536|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
53898|NCT01323660|215537|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
53899|NCT01323660|215538|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
53900|NCT01323660|215533|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
53901|NCT01323660|215534|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
53902|NCT01323660|215535|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
53903|NCT01323660|215536|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
53904|NCT01323660|215537|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
53905|NCT01323660|215538|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
53906|NCT01323660|215533|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
53907|NCT01323660|215534|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
53908|NCT01323660|215535|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
53909|NCT01323660|215536|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
53910|NCT01323660|215537|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
53911|NCT01323660|215538|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
53912|NCT01323647|215584|P2|Overall Study|Lost to Follow-up|0
53913|NCT01323647|215585|P1|Overall Study|Lost to Follow-up|2
53914|NCT01323647|215584|P2|Overall Study|Withdrawal by Subject|0
53915|NCT01323647|215585|P1|Overall Study|Withdrawal by Subject|5
53916|NCT01323647|215584|P2|Overall Study|Migrated/moved from study area|0
53917|NCT01323647|215585|P1|Overall Study|Migrated/moved from study area|2
53918|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
53919|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
53920|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
53921|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
53922|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
53923|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
53924|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
53925|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
53926|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
53927|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
53928|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
53929|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
53930|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
53931|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
53932|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
53933|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
53934|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
53935|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
53936|NCT01323634|215602|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
53937|NCT01323634|215603|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
53938|NCT01323634|215604|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
53939|NCT01323634|215602|P3|2-week Run-in Period|Adverse Event|0
53940|NCT01323634|215603|P2|2-week Run-in Period|Adverse Event|0
53941|NCT01323634|215604|P1|2-week Run-in Period|Adverse Event|1
53942|NCT01323634|215602|P3|2-week Run-in Period|Protocol Violation|0
53943|NCT01323634|215603|P2|2-week Run-in Period|Protocol Violation|0
53944|NCT01323634|215604|P1|2-week Run-in Period|Protocol Violation|1
53945|NCT01323634|215602|P3|2-week Run-in Period|Physician Decision|0
53946|NCT01323634|215603|P2|2-week Run-in Period|Physician Decision|0
53947|NCT01323634|215604|P1|2-week Run-in Period|Physician Decision|5
53948|NCT01323634|215602|P3|2-week Run-in Period|Withdrawal by Subject|0
53949|NCT01323634|215603|P2|2-week Run-in Period|Withdrawal by Subject|0
53950|NCT01323634|215604|P1|2-week Run-in Period|Withdrawal by Subject|7
53951|NCT01323634|215602|P3|2-week Run-in Period|Continuation Criteria not Met|0
53952|NCT01323634|215603|P2|2-week Run-in Period|Continuation Criteria not Met|0
53953|NCT01323634|215604|P1|2-week Run-in Period|Continuation Criteria not Met|73
53954|NCT01323634|215602|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
53955|NCT01323634|215603|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
53956|NCT01323634|215604|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
53957|NCT01323621|215614|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
53958|NCT01323621|215615|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
53959|NCT01323621|215616|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
53960|NCT01323621|215614|P3|12-week, Double-blind Treatment Period|Physician Decision|1
53961|NCT01323621|215615|P2|12-week, Double-blind Treatment Period|Physician Decision|2
53962|NCT01323621|215616|P1|12-week, Double-blind Treatment Period|Physician Decision|0
53963|NCT01323621|215614|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
53964|NCT01323621|215615|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
53965|NCT01323621|215616|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
53966|NCT01323621|215614|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
53967|NCT01323621|215615|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
53968|NCT01323621|215616|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
53969|NCT01323621|215614|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
53970|NCT01323621|215615|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
53971|NCT01323621|215616|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
53972|NCT01323621|215614|P3|12-week, Double-blind Treatment Period|Adverse Event|5
53973|NCT01323621|215615|P2|12-week, Double-blind Treatment Period|Adverse Event|1
53974|NCT01323621|215616|P1|12-week, Double-blind Treatment Period|Adverse Event|0
53975|NCT01323621|215614|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
53976|NCT01323621|215615|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
53977|NCT01323621|215616|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
53978|NCT01323621|215614|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
53979|NCT01323621|215615|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
53980|NCT01323621|215616|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
53981|NCT01323621|215614|P3|2-week, Single-blind Run In Period|Protocol Violation|0
53982|NCT01323621|215615|P2|2-week, Single-blind Run In Period|Protocol Violation|0
53983|NCT01323621|215616|P1|2-week, Single-blind Run In Period|Protocol Violation|1
53984|NCT01323621|215614|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
53985|NCT01323621|215615|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
53986|NCT01323621|215616|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
53987|NCT01323621|215614|P3|2-week, Single-blind Run In Period|Physician Decision|0
53988|NCT01323621|215615|P2|2-week, Single-blind Run In Period|Physician Decision|0
53989|NCT01323621|215616|P1|2-week, Single-blind Run In Period|Physician Decision|7
53990|NCT01323621|215614|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
53991|NCT01323621|215615|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
53992|NCT01323621|215616|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
53993|NCT01323582|215635|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
53994|NCT01323582|215636|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
53995|NCT01323582|215635|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
53996|NCT01323582|215636|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
53997|NCT01323582|215635|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
53998|NCT01323582|215636|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
53999|NCT01323478|215652|P1|Overall Study|Administrative or Other Reasons|8
54000|NCT01323478|215652|P1|Overall Study|Withdrawal of Consent|1
54001|NCT01323478|215652|P1|Overall Study|Protocol Violation|1
54002|NCT01323478|215652|P1|Overall Study|Non-compliance With Study Product|3
54003|NCT01323478|215652|P1|Overall Study|Lack of Efficacy|4
54004|NCT01323478|215652|P1|Overall Study|Adverse Event|7
54005|NCT01323387|215665|P1|Overall Study|radiographic data unavailable|1
54006|NCT01323387|215665|P1|Overall Study|Withdrawal by Subject|41
54007|NCT01323387|215665|P1|Overall Study|Revision|14
54008|NCT01323387|215665|P1|Overall Study|Withdrawal by Subject|1
54009|NCT01323387|215665|P1|Overall Study|Protocol Violation|11
54010|NCT01323387|215665|P1|Overall Study|Randomized but never treated|16
54011|NCT01323270|215678|P2|Overall Study|Randomized, but not vaccinated|0
54012|NCT01323270|215679|P1|Overall Study|Randomized, but not vaccinated|1
54013|NCT01323270|215678|P2|Overall Study|Death|0
54014|NCT01323270|215679|P1|Overall Study|Death|1
54015|NCT01323270|215678|P2|Overall Study|Not eligible|1
54016|NCT01323270|215679|P1|Overall Study|Not eligible|1
54017|NCT01323270|215678|P2|Overall Study|Physician Decision|2
54018|NCT01323270|215679|P1|Overall Study|Physician Decision|0
54019|NCT01323270|215678|P2|Overall Study|Unspecified|3
54020|NCT01323270|215679|P1|Overall Study|Unspecified|0
54021|NCT01323270|215678|P2|Overall Study|Adverse Event|0
54022|NCT01323270|215679|P1|Overall Study|Adverse Event|8
54023|NCT01323270|215678|P2|Overall Study|Lost to Follow-up|6
54024|NCT01323270|215679|P1|Overall Study|Lost to Follow-up|4
54025|NCT01323270|215678|P2|Overall Study|Protocol Violation|7
54026|NCT01323270|215679|P1|Overall Study|Protocol Violation|9
54027|NCT01323270|215678|P2|Overall Study|Withdrawal by Subject|10
54028|NCT01323270|215679|P1|Overall Study|Withdrawal by Subject|19
54029|NCT01323192|215701|P2|Overall Study|Nonmedical reasons|1
54030|NCT01323192|215702|P1|Overall Study|Nonmedical reasons|0
54031|NCT01323192|215701|P2|Overall Study|Noncompliance with study medication|3
54032|NCT01323192|215702|P1|Overall Study|Noncompliance with study medication|0
54033|NCT01323192|215701|P2|Overall Study|Withdrawal by Subject|1
54034|NCT01323192|215702|P1|Overall Study|Withdrawal by Subject|3
54035|NCT01323192|215701|P2|Overall Study|Adverse Event|1
54036|NCT01323192|215702|P1|Overall Study|Adverse Event|6
54037|NCT01322386|215941|P2|Overall Study|Physician Decision|1
54038|NCT01322386|215942|P1|Overall Study|Physician Decision|0
54039|NCT01322386|215941|P2|Overall Study|Protocol Violation|1
54040|NCT01322386|215942|P1|Overall Study|Protocol Violation|0
54041|NCT01322347|215957|P2|Overall Study|moved/changed dialysis|4
54042|NCT01322347|215958|P1|Overall Study|moved/changed dialysis|2
54043|NCT01322347|215957|P2|Overall Study|study drug withheld > 12 wks|1
54044|NCT01322347|215958|P1|Overall Study|study drug withheld > 12 wks|0
54045|NCT01322347|215957|P2|Overall Study|kidney transplant|1
54046|NCT01322347|215958|P1|Overall Study|kidney transplant|3
54047|NCT01322347|215957|P2|Overall Study|ineligible|3
54048|NCT01322347|215958|P1|Overall Study|ineligible|6
54049|NCT01322347|215957|P2|Overall Study|sponsor decision|3
54050|NCT01322347|215958|P1|Overall Study|sponsor decision|1
54051|NCT01322347|215957|P2|Overall Study|blood transfusion|5
54052|NCT01322347|215958|P1|Overall Study|blood transfusion|5
54053|NCT01322347|215957|P2|Overall Study|non-protocol change to ESA or IV iron|6
54054|NCT01322347|215958|P1|Overall Study|non-protocol change to ESA or IV iron|14
54055|NCT01322347|215957|P2|Overall Study|Withdrawal by Subject|4
54056|NCT01322347|215958|P1|Overall Study|Withdrawal by Subject|1
54057|NCT01322347|215957|P2|Overall Study|Protocol Violation|2
54058|NCT01322347|215958|P1|Overall Study|Protocol Violation|5
54059|NCT01322347|215957|P2|Overall Study|Physician Decision|1
54060|NCT01322347|215958|P1|Overall Study|Physician Decision|2
54061|NCT01322347|215957|P2|Overall Study|Death|3
54062|NCT01322347|215958|P1|Overall Study|Death|5
54063|NCT01322347|215957|P2|Overall Study|Adverse Event|2
54064|NCT01322347|215958|P1|Overall Study|Adverse Event|7
54065|NCT01322009|216021|P2|Overall Study|ng tube discontinued|1
54066|NCT01322009|216022|P1|Overall Study|ng tube discontinued|0
54067|NCT01322009|216021|P2|Overall Study|Adverse Event|1
54068|NCT01322009|216022|P1|Overall Study|Adverse Event|0
54069|NCT01322009|216021|P2|Overall Study|Death|1
54070|NCT01322009|216022|P1|Overall Study|Death|0
54071|NCT01321749|216032|P2|Overall Study|Withdrawal by Subject|4
54072|NCT01321749|216033|P1|Overall Study|Withdrawal by Subject|5
54073|NCT01321749|216032|P2|Overall Study|Protocol Violation|7
54074|NCT01321749|216033|P1|Overall Study|Protocol Violation|4
54075|NCT01321749|216032|P2|Overall Study|Lost to Follow-up|11
54076|NCT01321749|216033|P1|Overall Study|Lost to Follow-up|4
54077|NCT01321723|216042|P3|Overall Study|Withdrawal by Subject|2
54078|NCT01321723|216043|P2|Overall Study|Withdrawal by Subject|0
54079|NCT01321723|216044|P1|Overall Study|Withdrawal by Subject|2
54080|NCT01321723|216042|P3|Overall Study|Adverse Event|2
54081|NCT01321723|216043|P2|Overall Study|Adverse Event|5
54082|NCT01321723|216044|P1|Overall Study|Adverse Event|3
54083|NCT01321710|216066|P3|Overall Study|Lost to Follow-up|0
54084|NCT01321710|216067|P2|Overall Study|Lost to Follow-up|5
54085|NCT01321710|216068|P1|Overall Study|Lost to Follow-up|4
54086|NCT01321697|216083|P1|Overall Study|Study Terminated|7
54087|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Death|1
54088|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Death|1
54089|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Death|0
54090|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Death|0
54091|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Worsening disease|0
54092|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Worsening disease|1
54093|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Worsening disease|0
54094|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Worsening disease|0
54095|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
54096|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Lost to Follow-up|1
54097|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
54098|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Lost to Follow-up|0
54099|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Not specified|0
54100|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Not specified|5
54101|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Not specified|0
54102|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Not specified|0
54103|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
54104|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Withdrawal by Subject|1
54105|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
54106|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Withdrawal by Subject|0
54107|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Participant choice|0
54108|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Participant choice|3
54109|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Participant choice|0
54110|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Participant choice|0
54111|NCT01321554|216110|P4|OOL Lenvatinib Treatment Period|Adverse Event|1
54112|NCT01321554|216111|P3|OOL Lenvatinib Treatment Period|Adverse Event|16
54113|NCT01321554|216112|P2|OOL Lenvatinib Treatment Period|Adverse Event|0
54114|NCT01321554|216113|P1|OOL Lenvatinib Treatment Period|Adverse Event|0
54115|NCT01321554|216110|P4|Randomization Phase|Death|0
54116|NCT01321554|216111|P3|Randomization Phase|Death|0
54117|NCT01321554|216112|P2|Randomization Phase|Death|1
54118|NCT01321554|216113|P1|Randomization Phase|Death|0
54119|NCT01321554|216110|P4|Randomization Phase|Withdrawal by Subject|0
54120|NCT01321554|216111|P3|Randomization Phase|Withdrawal by Subject|0
54121|NCT01321554|216112|P2|Randomization Phase|Withdrawal by Subject|0
54122|NCT01321554|216113|P1|Randomization Phase|Withdrawal by Subject|4
54123|NCT01321554|216110|P4|Randomization Phase|Participant choice|0
54124|NCT01321554|216111|P3|Randomization Phase|Participant choice|0
54125|NCT01321554|216112|P2|Randomization Phase|Participant choice|0
54126|NCT01321554|216113|P1|Randomization Phase|Participant choice|4
54127|NCT01321554|216110|P4|Randomization Phase|Adverse Event|0
54128|NCT01321554|216111|P3|Randomization Phase|Adverse Event|0
54129|NCT01321554|216112|P2|Randomization Phase|Adverse Event|3
54130|NCT01321554|216113|P1|Randomization Phase|Adverse Event|37
54131|NCT01321008|216126|P1|Overall Study|Early Study Termination|1
54132|NCT01320943|216132|P2|Overall Study|Randomized but not Treated|1
54133|NCT01320943|216133|P1|Overall Study|Randomized but not Treated|0
54134|NCT01320943|216132|P2|Overall Study|Physician Decision|1
54135|NCT01320943|216133|P1|Overall Study|Physician Decision|0
54136|NCT01320943|216132|P2|Overall Study|Lost to Follow-up|0
54137|NCT01320943|216133|P1|Overall Study|Lost to Follow-up|1
54138|NCT01320735|216167|P1|Overall Study|Investigator Unable to be Contacted|17
54139|NCT01320735|216167|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
54140|NCT01320735|216167|P1|Overall Study|Not Specified|1
54141|NCT01320735|216167|P1|Overall Study|Protocol Violation|1
54142|NCT01320735|216167|P1|Overall Study|Progression/Hormone-Refractory Pca|55
54143|NCT01320735|216167|P1|Overall Study|Administrative Reason|6
54144|NCT01320735|216167|P1|Overall Study|Lost to Follow-up|13
54145|NCT01320735|216167|P1|Overall Study|Withdrawal by Subject|3
54146|NCT01320735|216167|P1|Overall Study|Adverse Event|3
54147|NCT01320722|216189|P5|Overall Study|Withdrew due to Health Condition|1
54148|NCT01320722|216190|P4|Overall Study|Withdrew due to Health Condition|0
54149|NCT01320722|216191|P3|Overall Study|Withdrew due to Health Condition|0
54150|NCT01320722|216192|P2|Overall Study|Withdrew due to Health Condition|0
54151|NCT01320722|216193|P1|Overall Study|Withdrew due to Health Condition|0
54152|NCT01320722|216189|P5|Overall Study|Started an Exclusionary Medication|1
54153|NCT01320722|216190|P4|Overall Study|Started an Exclusionary Medication|0
54154|NCT01320722|216191|P3|Overall Study|Started an Exclusionary Medication|0
54155|NCT01320722|216192|P2|Overall Study|Started an Exclusionary Medication|0
54156|NCT01320722|216193|P1|Overall Study|Started an Exclusionary Medication|0
54157|NCT01320722|216189|P5|Overall Study|Pregnancy|0
54158|NCT01320722|216190|P4|Overall Study|Pregnancy|1
54159|NCT01320722|216191|P3|Overall Study|Pregnancy|0
54160|NCT01320722|216192|P2|Overall Study|Pregnancy|0
54161|NCT01320722|216193|P1|Overall Study|Pregnancy|0
54162|NCT01320722|216189|P5|Overall Study|Not Compliant with Study Procedures|0
54163|NCT01320722|216190|P4|Overall Study|Not Compliant with Study Procedures|4
54164|NCT01320722|216191|P3|Overall Study|Not Compliant with Study Procedures|0
54165|NCT01320722|216192|P2|Overall Study|Not Compliant with Study Procedures|0
54166|NCT01320722|216193|P1|Overall Study|Not Compliant with Study Procedures|0
54167|NCT01320722|216189|P5|Overall Study|Adverse Event|0
54168|NCT01320722|216190|P4|Overall Study|Adverse Event|6
54169|NCT01320722|216191|P3|Overall Study|Adverse Event|3
54170|NCT01320722|216192|P2|Overall Study|Adverse Event|0
54171|NCT01320722|216193|P1|Overall Study|Adverse Event|0
54172|NCT01320722|216189|P5|Overall Study|Non-compliant with Medication|0
54173|NCT01320722|216190|P4|Overall Study|Non-compliant with Medication|0
54174|NCT01320722|216191|P3|Overall Study|Non-compliant with Medication|1
54175|NCT01320722|216192|P2|Overall Study|Non-compliant with Medication|0
54176|NCT01320722|216193|P1|Overall Study|Non-compliant with Medication|0
54177|NCT01320722|216189|P5|Overall Study|Participant Developed a Rash|1
54178|NCT01320722|216190|P4|Overall Study|Participant Developed a Rash|1
54179|NCT01320722|216191|P3|Overall Study|Participant Developed a Rash|2
54180|NCT01320722|216192|P2|Overall Study|Participant Developed a Rash|0
54181|NCT01320722|216193|P1|Overall Study|Participant Developed a Rash|0
54182|NCT01320722|216189|P5|Overall Study|Not Available for the 8 Week Visit|0
54183|NCT01320722|216190|P4|Overall Study|Not Available for the 8 Week Visit|0
54184|NCT01320722|216191|P3|Overall Study|Not Available for the 8 Week Visit|0
54185|NCT01320722|216192|P2|Overall Study|Not Available for the 8 Week Visit|3
54186|NCT01320722|216193|P1|Overall Study|Not Available for the 8 Week Visit|0
54187|NCT01320722|216189|P5|Overall Study|Lost to Follow-up|3
54188|NCT01320722|216190|P4|Overall Study|Lost to Follow-up|1
54189|NCT01320722|216191|P3|Overall Study|Lost to Follow-up|0
54190|NCT01320722|216192|P2|Overall Study|Lost to Follow-up|1
54191|NCT01320722|216193|P1|Overall Study|Lost to Follow-up|0
54192|NCT01320722|216189|P5|Overall Study|Did not Receive Intervention|2
54193|NCT01320722|216190|P4|Overall Study|Did not Receive Intervention|1
54194|NCT01320722|216191|P3|Overall Study|Did not Receive Intervention|1
54195|NCT01320722|216192|P2|Overall Study|Did not Receive Intervention|2
54196|NCT01320722|216193|P1|Overall Study|Did not Receive Intervention|3
54197|NCT01320683|216230|P1|Overall Study|Positive antibody response|1
54198|NCT01320293|216235|P1|Overall Study|Adverse Event|1
54199|NCT01320293|216235|P1|Overall Study|Lack of Efficacy|1
54200|NCT01320202|216243|P2|Overall Study|regained renal function|0
54201|NCT01320202|216244|P1|Overall Study|regained renal function|1
54202|NCT01320202|216243|P2|Overall Study|ineligible|0
54203|NCT01320202|216244|P1|Overall Study|ineligible|3
54204|NCT01320202|216243|P2|Overall Study|sponsor request|0
54205|NCT01320202|216244|P1|Overall Study|sponsor request|2
54206|NCT01320202|216243|P2|Overall Study|moved/changed dialysis|2
54207|NCT01320202|216244|P1|Overall Study|moved/changed dialysis|5
54208|NCT01320202|216243|P2|Overall Study|blood transfusion|7
54209|NCT01320202|216244|P1|Overall Study|blood transfusion|1
54210|NCT01320202|216243|P2|Overall Study|kidney transplant|2
54211|NCT01320202|216244|P1|Overall Study|kidney transplant|1
54212|NCT01320202|216243|P2|Overall Study|non-protocol change to ESA or IV iron|20
54213|NCT01320202|216244|P1|Overall Study|non-protocol change to ESA or IV iron|17
54214|NCT01320202|216243|P2|Overall Study|Withdrawal by Subject|3
54215|NCT01320202|216244|P1|Overall Study|Withdrawal by Subject|10
54216|NCT01320202|216243|P2|Overall Study|Protocol Violation|1
54217|NCT01320202|216244|P1|Overall Study|Protocol Violation|2
54218|NCT01320202|216243|P2|Overall Study|Physician Decision|1
54219|NCT01320202|216244|P1|Overall Study|Physician Decision|3
54220|NCT01320202|216243|P2|Overall Study|Lost to Follow-up|0
54221|NCT01320202|216244|P1|Overall Study|Lost to Follow-up|1
54222|NCT01320202|216243|P2|Overall Study|Death|3
54223|NCT01320202|216244|P1|Overall Study|Death|5
54224|NCT01320202|216243|P2|Overall Study|Adverse Event|5
54225|NCT01320202|216244|P1|Overall Study|Adverse Event|5
54226|NCT01319877|216308|P2|Overall Study|Reason Not Specified|5
54227|NCT01319877|216309|P1|Overall Study|Reason Not Specified|4
54228|NCT01319877|216308|P2|Overall Study|Withdrawal by Subject|1
54229|NCT01319877|216309|P1|Overall Study|Withdrawal by Subject|0
54230|NCT01319877|216308|P2|Overall Study|Disease Progression|2
54231|NCT01319877|216309|P1|Overall Study|Disease Progression|2
54232|NCT01319877|216308|P2|Overall Study|Physician Decision|0
54233|NCT01319877|216309|P1|Overall Study|Physician Decision|2
54234|NCT01319877|216308|P2|Overall Study|Lost to Follow-up|37
54235|NCT01319877|216309|P1|Overall Study|Lost to Follow-up|100
54236|NCT01319721|216459|P2|Overall Study|Lost to Follow-up|6
54237|NCT01319721|216460|P1|Overall Study|Lost to Follow-up|1
54238|NCT01319422|216513|P2|Overall Study|Withdrawal by Subject|0
54239|NCT01319422|216514|P1|Overall Study|Withdrawal by Subject|1
54240|NCT01319383|216532|P2|Overall Study|No in vivo response to interval doses|1
54241|NCT01319383|216533|P1|Overall Study|No in vivo response to interval doses|0
54242|NCT01319383|216532|P2|Overall Study|Lack of Efficacy|9
54243|NCT01319383|216533|P1|Overall Study|Lack of Efficacy|5
54244|NCT01319383|216532|P2|Overall Study|Physician Decision|0
54245|NCT01319383|216533|P1|Overall Study|Physician Decision|3
54246|NCT01319383|216532|P2|Overall Study|No ex vivo or in vivo response|0
54247|NCT01319383|216533|P1|Overall Study|No ex vivo or in vivo response|4
54248|NCT01318382|216559|P1|Overall Study|Protocol Violation|1
54249|NCT01318382|216559|P1|Overall Study|Device Malfunction|10
54250|NCT01318382|216559|P1|Overall Study|Physician Decision|2
54251|NCT01318876|216589|P1|Day 29 Survey|survey not completed-don't know why|1825
54252|NCT01318876|216589|P1|Day 8 Survey|survey not completed-don't know why|1724
54253|NCT01318876|216589|P1|Day 8 Survey|email address invalid|96
54254|NCT01318512|216687|P1|Maintenance Period (6 Months)|Protocol Violation|9
54255|NCT01318512|216687|P1|Maintenance Period (6 Months)|Death|2
54256|NCT01318499|216706|P3|Overall Study|Not Specified|22
54257|NCT01318499|216707|P2|Overall Study|Not Specified|10
54258|NCT01318499|216708|P1|Overall Study|Not Specified|7
54259|NCT01318499|216706|P3|Overall Study|Patient Did Not Use Study Medication|14
54418|NCT01317641|217188|P8|Overall Study|Protocol Violation|0
54260|NCT01318499|216707|P2|Overall Study|Patient Did Not Use Study Medication|28
54261|NCT01318499|216708|P1|Overall Study|Patient Did Not Use Study Medication|18
54262|NCT01318499|216706|P3|Overall Study|Protocol Violation|2
54263|NCT01318499|216707|P2|Overall Study|Protocol Violation|4
54264|NCT01318499|216708|P1|Overall Study|Protocol Violation|2
54265|NCT01318499|216706|P3|Overall Study|Treatment Failure|101
54266|NCT01318499|216707|P2|Overall Study|Treatment Failure|19
54267|NCT01318499|216708|P1|Overall Study|Treatment Failure|19
54268|NCT01318499|216706|P3|Overall Study|Noncompliance|0
54269|NCT01318499|216707|P2|Overall Study|Noncompliance|3
54270|NCT01318499|216708|P1|Overall Study|Noncompliance|2
54271|NCT01318499|216706|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
54272|NCT01318499|216707|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
54273|NCT01318499|216708|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
54274|NCT01318499|216706|P3|Overall Study|Adverse Event|6
54275|NCT01318499|216707|P2|Overall Study|Adverse Event|11
54276|NCT01318499|216708|P1|Overall Study|Adverse Event|16
54277|NCT01318135|216777|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
54278|NCT01318135|216778|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54279|NCT01318135|216779|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54280|NCT01318135|216780|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54281|NCT01318135|216781|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54282|NCT01318135|216782|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54283|NCT01318135|216783|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54284|NCT01318135|216784|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
54285|NCT01318135|216777|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
54286|NCT01318135|216778|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
54287|NCT01318135|216779|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
54288|NCT01318135|216780|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
54289|NCT01318135|216781|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
54290|NCT01318135|216782|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
54291|NCT01318135|216783|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
54292|NCT01318135|216784|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
54293|NCT01318135|216777|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
54294|NCT01318135|216778|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
54295|NCT01318135|216779|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
54296|NCT01318135|216780|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
54297|NCT01318135|216781|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
54298|NCT01318135|216782|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
54299|NCT01318135|216783|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
54300|NCT01318135|216784|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
54301|NCT01318135|216777|P8|Entered - Long-Term Extension Study|Protocol Violation|0
54302|NCT01318135|216778|P7|Entered - Long-Term Extension Study|Protocol Violation|0
54303|NCT01318135|216779|P6|Entered - Long-Term Extension Study|Protocol Violation|0
54304|NCT01318135|216780|P5|Entered - Long-Term Extension Study|Protocol Violation|1
54305|NCT01318135|216781|P4|Entered - Long-Term Extension Study|Protocol Violation|0
54306|NCT01318135|216782|P3|Entered - Long-Term Extension Study|Protocol Violation|0
54307|NCT01318135|216783|P2|Entered - Long-Term Extension Study|Protocol Violation|1
54308|NCT01318135|216784|P1|Entered - Long-Term Extension Study|Protocol Violation|1
54309|NCT01318135|216777|P8|Entered - Long-Term Extension Study|Adverse Event|0
54310|NCT01318135|216778|P7|Entered - Long-Term Extension Study|Adverse Event|0
54311|NCT01318135|216779|P6|Entered - Long-Term Extension Study|Adverse Event|2
54312|NCT01318135|216780|P5|Entered - Long-Term Extension Study|Adverse Event|4
54313|NCT01318135|216781|P4|Entered - Long-Term Extension Study|Adverse Event|3
54314|NCT01318135|216782|P3|Entered - Long-Term Extension Study|Adverse Event|4
54315|NCT01318135|216783|P2|Entered - Long-Term Extension Study|Adverse Event|3
54316|NCT01318135|216784|P1|Entered - Long-Term Extension Study|Adverse Event|9
54317|NCT01318135|216777|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
54318|NCT01318135|216778|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
54319|NCT01318135|216779|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
54320|NCT01318135|216780|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
54321|NCT01318135|216781|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
54322|NCT01318135|216782|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
54323|NCT01318135|216783|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
54324|NCT01318135|216784|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
54325|NCT01318135|216777|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
54326|NCT01318135|216778|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
54327|NCT01318135|216779|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
54328|NCT01318135|216780|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
54329|NCT01318135|216781|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
54330|NCT01318135|216782|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
54331|NCT01318135|216783|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
54332|NCT01318135|216784|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
54333|NCT01318122|216916|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
54334|NCT01318122|216917|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
54335|NCT01318122|216918|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
54336|NCT01318122|216919|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
54337|NCT01318122|216916|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
54338|NCT01318122|216917|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
54339|NCT01318122|216918|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
54340|NCT01318122|216919|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
54341|NCT01318122|216916|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
54342|NCT01318122|216917|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
54343|NCT01318122|216918|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
54344|NCT01318122|216919|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
54345|NCT01318122|216916|P4|Entered - Long-Term Extension Study|Adverse Event|4
54346|NCT01318122|216917|P3|Entered - Long-Term Extension Study|Adverse Event|2
54347|NCT01318122|216918|P2|Entered - Long-Term Extension Study|Adverse Event|6
54348|NCT01318122|216919|P1|Entered - Long-Term Extension Study|Adverse Event|6
54349|NCT01318122|216916|P4|Enrolled - Long-Term Extension Study|Other|0
54350|NCT01318122|216917|P3|Enrolled - Long-Term Extension Study|Other|0
54351|NCT01318122|216918|P2|Enrolled - Long-Term Extension Study|Other|0
54352|NCT01318122|216919|P1|Enrolled - Long-Term Extension Study|Other|1
54353|NCT01318122|216916|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
54354|NCT01318122|216917|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
54355|NCT01318122|216918|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
54356|NCT01318122|216919|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
54357|NCT01318109|216988|P3|Overall Study|Schedule Conflict|0
54358|NCT01318109|216989|P2|Overall Study|Schedule Conflict|1
54359|NCT01318109|216990|P1|Overall Study|Schedule Conflict|0
54360|NCT01318109|216988|P3|Overall Study|Withdrawal by Subject|0
54361|NCT01318109|216989|P2|Overall Study|Withdrawal by Subject|0
54362|NCT01318109|216990|P1|Overall Study|Withdrawal by Subject|1
54363|NCT01318109|216988|P3|Overall Study|Adverse Event|0
54364|NCT01318109|216989|P2|Overall Study|Adverse Event|2
54365|NCT01318109|216990|P1|Overall Study|Adverse Event|0
54366|NCT01318083|217025|P3|Overall Study|Lack of Study Medication Compliance|0
54367|NCT01318083|217026|P2|Overall Study|Lack of Study Medication Compliance|1
54368|NCT01318083|217027|P1|Overall Study|Lack of Study Medication Compliance|0
54369|NCT01318083|217025|P3|Overall Study|Treatment Complications|0
54370|NCT01318083|217026|P2|Overall Study|Treatment Complications|0
54371|NCT01318083|217027|P1|Overall Study|Treatment Complications|1
54372|NCT01318083|217025|P3|Overall Study|Lack of Efficacy|1
54373|NCT01318083|217026|P2|Overall Study|Lack of Efficacy|0
54374|NCT01318083|217027|P1|Overall Study|Lack of Efficacy|0
54375|NCT01318083|217025|P3|Overall Study|Withdrawal by Subject|2
54376|NCT01318083|217026|P2|Overall Study|Withdrawal by Subject|0
54377|NCT01318083|217027|P1|Overall Study|Withdrawal by Subject|1
54378|NCT01318083|217025|P3|Overall Study|Adverse Event|2
54379|NCT01318083|217026|P2|Overall Study|Adverse Event|1
54380|NCT01318083|217027|P1|Overall Study|Adverse Event|4
54381|NCT01318070|217062|P3|Overall Study|Principal Investigator Discretion|0
54382|NCT01318070|217063|P2|Overall Study|Principal Investigator Discretion|0
54383|NCT01318070|217064|P1|Overall Study|Principal Investigator Discretion|1
54384|NCT01318070|217062|P3|Overall Study|Lack of Efficacy|1
54385|NCT01318070|217063|P2|Overall Study|Lack of Efficacy|0
54386|NCT01318070|217064|P1|Overall Study|Lack of Efficacy|0
54387|NCT01318070|217062|P3|Overall Study|Withdrawal by Subject|1
54388|NCT01318070|217063|P2|Overall Study|Withdrawal by Subject|1
54389|NCT01318070|217064|P1|Overall Study|Withdrawal by Subject|0
54390|NCT01318070|217062|P3|Overall Study|Adverse Event|5
54391|NCT01318070|217063|P2|Overall Study|Adverse Event|1
54392|NCT01318070|217064|P1|Overall Study|Adverse Event|1
54393|NCT01317797|217108|P3|Overall Study|Withdrawal of Patient|1
54394|NCT01317797|217109|P2|Overall Study|Withdrawal of Patient|0
54395|NCT01317797|217110|P1|Overall Study|Withdrawal of Patient|0
54396|NCT01317797|217108|P3|Overall Study|Other|0
54397|NCT01317797|217109|P2|Overall Study|Other|1
54398|NCT01317797|217110|P1|Overall Study|Other|0
54399|NCT01317641|217187|P9|Overall Study|Withdrawal by Subject|0
54400|NCT01317641|217188|P8|Overall Study|Withdrawal by Subject|0
54401|NCT01317641|217189|P7|Overall Study|Withdrawal by Subject|1
54402|NCT01317641|217190|P6|Overall Study|Withdrawal by Subject|0
54403|NCT01317641|217191|P5|Overall Study|Withdrawal by Subject|0
54404|NCT01317641|217192|P4|Overall Study|Withdrawal by Subject|0
54405|NCT01317641|217193|P3|Overall Study|Withdrawal by Subject|0
54406|NCT01317641|217194|P2|Overall Study|Withdrawal by Subject|0
54407|NCT01317641|217195|P1|Overall Study|Withdrawal by Subject|0
54408|NCT01317641|217187|P9|Overall Study|Disease progression|4
54409|NCT01317641|217188|P8|Overall Study|Disease progression|3
54410|NCT01317641|217189|P7|Overall Study|Disease progression|0
54411|NCT01317641|217190|P6|Overall Study|Disease progression|0
54412|NCT01317641|217191|P5|Overall Study|Disease progression|0
54413|NCT01317641|217192|P4|Overall Study|Disease progression|0
54414|NCT01317641|217193|P3|Overall Study|Disease progression|0
54415|NCT01317641|217194|P2|Overall Study|Disease progression|0
54416|NCT01317641|217195|P1|Overall Study|Disease progression|0
54417|NCT01317641|217187|P9|Overall Study|Protocol Violation|0
54419|NCT01317641|217189|P7|Overall Study|Protocol Violation|0
54420|NCT01317641|217190|P6|Overall Study|Protocol Violation|0
54421|NCT01317641|217191|P5|Overall Study|Protocol Violation|0
54422|NCT01317641|217192|P4|Overall Study|Protocol Violation|0
54423|NCT01317641|217193|P3|Overall Study|Protocol Violation|0
54424|NCT01317641|217194|P2|Overall Study|Protocol Violation|0
54425|NCT01317641|217195|P1|Overall Study|Protocol Violation|1
54426|NCT01317641|217187|P9|Overall Study|Adverse Event|0
54427|NCT01317641|217188|P8|Overall Study|Adverse Event|1
54428|NCT01317641|217189|P7|Overall Study|Adverse Event|2
54429|NCT01317641|217190|P6|Overall Study|Adverse Event|0
54430|NCT01317641|217191|P5|Overall Study|Adverse Event|0
54431|NCT01317641|217192|P4|Overall Study|Adverse Event|1
54432|NCT01317641|217193|P3|Overall Study|Adverse Event|0
54433|NCT01317641|217194|P2|Overall Study|Adverse Event|1
54434|NCT01317641|217195|P1|Overall Study|Adverse Event|0
54435|NCT01317641|217187|P9|Overall Study|Not treated|1
54436|NCT01317641|217188|P8|Overall Study|Not treated|1
54437|NCT01317641|217189|P7|Overall Study|Not treated|0
54438|NCT01317641|217190|P6|Overall Study|Not treated|0
54439|NCT01317641|217191|P5|Overall Study|Not treated|0
54440|NCT01317641|217192|P4|Overall Study|Not treated|0
54441|NCT01317641|217193|P3|Overall Study|Not treated|0
54442|NCT01317641|217194|P2|Overall Study|Not treated|0
54443|NCT01317641|217195|P1|Overall Study|Not treated|0
54444|NCT01317615|217297|P1|Overall Study|Adverse Event|7
54445|NCT01317615|217297|P1|Overall Study|Abnormal laboratory value(s)|1
54446|NCT01317615|217297|P1|Overall Study|Withdrawal by Subject|5
54447|NCT01317615|217297|P1|Overall Study|Death|6
54448|NCT01317615|217297|P1|Overall Study|New cancer therapy|5
54449|NCT01317615|217297|P1|Overall Study|Disease progression|25
54450|NCT01317160|217308|P2|Overall Study|Withdrawal by Subject|2
54451|NCT01317160|217309|P1|Overall Study|Withdrawal by Subject|0
54452|NCT01317160|217308|P2|Overall Study|Lost to Follow-up|3
54453|NCT01317160|217309|P1|Overall Study|Lost to Follow-up|3
54454|NCT01317160|217308|P2|Overall Study|Incorrect inclusion|1
54455|NCT01317160|217309|P1|Overall Study|Incorrect inclusion|1
54456|NCT01317004|217319|P2|Overall Study|Adverse Event|3
54457|NCT01317004|217320|P1|Overall Study|Adverse Event|3
54458|NCT01317004|217319|P2|Overall Study|Protocol Violation|2
54459|NCT01317004|217320|P1|Overall Study|Protocol Violation|0
54460|NCT01317004|217319|P2|Overall Study|Withdrawal by Subject|4
54461|NCT01317004|217320|P1|Overall Study|Withdrawal by Subject|1
54462|NCT01316913|217353|P4|Overall Study|Withdrawal by Subject|6
54463|NCT01316913|217354|P3|Overall Study|Withdrawal by Subject|10
54464|NCT01316913|217355|P2|Overall Study|Withdrawal by Subject|9
54465|NCT01316913|217356|P1|Overall Study|Withdrawal by Subject|10
54466|NCT01316913|217353|P4|Overall Study|Lost to Follow-up|2
54467|NCT01316913|217354|P3|Overall Study|Lost to Follow-up|0
54468|NCT01316913|217355|P2|Overall Study|Lost to Follow-up|1
54469|NCT01316913|217356|P1|Overall Study|Lost to Follow-up|0
54470|NCT01316913|217353|P4|Overall Study|Protocol-defined Stopping Criteria|6
54471|NCT01316913|217354|P3|Overall Study|Protocol-defined Stopping Criteria|11
54472|NCT01316913|217355|P2|Overall Study|Protocol-defined Stopping Criteria|8
54473|NCT01316913|217356|P1|Overall Study|Protocol-defined Stopping Criteria|7
54474|NCT01316913|217353|P4|Overall Study|Protocol Violation|1
54475|NCT01316913|217354|P3|Overall Study|Protocol Violation|4
54476|NCT01316913|217355|P2|Overall Study|Protocol Violation|4
54477|NCT01316913|217356|P1|Overall Study|Protocol Violation|1
54478|NCT01316913|217353|P4|Overall Study|Lack of Efficacy|13
54479|NCT01316913|217354|P3|Overall Study|Lack of Efficacy|9
54480|NCT01316913|217355|P2|Overall Study|Lack of Efficacy|12
54481|NCT01316913|217356|P1|Overall Study|Lack of Efficacy|22
54482|NCT01316913|217353|P4|Overall Study|Adverse Event|11
54483|NCT01316913|217354|P3|Overall Study|Adverse Event|15
54484|NCT01316913|217355|P2|Overall Study|Adverse Event|20
54485|NCT01316913|217356|P1|Overall Study|Adverse Event|17
54486|NCT01316900|217378|P4|Overall Study|Withdrawal by Subject|9
54487|NCT01316900|217379|P3|Overall Study|Withdrawal by Subject|6
54488|NCT01316900|217380|P2|Overall Study|Withdrawal by Subject|8
54489|NCT01316900|217381|P1|Overall Study|Withdrawal by Subject|7
54490|NCT01316900|217378|P4|Overall Study|Lost to Follow-up|1
54491|NCT01316900|217379|P3|Overall Study|Lost to Follow-up|1
54492|NCT01316900|217380|P2|Overall Study|Lost to Follow-up|0
54493|NCT01316900|217381|P1|Overall Study|Lost to Follow-up|1
54494|NCT01316900|217378|P4|Overall Study|Protocol-defined Stopping Criteria|5
54495|NCT01316900|217379|P3|Overall Study|Protocol-defined Stopping Criteria|10
54496|NCT01316900|217380|P2|Overall Study|Protocol-defined Stopping Criteria|3
54497|NCT01316900|217381|P1|Overall Study|Protocol-defined Stopping Criteria|2
54498|NCT01316900|217378|P4|Overall Study|Protocol Violation|0
54499|NCT01316900|217379|P3|Overall Study|Protocol Violation|4
54500|NCT01316900|217380|P2|Overall Study|Protocol Violation|1
54501|NCT01316900|217381|P1|Overall Study|Protocol Violation|7
54502|NCT01316900|217378|P4|Overall Study|Lack of Efficacy|7
54503|NCT01316900|217379|P3|Overall Study|Lack of Efficacy|5
54504|NCT01316900|217380|P2|Overall Study|Lack of Efficacy|9
54505|NCT01316900|217381|P1|Overall Study|Lack of Efficacy|17
54506|NCT01316900|217378|P4|Overall Study|Adverse Event|9
54507|NCT01316900|217379|P3|Overall Study|Adverse Event|15
54508|NCT01316900|217380|P2|Overall Study|Adverse Event|10
54509|NCT01316900|217381|P1|Overall Study|Adverse Event|10
54510|NCT01316887|217402|P3|Overall Study|Withdrawal by Subject|15
54511|NCT01316887|217403|P2|Overall Study|Withdrawal by Subject|16
54512|NCT01316887|217404|P1|Overall Study|Withdrawal by Subject|8
54513|NCT01316887|217402|P3|Overall Study|Lost to Follow-up|5
54514|NCT01316887|217403|P2|Overall Study|Lost to Follow-up|7
54515|NCT01316887|217404|P1|Overall Study|Lost to Follow-up|1
54516|NCT01316887|217402|P3|Overall Study|Study Closed/Terminated|3
54517|NCT01316887|217403|P2|Overall Study|Study Closed/Terminated|4
54518|NCT01316887|217404|P1|Overall Study|Study Closed/Terminated|2
54519|NCT01316887|217402|P3|Overall Study|Protocol-defined Stopping Criteria|36
54520|NCT01316887|217403|P2|Overall Study|Protocol-defined Stopping Criteria|37
54521|NCT01316887|217404|P1|Overall Study|Protocol-defined Stopping Criteria|8
54522|NCT01316887|217402|P3|Overall Study|Protocol Violation|6
54523|NCT01316887|217403|P2|Overall Study|Protocol Violation|6
54524|NCT01316887|217404|P1|Overall Study|Protocol Violation|2
54525|NCT01316887|217402|P3|Overall Study|Lack of Efficacy|1
54526|NCT01316887|217403|P2|Overall Study|Lack of Efficacy|3
54527|NCT01316887|217404|P1|Overall Study|Lack of Efficacy|9
54528|NCT01316887|217402|P3|Overall Study|Adverse Event|17
54529|NCT01316887|217403|P2|Overall Study|Adverse Event|21
54530|NCT01316887|217404|P1|Overall Study|Adverse Event|13
54531|NCT01316692|217466|P1|Overall Study|Disease Progression|7
54532|NCT01316692|217466|P1|Overall Study|Adverse Event|5
54533|NCT01316614|217475|P1|Overall Study|Medically unstable|1
54534|NCT01316614|217475|P1|Overall Study|Inadequate number of passes|2
54535|NCT01316614|217475|P1|Overall Study|Cystic lesion|5
54536|NCT01316614|217475|P1|Overall Study|Cytology slides not available for review|4
54537|NCT01316614|217475|P1|Overall Study|No solid lesion and FNA not indicated|25
54538|NCT01316575|217492|P2|Overall Study|Required alternate treatment|1
54539|NCT01316575|217493|P1|Overall Study|Required alternate treatment|0
54540|NCT01316575|217492|P2|Overall Study|Withdrawal by Subject|0
54541|NCT01316575|217493|P1|Overall Study|Withdrawal by Subject|2
54542|NCT01316419|217505|P1|Overall Study|Lost to Follow-up|19
54543|NCT01316419|217505|P1|Overall Study|Violated inclusion/exclusion criterion|143
54544|NCT01316419|217505|P1|Overall Study|Not treated|103
54545|NCT01316380|217531|P3|Overall Study|Not treated|0
54546|NCT01316380|217532|P2|Overall Study|Not treated|0
54547|NCT01316380|217533|P1|Overall Study|Not treated|1
54548|NCT01316380|217531|P3|Overall Study|Other|1
54549|NCT01316380|217532|P2|Overall Study|Other|1
54550|NCT01316380|217533|P1|Overall Study|Other|0
54551|NCT01316380|217531|P3|Overall Study|Withdrawal by Subject|0
54552|NCT01316380|217532|P2|Overall Study|Withdrawal by Subject|2
54553|NCT01316380|217533|P1|Overall Study|Withdrawal by Subject|1
54554|NCT01316380|217531|P3|Overall Study|Protocol Violation|1
54555|NCT01316380|217532|P2|Overall Study|Protocol Violation|0
54556|NCT01316380|217533|P1|Overall Study|Protocol Violation|0
54557|NCT01316380|217531|P3|Overall Study|Adverse Event|1
54558|NCT01316380|217532|P2|Overall Study|Adverse Event|2
54559|NCT01316380|217533|P1|Overall Study|Adverse Event|0
54560|NCT01316224|217699|P1|Overall Study|Not Specified|1
54561|NCT01316224|217699|P1|Overall Study|Adverse Event With Treatment Failure|1
54562|NCT01316224|217699|P1|Overall Study|Withdrawal by Subject|1
54563|NCT01316224|217699|P1|Overall Study|Lack of Efficacy|1
54564|NCT01316224|217699|P1|Overall Study|Adverse Event|3
54565|NCT01316224|217699|P1|Overall Study|Protocol Violation|3
54566|NCT01316055|217716|P3|Overall Study|Lost to Follow-up|0
54567|NCT01316055|217717|P2|Overall Study|Lost to Follow-up|0
54568|NCT01316055|217718|P1|Overall Study|Lost to Follow-up|1
54569|NCT01315847|217743|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
54570|NCT01315847|217744|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
54571|NCT01315847|217743|P2|Part I, Period 1|Reached maximum number of arterial lines|0
54572|NCT01315847|217744|P1|Part I, Period 1|Reached maximum number of arterial lines|3
54573|NCT01315249|217788|P2|Overall Study|Death|1
54574|NCT01315249|217789|P1|Overall Study|Death|0
54575|NCT01315249|217788|P2|Overall Study|Lost to Follow-up|2
54576|NCT01315249|217789|P1|Overall Study|Lost to Follow-up|0
54577|NCT01315249|217788|P2|Overall Study|Lack of Efficacy|1
54578|NCT01315249|217789|P1|Overall Study|Lack of Efficacy|0
54579|NCT01315249|217788|P2|Overall Study|inability to use device|0
54580|NCT01315249|217789|P1|Overall Study|inability to use device|1
54581|NCT01315249|217788|P2|Overall Study|Administrative problems|0
54582|NCT01315249|217789|P1|Overall Study|Administrative problems|1
54583|NCT01315249|217788|P2|Overall Study|Abnormal test results|2
54584|NCT01315249|217789|P1|Overall Study|Abnormal test results|1
54585|NCT01315249|217788|P2|Overall Study|Protocol Violation|5
54586|NCT01315249|217789|P1|Overall Study|Protocol Violation|8
54587|NCT01315249|217788|P2|Overall Study|Withdrawal by Subject|10
54588|NCT01315249|217789|P1|Overall Study|Withdrawal by Subject|11
54589|NCT01315249|217788|P2|Overall Study|Adverse Event|26
54590|NCT01315249|217789|P1|Overall Study|Adverse Event|22
54591|NCT01315028|217851|P2|Overall Study|Death|1
54592|NCT01315028|217852|P1|Overall Study|Death|0
54593|NCT01315028|217851|P2|Overall Study|Lost to Follow-up|0
54594|NCT01315028|217852|P1|Overall Study|Lost to Follow-up|1
54595|NCT01314872|217882|P15|Period 2|Lost to Follow-up|6
54596|NCT01314872|217883|P14|Period 2|Lost to Follow-up|2
54597|NCT01314872|217884|P13|Period 2|Lost to Follow-up|7
54598|NCT01314872|217885|P12|Period 2|Lost to Follow-up|6
54599|NCT01314872|217886|P11|Period 2|Lost to Follow-up|0
54600|NCT01314872|217887|P10|Period 2|Lost to Follow-up|0
54601|NCT01314872|217888|P9|Period 2|Lost to Follow-up|0
54602|NCT01314872|217889|P8|Period 2|Lost to Follow-up|0
54603|NCT01314872|217890|P7|Period 2|Lost to Follow-up|0
54604|NCT01314872|217891|P6|Period 2|Lost to Follow-up|0
54605|NCT01314872|217892|P5|Period 2|Lost to Follow-up|0
54606|NCT01314872|217893|P4|Period 2|Lost to Follow-up|0
54607|NCT01314872|217894|P3|Period 2|Lost to Follow-up|0
54608|NCT01314872|217895|P2|Period 2|Lost to Follow-up|0
54609|NCT01314872|217896|P1|Period 2|Lost to Follow-up|0
54610|NCT01314872|217882|P15|Period 2|Withdrawal by Subject|4
54611|NCT01314872|217883|P14|Period 2|Withdrawal by Subject|12
54612|NCT01314872|217884|P13|Period 2|Withdrawal by Subject|17
54613|NCT01314872|217885|P12|Period 2|Withdrawal by Subject|14
54614|NCT01314872|217886|P11|Period 2|Withdrawal by Subject|0
54615|NCT01314872|217887|P10|Period 2|Withdrawal by Subject|0
54616|NCT01314872|217888|P9|Period 2|Withdrawal by Subject|0
54617|NCT01314872|217889|P8|Period 2|Withdrawal by Subject|0
54618|NCT01314872|217890|P7|Period 2|Withdrawal by Subject|0
54619|NCT01314872|217891|P6|Period 2|Withdrawal by Subject|0
54620|NCT01314872|217892|P5|Period 2|Withdrawal by Subject|0
54621|NCT01314872|217893|P4|Period 2|Withdrawal by Subject|0
54622|NCT01314872|217894|P3|Period 2|Withdrawal by Subject|0
54623|NCT01314872|217895|P2|Period 2|Withdrawal by Subject|0
54624|NCT01314872|217896|P1|Period 2|Withdrawal by Subject|0
54625|NCT01314872|217882|P15|Period 2|Adverse event, non-fatal|9
54626|NCT01314872|217883|P14|Period 2|Adverse event, non-fatal|24
54627|NCT01314872|217884|P13|Period 2|Adverse event, non-fatal|16
54628|NCT01314872|217885|P12|Period 2|Adverse event, non-fatal|13
54629|NCT01314872|217886|P11|Period 2|Adverse event, non-fatal|0
54630|NCT01314872|217887|P10|Period 2|Adverse event, non-fatal|0
54631|NCT01314872|217888|P9|Period 2|Adverse event, non-fatal|0
54632|NCT01314872|217889|P8|Period 2|Adverse event, non-fatal|0
54633|NCT01314872|217890|P7|Period 2|Adverse event, non-fatal|0
54634|NCT01314872|217891|P6|Period 2|Adverse event, non-fatal|0
54635|NCT01314872|217892|P5|Period 2|Adverse event, non-fatal|0
54636|NCT01314872|217893|P4|Period 2|Adverse event, non-fatal|0
54637|NCT01314872|217894|P3|Period 2|Adverse event, non-fatal|0
54638|NCT01314872|217895|P2|Period 2|Adverse event, non-fatal|0
54639|NCT01314872|217896|P1|Period 2|Adverse event, non-fatal|0
54640|NCT01314872|217882|P15|Period 2|Study terminated by Sponsor|0
54641|NCT01314872|217883|P14|Period 2|Study terminated by Sponsor|3
54642|NCT01314872|217884|P13|Period 2|Study terminated by Sponsor|2
54643|NCT01314872|217885|P12|Period 2|Study terminated by Sponsor|2
54644|NCT01314872|217886|P11|Period 2|Study terminated by Sponsor|0
54645|NCT01314872|217887|P10|Period 2|Study terminated by Sponsor|0
54646|NCT01314872|217888|P9|Period 2|Study terminated by Sponsor|0
54647|NCT01314872|217889|P8|Period 2|Study terminated by Sponsor|0
54648|NCT01314872|217890|P7|Period 2|Study terminated by Sponsor|0
54649|NCT01314872|217891|P6|Period 2|Study terminated by Sponsor|0
54650|NCT01314872|217892|P5|Period 2|Study terminated by Sponsor|0
54651|NCT01314872|217893|P4|Period 2|Study terminated by Sponsor|0
54652|NCT01314872|217894|P3|Period 2|Study terminated by Sponsor|0
54653|NCT01314872|217895|P2|Period 2|Study terminated by Sponsor|0
54654|NCT01314872|217896|P1|Period 2|Study terminated by Sponsor|0
54655|NCT01314872|217882|P15|Period 2|Pregnancy|1
54656|NCT01314872|217883|P14|Period 2|Pregnancy|0
54657|NCT01314872|217884|P13|Period 2|Pregnancy|0
54658|NCT01314872|217885|P12|Period 2|Pregnancy|0
54659|NCT01314872|217886|P11|Period 2|Pregnancy|0
54660|NCT01314872|217887|P10|Period 2|Pregnancy|0
54661|NCT01314872|217888|P9|Period 2|Pregnancy|0
54662|NCT01314872|217889|P8|Period 2|Pregnancy|0
54663|NCT01314872|217890|P7|Period 2|Pregnancy|0
54664|NCT01314872|217891|P6|Period 2|Pregnancy|0
54665|NCT01314872|217892|P5|Period 2|Pregnancy|0
54666|NCT01314872|217893|P4|Period 2|Pregnancy|0
54667|NCT01314872|217894|P3|Period 2|Pregnancy|0
54668|NCT01314872|217895|P2|Period 2|Pregnancy|0
54669|NCT01314872|217896|P1|Period 2|Pregnancy|0
54670|NCT01314872|217882|P15|Period 2|Lack of Efficacy|2
54671|NCT01314872|217883|P14|Period 2|Lack of Efficacy|9
54672|NCT01314872|217884|P13|Period 2|Lack of Efficacy|12
54673|NCT01314872|217885|P12|Period 2|Lack of Efficacy|7
54674|NCT01314872|217886|P11|Period 2|Lack of Efficacy|0
54675|NCT01314872|217887|P10|Period 2|Lack of Efficacy|0
54676|NCT01314872|217888|P9|Period 2|Lack of Efficacy|0
54677|NCT01314872|217889|P8|Period 2|Lack of Efficacy|0
54678|NCT01314872|217890|P7|Period 2|Lack of Efficacy|0
54679|NCT01314872|217891|P6|Period 2|Lack of Efficacy|0
54680|NCT01314872|217892|P5|Period 2|Lack of Efficacy|0
54681|NCT01314872|217893|P4|Period 2|Lack of Efficacy|0
54682|NCT01314872|217894|P3|Period 2|Lack of Efficacy|0
54683|NCT01314872|217895|P2|Period 2|Lack of Efficacy|0
54684|NCT01314872|217896|P1|Period 2|Lack of Efficacy|0
54685|NCT01314872|217882|P15|Period 2|Non-compliance with study drug|2
54686|NCT01314872|217883|P14|Period 2|Non-compliance with study drug|1
54687|NCT01314872|217884|P13|Period 2|Non-compliance with study drug|3
54688|NCT01314872|217885|P12|Period 2|Non-compliance with study drug|3
54689|NCT01314872|217886|P11|Period 2|Non-compliance with study drug|0
54690|NCT01314872|217887|P10|Period 2|Non-compliance with study drug|0
54691|NCT01314872|217888|P9|Period 2|Non-compliance with study drug|0
54692|NCT01314872|217889|P8|Period 2|Non-compliance with study drug|0
54693|NCT01314872|217890|P7|Period 2|Non-compliance with study drug|0
54694|NCT01314872|217891|P6|Period 2|Non-compliance with study drug|0
54695|NCT01314872|217892|P5|Period 2|Non-compliance with study drug|0
54696|NCT01314872|217893|P4|Period 2|Non-compliance with study drug|0
54697|NCT01314872|217894|P3|Period 2|Non-compliance with study drug|0
54698|NCT01314872|217895|P2|Period 2|Non-compliance with study drug|0
54699|NCT01314872|217896|P1|Period 2|Non-compliance with study drug|0
54700|NCT01314872|217882|P15|Period 2|Protocol Violation|0
54701|NCT01314872|217883|P14|Period 2|Protocol Violation|2
54702|NCT01314872|217884|P13|Period 2|Protocol Violation|3
54703|NCT01314872|217885|P12|Period 2|Protocol Violation|3
54704|NCT01314872|217886|P11|Period 2|Protocol Violation|0
54705|NCT01314872|217887|P10|Period 2|Protocol Violation|0
54706|NCT01314872|217888|P9|Period 2|Protocol Violation|0
54707|NCT01314872|217889|P8|Period 2|Protocol Violation|0
54708|NCT01314872|217890|P7|Period 2|Protocol Violation|0
54709|NCT01314872|217891|P6|Period 2|Protocol Violation|0
54710|NCT01314872|217892|P5|Period 2|Protocol Violation|0
54711|NCT01314872|217893|P4|Period 2|Protocol Violation|0
54712|NCT01314872|217894|P3|Period 2|Protocol Violation|0
54713|NCT01314872|217895|P2|Period 2|Protocol Violation|0
54714|NCT01314872|217896|P1|Period 2|Protocol Violation|0
54715|NCT01314872|217882|P15|Treatment Period 1|Lost to Follow-up|0
54716|NCT01314872|217883|P14|Treatment Period 1|Lost to Follow-up|0
54717|NCT01314872|217884|P13|Treatment Period 1|Lost to Follow-up|0
54718|NCT01314872|217885|P12|Treatment Period 1|Lost to Follow-up|0
54719|NCT01314872|217886|P11|Treatment Period 1|Lost to Follow-up|0
54720|NCT01314872|217887|P10|Treatment Period 1|Lost to Follow-up|0
54721|NCT01314872|217888|P9|Treatment Period 1|Lost to Follow-up|1
54722|NCT01314872|217889|P8|Treatment Period 1|Lost to Follow-up|1
54723|NCT01314872|217890|P7|Treatment Period 1|Lost to Follow-up|1
54724|NCT01314872|217891|P6|Treatment Period 1|Lost to Follow-up|1
54725|NCT01314872|217892|P5|Treatment Period 1|Lost to Follow-up|1
54726|NCT01314872|217893|P4|Treatment Period 1|Lost to Follow-up|2
54727|NCT01314872|217894|P3|Treatment Period 1|Lost to Follow-up|2
54728|NCT01314872|217895|P2|Treatment Period 1|Lost to Follow-up|1
54729|NCT01314872|217896|P1|Treatment Period 1|Lost to Follow-up|0
54730|NCT01314872|217882|P15|Treatment Period 1|Withdrawal by Subject|0
54731|NCT01314872|217883|P14|Treatment Period 1|Withdrawal by Subject|0
54732|NCT01314872|217884|P13|Treatment Period 1|Withdrawal by Subject|0
54733|NCT01314872|217885|P12|Treatment Period 1|Withdrawal by Subject|0
54734|NCT01314872|217886|P11|Treatment Period 1|Withdrawal by Subject|1
54735|NCT01314872|217887|P10|Treatment Period 1|Withdrawal by Subject|2
54736|NCT01314872|217888|P9|Treatment Period 1|Withdrawal by Subject|2
54737|NCT01314872|217889|P8|Treatment Period 1|Withdrawal by Subject|2
54738|NCT01314872|217890|P7|Treatment Period 1|Withdrawal by Subject|3
54739|NCT01314872|217891|P6|Treatment Period 1|Withdrawal by Subject|1
54740|NCT01314872|217892|P5|Treatment Period 1|Withdrawal by Subject|3
54741|NCT01314872|217893|P4|Treatment Period 1|Withdrawal by Subject|2
54742|NCT01314872|217894|P3|Treatment Period 1|Withdrawal by Subject|0
54743|NCT01314872|217895|P2|Treatment Period 1|Withdrawal by Subject|1
54744|NCT01314872|217896|P1|Treatment Period 1|Withdrawal by Subject|3
54745|NCT01314872|217882|P15|Treatment Period 1|Adverse event, non-fatal|0
54746|NCT01314872|217883|P14|Treatment Period 1|Adverse event, non-fatal|0
54747|NCT01314872|217884|P13|Treatment Period 1|Adverse event, non-fatal|0
54748|NCT01314872|217885|P12|Treatment Period 1|Adverse event, non-fatal|0
54749|NCT01314872|217886|P11|Treatment Period 1|Adverse event, non-fatal|1
54750|NCT01314872|217887|P10|Treatment Period 1|Adverse event, non-fatal|0
54751|NCT01314872|217888|P9|Treatment Period 1|Adverse event, non-fatal|3
54752|NCT01314872|217889|P8|Treatment Period 1|Adverse event, non-fatal|2
54753|NCT01314872|217890|P7|Treatment Period 1|Adverse event, non-fatal|4
54754|NCT01314872|217891|P6|Treatment Period 1|Adverse event, non-fatal|4
54755|NCT01314872|217892|P5|Treatment Period 1|Adverse event, non-fatal|2
54756|NCT01314872|217893|P4|Treatment Period 1|Adverse event, non-fatal|2
54757|NCT01314872|217894|P3|Treatment Period 1|Adverse event, non-fatal|3
54758|NCT01314872|217895|P2|Treatment Period 1|Adverse event, non-fatal|2
54759|NCT01314872|217896|P1|Treatment Period 1|Adverse event, non-fatal|4
54760|NCT01314872|217882|P15|Treatment Period 1|Lack of Efficacy|0
54761|NCT01314872|217883|P14|Treatment Period 1|Lack of Efficacy|0
54762|NCT01314872|217884|P13|Treatment Period 1|Lack of Efficacy|0
54763|NCT01314872|217885|P12|Treatment Period 1|Lack of Efficacy|0
54764|NCT01314872|217886|P11|Treatment Period 1|Lack of Efficacy|0
54765|NCT01314872|217887|P10|Treatment Period 1|Lack of Efficacy|0
54766|NCT01314872|217888|P9|Treatment Period 1|Lack of Efficacy|0
54767|NCT01314872|217889|P8|Treatment Period 1|Lack of Efficacy|2
54768|NCT01314872|217890|P7|Treatment Period 1|Lack of Efficacy|0
54769|NCT01314872|217891|P6|Treatment Period 1|Lack of Efficacy|1
54770|NCT01314872|217892|P5|Treatment Period 1|Lack of Efficacy|0
54771|NCT01314872|217893|P4|Treatment Period 1|Lack of Efficacy|0
54772|NCT01314872|217894|P3|Treatment Period 1|Lack of Efficacy|0
54773|NCT01314872|217895|P2|Treatment Period 1|Lack of Efficacy|0
54774|NCT01314872|217896|P1|Treatment Period 1|Lack of Efficacy|1
54775|NCT01314872|217882|P15|Treatment Period 1|Physician Decision|0
54776|NCT01314872|217883|P14|Treatment Period 1|Physician Decision|0
54777|NCT01314872|217884|P13|Treatment Period 1|Physician Decision|0
54778|NCT01314872|217885|P12|Treatment Period 1|Physician Decision|0
54779|NCT01314872|217886|P11|Treatment Period 1|Physician Decision|0
54780|NCT01314872|217887|P10|Treatment Period 1|Physician Decision|1
54781|NCT01314872|217888|P9|Treatment Period 1|Physician Decision|0
54782|NCT01314872|217889|P8|Treatment Period 1|Physician Decision|0
54783|NCT01314872|217890|P7|Treatment Period 1|Physician Decision|0
54784|NCT01314872|217891|P6|Treatment Period 1|Physician Decision|0
54785|NCT01314872|217892|P5|Treatment Period 1|Physician Decision|0
54786|NCT01314872|217893|P4|Treatment Period 1|Physician Decision|1
54787|NCT01314872|217894|P3|Treatment Period 1|Physician Decision|0
54788|NCT01314872|217895|P2|Treatment Period 1|Physician Decision|1
54789|NCT01314872|217896|P1|Treatment Period 1|Physician Decision|0
54790|NCT01314872|217882|P15|Treatment Period 1|Protocol Violation|0
54791|NCT01314872|217883|P14|Treatment Period 1|Protocol Violation|0
54792|NCT01314872|217884|P13|Treatment Period 1|Protocol Violation|0
54793|NCT01314872|217885|P12|Treatment Period 1|Protocol Violation|0
54794|NCT01314872|217886|P11|Treatment Period 1|Protocol Violation|1
54795|NCT01314872|217887|P10|Treatment Period 1|Protocol Violation|1
54796|NCT01314872|217888|P9|Treatment Period 1|Protocol Violation|0
54797|NCT01314872|217889|P8|Treatment Period 1|Protocol Violation|0
54798|NCT01314872|217890|P7|Treatment Period 1|Protocol Violation|0
54799|NCT01314872|217891|P6|Treatment Period 1|Protocol Violation|0
54800|NCT01314872|217892|P5|Treatment Period 1|Protocol Violation|1
54801|NCT01314872|217893|P4|Treatment Period 1|Protocol Violation|0
54802|NCT01314872|217894|P3|Treatment Period 1|Protocol Violation|1
54803|NCT01314872|217895|P2|Treatment Period 1|Protocol Violation|1
54804|NCT01314872|217896|P1|Treatment Period 1|Protocol Violation|2
54805|NCT01314716|218000|P2|Open-Label Phase|Physician Decision|4
54806|NCT01314716|218001|P1|Open-Label Phase|Physician Decision|5
54807|NCT01314716|218000|P2|Open-Label Phase|Withdrawal by Subject|2
54808|NCT01314716|218001|P1|Open-Label Phase|Withdrawal by Subject|1
54809|NCT01314716|218000|P2|Open-Label Phase|Adverse Event|6
54810|NCT01314716|218001|P1|Open-Label Phase|Adverse Event|4
54811|NCT01314716|218000|P2|Double-Blind Phase|Physician Decision|1
54812|NCT01314716|218001|P1|Double-Blind Phase|Physician Decision|0
54813|NCT01314716|218000|P2|Double-Blind Phase|Sponsor request|2
54814|NCT01314716|218001|P1|Double-Blind Phase|Sponsor request|1
54815|NCT01314716|218000|P2|Double-Blind Phase|Lost to Follow-up|1
54816|NCT01314716|218001|P1|Double-Blind Phase|Lost to Follow-up|0
54817|NCT01314716|218000|P2|Double-Blind Phase|Withdrawal by Subject|6
54818|NCT01314716|218001|P1|Double-Blind Phase|Withdrawal by Subject|5
54819|NCT01314716|218000|P2|Double-Blind Phase|Adverse Event|4
54820|NCT01314716|218001|P1|Double-Blind Phase|Adverse Event|10
54821|NCT01314716|218000|P2|Double-Blind Phase|Randomized but not treated|1
54822|NCT01314716|218001|P1|Double-Blind Phase|Randomized but not treated|1
54823|NCT01314703|218013|P1|Overall Study|screen failure and closed enrollment|8
54824|NCT01314443|218022|P4|Overall Study|Protocol Violation|1
54825|NCT01314443|218023|P3|Overall Study|Protocol Violation|1
54826|NCT01314443|218024|P2|Overall Study|Protocol Violation|2
54827|NCT01314443|218025|P1|Overall Study|Protocol Violation|2
54828|NCT01314443|218022|P4|Overall Study|Withdrawal by Subject|1
54829|NCT01314443|218023|P3|Overall Study|Withdrawal by Subject|1
54830|NCT01314443|218024|P2|Overall Study|Withdrawal by Subject|1
54831|NCT01314443|218025|P1|Overall Study|Withdrawal by Subject|2
54832|NCT01314261|218074|P4|Overall Study|Virologic Failure|1
54833|NCT01314261|218075|P3|Overall Study|Virologic Failure|0
54834|NCT01314261|218076|P2|Overall Study|Virologic Failure|1
54835|NCT01314261|218077|P1|Overall Study|Virologic Failure|0
54836|NCT01314261|218074|P4|Overall Study|Lost to Follow-up|2
54837|NCT01314261|218075|P3|Overall Study|Lost to Follow-up|2
54838|NCT01314261|218076|P2|Overall Study|Lost to Follow-up|0
54839|NCT01314261|218077|P1|Overall Study|Lost to Follow-up|1
54840|NCT01314261|218074|P4|Overall Study|Withdrawal by Subject|0
54841|NCT01314261|218075|P3|Overall Study|Withdrawal by Subject|1
54842|NCT01314261|218076|P2|Overall Study|Withdrawal by Subject|3
54843|NCT01314261|218077|P1|Overall Study|Withdrawal by Subject|0
54844|NCT01314261|218074|P4|Overall Study|Adverse Event|0
54845|NCT01314261|218075|P3|Overall Study|Adverse Event|0
54846|NCT01314261|218076|P2|Overall Study|Adverse Event|0
54847|NCT01314261|218077|P1|Overall Study|Adverse Event|1
54848|NCT01314118|218128|P1|Overall Study|Ongoing|62
54849|NCT01314118|218128|P1|Overall Study|Unspecified|2
54850|NCT01314118|218128|P1|Overall Study|Withdrawal by Subject|11
54851|NCT01314118|218128|P1|Overall Study|Protocol Violation|5
54852|NCT01314118|218128|P1|Overall Study|Death|4
54853|NCT01314118|218128|P1|Overall Study|Physician Decision|11
54854|NCT01314118|218128|P1|Overall Study|Progressive disease|27
54855|NCT01314118|218128|P1|Overall Study|Adverse Event|9
54856|NCT01314105|218137|P2|Overall Study|Progressive Disease|4
54857|NCT01314105|218138|P1|Overall Study|Progressive Disease|6
54858|NCT01313923|218231|P1|Overall Study|Physician Decision|3
54859|NCT01313884|218247|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
54860|NCT01313858|218254|P3|Overall Study|Lost to Follow-up|47
54861|NCT01313858|218255|P2|Overall Study|Lost to Follow-up|51
54862|NCT01313858|218256|P1|Overall Study|Lost to Follow-up|35
54863|NCT01313858|218254|P3|Overall Study|Premature Treatment Termination|191
54864|NCT01313858|218255|P2|Overall Study|Premature Treatment Termination|219
54865|NCT01313858|218256|P1|Overall Study|Premature Treatment Termination|251
54866|NCT01313780|218279|P2|Overall Study|missing data|3
54867|NCT01313780|218280|P1|Overall Study|missing data|3
54868|NCT01313780|218279|P2|Overall Study|Protocol Violation|4
54869|NCT01313780|218280|P1|Overall Study|Protocol Violation|10
54870|NCT01313780|218279|P2|Overall Study|Withdrawal by Subject|8
54871|NCT01313780|218280|P1|Overall Study|Withdrawal by Subject|2
54872|NCT01313780|218279|P2|Overall Study|Adverse Event|11
54873|NCT01313780|218280|P1|Overall Study|Adverse Event|6
54874|NCT01313780|218279|P2|Overall Study|Lack of Efficacy|2
54875|NCT01313780|218280|P1|Overall Study|Lack of Efficacy|4
54876|NCT01313728|218288|P1|Informed Consent to Baseline|Withdrawal by Subject|1
54877|NCT01313689|218305|P4|24-Week Randomization 2|Withdrawal by Subject|1
54878|NCT01313689|218306|P3|24-Week Randomization 2|Withdrawal by Subject|1
54879|NCT01313689|218307|P2|24-Week Randomization 2|Withdrawal by Subject|0
54880|NCT01313689|218308|P1|24-Week Randomization 2|Withdrawal by Subject|0
54881|NCT01313689|218305|P4|24-Week Randomization 2|Adverse Event|0
54882|NCT01313689|218306|P3|24-Week Randomization 2|Adverse Event|2
54883|NCT01313689|218307|P2|24-Week Randomization 2|Adverse Event|0
54884|NCT01313689|218308|P1|24-Week Randomization 2|Adverse Event|0
54885|NCT01313689|218305|P4|24-Week Randomization 1|Withdrawal by Subject|0
54886|NCT01313689|218306|P3|24-Week Randomization 1|Withdrawal by Subject|0
54887|NCT01313689|218307|P2|24-Week Randomization 1|Withdrawal by Subject|0
54888|NCT01313689|218308|P1|24-Week Randomization 1|Withdrawal by Subject|5
54889|NCT01313689|218305|P4|24-Week Randomization 1|Physician Decision|0
54890|NCT01313689|218306|P3|24-Week Randomization 1|Physician Decision|0
54891|NCT01313689|218307|P2|24-Week Randomization 1|Physician Decision|5
54892|NCT01313689|218308|P1|24-Week Randomization 1|Physician Decision|4
54893|NCT01313689|218305|P4|24-Week Randomization 1|Adverse Event|0
54894|NCT01313689|218306|P3|24-Week Randomization 1|Adverse Event|0
54895|NCT01313689|218307|P2|24-Week Randomization 1|Adverse Event|5
54896|NCT01313689|218308|P1|24-Week Randomization 1|Adverse Event|10
54897|NCT01313676|218375|P4|Overall Study|Missing|0
54898|NCT01313676|218376|P3|Overall Study|Missing|1
54899|NCT01313676|218377|P2|Overall Study|Missing|1
54900|NCT01313676|218378|P1|Overall Study|Missing|1
54901|NCT01313676|218375|P4|Overall Study|Investigator Site Closed|10
54902|NCT01313676|218376|P3|Overall Study|Investigator Site Closed|15
54903|NCT01313676|218377|P2|Overall Study|Investigator Site Closed|11
54904|NCT01313676|218378|P1|Overall Study|Investigator Site Closed|12
54905|NCT01313676|218375|P4|Overall Study|Sponsor Terminated Study Treatment|1
54906|NCT01313676|218376|P3|Overall Study|Sponsor Terminated Study Treatment|0
54907|NCT01313676|218377|P2|Overall Study|Sponsor Terminated Study Treatment|1
54908|NCT01313676|218378|P1|Overall Study|Sponsor Terminated Study Treatment|1
54909|NCT01313676|218375|P4|Overall Study|Decision by Participant or Proxy|492
54910|NCT01313676|218376|P3|Overall Study|Decision by Participant or Proxy|515
54911|NCT01313676|218377|P2|Overall Study|Decision by Participant or Proxy|527
54912|NCT01313676|218378|P1|Overall Study|Decision by Participant or Proxy|643
54913|NCT01313676|218375|P4|Overall Study|Physician Decision|48
54914|NCT01313676|218376|P3|Overall Study|Physician Decision|62
54915|NCT01313676|218377|P2|Overall Study|Physician Decision|64
54916|NCT01313676|218378|P1|Overall Study|Physician Decision|53
54917|NCT01313676|218375|P4|Overall Study|Lost to Follow-up|0
54918|NCT01313676|218376|P3|Overall Study|Lost to Follow-up|1
54919|NCT01313676|218377|P2|Overall Study|Lost to Follow-up|0
54920|NCT01313676|218378|P1|Overall Study|Lost to Follow-up|0
54921|NCT01313676|218375|P4|Overall Study|Study Closed/terminated|9
54922|NCT01313676|218376|P3|Overall Study|Study Closed/terminated|9
54923|NCT01313676|218377|P2|Overall Study|Study Closed/terminated|6
54924|NCT01313676|218378|P1|Overall Study|Study Closed/terminated|7
54925|NCT01313676|218375|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
54926|NCT01313676|218376|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
54927|NCT01313676|218377|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
54928|NCT01313676|218378|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
54929|NCT01313676|218375|P4|Overall Study|Protocol Violation|44
54930|NCT01313676|218376|P3|Overall Study|Protocol Violation|46
54931|NCT01313676|218377|P2|Overall Study|Protocol Violation|44
54932|NCT01313676|218378|P1|Overall Study|Protocol Violation|37
54933|NCT01313676|218375|P4|Overall Study|Lack of Efficacy|46
54934|NCT01313676|218376|P3|Overall Study|Lack of Efficacy|65
54935|NCT01313676|218377|P2|Overall Study|Lack of Efficacy|90
54936|NCT01313676|218378|P1|Overall Study|Lack of Efficacy|98
54937|NCT01313676|218375|P4|Overall Study|Adverse Event|333
54938|NCT01313676|218376|P3|Overall Study|Adverse Event|372
54939|NCT01313676|218377|P2|Overall Study|Adverse Event|365
54940|NCT01313676|218378|P1|Overall Study|Adverse Event|395
54941|NCT01313663|218398|P2|Overall Study|Withdrawal by Subject|1
54942|NCT01313663|218399|P1|Overall Study|Withdrawal by Subject|2
54943|NCT01313663|218398|P2|Overall Study|Physician Decision|2
54944|NCT01313663|218399|P1|Overall Study|Physician Decision|0
54945|NCT01313663|218398|P2|Overall Study|Lost to Follow-up|1
54946|NCT01313663|218399|P1|Overall Study|Lost to Follow-up|0
54947|NCT01313663|218398|P2|Overall Study|Study Closed/Terminated|4
54948|NCT01313663|218399|P1|Overall Study|Study Closed/Terminated|2
54949|NCT01313650|218437|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
54950|NCT01313650|218438|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
54951|NCT01313650|218439|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
54952|NCT01313650|218440|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
54953|NCT01313650|218437|P4|Overall Study|Protocol Violation|6
54954|NCT01313650|218438|P3|Overall Study|Protocol Violation|5
54955|NCT01313650|218439|P2|Overall Study|Protocol Violation|7
54956|NCT01313650|218440|P1|Overall Study|Protocol Violation|4
54957|NCT01313650|218437|P4|Overall Study|Withdrawal by Subject|15
54958|NCT01313650|218438|P3|Overall Study|Withdrawal by Subject|15
54959|NCT01313650|218439|P2|Overall Study|Withdrawal by Subject|20
54960|NCT01313650|218440|P1|Overall Study|Withdrawal by Subject|16
54961|NCT01313650|218437|P4|Overall Study|Lost to Follow-up|2
54962|NCT01313650|218438|P3|Overall Study|Lost to Follow-up|3
54963|NCT01313650|218439|P2|Overall Study|Lost to Follow-up|0
54964|NCT01313650|218440|P1|Overall Study|Lost to Follow-up|1
54965|NCT01313650|218437|P4|Overall Study|Lack of Efficacy|20
54966|NCT01313650|218438|P3|Overall Study|Lack of Efficacy|32
54967|NCT01313650|218439|P2|Overall Study|Lack of Efficacy|20
54968|NCT01313650|218440|P1|Overall Study|Lack of Efficacy|37
54969|NCT01313650|218437|P4|Overall Study|Adverse Event|23
54970|NCT01313650|218438|P3|Overall Study|Adverse Event|24
54971|NCT01313650|218439|P2|Overall Study|Adverse Event|34
54972|NCT01313650|218440|P1|Overall Study|Adverse Event|9
54973|NCT01313637|218466|P4|Overall Study|Withdrawal by Subject|15
54974|NCT01313637|218467|P3|Overall Study|Withdrawal by Subject|18
54975|NCT01313637|218468|P2|Overall Study|Withdrawal by Subject|13
54976|NCT01313637|218469|P1|Overall Study|Withdrawal by Subject|11
54977|NCT01313637|218466|P4|Overall Study|Lost to Follow-up|3
54978|NCT01313637|218467|P3|Overall Study|Lost to Follow-up|1
54979|NCT01313637|218468|P2|Overall Study|Lost to Follow-up|2
54980|NCT01313637|218469|P1|Overall Study|Lost to Follow-up|0
54981|NCT01313637|218466|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
54982|NCT01313637|218467|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
54983|NCT01313637|218468|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
54984|NCT01313637|218469|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
54985|NCT01313637|218466|P4|Overall Study|Protocol Violation|5
54986|NCT01313637|218467|P3|Overall Study|Protocol Violation|11
54987|NCT01313637|218468|P2|Overall Study|Protocol Violation|3
54988|NCT01313637|218469|P1|Overall Study|Protocol Violation|4
54989|NCT01313637|218466|P4|Overall Study|Lack of Efficacy|24
54990|NCT01313637|218467|P3|Overall Study|Lack of Efficacy|37
54991|NCT01313637|218468|P2|Overall Study|Lack of Efficacy|38
54992|NCT01313637|218469|P1|Overall Study|Lack of Efficacy|44
54993|NCT01313637|218466|P4|Overall Study|Adverse Event|18
54994|NCT01313637|218467|P3|Overall Study|Adverse Event|25
54995|NCT01313637|218468|P2|Overall Study|Adverse Event|24
54996|NCT01313637|218469|P1|Overall Study|Adverse Event|17
54997|NCT01313624|218493|P2|Open-Label Phase|Lost to Follow-up|1
54998|NCT01313624|218494|P1|Open-Label Phase|Lost to Follow-up|1
54999|NCT01313624|218493|P2|Open-Label Phase|Withdrawal by Subject|2
55000|NCT01313624|218494|P1|Open-Label Phase|Withdrawal by Subject|2
55001|NCT01313624|218493|P2|Open-Label Phase|Adverse Event|10
55002|NCT01313624|218494|P1|Open-Label Phase|Adverse Event|1
55003|NCT01313624|218493|P2|Double-Blind Phase|Lack of Efficacy|0
55004|NCT01313624|218494|P1|Double-Blind Phase|Lack of Efficacy|1
55005|NCT01313624|218493|P2|Double-Blind Phase|Physician Decision|0
55006|NCT01313624|218494|P1|Double-Blind Phase|Physician Decision|1
55007|NCT01313624|218493|P2|Double-Blind Phase|Lost to Follow-up|2
55008|NCT01313624|218494|P1|Double-Blind Phase|Lost to Follow-up|0
55009|NCT01313624|218493|P2|Double-Blind Phase|Withdrawal by Subject|4
55010|NCT01313624|218494|P1|Double-Blind Phase|Withdrawal by Subject|9
55011|NCT01313624|218493|P2|Double-Blind Phase|Adverse Event|4
55012|NCT01313624|218494|P1|Double-Blind Phase|Adverse Event|27
55013|NCT01313312|218590|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
55014|NCT01313312|218590|P1|Overall Study|Subject Withdrawn Early in Error|4
55015|NCT01313312|218590|P1|Overall Study|Observational Phase|1
55016|NCT01313312|218590|P1|Overall Study|Investigator Decision|1
55017|NCT01313312|218590|P1|Overall Study|Lack of Efficacy|3
55018|NCT01313312|218590|P1|Overall Study|Withdrawal by Subject|18
55019|NCT01313312|218590|P1|Overall Study|Adverse Event|5
55020|NCT01313299|218637|P3|Overall Study|Lack of subject compliance|1
55021|NCT01313299|218638|P2|Overall Study|Lack of subject compliance|0
55022|NCT01313299|218639|P1|Overall Study|Lack of subject compliance|0
55023|NCT01313299|218637|P3|Overall Study|Family reason and moved out of state|0
55024|NCT01313299|218638|P2|Overall Study|Family reason and moved out of state|2
55025|NCT01313299|218639|P1|Overall Study|Family reason and moved out of state|0
55026|NCT01313299|218637|P3|Overall Study|Withdrawal by Subject|2
55027|NCT01313299|218638|P2|Overall Study|Withdrawal by Subject|0
55028|NCT01313299|218639|P1|Overall Study|Withdrawal by Subject|1
55029|NCT01313299|218637|P3|Overall Study|Protocol Violation|0
55030|NCT01313299|218638|P2|Overall Study|Protocol Violation|0
55031|NCT01313299|218639|P1|Overall Study|Protocol Violation|2
55032|NCT01313299|218637|P3|Overall Study|Lost to Follow-up|0
55033|NCT01313299|218638|P2|Overall Study|Lost to Follow-up|0
55034|NCT01313299|218639|P1|Overall Study|Lost to Follow-up|1
55035|NCT01313299|218637|P3|Overall Study|Adverse Event|1
55036|NCT01313299|218638|P2|Overall Study|Adverse Event|1
55037|NCT01313299|218639|P1|Overall Study|Adverse Event|3
55038|NCT01313273|218655|P2|Overall Study|Screening Chromogranin A-in normal range|1
55039|NCT01313273|218656|P1|Overall Study|Screening Chromogranin A-in normal range|0
55040|NCT01313273|218655|P2|Overall Study|Withdrawal by Subject|0
55041|NCT01313273|218656|P1|Overall Study|Withdrawal by Subject|1
55042|NCT01313273|218655|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
55043|NCT01313273|218656|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
55044|NCT01313221|218671|P3|Overall Study|Pregnancy|2
55045|NCT01313221|218672|P2|Overall Study|Pregnancy|0
55046|NCT01313221|218673|P1|Overall Study|Pregnancy|0
55047|NCT01313221|218671|P3|Overall Study|Physician Decision|2
55048|NCT01313221|218672|P2|Overall Study|Physician Decision|0
55049|NCT01313221|218673|P1|Overall Study|Physician Decision|0
55050|NCT01313221|218671|P3|Overall Study|Disease progression|2
55051|NCT01313221|218672|P2|Overall Study|Disease progression|0
55052|NCT01313221|218673|P1|Overall Study|Disease progression|0
55053|NCT01313221|218671|P3|Overall Study|Adverse Event|7
55054|NCT01313221|218672|P2|Overall Study|Adverse Event|0
55055|NCT01313221|218673|P1|Overall Study|Adverse Event|0
55056|NCT01313221|218671|P3|Overall Study|Other|0
55057|NCT01313221|218672|P2|Overall Study|Other|0
55058|NCT01313221|218673|P1|Overall Study|Other|1
55059|NCT01313221|218671|P3|Overall Study|Lost to Follow-up|1
55060|NCT01313221|218672|P2|Overall Study|Lost to Follow-up|3
55061|NCT01313221|218673|P1|Overall Study|Lost to Follow-up|6
55062|NCT01313221|218671|P3|Overall Study|Requirement for alternative therapy|1
55063|NCT01313221|218672|P2|Overall Study|Requirement for alternative therapy|1
55064|NCT01313221|218673|P1|Overall Study|Requirement for alternative therapy|0
55065|NCT01313221|218671|P3|Overall Study|Withdrawal by Subject|5
55066|NCT01313221|218672|P2|Overall Study|Withdrawal by Subject|3
55067|NCT01313221|218673|P1|Overall Study|Withdrawal by Subject|2
55068|NCT01313221|218671|P3|Overall Study|Non-compliance|2
55069|NCT01313221|218672|P2|Overall Study|Non-compliance|0
55070|NCT01313221|218673|P1|Overall Study|Non-compliance|3
55071|NCT01313221|218671|P3|Overall Study|Protocol Violation|1
55072|NCT01313221|218672|P2|Overall Study|Protocol Violation|1
55073|NCT01313221|218673|P1|Overall Study|Protocol Violation|0
55074|NCT01313208|218725|P2|Open-label Phase (Weeks 13 - 24)|Other|0
55075|NCT01313208|218726|P1|Open-label Phase (Weeks 13 - 24)|Other|2
55076|NCT01313208|218725|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
55077|NCT01313208|218726|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
55078|NCT01313208|218725|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
55079|NCT01313208|218726|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
55080|NCT01313208|218725|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
55081|NCT01313208|218726|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
55082|NCT01313208|218725|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
55083|NCT01313208|218726|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
55084|NCT01313208|218725|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
55085|NCT01313208|218726|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
55086|NCT01313208|218725|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
55087|NCT01313208|218726|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
55088|NCT01313208|218725|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
55089|NCT01313208|218726|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
55090|NCT01313208|218725|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
55091|NCT01313208|218726|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
55092|NCT01313182|218816|P2|Overall Study|Protocol Violation|92
55093|NCT01313182|218817|P1|Overall Study|Protocol Violation|66
55094|NCT01313117|218823|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
55095|NCT01313117|218823|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
55096|NCT01313078|218830|P1|Overall Study|Withdrawal by Subject|1
55097|NCT01313078|218830|P1|Overall Study|Discontinued study drug|1
55098|NCT01313078|218830|P1|Overall Study|Death|1
55099|NCT01313039|218835|P1|Overall Study|Adverse Event|1
55100|NCT01313039|218835|P1|Overall Study|Physician Decision|1
55101|NCT01312961|218841|P2|Overall Study|Other than specified above|3
55102|NCT01312961|218842|P1|Overall Study|Other than specified above|2
55103|NCT01312961|218841|P2|Overall Study|Poor compliance to protocol|0
55104|NCT01312961|218842|P1|Overall Study|Poor compliance to protocol|1
55105|NCT01312961|218841|P2|Overall Study|Lack of Efficacy|1
55106|NCT01312961|218842|P1|Overall Study|Lack of Efficacy|11
55107|NCT01312961|218841|P2|Overall Study|Adverse Event|3
55108|NCT01312961|218842|P1|Overall Study|Adverse Event|3
55109|NCT01312467|218959|P1|Overall Study|Ineligible|4
55110|NCT01312467|218959|P1|Overall Study|Another medical condition|1
55111|NCT01312467|218959|P1|Overall Study|Deported to country of origin|1
55112|NCT01312467|218959|P1|Overall Study|Withdrawal by Subject|2
55113|NCT01312467|218959|P1|Overall Study|Lost to Follow-up|1
55114|NCT01312467|218959|P1|Overall Study|Adverse Event|4
55115|NCT01312428|218965|P2|Overall Study|Study Termination|4
55116|NCT01312428|218966|P1|Overall Study|Study Termination|3
55117|NCT01312129|218993|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
55118|NCT01312129|218994|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
55119|NCT01311687|219011|P2|PFS Follow-up Phase|On PFS follow-up at data cut-off|1
55120|NCT01311687|219012|P1|PFS Follow-up Phase|On PFS follow-up at data cut-off|3
55121|NCT01311687|219011|P2|Treatment Phase|On treatment at data cut-off|11
55122|NCT01311687|219012|P1|Treatment Phase|On treatment at data cut-off|60
55123|NCT01311661|219062|P1|Overall Study|Withdrawal by Subject|2
55124|NCT01311661|219062|P1|Overall Study|Protocol Violation|3
55125|NCT01311661|219062|P1|Overall Study|Adverse Event|2
55126|NCT01311557|219206|P2|Overall Study|Withdrawal by Subject|2
55127|NCT01311557|219207|P1|Overall Study|Withdrawal by Subject|1
55128|NCT01311557|219206|P2|Overall Study|Lost to Follow-up|1
55129|NCT01311557|219207|P1|Overall Study|Lost to Follow-up|0
55130|NCT01311557|219206|P2|Overall Study|Protocol Violation|2
55131|NCT01311557|219207|P1|Overall Study|Protocol Violation|4
55132|NCT01311557|219206|P2|Overall Study|Serious adverse event|1
55133|NCT01311557|219207|P1|Overall Study|Serious adverse event|0
55134|NCT01311505|219223|P2|First Intervention Period|Protocol Violation|1
55135|NCT01311505|219224|P1|First Intervention Period|Protocol Violation|0
55136|NCT01311024|219280|P2|Overall Study|Protocol Violation|22
55137|NCT01311024|219281|P1|Overall Study|Protocol Violation|35
55138|NCT01309997|219289|P2|Overall Study|Withdrawal by Subject|1
55139|NCT01309997|219290|P1|Overall Study|Withdrawal by Subject|1
55140|NCT01309997|219289|P2|Overall Study|Lack of Efficacy|2
55141|NCT01309997|219290|P1|Overall Study|Lack of Efficacy|2
55142|NCT01309997|219289|P2|Overall Study|Death|3
55143|NCT01309997|219290|P1|Overall Study|Death|1
55144|NCT01309997|219289|P2|Overall Study|Adverse Event|0
55145|NCT01309997|219290|P1|Overall Study|Adverse Event|1
55146|NCT01309919|219314|P2|Overall Study|Did not receive a postpartum IUD|48
55147|NCT01309919|219315|P1|Overall Study|Did not receive a postpartum IUD|17
55148|NCT01310803|219342|P2|Overall Study|Subject terminated by Sponsor|0
55149|NCT01310803|219343|P1|Overall Study|Subject terminated by Sponsor|1
55150|NCT01310777|219354|P3|Overall Study|Other|2
55151|NCT01310777|219355|P2|Overall Study|Other|1
55152|NCT01310777|219356|P1|Overall Study|Other|4
55153|NCT01310777|219354|P3|Overall Study|Inadequate Control of IOP|10
55154|NCT01310777|219355|P2|Overall Study|Inadequate Control of IOP|7
55155|NCT01310777|219356|P1|Overall Study|Inadequate Control of IOP|5
55156|NCT01310777|219354|P3|Overall Study|Patient's Decision Unrelated to AE|2
55157|NCT01310777|219355|P2|Overall Study|Patient's Decision Unrelated to AE|1
55158|NCT01310777|219356|P1|Overall Study|Patient's Decision Unrelated to AE|1
55159|NCT01310777|219354|P3|Overall Study|Lost to Follow-up|1
55160|NCT01310777|219355|P2|Overall Study|Lost to Follow-up|4
55161|NCT01310777|219356|P1|Overall Study|Lost to Follow-up|0
55162|NCT01310777|219354|P3|Overall Study|Adverse Event|15
55163|NCT01310777|219355|P2|Overall Study|Adverse Event|1
55164|NCT01310777|219356|P1|Overall Study|Adverse Event|23
55165|NCT01310699|219366|P2|Overall Study|Patients did not complete tandem.|6
55166|NCT01310699|219367|P1|Overall Study|Patients did not complete tandem.|4
55167|NCT01310413|219394|P7|From Day U0 to Day U385|Lost to Follow-up|2
55168|NCT01310413|219395|P6|From Day U0 to Day U385|Lost to Follow-up|0
55169|NCT01310413|219396|P5|From Day U0 to Day U385|Lost to Follow-up|0
55170|NCT01310413|219397|P4|From Day U0 to Day U385|Lost to Follow-up|0
55171|NCT01310413|219398|P3|From Day U0 to Day U385|Lost to Follow-up|0
55172|NCT01310413|219399|P2|From Day U0 to Day U385|Lost to Follow-up|0
55173|NCT01310413|219400|P1|From Day U0 to Day U385|Lost to Follow-up|0
55174|NCT01310413|219394|P7|From Day U0 to Day U385|Withdrawal by Subject|1
55175|NCT01310413|219395|P6|From Day U0 to Day U385|Withdrawal by Subject|0
55176|NCT01310413|219396|P5|From Day U0 to Day U385|Withdrawal by Subject|0
55177|NCT01310413|219397|P4|From Day U0 to Day U385|Withdrawal by Subject|0
55178|NCT01310413|219398|P3|From Day U0 to Day U385|Withdrawal by Subject|0
55179|NCT01310413|219399|P2|From Day U0 to Day U385|Withdrawal by Subject|0
55180|NCT01310413|219400|P1|From Day U0 to Day U385|Withdrawal by Subject|0
55181|NCT01310413|219394|P7|Day 0 to Day 385|Unspecified|0
55182|NCT01310413|219395|P6|Day 0 to Day 385|Unspecified|0
55183|NCT01310413|219396|P5|Day 0 to Day 385|Unspecified|0
55184|NCT01310413|219397|P4|Day 0 to Day 385|Unspecified|0
55185|NCT01310413|219398|P3|Day 0 to Day 385|Unspecified|3
55186|NCT01310413|219399|P2|Day 0 to Day 385|Unspecified|0
55187|NCT01310413|219400|P1|Day 0 to Day 385|Unspecified|1
55188|NCT01310413|219394|P7|Day 0 to Day 385|Migrated/moved from study area|0
55189|NCT01310413|219395|P6|Day 0 to Day 385|Migrated/moved from study area|0
55190|NCT01310413|219396|P5|Day 0 to Day 385|Migrated/moved from study area|1
55191|NCT01310413|219397|P4|Day 0 to Day 385|Migrated/moved from study area|1
55192|NCT01310413|219398|P3|Day 0 to Day 385|Migrated/moved from study area|1
55193|NCT01310413|219399|P2|Day 0 to Day 385|Migrated/moved from study area|3
55194|NCT01310413|219400|P1|Day 0 to Day 385|Migrated/moved from study area|3
55195|NCT01310413|219394|P7|Day 0 to Day 385|Lost to Follow-up|0
55196|NCT01310413|219395|P6|Day 0 to Day 385|Lost to Follow-up|2
55197|NCT01310413|219396|P5|Day 0 to Day 385|Lost to Follow-up|1
55198|NCT01310413|219397|P4|Day 0 to Day 385|Lost to Follow-up|5
55199|NCT01310413|219398|P3|Day 0 to Day 385|Lost to Follow-up|3
55200|NCT01310413|219399|P2|Day 0 to Day 385|Lost to Follow-up|3
55201|NCT01310413|219400|P1|Day 0 to Day 385|Lost to Follow-up|18
55202|NCT01310413|219394|P7|Day 0 to Day 385|Withdrawal by Subject|0
55203|NCT01310413|219395|P6|Day 0 to Day 385|Withdrawal by Subject|1
55204|NCT01310413|219396|P5|Day 0 to Day 385|Withdrawal by Subject|1
55205|NCT01310413|219397|P4|Day 0 to Day 385|Withdrawal by Subject|2
55206|NCT01310413|219398|P3|Day 0 to Day 385|Withdrawal by Subject|0
55207|NCT01310413|219399|P2|Day 0 to Day 385|Withdrawal by Subject|2
55208|NCT01310413|219400|P1|Day 0 to Day 385|Withdrawal by Subject|5
55209|NCT01310127|219582|P2|Overall Study|advanced psc cataract outlier|0
55210|NCT01310127|219583|P1|Overall Study|advanced psc cataract outlier|1
55211|NCT01310127|219582|P2|Overall Study|Protocol Violation|1
55212|NCT01310127|219583|P1|Overall Study|Protocol Violation|1
55213|NCT01309893|219595|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
55214|NCT01309893|219596|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
55215|NCT01309893|219595|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
55216|NCT01309893|219596|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
55217|NCT01309841|219620|P3|Overall Study|Severe non-compliance with protocol|2
55218|NCT01309841|219621|P2|Overall Study|Severe non-compliance with protocol|5
55219|NCT01309841|219622|P1|Overall Study|Severe non-compliance with protocol|0
55220|NCT01309841|219620|P3|Overall Study|Did Not Receive Treatment|1
55221|NCT01309841|219621|P2|Overall Study|Did Not Receive Treatment|0
55222|NCT01309841|219622|P1|Overall Study|Did Not Receive Treatment|2
55223|NCT01309841|219620|P3|Overall Study|Withdrawal by Subject|13
55224|NCT01309841|219621|P2|Overall Study|Withdrawal by Subject|6
55225|NCT01309841|219622|P1|Overall Study|Withdrawal by Subject|17
55226|NCT01309841|219620|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
55227|NCT01309841|219621|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
55228|NCT01309841|219622|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
55229|NCT01309841|219620|P3|Overall Study|Death|0
55230|NCT01309841|219621|P2|Overall Study|Death|0
55231|NCT01309841|219622|P1|Overall Study|Death|1
55232|NCT01309841|219620|P3|Overall Study|Adverse Event|11
55233|NCT01309841|219621|P2|Overall Study|Adverse Event|22
55234|NCT01309841|219622|P1|Overall Study|Adverse Event|9
55235|NCT01309841|219620|P3|Overall Study|Lack of Efficacy|2
55236|NCT01309841|219621|P2|Overall Study|Lack of Efficacy|0
55237|NCT01309841|219622|P1|Overall Study|Lack of Efficacy|0
55238|NCT01309841|219620|P3|Overall Study|Study-Specific Withdrawal Criteria|2
55239|NCT01309841|219621|P2|Overall Study|Study-Specific Withdrawal Criteria|1
55240|NCT01309841|219622|P1|Overall Study|Study-Specific Withdrawal Criteria|3
55241|NCT01309841|219620|P3|Overall Study|Lost to Follow-up|4
55242|NCT01309841|219621|P2|Overall Study|Lost to Follow-up|6
55243|NCT01309841|219622|P1|Overall Study|Lost to Follow-up|7
55244|NCT01309841|219620|P3|Overall Study|Other|1
55245|NCT01309841|219621|P2|Overall Study|Other|1
55246|NCT01309841|219622|P1|Overall Study|Other|0
55247|NCT01309828|219662|P2|Overall Study|Other|0
55248|NCT01309828|219663|P1|Overall Study|Other|1
55249|NCT01309828|219662|P2|Overall Study|Major Protocol Deviation|1
55250|NCT01309828|219663|P1|Overall Study|Major Protocol Deviation|0
55251|NCT01309828|219662|P2|Overall Study|Voluntary Withdrawal|4
55252|NCT01309828|219663|P1|Overall Study|Voluntary Withdrawal|5
55253|NCT01309828|219662|P2|Overall Study|Adverse Event|11
55254|NCT01309828|219663|P1|Overall Study|Adverse Event|10
55255|NCT01309737|219697|P5|Week 16 to 52|Unspecified|0
55256|NCT01309737|219698|P4|Week 16 to 52|Unspecified|2
55257|NCT01309737|219699|P3|Week 16 to 52|Unspecified|0
55258|NCT01309737|219700|P2|Week 16 to 52|Unspecified|12
55259|NCT01309737|219701|P1|Week 16 to 52|Unspecified|10
55260|NCT01309737|219697|P5|Week 16 to 52|Withdrawal by Subject|2
55261|NCT01309737|219698|P4|Week 16 to 52|Withdrawal by Subject|0
55262|NCT01309737|219699|P3|Week 16 to 52|Withdrawal by Subject|0
55263|NCT01309737|219700|P2|Week 16 to 52|Withdrawal by Subject|6
55264|NCT01309737|219701|P1|Week 16 to 52|Withdrawal by Subject|5
55265|NCT01309737|219697|P5|Week 16 to 52|Lost to Follow-up|4
55266|NCT01309737|219698|P4|Week 16 to 52|Lost to Follow-up|1
55267|NCT01309737|219699|P3|Week 16 to 52|Lost to Follow-up|0
55268|NCT01309737|219700|P2|Week 16 to 52|Lost to Follow-up|2
55269|NCT01309737|219701|P1|Week 16 to 52|Lost to Follow-up|4
55270|NCT01309737|219697|P5|Week 16 to 52|Lack of Efficacy|21
55271|NCT01309737|219698|P4|Week 16 to 52|Lack of Efficacy|25
55272|NCT01309737|219699|P3|Week 16 to 52|Lack of Efficacy|0
55273|NCT01309737|219700|P2|Week 16 to 52|Lack of Efficacy|76
55274|NCT01309737|219701|P1|Week 16 to 52|Lack of Efficacy|107
55275|NCT01309737|219697|P5|Week 16 to 52|Adverse Event|5
55276|NCT01309737|219698|P4|Week 16 to 52|Adverse Event|6
55277|NCT01309737|219699|P3|Week 16 to 52|Adverse Event|0
55278|NCT01309737|219700|P2|Week 16 to 52|Adverse Event|7
55279|NCT01309737|219701|P1|Week 16 to 52|Adverse Event|7
55280|NCT01309737|219697|P5|Week 16 to 52|Death|1
55281|NCT01309737|219698|P4|Week 16 to 52|Death|0
55282|NCT01309737|219699|P3|Week 16 to 52|Death|0
55283|NCT01309737|219700|P2|Week 16 to 52|Death|0
55284|NCT01309737|219701|P1|Week 16 to 52|Death|0
55285|NCT01309737|219697|P5|Week 0 to 16|Randomized, but not treated|0
55286|NCT01309737|219698|P4|Week 0 to 16|Randomized, but not treated|0
55287|NCT01309737|219699|P3|Week 0 to 16|Randomized, but not treated|0
55288|NCT01309737|219700|P2|Week 0 to 16|Randomized, but not treated|0
55289|NCT01309737|219701|P1|Week 0 to 16|Randomized, but not treated|1
55290|NCT01309737|219697|P5|Week 0 to 16|Unspecified|0
55291|NCT01309737|219698|P4|Week 0 to 16|Unspecified|0
55292|NCT01309737|219699|P3|Week 0 to 16|Unspecified|4
55293|NCT01309737|219700|P2|Week 0 to 16|Unspecified|14
55294|NCT01309737|219701|P1|Week 0 to 16|Unspecified|10
55295|NCT01309737|219697|P5|Week 0 to 16|Withdrawal by Subject|0
55296|NCT01309737|219698|P4|Week 0 to 16|Withdrawal by Subject|0
55297|NCT01309737|219699|P3|Week 0 to 16|Withdrawal by Subject|7
55298|NCT01309737|219700|P2|Week 0 to 16|Withdrawal by Subject|6
55299|NCT01309737|219701|P1|Week 0 to 16|Withdrawal by Subject|7
55300|NCT01309737|219697|P5|Week 0 to 16|Lost to Follow-up|0
55301|NCT01309737|219698|P4|Week 0 to 16|Lost to Follow-up|0
55302|NCT01309737|219699|P3|Week 0 to 16|Lost to Follow-up|3
55303|NCT01309737|219700|P2|Week 0 to 16|Lost to Follow-up|8
55304|NCT01309737|219701|P1|Week 0 to 16|Lost to Follow-up|7
55305|NCT01309737|219697|P5|Week 0 to 16|Lack of Efficacy|0
55306|NCT01309737|219698|P4|Week 0 to 16|Lack of Efficacy|0
55307|NCT01309737|219699|P3|Week 0 to 16|Lack of Efficacy|24
55308|NCT01309737|219700|P2|Week 0 to 16|Lack of Efficacy|2
55309|NCT01309737|219701|P1|Week 0 to 16|Lack of Efficacy|15
55310|NCT01309737|219697|P5|Week 0 to 16|Adverse Event|0
55311|NCT01309737|219698|P4|Week 0 to 16|Adverse Event|0
55312|NCT01309737|219699|P3|Week 0 to 16|Adverse Event|5
55313|NCT01309737|219700|P2|Week 0 to 16|Adverse Event|10
55314|NCT01309737|219701|P1|Week 0 to 16|Adverse Event|11
55315|NCT01309737|219697|P5|Week 0 to 16|Death|0
55316|NCT01309737|219698|P4|Week 0 to 16|Death|0
55317|NCT01309737|219699|P3|Week 0 to 16|Death|1
55318|NCT01309737|219700|P2|Week 0 to 16|Death|0
55319|NCT01309737|219701|P1|Week 0 to 16|Death|1
55320|NCT01309672|219896|P1|Overall Study|Withdrawal by Subject|3
55321|NCT01309672|219896|P1|Overall Study|Adverse Event|5
55322|NCT01309672|219896|P1|Overall Study|Unspecified|9
55323|NCT01309672|219896|P1|Overall Study|Lack of Efficacy|20
55324|NCT01309659|219906|P2|Overall Study|Protocol Violation|1
55325|NCT01309659|219907|P1|Overall Study|Protocol Violation|0
55326|NCT01309386|220012|P2|Overall Study|Adverse Event|8
55327|NCT01309386|220013|P1|Overall Study|Adverse Event|5
55328|NCT01309386|220012|P2|Overall Study|Lack of Efficacy|1
55329|NCT01309386|220013|P1|Overall Study|Lack of Efficacy|3
55330|NCT01309386|220012|P2|Overall Study|Physician Decision|1
55331|NCT01309386|220013|P1|Overall Study|Physician Decision|1
55332|NCT01309386|220012|P2|Overall Study|Progressive disease|11
55333|NCT01309386|220013|P1|Overall Study|Progressive disease|9
55334|NCT01309386|220012|P2|Overall Study|Withdrawal by Subject|0
55335|NCT01309386|220013|P1|Overall Study|Withdrawal by Subject|2
55336|NCT01309386|220012|P2|Overall Study|Unspecified|0
55337|NCT01309386|220013|P1|Overall Study|Unspecified|2
55338|NCT01309308|220061|P2|Overall Study|Lost to Follow-up|4
55339|NCT01309308|220062|P1|Overall Study|Lost to Follow-up|6
55340|NCT01309282|220070|P1|Overall Study|Lost to Follow-up|1
55341|NCT01309269|220087|P1|Overall Study|Enrolled but not Treated|107
55342|NCT01309269|220087|P1|Overall Study|Study Completion Data Not Recorded|95
55343|NCT01309269|220087|P1|Overall Study|Other|1
55344|NCT01309269|220087|P1|Overall Study|Unspecified|256
55345|NCT01309269|220087|P1|Overall Study|Administrative Problems|141
55346|NCT01309269|220087|P1|Overall Study|Kidney Transplant|25
55347|NCT01309269|220087|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
55348|NCT01309269|220087|P1|Overall Study|Lack of Acceptance|15
55349|NCT01309269|220087|P1|Overall Study|Withdrawal by Subject|25
55350|NCT01309269|220087|P1|Overall Study|Adverse Event|56
55351|NCT01309243|220095|P2|Extension Phase|Lost to Follow-up|0
55352|NCT01309243|220096|P1|Extension Phase|Lost to Follow-up|6
55353|NCT01309243|220095|P2|Randomized Phase Through Week 96|Protocol Violation|1
55354|NCT01309243|220096|P1|Randomized Phase Through Week 96|Protocol Violation|1
55355|NCT01309243|220095|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
55356|NCT01309243|220096|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
55357|NCT01309243|220095|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
55358|NCT01309243|220096|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
55359|NCT01309243|220095|P2|Randomized Phase Through Week 96|Withdrew Consent|18
55360|NCT01309243|220096|P1|Randomized Phase Through Week 96|Withdrew Consent|12
55361|NCT01309243|220095|P2|Randomized Phase Through Week 96|Investigators Discretion|6
55362|NCT01309243|220096|P1|Randomized Phase Through Week 96|Investigators Discretion|3
55363|NCT01309243|220095|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
55364|NCT01309243|220096|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
55365|NCT01309243|220095|P2|Randomized Phase Through Week 96|Pregnancy|0
55366|NCT01309243|220096|P1|Randomized Phase Through Week 96|Pregnancy|2
55367|NCT01309243|220095|P2|Randomized Phase Through Week 96|Death|1
55368|NCT01309243|220096|P1|Randomized Phase Through Week 96|Death|0
55369|NCT01309243|220095|P2|Randomized Phase Through Week 96|Adverse Event|43
55370|NCT01309243|220096|P1|Randomized Phase Through Week 96|Adverse Event|12
55686|NCT01306162|220905|P3|Period 1|Adverse Event|0
55371|NCT01309243|220095|P2|Randomized Phase Through Week 96|Randomized but not treated|7
55372|NCT01309243|220096|P1|Randomized Phase Through Week 96|Randomized but not treated|6
55373|NCT01309204|220122|P2|Overall Study|Other|1
55374|NCT01309204|220123|P1|Overall Study|Other|4
55375|NCT01309204|220122|P2|Overall Study|Inadequate control of IOP|4
55376|NCT01309204|220123|P1|Overall Study|Inadequate control of IOP|4
55377|NCT01309204|220122|P2|Overall Study|Subject's decision unrelated to an AE|10
55378|NCT01309204|220123|P1|Overall Study|Subject's decision unrelated to an AE|9
55379|NCT01309204|220122|P2|Overall Study|Lost to Follow-up|2
55380|NCT01309204|220123|P1|Overall Study|Lost to Follow-up|2
55381|NCT01309204|220122|P2|Overall Study|Adverse Event|58
55382|NCT01309204|220123|P1|Overall Study|Adverse Event|48
55383|NCT01309100|220129|P1|Overall Study|Positive Slit lamp finding|1
55384|NCT01309100|220129|P1|Overall Study|Protocol Violation|1
55385|NCT01308788|220177|P2|2-year Treatment|medication change by treating physician|11
55386|NCT01308788|220178|P1|2-year Treatment|medication change by treating physician|4
55387|NCT01308762|220213|P3|Overall Study|Protocol Violation|0
55388|NCT01308762|220214|P2|Overall Study|Protocol Violation|1
55389|NCT01308762|220215|P1|Overall Study|Protocol Violation|0
55390|NCT01308749|220228|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
55391|NCT01308749|220229|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
55392|NCT01308749|220228|P2|Period 2: Open Label Treatment|Adverse Event|1
55393|NCT01308749|220229|P1|Period 2: Open Label Treatment|Adverse Event|0
55394|NCT01308749|220228|P2|Period 1: Double Blind Treatment|Adverse Event|0
55395|NCT01308749|220229|P1|Period 1: Double Blind Treatment|Adverse Event|1
55396|NCT01308736|220259|P2|Overall Study|Did not attend a single session|5
55397|NCT01308736|220260|P1|Overall Study|Did not attend a single session|6
55398|NCT01308580|220283|P2|Overall Study|Lost to Follow-up|7
55399|NCT01308580|220284|P1|Overall Study|Lost to Follow-up|12
55400|NCT01308567|220327|P3|Overall Study|Lost to Follow-up|4
55401|NCT01308567|220328|P2|Overall Study|Lost to Follow-up|4
55402|NCT01308567|220329|P1|Overall Study|Lost to Follow-up|2
55403|NCT01308476|220369|P2|Overall Study|Other|0
55404|NCT01308476|220370|P1|Overall Study|Other|1
55405|NCT01308476|220369|P2|Overall Study|Lost to Follow-up|2
55406|NCT01308476|220370|P1|Overall Study|Lost to Follow-up|2
55407|NCT01308463|220390|P1|Overall Study|Revision|2
55408|NCT01308463|220390|P1|Overall Study|Death|4
55409|NCT01308463|220390|P1|Overall Study|Study Discontinued|23
55410|NCT01308424|220403|P3|Randomization|Physician Decision|1
55411|NCT01308424|220404|P2|Randomization|Physician Decision|1
55412|NCT01308424|220405|P1|Randomization|Physician Decision|0
55413|NCT01308424|220403|P3|Randomization|Lost to Follow-up|0
55414|NCT01308424|220404|P2|Randomization|Lost to Follow-up|1
55415|NCT01308424|220405|P1|Randomization|Lost to Follow-up|0
55416|NCT01308424|220403|P3|Randomization|Adverse Event|1
55417|NCT01308424|220404|P2|Randomization|Adverse Event|1
55418|NCT01308424|220405|P1|Randomization|Adverse Event|0
55419|NCT01308424|220403|P3|Baseline Eligibility|Screen Failures|0
55420|NCT01308424|220404|P2|Baseline Eligibility|Screen Failures|0
55421|NCT01308424|220405|P1|Baseline Eligibility|Screen Failures|71
55422|NCT01307787|220414|P2|Overall Study|Withdrawal by Subject|0
55423|NCT01307787|220415|P1|Overall Study|Withdrawal by Subject|2
55424|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
55425|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
55426|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
55427|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
55428|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
55429|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
55430|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
55431|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Unspecified|0
55432|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Unspecified|0
55433|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Unspecified|0
55434|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Unspecified|1
55435|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Unspecified|0
55436|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Unspecified|0
55437|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Unspecified|0
55438|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
55439|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
55440|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
55441|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
55442|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
55443|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
55444|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
55445|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
55446|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
55447|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
55448|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
55449|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
55450|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
55451|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
55452|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
55453|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|1
55454|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
55455|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
55456|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
55457|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
55458|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Non-compliance with study drug|0
55459|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
55460|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
55461|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
55462|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
55463|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
55464|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
55465|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
55466|NCT01307423|220457|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
55467|NCT01307423|220458|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
55468|NCT01307423|220459|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
55469|NCT01307423|220460|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
55470|NCT01307423|220461|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
55471|NCT01307423|220462|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
55472|NCT01307423|220463|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
55473|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
55474|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
55475|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
55476|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
55477|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
55478|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
55479|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
55480|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
55481|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
55482|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
55483|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
55484|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
55485|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
55486|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
55641|NCT01306968|220705|P3|Overall Study|Lost to Follow-up|0
55487|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
55488|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
55489|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
55490|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
55491|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
55492|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
55493|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
55494|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
55495|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
55496|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
55497|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
55498|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
55499|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
55500|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
55501|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
55502|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
55503|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
55504|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
55505|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
55506|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
55507|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
55508|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
55509|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
55510|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
55511|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
55512|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
55513|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
55514|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
55515|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
55516|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
55517|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
55518|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
55519|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
55520|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
55521|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
55522|NCT01307423|220457|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
55523|NCT01307423|220458|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
55524|NCT01307423|220459|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
55525|NCT01307423|220460|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
55526|NCT01307423|220461|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
55527|NCT01307423|220462|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
55528|NCT01307423|220463|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
55529|NCT01307319|220575|P3|Overall Study|Not specified|3
55530|NCT01307319|220576|P2|Overall Study|Not specified|4
55531|NCT01307319|220577|P1|Overall Study|Not specified|0
55532|NCT01307319|220575|P3|Overall Study|Withdrawal by Subject|2
55533|NCT01307319|220576|P2|Overall Study|Withdrawal by Subject|1
55534|NCT01307319|220577|P1|Overall Study|Withdrawal by Subject|0
55535|NCT01307319|220575|P3|Overall Study|Protocol Violation|0
55536|NCT01307319|220576|P2|Overall Study|Protocol Violation|1
55537|NCT01307319|220577|P1|Overall Study|Protocol Violation|1
55538|NCT01307319|220575|P3|Overall Study|Lost to Follow-up|1
55539|NCT01307319|220576|P2|Overall Study|Lost to Follow-up|0
55540|NCT01307319|220577|P1|Overall Study|Lost to Follow-up|1
55541|NCT01307319|220575|P3|Overall Study|Adverse Event|1
55542|NCT01307319|220576|P2|Overall Study|Adverse Event|2
55543|NCT01307319|220577|P1|Overall Study|Adverse Event|2
55544|NCT01307111|220591|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
55545|NCT01307111|220592|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
55546|NCT01307111|220591|P2|IUD Insertion|Lost to Follow-up|0
55547|NCT01307111|220592|P1|IUD Insertion|Lost to Follow-up|2
55548|NCT01307046|220602|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
55549|NCT01307046|220603|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
55550|NCT01307046|220602|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
55551|NCT01307046|220603|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
55552|NCT01307046|220602|P2|Overall Study|Withdrawal by Subject|1
55553|NCT01307046|220603|P1|Overall Study|Withdrawal by Subject|1
55554|NCT01307046|220602|P2|Overall Study|Physician Decision|0
55555|NCT01307046|220603|P1|Overall Study|Physician Decision|2
55556|NCT01307046|220602|P2|Overall Study|Lack of Efficacy|2
55557|NCT01307046|220603|P1|Overall Study|Lack of Efficacy|0
55558|NCT01307046|220602|P2|Overall Study|Adverse Event|3
55559|NCT01307046|220603|P1|Overall Study|Adverse Event|3
55560|NCT01307033|220615|P4|44-week Open-label Extension|Death|1
55561|NCT01307033|220616|P3|44-week Open-label Extension|Death|0
55562|NCT01307033|220617|P2|44-week Open-label Extension|Death|0
55563|NCT01307033|220618|P1|44-week Open-label Extension|Death|0
55642|NCT01306968|220706|P2|Overall Study|Lost to Follow-up|1
55564|NCT01307033|220615|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
55565|NCT01307033|220616|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
55566|NCT01307033|220617|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
55567|NCT01307033|220618|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
55568|NCT01307033|220615|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
55569|NCT01307033|220616|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
55570|NCT01307033|220617|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
55571|NCT01307033|220618|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
55572|NCT01307033|220615|P4|44-week Open-label Extension|Physician Decision|0
55573|NCT01307033|220616|P3|44-week Open-label Extension|Physician Decision|1
55574|NCT01307033|220617|P2|44-week Open-label Extension|Physician Decision|0
55575|NCT01307033|220618|P1|44-week Open-label Extension|Physician Decision|0
55576|NCT01307033|220615|P4|44-week Open-label Extension|Withdrawal by Subject|1
55577|NCT01307033|220616|P3|44-week Open-label Extension|Withdrawal by Subject|2
55578|NCT01307033|220617|P2|44-week Open-label Extension|Withdrawal by Subject|0
55579|NCT01307033|220618|P1|44-week Open-label Extension|Withdrawal by Subject|0
55580|NCT01307033|220615|P4|44-week Open-label Extension|Adverse Event|1
55581|NCT01307033|220616|P3|44-week Open-label Extension|Adverse Event|2
55582|NCT01307033|220617|P2|44-week Open-label Extension|Adverse Event|0
55583|NCT01307033|220618|P1|44-week Open-label Extension|Adverse Event|0
55584|NCT01307033|220615|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
55585|NCT01307033|220616|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
55586|NCT01307033|220617|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
55587|NCT01307033|220618|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
55588|NCT01307033|220615|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
55589|NCT01307033|220616|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
55590|NCT01307033|220617|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
55591|NCT01307033|220618|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
55592|NCT01307033|220615|P4|8-week Double-blind Period|Lack of Efficacy|0
55593|NCT01307033|220616|P3|8-week Double-blind Period|Lack of Efficacy|0
55594|NCT01307033|220617|P2|8-week Double-blind Period|Lack of Efficacy|0
55595|NCT01307033|220618|P1|8-week Double-blind Period|Lack of Efficacy|1
55596|NCT01307033|220615|P4|8-week Double-blind Period|Withdrawal by Subject|0
55597|NCT01307033|220616|P3|8-week Double-blind Period|Withdrawal by Subject|0
55598|NCT01307033|220617|P2|8-week Double-blind Period|Withdrawal by Subject|1
55599|NCT01307033|220618|P1|8-week Double-blind Period|Withdrawal by Subject|4
55600|NCT01307033|220615|P4|8-week Double-blind Period|Adverse Event|0
55601|NCT01307033|220616|P3|8-week Double-blind Period|Adverse Event|0
55602|NCT01307033|220617|P2|8-week Double-blind Period|Adverse Event|0
55603|NCT01307033|220618|P1|8-week Double-blind Period|Adverse Event|2
55604|NCT01307020|220640|P10|Overall Study|Electronic data capture failure|0
55605|NCT01307020|220641|P9|Overall Study|Electronic data capture failure|0
55606|NCT01307020|220642|P8|Overall Study|Electronic data capture failure|0
55607|NCT01307020|220643|P7|Overall Study|Electronic data capture failure|0
55608|NCT01307020|220644|P6|Overall Study|Electronic data capture failure|0
55609|NCT01307020|220645|P5|Overall Study|Electronic data capture failure|0
55610|NCT01307020|220646|P4|Overall Study|Electronic data capture failure|0
55611|NCT01307020|220647|P3|Overall Study|Electronic data capture failure|0
55612|NCT01307020|220648|P2|Overall Study|Electronic data capture failure|1
55613|NCT01307020|220649|P1|Overall Study|Electronic data capture failure|0
55614|NCT01307020|220640|P10|Overall Study|Lost to Follow-up|0
55615|NCT01307020|220641|P9|Overall Study|Lost to Follow-up|0
55616|NCT01307020|220642|P8|Overall Study|Lost to Follow-up|0
55617|NCT01307020|220643|P7|Overall Study|Lost to Follow-up|1
55618|NCT01307020|220644|P6|Overall Study|Lost to Follow-up|0
55619|NCT01307020|220645|P5|Overall Study|Lost to Follow-up|0
55620|NCT01307020|220646|P4|Overall Study|Lost to Follow-up|1
55621|NCT01307020|220647|P3|Overall Study|Lost to Follow-up|1
55622|NCT01307020|220648|P2|Overall Study|Lost to Follow-up|0
55623|NCT01307020|220649|P1|Overall Study|Lost to Follow-up|0
55624|NCT01306968|220704|P4|Overall Study|Withdrew over privacy concerns|1
55625|NCT01306968|220705|P3|Overall Study|Withdrew over privacy concerns|0
55626|NCT01306968|220706|P2|Overall Study|Withdrew over privacy concerns|0
55627|NCT01306968|220707|P1|Overall Study|Withdrew over privacy concerns|0
55628|NCT01306968|220704|P4|Overall Study|Withdrew - time commitment|2
55629|NCT01306968|220705|P3|Overall Study|Withdrew - time commitment|0
55630|NCT01306968|220706|P2|Overall Study|Withdrew - time commitment|0
55631|NCT01306968|220707|P1|Overall Study|Withdrew - time commitment|0
55632|NCT01306968|220704|P4|Overall Study|Relocated and left active duty|1
55633|NCT01306968|220705|P3|Overall Study|Relocated and left active duty|1
55634|NCT01306968|220706|P2|Overall Study|Relocated and left active duty|1
55635|NCT01306968|220707|P1|Overall Study|Relocated and left active duty|0
55636|NCT01306968|220704|P4|Overall Study|Physician Decision|0
55637|NCT01306968|220705|P3|Overall Study|Physician Decision|0
55638|NCT01306968|220706|P2|Overall Study|Physician Decision|1
55639|NCT01306968|220707|P1|Overall Study|Physician Decision|0
55640|NCT01306968|220704|P4|Overall Study|Lost to Follow-up|0
55643|NCT01306968|220707|P1|Overall Study|Lost to Follow-up|1
55644|NCT01306877|220731|P2|Overall Study|Physician Decision|1
55645|NCT01306877|220732|P1|Overall Study|Physician Decision|0
55646|NCT01306877|220731|P2|Overall Study|Lost to Follow-up|3
55647|NCT01306877|220732|P1|Overall Study|Lost to Follow-up|3
55648|NCT01306643|220750|P1|Overall Study|Other: Change in Eligibility Status|1
55649|NCT01306643|220750|P1|Overall Study|Disease Progression|7
55650|NCT01306643|220750|P1|Overall Study|Adverse Event|5
55651|NCT01306617|220762|P3|Overall Study|Non-compliance|0
55652|NCT01306617|220763|P2|Overall Study|Non-compliance|1
55653|NCT01306617|220764|P1|Overall Study|Non-compliance|0
55654|NCT01306617|220762|P3|Overall Study|Virologic Failure|5
55655|NCT01306617|220763|P2|Overall Study|Virologic Failure|0
55656|NCT01306617|220764|P1|Overall Study|Virologic Failure|0
55657|NCT01306617|220762|P3|Overall Study|Adverse Event|0
55658|NCT01306617|220763|P2|Overall Study|Adverse Event|0
55659|NCT01306617|220764|P1|Overall Study|Adverse Event|1
55660|NCT01306305|220807|P2|Overall Study|Withdrew consent|0
55661|NCT01306305|220808|P1|Overall Study|Withdrew consent|1
55662|NCT01306305|220807|P2|Overall Study|Lost to Follow-up|0
55663|NCT01306305|220808|P1|Overall Study|Lost to Follow-up|1
55664|NCT01306253|220845|P2|Overall Study|Lost to Follow-up|1
55665|NCT01306253|220846|P1|Overall Study|Lost to Follow-up|1
55666|NCT01306214|220863|P3|Overall Study|Not treated|1
55667|NCT01306214|220864|P2|Overall Study|Not treated|1
55668|NCT01306214|220865|P1|Overall Study|Not treated|1
55669|NCT01306214|220863|P3|Overall Study|Withdrawal by Subject|16
55670|NCT01306214|220864|P2|Overall Study|Withdrawal by Subject|22
55671|NCT01306214|220865|P1|Overall Study|Withdrawal by Subject|24
55672|NCT01306214|220863|P3|Overall Study|Lost to Follow-up|4
55673|NCT01306214|220864|P2|Overall Study|Lost to Follow-up|5
55674|NCT01306214|220865|P1|Overall Study|Lost to Follow-up|3
55675|NCT01306214|220863|P3|Overall Study|Death|1
55676|NCT01306214|220864|P2|Overall Study|Death|0
55677|NCT01306214|220865|P1|Overall Study|Death|0
55678|NCT01306201|220882|P1|Overall Study|Files unreadable|3
55679|NCT01306201|220882|P1|Overall Study|Files could not be processed|3
55680|NCT01306201|220882|P1|Overall Study|Arrhythmia|4
55681|NCT01306162|220904|P4|Washout 1|Non-compliance to protocol|0
55682|NCT01306162|220905|P3|Washout 1|Non-compliance to protocol|0
55683|NCT01306162|220906|P2|Washout 1|Non-compliance to protocol|1
55684|NCT01306162|220907|P1|Washout 1|Non-compliance to protocol|0
55685|NCT01306162|220904|P4|Period 1|Adverse Event|1
55687|NCT01306162|220906|P2|Period 1|Adverse Event|0
55688|NCT01306162|220907|P1|Period 1|Adverse Event|0
55689|NCT01306032|220941|P6|Disease Progression/Crossover|other/symptomatic progression|0
55690|NCT01306032|220942|P5|Disease Progression/Crossover|other/symptomatic progression|0
55691|NCT01306032|220943|P4|Disease Progression/Crossover|other/symptomatic progression|2
55692|NCT01306032|220944|P3|Disease Progression/Crossover|other/symptomatic progression|0
55693|NCT01306032|220945|P2|Disease Progression/Crossover|other/symptomatic progression|2
55694|NCT01306032|220946|P1|Disease Progression/Crossover|other/symptomatic progression|0
55695|NCT01306032|220941|P6|Disease Progression/Crossover|Withdrawal by Subject|0
55696|NCT01306032|220942|P5|Disease Progression/Crossover|Withdrawal by Subject|0
55697|NCT01306032|220943|P4|Disease Progression/Crossover|Withdrawal by Subject|1
55698|NCT01306032|220944|P3|Disease Progression/Crossover|Withdrawal by Subject|0
55699|NCT01306032|220945|P2|Disease Progression/Crossover|Withdrawal by Subject|0
55700|NCT01306032|220946|P1|Disease Progression/Crossover|Withdrawal by Subject|0
55701|NCT01306032|220941|P6|First Intervention|Progressive disease|0
55702|NCT01306032|220942|P5|First Intervention|Progressive disease|2
55703|NCT01306032|220943|P4|First Intervention|Progressive disease|0
55704|NCT01306032|220944|P3|First Intervention|Progressive disease|0
55705|NCT01306032|220945|P2|First Intervention|Progressive disease|0
55706|NCT01306032|220946|P1|First Intervention|Progressive disease|0
55707|NCT01306032|220941|P6|First Intervention|Ineligible|1
55708|NCT01306032|220942|P5|First Intervention|Ineligible|0
55709|NCT01306032|220943|P4|First Intervention|Ineligible|0
55710|NCT01306032|220944|P3|First Intervention|Ineligible|0
55711|NCT01306032|220945|P2|First Intervention|Ineligible|0
55712|NCT01306032|220946|P1|First Intervention|Ineligible|0
55713|NCT01306032|220941|P6|First Intervention|Death|0
55714|NCT01306032|220942|P5|First Intervention|Death|0
55715|NCT01306032|220943|P4|First Intervention|Death|0
55716|NCT01306032|220944|P3|First Intervention|Death|1
55717|NCT01306032|220945|P2|First Intervention|Death|0
55718|NCT01306032|220946|P1|First Intervention|Death|0
55719|NCT01306032|220941|P6|First Intervention|Withdrawal by Subject|0
55720|NCT01306032|220942|P5|First Intervention|Withdrawal by Subject|0
55721|NCT01306032|220943|P4|First Intervention|Withdrawal by Subject|1
55722|NCT01306032|220944|P3|First Intervention|Withdrawal by Subject|0
55723|NCT01306032|220945|P2|First Intervention|Withdrawal by Subject|2
55724|NCT01306032|220946|P1|First Intervention|Withdrawal by Subject|0
55725|NCT01306032|220941|P6|First Intervention|Adverse Event|1
55726|NCT01306032|220942|P5|First Intervention|Adverse Event|0
55727|NCT01306032|220943|P4|First Intervention|Adverse Event|0
55728|NCT01306032|220944|P3|First Intervention|Adverse Event|1
55729|NCT01306032|220945|P2|First Intervention|Adverse Event|0
55730|NCT01306032|220946|P1|First Intervention|Adverse Event|1
55731|NCT01305577|221026|P3|Overall Study|Protocol Deviation|1
55732|NCT01305577|221027|P2|Overall Study|Protocol Deviation|1
55733|NCT01305577|221028|P1|Overall Study|Protocol Deviation|0
55734|NCT01305577|221026|P3|Overall Study|Lost to Follow-up|2
55735|NCT01305577|221027|P2|Overall Study|Lost to Follow-up|3
55736|NCT01305577|221028|P1|Overall Study|Lost to Follow-up|4
55737|NCT01305577|221026|P3|Overall Study|Withdrawal by Subject|6
55738|NCT01305577|221027|P2|Overall Study|Withdrawal by Subject|5
55739|NCT01305577|221028|P1|Overall Study|Withdrawal by Subject|7
55740|NCT01305577|221026|P3|Overall Study|Adverse Event|1
55741|NCT01305577|221027|P2|Overall Study|Adverse Event|2
55742|NCT01305577|221028|P1|Overall Study|Adverse Event|2
55743|NCT01305564|221057|P1|Overall Study|Physician Decision|3
55744|NCT01305564|221057|P1|Overall Study|Withdrawal by Subject|1
55745|NCT01305564|221057|P1|Overall Study|Lost to Follow-up|12
55746|NCT01305564|221057|P1|Overall Study|Death|21
55747|NCT01305408|221084|P2|Overall Study|Not specified|0
55748|NCT01305408|221085|P1|Overall Study|Not specified|1
55749|NCT01305408|221084|P2|Overall Study|Noncompliance with study procedures|1
55750|NCT01305408|221085|P1|Overall Study|Noncompliance with study procedures|0
55751|NCT01305408|221084|P2|Overall Study|Noncompliance with study medication|1
55752|NCT01305408|221085|P1|Overall Study|Noncompliance with study medication|0
55753|NCT01305408|221084|P2|Overall Study|Lost to Follow-up|3
55754|NCT01305408|221085|P1|Overall Study|Lost to Follow-up|5
55755|NCT01305408|221084|P2|Overall Study|Protocol Violation|6
55756|NCT01305408|221085|P1|Overall Study|Protocol Violation|4
55757|NCT01305408|221084|P2|Overall Study|Withdrawal by Subject|9
55758|NCT01305408|221085|P1|Overall Study|Withdrawal by Subject|9
55759|NCT01305408|221084|P2|Overall Study|Lack of Efficacy|4
55760|NCT01305408|221085|P1|Overall Study|Lack of Efficacy|3
55761|NCT01305408|221084|P2|Overall Study|Adverse Event|7
55762|NCT01305408|221085|P1|Overall Study|Adverse Event|10
55763|NCT01305239|221161|P1|Overall Study|Exemestane taken prior to inclusion only|1
55764|NCT01305239|221161|P1|Overall Study|Adverse Event|22
55765|NCT01305200|221183|P3|Overall Study|Death|0
55766|NCT01305200|221184|P2|Overall Study|Death|2
55767|NCT01305200|221185|P1|Overall Study|Death|0
55768|NCT01305200|221183|P3|Overall Study|Ineligible|1
55769|NCT01305200|221184|P2|Overall Study|Ineligible|2
55770|NCT01305200|221185|P1|Overall Study|Ineligible|1
55771|NCT01305200|221183|P3|Overall Study|Withdrawal by Subject|1
55772|NCT01305200|221184|P2|Overall Study|Withdrawal by Subject|21
55773|NCT01305200|221185|P1|Overall Study|Withdrawal by Subject|24
55774|NCT01305200|221183|P3|Overall Study|Physician Decision|1
55775|NCT01305200|221184|P2|Overall Study|Physician Decision|6
55776|NCT01305200|221185|P1|Overall Study|Physician Decision|4
55777|NCT01305044|221215|P2|Overall Study|Withdrawal by Subject|6
55778|NCT01305044|221216|P1|Overall Study|Withdrawal by Subject|3
55779|NCT01304706|221246|P1|Overall Study|Discontinued due to failed drug admin.|1
55780|NCT01304706|221246|P1|Overall Study|Lost to Follow-up|7
55781|NCT01304706|221246|P1|Overall Study|Withdrawal by Subject|3
55782|NCT01304706|221246|P1|Overall Study|Death|3
55783|NCT01304706|221246|P1|Overall Study|Lack of Efficacy|1
55784|NCT01304706|221246|P1|Overall Study|Adverse Event|2
55785|NCT01304693|221255|P5|Overall Study|Decision Unrelated to an Adverse Event|0
55786|NCT01304693|221256|P4|Overall Study|Decision Unrelated to an Adverse Event|1
55787|NCT01304693|221257|P3|Overall Study|Decision Unrelated to an Adverse Event|1
55788|NCT01304693|221258|P2|Overall Study|Decision Unrelated to an Adverse Event|0
55789|NCT01304693|221259|P1|Overall Study|Decision Unrelated to an Adverse Event|0
55790|NCT01304693|221255|P5|Overall Study|Adverse Event|1
55791|NCT01304693|221256|P4|Overall Study|Adverse Event|0
55792|NCT01304693|221257|P3|Overall Study|Adverse Event|0
55793|NCT01304693|221258|P2|Overall Study|Adverse Event|0
55794|NCT01304693|221259|P1|Overall Study|Adverse Event|0
55795|NCT01304498|221306|P2|Overall Study|Lost to Follow-up|1
55796|NCT01304498|221307|P1|Overall Study|Lost to Follow-up|2
55797|NCT01304498|221306|P2|Overall Study|Protocol Violation|0
55798|NCT01304498|221307|P1|Overall Study|Protocol Violation|1
55799|NCT01304498|221306|P2|Overall Study|Withdrawal by Subject|3
55800|NCT01304498|221307|P1|Overall Study|Withdrawal by Subject|2
55801|NCT01304498|221306|P2|Overall Study|Adverse Event|1
55802|NCT01304498|221307|P1|Overall Study|Adverse Event|1
55803|NCT01304329|221327|P6|Third Intervention (3 Days)|Adverse Event|0
55804|NCT01304329|221328|P5|Third Intervention (3 Days)|Adverse Event|0
55805|NCT01304329|221329|P4|Third Intervention (3 Days)|Adverse Event|0
55806|NCT01304329|221330|P3|Third Intervention (3 Days)|Adverse Event|0
55807|NCT01304329|221331|P2|Third Intervention (3 Days)|Adverse Event|1
55808|NCT01304329|221332|P1|Third Intervention (3 Days)|Adverse Event|0
55809|NCT01304147|221466|P2|Second Intervention (7days)|Withdrawal by Subject|1
55810|NCT01304147|221467|P1|Second Intervention (7days)|Withdrawal by Subject|1
55811|NCT01303861|221501|P4|Overall Study|Pregnancy|0
55812|NCT01303861|221502|P3|Overall Study|Pregnancy|0
55813|NCT01303861|221503|P2|Overall Study|Pregnancy|0
55814|NCT01303861|221504|P1|Overall Study|Pregnancy|1
55815|NCT01303861|221501|P4|Overall Study|Adverse Event|5
55816|NCT01303861|221502|P3|Overall Study|Adverse Event|0
55817|NCT01303861|221503|P2|Overall Study|Adverse Event|1
55818|NCT01303861|221504|P1|Overall Study|Adverse Event|4
55819|NCT01303861|221501|P4|Overall Study|Withdrawal by Subject|23
55820|NCT01303861|221502|P3|Overall Study|Withdrawal by Subject|8
55821|NCT01303861|221503|P2|Overall Study|Withdrawal by Subject|8
55822|NCT01303861|221504|P1|Overall Study|Withdrawal by Subject|16
55823|NCT01303861|221501|P4|Overall Study|Lack of Efficacy|0
55824|NCT01303861|221502|P3|Overall Study|Lack of Efficacy|1
55825|NCT01303861|221503|P2|Overall Study|Lack of Efficacy|2
55826|NCT01303861|221504|P1|Overall Study|Lack of Efficacy|3
55827|NCT01303861|221501|P4|Overall Study|Lost to Follow-up|31
55828|NCT01303861|221502|P3|Overall Study|Lost to Follow-up|27
55829|NCT01303861|221503|P2|Overall Study|Lost to Follow-up|14
55830|NCT01303861|221504|P1|Overall Study|Lost to Follow-up|34
55831|NCT01303627|221563|P2|Overall Study|the failure while performing URS|1
55832|NCT01303627|221564|P1|Overall Study|the failure while performing URS|0
55833|NCT01303510|221572|P2|Overall Study|Lost to Follow-up|0
55834|NCT01303510|221573|P1|Overall Study|Lost to Follow-up|1
55835|NCT01303445|221587|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
55836|NCT01303445|221588|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
55837|NCT01303445|221587|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
55838|NCT01303445|221588|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
55839|NCT01303445|221587|P2|Washout (14 Days)|Lost to Follow-up|2
55840|NCT01303445|221588|P1|Washout (14 Days)|Lost to Follow-up|0
55841|NCT01303445|221587|P2|Washout (14 Days)|Protocol Violation|0
55842|NCT01303445|221588|P1|Washout (14 Days)|Protocol Violation|1
55843|NCT01303445|221587|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
55844|NCT01303445|221588|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
55845|NCT01303445|221587|P2|Second Intervention (7 Days)|Adverse Event|2
55846|NCT01303445|221588|P1|Second Intervention (7 Days)|Adverse Event|0
55847|NCT01303445|221587|P2|First Intervention (7 Days)|Withdrawal by Subject|0
55848|NCT01303445|221588|P1|First Intervention (7 Days)|Withdrawal by Subject|1
55849|NCT01303380|221629|P1|Overall Study|Lack of compliance to study procedures|1
55850|NCT01303159|221688|P1|Overall Study|Study Termination|7
55851|NCT01303159|221688|P1|Overall Study|Death|16
55852|NCT01302938|221695|P2|Overall Study|Adverse Event|0
55853|NCT01302938|221696|P1|Overall Study|Adverse Event|1
55854|NCT01302938|221695|P2|Overall Study|Withdrawal by Subject|0
55855|NCT01302938|221696|P1|Overall Study|Withdrawal by Subject|1
55856|NCT01302899|221741|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
55857|NCT01302899|221742|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
55858|NCT01302899|221741|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
55859|NCT01302899|221742|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
55860|NCT01302691|221822|P2|Overall Study|Protocol Violation|0
55861|NCT01302691|221823|P1|Overall Study|Protocol Violation|1
55862|NCT01302691|221822|P2|Overall Study|Physician Decision|1
55863|NCT01302691|221823|P1|Overall Study|Physician Decision|0
55864|NCT01302691|221822|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
55865|NCT01302691|221823|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
55866|NCT01302691|221822|P2|Overall Study|Lost to Follow-up|0
55867|NCT01302691|221823|P1|Overall Study|Lost to Follow-up|1
55868|NCT01302691|221822|P2|Overall Study|Death|1
55869|NCT01302691|221823|P1|Overall Study|Death|0
55870|NCT01302691|221822|P2|Overall Study|Adverse Event|0
55871|NCT01302691|221823|P1|Overall Study|Adverse Event|2
55872|NCT01302548|221843|P2|Overall Study|Lost to Follow-up|1
55873|NCT01302548|221844|P1|Overall Study|Lost to Follow-up|2
55874|NCT01302418|221894|P1|Overall Study|Non-evaluable|9
55875|NCT01302418|221894|P1|Overall Study|Protocol Violation|9
55876|NCT01302392|221900|P2|Overall Study|Withdrawal by Subject|1
55877|NCT01302392|221901|P1|Overall Study|Withdrawal by Subject|6
55878|NCT01302392|221900|P2|Overall Study|Lost to Follow-up|0
55879|NCT01302392|221901|P1|Overall Study|Lost to Follow-up|1
55880|NCT01302366|221921|P1|Overall Study|patient choice or noncompliance|5
55881|NCT01302119|221929|P2|Overall Study|Non-specific|1
55882|NCT01302119|221930|P1|Overall Study|Non-specific|4
55883|NCT01302119|221929|P2|Overall Study|Non-compliance|2
55884|NCT01302119|221930|P1|Overall Study|Non-compliance|4
55885|NCT01302119|221929|P2|Overall Study|Adverse Event|1
55886|NCT01302119|221930|P1|Overall Study|Adverse Event|2
55887|NCT01302119|221929|P2|Overall Study|Lost to Follow-up|4
55888|NCT01302119|221930|P1|Overall Study|Lost to Follow-up|10
55889|NCT01302119|221929|P2|Overall Study|Withdrawal by Subject|20
55890|NCT01302119|221930|P1|Overall Study|Withdrawal by Subject|30
55891|NCT01302067|221945|P3|Overall Study|Adverse Event|45
55892|NCT01302067|221946|P2|Overall Study|Adverse Event|14
55893|NCT01302067|221947|P1|Overall Study|Adverse Event|27
55894|NCT01302067|221945|P3|Overall Study|Protocol Violation|8
55895|NCT01302067|221946|P2|Overall Study|Protocol Violation|0
55896|NCT01302067|221947|P1|Overall Study|Protocol Violation|11
55897|NCT01302067|221945|P3|Overall Study|Not specified|3
55898|NCT01302067|221946|P2|Overall Study|Not specified|1
55899|NCT01302067|221947|P1|Overall Study|Not specified|1
55900|NCT01302067|221945|P3|Overall Study|Withdrawal by Subject|10
55901|NCT01302067|221946|P2|Overall Study|Withdrawal by Subject|6
55902|NCT01302067|221947|P1|Overall Study|Withdrawal by Subject|13
55903|NCT01302067|221945|P3|Overall Study|Lost to Follow-up|15
55904|NCT01302067|221946|P2|Overall Study|Lost to Follow-up|4
55905|NCT01302067|221947|P1|Overall Study|Lost to Follow-up|9
55906|NCT01302067|221945|P3|Overall Study|Lack of Efficacy|2
55907|NCT01302067|221946|P2|Overall Study|Lack of Efficacy|4
55908|NCT01302067|221947|P1|Overall Study|Lack of Efficacy|8
55909|NCT01302067|221945|P3|Overall Study|Physician Decision|14
55910|NCT01302067|221946|P2|Overall Study|Physician Decision|5
55911|NCT01302067|221947|P1|Overall Study|Physician Decision|9
55912|NCT01302067|221945|P3|Overall Study|Death|1
55913|NCT01302067|221946|P2|Overall Study|Death|0
55914|NCT01302067|221947|P1|Overall Study|Death|0
55915|NCT01302054|222018|P3|Double-Blind Treatment Phase|Unspecified|9
55916|NCT01302054|222019|P2|Double-Blind Treatment Phase|Unspecified|4
55917|NCT01302054|222020|P1|Double-Blind Treatment Phase|Unspecified|0
55918|NCT01302054|222018|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
55919|NCT01302054|222019|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
55920|NCT01302054|222020|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
55921|NCT01302054|222018|P3|Double-Blind Treatment Phase|Adverse Event|10
55922|NCT01302054|222019|P2|Double-Blind Treatment Phase|Adverse Event|10
55923|NCT01302054|222020|P1|Double-Blind Treatment Phase|Adverse Event|0
55924|NCT01302054|222018|P3|Double-Blind Treatment Phase|Protocol Violation|6
55925|NCT01302054|222019|P2|Double-Blind Treatment Phase|Protocol Violation|3
55926|NCT01302054|222020|P1|Double-Blind Treatment Phase|Protocol Violation|0
55927|NCT01302054|222018|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
55928|NCT01302054|222019|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
55929|NCT01302054|222020|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
55930|NCT01302054|222018|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
55931|NCT01302054|222019|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
55932|NCT01302054|222020|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
55933|NCT01302054|222018|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
55934|NCT01302054|222019|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
55935|NCT01302054|222020|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
55936|NCT01302054|222018|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
55937|NCT01302054|222019|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
55938|NCT01302054|222020|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
55939|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Unspecified|0
55940|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Unspecified|0
55941|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Unspecified|7
55942|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
55943|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
55944|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
55945|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
55946|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
55947|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
55948|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
55949|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
55950|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
55951|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
55952|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
55953|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
55954|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
55955|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
55956|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
55957|NCT01302054|222018|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
55958|NCT01302054|222019|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
55959|NCT01302054|222020|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
55960|NCT01302041|222047|P1|Overall Study|Other - Miscellaneous Reason|1
55961|NCT01302041|222047|P1|Overall Study|Withdrawal by Subject|1
55962|NCT01302041|222047|P1|Overall Study|Death|3
55963|NCT01302041|222047|P1|Overall Study|Continuing on Study|45
55964|NCT01301950|222089|P2|Overall Study|Surgery was cancelled by patient|1
55965|NCT01301950|222090|P1|Overall Study|Surgery was cancelled by patient|0
55966|NCT01301833|222108|P4|Overall Study|Personal matter|0
55967|NCT01301833|222109|P3|Overall Study|Personal matter|0
55968|NCT01301833|222110|P2|Overall Study|Personal matter|0
55969|NCT01301833|222111|P1|Overall Study|Personal matter|1
55970|NCT01301833|222108|P4|Overall Study|Withdrawal by Subject|2
55971|NCT01301833|222109|P3|Overall Study|Withdrawal by Subject|1
55972|NCT01301833|222110|P2|Overall Study|Withdrawal by Subject|1
55973|NCT01301833|222111|P1|Overall Study|Withdrawal by Subject|3
55974|NCT01301833|222108|P4|Overall Study|Physician Decision|0
55975|NCT01301833|222109|P3|Overall Study|Physician Decision|1
55976|NCT01301833|222110|P2|Overall Study|Physician Decision|1
55977|NCT01301833|222111|P1|Overall Study|Physician Decision|3
55978|NCT01301833|222108|P4|Overall Study|Lack of Efficacy|0
55979|NCT01301833|222109|P3|Overall Study|Lack of Efficacy|0
55980|NCT01301833|222110|P2|Overall Study|Lack of Efficacy|1
55981|NCT01301833|222111|P1|Overall Study|Lack of Efficacy|1
55982|NCT01301833|222108|P4|Overall Study|Adverse Event|5
55983|NCT01301833|222109|P3|Overall Study|Adverse Event|5
55984|NCT01301833|222110|P2|Overall Study|Adverse Event|5
55985|NCT01301833|222111|P1|Overall Study|Adverse Event|7
55986|NCT01301729|222149|P1|Overall Study|Violated Selection Criteria|1
55987|NCT01301729|222149|P1|Overall Study|Participant did not Return for Treatment|1
55988|NCT01301729|222149|P1|Overall Study|Withdrawal by Subject|2
55989|NCT01301508|222162|P2|Overall Study|Lost to Follow-up|1
55990|NCT01301508|222163|P1|Overall Study|Lost to Follow-up|0
55991|NCT01301508|222162|P2|Overall Study|Withdrawal by Subject|2
55992|NCT01301508|222163|P1|Overall Study|Withdrawal by Subject|1
55993|NCT01301274|222183|P2|Overall Study|Physician Decision|1
55994|NCT01301274|222184|P1|Overall Study|Physician Decision|2
55995|NCT01301092|222199|P3|Overall Study|Lost to Follow-up|1
55996|NCT01301092|222200|P2|Overall Study|Lost to Follow-up|0
55997|NCT01301092|222201|P1|Overall Study|Lost to Follow-up|0
55998|NCT01301079|222218|P2|Overall Study|Lost to Follow-up|2
55999|NCT01301079|222219|P1|Overall Study|Lost to Follow-up|2
56000|NCT01301066|222297|P2|Overall Study|Other|0
56001|NCT01301066|222298|P1|Overall Study|Other|2
56002|NCT01301066|222297|P2|Overall Study|Physician Decision|1
56003|NCT01301066|222298|P1|Overall Study|Physician Decision|0
56004|NCT01301066|222297|P2|Overall Study|Sponsor Decision|1
56005|NCT01301066|222298|P1|Overall Study|Sponsor Decision|2
56006|NCT01301066|222297|P2|Overall Study|Adverse Event|6
56007|NCT01301066|222298|P1|Overall Study|Adverse Event|6
56008|NCT01301066|222297|P2|Overall Study|Withdrawal by Subject|9
56009|NCT01301066|222298|P1|Overall Study|Withdrawal by Subject|4
56010|NCT01301066|222297|P2|Overall Study|Protocol Violation|7
56011|NCT01301066|222298|P1|Overall Study|Protocol Violation|8
56012|NCT01301066|222297|P2|Overall Study|Lost to Follow-up|11
56013|NCT01301066|222298|P1|Overall Study|Lost to Follow-up|5
56014|NCT01301027|222306|P2|Overall Study|Volume Overload|0
56015|NCT01301027|222307|P1|Overall Study|Volume Overload|3
56016|NCT01301027|222306|P2|Overall Study|Transplant|2
56017|NCT01301027|222307|P1|Overall Study|Transplant|0
56018|NCT01301027|222306|P2|Overall Study|Fracture|3
56019|NCT01301027|222307|P1|Overall Study|Fracture|1
56020|NCT01301027|222306|P2|Overall Study|Adverse Event|2
56021|NCT01301027|222307|P1|Overall Study|Adverse Event|0
56022|NCT01301027|222306|P2|Overall Study|Withdrawal by Subject|3
56023|NCT01301027|222307|P1|Overall Study|Withdrawal by Subject|2
56024|NCT01301027|222306|P2|Overall Study|Physician Decision|0
56025|NCT01301027|222307|P1|Overall Study|Physician Decision|2
56026|NCT01300923|222319|P2|Overall Study|Physician Decision|2
56027|NCT01300923|222320|P1|Overall Study|Physician Decision|0
56028|NCT01300819|222333|P2|Overall Study|Follow up call was not done|0
56029|NCT01300819|222334|P1|Overall Study|Follow up call was not done|1
56030|NCT01300819|222333|P2|Overall Study|Safety follow up not done by mistake|1
56031|NCT01300819|222334|P1|Overall Study|Safety follow up not done by mistake|0
56032|NCT01300819|222333|P2|Overall Study|Administrative reason|1
56033|NCT01300819|222334|P1|Overall Study|Administrative reason|0
56034|NCT01300819|222333|P2|Overall Study|Refusal to down titrate study drug|1
56035|NCT01300819|222334|P1|Overall Study|Refusal to down titrate study drug|0
56036|NCT01300819|222333|P2|Overall Study|Patient was 1 month late for Visit 10|1
56037|NCT01300819|222334|P1|Overall Study|Patient was 1 month late for Visit 10|0
56038|NCT01300819|222333|P2|Overall Study|Withdrawal by Subject|12
56039|NCT01300819|222334|P1|Overall Study|Withdrawal by Subject|10
56040|NCT01300819|222333|P2|Overall Study|Lack of Efficacy|1
56041|NCT01300819|222334|P1|Overall Study|Lack of Efficacy|2
56042|NCT01300819|222333|P2|Overall Study|Adverse Event|27
56043|NCT01300819|222334|P1|Overall Study|Adverse Event|9
56044|NCT01300767|222362|P1|Overall Study|Unacceptable fit|1
56045|NCT01300767|222362|P1|Overall Study|Biomicroscopy|1
56046|NCT01300767|222362|P1|Overall Study|Discomfort|2
56047|NCT01300741|222390|P1|Overall Study|Discomfort|1
56048|NCT01300741|222390|P1|Overall Study|Lost to Follow-up|1
56049|NCT01300741|222390|P1|Overall Study|Lens deposits|1
56050|NCT01300728|222420|P2|Overall Study|Physician Decision|0
56051|NCT01300728|222421|P1|Overall Study|Physician Decision|1
56052|NCT01300728|222420|P2|Overall Study|Withdrawal by Subject|1
56053|NCT01300728|222421|P1|Overall Study|Withdrawal by Subject|1
56054|NCT01300650|222435|P1|Overall Study|Adverse Event|1
56055|NCT01300546|222462|P2|Overall Study|Adverse Event|1
56056|NCT01300546|222463|P1|Overall Study|Adverse Event|0
56057|NCT01300546|222462|P2|Overall Study|Lack of Efficacy|3
56058|NCT01300546|222463|P1|Overall Study|Lack of Efficacy|0
56059|NCT01300546|222462|P2|Overall Study|Lost to Follow-up|2
56060|NCT01300546|222463|P1|Overall Study|Lost to Follow-up|0
56061|NCT01300546|222462|P2|Overall Study|Withdrawal by Subject|0
56062|NCT01300546|222463|P1|Overall Study|Withdrawal by Subject|1
56063|NCT01300455|222493|P2|Washout|Withdrawal by Subject|0
56064|NCT01300455|222494|P1|Washout|Withdrawal by Subject|1
56065|NCT01300351|222514|P2|Overall Study|Withdrawal by Subject|10
56066|NCT01300351|222515|P1|Overall Study|Withdrawal by Subject|7
56067|NCT01300351|222514|P2|Overall Study|Adverse Event|4
56068|NCT01300351|222515|P1|Overall Study|Adverse Event|0
56069|NCT01300351|222514|P2|Overall Study|Lost to Follow-up|1
56070|NCT01300351|222515|P1|Overall Study|Lost to Follow-up|0
56071|NCT01300351|222514|P2|Overall Study|Ongoing treatment at data cut-off|23
56072|NCT01300351|222515|P1|Overall Study|Ongoing treatment at data cut-off|27
56073|NCT01300351|222514|P2|Overall Study|Did not receive treatment|0
56074|NCT01300351|222515|P1|Overall Study|Did not receive treatment|2
56075|NCT01300338|222531|P2|Overall Study|Lost to Follow-up|0
56076|NCT01300338|222532|P1|Overall Study|Lost to Follow-up|5
56077|NCT01300286|222540|P1|Overall Study|did not get dosed|1
56078|NCT01300260|222550|P2|Period 2 of Study: Second Intervention|Adverse Event|1
56079|NCT01300260|222551|P1|Period 2 of Study: Second Intervention|Adverse Event|0
56080|NCT01300260|222550|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
56081|NCT01300260|222551|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
56082|NCT01300260|222550|P2|Period 1 of Study: First Intervention|Adverse Event|1
56083|NCT01300260|222551|P1|Period 1 of Study: First Intervention|Adverse Event|0
56084|NCT01300247|222583|P2|Overall Study|Non-Compliance|1
56085|NCT01300247|222584|P1|Overall Study|Non-Compliance|0
56086|NCT01300247|222583|P2|Overall Study|Withdrawal by Subject|0
56087|NCT01300247|222584|P1|Overall Study|Withdrawal by Subject|1
56088|NCT01300247|222583|P2|Overall Study|Lost to Follow-up|0
56089|NCT01300247|222584|P1|Overall Study|Lost to Follow-up|2
56090|NCT01300247|222583|P2|Overall Study|Death|1
56091|NCT01300247|222584|P1|Overall Study|Death|1
56092|NCT01300234|222616|P2|Overall Study|Lost to Follow-up|2
56093|NCT01300234|222617|P1|Overall Study|Lost to Follow-up|0
56094|NCT01300234|222616|P2|Overall Study|Withdrawal by Subject|5
56095|NCT01300234|222617|P1|Overall Study|Withdrawal by Subject|1
56096|NCT01300234|222616|P2|Overall Study|Protocol Violation|3
56097|NCT01300234|222617|P1|Overall Study|Protocol Violation|2
56098|NCT01300234|222616|P2|Overall Study|Adverse Event|0
56099|NCT01300234|222617|P1|Overall Study|Adverse Event|1
56100|NCT01300052|222649|P2|Overall Study|Protocol Violation|1
56101|NCT01300052|222650|P1|Overall Study|Protocol Violation|1
56102|NCT01300052|222649|P2|Overall Study|Withdrawal by Subject|2
56103|NCT01300052|222650|P1|Overall Study|Withdrawal by Subject|2
56104|NCT01300052|222649|P2|Overall Study|Adverse Event|0
56105|NCT01300052|222650|P1|Overall Study|Adverse Event|3
56106|NCT01299961|222668|P1|Overall Study|Lost to Follow-up|1
56107|NCT01299961|222668|P1|Overall Study|Lack of Efficacy|2
56108|NCT01299961|222668|P1|Overall Study|Adverse Event|3
56109|NCT01299909|222677|P3|Overall Study|Lost to Follow-up|17
56110|NCT01299909|222678|P2|Overall Study|Lost to Follow-up|18
56111|NCT01299909|222679|P1|Overall Study|Lost to Follow-up|22
56112|NCT01299896|222688|P2|Overall Study|Lost to Follow-up|11
56113|NCT01299896|222689|P1|Overall Study|Lost to Follow-up|0
56114|NCT01299896|222688|P2|Overall Study|Withdrawal by Subject|7
56115|NCT01299896|222689|P1|Overall Study|Withdrawal by Subject|1
56116|NCT01299805|222697|P2|Overall Study|Adverse Event|0
56117|NCT01299805|222698|P1|Overall Study|Adverse Event|2
56118|NCT01299584|222726|P1|Overall Study|Protocol Violation|9
56119|NCT01299571|222733|P1|Overall Study|Protocol Violation|107
56120|NCT01299480|222744|P5|Overall Study|Started, but not vaccinated|0
56121|NCT01299480|222745|P4|Overall Study|Started, but not vaccinated|1
56122|NCT01299480|222746|P3|Overall Study|Started, but not vaccinated|1
56123|NCT01299480|222747|P2|Overall Study|Started, but not vaccinated|0
56124|NCT01299480|222748|P1|Overall Study|Started, but not vaccinated|0
56125|NCT01299480|222744|P5|Overall Study|Unspecified|3
56126|NCT01299480|222745|P4|Overall Study|Unspecified|0
56127|NCT01299480|222746|P3|Overall Study|Unspecified|3
56128|NCT01299480|222747|P2|Overall Study|Unspecified|2
56129|NCT01299480|222748|P1|Overall Study|Unspecified|3
56130|NCT01299480|222744|P5|Overall Study|Lost to Follow-up|2
56131|NCT01299480|222745|P4|Overall Study|Lost to Follow-up|1
56132|NCT01299480|222746|P3|Overall Study|Lost to Follow-up|2
56133|NCT01299480|222747|P2|Overall Study|Lost to Follow-up|1
56134|NCT01299480|222748|P1|Overall Study|Lost to Follow-up|3
56135|NCT01299480|222744|P5|Overall Study|Physician Decision|0
56136|NCT01299480|222745|P4|Overall Study|Physician Decision|2
56137|NCT01299480|222746|P3|Overall Study|Physician Decision|0
56138|NCT01299480|222747|P2|Overall Study|Physician Decision|1
56139|NCT01299480|222748|P1|Overall Study|Physician Decision|1
56140|NCT01299480|222744|P5|Overall Study|Withdrawal due to pregnancy|0
56141|NCT01299480|222745|P4|Overall Study|Withdrawal due to pregnancy|0
56142|NCT01299480|222746|P3|Overall Study|Withdrawal due to pregnancy|1
56143|NCT01299480|222747|P2|Overall Study|Withdrawal due to pregnancy|1
56144|NCT01299480|222748|P1|Overall Study|Withdrawal due to pregnancy|0
56145|NCT01299480|222744|P5|Overall Study|Adverse Event|0
56146|NCT01299480|222745|P4|Overall Study|Adverse Event|4
56147|NCT01299480|222746|P3|Overall Study|Adverse Event|5
56148|NCT01299480|222747|P2|Overall Study|Adverse Event|4
56149|NCT01299480|222748|P1|Overall Study|Adverse Event|6
56150|NCT01299480|222744|P5|Overall Study|Withdrawal by Subject|4
56151|NCT01299480|222745|P4|Overall Study|Withdrawal by Subject|3
56152|NCT01299480|222746|P3|Overall Study|Withdrawal by Subject|7
56153|NCT01299480|222747|P2|Overall Study|Withdrawal by Subject|4
56154|NCT01299480|222748|P1|Overall Study|Withdrawal by Subject|3
56155|NCT01299480|222744|P5|Overall Study|Protocol Violation|1
56156|NCT01299480|222745|P4|Overall Study|Protocol Violation|1
56157|NCT01299480|222746|P3|Overall Study|Protocol Violation|8
56158|NCT01299480|222747|P2|Overall Study|Protocol Violation|5
56159|NCT01299480|222748|P1|Overall Study|Protocol Violation|7
56160|NCT01299480|222744|P5|Overall Study|No longer willing to participate|10
56161|NCT01299480|222745|P4|Overall Study|No longer willing to participate|13
56162|NCT01299480|222746|P3|Overall Study|No longer willing to participate|14
56163|NCT01299480|222747|P2|Overall Study|No longer willing to participate|17
56164|NCT01299480|222748|P1|Overall Study|No longer willing to participate|19
56165|NCT01299389|222950|P4|Post-observational|unspecified|6
56166|NCT01299389|222951|P3|Post-observational|unspecified|12
56167|NCT01299389|222952|P2|Post-observational|unspecified|0
56168|NCT01299389|222953|P1|Post-observational|unspecified|0
56169|NCT01299389|222950|P4|Double-blind|fail to meet “study population” criteria|0
56170|NCT01299389|222951|P3|Double-blind|fail to meet “study population” criteria|0
56171|NCT01299389|222952|P2|Double-blind|fail to meet “study population” criteria|1
56172|NCT01299389|222953|P1|Double-blind|fail to meet “study population” criteria|0
56173|NCT01299389|222950|P4|Double-blind|unspecified|0
56174|NCT01299389|222951|P3|Double-blind|unspecified|0
56175|NCT01299389|222952|P2|Double-blind|unspecified|1
56176|NCT01299389|222953|P1|Double-blind|unspecified|1
56177|NCT01299389|222950|P4|Double-blind|Withdrawal by Subject|0
56178|NCT01299389|222951|P3|Double-blind|Withdrawal by Subject|0
56179|NCT01299389|222952|P2|Double-blind|Withdrawal by Subject|13
56180|NCT01299389|222953|P1|Double-blind|Withdrawal by Subject|16
56181|NCT01299389|222950|P4|Double-blind|Lost to Follow-up|0
56182|NCT01299389|222951|P3|Double-blind|Lost to Follow-up|0
56183|NCT01299389|222952|P2|Double-blind|Lost to Follow-up|1
56184|NCT01299389|222953|P1|Double-blind|Lost to Follow-up|2
56185|NCT01299389|222950|P4|Double-blind|Lack of Efficacy|0
56186|NCT01299389|222951|P3|Double-blind|Lack of Efficacy|0
56187|NCT01299389|222952|P2|Double-blind|Lack of Efficacy|21
56188|NCT01299389|222953|P1|Double-blind|Lack of Efficacy|45
56189|NCT01299389|222950|P4|Double-blind|Adverse Event|0
56190|NCT01299389|222951|P3|Double-blind|Adverse Event|0
56191|NCT01299389|222952|P2|Double-blind|Adverse Event|27
56192|NCT01299389|222953|P1|Double-blind|Adverse Event|45
56193|NCT01299376|222975|P2|Extension (Weeks 9 to 52)|Physician Decision|0
56194|NCT01299376|222976|P1|Extension (Weeks 9 to 52)|Physician Decision|1
56195|NCT01299376|222975|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
56196|NCT01299376|222976|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
56197|NCT01299376|222975|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
56198|NCT01299376|222976|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
56199|NCT01299376|222975|P2|Extension (Weeks 9 to 52)|Adverse Event|3
56200|NCT01299376|222976|P1|Extension (Weeks 9 to 52)|Adverse Event|2
56201|NCT01299376|222975|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
56202|NCT01299376|222976|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
56203|NCT01299376|222975|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
56204|NCT01299376|222976|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
56205|NCT01299376|222975|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
56206|NCT01299376|222976|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
56207|NCT01299376|222975|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
56208|NCT01299376|222976|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
56209|NCT01299376|222975|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
56210|NCT01299376|222976|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
56211|NCT01299376|222975|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
56212|NCT01299376|222976|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
56213|NCT01299376|222975|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
56214|NCT01299376|222976|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
56215|NCT01299025|223050|P2|Overall Study|Lost to Follow-up|0
56216|NCT01299025|223051|P1|Overall Study|Lost to Follow-up|1
56217|NCT01299025|223050|P2|Overall Study|Withdrawal by Subject|1
56218|NCT01299025|223051|P1|Overall Study|Withdrawal by Subject|2
56219|NCT01298778|223065|P2|Overall Study|not meet inclusion/exclusion criteria|1
56220|NCT01298778|223066|P1|Overall Study|not meet inclusion/exclusion criteria|0
56221|NCT01298778|223065|P2|Overall Study|Protocol Violation|1
56222|NCT01298778|223066|P1|Overall Study|Protocol Violation|0
56223|NCT01298778|223065|P2|Overall Study|Withdrawal by Subject|1
56224|NCT01298778|223066|P1|Overall Study|Withdrawal by Subject|0
56225|NCT01298778|223065|P2|Overall Study|Incorrect use of VAS|0
56226|NCT01298778|223066|P1|Overall Study|Incorrect use of VAS|1
56227|NCT01298778|223065|P2|Overall Study|Lost to Follow-up|3
56228|NCT01298778|223066|P1|Overall Study|Lost to Follow-up|2
56229|NCT01298661|223089|P3|Overall Study|Withdrawal by Subject|2
56230|NCT01298661|223090|P2|Overall Study|Withdrawal by Subject|0
56231|NCT01298661|223091|P1|Overall Study|Withdrawal by Subject|2
56232|NCT01298648|223169|P1|Overall Study|Lost to Follow-up|21
56233|NCT01298648|223169|P1|Overall Study|Withdrawal by Subject|2
56234|NCT01298531|223189|P2|Overall Study|Not specified|1
56235|NCT01298531|223190|P1|Overall Study|Not specified|2
56236|NCT01298531|223189|P2|Overall Study|Does not meet entrance criteria|1
56237|NCT01298531|223190|P1|Overall Study|Does not meet entrance criteria|0
56238|NCT01298531|223189|P2|Overall Study|Adverse Event|3
56239|NCT01298531|223190|P1|Overall Study|Adverse Event|4
56240|NCT01298531|223189|P2|Overall Study|Protocol Violation|1
56241|NCT01298531|223190|P1|Overall Study|Protocol Violation|1
56242|NCT01298531|223189|P2|Overall Study|Lost to Follow-up|0
56243|NCT01298531|223190|P1|Overall Study|Lost to Follow-up|2
56244|NCT01298531|223189|P2|Overall Study|Lack of Efficacy|1
56245|NCT01298531|223190|P1|Overall Study|Lack of Efficacy|0
56246|NCT01298518|223319|P3|Overall Study|Withdrawal by Subject|1
56247|NCT01298518|223320|P2|Overall Study|Withdrawal by Subject|0
56248|NCT01298518|223321|P1|Overall Study|Withdrawal by Subject|0
56249|NCT01298492|223373|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
56250|NCT01298492|223373|P1|Overall Study|Adverse Event(Related to Study Drug)|8
56251|NCT01298492|223373|P1|Overall Study|Protocol Violation|2
56252|NCT01298492|223373|P1|Overall Study|Withdrawn Due to Pregnancy|1
56253|NCT01298492|223373|P1|Overall Study|Other (Unspecified)|7
56254|NCT01298492|223373|P1|Overall Study|Withdrawal by Subject|47
56255|NCT01298492|223373|P1|Overall Study|Lost to Follow-up|12
56256|NCT01298492|223373|P1|Overall Study|Insufficient Clinical Response|22
56257|NCT01298492|223373|P1|Overall Study|Death|2
56258|NCT01298362|223381|P2|Overall Study|Did not provide 12month BMD measurements|43
56259|NCT01298362|223382|P1|Overall Study|Did not provide 12month BMD measurements|38
56260|NCT01298323|223402|P2|Overall Study|Eligibility criteria not fulfilled|1
56261|NCT01298323|223403|P1|Overall Study|Eligibility criteria not fulfilled|0
56262|NCT01298323|223402|P2|Overall Study|Ongoing|55
56263|NCT01298323|223403|P1|Overall Study|Ongoing|55
56264|NCT01298323|223402|P2|Overall Study|Other|9
56265|NCT01298323|223403|P1|Overall Study|Other|10
56266|NCT01298323|223402|P2|Overall Study|Protocol Violation|0
56267|NCT01298323|223403|P1|Overall Study|Protocol Violation|1
56268|NCT01298323|223402|P2|Overall Study|Withdrawal by Subject|3
56269|NCT01298323|223403|P1|Overall Study|Withdrawal by Subject|6
56270|NCT01298323|223402|P2|Overall Study|Lost to Follow-up|0
56271|NCT01298323|223403|P1|Overall Study|Lost to Follow-up|1
56272|NCT01298323|223402|P2|Overall Study|Death|16
56273|NCT01298323|223403|P1|Overall Study|Death|11
56274|NCT01298323|223402|P2|Overall Study|Adverse Event|4
56275|NCT01298323|223403|P1|Overall Study|Adverse Event|2
56276|NCT01297920|223466|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
56277|NCT01297920|223467|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
56278|NCT01297920|223468|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
56279|NCT01297920|223466|P3|Overall Study|Inadequate Control of IOP|17
56280|NCT01297920|223467|P2|Overall Study|Inadequate Control of IOP|9
56281|NCT01297920|223468|P1|Overall Study|Inadequate Control of IOP|7
56282|NCT01297920|223466|P3|Overall Study|Protocol Violation|0
56283|NCT01297920|223467|P2|Overall Study|Protocol Violation|3
56284|NCT01297920|223468|P1|Overall Study|Protocol Violation|1
56285|NCT01297920|223466|P3|Overall Study|Noncompliance|0
56286|NCT01297920|223467|P2|Overall Study|Noncompliance|0
56287|NCT01297920|223468|P1|Overall Study|Noncompliance|1
56288|NCT01297920|223466|P3|Overall Study|Patient Decision Unrelated to AE|2
56289|NCT01297920|223467|P2|Overall Study|Patient Decision Unrelated to AE|5
56290|NCT01297920|223468|P1|Overall Study|Patient Decision Unrelated to AE|6
56291|NCT01297920|223466|P3|Overall Study|Adverse Event|38
56292|NCT01297920|223467|P2|Overall Study|Adverse Event|10
56293|NCT01297920|223468|P1|Overall Study|Adverse Event|42
56294|NCT01297517|223512|P3|Overall Study|Inadequate Control of IOP|2
56295|NCT01297517|223513|P2|Overall Study|Inadequate Control of IOP|1
56296|NCT01297517|223514|P1|Overall Study|Inadequate Control of IOP|1
56297|NCT01297517|223512|P3|Overall Study|Protocol Violation|1
56298|NCT01297517|223513|P2|Overall Study|Protocol Violation|1
56299|NCT01297517|223514|P1|Overall Study|Protocol Violation|1
56300|NCT01297517|223512|P3|Overall Study|Noncompliance|0
56301|NCT01297517|223513|P2|Overall Study|Noncompliance|0
56302|NCT01297517|223514|P1|Overall Study|Noncompliance|1
56303|NCT01297517|223512|P3|Overall Study|Patient Decision Unrelated to AE|7
56304|NCT01297517|223513|P2|Overall Study|Patient Decision Unrelated to AE|3
56305|NCT01297517|223514|P1|Overall Study|Patient Decision Unrelated to AE|2
56306|NCT01297517|223512|P3|Overall Study|Lost to Follow-up|1
56307|NCT01297517|223513|P2|Overall Study|Lost to Follow-up|0
56308|NCT01297517|223514|P1|Overall Study|Lost to Follow-up|1
56309|NCT01297517|223512|P3|Overall Study|Adverse Event|16
56310|NCT01297517|223513|P2|Overall Study|Adverse Event|7
56311|NCT01297517|223514|P1|Overall Study|Adverse Event|21
56312|NCT01297504|223522|P1|Overall Study|Protocol Violation|3
56313|NCT01297504|223522|P1|Overall Study|Site Closure|3
56314|NCT01297504|223522|P1|Overall Study|Withdrawal by Subject|9
56315|NCT01297504|223522|P1|Overall Study|Lost to Follow-up|43
56316|NCT01297504|223522|P1|Overall Study|Death|3
56317|NCT01297504|223522|P1|Overall Study|No Study Visits|4
56318|NCT01297504|223522|P1|Overall Study|Received Palivizumab in Previous Season|1
56319|NCT01297504|223522|P1|Overall Study|Invalid Consent|1
56320|NCT01297491|223536|P2|Overall Study|Death|1
56321|NCT01297491|223537|P1|Overall Study|Death|2
56322|NCT01297491|223536|P2|Overall Study|Patient/Guardian decision|4
56323|NCT01297491|223537|P1|Overall Study|Patient/Guardian decision|3
56324|NCT01297491|223536|P2|Overall Study|Progressive disease|20
56325|NCT01297491|223537|P1|Overall Study|Progressive disease|11
56326|NCT01297491|223536|P2|Overall Study|Physician Decision|2
56327|NCT01297491|223537|P1|Overall Study|Physician Decision|3
56328|NCT01297491|223536|P2|Overall Study|Adverse Event|6
56329|NCT01297491|223537|P1|Overall Study|Adverse Event|11
56330|NCT01297465|223555|P2|Overall Study|Intention to Freeze all Embryos|1
56331|NCT01297465|223556|P1|Overall Study|Intention to Freeze all Embryos|0
56332|NCT01297465|223555|P2|Overall Study|All Embryos Discarded|1
56333|NCT01297465|223556|P1|Overall Study|All Embryos Discarded|0
56334|NCT01297465|223555|P2|Overall Study|No Fertilization|4
56335|NCT01297465|223556|P1|Overall Study|No Fertilization|6
56336|NCT01297465|223555|P2|Overall Study|Poor oocyte quality|1
56337|NCT01297465|223556|P1|Overall Study|Poor oocyte quality|0
56338|NCT01297465|223555|P2|Overall Study|No Oocytes Retrieved|1
56339|NCT01297465|223556|P1|Overall Study|No Oocytes Retrieved|1
56340|NCT01297465|223555|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
56341|NCT01297465|223556|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
56342|NCT01297465|223555|P2|Overall Study|Lack of Ovarian Response|1
56343|NCT01297465|223556|P1|Overall Study|Lack of Ovarian Response|1
56344|NCT01297322|223609|P2|Overall Study|Withdrawal by Subject|1
56345|NCT01297322|223610|P1|Overall Study|Withdrawal by Subject|0
56346|NCT01297322|223609|P2|Overall Study|Lost to Follow-up|0
56347|NCT01297322|223610|P1|Overall Study|Lost to Follow-up|1
56348|NCT01297270|223638|P3|Overall Study|Not treated|0
56349|NCT01297270|223639|P2|Overall Study|Not treated|1
56350|NCT01297270|223640|P1|Overall Study|Not treated|0
56351|NCT01297270|223638|P3|Overall Study|Other reason not defined above|1
56352|NCT01297270|223639|P2|Overall Study|Other reason not defined above|3
56353|NCT01297270|223640|P1|Overall Study|Other reason not defined above|3
56354|NCT01297270|223638|P3|Overall Study|Withdrawal by Subject|7
56355|NCT01297270|223639|P2|Overall Study|Withdrawal by Subject|15
56356|NCT01297270|223640|P1|Overall Study|Withdrawal by Subject|7
56357|NCT01297270|223638|P3|Overall Study|Protocol Violation|0
56358|NCT01297270|223639|P2|Overall Study|Protocol Violation|2
56359|NCT01297270|223640|P1|Overall Study|Protocol Violation|0
56360|NCT01297270|223638|P3|Overall Study|Lost to Follow-up|1
56361|NCT01297270|223639|P2|Overall Study|Lost to Follow-up|2
56362|NCT01297270|223640|P1|Overall Study|Lost to Follow-up|1
56363|NCT01297270|223638|P3|Overall Study|Lack of Efficacy|15
56364|NCT01297270|223639|P2|Overall Study|Lack of Efficacy|17
56365|NCT01297270|223640|P1|Overall Study|Lack of Efficacy|15
56366|NCT01297270|223638|P3|Overall Study|Adverse Event|5
56367|NCT01297270|223639|P2|Overall Study|Adverse Event|32
56368|NCT01297270|223640|P1|Overall Study|Adverse Event|19
56369|NCT01297062|223689|P7|Overall Study|Subject Decision|2
56370|NCT01297062|223690|P6|Overall Study|Subject Decision|1
56371|NCT01297062|223691|P5|Overall Study|Subject Decision|1
56372|NCT01297062|223692|P4|Overall Study|Subject Decision|1
56373|NCT01297062|223693|P3|Overall Study|Subject Decision|0
56374|NCT01297062|223694|P2|Overall Study|Subject Decision|1
56375|NCT01297062|223695|P1|Overall Study|Subject Decision|1
56376|NCT01297062|223689|P7|Overall Study|Protocol Violation|0
56377|NCT01297062|223690|P6|Overall Study|Protocol Violation|0
56378|NCT01297062|223691|P5|Overall Study|Protocol Violation|1
56379|NCT01297062|223692|P4|Overall Study|Protocol Violation|0
56380|NCT01297062|223693|P3|Overall Study|Protocol Violation|0
56381|NCT01297062|223694|P2|Overall Study|Protocol Violation|0
56382|NCT01297062|223695|P1|Overall Study|Protocol Violation|0
56383|NCT01297062|223689|P7|Overall Study|Physician Decision|6
56384|NCT01297062|223690|P6|Overall Study|Physician Decision|0
56385|NCT01297062|223691|P5|Overall Study|Physician Decision|0
56386|NCT01297062|223692|P4|Overall Study|Physician Decision|0
56387|NCT01297062|223693|P3|Overall Study|Physician Decision|1
56388|NCT01297062|223694|P2|Overall Study|Physician Decision|0
56389|NCT01297062|223695|P1|Overall Study|Physician Decision|1
56390|NCT01297062|223689|P7|Overall Study|Adverse Event|0
56391|NCT01297062|223690|P6|Overall Study|Adverse Event|0
56392|NCT01297062|223691|P5|Overall Study|Adverse Event|0
56393|NCT01297062|223692|P4|Overall Study|Adverse Event|0
56394|NCT01297062|223693|P3|Overall Study|Adverse Event|1
56395|NCT01297062|223694|P2|Overall Study|Adverse Event|0
56396|NCT01297062|223695|P1|Overall Study|Adverse Event|2
56397|NCT01296698|223757|P2|Overall Study|Study Terminated by Sponsor|12
56398|NCT01296698|223758|P1|Overall Study|Study Terminated by Sponsor|209
56399|NCT01296698|223757|P2|Overall Study|Difficulty Contacting Subject|0
56400|NCT01296698|223758|P1|Overall Study|Difficulty Contacting Subject|2
56401|NCT01296698|223757|P2|Overall Study|Withdrawal by Subject|0
56402|NCT01296698|223758|P1|Overall Study|Withdrawal by Subject|12
56403|NCT01296698|223757|P2|Overall Study|Lost to Follow-up|1
56404|NCT01296698|223758|P1|Overall Study|Lost to Follow-up|19
56405|NCT01296698|223757|P2|Overall Study|Death|0
56406|NCT01296698|223758|P1|Overall Study|Death|1
56407|NCT01296698|223757|P2|Overall Study|Adverse Event|0
56408|NCT01296698|223758|P1|Overall Study|Adverse Event|1
56409|NCT01296412|223823|P2|Overall Study|Withdrawal by Subject|13
56410|NCT01296412|223824|P1|Overall Study|Withdrawal by Subject|10
56411|NCT01296412|223823|P2|Overall Study|Pregnancy|1
56412|NCT01296412|223824|P1|Overall Study|Pregnancy|0
56413|NCT01296412|223823|P2|Overall Study|Physician Decision|3
56414|NCT01296412|223824|P1|Overall Study|Physician Decision|1
56415|NCT01296412|223823|P2|Overall Study|Other reason not specified|15
56416|NCT01296412|223824|P1|Overall Study|Other reason not specified|20
56417|NCT01296412|223823|P2|Overall Study|Non-compliance with study drug|2
56418|NCT01296412|223824|P1|Overall Study|Non-compliance with study drug|1
56419|NCT01296412|223823|P2|Overall Study|Lost to Follow-up|7
56420|NCT01296412|223824|P1|Overall Study|Lost to Follow-up|10
56421|NCT01296412|223823|P2|Overall Study|Lack of Efficacy|0
56422|NCT01296412|223824|P1|Overall Study|Lack of Efficacy|1
56423|NCT01296412|223823|P2|Overall Study|Adverse Event|29
56424|NCT01296412|223824|P1|Overall Study|Adverse Event|8
56425|NCT01296152|223854|P1|Overall Study|Unwilling to adhere to study requirement|1
56426|NCT01296035|223881|P1|Overall Study|Withdrawal by Subject|1
56427|NCT01295905|223888|P2|Overall Study|Met exclusion criteria|0
56428|NCT01295905|223889|P1|Overall Study|Met exclusion criteria|1
56429|NCT01295905|223888|P2|Overall Study|Did not meet inclusion criteria|0
56430|NCT01295905|223889|P1|Overall Study|Did not meet inclusion criteria|1
56431|NCT01295814|223923|P2|Overall Study|Withdrawal by Subject|0
56432|NCT01295814|223924|P1|Overall Study|Withdrawal by Subject|2
56433|NCT01295814|223923|P2|Overall Study|Lack of Efficacy|2
56434|NCT01295814|223924|P1|Overall Study|Lack of Efficacy|0
56435|NCT01295281|223940|P2|First Intervention (7 Days)|Death|1
56436|NCT01295281|223941|P1|First Intervention (7 Days)|Death|0
56437|NCT01295034|223968|P2|Overall Study|Lost to Follow-up|5
56438|NCT01295034|223969|P1|Overall Study|Lost to Follow-up|5
56439|NCT01294917|223977|P1|Overall Study|Inconvenience|1
56440|NCT01294917|223977|P1|Overall Study|Relocation|5
56441|NCT01294800|223987|P4|Overall Study|Did Not Meet Protocol Eligibility|0
56442|NCT01294800|223988|P3|Overall Study|Did Not Meet Protocol Eligibility|1
56443|NCT01294800|223989|P2|Overall Study|Did Not Meet Protocol Eligibility|1
56444|NCT01294800|223990|P1|Overall Study|Did Not Meet Protocol Eligibility|2
56445|NCT01294800|223987|P4|Overall Study|Non-compliance With Protocol|0
56446|NCT01294800|223988|P3|Overall Study|Non-compliance With Protocol|1
56447|NCT01294800|223989|P2|Overall Study|Non-compliance With Protocol|1
56448|NCT01294800|223990|P1|Overall Study|Non-compliance With Protocol|0
56449|NCT01294800|223987|P4|Overall Study|Lost to Follow-up|0
56450|NCT01294800|223988|P3|Overall Study|Lost to Follow-up|1
56451|NCT01294800|223989|P2|Overall Study|Lost to Follow-up|0
56452|NCT01294800|223990|P1|Overall Study|Lost to Follow-up|0
56453|NCT01294800|223987|P4|Overall Study|Subject Withdrew Consent|11
56454|NCT01294800|223988|P3|Overall Study|Subject Withdrew Consent|2
56455|NCT01294800|223989|P2|Overall Study|Subject Withdrew Consent|2
56456|NCT01294800|223990|P1|Overall Study|Subject Withdrew Consent|2
56457|NCT01294800|223987|P4|Overall Study|Adverse Event|5
56458|NCT01294800|223988|P3|Overall Study|Adverse Event|12
56459|NCT01294800|223989|P2|Overall Study|Adverse Event|6
56460|NCT01294800|223990|P1|Overall Study|Adverse Event|7
56461|NCT01294787|224016|P6|Period 3|Adverse Event|0
56462|NCT01294787|224017|P5|Period 3|Adverse Event|1
56463|NCT01294787|224018|P4|Period 3|Adverse Event|0
56464|NCT01294787|224019|P3|Period 3|Adverse Event|0
56465|NCT01294787|224020|P2|Period 3|Adverse Event|0
56466|NCT01294787|224021|P1|Period 3|Adverse Event|0
56467|NCT01294787|224016|P6|Period 2|No longer needs study drug|0
56468|NCT01294787|224017|P5|Period 2|No longer needs study drug|0
56469|NCT01294787|224018|P4|Period 2|No longer needs study drug|1
56470|NCT01294787|224019|P3|Period 2|No longer needs study drug|0
56471|NCT01294787|224020|P2|Period 2|No longer needs study drug|0
56472|NCT01294787|224021|P1|Period 2|No longer needs study drug|0
56473|NCT01294787|224016|P6|Period 2|Adverse Event|0
56474|NCT01294787|224017|P5|Period 2|Adverse Event|0
56475|NCT01294787|224018|P4|Period 2|Adverse Event|1
56476|NCT01294787|224019|P3|Period 2|Adverse Event|0
56477|NCT01294787|224020|P2|Period 2|Adverse Event|3
56478|NCT01294787|224021|P1|Period 2|Adverse Event|0
56479|NCT01294787|224016|P6|Period 1|Administrative problem|1
56480|NCT01294787|224017|P5|Period 1|Administrative problem|0
56481|NCT01294787|224018|P4|Period 1|Administrative problem|0
56482|NCT01294787|224019|P3|Period 1|Administrative problem|1
56483|NCT01294787|224020|P2|Period 1|Administrative problem|0
56484|NCT01294787|224021|P1|Period 1|Administrative problem|0
56485|NCT01294787|224016|P6|Period 1|Withdrawal by Subject|1
56486|NCT01294787|224017|P5|Period 1|Withdrawal by Subject|1
56487|NCT01294787|224018|P4|Period 1|Withdrawal by Subject|1
56488|NCT01294787|224019|P3|Period 1|Withdrawal by Subject|0
56489|NCT01294787|224020|P2|Period 1|Withdrawal by Subject|0
56490|NCT01294787|224021|P1|Period 1|Withdrawal by Subject|0
56491|NCT01294787|224016|P6|Period 1|Adverse Event|0
56492|NCT01294787|224017|P5|Period 1|Adverse Event|1
56493|NCT01294787|224018|P4|Period 1|Adverse Event|0
56494|NCT01294787|224019|P3|Period 1|Adverse Event|0
56495|NCT01294787|224020|P2|Period 1|Adverse Event|0
56496|NCT01294787|224021|P1|Period 1|Adverse Event|0
56497|NCT01294696|224112|P1|Overall Study|Site closure|52
56498|NCT01294696|224112|P1|Overall Study|Missing BPI Response|7
56499|NCT01294696|224112|P1|Overall Study|Protocol Violation|8
56500|NCT01294696|224112|P1|Overall Study|Screening failures|7
56501|NCT01294683|224126|P2|Post Crossover (Period III)|Withdrawal by Subject|2
56502|NCT01294683|224127|P1|Post Crossover (Period III)|Withdrawal by Subject|3
56503|NCT01294683|224126|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
56504|NCT01294683|224127|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
56505|NCT01294683|224126|P2|Post Crossover (Period III)|Lost to Follow-up|3
56591|NCT01294046|224433|P1|Overall Study|Infection and surgical explant|1
56506|NCT01294683|224127|P1|Post Crossover (Period III)|Lost to Follow-up|1
56507|NCT01294683|224126|P2|Post Crossover (Period III)|Adverse Event|6
56508|NCT01294683|224127|P1|Post Crossover (Period III)|Adverse Event|6
56509|NCT01294683|224126|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
56510|NCT01294683|224127|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
56511|NCT01294683|224126|P2|Precrossover (Periods I/II)|Technical Problems|1
56512|NCT01294683|224127|P1|Precrossover (Periods I/II)|Technical Problems|0
56513|NCT01294683|224126|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
56514|NCT01294683|224127|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
56515|NCT01294683|224126|P2|Precrossover (Periods I/II)|Protocol Violation|5
56516|NCT01294683|224127|P1|Precrossover (Periods I/II)|Protocol Violation|5
56517|NCT01294683|224126|P2|Precrossover (Periods I/II)|Physician Decision|0
56518|NCT01294683|224127|P1|Precrossover (Periods I/II)|Physician Decision|1
56519|NCT01294683|224126|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
56520|NCT01294683|224127|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
56521|NCT01294683|224126|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
56522|NCT01294683|224127|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
56523|NCT01294683|224126|P2|Precrossover (Periods I/II)|Adverse Event|52
56524|NCT01294683|224127|P1|Precrossover (Periods I/II)|Adverse Event|49
56525|NCT01294644|224180|P3|Overall Study|Miscellaneous Reason|4
56526|NCT01294644|224181|P2|Overall Study|Miscellaneous Reason|1
56527|NCT01294644|224182|P1|Overall Study|Miscellaneous Reason|2
56528|NCT01294644|224180|P3|Overall Study|Lost to Follow-up|5
56529|NCT01294644|224181|P2|Overall Study|Lost to Follow-up|2
56530|NCT01294644|224182|P1|Overall Study|Lost to Follow-up|3
56531|NCT01294644|224180|P3|Overall Study|Withdrawal by Subject|4
56532|NCT01294644|224181|P2|Overall Study|Withdrawal by Subject|7
56533|NCT01294644|224182|P1|Overall Study|Withdrawal by Subject|3
56534|NCT01294644|224180|P3|Overall Study|Adverse Event|1
56535|NCT01294644|224181|P2|Overall Study|Adverse Event|0
56536|NCT01294644|224182|P1|Overall Study|Adverse Event|2
56537|NCT01294592|224213|P2|Overall Study|Withdrawal by Subject|28
56538|NCT01294592|224214|P1|Overall Study|Withdrawal by Subject|28
56539|NCT01294592|224213|P2|Overall Study|Physician Decision|11
56540|NCT01294592|224214|P1|Overall Study|Physician Decision|6
56541|NCT01294592|224213|P2|Overall Study|Lost to Follow-up|9
56542|NCT01294592|224214|P1|Overall Study|Lost to Follow-up|7
56543|NCT01294592|224213|P2|Overall Study|Protocol Violation|7
56544|NCT01294592|224214|P1|Overall Study|Protocol Violation|1
56545|NCT01294592|224213|P2|Overall Study|Lack of Efficacy|5
56546|NCT01294592|224214|P1|Overall Study|Lack of Efficacy|7
56547|NCT01294592|224213|P2|Overall Study|Adverse Event|13
56548|NCT01294592|224214|P1|Overall Study|Adverse Event|28
56549|NCT01294553|224242|P1|Overall Study|Protocol Violation|268
56550|NCT01294553|224242|P1|Overall Study|Duplicated Participants|1
56551|NCT01294514|224248|P1|Overall Study|Excluded due to Arrhythmia|1
56552|NCT01294462|224258|P2|Overall Study|Withdrawal by Subject|63
56553|NCT01294462|224259|P1|Overall Study|Withdrawal by Subject|65
56554|NCT01294462|224258|P2|Overall Study|Lost to Follow-up|0
56555|NCT01294462|224259|P1|Overall Study|Lost to Follow-up|1
56556|NCT01294449|224273|P2|Overall Study|Withdrawal by Subject|3
56557|NCT01294449|224274|P1|Overall Study|Withdrawal by Subject|1
56558|NCT01294449|224273|P2|Overall Study|Death|12
56559|NCT01294449|224274|P1|Overall Study|Death|11
56560|NCT01294436|224282|P2|Overall Study|poor/non-compliance|5
56561|NCT01294436|224283|P1|Overall Study|poor/non-compliance|2
56562|NCT01294436|224282|P2|Overall Study|subject no longer meets study criteria|20
56563|NCT01294436|224283|P1|Overall Study|subject no longer meets study criteria|5
56564|NCT01294436|224282|P2|Overall Study|Withdrawal by Subject|28
56565|NCT01294436|224283|P1|Overall Study|Withdrawal by Subject|11
56566|NCT01294436|224282|P2|Overall Study|Adverse Event|17
56567|NCT01294436|224283|P1|Overall Study|Adverse Event|10
56568|NCT01294423|224318|P3|Overall Study|poor/non-compliance|1
56569|NCT01294423|224319|P2|Overall Study|poor/non-compliance|0
56570|NCT01294423|224320|P1|Overall Study|poor/non-compliance|1
56571|NCT01294423|224318|P3|Overall Study|subject no longer meets study criteria|2
56572|NCT01294423|224319|P2|Overall Study|subject no longer meets study criteria|5
56573|NCT01294423|224320|P1|Overall Study|subject no longer meets study criteria|2
56574|NCT01294423|224318|P3|Overall Study|Withdrawal by Subject|2
56575|NCT01294423|224319|P2|Overall Study|Withdrawal by Subject|2
56576|NCT01294423|224320|P1|Overall Study|Withdrawal by Subject|1
56577|NCT01294423|224318|P3|Overall Study|Adverse Event|3
56578|NCT01294423|224319|P2|Overall Study|Adverse Event|2
56579|NCT01294423|224320|P1|Overall Study|Adverse Event|1
56580|NCT01294397|224334|P1|Overall Study|Administrative Decision|1
56581|NCT01294397|224334|P1|Overall Study|Withdrawal by Subject|1
56582|NCT01294371|224378|P1|Overall Study|Other|14
56583|NCT01294371|224378|P1|Overall Study|Administrative Reason|1
56584|NCT01294371|224378|P1|Overall Study|Lost to Follow-up|6
56585|NCT01294371|224378|P1|Overall Study|Withdrawal by Subject|12
56586|NCT01294371|224378|P1|Overall Study|Adverse Event|1
56587|NCT01294150|224423|P2|Overall Study|Physician Decision|2
56588|NCT01294150|224424|P1|Overall Study|Physician Decision|2
56589|NCT01294046|224433|P1|Overall Study|Stimulation response inadqequate|1
56590|NCT01294046|224433|P1|Overall Study|Eligibility criteria expanded|1
56592|NCT01293968|224448|P2|Overall Study|non-cooperation|3
56593|NCT01293968|224449|P1|Overall Study|non-cooperation|3
56594|NCT01293695|224469|P2|Overall Study|Lost to Follow-up|6
56595|NCT01293695|224470|P1|Overall Study|Lost to Follow-up|8
56596|NCT01293695|224469|P2|Overall Study|Withdrawal by Subject|1
56597|NCT01293695|224470|P1|Overall Study|Withdrawal by Subject|7
56598|NCT01293539|224484|P1|Overall Study|Physician Decision|1
56599|NCT01293240|224488|P1|Overall Study|Noncompliance|2
56600|NCT01293084|224503|P1|Overall Study|Withdrawal by Subject|2
56601|NCT01293084|224503|P1|Overall Study|Physician Decision|3
56602|NCT01293032|224515|P4|Treatment|Disease Progression, relapse|0
56603|NCT01293032|224516|P3|Treatment|Disease Progression, relapse|0
56604|NCT01293032|224517|P2|Treatment|Disease Progression, relapse|1
56605|NCT01293032|224518|P1|Treatment|Disease Progression, relapse|0
56606|NCT01293032|224515|P4|Treatment|Withdrawal by Subject|0
56607|NCT01293032|224516|P3|Treatment|Withdrawal by Subject|0
56608|NCT01293032|224517|P2|Treatment|Withdrawal by Subject|4
56609|NCT01293032|224518|P1|Treatment|Withdrawal by Subject|2
56610|NCT01293032|224515|P4|Treatment|Adverse Event|1
56611|NCT01293032|224516|P3|Treatment|Adverse Event|1
56612|NCT01293032|224517|P2|Treatment|Adverse Event|0
56613|NCT01293032|224518|P1|Treatment|Adverse Event|0
56614|NCT01293032|224515|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
56615|NCT01293032|224516|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
56616|NCT01293032|224517|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
56617|NCT01293032|224518|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
56618|NCT01293006|224529|P4|Period 2|Lost to Follow-up|0
56619|NCT01293006|224530|P3|Period 2|Lost to Follow-up|0
56620|NCT01293006|224531|P2|Period 2|Lost to Follow-up|0
56621|NCT01293006|224532|P1|Period 2|Lost to Follow-up|1
56622|NCT01292928|224553|P1|Overall Study|Physician Decision|2
56623|NCT01292928|224553|P1|Overall Study|Lost to Follow-up|6
56624|NCT01292928|224553|P1|Overall Study|Withdrawal by Subject|8
56625|NCT01292928|224553|P1|Overall Study|Death|8
56626|NCT01292876|224570|P1|Overall Study|Physician Decision|4
56627|NCT01292837|224576|P1|Overall Study|Further treatment determined|1
56628|NCT01292837|224576|P1|Overall Study|Adverse Event|1
56629|NCT01292603|224613|P6|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
56630|NCT01292603|224614|P5|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|10
56631|NCT01292603|224615|P4|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
56632|NCT01292603|224616|P3|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
56633|NCT01292603|224617|P2|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
56634|NCT01292603|224618|P1|Part 2: Survival Follow-UP|Ongoing survival Follow-Up|0
56635|NCT01292603|224613|P6|Part 2: Survival Follow-UP|Death|3
56636|NCT01292603|224614|P5|Part 2: Survival Follow-UP|Death|1
56637|NCT01292603|224615|P4|Part 2: Survival Follow-UP|Death|0
56638|NCT01292603|224616|P3|Part 2: Survival Follow-UP|Death|0
56639|NCT01292603|224617|P2|Part 2: Survival Follow-UP|Death|0
56640|NCT01292603|224618|P1|Part 2: Survival Follow-UP|Death|0
56641|NCT01292603|224613|P6|Part 2: Regular Follow-Up|Noncompliance|0
56642|NCT01292603|224614|P5|Part 2: Regular Follow-Up|Noncompliance|1
56643|NCT01292603|224615|P4|Part 2: Regular Follow-Up|Noncompliance|0
56644|NCT01292603|224616|P3|Part 2: Regular Follow-Up|Noncompliance|0
56645|NCT01292603|224617|P2|Part 2: Regular Follow-Up|Noncompliance|0
56646|NCT01292603|224618|P1|Part 2: Regular Follow-Up|Noncompliance|0
56647|NCT01292603|224613|P6|Part 2: Regular Follow-Up|Disease Progression|4
56648|NCT01292603|224614|P5|Part 2: Regular Follow-Up|Disease Progression|2
56649|NCT01292603|224615|P4|Part 2: Regular Follow-Up|Disease Progression|0
56650|NCT01292603|224616|P3|Part 2: Regular Follow-Up|Disease Progression|0
56651|NCT01292603|224617|P2|Part 2: Regular Follow-Up|Disease Progression|0
56652|NCT01292603|224618|P1|Part 2: Regular Follow-Up|Disease Progression|0
56653|NCT01292603|224613|P6|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|72
56654|NCT01292603|224614|P5|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|73
56655|NCT01292603|224615|P4|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
56656|NCT01292603|224616|P3|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
56657|NCT01292603|224617|P2|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
56658|NCT01292603|224618|P1|Part 2: Regular Follow-Up|Ongoing Regular Follow-Up|0
56659|NCT01292603|224613|P6|Part 2: Regular Follow-Up|Death|2
56660|NCT01292603|224614|P5|Part 2: Regular Follow-Up|Death|2
56661|NCT01292603|224615|P4|Part 2: Regular Follow-Up|Death|0
56662|NCT01292603|224616|P3|Part 2: Regular Follow-Up|Death|0
56663|NCT01292603|224617|P2|Part 2: Regular Follow-Up|Death|0
56664|NCT01292603|224618|P1|Part 2: Regular Follow-Up|Death|0
56665|NCT01292603|224613|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
56666|NCT01292603|224614|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
56667|NCT01292603|224615|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
56668|NCT01292603|224616|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
56669|NCT01292603|224617|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
56670|NCT01292603|224618|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
56671|NCT01292603|224613|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
56672|NCT01292603|224614|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
56673|NCT01292603|224615|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
56674|NCT01292603|224616|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
56675|NCT01292603|224617|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
56676|NCT01292603|224618|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
56677|NCT01292603|224613|P6|Part 2: Dose Confirmation Period|Adverse Event|9
56678|NCT01292603|224614|P5|Part 2: Dose Confirmation Period|Adverse Event|7
56679|NCT01292603|224615|P4|Part 2: Dose Confirmation Period|Adverse Event|0
56680|NCT01292603|224616|P3|Part 2: Dose Confirmation Period|Adverse Event|0
56681|NCT01292603|224617|P2|Part 2: Dose Confirmation Period|Adverse Event|0
56682|NCT01292603|224618|P1|Part 2: Dose Confirmation Period|Adverse Event|0
56683|NCT01292603|224613|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
56684|NCT01292603|224614|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
56685|NCT01292603|224615|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
56686|NCT01292603|224616|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
56687|NCT01292603|224617|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
56688|NCT01292603|224618|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
56689|NCT01292603|224613|P6|Part 2: Dose Confirmation Period|Physician Decision|0
56690|NCT01292603|224614|P5|Part 2: Dose Confirmation Period|Physician Decision|2
56691|NCT01292603|224615|P4|Part 2: Dose Confirmation Period|Physician Decision|0
56692|NCT01292603|224616|P3|Part 2: Dose Confirmation Period|Physician Decision|0
56693|NCT01292603|224617|P2|Part 2: Dose Confirmation Period|Physician Decision|0
56694|NCT01292603|224618|P1|Part 2: Dose Confirmation Period|Physician Decision|0
56695|NCT01292603|224613|P6|Part 2: Dose Confirmation Period|Death|0
56696|NCT01292603|224614|P5|Part 2: Dose Confirmation Period|Death|1
56697|NCT01292603|224615|P4|Part 2: Dose Confirmation Period|Death|0
56698|NCT01292603|224616|P3|Part 2: Dose Confirmation Period|Death|0
56699|NCT01292603|224617|P2|Part 2: Dose Confirmation Period|Death|0
56700|NCT01292603|224618|P1|Part 2: Dose Confirmation Period|Death|0
56701|NCT01292603|224613|P6|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
56702|NCT01292603|224614|P5|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
56703|NCT01292603|224615|P4|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|0
56704|NCT01292603|224616|P3|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|1
56705|NCT01292603|224617|P2|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|2
56706|NCT01292603|224618|P1|Part 1: Survival Follow-Up|Ongoing Survival Follow-UP|3
56707|NCT01292603|224613|P6|Part 1: Survival Follow-Up|Death|0
56708|NCT01292603|224614|P5|Part 1: Survival Follow-Up|Death|0
56709|NCT01292603|224615|P4|Part 1: Survival Follow-Up|Death|0
56710|NCT01292603|224616|P3|Part 1: Survival Follow-Up|Death|1
56711|NCT01292603|224617|P2|Part 1: Survival Follow-Up|Death|0
56712|NCT01292603|224618|P1|Part 1: Survival Follow-Up|Death|1
56713|NCT01292603|224613|P6|Part 1: Regular Follow-Up Period|Adverse Event|0
56714|NCT01292603|224614|P5|Part 1: Regular Follow-Up Period|Adverse Event|0
56715|NCT01292603|224615|P4|Part 1: Regular Follow-Up Period|Adverse Event|0
56716|NCT01292603|224616|P3|Part 1: Regular Follow-Up Period|Adverse Event|0
56717|NCT01292603|224617|P2|Part 1: Regular Follow-Up Period|Adverse Event|0
56718|NCT01292603|224618|P1|Part 1: Regular Follow-Up Period|Adverse Event|1
56719|NCT01292603|224613|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
56720|NCT01292603|224614|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
56721|NCT01292603|224615|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
56722|NCT01292603|224616|P3|Part 1: Regular Follow-Up Period|Disease Progression|2
56723|NCT01292603|224617|P2|Part 1: Regular Follow-Up Period|Disease Progression|2
56724|NCT01292603|224618|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
56725|NCT01292603|224613|P6|Part 1: Regular Follow-Up Period|Death|0
56726|NCT01292603|224614|P5|Part 1: Regular Follow-Up Period|Death|0
56727|NCT01292603|224615|P4|Part 1: Regular Follow-Up Period|Death|0
56728|NCT01292603|224616|P3|Part 1: Regular Follow-Up Period|Death|2
56729|NCT01292603|224617|P2|Part 1: Regular Follow-Up Period|Death|0
56730|NCT01292603|224618|P1|Part 1: Regular Follow-Up Period|Death|1
56731|NCT01292603|224613|P6|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
56732|NCT01292603|224614|P5|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
56733|NCT01292603|224615|P4|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|0
56734|NCT01292603|224616|P3|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|19
56735|NCT01292603|224617|P2|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|15
56736|NCT01292603|224618|P1|Part 1: Regular Follow-Up Period|Ongoing Regular Follow-Up|11
56737|NCT01292603|224613|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
56738|NCT01292603|224614|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
56739|NCT01292603|224615|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
56740|NCT01292603|224616|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
56741|NCT01292603|224617|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
56742|NCT01292603|224618|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
56743|NCT01292603|224613|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
56744|NCT01292603|224614|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
56745|NCT01292603|224615|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
56746|NCT01292603|224616|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
56747|NCT01292603|224617|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
56748|NCT01292603|224618|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
56749|NCT01292603|224613|P6|Part 1: Pilot Dose Selection Period|Death|0
56750|NCT01292603|224614|P5|Part 1: Pilot Dose Selection Period|Death|0
56751|NCT01292603|224615|P4|Part 1: Pilot Dose Selection Period|Death|1
56752|NCT01292603|224616|P3|Part 1: Pilot Dose Selection Period|Death|0
56753|NCT01292603|224617|P2|Part 1: Pilot Dose Selection Period|Death|0
56754|NCT01292603|224618|P1|Part 1: Pilot Dose Selection Period|Death|0
56755|NCT01292603|224613|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
56756|NCT01292603|224614|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
56757|NCT01292603|224615|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
56758|NCT01292603|224616|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
56759|NCT01292603|224617|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
56760|NCT01292603|224618|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
56761|NCT01292486|224671|P1|Overall Study|Physician Decision|1
56762|NCT01292486|224671|P1|Overall Study|Adverse Event|1
56763|NCT01292486|224671|P1|Overall Study|Did not meet screening criteria|2
56764|NCT01292486|224671|P1|Overall Study|Protocol Violation|2
56765|NCT01292473|224685|P4|Overall Study|Disease Progression|6
56766|NCT01292473|224686|P3|Overall Study|Disease Progression|3
56767|NCT01292473|224687|P2|Overall Study|Disease Progression|1
56768|NCT01292473|224688|P1|Overall Study|Disease Progression|0
56769|NCT01292473|224685|P4|Overall Study|Physician Decision|0
56770|NCT01292473|224686|P3|Overall Study|Physician Decision|0
56771|NCT01292473|224687|P2|Overall Study|Physician Decision|1
56772|NCT01292473|224688|P1|Overall Study|Physician Decision|0
56773|NCT01292473|224685|P4|Overall Study|Withdrawal by Subject|3
56774|NCT01292473|224686|P3|Overall Study|Withdrawal by Subject|3
56775|NCT01292473|224687|P2|Overall Study|Withdrawal by Subject|4
56776|NCT01292473|224688|P1|Overall Study|Withdrawal by Subject|3
56777|NCT01292473|224685|P4|Overall Study|Lost to Follow-up|2
56778|NCT01292473|224686|P3|Overall Study|Lost to Follow-up|2
56779|NCT01292473|224687|P2|Overall Study|Lost to Follow-up|1
56780|NCT01292473|224688|P1|Overall Study|Lost to Follow-up|1
56781|NCT01292473|224685|P4|Overall Study|Adverse Event|1
56782|NCT01292473|224686|P3|Overall Study|Adverse Event|1
56783|NCT01292473|224687|P2|Overall Study|Adverse Event|0
56784|NCT01292473|224688|P1|Overall Study|Adverse Event|1
56785|NCT01292239|224747|P2|Overall Study|Withdrawal by Subject|6
56786|NCT01292239|224748|P1|Overall Study|Withdrawal by Subject|3
56787|NCT01292239|224747|P2|Overall Study|Not specified|1
56788|NCT01292239|224748|P1|Overall Study|Not specified|1
56789|NCT01292226|224769|P1|Overall Study|Not specified|2
56790|NCT01292226|224769|P1|Overall Study|Withdrawal by Subject|1
56791|NCT01292226|224769|P1|Overall Study|Protocol Violation|3
56792|NCT01292226|224769|P1|Overall Study|Graft loss|1
56793|NCT01292226|224769|P1|Overall Study|Death|1
56794|NCT01292226|224769|P1|Overall Study|Adverse Event|5
56795|NCT01292187|224802|P2|Overall Study|All other reasons|3
56796|NCT01292187|224803|P1|Overall Study|All other reasons|1
56797|NCT01292187|224802|P2|Overall Study|Withdrawal by Subject|5
56798|NCT01292187|224803|P1|Overall Study|Withdrawal by Subject|6
56799|NCT01292187|224802|P2|Overall Study|Adverse Event|5
56800|NCT01292187|224803|P1|Overall Study|Adverse Event|10
56801|NCT01292057|224838|P2|Overall Study|Lost to Follow-up|1
56802|NCT01292057|224839|P1|Overall Study|Lost to Follow-up|1
56803|NCT01292057|224838|P2|Overall Study|Protocol Violation|1
56804|NCT01292057|224839|P1|Overall Study|Protocol Violation|1
56805|NCT01291277|224904|P2|Overall Study|Lost to Follow-up|1
56806|NCT01291277|224905|P1|Overall Study|Lost to Follow-up|3
56807|NCT01291277|224904|P2|Overall Study|Death|2
56808|NCT01291277|224905|P1|Overall Study|Death|2
56809|NCT01291225|224917|P2|Overall Study|Lost to Follow-up|39
56810|NCT01291225|224918|P1|Overall Study|Lost to Follow-up|85
56811|NCT01291173|224932|P4|Overall Study|Excluded therapy|0
56812|NCT01291173|224933|P3|Overall Study|Excluded therapy|1
56813|NCT01291173|224934|P2|Overall Study|Excluded therapy|0
56814|NCT01291173|224935|P1|Overall Study|Excluded therapy|0
56815|NCT01291173|224932|P4|Overall Study|Subject was unblinded|0
56816|NCT01291173|224933|P3|Overall Study|Subject was unblinded|1
56817|NCT01291173|224934|P2|Overall Study|Subject was unblinded|0
56818|NCT01291173|224935|P1|Overall Study|Subject was unblinded|0
56819|NCT01291173|224932|P4|Overall Study|Lack of compliance|1
56820|NCT01291173|224933|P3|Overall Study|Lack of compliance|0
56821|NCT01291173|224934|P2|Overall Study|Lack of compliance|0
56822|NCT01291173|224935|P1|Overall Study|Lack of compliance|0
56823|NCT01291173|224932|P4|Overall Study|Unable to meet visit schedule|0
56824|NCT01291173|224933|P3|Overall Study|Unable to meet visit schedule|1
56825|NCT01291173|224934|P2|Overall Study|Unable to meet visit schedule|0
56826|NCT01291173|224935|P1|Overall Study|Unable to meet visit schedule|0
56827|NCT01291173|224932|P4|Overall Study|Lost to Follow-up|2
56828|NCT01291173|224933|P3|Overall Study|Lost to Follow-up|3
56829|NCT01291173|224934|P2|Overall Study|Lost to Follow-up|6
56830|NCT01291173|224935|P1|Overall Study|Lost to Follow-up|4
56831|NCT01291173|224932|P4|Overall Study|Withdrawal by Subject|2
56832|NCT01291173|224933|P3|Overall Study|Withdrawal by Subject|4
56833|NCT01291173|224934|P2|Overall Study|Withdrawal by Subject|4
56834|NCT01291173|224935|P1|Overall Study|Withdrawal by Subject|6
56835|NCT01291173|224932|P4|Overall Study|Protocol Violation|5
56836|NCT01291173|224933|P3|Overall Study|Protocol Violation|2
56837|NCT01291173|224934|P2|Overall Study|Protocol Violation|2
56838|NCT01291173|224935|P1|Overall Study|Protocol Violation|7
56839|NCT01291173|224932|P4|Overall Study|Adverse Event|3
56840|NCT01291173|224933|P3|Overall Study|Adverse Event|1
56841|NCT01291173|224934|P2|Overall Study|Adverse Event|3
56842|NCT01291173|224935|P1|Overall Study|Adverse Event|0
56843|NCT01291017|225044|P1|Overall Study|Withdrawal by Subject|3
56844|NCT01291017|225044|P1|Overall Study|Lost to Follow-up|2
56845|NCT01290887|225077|P2|Overall Study|Not specified|6
56846|NCT01290887|225078|P1|Overall Study|Not specified|3
56847|NCT01290887|225077|P2|Overall Study|Sponsor closure of study|476
56848|NCT01290887|225078|P1|Overall Study|Sponsor closure of study|420
56849|NCT01290887|225077|P2|Overall Study|Non-compliance to study medications|0
56850|NCT01290887|225078|P1|Overall Study|Non-compliance to study medications|1
56851|NCT01290887|225077|P2|Overall Study|Non-compliance to study procedures|1
56852|NCT01290887|225078|P1|Overall Study|Non-compliance to study procedures|0
56853|NCT01290887|225077|P2|Overall Study|Lost to Follow-up|4
56854|NCT01290887|225078|P1|Overall Study|Lost to Follow-up|4
56855|NCT01290887|225077|P2|Overall Study|Protocol Violation|1
56856|NCT01290887|225078|P1|Overall Study|Protocol Violation|2
56857|NCT01290887|225077|P2|Overall Study|Withdrawal by Subject|32
56858|NCT01290887|225078|P1|Overall Study|Withdrawal by Subject|26
56859|NCT01290887|225077|P2|Overall Study|Lack of Efficacy|5
56860|NCT01290887|225078|P1|Overall Study|Lack of Efficacy|4
56861|NCT01290887|225077|P2|Overall Study|Adverse Event|11
56862|NCT01290887|225078|P1|Overall Study|Adverse Event|6
56863|NCT01290822|225116|P1|Overall Study|Physician Decision|10
56864|NCT01290822|225116|P1|Overall Study|Withdrawal by Subject|1
56865|NCT01290796|225125|P1|Overall Study|Withdrawal by Sponsor|1
56866|NCT01290796|225125|P1|Overall Study|Secondary Surgical Intervention|2
56867|NCT01290796|225125|P1|Overall Study|Physician Decision|2
56868|NCT01290796|225125|P1|Overall Study|Withdrawal by Subject|4
56869|NCT01290796|225125|P1|Overall Study|Lost to Follow-up|21
56870|NCT01290757|225141|P2|Overall Study|Other|1
56871|NCT01290757|225142|P1|Overall Study|Other|0
56872|NCT01290757|225141|P2|Overall Study|Protocol Violation|1
56873|NCT01290757|225142|P1|Overall Study|Protocol Violation|1
56874|NCT01290757|225141|P2|Overall Study|Adverse Event|0
56875|NCT01290757|225142|P1|Overall Study|Adverse Event|1
56876|NCT01290731|225158|P1|Overall Study|Withdrawal by Subject|1
56877|NCT01290718|225170|P1|Overall Study|Early termination of the study|4
56878|NCT01290679|225179|P2|Overall Study|Subject Entered Another Trial|5
56879|NCT01290679|225180|P1|Overall Study|Subject Entered Another Trial|0
56880|NCT01290679|225179|P2|Overall Study|Withdrawal by Subject|5
56881|NCT01290679|225180|P1|Overall Study|Withdrawal by Subject|6
56882|NCT01290679|225179|P2|Overall Study|Protocol Violation|1
56883|NCT01290679|225180|P1|Overall Study|Protocol Violation|0
56884|NCT01290679|225179|P2|Overall Study|Lost to Follow-up|10
56885|NCT01290679|225180|P1|Overall Study|Lost to Follow-up|8
56886|NCT01290679|225179|P2|Overall Study|Adverse Event|0
56887|NCT01290679|225180|P1|Overall Study|Adverse Event|2
56888|NCT01290666|225249|P1|Overall Study|Early Termination of Study|4
56889|NCT01290666|225249|P1|Overall Study|Withdrawal by Subject|23
56890|NCT01290666|225249|P1|Overall Study|Lost to Follow-up|11
56891|NCT01290341|225318|P2|Overall Study|Negative baseline culture and others|11
56892|NCT01290341|225319|P1|Overall Study|Negative baseline culture and others|44
56893|NCT01290341|225318|P2|Overall Study|Withdrawal by Subject|5
56894|NCT01290341|225319|P1|Overall Study|Withdrawal by Subject|19
56895|NCT01290341|225318|P2|Overall Study|Lost to Follow-up|10
56896|NCT01290341|225319|P1|Overall Study|Lost to Follow-up|21
56897|NCT01290341|225318|P2|Overall Study|Adverse Event|0
56898|NCT01290341|225319|P1|Overall Study|Adverse Event|1
56899|NCT01290341|225318|P2|Overall Study|Protocol Violation|3
56900|NCT01290341|225319|P1|Overall Study|Protocol Violation|7
56901|NCT01290263|225329|P5|Overall Study|Participant Non-Compliance|1
56902|NCT01290263|225330|P4|Overall Study|Participant Non-Compliance|1
56903|NCT01290263|225331|P3|Overall Study|Participant Non-Compliance|0
56904|NCT01290263|225332|P2|Overall Study|Participant Non-Compliance|0
56905|NCT01290263|225333|P1|Overall Study|Participant Non-Compliance|0
56906|NCT01290263|225329|P5|Overall Study|Withdrawal by Subject|2
56907|NCT01290263|225330|P4|Overall Study|Withdrawal by Subject|1
56908|NCT01290263|225331|P3|Overall Study|Withdrawal by Subject|0
56909|NCT01290263|225332|P2|Overall Study|Withdrawal by Subject|1
56910|NCT01290263|225333|P1|Overall Study|Withdrawal by Subject|3
56911|NCT01290263|225329|P5|Overall Study|Lack of Efficacy|33
56912|NCT01290263|225330|P4|Overall Study|Lack of Efficacy|24
56913|NCT01290263|225331|P3|Overall Study|Lack of Efficacy|7
56914|NCT01290263|225332|P2|Overall Study|Lack of Efficacy|2
56915|NCT01290263|225333|P1|Overall Study|Lack of Efficacy|8
56916|NCT01290263|225329|P5|Overall Study|Adverse Event|1
56917|NCT01290263|225330|P4|Overall Study|Adverse Event|1
56918|NCT01290263|225331|P3|Overall Study|Adverse Event|0
56919|NCT01290263|225332|P2|Overall Study|Adverse Event|0
56920|NCT01290263|225333|P1|Overall Study|Adverse Event|0
56921|NCT01290224|225349|P1|Overall Study|Refused Further Treatment|4
56922|NCT01290224|225349|P1|Overall Study|Adverse Event|1
56923|NCT01290094|225360|P1|Overall Study|Lost to Follow-up|5
56924|NCT01290094|225360|P1|Overall Study|Withdrawal by Subject|1
56925|NCT01290068|225373|P2|Overall Study|Other|1
56926|NCT01290068|225374|P1|Overall Study|Other|3
56927|NCT01290068|225373|P2|Overall Study|Withdrawal by subject prior to implant|2
56928|NCT01290068|225374|P1|Overall Study|Withdrawal by subject prior to implant|0
56929|NCT01290068|225373|P2|Overall Study|Lost to Follow-up|0
56930|NCT01290068|225374|P1|Overall Study|Lost to Follow-up|3
56931|NCT01290068|225373|P2|Overall Study|Adverse Event|3
56932|NCT01290068|225374|P1|Overall Study|Adverse Event|1
56933|NCT01290029|225386|P1|Overall Study|Other|2
56934|NCT01289990|225412|P13|Overall Study|Not treated|0
56935|NCT01289990|225413|P12|Overall Study|Not treated|2
56936|NCT01289990|225414|P11|Overall Study|Not treated|1
56937|NCT01289990|225415|P10|Overall Study|Not treated|0
56938|NCT01289990|225416|P9|Overall Study|Not treated|1
56939|NCT01289990|225417|P8|Overall Study|Not treated|0
56940|NCT01289990|225418|P7|Overall Study|Not treated|1
56941|NCT01289990|225419|P6|Overall Study|Not treated|0
56942|NCT01289990|225420|P5|Overall Study|Not treated|0
56943|NCT01289990|225421|P4|Overall Study|Not treated|0
56944|NCT01289990|225422|P3|Overall Study|Not treated|0
56945|NCT01289990|225423|P2|Overall Study|Not treated|0
56946|NCT01289990|225424|P1|Overall Study|Not treated|0
56947|NCT01289990|225412|P13|Overall Study|did not continue in extension|56
56948|NCT01289990|225413|P12|Overall Study|did not continue in extension|34
56949|NCT01289990|225414|P11|Overall Study|did not continue in extension|45
56950|NCT01289990|225415|P10|Overall Study|did not continue in extension|48
56951|NCT01289990|225416|P9|Overall Study|did not continue in extension|44
56952|NCT01289990|225417|P8|Overall Study|did not continue in extension|36
56953|NCT01289990|225418|P7|Overall Study|did not continue in extension|54
56954|NCT01289990|225419|P6|Overall Study|did not continue in extension|50
56955|NCT01289990|225420|P5|Overall Study|did not continue in extension|48
56956|NCT01289990|225421|P4|Overall Study|did not continue in extension|51
56957|NCT01289990|225422|P3|Overall Study|did not continue in extension|51
56958|NCT01289990|225423|P2|Overall Study|did not continue in extension|45
56959|NCT01289990|225424|P1|Overall Study|did not continue in extension|41
56960|NCT01289990|225412|P13|Overall Study|discontinued in preceding trial|24
56961|NCT01289990|225413|P12|Overall Study|discontinued in preceding trial|17
56962|NCT01289990|225414|P11|Overall Study|discontinued in preceding trial|17
56963|NCT01289990|225415|P10|Overall Study|discontinued in preceding trial|21
56964|NCT01289990|225416|P9|Overall Study|discontinued in preceding trial|17
56965|NCT01289990|225417|P8|Overall Study|discontinued in preceding trial|8
56966|NCT01289990|225418|P7|Overall Study|discontinued in preceding trial|18
56967|NCT01289990|225419|P6|Overall Study|discontinued in preceding trial|12
56968|NCT01289990|225420|P5|Overall Study|discontinued in preceding trial|11
56969|NCT01289990|225421|P4|Overall Study|discontinued in preceding trial|17
56970|NCT01289990|225422|P3|Overall Study|discontinued in preceding trial|41
56971|NCT01289990|225423|P2|Overall Study|discontinued in preceding trial|20
56972|NCT01289990|225424|P1|Overall Study|discontinued in preceding trial|18
56973|NCT01289990|225412|P13|Overall Study|Withdrawal by Subject|16
56974|NCT01289990|225413|P12|Overall Study|Withdrawal by Subject|13
56975|NCT01289990|225414|P11|Overall Study|Withdrawal by Subject|11
56976|NCT01289990|225415|P10|Overall Study|Withdrawal by Subject|13
56977|NCT01289990|225416|P9|Overall Study|Withdrawal by Subject|12
56978|NCT01289990|225417|P8|Overall Study|Withdrawal by Subject|9
56979|NCT01289990|225418|P7|Overall Study|Withdrawal by Subject|13
56980|NCT01289990|225419|P6|Overall Study|Withdrawal by Subject|7
56981|NCT01289990|225420|P5|Overall Study|Withdrawal by Subject|8
56982|NCT01289990|225421|P4|Overall Study|Withdrawal by Subject|13
56983|NCT01289990|225422|P3|Overall Study|Withdrawal by Subject|12
56984|NCT01289990|225423|P2|Overall Study|Withdrawal by Subject|14
56985|NCT01289990|225424|P1|Overall Study|Withdrawal by Subject|15
56986|NCT01289990|225412|P13|Overall Study|Lost to Follow-up|2
56987|NCT01289990|225413|P12|Overall Study|Lost to Follow-up|1
56988|NCT01289990|225414|P11|Overall Study|Lost to Follow-up|2
56989|NCT01289990|225415|P10|Overall Study|Lost to Follow-up|4
56990|NCT01289990|225416|P9|Overall Study|Lost to Follow-up|1
56991|NCT01289990|225417|P8|Overall Study|Lost to Follow-up|2
56992|NCT01289990|225418|P7|Overall Study|Lost to Follow-up|2
56993|NCT01289990|225419|P6|Overall Study|Lost to Follow-up|4
56994|NCT01289990|225420|P5|Overall Study|Lost to Follow-up|3
56995|NCT01289990|225421|P4|Overall Study|Lost to Follow-up|5
56996|NCT01289990|225422|P3|Overall Study|Lost to Follow-up|5
56997|NCT01289990|225423|P2|Overall Study|Lost to Follow-up|2
56998|NCT01289990|225424|P1|Overall Study|Lost to Follow-up|3
56999|NCT01289990|225412|P13|Overall Study|Death|0
57000|NCT01289990|225413|P12|Overall Study|Death|1
57001|NCT01289990|225414|P11|Overall Study|Death|0
57002|NCT01289990|225415|P10|Overall Study|Death|0
57003|NCT01289990|225416|P9|Overall Study|Death|0
57004|NCT01289990|225417|P8|Overall Study|Death|0
57005|NCT01289990|225418|P7|Overall Study|Death|0
57006|NCT01289990|225419|P6|Overall Study|Death|1
57007|NCT01289990|225420|P5|Overall Study|Death|2
57008|NCT01289990|225421|P4|Overall Study|Death|1
57009|NCT01289990|225422|P3|Overall Study|Death|0
57010|NCT01289990|225423|P2|Overall Study|Death|0
57011|NCT01289990|225424|P1|Overall Study|Death|0
57100|NCT01289041|225951|P1|Overall Study|Death|1
57012|NCT01289847|225608|P1|Overall Study|Patient could not comply with visits|1
57013|NCT01289821|225617|P1|Survival Follow-up Period|Clinical endpoint reached|16
57014|NCT01289821|225617|P1|Survival Follow-up Period|Lost to Follow-up|1
57015|NCT01289821|225617|P1|Survival Follow-up Period|Protocol Violation|1
57016|NCT01289821|225617|P1|Safety Follow-up Period|Unspecified reason|1
57017|NCT01289821|225617|P1|Safety Follow-up Period|Protocol Violation|3
57018|NCT01289821|225617|P1|Safety Follow-up Period|Withdrawal by Subject|1
57019|NCT01289821|225617|P1|Treatment Period|Therapeutic procedure required|1
57020|NCT01289821|225617|P1|Treatment Period|Clinical Progression|2
57021|NCT01289821|225617|P1|Treatment Period|Radiological Progression|43
57022|NCT01289821|225617|P1|Treatment Period|Adverse Event|4
57023|NCT01289821|225617|P1|Treatment Period|Physician Decision|3
57024|NCT01289821|225617|P1|Treatment Period|Withdrawal by Subject|1
57025|NCT01289782|225628|P2|Overall Study|Reason not specified|2
57026|NCT01289782|225629|P1|Overall Study|Reason not specified|1
57027|NCT01289782|225628|P2|Overall Study|Sponsor's Decision|0
57028|NCT01289782|225629|P1|Overall Study|Sponsor's Decision|1
57029|NCT01289782|225628|P2|Overall Study|Withdrawal by Subject|2
57030|NCT01289782|225629|P1|Overall Study|Withdrawal by Subject|8
57031|NCT01289782|225628|P2|Overall Study|Protocol Violation|1
57032|NCT01289782|225629|P1|Overall Study|Protocol Violation|1
57033|NCT01289782|225628|P2|Overall Study|Lost to Follow-up|7
57034|NCT01289782|225629|P1|Overall Study|Lost to Follow-up|14
57035|NCT01289639|225701|P3|Overall Study|Lost to Follow-up|0
57036|NCT01289639|225702|P2|Overall Study|Lost to Follow-up|0
57037|NCT01289639|225703|P1|Overall Study|Lost to Follow-up|1
57038|NCT01289574|225729|P3|Overall Study|Subject wanted alternate treatment|0
57039|NCT01289574|225730|P2|Overall Study|Subject wanted alternate treatment|1
57040|NCT01289574|225731|P1|Overall Study|Subject wanted alternate treatment|0
57041|NCT01289574|225729|P3|Overall Study|Adverse Event|0
57042|NCT01289574|225730|P2|Overall Study|Adverse Event|1
57043|NCT01289574|225731|P1|Overall Study|Adverse Event|0
57044|NCT01289574|225729|P3|Overall Study|Withdrawal by Subject|1
57045|NCT01289574|225730|P2|Overall Study|Withdrawal by Subject|1
57046|NCT01289574|225731|P1|Overall Study|Withdrawal by Subject|1
57047|NCT01289574|225729|P3|Overall Study|Lost to Follow-up|1
57048|NCT01289574|225730|P2|Overall Study|Lost to Follow-up|0
57049|NCT01289574|225731|P1|Overall Study|Lost to Follow-up|2
57050|NCT01289574|225729|P3|Overall Study|Lack of Efficacy|1
57051|NCT01289574|225730|P2|Overall Study|Lack of Efficacy|0
57052|NCT01289574|225731|P1|Overall Study|Lack of Efficacy|4
57053|NCT01289418|225803|P1|Day 29 Survey|participants did not complete the survey|2185
57054|NCT01289418|225803|P1|Day 29 Survey|email address invalid|283
57055|NCT01289418|225803|P1|Day 8 Survey|participants did not complete the survey|1935
57056|NCT01289418|225803|P1|Day 8 Survey|email address invalid|283
57057|NCT01289210|225822|P1|Overall Study|Adverse Event|1
57058|NCT01289119|225832|P6|Overall Study|Other|0
57059|NCT01289119|225833|P5|Overall Study|Other|0
57060|NCT01289119|225834|P4|Overall Study|Other|0
57061|NCT01289119|225835|P3|Overall Study|Other|1
57062|NCT01289119|225836|P2|Overall Study|Other|0
57063|NCT01289119|225837|P1|Overall Study|Other|1
57064|NCT01289119|225832|P6|Overall Study|Lack of Efficacy|1
57065|NCT01289119|225833|P5|Overall Study|Lack of Efficacy|1
57066|NCT01289119|225834|P4|Overall Study|Lack of Efficacy|1
57067|NCT01289119|225835|P3|Overall Study|Lack of Efficacy|1
57068|NCT01289119|225836|P2|Overall Study|Lack of Efficacy|1
57069|NCT01289119|225837|P1|Overall Study|Lack of Efficacy|0
57070|NCT01289119|225832|P6|Overall Study|Pregnancy|0
57071|NCT01289119|225833|P5|Overall Study|Pregnancy|0
57072|NCT01289119|225834|P4|Overall Study|Pregnancy|0
57073|NCT01289119|225835|P3|Overall Study|Pregnancy|0
57074|NCT01289119|225836|P2|Overall Study|Pregnancy|1
57075|NCT01289119|225837|P1|Overall Study|Pregnancy|0
57076|NCT01289119|225832|P6|Overall Study|Withdrawal by Subject|1
57077|NCT01289119|225833|P5|Overall Study|Withdrawal by Subject|1
57078|NCT01289119|225834|P4|Overall Study|Withdrawal by Subject|3
57079|NCT01289119|225835|P3|Overall Study|Withdrawal by Subject|4
57080|NCT01289119|225836|P2|Overall Study|Withdrawal by Subject|2
57081|NCT01289119|225837|P1|Overall Study|Withdrawal by Subject|4
57082|NCT01289119|225832|P6|Overall Study|Lost to Follow-up|1
57083|NCT01289119|225833|P5|Overall Study|Lost to Follow-up|0
57084|NCT01289119|225834|P4|Overall Study|Lost to Follow-up|0
57085|NCT01289119|225835|P3|Overall Study|Lost to Follow-up|0
57086|NCT01289119|225836|P2|Overall Study|Lost to Follow-up|3
57087|NCT01289119|225837|P1|Overall Study|Lost to Follow-up|0
57088|NCT01289119|225832|P6|Overall Study|Major Protocol Deviation|1
57089|NCT01289119|225833|P5|Overall Study|Major Protocol Deviation|2
57090|NCT01289119|225834|P4|Overall Study|Major Protocol Deviation|0
57091|NCT01289119|225835|P3|Overall Study|Major Protocol Deviation|3
57092|NCT01289119|225836|P2|Overall Study|Major Protocol Deviation|1
57093|NCT01289119|225837|P1|Overall Study|Major Protocol Deviation|2
57094|NCT01289119|225832|P6|Overall Study|Adverse Event|0
57095|NCT01289119|225833|P5|Overall Study|Adverse Event|1
57096|NCT01289119|225834|P4|Overall Study|Adverse Event|2
57097|NCT01289119|225835|P3|Overall Study|Adverse Event|0
57098|NCT01289119|225836|P2|Overall Study|Adverse Event|1
57099|NCT01289119|225837|P1|Overall Study|Adverse Event|2
57101|NCT01289041|225951|P1|Overall Study|Withdrawal by Subject|3
57102|NCT01289041|225951|P1|Overall Study|Progressive Disease|41
57103|NCT01289041|225951|P1|Overall Study|Physician Decision|1
57104|NCT01289041|225951|P1|Overall Study|Adverse Event|24
57105|NCT01289028|225963|P1|Overall Study|Missing reason for discon|1
57106|NCT01289028|225963|P1|Overall Study|Abnormal Lab Value|1
57107|NCT01289028|225963|P1|Overall Study|New Cancer Therapy|2
57108|NCT01289028|225963|P1|Overall Study|Lost to Follow-up|2
57109|NCT01289028|225963|P1|Overall Study|No longer required|2
57110|NCT01289028|225963|P1|Overall Study|Lack of Efficacy|2
57111|NCT01289028|225963|P1|Overall Study|Death|4
57112|NCT01289028|225963|P1|Overall Study|Withdrawal by Subject|6
57113|NCT01289028|225963|P1|Overall Study|Adverse Event|14
57114|NCT01289028|225963|P1|Overall Study|Progressive Disease|49
57115|NCT01289015|225977|P2|Overall Study|Negative baseline culture and others|20
57116|NCT01289015|225978|P1|Overall Study|Negative baseline culture and others|33
57117|NCT01289015|225977|P2|Overall Study|Disease progression|0
57118|NCT01289015|225978|P1|Overall Study|Disease progression|1
57119|NCT01289015|225977|P2|Overall Study|Withdrawal by Subject|8
57120|NCT01289015|225978|P1|Overall Study|Withdrawal by Subject|17
57121|NCT01289015|225977|P2|Overall Study|Lost to Follow-up|17
57122|NCT01289015|225978|P1|Overall Study|Lost to Follow-up|33
57123|NCT01289015|225977|P2|Overall Study|Adverse Event|0
57124|NCT01289015|225978|P1|Overall Study|Adverse Event|3
57125|NCT01289015|225977|P2|Overall Study|Protocol Violation|9
57126|NCT01289015|225978|P1|Overall Study|Protocol Violation|12
57127|NCT01288911|225988|P2|Overall Study|Randomized but never received study drug|2
57128|NCT01288911|225989|P1|Overall Study|Randomized but never received study drug|1
57129|NCT01288911|225988|P2|Overall Study|Miscellaneous Reason|39
57130|NCT01288911|225989|P1|Overall Study|Miscellaneous Reason|23
57131|NCT01288911|225988|P2|Overall Study|Withdrawal by Subject|21
57132|NCT01288911|225989|P1|Overall Study|Withdrawal by Subject|21
57133|NCT01288911|225988|P2|Overall Study|Protocol Violation|0
57134|NCT01288911|225989|P1|Overall Study|Protocol Violation|1
57135|NCT01288911|225988|P2|Overall Study|Progressive Disease|99
57136|NCT01288911|225989|P1|Overall Study|Progressive Disease|69
57137|NCT01288911|225988|P2|Overall Study|Lost to Follow-up|2
57138|NCT01288911|225989|P1|Overall Study|Lost to Follow-up|0
57139|NCT01288911|225988|P2|Overall Study|Death|7
57140|NCT01288911|225989|P1|Overall Study|Death|10
57141|NCT01288729|226071|P2|Overall Study|Withdrawal by Subject|0
57142|NCT01288729|226072|P1|Overall Study|Withdrawal by Subject|1
57143|NCT01288612|226081|P3|Overall Study|Unable to intubate|0
57144|NCT01288612|226082|P2|Overall Study|Unable to intubate|3
57145|NCT01288612|226083|P1|Overall Study|Unable to intubate|0
57146|NCT01288612|226081|P3|Overall Study|Declined|62
57147|NCT01288612|226082|P2|Overall Study|Declined|63
57148|NCT01288612|226083|P1|Overall Study|Declined|78
57149|NCT01288612|226081|P3|Overall Study|Unable to contact|20
57150|NCT01288612|226082|P2|Overall Study|Unable to contact|16
57151|NCT01288612|226083|P1|Overall Study|Unable to contact|11
57152|NCT01288469|226119|P3|Overall Study|Exclusion criteria finally met|0
57153|NCT01288469|226120|P2|Overall Study|Exclusion criteria finally met|0
57154|NCT01288469|226121|P1|Overall Study|Exclusion criteria finally met|1
57155|NCT01288469|226119|P3|Overall Study|Consent withdrawn by subject|1
57156|NCT01288469|226120|P2|Overall Study|Consent withdrawn by subject|1
57157|NCT01288469|226121|P1|Overall Study|Consent withdrawn by subject|1
57158|NCT01288469|226119|P3|Overall Study|Participant Moved|0
57159|NCT01288469|226120|P2|Overall Study|Participant Moved|0
57160|NCT01288469|226121|P1|Overall Study|Participant Moved|1
57161|NCT01288469|226119|P3|Overall Study|Poor compliance to protocol|0
57162|NCT01288469|226120|P2|Overall Study|Poor compliance to protocol|1
57163|NCT01288469|226121|P1|Overall Study|Poor compliance to protocol|0
57164|NCT01288469|226119|P3|Overall Study|Adverse Event|1
57165|NCT01288469|226120|P2|Overall Study|Adverse Event|1
57166|NCT01288469|226121|P1|Overall Study|Adverse Event|4
57167|NCT01288443|226153|P6|Overall Study|Other than above|0
57168|NCT01288443|226154|P5|Overall Study|Other than above|1
57169|NCT01288443|226155|P4|Overall Study|Other than above|2
57170|NCT01288443|226156|P3|Overall Study|Other than above|0
57171|NCT01288443|226157|P2|Overall Study|Other than above|0
57172|NCT01288443|226158|P1|Overall Study|Other than above|0
57173|NCT01288443|226153|P6|Overall Study|Study drug auto-injector administration|1
57174|NCT01288443|226154|P5|Overall Study|Study drug auto-injector administration|1
57175|NCT01288443|226155|P4|Overall Study|Study drug auto-injector administration|0
57176|NCT01288443|226156|P3|Overall Study|Study drug auto-injector administration|0
57177|NCT01288443|226157|P2|Overall Study|Study drug auto-injector administration|0
57178|NCT01288443|226158|P1|Overall Study|Study drug auto-injector administration|0
57179|NCT01288443|226153|P6|Overall Study|Lost to Follow-up|0
57180|NCT01288443|226154|P5|Overall Study|Lost to Follow-up|0
57181|NCT01288443|226155|P4|Overall Study|Lost to Follow-up|0
57182|NCT01288443|226156|P3|Overall Study|Lost to Follow-up|0
57183|NCT01288443|226157|P2|Overall Study|Lost to Follow-up|1
57184|NCT01288443|226158|P1|Overall Study|Lost to Follow-up|0
57185|NCT01288443|226153|P6|Overall Study|Consent withdrawn by Participant|1
57186|NCT01288443|226154|P5|Overall Study|Consent withdrawn by Participant|0
57187|NCT01288443|226155|P4|Overall Study|Consent withdrawn by Participant|0
57188|NCT01288443|226156|P3|Overall Study|Consent withdrawn by Participant|0
57189|NCT01288443|226157|P2|Overall Study|Consent withdrawn by Participant|0
57190|NCT01288443|226158|P1|Overall Study|Consent withdrawn by Participant|0
57191|NCT01288443|226153|P6|Overall Study|Participant Moved|1
57192|NCT01288443|226154|P5|Overall Study|Participant Moved|2
57193|NCT01288443|226155|P4|Overall Study|Participant Moved|1
57194|NCT01288443|226156|P3|Overall Study|Participant Moved|0
57195|NCT01288443|226157|P2|Overall Study|Participant Moved|0
57196|NCT01288443|226158|P1|Overall Study|Participant Moved|0
57197|NCT01288443|226153|P6|Overall Study|Poor compliance to protocol|1
57198|NCT01288443|226154|P5|Overall Study|Poor compliance to protocol|0
57199|NCT01288443|226155|P4|Overall Study|Poor compliance to protocol|0
57200|NCT01288443|226156|P3|Overall Study|Poor compliance to protocol|0
57201|NCT01288443|226157|P2|Overall Study|Poor compliance to protocol|0
57202|NCT01288443|226158|P1|Overall Study|Poor compliance to protocol|0
57203|NCT01288443|226153|P6|Overall Study|Adverse Event|1
57204|NCT01288443|226154|P5|Overall Study|Adverse Event|3
57205|NCT01288443|226155|P4|Overall Study|Adverse Event|1
57206|NCT01288443|226156|P3|Overall Study|Adverse Event|1
57207|NCT01288443|226157|P2|Overall Study|Adverse Event|0
57208|NCT01288443|226158|P1|Overall Study|Adverse Event|0
57209|NCT01288287|226208|P1|Overall Study|Unknown Status|7
57210|NCT01288287|226208|P1|Overall Study|Unknown Reason|1
57211|NCT01288287|226208|P1|Overall Study|Other Reason|13
57212|NCT01288287|226208|P1|Overall Study|Lack of Efficacy|13
57213|NCT01288287|226208|P1|Overall Study|Withdrawal by Subject|4
57214|NCT01288287|226208|P1|Overall Study|Lost to Follow-up|8
57215|NCT01288209|226223|P2|Overall Study|Not specified|0
57216|NCT01288209|226224|P1|Overall Study|Not specified|1
57217|NCT01288209|226223|P2|Overall Study|Withdrawal by Subject|3
57218|NCT01288209|226224|P1|Overall Study|Withdrawal by Subject|1
57219|NCT01288079|226254|P4|Overall Study|Other or Study Termination|8
57220|NCT01288079|226255|P3|Overall Study|Other or Study Termination|14
57221|NCT01288079|226256|P2|Overall Study|Other or Study Termination|15
57222|NCT01288079|226257|P1|Overall Study|Other or Study Termination|11
57223|NCT01288079|226254|P4|Overall Study|Lost to Follow-up|0
57224|NCT01288079|226255|P3|Overall Study|Lost to Follow-up|1
57225|NCT01288079|226256|P2|Overall Study|Lost to Follow-up|1
57226|NCT01288079|226257|P1|Overall Study|Lost to Follow-up|1
57227|NCT01288079|226254|P4|Overall Study|Study-Specific Withdrawal Criteria|0
57228|NCT01288079|226255|P3|Overall Study|Study-Specific Withdrawal Criteria|0
57229|NCT01288079|226256|P2|Overall Study|Study-Specific Withdrawal Criteria|1
57230|NCT01288079|226257|P1|Overall Study|Study-Specific Withdrawal Criteria|1
57231|NCT01288079|226254|P4|Overall Study|Lack of Efficacy|2
57232|NCT01288079|226255|P3|Overall Study|Lack of Efficacy|0
57233|NCT01288079|226256|P2|Overall Study|Lack of Efficacy|2
57234|NCT01288079|226257|P1|Overall Study|Lack of Efficacy|2
57235|NCT01288079|226254|P4|Overall Study|Condition under Investigation Worsened|1
57236|NCT01288079|226255|P3|Overall Study|Condition under Investigation Worsened|0
57237|NCT01288079|226256|P2|Overall Study|Condition under Investigation Worsened|0
57238|NCT01288079|226257|P1|Overall Study|Condition under Investigation Worsened|0
57239|NCT01288079|226254|P4|Overall Study|Severe Non-Compliance to Protocol|3
57240|NCT01288079|226255|P3|Overall Study|Severe Non-Compliance to Protocol|1
57241|NCT01288079|226256|P2|Overall Study|Severe Non-Compliance to Protocol|3
57242|NCT01288079|226257|P1|Overall Study|Severe Non-Compliance to Protocol|1
57243|NCT01288079|226254|P4|Overall Study|Adverse Event|3
57244|NCT01288079|226255|P3|Overall Study|Adverse Event|2
57245|NCT01288079|226256|P2|Overall Study|Adverse Event|1
57246|NCT01288079|226257|P1|Overall Study|Adverse Event|2
57247|NCT01288079|226254|P4|Overall Study|Withdrawal by Subject|0
57248|NCT01288079|226255|P3|Overall Study|Withdrawal by Subject|1
57249|NCT01288079|226256|P2|Overall Study|Withdrawal by Subject|4
57250|NCT01288079|226257|P1|Overall Study|Withdrawal by Subject|2
57251|NCT01287897|226281|P4|Overall Study|Unspecified|0
57252|NCT01287897|226282|P3|Overall Study|Unspecified|1
57253|NCT01287897|226283|P2|Overall Study|Unspecified|0
57254|NCT01287897|226284|P1|Overall Study|Unspecified|1
57255|NCT01287897|226281|P4|Overall Study|Not meeting entrance criteria|0
57256|NCT01287897|226282|P3|Overall Study|Not meeting entrance criteria|0
57257|NCT01287897|226283|P2|Overall Study|Not meeting entrance criteria|1
57258|NCT01287897|226284|P1|Overall Study|Not meeting entrance criteria|1
57259|NCT01287897|226281|P4|Overall Study|Not consented properly|0
57260|NCT01287897|226282|P3|Overall Study|Not consented properly|0
57261|NCT01287897|226283|P2|Overall Study|Not consented properly|1
57262|NCT01287897|226284|P1|Overall Study|Not consented properly|0
57263|NCT01287897|226281|P4|Overall Study|Withdrawal by Subject|2
57264|NCT01287897|226282|P3|Overall Study|Withdrawal by Subject|3
57265|NCT01287897|226283|P2|Overall Study|Withdrawal by Subject|5
57266|NCT01287897|226284|P1|Overall Study|Withdrawal by Subject|1
57267|NCT01287897|226281|P4|Overall Study|Lost to Follow-up|0
57268|NCT01287897|226282|P3|Overall Study|Lost to Follow-up|2
57269|NCT01287897|226283|P2|Overall Study|Lost to Follow-up|0
57270|NCT01287897|226284|P1|Overall Study|Lost to Follow-up|0
57271|NCT01287897|226281|P4|Overall Study|Protocol Violation|1
57272|NCT01287897|226282|P3|Overall Study|Protocol Violation|0
57273|NCT01287897|226283|P2|Overall Study|Protocol Violation|1
57274|NCT01287897|226284|P1|Overall Study|Protocol Violation|1
57275|NCT01287897|226281|P4|Overall Study|Lack of Efficacy|0
57276|NCT01287897|226282|P3|Overall Study|Lack of Efficacy|0
57277|NCT01287897|226283|P2|Overall Study|Lack of Efficacy|0
57278|NCT01287897|226284|P1|Overall Study|Lack of Efficacy|2
57279|NCT01287897|226281|P4|Overall Study|Adverse Event|4
57280|NCT01287897|226282|P3|Overall Study|Adverse Event|6
57281|NCT01287897|226283|P2|Overall Study|Adverse Event|3
57282|NCT01287897|226284|P1|Overall Study|Adverse Event|5
57283|NCT01287832|226335|P2|Overall Study|Death|1
57284|NCT01287832|226336|P1|Overall Study|Death|0
57285|NCT01287832|226335|P2|Overall Study|Adverse Event|0
57286|NCT01287832|226336|P1|Overall Study|Adverse Event|1
57287|NCT01287754|226344|P2|Overall Study|Protocol Violation|3
57288|NCT01287754|226345|P1|Overall Study|Protocol Violation|0
57289|NCT01287754|226344|P2|Overall Study|Lost to Follow-up|6
57290|NCT01287754|226345|P1|Overall Study|Lost to Follow-up|1
57291|NCT01287754|226344|P2|Overall Study|Death|12
57292|NCT01287754|226345|P1|Overall Study|Death|2
57293|NCT01287741|226357|P2|Overall Study|Reason not specified|9
57294|NCT01287741|226358|P1|Overall Study|Reason not specified|14
57295|NCT01287741|226357|P2|Overall Study|Progressive disease|148
57296|NCT01287741|226358|P1|Overall Study|Progressive disease|173
57297|NCT01287741|226357|P2|Overall Study|Continued in the study|455
57298|NCT01287741|226358|P1|Overall Study|Continued in the study|446
57299|NCT01287741|226357|P2|Overall Study|Adverse Event|4
57300|NCT01287741|226358|P1|Overall Study|Adverse Event|3
57301|NCT01287741|226357|P2|Overall Study|Death|38
57302|NCT01287741|226358|P1|Overall Study|Death|31
57303|NCT01287741|226357|P2|Overall Study|Lost to Follow-up|8
57304|NCT01287741|226358|P1|Overall Study|Lost to Follow-up|5
57305|NCT01287741|226357|P2|Overall Study|Non-compliance|3
57306|NCT01287741|226358|P1|Overall Study|Non-compliance|2
57307|NCT01287741|226357|P2|Overall Study|Physician Decision|19
57308|NCT01287741|226358|P1|Overall Study|Physician Decision|12
57309|NCT01287741|226357|P2|Overall Study|Protocol Violation|0
57310|NCT01287741|226358|P1|Overall Study|Protocol Violation|1
57311|NCT01287741|226357|P2|Overall Study|Withdrawal by Subject|22
57312|NCT01287741|226358|P1|Overall Study|Withdrawal by Subject|25
57313|NCT01287611|226394|P2|Overall Study|Exclusion due to expanded Kerr incision|3
57314|NCT01287611|226395|P1|Overall Study|Exclusion due to expanded Kerr incision|4
57315|NCT01287611|226394|P2|Overall Study|Lost to Follow-up|16
57316|NCT01287611|226395|P1|Overall Study|Lost to Follow-up|29
57317|NCT01287416|226405|P2|6 Month Follow-up|Lost to Follow-up|2
57318|NCT01287416|226406|P1|6 Month Follow-up|Lost to Follow-up|3
57319|NCT01287416|226405|P2|Pre-post Training|Lost to Follow-up|1
57320|NCT01287416|226406|P1|Pre-post Training|Lost to Follow-up|5
57321|NCT01287416|226405|P2|Pre-post Training|Withdrawal by Subject|24
57322|NCT01287416|226406|P1|Pre-post Training|Withdrawal by Subject|17
57323|NCT01287403|226442|P1|1st Intervention (1 Day)|Adverse Event|1
57324|NCT01287364|226458|P2|Overall Study|Other Reason|2
57325|NCT01287364|226459|P1|Overall Study|Other Reason|4
57326|NCT01287364|226458|P2|Overall Study|Protocol Violation|5
57327|NCT01287364|226459|P1|Overall Study|Protocol Violation|5
57328|NCT01287364|226458|P2|Overall Study|Adverse Event|3
57329|NCT01287364|226459|P1|Overall Study|Adverse Event|0
57330|NCT01287221|226481|P2|Overall Study|Withdrawal by Subject|1
57331|NCT01287221|226482|P1|Overall Study|Withdrawal by Subject|0
57332|NCT01287221|226481|P2|Overall Study|Adverse Event|3
57333|NCT01287221|226482|P1|Overall Study|Adverse Event|3
57334|NCT01287221|226481|P2|Overall Study|Lack of Perceived Benefit|1
57335|NCT01287221|226482|P1|Overall Study|Lack of Perceived Benefit|1
57336|NCT01287195|226509|P1|Overall Study|Withdrawal by Subject|2
57337|NCT01287117|226524|P4|Overall Study|Disease Progression|5
57338|NCT01287117|226525|P3|Overall Study|Disease Progression|6
57339|NCT01287117|226526|P2|Overall Study|Disease Progression|5
57340|NCT01287117|226527|P1|Overall Study|Disease Progression|10
57341|NCT01287117|226524|P4|Overall Study|Patient/Legal Guardian's Decision|5
57342|NCT01287117|226525|P3|Overall Study|Patient/Legal Guardian's Decision|8
57343|NCT01287117|226526|P2|Overall Study|Patient/Legal Guardian's Decision|6
57344|NCT01287117|226527|P1|Overall Study|Patient/Legal Guardian's Decision|2
57345|NCT01287117|226524|P4|Overall Study|Physician Decision|1
57346|NCT01287117|226525|P3|Overall Study|Physician Decision|1
57347|NCT01287117|226526|P2|Overall Study|Physician Decision|1
57348|NCT01287117|226527|P1|Overall Study|Physician Decision|0
57349|NCT01287117|226524|P4|Overall Study|Lost to Follow-up|0
57350|NCT01287117|226525|P3|Overall Study|Lost to Follow-up|0
57351|NCT01287117|226526|P2|Overall Study|Lost to Follow-up|1
57352|NCT01287117|226527|P1|Overall Study|Lost to Follow-up|1
57353|NCT01287117|226524|P4|Overall Study|Adverse Event|1
57354|NCT01287117|226525|P3|Overall Study|Adverse Event|1
57355|NCT01287117|226526|P2|Overall Study|Adverse Event|1
57356|NCT01287117|226527|P1|Overall Study|Adverse Event|2
57357|NCT01287065|226573|P6|Treatment Period 1|Withdrawal by Subject|1
57358|NCT01287065|226574|P5|Treatment Period 1|Withdrawal by Subject|0
57359|NCT01287065|226575|P4|Treatment Period 1|Withdrawal by Subject|0
57360|NCT01287065|226576|P3|Treatment Period 1|Withdrawal by Subject|0
57361|NCT01287065|226577|P2|Treatment Period 1|Withdrawal by Subject|0
57362|NCT01287065|226578|P1|Treatment Period 1|Withdrawal by Subject|0
57363|NCT01287065|226573|P6|Treatment Period 1|Adverse Event|0
57364|NCT01287065|226574|P5|Treatment Period 1|Adverse Event|1
57365|NCT01287065|226575|P4|Treatment Period 1|Adverse Event|0
57366|NCT01287065|226576|P3|Treatment Period 1|Adverse Event|0
57367|NCT01287065|226577|P2|Treatment Period 1|Adverse Event|0
57368|NCT01287065|226578|P1|Treatment Period 1|Adverse Event|0
57369|NCT01287039|226597|P2|Overall Study|Lost to Follow-up|2
57370|NCT01287039|226598|P1|Overall Study|Lost to Follow-up|3
57371|NCT01287039|226597|P2|Overall Study|Withdrawal by Subject|11
57372|NCT01287039|226598|P1|Overall Study|Withdrawal by Subject|14
57373|NCT01287039|226597|P2|Overall Study|Adverse Event|4
57374|NCT01287039|226598|P1|Overall Study|Adverse Event|7
57375|NCT01287039|226597|P2|Overall Study|Change of residence|0
57376|NCT01287039|226598|P1|Overall Study|Change of residence|1
57377|NCT01287039|226597|P2|Overall Study|Death|0
57378|NCT01287039|226598|P1|Overall Study|Death|1
57379|NCT01287039|226597|P2|Overall Study|Problem with travel|1
57380|NCT01287039|226598|P1|Overall Study|Problem with travel|0
57381|NCT01287039|226597|P2|Overall Study|Noncompliance with study medication|1
57382|NCT01287039|226598|P1|Overall Study|Noncompliance with study medication|0
57383|NCT01287039|226597|P2|Overall Study|Excluded medication taken|0
57384|NCT01287039|226598|P1|Overall Study|Excluded medication taken|1
57385|NCT01287039|226597|P2|Overall Study|Protocol Violation|3
57386|NCT01287039|226598|P1|Overall Study|Protocol Violation|2
57387|NCT01287039|226597|P2|Overall Study|Elective surgery|1
57388|NCT01287039|226598|P1|Overall Study|Elective surgery|0
57389|NCT01287039|226597|P2|Overall Study|Change of location/residence|3
57390|NCT01287039|226598|P1|Overall Study|Change of location/residence|0
57391|NCT01287039|226597|P2|Overall Study|Noncompliance with study procedures|1
57392|NCT01287039|226598|P1|Overall Study|Noncompliance with study procedures|0
57393|NCT01286753|226665|P2|Overall Study|Participant to Receive Radiotherapy|0
57394|NCT01286753|226666|P1|Overall Study|Participant to Receive Radiotherapy|1
57395|NCT01286753|226665|P2|Overall Study|Discontinued to Join Extension Study|4
57396|NCT01286753|226666|P1|Overall Study|Discontinued to Join Extension Study|6
57397|NCT01286753|226665|P2|Overall Study|Withdrawal of Consent|2
57398|NCT01286753|226666|P1|Overall Study|Withdrawal of Consent|0
57399|NCT01286753|226665|P2|Overall Study|Refused Treatment|0
57400|NCT01286753|226666|P1|Overall Study|Refused Treatment|1
57401|NCT01286753|226665|P2|Overall Study|Progression|13
57402|NCT01286753|226666|P1|Overall Study|Progression|11
57403|NCT01286753|226665|P2|Overall Study|Adverse Event|6
57404|NCT01286753|226666|P1|Overall Study|Adverse Event|7
57405|NCT01286740|226684|P1|Overall Study|Protocol Violation|1
57406|NCT01286740|226684|P1|Overall Study|Enrolled but not treated|1
57407|NCT01286558|226702|P2|Overall Study|Withdrawal by Subject|1
57408|NCT01286558|226703|P1|Overall Study|Withdrawal by Subject|0
57409|NCT01286558|226702|P2|Overall Study|Adverse Event|1
57410|NCT01286558|226703|P1|Overall Study|Adverse Event|1
57411|NCT01286480|226739|P2|Overall Study|Withdrawal by Subject|3
57412|NCT01286480|226740|P1|Overall Study|Withdrawal by Subject|5
57413|NCT01286311|226816|P2|Overall Study|Physician did not want outreach sent|0
57414|NCT01286311|226817|P1|Overall Study|Physician did not want outreach sent|14
57415|NCT01286207|226834|P3|Overall Study|Unspecified|13
57416|NCT01286207|226835|P2|Overall Study|Unspecified|47
57417|NCT01286207|226836|P1|Overall Study|Unspecified|37
57418|NCT01286207|226834|P3|Overall Study|Lack of Response|8
57419|NCT01286207|226835|P2|Overall Study|Lack of Response|38
57420|NCT01286207|226836|P1|Overall Study|Lack of Response|92
57421|NCT01286207|226834|P3|Overall Study|Withdrawal by Subject|41
57422|NCT01286207|226835|P2|Overall Study|Withdrawal by Subject|79
57423|NCT01286207|226836|P1|Overall Study|Withdrawal by Subject|93
57424|NCT01286207|226834|P3|Overall Study|Lost to Follow-up|20
57425|NCT01286207|226835|P2|Overall Study|Lost to Follow-up|43
57426|NCT01286207|226836|P1|Overall Study|Lost to Follow-up|49
57427|NCT01286207|226834|P3|Overall Study|Adverse Event|8
57428|NCT01286207|226835|P2|Overall Study|Adverse Event|41
57429|NCT01286207|226836|P1|Overall Study|Adverse Event|27
57430|NCT01286168|226856|P1|Overall Study|Surgical Drains Fell Out at Home|2
57431|NCT01286168|226856|P1|Overall Study|Withdrawal by Subject|1
57432|NCT01286129|226870|P2|Overall Study|Could not comply with study requirements|4
57433|NCT01286129|226871|P1|Overall Study|Could not comply with study requirements|4
57434|NCT01286129|226870|P2|Overall Study|Withdrawal by Subject|1
57435|NCT01286129|226871|P1|Overall Study|Withdrawal by Subject|4
57436|NCT01286077|226881|P2|Overall Study|refill medication not received in time|0
57437|NCT01286077|226882|P1|Overall Study|refill medication not received in time|1
57438|NCT01286077|226881|P2|Overall Study|Progression of disease|1
57439|NCT01286077|226882|P1|Overall Study|Progression of disease|0
57440|NCT01286077|226881|P2|Overall Study|Patient's decision to stop treatment|0
57441|NCT01286077|226882|P1|Overall Study|Patient's decision to stop treatment|3
57442|NCT01286077|226881|P2|Overall Study|The subject starts with alternative MMY|3
57443|NCT01286077|226882|P1|Overall Study|The subject starts with alternative MMY|0
57444|NCT01286077|226881|P2|Overall Study|Non-compliance|0
57445|NCT01286077|226882|P1|Overall Study|Non-compliance|1
57446|NCT01286077|226881|P2|Overall Study|Intercurrent illness|0
57447|NCT01286077|226882|P1|Overall Study|Intercurrent illness|1
57448|NCT01286077|226881|P2|Overall Study|Withdrawal by Subject|2
57449|NCT01286077|226882|P1|Overall Study|Withdrawal by Subject|0
57450|NCT01286077|226881|P2|Overall Study|Protocol Violation|1
57451|NCT01286077|226882|P1|Overall Study|Protocol Violation|1
57452|NCT01286077|226881|P2|Overall Study|Death|0
57453|NCT01286077|226882|P1|Overall Study|Death|1
57454|NCT01286077|226881|P2|Overall Study|Adverse Event|0
57455|NCT01286077|226882|P1|Overall Study|Adverse Event|2
57456|NCT01286012|226918|P2|Overall Study|peritoneal dialysis, randomized in error|3
57457|NCT01286012|226919|P1|Overall Study|peritoneal dialysis, randomized in error|1
57458|NCT01286012|226918|P2|Overall Study|Physician Decision|0
57459|NCT01286012|226919|P1|Overall Study|Physician Decision|2
57460|NCT01286012|226918|P2|Overall Study|Withdrawal by Subject|4
57461|NCT01286012|226919|P1|Overall Study|Withdrawal by Subject|4
57462|NCT01286012|226918|P2|Overall Study|Protocol Violation|1
57463|NCT01286012|226919|P1|Overall Study|Protocol Violation|1
57464|NCT01286012|226918|P2|Overall Study|Death|3
57465|NCT01286012|226919|P1|Overall Study|Death|2
57466|NCT01286012|226918|P2|Overall Study|Adverse Event|3
57467|NCT01286012|226919|P1|Overall Study|Adverse Event|3
57468|NCT01285908|226936|P3|Baseline Measurement|unable to tolerate procedure|0
57469|NCT01285908|226937|P2|Baseline Measurement|unable to tolerate procedure|0
57470|NCT01285908|226938|P1|Baseline Measurement|unable to tolerate procedure|1
57471|NCT01285908|226936|P3|Baseline Measurement|History of stroke, exclusion criteria|0
57472|NCT01285908|226937|P2|Baseline Measurement|History of stroke, exclusion criteria|0
57473|NCT01285908|226938|P1|Baseline Measurement|History of stroke, exclusion criteria|1
57474|NCT01285908|226936|P3|Baseline Measurement|unable to insert catheter|0
57475|NCT01285908|226937|P2|Baseline Measurement|unable to insert catheter|0
57476|NCT01285908|226938|P1|Baseline Measurement|unable to insert catheter|1
57477|NCT01285609|227032|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
57478|NCT01285609|227033|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
57479|NCT01285609|227032|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
57480|NCT01285609|227033|P1|Treated With Blinded Therapy|Poor/Non-Compliance|0
57481|NCT01285609|227032|P2|Treated With Blinded Therapy|Not Reported|4
57482|NCT01285609|227033|P1|Treated With Blinded Therapy|Not Reported|4
57483|NCT01285609|227032|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
57484|NCT01285609|227033|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
57485|NCT01285609|227032|P2|Treated With Blinded Therapy|Death|3
57486|NCT01285609|227033|P1|Treated With Blinded Therapy|Death|11
57487|NCT01285609|227032|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
57488|NCT01285609|227033|P1|Treated With Blinded Therapy|Withdrawal by Subject|18
57489|NCT01285609|227032|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
57490|NCT01285609|227033|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
57491|NCT01285609|227032|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
57492|NCT01285609|227033|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
57493|NCT01285609|227032|P2|Treated With Blinded Therapy|Progressive Disease|305
57494|NCT01285609|227033|P1|Treated With Blinded Therapy|Progressive Disease|220
57495|NCT01285609|227032|P2|Randomized|Randomized but not Treated|4
57496|NCT01285609|227033|P1|Randomized|Randomized but not Treated|4
57497|NCT01285609|227032|P2|Randomized|Undisclosed Reasons|0
57498|NCT01285609|227033|P1|Randomized|Undisclosed Reasons|1
57499|NCT01285609|227032|P2|Randomized|Subject No Longer Met Study Criteria|1
57500|NCT01285609|227033|P1|Randomized|Subject No Longer Met Study Criteria|1
57501|NCT01285609|227032|P2|Randomized|Withdrawal by Subject|11
57502|NCT01285609|227033|P1|Randomized|Withdrawal by Subject|8
57503|NCT01285609|227032|P2|Randomized|Death|7
57504|NCT01285609|227033|P1|Randomized|Death|5
57505|NCT01285609|227032|P2|Randomized|Study Drug Toxicity|14
57506|NCT01285609|227033|P1|Randomized|Study Drug Toxicity|13
57507|NCT01285609|227032|P2|Randomized|Adverse Event Unrelated to Study Drug|18
57508|NCT01285609|227033|P1|Randomized|Adverse Event Unrelated to Study Drug|18
57509|NCT01285609|227032|P2|Randomized|Progressive Disease|61
57510|NCT01285609|227033|P1|Randomized|Progressive Disease|41
57511|NCT01285518|227051|P8|Overall Study|Lost to Follow-up|0
57512|NCT01285518|227052|P7|Overall Study|Lost to Follow-up|0
57513|NCT01285518|227053|P6|Overall Study|Lost to Follow-up|1
57514|NCT01285518|227054|P5|Overall Study|Lost to Follow-up|0
57515|NCT01285518|227055|P4|Overall Study|Lost to Follow-up|0
57516|NCT01285518|227056|P3|Overall Study|Lost to Follow-up|0
57517|NCT01285518|227057|P2|Overall Study|Lost to Follow-up|0
57518|NCT01285518|227058|P1|Overall Study|Lost to Follow-up|0
57519|NCT01285492|227318|P2|Overall Study|Death|0
57520|NCT01285492|227319|P1|Overall Study|Death|1
57521|NCT01285492|227318|P2|Overall Study|Withdrawal by Subject|1
57522|NCT01285492|227319|P1|Overall Study|Withdrawal by Subject|2
57523|NCT01285492|227318|P2|Overall Study|Protocol Violation|0
57524|NCT01285492|227319|P1|Overall Study|Protocol Violation|3
57525|NCT01285492|227318|P2|Overall Study|Adverse Event|0
57526|NCT01285492|227319|P1|Overall Study|Adverse Event|11
57527|NCT01285401|227351|P2|Overall Study|Prematurely withdrawn from the study|29
57528|NCT01285401|227352|P1|Overall Study|Prematurely withdrawn from the study|17
57529|NCT01285323|227392|P2|Overall Study|Not specified|3
57530|NCT01285323|227393|P1|Overall Study|Not specified|1
57531|NCT01285323|227392|P2|Overall Study|Lost to Follow-up|1
57532|NCT01285323|227393|P1|Overall Study|Lost to Follow-up|1
57533|NCT01285323|227392|P2|Overall Study|Non-compliance with study procedures|3
57534|NCT01285323|227393|P1|Overall Study|Non-compliance with study procedures|2
57535|NCT01285323|227392|P2|Overall Study|Protocol Violation|2
57536|NCT01285323|227393|P1|Overall Study|Protocol Violation|1
57537|NCT01285323|227392|P2|Overall Study|Withdrawal by Subject|11
57538|NCT01285323|227393|P1|Overall Study|Withdrawal by Subject|15
57539|NCT01285323|227392|P2|Overall Study|Lack of Efficacy|2
57540|NCT01285323|227393|P1|Overall Study|Lack of Efficacy|4
57541|NCT01285323|227392|P2|Overall Study|Adverse Event|8
57542|NCT01285323|227393|P1|Overall Study|Adverse Event|9
57543|NCT01285310|227428|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
57544|NCT01285310|227429|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
57545|NCT01285310|227430|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
57546|NCT01285310|227431|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
57547|NCT01285310|227432|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
57548|NCT01285310|227428|P5|Active Treatment Phase: Weeks 25-52|Not Specified|0
57549|NCT01285310|227429|P4|Active Treatment Phase: Weeks 25-52|Not Specified|0
57550|NCT01285310|227430|P3|Active Treatment Phase: Weeks 25-52|Not Specified|0
57551|NCT01285310|227431|P2|Active Treatment Phase: Weeks 25-52|Not Specified|1
57552|NCT01285310|227432|P1|Active Treatment Phase: Weeks 25-52|Not Specified|0
57553|NCT01285310|227428|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
57554|NCT01285310|227429|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
57555|NCT01285310|227430|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
57556|NCT01285310|227431|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
57557|NCT01285310|227432|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
57558|NCT01285310|227428|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
57559|NCT01285310|227429|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
57560|NCT01285310|227430|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
57561|NCT01285310|227431|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
57562|NCT01285310|227432|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
57563|NCT01285310|227428|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
57564|NCT01285310|227429|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
57565|NCT01285310|227430|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
57566|NCT01285310|227431|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
57567|NCT01285310|227432|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
57568|NCT01285310|227428|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
57569|NCT01285310|227429|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
57570|NCT01285310|227430|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
57571|NCT01285310|227431|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
57572|NCT01285310|227432|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
57573|NCT01285310|227428|P5|Placebo Controlled Phase: Weeks 0-24|Not specified|0
57574|NCT01285310|227429|P4|Placebo Controlled Phase: Weeks 0-24|Not specified|0
57575|NCT01285310|227430|P3|Placebo Controlled Phase: Weeks 0-24|Not specified|1
57576|NCT01285310|227431|P2|Placebo Controlled Phase: Weeks 0-24|Not specified|0
57577|NCT01285310|227432|P1|Placebo Controlled Phase: Weeks 0-24|Not specified|1
57578|NCT01285310|227428|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
57579|NCT01285310|227429|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
57580|NCT01285310|227430|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
57581|NCT01285310|227431|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
57582|NCT01285310|227432|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
57583|NCT01285310|227428|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
57584|NCT01285310|227429|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
57585|NCT01285310|227430|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
57586|NCT01285310|227431|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
57587|NCT01285310|227432|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
57588|NCT01285310|227428|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
57589|NCT01285310|227429|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
57590|NCT01285310|227430|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
57591|NCT01285310|227431|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
57592|NCT01285310|227432|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
57593|NCT01285310|227428|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
57594|NCT01285310|227429|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
57595|NCT01285310|227430|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
57596|NCT01285310|227431|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
57597|NCT01285310|227432|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
57598|NCT01285310|227428|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
57599|NCT01285310|227429|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
57600|NCT01285310|227430|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
57601|NCT01285310|227431|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
57602|NCT01285310|227432|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
57603|NCT01284959|227697|P3|Overall Study|Adverse Event|1
57604|NCT01284959|227698|P2|Overall Study|Adverse Event|0
57605|NCT01284959|227699|P1|Overall Study|Adverse Event|0
57606|NCT01284959|227697|P3|Overall Study|Withdrawal by Subject|0
57607|NCT01284959|227698|P2|Overall Study|Withdrawal by Subject|0
57608|NCT01284959|227699|P1|Overall Study|Withdrawal by Subject|1
57609|NCT01284634|227729|P4|Overall Study|Adverse Event|1
57610|NCT01284634|227730|P3|Overall Study|Adverse Event|2
57611|NCT01284634|227731|P2|Overall Study|Adverse Event|0
57612|NCT01284634|227732|P1|Overall Study|Adverse Event|1
57613|NCT01284621|227874|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
57614|NCT01284621|227875|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
57615|NCT01284621|227876|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
57616|NCT01284621|227877|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
57617|NCT01284621|227878|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
57618|NCT01284621|227879|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
57619|NCT01284504|227936|P2|Overall Study|Withdrawal by Subject|0
57620|NCT01284504|227937|P1|Overall Study|Withdrawal by Subject|1
57621|NCT01284491|227943|P1|Overall Study|Study termination|13
57622|NCT01284361|227953|P1|Overall Study|Lost to Follow-up|2
57623|NCT01284361|227953|P1|Overall Study|Adverse Event|1
57624|NCT01284361|227953|P1|Overall Study|Protocol Violation|5
57625|NCT01284361|227953|P1|Overall Study|Withdrawal by Subject|1
57626|NCT01284114|227974|P1|Overall Study|dizziness|1
57627|NCT01284114|227974|P1|Overall Study|Symptomatic hypotension|1
57628|NCT01284114|227974|P1|Overall Study|From the results of ALLTITUDE study|1
57629|NCT01284114|227974|P1|Overall Study|viral infection|1
57630|NCT01284062|227986|P4|Overall Study|Site Closed|0
57631|NCT01284062|227987|P3|Overall Study|Site Closed|1
57632|NCT01284062|227988|P2|Overall Study|Site Closed|0
57633|NCT01284062|227989|P1|Overall Study|Site Closed|0
57634|NCT01284062|227986|P4|Overall Study|Unspecified|1
57635|NCT01284062|227987|P3|Overall Study|Unspecified|0
57636|NCT01284062|227988|P2|Overall Study|Unspecified|0
57637|NCT01284062|227989|P1|Overall Study|Unspecified|0
57638|NCT01284062|227986|P4|Overall Study|Withdrawal by Subject|5
57639|NCT01284062|227987|P3|Overall Study|Withdrawal by Subject|2
57640|NCT01284062|227988|P2|Overall Study|Withdrawal by Subject|1
57641|NCT01284062|227989|P1|Overall Study|Withdrawal by Subject|3
57642|NCT01284062|227986|P4|Overall Study|Protocol Violation|2
57643|NCT01284062|227987|P3|Overall Study|Protocol Violation|0
57644|NCT01284062|227988|P2|Overall Study|Protocol Violation|0
57645|NCT01284062|227989|P1|Overall Study|Protocol Violation|1
57646|NCT01284062|227986|P4|Overall Study|Medication error without adverse event|0
57647|NCT01284062|227987|P3|Overall Study|Medication error without adverse event|1
57648|NCT01284062|227988|P2|Overall Study|Medication error without adverse event|0
57649|NCT01284062|227989|P1|Overall Study|Medication error without adverse event|0
57650|NCT01284062|227986|P4|Overall Study|Lack of Efficacy|1
57651|NCT01284062|227987|P3|Overall Study|Lack of Efficacy|2
57652|NCT01284062|227988|P2|Overall Study|Lack of Efficacy|2
57653|NCT01284062|227989|P1|Overall Study|Lack of Efficacy|3
57654|NCT01284062|227986|P4|Overall Study|Adverse Event|5
57655|NCT01284062|227987|P3|Overall Study|Adverse Event|0
57656|NCT01284062|227988|P2|Overall Study|Adverse Event|5
57657|NCT01284062|227989|P1|Overall Study|Adverse Event|4
57658|NCT01283971|228063|P2|Overall Study|Administrative reasons|1
57659|NCT01283971|228064|P1|Overall Study|Administrative reasons|1
57660|NCT01283971|228063|P2|Overall Study|Failure to return|1
57661|NCT01283971|228064|P1|Overall Study|Failure to return|0
57662|NCT01283971|228063|P2|Overall Study|Refused treatment|1
57663|NCT01283971|228064|P1|Overall Study|Refused treatment|3
57664|NCT01283971|228063|P2|Overall Study|Protocol Violation|1
57665|NCT01283971|228064|P1|Overall Study|Protocol Violation|5
57666|NCT01283971|228063|P2|Overall Study|Insufficient therapeutic responses|3
57667|NCT01283971|228064|P1|Overall Study|Insufficient therapeutic responses|3
57668|NCT01283971|228063|P2|Overall Study|Adverse Event|5
57669|NCT01283971|228064|P1|Overall Study|Adverse Event|3
57670|NCT01283581|228111|P3|Overall Study|"Early termination"|1
57671|NCT01283581|228112|P2|Overall Study|"Early termination"|0
57672|NCT01283581|228113|P1|Overall Study|"Early termination"|0
57673|NCT01283581|228111|P3|Overall Study|Investigator unblinded|1
57674|NCT01283581|228112|P2|Overall Study|Investigator unblinded|0
57675|NCT01283581|228113|P1|Overall Study|Investigator unblinded|0
57676|NCT01283581|228111|P3|Overall Study|Noncompliance|0
57677|NCT01283581|228112|P2|Overall Study|Noncompliance|0
57678|NCT01283581|228113|P1|Overall Study|Noncompliance|1
57679|NCT01283581|228111|P3|Overall Study|Protocol Violation|2
57680|NCT01283581|228112|P2|Overall Study|Protocol Violation|1
57681|NCT01283581|228113|P1|Overall Study|Protocol Violation|0
57682|NCT01283581|228111|P3|Overall Study|Physician Decision|2
57683|NCT01283581|228112|P2|Overall Study|Physician Decision|1
57684|NCT01283581|228113|P1|Overall Study|Physician Decision|0
57685|NCT01283581|228111|P3|Overall Study|Adverse Event|4
57686|NCT01283581|228112|P2|Overall Study|Adverse Event|1
57687|NCT01283581|228113|P1|Overall Study|Adverse Event|1
57688|NCT01283581|228111|P3|Overall Study|Withdrawal by Subject|2
57689|NCT01283581|228112|P2|Overall Study|Withdrawal by Subject|5
57690|NCT01283581|228113|P1|Overall Study|Withdrawal by Subject|2
57691|NCT01283581|228111|P3|Overall Study|Lost to Follow-up|8
57692|NCT01283581|228112|P2|Overall Study|Lost to Follow-up|6
57693|NCT01283581|228113|P1|Overall Study|Lost to Follow-up|8
57694|NCT01283516|228177|P9|Overall Study|Withdrawal by Subject|11
57695|NCT01283516|228178|P8|Overall Study|Withdrawal by Subject|0
57696|NCT01283516|228179|P7|Overall Study|Withdrawal by Subject|0
57697|NCT01283516|228180|P6|Overall Study|Withdrawal by Subject|0
57698|NCT01283516|228181|P5|Overall Study|Withdrawal by Subject|1
57699|NCT01283516|228182|P4|Overall Study|Withdrawal by Subject|0
57700|NCT01283516|228183|P3|Overall Study|Withdrawal by Subject|0
57701|NCT01283516|228184|P2|Overall Study|Withdrawal by Subject|0
57702|NCT01283516|228185|P1|Overall Study|Withdrawal by Subject|0
57703|NCT01283516|228177|P9|Overall Study|Disease Progression|81
57704|NCT01283516|228178|P8|Overall Study|Disease Progression|2
57705|NCT01283516|228179|P7|Overall Study|Disease Progression|6
57706|NCT01283516|228180|P6|Overall Study|Disease Progression|7
57707|NCT01283516|228181|P5|Overall Study|Disease Progression|12
57708|NCT01283516|228182|P4|Overall Study|Disease Progression|3
57709|NCT01283516|228183|P3|Overall Study|Disease Progression|2
57710|NCT01283516|228184|P2|Overall Study|Disease Progression|2
57711|NCT01283516|228185|P1|Overall Study|Disease Progression|2
57712|NCT01283516|228177|P9|Overall Study|Death|6
57713|NCT01283516|228178|P8|Overall Study|Death|1
57714|NCT01283516|228179|P7|Overall Study|Death|0
57715|NCT01283516|228180|P6|Overall Study|Death|1
57716|NCT01283516|228181|P5|Overall Study|Death|0
57717|NCT01283516|228182|P4|Overall Study|Death|0
57718|NCT01283516|228183|P3|Overall Study|Death|0
57719|NCT01283516|228184|P2|Overall Study|Death|0
57720|NCT01283516|228185|P1|Overall Study|Death|0
57721|NCT01283516|228177|P9|Overall Study|Adverse Event|24
57722|NCT01283516|228178|P8|Overall Study|Adverse Event|0
57723|NCT01283516|228179|P7|Overall Study|Adverse Event|2
57724|NCT01283516|228180|P6|Overall Study|Adverse Event|0
57725|NCT01283516|228181|P5|Overall Study|Adverse Event|0
57726|NCT01283516|228182|P4|Overall Study|Adverse Event|0
57727|NCT01283516|228183|P3|Overall Study|Adverse Event|0
57728|NCT01283516|228184|P2|Overall Study|Adverse Event|0
57729|NCT01283516|228185|P1|Overall Study|Adverse Event|0
57730|NCT01283464|228209|P2|Overall Study|Physician Decision|0
57731|NCT01283464|228210|P1|Overall Study|Physician Decision|1
57732|NCT01283464|228209|P2|Overall Study|Withdrawal by Subject|0
57733|NCT01283464|228210|P1|Overall Study|Withdrawal by Subject|1
57734|NCT01283464|228209|P2|Overall Study|Lost to Follow-up|1
57735|NCT01283464|228210|P1|Overall Study|Lost to Follow-up|0
57736|NCT01283334|228216|P1|Overall Study|Physician Decision|1
57737|NCT01283334|228216|P1|Overall Study|Adverse Event|4
57738|NCT01283334|228216|P1|Overall Study|Inability to Swallow Everolimus Pills|1
57739|NCT01283334|228216|P1|Overall Study|Withdrawal by Subject|1
57740|NCT01283282|228231|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
57741|NCT01283282|228232|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
57742|NCT01283282|228231|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
57743|NCT01283282|228232|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
57744|NCT01283282|228231|P2|First Intervention (6 Weeks)|Physician Decision|1
57745|NCT01283282|228232|P1|First Intervention (6 Weeks)|Physician Decision|0
57746|NCT01283152|228252|P2|Overall Study|Refused HESA|0
57747|NCT01283152|228253|P1|Overall Study|Refused HESA|1
57748|NCT01283152|228252|P2|Overall Study|Discharged prior to 24 hr assessment|0
57749|NCT01283152|228253|P1|Overall Study|Discharged prior to 24 hr assessment|1
57750|NCT01283139|228267|P4|Overall Study|Participant randomized in error|0
57751|NCT01283139|228268|P3|Overall Study|Participant randomized in error|1
57752|NCT01283139|228269|P2|Overall Study|Participant randomized in error|0
57753|NCT01283139|228270|P1|Overall Study|Participant randomized in error|0
57754|NCT01283139|228267|P4|Overall Study|Missed follow-up visit|2
57755|NCT01283139|228268|P3|Overall Study|Missed follow-up visit|2
57756|NCT01283139|228269|P2|Overall Study|Missed follow-up visit|1
57757|NCT01283139|228270|P1|Overall Study|Missed follow-up visit|0
57758|NCT01283139|228267|P4|Overall Study|Pregnancy|0
57759|NCT01283139|228268|P3|Overall Study|Pregnancy|1
57760|NCT01283139|228269|P2|Overall Study|Pregnancy|1
57761|NCT01283139|228270|P1|Overall Study|Pregnancy|0
57762|NCT01283139|228267|P4|Overall Study|Participant's refusal to continue|1
57763|NCT01283139|228268|P3|Overall Study|Participant's refusal to continue|1
57764|NCT01283139|228269|P2|Overall Study|Participant's refusal to continue|3
57765|NCT01283139|228270|P1|Overall Study|Participant's refusal to continue|0
57766|NCT01283139|228267|P4|Overall Study|Early termination due to AE/SAE|0
57767|NCT01283139|228268|P3|Overall Study|Early termination due to AE/SAE|0
57768|NCT01283139|228269|P2|Overall Study|Early termination due to AE/SAE|1
57769|NCT01283139|228270|P1|Overall Study|Early termination due to AE/SAE|1
57770|NCT01283139|228267|P4|Overall Study|Lack of Efficacy|1
57771|NCT01283139|228268|P3|Overall Study|Lack of Efficacy|2
57772|NCT01283139|228269|P2|Overall Study|Lack of Efficacy|2
57773|NCT01283139|228270|P1|Overall Study|Lack of Efficacy|1
57774|NCT01283139|228267|P4|Overall Study|Death|2
57775|NCT01283139|228268|P3|Overall Study|Death|2
57776|NCT01283139|228269|P2|Overall Study|Death|0
57777|NCT01283139|228270|P1|Overall Study|Death|2
57778|NCT01283139|228267|P4|Overall Study|Withdrawal by Subject|8
57779|NCT01283139|228268|P3|Overall Study|Withdrawal by Subject|6
57780|NCT01283139|228269|P2|Overall Study|Withdrawal by Subject|8
57781|NCT01283139|228270|P1|Overall Study|Withdrawal by Subject|8
57782|NCT01283139|228267|P4|Overall Study|Lost to Follow-up|1
57783|NCT01283139|228268|P3|Overall Study|Lost to Follow-up|3
57784|NCT01283139|228269|P2|Overall Study|Lost to Follow-up|2
57785|NCT01283139|228270|P1|Overall Study|Lost to Follow-up|5
57786|NCT01283035|228312|P1|Overall Study|Subject later found ineligible|1
57787|NCT01282866|228327|P1|Overall Study|Adverse Event|1
57788|NCT01282814|228335|P2|Washout of 7 Days|Withdrawal by Subject|0
57789|NCT01282814|228336|P1|Washout of 7 Days|Withdrawal by Subject|2
57790|NCT01282814|228335|P2|First Intervention|Emesis During Dosing Interval|3
57791|NCT01282814|228336|P1|First Intervention|Emesis During Dosing Interval|0
57792|NCT01282801|228348|P2|Second Intervention|Emesis During Critical Breakfast|1
57793|NCT01282801|228349|P1|Second Intervention|Emesis During Critical Breakfast|0
57794|NCT01282476|228373|P1|Overall Study|Death|11
57795|NCT01282424|228379|P1|Overall Study|Investigator Request|7
57796|NCT01282424|228379|P1|Overall Study|Withdrew Consent|4
57797|NCT01282424|228379|P1|Overall Study|Adverse Event|25
57798|NCT01282424|228379|P1|Overall Study|Treatment Ongoing|40
57799|NCT01282372|228396|P1|Overall Study|Adverse Event|12
57800|NCT01282372|228396|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
57801|NCT01282372|228396|P1|Overall Study|Presence of AE, Regression of Symptoms|1
57802|NCT01282372|228396|P1|Overall Study|Presence of AE, Lack of Efficacy|1
57803|NCT01282372|228396|P1|Overall Study|Death|1
57804|NCT01282372|228396|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
57805|NCT01282372|228396|P1|Overall Study|Withdrawal by Subject|11
57806|NCT01282372|228396|P1|Overall Study|Lost to Follow-up|23
57807|NCT01282372|228396|P1|Overall Study|Lack of Efficacy / Exacerbation|25
57808|NCT01282294|228424|P1|Overall Study|Physician Decision|1
57809|NCT01282294|228424|P1|Overall Study|Patient non-compliance|2
57810|NCT01282294|228424|P1|Overall Study|Adverse Event|1
57811|NCT01282294|228424|P1|Overall Study|Screening failure|1
57812|NCT01282294|228424|P1|Overall Study|Lost to Follow-up|14
57813|NCT01282229|228453|P1|Overall Study|Protocol Violation|2
57814|NCT01282203|228483|P1|Overall Study|Adverse Event|1
57815|NCT01282164|228505|P2|Overall Study|Lack of hypoglycemia during ITT|0
57816|NCT01282164|228506|P1|Overall Study|Lack of hypoglycemia during ITT|1
57817|NCT01281917|228557|P1|Overall Study|Withdrawal by Subject|1
57818|NCT01281865|228569|P2|Overall Study|Lack of Efficacy|0
57819|NCT01281865|228570|P1|Overall Study|Lack of Efficacy|1
57820|NCT01281865|228569|P2|Overall Study|Withdrawal by Subject|0
57821|NCT01281865|228570|P1|Overall Study|Withdrawal by Subject|1
57822|NCT01281865|228569|P2|Overall Study|Adverse Event|1
57823|NCT01281865|228570|P1|Overall Study|Adverse Event|1
57824|NCT01281839|228578|P2|Overall Study|Reason not specified|1
57825|NCT01281839|228579|P1|Overall Study|Reason not specified|0
57826|NCT01281839|228578|P2|Overall Study|Withdrawal by Subject|10
57827|NCT01281839|228579|P1|Overall Study|Withdrawal by Subject|4
57828|NCT01281839|228578|P2|Overall Study|Lost to Follow-up|3
57829|NCT01281839|228579|P1|Overall Study|Lost to Follow-up|6
57830|NCT01281644|228640|P1|Overall Study|Withdrawal by Subject|2
57831|NCT01281644|228640|P1|Overall Study|Lost to Follow-up|3
57832|NCT01281306|228681|P7|Overall Study|Randomized in error|0
57833|NCT01281306|228682|P6|Overall Study|Randomized in error|0
57834|NCT01281306|228683|P5|Overall Study|Randomized in error|0
57835|NCT01281306|228684|P4|Overall Study|Randomized in error|1
57836|NCT01281306|228685|P3|Overall Study|Randomized in error|0
57837|NCT01281306|228686|P2|Overall Study|Randomized in error|0
57838|NCT01281306|228687|P1|Overall Study|Randomized in error|1
57839|NCT01281306|228681|P7|Overall Study|Adverse Event|3
57840|NCT01281306|228682|P6|Overall Study|Adverse Event|3
57841|NCT01281306|228683|P5|Overall Study|Adverse Event|5
57842|NCT01281306|228684|P4|Overall Study|Adverse Event|3
57843|NCT01281306|228685|P3|Overall Study|Adverse Event|2
57844|NCT01281306|228686|P2|Overall Study|Adverse Event|2
57845|NCT01281306|228687|P1|Overall Study|Adverse Event|3
57846|NCT01281306|228681|P7|Overall Study|Death|0
57847|NCT01281306|228682|P6|Overall Study|Death|0
57848|NCT01281306|228683|P5|Overall Study|Death|0
57849|NCT01281306|228684|P4|Overall Study|Death|0
57850|NCT01281306|228685|P3|Overall Study|Death|0
57851|NCT01281306|228686|P2|Overall Study|Death|0
57852|NCT01281306|228687|P1|Overall Study|Death|1
57853|NCT01281306|228681|P7|Overall Study|Lost to Follow-up|1
57854|NCT01281306|228682|P6|Overall Study|Lost to Follow-up|0
57855|NCT01281306|228683|P5|Overall Study|Lost to Follow-up|0
57856|NCT01281306|228684|P4|Overall Study|Lost to Follow-up|2
57857|NCT01281306|228685|P3|Overall Study|Lost to Follow-up|0
57858|NCT01281306|228686|P2|Overall Study|Lost to Follow-up|0
57859|NCT01281306|228687|P1|Overall Study|Lost to Follow-up|1
57860|NCT01281306|228681|P7|Overall Study|Condition no longer requires study drug|1
57861|NCT01281306|228682|P6|Overall Study|Condition no longer requires study drug|1
57862|NCT01281306|228683|P5|Overall Study|Condition no longer requires study drug|0
57863|NCT01281306|228684|P4|Overall Study|Condition no longer requires study drug|0
57864|NCT01281306|228685|P3|Overall Study|Condition no longer requires study drug|0
57865|NCT01281306|228686|P2|Overall Study|Condition no longer requires study drug|0
57866|NCT01281306|228687|P1|Overall Study|Condition no longer requires study drug|1
57867|NCT01281306|228681|P7|Overall Study|Protocol deviation|0
57868|NCT01281306|228682|P6|Overall Study|Protocol deviation|0
57869|NCT01281306|228683|P5|Overall Study|Protocol deviation|1
57870|NCT01281306|228684|P4|Overall Study|Protocol deviation|1
57871|NCT01281306|228685|P3|Overall Study|Protocol deviation|1
57872|NCT01281306|228686|P2|Overall Study|Protocol deviation|1
57873|NCT01281306|228687|P1|Overall Study|Protocol deviation|0
57874|NCT01281306|228681|P7|Overall Study|Withdrawal by Subject|1
57875|NCT01281306|228682|P6|Overall Study|Withdrawal by Subject|3
57876|NCT01281306|228683|P5|Overall Study|Withdrawal by Subject|1
57877|NCT01281306|228684|P4|Overall Study|Withdrawal by Subject|4
57878|NCT01281306|228685|P3|Overall Study|Withdrawal by Subject|2
57879|NCT01281306|228686|P2|Overall Study|Withdrawal by Subject|0
57880|NCT01281306|228687|P1|Overall Study|Withdrawal by Subject|1
57881|NCT01281306|228681|P7|Overall Study|Lack of Efficacy|1
57882|NCT01281306|228682|P6|Overall Study|Lack of Efficacy|0
57883|NCT01281306|228683|P5|Overall Study|Lack of Efficacy|2
57884|NCT01281306|228684|P4|Overall Study|Lack of Efficacy|0
57885|NCT01281306|228685|P3|Overall Study|Lack of Efficacy|3
57886|NCT01281306|228686|P2|Overall Study|Lack of Efficacy|1
57887|NCT01281306|228687|P1|Overall Study|Lack of Efficacy|0
57888|NCT01281202|228803|P2|Overall Study|Incarceration|3
57889|NCT01281202|228804|P1|Overall Study|Incarceration|0
57890|NCT01281202|228803|P2|Overall Study|Lost to Follow-up|13
57891|NCT01281202|228804|P1|Overall Study|Lost to Follow-up|11
57892|NCT01281202|228803|P2|Overall Study|Administrative|8
57893|NCT01281202|228804|P1|Overall Study|Administrative|2
57894|NCT01281202|228803|P2|Overall Study|Protocol Violation|10
57895|NCT01281202|228804|P1|Overall Study|Protocol Violation|11
57896|NCT01281202|228803|P2|Overall Study|Withdrawal by Subject|2
57897|NCT01281202|228804|P1|Overall Study|Withdrawal by Subject|2
57898|NCT01281202|228803|P2|Overall Study|Adverse Event|0
57899|NCT01281202|228804|P1|Overall Study|Adverse Event|2
57900|NCT01281124|228812|P1|Overall Study|Death|1
57901|NCT01280981|228827|P1|Overall Study|Study site closure|1
57902|NCT01280981|228827|P1|Overall Study|Elective surgery|2
57903|NCT01280981|228827|P1|Overall Study|Withdrawal of consent|3
57904|NCT01280981|228827|P1|Overall Study|Non-compliance with protocol|3
57905|NCT01280981|228827|P1|Overall Study|Failed to return|45
57906|NCT01280981|228827|P1|Overall Study|Irregular or discontinued menses|3
57907|NCT01280981|228827|P1|Overall Study|Adverse Event|6
57908|NCT01280981|228827|P1|Overall Study|Lost to Follow-up|3
57909|NCT01280981|228827|P1|Overall Study|Lack of Efficacy|13
57910|NCT01280981|228827|P1|Overall Study|Protocol Violation|2
57911|NCT01280981|228827|P1|Overall Study|Withdrawal by Subject|11
57912|NCT01280968|228838|P2|Overall Study|Unable to Smoke in Supine Position|0
57913|NCT01280968|228839|P1|Overall Study|Unable to Smoke in Supine Position|1
57914|NCT01280968|228838|P2|Overall Study|Pre-existing Neurological Condition|0
57915|NCT01280968|228839|P1|Overall Study|Pre-existing Neurological Condition|1
57916|NCT01280968|228838|P2|Overall Study|Scheduling Conflicts|1
57917|NCT01280968|228839|P1|Overall Study|Scheduling Conflicts|1
57918|NCT01280968|228838|P2|Overall Study|Adverse Event|0
57919|NCT01280968|228839|P1|Overall Study|Adverse Event|1
57920|NCT01280968|228838|P2|Overall Study|Anxiety|0
57921|NCT01280968|228839|P1|Overall Study|Anxiety|2
57922|NCT01280968|228838|P2|Overall Study|Commuting Problems|0
57923|NCT01280968|228839|P1|Overall Study|Commuting Problems|2
57924|NCT01280968|228838|P2|Overall Study|Unable to Follow Experimental Protocol|0
57925|NCT01280968|228839|P1|Overall Study|Unable to Follow Experimental Protocol|2
57926|NCT01280968|228838|P2|Overall Study|Lost to Follow-up|2
57927|NCT01280968|228839|P1|Overall Study|Lost to Follow-up|8
57928|NCT01280955|228855|P1|Overall Study|Withdrawal by Subject|1
57929|NCT01280955|228855|P1|Overall Study|Death|2
57930|NCT01280656|228935|P3|Overall Study|Other|7
57931|NCT01280656|228936|P2|Overall Study|Other|7
57932|NCT01280656|228937|P1|Overall Study|Other|1
57933|NCT01280656|228935|P3|Overall Study|Treatment shortening (RGT)|5
57934|NCT01280656|228936|P2|Overall Study|Treatment shortening (RGT)|4
57935|NCT01280656|228937|P1|Overall Study|Treatment shortening (RGT)|0
57936|NCT01280656|228935|P3|Overall Study|Lack of Efficacy|38
57937|NCT01280656|228936|P2|Overall Study|Lack of Efficacy|22
57938|NCT01280656|228937|P1|Overall Study|Lack of Efficacy|1
57939|NCT01280656|228935|P3|Overall Study|Adverse Event|13
57940|NCT01280656|228936|P2|Overall Study|Adverse Event|14
57941|NCT01280656|228937|P1|Overall Study|Adverse Event|1
57942|NCT01280591|229004|P4|Overall Study|Does not meet exclusion #27 criteria|1
57943|NCT01280591|229005|P3|Overall Study|Does not meet exclusion #27 criteria|0
57944|NCT01280591|229006|P2|Overall Study|Does not meet exclusion #27 criteria|0
57945|NCT01280591|229007|P1|Overall Study|Does not meet exclusion #27 criteria|0
57946|NCT01280591|229004|P4|Overall Study|Withdrawal by Subject|2
57947|NCT01280591|229005|P3|Overall Study|Withdrawal by Subject|0
57948|NCT01280591|229006|P2|Overall Study|Withdrawal by Subject|0
57949|NCT01280591|229007|P1|Overall Study|Withdrawal by Subject|0
57950|NCT01280357|229112|P1|Overall Study|IInsufficient data/No data supplied|12
57951|NCT01280357|229112|P1|Overall Study|Excluded no internal monitoring|14
57952|NCT01280266|229121|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
57953|NCT01280266|229122|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
57954|NCT01280266|229121|P2|First Intervention (Week 1-4)|Adverse Event|0
57955|NCT01280266|229122|P1|First Intervention (Week 1-4)|Adverse Event|1
57956|NCT01279447|229194|P2|Overall Study|Lost to Follow-up|1
57957|NCT01279447|229195|P1|Overall Study|Lost to Follow-up|3
57958|NCT01279200|229222|P2|Overall Study|Adverse Event|0
57959|NCT01279200|229223|P1|Overall Study|Adverse Event|1
57960|NCT01279200|229222|P2|Overall Study|Lost to Follow-up|1
57961|NCT01279200|229223|P1|Overall Study|Lost to Follow-up|0
57962|NCT01279200|229222|P2|Overall Study|ultrasound screening failure|1
57963|NCT01279200|229223|P1|Overall Study|ultrasound screening failure|0
57964|NCT01279200|229222|P2|Overall Study|Inconvenience of ultrasound visit|1
57965|NCT01279200|229223|P1|Overall Study|Inconvenience of ultrasound visit|0
57966|NCT01279200|229222|P2|Overall Study|Patient withdrawal due to high cost|1
57967|NCT01279200|229223|P1|Overall Study|Patient withdrawal due to high cost|0
57968|NCT01279200|229222|P2|Overall Study|Withdrawal by Subject|3
57969|NCT01279200|229223|P1|Overall Study|Withdrawal by Subject|1
57970|NCT01279070|229244|P2|Overall Study|Acute exacerbation|1
57971|NCT01279070|229245|P1|Overall Study|Acute exacerbation|3
57972|NCT01279070|229244|P2|Overall Study|Withdrawal by Subject|3
57973|NCT01279070|229245|P1|Overall Study|Withdrawal by Subject|2
57974|NCT01279044|229264|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
57975|NCT01279044|229265|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
57976|NCT01279044|229266|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
57977|NCT01279044|229264|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
57978|NCT01279044|229265|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
57979|NCT01279044|229266|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
57980|NCT01279044|229264|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
57981|NCT01279044|229265|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
57982|NCT01279044|229266|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
57983|NCT01278797|229340|P2|Period 1|Protocol Violation|0
57984|NCT01278797|229341|P1|Period 1|Protocol Violation|1
57985|NCT01278797|229340|P2|Period 1|Adverse Event|1
57986|NCT01278797|229341|P1|Period 1|Adverse Event|0
57987|NCT01278745|229353|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
57988|NCT01278745|229354|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
57989|NCT01278745|229355|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
57990|NCT01278745|229356|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
57991|NCT01278745|229353|P4|Overall Study|Ineligible|61
57992|NCT01278745|229354|P3|Overall Study|Ineligible|42
57993|NCT01278745|229355|P2|Overall Study|Ineligible|0
57994|NCT01278745|229356|P1|Overall Study|Ineligible|0
57995|NCT01278745|229353|P4|Overall Study|Sponsor Decision|6
57996|NCT01278745|229354|P3|Overall Study|Sponsor Decision|62
57997|NCT01278745|229355|P2|Overall Study|Sponsor Decision|0
57998|NCT01278745|229356|P1|Overall Study|Sponsor Decision|1
57999|NCT01278745|229353|P4|Overall Study|Withdrawal by Subject|1
58000|NCT01278745|229354|P3|Overall Study|Withdrawal by Subject|5
58001|NCT01278745|229355|P2|Overall Study|Withdrawal by Subject|1
58002|NCT01278745|229356|P1|Overall Study|Withdrawal by Subject|1
58003|NCT01278745|229353|P4|Overall Study|Physician Decision|9
58004|NCT01278745|229354|P3|Overall Study|Physician Decision|0
58005|NCT01278745|229355|P2|Overall Study|Physician Decision|0
58006|NCT01278745|229356|P1|Overall Study|Physician Decision|1
58007|NCT01278745|229353|P4|Overall Study|Death|0
58008|NCT01278745|229354|P3|Overall Study|Death|7
58009|NCT01278745|229355|P2|Overall Study|Death|5
58010|NCT01278745|229356|P1|Overall Study|Death|2
58011|NCT01278615|229388|P1|Overall Study|Withdrawal by Subject|2
58012|NCT01278407|229414|P5|Extension Phase|Not Specified|3
58013|NCT01278407|229415|P4|Extension Phase|Not Specified|1
58014|NCT01278407|229416|P3|Extension Phase|Not Specified|0
58015|NCT01278407|229417|P2|Extension Phase|Not Specified|0
58016|NCT01278407|229418|P1|Extension Phase|Not Specified|0
58017|NCT01278407|229414|P5|Extension Phase|Participant's Choice|11
58018|NCT01278407|229415|P4|Extension Phase|Participant's Choice|4
58019|NCT01278407|229416|P3|Extension Phase|Participant's Choice|0
58020|NCT01278407|229417|P2|Extension Phase|Participant's Choice|0
58021|NCT01278407|229418|P1|Extension Phase|Participant's Choice|0
58022|NCT01278407|229414|P5|Extension Phase|Adverse Event|16
58023|NCT01278407|229415|P4|Extension Phase|Adverse Event|7
58024|NCT01278407|229416|P3|Extension Phase|Adverse Event|0
58025|NCT01278407|229417|P2|Extension Phase|Adverse Event|0
58026|NCT01278407|229418|P1|Extension Phase|Adverse Event|0
58027|NCT01278407|229414|P5|Confirmatory Phase|Not Specified|0
58028|NCT01278407|229415|P4|Confirmatory Phase|Not Specified|0
58029|NCT01278407|229416|P3|Confirmatory Phase|Not Specified|2
58030|NCT01278407|229417|P2|Confirmatory Phase|Not Specified|1
58031|NCT01278407|229418|P1|Confirmatory Phase|Not Specified|1
58032|NCT01278407|229414|P5|Confirmatory Phase|Participant's Choice|0
58033|NCT01278407|229415|P4|Confirmatory Phase|Participant's Choice|0
58034|NCT01278407|229416|P3|Confirmatory Phase|Participant's Choice|3
58035|NCT01278407|229417|P2|Confirmatory Phase|Participant's Choice|5
58036|NCT01278407|229418|P1|Confirmatory Phase|Participant's Choice|3
58037|NCT01278407|229414|P5|Confirmatory Phase|Adverse Event|0
58038|NCT01278407|229415|P4|Confirmatory Phase|Adverse Event|0
58039|NCT01278407|229416|P3|Confirmatory Phase|Adverse Event|1
58040|NCT01278407|229417|P2|Confirmatory Phase|Adverse Event|10
58041|NCT01278407|229418|P1|Confirmatory Phase|Adverse Event|5
58042|NCT01278394|229431|P1|Overall Study|Lost to Follow-up|1
58043|NCT01278342|229444|P3|Overall Study|Other|0
58044|NCT01278342|229445|P2|Overall Study|Other|0
58045|NCT01278342|229446|P1|Overall Study|Other|1
58046|NCT01278342|229444|P3|Overall Study|Administrative problems|0
58047|NCT01278342|229445|P2|Overall Study|Administrative problems|0
58048|NCT01278342|229446|P1|Overall Study|Administrative problems|2
58049|NCT01278342|229444|P3|Overall Study|Lost to Follow-up|0
58050|NCT01278342|229445|P2|Overall Study|Lost to Follow-up|0
58051|NCT01278342|229446|P1|Overall Study|Lost to Follow-up|1
58052|NCT01278342|229444|P3|Overall Study|Physician Decision|0
58053|NCT01278342|229445|P2|Overall Study|Physician Decision|1
58054|NCT01278342|229446|P1|Overall Study|Physician Decision|0
58055|NCT01278173|229466|P1|Overall Study|Withdrawal by Subject|1
58056|NCT01278173|229466|P1|Overall Study|Protocol Violation|1
58057|NCT01278173|229466|P1|Overall Study|Administrative or other reason|4
58058|NCT01278173|229466|P1|Overall Study|Adverse Event|8
58059|NCT01278173|229466|P1|Overall Study|Lack of Efficacy|13
58060|NCT01278160|229473|P2|Overall Study|Unclassified|2
58061|NCT01278160|229474|P1|Overall Study|Unclassified|1
58062|NCT01278160|229473|P2|Overall Study|Withdrawal by Subject|2
58063|NCT01278160|229474|P1|Overall Study|Withdrawal by Subject|3
58064|NCT01278160|229473|P2|Overall Study|Lost to Follow-up|1
58065|NCT01278160|229474|P1|Overall Study|Lost to Follow-up|0
58066|NCT01278160|229473|P2|Overall Study|Adverse Event|1
58067|NCT01278160|229474|P1|Overall Study|Adverse Event|1
58068|NCT01278030|229490|P2|Overall Study|Withdrawal by Subject|4
58069|NCT01278030|229491|P1|Overall Study|Withdrawal by Subject|8
58070|NCT01277861|229499|P2|Overall Study|Physician Decision|2
58071|NCT01277861|229500|P1|Overall Study|Physician Decision|2
58072|NCT01277822|229512|P2|Overall Study|Participant moved|0
58073|NCT01277822|229513|P1|Overall Study|Participant moved|1
58074|NCT01277822|229512|P2|Overall Study|Contraindicated medication used|1
58075|NCT01277822|229513|P1|Overall Study|Contraindicated medication used|2
58076|NCT01277822|229512|P2|Overall Study|Lost to Follow-up|1
58077|NCT01277822|229513|P1|Overall Study|Lost to Follow-up|2
58078|NCT01277822|229512|P2|Overall Study|Protocol Violation|0
58079|NCT01277822|229513|P1|Overall Study|Protocol Violation|1
58080|NCT01277822|229512|P2|Overall Study|Physician Decision|1
58081|NCT01277822|229513|P1|Overall Study|Physician Decision|1
58082|NCT01277822|229512|P2|Overall Study|Withdrawal by Subject|7
58083|NCT01277822|229513|P1|Overall Study|Withdrawal by Subject|6
58084|NCT01277822|229512|P2|Overall Study|Adverse Event|1
58085|NCT01277822|229513|P1|Overall Study|Adverse Event|2
58086|NCT01277757|229533|P1|Overall Study|Withdrawal by Subject|1
58087|NCT01277757|229533|P1|Overall Study|Disease Progression|1
58088|NCT01277718|229540|P2|Period 2 - Second Intervention|Physician Decision|2
58089|NCT01277718|229541|P1|Period 2 - Second Intervention|Physician Decision|0
58090|NCT01277718|229540|P2|Period 2 - Second Intervention|Protocol Violation|1
58091|NCT01277718|229541|P1|Period 2 - Second Intervention|Protocol Violation|0
58092|NCT01277601|229556|P4|Overall Study|Subject Terminated from Study by Sponsor|2
58093|NCT01277601|229557|P3|Overall Study|Subject Terminated from Study by Sponsor|0
58094|NCT01277601|229558|P2|Overall Study|Subject Terminated from Study by Sponsor|1
58095|NCT01277601|229559|P1|Overall Study|Subject Terminated from Study by Sponsor|0
58096|NCT01277601|229556|P4|Overall Study|Protocol Violation|0
58097|NCT01277601|229557|P3|Overall Study|Protocol Violation|5
58098|NCT01277601|229558|P2|Overall Study|Protocol Violation|2
58099|NCT01277601|229559|P1|Overall Study|Protocol Violation|0
58100|NCT01277601|229556|P4|Overall Study|Subject Never Dosed with Study Drug|1
58101|NCT01277601|229557|P3|Overall Study|Subject Never Dosed with Study Drug|3
58102|NCT01277601|229558|P2|Overall Study|Subject Never Dosed with Study Drug|2
58103|NCT01277601|229559|P1|Overall Study|Subject Never Dosed with Study Drug|1
58104|NCT01277601|229556|P4|Overall Study|Noncompliance with Study Drug|0
58105|NCT01277601|229557|P3|Overall Study|Noncompliance with Study Drug|2
58106|NCT01277601|229558|P2|Overall Study|Noncompliance with Study Drug|3
58107|NCT01277601|229559|P1|Overall Study|Noncompliance with Study Drug|1
58108|NCT01277601|229556|P4|Overall Study|Pregnancy|1
58109|NCT01277601|229557|P3|Overall Study|Pregnancy|4
58110|NCT01277601|229558|P2|Overall Study|Pregnancy|2
58111|NCT01277601|229559|P1|Overall Study|Pregnancy|2
58112|NCT01277601|229556|P4|Overall Study|Physician Decision|6
58113|NCT01277601|229557|P3|Overall Study|Physician Decision|1
58114|NCT01277601|229558|P2|Overall Study|Physician Decision|5
58115|NCT01277601|229559|P1|Overall Study|Physician Decision|3
58116|NCT01277601|229556|P4|Overall Study|Lost to Follow-up|2
58117|NCT01277601|229557|P3|Overall Study|Lost to Follow-up|4
58118|NCT01277601|229558|P2|Overall Study|Lost to Follow-up|9
58119|NCT01277601|229559|P1|Overall Study|Lost to Follow-up|7
58120|NCT01277601|229556|P4|Overall Study|Withdrawal by Subject|17
58121|NCT01277601|229557|P3|Overall Study|Withdrawal by Subject|8
58122|NCT01277601|229558|P2|Overall Study|Withdrawal by Subject|21
58123|NCT01277601|229559|P1|Overall Study|Withdrawal by Subject|18
58124|NCT01277601|229556|P4|Overall Study|Adverse Event|7
58125|NCT01277601|229557|P3|Overall Study|Adverse Event|0
58126|NCT01277601|229558|P2|Overall Study|Adverse Event|3
58127|NCT01277601|229559|P1|Overall Study|Adverse Event|5
58128|NCT01277549|229650|P2|Overall Study|Physician Decision|1
58129|NCT01277549|229651|P1|Overall Study|Physician Decision|2
58130|NCT01277549|229650|P2|Overall Study|Protocol Violation|1
58131|NCT01277549|229651|P1|Overall Study|Protocol Violation|10
58132|NCT01277549|229650|P2|Overall Study|Withdrawal by Subject|3
58133|NCT01277549|229651|P1|Overall Study|Withdrawal by Subject|1
58134|NCT01277549|229650|P2|Overall Study|Failed to meet eligibility criteria|9
58135|NCT01277549|229651|P1|Overall Study|Failed to meet eligibility criteria|13
58136|NCT01277523|229668|P3|Overall Study|Other Reason not Defined|0
58137|NCT01277523|229669|P2|Overall Study|Other Reason not Defined|1
58138|NCT01277523|229670|P1|Overall Study|Other Reason not Defined|0
58139|NCT01277523|229668|P3|Overall Study|Protocol Violation|0
58140|NCT01277523|229669|P2|Overall Study|Protocol Violation|0
58141|NCT01277523|229670|P1|Overall Study|Protocol Violation|2
58142|NCT01277523|229668|P3|Overall Study|Adverse Event|0
58143|NCT01277523|229669|P2|Overall Study|Adverse Event|0
58144|NCT01277523|229670|P1|Overall Study|Adverse Event|1
58145|NCT01277510|229722|P2|Open-label Phase|Never received investigational product|0
58146|NCT01277510|229723|P1|Open-label Phase|Never received investigational product|2
58147|NCT01277510|229722|P2|Open-label Phase|Protocol-specified criteria|0
58148|NCT01277510|229723|P1|Open-label Phase|Protocol-specified criteria|1
58149|NCT01277510|229722|P2|Open-label Phase|Administrative decision|3
58150|NCT01277510|229723|P1|Open-label Phase|Administrative decision|4
58151|NCT01277510|229722|P2|Double-blind Phase|Other|1
58152|NCT01277510|229723|P1|Double-blind Phase|Other|1
58153|NCT01277510|229722|P2|Double-blind Phase|Protocol-specified criteria|6
58154|NCT01277510|229723|P1|Double-blind Phase|Protocol-specified criteria|2
58155|NCT01277510|229722|P2|Double-blind Phase|Death|1
58156|NCT01277510|229723|P1|Double-blind Phase|Death|0
58157|NCT01277510|229722|P2|Double-blind Phase|Administrative decision|9
58158|NCT01277510|229723|P1|Double-blind Phase|Administrative decision|7
58159|NCT01277510|229722|P2|Double-blind Phase|Withdrawal by Subject|0
58160|NCT01277510|229723|P1|Double-blind Phase|Withdrawal by Subject|2
58161|NCT01277510|229722|P2|Double-blind Phase|Adverse Event|0
58162|NCT01277510|229723|P1|Double-blind Phase|Adverse Event|1
58163|NCT01277510|229722|P2|Double-blind Phase|Non-compliance|1
58164|NCT01277510|229723|P1|Double-blind Phase|Non-compliance|0
58165|NCT01277302|229757|P3|8-Month Alternate Dose Regimen Period|Relocation|1
58166|NCT01277302|229758|P2|8-Month Alternate Dose Regimen Period|Relocation|0
58167|NCT01277302|229759|P1|8-Month Alternate Dose Regimen Period|Relocation|1
58168|NCT01277302|229757|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
58169|NCT01277302|229758|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
58170|NCT01277302|229759|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
58171|NCT01277302|229757|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
58172|NCT01277302|229758|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
58173|NCT01277302|229759|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
58174|NCT01277302|229757|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
58175|NCT01277302|229758|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
58176|NCT01277302|229759|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
58177|NCT01277302|229757|P3|8-Month Alternate Dose Regimen Period|Death|0
58178|NCT01277302|229758|P2|8-Month Alternate Dose Regimen Period|Death|1
58179|NCT01277302|229759|P1|8-Month Alternate Dose Regimen Period|Death|0
58180|NCT01277302|229757|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
58181|NCT01277302|229758|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
58182|NCT01277302|229759|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
58183|NCT01277302|229757|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
58184|NCT01277302|229758|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
58185|NCT01277302|229759|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
58186|NCT01277302|229757|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
58187|NCT01277302|229758|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
58188|NCT01277302|229759|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
58189|NCT01277302|229757|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
58190|NCT01277302|229758|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
58191|NCT01277302|229759|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
58192|NCT01277211|229791|P2|Overall Study|Discontinued prior to treatment|13
58193|NCT01277211|229792|P1|Overall Study|Discontinued prior to treatment|24
58194|NCT01277211|229791|P2|Overall Study|Pregnancy wish|2
58195|NCT01277211|229792|P1|Overall Study|Pregnancy wish|0
58196|NCT01277211|229791|P2|Overall Study|Administrative|0
58197|NCT01277211|229792|P1|Overall Study|Administrative|3
58198|NCT01277211|229791|P2|Overall Study|Did not meet protocol eligibility|0
58199|NCT01277211|229792|P1|Overall Study|Did not meet protocol eligibility|1
58200|NCT01277211|229791|P2|Overall Study|Non-compliance with protocol|4
58201|NCT01277211|229792|P1|Overall Study|Non-compliance with protocol|13
58202|NCT01277211|229791|P2|Overall Study|Withdrew Consent|9
58203|NCT01277211|229792|P1|Overall Study|Withdrew Consent|9
58204|NCT01277211|229791|P2|Overall Study|Did not wish to continue|0
58205|NCT01277211|229792|P1|Overall Study|Did not wish to continue|17
58206|NCT01277211|229791|P2|Overall Study|Lost to Follow-up|9
58207|NCT01277211|229792|P1|Overall Study|Lost to Follow-up|14
58208|NCT01277211|229791|P2|Overall Study|Pregnancy|4
58209|NCT01277211|229792|P1|Overall Study|Pregnancy|9
58210|NCT01277211|229791|P2|Overall Study|Adverse Event|22
58211|NCT01277211|229792|P1|Overall Study|Adverse Event|60
58212|NCT01277042|229844|P2|Overall Study|Withdrawal by Subject|0
58213|NCT01277042|229845|P1|Overall Study|Withdrawal by Subject|2
58214|NCT01277042|229844|P2|Overall Study|Lost to Follow-up|2
58215|NCT01277042|229845|P1|Overall Study|Lost to Follow-up|2
58216|NCT01277042|229844|P2|Overall Study|Adverse Event|3
58217|NCT01277042|229845|P1|Overall Study|Adverse Event|4
58218|NCT01276847|229870|P3|Overall Study|Withdrawal by Subject|0
58219|NCT01276847|229871|P2|Overall Study|Withdrawal by Subject|0
58220|NCT01276847|229872|P1|Overall Study|Withdrawal by Subject|1
58221|NCT01276821|229882|P2|Overall Study|Protocol Violation|1
58222|NCT01276821|229883|P1|Overall Study|Protocol Violation|0
58223|NCT01276756|229903|P2|Overall Study|Adverse Event|2
58224|NCT01276756|229904|P1|Overall Study|Adverse Event|3
58225|NCT01276756|229903|P2|Overall Study|Lost to Follow-up|0
58226|NCT01276756|229904|P1|Overall Study|Lost to Follow-up|2
58227|NCT01276639|229921|P5|Week 16 to 52|Unspecified|3
58228|NCT01276639|229922|P4|Week 16 to 52|Unspecified|1
58229|NCT01276639|229923|P3|Week 16 to 52|Unspecified|0
58230|NCT01276639|229924|P2|Week 16 to 52|Unspecified|12
58231|NCT01276639|229925|P1|Week 16 to 52|Unspecified|10
58232|NCT01276639|229921|P5|Week 16 to 52|Withdrawal by Subject|1
58233|NCT01276639|229922|P4|Week 16 to 52|Withdrawal by Subject|0
58234|NCT01276639|229923|P3|Week 16 to 52|Withdrawal by Subject|0
58235|NCT01276639|229924|P2|Week 16 to 52|Withdrawal by Subject|4
58236|NCT01276639|229925|P1|Week 16 to 52|Withdrawal by Subject|4
58237|NCT01276639|229921|P5|Week 16 to 52|Lost to Follow-up|1
58238|NCT01276639|229922|P4|Week 16 to 52|Lost to Follow-up|0
58239|NCT01276639|229923|P3|Week 16 to 52|Lost to Follow-up|0
58240|NCT01276639|229924|P2|Week 16 to 52|Lost to Follow-up|1
58241|NCT01276639|229925|P1|Week 16 to 52|Lost to Follow-up|3
58242|NCT01276639|229921|P5|Week 16 to 52|Lack of Efficacy|13
58243|NCT01276639|229922|P4|Week 16 to 52|Lack of Efficacy|14
58244|NCT01276639|229923|P3|Week 16 to 52|Lack of Efficacy|0
58245|NCT01276639|229924|P2|Week 16 to 52|Lack of Efficacy|71
58246|NCT01276639|229925|P1|Week 16 to 52|Lack of Efficacy|99
58247|NCT01276639|229921|P5|Week 16 to 52|Adverse Event|3
58248|NCT01276639|229922|P4|Week 16 to 52|Adverse Event|1
58249|NCT01276639|229923|P3|Week 16 to 52|Adverse Event|0
58250|NCT01276639|229924|P2|Week 16 to 52|Adverse Event|13
58251|NCT01276639|229925|P1|Week 16 to 52|Adverse Event|10
58252|NCT01276639|229921|P5|Week 16 to 52|Death|0
58253|NCT01276639|229922|P4|Week 16 to 52|Death|0
58254|NCT01276639|229923|P3|Week 16 to 52|Death|0
58255|NCT01276639|229924|P2|Week 16 to 52|Death|0
58256|NCT01276639|229925|P1|Week 16 to 52|Death|1
58257|NCT01276639|229921|P5|Week 0 to 16|Randomized, But Not Treated|0
58258|NCT01276639|229922|P4|Week 0 to 16|Randomized, But Not Treated|0
58259|NCT01276639|229923|P3|Week 0 to 16|Randomized, But Not Treated|0
58260|NCT01276639|229924|P2|Week 0 to 16|Randomized, But Not Treated|1
58261|NCT01276639|229925|P1|Week 0 to 16|Randomized, But Not Treated|0
58262|NCT01276639|229921|P5|Week 0 to 16|Unspecified|0
58263|NCT01276639|229922|P4|Week 0 to 16|Unspecified|0
58264|NCT01276639|229923|P3|Week 0 to 16|Unspecified|2
58265|NCT01276639|229924|P2|Week 0 to 16|Unspecified|7
58266|NCT01276639|229925|P1|Week 0 to 16|Unspecified|7
58267|NCT01276639|229921|P5|Week 0 to 16|Withdrawal by Subject|0
58268|NCT01276639|229922|P4|Week 0 to 16|Withdrawal by Subject|0
58269|NCT01276639|229923|P3|Week 0 to 16|Withdrawal by Subject|4
58270|NCT01276639|229924|P2|Week 0 to 16|Withdrawal by Subject|5
58271|NCT01276639|229925|P1|Week 0 to 16|Withdrawal by Subject|8
58272|NCT01276639|229921|P5|Week 0 to 16|Lost to Follow-up|0
58273|NCT01276639|229922|P4|Week 0 to 16|Lost to Follow-up|0
58274|NCT01276639|229923|P3|Week 0 to 16|Lost to Follow-up|3
58275|NCT01276639|229924|P2|Week 0 to 16|Lost to Follow-up|5
58276|NCT01276639|229925|P1|Week 0 to 16|Lost to Follow-up|3
58277|NCT01276639|229921|P5|Week 0 to 16|Lack of Efficacy|0
58278|NCT01276639|229922|P4|Week 0 to 16|Lack of Efficacy|0
58279|NCT01276639|229923|P3|Week 0 to 16|Lack of Efficacy|25
58280|NCT01276639|229924|P2|Week 0 to 16|Lack of Efficacy|15
58281|NCT01276639|229925|P1|Week 0 to 16|Lack of Efficacy|20
58282|NCT01276639|229921|P5|Week 0 to 16|Adverse Event|0
58283|NCT01276639|229922|P4|Week 0 to 16|Adverse Event|0
58284|NCT01276639|229923|P3|Week 0 to 16|Adverse Event|11
58285|NCT01276639|229924|P2|Week 0 to 16|Adverse Event|8
58286|NCT01276639|229925|P1|Week 0 to 16|Adverse Event|11
58287|NCT01276639|229921|P5|Week 0 to 16|Death|0
58288|NCT01276639|229922|P4|Week 0 to 16|Death|0
58289|NCT01276639|229923|P3|Week 0 to 16|Death|0
58290|NCT01276639|229924|P2|Week 0 to 16|Death|0
58291|NCT01276639|229925|P1|Week 0 to 16|Death|1
58292|NCT01276509|230130|P4|Overall Study|Unspecified|0
58293|NCT01276509|230131|P3|Overall Study|Unspecified|0
58294|NCT01276509|230132|P2|Overall Study|Unspecified|1
58295|NCT01276509|230133|P1|Overall Study|Unspecified|0
58296|NCT01276509|230130|P4|Overall Study|Withdrawal by Subject|0
58297|NCT01276509|230131|P3|Overall Study|Withdrawal by Subject|0
58298|NCT01276509|230132|P2|Overall Study|Withdrawal by Subject|2
58299|NCT01276509|230133|P1|Overall Study|Withdrawal by Subject|1
58300|NCT01276509|230130|P4|Overall Study|Pregnancy|0
58301|NCT01276509|230131|P3|Overall Study|Pregnancy|0
58302|NCT01276509|230132|P2|Overall Study|Pregnancy|0
58303|NCT01276509|230133|P1|Overall Study|Pregnancy|1
58304|NCT01276509|230130|P4|Overall Study|Lack of Efficacy|2
58305|NCT01276509|230131|P3|Overall Study|Lack of Efficacy|1
58306|NCT01276509|230132|P2|Overall Study|Lack of Efficacy|1
58307|NCT01276509|230133|P1|Overall Study|Lack of Efficacy|2
58308|NCT01276509|230130|P4|Overall Study|Adverse Event|3
58309|NCT01276509|230131|P3|Overall Study|Adverse Event|4
58310|NCT01276509|230132|P2|Overall Study|Adverse Event|8
58311|NCT01276509|230133|P1|Overall Study|Adverse Event|9
58312|NCT01276457|230186|P2|Extension Study|Lack of Efficacy|1
58313|NCT01276457|230187|P1|Extension Study|Lack of Efficacy|3
58314|NCT01276457|230186|P2|Extension Study|Death|1
58315|NCT01276457|230187|P1|Extension Study|Death|0
58316|NCT01276457|230186|P2|Extension Study|Lost to Follow-up|0
58317|NCT01276457|230187|P1|Extension Study|Lost to Follow-up|3
58318|NCT01276457|230186|P2|Core Study|Lack of Efficacy|12
58319|NCT01276457|230187|P1|Core Study|Lack of Efficacy|3
58320|NCT01276457|230186|P2|Core Study|Death|2
58321|NCT01276457|230187|P1|Core Study|Death|2
58322|NCT01276457|230186|P2|Core Study|Administrative problems|1
58323|NCT01276457|230187|P1|Core Study|Administrative problems|1
58324|NCT01276457|230186|P2|Core Study|Lost to Follow-up|2
58325|NCT01276457|230187|P1|Core Study|Lost to Follow-up|1
58326|NCT01276457|230186|P2|Core Study|Adverse Event|3
58327|NCT01276457|230187|P1|Core Study|Adverse Event|6
58328|NCT01276353|230201|P2|Extension|Prohibited concomitant medications|1
58329|NCT01276353|230202|P1|Extension|Prohibited concomitant medications|0
58330|NCT01276353|230201|P2|Extension|Physician Decision|0
58331|NCT01276353|230202|P1|Extension|Physician Decision|1
58332|NCT01276353|230201|P2|Extension|Withdrawal of study drug 4 days in a row|1
58333|NCT01276353|230202|P1|Extension|Withdrawal of study drug 4 days in a row|3
58334|NCT01276353|230201|P2|Extension|Withdrawal by Subject|2
58335|NCT01276353|230202|P1|Extension|Withdrawal by Subject|1
58336|NCT01276353|230201|P2|Extension|Adverse Event|5
58337|NCT01276353|230202|P1|Extension|Adverse Event|2
58338|NCT01276353|230201|P2|Double-blind|Withdrawal by Subject|0
58339|NCT01276353|230202|P1|Double-blind|Withdrawal by Subject|1
58340|NCT01276353|230201|P2|Double-blind|Adverse Event|0
58341|NCT01276353|230202|P1|Double-blind|Adverse Event|2
58342|NCT01276327|230214|P2|Overall Study|Withdrawal by Subject|0
58343|NCT01276327|230215|P1|Overall Study|Withdrawal by Subject|1
58344|NCT01276327|230214|P2|Overall Study|Adverse Event|3
58345|NCT01276327|230215|P1|Overall Study|Adverse Event|1
58346|NCT01276288|230265|P4|Overall Study|not treated|0
58347|NCT01276288|230266|P3|Overall Study|not treated|0
58348|NCT01276288|230267|P2|Overall Study|not treated|0
58349|NCT01276288|230268|P1|Overall Study|not treated|1
58350|NCT01276288|230265|P4|Overall Study|Adverse Event|0
58351|NCT01276288|230266|P3|Overall Study|Adverse Event|0
58352|NCT01276288|230267|P2|Overall Study|Adverse Event|1
58353|NCT01276288|230268|P1|Overall Study|Adverse Event|1
58354|NCT01276223|230395|P3|Overall Study|Protocol Violation|0
58355|NCT01276223|230396|P2|Overall Study|Protocol Violation|0
58356|NCT01276223|230397|P1|Overall Study|Protocol Violation|1
58357|NCT01276223|230395|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
58358|NCT01276223|230396|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
58359|NCT01276223|230397|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
58360|NCT01276223|230395|P3|Overall Study|Not specified|1
58361|NCT01276223|230396|P2|Overall Study|Not specified|0
58362|NCT01276223|230397|P1|Overall Study|Not specified|0
58363|NCT01276223|230395|P3|Overall Study|Lost to Follow-up|1
58364|NCT01276223|230396|P2|Overall Study|Lost to Follow-up|0
58365|NCT01276223|230397|P1|Overall Study|Lost to Follow-up|0
58366|NCT01276223|230395|P3|Overall Study|Adverse Event|1
58367|NCT01276223|230396|P2|Overall Study|Adverse Event|4
58368|NCT01276223|230397|P1|Overall Study|Adverse Event|7
58369|NCT01276106|230438|P4|Overall Study|Insufficient therapeutic effects|0
58370|NCT01276106|230439|P3|Overall Study|Insufficient therapeutic effects|2
58371|NCT01276106|230440|P2|Overall Study|Insufficient therapeutic effects|0
58372|NCT01276106|230441|P1|Overall Study|Insufficient therapeutic effects|0
58373|NCT01276106|230438|P4|Overall Study|Protocol Violation|2
58374|NCT01276106|230439|P3|Overall Study|Protocol Violation|0
58375|NCT01276106|230440|P2|Overall Study|Protocol Violation|1
58376|NCT01276106|230441|P1|Overall Study|Protocol Violation|1
58377|NCT01276106|230438|P4|Overall Study|Physician Decision|1
58378|NCT01276106|230439|P3|Overall Study|Physician Decision|1
58379|NCT01276106|230440|P2|Overall Study|Physician Decision|0
58380|NCT01276106|230441|P1|Overall Study|Physician Decision|0
58381|NCT01276106|230438|P4|Overall Study|Lost to Follow-up|0
58382|NCT01276106|230439|P3|Overall Study|Lost to Follow-up|1
58383|NCT01276106|230440|P2|Overall Study|Lost to Follow-up|1
58384|NCT01276106|230441|P1|Overall Study|Lost to Follow-up|2
58385|NCT01276106|230438|P4|Overall Study|Lack of Efficacy|1
58386|NCT01276106|230439|P3|Overall Study|Lack of Efficacy|0
58387|NCT01276106|230440|P2|Overall Study|Lack of Efficacy|1
58388|NCT01276106|230441|P1|Overall Study|Lack of Efficacy|0
58389|NCT01276106|230438|P4|Overall Study|Withdrawal by Subject|6
58390|NCT01276106|230439|P3|Overall Study|Withdrawal by Subject|1
58391|NCT01276106|230440|P2|Overall Study|Withdrawal by Subject|3
58392|NCT01276106|230441|P1|Overall Study|Withdrawal by Subject|6
58393|NCT01276106|230438|P4|Overall Study|Adverse Event|3
58394|NCT01276106|230439|P3|Overall Study|Adverse Event|11
58395|NCT01276106|230440|P2|Overall Study|Adverse Event|3
58396|NCT01276106|230441|P1|Overall Study|Adverse Event|3
58397|NCT01276054|230453|P2|Overall Study|No one to oversee trial after P.I. left|2
58398|NCT01276054|230454|P1|Overall Study|No one to oversee trial after P.I. left|2
58399|NCT01275833|230462|P2|Overall Study|Study terminated|1
58400|NCT01275833|230463|P1|Overall Study|Study terminated|1
58401|NCT01275755|230471|P2|Run-out Placebo Period|Lost to Follow-up|0
58402|NCT01275755|230472|P1|Run-out Placebo Period|Lost to Follow-up|1
58403|NCT01275755|230471|P2|Double-blind Treatment Period|Withdrawal by Subject|0
58404|NCT01275755|230472|P1|Double-blind Treatment Period|Withdrawal by Subject|1
58405|NCT01275755|230471|P2|Double-blind Treatment Period|Lost to Follow-up|1
58406|NCT01275755|230472|P1|Double-blind Treatment Period|Lost to Follow-up|1
58407|NCT01275755|230471|P2|Double-blind Treatment Period|Adverse Event|2
58408|NCT01275755|230472|P1|Double-blind Treatment Period|Adverse Event|0
58409|NCT01275625|230478|P1|Overall Study|Not specified|1
58410|NCT01275625|230478|P1|Overall Study|Adverse Event|4
58411|NCT01275625|230478|P1|Overall Study|Protocol Violation|1
58412|NCT01275625|230478|P1|Overall Study|Withdrawal by Subject|3
58413|NCT01275625|230478|P1|Overall Study|Lost to Follow-up|1
58414|NCT01275625|230478|P1|Overall Study|Lack of Efficacy|2
58415|NCT01275625|230478|P1|Overall Study|Death|1
58416|NCT01275430|230496|P1|Overall Study|Inability to achieve maximum p-wave|1
58417|NCT01275430|230496|P1|Overall Study|Device Malfunction|1
58418|NCT01275430|230496|P1|Overall Study|No Contrast Injection|6
58419|NCT01275430|230496|P1|Overall Study|Adverse Event|1
58420|NCT01275196|230515|P2|Overall Study|Suboptimal response/treatment failure|6
58421|NCT01275196|230516|P1|Overall Study|Suboptimal response/treatment failure|5
58422|NCT01275196|230515|P2|Overall Study|Protocol Violation|0
58423|NCT01275196|230516|P1|Overall Study|Protocol Violation|1
58424|NCT01275196|230515|P2|Overall Study|Disease Progression|5
58425|NCT01275196|230516|P1|Overall Study|Disease Progression|6
58426|NCT01275196|230515|P2|Overall Study|Lost to Follow-up|0
58427|NCT01275196|230516|P1|Overall Study|Lost to Follow-up|1
58428|NCT01275196|230515|P2|Overall Study|Withdrawal by Subject|5
58429|NCT01275196|230516|P1|Overall Study|Withdrawal by Subject|4
58430|NCT01275196|230515|P2|Overall Study|Adverse Event|5
58431|NCT01275196|230516|P1|Overall Study|Adverse Event|3
58432|NCT01275131|230559|P4|Period 2 (Crossover)|Withdrawal by Subject|2
58433|NCT01275131|230560|P3|Period 2 (Crossover)|Withdrawal by Subject|1
58434|NCT01275131|230561|P2|Period 2 (Crossover)|Withdrawal by Subject|0
58435|NCT01275131|230562|P1|Period 2 (Crossover)|Withdrawal by Subject|1
58436|NCT01275131|230559|P4|Period 2 (Crossover)|Adverse Event|0
58437|NCT01275131|230560|P3|Period 2 (Crossover)|Adverse Event|0
58438|NCT01275131|230561|P2|Period 2 (Crossover)|Adverse Event|1
58439|NCT01275131|230562|P1|Period 2 (Crossover)|Adverse Event|0
58440|NCT01275131|230559|P4|Period 1|Physician Decision|0
58441|NCT01275131|230560|P3|Period 1|Physician Decision|0
58442|NCT01275131|230561|P2|Period 1|Physician Decision|0
58443|NCT01275131|230562|P1|Period 1|Physician Decision|1
58444|NCT01275131|230559|P4|Period 1|Withdrawal by Subject|2
58445|NCT01275131|230560|P3|Period 1|Withdrawal by Subject|3
58446|NCT01275131|230561|P2|Period 1|Withdrawal by Subject|0
58447|NCT01275131|230562|P1|Period 1|Withdrawal by Subject|1
58448|NCT01275066|230605|P3|Overall Study|Not Diagnosed w/ Disease|0
58449|NCT01275066|230606|P2|Overall Study|Not Diagnosed w/ Disease|0
58450|NCT01275066|230607|P1|Overall Study|Not Diagnosed w/ Disease|1
58451|NCT01275066|230605|P3|Overall Study|Withdrawal by Subject|1
58452|NCT01275066|230606|P2|Overall Study|Withdrawal by Subject|0
58453|NCT01275066|230607|P1|Overall Study|Withdrawal by Subject|0
58454|NCT01274715|230640|P1|Overall Study|After consent, met exclusion criteria.|1
58455|NCT01274715|230640|P1|Overall Study|After consent, met exclusion criteria.|1
58456|NCT01274715|230640|P1|Overall Study|After consent, met exclusion criteria.|1
58457|NCT01274715|230640|P1|Overall Study|Lost to Follow-up|1
58458|NCT01274637|230647|P2|Overall Study|Lost to Follow-up|1
58459|NCT01274637|230648|P1|Overall Study|Lost to Follow-up|0
58460|NCT01274637|230647|P2|Overall Study|Withdrawal by Subject|1
58461|NCT01274637|230648|P1|Overall Study|Withdrawal by Subject|0
58462|NCT01274559|230683|P2|Overall Study|Withdrawal by Subject|13
58463|NCT01274559|230684|P1|Overall Study|Withdrawal by Subject|25
58464|NCT01274559|230683|P2|Overall Study|Study Terminated by Sponsor|87
58465|NCT01274559|230684|P1|Overall Study|Study Terminated by Sponsor|79
58466|NCT01274559|230683|P2|Overall Study|Protocol Violation|23
58467|NCT01274559|230684|P1|Overall Study|Protocol Violation|28
58468|NCT01274559|230683|P2|Overall Study|Physician Decision|1
58469|NCT01274559|230684|P1|Overall Study|Physician Decision|2
58470|NCT01274559|230683|P2|Overall Study|Non-compliance with Study Drug|4
58471|NCT01274559|230684|P1|Overall Study|Non-compliance with Study Drug|2
58472|NCT01274559|230683|P2|Overall Study|Lost to Follow-up|3
58473|NCT01274559|230684|P1|Overall Study|Lost to Follow-up|3
58474|NCT01274559|230683|P2|Overall Study|Death|1
58475|NCT01274559|230684|P1|Overall Study|Death|1
58476|NCT01274559|230683|P2|Overall Study|Adverse Event|13
58477|NCT01274559|230684|P1|Overall Study|Adverse Event|57
58478|NCT01274533|230734|P1|Overall Study|Disease progression|2
58479|NCT01274533|230734|P1|Overall Study|Non-compliance|1
58480|NCT01274533|230734|P1|Overall Study|Withdrawal by Subject|1
58481|NCT01274429|230739|P1|Overall Study|Study closed do to lack of funding|5
58482|NCT01273883|230748|P2|Second Intervention|Lack of Efficacy|0
58483|NCT01273883|230749|P1|Second Intervention|Lack of Efficacy|1
58484|NCT01273883|230748|P2|Second Intervention|Lost to Follow-up|1
58485|NCT01273883|230749|P1|Second Intervention|Lost to Follow-up|1
58486|NCT01273883|230748|P2|First Intervention|Adverse Event|1
58487|NCT01273883|230749|P1|First Intervention|Adverse Event|2
58488|NCT01273818|230775|P3|Overall Study|Physician Decision|9
58489|NCT01273818|230776|P2|Overall Study|Physician Decision|2
58490|NCT01273818|230777|P1|Overall Study|Physician Decision|13
58491|NCT01273805|230787|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
58492|NCT01273805|230788|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
58493|NCT01273623|230815|P1|Overall Study|did not meet IVUS criteria|29
58494|NCT01273597|230822|P1|Overall Study|Reason Not Reported|1
58495|NCT01273597|230822|P1|Overall Study|Underwent Kidney Transplantation|2
58496|NCT01273597|230822|P1|Overall Study|Adverse Event|5
58497|NCT01273519|230837|P3|Overall Study|Not Specified|1
58498|NCT01273519|230838|P2|Overall Study|Not Specified|1
58499|NCT01273519|230839|P1|Overall Study|Not Specified|6
58500|NCT01273519|230837|P3|Overall Study|Lack of Efficacy|4
58501|NCT01273519|230838|P2|Overall Study|Lack of Efficacy|3
58502|NCT01273519|230839|P1|Overall Study|Lack of Efficacy|8
58503|NCT01273519|230837|P3|Overall Study|Lost to Follow-up|3
58504|NCT01273519|230838|P2|Overall Study|Lost to Follow-up|1
58505|NCT01273519|230839|P1|Overall Study|Lost to Follow-up|2
58506|NCT01273519|230837|P3|Overall Study|Adverse Event|0
58507|NCT01273519|230838|P2|Overall Study|Adverse Event|0
58508|NCT01273519|230839|P1|Overall Study|Adverse Event|3
58509|NCT01273181|230876|P4|Phase 2, Dose 2|Death during treatment|1
58510|NCT01273181|230877|P3|Phase 2, Dose 2|Death during treatment|0
58511|NCT01273181|230878|P2|Phase 2, Dose 2|Death during treatment|0
58512|NCT01273181|230879|P1|Phase 2, Dose 2|Death during treatment|0
58513|NCT01273181|230876|P4|Phase 2, Dose 1|Study termination|0
58514|NCT01273181|230877|P3|Phase 2, Dose 1|Study termination|1
58515|NCT01273181|230878|P2|Phase 2, Dose 1|Study termination|0
58516|NCT01273181|230879|P1|Phase 2, Dose 1|Study termination|0
58517|NCT01273181|230876|P4|Phase I, Dose 2|Death during treatment|0
58518|NCT01273181|230877|P3|Phase I, Dose 2|Death during treatment|0
58519|NCT01273181|230878|P2|Phase I, Dose 2|Death during treatment|1
58520|NCT01273181|230879|P1|Phase I, Dose 2|Death during treatment|0
58521|NCT01273181|230876|P4|Phase I, Dose 1|Study termination|0
58522|NCT01273181|230877|P3|Phase I, Dose 1|Study termination|0
58523|NCT01273181|230878|P2|Phase I, Dose 1|Study termination|0
58524|NCT01273181|230879|P1|Phase I, Dose 1|Study termination|1
58525|NCT01273064|230898|P5|Overall Study|Physician Decision|1
58526|NCT01273064|230899|P4|Overall Study|Physician Decision|0
58527|NCT01273064|230900|P3|Overall Study|Physician Decision|0
58528|NCT01273064|230901|P2|Overall Study|Physician Decision|0
58529|NCT01273064|230902|P1|Overall Study|Physician Decision|0
58530|NCT01273064|230898|P5|Overall Study|Lost to Follow-up|0
58531|NCT01273064|230899|P4|Overall Study|Lost to Follow-up|0
58532|NCT01273064|230900|P3|Overall Study|Lost to Follow-up|0
58533|NCT01273064|230901|P2|Overall Study|Lost to Follow-up|0
58534|NCT01273064|230902|P1|Overall Study|Lost to Follow-up|1
58535|NCT01273064|230898|P5|Overall Study|Study Termination|8
58536|NCT01273064|230899|P4|Overall Study|Study Termination|16
58537|NCT01273064|230900|P3|Overall Study|Study Termination|26
58538|NCT01273064|230901|P2|Overall Study|Study Termination|27
58539|NCT01273064|230902|P1|Overall Study|Study Termination|13
58540|NCT01273064|230898|P5|Overall Study|Withdrawal by Subject|0
58541|NCT01273064|230899|P4|Overall Study|Withdrawal by Subject|2
58542|NCT01273064|230900|P3|Overall Study|Withdrawal by Subject|2
58543|NCT01273064|230901|P2|Overall Study|Withdrawal by Subject|2
58544|NCT01273064|230902|P1|Overall Study|Withdrawal by Subject|4
58545|NCT01273064|230898|P5|Overall Study|Adverse Event|1
58546|NCT01273064|230899|P4|Overall Study|Adverse Event|2
58547|NCT01273064|230900|P3|Overall Study|Adverse Event|3
58548|NCT01273064|230901|P2|Overall Study|Adverse Event|1
58549|NCT01273064|230902|P1|Overall Study|Adverse Event|5
58550|NCT01273038|230921|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
58551|NCT01273038|230922|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
58552|NCT01273038|230921|P2|Second Intervention (14 Days)|Adverse Event|1
58553|NCT01273038|230922|P1|Second Intervention (14 Days)|Adverse Event|0
58554|NCT01272947|230930|P2|Overall Study|Abnormal Laboratory Value|2
58555|NCT01272947|230931|P1|Overall Study|Abnormal Laboratory Value|2
58556|NCT01272934|230941|P2|Overall Study|Abnormal Laboratory Value|1
58557|NCT01272934|230942|P1|Overall Study|Abnormal Laboratory Value|0
58558|NCT01272934|230941|P2|Overall Study|Adverse Event|1
58559|NCT01272934|230942|P1|Overall Study|Adverse Event|0
58560|NCT01272921|230952|P2|Overall Study|Protocol Violation|1
58561|NCT01272921|230953|P1|Overall Study|Protocol Violation|2
58562|NCT01272908|230961|P1|Re-Treatment Period|Withdrawal by Subject|1
58563|NCT01272908|230961|P1|Re-Treatment Period|Lack of Efficacy|3
58564|NCT01272908|230961|P1|Re-Treatment Period|Adverse Event|2
58565|NCT01272908|230961|P1|Initial Treatment Period|Withdrawal by Subject|1
58566|NCT01272908|230961|P1|Initial Treatment Period|Protocol Violation|1
58567|NCT01272908|230961|P1|Initial Treatment Period|Lack of Efficacy|5
58568|NCT01272908|230961|P1|Initial Treatment Period|Adverse Event|1
58569|NCT01272869|231001|P2|Period 2 (14 Days)|Adverse Event|0
58570|NCT01272869|231002|P1|Period 2 (14 Days)|Adverse Event|1
58571|NCT01272804|231014|P6|Overall Study|Adverse Event|1
58572|NCT01272804|231015|P5|Overall Study|Adverse Event|2
58573|NCT01272804|231016|P4|Overall Study|Adverse Event|0
58574|NCT01272804|231017|P3|Overall Study|Adverse Event|0
58575|NCT01272804|231018|P2|Overall Study|Adverse Event|0
58576|NCT01272804|231019|P1|Overall Study|Adverse Event|1
58577|NCT01272661|231177|P3|Overall Study|lost to followup/case closed/ no birth|72
58578|NCT01272661|231178|P2|Overall Study|lost to followup/case closed/ no birth|209
58579|NCT01272661|231179|P1|Overall Study|lost to followup/case closed/ no birth|126
58580|NCT01272635|231204|P4|Overall Study|Lost to Follow-up|23
58581|NCT01272635|231205|P3|Overall Study|Lost to Follow-up|31
58582|NCT01272635|231206|P2|Overall Study|Lost to Follow-up|20
58583|NCT01272635|231207|P1|Overall Study|Lost to Follow-up|31
58584|NCT01272232|231272|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
58585|NCT01272232|231273|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
58586|NCT01272232|231274|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
58587|NCT01272232|231272|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
58588|NCT01272232|231273|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
58589|NCT01272232|231274|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
58590|NCT01272232|231272|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
58591|NCT01272232|231273|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
58592|NCT01272232|231274|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
58593|NCT01272232|231272|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
58594|NCT01272232|231273|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
58595|NCT01272232|231274|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
58596|NCT01272232|231272|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
58597|NCT01272232|231273|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
58598|NCT01272232|231274|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
58599|NCT01272232|231272|P3|Weeks 0-56|Unclassified|12
58600|NCT01272232|231273|P2|Weeks 0-56|Unclassified|7
58601|NCT01272232|231274|P1|Weeks 0-56|Unclassified|16
58602|NCT01272232|231272|P3|Weeks 0-56|Withdrawal criteria|37
58603|NCT01272232|231273|P2|Weeks 0-56|Withdrawal criteria|14
58604|NCT01272232|231274|P1|Weeks 0-56|Withdrawal criteria|32
58605|NCT01272232|231272|P3|Weeks 0-56|Protocol Violation|13
58606|NCT01272232|231273|P2|Weeks 0-56|Protocol Violation|8
58607|NCT01272232|231274|P1|Weeks 0-56|Protocol Violation|12
58608|NCT01272232|231272|P3|Weeks 0-56|Lack of Efficacy|3
58609|NCT01272232|231273|P2|Weeks 0-56|Lack of Efficacy|0
58610|NCT01272232|231274|P1|Weeks 0-56|Lack of Efficacy|0
58611|NCT01272232|231272|P3|Weeks 0-56|Adverse Event|7
58612|NCT01272232|231273|P2|Weeks 0-56|Adverse Event|18
58613|NCT01272232|231274|P1|Weeks 0-56|Adverse Event|39
58614|NCT01272219|231319|P6|Main + Extension Period: Week 0-172|Unclassified|51
58615|NCT01272219|231320|P5|Main + Extension Period: Week 0-172|Unclassified|61
58616|NCT01272219|231321|P4|Main + Extension Period: Week 0-172|Unclassified|0
58617|NCT01272219|231322|P3|Main + Extension Period: Week 0-172|Unclassified|0
58618|NCT01272219|231323|P2|Main + Extension Period: Week 0-172|Unclassified|0
58619|NCT01272219|231324|P1|Main + Extension Period: Week 0-172|Unclassified|0
58620|NCT01272219|231319|P6|Main + Extension Period: Week 0-172|Missing reason|0
58621|NCT01272219|231320|P5|Main + Extension Period: Week 0-172|Missing reason|1
58622|NCT01272219|231321|P4|Main + Extension Period: Week 0-172|Missing reason|0
58623|NCT01272219|231322|P3|Main + Extension Period: Week 0-172|Missing reason|0
58624|NCT01272219|231323|P2|Main + Extension Period: Week 0-172|Missing reason|0
58625|NCT01272219|231324|P1|Main + Extension Period: Week 0-172|Missing reason|0
58626|NCT01272219|231319|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
58627|NCT01272219|231320|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
58628|NCT01272219|231321|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
58629|NCT01272219|231322|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
58630|NCT01272219|231323|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
58631|NCT01272219|231324|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
58632|NCT01272219|231319|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
58633|NCT01272219|231320|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
58634|NCT01272219|231321|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
58635|NCT01272219|231322|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
58636|NCT01272219|231323|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
58637|NCT01272219|231324|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
58638|NCT01272219|231319|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
58639|NCT01272219|231320|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
58640|NCT01272219|231321|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
58641|NCT01272219|231322|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
58642|NCT01272219|231323|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
58643|NCT01272219|231324|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
58644|NCT01272219|231319|P6|Main + Extension Period: Week 0-172|Adverse Event|43
58645|NCT01272219|231320|P5|Main + Extension Period: Week 0-172|Adverse Event|191
58646|NCT01272219|231321|P4|Main + Extension Period: Week 0-172|Adverse Event|0
58647|NCT01272219|231322|P3|Main + Extension Period: Week 0-172|Adverse Event|0
58648|NCT01272219|231323|P2|Main + Extension Period: Week 0-172|Adverse Event|0
58649|NCT01272219|231324|P1|Main + Extension Period: Week 0-172|Adverse Event|0
58650|NCT01272219|231319|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
58651|NCT01272219|231320|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
58652|NCT01272219|231321|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
58653|NCT01272219|231322|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
58654|NCT01272219|231323|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
58655|NCT01272219|231324|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
58656|NCT01272219|231319|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
58657|NCT01272219|231320|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
58658|NCT01272219|231321|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
58659|NCT01272219|231322|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
58660|NCT01272219|231323|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
58661|NCT01272219|231324|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
58662|NCT01272219|231319|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
58663|NCT01272219|231320|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
58664|NCT01272219|231321|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
58665|NCT01272219|231322|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
58666|NCT01272219|231323|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
58667|NCT01272219|231324|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
58668|NCT01272219|231319|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
58669|NCT01272219|231320|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
58670|NCT01272219|231321|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
58671|NCT01272219|231322|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
58672|NCT01272219|231323|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
58673|NCT01272219|231324|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
58674|NCT01272219|231319|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
58675|NCT01272219|231320|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
58676|NCT01272219|231321|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
58677|NCT01272219|231322|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
58678|NCT01272219|231323|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
58679|NCT01272219|231324|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
58680|NCT01272219|231319|P6|Main Period: Week 0 to Week 56|Unclassified|34
58681|NCT01272219|231320|P5|Main Period: Week 0 to Week 56|Unclassified|42
58682|NCT01272219|231321|P4|Main Period: Week 0 to Week 56|Unclassified|29
58683|NCT01272219|231322|P3|Main Period: Week 0 to Week 56|Unclassified|0
58684|NCT01272219|231323|P2|Main Period: Week 0 to Week 56|Unclassified|0
58685|NCT01272219|231324|P1|Main Period: Week 0 to Week 56|Unclassified|36
58686|NCT01272219|231319|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
58687|NCT01272219|231320|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
58688|NCT01272219|231321|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
58689|NCT01272219|231322|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
58690|NCT01272219|231323|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
58691|NCT01272219|231324|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
58692|NCT01272219|231319|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
58693|NCT01272219|231320|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
58694|NCT01272219|231321|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
58695|NCT01272219|231322|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
58696|NCT01272219|231323|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
58697|NCT01272219|231324|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
58698|NCT01272219|231319|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
58699|NCT01272219|231320|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
58700|NCT01272219|231321|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
58701|NCT01272219|231322|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
58702|NCT01272219|231323|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
58703|NCT01272219|231324|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
58704|NCT01272219|231319|P6|Main Period: Week 0 to Week 56|Adverse Event|29
58705|NCT01272219|231320|P5|Main Period: Week 0 to Week 56|Adverse Event|152
58706|NCT01272219|231321|P4|Main Period: Week 0 to Week 56|Adverse Event|16
58707|NCT01272219|231322|P3|Main Period: Week 0 to Week 56|Adverse Event|0
58708|NCT01272219|231323|P2|Main Period: Week 0 to Week 56|Adverse Event|0
58709|NCT01272219|231324|P1|Main Period: Week 0 to Week 56|Adverse Event|86
58710|NCT01272193|231358|P2|Overall Study|Unclassified|7
58711|NCT01272193|231359|P1|Overall Study|Unclassified|8
58712|NCT01272193|231358|P2|Overall Study|Withdrawal Criteria|1
58713|NCT01272193|231359|P1|Overall Study|Withdrawal Criteria|1
58714|NCT01272193|231358|P2|Overall Study|Lack of Efficacy|3
58715|NCT01272193|231359|P1|Overall Study|Lack of Efficacy|0
58716|NCT01272193|231358|P2|Overall Study|Adverse Event|1
58717|NCT01272193|231359|P1|Overall Study|Adverse Event|1
58718|NCT01272180|231379|P4|Overall Study|Protocol Violation|1
58719|NCT01272180|231380|P3|Overall Study|Protocol Violation|0
58720|NCT01272180|231381|P2|Overall Study|Protocol Violation|1
58721|NCT01272180|231382|P1|Overall Study|Protocol Violation|0
58722|NCT01272180|231379|P4|Overall Study|Inappropriate enrollment|1
58723|NCT01272180|231380|P3|Overall Study|Inappropriate enrollment|1
58724|NCT01272180|231381|P2|Overall Study|Inappropriate enrollment|0
58725|NCT01272180|231382|P1|Overall Study|Inappropriate enrollment|0
58726|NCT01272180|231379|P4|Overall Study|Lost to Follow-up|10
58727|NCT01272180|231380|P3|Overall Study|Lost to Follow-up|8
58728|NCT01272180|231381|P2|Overall Study|Lost to Follow-up|14
58729|NCT01272180|231382|P1|Overall Study|Lost to Follow-up|15
58730|NCT01272180|231379|P4|Overall Study|Withdrawal by Subject|2
58731|NCT01272180|231380|P3|Overall Study|Withdrawal by Subject|3
58732|NCT01272180|231381|P2|Overall Study|Withdrawal by Subject|6
58733|NCT01272180|231382|P1|Overall Study|Withdrawal by Subject|2
58734|NCT01272180|231379|P4|Overall Study|Adverse Event|0
58735|NCT01272180|231380|P3|Overall Study|Adverse Event|1
58736|NCT01272180|231381|P2|Overall Study|Adverse Event|0
58737|NCT01272180|231382|P1|Overall Study|Adverse Event|0
58738|NCT01272011|231431|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
58739|NCT01272011|231432|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
58740|NCT01272011|231433|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
58741|NCT01271803|231500|P12|Stage 2|Ongoing in the Study|14
58742|NCT01271803|231501|P11|Stage 2|Ongoing in the Study|6
58743|NCT01271803|231502|P10|Stage 2|Ongoing in the Study|0
58744|NCT01271803|231503|P9|Stage 2|Ongoing in the Study|0
58745|NCT01271803|231504|P8|Stage 2|Ongoing in the Study|0
58746|NCT01271803|231505|P7|Stage 2|Ongoing in the Study|0
58747|NCT01271803|231506|P6|Stage 2|Ongoing in the Study|0
58748|NCT01271803|231507|P5|Stage 2|Ongoing in the Study|0
58749|NCT01271803|231508|P4|Stage 2|Ongoing in the Study|0
58750|NCT01271803|231509|P3|Stage 2|Ongoing in the Study|0
58751|NCT01271803|231510|P2|Stage 2|Ongoing in the Study|0
58752|NCT01271803|231511|P1|Stage 2|Ongoing in the Study|0
58753|NCT01271803|231500|P12|Stage 2|Unspecified|0
58754|NCT01271803|231501|P11|Stage 2|Unspecified|1
58755|NCT01271803|231502|P10|Stage 2|Unspecified|0
58756|NCT01271803|231503|P9|Stage 2|Unspecified|0
58757|NCT01271803|231504|P8|Stage 2|Unspecified|0
58758|NCT01271803|231505|P7|Stage 2|Unspecified|0
58759|NCT01271803|231506|P6|Stage 2|Unspecified|0
58760|NCT01271803|231507|P5|Stage 2|Unspecified|0
58761|NCT01271803|231508|P4|Stage 2|Unspecified|0
58762|NCT01271803|231509|P3|Stage 2|Unspecified|0
58763|NCT01271803|231510|P2|Stage 2|Unspecified|0
58764|NCT01271803|231511|P1|Stage 2|Unspecified|0
58765|NCT01271803|231500|P12|Stage 2|Physician Decision|1
58766|NCT01271803|231501|P11|Stage 2|Physician Decision|0
58767|NCT01271803|231502|P10|Stage 2|Physician Decision|0
58768|NCT01271803|231503|P9|Stage 2|Physician Decision|0
58769|NCT01271803|231504|P8|Stage 2|Physician Decision|0
58770|NCT01271803|231505|P7|Stage 2|Physician Decision|0
58771|NCT01271803|231506|P6|Stage 2|Physician Decision|0
58772|NCT01271803|231507|P5|Stage 2|Physician Decision|0
58773|NCT01271803|231508|P4|Stage 2|Physician Decision|0
58774|NCT01271803|231509|P3|Stage 2|Physician Decision|0
58775|NCT01271803|231510|P2|Stage 2|Physician Decision|0
58776|NCT01271803|231511|P1|Stage 2|Physician Decision|0
58777|NCT01271803|231500|P12|Stage 2|Withdrawal by Subject|2
58778|NCT01271803|231501|P11|Stage 2|Withdrawal by Subject|0
58779|NCT01271803|231502|P10|Stage 2|Withdrawal by Subject|0
58780|NCT01271803|231503|P9|Stage 2|Withdrawal by Subject|0
58781|NCT01271803|231504|P8|Stage 2|Withdrawal by Subject|0
58782|NCT01271803|231505|P7|Stage 2|Withdrawal by Subject|0
58783|NCT01271803|231506|P6|Stage 2|Withdrawal by Subject|0
58784|NCT01271803|231507|P5|Stage 2|Withdrawal by Subject|0
58785|NCT01271803|231508|P4|Stage 2|Withdrawal by Subject|0
58786|NCT01271803|231509|P3|Stage 2|Withdrawal by Subject|0
58787|NCT01271803|231510|P2|Stage 2|Withdrawal by Subject|0
58788|NCT01271803|231511|P1|Stage 2|Withdrawal by Subject|0
58789|NCT01271803|231500|P12|Stage 2|Death|2
58790|NCT01271803|231501|P11|Stage 2|Death|2
58791|NCT01271803|231502|P10|Stage 2|Death|0
58792|NCT01271803|231503|P9|Stage 2|Death|0
58793|NCT01271803|231504|P8|Stage 2|Death|0
58794|NCT01271803|231505|P7|Stage 2|Death|0
58795|NCT01271803|231506|P6|Stage 2|Death|0
58796|NCT01271803|231507|P5|Stage 2|Death|0
58797|NCT01271803|231508|P4|Stage 2|Death|0
58798|NCT01271803|231509|P3|Stage 2|Death|0
58799|NCT01271803|231510|P2|Stage 2|Death|0
58800|NCT01271803|231511|P1|Stage 2|Death|0
58801|NCT01271803|231500|P12|Stage 2|Adverse Event|3
58802|NCT01271803|231501|P11|Stage 2|Adverse Event|1
58803|NCT01271803|231502|P10|Stage 2|Adverse Event|0
58804|NCT01271803|231503|P9|Stage 2|Adverse Event|0
58805|NCT01271803|231504|P8|Stage 2|Adverse Event|0
58806|NCT01271803|231505|P7|Stage 2|Adverse Event|0
58807|NCT01271803|231506|P6|Stage 2|Adverse Event|0
58808|NCT01271803|231507|P5|Stage 2|Adverse Event|0
58809|NCT01271803|231508|P4|Stage 2|Adverse Event|0
58810|NCT01271803|231509|P3|Stage 2|Adverse Event|0
58811|NCT01271803|231510|P2|Stage 2|Adverse Event|0
58812|NCT01271803|231511|P1|Stage 2|Adverse Event|0
58813|NCT01271803|231500|P12|Stage 2|Progressive disease|17
58814|NCT01271803|231501|P11|Stage 2|Progressive disease|17
58815|NCT01271803|231502|P10|Stage 2|Progressive disease|0
58816|NCT01271803|231503|P9|Stage 2|Progressive disease|0
58817|NCT01271803|231504|P8|Stage 2|Progressive disease|0
58818|NCT01271803|231505|P7|Stage 2|Progressive disease|0
58819|NCT01271803|231506|P6|Stage 2|Progressive disease|0
58820|NCT01271803|231507|P5|Stage 2|Progressive disease|0
58821|NCT01271803|231508|P4|Stage 2|Progressive disease|0
58822|NCT01271803|231509|P3|Stage 2|Progressive disease|0
58823|NCT01271803|231510|P2|Stage 2|Progressive disease|0
58824|NCT01271803|231511|P1|Stage 2|Progressive disease|0
58825|NCT01271803|231500|P12|Stage 1|Ongoing in the Study|0
58826|NCT01271803|231501|P11|Stage 1|Ongoing in the Study|0
58827|NCT01271803|231502|P10|Stage 1|Ongoing in the Study|0
58828|NCT01271803|231503|P9|Stage 1|Ongoing in the Study|1
58829|NCT01271803|231504|P8|Stage 1|Ongoing in the Study|1
58830|NCT01271803|231505|P7|Stage 1|Ongoing in the Study|1
58831|NCT01271803|231506|P6|Stage 1|Ongoing in the Study|0
58832|NCT01271803|231507|P5|Stage 1|Ongoing in the Study|3
58833|NCT01271803|231508|P4|Stage 1|Ongoing in the Study|1
58834|NCT01271803|231509|P3|Stage 1|Ongoing in the Study|11
58835|NCT01271803|231510|P2|Stage 1|Ongoing in the Study|1
58836|NCT01271803|231511|P1|Stage 1|Ongoing in the Study|0
58837|NCT01271803|231500|P12|Stage 1|Unspecified|0
58838|NCT01271803|231501|P11|Stage 1|Unspecified|0
58839|NCT01271803|231502|P10|Stage 1|Unspecified|0
58840|NCT01271803|231503|P9|Stage 1|Unspecified|0
58841|NCT01271803|231504|P8|Stage 1|Unspecified|0
58842|NCT01271803|231505|P7|Stage 1|Unspecified|0
58843|NCT01271803|231506|P6|Stage 1|Unspecified|0
58844|NCT01271803|231507|P5|Stage 1|Unspecified|0
58845|NCT01271803|231508|P4|Stage 1|Unspecified|0
58846|NCT01271803|231509|P3|Stage 1|Unspecified|2
58847|NCT01271803|231510|P2|Stage 1|Unspecified|0
58848|NCT01271803|231511|P1|Stage 1|Unspecified|0
58849|NCT01271803|231500|P12|Stage 1|Withdrawal by Subject|0
58850|NCT01271803|231501|P11|Stage 1|Withdrawal by Subject|0
58851|NCT01271803|231502|P10|Stage 1|Withdrawal by Subject|0
58852|NCT01271803|231503|P9|Stage 1|Withdrawal by Subject|0
58853|NCT01271803|231504|P8|Stage 1|Withdrawal by Subject|0
58854|NCT01271803|231505|P7|Stage 1|Withdrawal by Subject|0
58855|NCT01271803|231506|P6|Stage 1|Withdrawal by Subject|0
58856|NCT01271803|231507|P5|Stage 1|Withdrawal by Subject|0
58857|NCT01271803|231508|P4|Stage 1|Withdrawal by Subject|0
58858|NCT01271803|231509|P3|Stage 1|Withdrawal by Subject|1
58859|NCT01271803|231510|P2|Stage 1|Withdrawal by Subject|0
58860|NCT01271803|231511|P1|Stage 1|Withdrawal by Subject|0
58861|NCT01271803|231500|P12|Stage 1|Physician Decision|0
58862|NCT01271803|231501|P11|Stage 1|Physician Decision|0
58863|NCT01271803|231502|P10|Stage 1|Physician Decision|0
58864|NCT01271803|231503|P9|Stage 1|Physician Decision|0
58865|NCT01271803|231504|P8|Stage 1|Physician Decision|0
58866|NCT01271803|231505|P7|Stage 1|Physician Decision|1
58867|NCT01271803|231506|P6|Stage 1|Physician Decision|0
58868|NCT01271803|231507|P5|Stage 1|Physician Decision|0
58869|NCT01271803|231508|P4|Stage 1|Physician Decision|0
58870|NCT01271803|231509|P3|Stage 1|Physician Decision|0
58871|NCT01271803|231510|P2|Stage 1|Physician Decision|0
58872|NCT01271803|231511|P1|Stage 1|Physician Decision|1
58873|NCT01271803|231500|P12|Stage 1|Death|0
58874|NCT01271803|231501|P11|Stage 1|Death|0
58875|NCT01271803|231502|P10|Stage 1|Death|0
58876|NCT01271803|231503|P9|Stage 1|Death|0
58877|NCT01271803|231504|P8|Stage 1|Death|0
58878|NCT01271803|231505|P7|Stage 1|Death|0
58879|NCT01271803|231506|P6|Stage 1|Death|1
58880|NCT01271803|231507|P5|Stage 1|Death|0
58881|NCT01271803|231508|P4|Stage 1|Death|0
58882|NCT01271803|231509|P3|Stage 1|Death|0
58883|NCT01271803|231510|P2|Stage 1|Death|0
58884|NCT01271803|231511|P1|Stage 1|Death|1
58885|NCT01271803|231500|P12|Stage 1|Adverse Event|0
58886|NCT01271803|231501|P11|Stage 1|Adverse Event|0
58887|NCT01271803|231502|P10|Stage 1|Adverse Event|0
58888|NCT01271803|231503|P9|Stage 1|Adverse Event|0
58889|NCT01271803|231504|P8|Stage 1|Adverse Event|0
58890|NCT01271803|231505|P7|Stage 1|Adverse Event|0
58891|NCT01271803|231506|P6|Stage 1|Adverse Event|0
58892|NCT01271803|231507|P5|Stage 1|Adverse Event|0
58893|NCT01271803|231508|P4|Stage 1|Adverse Event|0
58894|NCT01271803|231509|P3|Stage 1|Adverse Event|1
58895|NCT01271803|231510|P2|Stage 1|Adverse Event|0
58896|NCT01271803|231511|P1|Stage 1|Adverse Event|0
58897|NCT01271803|231500|P12|Stage 1|Progressive disease|0
58898|NCT01271803|231501|P11|Stage 1|Progressive disease|0
58899|NCT01271803|231502|P10|Stage 1|Progressive disease|2
58900|NCT01271803|231503|P9|Stage 1|Progressive disease|4
58901|NCT01271803|231504|P8|Stage 1|Progressive disease|2
58902|NCT01271803|231505|P7|Stage 1|Progressive disease|2
58903|NCT01271803|231506|P6|Stage 1|Progressive disease|3
58904|NCT01271803|231507|P5|Stage 1|Progressive disease|1
58905|NCT01271803|231508|P4|Stage 1|Progressive disease|2
58906|NCT01271803|231509|P3|Stage 1|Progressive disease|12
58907|NCT01271803|231510|P2|Stage 1|Progressive disease|7
58908|NCT01271803|231511|P1|Stage 1|Progressive disease|3
58909|NCT01271712|231684|P2|Survival Follow-up|Ongoing with open-label treatment|1
58910|NCT01271712|231685|P1|Survival Follow-up|Ongoing with open-label treatment|14
58911|NCT01271712|231684|P2|Survival Follow-up|Death|3
58912|NCT01271712|231685|P1|Survival Follow-up|Death|13
58913|NCT01271712|231684|P2|Safety Follow-up|Ongoing with open-label treatment|0
58914|NCT01271712|231685|P1|Safety Follow-up|Ongoing with open-label treatment|3
58915|NCT01271712|231684|P2|Safety Follow-up|Protocol Violation|0
58916|NCT01271712|231685|P1|Safety Follow-up|Protocol Violation|1
58917|NCT01271712|231684|P2|Safety Follow-up|Withdrawal by Subject|1
58918|NCT01271712|231685|P1|Safety Follow-up|Withdrawal by Subject|1
58919|NCT01271712|231684|P2|Safety Follow-up|Death|2
58920|NCT01271712|231685|P1|Safety Follow-up|Death|4
58921|NCT01271712|231684|P2|Open Label Treatment|Ongoing with open-label treatment|33
58922|NCT01271712|231685|P1|Open Label Treatment|Ongoing with open-label treatment|24
58923|NCT01271712|231684|P2|Open Label Treatment|Progressive disease|13
58924|NCT01271712|231685|P1|Open Label Treatment|Progressive disease|12
58925|NCT01271712|231684|P2|Open Label Treatment|Adverse Event|4
58926|NCT01271712|231685|P1|Open Label Treatment|Adverse Event|2
58927|NCT01271712|231684|P2|Open Label Treatment|Physician Decision|0
58928|NCT01271712|231685|P1|Open Label Treatment|Physician Decision|2
58929|NCT01271712|231684|P2|Open Label Treatment|Withdrawal by Subject|5
58930|NCT01271712|231685|P1|Open Label Treatment|Withdrawal by Subject|0
58931|NCT01271712|231684|P2|Open Label Treatment|Death|1
58932|NCT01271712|231685|P1|Open Label Treatment|Death|1
58933|NCT01271712|231684|P2|Double Blind Treatment|receive no study drug|0
58934|NCT01271712|231685|P1|Double Blind Treatment|receive no study drug|1
58935|NCT01271712|231684|P2|Double Blind Treatment|Ongoing in double-blind treatment|3
58936|NCT01271712|231685|P1|Double Blind Treatment|Ongoing in double-blind treatment|53
58937|NCT01271712|231684|P2|Double Blind Treatment|Non compliance with study drug|0
58938|NCT01271712|231685|P1|Double Blind Treatment|Non compliance with study drug|2
58939|NCT01271712|231684|P2|Double Blind Treatment|Withdrawal by Subject|0
58940|NCT01271712|231685|P1|Double Blind Treatment|Withdrawal by Subject|4
58941|NCT01271712|231684|P2|Double Blind Treatment|Progressive disease|3
58942|NCT01271712|231685|P1|Double Blind Treatment|Progressive disease|21
58943|NCT01271712|231684|P2|Double Blind Treatment|Adverse Event|4
58944|NCT01271712|231685|P1|Double Blind Treatment|Adverse Event|8
58945|NCT01271712|231684|P2|Double Blind Treatment|Lack of Efficacy|0
58946|NCT01271712|231685|P1|Double Blind Treatment|Lack of Efficacy|1
58947|NCT01271712|231684|P2|Double Blind Treatment|Death|0
58948|NCT01271712|231685|P1|Double Blind Treatment|Death|2
58949|NCT01270971|231780|P2|Overall Study|Non-specific|3
58950|NCT01270971|231781|P1|Overall Study|Non-specific|7
58951|NCT01270971|231780|P2|Overall Study|Non compliance|2
58952|NCT01270971|231781|P1|Overall Study|Non compliance|2
58953|NCT01270971|231780|P2|Overall Study|Adverse Event|2
58954|NCT01270971|231781|P1|Overall Study|Adverse Event|1
58955|NCT01270971|231780|P2|Overall Study|Lost to Follow-up|5
58956|NCT01270971|231781|P1|Overall Study|Lost to Follow-up|18
58957|NCT01270971|231780|P2|Overall Study|Withdrawal by Subject|11
58958|NCT01270971|231781|P1|Overall Study|Withdrawal by Subject|24
58959|NCT01270958|231793|P1|Overall Study|Did not meet inclusion criteria for age|2
58960|NCT01270958|231793|P1|Overall Study|Lost to Follow-up|2
58961|NCT01270880|231822|P1|Overall Study|Never rec'd treatment, but registered.|1
58962|NCT01270841|231847|P4|Overall Study|Enrolled in error|0
58963|NCT01270841|231848|P3|Overall Study|Enrolled in error|0
58964|NCT01270841|231849|P2|Overall Study|Enrolled in error|1
58965|NCT01270841|231850|P1|Overall Study|Enrolled in error|0
58966|NCT01270841|231847|P4|Overall Study|Protocol Violation|0
58967|NCT01270841|231848|P3|Overall Study|Protocol Violation|0
58968|NCT01270841|231849|P2|Overall Study|Protocol Violation|5
58969|NCT01270841|231850|P1|Overall Study|Protocol Violation|1
58970|NCT01270841|231847|P4|Overall Study|Did not qualify|5
58971|NCT01270841|231848|P3|Overall Study|Did not qualify|4
58972|NCT01270841|231849|P2|Overall Study|Did not qualify|3
58973|NCT01270841|231850|P1|Overall Study|Did not qualify|6
58974|NCT01270841|231847|P4|Overall Study|Physician Decision|0
58975|NCT01270841|231848|P3|Overall Study|Physician Decision|0
58976|NCT01270841|231849|P2|Overall Study|Physician Decision|1
58977|NCT01270841|231850|P1|Overall Study|Physician Decision|0
58978|NCT01270841|231847|P4|Overall Study|Lost to Follow-up|2
58979|NCT01270841|231848|P3|Overall Study|Lost to Follow-up|4
58980|NCT01270841|231849|P2|Overall Study|Lost to Follow-up|1
58981|NCT01270841|231850|P1|Overall Study|Lost to Follow-up|3
58982|NCT01270841|231847|P4|Overall Study|Withdrawal by Subject|3
58983|NCT01270841|231848|P3|Overall Study|Withdrawal by Subject|3
58984|NCT01270841|231849|P2|Overall Study|Withdrawal by Subject|2
58985|NCT01270841|231850|P1|Overall Study|Withdrawal by Subject|3
58986|NCT01270841|231847|P4|Overall Study|Adverse Event|3
58987|NCT01270841|231848|P3|Overall Study|Adverse Event|0
58988|NCT01270841|231849|P2|Overall Study|Adverse Event|1
58989|NCT01270841|231850|P1|Overall Study|Adverse Event|0
58990|NCT01270828|231874|P3|Double Blind Phase|Adverse event related to study drug|0
58991|NCT01270828|231875|P2|Double Blind Phase|Adverse event related to study drug|7
58992|NCT01270828|231876|P1|Double Blind Phase|Adverse event related to study drug|5
58993|NCT01270828|231874|P3|Double Blind Phase|Adverse event not related to study drug|0
58994|NCT01270828|231875|P2|Double Blind Phase|Adverse event not related to study drug|1
58995|NCT01270828|231876|P1|Double Blind Phase|Adverse event not related to study drug|1
58996|NCT01270828|231874|P3|Double Blind Phase|Lack of Efficacy|0
58997|NCT01270828|231875|P2|Double Blind Phase|Lack of Efficacy|11
58998|NCT01270828|231876|P1|Double Blind Phase|Lack of Efficacy|2
58999|NCT01270828|231874|P3|Double Blind Phase|Lost to Follow-up|0
59000|NCT01270828|231875|P2|Double Blind Phase|Lost to Follow-up|2
59001|NCT01270828|231876|P1|Double Blind Phase|Lost to Follow-up|1
59002|NCT01270828|231874|P3|Double Blind Phase|Withdrawal by Subject|0
59003|NCT01270828|231875|P2|Double Blind Phase|Withdrawal by Subject|15
59004|NCT01270828|231876|P1|Double Blind Phase|Withdrawal by Subject|6
59005|NCT01270828|231874|P3|Double Blind Phase|Reason Unspecified|0
59006|NCT01270828|231875|P2|Double Blind Phase|Reason Unspecified|4
59007|NCT01270828|231876|P1|Double Blind Phase|Reason Unspecified|7
59008|NCT01270828|231874|P3|Double Blind Phase|Protocol and GCP non-compliance|0
59009|NCT01270828|231875|P2|Double Blind Phase|Protocol and GCP non-compliance|3
59010|NCT01270828|231876|P1|Double Blind Phase|Protocol and GCP non-compliance|4
59011|NCT01270828|231874|P3|Double Blind Phase|Protocol Violation|0
59012|NCT01270828|231875|P2|Double Blind Phase|Protocol Violation|1
59013|NCT01270828|231876|P1|Double Blind Phase|Protocol Violation|0
59014|NCT01270828|231874|P3|Double Blind Phase|Death|0
59015|NCT01270828|231875|P2|Double Blind Phase|Death|1
59016|NCT01270828|231876|P1|Double Blind Phase|Death|0
59017|NCT01270828|231874|P3|Pregabalin CR SB|Protocol Violation|8
59018|NCT01270828|231875|P2|Pregabalin CR SB|Protocol Violation|0
59019|NCT01270828|231876|P1|Pregabalin CR SB|Protocol Violation|0
59020|NCT01270828|231874|P3|Pregabalin CR SB|Unrelated AE|8
59021|NCT01270828|231875|P2|Pregabalin CR SB|Unrelated AE|0
59022|NCT01270828|231876|P1|Pregabalin CR SB|Unrelated AE|0
59023|NCT01270828|231874|P3|Pregabalin CR SB|Lost to Follow-up|10
59024|NCT01270828|231875|P2|Pregabalin CR SB|Lost to Follow-up|0
59025|NCT01270828|231876|P1|Pregabalin CR SB|Lost to Follow-up|0
59026|NCT01270828|231874|P3|Pregabalin CR SB|Withdrawal by Subject|29
59027|NCT01270828|231875|P2|Pregabalin CR SB|Withdrawal by Subject|0
59028|NCT01270828|231876|P1|Pregabalin CR SB|Withdrawal by Subject|0
59029|NCT01270828|231874|P3|Pregabalin CR SB|Lack of Efficacy|32
59030|NCT01270828|231875|P2|Pregabalin CR SB|Lack of Efficacy|0
59031|NCT01270828|231876|P1|Pregabalin CR SB|Lack of Efficacy|0
59032|NCT01270828|231874|P3|Pregabalin CR SB|Related adverse event|46
59033|NCT01270828|231875|P2|Pregabalin CR SB|Related adverse event|0
59034|NCT01270828|231876|P1|Pregabalin CR SB|Related adverse event|0
59035|NCT01270828|231874|P3|Pregabalin CR SB|Enrolled but not treated|5
59036|NCT01270828|231875|P2|Pregabalin CR SB|Enrolled but not treated|0
59037|NCT01270828|231876|P1|Pregabalin CR SB|Enrolled but not treated|0
59038|NCT01270828|231874|P3|Pregabalin CR SB|Reason Unspecified|8
59039|NCT01270828|231875|P2|Pregabalin CR SB|Reason Unspecified|0
59040|NCT01270828|231876|P1|Pregabalin CR SB|Reason Unspecified|0
59041|NCT01270802|231918|P2|Overall Study|Lost to Follow-up|1
59042|NCT01270802|231919|P1|Overall Study|Lost to Follow-up|0
59043|NCT01270802|231918|P2|Overall Study|Adverse Event|0
59044|NCT01270802|231919|P1|Overall Study|Adverse Event|1
59045|NCT01270802|231918|P2|Overall Study|Withdrawal by Subject|0
59046|NCT01270802|231919|P1|Overall Study|Withdrawal by Subject|1
59047|NCT01270620|232066|P2|Overall Study|Withdrawal by Subject|3
59048|NCT01270620|232067|P1|Overall Study|Withdrawal by Subject|1
59049|NCT01270503|232162|P1|Overall Study|Lost to Follow-up|1
59050|NCT01270464|232170|P3|Overall Study|Not Specified|3
59051|NCT01270464|232171|P2|Overall Study|Not Specified|1
59052|NCT01270464|232172|P1|Overall Study|Not Specified|1
59053|NCT01270464|232170|P3|Overall Study|Lost to Follow-up|1
59054|NCT01270464|232171|P2|Overall Study|Lost to Follow-up|3
59055|NCT01270464|232172|P1|Overall Study|Lost to Follow-up|2
59056|NCT01270464|232170|P3|Overall Study|Withdrawal by Subject|4
59057|NCT01270464|232171|P2|Overall Study|Withdrawal by Subject|1
59058|NCT01270464|232172|P1|Overall Study|Withdrawal by Subject|2
59059|NCT01270464|232170|P3|Overall Study|Adverse Event|7
59060|NCT01270464|232171|P2|Overall Study|Adverse Event|1
59061|NCT01270464|232172|P1|Overall Study|Adverse Event|9
59062|NCT01270464|232170|P3|Overall Study|Lack of Efficacy|1
59063|NCT01270464|232171|P2|Overall Study|Lack of Efficacy|3
59064|NCT01270464|232172|P1|Overall Study|Lack of Efficacy|2
59065|NCT01270464|232170|P3|Overall Study|Protocol Violation|2
59066|NCT01270464|232171|P2|Overall Study|Protocol Violation|3
59067|NCT01270464|232172|P1|Overall Study|Protocol Violation|4
59068|NCT01270256|232221|P2|Overall Study|Withdrawal by Subject|0
59069|NCT01270256|232222|P1|Overall Study|Withdrawal by Subject|1
59070|NCT01270139|232231|P3|Overall Study|Lost to Follow-up|2
59071|NCT01270139|232232|P2|Overall Study|Lost to Follow-up|9
59072|NCT01270139|232233|P1|Overall Study|Lost to Follow-up|10
59073|NCT01270139|232231|P3|Overall Study|Adverse Event|18
59074|NCT01270139|232232|P2|Overall Study|Adverse Event|17
59075|NCT01270139|232233|P1|Overall Study|Adverse Event|8
59076|NCT01269918|232285|P2|Overall Study|Did not receive study drug|3
59077|NCT01269918|232286|P1|Overall Study|Did not receive study drug|0
59078|NCT01269346|232350|P1|Extension Phase|Started a prohibited con med|1
59079|NCT01269346|232350|P1|Extension Phase|Clinical progression|1
59167|NCT01266850|232887|P3|Overall Study|Site Closure|1
59080|NCT01269346|232350|P1|Extension Phase|Physician decision or participant choice|9
59081|NCT01269346|232350|P1|Extension Phase|Disease progression|22
59082|NCT01269346|232350|P1|Extension Phase|Withdrawal by Subject|4
59083|NCT01269346|232350|P1|Extension Phase|Adverse Event|6
59084|NCT01269346|232350|P1|Treatment Phase|Not specified|2
59085|NCT01269346|232350|P1|Treatment Phase|Withdrawal by Subject|1
59086|NCT01269346|232350|P1|Treatment Phase|Adverse Event|3
59087|NCT01269346|232350|P1|Treatment Phase|Disease progression|3
59088|NCT01269125|232361|P3|Overall Study|Lost to Follow-up|0
59089|NCT01269125|232362|P2|Overall Study|Lost to Follow-up|0
59090|NCT01269125|232363|P1|Overall Study|Lost to Follow-up|4
59091|NCT01269125|232361|P3|Overall Study|Adverse Event|0
59092|NCT01269125|232362|P2|Overall Study|Adverse Event|5
59093|NCT01269125|232363|P1|Overall Study|Adverse Event|3
59094|NCT01268891|232402|P2|Overall Study|Administrative or other reason(s)|0
59095|NCT01268891|232403|P1|Overall Study|Administrative or other reason(s)|1
59096|NCT01268891|232402|P2|Overall Study|Withdrawal of Consent|1
59097|NCT01268891|232403|P1|Overall Study|Withdrawal of Consent|3
59098|NCT01268891|232402|P2|Overall Study|Lack of Efficacy|0
59099|NCT01268891|232403|P1|Overall Study|Lack of Efficacy|1
59100|NCT01268891|232402|P2|Overall Study|Adverse Event|7
59101|NCT01268891|232403|P1|Overall Study|Adverse Event|3
59102|NCT01268566|232422|P1|Overall Study|Death|30
59103|NCT01268566|232422|P1|Overall Study|Withdrawal by Subject|12
59104|NCT01268566|232422|P1|Overall Study|Lost to Follow-up|1
59105|NCT01268501|232440|P1|Overall Study|Handling Difficulties|2
59106|NCT01268501|232440|P1|Overall Study|Unacceptable Subjective Vision|3
59107|NCT01268501|232440|P1|Overall Study|Withdrawal by Subject|3
59108|NCT01268501|232440|P1|Overall Study|Lost to Follow-up|1
59109|NCT01268488|232444|P1|Overall Study|Physician Decision|2
59110|NCT01268488|232444|P1|Overall Study|Adverse Event|3
59111|NCT01268306|232451|P1|Overall Study|Lost to Follow-up|1
59112|NCT01268293|232455|P1|Overall Study|Subject choice|1
59113|NCT01268293|232455|P1|Overall Study|Adverse Event|1
59114|NCT01268293|232455|P1|Overall Study|Disease progression|7
59115|NCT01268267|232460|P1|Overall Study|Protocol Violation|1
59116|NCT01268150|232481|P1|Extension Phase|Not specified|6
59117|NCT01268150|232481|P1|Extension Phase|Disease progression|18
59118|NCT01268150|232481|P1|Extension Phase|Adverse Event|3
59119|NCT01268150|232481|P1|Treatment Phase|Not specified|4
59120|NCT01268150|232481|P1|Treatment Phase|Withdrawal by Subject|3
59121|NCT01268150|232481|P1|Treatment Phase|Adverse Event|3
59122|NCT01268150|232481|P1|Treatment Phase|Progression of disease|18
59123|NCT01268098|232500|P2|Overall Study|Adverse Event|0
59124|NCT01268098|232501|P1|Overall Study|Adverse Event|1
59125|NCT01267994|232509|P1|Overall Study|Adverse Event|2
59126|NCT01267266|232578|P2|Lead-in Phase|Withdrawal by Subject|0
59127|NCT01267266|232579|P1|Lead-in Phase|Withdrawal by Subject|1
59128|NCT01267266|232578|P2|Lead-in Phase|Adverse Event|0
59129|NCT01267266|232579|P1|Lead-in Phase|Adverse Event|2
59130|NCT01267266|232578|P2|Lead-in Phase|Lack of Efficacy|0
59131|NCT01267266|232579|P1|Lead-in Phase|Lack of Efficacy|20
59132|NCT01267266|232578|P2|Enrollment Phase|Withdrawal by Subject|0
59133|NCT01267266|232579|P1|Enrollment Phase|Withdrawal by Subject|2
59134|NCT01267253|232592|P1|Overall Study|Inevaluable-never received study treatme|2
59135|NCT01267253|232592|P1|Overall Study|Ineligible - required test not done|1
59136|NCT01267201|232627|P6|Second Intervention Period|Withdrawal by Subject|0
59137|NCT01267201|232628|P5|Second Intervention Period|Withdrawal by Subject|0
59138|NCT01267201|232629|P4|Second Intervention Period|Withdrawal by Subject|0
59139|NCT01267201|232630|P3|Second Intervention Period|Withdrawal by Subject|0
59140|NCT01267201|232631|P2|Second Intervention Period|Withdrawal by Subject|1
59141|NCT01267201|232632|P1|Second Intervention Period|Withdrawal by Subject|0
59142|NCT01267201|232627|P6|First Intervention Period|Withdrawal by Subject|0
59143|NCT01267201|232628|P5|First Intervention Period|Withdrawal by Subject|0
59144|NCT01267201|232629|P4|First Intervention Period|Withdrawal by Subject|0
59145|NCT01267201|232630|P3|First Intervention Period|Withdrawal by Subject|0
59146|NCT01267201|232631|P2|First Intervention Period|Withdrawal by Subject|0
59147|NCT01267201|232632|P1|First Intervention Period|Withdrawal by Subject|1
59148|NCT01267175|232649|P1|Overall Study|Lost to Follow-up|1
59149|NCT01267175|232649|P1|Overall Study|Withdrawal by Subject|1
59150|NCT01266967|232721|P2|Overall Study|Withdrawal by Subject|3
59151|NCT01266967|232722|P1|Overall Study|Withdrawal by Subject|3
59152|NCT01266967|232721|P2|Overall Study|Physician Decision|1
59153|NCT01266967|232722|P1|Overall Study|Physician Decision|0
59154|NCT01266967|232721|P2|Overall Study|Lost to Follow-up|1
59155|NCT01266967|232722|P1|Overall Study|Lost to Follow-up|2
59156|NCT01266967|232721|P2|Overall Study|Study Closed/Terminated|17
59157|NCT01266967|232722|P1|Overall Study|Study Closed/Terminated|15
59158|NCT01266967|232721|P2|Overall Study|Death|61
59159|NCT01266967|232722|P1|Overall Study|Death|69
59160|NCT01266876|232774|P5|Overall Study|Adverse Event|0
59161|NCT01266876|232775|P4|Overall Study|Adverse Event|1
59162|NCT01266876|232776|P3|Overall Study|Adverse Event|0
59163|NCT01266876|232777|P2|Overall Study|Adverse Event|0
59164|NCT01266876|232778|P1|Overall Study|Adverse Event|0
59165|NCT01266850|232885|P5|Overall Study|Site Closure|0
59166|NCT01266850|232886|P4|Overall Study|Site Closure|1
59168|NCT01266850|232888|P2|Overall Study|Site Closure|1
59169|NCT01266850|232889|P1|Overall Study|Site Closure|0
59170|NCT01266850|232885|P5|Overall Study|Adverse Event|1
59171|NCT01266850|232886|P4|Overall Study|Adverse Event|0
59172|NCT01266850|232887|P3|Overall Study|Adverse Event|0
59173|NCT01266850|232888|P2|Overall Study|Adverse Event|0
59174|NCT01266850|232889|P1|Overall Study|Adverse Event|0
59175|NCT01266850|232885|P5|Overall Study|Protocol Violation|2
59176|NCT01266850|232886|P4|Overall Study|Protocol Violation|1
59177|NCT01266850|232887|P3|Overall Study|Protocol Violation|0
59178|NCT01266850|232888|P2|Overall Study|Protocol Violation|1
59179|NCT01266850|232889|P1|Overall Study|Protocol Violation|0
59180|NCT01266850|232885|P5|Overall Study|Physician Decision|3
59181|NCT01266850|232886|P4|Overall Study|Physician Decision|4
59182|NCT01266850|232887|P3|Overall Study|Physician Decision|4
59183|NCT01266850|232888|P2|Overall Study|Physician Decision|6
59184|NCT01266850|232889|P1|Overall Study|Physician Decision|3
59185|NCT01266850|232885|P5|Overall Study|Withdrawal by Subject|12
59186|NCT01266850|232886|P4|Overall Study|Withdrawal by Subject|9
59187|NCT01266850|232887|P3|Overall Study|Withdrawal by Subject|6
59188|NCT01266850|232888|P2|Overall Study|Withdrawal by Subject|9
59189|NCT01266850|232889|P1|Overall Study|Withdrawal by Subject|8
59190|NCT01266850|232885|P5|Overall Study|Lost to Follow-up|12
59191|NCT01266850|232886|P4|Overall Study|Lost to Follow-up|13
59192|NCT01266850|232887|P3|Overall Study|Lost to Follow-up|13
59193|NCT01266850|232888|P2|Overall Study|Lost to Follow-up|19
59194|NCT01266850|232889|P1|Overall Study|Lost to Follow-up|19
59195|NCT01266824|232943|P2|Overall Study|Study terminated prior to completion|3
59196|NCT01266824|232944|P1|Overall Study|Study terminated prior to completion|2
59197|NCT01266291|232965|P1|Overall Study|Adverse Event|1
59198|NCT01266265|232972|P2|Overall Study|Clinical worsening|1
59199|NCT01266265|232973|P1|Overall Study|Clinical worsening|1
59200|NCT01266265|232972|P2|Overall Study|Site closed early|3
59201|NCT01266265|232973|P1|Overall Study|Site closed early|4
59202|NCT01266265|232972|P2|Overall Study|Lung transplant|5
59203|NCT01266265|232973|P1|Overall Study|Lung transplant|6
59204|NCT01266265|232972|P2|Overall Study|Non-compliance|5
59205|NCT01266265|232973|P1|Overall Study|Non-compliance|8
59206|NCT01266265|232972|P2|Overall Study|Enrolled in another clinical study|26
59207|NCT01266265|232973|P1|Overall Study|Enrolled in another clinical study|15
59208|NCT01266265|232972|P2|Overall Study|Stopped/changed PAH medication(s)|9
59209|NCT01266265|232973|P1|Overall Study|Stopped/changed PAH medication(s)|16
59300|NCT01265563|233287|P3|Overall Study|Withdrawal by Subject|1
59210|NCT01266265|232972|P2|Overall Study|Transferred care to another provider|28
59211|NCT01266265|232973|P1|Overall Study|Transferred care to another provider|22
59212|NCT01266265|232972|P2|Overall Study|Respiratory-related adverse event|1
59213|NCT01266265|232973|P1|Overall Study|Respiratory-related adverse event|2
59214|NCT01266265|232972|P2|Overall Study|Withdrawal by Subject|11
59215|NCT01266265|232973|P1|Overall Study|Withdrawal by Subject|13
59216|NCT01266265|232972|P2|Overall Study|Lost to Follow-up|28
59217|NCT01266265|232973|P1|Overall Study|Lost to Follow-up|23
59218|NCT01266265|232972|P2|Overall Study|Death|73
59219|NCT01266265|232973|P1|Overall Study|Death|95
59220|NCT01266148|232981|P2|Overall Study|missing mGFR value + AE|0
59221|NCT01266148|232982|P1|Overall Study|missing mGFR value + AE|1
59222|NCT01266148|232981|P2|Overall Study|Death|3
59223|NCT01266148|232982|P1|Overall Study|Death|2
59224|NCT01266148|232981|P2|Overall Study|2 2R rejections|0
59225|NCT01266148|232982|P1|Overall Study|2 2R rejections|1
59226|NCT01266148|232981|P2|Overall Study|Ongoing rejection|0
59227|NCT01266148|232982|P1|Overall Study|Ongoing rejection|1
59228|NCT01266148|232981|P2|Overall Study|Adverse Event|0
59229|NCT01266148|232982|P1|Overall Study|Adverse Event|2
59230|NCT01266122|233010|P2|Overall Study|Lost to Follow-up|6
59231|NCT01266122|233011|P1|Overall Study|Lost to Follow-up|6
59232|NCT01266070|233019|P1|Overall Study|Protocol Violation|1
59233|NCT01266070|233019|P1|Overall Study|Adverse Event|3
59234|NCT01266031|233027|P3|Overall Study|Adverse Event|3
59235|NCT01266031|233028|P2|Overall Study|Adverse Event|0
59236|NCT01266031|233029|P1|Overall Study|Adverse Event|0
59237|NCT01266031|233027|P3|Overall Study|Not treated|0
59238|NCT01266031|233028|P2|Overall Study|Not treated|3
59239|NCT01266031|233029|P1|Overall Study|Not treated|0
59240|NCT01266018|233037|P2|Overall Study|Progressive disease|1
59241|NCT01266018|233038|P1|Overall Study|Progressive disease|0
59242|NCT01266018|233037|P2|Overall Study|Physician Decision|0
59243|NCT01266018|233038|P1|Overall Study|Physician Decision|1
59244|NCT01265992|233049|P1|Overall Study|Did not receive treatment|1
59245|NCT01265992|233049|P1|Overall Study|Stopped treatment|3
59246|NCT01265992|233049|P1|Overall Study|Administrative reasons|2
59247|NCT01265992|233049|P1|Overall Study|Adverse Event|1
59248|NCT01265992|233049|P1|Overall Study|Withdrawal by Subject|1
59249|NCT01265992|233049|P1|Overall Study|Lost to Follow-up|1
59250|NCT01265953|233077|P2|Overall Study|Non compliance|3
59251|NCT01265953|233078|P1|Overall Study|Non compliance|5
59252|NCT01265875|233090|P1|Overall Study|Uncooperative/unreliable|1
59253|NCT01265823|233098|P1|Overall Study|Participant Request|1
59254|NCT01265823|233098|P1|Overall Study|Protocol Violation|1
59255|NCT01265823|233098|P1|Overall Study|Failure to Return|4
59256|NCT01265823|233098|P1|Overall Study|Unsatisfactory Response Efficacy|1
59257|NCT01265797|233127|P2|Open Label Month|Lost to Follow-up|1
59258|NCT01265797|233128|P1|Open Label Month|Lost to Follow-up|0
59259|NCT01265797|233127|P2|Blinded Month|Diary data incomplete|1
59260|NCT01265797|233128|P1|Blinded Month|Diary data incomplete|0
59261|NCT01265797|233127|P2|Blinded Month|Adverse Event|0
59262|NCT01265797|233128|P1|Blinded Month|Adverse Event|2
59263|NCT01265797|233127|P2|Blinded Month|Protocol Violation|1
59264|NCT01265797|233128|P1|Blinded Month|Protocol Violation|2
59265|NCT01265797|233127|P2|Blinded Month|Lost to Follow-up|0
59266|NCT01265797|233128|P1|Blinded Month|Lost to Follow-up|1
59267|NCT01265797|233127|P2|Blinded Month|Lack of Efficacy|0
59268|NCT01265797|233128|P1|Blinded Month|Lack of Efficacy|5
59269|NCT01265797|233127|P2|Run-in Month|1st seizure during run-in month|1
59270|NCT01265797|233128|P1|Run-in Month|1st seizure during run-in month|0
59271|NCT01265797|233127|P2|Run-in Month|Withdrawal by Subject|4
59272|NCT01265797|233128|P1|Run-in Month|Withdrawal by Subject|0
59273|NCT01265784|233159|P3|Overall Study|Incorrectly Randomized|1
59274|NCT01265784|233160|P2|Overall Study|Incorrectly Randomized|0
59275|NCT01265784|233161|P1|Overall Study|Incorrectly Randomized|0
59276|NCT01265784|233159|P3|Overall Study|Protocol Violation|0
59277|NCT01265784|233160|P2|Overall Study|Protocol Violation|0
59278|NCT01265784|233161|P1|Overall Study|Protocol Violation|2
59279|NCT01265784|233159|P3|Overall Study|Death|0
59280|NCT01265784|233160|P2|Overall Study|Death|0
59281|NCT01265784|233161|P1|Overall Study|Death|3
59282|NCT01265784|233159|P3|Overall Study|Adverse Event|0
59283|NCT01265784|233160|P2|Overall Study|Adverse Event|0
59284|NCT01265784|233161|P1|Overall Study|Adverse Event|1
59285|NCT01265784|233159|P3|Overall Study|Physician Decision|1
59286|NCT01265784|233160|P2|Overall Study|Physician Decision|0
59287|NCT01265784|233161|P1|Overall Study|Physician Decision|1
59288|NCT01265784|233159|P3|Overall Study|Withdrawal by Subject|0
59289|NCT01265784|233160|P2|Overall Study|Withdrawal by Subject|5
59290|NCT01265784|233161|P1|Overall Study|Withdrawal by Subject|0
59291|NCT01265784|233159|P3|Overall Study|Lost to Follow-up|2
59292|NCT01265784|233160|P2|Overall Study|Lost to Follow-up|3
59293|NCT01265784|233161|P1|Overall Study|Lost to Follow-up|5
59294|NCT01265615|233231|P4|Overall Study|Protocol Violation|3
59295|NCT01265615|233232|P3|Overall Study|Protocol Violation|4
59296|NCT01265615|233233|P2|Overall Study|Protocol Violation|2
59297|NCT01265615|233234|P1|Overall Study|Protocol Violation|2
59298|NCT01265563|233285|P5|Overall Study|Withdrawal by Subject|2
59299|NCT01265563|233286|P4|Overall Study|Withdrawal by Subject|0
59301|NCT01265563|233288|P2|Overall Study|Withdrawal by Subject|1
59302|NCT01265563|233289|P1|Overall Study|Withdrawal by Subject|0
59303|NCT01265511|233329|P2|Overall Study|Met stopping rules|2
59304|NCT01265511|233330|P1|Overall Study|Met stopping rules|0
59305|NCT01265511|233329|P2|Overall Study|Lack of Efficacy|1
59306|NCT01265511|233330|P1|Overall Study|Lack of Efficacy|2
59307|NCT01265498|233344|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
59308|NCT01265498|233345|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
59309|NCT01265420|233481|P1|Overall Study|Lost to Follow-up|1
59310|NCT01265394|233485|P1|Overall Study|Subjects withdrawn|37
59311|NCT01265056|233492|P2|Overall Study|Withdrawal by Subject|1
59312|NCT01265056|233493|P1|Overall Study|Withdrawal by Subject|1
59313|NCT01265056|233492|P2|Overall Study|Withdrawal by Subject|1
59314|NCT01265056|233493|P1|Overall Study|Withdrawal by Subject|1
59315|NCT01264939|233520|P2|Overall Study|Disease Progression|11
59316|NCT01264939|233521|P1|Overall Study|Disease Progression|8
59317|NCT01264939|233520|P2|Overall Study|Patient/Guardian Decision|10
59318|NCT01264939|233521|P1|Overall Study|Patient/Guardian Decision|8
59319|NCT01264939|233520|P2|Overall Study|Physician Decision|1
59320|NCT01264939|233521|P1|Overall Study|Physician Decision|1
59321|NCT01264939|233520|P2|Overall Study|Lost to Follow-up|3
59322|NCT01264939|233521|P1|Overall Study|Lost to Follow-up|0
59323|NCT01264939|233520|P2|Overall Study|Adverse Event|3
59324|NCT01264939|233521|P1|Overall Study|Adverse Event|1
59325|NCT01263925|233549|P2|Overall Study|Withdrawal/ Not specified|1
59326|NCT01263925|233550|P1|Overall Study|Withdrawal/ Not specified|0
59327|NCT01263925|233549|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
59328|NCT01263925|233550|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
59329|NCT01263925|233549|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
59330|NCT01263925|233550|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
59331|NCT01263925|233549|P2|Overall Study|AE/ Withdrawal|4
59332|NCT01263925|233550|P1|Overall Study|AE/ Withdrawal|1
59333|NCT01263925|233549|P2|Overall Study|AE/ Unsatisfactory Compliance|2
59334|NCT01263925|233550|P1|Overall Study|AE/ Unsatisfactory Compliance|2
59335|NCT01263925|233549|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
59336|NCT01263925|233550|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
59337|NCT01263925|233549|P2|Overall Study|Lost to Follow-up|1
59338|NCT01263925|233550|P1|Overall Study|Lost to Follow-up|3
59339|NCT01263925|233549|P2|Overall Study|Not specified|4
59340|NCT01263925|233550|P1|Overall Study|Not specified|4
59341|NCT01263925|233549|P2|Overall Study|Withdrawal by Subject|8
59342|NCT01263925|233550|P1|Overall Study|Withdrawal by Subject|6
59343|NCT01263925|233549|P2|Overall Study|Unsatisfactory Compliance of Subject|5
59344|NCT01263925|233550|P1|Overall Study|Unsatisfactory Compliance of Subject|8
59345|NCT01263925|233549|P2|Overall Study|Adverse Event|22
59346|NCT01263925|233550|P1|Overall Study|Adverse Event|23
59347|NCT01263925|233549|P2|Overall Study|Lack of Efficacy|1
59348|NCT01263925|233550|P1|Overall Study|Lack of Efficacy|0
59349|NCT01263925|233549|P2|Overall Study|Protocol Violation|0
59350|NCT01263925|233550|P1|Overall Study|Protocol Violation|1
59351|NCT01263873|233584|P2|Overall Study|One provider unable to complete numbers|1
59352|NCT01263873|233585|P1|Overall Study|One provider unable to complete numbers|1
59353|NCT01264887|233595|P1|Overall Study|Not Specified|2
59354|NCT01264887|233595|P1|Overall Study|Sponsor Decision Administrative Reasons|2
59355|NCT01264887|233595|P1|Overall Study|Withdrawal by Subject|6
59356|NCT01264887|233595|P1|Overall Study|Physician Decision|4
59357|NCT01264887|233595|P1|Overall Study|Lack of Efficacy|5
59358|NCT01264887|233595|P1|Overall Study|Death|7
59359|NCT01264887|233595|P1|Overall Study|Adverse Event|5
59360|NCT01264835|233606|P1|Overall Study|Lost to Follow-up|1
59361|NCT01264770|233616|P6|Overall Study|Adverse Event|1
59362|NCT01264770|233617|P5|Overall Study|Adverse Event|2
59363|NCT01264770|233618|P4|Overall Study|Adverse Event|0
59364|NCT01264770|233619|P3|Overall Study|Adverse Event|8
59365|NCT01264770|233620|P2|Overall Study|Adverse Event|7
59366|NCT01264770|233621|P1|Overall Study|Adverse Event|7
59367|NCT01264770|233616|P6|Overall Study|Lost to Follow-up|0
59368|NCT01264770|233617|P5|Overall Study|Lost to Follow-up|0
59369|NCT01264770|233618|P4|Overall Study|Lost to Follow-up|1
59370|NCT01264770|233619|P3|Overall Study|Lost to Follow-up|1
59371|NCT01264770|233620|P2|Overall Study|Lost to Follow-up|0
59372|NCT01264770|233621|P1|Overall Study|Lost to Follow-up|0
59373|NCT01264770|233616|P6|Overall Study|Dev. of study specific discont. criteria|1
59374|NCT01264770|233617|P5|Overall Study|Dev. of study specific discont. criteria|1
59375|NCT01264770|233618|P4|Overall Study|Dev. of study specific discont. criteria|0
59376|NCT01264770|233619|P3|Overall Study|Dev. of study specific discont. criteria|0
59377|NCT01264770|233620|P2|Overall Study|Dev. of study specific discont. criteria|0
59378|NCT01264770|233621|P1|Overall Study|Dev. of study specific discont. criteria|2
59379|NCT01264770|233616|P6|Overall Study|Lack of therapeutic response|0
59380|NCT01264770|233617|P5|Overall Study|Lack of therapeutic response|1
59381|NCT01264770|233618|P4|Overall Study|Lack of therapeutic response|1
59382|NCT01264770|233619|P3|Overall Study|Lack of therapeutic response|2
59383|NCT01264770|233620|P2|Overall Study|Lack of therapeutic response|0
59384|NCT01264770|233621|P1|Overall Study|Lack of therapeutic response|1
59385|NCT01264770|233616|P6|Overall Study|Severe non-compliance to protocol|0
59386|NCT01264770|233617|P5|Overall Study|Severe non-compliance to protocol|0
59387|NCT01264770|233618|P4|Overall Study|Severe non-compliance to protocol|1
59388|NCT01264770|233619|P3|Overall Study|Severe non-compliance to protocol|1
59389|NCT01264770|233620|P2|Overall Study|Severe non-compliance to protocol|0
59390|NCT01264770|233621|P1|Overall Study|Severe non-compliance to protocol|0
59391|NCT01264770|233616|P6|Overall Study|e.g., change in circumstances|4
59392|NCT01264770|233617|P5|Overall Study|e.g., change in circumstances|4
59393|NCT01264770|233618|P4|Overall Study|e.g., change in circumstances|3
59394|NCT01264770|233619|P3|Overall Study|e.g., change in circumstances|3
59395|NCT01264770|233620|P2|Overall Study|e.g., change in circumstances|3
59396|NCT01264770|233621|P1|Overall Study|e.g., change in circumstances|8
59397|NCT01264770|233616|P6|Overall Study|Not reported|0
59398|NCT01264770|233617|P5|Overall Study|Not reported|0
59399|NCT01264770|233618|P4|Overall Study|Not reported|0
59400|NCT01264770|233619|P3|Overall Study|Not reported|1
59401|NCT01264770|233620|P2|Overall Study|Not reported|0
59402|NCT01264770|233621|P1|Overall Study|Not reported|0
59403|NCT01264380|233722|P3|Period C|Adverse Event|1
59404|NCT01264380|233723|P2|Period C|Adverse Event|0
59405|NCT01264380|233724|P1|Period C|Adverse Event|0
59406|NCT01264380|233722|P3|Period C|Withdrawal by Subject|1
59407|NCT01264380|233723|P2|Period C|Withdrawal by Subject|0
59408|NCT01264380|233724|P1|Period C|Withdrawal by Subject|0
59409|NCT01264380|233722|P3|Period C|Follow-up for survival status|6
59410|NCT01264380|233723|P2|Period C|Follow-up for survival status|0
59411|NCT01264380|233724|P1|Period C|Follow-up for survival status|0
59412|NCT01264380|233722|P3|Period C|Death|2
59413|NCT01264380|233723|P2|Period C|Death|0
59414|NCT01264380|233724|P1|Period C|Death|0
59415|NCT01264380|233722|P3|Period C|Disease Progression|4
59416|NCT01264380|233723|P2|Period C|Disease Progression|0
59417|NCT01264380|233724|P1|Period C|Disease Progression|0
59418|NCT01264081|233745|P1|Started Treatment|Not complete cycle 1 due to death|1
59419|NCT01264081|233745|P1|Started Treatment|Withdrawal by Subject|1
59420|NCT01264081|233745|P1|Participants Screened|Screening failures|30
59421|NCT01264016|233750|P1|Overall Study|Felt faint at sight of blood|1
59422|NCT01264016|233750|P1|Overall Study|Withdrawal by Subject|1
59423|NCT01263691|233791|P6|Overall Study|Adverse Event|0
59424|NCT01263691|233792|P5|Overall Study|Adverse Event|0
59425|NCT01263691|233793|P4|Overall Study|Adverse Event|0
59426|NCT01263691|233794|P3|Overall Study|Adverse Event|0
59427|NCT01263691|233795|P2|Overall Study|Adverse Event|0
59428|NCT01263691|233796|P1|Overall Study|Adverse Event|1
59429|NCT01263691|233791|P6|Overall Study|Withdrawal by Subject|0
59430|NCT01263691|233792|P5|Overall Study|Withdrawal by Subject|0
59431|NCT01263691|233793|P4|Overall Study|Withdrawal by Subject|0
59432|NCT01263691|233794|P3|Overall Study|Withdrawal by Subject|0
59433|NCT01263691|233795|P2|Overall Study|Withdrawal by Subject|0
59434|NCT01263691|233796|P1|Overall Study|Withdrawal by Subject|1
59435|NCT01263691|233791|P6|Overall Study|Lost to Follow-up|0
59436|NCT01263691|233792|P5|Overall Study|Lost to Follow-up|0
59437|NCT01263691|233793|P4|Overall Study|Lost to Follow-up|1
59438|NCT01263691|233794|P3|Overall Study|Lost to Follow-up|1
59439|NCT01263691|233795|P2|Overall Study|Lost to Follow-up|0
59440|NCT01263691|233796|P1|Overall Study|Lost to Follow-up|1
59441|NCT01263665|233906|P1|Overall Study|Surgical Bypass|2
59442|NCT01263665|233906|P1|Overall Study|Amputation above the ankle|1
59443|NCT01263665|233906|P1|Overall Study|Death|2
59444|NCT01263665|233906|P1|Overall Study|Lost to Follow-up|3
59445|NCT01263665|233906|P1|Overall Study|Withdrew Consent|1
59446|NCT01263639|233913|P2|Overall Study|Exclusion =Admission greater than 7 days|9
59447|NCT01263639|233914|P1|Overall Study|Exclusion =Admission greater than 7 days|7
59448|NCT01263639|233913|P2|Overall Study|Lost to Follow-up|70
59449|NCT01263639|233914|P1|Overall Study|Lost to Follow-up|66
59450|NCT01263561|233922|P2|Overall Study|Death|2
59451|NCT01263561|233923|P1|Overall Study|Death|1
59452|NCT01263509|233935|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
59453|NCT01263509|233936|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
59454|NCT01263509|233937|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
59455|NCT01263509|233938|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
59456|NCT01263509|233935|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
59457|NCT01263509|233936|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
59458|NCT01263509|233937|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
59459|NCT01263509|233938|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
59460|NCT01263509|233935|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
59461|NCT01263509|233936|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
59462|NCT01263509|233937|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
59463|NCT01263509|233938|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
59464|NCT01263509|233935|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
59465|NCT01263509|233936|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
59466|NCT01263509|233937|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
59467|NCT01263509|233938|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
59468|NCT01263509|233935|P4|Entered - Long-Term Extension Study|Adverse Event|1
59469|NCT01263509|233936|P3|Entered - Long-Term Extension Study|Adverse Event|4
59470|NCT01263509|233937|P2|Entered - Long-Term Extension Study|Adverse Event|5
59471|NCT01263509|233938|P1|Entered - Long-Term Extension Study|Adverse Event|5
59472|NCT01263496|234067|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
59473|NCT01263496|234068|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
59474|NCT01263496|234069|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
59475|NCT01263496|234070|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
59476|NCT01263496|234071|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
59477|NCT01263496|234072|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
59478|NCT01263496|234073|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
59479|NCT01263496|234074|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
59480|NCT01263496|234075|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
59481|NCT01263496|234067|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
59482|NCT01263496|234068|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
59483|NCT01263496|234069|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
59484|NCT01263496|234070|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
59485|NCT01263496|234071|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
59486|NCT01263496|234072|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
59487|NCT01263496|234073|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
59488|NCT01263496|234074|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
59489|NCT01263496|234075|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
59490|NCT01263496|234067|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
59491|NCT01263496|234068|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
59492|NCT01263496|234069|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
59493|NCT01263496|234070|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
59494|NCT01263496|234071|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
59495|NCT01263496|234072|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
59496|NCT01263496|234073|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
59497|NCT01263496|234074|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
59498|NCT01263496|234075|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
59499|NCT01263496|234067|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
59500|NCT01263496|234068|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
59501|NCT01263496|234069|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
59502|NCT01263496|234070|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
59503|NCT01263496|234071|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
59504|NCT01263496|234072|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
59505|NCT01263496|234073|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
59506|NCT01263496|234074|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
59507|NCT01263496|234075|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
59508|NCT01263496|234067|P9|Entered - Long-Term Extension Study|Adverse Event|1
59509|NCT01263496|234068|P8|Entered - Long-Term Extension Study|Adverse Event|0
59510|NCT01263496|234069|P7|Entered - Long-Term Extension Study|Adverse Event|0
59511|NCT01263496|234070|P6|Entered - Long-Term Extension Study|Adverse Event|0
59512|NCT01263496|234071|P5|Entered - Long-Term Extension Study|Adverse Event|1
59513|NCT01263496|234072|P4|Entered - Long-Term Extension Study|Adverse Event|3
59514|NCT01263496|234073|P3|Entered - Long-Term Extension Study|Adverse Event|6
59515|NCT01263496|234074|P2|Entered - Long-Term Extension Study|Adverse Event|5
59516|NCT01263496|234075|P1|Entered - Long-Term Extension Study|Adverse Event|0
59517|NCT01263496|234067|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
59518|NCT01263496|234068|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
59519|NCT01263496|234069|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
59520|NCT01263496|234070|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
59521|NCT01263496|234071|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
59522|NCT01263496|234072|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
59523|NCT01263496|234073|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
59524|NCT01263496|234074|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
59525|NCT01263496|234075|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
59526|NCT01263496|234067|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
59527|NCT01263496|234068|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
59528|NCT01263496|234069|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
59529|NCT01263496|234070|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
59530|NCT01263496|234071|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
59531|NCT01263496|234072|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
59532|NCT01263496|234073|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
59533|NCT01263496|234074|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
59534|NCT01263496|234075|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
59535|NCT01263483|234370|P3|Overall Study|Participant Unavailability|1
59536|NCT01263483|234371|P2|Overall Study|Participant Unavailability|1
59537|NCT01263483|234372|P1|Overall Study|Participant Unavailability|0
59538|NCT01263483|234370|P3|Overall Study|Protocol Violation|1
59539|NCT01263483|234371|P2|Overall Study|Protocol Violation|1
59540|NCT01263483|234372|P1|Overall Study|Protocol Violation|0
59541|NCT01263483|234370|P3|Overall Study|Lack of Efficacy|0
59542|NCT01263483|234371|P2|Overall Study|Lack of Efficacy|0
59543|NCT01263483|234372|P1|Overall Study|Lack of Efficacy|2
59544|NCT01263483|234370|P3|Overall Study|Withdrawal by Subject|0
59545|NCT01263483|234371|P2|Overall Study|Withdrawal by Subject|0
59546|NCT01263483|234372|P1|Overall Study|Withdrawal by Subject|1
59547|NCT01263483|234370|P3|Overall Study|Adverse Event|3
59548|NCT01263483|234371|P2|Overall Study|Adverse Event|0
59549|NCT01263483|234372|P1|Overall Study|Adverse Event|4
59550|NCT01263470|234434|P6|Overall Study|Study Drug Non-compliance|0
59551|NCT01263470|234435|P5|Overall Study|Study Drug Non-compliance|1
59552|NCT01263470|234436|P4|Overall Study|Study Drug Non-compliance|0
59553|NCT01263470|234437|P3|Overall Study|Study Drug Non-compliance|0
59554|NCT01263470|234438|P2|Overall Study|Study Drug Non-compliance|0
59555|NCT01263470|234439|P1|Overall Study|Study Drug Non-compliance|0
59556|NCT01263470|234434|P6|Overall Study|Participant Unavailability|0
59557|NCT01263470|234435|P5|Overall Study|Participant Unavailability|0
59558|NCT01263470|234436|P4|Overall Study|Participant Unavailability|0
59559|NCT01263470|234437|P3|Overall Study|Participant Unavailability|0
59560|NCT01263470|234438|P2|Overall Study|Participant Unavailability|1
59561|NCT01263470|234439|P1|Overall Study|Participant Unavailability|0
59562|NCT01263470|234434|P6|Overall Study|Lack of Efficacy|0
59563|NCT01263470|234435|P5|Overall Study|Lack of Efficacy|0
59564|NCT01263470|234436|P4|Overall Study|Lack of Efficacy|0
59565|NCT01263470|234437|P3|Overall Study|Lack of Efficacy|2
59566|NCT01263470|234438|P2|Overall Study|Lack of Efficacy|0
59567|NCT01263470|234439|P1|Overall Study|Lack of Efficacy|0
59568|NCT01263470|234434|P6|Overall Study|Withdrawal by Subject|2
59569|NCT01263470|234435|P5|Overall Study|Withdrawal by Subject|0
59570|NCT01263470|234436|P4|Overall Study|Withdrawal by Subject|2
59571|NCT01263470|234437|P3|Overall Study|Withdrawal by Subject|1
59572|NCT01263470|234438|P2|Overall Study|Withdrawal by Subject|1
59573|NCT01263470|234439|P1|Overall Study|Withdrawal by Subject|0
59574|NCT01263470|234434|P6|Overall Study|Protocol Violation|1
59575|NCT01263470|234435|P5|Overall Study|Protocol Violation|0
59576|NCT01263470|234436|P4|Overall Study|Protocol Violation|0
59577|NCT01263470|234437|P3|Overall Study|Protocol Violation|0
59578|NCT01263470|234438|P2|Overall Study|Protocol Violation|1
59579|NCT01263470|234439|P1|Overall Study|Protocol Violation|0
59580|NCT01263470|234434|P6|Overall Study|Adverse Event|2
59581|NCT01263470|234435|P5|Overall Study|Adverse Event|2
59582|NCT01263470|234436|P4|Overall Study|Adverse Event|1
59583|NCT01263470|234437|P3|Overall Study|Adverse Event|1
59584|NCT01263470|234438|P2|Overall Study|Adverse Event|2
59585|NCT01263470|234439|P1|Overall Study|Adverse Event|2
59586|NCT01263444|234549|P1|Overall Study|Protocol Violation|1
59587|NCT01263444|234549|P1|Overall Study|Withdrawal by Subject|1
59588|NCT01263444|234549|P1|Overall Study|Adverse Event|8
59589|NCT01263054|234590|P2|Overall Study|Other|1
59590|NCT01263054|234591|P1|Overall Study|Other|0
59591|NCT01263054|234590|P2|Overall Study|Qualification Violation|0
59592|NCT01263054|234591|P1|Overall Study|Qualification Violation|1
59593|NCT01263054|234590|P2|Overall Study|Withdrawal by Subject|3
59594|NCT01263054|234591|P1|Overall Study|Withdrawal by Subject|1
59595|NCT01263054|234590|P2|Overall Study|Lost to Follow-up|2
59596|NCT01263054|234591|P1|Overall Study|Lost to Follow-up|2
59597|NCT01263054|234590|P2|Overall Study|Death|0
59598|NCT01263054|234591|P1|Overall Study|Death|1
59599|NCT01263028|234609|P1|Overall Study|Study terminated due to low enrollment.|4
59600|NCT01263028|234609|P1|Overall Study|Adverse Event|1
59601|NCT01263028|234609|P1|Overall Study|Withdrawal by Subject|1
59602|NCT01263015|234619|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
59603|NCT01263015|234620|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
59604|NCT01263015|234619|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
59605|NCT01263015|234620|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
59606|NCT01263015|234619|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
59607|NCT01263015|234620|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
59608|NCT01263015|234619|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
59609|NCT01263015|234620|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
59610|NCT01263015|234619|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
59611|NCT01263015|234620|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
59612|NCT01263015|234619|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
59613|NCT01263015|234620|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
59614|NCT01263015|234619|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
59615|NCT01263015|234620|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
59616|NCT01263015|234619|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
59617|NCT01263015|234620|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
59618|NCT01263015|234619|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
59619|NCT01263015|234620|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
59620|NCT01263015|234619|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
59621|NCT01263015|234620|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
59622|NCT01263015|234619|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
59623|NCT01263015|234620|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
59624|NCT01263015|234619|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
59625|NCT01263015|234620|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
59626|NCT01262989|234646|P2|Period 2|Intercurrent disease|1
59627|NCT01262989|234647|P1|Period 2|Intercurrent disease|0
59628|NCT01262989|234646|P2|Period 1|Positive answer for exclusion criteria|1
59629|NCT01262989|234647|P1|Period 1|Positive answer for exclusion criteria|0
59630|NCT01262989|234646|P2|Period 1|Intercurrent disease|1
59631|NCT01262989|234647|P1|Period 1|Intercurrent disease|0
59632|NCT01262989|234646|P2|Period 1|Lost to Follow-up|1
59633|NCT01262989|234647|P1|Period 1|Lost to Follow-up|1
59634|NCT01262872|234665|P8|Step 2|Migrated/moved from study area|3
59635|NCT01262872|234666|P7|Step 2|Migrated/moved from study area|2
59636|NCT01262872|234667|P6|Step 2|Migrated/moved from study area|6
59637|NCT01262872|234668|P5|Step 2|Migrated/moved from study area|2
59638|NCT01262872|234669|P4|Step 2|Migrated/moved from study area|3
59639|NCT01262872|234670|P3|Step 2|Migrated/moved from study area|4
59640|NCT01262872|234671|P2|Step 2|Migrated/moved from study area|0
59641|NCT01262872|234672|P1|Step 2|Migrated/moved from study area|0
59642|NCT01262872|234665|P8|Step 2|Withdrawal by Subject|1
59643|NCT01262872|234666|P7|Step 2|Withdrawal by Subject|2
59644|NCT01262872|234667|P6|Step 2|Withdrawal by Subject|1
59645|NCT01262872|234668|P5|Step 2|Withdrawal by Subject|3
59646|NCT01262872|234669|P4|Step 2|Withdrawal by Subject|6
59647|NCT01262872|234670|P3|Step 2|Withdrawal by Subject|4
59648|NCT01262872|234671|P2|Step 2|Withdrawal by Subject|0
59649|NCT01262872|234672|P1|Step 2|Withdrawal by Subject|0
59650|NCT01262872|234665|P8|Step 2|Protocol Violation|1
59651|NCT01262872|234666|P7|Step 2|Protocol Violation|3
59652|NCT01262872|234667|P6|Step 2|Protocol Violation|0
59653|NCT01262872|234668|P5|Step 2|Protocol Violation|0
59654|NCT01262872|234669|P4|Step 2|Protocol Violation|0
59655|NCT01262872|234670|P3|Step 2|Protocol Violation|1
59656|NCT01262872|234671|P2|Step 2|Protocol Violation|0
59657|NCT01262872|234672|P1|Step 2|Protocol Violation|0
59658|NCT01262872|234665|P8|Step 2|Death|1
59659|NCT01262872|234666|P7|Step 2|Death|2
59660|NCT01262872|234667|P6|Step 2|Death|2
59661|NCT01262872|234668|P5|Step 2|Death|0
59662|NCT01262872|234669|P4|Step 2|Death|1
59663|NCT01262872|234670|P3|Step 2|Death|0
59664|NCT01262872|234671|P2|Step 2|Death|0
59665|NCT01262872|234672|P1|Step 2|Death|0
59666|NCT01262820|234934|P1|Overall Study|Drug held for 21+ days|1
59667|NCT01262820|234934|P1|Overall Study|Lack of Efficacy|9
59668|NCT01262820|234934|P1|Overall Study|Adverse Event|5
59669|NCT01262573|234956|P2|Overall Study|Withdrawal by Subject|1
59670|NCT01262573|234957|P1|Overall Study|Withdrawal by Subject|0
59674|NCT01262456|235019|P3|1-Month Open-Label Extension Period|Other Reason|0
59675|NCT01262456|235020|P2|1-Month Open-Label Extension Period|Other Reason|1
59676|NCT01262456|235021|P1|1-Month Open-Label Extension Period|Other Reason|0
59677|NCT01262456|235019|P3|1-Month Open-Label Extension Period|Protocol Violation|2
59678|NCT01262456|235020|P2|1-Month Open-Label Extension Period|Protocol Violation|0
59679|NCT01262456|235021|P1|1-Month Open-Label Extension Period|Protocol Violation|1
59680|NCT01262456|235019|P3|1-Month Open-Label Extension Period|Adverse Event|2
59681|NCT01262456|235020|P2|1-Month Open-Label Extension Period|Adverse Event|0
59682|NCT01262456|235021|P1|1-Month Open-Label Extension Period|Adverse Event|2
59683|NCT01262456|235019|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
59684|NCT01262456|235020|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
59685|NCT01262456|235021|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
59686|NCT01262456|235019|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
59687|NCT01262456|235020|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
59688|NCT01262456|235021|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
59689|NCT01262456|235019|P3|3-Month Double-Blind Period|Protocol Violation|6
59690|NCT01262456|235020|P2|3-Month Double-Blind Period|Protocol Violation|6
59691|NCT01262456|235021|P1|3-Month Double-Blind Period|Protocol Violation|3
59692|NCT01262456|235019|P3|3-Month Double-Blind Period|Adverse Event|8
59693|NCT01262456|235020|P2|3-Month Double-Blind Period|Adverse Event|4
59694|NCT01262456|235021|P1|3-Month Double-Blind Period|Adverse Event|6
59695|NCT01262456|235019|P3|3-Month Double-Blind Period|Lost to Follow-up|3
59696|NCT01262456|235020|P2|3-Month Double-Blind Period|Lost to Follow-up|5
59697|NCT01262456|235021|P1|3-Month Double-Blind Period|Lost to Follow-up|4
59698|NCT01262456|235019|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
59699|NCT01262456|235020|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
59700|NCT01262456|235021|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
59701|NCT01262352|235064|P2|Washout|Extended Washout|1
59702|NCT01262352|235065|P1|Washout|Extended Washout|0
59703|NCT01262352|235064|P2|Washout|Adverse Event|1
59704|NCT01262352|235065|P1|Washout|Adverse Event|1
59705|NCT01262352|235064|P2|Period 1|Illness after randomization|0
59706|NCT01262352|235065|P1|Period 1|Illness after randomization|1
59707|NCT01262287|235083|P2|Overall Study|Lost to Follow-up|1
59708|NCT01262287|235084|P1|Overall Study|Lost to Follow-up|2
59709|NCT01262092|235145|P2|Gabapentin Taper|noncompliance - missed medications|0
59710|NCT01262092|235146|P1|Gabapentin Taper|noncompliance - missed medications|1
59711|NCT01262092|235145|P2|Buprenorphine Taper|noncompliance - missed medication|1
59712|NCT01262092|235146|P1|Buprenorphine Taper|noncompliance - missed medication|1
59713|NCT01262092|235145|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
59714|NCT01262092|235146|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
59715|NCT01262092|235145|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
59716|NCT01262092|235146|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
59717|NCT01262027|235152|P1|Overall Study|Protocol Violation|1
59718|NCT01262027|235152|P1|Overall Study|Withdrawal by Subject|3
59719|NCT01262027|235152|P1|Overall Study|Adverse Event|1
59720|NCT01261975|235157|P1|Overall Study|Surgical complication|1
59721|NCT01261624|235178|P2|Week 13 to Week 24|Insufficient Response|1
59722|NCT01261624|235179|P1|Week 13 to Week 24|Insufficient Response|0
59723|NCT01261624|235178|P2|Week 0 to Week 12|Insufficient Response|2
59724|NCT01261624|235179|P1|Week 0 to Week 12|Insufficient Response|0
59725|NCT01261624|235178|P2|Week 0 to Week 12|Disease Progression|1
59726|NCT01261624|235179|P1|Week 0 to Week 12|Disease Progression|1
59727|NCT01261390|235220|P4|Overall Study|Lost to Follow-up|6
59728|NCT01261390|235221|P3|Overall Study|Lost to Follow-up|5
59729|NCT01261390|235222|P2|Overall Study|Lost to Follow-up|6
59730|NCT01261390|235223|P1|Overall Study|Lost to Follow-up|1
59731|NCT01261390|235220|P4|Overall Study|Loss of Interest in the Study|0
59732|NCT01261390|235221|P3|Overall Study|Loss of Interest in the Study|0
59733|NCT01261390|235222|P2|Overall Study|Loss of Interest in the Study|1
59734|NCT01261390|235223|P1|Overall Study|Loss of Interest in the Study|3
59735|NCT01261390|235220|P4|Overall Study|Relocation|0
59736|NCT01261390|235221|P3|Overall Study|Relocation|0
59737|NCT01261390|235222|P2|Overall Study|Relocation|1
59738|NCT01261390|235223|P1|Overall Study|Relocation|0
59739|NCT01261390|235220|P4|Overall Study|Dissatisfaction with Treatment|2
59740|NCT01261390|235221|P3|Overall Study|Dissatisfaction with Treatment|1
59741|NCT01261390|235222|P2|Overall Study|Dissatisfaction with Treatment|1
59742|NCT01261390|235223|P1|Overall Study|Dissatisfaction with Treatment|2
59743|NCT01261390|235220|P4|Overall Study|Significant Concurrent Illness|0
59744|NCT01261390|235221|P3|Overall Study|Significant Concurrent Illness|1
59745|NCT01261390|235222|P2|Overall Study|Significant Concurrent Illness|0
59746|NCT01261390|235223|P1|Overall Study|Significant Concurrent Illness|1
59747|NCT01261325|235388|P3|Overall Study|AE, serious fatal|2
59748|NCT01261325|235389|P2|Overall Study|AE, serious fatal|0
59749|NCT01261325|235390|P1|Overall Study|AE, serious fatal|0
59750|NCT01261325|235388|P3|Overall Study|Lost to Follow-up|3
59751|NCT01261325|235389|P2|Overall Study|Lost to Follow-up|1
59752|NCT01261325|235390|P1|Overall Study|Lost to Follow-up|0
59753|NCT01261325|235388|P3|Overall Study|Protocol Violation|1
59754|NCT01261325|235389|P2|Overall Study|Protocol Violation|3
59755|NCT01261325|235390|P1|Overall Study|Protocol Violation|0
59756|NCT01261325|235388|P3|Overall Study|Randomized in Error|1
59757|NCT01261325|235389|P2|Overall Study|Randomized in Error|0
59758|NCT01261325|235390|P1|Overall Study|Randomized in Error|0
59759|NCT01261325|235388|P3|Overall Study|Screen Failure|0
59760|NCT01261325|235389|P2|Overall Study|Screen Failure|0
59761|NCT01261325|235390|P1|Overall Study|Screen Failure|1
59762|NCT01261325|235388|P3|Overall Study|Erroneously Randomized|0
59763|NCT01261325|235389|P2|Overall Study|Erroneously Randomized|0
59764|NCT01261325|235390|P1|Overall Study|Erroneously Randomized|1
59765|NCT01261325|235388|P3|Overall Study|Patient Randomized by Mistake|0
59766|NCT01261325|235389|P2|Overall Study|Patient Randomized by Mistake|1
59767|NCT01261325|235390|P1|Overall Study|Patient Randomized by Mistake|0
59768|NCT01261325|235388|P3|Overall Study|Non Compliance|0
59769|NCT01261325|235389|P2|Overall Study|Non Compliance|0
59770|NCT01261325|235390|P1|Overall Study|Non Compliance|2
59771|NCT01261325|235388|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
59772|NCT01261325|235389|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
59773|NCT01261325|235390|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
59774|NCT01261325|235388|P3|Overall Study|AE, non-serious non-fatal|13
59775|NCT01261325|235389|P2|Overall Study|AE, non-serious non-fatal|15
59776|NCT01261325|235390|P1|Overall Study|AE, non-serious non-fatal|9
59777|NCT01261325|235388|P3|Overall Study|SAE, non-fatal|1
59778|NCT01261325|235389|P2|Overall Study|SAE, non-fatal|5
59779|NCT01261325|235390|P1|Overall Study|SAE, non-fatal|1
59780|NCT01261325|235388|P3|Overall Study|Withdrawal by Subject|4
59781|NCT01261325|235389|P2|Overall Study|Withdrawal by Subject|2
59782|NCT01261325|235390|P1|Overall Study|Withdrawal by Subject|2
59783|NCT01261325|235388|P3|Overall Study|Lack of Efficacy|0
59784|NCT01261325|235389|P2|Overall Study|Lack of Efficacy|1
59785|NCT01261325|235390|P1|Overall Study|Lack of Efficacy|1
59786|NCT01261000|235428|P1|Overall Study|Screen failure|1
59787|NCT01260948|235434|P2|Second Intervention|Emesis|1
59788|NCT01260948|235435|P1|Second Intervention|Emesis|0
59789|NCT01260948|235434|P2|Washout of 28 Days|Withdrawal by Subject|3
59790|NCT01260948|235435|P1|Washout of 28 Days|Withdrawal by Subject|1
59791|NCT01260922|235445|P2|Second Intervention|Emesis|2
59792|NCT01260922|235446|P1|Second Intervention|Emesis|0
59793|NCT01260922|235445|P2|Washout of 28 Days|Withdrawal by Subject|2
59794|NCT01260922|235446|P1|Washout of 28 Days|Withdrawal by Subject|4
59795|NCT01260922|235445|P2|First Intervention|Withdrawal by Subject|1
59796|NCT01260922|235446|P1|First Intervention|Withdrawal by Subject|0
59797|NCT01260896|235456|P2|First Intervention|Withdrawn Due to Emesis|0
59798|NCT01260896|235457|P1|First Intervention|Withdrawn Due to Emesis|2
59799|NCT01260701|235515|P1|Overall Study|Did not begin protocol therapy|1
59800|NCT01260701|235515|P1|Overall Study|Ineligible|4
59801|NCT01260701|235515|P1|Overall Study|Under review|1
59802|NCT01260701|235515|P1|Overall Study|Not protocol specified|3
59803|NCT01260701|235515|P1|Overall Study|Death|2
59804|NCT01260701|235515|P1|Overall Study|Progression|53
59805|NCT01260701|235515|P1|Overall Study|Withdrawal by Subject|2
59806|NCT01260701|235515|P1|Overall Study|Adverse Event|9
59807|NCT01260584|235568|P4|Period 2|Withdrawal by Subject|0
59808|NCT01260584|235569|P3|Period 2|Withdrawal by Subject|0
59809|NCT01260584|235570|P2|Period 2|Withdrawal by Subject|1
59810|NCT01260584|235571|P1|Period 2|Withdrawal by Subject|0
59811|NCT01260584|235568|P4|Period 2|Adverse Event|0
59812|NCT01260584|235569|P3|Period 2|Adverse Event|2
59813|NCT01260584|235570|P2|Period 2|Adverse Event|0
59814|NCT01260584|235571|P1|Period 2|Adverse Event|1
59815|NCT01260584|235568|P4|Period 2|Protocol Violation|1
59816|NCT01260584|235569|P3|Period 2|Protocol Violation|3
59817|NCT01260584|235570|P2|Period 2|Protocol Violation|2
59818|NCT01260584|235571|P1|Period 2|Protocol Violation|0
59819|NCT01260584|235568|P4|Period 1|Adverse Event|0
59820|NCT01260584|235569|P3|Period 1|Adverse Event|1
59821|NCT01260584|235570|P2|Period 1|Adverse Event|0
59822|NCT01260584|235571|P1|Period 1|Adverse Event|0
59823|NCT01260584|235568|P4|Period 1|Protocol Violation|1
59824|NCT01260584|235569|P3|Period 1|Protocol Violation|1
59825|NCT01260584|235570|P2|Period 1|Protocol Violation|0
59826|NCT01260584|235571|P1|Period 1|Protocol Violation|0
59827|NCT01260467|235614|P1|Overall Study|Withdrawal by Subject|2
59828|NCT01260350|235646|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
59829|NCT01260350|235647|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
59830|NCT01260350|235648|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
59831|NCT01260350|235649|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
59832|NCT01260350|235650|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
59833|NCT01260350|235651|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
59834|NCT01260350|235652|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
59835|NCT01260350|235653|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
59836|NCT01260350|235654|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
59837|NCT01260350|235655|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
59923|NCT01259713|236017|P2|Overall Study|Death Not Related to IFI|1
59838|NCT01260350|235656|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
59839|NCT01260350|235657|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
59840|NCT01260350|235658|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
59841|NCT01260350|235659|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
59842|NCT01260350|235660|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
59843|NCT01260350|235661|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
59844|NCT01260350|235662|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
59845|NCT01260350|235663|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
59846|NCT01260350|235664|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
59847|NCT01260350|235665|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
59848|NCT01260350|235666|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
59849|NCT01260350|235667|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
59850|NCT01260350|235646|P22|Overall Study|Lack of Efficacy|0
59851|NCT01260350|235647|P21|Overall Study|Lack of Efficacy|3
59852|NCT01260350|235648|P20|Overall Study|Lack of Efficacy|0
59853|NCT01260350|235649|P19|Overall Study|Lack of Efficacy|0
59854|NCT01260350|235650|P18|Overall Study|Lack of Efficacy|1
59855|NCT01260350|235651|P17|Overall Study|Lack of Efficacy|0
59856|NCT01260350|235652|P16|Overall Study|Lack of Efficacy|0
59857|NCT01260350|235653|P15|Overall Study|Lack of Efficacy|0
59858|NCT01260350|235654|P14|Overall Study|Lack of Efficacy|0
59859|NCT01260350|235655|P13|Overall Study|Lack of Efficacy|0
59860|NCT01260350|235656|P12|Overall Study|Lack of Efficacy|0
59861|NCT01260350|235657|P11|Overall Study|Lack of Efficacy|0
59862|NCT01260350|235658|P10|Overall Study|Lack of Efficacy|0
59863|NCT01260350|235659|P9|Overall Study|Lack of Efficacy|0
59864|NCT01260350|235660|P8|Overall Study|Lack of Efficacy|0
59865|NCT01260350|235661|P7|Overall Study|Lack of Efficacy|0
59866|NCT01260350|235662|P6|Overall Study|Lack of Efficacy|0
59867|NCT01260350|235663|P5|Overall Study|Lack of Efficacy|0
59868|NCT01260350|235664|P4|Overall Study|Lack of Efficacy|0
59869|NCT01260350|235665|P3|Overall Study|Lack of Efficacy|0
59870|NCT01260350|235666|P2|Overall Study|Lack of Efficacy|0
59871|NCT01260350|235667|P1|Overall Study|Lack of Efficacy|0
59872|NCT01260311|235874|P1|Overall Study|Fesoterodine Started Before Enrollment|1
59873|NCT01260311|235874|P1|Overall Study|Medication Stopped|1
59874|NCT01260311|235874|P1|Overall Study|Gone to Province|2
59875|NCT01260311|235874|P1|Overall Study|Financial Constraints|77
59876|NCT01260311|235874|P1|Overall Study|Withdrawal by Subject|6
59877|NCT01260311|235874|P1|Overall Study|Lost to Follow-up|25
59878|NCT01260311|235874|P1|Overall Study|Lack of Efficacy|4
59879|NCT01260311|235874|P1|Overall Study|Adverse Event|11
59880|NCT01260194|235905|P1|Overall Study|Withdrawal of Consent|1
59881|NCT01260142|235923|P6|Treatment Period 1|Withdrawal by Subject|1
59882|NCT01260142|235924|P5|Treatment Period 1|Withdrawal by Subject|0
59883|NCT01260142|235925|P4|Treatment Period 1|Withdrawal by Subject|0
59884|NCT01260142|235926|P3|Treatment Period 1|Withdrawal by Subject|0
59885|NCT01260142|235927|P2|Treatment Period 1|Withdrawal by Subject|0
59886|NCT01260142|235928|P1|Treatment Period 1|Withdrawal by Subject|0
59887|NCT01260142|235923|P6|Treatment Period 1|Unexplained elevated sys. BP|0
59888|NCT01260142|235924|P5|Treatment Period 1|Unexplained elevated sys. BP|1
59889|NCT01260142|235925|P4|Treatment Period 1|Unexplained elevated sys. BP|0
59890|NCT01260142|235926|P3|Treatment Period 1|Unexplained elevated sys. BP|0
59891|NCT01260142|235927|P2|Treatment Period 1|Unexplained elevated sys. BP|0
59892|NCT01260142|235928|P1|Treatment Period 1|Unexplained elevated sys. BP|0
59893|NCT01260142|235923|P6|Treatment Period 1|Study on hold|2
59894|NCT01260142|235924|P5|Treatment Period 1|Study on hold|1
59895|NCT01260142|235925|P4|Treatment Period 1|Study on hold|0
59896|NCT01260142|235926|P3|Treatment Period 1|Study on hold|0
59897|NCT01260142|235927|P2|Treatment Period 1|Study on hold|1
59898|NCT01260142|235928|P1|Treatment Period 1|Study on hold|1
59899|NCT01259726|235982|P4|Overall Study|Lost to Follow-up|3
59900|NCT01259726|235983|P3|Overall Study|Lost to Follow-up|1
59901|NCT01259726|235984|P2|Overall Study|Lost to Follow-up|1
59902|NCT01259726|235985|P1|Overall Study|Lost to Follow-up|1
59903|NCT01259726|235982|P4|Overall Study|Withdrawal by Subject|1
59904|NCT01259726|235983|P3|Overall Study|Withdrawal by Subject|2
59905|NCT01259726|235984|P2|Overall Study|Withdrawal by Subject|3
59906|NCT01259726|235985|P1|Overall Study|Withdrawal by Subject|1
59907|NCT01259726|235982|P4|Overall Study|Physician Decision|1
59908|NCT01259726|235983|P3|Overall Study|Physician Decision|1
59909|NCT01259726|235984|P2|Overall Study|Physician Decision|0
59910|NCT01259726|235985|P1|Overall Study|Physician Decision|2
59911|NCT01259726|235982|P4|Overall Study|Death|0
59912|NCT01259726|235983|P3|Overall Study|Death|0
59913|NCT01259726|235984|P2|Overall Study|Death|0
59914|NCT01259726|235985|P1|Overall Study|Death|1
59915|NCT01259713|236017|P2|Overall Study|Subject Withdrew Consent|7
59916|NCT01259713|236018|P1|Overall Study|Subject Withdrew Consent|12
59917|NCT01259713|236017|P2|Overall Study|Protocol Violation|4
59918|NCT01259713|236018|P1|Overall Study|Protocol Violation|5
59919|NCT01259713|236017|P2|Overall Study|Lack of Efficacy|0
59920|NCT01259713|236018|P1|Overall Study|Lack of Efficacy|2
59921|NCT01259713|236017|P2|Overall Study|Investigators Discretion|6
59922|NCT01259713|236018|P1|Overall Study|Investigators Discretion|14
59924|NCT01259713|236018|P1|Overall Study|Death Not Related to IFI|8
59925|NCT01259713|236017|P2|Overall Study|Adverse Event|23
59926|NCT01259713|236018|P1|Overall Study|Adverse Event|54
59927|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
59928|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
59929|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
59930|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
59931|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
59932|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
59933|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
59934|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
59935|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
59936|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
59937|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
59938|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
59939|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
59940|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
59941|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
59942|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
59943|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
59944|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
59945|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
59946|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
59947|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
59948|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
59949|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
59950|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
59951|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
59952|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
59953|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
59954|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
59955|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
59956|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
59957|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
59958|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
59959|NCT01259492|236044|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
59960|NCT01259492|236045|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
59961|NCT01259492|236046|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
59962|NCT01259492|236047|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
59963|NCT01259492|236044|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
59964|NCT01259492|236045|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
59965|NCT01259492|236046|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
59966|NCT01259492|236047|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
59967|NCT01259492|236044|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
59968|NCT01259492|236045|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
59969|NCT01259492|236046|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
59970|NCT01259492|236047|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
59971|NCT01259492|236044|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
59972|NCT01259492|236045|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
59973|NCT01259492|236046|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
59974|NCT01259492|236047|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
59975|NCT01259492|236044|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
59976|NCT01259492|236045|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
59977|NCT01259492|236046|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
59978|NCT01259492|236047|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
59979|NCT01259492|236044|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
59980|NCT01259492|236045|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
59981|NCT01259492|236046|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
59982|NCT01259492|236047|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
59983|NCT01259492|236044|P4|Period 1 (9 Weeks)|Protocol Violation|1
59984|NCT01259492|236045|P3|Period 1 (9 Weeks)|Protocol Violation|3
59985|NCT01259492|236046|P2|Period 1 (9 Weeks)|Protocol Violation|6
59986|NCT01259492|236047|P1|Period 1 (9 Weeks)|Protocol Violation|5
59987|NCT01259492|236044|P4|Period 1 (9 Weeks)|Administrative Problems|2
59988|NCT01259492|236045|P3|Period 1 (9 Weeks)|Administrative Problems|1
59989|NCT01259492|236046|P2|Period 1 (9 Weeks)|Administrative Problems|1
59990|NCT01259492|236047|P1|Period 1 (9 Weeks)|Administrative Problems|0
59991|NCT01259492|236044|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
59992|NCT01259492|236045|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
59993|NCT01259492|236046|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
59994|NCT01259492|236047|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
59995|NCT01259492|236044|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
59996|NCT01259492|236045|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
59997|NCT01259492|236046|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
59998|NCT01259492|236047|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
59999|NCT01259492|236044|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
60000|NCT01259492|236045|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
60001|NCT01259492|236046|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
60002|NCT01259492|236047|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
60003|NCT01259492|236044|P4|Period 1 (9 Weeks)|Adverse Event|3
60004|NCT01259492|236045|P3|Period 1 (9 Weeks)|Adverse Event|26
60005|NCT01259492|236046|P2|Period 1 (9 Weeks)|Adverse Event|18
60006|NCT01259492|236047|P1|Period 1 (9 Weeks)|Adverse Event|13
60007|NCT01259466|236096|P2|Overall Study|Withdrawal by Subject|9
60008|NCT01259466|236097|P1|Overall Study|Withdrawal by Subject|1
60009|NCT01259401|236135|P2|4-month Follow-up|Lost to Follow-up|1
60010|NCT01259401|236136|P1|4-month Follow-up|Lost to Follow-up|0
60011|NCT01259401|236135|P2|4-month Follow-up|Death|1
60012|NCT01259401|236136|P1|4-month Follow-up|Death|0
60013|NCT01259375|236144|P1|Overall Study|Adverse Event|1
60014|NCT01259297|236161|P8|Double Blind Randomized Period|Other reasons|1
60015|NCT01259297|236162|P7|Double Blind Randomized Period|Other reasons|3
60016|NCT01259297|236163|P6|Double Blind Randomized Period|Other reasons|2
60017|NCT01259297|236164|P5|Double Blind Randomized Period|Other reasons|1
60018|NCT01259297|236165|P4|Double Blind Randomized Period|Other reasons|0
60019|NCT01259297|236166|P3|Double Blind Randomized Period|Other reasons|0
60020|NCT01259297|236167|P2|Double Blind Randomized Period|Other reasons|1
60021|NCT01259297|236168|P1|Double Blind Randomized Period|Other reasons|0
60022|NCT01259297|236161|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
60023|NCT01259297|236162|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
60024|NCT01259297|236163|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
60025|NCT01259297|236164|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
60026|NCT01259297|236165|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
60027|NCT01259297|236166|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
60028|NCT01259297|236167|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
60029|NCT01259297|236168|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
60030|NCT01259297|236161|P8|Double Blind Randomized Period|Death|1
60031|NCT01259297|236162|P7|Double Blind Randomized Period|Death|2
60032|NCT01259297|236163|P6|Double Blind Randomized Period|Death|5
60033|NCT01259297|236164|P5|Double Blind Randomized Period|Death|1
60034|NCT01259297|236165|P4|Double Blind Randomized Period|Death|2
60035|NCT01259297|236166|P3|Double Blind Randomized Period|Death|1
60036|NCT01259297|236167|P2|Double Blind Randomized Period|Death|1
60037|NCT01259297|236168|P1|Double Blind Randomized Period|Death|1
60038|NCT01259284|236199|P3|Overall Study|Study Termination|0
60039|NCT01259284|236200|P2|Overall Study|Study Termination|0
60040|NCT01259284|236201|P1|Overall Study|Study Termination|2
60041|NCT01259245|236211|P2|Overall Study|Death|2
60042|NCT01259245|236212|P1|Overall Study|Death|1
60043|NCT01259245|236211|P2|Overall Study|Withdrawal by Subject|24
60044|NCT01259245|236212|P1|Overall Study|Withdrawal by Subject|27
60045|NCT01259115|236287|P2|Period 2|Adverse Event|0
60046|NCT01259115|236288|P1|Period 2|Adverse Event|1
60047|NCT01259115|236287|P2|Period 1|Lost to Follow-up|1
60048|NCT01259115|236288|P1|Period 1|Lost to Follow-up|0
60049|NCT01259115|236287|P2|Period 1|Protocol Violation|0
60050|NCT01259115|236288|P1|Period 1|Protocol Violation|2
60051|NCT01259115|236287|P2|Period 1|Adverse Event|0
60052|NCT01259115|236288|P1|Period 1|Adverse Event|1
60053|NCT01259102|236324|P5|Overall Study|Other|1
60054|NCT01259102|236325|P4|Overall Study|Other|1
60055|NCT01259102|236326|P3|Overall Study|Other|1
60056|NCT01259102|236327|P2|Overall Study|Other|0
60057|NCT01259102|236328|P1|Overall Study|Other|0
60058|NCT01259102|236324|P5|Overall Study|Adverse Event|0
60059|NCT01259102|236325|P4|Overall Study|Adverse Event|1
60060|NCT01259102|236326|P3|Overall Study|Adverse Event|1
60061|NCT01259102|236327|P2|Overall Study|Adverse Event|0
60062|NCT01259102|236328|P1|Overall Study|Adverse Event|1
60063|NCT01259024|236385|P1|Overall Study|Physician Decision|1
60064|NCT01258998|236389|P1|Overall Study|Ineligible|1
60065|NCT01258803|236422|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
60066|NCT01258803|236423|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
60067|NCT01258803|236424|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
60068|NCT01258803|236425|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
60069|NCT01258803|236426|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
60070|NCT01258803|236427|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
60071|NCT01258803|236422|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
60072|NCT01258803|236423|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
60073|NCT01258803|236424|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
60074|NCT01258803|236425|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
60075|NCT01258803|236426|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
60076|NCT01258803|236427|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
60077|NCT01258803|236422|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
60078|NCT01258803|236423|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
60079|NCT01258803|236424|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
60080|NCT01258803|236425|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
60081|NCT01258803|236426|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
60082|NCT01258803|236427|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
60083|NCT01258738|236464|P2|Open-label Period|Withdrawn due to pregnancy|1
60084|NCT01258738|236465|P1|Open-label Period|Withdrawn due to pregnancy|1
60085|NCT01258738|236464|P2|Open-label Period|Other Reasons|1
60086|NCT01258738|236465|P1|Open-label Period|Other Reasons|0
60087|NCT01258738|236464|P2|Open-label Period|Adverse Event|5
60088|NCT01258738|236465|P1|Open-label Period|Adverse Event|4
60089|NCT01258738|236464|P2|Open-label Period|Protocol Violation|2
60090|NCT01258738|236465|P1|Open-label Period|Protocol Violation|2
60091|NCT01258738|236464|P2|Open-label Period|Withdrawal by Subject|6
60092|NCT01258738|236465|P1|Open-label Period|Withdrawal by Subject|5
60093|NCT01258738|236464|P2|Open-label Period|Lost to Follow-up|2
60094|NCT01258738|236465|P1|Open-label Period|Lost to Follow-up|0
60095|NCT01258738|236464|P2|Open-label Period|Insufficient clinical response|3
60096|NCT01258738|236465|P1|Open-label Period|Insufficient clinical response|5
60097|NCT01258738|236464|P2|Open-label Period|Did not meet inclusion criteria|1
60098|NCT01258738|236465|P1|Open-label Period|Did not meet inclusion criteria|0
60099|NCT01258738|236464|P2|Double-blind Period|Adverse Event|1
60100|NCT01258738|236465|P1|Double-blind Period|Adverse Event|3
60101|NCT01258738|236464|P2|Double-blind Period|Protocol Violation|1
60102|NCT01258738|236465|P1|Double-blind Period|Protocol Violation|1
60103|NCT01258738|236464|P2|Double-blind Period|Withdrawal by Subject|2
60104|NCT01258738|236465|P1|Double-blind Period|Withdrawal by Subject|2
60105|NCT01258738|236464|P2|Double-blind Period|Did not meet inclusion criteria|3
60106|NCT01258738|236465|P1|Double-blind Period|Did not meet inclusion criteria|3
60107|NCT01258660|236603|P2|Overall Study|Invalid for primary analysis data set|6
60108|NCT01258660|236604|P1|Overall Study|Invalid for primary analysis data set|4
60109|NCT01258660|236603|P2|Overall Study|Protocol Violation|1
60110|NCT01258660|236604|P1|Overall Study|Protocol Violation|0
60111|NCT01258660|236603|P2|Overall Study|due to relocation|0
60112|NCT01258660|236604|P1|Overall Study|due to relocation|2
60113|NCT01258660|236603|P2|Overall Study|Withdrawal by Subject|0
60114|NCT01258660|236604|P1|Overall Study|Withdrawal by Subject|3
60115|NCT01258660|236603|P2|Overall Study|Adverse Event|4
60116|NCT01258660|236604|P1|Overall Study|Adverse Event|2
60117|NCT01258595|236623|P2|Overall Study|Withdrawal by Subject|1
60118|NCT01258595|236624|P1|Overall Study|Withdrawal by Subject|0
60119|NCT01258595|236623|P2|Overall Study|Lost to Follow-up|0
60120|NCT01258595|236624|P1|Overall Study|Lost to Follow-up|1
60121|NCT01256684|236661|P3|Overall Study|Entry criteria not met/non-compliance|6
60122|NCT01256684|236662|P2|Overall Study|Entry criteria not met/non-compliance|7
60123|NCT01256684|236663|P1|Overall Study|Entry criteria not met/non-compliance|4
60124|NCT01256684|236661|P3|Overall Study|Lack of Efficacy|1
60125|NCT01256684|236662|P2|Overall Study|Lack of Efficacy|1
60126|NCT01256684|236663|P1|Overall Study|Lack of Efficacy|0
60127|NCT01256684|236661|P3|Overall Study|Physician Decision|0
60128|NCT01256684|236662|P2|Overall Study|Physician Decision|1
60129|NCT01256684|236663|P1|Overall Study|Physician Decision|0
60130|NCT01256684|236661|P3|Overall Study|Withdrawal by Subject|2
60131|NCT01256684|236662|P2|Overall Study|Withdrawal by Subject|0
60132|NCT01256684|236663|P1|Overall Study|Withdrawal by Subject|4
60133|NCT01256684|236661|P3|Overall Study|Adverse Event|2
60134|NCT01256684|236662|P2|Overall Study|Adverse Event|4
60135|NCT01256684|236663|P1|Overall Study|Adverse Event|1
60136|NCT01256658|236697|P2|Period 1|Death|44
60137|NCT01256658|236698|P1|Period 1|Death|48
60138|NCT01256658|236697|P2|Period 1|Withdrawal by Subject|43
60139|NCT01256658|236698|P1|Period 1|Withdrawal by Subject|35
60140|NCT01256658|236697|P2|Period 1|Lost to Follow-up|661
60141|NCT01256658|236698|P1|Period 1|Lost to Follow-up|837
60142|NCT01256567|236748|P1|Overall Study|Withdrawal by Subject|1
60143|NCT01256502|236758|P1|Overall Study|Protocol deviation|1
60144|NCT01256502|236758|P1|Overall Study|Personal reasons|5
60145|NCT01256502|236758|P1|Overall Study|Had scaffold removed|4
60146|NCT01256476|236770|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
60147|NCT01256476|236771|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
60148|NCT01256476|236770|P2|Overall Study|Subject non-compliance|1
60149|NCT01256476|236771|P1|Overall Study|Subject non-compliance|0
60150|NCT01256476|236770|P2|Overall Study|Physician Decision|1
60151|NCT01256476|236771|P1|Overall Study|Physician Decision|0
60152|NCT01256476|236770|P2|Overall Study|Persistent ALT or AST elevation|0
60153|NCT01256476|236771|P1|Overall Study|Persistent ALT or AST elevation|1
60154|NCT01256476|236770|P2|Overall Study|Lost to Follow-up|2
60155|NCT01256476|236771|P1|Overall Study|Lost to Follow-up|1
60156|NCT01256476|236770|P2|Overall Study|Withdrawal by Subject|1
60157|NCT01256476|236771|P1|Overall Study|Withdrawal by Subject|2
60158|NCT01256476|236770|P2|Overall Study|Adverse Event|1
60159|NCT01256476|236771|P1|Overall Study|Adverse Event|2
60160|NCT01256450|236779|P3|Double-blind Treatment|Not specified|12
60161|NCT01256450|236780|P2|Double-blind Treatment|Not specified|9
60162|NCT01256450|236781|P1|Double-blind Treatment|Not specified|0
60163|NCT01256450|236779|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
60164|NCT01256450|236780|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
60165|NCT01256450|236781|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
60166|NCT01256450|236779|P3|Double-blind Treatment|Non-compliance|4
60167|NCT01256450|236780|P2|Double-blind Treatment|Non-compliance|5
60168|NCT01256450|236781|P1|Double-blind Treatment|Non-compliance|0
60169|NCT01256450|236779|P3|Double-blind Treatment|Lack of analgesic effect|6
60170|NCT01256450|236780|P2|Double-blind Treatment|Lack of analgesic effect|5
60171|NCT01256450|236781|P1|Double-blind Treatment|Lack of analgesic effect|0
60172|NCT01256450|236779|P3|Double-blind Treatment|Withdrawal by Subject|1
60173|NCT01256450|236780|P2|Double-blind Treatment|Withdrawal by Subject|0
60174|NCT01256450|236781|P1|Double-blind Treatment|Withdrawal by Subject|0
60175|NCT01256450|236779|P3|Double-blind Treatment|Lost to Follow-up|7
60176|NCT01256450|236780|P2|Double-blind Treatment|Lost to Follow-up|1
60177|NCT01256450|236781|P1|Double-blind Treatment|Lost to Follow-up|0
60178|NCT01256450|236779|P3|Double-blind Treatment|Adverse Event|6
60179|NCT01256450|236780|P2|Double-blind Treatment|Adverse Event|8
60180|NCT01256450|236781|P1|Double-blind Treatment|Adverse Event|0
60181|NCT01256450|236779|P3|Open-label Titration|Not specified|0
60182|NCT01256450|236780|P2|Open-label Titration|Not specified|0
60183|NCT01256450|236781|P1|Open-label Titration|Not specified|13
60184|NCT01256450|236779|P3|Open-label Titration|Screen failure|0
60185|NCT01256450|236780|P2|Open-label Titration|Screen failure|0
60186|NCT01256450|236781|P1|Open-label Titration|Screen failure|1
60187|NCT01256450|236779|P3|Open-label Titration|Non-compliance|0
60188|NCT01256450|236780|P2|Open-label Titration|Non-compliance|0
60189|NCT01256450|236781|P1|Open-label Titration|Non-compliance|9
60190|NCT01256450|236779|P3|Open-label Titration|Lack of analgesic effect|0
60191|NCT01256450|236780|P2|Open-label Titration|Lack of analgesic effect|0
60192|NCT01256450|236781|P1|Open-label Titration|Lack of analgesic effect|30
60193|NCT01256450|236779|P3|Open-label Titration|Lost to Follow-up|0
60194|NCT01256450|236780|P2|Open-label Titration|Lost to Follow-up|0
60195|NCT01256450|236781|P1|Open-label Titration|Lost to Follow-up|7
60196|NCT01256450|236779|P3|Open-label Titration|Adverse Event|0
60197|NCT01256450|236780|P2|Open-label Titration|Adverse Event|0
60198|NCT01256450|236781|P1|Open-label Titration|Adverse Event|39
60199|NCT01258101|236894|P4|Overall Study|Other reason|8
60200|NCT01258101|236895|P3|Overall Study|Other reason|1
60201|NCT01258101|236896|P2|Overall Study|Other reason|8
60202|NCT01258101|236897|P1|Overall Study|Other reason|7
60203|NCT01258101|236894|P4|Overall Study|PCR positive at week 24|1
60204|NCT01258101|236895|P3|Overall Study|PCR positive at week 24|0
60205|NCT01258101|236896|P2|Overall Study|PCR positive at week 24|0
60206|NCT01258101|236897|P1|Overall Study|PCR positive at week 24|0
60207|NCT01258101|236894|P4|Overall Study|Lost to Follow-up|6
60208|NCT01258101|236895|P3|Overall Study|Lost to Follow-up|0
60209|NCT01258101|236896|P2|Overall Study|Lost to Follow-up|5
60210|NCT01258101|236897|P1|Overall Study|Lost to Follow-up|5
60211|NCT01258101|236894|P4|Overall Study|Patient´s compliance|2
60212|NCT01258101|236895|P3|Overall Study|Patient´s compliance|1
60213|NCT01258101|236896|P2|Overall Study|Patient´s compliance|3
60214|NCT01258101|236897|P1|Overall Study|Patient´s compliance|4
60215|NCT01258101|236894|P4|Overall Study|Patient is not able to attend visits|6
60216|NCT01258101|236895|P3|Overall Study|Patient is not able to attend visits|7
60217|NCT01258101|236896|P2|Overall Study|Patient is not able to attend visits|9
60218|NCT01258101|236897|P1|Overall Study|Patient is not able to attend visits|8
60219|NCT01258101|236894|P4|Overall Study|Informed consent has been withdrawn|1
60220|NCT01258101|236895|P3|Overall Study|Informed consent has been withdrawn|1
60221|NCT01258101|236896|P2|Overall Study|Informed consent has been withdrawn|2
60222|NCT01258101|236897|P1|Overall Study|Informed consent has been withdrawn|2
60223|NCT01258101|236894|P4|Overall Study|Extra exclusion criterion amended|1
60224|NCT01258101|236895|P3|Overall Study|Extra exclusion criterion amended|1
60225|NCT01258101|236896|P2|Overall Study|Extra exclusion criterion amended|1
60226|NCT01258101|236897|P1|Overall Study|Extra exclusion criterion amended|2
60227|NCT01258101|236894|P4|Overall Study|Adverse Event|0
60228|NCT01258101|236895|P3|Overall Study|Adverse Event|0
60229|NCT01258101|236896|P2|Overall Study|Adverse Event|6
60230|NCT01258101|236897|P1|Overall Study|Adverse Event|5
60231|NCT01257581|237022|P3|Overall Study|Death|4
60232|NCT01257581|237023|P2|Overall Study|Death|2
60233|NCT01257581|237024|P1|Overall Study|Death|2
60234|NCT01257581|237022|P3|Overall Study|Early Termination|2
60235|NCT01257581|237023|P2|Overall Study|Early Termination|1
60236|NCT01257581|237024|P1|Overall Study|Early Termination|3
60237|NCT01257542|237064|P2|Overall Study|Withdrawal by Subject|2
60238|NCT01257542|237065|P1|Overall Study|Withdrawal by Subject|0
60239|NCT01257542|237064|P2|Overall Study|Protocol Violation|5
60240|NCT01257542|237065|P1|Overall Study|Protocol Violation|3
60241|NCT01257503|237085|P2|Overall Study|strep culture positive at enrollment|0
60242|NCT01257503|237086|P1|Overall Study|strep culture positive at enrollment|1
60243|NCT01257503|237085|P2|Overall Study|Over 5 years old at enrollment|1
60244|NCT01257503|237086|P1|Overall Study|Over 5 years old at enrollment|0
60245|NCT01257503|237085|P2|Overall Study|Lost to Follow-up|10
60246|NCT01257503|237086|P1|Overall Study|Lost to Follow-up|7
60247|NCT01257425|237115|P2|Overall Study|Death|0
60248|NCT01257425|237116|P1|Overall Study|Death|1
60249|NCT01257425|237115|P2|Overall Study|Withdrawal by Subject|1
60250|NCT01257425|237116|P1|Overall Study|Withdrawal by Subject|0
60251|NCT01257425|237115|P2|Overall Study|Protocol Violation|1
60252|NCT01257425|237116|P1|Overall Study|Protocol Violation|1
60253|NCT01257425|237115|P2|Overall Study|Adverse Event|1
60254|NCT01257425|237116|P1|Overall Study|Adverse Event|1
60255|NCT01257425|237115|P2|Overall Study|Lack of Efficacy|3
60256|NCT01257425|237116|P1|Overall Study|Lack of Efficacy|3
60257|NCT01257230|237158|P3|Overall Study|Other reason not defined above|3
60258|NCT01257230|237159|P2|Overall Study|Other reason not defined above|5
60259|NCT01257230|237160|P1|Overall Study|Other reason not defined above|1
60260|NCT01257230|237158|P3|Overall Study|Withdrawal by Subject|1
60261|NCT01257230|237159|P2|Overall Study|Withdrawal by Subject|4
60262|NCT01257230|237160|P1|Overall Study|Withdrawal by Subject|0
60263|NCT01257230|237158|P3|Overall Study|Protocol Violation|1
60264|NCT01257230|237159|P2|Overall Study|Protocol Violation|0
60265|NCT01257230|237160|P1|Overall Study|Protocol Violation|3
60266|NCT01257230|237158|P3|Overall Study|Lack of Efficacy|0
60267|NCT01257230|237159|P2|Overall Study|Lack of Efficacy|1
60268|NCT01257230|237160|P1|Overall Study|Lack of Efficacy|0
60269|NCT01257230|237158|P3|Overall Study|Adverse Event|0
60270|NCT01257230|237159|P2|Overall Study|Adverse Event|0
60271|NCT01257230|237160|P1|Overall Study|Adverse Event|2
60272|NCT01257230|237158|P3|Overall Study|Not Treated|1
60273|NCT01257230|237159|P2|Overall Study|Not Treated|0
60274|NCT01257230|237160|P1|Overall Study|Not Treated|0
60275|NCT01257204|237237|P3|Follow-up Period (up to Week 48)|Unspecified|5
60276|NCT01257204|237238|P2|Follow-up Period (up to Week 48)|Unspecified|0
60277|NCT01257204|237239|P1|Follow-up Period (up to Week 48)|Unspecified|0
60278|NCT01257204|237237|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
60279|NCT01257204|237238|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
60280|NCT01257204|237239|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
60281|NCT01257204|237237|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
60282|NCT01257204|237238|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
60283|NCT01257204|237239|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
60284|NCT01257204|237237|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
60285|NCT01257204|237238|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
60286|NCT01257204|237239|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
60287|NCT01257204|237237|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
60288|NCT01257204|237238|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
60289|NCT01257204|237239|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
60290|NCT01257204|237237|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
60291|NCT01257204|237238|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
60292|NCT01257204|237239|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
60293|NCT01257204|237237|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
60294|NCT01257204|237238|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
60295|NCT01257204|237239|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
60296|NCT01257204|237237|P3|Treatment Period (up to Week 24)|Adverse Event|2
60297|NCT01257204|237238|P2|Treatment Period (up to Week 24)|Adverse Event|1
60298|NCT01257204|237239|P1|Treatment Period (up to Week 24)|Adverse Event|3
60299|NCT01257204|237237|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
60300|NCT01257204|237238|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
60301|NCT01257204|237239|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
60302|NCT01256411|237316|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
60303|NCT01256411|237317|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
60304|NCT01256411|237318|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
60305|NCT01256411|237319|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
60306|NCT01256411|237320|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
60307|NCT01256411|237321|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
60308|NCT01256411|237316|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
60309|NCT01256411|237317|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
60310|NCT01256411|237318|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
60311|NCT01256411|237319|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
60312|NCT01256411|237320|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
60313|NCT01256411|237321|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
60314|NCT01256411|237316|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
60315|NCT01256411|237317|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
60316|NCT01256411|237318|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
60317|NCT01256411|237319|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
60318|NCT01256411|237320|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
60319|NCT01256411|237321|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
60320|NCT01256411|237316|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
60321|NCT01256411|237317|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
60322|NCT01256411|237318|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
60323|NCT01256411|237319|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
60324|NCT01256411|237320|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
60325|NCT01256411|237321|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
60326|NCT01256411|237316|P6|Extension by Mono or Combination Therapy|Adverse Event|1
60327|NCT01256411|237317|P5|Extension by Mono or Combination Therapy|Adverse Event|6
60328|NCT01256411|237318|P4|Extension by Mono or Combination Therapy|Adverse Event|0
60329|NCT01256411|237319|P3|Extension by Mono or Combination Therapy|Adverse Event|0
60330|NCT01256411|237320|P2|Extension by Mono or Combination Therapy|Adverse Event|0
60331|NCT01256411|237321|P1|Extension by Mono or Combination Therapy|Adverse Event|0
60332|NCT01256411|237316|P6|Extension by Maximum Treatment|Adverse Event|0
60333|NCT01256411|237317|P5|Extension by Maximum Treatment|Adverse Event|0
60334|NCT01256411|237318|P4|Extension by Maximum Treatment|Adverse Event|0
60335|NCT01256411|237319|P3|Extension by Maximum Treatment|Adverse Event|1
60336|NCT01256411|237320|P2|Extension by Maximum Treatment|Adverse Event|2
60337|NCT01256411|237321|P1|Extension by Maximum Treatment|Adverse Event|4
60338|NCT01256411|237316|P6|Extension by Maximum Treatment|Lack of Efficacy|0
60339|NCT01256411|237317|P5|Extension by Maximum Treatment|Lack of Efficacy|0
60340|NCT01256411|237318|P4|Extension by Maximum Treatment|Lack of Efficacy|0
60341|NCT01256411|237319|P3|Extension by Maximum Treatment|Lack of Efficacy|1
60342|NCT01256411|237320|P2|Extension by Maximum Treatment|Lack of Efficacy|0
60343|NCT01256411|237321|P1|Extension by Maximum Treatment|Lack of Efficacy|1
60344|NCT01256411|237316|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
60345|NCT01256411|237317|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
60346|NCT01256411|237318|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
60347|NCT01256411|237319|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
60348|NCT01256411|237320|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
60349|NCT01256411|237321|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
60350|NCT01256411|237316|P6|Extension by Maximum Treatment|Lost to Follow-up|0
60351|NCT01256411|237317|P5|Extension by Maximum Treatment|Lost to Follow-up|0
60352|NCT01256411|237318|P4|Extension by Maximum Treatment|Lost to Follow-up|0
60353|NCT01256411|237319|P3|Extension by Maximum Treatment|Lost to Follow-up|0
60354|NCT01256411|237320|P2|Extension by Maximum Treatment|Lost to Follow-up|2
60355|NCT01256411|237321|P1|Extension by Maximum Treatment|Lost to Follow-up|1
60356|NCT01256411|237316|P6|Extension by Maximum Treatment|Protocol deviation|0
60357|NCT01256411|237317|P5|Extension by Maximum Treatment|Protocol deviation|0
60358|NCT01256411|237318|P4|Extension by Maximum Treatment|Protocol deviation|0
60359|NCT01256411|237319|P3|Extension by Maximum Treatment|Protocol deviation|1
60360|NCT01256411|237320|P2|Extension by Maximum Treatment|Protocol deviation|0
60361|NCT01256411|237321|P1|Extension by Maximum Treatment|Protocol deviation|0
60362|NCT01256385|237347|P2|Overall Study|Withdrawal by Subject|2
60363|NCT01256385|237348|P1|Overall Study|Withdrawal by Subject|2
60364|NCT01256385|237347|P2|Overall Study|Physician Decision|1
60365|NCT01256385|237348|P1|Overall Study|Physician Decision|1
60366|NCT01256294|237368|P2|Overall Study|Protocol deviation|1
60367|NCT01256294|237369|P1|Overall Study|Protocol deviation|2
60368|NCT01256294|237368|P2|Overall Study|Withdrawal by Subject|1
60369|NCT01256294|237369|P1|Overall Study|Withdrawal by Subject|1
60370|NCT01256294|237368|P2|Overall Study|Adverse Event|0
60371|NCT01256294|237369|P1|Overall Study|Adverse Event|1
60372|NCT01256190|237391|P2|Overall Study|Lost to Follow-up|0
60373|NCT01256190|237392|P1|Overall Study|Lost to Follow-up|2
60374|NCT01256177|237408|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
60375|NCT01256177|237409|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
60376|NCT01256177|237408|P2|Overall Study|Lack of Efficacy|2
60377|NCT01256177|237409|P1|Overall Study|Lack of Efficacy|11
60378|NCT01256177|237408|P2|Overall Study|Condition under Investigation Worsened|0
60379|NCT01256177|237409|P1|Overall Study|Condition under Investigation Worsened|1
60380|NCT01256177|237408|P2|Overall Study|Severe Non-Compliance to Protocol|2
60381|NCT01256177|237409|P1|Overall Study|Severe Non-Compliance to Protocol|4
60382|NCT01256177|237408|P2|Overall Study|Adverse Event|9
60383|NCT01256177|237409|P1|Overall Study|Adverse Event|8
60384|NCT01256177|237408|P2|Overall Study|Lost to Follow-up|2
60385|NCT01256177|237409|P1|Overall Study|Lost to Follow-up|2
60386|NCT01256177|237408|P2|Overall Study|Withdrawal by Subject|22
60387|NCT01256177|237409|P1|Overall Study|Withdrawal by Subject|23
60388|NCT01256060|237465|P4|Overall Study|Lost to Follow-up|0
60389|NCT01256060|237466|P3|Overall Study|Lost to Follow-up|0
60390|NCT01256060|237467|P2|Overall Study|Lost to Follow-up|1
60391|NCT01256060|237468|P1|Overall Study|Lost to Follow-up|0
60392|NCT01256008|237487|P3|Overall Study|Withdrawal by Subject|10
60393|NCT01256008|237488|P2|Overall Study|Withdrawal by Subject|3
60394|NCT01256008|237489|P1|Overall Study|Withdrawal by Subject|2
60395|NCT01256008|237487|P3|Overall Study|Lost to Follow-up|11
60396|NCT01256008|237488|P2|Overall Study|Lost to Follow-up|4
60397|NCT01256008|237489|P1|Overall Study|Lost to Follow-up|6
60398|NCT01255904|237511|P2|Overall Study|Physician Decision|4
60399|NCT01255904|237512|P1|Overall Study|Physician Decision|1
60400|NCT01255787|237522|P4|Overall Study|Noncompliance with Study Drug|0
60401|NCT01255787|237523|P3|Overall Study|Noncompliance with Study Drug|0
60402|NCT01255787|237524|P2|Overall Study|Noncompliance with Study Drug|1
60403|NCT01255787|237525|P1|Overall Study|Noncompliance with Study Drug|3
60404|NCT01255787|237522|P4|Overall Study|Lack of Efficacy|2
60405|NCT01255787|237523|P3|Overall Study|Lack of Efficacy|2
60406|NCT01255787|237524|P2|Overall Study|Lack of Efficacy|2
60407|NCT01255787|237525|P1|Overall Study|Lack of Efficacy|2
60408|NCT01255787|237522|P4|Overall Study|Pregnancy|1
60409|NCT01255787|237523|P3|Overall Study|Pregnancy|0
60410|NCT01255787|237524|P2|Overall Study|Pregnancy|0
60411|NCT01255787|237525|P1|Overall Study|Pregnancy|0
60412|NCT01255787|237522|P4|Overall Study|Withdrawal of Consent|4
60413|NCT01255787|237523|P3|Overall Study|Withdrawal of Consent|3
60414|NCT01255787|237524|P2|Overall Study|Withdrawal of Consent|9
60415|NCT01255787|237525|P1|Overall Study|Withdrawal of Consent|3
60416|NCT01255787|237522|P4|Overall Study|Lost to Follow-up|2
60417|NCT01255787|237523|P3|Overall Study|Lost to Follow-up|4
60418|NCT01255787|237524|P2|Overall Study|Lost to Follow-up|2
60419|NCT01255787|237525|P1|Overall Study|Lost to Follow-up|1
60420|NCT01255787|237522|P4|Overall Study|Major Protocol Deviation|4
60421|NCT01255787|237523|P3|Overall Study|Major Protocol Deviation|0
60422|NCT01255787|237524|P2|Overall Study|Major Protocol Deviation|1
60423|NCT01255787|237525|P1|Overall Study|Major Protocol Deviation|1
60424|NCT01255787|237522|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
60425|NCT01255787|237523|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
60426|NCT01255787|237524|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
60427|NCT01255787|237525|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
60428|NCT01255761|237553|P2|Overall Study|Other Reasons|18
60429|NCT01255761|237554|P1|Overall Study|Other Reasons|37
60430|NCT01255761|237553|P2|Overall Study|Withdrawal by Subject|27
60431|NCT01255761|237554|P1|Overall Study|Withdrawal by Subject|11
60432|NCT01255761|237553|P2|Overall Study|Lost to Follow-up|8
60433|NCT01255761|237554|P1|Overall Study|Lost to Follow-up|10
60434|NCT01255761|237553|P2|Overall Study|Protocol Violation|5
60435|NCT01255761|237554|P1|Overall Study|Protocol Violation|9
60436|NCT01255761|237553|P2|Overall Study|Lack of Efficacy|74
60437|NCT01255761|237554|P1|Overall Study|Lack of Efficacy|86
60438|NCT01255761|237553|P2|Overall Study|Adverse Event|43
60439|NCT01255761|237554|P1|Overall Study|Adverse Event|29
60440|NCT01255722|237639|P3|Overall Study|beta-blocker contraindicated|0
60441|NCT01255722|237640|P2|Overall Study|beta-blocker contraindicated|0
60442|NCT01255722|237641|P1|Overall Study|beta-blocker contraindicated|2
60443|NCT01255722|237639|P3|Overall Study|asymptomatic patient|0
60444|NCT01255722|237640|P2|Overall Study|asymptomatic patient|0
60445|NCT01255722|237641|P1|Overall Study|asymptomatic patient|1
60446|NCT01255722|237639|P3|Overall Study|Adverse Event|1
60447|NCT01255722|237640|P2|Overall Study|Adverse Event|1
60448|NCT01255722|237641|P1|Overall Study|Adverse Event|0
60449|NCT01255631|237666|P2|Overall Study|poor enrollment, no data analyzed|6
60450|NCT01255631|237667|P1|Overall Study|poor enrollment, no data analyzed|9
60451|NCT01255592|237685|P2|Overall Study|Other|1
60452|NCT01255592|237686|P1|Overall Study|Other|0
60453|NCT01255592|237685|P2|Overall Study|Withdrawal by Subject|0
60454|NCT01255592|237686|P1|Overall Study|Withdrawal by Subject|1
60455|NCT01255592|237685|P2|Overall Study|Adverse Event|0
60456|NCT01255592|237686|P1|Overall Study|Adverse Event|5
60457|NCT01255436|237749|P2|Overall Study|Death, stroke, or MI|3
60458|NCT01255436|237750|P1|Overall Study|Death, stroke, or MI|4
60459|NCT01255436|237749|P2|Overall Study|Lost to Follow-up|191
60460|NCT01255436|237750|P1|Overall Study|Lost to Follow-up|178
60461|NCT01255423|237764|P2|Overall Study|Use of prohibited medications|1
60462|NCT01255423|237765|P1|Overall Study|Use of prohibited medications|0
60463|NCT01255423|237764|P2|Overall Study|Abnormal Laboratory value|2
60464|NCT01255423|237765|P1|Overall Study|Abnormal Laboratory value|3
60465|NCT01255306|237781|P2|Overall Study|Physician Decision|1
60466|NCT01255306|237782|P1|Overall Study|Physician Decision|1
60467|NCT01254890|237798|P2|Overall Study|Disease Progression|5
60468|NCT01254890|237799|P1|Overall Study|Disease Progression|0
60469|NCT01254890|237798|P2|Overall Study|Withdrawal by Subject|2
60470|NCT01254890|237799|P1|Overall Study|Withdrawal by Subject|1
60471|NCT01254890|237798|P2|Overall Study|Ineligible|3
60472|NCT01254890|237799|P1|Overall Study|Ineligible|0
60473|NCT01254747|237833|P4|Overall Study|Discomfort|0
60474|NCT01254747|237834|P3|Overall Study|Discomfort|0
60475|NCT01254747|237835|P2|Overall Study|Discomfort|4
60476|NCT01254747|237836|P1|Overall Study|Discomfort|0
60477|NCT01254747|237833|P4|Overall Study|Biomicroscopy|0
60478|NCT01254747|237834|P3|Overall Study|Biomicroscopy|1
60479|NCT01254747|237835|P2|Overall Study|Biomicroscopy|0
60480|NCT01254747|237836|P1|Overall Study|Biomicroscopy|0
60481|NCT01254747|237833|P4|Overall Study|Lost to Follow-up|0
60482|NCT01254747|237834|P3|Overall Study|Lost to Follow-up|1
60483|NCT01254747|237835|P2|Overall Study|Lost to Follow-up|0
60484|NCT01254747|237836|P1|Overall Study|Lost to Follow-up|0
60485|NCT01254747|237833|P4|Overall Study|Symptoms and problems|0
60486|NCT01254747|237834|P3|Overall Study|Symptoms and problems|1
60487|NCT01254747|237835|P2|Overall Study|Symptoms and problems|2
60488|NCT01254747|237836|P1|Overall Study|Symptoms and problems|0
60489|NCT01254747|237833|P4|Overall Study|Difficult removal handling|0
60490|NCT01254747|237834|P3|Overall Study|Difficult removal handling|1
60491|NCT01254747|237835|P2|Overall Study|Difficult removal handling|0
60492|NCT01254747|237836|P1|Overall Study|Difficult removal handling|0
60493|NCT01254747|237833|P4|Overall Study|Unacceptable subjective vision|2
60494|NCT01254747|237834|P3|Overall Study|Unacceptable subjective vision|0
60495|NCT01254747|237835|P2|Overall Study|Unacceptable subjective vision|0
60496|NCT01254747|237836|P1|Overall Study|Unacceptable subjective vision|0
60497|NCT01254721|237876|P2|Overall Study|Wrongly randomization|1
60498|NCT01254721|237877|P1|Overall Study|Wrongly randomization|0
60499|NCT01254721|237876|P2|Overall Study|Withdrawal by Subject|11
60500|NCT01254721|237877|P1|Overall Study|Withdrawal by Subject|8
60501|NCT01254721|237876|P2|Overall Study|Adverse Event|3
60502|NCT01254721|237877|P1|Overall Study|Adverse Event|2
60503|NCT01254721|237876|P2|Overall Study|technical problum|0
60504|NCT01254721|237877|P1|Overall Study|technical problum|1
60505|NCT01254721|237876|P2|Overall Study|Death|1
60506|NCT01254721|237877|P1|Overall Study|Death|0
60507|NCT01254721|237876|P2|Overall Study|Lack of Efficacy|2
60508|NCT01254721|237877|P1|Overall Study|Lack of Efficacy|4
60509|NCT01254721|237876|P2|Overall Study|Lost to Follow-up|4
60510|NCT01254721|237877|P1|Overall Study|Lost to Follow-up|0
60511|NCT01254669|237887|P2|Overall Study|called to clinic during intervention|1
60512|NCT01254669|237888|P1|Overall Study|called to clinic during intervention|1
60513|NCT01254669|237887|P2|Overall Study|time constraint|2
60514|NCT01254669|237888|P1|Overall Study|time constraint|2
60515|NCT01254669|237887|P2|Overall Study|Withdrawal by Subject|1
60516|NCT01254669|237888|P1|Overall Study|Withdrawal by Subject|0
60517|NCT01254656|237899|P3|Overall Study|Death|0
60518|NCT01254656|237900|P2|Overall Study|Death|1
60519|NCT01254656|237901|P1|Overall Study|Death|0
60520|NCT01254656|237899|P3|Overall Study|Adverse Event|0
60521|NCT01254656|237900|P2|Overall Study|Adverse Event|1
60522|NCT01254656|237901|P1|Overall Study|Adverse Event|1
60523|NCT01254656|237899|P3|Overall Study|Pregnancy|2
60524|NCT01254656|237900|P2|Overall Study|Pregnancy|0
60525|NCT01254656|237901|P1|Overall Study|Pregnancy|0
60526|NCT01254656|237899|P3|Overall Study|Withdrawal by Subject|1
60527|NCT01254656|237900|P2|Overall Study|Withdrawal by Subject|2
60528|NCT01254656|237901|P1|Overall Study|Withdrawal by Subject|2
60529|NCT01254656|237899|P3|Overall Study|Lost to Follow-up|2
60530|NCT01254656|237900|P2|Overall Study|Lost to Follow-up|0
60531|NCT01254656|237901|P1|Overall Study|Lost to Follow-up|1
60532|NCT01254656|237899|P3|Overall Study|Lack of Efficacy|0
60533|NCT01254656|237900|P2|Overall Study|Lack of Efficacy|0
60534|NCT01254656|237901|P1|Overall Study|Lack of Efficacy|3
60535|NCT01254656|237899|P3|Overall Study|Discontinued due to termination of study|13
60536|NCT01254656|237900|P2|Overall Study|Discontinued due to termination of study|39
60537|NCT01254656|237901|P1|Overall Study|Discontinued due to termination of study|40
60538|NCT01254643|237927|P1|Overall Study|Withdrawal by Subject|1
60539|NCT01254604|237937|P2|Overall Study|Adverse Event|2
60540|NCT01254604|237938|P1|Overall Study|Adverse Event|3
60541|NCT01254604|237937|P2|Overall Study|Withdrawal by Subject|4
60542|NCT01254604|237938|P1|Overall Study|Withdrawal by Subject|2
60543|NCT01254604|237937|P2|Overall Study|Protocol Violation|2
60544|NCT01254604|237938|P1|Overall Study|Protocol Violation|2
60545|NCT01254604|237937|P2|Overall Study|Lost to Follow-up|1
60546|NCT01254604|237938|P1|Overall Study|Lost to Follow-up|1
60547|NCT01254565|237956|P6|Overall Study|Other|0
60548|NCT01254565|237957|P5|Overall Study|Other|0
60549|NCT01254565|237958|P4|Overall Study|Other|1
60550|NCT01254565|237959|P3|Overall Study|Other|0
60551|NCT01254565|237960|P2|Overall Study|Other|0
60552|NCT01254565|237961|P1|Overall Study|Other|0
60553|NCT01254565|237956|P6|Overall Study|Did not Receive Treatment|4
60554|NCT01254565|237957|P5|Overall Study|Did not Receive Treatment|3
60555|NCT01254565|237958|P4|Overall Study|Did not Receive Treatment|0
60556|NCT01254565|237959|P3|Overall Study|Did not Receive Treatment|0
60557|NCT01254565|237960|P2|Overall Study|Did not Receive Treatment|1
60558|NCT01254565|237961|P1|Overall Study|Did not Receive Treatment|1
60559|NCT01254565|237956|P6|Overall Study|Non-compliance to Study Procedures|0
60560|NCT01254565|237957|P5|Overall Study|Non-compliance to Study Procedures|1
60561|NCT01254565|237958|P4|Overall Study|Non-compliance to Study Procedures|0
60562|NCT01254565|237959|P3|Overall Study|Non-compliance to Study Procedures|0
60563|NCT01254565|237960|P2|Overall Study|Non-compliance to Study Procedures|0
60564|NCT01254565|237961|P1|Overall Study|Non-compliance to Study Procedures|0
60565|NCT01254409|238015|P4|Overall Study|Adverse Event|0
60566|NCT01254409|238016|P3|Overall Study|Adverse Event|0
60567|NCT01254409|238017|P2|Overall Study|Adverse Event|1
60568|NCT01254409|238018|P1|Overall Study|Adverse Event|0
60569|NCT01254344|238087|P2|Overall Study|Withdrawal by Subject|6
60570|NCT01254344|238088|P1|Overall Study|Withdrawal by Subject|3
60571|NCT01254344|238087|P2|Overall Study|Protocol Violation|4
60572|NCT01254344|238088|P1|Overall Study|Protocol Violation|1
60573|NCT01254344|238087|P2|Overall Study|Physician Decision|4
60574|NCT01254344|238088|P1|Overall Study|Physician Decision|7
60575|NCT01254344|238087|P2|Overall Study|Adverse Event|5
60576|NCT01254344|238088|P1|Overall Study|Adverse Event|2
60577|NCT01254331|238096|P1|Extension Phase|Lost to Follow-up|3
60578|NCT01254331|238096|P1|Extension Phase|Lack of Efficacy|1
60579|NCT01254331|238096|P1|Initial Phase|Pregnancy|1
60580|NCT01254331|238096|P1|Initial Phase|Withdrawal by Subject|1
60581|NCT01254331|238096|P1|Initial Phase|Adverse Event|3
60582|NCT01254318|238114|P1|Overall Study|Death|47
60583|NCT01254318|238114|P1|Overall Study|Lost to Follow-up|5
60584|NCT01254305|238123|P3|Overall Study|Other Reasons|2
60585|NCT01254305|238124|P2|Overall Study|Other Reasons|0
60586|NCT01254305|238125|P1|Overall Study|Other Reasons|0
60587|NCT01254305|238123|P3|Overall Study|Lost to Follow-up|5
60588|NCT01254305|238124|P2|Overall Study|Lost to Follow-up|6
60589|NCT01254305|238125|P1|Overall Study|Lost to Follow-up|10
60590|NCT01254305|238123|P3|Overall Study|Withdrawal by Subject|4
60591|NCT01254305|238124|P2|Overall Study|Withdrawal by Subject|2
60592|NCT01254305|238125|P1|Overall Study|Withdrawal by Subject|4
60593|NCT01254305|238123|P3|Overall Study|Protocol Violation|3
60594|NCT01254305|238124|P2|Overall Study|Protocol Violation|7
60595|NCT01254305|238125|P1|Overall Study|Protocol Violation|1
60596|NCT01254305|238123|P3|Overall Study|Lack of Efficacy|1
60597|NCT01254305|238124|P2|Overall Study|Lack of Efficacy|0
60598|NCT01254305|238125|P1|Overall Study|Lack of Efficacy|1
60599|NCT01254305|238123|P3|Overall Study|Adverse Event|2
60600|NCT01254305|238124|P2|Overall Study|Adverse Event|3
60601|NCT01254305|238125|P1|Overall Study|Adverse Event|6
60602|NCT01254292|238141|P2|LCS12 Extension Phase|Lost to Follow-up|0
60603|NCT01254292|238142|P1|LCS12 Extension Phase|Lost to Follow-up|1
60604|NCT01254292|238141|P2|LCS12 Extension Phase|Pregnancy|0
60605|NCT01254292|238142|P1|LCS12 Extension Phase|Pregnancy|2
60606|NCT01254292|238141|P2|LCS12 Extension Phase|Other unknown|0
60607|NCT01254292|238142|P1|LCS12 Extension Phase|Other unknown|4
60608|NCT01254292|238141|P2|LCS12 Extension Phase|Withdrawal by Subject|0
60609|NCT01254292|238142|P1|LCS12 Extension Phase|Withdrawal by Subject|7
60610|NCT01254292|238141|P2|LCS12 Extension Phase|Adverse Event|0
60611|NCT01254292|238142|P1|LCS12 Extension Phase|Adverse Event|9
60612|NCT01254292|238141|P2|LCS12 Extension Phase|Wish for pregnancy|0
60613|NCT01254292|238142|P1|LCS12 Extension Phase|Wish for pregnancy|14
60614|NCT01254292|238141|P2|Comparative Phase|Wish for pregnancy|6
60615|NCT01254292|238142|P1|Comparative Phase|Wish for pregnancy|4
60616|NCT01254292|238141|P2|Comparative Phase|Protocol Violation|2
60617|NCT01254292|238142|P1|Comparative Phase|Protocol Violation|1
60618|NCT01254292|238141|P2|Comparative Phase|Withdrawal by Subject|21
60619|NCT01254292|238142|P1|Comparative Phase|Withdrawal by Subject|20
60620|NCT01254292|238141|P2|Comparative Phase|Pregnancy|6
60621|NCT01254292|238142|P1|Comparative Phase|Pregnancy|2
60622|NCT01254292|238141|P2|Comparative Phase|Lost to Follow-up|21
60623|NCT01254292|238142|P1|Comparative Phase|Lost to Follow-up|3
60624|NCT01254292|238141|P2|Comparative Phase|Adverse Event|25
60625|NCT01254292|238142|P1|Comparative Phase|Adverse Event|25
60626|NCT01254188|238215|P1|Overall Study|per investigator discretion|20
60627|NCT01254188|238215|P1|Overall Study|Adverse Event|43
60628|NCT01254188|238215|P1|Overall Study|Withdrawal by Subject|7
60629|NCT01254188|238215|P1|Overall Study|Lost to Follow-up|5
60630|NCT01254188|238215|P1|Overall Study|Death|4
60631|NCT01254188|238215|P1|Overall Study|Pregnancy|2
60632|NCT01254188|238215|P1|Overall Study|Protocol Violation|6
60633|NCT01254188|238215|P1|Overall Study|Disease Progression|6
60634|NCT01254045|238226|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
60635|NCT01254045|238227|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
60636|NCT01254045|238228|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
60637|NCT01254045|238229|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
60638|NCT01254045|238230|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
60639|NCT01254045|238231|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
60640|NCT01253811|238285|P1|Overall Study|Withdrawal criteria|1
60641|NCT01253577|238304|P1|Overall Study|Lost to Follow-up|3
60642|NCT01253564|238312|P1|Overall Study|Serious Adverse Event|1
60643|NCT01253564|238312|P1|Overall Study|Withdrawal by Subject|1
60644|NCT01253564|238312|P1|Overall Study|Disease Progression|22
60645|NCT01253447|238356|P1|Overall Study|Adverse Event|2
60646|NCT01253408|238363|P3|Overall Study|Adverse Event|0
60647|NCT01253408|238364|P2|Overall Study|Adverse Event|1
60648|NCT01253408|238365|P1|Overall Study|Adverse Event|0
60649|NCT01253369|238388|P1|Overall Study|Not Evaluable|3
60650|NCT01253369|238388|P1|Overall Study|Progressive disease|23
60651|NCT01253369|238388|P1|Overall Study|Death|1
60652|NCT01253369|238388|P1|Overall Study|Withdrawal by Subject|2
60653|NCT01253369|238388|P1|Overall Study|Adverse Event|4
60654|NCT01253317|238418|P1|Overall Study|Adverse Event|2
60655|NCT01253304|238430|P4|Overall Study|Adverse Event|1
60656|NCT01253304|238431|P3|Overall Study|Adverse Event|0
60657|NCT01253304|238432|P2|Overall Study|Adverse Event|0
60658|NCT01253304|238433|P1|Overall Study|Adverse Event|0
60659|NCT01253265|238472|P5|Overall Study|Withdrawal by Subject|1
60660|NCT01253265|238473|P4|Overall Study|Withdrawal by Subject|0
60661|NCT01253265|238474|P3|Overall Study|Withdrawal by Subject|0
60662|NCT01253265|238475|P2|Overall Study|Withdrawal by Subject|0
60663|NCT01253265|238476|P1|Overall Study|Withdrawal by Subject|0
60664|NCT01253265|238472|P5|Overall Study|Met Predefined Discontinuation Criteria|0
60665|NCT01253265|238473|P4|Overall Study|Met Predefined Discontinuation Criteria|0
60666|NCT01253265|238474|P3|Overall Study|Met Predefined Discontinuation Criteria|0
60667|NCT01253265|238475|P2|Overall Study|Met Predefined Discontinuation Criteria|0
60668|NCT01253265|238476|P1|Overall Study|Met Predefined Discontinuation Criteria|1
60669|NCT01253187|238520|P6|Period 3|non-compliance|0
60670|NCT01253187|238521|P5|Period 3|non-compliance|1
60671|NCT01253187|238522|P4|Period 3|non-compliance|0
60672|NCT01253187|238523|P3|Period 3|non-compliance|0
60673|NCT01253187|238524|P2|Period 3|non-compliance|0
60674|NCT01253187|238525|P1|Period 3|non-compliance|0
60675|NCT01253187|238520|P6|Period 3|difficulty with blood sampling|0
60676|NCT01253187|238521|P5|Period 3|difficulty with blood sampling|0
60677|NCT01253187|238522|P4|Period 3|difficulty with blood sampling|0
60678|NCT01253187|238523|P3|Period 3|difficulty with blood sampling|0
60679|NCT01253187|238524|P2|Period 3|difficulty with blood sampling|1
60680|NCT01253187|238525|P1|Period 3|difficulty with blood sampling|0
60681|NCT01253187|238520|P6|Period 3|Pregnancy|0
60682|NCT01253187|238521|P5|Period 3|Pregnancy|0
60683|NCT01253187|238522|P4|Period 3|Pregnancy|0
60684|NCT01253187|238523|P3|Period 3|Pregnancy|0
60685|NCT01253187|238524|P2|Period 3|Pregnancy|0
60686|NCT01253187|238525|P1|Period 3|Pregnancy|1
60687|NCT01253187|238520|P6|Period 2|Withdrawal by Subject|0
60688|NCT01253187|238521|P5|Period 2|Withdrawal by Subject|1
60689|NCT01253187|238522|P4|Period 2|Withdrawal by Subject|0
60690|NCT01253187|238523|P3|Period 2|Withdrawal by Subject|0
60691|NCT01253187|238524|P2|Period 2|Withdrawal by Subject|0
60692|NCT01253187|238525|P1|Period 2|Withdrawal by Subject|0
60693|NCT01253174|238554|P6|Period 3|Pregnancy|0
60694|NCT01253174|238555|P5|Period 3|Pregnancy|0
60695|NCT01253174|238556|P4|Period 3|Pregnancy|0
60696|NCT01253174|238557|P3|Period 3|Pregnancy|1
60697|NCT01253174|238558|P2|Period 3|Pregnancy|0
60698|NCT01253174|238559|P1|Period 3|Pregnancy|0
60699|NCT01253174|238554|P6|Period 3|Withdrawal by Subject|0
60700|NCT01253174|238555|P5|Period 3|Withdrawal by Subject|1
60701|NCT01253174|238556|P4|Period 3|Withdrawal by Subject|0
60702|NCT01253174|238557|P3|Period 3|Withdrawal by Subject|0
60703|NCT01253174|238558|P2|Period 3|Withdrawal by Subject|1
60704|NCT01253174|238559|P1|Period 3|Withdrawal by Subject|0
60705|NCT01253174|238554|P6|Period 2|Adverse Event|0
60706|NCT01253174|238555|P5|Period 2|Adverse Event|0
60707|NCT01253174|238556|P4|Period 2|Adverse Event|0
60708|NCT01253174|238557|P3|Period 2|Adverse Event|1
60709|NCT01253174|238558|P2|Period 2|Adverse Event|0
60710|NCT01253174|238559|P1|Period 2|Adverse Event|0
60711|NCT01253174|238554|P6|Period 1|Randomized but not treated|0
60712|NCT01253174|238555|P5|Period 1|Randomized but not treated|1
60713|NCT01253174|238556|P4|Period 1|Randomized but not treated|0
60714|NCT01253174|238557|P3|Period 1|Randomized but not treated|1
60715|NCT01253174|238558|P2|Period 1|Randomized but not treated|1
60716|NCT01253174|238559|P1|Period 1|Randomized but not treated|0
60717|NCT01253135|238594|P1|Amended Protocol|Non-compliance|1
60718|NCT01253135|238594|P1|Original Protocol|Protocol Amendment|15
60719|NCT01253044|238613|P2|Overall Study|Lost to Follow-up|29
60720|NCT01253044|238614|P1|Overall Study|Lost to Follow-up|38
60721|NCT01253018|238624|P2|Overall Study|Withdrawal by Subject|1
60722|NCT01253018|238625|P1|Overall Study|Withdrawal by Subject|1
60723|NCT01253018|238624|P2|Overall Study|Robot Repair Issues|0
60724|NCT01253018|238625|P1|Overall Study|Robot Repair Issues|2
60725|NCT01253018|238624|P2|Overall Study|Lost to Follow-up|1
60726|NCT01253018|238625|P1|Overall Study|Lost to Follow-up|1
60727|NCT01252966|238639|P2|Overall Study|Withdrawal by Subject|3
60728|NCT01252966|238640|P1|Overall Study|Withdrawal by Subject|7
60729|NCT01252966|238639|P2|Overall Study|Lost to Follow-up|10
60730|NCT01252966|238640|P1|Overall Study|Lost to Follow-up|16
60731|NCT01252940|238656|P2|Extension Phase|Withdrawal by Subject|1
60732|NCT01252940|238657|P1|Extension Phase|Withdrawal by Subject|1
60733|NCT01252940|238656|P2|Extension Phase|Subject Non-compliance|0
60734|NCT01252940|238657|P1|Extension Phase|Subject Non-compliance|1
60735|NCT01252940|238656|P2|Extension Phase|Physician Decision|1
60736|NCT01252940|238657|P1|Extension Phase|Physician Decision|0
60737|NCT01252940|238656|P2|Extension Phase|Lost to Follow-up|0
60738|NCT01252940|238657|P1|Extension Phase|Lost to Follow-up|5
60739|NCT01252940|238656|P2|Extension Phase|Lack of Efficacy|0
60740|NCT01252940|238657|P1|Extension Phase|Lack of Efficacy|1
60741|NCT01252940|238656|P2|Extension Phase|Adverse Event|1
60742|NCT01252940|238657|P1|Extension Phase|Adverse Event|2
60743|NCT01252940|238656|P2|Main Study Phase|Subject Non-compliance|1
60744|NCT01252940|238657|P1|Main Study Phase|Subject Non-compliance|1
60745|NCT01252940|238656|P2|Main Study Phase|Withdrawal by Subject|5
60746|NCT01252940|238657|P1|Main Study Phase|Withdrawal by Subject|6
60747|NCT01252940|238656|P2|Main Study Phase|Protocol Violation|2
60748|NCT01252940|238657|P1|Main Study Phase|Protocol Violation|4
60749|NCT01252940|238656|P2|Main Study Phase|Physician Decision|0
60750|NCT01252940|238657|P1|Main Study Phase|Physician Decision|1
60751|NCT01252940|238656|P2|Main Study Phase|Lost to Follow-up|1
60752|NCT01252940|238657|P1|Main Study Phase|Lost to Follow-up|6
60753|NCT01252940|238656|P2|Main Study Phase|Lack of Efficacy|0
60754|NCT01252940|238657|P1|Main Study Phase|Lack of Efficacy|1
60755|NCT01252940|238656|P2|Main Study Phase|Adverse Event|1
60756|NCT01252940|238657|P1|Main Study Phase|Adverse Event|3
60757|NCT01252940|238656|P2|Main Study Phase|Randomized but not treated|2
60758|NCT01252940|238657|P1|Main Study Phase|Randomized but not treated|4
60759|NCT01252810|238688|P2|Overall Study|Various reasons|0
60760|NCT01252810|238689|P1|Overall Study|Various reasons|8
60761|NCT01252810|238688|P2|Overall Study|Physician Decision|1
60762|NCT01252810|238689|P1|Overall Study|Physician Decision|2
60763|NCT01252810|238688|P2|Overall Study|Lost to Follow-up|1
60764|NCT01252810|238689|P1|Overall Study|Lost to Follow-up|0
60765|NCT01252810|238688|P2|Overall Study|Withdrawal by Subject|1
60766|NCT01252810|238689|P1|Overall Study|Withdrawal by Subject|4
60767|NCT01252355|238702|P3|Overall Study|Other Than Above|7
60768|NCT01252355|238703|P2|Overall Study|Other Than Above|7
60769|NCT01252355|238704|P1|Overall Study|Other Than Above|8
60770|NCT01252355|238702|P3|Overall Study|Randomized but not Treated|0
60771|NCT01252355|238703|P2|Overall Study|Randomized but not Treated|0
60772|NCT01252355|238704|P1|Overall Study|Randomized but not Treated|2
60773|NCT01252355|238702|P3|Overall Study|Sponsor Early Termination of Study|146
60774|NCT01252355|238703|P2|Overall Study|Sponsor Early Termination of Study|149
60775|NCT01252355|238704|P1|Overall Study|Sponsor Early Termination of Study|149
60776|NCT01252355|238702|P3|Overall Study|Progressive Disease|0
60777|NCT01252355|238703|P2|Overall Study|Progressive Disease|0
60778|NCT01252355|238704|P1|Overall Study|Progressive Disease|2
60779|NCT01252355|238702|P3|Overall Study|Poor Compliance to Protocol|1
60780|NCT01252355|238703|P2|Overall Study|Poor Compliance to Protocol|1
60781|NCT01252355|238704|P1|Overall Study|Poor Compliance to Protocol|1
60782|NCT01252355|238702|P3|Overall Study|Lost to Follow-up|1
60783|NCT01252355|238703|P2|Overall Study|Lost to Follow-up|0
60784|NCT01252355|238704|P1|Overall Study|Lost to Follow-up|0
60785|NCT01252355|238702|P3|Overall Study|Lack of Efficacy|2
60786|NCT01252355|238703|P2|Overall Study|Lack of Efficacy|4
60787|NCT01252355|238704|P1|Overall Study|Lack of Efficacy|6
60788|NCT01252355|238702|P3|Overall Study|Adverse Event|22
60789|NCT01252355|238703|P2|Overall Study|Adverse Event|17
60790|NCT01252355|238704|P1|Overall Study|Adverse Event|9
60791|NCT01252290|238742|P1|Overall Study|Withdrawal by Subject|1
60792|NCT01252251|238758|P1|Overall Study|Withdrawal by Subject|1
60793|NCT01252238|238770|P3|Overall Study|Sponsor terminated study|4
60794|NCT01252238|238771|P2|Overall Study|Sponsor terminated study|4
60795|NCT01252238|238772|P1|Overall Study|Sponsor terminated study|4
60796|NCT01252186|238783|P3|Overall Study|Other - Miscellaneous Reasons|7
60797|NCT01252186|238784|P2|Overall Study|Other - Miscellaneous Reasons|5
60798|NCT01252186|238785|P1|Overall Study|Other - Miscellaneous Reasons|5
60799|NCT01252186|238783|P3|Overall Study|Lost to Follow-up|11
60800|NCT01252186|238784|P2|Overall Study|Lost to Follow-up|10
60801|NCT01252186|238785|P1|Overall Study|Lost to Follow-up|10
60802|NCT01252186|238783|P3|Overall Study|Sponsor Request|0
60803|NCT01252186|238784|P2|Overall Study|Sponsor Request|1
60804|NCT01252186|238785|P1|Overall Study|Sponsor Request|2
60805|NCT01252186|238783|P3|Overall Study|Pregnancy|0
60806|NCT01252186|238784|P2|Overall Study|Pregnancy|2
60807|NCT01252186|238785|P1|Overall Study|Pregnancy|2
60808|NCT01252186|238783|P3|Overall Study|Protocol Violation|1
60809|NCT01252186|238784|P2|Overall Study|Protocol Violation|0
60810|NCT01252186|238785|P1|Overall Study|Protocol Violation|0
60811|NCT01252186|238783|P3|Overall Study|Non-compliance|4
60812|NCT01252186|238784|P2|Overall Study|Non-compliance|3
60813|NCT01252186|238785|P1|Overall Study|Non-compliance|0
60814|NCT01252186|238783|P3|Overall Study|Physician Decision|1
60815|NCT01252186|238784|P2|Overall Study|Physician Decision|0
60816|NCT01252186|238785|P1|Overall Study|Physician Decision|0
60817|NCT01252186|238783|P3|Overall Study|Withdrawal by Subject|2
60818|NCT01252186|238784|P2|Overall Study|Withdrawal by Subject|5
60819|NCT01252186|238785|P1|Overall Study|Withdrawal by Subject|2
60820|NCT01252186|238783|P3|Overall Study|Adverse Event|8
60821|NCT01252186|238784|P2|Overall Study|Adverse Event|6
60822|NCT01252186|238785|P1|Overall Study|Adverse Event|9
60823|NCT01252134|238858|P6|Period 1, 8 Hours|Personal Reasons|0
60824|NCT01252134|238859|P5|Period 1, 8 Hours|Personal Reasons|0
60825|NCT01252134|238860|P4|Period 1, 8 Hours|Personal Reasons|0
60826|NCT01252134|238861|P3|Period 1, 8 Hours|Personal Reasons|1
60827|NCT01252134|238862|P2|Period 1, 8 Hours|Personal Reasons|1
60828|NCT01252134|238863|P1|Period 1, 8 Hours|Personal Reasons|0
60829|NCT01252095|238882|P2|Overall Study|Disease progression|0
60830|NCT01252095|238883|P1|Overall Study|Disease progression|1
60831|NCT01251952|238901|P1|Overall Study|Adverse Event|1
60832|NCT01251770|238907|P2|Overall Study|Protocol Violation|7
60833|NCT01251770|238908|P1|Overall Study|Protocol Violation|13
60834|NCT01251653|238959|P9|Overall Study|Other reason not mentioned above|0
60835|NCT01251653|238960|P8|Overall Study|Other reason not mentioned above|2
60836|NCT01251653|238961|P7|Overall Study|Other reason not mentioned above|0
60837|NCT01251653|238962|P6|Overall Study|Other reason not mentioned above|0
60838|NCT01251653|238963|P5|Overall Study|Other reason not mentioned above|0
60839|NCT01251653|238964|P4|Overall Study|Other reason not mentioned above|0
60840|NCT01251653|238965|P3|Overall Study|Other reason not mentioned above|0
60841|NCT01251653|238966|P2|Overall Study|Other reason not mentioned above|0
60842|NCT01251653|238967|P1|Overall Study|Other reason not mentioned above|0
60843|NCT01251653|238959|P9|Overall Study|Withdrawal by Subject|0
60844|NCT01251653|238960|P8|Overall Study|Withdrawal by Subject|1
60845|NCT01251653|238961|P7|Overall Study|Withdrawal by Subject|0
60846|NCT01251653|238962|P6|Overall Study|Withdrawal by Subject|1
60847|NCT01251653|238963|P5|Overall Study|Withdrawal by Subject|1
60848|NCT01251653|238964|P4|Overall Study|Withdrawal by Subject|0
60849|NCT01251653|238965|P3|Overall Study|Withdrawal by Subject|1
60850|NCT01251653|238966|P2|Overall Study|Withdrawal by Subject|0
60851|NCT01251653|238967|P1|Overall Study|Withdrawal by Subject|1
60852|NCT01251653|238959|P9|Overall Study|Adverse Event|1
60853|NCT01251653|238960|P8|Overall Study|Adverse Event|2
60854|NCT01251653|238961|P7|Overall Study|Adverse Event|2
60855|NCT01251653|238962|P6|Overall Study|Adverse Event|0
60856|NCT01251653|238963|P5|Overall Study|Adverse Event|1
60857|NCT01251653|238964|P4|Overall Study|Adverse Event|1
60858|NCT01251653|238965|P3|Overall Study|Adverse Event|2
60859|NCT01251653|238966|P2|Overall Study|Adverse Event|0
60860|NCT01251653|238967|P1|Overall Study|Adverse Event|1
60861|NCT01251653|238959|P9|Overall Study|Dose-limiting toxicity|0
60862|NCT01251653|238960|P8|Overall Study|Dose-limiting toxicity|0
60863|NCT01251653|238961|P7|Overall Study|Dose-limiting toxicity|2
60864|NCT01251653|238962|P6|Overall Study|Dose-limiting toxicity|0
60865|NCT01251653|238963|P5|Overall Study|Dose-limiting toxicity|0
60866|NCT01251653|238964|P4|Overall Study|Dose-limiting toxicity|1
60867|NCT01251653|238965|P3|Overall Study|Dose-limiting toxicity|1
60868|NCT01251653|238966|P2|Overall Study|Dose-limiting toxicity|1
60869|NCT01251653|238967|P1|Overall Study|Dose-limiting toxicity|0
60870|NCT01251653|238959|P9|Overall Study|Progressive Disease|5
60871|NCT01251653|238960|P8|Overall Study|Progressive Disease|7
60872|NCT01251653|238961|P7|Overall Study|Progressive Disease|14
60873|NCT01251653|238962|P6|Overall Study|Progressive Disease|17
60874|NCT01251653|238963|P5|Overall Study|Progressive Disease|0
60875|NCT01251653|238964|P4|Overall Study|Progressive Disease|4
60876|NCT01251653|238965|P3|Overall Study|Progressive Disease|16
60877|NCT01251653|238966|P2|Overall Study|Progressive Disease|7
60878|NCT01251653|238967|P1|Overall Study|Progressive Disease|1
60879|NCT01251614|239095|P3|Overall Study|Lost to Follow-up|0
60880|NCT01251614|239096|P2|Overall Study|Lost to Follow-up|1
60881|NCT01251614|239097|P1|Overall Study|Lost to Follow-up|0
60882|NCT01251614|239095|P3|Overall Study|Withdrawal by Subject|1
60883|NCT01251614|239096|P2|Overall Study|Withdrawal by Subject|2
60884|NCT01251614|239097|P1|Overall Study|Withdrawal by Subject|0
60885|NCT01251614|239095|P3|Overall Study|Loss of Disease Control|0
60886|NCT01251614|239096|P2|Overall Study|Loss of Disease Control|1
60887|NCT01251614|239097|P1|Overall Study|Loss of Disease Control|0
60888|NCT01251614|239095|P3|Overall Study|Pregnancy|2
60889|NCT01251614|239096|P2|Overall Study|Pregnancy|0
60890|NCT01251614|239097|P1|Overall Study|Pregnancy|0
60891|NCT01251614|239095|P3|Overall Study|Clearing of Psoriatic Lesions|0
60892|NCT01251614|239096|P2|Overall Study|Clearing of Psoriatic Lesions|0
60893|NCT01251614|239097|P1|Overall Study|Clearing of Psoriatic Lesions|1
60894|NCT01251614|239095|P3|Overall Study|Lack of Efficacy|4
60895|NCT01251614|239096|P2|Overall Study|Lack of Efficacy|9
60896|NCT01251614|239097|P1|Overall Study|Lack of Efficacy|1
60897|NCT01251614|239095|P3|Overall Study|Adverse Event|1
60898|NCT01251614|239096|P2|Overall Study|Adverse Event|0
60899|NCT01251614|239097|P1|Overall Study|Adverse Event|1
60900|NCT01251380|239204|P1|Overall Study|Lost to Follow-up|2
60901|NCT01251380|239204|P1|Overall Study|Adverse Event|1
60902|NCT01251380|239204|P1|Overall Study|Lack of Efficacy|1
60903|NCT01251380|239204|P1|Overall Study|Withdrawal by Subject|6
60904|NCT01251380|239204|P1|Overall Study|Other (Not otherwise specified)|12
60905|NCT01251354|239228|P1|Overall Study|Disease Progression|4
60906|NCT01251354|239228|P1|Overall Study|Investigator's Decision|1
60907|NCT01251354|239228|P1|Overall Study|Adverse Event|1
60908|NCT01251276|239271|P2|Overall Study|Lost to Follow-up|1
60909|NCT01251276|239272|P1|Overall Study|Lost to Follow-up|0
60910|NCT01251276|239271|P2|Overall Study|Protocol Violation|0
60911|NCT01251276|239272|P1|Overall Study|Protocol Violation|1
60912|NCT01251146|239290|P2|Overall Study|Lost to Follow-up|10
60913|NCT01251146|239291|P1|Overall Study|Lost to Follow-up|3
60914|NCT01251120|239313|P2|Overall Study|Lack of Efficacy|1
60915|NCT01251120|239314|P1|Overall Study|Lack of Efficacy|0
60916|NCT01250925|239379|P3|Overall Study|Adverse Event|1
60917|NCT01250925|239380|P2|Overall Study|Adverse Event|0
60918|NCT01250925|239381|P1|Overall Study|Adverse Event|0
60919|NCT01250925|239379|P3|Overall Study|Physician Decision|1
60920|NCT01250925|239380|P2|Overall Study|Physician Decision|2
60921|NCT01250925|239381|P1|Overall Study|Physician Decision|0
60922|NCT01250925|239379|P3|Overall Study|Protocol Violation|0
60923|NCT01250925|239380|P2|Overall Study|Protocol Violation|0
60924|NCT01250925|239381|P1|Overall Study|Protocol Violation|2
60925|NCT01250925|239379|P3|Overall Study|Withdrawal by Subject|0
60926|NCT01250925|239380|P2|Overall Study|Withdrawal by Subject|0
60927|NCT01250925|239381|P1|Overall Study|Withdrawal by Subject|2
60928|NCT01250925|239379|P3|Overall Study|Lost to Follow-up|0
60929|NCT01250925|239380|P2|Overall Study|Lost to Follow-up|1
60930|NCT01250925|239381|P1|Overall Study|Lost to Follow-up|1
60931|NCT01250769|239447|P4|Overall Study|Adverse Event|0
60932|NCT01250769|239448|P3|Overall Study|Adverse Event|1
60933|NCT01250769|239449|P2|Overall Study|Adverse Event|0
60934|NCT01250769|239450|P1|Overall Study|Adverse Event|0
60935|NCT01250769|239447|P4|Overall Study|Withdrawal by Subject|0
60936|NCT01250769|239448|P3|Overall Study|Withdrawal by Subject|1
60937|NCT01250769|239449|P2|Overall Study|Withdrawal by Subject|1
60938|NCT01250769|239450|P1|Overall Study|Withdrawal by Subject|0
60939|NCT01250756|239482|P2|After Toddler Dose|Adverse Event|1
60940|NCT01250756|239483|P1|After Toddler Dose|Adverse Event|0
60941|NCT01250756|239482|P2|Toddler Dose|Adverse Event|1
60942|NCT01250756|239483|P1|Toddler Dose|Adverse Event|0
60943|NCT01250756|239482|P2|After Infant Series|Unspecified|1
60944|NCT01250756|239483|P1|After Infant Series|Unspecified|2
60945|NCT01250756|239482|P2|After Infant Series|Withdrawal by Subject|1
60946|NCT01250756|239483|P1|After Infant Series|Withdrawal by Subject|4
60947|NCT01250756|239482|P2|After Infant Series|Adverse Event|2
60948|NCT01250756|239483|P1|After Infant Series|Adverse Event|5
60949|NCT01250756|239482|P2|Infant Series|Unspecified|0
60950|NCT01250756|239483|P1|Infant Series|Unspecified|22
60951|NCT01250756|239482|P2|Infant Series|Randomized, Not Vaccinated|2
60952|NCT01250756|239483|P1|Infant Series|Randomized, Not Vaccinated|2
60953|NCT01250756|239482|P2|Infant Series|Withdrawal by Subject|5
60954|NCT01250756|239483|P1|Infant Series|Withdrawal by Subject|4
60955|NCT01250509|239600|P2|Overall Study|Lost to Follow-up|2
60956|NCT01250509|239601|P1|Overall Study|Lost to Follow-up|5
60957|NCT01250418|239615|P2|Overall Study|monitor data failure|1
60958|NCT01250418|239616|P1|Overall Study|monitor data failure|1
60959|NCT01250379|239624|P2|Overall Study|Participant noncompliance|0
60960|NCT01250379|239625|P1|Overall Study|Participant noncompliance|2
60961|NCT01250379|239624|P2|Overall Study|Not specified|4
60962|NCT01250379|239625|P1|Overall Study|Not specified|0
60963|NCT01250379|239624|P2|Overall Study|Adverse Event|4
60964|NCT01250379|239625|P1|Overall Study|Adverse Event|5
60965|NCT01250379|239624|P2|Overall Study|Lost to Follow-up|6
60966|NCT01250379|239625|P1|Overall Study|Lost to Follow-up|9
60967|NCT01250379|239624|P2|Overall Study|Protocol Violation|8
60968|NCT01250379|239625|P1|Overall Study|Protocol Violation|2
60969|NCT01250379|239624|P2|Overall Study|Physician Decision|3
60970|NCT01250379|239625|P1|Overall Study|Physician Decision|11
60971|NCT01250379|239624|P2|Overall Study|Withdrawal by Subject|20
60972|NCT01250379|239625|P1|Overall Study|Withdrawal by Subject|32
60973|NCT01250379|239624|P2|Overall Study|Death|148
60974|NCT01250379|239625|P1|Overall Study|Death|141
60975|NCT01250171|239714|P3|Overall Study|Administrative reasons|0
60976|NCT01250171|239715|P2|Overall Study|Administrative reasons|0
60977|NCT01250171|239716|P1|Overall Study|Administrative reasons|1
60978|NCT01250145|239747|P2|Overall Study|Withdrawal by Subject|4
60979|NCT01250145|239748|P1|Overall Study|Withdrawal by Subject|0
60980|NCT01250145|239747|P2|Overall Study|Adverse Event|1
60981|NCT01250145|239748|P1|Overall Study|Adverse Event|2
60982|NCT01250119|239768|P2|Treatment Phase|Unknown reason|4
60983|NCT01250119|239769|P1|Treatment Phase|Unknown reason|0
60984|NCT01250119|239768|P2|Treatment Phase|Adverse Event|2
60985|NCT01250119|239769|P1|Treatment Phase|Adverse Event|0
60986|NCT01250119|239768|P2|Treatment Phase|Withdrawal by Subject|1
60987|NCT01250119|239769|P1|Treatment Phase|Withdrawal by Subject|0
60988|NCT01250119|239768|P2|Treatment Phase|Death|2
60989|NCT01250119|239769|P1|Treatment Phase|Death|0
60990|NCT01250119|239768|P2|Treatment Phase|Progressive Disease|32
60991|NCT01250119|239769|P1|Treatment Phase|Progressive Disease|0
60992|NCT01250119|239768|P2|Diagnostic Phase|Participants Not Tested|0
60993|NCT01250119|239769|P1|Diagnostic Phase|Participants Not Tested|44
60994|NCT01250119|239768|P2|Diagnostic Phase|Failed to Produce a Test Results|0
60995|NCT01250119|239769|P1|Diagnostic Phase|Failed to Produce a Test Results|69
60996|NCT01250054|239784|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
60997|NCT01250054|239785|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
60998|NCT01250002|239793|P2|Overall Study|Change to open surgical procedure|3
60999|NCT01250002|239794|P1|Overall Study|Change to open surgical procedure|4
61000|NCT01249833|239859|P2|Overall Study|Lost to Follow-up|1
61001|NCT01249833|239860|P1|Overall Study|Lost to Follow-up|0
61002|NCT01249664|239874|P2|Overall Study|Adverse Event|0
61003|NCT01249664|239875|P1|Overall Study|Adverse Event|1
61004|NCT01249664|239874|P2|Overall Study|Withdrawal by Subject|0
61005|NCT01249664|239875|P1|Overall Study|Withdrawal by Subject|5
61006|NCT01249651|239925|P1|Overall Study|Sponsor Decision|1
61007|NCT01249651|239925|P1|Overall Study|Protocol Violation|1
61008|NCT01249651|239925|P1|Overall Study|Adverse Event|1
61009|NCT01249651|239925|P1|Overall Study|Withdrawal by Subject|4
61010|NCT01249417|239935|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
61011|NCT01249417|239936|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
61012|NCT01249417|239937|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
61013|NCT01249417|239935|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
61014|NCT01249417|239936|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
61015|NCT01249417|239937|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
61016|NCT01249417|239935|P3|Treatment Phase - ITT Population|Adverse Event|1
61017|NCT01249417|239936|P2|Treatment Phase - ITT Population|Adverse Event|0
61018|NCT01249417|239937|P1|Treatment Phase - ITT Population|Adverse Event|0
61019|NCT01249417|239935|P3|Treatment Phase - ITT Population|Not specified|1
61020|NCT01249417|239936|P2|Treatment Phase - ITT Population|Not specified|0
61021|NCT01249417|239937|P1|Treatment Phase - ITT Population|Not specified|0
61022|NCT01249417|239935|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
61023|NCT01249417|239936|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
61024|NCT01249417|239937|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
61025|NCT01249417|239935|P3|Randomised Population|Study treatment not received|2
61026|NCT01249417|239936|P2|Randomised Population|Study treatment not received|0
61027|NCT01249417|239937|P1|Randomised Population|Study treatment not received|0
61028|NCT01249274|239953|P2|Overall Study|Received inpatient substance treatment|2
61029|NCT01249274|239954|P1|Overall Study|Received inpatient substance treatment|1
61030|NCT01249274|239953|P2|Overall Study|Lost to Follow-up|4
61031|NCT01249274|239954|P1|Overall Study|Lost to Follow-up|3
61032|NCT01249261|239980|P2|Overall Study|Withdrawal by Subject|0
61033|NCT01249261|239981|P1|Overall Study|Withdrawal by Subject|1
61034|NCT01249157|240009|P1|Overall Study|Withdrawal by Subject|1
61035|NCT01249131|240013|P6|Washout Period of 10 Days|Adverse Event|0
61036|NCT01249131|240014|P5|Washout Period of 10 Days|Adverse Event|1
61037|NCT01249131|240015|P4|Washout Period of 10 Days|Adverse Event|0
61038|NCT01249131|240016|P3|Washout Period of 10 Days|Adverse Event|0
61039|NCT01249131|240017|P2|Washout Period of 10 Days|Adverse Event|0
61040|NCT01249131|240018|P1|Washout Period of 10 Days|Adverse Event|0
61041|NCT01249118|240038|P3|First Washout Period|Physician Decision|0
61042|NCT01249118|240039|P2|First Washout Period|Physician Decision|1
61043|NCT01249118|240040|P1|First Washout Period|Physician Decision|0
61044|NCT01249092|240074|P1|Overall Study|Unable to tolerate expected SE -nausea|1
61045|NCT01249092|240074|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
61046|NCT01248949|240085|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
61047|NCT01248949|240086|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
61048|NCT01248949|240087|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
61049|NCT01248949|240088|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
61050|NCT01248949|240089|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
61051|NCT01248949|240085|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
61052|NCT01248949|240086|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
61053|NCT01248949|240087|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
61054|NCT01248949|240088|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
61055|NCT01248949|240089|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
61056|NCT01248949|240085|P5|Overall Study|Pi Decision Due To Declining Status|0
61057|NCT01248949|240086|P4|Overall Study|Pi Decision Due To Declining Status|0
61058|NCT01248949|240087|P3|Overall Study|Pi Decision Due To Declining Status|1
61059|NCT01248949|240088|P2|Overall Study|Pi Decision Due To Declining Status|0
61060|NCT01248949|240089|P1|Overall Study|Pi Decision Due To Declining Status|0
61061|NCT01248949|240085|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
61062|NCT01248949|240086|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
61063|NCT01248949|240087|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
61064|NCT01248949|240088|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
61065|NCT01248949|240089|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
61066|NCT01248949|240085|P5|Overall Study|Participant Went To Hospice|0
61067|NCT01248949|240086|P4|Overall Study|Participant Went To Hospice|0
61068|NCT01248949|240087|P3|Overall Study|Participant Went To Hospice|1
61069|NCT01248949|240088|P2|Overall Study|Participant Went To Hospice|0
61070|NCT01248949|240089|P1|Overall Study|Participant Went To Hospice|0
61071|NCT01248949|240085|P5|Overall Study|Entered Hospice And Refused Follow Up|1
61072|NCT01248949|240086|P4|Overall Study|Entered Hospice And Refused Follow Up|0
61073|NCT01248949|240087|P3|Overall Study|Entered Hospice And Refused Follow Up|0
61074|NCT01248949|240088|P2|Overall Study|Entered Hospice And Refused Follow Up|0
61075|NCT01248949|240089|P1|Overall Study|Entered Hospice And Refused Follow Up|0
61076|NCT01248949|240085|P5|Overall Study|Palliative Radiation To Brain Metastases|0
61077|NCT01248949|240086|P4|Overall Study|Palliative Radiation To Brain Metastases|0
61078|NCT01248949|240087|P3|Overall Study|Palliative Radiation To Brain Metastases|0
61079|NCT01248949|240088|P2|Overall Study|Palliative Radiation To Brain Metastases|0
61080|NCT01248949|240089|P1|Overall Study|Palliative Radiation To Brain Metastases|1
61081|NCT01248949|240085|P5|Overall Study|Alternative Therapy.|0
61082|NCT01248949|240086|P4|Overall Study|Alternative Therapy.|0
61083|NCT01248949|240087|P3|Overall Study|Alternative Therapy.|0
61084|NCT01248949|240088|P2|Overall Study|Alternative Therapy.|0
61085|NCT01248949|240089|P1|Overall Study|Alternative Therapy.|1
61086|NCT01248949|240085|P5|Overall Study|Alternative Therapy|0
61087|NCT01248949|240086|P4|Overall Study|Alternative Therapy|0
61088|NCT01248949|240087|P3|Overall Study|Alternative Therapy|0
61089|NCT01248949|240088|P2|Overall Study|Alternative Therapy|0
61090|NCT01248949|240089|P1|Overall Study|Alternative Therapy|1
61091|NCT01248949|240085|P5|Overall Study|Death|2
61092|NCT01248949|240086|P4|Overall Study|Death|6
61093|NCT01248949|240087|P3|Overall Study|Death|21
61094|NCT01248949|240088|P2|Overall Study|Death|7
61095|NCT01248949|240089|P1|Overall Study|Death|22
61096|NCT01248949|240085|P5|Overall Study|Withdrawal by Subject|1
61097|NCT01248949|240086|P4|Overall Study|Withdrawal by Subject|3
61098|NCT01248949|240087|P3|Overall Study|Withdrawal by Subject|11
61099|NCT01248949|240088|P2|Overall Study|Withdrawal by Subject|3
61100|NCT01248949|240089|P1|Overall Study|Withdrawal by Subject|5
61101|NCT01248949|240085|P5|Overall Study|Lost to Follow-up|0
61102|NCT01248949|240086|P4|Overall Study|Lost to Follow-up|1
61103|NCT01248949|240087|P3|Overall Study|Lost to Follow-up|2
61104|NCT01248949|240088|P2|Overall Study|Lost to Follow-up|2
61105|NCT01248949|240089|P1|Overall Study|Lost to Follow-up|2
61106|NCT01248936|240201|P1|Overall Study|Other reason|3
61107|NCT01248936|240201|P1|Overall Study|Refused Treatment|1
61108|NCT01248936|240201|P1|Overall Study|Lost to Follow-up|7
61109|NCT01248936|240201|P1|Overall Study|Adverse Event|8
61110|NCT01248936|240201|P1|Overall Study|Withdrawal of Consent|20
61111|NCT01248936|240201|P1|Overall Study|Death|26
61112|NCT01248936|240201|P1|Overall Study|Progression of Disease|50
61113|NCT01248936|240201|P1|Overall Study|Sponsor Decision|259
61114|NCT01248884|240214|P3|Overall Study|Adverse Event|0
61115|NCT01248884|240215|P2|Overall Study|Adverse Event|0
61116|NCT01248884|240216|P1|Overall Study|Adverse Event|1
61117|NCT01248884|240214|P3|Overall Study|Withdrawal by Subject|1
61118|NCT01248884|240215|P2|Overall Study|Withdrawal by Subject|3
61119|NCT01248884|240216|P1|Overall Study|Withdrawal by Subject|1
61120|NCT01248793|240268|P2|Overall Study|Withdrawal by Subject|3
61121|NCT01248793|240269|P1|Overall Study|Withdrawal by Subject|3
61122|NCT01248793|240268|P2|Overall Study|Protocol Violation|1
61123|NCT01248793|240269|P1|Overall Study|Protocol Violation|0
61124|NCT01248793|240268|P2|Overall Study|Adverse Event|1
61125|NCT01248793|240269|P1|Overall Study|Adverse Event|1
61126|NCT01248793|240268|P2|Overall Study|Lost to Follow-up|1
61127|NCT01248793|240269|P1|Overall Study|Lost to Follow-up|0
61128|NCT01248780|240283|P2|Overall Study|Not treated|1
61129|NCT01248780|240284|P1|Overall Study|Not treated|0
61130|NCT01248780|240283|P2|Overall Study|Withdrawal by Subject|4
61131|NCT01248780|240284|P1|Overall Study|Withdrawal by Subject|4
61132|NCT01248780|240283|P2|Overall Study|Protocol Violation|1
61133|NCT01248780|240284|P1|Overall Study|Protocol Violation|1
61134|NCT01248780|240283|P2|Overall Study|Adverse Event|7
61135|NCT01248780|240284|P1|Overall Study|Adverse Event|2
61136|NCT01248780|240283|P2|Overall Study|Death|1
61137|NCT01248780|240284|P1|Overall Study|Death|0
61138|NCT01248780|240283|P2|Overall Study|Lost to Follow-up|1
61139|NCT01248780|240284|P1|Overall Study|Lost to Follow-up|0
61140|NCT01248780|240283|P2|Overall Study|Lack of Efficacy|0
61141|NCT01248780|240284|P1|Overall Study|Lack of Efficacy|2
61142|NCT01248728|240298|P2|Overall Study|Lack of Efficacy|0
61143|NCT01248728|240299|P1|Overall Study|Lack of Efficacy|1
61144|NCT01248728|240298|P2|Overall Study|Withdrawal by Subject|1
61145|NCT01248728|240299|P1|Overall Study|Withdrawal by Subject|2
61146|NCT01248728|240298|P2|Overall Study|Adverse Event|1
61147|NCT01248728|240299|P1|Overall Study|Adverse Event|1
61148|NCT01248468|240316|P3|Overall Study|Withdrawal by Subject|0
61149|NCT01248468|240317|P2|Overall Study|Withdrawal by Subject|2
61150|NCT01248468|240318|P1|Overall Study|Withdrawal by Subject|4
61151|NCT01248468|240316|P3|Overall Study|Pregnancy|0
61152|NCT01248468|240317|P2|Overall Study|Pregnancy|0
61153|NCT01248468|240318|P1|Overall Study|Pregnancy|1
61154|NCT01248468|240316|P3|Overall Study|Lost to Follow-up|4
61155|NCT01248468|240317|P2|Overall Study|Lost to Follow-up|12
61156|NCT01248468|240318|P1|Overall Study|Lost to Follow-up|9
61157|NCT01248468|240316|P3|Overall Study|Administrative problem|0
61158|NCT01248468|240317|P2|Overall Study|Administrative problem|0
61159|NCT01248468|240318|P1|Overall Study|Administrative problem|1
61160|NCT01248455|240335|P1|Overall Study|switched to alternate treatment|1
61161|NCT01248364|240344|P4|Overall Study|Adverse Event|0
61162|NCT01248364|240345|P3|Overall Study|Adverse Event|0
61163|NCT01248364|240346|P2|Overall Study|Adverse Event|1
61164|NCT01248364|240347|P1|Overall Study|Adverse Event|0
61165|NCT01248130|240410|P2|Overall Study|Ineligible|0
61166|NCT01248130|240411|P1|Overall Study|Ineligible|1
61167|NCT01248130|240410|P2|Overall Study|Protocol Violation|0
61168|NCT01248130|240411|P1|Overall Study|Protocol Violation|1
61169|NCT01248065|240419|P2|Overall Study|Other|5
61170|NCT01248065|240420|P1|Overall Study|Other|3
61171|NCT01248065|240419|P2|Overall Study|Third treatment failure event|1
61172|NCT01248065|240420|P1|Overall Study|Third treatment failure event|3
61173|NCT01248065|240419|P2|Overall Study|Adverse Event|0
61174|NCT01248065|240420|P1|Overall Study|Adverse Event|3
61175|NCT01248065|240419|P2|Overall Study|Withdrawal by Subject|11
61176|NCT01248065|240420|P1|Overall Study|Withdrawal by Subject|14
61177|NCT01248065|240419|P2|Overall Study|Lost to Follow-up|5
61178|NCT01248065|240420|P1|Overall Study|Lost to Follow-up|3
61179|NCT01248013|240430|P1|Overall Study|Withdrawal by Subject|14
61180|NCT01247922|240445|P1|Overall Study|Disease progression|4
61181|NCT01247324|240511|P2|Overall Study|Lost to Follow-up|1
61182|NCT01247324|240512|P1|Overall Study|Lost to Follow-up|1
61183|NCT01247324|240511|P2|Overall Study|Adverse Event|13
61184|NCT01247324|240512|P1|Overall Study|Adverse Event|25
61185|NCT01247324|240511|P2|Overall Study|Consent withdrawn by participant|8
61186|NCT01247324|240512|P1|Overall Study|Consent withdrawn by participant|13
61187|NCT01247324|240511|P2|Overall Study|Reason not specified|8
61188|NCT01247324|240512|P1|Overall Study|Reason not specified|11
61189|NCT01247324|240511|P2|Overall Study|Protocol Violation|2
61190|NCT01247324|240512|P1|Overall Study|Protocol Violation|1
61191|NCT01247324|240511|P2|Overall Study|Pregnancy|3
61192|NCT01247324|240512|P1|Overall Study|Pregnancy|2
61193|NCT01247324|240511|P2|Overall Study|Non-compliance|0
61194|NCT01247324|240512|P1|Overall Study|Non-compliance|2
61195|NCT01247324|240511|P2|Overall Study|Lack of Efficacy|8
61196|NCT01247324|240512|P1|Overall Study|Lack of Efficacy|12
61197|NCT01247324|240511|P2|Overall Study|Non-compliance with study drug|0
61198|NCT01247324|240512|P1|Overall Study|Non-compliance with study drug|3
61199|NCT01247324|240511|P2|Overall Study|Physician Decision|1
61200|NCT01247324|240512|P1|Overall Study|Physician Decision|0
61201|NCT01247324|240511|P2|Overall Study|Death|0
61202|NCT01247324|240512|P1|Overall Study|Death|1
61203|NCT01247090|240605|P3|Overall Study|Withdrawal by Subject|0
61204|NCT01247090|240606|P2|Overall Study|Withdrawal by Subject|1
61205|NCT01247090|240607|P1|Overall Study|Withdrawal by Subject|0
61206|NCT01247090|240605|P3|Overall Study|Physician Decision|0
61207|NCT01247090|240606|P2|Overall Study|Physician Decision|0
61208|NCT01247090|240607|P1|Overall Study|Physician Decision|1
61209|NCT01246999|240636|P4|Overall Study|Withdrawal by Subject|2
61210|NCT01246999|240637|P3|Overall Study|Withdrawal by Subject|0
61211|NCT01246999|240638|P2|Overall Study|Withdrawal by Subject|0
61212|NCT01246999|240639|P1|Overall Study|Withdrawal by Subject|0
61213|NCT01246999|240636|P4|Overall Study|Lost to Follow-up|0
61214|NCT01246999|240637|P3|Overall Study|Lost to Follow-up|0
61215|NCT01246999|240638|P2|Overall Study|Lost to Follow-up|1
61216|NCT01246999|240639|P1|Overall Study|Lost to Follow-up|0
61217|NCT01246973|240674|P2|Overall Study|Withdrawal by Subject|13
61218|NCT01246973|240675|P1|Overall Study|Withdrawal by Subject|7
61219|NCT01246973|240674|P2|Overall Study|Adverse Event|9
61220|NCT01246973|240675|P1|Overall Study|Adverse Event|16
61221|NCT01246973|240674|P2|Overall Study|unspecified|25
61222|NCT01246973|240675|P1|Overall Study|unspecified|38
61223|NCT01246960|240685|P2|Overall Study|Withdrawal (by participant or physician)|3
61224|NCT01246960|240686|P1|Overall Study|Withdrawal (by participant or physician)|3
61225|NCT01246960|240685|P2|Overall Study|Lost to Follow-up|1
61226|NCT01246960|240686|P1|Overall Study|Lost to Follow-up|3
61227|NCT01246206|240777|P1|Overall Study|Patient did not receive study regiments.|1
61228|NCT01246011|240800|P3|Overall Study|Withdrawal by Subject|1
61229|NCT01246011|240801|P2|Overall Study|Withdrawal by Subject|0
61230|NCT01246011|240802|P1|Overall Study|Withdrawal by Subject|0
61231|NCT01246011|240800|P3|Overall Study|If needed warfarin clinically, withdrawn|3
61232|NCT01246011|240801|P2|Overall Study|If needed warfarin clinically, withdrawn|0
61233|NCT01246011|240802|P1|Overall Study|If needed warfarin clinically, withdrawn|0
61234|NCT01245764|240814|P4|Study Phase A|Lost to Follow-up|0
61235|NCT01245764|240815|P3|Study Phase A|Lost to Follow-up|5
61236|NCT01245764|240816|P2|Study Phase A|Lost to Follow-up|0
61237|NCT01245764|240817|P1|Study Phase A|Lost to Follow-up|0
61238|NCT01245764|240814|P4|Study Phase A|Protocol Violation|2
61239|NCT01245764|240815|P3|Study Phase A|Protocol Violation|2
61240|NCT01245764|240816|P2|Study Phase A|Protocol Violation|3
61241|NCT01245764|240817|P1|Study Phase A|Protocol Violation|6
61242|NCT01245764|240814|P4|Study Phase A|Other|1
61243|NCT01245764|240815|P3|Study Phase A|Other|3
61244|NCT01245764|240816|P2|Study Phase A|Other|2
61245|NCT01245764|240817|P1|Study Phase A|Other|3
61246|NCT01245751|240855|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
61247|NCT01245751|240856|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
61248|NCT01245751|240857|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
61249|NCT01245751|240858|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
61250|NCT01245751|240855|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
61251|NCT01245751|240856|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
61252|NCT01245751|240857|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
61253|NCT01245751|240858|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
61254|NCT01245751|240855|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
61255|NCT01245751|240856|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
61256|NCT01245751|240857|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
61257|NCT01245751|240858|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
61258|NCT01245387|240952|P1|Overall Study|Missing discontinuation status|369
61259|NCT01245387|240952|P1|Overall Study|Unspecified|131
61260|NCT01245387|240952|P1|Overall Study|Death|3
61261|NCT01245387|240952|P1|Overall Study|Adverse Event|9
61262|NCT01245387|240952|P1|Overall Study|Lack of Efficacy|195
61263|NCT01245387|240952|P1|Overall Study|Lost to Follow-up|106
61264|NCT01245374|241001|P1|Overall Study|Withdrawal by Subject|3
61265|NCT01245374|241001|P1|Overall Study|Protocol Violation|1
61266|NCT01245283|241024|P3|Overall Study|Lost to Follow-up|11
61267|NCT01245283|241025|P2|Overall Study|Lost to Follow-up|11
61268|NCT01245283|241026|P1|Overall Study|Lost to Follow-up|14
61269|NCT01245140|241071|P2|Overall Study|Refused Treatment/Did Not Coopera|1
61270|NCT01245140|241072|P1|Overall Study|Refused Treatment/Did Not Coopera|0
61271|NCT01245140|241071|P2|Overall Study|Withdrawal by Subject|1
61272|NCT01245140|241072|P1|Overall Study|Withdrawal by Subject|0
61273|NCT01245140|241071|P2|Overall Study|Protocol Violation|1
61274|NCT01245140|241072|P1|Overall Study|Protocol Violation|0
61275|NCT01245140|241071|P2|Overall Study|Lack of Efficacy|4
61276|NCT01245140|241072|P1|Overall Study|Lack of Efficacy|2
61277|NCT01245140|241071|P2|Overall Study|Adverse Event|3
61278|NCT01245140|241072|P1|Overall Study|Adverse Event|1
61279|NCT01245101|241128|P2|Period 3 (Treatment)|Withdrawal by Subject|0
61280|NCT01245101|241129|P1|Period 3 (Treatment)|Withdrawal by Subject|1
61281|NCT01245101|241128|P2|Period 2 (Washout)|Withdrawal by Subject|0
61282|NCT01245101|241129|P1|Period 2 (Washout)|Withdrawal by Subject|1
61283|NCT01245101|241128|P2|Period 1 (Treatment)|Withdrawal by Subject|0
61284|NCT01245101|241129|P1|Period 1 (Treatment)|Withdrawal by Subject|2
61285|NCT01245062|241139|P3|Cross-over Phase|Ongoing|34
61286|NCT01245062|241140|P2|Cross-over Phase|Ongoing|0
61287|NCT01245062|241141|P1|Cross-over Phase|Ongoing|0
61288|NCT01245062|241139|P3|Cross-over Phase|Withdrew Consent|3
61289|NCT01245062|241140|P2|Cross-over Phase|Withdrew Consent|0
61290|NCT01245062|241141|P1|Cross-over Phase|Withdrew Consent|0
61291|NCT01245062|241139|P3|Cross-over Phase|Death|14
61292|NCT01245062|241140|P2|Cross-over Phase|Death|0
61293|NCT01245062|241141|P1|Cross-over Phase|Death|0
61294|NCT01245062|241139|P3|Randomization Phase|Ongoing|0
61295|NCT01245062|241140|P2|Randomization Phase|Ongoing|65
61296|NCT01245062|241141|P1|Randomization Phase|Ongoing|169
61297|NCT01245062|241139|P3|Randomization Phase|Withdrew Consent|0
61298|NCT01245062|241140|P2|Randomization Phase|Withdrew Consent|10
61299|NCT01245062|241141|P1|Randomization Phase|Withdrew Consent|6
61300|NCT01245062|241139|P3|Randomization Phase|Physician Decision|0
61301|NCT01245062|241140|P2|Randomization Phase|Physician Decision|3
61302|NCT01245062|241141|P1|Randomization Phase|Physician Decision|2
61303|NCT01245062|241139|P3|Randomization Phase|Lost to Follow-up|0
61304|NCT01245062|241140|P2|Randomization Phase|Lost to Follow-up|1
61305|NCT01245062|241141|P1|Randomization Phase|Lost to Follow-up|2
61306|NCT01245062|241139|P3|Randomization Phase|Death|0
61307|NCT01245062|241140|P2|Randomization Phase|Death|29
61308|NCT01245062|241141|P1|Randomization Phase|Death|35
61309|NCT01245049|241175|P2|Overall Study|Lost to Follow-up|2
61310|NCT01245049|241176|P1|Overall Study|Lost to Follow-up|1
61311|NCT01245049|241175|P2|Overall Study|Withdrawal by Subject|1
61312|NCT01245049|241176|P1|Overall Study|Withdrawal by Subject|0
61313|NCT01245049|241175|P2|Overall Study|Migrated/moved from study area|1
61314|NCT01245049|241176|P1|Overall Study|Migrated/moved from study area|0
61315|NCT01244984|241229|P3|Overall Study|Withdrawal by Subject|2
61316|NCT01244984|241230|P2|Overall Study|Withdrawal by Subject|2
61317|NCT01244984|241231|P1|Overall Study|Withdrawal by Subject|1
61318|NCT01244984|241229|P3|Overall Study|Protocol Defined Stopping Criteria|0
61319|NCT01244984|241230|P2|Overall Study|Protocol Defined Stopping Criteria|1
61320|NCT01244984|241231|P1|Overall Study|Protocol Defined Stopping Criteria|1
61321|NCT01244984|241229|P3|Overall Study|Protocol Violation|0
61322|NCT01244984|241230|P2|Overall Study|Protocol Violation|0
61323|NCT01244984|241231|P1|Overall Study|Protocol Violation|1
61324|NCT01244984|241229|P3|Overall Study|Adverse Event|2
61325|NCT01244984|241230|P2|Overall Study|Adverse Event|11
61326|NCT01244984|241231|P1|Overall Study|Adverse Event|2
61327|NCT01244906|241305|P1|Overall Study|Progression of disease post treatment|6
61328|NCT01244906|241305|P1|Overall Study|Death|2
61333|NCT01244828|241327|P1|Overall Study|Other reason (not specified)|1
61334|NCT01244828|241327|P1|Overall Study|Lost to Follow-up|2
61335|NCT01244828|241327|P1|Overall Study|Lack of Efficacy|7
61336|NCT01244828|241327|P1|Overall Study|Withdrawal by Subject|31
61337|NCT01244828|241327|P1|Overall Study|Adverse Event|37
61338|NCT01244815|241343|P4|Overall Study|Did Not Meet Protocol Eligibility|0
61339|NCT01244815|241344|P3|Overall Study|Did Not Meet Protocol Eligibility|0
61340|NCT01244815|241345|P2|Overall Study|Did Not Meet Protocol Eligibility|1
61341|NCT01244815|241346|P1|Overall Study|Did Not Meet Protocol Eligibility|0
61342|NCT01244815|241343|P4|Overall Study|Protocol Violation|1
61343|NCT01244815|241344|P3|Overall Study|Protocol Violation|3
61344|NCT01244815|241345|P2|Overall Study|Protocol Violation|4
61345|NCT01244815|241346|P1|Overall Study|Protocol Violation|7
61346|NCT01244815|241343|P4|Overall Study|Withdrawal by Subject|3
61347|NCT01244815|241344|P3|Overall Study|Withdrawal by Subject|0
61348|NCT01244815|241345|P2|Overall Study|Withdrawal by Subject|2
61349|NCT01244815|241346|P1|Overall Study|Withdrawal by Subject|0
61350|NCT01244815|241343|P4|Overall Study|Lost to Follow-up|2
61351|NCT01244815|241344|P3|Overall Study|Lost to Follow-up|3
61352|NCT01244815|241345|P2|Overall Study|Lost to Follow-up|2
61353|NCT01244815|241346|P1|Overall Study|Lost to Follow-up|3
61354|NCT01244815|241343|P4|Overall Study|Treatment Failure|1
61355|NCT01244815|241344|P3|Overall Study|Treatment Failure|0
61356|NCT01244815|241345|P2|Overall Study|Treatment Failure|0
61357|NCT01244815|241346|P1|Overall Study|Treatment Failure|0
61358|NCT01244815|241343|P4|Overall Study|Adverse Event|5
61359|NCT01244815|241344|P3|Overall Study|Adverse Event|5
61360|NCT01244815|241345|P2|Overall Study|Adverse Event|7
61361|NCT01244815|241346|P1|Overall Study|Adverse Event|4
61362|NCT01244815|241343|P4|Overall Study|Not Treated|0
61363|NCT01244815|241344|P3|Overall Study|Not Treated|0
61364|NCT01244815|241345|P2|Overall Study|Not Treated|1
61365|NCT01244815|241346|P1|Overall Study|Not Treated|0
61366|NCT01244620|241432|P4|Overall Study|Study terminated|4
61367|NCT01244620|241433|P3|Overall Study|Study terminated|4
61368|NCT01244620|241434|P2|Overall Study|Study terminated|4
61369|NCT01244620|241435|P1|Overall Study|Study terminated|4
61370|NCT01244516|241494|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
61371|NCT01244516|241495|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
61372|NCT01244516|241496|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
61373|NCT01244516|241494|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
61374|NCT01244516|241495|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
61375|NCT01244516|241496|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
61376|NCT01244516|241494|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
61377|NCT01244516|241495|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
61378|NCT01244516|241496|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
61379|NCT01244516|241494|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
61380|NCT01244516|241495|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
61381|NCT01244516|241496|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
61382|NCT01244516|241494|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
61383|NCT01244516|241495|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
61384|NCT01244516|241496|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
61385|NCT01244516|241494|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
61386|NCT01244516|241495|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
61387|NCT01244516|241496|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
61388|NCT01244516|241494|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
61389|NCT01244516|241495|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
61390|NCT01244516|241496|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
61391|NCT01244490|241517|P3|Overall Study|Not specified|1
61392|NCT01244490|241518|P2|Overall Study|Not specified|0
61393|NCT01244490|241519|P1|Overall Study|Not specified|0
61394|NCT01244490|241517|P3|Overall Study|Lost to Follow-up|3
61395|NCT01244490|241518|P2|Overall Study|Lost to Follow-up|6
61396|NCT01244490|241519|P1|Overall Study|Lost to Follow-up|0
61397|NCT01244490|241517|P3|Overall Study|Adverse Event|5
61398|NCT01244490|241518|P2|Overall Study|Adverse Event|9
61399|NCT01244490|241519|P1|Overall Study|Adverse Event|1
61400|NCT01244490|241517|P3|Overall Study|Withdrawal by Subject|9
61401|NCT01244490|241518|P2|Overall Study|Withdrawal by Subject|4
61402|NCT01244490|241519|P1|Overall Study|Withdrawal by Subject|4
61403|NCT01244490|241517|P3|Overall Study|Lack of Efficacy|5
61404|NCT01244490|241518|P2|Overall Study|Lack of Efficacy|5
61405|NCT01244490|241519|P1|Overall Study|Lack of Efficacy|14
61406|NCT01244425|241587|P2|Overall Study|Adverse Event|1
61407|NCT01244425|241588|P1|Overall Study|Adverse Event|1
61408|NCT01244425|241587|P2|Overall Study|Withdrawal by Subject|2
61409|NCT01244425|241588|P1|Overall Study|Withdrawal by Subject|2
61410|NCT01244126|241620|P3|Overall Study|Protocol Violation|9
61411|NCT01244126|241621|P2|Overall Study|Protocol Violation|3
61412|NCT01244126|241622|P1|Overall Study|Protocol Violation|3
61413|NCT01244061|241635|P2|Overall Study|Randomized but not treated|2
61414|NCT01244061|241636|P1|Overall Study|Randomized but not treated|2
61415|NCT01244061|241635|P2|Overall Study|Adverse Event|2
61416|NCT01244061|241636|P1|Overall Study|Adverse Event|5
61417|NCT01244061|241635|P2|Overall Study|Protocol Violation|1
61418|NCT01244061|241636|P1|Overall Study|Protocol Violation|1
61419|NCT01244061|241635|P2|Overall Study|Not specified|19
61420|NCT01244061|241636|P1|Overall Study|Not specified|8
61421|NCT01244061|241635|P2|Overall Study|Withdrawal by Subject|46
61422|NCT01244061|241636|P1|Overall Study|Withdrawal by Subject|29
61423|NCT01244061|241635|P2|Overall Study|Lost to Follow-up|30
61424|NCT01244061|241636|P1|Overall Study|Lost to Follow-up|34
61425|NCT01244061|241635|P2|Overall Study|Lack of Efficacy|3
61426|NCT01244061|241636|P1|Overall Study|Lack of Efficacy|1
61427|NCT01244061|241635|P2|Overall Study|Did not meet entrance criteria|0
61428|NCT01244061|241636|P1|Overall Study|Did not meet entrance criteria|1
61429|NCT01244061|241635|P2|Overall Study|Death|0
61430|NCT01244061|241636|P1|Overall Study|Death|1
61431|NCT01243944|241650|P2|Overall Study|Physician Decision|2
61432|NCT01243944|241651|P1|Overall Study|Physician Decision|2
61433|NCT01243944|241650|P2|Overall Study|Patient decision|5
61434|NCT01243944|241651|P1|Overall Study|Patient decision|6
61435|NCT01243944|241650|P2|Overall Study|Disease progression|1
61436|NCT01243944|241651|P1|Overall Study|Disease progression|5
61437|NCT01243944|241650|P2|Overall Study|Lack of Efficacy|98
61438|NCT01243944|241651|P1|Overall Study|Lack of Efficacy|0
61439|NCT01243944|241650|P2|Overall Study|Adverse Event|2
61440|NCT01243944|241651|P1|Overall Study|Adverse Event|4
61441|NCT01243892|241675|P2|Overall Study|Did not meet eligibility criteria|0
61442|NCT01243892|241676|P1|Overall Study|Did not meet eligibility criteria|2
61443|NCT01243775|241686|P1|Overall Study|Withdrawal by Subject|2
61444|NCT01243671|241693|P1|Overall Study|Not Specified|1
61445|NCT01243671|241693|P1|Overall Study|Anti-adalimumab antibody positive|1
61446|NCT01243671|241693|P1|Overall Study|Adverse Event|3
61447|NCT01243411|241740|P1|Overall Study|Other|8
61448|NCT01243411|241740|P1|Overall Study|Adverse Event|5
61449|NCT01243411|241740|P1|Overall Study|Lost to Follow-up|10
61450|NCT01243411|241740|P1|Overall Study|Withdrawal by Subject|18
61451|NCT01243242|241847|P2|Overall Study|non compliance|0
61452|NCT01243242|241848|P1|Overall Study|non compliance|1
61453|NCT01243242|241847|P2|Overall Study|sponsor decision|1
61454|NCT01243242|241848|P1|Overall Study|sponsor decision|0
61455|NCT01243242|241847|P2|Overall Study|Physician Decision|1
61456|NCT01243242|241848|P1|Overall Study|Physician Decision|0
61457|NCT01243242|241847|P2|Overall Study|Withdrawal by Subject|1
61458|NCT01243242|241848|P1|Overall Study|Withdrawal by Subject|1
61459|NCT01243242|241847|P2|Overall Study|Adverse Event|1
61460|NCT01243242|241848|P1|Overall Study|Adverse Event|1
61461|NCT01243177|241862|P2|Overall Study|Other Reason|12
61462|NCT01243177|241863|P1|Overall Study|Other Reason|11
61463|NCT01243177|241862|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
61464|NCT01243177|241863|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
61465|NCT01243177|241862|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
61466|NCT01243177|241863|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
61467|NCT01243177|241862|P2|Overall Study|AE, non-serious non-fatal|58
61468|NCT01243177|241863|P1|Overall Study|AE, non-serious non-fatal|40
61469|NCT01243177|241862|P2|Overall Study|SAE, non-fatal|9
61470|NCT01243177|241863|P1|Overall Study|SAE, non-fatal|7
61471|NCT01243177|241862|P2|Overall Study|AE, serious fatal|1
61472|NCT01243177|241863|P1|Overall Study|AE, serious fatal|0
61473|NCT01243177|241862|P2|Overall Study|Withdrawal by Subject|38
61474|NCT01243177|241863|P1|Overall Study|Withdrawal by Subject|46
61475|NCT01243177|241862|P2|Overall Study|Lost to Follow-up|18
61476|NCT01243177|241863|P1|Overall Study|Lost to Follow-up|15
61477|NCT01243177|241862|P2|Overall Study|Protocol Violation|10
61478|NCT01243177|241863|P1|Overall Study|Protocol Violation|11
61479|NCT01243177|241862|P2|Overall Study|Lack of Efficacy|31
61480|NCT01243177|241863|P1|Overall Study|Lack of Efficacy|47
61481|NCT01242813|241884|P1|Overall Study|Lost to Follow-up|2
61482|NCT01242748|241906|P2|Overall Study|Miscellaneous reasons|3
61483|NCT01242748|241907|P1|Overall Study|Miscellaneous reasons|8
61484|NCT01242748|241906|P2|Overall Study|Withdrawal by Subject|2
61485|NCT01242748|241907|P1|Overall Study|Withdrawal by Subject|10
61486|NCT01242748|241906|P2|Overall Study|Protocol Violation|0
61487|NCT01242748|241907|P1|Overall Study|Protocol Violation|1
61488|NCT01242748|241906|P2|Overall Study|Physician Decision|2
61489|NCT01242748|241907|P1|Overall Study|Physician Decision|3
61490|NCT01242748|241906|P2|Overall Study|Lost to Follow-up|2
61491|NCT01242748|241907|P1|Overall Study|Lost to Follow-up|6
61492|NCT01242748|241906|P2|Overall Study|Adverse Event|5
61493|NCT01242748|241907|P1|Overall Study|Adverse Event|10
61494|NCT01242514|241947|P3|Overall Study|Adverse Event|19
61495|NCT01242514|241948|P2|Overall Study|Adverse Event|18
61496|NCT01242514|241949|P1|Overall Study|Adverse Event|129
61497|NCT01242514|241947|P3|Overall Study|Lost to Follow-up|4
61498|NCT01242514|241948|P2|Overall Study|Lost to Follow-up|5
61499|NCT01242514|241949|P1|Overall Study|Lost to Follow-up|14
61500|NCT01242514|241947|P3|Overall Study|Dev. of study specific discont. criteria|5
61501|NCT01242514|241948|P2|Overall Study|Dev. of study specific discont. criteria|3
61589|NCT01241552|242274|P1|Overall Study|Protocol Violation|0
61502|NCT01242514|241949|P1|Overall Study|Dev. of study specific discont. criteria|21
61503|NCT01242514|241947|P3|Overall Study|Lack of therapeutic response|10
61504|NCT01242514|241948|P2|Overall Study|Lack of therapeutic response|16
61505|NCT01242514|241949|P1|Overall Study|Lack of therapeutic response|99
61506|NCT01242514|241947|P3|Overall Study|Severe non-compliance to protocol|1
61507|NCT01242514|241948|P2|Overall Study|Severe non-compliance to protocol|2
61508|NCT01242514|241949|P1|Overall Study|Severe non-compliance to protocol|5
61509|NCT01242514|241947|P3|Overall Study|Subject decision|2
61510|NCT01242514|241948|P2|Overall Study|Subject decision|8
61511|NCT01242514|241949|P1|Overall Study|Subject decision|33
61512|NCT01242514|241947|P3|Overall Study|e.g., project closure|171
61513|NCT01242514|241948|P2|Overall Study|e.g., project closure|305
61514|NCT01242514|241949|P1|Overall Study|e.g., project closure|1042
61515|NCT01242371|241968|P2|Overall Study|Protocol Violation|3
61516|NCT01242371|241969|P1|Overall Study|Protocol Violation|0
61517|NCT01242371|241968|P2|Overall Study|Withdrawal by Subject|2
61518|NCT01242371|241969|P1|Overall Study|Withdrawal by Subject|2
61519|NCT01242176|241975|P2|Washout Period of 7 Days|Non-compliant with protocol|0
61520|NCT01242176|241976|P1|Washout Period of 7 Days|Non-compliant with protocol|1
61521|NCT01242176|241975|P2|Washout Period of 7 Days|Adverse Event|2
61522|NCT01242176|241976|P1|Washout Period of 7 Days|Adverse Event|0
61523|NCT01242111|241986|P1|Overall Study|Did not consent to MOR-100 follow-up|1
61524|NCT01242111|241986|P1|Overall Study|Withdrawal by Subject|1
61525|NCT01242111|241986|P1|Overall Study|Adverse Event|1
61526|NCT01242085|241998|P3|Overall Study|medically unable to have surgery|0
61527|NCT01242085|241999|P2|Overall Study|medically unable to have surgery|5
61528|NCT01242085|242000|P1|Overall Study|medically unable to have surgery|4
61529|NCT01242085|241998|P3|Overall Study|Withdrawal by Subject|0
61530|NCT01242085|241999|P2|Overall Study|Withdrawal by Subject|2
61531|NCT01242085|242000|P1|Overall Study|Withdrawal by Subject|4
61532|NCT01242020|242010|P2|Overall Study|Failed screening|0
61533|NCT01242020|242011|P1|Overall Study|Failed screening|1
61534|NCT01242020|242010|P2|Overall Study|Withdrawal by Subject|0
61535|NCT01242020|242011|P1|Overall Study|Withdrawal by Subject|2
61536|NCT01241760|242041|P2|Overall Study|Not specified|1
61537|NCT01241760|242042|P1|Overall Study|Not specified|1
61538|NCT01241760|242041|P2|Overall Study|Switch To Commercially Available Medicat|4
61539|NCT01241760|242042|P1|Overall Study|Switch To Commercially Available Medicat|1
61540|NCT01241760|242041|P2|Overall Study|Withdrawal by Subject|13
61541|NCT01241760|242042|P1|Overall Study|Withdrawal by Subject|13
61542|NCT01241760|242041|P2|Overall Study|Lost to Follow-up|22
61543|NCT01241760|242042|P1|Overall Study|Lost to Follow-up|18
61544|NCT01241760|242041|P2|Overall Study|Adverse Event|0
61545|NCT01241760|242042|P1|Overall Study|Adverse Event|1
61546|NCT01241591|242065|P4|Overall Study|Adverse Event|4
61547|NCT01241591|242066|P3|Overall Study|Adverse Event|12
61548|NCT01241591|242067|P2|Overall Study|Adverse Event|11
61549|NCT01241591|242068|P1|Overall Study|Adverse Event|3
61550|NCT01241591|242065|P4|Overall Study|Not specified|1
61551|NCT01241591|242066|P3|Overall Study|Not specified|0
61552|NCT01241591|242067|P2|Overall Study|Not specified|1
61553|NCT01241591|242068|P1|Overall Study|Not specified|0
61554|NCT01241591|242065|P4|Overall Study|Withdrawal by Subject|2
61555|NCT01241591|242066|P3|Overall Study|Withdrawal by Subject|2
61556|NCT01241591|242067|P2|Overall Study|Withdrawal by Subject|4
61557|NCT01241591|242068|P1|Overall Study|Withdrawal by Subject|6
61558|NCT01241591|242065|P4|Overall Study|Screen Failure|0
61559|NCT01241591|242066|P3|Overall Study|Screen Failure|1
61560|NCT01241591|242067|P2|Overall Study|Screen Failure|2
61561|NCT01241591|242068|P1|Overall Study|Screen Failure|3
61562|NCT01241591|242065|P4|Overall Study|Lost to Follow-up|2
61563|NCT01241591|242066|P3|Overall Study|Lost to Follow-up|2
61564|NCT01241591|242067|P2|Overall Study|Lost to Follow-up|2
61565|NCT01241591|242068|P1|Overall Study|Lost to Follow-up|1
61566|NCT01241591|242065|P4|Overall Study|Protocol Violation|0
61567|NCT01241591|242066|P3|Overall Study|Protocol Violation|3
61568|NCT01241591|242067|P2|Overall Study|Protocol Violation|2
61569|NCT01241591|242068|P1|Overall Study|Protocol Violation|5
61570|NCT01241591|242065|P4|Overall Study|Lack of Efficacy|3
61571|NCT01241591|242066|P3|Overall Study|Lack of Efficacy|2
61572|NCT01241591|242067|P2|Overall Study|Lack of Efficacy|2
61573|NCT01241591|242068|P1|Overall Study|Lack of Efficacy|5
61574|NCT01241552|242271|P4|Overall Study|Lost to Follow-up|16
61575|NCT01241552|242272|P3|Overall Study|Lost to Follow-up|15
61576|NCT01241552|242273|P2|Overall Study|Lost to Follow-up|11
61577|NCT01241552|242274|P1|Overall Study|Lost to Follow-up|2
61578|NCT01241552|242271|P4|Overall Study|Physician Decision|3
61579|NCT01241552|242272|P3|Overall Study|Physician Decision|2
61580|NCT01241552|242273|P2|Overall Study|Physician Decision|4
61581|NCT01241552|242274|P1|Overall Study|Physician Decision|2
61582|NCT01241552|242271|P4|Overall Study|Withdrawal by Subject|15
61583|NCT01241552|242272|P3|Overall Study|Withdrawal by Subject|14
61584|NCT01241552|242273|P2|Overall Study|Withdrawal by Subject|15
61585|NCT01241552|242274|P1|Overall Study|Withdrawal by Subject|7
61586|NCT01241552|242271|P4|Overall Study|Protocol Violation|1
61587|NCT01241552|242272|P3|Overall Study|Protocol Violation|6
61588|NCT01241552|242273|P2|Overall Study|Protocol Violation|2
61590|NCT01241552|242271|P4|Overall Study|Progressive Disease|2
61591|NCT01241552|242272|P3|Overall Study|Progressive Disease|1
61592|NCT01241552|242273|P2|Overall Study|Progressive Disease|0
61593|NCT01241552|242274|P1|Overall Study|Progressive Disease|0
61594|NCT01241552|242271|P4|Overall Study|Technical Problems|2
61595|NCT01241552|242272|P3|Overall Study|Technical Problems|2
61596|NCT01241552|242273|P2|Overall Study|Technical Problems|0
61597|NCT01241552|242274|P1|Overall Study|Technical Problems|2
61598|NCT01241552|242271|P4|Overall Study|Adverse Event|0
61599|NCT01241552|242272|P3|Overall Study|Adverse Event|0
61600|NCT01241552|242273|P2|Overall Study|Adverse Event|1
61601|NCT01241552|242274|P1|Overall Study|Adverse Event|1
61602|NCT01241552|242271|P4|Overall Study|Death|25
61603|NCT01241552|242272|P3|Overall Study|Death|20
61604|NCT01241552|242273|P2|Overall Study|Death|30
61605|NCT01241552|242274|P1|Overall Study|Death|26
61606|NCT01241552|242271|P4|Overall Study|Lack of Efficacy|0
61607|NCT01241552|242272|P3|Overall Study|Lack of Efficacy|0
61608|NCT01241552|242273|P2|Overall Study|Lack of Efficacy|0
61609|NCT01241552|242274|P1|Overall Study|Lack of Efficacy|1
61610|NCT01241292|242369|P2|Overall Study|Withdrawal by Subject|2
61611|NCT01241292|242370|P1|Overall Study|Withdrawal by Subject|0
61612|NCT01241292|242369|P2|Overall Study|Disease Progression|0
61613|NCT01241292|242370|P1|Overall Study|Disease Progression|1
61614|NCT01241279|242394|P2|Overall Study|Lost to Follow-up|1
61615|NCT01241279|242395|P1|Overall Study|Lost to Follow-up|0
61616|NCT01241240|242405|P2|Overall Study|Personal Reasons|1
61617|NCT01241240|242406|P1|Overall Study|Personal Reasons|1
61618|NCT01241240|242405|P2|Overall Study|Lost to Follow-up|4
61619|NCT01241240|242406|P1|Overall Study|Lost to Follow-up|2
61620|NCT01241240|242405|P2|Overall Study|Adverse Event|4
61621|NCT01241240|242406|P1|Overall Study|Adverse Event|5
61622|NCT01240915|242424|P9|Overall Study|Insufficient Clinical Response|3
61623|NCT01240915|242425|P8|Overall Study|Insufficient Clinical Response|0
61624|NCT01240915|242426|P7|Overall Study|Insufficient Clinical Response|6
61625|NCT01240915|242427|P6|Overall Study|Insufficient Clinical Response|3
61626|NCT01240915|242428|P5|Overall Study|Insufficient Clinical Response|1
61627|NCT01240915|242429|P4|Overall Study|Insufficient Clinical Response|0
61628|NCT01240915|242430|P3|Overall Study|Insufficient Clinical Response|0
61629|NCT01240915|242431|P2|Overall Study|Insufficient Clinical Response|0
61630|NCT01240915|242432|P1|Overall Study|Insufficient Clinical Response|0
61631|NCT01240915|242424|P9|Overall Study|Unspecified|0
61632|NCT01240915|242425|P8|Overall Study|Unspecified|0
61633|NCT01240915|242426|P7|Overall Study|Unspecified|0
61634|NCT01240915|242427|P6|Overall Study|Unspecified|0
61635|NCT01240915|242428|P5|Overall Study|Unspecified|2
61636|NCT01240915|242429|P4|Overall Study|Unspecified|0
61637|NCT01240915|242430|P3|Overall Study|Unspecified|0
61638|NCT01240915|242431|P2|Overall Study|Unspecified|0
61639|NCT01240915|242432|P1|Overall Study|Unspecified|0
61640|NCT01240915|242424|P9|Overall Study|Withdrawal by Subject|3
61641|NCT01240915|242425|P8|Overall Study|Withdrawal by Subject|3
61642|NCT01240915|242426|P7|Overall Study|Withdrawal by Subject|2
61643|NCT01240915|242427|P6|Overall Study|Withdrawal by Subject|4
61644|NCT01240915|242428|P5|Overall Study|Withdrawal by Subject|0
61645|NCT01240915|242429|P4|Overall Study|Withdrawal by Subject|2
61646|NCT01240915|242430|P3|Overall Study|Withdrawal by Subject|0
61647|NCT01240915|242431|P2|Overall Study|Withdrawal by Subject|1
61648|NCT01240915|242432|P1|Overall Study|Withdrawal by Subject|2
61649|NCT01240915|242424|P9|Overall Study|Lost to Follow-up|1
61650|NCT01240915|242425|P8|Overall Study|Lost to Follow-up|1
61651|NCT01240915|242426|P7|Overall Study|Lost to Follow-up|0
61652|NCT01240915|242427|P6|Overall Study|Lost to Follow-up|1
61653|NCT01240915|242428|P5|Overall Study|Lost to Follow-up|1
61654|NCT01240915|242429|P4|Overall Study|Lost to Follow-up|0
61655|NCT01240915|242430|P3|Overall Study|Lost to Follow-up|0
61656|NCT01240915|242431|P2|Overall Study|Lost to Follow-up|0
61657|NCT01240915|242432|P1|Overall Study|Lost to Follow-up|0
61658|NCT01240915|242424|P9|Overall Study|Adverse Event|1
61659|NCT01240915|242425|P8|Overall Study|Adverse Event|0
61660|NCT01240915|242426|P7|Overall Study|Adverse Event|0
61661|NCT01240915|242427|P6|Overall Study|Adverse Event|2
61662|NCT01240915|242428|P5|Overall Study|Adverse Event|0
61663|NCT01240915|242429|P4|Overall Study|Adverse Event|1
61664|NCT01240915|242430|P3|Overall Study|Adverse Event|0
61665|NCT01240915|242431|P2|Overall Study|Adverse Event|0
61666|NCT01240915|242432|P1|Overall Study|Adverse Event|0
61667|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
61668|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
61669|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
61670|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Not specified|5
61671|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Not specified|1
61672|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Not specified|0
61673|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
61674|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
61675|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
61676|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
61677|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
61678|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
61679|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
61680|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
61681|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
61682|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
61683|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
61684|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
61685|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
61686|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
61687|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
61688|NCT01240863|242706|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
61689|NCT01240863|242707|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
61690|NCT01240863|242708|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
61691|NCT01240863|242706|P3|Open-label Titration Period|Not specified|0
61692|NCT01240863|242707|P2|Open-label Titration Period|Not specified|0
61693|NCT01240863|242708|P1|Open-label Titration Period|Not specified|7
61694|NCT01240863|242706|P3|Open-label Titration Period|Dropped out prior to dosing|0
61695|NCT01240863|242707|P2|Open-label Titration Period|Dropped out prior to dosing|0
61696|NCT01240863|242708|P1|Open-label Titration Period|Dropped out prior to dosing|2
61697|NCT01240863|242706|P3|Open-label Titration Period|Noncompliance to study procedures|0
61698|NCT01240863|242707|P2|Open-label Titration Period|Noncompliance to study procedures|0
61699|NCT01240863|242708|P1|Open-label Titration Period|Noncompliance to study procedures|3
61700|NCT01240863|242706|P3|Open-label Titration Period|Noncompliance to study drug admin|0
61701|NCT01240863|242707|P2|Open-label Titration Period|Noncompliance to study drug admin|0
61702|NCT01240863|242708|P1|Open-label Titration Period|Noncompliance to study drug admin|3
61703|NCT01240863|242706|P3|Open-label Titration Period|Protocol Violation|0
61704|NCT01240863|242707|P2|Open-label Titration Period|Protocol Violation|0
61705|NCT01240863|242708|P1|Open-label Titration Period|Protocol Violation|7
61706|NCT01240863|242706|P3|Open-label Titration Period|Withdrawal by Subject|0
61707|NCT01240863|242707|P2|Open-label Titration Period|Withdrawal by Subject|0
61708|NCT01240863|242708|P1|Open-label Titration Period|Withdrawal by Subject|9
61709|NCT01240863|242706|P3|Open-label Titration Period|Lack of Efficacy|0
61710|NCT01240863|242707|P2|Open-label Titration Period|Lack of Efficacy|0
61711|NCT01240863|242708|P1|Open-label Titration Period|Lack of Efficacy|19
61712|NCT01240863|242706|P3|Open-label Titration Period|Adverse Event|0
61713|NCT01240863|242707|P2|Open-label Titration Period|Adverse Event|0
61714|NCT01240863|242708|P1|Open-label Titration Period|Adverse Event|47
61715|NCT01240811|242770|P3|Overall Study|Withdrawal by Subject|1
61716|NCT01240811|242771|P2|Overall Study|Withdrawal by Subject|0
61717|NCT01240811|242772|P1|Overall Study|Withdrawal by Subject|0
61718|NCT01240811|242770|P3|Overall Study|Physician Decision|0
61719|NCT01240811|242771|P2|Overall Study|Physician Decision|1
61720|NCT01240811|242772|P1|Overall Study|Physician Decision|0
61721|NCT01240785|242782|P2|Overall Study|Protocol Violation|3
61722|NCT01240785|242783|P1|Overall Study|Protocol Violation|0
61723|NCT01240785|242782|P2|Overall Study|Lost to Follow-up|0
61724|NCT01240785|242783|P1|Overall Study|Lost to Follow-up|1
61725|NCT01240746|242814|P3|Overall Study|Withdrawal by Subject|59
61726|NCT01240746|242815|P2|Overall Study|Withdrawal by Subject|13
61727|NCT01240746|242816|P1|Overall Study|Withdrawal by Subject|10
61728|NCT01240746|242814|P3|Overall Study|Protocol Violation|72
61729|NCT01240746|242815|P2|Overall Study|Protocol Violation|15
61730|NCT01240746|242816|P1|Overall Study|Protocol Violation|24
61731|NCT01240746|242814|P3|Overall Study|Lost to Follow-up|102
61732|NCT01240746|242815|P2|Overall Study|Lost to Follow-up|20
61733|NCT01240746|242816|P1|Overall Study|Lost to Follow-up|23
61734|NCT01240746|242814|P3|Overall Study|Adverse Event|10
61735|NCT01240746|242815|P2|Overall Study|Adverse Event|0
61736|NCT01240746|242816|P1|Overall Study|Adverse Event|2
61737|NCT01240590|242871|P5|Phase II|Refused further treatment|1
61738|NCT01240590|242872|P4|Phase II|Refused further treatment|2
61739|NCT01240590|242873|P3|Phase II|Refused further treatment|0
61740|NCT01240590|242874|P2|Phase II|Refused further treatment|0
61741|NCT01240590|242875|P1|Phase II|Refused further treatment|0
61742|NCT01240590|242871|P5|Phase I|Refused further treatment|0
61743|NCT01240590|242872|P4|Phase I|Refused further treatment|0
61744|NCT01240590|242873|P3|Phase I|Refused further treatment|3
61745|NCT01240590|242874|P2|Phase I|Refused further treatment|0
61746|NCT01240590|242875|P1|Phase I|Refused further treatment|0
61747|NCT01240551|242903|P2|Overall Study|Lost to Follow-up|1
61748|NCT01240551|242904|P1|Overall Study|Lost to Follow-up|1
61749|NCT01240551|242903|P2|Overall Study|Refused further treatment|2
61750|NCT01240551|242904|P1|Overall Study|Refused further treatment|3
61751|NCT01240382|242914|P2|Overall Study|Fear of adverse events|1
61752|NCT01240382|242915|P1|Overall Study|Fear of adverse events|0
61753|NCT01240382|242914|P2|Overall Study|Lack of Efficacy|2
61754|NCT01240382|242915|P1|Overall Study|Lack of Efficacy|0
61755|NCT01240382|242914|P2|Overall Study|Adverse Event|1
61756|NCT01240382|242915|P1|Overall Study|Adverse Event|2
61757|NCT01240356|242925|P2|Overall Study|MRI contraindication|0
61758|NCT01240356|242926|P1|Overall Study|MRI contraindication|1
61759|NCT01240356|242925|P2|Overall Study|Withdrawal by Subject|0
61760|NCT01240356|242926|P1|Overall Study|Withdrawal by Subject|2
61761|NCT01240200|242945|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
61762|NCT01240200|242946|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
61763|NCT01240135|242954|P2|Period Two, 14 Days of Wear|Adverse Event|1
61764|NCT01240135|242955|P1|Period Two, 14 Days of Wear|Adverse Event|0
61765|NCT01240135|242954|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
61766|NCT01240135|242955|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
61767|NCT01239992|242970|P1|Overall Study|Withdrawal by Subject|2
61768|NCT01239797|242979|P2|Treated Participants|Poor/Non-compliance|1
61769|NCT01239797|242980|P1|Treated Participants|Poor/Non-compliance|0
61770|NCT01239797|242979|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
61771|NCT01239797|242980|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
61772|NCT01239797|242979|P2|Treated Participants|Death|1
61773|NCT01239797|242980|P1|Treated Participants|Death|1
61774|NCT01239797|242979|P2|Treated Participants|Non-specified|11
61775|NCT01239797|242980|P1|Treated Participants|Non-specified|1
61776|NCT01239797|242979|P2|Treated Participants|Withdrawal by Subject|23
61777|NCT01239797|242980|P1|Treated Participants|Withdrawal by Subject|27
61778|NCT01239797|242979|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
61779|NCT01239797|242980|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
61780|NCT01239797|242979|P2|Treated Participants|Study Drug Toxicity|44
61781|NCT01239797|242980|P1|Treated Participants|Study Drug Toxicity|30
61782|NCT01239797|242979|P2|Treated Participants|Disease Progression|161
61783|NCT01239797|242980|P1|Treated Participants|Disease Progression|153
61784|NCT01239745|242988|P1|Overall Study|Adverse Event|1
61785|NCT01239745|242988|P1|Overall Study|Study terminated by sponsor|45
61786|NCT01239732|242999|P1|Overall Study|Unspecified|19
61787|NCT01239732|242999|P1|Overall Study|Treatment failure|2
61788|NCT01239732|242999|P1|Overall Study|Investigator's decision|4
61789|NCT01239732|242999|P1|Overall Study|Study termination by sponsor|2
61790|NCT01239732|242999|P1|Overall Study|Participant non compliance|5
61791|NCT01239732|242999|P1|Overall Study|Protocol Violation|3
61792|NCT01239732|242999|P1|Overall Study|Adverse Event|6
61793|NCT01239732|242999|P1|Overall Study|Withdrawal by Subject|87
61794|NCT01239732|242999|P1|Overall Study|Death|226
61795|NCT01239732|242999|P1|Overall Study|Termination of study per protocol|667
61796|NCT01239680|243012|P2|Overall Study|Withdrawal by Subject|0
61797|NCT01239680|243013|P1|Overall Study|Withdrawal by Subject|2
61798|NCT01239394|243036|P1|Overall Study|Adverse Event|1
61799|NCT01239381|243043|P1|Overall Study|Withdrawal by Subject|1
61800|NCT01239381|243043|P1|Overall Study|Protocol Violation|1
61801|NCT01239342|243061|P2|Overall Study|Reason Unknown|1
61802|NCT01239342|243062|P1|Overall Study|Reason Unknown|1
61803|NCT01239342|243061|P2|Overall Study|Withdrawal by Subject|5
61804|NCT01239342|243062|P1|Overall Study|Withdrawal by Subject|1
61805|NCT01239342|243061|P2|Overall Study|Adverse Event|0
61806|NCT01239342|243062|P1|Overall Study|Adverse Event|1
61807|NCT01239316|243078|P1|Overall Study|Adverse Event|1
61808|NCT01239316|243078|P1|Overall Study|Progression/Relapse|11
61809|NCT01239121|243093|P3|Overall Study|Withdrawal by Subject|0
61810|NCT01239121|243094|P2|Overall Study|Withdrawal by Subject|4
61811|NCT01239121|243095|P1|Overall Study|Withdrawal by Subject|2
61812|NCT01239043|243117|P2|Overall Study|Protocol Violation|1
61813|NCT01239043|243118|P1|Overall Study|Protocol Violation|2
61814|NCT01238991|243146|P10|Overall Study|Admission to a nursing home|0
61815|NCT01238991|243147|P9|Overall Study|Admission to a nursing home|0
61816|NCT01238991|243148|P8|Overall Study|Admission to a nursing home|0
61817|NCT01238991|243149|P7|Overall Study|Admission to a nursing home|0
61818|NCT01238991|243150|P6|Overall Study|Admission to a nursing home|0
61819|NCT01238991|243151|P5|Overall Study|Admission to a nursing home|0
61820|NCT01238991|243152|P4|Overall Study|Admission to a nursing home|0
61821|NCT01238991|243153|P3|Overall Study|Admission to a nursing home|1
61822|NCT01238991|243154|P2|Overall Study|Admission to a nursing home|0
61823|NCT01238991|243155|P1|Overall Study|Admission to a nursing home|1
61824|NCT01238991|243146|P10|Overall Study|Caregiver's request|0
61825|NCT01238991|243147|P9|Overall Study|Caregiver's request|1
61826|NCT01238991|243148|P8|Overall Study|Caregiver's request|0
61827|NCT01238991|243149|P7|Overall Study|Caregiver's request|0
61828|NCT01238991|243150|P6|Overall Study|Caregiver's request|0
61829|NCT01238991|243151|P5|Overall Study|Caregiver's request|0
61830|NCT01238991|243152|P4|Overall Study|Caregiver's request|0
61831|NCT01238991|243153|P3|Overall Study|Caregiver's request|0
61832|NCT01238991|243154|P2|Overall Study|Caregiver's request|0
61833|NCT01238991|243155|P1|Overall Study|Caregiver's request|0
61834|NCT01238991|243146|P10|Overall Study|Study Terminated by Sponsor|2
61835|NCT01238991|243147|P9|Overall Study|Study Terminated by Sponsor|2
61836|NCT01238991|243148|P8|Overall Study|Study Terminated by Sponsor|4
61837|NCT01238991|243149|P7|Overall Study|Study Terminated by Sponsor|7
61838|NCT01238991|243150|P6|Overall Study|Study Terminated by Sponsor|0
61839|NCT01238991|243151|P5|Overall Study|Study Terminated by Sponsor|1
61840|NCT01238991|243152|P4|Overall Study|Study Terminated by Sponsor|0
61841|NCT01238991|243153|P3|Overall Study|Study Terminated by Sponsor|0
61842|NCT01238991|243154|P2|Overall Study|Study Terminated by Sponsor|0
61843|NCT01238991|243155|P1|Overall Study|Study Terminated by Sponsor|0
61844|NCT01238991|243146|P10|Overall Study|Withdrawal by Subject|0
61845|NCT01238991|243147|P9|Overall Study|Withdrawal by Subject|0
61846|NCT01238991|243148|P8|Overall Study|Withdrawal by Subject|0
61847|NCT01238991|243149|P7|Overall Study|Withdrawal by Subject|0
61848|NCT01238991|243150|P6|Overall Study|Withdrawal by Subject|0
61849|NCT01238991|243151|P5|Overall Study|Withdrawal by Subject|0
61850|NCT01238991|243152|P4|Overall Study|Withdrawal by Subject|0
61851|NCT01238991|243153|P3|Overall Study|Withdrawal by Subject|1
61852|NCT01238991|243154|P2|Overall Study|Withdrawal by Subject|0
61853|NCT01238991|243155|P1|Overall Study|Withdrawal by Subject|0
61854|NCT01238991|243146|P10|Overall Study|Lack of Efficacy|0
61855|NCT01238991|243147|P9|Overall Study|Lack of Efficacy|1
61856|NCT01238991|243148|P8|Overall Study|Lack of Efficacy|0
61857|NCT01238991|243149|P7|Overall Study|Lack of Efficacy|0
61858|NCT01238991|243150|P6|Overall Study|Lack of Efficacy|0
61859|NCT01238991|243151|P5|Overall Study|Lack of Efficacy|0
61860|NCT01238991|243152|P4|Overall Study|Lack of Efficacy|0
61861|NCT01238991|243153|P3|Overall Study|Lack of Efficacy|1
61862|NCT01238991|243154|P2|Overall Study|Lack of Efficacy|0
61863|NCT01238991|243155|P1|Overall Study|Lack of Efficacy|0
61864|NCT01238991|243146|P10|Overall Study|Death|0
61865|NCT01238991|243147|P9|Overall Study|Death|0
61866|NCT01238991|243148|P8|Overall Study|Death|0
61867|NCT01238991|243149|P7|Overall Study|Death|0
61868|NCT01238991|243150|P6|Overall Study|Death|0
61869|NCT01238991|243151|P5|Overall Study|Death|0
61870|NCT01238991|243152|P4|Overall Study|Death|1
61871|NCT01238991|243153|P3|Overall Study|Death|0
61872|NCT01238991|243154|P2|Overall Study|Death|0
61873|NCT01238991|243155|P1|Overall Study|Death|0
61874|NCT01238991|243146|P10|Overall Study|Adverse Event|0
61875|NCT01238991|243147|P9|Overall Study|Adverse Event|0
61876|NCT01238991|243148|P8|Overall Study|Adverse Event|1
61877|NCT01238991|243149|P7|Overall Study|Adverse Event|1
61878|NCT01238991|243150|P6|Overall Study|Adverse Event|0
61879|NCT01238991|243151|P5|Overall Study|Adverse Event|1
61880|NCT01238991|243152|P4|Overall Study|Adverse Event|1
61881|NCT01238991|243153|P3|Overall Study|Adverse Event|3
61882|NCT01238991|243154|P2|Overall Study|Adverse Event|0
61883|NCT01238991|243155|P1|Overall Study|Adverse Event|1
61884|NCT01238900|243242|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
61885|NCT01238900|243242|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
61886|NCT01238861|243256|P6|Overall Study|Withdrawal by Subject|9
61887|NCT01238861|243257|P5|Overall Study|Withdrawal by Subject|10
61888|NCT01238861|243258|P4|Overall Study|Withdrawal by Subject|8
61889|NCT01238861|243259|P3|Overall Study|Withdrawal by Subject|4
61890|NCT01238861|243260|P2|Overall Study|Withdrawal by Subject|5
61891|NCT01238861|243261|P1|Overall Study|Withdrawal by Subject|6
61892|NCT01238861|243256|P6|Overall Study|Adverse Event|0
61893|NCT01238861|243257|P5|Overall Study|Adverse Event|0
61894|NCT01238861|243258|P4|Overall Study|Adverse Event|0
61895|NCT01238861|243259|P3|Overall Study|Adverse Event|0
61896|NCT01238861|243260|P2|Overall Study|Adverse Event|1
61897|NCT01238861|243261|P1|Overall Study|Adverse Event|0
61898|NCT01238861|243256|P6|Overall Study|Lack of compliance|1
61899|NCT01238861|243257|P5|Overall Study|Lack of compliance|0
61900|NCT01238861|243258|P4|Overall Study|Lack of compliance|0
61901|NCT01238861|243259|P3|Overall Study|Lack of compliance|0
61902|NCT01238861|243260|P2|Overall Study|Lack of compliance|0
61903|NCT01238861|243261|P1|Overall Study|Lack of compliance|0
61904|NCT01238861|243256|P6|Overall Study|Serious adverse event|1
61905|NCT01238861|243257|P5|Overall Study|Serious adverse event|0
61906|NCT01238861|243258|P4|Overall Study|Serious adverse event|0
61907|NCT01238861|243259|P3|Overall Study|Serious adverse event|0
61908|NCT01238861|243260|P2|Overall Study|Serious adverse event|0
61909|NCT01238861|243261|P1|Overall Study|Serious adverse event|0
61910|NCT01238861|243256|P6|Overall Study|Unable to continue visits|1
61911|NCT01238861|243257|P5|Overall Study|Unable to continue visits|0
61912|NCT01238861|243258|P4|Overall Study|Unable to continue visits|1
61913|NCT01238861|243259|P3|Overall Study|Unable to continue visits|0
61914|NCT01238861|243260|P2|Overall Study|Unable to continue visits|0
61915|NCT01238861|243261|P1|Overall Study|Unable to continue visits|0
61916|NCT01238861|243256|P6|Overall Study|Personal problems|0
61917|NCT01238861|243257|P5|Overall Study|Personal problems|0
61918|NCT01238861|243258|P4|Overall Study|Personal problems|1
61919|NCT01238861|243259|P3|Overall Study|Personal problems|0
61920|NCT01238861|243260|P2|Overall Study|Personal problems|0
61921|NCT01238861|243261|P1|Overall Study|Personal problems|0
61922|NCT01238861|243256|P6|Overall Study|Strongyloides stercoralis antibodies +|0
61923|NCT01238861|243257|P5|Overall Study|Strongyloides stercoralis antibodies +|0
61924|NCT01238861|243258|P4|Overall Study|Strongyloides stercoralis antibodies +|1
61925|NCT01238861|243259|P3|Overall Study|Strongyloides stercoralis antibodies +|0
61926|NCT01238861|243260|P2|Overall Study|Strongyloides stercoralis antibodies +|0
61927|NCT01238861|243261|P1|Overall Study|Strongyloides stercoralis antibodies +|0
61928|NCT01238861|243256|P6|Overall Study|Subject moved out of state/area|0
61929|NCT01238861|243257|P5|Overall Study|Subject moved out of state/area|0
61930|NCT01238861|243258|P4|Overall Study|Subject moved out of state/area|1
61931|NCT01238861|243259|P3|Overall Study|Subject moved out of state/area|1
61932|NCT01238861|243260|P2|Overall Study|Subject moved out of state/area|0
61933|NCT01238861|243261|P1|Overall Study|Subject moved out of state/area|0
61934|NCT01238861|243256|P6|Overall Study|Subject traveled to Argentina by 1 year|0
61935|NCT01238861|243257|P5|Overall Study|Subject traveled to Argentina by 1 year|0
61936|NCT01238861|243258|P4|Overall Study|Subject traveled to Argentina by 1 year|0
61937|NCT01238861|243259|P3|Overall Study|Subject traveled to Argentina by 1 year|1
61938|NCT01238861|243260|P2|Overall Study|Subject traveled to Argentina by 1 year|0
61939|NCT01238861|243261|P1|Overall Study|Subject traveled to Argentina by 1 year|0
61940|NCT01238861|243256|P6|Overall Study|Incorrect enrollment/randomization|0
61941|NCT01238861|243257|P5|Overall Study|Incorrect enrollment/randomization|1
61942|NCT01238861|243258|P4|Overall Study|Incorrect enrollment/randomization|0
61943|NCT01238861|243259|P3|Overall Study|Incorrect enrollment/randomization|1
61944|NCT01238861|243260|P2|Overall Study|Incorrect enrollment/randomization|0
61945|NCT01238861|243261|P1|Overall Study|Incorrect enrollment/randomization|0
61946|NCT01238861|243256|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
61947|NCT01238861|243257|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
61948|NCT01238861|243258|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
61949|NCT01238861|243259|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
61950|NCT01238861|243260|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
61951|NCT01238861|243261|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
61952|NCT01238861|243256|P6|Overall Study|Unplanned surgery|0
61953|NCT01238861|243257|P5|Overall Study|Unplanned surgery|0
61954|NCT01238861|243258|P4|Overall Study|Unplanned surgery|0
61955|NCT01238861|243259|P3|Overall Study|Unplanned surgery|0
61956|NCT01238861|243260|P2|Overall Study|Unplanned surgery|0
61957|NCT01238861|243261|P1|Overall Study|Unplanned surgery|1
61958|NCT01238861|243256|P6|Overall Study|Lost to Follow-up|2
61959|NCT01238861|243257|P5|Overall Study|Lost to Follow-up|1
61960|NCT01238861|243258|P4|Overall Study|Lost to Follow-up|1
61961|NCT01238861|243259|P3|Overall Study|Lost to Follow-up|3
61962|NCT01238861|243260|P2|Overall Study|Lost to Follow-up|2
61963|NCT01238861|243261|P1|Overall Study|Lost to Follow-up|4
61964|NCT01238848|243341|P2|Overall Study|Physician Decision|5
61965|NCT01238848|243342|P1|Overall Study|Physician Decision|13
61966|NCT01238822|243350|P1|Overall Study|COULD NOT SWALLOW PILLS|3
61967|NCT01238588|243377|P1|Overall Study|Physician Decision|2
61968|NCT01238588|243377|P1|Overall Study|Withdrawal by Subject|1
61969|NCT01238575|243390|P2|Overall Study|Adverse Event|0
61970|NCT01238575|243391|P1|Overall Study|Adverse Event|2
61971|NCT01238575|243390|P2|Overall Study|Lack of Efficacy|4
61972|NCT01238575|243391|P1|Overall Study|Lack of Efficacy|2
61973|NCT01238211|243443|P1|Overall Study|Investigator/Patient Decision|3
61974|NCT01238211|243443|P1|Overall Study|Non-protocol treatment|4
61975|NCT01238211|243443|P1|Overall Study|Withdrawal by Subject|7
61976|NCT01238211|243443|P1|Overall Study|Relapse/Progression|2
61977|NCT01238211|243443|P1|Overall Study|Death|4
61978|NCT01238211|243443|P1|Overall Study|Adverse Event|7
61979|NCT01238211|243443|P1|Overall Study|Continues active treatment|31
61980|NCT01237340|243476|P1|Overall Study|Early termination of the trial|36
61981|NCT01237340|243476|P1|Overall Study|Withdrawal by Subject|1
61982|NCT01237340|243476|P1|Overall Study|Adverse Event|3
61983|NCT01237327|243490|P2|Overall Study|Lost to Follow-up|0
61984|NCT01237327|243491|P1|Overall Study|Lost to Follow-up|3
61985|NCT01237327|243490|P2|Overall Study|Withdrawal by Subject|3
61986|NCT01237327|243491|P1|Overall Study|Withdrawal by Subject|1
61987|NCT01237327|243490|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
61988|NCT01237327|243491|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
61989|NCT01237327|243490|P2|Overall Study|Progression of Disease: Extension Study|13
61990|NCT01237327|243491|P1|Overall Study|Progression of Disease: Extension Study|15
61991|NCT01237327|243490|P2|Overall Study|Progression of Disease: Core Study|22
61992|NCT01237327|243491|P1|Overall Study|Progression of Disease: Core Study|18
61993|NCT01237327|243490|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
61994|NCT01237327|243491|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
61995|NCT01237327|243490|P2|Overall Study|Protocol Violation: Core Study|0
61996|NCT01237327|243491|P1|Overall Study|Protocol Violation: Core Study|1
61997|NCT01237223|243520|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
61998|NCT01237223|243521|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
61999|NCT01237223|243522|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
62000|NCT01237223|243523|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
62001|NCT01237223|243524|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
62002|NCT01237223|243525|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
62003|NCT01237223|243520|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
62004|NCT01237223|243521|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
62005|NCT01237223|243522|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
62006|NCT01237223|243523|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
62007|NCT01237223|243524|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
62008|NCT01237223|243525|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
62009|NCT01237223|243520|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
62010|NCT01237223|243521|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
62011|NCT01237223|243522|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
62012|NCT01237223|243523|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
62013|NCT01237223|243524|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
62014|NCT01237223|243525|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
62015|NCT01237223|243520|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
62016|NCT01237223|243521|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
62017|NCT01237223|243522|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
62018|NCT01237223|243523|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
62019|NCT01237223|243524|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
62020|NCT01237223|243525|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
62021|NCT01237223|243520|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
62022|NCT01237223|243521|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
62023|NCT01237223|243522|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
62024|NCT01237223|243523|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
62025|NCT01237223|243524|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
62026|NCT01237223|243525|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
62027|NCT01237223|243520|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
62028|NCT01237223|243521|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
62029|NCT01237223|243522|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
62030|NCT01237223|243523|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
62031|NCT01237223|243524|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
62032|NCT01237223|243525|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
62033|NCT01237223|243520|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
62034|NCT01237223|243521|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
62035|NCT01237223|243522|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
62036|NCT01237223|243523|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
62037|NCT01237223|243524|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
62189|NCT01235442|244244|P1|Overall Study|Administrative decision|1
62038|NCT01237223|243525|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
62039|NCT01237223|243520|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
62040|NCT01237223|243521|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
62041|NCT01237223|243522|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
62042|NCT01237223|243523|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
62043|NCT01237223|243524|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
62044|NCT01237223|243525|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
62045|NCT01237223|243520|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
62046|NCT01237223|243521|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
62047|NCT01237223|243522|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
62048|NCT01237223|243523|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
62049|NCT01237223|243524|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
62050|NCT01237223|243525|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
62051|NCT01237223|243520|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
62052|NCT01237223|243521|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
62053|NCT01237223|243522|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
62054|NCT01237223|243523|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
62055|NCT01237223|243524|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
62056|NCT01237223|243525|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
62057|NCT01237054|243584|P1|Overall Study|imaging 10C0096|1
62058|NCT01236573|243616|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
62059|NCT01236573|243617|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62060|NCT01236573|243618|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62061|NCT01236573|243619|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62062|NCT01236573|243620|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62063|NCT01236573|243621|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62064|NCT01236573|243622|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62065|NCT01236573|243623|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62066|NCT01236573|243624|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62067|NCT01236573|243625|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62068|NCT01236573|243626|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
62069|NCT01236573|243616|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62070|NCT01236573|243617|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62071|NCT01236573|243618|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
62072|NCT01236573|243619|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62073|NCT01236573|243620|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62074|NCT01236573|243621|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62075|NCT01236573|243622|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62076|NCT01236573|243623|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62077|NCT01236573|243624|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62078|NCT01236573|243625|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62079|NCT01236573|243626|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
62080|NCT01236573|243616|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62081|NCT01236573|243617|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
62082|NCT01236573|243618|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
62083|NCT01236573|243619|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62084|NCT01236573|243620|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
62085|NCT01236573|243621|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62086|NCT01236573|243622|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62087|NCT01236573|243623|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62088|NCT01236573|243624|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62089|NCT01236573|243625|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62090|NCT01236573|243626|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
62091|NCT01236534|243664|P2|Overall Study|Adverse Event|0
62092|NCT01236534|243665|P1|Overall Study|Adverse Event|3
62093|NCT01236365|243695|P2|Overall Study|Dropped at Randomization due to high LFT|0
62094|NCT01236365|243696|P1|Overall Study|Dropped at Randomization due to high LFT|1
62095|NCT01236365|243695|P2|Overall Study|Moved Out of State|0
62096|NCT01236365|243696|P1|Overall Study|Moved Out of State|1
62097|NCT01236365|243695|P2|Overall Study|Lost to Follow-up|2
62098|NCT01236365|243696|P1|Overall Study|Lost to Follow-up|0
62099|NCT01236339|243710|P2|Overall Study|Termination of study by sponsor|13
62100|NCT01236339|243711|P1|Overall Study|Termination of study by sponsor|11
62101|NCT01236118|243779|P3|Overall Study|Withdrawal by Subject|1
62102|NCT01236118|243780|P2|Overall Study|Withdrawal by Subject|0
62103|NCT01236118|243781|P1|Overall Study|Withdrawal by Subject|0
62104|NCT01236118|243779|P3|Overall Study|Physician Decision|0
62105|NCT01236118|243780|P2|Overall Study|Physician Decision|1
62106|NCT01236118|243781|P1|Overall Study|Physician Decision|0
62107|NCT01236118|243779|P3|Overall Study|Adverse Event|2
62108|NCT01236118|243780|P2|Overall Study|Adverse Event|0
62109|NCT01236118|243781|P1|Overall Study|Adverse Event|2
62110|NCT01236001|243982|P2|Overall Study|Planned Visit After End of Study|1
62111|NCT01236001|243983|P1|Overall Study|Planned Visit After End of Study|0
62112|NCT01236001|243982|P2|Overall Study|Incompliance|0
62113|NCT01236001|243983|P1|Overall Study|Incompliance|1
62114|NCT01236001|243982|P2|Overall Study|Lost to Follow-up|1
62115|NCT01236001|243983|P1|Overall Study|Lost to Follow-up|6
62116|NCT01236001|243982|P2|Overall Study|Lack of Efficacy|6
62117|NCT01236001|243983|P1|Overall Study|Lack of Efficacy|6
62118|NCT01236001|243982|P2|Overall Study|Adverse Event|14
62119|NCT01236001|243983|P1|Overall Study|Adverse Event|5
62120|NCT01235975|244015|P2|Overall Study|Lost to Follow-up|3
62121|NCT01235975|244016|P1|Overall Study|Lost to Follow-up|7
62122|NCT01235975|244015|P2|Overall Study|Migrated/moved from study area|1
62123|NCT01235975|244016|P1|Overall Study|Migrated/moved from study area|2
62124|NCT01235975|244015|P2|Overall Study|Withdrawal by Subject|2
62125|NCT01235975|244016|P1|Overall Study|Withdrawal by Subject|8
62126|NCT01235975|244015|P2|Overall Study|Serious Adverse Event|1
62127|NCT01235975|244016|P1|Overall Study|Serious Adverse Event|0
62128|NCT01235741|244071|P3|Follow-Up Post Treatment up to Month 6|not specified|0
62129|NCT01235741|244072|P2|Follow-Up Post Treatment up to Month 6|not specified|1
62130|NCT01235741|244073|P1|Follow-Up Post Treatment up to Month 6|not specified|0
62131|NCT01235741|244071|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
62132|NCT01235741|244072|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
62133|NCT01235741|244073|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
62134|NCT01235741|244071|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
62135|NCT01235741|244072|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
62136|NCT01235741|244073|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
62137|NCT01235741|244071|P3|Randomized to Treatment|Sponsor terminated study|34
62138|NCT01235741|244072|P2|Randomized to Treatment|Sponsor terminated study|35
62139|NCT01235741|244073|P1|Randomized to Treatment|Sponsor terminated study|0
62140|NCT01235741|244071|P3|Randomized to Treatment|Adverse Event|1
62141|NCT01235741|244072|P2|Randomized to Treatment|Adverse Event|1
62142|NCT01235741|244073|P1|Randomized to Treatment|Adverse Event|0
62143|NCT01235741|244071|P3|Randomized to Treatment|Withdrawal by Subject|1
62144|NCT01235741|244072|P2|Randomized to Treatment|Withdrawal by Subject|0
62145|NCT01235741|244073|P1|Randomized to Treatment|Withdrawal by Subject|0
62146|NCT01235741|244071|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
62147|NCT01235741|244072|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
62148|NCT01235741|244073|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
62149|NCT01235741|244071|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
62150|NCT01235741|244072|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
62151|NCT01235741|244073|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
62152|NCT01235741|244071|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
62153|NCT01235741|244072|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
62154|NCT01235741|244073|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
62155|NCT01235741|244071|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
62156|NCT01235741|244072|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
62157|NCT01235741|244073|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
62158|NCT01235741|244071|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
62159|NCT01235741|244072|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
62160|NCT01235741|244073|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
62161|NCT01235741|244071|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
62162|NCT01235741|244072|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
62163|NCT01235741|244073|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
62164|NCT01235728|244100|P8|Overall Study|Protocol Violation|0
62165|NCT01235728|244101|P7|Overall Study|Protocol Violation|0
62166|NCT01235728|244102|P6|Overall Study|Protocol Violation|0
62167|NCT01235728|244103|P5|Overall Study|Protocol Violation|0
62168|NCT01235728|244104|P4|Overall Study|Protocol Violation|1
62169|NCT01235728|244105|P3|Overall Study|Protocol Violation|0
62170|NCT01235728|244106|P2|Overall Study|Protocol Violation|0
62171|NCT01235728|244107|P1|Overall Study|Protocol Violation|0
62172|NCT01235715|244117|P2|Overall Study|Physician Decision|2
62173|NCT01235715|244118|P1|Overall Study|Physician Decision|0
62174|NCT01235598|244158|P2|Overall Study|Withdrawal by Subject|0
62175|NCT01235598|244159|P1|Overall Study|Withdrawal by Subject|1
62176|NCT01235598|244158|P2|Overall Study|Lack of Efficacy|1
62177|NCT01235598|244159|P1|Overall Study|Lack of Efficacy|0
62178|NCT01235598|244158|P2|Overall Study|Adverse Event|3
62179|NCT01235598|244159|P1|Overall Study|Adverse Event|0
62180|NCT01235546|244204|P2|Overall Study|Protocol Violation|1
62181|NCT01235546|244205|P1|Overall Study|Protocol Violation|1
62182|NCT01235546|244204|P2|Overall Study|Staff error, medication not administered|0
62183|NCT01235546|244205|P1|Overall Study|Staff error, medication not administered|1
62184|NCT01235507|244229|P1|Overall Study|Withdrawal by Subject|1
62185|NCT01235507|244229|P1|Overall Study|Adverse Event|1
62186|NCT01235442|244243|P2|Overall Study|Other unspecified|2
62187|NCT01235442|244244|P1|Overall Study|Other unspecified|1
62188|NCT01235442|244243|P2|Overall Study|Administrative decision|2
62190|NCT01235442|244243|P2|Overall Study|Noncompliance|2
62191|NCT01235442|244244|P1|Overall Study|Noncompliance|1
62192|NCT01235442|244243|P2|Overall Study|Lack of Efficacy|3
62193|NCT01235442|244244|P1|Overall Study|Lack of Efficacy|1
62194|NCT01235442|244243|P2|Overall Study|Withdrawal by Subject|9
62195|NCT01235442|244244|P1|Overall Study|Withdrawal by Subject|15
62196|NCT01235442|244243|P2|Overall Study|Adverse Event|6
62197|NCT01235442|244244|P1|Overall Study|Adverse Event|4
62198|NCT01235442|244243|P2|Overall Study|Protocol Violation|3
62199|NCT01235442|244244|P1|Overall Study|Protocol Violation|3
62200|NCT01235442|244243|P2|Overall Study|Ineligibility determined|4
62201|NCT01235442|244244|P1|Overall Study|Ineligibility determined|5
62202|NCT01235442|244243|P2|Overall Study|Pregnancy|1
62203|NCT01235442|244244|P1|Overall Study|Pregnancy|1
62204|NCT01235442|244243|P2|Overall Study|Death|2
62205|NCT01235442|244244|P1|Overall Study|Death|0
62206|NCT01235442|244243|P2|Overall Study|Lost to Follow-up|10
62207|NCT01235442|244244|P1|Overall Study|Lost to Follow-up|12
62208|NCT01235403|244262|P1|Overall Study|Other reasons for premature termination|4
62209|NCT01235403|244262|P1|Overall Study|Lack of Efficacy|2
62210|NCT01235403|244262|P1|Overall Study|Withdrawal by Subject|4
62211|NCT01235403|244262|P1|Overall Study|Lost to Follow-up|2
62212|NCT01235403|244262|P1|Overall Study|Adverse Event|14
62213|NCT01235338|244279|P2|Overall Study|Prohibited meds|0
62214|NCT01235338|244280|P1|Overall Study|Prohibited meds|1
62215|NCT01235338|244279|P2|Overall Study|Positive drug screen|1
62216|NCT01235338|244280|P1|Overall Study|Positive drug screen|0
62217|NCT01235338|244279|P2|Overall Study|Exclusion criteria violations|1
62218|NCT01235338|244280|P1|Overall Study|Exclusion criteria violations|1
62219|NCT01235338|244279|P2|Overall Study|Withdrawal by Subject|0
62220|NCT01235338|244280|P1|Overall Study|Withdrawal by Subject|5
62221|NCT01235338|244279|P2|Overall Study|Protocol Violation|1
62222|NCT01235338|244280|P1|Overall Study|Protocol Violation|1
62223|NCT01235338|244279|P2|Overall Study|Adverse Event|2
62224|NCT01235338|244280|P1|Overall Study|Adverse Event|3
62225|NCT01235234|244325|P3|Overall Study|Adverse Event|1
62226|NCT01235234|244326|P2|Overall Study|Adverse Event|2
62227|NCT01235234|244327|P1|Overall Study|Adverse Event|2
62228|NCT01234883|244371|P2|Overall Study|Inclusion/exclusion failure|0
62229|NCT01234883|244372|P1|Overall Study|Inclusion/exclusion failure|1
62230|NCT01234883|244371|P2|Overall Study|Technical difficulties with IV infusion|1
62231|NCT01234883|244372|P1|Overall Study|Technical difficulties with IV infusion|0
62232|NCT01234883|244371|P2|Overall Study|Parent/guardian withdrew consent|2
62233|NCT01234883|244372|P1|Overall Study|Parent/guardian withdrew consent|1
62234|NCT01234883|244371|P2|Overall Study|Early treatment release|10
62235|NCT01234883|244372|P1|Overall Study|Early treatment release|8
62236|NCT01234675|244414|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
62237|NCT01234675|244415|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
62238|NCT01234675|244414|P2|First Intervention (6 Weeks)|Adverse Event|1
62239|NCT01234675|244415|P1|First Intervention (6 Weeks)|Adverse Event|0
62240|NCT01234467|244429|P1|Overall Study|Other complicating disease (stroke)|1
62241|NCT01234467|244429|P1|Overall Study|Physician Decision|1
62242|NCT01234467|244429|P1|Overall Study|Clinical deterioration|1
62243|NCT01234467|244429|P1|Overall Study|Disease Progression|2
62244|NCT01234467|244429|P1|Overall Study|Withdrawal by Subject|2
62245|NCT01234467|244429|P1|Overall Study|Death|2
62246|NCT01234467|244429|P1|Overall Study|Adverse Event|3
62247|NCT01234337|244440|P2|Overall Study|Withdrawal by Subject|7
62248|NCT01234337|244441|P1|Overall Study|Withdrawal by Subject|11
62249|NCT01234337|244440|P2|Overall Study|Protocol Violation|3
62250|NCT01234337|244441|P1|Overall Study|Protocol Violation|2
62251|NCT01234337|244440|P2|Overall Study|Lost to Follow-up|1
62252|NCT01234337|244441|P1|Overall Study|Lost to Follow-up|0
62253|NCT01234337|244440|P2|Overall Study|Randomized but not Treated|4
62254|NCT01234337|244441|P1|Overall Study|Randomized but not Treated|6
62255|NCT01234337|244440|P2|Overall Study|Non-compliant with study medication|2
62256|NCT01234337|244441|P1|Overall Study|Non-compliant with study medication|3
62257|NCT01234337|244440|P2|Overall Study|InvestigatorDecision notProtocolDriven|3
62258|NCT01234337|244441|P1|Overall Study|InvestigatorDecision notProtocolDriven|4
62259|NCT01234337|244440|P2|Overall Study|Ongoing|24
62260|NCT01234337|244441|P1|Overall Study|Ongoing|16
62261|NCT01234337|244440|P2|Overall Study|Adverse Event|20
62262|NCT01234337|244441|P1|Overall Study|Adverse Event|55
62263|NCT01233999|244501|P1|Overall Study|Lost to Follow-up|1
62264|NCT01233999|244501|P1|Overall Study|Withdrawal by Subject|1
62265|NCT01233869|244520|P4|Extended Treatment Period (46 Months)|Adverse Event|1
62266|NCT01233869|244521|P3|Extended Treatment Period (46 Months)|Adverse Event|0
62267|NCT01233869|244522|P2|Extended Treatment Period (46 Months)|Adverse Event|0
62268|NCT01233869|244523|P1|Extended Treatment Period (46 Months)|Adverse Event|1
62269|NCT01233869|244520|P4|Extended Treatment Period (46 Months)|Unspecified|3
62270|NCT01233869|244521|P3|Extended Treatment Period (46 Months)|Unspecified|0
62271|NCT01233869|244522|P2|Extended Treatment Period (46 Months)|Unspecified|0
62272|NCT01233869|244523|P1|Extended Treatment Period (46 Months)|Unspecified|3
62273|NCT01233869|244520|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
62274|NCT01233869|244521|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
62275|NCT01233869|244522|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
62276|NCT01233869|244523|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
62277|NCT01233869|244520|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
62278|NCT01233869|244521|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
62279|NCT01233869|244522|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
62280|NCT01233869|244523|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
62281|NCT01233869|244520|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
62282|NCT01233869|244521|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
62283|NCT01233869|244522|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
62284|NCT01233869|244523|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
62285|NCT01233869|244520|P4|Initial Treatment Period (24 Months)|Adverse Event|3
62286|NCT01233869|244521|P3|Initial Treatment Period (24 Months)|Adverse Event|0
62287|NCT01233869|244522|P2|Initial Treatment Period (24 Months)|Adverse Event|17
62288|NCT01233869|244523|P1|Initial Treatment Period (24 Months)|Adverse Event|9
62289|NCT01233869|244520|P4|Initial Treatment Period (24 Months)|Death|0
62290|NCT01233869|244521|P3|Initial Treatment Period (24 Months)|Death|0
62291|NCT01233869|244522|P2|Initial Treatment Period (24 Months)|Death|0
62292|NCT01233869|244523|P1|Initial Treatment Period (24 Months)|Death|1
62293|NCT01233817|244609|P1|Overall Study|Withdrawal by Subject|2
62294|NCT01233817|244609|P1|Overall Study|Lost to Follow-up|1
62295|NCT01233687|244656|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
62296|NCT01233687|244656|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
62297|NCT01233687|244656|P1|Phase II AMG 102 + Erlotinib|Death|1
62298|NCT01232569|244666|P4|Double-blind Treatment Period|Death|0
62299|NCT01232569|244667|P3|Double-blind Treatment Period|Death|0
62300|NCT01232569|244668|P2|Double-blind Treatment Period|Death|0
62301|NCT01232569|244669|P1|Double-blind Treatment Period|Death|2
62302|NCT01232569|244666|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
62303|NCT01232569|244667|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
62304|NCT01232569|244668|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
62305|NCT01232569|244669|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
62306|NCT01232569|244666|P4|Double-blind Treatment Period|Physician Decision|0
62307|NCT01232569|244667|P3|Double-blind Treatment Period|Physician Decision|0
62308|NCT01232569|244668|P2|Double-blind Treatment Period|Physician Decision|0
62309|NCT01232569|244669|P1|Double-blind Treatment Period|Physician Decision|1
62310|NCT01232569|244666|P4|Double-blind Treatment Period|Lack of Efficacy|0
62311|NCT01232569|244667|P3|Double-blind Treatment Period|Lack of Efficacy|0
62312|NCT01232569|244668|P2|Double-blind Treatment Period|Lack of Efficacy|2
62313|NCT01232569|244669|P1|Double-blind Treatment Period|Lack of Efficacy|1
62314|NCT01232569|244666|P4|Double-blind Treatment Period|Lost to Follow-up|0
62315|NCT01232569|244667|P3|Double-blind Treatment Period|Lost to Follow-up|0
62316|NCT01232569|244668|P2|Double-blind Treatment Period|Lost to Follow-up|0
62317|NCT01232569|244669|P1|Double-blind Treatment Period|Lost to Follow-up|4
62318|NCT01232569|244666|P4|Double-blind Treatment Period|Escape|0
62319|NCT01232569|244667|P3|Double-blind Treatment Period|Escape|0
62320|NCT01232569|244668|P2|Double-blind Treatment Period|Escape|2
62321|NCT01232569|244669|P1|Double-blind Treatment Period|Escape|2
62322|NCT01232569|244666|P4|Double-blind Treatment Period|Withdrawal by Subject|0
62323|NCT01232569|244667|P3|Double-blind Treatment Period|Withdrawal by Subject|0
62324|NCT01232569|244668|P2|Double-blind Treatment Period|Withdrawal by Subject|2
62325|NCT01232569|244669|P1|Double-blind Treatment Period|Withdrawal by Subject|9
62326|NCT01232491|244749|P2|Overall Study|Other|18
62327|NCT01232491|244750|P1|Overall Study|Other|21
62328|NCT01232491|244749|P2|Overall Study|Withdrawal Criteria|21
62329|NCT01232491|244750|P1|Overall Study|Withdrawal Criteria|12
62330|NCT01232491|244749|P2|Overall Study|Protocol Violation|11
62331|NCT01232491|244750|P1|Overall Study|Protocol Violation|13
62332|NCT01232491|244749|P2|Overall Study|Lack of Efficacy|5
62333|NCT01232491|244750|P1|Overall Study|Lack of Efficacy|1
62334|NCT01232491|244749|P2|Overall Study|Adverse Event|8
62335|NCT01232491|244750|P1|Overall Study|Adverse Event|13
62336|NCT01233284|244777|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
62337|NCT01233284|244778|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
62338|NCT01233284|244779|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
62339|NCT01233284|244780|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
62340|NCT01233284|244781|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
62341|NCT01233284|244777|P5|Period 4 (4 Weeks)|Adverse Event|0
62342|NCT01233284|244778|P4|Period 4 (4 Weeks)|Adverse Event|0
62343|NCT01233284|244779|P3|Period 4 (4 Weeks)|Adverse Event|0
62344|NCT01233284|244780|P2|Period 4 (4 Weeks)|Adverse Event|1
62345|NCT01233284|244781|P1|Period 4 (4 Weeks)|Adverse Event|0
62346|NCT01233284|244777|P5|Period 3 (4 Weeks)|Other|0
62347|NCT01233284|244778|P4|Period 3 (4 Weeks)|Other|1
62348|NCT01233284|244779|P3|Period 3 (4 Weeks)|Other|0
62349|NCT01233284|244780|P2|Period 3 (4 Weeks)|Other|0
62350|NCT01233284|244781|P1|Period 3 (4 Weeks)|Other|0
62351|NCT01233284|244777|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
62352|NCT01233284|244778|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
62353|NCT01233284|244779|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
62354|NCT01233284|244780|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
62355|NCT01233284|244781|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
62356|NCT01233284|244777|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
62357|NCT01233284|244778|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
62358|NCT01233284|244779|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
62359|NCT01233284|244780|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
62360|NCT01233284|244781|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
62361|NCT01233284|244777|P5|Period 1 (4 Weeks)|Other|0
62362|NCT01233284|244778|P4|Period 1 (4 Weeks)|Other|0
62363|NCT01233284|244779|P3|Period 1 (4 Weeks)|Other|1
62364|NCT01233284|244780|P2|Period 1 (4 Weeks)|Other|0
62365|NCT01233284|244781|P1|Period 1 (4 Weeks)|Other|0
62366|NCT01233284|244777|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
62367|NCT01233284|244778|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
62368|NCT01233284|244779|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
62369|NCT01233284|244780|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
62370|NCT01233284|244781|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
62371|NCT01233284|244777|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
62372|NCT01233284|244778|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
62373|NCT01233284|244779|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
62374|NCT01233284|244780|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
62375|NCT01233284|244781|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
62376|NCT01233258|244862|P6|First Intervention (6 Months)|Non-compliance with study medication|0
62377|NCT01233258|244863|P5|First Intervention (6 Months)|Non-compliance with study medication|0
62378|NCT01233258|244864|P4|First Intervention (6 Months)|Non-compliance with study medication|0
62379|NCT01233258|244865|P3|First Intervention (6 Months)|Non-compliance with study medication|0
62380|NCT01233258|244866|P2|First Intervention (6 Months)|Non-compliance with study medication|0
62381|NCT01233258|244867|P1|First Intervention (6 Months)|Non-compliance with study medication|1
62382|NCT01233258|244862|P6|First Intervention (6 Months)|Protocol Violation|0
62383|NCT01233258|244863|P5|First Intervention (6 Months)|Protocol Violation|0
62384|NCT01233258|244864|P4|First Intervention (6 Months)|Protocol Violation|0
62385|NCT01233258|244865|P3|First Intervention (6 Months)|Protocol Violation|1
62386|NCT01233258|244866|P2|First Intervention (6 Months)|Protocol Violation|0
62387|NCT01233258|244867|P1|First Intervention (6 Months)|Protocol Violation|0
62388|NCT01233258|244862|P6|First Intervention (6 Months)|Withdrawal by Subject|1
62389|NCT01233258|244863|P5|First Intervention (6 Months)|Withdrawal by Subject|0
62390|NCT01233258|244864|P4|First Intervention (6 Months)|Withdrawal by Subject|1
62391|NCT01233258|244865|P3|First Intervention (6 Months)|Withdrawal by Subject|0
62392|NCT01233258|244866|P2|First Intervention (6 Months)|Withdrawal by Subject|0
62393|NCT01233258|244867|P1|First Intervention (6 Months)|Withdrawal by Subject|0
62394|NCT01233232|244887|P3|Overall Study|Voluntary Discontinuation by Subject|0
62395|NCT01233232|244888|P2|Overall Study|Voluntary Discontinuation by Subject|0
62396|NCT01233232|244889|P1|Overall Study|Voluntary Discontinuation by Subject|1
62397|NCT01233076|244942|P2|Period 2, One Week|Lost to Follow-up|0
62398|NCT01233076|244943|P1|Period 2, One Week|Lost to Follow-up|1
62399|NCT01232894|244966|P2|Overall Study|Physician Decision|1
62400|NCT01232894|244967|P1|Overall Study|Physician Decision|2
62401|NCT01232894|244966|P2|Overall Study|Withdrawal by Subject|5
62402|NCT01232894|244967|P1|Overall Study|Withdrawal by Subject|8
62403|NCT01232894|244966|P2|Overall Study|Protocol Violation|1
62404|NCT01232894|244967|P1|Overall Study|Protocol Violation|1
62405|NCT01232894|244966|P2|Overall Study|Death|0
62406|NCT01232894|244967|P1|Overall Study|Death|1
62407|NCT01232894|244966|P2|Overall Study|Lost to Follow-up|1
62408|NCT01232894|244967|P1|Overall Study|Lost to Follow-up|0
62409|NCT01232868|244975|P2|Overall Study|Lost to Follow-up|4
62410|NCT01232868|244976|P1|Overall Study|Lost to Follow-up|2
62411|NCT01232790|244990|P2|Second Crossover|Withdrawal by Subject|2
62412|NCT01232790|244991|P1|Second Crossover|Withdrawal by Subject|1
62413|NCT01232790|244990|P2|First Crossover|Withdrawal by Subject|0
62414|NCT01232790|244991|P1|First Crossover|Withdrawal by Subject|1
62415|NCT01232790|244990|P2|Initial Assessment|Withdrawal by Subject|1
62416|NCT01232790|244991|P1|Initial Assessment|Withdrawal by Subject|0
62417|NCT01232790|244990|P2|Randomization|Physician Decision|1
62418|NCT01232790|244991|P1|Randomization|Physician Decision|0
62419|NCT01232790|244990|P2|Randomization|Protocol Violation|1
62420|NCT01232790|244991|P1|Randomization|Protocol Violation|0
62421|NCT01232790|244990|P2|Randomization|Withdrawal by Subject|0
62422|NCT01232790|244991|P1|Randomization|Withdrawal by Subject|2
62423|NCT01232296|245047|P2|Overall Study|Death|6
62424|NCT01232296|245048|P1|Overall Study|Death|1
62425|NCT01232296|245047|P2|Overall Study|Subject/guardian decision|2
62426|NCT01232296|245048|P1|Overall Study|Subject/guardian decision|10
62427|NCT01232296|245047|P2|Overall Study|Technical problems|0
62428|NCT01232296|245048|P1|Overall Study|Technical problems|3
62429|NCT01232296|245047|P2|Overall Study|Study terminated by sponsor|1
62430|NCT01232296|245048|P1|Overall Study|Study terminated by sponsor|0
62431|NCT01232296|245047|P2|Overall Study|Progressive disease|61
62432|NCT01232296|245048|P1|Overall Study|Progressive disease|43
62433|NCT01232296|245047|P2|Overall Study|Physician Decision|1
62434|NCT01232296|245048|P1|Overall Study|Physician Decision|1
62435|NCT01232296|245047|P2|Overall Study|Adverse Event|12
62436|NCT01232296|245048|P1|Overall Study|Adverse Event|24
62437|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62438|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62439|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|1
62440|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62441|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62442|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62443|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62444|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Unspecified|0
62445|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
62446|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62447|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62448|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62449|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62450|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62451|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62452|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
62453|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
62454|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
62455|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
62456|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
62457|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
62458|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
62459|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
62460|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
62461|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62462|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62463|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62464|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
62465|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62466|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62467|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62468|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
62469|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
62470|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
62471|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
62472|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
62473|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
62474|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
62475|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
62476|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
62477|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
62478|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
62479|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
62480|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
62481|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
62482|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
62483|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
62484|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
62485|NCT01232283|245065|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
62486|NCT01232283|245066|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
62487|NCT01232283|245067|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
62488|NCT01232283|245068|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
62489|NCT01232283|245069|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
62490|NCT01232283|245070|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
62491|NCT01232283|245071|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
62492|NCT01232283|245072|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
62493|NCT01232283|245065|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
62494|NCT01232283|245066|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
62495|NCT01232283|245067|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
62496|NCT01232283|245068|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
62497|NCT01232283|245069|P4|Maintenance Phase (Weeks16-32)|Unspecified|0
62498|NCT01232283|245070|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
62499|NCT01232283|245071|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
62500|NCT01232283|245072|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
62501|NCT01232283|245065|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
62502|NCT01232283|245066|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
62503|NCT01232283|245067|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
62504|NCT01232283|245068|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
62505|NCT01232283|245069|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
62506|NCT01232283|245070|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
62507|NCT01232283|245071|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
62508|NCT01232283|245072|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
62509|NCT01232283|245065|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
62510|NCT01232283|245066|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
62511|NCT01232283|245067|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
62512|NCT01232283|245068|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
62513|NCT01232283|245069|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
62514|NCT01232283|245070|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
62515|NCT01232283|245071|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
62516|NCT01232283|245072|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
62517|NCT01232283|245065|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62518|NCT01232283|245066|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62519|NCT01232283|245067|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62520|NCT01232283|245068|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62521|NCT01232283|245069|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62522|NCT01232283|245070|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
62523|NCT01232283|245071|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62524|NCT01232283|245072|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
62525|NCT01232283|245065|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
62526|NCT01232283|245066|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
62527|NCT01232283|245067|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
62528|NCT01232283|245068|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
62529|NCT01232283|245069|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
62530|NCT01232283|245070|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
62531|NCT01232283|245071|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
62532|NCT01232283|245072|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
62533|NCT01232283|245065|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
62534|NCT01232283|245066|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
62535|NCT01232283|245067|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
62536|NCT01232283|245068|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
62537|NCT01232283|245069|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
62538|NCT01232283|245070|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
62539|NCT01232283|245071|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
62540|NCT01232283|245072|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
62541|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
62542|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
62543|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
62544|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
62545|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
62546|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Not specified|0
62547|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Not specified|1
62548|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Not specified|2
62549|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
62550|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
62551|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
62552|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
62553|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
62554|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
62555|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
62556|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
62557|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
62558|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
62559|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
62560|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
62561|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
62562|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
62563|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
62564|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
62565|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
62566|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
62567|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
62568|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
62569|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
62570|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
62571|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
62572|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
62573|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62574|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62575|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62576|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62577|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62578|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62579|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
62580|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
62581|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
62582|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
62583|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
62584|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
62585|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
62586|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
62587|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
62588|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
62589|NCT01232283|245065|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
62590|NCT01232283|245066|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
62591|NCT01232283|245067|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
62592|NCT01232283|245068|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
62593|NCT01232283|245069|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
62594|NCT01232283|245070|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
62595|NCT01232283|245071|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
62596|NCT01232283|245072|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
62597|NCT01232127|245111|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
62598|NCT01232127|245112|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
62599|NCT01232127|245113|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
62600|NCT01231984|245137|P4|Study Period 2|Did not continue to meet I/E Criteria|1
62601|NCT01231984|245138|P3|Study Period 2|Did not continue to meet I/E Criteria|0
62602|NCT01231984|245139|P2|Study Period 2|Did not continue to meet I/E Criteria|1
62603|NCT01231984|245140|P1|Study Period 2|Did not continue to meet I/E Criteria|1
62604|NCT01231984|245137|P4|Study Period 2|Lost to Follow-up|3
62605|NCT01231984|245138|P3|Study Period 2|Lost to Follow-up|0
62606|NCT01231984|245139|P2|Study Period 2|Lost to Follow-up|0
62607|NCT01231984|245140|P1|Study Period 2|Lost to Follow-up|1
62608|NCT01231984|245137|P4|Study Period 2|Withdrawal by Subject|0
62609|NCT01231984|245138|P3|Study Period 2|Withdrawal by Subject|0
62610|NCT01231984|245139|P2|Study Period 2|Withdrawal by Subject|1
62611|NCT01231984|245140|P1|Study Period 2|Withdrawal by Subject|1
62612|NCT01231984|245137|P4|Study Period 1|Not Specified|1
62613|NCT01231984|245138|P3|Study Period 1|Not Specified|0
62614|NCT01231984|245139|P2|Study Period 1|Not Specified|0
62615|NCT01231984|245140|P1|Study Period 1|Not Specified|0
62616|NCT01231984|245137|P4|Study Period 1|Adverse Event|0
62617|NCT01231984|245138|P3|Study Period 1|Adverse Event|0
62618|NCT01231984|245139|P2|Study Period 1|Adverse Event|0
62619|NCT01231984|245140|P1|Study Period 1|Adverse Event|1
62620|NCT01231984|245137|P4|Study Period 1|Protocol Violation|3
62621|NCT01231984|245138|P3|Study Period 1|Protocol Violation|2
62622|NCT01231984|245139|P2|Study Period 1|Protocol Violation|4
62623|NCT01231984|245140|P1|Study Period 1|Protocol Violation|3
62624|NCT01231984|245137|P4|Study Period 1|Non-compliance with study requirements|1
62625|NCT01231984|245138|P3|Study Period 1|Non-compliance with study requirements|2
62626|NCT01231984|245139|P2|Study Period 1|Non-compliance with study requirements|0
62627|NCT01231984|245140|P1|Study Period 1|Non-compliance with study requirements|5
62628|NCT01231984|245137|P4|Study Period 1|Screen Failure|1
62629|NCT01231984|245138|P3|Study Period 1|Screen Failure|0
62630|NCT01231984|245139|P2|Study Period 1|Screen Failure|0
62631|NCT01231984|245140|P1|Study Period 1|Screen Failure|0
62632|NCT01231984|245137|P4|Study Period 1|Did not continue to meet I/E Criteria|2
62633|NCT01231984|245138|P3|Study Period 1|Did not continue to meet I/E Criteria|2
62634|NCT01231984|245139|P2|Study Period 1|Did not continue to meet I/E Criteria|2
62635|NCT01231984|245140|P1|Study Period 1|Did not continue to meet I/E Criteria|2
62636|NCT01231984|245137|P4|Study Period 1|Lost to Follow-up|0
62637|NCT01231984|245138|P3|Study Period 1|Lost to Follow-up|1
62638|NCT01231984|245139|P2|Study Period 1|Lost to Follow-up|1
62639|NCT01231984|245140|P1|Study Period 1|Lost to Follow-up|1
62640|NCT01231984|245137|P4|Study Period 1|Withdrawal by Subject|1
62641|NCT01231984|245138|P3|Study Period 1|Withdrawal by Subject|0
62642|NCT01231984|245139|P2|Study Period 1|Withdrawal by Subject|0
62643|NCT01231984|245140|P1|Study Period 1|Withdrawal by Subject|0
62644|NCT01231607|245198|P5|Overall Study|Withdrawal by Subject|9
62645|NCT01231607|245199|P4|Overall Study|Withdrawal by Subject|17
62646|NCT01231607|245200|P3|Overall Study|Withdrawal by Subject|14
62647|NCT01231607|245201|P2|Overall Study|Withdrawal by Subject|9
62648|NCT01231607|245202|P1|Overall Study|Withdrawal by Subject|9
62649|NCT01231607|245198|P5|Overall Study|Protocol Violation|2
62650|NCT01231607|245199|P4|Overall Study|Protocol Violation|2
62651|NCT01231607|245200|P3|Overall Study|Protocol Violation|0
62652|NCT01231607|245201|P2|Overall Study|Protocol Violation|2
62653|NCT01231607|245202|P1|Overall Study|Protocol Violation|3
62654|NCT01231607|245198|P5|Overall Study|Physician Decision|4
62655|NCT01231607|245199|P4|Overall Study|Physician Decision|5
62656|NCT01231607|245200|P3|Overall Study|Physician Decision|3
62657|NCT01231607|245201|P2|Overall Study|Physician Decision|4
62658|NCT01231607|245202|P1|Overall Study|Physician Decision|4
62659|NCT01231607|245198|P5|Overall Study|Lost to Follow-up|4
62660|NCT01231607|245199|P4|Overall Study|Lost to Follow-up|10
62661|NCT01231607|245200|P3|Overall Study|Lost to Follow-up|10
62662|NCT01231607|245201|P2|Overall Study|Lost to Follow-up|11
62663|NCT01231607|245202|P1|Overall Study|Lost to Follow-up|13
62664|NCT01231607|245198|P5|Overall Study|Adverse Event|5
62665|NCT01231607|245199|P4|Overall Study|Adverse Event|4
62666|NCT01231607|245200|P3|Overall Study|Adverse Event|4
62667|NCT01231607|245201|P2|Overall Study|Adverse Event|8
62668|NCT01231607|245202|P1|Overall Study|Adverse Event|0
62669|NCT01231581|245294|P2|Overall Study|Ongoing|0
62670|NCT01231581|245295|P1|Overall Study|Ongoing|1
62671|NCT01231581|245294|P2|Overall Study|Death|64
62672|NCT01231581|245295|P1|Overall Study|Death|65
62673|NCT01231581|245294|P2|Overall Study|Study Closed/Terminated|5
62674|NCT01231581|245295|P1|Overall Study|Study Closed/Terminated|6
62675|NCT01231581|245294|P2|Overall Study|Withdrawal by Subject|9
62676|NCT01231581|245295|P1|Overall Study|Withdrawal by Subject|6
62677|NCT01231581|245294|P2|Overall Study|Lost to Follow-up|2
62678|NCT01231581|245295|P1|Overall Study|Lost to Follow-up|2
62679|NCT01231516|245315|P2|Open-label Phase|Ongoing at the time of analysis|23
62680|NCT01231516|245316|P1|Open-label Phase|Ongoing at the time of analysis|282
62681|NCT01231516|245315|P2|Open-label Phase|Withdrawal by Subject|0
62682|NCT01231516|245316|P1|Open-label Phase|Withdrawal by Subject|1
62683|NCT01231516|245315|P2|Open-label Phase|Lost to Follow-up|0
62684|NCT01231516|245316|P1|Open-label Phase|Lost to Follow-up|3
62685|NCT01231516|245315|P2|Open-label Phase|Protocol Violation|0
62686|NCT01231516|245316|P1|Open-label Phase|Protocol Violation|2
62687|NCT01231516|245315|P2|Open-label Phase|Lack of Efficacy|3
62688|NCT01231516|245316|P1|Open-label Phase|Lack of Efficacy|7
62689|NCT01231516|245315|P2|48 Week Double-blind Phase|Site Closed|1
62690|NCT01231516|245316|P1|48 Week Double-blind Phase|Site Closed|3
62691|NCT01231516|245315|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
62692|NCT01231516|245316|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
62693|NCT01231516|245315|P2|48 Week Double-blind Phase|Physician Decision|1
62694|NCT01231516|245316|P1|48 Week Double-blind Phase|Physician Decision|1
62695|NCT01231516|245315|P2|48 Week Double-blind Phase|Lost to Follow-up|10
62696|NCT01231516|245316|P1|48 Week Double-blind Phase|Lost to Follow-up|5
62697|NCT01231516|245315|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
62698|NCT01231516|245316|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
62699|NCT01231516|245315|P2|48 Week Double-blind Phase|Protocol Violation|6
62700|NCT01231516|245316|P1|48 Week Double-blind Phase|Protocol Violation|9
62701|NCT01231516|245315|P2|48 Week Double-blind Phase|Lack of Efficacy|42
62702|NCT01231516|245316|P1|48 Week Double-blind Phase|Lack of Efficacy|20
62703|NCT01231516|245315|P2|48 Week Double-blind Phase|Adverse Event|11
62704|NCT01231516|245316|P1|48 Week Double-blind Phase|Adverse Event|4
62705|NCT01231503|245346|P8|Overall Study|Protocol Violation|0
62706|NCT01231503|245347|P7|Overall Study|Protocol Violation|0
62707|NCT01231503|245348|P6|Overall Study|Protocol Violation|0
62708|NCT01231503|245349|P5|Overall Study|Protocol Violation|0
62709|NCT01231503|245350|P4|Overall Study|Protocol Violation|1
62710|NCT01231503|245351|P3|Overall Study|Protocol Violation|0
62711|NCT01231503|245352|P2|Overall Study|Protocol Violation|0
62712|NCT01231503|245353|P1|Overall Study|Protocol Violation|0
62713|NCT01231503|245346|P8|Overall Study|Lost to Follow-up|6
62714|NCT01231503|245347|P7|Overall Study|Lost to Follow-up|6
62715|NCT01231503|245348|P6|Overall Study|Lost to Follow-up|9
62716|NCT01231503|245349|P5|Overall Study|Lost to Follow-up|7
62717|NCT01231503|245350|P4|Overall Study|Lost to Follow-up|5
62718|NCT01231503|245351|P3|Overall Study|Lost to Follow-up|8
62719|NCT01231503|245352|P2|Overall Study|Lost to Follow-up|10
62720|NCT01231503|245353|P1|Overall Study|Lost to Follow-up|8
62721|NCT01231503|245346|P8|Overall Study|Withdrawal by Subject|2
62722|NCT01231503|245347|P7|Overall Study|Withdrawal by Subject|1
62723|NCT01231503|245348|P6|Overall Study|Withdrawal by Subject|5
62724|NCT01231503|245349|P5|Overall Study|Withdrawal by Subject|3
62725|NCT01231503|245350|P4|Overall Study|Withdrawal by Subject|1
62726|NCT01231503|245351|P3|Overall Study|Withdrawal by Subject|3
62727|NCT01231503|245352|P2|Overall Study|Withdrawal by Subject|3
62728|NCT01231503|245353|P1|Overall Study|Withdrawal by Subject|6
62729|NCT01231503|245346|P8|Overall Study|Adverse event, serious fatal|0
62730|NCT01231503|245347|P7|Overall Study|Adverse event, serious fatal|0
62731|NCT01231503|245348|P6|Overall Study|Adverse event, serious fatal|1
62732|NCT01231503|245349|P5|Overall Study|Adverse event, serious fatal|0
62733|NCT01231503|245350|P4|Overall Study|Adverse event, serious fatal|1
62734|NCT01231503|245351|P3|Overall Study|Adverse event, serious fatal|1
62735|NCT01231503|245352|P2|Overall Study|Adverse event, serious fatal|0
62736|NCT01231503|245353|P1|Overall Study|Adverse event, serious fatal|0
62737|NCT01231503|245346|P8|Overall Study|Adverse Event|0
62738|NCT01231503|245347|P7|Overall Study|Adverse Event|0
62739|NCT01231503|245348|P6|Overall Study|Adverse Event|1
62740|NCT01231503|245349|P5|Overall Study|Adverse Event|0
62741|NCT01231503|245350|P4|Overall Study|Adverse Event|0
62742|NCT01231503|245351|P3|Overall Study|Adverse Event|0
62743|NCT01231503|245352|P2|Overall Study|Adverse Event|0
62744|NCT01231503|245353|P1|Overall Study|Adverse Event|0
62745|NCT01231464|245569|P2|Overall Study|Withdrawal by Subject|2
62746|NCT01231464|245570|P1|Overall Study|Withdrawal by Subject|3
62747|NCT01231464|245569|P2|Overall Study|Lost to Follow-up|2
62748|NCT01231464|245570|P1|Overall Study|Lost to Follow-up|1
62749|NCT01231464|245569|P2|Overall Study|Protocol Violation|2
62750|NCT01231464|245570|P1|Overall Study|Protocol Violation|1
62751|NCT01231464|245569|P2|Overall Study|Adverse Event|1
62752|NCT01231464|245570|P1|Overall Study|Adverse Event|0
62753|NCT01231373|245591|P4|Overall Study|Withdrew Consent|0
62754|NCT01231373|245592|P3|Overall Study|Withdrew Consent|0
62755|NCT01231373|245593|P2|Overall Study|Withdrew Consent|0
62756|NCT01231373|245594|P1|Overall Study|Withdrew Consent|1
62757|NCT01231373|245591|P4|Overall Study|Lost to Follow-up|1
62758|NCT01231373|245592|P3|Overall Study|Lost to Follow-up|0
62759|NCT01231373|245593|P2|Overall Study|Lost to Follow-up|0
62760|NCT01231373|245594|P1|Overall Study|Lost to Follow-up|0
62761|NCT01231373|245591|P4|Overall Study|Withdrew consent prior to randomization|0
62762|NCT01231373|245592|P3|Overall Study|Withdrew consent prior to randomization|0
62763|NCT01231373|245593|P2|Overall Study|Withdrew consent prior to randomization|1
62764|NCT01231373|245594|P1|Overall Study|Withdrew consent prior to randomization|2
62765|NCT01231321|245633|P1|Overall Study|Lack of Efficacy|2
62766|NCT01231321|245633|P1|Overall Study|Adverse Event|3
62767|NCT01230892|245656|P2|Overall Study|Lost to Follow-up|0
62768|NCT01230892|245657|P1|Overall Study|Lost to Follow-up|2
62769|NCT01230892|245656|P2|Overall Study|Withdrawal by Subject|1
62770|NCT01230892|245657|P1|Overall Study|Withdrawal by Subject|1
62771|NCT01230827|245667|P4|Overall Study|Study terminated by Sponsor|63
62772|NCT01230827|245668|P3|Overall Study|Study terminated by Sponsor|56
62773|NCT01230827|245669|P2|Overall Study|Study terminated by Sponsor|2
62774|NCT01230827|245670|P1|Overall Study|Study terminated by Sponsor|0
62775|NCT01230827|245667|P4|Overall Study|Recovery|0
62776|NCT01230827|245668|P3|Overall Study|Recovery|0
62777|NCT01230827|245669|P2|Overall Study|Recovery|6
62778|NCT01230827|245670|P1|Overall Study|Recovery|0
62779|NCT01230827|245667|P4|Overall Study|Adverse Event|7
62780|NCT01230827|245668|P3|Overall Study|Adverse Event|3
62781|NCT01230827|245669|P2|Overall Study|Adverse Event|2
62782|NCT01230827|245670|P1|Overall Study|Adverse Event|4
62783|NCT01230827|245667|P4|Overall Study|Lack of Efficacy|3
62784|NCT01230827|245668|P3|Overall Study|Lack of Efficacy|2
62785|NCT01230827|245669|P2|Overall Study|Lack of Efficacy|1
62786|NCT01230827|245670|P1|Overall Study|Lack of Efficacy|14
62787|NCT01230827|245667|P4|Overall Study|Withdrawal by Subject|2
62788|NCT01230827|245668|P3|Overall Study|Withdrawal by Subject|3
62789|NCT01230827|245669|P2|Overall Study|Withdrawal by Subject|0
62790|NCT01230827|245670|P1|Overall Study|Withdrawal by Subject|1
62791|NCT01230827|245667|P4|Overall Study|Lost to Follow-up|3
62792|NCT01230827|245668|P3|Overall Study|Lost to Follow-up|1
62793|NCT01230827|245669|P2|Overall Study|Lost to Follow-up|0
62794|NCT01230827|245670|P1|Overall Study|Lost to Follow-up|0
62795|NCT01230814|245686|P2|Overall Study|Discontinued (not due to adverse event)|1
62796|NCT01230814|245687|P1|Overall Study|Discontinued (not due to adverse event)|2
62797|NCT01230814|245686|P2|Overall Study|Lost to Follow-up|3
62798|NCT01230814|245687|P1|Overall Study|Lost to Follow-up|11
62799|NCT01230788|245699|P1|Overall Study|Prescribed exclusion drug|1
62800|NCT01230749|245711|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
62801|NCT01230749|245712|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
62802|NCT01230749|245713|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
62803|NCT01230749|245714|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
62804|NCT01230749|245711|P4|Overall Study|Withdrawal by Subject|0
62805|NCT01230749|245712|P3|Overall Study|Withdrawal by Subject|0
62806|NCT01230749|245713|P2|Overall Study|Withdrawal by Subject|1
62807|NCT01230749|245714|P1|Overall Study|Withdrawal by Subject|0
62808|NCT01230749|245711|P4|Overall Study|Physician Decision|0
62809|NCT01230749|245712|P3|Overall Study|Physician Decision|1
62810|NCT01230749|245713|P2|Overall Study|Physician Decision|0
62811|NCT01230749|245714|P1|Overall Study|Physician Decision|0
62812|NCT01230749|245711|P4|Overall Study|Adverse Event|1
62813|NCT01230749|245712|P3|Overall Study|Adverse Event|0
62814|NCT01230749|245713|P2|Overall Study|Adverse Event|0
62815|NCT01230749|245714|P1|Overall Study|Adverse Event|0
62816|NCT01230710|245749|P1|Overall Study|Withdrawal of Consent|1
62817|NCT01230710|245749|P1|Overall Study|Death|4
62818|NCT01230710|245749|P1|Overall Study|Lost to Follow-up|3
62819|NCT01230710|245749|P1|Overall Study|Disease Progression|41
62820|NCT01230307|245804|P2|Overall Study|LVAD Placement|2
62821|NCT01230307|245805|P1|Overall Study|LVAD Placement|0
62822|NCT01230060|245825|P1|Overall Study|Withdrawal by Subject|1
62823|NCT01229735|245898|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
62824|NCT01229735|245899|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
62825|NCT01229735|245898|P2|Overall Study|AE, non-serious non-fatal|17
62826|NCT01229735|245899|P1|Overall Study|AE, non-serious non-fatal|13
62827|NCT01229735|245898|P2|Overall Study|SAE, non-fatal|4
62828|NCT01229735|245899|P1|Overall Study|SAE, non-fatal|0
62829|NCT01229735|245898|P2|Overall Study|Other Reason|10
62830|NCT01229735|245899|P1|Overall Study|Other Reason|13
62831|NCT01229735|245898|P2|Overall Study|Withdrawal by Subject|17
62832|NCT01229735|245899|P1|Overall Study|Withdrawal by Subject|18
62833|NCT01229735|245898|P2|Overall Study|Lost to Follow-up|2
62834|NCT01229735|245899|P1|Overall Study|Lost to Follow-up|0
62835|NCT01229735|245898|P2|Overall Study|Protocol Violation|8
62836|NCT01229735|245899|P1|Overall Study|Protocol Violation|13
62837|NCT01229735|245898|P2|Overall Study|Lack of Efficacy|8
62838|NCT01229735|245899|P1|Overall Study|Lack of Efficacy|8
62839|NCT01229436|245947|P1|Overall Study|Lost to Follow-up|3
62840|NCT01229436|245947|P1|Overall Study|Withdrawal by Subject|2
62841|NCT01229397|246009|P2|Overall Study|Migrated/moved from study area|0
62842|NCT01229397|246010|P1|Overall Study|Migrated/moved from study area|1
62843|NCT01229397|246009|P2|Overall Study|Lost to Follow-up|6
62844|NCT01229397|246010|P1|Overall Study|Lost to Follow-up|7
62845|NCT01229397|246009|P2|Overall Study|Withdrawal by Subject|3
62846|NCT01229397|246010|P1|Overall Study|Withdrawal by Subject|3
62847|NCT01229371|246028|P4|Overall Study|Withdrawal by Subject|0
62848|NCT01229371|246029|P3|Overall Study|Withdrawal by Subject|0
62849|NCT01229371|246030|P2|Overall Study|Withdrawal by Subject|1
62850|NCT01229371|246031|P1|Overall Study|Withdrawal by Subject|0
62851|NCT01229176|246082|P8|Overall Study|Lost to Follow-up|2
62852|NCT01229176|246083|P7|Overall Study|Lost to Follow-up|0
62853|NCT01229176|246084|P6|Overall Study|Lost to Follow-up|1
62854|NCT01229176|246085|P5|Overall Study|Lost to Follow-up|1
62855|NCT01229176|246086|P4|Overall Study|Lost to Follow-up|0
62856|NCT01229176|246087|P3|Overall Study|Lost to Follow-up|0
62857|NCT01229176|246088|P2|Overall Study|Lost to Follow-up|3
62858|NCT01229176|246089|P1|Overall Study|Lost to Follow-up|0
62859|NCT01229176|246082|P8|Overall Study|Withdrawal by Subject|1
62860|NCT01229176|246083|P7|Overall Study|Withdrawal by Subject|0
62861|NCT01229176|246084|P6|Overall Study|Withdrawal by Subject|1
62862|NCT01229176|246085|P5|Overall Study|Withdrawal by Subject|1
62863|NCT01229176|246086|P4|Overall Study|Withdrawal by Subject|1
62864|NCT01229176|246087|P3|Overall Study|Withdrawal by Subject|0
62865|NCT01229176|246088|P2|Overall Study|Withdrawal by Subject|0
62866|NCT01229176|246089|P1|Overall Study|Withdrawal by Subject|0
62867|NCT01229150|246143|P4|Overall Study|Toxicity|0
62868|NCT01229150|246144|P3|Overall Study|Toxicity|0
62869|NCT01229150|246145|P2|Overall Study|Toxicity|2
62870|NCT01229150|246146|P1|Overall Study|Toxicity|2
62871|NCT01229111|246203|P1|Overall Study|Death|1
62872|NCT01228747|246252|P2|Overall Study|Other Reason|5
62873|NCT01228747|246253|P1|Overall Study|Other Reason|2
62874|NCT01228747|246252|P2|Overall Study|Withdrawal by Subject|1
62875|NCT01228747|246253|P1|Overall Study|Withdrawal by Subject|5
62876|NCT01228747|246252|P2|Overall Study|Lost to Follow-up|3
62877|NCT01228747|246253|P1|Overall Study|Lost to Follow-up|4
62878|NCT01228747|246252|P2|Overall Study|Protocol Violation|5
62879|NCT01228747|246253|P1|Overall Study|Protocol Violation|6
62880|NCT01228747|246252|P2|Overall Study|Lack of Efficacy|27
62881|NCT01228747|246253|P1|Overall Study|Lack of Efficacy|40
62882|NCT01228747|246252|P2|Overall Study|Adverse Event|4
62883|NCT01228747|246253|P1|Overall Study|Adverse Event|8
62884|NCT01228734|246269|P2|Overall Study|Randomized, but not treated|4
62885|NCT01228734|246270|P1|Overall Study|Randomized, but not treated|0
62886|NCT01228734|246269|P2|Overall Study|Ongoing at clinical cut-off date|4
62887|NCT01228734|246270|P1|Overall Study|Ongoing at clinical cut-off date|16
62888|NCT01228591|246284|P2|Baseline|Lack of Efficacy|2
62889|NCT01228591|246285|P1|Baseline|Lack of Efficacy|1
62890|NCT01228175|246312|P2|Overall Study|Physician Decision|1
62891|NCT01228175|246313|P1|Overall Study|Physician Decision|1
62892|NCT01228175|246312|P2|Overall Study|Withdrawal by Subject|2
62893|NCT01228175|246313|P1|Overall Study|Withdrawal by Subject|1
62894|NCT01228175|246312|P2|Overall Study|Lost to Follow-up|50
62895|NCT01228175|246313|P1|Overall Study|Lost to Follow-up|61
62896|NCT01228071|246355|P1|Overall Study|Withdrawal by Subject|1
62897|NCT01228071|246355|P1|Overall Study|Protocol Violation|1
62898|NCT01228019|246361|P1|Overall Study|Violation of Entry Criterion|9
62899|NCT01228019|246361|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
62900|NCT01228019|246361|P1|Overall Study|Missing pre-treatment data|72
62901|NCT01228019|246361|P1|Overall Study|Duplicate enrollment|1
62902|NCT01228019|246361|P1|Overall Study|Dose Violation|70
62903|NCT01227967|246427|P2|Overall Study|Taking Additional Antiviral Drug|0
62904|NCT01227967|246428|P1|Overall Study|Taking Additional Antiviral Drug|1
62905|NCT01227967|246427|P2|Overall Study|Never Started Treatment|4
62906|NCT01227967|246428|P1|Overall Study|Never Started Treatment|0
62907|NCT01227967|246427|P2|Overall Study|Physician Decision|1
62908|NCT01227967|246428|P1|Overall Study|Physician Decision|0
62909|NCT01227967|246427|P2|Overall Study|Withdrawal by Subject|3
62910|NCT01227967|246428|P1|Overall Study|Withdrawal by Subject|4
62911|NCT01227967|246427|P2|Overall Study|Lost to Follow-up|3
62912|NCT01227967|246428|P1|Overall Study|Lost to Follow-up|8
62913|NCT01227967|246427|P2|Overall Study|Death|1
62914|NCT01227967|246428|P1|Overall Study|Death|0
62915|NCT01227967|246427|P2|Overall Study|Protocol Violation|1
62916|NCT01227967|246428|P1|Overall Study|Protocol Violation|3
62917|NCT01227928|246464|P2|Overall Study|Death|12
62918|NCT01227928|246465|P1|Overall Study|Death|14
62919|NCT01227928|246464|P2|Overall Study|Withdrawal by Subject|3
62920|NCT01227928|246465|P1|Overall Study|Withdrawal by Subject|4
62921|NCT01227928|246464|P2|Overall Study|Lost to Follow-up|2
62922|NCT01227928|246465|P1|Overall Study|Lost to Follow-up|4
62923|NCT01227902|246503|P4|Overall Study|Withdrawal by Subject|3
62924|NCT01227902|246504|P3|Overall Study|Withdrawal by Subject|4
62925|NCT01227902|246505|P2|Overall Study|Withdrawal by Subject|2
62926|NCT01227902|246506|P1|Overall Study|Withdrawal by Subject|4
62927|NCT01227902|246503|P4|Overall Study|Physician Decision|0
62928|NCT01227902|246504|P3|Overall Study|Physician Decision|1
62929|NCT01227902|246505|P2|Overall Study|Physician Decision|1
62930|NCT01227902|246506|P1|Overall Study|Physician Decision|0
62931|NCT01227902|246503|P4|Overall Study|Lost to Follow-up|2
62932|NCT01227902|246504|P3|Overall Study|Lost to Follow-up|1
62933|NCT01227902|246505|P2|Overall Study|Lost to Follow-up|0
62934|NCT01227902|246506|P1|Overall Study|Lost to Follow-up|0
62935|NCT01227902|246503|P4|Overall Study|Protocol Violation|0
62936|NCT01227902|246504|P3|Overall Study|Protocol Violation|0
62937|NCT01227902|246505|P2|Overall Study|Protocol Violation|0
62938|NCT01227902|246506|P1|Overall Study|Protocol Violation|1
62939|NCT01227902|246503|P4|Overall Study|Lack of Efficacy|1
62940|NCT01227902|246504|P3|Overall Study|Lack of Efficacy|2
62941|NCT01227902|246505|P2|Overall Study|Lack of Efficacy|2
62942|NCT01227902|246506|P1|Overall Study|Lack of Efficacy|1
62943|NCT01227902|246503|P4|Overall Study|Adverse Event|4
62944|NCT01227902|246504|P3|Overall Study|Adverse Event|11
62945|NCT01227902|246505|P2|Overall Study|Adverse Event|8
62946|NCT01227902|246506|P1|Overall Study|Adverse Event|12
62947|NCT01227889|246599|P2|Crossover Phase|In Follow-up|11
62948|NCT01227889|246600|P1|Crossover Phase|In Follow-up|0
62949|NCT01227889|246599|P2|Crossover Phase|Ongoing|4
62950|NCT01227889|246600|P1|Crossover Phase|Ongoing|0
62951|NCT01227889|246599|P2|Crossover Phase|Death|20
62952|NCT01227889|246600|P1|Crossover Phase|Death|0
62953|NCT01227889|246599|P2|Crossover Phase|Withdrawal by Subject|1
62954|NCT01227889|246600|P1|Crossover Phase|Withdrawal by Subject|0
62955|NCT01227889|246599|P2|Randomized Phase (RP)|In Follow-up|10
62956|NCT01227889|246600|P1|Randomized Phase (RP)|In Follow-up|49
62957|NCT01227889|246599|P2|Randomized Phase (RP)|Ongoing|2
62958|NCT01227889|246600|P1|Randomized Phase (RP)|Ongoing|53
62959|NCT01227889|246599|P2|Randomized Phase (RP)|Crossed Over|36
62960|NCT01227889|246600|P1|Randomized Phase (RP)|Crossed Over|0
62961|NCT01227889|246599|P2|Randomized Phase (RP)|Death|8
62962|NCT01227889|246600|P1|Randomized Phase (RP)|Death|78
62963|NCT01227889|246599|P2|Randomized Phase (RP)|Withdrawal by Subject|5
62964|NCT01227889|246600|P1|Randomized Phase (RP)|Withdrawal by Subject|2
62965|NCT01227889|246599|P2|Randomized Phase (RP)|Physician Decision|1
62966|NCT01227889|246600|P1|Randomized Phase (RP)|Physician Decision|2
62967|NCT01227889|246599|P2|Randomized Phase (RP)|Lost to Follow-up|1
62968|NCT01227889|246600|P1|Randomized Phase (RP)|Lost to Follow-up|3
62969|NCT01227824|246628|P2|Open-label Phase|Ongoing|0
62970|NCT01227824|246629|P1|Open-label Phase|Ongoing|337
62971|NCT01227824|246628|P2|Open-label Phase|Protocol Violation|0
62972|NCT01227824|246629|P1|Open-label Phase|Protocol Violation|1
62973|NCT01227824|246628|P2|Double-blind Phase|Withdrawal by Subject|14
62974|NCT01227824|246629|P1|Double-blind Phase|Withdrawal by Subject|10
62975|NCT01227824|246628|P2|Double-blind Phase|Lost to Follow-up|10
62976|NCT01227824|246629|P1|Double-blind Phase|Lost to Follow-up|6
62977|NCT01227824|246628|P2|Double-blind Phase|Study Closed/Terminated|4
62978|NCT01227824|246629|P1|Double-blind Phase|Study Closed/Terminated|6
62979|NCT01227824|246628|P2|Double-blind Phase|Met Protocol-defined Stopping Criteria|3
62980|NCT01227824|246629|P1|Double-blind Phase|Met Protocol-defined Stopping Criteria|2
62981|NCT01227824|246628|P2|Double-blind Phase|Protocol Violation|16
62982|NCT01227824|246629|P1|Double-blind Phase|Protocol Violation|13
62983|NCT01227824|246628|P2|Double-blind Phase|Lack of Efficacy|25
62984|NCT01227824|246629|P1|Double-blind Phase|Lack of Efficacy|17
62985|NCT01227824|246628|P2|Double-blind Phase|Adverse Event|7
62986|NCT01227824|246629|P1|Double-blind Phase|Adverse Event|8
62987|NCT01227707|246723|P1|Overall Study|Death|1
62988|NCT01227707|246723|P1|Overall Study|Medical decision|6
62989|NCT01227707|246723|P1|Overall Study|Patient non-compliance|3
62990|NCT01227707|246723|P1|Overall Study|Withdrawal by Subject|1
62991|NCT01227707|246723|P1|Overall Study|Progression of disease|3
62992|NCT01227707|246723|P1|Overall Study|Adverse Event|10
62993|NCT01227668|246750|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
62994|NCT01227668|246751|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
62995|NCT01227668|246750|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
62996|NCT01227668|246751|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
62997|NCT01227668|246750|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
62998|NCT01227668|246751|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
62999|NCT01227668|246750|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
63000|NCT01227668|246751|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
63001|NCT01227668|246750|P2|Phase 2 (Randomization Phase)|Adverse Event|1
63002|NCT01227668|246751|P1|Phase 2 (Randomization Phase)|Adverse Event|0
63003|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
63004|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
63005|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
63006|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
63007|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
63008|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
63009|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
63010|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
63011|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
63012|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
63013|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
63014|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
63015|NCT01227668|246750|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
63016|NCT01227668|246751|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
63017|NCT01227629|246797|P10|Overall Study|Not Specified|1
63018|NCT01227629|246798|P9|Overall Study|Not Specified|2
63019|NCT01227629|246799|P8|Overall Study|Not Specified|0
63020|NCT01227629|246800|P7|Overall Study|Not Specified|0
63021|NCT01227629|246801|P6|Overall Study|Not Specified|0
63022|NCT01227629|246802|P5|Overall Study|Not Specified|0
63023|NCT01227629|246803|P4|Overall Study|Not Specified|1
63024|NCT01227629|246804|P3|Overall Study|Not Specified|0
63025|NCT01227629|246805|P2|Overall Study|Not Specified|0
63026|NCT01227629|246806|P1|Overall Study|Not Specified|0
63027|NCT01227629|246797|P10|Overall Study|Withdrawal by Subject|1
63028|NCT01227629|246798|P9|Overall Study|Withdrawal by Subject|0
63029|NCT01227629|246799|P8|Overall Study|Withdrawal by Subject|0
63030|NCT01227629|246800|P7|Overall Study|Withdrawal by Subject|2
63031|NCT01227629|246801|P6|Overall Study|Withdrawal by Subject|0
63032|NCT01227629|246802|P5|Overall Study|Withdrawal by Subject|0
63033|NCT01227629|246803|P4|Overall Study|Withdrawal by Subject|0
63034|NCT01227629|246804|P3|Overall Study|Withdrawal by Subject|0
63035|NCT01227629|246805|P2|Overall Study|Withdrawal by Subject|0
63036|NCT01227629|246806|P1|Overall Study|Withdrawal by Subject|0
63037|NCT01227629|246797|P10|Overall Study|Lost to Follow-up|0
63038|NCT01227629|246798|P9|Overall Study|Lost to Follow-up|0
63039|NCT01227629|246799|P8|Overall Study|Lost to Follow-up|0
63040|NCT01227629|246800|P7|Overall Study|Lost to Follow-up|0
63041|NCT01227629|246801|P6|Overall Study|Lost to Follow-up|0
63042|NCT01227629|246802|P5|Overall Study|Lost to Follow-up|1
63043|NCT01227629|246803|P4|Overall Study|Lost to Follow-up|0
63044|NCT01227629|246804|P3|Overall Study|Lost to Follow-up|0
63045|NCT01227629|246805|P2|Overall Study|Lost to Follow-up|0
63046|NCT01227629|246806|P1|Overall Study|Lost to Follow-up|0
63047|NCT01227629|246797|P10|Overall Study|Protocol Violation|0
63048|NCT01227629|246798|P9|Overall Study|Protocol Violation|0
63049|NCT01227629|246799|P8|Overall Study|Protocol Violation|0
63050|NCT01227629|246800|P7|Overall Study|Protocol Violation|0
63051|NCT01227629|246801|P6|Overall Study|Protocol Violation|0
63052|NCT01227629|246802|P5|Overall Study|Protocol Violation|0
63053|NCT01227629|246803|P4|Overall Study|Protocol Violation|1
63054|NCT01227629|246804|P3|Overall Study|Protocol Violation|0
63055|NCT01227629|246805|P2|Overall Study|Protocol Violation|0
63056|NCT01227629|246806|P1|Overall Study|Protocol Violation|0
63057|NCT01227629|246797|P10|Overall Study|Adverse Event|0
63058|NCT01227629|246798|P9|Overall Study|Adverse Event|4
63059|NCT01227629|246799|P8|Overall Study|Adverse Event|6
63060|NCT01227629|246800|P7|Overall Study|Adverse Event|6
63061|NCT01227629|246801|P6|Overall Study|Adverse Event|1
63062|NCT01227629|246802|P5|Overall Study|Adverse Event|1
63063|NCT01227629|246803|P4|Overall Study|Adverse Event|6
63064|NCT01227629|246804|P3|Overall Study|Adverse Event|1
63065|NCT01227629|246805|P2|Overall Study|Adverse Event|2
63066|NCT01227629|246806|P1|Overall Study|Adverse Event|2
63067|NCT01227577|247042|P1|Overall Study|Adverse Event|17
63068|NCT01227577|247042|P1|Overall Study|Lack of Efficacy|5
63069|NCT01227577|247042|P1|Overall Study|Withdrawal by Subject|4
63070|NCT01227577|247042|P1|Overall Study|Lost to Follow-up|1
63071|NCT01227577|247042|P1|Overall Study|Administrative problems|2
63072|NCT01227577|247042|P1|Overall Study|Death|3
63073|NCT01227577|247042|P1|Overall Study|Protocol deviation|3
63074|NCT01227564|247057|P3|Overall Study|Participant moved to another town|1
63075|NCT01227564|247058|P2|Overall Study|Participant moved to another town|0
63076|NCT01227564|247059|P1|Overall Study|Participant moved to another town|0
63077|NCT01227564|247057|P3|Overall Study|No Longer Willing to Participate|5
63078|NCT01227564|247058|P2|Overall Study|No Longer Willing to Participate|2
63079|NCT01227564|247059|P1|Overall Study|No Longer Willing to Participate|4
63080|NCT01227512|247197|P2|Overall Study|Participant met withdrawal criteria|1
63081|NCT01227512|247198|P1|Overall Study|Participant met withdrawal criteria|0
63082|NCT01227512|247197|P2|Overall Study|Withdrawal by Subject|0
63083|NCT01227512|247198|P1|Overall Study|Withdrawal by Subject|3
63084|NCT01227512|247197|P2|Overall Study|Adverse Event|3
63085|NCT01227512|247198|P1|Overall Study|Adverse Event|4
63086|NCT01227512|247197|P2|Overall Study|Physician Decision|6
63087|NCT01227512|247198|P1|Overall Study|Physician Decision|6
63088|NCT01227421|247232|P3|Overall Study|Randomized in error|0
63089|NCT01227421|247233|P2|Overall Study|Randomized in error|1
63090|NCT01227421|247234|P1|Overall Study|Randomized in error|1
63091|NCT01227421|247232|P3|Overall Study|Protocol Violation|2
63092|NCT01227421|247233|P2|Overall Study|Protocol Violation|1
63093|NCT01227421|247234|P1|Overall Study|Protocol Violation|1
63094|NCT01227421|247232|P3|Overall Study|Withdrawal by Subject|1
63095|NCT01227421|247233|P2|Overall Study|Withdrawal by Subject|2
63096|NCT01227421|247234|P1|Overall Study|Withdrawal by Subject|1
63097|NCT01227421|247232|P3|Overall Study|Adverse Event|2
63098|NCT01227421|247233|P2|Overall Study|Adverse Event|7
63099|NCT01227421|247234|P1|Overall Study|Adverse Event|2
63100|NCT01227421|247232|P3|Overall Study|Lost to Follow-up|5
63101|NCT01227421|247233|P2|Overall Study|Lost to Follow-up|7
63102|NCT01227421|247234|P1|Overall Study|Lost to Follow-up|6
63103|NCT01227395|247286|P2|Overall Study|Protocol Violation|1
63104|NCT01227395|247287|P1|Overall Study|Protocol Violation|0
63105|NCT01227278|247327|P2|Overall Study|Unspecified|2
63106|NCT01227278|247328|P1|Overall Study|Unspecified|1
63107|NCT01227278|247327|P2|Overall Study|Death|2
63108|NCT01227278|247328|P1|Overall Study|Death|0
63109|NCT01227278|247327|P2|Overall Study|Withdrawal by Subject|4
63110|NCT01227278|247328|P1|Overall Study|Withdrawal by Subject|4
63111|NCT01227265|247355|P3|Overall Study|Adverse Event|5
63112|NCT01227265|247356|P2|Overall Study|Adverse Event|10
63113|NCT01227265|247357|P1|Overall Study|Adverse Event|6
63114|NCT01227265|247355|P3|Overall Study|Lost to Follow-up|3
63115|NCT01227265|247356|P2|Overall Study|Lost to Follow-up|0
63116|NCT01227265|247357|P1|Overall Study|Lost to Follow-up|2
63117|NCT01227265|247355|P3|Overall Study|Withdrawal by Subject|3
63118|NCT01227265|247356|P2|Overall Study|Withdrawal by Subject|7
63119|NCT01227265|247357|P1|Overall Study|Withdrawal by Subject|7
63120|NCT01227265|247355|P3|Overall Study|Protocol Violation|0
63121|NCT01227265|247356|P2|Overall Study|Protocol Violation|1
63122|NCT01227265|247357|P1|Overall Study|Protocol Violation|2
63123|NCT01227265|247355|P3|Overall Study|Did Not Meet Protocol Eligibility|1
63124|NCT01227265|247356|P2|Overall Study|Did Not Meet Protocol Eligibility|0
63125|NCT01227265|247357|P1|Overall Study|Did Not Meet Protocol Eligibility|0
63126|NCT01227265|247355|P3|Overall Study|Administrative|2
63127|NCT01227265|247356|P2|Overall Study|Administrative|0
63128|NCT01227265|247357|P1|Overall Study|Administrative|1
63129|NCT01227265|247355|P3|Overall Study|Did Not Receive Treatment|0
63130|NCT01227265|247356|P2|Overall Study|Did Not Receive Treatment|2
63131|NCT01227265|247357|P1|Overall Study|Did Not Receive Treatment|1
63132|NCT01227018|247394|P1|Overall Study|Withdrew after beginning treatment|4
63133|NCT01227018|247394|P1|Overall Study|Toxicity|2
63134|NCT01227018|247394|P1|Overall Study|Disease progression|9
63135|NCT01226745|247421|P6|Overall Study|Unspecified|1
63136|NCT01226745|247422|P5|Overall Study|Unspecified|3
63137|NCT01226745|247423|P4|Overall Study|Unspecified|4
63138|NCT01226745|247424|P3|Overall Study|Unspecified|8
63139|NCT01226745|247425|P2|Overall Study|Unspecified|7
63140|NCT01226745|247426|P1|Overall Study|Unspecified|6
63141|NCT01226745|247421|P6|Overall Study|Death|1
63142|NCT01226745|247422|P5|Overall Study|Death|0
63143|NCT01226745|247423|P4|Overall Study|Death|0
63144|NCT01226745|247424|P3|Overall Study|Death|0
63145|NCT01226745|247425|P2|Overall Study|Death|0
63146|NCT01226745|247426|P1|Overall Study|Death|1
63147|NCT01226745|247421|P6|Overall Study|Lost to Follow-up|2
63148|NCT01226745|247422|P5|Overall Study|Lost to Follow-up|1
63149|NCT01226745|247423|P4|Overall Study|Lost to Follow-up|1
63150|NCT01226745|247424|P3|Overall Study|Lost to Follow-up|6
63151|NCT01226745|247425|P2|Overall Study|Lost to Follow-up|6
63152|NCT01226745|247426|P1|Overall Study|Lost to Follow-up|2
63153|NCT01226745|247421|P6|Overall Study|Did not complete schedule of assessments|1
63154|NCT01226745|247422|P5|Overall Study|Did not complete schedule of assessments|0
63155|NCT01226745|247423|P4|Overall Study|Did not complete schedule of assessments|0
63156|NCT01226745|247424|P3|Overall Study|Did not complete schedule of assessments|6
63157|NCT01226745|247425|P2|Overall Study|Did not complete schedule of assessments|3
63158|NCT01226745|247426|P1|Overall Study|Did not complete schedule of assessments|8
63159|NCT01226511|247622|P2|Taper Period|Parent/Caregiver Decision|1
63160|NCT01226511|247623|P1|Taper Period|Parent/Caregiver Decision|1
63161|NCT01226511|247622|P2|Taper Period|Protocol Violation|0
63162|NCT01226511|247623|P1|Taper Period|Protocol Violation|1
63163|NCT01226511|247622|P2|Taper Period|Lost to Follow-up|2
63164|NCT01226511|247623|P1|Taper Period|Lost to Follow-up|2
63165|NCT01226511|247622|P2|Taper Period|Adverse Event|0
63166|NCT01226511|247623|P1|Taper Period|Adverse Event|1
63167|NCT01226511|247622|P2|Extension Treatment Period|Sponsor Decision|1
63168|NCT01226511|247623|P1|Extension Treatment Period|Sponsor Decision|1
63169|NCT01226511|247622|P2|Extension Treatment Period|Parent/Caregiver Decision|8
63170|NCT01226511|247623|P1|Extension Treatment Period|Parent/Caregiver Decision|8
63171|NCT01226511|247622|P2|Extension Treatment Period|Withdrawal by Subject|3
63172|NCT01226511|247623|P1|Extension Treatment Period|Withdrawal by Subject|1
63173|NCT01226511|247622|P2|Extension Treatment Period|Protocol Violation|2
63174|NCT01226511|247623|P1|Extension Treatment Period|Protocol Violation|2
63175|NCT01226511|247622|P2|Extension Treatment Period|Lost to Follow-up|3
63176|NCT01226511|247623|P1|Extension Treatment Period|Lost to Follow-up|4
63177|NCT01226511|247622|P2|Extension Treatment Period|Lack of Efficacy|2
63178|NCT01226511|247623|P1|Extension Treatment Period|Lack of Efficacy|3
63179|NCT01226511|247622|P2|Extension Treatment Period|Adverse Event|8
63180|NCT01226511|247623|P1|Extension Treatment Period|Adverse Event|8
63181|NCT01226511|247622|P2|Acute Treatment Period|Withdrawal by Subject|6
63182|NCT01226511|247623|P1|Acute Treatment Period|Withdrawal by Subject|10
63183|NCT01226511|247622|P2|Acute Treatment Period|Protocol Violation|5
63184|NCT01226511|247623|P1|Acute Treatment Period|Protocol Violation|5
63185|NCT01226511|247622|P2|Acute Treatment Period|Parent/caregiver decision|7
63186|NCT01226511|247623|P1|Acute Treatment Period|Parent/caregiver decision|5
63187|NCT01226511|247622|P2|Acute Treatment Period|Lost to Follow-up|6
63188|NCT01226511|247623|P1|Acute Treatment Period|Lost to Follow-up|3
63189|NCT01226511|247622|P2|Acute Treatment Period|Lack of Efficacy|1
63190|NCT01226511|247623|P1|Acute Treatment Period|Lack of Efficacy|2
63191|NCT01226511|247622|P2|Acute Treatment Period|Adverse Event|6
63192|NCT01226511|247623|P1|Acute Treatment Period|Adverse Event|7
63193|NCT01226459|247661|P2|Overall Study|Pregnancy|0
63194|NCT01226459|247662|P1|Overall Study|Pregnancy|1
63195|NCT01226459|247661|P2|Overall Study|Lost to Follow-up|8
63196|NCT01226459|247662|P1|Overall Study|Lost to Follow-up|4
63197|NCT01226459|247661|P2|Overall Study|Withdrawal by Subject|13
63198|NCT01226459|247662|P1|Overall Study|Withdrawal by Subject|10
63199|NCT01226459|247661|P2|Overall Study|Protocol Violation|3
63200|NCT01226459|247662|P1|Overall Study|Protocol Violation|4
63201|NCT01226459|247661|P2|Overall Study|Adverse Event|8
63202|NCT01226459|247662|P1|Overall Study|Adverse Event|2
63203|NCT01226121|247680|P3|Overall Study|Lost to Follow-up|1
63204|NCT01226121|247681|P2|Overall Study|Lost to Follow-up|0
63205|NCT01226121|247682|P1|Overall Study|Lost to Follow-up|2
63206|NCT01226095|247693|P1|Overall Study|Poor compliance|1
63207|NCT01226043|247718|P4|30-week Observational Phase|Physician Decision|2
63208|NCT01226043|247719|P3|30-week Observational Phase|Physician Decision|2
63209|NCT01226043|247720|P2|30-week Observational Phase|Physician Decision|0
63210|NCT01226043|247721|P1|30-week Observational Phase|Physician Decision|0
63211|NCT01226043|247718|P4|30-week Observational Phase|Withdrawal by Subject|7
63212|NCT01226043|247719|P3|30-week Observational Phase|Withdrawal by Subject|1
63213|NCT01226043|247720|P2|30-week Observational Phase|Withdrawal by Subject|0
63214|NCT01226043|247721|P1|30-week Observational Phase|Withdrawal by Subject|0
63215|NCT01226043|247718|P4|30-week Observational Phase|Lost to Follow-up|2
63216|NCT01226043|247719|P3|30-week Observational Phase|Lost to Follow-up|2
63217|NCT01226043|247720|P2|30-week Observational Phase|Lost to Follow-up|0
63218|NCT01226043|247721|P1|30-week Observational Phase|Lost to Follow-up|0
63219|NCT01226043|247718|P4|30-week Observational Phase|Protocol Violation|1
63220|NCT01226043|247719|P3|30-week Observational Phase|Protocol Violation|0
63221|NCT01226043|247720|P2|30-week Observational Phase|Protocol Violation|0
63222|NCT01226043|247721|P1|30-week Observational Phase|Protocol Violation|0
63223|NCT01226043|247718|P4|30-week Observational Phase|Adverse Event|1
63224|NCT01226043|247719|P3|30-week Observational Phase|Adverse Event|1
63225|NCT01226043|247720|P2|30-week Observational Phase|Adverse Event|0
63226|NCT01226043|247721|P1|30-week Observational Phase|Adverse Event|0
63227|NCT01226043|247718|P4|6-week Re-randomization Phase|completed in error|1
63228|NCT01226043|247719|P3|6-week Re-randomization Phase|completed in error|0
63229|NCT01226043|247720|P2|6-week Re-randomization Phase|completed in error|0
63311|NCT01225822|247911|P5|Overall Study|Protocol Violation|4
63230|NCT01226043|247721|P1|6-week Re-randomization Phase|completed in error|0
63231|NCT01226043|247718|P4|6-week Re-randomization Phase|Physician Decision|2
63232|NCT01226043|247719|P3|6-week Re-randomization Phase|Physician Decision|3
63233|NCT01226043|247720|P2|6-week Re-randomization Phase|Physician Decision|0
63234|NCT01226043|247721|P1|6-week Re-randomization Phase|Physician Decision|0
63235|NCT01226043|247718|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
63236|NCT01226043|247719|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
63237|NCT01226043|247720|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
63238|NCT01226043|247721|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
63239|NCT01226043|247718|P4|6-week Re-randomization Phase|Lost to Follow-up|3
63240|NCT01226043|247719|P3|6-week Re-randomization Phase|Lost to Follow-up|1
63241|NCT01226043|247720|P2|6-week Re-randomization Phase|Lost to Follow-up|0
63242|NCT01226043|247721|P1|6-week Re-randomization Phase|Lost to Follow-up|0
63243|NCT01226043|247718|P4|6-week Re-randomization Phase|Protocol Violation|1
63244|NCT01226043|247719|P3|6-week Re-randomization Phase|Protocol Violation|1
63245|NCT01226043|247720|P2|6-week Re-randomization Phase|Protocol Violation|0
63246|NCT01226043|247721|P1|6-week Re-randomization Phase|Protocol Violation|0
63247|NCT01226043|247718|P4|6-week Re-randomization Phase|Adverse Event|1
63248|NCT01226043|247719|P3|6-week Re-randomization Phase|Adverse Event|1
63249|NCT01226043|247720|P2|6-week Re-randomization Phase|Adverse Event|0
63250|NCT01226043|247721|P1|6-week Re-randomization Phase|Adverse Event|0
63251|NCT01226043|247718|P4|4-week Crossover Phase - Period 2|Physician Decision|0
63252|NCT01226043|247719|P3|4-week Crossover Phase - Period 2|Physician Decision|0
63253|NCT01226043|247720|P2|4-week Crossover Phase - Period 2|Physician Decision|5
63254|NCT01226043|247721|P1|4-week Crossover Phase - Period 2|Physician Decision|4
63255|NCT01226043|247718|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
63256|NCT01226043|247719|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
63257|NCT01226043|247720|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
63258|NCT01226043|247721|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
63259|NCT01226043|247718|P4|4-week Crossover Phase - Period 1|Physician Decision|0
63260|NCT01226043|247719|P3|4-week Crossover Phase - Period 1|Physician Decision|0
63261|NCT01226043|247720|P2|4-week Crossover Phase - Period 1|Physician Decision|6
63262|NCT01226043|247721|P1|4-week Crossover Phase - Period 1|Physician Decision|0
63263|NCT01226043|247718|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
63264|NCT01226043|247719|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
63265|NCT01226043|247720|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
63266|NCT01226043|247721|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
63267|NCT01226043|247718|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
63268|NCT01226043|247719|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
63269|NCT01226043|247720|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
63270|NCT01226043|247721|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
63271|NCT01226043|247718|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
63272|NCT01226043|247719|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
63273|NCT01226043|247720|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
63274|NCT01226043|247721|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
63275|NCT01225991|247759|P1|Overall Study|Withdrawal by Subject|6
63276|NCT01225952|247766|P3|Overall Study|Surgical complications|0
63277|NCT01225952|247767|P2|Overall Study|Surgical complications|0
63278|NCT01225952|247768|P1|Overall Study|Surgical complications|1
63279|NCT01225952|247766|P3|Overall Study|Withdrawal by Subject|5
63280|NCT01225952|247767|P2|Overall Study|Withdrawal by Subject|4
63281|NCT01225952|247768|P1|Overall Study|Withdrawal by Subject|4
63282|NCT01225952|247766|P3|Overall Study|Study Eye Explanted|1
63283|NCT01225952|247767|P2|Overall Study|Study Eye Explanted|0
63284|NCT01225952|247768|P1|Overall Study|Study Eye Explanted|0
63285|NCT01225952|247766|P3|Overall Study|Lost to Follow-up|0
63286|NCT01225952|247767|P2|Overall Study|Lost to Follow-up|0
63287|NCT01225952|247768|P1|Overall Study|Lost to Follow-up|1
63288|NCT01225835|247862|P2|Overall Study|not specified|1
63289|NCT01225835|247863|P1|Overall Study|not specified|1
63290|NCT01225835|247862|P2|Overall Study|Adverse Event|1
63291|NCT01225835|247863|P1|Overall Study|Adverse Event|2
63292|NCT01225835|247862|P2|Overall Study|Did not meet hCG criterion|0
63293|NCT01225835|247863|P1|Overall Study|Did not meet hCG criterion|2
63294|NCT01225835|247862|P2|Overall Study|Completed protocol|1
63295|NCT01225835|247863|P1|Overall Study|Completed protocol|2
63296|NCT01225822|247911|P5|Overall Study|Not Specified|7
63297|NCT01225822|247912|P4|Overall Study|Not Specified|10
63298|NCT01225822|247913|P3|Overall Study|Not Specified|7
63299|NCT01225822|247914|P2|Overall Study|Not Specified|10
63300|NCT01225822|247915|P1|Overall Study|Not Specified|13
63301|NCT01225822|247911|P5|Overall Study|Withdrawal by Subject|6
63302|NCT01225822|247912|P4|Overall Study|Withdrawal by Subject|11
63303|NCT01225822|247913|P3|Overall Study|Withdrawal by Subject|7
63304|NCT01225822|247914|P2|Overall Study|Withdrawal by Subject|7
63305|NCT01225822|247915|P1|Overall Study|Withdrawal by Subject|6
63306|NCT01225822|247911|P5|Overall Study|Lost to Follow-up|0
63307|NCT01225822|247912|P4|Overall Study|Lost to Follow-up|1
63308|NCT01225822|247913|P3|Overall Study|Lost to Follow-up|0
63309|NCT01225822|247914|P2|Overall Study|Lost to Follow-up|0
63310|NCT01225822|247915|P1|Overall Study|Lost to Follow-up|0
63312|NCT01225822|247912|P4|Overall Study|Protocol Violation|7
63313|NCT01225822|247913|P3|Overall Study|Protocol Violation|6
63314|NCT01225822|247914|P2|Overall Study|Protocol Violation|8
63315|NCT01225822|247915|P1|Overall Study|Protocol Violation|6
63316|NCT01225822|247911|P5|Overall Study|Adverse Event|14
63317|NCT01225822|247912|P4|Overall Study|Adverse Event|23
63318|NCT01225822|247913|P3|Overall Study|Adverse Event|18
63319|NCT01225822|247914|P2|Overall Study|Adverse Event|31
63320|NCT01225822|247915|P1|Overall Study|Adverse Event|13
63321|NCT01225731|247982|P13|Part 3|Withdrawal by Subject|4
63322|NCT01225731|247983|P12|Part 3|Withdrawal by Subject|6
63323|NCT01225731|247984|P11|Part 3|Withdrawal by Subject|4
63324|NCT01225731|247985|P10|Part 3|Withdrawal by Subject|0
63325|NCT01225731|247986|P9|Part 3|Withdrawal by Subject|0
63326|NCT01225731|247987|P8|Part 3|Withdrawal by Subject|0
63327|NCT01225731|247988|P7|Part 3|Withdrawal by Subject|0
63328|NCT01225731|247989|P6|Part 3|Withdrawal by Subject|0
63329|NCT01225731|247990|P5|Part 3|Withdrawal by Subject|0
63330|NCT01225731|247991|P4|Part 3|Withdrawal by Subject|0
63331|NCT01225731|247992|P3|Part 3|Withdrawal by Subject|0
63332|NCT01225731|247993|P2|Part 3|Withdrawal by Subject|0
63333|NCT01225731|247994|P1|Part 3|Withdrawal by Subject|0
63334|NCT01225731|247982|P13|Part 3|Physician Decision|2
63335|NCT01225731|247983|P12|Part 3|Physician Decision|1
63336|NCT01225731|247984|P11|Part 3|Physician Decision|0
63337|NCT01225731|247985|P10|Part 3|Physician Decision|0
63338|NCT01225731|247986|P9|Part 3|Physician Decision|0
63339|NCT01225731|247987|P8|Part 3|Physician Decision|0
63340|NCT01225731|247988|P7|Part 3|Physician Decision|0
63341|NCT01225731|247989|P6|Part 3|Physician Decision|0
63342|NCT01225731|247990|P5|Part 3|Physician Decision|0
63343|NCT01225731|247991|P4|Part 3|Physician Decision|0
63344|NCT01225731|247992|P3|Part 3|Physician Decision|0
63345|NCT01225731|247993|P2|Part 3|Physician Decision|0
63346|NCT01225731|247994|P1|Part 3|Physician Decision|0
63347|NCT01225731|247982|P13|Part 3|Lost to Follow-up|1
63348|NCT01225731|247983|P12|Part 3|Lost to Follow-up|2
63349|NCT01225731|247984|P11|Part 3|Lost to Follow-up|1
63350|NCT01225731|247985|P10|Part 3|Lost to Follow-up|0
63351|NCT01225731|247986|P9|Part 3|Lost to Follow-up|0
63352|NCT01225731|247987|P8|Part 3|Lost to Follow-up|0
63353|NCT01225731|247988|P7|Part 3|Lost to Follow-up|0
63354|NCT01225731|247989|P6|Part 3|Lost to Follow-up|0
63355|NCT01225731|247990|P5|Part 3|Lost to Follow-up|0
63356|NCT01225731|247991|P4|Part 3|Lost to Follow-up|0
63357|NCT01225731|247992|P3|Part 3|Lost to Follow-up|0
63358|NCT01225731|247993|P2|Part 3|Lost to Follow-up|0
63359|NCT01225731|247994|P1|Part 3|Lost to Follow-up|0
63360|NCT01225731|247982|P13|Part 3|Adverse Event|0
63361|NCT01225731|247983|P12|Part 3|Adverse Event|1
63362|NCT01225731|247984|P11|Part 3|Adverse Event|1
63363|NCT01225731|247985|P10|Part 3|Adverse Event|0
63364|NCT01225731|247986|P9|Part 3|Adverse Event|0
63365|NCT01225731|247987|P8|Part 3|Adverse Event|0
63366|NCT01225731|247988|P7|Part 3|Adverse Event|0
63367|NCT01225731|247989|P6|Part 3|Adverse Event|0
63368|NCT01225731|247990|P5|Part 3|Adverse Event|0
63369|NCT01225731|247991|P4|Part 3|Adverse Event|0
63370|NCT01225731|247992|P3|Part 3|Adverse Event|0
63371|NCT01225731|247993|P2|Part 3|Adverse Event|0
63372|NCT01225731|247994|P1|Part 3|Adverse Event|0
63373|NCT01225731|247982|P13|Part 2|Withdrawal by Subject|0
63374|NCT01225731|247983|P12|Part 2|Withdrawal by Subject|0
63375|NCT01225731|247984|P11|Part 2|Withdrawal by Subject|0
63376|NCT01225731|247985|P10|Part 2|Withdrawal by Subject|0
63377|NCT01225731|247986|P9|Part 2|Withdrawal by Subject|1
63378|NCT01225731|247987|P8|Part 2|Withdrawal by Subject|4
63379|NCT01225731|247988|P7|Part 2|Withdrawal by Subject|3
63380|NCT01225731|247989|P6|Part 2|Withdrawal by Subject|1
63381|NCT01225731|247990|P5|Part 2|Withdrawal by Subject|0
63382|NCT01225731|247991|P4|Part 2|Withdrawal by Subject|0
63383|NCT01225731|247992|P3|Part 2|Withdrawal by Subject|0
63384|NCT01225731|247993|P2|Part 2|Withdrawal by Subject|0
63385|NCT01225731|247994|P1|Part 2|Withdrawal by Subject|0
63386|NCT01225731|247982|P13|Part 2|Physician Decision|0
63387|NCT01225731|247983|P12|Part 2|Physician Decision|0
63388|NCT01225731|247984|P11|Part 2|Physician Decision|0
63389|NCT01225731|247985|P10|Part 2|Physician Decision|0
63390|NCT01225731|247986|P9|Part 2|Physician Decision|2
63391|NCT01225731|247987|P8|Part 2|Physician Decision|2
63392|NCT01225731|247988|P7|Part 2|Physician Decision|0
63393|NCT01225731|247989|P6|Part 2|Physician Decision|0
63394|NCT01225731|247990|P5|Part 2|Physician Decision|0
63395|NCT01225731|247991|P4|Part 2|Physician Decision|0
63396|NCT01225731|247992|P3|Part 2|Physician Decision|0
63397|NCT01225731|247993|P2|Part 2|Physician Decision|0
63398|NCT01225731|247994|P1|Part 2|Physician Decision|0
63399|NCT01225731|247982|P13|Part 2|Lost to Follow-up|0
63400|NCT01225731|247983|P12|Part 2|Lost to Follow-up|0
63401|NCT01225731|247984|P11|Part 2|Lost to Follow-up|0
63402|NCT01225731|247985|P10|Part 2|Lost to Follow-up|0
63403|NCT01225731|247986|P9|Part 2|Lost to Follow-up|1
63404|NCT01225731|247987|P8|Part 2|Lost to Follow-up|3
63405|NCT01225731|247988|P7|Part 2|Lost to Follow-up|0
63406|NCT01225731|247989|P6|Part 2|Lost to Follow-up|0
63407|NCT01225731|247990|P5|Part 2|Lost to Follow-up|0
63408|NCT01225731|247991|P4|Part 2|Lost to Follow-up|0
63409|NCT01225731|247992|P3|Part 2|Lost to Follow-up|0
63410|NCT01225731|247993|P2|Part 2|Lost to Follow-up|0
63411|NCT01225731|247994|P1|Part 2|Lost to Follow-up|0
63412|NCT01225731|247982|P13|Part 2|Pregnancy|0
63413|NCT01225731|247983|P12|Part 2|Pregnancy|0
63414|NCT01225731|247984|P11|Part 2|Pregnancy|0
63415|NCT01225731|247985|P10|Part 2|Pregnancy|0
63416|NCT01225731|247986|P9|Part 2|Pregnancy|1
63417|NCT01225731|247987|P8|Part 2|Pregnancy|0
63418|NCT01225731|247988|P7|Part 2|Pregnancy|1
63419|NCT01225731|247989|P6|Part 2|Pregnancy|0
63420|NCT01225731|247990|P5|Part 2|Pregnancy|0
63421|NCT01225731|247991|P4|Part 2|Pregnancy|0
63422|NCT01225731|247992|P3|Part 2|Pregnancy|0
63423|NCT01225731|247993|P2|Part 2|Pregnancy|0
63424|NCT01225731|247994|P1|Part 2|Pregnancy|0
63425|NCT01225731|247982|P13|Part 2|Lack of Efficacy|0
63426|NCT01225731|247983|P12|Part 2|Lack of Efficacy|0
63427|NCT01225731|247984|P11|Part 2|Lack of Efficacy|0
63428|NCT01225731|247985|P10|Part 2|Lack of Efficacy|0
63429|NCT01225731|247986|P9|Part 2|Lack of Efficacy|3
63430|NCT01225731|247987|P8|Part 2|Lack of Efficacy|12
63431|NCT01225731|247988|P7|Part 2|Lack of Efficacy|0
63432|NCT01225731|247989|P6|Part 2|Lack of Efficacy|1
63433|NCT01225731|247990|P5|Part 2|Lack of Efficacy|0
63434|NCT01225731|247991|P4|Part 2|Lack of Efficacy|0
63435|NCT01225731|247992|P3|Part 2|Lack of Efficacy|0
63436|NCT01225731|247993|P2|Part 2|Lack of Efficacy|0
63437|NCT01225731|247994|P1|Part 2|Lack of Efficacy|0
63438|NCT01225731|247982|P13|Part 2|Adverse Event|0
63439|NCT01225731|247983|P12|Part 2|Adverse Event|0
63440|NCT01225731|247984|P11|Part 2|Adverse Event|0
63441|NCT01225731|247985|P10|Part 2|Adverse Event|0
63442|NCT01225731|247986|P9|Part 2|Adverse Event|2
63443|NCT01225731|247987|P8|Part 2|Adverse Event|4
63444|NCT01225731|247988|P7|Part 2|Adverse Event|4
63445|NCT01225731|247989|P6|Part 2|Adverse Event|0
63446|NCT01225731|247990|P5|Part 2|Adverse Event|0
63447|NCT01225731|247991|P4|Part 2|Adverse Event|0
63448|NCT01225731|247992|P3|Part 2|Adverse Event|0
63449|NCT01225731|247993|P2|Part 2|Adverse Event|0
63450|NCT01225731|247994|P1|Part 2|Adverse Event|0
63451|NCT01225731|247982|P13|Part 2|Protocol Violation|0
63452|NCT01225731|247983|P12|Part 2|Protocol Violation|0
63453|NCT01225731|247984|P11|Part 2|Protocol Violation|0
63454|NCT01225731|247985|P10|Part 2|Protocol Violation|0
63455|NCT01225731|247986|P9|Part 2|Protocol Violation|1
63456|NCT01225731|247987|P8|Part 2|Protocol Violation|0
63457|NCT01225731|247988|P7|Part 2|Protocol Violation|0
63458|NCT01225731|247989|P6|Part 2|Protocol Violation|1
63459|NCT01225731|247990|P5|Part 2|Protocol Violation|0
63460|NCT01225731|247991|P4|Part 2|Protocol Violation|0
63461|NCT01225731|247992|P3|Part 2|Protocol Violation|0
63462|NCT01225731|247993|P2|Part 2|Protocol Violation|0
63463|NCT01225731|247994|P1|Part 2|Protocol Violation|0
63464|NCT01225731|247982|P13|Part 1|Protocol Violation|0
63465|NCT01225731|247983|P12|Part 1|Protocol Violation|0
63466|NCT01225731|247984|P11|Part 1|Protocol Violation|0
63467|NCT01225731|247985|P10|Part 1|Protocol Violation|0
63468|NCT01225731|247986|P9|Part 1|Protocol Violation|0
63469|NCT01225731|247987|P8|Part 1|Protocol Violation|0
63470|NCT01225731|247988|P7|Part 1|Protocol Violation|0
63471|NCT01225731|247989|P6|Part 1|Protocol Violation|0
63472|NCT01225731|247990|P5|Part 1|Protocol Violation|0
63473|NCT01225731|247991|P4|Part 1|Protocol Violation|1
63474|NCT01225731|247992|P3|Part 1|Protocol Violation|0
63475|NCT01225731|247993|P2|Part 1|Protocol Violation|0
63476|NCT01225731|247994|P1|Part 1|Protocol Violation|0
63477|NCT01225731|247982|P13|Part 1|Withdrawal by Subject|0
63478|NCT01225731|247983|P12|Part 1|Withdrawal by Subject|0
63479|NCT01225731|247984|P11|Part 1|Withdrawal by Subject|0
63480|NCT01225731|247985|P10|Part 1|Withdrawal by Subject|0
63481|NCT01225731|247986|P9|Part 1|Withdrawal by Subject|0
63482|NCT01225731|247987|P8|Part 1|Withdrawal by Subject|0
63483|NCT01225731|247988|P7|Part 1|Withdrawal by Subject|0
63484|NCT01225731|247989|P6|Part 1|Withdrawal by Subject|0
63485|NCT01225731|247990|P5|Part 1|Withdrawal by Subject|4
63486|NCT01225731|247991|P4|Part 1|Withdrawal by Subject|0
63487|NCT01225731|247992|P3|Part 1|Withdrawal by Subject|0
63488|NCT01225731|247993|P2|Part 1|Withdrawal by Subject|3
63489|NCT01225731|247994|P1|Part 1|Withdrawal by Subject|0
63490|NCT01225731|247982|P13|Part 1|Adverse Event|0
63491|NCT01225731|247983|P12|Part 1|Adverse Event|0
63492|NCT01225731|247984|P11|Part 1|Adverse Event|0
63493|NCT01225731|247985|P10|Part 1|Adverse Event|0
63494|NCT01225731|247986|P9|Part 1|Adverse Event|0
63495|NCT01225731|247987|P8|Part 1|Adverse Event|0
63496|NCT01225731|247988|P7|Part 1|Adverse Event|0
63497|NCT01225731|247989|P6|Part 1|Adverse Event|0
63498|NCT01225731|247990|P5|Part 1|Adverse Event|1
63499|NCT01225731|247991|P4|Part 1|Adverse Event|1
63500|NCT01225731|247992|P3|Part 1|Adverse Event|1
63501|NCT01225731|247993|P2|Part 1|Adverse Event|2
63502|NCT01225731|247994|P1|Part 1|Adverse Event|1
63503|NCT01225731|247982|P13|Part 1|Did not meet eligibility criteria|0
63504|NCT01225731|247983|P12|Part 1|Did not meet eligibility criteria|0
63505|NCT01225731|247984|P11|Part 1|Did not meet eligibility criteria|0
63506|NCT01225731|247985|P10|Part 1|Did not meet eligibility criteria|0
63507|NCT01225731|247986|P9|Part 1|Did not meet eligibility criteria|0
63508|NCT01225731|247987|P8|Part 1|Did not meet eligibility criteria|0
63509|NCT01225731|247988|P7|Part 1|Did not meet eligibility criteria|0
63510|NCT01225731|247989|P6|Part 1|Did not meet eligibility criteria|0
63511|NCT01225731|247990|P5|Part 1|Did not meet eligibility criteria|1
63512|NCT01225731|247991|P4|Part 1|Did not meet eligibility criteria|0
63513|NCT01225731|247992|P3|Part 1|Did not meet eligibility criteria|0
63514|NCT01225731|247993|P2|Part 1|Did not meet eligibility criteria|0
63515|NCT01225731|247994|P1|Part 1|Did not meet eligibility criteria|1
63516|NCT01225562|248089|P3|Overall Study|Lost to Follow-up|1
63517|NCT01225562|248090|P2|Overall Study|Lost to Follow-up|6
63518|NCT01225562|248091|P1|Overall Study|Lost to Follow-up|3
63519|NCT01225562|248089|P3|Overall Study|Withdrawal by Subject|52
63520|NCT01225562|248090|P2|Overall Study|Withdrawal by Subject|50
63521|NCT01225562|248091|P1|Overall Study|Withdrawal by Subject|52
63522|NCT01225549|248108|P10|Period 6 - Washout|Disallowed medication|0
63523|NCT01225549|248109|P9|Period 6 - Washout|Disallowed medication|0
63524|NCT01225549|248110|P8|Period 6 - Washout|Disallowed medication|0
63525|NCT01225549|248111|P7|Period 6 - Washout|Disallowed medication|0
63526|NCT01225549|248112|P6|Period 6 - Washout|Disallowed medication|0
63527|NCT01225549|248113|P5|Period 6 - Washout|Disallowed medication|0
63528|NCT01225549|248114|P4|Period 6 - Washout|Disallowed medication|1
63529|NCT01225549|248115|P3|Period 6 - Washout|Disallowed medication|0
63530|NCT01225549|248116|P2|Period 6 - Washout|Disallowed medication|0
63531|NCT01225549|248117|P1|Period 6 - Washout|Disallowed medication|0
63532|NCT01225549|248108|P10|Period 4 - Washout|Disallowed medication|0
63533|NCT01225549|248109|P9|Period 4 - Washout|Disallowed medication|0
63534|NCT01225549|248110|P8|Period 4 - Washout|Disallowed medication|0
63535|NCT01225549|248111|P7|Period 4 - Washout|Disallowed medication|0
63536|NCT01225549|248112|P6|Period 4 - Washout|Disallowed medication|0
63537|NCT01225549|248113|P5|Period 4 - Washout|Disallowed medication|0
63538|NCT01225549|248114|P4|Period 4 - Washout|Disallowed medication|0
63539|NCT01225549|248115|P3|Period 4 - Washout|Disallowed medication|0
63540|NCT01225549|248116|P2|Period 4 - Washout|Disallowed medication|1
63541|NCT01225549|248117|P1|Period 4 - Washout|Disallowed medication|0
63542|NCT01225211|248200|P10|Overall Study|Unspecified|1
63543|NCT01225211|248201|P9|Overall Study|Unspecified|0
63544|NCT01225211|248202|P8|Overall Study|Unspecified|0
63545|NCT01225211|248203|P7|Overall Study|Unspecified|0
63546|NCT01225211|248204|P6|Overall Study|Unspecified|0
63547|NCT01225211|248205|P5|Overall Study|Unspecified|0
63548|NCT01225211|248206|P4|Overall Study|Unspecified|0
63549|NCT01225211|248207|P3|Overall Study|Unspecified|0
63550|NCT01225211|248208|P2|Overall Study|Unspecified|0
63551|NCT01225211|248209|P1|Overall Study|Unspecified|0
63552|NCT01225211|248200|P10|Overall Study|Withdrawal by Subject|3
63553|NCT01225211|248201|P9|Overall Study|Withdrawal by Subject|1
63554|NCT01225211|248202|P8|Overall Study|Withdrawal by Subject|0
63555|NCT01225211|248203|P7|Overall Study|Withdrawal by Subject|1
63556|NCT01225211|248204|P6|Overall Study|Withdrawal by Subject|0
63557|NCT01225211|248205|P5|Overall Study|Withdrawal by Subject|0
63558|NCT01225211|248206|P4|Overall Study|Withdrawal by Subject|0
63559|NCT01225211|248207|P3|Overall Study|Withdrawal by Subject|0
63560|NCT01225211|248208|P2|Overall Study|Withdrawal by Subject|0
63561|NCT01225211|248209|P1|Overall Study|Withdrawal by Subject|0
63562|NCT01225211|248200|P10|Overall Study|Adverse Event|1
63563|NCT01225211|248201|P9|Overall Study|Adverse Event|0
63564|NCT01225211|248202|P8|Overall Study|Adverse Event|0
63565|NCT01225211|248203|P7|Overall Study|Adverse Event|0
63566|NCT01225211|248204|P6|Overall Study|Adverse Event|0
63567|NCT01225211|248205|P5|Overall Study|Adverse Event|0
63568|NCT01225211|248206|P4|Overall Study|Adverse Event|0
63569|NCT01225211|248207|P3|Overall Study|Adverse Event|1
63570|NCT01225211|248208|P2|Overall Study|Adverse Event|0
63571|NCT01225211|248209|P1|Overall Study|Adverse Event|0
63572|NCT01225159|248312|P2|Overall Study|Change operation|0
63573|NCT01225159|248313|P1|Overall Study|Change operation|1
63574|NCT01225146|248323|P2|Overall Study|Sponsor discontinued making 2mg drug|2
63575|NCT01225146|248324|P1|Overall Study|Sponsor discontinued making 2mg drug|0
63576|NCT01224821|248390|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
63577|NCT01224821|248390|P1|Long-Term Follow-Up|Death|2
63578|NCT01224821|248390|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
63579|NCT01224821|248390|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
63580|NCT01224821|248390|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
63581|NCT01224821|248390|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
63582|NCT01224821|248390|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
63583|NCT01224821|248390|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
63584|NCT01224782|248409|P1|Overall Study|Transplantation|1
63585|NCT01224782|248409|P1|Overall Study|Deterioration|1
63586|NCT01224782|248409|P1|Overall Study|Financial Reasons|1
63587|NCT01224782|248409|P1|Overall Study|Change of Treatment|1
63588|NCT01224782|248409|P1|Overall Study|Start of Dialysis|3
63589|NCT01224782|248409|P1|Overall Study|Not Specified|4
63590|NCT01224782|248409|P1|Overall Study|Noncompliance|10
63591|NCT01224782|248409|P1|Overall Study|Adverse Reaction|11
63592|NCT01224782|248409|P1|Overall Study|Adverse Event|12
63593|NCT01224782|248409|P1|Overall Study|Improvement|13
63594|NCT01224782|248409|P1|Overall Study|Death|14
63595|NCT01224782|248409|P1|Overall Study|Withdrawal by Subject|16
63596|NCT01224782|248409|P1|Overall Study|Lost to Follow-up|177
63597|NCT01224639|248426|P8|Overall Study|Adverse Event|1
63598|NCT01224639|248427|P7|Overall Study|Adverse Event|0
63599|NCT01224639|248428|P6|Overall Study|Adverse Event|0
63600|NCT01224639|248429|P5|Overall Study|Adverse Event|0
63601|NCT01224639|248430|P4|Overall Study|Adverse Event|0
63602|NCT01224639|248431|P3|Overall Study|Adverse Event|0
63603|NCT01224639|248432|P2|Overall Study|Adverse Event|0
63604|NCT01224639|248433|P1|Overall Study|Adverse Event|0
63605|NCT01224639|248426|P8|Overall Study|Withdrawal by Subject|1
63606|NCT01224639|248427|P7|Overall Study|Withdrawal by Subject|1
63607|NCT01224639|248428|P6|Overall Study|Withdrawal by Subject|0
63608|NCT01224639|248429|P5|Overall Study|Withdrawal by Subject|2
63609|NCT01224639|248430|P4|Overall Study|Withdrawal by Subject|0
63610|NCT01224639|248431|P3|Overall Study|Withdrawal by Subject|0
63611|NCT01224639|248432|P2|Overall Study|Withdrawal by Subject|0
63612|NCT01224639|248433|P1|Overall Study|Withdrawal by Subject|0
63613|NCT01224431|248551|P2|Overall Study|no video record|1
63614|NCT01224431|248552|P1|Overall Study|no video record|0
63615|NCT01224431|248551|P2|Overall Study|not randomized|4
63616|NCT01224431|248552|P1|Overall Study|not randomized|0
63617|NCT01224171|248571|P2|Overall Study|Lost to Follow-up|3
63618|NCT01224171|248572|P1|Overall Study|Lost to Follow-up|0
63619|NCT01224171|248571|P2|Overall Study|Withdrawal of Consent|4
63620|NCT01224171|248572|P1|Overall Study|Withdrawal of Consent|2
63621|NCT01224171|248571|P2|Overall Study|Lack of Efficacy|1
63622|NCT01224171|248572|P1|Overall Study|Lack of Efficacy|5
63623|NCT01224171|248571|P2|Overall Study|Protocol Violation|1
63624|NCT01224171|248572|P1|Overall Study|Protocol Violation|0
63625|NCT01224171|248571|P2|Overall Study|Adverse Event|4
63626|NCT01224171|248572|P1|Overall Study|Adverse Event|8
63627|NCT01222533|248592|P1|Overall Study|Other|4
63628|NCT01222533|248592|P1|Overall Study|Withdrawal by Subject|5
63629|NCT01222533|248592|P1|Overall Study|Adverse Event|5
63630|NCT01222520|248731|P2|Double-blind Period|Study medication stolen|0
63631|NCT01222520|248732|P1|Double-blind Period|Study medication stolen|1
63632|NCT01222520|248731|P2|Double-blind Period|Lack of Efficacy|1
63633|NCT01222520|248732|P1|Double-blind Period|Lack of Efficacy|0
63634|NCT01222520|248731|P2|Double-blind Period|Adverse Event|1
63635|NCT01222520|248732|P1|Double-blind Period|Adverse Event|0
63636|NCT01222520|248731|P2|Open-label run-in Period|Number of patients fulfilled|3
63637|NCT01222520|248732|P1|Open-label run-in Period|Number of patients fulfilled|0
63638|NCT01222520|248731|P2|Open-label run-in Period|Blood pressure criteria not met|18
63639|NCT01222520|248732|P1|Open-label run-in Period|Blood pressure criteria not met|0
63640|NCT01222520|248731|P2|Open-label run-in Period|Withdrawal by Subject|2
63641|NCT01222520|248732|P1|Open-label run-in Period|Withdrawal by Subject|0
63642|NCT01222507|248750|P1|Overall Study|Withdrawal by Subject|1
63643|NCT01222507|248750|P1|Overall Study|Physician Decision|1
63644|NCT01222416|248756|P2|Overall Study|Death|0
63645|NCT01222416|248757|P1|Overall Study|Death|1
63646|NCT01222416|248756|P2|Overall Study|missed view/scan|0
63647|NCT01222416|248757|P1|Overall Study|missed view/scan|1
63648|NCT01222416|248756|P2|Overall Study|scheduling|0
63649|NCT01222416|248757|P1|Overall Study|scheduling|6
63650|NCT01222416|248756|P2|Overall Study|Withdrawal by Subject|0
63651|NCT01222416|248757|P1|Overall Study|Withdrawal by Subject|5
63652|NCT01222416|248756|P2|Overall Study|Adverse Event|0
63653|NCT01222416|248757|P1|Overall Study|Adverse Event|4
63654|NCT01222416|248756|P2|Overall Study|ineligible;metastasis|0
63655|NCT01222416|248757|P1|Overall Study|ineligible;metastasis|3
63656|NCT01223937|248780|P2|Overall Study|Not specified|1
63657|NCT01223937|248781|P1|Overall Study|Not specified|4
63658|NCT01223937|248780|P2|Overall Study|Protocol Violation|7
63659|NCT01223937|248781|P1|Overall Study|Protocol Violation|8
63660|NCT01223937|248780|P2|Overall Study|Adverse Event|4
63661|NCT01223937|248781|P1|Overall Study|Adverse Event|1
63662|NCT01223937|248780|P2|Overall Study|Lost to Follow-up|4
63663|NCT01223937|248781|P1|Overall Study|Lost to Follow-up|1
63664|NCT01223937|248780|P2|Overall Study|Withdrawal by Subject|2
63665|NCT01223937|248781|P1|Overall Study|Withdrawal by Subject|3
63666|NCT01222403|248820|P2|Overall Study|Inappropriate enrollment|2
63667|NCT01222403|248821|P1|Overall Study|Inappropriate enrollment|0
63668|NCT01223365|248873|P1|Open-label Treatment Period|Physician Decision|2
63669|NCT01223365|248873|P1|Open-label Treatment Period|Starting physical therapy|1
63670|NCT01223365|248873|P1|Open-label Treatment Period|"Out of window"|1
63671|NCT01223365|248873|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
63672|NCT01223365|248873|P1|Open-label Treatment Period|Moved out of area|2
63673|NCT01223365|248873|P1|Open-label Treatment Period|Noncompliance with study procedures|6
63674|NCT01223365|248873|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
63675|NCT01223365|248873|P1|Open-label Treatment Period|Lost to Follow-up|7
63676|NCT01223365|248873|P1|Open-label Treatment Period|Protocol Violation|15
63677|NCT01223365|248873|P1|Open-label Treatment Period|Withdrawal by Subject|19
63678|NCT01223365|248873|P1|Open-label Treatment Period|Lack of Efficacy|2
63679|NCT01223365|248873|P1|Open-label Treatment Period|Adverse Event|39
63680|NCT01223365|248873|P1|Open-label Titration Period|Starting physical therapy|1
63681|NCT01223365|248873|P1|Open-label Titration Period|Noncompliance with study procedures|2
63682|NCT01223365|248873|P1|Open-label Titration Period|Noncompliance with study drug admin|1
63683|NCT01223365|248873|P1|Open-label Titration Period|Lost to Follow-up|2
63684|NCT01223365|248873|P1|Open-label Titration Period|Protocol Violation|1
63685|NCT01223365|248873|P1|Open-label Titration Period|Withdrawal by Subject|5
63686|NCT01223365|248873|P1|Open-label Titration Period|Lack of Efficacy|3
63687|NCT01223365|248873|P1|Open-label Titration Period|Adverse Event|23
63688|NCT01223365|248873|P1|Open-label Titration Period|Enrolled but not treated|1
63689|NCT01223196|248939|P2|Overall Study|Withdrawal by Subject|0
63690|NCT01223196|248940|P1|Overall Study|Withdrawal by Subject|1
63691|NCT01223196|248939|P2|Overall Study|Physician Decision|0
63692|NCT01223196|248940|P1|Overall Study|Physician Decision|1
63693|NCT01223196|248939|P2|Overall Study|Lost to Follow-up|0
63694|NCT01223196|248940|P1|Overall Study|Lost to Follow-up|2
63695|NCT01223027|248952|P2|Overall Study|Study terminated by sponsor|8
63696|NCT01223027|248953|P1|Overall Study|Study terminated by sponsor|2
63697|NCT01223027|248952|P2|Overall Study|New therapy for study indication|8
63698|NCT01223027|248953|P1|Overall Study|New therapy for study indication|17
63699|NCT01223027|248952|P2|Overall Study|Subject/guardian decicion|16
63700|NCT01223027|248953|P1|Overall Study|Subject/guardian decicion|18
63701|NCT01223027|248952|P2|Overall Study|Protocol Violation|1
63702|NCT01223027|248953|P1|Overall Study|Protocol Violation|2
63703|NCT01223027|248952|P2|Overall Study|Progressive Disease|183
63704|NCT01223027|248953|P1|Overall Study|Progressive Disease|167
63705|NCT01223027|248952|P2|Overall Study|Physician Decision|8
63706|NCT01223027|248953|P1|Overall Study|Physician Decision|4
63707|NCT01223027|248952|P2|Overall Study|Lost to Follow-up|1
63708|NCT01223027|248953|P1|Overall Study|Lost to Follow-up|2
63709|NCT01223027|248952|P2|Overall Study|Death|42
63710|NCT01223027|248953|P1|Overall Study|Death|42
63711|NCT01223027|248952|P2|Overall Study|Adverse Event|10
63712|NCT01223027|248953|P1|Overall Study|Adverse Event|20
63713|NCT01222715|249005|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
63714|NCT01222715|249006|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
63715|NCT01222715|249005|P2|Overall Study|Ineligible|1
63716|NCT01222715|249006|P1|Overall Study|Ineligible|0
63717|NCT01222715|249005|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
63718|NCT01222715|249006|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
63719|NCT01222715|249005|P2|Overall Study|Refusal of further protocol therapy|4
63720|NCT01222715|249006|P1|Overall Study|Refusal of further protocol therapy|0
63721|NCT01222715|249005|P2|Overall Study|Physician Decision|2
63722|NCT01222715|249006|P1|Overall Study|Physician Decision|12
63723|NCT01222715|249005|P2|Overall Study|Lack of Efficacy|14
63724|NCT01222715|249006|P1|Overall Study|Lack of Efficacy|22
63725|NCT01222715|249005|P2|Overall Study|Death|1
63726|NCT01222715|249006|P1|Overall Study|Death|0
63727|NCT01222715|249005|P2|Overall Study|Adverse Event|4
63728|NCT01222715|249006|P1|Overall Study|Adverse Event|0
63729|NCT01222104|249105|P1|Overall Study|Death|10
63730|NCT01222104|249105|P1|Overall Study|Lost to Follow-up|37
63731|NCT01222078|249119|P1|Overall Study|Early termination of the study|1
63732|NCT01221948|249153|P1|Overall Study|Protocol Violation|4
63733|NCT01221948|249153|P1|Overall Study|Death|1
63734|NCT01221948|249153|P1|Overall Study|not disclosed|2
63735|NCT01221948|249153|P1|Overall Study|Withdrawal by Subject|2
63736|NCT01221948|249153|P1|Overall Study|Physician Decision|5
63737|NCT01221753|249164|P1|Overall Study|Adverse Event|1
63738|NCT01221727|249171|P2|Overall Study|Withdrawal by Subject|1
63739|NCT01221727|249172|P1|Overall Study|Withdrawal by Subject|1
63740|NCT01221727|249171|P2|Overall Study|Physician Decision|0
63741|NCT01221727|249172|P1|Overall Study|Physician Decision|2
63742|NCT01221623|249193|P2|Overall Study|Other|2
63743|NCT01221623|249194|P1|Overall Study|Other|5
63744|NCT01221623|249193|P2|Overall Study|Death|0
63745|NCT01221623|249194|P1|Overall Study|Death|1
63746|NCT01221623|249193|P2|Overall Study|Adverse Event|3
63747|NCT01221623|249194|P1|Overall Study|Adverse Event|6
63748|NCT01221623|249193|P2|Overall Study|Lost to Follow-up|1
63749|NCT01221623|249194|P1|Overall Study|Lost to Follow-up|7
63750|NCT01221623|249193|P2|Overall Study|Withdrawal by Subject|8
63751|NCT01221623|249194|P1|Overall Study|Withdrawal by Subject|19
63752|NCT01221597|249218|P2|Overall Study|Death|0
63753|NCT01221597|249219|P1|Overall Study|Death|2
63754|NCT01221597|249218|P2|Overall Study|Other|4
63755|NCT01221597|249219|P1|Overall Study|Other|3
63756|NCT01221597|249218|P2|Overall Study|Protocol Violation|0
63757|NCT01221597|249219|P1|Overall Study|Protocol Violation|1
63758|NCT01221597|249218|P2|Overall Study|Lost to Follow-up|5
63759|NCT01221597|249219|P1|Overall Study|Lost to Follow-up|6
63760|NCT01221597|249218|P2|Overall Study|Withdrawal by Subject|6
63761|NCT01221597|249219|P1|Overall Study|Withdrawal by Subject|20
63762|NCT01221597|249218|P2|Overall Study|Adverse Event|1
63763|NCT01221597|249219|P1|Overall Study|Adverse Event|4
63764|NCT01221363|249276|P2|Overall Study|Withdrawal by Subject|5
63765|NCT01221363|249277|P1|Overall Study|Withdrawal by Subject|11
63766|NCT01221363|249276|P2|Overall Study|Pregnancy|0
63767|NCT01221363|249277|P1|Overall Study|Pregnancy|1
63768|NCT01221350|249287|P2|Overall Study|Withdrawal by Subject|2
63769|NCT01221350|249288|P1|Overall Study|Withdrawal by Subject|4
63770|NCT01221350|249287|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
63771|NCT01221350|249288|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
63772|NCT01221350|249287|P2|Overall Study|Discontinued intervention (GERD)|0
63773|NCT01221350|249288|P1|Overall Study|Discontinued intervention (GERD)|1
63774|NCT01221285|249347|P1|Overall Study|Withdrawal by Subject|1
63775|NCT01221272|249356|P2|Period 2|Adverse Event|2
63776|NCT01221272|249357|P1|Period 2|Adverse Event|0
63777|NCT01221272|249356|P2|Period 1|Significant Dosing Noncompliance|1
63778|NCT01221272|249357|P1|Period 1|Significant Dosing Noncompliance|0
63779|NCT01221272|249356|P2|Period 1|Consent Withdrawal|1
63780|NCT01221272|249357|P1|Period 1|Consent Withdrawal|0
63781|NCT01221272|249356|P2|Period 1|Adverse Event|0
63782|NCT01221272|249357|P1|Period 1|Adverse Event|2
63783|NCT01221090|249376|P4|Overall Study|Withdrawal by Subject|2
63784|NCT01221090|249377|P3|Overall Study|Withdrawal by Subject|27
63785|NCT01221090|249378|P2|Overall Study|Withdrawal by Subject|22
63786|NCT01221090|249379|P1|Overall Study|Withdrawal by Subject|0
63787|NCT01221090|249376|P4|Overall Study|Non-Compliant or Unable to Contact|20
63788|NCT01221090|249377|P3|Overall Study|Non-Compliant or Unable to Contact|15
63789|NCT01221090|249378|P2|Overall Study|Non-Compliant or Unable to Contact|12
63790|NCT01221090|249379|P1|Overall Study|Non-Compliant or Unable to Contact|15
63791|NCT01220609|249424|P1|Overall Study|Ineligible-Never treated|1
63792|NCT01220609|249424|P1|Overall Study|Ineligible- Wrong cell type|1
63793|NCT01220609|249424|P1|Overall Study|Ineligible-Wrong primary cancer site|1
63794|NCT01220557|249432|P2|Overall Study|attended less than 6 lessons|2
63795|NCT01220557|249433|P1|Overall Study|attended less than 6 lessons|1
63796|NCT01220557|249432|P2|Overall Study|Lost to Follow-up|3
63797|NCT01220557|249433|P1|Overall Study|Lost to Follow-up|5
63798|NCT01220401|249464|P1|Overall Study|Protocol Violation|1
63799|NCT01220401|249464|P1|Overall Study|Withdrawal by Subject|2
63800|NCT01220297|249473|P1|Overall Study|Lost to Follow-up|1
63801|NCT01220297|249473|P1|Overall Study|Death|2
63802|NCT01220180|249490|P1|Overall Study|Randomized but not treated|1
63803|NCT01220180|249490|P1|Overall Study|Death|1
63804|NCT01220180|249490|P1|Overall Study|Lack of Efficacy|22
63805|NCT01220180|249490|P1|Overall Study|Adverse Event|35
63806|NCT01220180|249490|P1|Overall Study|Unspecified|72
63807|NCT01220180|249490|P1|Overall Study|Lost to Follow-up|76
63808|NCT01220128|249520|P7|Overall Study|Consent withdrawn by subject|0
63809|NCT01220128|249521|P6|Overall Study|Consent withdrawn by subject|0
63810|NCT01220128|249522|P5|Overall Study|Consent withdrawn by subject|0
63811|NCT01220128|249523|P4|Overall Study|Consent withdrawn by subject|0
63812|NCT01220128|249524|P3|Overall Study|Consent withdrawn by subject|0
63813|NCT01220128|249525|P2|Overall Study|Consent withdrawn by subject|0
63814|NCT01220128|249526|P1|Overall Study|Consent withdrawn by subject|1
63815|NCT01220128|249520|P7|Overall Study|Unspecified|0
63816|NCT01220128|249521|P6|Overall Study|Unspecified|0
63817|NCT01220128|249522|P5|Overall Study|Unspecified|0
63818|NCT01220128|249523|P4|Overall Study|Unspecified|0
63819|NCT01220128|249524|P3|Overall Study|Unspecified|1
63820|NCT01220128|249525|P2|Overall Study|Unspecified|0
63821|NCT01220128|249526|P1|Overall Study|Unspecified|0
63822|NCT01220128|249520|P7|Overall Study|Adverse event, non-fatal|3
63823|NCT01220128|249521|P6|Overall Study|Adverse event, non-fatal|0
63824|NCT01220128|249522|P5|Overall Study|Adverse event, non-fatal|0
63825|NCT01220128|249523|P4|Overall Study|Adverse event, non-fatal|0
63826|NCT01220128|249524|P3|Overall Study|Adverse event, non-fatal|0
63827|NCT01220128|249525|P2|Overall Study|Adverse event, non-fatal|0
63828|NCT01220128|249526|P1|Overall Study|Adverse event, non-fatal|1
63829|NCT01220128|249520|P7|Overall Study|Adverse event, serious fatal|1
63830|NCT01220128|249521|P6|Overall Study|Adverse event, serious fatal|0
63831|NCT01220128|249522|P5|Overall Study|Adverse event, serious fatal|0
63832|NCT01220128|249523|P4|Overall Study|Adverse event, serious fatal|0
63833|NCT01220128|249524|P3|Overall Study|Adverse event, serious fatal|0
63834|NCT01220128|249525|P2|Overall Study|Adverse event, serious fatal|0
63835|NCT01220128|249526|P1|Overall Study|Adverse event, serious fatal|2
63836|NCT01220128|249520|P7|Overall Study|Sponsor study termination|1
63837|NCT01220128|249521|P6|Overall Study|Sponsor study termination|0
63838|NCT01220128|249522|P5|Overall Study|Sponsor study termination|0
63839|NCT01220128|249523|P4|Overall Study|Sponsor study termination|0
63840|NCT01220128|249524|P3|Overall Study|Sponsor study termination|0
63841|NCT01220128|249525|P2|Overall Study|Sponsor study termination|1
63842|NCT01220128|249526|P1|Overall Study|Sponsor study termination|0
63843|NCT01220128|249520|P7|Overall Study|Progressive disease|0
63844|NCT01220128|249521|P6|Overall Study|Progressive disease|0
63845|NCT01220128|249522|P5|Overall Study|Progressive disease|0
63846|NCT01220128|249523|P4|Overall Study|Progressive disease|0
63847|NCT01220128|249524|P3|Overall Study|Progressive disease|2
63848|NCT01220128|249525|P2|Overall Study|Progressive disease|0
63849|NCT01220128|249526|P1|Overall Study|Progressive disease|0
63850|NCT01219985|249731|P1|Overall Study|Physician Decision|20
63851|NCT01219933|249737|P1|Overall Study|Lack of Efficacy|1
63852|NCT01219933|249737|P1|Overall Study|Protocol Violation|8
63853|NCT01219933|249737|P1|Overall Study|Withdrawal by Subject|5
63854|NCT01219933|249737|P1|Overall Study|GC free|1
63855|NCT01219933|249737|P1|Overall Study|Lost to Follow-up|3
63856|NCT01219933|249737|P1|Overall Study|No LDA maintained|7
63857|NCT01219933|249737|P1|Overall Study|No LDA reached|5
63858|NCT01219933|249737|P1|Overall Study|Adverse Event|8
63859|NCT01218867|249947|P11|Overall Study|Death during treatment|0
63860|NCT01218867|249948|P10|Overall Study|Death during treatment|0
63861|NCT01218867|249949|P9|Overall Study|Death during treatment|0
63862|NCT01218867|249950|P8|Overall Study|Death during treatment|0
63863|NCT01218867|249951|P7|Overall Study|Death during treatment|1
63864|NCT01218867|249952|P6|Overall Study|Death during treatment|0
63865|NCT01218867|249953|P5|Overall Study|Death during treatment|0
63866|NCT01218867|249954|P4|Overall Study|Death during treatment|0
63867|NCT01218867|249955|P3|Overall Study|Death during treatment|0
63868|NCT01218867|249956|P2|Overall Study|Death during treatment|0
63869|NCT01218867|249957|P1|Overall Study|Death during treatment|0
63870|NCT01218802|250005|P2|Overall Study|Incarcerated|0
63871|NCT01218802|250006|P1|Overall Study|Incarcerated|2
63872|NCT01218802|250005|P2|Overall Study|Adverse Event|2
63873|NCT01218802|250006|P1|Overall Study|Adverse Event|0
63874|NCT01218802|250005|P2|Overall Study|Withdrawal by Subject|10
63875|NCT01218802|250006|P1|Overall Study|Withdrawal by Subject|3
63876|NCT01218802|250005|P2|Overall Study|Lost to Follow-up|6
63877|NCT01218802|250006|P1|Overall Study|Lost to Follow-up|5
63878|NCT01218646|250018|P4|Overall Study|Protocol Violation|1
63879|NCT01218646|250019|P3|Overall Study|Protocol Violation|1
63880|NCT01218646|250020|P2|Overall Study|Protocol Violation|0
63881|NCT01218646|250021|P1|Overall Study|Protocol Violation|0
63882|NCT01218646|250018|P4|Overall Study|Lost to Follow-up|0
63883|NCT01218646|250019|P3|Overall Study|Lost to Follow-up|0
63884|NCT01218646|250020|P2|Overall Study|Lost to Follow-up|0
63885|NCT01218646|250021|P1|Overall Study|Lost to Follow-up|1
63886|NCT01218646|250018|P4|Overall Study|Adverse Event|0
63887|NCT01218646|250019|P3|Overall Study|Adverse Event|1
63888|NCT01218646|250020|P2|Overall Study|Adverse Event|0
63889|NCT01218646|250021|P1|Overall Study|Adverse Event|0
63890|NCT01218594|250059|P1|Overall Study|Physician Decision|6
63891|NCT01218594|250059|P1|Overall Study|Adverse Event|2
63892|NCT01218594|250059|P1|Overall Study|Withdrawal by Subject|3
63893|NCT01218594|250059|P1|Overall Study|Death|1
63894|NCT01218477|250067|P4|Overall Study|Maximum clinical benefit|0
63895|NCT01218477|250068|P3|Overall Study|Maximum clinical benefit|0
63896|NCT01218477|250069|P2|Overall Study|Maximum clinical benefit|2
63897|NCT01218477|250070|P1|Overall Study|Maximum clinical benefit|0
63898|NCT01218477|250067|P4|Overall Study|Administrative reason by sponsor|0
63899|NCT01218477|250068|P3|Overall Study|Administrative reason by sponsor|1
63900|NCT01218477|250069|P2|Overall Study|Administrative reason by sponsor|0
63901|NCT01218477|250070|P1|Overall Study|Administrative reason by sponsor|0
63902|NCT01218477|250067|P4|Overall Study|Prepared for cell transplantation|0
63903|NCT01218477|250068|P3|Overall Study|Prepared for cell transplantation|1
63904|NCT01218477|250069|P2|Overall Study|Prepared for cell transplantation|1
63905|NCT01218477|250070|P1|Overall Study|Prepared for cell transplantation|0
63906|NCT01218477|250067|P4|Overall Study|Withdrawal by Subject|0
63907|NCT01218477|250068|P3|Overall Study|Withdrawal by Subject|1
63908|NCT01218477|250069|P2|Overall Study|Withdrawal by Subject|0
63909|NCT01218477|250070|P1|Overall Study|Withdrawal by Subject|0
63910|NCT01218477|250067|P4|Overall Study|No longer meets study criteria|0
63911|NCT01218477|250068|P3|Overall Study|No longer meets study criteria|0
63912|NCT01218477|250069|P2|Overall Study|No longer meets study criteria|0
63913|NCT01218477|250070|P1|Overall Study|No longer meets study criteria|1
63914|NCT01218477|250067|P4|Overall Study|Study drug toxicity|0
63915|NCT01218477|250068|P3|Overall Study|Study drug toxicity|5
63916|NCT01218477|250069|P2|Overall Study|Study drug toxicity|2
63917|NCT01218477|250070|P1|Overall Study|Study drug toxicity|0
63918|NCT01218477|250067|P4|Overall Study|Disease progression|2
63919|NCT01218477|250068|P3|Overall Study|Disease progression|6
63920|NCT01218477|250069|P2|Overall Study|Disease progression|3
63921|NCT01218477|250070|P1|Overall Study|Disease progression|2
63922|NCT01218438|250087|P1|Epoch 4|Withdrawal by Subject|2
63923|NCT01218438|250087|P1|Epoch 4|Physician Decision|1
63924|NCT01218438|250087|P1|Epoch 3|Adverse Event|1
63925|NCT01218438|250087|P1|Epoch 3|Withdrawal by Subject|3
63926|NCT01218438|250087|P1|Epoch 1|Adverse Event|1
63927|NCT01218438|250087|P1|Epoch 1|Physician Decision|2
63928|NCT01218308|250253|P2|Overall Study|Unspecified|21
63929|NCT01218308|250254|P1|Overall Study|Unspecified|14
63930|NCT01218308|250253|P2|Overall Study|Lost to Follow-up|31
63931|NCT01218308|250254|P1|Overall Study|Lost to Follow-up|27
63932|NCT01218308|250253|P2|Overall Study|Withdrawal by Subject|64
63933|NCT01218308|250254|P1|Overall Study|Withdrawal by Subject|61
63934|NCT01218308|250253|P2|Overall Study|Protocol Violation|2
63935|NCT01218308|250254|P1|Overall Study|Protocol Violation|0
63936|NCT01218308|250253|P2|Overall Study|Adverse Event|2
63937|NCT01218308|250254|P1|Overall Study|Adverse Event|1
63938|NCT01218243|250298|P2|Overall Study|Protocol Violation|10
63939|NCT01218243|250299|P1|Overall Study|Protocol Violation|5
63940|NCT01218243|250298|P2|Overall Study|Lost to Follow-up|3
63941|NCT01218243|250299|P1|Overall Study|Lost to Follow-up|3
63942|NCT01218243|250298|P2|Overall Study|Lack of Efficacy|1
63943|NCT01218243|250299|P1|Overall Study|Lack of Efficacy|1
63944|NCT01218100|250317|P4|Overall Study|Other Reason|4
63945|NCT01218100|250318|P3|Overall Study|Other Reason|6
63946|NCT01218100|250319|P2|Overall Study|Other Reason|2
63947|NCT01218100|250320|P1|Overall Study|Other Reason|2
63948|NCT01218100|250317|P4|Overall Study|Lost to Follow-up|1
63949|NCT01218100|250318|P3|Overall Study|Lost to Follow-up|2
63950|NCT01218100|250319|P2|Overall Study|Lost to Follow-up|8
63951|NCT01218100|250320|P1|Overall Study|Lost to Follow-up|3
63952|NCT01218100|250317|P4|Overall Study|Withdrawal by Subject|7
63953|NCT01218100|250318|P3|Overall Study|Withdrawal by Subject|6
63954|NCT01218100|250319|P2|Overall Study|Withdrawal by Subject|2
63955|NCT01218100|250320|P1|Overall Study|Withdrawal by Subject|5
63956|NCT01218100|250317|P4|Overall Study|Protocol Violation|1
63957|NCT01218100|250318|P3|Overall Study|Protocol Violation|1
63958|NCT01218100|250319|P2|Overall Study|Protocol Violation|0
63959|NCT01218100|250320|P1|Overall Study|Protocol Violation|0
63960|NCT01218100|250317|P4|Overall Study|Lack of Efficacy|12
63961|NCT01218100|250318|P3|Overall Study|Lack of Efficacy|5
63962|NCT01218100|250319|P2|Overall Study|Lack of Efficacy|6
63963|NCT01218100|250320|P1|Overall Study|Lack of Efficacy|9
63964|NCT01218100|250317|P4|Overall Study|Adverse Event|7
63965|NCT01218100|250318|P3|Overall Study|Adverse Event|6
63966|NCT01218100|250319|P2|Overall Study|Adverse Event|6
63967|NCT01218100|250320|P1|Overall Study|Adverse Event|4
63968|NCT01218100|250317|P4|Overall Study|Did not meet InclusionExclusion criteria|2
63969|NCT01218100|250318|P3|Overall Study|Did not meet InclusionExclusion criteria|1
63970|NCT01218100|250319|P2|Overall Study|Did not meet InclusionExclusion criteria|1
63971|NCT01218100|250320|P1|Overall Study|Did not meet InclusionExclusion criteria|1
63972|NCT01218087|250336|P2|Overall Study|Transferred|5
63973|NCT01218087|250337|P1|Overall Study|Transferred|8
63974|NCT01218087|250336|P2|Overall Study|Withdrawal by Subject|0
63975|NCT01218087|250337|P1|Overall Study|Withdrawal by Subject|5
63976|NCT01218087|250336|P2|Overall Study|Death|1
63977|NCT01218087|250337|P1|Overall Study|Death|2
63978|NCT01218009|250347|P2|Overall Study|Sponsor terminated study|163
63979|NCT01218009|250348|P1|Overall Study|Sponsor terminated study|161
63980|NCT01218009|250347|P2|Overall Study|Withdrawal by Subject|1
63981|NCT01218009|250348|P1|Overall Study|Withdrawal by Subject|3
63982|NCT01218009|250347|P2|Overall Study|Protocol Violation|1
63983|NCT01218009|250348|P1|Overall Study|Protocol Violation|2
63984|NCT01217957|250371|P5|Phase 2|Withdrawal by Patient|1
63985|NCT01217957|250372|P4|Phase 2|Withdrawal by Patient|0
63986|NCT01217957|250373|P3|Phase 2|Withdrawal by Patient|0
63987|NCT01217957|250374|P2|Phase 2|Withdrawal by Patient|0
63988|NCT01217957|250375|P1|Phase 2|Withdrawal by Patient|0
63989|NCT01217957|250371|P5|Phase 1|Withdrawal by Patient|0
63990|NCT01217957|250372|P4|Phase 1|Withdrawal by Patient|1
63991|NCT01217957|250373|P3|Phase 1|Withdrawal by Patient|1
63992|NCT01217957|250374|P2|Phase 1|Withdrawal by Patient|0
63993|NCT01217957|250375|P1|Phase 1|Withdrawal by Patient|1
63994|NCT01217944|250434|P3|Overall Study|Lack of Efficacy|0
63995|NCT01217944|250435|P2|Overall Study|Lack of Efficacy|0
63996|NCT01217944|250436|P1|Overall Study|Lack of Efficacy|1
63997|NCT01217944|250434|P3|Overall Study|Withdrawal by Subject|0
63998|NCT01217944|250435|P2|Overall Study|Withdrawal by Subject|2
63999|NCT01217944|250436|P1|Overall Study|Withdrawal by Subject|1
64000|NCT01217944|250434|P3|Overall Study|Lost to Follow-up|0
64001|NCT01217944|250435|P2|Overall Study|Lost to Follow-up|1
64002|NCT01217944|250436|P1|Overall Study|Lost to Follow-up|3
64003|NCT01217944|250434|P3|Overall Study|Protocol Violation|0
64004|NCT01217944|250435|P2|Overall Study|Protocol Violation|1
64005|NCT01217944|250436|P1|Overall Study|Protocol Violation|1
64006|NCT01217892|250479|P4|Overall Study|Poor/Non-Compliance|0
64007|NCT01217892|250480|P3|Overall Study|Poor/Non-Compliance|1
64008|NCT01217892|250481|P2|Overall Study|Poor/Non-Compliance|0
64009|NCT01217892|250482|P1|Overall Study|Poor/Non-Compliance|0
64010|NCT01217892|250479|P4|Overall Study|Incorrect enrollment|0
64011|NCT01217892|250480|P3|Overall Study|Incorrect enrollment|1
64012|NCT01217892|250481|P2|Overall Study|Incorrect enrollment|1
64013|NCT01217892|250482|P1|Overall Study|Incorrect enrollment|0
64014|NCT01217892|250479|P4|Overall Study|Subject no longer meets study criteria|8
64015|NCT01217892|250480|P3|Overall Study|Subject no longer meets study criteria|4
64016|NCT01217892|250481|P2|Overall Study|Subject no longer meets study criteria|2
64017|NCT01217892|250482|P1|Overall Study|Subject no longer meets study criteria|5
64018|NCT01217892|250479|P4|Overall Study|Lab value|0
64019|NCT01217892|250480|P3|Overall Study|Lab value|1
64020|NCT01217892|250481|P2|Overall Study|Lab value|0
64021|NCT01217892|250482|P1|Overall Study|Lab value|1
64022|NCT01217892|250479|P4|Overall Study|Withdrawal by Subject|0
64023|NCT01217892|250480|P3|Overall Study|Withdrawal by Subject|1
64024|NCT01217892|250481|P2|Overall Study|Withdrawal by Subject|2
64025|NCT01217892|250482|P1|Overall Study|Withdrawal by Subject|0
64026|NCT01217892|250479|P4|Overall Study|Adverse Event|0
64027|NCT01217892|250480|P3|Overall Study|Adverse Event|1
64028|NCT01217892|250481|P2|Overall Study|Adverse Event|1
64029|NCT01217892|250482|P1|Overall Study|Adverse Event|1
64030|NCT01217801|250528|P2|Period 1|Withdrawal by Subject|1
64031|NCT01217801|250529|P1|Period 1|Withdrawal by Subject|0
64032|NCT01217801|250528|P2|Period 1|Protocol Violation|1
64033|NCT01217801|250529|P1|Period 1|Protocol Violation|1
64034|NCT01217606|250571|P2|9-Month Masked Extension|Lack of Efficacy|0
64035|NCT01217606|250572|P1|9-Month Masked Extension|Lack of Efficacy|2
64036|NCT01217606|250571|P2|9-Month Masked Extension|Pregnancy|0
64037|NCT01217606|250572|P1|9-Month Masked Extension|Pregnancy|1
64038|NCT01217606|250571|P2|9-Month Masked Extension|Lost to Follow-up|0
64039|NCT01217606|250572|P1|9-Month Masked Extension|Lost to Follow-up|1
64040|NCT01217606|250571|P2|9-Month Masked Extension|Personal Reasons|1
64041|NCT01217606|250572|P1|9-Month Masked Extension|Personal Reasons|2
64042|NCT01217606|250571|P2|9-Month Masked Extension|Other Reasons|4
64043|NCT01217606|250572|P1|9-Month Masked Extension|Other Reasons|4
64044|NCT01217606|250571|P2|9-Month Masked Extension|Adverse Event|6
64045|NCT01217606|250572|P1|9-Month Masked Extension|Adverse Event|3
64046|NCT01217606|250571|P2|Initial Treatment Phase|Adverse Event|6
64047|NCT01217606|250572|P1|Initial Treatment Phase|Adverse Event|10
64048|NCT01217606|250571|P2|Initial Treatment Phase|Lack of Efficacy|0
64049|NCT01217606|250572|P1|Initial Treatment Phase|Lack of Efficacy|1
64050|NCT01217606|250571|P2|Initial Treatment Phase|Personal Reasons|2
64051|NCT01217606|250572|P1|Initial Treatment Phase|Personal Reasons|0
64052|NCT01217606|250571|P2|Initial Treatment Phase|Protocol Violation|2
64053|NCT01217606|250572|P1|Initial Treatment Phase|Protocol Violation|3
64054|NCT01217606|250571|P2|Initial Treatment Phase|Other Reasons|2
64055|NCT01217606|250572|P1|Initial Treatment Phase|Other Reasons|0
64056|NCT01217476|250603|P2|Overall Study|Other|0
64057|NCT01217476|250604|P1|Overall Study|Other|2
64058|NCT01217476|250603|P2|Overall Study|Protocol Deviation|0
64059|NCT01217476|250604|P1|Overall Study|Protocol Deviation|1
64060|NCT01217476|250603|P2|Overall Study|Surgery on the Target Limb|2
64061|NCT01217476|250604|P1|Overall Study|Surgery on the Target Limb|0
64062|NCT01217476|250603|P2|Overall Study|Withdrawal by Subject|3
64063|NCT01217476|250604|P1|Overall Study|Withdrawal by Subject|3
64064|NCT01217476|250603|P2|Overall Study|Physician Decision|1
64065|NCT01217476|250604|P1|Overall Study|Physician Decision|0
64066|NCT01217476|250603|P2|Overall Study|Adverse Event|1
64067|NCT01217476|250604|P1|Overall Study|Adverse Event|6
64068|NCT01217463|250614|P2|Overall Study|Other|1
64069|NCT01217463|250615|P1|Overall Study|Other|1
64070|NCT01217463|250614|P2|Overall Study|Patient Non-compliant|0
64071|NCT01217463|250615|P1|Overall Study|Patient Non-compliant|1
64072|NCT01217463|250614|P2|Overall Study|Surgery on the Target Limb|1
64073|NCT01217463|250615|P1|Overall Study|Surgery on the Target Limb|0
64074|NCT01217463|250614|P2|Overall Study|Withdrawal by Subject|0
64075|NCT01217463|250615|P1|Overall Study|Withdrawal by Subject|3
64076|NCT01217463|250614|P2|Overall Study|Physician Decision|1
64077|NCT01217463|250615|P1|Overall Study|Physician Decision|0
64078|NCT01217463|250614|P2|Overall Study|Adverse Event|5
64079|NCT01217463|250615|P1|Overall Study|Adverse Event|8
64080|NCT01217112|250642|P5|Overall Study|Physician Decision|1
64081|NCT01217112|250643|P4|Overall Study|Physician Decision|0
64082|NCT01217112|250644|P3|Overall Study|Physician Decision|0
64083|NCT01217112|250645|P2|Overall Study|Physician Decision|0
64084|NCT01217112|250646|P1|Overall Study|Physician Decision|0
64085|NCT01217112|250642|P5|Overall Study|Withdrawal by Subject|0
64086|NCT01217112|250643|P4|Overall Study|Withdrawal by Subject|0
64087|NCT01217112|250644|P3|Overall Study|Withdrawal by Subject|1
64088|NCT01217112|250645|P2|Overall Study|Withdrawal by Subject|0
64089|NCT01217112|250646|P1|Overall Study|Withdrawal by Subject|0
64090|NCT01217112|250642|P5|Overall Study|Adverse Event|0
64091|NCT01217112|250643|P4|Overall Study|Adverse Event|2
64092|NCT01217112|250644|P3|Overall Study|Adverse Event|0
64093|NCT01217112|250645|P2|Overall Study|Adverse Event|2
64094|NCT01217112|250646|P1|Overall Study|Adverse Event|0
64095|NCT01217073|250879|P8|Extension Period|Withdrawal by Subject|8
64096|NCT01217073|250880|P7|Extension Period|Withdrawal by Subject|30
64097|NCT01217073|250881|P6|Extension Period|Withdrawal by Subject|0
64098|NCT01217073|250882|P5|Extension Period|Withdrawal by Subject|0
64099|NCT01217073|250883|P4|Extension Period|Withdrawal by Subject|0
64100|NCT01217073|250884|P3|Extension Period|Withdrawal by Subject|0
64101|NCT01217073|250885|P2|Extension Period|Withdrawal by Subject|0
64102|NCT01217073|250886|P1|Extension Period|Withdrawal by Subject|0
64103|NCT01217073|250879|P8|Extension Period|Site discontinued study participation|2
64104|NCT01217073|250880|P7|Extension Period|Site discontinued study participation|7
64105|NCT01217073|250881|P6|Extension Period|Site discontinued study participation|0
64106|NCT01217073|250882|P5|Extension Period|Site discontinued study participation|0
64107|NCT01217073|250883|P4|Extension Period|Site discontinued study participation|0
64108|NCT01217073|250884|P3|Extension Period|Site discontinued study participation|0
64109|NCT01217073|250885|P2|Extension Period|Site discontinued study participation|0
64110|NCT01217073|250886|P1|Extension Period|Site discontinued study participation|0
64111|NCT01217073|250879|P8|Extension Period|Protocol Violation|1
64112|NCT01217073|250880|P7|Extension Period|Protocol Violation|2
64113|NCT01217073|250881|P6|Extension Period|Protocol Violation|0
64114|NCT01217073|250882|P5|Extension Period|Protocol Violation|0
64115|NCT01217073|250883|P4|Extension Period|Protocol Violation|0
64116|NCT01217073|250884|P3|Extension Period|Protocol Violation|0
64117|NCT01217073|250885|P2|Extension Period|Protocol Violation|0
64118|NCT01217073|250886|P1|Extension Period|Protocol Violation|0
64119|NCT01217073|250879|P8|Extension Period|Physician Decision|1
64120|NCT01217073|250880|P7|Extension Period|Physician Decision|4
64121|NCT01217073|250881|P6|Extension Period|Physician Decision|0
64122|NCT01217073|250882|P5|Extension Period|Physician Decision|0
64123|NCT01217073|250883|P4|Extension Period|Physician Decision|0
64124|NCT01217073|250884|P3|Extension Period|Physician Decision|0
64125|NCT01217073|250885|P2|Extension Period|Physician Decision|0
64126|NCT01217073|250886|P1|Extension Period|Physician Decision|0
64127|NCT01217073|250879|P8|Extension Period|Non-compliance with study drug|1
64128|NCT01217073|250880|P7|Extension Period|Non-compliance with study drug|0
64129|NCT01217073|250881|P6|Extension Period|Non-compliance with study drug|0
64130|NCT01217073|250882|P5|Extension Period|Non-compliance with study drug|0
64131|NCT01217073|250883|P4|Extension Period|Non-compliance with study drug|0
64132|NCT01217073|250884|P3|Extension Period|Non-compliance with study drug|0
64133|NCT01217073|250885|P2|Extension Period|Non-compliance with study drug|0
64134|NCT01217073|250886|P1|Extension Period|Non-compliance with study drug|0
64135|NCT01217073|250879|P8|Extension Period|Lost to Follow-up|1
64136|NCT01217073|250880|P7|Extension Period|Lost to Follow-up|9
64137|NCT01217073|250881|P6|Extension Period|Lost to Follow-up|0
64138|NCT01217073|250882|P5|Extension Period|Lost to Follow-up|0
64139|NCT01217073|250883|P4|Extension Period|Lost to Follow-up|0
64140|NCT01217073|250884|P3|Extension Period|Lost to Follow-up|0
64141|NCT01217073|250885|P2|Extension Period|Lost to Follow-up|0
64142|NCT01217073|250886|P1|Extension Period|Lost to Follow-up|0
64143|NCT01217073|250879|P8|Extension Period|Lack of Efficacy|0
64144|NCT01217073|250880|P7|Extension Period|Lack of Efficacy|3
64145|NCT01217073|250881|P6|Extension Period|Lack of Efficacy|0
64146|NCT01217073|250882|P5|Extension Period|Lack of Efficacy|0
64147|NCT01217073|250883|P4|Extension Period|Lack of Efficacy|0
64148|NCT01217073|250884|P3|Extension Period|Lack of Efficacy|0
64149|NCT01217073|250885|P2|Extension Period|Lack of Efficacy|0
64150|NCT01217073|250886|P1|Extension Period|Lack of Efficacy|0
64151|NCT01217073|250879|P8|Extension Period|Excluded medication|0
64152|NCT01217073|250880|P7|Extension Period|Excluded medication|2
64153|NCT01217073|250881|P6|Extension Period|Excluded medication|0
64154|NCT01217073|250882|P5|Extension Period|Excluded medication|0
64155|NCT01217073|250883|P4|Extension Period|Excluded medication|0
64156|NCT01217073|250884|P3|Extension Period|Excluded medication|0
64157|NCT01217073|250885|P2|Extension Period|Excluded medication|0
64158|NCT01217073|250886|P1|Extension Period|Excluded medication|0
64159|NCT01217073|250879|P8|Extension Period|Death|0
64160|NCT01217073|250880|P7|Extension Period|Death|1
64161|NCT01217073|250881|P6|Extension Period|Death|0
64162|NCT01217073|250882|P5|Extension Period|Death|0
64163|NCT01217073|250883|P4|Extension Period|Death|0
64164|NCT01217073|250884|P3|Extension Period|Death|0
64165|NCT01217073|250885|P2|Extension Period|Death|0
64166|NCT01217073|250886|P1|Extension Period|Death|0
64167|NCT01217073|250879|P8|Extension Period|Creatinine/eGFR|1
64168|NCT01217073|250880|P7|Extension Period|Creatinine/eGFR|11
64169|NCT01217073|250881|P6|Extension Period|Creatinine/eGFR|0
64170|NCT01217073|250882|P5|Extension Period|Creatinine/eGFR|0
64171|NCT01217073|250883|P4|Extension Period|Creatinine/eGFR|0
64172|NCT01217073|250884|P3|Extension Period|Creatinine/eGFR|0
64173|NCT01217073|250885|P2|Extension Period|Creatinine/eGFR|0
64174|NCT01217073|250886|P1|Extension Period|Creatinine/eGFR|0
64175|NCT01217073|250879|P8|Extension Period|Contraindication to study medication|0
64176|NCT01217073|250880|P7|Extension Period|Contraindication to study medication|1
64177|NCT01217073|250881|P6|Extension Period|Contraindication to study medication|0
64178|NCT01217073|250882|P5|Extension Period|Contraindication to study medication|0
64179|NCT01217073|250883|P4|Extension Period|Contraindication to study medication|0
64180|NCT01217073|250884|P3|Extension Period|Contraindication to study medication|0
64181|NCT01217073|250885|P2|Extension Period|Contraindication to study medication|0
64182|NCT01217073|250886|P1|Extension Period|Contraindication to study medication|0
64183|NCT01217073|250879|P8|Extension Period|ALT/AST|0
64184|NCT01217073|250880|P7|Extension Period|ALT/AST|2
64185|NCT01217073|250881|P6|Extension Period|ALT/AST|0
64186|NCT01217073|250882|P5|Extension Period|ALT/AST|0
64187|NCT01217073|250883|P4|Extension Period|ALT/AST|0
64188|NCT01217073|250884|P3|Extension Period|ALT/AST|0
64189|NCT01217073|250885|P2|Extension Period|ALT/AST|0
64190|NCT01217073|250886|P1|Extension Period|ALT/AST|0
64191|NCT01217073|250879|P8|Extension Period|Adverse Event|5
64192|NCT01217073|250880|P7|Extension Period|Adverse Event|19
64193|NCT01217073|250881|P6|Extension Period|Adverse Event|0
64194|NCT01217073|250882|P5|Extension Period|Adverse Event|0
64195|NCT01217073|250883|P4|Extension Period|Adverse Event|0
64196|NCT01217073|250884|P3|Extension Period|Adverse Event|0
64197|NCT01217073|250885|P2|Extension Period|Adverse Event|0
64198|NCT01217073|250886|P1|Extension Period|Adverse Event|0
64199|NCT01217073|250879|P8|Base Period|Withdrawal by Subject|0
64200|NCT01217073|250880|P7|Base Period|Withdrawal by Subject|0
64201|NCT01217073|250881|P6|Base Period|Withdrawal by Subject|5
64202|NCT01217073|250882|P5|Base Period|Withdrawal by Subject|5
64203|NCT01217073|250883|P4|Base Period|Withdrawal by Subject|1
64204|NCT01217073|250884|P3|Base Period|Withdrawal by Subject|5
64205|NCT01217073|250885|P2|Base Period|Withdrawal by Subject|5
64206|NCT01217073|250886|P1|Base Period|Withdrawal by Subject|4
64207|NCT01217073|250879|P8|Base Period|Protocol Violation|0
64208|NCT01217073|250880|P7|Base Period|Protocol Violation|0
64209|NCT01217073|250881|P6|Base Period|Protocol Violation|2
64210|NCT01217073|250882|P5|Base Period|Protocol Violation|1
64211|NCT01217073|250883|P4|Base Period|Protocol Violation|0
64212|NCT01217073|250884|P3|Base Period|Protocol Violation|0
64213|NCT01217073|250885|P2|Base Period|Protocol Violation|0
64214|NCT01217073|250886|P1|Base Period|Protocol Violation|1
64215|NCT01217073|250879|P8|Base Period|Physician Decision|0
64216|NCT01217073|250880|P7|Base Period|Physician Decision|0
64217|NCT01217073|250881|P6|Base Period|Physician Decision|0
64218|NCT01217073|250882|P5|Base Period|Physician Decision|1
64219|NCT01217073|250883|P4|Base Period|Physician Decision|0
64220|NCT01217073|250884|P3|Base Period|Physician Decision|0
64221|NCT01217073|250885|P2|Base Period|Physician Decision|0
64222|NCT01217073|250886|P1|Base Period|Physician Decision|0
64223|NCT01217073|250879|P8|Base Period|Lost to Follow-up|0
64224|NCT01217073|250880|P7|Base Period|Lost to Follow-up|0
64225|NCT01217073|250881|P6|Base Period|Lost to Follow-up|0
64226|NCT01217073|250882|P5|Base Period|Lost to Follow-up|3
64227|NCT01217073|250883|P4|Base Period|Lost to Follow-up|1
64228|NCT01217073|250884|P3|Base Period|Lost to Follow-up|1
64229|NCT01217073|250885|P2|Base Period|Lost to Follow-up|0
64230|NCT01217073|250886|P1|Base Period|Lost to Follow-up|0
64231|NCT01217073|250879|P8|Base Period|Lack of Efficacy|0
64232|NCT01217073|250880|P7|Base Period|Lack of Efficacy|0
64233|NCT01217073|250881|P6|Base Period|Lack of Efficacy|1
64234|NCT01217073|250882|P5|Base Period|Lack of Efficacy|0
64235|NCT01217073|250883|P4|Base Period|Lack of Efficacy|0
64236|NCT01217073|250884|P3|Base Period|Lack of Efficacy|0
64237|NCT01217073|250885|P2|Base Period|Lack of Efficacy|0
64238|NCT01217073|250886|P1|Base Period|Lack of Efficacy|0
64239|NCT01217073|250879|P8|Base Period|Excluded medication|0
64240|NCT01217073|250880|P7|Base Period|Excluded medication|0
64241|NCT01217073|250881|P6|Base Period|Excluded medication|0
64242|NCT01217073|250882|P5|Base Period|Excluded medication|1
64243|NCT01217073|250883|P4|Base Period|Excluded medication|0
64244|NCT01217073|250884|P3|Base Period|Excluded medication|0
64245|NCT01217073|250885|P2|Base Period|Excluded medication|0
64246|NCT01217073|250886|P1|Base Period|Excluded medication|0
64247|NCT01217073|250879|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
64248|NCT01217073|250880|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
64249|NCT01217073|250881|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
64250|NCT01217073|250882|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
64251|NCT01217073|250883|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
64252|NCT01217073|250884|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
64253|NCT01217073|250885|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
64254|NCT01217073|250886|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
64255|NCT01217073|250879|P8|Base Period|Adverse Event|0
64256|NCT01217073|250880|P7|Base Period|Adverse Event|0
64257|NCT01217073|250881|P6|Base Period|Adverse Event|1
64258|NCT01217073|250882|P5|Base Period|Adverse Event|4
64259|NCT01217073|250883|P4|Base Period|Adverse Event|0
64260|NCT01217073|250884|P3|Base Period|Adverse Event|1
64261|NCT01217073|250885|P2|Base Period|Adverse Event|0
64262|NCT01217073|250886|P1|Base Period|Adverse Event|1
64263|NCT01216319|251062|P1|Overall Study|Unanticipated chemo for breast cancer|2
64264|NCT01216319|251062|P1|Overall Study|Lost to Follow-up|2
64265|NCT01216163|251079|P3|Overall Study|Withdrawal by Subject|0
64266|NCT01216163|251080|P2|Overall Study|Withdrawal by Subject|1
64267|NCT01216163|251081|P1|Overall Study|Withdrawal by Subject|1
64268|NCT01216072|251133|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
64269|NCT01216072|251134|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
64270|NCT01216072|251133|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
64271|NCT01216072|251134|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
64272|NCT01216072|251133|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
64273|NCT01216072|251134|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
64274|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
64275|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
64276|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
64277|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
64278|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
64279|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
64280|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
64281|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
64282|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
64283|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
64284|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
64285|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
64286|NCT01216072|251133|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
64287|NCT01216072|251134|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
64288|NCT01215981|251162|P2|Overall Study|Withdrawal by Subject|0
64289|NCT01215981|251163|P1|Overall Study|Withdrawal by Subject|1
64290|NCT01215981|251162|P2|Overall Study|Protocol Violation|0
64291|NCT01215981|251163|P1|Overall Study|Protocol Violation|1
64292|NCT01215981|251162|P2|Overall Study|Physician Decision|1
64293|NCT01215981|251163|P1|Overall Study|Physician Decision|0
64294|NCT01215968|251173|P2|Overall Study|Not received study drug|1
64295|NCT01215968|251174|P1|Overall Study|Not received study drug|0
64296|NCT01215968|251173|P2|Overall Study|Protocol Violation|4
64297|NCT01215968|251174|P1|Overall Study|Protocol Violation|2
64298|NCT01215968|251173|P2|Overall Study|Adverse Event|2
64299|NCT01215968|251174|P1|Overall Study|Adverse Event|0
64300|NCT01215955|251194|P4|Overall Study|Quality Issues|2
64301|NCT01215955|251195|P3|Overall Study|Quality Issues|3
64302|NCT01215955|251196|P2|Overall Study|Quality Issues|0
64303|NCT01215955|251197|P1|Overall Study|Quality Issues|0
64304|NCT01215955|251194|P4|Overall Study|Withdrawal by Subject|9
64305|NCT01215955|251195|P3|Overall Study|Withdrawal by Subject|13
64306|NCT01215955|251196|P2|Overall Study|Withdrawal by Subject|15
64307|NCT01215955|251197|P1|Overall Study|Withdrawal by Subject|14
64308|NCT01215955|251194|P4|Overall Study|Sponsor Decision|1
64309|NCT01215955|251195|P3|Overall Study|Sponsor Decision|0
64310|NCT01215955|251196|P2|Overall Study|Sponsor Decision|2
64311|NCT01215955|251197|P1|Overall Study|Sponsor Decision|1
64312|NCT01215955|251194|P4|Overall Study|Protocol Violation|8
64313|NCT01215955|251195|P3|Overall Study|Protocol Violation|8
64314|NCT01215955|251196|P2|Overall Study|Protocol Violation|13
64315|NCT01215955|251197|P1|Overall Study|Protocol Violation|17
64316|NCT01215955|251194|P4|Overall Study|Physician Decision|11
64317|NCT01215955|251195|P3|Overall Study|Physician Decision|8
64318|NCT01215955|251196|P2|Overall Study|Physician Decision|10
64319|NCT01215955|251197|P1|Overall Study|Physician Decision|4
64320|NCT01215955|251194|P4|Overall Study|Lost to Follow-up|9
64321|NCT01215955|251195|P3|Overall Study|Lost to Follow-up|8
64322|NCT01215955|251196|P2|Overall Study|Lost to Follow-up|4
64323|NCT01215955|251197|P1|Overall Study|Lost to Follow-up|4
64324|NCT01215955|251194|P4|Overall Study|Lack of Efficacy|0
64325|NCT01215955|251195|P3|Overall Study|Lack of Efficacy|1
64326|NCT01215955|251196|P2|Overall Study|Lack of Efficacy|2
64327|NCT01215955|251197|P1|Overall Study|Lack of Efficacy|1
64328|NCT01215955|251194|P4|Overall Study|Entry Criteria Not Met|7
64329|NCT01215955|251195|P3|Overall Study|Entry Criteria Not Met|4
64330|NCT01215955|251196|P2|Overall Study|Entry Criteria Not Met|3
64331|NCT01215955|251197|P1|Overall Study|Entry Criteria Not Met|1
64332|NCT01215955|251194|P4|Overall Study|Death|3
64333|NCT01215955|251195|P3|Overall Study|Death|1
64334|NCT01215955|251196|P2|Overall Study|Death|0
64335|NCT01215955|251197|P1|Overall Study|Death|2
64336|NCT01215955|251194|P4|Overall Study|Adverse Event|3
64337|NCT01215955|251195|P3|Overall Study|Adverse Event|2
64338|NCT01215955|251196|P2|Overall Study|Adverse Event|4
64339|NCT01215955|251197|P1|Overall Study|Adverse Event|1
64340|NCT01215851|251278|P6|Follow up Period|Lost to Follow-up|1
64341|NCT01215851|251279|P5|Follow up Period|Lost to Follow-up|0
64342|NCT01215851|251280|P4|Follow up Period|Lost to Follow-up|0
64343|NCT01215851|251281|P3|Follow up Period|Lost to Follow-up|0
64344|NCT01215851|251282|P2|Follow up Period|Lost to Follow-up|0
64345|NCT01215851|251283|P1|Follow up Period|Lost to Follow-up|0
64346|NCT01215851|251278|P6|Treatment Period|Adverse Event|1
64347|NCT01215851|251279|P5|Treatment Period|Adverse Event|0
64348|NCT01215851|251280|P4|Treatment Period|Adverse Event|3
64349|NCT01215851|251281|P3|Treatment Period|Adverse Event|1
64350|NCT01215851|251282|P2|Treatment Period|Adverse Event|1
64351|NCT01215851|251283|P1|Treatment Period|Adverse Event|1
64352|NCT01215734|251342|P2|Overall Study|Death|1
64353|NCT01215734|251343|P1|Overall Study|Death|0
64354|NCT01215721|251351|P1|Overall Study|Adverse Event|2
64355|NCT01215513|251483|P1|Overall Study|Miscellaneous reasons (CS42A)|2
64356|NCT01215513|251483|P1|Overall Study|Withdrawal by subject (CS42A)|5
64357|NCT01215513|251483|P1|Overall Study|Physician decision (CS42A)|6
64358|NCT01215513|251483|P1|Overall Study|Adverse event (CS42A)|2
64359|NCT01215513|251483|P1|Overall Study|Not enrolled from CS42 to CS42A|21
64360|NCT01215513|251483|P1|Overall Study|Not completed CS42|9
64361|NCT01215435|251492|P2|Overall Study|Unclassified|5
64362|NCT01215435|251493|P1|Overall Study|Unclassified|5
64363|NCT01215435|251492|P2|Overall Study|Lost to Follow-up|0
64364|NCT01215435|251493|P1|Overall Study|Lost to Follow-up|3
64365|NCT01215435|251492|P2|Overall Study|Withdrawal Criteria|11
64366|NCT01215435|251493|P1|Overall Study|Withdrawal Criteria|8
64367|NCT01215435|251492|P2|Overall Study|Protocol Violation|0
64368|NCT01215435|251493|P1|Overall Study|Protocol Violation|2
64369|NCT01215435|251492|P2|Overall Study|Adverse Event|0
64370|NCT01215435|251493|P1|Overall Study|Adverse Event|1
64371|NCT01215422|251507|P4|Overall Study|Did not complete all intubations|0
64372|NCT01215422|251508|P3|Overall Study|Did not complete all intubations|0
64373|NCT01215422|251509|P2|Overall Study|Did not complete all intubations|0
64374|NCT01215422|251510|P1|Overall Study|Did not complete all intubations|7
64375|NCT01215422|251507|P4|Overall Study|Failed intubations|8
64376|NCT01215422|251508|P3|Overall Study|Failed intubations|3
64377|NCT01215422|251509|P2|Overall Study|Failed intubations|0
64378|NCT01215422|251510|P1|Overall Study|Failed intubations|0
64379|NCT01215422|251507|P4|Overall Study|Relocation|0
64380|NCT01215422|251508|P3|Overall Study|Relocation|0
64381|NCT01215422|251509|P2|Overall Study|Relocation|0
64382|NCT01215422|251510|P1|Overall Study|Relocation|1
64383|NCT01215357|251532|P1|Overall Study|Protocol Violation|9
64384|NCT01215357|251532|P1|Overall Study|Withdrawal by Subject|3
64385|NCT01215227|251651|P6|Overall Study|Randomized but not treated|1
64386|NCT01215227|251652|P5|Overall Study|Randomized but not treated|0
64387|NCT01215227|251653|P4|Overall Study|Randomized but not treated|1
64388|NCT01215227|251654|P3|Overall Study|Randomized but not treated|1
64389|NCT01215227|251655|P2|Overall Study|Randomized but not treated|0
64390|NCT01215227|251656|P1|Overall Study|Randomized but not treated|0
64391|NCT01215227|251651|P6|Overall Study|Missing Status|0
64392|NCT01215227|251652|P5|Overall Study|Missing Status|0
64393|NCT01215227|251653|P4|Overall Study|Missing Status|0
64394|NCT01215227|251654|P3|Overall Study|Missing Status|0
64395|NCT01215227|251655|P2|Overall Study|Missing Status|1
64396|NCT01215227|251656|P1|Overall Study|Missing Status|0
64397|NCT01215227|251651|P6|Overall Study|Administrative|40
64398|NCT01215227|251652|P5|Overall Study|Administrative|28
64399|NCT01215227|251653|P4|Overall Study|Administrative|24
64400|NCT01215227|251654|P3|Overall Study|Administrative|42
64401|NCT01215227|251655|P2|Overall Study|Administrative|73
64402|NCT01215227|251656|P1|Overall Study|Administrative|83
64403|NCT01215227|251651|P6|Overall Study|Non-Compliance With Protocol|0
64404|NCT01215227|251652|P5|Overall Study|Non-Compliance With Protocol|0
64405|NCT01215227|251653|P4|Overall Study|Non-Compliance With Protocol|0
64406|NCT01215227|251654|P3|Overall Study|Non-Compliance With Protocol|1
64407|NCT01215227|251655|P2|Overall Study|Non-Compliance With Protocol|6
64408|NCT01215227|251656|P1|Overall Study|Non-Compliance With Protocol|2
64409|NCT01215227|251651|P6|Overall Study|Subject Withdrew Consent|8
64410|NCT01215227|251652|P5|Overall Study|Subject Withdrew Consent|11
64411|NCT01215227|251653|P4|Overall Study|Subject Withdrew Consent|10
64412|NCT01215227|251654|P3|Overall Study|Subject Withdrew Consent|7
64413|NCT01215227|251655|P2|Overall Study|Subject Withdrew Consent|20
64414|NCT01215227|251656|P1|Overall Study|Subject Withdrew Consent|16
64415|NCT01215227|251651|P6|Overall Study|Lost to Follow-up|2
64416|NCT01215227|251652|P5|Overall Study|Lost to Follow-up|1
64417|NCT01215227|251653|P4|Overall Study|Lost to Follow-up|1
64418|NCT01215227|251654|P3|Overall Study|Lost to Follow-up|1
64419|NCT01215227|251655|P2|Overall Study|Lost to Follow-up|4
64420|NCT01215227|251656|P1|Overall Study|Lost to Follow-up|1
64421|NCT01215227|251651|P6|Overall Study|Treatment Failure|1
64422|NCT01215227|251652|P5|Overall Study|Treatment Failure|1
64423|NCT01215227|251653|P4|Overall Study|Treatment Failure|5
64424|NCT01215227|251654|P3|Overall Study|Treatment Failure|1
64425|NCT01215227|251655|P2|Overall Study|Treatment Failure|4
64426|NCT01215227|251656|P1|Overall Study|Treatment Failure|8
64427|NCT01215227|251651|P6|Overall Study|Adverse Event|6
64428|NCT01215227|251652|P5|Overall Study|Adverse Event|7
64429|NCT01215227|251653|P4|Overall Study|Adverse Event|8
64430|NCT01215227|251654|P3|Overall Study|Adverse Event|4
64431|NCT01215227|251655|P2|Overall Study|Adverse Event|11
64432|NCT01215227|251656|P1|Overall Study|Adverse Event|11
64433|NCT01215097|251775|P2|Overall Study|patient's private reason|1
64434|NCT01215097|251776|P1|Overall Study|patient's private reason|1
64435|NCT01215097|251775|P2|Overall Study|patient's refusal to come|2
64436|NCT01215097|251776|P1|Overall Study|patient's refusal to come|2
64437|NCT01215097|251775|P2|Overall Study|Lack of Efficacy|3
64438|NCT01215097|251776|P1|Overall Study|Lack of Efficacy|0
64439|NCT01215097|251775|P2|Overall Study|Withdrawal by Subject|3
64440|NCT01215097|251776|P1|Overall Study|Withdrawal by Subject|6
64441|NCT01215097|251775|P2|Overall Study|Lost to Follow-up|0
64442|NCT01215097|251776|P1|Overall Study|Lost to Follow-up|2
64443|NCT01215097|251775|P2|Overall Study|Protocol Violation|2
64444|NCT01215097|251776|P1|Overall Study|Protocol Violation|0
64445|NCT01215097|251775|P2|Overall Study|Adverse Event|3
64446|NCT01215097|251776|P1|Overall Study|Adverse Event|1
64447|NCT01215032|251808|P1|Overall Study|Lack of Efficacy|17
64448|NCT01215032|251808|P1|Overall Study|Adverse Event|3
64449|NCT01214915|251833|P1|Overall Study|Lack of Efficacy|3
64450|NCT01214915|251833|P1|Overall Study|Adverse Event|8
64451|NCT01214850|251844|P3|Overall Study|Unable to classify|1
64452|NCT01214850|251845|P2|Overall Study|Unable to classify|1
64453|NCT01214850|251846|P1|Overall Study|Unable to classify|2
64454|NCT01214850|251844|P3|Overall Study|Administrative reason|0
64455|NCT01214850|251845|P2|Overall Study|Administrative reason|0
64456|NCT01214850|251846|P1|Overall Study|Administrative reason|1
64457|NCT01214850|251844|P3|Overall Study|Inappropriate enrollment|0
64458|NCT01214850|251845|P2|Overall Study|Inappropriate enrollment|1
64459|NCT01214850|251846|P1|Overall Study|Inappropriate enrollment|2
64460|NCT01214850|251844|P3|Overall Study|Adverse event or death|3
64461|NCT01214850|251845|P2|Overall Study|Adverse event or death|8
64462|NCT01214850|251846|P1|Overall Study|Adverse event or death|11
64463|NCT01214850|251844|P3|Overall Study|Protocol Violation|6
64464|NCT01214850|251845|P2|Overall Study|Protocol Violation|5
64465|NCT01214850|251846|P1|Overall Study|Protocol Violation|5
64466|NCT01214850|251844|P3|Overall Study|Lost to Follow-up|123
64467|NCT01214850|251845|P2|Overall Study|Lost to Follow-up|98
64468|NCT01214850|251846|P1|Overall Study|Lost to Follow-up|124
64469|NCT01214850|251844|P3|Overall Study|Withdrawal by Subject|28
64470|NCT01214850|251845|P2|Overall Study|Withdrawal by Subject|31
64471|NCT01214850|251846|P1|Overall Study|Withdrawal by Subject|38
64472|NCT01214837|251930|P3|Overall Study|Unable to Classify|0
64473|NCT01214837|251931|P2|Overall Study|Unable to Classify|3
64474|NCT01214837|251932|P1|Overall Study|Unable to Classify|1
64475|NCT01214837|251930|P3|Overall Study|Protocol Violation|5
64476|NCT01214837|251931|P2|Overall Study|Protocol Violation|1
64477|NCT01214837|251932|P1|Overall Study|Protocol Violation|3
64478|NCT01214837|251930|P3|Overall Study|Administrative Reason|4
64479|NCT01214837|251931|P2|Overall Study|Administrative Reason|6
64480|NCT01214837|251932|P1|Overall Study|Administrative Reason|2
64481|NCT01214837|251930|P3|Overall Study|Inappropriate Enrolment|2
64482|NCT01214837|251931|P2|Overall Study|Inappropriate Enrolment|1
64483|NCT01214837|251932|P1|Overall Study|Inappropriate Enrolment|0
64484|NCT01214837|251930|P3|Overall Study|Lost to Follow-up|21
64485|NCT01214837|251931|P2|Overall Study|Lost to Follow-up|15
64486|NCT01214837|251932|P1|Overall Study|Lost to Follow-up|20
64487|NCT01214837|251930|P3|Overall Study|Withdrawal by Subject|28
64488|NCT01214837|251931|P2|Overall Study|Withdrawal by Subject|36
64489|NCT01214837|251932|P1|Overall Study|Withdrawal by Subject|27
64490|NCT01214837|251930|P3|Overall Study|Adverse Event|1
64491|NCT01214837|251931|P2|Overall Study|Adverse Event|2
64492|NCT01214837|251932|P1|Overall Study|Adverse Event|1
64493|NCT01214837|251930|P3|Overall Study|Death|1
64494|NCT01214837|251931|P2|Overall Study|Death|0
64495|NCT01214837|251932|P1|Overall Study|Death|0
64496|NCT01214720|252055|P2|Overall Study|Lost to Follow-up|2
64497|NCT01214720|252056|P1|Overall Study|Lost to Follow-up|6
64498|NCT01214720|252055|P2|Overall Study|Alive and in follow-up|48
64499|NCT01214720|252056|P1|Overall Study|Alive and in follow-up|45
64500|NCT01214720|252055|P2|Overall Study|Alive and still on treatment|18
64501|NCT01214720|252056|P1|Overall Study|Alive and still on treatment|34
64502|NCT01214616|252077|P4|Overall Study|Withdrawal by Subject|1
64503|NCT01214616|252078|P3|Overall Study|Withdrawal by Subject|0
64504|NCT01214616|252079|P2|Overall Study|Withdrawal by Subject|0
64505|NCT01214616|252080|P1|Overall Study|Withdrawal by Subject|1
64506|NCT01214616|252077|P4|Overall Study|Other adverse events|1
64507|NCT01214616|252078|P3|Overall Study|Other adverse events|1
64508|NCT01214616|252079|P2|Overall Study|Other adverse events|1
64509|NCT01214616|252080|P1|Overall Study|Other adverse events|0
64510|NCT01214616|252077|P4|Overall Study|Dose limiting toxicity|0
64511|NCT01214616|252078|P3|Overall Study|Dose limiting toxicity|0
64512|NCT01214616|252079|P2|Overall Study|Dose limiting toxicity|2
64513|NCT01214616|252080|P1|Overall Study|Dose limiting toxicity|0
64514|NCT01214616|252077|P4|Overall Study|Progressive disease|4
64515|NCT01214616|252078|P3|Overall Study|Progressive disease|2
64516|NCT01214616|252079|P2|Overall Study|Progressive disease|2
64517|NCT01214616|252080|P1|Overall Study|Progressive disease|2
64518|NCT01214434|252116|P2|Overall Study|Site error|0
64519|NCT01214434|252117|P1|Overall Study|Site error|1
64520|NCT01214434|252116|P2|Overall Study|Lost to Follow-up|2
64521|NCT01214434|252117|P1|Overall Study|Lost to Follow-up|2
64522|NCT01214434|252116|P2|Overall Study|Withdrawal by Subject|0
64523|NCT01214434|252117|P1|Overall Study|Withdrawal by Subject|1
64524|NCT01214395|252133|P1|Overall Study|All patients had infection|5
64525|NCT01214252|252142|P1|Overall Study|Not eligible per protocol|82
64526|NCT01214239|252150|P2|Overall Study|patient's private reason|1
64527|NCT01214239|252151|P1|Overall Study|patient's private reason|1
64528|NCT01214239|252150|P2|Overall Study|Lack of Efficacy|2
64529|NCT01214239|252151|P1|Overall Study|Lack of Efficacy|1
64530|NCT01214239|252150|P2|Overall Study|Withdrawal by Subject|9
64531|NCT01214239|252151|P1|Overall Study|Withdrawal by Subject|4
64532|NCT01214239|252150|P2|Overall Study|Lost to Follow-up|1
64533|NCT01214239|252151|P1|Overall Study|Lost to Follow-up|1
64534|NCT01214239|252150|P2|Overall Study|Protocol Violation|1
64535|NCT01214239|252151|P1|Overall Study|Protocol Violation|2
64536|NCT01214239|252150|P2|Overall Study|Adverse Event|4
64537|NCT01214239|252151|P1|Overall Study|Adverse Event|3
64538|NCT01214187|252185|P2|Overall Study|Withdrawal by Subject|3
64539|NCT01214187|252186|P1|Overall Study|Withdrawal by Subject|0
64540|NCT01214187|252185|P2|Overall Study|Death|1
64541|NCT01214187|252186|P1|Overall Study|Death|1
64542|NCT01214187|252185|P2|Overall Study|Adverse Event|2
64543|NCT01214187|252186|P1|Overall Study|Adverse Event|6
64544|NCT01214174|252203|P3|Overall Study|Withdrawal by Subject|1
64545|NCT01214174|252204|P2|Overall Study|Withdrawal by Subject|0
64546|NCT01214174|252205|P1|Overall Study|Withdrawal by Subject|0
64547|NCT01213966|252359|P4|Overall Study|Protocol Violation|1
64548|NCT01213966|252360|P3|Overall Study|Protocol Violation|3
64549|NCT01213966|252361|P2|Overall Study|Protocol Violation|0
64550|NCT01213966|252362|P1|Overall Study|Protocol Violation|1
64551|NCT01213836|252374|P2|Period 1, First Intervention|Withdrawal by Subject|1
64552|NCT01213836|252375|P1|Period 1, First Intervention|Withdrawal by Subject|1
64553|NCT01213836|252374|P2|Period 1, First Intervention|Protocol Violation|1
64554|NCT01213836|252375|P1|Period 1, First Intervention|Protocol Violation|0
64555|NCT01213836|252374|P2|Period 1, First Intervention|Adverse Event|1
64556|NCT01213836|252375|P1|Period 1, First Intervention|Adverse Event|2
64557|NCT01213264|252421|P3|Overall Study|Lost to Follow-up|6
64558|NCT01213264|252422|P2|Overall Study|Lost to Follow-up|2
64559|NCT01213264|252423|P1|Overall Study|Lost to Follow-up|1
64560|NCT01213264|252421|P3|Overall Study|Adverse Event|0
64561|NCT01213264|252422|P2|Overall Study|Adverse Event|0
64562|NCT01213264|252423|P1|Overall Study|Adverse Event|1
64563|NCT01213251|252443|P3|Overall Study|Missed 18-Month Follow-up|1
64564|NCT01213251|252444|P2|Overall Study|Missed 18-Month Follow-up|0
64565|NCT01213251|252445|P1|Overall Study|Missed 18-Month Follow-up|0
64566|NCT01213251|252443|P3|Overall Study|Protocol Violation|0
64567|NCT01213251|252444|P2|Overall Study|Protocol Violation|1
64568|NCT01213251|252445|P1|Overall Study|Protocol Violation|1
64569|NCT01213251|252443|P3|Overall Study|Exit|8
64570|NCT01213251|252444|P2|Overall Study|Exit|2
64571|NCT01213251|252445|P1|Overall Study|Exit|3
64572|NCT01213251|252443|P3|Overall Study|Death|2
64573|NCT01213251|252444|P2|Overall Study|Death|1
64574|NCT01213251|252445|P1|Overall Study|Death|2
64575|NCT01213173|252472|P2|Overall Study|Incorrect Enrollment|3
64576|NCT01213173|252473|P1|Overall Study|Incorrect Enrollment|1
64577|NCT01213173|252472|P2|Overall Study|Withdrawal by Subject|5
64578|NCT01213173|252473|P1|Overall Study|Withdrawal by Subject|5
64579|NCT01213173|252472|P2|Overall Study|Adverse Event|8
64580|NCT01213173|252473|P1|Overall Study|Adverse Event|4
64581|NCT01213173|252472|P2|Overall Study|Protocol Violation|0
64582|NCT01213173|252473|P1|Overall Study|Protocol Violation|2
64583|NCT01212991|252534|P2|Overall Study|Continuing Treatment|61
64584|NCT01212991|252535|P1|Overall Study|Continuing Treatment|367
64585|NCT01212991|252534|P2|Overall Study|Withdrawal by Subject|14
64586|NCT01212991|252535|P1|Overall Study|Withdrawal by Subject|4
64587|NCT01212991|252534|P2|Overall Study|Death|299
64588|NCT01212991|252535|P1|Overall Study|Death|241
64589|NCT01212991|252534|P2|Overall Study|Lost to Follow-up|0
64590|NCT01212991|252535|P1|Overall Study|Lost to Follow-up|1
64591|NCT01212770|252567|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64592|NCT01212770|252568|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64593|NCT01212770|252569|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64594|NCT01212770|252570|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
64595|NCT01212770|252571|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
64596|NCT01212770|252572|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64597|NCT01212770|252573|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64598|NCT01212770|252567|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
64599|NCT01212770|252568|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
64600|NCT01212770|252569|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
64601|NCT01212770|252570|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
64602|NCT01212770|252571|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
64603|NCT01212770|252572|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
64604|NCT01212770|252573|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
64605|NCT01212770|252567|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64606|NCT01212770|252568|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64607|NCT01212770|252569|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64608|NCT01212770|252570|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64609|NCT01212770|252571|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
64610|NCT01212770|252572|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64611|NCT01212770|252573|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64612|NCT01212770|252567|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
64613|NCT01212770|252568|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
64614|NCT01212770|252569|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
64615|NCT01212770|252570|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
64616|NCT01212770|252571|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
64617|NCT01212770|252572|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
64618|NCT01212770|252573|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
64619|NCT01212770|252567|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
64620|NCT01212770|252568|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
64621|NCT01212770|252569|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
64622|NCT01212770|252570|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
64623|NCT01212770|252571|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
64624|NCT01212770|252572|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
64625|NCT01212770|252573|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
64626|NCT01212770|252567|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
64627|NCT01212770|252568|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
64628|NCT01212770|252569|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
64629|NCT01212770|252570|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
64630|NCT01212770|252571|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
64631|NCT01212770|252572|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
64632|NCT01212770|252573|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
64633|NCT01212770|252567|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64634|NCT01212770|252568|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64635|NCT01212770|252569|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64636|NCT01212770|252570|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64637|NCT01212770|252571|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
64638|NCT01212770|252572|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
64639|NCT01212770|252573|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|3
64640|NCT01212770|252567|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64641|NCT01212770|252568|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64642|NCT01212770|252569|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64643|NCT01212770|252570|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64644|NCT01212770|252571|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
64645|NCT01212770|252572|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64646|NCT01212770|252573|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64647|NCT01212770|252567|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64648|NCT01212770|252568|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64649|NCT01212770|252569|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64650|NCT01212770|252570|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64651|NCT01212770|252571|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
64652|NCT01212770|252572|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64653|NCT01212770|252573|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
64654|NCT01212770|252567|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64655|NCT01212770|252568|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64656|NCT01212770|252569|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64657|NCT01212770|252570|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64658|NCT01212770|252571|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
64659|NCT01212770|252572|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
64660|NCT01212770|252573|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
64661|NCT01212770|252567|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64662|NCT01212770|252568|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64663|NCT01212770|252569|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64664|NCT01212770|252570|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64665|NCT01212770|252571|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
64666|NCT01212770|252572|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
64667|NCT01212770|252573|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
64668|NCT01212770|252567|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64669|NCT01212770|252568|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64670|NCT01212770|252569|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64671|NCT01212770|252570|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64672|NCT01212770|252571|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
64673|NCT01212770|252572|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
64674|NCT01212770|252573|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
64675|NCT01212757|252763|P7|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64676|NCT01212757|252764|P6|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64677|NCT01212757|252765|P5|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64678|NCT01212757|252766|P4|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64679|NCT01212757|252767|P3|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
64680|NCT01212757|252768|P2|Active Treatment Phase (Weeks 25 - 52)|Unspecified|1
64681|NCT01212757|252769|P1|Active Treatment Phase (Weeks 25 - 52)|Unspecified|0
64682|NCT01212757|252763|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64683|NCT01212757|252764|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64684|NCT01212757|252765|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
64685|NCT01212757|252766|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64686|NCT01212757|252767|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64687|NCT01212757|252768|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
64688|NCT01212757|252769|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
64689|NCT01212757|252763|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
64690|NCT01212757|252764|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
64691|NCT01212757|252765|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
64692|NCT01212757|252766|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
64693|NCT01212757|252767|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|7
64694|NCT01212757|252768|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
64695|NCT01212757|252769|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
64696|NCT01212757|252763|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
64697|NCT01212757|252764|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
64698|NCT01212757|252765|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
64699|NCT01212757|252766|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
64700|NCT01212757|252767|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|2
64701|NCT01212757|252768|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
64702|NCT01212757|252769|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
64703|NCT01212757|252763|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
64704|NCT01212757|252764|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
64705|NCT01212757|252765|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
64706|NCT01212757|252766|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
64707|NCT01212757|252767|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
64708|NCT01212757|252768|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
64709|NCT01212757|252769|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
64710|NCT01212757|252763|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
64711|NCT01212757|252764|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
64712|NCT01212757|252765|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
64713|NCT01212757|252766|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
64714|NCT01212757|252767|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|3
64715|NCT01212757|252768|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
64716|NCT01212757|252769|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
64717|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64718|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64719|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64720|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64721|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Unspecified|0
64722|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Unspecified|2
64723|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Unspecified|1
64724|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64725|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64726|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64727|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64728|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
64729|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
64730|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
64731|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64732|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64733|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64734|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
64735|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
64736|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
64737|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
64738|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
64739|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
64740|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
64741|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
64742|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
64743|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
64744|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
64745|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64746|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64747|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64748|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
64749|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
64750|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
64751|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
64752|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64753|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64754|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64755|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
64756|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
64757|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
64758|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
64759|NCT01212757|252763|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64760|NCT01212757|252764|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64761|NCT01212757|252765|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64762|NCT01212757|252766|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
64763|NCT01212757|252767|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
64764|NCT01212757|252768|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
64765|NCT01212757|252769|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
64766|NCT01212185|253001|P2|Overall Study|Protocol Violation|1
64767|NCT01212185|253002|P1|Overall Study|Protocol Violation|2
64768|NCT01212159|253021|P2|Overall Study|Withdrawal by Subject|12
64769|NCT01212159|253022|P1|Overall Study|Withdrawal by Subject|12
64770|NCT01212094|253035|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
64771|NCT01212094|253036|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
64772|NCT01212094|253037|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
64773|NCT01212094|253035|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
64774|NCT01212094|253036|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
64775|NCT01212094|253037|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
64776|NCT01212094|253035|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
64777|NCT01212094|253036|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
64778|NCT01212094|253037|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
64779|NCT01212094|253035|P3|Year 1: Baseline Monitoring|Started on DMT|0
64780|NCT01212094|253036|P2|Year 1: Baseline Monitoring|Started on DMT|0
64781|NCT01212094|253037|P1|Year 1: Baseline Monitoring|Started on DMT|2
64782|NCT01212094|253035|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
64783|NCT01212094|253036|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
64784|NCT01212094|253037|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
64785|NCT01212094|253035|P3|Year 1: Baseline Monitoring|Study terminated|0
64786|NCT01212094|253036|P2|Year 1: Baseline Monitoring|Study terminated|0
64787|NCT01212094|253037|P1|Year 1: Baseline Monitoring|Study terminated|7
64788|NCT01211769|253084|P4|Overall Study|Adverse Event|1
64789|NCT01211769|253085|P3|Overall Study|Adverse Event|1
64790|NCT01211769|253086|P2|Overall Study|Adverse Event|1
64791|NCT01211769|253087|P1|Overall Study|Adverse Event|0
64792|NCT01211769|253084|P4|Overall Study|Physician Decision|1
64793|NCT01211769|253085|P3|Overall Study|Physician Decision|2
64794|NCT01211769|253086|P2|Overall Study|Physician Decision|0
64795|NCT01211769|253087|P1|Overall Study|Physician Decision|2
64796|NCT01211769|253084|P4|Overall Study|Lost to Follow-up|9
64797|NCT01211769|253085|P3|Overall Study|Lost to Follow-up|5
64798|NCT01211769|253086|P2|Overall Study|Lost to Follow-up|9
64799|NCT01211769|253087|P1|Overall Study|Lost to Follow-up|7
64800|NCT01211665|253126|P2|Overall Study|Death|0
64801|NCT01211665|253127|P1|Overall Study|Death|1
64802|NCT01211665|253126|P2|Overall Study|Withdrawal by Subject|0
64803|NCT01211665|253127|P1|Overall Study|Withdrawal by Subject|1
64804|NCT01211613|253154|P3|Overall Study|Withdrawal by Subject|0
64805|NCT01211613|253155|P2|Overall Study|Withdrawal by Subject|0
64806|NCT01211613|253156|P1|Overall Study|Withdrawal by Subject|1
64807|NCT01211613|253154|P3|Overall Study|Lost to Follow-up|2
64808|NCT01211613|253155|P2|Overall Study|Lost to Follow-up|2
64809|NCT01211613|253156|P1|Overall Study|Lost to Follow-up|2
64810|NCT01211535|253169|P2|Overall Study|Adverse Event|1
64811|NCT01211535|253170|P1|Overall Study|Adverse Event|0
64812|NCT01211197|253189|P6|Washout Period 2 (7 Days)|Adverse Event|0
64813|NCT01211197|253190|P5|Washout Period 2 (7 Days)|Adverse Event|0
64814|NCT01211197|253191|P4|Washout Period 2 (7 Days)|Adverse Event|0
64815|NCT01211197|253192|P3|Washout Period 2 (7 Days)|Adverse Event|0
64816|NCT01211197|253193|P2|Washout Period 2 (7 Days)|Adverse Event|0
64817|NCT01211197|253194|P1|Washout Period 2 (7 Days)|Adverse Event|1
64818|NCT01211197|253189|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
64819|NCT01211197|253190|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
64820|NCT01211197|253191|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
64821|NCT01211197|253192|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
64822|NCT01211197|253193|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
64823|NCT01211197|253194|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
64824|NCT01211184|253241|P3|Overall Study|Withdrawal by Subject|1
64825|NCT01211184|253242|P2|Overall Study|Withdrawal by Subject|2
64826|NCT01211184|253243|P1|Overall Study|Withdrawal by Subject|0
64827|NCT01211145|253258|P4|Overall Study|Patient decision|2
64828|NCT01211145|253259|P3|Overall Study|Patient decision|0
64829|NCT01211145|253260|P2|Overall Study|Patient decision|1
64830|NCT01211145|253261|P1|Overall Study|Patient decision|2
64831|NCT01211145|253258|P4|Overall Study|Eligibility criteria not fulfilled|15
64832|NCT01211145|253259|P3|Overall Study|Eligibility criteria not fulfilled|10
64833|NCT01211145|253260|P2|Overall Study|Eligibility criteria not fulfilled|12
64834|NCT01211145|253261|P1|Overall Study|Eligibility criteria not fulfilled|16
64835|NCT01211145|253258|P4|Overall Study|Severe noncompliance to protocol|0
64836|NCT01211145|253259|P3|Overall Study|Severe noncompliance to protocol|0
64837|NCT01211145|253260|P2|Overall Study|Severe noncompliance to protocol|0
64838|NCT01211145|253261|P1|Overall Study|Severe noncompliance to protocol|1
64839|NCT01211145|253258|P4|Overall Study|Study-specific withdrawal criteria|0
64840|NCT01211145|253259|P3|Overall Study|Study-specific withdrawal criteria|0
64841|NCT01211145|253260|P2|Overall Study|Study-specific withdrawal criteria|0
64842|NCT01211145|253261|P1|Overall Study|Study-specific withdrawal criteria|1
64843|NCT01211145|253258|P4|Overall Study|Lost to Follow-up|2
64844|NCT01211145|253259|P3|Overall Study|Lost to Follow-up|1
64845|NCT01211145|253260|P2|Overall Study|Lost to Follow-up|2
64846|NCT01211145|253261|P1|Overall Study|Lost to Follow-up|3
64847|NCT01211145|253258|P4|Overall Study|Reason not specified|1
64848|NCT01211145|253259|P3|Overall Study|Reason not specified|2
64849|NCT01211145|253260|P2|Overall Study|Reason not specified|2
64850|NCT01211145|253261|P1|Overall Study|Reason not specified|3
64851|NCT01210807|253315|P2|Overall Study|Not implanted bilaterally|1
64852|NCT01210807|253316|P1|Overall Study|Not implanted bilaterally|2
64853|NCT01210807|253315|P2|Overall Study|Lost to Follow-up|2
64854|NCT01210807|253316|P1|Overall Study|Lost to Follow-up|1
64855|NCT01210690|253331|P1|Overall Study|Patient could not take glucose|1
64856|NCT01210690|253331|P1|Overall Study|Patient refused to swallow|1
64857|NCT01210690|253331|P1|Overall Study|Withdrawal by Subject|1
64858|NCT01210690|253331|P1|Overall Study|Disease Remission|1
64859|NCT01210690|253331|P1|Overall Study|Lost to Follow-up|3
64860|NCT01210690|253331|P1|Overall Study|Lack of Efficacy|12
64861|NCT01210690|253331|P1|Overall Study|Adverse Event|7
64862|NCT01210651|253346|P2|Overall Study|Injury outside study|0
64863|NCT01210651|253347|P1|Overall Study|Injury outside study|2
64864|NCT01210651|253346|P2|Overall Study|Withdrawal by Subject|1
64865|NCT01210651|253347|P1|Overall Study|Withdrawal by Subject|1
64866|NCT01210651|253346|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
64867|NCT01210651|253347|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
64868|NCT01210651|253346|P2|Overall Study|schedule conflicts|5
64869|NCT01210651|253347|P1|Overall Study|schedule conflicts|1
64870|NCT01210651|253346|P2|Overall Study|Lost to Follow-up|1
64871|NCT01210651|253347|P1|Overall Study|Lost to Follow-up|1
64872|NCT01210495|253365|P4|Overall Study|Lost to Follow-up|0
64873|NCT01210495|253366|P3|Overall Study|Lost to Follow-up|1
64874|NCT01210495|253367|P2|Overall Study|Lost to Follow-up|0
64875|NCT01210495|253368|P1|Overall Study|Lost to Follow-up|0
64876|NCT01210495|253365|P4|Overall Study|Ongoing on Treatment|1
64877|NCT01210495|253366|P3|Overall Study|Ongoing on Treatment|7
64878|NCT01210495|253367|P2|Overall Study|Ongoing on Treatment|0
64879|NCT01210495|253368|P1|Overall Study|Ongoing on Treatment|0
64880|NCT01210495|253365|P4|Overall Study|Ongoing in Follow-up|13
64881|NCT01210495|253366|P3|Overall Study|Ongoing in Follow-up|14
64882|NCT01210495|253367|P2|Overall Study|Ongoing in Follow-up|1
64883|NCT01210495|253368|P1|Overall Study|Ongoing in Follow-up|0
64884|NCT01210495|253365|P4|Overall Study|Death|52
64885|NCT01210495|253366|P3|Overall Study|Death|101
64886|NCT01210495|253367|P2|Overall Study|Death|6
64887|NCT01210495|253368|P1|Overall Study|Death|14
64888|NCT01210495|253365|P4|Overall Study|Participant Refused Further Follow-Up|2
64889|NCT01210495|253366|P3|Overall Study|Participant Refused Further Follow-Up|11
64890|NCT01210495|253367|P2|Overall Study|Participant Refused Further Follow-Up|0
64891|NCT01210495|253368|P1|Overall Study|Participant Refused Further Follow-Up|1
64892|NCT01210443|253430|P1|Overall Study|Study terminated by sponsor|2
64893|NCT01210144|253454|P2|Overall Study|No transfer|0
64894|NCT01210144|253455|P1|Overall Study|No transfer|1
64895|NCT01210144|253454|P2|Overall Study|No fertilization|0
64896|NCT01210144|253455|P1|Overall Study|No fertilization|1
64897|NCT01210144|253454|P2|Overall Study|Lack of ovarian response|0
64898|NCT01210144|253455|P1|Overall Study|Lack of ovarian response|1
64899|NCT01210118|253477|P2|Overall Study|Spontaneous abortion|3
64900|NCT01210118|253478|P1|Overall Study|Spontaneous abortion|1
64901|NCT01210118|253477|P2|Overall Study|Protocol Violation|1
64902|NCT01210118|253478|P1|Overall Study|Protocol Violation|1
64903|NCT01210118|253477|P2|Overall Study|Lost to Follow-up|1
64904|NCT01210118|253478|P1|Overall Study|Lost to Follow-up|1
64905|NCT01210001|253502|P3|Overall Study|Other reason not defined above|1
64906|NCT01210001|253503|P2|Overall Study|Other reason not defined above|2
64907|NCT01210001|253504|P1|Overall Study|Other reason not defined above|2
64908|NCT01210001|253502|P3|Overall Study|Patient refusal to continue,not due toAE|1
64909|NCT01210001|253503|P2|Overall Study|Patient refusal to continue,not due toAE|2
64910|NCT01210001|253504|P1|Overall Study|Patient refusal to continue,not due toAE|6
64911|NCT01210001|253502|P3|Overall Study|Lost to Follow-up|2
64912|NCT01210001|253503|P2|Overall Study|Lost to Follow-up|3
64913|NCT01210001|253504|P1|Overall Study|Lost to Follow-up|4
64914|NCT01210001|253502|P3|Overall Study|Non compliant with protocol|3
64915|NCT01210001|253503|P2|Overall Study|Non compliant with protocol|2
64916|NCT01210001|253504|P1|Overall Study|Non compliant with protocol|2
64917|NCT01210001|253502|P3|Overall Study|Adverse Event|5
64918|NCT01210001|253503|P2|Overall Study|Adverse Event|2
64919|NCT01210001|253504|P1|Overall Study|Adverse Event|4
64920|NCT01210001|253502|P3|Overall Study|Not treated|0
64921|NCT01210001|253503|P2|Overall Study|Not treated|0
64922|NCT01210001|253504|P1|Overall Study|Not treated|1
64923|NCT01209949|253524|P1|Overall Study|Lost to Follow-up|3
64924|NCT01209780|253534|P5|Overall Study|Inappropriate enrollment|1
64925|NCT01209780|253535|P4|Overall Study|Inappropriate enrollment|0
64926|NCT01209780|253536|P3|Overall Study|Inappropriate enrollment|0
64927|NCT01209780|253537|P2|Overall Study|Inappropriate enrollment|2
64928|NCT01209780|253538|P1|Overall Study|Inappropriate enrollment|0
64929|NCT01209780|253534|P5|Overall Study|Protocol Violation|0
64930|NCT01209780|253535|P4|Overall Study|Protocol Violation|0
64931|NCT01209780|253536|P3|Overall Study|Protocol Violation|0
64932|NCT01209780|253537|P2|Overall Study|Protocol Violation|1
64933|NCT01209780|253538|P1|Overall Study|Protocol Violation|0
64934|NCT01209780|253534|P5|Overall Study|Lost to Follow-up|4
64935|NCT01209780|253535|P4|Overall Study|Lost to Follow-up|9
64936|NCT01209780|253536|P3|Overall Study|Lost to Follow-up|3
64937|NCT01209780|253537|P2|Overall Study|Lost to Follow-up|12
64938|NCT01209780|253538|P1|Overall Study|Lost to Follow-up|17
64939|NCT01209780|253534|P5|Overall Study|Withdrawal by Subject|0
64940|NCT01209780|253535|P4|Overall Study|Withdrawal by Subject|1
64941|NCT01209780|253536|P3|Overall Study|Withdrawal by Subject|1
64942|NCT01209780|253537|P2|Overall Study|Withdrawal by Subject|2
64943|NCT01209780|253538|P1|Overall Study|Withdrawal by Subject|9
64944|NCT01209780|253534|P5|Overall Study|Adverse Event|0
64945|NCT01209780|253535|P4|Overall Study|Adverse Event|0
64946|NCT01209780|253536|P3|Overall Study|Adverse Event|0
64947|NCT01209780|253537|P2|Overall Study|Adverse Event|1
64948|NCT01209780|253538|P1|Overall Study|Adverse Event|0
64949|NCT01209767|253564|P1|Overall Study|Lost to Follow-up|3
64950|NCT01209767|253564|P1|Overall Study|Withdrawal by Subject|1
64951|NCT01209689|253633|P2|Overall Study|Sponsor's Decision to Stop the Study|17
64952|NCT01209689|253634|P1|Overall Study|Sponsor's Decision to Stop the Study|68
64953|NCT01209689|253633|P2|Overall Study|Failure to Return|0
64954|NCT01209689|253634|P1|Overall Study|Failure to Return|3
64955|NCT01209689|253633|P2|Overall Study|Violation of Selection Criteria at Entry|0
64956|NCT01209689|253634|P1|Overall Study|Violation of Selection Criteria at Entry|1
64957|NCT01209689|253633|P2|Overall Study|Adverse Event|0
64958|NCT01209689|253634|P1|Overall Study|Adverse Event|4
64959|NCT01209689|253633|P2|Overall Study|Refused Treatment|3
64960|NCT01209689|253634|P1|Overall Study|Refused Treatment|8
64961|NCT01209689|253633|P2|Overall Study|Insufficient Therapeutic Response|2
64962|NCT01209689|253634|P1|Overall Study|Insufficient Therapeutic Response|7
64963|NCT01209624|253640|P1|Overall Study|Unspecified|4
64964|NCT01209624|253640|P1|Overall Study|Lost to Follow-up|290
64965|NCT01209624|253640|P1|Overall Study|Lack of Efficacy|17
64966|NCT01209624|253640|P1|Overall Study|Adverse Event|13
64967|NCT01209624|253640|P1|Overall Study|Death|2
64968|NCT01209520|253671|P1|Overall Study|Withdrawal by Subject|3
64969|NCT01209286|253679|P3|Overall Study|Other|0
64970|NCT01209286|253680|P2|Overall Study|Other|1
64971|NCT01209286|253681|P1|Overall Study|Other|0
64972|NCT01209286|253679|P3|Overall Study|Physician Decision|0
64973|NCT01209286|253680|P2|Overall Study|Physician Decision|2
64974|NCT01209286|253681|P1|Overall Study|Physician Decision|0
64975|NCT01209286|253679|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
64976|NCT01209286|253680|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
64977|NCT01209286|253681|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
64978|NCT01209286|253679|P3|Overall Study|Hematological Relapse After Remission|1
64979|NCT01209286|253680|P2|Overall Study|Hematological Relapse After Remission|1
64980|NCT01209286|253681|P1|Overall Study|Hematological Relapse After Remission|0
64981|NCT01209286|253679|P3|Overall Study|Adverse Event|1
64982|NCT01209286|253680|P2|Overall Study|Adverse Event|3
64983|NCT01209286|253681|P1|Overall Study|Adverse Event|4
64984|NCT01209143|253790|P2|Overall Study|Disease progression|16
64985|NCT01209143|253791|P1|Overall Study|Disease progression|11
64986|NCT01209143|253790|P2|Overall Study|Withdrawal by Subject|1
64987|NCT01209143|253791|P1|Overall Study|Withdrawal by Subject|2
64988|NCT01209143|253790|P2|Overall Study|Lost to Follow-up|0
64989|NCT01209143|253791|P1|Overall Study|Lost to Follow-up|1
64990|NCT01209143|253790|P2|Overall Study|Physician Decision|1
64991|NCT01209143|253791|P1|Overall Study|Physician Decision|3
64992|NCT01209143|253790|P2|Overall Study|Death|1
64993|NCT01209143|253791|P1|Overall Study|Death|0
64994|NCT01209143|253790|P2|Overall Study|Adverse Event|1
64995|NCT01209143|253791|P1|Overall Study|Adverse Event|2
64996|NCT01208961|253799|P2|High-Fat Period III|Protocol Violation|0
64997|NCT01208961|253800|P1|High-Fat Period III|Protocol Violation|1
64998|NCT01208415|253809|P1|Overall Study|Still be eligible for follow-up|33
64999|NCT01208415|253809|P1|Overall Study|Device not placed|1
65000|NCT01208415|253809|P1|Overall Study|Withdrawal by Subject|3
65001|NCT01208415|253809|P1|Overall Study|Lost to Follow-up|2
65002|NCT01208415|253809|P1|Overall Study|Death|1
65003|NCT01208402|253815|P2|Overall Study|Withdrawal by Subject|0
65004|NCT01208402|253816|P1|Overall Study|Withdrawal by Subject|1
65005|NCT01208337|253832|P1|Overall Study|Death|3
65006|NCT01208233|253846|P6|Overall Study|Withdrawal by Subject|2
65007|NCT01208233|253847|P5|Overall Study|Withdrawal by Subject|4
65008|NCT01208233|253848|P4|Overall Study|Withdrawal by Subject|1
65009|NCT01208233|253849|P3|Overall Study|Withdrawal by Subject|1
65010|NCT01208233|253850|P2|Overall Study|Withdrawal by Subject|0
65011|NCT01208233|253851|P1|Overall Study|Withdrawal by Subject|1
65012|NCT01208233|253846|P6|Overall Study|Unspecified|1
65013|NCT01208233|253847|P5|Overall Study|Unspecified|0
65014|NCT01208233|253848|P4|Overall Study|Unspecified|0
65015|NCT01208233|253849|P3|Overall Study|Unspecified|0
65016|NCT01208233|253850|P2|Overall Study|Unspecified|1
65017|NCT01208233|253851|P1|Overall Study|Unspecified|2
65018|NCT01208233|253846|P6|Overall Study|Protocol Violation|0
65019|NCT01208233|253847|P5|Overall Study|Protocol Violation|3
65020|NCT01208233|253848|P4|Overall Study|Protocol Violation|0
65021|NCT01208233|253849|P3|Overall Study|Protocol Violation|0
65022|NCT01208233|253850|P2|Overall Study|Protocol Violation|0
65023|NCT01208233|253851|P1|Overall Study|Protocol Violation|0
65024|NCT01208233|253846|P6|Overall Study|Study terminated by sponsor|7
65025|NCT01208233|253847|P5|Overall Study|Study terminated by sponsor|10
65026|NCT01208233|253848|P4|Overall Study|Study terminated by sponsor|0
65027|NCT01208233|253849|P3|Overall Study|Study terminated by sponsor|0
65028|NCT01208233|253850|P2|Overall Study|Study terminated by sponsor|0
65029|NCT01208233|253851|P1|Overall Study|Study terminated by sponsor|0
65030|NCT01208233|253846|P6|Overall Study|Medication error without adverse event|1
65031|NCT01208233|253847|P5|Overall Study|Medication error without adverse event|0
65032|NCT01208233|253848|P4|Overall Study|Medication error without adverse event|0
65033|NCT01208233|253849|P3|Overall Study|Medication error without adverse event|0
65034|NCT01208233|253850|P2|Overall Study|Medication error without adverse event|0
65035|NCT01208233|253851|P1|Overall Study|Medication error without adverse event|0
65036|NCT01208233|253846|P6|Overall Study|Did not meet entrance criteria|0
65037|NCT01208233|253847|P5|Overall Study|Did not meet entrance criteria|1
65038|NCT01208233|253848|P4|Overall Study|Did not meet entrance criteria|0
65039|NCT01208233|253849|P3|Overall Study|Did not meet entrance criteria|1
65040|NCT01208233|253850|P2|Overall Study|Did not meet entrance criteria|1
65041|NCT01208233|253851|P1|Overall Study|Did not meet entrance criteria|2
65042|NCT01208233|253846|P6|Overall Study|Death|5
65043|NCT01208233|253847|P5|Overall Study|Death|3
65044|NCT01208233|253848|P4|Overall Study|Death|0
65045|NCT01208233|253849|P3|Overall Study|Death|0
65046|NCT01208233|253850|P2|Overall Study|Death|0
65047|NCT01208233|253851|P1|Overall Study|Death|0
65048|NCT01208233|253846|P6|Overall Study|Adverse Event|5
65049|NCT01208233|253847|P5|Overall Study|Adverse Event|3
65050|NCT01208233|253848|P4|Overall Study|Adverse Event|0
65051|NCT01208233|253849|P3|Overall Study|Adverse Event|2
65052|NCT01208233|253850|P2|Overall Study|Adverse Event|1
65053|NCT01208233|253851|P1|Overall Study|Adverse Event|0
65054|NCT01208207|253976|P7|Part II|Technical Problems|0
65055|NCT01208207|253977|P6|Part II|Technical Problems|1
65056|NCT01208207|253978|P5|Part II|Technical Problems|0
65057|NCT01208207|253979|P4|Part II|Technical Problems|1
65058|NCT01208207|253980|P3|Part II|Technical Problems|0
65059|NCT01208207|253981|P2|Part II|Technical Problems|0
65060|NCT01208207|253982|P1|Part II|Technical Problems|0
65061|NCT01208207|253976|P7|Part II|Protocol Violation|0
65062|NCT01208207|253977|P6|Part II|Protocol Violation|0
65063|NCT01208207|253978|P5|Part II|Protocol Violation|0
65064|NCT01208207|253979|P4|Part II|Protocol Violation|1
65065|NCT01208207|253980|P3|Part II|Protocol Violation|0
65066|NCT01208207|253981|P2|Part II|Protocol Violation|0
65067|NCT01208207|253982|P1|Part II|Protocol Violation|0
65068|NCT01208207|253976|P7|Part II|Physician Decision|0
65069|NCT01208207|253977|P6|Part II|Physician Decision|2
65070|NCT01208207|253978|P5|Part II|Physician Decision|0
65071|NCT01208207|253979|P4|Part II|Physician Decision|1
65072|NCT01208207|253980|P3|Part II|Physician Decision|0
65073|NCT01208207|253981|P2|Part II|Physician Decision|0
65074|NCT01208207|253982|P1|Part II|Physician Decision|0
65075|NCT01208207|253976|P7|Part II|Non-Compliance With Study Drug|0
65076|NCT01208207|253977|P6|Part II|Non-Compliance With Study Drug|1
65077|NCT01208207|253978|P5|Part II|Non-Compliance With Study Drug|1
65078|NCT01208207|253979|P4|Part II|Non-Compliance With Study Drug|4
65079|NCT01208207|253980|P3|Part II|Non-Compliance With Study Drug|0
65080|NCT01208207|253981|P2|Part II|Non-Compliance With Study Drug|0
65081|NCT01208207|253982|P1|Part II|Non-Compliance With Study Drug|0
65082|NCT01208207|253976|P7|Part II|Lost to Follow-up|1
65083|NCT01208207|253977|P6|Part II|Lost to Follow-up|2
65084|NCT01208207|253978|P5|Part II|Lost to Follow-up|0
65085|NCT01208207|253979|P4|Part II|Lost to Follow-up|4
65086|NCT01208207|253980|P3|Part II|Lost to Follow-up|0
65087|NCT01208207|253981|P2|Part II|Lost to Follow-up|0
65088|NCT01208207|253982|P1|Part II|Lost to Follow-up|0
65089|NCT01208207|253976|P7|Part II|Lack of Efficacy|3
65090|NCT01208207|253977|P6|Part II|Lack of Efficacy|3
65091|NCT01208207|253978|P5|Part II|Lack of Efficacy|4
65092|NCT01208207|253979|P4|Part II|Lack of Efficacy|6
65093|NCT01208207|253980|P3|Part II|Lack of Efficacy|0
65094|NCT01208207|253981|P2|Part II|Lack of Efficacy|0
65095|NCT01208207|253982|P1|Part II|Lack of Efficacy|0
65096|NCT01208207|253976|P7|Part II|Adverse Event|2
65097|NCT01208207|253977|P6|Part II|Adverse Event|4
65098|NCT01208207|253978|P5|Part II|Adverse Event|9
65099|NCT01208207|253979|P4|Part II|Adverse Event|5
65100|NCT01208207|253980|P3|Part II|Adverse Event|0
65101|NCT01208207|253981|P2|Part II|Adverse Event|0
65102|NCT01208207|253982|P1|Part II|Adverse Event|0
65103|NCT01208207|253976|P7|Part II|Withdrawal by Subject|5
65104|NCT01208207|253977|P6|Part II|Withdrawal by Subject|3
65105|NCT01208207|253978|P5|Part II|Withdrawal by Subject|9
65106|NCT01208207|253979|P4|Part II|Withdrawal by Subject|10
65107|NCT01208207|253980|P3|Part II|Withdrawal by Subject|0
65108|NCT01208207|253981|P2|Part II|Withdrawal by Subject|0
65109|NCT01208207|253982|P1|Part II|Withdrawal by Subject|0
65110|NCT01208207|253976|P7|Part I|Withdrawal by Subject|0
65111|NCT01208207|253977|P6|Part I|Withdrawal by Subject|0
65112|NCT01208207|253978|P5|Part I|Withdrawal by Subject|0
65113|NCT01208207|253979|P4|Part I|Withdrawal by Subject|0
65114|NCT01208207|253980|P3|Part I|Withdrawal by Subject|4
65115|NCT01208207|253981|P2|Part I|Withdrawal by Subject|4
65116|NCT01208207|253982|P1|Part I|Withdrawal by Subject|14
65117|NCT01208207|253976|P7|Part I|Protocol Violation|0
65118|NCT01208207|253977|P6|Part I|Protocol Violation|0
65119|NCT01208207|253978|P5|Part I|Protocol Violation|0
65120|NCT01208207|253979|P4|Part I|Protocol Violation|0
65121|NCT01208207|253980|P3|Part I|Protocol Violation|2
65122|NCT01208207|253981|P2|Part I|Protocol Violation|0
65123|NCT01208207|253982|P1|Part I|Protocol Violation|8
65124|NCT01208207|253976|P7|Part I|Progressive Disease|0
65125|NCT01208207|253977|P6|Part I|Progressive Disease|0
65126|NCT01208207|253978|P5|Part I|Progressive Disease|0
65127|NCT01208207|253979|P4|Part I|Progressive Disease|0
65128|NCT01208207|253980|P3|Part I|Progressive Disease|0
65129|NCT01208207|253981|P2|Part I|Progressive Disease|0
65130|NCT01208207|253982|P1|Part I|Progressive Disease|1
65131|NCT01208207|253976|P7|Part I|Physician Decision|0
65132|NCT01208207|253977|P6|Part I|Physician Decision|0
65133|NCT01208207|253978|P5|Part I|Physician Decision|0
65134|NCT01208207|253979|P4|Part I|Physician Decision|0
65135|NCT01208207|253980|P3|Part I|Physician Decision|0
65136|NCT01208207|253981|P2|Part I|Physician Decision|1
65137|NCT01208207|253982|P1|Part I|Physician Decision|0
65138|NCT01208207|253976|P7|Part I|Non-Compliance With Study Drug|0
65139|NCT01208207|253977|P6|Part I|Non-Compliance With Study Drug|0
65140|NCT01208207|253978|P5|Part I|Non-Compliance With Study Drug|0
65141|NCT01208207|253979|P4|Part I|Non-Compliance With Study Drug|0
65142|NCT01208207|253980|P3|Part I|Non-Compliance With Study Drug|1
65143|NCT01208207|253981|P2|Part I|Non-Compliance With Study Drug|0
65144|NCT01208207|253982|P1|Part I|Non-Compliance With Study Drug|1
65145|NCT01208207|253976|P7|Part I|Lost to Follow-up|0
65146|NCT01208207|253977|P6|Part I|Lost to Follow-up|0
65147|NCT01208207|253978|P5|Part I|Lost to Follow-up|0
65148|NCT01208207|253979|P4|Part I|Lost to Follow-up|0
65149|NCT01208207|253980|P3|Part I|Lost to Follow-up|0
65150|NCT01208207|253981|P2|Part I|Lost to Follow-up|1
65151|NCT01208207|253982|P1|Part I|Lost to Follow-up|6
65152|NCT01208207|253976|P7|Part I|Lack of Efficacy|0
65153|NCT01208207|253977|P6|Part I|Lack of Efficacy|0
65154|NCT01208207|253978|P5|Part I|Lack of Efficacy|0
65155|NCT01208207|253979|P4|Part I|Lack of Efficacy|0
65156|NCT01208207|253980|P3|Part I|Lack of Efficacy|2
65157|NCT01208207|253981|P2|Part I|Lack of Efficacy|3
65158|NCT01208207|253982|P1|Part I|Lack of Efficacy|21
65159|NCT01208207|253976|P7|Part I|Adverse Event|0
65160|NCT01208207|253977|P6|Part I|Adverse Event|0
65161|NCT01208207|253978|P5|Part I|Adverse Event|0
65162|NCT01208207|253979|P4|Part I|Adverse Event|0
65163|NCT01208207|253980|P3|Part I|Adverse Event|6
65164|NCT01208207|253981|P2|Part I|Adverse Event|2
65165|NCT01208207|253982|P1|Part I|Adverse Event|19
65166|NCT01208181|254009|P5|Part 2|Lack of Efficacy|0
65167|NCT01208181|254010|P4|Part 2|Lack of Efficacy|7
65168|NCT01208181|254011|P3|Part 2|Lack of Efficacy|5
65169|NCT01208181|254012|P2|Part 2|Lack of Efficacy|0
65170|NCT01208181|254013|P1|Part 2|Lack of Efficacy|0
65171|NCT01208181|254009|P5|Part 2|Lost to Follow-up|0
65172|NCT01208181|254010|P4|Part 2|Lost to Follow-up|2
65173|NCT01208181|254011|P3|Part 2|Lost to Follow-up|1
65174|NCT01208181|254012|P2|Part 2|Lost to Follow-up|0
65175|NCT01208181|254013|P1|Part 2|Lost to Follow-up|0
65176|NCT01208181|254009|P5|Part 2|Non-compliance with study drug|0
65177|NCT01208181|254010|P4|Part 2|Non-compliance with study drug|1
65178|NCT01208181|254011|P3|Part 2|Non-compliance with study drug|1
65179|NCT01208181|254012|P2|Part 2|Non-compliance with study drug|0
65180|NCT01208181|254013|P1|Part 2|Non-compliance with study drug|0
65181|NCT01208181|254009|P5|Part 2|Physician Decision|0
65182|NCT01208181|254010|P4|Part 2|Physician Decision|2
65183|NCT01208181|254011|P3|Part 2|Physician Decision|1
65184|NCT01208181|254012|P2|Part 2|Physician Decision|0
65185|NCT01208181|254013|P1|Part 2|Physician Decision|0
65186|NCT01208181|254009|P5|Part 2|Protocol Violation|0
65187|NCT01208181|254010|P4|Part 2|Protocol Violation|0
65188|NCT01208181|254011|P3|Part 2|Protocol Violation|1
65189|NCT01208181|254012|P2|Part 2|Protocol Violation|0
65190|NCT01208181|254013|P1|Part 2|Protocol Violation|0
65191|NCT01208181|254009|P5|Part 2|Withdrawal by Subject|0
65192|NCT01208181|254010|P4|Part 2|Withdrawal by Subject|1
65193|NCT01208181|254011|P3|Part 2|Withdrawal by Subject|1
65194|NCT01208181|254012|P2|Part 2|Withdrawal by Subject|0
65195|NCT01208181|254013|P1|Part 2|Withdrawal by Subject|0
65196|NCT01208181|254009|P5|Part 2|Adverse Event|0
65197|NCT01208181|254010|P4|Part 2|Adverse Event|7
65198|NCT01208181|254011|P3|Part 2|Adverse Event|6
65199|NCT01208181|254012|P2|Part 2|Adverse Event|0
65200|NCT01208181|254013|P1|Part 2|Adverse Event|0
65201|NCT01208181|254009|P5|Part 1|Adverse Event|4
65202|NCT01208181|254010|P4|Part 1|Adverse Event|0
65203|NCT01208181|254011|P3|Part 1|Adverse Event|0
65204|NCT01208181|254012|P2|Part 1|Adverse Event|24
65205|NCT01208181|254013|P1|Part 1|Adverse Event|26
65206|NCT01208181|254009|P5|Part 1|Lack of Efficacy|17
65207|NCT01208181|254010|P4|Part 1|Lack of Efficacy|0
65208|NCT01208181|254011|P3|Part 1|Lack of Efficacy|0
65209|NCT01208181|254012|P2|Part 1|Lack of Efficacy|12
65210|NCT01208181|254013|P1|Part 1|Lack of Efficacy|37
65211|NCT01208181|254009|P5|Part 1|Lost to Follow-up|1
65212|NCT01208181|254010|P4|Part 1|Lost to Follow-up|0
65213|NCT01208181|254011|P3|Part 1|Lost to Follow-up|0
65214|NCT01208181|254012|P2|Part 1|Lost to Follow-up|3
65215|NCT01208181|254013|P1|Part 1|Lost to Follow-up|5
65216|NCT01208181|254009|P5|Part 1|Non-compliance with study drug|0
65217|NCT01208181|254010|P4|Part 1|Non-compliance with study drug|0
65218|NCT01208181|254011|P3|Part 1|Non-compliance with study drug|0
65219|NCT01208181|254012|P2|Part 1|Non-compliance with study drug|1
65220|NCT01208181|254013|P1|Part 1|Non-compliance with study drug|1
65221|NCT01208181|254009|P5|Part 1|Physician Decision|0
65222|NCT01208181|254010|P4|Part 1|Physician Decision|0
65223|NCT01208181|254011|P3|Part 1|Physician Decision|0
65224|NCT01208181|254012|P2|Part 1|Physician Decision|0
65225|NCT01208181|254013|P1|Part 1|Physician Decision|4
65226|NCT01208181|254009|P5|Part 1|Protocol Violation|0
65227|NCT01208181|254010|P4|Part 1|Protocol Violation|0
65228|NCT01208181|254011|P3|Part 1|Protocol Violation|0
65229|NCT01208181|254012|P2|Part 1|Protocol Violation|5
65230|NCT01208181|254013|P1|Part 1|Protocol Violation|10
65231|NCT01208181|254009|P5|Part 1|Technical problem|0
65232|NCT01208181|254010|P4|Part 1|Technical problem|0
65233|NCT01208181|254011|P3|Part 1|Technical problem|0
65234|NCT01208181|254012|P2|Part 1|Technical problem|0
65235|NCT01208181|254013|P1|Part 1|Technical problem|5
65236|NCT01208181|254009|P5|Part 1|Withdrawal by Subject|0
65237|NCT01208181|254010|P4|Part 1|Withdrawal by Subject|0
65238|NCT01208181|254011|P3|Part 1|Withdrawal by Subject|0
65239|NCT01208181|254012|P2|Part 1|Withdrawal by Subject|10
65240|NCT01208181|254013|P1|Part 1|Withdrawal by Subject|11
65241|NCT01207687|254070|P1|Overall Study|Withdrawal by Subject|1
65242|NCT01207687|254070|P1|Overall Study|Adverse Event|1
65243|NCT01207596|254090|P1|Overall Study|Withdrawal by Subject|1
65244|NCT01207596|254090|P1|Overall Study|Adverse Event|3
65245|NCT01207596|254090|P1|Overall Study|Lack of Efficacy|1
65246|NCT01207596|254090|P1|Overall Study|Physician Decision|4
65247|NCT01207583|254103|P3|Overall Study|Lost to Follow-up|0
65248|NCT01207583|254104|P2|Overall Study|Lost to Follow-up|2
65249|NCT01207583|254105|P1|Overall Study|Lost to Follow-up|0
65250|NCT01207583|254103|P3|Overall Study|Participant failed to return|0
65251|NCT01207583|254104|P2|Overall Study|Participant failed to return|0
65252|NCT01207583|254105|P1|Overall Study|Participant failed to return|1
65253|NCT01207583|254103|P3|Overall Study|Withdrawal by Subject|1
65254|NCT01207583|254104|P2|Overall Study|Withdrawal by Subject|3
65255|NCT01207583|254105|P1|Overall Study|Withdrawal by Subject|0
65256|NCT01207492|254158|P1|Overall Study|Toxicity|1
65257|NCT01207492|254158|P1|Overall Study|Progressive disease|3
65258|NCT01207492|254158|P1|Overall Study|Physician Decision|1
65259|NCT01207492|254158|P1|Overall Study|Withdrawal by Subject|9
65260|NCT01207492|254158|P1|Overall Study|Still on study|1
65261|NCT01207453|254173|P2|2nd Intervention|Lost to Follow-up|0
65262|NCT01207453|254174|P1|2nd Intervention|Lost to Follow-up|1
65263|NCT01207453|254173|P2|2nd Intervention|Adverse Event|2
65264|NCT01207453|254174|P1|2nd Intervention|Adverse Event|1
65265|NCT01207453|254173|P2|Washout|Lost to Follow-up|0
65266|NCT01207453|254174|P1|Washout|Lost to Follow-up|1
65267|NCT01207453|254173|P2|Washout|Adverse Event|0
65268|NCT01207453|254174|P1|Washout|Adverse Event|1
65269|NCT01207453|254173|P2|First Intervention|Adverse Event|1
65270|NCT01207453|254174|P1|First Intervention|Adverse Event|2
65271|NCT01207427|254196|P3|Double-blind Treatment Period|Withdrawal by Subject|0
65272|NCT01207427|254197|P2|Double-blind Treatment Period|Withdrawal by Subject|0
65273|NCT01207427|254198|P1|Double-blind Treatment Period|Withdrawal by Subject|1
65274|NCT01207427|254196|P3|Double-blind Treatment Period|Protocol Violation|1
65275|NCT01207427|254197|P2|Double-blind Treatment Period|Protocol Violation|1
65276|NCT01207427|254198|P1|Double-blind Treatment Period|Protocol Violation|2
65277|NCT01207427|254196|P3|Double-blind Treatment Period|Lost to Follow-up|1
65278|NCT01207427|254197|P2|Double-blind Treatment Period|Lost to Follow-up|0
65279|NCT01207427|254198|P1|Double-blind Treatment Period|Lost to Follow-up|0
65280|NCT01207427|254196|P3|Double-blind Treatment Period|Adverse Event|0
65281|NCT01207427|254197|P2|Double-blind Treatment Period|Adverse Event|1
65282|NCT01207427|254198|P1|Double-blind Treatment Period|Adverse Event|0
65283|NCT01207414|254208|P2|Overall Study|Randomized in error|0
65284|NCT01207414|254209|P1|Overall Study|Randomized in error|1
65285|NCT01207414|254208|P2|Overall Study|Protocol deviation|9
65286|NCT01207414|254209|P1|Overall Study|Protocol deviation|12
65287|NCT01207414|254208|P2|Overall Study|Administrative problems|1
65288|NCT01207414|254209|P1|Overall Study|Administrative problems|1
65289|NCT01207414|254208|P2|Overall Study|Lost to Follow-up|17
65290|NCT01207414|254209|P1|Overall Study|Lost to Follow-up|15
65291|NCT01207414|254208|P2|Overall Study|Patient withdrew consent|11
65292|NCT01207414|254209|P1|Overall Study|Patient withdrew consent|14
65293|NCT01207414|254208|P2|Overall Study|Unsatisfactory therapeutic effect|4
65294|NCT01207414|254209|P1|Overall Study|Unsatisfactory therapeutic effect|5
65295|NCT01207414|254208|P2|Overall Study|Abnormal test procedure results|1
65296|NCT01207414|254209|P1|Overall Study|Abnormal test procedure results|0
65297|NCT01207414|254208|P2|Overall Study|Adverse Event|39
65298|NCT01207414|254209|P1|Overall Study|Adverse Event|25
65299|NCT01207388|254234|P1|Overall Study|Other|1
65300|NCT01207388|254234|P1|Overall Study|Physician Decision|2
65301|NCT01207388|254234|P1|Overall Study|Disease Relapse|10
65302|NCT01207388|254234|P1|Overall Study|Adverse Event|20
65303|NCT01207219|254257|P3|Overall Study|Lost to Follow-up|6
65304|NCT01207219|254258|P2|Overall Study|Lost to Follow-up|8
65305|NCT01207219|254259|P1|Overall Study|Lost to Follow-up|6
65306|NCT01207219|254257|P3|Overall Study|changed diagnosis during study period|1
65307|NCT01207219|254258|P2|Overall Study|changed diagnosis during study period|3
65308|NCT01207219|254259|P1|Overall Study|changed diagnosis during study period|5
65309|NCT01207102|254279|P1|Overall Study|Withdrawal by Treating Physician|1
65310|NCT01207102|254279|P1|Overall Study|progression|2
65311|NCT01207102|254279|P1|Overall Study|Adverse Event|2
65312|NCT01207102|254279|P1|Overall Study|Withdrawal by Subject|5
65313|NCT01206777|254292|P1|Overall Study|Adverse Event|1
65314|NCT01206777|254292|P1|Overall Study|Death|1
65315|NCT01206582|254348|P2|Overall Study|Discontinued intervention before week 8|2
65316|NCT01206582|254349|P1|Overall Study|Discontinued intervention before week 8|1
65317|NCT01206582|254348|P2|Overall Study|Withdrew prior to study|0
65318|NCT01206582|254349|P1|Overall Study|Withdrew prior to study|1
65319|NCT01206517|254381|P6|Overall Study|Withdrawal by Subject|0
65320|NCT01206517|254382|P5|Overall Study|Withdrawal by Subject|1
65321|NCT01206517|254383|P4|Overall Study|Withdrawal by Subject|0
65322|NCT01206517|254384|P3|Overall Study|Withdrawal by Subject|2
65323|NCT01206517|254385|P2|Overall Study|Withdrawal by Subject|0
65324|NCT01206517|254386|P1|Overall Study|Withdrawal by Subject|0
65325|NCT01206439|254443|P1|Overall Study|subject did not meet inclusion criteria|1
65326|NCT01206322|254466|P4|Overall Study|Adverse Event|1
65327|NCT01206322|254467|P3|Overall Study|Adverse Event|0
65328|NCT01206322|254468|P2|Overall Study|Adverse Event|0
65329|NCT01206322|254469|P1|Overall Study|Adverse Event|0
65330|NCT01206140|254485|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
65331|NCT01206140|254486|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
65332|NCT01206101|254498|P2|Overall Study|Unclassified|0
65333|NCT01206101|254499|P1|Overall Study|Unclassified|1
65334|NCT01206101|254498|P2|Overall Study|Physician Decision|1
65335|NCT01206101|254499|P1|Overall Study|Physician Decision|0
65336|NCT01206101|254498|P2|Overall Study|Adverse Event|0
65337|NCT01206101|254499|P1|Overall Study|Adverse Event|1
65338|NCT01205685|254515|P1|Overall Study|Withdrawal by Subject|1
65339|NCT01205685|254515|P1|Overall Study|Disease Progression|10
65340|NCT01205581|254532|P6|Overall Study|Withdrawal by Subject|0
65341|NCT01205581|254533|P5|Overall Study|Withdrawal by Subject|0
65342|NCT01205581|254534|P4|Overall Study|Withdrawal by Subject|0
65343|NCT01205581|254535|P3|Overall Study|Withdrawal by Subject|0
65344|NCT01205581|254536|P2|Overall Study|Withdrawal by Subject|0
65345|NCT01205581|254537|P1|Overall Study|Withdrawal by Subject|1
65346|NCT01205451|254620|P2|Overall Study|Withdrawal by Subject|9
65347|NCT01205451|254621|P1|Overall Study|Withdrawal by Subject|5
65348|NCT01205451|254620|P2|Overall Study|Lost to Follow-up|1
65349|NCT01205451|254621|P1|Overall Study|Lost to Follow-up|1
65350|NCT01205269|254669|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
65351|NCT01205269|254670|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
65352|NCT01205269|254671|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
65353|NCT01205269|254672|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
65354|NCT01205269|254673|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
65355|NCT01205269|254674|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
65356|NCT01205230|254714|P2|Overall Study|Physician Decision|0
65357|NCT01205230|254715|P1|Overall Study|Physician Decision|1
65358|NCT01205230|254714|P2|Overall Study|Adverse Event|0
65359|NCT01205230|254715|P1|Overall Study|Adverse Event|4
65360|NCT01205126|254760|P2|Maintenance Phase|Withdrawal by Subject|11
65361|NCT01205126|254761|P1|Maintenance Phase|Withdrawal by Subject|8
65362|NCT01205126|254760|P2|Maintenance Phase|Lost to Follow-up|5
65363|NCT01205126|254761|P1|Maintenance Phase|Lost to Follow-up|5
65364|NCT01205126|254760|P2|Maintenance Phase|Unspecified|8
65365|NCT01205126|254761|P1|Maintenance Phase|Unspecified|11
65366|NCT01205126|254760|P2|Maintenance Phase|Prohibited drugs used|0
65367|NCT01205126|254761|P1|Maintenance Phase|Prohibited drugs used|1
65368|NCT01205126|254760|P2|Maintenance Phase|More than the maximum dosage required|5
65369|NCT01205126|254761|P1|Maintenance Phase|More than the maximum dosage required|5
65370|NCT01205126|254760|P2|Maintenance Phase|Death|4
65371|NCT01205126|254761|P1|Maintenance Phase|Death|4
65372|NCT01205126|254760|P2|Maintenance Phase|Adverse Event|7
65373|NCT01205126|254761|P1|Maintenance Phase|Adverse Event|3
65374|NCT01205126|254760|P2|Between Titration & Maintenance Phase|Unspecified|4
65375|NCT01205126|254761|P1|Between Titration & Maintenance Phase|Unspecified|0
65376|NCT01205126|254760|P2|Titration Phase|Unspecified|6
65377|NCT01205126|254761|P1|Titration Phase|Unspecified|8
65378|NCT01205126|254760|P2|Titration Phase|More than maximum dosage required|3
65379|NCT01205126|254761|P1|Titration Phase|More than maximum dosage required|2
65380|NCT01205126|254760|P2|Titration Phase|No stable titration dose|0
65381|NCT01205126|254761|P1|Titration Phase|No stable titration dose|1
65382|NCT01205126|254760|P2|Titration Phase|Lost to Follow-up|2
65383|NCT01205126|254761|P1|Titration Phase|Lost to Follow-up|2
65384|NCT01205126|254760|P2|Titration Phase|Withdrawal by Subject|5
65385|NCT01205126|254761|P1|Titration Phase|Withdrawal by Subject|5
65386|NCT01205126|254760|P2|Titration Phase|Adverse Event|3
65387|NCT01205126|254761|P1|Titration Phase|Adverse Event|5
65388|NCT01205035|254779|P2|Overall Study|Physician Decision|0
65389|NCT01205035|254780|P1|Overall Study|Physician Decision|1
65390|NCT01205035|254779|P2|Overall Study|Withdrawal by Subject|0
65391|NCT01205035|254780|P1|Overall Study|Withdrawal by Subject|1
65392|NCT01204775|254815|P2|Overall Study|Withdrawal by Subject|0
65393|NCT01204775|254816|P1|Overall Study|Withdrawal by Subject|1
65394|NCT01204775|254815|P2|Overall Study|Poor/non-compliance|1
65395|NCT01204775|254816|P1|Overall Study|Poor/non-compliance|0
65396|NCT01204697|254841|P2|Overall Study|Randomized, but not treated|1
65397|NCT01204697|254842|P1|Overall Study|Randomized, but not treated|0
65398|NCT01204697|254841|P2|Overall Study|Withdrawal by Subject|4
65399|NCT01204697|254842|P1|Overall Study|Withdrawal by Subject|2
65400|NCT01204697|254841|P2|Overall Study|Lost to Follow-up|4
65401|NCT01204697|254842|P1|Overall Study|Lost to Follow-up|3
65402|NCT01204697|254841|P2|Overall Study|Death|27
65403|NCT01204697|254842|P1|Overall Study|Death|26
65404|NCT01204671|254863|P5|Overall Study|Physician Decision|0
65405|NCT01204671|254864|P4|Overall Study|Physician Decision|1
65406|NCT01204671|254865|P3|Overall Study|Physician Decision|0
65407|NCT01204671|254866|P2|Overall Study|Physician Decision|0
65408|NCT01204671|254867|P1|Overall Study|Physician Decision|0
65409|NCT01204671|254863|P5|Overall Study|Unknown Completion Status|0
65410|NCT01204671|254864|P4|Overall Study|Unknown Completion Status|0
65411|NCT01204671|254865|P3|Overall Study|Unknown Completion Status|0
65412|NCT01204671|254866|P2|Overall Study|Unknown Completion Status|1
65413|NCT01204671|254867|P1|Overall Study|Unknown Completion Status|1
65414|NCT01204671|254863|P5|Overall Study|Lost to Follow-up|0
65415|NCT01204671|254864|P4|Overall Study|Lost to Follow-up|4
65416|NCT01204671|254865|P3|Overall Study|Lost to Follow-up|6
65417|NCT01204671|254866|P2|Overall Study|Lost to Follow-up|8
65418|NCT01204671|254867|P1|Overall Study|Lost to Follow-up|7
65419|NCT01204671|254863|P5|Overall Study|Withdrawal by Subject|3
65420|NCT01204671|254864|P4|Overall Study|Withdrawal by Subject|5
65421|NCT01204671|254865|P3|Overall Study|Withdrawal by Subject|4
65422|NCT01204671|254866|P2|Overall Study|Withdrawal by Subject|3
65423|NCT01204671|254867|P1|Overall Study|Withdrawal by Subject|2
65424|NCT01204671|254863|P5|Overall Study|Adverse Event|1
65425|NCT01204671|254864|P4|Overall Study|Adverse Event|3
65426|NCT01204671|254865|P3|Overall Study|Adverse Event|3
65427|NCT01204671|254866|P2|Overall Study|Adverse Event|3
65428|NCT01204671|254867|P1|Overall Study|Adverse Event|4
65429|NCT01204658|254929|P4|Primary Phase|Adverse Event|0
65430|NCT01204658|254930|P3|Primary Phase|Adverse Event|1
65431|NCT01204658|254931|P2|Primary Phase|Adverse Event|0
65432|NCT01204658|254932|P1|Primary Phase|Adverse Event|0
65433|NCT01204398|255042|P1|Overall Study|Adverse Event|1
65434|NCT01204294|255059|P7|Overall Study|Other (house moving)|0
65435|NCT01204294|255060|P6|Overall Study|Other (house moving)|0
65436|NCT01204294|255061|P5|Overall Study|Other (house moving)|0
65437|NCT01204294|255062|P4|Overall Study|Other (house moving)|0
65438|NCT01204294|255063|P3|Overall Study|Other (house moving)|1
65439|NCT01204294|255064|P2|Overall Study|Other (house moving)|0
65440|NCT01204294|255065|P1|Overall Study|Other (house moving)|0
65441|NCT01204294|255059|P7|Overall Study|Lack of Efficacy|0
65442|NCT01204294|255060|P6|Overall Study|Lack of Efficacy|0
65443|NCT01204294|255061|P5|Overall Study|Lack of Efficacy|0
65444|NCT01204294|255062|P4|Overall Study|Lack of Efficacy|2
65445|NCT01204294|255063|P3|Overall Study|Lack of Efficacy|0
65446|NCT01204294|255064|P2|Overall Study|Lack of Efficacy|0
65447|NCT01204294|255065|P1|Overall Study|Lack of Efficacy|0
65448|NCT01204294|255059|P7|Overall Study|Withdrawal by Subject|2
65449|NCT01204294|255060|P6|Overall Study|Withdrawal by Subject|1
65450|NCT01204294|255061|P5|Overall Study|Withdrawal by Subject|1
65451|NCT01204294|255062|P4|Overall Study|Withdrawal by Subject|1
65452|NCT01204294|255063|P3|Overall Study|Withdrawal by Subject|2
65453|NCT01204294|255064|P2|Overall Study|Withdrawal by Subject|2
65454|NCT01204294|255065|P1|Overall Study|Withdrawal by Subject|0
65455|NCT01204294|255059|P7|Overall Study|Protocol Violation|0
65456|NCT01204294|255060|P6|Overall Study|Protocol Violation|0
65457|NCT01204294|255061|P5|Overall Study|Protocol Violation|0
65458|NCT01204294|255062|P4|Overall Study|Protocol Violation|1
65459|NCT01204294|255063|P3|Overall Study|Protocol Violation|2
65460|NCT01204294|255064|P2|Overall Study|Protocol Violation|0
65461|NCT01204294|255065|P1|Overall Study|Protocol Violation|1
65462|NCT01204294|255059|P7|Overall Study|Adverse Event|0
65463|NCT01204294|255060|P6|Overall Study|Adverse Event|4
65464|NCT01204294|255061|P5|Overall Study|Adverse Event|1
65465|NCT01204294|255062|P4|Overall Study|Adverse Event|7
65466|NCT01204294|255063|P3|Overall Study|Adverse Event|0
65467|NCT01204294|255064|P2|Overall Study|Adverse Event|6
65468|NCT01204294|255065|P1|Overall Study|Adverse Event|2
65469|NCT01203956|255098|P2|Second Two-week Period|Non-compliant: no evaluable results|6
65470|NCT01203956|255099|P1|Second Two-week Period|Non-compliant: no evaluable results|5
65471|NCT01203930|255108|P2|Overall Study|Adverse Event|5
65472|NCT01203930|255109|P1|Overall Study|Adverse Event|17
65473|NCT01203930|255108|P2|Overall Study|Poor tolerance of study drug|1
65474|NCT01203930|255109|P1|Overall Study|Poor tolerance of study drug|0
65475|NCT01203930|255108|P2|Overall Study|Study Terminated by Sponsor|12
65476|NCT01203930|255109|P1|Overall Study|Study Terminated by Sponsor|0
65477|NCT01203930|255108|P2|Overall Study|Investigator Request|8
65478|NCT01203930|255109|P1|Overall Study|Investigator Request|0
65479|NCT01203930|255108|P2|Overall Study|Withdrew Consent|10
65480|NCT01203930|255109|P1|Overall Study|Withdrew Consent|1
65481|NCT01203930|255108|P2|Overall Study|Death|1
65482|NCT01203930|255109|P1|Overall Study|Death|3
65483|NCT01203930|255108|P2|Overall Study|Disease Progression|4
65484|NCT01203930|255109|P1|Overall Study|Disease Progression|0
65485|NCT01203917|255131|P1|Overall Study|Due to EGFR M+I patient|1
65486|NCT01203917|255131|P1|Overall Study|Due to objective disease progression|1
65487|NCT01203917|255131|P1|Overall Study|Withdrawal by Subject|3
65488|NCT01203917|255131|P1|Overall Study|Lost to Follow-up|2
65489|NCT01203917|255131|P1|Overall Study|Death|29
65490|NCT01203878|255144|P3|Overall Study|Adverse Event|2
65491|NCT01203878|255145|P2|Overall Study|Adverse Event|0
65492|NCT01203878|255146|P1|Overall Study|Adverse Event|0
65493|NCT01203878|255144|P3|Overall Study|Withdrawal by Subject|1
65494|NCT01203878|255145|P2|Overall Study|Withdrawal by Subject|0
65495|NCT01203878|255146|P1|Overall Study|Withdrawal by Subject|0
65496|NCT01203852|255157|P1|Washout 2 Weeks|Physician Decision|46
65497|NCT01203852|255157|P1|Metoprolol 8 Weeks|Physician Decision|470
65498|NCT01203787|255175|P2|Overall Study|Adverse Event|15
65499|NCT01203787|255176|P1|Overall Study|Adverse Event|11
65500|NCT01203787|255175|P2|Overall Study|Lost to Follow-up|0
65501|NCT01203787|255176|P1|Overall Study|Lost to Follow-up|2
65502|NCT01203787|255175|P2|Overall Study|Withdrawal by Subject|2
65503|NCT01203787|255176|P1|Overall Study|Withdrawal by Subject|6
65504|NCT01203787|255175|P2|Overall Study|Death|10
65505|NCT01203787|255176|P1|Overall Study|Death|12
65506|NCT01203098|255228|P3|Overall Study|Withdrawal by Subject|3
65507|NCT01203098|255229|P2|Overall Study|Withdrawal by Subject|1
65508|NCT01203098|255230|P1|Overall Study|Withdrawal by Subject|1
65509|NCT01203098|255228|P3|Overall Study|Physician Decision|0
65510|NCT01203098|255229|P2|Overall Study|Physician Decision|2
65511|NCT01203098|255230|P1|Overall Study|Physician Decision|2
65512|NCT01203098|255228|P3|Overall Study|Lost to Follow-up|1
65513|NCT01203098|255229|P2|Overall Study|Lost to Follow-up|0
65514|NCT01203098|255230|P1|Overall Study|Lost to Follow-up|0
65515|NCT01203098|255228|P3|Overall Study|Adverse Event|7
65516|NCT01203098|255229|P2|Overall Study|Adverse Event|1
65517|NCT01203098|255230|P1|Overall Study|Adverse Event|3
65518|NCT01203072|255246|P5|Overall Study|Withdrawal by Subject|3
65519|NCT01203072|255247|P4|Overall Study|Withdrawal by Subject|2
65520|NCT01203072|255248|P3|Overall Study|Withdrawal by Subject|1
65521|NCT01203072|255249|P2|Overall Study|Withdrawal by Subject|2
65522|NCT01203072|255250|P1|Overall Study|Withdrawal by Subject|2
65523|NCT01203072|255246|P5|Overall Study|Protocol Violation|1
65524|NCT01203072|255247|P4|Overall Study|Protocol Violation|0
65525|NCT01203072|255248|P3|Overall Study|Protocol Violation|0
65526|NCT01203072|255249|P2|Overall Study|Protocol Violation|0
65527|NCT01203072|255250|P1|Overall Study|Protocol Violation|2
65528|NCT01203072|255246|P5|Overall Study|Lost to Follow-up|0
65529|NCT01203072|255247|P4|Overall Study|Lost to Follow-up|0
65530|NCT01203072|255248|P3|Overall Study|Lost to Follow-up|0
65531|NCT01203072|255249|P2|Overall Study|Lost to Follow-up|1
65532|NCT01203072|255250|P1|Overall Study|Lost to Follow-up|0
65533|NCT01203072|255246|P5|Overall Study|Lack of Efficacy|0
65534|NCT01203072|255247|P4|Overall Study|Lack of Efficacy|0
65535|NCT01203072|255248|P3|Overall Study|Lack of Efficacy|0
65536|NCT01203072|255249|P2|Overall Study|Lack of Efficacy|0
65537|NCT01203072|255250|P1|Overall Study|Lack of Efficacy|1
65538|NCT01203072|255246|P5|Overall Study|Adverse Event|2
65539|NCT01203072|255247|P4|Overall Study|Adverse Event|4
65540|NCT01203072|255248|P3|Overall Study|Adverse Event|2
65541|NCT01203072|255249|P2|Overall Study|Adverse Event|3
65542|NCT01203072|255250|P1|Overall Study|Adverse Event|5
65543|NCT01202955|255280|P2|Period 1: 10 Days|Withdrawal by Subject|2
65544|NCT01202955|255281|P1|Period 1: 10 Days|Withdrawal by Subject|0
65545|NCT01202903|255293|P2|Overall Study|Withdrawal by Subject|4
65546|NCT01202903|255294|P1|Overall Study|Withdrawal by Subject|4
65547|NCT01202903|255293|P2|Overall Study|Adverse Event|3
65548|NCT01202903|255294|P1|Overall Study|Adverse Event|3
65549|NCT01202903|255293|P2|Overall Study|Lack of Efficacy|3
65550|NCT01202903|255294|P1|Overall Study|Lack of Efficacy|1
65551|NCT01202903|255293|P2|Overall Study|Lost to Follow-up|1
65552|NCT01202903|255294|P1|Overall Study|Lost to Follow-up|1
65553|NCT01202903|255293|P2|Overall Study|Death|0
65554|NCT01202903|255294|P1|Overall Study|Death|1
65555|NCT01202903|255293|P2|Overall Study|Protocol Violation|1
65556|NCT01202903|255294|P1|Overall Study|Protocol Violation|0
65557|NCT01202903|255293|P2|Overall Study|Administrative Probelms|4
65558|NCT01202903|255294|P1|Overall Study|Administrative Probelms|1
65559|NCT01202877|255321|P3|Overall Study|Death|1
65560|NCT01202877|255322|P2|Overall Study|Death|0
65561|NCT01202877|255323|P1|Overall Study|Death|0
65562|NCT01202877|255321|P3|Overall Study|Withdrawal by Subject|1
65563|NCT01202877|255322|P2|Overall Study|Withdrawal by Subject|0
65564|NCT01202877|255323|P1|Overall Study|Withdrawal by Subject|0
65565|NCT01202877|255321|P3|Overall Study|Adverse Event|2
65566|NCT01202877|255322|P2|Overall Study|Adverse Event|0
65567|NCT01202877|255323|P1|Overall Study|Adverse Event|0
65568|NCT01202877|255321|P3|Overall Study|Disease Progression|2
65569|NCT01202877|255322|P2|Overall Study|Disease Progression|1
65570|NCT01202877|255323|P1|Overall Study|Disease Progression|0
65571|NCT01202747|255332|P1|Overall Study|Withdrawal by Subject|1
65572|NCT01202591|255364|P6|Overall Study|Objective Disease Progression|0
65573|NCT01202591|255365|P5|Overall Study|Objective Disease Progression|2
65574|NCT01202591|255366|P4|Overall Study|Objective Disease Progression|0
65575|NCT01202591|255367|P3|Overall Study|Objective Disease Progression|0
65576|NCT01202591|255368|P2|Overall Study|Objective Disease Progression|0
65577|NCT01202591|255369|P1|Overall Study|Objective Disease Progression|0
65578|NCT01202591|255364|P6|Overall Study|Withdrawal by Subject|1
65579|NCT01202591|255365|P5|Overall Study|Withdrawal by Subject|2
65580|NCT01202591|255366|P4|Overall Study|Withdrawal by Subject|0
65581|NCT01202591|255367|P3|Overall Study|Withdrawal by Subject|0
65582|NCT01202591|255368|P2|Overall Study|Withdrawal by Subject|0
65583|NCT01202591|255369|P1|Overall Study|Withdrawal by Subject|0
65584|NCT01202591|255364|P6|Overall Study|Other reason as per investigator|3
65585|NCT01202591|255365|P5|Overall Study|Other reason as per investigator|1
65586|NCT01202591|255366|P4|Overall Study|Other reason as per investigator|3
65587|NCT01202591|255367|P3|Overall Study|Other reason as per investigator|7
65588|NCT01202591|255368|P2|Overall Study|Other reason as per investigator|4
65589|NCT01202591|255369|P1|Overall Study|Other reason as per investigator|3
65590|NCT01202591|255364|P6|Overall Study|Adverse Event|0
65591|NCT01202591|255365|P5|Overall Study|Adverse Event|0
65592|NCT01202591|255366|P4|Overall Study|Adverse Event|4
65593|NCT01202591|255367|P3|Overall Study|Adverse Event|4
65594|NCT01202591|255368|P2|Overall Study|Adverse Event|1
65595|NCT01202591|255369|P1|Overall Study|Adverse Event|2
65596|NCT01202279|255415|P2|Overall Study|study compliance|2
65597|NCT01202279|255416|P1|Overall Study|study compliance|5
65598|NCT01202279|255415|P2|Overall Study|Protocol Violation|1
65599|NCT01202279|255416|P1|Overall Study|Protocol Violation|1
65600|NCT01202279|255415|P2|Overall Study|Lost to Follow-up|7
65601|NCT01202279|255416|P1|Overall Study|Lost to Follow-up|10
65602|NCT01202279|255415|P2|Overall Study|Physician Decision|1
65603|NCT01202279|255416|P1|Overall Study|Physician Decision|0
65604|NCT01202279|255415|P2|Overall Study|Withdrawal by Subject|10
65605|NCT01202279|255416|P1|Overall Study|Withdrawal by Subject|13
65606|NCT01202279|255415|P2|Overall Study|Adverse Event|6
65607|NCT01202279|255416|P1|Overall Study|Adverse Event|8
65608|NCT01202227|255468|P1|Overall Study|Lack of Efficacy|1
65609|NCT01202227|255468|P1|Overall Study|Withdrawal by Subject|2
65610|NCT01202227|255468|P1|Overall Study|Adverse Event|16
65611|NCT01202188|255492|P5|Overall Study|Abnormal test procedure result (s)|0
65612|NCT01202188|255493|P4|Overall Study|Abnormal test procedure result (s)|0
65613|NCT01202188|255494|P3|Overall Study|Abnormal test procedure result (s)|2
65614|NCT01202188|255495|P2|Overall Study|Abnormal test procedure result (s)|0
65615|NCT01202188|255496|P1|Overall Study|Abnormal test procedure result (s)|0
65616|NCT01202188|255492|P5|Overall Study|Death|0
65617|NCT01202188|255493|P4|Overall Study|Death|1
65618|NCT01202188|255494|P3|Overall Study|Death|1
65619|NCT01202188|255495|P2|Overall Study|Death|1
65620|NCT01202188|255496|P1|Overall Study|Death|1
65621|NCT01202188|255492|P5|Overall Study|Lost to Follow-up|1
65622|NCT01202188|255493|P4|Overall Study|Lost to Follow-up|4
65623|NCT01202188|255494|P3|Overall Study|Lost to Follow-up|0
65624|NCT01202188|255495|P2|Overall Study|Lost to Follow-up|1
65625|NCT01202188|255496|P1|Overall Study|Lost to Follow-up|1
65626|NCT01202188|255492|P5|Overall Study|Unsatisfactory therapeutic effect|8
65627|NCT01202188|255493|P4|Overall Study|Unsatisfactory therapeutic effect|5
65628|NCT01202188|255494|P3|Overall Study|Unsatisfactory therapeutic effect|2
65629|NCT01202188|255495|P2|Overall Study|Unsatisfactory therapeutic effect|8
65630|NCT01202188|255496|P1|Overall Study|Unsatisfactory therapeutic effect|2
65631|NCT01202188|255492|P5|Overall Study|Administrative problems|2
65632|NCT01202188|255493|P4|Overall Study|Administrative problems|1
65633|NCT01202188|255494|P3|Overall Study|Administrative problems|1
65634|NCT01202188|255495|P2|Overall Study|Administrative problems|2
65635|NCT01202188|255496|P1|Overall Study|Administrative problems|3
65636|NCT01202188|255492|P5|Overall Study|Adverse Event|10
65637|NCT01202188|255493|P4|Overall Study|Adverse Event|10
65638|NCT01202188|255494|P3|Overall Study|Adverse Event|13
65639|NCT01202188|255495|P2|Overall Study|Adverse Event|23
65640|NCT01202188|255496|P1|Overall Study|Adverse Event|5
65641|NCT01202188|255492|P5|Overall Study|Subject withdrew consent|13
65642|NCT01202188|255493|P4|Overall Study|Subject withdrew consent|11
65643|NCT01202188|255494|P3|Overall Study|Subject withdrew consent|22
65644|NCT01202188|255495|P2|Overall Study|Subject withdrew consent|13
65645|NCT01202188|255496|P1|Overall Study|Subject withdrew consent|12
65646|NCT01202188|255492|P5|Overall Study|Protocol deviation|11
65647|NCT01202188|255493|P4|Overall Study|Protocol deviation|10
65648|NCT01202188|255494|P3|Overall Study|Protocol deviation|12
65649|NCT01202188|255495|P2|Overall Study|Protocol deviation|8
65650|NCT01202188|255496|P1|Overall Study|Protocol deviation|14
65651|NCT01201967|255643|P2|Overall Study|Lost to Follow-up|5
65652|NCT01201967|255644|P1|Overall Study|Lost to Follow-up|6
65653|NCT01201915|255669|P3|Overall Study|Target Lesion Progression|0
65654|NCT01201915|255670|P2|Overall Study|Target Lesion Progression|3
65655|NCT01201915|255671|P1|Overall Study|Target Lesion Progression|0
65656|NCT01201915|255669|P3|Overall Study|Subject Decision|5
65657|NCT01201915|255670|P2|Overall Study|Subject Decision|3
65658|NCT01201915|255671|P1|Overall Study|Subject Decision|3
65659|NCT01201915|255669|P3|Overall Study|Physician Decision|0
65660|NCT01201915|255670|P2|Overall Study|Physician Decision|0
65661|NCT01201915|255671|P1|Overall Study|Physician Decision|3
65662|NCT01201915|255669|P3|Overall Study|Lost to Follow-up|0
65663|NCT01201915|255670|P2|Overall Study|Lost to Follow-up|4
65664|NCT01201915|255671|P1|Overall Study|Lost to Follow-up|0
65665|NCT01201915|255669|P3|Overall Study|Adverse Event|1
65666|NCT01201915|255670|P2|Overall Study|Adverse Event|1
65667|NCT01201915|255671|P1|Overall Study|Adverse Event|2
65668|NCT01201811|255682|P1|Overall Study|Physician Decision|1
65669|NCT01201811|255682|P1|Overall Study|Treatment Failure|2
65670|NCT01201811|255682|P1|Overall Study|Death|4
65671|NCT01201811|255682|P1|Overall Study|Withdrawal by Subject|3
65672|NCT01201811|255682|P1|Overall Study|Disease progression|3
65673|NCT01201811|255682|P1|Overall Study|Adverse Event|6
65674|NCT01201798|255704|P2|Overall Study|Treatment Failure|8
65675|NCT01201798|255705|P1|Overall Study|Treatment Failure|1
65676|NCT01201798|255704|P2|Overall Study|Protocol Violation|1
65677|NCT01201798|255705|P1|Overall Study|Protocol Violation|1
65678|NCT01201798|255704|P2|Overall Study|Noncompliance|0
65679|NCT01201798|255705|P1|Overall Study|Noncompliance|1
65680|NCT01201798|255704|P2|Overall Study|Decision Unrelated to an Adverse Event|1
65681|NCT01201798|255705|P1|Overall Study|Decision Unrelated to an Adverse Event|1
65682|NCT01201798|255704|P2|Overall Study|Lost to Follow-up|5
65683|NCT01201798|255705|P1|Overall Study|Lost to Follow-up|3
65684|NCT01201798|255704|P2|Overall Study|Adverse Event|0
65685|NCT01201798|255705|P1|Overall Study|Adverse Event|2
65686|NCT01201785|255729|P1|Overall Study|Lost to Follow-up|16
65687|NCT01201759|255746|P2|Visit 4 Crossover|Lost to Follow-up|1
65688|NCT01201759|255747|P1|Visit 4 Crossover|Lost to Follow-up|0
65689|NCT01201759|255746|P2|Visit 3 - Washout|Lost to Follow-up|0
65690|NCT01201759|255747|P1|Visit 3 - Washout|Lost to Follow-up|1
65691|NCT01201759|255746|P2|Visit 3 - Washout|Adverse Event|3
65692|NCT01201759|255747|P1|Visit 3 - Washout|Adverse Event|0
65693|NCT01201759|255746|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
65694|NCT01201759|255747|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
65695|NCT01201343|255776|P1|Overall Study|Randomized, not treated|3
65696|NCT01201343|255776|P1|Overall Study|Participant wrongly included in trial|1
65697|NCT01201343|255776|P1|Overall Study|Lack of Efficacy|2
65698|NCT01201343|255776|P1|Overall Study|Lost to Follow-up|2
65699|NCT01201343|255776|P1|Overall Study|Withdrawal by Subject|5
65700|NCT01201343|255776|P1|Overall Study|Adverse Event|6
65701|NCT01201317|255790|P3|Overall Study|Safety, possible history of tuberculosis|1
65702|NCT01201317|255791|P2|Overall Study|Safety, possible history of tuberculosis|0
65703|NCT01201317|255792|P1|Overall Study|Safety, possible history of tuberculosis|0
65704|NCT01201317|255790|P3|Overall Study|Lack of Efficacy|0
65705|NCT01201317|255791|P2|Overall Study|Lack of Efficacy|0
65706|NCT01201317|255792|P1|Overall Study|Lack of Efficacy|1
65707|NCT01201317|255790|P3|Overall Study|Decrease in renal function|0
65708|NCT01201317|255791|P2|Overall Study|Decrease in renal function|1
65709|NCT01201317|255792|P1|Overall Study|Decrease in renal function|0
65710|NCT01201317|255790|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
65711|NCT01201317|255791|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
65712|NCT01201317|255792|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
65713|NCT01201317|255790|P3|Overall Study|Study-specific withdrawal criteria|1
65714|NCT01201317|255791|P2|Overall Study|Study-specific withdrawal criteria|0
65715|NCT01201317|255792|P1|Overall Study|Study-specific withdrawal criteria|0
65716|NCT01201317|255790|P3|Overall Study|Death|0
65717|NCT01201317|255791|P2|Overall Study|Death|1
65718|NCT01201317|255792|P1|Overall Study|Death|0
65719|NCT01201317|255790|P3|Overall Study|Protocol Violation|1
65720|NCT01201317|255791|P2|Overall Study|Protocol Violation|1
65721|NCT01201317|255792|P1|Overall Study|Protocol Violation|0
65722|NCT01201317|255790|P3|Overall Study|Screen failure|0
65723|NCT01201317|255791|P2|Overall Study|Screen failure|1
65724|NCT01201317|255792|P1|Overall Study|Screen failure|1
65725|NCT01201317|255790|P3|Overall Study|Adverse Event|2
65726|NCT01201317|255791|P2|Overall Study|Adverse Event|2
65727|NCT01201317|255792|P1|Overall Study|Adverse Event|2
65728|NCT01201317|255790|P3|Overall Study|Withdrawal by Subject|3
65729|NCT01201317|255791|P2|Overall Study|Withdrawal by Subject|0
65730|NCT01201317|255792|P1|Overall Study|Withdrawal by Subject|5
65731|NCT01201265|255812|P1|Overall Study|Disease Progression|4
65732|NCT01201265|255812|P1|Overall Study|Withdrawal by Subject|7
65733|NCT01201265|255812|P1|Overall Study|Lost to Follow-up|10
65734|NCT01201265|255812|P1|Overall Study|Insufficient Therapeutic Response|3
65735|NCT01201265|255812|P1|Overall Study|Death|14
65736|NCT01200992|255826|P2|Overall Study|Randomized but not treated|0
65737|NCT01200992|255827|P1|Overall Study|Randomized but not treated|2
65738|NCT01200992|255826|P2|Overall Study|Study terminated early|41
65739|NCT01200992|255827|P1|Overall Study|Study terminated early|35
65740|NCT01200810|255841|P2|Overall Study|Sponsor stopped making study drug|3
65741|NCT01200810|255842|P1|Overall Study|Sponsor stopped making study drug|3
65742|NCT01200810|255841|P2|Overall Study|Withdrawal by Subject|2
65743|NCT01200810|255842|P1|Overall Study|Withdrawal by Subject|1
65744|NCT01200810|255841|P2|Overall Study|Physician Decision|0
65745|NCT01200810|255842|P1|Overall Study|Physician Decision|1
65746|NCT01200797|255860|P1|Overall Study|Disease Progression|13
65747|NCT01200797|255860|P1|Overall Study|Adverse Event|4
65748|NCT01200797|255860|P1|Overall Study|symptomatic deterioration|2
65749|NCT01200758|255870|P4|Stage 2|Death|5
65750|NCT01200758|255871|P3|Stage 2|Death|3
65751|NCT01200758|255872|P2|Stage 2|Death|0
65752|NCT01200758|255873|P1|Stage 2|Death|0
65753|NCT01200758|255870|P4|Stage 2|Protocol Violation|4
65754|NCT01200758|255871|P3|Stage 2|Protocol Violation|1
65755|NCT01200758|255872|P2|Stage 2|Protocol Violation|0
65756|NCT01200758|255873|P1|Stage 2|Protocol Violation|0
65757|NCT01200758|255870|P4|Stage 2|Lost to Follow-up|1
65758|NCT01200758|255871|P3|Stage 2|Lost to Follow-up|3
65759|NCT01200758|255872|P2|Stage 2|Lost to Follow-up|0
65760|NCT01200758|255873|P1|Stage 2|Lost to Follow-up|0
65761|NCT01200758|255870|P4|Stage 2|Withdrawal by Subject|1
65762|NCT01200758|255871|P3|Stage 2|Withdrawal by Subject|4
65763|NCT01200758|255872|P2|Stage 2|Withdrawal by Subject|0
65764|NCT01200758|255873|P1|Stage 2|Withdrawal by Subject|0
65765|NCT01200758|255870|P4|Stage 2|Adverse Event|9
65766|NCT01200758|255871|P3|Stage 2|Adverse Event|5
65767|NCT01200758|255872|P2|Stage 2|Adverse Event|0
65768|NCT01200758|255873|P1|Stage 2|Adverse Event|0
65769|NCT01200758|255870|P4|Stage 2|Physician Decision|7
65770|NCT01200758|255871|P3|Stage 2|Physician Decision|5
65771|NCT01200758|255872|P2|Stage 2|Physician Decision|0
65772|NCT01200758|255873|P1|Stage 2|Physician Decision|0
65773|NCT01200758|255870|P4|Stage 2|Lack of Efficacy|2
65774|NCT01200758|255871|P3|Stage 2|Lack of Efficacy|4
65775|NCT01200758|255872|P2|Stage 2|Lack of Efficacy|0
65776|NCT01200758|255873|P1|Stage 2|Lack of Efficacy|0
65777|NCT01200758|255870|P4|Stage 2|Disease Progression|21
65778|NCT01200758|255871|P3|Stage 2|Disease Progression|16
65779|NCT01200758|255872|P2|Stage 2|Disease Progression|0
65780|NCT01200758|255873|P1|Stage 2|Disease Progression|0
65781|NCT01200758|255870|P4|Stage I|Disease Progression|0
65782|NCT01200758|255871|P3|Stage I|Disease Progression|0
65783|NCT01200758|255872|P2|Stage I|Disease Progression|7
65784|NCT01200758|255873|P1|Stage I|Disease Progression|9
65785|NCT01200758|255870|P4|Stage I|Withdrawal by Subject|0
65786|NCT01200758|255871|P3|Stage I|Withdrawal by Subject|0
65787|NCT01200758|255872|P2|Stage I|Withdrawal by Subject|2
65788|NCT01200758|255873|P1|Stage I|Withdrawal by Subject|1
65789|NCT01200758|255870|P4|Stage I|Adverse Event|0
65790|NCT01200758|255871|P3|Stage I|Adverse Event|0
65791|NCT01200758|255872|P2|Stage I|Adverse Event|5
65792|NCT01200758|255873|P1|Stage I|Adverse Event|5
65793|NCT01200758|255870|P4|Stage I|Lack of Efficacy|0
65794|NCT01200758|255871|P3|Stage I|Lack of Efficacy|0
65795|NCT01200758|255872|P2|Stage I|Lack of Efficacy|1
65796|NCT01200758|255873|P1|Stage I|Lack of Efficacy|2
65797|NCT01200758|255870|P4|Stage I|Physician Decision|0
65798|NCT01200758|255871|P3|Stage I|Physician Decision|0
65799|NCT01200758|255872|P2|Stage I|Physician Decision|1
65800|NCT01200758|255873|P1|Stage I|Physician Decision|1
65801|NCT01200758|255870|P4|Stage I|Death|0
65802|NCT01200758|255871|P3|Stage I|Death|0
65803|NCT01200758|255872|P2|Stage I|Death|1
65804|NCT01200758|255873|P1|Stage I|Death|0
65805|NCT01200524|255947|P3|Overall Study|Non availability of study nurse|1
65806|NCT01200524|255948|P2|Overall Study|Non availability of study nurse|0
65807|NCT01200524|255949|P1|Overall Study|Non availability of study nurse|0
65808|NCT01200524|255947|P3|Overall Study|Adverse Event|0
65809|NCT01200524|255948|P2|Overall Study|Adverse Event|0
65810|NCT01200524|255949|P1|Overall Study|Adverse Event|1
65811|NCT01200524|255947|P3|Overall Study|Withdrawal by Subject|3
65812|NCT01200524|255948|P2|Overall Study|Withdrawal by Subject|1
65813|NCT01200524|255949|P1|Overall Study|Withdrawal by Subject|1
65814|NCT01200511|255969|P1|Overall Study|Adverse Event|1
65815|NCT01200511|255969|P1|Overall Study|Withdrawal by Subject|1
65816|NCT01200511|255969|P1|Overall Study|Lost to Follow-up|3
65817|NCT01200368|256007|P3|Toddler Dose|Adverse Event|1
65818|NCT01200368|256008|P2|Toddler Dose|Adverse Event|3
65819|NCT01200368|256009|P1|Toddler Dose|Adverse Event|0
65820|NCT01200368|256007|P3|After Infant Series|Unspecified|2
65821|NCT01200368|256008|P2|After Infant Series|Unspecified|2
65822|NCT01200368|256009|P1|After Infant Series|Unspecified|1
65823|NCT01200368|256007|P3|After Infant Series|Lost to Follow-up|0
65824|NCT01200368|256008|P2|After Infant Series|Lost to Follow-up|0
65825|NCT01200368|256009|P1|After Infant Series|Lost to Follow-up|1
65826|NCT01200368|256007|P3|After Infant Series|Withdrawal by Subject|4
65827|NCT01200368|256008|P2|After Infant Series|Withdrawal by Subject|8
65828|NCT01200368|256009|P1|After Infant Series|Withdrawal by Subject|10
65829|NCT01200368|256007|P3|After Infant Series|Adverse Event|3
65830|NCT01200368|256008|P2|After Infant Series|Adverse Event|6
65831|NCT01200368|256009|P1|After Infant Series|Adverse Event|6
65832|NCT01200368|256007|P3|Infant Series|Unspecified|0
65833|NCT01200368|256008|P2|Infant Series|Unspecified|0
65834|NCT01200368|256009|P1|Infant Series|Unspecified|1
65835|NCT01200368|256007|P3|Infant Series|Randomized, not vaccinated|1
65836|NCT01200368|256008|P2|Infant Series|Randomized, not vaccinated|1
65837|NCT01200368|256009|P1|Infant Series|Randomized, not vaccinated|0
65838|NCT01200368|256007|P3|Infant Series|Did not meet entrance criteria|0
65839|NCT01200368|256008|P2|Infant Series|Did not meet entrance criteria|1
65840|NCT01200368|256009|P1|Infant Series|Did not meet entrance criteria|0
65841|NCT01200368|256007|P3|Infant Series|Withdrawal by Subject|2
65842|NCT01200368|256008|P2|Infant Series|Withdrawal by Subject|2
65843|NCT01200368|256009|P1|Infant Series|Withdrawal by Subject|0
65844|NCT01200368|256007|P3|Infant Series|Adverse Event|3
65845|NCT01200368|256008|P2|Infant Series|Adverse Event|2
65846|NCT01200368|256009|P1|Infant Series|Adverse Event|2
65847|NCT01200355|256075|P2|Overall Study|Death|2
65848|NCT01200355|256076|P1|Overall Study|Death|7
65849|NCT01200342|256086|P1|Overall Study|Disease Progression|1
65850|NCT01200069|256097|P2|Overall Study|Withdrawal by Subject|1
65851|NCT01200069|256098|P1|Overall Study|Withdrawal by Subject|0
65852|NCT01199939|256167|P1|Overall Study|Reached a virologic endpoint|4
65853|NCT01199939|256167|P1|Overall Study|Lost to Follow-up|2
65854|NCT01199939|256167|P1|Overall Study|Protocol Violation|3
65855|NCT01199939|256167|P1|Overall Study|Adverse Event|4
65856|NCT01199861|256199|P2|Overall Study|Adverse Event|0
65857|NCT01199861|256200|P1|Overall Study|Adverse Event|1
65858|NCT01199861|256199|P2|Overall Study|Administrative problems|0
65859|NCT01199861|256200|P1|Overall Study|Administrative problems|1
65860|NCT01199822|256221|P3|Overall Study|Investigator discontinued therapy|0
65861|NCT01199822|256222|P2|Overall Study|Investigator discontinued therapy|1
65862|NCT01199822|256223|P1|Overall Study|Investigator discontinued therapy|0
65863|NCT01199705|256269|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
65864|NCT01199601|256301|P2|Overall Study|Insecurity prevented staff interviewing.|9
65865|NCT01199601|256302|P1|Overall Study|Insecurity prevented staff interviewing.|7
65866|NCT01199601|256301|P2|Overall Study|Withdrawal by Subject|3
65867|NCT01199601|256302|P1|Overall Study|Withdrawal by Subject|15
65868|NCT01199601|256301|P2|Overall Study|Lost to Follow-up|66
65869|NCT01199601|256302|P1|Overall Study|Lost to Follow-up|47
65870|NCT01199471|256312|P1|Overall Study|Physician Decision|1
65871|NCT01199471|256312|P1|Overall Study|Withdrawal by Subject|1
65872|NCT01199471|256312|P1|Overall Study|Protocol Violation|4
65873|NCT01199042|256338|P1|At Home (3 Months)|Lost to Follow-up|1
65874|NCT01199042|256338|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
65875|NCT01199016|256347|P1|Overall Study|Lost to Follow-up|25
65876|NCT01199016|256347|P1|Overall Study|Withdrawal by Subject|21
65877|NCT01199016|256347|P1|Overall Study|Other|13
65878|NCT01199016|256347|P1|Overall Study|Protocol Violation|9
65879|NCT01199016|256347|P1|Overall Study|Entrance criteria|5
65880|NCT01199016|256347|P1|Overall Study|No longer meets eligibility criteria|4
65881|NCT01198977|256356|P2|Overall Study|Lost to Follow-up|0
65882|NCT01198977|256357|P1|Overall Study|Lost to Follow-up|1
65883|NCT01198873|256369|P2|Overall Study|Other than above|2
65884|NCT01198873|256370|P1|Overall Study|Other than above|4
65885|NCT01198873|256369|P2|Overall Study|Study closure|23
65886|NCT01198873|256370|P1|Overall Study|Study closure|29
65887|NCT01198873|256369|P2|Overall Study|Adverse Event|7
65888|NCT01198873|256370|P1|Overall Study|Adverse Event|4
65889|NCT01198795|256384|P1|Overall Study|Other Reason|4
65890|NCT01198795|256384|P1|Overall Study|Protocol Violation|2
65891|NCT01198795|256384|P1|Overall Study|Lack of Efficacy|5
65892|NCT01198795|256384|P1|Overall Study|Adverse Event|9
65893|NCT01198795|256384|P1|Overall Study|Lost to Follow-up|15
65894|NCT01198795|256384|P1|Overall Study|Withdrawal by Subject|17
65895|NCT01198795|256384|P1|Overall Study|Did not meet InclusionExclusion criteria|30
65896|NCT01198756|256401|P4|Overall Study|Lost to Follow-up|18
65897|NCT01198756|256402|P3|Overall Study|Lost to Follow-up|23
65898|NCT01198756|256403|P2|Overall Study|Lost to Follow-up|36
65899|NCT01198756|256404|P1|Overall Study|Lost to Follow-up|29
65900|NCT01198756|256401|P4|Overall Study|Withdrawal by Subject|5
65901|NCT01198756|256402|P3|Overall Study|Withdrawal by Subject|7
65902|NCT01198756|256403|P2|Overall Study|Withdrawal by Subject|4
65903|NCT01198756|256404|P1|Overall Study|Withdrawal by Subject|9
65904|NCT01198756|256401|P4|Overall Study|Protocol Violation|2
65905|NCT01198756|256402|P3|Overall Study|Protocol Violation|0
65906|NCT01198756|256403|P2|Overall Study|Protocol Violation|0
65907|NCT01198756|256404|P1|Overall Study|Protocol Violation|0
65908|NCT01198756|256401|P4|Overall Study|Adverse Event|1
65909|NCT01198756|256402|P3|Overall Study|Adverse Event|0
65910|NCT01198756|256403|P2|Overall Study|Adverse Event|0
65911|NCT01198756|256404|P1|Overall Study|Adverse Event|0
65912|NCT01198600|256515|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
65913|NCT01198600|256516|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
65914|NCT01198600|256517|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
65915|NCT01198600|256518|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
65916|NCT01198600|256515|P4|Phase 2: 56 Days of Wear|Relocation|0
65917|NCT01198600|256516|P3|Phase 2: 56 Days of Wear|Relocation|2
65918|NCT01198600|256517|P2|Phase 2: 56 Days of Wear|Relocation|0
65919|NCT01198600|256518|P1|Phase 2: 56 Days of Wear|Relocation|0
65920|NCT01198600|256515|P4|Phase 2: 56 Days of Wear|Inconvenience|0
65921|NCT01198600|256516|P3|Phase 2: 56 Days of Wear|Inconvenience|2
65922|NCT01198600|256517|P2|Phase 2: 56 Days of Wear|Inconvenience|0
65923|NCT01198600|256518|P1|Phase 2: 56 Days of Wear|Inconvenience|0
65924|NCT01198600|256515|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
65925|NCT01198600|256516|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
65926|NCT01198600|256517|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
65927|NCT01198600|256518|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
65928|NCT01198600|256515|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
65929|NCT01198600|256516|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
65930|NCT01198600|256517|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
65931|NCT01198600|256518|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
65932|NCT01198600|256515|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
65933|NCT01198600|256516|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
65934|NCT01198600|256517|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
65935|NCT01198600|256518|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
65936|NCT01198600|256515|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
65937|NCT01198600|256516|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
65938|NCT01198600|256517|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
65939|NCT01198600|256518|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
65940|NCT01198574|256544|P4|Overall Study|Resigned from schools|4
65941|NCT01198574|256545|P3|Overall Study|Resigned from schools|1
65942|NCT01198574|256546|P2|Overall Study|Resigned from schools|1
65943|NCT01198574|256547|P1|Overall Study|Resigned from schools|4
65944|NCT01198548|256565|P1|Overall Study|Administrative Decision|1
65945|NCT01198548|256565|P1|Overall Study|Disease Progression|9
65946|NCT01198509|256580|P6|Overall Study|Withdrawal by Subject|0
65947|NCT01198509|256581|P5|Overall Study|Withdrawal by Subject|0
65948|NCT01198509|256582|P4|Overall Study|Withdrawal by Subject|0
65949|NCT01198509|256583|P3|Overall Study|Withdrawal by Subject|0
65950|NCT01198509|256584|P2|Overall Study|Withdrawal by Subject|0
65951|NCT01198509|256585|P1|Overall Study|Withdrawal by Subject|1
65952|NCT01198275|256661|P2|Overall Study|spontaneous return to sinus rhythm|2
65953|NCT01198275|256662|P1|Overall Study|spontaneous return to sinus rhythm|4
65954|NCT01198275|256661|P2|Overall Study|Adverse Event|3
65955|NCT01198275|256662|P1|Overall Study|Adverse Event|2
65956|NCT01198145|256670|P2|Overall Study|Withdrawal by Subject|1
65957|NCT01198145|256671|P1|Overall Study|Withdrawal by Subject|1
65958|NCT01197911|256694|P3|Overall Study|Adverse Event|1
65959|NCT01197911|256695|P2|Overall Study|Adverse Event|0
65960|NCT01197911|256696|P1|Overall Study|Adverse Event|0
65961|NCT01197794|256811|P7|Overall Study|Other|4
65962|NCT01197794|256812|P6|Overall Study|Other|2
65963|NCT01197794|256813|P5|Overall Study|Other|2
65964|NCT01197794|256814|P4|Overall Study|Other|0
65965|NCT01197794|256815|P3|Overall Study|Other|3
65966|NCT01197794|256816|P2|Overall Study|Other|1
65967|NCT01197794|256817|P1|Overall Study|Other|1
65968|NCT01197794|256811|P7|Overall Study|Lost to Follow-up|0
65969|NCT01197794|256812|P6|Overall Study|Lost to Follow-up|1
65970|NCT01197794|256813|P5|Overall Study|Lost to Follow-up|0
65971|NCT01197794|256814|P4|Overall Study|Lost to Follow-up|1
65972|NCT01197794|256815|P3|Overall Study|Lost to Follow-up|0
65973|NCT01197794|256816|P2|Overall Study|Lost to Follow-up|1
65974|NCT01197794|256817|P1|Overall Study|Lost to Follow-up|1
65975|NCT01197794|256811|P7|Overall Study|Withdrawal by Subject|6
65976|NCT01197794|256812|P6|Overall Study|Withdrawal by Subject|5
65977|NCT01197794|256813|P5|Overall Study|Withdrawal by Subject|1
65978|NCT01197794|256814|P4|Overall Study|Withdrawal by Subject|1
65979|NCT01197794|256815|P3|Overall Study|Withdrawal by Subject|4
65980|NCT01197794|256816|P2|Overall Study|Withdrawal by Subject|3
65981|NCT01197794|256817|P1|Overall Study|Withdrawal by Subject|3
65982|NCT01197794|256811|P7|Overall Study|Eligibility criteria not fulfilled|6
65983|NCT01197794|256812|P6|Overall Study|Eligibility criteria not fulfilled|9
65984|NCT01197794|256813|P5|Overall Study|Eligibility criteria not fulfilled|5
65985|NCT01197794|256814|P4|Overall Study|Eligibility criteria not fulfilled|5
65986|NCT01197794|256815|P3|Overall Study|Eligibility criteria not fulfilled|2
65987|NCT01197794|256816|P2|Overall Study|Eligibility criteria not fulfilled|8
65988|NCT01197794|256817|P1|Overall Study|Eligibility criteria not fulfilled|5
65989|NCT01197794|256811|P7|Overall Study|Development of study withdrawal criteria|1
65990|NCT01197794|256812|P6|Overall Study|Development of study withdrawal criteria|0
65991|NCT01197794|256813|P5|Overall Study|Development of study withdrawal criteria|0
65992|NCT01197794|256814|P4|Overall Study|Development of study withdrawal criteria|1
65993|NCT01197794|256815|P3|Overall Study|Development of study withdrawal criteria|0
65994|NCT01197794|256816|P2|Overall Study|Development of study withdrawal criteria|0
65995|NCT01197794|256817|P1|Overall Study|Development of study withdrawal criteria|3
65996|NCT01197794|256811|P7|Overall Study|Protocol Violation|1
65997|NCT01197794|256812|P6|Overall Study|Protocol Violation|0
65998|NCT01197794|256813|P5|Overall Study|Protocol Violation|2
65999|NCT01197794|256814|P4|Overall Study|Protocol Violation|0
66000|NCT01197794|256815|P3|Overall Study|Protocol Violation|0
66001|NCT01197794|256816|P2|Overall Study|Protocol Violation|0
66002|NCT01197794|256817|P1|Overall Study|Protocol Violation|0
66003|NCT01197794|256811|P7|Overall Study|Adverse Event|3
66004|NCT01197794|256812|P6|Overall Study|Adverse Event|2
66005|NCT01197794|256813|P5|Overall Study|Adverse Event|4
66006|NCT01197794|256814|P4|Overall Study|Adverse Event|4
66007|NCT01197794|256815|P3|Overall Study|Adverse Event|4
66008|NCT01197794|256816|P2|Overall Study|Adverse Event|2
66009|NCT01197794|256817|P1|Overall Study|Adverse Event|3
66010|NCT01197755|256899|P3|Overall Study|eg, change in circumstances|2
66011|NCT01197755|256900|P2|Overall Study|eg, change in circumstances|3
66012|NCT01197755|256901|P1|Overall Study|eg, change in circumstances|7
66013|NCT01197755|256899|P3|Overall Study|Lost to Follow-up|1
66014|NCT01197755|256900|P2|Overall Study|Lost to Follow-up|0
66015|NCT01197755|256901|P1|Overall Study|Lost to Follow-up|0
66016|NCT01197755|256899|P3|Overall Study|Withdrawal by Subject|0
66017|NCT01197755|256900|P2|Overall Study|Withdrawal by Subject|0
66018|NCT01197755|256901|P1|Overall Study|Withdrawal by Subject|1
66019|NCT01197755|256899|P3|Overall Study|Severe non-compliance to the protocol|2
66020|NCT01197755|256900|P2|Overall Study|Severe non-compliance to the protocol|1
66021|NCT01197755|256901|P1|Overall Study|Severe non-compliance to the protocol|2
66022|NCT01197755|256899|P3|Overall Study|Lack of therapeutic response|4
66023|NCT01197755|256900|P2|Overall Study|Lack of therapeutic response|7
66024|NCT01197755|256901|P1|Overall Study|Lack of therapeutic response|0
66025|NCT01197755|256899|P3|Overall Study|Entered the long-term extension study|35
66026|NCT01197755|256900|P2|Overall Study|Entered the long-term extension study|21
66027|NCT01197755|256901|P1|Overall Study|Entered the long-term extension study|18
66028|NCT01197755|256899|P3|Overall Study|Study-specific discontinuation criteria|0
66029|NCT01197755|256900|P2|Overall Study|Study-specific discontinuation criteria|1
66030|NCT01197755|256901|P1|Overall Study|Study-specific discontinuation criteria|2
66031|NCT01197755|256899|P3|Overall Study|Adverse Event|10
66032|NCT01197755|256900|P2|Overall Study|Adverse Event|10
66033|NCT01197755|256901|P1|Overall Study|Adverse Event|8
66034|NCT01197560|256943|P2|Overall Study|Missing|1
66035|NCT01197560|256944|P1|Overall Study|Missing|0
66036|NCT01197560|256943|P2|Overall Study|Elected to discontinue before cycle end|2
66037|NCT01197560|256944|P1|Overall Study|Elected to discontinue before cycle end|0
66038|NCT01197560|256943|P2|Overall Study|Proceeded to transplant|1
66039|NCT01197560|256944|P1|Overall Study|Proceeded to transplant|1
66040|NCT01197560|256943|P2|Overall Study|Disease progression|35
66041|NCT01197560|256944|P1|Overall Study|Disease progression|39
66042|NCT01197560|256943|P2|Overall Study|Withdrawal by Subject|1
66043|NCT01197560|256944|P1|Overall Study|Withdrawal by Subject|1
66044|NCT01197560|256943|P2|Overall Study|Death|5
66045|NCT01197560|256944|P1|Overall Study|Death|1
66046|NCT01197560|256943|P2|Overall Study|Adverse Event|8
66047|NCT01197560|256944|P1|Overall Study|Adverse Event|4
66048|NCT01197534|256977|P3|Overall Study|Adverse Event|24
66049|NCT01197534|256978|P2|Overall Study|Adverse Event|36
66050|NCT01197534|256979|P1|Overall Study|Adverse Event|35
66051|NCT01197534|256977|P3|Overall Study|Lost to Follow-up|2
66052|NCT01197534|256978|P2|Overall Study|Lost to Follow-up|4
66053|NCT01197534|256979|P1|Overall Study|Lost to Follow-up|1
66054|NCT01197534|256977|P3|Overall Study|Dev. of study specific discont. criteria|2
66055|NCT01197534|256978|P2|Overall Study|Dev. of study specific discont. criteria|6
66056|NCT01197534|256979|P1|Overall Study|Dev. of study specific discont. criteria|13
66057|NCT01197534|256977|P3|Overall Study|Lack of therapeutic response|9
66058|NCT01197534|256978|P2|Overall Study|Lack of therapeutic response|4
66059|NCT01197534|256979|P1|Overall Study|Lack of therapeutic response|9
66060|NCT01197534|256977|P3|Overall Study|Severe non-compliance to protocol|1
66061|NCT01197534|256978|P2|Overall Study|Severe non-compliance to protocol|4
66062|NCT01197534|256979|P1|Overall Study|Severe non-compliance to protocol|3
66063|NCT01197534|256977|P3|Overall Study|Enrolment in long term extension|119
66064|NCT01197534|256978|P2|Overall Study|Enrolment in long term extension|66
66065|NCT01197534|256979|P1|Overall Study|Enrolment in long term extension|57
66066|NCT01197534|256977|P3|Overall Study|Not reported|16
66067|NCT01197534|256978|P2|Overall Study|Not reported|10
66068|NCT01197534|256979|P1|Overall Study|Not reported|16
66069|NCT01197521|257023|P3|Overall Study|Adverse Event|24
66070|NCT01197521|257024|P2|Overall Study|Adverse Event|28
66071|NCT01197521|257025|P1|Overall Study|Adverse Event|25
66072|NCT01197521|257023|P3|Overall Study|Lost to Follow-up|2
66073|NCT01197521|257024|P2|Overall Study|Lost to Follow-up|2
66074|NCT01197521|257025|P1|Overall Study|Lost to Follow-up|3
66075|NCT01197521|257023|P3|Overall Study|Dev. of study specific discont. criteria|2
66076|NCT01197521|257024|P2|Overall Study|Dev. of study specific discont. criteria|16
66077|NCT01197521|257025|P1|Overall Study|Dev. of study specific discont. criteria|6
66078|NCT01197521|257023|P3|Overall Study|Lack of therapeutic response|4
66079|NCT01197521|257024|P2|Overall Study|Lack of therapeutic response|3
66080|NCT01197521|257025|P1|Overall Study|Lack of therapeutic response|2
66081|NCT01197521|257023|P3|Overall Study|Severe non-compliance to protocol|3
66082|NCT01197521|257024|P2|Overall Study|Severe non-compliance to protocol|3
66083|NCT01197521|257025|P1|Overall Study|Severe non-compliance to protocol|1
66084|NCT01197521|257023|P3|Overall Study|Enrolment in long term extension|87
66085|NCT01197521|257024|P2|Overall Study|Enrolment in long term extension|36
66086|NCT01197521|257025|P1|Overall Study|Enrolment in long term extension|42
66087|NCT01197521|257023|P3|Overall Study|Not reported|21
66088|NCT01197521|257024|P2|Overall Study|Not reported|25
66089|NCT01197521|257025|P1|Overall Study|Not reported|24
66090|NCT01197508|257070|P4|Overall Study|Not specified|2
66091|NCT01197508|257071|P3|Overall Study|Not specified|2
66092|NCT01197508|257072|P2|Overall Study|Not specified|3
66093|NCT01197508|257073|P1|Overall Study|Not specified|2
66094|NCT01197508|257070|P4|Overall Study|Lost to Follow-up|0
66095|NCT01197508|257071|P3|Overall Study|Lost to Follow-up|2
66096|NCT01197508|257072|P2|Overall Study|Lost to Follow-up|1
66097|NCT01197508|257073|P1|Overall Study|Lost to Follow-up|1
66098|NCT01197508|257070|P4|Overall Study|Study-specific withdrawal criteria|2
66099|NCT01197508|257071|P3|Overall Study|Study-specific withdrawal criteria|1
66100|NCT01197508|257072|P2|Overall Study|Study-specific withdrawal criteria|0
66101|NCT01197508|257073|P1|Overall Study|Study-specific withdrawal criteria|0
66102|NCT01197508|257070|P4|Overall Study|Lack of Efficacy|1
66103|NCT01197508|257071|P3|Overall Study|Lack of Efficacy|2
66104|NCT01197508|257072|P2|Overall Study|Lack of Efficacy|2
66105|NCT01197508|257073|P1|Overall Study|Lack of Efficacy|1
66106|NCT01197508|257070|P4|Overall Study|Condition under investigation worsened|1
66107|NCT01197508|257071|P3|Overall Study|Condition under investigation worsened|1
66108|NCT01197508|257072|P2|Overall Study|Condition under investigation worsened|1
66109|NCT01197508|257073|P1|Overall Study|Condition under investigation worsened|1
66110|NCT01197508|257070|P4|Overall Study|Severe non-compliance to protocol|3
66111|NCT01197508|257071|P3|Overall Study|Severe non-compliance to protocol|1
66112|NCT01197508|257072|P2|Overall Study|Severe non-compliance to protocol|3
66113|NCT01197508|257073|P1|Overall Study|Severe non-compliance to protocol|0
66114|NCT01197508|257070|P4|Overall Study|Adverse Event|3
66115|NCT01197508|257071|P3|Overall Study|Adverse Event|23
66116|NCT01197508|257072|P2|Overall Study|Adverse Event|13
66117|NCT01197508|257073|P1|Overall Study|Adverse Event|10
66118|NCT01197508|257070|P4|Overall Study|Eligiblity criteria not fulfilled|0
66119|NCT01197508|257071|P3|Overall Study|Eligiblity criteria not fulfilled|2
66120|NCT01197508|257072|P2|Overall Study|Eligiblity criteria not fulfilled|0
66210|NCT01196078|257546|P1|Overall Study|Protocol Violation|2
66121|NCT01197508|257073|P1|Overall Study|Eligiblity criteria not fulfilled|0
66122|NCT01197508|257070|P4|Overall Study|Withdrawal by Subject|4
66123|NCT01197508|257071|P3|Overall Study|Withdrawal by Subject|15
66124|NCT01197508|257072|P2|Overall Study|Withdrawal by Subject|7
66125|NCT01197508|257073|P1|Overall Study|Withdrawal by Subject|8
66126|NCT01197417|257183|P2|Overall Study|No 25-hour magnesium level|2
66127|NCT01197417|257184|P1|Overall Study|No 25-hour magnesium level|0
66128|NCT01197417|257183|P2|Overall Study|Found to be ineligible|5
66129|NCT01197417|257184|P1|Overall Study|Found to be ineligible|2
66130|NCT01197417|257183|P2|Overall Study|Hypotension|2
66131|NCT01197417|257184|P1|Overall Study|Hypotension|1
66132|NCT01197417|257183|P2|Overall Study|Not consented in time to receive drug|1
66133|NCT01197417|257184|P1|Overall Study|Not consented in time to receive drug|0
66134|NCT01197417|257183|P2|Overall Study|Subject transferred to intensive care|1
66135|NCT01197417|257184|P1|Overall Study|Subject transferred to intensive care|0
66136|NCT01197417|257183|P2|Overall Study|Site miscommunication|1
66137|NCT01197417|257184|P1|Overall Study|Site miscommunication|0
66138|NCT01197417|257183|P2|Overall Study|Withdrawal by Subject|4
66139|NCT01197417|257184|P1|Overall Study|Withdrawal by Subject|2
66140|NCT01197417|257183|P2|Overall Study|Physician Decision|2
66141|NCT01197417|257184|P1|Overall Study|Physician Decision|3
66142|NCT01196988|257217|P4|Overall Study|Unspecified|0
66143|NCT01196988|257218|P3|Overall Study|Unspecified|0
66144|NCT01196988|257219|P2|Overall Study|Unspecified|0
66145|NCT01196988|257220|P1|Overall Study|Unspecified|2
66146|NCT01196988|257217|P4|Overall Study|Lost to Follow-up|1
66147|NCT01196988|257218|P3|Overall Study|Lost to Follow-up|21
66148|NCT01196988|257219|P2|Overall Study|Lost to Follow-up|29
66149|NCT01196988|257220|P1|Overall Study|Lost to Follow-up|16
66150|NCT01196988|257217|P4|Overall Study|Withdrawal by Subject|0
66151|NCT01196988|257218|P3|Overall Study|Withdrawal by Subject|4
66152|NCT01196988|257219|P2|Overall Study|Withdrawal by Subject|1
66153|NCT01196988|257220|P1|Overall Study|Withdrawal by Subject|5
66154|NCT01196988|257217|P4|Overall Study|Adverse Event|0
66155|NCT01196988|257218|P3|Overall Study|Adverse Event|0
66156|NCT01196988|257219|P2|Overall Study|Adverse Event|2
66157|NCT01196988|257220|P1|Overall Study|Adverse Event|1
66158|NCT01196975|257314|P5|Overall Study|Lost to Follow-up|11
66159|NCT01196975|257315|P4|Overall Study|Lost to Follow-up|5
66160|NCT01196975|257316|P3|Overall Study|Lost to Follow-up|5
66161|NCT01196975|257317|P2|Overall Study|Lost to Follow-up|6
66162|NCT01196975|257318|P1|Overall Study|Lost to Follow-up|11
66163|NCT01196975|257314|P5|Overall Study|Withdrawal by Subject|0
66164|NCT01196975|257315|P4|Overall Study|Withdrawal by Subject|1
66165|NCT01196975|257316|P3|Overall Study|Withdrawal by Subject|0
66166|NCT01196975|257317|P2|Overall Study|Withdrawal by Subject|1
66167|NCT01196975|257318|P1|Overall Study|Withdrawal by Subject|2
66168|NCT01196975|257314|P5|Overall Study|Adverse Event|2
66169|NCT01196975|257315|P4|Overall Study|Adverse Event|0
66170|NCT01196975|257316|P3|Overall Study|Adverse Event|0
66171|NCT01196975|257317|P2|Overall Study|Adverse Event|2
66172|NCT01196975|257318|P1|Overall Study|Adverse Event|2
66173|NCT01196741|257456|P2|Overall Study|Protocol Violation|1
66174|NCT01196741|257457|P1|Overall Study|Protocol Violation|2
66175|NCT01196741|257456|P2|Overall Study|Other|2
66176|NCT01196741|257457|P1|Overall Study|Other|3
66177|NCT01196741|257456|P2|Overall Study|Other reason|3
66178|NCT01196741|257457|P1|Overall Study|Other reason|3
66179|NCT01196741|257456|P2|Overall Study|Withdrawal by Subject|0
66180|NCT01196741|257457|P1|Overall Study|Withdrawal by Subject|3
66181|NCT01196741|257456|P2|Overall Study|Dose limiting Adverse Event|1
66182|NCT01196741|257457|P1|Overall Study|Dose limiting Adverse Event|2
66183|NCT01196741|257456|P2|Overall Study|Serious Adverse Event|1
66184|NCT01196741|257457|P1|Overall Study|Serious Adverse Event|3
66185|NCT01196741|257456|P2|Overall Study|Adverse Event|6
66186|NCT01196741|257457|P1|Overall Study|Adverse Event|10
66187|NCT01196741|257456|P2|Overall Study|Disease progression|14
66188|NCT01196741|257457|P1|Overall Study|Disease progression|34
66189|NCT01196429|257483|P2|Overall Study|Refused – Never Treated|0
66190|NCT01196429|257484|P1|Overall Study|Refused – Never Treated|1
66191|NCT01196429|257483|P2|Overall Study|Ineligible - wrong cell type|0
66192|NCT01196429|257484|P1|Overall Study|Ineligible - wrong cell type|1
66193|NCT01196429|257483|P2|Overall Study|Ineligible - inadequate pathology|0
66194|NCT01196429|257484|P1|Overall Study|Ineligible - inadequate pathology|1
66195|NCT01196104|257502|P2|Overall Study|Various|1
66196|NCT01196104|257503|P1|Overall Study|Various|0
66197|NCT01196104|257502|P2|Overall Study|Withdrawal by Subject|3
66198|NCT01196104|257503|P1|Overall Study|Withdrawal by Subject|3
66199|NCT01196104|257502|P2|Overall Study|Physician Decision|1
66200|NCT01196104|257503|P1|Overall Study|Physician Decision|0
66201|NCT01196104|257502|P2|Overall Study|Lost to Follow-up|0
66202|NCT01196104|257503|P1|Overall Study|Lost to Follow-up|1
66203|NCT01196078|257545|P2|Overall Study|Death|4
66204|NCT01196078|257546|P1|Overall Study|Death|6
66205|NCT01196078|257545|P2|Overall Study|Lost to Follow-up|0
66206|NCT01196078|257546|P1|Overall Study|Lost to Follow-up|1
66207|NCT01196078|257545|P2|Overall Study|Lack of Efficacy|23
66208|NCT01196078|257546|P1|Overall Study|Lack of Efficacy|17
66209|NCT01196078|257545|P2|Overall Study|Protocol Violation|1
66211|NCT01196078|257545|P2|Overall Study|Adverse Event|4
66212|NCT01196078|257546|P1|Overall Study|Adverse Event|4
66213|NCT01196078|257545|P2|Overall Study|Withdrawal by Subject|5
66214|NCT01196078|257546|P1|Overall Study|Withdrawal by Subject|3
66215|NCT01196052|257574|P1|Overall Study|Withdrawal by Subject|6
66216|NCT01196052|257574|P1|Overall Study|Reason not Specified|5
66217|NCT01196052|257574|P1|Overall Study|Noncompliance to Protocol Requirements|2
66218|NCT01196052|257574|P1|Overall Study|Lost to Follow-up|1
66219|NCT01196052|257574|P1|Overall Study|Adverse Event|9
66220|NCT01196026|257591|P6|Overall Study|Unspecified|0
66221|NCT01196026|257592|P5|Overall Study|Unspecified|0
66222|NCT01196026|257593|P4|Overall Study|Unspecified|0
66223|NCT01196026|257594|P3|Overall Study|Unspecified|0
66224|NCT01196026|257595|P2|Overall Study|Unspecified|1
66225|NCT01196026|257596|P1|Overall Study|Unspecified|0
66226|NCT01196026|257591|P6|Overall Study|Lost to Follow-up|0
66227|NCT01196026|257592|P5|Overall Study|Lost to Follow-up|1
66228|NCT01196026|257593|P4|Overall Study|Lost to Follow-up|0
66229|NCT01196026|257594|P3|Overall Study|Lost to Follow-up|0
66230|NCT01196026|257595|P2|Overall Study|Lost to Follow-up|3
66231|NCT01196026|257596|P1|Overall Study|Lost to Follow-up|0
66232|NCT01196026|257591|P6|Overall Study|Withdrawal by Subject|0
66233|NCT01196026|257592|P5|Overall Study|Withdrawal by Subject|0
66234|NCT01196026|257593|P4|Overall Study|Withdrawal by Subject|0
66235|NCT01196026|257594|P3|Overall Study|Withdrawal by Subject|0
66236|NCT01196026|257595|P2|Overall Study|Withdrawal by Subject|4
66237|NCT01196026|257596|P1|Overall Study|Withdrawal by Subject|1
66238|NCT01195948|257832|P3|Overall Study|Lost to Follow-up|2
66239|NCT01195948|257833|P2|Overall Study|Lost to Follow-up|1
66240|NCT01195948|257834|P1|Overall Study|Lost to Follow-up|0
66241|NCT01195844|257866|P1|Overall Study|Fecal sample not collected|40
66242|NCT01195831|257883|P2|Overall Study|Protocol Violation|2
66243|NCT01195831|257884|P1|Overall Study|Protocol Violation|0
66244|NCT01195831|257883|P2|Overall Study|Adverse Event|2
66245|NCT01195831|257884|P1|Overall Study|Adverse Event|4
66246|NCT01195831|257883|P2|Overall Study|Withdrawal by Subject|2
66247|NCT01195831|257884|P1|Overall Study|Withdrawal by Subject|2
66248|NCT01195831|257883|P2|Overall Study|Lost to Follow-up|4
66249|NCT01195831|257884|P1|Overall Study|Lost to Follow-up|2
66250|NCT01195675|258124|P1|Overall Study|Withdrawal by Subject|2
66251|NCT01195675|258124|P1|Overall Study|Adverse Event|1
66252|NCT01195662|258157|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
66253|NCT01195662|258158|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
66254|NCT01195662|258159|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
66255|NCT01195662|258157|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
66256|NCT01195662|258158|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
66257|NCT01195662|258159|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
66258|NCT01195662|258157|P3|Double Blind Treatment Period|Missing disposition information|1
66259|NCT01195662|258158|P2|Double Blind Treatment Period|Missing disposition information|1
66260|NCT01195662|258159|P1|Double Blind Treatment Period|Missing disposition information|0
66261|NCT01195662|258157|P3|Double Blind Treatment Period|Non-specified|0
66262|NCT01195662|258158|P2|Double Blind Treatment Period|Non-specified|0
66263|NCT01195662|258159|P1|Double Blind Treatment Period|Non-specified|3
66264|NCT01195662|258157|P3|Double Blind Treatment Period|Lack of Efficacy|0
66265|NCT01195662|258158|P2|Double Blind Treatment Period|Lack of Efficacy|0
66266|NCT01195662|258159|P1|Double Blind Treatment Period|Lack of Efficacy|2
66267|NCT01195662|258157|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
66268|NCT01195662|258158|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
66269|NCT01195662|258159|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
66270|NCT01195662|258157|P3|Double Blind Treatment Period|Requested discontinue treatment|1
66271|NCT01195662|258158|P2|Double Blind Treatment Period|Requested discontinue treatment|0
66272|NCT01195662|258159|P1|Double Blind Treatment Period|Requested discontinue treatment|1
66273|NCT01195662|258157|P3|Double Blind Treatment Period|Administrative reason|1
66274|NCT01195662|258158|P2|Double Blind Treatment Period|Administrative reason|1
66275|NCT01195662|258159|P1|Double Blind Treatment Period|Administrative reason|2
66276|NCT01195662|258157|P3|Double Blind Treatment Period|Lost to Follow-up|3
66277|NCT01195662|258158|P2|Double Blind Treatment Period|Lost to Follow-up|2
66278|NCT01195662|258159|P1|Double Blind Treatment Period|Lost to Follow-up|3
66279|NCT01195662|258157|P3|Double Blind Treatment Period|Withdrawal by Subject|4
66280|NCT01195662|258158|P2|Double Blind Treatment Period|Withdrawal by Subject|4
66281|NCT01195662|258159|P1|Double Blind Treatment Period|Withdrawal by Subject|6
66282|NCT01195662|258157|P3|Double Blind Treatment Period|Adverse Event|2
66283|NCT01195662|258158|P2|Double Blind Treatment Period|Adverse Event|1
66284|NCT01195662|258159|P1|Double Blind Treatment Period|Adverse Event|4
66285|NCT01195636|258189|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
66286|NCT01195636|258190|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
66287|NCT01195636|258189|P2|Second Intervention (3 Weeks)|Adverse Event|1
66288|NCT01195636|258190|P1|Second Intervention (3 Weeks)|Adverse Event|1
66289|NCT01195636|258189|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
66290|NCT01195636|258190|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
66291|NCT01195636|258189|P2|Washout Period (2 Weeks)|Adverse Event|1
66292|NCT01195636|258190|P1|Washout Period (2 Weeks)|Adverse Event|1
66293|NCT01195636|258189|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
66294|NCT01195636|258190|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
66295|NCT01195636|258189|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
66296|NCT01195636|258190|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
66297|NCT01195636|258189|P2|First Intervention (3 Weeks)|Protocol Violation|0
66298|NCT01195636|258190|P1|First Intervention (3 Weeks)|Protocol Violation|1
66299|NCT01195636|258189|P2|First Intervention (3 Weeks)|Adverse Event|3
66300|NCT01195636|258190|P1|First Intervention (3 Weeks)|Adverse Event|2
66301|NCT01195623|258216|P2|Overall Study|Lost to Follow-up|37
66302|NCT01195623|258217|P1|Overall Study|Lost to Follow-up|35
66303|NCT01195415|258251|P1|Overall Study|No repeat biopsy due to progression|2
66304|NCT01195363|258260|P2|Overall Study|incarceration|0
66305|NCT01195363|258261|P1|Overall Study|incarceration|1
66306|NCT01195363|258260|P2|Overall Study|Lack of Efficacy|4
66307|NCT01195363|258261|P1|Overall Study|Lack of Efficacy|0
66308|NCT01195363|258260|P2|Overall Study|Adverse Event|1
66309|NCT01195363|258261|P1|Overall Study|Adverse Event|3
66310|NCT01195363|258260|P2|Overall Study|Lost to Follow-up|4
66311|NCT01195363|258261|P1|Overall Study|Lost to Follow-up|7
66312|NCT01195272|258267|P1|Overall Study|Lack of Efficacy|3
66313|NCT01195272|258267|P1|Overall Study|Adverse Event|1
66314|NCT01195103|258296|P3|Overall Study|Withdrawal by Subject|0
66315|NCT01195103|258297|P2|Overall Study|Withdrawal by Subject|0
66316|NCT01195103|258298|P1|Overall Study|Withdrawal by Subject|1
66317|NCT01195090|258308|P2|Overall Study|Protocol Violation|4
66318|NCT01195090|258309|P1|Overall Study|Protocol Violation|3
66319|NCT01195090|258308|P2|Overall Study|Lost to Follow-up|2
66320|NCT01195090|258309|P1|Overall Study|Lost to Follow-up|2
66321|NCT01195090|258308|P2|Overall Study|Adverse Event|2
66322|NCT01195090|258309|P1|Overall Study|Adverse Event|1
66323|NCT01194999|258378|P1|Overall Study|Lost to Follow-up|17
66324|NCT01194973|258382|P1|26 Week Treatment Period|Pregnancy|1
66325|NCT01194973|258382|P1|26 Week Treatment Period|Lack of Efficacy|1
66326|NCT01194973|258382|P1|26 Week Treatment Period|Adverse Event|1
66327|NCT01194973|258382|P1|Screening Period|Screen Failure|3
66328|NCT01194869|258402|P1|Overall Study|Toxicity|2
66329|NCT01194869|258402|P1|Overall Study|Disease Progression|2
66330|NCT01194830|258433|P2|Overall Study|Other Reason|8
66331|NCT01194830|258434|P1|Overall Study|Other Reason|12
66332|NCT01194830|258433|P2|Overall Study|Non-compliance issues|4
66333|NCT01194830|258434|P1|Overall Study|Non-compliance issues|4
66334|NCT01194830|258433|P2|Overall Study|Lack of Efficacy|1
66335|NCT01194830|258434|P1|Overall Study|Lack of Efficacy|1
66336|NCT01194830|258433|P2|Overall Study|Withdrawal by Subject|1
66337|NCT01194830|258434|P1|Overall Study|Withdrawal by Subject|2
66338|NCT01194830|258433|P2|Overall Study|Lost to Follow-up|7
66339|NCT01194830|258434|P1|Overall Study|Lost to Follow-up|9
66340|NCT01194830|258433|P2|Overall Study|Protocol Violation|4
66341|NCT01194830|258434|P1|Overall Study|Protocol Violation|5
66342|NCT01194830|258433|P2|Overall Study|Adverse Event|2
66343|NCT01194830|258434|P1|Overall Study|Adverse Event|3
66344|NCT01194154|258458|P2|Overall Study|Did not receive study medication|4
66345|NCT01194154|258459|P1|Overall Study|Did not receive study medication|2
66346|NCT01194154|258458|P2|Overall Study|Unspecified|0
66347|NCT01194154|258459|P1|Overall Study|Unspecified|4
66348|NCT01194154|258458|P2|Overall Study|Treatment with prohibited medication|5
66349|NCT01194154|258459|P1|Overall Study|Treatment with prohibited medication|4
66350|NCT01194154|258458|P2|Overall Study|Skipping of CERA treatment at two visits|0
66351|NCT01194154|258459|P1|Overall Study|Skipping of CERA treatment at two visits|3
66352|NCT01194154|258458|P2|Overall Study|Hemoglobin increase|3
66353|NCT01194154|258459|P1|Overall Study|Hemoglobin increase|12
66354|NCT01194154|258458|P2|Overall Study|Hemoglobin decrease|1
66355|NCT01194154|258459|P1|Overall Study|Hemoglobin decrease|0
66356|NCT01194154|258458|P2|Overall Study|Blood pressure increase|3
66357|NCT01194154|258459|P1|Overall Study|Blood pressure increase|5
66358|NCT01194154|258458|P2|Overall Study|Withdrawal by Subject|6
66359|NCT01194154|258459|P1|Overall Study|Withdrawal by Subject|5
66360|NCT01194154|258458|P2|Overall Study|Protocol Violation|1
66361|NCT01194154|258459|P1|Overall Study|Protocol Violation|0
66362|NCT01194154|258458|P2|Overall Study|Lost to Follow-up|3
66363|NCT01194154|258459|P1|Overall Study|Lost to Follow-up|2
66364|NCT01194154|258458|P2|Overall Study|Adverse Event|7
66365|NCT01194154|258459|P1|Overall Study|Adverse Event|12
66366|NCT01194531|258499|P2|Overall Study|Physician Decision|2
66367|NCT01194531|258500|P1|Overall Study|Physician Decision|0
66368|NCT01194531|258499|P2|Overall Study|Protocol Violation|1
66369|NCT01194531|258500|P1|Overall Study|Protocol Violation|4
66370|NCT01194531|258499|P2|Overall Study|Withdrawal by Subject|0
66371|NCT01194531|258500|P1|Overall Study|Withdrawal by Subject|1
66372|NCT01194440|258544|P1|Overall Study|Lost to Follow-up|1
66373|NCT01194440|258544|P1|Overall Study|Withdrawal by Subject|2
66374|NCT01194440|258544|P1|Overall Study|Adverse Event|9
66375|NCT01194414|258554|P4|72 Weeks Open Label Extension|Death|2
66376|NCT01194414|258555|P3|72 Weeks Open Label Extension|Death|0
66377|NCT01194414|258556|P2|72 Weeks Open Label Extension|Death|2
66378|NCT01194414|258557|P1|72 Weeks Open Label Extension|Death|1
66379|NCT01194414|258554|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
66380|NCT01194414|258555|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
66381|NCT01194414|258556|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
66382|NCT01194414|258557|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
66383|NCT01194414|258554|P4|72 Weeks Open Label Extension|Adverse Event|12
66384|NCT01194414|258555|P3|72 Weeks Open Label Extension|Adverse Event|2
66385|NCT01194414|258556|P2|72 Weeks Open Label Extension|Adverse Event|21
66386|NCT01194414|258557|P1|72 Weeks Open Label Extension|Adverse Event|35
66387|NCT01194414|258554|P4|72 Weeks Open Label Extension|Protocol Violation|1
66388|NCT01194414|258555|P3|72 Weeks Open Label Extension|Protocol Violation|0
66389|NCT01194414|258556|P2|72 Weeks Open Label Extension|Protocol Violation|0
66390|NCT01194414|258557|P1|72 Weeks Open Label Extension|Protocol Violation|0
66391|NCT01194414|258554|P4|72 Weeks Open Label Extension|Other|0
66392|NCT01194414|258555|P3|72 Weeks Open Label Extension|Other|0
66393|NCT01194414|258556|P2|72 Weeks Open Label Extension|Other|1
66394|NCT01194414|258557|P1|72 Weeks Open Label Extension|Other|2
66395|NCT01194414|258554|P4|72 Weeks Open Label Extension|Pregnancy|1
66396|NCT01194414|258555|P3|72 Weeks Open Label Extension|Pregnancy|1
66397|NCT01194414|258556|P2|72 Weeks Open Label Extension|Pregnancy|3
66398|NCT01194414|258557|P1|72 Weeks Open Label Extension|Pregnancy|1
66399|NCT01194414|258554|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
66400|NCT01194414|258555|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
66401|NCT01194414|258556|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
66402|NCT01194414|258557|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
66403|NCT01194414|258554|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
66404|NCT01194414|258555|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
66405|NCT01194414|258556|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
66406|NCT01194414|258557|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
66407|NCT01194414|258554|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
66408|NCT01194414|258555|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
66409|NCT01194414|258556|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
66410|NCT01194414|258557|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
66411|NCT01194414|258554|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
66412|NCT01194414|258555|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
66413|NCT01194414|258556|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
66414|NCT01194414|258557|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
66415|NCT01194414|258554|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
66416|NCT01194414|258555|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
66417|NCT01194414|258556|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
66418|NCT01194414|258557|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
66419|NCT01194414|258554|P4|24 Weeks Double Blind Period|Death|0
66420|NCT01194414|258555|P3|24 Weeks Double Blind Period|Death|0
66421|NCT01194414|258556|P2|24 Weeks Double Blind Period|Death|1
66422|NCT01194414|258557|P1|24 Weeks Double Blind Period|Death|0
66423|NCT01194414|258554|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
66424|NCT01194414|258555|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
66425|NCT01194414|258556|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
66426|NCT01194414|258557|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
66427|NCT01194414|258554|P4|24 Weeks Double Blind Period|Adverse Event|0
66428|NCT01194414|258555|P3|24 Weeks Double Blind Period|Adverse Event|0
66429|NCT01194414|258556|P2|24 Weeks Double Blind Period|Adverse Event|40
66430|NCT01194414|258557|P1|24 Weeks Double Blind Period|Adverse Event|28
66431|NCT01194414|258554|P4|24 Weeks Double Blind Period|Other|0
66432|NCT01194414|258555|P3|24 Weeks Double Blind Period|Other|0
66433|NCT01194414|258556|P2|24 Weeks Double Blind Period|Other|1
66434|NCT01194414|258557|P1|24 Weeks Double Blind Period|Other|0
66435|NCT01194414|258554|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
66436|NCT01194414|258555|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
66437|NCT01194414|258556|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
66438|NCT01194414|258557|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
66439|NCT01194414|258554|P4|24 Weeks Double Blind Period|Pregnancy|0
66440|NCT01194414|258555|P3|24 Weeks Double Blind Period|Pregnancy|0
66441|NCT01194414|258556|P2|24 Weeks Double Blind Period|Pregnancy|2
66442|NCT01194414|258557|P1|24 Weeks Double Blind Period|Pregnancy|2
66443|NCT01194414|258554|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
66444|NCT01194414|258555|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
66445|NCT01194414|258556|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
66446|NCT01194414|258557|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
66447|NCT01194414|258554|P4|24 Weeks Double Blind Period|Protocol Violation|0
66448|NCT01194414|258555|P3|24 Weeks Double Blind Period|Protocol Violation|0
66449|NCT01194414|258556|P2|24 Weeks Double Blind Period|Protocol Violation|3
66450|NCT01194414|258557|P1|24 Weeks Double Blind Period|Protocol Violation|5
66451|NCT01194414|258554|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
66452|NCT01194414|258555|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
66453|NCT01194414|258556|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
66454|NCT01194414|258557|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
66455|NCT01194414|258554|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
66456|NCT01194414|258555|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
66457|NCT01194414|258556|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
66458|NCT01194414|258557|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
66459|NCT01194258|258628|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
66460|NCT01194258|258629|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
66461|NCT01194258|258630|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
66462|NCT01194258|258631|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
66463|NCT01194258|258632|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
66464|NCT01194258|258628|P5|Period 2 (12 Weeks)|Adverse Event|0
66465|NCT01194258|258629|P4|Period 2 (12 Weeks)|Adverse Event|0
66466|NCT01194258|258630|P3|Period 2 (12 Weeks)|Adverse Event|0
66467|NCT01194258|258631|P2|Period 2 (12 Weeks)|Adverse Event|1
66468|NCT01194258|258632|P1|Period 2 (12 Weeks)|Adverse Event|0
66469|NCT01194258|258628|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
66470|NCT01194258|258629|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
66471|NCT01194258|258630|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
66472|NCT01194258|258631|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
66473|NCT01194258|258632|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
66474|NCT01194258|258628|P5|Period 1 (12 Weeks)|Death|1
66475|NCT01194258|258629|P4|Period 1 (12 Weeks)|Death|0
66476|NCT01194258|258630|P3|Period 1 (12 Weeks)|Death|0
66477|NCT01194258|258631|P2|Period 1 (12 Weeks)|Death|0
66478|NCT01194258|258632|P1|Period 1 (12 Weeks)|Death|0
66479|NCT01194258|258628|P5|Titration Period|Titration failure|0
66480|NCT01194258|258629|P4|Titration Period|Titration failure|0
66481|NCT01194258|258630|P3|Titration Period|Titration failure|0
66482|NCT01194258|258631|P2|Titration Period|Titration failure|0
66483|NCT01194258|258632|P1|Titration Period|Titration failure|3
66484|NCT01194258|258628|P5|Titration Period|Lost to Follow-up|0
66485|NCT01194258|258629|P4|Titration Period|Lost to Follow-up|0
66486|NCT01194258|258630|P3|Titration Period|Lost to Follow-up|0
66487|NCT01194258|258631|P2|Titration Period|Lost to Follow-up|0
66488|NCT01194258|258632|P1|Titration Period|Lost to Follow-up|2
66489|NCT01194258|258628|P5|Titration Period|Withdrawal by Subject|0
66490|NCT01194258|258629|P4|Titration Period|Withdrawal by Subject|0
66491|NCT01194258|258630|P3|Titration Period|Withdrawal by Subject|0
66492|NCT01194258|258631|P2|Titration Period|Withdrawal by Subject|0
66493|NCT01194258|258632|P1|Titration Period|Withdrawal by Subject|6
66494|NCT01194245|258656|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
66495|NCT01194245|258657|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
66496|NCT01194245|258658|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
66497|NCT01194245|258659|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
66498|NCT01194245|258660|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
66499|NCT01194245|258656|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
66500|NCT01194245|258657|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
66501|NCT01194245|258658|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
66502|NCT01194245|258659|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
66503|NCT01194245|258660|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
66504|NCT01194245|258656|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
66505|NCT01194245|258657|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
66506|NCT01194245|258658|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
66507|NCT01194245|258659|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
66508|NCT01194245|258660|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
66509|NCT01194245|258656|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
66510|NCT01194245|258657|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
66511|NCT01194245|258658|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
66512|NCT01194245|258659|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
66513|NCT01194245|258660|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
66514|NCT01194245|258656|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
66515|NCT01194245|258657|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
66516|NCT01194245|258658|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
66517|NCT01194245|258659|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
66518|NCT01194245|258660|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
66519|NCT01194245|258656|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
66520|NCT01194245|258657|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
66521|NCT01194245|258658|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
66522|NCT01194245|258659|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
66523|NCT01194245|258660|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
66524|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66525|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|1
66526|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66527|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66528|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66529|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66530|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66531|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Not specified|0
66532|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
66533|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66534|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66535|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66536|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66537|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66538|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66539|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
66540|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
66541|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|5
66542|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
66543|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
66544|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
66545|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
66546|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
66547|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
66548|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|6
66549|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|12
66550|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
66551|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|1
66552|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
66553|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
66554|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
66555|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
66556|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
66557|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|2
66558|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
66559|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|1
66560|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
66561|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
66562|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
66563|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Non-compliance with Study Drug|0
66564|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|33
66565|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|35
66566|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
66567|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|1
66568|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
66569|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
66570|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
66571|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
66572|NCT01194219|258681|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|5
66573|NCT01194219|258682|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|6
66574|NCT01194219|258683|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
66575|NCT01194219|258684|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
66576|NCT01194219|258685|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
66577|NCT01194219|258686|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
66578|NCT01194219|258687|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
66579|NCT01194219|258688|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
66580|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Unspecified|0
66581|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Unspecified|0
66582|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Unspecified|0
66583|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Unspecified|0
66584|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Unspecified|1
66585|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Unspecified|2
66586|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Unspecified|0
66587|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Unspecified|0
66588|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66589|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66590|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66591|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66592|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Protocol Violation|1
66593|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66594|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66595|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Protocol Violation|0
66596|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66597|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66598|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66599|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66600|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66601|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|9
66602|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66603|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
66604|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
66605|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
66606|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
66607|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
66608|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|3
66609|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|12
66610|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
66611|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
66612|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
66613|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
66614|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
66615|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
66616|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|1
66617|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|2
66618|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
66619|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Non-compliance with Study Drug|0
66620|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
66621|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
66622|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
66623|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
66624|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|15
66625|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|37
66626|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
66627|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
66628|NCT01194219|258681|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
66629|NCT01194219|258682|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
66630|NCT01194219|258683|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
66631|NCT01194219|258684|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
66632|NCT01194219|258685|P4|Maintenance Phase (Weeks16-32)|Adverse Event|9
66633|NCT01194219|258686|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
66634|NCT01194219|258687|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
66635|NCT01194219|258688|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
66636|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
66637|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
66638|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
66639|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
66640|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
66641|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Unspecified|0
66642|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
66643|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Unspecified|1
66644|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
66645|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
66646|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
66647|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
66648|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
66649|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
66650|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|1
66651|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|7
66652|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
66653|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
66654|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
66655|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
66656|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
66657|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
66658|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|9
66659|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|7
66660|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Death|0
66661|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Death|0
66662|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Death|0
66663|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Death|0
66664|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Death|0
66665|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Death|0
66666|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Death|1
66667|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Death|0
66668|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
66669|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
66670|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
66671|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
66672|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
66673|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
66674|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
66675|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|12
66676|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66677|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66678|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66679|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66680|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66681|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66682|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
66683|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|7
66684|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
66685|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
66686|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
66687|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
66688|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
66689|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
66690|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|7
66691|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
66692|NCT01194219|258681|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
66693|NCT01194219|258682|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
66694|NCT01194219|258683|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
66695|NCT01194219|258684|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
66696|NCT01194219|258685|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
66697|NCT01194219|258686|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
66698|NCT01194219|258687|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|5
66699|NCT01194219|258688|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|23
66700|NCT01193920|258728|P10|Overall Study|Unable to classify|0
66701|NCT01193920|258729|P9|Overall Study|Unable to classify|0
66702|NCT01193920|258730|P8|Overall Study|Unable to classify|1
66703|NCT01193920|258731|P7|Overall Study|Unable to classify|0
66704|NCT01193920|258732|P6|Overall Study|Unable to classify|0
66705|NCT01193920|258733|P5|Overall Study|Unable to classify|0
66706|NCT01193920|258734|P4|Overall Study|Unable to classify|1
66707|NCT01193920|258735|P3|Overall Study|Unable to classify|0
66708|NCT01193920|258736|P2|Overall Study|Unable to classify|0
66709|NCT01193920|258737|P1|Overall Study|Unable to classify|0
66710|NCT01193920|258728|P10|Overall Study|Death|4
66711|NCT01193920|258729|P9|Overall Study|Death|2
66712|NCT01193920|258730|P8|Overall Study|Death|3
66713|NCT01193920|258731|P7|Overall Study|Death|2
66714|NCT01193920|258732|P6|Overall Study|Death|0
66715|NCT01193920|258733|P5|Overall Study|Death|0
66716|NCT01193920|258734|P4|Overall Study|Death|1
66717|NCT01193920|258735|P3|Overall Study|Death|0
66718|NCT01193920|258736|P2|Overall Study|Death|0
66719|NCT01193920|258737|P1|Overall Study|Death|0
66720|NCT01193920|258728|P10|Overall Study|Protocol Violation|0
66721|NCT01193920|258729|P9|Overall Study|Protocol Violation|0
66722|NCT01193920|258730|P8|Overall Study|Protocol Violation|0
66723|NCT01193920|258731|P7|Overall Study|Protocol Violation|0
66724|NCT01193920|258732|P6|Overall Study|Protocol Violation|0
66725|NCT01193920|258733|P5|Overall Study|Protocol Violation|0
66726|NCT01193920|258734|P4|Overall Study|Protocol Violation|0
66727|NCT01193920|258735|P3|Overall Study|Protocol Violation|0
66728|NCT01193920|258736|P2|Overall Study|Protocol Violation|0
66729|NCT01193920|258737|P1|Overall Study|Protocol Violation|1
66730|NCT01193920|258728|P10|Overall Study|Lost to Follow-up|3
66731|NCT01193920|258729|P9|Overall Study|Lost to Follow-up|2
66732|NCT01193920|258730|P8|Overall Study|Lost to Follow-up|0
66733|NCT01193920|258731|P7|Overall Study|Lost to Follow-up|1
66734|NCT01193920|258732|P6|Overall Study|Lost to Follow-up|3
66735|NCT01193920|258733|P5|Overall Study|Lost to Follow-up|3
66736|NCT01193920|258734|P4|Overall Study|Lost to Follow-up|1
66737|NCT01193920|258735|P3|Overall Study|Lost to Follow-up|1
66738|NCT01193920|258736|P2|Overall Study|Lost to Follow-up|0
66739|NCT01193920|258737|P1|Overall Study|Lost to Follow-up|1
66740|NCT01193920|258728|P10|Overall Study|Withdrawal by Subject|0
66741|NCT01193920|258729|P9|Overall Study|Withdrawal by Subject|1
66742|NCT01193920|258730|P8|Overall Study|Withdrawal by Subject|0
66743|NCT01193920|258731|P7|Overall Study|Withdrawal by Subject|3
66744|NCT01193920|258732|P6|Overall Study|Withdrawal by Subject|1
66745|NCT01193920|258733|P5|Overall Study|Withdrawal by Subject|3
66746|NCT01193920|258734|P4|Overall Study|Withdrawal by Subject|1
66747|NCT01193920|258735|P3|Overall Study|Withdrawal by Subject|5
66748|NCT01193920|258736|P2|Overall Study|Withdrawal by Subject|0
66749|NCT01193920|258737|P1|Overall Study|Withdrawal by Subject|1
66750|NCT01193686|258830|P2|Overall Study|Removed by Investigators; unable to matc|0
66751|NCT01193686|258831|P1|Overall Study|Removed by Investigators; unable to matc|3
66752|NCT01193686|258830|P2|Overall Study|Withdrawal by Subject|1
66753|NCT01193686|258831|P1|Overall Study|Withdrawal by Subject|4
66754|NCT01193660|258848|P3|Overall Study|Physician Decision|1
66755|NCT01193660|258849|P2|Overall Study|Physician Decision|0
66756|NCT01193660|258850|P1|Overall Study|Physician Decision|1
66757|NCT01193660|258848|P3|Overall Study|Death|0
66758|NCT01193660|258849|P2|Overall Study|Death|0
66759|NCT01193660|258850|P1|Overall Study|Death|1
66760|NCT01193660|258848|P3|Overall Study|Withdrawal by Subject|1
66761|NCT01193660|258849|P2|Overall Study|Withdrawal by Subject|3
66762|NCT01193660|258850|P1|Overall Study|Withdrawal by Subject|2
66763|NCT01193608|258894|P6|Overall Study|Adverse Event|0
66764|NCT01193608|258895|P5|Overall Study|Adverse Event|1
66765|NCT01193608|258896|P4|Overall Study|Adverse Event|0
66766|NCT01193608|258897|P3|Overall Study|Adverse Event|0
66767|NCT01193608|258898|P2|Overall Study|Adverse Event|0
66768|NCT01193608|258899|P1|Overall Study|Adverse Event|0
66769|NCT01193608|258894|P6|Overall Study|Lost to Follow-up|2
66770|NCT01193608|258895|P5|Overall Study|Lost to Follow-up|1
66771|NCT01193608|258896|P4|Overall Study|Lost to Follow-up|0
66772|NCT01193608|258897|P3|Overall Study|Lost to Follow-up|0
66773|NCT01193608|258898|P2|Overall Study|Lost to Follow-up|0
66774|NCT01193608|258899|P1|Overall Study|Lost to Follow-up|0
66775|NCT01193608|258894|P6|Overall Study|Withdrawal by Subject|0
66776|NCT01193608|258895|P5|Overall Study|Withdrawal by Subject|3
66777|NCT01193608|258896|P4|Overall Study|Withdrawal by Subject|3
66778|NCT01193608|258897|P3|Overall Study|Withdrawal by Subject|2
66779|NCT01193608|258898|P2|Overall Study|Withdrawal by Subject|1
66780|NCT01193608|258899|P1|Overall Study|Withdrawal by Subject|0
66781|NCT01193608|258894|P6|Overall Study|Unspecified|0
66782|NCT01193608|258895|P5|Overall Study|Unspecified|0
66783|NCT01193608|258896|P4|Overall Study|Unspecified|0
66784|NCT01193608|258897|P3|Overall Study|Unspecified|0
66785|NCT01193608|258898|P2|Overall Study|Unspecified|1
66786|NCT01193608|258899|P1|Overall Study|Unspecified|0
66787|NCT01193582|259136|P4|12 Month Follow-up|Withdrawal by Subject|11
66788|NCT01193582|259137|P3|12 Month Follow-up|Withdrawal by Subject|3
66789|NCT01193582|259138|P2|12 Month Follow-up|Withdrawal by Subject|0
66790|NCT01193582|259139|P1|12 Month Follow-up|Withdrawal by Subject|6
66791|NCT01193582|259136|P4|12 Month Follow-up|Death|0
66792|NCT01193582|259137|P3|12 Month Follow-up|Death|1
66793|NCT01193582|259138|P2|12 Month Follow-up|Death|0
66794|NCT01193582|259139|P1|12 Month Follow-up|Death|0
66795|NCT01193582|259136|P4|Vaccination Series|Withdrawal by Subject|3
66796|NCT01193582|259137|P3|Vaccination Series|Withdrawal by Subject|8
66797|NCT01193582|259138|P2|Vaccination Series|Withdrawal by Subject|13
66798|NCT01193582|259139|P1|Vaccination Series|Withdrawal by Subject|11
66799|NCT01193556|259169|P2|Overall Study|Study termination|25
66800|NCT01193556|259170|P1|Overall Study|Study termination|26
66801|NCT01193348|259178|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
66802|NCT01193348|259178|P1|Extension Treatment Period|Physician Decision|1
66803|NCT01193348|259178|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
66804|NCT01193348|259178|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
66805|NCT01193348|259178|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
66806|NCT01193348|259178|P1|Screening Period|Screen Failure|5
66807|NCT01193335|259198|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
66808|NCT01193335|259199|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
66809|NCT01193335|259198|P2|2-Year Follow-up|No Longer Willing to Participate|6
66810|NCT01193335|259199|P1|2-Year Follow-up|No Longer Willing to Participate|5
66811|NCT01193335|259198|P2|1-Year Follow-up|Lost to Follow-up|0
66812|NCT01193335|259199|P1|1-Year Follow-up|Lost to Follow-up|4
66813|NCT01193335|259198|P2|1-Year Follow-up|No Longer Willing to Participate|9
66814|NCT01193335|259199|P1|1-Year Follow-up|No Longer Willing to Participate|7
66815|NCT01193335|259198|P2|After Infant Series|No Longer Met Eligibility Criteria|1
66816|NCT01193335|259199|P1|After Infant Series|No Longer Met Eligibility Criteria|0
66817|NCT01193335|259198|P2|After Infant Series|Lost to Follow-up|2
66818|NCT01193335|259199|P1|After Infant Series|Lost to Follow-up|1
66819|NCT01193283|259294|P1|Overall Study|Death|1
66820|NCT01193244|259300|P2|Overall Study|Lost to Follow-up|15
66821|NCT01193244|259301|P1|Overall Study|Lost to Follow-up|6
66822|NCT01193244|259300|P2|Overall Study|Other|278
66823|NCT01193244|259301|P1|Overall Study|Other|303
66824|NCT01193244|259300|P2|Overall Study|Withdrawal by Subject|97
66825|NCT01193244|259301|P1|Overall Study|Withdrawal by Subject|79
66826|NCT01193218|259356|P8|12-52 Weeks|Other reason than above|0
66827|NCT01193218|259357|P7|12-52 Weeks|Other reason than above|0
66828|NCT01193218|259358|P6|12-52 Weeks|Other reason than above|0
66829|NCT01193218|259359|P5|12-52 Weeks|Other reason than above|1
66830|NCT01193218|259360|P4|12-52 Weeks|Other reason than above|1
66831|NCT01193218|259361|P3|12-52 Weeks|Other reason than above|0
66832|NCT01193218|259362|P2|12-52 Weeks|Other reason than above|0
66833|NCT01193218|259363|P1|12-52 Weeks|Other reason than above|1
66834|NCT01193218|259356|P8|12-52 Weeks|Withdrawal by Subject|2
66835|NCT01193218|259357|P7|12-52 Weeks|Withdrawal by Subject|1
66836|NCT01193218|259358|P6|12-52 Weeks|Withdrawal by Subject|2
66837|NCT01193218|259359|P5|12-52 Weeks|Withdrawal by Subject|0
66838|NCT01193218|259360|P4|12-52 Weeks|Withdrawal by Subject|0
66839|NCT01193218|259361|P3|12-52 Weeks|Withdrawal by Subject|3
66840|NCT01193218|259362|P2|12-52 Weeks|Withdrawal by Subject|0
66841|NCT01193218|259363|P1|12-52 Weeks|Withdrawal by Subject|3
66842|NCT01193218|259356|P8|12-52 Weeks|Lack of Efficacy|0
66843|NCT01193218|259357|P7|12-52 Weeks|Lack of Efficacy|1
66844|NCT01193218|259358|P6|12-52 Weeks|Lack of Efficacy|0
66845|NCT01193218|259359|P5|12-52 Weeks|Lack of Efficacy|0
66846|NCT01193218|259360|P4|12-52 Weeks|Lack of Efficacy|0
66847|NCT01193218|259361|P3|12-52 Weeks|Lack of Efficacy|0
66848|NCT01193218|259362|P2|12-52 Weeks|Lack of Efficacy|0
66849|NCT01193218|259363|P1|12-52 Weeks|Lack of Efficacy|0
66850|NCT01193218|259356|P8|12-52 Weeks|Adverse Event|2
66851|NCT01193218|259357|P7|12-52 Weeks|Adverse Event|1
66852|NCT01193218|259358|P6|12-52 Weeks|Adverse Event|3
66853|NCT01193218|259359|P5|12-52 Weeks|Adverse Event|3
66854|NCT01193218|259360|P4|12-52 Weeks|Adverse Event|2
66855|NCT01193218|259361|P3|12-52 Weeks|Adverse Event|1
66856|NCT01193218|259362|P2|12-52 Weeks|Adverse Event|0
66857|NCT01193218|259363|P1|12-52 Weeks|Adverse Event|1
66858|NCT01193218|259356|P8|0-12 Weeks|Withdrawal by Subject|0
66859|NCT01193218|259357|P7|0-12 Weeks|Withdrawal by Subject|1
66860|NCT01193218|259358|P6|0-12 Weeks|Withdrawal by Subject|0
66861|NCT01193218|259359|P5|0-12 Weeks|Withdrawal by Subject|0
66862|NCT01193218|259360|P4|0-12 Weeks|Withdrawal by Subject|0
66863|NCT01193218|259361|P3|0-12 Weeks|Withdrawal by Subject|2
66864|NCT01193218|259362|P2|0-12 Weeks|Withdrawal by Subject|0
66865|NCT01193218|259363|P1|0-12 Weeks|Withdrawal by Subject|3
66866|NCT01193218|259356|P8|0-12 Weeks|Protocol Violation|0
66867|NCT01193218|259357|P7|0-12 Weeks|Protocol Violation|0
66868|NCT01193218|259358|P6|0-12 Weeks|Protocol Violation|1
66869|NCT01193218|259359|P5|0-12 Weeks|Protocol Violation|1
66870|NCT01193218|259360|P4|0-12 Weeks|Protocol Violation|0
66871|NCT01193218|259361|P3|0-12 Weeks|Protocol Violation|0
66872|NCT01193218|259362|P2|0-12 Weeks|Protocol Violation|0
66873|NCT01193218|259363|P1|0-12 Weeks|Protocol Violation|0
66874|NCT01193218|259356|P8|0-12 Weeks|Adverse Event|0
66875|NCT01193218|259357|P7|0-12 Weeks|Adverse Event|2
66876|NCT01193218|259358|P6|0-12 Weeks|Adverse Event|2
66877|NCT01193218|259359|P5|0-12 Weeks|Adverse Event|0
66878|NCT01193218|259360|P4|0-12 Weeks|Adverse Event|0
66879|NCT01193218|259361|P3|0-12 Weeks|Adverse Event|1
66880|NCT01193218|259362|P2|0-12 Weeks|Adverse Event|0
66881|NCT01193218|259363|P1|0-12 Weeks|Adverse Event|6
66882|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
66883|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
66884|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
66885|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
66886|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
66887|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
66888|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Pregnancy|0
66889|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Pregnancy|1
66890|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
66891|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
66892|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Death|0
66893|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Death|2
66894|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Adverse Event|3
66895|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Adverse Event|12
66896|NCT01193153|259394|P2|Double Blind Relapse Prevention Period|Unspecified|3
66897|NCT01193153|259395|P1|Double Blind Relapse Prevention Period|Unspecified|2
66898|NCT01193153|259394|P2|Open-label Stabilization Period|Unspecified|0
66899|NCT01193153|259395|P1|Open-label Stabilization Period|Unspecified|8
66900|NCT01193153|259394|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
66901|NCT01193153|259395|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
66902|NCT01193153|259394|P2|Open-label Stabilization Period|Withdrawal by Subject|0
66903|NCT01193153|259395|P1|Open-label Stabilization Period|Withdrawal by Subject|29
66904|NCT01193153|259394|P2|Open-label Stabilization Period|Lack of Efficacy|0
66905|NCT01193153|259395|P1|Open-label Stabilization Period|Lack of Efficacy|5
66906|NCT01193153|259394|P2|Open-label Stabilization Period|Lost to Follow-up|0
66907|NCT01193153|259395|P1|Open-label Stabilization Period|Lost to Follow-up|10
66908|NCT01193153|259394|P2|Open-label Stabilization Period|Death|0
66909|NCT01193153|259395|P1|Open-label Stabilization Period|Death|2
66910|NCT01193153|259394|P2|Open-label Stabilization Period|Adverse Event|0
66911|NCT01193153|259395|P1|Open-label Stabilization Period|Adverse Event|9
66912|NCT01193153|259394|P2|Open-label Lead in Period|Lack of Efficacy|0
66913|NCT01193153|259395|P1|Open-label Lead in Period|Lack of Efficacy|26
66914|NCT01193153|259394|P2|Open-label Lead in Period|Death|0
66915|NCT01193153|259395|P1|Open-label Lead in Period|Death|1
66916|NCT01193153|259394|P2|Open-label Lead in Period|Adverse Event|0
66917|NCT01193153|259395|P1|Open-label Lead in Period|Adverse Event|41
66918|NCT01193153|259394|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
66919|NCT01193153|259395|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
66920|NCT01193153|259394|P2|Open-label Lead in Period|Unspecified|0
66921|NCT01193153|259395|P1|Open-label Lead in Period|Unspecified|14
66922|NCT01193153|259394|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
66923|NCT01193153|259395|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
66924|NCT01193153|259394|P2|Open-label Lead in Period|Withdrawal by Subject|0
66925|NCT01193153|259395|P1|Open-label Lead in Period|Withdrawal by Subject|69
66926|NCT01193153|259394|P2|Open-label Lead in Period|Pregnancy|0
66927|NCT01193153|259395|P1|Open-label Lead in Period|Pregnancy|1
66928|NCT01193153|259394|P2|Open-label Lead in Period|Lost to Follow-up|0
66929|NCT01193153|259395|P1|Open-label Lead in Period|Lost to Follow-up|32
66930|NCT01193127|259430|P4|Treated|Withdrawal by Subject|1
66931|NCT01193127|259431|P3|Treated|Withdrawal by Subject|0
66932|NCT01193127|259432|P2|Treated|Withdrawal by Subject|0
66933|NCT01193127|259433|P1|Treated|Withdrawal by Subject|0
66934|NCT01193127|259430|P4|Randomized|Surgery Cancelled|1
66935|NCT01193127|259431|P3|Randomized|Surgery Cancelled|0
66936|NCT01193127|259432|P2|Randomized|Surgery Cancelled|0
66937|NCT01193127|259433|P1|Randomized|Surgery Cancelled|0
66938|NCT01193101|259758|P4|Overall Study|Abnormal test procedure results|0
66939|NCT01193101|259759|P3|Overall Study|Abnormal test procedure results|0
66940|NCT01193101|259760|P2|Overall Study|Abnormal test procedure results|1
66941|NCT01193101|259761|P1|Overall Study|Abnormal test procedure results|0
66942|NCT01193101|259758|P4|Overall Study|Administrative problems|0
66943|NCT01193101|259759|P3|Overall Study|Administrative problems|1
66944|NCT01193101|259760|P2|Overall Study|Administrative problems|0
66945|NCT01193101|259761|P1|Overall Study|Administrative problems|0
66946|NCT01193101|259758|P4|Overall Study|Withdrawal by Subject|1
66947|NCT01193101|259759|P3|Overall Study|Withdrawal by Subject|1
66948|NCT01193101|259760|P2|Overall Study|Withdrawal by Subject|4
66949|NCT01193101|259761|P1|Overall Study|Withdrawal by Subject|2
66950|NCT01193101|259758|P4|Overall Study|Lack of Efficacy|8
66951|NCT01193101|259759|P3|Overall Study|Lack of Efficacy|0
66952|NCT01193101|259760|P2|Overall Study|Lack of Efficacy|1
66953|NCT01193101|259761|P1|Overall Study|Lack of Efficacy|3
66954|NCT01193101|259758|P4|Overall Study|Adverse Event|3
66955|NCT01193101|259759|P3|Overall Study|Adverse Event|1
66956|NCT01193101|259760|P2|Overall Study|Adverse Event|1
66957|NCT01193101|259761|P1|Overall Study|Adverse Event|0
66958|NCT01192776|259852|P4|Overall Study|Lost to Follow-up|5
66959|NCT01192776|259853|P3|Overall Study|Lost to Follow-up|3
66960|NCT01192776|259854|P2|Overall Study|Lost to Follow-up|6
66961|NCT01192776|259855|P1|Overall Study|Lost to Follow-up|3
66962|NCT01192776|259852|P4|Overall Study|Death|15
66963|NCT01192776|259853|P3|Overall Study|Death|18
66964|NCT01192776|259854|P2|Overall Study|Death|15
66965|NCT01192776|259855|P1|Overall Study|Death|8
66966|NCT01192516|259929|P3|Overall Study|Unable to follow Actiwatch instructions|0
66967|NCT01192516|259930|P2|Overall Study|Unable to follow Actiwatch instructions|2
66968|NCT01192516|259931|P1|Overall Study|Unable to follow Actiwatch instructions|4
66969|NCT01192516|259929|P3|Overall Study|started new treatment|0
66970|NCT01192516|259930|P2|Overall Study|started new treatment|1
66971|NCT01192516|259931|P1|Overall Study|started new treatment|5
66972|NCT01192516|259929|P3|Overall Study|Withdrawal by Subject|1
66973|NCT01192516|259930|P2|Overall Study|Withdrawal by Subject|4
66974|NCT01192516|259931|P1|Overall Study|Withdrawal by Subject|4
66975|NCT01192516|259929|P3|Overall Study|Lost to Follow-up|7
66976|NCT01192516|259930|P2|Overall Study|Lost to Follow-up|10
66977|NCT01192516|259931|P1|Overall Study|Lost to Follow-up|7
66978|NCT01192412|259965|P2|Overall Study|Withdrawal by Subject|1
66979|NCT01192412|259966|P1|Overall Study|Withdrawal by Subject|2
66980|NCT01192412|259965|P2|Overall Study|Lost to Follow-up|1
66981|NCT01192412|259966|P1|Overall Study|Lost to Follow-up|2
66982|NCT01192347|259974|P1|Overall Study|Patient did not show up for visits|1
66983|NCT01192347|259974|P1|Overall Study|Patient not visiting hospital regularly|1
66984|NCT01192347|259974|P1|Overall Study|Patient seen in different hospital|1
66985|NCT01192347|259974|P1|Overall Study|Suspected serious adverse drug reaction|1
66986|NCT01192347|259974|P1|Overall Study|Adverse Event|1
66987|NCT01192347|259974|P1|Overall Study|Withdrawal by Subject|1
66988|NCT01192347|259974|P1|Overall Study|Lost to Follow-up|3
66989|NCT01192347|259974|P1|Overall Study|Death|3
66990|NCT01192295|259997|P2|Overall Study|Administrative|6
66991|NCT01192295|259998|P1|Overall Study|Administrative|4
66992|NCT01192295|259997|P2|Overall Study|Lack of Efficacy|5
66993|NCT01192295|259998|P1|Overall Study|Lack of Efficacy|0
66994|NCT01192295|259997|P2|Overall Study|Lost to Follow-up|1
66995|NCT01192295|259998|P1|Overall Study|Lost to Follow-up|0
66996|NCT01192295|259997|P2|Overall Study|Withdrawal by Subject|4
66997|NCT01192295|259998|P1|Overall Study|Withdrawal by Subject|3
66998|NCT01192295|259997|P2|Overall Study|Adverse Event|7
66999|NCT01192295|259998|P1|Overall Study|Adverse Event|3
67000|NCT01192204|260032|P2|Overall Study|could not keep recall appointments|0
67001|NCT01192204|260033|P1|Overall Study|could not keep recall appointments|1
67002|NCT01192191|260045|P2|Overall Study|Withdrawal by Subject|6
67003|NCT01192191|260046|P1|Overall Study|Withdrawal by Subject|1
67004|NCT01192191|260045|P2|Overall Study|Lost to Follow-up|1
67005|NCT01192191|260046|P1|Overall Study|Lost to Follow-up|0
67006|NCT01192191|260045|P2|Overall Study|Participants Reached Stopping Criteria|2
67007|NCT01192191|260046|P1|Overall Study|Participants Reached Stopping Criteria|3
67008|NCT01192191|260045|P2|Overall Study|Adverse Event|12
67009|NCT01192191|260046|P1|Overall Study|Adverse Event|7
67010|NCT01192178|260072|P2|Overall Study|Lack of Efficacy|2
67011|NCT01192178|260073|P1|Overall Study|Lack of Efficacy|1
67012|NCT01192178|260072|P2|Overall Study|Adverse Event|1
67013|NCT01192178|260073|P1|Overall Study|Adverse Event|2
67014|NCT01192178|260072|P2|Overall Study|Lost to Follow-up|3
67015|NCT01192178|260073|P1|Overall Study|Lost to Follow-up|3
67016|NCT01192178|260072|P2|Overall Study|Physician Decision|4
67017|NCT01192178|260073|P1|Overall Study|Physician Decision|2
67018|NCT01192178|260072|P2|Overall Study|Protocol Violation|3
67019|NCT01192178|260073|P1|Overall Study|Protocol Violation|10
67020|NCT01192178|260072|P2|Overall Study|Withdrawal by Subject|10
67021|NCT01192178|260073|P1|Overall Study|Withdrawal by Subject|6
67022|NCT01192152|260093|P2|Period 3|family emergency|0
67023|NCT01192152|260094|P1|Period 3|family emergency|1
67024|NCT01192152|260093|P2|Period 1|left prematurely (while on treatment B)|1
67025|NCT01192152|260094|P1|Period 1|left prematurely (while on treatment B)|0
67026|NCT01192126|260265|P2|First Intervention (1 Week)|Lost to Follow-up|1
67027|NCT01192126|260266|P1|First Intervention (1 Week)|Lost to Follow-up|1
67028|NCT01192126|260265|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
67029|NCT01192126|260266|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
67030|NCT01192022|260278|P5|Overall Study|Parents did not allow all follow up|0
67031|NCT01192022|260279|P4|Overall Study|Parents did not allow all follow up|1
67032|NCT01192022|260280|P3|Overall Study|Parents did not allow all follow up|0
67033|NCT01192022|260281|P2|Overall Study|Parents did not allow all follow up|0
67034|NCT01192022|260282|P1|Overall Study|Parents did not allow all follow up|0
67035|NCT01192022|260278|P5|Overall Study|Patient needed surgery|0
67036|NCT01192022|260279|P4|Overall Study|Patient needed surgery|0
67037|NCT01192022|260280|P3|Overall Study|Patient needed surgery|0
67038|NCT01192022|260281|P2|Overall Study|Patient needed surgery|1
67039|NCT01192022|260282|P1|Overall Study|Patient needed surgery|0
67040|NCT01192022|260278|P5|Overall Study|Patient too sick from chemotherapy|0
67041|NCT01192022|260279|P4|Overall Study|Patient too sick from chemotherapy|0
67042|NCT01192022|260280|P3|Overall Study|Patient too sick from chemotherapy|0
67043|NCT01192022|260281|P2|Overall Study|Patient too sick from chemotherapy|1
67044|NCT01192022|260282|P1|Overall Study|Patient too sick from chemotherapy|0
67045|NCT01192022|260278|P5|Overall Study|Physician withdrew-patient hardship|0
67046|NCT01192022|260279|P4|Overall Study|Physician withdrew-patient hardship|0
67047|NCT01192022|260280|P3|Overall Study|Physician withdrew-patient hardship|0
67048|NCT01192022|260281|P2|Overall Study|Physician withdrew-patient hardship|0
67049|NCT01192022|260282|P1|Overall Study|Physician withdrew-patient hardship|1
67050|NCT01192022|260278|P5|Overall Study|Fatal Adverse Event|1
67051|NCT01192022|260279|P4|Overall Study|Fatal Adverse Event|0
67052|NCT01192022|260280|P3|Overall Study|Fatal Adverse Event|0
67053|NCT01192022|260281|P2|Overall Study|Fatal Adverse Event|6
67054|NCT01192022|260282|P1|Overall Study|Fatal Adverse Event|4
67055|NCT01192022|260278|P5|Overall Study|Adverse Event|0
67056|NCT01192022|260279|P4|Overall Study|Adverse Event|0
67057|NCT01192022|260280|P3|Overall Study|Adverse Event|0
67058|NCT01192022|260281|P2|Overall Study|Adverse Event|0
67059|NCT01192022|260282|P1|Overall Study|Adverse Event|1
67060|NCT01192022|260278|P5|Overall Study|Lost to Follow-up|0
67061|NCT01192022|260279|P4|Overall Study|Lost to Follow-up|1
67062|NCT01192022|260280|P3|Overall Study|Lost to Follow-up|1
67063|NCT01192022|260281|P2|Overall Study|Lost to Follow-up|2
67064|NCT01192022|260282|P1|Overall Study|Lost to Follow-up|4
67065|NCT01192022|260278|P5|Overall Study|Withdrawal of Consent|0
67066|NCT01192022|260279|P4|Overall Study|Withdrawal of Consent|0
67067|NCT01192022|260280|P3|Overall Study|Withdrawal of Consent|0
67068|NCT01192022|260281|P2|Overall Study|Withdrawal of Consent|1
67069|NCT01192022|260282|P1|Overall Study|Withdrawal of Consent|3
67070|NCT01191944|260305|P2|Overall Study|Other|3
67071|NCT01191944|260306|P1|Overall Study|Other|1
67072|NCT01191944|260305|P2|Overall Study|Withdrawal by Subject|2
67073|NCT01191944|260306|P1|Overall Study|Withdrawal by Subject|4
67074|NCT01191944|260305|P2|Overall Study|Protocol Violation|2
67075|NCT01191944|260306|P1|Overall Study|Protocol Violation|1
67076|NCT01191944|260305|P2|Overall Study|Adverse Event|12
67077|NCT01191944|260306|P1|Overall Study|Adverse Event|11
67078|NCT01191801|260361|P2|Overall Study|Not Provided|27
67079|NCT01191801|260362|P1|Overall Study|Not Provided|45
67080|NCT01191801|260361|P2|Overall Study|Withdrawal by Subject|4
67081|NCT01191801|260362|P1|Overall Study|Withdrawal by Subject|1
67082|NCT01191801|260361|P2|Overall Study|Physician Decision|24
67083|NCT01191801|260362|P1|Overall Study|Physician Decision|47
67084|NCT01191801|260361|P2|Overall Study|Protocol Violation|4
67085|NCT01191801|260362|P1|Overall Study|Protocol Violation|2
67086|NCT01191801|260361|P2|Overall Study|Adverse Event|8
67087|NCT01191801|260362|P1|Overall Study|Adverse Event|9
67088|NCT01191801|260361|P2|Overall Study|Lack of Efficacy|258
67089|NCT01191801|260362|P1|Overall Study|Lack of Efficacy|176
67090|NCT01191801|260361|P2|Overall Study|Death|12
67091|NCT01191801|260362|P1|Overall Study|Death|36
67092|NCT01191788|260382|P2|Overall Study|Lost to Follow-up|22
67093|NCT01191788|260383|P1|Overall Study|Lost to Follow-up|21
67094|NCT01191762|260393|P2|Overall Study|Adverse Event|0
67095|NCT01191762|260394|P1|Overall Study|Adverse Event|1
67096|NCT01191268|260533|P3|Overall Study|Sponsor Decision|0
67097|NCT01191268|260534|P2|Overall Study|Sponsor Decision|2
67098|NCT01191268|260535|P1|Overall Study|Sponsor Decision|0
67099|NCT01191268|260533|P3|Overall Study|Protocol Violation|1
67100|NCT01191268|260534|P2|Overall Study|Protocol Violation|0
67101|NCT01191268|260535|P1|Overall Study|Protocol Violation|1
67102|NCT01191268|260533|P3|Overall Study|Death|3
67103|NCT01191268|260534|P2|Overall Study|Death|1
67104|NCT01191268|260535|P1|Overall Study|Death|0
67105|NCT01191268|260533|P3|Overall Study|Entry Criteria Not Met|1
67106|NCT01191268|260534|P2|Overall Study|Entry Criteria Not Met|1
67107|NCT01191268|260535|P1|Overall Study|Entry Criteria Not Met|3
67108|NCT01191268|260533|P3|Overall Study|Lost to Follow-up|9
67109|NCT01191268|260534|P2|Overall Study|Lost to Follow-up|5
67110|NCT01191268|260535|P1|Overall Study|Lost to Follow-up|8
67111|NCT01191268|260533|P3|Overall Study|Physician Decision|9
67112|NCT01191268|260534|P2|Overall Study|Physician Decision|8
67113|NCT01191268|260535|P1|Overall Study|Physician Decision|6
67114|NCT01191268|260533|P3|Overall Study|Adverse Event|8
67115|NCT01191268|260534|P2|Overall Study|Adverse Event|13
67116|NCT01191268|260535|P1|Overall Study|Adverse Event|21
67117|NCT01191268|260533|P3|Overall Study|Withdrawal by Subject|21
67118|NCT01191268|260534|P2|Overall Study|Withdrawal by Subject|25
67119|NCT01191268|260535|P1|Overall Study|Withdrawal by Subject|19
67120|NCT01191190|260676|P1|Overall Study|Withdrawal by Subject|1
67121|NCT01191086|260689|P1|Overall Study|Other|1
67122|NCT01191086|260689|P1|Overall Study|Discontinuation criterion met|1
67123|NCT01191086|260689|P1|Overall Study|Withdrawal by Subject|24
67124|NCT01191086|260689|P1|Overall Study|Physician Decision|2
67125|NCT01191086|260689|P1|Overall Study|Lost to Follow-up|4
67126|NCT01191086|260689|P1|Overall Study|Lack of Efficacy|10
67127|NCT01191086|260689|P1|Overall Study|Adverse Event|20
67128|NCT01191008|260693|P1|Overall Study|Lost to Follow-up|8
67129|NCT01191008|260693|P1|Overall Study|Protocol Violation|7
67130|NCT01190891|260701|P2|Overall Study|Withdrawal by Subject|0
67131|NCT01190891|260702|P1|Overall Study|Withdrawal by Subject|5
67132|NCT01190891|260701|P2|Overall Study|Protocol Violation|0
67133|NCT01190891|260702|P1|Overall Study|Protocol Violation|1
67134|NCT01190865|260727|P1|Overall Study|Non-compliance|2
67135|NCT01190865|260727|P1|Overall Study|Withdrawal by Subject|1
67136|NCT01190839|260734|P2|Overall Study|Randomized but not treated|4
67137|NCT01190839|260735|P1|Overall Study|Randomized but not treated|2
67138|NCT01190839|260734|P2|Overall Study|Undefined|31
67139|NCT01190839|260735|P1|Overall Study|Undefined|35
67140|NCT01190839|260734|P2|Overall Study|Trial stopped by Sponsor|68
67141|NCT01190839|260735|P1|Overall Study|Trial stopped by Sponsor|71
67142|NCT01190839|260734|P2|Overall Study|Death|0
67143|NCT01190839|260735|P1|Overall Study|Death|1
67144|NCT01190839|260734|P2|Overall Study|Lost to Follow-up|1
67145|NCT01190839|260735|P1|Overall Study|Lost to Follow-up|7
67146|NCT01190839|260734|P2|Overall Study|Protocol Violation|2
67147|NCT01190839|260735|P1|Overall Study|Protocol Violation|2
67148|NCT01190839|260734|P2|Overall Study|Adverse Event|41
67149|NCT01190839|260735|P1|Overall Study|Adverse Event|32
67150|NCT01190813|260749|P2|Overall Study|Adverse Event|1
67151|NCT01190813|260750|P1|Overall Study|Adverse Event|0
67152|NCT01190813|260749|P2|Overall Study|Refused study treatment after randomized|0
67153|NCT01190813|260750|P1|Overall Study|Refused study treatment after randomized|1
67154|NCT01190813|260749|P2|Overall Study|Withdrawal by Subject|1
67155|NCT01190813|260750|P1|Overall Study|Withdrawal by Subject|2
67156|NCT01190813|260749|P2|Overall Study|Lost to Follow-up|2
67157|NCT01190813|260750|P1|Overall Study|Lost to Follow-up|1
67158|NCT01190514|260871|P4|Third Intervention (Period 3)|Adverse Event|0
67159|NCT01190514|260872|P3|Third Intervention (Period 3)|Adverse Event|0
67160|NCT01190514|260873|P2|Third Intervention (Period 3)|Adverse Event|0
67161|NCT01190514|260874|P1|Third Intervention (Period 3)|Adverse Event|1
67162|NCT01190514|260871|P4|First Intervention (Period 1)|Adverse Event|0
67163|NCT01190514|260872|P3|First Intervention (Period 1)|Adverse Event|0
67164|NCT01190514|260873|P2|First Intervention (Period 1)|Adverse Event|0
67165|NCT01190514|260874|P1|First Intervention (Period 1)|Adverse Event|1
67166|NCT01190436|260904|P1|Overall Study|Unspecified|4
67167|NCT01190436|260904|P1|Overall Study|Lost to Follow-up|35
67168|NCT01190267|260929|P2|Overall Study|Protocol Violation|1
67169|NCT01190267|260930|P1|Overall Study|Protocol Violation|8
67170|NCT01190267|260929|P2|Overall Study|Withdrawal by Subject|1
67171|NCT01190267|260930|P1|Overall Study|Withdrawal by Subject|13
67172|NCT01190267|260929|P2|Overall Study|Lost to Follow-up|0
67173|NCT01190267|260930|P1|Overall Study|Lost to Follow-up|2
67174|NCT01190267|260929|P2|Overall Study|Treatment Failure|2
67175|NCT01190267|260930|P1|Overall Study|Treatment Failure|8
67176|NCT01190267|260929|P2|Overall Study|Adverse Event|0
67177|NCT01190267|260930|P1|Overall Study|Adverse Event|10
67178|NCT01190254|260941|P3|Overall Study|Did not meet protocol eligibility|0
67179|NCT01190254|260942|P2|Overall Study|Did not meet protocol eligibility|0
67180|NCT01190254|260943|P1|Overall Study|Did not meet protocol eligibility|1
67181|NCT01190254|260941|P3|Overall Study|Protocol Violation|2
67182|NCT01190254|260942|P2|Overall Study|Protocol Violation|0
67183|NCT01190254|260943|P1|Overall Study|Protocol Violation|2
67184|NCT01190254|260941|P3|Overall Study|Withdrawal by Subject|7
67185|NCT01190254|260942|P2|Overall Study|Withdrawal by Subject|5
67186|NCT01190254|260943|P1|Overall Study|Withdrawal by Subject|4
67187|NCT01190254|260941|P3|Overall Study|Lost to Follow-up|0
67188|NCT01190254|260942|P2|Overall Study|Lost to Follow-up|2
67189|NCT01190254|260943|P1|Overall Study|Lost to Follow-up|4
67190|NCT01190254|260941|P3|Overall Study|Lack of Efficacy|5
67191|NCT01190254|260942|P2|Overall Study|Lack of Efficacy|4
67192|NCT01190254|260943|P1|Overall Study|Lack of Efficacy|7
67193|NCT01190254|260941|P3|Overall Study|Adverse Event|8
67194|NCT01190254|260942|P2|Overall Study|Adverse Event|6
67195|NCT01190254|260943|P1|Overall Study|Adverse Event|3
67196|NCT01190215|261007|P2|Up to Month 6|Lost to Follow-up|0
67197|NCT01190215|261008|P1|Up to Month 6|Lost to Follow-up|2
67198|NCT01190150|261078|P2|Washout|Difficulty in adherence|1
67199|NCT01190150|261079|P1|Washout|Difficulty in adherence|0
67200|NCT01190150|261078|P2|Washout|Withdrawal by Subject|1
67201|NCT01190150|261079|P1|Washout|Withdrawal by Subject|0
67202|NCT01190150|261078|P2|First Treatment|Withdrawal by Subject|0
67203|NCT01190150|261079|P1|First Treatment|Withdrawal by Subject|1
67204|NCT01190124|261106|P3|Overall Study|Lost to Follow-up|0
67205|NCT01190124|261107|P2|Overall Study|Lost to Follow-up|0
67206|NCT01190124|261108|P1|Overall Study|Lost to Follow-up|2
67207|NCT01190124|261106|P3|Overall Study|Therapeutic Failure|1
67208|NCT01190124|261107|P2|Overall Study|Therapeutic Failure|0
67209|NCT01190124|261108|P1|Overall Study|Therapeutic Failure|12
67210|NCT01190124|261106|P3|Overall Study|Death|0
67211|NCT01190124|261107|P2|Overall Study|Death|0
67212|NCT01190124|261108|P1|Overall Study|Death|3
67213|NCT01190098|261146|P2|Overall Study|Other|1
67214|NCT01190098|261147|P1|Overall Study|Other|0
67215|NCT01190098|261146|P2|Overall Study|Lack of transportation|0
67216|NCT01190098|261147|P1|Overall Study|Lack of transportation|1
67217|NCT01190098|261146|P2|Overall Study|Patient coomorbidity|1
67218|NCT01190098|261147|P1|Overall Study|Patient coomorbidity|0
67219|NCT01190098|261146|P2|Overall Study|Adverse Event|0
67220|NCT01190098|261147|P1|Overall Study|Adverse Event|2
67221|NCT01190007|261186|P1|Overall Study|Participant was arrested|1
67222|NCT01190007|261186|P1|Overall Study|Difficulty of visit for complications|1
67223|NCT01190007|261186|P1|Overall Study|Adverse Event|8
67224|NCT01190007|261186|P1|Overall Study|Withdrawal by Subject|4
67225|NCT01189890|261203|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
67226|NCT01189890|261204|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
67227|NCT01189890|261203|P2|Overall Study|Physician Decision|4
67228|NCT01189890|261204|P1|Overall Study|Physician Decision|5
67229|NCT01189890|261203|P2|Overall Study|Non Compliance|1
67230|NCT01189890|261204|P1|Overall Study|Non Compliance|0
67231|NCT01189890|261203|P2|Overall Study|Withdrawal by Subject|11
67232|NCT01189890|261204|P1|Overall Study|Withdrawal by Subject|15
67233|NCT01189890|261203|P2|Overall Study|Protocol Violation|5
67234|NCT01189890|261204|P1|Overall Study|Protocol Violation|1
67235|NCT01189890|261203|P2|Overall Study|Lost to Follow-up|7
67236|NCT01189890|261204|P1|Overall Study|Lost to Follow-up|1
67237|NCT01189890|261203|P2|Overall Study|Lack of Efficacy|2
67238|NCT01189890|261204|P1|Overall Study|Lack of Efficacy|7
67239|NCT01189890|261203|P2|Overall Study|Adverse Event|4
67240|NCT01189890|261204|P1|Overall Study|Adverse Event|3
67241|NCT01189812|261226|P2|Overall Study|Moved out of State|2
67242|NCT01189812|261227|P1|Overall Study|Moved out of State|1
67243|NCT01189812|261226|P2|Overall Study|Out of Window|3
67244|NCT01189812|261227|P1|Overall Study|Out of Window|4
67245|NCT01189812|261226|P2|Overall Study|Adverse Event|0
67246|NCT01189812|261227|P1|Overall Study|Adverse Event|1
67247|NCT01189812|261226|P2|Overall Study|Withdrawal by Subject|3
67248|NCT01189812|261227|P1|Overall Study|Withdrawal by Subject|2
67249|NCT01189604|261311|P7|Overall Study|Withdrawal by Subject|0
67250|NCT01189604|261312|P6|Overall Study|Withdrawal by Subject|0
67251|NCT01189604|261313|P5|Overall Study|Withdrawal by Subject|0
67252|NCT01189604|261314|P4|Overall Study|Withdrawal by Subject|0
67253|NCT01189604|261315|P3|Overall Study|Withdrawal by Subject|0
67254|NCT01189604|261316|P2|Overall Study|Withdrawal by Subject|0
67255|NCT01189604|261317|P1|Overall Study|Withdrawal by Subject|1
67256|NCT01189604|261311|P7|Overall Study|Adverse Event|1
67257|NCT01189604|261312|P6|Overall Study|Adverse Event|0
67258|NCT01189604|261313|P5|Overall Study|Adverse Event|2
67259|NCT01189604|261314|P4|Overall Study|Adverse Event|0
67260|NCT01189604|261315|P3|Overall Study|Adverse Event|0
67261|NCT01189604|261316|P2|Overall Study|Adverse Event|1
67262|NCT01189604|261317|P1|Overall Study|Adverse Event|0
67263|NCT01189604|261311|P7|Overall Study|Impossible to visit|0
67264|NCT01189604|261312|P6|Overall Study|Impossible to visit|1
67265|NCT01189604|261313|P5|Overall Study|Impossible to visit|0
67266|NCT01189604|261314|P4|Overall Study|Impossible to visit|0
67267|NCT01189604|261315|P3|Overall Study|Impossible to visit|0
67268|NCT01189604|261316|P2|Overall Study|Impossible to visit|0
67269|NCT01189604|261317|P1|Overall Study|Impossible to visit|0
67270|NCT01189500|261361|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
67271|NCT01189500|261361|P1|Period 1: TAMOX Alone|Adverse Event|1
67272|NCT01189487|261422|P1|Overall Study|Adverse Event|1
67273|NCT01189487|261422|P1|Overall Study|Lack of Efficacy|2
67274|NCT01189461|261430|P1|Overall Study|Unspecified|8
67275|NCT01189461|261430|P1|Overall Study|Did not meet entrance criteria|3
67276|NCT01189461|261430|P1|Overall Study|Adverse Event|2
67277|NCT01189461|261430|P1|Overall Study|Protocol Violation|1
67278|NCT01189461|261430|P1|Overall Study|Withdrawal by Subject|6
67279|NCT01189461|261430|P1|Overall Study|Lost to Follow-up|1
67280|NCT01189461|261430|P1|Overall Study|Lack of Efficacy|13
67281|NCT01189435|261437|P1|Overall Study|Physician Decision|1
67282|NCT01189435|261437|P1|Overall Study|Withdrawal by Subject|1
67283|NCT01189227|261519|P2|Overall Study|Study terminated due to low accrual|3
67284|NCT01189227|261520|P1|Overall Study|Study terminated due to low accrual|6
67285|NCT01189201|261526|P1|Overall Study|Adverse Event|1
67286|NCT01189032|261629|P3|Overall Study|Protocol Violation|1
67287|NCT01189032|261630|P2|Overall Study|Protocol Violation|1
67288|NCT01189032|261631|P1|Overall Study|Protocol Violation|1
67289|NCT01189032|261629|P3|Overall Study|Withdrawal by Subject|1
67290|NCT01189032|261630|P2|Overall Study|Withdrawal by Subject|0
67291|NCT01189032|261631|P1|Overall Study|Withdrawal by Subject|1
67292|NCT01189032|261629|P3|Overall Study|Lack of Efficacy|0
67293|NCT01189032|261630|P2|Overall Study|Lack of Efficacy|3
67294|NCT01189032|261631|P1|Overall Study|Lack of Efficacy|2
67295|NCT01189032|261629|P3|Overall Study|Adverse Event|4
67296|NCT01189032|261630|P2|Overall Study|Adverse Event|3
67297|NCT01189032|261631|P1|Overall Study|Adverse Event|1
67298|NCT01188967|261641|P2|Overall Study|Lost to Follow-up|2
67299|NCT01188967|261642|P1|Overall Study|Lost to Follow-up|3
67300|NCT01188967|261641|P2|Overall Study|Physician Decision|1
67301|NCT01188967|261642|P1|Overall Study|Physician Decision|1
67302|NCT01188967|261641|P2|Overall Study|Withdrawal by Subject|1
67303|NCT01188967|261642|P1|Overall Study|Withdrawal by Subject|1
67304|NCT01188811|261685|P2|Overall Study|Adverse Event|0
67305|NCT01188811|261686|P1|Overall Study|Adverse Event|6
67306|NCT01188811|261685|P2|Overall Study|Withdrawal by Subject|2
67307|NCT01188811|261686|P1|Overall Study|Withdrawal by Subject|0
67308|NCT01188798|261698|P2|Overall Study|Protocol closure|1
67309|NCT01188798|261699|P1|Overall Study|Protocol closure|1
67310|NCT01188798|261698|P2|Overall Study|Required additional transplant|1
67311|NCT01188798|261699|P1|Overall Study|Required additional transplant|1
67312|NCT01188798|261698|P2|Overall Study|Death|1
67313|NCT01188798|261699|P1|Overall Study|Death|0
67314|NCT01188772|261711|P4|Overall Study|Withdrawal by Subject|0
67315|NCT01188772|261712|P3|Overall Study|Withdrawal by Subject|2
67316|NCT01188772|261713|P2|Overall Study|Withdrawal by Subject|0
67317|NCT01188772|261714|P1|Overall Study|Withdrawal by Subject|0
67318|NCT01188772|261711|P4|Overall Study|Virologic Failure|0
67319|NCT01188772|261712|P3|Overall Study|Virologic Failure|0
67320|NCT01188772|261713|P2|Overall Study|Virologic Failure|0
67321|NCT01188772|261714|P1|Overall Study|Virologic Failure|1
67322|NCT01188772|261711|P4|Overall Study|Treatment Failure|0
67323|NCT01188772|261712|P3|Overall Study|Treatment Failure|1
67324|NCT01188772|261713|P2|Overall Study|Treatment Failure|0
67325|NCT01188772|261714|P1|Overall Study|Treatment Failure|0
67326|NCT01188772|261711|P4|Overall Study|Terminated by Sponsor|0
67327|NCT01188772|261712|P3|Overall Study|Terminated by Sponsor|1
67328|NCT01188772|261713|P2|Overall Study|Terminated by Sponsor|0
67329|NCT01188772|261714|P1|Overall Study|Terminated by Sponsor|0
67330|NCT01188772|261711|P4|Overall Study|Physician Decision|0
67331|NCT01188772|261712|P3|Overall Study|Physician Decision|1
67332|NCT01188772|261713|P2|Overall Study|Physician Decision|0
67333|NCT01188772|261714|P1|Overall Study|Physician Decision|0
67334|NCT01188772|261711|P4|Overall Study|Non-responder|0
67335|NCT01188772|261712|P3|Overall Study|Non-responder|3
67336|NCT01188772|261713|P2|Overall Study|Non-responder|0
67337|NCT01188772|261714|P1|Overall Study|Non-responder|0
67338|NCT01188772|261711|P4|Overall Study|Lost to Follow-up|1
67339|NCT01188772|261712|P3|Overall Study|Lost to Follow-up|1
67340|NCT01188772|261713|P2|Overall Study|Lost to Follow-up|1
67341|NCT01188772|261714|P1|Overall Study|Lost to Follow-up|4
67342|NCT01188772|261711|P4|Overall Study|Adverse Event|0
67343|NCT01188772|261712|P3|Overall Study|Adverse Event|2
67344|NCT01188772|261713|P2|Overall Study|Adverse Event|1
67345|NCT01188772|261714|P1|Overall Study|Adverse Event|0
67346|NCT01188772|261711|P4|Overall Study|Randomized but Not Treated|0
67347|NCT01188772|261712|P3|Overall Study|Randomized but Not Treated|0
67348|NCT01188772|261713|P2|Overall Study|Randomized but Not Treated|1
67349|NCT01188772|261714|P1|Overall Study|Randomized but Not Treated|0
67350|NCT01188681|261786|P4|Overall Study|Withdrawal by Subject|1
67351|NCT01188681|261787|P3|Overall Study|Withdrawal by Subject|0
67352|NCT01188681|261788|P2|Overall Study|Withdrawal by Subject|0
67353|NCT01188681|261789|P1|Overall Study|Withdrawal by Subject|0
67354|NCT01188681|261786|P4|Overall Study|bladder cancer|0
67355|NCT01188681|261787|P3|Overall Study|bladder cancer|1
67356|NCT01188681|261788|P2|Overall Study|bladder cancer|0
67357|NCT01188681|261789|P1|Overall Study|bladder cancer|0
67358|NCT01188668|261803|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
67359|NCT01188668|261803|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
67360|NCT01188668|261803|P1|Period 1: ARIP Alone|Protocol Violation|2
67361|NCT01188655|261836|P1|Overall Study|Unspecified|11
67362|NCT01188655|261836|P1|Overall Study|Lost to Follow-up|1
67363|NCT01188655|261836|P1|Overall Study|Lack of Efficacy|1
67364|NCT01188564|261880|P2|Double-blind Phase|randomized not treated|0
67365|NCT01188564|261881|P1|Double-blind Phase|randomized not treated|1
67366|NCT01188551|261893|P4|Overall Study|Pharmacy issues|0
67367|NCT01188551|261894|P3|Overall Study|Pharmacy issues|0
67368|NCT01188551|261895|P2|Overall Study|Pharmacy issues|0
67369|NCT01188551|261896|P1|Overall Study|Pharmacy issues|1
67370|NCT01188538|261912|P2|Overall Study|Lost to Follow-up|1
67371|NCT01188538|261913|P1|Overall Study|Lost to Follow-up|0
67372|NCT01188343|261971|P3|Overall Study|Withdrawal by Subject|0
67373|NCT01188343|261972|P2|Overall Study|Withdrawal by Subject|24
67374|NCT01188343|261973|P1|Overall Study|Withdrawal by Subject|1
67375|NCT01188343|261971|P3|Overall Study|Not vaccinated|1
67376|NCT01188343|261972|P2|Overall Study|Not vaccinated|2
67377|NCT01188343|261973|P1|Overall Study|Not vaccinated|0
67378|NCT01188226|261999|P1|Overall Study|Withdrawal by Subject|4
67379|NCT01187953|262045|P2|Overall Study|Withdrawal by Subject|3
67380|NCT01187953|262046|P1|Overall Study|Withdrawal by Subject|3
67381|NCT01187953|262045|P2|Overall Study|Lost to Follow-up|3
67382|NCT01187953|262046|P1|Overall Study|Lost to Follow-up|0
67383|NCT01187953|262045|P2|Overall Study|Adverse Event|2
67384|NCT01187953|262046|P1|Overall Study|Adverse Event|1
67385|NCT01187953|262045|P2|Overall Study|Death|13
67386|NCT01187953|262046|P1|Overall Study|Death|11
67387|NCT01187901|262060|P2|Overall Study|Pregnancy|2
67388|NCT01187901|262061|P1|Overall Study|Pregnancy|0
67389|NCT01187901|262060|P2|Overall Study|No Endpoint due to Early Study Halt|3
67390|NCT01187901|262061|P1|Overall Study|No Endpoint due to Early Study Halt|2
67391|NCT01187901|262060|P2|Overall Study|Adverse Event|0
67392|NCT01187901|262061|P1|Overall Study|Adverse Event|3
67393|NCT01187901|262060|P2|Overall Study|Suspected Allergic Reaction|1
67394|NCT01187901|262061|P1|Overall Study|Suspected Allergic Reaction|1
67395|NCT01187901|262060|P2|Overall Study|Unrelated Health Reasons|2
67396|NCT01187901|262061|P1|Overall Study|Unrelated Health Reasons|1
67397|NCT01187901|262060|P2|Overall Study|Lost to Follow-up|2
67398|NCT01187901|262061|P1|Overall Study|Lost to Follow-up|1
67399|NCT01187901|262060|P2|Overall Study|Protocol Violation|0
67400|NCT01187901|262061|P1|Overall Study|Protocol Violation|1
67401|NCT01187550|262102|P2|Overall Study|Randomized but not treated|0
67402|NCT01187550|262103|P1|Overall Study|Randomized but not treated|8
67403|NCT01187550|262102|P2|Overall Study|Unspecified|0
67404|NCT01187550|262103|P1|Overall Study|Unspecified|3
67405|NCT01187550|262102|P2|Overall Study|Protocol Violation|1
67406|NCT01187550|262103|P1|Overall Study|Protocol Violation|3
67407|NCT01187433|262259|P2|Overall Study|Withdrawal by Subject|2
67408|NCT01187433|262260|P1|Overall Study|Withdrawal by Subject|5
67409|NCT01187433|262259|P2|Overall Study|Protocol Violation|2
67410|NCT01187433|262260|P1|Overall Study|Protocol Violation|6
67411|NCT01187043|262304|P5|Overall Study|Unable to make scheduled visits|1
67412|NCT01187043|262305|P4|Overall Study|Unable to make scheduled visits|0
67413|NCT01187043|262306|P3|Overall Study|Unable to make scheduled visits|4
67414|NCT01187043|262307|P2|Overall Study|Unable to make scheduled visits|0
67415|NCT01187043|262308|P1|Overall Study|Unable to make scheduled visits|1
67416|NCT01187043|262304|P5|Overall Study|Adverse Event|1
67417|NCT01187043|262305|P4|Overall Study|Adverse Event|0
67418|NCT01187043|262306|P3|Overall Study|Adverse Event|0
67419|NCT01187043|262307|P2|Overall Study|Adverse Event|0
67420|NCT01187043|262308|P1|Overall Study|Adverse Event|0
67421|NCT01186939|262334|P1|Overall Study|Transformation to AML|1
67422|NCT01186939|262334|P1|Overall Study|Bone marrow transplant|1
67423|NCT01186939|262334|P1|Overall Study|Myocardial infarction|1
67424|NCT01186939|262334|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
67425|NCT01186939|262334|P1|Overall Study|Started additional treatment|1
67426|NCT01186939|262334|P1|Overall Study|Sponsor decision|4
67427|NCT01186939|262334|P1|Overall Study|Program closed|5
67428|NCT01186939|262334|P1|Overall Study|No longer receiving clinical benefit|17
67429|NCT01186939|262334|P1|Overall Study|Withdrawal by Subject|2
67430|NCT01186939|262334|P1|Overall Study|Death|7
67431|NCT01186848|262338|P1|Overall Study|Adverse Event|2
67432|NCT01186848|262338|P1|Overall Study|Withdrawal by Subject|2
67433|NCT01186848|262338|P1|Overall Study|Lost to Follow-up|4
67434|NCT01186796|262346|P2|Overall Study|Protocol Violation|1
67435|NCT01186796|262347|P1|Overall Study|Protocol Violation|0
67436|NCT01186796|262346|P2|Overall Study|Withdrawal by Subject|1
67437|NCT01186796|262347|P1|Overall Study|Withdrawal by Subject|1
67438|NCT01186796|262346|P2|Overall Study|Adverse Event|0
67439|NCT01186796|262347|P1|Overall Study|Adverse Event|3
67440|NCT01186744|262367|P6|Overall Study|Death|0
67441|NCT01186744|262368|P5|Overall Study|Death|0
67442|NCT01186744|262369|P4|Overall Study|Death|0
67443|NCT01186744|262370|P3|Overall Study|Death|0
67444|NCT01186744|262371|P2|Overall Study|Death|0
67445|NCT01186744|262372|P1|Overall Study|Death|1
67446|NCT01186744|262367|P6|Overall Study|Adverse Event|4
67447|NCT01186744|262368|P5|Overall Study|Adverse Event|1
67448|NCT01186744|262369|P4|Overall Study|Adverse Event|0
67449|NCT01186744|262370|P3|Overall Study|Adverse Event|1
67450|NCT01186744|262371|P2|Overall Study|Adverse Event|14
67451|NCT01186744|262372|P1|Overall Study|Adverse Event|10
67452|NCT01186744|262367|P6|Overall Study|Not specified|5
67453|NCT01186744|262368|P5|Overall Study|Not specified|1
67454|NCT01186744|262369|P4|Overall Study|Not specified|2
67455|NCT01186744|262370|P3|Overall Study|Not specified|1
67456|NCT01186744|262371|P2|Overall Study|Not specified|10
67457|NCT01186744|262372|P1|Overall Study|Not specified|9
67458|NCT01186744|262367|P6|Overall Study|Study terminated by Sponsor|0
67459|NCT01186744|262368|P5|Overall Study|Study terminated by Sponsor|0
67460|NCT01186744|262369|P4|Overall Study|Study terminated by Sponsor|0
67461|NCT01186744|262370|P3|Overall Study|Study terminated by Sponsor|0
67462|NCT01186744|262371|P2|Overall Study|Study terminated by Sponsor|0
67463|NCT01186744|262372|P1|Overall Study|Study terminated by Sponsor|1
67464|NCT01186744|262367|P6|Overall Study|Withdrawal by Subject|6
67465|NCT01186744|262368|P5|Overall Study|Withdrawal by Subject|0
67466|NCT01186744|262369|P4|Overall Study|Withdrawal by Subject|5
67467|NCT01186744|262370|P3|Overall Study|Withdrawal by Subject|2
67468|NCT01186744|262371|P2|Overall Study|Withdrawal by Subject|10
67469|NCT01186744|262372|P1|Overall Study|Withdrawal by Subject|14
67470|NCT01186744|262367|P6|Overall Study|Screen failure|0
67471|NCT01186744|262368|P5|Overall Study|Screen failure|0
67472|NCT01186744|262369|P4|Overall Study|Screen failure|1
67473|NCT01186744|262370|P3|Overall Study|Screen failure|0
67474|NCT01186744|262371|P2|Overall Study|Screen failure|1
67475|NCT01186744|262372|P1|Overall Study|Screen failure|1
67476|NCT01186744|262367|P6|Overall Study|Lost to Follow-up|4
67477|NCT01186744|262368|P5|Overall Study|Lost to Follow-up|1
67478|NCT01186744|262369|P4|Overall Study|Lost to Follow-up|1
67479|NCT01186744|262370|P3|Overall Study|Lost to Follow-up|2
67480|NCT01186744|262371|P2|Overall Study|Lost to Follow-up|16
67481|NCT01186744|262372|P1|Overall Study|Lost to Follow-up|15
67482|NCT01186744|262367|P6|Overall Study|Protocol Violation|2
67483|NCT01186744|262368|P5|Overall Study|Protocol Violation|1
67484|NCT01186744|262369|P4|Overall Study|Protocol Violation|1
67485|NCT01186744|262370|P3|Overall Study|Protocol Violation|0
67486|NCT01186744|262371|P2|Overall Study|Protocol Violation|2
67487|NCT01186744|262372|P1|Overall Study|Protocol Violation|1
67488|NCT01186744|262367|P6|Overall Study|Lack of Efficacy|5
67489|NCT01186744|262368|P5|Overall Study|Lack of Efficacy|2
67490|NCT01186744|262369|P4|Overall Study|Lack of Efficacy|2
67491|NCT01186744|262370|P3|Overall Study|Lack of Efficacy|0
67492|NCT01186744|262371|P2|Overall Study|Lack of Efficacy|99
67493|NCT01186744|262372|P1|Overall Study|Lack of Efficacy|156
67494|NCT01186692|262792|P1|Overall Study|Adverse Event|2
67495|NCT01186692|262792|P1|Overall Study|Futher testing contraindicated implant|19
67496|NCT01186692|262792|P1|Overall Study|Not Catheterized|11
67497|NCT01186458|262819|P1|Overall Study|Adverse Event|1
67498|NCT01186419|262828|P2|Overall Study|Not specified|1
67499|NCT01186419|262829|P1|Overall Study|Not specified|1
67500|NCT01186419|262828|P2|Overall Study|Physician Decision|3
67501|NCT01186419|262829|P1|Overall Study|Physician Decision|0
67502|NCT01186419|262828|P2|Overall Study|Adverse Event|2
67503|NCT01186419|262829|P1|Overall Study|Adverse Event|1
67504|NCT01186419|262828|P2|Overall Study|Withdrawal by Subject|3
67505|NCT01186419|262829|P1|Overall Study|Withdrawal by Subject|5
67506|NCT01185964|262867|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
67507|NCT01185964|262868|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
67508|NCT01185964|262869|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
67509|NCT01185964|262870|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
67510|NCT01185964|262867|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
67511|NCT01185964|262868|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
67512|NCT01185964|262869|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
67513|NCT01185964|262870|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
67514|NCT01185964|262867|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
67515|NCT01185964|262868|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
67516|NCT01185964|262869|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
67517|NCT01185964|262870|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
67518|NCT01185964|262867|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
67519|NCT01185964|262868|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
67520|NCT01185964|262869|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
67521|NCT01185964|262870|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
67522|NCT01185964|262867|P4|Phase 1b and Phase 2|Adverse Event|0
67523|NCT01185964|262868|P3|Phase 1b and Phase 2|Adverse Event|2
67524|NCT01185964|262869|P2|Phase 1b and Phase 2|Adverse Event|0
67525|NCT01185964|262870|P1|Phase 1b and Phase 2|Adverse Event|1
67526|NCT01185964|262867|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
67527|NCT01185964|262868|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
67528|NCT01185964|262869|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
67529|NCT01185964|262870|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
67530|NCT01185964|262867|P4|Phase 1b and Phase 2|Other Therapy Started|0
67531|NCT01185964|262868|P3|Phase 1b and Phase 2|Other Therapy Started|3
67532|NCT01185964|262869|P2|Phase 1b and Phase 2|Other Therapy Started|3
67533|NCT01185964|262870|P1|Phase 1b and Phase 2|Other Therapy Started|0
67534|NCT01185964|262867|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
67535|NCT01185964|262868|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
67536|NCT01185964|262869|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
67537|NCT01185964|262870|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
67538|NCT01185834|262896|P1|Overall Study|Early exit - Site error|2
67539|NCT01185834|262896|P1|Overall Study|Time/Job Conflict|2
67540|NCT01185834|262896|P1|Overall Study|Biomicroscopy|4
67541|NCT01185834|262896|P1|Overall Study|Discomfort|4
67542|NCT01185834|262896|P1|Overall Study|Lost to Follow-up|2
67543|NCT01185782|262903|P2|Overall Study|Randomized but not treated|4
67544|NCT01185782|262904|P1|Overall Study|Randomized but not treated|0
67545|NCT01185782|262903|P2|Overall Study|Unspecified|5
67546|NCT01185782|262904|P1|Overall Study|Unspecified|2
67547|NCT01185782|262903|P2|Overall Study|Poor Response to Treatment|1
67548|NCT01185782|262904|P1|Overall Study|Poor Response to Treatment|3
67549|NCT01185782|262903|P2|Overall Study|Protocol Violation|0
67550|NCT01185782|262904|P1|Overall Study|Protocol Violation|1
67551|NCT01185782|262903|P2|Overall Study|Adverse Event|1
67552|NCT01185782|262904|P1|Overall Study|Adverse Event|0
67553|NCT01185704|262932|P2|Overall Study|Ectopic pregnancy|1
67554|NCT01185704|262933|P1|Overall Study|Ectopic pregnancy|0
67555|NCT01185704|262932|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
67556|NCT01185704|262933|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
67557|NCT01185704|262932|P2|Overall Study|Lack of ovarian response|1
67558|NCT01185704|262933|P1|Overall Study|Lack of ovarian response|5
67559|NCT01185704|262932|P2|Overall Study|Randomized but not treated|3
67560|NCT01185704|262933|P1|Overall Study|Randomized but not treated|3
67561|NCT01185600|262969|P2|Overall Study|Hold by DSMB|2
67562|NCT01185600|262970|P1|Overall Study|Hold by DSMB|1
67563|NCT01185600|262969|P2|Overall Study|Withdrawal by Subject|1
67564|NCT01185600|262970|P1|Overall Study|Withdrawal by Subject|1
67565|NCT01185600|262969|P2|Overall Study|Physician Decision|35
67566|NCT01185600|262970|P1|Overall Study|Physician Decision|29
67567|NCT01185600|262969|P2|Overall Study|Lost to Follow-up|5
67568|NCT01185600|262970|P1|Overall Study|Lost to Follow-up|0
67569|NCT01185600|262969|P2|Overall Study|Death|1
67570|NCT01185600|262970|P1|Overall Study|Death|0
67571|NCT01185600|262969|P2|Overall Study|Adverse Event|1
67572|NCT01185600|262970|P1|Overall Study|Adverse Event|1
67573|NCT01185561|262992|P2|Overall Study|Withdrawal by Subject|8
67574|NCT01185561|262993|P1|Overall Study|Withdrawal by Subject|2
67575|NCT01185561|262992|P2|Overall Study|Lost to Follow-up|4
67576|NCT01185561|262993|P1|Overall Study|Lost to Follow-up|0
67577|NCT01185522|263005|P1|Overall Study|Other reasons|12
67578|NCT01185522|263005|P1|Overall Study|Poor tolerance|39
67579|NCT01185522|263005|P1|Overall Study|Withdrawal by Subject|10
67580|NCT01185522|263005|P1|Overall Study|Lost to Follow-up|19
67581|NCT01185522|263005|P1|Overall Study|Lack of Efficacy|28
67582|NCT01185509|263031|P2|Overall Study|Intercurrent Illness|1
67583|NCT01185509|263032|P1|Overall Study|Intercurrent Illness|0
67584|NCT01185509|263031|P2|Overall Study|Death|1
67585|NCT01185509|263032|P1|Overall Study|Death|0
67586|NCT01185509|263031|P2|Overall Study|Withdrawal by Subject|1
67587|NCT01185509|263032|P1|Overall Study|Withdrawal by Subject|0
67588|NCT01185509|263031|P2|Overall Study|Physician Decision|2
67589|NCT01185509|263032|P1|Overall Study|Physician Decision|2
67590|NCT01185509|263031|P2|Overall Study|Progression/Relapse|15
67591|NCT01185509|263032|P1|Overall Study|Progression/Relapse|9
67592|NCT01185353|263047|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
67593|NCT01185353|263048|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
67594|NCT01185353|263049|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
67595|NCT01185353|263050|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
67596|NCT01185353|263051|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
67597|NCT01185353|263052|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
67598|NCT01185353|263053|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
67599|NCT01185353|263054|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
67600|NCT01185353|263055|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
67601|NCT01185353|263056|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
67602|NCT01185353|263047|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
67603|NCT01185353|263048|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
67604|NCT01185353|263049|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
67605|NCT01185353|263050|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67606|NCT01185353|263051|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67607|NCT01185353|263052|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67608|NCT01185353|263053|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67609|NCT01185353|263054|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67610|NCT01185353|263055|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67611|NCT01185353|263056|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
67612|NCT01185353|263047|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67613|NCT01185353|263048|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
67614|NCT01185353|263049|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
67615|NCT01185353|263050|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67616|NCT01185353|263051|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67617|NCT01185353|263052|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67618|NCT01185353|263053|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67619|NCT01185353|263054|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67620|NCT01185353|263055|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67621|NCT01185353|263056|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
67622|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Reason missing|0
67623|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Reason missing|1
67624|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Reason missing|0
67625|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Reason missing|0
67626|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Reason missing|0
67627|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Reason missing|0
67628|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Reason missing|0
67629|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Reason missing|0
67630|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Reason missing|0
67631|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Reason missing|0
67632|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
67633|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
67634|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
67635|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
67636|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
67637|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
67638|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
67639|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
67640|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
67641|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
67642|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
67643|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67644|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67645|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67646|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67647|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67648|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67649|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67650|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67651|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
67652|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Death|1
67653|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Death|0
67654|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Death|0
67655|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Death|0
67656|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Death|0
67657|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Death|0
67658|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Death|0
67659|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Death|0
67660|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Death|0
67661|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Death|0
67662|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67663|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
67664|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67665|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67666|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67667|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67668|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67669|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67670|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67671|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
67672|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
67673|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
67674|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
67675|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67676|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67677|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67678|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67679|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67680|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67681|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
67682|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
67683|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
67684|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
67685|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67686|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67687|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67688|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67689|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67690|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67691|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
67692|NCT01185353|263047|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
67693|NCT01185353|263048|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
67694|NCT01185353|263049|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
67695|NCT01185353|263050|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
67696|NCT01185353|263051|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
67697|NCT01185353|263052|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
67698|NCT01185353|263053|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
67699|NCT01185353|263054|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
67700|NCT01185353|263055|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
67701|NCT01185353|263056|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
67702|NCT01185353|263047|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67703|NCT01185353|263048|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67704|NCT01185353|263049|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67705|NCT01185353|263050|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
67706|NCT01185353|263051|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67707|NCT01185353|263052|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67708|NCT01185353|263053|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67709|NCT01185353|263054|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67710|NCT01185353|263055|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67711|NCT01185353|263056|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
67712|NCT01185353|263047|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
67713|NCT01185353|263048|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
67714|NCT01185353|263049|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
67715|NCT01185353|263050|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
67716|NCT01185353|263051|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
67717|NCT01185353|263052|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
67718|NCT01185353|263053|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
67719|NCT01185353|263054|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
67720|NCT01185353|263055|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
67721|NCT01185353|263056|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
67722|NCT01185353|263047|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67723|NCT01185353|263048|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67724|NCT01185353|263049|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67725|NCT01185353|263050|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
67726|NCT01185353|263051|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67727|NCT01185353|263052|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67728|NCT01185353|263053|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
67729|NCT01185353|263054|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67730|NCT01185353|263055|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67731|NCT01185353|263056|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
67732|NCT01185353|263047|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67733|NCT01185353|263048|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67734|NCT01185353|263049|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67735|NCT01185353|263050|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67736|NCT01185353|263051|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67737|NCT01185353|263052|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67738|NCT01185353|263053|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
67739|NCT01185353|263054|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67740|NCT01185353|263055|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
67741|NCT01185353|263056|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
67742|NCT01185353|263047|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
67743|NCT01185353|263048|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
67744|NCT01185353|263049|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
67745|NCT01185353|263050|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
67746|NCT01185353|263051|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
67747|NCT01185353|263052|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
67748|NCT01185353|263053|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
67749|NCT01185353|263054|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
67750|NCT01185353|263055|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
67751|NCT01185353|263056|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
67752|NCT01185353|263047|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67753|NCT01185353|263048|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67754|NCT01185353|263049|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67755|NCT01185353|263050|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67756|NCT01185353|263051|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67757|NCT01185353|263052|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
67758|NCT01185353|263053|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67759|NCT01185353|263054|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67760|NCT01185353|263055|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
67761|NCT01185353|263056|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
67762|NCT01185353|263047|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
67763|NCT01185353|263048|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
67764|NCT01185353|263049|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
67765|NCT01185353|263050|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
67766|NCT01185353|263051|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
67767|NCT01185353|263052|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
67768|NCT01185353|263053|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
67769|NCT01185353|263054|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
67770|NCT01185353|263055|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
67771|NCT01185353|263056|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
67772|NCT01185353|263047|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
67773|NCT01185353|263048|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
67774|NCT01185353|263049|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
67775|NCT01185353|263050|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
67776|NCT01185353|263051|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
67777|NCT01185353|263052|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
67778|NCT01185353|263053|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
67779|NCT01185353|263054|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
67780|NCT01185353|263055|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
67781|NCT01185353|263056|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
67782|NCT01185353|263047|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67783|NCT01185353|263048|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67784|NCT01185353|263049|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67785|NCT01185353|263050|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67786|NCT01185353|263051|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67787|NCT01185353|263052|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
67788|NCT01185353|263053|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67789|NCT01185353|263054|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67790|NCT01185353|263055|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
67791|NCT01185353|263056|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
67792|NCT01185353|263047|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67793|NCT01185353|263048|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67794|NCT01185353|263049|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67795|NCT01185353|263050|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67796|NCT01185353|263051|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67797|NCT01185353|263052|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
67798|NCT01185353|263053|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67799|NCT01185353|263054|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67800|NCT01185353|263055|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67801|NCT01185353|263056|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
67802|NCT01185353|263047|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
67803|NCT01185353|263048|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
67804|NCT01185353|263049|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
67805|NCT01185353|263050|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
67806|NCT01185353|263051|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
67807|NCT01185353|263052|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
67808|NCT01185353|263053|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
67809|NCT01185353|263054|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
67810|NCT01185353|263055|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
67811|NCT01185353|263056|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
67812|NCT01185301|263218|P4|Overall Study|Other Reason|2
67813|NCT01185301|263219|P3|Overall Study|Other Reason|2
67814|NCT01185301|263220|P2|Overall Study|Other Reason|2
67815|NCT01185301|263221|P1|Overall Study|Other Reason|3
67816|NCT01185301|263218|P4|Overall Study|Lost to Follow-up|1
67817|NCT01185301|263219|P3|Overall Study|Lost to Follow-up|0
67818|NCT01185301|263220|P2|Overall Study|Lost to Follow-up|0
67819|NCT01185301|263221|P1|Overall Study|Lost to Follow-up|2
67820|NCT01185301|263218|P4|Overall Study|Withdrawal by Subject|3
67821|NCT01185301|263219|P3|Overall Study|Withdrawal by Subject|2
67822|NCT01185301|263220|P2|Overall Study|Withdrawal by Subject|5
67823|NCT01185301|263221|P1|Overall Study|Withdrawal by Subject|7
67824|NCT01185301|263218|P4|Overall Study|Adverse Event|3
67825|NCT01185301|263219|P3|Overall Study|Adverse Event|2
67826|NCT01185301|263220|P2|Overall Study|Adverse Event|0
67827|NCT01185301|263221|P1|Overall Study|Adverse Event|3
67828|NCT01185288|263281|P2|Overall Study|Noncompliance|1
67829|NCT01185288|263282|P1|Overall Study|Noncompliance|0
67830|NCT01185288|263281|P2|Overall Study|Did not meet inclusion criteria|0
67831|NCT01185288|263282|P1|Overall Study|Did not meet inclusion criteria|1
67832|NCT01185288|263281|P2|Overall Study|Investigator discretion|0
67833|NCT01185288|263282|P1|Overall Study|Investigator discretion|1
67834|NCT01185288|263281|P2|Overall Study|Lack of Efficacy|0
67835|NCT01185288|263282|P1|Overall Study|Lack of Efficacy|2
67836|NCT01185288|263281|P2|Overall Study|Lost to Follow-up|5
67837|NCT01185288|263282|P1|Overall Study|Lost to Follow-up|2
67838|NCT01185288|263281|P2|Overall Study|Withdrawal by Subject|4
67839|NCT01185288|263282|P1|Overall Study|Withdrawal by Subject|6
67840|NCT01185288|263281|P2|Overall Study|Adverse Event|6
67841|NCT01185288|263282|P1|Overall Study|Adverse Event|7
67842|NCT01185249|263300|P1|Overall Study|Patients discharged or change in status|42
67843|NCT01185080|263308|P3|Overall Study|Personal reasons|1
67844|NCT01185080|263309|P2|Overall Study|Personal reasons|0
67845|NCT01185080|263310|P1|Overall Study|Personal reasons|0
67846|NCT01185080|263308|P3|Overall Study|Adverse Event|0
67847|NCT01185080|263309|P2|Overall Study|Adverse Event|1
67848|NCT01185080|263310|P1|Overall Study|Adverse Event|1
67849|NCT01184989|263362|P1|Overall Study|Withdrawal by Subject|1
67850|NCT01184989|263362|P1|Overall Study|Adverse Event|11
67851|NCT01184872|263382|P2|Overall Study|Protocol deviation|0
67852|NCT01184872|263383|P1|Overall Study|Protocol deviation|1
67853|NCT01184872|263382|P2|Overall Study|Administrative problems|1
67854|NCT01184872|263383|P1|Overall Study|Administrative problems|1
67855|NCT01184872|263382|P2|Overall Study|Lost to Follow-up|1
67856|NCT01184872|263383|P1|Overall Study|Lost to Follow-up|0
67857|NCT01184872|263382|P2|Overall Study|Withdrawal by Subject|0
67858|NCT01184872|263383|P1|Overall Study|Withdrawal by Subject|2
67859|NCT01184872|263382|P2|Overall Study|Unsatisfactory therapeutic effect|2
67860|NCT01184872|263383|P1|Overall Study|Unsatisfactory therapeutic effect|3
67861|NCT01184872|263382|P2|Overall Study|Adverse Event|4
67862|NCT01184872|263383|P1|Overall Study|Adverse Event|3
67863|NCT01184859|263402|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
67864|NCT01184859|263403|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
67865|NCT01184859|263404|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
67866|NCT01184859|263405|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
67867|NCT01184859|263406|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
67868|NCT01184859|263402|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
67869|NCT01184859|263403|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
67870|NCT01184859|263404|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
67871|NCT01184859|263405|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
67872|NCT01184859|263406|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
67873|NCT01184859|263402|P5|Period 1: Single Dose|Adverse Event|1
67874|NCT01184859|263403|P4|Period 1: Single Dose|Adverse Event|0
67875|NCT01184859|263404|P3|Period 1: Single Dose|Adverse Event|0
67876|NCT01184859|263405|P2|Period 1: Single Dose|Adverse Event|0
67877|NCT01184859|263406|P1|Period 1: Single Dose|Adverse Event|0
67878|NCT01184859|263402|P5|Period 1: Single Dose|Protocol Violation|0
67879|NCT01184859|263403|P4|Period 1: Single Dose|Protocol Violation|0
67880|NCT01184859|263404|P3|Period 1: Single Dose|Protocol Violation|0
67881|NCT01184859|263405|P2|Period 1: Single Dose|Protocol Violation|1
67882|NCT01184859|263406|P1|Period 1: Single Dose|Protocol Violation|0
67883|NCT01184859|263402|P5|Period 1: Single Dose|Insufficient urine production|0
67884|NCT01184859|263403|P4|Period 1: Single Dose|Insufficient urine production|0
67885|NCT01184859|263404|P3|Period 1: Single Dose|Insufficient urine production|0
67886|NCT01184859|263405|P2|Period 1: Single Dose|Insufficient urine production|1
67887|NCT01184859|263406|P1|Period 1: Single Dose|Insufficient urine production|0
67888|NCT01184846|263498|P1|Overall Study|Insufficient response|1
67889|NCT01184846|263498|P1|Overall Study|Adverse Event|2
67890|NCT01184118|263552|P1|Overall Study|Withdrawal by Subject|5
67891|NCT01184118|263552|P1|Overall Study|Exclusionary medical condition|2
67892|NCT01184118|263552|P1|Overall Study|FEV1 <60% predicted|2
67893|NCT01184118|263552|P1|Overall Study|No physiologic confirmation of asthma|8
67894|NCT01184118|263552|P1|Overall Study|Only asthma step 1 - screen fail|1
67895|NCT01184079|263560|P2|Overall Study|Lost to Follow-up|2
67896|NCT01184079|263561|P1|Overall Study|Lost to Follow-up|14
67897|NCT01184053|263571|P1|Overall Study|progression while on treatment|3
67898|NCT01183975|263587|P1|Overall Study|Lost to Follow-up|73
67899|NCT01183858|263594|P2|Overall Study|Lost to Follow-up|1
67900|NCT01183858|263595|P1|Overall Study|Lost to Follow-up|1
67901|NCT01183858|263594|P2|Overall Study|Death related to Progressive Disease|5
67902|NCT01183858|263595|P1|Overall Study|Death related to Progressive Disease|4
67903|NCT01183858|263594|P2|Overall Study|Progressive Disease|115
67904|NCT01183858|263595|P1|Overall Study|Progressive Disease|112
67905|NCT01183858|263594|P2|Overall Study|Administrative/Other|6
67906|NCT01183858|263595|P1|Overall Study|Administrative/Other|6
67907|NCT01183858|263594|P2|Overall Study|Protocol Violation|0
67908|NCT01183858|263595|P1|Overall Study|Protocol Violation|1
67909|NCT01183858|263594|P2|Overall Study|Discontinued Smoking|1
67910|NCT01183858|263595|P1|Overall Study|Discontinued Smoking|3
67911|NCT01183858|263594|P2|Overall Study|Withdrew Consent|4
67912|NCT01183858|263595|P1|Overall Study|Withdrew Consent|4
67913|NCT01183858|263594|P2|Overall Study|Refused Treatment|4
67914|NCT01183858|263595|P1|Overall Study|Refused Treatment|1
67915|NCT01183858|263594|P2|Overall Study|Insufficient Therapeutic Response|0
67916|NCT01183858|263595|P1|Overall Study|Insufficient Therapeutic Response|2
67917|NCT01183858|263594|P2|Overall Study|Investigator's Decision|3
67918|NCT01183858|263595|P1|Overall Study|Investigator's Decision|0
67919|NCT01183858|263594|P2|Overall Study|Adverse Event|11
67920|NCT01183858|263595|P1|Overall Study|Adverse Event|14
67921|NCT01183858|263594|P2|Overall Study|Death not related to Progressive Disease|6
67922|NCT01183858|263595|P1|Overall Study|Death not related to Progressive Disease|5
67923|NCT01183780|263617|P2|Overall Study|Lost to Follow-up|11
67924|NCT01183780|263618|P1|Overall Study|Lost to Follow-up|6
67925|NCT01183780|263617|P2|Overall Study|Withdrawal by Subject|14
67926|NCT01183780|263618|P1|Overall Study|Withdrawal by Subject|25
67927|NCT01183468|263678|P4|Overall Study|Withdrawal by Subject|0
67928|NCT01183468|263679|P3|Overall Study|Withdrawal by Subject|0
67929|NCT01183468|263680|P2|Overall Study|Withdrawal by Subject|1
67930|NCT01183468|263681|P1|Overall Study|Withdrawal by Subject|0
67931|NCT01183468|263678|P4|Overall Study|Physician Decision|0
67932|NCT01183468|263679|P3|Overall Study|Physician Decision|0
67933|NCT01183468|263680|P2|Overall Study|Physician Decision|0
67934|NCT01183468|263681|P1|Overall Study|Physician Decision|1
67935|NCT01183468|263678|P4|Overall Study|Lost to Follow-up|0
67936|NCT01183468|263679|P3|Overall Study|Lost to Follow-up|0
67937|NCT01183468|263680|P2|Overall Study|Lost to Follow-up|1
67938|NCT01183468|263681|P1|Overall Study|Lost to Follow-up|2
67939|NCT01183390|263691|P2|First Intervention|Adverse Event|1
67940|NCT01183390|263692|P1|First Intervention|Adverse Event|0
67941|NCT01183234|263723|P2|First Intervention|Adverse Event|0
67942|NCT01183234|263724|P1|First Intervention|Adverse Event|1
67943|NCT01183104|263818|P2|Overall Study|Did not receive study drug|9
67944|NCT01183104|263819|P1|Overall Study|Did not receive study drug|5
67945|NCT01183104|263818|P2|Overall Study|Nonparticipation in Extension Study|50
67946|NCT01183104|263819|P1|Overall Study|Nonparticipation in Extension Study|39
67947|NCT01183104|263818|P2|Overall Study|Withdrawal by Subject|11
67948|NCT01183104|263819|P1|Overall Study|Withdrawal by Subject|6
67949|NCT01183104|263818|P2|Overall Study|Physician Decision|8
67950|NCT01183104|263819|P1|Overall Study|Physician Decision|5
67951|NCT01183104|263818|P2|Overall Study|Lost to Follow-up|7
67952|NCT01183104|263819|P1|Overall Study|Lost to Follow-up|14
67953|NCT01183104|263818|P2|Overall Study|Death|1
67954|NCT01183104|263819|P1|Overall Study|Death|0
67955|NCT01183104|263818|P2|Overall Study|Adverse Event|6
67956|NCT01183104|263819|P1|Overall Study|Adverse Event|8
67957|NCT01183065|263835|P1|Overall Study|Patient no longer fits eligibility crite|1
67958|NCT01183013|263846|P7|Overall Study|Reasons other than stated above|13
67959|NCT01183013|263847|P6|Overall Study|Reasons other than stated above|15
67960|NCT01183013|263848|P5|Overall Study|Reasons other than stated above|12
67961|NCT01183013|263849|P4|Overall Study|Reasons other than stated above|12
67962|NCT01183013|263850|P3|Overall Study|Reasons other than stated above|17
67963|NCT01183013|263851|P2|Overall Study|Reasons other than stated above|11
67964|NCT01183013|263852|P1|Overall Study|Reasons other than stated above|15
67965|NCT01183013|263846|P7|Overall Study|Withdrawal by Subject|10
67966|NCT01183013|263847|P6|Overall Study|Withdrawal by Subject|9
67967|NCT01183013|263848|P5|Overall Study|Withdrawal by Subject|7
67968|NCT01183013|263849|P4|Overall Study|Withdrawal by Subject|8
67969|NCT01183013|263850|P3|Overall Study|Withdrawal by Subject|10
67970|NCT01183013|263851|P2|Overall Study|Withdrawal by Subject|13
67971|NCT01183013|263852|P1|Overall Study|Withdrawal by Subject|9
67972|NCT01183013|263846|P7|Overall Study|Lost to Follow-up|5
67973|NCT01183013|263847|P6|Overall Study|Lost to Follow-up|6
67974|NCT01183013|263848|P5|Overall Study|Lost to Follow-up|2
67975|NCT01183013|263849|P4|Overall Study|Lost to Follow-up|3
67976|NCT01183013|263850|P3|Overall Study|Lost to Follow-up|4
67977|NCT01183013|263851|P2|Overall Study|Lost to Follow-up|3
67978|NCT01183013|263852|P1|Overall Study|Lost to Follow-up|7
67979|NCT01183013|263846|P7|Overall Study|Protocol Violation|3
67980|NCT01183013|263847|P6|Overall Study|Protocol Violation|3
67981|NCT01183013|263848|P5|Overall Study|Protocol Violation|4
67982|NCT01183013|263849|P4|Overall Study|Protocol Violation|0
67983|NCT01183013|263850|P3|Overall Study|Protocol Violation|4
67984|NCT01183013|263851|P2|Overall Study|Protocol Violation|2
67985|NCT01183013|263852|P1|Overall Study|Protocol Violation|5
67986|NCT01183013|263846|P7|Overall Study|Lack of Efficacy|0
67987|NCT01183013|263847|P6|Overall Study|Lack of Efficacy|2
67988|NCT01183013|263848|P5|Overall Study|Lack of Efficacy|1
67989|NCT01183013|263849|P4|Overall Study|Lack of Efficacy|2
67990|NCT01183013|263850|P3|Overall Study|Lack of Efficacy|1
67991|NCT01183013|263851|P2|Overall Study|Lack of Efficacy|2
67992|NCT01183013|263852|P1|Overall Study|Lack of Efficacy|3
67993|NCT01183013|263846|P7|Overall Study|Adverse Event|6
67994|NCT01183013|263847|P6|Overall Study|Adverse Event|10
67995|NCT01183013|263848|P5|Overall Study|Adverse Event|10
67996|NCT01183013|263849|P4|Overall Study|Adverse Event|5
67997|NCT01183013|263850|P3|Overall Study|Adverse Event|5
67998|NCT01183013|263851|P2|Overall Study|Adverse Event|8
67999|NCT01183013|263852|P1|Overall Study|Adverse Event|6
68000|NCT01182428|263976|P2|Overall Study|Withdrawal by Subject|0
68001|NCT01182428|263977|P1|Overall Study|Withdrawal by Subject|1
68002|NCT01182428|263976|P2|Overall Study|Lost to Follow-up|1
68003|NCT01182428|263977|P1|Overall Study|Lost to Follow-up|9
68004|NCT01182428|263976|P2|Overall Study|Physician Decision|0
68005|NCT01182428|263977|P1|Overall Study|Physician Decision|1
68006|NCT01182337|264052|P2|Overall Study|Lost to Follow-up|1
68007|NCT01182337|264053|P1|Overall Study|Lost to Follow-up|0
68008|NCT01182337|264052|P2|Overall Study|Withdrawal by Subject|1
68009|NCT01182337|264053|P1|Overall Study|Withdrawal by Subject|3
68010|NCT01182298|264071|P1|Overall Study|Withdrawal by Subject|2
68011|NCT01182298|264071|P1|Overall Study|Lack of Efficacy|4
68012|NCT01182285|264075|P3|Third Intervention Week 11-52|Other|2
68013|NCT01182285|264076|P2|Third Intervention Week 11-52|Other|0
68014|NCT01182285|264077|P1|Third Intervention Week 11-52|Other|0
68015|NCT01182285|264075|P3|Third Intervention Week 11-52|Disease Progression|6
68016|NCT01182285|264076|P2|Third Intervention Week 11-52|Disease Progression|0
68017|NCT01182285|264077|P1|Third Intervention Week 11-52|Disease Progression|0
68018|NCT01182285|264075|P3|First Intervention Week 1-10|Non-compliance|0
68019|NCT01182285|264076|P2|First Intervention Week 1-10|Non-compliance|0
68020|NCT01182285|264077|P1|First Intervention Week 1-10|Non-compliance|1
68021|NCT01182285|264075|P3|First Intervention Week 1-10|Adverse Event|0
68022|NCT01182285|264076|P2|First Intervention Week 1-10|Adverse Event|0
68023|NCT01182285|264077|P1|First Intervention Week 1-10|Adverse Event|1
68024|NCT01182285|264075|P3|First Intervention Week 1-10|Disease progression|0
68025|NCT01182285|264076|P2|First Intervention Week 1-10|Disease progression|0
68026|NCT01182285|264077|P1|First Intervention Week 1-10|Disease progression|1
68027|NCT01182207|264087|P2|Second Intervention|Emeses within 1 hour of dosing|0
68028|NCT01182207|264088|P1|Second Intervention|Emeses within 1 hour of dosing|1
68118|NCT01181141|264468|P2|Overall Study|Physician Decision|0
68029|NCT01182207|264087|P2|First Intervention|Positive Hepatitis Results|1
68030|NCT01182207|264088|P1|First Intervention|Positive Hepatitis Results|0
68031|NCT01182194|264106|P2|Washout of 28 Days|Withdrawal by Subject|0
68032|NCT01182194|264107|P1|Washout of 28 Days|Withdrawal by Subject|1
68033|NCT01182181|264125|P2|Washout of 21 Days|Withdrawal by Subject|1
68034|NCT01182181|264126|P1|Washout of 21 Days|Withdrawal by Subject|0
68035|NCT01182181|264125|P2|First Intervention|Adverse Event|0
68036|NCT01182181|264126|P1|First Intervention|Adverse Event|1
68037|NCT01181986|264151|P3|Phase 2|Medical condition|0
68038|NCT01181986|264152|P2|Phase 2|Medical condition|1
68039|NCT01181986|264153|P1|Phase 2|Medical condition|0
68040|NCT01181986|264151|P3|Phase 2|Adverse Event|0
68041|NCT01181986|264152|P2|Phase 2|Adverse Event|3
68042|NCT01181986|264153|P1|Phase 2|Adverse Event|0
68043|NCT01181986|264151|P3|Phase 1|Protocol Violation|0
68044|NCT01181986|264152|P2|Phase 1|Protocol Violation|0
68045|NCT01181986|264153|P1|Phase 1|Protocol Violation|1
68046|NCT01181986|264151|P3|Phase 1|Adverse Event|1
68047|NCT01181986|264152|P2|Phase 1|Adverse Event|0
68048|NCT01181986|264153|P1|Phase 1|Adverse Event|0
68049|NCT01181986|264151|P3|Phase 1|Lost to Follow-up|1
68050|NCT01181986|264152|P2|Phase 1|Lost to Follow-up|1
68051|NCT01181986|264153|P1|Phase 1|Lost to Follow-up|0
68052|NCT01181921|264174|P1|Overall Study|Lost to Follow-up|1
68053|NCT01181895|264181|P3|Overall Study|Withdrawal by Subject|5
68054|NCT01181895|264182|P2|Overall Study|Withdrawal by Subject|0
68055|NCT01181895|264183|P1|Overall Study|Withdrawal by Subject|3
68056|NCT01181895|264181|P3|Overall Study|Investigator Discretion|1
68057|NCT01181895|264182|P2|Overall Study|Investigator Discretion|2
68058|NCT01181895|264183|P1|Overall Study|Investigator Discretion|1
68059|NCT01181895|264181|P3|Overall Study|Lost to Follow-up|2
68060|NCT01181895|264182|P2|Overall Study|Lost to Follow-up|1
68061|NCT01181895|264183|P1|Overall Study|Lost to Follow-up|0
68062|NCT01181895|264181|P3|Overall Study|Protocol Violation|0
68063|NCT01181895|264182|P2|Overall Study|Protocol Violation|1
68064|NCT01181895|264183|P1|Overall Study|Protocol Violation|2
68065|NCT01181895|264181|P3|Overall Study|Lack of Efficacy|9
68066|NCT01181895|264182|P2|Overall Study|Lack of Efficacy|9
68067|NCT01181895|264183|P1|Overall Study|Lack of Efficacy|8
68068|NCT01181895|264181|P3|Overall Study|Adverse Event|1
68069|NCT01181895|264182|P2|Overall Study|Adverse Event|1
68070|NCT01181895|264183|P1|Overall Study|Adverse Event|3
68071|NCT01181778|264241|P1|Overall Study|Physician Decision|48
68072|NCT01181726|264249|P2|First Intervention|Adverse Event|0
68073|NCT01181726|264250|P1|First Intervention|Adverse Event|1
68074|NCT01181609|264296|P1|Overall Study|Death|50
68075|NCT01181609|264296|P1|Overall Study|Lost to Follow-up|1
68076|NCT01181609|264296|P1|Overall Study|Withdrawal by Subject|1
68077|NCT01181609|264296|P1|Overall Study|Adverse Event|1
68078|NCT01181531|264309|P2|Overall Study|Adverse Event|1
68079|NCT01181531|264310|P1|Overall Study|Adverse Event|0
68080|NCT01181531|264309|P2|Overall Study|Death|12
68081|NCT01181531|264310|P1|Overall Study|Death|9
68082|NCT01181531|264309|P2|Overall Study|Protocol Violation|6
68083|NCT01181531|264310|P1|Overall Study|Protocol Violation|6
68084|NCT01181531|264309|P2|Overall Study|Withdrawal by Subject|7
68085|NCT01181531|264310|P1|Overall Study|Withdrawal by Subject|8
68086|NCT01181531|264309|P2|Overall Study|Pregnancy|1
68087|NCT01181531|264310|P1|Overall Study|Pregnancy|0
68088|NCT01181531|264309|P2|Overall Study|Protocol Specified Criteria|8
68089|NCT01181531|264310|P1|Overall Study|Protocol Specified Criteria|15
68090|NCT01181531|264309|P2|Overall Study|Ineligibility determined|2
68091|NCT01181531|264310|P1|Overall Study|Ineligibility determined|1
68092|NCT01181531|264309|P2|Overall Study|Noncompliance|2
68093|NCT01181531|264310|P1|Overall Study|Noncompliance|2
68094|NCT01181531|264309|P2|Overall Study|Physician Decision|1
68095|NCT01181531|264310|P1|Overall Study|Physician Decision|3
68096|NCT01181531|264309|P2|Overall Study|Partial consent by subject withdrawn|1
68097|NCT01181531|264310|P1|Overall Study|Partial consent by subject withdrawn|0
68098|NCT01181531|264309|P2|Overall Study|Not known|12
68099|NCT01181531|264310|P1|Overall Study|Not known|17
68100|NCT01181271|264433|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
68101|NCT01181271|264433|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
68102|NCT01181271|264433|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
68103|NCT01181271|264433|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
68104|NCT01181167|264457|P2|Overall Study|Withdrawal by Subject|8
68105|NCT01181167|264458|P1|Overall Study|Withdrawal by Subject|6
68106|NCT01181167|264457|P2|Overall Study|Protocol Violation|0
68107|NCT01181167|264458|P1|Overall Study|Protocol Violation|3
68108|NCT01181167|264457|P2|Overall Study|Physician Decision|3
68109|NCT01181167|264458|P1|Overall Study|Physician Decision|2
68110|NCT01181167|264457|P2|Overall Study|Lost to Follow-up|0
68111|NCT01181167|264458|P1|Overall Study|Lost to Follow-up|1
68112|NCT01181167|264457|P2|Overall Study|Adverse Event|21
68113|NCT01181167|264458|P1|Overall Study|Adverse Event|11
68114|NCT01181141|264468|P2|Overall Study|Withdrawal by Subject|1
68115|NCT01181141|264469|P1|Overall Study|Withdrawal by Subject|3
68116|NCT01181141|264468|P2|Overall Study|Protocol Violation|1
68117|NCT01181141|264469|P1|Overall Study|Protocol Violation|3
68119|NCT01181141|264469|P1|Overall Study|Physician Decision|2
68120|NCT01181141|264468|P2|Overall Study|Lost to Follow-up|1
68121|NCT01181141|264469|P1|Overall Study|Lost to Follow-up|1
68122|NCT01181141|264468|P2|Overall Study|Lack of Efficacy|0
68123|NCT01181141|264469|P1|Overall Study|Lack of Efficacy|1
68124|NCT01181141|264468|P2|Overall Study|Adverse Event|1
68125|NCT01181141|264469|P1|Overall Study|Adverse Event|2
68126|NCT01181128|264478|P3|Overall Study|Not Specified|1
68127|NCT01181128|264479|P2|Overall Study|Not Specified|1
68128|NCT01181128|264480|P1|Overall Study|Not Specified|1
68129|NCT01181128|264478|P3|Overall Study|Adverse Event|0
68130|NCT01181128|264479|P2|Overall Study|Adverse Event|2
68131|NCT01181128|264480|P1|Overall Study|Adverse Event|0
68132|NCT01181128|264478|P3|Overall Study|Physician Decision|0
68133|NCT01181128|264479|P2|Overall Study|Physician Decision|0
68134|NCT01181128|264480|P1|Overall Study|Physician Decision|2
68135|NCT01181128|264478|P3|Overall Study|Death|0
68136|NCT01181128|264479|P2|Overall Study|Death|0
68137|NCT01181128|264480|P1|Overall Study|Death|1
68138|NCT01181128|264478|P3|Overall Study|Withdrawal by Subject|0
68139|NCT01181128|264479|P2|Overall Study|Withdrawal by Subject|2
68140|NCT01181128|264480|P1|Overall Study|Withdrawal by Subject|2
68141|NCT01181102|264568|P2|Overall Study|Withdrawal by Subject|12
68142|NCT01181102|264569|P1|Overall Study|Withdrawal by Subject|10
68143|NCT01181102|264568|P2|Overall Study|Protocol Violation|6
68144|NCT01181102|264569|P1|Overall Study|Protocol Violation|5
68145|NCT01181102|264568|P2|Overall Study|Physician Decision|1
68146|NCT01181102|264569|P1|Overall Study|Physician Decision|3
68147|NCT01181102|264568|P2|Overall Study|Lost to Follow-up|0
68148|NCT01181102|264569|P1|Overall Study|Lost to Follow-up|2
68149|NCT01181102|264568|P2|Overall Study|Lack of Efficacy|1
68150|NCT01181102|264569|P1|Overall Study|Lack of Efficacy|3
68151|NCT01181102|264568|P2|Overall Study|Adverse Event|26
68152|NCT01181102|264569|P1|Overall Study|Adverse Event|28
68153|NCT01181011|264590|P1|Overall Study|Lost to Follow-up|1
68154|NCT01181011|264590|P1|Overall Study|Adverse Event|2
68155|NCT01180998|264640|P3|Overall Study|Poor lens handling|2
68156|NCT01180998|264641|P2|Overall Study|Poor lens handling|0
68157|NCT01180998|264642|P1|Overall Study|Poor lens handling|0
68158|NCT01180998|264640|P3|Overall Study|Poor comfort|4
68159|NCT01180998|264641|P2|Overall Study|Poor comfort|0
68160|NCT01180998|264642|P1|Overall Study|Poor comfort|3
68161|NCT01180998|264640|P3|Overall Study|Withdrawal by Subject|1
68162|NCT01180998|264641|P2|Overall Study|Withdrawal by Subject|0
68163|NCT01180998|264642|P1|Overall Study|Withdrawal by Subject|0
68164|NCT01180998|264640|P3|Overall Study|Protocol Violation|0
68165|NCT01180998|264641|P2|Overall Study|Protocol Violation|2
68166|NCT01180998|264642|P1|Overall Study|Protocol Violation|1
68167|NCT01180998|264640|P3|Overall Study|Lost to Follow-up|1
68168|NCT01180998|264641|P2|Overall Study|Lost to Follow-up|0
68169|NCT01180998|264642|P1|Overall Study|Lost to Follow-up|0
68170|NCT01180998|264640|P3|Overall Study|Poor Vision|2
68171|NCT01180998|264641|P2|Overall Study|Poor Vision|2
68172|NCT01180998|264642|P1|Overall Study|Poor Vision|0
68173|NCT01180985|264656|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
68174|NCT01180985|264657|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
68175|NCT01180790|264696|P7|Overall Study|Severe coronary atherosclerosis (death)|0
68176|NCT01180790|264697|P6|Overall Study|Severe coronary atherosclerosis (death)|0
68177|NCT01180790|264698|P5|Overall Study|Severe coronary atherosclerosis (death)|0
68178|NCT01180790|264699|P4|Overall Study|Severe coronary atherosclerosis (death)|0
68179|NCT01180790|264700|P3|Overall Study|Severe coronary atherosclerosis (death)|1
68180|NCT01180790|264701|P2|Overall Study|Severe coronary atherosclerosis (death)|0
68181|NCT01180790|264702|P1|Overall Study|Severe coronary atherosclerosis (death)|0
68182|NCT01180790|264696|P7|Overall Study|compliance|0
68183|NCT01180790|264697|P6|Overall Study|compliance|0
68184|NCT01180790|264698|P5|Overall Study|compliance|0
68185|NCT01180790|264699|P4|Overall Study|compliance|0
68186|NCT01180790|264700|P3|Overall Study|compliance|0
68187|NCT01180790|264701|P2|Overall Study|compliance|1
68188|NCT01180790|264702|P1|Overall Study|compliance|0
68189|NCT01180790|264696|P7|Overall Study|Lack of Efficacy|0
68190|NCT01180790|264697|P6|Overall Study|Lack of Efficacy|3
68191|NCT01180790|264698|P5|Overall Study|Lack of Efficacy|1
68192|NCT01180790|264699|P4|Overall Study|Lack of Efficacy|6
68193|NCT01180790|264700|P3|Overall Study|Lack of Efficacy|5
68194|NCT01180790|264701|P2|Overall Study|Lack of Efficacy|2
68195|NCT01180790|264702|P1|Overall Study|Lack of Efficacy|1
68196|NCT01180790|264696|P7|Overall Study|Physician Decision|0
68197|NCT01180790|264697|P6|Overall Study|Physician Decision|0
68198|NCT01180790|264698|P5|Overall Study|Physician Decision|0
68199|NCT01180790|264699|P4|Overall Study|Physician Decision|1
68200|NCT01180790|264700|P3|Overall Study|Physician Decision|0
68201|NCT01180790|264701|P2|Overall Study|Physician Decision|0
68202|NCT01180790|264702|P1|Overall Study|Physician Decision|1
68203|NCT01180790|264696|P7|Overall Study|Lost to Follow-up|1
68204|NCT01180790|264697|P6|Overall Study|Lost to Follow-up|0
68205|NCT01180790|264698|P5|Overall Study|Lost to Follow-up|1
68206|NCT01180790|264699|P4|Overall Study|Lost to Follow-up|2
68207|NCT01180790|264700|P3|Overall Study|Lost to Follow-up|0
68208|NCT01180790|264701|P2|Overall Study|Lost to Follow-up|1
68209|NCT01180790|264702|P1|Overall Study|Lost to Follow-up|3
68210|NCT01180790|264696|P7|Overall Study|Withdrawal by Subject|0
68211|NCT01180790|264697|P6|Overall Study|Withdrawal by Subject|1
68212|NCT01180790|264698|P5|Overall Study|Withdrawal by Subject|2
68213|NCT01180790|264699|P4|Overall Study|Withdrawal by Subject|0
68214|NCT01180790|264700|P3|Overall Study|Withdrawal by Subject|5
68215|NCT01180790|264701|P2|Overall Study|Withdrawal by Subject|0
68216|NCT01180790|264702|P1|Overall Study|Withdrawal by Subject|3
68217|NCT01180790|264696|P7|Overall Study|Adverse Event|0
68218|NCT01180790|264697|P6|Overall Study|Adverse Event|3
68219|NCT01180790|264698|P5|Overall Study|Adverse Event|1
68220|NCT01180790|264699|P4|Overall Study|Adverse Event|0
68221|NCT01180790|264700|P3|Overall Study|Adverse Event|2
68222|NCT01180790|264701|P2|Overall Study|Adverse Event|1
68223|NCT01180790|264702|P1|Overall Study|Adverse Event|1
68224|NCT01180777|264767|P1|Overall Study|Adverse Event|1
68225|NCT01180777|264767|P1|Overall Study|Lost to Follow-up|1
68226|NCT01180777|264767|P1|Overall Study|Poor lens fit|4
68227|NCT01180777|264767|P1|Overall Study|Protocol Violation|6
68228|NCT01180660|264781|P2|Overall Study|Changed to open surgery|0
68229|NCT01180660|264782|P1|Overall Study|Changed to open surgery|1
68230|NCT01180647|264792|P2|Overall Study|Lost to Follow-up|6
68231|NCT01180647|264793|P1|Overall Study|Lost to Follow-up|5
68232|NCT01180400|264811|P2|Overall Study|Not specified|1
68233|NCT01180400|264812|P1|Overall Study|Not specified|0
68234|NCT01180400|264811|P2|Overall Study|Lost to Follow-up|3
68235|NCT01180400|264812|P1|Overall Study|Lost to Follow-up|2
68236|NCT01180400|264811|P2|Overall Study|Study-specific withdrawal criteria|2
68237|NCT01180400|264812|P1|Overall Study|Study-specific withdrawal criteria|1
68238|NCT01180400|264811|P2|Overall Study|Lack of Efficacy|0
68239|NCT01180400|264812|P1|Overall Study|Lack of Efficacy|2
68240|NCT01180400|264811|P2|Overall Study|Condition under investigation worsened|1
68241|NCT01180400|264812|P1|Overall Study|Condition under investigation worsened|2
68242|NCT01180400|264811|P2|Overall Study|Severe non-compliance to protocol|2
68243|NCT01180400|264812|P1|Overall Study|Severe non-compliance to protocol|1
68244|NCT01180400|264811|P2|Overall Study|Adverse Event|10
68245|NCT01180400|264812|P1|Overall Study|Adverse Event|12
68246|NCT01180400|264811|P2|Overall Study|Eligibility criteria not fulfilled|2
68247|NCT01180400|264812|P1|Overall Study|Eligibility criteria not fulfilled|0
68248|NCT01180400|264811|P2|Overall Study|Withdrawal by Subject|6
68249|NCT01180400|264812|P1|Overall Study|Withdrawal by Subject|5
68250|NCT01180296|264860|P2|Overall Study|Protocol Violation|2
68251|NCT01180296|264861|P1|Overall Study|Protocol Violation|1
68252|NCT01180244|264869|P2|Overall Study|Lost to Follow-up|0
68253|NCT01180244|264870|P1|Overall Study|Lost to Follow-up|1
68254|NCT01180244|264869|P2|Overall Study|Protocol Violation|0
68255|NCT01180244|264870|P1|Overall Study|Protocol Violation|1
68256|NCT01180244|264869|P2|Overall Study|Withdrawal by Subject|1
68257|NCT01180244|264870|P1|Overall Study|Withdrawal by Subject|0
68258|NCT01180244|264869|P2|Overall Study|Adverse Event|0
68259|NCT01180244|264870|P1|Overall Study|Adverse Event|1
68260|NCT01180244|264869|P2|Overall Study|Physician Decision|0
68261|NCT01180244|264870|P1|Overall Study|Physician Decision|3
68262|NCT01180244|264869|P2|Overall Study|Lack of Efficacy|7
68263|NCT01180244|264870|P1|Overall Study|Lack of Efficacy|0
68264|NCT01180049|264915|P2|Overall Study|Ongoing on treatment|10
68265|NCT01180049|264916|P1|Overall Study|Ongoing on treatment|18
68266|NCT01180049|264915|P2|Overall Study|Death|28
68267|NCT01180049|264916|P1|Overall Study|Death|23
68268|NCT01180049|264915|P2|Overall Study|Lost to Follow-up|1
68269|NCT01180049|264916|P1|Overall Study|Lost to Follow-up|0
68270|NCT01180049|264915|P2|Overall Study|Participant Refused Follow Up|3
68271|NCT01180049|264916|P1|Overall Study|Participant Refused Follow Up|5
68272|NCT01180049|264915|P2|Overall Study|Enrolled to Another Clinical Trial|1
68273|NCT01180049|264916|P1|Overall Study|Enrolled to Another Clinical Trial|1
68274|NCT01179919|264942|P1|Overall Study|Adverse Event|1
68275|NCT01179919|264942|P1|Overall Study|Protocol Violation|1
68276|NCT01179737|264951|P4|Extension|The study was terminated|0
68277|NCT01179737|264952|P3|Extension|The study was terminated|0
68278|NCT01179737|264953|P2|Extension|The study was terminated|0
68279|NCT01179737|264954|P1|Extension|The study was terminated|3
68280|NCT01179737|264951|P4|Cohort 1 & Cohort 2 Expansion|Death|0
68281|NCT01179737|264952|P3|Cohort 1 & Cohort 2 Expansion|Death|0
68282|NCT01179737|264953|P2|Cohort 1 & Cohort 2 Expansion|Death|0
68283|NCT01179737|264954|P1|Cohort 1 & Cohort 2 Expansion|Death|1
68284|NCT01179737|264951|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
68285|NCT01179737|264952|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
68286|NCT01179737|264953|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
68287|NCT01179737|264954|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
68288|NCT01179737|264951|P4|Cohort 1 & Cohort 2|Death|0
68289|NCT01179737|264952|P3|Cohort 1 & Cohort 2|Death|1
68290|NCT01179737|264953|P2|Cohort 1 & Cohort 2|Death|0
68291|NCT01179737|264954|P1|Cohort 1 & Cohort 2|Death|0
68292|NCT01179737|264951|P4|Cohort 1 & Cohort 2|Administrative problems|4
68293|NCT01179737|264952|P3|Cohort 1 & Cohort 2|Administrative problems|2
68294|NCT01179737|264953|P2|Cohort 1 & Cohort 2|Administrative problems|0
68295|NCT01179737|264954|P1|Cohort 1 & Cohort 2|Administrative problems|0
68296|NCT01179737|264951|P4|Cohort 1 & Cohort 2|Withdrew consent|0
68297|NCT01179737|264952|P3|Cohort 1 & Cohort 2|Withdrew consent|0
68298|NCT01179737|264953|P2|Cohort 1 & Cohort 2|Withdrew consent|0
68299|NCT01179737|264954|P1|Cohort 1 & Cohort 2|Withdrew consent|2
68300|NCT01179737|264951|P4|Cohort 1 & Cohort 2|Adverse Event|0
68301|NCT01179737|264952|P3|Cohort 1 & Cohort 2|Adverse Event|1
68302|NCT01179737|264953|P2|Cohort 1 & Cohort 2|Adverse Event|1
68303|NCT01179737|264954|P1|Cohort 1 & Cohort 2|Adverse Event|3
68304|NCT00000378|264974|P2|Overall Study|Lack of Efficacy|14
68305|NCT00000378|264975|P1|Overall Study|Lack of Efficacy|16
68306|NCT00000620|265025|P8|Overall Study|missed closeout visit|16
68307|NCT00000620|265026|P7|Overall Study|missed closeout visit|13
68308|NCT00000620|265027|P6|Overall Study|missed closeout visit|28
68309|NCT00000620|265028|P5|Overall Study|missed closeout visit|26
68310|NCT00000620|265029|P4|Overall Study|missed closeout visit|11
68311|NCT00000620|265030|P3|Overall Study|missed closeout visit|16
68312|NCT00000620|265031|P2|Overall Study|missed closeout visit|28
68313|NCT00000620|265032|P1|Overall Study|missed closeout visit|22
68314|NCT00000620|265025|P8|Overall Study|Withdrawal by Subject|21
68315|NCT00000620|265026|P7|Overall Study|Withdrawal by Subject|32
68316|NCT00000620|265027|P6|Overall Study|Withdrawal by Subject|32
68317|NCT00000620|265028|P5|Overall Study|Withdrawal by Subject|30
68318|NCT00000620|265029|P4|Overall Study|Withdrawal by Subject|27
68319|NCT00000620|265030|P3|Overall Study|Withdrawal by Subject|28
68320|NCT00000620|265031|P2|Overall Study|Withdrawal by Subject|27
68321|NCT00000620|265032|P1|Overall Study|Withdrawal by Subject|40
68322|NCT00000620|265025|P8|Overall Study|Lost to Follow-up|14
68323|NCT00000620|265026|P7|Overall Study|Lost to Follow-up|13
68324|NCT00000620|265027|P6|Overall Study|Lost to Follow-up|15
68325|NCT00000620|265028|P5|Overall Study|Lost to Follow-up|15
68326|NCT00000620|265029|P4|Overall Study|Lost to Follow-up|14
68327|NCT00000620|265030|P3|Overall Study|Lost to Follow-up|14
68328|NCT00000620|265031|P2|Overall Study|Lost to Follow-up|14
68329|NCT00000620|265032|P1|Overall Study|Lost to Follow-up|14
68330|NCT00000620|265025|P8|Overall Study|Death|95
68331|NCT00000620|265026|P7|Overall Study|Death|91
68332|NCT00000620|265027|P6|Overall Study|Death|77
68333|NCT00000620|265028|P5|Overall Study|Death|64
68334|NCT00000620|265029|P4|Overall Study|Death|126
68335|NCT00000620|265030|P3|Overall Study|Death|112
68336|NCT00000620|265031|P2|Overall Study|Death|67
68337|NCT00000620|265032|P1|Overall Study|Death|86
68338|NCT00000135|265072|P2|Overall Study|Death|14
68339|NCT00000135|265073|P1|Overall Study|Death|27
68340|NCT00001213|265135|P1|Overall Study|Death|18
68341|NCT00001262|265143|P3|Overall Study|Withdrawal by Subject|0
68342|NCT00001262|265144|P2|Overall Study|Withdrawal by Subject|3
68343|NCT00001262|265145|P1|Overall Study|Withdrawal by Subject|0
68344|NCT00001262|265143|P3|Overall Study|Death|0
68345|NCT00001262|265144|P2|Overall Study|Death|11
68346|NCT00001262|265145|P1|Overall Study|Death|10
68347|NCT00001566|265192|P1|Overall Study|unable to complete initial apheresis|1
68348|NCT00001566|265192|P1|Overall Study|Lost to Follow-up|1
68349|NCT00001566|265192|P1|Overall Study|Death|13
68350|NCT00001566|265192|P1|Overall Study|stopped after C3 due to symptomatic PD|1
68351|NCT00001566|265192|P1|Overall Study|patients' choice to discontinue protocol|3
68352|NCT00001575|265204|P1|Overall Study|Withdrawn/deaths|23
68353|NCT00001575|265204|P1|Overall Study|Screening failures-Ph I portion|22
68354|NCT00001596|265223|P2|Overall Study|Adverse Event|0
68355|NCT00001596|265224|P1|Overall Study|Adverse Event|1
68356|NCT00001596|265223|P2|Overall Study|Study Termination|9
68357|NCT00001596|265224|P1|Overall Study|Study Termination|12
68358|NCT00001596|265223|P2|Overall Study|Withdrawal by Subject|1
68359|NCT00001596|265224|P1|Overall Study|Withdrawal by Subject|3
68360|NCT00001596|265223|P2|Overall Study|Death|0
68361|NCT00001596|265224|P1|Overall Study|Death|1
68362|NCT00001832|265258|P15|Treatment Period|Not treated|0
68363|NCT00001832|265259|P14|Treatment Period|Not treated|0
68364|NCT00001832|265260|P13|Treatment Period|Not treated|0
68365|NCT00001832|265261|P12|Treatment Period|Not treated|0
68366|NCT00001832|265262|P11|Treatment Period|Not treated|0
68367|NCT00001832|265263|P10|Treatment Period|Not treated|0
68368|NCT00001832|265264|P9|Treatment Period|Not treated|0
68369|NCT00001832|265265|P8|Treatment Period|Not treated|1
68370|NCT00001832|265266|P7|Treatment Period|Not treated|0
68371|NCT00001832|265267|P6|Treatment Period|Not treated|0
68372|NCT00001832|265268|P5|Treatment Period|Not treated|0
68373|NCT00001832|265269|P4|Treatment Period|Not treated|0
68374|NCT00001832|265270|P3|Treatment Period|Not treated|0
68375|NCT00001832|265271|P2|Treatment Period|Not treated|0
68376|NCT00001832|265272|P1|Treatment Period|Not treated|0
68377|NCT00001832|265258|P15|Treatment Period|Death during treatment|0
68378|NCT00001832|265259|P14|Treatment Period|Death during treatment|0
68379|NCT00001832|265260|P13|Treatment Period|Death during treatment|0
68380|NCT00001832|265261|P12|Treatment Period|Death during treatment|0
68381|NCT00001832|265262|P11|Treatment Period|Death during treatment|0
68382|NCT00001832|265263|P10|Treatment Period|Death during treatment|0
68383|NCT00001832|265264|P9|Treatment Period|Death during treatment|0
68384|NCT00001832|265265|P8|Treatment Period|Death during treatment|0
68385|NCT00001832|265266|P7|Treatment Period|Death during treatment|0
68386|NCT00001832|265267|P6|Treatment Period|Death during treatment|1
68387|NCT00001832|265268|P5|Treatment Period|Death during treatment|0
68388|NCT00001832|265269|P4|Treatment Period|Death during treatment|0
68389|NCT00001832|265270|P3|Treatment Period|Death during treatment|0
68390|NCT00001832|265271|P2|Treatment Period|Death during treatment|0
68391|NCT00001832|265272|P1|Treatment Period|Death during treatment|0
68392|NCT00001832|265258|P15|Apheresis Period|not able to manufacture treatment cells|0
68393|NCT00001832|265259|P14|Apheresis Period|not able to manufacture treatment cells|0
68394|NCT00001832|265260|P13|Apheresis Period|not able to manufacture treatment cells|0
68395|NCT00001832|265261|P12|Apheresis Period|not able to manufacture treatment cells|0
68396|NCT00001832|265262|P11|Apheresis Period|not able to manufacture treatment cells|0
68397|NCT00001832|265263|P10|Apheresis Period|not able to manufacture treatment cells|0
68398|NCT00001832|265264|P9|Apheresis Period|not able to manufacture treatment cells|0
68399|NCT00001832|265265|P8|Apheresis Period|not able to manufacture treatment cells|0
68400|NCT00001832|265266|P7|Apheresis Period|not able to manufacture treatment cells|0
68401|NCT00001832|265267|P6|Apheresis Period|not able to manufacture treatment cells|0
68402|NCT00001832|265268|P5|Apheresis Period|not able to manufacture treatment cells|0
68403|NCT00001832|265269|P4|Apheresis Period|not able to manufacture treatment cells|0
68404|NCT00001832|265270|P3|Apheresis Period|not able to manufacture treatment cells|0
68405|NCT00001832|265271|P2|Apheresis Period|not able to manufacture treatment cells|0
68406|NCT00001832|265272|P1|Apheresis Period|not able to manufacture treatment cells|60
68407|NCT00001941|265316|P5|Overall Study|not treated- rapidly progressing disease|1
68408|NCT00001941|265317|P4|Overall Study|not treated- rapidly progressing disease|0
68409|NCT00001941|265318|P3|Overall Study|not treated- rapidly progressing disease|0
68410|NCT00001941|265319|P2|Overall Study|not treated- rapidly progressing disease|0
68411|NCT00001941|265320|P1|Overall Study|not treated- rapidly progressing disease|0
68412|NCT00001959|265327|P1|Overall Study|non-compliance|1
68413|NCT00001959|265327|P1|Overall Study|disabling sedation|1
68414|NCT00001959|265327|P1|Overall Study|newly diagnosed colon cancer|1
68415|NCT00001962|265333|P1|Overall Study|Adverse Event|1
68416|NCT00001962|265333|P1|Overall Study|Lost to Follow-up|2
68417|NCT00001962|265333|P1|Overall Study|Death|1
68418|NCT00001962|265333|P1|Overall Study|Lack of Accrual|6
68419|NCT00001962|265333|P1|Overall Study|Lack of Efficacy|18
68420|NCT00002525|265349|P2|Overall Study|Never start protocol therapy|0
68421|NCT00002525|265350|P1|Overall Study|Never start protocol therapy|8
68422|NCT00002525|265349|P2|Overall Study|Other|0
68423|NCT00002525|265350|P1|Overall Study|Other|26
68424|NCT00002525|265349|P2|Overall Study|Error|0
68425|NCT00002525|265350|P1|Overall Study|Error|6
68426|NCT00002525|265349|P2|Overall Study|Duke's A, B1, D disease|0
68427|NCT00002525|265350|P1|Overall Study|Duke's A, B1, D disease|92
68428|NCT00002525|265349|P2|Overall Study|Other complicating disease|0
68429|NCT00002525|265350|P1|Overall Study|Other complicating disease|1
68430|NCT00002525|265349|P2|Overall Study|Start non-protocol therapy|0
68431|NCT00002525|265350|P1|Overall Study|Start non-protocol therapy|1
68432|NCT00002525|265349|P2|Overall Study|Withdrawal by Subject|0
68433|NCT00002525|265350|P1|Overall Study|Withdrawal by Subject|11
68434|NCT00002525|265349|P2|Overall Study|Death|0
68435|NCT00002525|265350|P1|Overall Study|Death|5
68436|NCT00002525|265349|P2|Overall Study|Adverse Event|0
68437|NCT00002525|265350|P1|Overall Study|Adverse Event|36
68438|NCT00002540|265366|P2|Overall Study|Refused Screen (Prostate Screening)|2433
68439|NCT00002540|265367|P1|Overall Study|Refused Screen (Prostate Screening)|0
68440|NCT00002540|265366|P2|Overall Study|Refused ASU (Control)|0
68441|NCT00002540|265367|P1|Overall Study|Refused ASU (Control)|597
68442|NCT00002540|265366|P2|Overall Study|Died Before ASU (Control)|0
68443|NCT00002540|265367|P1|Overall Study|Died Before ASU (Control)|202
68444|NCT00002540|265366|P2|Overall Study|Died Before Randomization|6
68445|NCT00002540|265367|P1|Overall Study|Died Before Randomization|2
68446|NCT00002540|265366|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
68447|NCT00002540|265367|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
68448|NCT00002558|265395|P2|Overall Study|Withdrawal by Subject|1
68449|NCT00002558|265396|P1|Overall Study|Withdrawal by Subject|0
68450|NCT00002597|265404|P2|Overall Study|Withdrawal by Subject|6
68451|NCT00002597|265405|P1|Overall Study|Withdrawal by Subject|7
68452|NCT00002597|265404|P2|Overall Study|Protocol Violation|17
68453|NCT00002597|265405|P1|Overall Study|Protocol Violation|19
68454|NCT00002651|265437|P3|Consolidation and Randomization|not eligible|112
68455|NCT00002651|265438|P2|Consolidation and Randomization|not eligible|102
68456|NCT00002651|265439|P1|Consolidation and Randomization|not eligible|0
68457|NCT00002651|265437|P3|Consolidation and Randomization|not specified|313
68458|NCT00002651|265438|P2|Consolidation and Randomization|not specified|314
68459|NCT00002651|265439|P1|Consolidation and Randomization|not specified|0
68460|NCT00002651|265437|P3|Consolidation and Randomization|Death|48
68461|NCT00002651|265438|P2|Consolidation and Randomization|Death|38
68462|NCT00002651|265439|P1|Consolidation and Randomization|Death|0
68463|NCT00002651|265437|P3|Consolidation and Randomization|Progression/relapse|298
68464|NCT00002651|265438|P2|Consolidation and Randomization|Progression/relapse|295
68465|NCT00002651|265439|P1|Consolidation and Randomization|Progression/relapse|0
68466|NCT00002651|265437|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
68467|NCT00002651|265438|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
68468|NCT00002651|265439|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
68469|NCT00002651|265437|P3|Consolidation and Randomization|Adverse Event|14
68470|NCT00002651|265438|P2|Consolidation and Randomization|Adverse Event|36
68471|NCT00002651|265439|P1|Consolidation and Randomization|Adverse Event|0
68472|NCT00002651|265437|P3|Induction|not eligible|0
68473|NCT00002651|265438|P2|Induction|not eligible|0
68474|NCT00002651|265439|P1|Induction|not eligible|90
68475|NCT00002651|265437|P3|Induction|not specified|0
68476|NCT00002651|265438|P2|Induction|not specified|0
68477|NCT00002651|265439|P1|Induction|not specified|823
68478|NCT00002651|265437|P3|Induction|Death|0
68479|NCT00002651|265438|P2|Induction|Death|0
68480|NCT00002651|265439|P1|Induction|Death|62
68481|NCT00002651|265437|P3|Induction|Progression/relapse|0
68482|NCT00002651|265438|P2|Induction|Progression/relapse|0
68483|NCT00002651|265439|P1|Induction|Progression/relapse|274
68484|NCT00002651|265437|P3|Induction|Refusal unrelated to adverse event|0
68485|NCT00002651|265438|P2|Induction|Refusal unrelated to adverse event|0
68486|NCT00002651|265439|P1|Induction|Refusal unrelated to adverse event|50
68487|NCT00002651|265437|P3|Induction|Adverse Event|0
68488|NCT00002651|265438|P2|Induction|Adverse Event|0
68489|NCT00002651|265439|P1|Induction|Adverse Event|44
68490|NCT00001703|265486|P1|Overall Study|recurrent disease|2
68491|NCT00001703|265486|P1|Overall Study|No evidence of disease|1
68492|NCT00001703|265486|P1|Overall Study|progressed disease|2
68493|NCT00001723|265493|P2|Overall Study|medication intolerance|2
68494|NCT00001723|265494|P1|Overall Study|medication intolerance|1
68495|NCT00001723|265493|P2|Overall Study|Lost to Follow-up|2
68496|NCT00001723|265494|P1|Overall Study|Lost to Follow-up|2
68497|NCT00001723|265493|P2|Overall Study|Lack of family interest|5
68498|NCT00001723|265494|P1|Overall Study|Lack of family interest|4
68499|NCT00001723|265493|P2|Overall Study|Lack of Efficacy|7
68500|NCT00001723|265494|P1|Overall Study|Lack of Efficacy|6
68501|NCT00002766|265512|P2|Overall Study|Protocol Violation|0
68502|NCT00002766|265513|P1|Overall Study|Protocol Violation|1
68503|NCT00002766|265512|P2|Overall Study|Adverse Event|1
68504|NCT00002766|265513|P1|Overall Study|Adverse Event|1
68505|NCT00002766|265512|P2|Overall Study|Patient Not Treated|2
68506|NCT00002766|265513|P1|Overall Study|Patient Not Treated|1
68507|NCT00002766|265512|P2|Overall Study|Withdrawal by Subject|1
68508|NCT00002766|265513|P1|Overall Study|Withdrawal by Subject|0
68509|NCT00002842|265519|P1|Overall Study|ineligible for surgical resection|27
68510|NCT00002850|265526|P3|Overall Study|Withdrawal by Subject|0
68511|NCT00002850|265527|P2|Overall Study|Withdrawal by Subject|1
68512|NCT00002850|265528|P1|Overall Study|Withdrawal by Subject|0
68513|NCT00002850|265526|P3|Overall Study|Protocol Violation|1
68514|NCT00002850|265527|P2|Overall Study|Protocol Violation|0
68515|NCT00002850|265528|P1|Overall Study|Protocol Violation|1
68516|NCT00002850|265526|P3|Overall Study|Death|3
68517|NCT00002850|265527|P2|Overall Study|Death|1
68518|NCT00002850|265528|P1|Overall Study|Death|4
68519|NCT00002874|265538|P2|Overall Study|Protocol Violation|34
68520|NCT00002874|265539|P1|Overall Study|Protocol Violation|44
68521|NCT00002874|265538|P2|Overall Study|Withdrawal by Subject|1
68522|NCT00002874|265539|P1|Overall Study|Withdrawal by Subject|1
68523|NCT00002931|265561|P1|Overall Study|rapidly progressing disease during|2
68524|NCT00003457|265571|P1|Overall Study|Not evaluable|9
68525|NCT00003458|265576|P1|Overall Study|Not evaluable|4
68526|NCT00003470|265601|P1|Overall Study|Not evaluable|6
68527|NCT00003473|265606|P1|Overall Study|Three patients were not evaluable.|3
68528|NCT00003475|265611|P1|Overall Study|Not evaluable|13
68529|NCT00003476|265616|P1|Overall Study|Not evaluable|1
68530|NCT00003477|265621|P1|Overall Study|Not evalauable|4
68531|NCT00003479|265626|P1|Overall Study|Not evaluable|3
68532|NCT00003483|265631|P1|Overall Study|Not evaluable|1
68533|NCT00003537|265636|P1|Overall Study|Not evalauable|1
68534|NCT00003590|265641|P1|Overall Study|Physician Decision|1
68535|NCT00003590|265641|P1|Overall Study|Death|1
68536|NCT00003590|265641|P1|Overall Study|Lack of Efficacy|11
68537|NCT00003590|265641|P1|Overall Study|Withdrawal by Subject|1
68538|NCT00003590|265641|P1|Overall Study|Adverse Event|7
68539|NCT00003590|265641|P1|Overall Study|Ineligible Patient|1
68540|NCT00003631|265649|P3|Overall Study|Evaluable for toxicity only|2
68541|NCT00003631|265650|P2|Overall Study|Evaluable for toxicity only|0
68542|NCT00003631|265651|P1|Overall Study|Evaluable for toxicity only|0
68543|NCT00003631|265649|P3|Overall Study|Death|1
68544|NCT00003631|265650|P2|Overall Study|Death|0
68545|NCT00003631|265651|P1|Overall Study|Death|0
68546|NCT00003631|265649|P3|Overall Study|Adverse Event|5
68547|NCT00003631|265650|P2|Overall Study|Adverse Event|1
68548|NCT00003631|265651|P1|Overall Study|Adverse Event|1
68549|NCT00003631|265649|P3|Overall Study|Protocol Violation|0
68550|NCT00003631|265650|P2|Overall Study|Protocol Violation|0
68551|NCT00003631|265651|P1|Overall Study|Protocol Violation|1
68552|NCT00003631|265649|P3|Overall Study|Patient not treated|1
68553|NCT00003631|265650|P2|Overall Study|Patient not treated|0
68554|NCT00003631|265651|P1|Overall Study|Patient not treated|1
68555|NCT00003782|265666|P3|Overall Study|No follow up data|26
68556|NCT00003782|265667|P2|Overall Study|No follow up data|31
68557|NCT00003782|265668|P1|Overall Study|No follow up data|30
68558|NCT00003869|265685|P2|Overall Study|Alternative treatmnt, medical problems|4
68559|NCT00003869|265686|P1|Overall Study|Alternative treatmnt, medical problems|5
68560|NCT00003869|265685|P2|Overall Study|Death|2
68561|NCT00003869|265686|P1|Overall Study|Death|1
68562|NCT00003869|265685|P2|Overall Study|Withdrawal by Subject|3
68563|NCT00003869|265686|P1|Overall Study|Withdrawal by Subject|21
68564|NCT00003869|265685|P2|Overall Study|Adverse Event|3
68565|NCT00003869|265686|P1|Overall Study|Adverse Event|14
68566|NCT00003875|265702|P1|Overall Study|Screen Failed|1
68567|NCT00003199|265709|P1|Overall Study|Screen fail|15
68568|NCT00003199|265709|P1|Overall Study|Lack of insurance clearance|2
68569|NCT00003199|265709|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
68570|NCT00003222|265717|P2|Overall Study|Physician Decision|1
68571|NCT00003222|265718|P1|Overall Study|Physician Decision|0
68572|NCT00003298|265757|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
68573|NCT00003298|265757|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
68574|NCT00003298|265757|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
68575|NCT00003298|265757|P1|Step 2 (Adjuvant Therapy)|Death|1
68576|NCT00003298|265757|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
68577|NCT00003298|265757|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
68578|NCT00003298|265757|P1|Re-register to Step 2 After Surgery|Reason unknown|1
68579|NCT00003298|265757|P1|Re-register to Step 2 After Surgery|Other complications|2
68580|NCT00003298|265757|P1|Re-register to Step 2 After Surgery|Positive margins|5
68581|NCT00003298|265757|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
68582|NCT00003298|265757|P1|Surgery|Unevaluable and off study|2
68583|NCT00003298|265757|P1|Surgery|Progression before surgery|2
68584|NCT00003298|265757|P1|Surgery|Unresectable at surgery|3
68585|NCT00003298|265757|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
68586|NCT00003298|265757|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
68587|NCT00003377|265770|P5|Period II|Ureteral stent complications|1
68588|NCT00003377|265771|P4|Period II|Ureteral stent complications|0
68589|NCT00003377|265772|P3|Period II|Ureteral stent complications|0
68590|NCT00003377|265773|P2|Period II|Ureteral stent complications|0
68591|NCT00003377|265774|P1|Period II|Ureteral stent complications|0
68592|NCT00003377|265770|P5|Period I|Dose Limiting Toxicity(DLT)|0
68593|NCT00003377|265771|P4|Period I|Dose Limiting Toxicity(DLT)|1
68594|NCT00003377|265772|P3|Period I|Dose Limiting Toxicity(DLT)|1
68595|NCT00003377|265773|P2|Period I|Dose Limiting Toxicity(DLT)|0
68596|NCT00003377|265774|P1|Period I|Dose Limiting Toxicity(DLT)|0
68597|NCT00003389|265790|P2|Overall Study|Ineligible|27
68598|NCT00003389|265791|P1|Overall Study|Ineligible|33
68599|NCT00003389|265790|P2|Overall Study|Off-treatment reason missing|21
68600|NCT00003389|265791|P1|Overall Study|Off-treatment reason missing|31
68601|NCT00003389|265790|P2|Overall Study|Complicating disease|0
68602|NCT00003389|265791|P1|Overall Study|Complicating disease|1
68603|NCT00003389|265790|P2|Overall Study|Alternative therapy|1
68604|NCT00003389|265791|P1|Overall Study|Alternative therapy|2
68605|NCT00003389|265790|P2|Overall Study|Withdrawal by Subject|5
68606|NCT00003389|265791|P1|Overall Study|Withdrawal by Subject|12
68607|NCT00003389|265790|P2|Overall Study|Death|3
68608|NCT00003389|265791|P1|Overall Study|Death|0
68609|NCT00003389|265790|P2|Overall Study|Adverse Event|2
68610|NCT00003389|265791|P1|Overall Study|Adverse Event|13
68611|NCT00003389|265790|P2|Overall Study|Disease progression|1
68612|NCT00003389|265791|P1|Overall Study|Disease progression|6
68613|NCT00003895|265803|P2|Overall Study|Withdrawal by Subject|3
68614|NCT00003895|265804|P1|Overall Study|Withdrawal by Subject|0
68615|NCT00003895|265803|P2|Overall Study|Patient Vacation|0
68616|NCT00003895|265804|P1|Overall Study|Patient Vacation|2
68617|NCT00003895|265803|P2|Overall Study|Lack of Efficacy|1
68618|NCT00003895|265804|P1|Overall Study|Lack of Efficacy|1
68619|NCT00003895|265803|P2|Overall Study|Adverse Event|0
68620|NCT00003895|265804|P1|Overall Study|Adverse Event|4
68621|NCT00003896|265810|P1|Overall Study|ineligible|5
68622|NCT00003896|265810|P1|Overall Study|not protocol specified|3
68623|NCT00003896|265810|P1|Overall Study|Death|3
68624|NCT00003896|265810|P1|Overall Study|Lack of Efficacy|1
68625|NCT00003896|265810|P1|Overall Study|Withdrawal by Subject|1
68626|NCT00003896|265810|P1|Overall Study|Adverse Event|16
68627|NCT00003901|265816|P1|Overall Study|Medical problems|6
68628|NCT00003901|265816|P1|Overall Study|Chest X-Ray not done prior registration|1
68629|NCT00003901|265816|P1|Overall Study|CT Scan not within protocol requirement|2
68630|NCT00003901|265816|P1|Overall Study|Ineligible|6
68631|NCT00003901|265816|P1|Overall Study|Withdrawal by Subject|1
68632|NCT00003901|265816|P1|Overall Study|Adverse Event|1
68633|NCT00003907|265829|P2|Overall Study|ineligible or not treated|2
68634|NCT00003907|265830|P1|Overall Study|ineligible or not treated|2
68635|NCT00003907|265829|P2|Overall Study|Not specified|3
68636|NCT00003907|265830|P1|Overall Study|Not specified|1
68637|NCT00003907|265829|P2|Overall Study|Complicating disease|0
68638|NCT00003907|265830|P1|Overall Study|Complicating disease|1
68639|NCT00003907|265829|P2|Overall Study|Progressive disease|4
68640|NCT00003907|265830|P1|Overall Study|Progressive disease|4
68641|NCT00003907|265829|P2|Overall Study|Withdrawal by Subject|3
68642|NCT00003907|265830|P1|Overall Study|Withdrawal by Subject|1
68643|NCT00003907|265829|P2|Overall Study|Death|0
68644|NCT00003907|265830|P1|Overall Study|Death|2
68645|NCT00003907|265829|P2|Overall Study|Adverse Event|11
68646|NCT00003907|265830|P1|Overall Study|Adverse Event|2
68647|NCT00004228|265880|P7|Overall Study|ineligible|5
68648|NCT00004228|265881|P6|Overall Study|ineligible|2
68649|NCT00004228|265882|P5|Overall Study|ineligible|1
68650|NCT00004228|265883|P4|Overall Study|ineligible|1
68651|NCT00004228|265884|P3|Overall Study|ineligible|4
68652|NCT00004228|265885|P2|Overall Study|ineligible|2
68653|NCT00004228|265886|P1|Overall Study|ineligible|4
68654|NCT00004228|265880|P7|Overall Study|Other|0
68655|NCT00004228|265881|P6|Overall Study|Other|0
68656|NCT00004228|265882|P5|Overall Study|Other|0
68657|NCT00004228|265883|P4|Overall Study|Other|0
68658|NCT00004228|265884|P3|Overall Study|Other|1
68659|NCT00004228|265885|P2|Overall Study|Other|0
68660|NCT00004228|265886|P1|Overall Study|Other|0
68661|NCT00004228|265880|P7|Overall Study|Withdrawal by Subject|2
68662|NCT00004228|265881|P6|Overall Study|Withdrawal by Subject|1
68663|NCT00004228|265882|P5|Overall Study|Withdrawal by Subject|2
68664|NCT00004228|265883|P4|Overall Study|Withdrawal by Subject|0
68665|NCT00004228|265884|P3|Overall Study|Withdrawal by Subject|1
68666|NCT00004228|265885|P2|Overall Study|Withdrawal by Subject|0
68667|NCT00004228|265886|P1|Overall Study|Withdrawal by Subject|3
68668|NCT00004228|265880|P7|Overall Study|Protocol Violation|0
68669|NCT00004228|265881|P6|Overall Study|Protocol Violation|2
68670|NCT00004228|265882|P5|Overall Study|Protocol Violation|1
68671|NCT00004228|265883|P4|Overall Study|Protocol Violation|1
68672|NCT00004228|265884|P3|Overall Study|Protocol Violation|2
68673|NCT00004228|265885|P2|Overall Study|Protocol Violation|5
68674|NCT00004228|265886|P1|Overall Study|Protocol Violation|0
68675|NCT00004228|265880|P7|Overall Study|Physician Decision|1
68676|NCT00004228|265881|P6|Overall Study|Physician Decision|1
68677|NCT00004228|265882|P5|Overall Study|Physician Decision|1
68678|NCT00004228|265883|P4|Overall Study|Physician Decision|2
68679|NCT00004228|265884|P3|Overall Study|Physician Decision|3
68680|NCT00004228|265885|P2|Overall Study|Physician Decision|0
68681|NCT00004228|265886|P1|Overall Study|Physician Decision|1
68682|NCT00004228|265880|P7|Overall Study|Lost to Follow-up|0
68683|NCT00004228|265881|P6|Overall Study|Lost to Follow-up|0
68684|NCT00004228|265882|P5|Overall Study|Lost to Follow-up|0
68685|NCT00004228|265883|P4|Overall Study|Lost to Follow-up|0
68686|NCT00004228|265884|P3|Overall Study|Lost to Follow-up|1
68687|NCT00004228|265885|P2|Overall Study|Lost to Follow-up|0
68688|NCT00004228|265886|P1|Overall Study|Lost to Follow-up|0
68689|NCT00004228|265880|P7|Overall Study|Lack of Efficacy|4
68690|NCT00004228|265881|P6|Overall Study|Lack of Efficacy|8
68691|NCT00004228|265882|P5|Overall Study|Lack of Efficacy|9
68692|NCT00004228|265883|P4|Overall Study|Lack of Efficacy|3
68693|NCT00004228|265884|P3|Overall Study|Lack of Efficacy|5
68694|NCT00004228|265885|P2|Overall Study|Lack of Efficacy|6
68695|NCT00004228|265886|P1|Overall Study|Lack of Efficacy|1
68696|NCT00004228|265880|P7|Overall Study|Death|0
68697|NCT00004228|265881|P6|Overall Study|Death|0
68698|NCT00004228|265882|P5|Overall Study|Death|1
68699|NCT00004228|265883|P4|Overall Study|Death|0
68700|NCT00004228|265884|P3|Overall Study|Death|2
68701|NCT00004228|265885|P2|Overall Study|Death|1
68702|NCT00004228|265886|P1|Overall Study|Death|0
68703|NCT00004228|265880|P7|Overall Study|Adverse Event|0
68704|NCT00004228|265881|P6|Overall Study|Adverse Event|0
68705|NCT00004228|265882|P5|Overall Study|Adverse Event|1
68706|NCT00004228|265883|P4|Overall Study|Adverse Event|0
68707|NCT00004228|265884|P3|Overall Study|Adverse Event|0
68708|NCT00004228|265885|P2|Overall Study|Adverse Event|1
68709|NCT00004228|265886|P1|Overall Study|Adverse Event|0
68710|NCT00003138|265911|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
68711|NCT00003138|265912|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
68712|NCT00003138|265911|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
68713|NCT00003138|265912|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
68714|NCT00003138|265911|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
68715|NCT00003138|265912|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
68716|NCT00003138|265911|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
68717|NCT00003138|265912|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
68718|NCT00003138|265911|P2|Step 1|Never started treatment|0
68719|NCT00003138|265912|P1|Step 1|Never started treatment|1
68720|NCT00003138|265911|P2|Step 1|Reasons off treatment not documented|57
68721|NCT00003138|265912|P1|Step 1|Reasons off treatment not documented|60
68722|NCT00003641|265927|P2|Overall Study|Never started interferon|12
68723|NCT00003641|265928|P1|Overall Study|Never started interferon|567
68724|NCT00003641|265927|P2|Overall Study|Should not receive interferon therapy|0
68725|NCT00003641|265928|P1|Overall Study|Should not receive interferon therapy|2
68726|NCT00003641|265927|P2|Overall Study|Unknown/missing|22
68727|NCT00003641|265928|P1|Overall Study|Unknown/missing|0
68728|NCT00003641|265927|P2|Overall Study|Disease progression|2
68729|NCT00003641|265928|P1|Overall Study|Disease progression|0
68730|NCT00003641|265927|P2|Overall Study|Adverse Event|38
68731|NCT00003641|265928|P1|Overall Study|Adverse Event|0
68732|NCT00003641|265927|P2|Overall Study|Withdrawal by Subject|100
68733|NCT00003641|265928|P1|Overall Study|Withdrawal by Subject|0
68734|NCT00003659|265936|P1|Overall Study|Withdrawal by Subject|3
68735|NCT00004732|265944|P2|Overall Study|Lost to Follow-up|47
68736|NCT00004732|265945|P1|Overall Study|Lost to Follow-up|33
68737|NCT00004732|265944|P2|Overall Study|Withdrawal by Subject|64
68738|NCT00004732|265945|P1|Overall Study|Withdrawal by Subject|36
68739|NCT00004859|265955|P2|Overall Study|Not specified|21
68740|NCT00004859|265956|P1|Overall Study|Not specified|13
68741|NCT00004859|265955|P2|Overall Study|missing data|11
68742|NCT00004859|265956|P1|Overall Study|missing data|14
68743|NCT00004859|265955|P2|Overall Study|error|1
68744|NCT00004859|265956|P1|Overall Study|error|3
68745|NCT00004859|265955|P2|Overall Study|other disease|3
68746|NCT00004859|265956|P1|Overall Study|other disease|0
68747|NCT00004859|265955|P2|Overall Study|Protocol Violation|2
68748|NCT00004859|265956|P1|Overall Study|Protocol Violation|2
68749|NCT00004859|265955|P2|Overall Study|Withdrawal by Subject|33
68750|NCT00004859|265956|P1|Overall Study|Withdrawal by Subject|7
68751|NCT00004859|265955|P2|Overall Study|Death|5
68752|NCT00004859|265956|P1|Overall Study|Death|5
68753|NCT00004859|265955|P2|Overall Study|Adverse Event|93
68754|NCT00004859|265956|P1|Overall Study|Adverse Event|31
68755|NCT00004859|265955|P2|Overall Study|Lack of Efficacy|113
68756|NCT00004859|265956|P1|Overall Study|Lack of Efficacy|43
68757|NCT00004888|265968|P2|Overall Study|Toxic death|0
68758|NCT00004888|265969|P1|Overall Study|Toxic death|1
68759|NCT00004888|265968|P2|Overall Study|Death without progressive disease|1
68760|NCT00004888|265969|P1|Overall Study|Death without progressive disease|0
68761|NCT00004888|265968|P2|Overall Study|Progressive Disease|9
68762|NCT00004888|265969|P1|Overall Study|Progressive Disease|4
68763|NCT00004888|265968|P2|Overall Study|Physician Decision|1
68764|NCT00004888|265969|P1|Overall Study|Physician Decision|1
68765|NCT00004888|265968|P2|Overall Study|Withdrawal by Subject|3
68766|NCT00004888|265969|P1|Overall Study|Withdrawal by Subject|0
68767|NCT00004888|265968|P2|Overall Study|Adverse Event|10
68768|NCT00004888|265969|P1|Overall Study|Adverse Event|5
68769|NCT00004978|265987|P2|Overall Study|site closure - not in analysis cohort|20
68770|NCT00004978|265988|P1|Overall Study|site closure - not in analysis cohort|19
68771|NCT00004978|265987|P2|Overall Study|Withdrawal by Subject|26
68772|NCT00004978|265988|P1|Overall Study|Withdrawal by Subject|17
68773|NCT00004978|265987|P2|Overall Study|Lost to Follow-up|108
68774|NCT00004978|265988|P1|Overall Study|Lost to Follow-up|101
68775|NCT00004978|265987|P2|Overall Study|Death|116
68776|NCT00004978|265988|P1|Overall Study|Death|107
68777|NCT00004980|266014|P2|Overall Study|Physician Decision|1
68778|NCT00004980|266015|P1|Overall Study|Physician Decision|0
68779|NCT00004980|266014|P2|Overall Study|memory difficulties|1
68780|NCT00004980|266015|P1|Overall Study|memory difficulties|1
68781|NCT00004980|266014|P2|Overall Study|Withdrawal by Subject|0
68782|NCT00004980|266015|P1|Overall Study|Withdrawal by Subject|1
68783|NCT00004412|266039|P3|Randomized Period|Moved to Crossover Period|0
68784|NCT00004412|266040|P2|Randomized Period|Moved to Crossover Period|0
68785|NCT00004412|266041|P1|Randomized Period|Moved to Crossover Period|3
68786|NCT00004562|266087|P2|Overall Study|Lost to Follow-up|91
68787|NCT00004562|266088|P1|Overall Study|Lost to Follow-up|102
68788|NCT00004563|266098|P2|Overall Study|Death|3
68789|NCT00004563|266099|P1|Overall Study|Death|2
68790|NCT00004563|266098|P2|Overall Study|Lack of Efficacy|5
68791|NCT00004563|266099|P1|Overall Study|Lack of Efficacy|3
68792|NCT00004563|266098|P2|Overall Study|Withdrawal by Subject|16
68793|NCT00004563|266099|P1|Overall Study|Withdrawal by Subject|20
68794|NCT00004635|266111|P2|Period Two|discrepancy in data entry|1
68795|NCT00004635|266112|P1|Period Two|discrepancy in data entry|0
68796|NCT00004635|266111|P2|Period Two|Lost to Follow-up|0
68797|NCT00004635|266112|P1|Period Two|Lost to Follow-up|1
68798|NCT00004635|266111|P2|Period Two|secondary malignancy|1
68799|NCT00004635|266112|P1|Period Two|secondary malignancy|1
68800|NCT00004635|266111|P2|Period Two|travel issues|1
68801|NCT00004635|266112|P1|Period Two|travel issues|0
68802|NCT00004635|266111|P2|Period Two|health problem|1
68803|NCT00004635|266112|P1|Period Two|health problem|1
68804|NCT00004635|266111|P2|Period Two|refused|2
68805|NCT00004635|266112|P1|Period Two|refused|0
68806|NCT00004635|266111|P2|Period Two|Adverse Event|0
68807|NCT00004635|266112|P1|Period Two|Adverse Event|1
68808|NCT00004635|266111|P2|Period Two|progression|3
68809|NCT00004635|266112|P1|Period Two|progression|2
68810|NCT00004635|266111|P2|Period One|discrepancy in data entry|1
68811|NCT00004635|266112|P1|Period One|discrepancy in data entry|0
68812|NCT00004635|266111|P2|Period One|health problem|1
68813|NCT00004635|266112|P1|Period One|health problem|0
68814|NCT00004635|266111|P2|Period One|progressed|2
68815|NCT00004635|266112|P1|Period One|progressed|0
68816|NCT00004635|266111|P2|Period One|second malignancy|0
68817|NCT00004635|266112|P1|Period One|second malignancy|1
68818|NCT00004635|266111|P2|Period One|PSA did not go <5 ng/mL|0
68819|NCT00004635|266112|P1|Period One|PSA did not go <5 ng/mL|1
68820|NCT00004635|266111|P2|Period One|Protocol Violation|0
68821|NCT00004635|266112|P1|Period One|Protocol Violation|1
68822|NCT00004635|266111|P2|Period One|Withdrawal by Subject|1
68823|NCT00004635|266112|P1|Period One|Withdrawal by Subject|1
68824|NCT00004635|266111|P2|Period One|refused|1
68825|NCT00004635|266112|P1|Period One|refused|2
68826|NCT00005879|266124|P2|Overall Study|Withdrawal by Subject|10
68827|NCT00005879|266125|P1|Overall Study|Withdrawal by Subject|8
68828|NCT00005906|266152|P1|Overall Study|Lack of Efficacy|3
68829|NCT00005908|266158|P2|Overall Study|Withdrawal by Subject|0
68830|NCT00005908|266159|P1|Overall Study|Withdrawal by Subject|1
68831|NCT00005937|266168|P1|Overall Study|Lack of Efficacy|5
68832|NCT00005947|266174|P2|Overall Study|Site Closure|0
68833|NCT00005947|266175|P1|Overall Study|Site Closure|1
68834|NCT00005947|266174|P2|Overall Study|Patient Refused to Continue|1
68835|NCT00005947|266175|P1|Overall Study|Patient Refused to Continue|2
68836|NCT00005947|266174|P2|Overall Study|Death|40
68837|NCT00005947|266175|P1|Overall Study|Death|54
68838|NCT00005957|266185|P2|Overall Study|Crossover to the other arm|19
68839|NCT00005957|266186|P1|Overall Study|Crossover to the other arm|5
68840|NCT00005957|266185|P2|Overall Study|No treated|9
68841|NCT00005957|266186|P1|Overall Study|No treated|3
68842|NCT00006237|266196|P2|Overall Study|Not protocol specified|5
68843|NCT00006237|266197|P1|Overall Study|Not protocol specified|14
68844|NCT00006237|266196|P2|Overall Study|Withdrawal by Subject|1
68845|NCT00006237|266197|P1|Overall Study|Withdrawal by Subject|0
68846|NCT00006237|266196|P2|Overall Study|Not eligible|20
68847|NCT00006237|266197|P1|Overall Study|Not eligible|9
68848|NCT00006237|266196|P2|Overall Study|Progression/relapse|2
68849|NCT00006237|266197|P1|Overall Study|Progression/relapse|54
68850|NCT00006237|266196|P2|Overall Study|Refusal unrelated to adverse effects|4
68851|NCT00006237|266197|P1|Overall Study|Refusal unrelated to adverse effects|8
68852|NCT00006237|266196|P2|Overall Study|Death|0
68853|NCT00006237|266197|P1|Overall Study|Death|1
68854|NCT00006237|266196|P2|Overall Study|Adverse Event|29
68855|NCT00006237|266197|P1|Overall Study|Adverse Event|39
68856|NCT00006289|266218|P2|Second Intervention (5 Weeks)|Protocol Violation|1
68857|NCT00006289|266219|P1|Second Intervention (5 Weeks)|Protocol Violation|1
68858|NCT00006289|266218|P2|First Intervention (5 Weeks)|Adverse Event|0
68859|NCT00006289|266219|P1|First Intervention (5 Weeks)|Adverse Event|1
68860|NCT00006305|266239|P4|Overall Study|Withdrawal by Subject|14
68861|NCT00006305|266240|P3|Overall Study|Withdrawal by Subject|15
68862|NCT00006305|266241|P2|Overall Study|Withdrawal by Subject|10
68863|NCT00006305|266242|P1|Overall Study|Withdrawal by Subject|17
68864|NCT00006389|266256|P1|Overall Study|Adverse Event|1
68865|NCT00006392|266266|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
68866|NCT00006392|266267|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
68867|NCT00006392|266268|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
68868|NCT00006392|266269|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
68869|NCT00006392|266266|P4|Overall Study|Ineligible|5
68870|NCT00006392|266267|P3|Overall Study|Ineligible|5
68871|NCT00006392|266268|P2|Overall Study|Ineligible|3
68872|NCT00006392|266269|P1|Overall Study|Ineligible|11
68873|NCT00006409|266305|P6|Post-3 Year Intervention|Protocol Violation|62
68874|NCT00006409|266306|P5|Post-3 Year Intervention|Protocol Violation|62
68875|NCT00006409|266307|P4|Post-3 Year Intervention|Protocol Violation|0
68876|NCT00006409|266308|P3|Post-3 Year Intervention|Protocol Violation|0
68877|NCT00006409|266309|P2|Post-3 Year Intervention|Protocol Violation|0
68878|NCT00006409|266310|P1|Post-3 Year Intervention|Protocol Violation|0
68879|NCT00006409|266305|P6|Post-2 Year Intervention|Protocol Violation|0
68880|NCT00006409|266306|P5|Post-2 Year Intervention|Protocol Violation|0
68881|NCT00006409|266307|P4|Post-2 Year Intervention|Protocol Violation|168
68882|NCT00006409|266308|P3|Post-2 Year Intervention|Protocol Violation|251
68883|NCT00006409|266309|P2|Post-2 Year Intervention|Protocol Violation|0
68884|NCT00006409|266310|P1|Post-2 Year Intervention|Protocol Violation|0
68885|NCT00006409|266305|P6|Baseline|Protocol Violation|0
68886|NCT00006409|266306|P5|Baseline|Protocol Violation|0
68887|NCT00006409|266307|P4|Baseline|Protocol Violation|0
68888|NCT00006409|266308|P3|Baseline|Protocol Violation|0
68889|NCT00006409|266309|P2|Baseline|Protocol Violation|70
68890|NCT00006409|266310|P1|Baseline|Protocol Violation|48
68891|NCT00005047|266334|P4|Overall Study|Lack of Efficacy|0
68892|NCT00005047|266335|P3|Overall Study|Lack of Efficacy|0
68893|NCT00005047|266336|P2|Overall Study|Lack of Efficacy|0
68894|NCT00005047|266337|P1|Overall Study|Lack of Efficacy|1
68895|NCT00005047|266334|P4|Overall Study|Lost to Follow-up|0
68896|NCT00005047|266335|P3|Overall Study|Lost to Follow-up|0
68897|NCT00005047|266336|P2|Overall Study|Lost to Follow-up|0
68898|NCT00005047|266337|P1|Overall Study|Lost to Follow-up|1
68899|NCT00005047|266334|P4|Overall Study|Adverse Event|0
68900|NCT00005047|266335|P3|Overall Study|Adverse Event|0
68901|NCT00005047|266336|P2|Overall Study|Adverse Event|0
68902|NCT00005047|266337|P1|Overall Study|Adverse Event|5
68903|NCT00005047|266334|P4|Overall Study|Withdrawal by Subject|0
68904|NCT00005047|266335|P3|Overall Study|Withdrawal by Subject|0
68905|NCT00005047|266336|P2|Overall Study|Withdrawal by Subject|0
68906|NCT00005047|266337|P1|Overall Study|Withdrawal by Subject|12
68907|NCT00006478|266368|P1|Overall Study|Physician Decision|6
68908|NCT00006478|266368|P1|Overall Study|Vaccine could not be produced|1
68909|NCT00006489|266376|P4|Overall Study|Death|1
68910|NCT00006489|266377|P3|Overall Study|Death|0
68911|NCT00006489|266378|P2|Overall Study|Death|0
68912|NCT00006489|266379|P1|Overall Study|Death|0
68913|NCT00006489|266376|P4|Overall Study|Scheduling Conflict|1
68914|NCT00006489|266377|P3|Overall Study|Scheduling Conflict|2
68915|NCT00006489|266378|P2|Overall Study|Scheduling Conflict|3
68916|NCT00006489|266379|P1|Overall Study|Scheduling Conflict|0
68917|NCT00006489|266376|P4|Overall Study|Withdrawal by Subject|6
68918|NCT00006489|266377|P3|Overall Study|Withdrawal by Subject|9
68919|NCT00006489|266378|P2|Overall Study|Withdrawal by Subject|9
68920|NCT00006489|266379|P1|Overall Study|Withdrawal by Subject|10
68921|NCT00006489|266376|P4|Overall Study|Adverse Event|3
68922|NCT00006489|266377|P3|Overall Study|Adverse Event|4
68923|NCT00006489|266378|P2|Overall Study|Adverse Event|2
68924|NCT00006489|266379|P1|Overall Study|Adverse Event|3
68925|NCT00006604|266404|P17|Overall Study|Other Reason|0
68926|NCT00006604|266405|P16|Overall Study|Other Reason|0
68927|NCT00006604|266406|P15|Overall Study|Other Reason|0
68928|NCT00006604|266407|P14|Overall Study|Other Reason|0
68929|NCT00006604|266408|P13|Overall Study|Other Reason|0
68930|NCT00006604|266409|P12|Overall Study|Other Reason|0
68931|NCT00006604|266410|P11|Overall Study|Other Reason|0
68932|NCT00006604|266411|P10|Overall Study|Other Reason|1
68933|NCT00006604|266412|P9|Overall Study|Other Reason|0
68934|NCT00006604|266413|P8|Overall Study|Other Reason|0
68935|NCT00006604|266414|P7|Overall Study|Other Reason|0
68936|NCT00006604|266415|P6|Overall Study|Other Reason|1
68937|NCT00006604|266416|P5|Overall Study|Other Reason|0
68938|NCT00006604|266417|P4|Overall Study|Other Reason|0
68939|NCT00006604|266418|P3|Overall Study|Other Reason|0
68940|NCT00006604|266419|P2|Overall Study|Other Reason|0
68941|NCT00006604|266420|P1|Overall Study|Other Reason|0
68942|NCT00006604|266404|P17|Overall Study|Lost to Follow-up|3
68943|NCT00006604|266405|P16|Overall Study|Lost to Follow-up|1
68944|NCT00006604|266406|P15|Overall Study|Lost to Follow-up|0
68945|NCT00006604|266407|P14|Overall Study|Lost to Follow-up|0
68946|NCT00006604|266408|P13|Overall Study|Lost to Follow-up|0
68947|NCT00006604|266409|P12|Overall Study|Lost to Follow-up|0
68948|NCT00006604|266410|P11|Overall Study|Lost to Follow-up|0
68949|NCT00006604|266411|P10|Overall Study|Lost to Follow-up|2
68950|NCT00006604|266412|P9|Overall Study|Lost to Follow-up|0
68951|NCT00006604|266413|P8|Overall Study|Lost to Follow-up|1
68952|NCT00006604|266414|P7|Overall Study|Lost to Follow-up|0
68953|NCT00006604|266415|P6|Overall Study|Lost to Follow-up|0
68954|NCT00006604|266416|P5|Overall Study|Lost to Follow-up|0
68955|NCT00006604|266417|P4|Overall Study|Lost to Follow-up|0
68956|NCT00006604|266418|P3|Overall Study|Lost to Follow-up|0
68957|NCT00006604|266419|P2|Overall Study|Lost to Follow-up|0
68958|NCT00006604|266420|P1|Overall Study|Lost to Follow-up|0
68959|NCT00006604|266404|P17|Overall Study|Subj/parent not willing to adhere to req|4
68960|NCT00006604|266405|P16|Overall Study|Subj/parent not willing to adhere to req|3
68961|NCT00006604|266406|P15|Overall Study|Subj/parent not willing to adhere to req|3
68962|NCT00006604|266407|P14|Overall Study|Subj/parent not willing to adhere to req|2
68963|NCT00006604|266408|P13|Overall Study|Subj/parent not willing to adhere to req|0
68964|NCT00006604|266409|P12|Overall Study|Subj/parent not willing to adhere to req|0
68965|NCT00006604|266410|P11|Overall Study|Subj/parent not willing to adhere to req|3
68966|NCT00006604|266411|P10|Overall Study|Subj/parent not willing to adhere to req|6
68967|NCT00006604|266412|P9|Overall Study|Subj/parent not willing to adhere to req|0
68968|NCT00006604|266413|P8|Overall Study|Subj/parent not willing to adhere to req|1
68969|NCT00006604|266414|P7|Overall Study|Subj/parent not willing to adhere to req|3
68970|NCT00006604|266415|P6|Overall Study|Subj/parent not willing to adhere to req|0
68971|NCT00006604|266416|P5|Overall Study|Subj/parent not willing to adhere to req|0
68972|NCT00006604|266417|P4|Overall Study|Subj/parent not willing to adhere to req|3
68973|NCT00006604|266418|P3|Overall Study|Subj/parent not willing to adhere to req|1
68974|NCT00006604|266419|P2|Overall Study|Subj/parent not willing to adhere to req|0
68975|NCT00006604|266420|P1|Overall Study|Subj/parent not willing to adhere to req|0
68976|NCT00006604|266404|P17|Overall Study|Withdrawal by Subject|1
68977|NCT00006604|266405|P16|Overall Study|Withdrawal by Subject|0
68978|NCT00006604|266406|P15|Overall Study|Withdrawal by Subject|1
68979|NCT00006604|266407|P14|Overall Study|Withdrawal by Subject|2
68980|NCT00006604|266408|P13|Overall Study|Withdrawal by Subject|1
68981|NCT00006604|266409|P12|Overall Study|Withdrawal by Subject|0
68982|NCT00006604|266410|P11|Overall Study|Withdrawal by Subject|2
68983|NCT00006604|266411|P10|Overall Study|Withdrawal by Subject|3
68984|NCT00006604|266412|P9|Overall Study|Withdrawal by Subject|1
68985|NCT00006604|266413|P8|Overall Study|Withdrawal by Subject|0
68986|NCT00006604|266414|P7|Overall Study|Withdrawal by Subject|2
68987|NCT00006604|266415|P6|Overall Study|Withdrawal by Subject|2
68988|NCT00006604|266416|P5|Overall Study|Withdrawal by Subject|1
68989|NCT00006604|266417|P4|Overall Study|Withdrawal by Subject|0
68990|NCT00006604|266418|P3|Overall Study|Withdrawal by Subject|2
68991|NCT00006604|266419|P2|Overall Study|Withdrawal by Subject|0
68992|NCT00006604|266420|P1|Overall Study|Withdrawal by Subject|1
68993|NCT00006604|266404|P17|Overall Study|Site closing|1
68994|NCT00006604|266405|P16|Overall Study|Site closing|0
68995|NCT00006604|266406|P15|Overall Study|Site closing|0
68996|NCT00006604|266407|P14|Overall Study|Site closing|1
68997|NCT00006604|266408|P13|Overall Study|Site closing|1
68998|NCT00006604|266409|P12|Overall Study|Site closing|1
68999|NCT00006604|266410|P11|Overall Study|Site closing|0
69000|NCT00006604|266411|P10|Overall Study|Site closing|0
69001|NCT00006604|266412|P9|Overall Study|Site closing|0
69002|NCT00006604|266413|P8|Overall Study|Site closing|1
69003|NCT00006604|266414|P7|Overall Study|Site closing|0
69004|NCT00006604|266415|P6|Overall Study|Site closing|0
69005|NCT00006604|266416|P5|Overall Study|Site closing|0
69006|NCT00006604|266417|P4|Overall Study|Site closing|1
69007|NCT00006604|266418|P3|Overall Study|Site closing|1
69008|NCT00006604|266419|P2|Overall Study|Site closing|0
69009|NCT00006604|266420|P1|Overall Study|Site closing|0
69010|NCT00006604|266404|P17|Overall Study|Subj/Parent not able to get to clinic|0
69011|NCT00006604|266405|P16|Overall Study|Subj/Parent not able to get to clinic|0
69012|NCT00006604|266406|P15|Overall Study|Subj/Parent not able to get to clinic|3
69013|NCT00006604|266407|P14|Overall Study|Subj/Parent not able to get to clinic|1
69014|NCT00006604|266408|P13|Overall Study|Subj/Parent not able to get to clinic|1
69015|NCT00006604|266409|P12|Overall Study|Subj/Parent not able to get to clinic|1
69016|NCT00006604|266410|P11|Overall Study|Subj/Parent not able to get to clinic|2
69017|NCT00006604|266411|P10|Overall Study|Subj/Parent not able to get to clinic|1
69018|NCT00006604|266412|P9|Overall Study|Subj/Parent not able to get to clinic|0
69019|NCT00006604|266413|P8|Overall Study|Subj/Parent not able to get to clinic|0
69020|NCT00006604|266414|P7|Overall Study|Subj/Parent not able to get to clinic|1
69021|NCT00006604|266415|P6|Overall Study|Subj/Parent not able to get to clinic|0
69022|NCT00006604|266416|P5|Overall Study|Subj/Parent not able to get to clinic|1
69023|NCT00006604|266417|P4|Overall Study|Subj/Parent not able to get to clinic|1
69024|NCT00006604|266418|P3|Overall Study|Subj/Parent not able to get to clinic|0
69025|NCT00006604|266419|P2|Overall Study|Subj/Parent not able to get to clinic|0
69026|NCT00006604|266420|P1|Overall Study|Subj/Parent not able to get to clinic|0
69027|NCT00006604|266404|P17|Overall Study|Severe debilitation, unable to continue|0
69028|NCT00006604|266405|P16|Overall Study|Severe debilitation, unable to continue|0
69029|NCT00006604|266406|P15|Overall Study|Severe debilitation, unable to continue|2
69030|NCT00006604|266407|P14|Overall Study|Severe debilitation, unable to continue|0
69031|NCT00006604|266408|P13|Overall Study|Severe debilitation, unable to continue|1
69032|NCT00006604|266409|P12|Overall Study|Severe debilitation, unable to continue|2
69033|NCT00006604|266410|P11|Overall Study|Severe debilitation, unable to continue|0
69034|NCT00006604|266411|P10|Overall Study|Severe debilitation, unable to continue|5
69035|NCT00006604|266412|P9|Overall Study|Severe debilitation, unable to continue|0
69036|NCT00006604|266413|P8|Overall Study|Severe debilitation, unable to continue|0
69037|NCT00006604|266414|P7|Overall Study|Severe debilitation, unable to continue|3
69038|NCT00006604|266415|P6|Overall Study|Severe debilitation, unable to continue|0
69039|NCT00006604|266416|P5|Overall Study|Severe debilitation, unable to continue|0
69040|NCT00006604|266417|P4|Overall Study|Severe debilitation, unable to continue|0
69041|NCT00006604|266418|P3|Overall Study|Severe debilitation, unable to continue|0
69042|NCT00006604|266419|P2|Overall Study|Severe debilitation, unable to continue|0
69043|NCT00006604|266420|P1|Overall Study|Severe debilitation, unable to continue|0
69044|NCT00006604|266404|P17|Overall Study|Death|0
69045|NCT00006604|266405|P16|Overall Study|Death|0
69046|NCT00006604|266406|P15|Overall Study|Death|0
69047|NCT00006604|266407|P14|Overall Study|Death|0
69048|NCT00006604|266408|P13|Overall Study|Death|0
69049|NCT00006604|266409|P12|Overall Study|Death|1
69050|NCT00006604|266410|P11|Overall Study|Death|1
69051|NCT00006604|266411|P10|Overall Study|Death|1
69052|NCT00006604|266412|P9|Overall Study|Death|0
69053|NCT00006604|266413|P8|Overall Study|Death|0
69054|NCT00006604|266414|P7|Overall Study|Death|0
69055|NCT00006604|266415|P6|Overall Study|Death|0
69056|NCT00006604|266416|P5|Overall Study|Death|0
69057|NCT00006604|266417|P4|Overall Study|Death|0
69058|NCT00006604|266418|P3|Overall Study|Death|0
69059|NCT00006604|266419|P2|Overall Study|Death|0
69060|NCT00006604|266420|P1|Overall Study|Death|0
69061|NCT00006604|266404|P17|Overall Study|Randomization entry error-no RX, no FU|0
69062|NCT00006604|266405|P16|Overall Study|Randomization entry error-no RX, no FU|0
69063|NCT00006604|266406|P15|Overall Study|Randomization entry error-no RX, no FU|0
69064|NCT00006604|266407|P14|Overall Study|Randomization entry error-no RX, no FU|0
69065|NCT00006604|266408|P13|Overall Study|Randomization entry error-no RX, no FU|0
69066|NCT00006604|266409|P12|Overall Study|Randomization entry error-no RX, no FU|1
69067|NCT00006604|266410|P11|Overall Study|Randomization entry error-no RX, no FU|0
69068|NCT00006604|266411|P10|Overall Study|Randomization entry error-no RX, no FU|0
69069|NCT00006604|266412|P9|Overall Study|Randomization entry error-no RX, no FU|0
69070|NCT00006604|266413|P8|Overall Study|Randomization entry error-no RX, no FU|0
69071|NCT00006604|266414|P7|Overall Study|Randomization entry error-no RX, no FU|0
69072|NCT00006604|266415|P6|Overall Study|Randomization entry error-no RX, no FU|0
69073|NCT00006604|266416|P5|Overall Study|Randomization entry error-no RX, no FU|0
69074|NCT00006604|266417|P4|Overall Study|Randomization entry error-no RX, no FU|0
69075|NCT00006604|266418|P3|Overall Study|Randomization entry error-no RX, no FU|0
69076|NCT00006604|266419|P2|Overall Study|Randomization entry error-no RX, no FU|0
69077|NCT00006604|266420|P1|Overall Study|Randomization entry error-no RX, no FU|0
69078|NCT00006604|266404|P17|Overall Study|Met study objective - no further FU|0
69079|NCT00006604|266405|P16|Overall Study|Met study objective - no further FU|1
69080|NCT00006604|266406|P15|Overall Study|Met study objective - no further FU|1
69081|NCT00006604|266407|P14|Overall Study|Met study objective - no further FU|0
69082|NCT00006604|266408|P13|Overall Study|Met study objective - no further FU|0
69083|NCT00006604|266409|P12|Overall Study|Met study objective - no further FU|0
69084|NCT00006604|266410|P11|Overall Study|Met study objective - no further FU|0
69085|NCT00006604|266411|P10|Overall Study|Met study objective - no further FU|0
69086|NCT00006604|266412|P9|Overall Study|Met study objective - no further FU|0
69087|NCT00006604|266413|P8|Overall Study|Met study objective - no further FU|0
69088|NCT00006604|266414|P7|Overall Study|Met study objective - no further FU|0
69089|NCT00006604|266415|P6|Overall Study|Met study objective - no further FU|0
69090|NCT00006604|266416|P5|Overall Study|Met study objective - no further FU|0
69091|NCT00006604|266417|P4|Overall Study|Met study objective - no further FU|0
69092|NCT00006604|266418|P3|Overall Study|Met study objective - no further FU|0
69093|NCT00006604|266419|P2|Overall Study|Met study objective - no further FU|0
69094|NCT00006604|266420|P1|Overall Study|Met study objective - no further FU|1
69095|NCT00006721|266537|P3|Overall Study|Eligible but no Treatment Received|0
69096|NCT00006721|266538|P2|Overall Study|Eligible but no Treatment Received|0
69097|NCT00006721|266539|P1|Overall Study|Eligible but no Treatment Received|1
69098|NCT00006721|266537|P3|Overall Study|Ineligible|10
69099|NCT00006721|266538|P2|Overall Study|Ineligible|12
69100|NCT00006721|266539|P1|Overall Study|Ineligible|2
69101|NCT00006721|266537|P3|Overall Study|Other - Not Protocol Specified|7
69102|NCT00006721|266538|P2|Overall Study|Other - Not Protocol Specified|7
69103|NCT00006721|266539|P1|Overall Study|Other - Not Protocol Specified|0
69104|NCT00006721|266537|P3|Overall Study|Death|2
69105|NCT00006721|266538|P2|Overall Study|Death|1
69106|NCT00006721|266539|P1|Overall Study|Death|0
69107|NCT00006721|266537|P3|Overall Study|Progression/Relapse|2
69108|NCT00006721|266538|P2|Overall Study|Progression/Relapse|1
69109|NCT00006721|266539|P1|Overall Study|Progression/Relapse|0
69110|NCT00006721|266537|P3|Overall Study|Refusal Unrelated to Adverse Event|8
69111|NCT00006721|266538|P2|Overall Study|Refusal Unrelated to Adverse Event|0
69112|NCT00006721|266539|P1|Overall Study|Refusal Unrelated to Adverse Event|1
69113|NCT00006721|266537|P3|Overall Study|Adverse Event|4
69114|NCT00006721|266538|P2|Overall Study|Adverse Event|4
69115|NCT00006721|266539|P1|Overall Study|Adverse Event|0
69116|NCT00006903|266559|P3|Overall Study|Ineligible|2
69117|NCT00006903|266560|P2|Overall Study|Ineligible|1
69118|NCT00006903|266561|P1|Overall Study|Ineligible|10
69119|NCT00006903|266559|P3|Overall Study|Patient never treated|1
69120|NCT00006903|266560|P2|Overall Study|Patient never treated|0
69121|NCT00006903|266561|P1|Overall Study|Patient never treated|0
69122|NCT00006903|266559|P3|Overall Study|Death|0
69123|NCT00006903|266560|P2|Overall Study|Death|1
69124|NCT00006903|266561|P1|Overall Study|Death|0
69125|NCT00006903|266559|P3|Overall Study|Adverse Event|1
69126|NCT00006903|266560|P2|Overall Study|Adverse Event|0
69127|NCT00006903|266561|P1|Overall Study|Adverse Event|0
69128|NCT00006903|266559|P3|Overall Study|Refused further treatment|1
69129|NCT00006903|266560|P2|Overall Study|Refused further treatment|2
69130|NCT00006903|266561|P1|Overall Study|Refused further treatment|0
69131|NCT00006903|266559|P3|Overall Study|Still receiving treatment|1
69132|NCT00006903|266560|P2|Overall Study|Still receiving treatment|0
69133|NCT00006903|266561|P1|Overall Study|Still receiving treatment|0
69134|NCT00006916|266566|P1|Overall Study|Complication of device insertion|1
69135|NCT00006916|266566|P1|Overall Study|Device not inserted|4
69136|NCT00007345|266572|P2|Overall Study|Death on study|1
69137|NCT00007345|266573|P1|Overall Study|Death on study|1
69138|NCT00007345|266572|P2|Overall Study|Intercurrent illness|0
69139|NCT00007345|266573|P1|Overall Study|Intercurrent illness|1
69140|NCT00007345|266572|P2|Overall Study|Switched to alternative treatment|3
69141|NCT00007345|266573|P1|Overall Study|Switched to alternative treatment|0
69142|NCT00007345|266572|P2|Overall Study|Refused further treatment|7
69143|NCT00007345|266573|P1|Overall Study|Refused further treatment|0
69144|NCT00007475|266594|P4|Overall Study|Adverse Event|0
69145|NCT00007475|266595|P3|Overall Study|Adverse Event|0
69146|NCT00007475|266596|P2|Overall Study|Adverse Event|0
69147|NCT00007475|266597|P1|Overall Study|Adverse Event|3
69148|NCT00007475|266594|P4|Overall Study|Withdrawal by Subject|0
69149|NCT00007475|266595|P3|Overall Study|Withdrawal by Subject|0
69150|NCT00007475|266596|P2|Overall Study|Withdrawal by Subject|0
69151|NCT00007475|266597|P1|Overall Study|Withdrawal by Subject|1
69152|NCT00008138|266626|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
69153|NCT00008138|266626|P1|Post-Cytoreduction Chemotherapy|Progression|1
69154|NCT00008138|266626|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
69155|NCT00008138|266626|P1|Interval Debulking|Withdrawal by Subject|2
69156|NCT00008138|266626|P1|Neoadjuvant Chemotherapy|not protocol specified|8
69157|NCT00008138|266626|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
69158|NCT00008138|266626|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
69159|NCT00008138|266626|P1|Neoadjuvant Chemotherapy|Adverse Event|3
69160|NCT00008385|266634|P2|Overall Study|Not start protocol therapy|175
69161|NCT00008385|266635|P1|Overall Study|Not start protocol therapy|44
69162|NCT00008385|266634|P2|Overall Study|Not specified|212
69163|NCT00008385|266635|P1|Overall Study|Not specified|105
69164|NCT00008385|266634|P2|Overall Study|Maximum dose reached|2
69165|NCT00008385|266635|P1|Overall Study|Maximum dose reached|0
69166|NCT00008385|266634|P2|Overall Study|Other complicating disease|30
69167|NCT00008385|266635|P1|Overall Study|Other complicating disease|17
69168|NCT00008385|266634|P2|Overall Study|Start non-protocol therapy|1
69169|NCT00008385|266635|P1|Overall Study|Start non-protocol therapy|3
69170|NCT00008385|266634|P2|Overall Study|Withdrawal by Subject|157
69171|NCT00008385|266635|P1|Overall Study|Withdrawal by Subject|67
69172|NCT00008385|266634|P2|Overall Study|Death|18
69173|NCT00008385|266635|P1|Overall Study|Death|12
69174|NCT00008385|266634|P2|Overall Study|Adverse Event|20
69175|NCT00008385|266635|P1|Overall Study|Adverse Event|8
69176|NCT00008385|266634|P2|Overall Study|Progressive disease|117
69177|NCT00008385|266635|P1|Overall Study|Progressive disease|52
69178|NCT00008385|266634|P2|Overall Study|Off treatment reasons not reported|70
69179|NCT00008385|266635|P1|Overall Study|Off treatment reasons not reported|79
69180|NCT00006011|266648|P3|Overall Study|Ineligible|9
69181|NCT00006011|266649|P2|Overall Study|Ineligible|16
69182|NCT00006011|266650|P1|Overall Study|Ineligible|18
69183|NCT00006011|266648|P3|Overall Study|Not specified|5
69184|NCT00006011|266649|P2|Overall Study|Not specified|2
69185|NCT00006011|266650|P1|Overall Study|Not specified|4
69186|NCT00006011|266648|P3|Overall Study|Death|2
69187|NCT00006011|266649|P2|Overall Study|Death|1
69188|NCT00006011|266650|P1|Overall Study|Death|0
69189|NCT00006011|266648|P3|Overall Study|Adverse Event|5
69190|NCT00006011|266649|P2|Overall Study|Adverse Event|39
69191|NCT00006011|266650|P1|Overall Study|Adverse Event|15
69192|NCT00006011|266648|P3|Overall Study|Refused further treatment|26
69193|NCT00006011|266649|P2|Overall Study|Refused further treatment|13
69194|NCT00006011|266650|P1|Overall Study|Refused further treatment|15
69195|NCT00006011|266648|P3|Overall Study|Disease progression|26
69196|NCT00006011|266649|P2|Overall Study|Disease progression|6
69197|NCT00006011|266650|P1|Overall Study|Disease progression|13
69198|NCT00006164|266692|P2|Overall Study|Withdrew or lost to follow-up|81
69199|NCT00006164|266693|P1|Overall Study|Withdrew or lost to follow-up|70
69200|NCT00006184|266751|P2|Overall Study|Death|0
69201|NCT00006184|266752|P1|Overall Study|Death|1
69202|NCT00014495|266763|P4|Overall Study|Clinical deterioration|1
69203|NCT00014495|266764|P3|Overall Study|Clinical deterioration|0
69204|NCT00014495|266765|P2|Overall Study|Clinical deterioration|0
69205|NCT00014495|266766|P1|Overall Study|Clinical deterioration|0
69206|NCT00014495|266763|P4|Overall Study|Death|0
69207|NCT00014495|266764|P3|Overall Study|Death|1
69208|NCT00014495|266765|P2|Overall Study|Death|0
69209|NCT00014495|266766|P1|Overall Study|Death|0
69210|NCT00014911|266777|P1|Overall Study|Immunosuppression-related Side Effects|1
69211|NCT00014911|266777|P1|Overall Study|Unknown Reasons|2
69212|NCT00014911|266777|P1|Overall Study|Withdrawal by Subject|6
69213|NCT00014911|266777|P1|Overall Study|Lost to Follow-up|1
69214|NCT00014911|266777|P1|Overall Study|Adverse Event|1
69215|NCT00015457|266786|P2|Second Intervention|Withdrawal by Subject|0
69216|NCT00015457|266787|P1|Second Intervention|Withdrawal by Subject|1
69217|NCT00015457|266786|P2|First Intervention|Lack of Efficacy|1
69218|NCT00015457|266787|P1|First Intervention|Lack of Efficacy|0
69219|NCT00015457|266786|P2|First Intervention|Adverse Event|2
69220|NCT00015457|266787|P1|First Intervention|Adverse Event|0
69221|NCT00016354|266801|P8|Overall Study|Lack of Efficacy|1
69222|NCT00016354|266802|P7|Overall Study|Lack of Efficacy|0
69223|NCT00016354|266803|P6|Overall Study|Lack of Efficacy|0
69224|NCT00016354|266804|P5|Overall Study|Lack of Efficacy|0
69225|NCT00016354|266805|P4|Overall Study|Lack of Efficacy|0
69226|NCT00016354|266806|P3|Overall Study|Lack of Efficacy|0
69227|NCT00016354|266807|P2|Overall Study|Lack of Efficacy|0
69228|NCT00016354|266808|P1|Overall Study|Lack of Efficacy|0
69229|NCT00019604|266822|P1|Overall Study|Details for other not available|4
69230|NCT00019604|266822|P1|Overall Study|Unable to evaluate|1
69231|NCT00019604|266822|P1|Overall Study|Too much disease|1
69232|NCT00019604|266822|P1|Overall Study|Pt going to immunotherapy study|1
69233|NCT00019604|266822|P1|Overall Study|Started new chemo regimen|1
69234|NCT00019604|266822|P1|Overall Study|Resectable disease|1
69235|NCT00019604|266822|P1|Overall Study|Non compliant|1
69236|NCT00019604|266822|P1|Overall Study|Non compliant on systemic CH|1
69237|NCT00019604|266822|P1|Overall Study|Move to a different study|1
69238|NCT00019604|266822|P1|Overall Study|Going to have liver transplant|1
69239|NCT00019604|266822|P1|Overall Study|Carcinoid tumor, not treatable|1
69240|NCT00019604|266822|P1|Overall Study|Refused treatment|1
69241|NCT00019604|266822|P1|Overall Study|Progressive disease|23
69242|NCT00019604|266822|P1|Overall Study|Death|1
69243|NCT00009737|266851|P2|Overall Study|Administrative/Other Reasons|1
69244|NCT00009737|266852|P1|Overall Study|Administrative/Other Reasons|7
69245|NCT00009737|266851|P2|Overall Study|Lost to Follow-up|1
69246|NCT00009737|266852|P1|Overall Study|Lost to Follow-up|1
69247|NCT00009737|266851|P2|Overall Study|Refused Treatment|16
69248|NCT00009737|266852|P1|Overall Study|Refused Treatment|15
69249|NCT00009737|266851|P2|Overall Study|Other Protocol Violation|0
69250|NCT00009737|266852|P1|Overall Study|Other Protocol Violation|1
69251|NCT00009737|266851|P2|Overall Study|Violation of Selection Criteria at Entry|9
69252|NCT00009737|266852|P1|Overall Study|Violation of Selection Criteria at Entry|13
69253|NCT00009737|266851|P2|Overall Study|Lack of Efficacy|15
69254|NCT00009737|266852|P1|Overall Study|Lack of Efficacy|17
69255|NCT00009737|266851|P2|Overall Study|Death|6
69256|NCT00009737|266852|P1|Overall Study|Death|4
69257|NCT00009737|266851|P2|Overall Study|Adverse Event|75
69258|NCT00009737|266852|P1|Overall Study|Adverse Event|112
69259|NCT00012012|266891|P2|Overall Study|Withdrawal by Subject|2
69260|NCT00012012|266892|P1|Overall Study|Withdrawal by Subject|0
69261|NCT00012012|266891|P2|Overall Study|Protocol Violation|1
69262|NCT00012012|266892|P1|Overall Study|Protocol Violation|1
69263|NCT00013611|266935|P2|Overall Study|Lost to Follow-up|100
69264|NCT00013611|266936|P1|Overall Study|Lost to Follow-up|91
69265|NCT00021229|266955|P3|Overall Study|Punctate hemmorrhage post RT|0
69266|NCT00021229|266956|P2|Overall Study|Punctate hemmorrhage post RT|0
69267|NCT00021229|266957|P1|Overall Study|Punctate hemmorrhage post RT|2
69268|NCT00021229|266955|P3|Overall Study|Physician Decision|1
69269|NCT00021229|266956|P2|Overall Study|Physician Decision|0
69270|NCT00021229|266957|P1|Overall Study|Physician Decision|0
69271|NCT00021229|266955|P3|Overall Study|Protocol Violation|0
69272|NCT00021229|266956|P2|Overall Study|Protocol Violation|1
69273|NCT00021229|266957|P1|Overall Study|Protocol Violation|1
69274|NCT00021229|266955|P3|Overall Study|Progressive Disease|12
69275|NCT00021229|266956|P2|Overall Study|Progressive Disease|19
69276|NCT00021229|266957|P1|Overall Study|Progressive Disease|15
69277|NCT00021229|266955|P3|Overall Study|Withdrawal by Subject|1
69278|NCT00021229|266956|P2|Overall Study|Withdrawal by Subject|7
69279|NCT00021229|266957|P1|Overall Study|Withdrawal by Subject|7
69280|NCT00021229|266955|P3|Overall Study|Death|0
69281|NCT00021229|266956|P2|Overall Study|Death|1
69282|NCT00021229|266957|P1|Overall Study|Death|0
69283|NCT00021229|266955|P3|Overall Study|Adverse Event|2
69284|NCT00021229|266956|P2|Overall Study|Adverse Event|5
69285|NCT00021229|266957|P1|Overall Study|Adverse Event|10
69286|NCT00021255|266986|P3|Overall Study|Randomized but not treated|18
69287|NCT00021255|266987|P2|Overall Study|Randomized but not treated|2
69288|NCT00021255|266988|P1|Overall Study|Randomized but not treated|28
69289|NCT00021255|266986|P3|Overall Study|Missing|13
69290|NCT00021255|266987|P2|Overall Study|Missing|27
69291|NCT00021255|266988|P1|Overall Study|Missing|0
69292|NCT00021255|266986|P3|Overall Study|Other than specified above|19
69293|NCT00021255|266987|P2|Overall Study|Other than specified above|38
69294|NCT00021255|266988|P1|Overall Study|Other than specified above|0
69295|NCT00021255|266986|P3|Overall Study|Protocol Violation|0
69296|NCT00021255|266987|P2|Overall Study|Protocol Violation|2
69297|NCT00021255|266988|P1|Overall Study|Protocol Violation|0
69298|NCT00021255|266986|P3|Overall Study|Adverse Event|18
69299|NCT00021255|266987|P2|Overall Study|Adverse Event|30
69300|NCT00021255|266988|P1|Overall Study|Adverse Event|46
69301|NCT00021255|266986|P3|Overall Study|Herceptin toxicity|6
69302|NCT00021255|266987|P2|Overall Study|Herceptin toxicity|22
69303|NCT00021255|266988|P1|Overall Study|Herceptin toxicity|0
69304|NCT00021255|266986|P3|Overall Study|Cardiac toxicity|32
69305|NCT00021255|266987|P2|Overall Study|Cardiac toxicity|61
69306|NCT00021255|266988|P1|Overall Study|Cardiac toxicity|0
69307|NCT00021255|266986|P3|Overall Study|Lost to Follow-up|3
69308|NCT00021255|266987|P2|Overall Study|Lost to Follow-up|2
69309|NCT00021255|266988|P1|Overall Study|Lost to Follow-up|0
69310|NCT00021255|266986|P3|Overall Study|Withdrawal by Subject|26
69311|NCT00021255|266987|P2|Overall Study|Withdrawal by Subject|64
69312|NCT00021255|266988|P1|Overall Study|Withdrawal by Subject|41
69313|NCT00021255|266986|P3|Overall Study|Second primary malignancy|1
69314|NCT00021255|266987|P2|Overall Study|Second primary malignancy|4
69315|NCT00021255|266988|P1|Overall Study|Second primary malignancy|0
69316|NCT00021255|266986|P3|Overall Study|Breast cancer relapse|11
69317|NCT00021255|266987|P2|Overall Study|Breast cancer relapse|18
69318|NCT00021255|266988|P1|Overall Study|Breast cancer relapse|5
69319|NCT00021255|266986|P3|Overall Study|Death|2
69320|NCT00021255|266987|P2|Overall Study|Death|0
69321|NCT00021255|266988|P1|Overall Study|Death|1
69322|NCT00024258|267002|P1|Overall Study|Disease Progression|8
69323|NCT00024258|267002|P1|Overall Study|Withdrawal by Subject|1
69324|NCT00025155|267006|P1|Overall Study|Ineligible: Second primary cancer site|1
69325|NCT00025155|267006|P1|Overall Study|Ineligible: Wrong primary cancer site|1
69326|NCT00025233|267012|P1|Overall Study|Never treated|1
69327|NCT00025233|267012|P1|Overall Study|Ineligible: improper prior treatment|1
69328|NCT00025233|267012|P1|Overall Study|Ineligible: wrong primary|1
69329|NCT00025233|267012|P1|Overall Study|Ineligible: wrong cell type|1
69330|NCT00025259|267025|P7|Overall Study|Adverse Event|0
69331|NCT00025259|267026|P6|Overall Study|Adverse Event|0
69332|NCT00025259|267027|P5|Overall Study|Adverse Event|0
69333|NCT00025259|267028|P4|Overall Study|Adverse Event|0
69334|NCT00025259|267029|P3|Overall Study|Adverse Event|0
69335|NCT00025259|267030|P2|Overall Study|Adverse Event|0
69336|NCT00025259|267031|P1|Overall Study|Adverse Event|1
69337|NCT00025259|267025|P7|Overall Study|Randomization error|2
69338|NCT00025259|267026|P6|Overall Study|Randomization error|7
69339|NCT00025259|267027|P5|Overall Study|Randomization error|1
69340|NCT00025259|267028|P4|Overall Study|Randomization error|0
69341|NCT00025259|267029|P3|Overall Study|Randomization error|0
69342|NCT00025259|267030|P2|Overall Study|Randomization error|0
69343|NCT00025259|267031|P1|Overall Study|Randomization error|1
69344|NCT00025259|267025|P7|Overall Study|Ineligible|1
69345|NCT00025259|267026|P6|Overall Study|Ineligible|0
69346|NCT00025259|267027|P5|Overall Study|Ineligible|6
69347|NCT00025259|267028|P4|Overall Study|Ineligible|0
69348|NCT00025259|267029|P3|Overall Study|Ineligible|0
69349|NCT00025259|267030|P2|Overall Study|Ineligible|1
69350|NCT00025259|267031|P1|Overall Study|Ineligible|14
69351|NCT00025259|267025|P7|Overall Study|Withdrawal by Subject|3
69352|NCT00025259|267026|P6|Overall Study|Withdrawal by Subject|8
69353|NCT00025259|267027|P5|Overall Study|Withdrawal by Subject|11
69354|NCT00025259|267028|P4|Overall Study|Withdrawal by Subject|14
69355|NCT00025259|267029|P3|Overall Study|Withdrawal by Subject|6
69356|NCT00025259|267030|P2|Overall Study|Withdrawal by Subject|27
69357|NCT00025259|267031|P1|Overall Study|Withdrawal by Subject|9
69358|NCT00025259|267025|P7|Overall Study|Protocol Violation|3
69359|NCT00025259|267026|P6|Overall Study|Protocol Violation|1
69360|NCT00025259|267027|P5|Overall Study|Protocol Violation|2
69361|NCT00025259|267028|P4|Overall Study|Protocol Violation|1
69362|NCT00025259|267029|P3|Overall Study|Protocol Violation|2
69363|NCT00025259|267030|P2|Overall Study|Protocol Violation|2
69364|NCT00025259|267031|P1|Overall Study|Protocol Violation|3
69365|NCT00025259|267025|P7|Overall Study|Physician Decision|1
69366|NCT00025259|267026|P6|Overall Study|Physician Decision|2
69367|NCT00025259|267027|P5|Overall Study|Physician Decision|4
69368|NCT00025259|267028|P4|Overall Study|Physician Decision|5
69369|NCT00025259|267029|P3|Overall Study|Physician Decision|0
69370|NCT00025259|267030|P2|Overall Study|Physician Decision|1
69371|NCT00025259|267031|P1|Overall Study|Physician Decision|12
69372|NCT00025259|267025|P7|Overall Study|Lost to Follow-up|1
69373|NCT00025259|267026|P6|Overall Study|Lost to Follow-up|3
69374|NCT00025259|267027|P5|Overall Study|Lost to Follow-up|1
69375|NCT00025259|267028|P4|Overall Study|Lost to Follow-up|13
69376|NCT00025259|267029|P3|Overall Study|Lost to Follow-up|13
69377|NCT00025259|267030|P2|Overall Study|Lost to Follow-up|9
69378|NCT00025259|267031|P1|Overall Study|Lost to Follow-up|2
69379|NCT00025259|267025|P7|Overall Study|Lack of Efficacy|38
69380|NCT00025259|267026|P6|Overall Study|Lack of Efficacy|30
69381|NCT00025259|267027|P5|Overall Study|Lack of Efficacy|11
69382|NCT00025259|267028|P4|Overall Study|Lack of Efficacy|78
69383|NCT00025259|267029|P3|Overall Study|Lack of Efficacy|60
69384|NCT00025259|267030|P2|Overall Study|Lack of Efficacy|46
69385|NCT00025259|267031|P1|Overall Study|Lack of Efficacy|2
69386|NCT00025259|267025|P7|Overall Study|Death|2
69387|NCT00025259|267026|P6|Overall Study|Death|1
69388|NCT00025259|267027|P5|Overall Study|Death|0
69389|NCT00025259|267028|P4|Overall Study|Death|3
69390|NCT00025259|267029|P3|Overall Study|Death|0
69391|NCT00025259|267030|P2|Overall Study|Death|3
69392|NCT00025259|267031|P1|Overall Study|Death|1
69393|NCT00025506|267067|P1|Overall Study|Never Treated|2
69394|NCT00025506|267067|P1|Overall Study|Ineligible: inadequate pathology|2
69395|NCT00025506|267067|P1|Overall Study|Ineligible: wrong cell type|5
69396|NCT00025506|267067|P1|Overall Study|Ineligible: clerical error|1
69397|NCT00025662|267073|P1|Overall Study|Technical failure of manipulation|1
69398|NCT00025662|267073|P1|Overall Study|Withdrawal by Subject|2
69399|NCT00025883|267083|P1|Overall Study|didn't reach 6 months of Metreleptin|10
69400|NCT00025883|267083|P1|Overall Study|Adverse Event|1
69401|NCT00025883|267083|P1|Overall Study|Death|1
69402|NCT00025883|267083|P1|Overall Study|no baseline data|1
69403|NCT00025883|267083|P1|Overall Study|had atypical progeriod lipodystrophy|4
69404|NCT00026312|267114|P2|Overall Study|Refusal by patient/parent/guardian|59
69405|NCT00026312|267115|P1|Overall Study|Refusal by patient/parent/guardian|8
69406|NCT00026312|267114|P2|Overall Study|Entry onto another COG study|1
69407|NCT00026312|267115|P1|Overall Study|Entry onto another COG study|0
69408|NCT00026312|267114|P2|Overall Study|Ineligible|5
69409|NCT00026312|267115|P1|Overall Study|Ineligible|4
69410|NCT00026312|267114|P2|Overall Study|Withdrawal by Subject|6
69411|NCT00026312|267115|P1|Overall Study|Withdrawal by Subject|1
69412|NCT00026312|267114|P2|Overall Study|Protocol Violation|3
69413|NCT00026312|267115|P1|Overall Study|Protocol Violation|0
69414|NCT00026312|267114|P2|Overall Study|Physician Decision|37
69415|NCT00026312|267115|P1|Overall Study|Physician Decision|1
69416|NCT00026312|267114|P2|Overall Study|Lost to Follow-up|5
69417|NCT00026312|267115|P1|Overall Study|Lost to Follow-up|0
69418|NCT00026312|267114|P2|Overall Study|Lack of Efficacy|114
69419|NCT00026312|267115|P1|Overall Study|Lack of Efficacy|19
69420|NCT00026312|267114|P2|Overall Study|Death|7
69421|NCT00026312|267115|P1|Overall Study|Death|1
69422|NCT00026312|267114|P2|Overall Study|Adverse Event|32
69423|NCT00026312|267115|P1|Overall Study|Adverse Event|0
69424|NCT00026494|267134|P4|Overall Study|Clinical progression|0
69425|NCT00026494|267135|P3|Overall Study|Clinical progression|3
69426|NCT00026494|267136|P2|Overall Study|Clinical progression|0
69427|NCT00026494|267137|P1|Overall Study|Clinical progression|0
69428|NCT00026494|267134|P4|Overall Study|Patient not treated|0
69429|NCT00026494|267135|P3|Overall Study|Patient not treated|2
69430|NCT00026494|267136|P2|Overall Study|Patient not treated|0
69431|NCT00026494|267137|P1|Overall Study|Patient not treated|0
69432|NCT00026494|267134|P4|Overall Study|Patient non-compliance|0
69433|NCT00026494|267135|P3|Overall Study|Patient non-compliance|0
69434|NCT00026494|267136|P2|Overall Study|Patient non-compliance|0
69435|NCT00026494|267137|P1|Overall Study|Patient non-compliance|1
69436|NCT00026494|267134|P4|Overall Study|Withdrawal by Subject|0
69437|NCT00026494|267135|P3|Overall Study|Withdrawal by Subject|1
69438|NCT00026494|267136|P2|Overall Study|Withdrawal by Subject|0
69439|NCT00026494|267137|P1|Overall Study|Withdrawal by Subject|1
69440|NCT00010257|267149|P2|Overall Study|Withdrawal by Subject|0
69441|NCT00010257|267150|P1|Overall Study|Withdrawal by Subject|1
69442|NCT00010803|267165|P2|Overall Study|Withdrawal by Subject|98
69443|NCT00010803|267166|P1|Overall Study|Withdrawal by Subject|97
69444|NCT00027027|267185|P5|Overall Study|Withdrawal by Subject|1
69445|NCT00027027|267186|P4|Overall Study|Withdrawal by Subject|0
69446|NCT00027027|267187|P3|Overall Study|Withdrawal by Subject|0
69447|NCT00027027|267188|P2|Overall Study|Withdrawal by Subject|0
69448|NCT00027027|267189|P1|Overall Study|Withdrawal by Subject|0
69449|NCT00027027|267185|P5|Overall Study|Physician Decision Due To PD|5
69450|NCT00027027|267186|P4|Overall Study|Physician Decision Due To PD|3
69451|NCT00027027|267187|P3|Overall Study|Physician Decision Due To PD|2
69452|NCT00027027|267188|P2|Overall Study|Physician Decision Due To PD|3
69453|NCT00027027|267189|P1|Overall Study|Physician Decision Due To PD|2
69454|NCT00027027|267185|P5|Overall Study|PD Requiring Surgery|0
69455|NCT00027027|267186|P4|Overall Study|PD Requiring Surgery|0
69456|NCT00027027|267187|P3|Overall Study|PD Requiring Surgery|1
69457|NCT00027027|267188|P2|Overall Study|PD Requiring Surgery|0
69458|NCT00027027|267189|P1|Overall Study|PD Requiring Surgery|0
69459|NCT00027027|267185|P5|Overall Study|Clinical Symptoms Progression not PD|0
69460|NCT00027027|267186|P4|Overall Study|Clinical Symptoms Progression not PD|0
69461|NCT00027027|267187|P3|Overall Study|Clinical Symptoms Progression not PD|0
69462|NCT00027027|267188|P2|Overall Study|Clinical Symptoms Progression not PD|0
69463|NCT00027027|267189|P1|Overall Study|Clinical Symptoms Progression not PD|1
69464|NCT00027027|267185|P5|Overall Study|Admitted for Signs of PD|1
69465|NCT00027027|267186|P4|Overall Study|Admitted for Signs of PD|0
69466|NCT00027027|267187|P3|Overall Study|Admitted for Signs of PD|0
69467|NCT00027027|267188|P2|Overall Study|Admitted for Signs of PD|0
69468|NCT00027027|267189|P1|Overall Study|Admitted for Signs of PD|0
69469|NCT00027027|267185|P5|Overall Study|Adverse Event|1
69470|NCT00027027|267186|P4|Overall Study|Adverse Event|0
69471|NCT00027027|267187|P3|Overall Study|Adverse Event|1
69472|NCT00027027|267188|P2|Overall Study|Adverse Event|0
69473|NCT00027027|267189|P1|Overall Study|Adverse Event|0
69474|NCT00027560|267234|P1|Overall Study|Withdrawal by Subject|1
69475|NCT00027846|267246|P3|Overall Study|Neuraxis dissemination during/after ther|5
69476|NCT00027846|267247|P2|Overall Study|Neuraxis dissemination during/after ther|2
69477|NCT00027846|267248|P1|Overall Study|Neuraxis dissemination during/after ther|0
69478|NCT00027846|267246|P3|Overall Study|Entry into another COG therapeutic study|2
69479|NCT00027846|267247|P2|Overall Study|Entry into another COG therapeutic study|5
69480|NCT00027846|267248|P1|Overall Study|Entry into another COG therapeutic study|0
69481|NCT00027846|267246|P3|Overall Study|Ineligible for study|14
69482|NCT00027846|267247|P2|Overall Study|Ineligible for study|6
69483|NCT00027846|267248|P1|Overall Study|Ineligible for study|2
69484|NCT00027846|267246|P3|Overall Study|Withdrawal by Subject|7
69485|NCT00027846|267247|P2|Overall Study|Withdrawal by Subject|14
69486|NCT00027846|267248|P1|Overall Study|Withdrawal by Subject|0
69487|NCT00027846|267246|P3|Overall Study|Lost to Follow-up|9
69488|NCT00027846|267247|P2|Overall Study|Lost to Follow-up|41
69489|NCT00027846|267248|P1|Overall Study|Lost to Follow-up|0
69490|NCT00028002|267266|P1|Overall Study|Ineligible|8
69491|NCT00028002|267266|P1|Overall Study|Withdrawal by Subject|3
69492|NCT00028769|267283|P1|Overall Study|Not Analyzable|1
69493|NCT00028769|267283|P1|Overall Study|Ineligible|5
69494|NCT00028769|267283|P1|Overall Study|Other - Not Protocol Specified|1
69495|NCT00028769|267283|P1|Overall Study|Progression or Death|31
69496|NCT00028769|267283|P1|Overall Study|Refusal Unrelated to Adverse Events|1
69497|NCT00028769|267283|P1|Overall Study|Adverse Event|2
69498|NCT00029146|267300|P2|Overall Study|Lost to Follow-up|1
69499|NCT00029146|267301|P1|Overall Study|Lost to Follow-up|2
69500|NCT00022516|267390|P2|Overall Study|Incomplete documentation|27
69501|NCT00022516|267391|P1|Overall Study|Incomplete documentation|0
69502|NCT00022516|267390|P2|Overall Study|Withdrawal by Subject|113
69503|NCT00022516|267391|P1|Overall Study|Withdrawal by Subject|2
69504|NCT00022516|267390|P2|Overall Study|Protocol Violation|3
69505|NCT00022516|267391|P1|Overall Study|Protocol Violation|1
69506|NCT00022516|267390|P2|Overall Study|Physician Decision|1
69507|NCT00022516|267391|P1|Overall Study|Physician Decision|0
69508|NCT00022516|267390|P2|Overall Study|Lack of Efficacy|27
69509|NCT00022516|267391|P1|Overall Study|Lack of Efficacy|0
69510|NCT00022516|267390|P2|Overall Study|Adverse Event|59
69511|NCT00022516|267391|P1|Overall Study|Adverse Event|0
69512|NCT00022633|267405|P2|Overall Study|Ineligible|0
69513|NCT00022633|267406|P1|Overall Study|Ineligible|4
69514|NCT00022633|267405|P2|Overall Study|Other - not protocol specified|2
69515|NCT00022633|267406|P1|Overall Study|Other - not protocol specified|3
69516|NCT00022633|267405|P2|Overall Study|Death|0
69517|NCT00022633|267406|P1|Overall Study|Death|4
69518|NCT00022633|267405|P2|Overall Study|Progression/relapse|2
69519|NCT00022633|267406|P1|Overall Study|Progression/relapse|9
69520|NCT00022633|267405|P2|Overall Study|Refusal unrelated to adverse event|0
69521|NCT00022633|267406|P1|Overall Study|Refusal unrelated to adverse event|1
69522|NCT00022633|267405|P2|Overall Study|Adverse Event|1
69523|NCT00022633|267406|P1|Overall Study|Adverse Event|11
69524|NCT00022659|267417|P1|Overall Study|Never treated|1
69525|NCT00022659|267417|P1|Overall Study|Ineligible: wrong primary|1
69526|NCT00022672|267425|P2|Extension Phase|Other|1
69527|NCT00022672|267426|P1|Extension Phase|Other|1
69528|NCT00022672|267425|P2|Extension Phase|Refused Treatment|2
69529|NCT00022672|267426|P1|Extension Phase|Refused Treatment|0
69530|NCT00022672|267425|P2|Extension Phase|Insufficient Therapeutic Response|44
69531|NCT00022672|267426|P1|Extension Phase|Insufficient Therapeutic Response|1
69532|NCT00022672|267425|P2|Extension Phase|Death|1
69533|NCT00022672|267426|P1|Extension Phase|Death|0
69534|NCT00022672|267425|P2|Extension Phase|Adverse Event|3
69535|NCT00022672|267426|P1|Extension Phase|Adverse Event|1
69536|NCT00022672|267425|P2|Main Phase: 24 Months|Other|0
69537|NCT00022672|267426|P1|Main Phase: 24 Months|Other|1
69538|NCT00022672|267425|P2|Main Phase: 24 Months|Failure to Return|1
69539|NCT00022672|267426|P1|Main Phase: 24 Months|Failure to Return|1
69540|NCT00022672|267425|P2|Main Phase: 24 Months|Refused Treatment|4
69541|NCT00022672|267426|P1|Main Phase: 24 Months|Refused Treatment|3
69542|NCT00022672|267425|P2|Main Phase: 24 Months|Other Protocol Violation|0
69543|NCT00022672|267426|P1|Main Phase: 24 Months|Other Protocol Violation|1
69544|NCT00022672|267425|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
69545|NCT00022672|267426|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
69546|NCT00022672|267425|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
69547|NCT00022672|267426|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
69548|NCT00022672|267425|P2|Main Phase: 24 Months|Death|3
69549|NCT00022672|267426|P1|Main Phase: 24 Months|Death|0
69550|NCT00022672|267425|P2|Main Phase: 24 Months|Adverse Event|0
69551|NCT00022672|267426|P1|Main Phase: 24 Months|Adverse Event|6
69552|NCT00022698|267461|P2|Overall Study|Administrative /other|7
69553|NCT00022698|267462|P1|Overall Study|Administrative /other|1
69554|NCT00022698|267461|P2|Overall Study|Insufficient therapeutic response|14
69555|NCT00022698|267462|P1|Overall Study|Insufficient therapeutic response|2
69556|NCT00022698|267461|P2|Overall Study|Refused treatment|2
69557|NCT00022698|267462|P1|Overall Study|Refused treatment|0
69558|NCT00022698|267461|P2|Overall Study|Failure to return|1
69559|NCT00022698|267462|P1|Overall Study|Failure to return|0
69560|NCT00022698|267461|P2|Overall Study|Death|2
69561|NCT00022698|267462|P1|Overall Study|Death|0
69562|NCT00022698|267461|P2|Overall Study|Adverse Event|9
69563|NCT00022698|267462|P1|Overall Study|Adverse Event|5
69564|NCT00022763|267487|P2|Overall Study|Admin|2
69565|NCT00022763|267488|P1|Overall Study|Admin|3
69566|NCT00022763|267487|P2|Overall Study|Insufficient Therapy|0
69567|NCT00022763|267488|P1|Overall Study|Insufficient Therapy|1
69568|NCT00022763|267487|P2|Overall Study|Withdrawal by Subject|7
69569|NCT00022763|267488|P1|Overall Study|Withdrawal by Subject|4
69570|NCT00022763|267487|P2|Overall Study|Lost to Follow-up|3
69571|NCT00022763|267488|P1|Overall Study|Lost to Follow-up|0
69572|NCT00022763|267487|P2|Overall Study|Death|1
69573|NCT00022763|267488|P1|Overall Study|Death|0
69574|NCT00022763|267487|P2|Overall Study|Injection Site Reactions|2
69575|NCT00022763|267488|P1|Overall Study|Injection Site Reactions|0
69576|NCT00022763|267487|P2|Overall Study|Adverse Event|2
69577|NCT00022763|267488|P1|Overall Study|Adverse Event|1
69578|NCT00023322|267528|P1|Overall Study|Lost to Follow-up|1
69579|NCT00023452|267535|P2|Overall Study|Other|69
69580|NCT00023452|267536|P1|Overall Study|Other|204
69581|NCT00023452|267535|P2|Overall Study|Pregnant|20
69582|NCT00023452|267536|P1|Overall Study|Pregnant|53
69583|NCT00023452|267535|P2|Overall Study|Refused Treatment (continued follow-up)|224
69584|NCT00023452|267536|P1|Overall Study|Refused Treatment (continued follow-up)|225
69585|NCT00023452|267535|P2|Overall Study|Physician Decision|21
69586|NCT00023452|267536|P1|Overall Study|Physician Decision|49
69587|NCT00023452|267535|P2|Overall Study|Lost to Follow-up|60
69588|NCT00023452|267536|P1|Overall Study|Lost to Follow-up|293
69589|NCT00023452|267535|P2|Overall Study|Adverse Event|196
69590|NCT00023452|267536|P1|Overall Study|Adverse Event|139
69591|NCT00023452|267535|P2|Overall Study|Withdrawal by Subject|54
69592|NCT00023452|267536|P1|Overall Study|Withdrawal by Subject|66
69593|NCT00023452|267535|P2|Overall Study|Death|0
69594|NCT00023452|267536|P1|Overall Study|Death|2
69595|NCT00023452|267535|P2|Overall Study|Out of Window|69
69596|NCT00023452|267536|P1|Overall Study|Out of Window|129
69597|NCT00023452|267535|P2|Overall Study|Ineligible for Study|159
69598|NCT00023452|267536|P1|Overall Study|Ineligible for Study|163
69599|NCT00023595|267565|P5|10 Year Follow up|Lost to Follow-up|0
69600|NCT00023595|267566|P4|10 Year Follow up|Lost to Follow-up|0
69601|NCT00023595|267567|P3|10 Year Follow up|Lost to Follow-up|3
69602|NCT00023595|267568|P2|10 Year Follow up|Lost to Follow-up|10
69603|NCT00023595|267569|P1|10 Year Follow up|Lost to Follow-up|12
69604|NCT00023595|267565|P5|5 Year Follow up|Lost to Follow-up|3
69605|NCT00023595|267566|P4|5 Year Follow up|Lost to Follow-up|7
69606|NCT00023595|267567|P3|5 Year Follow up|Lost to Follow-up|1
69607|NCT00023595|267568|P2|5 Year Follow up|Lost to Follow-up|2
69608|NCT00023595|267569|P1|5 Year Follow up|Lost to Follow-up|2
69609|NCT00023673|267781|P4|Overall Study|Patient withdrew consent|1
69610|NCT00023673|267782|P3|Overall Study|Patient withdrew consent|0
69611|NCT00023673|267783|P2|Overall Study|Patient withdrew consent|0
69612|NCT00023673|267784|P1|Overall Study|Patient withdrew consent|0
69613|NCT00023673|267781|P4|Overall Study|Ineligible / no protocol treatment|1
69614|NCT00023673|267782|P3|Overall Study|Ineligible / no protocol treatment|0
69615|NCT00023673|267783|P2|Overall Study|Ineligible / no protocol treatment|0
69616|NCT00023673|267784|P1|Overall Study|Ineligible / no protocol treatment|0
69617|NCT00023712|267793|P2|Overall Study|Never treated|1
69618|NCT00023712|267794|P1|Overall Study|Never treated|1
69619|NCT00023712|267793|P2|Overall Study|Not platinum sensitive|0
69620|NCT00023712|267794|P1|Overall Study|Not platinum sensitive|1
69621|NCT00023764|267806|P1|Overall Study|delay in obtaining staging images|1
69622|NCT00023764|267806|P1|Overall Study|patient received other treatment|1
69623|NCT00023764|267806|P1|Overall Study|Progression of disease|6
69624|NCT00023764|267806|P1|Overall Study|Withdrawal by Subject|1
69625|NCT00023764|267806|P1|Overall Study|Adverse Event|4
69626|NCT00023764|267806|P1|Overall Study|Other|1
69627|NCT00024167|267829|P2|Overall Study|Death|47
69628|NCT00024167|267830|P1|Overall Study|Death|53
69629|NCT00037830|267848|P3|Overall Study|Unrelated Medical Problem|0
69630|NCT00037830|267849|P2|Overall Study|Unrelated Medical Problem|0
69631|NCT00037830|267850|P1|Overall Study|Unrelated Medical Problem|2
69632|NCT00037830|267848|P3|Overall Study|Protocol Violation|0
69633|NCT00037830|267849|P2|Overall Study|Protocol Violation|2
69634|NCT00037830|267850|P1|Overall Study|Protocol Violation|2
69635|NCT00037830|267848|P3|Overall Study|Withdrawal by Subject|1
69636|NCT00037830|267849|P2|Overall Study|Withdrawal by Subject|5
69637|NCT00037830|267850|P1|Overall Study|Withdrawal by Subject|4
69638|NCT00037830|267848|P3|Overall Study|Adverse Event|0
69639|NCT00037830|267849|P2|Overall Study|Adverse Event|0
69640|NCT00037830|267850|P1|Overall Study|Adverse Event|2
69641|NCT00038103|267873|P2|Overall Study|Randomized/never treated|0
69642|NCT00038103|267874|P1|Overall Study|Randomized/never treated|2
69643|NCT00038103|267873|P2|Overall Study|Sponsor Decision|1
69644|NCT00038103|267874|P1|Overall Study|Sponsor Decision|0
69645|NCT00038103|267873|P2|Overall Study|Protocol Violation|2
69646|NCT00038103|267874|P1|Overall Study|Protocol Violation|0
69647|NCT00038103|267873|P2|Overall Study|Lost to Follow-up|3
69648|NCT00038103|267874|P1|Overall Study|Lost to Follow-up|0
69649|NCT00038103|267873|P2|Overall Study|Withdrawal by Subject|3
69650|NCT00038103|267874|P1|Overall Study|Withdrawal by Subject|0
69651|NCT00038103|267873|P2|Overall Study|Lack of Efficacy|41
69652|NCT00038103|267874|P1|Overall Study|Lack of Efficacy|48
69653|NCT00038103|267873|P2|Overall Study|Adverse Event|6
69654|NCT00038103|267874|P1|Overall Study|Adverse Event|5
69655|NCT00038467|267896|P2|Overall Study|Unspecified|28
69656|NCT00038467|267897|P1|Overall Study|Unspecified|26
69657|NCT00038467|267896|P2|Overall Study|Randomized, but not treated|35
69658|NCT00038467|267897|P1|Overall Study|Randomized, but not treated|31
69659|NCT00038467|267896|P2|Overall Study|Recurrence|179
69660|NCT00038467|267897|P1|Overall Study|Recurrence|109
69661|NCT00038467|267896|P2|Overall Study|Lost to Follow-up|10
69662|NCT00038467|267897|P1|Overall Study|Lost to Follow-up|15
69663|NCT00038467|267896|P2|Overall Study|Death|16
69664|NCT00038467|267897|P1|Overall Study|Death|22
69665|NCT00038467|267896|P2|Overall Study|Protocol Violation|22
69666|NCT00038467|267897|P1|Overall Study|Protocol Violation|19
69667|NCT00038467|267896|P2|Overall Study|Withdrawal by Subject|107
69668|NCT00038467|267897|P1|Overall Study|Withdrawal by Subject|150
69669|NCT00038467|267896|P2|Overall Study|Adverse Event|145
69670|NCT00038467|267897|P1|Overall Study|Adverse Event|170
69671|NCT00038948|267969|P2|Overall Study|Lack of Efficacy|6
69672|NCT00038948|267970|P1|Overall Study|Lack of Efficacy|3
69673|NCT00038948|267969|P2|Overall Study|Protocol Violation|7
69674|NCT00038948|267970|P1|Overall Study|Protocol Violation|3
69675|NCT00038948|267969|P2|Overall Study|Withdrawal by Subject|10
69676|NCT00038948|267970|P1|Overall Study|Withdrawal by Subject|23
69677|NCT00038948|267969|P2|Overall Study|Nonmedical event|7
69678|NCT00038948|267970|P1|Overall Study|Nonmedical event|5
69679|NCT00038948|267969|P2|Overall Study|Lost to Follow-up|4
69680|NCT00038948|267970|P1|Overall Study|Lost to Follow-up|4
69681|NCT00038948|267969|P2|Overall Study|Adverse Event|43
69682|NCT00038948|267970|P1|Overall Study|Adverse Event|131
69683|NCT00039130|267982|P1|Overall Study|Physician Decision|3
69684|NCT00039130|267982|P1|Overall Study|Subsequent treatment|2
69685|NCT00039130|267982|P1|Overall Study|Progression|2
69686|NCT00039130|267982|P1|Overall Study|Withdrawal by Subject|3
69687|NCT00039130|267982|P1|Overall Study|Death|9
69688|NCT00039130|267982|P1|Overall Study|Adverse Event|11
69689|NCT00021541|267994|P2|Period 2-crossover|Pts that did not progress|3
69690|NCT00021541|267995|P1|Period 2-crossover|Pts that did not progress|2
69691|NCT00021541|267994|P2|Period 2-crossover|non-adherence|0
69692|NCT00021541|267995|P1|Period 2-crossover|non-adherence|1
69693|NCT00021541|267994|P2|Period 2-crossover|Adverse Event|2
69694|NCT00021541|267995|P1|Period 2-crossover|Adverse Event|2
69695|NCT00021541|267994|P2|Period 2-crossover|Withdrawal by Subject|4
69696|NCT00021541|267995|P1|Period 2-crossover|Withdrawal by Subject|3
69697|NCT00021541|267994|P2|Period 2-crossover|refused phase B|2
69698|NCT00021541|267995|P1|Period 2-crossover|refused phase B|2
69699|NCT00021541|267994|P2|Period 1-First Treatment|Ineligible|2
69700|NCT00021541|267995|P1|Period 1-First Treatment|Ineligible|0
69701|NCT00021541|267994|P2|Period 1-First Treatment|Pts that did not progress|2
69702|NCT00021541|267995|P1|Period 1-First Treatment|Pts that did not progress|2
69703|NCT00021541|267994|P2|Period 1-First Treatment|Death|0
69704|NCT00021541|267995|P1|Period 1-First Treatment|Death|1
69705|NCT00021541|267994|P2|Period 1-First Treatment|non-adherence|0
69706|NCT00021541|267995|P1|Period 1-First Treatment|non-adherence|3
69707|NCT00021541|267994|P2|Period 1-First Treatment|Adverse Event|1
69708|NCT00021541|267995|P1|Period 1-First Treatment|Adverse Event|2
69709|NCT00021541|267994|P2|Period 1-First Treatment|Withdrawal by Subject|3
69710|NCT00021541|267995|P1|Period 1-First Treatment|Withdrawal by Subject|3
69711|NCT00027378|268003|P2|Overall Study|Physician Decision|3
69712|NCT00027378|268004|P1|Overall Study|Physician Decision|0
69713|NCT00039377|268012|P4|Initial Registration|Withdrawal by Subject|0
69714|NCT00039377|268013|P3|Initial Registration|Withdrawal by Subject|0
69715|NCT00039377|268014|P2|Initial Registration|Withdrawal by Subject|0
69716|NCT00039377|268015|P1|Initial Registration|Withdrawal by Subject|3
69717|NCT00039377|268012|P4|Initial Registration|Received non-protocol therapy|0
69718|NCT00039377|268013|P3|Initial Registration|Received non-protocol therapy|0
69719|NCT00039377|268014|P2|Initial Registration|Received non-protocol therapy|0
69720|NCT00039377|268015|P1|Initial Registration|Received non-protocol therapy|11
69721|NCT00039377|268012|P4|Initial Registration|Relapsed|0
69722|NCT00039377|268013|P3|Initial Registration|Relapsed|0
69723|NCT00039377|268014|P2|Initial Registration|Relapsed|0
69724|NCT00039377|268015|P1|Initial Registration|Relapsed|6
69725|NCT00039377|268012|P4|Initial Registration|Adverse Event|0
69726|NCT00039377|268013|P3|Initial Registration|Adverse Event|0
69727|NCT00039377|268014|P2|Initial Registration|Adverse Event|0
69728|NCT00039377|268015|P1|Initial Registration|Adverse Event|2
69729|NCT00041470|268036|P1|Overall Study|Loss of Funding|38
69730|NCT00041756|268057|P5|Overall Study|Data Monitoring Committee Recommendation|21
69731|NCT00041756|268058|P4|Overall Study|Data Monitoring Committee Recommendation|0
69732|NCT00041756|268059|P3|Overall Study|Data Monitoring Committee Recommendation|0
69733|NCT00041756|268060|P2|Overall Study|Data Monitoring Committee Recommendation|0
69734|NCT00041756|268061|P1|Overall Study|Data Monitoring Committee Recommendation|0
69735|NCT00041756|268057|P5|Overall Study|Unable to meet protocol criteria|1
69736|NCT00041756|268058|P4|Overall Study|Unable to meet protocol criteria|0
69828|NCT00043186|268213|P5|Overall Study|Other|0
69737|NCT00041756|268059|P3|Overall Study|Unable to meet protocol criteria|1
69738|NCT00041756|268060|P2|Overall Study|Unable to meet protocol criteria|0
69739|NCT00041756|268061|P1|Overall Study|Unable to meet protocol criteria|0
69740|NCT00041756|268057|P5|Overall Study|Lost to Follow-up|0
69741|NCT00041756|268058|P4|Overall Study|Lost to Follow-up|1
69742|NCT00041756|268059|P3|Overall Study|Lost to Follow-up|0
69743|NCT00041756|268060|P2|Overall Study|Lost to Follow-up|1
69744|NCT00041756|268061|P1|Overall Study|Lost to Follow-up|0
69745|NCT00041756|268057|P5|Overall Study|Withdrawal by Subject|3
69746|NCT00041756|268058|P4|Overall Study|Withdrawal by Subject|2
69747|NCT00041756|268059|P3|Overall Study|Withdrawal by Subject|4
69748|NCT00041756|268060|P2|Overall Study|Withdrawal by Subject|3
69749|NCT00041756|268061|P1|Overall Study|Withdrawal by Subject|3
69750|NCT00041756|268057|P5|Overall Study|Protocol Violation|1
69751|NCT00041756|268058|P4|Overall Study|Protocol Violation|2
69752|NCT00041756|268059|P3|Overall Study|Protocol Violation|2
69753|NCT00041756|268060|P2|Overall Study|Protocol Violation|1
69754|NCT00041756|268061|P1|Overall Study|Protocol Violation|1
69755|NCT00041756|268057|P5|Overall Study|Adverse Event|34
69756|NCT00041756|268058|P4|Overall Study|Adverse Event|11
69757|NCT00041756|268059|P3|Overall Study|Adverse Event|6
69758|NCT00041756|268060|P2|Overall Study|Adverse Event|10
69759|NCT00041756|268061|P1|Overall Study|Adverse Event|4
69760|NCT00042432|268120|P2|Overall Study|Other|0
69761|NCT00042432|268121|P1|Overall Study|Other|2
69762|NCT00042432|268120|P2|Overall Study|Initiation of maintenance dialysis|1
69763|NCT00042432|268121|P1|Overall Study|Initiation of maintenance dialysis|1
69764|NCT00042432|268120|P2|Overall Study|Ineligibility determined|0
69765|NCT00042432|268121|P1|Overall Study|Ineligibility determined|1
69766|NCT00042432|268120|P2|Overall Study|Death|2
69767|NCT00042432|268121|P1|Overall Study|Death|0
69768|NCT00042432|268120|P2|Overall Study|Withdrawal by Subject|3
69769|NCT00042432|268121|P1|Overall Study|Withdrawal by Subject|1
69770|NCT00042432|268120|P2|Overall Study|Adverse Event|1
69771|NCT00042432|268121|P1|Overall Study|Adverse Event|4
69772|NCT00042939|268131|P2|Overall Study|Did not start treatment|1
69773|NCT00042939|268132|P1|Overall Study|Did not start treatment|2
69774|NCT00042939|268131|P2|Overall Study|Treatment break > 4 weeks|1
69775|NCT00042939|268132|P1|Overall Study|Treatment break > 4 weeks|0
69776|NCT00042939|268131|P2|Overall Study|Still on treatment|0
69777|NCT00042939|268132|P1|Overall Study|Still on treatment|1
69778|NCT00042939|268131|P2|Overall Study|Patient non-compliance|0
69779|NCT00042939|268132|P1|Overall Study|Patient non-compliance|1
69780|NCT00042939|268131|P2|Overall Study|Rising ca 19-9|0
69781|NCT00042939|268132|P1|Overall Study|Rising ca 19-9|1
69782|NCT00042939|268131|P2|Overall Study|QOL diminished|0
69783|NCT00042939|268132|P1|Overall Study|QOL diminished|1
69784|NCT00042939|268131|P2|Overall Study|Deterioration of health|4
69785|NCT00042939|268132|P1|Overall Study|Deterioration of health|3
69786|NCT00042939|268131|P2|Overall Study|Ineligible|2
69787|NCT00042939|268132|P1|Overall Study|Ineligible|2
69788|NCT00042939|268131|P2|Overall Study|Other disease|0
69789|NCT00042939|268132|P1|Overall Study|Other disease|1
69790|NCT00042939|268131|P2|Overall Study|Withdrawal by Subject|4
69791|NCT00042939|268132|P1|Overall Study|Withdrawal by Subject|3
69792|NCT00042939|268131|P2|Overall Study|Death|2
69793|NCT00042939|268132|P1|Overall Study|Death|3
69794|NCT00042939|268131|P2|Overall Study|Adverse Event|7
69795|NCT00042939|268132|P1|Overall Study|Adverse Event|6
69796|NCT00042991|268153|P7|Overall Study|Alternative Therapy|0
69797|NCT00042991|268154|P6|Overall Study|Alternative Therapy|0
69798|NCT00042991|268155|P5|Overall Study|Alternative Therapy|1
69799|NCT00042991|268156|P4|Overall Study|Alternative Therapy|0
69800|NCT00042991|268157|P3|Overall Study|Alternative Therapy|0
69801|NCT00042991|268158|P2|Overall Study|Alternative Therapy|0
69802|NCT00042991|268159|P1|Overall Study|Alternative Therapy|0
69803|NCT00042991|268153|P7|Overall Study|Disease Progression|2
69804|NCT00042991|268154|P6|Overall Study|Disease Progression|4
69805|NCT00042991|268155|P5|Overall Study|Disease Progression|1
69806|NCT00042991|268156|P4|Overall Study|Disease Progression|2
69807|NCT00042991|268157|P3|Overall Study|Disease Progression|2
69808|NCT00042991|268158|P2|Overall Study|Disease Progression|29
69809|NCT00042991|268159|P1|Overall Study|Disease Progression|5
69810|NCT00042991|268153|P7|Overall Study|Withdrawal by Subject|0
69811|NCT00042991|268154|P6|Overall Study|Withdrawal by Subject|0
69812|NCT00042991|268155|P5|Overall Study|Withdrawal by Subject|1
69813|NCT00042991|268156|P4|Overall Study|Withdrawal by Subject|0
69814|NCT00042991|268157|P3|Overall Study|Withdrawal by Subject|2
69815|NCT00042991|268158|P2|Overall Study|Withdrawal by Subject|7
69816|NCT00042991|268159|P1|Overall Study|Withdrawal by Subject|0
69817|NCT00042991|268153|P7|Overall Study|Adverse Event|0
69818|NCT00042991|268154|P6|Overall Study|Adverse Event|1
69819|NCT00042991|268155|P5|Overall Study|Adverse Event|0
69820|NCT00042991|268156|P4|Overall Study|Adverse Event|0
69821|NCT00042991|268157|P3|Overall Study|Adverse Event|2
69822|NCT00042991|268158|P2|Overall Study|Adverse Event|4
69823|NCT00042991|268159|P1|Overall Study|Adverse Event|1
69824|NCT00043186|268209|P9|Overall Study|Other|0
69825|NCT00043186|268210|P8|Overall Study|Other|0
69826|NCT00043186|268211|P7|Overall Study|Other|0
69827|NCT00043186|268212|P6|Overall Study|Other|0
69829|NCT00043186|268214|P4|Overall Study|Other|1
69830|NCT00043186|268215|P3|Overall Study|Other|1
69831|NCT00043186|268216|P2|Overall Study|Other|0
69832|NCT00043186|268217|P1|Overall Study|Other|0
69833|NCT00043186|268209|P9|Overall Study|Noncompliance|0
69834|NCT00043186|268210|P8|Overall Study|Noncompliance|0
69835|NCT00043186|268211|P7|Overall Study|Noncompliance|0
69836|NCT00043186|268212|P6|Overall Study|Noncompliance|0
69837|NCT00043186|268213|P5|Overall Study|Noncompliance|0
69838|NCT00043186|268214|P4|Overall Study|Noncompliance|1
69839|NCT00043186|268215|P3|Overall Study|Noncompliance|1
69840|NCT00043186|268216|P2|Overall Study|Noncompliance|0
69841|NCT00043186|268217|P1|Overall Study|Noncompliance|0
69842|NCT00043186|268209|P9|Overall Study|Lost to Follow-up|2
69843|NCT00043186|268210|P8|Overall Study|Lost to Follow-up|1
69844|NCT00043186|268211|P7|Overall Study|Lost to Follow-up|1
69845|NCT00043186|268212|P6|Overall Study|Lost to Follow-up|1
69846|NCT00043186|268213|P5|Overall Study|Lost to Follow-up|1
69847|NCT00043186|268214|P4|Overall Study|Lost to Follow-up|1
69848|NCT00043186|268215|P3|Overall Study|Lost to Follow-up|1
69849|NCT00043186|268216|P2|Overall Study|Lost to Follow-up|5
69850|NCT00043186|268217|P1|Overall Study|Lost to Follow-up|3
69851|NCT00043186|268209|P9|Overall Study|Ineligibility determined|1
69852|NCT00043186|268210|P8|Overall Study|Ineligibility determined|0
69853|NCT00043186|268211|P7|Overall Study|Ineligibility determined|0
69854|NCT00043186|268212|P6|Overall Study|Ineligibility determined|0
69855|NCT00043186|268213|P5|Overall Study|Ineligibility determined|0
69856|NCT00043186|268214|P4|Overall Study|Ineligibility determined|0
69857|NCT00043186|268215|P3|Overall Study|Ineligibility determined|0
69858|NCT00043186|268216|P2|Overall Study|Ineligibility determined|0
69859|NCT00043186|268217|P1|Overall Study|Ineligibility determined|0
69860|NCT00043186|268209|P9|Overall Study|Disease progression|0
69861|NCT00043186|268210|P8|Overall Study|Disease progression|4
69862|NCT00043186|268211|P7|Overall Study|Disease progression|0
69863|NCT00043186|268212|P6|Overall Study|Disease progression|0
69864|NCT00043186|268213|P5|Overall Study|Disease progression|0
69865|NCT00043186|268214|P4|Overall Study|Disease progression|3
69866|NCT00043186|268215|P3|Overall Study|Disease progression|0
69867|NCT00043186|268216|P2|Overall Study|Disease progression|0
69868|NCT00043186|268217|P1|Overall Study|Disease progression|1
69869|NCT00043186|268209|P9|Overall Study|Death|0
69870|NCT00043186|268210|P8|Overall Study|Death|0
69871|NCT00043186|268211|P7|Overall Study|Death|2
69872|NCT00043186|268212|P6|Overall Study|Death|0
69873|NCT00043186|268213|P5|Overall Study|Death|0
69874|NCT00043186|268214|P4|Overall Study|Death|0
69875|NCT00043186|268215|P3|Overall Study|Death|1
69876|NCT00043186|268216|P2|Overall Study|Death|0
69877|NCT00043186|268217|P1|Overall Study|Death|0
69878|NCT00043186|268209|P9|Overall Study|Withdrawal by Subject|10
69879|NCT00043186|268210|P8|Overall Study|Withdrawal by Subject|9
69880|NCT00043186|268211|P7|Overall Study|Withdrawal by Subject|12
69881|NCT00043186|268212|P6|Overall Study|Withdrawal by Subject|6
69882|NCT00043186|268213|P5|Overall Study|Withdrawal by Subject|14
69883|NCT00043186|268214|P4|Overall Study|Withdrawal by Subject|13
69884|NCT00043186|268215|P3|Overall Study|Withdrawal by Subject|11
69885|NCT00043186|268216|P2|Overall Study|Withdrawal by Subject|8
69886|NCT00043186|268217|P1|Overall Study|Withdrawal by Subject|11
69887|NCT00043186|268209|P9|Overall Study|Adverse Event|3
69888|NCT00043186|268210|P8|Overall Study|Adverse Event|1
69889|NCT00043186|268211|P7|Overall Study|Adverse Event|2
69890|NCT00043186|268212|P6|Overall Study|Adverse Event|1
69891|NCT00043186|268213|P5|Overall Study|Adverse Event|2
69892|NCT00043186|268214|P4|Overall Study|Adverse Event|3
69893|NCT00043186|268215|P3|Overall Study|Adverse Event|2
69894|NCT00043186|268216|P2|Overall Study|Adverse Event|2
69895|NCT00043186|268217|P1|Overall Study|Adverse Event|2
69896|NCT00043186|268209|P9|Overall Study|Physician Decision|1
69897|NCT00043186|268210|P8|Overall Study|Physician Decision|1
69898|NCT00043186|268211|P7|Overall Study|Physician Decision|0
69899|NCT00043186|268212|P6|Overall Study|Physician Decision|0
69900|NCT00043186|268213|P5|Overall Study|Physician Decision|1
69901|NCT00043186|268214|P4|Overall Study|Physician Decision|0
69902|NCT00043186|268215|P3|Overall Study|Physician Decision|3
69903|NCT00043186|268216|P2|Overall Study|Physician Decision|0
69904|NCT00043186|268217|P1|Overall Study|Physician Decision|0
69905|NCT00043550|268546|P3|Overall Study|Withdrawal by Subject|20
69906|NCT00043550|268547|P2|Overall Study|Withdrawal by Subject|12
69907|NCT00043550|268548|P1|Overall Study|Withdrawal by Subject|22
69908|NCT00030901|268558|P3|Randomization|Ineligible|14
69909|NCT00030901|268559|P2|Randomization|Ineligible|15
69910|NCT00030901|268560|P1|Randomization|Ineligible|0
69911|NCT00030901|268558|P3|Randomization|Other|33
69912|NCT00030901|268559|P2|Randomization|Other|36
69913|NCT00030901|268560|P1|Randomization|Other|0
69914|NCT00030901|268558|P3|Randomization|Death|3
69915|NCT00030901|268559|P2|Randomization|Death|1
69916|NCT00030901|268560|P1|Randomization|Death|0
69917|NCT00030901|268558|P3|Randomization|Progression/Relapse|21
69918|NCT00030901|268559|P2|Randomization|Progression/Relapse|22
69919|NCT00030901|268560|P1|Randomization|Progression/Relapse|0
69920|NCT00030901|268558|P3|Randomization|Refusal Unrelated to Adverse Event|10
69921|NCT00030901|268559|P2|Randomization|Refusal Unrelated to Adverse Event|16
69922|NCT00030901|268560|P1|Randomization|Refusal Unrelated to Adverse Event|0
69923|NCT00030901|268558|P3|Randomization|Adverse Event|7
69924|NCT00030901|268559|P2|Randomization|Adverse Event|11
69925|NCT00030901|268560|P1|Randomization|Adverse Event|0
69926|NCT00030901|268558|P3|Initial Registration|Ineligible|0
69927|NCT00030901|268559|P2|Initial Registration|Ineligible|0
69928|NCT00030901|268560|P1|Initial Registration|Ineligible|167
69929|NCT00031447|268575|P2|Overall Study|Disruption of blinded study drug supply|4
69930|NCT00031447|268576|P1|Overall Study|Disruption of blinded study drug supply|7
69931|NCT00031447|268575|P2|Overall Study|Re-activation of Disease|1
69932|NCT00031447|268576|P1|Overall Study|Re-activation of Disease|2
69933|NCT00031447|268575|P2|Overall Study|Non-compliant|1
69934|NCT00031447|268576|P1|Overall Study|Non-compliant|1
69935|NCT00031447|268575|P2|Overall Study|Lost to Follow-up|1
69936|NCT00031447|268576|P1|Overall Study|Lost to Follow-up|0
69937|NCT00031460|268590|P2|Overall Study|Confirmed unevaluable|1
69938|NCT00031460|268591|P1|Overall Study|Confirmed unevaluable|0
69939|NCT00031460|268590|P2|Overall Study|Disruption of blinded drug supply|0
69940|NCT00031460|268591|P1|Overall Study|Disruption of blinded drug supply|2
69941|NCT00031460|268590|P2|Overall Study|Reactivation of Disease|9
69942|NCT00031460|268591|P1|Overall Study|Reactivation of Disease|5
69943|NCT00031460|268590|P2|Overall Study|Death|1
69944|NCT00031460|268591|P1|Overall Study|Death|0
69945|NCT00031460|268590|P2|Overall Study|Non-Compliant|1
69946|NCT00031460|268591|P1|Overall Study|Non-Compliant|1
69947|NCT00031460|268590|P2|Overall Study|Withdrawal by Subject|1
69948|NCT00031460|268591|P1|Overall Study|Withdrawal by Subject|1
69949|NCT00031460|268590|P2|Overall Study|Lost to Follow-up|1
69950|NCT00031460|268591|P1|Overall Study|Lost to Follow-up|0
69951|NCT00031486|268605|P2|Overall Study|Unspecified|1
69952|NCT00031486|268606|P1|Overall Study|Unspecified|1
69953|NCT00031486|268605|P2|Overall Study|Did not meet eligibility requirement|1
69954|NCT00031486|268606|P1|Overall Study|Did not meet eligibility requirement|2
69955|NCT00031486|268605|P2|Overall Study|Non-compliant|4
69956|NCT00031486|268606|P1|Overall Study|Non-compliant|0
69957|NCT00031486|268605|P2|Overall Study|Death|3
69958|NCT00031486|268606|P1|Overall Study|Death|0
69959|NCT00031486|268605|P2|Overall Study|Withdrawal by Subject|2
69960|NCT00031486|268606|P1|Overall Study|Withdrawal by Subject|3
69961|NCT00031486|268605|P2|Overall Study|Lost to Follow-up|1
69962|NCT00031486|268606|P1|Overall Study|Lost to Follow-up|0
69963|NCT00031486|268605|P2|Overall Study|Adverse Event|0
69964|NCT00031486|268606|P1|Overall Study|Adverse Event|1
69965|NCT00031551|268632|P2|Overall Study|Withdrew due to chemotherapy effects|0
69966|NCT00031551|268633|P1|Overall Study|Withdrew due to chemotherapy effects|2
69967|NCT00031694|268643|P1|Overall Study|Withdrawal by Subject|5
69968|NCT00031694|268643|P1|Overall Study|Death|2
69969|NCT00031694|268643|P1|Overall Study|Adverse Event|12
69970|NCT00032487|268649|P2|Overall Study|Had other reason|12
69971|NCT00032487|268650|P1|Overall Study|Had other reason|12
69972|NCT00032487|268649|P2|Overall Study|Lost to Follow-up|58
69973|NCT00032487|268650|P1|Overall Study|Lost to Follow-up|57
69974|NCT00032487|268649|P2|Overall Study|Adverse Event|7
69975|NCT00032487|268650|P1|Overall Study|Adverse Event|3
69976|NCT00032487|268649|P2|Overall Study|Withdrawal by Subject|43
69977|NCT00032487|268650|P1|Overall Study|Withdrawal by Subject|67
69978|NCT00033293|268688|P2|Overall Study|Treatment refused|6
69979|NCT00033293|268689|P1|Overall Study|Treatment refused|0
69980|NCT00033293|268688|P2|Overall Study|Could not be weaned from steroid therapy|1
69981|NCT00033293|268689|P1|Overall Study|Could not be weaned from steroid therapy|1
69982|NCT00033293|268688|P2|Overall Study|Withdrawal by Subject|0
69983|NCT00033293|268689|P1|Overall Study|Withdrawal by Subject|1
69984|NCT00033293|268688|P2|Overall Study|Physician Decision|1
69985|NCT00033293|268689|P1|Overall Study|Physician Decision|3
69986|NCT00033293|268688|P2|Overall Study|Lost to Follow-up|1
69987|NCT00033293|268689|P1|Overall Study|Lost to Follow-up|0
69988|NCT00033293|268688|P2|Overall Study|Lack of Efficacy|8
69989|NCT00033293|268689|P1|Overall Study|Lack of Efficacy|5
69990|NCT00033293|268688|P2|Overall Study|Death|1
69991|NCT00033293|268689|P1|Overall Study|Death|0
69992|NCT00033371|268709|P2|Overall Study|Disease Progression|1
69993|NCT00033371|268710|P1|Overall Study|Disease Progression|0
69994|NCT00033371|268709|P2|Overall Study|Withdrawal by Subject|3
69995|NCT00033371|268710|P1|Overall Study|Withdrawal by Subject|3
69996|NCT00033371|268709|P2|Overall Study|Lost to Follow-up|1
69997|NCT00033371|268710|P1|Overall Study|Lost to Follow-up|2
69998|NCT00033371|268709|P2|Overall Study|Adverse Event|5
69999|NCT00033371|268710|P1|Overall Study|Adverse Event|1
70000|NCT00033514|268718|P2|Overall Study|Withdrawal by Subject|3
70001|NCT00033514|268719|P1|Overall Study|Withdrawal by Subject|0
70002|NCT00033514|268718|P2|Overall Study|Lost to Follow-up|1
70003|NCT00033514|268719|P1|Overall Study|Lost to Follow-up|1
70004|NCT00033540|268727|P1|Overall Study|Never received treatment|2
70005|NCT00033540|268727|P1|Overall Study|Ineligible|3
70006|NCT00033540|268727|P1|Overall Study|Not specified|5
70007|NCT00033540|268727|P1|Overall Study|Withdrawal by Subject|6
70008|NCT00033540|268727|P1|Overall Study|Progression|26
70009|NCT00033540|268727|P1|Overall Study|Death|1
70010|NCT00033540|268727|P1|Overall Study|Adverse Event|14
70011|NCT00033631|268737|P2|Overall Study|Withdrawal by Subject|4
70012|NCT00033631|268738|P1|Overall Study|Withdrawal by Subject|4
70013|NCT00033631|268737|P2|Overall Study|Protocol Violation|11
70014|NCT00033631|268738|P1|Overall Study|Protocol Violation|14
70015|NCT00033657|268758|P2|Adjuvant Chemotherapy|Other|2
70016|NCT00033657|268759|P1|Adjuvant Chemotherapy|Other|0
70017|NCT00033657|268758|P2|Adjuvant Chemotherapy|alternative therapy|0
70018|NCT00033657|268759|P1|Adjuvant Chemotherapy|alternative therapy|1
70019|NCT00033657|268758|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
70020|NCT00033657|268759|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
70021|NCT00033657|268758|P2|Adjuvant Chemotherapy|Death|1
70022|NCT00033657|268759|P1|Adjuvant Chemotherapy|Death|2
70023|NCT00033657|268758|P2|Adjuvant Chemotherapy|Adverse Event|10
70024|NCT00033657|268759|P1|Adjuvant Chemotherapy|Adverse Event|7
70025|NCT00033657|268758|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
70026|NCT00033657|268759|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
70027|NCT00033657|268758|P2|Surgical Resection|not complete resection|3
70028|NCT00033657|268759|P1|Surgical Resection|not complete resection|0
70029|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
70030|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
70031|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|Ineligible|4
70032|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|Ineligible|8
70033|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|other complicating disease|1
70034|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|other complicating disease|0
70035|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
70036|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
70037|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|Death|1
70038|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|Death|1
70039|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|Adverse Event|2
70040|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|Adverse Event|0
70041|NCT00033657|268758|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
70042|NCT00033657|268759|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
70043|NCT00035555|268774|P3|Overall Study|Received cyclosporin in error|1
70044|NCT00035555|268775|P2|Overall Study|Received cyclosporin in error|0
70045|NCT00035555|268776|P1|Overall Study|Received cyclosporin in error|0
70046|NCT00035555|268774|P3|Overall Study|Investigator deemed not a good candidate|1
70047|NCT00035555|268775|P2|Overall Study|Investigator deemed not a good candidate|0
70048|NCT00035555|268776|P1|Overall Study|Investigator deemed not a good candidate|0
70049|NCT00035555|268774|P3|Overall Study|Withdrawal by Subject|2
70050|NCT00035555|268775|P2|Overall Study|Withdrawal by Subject|0
70051|NCT00035555|268776|P1|Overall Study|Withdrawal by Subject|2
70052|NCT00035555|268774|P3|Overall Study|Treatment failure/lack of efficacy|3
70053|NCT00035555|268775|P2|Overall Study|Treatment failure/lack of efficacy|5
70054|NCT00035555|268776|P1|Overall Study|Treatment failure/lack of efficacy|7
70055|NCT00035555|268774|P3|Overall Study|Prohibited medication|0
70056|NCT00035555|268775|P2|Overall Study|Prohibited medication|1
70057|NCT00035555|268776|P1|Overall Study|Prohibited medication|1
70058|NCT00035555|268774|P3|Overall Study|Noncompliance|1
70059|NCT00035555|268775|P2|Overall Study|Noncompliance|1
70060|NCT00035555|268776|P1|Overall Study|Noncompliance|0
70061|NCT00035555|268774|P3|Overall Study|Lost to Follow-up|1
70062|NCT00035555|268775|P2|Overall Study|Lost to Follow-up|0
70063|NCT00035555|268776|P1|Overall Study|Lost to Follow-up|0
70064|NCT00035555|268774|P3|Overall Study|Death|2
70065|NCT00035555|268775|P2|Overall Study|Death|0
70066|NCT00035555|268776|P1|Overall Study|Death|0
70067|NCT00035555|268774|P3|Overall Study|Allograft loss|2
70068|NCT00035555|268775|P2|Overall Study|Allograft loss|1
70069|NCT00035555|268776|P1|Overall Study|Allograft loss|1
70070|NCT00035555|268774|P3|Overall Study|Adverse Event|9
70071|NCT00035555|268775|P2|Overall Study|Adverse Event|8
70072|NCT00035555|268776|P1|Overall Study|Adverse Event|5
70073|NCT00035815|268819|P2|Overall Study|Withdrawal by Subject|11
70074|NCT00035815|268820|P1|Overall Study|Withdrawal by Subject|17
70075|NCT00035932|268833|P3|Overall Study|Lack of Efficacy|28
70076|NCT00035932|268834|P2|Overall Study|Lack of Efficacy|33
70077|NCT00035932|268835|P1|Overall Study|Lack of Efficacy|33
70078|NCT00035932|268833|P3|Overall Study|Study Termination by Sponsor|0
70079|NCT00035932|268834|P2|Overall Study|Study Termination by Sponsor|0
70080|NCT00035932|268835|P1|Overall Study|Study Termination by Sponsor|1
70081|NCT00035932|268833|P3|Overall Study|Withdrawal by Subject|0
70082|NCT00035932|268834|P2|Overall Study|Withdrawal by Subject|5
70083|NCT00035932|268835|P1|Overall Study|Withdrawal by Subject|1
70084|NCT00035932|268833|P3|Overall Study|Protocol Violation While on Study|2
70085|NCT00035932|268834|P2|Overall Study|Protocol Violation While on Study|1
70086|NCT00035932|268835|P1|Overall Study|Protocol Violation While on Study|0
70087|NCT00035932|268833|P3|Overall Study|Noncompliance|6
70088|NCT00035932|268834|P2|Overall Study|Noncompliance|7
70089|NCT00035932|268835|P1|Overall Study|Noncompliance|6
70090|NCT00035932|268833|P3|Overall Study|Lost to Follow-up|3
70091|NCT00035932|268834|P2|Overall Study|Lost to Follow-up|4
70092|NCT00035932|268835|P1|Overall Study|Lost to Follow-up|4
70093|NCT00035932|268833|P3|Overall Study|Disease Progression / Relapse|0
70094|NCT00035932|268834|P2|Overall Study|Disease Progression / Relapse|1
70095|NCT00035932|268835|P1|Overall Study|Disease Progression / Relapse|1
70096|NCT00035932|268833|P3|Overall Study|Death|1
70097|NCT00035932|268834|P2|Overall Study|Death|0
70098|NCT00035932|268835|P1|Overall Study|Death|0
70099|NCT00035932|268833|P3|Overall Study|Adverse Event|9
70100|NCT00035932|268834|P2|Overall Study|Adverse Event|9
70101|NCT00035932|268835|P1|Overall Study|Adverse Event|10
70102|NCT00036270|268961|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
70103|NCT00036270|268962|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
70104|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Too early switch|103
70105|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Too early switch|0
70106|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
70107|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
70108|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Protocol Violation|91
70109|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Protocol Violation|23
70110|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
70111|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
70112|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Treatment refusal|208
70113|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Treatment refusal|113
70114|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Unspecified|288
70115|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Unspecified|277
70116|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Adverse Event|782
70117|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Adverse Event|501
70118|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
70119|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
70120|NCT00036270|268961|P2|Study Treatment to 5 Year Report|Ongoing|736
70121|NCT00036270|268962|P1|Study Treatment to 5 Year Report|Ongoing|1081
70122|NCT00036270|268961|P2|Randomized to Study Treatment|Withdrawal by Subject|7
70123|NCT00036270|268962|P1|Randomized to Study Treatment|Withdrawal by Subject|6
70124|NCT00030823|268987|P1|Overall Study|Withdrawal by Subject|1
70125|NCT00043979|268993|P3|Period 1|recipient with progressive disease|3
70126|NCT00043979|268994|P2|Period 1|recipient with progressive disease|4
70127|NCT00043979|268995|P1|Period 1|recipient with progressive disease|7
70128|NCT00044213|269066|P4|Overall Study|Lost to Follow-up|4
70129|NCT00044213|269067|P3|Overall Study|Lost to Follow-up|5
70130|NCT00044213|269068|P2|Overall Study|Lost to Follow-up|5
70131|NCT00044213|269069|P1|Overall Study|Lost to Follow-up|8
70132|NCT00044213|269066|P4|Overall Study|Death|49
70133|NCT00044213|269067|P3|Overall Study|Death|42
70134|NCT00044213|269068|P2|Overall Study|Death|42
70135|NCT00044213|269069|P1|Overall Study|Death|42
70136|NCT00044213|269066|P4|Overall Study|Withdrawal by Subject|83
70137|NCT00044213|269067|P3|Overall Study|Withdrawal by Subject|91
70138|NCT00044213|269068|P2|Overall Study|Withdrawal by Subject|65
70139|NCT00044213|269069|P1|Overall Study|Withdrawal by Subject|50
70140|NCT00046839|269144|P2|Overall Study|Withdrawal of consent|0
70141|NCT00046839|269145|P1|Overall Study|Withdrawal of consent|1
70142|NCT00046839|269144|P2|Overall Study|Ineligible / No protocol treatment|2
70143|NCT00046839|269145|P1|Overall Study|Ineligible / No protocol treatment|0
70144|NCT00046891|269154|P2|Overall Study|Adverse Event|5
70145|NCT00046891|269155|P1|Overall Study|Adverse Event|5
70146|NCT00046891|269154|P2|Overall Study|Withdrawal by Subject|15
70147|NCT00046891|269155|P1|Overall Study|Withdrawal by Subject|18
70148|NCT00046891|269154|P2|Overall Study|Ineligible|1
70149|NCT00046891|269155|P1|Overall Study|Ineligible|1
70150|NCT00046891|269154|P2|Overall Study|Cancels|9
70151|NCT00046891|269155|P1|Overall Study|Cancels|5
70152|NCT00046930|269175|P2|Overall Study|Ineligible|4
70153|NCT00046930|269176|P1|Overall Study|Ineligible|12
70154|NCT00047008|269191|P2|Overall Study|Ineligible|8
70155|NCT00047008|269192|P1|Overall Study|Ineligible|9
70156|NCT00047008|269191|P2|Overall Study|Withdrawn consent|3
70157|NCT00047008|269192|P1|Overall Study|Withdrawn consent|2
70158|NCT00047320|269198|P1|Overall Study|Ineligible|3
70159|NCT00047320|269198|P1|Overall Study|Withdrawal by Subject|6
70160|NCT00047320|269198|P1|Overall Study|Physician Decision|8
70161|NCT00047320|269198|P1|Overall Study|Lost to Follow-up|1
70162|NCT00047320|269198|P1|Overall Study|Lack of Efficacy|10
70163|NCT00047385|269204|P2|Overall Study|Eligible for screening but had no screen|492
70164|NCT00047385|269205|P1|Overall Study|Eligible for screening but had no screen|260
70165|NCT00047385|269204|P2|Overall Study|Lung Cancer diagnosed before screening|3
70166|NCT00047385|269205|P1|Overall Study|Lung Cancer diagnosed before screening|5
70167|NCT00047385|269204|P2|Overall Study|Death before any screening|5
70168|NCT00047385|269205|P1|Overall Study|Death before any screening|2
70169|NCT00047463|269225|P2|Overall Study|Withdrawal by Subject|3
70170|NCT00047463|269226|P1|Overall Study|Withdrawal by Subject|0
70171|NCT00047879|269248|P2|Overall Study|Progressive disease|3
70172|NCT00047879|269249|P1|Overall Study|Progressive disease|4
70173|NCT00048035|269265|P8|Extension Year 2|Early Withdrawals|3
70174|NCT00048035|269266|P7|Extension Year 2|Early Withdrawals|3
70175|NCT00048035|269267|P6|Extension Year 2|Early Withdrawals|0
70176|NCT00048035|269268|P5|Extension Year 2|Early Withdrawals|0
70177|NCT00048035|269269|P4|Extension Year 2|Early Withdrawals|0
70178|NCT00048035|269270|P3|Extension Year 2|Early Withdrawals|0
70179|NCT00048035|269271|P2|Extension Year 2|Early Withdrawals|0
70180|NCT00048035|269272|P1|Extension Year 2|Early Withdrawals|0
70181|NCT00048035|269265|P8|Extension Year 1|Early Withdrawals|11
70182|NCT00048035|269266|P7|Extension Year 1|Early Withdrawals|11
70183|NCT00048035|269267|P6|Extension Year 1|Early Withdrawals|0
70184|NCT00048035|269268|P5|Extension Year 1|Early Withdrawals|0
70185|NCT00048035|269269|P4|Extension Year 1|Early Withdrawals|0
70186|NCT00048035|269270|P3|Extension Year 1|Early Withdrawals|0
70187|NCT00048035|269271|P2|Extension Year 1|Early Withdrawals|0
70188|NCT00048035|269272|P1|Extension Year 1|Early Withdrawals|0
70189|NCT00048035|269265|P8|Core Period|Early Withdrawals|0
70190|NCT00048035|269266|P7|Core Period|Early Withdrawals|0
70191|NCT00048035|269267|P6|Core Period|Early Withdrawals|1
70192|NCT00048035|269268|P5|Core Period|Early Withdrawals|1
70193|NCT00048035|269269|P4|Core Period|Early Withdrawals|1
70194|NCT00048035|269270|P3|Core Period|Early Withdrawals|1
70195|NCT00048035|269271|P2|Core Period|Early Withdrawals|2
70196|NCT00048035|269272|P1|Core Period|Early Withdrawals|4
70197|NCT00048061|269312|P4|Overall Study|Early improvement|0
70198|NCT00048061|269313|P3|Overall Study|Early improvement|3
70199|NCT00048061|269314|P2|Overall Study|Early improvement|5
70200|NCT00048061|269315|P1|Overall Study|Early improvement|6
70201|NCT00048061|269312|P4|Overall Study|Did not follow-up|5
70202|NCT00048061|269313|P3|Overall Study|Did not follow-up|4
70203|NCT00048061|269314|P2|Overall Study|Did not follow-up|5
70204|NCT00048061|269315|P1|Overall Study|Did not follow-up|5
70205|NCT00048061|269312|P4|Overall Study|Withdrawal by Subject|32
70206|NCT00048061|269313|P3|Overall Study|Withdrawal by Subject|29
70207|NCT00048061|269314|P2|Overall Study|Withdrawal by Subject|29
70208|NCT00048061|269315|P1|Overall Study|Withdrawal by Subject|20
70209|NCT00048061|269312|P4|Overall Study|Lost to Follow-up|5
70210|NCT00048061|269313|P3|Overall Study|Lost to Follow-up|4
70211|NCT00048061|269314|P2|Overall Study|Lost to Follow-up|2
70212|NCT00048061|269315|P1|Overall Study|Lost to Follow-up|3
70213|NCT00048061|269312|P4|Overall Study|Adverse Event|37
70214|NCT00048061|269313|P3|Overall Study|Adverse Event|44
70215|NCT00048061|269314|P2|Overall Study|Adverse Event|32
70216|NCT00048061|269315|P1|Overall Study|Adverse Event|41
70217|NCT00048074|269388|P3|Overall Study|Social reasons|0
70218|NCT00048074|269389|P2|Overall Study|Social reasons|0
70219|NCT00048074|269390|P1|Overall Study|Social reasons|1
70220|NCT00048074|269388|P3|Overall Study|Out of station|1
70221|NCT00048074|269389|P2|Overall Study|Out of station|1
70222|NCT00048074|269390|P1|Overall Study|Out of station|0
70223|NCT00048074|269388|P3|Overall Study|Poor compliance|0
70224|NCT00048074|269389|P2|Overall Study|Poor compliance|1
70225|NCT00048074|269390|P1|Overall Study|Poor compliance|0
70226|NCT00048074|269388|P3|Overall Study|Husband ill|0
70227|NCT00048074|269389|P2|Overall Study|Husband ill|1
70228|NCT00048074|269390|P1|Overall Study|Husband ill|0
70229|NCT00048074|269388|P3|Overall Study|Study participation was terminated|0
70230|NCT00048074|269389|P2|Overall Study|Study participation was terminated|1
70231|NCT00048074|269390|P1|Overall Study|Study participation was terminated|0
70232|NCT00048074|269388|P3|Overall Study|Protocol Violation|0
70233|NCT00048074|269389|P2|Overall Study|Protocol Violation|3
70234|NCT00048074|269390|P1|Overall Study|Protocol Violation|1
70235|NCT00048074|269388|P3|Overall Study|Withdrawal by Subject|35
70236|NCT00048074|269389|P2|Overall Study|Withdrawal by Subject|30
70237|NCT00048074|269390|P1|Overall Study|Withdrawal by Subject|28
70238|NCT00048074|269388|P3|Overall Study|Lost to Follow-up|6
70239|NCT00048074|269389|P2|Overall Study|Lost to Follow-up|6
70240|NCT00048074|269390|P1|Overall Study|Lost to Follow-up|2
70241|NCT00048074|269388|P3|Overall Study|Death|2
70242|NCT00048074|269389|P2|Overall Study|Death|3
70243|NCT00048074|269390|P1|Overall Study|Death|3
70244|NCT00048074|269388|P3|Overall Study|Adverse Event|53
70245|NCT00048074|269389|P2|Overall Study|Adverse Event|41
70246|NCT00048074|269390|P1|Overall Study|Adverse Event|46
70247|NCT00048165|269445|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
70248|NCT00048165|269446|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
70249|NCT00048165|269445|P2|Completed 12 Months Study|Death|1
70250|NCT00048165|269446|P1|Completed 12 Months Study|Death|2
70251|NCT00048165|269445|P2|Completed 12 Months Study|Administration/Other|2
70252|NCT00048165|269446|P1|Completed 12 Months Study|Administration/Other|0
70253|NCT00048165|269445|P2|Completed 6 Months Study|Did not receive study drug|6
70254|NCT00048165|269446|P1|Completed 6 Months Study|Did not receive study drug|6
70255|NCT00048165|269445|P2|Completed 6 Months Study|Violation criteria|2
70256|NCT00048165|269446|P1|Completed 6 Months Study|Violation criteria|0
70257|NCT00048165|269445|P2|Completed 6 Months Study|Refused treatment|5
70258|NCT00048165|269446|P1|Completed 6 Months Study|Refused treatment|5
70259|NCT00048165|269445|P2|Completed 6 Months Study|Other violation|6
70260|NCT00048165|269446|P1|Completed 6 Months Study|Other violation|4
70261|NCT00048165|269445|P2|Completed 6 Months Study|Insufficient therapy|4
70262|NCT00048165|269446|P1|Completed 6 Months Study|Insufficient therapy|1
70263|NCT00048165|269445|P2|Completed 6 Months Study|Death|6
70264|NCT00048165|269446|P1|Completed 6 Months Study|Death|12
70265|NCT00048165|269445|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
70266|NCT00048165|269446|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
70267|NCT00048165|269445|P2|Completed 6 Months Study|Abnormality of laboratory test|0
70268|NCT00048165|269446|P1|Completed 6 Months Study|Abnormality of laboratory test|1
70269|NCT00048165|269445|P2|Completed 6 Months Study|Administration/Other|8
70270|NCT00048165|269446|P1|Completed 6 Months Study|Administration/Other|8
70271|NCT00048347|269478|P1|Overall Study|Screen failure|2
70272|NCT00048542|269486|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
70273|NCT00048542|269487|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
70274|NCT00048542|269488|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
70275|NCT00048542|269489|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
70276|NCT00048542|269490|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
70277|NCT00048542|269491|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
70278|NCT00048542|269492|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
70279|NCT00048542|269493|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
70280|NCT00048542|269486|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
70281|NCT00048542|269487|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
70282|NCT00048542|269488|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
70283|NCT00048542|269489|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
70284|NCT00048542|269490|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
70285|NCT00048542|269491|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
70286|NCT00048542|269492|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
70287|NCT00048542|269493|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
70288|NCT00048542|269486|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
70289|NCT00048542|269487|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
70290|NCT00048542|269488|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
70291|NCT00048542|269489|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
70292|NCT00048542|269490|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
70293|NCT00048542|269491|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
70294|NCT00048542|269492|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
70295|NCT00048542|269493|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
70296|NCT00048542|269486|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
70297|NCT00048542|269487|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
70298|NCT00048542|269488|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
70299|NCT00048542|269489|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
70300|NCT00048542|269490|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
70301|NCT00048542|269491|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
70302|NCT00048542|269492|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
70303|NCT00048542|269493|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
70304|NCT00048542|269486|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
70305|NCT00048542|269487|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
70306|NCT00048542|269488|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
70307|NCT00048542|269489|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
70308|NCT00048542|269490|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
70309|NCT00048542|269491|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
70310|NCT00048542|269492|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
70311|NCT00048542|269493|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
70312|NCT00048542|269486|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
70313|NCT00048542|269487|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
70314|NCT00048542|269488|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
70315|NCT00048542|269489|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
70316|NCT00048542|269490|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
70317|NCT00048542|269491|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
70318|NCT00048542|269492|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
70319|NCT00048542|269493|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
70320|NCT00048542|269486|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
70321|NCT00048542|269487|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
70322|NCT00048542|269488|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
70323|NCT00048542|269489|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
70324|NCT00048542|269490|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
70325|NCT00048542|269491|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
70326|NCT00048542|269492|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
70327|NCT00048542|269493|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
70328|NCT00048542|269486|P8|Open-Label Extension BSA Phase|Adverse Event|0
70329|NCT00048542|269487|P7|Open-Label Extension BSA Phase|Adverse Event|0
70330|NCT00048542|269488|P6|Open-Label Extension BSA Phase|Adverse Event|1
70331|NCT00048542|269489|P5|Open-Label Extension BSA Phase|Adverse Event|1
70332|NCT00048542|269490|P4|Open-Label Extension BSA Phase|Adverse Event|0
70333|NCT00048542|269491|P3|Open-Label Extension BSA Phase|Adverse Event|0
70334|NCT00048542|269492|P2|Open-Label Extension BSA Phase|Adverse Event|0
70335|NCT00048542|269493|P1|Open-Label Extension BSA Phase|Adverse Event|0
70336|NCT00048542|269486|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
70337|NCT00048542|269487|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
70338|NCT00048542|269488|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
70339|NCT00048542|269489|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
70340|NCT00048542|269490|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
70341|NCT00048542|269491|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
70342|NCT00048542|269492|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
70343|NCT00048542|269493|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
70344|NCT00048542|269486|P8|Open-Label Extension BSA Phase|Protocol Violation|0
70345|NCT00048542|269487|P7|Open-Label Extension BSA Phase|Protocol Violation|0
70346|NCT00048542|269488|P6|Open-Label Extension BSA Phase|Protocol Violation|1
70347|NCT00048542|269489|P5|Open-Label Extension BSA Phase|Protocol Violation|0
70348|NCT00048542|269490|P4|Open-Label Extension BSA Phase|Protocol Violation|0
70349|NCT00048542|269491|P3|Open-Label Extension BSA Phase|Protocol Violation|0
70350|NCT00048542|269492|P2|Open-Label Extension BSA Phase|Protocol Violation|0
70351|NCT00048542|269493|P1|Open-Label Extension BSA Phase|Protocol Violation|0
70352|NCT00048542|269486|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
70353|NCT00048542|269487|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
70354|NCT00048542|269488|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
70355|NCT00048542|269489|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
70356|NCT00048542|269490|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
70357|NCT00048542|269491|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
70358|NCT00048542|269492|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
70359|NCT00048542|269493|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
70360|NCT00048542|269486|P8|Double-Blind Phase|Randomized in error|0
70361|NCT00048542|269487|P7|Double-Blind Phase|Randomized in error|0
70362|NCT00048542|269488|P6|Double-Blind Phase|Randomized in error|0
70363|NCT00048542|269489|P5|Double-Blind Phase|Randomized in error|0
70364|NCT00048542|269490|P4|Double-Blind Phase|Randomized in error|0
70365|NCT00048542|269491|P3|Double-Blind Phase|Randomized in error|0
70366|NCT00048542|269492|P2|Double-Blind Phase|Randomized in error|0
70367|NCT00048542|269493|P1|Double-Blind Phase|Randomized in error|1
70368|NCT00048542|269486|P8|Double-Blind Phase|Sponsor request or decision|0
70369|NCT00048542|269487|P7|Double-Blind Phase|Sponsor request or decision|0
70370|NCT00048542|269488|P6|Double-Blind Phase|Sponsor request or decision|0
70371|NCT00048542|269489|P5|Double-Blind Phase|Sponsor request or decision|0
70372|NCT00048542|269490|P4|Double-Blind Phase|Sponsor request or decision|0
70373|NCT00048542|269491|P3|Double-Blind Phase|Sponsor request or decision|0
70374|NCT00048542|269492|P2|Double-Blind Phase|Sponsor request or decision|0
70375|NCT00048542|269493|P1|Double-Blind Phase|Sponsor request or decision|2
70376|NCT00048542|269486|P8|Double-Blind Phase|Protocol Violation|0
70377|NCT00048542|269487|P7|Double-Blind Phase|Protocol Violation|0
70378|NCT00048542|269488|P6|Double-Blind Phase|Protocol Violation|0
70379|NCT00048542|269489|P5|Double-Blind Phase|Protocol Violation|0
70380|NCT00048542|269490|P4|Double-Blind Phase|Protocol Violation|0
70381|NCT00048542|269491|P3|Double-Blind Phase|Protocol Violation|1
70382|NCT00048542|269492|P2|Double-Blind Phase|Protocol Violation|0
70383|NCT00048542|269493|P1|Double-Blind Phase|Protocol Violation|0
70384|NCT00048542|269486|P8|Double-Blind Phase|Withdrawal by Subject|0
70385|NCT00048542|269487|P7|Double-Blind Phase|Withdrawal by Subject|0
70386|NCT00048542|269488|P6|Double-Blind Phase|Withdrawal by Subject|0
70387|NCT00048542|269489|P5|Double-Blind Phase|Withdrawal by Subject|0
70388|NCT00048542|269490|P4|Double-Blind Phase|Withdrawal by Subject|0
70389|NCT00048542|269491|P3|Double-Blind Phase|Withdrawal by Subject|0
70390|NCT00048542|269492|P2|Double-Blind Phase|Withdrawal by Subject|1
70391|NCT00048542|269493|P1|Double-Blind Phase|Withdrawal by Subject|0
70392|NCT00048568|269561|P3|Open-Label Period|Lost to Follow-up|7
70393|NCT00048568|269562|P2|Open-Label Period|Lost to Follow-up|0
70394|NCT00048568|269563|P1|Open-Label Period|Lost to Follow-up|0
70395|NCT00048568|269561|P3|Open-Label Period|Unknown Reasons|25
70396|NCT00048568|269562|P2|Open-Label Period|Unknown Reasons|0
70397|NCT00048568|269563|P1|Open-Label Period|Unknown Reasons|0
70398|NCT00048568|269561|P3|Open-Label Period|Administrative Decision By Sponsor|1
70399|NCT00048568|269562|P2|Open-Label Period|Administrative Decision By Sponsor|0
70400|NCT00048568|269563|P1|Open-Label Period|Administrative Decision By Sponsor|0
70401|NCT00048568|269561|P3|Open-Label Period|No Longer Met Study Criteria|2
70402|NCT00048568|269562|P2|Open-Label Period|No Longer Met Study Criteria|0
70403|NCT00048568|269563|P1|Open-Label Period|No Longer Met Study Criteria|0
70404|NCT00048568|269561|P3|Open-Label Period|Pregnancy|5
70405|NCT00048568|269562|P2|Open-Label Period|Pregnancy|0
70406|NCT00048568|269563|P1|Open-Label Period|Pregnancy|0
70407|NCT00048568|269561|P3|Open-Label Period|Withdrawal by Subject|26
70408|NCT00048568|269562|P2|Open-Label Period|Withdrawal by Subject|0
70409|NCT00048568|269563|P1|Open-Label Period|Withdrawal by Subject|0
70410|NCT00048568|269561|P3|Open-Label Period|Lack of Efficacy|32
70411|NCT00048568|269562|P2|Open-Label Period|Lack of Efficacy|0
70412|NCT00048568|269563|P1|Open-Label Period|Lack of Efficacy|0
70413|NCT00048568|269561|P3|Open-Label Period|Adverse Event|49
70414|NCT00048568|269562|P2|Open-Label Period|Adverse Event|0
70415|NCT00048568|269563|P1|Open-Label Period|Adverse Event|0
70416|NCT00048568|269561|P3|Open-Label Period|Death|13
70417|NCT00048568|269562|P2|Open-Label Period|Death|0
70418|NCT00048568|269563|P1|Open-Label Period|Death|0
70419|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
70420|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
70421|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
70422|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
70423|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
70424|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
70425|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
70426|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
70427|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
70428|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
70429|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
70430|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
70431|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
70432|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
70433|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
70434|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
70435|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
70436|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
70437|NCT00048568|269561|P3|Double-Blind Period Days 170 to 365|Death|0
70438|NCT00048568|269562|P2|Double-Blind Period Days 170 to 365|Death|1
70439|NCT00048568|269563|P1|Double-Blind Period Days 170 to 365|Death|1
70440|NCT00048568|269561|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
70441|NCT00048568|269562|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
70442|NCT00048568|269563|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
70443|NCT00048568|269561|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
70444|NCT00048568|269562|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
70445|NCT00048568|269563|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
70446|NCT00048568|269561|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
70447|NCT00048568|269562|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
70448|NCT00048568|269563|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
70449|NCT00048568|269561|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
70450|NCT00048568|269562|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
70451|NCT00048568|269563|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
70452|NCT00048568|269561|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
70453|NCT00048568|269562|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
70454|NCT00048568|269563|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
70455|NCT00048581|269853|P3|Open-Label Period|Study Ended By Sponsor|1
70456|NCT00048581|269854|P2|Open-Label Period|Study Ended By Sponsor|0
70457|NCT00048581|269855|P1|Open-Label Period|Study Ended By Sponsor|0
70458|NCT00048581|269853|P3|Open-Label Period|Primary Investigator Retired|2
70459|NCT00048581|269854|P2|Open-Label Period|Primary Investigator Retired|0
70460|NCT00048581|269855|P1|Open-Label Period|Primary Investigator Retired|0
70461|NCT00048581|269853|P3|Open-Label Period|Problem With Transportation To Site|1
70462|NCT00048581|269854|P2|Open-Label Period|Problem With Transportation To Site|0
70463|NCT00048581|269855|P1|Open-Label Period|Problem With Transportation To Site|0
70464|NCT00048581|269853|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
70465|NCT00048581|269854|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
70466|NCT00048581|269855|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
70467|NCT00048581|269853|P3|Open-Label Period|Study Site Closure|2
70468|NCT00048581|269854|P2|Open-Label Period|Study Site Closure|0
70469|NCT00048581|269855|P1|Open-Label Period|Study Site Closure|0
70470|NCT00048581|269853|P3|Open-Label Period|Pregnancy|7
70471|NCT00048581|269854|P2|Open-Label Period|Pregnancy|0
70472|NCT00048581|269855|P1|Open-Label Period|Pregnancy|0
70473|NCT00048581|269853|P3|Open-Label Period|Poor/Non-compliance|5
70474|NCT00048581|269854|P2|Open-Label Period|Poor/Non-compliance|0
70475|NCT00048581|269855|P1|Open-Label Period|Poor/Non-compliance|0
70476|NCT00048581|269853|P3|Open-Label Period|No Longer Meets Study Criteria|2
70477|NCT00048581|269854|P2|Open-Label Period|No Longer Meets Study Criteria|0
70478|NCT00048581|269855|P1|Open-Label Period|No Longer Meets Study Criteria|0
70479|NCT00048581|269853|P3|Open-Label Period|Withdrawal by Subject|20
70480|NCT00048581|269854|P2|Open-Label Period|Withdrawal by Subject|0
70481|NCT00048581|269855|P1|Open-Label Period|Withdrawal by Subject|0
70482|NCT00048581|269853|P3|Open-Label Period|Lost to Follow-up|14
70483|NCT00048581|269854|P2|Open-Label Period|Lost to Follow-up|0
70484|NCT00048581|269855|P1|Open-Label Period|Lost to Follow-up|0
70485|NCT00048581|269853|P3|Open-Label Period|Lack of Efficacy|69
70486|NCT00048581|269854|P2|Open-Label Period|Lack of Efficacy|0
70487|NCT00048581|269855|P1|Open-Label Period|Lack of Efficacy|0
70488|NCT00048581|269853|P3|Open-Label Period|Adverse Event|37
70489|NCT00048581|269854|P2|Open-Label Period|Adverse Event|0
70490|NCT00048581|269855|P1|Open-Label Period|Adverse Event|0
70491|NCT00048581|269853|P3|Open-Label Period|Death|4
70492|NCT00048581|269854|P2|Open-Label Period|Death|0
70493|NCT00048581|269855|P1|Open-Label Period|Death|0
70494|NCT00048581|269853|P3|Double-Blind Period|Investigator Decision|0
70495|NCT00048581|269854|P2|Double-Blind Period|Investigator Decision|0
70496|NCT00048581|269855|P1|Double-Blind Period|Investigator Decision|1
70497|NCT00048581|269853|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
70498|NCT00048581|269854|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
70499|NCT00048581|269855|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
70500|NCT00048581|269853|P3|Double-Blind Period|Withdrawal by Subject|0
70501|NCT00048581|269854|P2|Double-Blind Period|Withdrawal by Subject|2
70502|NCT00048581|269855|P1|Double-Blind Period|Withdrawal by Subject|5
70503|NCT00048581|269853|P3|Double-Blind Period|Lost to Follow-up|0
70504|NCT00048581|269854|P2|Double-Blind Period|Lost to Follow-up|0
70505|NCT00048581|269855|P1|Double-Blind Period|Lost to Follow-up|5
70506|NCT00048581|269853|P3|Double-Blind Period|Lack of Efficacy|0
70507|NCT00048581|269854|P2|Double-Blind Period|Lack of Efficacy|27
70508|NCT00048581|269855|P1|Double-Blind Period|Lack of Efficacy|14
70509|NCT00048581|269853|P3|Double-Blind Period|Adverse Event|0
70510|NCT00048581|269854|P2|Double-Blind Period|Adverse Event|5
70511|NCT00048581|269855|P1|Double-Blind Period|Adverse Event|9
70512|NCT00048724|270022|P2|Overall Study|Administrative|1
70513|NCT00048724|270023|P1|Overall Study|Administrative|1
70514|NCT00048724|270022|P2|Overall Study|Did Not Meet Protocol Eligibility|2
70515|NCT00048724|270023|P1|Overall Study|Did Not Meet Protocol Eligibility|2
70516|NCT00048724|270022|P2|Overall Study|Noncompliance With Protocol|12
70517|NCT00048724|270023|P1|Overall Study|Noncompliance With Protocol|4
70518|NCT00048724|270022|P2|Overall Study|Protocol-defined Clinical Event|32
70519|NCT00048724|270023|P1|Overall Study|Protocol-defined Clinical Event|17
70520|NCT00048724|270022|P2|Overall Study|Lost to Follow-up|5
70521|NCT00048724|270023|P1|Overall Study|Lost to Follow-up|5
70522|NCT00048724|270022|P2|Overall Study|Withdrawal by Subject|54
70523|NCT00048724|270023|P1|Overall Study|Withdrawal by Subject|34
70524|NCT00048724|270022|P2|Overall Study|Adverse Event|12
70525|NCT00048724|270023|P1|Overall Study|Adverse Event|53
70526|NCT00039741|270063|P4|Overall Study|Missed final visit|2
70527|NCT00039741|270064|P3|Overall Study|Missed final visit|2
70528|NCT00039741|270065|P2|Overall Study|Missed final visit|1
70529|NCT00039741|270066|P1|Overall Study|Missed final visit|2
70530|NCT00039741|270063|P4|Overall Study|Withdrew consent|1
70531|NCT00039741|270064|P3|Overall Study|Withdrew consent|0
70532|NCT00039741|270065|P2|Overall Study|Withdrew consent|5
70533|NCT00039741|270066|P1|Overall Study|Withdrew consent|0
70534|NCT00039741|270063|P4|Overall Study|Non-compliance with protocol|0
70535|NCT00039741|270064|P3|Overall Study|Non-compliance with protocol|1
70536|NCT00039741|270065|P2|Overall Study|Non-compliance with protocol|0
70537|NCT00039741|270066|P1|Overall Study|Non-compliance with protocol|1
70538|NCT00039741|270063|P4|Overall Study|Moved|6
70539|NCT00039741|270064|P3|Overall Study|Moved|3
70540|NCT00039741|270065|P2|Overall Study|Moved|2
70541|NCT00039741|270066|P1|Overall Study|Moved|3
70542|NCT00039741|270063|P4|Overall Study|Not able to get to clinic|3
70543|NCT00039741|270064|P3|Overall Study|Not able to get to clinic|0
70544|NCT00039741|270065|P2|Overall Study|Not able to get to clinic|2
70545|NCT00039741|270066|P1|Overall Study|Not able to get to clinic|5
70546|NCT00039741|270063|P4|Overall Study|Confounding medical condition|0
70547|NCT00039741|270064|P3|Overall Study|Confounding medical condition|0
70548|NCT00039741|270065|P2|Overall Study|Confounding medical condition|0
70549|NCT00039741|270066|P1|Overall Study|Confounding medical condition|1
70550|NCT00039741|270063|P4|Overall Study|Lost to Follow-up|2
70551|NCT00039741|270064|P3|Overall Study|Lost to Follow-up|5
70552|NCT00039741|270065|P2|Overall Study|Lost to Follow-up|1
70553|NCT00039741|270066|P1|Overall Study|Lost to Follow-up|3
70554|NCT00039741|270063|P4|Overall Study|Death|0
70555|NCT00039741|270064|P3|Overall Study|Death|0
70556|NCT00039741|270065|P2|Overall Study|Death|1
70557|NCT00039741|270066|P1|Overall Study|Death|0
70558|NCT00039871|270108|P1|Overall Study|Never entered follow-up|7
70559|NCT00039871|270108|P1|Overall Study|Discontinued at Week 12 per protocol|1061
70560|NCT00039871|270108|P1|Overall Study|Administrative|1
70561|NCT00039871|270108|P1|Overall Study|Did not meet eligibility criteria|11
70562|NCT00039871|270108|P1|Overall Study|Withdrawal by Subject|97
70563|NCT00039871|270108|P1|Overall Study|Protocol Violation|24
70564|NCT00039871|270108|P1|Overall Study|Lost to Follow-up|18
70565|NCT00039871|270108|P1|Overall Study|Adverse Event|165
70566|NCT00040365|270114|P1|Overall Study|Lost to Follow-up|3
70567|NCT00040365|270114|P1|Overall Study|Progressive disease|7
70568|NCT00040365|270114|P1|Overall Study|Death|1
70569|NCT00040664|270123|P4|Overall Study|Non-viability of oral suspension|0
70570|NCT00040664|270124|P3|Overall Study|Non-viability of oral suspension|1
70571|NCT00040664|270125|P2|Overall Study|Non-viability of oral suspension|0
70572|NCT00040664|270126|P1|Overall Study|Non-viability of oral suspension|1
70573|NCT00040664|270123|P4|Overall Study|Change of formulation|0
70574|NCT00040664|270124|P3|Overall Study|Change of formulation|0
70575|NCT00040664|270125|P2|Overall Study|Change of formulation|2
70576|NCT00040664|270126|P1|Overall Study|Change of formulation|2
70577|NCT00040664|270123|P4|Overall Study|Pharmacokinetic target not achieved|1
70578|NCT00040664|270124|P3|Overall Study|Pharmacokinetic target not achieved|0
70579|NCT00040664|270125|P2|Overall Study|Pharmacokinetic target not achieved|1
70580|NCT00040664|270126|P1|Overall Study|Pharmacokinetic target not achieved|2
70581|NCT00040664|270123|P4|Overall Study|Poor taste|0
70582|NCT00040664|270124|P3|Overall Study|Poor taste|2
70583|NCT00040664|270125|P2|Overall Study|Poor taste|0
70584|NCT00040664|270126|P1|Overall Study|Poor taste|2
70585|NCT00040664|270123|P4|Overall Study|Medication adherence/compliance problems|5
70586|NCT00040664|270124|P3|Overall Study|Medication adherence/compliance problems|1
70587|NCT00040664|270125|P2|Overall Study|Medication adherence/compliance problems|2
70588|NCT00040664|270126|P1|Overall Study|Medication adherence/compliance problems|8
70589|NCT00040664|270123|P4|Overall Study|Pregnancy|3
70590|NCT00040664|270124|P3|Overall Study|Pregnancy|0
70591|NCT00040664|270125|P2|Overall Study|Pregnancy|0
70592|NCT00040664|270126|P1|Overall Study|Pregnancy|3
70593|NCT00040664|270123|P4|Overall Study|Withdrawal by Subject|4
70594|NCT00040664|270124|P3|Overall Study|Withdrawal by Subject|3
70595|NCT00040664|270125|P2|Overall Study|Withdrawal by Subject|0
70596|NCT00040664|270126|P1|Overall Study|Withdrawal by Subject|7
70597|NCT00040664|270123|P4|Overall Study|Protocol Violation|1
70598|NCT00040664|270124|P3|Overall Study|Protocol Violation|0
70599|NCT00040664|270125|P2|Overall Study|Protocol Violation|1
70600|NCT00040664|270126|P1|Overall Study|Protocol Violation|2
70601|NCT00040664|270123|P4|Overall Study|Lost to Follow-up|2
70602|NCT00040664|270124|P3|Overall Study|Lost to Follow-up|0
70603|NCT00040664|270125|P2|Overall Study|Lost to Follow-up|2
70604|NCT00040664|270126|P1|Overall Study|Lost to Follow-up|4
70605|NCT00040664|270123|P4|Overall Study|Insufficient CD4 response|0
70606|NCT00040664|270124|P3|Overall Study|Insufficient CD4 response|1
70607|NCT00040664|270125|P2|Overall Study|Insufficient CD4 response|0
70608|NCT00040664|270126|P1|Overall Study|Insufficient CD4 response|1
70609|NCT00040664|270123|P4|Overall Study|Lack of Efficacy|4
70610|NCT00040664|270124|P3|Overall Study|Lack of Efficacy|3
70611|NCT00040664|270125|P2|Overall Study|Lack of Efficacy|2
70612|NCT00040664|270126|P1|Overall Study|Lack of Efficacy|9
70613|NCT00040664|270123|P4|Overall Study|Adverse Event|7
70614|NCT00040664|270124|P3|Overall Study|Adverse Event|2
70615|NCT00040664|270125|P2|Overall Study|Adverse Event|3
70616|NCT00040664|270126|P1|Overall Study|Adverse Event|12
70617|NCT00040742|270178|P4|Overall Study|Other medical|5
70618|NCT00040742|270179|P3|Overall Study|Other medical|5
70619|NCT00040742|270180|P2|Overall Study|Other medical|5
70620|NCT00040742|270181|P1|Overall Study|Other medical|7
70621|NCT00040742|270178|P4|Overall Study|Incomplete Forms|5
70622|NCT00040742|270179|P3|Overall Study|Incomplete Forms|4
70623|NCT00040742|270180|P2|Overall Study|Incomplete Forms|10
70624|NCT00040742|270181|P1|Overall Study|Incomplete Forms|6
70625|NCT00040742|270178|P4|Overall Study|Chemotoxicity|2
70626|NCT00040742|270179|P3|Overall Study|Chemotoxicity|5
70627|NCT00040742|270180|P2|Overall Study|Chemotoxicity|3
70628|NCT00040742|270181|P1|Overall Study|Chemotoxicity|4
70629|NCT00040742|270178|P4|Overall Study|Withdrawal by Subject|13
70630|NCT00040742|270179|P3|Overall Study|Withdrawal by Subject|10
70631|NCT00040742|270180|P2|Overall Study|Withdrawal by Subject|15
70632|NCT00040742|270181|P1|Overall Study|Withdrawal by Subject|7
70633|NCT00040742|270178|P4|Overall Study|Adverse Event|9
70634|NCT00040742|270179|P3|Overall Study|Adverse Event|21
70635|NCT00040742|270180|P2|Overall Study|Adverse Event|16
70636|NCT00040742|270181|P1|Overall Study|Adverse Event|15
70637|NCT00040742|270178|P4|Overall Study|Death|0
70638|NCT00040742|270179|P3|Overall Study|Death|1
70639|NCT00040742|270180|P2|Overall Study|Death|0
70640|NCT00040742|270181|P1|Overall Study|Death|0
70641|NCT00041067|270251|P1|Overall Study|Ineligible|2
70642|NCT00041067|270251|P1|Overall Study|Other reasons|23
70643|NCT00041067|270251|P1|Overall Study|Patient refusal|12
70644|NCT00041067|270251|P1|Overall Study|Progression|19
70645|NCT00041067|270251|P1|Overall Study|Adverse Event|20
70646|NCT00041080|270260|P2|Overall Study|Ineligible|0
70647|NCT00041080|270261|P1|Overall Study|Ineligible|1
70648|NCT00041080|270260|P2|Overall Study|Did not start therapy|1
70649|NCT00041080|270261|P1|Overall Study|Did not start therapy|1
70650|NCT00041080|270260|P2|Overall Study|Concommitant Illness/Other|2
70651|NCT00041080|270261|P1|Overall Study|Concommitant Illness/Other|1
70652|NCT00041080|270260|P2|Overall Study|Withdrawal by Subject|6
70653|NCT00041080|270261|P1|Overall Study|Withdrawal by Subject|6
70654|NCT00041080|270260|P2|Overall Study|Adverse Event|1
70655|NCT00041080|270261|P1|Overall Study|Adverse Event|21
70656|NCT00041132|270294|P1|Overall Study|Physician Decision|2
70657|NCT00041132|270294|P1|Overall Study|Withdrawal by Subject|1
70658|NCT00041132|270294|P1|Overall Study|Not Eligible|7
70659|NCT00041132|270294|P1|Overall Study|Death|1
70660|NCT00041132|270294|P1|Overall Study|Adverse Event|19
70661|NCT00048932|270302|P3|Open Label Period (OL)|Participant Surgery|1
70662|NCT00048932|270303|P2|Open Label Period (OL)|Participant Surgery|0
70663|NCT00048932|270304|P1|Open Label Period (OL)|Participant Surgery|0
70664|NCT00048932|270302|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
70665|NCT00048932|270303|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
70666|NCT00048932|270304|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
70667|NCT00048932|270302|P3|Open Label Period (OL)|Site Staff Issues|2
70668|NCT00048932|270303|P2|Open Label Period (OL)|Site Staff Issues|0
70669|NCT00048932|270304|P1|Open Label Period (OL)|Site Staff Issues|0
70670|NCT00048932|270302|P3|Open Label Period (OL)|Investigator Decision|4
70671|NCT00048932|270303|P2|Open Label Period (OL)|Investigator Decision|0
70672|NCT00048932|270304|P1|Open Label Period (OL)|Investigator Decision|0
70673|NCT00048932|270302|P3|Open Label Period (OL)|Medication Lost Efficacy|1
70674|NCT00048932|270303|P2|Open Label Period (OL)|Medication Lost Efficacy|0
70675|NCT00048932|270304|P1|Open Label Period (OL)|Medication Lost Efficacy|0
70676|NCT00048932|270302|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
70677|NCT00048932|270303|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
70678|NCT00048932|270304|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
70679|NCT00048932|270302|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
70680|NCT00048932|270303|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
70681|NCT00048932|270304|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
70682|NCT00048932|270302|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
70683|NCT00048932|270303|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
70684|NCT00048932|270304|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
70685|NCT00048932|270302|P3|Open Label Period (OL)|Patient Decision|4
70686|NCT00048932|270303|P2|Open Label Period (OL)|Patient Decision|0
70687|NCT00048932|270304|P1|Open Label Period (OL)|Patient Decision|0
70688|NCT00048932|270302|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
70689|NCT00048932|270303|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
70690|NCT00048932|270304|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
70691|NCT00048932|270302|P3|Open Label Period (OL)|Trial Terminated|1
70692|NCT00048932|270303|P2|Open Label Period (OL)|Trial Terminated|0
70693|NCT00048932|270304|P1|Open Label Period (OL)|Trial Terminated|0
70694|NCT00048932|270302|P3|Open Label Period (OL)|Site Closure|3
70695|NCT00048932|270303|P2|Open Label Period (OL)|Site Closure|0
70696|NCT00048932|270304|P1|Open Label Period (OL)|Site Closure|0
70697|NCT00048932|270302|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
70698|NCT00048932|270303|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
70699|NCT00048932|270304|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
70700|NCT00048932|270302|P3|Open Label Period (OL)|Participant Relocated|6
70701|NCT00048932|270303|P2|Open Label Period (OL)|Participant Relocated|0
70702|NCT00048932|270304|P1|Open Label Period (OL)|Participant Relocated|0
70703|NCT00048932|270302|P3|Open Label Period (OL)|Participant Transportation Issues|1
70704|NCT00048932|270303|P2|Open Label Period (OL)|Participant Transportation Issues|0
70705|NCT00048932|270304|P1|Open Label Period (OL)|Participant Transportation Issues|0
70706|NCT00048932|270302|P3|Open Label Period (OL)|Investigator Retiring|2
70707|NCT00048932|270303|P2|Open Label Period (OL)|Investigator Retiring|0
70708|NCT00048932|270304|P1|Open Label Period (OL)|Investigator Retiring|0
70709|NCT00048932|270302|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
70710|NCT00048932|270303|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
70711|NCT00048932|270304|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
70712|NCT00048932|270302|P3|Open Label Period (OL)|Pregnancy|6
70713|NCT00048932|270303|P2|Open Label Period (OL)|Pregnancy|0
70714|NCT00048932|270304|P1|Open Label Period (OL)|Pregnancy|0
70715|NCT00048932|270302|P3|Open Label Period (OL)|Poor/Non-Compliance|13
70716|NCT00048932|270303|P2|Open Label Period (OL)|Poor/Non-Compliance|0
70717|NCT00048932|270304|P1|Open Label Period (OL)|Poor/Non-Compliance|0
70718|NCT00048932|270302|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
70719|NCT00048932|270303|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
70720|NCT00048932|270304|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
70721|NCT00048932|270302|P3|Open Label Period (OL)|Withdrawal by Subject|117
70722|NCT00048932|270303|P2|Open Label Period (OL)|Withdrawal by Subject|0
70723|NCT00048932|270304|P1|Open Label Period (OL)|Withdrawal by Subject|0
70724|NCT00048932|270302|P3|Open Label Period (OL)|Lost to Follow-up|27
70725|NCT00048932|270303|P2|Open Label Period (OL)|Lost to Follow-up|0
70726|NCT00048932|270304|P1|Open Label Period (OL)|Lost to Follow-up|0
70727|NCT00048932|270302|P3|Open Label Period (OL)|Lack of Efficacy|81
70728|NCT00048932|270303|P2|Open Label Period (OL)|Lack of Efficacy|0
70729|NCT00048932|270304|P1|Open Label Period (OL)|Lack of Efficacy|0
70730|NCT00048932|270302|P3|Open Label Period (OL)|Adverse Event|103
70731|NCT00048932|270303|P2|Open Label Period (OL)|Adverse Event|0
70732|NCT00048932|270304|P1|Open Label Period (OL)|Adverse Event|0
70733|NCT00048932|270302|P3|Open Label Period (OL)|Death|25
70734|NCT00048932|270303|P2|Open Label Period (OL)|Death|0
70735|NCT00048932|270304|P1|Open Label Period (OL)|Death|0
70736|NCT00048932|270302|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
70737|NCT00048932|270303|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
70738|NCT00048932|270304|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
70739|NCT00048932|270302|P3|Double Blind Period (DB)|Withdrawal by Subject|0
70740|NCT00048932|270303|P2|Double Blind Period (DB)|Withdrawal by Subject|10
70741|NCT00048932|270304|P1|Double Blind Period (DB)|Withdrawal by Subject|24
70742|NCT00048932|270302|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
70743|NCT00048932|270303|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
70744|NCT00048932|270304|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
70745|NCT00048932|270302|P3|Double Blind Period (DB)|Pregnancy|0
70746|NCT00048932|270303|P2|Double Blind Period (DB)|Pregnancy|0
70747|NCT00048932|270304|P1|Double Blind Period (DB)|Pregnancy|1
70748|NCT00048932|270302|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
70749|NCT00048932|270303|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
70750|NCT00048932|270304|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
70751|NCT00048932|270302|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
70752|NCT00048932|270303|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
70753|NCT00048932|270304|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
70754|NCT00048932|270302|P3|Double Blind Period (DB)|Relocation|0
70755|NCT00048932|270303|P2|Double Blind Period (DB)|Relocation|0
70756|NCT00048932|270304|P1|Double Blind Period (DB)|Relocation|1
70757|NCT00048932|270302|P3|Double Blind Period (DB)|Lost to Follow-up|0
70758|NCT00048932|270303|P2|Double Blind Period (DB)|Lost to Follow-up|4
70759|NCT00048932|270304|P1|Double Blind Period (DB)|Lost to Follow-up|3
70760|NCT00048932|270302|P3|Double Blind Period (DB)|Lack of Efficacy|0
70761|NCT00048932|270303|P2|Double Blind Period (DB)|Lack of Efficacy|44
70762|NCT00048932|270304|P1|Double Blind Period (DB)|Lack of Efficacy|26
70763|NCT00048932|270302|P3|Double Blind Period (DB)|Death|0
70764|NCT00048932|270303|P2|Double Blind Period (DB)|Death|3
70765|NCT00048932|270304|P1|Double Blind Period (DB)|Death|5
70766|NCT00048932|270302|P3|Double Blind Period (DB)|Adverse Event|0
70767|NCT00048932|270303|P2|Double Blind Period (DB)|Adverse Event|19
70768|NCT00048932|270304|P1|Double Blind Period (DB)|Adverse Event|51
70769|NCT00048932|270302|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
70770|NCT00048932|270303|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
70771|NCT00048932|270304|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
70772|NCT00048997|270330|P2|Overall Study|Withdrawal by Subject|1
70773|NCT00048997|270331|P1|Overall Study|Withdrawal by Subject|6
70774|NCT00048997|270330|P2|Overall Study|Protocol Violation|2
70775|NCT00048997|270331|P1|Overall Study|Protocol Violation|7
70776|NCT00049127|270350|P5|Overall Study|Withdrawal by Subject|0
70777|NCT00049127|270351|P4|Overall Study|Withdrawal by Subject|0
70778|NCT00049127|270352|P3|Overall Study|Withdrawal by Subject|1
70779|NCT00049127|270353|P2|Overall Study|Withdrawal by Subject|0
70780|NCT00049127|270354|P1|Overall Study|Withdrawal by Subject|0
70781|NCT00049257|270381|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
70782|NCT00049257|270381|P1|Carboplatin, Paclitaxel|Death|2
70783|NCT00049257|270381|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
70784|NCT00049257|270381|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
70785|NCT00051025|270390|P2|Overall Study|Death|1
70786|NCT00051025|270391|P1|Overall Study|Death|0
70787|NCT00051025|270390|P2|Overall Study|Withdrawal by Subject|1
70788|NCT00051025|270391|P1|Overall Study|Withdrawal by Subject|0
70789|NCT00051025|270390|P2|Overall Study|Adverse Event|1
70790|NCT00051025|270391|P1|Overall Study|Adverse Event|1
70791|NCT00051025|270390|P2|Overall Study|Progressive Disease|1
70792|NCT00051025|270391|P1|Overall Study|Progressive Disease|1
70793|NCT00051363|270405|P2|Overall Study|Excluded Pre-Randomization|5
70794|NCT00051363|270406|P1|Overall Study|Excluded Pre-Randomization|2
70795|NCT00051363|270405|P2|Overall Study|Death|2
70796|NCT00051363|270406|P1|Overall Study|Death|2
70797|NCT00051363|270405|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
70798|NCT00051363|270406|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
70799|NCT00051363|270405|P2|Overall Study|Dropped Post-Rand for Any Reason|126
70800|NCT00051363|270406|P1|Overall Study|Dropped Post-Rand for Any Reason|102
70801|NCT00051558|270442|P2|Overall Study|Physician Decision|0
70802|NCT00051558|270443|P1|Overall Study|Physician Decision|5
70803|NCT00051558|270442|P2|Overall Study|Significant Lab Value|0
70804|NCT00051558|270443|P1|Overall Study|Significant Lab Value|2
70805|NCT00051558|270442|P2|Overall Study|Unspecified|1
70806|NCT00051558|270443|P1|Overall Study|Unspecified|2
70807|NCT00051558|270442|P2|Overall Study|Sponsor Decision|1
70808|NCT00051558|270443|P1|Overall Study|Sponsor Decision|6
70809|NCT00051558|270442|P2|Overall Study|Protocol Entry Criteria Unmet|2
70810|NCT00051558|270443|P1|Overall Study|Protocol Entry Criteria Unmet|1
70811|NCT00051558|270442|P2|Overall Study|Protocol Violation|4
70812|NCT00051558|270443|P1|Overall Study|Protocol Violation|3
70813|NCT00051558|270442|P2|Overall Study|Lost to Follow-up|13
70814|NCT00051558|270443|P1|Overall Study|Lost to Follow-up|4
70815|NCT00051558|270442|P2|Overall Study|Death|15
70816|NCT00051558|270443|P1|Overall Study|Death|9
70817|NCT00051558|270442|P2|Overall Study|Withdrawal by Subject|42
70818|NCT00051558|270443|P1|Overall Study|Withdrawal by Subject|29
70819|NCT00051558|270442|P2|Overall Study|Adverse Event|18
70820|NCT00051558|270443|P1|Overall Study|Adverse Event|30
70821|NCT00051636|270479|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
70822|NCT00051636|270480|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
70823|NCT00051636|270479|P2|Period 2- Extended Observation Period|Death|5
70824|NCT00051636|270480|P1|Period 2- Extended Observation Period|Death|4
70825|NCT00051636|270479|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
70826|NCT00051636|270480|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
70827|NCT00051636|270479|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
70828|NCT00051636|270480|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
70829|NCT00051636|270479|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
70830|NCT00051636|270480|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
70831|NCT00051636|270479|P2|Period 1 - Core|Lost to Follow-up|2
70832|NCT00051636|270480|P1|Period 1 - Core|Lost to Follow-up|0
70833|NCT00051636|270479|P2|Period 1 - Core|Withdrawal by Subject|2
70834|NCT00051636|270480|P1|Period 1 - Core|Withdrawal by Subject|1
70835|NCT00051636|270479|P2|Period 1 - Core|Protocol Violation|0
70836|NCT00051636|270480|P1|Period 1 - Core|Protocol Violation|1
70837|NCT00051636|270479|P2|Period 1 - Core|Adverse Event|2
70838|NCT00051636|270480|P1|Period 1 - Core|Adverse Event|2
70839|NCT00052715|270528|P1|Overall Study|wrong histology|1
70840|NCT00052962|270537|P2|Overall Study|Not randomized/not evaluable|0
70841|NCT00052962|270538|P1|Overall Study|Not randomized/not evaluable|1
70842|NCT00052962|270537|P2|Overall Study|Not evaluable|2
70843|NCT00052962|270538|P1|Overall Study|Not evaluable|0
70844|NCT00053365|270551|P1|Overall Study|Never treated|4
70845|NCT00053365|270551|P1|Overall Study|Platinum-sensitive interval >12 months|1
70846|NCT00053365|270551|P1|Overall Study|Incorrect cell type|1
70847|NCT00053417|270560|P4|Overall Study|Lost to Follow-up|0
70848|NCT00053417|270561|P3|Overall Study|Lost to Follow-up|0
70849|NCT00053417|270562|P2|Overall Study|Lost to Follow-up|1
70850|NCT00053417|270563|P1|Overall Study|Lost to Follow-up|1
70851|NCT00053417|270560|P4|Overall Study|Withdrawal by Subject|0
70852|NCT00053417|270561|P3|Overall Study|Withdrawal by Subject|0
70853|NCT00053417|270562|P2|Overall Study|Withdrawal by Subject|1
70854|NCT00053417|270563|P1|Overall Study|Withdrawal by Subject|0
70855|NCT00053417|270560|P4|Overall Study|Non-Compliance|1
70856|NCT00053417|270561|P3|Overall Study|Non-Compliance|0
70857|NCT00053417|270562|P2|Overall Study|Non-Compliance|0
70858|NCT00053417|270563|P1|Overall Study|Non-Compliance|0
70859|NCT00053417|270560|P4|Overall Study|Adverse Event|5
70860|NCT00053417|270561|P3|Overall Study|Adverse Event|1
70861|NCT00053417|270562|P2|Overall Study|Adverse Event|0
70862|NCT00053417|270563|P1|Overall Study|Adverse Event|1
70863|NCT00053846|270715|P2|Overall Study|Pills too large|1
70864|NCT00053846|270716|P1|Overall Study|Pills too large|0
70865|NCT00053846|270715|P2|Overall Study|Quit due to side effects|3
70866|NCT00053846|270716|P1|Overall Study|Quit due to side effects|1
70867|NCT00053846|270715|P2|Overall Study|Did not return data|2
70868|NCT00053846|270716|P1|Overall Study|Did not return data|1
70869|NCT00053846|270715|P2|Overall Study|Became ineligible|1
70870|NCT00053846|270716|P1|Overall Study|Became ineligible|3
70871|NCT00053846|270715|P2|Overall Study|Expired|0
70872|NCT00053846|270716|P1|Overall Study|Expired|5
70873|NCT00053846|270715|P2|Overall Study|Became too ill|7
70874|NCT00053846|270716|P1|Overall Study|Became too ill|8
70875|NCT00053846|270715|P2|Overall Study|Changed mind|13
70876|NCT00053846|270716|P1|Overall Study|Changed mind|8
70877|NCT00044512|270722|P1|Follow Up|Lost to Follow-up|2
70878|NCT00045032|270745|P3|Overall Study|Not Specified|105
70879|NCT00045032|270746|P2|Overall Study|Not Specified|84
70880|NCT00045032|270747|P1|Overall Study|Not Specified|93
70881|NCT00045032|270745|P3|Overall Study|Failure to Return|61
70882|NCT00045032|270746|P2|Overall Study|Failure to Return|62
70883|NCT00045032|270747|P1|Overall Study|Failure to Return|57
70884|NCT00045032|270745|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
70885|NCT00045032|270746|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
70886|NCT00045032|270747|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
70887|NCT00045032|270745|P3|Overall Study|Other Protocol Violation|1
70888|NCT00045032|270746|P2|Overall Study|Other Protocol Violation|0
70889|NCT00045032|270747|P1|Overall Study|Other Protocol Violation|2
70890|NCT00045032|270745|P3|Overall Study|Violation of Selection Criteria at Entry|6
70891|NCT00045032|270746|P2|Overall Study|Violation of Selection Criteria at Entry|6
70892|NCT00045032|270747|P1|Overall Study|Violation of Selection Criteria at Entry|3
70893|NCT00045032|270745|P3|Overall Study|Insufficient Therapeutic Response|445
70894|NCT00045032|270746|P2|Overall Study|Insufficient Therapeutic Response|437
70895|NCT00045032|270747|P1|Overall Study|Insufficient Therapeutic Response|542
70896|NCT00045032|270745|P3|Overall Study|Death|17
70897|NCT00045032|270746|P2|Overall Study|Death|24
70898|NCT00045032|270747|P1|Overall Study|Death|22
70899|NCT00045032|270745|P3|Overall Study|Adverse Event/Intercurrent Illness|7
70900|NCT00045032|270746|P2|Overall Study|Adverse Event/Intercurrent Illness|2
70901|NCT00045032|270747|P1|Overall Study|Adverse Event/Intercurrent Illness|2
70902|NCT00045110|270877|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
70903|NCT00045110|270878|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
70904|NCT00045110|270879|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
70905|NCT00045110|270877|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
70906|NCT00045110|270878|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
70907|NCT00045110|270879|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
70908|NCT00045110|270877|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
70909|NCT00045110|270878|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
70910|NCT00045110|270879|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
70911|NCT00045162|270927|P2|Overall Study|Not specified|16
70912|NCT00045162|270928|P1|Overall Study|Not specified|21
70913|NCT00045162|270927|P2|Overall Study|Withdrawal by Subject|3
70914|NCT00045162|270928|P1|Overall Study|Withdrawal by Subject|5
70915|NCT00045162|270927|P2|Overall Study|Death|10
70916|NCT00045162|270928|P1|Overall Study|Death|10
70917|NCT00045162|270927|P2|Overall Study|Lack of Efficacy|29
70918|NCT00045162|270928|P1|Overall Study|Lack of Efficacy|32
70919|NCT00045162|270927|P2|Overall Study|Adverse Event|50
70920|NCT00045162|270928|P1|Overall Study|Adverse Event|55
70921|NCT00045162|270927|P2|Overall Study|Not treated|2
70922|NCT00045162|270928|P1|Overall Study|Not treated|7
70923|NCT00045162|270927|P2|Overall Study|Ineligible|8
70924|NCT00045162|270928|P1|Overall Study|Ineligible|12
70925|NCT00045305|270940|P1|Overall Study|site error|2
70926|NCT00045305|270940|P1|Overall Study|Death|3
70927|NCT00045305|270940|P1|Overall Study|Adverse Event|3
70928|NCT00045305|270940|P1|Overall Study|Lack of Efficacy|6
70929|NCT00045630|270962|P1|Overall Study|Ineligible|2
70930|NCT00045630|270962|P1|Overall Study|Death|1
70931|NCT00045630|270962|P1|Overall Study|Progression/relapse|1
70932|NCT00045630|270962|P1|Overall Study|Refusal unrelated to adverse event|1
70933|NCT00045630|270962|P1|Overall Study|Adverse Event|1
70934|NCT00045708|270971|P3|Phase 1|early progressive disease|0
70935|NCT00045708|270972|P2|Phase 1|early progressive disease|1
70936|NCT00045708|270973|P1|Phase 1|early progressive disease|0
70937|NCT00045734|270996|P1|Overall Study|Protocol Violation|1
70938|NCT00045942|271017|P9|PKC412A2104E2|Death|0
70939|NCT00045942|271018|P8|PKC412A2104E2|Death|0
70940|NCT00045942|271019|P7|PKC412A2104E2|Death|2
70941|NCT00045942|271020|P6|PKC412A2104E2|Death|1
70942|NCT00045942|271021|P5|PKC412A2104E2|Death|0
70943|NCT00045942|271022|P4|PKC412A2104E2|Death|0
70944|NCT00045942|271023|P3|PKC412A2104E2|Death|0
70945|NCT00045942|271024|P2|PKC412A2104E2|Death|0
70946|NCT00045942|271025|P1|PKC412A2104E2|Death|0
70947|NCT00045942|271017|P9|PKC412A2104E2|Adverse Event|0
70948|NCT00045942|271018|P8|PKC412A2104E2|Adverse Event|1
70949|NCT00045942|271019|P7|PKC412A2104E2|Adverse Event|3
70950|NCT00045942|271020|P6|PKC412A2104E2|Adverse Event|4
70951|NCT00045942|271021|P5|PKC412A2104E2|Adverse Event|0
70952|NCT00045942|271022|P4|PKC412A2104E2|Adverse Event|0
70953|NCT00045942|271023|P3|PKC412A2104E2|Adverse Event|0
70954|NCT00045942|271024|P2|PKC412A2104E2|Adverse Event|0
70955|NCT00045942|271025|P1|PKC412A2104E2|Adverse Event|0
70956|NCT00045942|271017|P9|PKC412A2104E2|Lack of Efficacy|6
70957|NCT00045942|271018|P8|PKC412A2104E2|Lack of Efficacy|2
70958|NCT00045942|271019|P7|PKC412A2104E2|Lack of Efficacy|2
70959|NCT00045942|271020|P6|PKC412A2104E2|Lack of Efficacy|3
70960|NCT00045942|271021|P5|PKC412A2104E2|Lack of Efficacy|0
70961|NCT00045942|271022|P4|PKC412A2104E2|Lack of Efficacy|0
70962|NCT00045942|271023|P3|PKC412A2104E2|Lack of Efficacy|0
70963|NCT00045942|271024|P2|PKC412A2104E2|Lack of Efficacy|0
70964|NCT00045942|271025|P1|PKC412A2104E2|Lack of Efficacy|0
70965|NCT00045942|271017|P9|PKC412A2104E2|Withdrawal by Subject|0
70966|NCT00045942|271018|P8|PKC412A2104E2|Withdrawal by Subject|1
70967|NCT00045942|271019|P7|PKC412A2104E2|Withdrawal by Subject|0
70968|NCT00045942|271020|P6|PKC412A2104E2|Withdrawal by Subject|1
70969|NCT00045942|271021|P5|PKC412A2104E2|Withdrawal by Subject|0
70970|NCT00045942|271022|P4|PKC412A2104E2|Withdrawal by Subject|0
70971|NCT00045942|271023|P3|PKC412A2104E2|Withdrawal by Subject|0
70972|NCT00045942|271024|P2|PKC412A2104E2|Withdrawal by Subject|0
70973|NCT00045942|271025|P1|PKC412A2104E2|Withdrawal by Subject|0
70974|NCT00045942|271017|P9|PKC412A2104E2|Lost to Follow-up|0
70975|NCT00045942|271018|P8|PKC412A2104E2|Lost to Follow-up|3
70976|NCT00045942|271019|P7|PKC412A2104E2|Lost to Follow-up|0
70977|NCT00045942|271020|P6|PKC412A2104E2|Lost to Follow-up|0
70978|NCT00045942|271021|P5|PKC412A2104E2|Lost to Follow-up|0
70979|NCT00045942|271022|P4|PKC412A2104E2|Lost to Follow-up|0
70980|NCT00045942|271023|P3|PKC412A2104E2|Lost to Follow-up|0
70981|NCT00045942|271024|P2|PKC412A2104E2|Lost to Follow-up|0
70982|NCT00045942|271025|P1|PKC412A2104E2|Lost to Follow-up|0
70983|NCT00045942|271017|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70984|NCT00045942|271018|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70985|NCT00045942|271019|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70986|NCT00045942|271020|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70987|NCT00045942|271021|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70988|NCT00045942|271022|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
70989|NCT00045942|271023|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
70990|NCT00045942|271024|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70991|NCT00045942|271025|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
70992|NCT00045942|271017|P9|PKC412A2104E1|Death|0
70993|NCT00045942|271018|P8|PKC412A2104E1|Death|0
70994|NCT00045942|271019|P7|PKC412A2104E1|Death|0
70995|NCT00045942|271020|P6|PKC412A2104E1|Death|0
70996|NCT00045942|271021|P5|PKC412A2104E1|Death|1
70997|NCT00045942|271022|P4|PKC412A2104E1|Death|1
70998|NCT00045942|271023|P3|PKC412A2104E1|Death|1
70999|NCT00045942|271024|P2|PKC412A2104E1|Death|4
71000|NCT00045942|271025|P1|PKC412A2104E1|Death|0
71001|NCT00045942|271017|P9|PKC412A2104E1|Adverse Event|0
71002|NCT00045942|271018|P8|PKC412A2104E1|Adverse Event|0
71003|NCT00045942|271019|P7|PKC412A2104E1|Adverse Event|0
71004|NCT00045942|271020|P6|PKC412A2104E1|Adverse Event|0
71005|NCT00045942|271021|P5|PKC412A2104E1|Adverse Event|6
71006|NCT00045942|271022|P4|PKC412A2104E1|Adverse Event|3
71007|NCT00045942|271023|P3|PKC412A2104E1|Adverse Event|1
71008|NCT00045942|271024|P2|PKC412A2104E1|Adverse Event|1
71009|NCT00045942|271025|P1|PKC412A2104E1|Adverse Event|0
71010|NCT00045942|271017|P9|PKC412A2104E1|Abnormal laboratory value|0
71011|NCT00045942|271018|P8|PKC412A2104E1|Abnormal laboratory value|0
71012|NCT00045942|271019|P7|PKC412A2104E1|Abnormal laboratory value|0
71013|NCT00045942|271020|P6|PKC412A2104E1|Abnormal laboratory value|0
71014|NCT00045942|271021|P5|PKC412A2104E1|Abnormal laboratory value|0
71015|NCT00045942|271022|P4|PKC412A2104E1|Abnormal laboratory value|0
71016|NCT00045942|271023|P3|PKC412A2104E1|Abnormal laboratory value|0
71017|NCT00045942|271024|P2|PKC412A2104E1|Abnormal laboratory value|1
71018|NCT00045942|271025|P1|PKC412A2104E1|Abnormal laboratory value|0
71019|NCT00045942|271017|P9|PKC412A2104E1|Lack of Efficacy|0
71020|NCT00045942|271018|P8|PKC412A2104E1|Lack of Efficacy|0
71021|NCT00045942|271019|P7|PKC412A2104E1|Lack of Efficacy|0
71022|NCT00045942|271020|P6|PKC412A2104E1|Lack of Efficacy|0
71023|NCT00045942|271021|P5|PKC412A2104E1|Lack of Efficacy|17
71024|NCT00045942|271022|P4|PKC412A2104E1|Lack of Efficacy|23
71025|NCT00045942|271023|P3|PKC412A2104E1|Lack of Efficacy|11
71026|NCT00045942|271024|P2|PKC412A2104E1|Lack of Efficacy|11
71027|NCT00045942|271025|P1|PKC412A2104E1|Lack of Efficacy|0
71028|NCT00045942|271017|P9|PKC412A2104E1|Condition no longer requires study drug|0
71029|NCT00045942|271018|P8|PKC412A2104E1|Condition no longer requires study drug|0
71030|NCT00045942|271019|P7|PKC412A2104E1|Condition no longer requires study drug|0
71031|NCT00045942|271020|P6|PKC412A2104E1|Condition no longer requires study drug|0
71032|NCT00045942|271021|P5|PKC412A2104E1|Condition no longer requires study drug|1
71033|NCT00045942|271022|P4|PKC412A2104E1|Condition no longer requires study drug|0
71034|NCT00045942|271023|P3|PKC412A2104E1|Condition no longer requires study drug|1
71035|NCT00045942|271024|P2|PKC412A2104E1|Condition no longer requires study drug|1
71036|NCT00045942|271025|P1|PKC412A2104E1|Condition no longer requires study drug|0
71037|NCT00045942|271017|P9|PKC412A2104E1|Withdrawal by Subject|0
71038|NCT00045942|271018|P8|PKC412A2104E1|Withdrawal by Subject|0
71039|NCT00045942|271019|P7|PKC412A2104E1|Withdrawal by Subject|0
71040|NCT00045942|271020|P6|PKC412A2104E1|Withdrawal by Subject|0
71041|NCT00045942|271021|P5|PKC412A2104E1|Withdrawal by Subject|2
71042|NCT00045942|271022|P4|PKC412A2104E1|Withdrawal by Subject|5
71043|NCT00045942|271023|P3|PKC412A2104E1|Withdrawal by Subject|2
71044|NCT00045942|271024|P2|PKC412A2104E1|Withdrawal by Subject|0
71045|NCT00045942|271025|P1|PKC412A2104E1|Withdrawal by Subject|0
71046|NCT00045942|271017|P9|PKC412A2104 (Core)|Death|0
71047|NCT00045942|271018|P8|PKC412A2104 (Core)|Death|0
71048|NCT00045942|271019|P7|PKC412A2104 (Core)|Death|0
71049|NCT00045942|271020|P6|PKC412A2104 (Core)|Death|0
71050|NCT00045942|271021|P5|PKC412A2104 (Core)|Death|0
71051|NCT00045942|271022|P4|PKC412A2104 (Core)|Death|0
71052|NCT00045942|271023|P3|PKC412A2104 (Core)|Death|0
71053|NCT00045942|271024|P2|PKC412A2104 (Core)|Death|0
71054|NCT00045942|271025|P1|PKC412A2104 (Core)|Death|1
71055|NCT00045942|271017|P9|PKC412A2104 (Core)|Lack of Efficacy|0
71056|NCT00045942|271018|P8|PKC412A2104 (Core)|Lack of Efficacy|0
71057|NCT00045942|271019|P7|PKC412A2104 (Core)|Lack of Efficacy|0
71058|NCT00045942|271020|P6|PKC412A2104 (Core)|Lack of Efficacy|0
71059|NCT00045942|271021|P5|PKC412A2104 (Core)|Lack of Efficacy|0
71060|NCT00045942|271022|P4|PKC412A2104 (Core)|Lack of Efficacy|0
71061|NCT00045942|271023|P3|PKC412A2104 (Core)|Lack of Efficacy|0
71062|NCT00045942|271024|P2|PKC412A2104 (Core)|Lack of Efficacy|0
71063|NCT00045942|271025|P1|PKC412A2104 (Core)|Lack of Efficacy|13
71064|NCT00045942|271017|P9|PKC412A2104 (Core)|Adverse Event|0
71065|NCT00045942|271018|P8|PKC412A2104 (Core)|Adverse Event|0
71066|NCT00045942|271019|P7|PKC412A2104 (Core)|Adverse Event|0
71067|NCT00045942|271020|P6|PKC412A2104 (Core)|Adverse Event|0
71068|NCT00045942|271021|P5|PKC412A2104 (Core)|Adverse Event|0
71069|NCT00045942|271022|P4|PKC412A2104 (Core)|Adverse Event|0
71070|NCT00045942|271023|P3|PKC412A2104 (Core)|Adverse Event|0
71071|NCT00045942|271024|P2|PKC412A2104 (Core)|Adverse Event|0
71072|NCT00045942|271025|P1|PKC412A2104 (Core)|Adverse Event|5
71073|NCT00045942|271017|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
71074|NCT00045942|271018|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
71075|NCT00045942|271019|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
71076|NCT00045942|271020|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
71077|NCT00045942|271021|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
71078|NCT00045942|271022|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
71079|NCT00045942|271023|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
71080|NCT00045942|271024|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
71081|NCT00045942|271025|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
71082|NCT00054132|271153|P1|Overall Study|Not Treated|1
71083|NCT00056160|271164|P2|Final Follow-up|Adverse Event|0
71084|NCT00056160|271165|P1|Final Follow-up|Adverse Event|1
71085|NCT00056160|271164|P2|Final Follow-up|Transferred into RevAssist Program|0
71086|NCT00056160|271165|P1|Final Follow-up|Transferred into RevAssist Program|2
71087|NCT00056160|271164|P2|Final Follow-up|Transferred into expanded access study.|0
71088|NCT00056160|271165|P1|Final Follow-up|Transferred into expanded access study.|3
71089|NCT00056160|271164|P2|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|0
71090|NCT00056160|271165|P1|Extended Follow-up Cutoff (23 Jul 2008)|Not specified|21
71091|NCT00056160|271164|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
71092|NCT00056160|271165|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
71093|NCT00056160|271164|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
71094|NCT00056160|271165|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
71095|NCT00056160|271164|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
71096|NCT00056160|271165|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
71097|NCT00056160|271164|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
71098|NCT00056160|271165|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
71099|NCT00056160|271164|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
71100|NCT00056160|271165|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
71101|NCT00056160|271164|P2|Up to Unblinding (07 Jun 2005)|Not specified|7
71102|NCT00056160|271165|P1|Up to Unblinding (07 Jun 2005)|Not specified|8
71103|NCT00056160|271164|P2|Up to Unblinding (07 Jun 2005)|Death|1
71104|NCT00056160|271165|P1|Up to Unblinding (07 Jun 2005)|Death|2
71105|NCT00056160|271164|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
71106|NCT00056160|271165|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
71107|NCT00056160|271164|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
71108|NCT00056160|271165|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
71109|NCT00056160|271164|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
71110|NCT00056160|271165|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
71111|NCT00056160|271164|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
71112|NCT00056160|271165|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
71113|NCT00056316|271179|P2|Overall Study|Death/NH placement of pt|1
71114|NCT00056316|271180|P1|Overall Study|Death/NH placement of pt|1
71115|NCT00056316|271179|P2|Overall Study|Withdrawal by Subject|2
71116|NCT00056316|271180|P1|Overall Study|Withdrawal by Subject|2
71117|NCT00056407|271194|P2|Overall Study|Missing|34
71118|NCT00056407|271195|P1|Overall Study|Missing|25
71119|NCT00056407|271194|P2|Overall Study|"Listed as Other on Case Report Form"|60
71120|NCT00056407|271195|P1|Overall Study|"Listed as Other on Case Report Form"|98
71121|NCT00056407|271194|P2|Overall Study|Diagnosed with Prostate Cancer|166
71122|NCT00056407|271195|P1|Overall Study|Diagnosed with Prostate Cancer|202
71123|NCT00056407|271194|P2|Overall Study|Protocol Violation|95
71124|NCT00056407|271195|P1|Overall Study|Protocol Violation|104
71125|NCT00056407|271194|P2|Overall Study|Lost to Follow-up|113
71126|NCT00056407|271195|P1|Overall Study|Lost to Follow-up|123
71127|NCT00056407|271194|P2|Overall Study|Withdrawal by Subject|361
71128|NCT00056407|271195|P1|Overall Study|Withdrawal by Subject|377
71129|NCT00056407|271194|P2|Overall Study|Adverse Event|364
71130|NCT00056407|271195|P1|Overall Study|Adverse Event|282
71131|NCT00056862|271291|P2|Overall Study|Protocol Violation|0
71132|NCT00056862|271292|P1|Overall Study|Protocol Violation|1
71133|NCT00057330|271308|P2|Overall Study|Unspecified|206
71134|NCT00057330|271309|P1|Overall Study|Unspecified|260
71135|NCT00057330|271308|P2|Overall Study|Physician Decision|0
71136|NCT00057330|271309|P1|Overall Study|Physician Decision|1
71137|NCT00057330|271308|P2|Overall Study|Lost to Follow-up|617
71138|NCT00057330|271309|P1|Overall Study|Lost to Follow-up|745
71139|NCT00057330|271308|P2|Overall Study|Withdrawal by Subject|84
71140|NCT00057330|271309|P1|Overall Study|Withdrawal by Subject|115
71141|NCT00057330|271308|P2|Overall Study|Protocol Violation|1
71142|NCT00057330|271309|P1|Overall Study|Protocol Violation|1
71143|NCT00057330|271308|P2|Overall Study|Death|0
71144|NCT00057330|271309|P1|Overall Study|Death|1
71145|NCT00057330|271308|P2|Overall Study|Adverse Event|12
71146|NCT00057330|271309|P1|Overall Study|Adverse Event|9
71147|NCT00057746|271389|P3|Overall Study|Withdrawal by Subject|1
71148|NCT00057746|271390|P2|Overall Study|Withdrawal by Subject|0
71149|NCT00057746|271391|P1|Overall Study|Withdrawal by Subject|0
71150|NCT00057811|271405|P2|Overall Study|Inevaluable|2
71151|NCT00057811|271406|P1|Overall Study|Inevaluable|1
71152|NCT00057811|271405|P2|Overall Study|Ineligible|2
71153|NCT00057811|271406|P1|Overall Study|Ineligible|4
71154|NCT00057811|271405|P2|Overall Study|Withdrawal by Subject|4
71155|NCT00057811|271406|P1|Overall Study|Withdrawal by Subject|3
71156|NCT00057811|271405|P2|Overall Study|Physician Decision|0
71157|NCT00057811|271406|P1|Overall Study|Physician Decision|1
71158|NCT00057811|271405|P2|Overall Study|Lack of Efficacy|4
71159|NCT00057811|271406|P1|Overall Study|Lack of Efficacy|1
71160|NCT00057837|271420|P2|Overall Study|Never started treatment|1
71161|NCT00057837|271421|P1|Overall Study|Never started treatment|1
71162|NCT00057837|271420|P2|Overall Study|Ineligible|3
71163|NCT00057837|271421|P1|Overall Study|Ineligible|3
71164|NCT00057837|271420|P2|Overall Study|Physician Decision|0
71165|NCT00057837|271421|P1|Overall Study|Physician Decision|1
71166|NCT00057837|271420|P2|Overall Study|Other complicating disease|1
71167|NCT00057837|271421|P1|Overall Study|Other complicating disease|2
71168|NCT00057837|271420|P2|Overall Study|Alternative therapy|1
71169|NCT00057837|271421|P1|Overall Study|Alternative therapy|0
71170|NCT00057837|271420|P2|Overall Study|Withdrawal by Subject|3
71171|NCT00057837|271421|P1|Overall Study|Withdrawal by Subject|5
71172|NCT00057837|271420|P2|Overall Study|Death|4
71173|NCT00057837|271421|P1|Overall Study|Death|5
71174|NCT00057837|271420|P2|Overall Study|Adverse Event|12
71175|NCT00057837|271421|P1|Overall Study|Adverse Event|2
71176|NCT00057837|271420|P2|Overall Study|Progression/relapse|14
71177|NCT00057837|271421|P1|Overall Study|Progression/relapse|12
71178|NCT00057863|271431|P1|Overall Study|Withdrawal by Subject|2
71179|NCT00057863|271431|P1|Overall Study|Death|1
71180|NCT00057876|271440|P2|Overall Study|other complicating disease|0
71181|NCT00057876|271441|P1|Overall Study|other complicating disease|1
71182|NCT00057876|271440|P2|Overall Study|other reason|2
71183|NCT00057876|271441|P1|Overall Study|other reason|2
71184|NCT00057876|271440|P2|Overall Study|Ineligible|2
71185|NCT00057876|271441|P1|Overall Study|Ineligible|1
71186|NCT00057876|271440|P2|Overall Study|Lack of Efficacy|8
71187|NCT00057876|271441|P1|Overall Study|Lack of Efficacy|10
71188|NCT00057876|271440|P2|Overall Study|Withdrawal by Subject|6
71189|NCT00057876|271441|P1|Overall Study|Withdrawal by Subject|5
71190|NCT00057876|271440|P2|Overall Study|Death|1
71191|NCT00057876|271441|P1|Overall Study|Death|2
71192|NCT00057876|271440|P2|Overall Study|Adverse Event|8
71193|NCT00057876|271441|P1|Overall Study|Adverse Event|8
71194|NCT00057941|271453|P2|Overall Study|Ineligible|5
71195|NCT00057941|271454|P1|Overall Study|Ineligible|2
71196|NCT00057941|271453|P2|Overall Study|insurance, symptomatic deterioration|3
71197|NCT00057941|271454|P1|Overall Study|insurance, symptomatic deterioration|1
71198|NCT00057941|271453|P2|Overall Study|still on treatment|1
71199|NCT00057941|271454|P1|Overall Study|still on treatment|3
71200|NCT00057941|271453|P2|Overall Study|Withdrawal by Subject|1
71201|NCT00057941|271454|P1|Overall Study|Withdrawal by Subject|6
71202|NCT00057941|271453|P2|Overall Study|Lack of Efficacy|53
71203|NCT00057941|271454|P1|Overall Study|Lack of Efficacy|54
71204|NCT00057941|271453|P2|Overall Study|Adverse Event|9
71205|NCT00057941|271454|P1|Overall Study|Adverse Event|7
71206|NCT00057941|271453|P2|Overall Study|Death|2
71207|NCT00057941|271454|P1|Overall Study|Death|1
71208|NCT00057954|271460|P1|Overall Study|Disease progression|1
71209|NCT00057954|271460|P1|Overall Study|Death|1
71210|NCT00058214|271482|P1|Overall Study|Adverse Event|1
71211|NCT00058539|271504|P1|Overall Study|Death|1
71212|NCT00058539|271504|P1|Overall Study|Physician Decision|9
71213|NCT00058539|271504|P1|Overall Study|Withdrawal by Subject|5
71214|NCT00058539|271504|P1|Overall Study|Adverse Event|3
71215|NCT00058539|271504|P1|Overall Study|Disease progression|24
71216|NCT00058552|271516|P2|Overall Study|Clinical disease progression|4
71217|NCT00058552|271517|P1|Overall Study|Clinical disease progression|0
71218|NCT00058552|271516|P2|Overall Study|Physician Decision|5
71219|NCT00058552|271517|P1|Overall Study|Physician Decision|2
71220|NCT00058552|271516|P2|Overall Study|Withdrawal by Subject|5
71221|NCT00058552|271517|P1|Overall Study|Withdrawal by Subject|3
71222|NCT00058552|271516|P2|Overall Study|Adverse Event|2
71223|NCT00058552|271517|P1|Overall Study|Adverse Event|4
71224|NCT00058552|271516|P2|Overall Study|Disease progression|44
71225|NCT00058552|271517|P1|Overall Study|Disease progression|52
71226|NCT00058552|271516|P2|Overall Study|Died prior to receiving treatment|2
71227|NCT00058552|271517|P1|Overall Study|Died prior to receiving treatment|4
71228|NCT00049322|271537|P2|Overall Study|refused angio|3
71229|NCT00049322|271538|P1|Overall Study|refused angio|0
71230|NCT00049322|271537|P2|Overall Study|Adverse Event|0
71231|NCT00049322|271538|P1|Overall Study|Adverse Event|1
71232|NCT00049322|271537|P2|Overall Study|disease burden|3
71233|NCT00049322|271538|P1|Overall Study|disease burden|0
71234|NCT00049517|271558|P6|Conditioning/Transplant|Reasons not reported|5
71235|NCT00049517|271559|P5|Conditioning/Transplant|Reasons not reported|5
71236|NCT00049517|271560|P4|Conditioning/Transplant|Reasons not reported|15
71237|NCT00049517|271561|P3|Conditioning/Transplant|Reasons not reported|18
71238|NCT00049517|271562|P2|Conditioning/Transplant|Reasons not reported|31
71239|NCT00049517|271563|P1|Conditioning/Transplant|Reasons not reported|25
71240|NCT00049517|271558|P6|Conditioning/Transplant|Other complicating disease|1
71241|NCT00049517|271559|P5|Conditioning/Transplant|Other complicating disease|0
71242|NCT00049517|271560|P4|Conditioning/Transplant|Other complicating disease|4
71243|NCT00049517|271561|P3|Conditioning/Transplant|Other complicating disease|0
71244|NCT00049517|271562|P2|Conditioning/Transplant|Other complicating disease|0
71245|NCT00049517|271563|P1|Conditioning/Transplant|Other complicating disease|2
71246|NCT00049517|271558|P6|Conditioning/Transplant|Alternative therapy|0
71247|NCT00049517|271559|P5|Conditioning/Transplant|Alternative therapy|1
71248|NCT00049517|271560|P4|Conditioning/Transplant|Alternative therapy|1
71249|NCT00049517|271561|P3|Conditioning/Transplant|Alternative therapy|2
71250|NCT00049517|271562|P2|Conditioning/Transplant|Alternative therapy|4
71251|NCT00049517|271563|P1|Conditioning/Transplant|Alternative therapy|4
71252|NCT00049517|271558|P6|Conditioning/Transplant|Withdrawal by Subject|0
71253|NCT00049517|271559|P5|Conditioning/Transplant|Withdrawal by Subject|0
71254|NCT00049517|271560|P4|Conditioning/Transplant|Withdrawal by Subject|7
71255|NCT00049517|271561|P3|Conditioning/Transplant|Withdrawal by Subject|4
71256|NCT00049517|271562|P2|Conditioning/Transplant|Withdrawal by Subject|8
71257|NCT00049517|271563|P1|Conditioning/Transplant|Withdrawal by Subject|4
71258|NCT00049517|271558|P6|Conditioning/Transplant|Death|0
71259|NCT00049517|271559|P5|Conditioning/Transplant|Death|0
71260|NCT00049517|271560|P4|Conditioning/Transplant|Death|2
71261|NCT00049517|271561|P3|Conditioning/Transplant|Death|0
71262|NCT00049517|271562|P2|Conditioning/Transplant|Death|0
71263|NCT00049517|271563|P1|Conditioning/Transplant|Death|1
71264|NCT00049517|271558|P6|Conditioning/Transplant|Adverse Event|0
71265|NCT00049517|271559|P5|Conditioning/Transplant|Adverse Event|0
71266|NCT00049517|271560|P4|Conditioning/Transplant|Adverse Event|8
71267|NCT00049517|271561|P3|Conditioning/Transplant|Adverse Event|4
71268|NCT00049517|271562|P2|Conditioning/Transplant|Adverse Event|1
71269|NCT00049517|271563|P1|Conditioning/Transplant|Adverse Event|2
71270|NCT00049517|271558|P6|Conditioning/Transplant|Disease progression|0
71271|NCT00049517|271559|P5|Conditioning/Transplant|Disease progression|0
71272|NCT00049517|271560|P4|Conditioning/Transplant|Disease progression|6
71273|NCT00049517|271561|P3|Conditioning/Transplant|Disease progression|10
71274|NCT00049517|271562|P2|Conditioning/Transplant|Disease progression|6
71275|NCT00049517|271563|P1|Conditioning/Transplant|Disease progression|14
71276|NCT00049517|271558|P6|Induction|Reasons not reported|25
71277|NCT00049517|271559|P5|Induction|Reasons not reported|22
71278|NCT00049517|271560|P4|Induction|Reasons not reported|0
71279|NCT00049517|271561|P3|Induction|Reasons not reported|0
71280|NCT00049517|271562|P2|Induction|Reasons not reported|0
71281|NCT00049517|271563|P1|Induction|Reasons not reported|0
71282|NCT00049517|271558|P6|Induction|Other complicating disease|0
71283|NCT00049517|271559|P5|Induction|Other complicating disease|3
71284|NCT00049517|271560|P4|Induction|Other complicating disease|0
71285|NCT00049517|271561|P3|Induction|Other complicating disease|0
71286|NCT00049517|271562|P2|Induction|Other complicating disease|0
71287|NCT00049517|271563|P1|Induction|Other complicating disease|0
71288|NCT00049517|271558|P6|Induction|Alternative therapy|2
71289|NCT00049517|271559|P5|Induction|Alternative therapy|2
71290|NCT00049517|271560|P4|Induction|Alternative therapy|0
71291|NCT00049517|271561|P3|Induction|Alternative therapy|0
71292|NCT00049517|271562|P2|Induction|Alternative therapy|0
71293|NCT00049517|271563|P1|Induction|Alternative therapy|0
71294|NCT00049517|271558|P6|Induction|Withdrawal by Subject|3
71295|NCT00049517|271559|P5|Induction|Withdrawal by Subject|1
71296|NCT00049517|271560|P4|Induction|Withdrawal by Subject|0
71297|NCT00049517|271561|P3|Induction|Withdrawal by Subject|0
71298|NCT00049517|271562|P2|Induction|Withdrawal by Subject|0
71299|NCT00049517|271563|P1|Induction|Withdrawal by Subject|0
71300|NCT00049517|271558|P6|Induction|Death|6
71301|NCT00049517|271559|P5|Induction|Death|9
71302|NCT00049517|271560|P4|Induction|Death|0
71303|NCT00049517|271561|P3|Induction|Death|0
71304|NCT00049517|271562|P2|Induction|Death|0
71305|NCT00049517|271563|P1|Induction|Death|0
71306|NCT00049517|271558|P6|Induction|Adverse Event|7
71307|NCT00049517|271559|P5|Induction|Adverse Event|5
71308|NCT00049517|271560|P4|Induction|Adverse Event|0
71309|NCT00049517|271561|P3|Induction|Adverse Event|0
71310|NCT00049517|271562|P2|Induction|Adverse Event|0
71311|NCT00049517|271563|P1|Induction|Adverse Event|0
71312|NCT00049517|271558|P6|Induction|Disease progression|11
71313|NCT00049517|271559|P5|Induction|Disease progression|18
71314|NCT00049517|271560|P4|Induction|Disease progression|0
71315|NCT00049517|271561|P3|Induction|Disease progression|0
71316|NCT00049517|271562|P2|Induction|Disease progression|0
71317|NCT00049517|271563|P1|Induction|Disease progression|0
71318|NCT00049530|271573|P1|Overall Study|ineligible|3
71319|NCT00049530|271573|P1|Overall Study|symptomatic deterioration|1
71320|NCT00049530|271573|P1|Overall Study|Death|1
71321|NCT00049530|271573|P1|Overall Study|Adverse Event|2
71322|NCT00049530|271573|P1|Overall Study|Lack of Efficacy|25
71323|NCT00049543|271582|P2|Overall Study|still on treatment|9
71324|NCT00049543|271583|P1|Overall Study|still on treatment|2
71325|NCT00049842|271595|P2|Follow-up Phase|Not specified|4
71326|NCT00049842|271596|P1|Follow-up Phase|Not specified|1
71327|NCT00049842|271595|P2|Follow-up Phase|Adverse Event|1
71328|NCT00049842|271596|P1|Follow-up Phase|Adverse Event|6
71329|NCT00049842|271595|P2|Treatment Phase|Did not meet protocol eligibility|1
71330|NCT00049842|271596|P1|Treatment Phase|Did not meet protocol eligibility|0
71331|NCT00049842|271595|P2|Treatment Phase|Administrative|3
71332|NCT00049842|271596|P1|Treatment Phase|Administrative|0
71333|NCT00049842|271595|P2|Treatment Phase|Lost to Follow-up|8
71334|NCT00049842|271596|P1|Treatment Phase|Lost to Follow-up|4
71335|NCT00049842|271595|P2|Treatment Phase|Non-compliance with protocol|8
71336|NCT00049842|271596|P1|Treatment Phase|Non-compliance with protocol|7
71337|NCT00049842|271595|P2|Treatment Phase|Withdrawal by Subject|46
71338|NCT00049842|271596|P1|Treatment Phase|Withdrawal by Subject|35
71339|NCT00049842|271595|P2|Treatment Phase|Adverse Event|12
71340|NCT00049842|271596|P1|Treatment Phase|Adverse Event|47
71341|NCT00050011|271614|P2|Overall Study|Unknown - Reason is missing|2
71342|NCT00050011|271615|P1|Overall Study|Unknown - Reason is missing|0
71343|NCT00050011|271614|P2|Overall Study|Death|4
71344|NCT00050011|271615|P1|Overall Study|Death|7
71345|NCT00050011|271614|P2|Overall Study|Administrative problems|6
71346|NCT00050011|271615|P1|Overall Study|Administrative problems|10
71347|NCT00050011|271614|P2|Overall Study|Lost to Follow-up|9
71348|NCT00050011|271615|P1|Overall Study|Lost to Follow-up|7
71349|NCT00050011|271614|P2|Overall Study|Withdrawal by Subject|26
71350|NCT00050011|271615|P1|Overall Study|Withdrawal by Subject|34
71351|NCT00050011|271614|P2|Overall Study|Protocol Violation|10
71352|NCT00050011|271615|P1|Overall Study|Protocol Violation|4
71353|NCT00050011|271614|P2|Overall Study|Participant condition no longer required|0
71354|NCT00050011|271615|P1|Overall Study|Participant condition no longer required|1
71355|NCT00050011|271614|P2|Overall Study|Lack of Efficacy|21
71356|NCT00050011|271615|P1|Overall Study|Lack of Efficacy|16
71357|NCT00050011|271614|P2|Overall Study|Abnormal test procedure results|1
71358|NCT00050011|271615|P1|Overall Study|Abnormal test procedure results|0
71359|NCT00050011|271614|P2|Overall Study|Abnormal laboratory value(s)|1
71360|NCT00050011|271615|P1|Overall Study|Abnormal laboratory value(s)|1
71361|NCT00050011|271614|P2|Overall Study|Adverse Event|46
71362|NCT00050011|271615|P1|Overall Study|Adverse Event|41
71363|NCT00050167|271662|P2|Overall Study|not eligible not invasive|1
71364|NCT00050167|271663|P1|Overall Study|not eligible not invasive|1
71365|NCT00050622|271669|P1|Overall Study|Adverse Event|1
71366|NCT00050778|271708|P3|Overall Study|Familial and personal reasons|0
71367|NCT00050778|271709|P2|Overall Study|Familial and personal reasons|0
71368|NCT00050778|271710|P1|Overall Study|Familial and personal reasons|1
71369|NCT00050778|271708|P3|Overall Study|Randomized but not treated|2
71370|NCT00050778|271709|P2|Overall Study|Randomized but not treated|5
71371|NCT00050778|271710|P1|Overall Study|Randomized but not treated|4
71372|NCT00050778|271708|P3|Overall Study|Withdrawal by Subject|4
71373|NCT00050778|271709|P2|Overall Study|Withdrawal by Subject|8
71374|NCT00050778|271710|P1|Overall Study|Withdrawal by Subject|6
71375|NCT00050778|271708|P3|Overall Study|Protocol Violation|1
71376|NCT00050778|271709|P2|Overall Study|Protocol Violation|0
71377|NCT00050778|271710|P1|Overall Study|Protocol Violation|2
71378|NCT00050778|271708|P3|Overall Study|Physician Decision|2
71379|NCT00050778|271709|P2|Overall Study|Physician Decision|0
71380|NCT00050778|271710|P1|Overall Study|Physician Decision|3
71381|NCT00050778|271708|P3|Overall Study|Lost to Follow-up|4
71382|NCT00050778|271709|P2|Overall Study|Lost to Follow-up|2
71383|NCT00050778|271710|P1|Overall Study|Lost to Follow-up|0
71384|NCT00050778|271708|P3|Overall Study|Lack of Efficacy|2
71385|NCT00050778|271709|P2|Overall Study|Lack of Efficacy|2
71386|NCT00050778|271710|P1|Overall Study|Lack of Efficacy|16
71387|NCT00050778|271708|P3|Overall Study|Death|1
71388|NCT00050778|271709|P2|Overall Study|Death|1
71389|NCT00050778|271710|P1|Overall Study|Death|0
71390|NCT00050778|271708|P3|Overall Study|Adverse Event|2
71391|NCT00050778|271709|P2|Overall Study|Adverse Event|3
71392|NCT00050778|271710|P1|Overall Study|Adverse Event|13
71393|NCT00050960|271738|P2|Overall Study|Death|15
71394|NCT00050960|271739|P1|Overall Study|Death|13
71395|NCT00050960|271738|P2|Overall Study|Non-compliance|1
71396|NCT00050960|271739|P1|Overall Study|Non-compliance|3
71397|NCT00050960|271738|P2|Overall Study|Administrative|46
71398|NCT00050960|271739|P1|Overall Study|Administrative|31
71399|NCT00050960|271738|P2|Overall Study|Withdrawal by Subject|18
71400|NCT00050960|271739|P1|Overall Study|Withdrawal by Subject|23
71401|NCT00050960|271738|P2|Overall Study|Lost to Follow-up|1
71402|NCT00050960|271739|P1|Overall Study|Lost to Follow-up|0
71403|NCT00050960|271738|P2|Overall Study|Adverse Event|61
71404|NCT00050960|271739|P1|Overall Study|Adverse Event|62
71405|NCT00050960|271738|P2|Overall Study|Complete Response|2
71406|NCT00050960|271739|P1|Overall Study|Complete Response|0
71407|NCT00050960|271738|P2|Overall Study|Partial Response|19
71408|NCT00050960|271739|P1|Overall Study|Partial Response|14
71409|NCT00050960|271738|P2|Overall Study|Stable Disease|48
71410|NCT00050960|271739|P1|Overall Study|Stable Disease|19
71411|NCT00050960|271738|P2|Overall Study|Progressive Disease|93
71412|NCT00050960|271739|P1|Overall Study|Progressive Disease|137
71413|NCT00058825|271749|P1|Overall Study|Death|3
71414|NCT00058825|271749|P1|Overall Study|Graft Failure|5
71415|NCT00058825|271749|P1|Overall Study|Progressive Disease|5
71416|NCT00058825|271749|P1|Overall Study|Relapse|9
71417|NCT00060840|271797|P2|Overall Study|Other|0
71418|NCT00060840|271798|P1|Overall Study|Other|1
71419|NCT00060840|271797|P2|Overall Study|Physician Decision|0
71420|NCT00060840|271798|P1|Overall Study|Physician Decision|1
71421|NCT00060840|271797|P2|Overall Study|Subinvestigator unavailable|1
71422|NCT00060840|271798|P1|Overall Study|Subinvestigator unavailable|0
71423|NCT00060840|271797|P2|Overall Study|Withdrawal by Subject|1
71424|NCT00060840|271798|P1|Overall Study|Withdrawal by Subject|0
71425|NCT00060840|271797|P2|Overall Study|Death|1
71426|NCT00060840|271798|P1|Overall Study|Death|0
71427|NCT00060840|271797|P2|Overall Study|Change in surgical plan|6
71428|NCT00060840|271798|P1|Overall Study|Change in surgical plan|2
71429|NCT00060944|271806|P2|Overall Study|randomized but not treated|4
71430|NCT00060944|271807|P1|Overall Study|randomized but not treated|6
71431|NCT00060944|271806|P2|Overall Study|Not specified|4
71432|NCT00060944|271807|P1|Overall Study|Not specified|2
71433|NCT00060944|271806|P2|Overall Study|Treatment Switch|13
71434|NCT00060944|271807|P1|Overall Study|Treatment Switch|0
71435|NCT00060944|271806|P2|Overall Study|Subject Ineligible To Continue|1
71436|NCT00060944|271807|P1|Overall Study|Subject Ineligible To Continue|2
71437|NCT00060944|271806|P2|Overall Study|Lost to Follow-up|0
71438|NCT00060944|271807|P1|Overall Study|Lost to Follow-up|1
71439|NCT00060944|271806|P2|Overall Study|Disease Progression|94
71440|NCT00060944|271807|P1|Overall Study|Disease Progression|93
71441|NCT00060944|271806|P2|Overall Study|Withdrawal by Subject|5
71442|NCT00060944|271807|P1|Overall Study|Withdrawal by Subject|18
71443|NCT00060944|271806|P2|Overall Study|Death|3
71444|NCT00060944|271807|P1|Overall Study|Death|2
71445|NCT00060944|271806|P2|Overall Study|Adverse Event|10
71446|NCT00060944|271807|P1|Overall Study|Adverse Event|12
71447|NCT00061048|271821|P1|Overall Study|disease progression|20
71448|NCT00061048|271821|P1|Overall Study|Adverse Event|2
71449|NCT00061633|271850|P2|Overall Study|Never received study treatment|2
71450|NCT00061633|271851|P1|Overall Study|Never received study treatment|0
71451|NCT00061633|271850|P2|Overall Study|Other|1
71452|NCT00061633|271851|P1|Overall Study|Other|1
71453|NCT00061633|271850|P2|Overall Study|Lost to Follow-up|4
71454|NCT00061633|271851|P1|Overall Study|Lost to Follow-up|1
71455|NCT00061633|271850|P2|Overall Study|Withdrawal by Subject|2
71456|NCT00061633|271851|P1|Overall Study|Withdrawal by Subject|2
71457|NCT00061633|271850|P2|Overall Study|Adverse Event|2
71458|NCT00061633|271851|P1|Overall Study|Adverse Event|1
71459|NCT00061932|271864|P2|Overall Study|Withdrawal by Subject|4
71460|NCT00061932|271865|P1|Overall Study|Withdrawal by Subject|13
71461|NCT00061945|271873|P2|Course IV: Alemtuzumab|Early exits|15
71462|NCT00061945|271874|P1|Course IV: Alemtuzumab|Early exits|6
71463|NCT00061945|271873|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
71464|NCT00061945|271874|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
71465|NCT00061945|271873|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
71466|NCT00061945|271874|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
71467|NCT00061945|271873|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
71468|NCT00061945|271874|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
71469|NCT00062010|271882|P1|Overall Study|Ineligible|3
71470|NCT00062374|271888|P1|Overall Study|Not treated|12
71471|NCT00062439|271893|P1|Consolidation Chemotherapy|Adverse Event|2
71472|NCT00062439|271893|P1|Surgery|Adverse Event|2
71473|NCT00062439|271893|P1|Surgery|Death|1
71474|NCT00062439|271893|P1|Surgery|Physician Decision|4
71475|NCT00062439|271893|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
71476|NCT00062439|271893|P1|Post Chemoradiation Assessment|Physician Decision|1
71477|NCT00062439|271893|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
71478|NCT00062439|271893|P1|Post Chemoradiation Assessment|Disease progression|2
71479|NCT00062439|271893|P1|Post Chemoradiation Assessment|Death|1
71480|NCT00062439|271893|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
71481|NCT00062439|271893|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
71482|NCT00062439|271893|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
71483|NCT00062439|271893|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
71484|NCT00062647|271907|P2|Overall Study|Never received study treatment|1
71485|NCT00062647|271908|P1|Overall Study|Never received study treatment|1
71486|NCT00062647|271907|P2|Overall Study|Other|4
71487|NCT00062647|271908|P1|Overall Study|Other|4
71488|NCT00062647|271907|P2|Overall Study|Failed continuation criteria|2
71489|NCT00062647|271908|P1|Overall Study|Failed continuation criteria|4
71490|NCT00062647|271907|P2|Overall Study|Lost to Follow-up|2
71491|NCT00062647|271908|P1|Overall Study|Lost to Follow-up|1
71492|NCT00062647|271907|P2|Overall Study|Protocol Violation|0
71493|NCT00062647|271908|P1|Overall Study|Protocol Violation|1
71494|NCT00062647|271907|P2|Overall Study|Withdrawal by Subject|1
71495|NCT00062647|271908|P1|Overall Study|Withdrawal by Subject|2
71496|NCT00062647|271907|P2|Overall Study|Adverse Event|1
71497|NCT00062647|271908|P1|Overall Study|Adverse Event|1
71498|NCT00062647|271907|P2|Overall Study|Death|2
71499|NCT00062647|271908|P1|Overall Study|Death|2
71500|NCT00062751|271935|P5|Overall Study|Death|0
71501|NCT00062751|271936|P4|Overall Study|Death|0
71502|NCT00062751|271937|P3|Overall Study|Death|1
71503|NCT00062751|271938|P2|Overall Study|Death|0
71504|NCT00062751|271939|P1|Overall Study|Death|1
71505|NCT00062751|271935|P5|Overall Study|Symptomatic deterioration|1
71506|NCT00062751|271936|P4|Overall Study|Symptomatic deterioration|0
71507|NCT00062751|271937|P3|Overall Study|Symptomatic deterioration|0
71508|NCT00062751|271938|P2|Overall Study|Symptomatic deterioration|1
71509|NCT00062751|271939|P1|Overall Study|Symptomatic deterioration|1
71510|NCT00062751|271935|P5|Overall Study|Withdrawal by Subject|0
71511|NCT00062751|271936|P4|Overall Study|Withdrawal by Subject|1
71512|NCT00062751|271937|P3|Overall Study|Withdrawal by Subject|2
71513|NCT00062751|271938|P2|Overall Study|Withdrawal by Subject|2
71514|NCT00062751|271939|P1|Overall Study|Withdrawal by Subject|1
71515|NCT00062751|271935|P5|Overall Study|Unspecified|1
71516|NCT00062751|271936|P4|Overall Study|Unspecified|0
71517|NCT00062751|271937|P3|Overall Study|Unspecified|1
71518|NCT00062751|271938|P2|Overall Study|Unspecified|3
71519|NCT00062751|271939|P1|Overall Study|Unspecified|2
71520|NCT00062751|271935|P5|Overall Study|Adverse Event|2
71521|NCT00062751|271936|P4|Overall Study|Adverse Event|2
71522|NCT00062751|271937|P3|Overall Study|Adverse Event|2
71523|NCT00062751|271938|P2|Overall Study|Adverse Event|7
71524|NCT00062751|271939|P1|Overall Study|Adverse Event|4
71525|NCT00062751|271935|P5|Overall Study|Disease progression|2
71526|NCT00062751|271936|P4|Overall Study|Disease progression|2
71527|NCT00062751|271937|P3|Overall Study|Disease progression|24
71528|NCT00062751|271938|P2|Overall Study|Disease progression|17
71529|NCT00062751|271939|P1|Overall Study|Disease progression|24
71530|NCT00054275|272015|P1|Overall Study|Physician Decision|1
71531|NCT00054275|272015|P1|Overall Study|Progressive disease in cycle 1|1
71532|NCT00054275|272015|P1|Overall Study|Adverse Event|5
71533|NCT00054275|272015|P1|Overall Study|Withdrawal by Subject|4
71534|NCT00054327|272027|P6|Overall Study|Engraftment failure|0
71535|NCT00054327|272028|P5|Overall Study|Engraftment failure|0
71536|NCT00054327|272029|P4|Overall Study|Engraftment failure|0
71537|NCT00054327|272030|P3|Overall Study|Engraftment failure|0
71538|NCT00054327|272031|P2|Overall Study|Engraftment failure|0
71539|NCT00054327|272032|P1|Overall Study|Engraftment failure|1
71540|NCT00054639|272070|P1|Overall Study|Physician Decision|1
71541|NCT00054639|272070|P1|Overall Study|Lack of Efficacy|1
71542|NCT00054691|272083|P1|Overall Study|Noncompliant|1
71543|NCT00054691|272083|P1|Overall Study|Unmeasurable Disease|2
71544|NCT00054704|272090|P2|Overall Study|Lost to Follow-up|0
71545|NCT00054704|272091|P1|Overall Study|Lost to Follow-up|1
71546|NCT00054704|272090|P2|Overall Study|Adverse Event|2
71547|NCT00054704|272091|P1|Overall Study|Adverse Event|3
71548|NCT00054704|272090|P2|Overall Study|Lack of Efficacy|3
71549|NCT00054704|272091|P1|Overall Study|Lack of Efficacy|1
71550|NCT00054717|272099|P2|Overall Study|Other reason not defined above|217
71551|NCT00054717|272100|P1|Overall Study|Other reason not defined above|117
71552|NCT00054717|272099|P2|Overall Study|Withdrawal by Subject|20
71553|NCT00054717|272100|P1|Overall Study|Withdrawal by Subject|32
71554|NCT00054717|272099|P2|Overall Study|Lost to Follow-up|13
71555|NCT00054717|272100|P1|Overall Study|Lost to Follow-up|23
71556|NCT00054717|272099|P2|Overall Study|Protocol Violation|19
71557|NCT00054717|272100|P1|Overall Study|Protocol Violation|18
71558|NCT00054717|272099|P2|Overall Study|Adverse Event|22
71559|NCT00054717|272100|P1|Overall Study|Adverse Event|70
71560|NCT00054717|272099|P2|Overall Study|Randomized but not treated|8
71561|NCT00054717|272100|P1|Overall Study|Randomized but not treated|2
71562|NCT00055471|272312|P3|Period 1: Dose Escalation Period|Disease progression|0
71563|NCT00055471|272313|P2|Period 1: Dose Escalation Period|Disease progression|1
71564|NCT00055471|272314|P1|Period 1: Dose Escalation Period|Disease progression|0
71565|NCT00055471|272312|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
71566|NCT00055471|272313|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
71567|NCT00055471|272314|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
71568|NCT00055471|272312|P3|Period 1: Dose Escalation Period|Adverse Event|2
71569|NCT00055471|272313|P2|Period 1: Dose Escalation Period|Adverse Event|1
71570|NCT00055471|272314|P1|Period 1: Dose Escalation Period|Adverse Event|0
71571|NCT00055497|272344|P4|Overall Study|Other|11
71572|NCT00055497|272345|P3|Overall Study|Other|0
71573|NCT00055497|272346|P2|Overall Study|Other|0
71574|NCT00055497|272347|P1|Overall Study|Other|0
71575|NCT00055497|272344|P4|Overall Study|Administrative Reasons|1
71576|NCT00055497|272345|P3|Overall Study|Administrative Reasons|0
71577|NCT00055497|272346|P2|Overall Study|Administrative Reasons|0
71578|NCT00055497|272347|P1|Overall Study|Administrative Reasons|0
71579|NCT00055497|272344|P4|Overall Study|Lack of Efficacy|27
71580|NCT00055497|272345|P3|Overall Study|Lack of Efficacy|0
71581|NCT00055497|272346|P2|Overall Study|Lack of Efficacy|0
71582|NCT00055497|272347|P1|Overall Study|Lack of Efficacy|1
71583|NCT00055497|272344|P4|Overall Study|Protocol Violation|3
71584|NCT00055497|272345|P3|Overall Study|Protocol Violation|0
71585|NCT00055497|272346|P2|Overall Study|Protocol Violation|0
71586|NCT00055497|272347|P1|Overall Study|Protocol Violation|0
71587|NCT00055497|272344|P4|Overall Study|Lost to Follow-up|5
71588|NCT00055497|272345|P3|Overall Study|Lost to Follow-up|0
71589|NCT00055497|272346|P2|Overall Study|Lost to Follow-up|1
71590|NCT00055497|272347|P1|Overall Study|Lost to Follow-up|0
71591|NCT00055497|272344|P4|Overall Study|Withdrawal by Subject|15
71592|NCT00055497|272345|P3|Overall Study|Withdrawal by Subject|1
71593|NCT00055497|272346|P2|Overall Study|Withdrawal by Subject|1
71594|NCT00055497|272347|P1|Overall Study|Withdrawal by Subject|3
71595|NCT00055497|272344|P4|Overall Study|Adverse Event|28
71596|NCT00055497|272345|P3|Overall Study|Adverse Event|1
71597|NCT00055497|272346|P2|Overall Study|Adverse Event|1
71598|NCT00055497|272347|P1|Overall Study|Adverse Event|1
71599|NCT00055601|272391|P2|Overall Study|No protocol treatment received|1
71600|NCT00055601|272392|P1|Overall Study|No protocol treatment received|1
71601|NCT00055601|272391|P2|Overall Study|Protocol Violation|1
71602|NCT00055601|272392|P1|Overall Study|Protocol Violation|1
71603|NCT00063154|272411|P1|Overall Study|Did not receive treatment|8
71604|NCT00063154|272411|P1|Overall Study|Reason unspecified|1
71605|NCT00063154|272411|P1|Overall Study|Death|3
71606|NCT00063154|272411|P1|Overall Study|Physician Decision|10
71607|NCT00063154|272411|P1|Overall Study|Adverse Event|2
71608|NCT00063154|272411|P1|Overall Study|Disease progression|27
71609|NCT00063258|272426|P2|Overall Study|Lack of Efficacy|0
71610|NCT00063258|272427|P1|Overall Study|Lack of Efficacy|2
71611|NCT00063258|272426|P2|Overall Study|Physician Decision|0
71612|NCT00063258|272427|P1|Overall Study|Physician Decision|2
71613|NCT00063934|272433|P1|Overall Study|Ineligible|1
71614|NCT00063986|272439|P1|Overall Study|Intra-operatively ineligible|4
71615|NCT00063986|272439|P1|Overall Study|Ineligible|1
71616|NCT00063986|272439|P1|Overall Study|Withdrawal by Subject|1
71617|NCT00064025|272451|P1|Overall Study|Inevaluable|3
71618|NCT00064025|272451|P1|Overall Study|Ineligible|4
71619|NCT00064259|272472|P4|Overall Study|Adverse Event|1
71620|NCT00064259|272473|P3|Overall Study|Adverse Event|0
71621|NCT00064259|272474|P2|Overall Study|Adverse Event|0
71622|NCT00064259|272475|P1|Overall Study|Adverse Event|1
71623|NCT00064298|272481|P2|Overall Study|Disease Progression|1
71624|NCT00064298|272482|P1|Overall Study|Disease Progression|2
71625|NCT00064298|272481|P2|Overall Study|Death|1
71626|NCT00064298|272482|P1|Overall Study|Death|0
71627|NCT00064298|272481|P2|Overall Study|Lost to Follow-up|2
71628|NCT00064298|272482|P1|Overall Study|Lost to Follow-up|2
71629|NCT00064298|272481|P2|Overall Study|Withdrawal by Subject|1
71630|NCT00064298|272482|P1|Overall Study|Withdrawal by Subject|2
71631|NCT00064350|272493|P3|Cross-Over|Other|0
71632|NCT00064350|272494|P2|Cross-Over|Other|2
71633|NCT00064350|272495|P1|Cross-Over|Other|0
71634|NCT00064350|272493|P3|Cross-Over|Ineligible or never started treatment|0
71635|NCT00064350|272494|P2|Cross-Over|Ineligible or never started treatment|6
71636|NCT00064350|272495|P1|Cross-Over|Ineligible or never started treatment|3
71637|NCT00064350|272493|P3|Cross-Over|Withdrawal by Subject|0
71638|NCT00064350|272494|P2|Cross-Over|Withdrawal by Subject|2
71639|NCT00064350|272495|P1|Cross-Over|Withdrawal by Subject|2
71640|NCT00064350|272493|P3|Cross-Over|Death|0
71641|NCT00064350|272494|P2|Cross-Over|Death|3
71642|NCT00064350|272495|P1|Cross-Over|Death|1
71643|NCT00064350|272493|P3|Cross-Over|Adverse Event|0
71644|NCT00064350|272494|P2|Cross-Over|Adverse Event|1
71645|NCT00064350|272495|P1|Cross-Over|Adverse Event|0
71646|NCT00064350|272493|P3|Randomization|Other|0
71647|NCT00064350|272494|P2|Randomization|Other|0
71648|NCT00064350|272495|P1|Randomization|Other|5
71649|NCT00064350|272493|P3|Randomization|Ineligible or never started treatment|0
71650|NCT00064350|272494|P2|Randomization|Ineligible or never started treatment|15
71651|NCT00064350|272495|P1|Randomization|Ineligible or never started treatment|9
71652|NCT00064350|272493|P3|Randomization|Withdrawal by Subject|0
71653|NCT00064350|272494|P2|Randomization|Withdrawal by Subject|0
71654|NCT00064350|272495|P1|Randomization|Withdrawal by Subject|1
71655|NCT00064350|272493|P3|Randomization|Death|0
71656|NCT00064350|272494|P2|Randomization|Death|0
71657|NCT00064350|272495|P1|Randomization|Death|3
71658|NCT00064350|272493|P3|Randomization|Adverse Event|0
71659|NCT00064350|272494|P2|Randomization|Adverse Event|3
71660|NCT00064350|272495|P1|Randomization|Adverse Event|8
71661|NCT00064350|272493|P3|Induction Treatment|Other|13
71662|NCT00064350|272494|P2|Induction Treatment|Other|0
71663|NCT00064350|272495|P1|Induction Treatment|Other|0
71664|NCT00064350|272493|P3|Induction Treatment|Ineligible or never started treatment|34
71665|NCT00064350|272494|P2|Induction Treatment|Ineligible or never started treatment|6
71666|NCT00064350|272495|P1|Induction Treatment|Ineligible or never started treatment|3
71667|NCT00064350|272493|P3|Induction Treatment|Withdrawal by Subject|21
71668|NCT00064350|272494|P2|Induction Treatment|Withdrawal by Subject|0
71669|NCT00064350|272495|P1|Induction Treatment|Withdrawal by Subject|0
71670|NCT00064350|272493|P3|Induction Treatment|Death|9
71671|NCT00064350|272494|P2|Induction Treatment|Death|0
71672|NCT00064350|272495|P1|Induction Treatment|Death|0
71673|NCT00064350|272493|P3|Induction Treatment|Adverse Event|49
71674|NCT00064350|272494|P2|Induction Treatment|Adverse Event|2
71675|NCT00064350|272495|P1|Induction Treatment|Adverse Event|0
71676|NCT00064350|272493|P3|Induction Treatment|Disease Progression|110
71677|NCT00064350|272494|P2|Induction Treatment|Disease Progression|1
71678|NCT00064350|272495|P1|Induction Treatment|Disease Progression|5
71679|NCT00064662|272512|P2|Overall Study|Administratively withdrawn|2
71680|NCT00064662|272513|P1|Overall Study|Administratively withdrawn|2
71681|NCT00064662|272512|P2|Overall Study|Withdrawal by Subject|14
71682|NCT00064662|272513|P1|Overall Study|Withdrawal by Subject|14
71683|NCT00064662|272512|P2|Overall Study|Lost to Follow-up|44
71684|NCT00064662|272513|P1|Overall Study|Lost to Follow-up|57
71685|NCT00064662|272512|P2|Overall Study|Death|1
71686|NCT00064662|272513|P1|Overall Study|Death|1
71687|NCT00064701|272524|P3|Clinical Continuation Phase|Patient opted out|1
71688|NCT00064701|272525|P2|Clinical Continuation Phase|Patient opted out|0
71689|NCT00064701|272526|P1|Clinical Continuation Phase|Patient opted out|0
71690|NCT00064701|272524|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
71691|NCT00064701|272525|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
71692|NCT00064701|272526|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
71693|NCT00064701|272524|P3|Clinical Continuation Phase|Discharged to nursing home|0
71694|NCT00064701|272525|P2|Clinical Continuation Phase|Discharged to nursing home|1
71695|NCT00064701|272526|P1|Clinical Continuation Phase|Discharged to nursing home|0
71696|NCT00064701|272524|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
71697|NCT00064701|272525|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
71698|NCT00064701|272526|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
71699|NCT00064701|272524|P3|Clinical Continuation Phase|Pancreas transplant|0
71700|NCT00064701|272525|P2|Clinical Continuation Phase|Pancreas transplant|0
71701|NCT00064701|272526|P1|Clinical Continuation Phase|Pancreas transplant|1
71702|NCT00064701|272524|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
71703|NCT00064701|272525|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
71704|NCT00064701|272526|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
71705|NCT00064701|272524|P3|Clinical Continuation Phase|Physician Decision|0
71706|NCT00064701|272525|P2|Clinical Continuation Phase|Physician Decision|3
71707|NCT00064701|272526|P1|Clinical Continuation Phase|Physician Decision|1
71708|NCT00064701|272524|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
71709|NCT00064701|272525|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
71710|NCT00064701|272526|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
71711|NCT00064701|272524|P3|Clinical Continuation Phase|Sponsor discontinued study|79
71712|NCT00064701|272525|P2|Clinical Continuation Phase|Sponsor discontinued study|129
71713|NCT00064701|272526|P1|Clinical Continuation Phase|Sponsor discontinued study|113
71714|NCT00064701|272524|P3|Clinical Continuation Phase|Rejection|2
71715|NCT00064701|272525|P2|Clinical Continuation Phase|Rejection|2
71716|NCT00064701|272526|P1|Clinical Continuation Phase|Rejection|1
71717|NCT00064701|272524|P3|Clinical Continuation Phase|Graft Failure|2
71718|NCT00064701|272525|P2|Clinical Continuation Phase|Graft Failure|5
71719|NCT00064701|272526|P1|Clinical Continuation Phase|Graft Failure|5
71720|NCT00064701|272524|P3|Clinical Continuation Phase|Lost to Follow-up|6
71721|NCT00064701|272525|P2|Clinical Continuation Phase|Lost to Follow-up|3
71722|NCT00064701|272526|P1|Clinical Continuation Phase|Lost to Follow-up|6
71723|NCT00064701|272524|P3|Clinical Continuation Phase|Withdrawal by Subject|22
71724|NCT00064701|272525|P2|Clinical Continuation Phase|Withdrawal by Subject|3
71725|NCT00064701|272526|P1|Clinical Continuation Phase|Withdrawal by Subject|22
71726|NCT00064701|272524|P3|Clinical Continuation Phase|Non-compliance|7
71727|NCT00064701|272525|P2|Clinical Continuation Phase|Non-compliance|6
71728|NCT00064701|272526|P1|Clinical Continuation Phase|Non-compliance|8
71729|NCT00064701|272524|P3|Clinical Continuation Phase|Adverse Event|14
71730|NCT00064701|272525|P2|Clinical Continuation Phase|Adverse Event|21
71731|NCT00064701|272526|P1|Clinical Continuation Phase|Adverse Event|12
71732|NCT00064701|272524|P3|One Year Post-transplant|Pancreas transplant|1
71733|NCT00064701|272525|P2|One Year Post-transplant|Pancreas transplant|0
71734|NCT00064701|272526|P1|One Year Post-transplant|Pancreas transplant|0
71735|NCT00064701|272524|P3|One Year Post-transplant|Poor absorption|0
71736|NCT00064701|272525|P2|One Year Post-transplant|Poor absorption|1
71737|NCT00064701|272526|P1|One Year Post-transplant|Poor absorption|0
71738|NCT00064701|272524|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
71739|NCT00064701|272525|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
71740|NCT00064701|272526|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
71741|NCT00064701|272524|P3|One Year Post-transplant|Incorrect study drug dispensed|0
71742|NCT00064701|272525|P2|One Year Post-transplant|Incorrect study drug dispensed|1
71743|NCT00064701|272526|P1|One Year Post-transplant|Incorrect study drug dispensed|0
71744|NCT00064701|272524|P3|One Year Post-transplant|Acute tubular necrosis|0
71745|NCT00064701|272525|P2|One Year Post-transplant|Acute tubular necrosis|0
71746|NCT00064701|272526|P1|One Year Post-transplant|Acute tubular necrosis|1
71747|NCT00064701|272524|P3|One Year Post-transplant|Converted to rapamycin|0
71748|NCT00064701|272525|P2|One Year Post-transplant|Converted to rapamycin|0
71749|NCT00064701|272526|P1|One Year Post-transplant|Converted to rapamycin|1
71750|NCT00064701|272524|P3|One Year Post-transplant|Lost to Follow-up|0
71751|NCT00064701|272525|P2|One Year Post-transplant|Lost to Follow-up|0
71752|NCT00064701|272526|P1|One Year Post-transplant|Lost to Follow-up|1
71753|NCT00064701|272524|P3|One Year Post-transplant|Withdrawal by Subject|1
71754|NCT00064701|272525|P2|One Year Post-transplant|Withdrawal by Subject|4
71755|NCT00064701|272526|P1|One Year Post-transplant|Withdrawal by Subject|0
71756|NCT00064701|272524|P3|One Year Post-transplant|Graft Failure|1
71757|NCT00064701|272525|P2|One Year Post-transplant|Graft Failure|2
71758|NCT00064701|272526|P1|One Year Post-transplant|Graft Failure|3
71759|NCT00064701|272524|P3|One Year Post-transplant|Non-compliance|5
71760|NCT00064701|272525|P2|One Year Post-transplant|Non-compliance|2
71761|NCT00064701|272526|P1|One Year Post-transplant|Non-compliance|4
71762|NCT00064701|272524|P3|One Year Post-transplant|Rejection|16
71763|NCT00064701|272525|P2|One Year Post-transplant|Rejection|1
71764|NCT00064701|272526|P1|One Year Post-transplant|Rejection|0
71765|NCT00064701|272524|P3|One Year Post-transplant|Adverse Event|37
71766|NCT00064701|272525|P2|One Year Post-transplant|Adverse Event|19
71767|NCT00064701|272526|P1|One Year Post-transplant|Adverse Event|23
71768|NCT00064701|272524|P3|One Year Post-transplant|Did not receive study drug|11
71769|NCT00064701|272525|P2|One Year Post-transplant|Did not receive study drug|12
71770|NCT00064701|272526|P1|One Year Post-transplant|Did not receive study drug|7
71771|NCT00064753|272578|P2|Overall Study|Lost to Follow-up|235
71772|NCT00064753|272579|P1|Overall Study|Lost to Follow-up|225
71773|NCT00064753|272578|P2|Overall Study|Withdrawal by Subject|171
71774|NCT00064753|272579|P1|Overall Study|Withdrawal by Subject|198
71775|NCT00064753|272578|P2|Overall Study|Death|242
71776|NCT00064753|272579|P1|Overall Study|Death|251
71777|NCT00064792|272609|P2|Overall Study|Adverse Event|0
71778|NCT00064792|272610|P1|Overall Study|Adverse Event|3
71779|NCT00064792|272609|P2|Overall Study|Withdrawal by Subject|0
71780|NCT00064792|272610|P1|Overall Study|Withdrawal by Subject|2
71781|NCT00064987|272631|P2|Overall Study|Physician Decision|0
71782|NCT00064987|272632|P1|Overall Study|Physician Decision|3
71783|NCT00065065|272652|P2|Overall Study|Other|2
71784|NCT00065065|272653|P1|Overall Study|Other|2
71785|NCT00065065|272652|P2|Overall Study|Lack of Efficacy|11
71786|NCT00065065|272653|P1|Overall Study|Lack of Efficacy|4
71787|NCT00065065|272652|P2|Overall Study|Withdrawal by Subject|5
71788|NCT00065065|272653|P1|Overall Study|Withdrawal by Subject|1
71789|NCT00065065|272652|P2|Overall Study|Adverse Event|2
71790|NCT00065065|272653|P1|Overall Study|Adverse Event|3
71791|NCT00065156|272661|P1|Overall Study|Secondary Malign Disease|1
71792|NCT00065156|272661|P1|Overall Study|Loss of Response|1
71793|NCT00065156|272661|P1|Overall Study|Non-Compliance|2
71794|NCT00065156|272661|P1|Overall Study|Investigator Decision|2
71795|NCT00065156|272661|P1|Overall Study|Disease Progression|7
71796|NCT00065156|272661|P1|Overall Study|Study Closed by Sponsor|2
71797|NCT00065156|272661|P1|Overall Study|Death|11
71798|NCT00065156|272661|P1|Overall Study|Lost to Follow-up|1
71799|NCT00065156|272661|P1|Overall Study|Withdrawal by Subject|8
71800|NCT00065156|272661|P1|Overall Study|Lack of Efficacy|52
71801|NCT00065156|272661|P1|Overall Study|Adverse Event|37
71802|NCT00065260|272678|P2|Overall Study|Death|1
71803|NCT00065260|272679|P1|Overall Study|Death|0
71804|NCT00065429|272692|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
71805|NCT00065429|272693|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
71806|NCT00065429|272694|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
71807|NCT00065429|272695|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
71808|NCT00065429|272696|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
71809|NCT00065429|272697|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
71810|NCT00065429|272698|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
71811|NCT00065429|272692|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
71812|NCT00065429|272693|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
71813|NCT00065429|272694|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
71814|NCT00065429|272695|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
71815|NCT00065429|272696|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
71816|NCT00065429|272697|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
71817|NCT00065429|272698|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
71818|NCT00065429|272692|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
71819|NCT00065429|272693|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
71820|NCT00065429|272694|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
71821|NCT00065429|272695|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
71822|NCT00065429|272696|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
71823|NCT00065429|272697|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
71824|NCT00065429|272698|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
71825|NCT00065429|272692|P7|Phase I - May 2001 - Oct 2002|Death|0
71826|NCT00065429|272693|P6|Phase I - May 2001 - Oct 2002|Death|0
71827|NCT00065429|272694|P5|Phase I - May 2001 - Oct 2002|Death|1
71828|NCT00065429|272695|P4|Phase I - May 2001 - Oct 2002|Death|0
71829|NCT00065429|272696|P3|Phase I - May 2001 - Oct 2002|Death|0
71830|NCT00065429|272697|P2|Phase I - May 2001 - Oct 2002|Death|0
71831|NCT00065429|272698|P1|Phase I - May 2001 - Oct 2002|Death|0
71832|NCT00065429|272692|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
71833|NCT00065429|272693|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
71834|NCT00065429|272694|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
71835|NCT00065429|272695|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
71836|NCT00065429|272696|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
71837|NCT00065429|272697|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
71838|NCT00065429|272698|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
71839|NCT00065429|272692|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
71840|NCT00065429|272693|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
71841|NCT00065429|272694|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
71842|NCT00065429|272695|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
71843|NCT00065429|272696|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
71844|NCT00065429|272697|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
71845|NCT00065429|272698|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
71846|NCT00065429|272692|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
71847|NCT00065429|272693|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
71848|NCT00065429|272694|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
71849|NCT00065429|272695|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
71850|NCT00065429|272696|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
71851|NCT00065429|272697|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
71852|NCT00065429|272698|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
71853|NCT00065442|272712|P2|Overall Study|Withdrawal by Subject|9
71854|NCT00065442|272713|P1|Overall Study|Withdrawal by Subject|3
71855|NCT00065442|272712|P2|Overall Study|Death|210
71856|NCT00065442|272713|P1|Overall Study|Death|121
71857|NCT00065442|272712|P2|Overall Study|Lost to Follow-up|1
71858|NCT00065442|272713|P1|Overall Study|Lost to Follow-up|1
71859|NCT00065468|272724|P3|Overall Study|Unspecified|18
71860|NCT00065468|272725|P2|Overall Study|Unspecified|24
71861|NCT00065468|272726|P1|Overall Study|Unspecified|14
71862|NCT00065468|272724|P3|Overall Study|Disease progression|1
71863|NCT00065468|272725|P2|Overall Study|Disease progression|0
71864|NCT00065468|272726|P1|Overall Study|Disease progression|0
71865|NCT00065468|272724|P3|Overall Study|Discontinuation of study by Sponsor|13
71866|NCT00065468|272725|P2|Overall Study|Discontinuation of study by Sponsor|9
71867|NCT00065468|272726|P1|Overall Study|Discontinuation of study by Sponsor|13
71868|NCT00065468|272724|P3|Overall Study|Lost to Follow-up|2
71869|NCT00065468|272725|P2|Overall Study|Lost to Follow-up|3
71870|NCT00065468|272726|P1|Overall Study|Lost to Follow-up|5
71871|NCT00065468|272724|P3|Overall Study|Withdrawal by Subject|5
71872|NCT00065468|272725|P2|Overall Study|Withdrawal by Subject|4
71873|NCT00065468|272726|P1|Overall Study|Withdrawal by Subject|3
71874|NCT00065468|272724|P3|Overall Study|Death|171
71875|NCT00065468|272725|P2|Overall Study|Death|169
71876|NCT00065468|272726|P1|Overall Study|Death|172
71877|NCT00065507|272757|P2|Overall Study|Subject No Longer Meets Study Criteria|0
71878|NCT00065507|272758|P1|Overall Study|Subject No Longer Meets Study Criteria|1
71879|NCT00065507|272757|P2|Overall Study|Subject Withdrew Consent|1
71880|NCT00065507|272758|P1|Overall Study|Subject Withdrew Consent|2
71881|NCT00065507|272757|P2|Overall Study|Lost to Follow-up|0
71882|NCT00065507|272758|P1|Overall Study|Lost to Follow-up|3
71883|NCT00065507|272757|P2|Overall Study|Poor/Non-compliance|2
71884|NCT00065507|272758|P1|Overall Study|Poor/Non-compliance|3
71885|NCT00065507|272757|P2|Overall Study|Lack of Efficacy|6
71886|NCT00065507|272758|P1|Overall Study|Lack of Efficacy|0
71887|NCT00065507|272757|P2|Overall Study|Adverse Event|3
71888|NCT00065507|272758|P1|Overall Study|Adverse Event|4
71889|NCT00065507|272757|P2|Overall Study|Death|17
71890|NCT00065507|272758|P1|Overall Study|Death|16
71891|NCT00066066|272881|P6|Overall Study|Lost to Follow-up|5
71892|NCT00066066|272882|P5|Overall Study|Lost to Follow-up|3
71893|NCT00066066|272883|P4|Overall Study|Lost to Follow-up|4
71894|NCT00066066|272884|P3|Overall Study|Lost to Follow-up|7
71895|NCT00066066|272885|P2|Overall Study|Lost to Follow-up|4
71896|NCT00066066|272886|P1|Overall Study|Lost to Follow-up|6
71897|NCT00066170|272904|P4|Overall Study|Other|0
71898|NCT00066170|272905|P3|Overall Study|Other|2
71899|NCT00066170|272906|P2|Overall Study|Other|5
71900|NCT00066170|272907|P1|Overall Study|Other|1
71901|NCT00066170|272904|P4|Overall Study|Protocol Violation|0
71902|NCT00066170|272905|P3|Overall Study|Protocol Violation|0
71903|NCT00066170|272906|P2|Overall Study|Protocol Violation|0
71904|NCT00066170|272907|P1|Overall Study|Protocol Violation|3
71905|NCT00066170|272904|P4|Overall Study|Non-Compliance with Trial Medicine|1
71906|NCT00066170|272905|P3|Overall Study|Non-Compliance with Trial Medicine|0
71907|NCT00066170|272906|P2|Overall Study|Non-Compliance with Trial Medicine|0
71908|NCT00066170|272907|P1|Overall Study|Non-Compliance with Trial Medicine|1
71909|NCT00066170|272904|P4|Overall Study|Lost to Follow-up|0
71910|NCT00066170|272905|P3|Overall Study|Lost to Follow-up|0
71911|NCT00066170|272906|P2|Overall Study|Lost to Follow-up|1
71912|NCT00066170|272907|P1|Overall Study|Lost to Follow-up|0
71913|NCT00066170|272904|P4|Overall Study|Serious Adverse Event|1
71914|NCT00066170|272905|P3|Overall Study|Serious Adverse Event|1
71915|NCT00066170|272906|P2|Overall Study|Serious Adverse Event|0
71916|NCT00066170|272907|P1|Overall Study|Serious Adverse Event|0
71917|NCT00066170|272904|P4|Overall Study|Adverse Event|7
71918|NCT00066170|272905|P3|Overall Study|Adverse Event|1
71919|NCT00066170|272906|P2|Overall Study|Adverse Event|4
71920|NCT00066170|272907|P1|Overall Study|Adverse Event|2
71921|NCT00066222|272917|P1|Overall Study|No protocol treatment received|1
71922|NCT00066365|272923|P2|Overall Study|Ineligible|2
71923|NCT00066365|272924|P1|Overall Study|Ineligible|4
71924|NCT00066365|272923|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
71925|NCT00066365|272924|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
71926|NCT00066365|272923|P2|Overall Study|Physician Decision|0
71927|NCT00066365|272924|P1|Overall Study|Physician Decision|1
71928|NCT00066365|272923|P2|Overall Study|Lack of Efficacy|12
71929|NCT00066365|272924|P1|Overall Study|Lack of Efficacy|15
71930|NCT00066365|272923|P2|Overall Study|Adverse Event|0
71931|NCT00066365|272924|P1|Overall Study|Adverse Event|1
71932|NCT00059215|272956|P4|Overall Study|Physician Decision|1
71933|NCT00059215|272957|P3|Overall Study|Physician Decision|1
71934|NCT00059215|272958|P2|Overall Study|Physician Decision|2
71935|NCT00059215|272959|P1|Overall Study|Physician Decision|1
71936|NCT00059215|272956|P4|Overall Study|Protocol entry criteria not met|2
71937|NCT00059215|272957|P3|Overall Study|Protocol entry criteria not met|0
71938|NCT00059215|272958|P2|Overall Study|Protocol entry criteria not met|1
71939|NCT00059215|272959|P1|Overall Study|Protocol entry criteria not met|1
71940|NCT00059215|272956|P4|Overall Study|Protocol Violation|0
71941|NCT00059215|272957|P3|Overall Study|Protocol Violation|1
71942|NCT00059215|272958|P2|Overall Study|Protocol Violation|0
71943|NCT00059215|272959|P1|Overall Study|Protocol Violation|1
71944|NCT00059215|272956|P4|Overall Study|Withdrawal by Subject|3
71945|NCT00059215|272957|P3|Overall Study|Withdrawal by Subject|1
71946|NCT00059215|272958|P2|Overall Study|Withdrawal by Subject|4
71947|NCT00059215|272959|P1|Overall Study|Withdrawal by Subject|4
71948|NCT00059215|272956|P4|Overall Study|Lost to Follow-up|0
71949|NCT00059215|272957|P3|Overall Study|Lost to Follow-up|0
71950|NCT00059215|272958|P2|Overall Study|Lost to Follow-up|2
71951|NCT00059215|272959|P1|Overall Study|Lost to Follow-up|1
71952|NCT00059215|272956|P4|Overall Study|Death|0
71953|NCT00059215|272957|P3|Overall Study|Death|3
71954|NCT00059215|272958|P2|Overall Study|Death|0
71955|NCT00059215|272959|P1|Overall Study|Death|0
71956|NCT00059215|272956|P4|Overall Study|Adverse Event|9
71957|NCT00059215|272957|P3|Overall Study|Adverse Event|9
71958|NCT00059215|272958|P2|Overall Study|Adverse Event|5
71959|NCT00059215|272959|P1|Overall Study|Adverse Event|5
71960|NCT00059332|272987|P2|Overall Study|Lost to Follow-up|1
71961|NCT00059332|272988|P1|Overall Study|Lost to Follow-up|1
71962|NCT00059332|272987|P2|Overall Study|Withdrawal by Subject|1
71963|NCT00059332|272988|P1|Overall Study|Withdrawal by Subject|2
71964|NCT00059787|273051|P1|Overall Study|Other|4
71965|NCT00059787|273051|P1|Overall Study|ineligible|1
71966|NCT00059787|273051|P1|Overall Study|disease progression|2
71967|NCT00059787|273051|P1|Overall Study|Adverse Event|13
71968|NCT00059839|273061|P2|Overall Study|Ineligible|3
71969|NCT00059839|273062|P1|Overall Study|Ineligible|1
71970|NCT00059839|273061|P2|Overall Study|Withdrawal by Subject|6
71971|NCT00059839|273062|P1|Overall Study|Withdrawal by Subject|1
71972|NCT00059839|273061|P2|Overall Study|Physician Decision|2
71973|NCT00059839|273062|P1|Overall Study|Physician Decision|1
71974|NCT00059839|273061|P2|Overall Study|Lost to Follow-up|0
71975|NCT00059839|273062|P1|Overall Study|Lost to Follow-up|2
71976|NCT00059839|273061|P2|Overall Study|Lack of Efficacy|5
71977|NCT00059839|273062|P1|Overall Study|Lack of Efficacy|6
71978|NCT00059839|273061|P2|Overall Study|Death|1
71979|NCT00059839|273062|P1|Overall Study|Death|1
71980|NCT00066469|273073|P1|Overall Study|ineligible|1
71981|NCT00066469|273073|P1|Overall Study|Withdrawal by Subject|1
71982|NCT00066469|273073|P1|Overall Study|Physician Decision|1
71983|NCT00066469|273073|P1|Overall Study|Lost to Follow-up|1
71984|NCT00066469|273073|P1|Overall Study|Lack of Efficacy|9
71985|NCT00066469|273073|P1|Overall Study|Death|3
71986|NCT00066573|273079|P2|Overall Study|Did not received protocol treatment|28
71987|NCT00066573|273080|P1|Overall Study|Did not received protocol treatment|28
71988|NCT00066690|273089|P3|Overall Study|Treatment Ongoing|282
71989|NCT00066690|273090|P2|Overall Study|Treatment Ongoing|278
71990|NCT00066690|273091|P1|Overall Study|Treatment Ongoing|246
71991|NCT00066690|273089|P3|Overall Study|Withdrawal by Subject|49
71992|NCT00066690|273090|P2|Overall Study|Withdrawal by Subject|55
71993|NCT00066690|273091|P1|Overall Study|Withdrawal by Subject|50
71994|NCT00066690|273089|P3|Overall Study|Lost to Follow-up|29
71995|NCT00066690|273090|P2|Overall Study|Lost to Follow-up|21
71996|NCT00066690|273091|P1|Overall Study|Lost to Follow-up|40
71997|NCT00066690|273089|P3|Overall Study|Lack of Efficacy|76
71998|NCT00066690|273090|P2|Overall Study|Lack of Efficacy|110
71999|NCT00066690|273091|P1|Overall Study|Lack of Efficacy|114
72000|NCT00066690|273089|P3|Overall Study|Death|2
72001|NCT00066690|273090|P2|Overall Study|Death|0
72002|NCT00066690|273091|P1|Overall Study|Death|3
72003|NCT00066690|273089|P3|Overall Study|Adverse Event|126
72004|NCT00066690|273090|P2|Overall Study|Adverse Event|58
72005|NCT00066690|273091|P1|Overall Study|Adverse Event|145
72006|NCT00066703|273107|P2|Overall Study|Treatment ongoing|311
72007|NCT00066703|273108|P1|Overall Study|Treatment ongoing|346
72008|NCT00066703|273107|P2|Overall Study|Withdrawal by Subject|63
72009|NCT00066703|273108|P1|Overall Study|Withdrawal by Subject|38
72010|NCT00066703|273107|P2|Overall Study|Lost to Follow-up|28
72011|NCT00066703|273108|P1|Overall Study|Lost to Follow-up|31
72012|NCT00066703|273107|P2|Overall Study|Lack of Efficacy|69
72013|NCT00066703|273108|P1|Overall Study|Lack of Efficacy|114
72014|NCT00066703|273107|P2|Overall Study|Death|0
72015|NCT00066703|273108|P1|Overall Study|Death|3
72016|NCT00066703|273107|P2|Overall Study|Adverse Event|111
72017|NCT00066703|273108|P1|Overall Study|Adverse Event|80
72018|NCT00066742|273118|P1|Consolidation Chemotherapy|Ineligible|2
72019|NCT00066742|273118|P1|Consolidation Chemotherapy|not protocol specified|1
72020|NCT00066742|273118|P1|Induction Chemoradiotherapy|Ineligible|3
72021|NCT00066742|273118|P1|Induction Chemoradiotherapy|not protocol specified|2
72022|NCT00066742|273118|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
72023|NCT00066742|273118|P1|Induction Chemoradiotherapy|Adverse Event|21
72024|NCT00066742|273118|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
72025|NCT00067470|273140|P2|Overall Study|Withdrawal by Subject|1
72026|NCT00067470|273141|P1|Overall Study|Withdrawal by Subject|0
72027|NCT00068107|273164|P1|Overall Study|Withdrawal by Subject|1
72028|NCT00068107|273164|P1|Overall Study|Death|2
72029|NCT00068107|273164|P1|Overall Study|end-stage renal disease|6
72030|NCT00068237|273175|P1|Overall Study|No protocol treatment received|2
72031|NCT00068237|273175|P1|Overall Study|Ineligible|3
72032|NCT00068380|273205|P1|Overall Study|Adverse Event|2
72033|NCT00068380|273205|P1|Overall Study|Withdrawal by Subject|3
72034|NCT00068393|273209|P1|Overall Study|Quality of life worsening|1
72035|NCT00068393|273209|P1|Overall Study|Alternative treatment|1
72036|NCT00068393|273209|P1|Overall Study|Withdrawal by Subject|3
72037|NCT00068393|273209|P1|Overall Study|Death|3
72038|NCT00068393|273209|P1|Overall Study|Adverse Event|2
72039|NCT00068419|273215|P1|Overall Study|Ineligible|11
72040|NCT00068419|273215|P1|Overall Study|Withdrawal by Subject|14
72041|NCT00068419|273215|P1|Overall Study|Physician Decision|7
72042|NCT00068419|273215|P1|Overall Study|Lost to Follow-up|1
72043|NCT00068419|273215|P1|Overall Study|Lack of Efficacy|24
72044|NCT00068419|273215|P1|Overall Study|Adverse Event|3
72045|NCT00068588|273226|P3|Overall Study|Poor KPS|1
72046|NCT00068588|273227|P2|Overall Study|Poor KPS|0
72047|NCT00068588|273228|P1|Overall Study|Poor KPS|0
72048|NCT00068588|273226|P3|Overall Study|Withdrawal by Subject|1
72049|NCT00068588|273227|P2|Overall Study|Withdrawal by Subject|0
72050|NCT00068588|273228|P1|Overall Study|Withdrawal by Subject|0
72051|NCT00068588|273226|P3|Overall Study|Adverse Event|2
72052|NCT00068588|273227|P2|Overall Study|Adverse Event|0
72053|NCT00068588|273228|P1|Overall Study|Adverse Event|0
72054|NCT00068601|273240|P2|Overall Study|Missing primary outcome data|34
72055|NCT00068601|273241|P1|Overall Study|Missing primary outcome data|30
72056|NCT00068601|273240|P2|Overall Study|Lost to Follow-up|2
72057|NCT00068601|273241|P1|Overall Study|Lost to Follow-up|3
72058|NCT00068601|273240|P2|Overall Study|Death|3
72059|NCT00068601|273241|P1|Overall Study|Death|11
72060|NCT00068601|273240|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
72061|NCT00068601|273241|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
72062|NCT00068601|273240|P2|Overall Study|Not evaluable: withdrew consent|4
72063|NCT00068601|273241|P1|Overall Study|Not evaluable: withdrew consent|5
72064|NCT00068601|273240|P2|Overall Study|Ineligible|13
72065|NCT00068601|273241|P1|Overall Study|Ineligible|11
72066|NCT00068822|273274|P2|First Randomized Intervention|Lost to Follow-up|2
72067|NCT00068822|273275|P1|First Randomized Intervention|Lost to Follow-up|1
72068|NCT00069095|273291|P6|Follow-up Phase|Death|101
72069|NCT00069095|273292|P5|Follow-up Phase|Death|92
72070|NCT00069095|273293|P4|Follow-up Phase|Death|112
72071|NCT00069095|273294|P3|Follow-up Phase|Death|120
72072|NCT00069095|273295|P2|Follow-up Phase|Death|206
72073|NCT00069095|273296|P1|Follow-up Phase|Death|174
72074|NCT00069095|273291|P6|Post-study Treatment Phase|Investigator decision|1
72075|NCT00069095|273292|P5|Post-study Treatment Phase|Investigator decision|0
72076|NCT00069095|273293|P4|Post-study Treatment Phase|Investigator decision|0
72077|NCT00069095|273294|P3|Post-study Treatment Phase|Investigator decision|0
72078|NCT00069095|273295|P2|Post-study Treatment Phase|Investigator decision|0
72079|NCT00069095|273296|P1|Post-study Treatment Phase|Investigator decision|0
72080|NCT00069095|273291|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
72081|NCT00069095|273292|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
72082|NCT00069095|273293|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
72083|NCT00069095|273294|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
72084|NCT00069095|273295|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
72085|NCT00069095|273296|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
72086|NCT00069095|273291|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
72087|NCT00069095|273292|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
72088|NCT00069095|273293|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
72089|NCT00069095|273294|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
72090|NCT00069095|273295|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
72091|NCT00069095|273296|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
72092|NCT00069095|273291|P6|Post-study Treatment Phase|Participant had progressive disease|0
72093|NCT00069095|273292|P5|Post-study Treatment Phase|Participant had progressive disease|1
72094|NCT00069095|273293|P4|Post-study Treatment Phase|Participant had progressive disease|0
72095|NCT00069095|273294|P3|Post-study Treatment Phase|Participant had progressive disease|0
72096|NCT00069095|273295|P2|Post-study Treatment Phase|Participant had progressive disease|0
72097|NCT00069095|273296|P1|Post-study Treatment Phase|Participant had progressive disease|0
72098|NCT00069095|273291|P6|Post-study Treatment Phase|Death|0
72099|NCT00069095|273292|P5|Post-study Treatment Phase|Death|1
72100|NCT00069095|273293|P4|Post-study Treatment Phase|Death|0
72101|NCT00069095|273294|P3|Post-study Treatment Phase|Death|0
72102|NCT00069095|273295|P2|Post-study Treatment Phase|Death|0
72103|NCT00069095|273296|P1|Post-study Treatment Phase|Death|0
72104|NCT00069095|273291|P6|Post-study Treatment Phase|Surgery|0
72105|NCT00069095|273292|P5|Post-study Treatment Phase|Surgery|1
72106|NCT00069095|273293|P4|Post-study Treatment Phase|Surgery|1
72107|NCT00069095|273294|P3|Post-study Treatment Phase|Surgery|0
72108|NCT00069095|273295|P2|Post-study Treatment Phase|Surgery|0
72109|NCT00069095|273296|P1|Post-study Treatment Phase|Surgery|0
72110|NCT00069095|273291|P6|Post-study Treatment Phase|Participant completed treatment|0
72111|NCT00069095|273292|P5|Post-study Treatment Phase|Participant completed treatment|0
72112|NCT00069095|273293|P4|Post-study Treatment Phase|Participant completed treatment|1
72113|NCT00069095|273294|P3|Post-study Treatment Phase|Participant completed treatment|0
72114|NCT00069095|273295|P2|Post-study Treatment Phase|Participant completed treatment|0
72115|NCT00069095|273296|P1|Post-study Treatment Phase|Participant completed treatment|0
72116|NCT00069095|273291|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
72117|NCT00069095|273292|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
72118|NCT00069095|273293|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
72119|NCT00069095|273294|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
72120|NCT00069095|273295|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
72121|NCT00069095|273296|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
72122|NCT00069095|273291|P6|Post-study Treatment Phase|Participant will start new treatment|0
72123|NCT00069095|273292|P5|Post-study Treatment Phase|Participant will start new treatment|0
72124|NCT00069095|273293|P4|Post-study Treatment Phase|Participant will start new treatment|0
72125|NCT00069095|273294|P3|Post-study Treatment Phase|Participant will start new treatment|1
72126|NCT00069095|273295|P2|Post-study Treatment Phase|Participant will start new treatment|0
72127|NCT00069095|273296|P1|Post-study Treatment Phase|Participant will start new treatment|0
72128|NCT00069095|273291|P6|Post-study Treatment Phase|Participant withdrew consent|0
72129|NCT00069095|273292|P5|Post-study Treatment Phase|Participant withdrew consent|0
72130|NCT00069095|273293|P4|Post-study Treatment Phase|Participant withdrew consent|0
72131|NCT00069095|273294|P3|Post-study Treatment Phase|Participant withdrew consent|1
72132|NCT00069095|273295|P2|Post-study Treatment Phase|Participant withdrew consent|0
72133|NCT00069095|273296|P1|Post-study Treatment Phase|Participant withdrew consent|0
72134|NCT00069095|273291|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
72135|NCT00069095|273292|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
72136|NCT00069095|273293|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
72137|NCT00069095|273294|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
72138|NCT00069095|273295|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
72139|NCT00069095|273296|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
72140|NCT00069095|273291|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
72141|NCT00069095|273292|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
72142|NCT00069095|273293|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
72143|NCT00069095|273294|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
72144|NCT00069095|273295|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
72145|NCT00069095|273296|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
72146|NCT00069095|273291|P6|Post-study Treatment Phase|Participant had complete response|0
72147|NCT00069095|273292|P5|Post-study Treatment Phase|Participant had complete response|0
72148|NCT00069095|273293|P4|Post-study Treatment Phase|Participant had complete response|0
72149|NCT00069095|273294|P3|Post-study Treatment Phase|Participant had complete response|0
72150|NCT00069095|273295|P2|Post-study Treatment Phase|Participant had complete response|1
72151|NCT00069095|273296|P1|Post-study Treatment Phase|Participant had complete response|1
72152|NCT00069095|273291|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
72153|NCT00069095|273292|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
72154|NCT00069095|273293|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
72155|NCT00069095|273294|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
72156|NCT00069095|273295|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
72157|NCT00069095|273296|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
72158|NCT00069095|273291|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
72159|NCT00069095|273292|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
72160|NCT00069095|273293|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
72161|NCT00069095|273294|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
72162|NCT00069095|273295|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
72163|NCT00069095|273296|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
72164|NCT00069095|273291|P6|Post-study Treatment Phase|Eligible for surgery|0
72165|NCT00069095|273292|P5|Post-study Treatment Phase|Eligible for surgery|0
72166|NCT00069095|273293|P4|Post-study Treatment Phase|Eligible for surgery|0
72167|NCT00069095|273294|P3|Post-study Treatment Phase|Eligible for surgery|0
72168|NCT00069095|273295|P2|Post-study Treatment Phase|Eligible for surgery|0
72169|NCT00069095|273296|P1|Post-study Treatment Phase|Eligible for surgery|2
72170|NCT00069095|273291|P6|Post-study Treatment Phase|Adverse Event|1
72171|NCT00069095|273292|P5|Post-study Treatment Phase|Adverse Event|5
72172|NCT00069095|273293|P4|Post-study Treatment Phase|Adverse Event|0
72173|NCT00069095|273294|P3|Post-study Treatment Phase|Adverse Event|1
72174|NCT00069095|273295|P2|Post-study Treatment Phase|Adverse Event|3
72175|NCT00069095|273296|P1|Post-study Treatment Phase|Adverse Event|2
72176|NCT00069095|273291|P6|Post-study Treatment Phase|Missing reason|17
72177|NCT00069095|273292|P5|Post-study Treatment Phase|Missing reason|18
72178|NCT00069095|273293|P4|Post-study Treatment Phase|Missing reason|8
72179|NCT00069095|273294|P3|Post-study Treatment Phase|Missing reason|12
72180|NCT00069095|273295|P2|Post-study Treatment Phase|Missing reason|3
72181|NCT00069095|273296|P1|Post-study Treatment Phase|Missing reason|1
72182|NCT00069095|273291|P6|Primary Treatment Phase|Violation criteria|5
72183|NCT00069095|273292|P5|Primary Treatment Phase|Violation criteria|1
72184|NCT00069095|273293|P4|Primary Treatment Phase|Violation criteria|3
72185|NCT00069095|273294|P3|Primary Treatment Phase|Violation criteria|4
72186|NCT00069095|273295|P2|Primary Treatment Phase|Violation criteria|2
72187|NCT00069095|273296|P1|Primary Treatment Phase|Violation criteria|0
72188|NCT00069095|273291|P6|Primary Treatment Phase|Other Violation|1
72189|NCT00069095|273292|P5|Primary Treatment Phase|Other Violation|0
72190|NCT00069095|273293|P4|Primary Treatment Phase|Other Violation|1
72191|NCT00069095|273294|P3|Primary Treatment Phase|Other Violation|1
72192|NCT00069095|273295|P2|Primary Treatment Phase|Other Violation|1
72193|NCT00069095|273296|P1|Primary Treatment Phase|Other Violation|0
72194|NCT00069095|273291|P6|Primary Treatment Phase|Withdrew|9
72195|NCT00069095|273292|P5|Primary Treatment Phase|Withdrew|4
72196|NCT00069095|273293|P4|Primary Treatment Phase|Withdrew|2
72197|NCT00069095|273294|P3|Primary Treatment Phase|Withdrew|8
72198|NCT00069095|273295|P2|Primary Treatment Phase|Withdrew|3
72199|NCT00069095|273296|P1|Primary Treatment Phase|Withdrew|2
72200|NCT00069095|273291|P6|Primary Treatment Phase|Refused treatment|27
72201|NCT00069095|273292|P5|Primary Treatment Phase|Refused treatment|24
72202|NCT00069095|273293|P4|Primary Treatment Phase|Refused treatment|31
72203|NCT00069095|273294|P3|Primary Treatment Phase|Refused treatment|17
72204|NCT00069095|273295|P2|Primary Treatment Phase|Refused treatment|26
72205|NCT00069095|273296|P1|Primary Treatment Phase|Refused treatment|15
72206|NCT00069095|273291|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
72207|NCT00069095|273292|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
72208|NCT00069095|273293|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
72209|NCT00069095|273294|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
72210|NCT00069095|273295|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
72211|NCT00069095|273296|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
72212|NCT00069095|273291|P6|Primary Treatment Phase|Failure to return|2
72213|NCT00069095|273292|P5|Primary Treatment Phase|Failure to return|0
72214|NCT00069095|273293|P4|Primary Treatment Phase|Failure to return|0
72215|NCT00069095|273294|P3|Primary Treatment Phase|Failure to return|0
72216|NCT00069095|273295|P2|Primary Treatment Phase|Failure to return|5
72217|NCT00069095|273296|P1|Primary Treatment Phase|Failure to return|5
72218|NCT00069095|273291|P6|Primary Treatment Phase|Death|8
72219|NCT00069095|273292|P5|Primary Treatment Phase|Death|8
72220|NCT00069095|273293|P4|Primary Treatment Phase|Death|5
72221|NCT00069095|273294|P3|Primary Treatment Phase|Death|2
72222|NCT00069095|273295|P2|Primary Treatment Phase|Death|8
72223|NCT00069095|273296|P1|Primary Treatment Phase|Death|14
72224|NCT00069095|273291|P6|Primary Treatment Phase|Adverse Event|101
72225|NCT00069095|273292|P5|Primary Treatment Phase|Adverse Event|109
72226|NCT00069095|273293|P4|Primary Treatment Phase|Adverse Event|72
72227|NCT00069095|273294|P3|Primary Treatment Phase|Adverse Event|71
72228|NCT00069095|273295|P2|Primary Treatment Phase|Adverse Event|92
72229|NCT00069095|273296|P1|Primary Treatment Phase|Adverse Event|99
72230|NCT00069095|273291|P6|Primary Treatment Phase|Admin/Other|42
72231|NCT00069095|273292|P5|Primary Treatment Phase|Admin/Other|48
72232|NCT00069095|273293|P4|Primary Treatment Phase|Admin/Other|45
72233|NCT00069095|273294|P3|Primary Treatment Phase|Admin/Other|31
72234|NCT00069095|273295|P2|Primary Treatment Phase|Admin/Other|38
72235|NCT00069095|273296|P1|Primary Treatment Phase|Admin/Other|29
72236|NCT00069095|273291|P6|Primary Treatment Phase|Ongoing|4
72237|NCT00069095|273292|P5|Primary Treatment Phase|Ongoing|7
72238|NCT00069095|273293|P4|Primary Treatment Phase|Ongoing|7
72239|NCT00069095|273294|P3|Primary Treatment Phase|Ongoing|5
72240|NCT00069095|273295|P2|Primary Treatment Phase|Ongoing|0
72241|NCT00069095|273296|P1|Primary Treatment Phase|Ongoing|0
72242|NCT00069108|273350|P2|Overall Study|Refused treatment|10
72243|NCT00069108|273351|P1|Overall Study|Refused treatment|5
72244|NCT00069108|273350|P2|Overall Study|Violation criteria|4
72245|NCT00069108|273351|P1|Overall Study|Violation criteria|1
72246|NCT00069108|273350|P2|Overall Study|Insufficient therapy|144
72247|NCT00069108|273351|P1|Overall Study|Insufficient therapy|117
72248|NCT00069108|273350|P2|Overall Study|Administration|4
72249|NCT00069108|273351|P1|Overall Study|Administration|15
72250|NCT00069108|273350|P2|Overall Study|Death|6
72251|NCT00069108|273351|P1|Overall Study|Death|6
72252|NCT00069108|273350|P2|Overall Study|Adverse Event|42
72253|NCT00069108|273351|P1|Overall Study|Adverse Event|64
72254|NCT00069108|273350|P2|Overall Study|Withdrawal by Subject|9
72255|NCT00069108|273351|P1|Overall Study|Withdrawal by Subject|5
72256|NCT00069121|273379|P2|Overall Study|Lost to Follow-up|57
72257|NCT00069121|273380|P1|Overall Study|Lost to Follow-up|57
72258|NCT00069121|273379|P2|Overall Study|Withdrawal by Subject|22
72259|NCT00069121|273380|P1|Overall Study|Withdrawal by Subject|20
72260|NCT00069121|273379|P2|Overall Study|Death|197
72261|NCT00069121|273380|P1|Overall Study|Death|225
72262|NCT00069238|273416|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
72263|NCT00069238|273417|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
72264|NCT00069238|273418|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
72265|NCT00069238|273416|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
72266|NCT00069238|273417|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
72267|NCT00069238|273418|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
72268|NCT00069238|273416|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
72269|NCT00069238|273417|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
72270|NCT00069238|273418|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
72271|NCT00069264|273423|P1|Overall Study|Discon Therapy|3
72272|NCT00069264|273423|P1|Overall Study|Withdrawal by Subject|3
72273|NCT00069264|273423|P1|Overall Study|Progressive Disease|23
72274|NCT00069264|273423|P1|Overall Study|Adverse Event|3
72275|NCT00069277|273427|P1|Overall Study|Physician Decision|2
72276|NCT00069277|273427|P1|Overall Study|Progressive Disease|15
72277|NCT00069277|273427|P1|Overall Study|Withdrawal by Subject|1
72278|NCT00069277|273427|P1|Overall Study|Adverse Event|3
72279|NCT00069641|273458|P3|Overall Study|Death|1
72280|NCT00069641|273459|P2|Overall Study|Death|0
72281|NCT00069641|273460|P1|Overall Study|Death|1
72282|NCT00069784|273487|P2|Overall Study|Other|0
72283|NCT00069784|273488|P1|Overall Study|Other|17
72284|NCT00069784|273487|P2|Overall Study|Withdrawal by Subject|0
72285|NCT00069784|273488|P1|Overall Study|Withdrawal by Subject|1090
72286|NCT00069784|273487|P2|Overall Study|Adverse Event|0
72287|NCT00069784|273488|P1|Overall Study|Adverse Event|105
72288|NCT00069823|273508|P2|Overall Study|Did not have follow-up diary cards|3
72289|NCT00069823|273509|P1|Overall Study|Did not have follow-up diary cards|6
72290|NCT00069953|273549|P1|Overall Study|Protocol Violation|2
72291|NCT00070018|273553|P1|Overall Study|Withdrawal by Subject|1
72292|NCT00070018|273553|P1|Overall Study|Lack of Efficacy|1
72293|NCT00070018|273553|P1|Overall Study|Adverse Event|2
72294|NCT00070109|273659|P5|Overall Study|removed from prot thpy prior to chemo|0
72295|NCT00070109|273660|P4|Overall Study|removed from prot thpy prior to chemo|1
72296|NCT00070109|273661|P3|Overall Study|removed from prot thpy prior to chemo|0
72297|NCT00070109|273662|P2|Overall Study|removed from prot thpy prior to chemo|0
72298|NCT00070109|273663|P1|Overall Study|removed from prot thpy prior to chemo|0
72299|NCT00070109|273659|P5|Overall Study|Adverse Event|2
72300|NCT00070109|273660|P4|Overall Study|Adverse Event|4
72301|NCT00070109|273661|P3|Overall Study|Adverse Event|2
72302|NCT00070109|273662|P2|Overall Study|Adverse Event|0
72303|NCT00070109|273663|P1|Overall Study|Adverse Event|0
72304|NCT00070109|273659|P5|Overall Study|Withdrawal by Subject|0
72305|NCT00070109|273660|P4|Overall Study|Withdrawal by Subject|0
72306|NCT00070109|273661|P3|Overall Study|Withdrawal by Subject|1
72307|NCT00070109|273662|P2|Overall Study|Withdrawal by Subject|1
72308|NCT00070109|273663|P1|Overall Study|Withdrawal by Subject|0
72309|NCT00070109|273659|P5|Overall Study|Physician Decision|0
72310|NCT00070109|273660|P4|Overall Study|Physician Decision|0
72311|NCT00070109|273661|P3|Overall Study|Physician Decision|0
72312|NCT00070109|273662|P2|Overall Study|Physician Decision|0
72313|NCT00070109|273663|P1|Overall Study|Physician Decision|1
72314|NCT00070109|273659|P5|Overall Study|Lack of Efficacy|5
72315|NCT00070109|273660|P4|Overall Study|Lack of Efficacy|15
72316|NCT00070109|273661|P3|Overall Study|Lack of Efficacy|5
72317|NCT00070109|273662|P2|Overall Study|Lack of Efficacy|4
72318|NCT00070109|273663|P1|Overall Study|Lack of Efficacy|6
72319|NCT00070109|273659|P5|Overall Study|Death|1
72320|NCT00070109|273660|P4|Overall Study|Death|0
72321|NCT00070109|273661|P3|Overall Study|Death|0
72322|NCT00070109|273662|P2|Overall Study|Death|1
72323|NCT00070109|273663|P1|Overall Study|Death|1
72324|NCT00070291|273682|P1|Step 2|Adverse Event|1
72325|NCT00070291|273682|P1|Step 1|Adverse Event|1
72326|NCT00070291|273682|P1|Step 1|Withdrawal by Subject|1
72327|NCT00070499|273691|P4|Overall Study|Not eligible|2
72328|NCT00070499|273692|P3|Overall Study|Not eligible|3
72329|NCT00070499|273693|P2|Overall Study|Not eligible|5
72330|NCT00070499|273694|P1|Overall Study|Not eligible|2
72331|NCT00070499|273691|P4|Overall Study|Did not start treatment|2
72332|NCT00070499|273692|P3|Overall Study|Did not start treatment|0
72333|NCT00070499|273693|P2|Overall Study|Did not start treatment|0
72334|NCT00070499|273694|P1|Overall Study|Did not start treatment|1
72335|NCT00070499|273691|P4|Overall Study|Still on protocol treatment|57
72336|NCT00070499|273692|P3|Overall Study|Still on protocol treatment|79
72337|NCT00070499|273693|P2|Overall Study|Still on protocol treatment|4
72338|NCT00070499|273694|P1|Overall Study|Still on protocol treatment|10
72339|NCT00070499|273691|P4|Overall Study|Other - not protocol specified|20
72340|NCT00070499|273692|P3|Overall Study|Other - not protocol specified|12
72341|NCT00070499|273693|P2|Overall Study|Other - not protocol specified|3
72342|NCT00070499|273694|P1|Overall Study|Other - not protocol specified|7
72343|NCT00070499|273691|P4|Overall Study|Death|2
72344|NCT00070499|273692|P3|Overall Study|Death|1
72345|NCT00070499|273693|P2|Overall Study|Death|1
72346|NCT00070499|273694|P1|Overall Study|Death|1
72347|NCT00070499|273691|P4|Overall Study|Progression/relapse|4
72348|NCT00070499|273692|P3|Overall Study|Progression/relapse|1
72349|NCT00070499|273693|P2|Overall Study|Progression/relapse|2
72350|NCT00070499|273694|P1|Overall Study|Progression/relapse|4
72351|NCT00070499|273691|P4|Overall Study|Refusal unrelated to adverse effects|8
72352|NCT00070499|273692|P3|Overall Study|Refusal unrelated to adverse effects|5
72353|NCT00070499|273693|P2|Overall Study|Refusal unrelated to adverse effects|5
72354|NCT00070499|273694|P1|Overall Study|Refusal unrelated to adverse effects|7
72355|NCT00070499|273691|P4|Overall Study|Adverse Event|15
72356|NCT00070499|273692|P3|Overall Study|Adverse Event|19
72357|NCT00070499|273693|P2|Overall Study|Adverse Event|6
72358|NCT00070499|273694|P1|Overall Study|Adverse Event|6
72359|NCT00071487|273724|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
72360|NCT00071487|273725|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
72361|NCT00071487|273726|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
72362|NCT00071487|273727|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
72363|NCT00071487|273724|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
72364|NCT00071487|273725|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
72365|NCT00071487|273726|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
72366|NCT00071487|273727|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
72367|NCT00071487|273724|P4|24-Week Open-Label Extension Period|Pregnancy|1
72368|NCT00071487|273725|P3|24-Week Open-Label Extension Period|Pregnancy|0
72369|NCT00071487|273726|P2|24-Week Open-Label Extension Period|Pregnancy|0
72370|NCT00071487|273727|P1|24-Week Open-Label Extension Period|Pregnancy|0
72371|NCT00071487|273724|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
72372|NCT00071487|273725|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
72373|NCT00071487|273726|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
72374|NCT00071487|273727|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
72375|NCT00071487|273724|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
72376|NCT00071487|273725|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
72377|NCT00071487|273726|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
72378|NCT00071487|273727|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
72379|NCT00071487|273724|P4|24-Week Open-Label Extension Period|Adverse Event|6
72380|NCT00071487|273725|P3|24-Week Open-Label Extension Period|Adverse Event|1
72381|NCT00071487|273726|P2|24-Week Open-Label Extension Period|Adverse Event|0
72382|NCT00071487|273727|P1|24-Week Open-Label Extension Period|Adverse Event|0
72383|NCT00071487|273724|P4|52-Week Double-Blind Period|Lack of Compliance|3
72384|NCT00071487|273725|P3|52-Week Double-Blind Period|Lack of Compliance|3
72385|NCT00071487|273726|P2|52-Week Double-Blind Period|Lack of Compliance|3
72386|NCT00071487|273727|P1|52-Week Double-Blind Period|Lack of Compliance|6
72387|NCT00071487|273724|P4|52-Week Double-Blind Period|Death|0
72388|NCT00071487|273725|P3|52-Week Double-Blind Period|Death|0
72389|NCT00071487|273726|P2|52-Week Double-Blind Period|Death|1
72390|NCT00071487|273727|P1|52-Week Double-Blind Period|Death|0
72391|NCT00071487|273724|P4|52-Week Double-Blind Period|Protocol Violation|0
72392|NCT00071487|273725|P3|52-Week Double-Blind Period|Protocol Violation|1
72393|NCT00071487|273726|P2|52-Week Double-Blind Period|Protocol Violation|1
72394|NCT00071487|273727|P1|52-Week Double-Blind Period|Protocol Violation|0
72395|NCT00071487|273724|P4|52-Week Double-Blind Period|Pregnancy|0
72396|NCT00071487|273725|P3|52-Week Double-Blind Period|Pregnancy|0
72397|NCT00071487|273726|P2|52-Week Double-Blind Period|Pregnancy|1
72398|NCT00071487|273727|P1|52-Week Double-Blind Period|Pregnancy|0
72399|NCT00071487|273724|P4|52-Week Double-Blind Period|Lost to Follow-up|2
72400|NCT00071487|273725|P3|52-Week Double-Blind Period|Lost to Follow-up|2
72401|NCT00071487|273726|P2|52-Week Double-Blind Period|Lost to Follow-up|0
72402|NCT00071487|273727|P1|52-Week Double-Blind Period|Lost to Follow-up|0
72403|NCT00071487|273724|P4|52-Week Double-Blind Period|Physician Decision|0
72404|NCT00071487|273725|P3|52-Week Double-Blind Period|Physician Decision|0
72405|NCT00071487|273726|P2|52-Week Double-Blind Period|Physician Decision|0
72406|NCT00071487|273727|P1|52-Week Double-Blind Period|Physician Decision|1
72407|NCT00071487|273724|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
72408|NCT00071487|273725|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
72409|NCT00071487|273726|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
72410|NCT00071487|273727|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
72411|NCT00071487|273724|P4|52-Week Double-Blind Period|Lack of Efficacy|1
72412|NCT00071487|273725|P3|52-Week Double-Blind Period|Lack of Efficacy|0
72413|NCT00071487|273726|P2|52-Week Double-Blind Period|Lack of Efficacy|2
72414|NCT00071487|273727|P1|52-Week Double-Blind Period|Lack of Efficacy|1
72415|NCT00071487|273724|P4|52-Week Double-Blind Period|Adverse Event|8
72416|NCT00071487|273725|P3|52-Week Double-Blind Period|Adverse Event|4
72417|NCT00071487|273726|P2|52-Week Double-Blind Period|Adverse Event|8
72418|NCT00071487|273727|P1|52-Week Double-Blind Period|Adverse Event|5
72419|NCT00071513|273773|P2|Follow-up Assessment|Withdrawal by Subject|6
72420|NCT00071513|273774|P1|Follow-up Assessment|Withdrawal by Subject|6
72421|NCT00071513|273773|P2|Intervention Component|Withdrawal by Subject|3
72422|NCT00071513|273774|P1|Intervention Component|Withdrawal by Subject|2
72423|NCT00071760|273801|P1|Overall Study|Ongoing|25
72424|NCT00071760|273801|P1|Overall Study|Study Team Rec./Resistance|1
72425|NCT00071760|273801|P1|Overall Study|Investigator's Recommendation (Rec.)|4
72426|NCT00071760|273801|P1|Overall Study|Relocation|1
72427|NCT00071760|273801|P1|Overall Study|Unavailability of RTV|8
72428|NCT00071760|273801|P1|Overall Study|Pulmonary Tuberculosis|1
72429|NCT00071760|273801|P1|Overall Study|Insufficient Viral Load Response|3
72430|NCT00071760|273801|P1|Overall Study|Withdrawal by Subject|3
72431|NCT00071760|273801|P1|Overall Study|Protocol Violation|1
72432|NCT00071760|273801|P1|Overall Study|Lost to Follow-up|4
72433|NCT00071760|273801|P1|Overall Study|Adverse Event|3
72434|NCT00071799|273862|P2|Overall Study|Not Documented|2
72435|NCT00071799|273863|P1|Overall Study|Not Documented|0
72436|NCT00071799|273862|P2|Overall Study|Different Central+Local Pathology Review|1
72437|NCT00071799|273863|P1|Overall Study|Different Central+Local Pathology Review|0
72438|NCT00071799|273862|P2|Overall Study|Disease Progression|20
72439|NCT00071799|273863|P1|Overall Study|Disease Progression|23
72440|NCT00071799|273862|P2|Overall Study|Lack of Efficacy|18
72441|NCT00071799|273863|P1|Overall Study|Lack of Efficacy|11
72442|NCT00071799|273862|P2|Overall Study|Physician Decision|2
72443|NCT00071799|273863|P1|Overall Study|Physician Decision|0
72444|NCT00071799|273862|P2|Overall Study|Withdrawal by Subject|37
72445|NCT00071799|273863|P1|Overall Study|Withdrawal by Subject|15
72446|NCT00071799|273862|P2|Overall Study|Lost to Follow-up|1
72447|NCT00071799|273863|P1|Overall Study|Lost to Follow-up|1
72448|NCT00071799|273862|P2|Overall Study|Protocol Violation|7
72449|NCT00071799|273863|P1|Overall Study|Protocol Violation|1
72450|NCT00071799|273862|P2|Overall Study|Adverse Event|10
72451|NCT00071799|273863|P1|Overall Study|Adverse Event|19
72452|NCT00071812|273907|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
72453|NCT00071812|273908|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
72454|NCT00071812|273909|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
72455|NCT00071812|273910|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
72456|NCT00071812|273907|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
72457|NCT00071812|273908|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
72458|NCT00071812|273909|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
72459|NCT00071812|273910|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
72460|NCT00071812|273907|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
72461|NCT00071812|273908|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
72462|NCT00071812|273909|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
72463|NCT00071812|273910|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
72464|NCT00071812|273907|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
72465|NCT00071812|273908|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
72466|NCT00071812|273909|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
72467|NCT00071812|273910|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
72468|NCT00071812|273907|P4|24-Week Open-Label Extension Period|Adverse Event|7
72469|NCT00071812|273908|P3|24-Week Open-Label Extension Period|Adverse Event|0
72470|NCT00071812|273909|P2|24-Week Open-Label Extension Period|Adverse Event|0
72471|NCT00071812|273910|P1|24-Week Open-Label Extension Period|Adverse Event|0
72472|NCT00071812|273907|P4|24-Week Double-Blind Period|Protocol Violation|1
72473|NCT00071812|273908|P3|24-Week Double-Blind Period|Protocol Violation|0
72474|NCT00071812|273909|P2|24-Week Double-Blind Period|Protocol Violation|0
72475|NCT00071812|273910|P1|24-Week Double-Blind Period|Protocol Violation|0
72476|NCT00071812|273907|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
72477|NCT00071812|273908|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
72478|NCT00071812|273909|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
72479|NCT00071812|273910|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
72480|NCT00071812|273907|P4|24-Week Double-Blind Period|Lost to Follow-up|0
72481|NCT00071812|273908|P3|24-Week Double-Blind Period|Lost to Follow-up|1
72482|NCT00071812|273909|P2|24-Week Double-Blind Period|Lost to Follow-up|1
72483|NCT00071812|273910|P1|24-Week Double-Blind Period|Lost to Follow-up|0
72484|NCT00071812|273907|P4|24-Week Double-Blind Period|Lack of Efficacy|1
72485|NCT00071812|273908|P3|24-Week Double-Blind Period|Lack of Efficacy|2
72486|NCT00071812|273909|P2|24-Week Double-Blind Period|Lack of Efficacy|1
72487|NCT00071812|273910|P1|24-Week Double-Blind Period|Lack of Efficacy|3
72488|NCT00071812|273907|P4|24-Week Double-Blind Period|Adverse Event|4
72489|NCT00071812|273908|P3|24-Week Double-Blind Period|Adverse Event|4
72490|NCT00071812|273909|P2|24-Week Double-Blind Period|Adverse Event|3
72491|NCT00071812|273910|P1|24-Week Double-Blind Period|Adverse Event|2
72492|NCT00071981|273967|P4|Overall Study|others (not specified in the study)|0
72493|NCT00071981|273968|P3|Overall Study|others (not specified in the study)|2
72494|NCT00071981|273969|P2|Overall Study|others (not specified in the study)|2
72495|NCT00071981|273970|P1|Overall Study|others (not specified in the study)|0
72496|NCT00071981|273967|P4|Overall Study|No protocol therapy|0
72497|NCT00071981|273968|P3|Overall Study|No protocol therapy|1
72498|NCT00071981|273969|P2|Overall Study|No protocol therapy|5
72499|NCT00071981|273970|P1|Overall Study|No protocol therapy|2
72500|NCT00071981|273967|P4|Overall Study|Withdrawal by Subject|0
72501|NCT00071981|273968|P3|Overall Study|Withdrawal by Subject|0
72502|NCT00071981|273969|P2|Overall Study|Withdrawal by Subject|1
72503|NCT00071981|273970|P1|Overall Study|Withdrawal by Subject|3
72504|NCT00071981|273967|P4|Overall Study|Death|1
72505|NCT00071981|273968|P3|Overall Study|Death|1
72506|NCT00071981|273969|P2|Overall Study|Death|0
72507|NCT00071981|273970|P1|Overall Study|Death|0
72508|NCT00071981|273967|P4|Overall Study|Adverse Event|1
72509|NCT00071981|273968|P3|Overall Study|Adverse Event|3
72510|NCT00071981|273969|P2|Overall Study|Adverse Event|4
72511|NCT00071981|273970|P1|Overall Study|Adverse Event|4
72512|NCT00071981|273967|P4|Overall Study|Lack of Efficacy|43
72513|NCT00071981|273968|P3|Overall Study|Lack of Efficacy|30
72514|NCT00071981|273969|P2|Overall Study|Lack of Efficacy|29
72515|NCT00071981|273970|P1|Overall Study|Lack of Efficacy|37
72516|NCT00072176|273998|P2|Overall Study|Protocol Violation|1
72517|NCT00072176|273999|P1|Overall Study|Protocol Violation|0
72518|NCT00072176|273998|P2|Overall Study|Withdrawal by Subject|0
72519|NCT00072176|273999|P1|Overall Study|Withdrawal by Subject|1
72520|NCT00072189|274007|P1|Overall Study|Withdrawal by Subject|1
72521|NCT00072280|274015|P2|Follow-up|Early termination of study|2
72522|NCT00072280|274016|P1|Follow-up|Early termination of study|2
72523|NCT00072280|274015|P2|Treatment|Found ineligible|2
72524|NCT00072280|274016|P1|Treatment|Found ineligible|1
72525|NCT00072293|274023|P2|Overall Study|Withdrawal by Subject|1
72526|NCT00072293|274024|P1|Overall Study|Withdrawal by Subject|0
72527|NCT00072293|274023|P2|Overall Study|Lost to Follow-up|1
72528|NCT00072293|274024|P1|Overall Study|Lost to Follow-up|1
72529|NCT00072475|274041|P1|Overall Study|Patient/Investigator Decision|4
72530|NCT00072475|274041|P1|Overall Study|Withdrawal by Subject|46
72531|NCT00072475|274041|P1|Overall Study|Death|3
72532|NCT00072475|274041|P1|Overall Study|Adverse Event|44
72533|NCT00073008|274073|P2|Overall Study|"Other selected on Case Report Form"|5
72534|NCT00073008|274074|P1|Overall Study|"Other selected on Case Report Form"|7
72535|NCT00073008|274073|P2|Overall Study|Death|47
72536|NCT00073008|274074|P1|Overall Study|Death|46
72537|NCT00073008|274073|P2|Overall Study|Lost to Follow-up|3
72538|NCT00073008|274074|P1|Overall Study|Lost to Follow-up|1
72539|NCT00073008|274073|P2|Overall Study|Withdrawal by Subject|2
72540|NCT00073008|274074|P1|Overall Study|Withdrawal by Subject|2
72541|NCT00073008|274073|P2|Overall Study|Missing|6
72542|NCT00073008|274074|P1|Overall Study|Missing|6
72543|NCT00073021|274106|P2|Overall Study|Lack of Efficacy|5
72544|NCT00073021|274107|P1|Overall Study|Lack of Efficacy|11
72545|NCT00073021|274106|P2|Overall Study|Physician Decision|1
72546|NCT00073021|274107|P1|Overall Study|Physician Decision|3
72547|NCT00073021|274106|P2|Overall Study|Withdrawal by Subject|5
72548|NCT00073021|274107|P1|Overall Study|Withdrawal by Subject|6
72549|NCT00073021|274106|P2|Overall Study|Adverse Event|4
72550|NCT00073021|274107|P1|Overall Study|Adverse Event|4
72551|NCT00073021|274106|P2|Overall Study|Protocol Violation|1
72552|NCT00073021|274107|P1|Overall Study|Protocol Violation|2
72553|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
72554|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
72555|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
72556|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
72557|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
72558|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
72559|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
72560|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
72561|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
72562|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
72563|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
72564|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
72639|NCT00074152|274356|P1|Overall Study|Lack of Efficacy|34
72565|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
72566|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
72567|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
72568|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
72569|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
72570|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
72571|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
72572|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
72573|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
72574|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
72575|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
72576|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
72577|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
72578|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
72579|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
72580|NCT00073307|274148|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
72581|NCT00073307|274149|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
72582|NCT00073307|274150|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
72583|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
72584|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
72585|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
72586|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
72587|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
72588|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
72589|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
72590|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
72591|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
72592|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
72593|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
72594|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
72595|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
72596|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
72597|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
72598|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
72599|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
72684|NCT00075218|274475|P3|Double-Blind Treatment|Lost to Follow-up|0
72600|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
72601|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
72602|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
72603|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
72604|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
72605|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
72606|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
72607|NCT00073307|274148|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
72608|NCT00073307|274149|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
72609|NCT00073307|274150|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
72610|NCT00073528|274183|P2|Overall Study|Ongoing|344
72611|NCT00073528|274184|P1|Overall Study|Ongoing|349
72612|NCT00073528|274183|P2|Overall Study|Non-compliance|1
72613|NCT00073528|274184|P1|Overall Study|Non-compliance|0
72614|NCT00073528|274183|P2|Overall Study|Enrolled in Error|1
72615|NCT00073528|274184|P1|Overall Study|Enrolled in Error|0
72616|NCT00073528|274183|P2|Overall Study|Participant Was Unblinded|1
72617|NCT00073528|274184|P1|Overall Study|Participant Was Unblinded|0
72618|NCT00073528|274183|P2|Overall Study|Progressive Disease|1
72619|NCT00073528|274184|P1|Overall Study|Progressive Disease|0
72620|NCT00073528|274183|P2|Overall Study|Randomized in Error; Not Treated|0
72621|NCT00073528|274184|P1|Overall Study|Randomized in Error; Not Treated|2
72622|NCT00073528|274183|P2|Overall Study|Mastectomy Intervention|0
72623|NCT00073528|274184|P1|Overall Study|Mastectomy Intervention|1
72624|NCT00073528|274183|P2|Overall Study|Death|238
72625|NCT00073528|274184|P1|Overall Study|Death|229
72626|NCT00073528|274183|P2|Overall Study|Protocol Violation|5
72627|NCT00073528|274184|P1|Overall Study|Protocol Violation|3
72628|NCT00073528|274183|P2|Overall Study|Lost to Follow-up|22
72629|NCT00073528|274184|P1|Overall Study|Lost to Follow-up|26
72630|NCT00073528|274183|P2|Overall Study|Withdrawal by Subject|29
72631|NCT00073528|274184|P1|Overall Study|Withdrawal by Subject|34
72632|NCT00073918|274258|P1|Overall Study|Eligibility requirement not met-low CD20|1
72633|NCT00073918|274258|P1|Overall Study|Rapid disease progression|2
72634|NCT00073918|274258|P1|Overall Study|Eligibility requirement not met - HAMA+|1
72635|NCT00073983|274265|P1|Overall Study|not evaluable|1
72636|NCT00066807|274289|P2|Overall Study|Study was terminated early|15
72637|NCT00066807|274290|P1|Overall Study|Study was terminated early|14
72638|NCT00074152|274355|P2|Overall Study|Lack of Efficacy|24
72640|NCT00074152|274355|P2|Overall Study|Death|9
72641|NCT00074152|274356|P1|Overall Study|Death|21
72642|NCT00074412|274377|P2|Overall Study|Lost to Follow-up|58
72643|NCT00074412|274378|P1|Overall Study|Lost to Follow-up|52
72644|NCT00074412|274377|P2|Overall Study|Death|26
72645|NCT00074412|274378|P1|Overall Study|Death|30
72646|NCT00074958|274426|P1|Overall Study|Adverse Event|1
72647|NCT00074984|274433|P2|Overall Study|Patient Withdrawn Per Protocol|3
72648|NCT00074984|274434|P1|Overall Study|Patient Withdrawn Per Protocol|0
72649|NCT00074984|274433|P2|Overall Study|Withdrawal by Subject|3
72650|NCT00074984|274434|P1|Overall Study|Withdrawal by Subject|2
72651|NCT00074984|274433|P2|Overall Study|Death|2
72652|NCT00074984|274434|P1|Overall Study|Death|1
72653|NCT00075023|274451|P2|Pilot Study|Withdrawal by Subject|0
72654|NCT00075023|274452|P1|Pilot Study|Withdrawal by Subject|1
72655|NCT00075023|274451|P2|Pilot Study|Physician Decision|2
72656|NCT00075023|274452|P1|Pilot Study|Physician Decision|1
72657|NCT00075218|274475|P3|Open-Label Treatment|enrolled in a separate continuation|9
72658|NCT00075218|274476|P2|Open-Label Treatment|enrolled in a separate continuation|0
72659|NCT00075218|274477|P1|Open-Label Treatment|enrolled in a separate continuation|0
72660|NCT00075218|274475|P3|Open-Label Treatment|Protocol Violation|1
72661|NCT00075218|274476|P2|Open-Label Treatment|Protocol Violation|0
72662|NCT00075218|274477|P1|Open-Label Treatment|Protocol Violation|0
72663|NCT00075218|274475|P3|Open-Label Treatment|Decision of Sponsor|8
72664|NCT00075218|274476|P2|Open-Label Treatment|Decision of Sponsor|0
72665|NCT00075218|274477|P1|Open-Label Treatment|Decision of Sponsor|0
72666|NCT00075218|274475|P3|Open-Label Treatment|Withdrawal by Subject|12
72667|NCT00075218|274476|P2|Open-Label Treatment|Withdrawal by Subject|0
72668|NCT00075218|274477|P1|Open-Label Treatment|Withdrawal by Subject|0
72669|NCT00075218|274475|P3|Open-Label Treatment|Adverse Event|51
72670|NCT00075218|274476|P2|Open-Label Treatment|Adverse Event|0
72671|NCT00075218|274477|P1|Open-Label Treatment|Adverse Event|0
72672|NCT00075218|274475|P3|Open-Label Treatment|Lack of Efficacy|174
72673|NCT00075218|274476|P2|Open-Label Treatment|Lack of Efficacy|0
72674|NCT00075218|274477|P1|Open-Label Treatment|Lack of Efficacy|0
72675|NCT00075218|274475|P3|Double-Blind Treatment|No study medication taken|0
72676|NCT00075218|274476|P2|Double-Blind Treatment|No study medication taken|0
72677|NCT00075218|274477|P1|Double-Blind Treatment|No study medication taken|2
72678|NCT00075218|274475|P3|Double-Blind Treatment|Decision of Sponsor|0
72679|NCT00075218|274476|P2|Double-Blind Treatment|Decision of Sponsor|1
72680|NCT00075218|274477|P1|Double-Blind Treatment|Decision of Sponsor|0
72681|NCT00075218|274475|P3|Double-Blind Treatment|Lack of Efficacy|0
72682|NCT00075218|274476|P2|Double-Blind Treatment|Lack of Efficacy|6
72683|NCT00075218|274477|P1|Double-Blind Treatment|Lack of Efficacy|58
72685|NCT00075218|274476|P2|Double-Blind Treatment|Lost to Follow-up|0
72686|NCT00075218|274477|P1|Double-Blind Treatment|Lost to Follow-up|1
72687|NCT00075218|274475|P3|Double-Blind Treatment|Withdrawal by Subject|0
72688|NCT00075218|274476|P2|Double-Blind Treatment|Withdrawal by Subject|4
72689|NCT00075218|274477|P1|Double-Blind Treatment|Withdrawal by Subject|7
72690|NCT00075218|274475|P3|Double-Blind Treatment|Adverse Event|0
72691|NCT00075218|274476|P2|Double-Blind Treatment|Adverse Event|4
72692|NCT00075218|274477|P1|Double-Blind Treatment|Adverse Event|23
72693|NCT00075270|274512|P2|Overall Study|Missing|13
72694|NCT00075270|274513|P1|Overall Study|Missing|26
72695|NCT00075270|274512|P2|Overall Study|Other/Unknown|5
72696|NCT00075270|274513|P1|Overall Study|Other/Unknown|9
72697|NCT00075270|274512|P2|Overall Study|Death|215
72698|NCT00075270|274513|P1|Overall Study|Death|198
72699|NCT00075270|274512|P2|Overall Study|Protocol Violation|2
72700|NCT00075270|274513|P1|Overall Study|Protocol Violation|0
72701|NCT00075270|274512|P2|Overall Study|Lost to Follow-up|28
72702|NCT00075270|274513|P1|Overall Study|Lost to Follow-up|25
72703|NCT00075270|274512|P2|Overall Study|Withdrawal by Subject|21
72704|NCT00075270|274513|P1|Overall Study|Withdrawal by Subject|28
72705|NCT00075400|274557|P1|Overall Study|Never treated|2
72706|NCT00075400|274557|P1|Overall Study|Ineligible: wrong primary|1
72707|NCT00075478|274565|P2|Overall Study|Physician Decision|1
72708|NCT00075478|274566|P1|Overall Study|Physician Decision|0
72709|NCT00075478|274565|P2|Overall Study|not eligible|0
72710|NCT00075478|274566|P1|Overall Study|not eligible|1
72711|NCT00075504|274588|P2|Overall Study|Withdrawal by Subject|7
72712|NCT00075504|274589|P1|Overall Study|Withdrawal by Subject|9
72713|NCT00075582|274601|P2|Overall Study|Ineligible for study|16
72714|NCT00075582|274602|P1|Overall Study|Ineligible for study|36
72715|NCT00075582|274601|P2|Overall Study|Withdrawal by Subject|2
72716|NCT00075582|274602|P1|Overall Study|Withdrawal by Subject|2
72717|NCT00075582|274601|P2|Overall Study|Physician Decision|8
72718|NCT00075582|274602|P1|Overall Study|Physician Decision|5
72719|NCT00075582|274601|P2|Overall Study|Lack of Efficacy|8
72720|NCT00075582|274602|P1|Overall Study|Lack of Efficacy|4
72721|NCT00075582|274601|P2|Overall Study|Adverse Event|1
72722|NCT00075582|274602|P1|Overall Study|Adverse Event|3
72723|NCT00075725|274628|P12|Overall Study|Pt incarcerated|0
72724|NCT00075725|274629|P11|Overall Study|Pt incarcerated|0
72725|NCT00075725|274630|P10|Overall Study|Pt incarcerated|0
72726|NCT00075725|274631|P9|Overall Study|Pt incarcerated|0
72727|NCT00075725|274632|P8|Overall Study|Pt incarcerated|1
72728|NCT00075725|274633|P7|Overall Study|Pt incarcerated|0
72729|NCT00075725|274634|P6|Overall Study|Pt incarcerated|0
72730|NCT00075725|274635|P5|Overall Study|Pt incarcerated|0
72731|NCT00075725|274636|P4|Overall Study|Pt incarcerated|0
72732|NCT00075725|274637|P3|Overall Study|Pt incarcerated|0
72733|NCT00075725|274638|P2|Overall Study|Pt incarcerated|0
72734|NCT00075725|274639|P1|Overall Study|Pt incarcerated|0
72735|NCT00075725|274628|P12|Overall Study|Pt care terminated due to pt behavior|0
72736|NCT00075725|274629|P11|Overall Study|Pt care terminated due to pt behavior|0
72737|NCT00075725|274630|P10|Overall Study|Pt care terminated due to pt behavior|0
72738|NCT00075725|274631|P9|Overall Study|Pt care terminated due to pt behavior|0
72739|NCT00075725|274632|P8|Overall Study|Pt care terminated due to pt behavior|1
72740|NCT00075725|274633|P7|Overall Study|Pt care terminated due to pt behavior|0
72741|NCT00075725|274634|P6|Overall Study|Pt care terminated due to pt behavior|0
72742|NCT00075725|274635|P5|Overall Study|Pt care terminated due to pt behavior|0
72743|NCT00075725|274636|P4|Overall Study|Pt care terminated due to pt behavior|0
72744|NCT00075725|274637|P3|Overall Study|Pt care terminated due to pt behavior|0
72745|NCT00075725|274638|P2|Overall Study|Pt care terminated due to pt behavior|0
72746|NCT00075725|274639|P1|Overall Study|Pt care terminated due to pt behavior|0
72747|NCT00075725|274628|P12|Overall Study|Other complications|0
72748|NCT00075725|274629|P11|Overall Study|Other complications|0
72749|NCT00075725|274630|P10|Overall Study|Other complications|0
72750|NCT00075725|274631|P9|Overall Study|Other complications|0
72751|NCT00075725|274632|P8|Overall Study|Other complications|0
72752|NCT00075725|274633|P7|Overall Study|Other complications|0
72753|NCT00075725|274634|P6|Overall Study|Other complications|1
72754|NCT00075725|274635|P5|Overall Study|Other complications|0
72755|NCT00075725|274636|P4|Overall Study|Other complications|0
72756|NCT00075725|274637|P3|Overall Study|Other complications|0
72757|NCT00075725|274638|P2|Overall Study|Other complications|0
72758|NCT00075725|274639|P1|Overall Study|Other complications|0
72759|NCT00075725|274628|P12|Overall Study|Study Closure|0
72760|NCT00075725|274629|P11|Overall Study|Study Closure|0
72761|NCT00075725|274630|P10|Overall Study|Study Closure|0
72762|NCT00075725|274631|P9|Overall Study|Study Closure|0
72763|NCT00075725|274632|P8|Overall Study|Study Closure|1
72764|NCT00075725|274633|P7|Overall Study|Study Closure|0
72765|NCT00075725|274634|P6|Overall Study|Study Closure|3
72766|NCT00075725|274635|P5|Overall Study|Study Closure|1
72767|NCT00075725|274636|P4|Overall Study|Study Closure|0
72768|NCT00075725|274637|P3|Overall Study|Study Closure|0
72769|NCT00075725|274638|P2|Overall Study|Study Closure|0
72770|NCT00075725|274639|P1|Overall Study|Study Closure|1
72771|NCT00075725|274628|P12|Overall Study|Institution Terminated|0
72772|NCT00075725|274629|P11|Overall Study|Institution Terminated|0
72773|NCT00075725|274630|P10|Overall Study|Institution Terminated|0
72774|NCT00075725|274631|P9|Overall Study|Institution Terminated|0
72775|NCT00075725|274632|P8|Overall Study|Institution Terminated|3
72776|NCT00075725|274633|P7|Overall Study|Institution Terminated|0
72777|NCT00075725|274634|P6|Overall Study|Institution Terminated|0
72778|NCT00075725|274635|P5|Overall Study|Institution Terminated|1
72779|NCT00075725|274636|P4|Overall Study|Institution Terminated|0
72780|NCT00075725|274637|P3|Overall Study|Institution Terminated|0
72781|NCT00075725|274638|P2|Overall Study|Institution Terminated|0
72782|NCT00075725|274639|P1|Overall Study|Institution Terminated|0
72783|NCT00075725|274628|P12|Overall Study|Pt relocated|0
72784|NCT00075725|274629|P11|Overall Study|Pt relocated|0
72785|NCT00075725|274630|P10|Overall Study|Pt relocated|0
72786|NCT00075725|274631|P9|Overall Study|Pt relocated|1
72787|NCT00075725|274632|P8|Overall Study|Pt relocated|2
72788|NCT00075725|274633|P7|Overall Study|Pt relocated|1
72789|NCT00075725|274634|P6|Overall Study|Pt relocated|1
72790|NCT00075725|274635|P5|Overall Study|Pt relocated|0
72791|NCT00075725|274636|P4|Overall Study|Pt relocated|2
72792|NCT00075725|274637|P3|Overall Study|Pt relocated|0
72793|NCT00075725|274638|P2|Overall Study|Pt relocated|0
72794|NCT00075725|274639|P1|Overall Study|Pt relocated|0
72795|NCT00075725|274628|P12|Overall Study|Pt received additional steroids|0
72796|NCT00075725|274629|P11|Overall Study|Pt received additional steroids|0
72797|NCT00075725|274630|P10|Overall Study|Pt received additional steroids|0
72798|NCT00075725|274631|P9|Overall Study|Pt received additional steroids|0
72799|NCT00075725|274632|P8|Overall Study|Pt received additional steroids|0
72800|NCT00075725|274633|P7|Overall Study|Pt received additional steroids|0
72801|NCT00075725|274634|P6|Overall Study|Pt received additional steroids|0
72802|NCT00075725|274635|P5|Overall Study|Pt received additional steroids|0
72803|NCT00075725|274636|P4|Overall Study|Pt received additional steroids|1
72804|NCT00075725|274637|P3|Overall Study|Pt received additional steroids|0
72805|NCT00075725|274638|P2|Overall Study|Pt received additional steroids|0
72806|NCT00075725|274639|P1|Overall Study|Pt received additional steroids|0
72807|NCT00075725|274628|P12|Overall Study|Pt went to transplant|0
72808|NCT00075725|274629|P11|Overall Study|Pt went to transplant|0
72809|NCT00075725|274630|P10|Overall Study|Pt went to transplant|0
72810|NCT00075725|274631|P9|Overall Study|Pt went to transplant|0
72811|NCT00075725|274632|P8|Overall Study|Pt went to transplant|0
72812|NCT00075725|274633|P7|Overall Study|Pt went to transplant|0
72813|NCT00075725|274634|P6|Overall Study|Pt went to transplant|1
72814|NCT00075725|274635|P5|Overall Study|Pt went to transplant|0
72815|NCT00075725|274636|P4|Overall Study|Pt went to transplant|1
72816|NCT00075725|274637|P3|Overall Study|Pt went to transplant|0
72817|NCT00075725|274638|P2|Overall Study|Pt went to transplant|0
72818|NCT00075725|274639|P1|Overall Study|Pt went to transplant|0
72819|NCT00075725|274628|P12|Overall Study|specimen(s) not submitted|0
72820|NCT00075725|274629|P11|Overall Study|specimen(s) not submitted|0
72821|NCT00075725|274630|P10|Overall Study|specimen(s) not submitted|0
72822|NCT00075725|274631|P9|Overall Study|specimen(s) not submitted|0
72823|NCT00075725|274632|P8|Overall Study|specimen(s) not submitted|0
72824|NCT00075725|274633|P7|Overall Study|specimen(s) not submitted|0
72825|NCT00075725|274634|P6|Overall Study|specimen(s) not submitted|0
72826|NCT00075725|274635|P5|Overall Study|specimen(s) not submitted|0
72827|NCT00075725|274636|P4|Overall Study|specimen(s) not submitted|0
72828|NCT00075725|274637|P3|Overall Study|specimen(s) not submitted|2
72829|NCT00075725|274638|P2|Overall Study|specimen(s) not submitted|0
72830|NCT00075725|274639|P1|Overall Study|specimen(s) not submitted|0
72831|NCT00075725|274628|P12|Overall Study|Unsuccessful institutional transfer|0
72832|NCT00075725|274629|P11|Overall Study|Unsuccessful institutional transfer|0
72833|NCT00075725|274630|P10|Overall Study|Unsuccessful institutional transfer|1
72834|NCT00075725|274631|P9|Overall Study|Unsuccessful institutional transfer|0
72835|NCT00075725|274632|P8|Overall Study|Unsuccessful institutional transfer|0
72836|NCT00075725|274633|P7|Overall Study|Unsuccessful institutional transfer|0
72837|NCT00075725|274634|P6|Overall Study|Unsuccessful institutional transfer|0
72838|NCT00075725|274635|P5|Overall Study|Unsuccessful institutional transfer|0
72839|NCT00075725|274636|P4|Overall Study|Unsuccessful institutional transfer|0
72840|NCT00075725|274637|P3|Overall Study|Unsuccessful institutional transfer|2
72841|NCT00075725|274638|P2|Overall Study|Unsuccessful institutional transfer|0
72842|NCT00075725|274639|P1|Overall Study|Unsuccessful institutional transfer|0
72843|NCT00075725|274628|P12|Overall Study|Clinic chart lost unable to recreate|0
72844|NCT00075725|274629|P11|Overall Study|Clinic chart lost unable to recreate|0
72845|NCT00075725|274630|P10|Overall Study|Clinic chart lost unable to recreate|0
72846|NCT00075725|274631|P9|Overall Study|Clinic chart lost unable to recreate|0
72847|NCT00075725|274632|P8|Overall Study|Clinic chart lost unable to recreate|0
72848|NCT00075725|274633|P7|Overall Study|Clinic chart lost unable to recreate|0
72849|NCT00075725|274634|P6|Overall Study|Clinic chart lost unable to recreate|0
72850|NCT00075725|274635|P5|Overall Study|Clinic chart lost unable to recreate|0
72851|NCT00075725|274636|P4|Overall Study|Clinic chart lost unable to recreate|0
72852|NCT00075725|274637|P3|Overall Study|Clinic chart lost unable to recreate|1
72853|NCT00075725|274638|P2|Overall Study|Clinic chart lost unable to recreate|0
72854|NCT00075725|274639|P1|Overall Study|Clinic chart lost unable to recreate|0
72855|NCT00075725|274628|P12|Overall Study|Pt trying to find a BM donor|0
72856|NCT00075725|274629|P11|Overall Study|Pt trying to find a BM donor|0
72857|NCT00075725|274630|P10|Overall Study|Pt trying to find a BM donor|0
72858|NCT00075725|274631|P9|Overall Study|Pt trying to find a BM donor|0
72859|NCT00075725|274632|P8|Overall Study|Pt trying to find a BM donor|0
72860|NCT00075725|274633|P7|Overall Study|Pt trying to find a BM donor|0
72861|NCT00075725|274634|P6|Overall Study|Pt trying to find a BM donor|0
72862|NCT00075725|274635|P5|Overall Study|Pt trying to find a BM donor|0
72863|NCT00075725|274636|P4|Overall Study|Pt trying to find a BM donor|0
72864|NCT00075725|274637|P3|Overall Study|Pt trying to find a BM donor|0
72865|NCT00075725|274638|P2|Overall Study|Pt trying to find a BM donor|1
72866|NCT00075725|274639|P1|Overall Study|Pt trying to find a BM donor|0
72867|NCT00075725|274628|P12|Overall Study|Other|3
72868|NCT00075725|274629|P11|Overall Study|Other|0
72869|NCT00075725|274630|P10|Overall Study|Other|1
72870|NCT00075725|274631|P9|Overall Study|Other|2
72871|NCT00075725|274632|P8|Overall Study|Other|9
72872|NCT00075725|274633|P7|Overall Study|Other|2
72873|NCT00075725|274634|P6|Overall Study|Other|4
72874|NCT00075725|274635|P5|Overall Study|Other|1
72875|NCT00075725|274636|P4|Overall Study|Other|1
72876|NCT00075725|274637|P3|Overall Study|Other|1
72877|NCT00075725|274638|P2|Overall Study|Other|2
72878|NCT00075725|274639|P1|Overall Study|Other|4
72879|NCT00075725|274628|P12|Overall Study|Inevaluable|0
72880|NCT00075725|274629|P11|Overall Study|Inevaluable|1
72881|NCT00075725|274630|P10|Overall Study|Inevaluable|0
72882|NCT00075725|274631|P9|Overall Study|Inevaluable|2
72883|NCT00075725|274632|P8|Overall Study|Inevaluable|11
72884|NCT00075725|274633|P7|Overall Study|Inevaluable|1
72885|NCT00075725|274634|P6|Overall Study|Inevaluable|9
72886|NCT00075725|274635|P5|Overall Study|Inevaluable|2
72887|NCT00075725|274636|P4|Overall Study|Inevaluable|2
72888|NCT00075725|274637|P3|Overall Study|Inevaluable|4
72889|NCT00075725|274638|P2|Overall Study|Inevaluable|1
72890|NCT00075725|274639|P1|Overall Study|Inevaluable|1
72891|NCT00075725|274628|P12|Overall Study|Pt has very high risk ALL characteristic|3
72892|NCT00075725|274629|P11|Overall Study|Pt has very high risk ALL characteristic|0
72893|NCT00075725|274630|P10|Overall Study|Pt has very high risk ALL characteristic|1
72894|NCT00075725|274631|P9|Overall Study|Pt has very high risk ALL characteristic|29
72895|NCT00075725|274632|P8|Overall Study|Pt has very high risk ALL characteristic|74
72896|NCT00075725|274633|P7|Overall Study|Pt has very high risk ALL characteristic|23
72897|NCT00075725|274634|P6|Overall Study|Pt has very high risk ALL characteristic|75
72898|NCT00075725|274635|P5|Overall Study|Pt has very high risk ALL characteristic|11
72899|NCT00075725|274636|P4|Overall Study|Pt has very high risk ALL characteristic|18
72900|NCT00075725|274637|P3|Overall Study|Pt has very high risk ALL characteristic|26
72901|NCT00075725|274638|P2|Overall Study|Pt has very high risk ALL characteristic|11
72902|NCT00075725|274639|P1|Overall Study|Pt has very high risk ALL characteristic|15
72903|NCT00075725|274628|P12|Overall Study|MRD positive after extended ind|0
72904|NCT00075725|274629|P11|Overall Study|MRD positive after extended ind|0
72905|NCT00075725|274630|P10|Overall Study|MRD positive after extended ind|0
72906|NCT00075725|274631|P9|Overall Study|MRD positive after extended ind|0
72907|NCT00075725|274632|P8|Overall Study|MRD positive after extended ind|1
72908|NCT00075725|274633|P7|Overall Study|MRD positive after extended ind|0
72909|NCT00075725|274634|P6|Overall Study|MRD positive after extended ind|2
72910|NCT00075725|274635|P5|Overall Study|MRD positive after extended ind|1
72911|NCT00075725|274636|P4|Overall Study|MRD positive after extended ind|0
72912|NCT00075725|274637|P3|Overall Study|MRD positive after extended ind|1
72913|NCT00075725|274638|P2|Overall Study|MRD positive after extended ind|1
72914|NCT00075725|274639|P1|Overall Study|MRD positive after extended ind|0
72915|NCT00075725|274628|P12|Overall Study|Insurance issues|0
72916|NCT00075725|274629|P11|Overall Study|Insurance issues|0
72917|NCT00075725|274630|P10|Overall Study|Insurance issues|0
72918|NCT00075725|274631|P9|Overall Study|Insurance issues|0
72919|NCT00075725|274632|P8|Overall Study|Insurance issues|1
72920|NCT00075725|274633|P7|Overall Study|Insurance issues|0
72921|NCT00075725|274634|P6|Overall Study|Insurance issues|1
72922|NCT00075725|274635|P5|Overall Study|Insurance issues|1
72923|NCT00075725|274636|P4|Overall Study|Insurance issues|1
72924|NCT00075725|274637|P3|Overall Study|Insurance issues|0
72925|NCT00075725|274638|P2|Overall Study|Insurance issues|1
72926|NCT00075725|274639|P1|Overall Study|Insurance issues|0
72927|NCT00075725|274628|P12|Overall Study|Pt age out of range for treatment|0
72928|NCT00075725|274629|P11|Overall Study|Pt age out of range for treatment|0
72929|NCT00075725|274630|P10|Overall Study|Pt age out of range for treatment|0
72930|NCT00075725|274631|P9|Overall Study|Pt age out of range for treatment|0
72931|NCT00075725|274632|P8|Overall Study|Pt age out of range for treatment|1
72932|NCT00075725|274633|P7|Overall Study|Pt age out of range for treatment|0
72933|NCT00075725|274634|P6|Overall Study|Pt age out of range for treatment|1
72934|NCT00075725|274635|P5|Overall Study|Pt age out of range for treatment|0
72935|NCT00075725|274636|P4|Overall Study|Pt age out of range for treatment|0
72936|NCT00075725|274637|P3|Overall Study|Pt age out of range for treatment|0
72937|NCT00075725|274638|P2|Overall Study|Pt age out of range for treatment|1
72938|NCT00075725|274639|P1|Overall Study|Pt age out of range for treatment|0
72939|NCT00075725|274628|P12|Overall Study|Pt non compliant with therapy|0
72940|NCT00075725|274629|P11|Overall Study|Pt non compliant with therapy|0
72941|NCT00075725|274630|P10|Overall Study|Pt non compliant with therapy|0
72942|NCT00075725|274631|P9|Overall Study|Pt non compliant with therapy|3
72943|NCT00075725|274632|P8|Overall Study|Pt non compliant with therapy|5
72944|NCT00075725|274633|P7|Overall Study|Pt non compliant with therapy|2
72945|NCT00075725|274634|P6|Overall Study|Pt non compliant with therapy|14
72946|NCT00075725|274635|P5|Overall Study|Pt non compliant with therapy|2
72947|NCT00075725|274636|P4|Overall Study|Pt non compliant with therapy|0
72948|NCT00075725|274637|P3|Overall Study|Pt non compliant with therapy|1
72949|NCT00075725|274638|P2|Overall Study|Pt non compliant with therapy|1
72950|NCT00075725|274639|P1|Overall Study|Pt non compliant with therapy|2
72951|NCT00075725|274628|P12|Overall Study|Pt/Guardian refused RT therapy|0
72952|NCT00075725|274629|P11|Overall Study|Pt/Guardian refused RT therapy|0
72953|NCT00075725|274630|P10|Overall Study|Pt/Guardian refused RT therapy|0
72954|NCT00075725|274631|P9|Overall Study|Pt/Guardian refused RT therapy|0
72955|NCT00075725|274632|P8|Overall Study|Pt/Guardian refused RT therapy|0
72956|NCT00075725|274633|P7|Overall Study|Pt/Guardian refused RT therapy|0
72957|NCT00075725|274634|P6|Overall Study|Pt/Guardian refused RT therapy|0
72958|NCT00075725|274635|P5|Overall Study|Pt/Guardian refused RT therapy|1
72959|NCT00075725|274636|P4|Overall Study|Pt/Guardian refused RT therapy|2
72960|NCT00075725|274637|P3|Overall Study|Pt/Guardian refused RT therapy|1
72961|NCT00075725|274638|P2|Overall Study|Pt/Guardian refused RT therapy|0
72962|NCT00075725|274639|P1|Overall Study|Pt/Guardian refused RT therapy|1
72963|NCT00075725|274628|P12|Overall Study|Ineligible or wrong diagnosis|4
72964|NCT00075725|274629|P11|Overall Study|Ineligible or wrong diagnosis|2
72965|NCT00075725|274630|P10|Overall Study|Ineligible or wrong diagnosis|1
72966|NCT00075725|274631|P9|Overall Study|Ineligible or wrong diagnosis|10
72967|NCT00075725|274632|P8|Overall Study|Ineligible or wrong diagnosis|9
72968|NCT00075725|274633|P7|Overall Study|Ineligible or wrong diagnosis|6
72969|NCT00075725|274634|P6|Overall Study|Ineligible or wrong diagnosis|17
72970|NCT00075725|274635|P5|Overall Study|Ineligible or wrong diagnosis|3
72971|NCT00075725|274636|P4|Overall Study|Ineligible or wrong diagnosis|10
72972|NCT00075725|274637|P3|Overall Study|Ineligible or wrong diagnosis|3
72973|NCT00075725|274638|P2|Overall Study|Ineligible or wrong diagnosis|3
72974|NCT00075725|274639|P1|Overall Study|Ineligible or wrong diagnosis|8
72975|NCT00075725|274628|P12|Overall Study|Patient off treatment|0
72976|NCT00075725|274629|P11|Overall Study|Patient off treatment|0
72977|NCT00075725|274630|P10|Overall Study|Patient off treatment|0
72978|NCT00075725|274631|P9|Overall Study|Patient off treatment|1
72979|NCT00075725|274632|P8|Overall Study|Patient off treatment|2
72980|NCT00075725|274633|P7|Overall Study|Patient off treatment|0
72981|NCT00075725|274634|P6|Overall Study|Patient off treatment|0
72982|NCT00075725|274635|P5|Overall Study|Patient off treatment|1
72983|NCT00075725|274636|P4|Overall Study|Patient off treatment|2
72984|NCT00075725|274637|P3|Overall Study|Patient off treatment|1
72985|NCT00075725|274638|P2|Overall Study|Patient off treatment|0
72986|NCT00075725|274639|P1|Overall Study|Patient off treatment|0
72987|NCT00075725|274628|P12|Overall Study|Disease Progression, all other reasons|5
72988|NCT00075725|274629|P11|Overall Study|Disease Progression, all other reasons|0
72989|NCT00075725|274630|P10|Overall Study|Disease Progression, all other reasons|4
72990|NCT00075725|274631|P9|Overall Study|Disease Progression, all other reasons|21
72991|NCT00075725|274632|P8|Overall Study|Disease Progression, all other reasons|46
72992|NCT00075725|274633|P7|Overall Study|Disease Progression, all other reasons|20
72993|NCT00075725|274634|P6|Overall Study|Disease Progression, all other reasons|59
72994|NCT00075725|274635|P5|Overall Study|Disease Progression, all other reasons|21
72995|NCT00075725|274636|P4|Overall Study|Disease Progression, all other reasons|6
72996|NCT00075725|274637|P3|Overall Study|Disease Progression, all other reasons|33
72997|NCT00075725|274638|P2|Overall Study|Disease Progression, all other reasons|5
72998|NCT00075725|274639|P1|Overall Study|Disease Progression, all other reasons|17
72999|NCT00075725|274628|P12|Overall Study|Withdrawal by Subject|0
73000|NCT00075725|274629|P11|Overall Study|Withdrawal by Subject|0
73001|NCT00075725|274630|P10|Overall Study|Withdrawal by Subject|2
73002|NCT00075725|274631|P9|Overall Study|Withdrawal by Subject|10
73003|NCT00075725|274632|P8|Overall Study|Withdrawal by Subject|31
73004|NCT00075725|274633|P7|Overall Study|Withdrawal by Subject|7
73005|NCT00075725|274634|P6|Overall Study|Withdrawal by Subject|27
73006|NCT00075725|274635|P5|Overall Study|Withdrawal by Subject|6
73007|NCT00075725|274636|P4|Overall Study|Withdrawal by Subject|10
73008|NCT00075725|274637|P3|Overall Study|Withdrawal by Subject|6
73009|NCT00075725|274638|P2|Overall Study|Withdrawal by Subject|3
73010|NCT00075725|274639|P1|Overall Study|Withdrawal by Subject|12
73011|NCT00075725|274628|P12|Overall Study|Protocol Violation|1
73012|NCT00075725|274629|P11|Overall Study|Protocol Violation|0
73013|NCT00075725|274630|P10|Overall Study|Protocol Violation|0
73014|NCT00075725|274631|P9|Overall Study|Protocol Violation|3
73015|NCT00075725|274632|P8|Overall Study|Protocol Violation|2
73016|NCT00075725|274633|P7|Overall Study|Protocol Violation|1
73017|NCT00075725|274634|P6|Overall Study|Protocol Violation|2
73018|NCT00075725|274635|P5|Overall Study|Protocol Violation|3
73019|NCT00075725|274636|P4|Overall Study|Protocol Violation|3
73020|NCT00075725|274637|P3|Overall Study|Protocol Violation|0
73021|NCT00075725|274638|P2|Overall Study|Protocol Violation|1
73022|NCT00075725|274639|P1|Overall Study|Protocol Violation|1
73023|NCT00075725|274628|P12|Overall Study|Pregnancy|0
73024|NCT00075725|274629|P11|Overall Study|Pregnancy|0
73025|NCT00075725|274630|P10|Overall Study|Pregnancy|0
73026|NCT00075725|274631|P9|Overall Study|Pregnancy|0
73027|NCT00075725|274632|P8|Overall Study|Pregnancy|1
73028|NCT00075725|274633|P7|Overall Study|Pregnancy|0
73029|NCT00075725|274634|P6|Overall Study|Pregnancy|1
73030|NCT00075725|274635|P5|Overall Study|Pregnancy|0
73031|NCT00075725|274636|P4|Overall Study|Pregnancy|0
73032|NCT00075725|274637|P3|Overall Study|Pregnancy|0
73033|NCT00075725|274638|P2|Overall Study|Pregnancy|0
73034|NCT00075725|274639|P1|Overall Study|Pregnancy|0
73035|NCT00075725|274628|P12|Overall Study|Physician Decision|0
73036|NCT00075725|274629|P11|Overall Study|Physician Decision|1
73037|NCT00075725|274630|P10|Overall Study|Physician Decision|0
73038|NCT00075725|274631|P9|Overall Study|Physician Decision|5
73039|NCT00075725|274632|P8|Overall Study|Physician Decision|17
73040|NCT00075725|274633|P7|Overall Study|Physician Decision|3
73041|NCT00075725|274634|P6|Overall Study|Physician Decision|19
73042|NCT00075725|274635|P5|Overall Study|Physician Decision|4
73043|NCT00075725|274636|P4|Overall Study|Physician Decision|8
73044|NCT00075725|274637|P3|Overall Study|Physician Decision|5
73045|NCT00075725|274638|P2|Overall Study|Physician Decision|6
73046|NCT00075725|274639|P1|Overall Study|Physician Decision|2
73047|NCT00075725|274628|P12|Overall Study|Lost to Follow-up|0
73048|NCT00075725|274629|P11|Overall Study|Lost to Follow-up|0
73049|NCT00075725|274630|P10|Overall Study|Lost to Follow-up|0
73050|NCT00075725|274631|P9|Overall Study|Lost to Follow-up|1
73051|NCT00075725|274632|P8|Overall Study|Lost to Follow-up|4
73052|NCT00075725|274633|P7|Overall Study|Lost to Follow-up|2
73053|NCT00075725|274634|P6|Overall Study|Lost to Follow-up|13
73054|NCT00075725|274635|P5|Overall Study|Lost to Follow-up|0
73055|NCT00075725|274636|P4|Overall Study|Lost to Follow-up|1
73056|NCT00075725|274637|P3|Overall Study|Lost to Follow-up|4
73057|NCT00075725|274638|P2|Overall Study|Lost to Follow-up|1
73058|NCT00075725|274639|P1|Overall Study|Lost to Follow-up|1
73059|NCT00075725|274628|P12|Overall Study|Death|0
73060|NCT00075725|274629|P11|Overall Study|Death|3
73061|NCT00075725|274630|P10|Overall Study|Death|4
73062|NCT00075725|274631|P9|Overall Study|Death|14
73063|NCT00075725|274632|P8|Overall Study|Death|22
73064|NCT00075725|274633|P7|Overall Study|Death|4
73065|NCT00075725|274634|P6|Overall Study|Death|25
73066|NCT00075725|274635|P5|Overall Study|Death|3
73067|NCT00075725|274636|P4|Overall Study|Death|2
73068|NCT00075725|274637|P3|Overall Study|Death|10
73069|NCT00075725|274638|P2|Overall Study|Death|5
73070|NCT00075725|274639|P1|Overall Study|Death|3
73071|NCT00075725|274628|P12|Overall Study|Adverse Event|2
73072|NCT00075725|274629|P11|Overall Study|Adverse Event|2
73073|NCT00075725|274630|P10|Overall Study|Adverse Event|4
73074|NCT00075725|274631|P9|Overall Study|Adverse Event|15
73075|NCT00075725|274632|P8|Overall Study|Adverse Event|51
73076|NCT00075725|274633|P7|Overall Study|Adverse Event|3
73077|NCT00075725|274634|P6|Overall Study|Adverse Event|38
73078|NCT00075725|274635|P5|Overall Study|Adverse Event|4
73079|NCT00075725|274636|P4|Overall Study|Adverse Event|8
73080|NCT00075725|274637|P3|Overall Study|Adverse Event|20
73081|NCT00075725|274638|P2|Overall Study|Adverse Event|6
73082|NCT00075725|274639|P1|Overall Study|Adverse Event|6
73083|NCT00075764|274730|P2|Overall Study|Under review|1
73084|NCT00075764|274731|P1|Overall Study|Under review|0
73085|NCT00075764|274730|P2|Overall Study|Not protocol specified|19
73086|NCT00075764|274731|P1|Overall Study|Not protocol specified|27
73087|NCT00075764|274730|P2|Overall Study|Delinquent|2
73088|NCT00075764|274731|P1|Overall Study|Delinquent|4
73089|NCT00075764|274730|P2|Overall Study|Still on treatment|15
73090|NCT00075764|274731|P1|Overall Study|Still on treatment|8
73091|NCT00075764|274730|P2|Overall Study|Progression|274
73092|NCT00075764|274731|P1|Overall Study|Progression|269
73093|NCT00075764|274730|P2|Overall Study|Withdrawal by Subject|18
73094|NCT00075764|274731|P1|Overall Study|Withdrawal by Subject|28
73095|NCT00075764|274730|P2|Overall Study|Death|8
73096|NCT00075764|274731|P1|Overall Study|Death|4
73097|NCT00075764|274730|P2|Overall Study|Adverse Event|12
73098|NCT00075764|274731|P1|Overall Study|Adverse Event|5
73099|NCT00075816|274774|P2|Overall Study|Did not undergo transplantation|11
73100|NCT00075816|274775|P1|Overall Study|Did not undergo transplantation|14
73101|NCT00075881|274848|P1|Overall Study|never start protocol therapy|1
73102|NCT00075881|274848|P1|Overall Study|Ineligible|1
73103|NCT00075881|274848|P1|Overall Study|missing data|2
73104|NCT00075881|274848|P1|Overall Study|other|4
73105|NCT00075881|274848|P1|Overall Study|other complicating disease|3
73106|NCT00075881|274848|P1|Overall Study|Protocol Violation|4
73107|NCT00075881|274848|P1|Overall Study|Withdrawal by Subject|2
73108|NCT00075881|274848|P1|Overall Study|Death|1
73109|NCT00075881|274848|P1|Overall Study|Adverse Event|7
73110|NCT00075881|274848|P1|Overall Study|Lack of Efficacy|18
73111|NCT00075946|274859|P5|Overall Study|Other|0
73112|NCT00075946|274860|P4|Overall Study|Other|2
73113|NCT00075946|274861|P3|Overall Study|Other|0
73114|NCT00075946|274862|P2|Overall Study|Other|13
73115|NCT00075946|274863|P1|Overall Study|Other|5
73116|NCT00075946|274859|P5|Overall Study|Time to progression less than 6 months|0
73117|NCT00075946|274860|P4|Overall Study|Time to progression less than 6 months|3
73118|NCT00075946|274861|P3|Overall Study|Time to progression less than 6 months|8
73119|NCT00075946|274862|P2|Overall Study|Time to progression less than 6 months|30
73120|NCT00075946|274863|P1|Overall Study|Time to progression less than 6 months|15
73121|NCT00075946|274859|P5|Overall Study|No response to retreatment|0
73122|NCT00075946|274860|P4|Overall Study|No response to retreatment|0
73123|NCT00075946|274861|P3|Overall Study|No response to retreatment|2
73124|NCT00075946|274862|P2|Overall Study|No response to retreatment|0
73125|NCT00075946|274863|P1|Overall Study|No response to retreatment|23
73126|NCT00075946|274859|P5|Overall Study|Other complicating disease|0
73127|NCT00075946|274860|P4|Overall Study|Other complicating disease|4
73128|NCT00075946|274861|P3|Overall Study|Other complicating disease|1
73129|NCT00075946|274862|P2|Overall Study|Other complicating disease|13
73130|NCT00075946|274863|P1|Overall Study|Other complicating disease|7
73131|NCT00075946|274859|P5|Overall Study|Alternative therapy|0
73132|NCT00075946|274860|P4|Overall Study|Alternative therapy|0
73133|NCT00075946|274861|P3|Overall Study|Alternative therapy|5
73134|NCT00075946|274862|P2|Overall Study|Alternative therapy|2
73135|NCT00075946|274863|P1|Overall Study|Alternative therapy|16
73136|NCT00075946|274859|P5|Overall Study|Withdrawal by Subject|0
73137|NCT00075946|274860|P4|Overall Study|Withdrawal by Subject|9
73138|NCT00075946|274861|P3|Overall Study|Withdrawal by Subject|4
73139|NCT00075946|274862|P2|Overall Study|Withdrawal by Subject|58
73140|NCT00075946|274863|P1|Overall Study|Withdrawal by Subject|23
73141|NCT00075946|274859|P5|Overall Study|Death|0
73142|NCT00075946|274860|P4|Overall Study|Death|0
73143|NCT00075946|274861|P3|Overall Study|Death|0
73144|NCT00075946|274862|P2|Overall Study|Death|1
73145|NCT00075946|274863|P1|Overall Study|Death|0
73146|NCT00075946|274859|P5|Overall Study|Adverse Event|0
73147|NCT00075946|274860|P4|Overall Study|Adverse Event|2
73148|NCT00075946|274861|P3|Overall Study|Adverse Event|0
73149|NCT00075946|274862|P2|Overall Study|Adverse Event|10
73150|NCT00075946|274863|P1|Overall Study|Adverse Event|2
73151|NCT00075946|274859|P5|Overall Study|Still on treatment at time of analysis|0
73152|NCT00075946|274860|P4|Overall Study|Still on treatment at time of analysis|9
73153|NCT00075946|274861|P3|Overall Study|Still on treatment at time of analysis|3
73154|NCT00075946|274862|P2|Overall Study|Still on treatment at time of analysis|19
73155|NCT00075946|274863|P1|Overall Study|Still on treatment at time of analysis|52
73156|NCT00075946|274859|P5|Overall Study|Incorrectly randomized (no response)|0
73157|NCT00075946|274860|P4|Overall Study|Incorrectly randomized (no response)|1
73158|NCT00075946|274861|P3|Overall Study|Incorrectly randomized (no response)|5
73159|NCT00075946|274862|P2|Overall Study|Incorrectly randomized (no response)|5
73160|NCT00075946|274863|P1|Overall Study|Incorrectly randomized (no response)|5
73161|NCT00075946|274859|P5|Overall Study|Did not achieve response after induction|182
73162|NCT00075946|274860|P4|Overall Study|Did not achieve response after induction|0
73163|NCT00075946|274861|P3|Overall Study|Did not achieve response after induction|0
73164|NCT00075946|274862|P2|Overall Study|Did not achieve response after induction|0
73165|NCT00075946|274863|P1|Overall Study|Did not achieve response after induction|0
73166|NCT00075946|274859|P5|Overall Study|Path ineligible: undetermined histology|6
73167|NCT00075946|274860|P4|Overall Study|Path ineligible: undetermined histology|0
73168|NCT00075946|274861|P3|Overall Study|Path ineligible: undetermined histology|0
73169|NCT00075946|274862|P2|Overall Study|Path ineligible: undetermined histology|0
73170|NCT00075946|274863|P1|Overall Study|Path ineligible: undetermined histology|0
73171|NCT00076011|274878|P1|Overall Study|Ongoing|1
73172|NCT00076011|274878|P1|Overall Study|Unspecified|11
73173|NCT00076011|274878|P1|Overall Study|Study terminated by sponsor|3
73174|NCT00076011|274878|P1|Overall Study|Withdrawal by Subject|1
73175|NCT00076011|274878|P1|Overall Study|Lack of Efficacy|25
73176|NCT00076011|274878|P1|Overall Study|Adverse Event|10
73177|NCT00076011|274878|P1|Overall Study|Death|1
73178|NCT00076024|274889|P4|Phase 2, Open-label|Unspecified|2
73179|NCT00076024|274890|P3|Phase 2, Open-label|Unspecified|0
73180|NCT00076024|274891|P2|Phase 2, Open-label|Unspecified|0
73181|NCT00076024|274892|P1|Phase 2, Open-label|Unspecified|0
73182|NCT00076024|274889|P4|Phase 2, Open-label|Withdrawal by Subject|1
73183|NCT00076024|274890|P3|Phase 2, Open-label|Withdrawal by Subject|0
73184|NCT00076024|274891|P2|Phase 2, Open-label|Withdrawal by Subject|0
73185|NCT00076024|274892|P1|Phase 2, Open-label|Withdrawal by Subject|0
73186|NCT00076024|274889|P4|Phase 2, Open-label|Lack of Efficacy|11
73187|NCT00076024|274890|P3|Phase 2, Open-label|Lack of Efficacy|0
73188|NCT00076024|274891|P2|Phase 2, Open-label|Lack of Efficacy|0
73189|NCT00076024|274892|P1|Phase 2, Open-label|Lack of Efficacy|0
73190|NCT00076024|274889|P4|Phase 2, Open-label|Adverse Event|2
73191|NCT00076024|274890|P3|Phase 2, Open-label|Adverse Event|0
73192|NCT00076024|274891|P2|Phase 2, Open-label|Adverse Event|0
73193|NCT00076024|274892|P1|Phase 2, Open-label|Adverse Event|0
73194|NCT00076024|274889|P4|Phase 2, Double-blind|Randomized but not treated|0
73195|NCT00076024|274890|P3|Phase 2, Double-blind|Randomized but not treated|0
73196|NCT00076024|274891|P2|Phase 2, Double-blind|Randomized but not treated|1
73197|NCT00076024|274892|P1|Phase 2, Double-blind|Randomized but not treated|0
73198|NCT00076024|274889|P4|Phase 2, Double-blind|Un-specified|0
73199|NCT00076024|274890|P3|Phase 2, Double-blind|Un-specified|6
73200|NCT00076024|274891|P2|Phase 2, Double-blind|Un-specified|14
73201|NCT00076024|274892|P1|Phase 2, Double-blind|Un-specified|0
73202|NCT00076024|274889|P4|Phase 2, Double-blind|Adverse Event|0
73203|NCT00076024|274890|P3|Phase 2, Double-blind|Adverse Event|6
73204|NCT00076024|274891|P2|Phase 2, Double-blind|Adverse Event|25
73205|NCT00076024|274892|P1|Phase 2, Double-blind|Adverse Event|0
73206|NCT00076024|274889|P4|Phase 2, Double-blind|Withdrawal by Subject|0
73207|NCT00076024|274890|P3|Phase 2, Double-blind|Withdrawal by Subject|4
73208|NCT00076024|274891|P2|Phase 2, Double-blind|Withdrawal by Subject|13
73209|NCT00076024|274892|P1|Phase 2, Double-blind|Withdrawal by Subject|0
73210|NCT00076024|274889|P4|Phase 2, Double-blind|Lack of Efficacy|0
73211|NCT00076024|274890|P3|Phase 2, Double-blind|Lack of Efficacy|40
73212|NCT00076024|274891|P2|Phase 2, Double-blind|Lack of Efficacy|59
73213|NCT00076024|274892|P1|Phase 2, Double-blind|Lack of Efficacy|0
73214|NCT00076024|274889|P4|Phase 1, Lead-in|Clinical progression|0
73215|NCT00076024|274890|P3|Phase 1, Lead-in|Clinical progression|0
73216|NCT00076024|274891|P2|Phase 1, Lead-in|Clinical progression|0
73217|NCT00076024|274892|P1|Phase 1, Lead-in|Clinical progression|1
73218|NCT00076024|274889|P4|Phase 1, Lead-in|Adverse Event|0
73219|NCT00076024|274890|P3|Phase 1, Lead-in|Adverse Event|0
73220|NCT00076024|274891|P2|Phase 1, Lead-in|Adverse Event|0
73221|NCT00076024|274892|P1|Phase 1, Lead-in|Adverse Event|1
73222|NCT00076024|274889|P4|Phase 1, Lead-in|Lack of Efficacy|0
73223|NCT00076024|274890|P3|Phase 1, Lead-in|Lack of Efficacy|0
73224|NCT00076024|274891|P2|Phase 1, Lead-in|Lack of Efficacy|0
73225|NCT00076024|274892|P1|Phase 1, Lead-in|Lack of Efficacy|4
73226|NCT00076336|274965|P2|Overall Study|Treatment failure|5
73227|NCT00076336|274966|P1|Overall Study|Treatment failure|4
73228|NCT00076336|274965|P2|Overall Study|Virologic Breakthrough|16
73229|NCT00076336|274966|P1|Overall Study|Virologic Breakthrough|14
73230|NCT00076336|274965|P2|Overall Study|Liver Transplantation|3
73231|NCT00076336|274966|P1|Overall Study|Liver Transplantation|3
73232|NCT00076336|274965|P2|Overall Study|Patient, Investigator, Sponsor request|6
73233|NCT00076336|274966|P1|Overall Study|Patient, Investigator, Sponsor request|8
73234|NCT00076336|274965|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
73235|NCT00076336|274966|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
73236|NCT00076336|274965|P2|Overall Study|Non-Compliance|0
73237|NCT00076336|274966|P1|Overall Study|Non-Compliance|2
73238|NCT00076336|274965|P2|Overall Study|Lost to Follow-up|4
73239|NCT00076336|274966|P1|Overall Study|Lost to Follow-up|4
73240|NCT00076336|274965|P2|Overall Study|Adverse Event|4
73241|NCT00076336|274966|P1|Overall Study|Adverse Event|4
73242|NCT00076336|274965|P2|Overall Study|Death|17
73243|NCT00076336|274966|P1|Overall Study|Death|13
73244|NCT00076570|274982|P2|Overall Study|Drug intolerance|8
73245|NCT00076570|274983|P1|Overall Study|Drug intolerance|8
73246|NCT00076752|275013|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
73247|NCT00076752|275013|P1|Overall Study|Death|2
73248|NCT00076804|275034|P2|Overall Study|Early study Closure|32
73249|NCT00076804|275035|P1|Overall Study|Early study Closure|32
73250|NCT00076804|275034|P2|Overall Study|Withdrawal by Subject|8
73251|NCT00076804|275035|P1|Overall Study|Withdrawal by Subject|10
73252|NCT00076804|275034|P2|Overall Study|Lost to Follow-up|9
73253|NCT00076804|275035|P1|Overall Study|Lost to Follow-up|9
73254|NCT00076804|275034|P2|Overall Study|Death|20
73255|NCT00076804|275035|P1|Overall Study|Death|9
73256|NCT00076999|275051|P5|Overall Study|Other reason (not specified)|13
73257|NCT00076999|275052|P4|Overall Study|Other reason (not specified)|1
73258|NCT00076999|275053|P3|Overall Study|Other reason (not specified)|4
73259|NCT00076999|275054|P2|Overall Study|Other reason (not specified)|8
73260|NCT00076999|275055|P1|Overall Study|Other reason (not specified)|8
73261|NCT00076999|275051|P5|Overall Study|Withdrawal by Subject|1
73262|NCT00076999|275052|P4|Overall Study|Withdrawal by Subject|0
73263|NCT00076999|275053|P3|Overall Study|Withdrawal by Subject|3
73264|NCT00076999|275054|P2|Overall Study|Withdrawal by Subject|4
73265|NCT00076999|275055|P1|Overall Study|Withdrawal by Subject|0
73266|NCT00076999|275051|P5|Overall Study|Lost to Follow-up|0
73267|NCT00076999|275052|P4|Overall Study|Lost to Follow-up|0
73268|NCT00076999|275053|P3|Overall Study|Lost to Follow-up|0
73269|NCT00076999|275054|P2|Overall Study|Lost to Follow-up|1
73270|NCT00076999|275055|P1|Overall Study|Lost to Follow-up|2
73271|NCT00076999|275051|P5|Overall Study|Protocol Violation|9
73272|NCT00076999|275052|P4|Overall Study|Protocol Violation|0
73273|NCT00076999|275053|P3|Overall Study|Protocol Violation|4
73274|NCT00076999|275054|P2|Overall Study|Protocol Violation|3
73275|NCT00076999|275055|P1|Overall Study|Protocol Violation|0
73276|NCT00076999|275051|P5|Overall Study|Adverse Event|2
73277|NCT00076999|275052|P4|Overall Study|Adverse Event|0
73278|NCT00076999|275053|P3|Overall Study|Adverse Event|6
73279|NCT00076999|275054|P2|Overall Study|Adverse Event|8
73280|NCT00076999|275055|P1|Overall Study|Adverse Event|2
73281|NCT00077207|275172|P1|Overall Study|Ineligible|1
73282|NCT00077207|275172|P1|Overall Study|Withdrawal by Subject|6
73283|NCT00077207|275172|P1|Overall Study|Physician Decision|6
73284|NCT00077207|275172|P1|Overall Study|Lack of Efficacy|12
73285|NCT00077207|275172|P1|Overall Study|Adverse Event|5
73286|NCT00077376|275177|P1|Overall Study|Insurance ran out|1
73287|NCT00077376|275177|P1|Overall Study|Surgery|1
73288|NCT00077376|275177|P1|Overall Study|Symptomatic deterioration|1
73289|NCT00077376|275177|P1|Overall Study|Still on treatment|1
73290|NCT00077376|275177|P1|Overall Study|Complicating disease|1
73291|NCT00077376|275177|P1|Overall Study|Alternative therapy|5
73292|NCT00077376|275177|P1|Overall Study|Physician Decision|1
73293|NCT00077376|275177|P1|Overall Study|Death|1
73294|NCT00077376|275177|P1|Overall Study|Withdrawal by Subject|2
73295|NCT00077376|275177|P1|Overall Study|Adverse Event|8
73296|NCT00070564|275192|P6|Overall Study|Not reported|0
73297|NCT00070564|275193|P5|Overall Study|Not reported|1
73298|NCT00070564|275194|P4|Overall Study|Not reported|0
73299|NCT00070564|275195|P3|Overall Study|Not reported|0
73300|NCT00070564|275196|P2|Overall Study|Not reported|0
73301|NCT00070564|275197|P1|Overall Study|Not reported|0
73302|NCT00070564|275192|P6|Overall Study|Withdrawal by Subject|8
73303|NCT00070564|275193|P5|Overall Study|Withdrawal by Subject|8
73304|NCT00070564|275194|P4|Overall Study|Withdrawal by Subject|30
73305|NCT00070564|275195|P3|Overall Study|Withdrawal by Subject|23
73306|NCT00070564|275196|P2|Overall Study|Withdrawal by Subject|37
73307|NCT00070564|275197|P1|Overall Study|Withdrawal by Subject|26
73308|NCT00070564|275192|P6|Overall Study|Other, not protocol specified|7
73309|NCT00070564|275193|P5|Overall Study|Other, not protocol specified|6
73310|NCT00070564|275194|P4|Overall Study|Other, not protocol specified|19
73311|NCT00070564|275195|P3|Overall Study|Other, not protocol specified|14
73312|NCT00070564|275196|P2|Overall Study|Other, not protocol specified|15
73313|NCT00070564|275197|P1|Overall Study|Other, not protocol specified|17
73314|NCT00070564|275192|P6|Overall Study|Death|1
73315|NCT00070564|275193|P5|Overall Study|Death|0
73316|NCT00070564|275194|P4|Overall Study|Death|3
73317|NCT00070564|275195|P3|Overall Study|Death|5
73318|NCT00070564|275196|P2|Overall Study|Death|1
73319|NCT00070564|275197|P1|Overall Study|Death|4
73320|NCT00070564|275192|P6|Overall Study|Adverse Event|36
73321|NCT00070564|275193|P5|Overall Study|Adverse Event|63
73322|NCT00070564|275194|P4|Overall Study|Adverse Event|108
73323|NCT00070564|275195|P3|Overall Study|Adverse Event|120
73324|NCT00070564|275196|P2|Overall Study|Adverse Event|142
73325|NCT00070564|275197|P1|Overall Study|Adverse Event|150
73326|NCT00070564|275192|P6|Overall Study|Delinquent|0
73327|NCT00070564|275193|P5|Overall Study|Delinquent|0
73328|NCT00070564|275194|P4|Overall Study|Delinquent|0
73329|NCT00070564|275195|P3|Overall Study|Delinquent|2
73330|NCT00070564|275196|P2|Overall Study|Delinquent|4
73331|NCT00070564|275197|P1|Overall Study|Delinquent|1
73332|NCT00070564|275192|P6|Overall Study|Progression|0
73333|NCT00070564|275193|P5|Overall Study|Progression|1
73334|NCT00070564|275194|P4|Overall Study|Progression|7
73335|NCT00070564|275195|P3|Overall Study|Progression|7
73336|NCT00070564|275196|P2|Overall Study|Progression|4
73337|NCT00070564|275197|P1|Overall Study|Progression|2
73338|NCT00070941|275242|P3|Overall Study|Adverse Event|4
73339|NCT00070941|275243|P2|Overall Study|Adverse Event|8
73340|NCT00070941|275244|P1|Overall Study|Adverse Event|10
73341|NCT00071006|275252|P1|Overall Study|Unspecified|3
73342|NCT00071006|275252|P1|Overall Study|Withdrawal by Subject|1
73343|NCT00071006|275252|P1|Overall Study|Adverse Event|1
73344|NCT00071006|275252|P1|Overall Study|Lack of Efficacy|7
73345|NCT00071032|275264|P2|Overall Study|Missing Primary Outcome|1
73346|NCT00071032|275265|P1|Overall Study|Missing Primary Outcome|0
73347|NCT00071032|275264|P2|Overall Study|Withdrawal by Subject|6
73348|NCT00071032|275265|P1|Overall Study|Withdrawal by Subject|8
73349|NCT00071032|275264|P2|Overall Study|Lost to Follow-up|1
73350|NCT00071032|275265|P1|Overall Study|Lost to Follow-up|1
73351|NCT00071058|275273|P1|Overall Study|brain tumor-removed from study|1
73352|NCT00071110|275280|P2|Overall Study|Protocol Violation|4
73353|NCT00071110|275281|P1|Overall Study|Protocol Violation|0
73354|NCT00071396|275293|P1|Overall Study|Physician Decision|2
73355|NCT00071396|275293|P1|Overall Study|Withdrawal by Subject|1
73356|NCT00077610|275300|P3|Overall Study|Sponsors decision to withdraw|1
73357|NCT00077610|275301|P2|Overall Study|Sponsors decision to withdraw|0
73358|NCT00077610|275302|P1|Overall Study|Sponsors decision to withdraw|0
73359|NCT00077610|275300|P3|Overall Study|Financial issues|0
73360|NCT00077610|275301|P2|Overall Study|Financial issues|1
73361|NCT00077610|275302|P1|Overall Study|Financial issues|0
73362|NCT00077610|275300|P3|Overall Study|Relocation|5
73363|NCT00077610|275301|P2|Overall Study|Relocation|8
73364|NCT00077610|275302|P1|Overall Study|Relocation|0
73365|NCT00077610|275300|P3|Overall Study|Change in dialysis modality|0
73366|NCT00077610|275301|P2|Overall Study|Change in dialysis modality|0
73367|NCT00077610|275302|P1|Overall Study|Change in dialysis modality|1
73368|NCT00077610|275300|P3|Overall Study|Transfer to other center for surgery|0
73369|NCT00077610|275301|P2|Overall Study|Transfer to other center for surgery|0
73370|NCT00077610|275302|P1|Overall Study|Transfer to other center for surgery|1
73371|NCT00077610|275300|P3|Overall Study|Transfer to satellite unit|0
73372|NCT00077610|275301|P2|Overall Study|Transfer to satellite unit|0
73373|NCT00077610|275302|P1|Overall Study|Transfer to satellite unit|1
73374|NCT00077610|275300|P3|Overall Study|Transferred to nursing home|1
73375|NCT00077610|275301|P2|Overall Study|Transferred to nursing home|0
73376|NCT00077610|275302|P1|Overall Study|Transferred to nursing home|0
73377|NCT00077610|275300|P3|Overall Study|Transferred to other unit|1
73378|NCT00077610|275301|P2|Overall Study|Transferred to other unit|0
73379|NCT00077610|275302|P1|Overall Study|Transferred to other unit|0
73380|NCT00077610|275300|P3|Overall Study|Given Epogen in hospital|0
73381|NCT00077610|275301|P2|Overall Study|Given Epogen in hospital|0
73382|NCT00077610|275302|P1|Overall Study|Given Epogen in hospital|1
73383|NCT00077610|275300|P3|Overall Study|Worsening of health condition|0
73384|NCT00077610|275301|P2|Overall Study|Worsening of health condition|1
73385|NCT00077610|275302|P1|Overall Study|Worsening of health condition|1
73386|NCT00077610|275300|P3|Overall Study|Principal Investigator's decision|1
73387|NCT00077610|275301|P2|Overall Study|Principal Investigator's decision|0
73388|NCT00077610|275302|P1|Overall Study|Principal Investigator's decision|1
73389|NCT00077610|275300|P3|Overall Study|Multiple blood transfusions|1
73390|NCT00077610|275301|P2|Overall Study|Multiple blood transfusions|0
73391|NCT00077610|275302|P1|Overall Study|Multiple blood transfusions|0
73392|NCT00077610|275300|P3|Overall Study|Insufficient Therapeutic Response|0
73393|NCT00077610|275301|P2|Overall Study|Insufficient Therapeutic Response|0
73394|NCT00077610|275302|P1|Overall Study|Insufficient Therapeutic Response|1
73395|NCT00077610|275300|P3|Overall Study|Withdrew from dialysis care|3
73396|NCT00077610|275301|P2|Overall Study|Withdrew from dialysis care|0
73397|NCT00077610|275302|P1|Overall Study|Withdrew from dialysis care|5
73398|NCT00077610|275300|P3|Overall Study|Renal transplant|11
73399|NCT00077610|275301|P2|Overall Study|Renal transplant|15
73400|NCT00077610|275302|P1|Overall Study|Renal transplant|12
73401|NCT00077610|275300|P3|Overall Study|Death|13
73402|NCT00077610|275301|P2|Overall Study|Death|13
73403|NCT00077610|275302|P1|Overall Study|Death|17
73404|NCT00077610|275300|P3|Overall Study|Withdrawal by Subject|6
73405|NCT00077610|275301|P2|Overall Study|Withdrawal by Subject|10
73406|NCT00077610|275302|P1|Overall Study|Withdrawal by Subject|4
73407|NCT00077610|275300|P3|Overall Study|Lost to Follow-up|2
73408|NCT00077610|275301|P2|Overall Study|Lost to Follow-up|1
73409|NCT00077610|275302|P1|Overall Study|Lost to Follow-up|0
73410|NCT00077610|275300|P3|Overall Study|Adverse Event|1
73411|NCT00077610|275301|P2|Overall Study|Adverse Event|7
73412|NCT00077610|275302|P1|Overall Study|Adverse Event|9
73413|NCT00077623|275334|P3|Overall Study|Failure to return|0
73414|NCT00077623|275335|P2|Overall Study|Failure to return|0
73415|NCT00077623|275336|P1|Overall Study|Failure to return|1
73416|NCT00077623|275334|P3|Overall Study|Death|11
73417|NCT00077623|275335|P2|Overall Study|Death|18
73418|NCT00077623|275336|P1|Overall Study|Death|12
73419|NCT00077623|275334|P3|Overall Study|Insufficient therapeutic response|0
73420|NCT00077623|275335|P2|Overall Study|Insufficient therapeutic response|0
73421|NCT00077623|275336|P1|Overall Study|Insufficient therapeutic response|2
73422|NCT00077623|275334|P3|Overall Study|Other-Non safety reason|19
73423|NCT00077623|275335|P2|Overall Study|Other-Non safety reason|15
73424|NCT00077623|275336|P1|Overall Study|Other-Non safety reason|18
73425|NCT00077623|275334|P3|Overall Study|Withdrawal by Subject|1
73426|NCT00077623|275335|P2|Overall Study|Withdrawal by Subject|10
73427|NCT00077623|275336|P1|Overall Study|Withdrawal by Subject|2
73428|NCT00077623|275334|P3|Overall Study|Adverse Event|1
73429|NCT00077623|275335|P2|Overall Study|Adverse Event|0
73430|NCT00077623|275336|P1|Overall Study|Adverse Event|1
73431|NCT00077636|275370|P2|Overall Study|Abnormality Of Laboratory Test|2
73432|NCT00077636|275371|P1|Overall Study|Abnormality Of Laboratory Test|3
73433|NCT00077636|275370|P2|Overall Study|Lost to Follow-up|18
73434|NCT00077636|275371|P1|Overall Study|Lost to Follow-up|10
73435|NCT00077636|275370|P2|Overall Study|Protocol Violation|2
73436|NCT00077636|275371|P1|Overall Study|Protocol Violation|0
73437|NCT00077636|275370|P2|Overall Study|Adverse Event|34
73438|NCT00077636|275371|P1|Overall Study|Adverse Event|17
73439|NCT00077636|275370|P2|Overall Study|Withdrawal by Subject|2
73440|NCT00077636|275371|P1|Overall Study|Withdrawal by Subject|2
73441|NCT00077636|275370|P2|Overall Study|Admin|3
73442|NCT00077636|275371|P1|Overall Study|Admin|3
73443|NCT00077636|275370|P2|Overall Study|Refused Treatment|31
73444|NCT00077636|275371|P1|Overall Study|Refused Treatment|9
73445|NCT00077649|275393|P4|Overall Study|Randomized but never dosed|0
73446|NCT00077649|275394|P3|Overall Study|Randomized but never dosed|0
73447|NCT00077649|275395|P2|Overall Study|Randomized but never dosed|0
73448|NCT00077649|275396|P1|Overall Study|Randomized but never dosed|1
73449|NCT00077649|275393|P4|Overall Study|Abnormality of Laboratory Test|2
73450|NCT00077649|275394|P3|Overall Study|Abnormality of Laboratory Test|1
73451|NCT00077649|275395|P2|Overall Study|Abnormality of Laboratory Test|2
73452|NCT00077649|275396|P1|Overall Study|Abnormality of Laboratory Test|1
73453|NCT00077649|275393|P4|Overall Study|Lost to Follow-up|2
73454|NCT00077649|275394|P3|Overall Study|Lost to Follow-up|3
73455|NCT00077649|275395|P2|Overall Study|Lost to Follow-up|2
73456|NCT00077649|275396|P1|Overall Study|Lost to Follow-up|2
73457|NCT00077649|275393|P4|Overall Study|Withdrawal by Subject|2
73458|NCT00077649|275394|P3|Overall Study|Withdrawal by Subject|1
73459|NCT00077649|275395|P2|Overall Study|Withdrawal by Subject|1
73460|NCT00077649|275396|P1|Overall Study|Withdrawal by Subject|0
73461|NCT00077649|275393|P4|Overall Study|Lack of Efficacy|2
73462|NCT00077649|275394|P3|Overall Study|Lack of Efficacy|3
73463|NCT00077649|275395|P2|Overall Study|Lack of Efficacy|3
73464|NCT00077649|275396|P1|Overall Study|Lack of Efficacy|5
73465|NCT00077649|275393|P4|Overall Study|Adverse Event|9
73466|NCT00077649|275394|P3|Overall Study|Adverse Event|7
73467|NCT00077649|275395|P2|Overall Study|Adverse Event|1
73468|NCT00077649|275396|P1|Overall Study|Adverse Event|5
73469|NCT00077675|275444|P2|Overall Study|Never received study treatment|3
73470|NCT00077675|275445|P1|Overall Study|Never received study treatment|3
73471|NCT00077675|275444|P2|Overall Study|Other|1
73472|NCT00077675|275445|P1|Overall Study|Other|0
73473|NCT00077675|275444|P2|Overall Study|Withdrawal by Subject|0
73474|NCT00077675|275445|P1|Overall Study|Withdrawal by Subject|1
73475|NCT00077675|275444|P2|Overall Study|Lost to Follow-up|3
73476|NCT00077675|275445|P1|Overall Study|Lost to Follow-up|6
73477|NCT00077675|275444|P2|Overall Study|Adverse Event|2
73478|NCT00077675|275445|P1|Overall Study|Adverse Event|1
73479|NCT00077766|275453|P2|Overall Study|Participants Vacation|1
73480|NCT00077766|275454|P1|Overall Study|Participants Vacation|2
73481|NCT00077766|275453|P2|Overall Study|Stop Dialysis|1
73482|NCT00077766|275454|P1|Overall Study|Stop Dialysis|0
73483|NCT00077766|275453|P2|Overall Study|Started Nocturnal Dialysis|1
73484|NCT00077766|275454|P1|Overall Study|Started Nocturnal Dialysis|0
73485|NCT00077766|275453|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
73486|NCT00077766|275454|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
73487|NCT00077766|275453|P2|Overall Study|Dialysis|1
73488|NCT00077766|275454|P1|Overall Study|Dialysis|0
73489|NCT00077766|275453|P2|Overall Study|Dialysis Discontinued|0
73490|NCT00077766|275454|P1|Overall Study|Dialysis Discontinued|1
73491|NCT00077766|275453|P2|Overall Study|Participant's decision|0
73492|NCT00077766|275454|P1|Overall Study|Participant's decision|1
73493|NCT00077766|275453|P2|Overall Study|Investigators Discretion|0
73494|NCT00077766|275454|P1|Overall Study|Investigators Discretion|1
73495|NCT00077766|275453|P2|Overall Study|Transplantation|1
73496|NCT00077766|275454|P1|Overall Study|Transplantation|5
73497|NCT00077766|275453|P2|Overall Study|Kidney Transplantation|5
73498|NCT00077766|275454|P1|Overall Study|Kidney Transplantation|9
73499|NCT00077766|275453|P2|Overall Study|Protocol Violation|0
73500|NCT00077766|275454|P1|Overall Study|Protocol Violation|1
73501|NCT00077766|275453|P2|Overall Study|Lost to Follow-up|0
73502|NCT00077766|275454|P1|Overall Study|Lost to Follow-up|2
73503|NCT00077766|275453|P2|Overall Study|Death|10
73504|NCT00077766|275454|P1|Overall Study|Death|12
73505|NCT00077766|275453|P2|Overall Study|Withdrawal by Subject|3
73506|NCT00077766|275454|P1|Overall Study|Withdrawal by Subject|4
73507|NCT00077766|275453|P2|Overall Study|Adverse Event|1
73508|NCT00077766|275454|P1|Overall Study|Adverse Event|1
73509|NCT00078312|275483|P1|Overall Study|Miscellaneous|33
73510|NCT00078312|275483|P1|Overall Study|Withdrawal by Subject|33
73511|NCT00078312|275483|P1|Overall Study|Protocol Violation|3
73512|NCT00078312|275483|P1|Overall Study|Physician Decision|9
73513|NCT00078312|275483|P1|Overall Study|Lost to Follow-up|41
73514|NCT00078312|275483|P1|Overall Study|Lack of Efficacy|15
73515|NCT00078312|275483|P1|Overall Study|Adverse Event|43
73516|NCT00078325|275490|P3|Overall Study|Miscellaneous|1
73517|NCT00078325|275491|P2|Overall Study|Miscellaneous|1
73518|NCT00078325|275492|P1|Overall Study|Miscellaneous|1
73519|NCT00078325|275490|P3|Overall Study|Physician Decision|1
73520|NCT00078325|275491|P2|Overall Study|Physician Decision|0
73521|NCT00078325|275492|P1|Overall Study|Physician Decision|2
73522|NCT00078325|275490|P3|Overall Study|Lost to Follow-up|1
73523|NCT00078325|275491|P2|Overall Study|Lost to Follow-up|1
73524|NCT00078325|275492|P1|Overall Study|Lost to Follow-up|0
73525|NCT00078325|275490|P3|Overall Study|Withdrawal by Subject|3
73526|NCT00078325|275491|P2|Overall Study|Withdrawal by Subject|5
73527|NCT00078325|275492|P1|Overall Study|Withdrawal by Subject|1
73528|NCT00078325|275490|P3|Overall Study|Protocol Violation|0
73529|NCT00078325|275491|P2|Overall Study|Protocol Violation|2
73530|NCT00078325|275492|P1|Overall Study|Protocol Violation|2
73531|NCT00078325|275490|P3|Overall Study|Adverse Event|5
73532|NCT00078325|275491|P2|Overall Study|Adverse Event|10
73533|NCT00078325|275492|P1|Overall Study|Adverse Event|15
73534|NCT00078377|275506|P3|Overall Study|Miscellaneous|1
73535|NCT00078377|275507|P2|Overall Study|Miscellaneous|6
73536|NCT00078377|275508|P1|Overall Study|Miscellaneous|2
73537|NCT00078377|275506|P3|Overall Study|Withdrawal by Subject|4
73538|NCT00078377|275507|P2|Overall Study|Withdrawal by Subject|4
73539|NCT00078377|275508|P1|Overall Study|Withdrawal by Subject|3
73540|NCT00078377|275506|P3|Overall Study|Physician Decision|0
73541|NCT00078377|275507|P2|Overall Study|Physician Decision|0
73542|NCT00078377|275508|P1|Overall Study|Physician Decision|2
73543|NCT00078377|275506|P3|Overall Study|Lost to Follow-up|1
73544|NCT00078377|275507|P2|Overall Study|Lost to Follow-up|1
73545|NCT00078377|275508|P1|Overall Study|Lost to Follow-up|0
73546|NCT00078377|275506|P3|Overall Study|Lack of Efficacy|2
73547|NCT00078377|275507|P2|Overall Study|Lack of Efficacy|0
73548|NCT00078377|275508|P1|Overall Study|Lack of Efficacy|2
73549|NCT00078377|275506|P3|Overall Study|Adverse Event|1
73550|NCT00078377|275507|P2|Overall Study|Adverse Event|5
73551|NCT00078377|275508|P1|Overall Study|Adverse Event|2
73552|NCT00078767|275640|P2|Overall Study|Withdrawal by Subject|1
73553|NCT00078767|275641|P1|Overall Study|Withdrawal by Subject|1
73554|NCT00078949|275659|P4|Maintenance|No treated|3
73555|NCT00078949|275660|P3|Maintenance|No treated|3
73556|NCT00078949|275661|P2|Maintenance|No treated|0
73557|NCT00078949|275662|P1|Maintenance|No treated|0
73558|NCT00078949|275659|P4|Salvage|No treated|0
73559|NCT00078949|275660|P3|Salvage|No treated|0
73560|NCT00078949|275661|P2|Salvage|No treated|5
73561|NCT00078949|275662|P1|Salvage|No treated|4
73562|NCT00079040|275687|P1|Overall Study|Ineligible|1
73563|NCT00079040|275687|P1|Overall Study|Withdrew before treatment|1
73564|NCT00079183|275693|P1|Overall Study|Specimen collection non-compliance|1
73565|NCT00079183|275693|P1|Overall Study|Study medication non-compliance|2
73566|NCT00079183|275693|P1|Overall Study|Withdrawal by Subject|4
73567|NCT00079274|275715|P7|Overall Study|Not Specified|0
73568|NCT00079274|275716|P6|Overall Study|Not Specified|2
73569|NCT00079274|275717|P5|Overall Study|Not Specified|1
73570|NCT00079274|275718|P4|Overall Study|Not Specified|55
73571|NCT00079274|275719|P3|Overall Study|Not Specified|5
73572|NCT00079274|275720|P2|Overall Study|Not Specified|7
73573|NCT00079274|275721|P1|Overall Study|Not Specified|43
73574|NCT00079274|275715|P7|Overall Study|Cytogenetic resistance|0
73575|NCT00079274|275716|P6|Overall Study|Cytogenetic resistance|0
73576|NCT00079274|275717|P5|Overall Study|Cytogenetic resistance|0
73577|NCT00079274|275718|P4|Overall Study|Cytogenetic resistance|2
73578|NCT00079274|275719|P3|Overall Study|Cytogenetic resistance|0
73579|NCT00079274|275720|P2|Overall Study|Cytogenetic resistance|0
73580|NCT00079274|275721|P1|Overall Study|Cytogenetic resistance|0
73581|NCT00079274|275715|P7|Overall Study|Death|0
73582|NCT00079274|275716|P6|Overall Study|Death|0
73583|NCT00079274|275717|P5|Overall Study|Death|0
73584|NCT00079274|275718|P4|Overall Study|Death|15
73585|NCT00079274|275719|P3|Overall Study|Death|1
73586|NCT00079274|275720|P2|Overall Study|Death|0
73587|NCT00079274|275721|P1|Overall Study|Death|4
73588|NCT00079274|275715|P7|Overall Study|Other Medical Problems|0
73589|NCT00079274|275716|P6|Overall Study|Other Medical Problems|0
73590|NCT00079274|275717|P5|Overall Study|Other Medical Problems|0
73591|NCT00079274|275718|P4|Overall Study|Other Medical Problems|7
73592|NCT00079274|275719|P3|Overall Study|Other Medical Problems|0
73593|NCT00079274|275720|P2|Overall Study|Other Medical Problems|1
73594|NCT00079274|275721|P1|Overall Study|Other Medical Problems|6
73595|NCT00079274|275715|P7|Overall Study|Alternate Treatment|0
73596|NCT00079274|275716|P6|Overall Study|Alternate Treatment|0
73597|NCT00079274|275717|P5|Overall Study|Alternate Treatment|0
73598|NCT00079274|275718|P4|Overall Study|Alternate Treatment|3
73599|NCT00079274|275719|P3|Overall Study|Alternate Treatment|0
73600|NCT00079274|275720|P2|Overall Study|Alternate Treatment|1
73601|NCT00079274|275721|P1|Overall Study|Alternate Treatment|6
73602|NCT00079274|275715|P7|Overall Study|Recurrence|0
73603|NCT00079274|275716|P6|Overall Study|Recurrence|2
73604|NCT00079274|275717|P5|Overall Study|Recurrence|0
73605|NCT00079274|275718|P4|Overall Study|Recurrence|15
73606|NCT00079274|275719|P3|Overall Study|Recurrence|1
73607|NCT00079274|275720|P2|Overall Study|Recurrence|0
73608|NCT00079274|275721|P1|Overall Study|Recurrence|21
73609|NCT00079274|275715|P7|Overall Study|Adverse Event|0
73610|NCT00079274|275716|P6|Overall Study|Adverse Event|8
73611|NCT00079274|275717|P5|Overall Study|Adverse Event|7
73612|NCT00079274|275718|P4|Overall Study|Adverse Event|184
73613|NCT00079274|275719|P3|Overall Study|Adverse Event|8
73614|NCT00079274|275720|P2|Overall Study|Adverse Event|8
73615|NCT00079274|275721|P1|Overall Study|Adverse Event|130
73616|NCT00079274|275715|P7|Overall Study|Withdrawal by Subject|0
73617|NCT00079274|275716|P6|Overall Study|Withdrawal by Subject|8
73618|NCT00079274|275717|P5|Overall Study|Withdrawal by Subject|7
73619|NCT00079274|275718|P4|Overall Study|Withdrawal by Subject|163
73620|NCT00079274|275719|P3|Overall Study|Withdrawal by Subject|12
73621|NCT00079274|275720|P2|Overall Study|Withdrawal by Subject|10
73622|NCT00079274|275721|P1|Overall Study|Withdrawal by Subject|111
73623|NCT00079339|275747|P3|Overall Study|Disease progression|2
73624|NCT00079339|275748|P2|Overall Study|Disease progression|28
73625|NCT00079339|275749|P1|Overall Study|Disease progression|3
73626|NCT00079339|275747|P3|Overall Study|Withdrawal by Subject|1
73627|NCT00079339|275748|P2|Overall Study|Withdrawal by Subject|4
73628|NCT00079339|275749|P1|Overall Study|Withdrawal by Subject|0
73629|NCT00079339|275747|P3|Overall Study|Non-compliance|1
73630|NCT00079339|275748|P2|Overall Study|Non-compliance|0
73631|NCT00079339|275749|P1|Overall Study|Non-compliance|0
73632|NCT00079339|275747|P3|Overall Study|Death|0
73633|NCT00079339|275748|P2|Overall Study|Death|0
73634|NCT00079339|275749|P1|Overall Study|Death|1
73635|NCT00079339|275747|P3|Overall Study|Adverse Event|2
73636|NCT00079339|275748|P2|Overall Study|Adverse Event|7
73637|NCT00079339|275749|P1|Overall Study|Adverse Event|1
73638|NCT00079391|275763|P1|Overall Study|Withdrawal by Subject|1
73639|NCT00079417|275772|P1|Overall Study|ineligible|1
73640|NCT00079417|275772|P1|Overall Study|Tumor requires non-protocol radiotherapy|2
73641|NCT00079417|275772|P1|Overall Study|Tumor requires non-protocol chemotherapy|1
73642|NCT00079417|275772|P1|Overall Study|Physician Decision|5
73643|NCT00079677|275778|P2|Overall Study|Miscellaneous|0
73644|NCT00079677|275779|P1|Overall Study|Miscellaneous|2
73645|NCT00079677|275778|P2|Overall Study|Withdrawal by Subject|3
73646|NCT00079677|275779|P1|Overall Study|Withdrawal by Subject|5
73647|NCT00079677|275778|P2|Overall Study|Protocol Violation|3
73648|NCT00079677|275779|P1|Overall Study|Protocol Violation|2
73649|NCT00079677|275778|P2|Overall Study|Physician Decision|0
73650|NCT00079677|275779|P1|Overall Study|Physician Decision|3
73651|NCT00079677|275778|P2|Overall Study|Lost to Follow-up|2
73652|NCT00079677|275779|P1|Overall Study|Lost to Follow-up|2
73653|NCT00079677|275778|P2|Overall Study|Lack of Efficacy|0
73654|NCT00079677|275779|P1|Overall Study|Lack of Efficacy|1
73655|NCT00079677|275778|P2|Overall Study|Adverse Event|6
73656|NCT00079677|275779|P1|Overall Study|Adverse Event|5
73657|NCT00079781|275790|P3|Follow-up Period|Death|1
73658|NCT00079781|275791|P2|Follow-up Period|Death|0
73659|NCT00079781|275792|P1|Follow-up Period|Death|0
73660|NCT00079781|275790|P3|Follow-up Period|Lost to Follow-up|0
73661|NCT00079781|275791|P2|Follow-up Period|Lost to Follow-up|0
73662|NCT00079781|275792|P1|Follow-up Period|Lost to Follow-up|1
73663|NCT00079781|275790|P3|Follow-up Period|Withdrawal by Subject|1
73664|NCT00079781|275791|P2|Follow-up Period|Withdrawal by Subject|0
73665|NCT00079781|275792|P1|Follow-up Period|Withdrawal by Subject|3
73666|NCT00079781|275790|P3|Pre-implant Period|Did not meet I/E criteria|1
73667|NCT00079781|275791|P2|Pre-implant Period|Did not meet I/E criteria|1
73668|NCT00079781|275792|P1|Pre-implant Period|Did not meet I/E criteria|1
73669|NCT00079781|275790|P3|Pre-implant Period|Withdrawal by Subject|0
73670|NCT00079781|275791|P2|Pre-implant Period|Withdrawal by Subject|0
73671|NCT00079781|275792|P1|Pre-implant Period|Withdrawal by Subject|2
73672|NCT00079937|275801|P2|Overall Study|Administrative problems|11
73673|NCT00079937|275802|P1|Overall Study|Administrative problems|22
73674|NCT00079937|275801|P2|Overall Study|Lost to Follow-up|5
73675|NCT00079937|275802|P1|Overall Study|Lost to Follow-up|12
73676|NCT00079937|275801|P2|Overall Study|Withdrawal by Subject|7
73677|NCT00079937|275802|P1|Overall Study|Withdrawal by Subject|21
73678|NCT00079937|275801|P2|Overall Study|Protocol Violation|6
73679|NCT00079937|275802|P1|Overall Study|Protocol Violation|8
73680|NCT00079937|275801|P2|Overall Study|Subject no longer requires study drug|0
73681|NCT00079937|275802|P1|Overall Study|Subject no longer requires study drug|3
73682|NCT00079937|275801|P2|Overall Study|Unsatisfactory therapeutic effect|2
73683|NCT00079937|275802|P1|Overall Study|Unsatisfactory therapeutic effect|1
73684|NCT00079937|275801|P2|Overall Study|Adverse Event|1
73685|NCT00079937|275802|P1|Overall Study|Adverse Event|2
73686|NCT00080119|275822|P4|Overall Study|Lost to Follow-up|14
73687|NCT00080119|275823|P3|Overall Study|Lost to Follow-up|19
73688|NCT00080119|275824|P2|Overall Study|Lost to Follow-up|19
73689|NCT00080119|275825|P1|Overall Study|Lost to Follow-up|16
73690|NCT00080119|275822|P4|Overall Study|Unwilling to adhere to study requirement|1
73691|NCT00080119|275823|P3|Overall Study|Unwilling to adhere to study requirement|5
73692|NCT00080119|275824|P2|Overall Study|Unwilling to adhere to study requirement|2
73693|NCT00080119|275825|P1|Overall Study|Unwilling to adhere to study requirement|3
73694|NCT00080119|275822|P4|Overall Study|Consent withdrawn|6
73695|NCT00080119|275823|P3|Overall Study|Consent withdrawn|4
73696|NCT00080119|275824|P2|Overall Study|Consent withdrawn|17
73697|NCT00080119|275825|P1|Overall Study|Consent withdrawn|13
73698|NCT00080119|275822|P4|Overall Study|Unable to get to clinic|1
73699|NCT00080119|275823|P3|Overall Study|Unable to get to clinic|7
73700|NCT00080119|275824|P2|Overall Study|Unable to get to clinic|24
73701|NCT00080119|275825|P1|Overall Study|Unable to get to clinic|24
73702|NCT00080119|275822|P4|Overall Study|Discontinued because of study closure|141
73703|NCT00080119|275823|P3|Overall Study|Discontinued because of study closure|130
73704|NCT00080119|275824|P2|Overall Study|Discontinued because of study closure|0
73705|NCT00080119|275825|P1|Overall Study|Discontinued because of study closure|0
73706|NCT00080223|275857|P1|Overall Study|Physician Decision|1
73707|NCT00080223|275857|P1|Overall Study|Participant unwilling to continue|2
73708|NCT00080223|275857|P1|Overall Study|Non-compliance With Study Treatment|7
73709|NCT00080223|275857|P1|Overall Study|Lung Transplantation|9
73710|NCT00080223|275857|P1|Overall Study|Withdrawal by Subject|13
73711|NCT00080223|275857|P1|Overall Study|Death|21
73712|NCT00080223|275857|P1|Overall Study|Adverse Event|23
73713|NCT00080288|275867|P2|Overall Study|Miscellaneous|11
73714|NCT00080288|275868|P1|Overall Study|Miscellaneous|11
73715|NCT00080288|275867|P2|Overall Study|Withdrawal by Subject|16
73716|NCT00080288|275868|P1|Overall Study|Withdrawal by Subject|3
73717|NCT00080288|275867|P2|Overall Study|Physician Decision|2
73718|NCT00080288|275868|P1|Overall Study|Physician Decision|6
73719|NCT00080288|275867|P2|Overall Study|Lost to Follow-up|5
73720|NCT00080288|275868|P1|Overall Study|Lost to Follow-up|3
73721|NCT00080288|275867|P2|Overall Study|Adverse Event|4
73722|NCT00080288|275868|P1|Overall Study|Adverse Event|7
73723|NCT00080301|275878|P2|Overall Study|Still on Treatment as of CSR date|1
73724|NCT00080301|275879|P1|Overall Study|Still on Treatment as of CSR date|0
73725|NCT00080301|275878|P2|Overall Study|Randomized but Never Treated|10
73726|NCT00080301|275879|P1|Overall Study|Randomized but Never Treated|5
73727|NCT00080483|275910|P2|Overall Study|Physician Decision|1
73728|NCT00080483|275911|P1|Overall Study|Physician Decision|1
73729|NCT00080483|275910|P2|Overall Study|Lost to Follow-up|1
73730|NCT00080483|275911|P1|Overall Study|Lost to Follow-up|1
73731|NCT00080899|275922|P1|Overall Study|Adverse Event|1
73732|NCT00074581|275929|P2|Overall Study|Other|19
73733|NCT00074581|275930|P1|Overall Study|Other|14
73734|NCT00074581|275929|P2|Overall Study|Ended relationship w. index participant|106
73735|NCT00074581|275930|P1|Overall Study|Ended relationship w. index participant|117
73736|NCT00074581|275929|P2|Overall Study|Lost to Follow-up|11
73737|NCT00074581|275930|P1|Overall Study|Lost to Follow-up|16
73738|NCT00074581|275929|P2|Overall Study|Were withdrawn by investigator|2
73739|NCT00074581|275930|P1|Overall Study|Were withdrawn by investigator|5
73740|NCT00074581|275929|P2|Overall Study|Relocated|9
73741|NCT00074581|275930|P1|Overall Study|Relocated|14
73742|NCT00074581|275929|P2|Overall Study|Unable to adhere to visit schedule|14
73743|NCT00074581|275930|P1|Overall Study|Unable to adhere to visit schedule|13
73744|NCT00074581|275929|P2|Overall Study|Withdrawal by Subject|49
73745|NCT00074581|275930|P1|Overall Study|Withdrawal by Subject|50
73746|NCT00074581|275929|P2|Overall Study|Death|16
73747|NCT00074581|275930|P1|Overall Study|Death|15
73748|NCT00074711|275940|P2|Overall Study|Participant stopped study drug|6
73749|NCT00074711|275941|P1|Overall Study|Participant stopped study drug|4
73750|NCT00074711|275940|P2|Overall Study|Lost to Follow-up|8
73751|NCT00074711|275941|P1|Overall Study|Lost to Follow-up|10
73752|NCT00074711|275940|P2|Overall Study|Withdrawal by Subject|1
73753|NCT00074711|275941|P1|Overall Study|Withdrawal by Subject|1
73754|NCT00080938|275966|P1|Overall Study|Ineligible|4
73755|NCT00080938|275966|P1|Overall Study|Not started protocol therapy|1
73756|NCT00080938|275966|P1|Overall Study|other disease|1
73757|NCT00080938|275966|P1|Overall Study|Lack of Efficacy|7
73758|NCT00080938|275966|P1|Overall Study|Death|2
73759|NCT00080938|275966|P1|Overall Study|Withdrawal by Subject|6
73760|NCT00080938|275966|P1|Overall Study|Adverse Event|3
73761|NCT00081159|275975|P2|Overall Study|Lost to Follow-up|1
73762|NCT00081159|275976|P1|Overall Study|Lost to Follow-up|2
73763|NCT00081159|275975|P2|Overall Study|Myelosuppression prior to treatment|1
73764|NCT00081159|275976|P1|Overall Study|Myelosuppression prior to treatment|0
73765|NCT00081159|275975|P2|Overall Study|Withdrawal by Subject|3
73766|NCT00081159|275976|P1|Overall Study|Withdrawal by Subject|0
73767|NCT00081289|275988|P2|Overall Study|Ineligible / no protocol treatment|4
73768|NCT00081289|275989|P1|Overall Study|Ineligible / no protocol treatment|3
73769|NCT00081289|275988|P2|Overall Study|Accrued prior to chemotherapy amendment|17
73770|NCT00081289|275989|P1|Overall Study|Accrued prior to chemotherapy amendment|18
73771|NCT00082173|276065|P2|Overall Study|Culture negative or resistant at baselin|6
73772|NCT00082173|276066|P1|Overall Study|Culture negative or resistant at baselin|5
73773|NCT00082173|276065|P2|Overall Study|Adverse Event|0
73774|NCT00082173|276066|P1|Overall Study|Adverse Event|1
73775|NCT00082173|276065|P2|Overall Study|Lost to Follow-up|0
73776|NCT00082173|276066|P1|Overall Study|Lost to Follow-up|1
73777|NCT00082173|276065|P2|Overall Study|Withdrawal by Subject|5
73778|NCT00082173|276066|P1|Overall Study|Withdrawal by Subject|3
73779|NCT00082355|276101|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
73780|NCT00082355|276101|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
73781|NCT00082355|276101|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
73782|NCT00082368|276106|P1|Overall Study|Not treated-pt had poor IV access|1
73783|NCT00082381|276113|P2|Overall Study|Loss of Glucose Control|0
73784|NCT00082381|276114|P1|Overall Study|Loss of Glucose Control|4
73785|NCT00082381|276113|P2|Overall Study|Protocol Violation|11
73786|NCT00082381|276114|P1|Overall Study|Protocol Violation|10
73787|NCT00082381|276113|P2|Overall Study|Physician Decision|2
73788|NCT00082381|276114|P1|Overall Study|Physician Decision|1
73789|NCT00082381|276113|P2|Overall Study|Patient Decision|4
73790|NCT00082381|276114|P1|Overall Study|Patient Decision|8
73791|NCT00082381|276113|P2|Overall Study|Lost to Follow-up|7
73792|NCT00082381|276114|P1|Overall Study|Lost to Follow-up|5
73793|NCT00082381|276113|P2|Overall Study|Adverse Event|2
73794|NCT00082381|276114|P1|Overall Study|Adverse Event|27
73795|NCT00082407|276134|P2|Overall Study|Lost to Follow-up|3
73796|NCT00082407|276135|P1|Overall Study|Lost to Follow-up|0
73797|NCT00082407|276134|P2|Overall Study|Death|1
73798|NCT00082407|276135|P1|Overall Study|Death|2
73799|NCT00082407|276134|P2|Overall Study|Loss of Glucose Control|2
73800|NCT00082407|276135|P1|Overall Study|Loss of Glucose Control|2
73801|NCT00082407|276134|P2|Overall Study|Physician Decision|3
73802|NCT00082407|276135|P1|Overall Study|Physician Decision|5
73803|NCT00082407|276134|P2|Overall Study|Patient Decision|6
73804|NCT00082407|276135|P1|Overall Study|Patient Decision|13
73805|NCT00082407|276134|P2|Overall Study|Protocol Violation|12
73806|NCT00082407|276135|P1|Overall Study|Protocol Violation|14
73807|NCT00082407|276134|P2|Overall Study|Adverse Event|0
73808|NCT00082407|276135|P1|Overall Study|Adverse Event|20
73809|NCT00082433|276155|P2|Overall Study|Impending surgery|1
73810|NCT00082433|276156|P1|Overall Study|Impending surgery|0
73811|NCT00082433|276155|P2|Overall Study|New primary cancer|0
73812|NCT00082433|276156|P1|Overall Study|New primary cancer|1
73813|NCT00082433|276155|P2|Overall Study|Noncompliance|1
73814|NCT00082433|276156|P1|Overall Study|Noncompliance|2
73815|NCT00082433|276155|P2|Overall Study|Ineligible|1
73816|NCT00082433|276156|P1|Overall Study|Ineligible|2
73817|NCT00082433|276155|P2|Overall Study|Not Treated|11
73818|NCT00082433|276156|P1|Overall Study|Not Treated|12
73819|NCT00082433|276155|P2|Overall Study|Still On Treatment|1
73820|NCT00082433|276156|P1|Overall Study|Still On Treatment|2
73821|NCT00082433|276155|P2|Overall Study|Withdrawal by Subject|30
73822|NCT00082433|276156|P1|Overall Study|Withdrawal by Subject|55
73823|NCT00082433|276155|P2|Overall Study|Study Drug Toxicity|66
73824|NCT00082433|276156|P1|Overall Study|Study Drug Toxicity|179
73825|NCT00082433|276155|P2|Overall Study|Lost to Follow-up|2
73826|NCT00082433|276156|P1|Overall Study|Lost to Follow-up|1
73827|NCT00082433|276155|P2|Overall Study|Physician Decision|61
73828|NCT00082433|276156|P1|Overall Study|Physician Decision|50
73829|NCT00082433|276155|P2|Overall Study|Disease Progression/Relapse|388
73830|NCT00082433|276156|P1|Overall Study|Disease Progression/Relapse|270
73831|NCT00082433|276155|P2|Overall Study|Death|18
73832|NCT00082433|276156|P1|Overall Study|Death|8
73833|NCT00082433|276155|P2|Overall Study|Adverse Event|17
73834|NCT00082433|276156|P1|Overall Study|Adverse Event|12
73835|NCT00082758|276177|P3|Overall Study|Protocol Violation|0
73836|NCT00082758|276178|P2|Overall Study|Protocol Violation|1
73837|NCT00082758|276179|P1|Overall Study|Protocol Violation|0
73838|NCT00082758|276177|P3|Overall Study|Withdrawal by Subject|0
73839|NCT00082758|276178|P2|Overall Study|Withdrawal by Subject|0
73840|NCT00082758|276179|P1|Overall Study|Withdrawal by Subject|3
73841|NCT00082758|276177|P3|Overall Study|Physician Decision|0
73842|NCT00082758|276178|P2|Overall Study|Physician Decision|1
73843|NCT00082758|276179|P1|Overall Study|Physician Decision|0
73844|NCT00082758|276177|P3|Overall Study|Lack of Efficacy|0
73845|NCT00082758|276178|P2|Overall Study|Lack of Efficacy|13
73846|NCT00082758|276179|P1|Overall Study|Lack of Efficacy|12
73847|NCT00082758|276177|P3|Overall Study|Adverse Event|0
73848|NCT00082758|276178|P2|Overall Study|Adverse Event|2
73849|NCT00082758|276179|P1|Overall Study|Adverse Event|0
73850|NCT00082810|276187|P1|Overall Study|Withdrawal by Subject|4
73851|NCT00082810|276187|P1|Overall Study|Progressive disease|24
73852|NCT00082810|276187|P1|Overall Study|Adverse Event|3
73853|NCT00082888|276194|P1|Overall Study|Still receiving treatment|4
73854|NCT00082888|276194|P1|Overall Study|Other Medical Problems|2
73855|NCT00082888|276194|P1|Overall Study|Alternate Treatment|1
73856|NCT00082888|276194|P1|Overall Study|Withdrawal by Subject|9
73857|NCT00082888|276194|P1|Overall Study|Adverse Event|4
73858|NCT00082888|276194|P1|Overall Study|Death|2
73859|NCT00083226|276231|P1|Overall Study|ineligible or not receiving treatment|4
73860|NCT00083226|276231|P1|Overall Study|Other|2
73861|NCT00083226|276231|P1|Overall Study|Withdrawal by Subject|4
73862|NCT00083226|276231|P1|Overall Study|Death|4
73863|NCT00083226|276231|P1|Overall Study|Adverse Event|9
73864|NCT00083226|276231|P1|Overall Study|Lack of Efficacy|19
73865|NCT00083616|276250|P1|Overall Study|Other|6
73866|NCT00083616|276250|P1|Overall Study|Non-compliance|1
73867|NCT00083616|276250|P1|Overall Study|Ineligibility determined|2
73868|NCT00083616|276250|P1|Overall Study|Withdrawal by Subject|3
73869|NCT00083616|276250|P1|Overall Study|Physician Decision|2
73870|NCT00083616|276250|P1|Overall Study|Lost to Follow-up|1
73871|NCT00083616|276250|P1|Overall Study|Disease Progression|16
73872|NCT00083759|276274|P2|Overall Study|Other|13
73873|NCT00083759|276275|P1|Overall Study|Other|14
73874|NCT00083759|276274|P2|Overall Study|Sponsor's Discretion|29
73875|NCT00083759|276275|P1|Overall Study|Sponsor's Discretion|28
73876|NCT00083759|276274|P2|Overall Study|Non-Compliance|0
73877|NCT00083759|276275|P1|Overall Study|Non-Compliance|1
73878|NCT00083759|276274|P2|Overall Study|Subject Withdrew Consent|2
73879|NCT00083759|276275|P1|Overall Study|Subject Withdrew Consent|2
73880|NCT00083759|276274|P2|Overall Study|Inadequate Therapeutic Response|35
73881|NCT00083759|276275|P1|Overall Study|Inadequate Therapeutic Response|32
73882|NCT00083759|276274|P2|Overall Study|Death|1
73883|NCT00083759|276275|P1|Overall Study|Death|1
73884|NCT00083759|276274|P2|Overall Study|Lost to Follow-up|0
73885|NCT00083759|276275|P1|Overall Study|Lost to Follow-up|1
73886|NCT00083759|276274|P2|Overall Study|Adverse Event|3
73887|NCT00083759|276275|P1|Overall Study|Adverse Event|5
73888|NCT00083889|276285|P2|Overall Study|Crossover to SU011248|25
73889|NCT00083889|276286|P1|Overall Study|Crossover to SU011248|0
73890|NCT00083889|276285|P2|Overall Study|Completed on marketed sunitinub|0
73891|NCT00083889|276286|P1|Overall Study|Completed on marketed sunitinub|3
73892|NCT00083889|276285|P2|Overall Study|Randomized: did not take study drug|15
73893|NCT00083889|276286|P1|Overall Study|Randomized: did not take study drug|0
73894|NCT00083889|276285|P2|Overall Study|Decision of sponsor|4
73895|NCT00083889|276286|P1|Overall Study|Decision of sponsor|32
73896|NCT00083889|276285|P2|Overall Study|Lack of Efficacy|219
73897|NCT00083889|276286|P1|Overall Study|Lack of Efficacy|240
73898|NCT00083889|276285|P2|Overall Study|Withdrawal by Subject|24
73899|NCT00083889|276286|P1|Overall Study|Withdrawal by Subject|22
73900|NCT00083889|276285|P2|Overall Study|Protocol Violation|2
73901|NCT00083889|276286|P1|Overall Study|Protocol Violation|2
73902|NCT00083889|276285|P2|Overall Study|Adverse Event|86
73903|NCT00083889|276286|P1|Overall Study|Adverse Event|76
73904|NCT00083915|276337|P2|Overall Study|Insurance issues|1
73905|NCT00083915|276338|P1|Overall Study|Insurance issues|1
73906|NCT00083915|276337|P2|Overall Study|No response|1
73907|NCT00083915|276338|P1|Overall Study|No response|3
73908|NCT00083915|276337|P2|Overall Study|Failure to collect|0
73909|NCT00083915|276338|P1|Overall Study|Failure to collect|3
73910|NCT00083915|276337|P2|Overall Study|disease progression|23
73911|NCT00083915|276338|P1|Overall Study|disease progression|18
73912|NCT00083915|276337|P2|Overall Study|Withdrawal by Subject|3
73913|NCT00083915|276338|P1|Overall Study|Withdrawal by Subject|8
73914|NCT00083915|276337|P2|Overall Study|Physician Decision|6
73915|NCT00083915|276338|P1|Overall Study|Physician Decision|11
73916|NCT00083915|276337|P2|Overall Study|Death|3
73917|NCT00083915|276338|P1|Overall Study|Death|6
73918|NCT00084084|276344|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
73919|NCT00084084|276344|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
73920|NCT00084136|276355|P3|NRTI Comparison|Not reason above|0
73921|NCT00084136|276356|P2|NRTI Comparison|Not reason above|0
73922|NCT00084136|276357|P1|NRTI Comparison|Not reason above|1
73923|NCT00084136|276355|P3|NRTI Comparison|Clinic site closed|14
73924|NCT00084136|276356|P2|NRTI Comparison|Clinic site closed|0
73925|NCT00084136|276357|P1|NRTI Comparison|Clinic site closed|12
73926|NCT00084136|276355|P3|NRTI Comparison|Withdrawal by Subject|38
73927|NCT00084136|276356|P2|NRTI Comparison|Withdrawal by Subject|0
73928|NCT00084136|276357|P1|NRTI Comparison|Withdrawal by Subject|54
73929|NCT00084136|276355|P3|NRTI Comparison|Lost to Follow-up|12
73930|NCT00084136|276356|P2|NRTI Comparison|Lost to Follow-up|0
73931|NCT00084136|276357|P1|NRTI Comparison|Lost to Follow-up|14
73932|NCT00084136|276355|P3|NRTI Comparison|Death|18
73933|NCT00084136|276356|P2|NRTI Comparison|Death|0
73934|NCT00084136|276357|P1|NRTI Comparison|Death|20
73935|NCT00084136|276355|P3|PI Comparison|Clinic site closed|0
73936|NCT00084136|276356|P2|PI Comparison|Clinic site closed|0
73937|NCT00084136|276357|P1|PI Comparison|Clinic site closed|1
73938|NCT00084136|276355|P3|PI Comparison|Withdrawal by Subject|0
73939|NCT00084136|276356|P2|PI Comparison|Withdrawal by Subject|30
73940|NCT00084136|276357|P1|PI Comparison|Withdrawal by Subject|33
73941|NCT00084136|276355|P3|PI Comparison|Lost to Follow-up|0
73942|NCT00084136|276356|P2|PI Comparison|Lost to Follow-up|8
73943|NCT00084136|276357|P1|PI Comparison|Lost to Follow-up|11
73944|NCT00084136|276355|P3|PI Comparison|Death|0
73945|NCT00084136|276356|P2|PI Comparison|Death|9
73946|NCT00084136|276357|P1|PI Comparison|Death|10
73947|NCT00084266|276418|P2|Overall Study|Randomized not treated|20
73948|NCT00084266|276419|P1|Overall Study|Randomized not treated|21
73949|NCT00084266|276418|P2|Overall Study|Unspecified|344
73950|NCT00084266|276419|P1|Overall Study|Unspecified|360
73951|NCT00084266|276418|P2|Overall Study|Participant not willing to participate|8
73952|NCT00084266|276419|P1|Overall Study|Participant not willing to participate|3
73953|NCT00084266|276418|P2|Overall Study|Lost to Follow-up|3
73954|NCT00084266|276419|P1|Overall Study|Lost to Follow-up|5
73955|NCT00084266|276418|P2|Overall Study|Lack of Efficacy|4
73956|NCT00084266|276419|P1|Overall Study|Lack of Efficacy|2
73957|NCT00084266|276418|P2|Overall Study|Adverse Event|5
73958|NCT00084266|276419|P1|Overall Study|Adverse Event|8
73959|NCT00084266|276418|P2|Overall Study|Death|39
73960|NCT00084266|276419|P1|Overall Study|Death|42
73961|NCT00084318|276455|P2|Overall Study|No protocol treatment|0
73962|NCT00084318|276456|P1|Overall Study|No protocol treatment|2
73963|NCT00084318|276455|P2|Overall Study|Protocol Violation|11
73964|NCT00084318|276456|P1|Overall Study|Protocol Violation|15
73965|NCT00084318|276455|P2|Overall Study|Withdrawal by Subject|2
73966|NCT00084318|276456|P1|Overall Study|Withdrawal by Subject|5
73967|NCT00077857|276510|P2|Overall Study|Other|13
73968|NCT00077857|276511|P1|Overall Study|Other|15
73969|NCT00077857|276510|P2|Overall Study|Failure to return|5
73970|NCT00077857|276511|P1|Overall Study|Failure to return|5
73971|NCT00077857|276510|P2|Overall Study|Refused treatment|21
73972|NCT00077857|276511|P1|Overall Study|Refused treatment|29
73973|NCT00077857|276510|P2|Overall Study|Other protocol violation|1
73974|NCT00077857|276511|P1|Overall Study|Other protocol violation|0
73975|NCT00077857|276510|P2|Overall Study|Violation of selection criteria at entry|1
73976|NCT00077857|276511|P1|Overall Study|Violation of selection criteria at entry|3
73977|NCT00077857|276510|P2|Overall Study|Insufficient therapeutic response|128
73978|NCT00077857|276511|P1|Overall Study|Insufficient therapeutic response|112
73979|NCT00077857|276510|P2|Overall Study|Death|3
73980|NCT00077857|276511|P1|Overall Study|Death|7
73981|NCT00077857|276510|P2|Overall Study|Adverse Event|32
73982|NCT00077857|276511|P1|Overall Study|Adverse Event|30
73983|NCT00077974|276534|P1|Overall Study|Decision of Sponsor|2
73984|NCT00077974|276534|P1|Overall Study|Lack of Efficacy|76
73985|NCT00077974|276534|P1|Overall Study|Withdrawal by Subject|3
73986|NCT00077974|276534|P1|Overall Study|Protocol Violation|1
73987|NCT00077974|276534|P1|Overall Study|Adverse Event|22
73988|NCT00084487|276549|P1|Overall Study|Death|1
73989|NCT00084617|276557|P1|Overall Study|Protocol Violation|1
73990|NCT00084617|276557|P1|Overall Study|Lack of Efficacy|1
73991|NCT00084617|276557|P1|Overall Study|Withdrawal by Subject|7
73992|NCT00084682|276563|P1|Overall Study|Withdrawal by Subject|1
73993|NCT00084747|276567|P1|Overall Study|Withdrawal by Subject|2
73994|NCT00084747|276567|P1|Overall Study|Death|3
73995|NCT00084747|276567|P1|Overall Study|Relapsed|8
73996|NCT00085202|276574|P2|Overall Study|Progressive disease|11
73997|NCT00085202|276575|P1|Overall Study|Progressive disease|1
73998|NCT00085202|276574|P2|Overall Study|Physician Decision|1
73999|NCT00085202|276575|P1|Overall Study|Physician Decision|4
74000|NCT00085202|276574|P2|Overall Study|Withdrawal by Subject|1
74001|NCT00085202|276575|P1|Overall Study|Withdrawal by Subject|2
74002|NCT00085202|276574|P2|Overall Study|Non-specified|5
74003|NCT00085202|276575|P1|Overall Study|Non-specified|3
74004|NCT00085202|276574|P2|Overall Study|Excessive toxicity|5
74005|NCT00085202|276575|P1|Overall Study|Excessive toxicity|6
74006|NCT00085202|276574|P2|Overall Study|Bone involvement confirmed by bone scan|1
74007|NCT00085202|276575|P1|Overall Study|Bone involvement confirmed by bone scan|0
74008|NCT00085202|276574|P2|Overall Study|Still on therapy|0
74009|NCT00085202|276575|P1|Overall Study|Still on therapy|2
74010|NCT00085423|276624|P1|Overall Study|screen failure|1
74011|NCT00085423|276624|P1|Overall Study|Withdrawal by Subject|1
74012|NCT00085540|276636|P2|Overall Study|Protocol Violation|1
74013|NCT00085540|276637|P1|Overall Study|Protocol Violation|0
74014|NCT00085540|276636|P2|Overall Study|Withdrawal by Subject|1
74015|NCT00085540|276637|P1|Overall Study|Withdrawal by Subject|0
74016|NCT00085566|276647|P3|Overall Study|Clinical progression|1
74017|NCT00085566|276648|P2|Overall Study|Clinical progression|0
74018|NCT00085566|276649|P1|Overall Study|Clinical progression|0
74019|NCT00085566|276647|P3|Overall Study|Patient Not treated|3
74020|NCT00085566|276648|P2|Overall Study|Patient Not treated|0
74021|NCT00085566|276649|P1|Overall Study|Patient Not treated|0
74022|NCT00085566|276647|P3|Overall Study|Adverse Event|10
74023|NCT00085566|276648|P2|Overall Study|Adverse Event|0
74024|NCT00085566|276649|P1|Overall Study|Adverse Event|0
74025|NCT00085631|276657|P3|Overall Study|Missing Data|7
74026|NCT00085631|276658|P2|Overall Study|Missing Data|11
74027|NCT00085631|276659|P1|Overall Study|Missing Data|4
74028|NCT00085644|276668|P3|Open-Label Period|Personal reason|4
74029|NCT00085644|276669|P2|Open-Label Period|Personal reason|0
74030|NCT00085644|276670|P1|Open-Label Period|Personal reason|0
74031|NCT00085644|276668|P3|Open-Label Period|Protocol Violation|4
74032|NCT00085644|276669|P2|Open-Label Period|Protocol Violation|0
74033|NCT00085644|276670|P1|Open-Label Period|Protocol Violation|0
74034|NCT00085644|276668|P3|Open-Label Period|Contemplating pregnancy|3
74035|NCT00085644|276669|P2|Open-Label Period|Contemplating pregnancy|0
74036|NCT00085644|276670|P1|Open-Label Period|Contemplating pregnancy|0
74037|NCT00085644|276668|P3|Open-Label Period|Pregnancy|3
74038|NCT00085644|276669|P2|Open-Label Period|Pregnancy|0
74039|NCT00085644|276670|P1|Open-Label Period|Pregnancy|0
74040|NCT00085644|276668|P3|Open-Label Period|Lack of Efficacy|15
74041|NCT00085644|276669|P2|Open-Label Period|Lack of Efficacy|0
74042|NCT00085644|276670|P1|Open-Label Period|Lack of Efficacy|0
74043|NCT00085644|276668|P3|Open-Label Period|Lost to Follow-up|13
74044|NCT00085644|276669|P2|Open-Label Period|Lost to Follow-up|0
74045|NCT00085644|276670|P1|Open-Label Period|Lost to Follow-up|0
74046|NCT00085644|276668|P3|Open-Label Period|Withdrawal by Subject|29
74047|NCT00085644|276669|P2|Open-Label Period|Withdrawal by Subject|0
74048|NCT00085644|276670|P1|Open-Label Period|Withdrawal by Subject|0
74049|NCT00085644|276668|P3|Open-Label Period|Adverse Event|38
74050|NCT00085644|276669|P2|Open-Label Period|Adverse Event|0
74051|NCT00085644|276670|P1|Open-Label Period|Adverse Event|0
74052|NCT00085644|276668|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
74053|NCT00085644|276669|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
74054|NCT00085644|276670|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
74055|NCT00085644|276668|P3|Double-Blind Period|Contemplating pregnancy|0
74056|NCT00085644|276669|P2|Double-Blind Period|Contemplating pregnancy|0
74057|NCT00085644|276670|P1|Double-Blind Period|Contemplating pregnancy|1
74058|NCT00085644|276668|P3|Double-Blind Period|Lack/loss of efficacy|0
74059|NCT00085644|276669|P2|Double-Blind Period|Lack/loss of efficacy|2
74060|NCT00085644|276670|P1|Double-Blind Period|Lack/loss of efficacy|2
74061|NCT00085644|276668|P3|Double-Blind Period|Lost to Follow-up|0
74062|NCT00085644|276669|P2|Double-Blind Period|Lost to Follow-up|1
74063|NCT00085644|276670|P1|Double-Blind Period|Lost to Follow-up|2
74064|NCT00085644|276668|P3|Double-Blind Period|Withdrawal by Subject|0
74065|NCT00085644|276669|P2|Double-Blind Period|Withdrawal by Subject|0
74066|NCT00085644|276670|P1|Double-Blind Period|Withdrawal by Subject|3
74067|NCT00085644|276668|P3|Double-Blind Period|Adverse Event|0
74068|NCT00085644|276669|P2|Double-Blind Period|Adverse Event|2
74069|NCT00085644|276670|P1|Double-Blind Period|Adverse Event|5
74070|NCT00085709|276713|P2|Overall Study|Withdrawal by Subject|1
74071|NCT00085709|276714|P1|Overall Study|Withdrawal by Subject|2
74072|NCT00085709|276713|P2|Overall Study|Not eligible|19
74073|NCT00085709|276714|P1|Overall Study|Not eligible|19
74074|NCT00085709|276713|P2|Overall Study|Not protocol specified|22
74075|NCT00085709|276714|P1|Overall Study|Not protocol specified|12
74076|NCT00085709|276713|P2|Overall Study|Progression|4
74077|NCT00085709|276714|P1|Overall Study|Progression|3
74078|NCT00085709|276713|P2|Overall Study|Refusal unrelated to adverse events|2
74079|NCT00085709|276714|P1|Overall Study|Refusal unrelated to adverse events|1
74080|NCT00085709|276713|P2|Overall Study|Death|2
74081|NCT00085709|276714|P1|Overall Study|Death|8
74082|NCT00085709|276713|P2|Overall Study|Adverse Event|0
74083|NCT00085709|276714|P1|Overall Study|Adverse Event|8
74084|NCT00085735|276734|P6|Overall Study|Pt transferred to inst w/out study open|0
74085|NCT00085735|276735|P5|Overall Study|Pt transferred to inst w/out study open|0
74086|NCT00085735|276736|P4|Overall Study|Pt transferred to inst w/out study open|0
74087|NCT00085735|276737|P3|Overall Study|Pt transferred to inst w/out study open|0
74088|NCT00085735|276738|P2|Overall Study|Pt transferred to inst w/out study open|0
74089|NCT00085735|276739|P1|Overall Study|Pt transferred to inst w/out study open|1
74090|NCT00085735|276734|P6|Overall Study|Reason not documented|0
74091|NCT00085735|276735|P5|Overall Study|Reason not documented|1
74092|NCT00085735|276736|P4|Overall Study|Reason not documented|0
74093|NCT00085735|276737|P3|Overall Study|Reason not documented|1
74094|NCT00085735|276738|P2|Overall Study|Reason not documented|0
74095|NCT00085735|276739|P1|Overall Study|Reason not documented|1
74096|NCT00085735|276734|P6|Overall Study|Excess residual disease|4
74097|NCT00085735|276735|P5|Overall Study|Excess residual disease|1
74098|NCT00085735|276736|P4|Overall Study|Excess residual disease|1
74099|NCT00085735|276737|P3|Overall Study|Excess residual disease|1
74100|NCT00085735|276738|P2|Overall Study|Excess residual disease|2
74101|NCT00085735|276739|P1|Overall Study|Excess residual disease|2
74102|NCT00085735|276734|P6|Overall Study|Patient ineligible|8
74103|NCT00085735|276735|P5|Overall Study|Patient ineligible|17
74104|NCT00085735|276736|P4|Overall Study|Patient ineligible|7
74105|NCT00085735|276737|P3|Overall Study|Patient ineligible|3
74106|NCT00085735|276738|P2|Overall Study|Patient ineligible|0
74107|NCT00085735|276739|P1|Overall Study|Patient ineligible|1
74108|NCT00085735|276734|P6|Overall Study|Withdrawal by Subject|8
74109|NCT00085735|276735|P5|Overall Study|Withdrawal by Subject|7
74110|NCT00085735|276736|P4|Overall Study|Withdrawal by Subject|5
74111|NCT00085735|276737|P3|Overall Study|Withdrawal by Subject|4
74112|NCT00085735|276738|P2|Overall Study|Withdrawal by Subject|0
74113|NCT00085735|276739|P1|Overall Study|Withdrawal by Subject|1
74114|NCT00085735|276734|P6|Overall Study|Protocol Violation|0
74115|NCT00085735|276735|P5|Overall Study|Protocol Violation|0
74116|NCT00085735|276736|P4|Overall Study|Protocol Violation|0
74117|NCT00085735|276737|P3|Overall Study|Protocol Violation|0
74118|NCT00085735|276738|P2|Overall Study|Protocol Violation|0
74119|NCT00085735|276739|P1|Overall Study|Protocol Violation|1
74120|NCT00085735|276734|P6|Overall Study|Physician Decision|8
74121|NCT00085735|276735|P5|Overall Study|Physician Decision|11
74122|NCT00085735|276736|P4|Overall Study|Physician Decision|3
74123|NCT00085735|276737|P3|Overall Study|Physician Decision|2
74124|NCT00085735|276738|P2|Overall Study|Physician Decision|3
74125|NCT00085735|276739|P1|Overall Study|Physician Decision|2
74126|NCT00085735|276734|P6|Overall Study|Lost to Follow-up|0
74127|NCT00085735|276735|P5|Overall Study|Lost to Follow-up|1
74128|NCT00085735|276736|P4|Overall Study|Lost to Follow-up|0
74129|NCT00085735|276737|P3|Overall Study|Lost to Follow-up|0
74130|NCT00085735|276738|P2|Overall Study|Lost to Follow-up|1
74131|NCT00085735|276739|P1|Overall Study|Lost to Follow-up|0
74132|NCT00085735|276734|P6|Overall Study|Lack of Efficacy|3
74133|NCT00085735|276735|P5|Overall Study|Lack of Efficacy|4
74134|NCT00085735|276736|P4|Overall Study|Lack of Efficacy|3
74135|NCT00085735|276737|P3|Overall Study|Lack of Efficacy|6
74136|NCT00085735|276738|P2|Overall Study|Lack of Efficacy|4
74137|NCT00085735|276739|P1|Overall Study|Lack of Efficacy|2
74138|NCT00085735|276734|P6|Overall Study|Adverse Event|0
74139|NCT00085735|276735|P5|Overall Study|Adverse Event|0
74140|NCT00085735|276736|P4|Overall Study|Adverse Event|0
74141|NCT00085735|276737|P3|Overall Study|Adverse Event|0
74142|NCT00085735|276738|P2|Overall Study|Adverse Event|0
74143|NCT00085735|276739|P1|Overall Study|Adverse Event|1
74144|NCT00085917|276780|P2|Overall Study|Adverse Event|3
74145|NCT00085917|276781|P1|Overall Study|Adverse Event|4
74146|NCT00086047|276793|P2|Overall Study|Physician Decision|1
74147|NCT00086047|276794|P1|Overall Study|Physician Decision|0
74148|NCT00086047|276793|P2|Overall Study|Lost to Follow-up|6
74149|NCT00086047|276794|P1|Overall Study|Lost to Follow-up|7
74150|NCT00086190|276814|P3|Overall Study|Worsening depression|2
74151|NCT00086190|276815|P2|Overall Study|Worsening depression|0
74152|NCT00086190|276816|P1|Overall Study|Worsening depression|0
74153|NCT00086190|276814|P3|Overall Study|Moved|0
74154|NCT00086190|276815|P2|Overall Study|Moved|0
74155|NCT00086190|276816|P1|Overall Study|Moved|1
74156|NCT00086190|276814|P3|Overall Study|Protocol Violation|0
74157|NCT00086190|276815|P2|Overall Study|Protocol Violation|0
74158|NCT00086190|276816|P1|Overall Study|Protocol Violation|1
74159|NCT00086190|276814|P3|Overall Study|Withdrawal by Subject|2
74160|NCT00086190|276815|P2|Overall Study|Withdrawal by Subject|2
74161|NCT00086190|276816|P1|Overall Study|Withdrawal by Subject|0
74162|NCT00086190|276814|P3|Overall Study|Adverse Event|2
74163|NCT00086190|276815|P2|Overall Study|Adverse Event|2
74164|NCT00086190|276816|P1|Overall Study|Adverse Event|6
74165|NCT00086281|276887|P15|Phase 2|Adverse Event|0
74166|NCT00086281|276888|P14|Phase 2|Adverse Event|1
74167|NCT00086281|276889|P13|Phase 2|Adverse Event|1
74168|NCT00086281|276890|P12|Phase 2|Adverse Event|0
74169|NCT00086281|276891|P11|Phase 2|Adverse Event|0
74170|NCT00086281|276892|P10|Phase 2|Adverse Event|0
74171|NCT00086281|276893|P9|Phase 2|Adverse Event|0
74172|NCT00086281|276894|P8|Phase 2|Adverse Event|0
74173|NCT00086281|276895|P7|Phase 2|Adverse Event|0
74174|NCT00086281|276896|P6|Phase 2|Adverse Event|0
74175|NCT00086281|276897|P5|Phase 2|Adverse Event|0
74176|NCT00086281|276898|P4|Phase 2|Adverse Event|0
74177|NCT00086281|276899|P3|Phase 2|Adverse Event|0
74178|NCT00086281|276900|P2|Phase 2|Adverse Event|0
74179|NCT00086281|276901|P1|Phase 2|Adverse Event|0
74180|NCT00086281|276887|P15|Phase 1|Serious Adverse Event|1
74181|NCT00086281|276888|P14|Phase 1|Serious Adverse Event|0
74182|NCT00086281|276889|P13|Phase 1|Serious Adverse Event|0
74183|NCT00086281|276890|P12|Phase 1|Serious Adverse Event|0
74184|NCT00086281|276891|P11|Phase 1|Serious Adverse Event|0
74185|NCT00086281|276892|P10|Phase 1|Serious Adverse Event|0
74186|NCT00086281|276893|P9|Phase 1|Serious Adverse Event|0
74187|NCT00086281|276894|P8|Phase 1|Serious Adverse Event|0
74188|NCT00086281|276895|P7|Phase 1|Serious Adverse Event|0
74189|NCT00086281|276896|P6|Phase 1|Serious Adverse Event|0
74190|NCT00086281|276897|P5|Phase 1|Serious Adverse Event|0
74191|NCT00086281|276898|P4|Phase 1|Serious Adverse Event|0
74192|NCT00086281|276899|P3|Phase 1|Serious Adverse Event|0
74193|NCT00086281|276900|P2|Phase 1|Serious Adverse Event|0
74194|NCT00086281|276901|P1|Phase 1|Serious Adverse Event|0
74195|NCT00086281|276887|P15|Phase 1|Protocol Violation|0
74196|NCT00086281|276888|P14|Phase 1|Protocol Violation|0
74197|NCT00086281|276889|P13|Phase 1|Protocol Violation|0
74198|NCT00086281|276890|P12|Phase 1|Protocol Violation|0
74199|NCT00086281|276891|P11|Phase 1|Protocol Violation|1
74200|NCT00086281|276892|P10|Phase 1|Protocol Violation|0
74201|NCT00086281|276893|P9|Phase 1|Protocol Violation|0
74202|NCT00086281|276894|P8|Phase 1|Protocol Violation|0
74203|NCT00086281|276895|P7|Phase 1|Protocol Violation|0
74204|NCT00086281|276896|P6|Phase 1|Protocol Violation|0
74205|NCT00086281|276897|P5|Phase 1|Protocol Violation|0
74206|NCT00086281|276898|P4|Phase 1|Protocol Violation|0
74207|NCT00086281|276899|P3|Phase 1|Protocol Violation|0
74208|NCT00086281|276900|P2|Phase 1|Protocol Violation|0
74209|NCT00086281|276901|P1|Phase 1|Protocol Violation|0
74210|NCT00086281|276887|P15|Phase 1|Adverse Event|2
74211|NCT00086281|276888|P14|Phase 1|Adverse Event|1
74212|NCT00086281|276889|P13|Phase 1|Adverse Event|1
74213|NCT00086281|276890|P12|Phase 1|Adverse Event|1
74214|NCT00086281|276891|P11|Phase 1|Adverse Event|2
74215|NCT00086281|276892|P10|Phase 1|Adverse Event|1
74216|NCT00086281|276893|P9|Phase 1|Adverse Event|0
74217|NCT00086281|276894|P8|Phase 1|Adverse Event|0
74218|NCT00086281|276895|P7|Phase 1|Adverse Event|0
74219|NCT00086281|276896|P6|Phase 1|Adverse Event|0
74220|NCT00086281|276897|P5|Phase 1|Adverse Event|0
74221|NCT00086281|276898|P4|Phase 1|Adverse Event|0
74222|NCT00086281|276899|P3|Phase 1|Adverse Event|0
74223|NCT00086281|276900|P2|Phase 1|Adverse Event|0
74224|NCT00086281|276901|P1|Phase 1|Adverse Event|0
74225|NCT00086307|276914|P3|Overall Study|Withdrawal by Subject|2
74226|NCT00086307|276915|P2|Overall Study|Withdrawal by Subject|0
74227|NCT00086307|276916|P1|Overall Study|Withdrawal by Subject|0
74228|NCT00086307|276914|P3|Overall Study|Fatigue and difficulty falling asleep|1
74229|NCT00086307|276915|P2|Overall Study|Fatigue and difficulty falling asleep|0
74230|NCT00086307|276916|P1|Overall Study|Fatigue and difficulty falling asleep|0
74231|NCT00086307|276914|P3|Overall Study|Suicidal ideation|1
74232|NCT00086307|276915|P2|Overall Study|Suicidal ideation|0
74233|NCT00086307|276916|P1|Overall Study|Suicidal ideation|0
74234|NCT00086307|276914|P3|Overall Study|Constipation and sleepiness|1
74235|NCT00086307|276915|P2|Overall Study|Constipation and sleepiness|0
74236|NCT00086307|276916|P1|Overall Study|Constipation and sleepiness|0
74237|NCT00086307|276914|P3|Overall Study|Nausea and headaches|1
74238|NCT00086307|276915|P2|Overall Study|Nausea and headaches|0
74239|NCT00086307|276916|P1|Overall Study|Nausea and headaches|0
74240|NCT00086307|276914|P3|Overall Study|Shortness of breath and muscle spasms|0
74241|NCT00086307|276915|P2|Overall Study|Shortness of breath and muscle spasms|0
74242|NCT00086307|276916|P1|Overall Study|Shortness of breath and muscle spasms|1
74243|NCT00086307|276914|P3|Overall Study|Lack of Efficacy|2
74244|NCT00086307|276915|P2|Overall Study|Lack of Efficacy|1
74245|NCT00086307|276916|P1|Overall Study|Lack of Efficacy|1
74246|NCT00086346|276926|P2|Patients Dosed With Test Article|Lack of Efficacy|0
74247|NCT00086346|276927|P1|Patients Dosed With Test Article|Lack of Efficacy|11
74248|NCT00086346|276926|P2|Patients Dosed With Test Article|Protocol Violation|3
74249|NCT00086346|276927|P1|Patients Dosed With Test Article|Protocol Violation|11
74250|NCT00086346|276926|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
74251|NCT00086346|276927|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
74252|NCT00086346|276926|P2|Patients Dosed With Test Article|Nonmedical event|3
74253|NCT00086346|276927|P1|Patients Dosed With Test Article|Nonmedical event|7
74254|NCT00086346|276926|P2|Patients Dosed With Test Article|Lost to Follow-up|3
74255|NCT00086346|276927|P1|Patients Dosed With Test Article|Lost to Follow-up|1
74256|NCT00086346|276926|P2|Patients Dosed With Test Article|Adverse Event|11
74257|NCT00086346|276927|P1|Patients Dosed With Test Article|Adverse Event|94
74258|NCT00086346|276926|P2|Randomization|Did not receive test article|4
74259|NCT00086346|276927|P1|Randomization|Did not receive test article|4
74260|NCT00086385|276943|P4|Overall Study|Death|1
74261|NCT00086385|276944|P3|Overall Study|Death|1
74262|NCT00086385|276945|P2|Overall Study|Death|2
74263|NCT00086385|276946|P1|Overall Study|Death|2
74264|NCT00086411|276960|P4|Overall Study|Lost to Follow-up|12
74265|NCT00086411|276961|P3|Overall Study|Lost to Follow-up|13
74266|NCT00086411|276962|P2|Overall Study|Lost to Follow-up|11
74267|NCT00086411|276963|P1|Overall Study|Lost to Follow-up|11
74268|NCT00086502|276990|P2|Overall Study|Patient Accidentally Unblinded|0
74269|NCT00086502|276991|P1|Overall Study|Patient Accidentally Unblinded|1
74270|NCT00086502|276990|P2|Overall Study|Protocol Discontinuation Criteria|3
74271|NCT00086502|276991|P1|Overall Study|Protocol Discontinuation Criteria|1
74272|NCT00086502|276990|P2|Overall Study|Patient Moved|1
74273|NCT00086502|276991|P1|Overall Study|Patient Moved|1
74274|NCT00086502|276990|P2|Overall Study|Withdrawal by Subject|6
74275|NCT00086502|276991|P1|Overall Study|Withdrawal by Subject|5
74276|NCT00086502|276990|P2|Overall Study|Protocol Violation|3
74277|NCT00086502|276991|P1|Overall Study|Protocol Violation|3
74278|NCT00086502|276990|P2|Overall Study|Pregnancy|1
74279|NCT00086502|276991|P1|Overall Study|Pregnancy|0
74280|NCT00086502|276990|P2|Overall Study|Physician Decision|1
74281|NCT00086502|276991|P1|Overall Study|Physician Decision|1
74282|NCT00086502|276990|P2|Overall Study|Lost to Follow-up|1
74283|NCT00086502|276991|P1|Overall Study|Lost to Follow-up|3
74284|NCT00086502|276990|P2|Overall Study|Lack of Efficacy|2
74285|NCT00086502|276991|P1|Overall Study|Lack of Efficacy|0
74286|NCT00086502|276990|P2|Overall Study|Adverse Event|2
74287|NCT00086502|276991|P1|Overall Study|Adverse Event|11
74288|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Discontinued in error|0
74289|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Discontinued in error|1
74290|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
74291|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
74292|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
74293|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
74294|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Patient Died|1
74295|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Patient Died|3
74296|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
74297|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
74298|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
74299|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
74300|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Patient Moved|2
74301|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Patient Moved|2
74302|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
74303|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
74304|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Protocol Violation|0
74305|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Protocol Violation|1
74306|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Physician Decision|0
74307|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Physician Decision|3
74308|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
74309|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
74310|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
74311|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
74312|NCT00086515|277001|P2|Phase B (Weeks 24-104)|Adverse Event|10
74313|NCT00086515|277002|P1|Phase B (Weeks 24-104)|Adverse Event|16
74314|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
74315|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
74316|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Poor compliance|0
74317|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Poor compliance|1
74318|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
74319|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
74320|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
74321|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
74322|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Protocol Violation|1
74323|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Protocol Violation|0
74324|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
74325|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
74326|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
74327|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
74328|NCT00086515|277001|P2|Phase A to Phase B Transition Period|Adverse Event|1
74329|NCT00086515|277002|P1|Phase A to Phase B Transition Period|Adverse Event|2
74330|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
74331|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
74332|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
74333|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
74334|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Poor compliance|0
74335|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Poor compliance|1
74336|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
74337|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
74338|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Patient Moved|3
74339|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Patient Moved|2
74340|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
74341|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
74342|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Protocol Violation|1
74343|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Protocol Violation|3
74344|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
74345|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
74346|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
74347|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
74348|NCT00086515|277001|P2|Phase A (Weeks 0-24)|Adverse Event|9
74349|NCT00086515|277002|P1|Phase A (Weeks 0-24)|Adverse Event|17
74350|NCT00086580|277014|P2|Observation Period|Not specified|7
74351|NCT00086580|277015|P1|Observation Period|Not specified|8
74352|NCT00086580|277014|P2|Observation Period|Death|55
74353|NCT00086580|277015|P1|Observation Period|Death|33
74354|NCT00086580|277014|P2|Observation Period|Withdrawal by Subject|2
74355|NCT00086580|277015|P1|Observation Period|Withdrawal by Subject|4
74356|NCT00086580|277014|P2|Observation Period|Unable to comply with protocol|1
74357|NCT00086580|277015|P1|Observation Period|Unable to comply with protocol|1
74358|NCT00086580|277014|P2|Follow-up Period|Not specified|6
74359|NCT00086580|277015|P1|Follow-up Period|Not specified|7
74360|NCT00086580|277014|P2|Follow-up Period|Death|7
74361|NCT00086580|277015|P1|Follow-up Period|Death|13
74362|NCT00086580|277014|P2|Follow-up Period|AE - not related|0
74363|NCT00086580|277015|P1|Follow-up Period|AE - not related|1
74364|NCT00086580|277014|P2|Follow-up Period|Physician Decision|1
74365|NCT00086580|277015|P1|Follow-up Period|Physician Decision|0
74366|NCT00086580|277014|P2|Follow-up Period|Withdrawal by Subject|6
74367|NCT00086580|277015|P1|Follow-up Period|Withdrawal by Subject|6
74368|NCT00086580|277014|P2|Follow-up Period|Unable to comply with protocol|0
74369|NCT00086580|277015|P1|Follow-up Period|Unable to comply with protocol|5
74370|NCT00086580|277014|P2|Follow-up Period|Disease progression|99
74371|NCT00086580|277015|P1|Follow-up Period|Disease progression|72
74372|NCT00086580|277014|P2|Treatment Period|Not specified|3
74373|NCT00086580|277015|P1|Treatment Period|Not specified|5
74374|NCT00086580|277014|P2|Treatment Period|Death|7
74375|NCT00086580|277015|P1|Treatment Period|Death|5
74376|NCT00086580|277014|P2|Treatment Period|Anemia or thrombocytopenia|4
74377|NCT00086580|277015|P1|Treatment Period|Anemia or thrombocytopenia|1
74378|NCT00086580|277014|P2|Treatment Period|Toxicity - treatment related|15
74379|NCT00086580|277015|P1|Treatment Period|Toxicity - treatment related|15
74380|NCT00086580|277014|P2|Treatment Period|AE - not treatment related|7
74381|NCT00086580|277015|P1|Treatment Period|AE - not treatment related|7
74382|NCT00086580|277014|P2|Treatment Period|Physician Decision|7
74383|NCT00086580|277015|P1|Treatment Period|Physician Decision|13
74384|NCT00086580|277014|P2|Treatment Period|Withdrawal by Subject|8
74385|NCT00086580|277015|P1|Treatment Period|Withdrawal by Subject|7
74386|NCT00086580|277014|P2|Treatment Period|Unable to comply with protocol|1
74387|NCT00086580|277015|P1|Treatment Period|Unable to comply with protocol|3
74388|NCT00086580|277014|P2|Treatment Period|Disease progression|8
74389|NCT00086580|277015|P1|Treatment Period|Disease progression|9
74390|NCT00086619|277061|P2|Overall Study|Protocol Violation|1
74391|NCT00086619|277062|P1|Overall Study|Protocol Violation|1
74392|NCT00086619|277061|P2|Overall Study|Adverse Event|10
74393|NCT00086619|277062|P1|Overall Study|Adverse Event|8
74394|NCT00086619|277061|P2|Overall Study|Withdrawal by Subject|6
74395|NCT00086619|277062|P1|Overall Study|Withdrawal by Subject|6
74396|NCT00086684|277073|P3|Overall Study|Not specified|3
74397|NCT00086684|277074|P2|Overall Study|Not specified|2
74398|NCT00086684|277075|P1|Overall Study|Not specified|4
74399|NCT00086684|277073|P3|Overall Study|WITHDRAWAL OF CONSENT|5
74400|NCT00086684|277074|P2|Overall Study|WITHDRAWAL OF CONSENT|7
74401|NCT00086684|277075|P1|Overall Study|WITHDRAWAL OF CONSENT|5
74402|NCT00086684|277073|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
74403|NCT00086684|277074|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
74404|NCT00086684|277075|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
74405|NCT00086684|277073|P3|Overall Study|NONCOMPLIANCE|6
74406|NCT00086684|277074|P2|Overall Study|NONCOMPLIANCE|7
74407|NCT00086684|277075|P1|Overall Study|NONCOMPLIANCE|5
74408|NCT00086684|277073|P3|Overall Study|Withdrawal by Subject|10
74409|NCT00086684|277074|P2|Overall Study|Withdrawal by Subject|4
74410|NCT00086684|277075|P1|Overall Study|Withdrawal by Subject|0
74411|NCT00086684|277073|P3|Overall Study|Protocol Violation|0
74412|NCT00086684|277074|P2|Overall Study|Protocol Violation|3
74413|NCT00086684|277075|P1|Overall Study|Protocol Violation|8
74414|NCT00086684|277073|P3|Overall Study|Lost to Follow-up|10
74415|NCT00086684|277074|P2|Overall Study|Lost to Follow-up|8
74416|NCT00086684|277075|P1|Overall Study|Lost to Follow-up|15
74417|NCT00086684|277073|P3|Overall Study|Lack of Efficacy|5
74418|NCT00086684|277074|P2|Overall Study|Lack of Efficacy|6
74419|NCT00086684|277075|P1|Overall Study|Lack of Efficacy|6
74420|NCT00086684|277073|P3|Overall Study|Adverse Event|14
74421|NCT00086684|277074|P2|Overall Study|Adverse Event|17
74422|NCT00086684|277075|P1|Overall Study|Adverse Event|12
74423|NCT00086996|277098|P1|Overall Study|not eligible|5
74424|NCT00086996|277098|P1|Overall Study|not specified|6
74425|NCT00086996|277098|P1|Overall Study|Withdrawal by Subject|13
74426|NCT00086996|277098|P1|Overall Study|progression/relapse|7
74427|NCT00086996|277098|P1|Overall Study|Death|4
74428|NCT00086996|277098|P1|Overall Study|Adverse Event|29
74429|NCT00087139|277108|P3|Overall Study|Extradural disease|1
74430|NCT00087139|277109|P2|Overall Study|Extradural disease|0
74431|NCT00087139|277110|P1|Overall Study|Extradural disease|0
74432|NCT00087139|277108|P3|Overall Study|Response achieved|0
74433|NCT00087139|277109|P2|Overall Study|Response achieved|1
74434|NCT00087139|277110|P1|Overall Study|Response achieved|0
74435|NCT00087139|277108|P3|Overall Study|Use of coumadin|0
74436|NCT00087139|277109|P2|Overall Study|Use of coumadin|0
74437|NCT00087139|277110|P1|Overall Study|Use of coumadin|1
74438|NCT00087139|277108|P3|Overall Study|Symptomatic deterioration|3
74439|NCT00087139|277109|P2|Overall Study|Symptomatic deterioration|1
74440|NCT00087139|277110|P1|Overall Study|Symptomatic deterioration|1
74441|NCT00087139|277108|P3|Overall Study|Ineligible|4
74442|NCT00087139|277109|P2|Overall Study|Ineligible|7
74443|NCT00087139|277110|P1|Overall Study|Ineligible|4
74444|NCT00087139|277108|P3|Overall Study|Disease progression|12
74445|NCT00087139|277109|P2|Overall Study|Disease progression|19
74446|NCT00087139|277110|P1|Overall Study|Disease progression|9
74447|NCT00087139|277108|P3|Overall Study|Physician Decision|1
74448|NCT00087139|277109|P2|Overall Study|Physician Decision|1
74449|NCT00087139|277110|P1|Overall Study|Physician Decision|1
74450|NCT00087139|277108|P3|Overall Study|Withdrawal by Subject|2
74451|NCT00087139|277109|P2|Overall Study|Withdrawal by Subject|2
74452|NCT00087139|277110|P1|Overall Study|Withdrawal by Subject|3
74453|NCT00087139|277108|P3|Overall Study|Death|0
74454|NCT00087139|277109|P2|Overall Study|Death|1
74455|NCT00087139|277110|P1|Overall Study|Death|2
74456|NCT00087139|277108|P3|Overall Study|Adverse Event|13
74457|NCT00087139|277109|P2|Overall Study|Adverse Event|17
74458|NCT00087139|277110|P1|Overall Study|Adverse Event|18
74459|NCT00087152|277125|P1|Overall Study|Ineligible|6
74460|NCT00087438|277131|P1|Overall Study|Ineligible / No protocol treatment|4
74461|NCT00087490|277137|P2|Overall Study|Randomized but not treated|18
74462|NCT00087490|277138|P1|Overall Study|Randomized but not treated|7
74463|NCT00087490|277137|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
74464|NCT00087490|277138|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
74465|NCT00087490|277137|P2|Overall Study|Protocol Violation or (/) Unspecified|201
74466|NCT00087490|277138|P1|Overall Study|Protocol Violation or (/) Unspecified|214
74467|NCT00087490|277137|P2|Overall Study|Lack of Efficacy|2
74468|NCT00087490|277138|P1|Overall Study|Lack of Efficacy|0
74469|NCT00087490|277137|P2|Overall Study|Adverse Event|8
74470|NCT00087490|277138|P1|Overall Study|Adverse Event|3
74471|NCT00087490|277137|P2|Overall Study|Death|4
74472|NCT00087490|277138|P1|Overall Study|Death|6
74473|NCT00087516|277175|P4|Overall Study|Unspecified|0
74474|NCT00087516|277176|P3|Overall Study|Unspecified|1
74475|NCT00087516|277177|P2|Overall Study|Unspecified|0
74476|NCT00087516|277178|P1|Overall Study|Unspecified|0
74477|NCT00087516|277175|P4|Overall Study|Recommendation of Primary Care Physician|1
74478|NCT00087516|277176|P3|Overall Study|Recommendation of Primary Care Physician|0
74479|NCT00087516|277177|P2|Overall Study|Recommendation of Primary Care Physician|0
74480|NCT00087516|277178|P1|Overall Study|Recommendation of Primary Care Physician|0
74481|NCT00087516|277175|P4|Overall Study|Patient was non-compliant|0
74482|NCT00087516|277176|P3|Overall Study|Patient was non-compliant|0
74483|NCT00087516|277177|P2|Overall Study|Patient was non-compliant|1
74484|NCT00087516|277178|P1|Overall Study|Patient was non-compliant|3
74485|NCT00087516|277175|P4|Overall Study|Patient moved|0
74486|NCT00087516|277176|P3|Overall Study|Patient moved|1
74487|NCT00087516|277177|P2|Overall Study|Patient moved|2
74488|NCT00087516|277178|P1|Overall Study|Patient moved|3
74489|NCT00087516|277175|P4|Overall Study|Protocol specified discontinuation|26
74490|NCT00087516|277176|P3|Overall Study|Protocol specified discontinuation|33
74491|NCT00087516|277177|P2|Overall Study|Protocol specified discontinuation|33
74492|NCT00087516|277178|P1|Overall Study|Protocol specified discontinuation|35
74493|NCT00087516|277175|P4|Overall Study|Site terminated|0
74494|NCT00087516|277176|P3|Overall Study|Site terminated|1
74495|NCT00087516|277177|P2|Overall Study|Site terminated|2
74496|NCT00087516|277178|P1|Overall Study|Site terminated|0
74497|NCT00087516|277175|P4|Overall Study|Withdrawal by Subject|12
74498|NCT00087516|277176|P3|Overall Study|Withdrawal by Subject|11
74499|NCT00087516|277177|P2|Overall Study|Withdrawal by Subject|27
74500|NCT00087516|277178|P1|Overall Study|Withdrawal by Subject|16
74501|NCT00087516|277175|P4|Overall Study|Protocol Violation|6
74502|NCT00087516|277176|P3|Overall Study|Protocol Violation|3
74503|NCT00087516|277177|P2|Overall Study|Protocol Violation|8
74504|NCT00087516|277178|P1|Overall Study|Protocol Violation|4
74505|NCT00087516|277175|P4|Overall Study|Lost to Follow-up|5
74506|NCT00087516|277176|P3|Overall Study|Lost to Follow-up|5
74507|NCT00087516|277177|P2|Overall Study|Lost to Follow-up|6
74508|NCT00087516|277178|P1|Overall Study|Lost to Follow-up|8
74509|NCT00087516|277175|P4|Overall Study|Lack of Efficacy|29
74510|NCT00087516|277176|P3|Overall Study|Lack of Efficacy|39
74511|NCT00087516|277177|P2|Overall Study|Lack of Efficacy|80
74512|NCT00087516|277178|P1|Overall Study|Lack of Efficacy|82
74513|NCT00087516|277175|P4|Overall Study|Adverse Event|6
74514|NCT00087516|277176|P3|Overall Study|Adverse Event|3
74515|NCT00087516|277177|P2|Overall Study|Adverse Event|10
74516|NCT00087516|277178|P1|Overall Study|Adverse Event|10
74517|NCT00087529|277207|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
74518|NCT00087529|277208|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
74519|NCT00087529|277207|P2|Overall Study|Disease Progression|4
74520|NCT00087529|277208|P1|Overall Study|Disease Progression|5
74521|NCT00087529|277207|P2|Overall Study|Participant Noncompliance|1
74522|NCT00087529|277208|P1|Overall Study|Participant Noncompliance|0
74523|NCT00087529|277207|P2|Overall Study|Initiation of Excluded Therapy|1
74524|NCT00087529|277208|P1|Overall Study|Initiation of Excluded Therapy|0
74525|NCT00087529|277207|P2|Overall Study|Physician Decision|8
74526|NCT00087529|277208|P1|Overall Study|Physician Decision|4
74527|NCT00087529|277207|P2|Overall Study|Participant Decision|37
74528|NCT00087529|277208|P1|Overall Study|Participant Decision|14
74529|NCT00087529|277207|P2|Overall Study|Lost to Follow-up|3
74530|NCT00087529|277208|P1|Overall Study|Lost to Follow-up|2
74531|NCT00087529|277207|P2|Overall Study|Pregnancy|1
74532|NCT00087529|277208|P1|Overall Study|Pregnancy|0
74533|NCT00087529|277207|P2|Overall Study|Adverse Event|8
74534|NCT00087529|277208|P1|Overall Study|Adverse Event|0
74535|NCT00087529|277207|P2|Overall Study|Death|0
74536|NCT00087529|277208|P1|Overall Study|Death|1
74537|NCT00087555|277223|P3|Overall Study|Patient wanted to go back on Med|0
74538|NCT00087555|277224|P2|Overall Study|Patient wanted to go back on Med|0
74539|NCT00087555|277225|P1|Overall Study|Patient wanted to go back on Med|1
74540|NCT00087555|277223|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
74541|NCT00087555|277224|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
74542|NCT00087555|277225|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
74543|NCT00087555|277223|P3|Overall Study|Non Compliance|1
74544|NCT00087555|277224|P2|Overall Study|Non Compliance|0
74545|NCT00087555|277225|P1|Overall Study|Non Compliance|0
74546|NCT00087555|277223|P3|Overall Study|Lack of Efficacy|1
74547|NCT00087555|277224|P2|Overall Study|Lack of Efficacy|0
74548|NCT00087555|277225|P1|Overall Study|Lack of Efficacy|2
74549|NCT00087555|277223|P3|Overall Study|Withdrawal by Subject|1
74550|NCT00087555|277224|P2|Overall Study|Withdrawal by Subject|2
74551|NCT00087555|277225|P1|Overall Study|Withdrawal by Subject|3
74552|NCT00087555|277223|P3|Overall Study|Pregnancy|1
74553|NCT00087555|277224|P2|Overall Study|Pregnancy|1
74554|NCT00087555|277225|P1|Overall Study|Pregnancy|0
74555|NCT00087555|277223|P3|Overall Study|Screen Failure|0
74556|NCT00087555|277224|P2|Overall Study|Screen Failure|1
74557|NCT00087555|277225|P1|Overall Study|Screen Failure|1
74558|NCT00087555|277223|P3|Overall Study|Protocol Violation|2
74559|NCT00087555|277224|P2|Overall Study|Protocol Violation|0
74560|NCT00087555|277225|P1|Overall Study|Protocol Violation|0
74561|NCT00087555|277223|P3|Overall Study|Non - Compliance|0
74562|NCT00087555|277224|P2|Overall Study|Non - Compliance|0
74563|NCT00087555|277225|P1|Overall Study|Non - Compliance|1
74564|NCT00087555|277223|P3|Overall Study|Lost to Follow-up|1
74565|NCT00087555|277224|P2|Overall Study|Lost to Follow-up|1
74566|NCT00087555|277225|P1|Overall Study|Lost to Follow-up|0
74567|NCT00087555|277223|P3|Overall Study|Adverse Event|14
74568|NCT00087555|277224|P2|Overall Study|Adverse Event|6
74569|NCT00087555|277225|P1|Overall Study|Adverse Event|3
74570|NCT00087568|277235|P2|Overall Study|Lack of Efficacy|1
74571|NCT00087568|277236|P1|Overall Study|Lack of Efficacy|24
74572|NCT00087568|277235|P2|Overall Study|Lost to Follow-up|0
74573|NCT00087568|277236|P1|Overall Study|Lost to Follow-up|1
74574|NCT00087568|277235|P2|Overall Study|Withdrawal by Subject|1
74575|NCT00087568|277236|P1|Overall Study|Withdrawal by Subject|1
74576|NCT00087568|277235|P2|Overall Study|Adverse Event|0
74577|NCT00087568|277236|P1|Overall Study|Adverse Event|4
74578|NCT00087594|277262|P2|Overall Study|Lack of Efficacy|5
74579|NCT00087594|277263|P1|Overall Study|Lack of Efficacy|2
74580|NCT00087594|277262|P2|Overall Study|Withdrawal by Subject|2
74581|NCT00087594|277263|P1|Overall Study|Withdrawal by Subject|4
74582|NCT00087594|277262|P2|Overall Study|Lost to Follow-up|2
74583|NCT00087594|277263|P1|Overall Study|Lost to Follow-up|0
74584|NCT00087594|277262|P2|Overall Study|Adverse Event|3
74585|NCT00087594|277263|P1|Overall Study|Adverse Event|2
74586|NCT00087607|277297|P2|Overall Study|Violation of Selection Criteria at Entry|1
74587|NCT00087607|277298|P1|Overall Study|Violation of Selection Criteria at Entry|0
74588|NCT00087607|277297|P2|Overall Study|Other Protocol Violation|2
74589|NCT00087607|277298|P1|Overall Study|Other Protocol Violation|5
74590|NCT00087607|277297|P2|Overall Study|Refused Treatment|7
74591|NCT00087607|277298|P1|Overall Study|Refused Treatment|5
74592|NCT00087607|277297|P2|Overall Study|Administrative|12
74593|NCT00087607|277298|P1|Overall Study|Administrative|12
74594|NCT00087607|277297|P2|Overall Study|Withdrew Consent|16
74595|NCT00087607|277298|P1|Overall Study|Withdrew Consent|12
74596|NCT00087607|277297|P2|Overall Study|Failure to return|17
74597|NCT00087607|277298|P1|Overall Study|Failure to return|21
74598|NCT00087607|277297|P2|Overall Study|Insufficient Therapeutic Response|42
74599|NCT00087607|277298|P1|Overall Study|Insufficient Therapeutic Response|53
74600|NCT00087607|277297|P2|Overall Study|Death|1
74601|NCT00087607|277298|P1|Overall Study|Death|0
74602|NCT00087607|277297|P2|Overall Study|Adverse Event|24
74603|NCT00087607|277298|P1|Overall Study|Adverse Event|14
74604|NCT00087646|277351|P4|Overall Study|Violation of Selection Criteria at Entry|1
74605|NCT00087646|277352|P3|Overall Study|Violation of Selection Criteria at Entry|0
74606|NCT00087646|277353|P2|Overall Study|Violation of Selection Criteria at Entry|0
74607|NCT00087646|277354|P1|Overall Study|Violation of Selection Criteria at Entry|1
74608|NCT00087646|277351|P4|Overall Study|Other Protocol Violation|0
74609|NCT00087646|277352|P3|Overall Study|Other Protocol Violation|0
74610|NCT00087646|277353|P2|Overall Study|Other Protocol Violation|1
74611|NCT00087646|277354|P1|Overall Study|Other Protocol Violation|3
74612|NCT00087646|277351|P4|Overall Study|Administrative/Other|2
74613|NCT00087646|277352|P3|Overall Study|Administrative/Other|1
74614|NCT00087646|277353|P2|Overall Study|Administrative/Other|1
74615|NCT00087646|277354|P1|Overall Study|Administrative/Other|6
74616|NCT00087646|277351|P4|Overall Study|Failure to Return|3
74617|NCT00087646|277352|P3|Overall Study|Failure to Return|2
74618|NCT00087646|277353|P2|Overall Study|Failure to Return|2
74619|NCT00087646|277354|P1|Overall Study|Failure to Return|5
74620|NCT00087646|277351|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
74621|NCT00087646|277352|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
74622|NCT00087646|277353|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
74623|NCT00087646|277354|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
74624|NCT00087646|277351|P4|Overall Study|Insufficient therapeutic response|51
74625|NCT00087646|277352|P3|Overall Study|Insufficient therapeutic response|38
74626|NCT00087646|277353|P2|Overall Study|Insufficient therapeutic response|24
74627|NCT00087646|277354|P1|Overall Study|Insufficient therapeutic response|64
74628|NCT00087646|277351|P4|Overall Study|Withdrawal by Subject|2
74629|NCT00087646|277352|P3|Overall Study|Withdrawal by Subject|2
74630|NCT00087646|277353|P2|Overall Study|Withdrawal by Subject|1
74631|NCT00087646|277354|P1|Overall Study|Withdrawal by Subject|6
74632|NCT00087646|277351|P4|Overall Study|Death|0
74633|NCT00087646|277352|P3|Overall Study|Death|0
74634|NCT00087646|277353|P2|Overall Study|Death|1
74635|NCT00087646|277354|P1|Overall Study|Death|0
74636|NCT00087646|277351|P4|Overall Study|Adverse Event|20
74637|NCT00087646|277352|P3|Overall Study|Adverse Event|18
74638|NCT00087646|277353|P2|Overall Study|Adverse Event|6
74639|NCT00087646|277354|P1|Overall Study|Adverse Event|37
74640|NCT00087685|277384|P1|Overall Study|Withdrawal by Subject|3
74641|NCT00087685|277384|P1|Overall Study|Progressive Disease|5
74642|NCT00087685|277384|P1|Overall Study|Non-Compliance|1
74643|NCT00087685|277384|P1|Overall Study|Adverse Event|5
74644|NCT00087698|277389|P1|Overall Study|Protocol Violation|1
74645|NCT00087698|277389|P1|Overall Study|Death from Study Drug Toxicity|2
74646|NCT00087698|277389|P1|Overall Study|Death from Study Disease|2
74647|NCT00087698|277389|P1|Overall Study|Clinical Relapse|1
74648|NCT00087698|277389|P1|Overall Study|Protocol Entry Criteria Not Met|2
74649|NCT00087698|277389|P1|Overall Study|Lack of Efficacy, Physician Perception|3
74650|NCT00087698|277389|P1|Overall Study|Withdrawal by Subject|4
74651|NCT00087698|277389|P1|Overall Study|Adverse Event|4
74652|NCT00087698|277389|P1|Overall Study|Death from Other Causes|3
74653|NCT00087698|277389|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
74654|NCT00081458|277401|P3|Overall Study|Randomized but not dosed|1
74655|NCT00081458|277402|P2|Overall Study|Randomized but not dosed|0
74656|NCT00081458|277403|P1|Overall Study|Randomized but not dosed|0
74657|NCT00081458|277401|P3|Overall Study|Withdrawal by Subject|1
74658|NCT00081458|277402|P2|Overall Study|Withdrawal by Subject|3
74659|NCT00081458|277403|P1|Overall Study|Withdrawal by Subject|0
74660|NCT00081458|277401|P3|Overall Study|Adverse Event|2
74661|NCT00081458|277402|P2|Overall Study|Adverse Event|5
74662|NCT00081458|277403|P1|Overall Study|Adverse Event|1
74663|NCT00081497|277416|P2|Overall Study|Non-compliance|1
74664|NCT00081497|277417|P1|Overall Study|Non-compliance|0
74665|NCT00081497|277416|P2|Overall Study|Withdrawal by Subject|0
74666|NCT00081497|277417|P1|Overall Study|Withdrawal by Subject|1
74667|NCT00081497|277416|P2|Overall Study|Death|1
74668|NCT00081497|277417|P1|Overall Study|Death|0
74669|NCT00081497|277416|P2|Overall Study|Adverse Event|0
74670|NCT00081497|277417|P1|Overall Study|Adverse Event|2
74671|NCT00081653|277434|P2|Overall Study|Loss of bone mass|2
74672|NCT00081653|277435|P1|Overall Study|Loss of bone mass|0
74673|NCT00081653|277434|P2|Overall Study|Participant leaving country|0
74674|NCT00081653|277435|P1|Overall Study|Participant leaving country|1
74675|NCT00081653|277434|P2|Overall Study|Bone loss|0
74676|NCT00081653|277435|P1|Overall Study|Bone loss|2
74677|NCT00081653|277434|P2|Overall Study|Low bone mineral density|0
74678|NCT00081653|277435|P1|Overall Study|Low bone mineral density|1
74679|NCT00081653|277434|P2|Overall Study|Refused Treatment|14
74680|NCT00081653|277435|P1|Overall Study|Refused Treatment|18
74681|NCT00081653|277434|P2|Overall Study|Lost to Follow-up|4
74682|NCT00081653|277435|P1|Overall Study|Lost to Follow-up|2
74683|NCT00081653|277434|P2|Overall Study|Adverse Event|17
74684|NCT00081653|277435|P1|Overall Study|Adverse Event|23
74685|NCT00081731|277453|P2|Overall Study|scientific integrity issue|8
74686|NCT00081731|277454|P1|Overall Study|scientific integrity issue|8
74687|NCT00081770|277475|P3|Overall Study|Not Specified|8
74688|NCT00081770|277476|P2|Overall Study|Not Specified|7
74689|NCT00081770|277477|P1|Overall Study|Not Specified|2
74690|NCT00081770|277475|P3|Overall Study|Administrative|1
74691|NCT00081770|277476|P2|Overall Study|Administrative|0
74692|NCT00081770|277477|P1|Overall Study|Administrative|1
74693|NCT00081770|277475|P3|Overall Study|Did not meet protocol eligibility|3
74694|NCT00081770|277476|P2|Overall Study|Did not meet protocol eligibility|0
74695|NCT00081770|277477|P1|Overall Study|Did not meet protocol eligibility|2
74696|NCT00081770|277475|P3|Overall Study|Withdrawal by Subject|42
74697|NCT00081770|277476|P2|Overall Study|Withdrawal by Subject|40
74698|NCT00081770|277477|P1|Overall Study|Withdrawal by Subject|45
74699|NCT00081770|277475|P3|Overall Study|Protocol Violation|10
74700|NCT00081770|277476|P2|Overall Study|Protocol Violation|10
74701|NCT00081770|277477|P1|Overall Study|Protocol Violation|15
74702|NCT00081770|277475|P3|Overall Study|Lost to Follow-up|45
74703|NCT00081770|277476|P2|Overall Study|Lost to Follow-up|34
74704|NCT00081770|277477|P1|Overall Study|Lost to Follow-up|45
74705|NCT00081770|277475|P3|Overall Study|Lack of Efficacy|211
74706|NCT00081770|277476|P2|Overall Study|Lack of Efficacy|357
74707|NCT00081770|277477|P1|Overall Study|Lack of Efficacy|262
74708|NCT00081770|277475|P3|Overall Study|Adverse Event|136
74709|NCT00081770|277476|P2|Overall Study|Adverse Event|98
74710|NCT00081770|277477|P1|Overall Study|Adverse Event|130
74711|NCT00088153|277496|P2|Overall Study|Lost to Follow-up|12
74712|NCT00088153|277497|P1|Overall Study|Lost to Follow-up|11
74713|NCT00088153|277496|P2|Overall Study|Withdrawal by Subject|10
74714|NCT00088153|277497|P1|Overall Study|Withdrawal by Subject|10
74715|NCT00088153|277496|P2|Overall Study|Physician Decision|3
74716|NCT00088153|277497|P1|Overall Study|Physician Decision|3
74717|NCT00088166|277509|P2|Overall Study|Withdrawal by Subject|5
74718|NCT00088166|277510|P1|Overall Study|Withdrawal by Subject|5
74719|NCT00088166|277509|P2|Overall Study|Patient deterioration|39
74720|NCT00088166|277510|P1|Overall Study|Patient deterioration|29
74721|NCT00088166|277509|P2|Overall Study|Protocol Violation|5
74722|NCT00088166|277510|P1|Overall Study|Protocol Violation|1
74723|NCT00088166|277509|P2|Overall Study|Physician Decision|1
74724|NCT00088166|277510|P1|Overall Study|Physician Decision|4
74725|NCT00088166|277509|P2|Overall Study|Lost to Follow-up|1
74726|NCT00088166|277510|P1|Overall Study|Lost to Follow-up|0
74727|NCT00088166|277509|P2|Overall Study|Death|1
74728|NCT00088166|277510|P1|Overall Study|Death|3
74729|NCT00088166|277509|P2|Overall Study|Adverse Event|9
74730|NCT00088166|277510|P1|Overall Study|Adverse Event|11
74731|NCT00090220|277543|P6|Long-term Follow-up (EXT2)|Other|0
74732|NCT00090220|277544|P5|Long-term Follow-up (EXT2)|Other|1
74733|NCT00090220|277545|P4|Long-term Follow-up (EXT2)|Other|0
74734|NCT00090220|277546|P3|Long-term Follow-up (EXT2)|Other|0
74735|NCT00090220|277547|P2|Long-term Follow-up (EXT2)|Other|0
74736|NCT00090220|277548|P1|Long-term Follow-up (EXT2)|Other|0
74737|NCT00090220|277543|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
74738|NCT00090220|277544|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
74739|NCT00090220|277545|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
74740|NCT00090220|277546|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
74741|NCT00090220|277547|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
74742|NCT00090220|277548|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
74743|NCT00090220|277543|P6|Long-term Follow-up (EXT2)|Death|1
74744|NCT00090220|277544|P5|Long-term Follow-up (EXT2)|Death|1
74745|NCT00090220|277545|P4|Long-term Follow-up (EXT2)|Death|0
74746|NCT00090220|277546|P3|Long-term Follow-up (EXT2)|Death|0
74747|NCT00090220|277547|P2|Long-term Follow-up (EXT2)|Death|0
74748|NCT00090220|277548|P1|Long-term Follow-up (EXT2)|Death|0
74749|NCT00090220|277543|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
74750|NCT00090220|277544|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
74751|NCT00090220|277545|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
74752|NCT00090220|277546|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
74753|NCT00090220|277547|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
74754|NCT00090220|277548|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
74755|NCT00090220|277543|P6|Extension 1 (EXT1)|Other reason|0
74756|NCT00090220|277544|P5|Extension 1 (EXT1)|Other reason|0
74757|NCT00090220|277545|P4|Extension 1 (EXT1)|Other reason|0
74758|NCT00090220|277546|P3|Extension 1 (EXT1)|Other reason|2
74759|NCT00090220|277547|P2|Extension 1 (EXT1)|Other reason|0
74760|NCT00090220|277548|P1|Extension 1 (EXT1)|Other reason|0
74761|NCT00090220|277543|P6|Extension 1 (EXT1)|Protocol Violation|0
74762|NCT00090220|277544|P5|Extension 1 (EXT1)|Protocol Violation|0
74763|NCT00090220|277545|P4|Extension 1 (EXT1)|Protocol Violation|1
74764|NCT00090220|277546|P3|Extension 1 (EXT1)|Protocol Violation|0
74765|NCT00090220|277547|P2|Extension 1 (EXT1)|Protocol Violation|0
74766|NCT00090220|277548|P1|Extension 1 (EXT1)|Protocol Violation|0
74767|NCT00090220|277543|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
74768|NCT00090220|277544|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
74769|NCT00090220|277545|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
74770|NCT00090220|277546|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
74771|NCT00090220|277547|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
74772|NCT00090220|277548|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
74773|NCT00090220|277543|P6|Extension 1 (EXT1)|Moved|0
74774|NCT00090220|277544|P5|Extension 1 (EXT1)|Moved|0
74775|NCT00090220|277545|P4|Extension 1 (EXT1)|Moved|1
74776|NCT00090220|277546|P3|Extension 1 (EXT1)|Moved|2
74777|NCT00090220|277547|P2|Extension 1 (EXT1)|Moved|0
74778|NCT00090220|277548|P1|Extension 1 (EXT1)|Moved|0
74779|NCT00090220|277543|P6|Extension 1 (EXT1)|Lost to Follow-up|0
74780|NCT00090220|277544|P5|Extension 1 (EXT1)|Lost to Follow-up|0
74781|NCT00090220|277545|P4|Extension 1 (EXT1)|Lost to Follow-up|0
74782|NCT00090220|277546|P3|Extension 1 (EXT1)|Lost to Follow-up|22
74783|NCT00090220|277547|P2|Extension 1 (EXT1)|Lost to Follow-up|0
74784|NCT00090220|277548|P1|Extension 1 (EXT1)|Lost to Follow-up|0
74785|NCT00090220|277543|P6|Extension 1 (EXT1)|Adverse Event|0
74786|NCT00090220|277544|P5|Extension 1 (EXT1)|Adverse Event|0
74787|NCT00090220|277545|P4|Extension 1 (EXT1)|Adverse Event|0
74788|NCT00090220|277546|P3|Extension 1 (EXT1)|Adverse Event|4
74789|NCT00090220|277547|P2|Extension 1 (EXT1)|Adverse Event|0
74790|NCT00090220|277548|P1|Extension 1 (EXT1)|Adverse Event|0
74791|NCT00090220|277543|P6|Base Study Follow-up Period|Unspecified|0
74792|NCT00090220|277544|P5|Base Study Follow-up Period|Unspecified|0
74793|NCT00090220|277545|P4|Base Study Follow-up Period|Unspecified|0
74794|NCT00090220|277546|P3|Base Study Follow-up Period|Unspecified|0
74795|NCT00090220|277547|P2|Base Study Follow-up Period|Unspecified|21
74796|NCT00090220|277548|P1|Base Study Follow-up Period|Unspecified|19
74797|NCT00090220|277543|P6|Base Study Follow-up Period|Patient Moved|0
74798|NCT00090220|277544|P5|Base Study Follow-up Period|Patient Moved|0
74799|NCT00090220|277545|P4|Base Study Follow-up Period|Patient Moved|0
74800|NCT00090220|277546|P3|Base Study Follow-up Period|Patient Moved|0
74801|NCT00090220|277547|P2|Base Study Follow-up Period|Patient Moved|28
74802|NCT00090220|277548|P1|Base Study Follow-up Period|Patient Moved|20
74803|NCT00090220|277543|P6|Base Study Follow-up Period|Withdrawal by Subject|0
74804|NCT00090220|277544|P5|Base Study Follow-up Period|Withdrawal by Subject|0
74805|NCT00090220|277545|P4|Base Study Follow-up Period|Withdrawal by Subject|0
74806|NCT00090220|277546|P3|Base Study Follow-up Period|Withdrawal by Subject|0
74807|NCT00090220|277547|P2|Base Study Follow-up Period|Withdrawal by Subject|36
74808|NCT00090220|277548|P1|Base Study Follow-up Period|Withdrawal by Subject|27
74809|NCT00090220|277543|P6|Base Study Follow-up Period|Lost to Follow-up|0
74810|NCT00090220|277544|P5|Base Study Follow-up Period|Lost to Follow-up|0
74811|NCT00090220|277545|P4|Base Study Follow-up Period|Lost to Follow-up|0
74812|NCT00090220|277546|P3|Base Study Follow-up Period|Lost to Follow-up|0
74813|NCT00090220|277547|P2|Base Study Follow-up Period|Lost to Follow-up|78
74814|NCT00090220|277548|P1|Base Study Follow-up Period|Lost to Follow-up|88
74815|NCT00090220|277543|P6|Base Study Follow-up Period|Adverse Event|0
74816|NCT00090220|277544|P5|Base Study Follow-up Period|Adverse Event|0
74817|NCT00090220|277545|P4|Base Study Follow-up Period|Adverse Event|0
74818|NCT00090220|277546|P3|Base Study Follow-up Period|Adverse Event|0
74819|NCT00090220|277547|P2|Base Study Follow-up Period|Adverse Event|1
74820|NCT00090220|277548|P1|Base Study Follow-up Period|Adverse Event|6
74821|NCT00090220|277543|P6|Base Study Vaccination Period|Unspecified|0
74822|NCT00090220|277544|P5|Base Study Vaccination Period|Unspecified|0
74823|NCT00090220|277545|P4|Base Study Vaccination Period|Unspecified|0
74824|NCT00090220|277546|P3|Base Study Vaccination Period|Unspecified|0
74825|NCT00090220|277547|P2|Base Study Vaccination Period|Unspecified|4
74826|NCT00090220|277548|P1|Base Study Vaccination Period|Unspecified|4
74827|NCT00090220|277543|P6|Base Study Vaccination Period|Patient Moved|0
74828|NCT00090220|277544|P5|Base Study Vaccination Period|Patient Moved|0
74829|NCT00090220|277545|P4|Base Study Vaccination Period|Patient Moved|0
74830|NCT00090220|277546|P3|Base Study Vaccination Period|Patient Moved|0
74831|NCT00090220|277547|P2|Base Study Vaccination Period|Patient Moved|2
74832|NCT00090220|277548|P1|Base Study Vaccination Period|Patient Moved|6
74833|NCT00090220|277543|P6|Base Study Vaccination Period|Withdrawal by Subject|0
74834|NCT00090220|277544|P5|Base Study Vaccination Period|Withdrawal by Subject|0
74835|NCT00090220|277545|P4|Base Study Vaccination Period|Withdrawal by Subject|0
74836|NCT00090220|277546|P3|Base Study Vaccination Period|Withdrawal by Subject|0
74837|NCT00090220|277547|P2|Base Study Vaccination Period|Withdrawal by Subject|27
74838|NCT00090220|277548|P1|Base Study Vaccination Period|Withdrawal by Subject|23
74839|NCT00090220|277543|P6|Base Study Vaccination Period|Lost to Follow-up|0
74840|NCT00090220|277544|P5|Base Study Vaccination Period|Lost to Follow-up|0
74841|NCT00090220|277545|P4|Base Study Vaccination Period|Lost to Follow-up|0
74842|NCT00090220|277546|P3|Base Study Vaccination Period|Lost to Follow-up|0
74843|NCT00090220|277547|P2|Base Study Vaccination Period|Lost to Follow-up|28
74844|NCT00090220|277548|P1|Base Study Vaccination Period|Lost to Follow-up|24
74845|NCT00090220|277543|P6|Base Study Vaccination Period|Adverse Event|0
74846|NCT00090220|277544|P5|Base Study Vaccination Period|Adverse Event|0
74847|NCT00090220|277545|P4|Base Study Vaccination Period|Adverse Event|0
74848|NCT00090220|277546|P3|Base Study Vaccination Period|Adverse Event|0
74849|NCT00090220|277547|P2|Base Study Vaccination Period|Adverse Event|1
74850|NCT00090220|277548|P1|Base Study Vaccination Period|Adverse Event|6
74851|NCT00090220|277543|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
74852|NCT00090220|277544|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
74853|NCT00090220|277545|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
74854|NCT00090220|277546|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
74855|NCT00090220|277547|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
74856|NCT00090220|277548|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
74857|NCT00090233|277642|P2|Overall Study|Data not available at data cut-off point|1563
74858|NCT00090233|277643|P1|Overall Study|Data not available at data cut-off point|1552
74859|NCT00090233|277642|P2|Overall Study|Not Specified|1160
74860|NCT00090233|277643|P1|Overall Study|Not Specified|1211
74861|NCT00090233|277642|P2|Overall Study|Moved|189
74862|NCT00090233|277643|P1|Overall Study|Moved|203
74863|NCT00090233|277642|P2|Overall Study|Withdrawal by Subject|211
74864|NCT00090233|277643|P1|Overall Study|Withdrawal by Subject|182
74865|NCT00090233|277642|P2|Overall Study|Protocol Violation|1022
74866|NCT00090233|277643|P1|Overall Study|Protocol Violation|960
74867|NCT00090233|277642|P2|Overall Study|Lost to Follow-up|95
74868|NCT00090233|277643|P1|Overall Study|Lost to Follow-up|68
74869|NCT00090233|277642|P2|Overall Study|Adverse Event|198
74870|NCT00090233|277643|P1|Overall Study|Adverse Event|214
74871|NCT00090233|277642|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
74872|NCT00090233|277643|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
74873|NCT00090259|277667|P2|Overall Study|Investigator site closed|7
74874|NCT00090259|277668|P1|Overall Study|Investigator site closed|11
74875|NCT00090259|277667|P2|Overall Study|Withdrawal by Subject|15
74876|NCT00090259|277668|P1|Overall Study|Withdrawal by Subject|21
74877|NCT00090259|277667|P2|Overall Study|Lost to Follow-up|26
74878|NCT00090259|277668|P1|Overall Study|Lost to Follow-up|30
74879|NCT00090285|277684|P4|Extension 1|Moved|0
74880|NCT00090285|277685|P3|Extension 1|Moved|3
74881|NCT00090285|277686|P2|Extension 1|Moved|0
74882|NCT00090285|277687|P1|Extension 1|Moved|0
74883|NCT00090285|277684|P4|Extension 1|Other Reason|0
74884|NCT00090285|277685|P3|Extension 1|Other Reason|4
74885|NCT00090285|277686|P2|Extension 1|Other Reason|0
74886|NCT00090285|277687|P1|Extension 1|Other Reason|0
74887|NCT00090285|277684|P4|Extension 1|Withdrawal by Subject|1
74888|NCT00090285|277685|P3|Extension 1|Withdrawal by Subject|13
74889|NCT00090285|277686|P2|Extension 1|Withdrawal by Subject|0
74890|NCT00090285|277687|P1|Extension 1|Withdrawal by Subject|0
74891|NCT00090285|277684|P4|Extension 1|Lost to Follow-up|0
74892|NCT00090285|277685|P3|Extension 1|Lost to Follow-up|35
74893|NCT00090285|277686|P2|Extension 1|Lost to Follow-up|0
74894|NCT00090285|277687|P1|Extension 1|Lost to Follow-up|0
74895|NCT00090285|277684|P4|Extension 1|Adverse Event|0
74896|NCT00090285|277685|P3|Extension 1|Adverse Event|2
74897|NCT00090285|277686|P2|Extension 1|Adverse Event|0
74898|NCT00090285|277687|P1|Extension 1|Adverse Event|0
74899|NCT00090285|277684|P4|Base Study Follow-up Period|Subject Incarcerated|0
74900|NCT00090285|277685|P3|Base Study Follow-up Period|Subject Incarcerated|0
74901|NCT00090285|277686|P2|Base Study Follow-up Period|Subject Incarcerated|2
74902|NCT00090285|277687|P1|Base Study Follow-up Period|Subject Incarcerated|0
74903|NCT00090285|277684|P4|Base Study Follow-up Period|Uncooperative|0
74904|NCT00090285|277685|P3|Base Study Follow-up Period|Uncooperative|0
74905|NCT00090285|277686|P2|Base Study Follow-up Period|Uncooperative|4
74906|NCT00090285|277687|P1|Base Study Follow-up Period|Uncooperative|3
74907|NCT00090285|277684|P4|Base Study Follow-up Period|Protocol Violation|0
74908|NCT00090285|277685|P3|Base Study Follow-up Period|Protocol Violation|0
74909|NCT00090285|277686|P2|Base Study Follow-up Period|Protocol Violation|0
74910|NCT00090285|277687|P1|Base Study Follow-up Period|Protocol Violation|1
74911|NCT00090285|277684|P4|Base Study Follow-up Period|Unspecified|0
74912|NCT00090285|277685|P3|Base Study Follow-up Period|Unspecified|0
74913|NCT00090285|277686|P2|Base Study Follow-up Period|Unspecified|0
74914|NCT00090285|277687|P1|Base Study Follow-up Period|Unspecified|2
74915|NCT00090285|277684|P4|Base Study Follow-up Period|Moved|0
74916|NCT00090285|277685|P3|Base Study Follow-up Period|Moved|0
74917|NCT00090285|277686|P2|Base Study Follow-up Period|Moved|36
74918|NCT00090285|277687|P1|Base Study Follow-up Period|Moved|41
74919|NCT00090285|277684|P4|Base Study Follow-up Period|Withdrawal by Subject|0
74920|NCT00090285|277685|P3|Base Study Follow-up Period|Withdrawal by Subject|0
74921|NCT00090285|277686|P2|Base Study Follow-up Period|Withdrawal by Subject|64
74922|NCT00090285|277687|P1|Base Study Follow-up Period|Withdrawal by Subject|53
74923|NCT00090285|277684|P4|Base Study Follow-up Period|Lost to Follow-up|0
74924|NCT00090285|277685|P3|Base Study Follow-up Period|Lost to Follow-up|0
74925|NCT00090285|277686|P2|Base Study Follow-up Period|Lost to Follow-up|226
74926|NCT00090285|277687|P1|Base Study Follow-up Period|Lost to Follow-up|232
74927|NCT00090285|277684|P4|Base Study Follow-up Period|Adverse Event|0
74928|NCT00090285|277685|P3|Base Study Follow-up Period|Adverse Event|0
74929|NCT00090285|277686|P2|Base Study Follow-up Period|Adverse Event|10
74930|NCT00090285|277687|P1|Base Study Follow-up Period|Adverse Event|3
74931|NCT00090285|277684|P4|Base Study Vaccination Period|HIV positive|0
74932|NCT00090285|277685|P3|Base Study Vaccination Period|HIV positive|0
74933|NCT00090285|277686|P2|Base Study Vaccination Period|HIV positive|1
74934|NCT00090285|277687|P1|Base Study Vaccination Period|HIV positive|1
74935|NCT00090285|277684|P4|Base Study Vaccination Period|Subject Incarcerated|0
74936|NCT00090285|277685|P3|Base Study Vaccination Period|Subject Incarcerated|0
74937|NCT00090285|277686|P2|Base Study Vaccination Period|Subject Incarcerated|2
74938|NCT00090285|277687|P1|Base Study Vaccination Period|Subject Incarcerated|2
74939|NCT00090285|277684|P4|Base Study Vaccination Period|Unspecified|0
74940|NCT00090285|277685|P3|Base Study Vaccination Period|Unspecified|0
74941|NCT00090285|277686|P2|Base Study Vaccination Period|Unspecified|2
74942|NCT00090285|277687|P1|Base Study Vaccination Period|Unspecified|2
74943|NCT00090285|277684|P4|Base Study Vaccination Period|Site Terminated|0
74944|NCT00090285|277685|P3|Base Study Vaccination Period|Site Terminated|0
74945|NCT00090285|277686|P2|Base Study Vaccination Period|Site Terminated|0
74946|NCT00090285|277687|P1|Base Study Vaccination Period|Site Terminated|1
74947|NCT00090285|277684|P4|Base Study Vaccination Period|Moved|0
74948|NCT00090285|277685|P3|Base Study Vaccination Period|Moved|0
74949|NCT00090285|277686|P2|Base Study Vaccination Period|Moved|21
74950|NCT00090285|277687|P1|Base Study Vaccination Period|Moved|20
74951|NCT00090285|277684|P4|Base Study Vaccination Period|Uncooperative|0
74952|NCT00090285|277685|P3|Base Study Vaccination Period|Uncooperative|0
74953|NCT00090285|277686|P2|Base Study Vaccination Period|Uncooperative|2
74954|NCT00090285|277687|P1|Base Study Vaccination Period|Uncooperative|2
74955|NCT00090285|277684|P4|Base Study Vaccination Period|Withdrawal by Subject|0
74956|NCT00090285|277685|P3|Base Study Vaccination Period|Withdrawal by Subject|0
74957|NCT00090285|277686|P2|Base Study Vaccination Period|Withdrawal by Subject|69
74958|NCT00090285|277687|P1|Base Study Vaccination Period|Withdrawal by Subject|64
74959|NCT00090285|277684|P4|Base Study Vaccination Period|Protocol Violation|0
74960|NCT00090285|277685|P3|Base Study Vaccination Period|Protocol Violation|0
74961|NCT00090285|277686|P2|Base Study Vaccination Period|Protocol Violation|3
74962|NCT00090285|277687|P1|Base Study Vaccination Period|Protocol Violation|2
74963|NCT00090285|277684|P4|Base Study Vaccination Period|Lost to Follow-up|0
74964|NCT00090285|277685|P3|Base Study Vaccination Period|Lost to Follow-up|0
74965|NCT00090285|277686|P2|Base Study Vaccination Period|Lost to Follow-up|112
74966|NCT00090285|277687|P1|Base Study Vaccination Period|Lost to Follow-up|111
74967|NCT00090285|277684|P4|Base Study Vaccination Period|Adverse Event|0
74968|NCT00090285|277685|P3|Base Study Vaccination Period|Adverse Event|0
74969|NCT00090285|277686|P2|Base Study Vaccination Period|Adverse Event|4
74970|NCT00090285|277687|P1|Base Study Vaccination Period|Adverse Event|2
74971|NCT00090285|277684|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
74972|NCT00090285|277685|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
74973|NCT00090285|277686|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
74974|NCT00090285|277687|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
74975|NCT00090363|277707|P3|Overall Study|Continuing on study off treatment|16
74976|NCT00090363|277708|P2|Overall Study|Continuing on study off treatment|13
74977|NCT00090363|277709|P1|Overall Study|Continuing on study off treatment|14
74978|NCT00090363|277707|P3|Overall Study|Reasons not specified|1
74979|NCT00090363|277708|P2|Overall Study|Reasons not specified|1
74980|NCT00090363|277709|P1|Overall Study|Reasons not specified|2
74981|NCT00090363|277707|P3|Overall Study|Consent expired|9
74982|NCT00090363|277708|P2|Overall Study|Consent expired|10
74983|NCT00090363|277709|P1|Overall Study|Consent expired|7
74984|NCT00090363|277707|P3|Overall Study|Eligibility criteria not fulfilled|1
74985|NCT00090363|277708|P2|Overall Study|Eligibility criteria not fulfilled|0
74986|NCT00090363|277709|P1|Overall Study|Eligibility criteria not fulfilled|0
74987|NCT00090363|277707|P3|Overall Study|Study-specific discontinuation criteria|62
74988|NCT00090363|277708|P2|Overall Study|Study-specific discontinuation criteria|74
74989|NCT00090363|277709|P1|Overall Study|Study-specific discontinuation criteria|75
74990|NCT00090363|277707|P3|Overall Study|Withdrawal by Subject|6
74991|NCT00090363|277708|P2|Overall Study|Withdrawal by Subject|7
74992|NCT00090363|277709|P1|Overall Study|Withdrawal by Subject|7
74993|NCT00090363|277707|P3|Overall Study|Lost to Follow-up|1
74994|NCT00090363|277708|P2|Overall Study|Lost to Follow-up|2
74995|NCT00090363|277709|P1|Overall Study|Lost to Follow-up|1
74996|NCT00090402|277732|P3|Overall Study|stopped taking study medication|1
74997|NCT00090402|277733|P2|Overall Study|stopped taking study medication|0
74998|NCT00090402|277734|P1|Overall Study|stopped taking study medication|1
74999|NCT00090402|277732|P3|Overall Study|subject moved|0
75000|NCT00090402|277733|P2|Overall Study|subject moved|1
75001|NCT00090402|277734|P1|Overall Study|subject moved|0
75002|NCT00090402|277732|P3|Overall Study|Death|0
75003|NCT00090402|277733|P2|Overall Study|Death|1
75004|NCT00090402|277734|P1|Overall Study|Death|1
75005|NCT00090493|277748|P1|Overall Study|Physician Decision|2
75006|NCT00090519|277754|P2|Overall Study|Sponsor Decision|1
75007|NCT00090519|277755|P1|Overall Study|Sponsor Decision|3
75008|NCT00090519|277754|P2|Overall Study|Physician Decision|3
75009|NCT00090519|277755|P1|Overall Study|Physician Decision|2
75010|NCT00090519|277754|P2|Overall Study|Withdrawal by Subject|29
75011|NCT00090519|277755|P1|Overall Study|Withdrawal by Subject|28
75012|NCT00090519|277754|P2|Overall Study|Lost to Follow-up|29
75013|NCT00090519|277755|P1|Overall Study|Lost to Follow-up|26
75014|NCT00090519|277754|P2|Overall Study|Death|9
75015|NCT00090519|277755|P1|Overall Study|Death|9
75016|NCT00090519|277754|P2|Overall Study|Adverse Event|4
75017|NCT00090519|277755|P1|Overall Study|Adverse Event|5
75018|NCT00090545|277781|P2|Overall Study|Adverse Event|2
75019|NCT00090545|277782|P1|Overall Study|Adverse Event|0
75020|NCT00090545|277781|P2|Overall Study|Death|1
75021|NCT00090545|277782|P1|Overall Study|Death|0
75022|NCT00090545|277781|P2|Overall Study|Refused further treatment|4
75023|NCT00090545|277782|P1|Overall Study|Refused further treatment|1
75024|NCT00090545|277781|P2|Overall Study|Disease progression on study|17
75025|NCT00090545|277782|P1|Overall Study|Disease progression on study|21
75026|NCT00090584|277792|P2|Baseline to 8 Months|Lost to Follow-up|41
75027|NCT00090584|277793|P1|Baseline to 8 Months|Lost to Follow-up|44
75028|NCT00090584|277792|P2|Baseline to 10 Weeks|Lost to Follow-up|12
75029|NCT00090584|277793|P1|Baseline to 10 Weeks|Lost to Follow-up|15
75030|NCT00090610|277825|P2|Overall Study|Withdrawal by Subject|1
75031|NCT00090610|277826|P1|Overall Study|Withdrawal by Subject|1
75032|NCT00090753|277842|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
75033|NCT00090753|277843|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
75034|NCT00090753|277842|P2|Extended Treatment Period|Mircera Commercialization|93
75035|NCT00090753|277843|P1|Extended Treatment Period|Mircera Commercialization|188
75036|NCT00090753|277842|P2|Extended Treatment Period|Renal Transplant|12
75037|NCT00090753|277843|P1|Extended Treatment Period|Renal Transplant|15
75038|NCT00090753|277842|P2|Extended Treatment Period|Lost to Follow-up|1
75039|NCT00090753|277843|P1|Extended Treatment Period|Lost to Follow-up|3
75040|NCT00090753|277842|P2|Extended Treatment Period|Refused Treatment|12
75041|NCT00090753|277843|P1|Extended Treatment Period|Refused Treatment|18
75042|NCT00090753|277842|P2|Extended Treatment Period|Lack of Efficacy|0
75043|NCT00090753|277843|P1|Extended Treatment Period|Lack of Efficacy|1
75044|NCT00090753|277842|P2|Extended Treatment Period|Death|30
75045|NCT00090753|277843|P1|Extended Treatment Period|Death|58
75046|NCT00090753|277842|P2|Extended Treatment Period|Adverse Event|0
75047|NCT00090753|277843|P1|Extended Treatment Period|Adverse Event|11
75048|NCT00090753|277842|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
75049|NCT00090753|277843|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
75050|NCT00090753|277842|P2|First Treatment Period|Mircera Commercialization|0
75051|NCT00090753|277843|P1|First Treatment Period|Mircera Commercialization|1
75052|NCT00090753|277842|P2|First Treatment Period|Renal Transplant|50
75053|NCT00090753|277843|P1|First Treatment Period|Renal Transplant|70
75054|NCT00090753|277842|P2|First Treatment Period|Lost to Follow-up|4
75055|NCT00090753|277843|P1|First Treatment Period|Lost to Follow-up|4
75056|NCT00090753|277842|P2|First Treatment Period|Refused Treatment|25
75057|NCT00090753|277843|P1|First Treatment Period|Refused Treatment|32
75058|NCT00090753|277842|P2|First Treatment Period|Lack of Efficacy|1
75059|NCT00090753|277843|P1|First Treatment Period|Lack of Efficacy|2
75060|NCT00090753|277842|P2|First Treatment Period|Death|62
75061|NCT00090753|277843|P1|First Treatment Period|Death|88
75062|NCT00090753|277842|P2|First Treatment Period|Adverse Event|8
75063|NCT00090753|277843|P1|First Treatment Period|Adverse Event|20
75064|NCT00090766|277854|P3|Overall Study|Lost to Follow-up|2
75065|NCT00090766|277855|P2|Overall Study|Lost to Follow-up|0
75066|NCT00090766|277856|P1|Overall Study|Lost to Follow-up|2
75067|NCT00090766|277854|P3|Overall Study|Admin|0
75068|NCT00090766|277855|P2|Overall Study|Admin|2
75069|NCT00090766|277856|P1|Overall Study|Admin|0
75070|NCT00090766|277854|P3|Overall Study|Death|0
75071|NCT00090766|277855|P2|Overall Study|Death|0
75072|NCT00090766|277856|P1|Overall Study|Death|1
75073|NCT00090766|277854|P3|Overall Study|Nephrectomy Planned|1
75074|NCT00090766|277855|P2|Overall Study|Nephrectomy Planned|0
75075|NCT00090766|277856|P1|Overall Study|Nephrectomy Planned|0
75076|NCT00090779|277898|P2|Step 3|Off extended study due to study closure|3
75077|NCT00090779|277899|P1|Step 3|Off extended study due to study closure|4
75078|NCT00090779|277898|P2|Step 3|Initiation of ART and off extended study|2
75079|NCT00090779|277899|P1|Step 3|Initiation of ART and off extended study|3
75080|NCT00090779|277898|P2|Step 2|Non-compliance to study requirements|1
75081|NCT00090779|277899|P1|Step 2|Non-compliance to study requirements|0
75082|NCT00090779|277898|P2|Step 2|Subject relocated|1
75083|NCT00090779|277899|P1|Step 2|Subject relocated|0
75084|NCT00090779|277898|P2|Step 2|Off study per study closure|16
75085|NCT00090779|277899|P1|Step 2|Off study per study closure|6
75086|NCT00090779|277898|P2|Step 1|Subject relocated|8
75087|NCT00090779|277899|P1|Step 1|Subject relocated|2
75088|NCT00090779|277898|P2|Step 1|Non-compliance to study requirements|1
75089|NCT00090779|277899|P1|Step 1|Non-compliance to study requirements|0
75090|NCT00090779|277898|P2|Step 1|Pregnancy|0
75091|NCT00090779|277899|P1|Step 1|Pregnancy|1
75092|NCT00090779|277898|P2|Step 1|Physician Decision|0
75093|NCT00090779|277899|P1|Step 1|Physician Decision|1
75094|NCT00090779|277898|P2|Step 1|Death|2
75095|NCT00090779|277899|P1|Step 1|Death|0
75096|NCT00090779|277898|P2|Step 1|Lost to Follow-up|2
75097|NCT00090779|277899|P1|Step 1|Lost to Follow-up|3
75098|NCT00090779|277898|P2|Step 1|Withdrawal by Subject|2
75099|NCT00090779|277899|P1|Step 1|Withdrawal by Subject|4
75100|NCT00090857|277931|P2|Overall Study|Adverse Event|2
75101|NCT00090857|277932|P1|Overall Study|Adverse Event|2
75102|NCT00090857|277931|P2|Overall Study|Withdrawal by Subject|0
75103|NCT00090857|277932|P1|Overall Study|Withdrawal by Subject|2
75104|NCT00090857|277931|P2|Overall Study|Lost to Follow-up|1
75105|NCT00090857|277932|P1|Overall Study|Lost to Follow-up|0
75106|NCT00090987|277960|P1|Overall Study|Incarcerated|1
75107|NCT00090987|277960|P1|Overall Study|Non-compliance|4
75108|NCT00090987|277960|P1|Overall Study|alternative therapy|1
75109|NCT00090987|277960|P1|Overall Study|Withdrawal by Subject|3
75110|NCT00090987|277960|P1|Overall Study|Lack of Efficacy|7
75111|NCT00090987|277960|P1|Overall Study|Adverse Event|5
75112|NCT00091026|277966|P2|Overall Study|Unknown-never received treatment|1
75113|NCT00091026|277967|P1|Overall Study|Unknown-never received treatment|0
75114|NCT00091026|277966|P2|Overall Study|Patient withdrew and never received trea|2
75115|NCT00091026|277967|P1|Overall Study|Patient withdrew and never received trea|0
75116|NCT00091026|277966|P2|Overall Study|Patient deemed non eligible-never receiv|0
75117|NCT00091026|277967|P1|Overall Study|Patient deemed non eligible-never receiv|1
75118|NCT00091169|277979|P2|Overall Study|Not start protocol therapy|17
75119|NCT00091169|277980|P1|Overall Study|Not start protocol therapy|26
75120|NCT00091169|277979|P2|Overall Study|Other|4
75121|NCT00091169|277980|P1|Overall Study|Other|3
75122|NCT00091169|277979|P2|Overall Study|Withdrawal by Subject|13
75123|NCT00091169|277980|P1|Overall Study|Withdrawal by Subject|10
75124|NCT00091169|277979|P2|Overall Study|Death|1
75125|NCT00091169|277980|P1|Overall Study|Death|4
75126|NCT00091169|277979|P2|Overall Study|Adverse Event|17
75127|NCT00091169|277980|P1|Overall Study|Adverse Event|11
75128|NCT00091169|277979|P2|Overall Study|Disease progression|1
75129|NCT00091169|277980|P1|Overall Study|Disease progression|3
75130|NCT00091390|278008|P1|Overall Study|Protocol Violation|2
75131|NCT00091390|278008|P1|Overall Study|Withdrawal by Subject|2
75132|NCT00091442|278014|P2|Overall Study|Not Specified|6
75133|NCT00091442|278015|P1|Overall Study|Not Specified|2
75134|NCT00091442|278014|P2|Overall Study|Lost to Follow-up|3
75135|NCT00091442|278015|P1|Overall Study|Lost to Follow-up|1
75136|NCT00091442|278014|P2|Overall Study|Death|7
75137|NCT00091442|278015|P1|Overall Study|Death|9
75138|NCT00091442|278014|P2|Overall Study|2cycles therapy beyond Complete response|16
75139|NCT00091442|278015|P1|Overall Study|2cycles therapy beyond Complete response|9
75140|NCT00091442|278014|P2|Overall Study|Adverse Event|48
75141|NCT00091442|278015|P1|Overall Study|Adverse Event|29
75142|NCT00091442|278014|P2|Overall Study|Withdrawal by Subject|46
75143|NCT00091442|278015|P1|Overall Study|Withdrawal by Subject|38
75144|NCT00091442|278014|P2|Overall Study|Physician Decision|58
75145|NCT00091442|278015|P1|Overall Study|Physician Decision|61
75146|NCT00091442|278014|P2|Overall Study|Progressive Disease|189
75147|NCT00091442|278015|P1|Overall Study|Progressive Disease|220
75148|NCT00091572|278044|P2|Overall Study|Toxicity (Related AE)|9
75149|NCT00091572|278045|P1|Overall Study|Toxicity (Related AE)|53
75150|NCT00091572|278044|P2|Overall Study|Major Protocol Violation|0
75151|NCT00091572|278045|P1|Overall Study|Major Protocol Violation|2
75152|NCT00091572|278044|P2|Overall Study|Ongoing (still on treatment)|12
75153|NCT00091572|278045|P1|Overall Study|Ongoing (still on treatment)|8
75154|NCT00091572|278044|P2|Overall Study|Other Reason|13
75155|NCT00091572|278045|P1|Overall Study|Other Reason|6
75156|NCT00091572|278044|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
75157|NCT00091572|278045|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
75158|NCT00091572|278044|P2|Overall Study|Death not due to malignancy/toxicity|3
75159|NCT00091572|278045|P1|Overall Study|Death not due to malignancy/toxicity|1
75160|NCT00091572|278044|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
75161|NCT00091572|278045|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
75162|NCT00091572|278044|P2|Overall Study|Lost to Follow-up|1
75163|NCT00091572|278045|P1|Overall Study|Lost to Follow-up|1
75164|NCT00091793|278059|P2|Overall Study|Other|0
75165|NCT00091793|278060|P1|Overall Study|Other|2
75166|NCT00091793|278059|P2|Overall Study|Noncompliance|0
75167|NCT00091793|278060|P1|Overall Study|Noncompliance|2
75168|NCT00091793|278059|P2|Overall Study|Lost to Follow-up|5
75169|NCT00091793|278060|P1|Overall Study|Lost to Follow-up|7
75170|NCT00091793|278059|P2|Overall Study|Ineligibility determined|0
75171|NCT00091793|278060|P1|Overall Study|Ineligibility determined|2
75172|NCT00091793|278059|P2|Overall Study|Withdrawal by Subject|15
75173|NCT00091793|278060|P1|Overall Study|Withdrawal by Subject|10
75174|NCT00091793|278059|P2|Overall Study|Adverse Event|2
75175|NCT00091793|278060|P1|Overall Study|Adverse Event|1
75176|NCT00091819|278084|P2|Overall Study|Never received study treatment|4
75177|NCT00091819|278085|P1|Overall Study|Never received study treatment|3
75178|NCT00091819|278084|P2|Overall Study|Other|3
75179|NCT00091819|278085|P1|Overall Study|Other|2
75180|NCT00091819|278084|P2|Overall Study|Protocol Violation|2
75181|NCT00091819|278085|P1|Overall Study|Protocol Violation|1
75182|NCT00091819|278084|P2|Overall Study|Withdrawal by Subject|8
75183|NCT00091819|278085|P1|Overall Study|Withdrawal by Subject|5
75184|NCT00091819|278084|P2|Overall Study|Lost to Follow-up|23
75185|NCT00091819|278085|P1|Overall Study|Lost to Follow-up|26
75186|NCT00091819|278084|P2|Overall Study|Death|5
75187|NCT00091819|278085|P1|Overall Study|Death|4
75188|NCT00091819|278084|P2|Overall Study|Adverse Event|1
75189|NCT00091819|278085|P1|Overall Study|Adverse Event|1
75190|NCT00091832|278097|P6|Overall Study|Protocol Violation|1
75191|NCT00091832|278098|P5|Overall Study|Protocol Violation|0
75192|NCT00091832|278099|P4|Overall Study|Protocol Violation|0
75193|NCT00091832|278100|P3|Overall Study|Protocol Violation|1
75194|NCT00091832|278101|P2|Overall Study|Protocol Violation|0
75195|NCT00091832|278102|P1|Overall Study|Protocol Violation|0
75196|NCT00091832|278097|P6|Overall Study|Other|0
75197|NCT00091832|278098|P5|Overall Study|Other|0
75198|NCT00091832|278099|P4|Overall Study|Other|0
75199|NCT00091832|278100|P3|Overall Study|Other|2
75200|NCT00091832|278101|P2|Overall Study|Other|1
75201|NCT00091832|278102|P1|Overall Study|Other|0
75202|NCT00091832|278097|P6|Overall Study|Noncompliance|0
75203|NCT00091832|278098|P5|Overall Study|Noncompliance|0
75204|NCT00091832|278099|P4|Overall Study|Noncompliance|0
75205|NCT00091832|278100|P3|Overall Study|Noncompliance|0
75206|NCT00091832|278101|P2|Overall Study|Noncompliance|1
75207|NCT00091832|278102|P1|Overall Study|Noncompliance|0
75208|NCT00091832|278097|P6|Overall Study|Lost to Follow-up|1
75209|NCT00091832|278098|P5|Overall Study|Lost to Follow-up|2
75210|NCT00091832|278099|P4|Overall Study|Lost to Follow-up|3
75211|NCT00091832|278100|P3|Overall Study|Lost to Follow-up|3
75212|NCT00091832|278101|P2|Overall Study|Lost to Follow-up|0
75213|NCT00091832|278102|P1|Overall Study|Lost to Follow-up|1
75214|NCT00091832|278097|P6|Overall Study|Ineligibility Determined|0
75215|NCT00091832|278098|P5|Overall Study|Ineligibility Determined|1
75216|NCT00091832|278099|P4|Overall Study|Ineligibility Determined|0
75217|NCT00091832|278100|P3|Overall Study|Ineligibility Determined|1
75218|NCT00091832|278101|P2|Overall Study|Ineligibility Determined|0
75219|NCT00091832|278102|P1|Overall Study|Ineligibility Determined|0
75220|NCT00091832|278097|P6|Overall Study|Disease Progression|2
75221|NCT00091832|278098|P5|Overall Study|Disease Progression|1
75222|NCT00091832|278099|P4|Overall Study|Disease Progression|1
75223|NCT00091832|278100|P3|Overall Study|Disease Progression|0
75224|NCT00091832|278101|P2|Overall Study|Disease Progression|0
75225|NCT00091832|278102|P1|Overall Study|Disease Progression|2
75226|NCT00091832|278097|P6|Overall Study|Death|6
75227|NCT00091832|278098|P5|Overall Study|Death|5
75228|NCT00091832|278099|P4|Overall Study|Death|8
75229|NCT00091832|278100|P3|Overall Study|Death|5
75230|NCT00091832|278101|P2|Overall Study|Death|4
75231|NCT00091832|278102|P1|Overall Study|Death|6
75232|NCT00091832|278097|P6|Overall Study|Withdrawal by Subject|1
75233|NCT00091832|278098|P5|Overall Study|Withdrawal by Subject|3
75234|NCT00091832|278099|P4|Overall Study|Withdrawal by Subject|1
75235|NCT00091832|278100|P3|Overall Study|Withdrawal by Subject|0
75236|NCT00091832|278101|P2|Overall Study|Withdrawal by Subject|5
75237|NCT00091832|278102|P1|Overall Study|Withdrawal by Subject|4
75238|NCT00091832|278097|P6|Overall Study|Adverse Event|0
75239|NCT00091832|278098|P5|Overall Study|Adverse Event|3
75240|NCT00091832|278099|P4|Overall Study|Adverse Event|1
75241|NCT00091832|278100|P3|Overall Study|Adverse Event|0
75242|NCT00091832|278101|P2|Overall Study|Adverse Event|0
75243|NCT00091832|278102|P1|Overall Study|Adverse Event|0
75244|NCT00091832|278097|P6|Overall Study|Physician Decision|0
75245|NCT00091832|278098|P5|Overall Study|Physician Decision|0
75246|NCT00091832|278099|P4|Overall Study|Physician Decision|0
75247|NCT00091832|278100|P3|Overall Study|Physician Decision|0
75248|NCT00091832|278101|P2|Overall Study|Physician Decision|0
75249|NCT00091832|278102|P1|Overall Study|Physician Decision|1
75250|NCT00091949|278220|P2|Overall Study|Lost to Follow-up|41
75251|NCT00091949|278221|P1|Overall Study|Lost to Follow-up|58
75252|NCT00091949|278220|P2|Overall Study|Withdrawal by Subject|110
75253|NCT00091949|278221|P1|Overall Study|Withdrawal by Subject|117
75254|NCT00092118|278263|P2|Overall Study|Not Specified|5
75255|NCT00092118|278264|P1|Overall Study|Not Specified|6
75256|NCT00092118|278263|P2|Overall Study|Withdrawal by Subject|10
75257|NCT00092118|278264|P1|Overall Study|Withdrawal by Subject|4
75258|NCT00092118|278263|P2|Overall Study|Protocol Violation|25
75259|NCT00092118|278264|P1|Overall Study|Protocol Violation|23
75260|NCT00092118|278263|P2|Overall Study|Lost to Follow-up|3
75261|NCT00092118|278264|P1|Overall Study|Lost to Follow-up|4
75262|NCT00092118|278263|P2|Overall Study|Lack of Efficacy|14
75263|NCT00092118|278264|P1|Overall Study|Lack of Efficacy|12
75264|NCT00092118|278263|P2|Overall Study|Adverse Event|32
75265|NCT00092118|278264|P1|Overall Study|Adverse Event|35
75266|NCT00092131|278274|P2|Treatment Period II|Adverse Event|1
75267|NCT00092131|278275|P1|Treatment Period II|Adverse Event|0
75268|NCT00092131|278274|P2|Treatment Period I|Adverse Event|0
75269|NCT00092131|278275|P1|Treatment Period I|Adverse Event|1
75270|NCT00092417|278305|P2|Overall Study|Not Specified|0
75271|NCT00092417|278306|P1|Overall Study|Not Specified|1
75272|NCT00092417|278305|P2|Overall Study|Withdrawal by Subject|1
75273|NCT00092417|278306|P1|Overall Study|Withdrawal by Subject|2
75274|NCT00092417|278305|P2|Overall Study|Lost to Follow-up|0
75275|NCT00092417|278306|P1|Overall Study|Lost to Follow-up|2
75276|NCT00092443|278322|P2|Overall Study|Not Specified|13
75277|NCT00092443|278323|P1|Overall Study|Not Specified|17
75278|NCT00092443|278322|P2|Overall Study|Moved|5
75279|NCT00092443|278323|P1|Overall Study|Moved|5
75280|NCT00092443|278322|P2|Overall Study|Withdrawal by Subject|11
75281|NCT00092443|278323|P1|Overall Study|Withdrawal by Subject|9
75282|NCT00092443|278322|P2|Overall Study|Protocol Violation|9
75283|NCT00092443|278323|P1|Overall Study|Protocol Violation|11
75284|NCT00092443|278322|P2|Overall Study|Lost to Follow-up|3
75285|NCT00092443|278323|P1|Overall Study|Lost to Follow-up|7
75286|NCT00092443|278322|P2|Overall Study|Adverse Event|13
75287|NCT00092443|278323|P1|Overall Study|Adverse Event|9
75288|NCT00092456|278343|P4|Overall Study|Not Specified|0
75289|NCT00092456|278344|P3|Overall Study|Not Specified|3
75290|NCT00092456|278345|P2|Overall Study|Not Specified|2
75291|NCT00092456|278346|P1|Overall Study|Not Specified|4
75292|NCT00092456|278343|P4|Overall Study|Moved|1
75293|NCT00092456|278344|P3|Overall Study|Moved|0
75294|NCT00092456|278345|P2|Overall Study|Moved|1
75295|NCT00092456|278346|P1|Overall Study|Moved|1
75296|NCT00092456|278343|P4|Overall Study|Withdrawal by Subject|6
75297|NCT00092456|278344|P3|Overall Study|Withdrawal by Subject|16
75298|NCT00092456|278345|P2|Overall Study|Withdrawal by Subject|5
75299|NCT00092456|278346|P1|Overall Study|Withdrawal by Subject|13
75300|NCT00092456|278343|P4|Overall Study|Protocol Violation|6
75301|NCT00092456|278344|P3|Overall Study|Protocol Violation|8
75302|NCT00092456|278345|P2|Overall Study|Protocol Violation|7
75303|NCT00092456|278346|P1|Overall Study|Protocol Violation|5
75304|NCT00092456|278343|P4|Overall Study|Lost to Follow-up|2
75305|NCT00092456|278344|P3|Overall Study|Lost to Follow-up|1
75306|NCT00092456|278345|P2|Overall Study|Lost to Follow-up|2
75307|NCT00092456|278346|P1|Overall Study|Lost to Follow-up|2
75308|NCT00092456|278343|P4|Overall Study|Adverse Event|1
75309|NCT00092456|278344|P3|Overall Study|Adverse Event|1
75310|NCT00092456|278345|P2|Overall Study|Adverse Event|0
75311|NCT00092456|278346|P1|Overall Study|Adverse Event|0
75312|NCT00092495|278396|P5|Base Study Follow-up Period|Withdrawal by Subject|0
75313|NCT00092495|278397|P4|Base Study Follow-up Period|Withdrawal by Subject|0
75314|NCT00092495|278398|P3|Base Study Follow-up Period|Withdrawal by Subject|0
75315|NCT00092495|278399|P2|Base Study Follow-up Period|Withdrawal by Subject|0
75316|NCT00092495|278400|P1|Base Study Follow-up Period|Withdrawal by Subject|2
75317|NCT00092495|278396|P5|Base Study Follow-up Period|Lost to Follow-up|0
75318|NCT00092495|278397|P4|Base Study Follow-up Period|Lost to Follow-up|12
75319|NCT00092495|278398|P3|Base Study Follow-up Period|Lost to Follow-up|3
75320|NCT00092495|278399|P2|Base Study Follow-up Period|Lost to Follow-up|3
75321|NCT00092495|278400|P1|Base Study Follow-up Period|Lost to Follow-up|1
75322|NCT00092495|278396|P5|Base Study Follow-up Period|Extended|0
75323|NCT00092495|278397|P4|Base Study Follow-up Period|Extended|2
75324|NCT00092495|278398|P3|Base Study Follow-up Period|Extended|1
75325|NCT00092495|278399|P2|Base Study Follow-up Period|Extended|0
75326|NCT00092495|278400|P1|Base Study Follow-up Period|Extended|0
75327|NCT00092495|278396|P5|Base Study Vaccination Period|Withdrawal by Subject|0
75328|NCT00092495|278397|P4|Base Study Vaccination Period|Withdrawal by Subject|25
75329|NCT00092495|278398|P3|Base Study Vaccination Period|Withdrawal by Subject|14
75330|NCT00092495|278399|P2|Base Study Vaccination Period|Withdrawal by Subject|10
75331|NCT00092495|278400|P1|Base Study Vaccination Period|Withdrawal by Subject|9
75332|NCT00092495|278396|P5|Base Study Vaccination Period|Protocol Violation|0
75333|NCT00092495|278397|P4|Base Study Vaccination Period|Protocol Violation|0
75334|NCT00092495|278398|P3|Base Study Vaccination Period|Protocol Violation|0
75335|NCT00092495|278399|P2|Base Study Vaccination Period|Protocol Violation|0
75336|NCT00092495|278400|P1|Base Study Vaccination Period|Protocol Violation|1
75337|NCT00092495|278396|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
75338|NCT00092495|278397|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
75339|NCT00092495|278398|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
75340|NCT00092495|278399|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
75341|NCT00092495|278400|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
75342|NCT00092495|278396|P5|Base Study Vaccination Period|Pregnancy|0
75343|NCT00092495|278397|P4|Base Study Vaccination Period|Pregnancy|0
75344|NCT00092495|278398|P3|Base Study Vaccination Period|Pregnancy|0
75345|NCT00092495|278399|P2|Base Study Vaccination Period|Pregnancy|0
75346|NCT00092495|278400|P1|Base Study Vaccination Period|Pregnancy|2
75347|NCT00092495|278396|P5|Base Study Vaccination Period|Unspecified|0
75348|NCT00092495|278397|P4|Base Study Vaccination Period|Unspecified|2
75349|NCT00092495|278398|P3|Base Study Vaccination Period|Unspecified|0
75350|NCT00092495|278399|P2|Base Study Vaccination Period|Unspecified|1
75351|NCT00092495|278400|P1|Base Study Vaccination Period|Unspecified|1
75352|NCT00092495|278396|P5|Base Study Vaccination Period|Moved|0
75353|NCT00092495|278397|P4|Base Study Vaccination Period|Moved|2
75354|NCT00092495|278398|P3|Base Study Vaccination Period|Moved|2
75355|NCT00092495|278399|P2|Base Study Vaccination Period|Moved|1
75356|NCT00092495|278400|P1|Base Study Vaccination Period|Moved|3
75357|NCT00092495|278396|P5|Base Study Vaccination Period|Lost to Follow-up|0
75358|NCT00092495|278397|P4|Base Study Vaccination Period|Lost to Follow-up|36
75359|NCT00092495|278398|P3|Base Study Vaccination Period|Lost to Follow-up|11
75360|NCT00092495|278399|P2|Base Study Vaccination Period|Lost to Follow-up|6
75361|NCT00092495|278400|P1|Base Study Vaccination Period|Lost to Follow-up|16
75362|NCT00092495|278396|P5|Base Study Vaccination Period|Adverse Event|0
75363|NCT00092495|278397|P4|Base Study Vaccination Period|Adverse Event|3
75364|NCT00092495|278398|P3|Base Study Vaccination Period|Adverse Event|0
75365|NCT00092495|278399|P2|Base Study Vaccination Period|Adverse Event|0
75366|NCT00092495|278400|P1|Base Study Vaccination Period|Adverse Event|1
75367|NCT00092495|278396|P5|Base Study Vaccination Period|*Pregnancy|0
75368|NCT00092495|278397|P4|Base Study Vaccination Period|*Pregnancy|7
75369|NCT00092495|278398|P3|Base Study Vaccination Period|*Pregnancy|5
75370|NCT00092495|278399|P2|Base Study Vaccination Period|*Pregnancy|2
75371|NCT00092495|278400|P1|Base Study Vaccination Period|*Pregnancy|0
75372|NCT00092495|278396|P5|Base Study Vaccination Period|*Other reasons|0
75373|NCT00092495|278397|P4|Base Study Vaccination Period|*Other reasons|1
75374|NCT00092495|278398|P3|Base Study Vaccination Period|*Other reasons|0
75375|NCT00092495|278399|P2|Base Study Vaccination Period|*Other reasons|0
75376|NCT00092495|278400|P1|Base Study Vaccination Period|*Other reasons|1
75377|NCT00092495|278396|P5|Base Study Vaccination Period|*Clinical AE|0
75378|NCT00092495|278397|P4|Base Study Vaccination Period|*Clinical AE|2
75379|NCT00092495|278398|P3|Base Study Vaccination Period|*Clinical AE|1
75380|NCT00092495|278399|P2|Base Study Vaccination Period|*Clinical AE|0
75381|NCT00092495|278400|P1|Base Study Vaccination Period|*Clinical AE|1
75382|NCT00092495|278396|P5|Base Study Vaccination Period|Extended|0
75383|NCT00092495|278397|P4|Base Study Vaccination Period|Extended|1
75384|NCT00092495|278398|P3|Base Study Vaccination Period|Extended|0
75385|NCT00092495|278399|P2|Base Study Vaccination Period|Extended|0
75386|NCT00092495|278400|P1|Base Study Vaccination Period|Extended|0
75387|NCT00092495|278396|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
75388|NCT00092495|278397|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
75389|NCT00092495|278398|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
75390|NCT00092495|278399|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
75391|NCT00092495|278400|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
75392|NCT00092521|278465|P4|Extension Study (Group 4)|Unable/unwilling to return|25
75393|NCT00092521|278466|P3|Extension Study (Group 4)|Unable/unwilling to return|0
75394|NCT00092521|278467|P2|Extension Study (Group 4)|Unable/unwilling to return|0
75395|NCT00092521|278468|P1|Extension Study (Group 4)|Unable/unwilling to return|0
75396|NCT00092521|278465|P4|Extension Study (Group 4)|Site Terminated|4
75397|NCT00092521|278466|P3|Extension Study (Group 4)|Site Terminated|0
75398|NCT00092521|278467|P2|Extension Study (Group 4)|Site Terminated|0
75399|NCT00092521|278468|P1|Extension Study (Group 4)|Site Terminated|0
75400|NCT00092521|278465|P4|Extension Study (Group 4)|Moved|16
75401|NCT00092521|278466|P3|Extension Study (Group 4)|Moved|0
75402|NCT00092521|278467|P2|Extension Study (Group 4)|Moved|0
75403|NCT00092521|278468|P1|Extension Study (Group 4)|Moved|0
75404|NCT00092521|278465|P4|Extension Study (Group 4)|Withdrawal by Subject|46
75405|NCT00092521|278466|P3|Extension Study (Group 4)|Withdrawal by Subject|0
75406|NCT00092521|278467|P2|Extension Study (Group 4)|Withdrawal by Subject|0
75407|NCT00092521|278468|P1|Extension Study (Group 4)|Withdrawal by Subject|0
75408|NCT00092521|278465|P4|Extension Study (Group 4)|Protocol Violation|2
75409|NCT00092521|278466|P3|Extension Study (Group 4)|Protocol Violation|0
75410|NCT00092521|278467|P2|Extension Study (Group 4)|Protocol Violation|0
75411|NCT00092521|278468|P1|Extension Study (Group 4)|Protocol Violation|0
75412|NCT00092521|278465|P4|Extension Study (Group 4)|Pregnancy|4
75413|NCT00092521|278466|P3|Extension Study (Group 4)|Pregnancy|0
75414|NCT00092521|278467|P2|Extension Study (Group 4)|Pregnancy|0
75415|NCT00092521|278468|P1|Extension Study (Group 4)|Pregnancy|0
75416|NCT00092521|278465|P4|Extension Study (Group 4)|Lost to Follow-up|87
75417|NCT00092521|278466|P3|Extension Study (Group 4)|Lost to Follow-up|0
75418|NCT00092521|278467|P2|Extension Study (Group 4)|Lost to Follow-up|0
75419|NCT00092521|278468|P1|Extension Study (Group 4)|Lost to Follow-up|0
75420|NCT00092521|278465|P4|Extension Study (Group 4)|Adverse Event|2
75421|NCT00092521|278466|P3|Extension Study (Group 4)|Adverse Event|0
75422|NCT00092521|278467|P2|Extension Study (Group 4)|Adverse Event|0
75423|NCT00092521|278468|P1|Extension Study (Group 4)|Adverse Event|0
75424|NCT00092521|278465|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
75425|NCT00092521|278466|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
75426|NCT00092521|278467|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
75427|NCT00092521|278468|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
75428|NCT00092521|278465|P4|Follow-Up (After Month 7)|Visits Compressed|0
75429|NCT00092521|278466|P3|Follow-Up (After Month 7)|Visits Compressed|5
75430|NCT00092521|278467|P2|Follow-Up (After Month 7)|Visits Compressed|0
75431|NCT00092521|278468|P1|Follow-Up (After Month 7)|Visits Compressed|5
75432|NCT00092521|278465|P4|Follow-Up (After Month 7)|Travel|0
75433|NCT00092521|278466|P3|Follow-Up (After Month 7)|Travel|0
75434|NCT00092521|278467|P2|Follow-Up (After Month 7)|Travel|0
75435|NCT00092521|278468|P1|Follow-Up (After Month 7)|Travel|2
75436|NCT00092521|278465|P4|Follow-Up (After Month 7)|Site Terminated|0
75437|NCT00092521|278466|P3|Follow-Up (After Month 7)|Site Terminated|3
75438|NCT00092521|278467|P2|Follow-Up (After Month 7)|Site Terminated|0
75439|NCT00092521|278468|P1|Follow-Up (After Month 7)|Site Terminated|3
75440|NCT00092521|278465|P4|Follow-Up (After Month 7)|Moved|0
75441|NCT00092521|278466|P3|Follow-Up (After Month 7)|Moved|28
75442|NCT00092521|278467|P2|Follow-Up (After Month 7)|Moved|2
75443|NCT00092521|278468|P1|Follow-Up (After Month 7)|Moved|32
75444|NCT00092521|278465|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
75445|NCT00092521|278466|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
75446|NCT00092521|278467|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
75447|NCT00092521|278468|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
75448|NCT00092521|278465|P4|Follow-Up (After Month 7)|Protocol Violation|0
75449|NCT00092521|278466|P3|Follow-Up (After Month 7)|Protocol Violation|5
75450|NCT00092521|278467|P2|Follow-Up (After Month 7)|Protocol Violation|1
75451|NCT00092521|278468|P1|Follow-Up (After Month 7)|Protocol Violation|1
75452|NCT00092521|278465|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
75453|NCT00092521|278466|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
75454|NCT00092521|278467|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
75455|NCT00092521|278468|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
75456|NCT00092521|278465|P4|Follow-Up (After Month 7)|Death|0
75457|NCT00092521|278466|P3|Follow-Up (After Month 7)|Death|1
75458|NCT00092521|278467|P2|Follow-Up (After Month 7)|Death|0
75459|NCT00092521|278468|P1|Follow-Up (After Month 7)|Death|2
75460|NCT00092521|278465|P4|Follow-Up (After Month 7)|Adverse Event|0
75461|NCT00092521|278466|P3|Follow-Up (After Month 7)|Adverse Event|0
75462|NCT00092521|278467|P2|Follow-Up (After Month 7)|Adverse Event|0
75463|NCT00092521|278468|P1|Follow-Up (After Month 7)|Adverse Event|1
75464|NCT00092521|278465|P4|Follow-Up (After Month 7)|Subjects in Extension|0
75465|NCT00092521|278466|P3|Follow-Up (After Month 7)|Subjects in Extension|412
75466|NCT00092521|278467|P2|Follow-Up (After Month 7)|Subjects in Extension|109
75467|NCT00092521|278468|P1|Follow-Up (After Month 7)|Subjects in Extension|13
75468|NCT00092521|278465|P4|Follow-Up (After Month 7)|Subjects Continuing|0
75469|NCT00092521|278466|P3|Follow-Up (After Month 7)|Subjects Continuing|35
75470|NCT00092521|278467|P2|Follow-Up (After Month 7)|Subjects Continuing|4
75471|NCT00092521|278468|P1|Follow-Up (After Month 7)|Subjects Continuing|34
75472|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
75473|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
75474|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
75475|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
75476|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
75477|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
75478|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
75479|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
75480|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Moved|0
75481|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Moved|18
75482|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Moved|1
75483|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Moved|14
75484|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
75485|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
75486|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
75487|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
75488|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
75489|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
75490|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
75491|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
75492|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
75493|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
75494|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
75495|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
75496|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Death|0
75497|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Death|1
75498|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Death|0
75499|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Death|0
75500|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
75501|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
75502|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
75503|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
75504|NCT00092521|278465|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
75505|NCT00092521|278466|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
75506|NCT00092521|278467|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
75507|NCT00092521|278468|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
75508|NCT00092534|278480|P3|Extension Study|Protocol Deviation|15
75509|NCT00092534|278481|P2|Extension Study|Protocol Deviation|0
75510|NCT00092534|278482|P1|Extension Study|Protocol Deviation|0
75511|NCT00092534|278480|P3|Extension Study|Study Ended|29
75512|NCT00092534|278481|P2|Extension Study|Study Ended|0
75513|NCT00092534|278482|P1|Extension Study|Study Ended|0
75514|NCT00092534|278480|P3|Extension Study|Site Closed|21
75515|NCT00092534|278481|P2|Extension Study|Site Closed|0
75516|NCT00092534|278482|P1|Extension Study|Site Closed|0
75517|NCT00092534|278480|P3|Extension Study|Travel|2
75518|NCT00092534|278481|P2|Extension Study|Travel|0
75519|NCT00092534|278482|P1|Extension Study|Travel|0
75520|NCT00092534|278480|P3|Extension Study|Moved|6
75521|NCT00092534|278481|P2|Extension Study|Moved|0
75522|NCT00092534|278482|P1|Extension Study|Moved|0
75523|NCT00092534|278480|P3|Extension Study|Withdrawal by Subject|18
75524|NCT00092534|278481|P2|Extension Study|Withdrawal by Subject|0
75525|NCT00092534|278482|P1|Extension Study|Withdrawal by Subject|0
75526|NCT00092534|278480|P3|Extension Study|Pregnancy|12
75527|NCT00092534|278481|P2|Extension Study|Pregnancy|0
75528|NCT00092534|278482|P1|Extension Study|Pregnancy|0
75529|NCT00092534|278480|P3|Extension Study|Physician Decision|1
75530|NCT00092534|278481|P2|Extension Study|Physician Decision|0
75531|NCT00092534|278482|P1|Extension Study|Physician Decision|0
75532|NCT00092534|278480|P3|Extension Study|Lost to Follow-up|41
75533|NCT00092534|278481|P2|Extension Study|Lost to Follow-up|0
75534|NCT00092534|278482|P1|Extension Study|Lost to Follow-up|0
75535|NCT00092534|278480|P3|Base Study Follow Up Period|Subjects in extension|0
75536|NCT00092534|278481|P2|Base Study Follow Up Period|Subjects in extension|371
75537|NCT00092534|278482|P1|Base Study Follow Up Period|Subjects in extension|15
75538|NCT00092534|278480|P3|Base Study Follow Up Period|Subjects continuing|0
75539|NCT00092534|278481|P2|Base Study Follow Up Period|Subjects continuing|31
75540|NCT00092534|278482|P1|Base Study Follow Up Period|Subjects continuing|27
75541|NCT00092534|278480|P3|Base Study Follow Up Period|Site Closed|0
75542|NCT00092534|278481|P2|Base Study Follow Up Period|Site Closed|2
75543|NCT00092534|278482|P1|Base Study Follow Up Period|Site Closed|0
75544|NCT00092534|278480|P3|Base Study Follow Up Period|Travel|0
75545|NCT00092534|278481|P2|Base Study Follow Up Period|Travel|7
75546|NCT00092534|278482|P1|Base Study Follow Up Period|Travel|10
75547|NCT00092534|278480|P3|Base Study Follow Up Period|Moved|0
75548|NCT00092534|278481|P2|Base Study Follow Up Period|Moved|58
75549|NCT00092534|278482|P1|Base Study Follow Up Period|Moved|62
75550|NCT00092534|278480|P3|Base Study Follow Up Period|Withdrawal by Subject|0
75551|NCT00092534|278481|P2|Base Study Follow Up Period|Withdrawal by Subject|62
75552|NCT00092534|278482|P1|Base Study Follow Up Period|Withdrawal by Subject|71
75553|NCT00092534|278480|P3|Base Study Follow Up Period|Protocol Violation|0
75554|NCT00092534|278481|P2|Base Study Follow Up Period|Protocol Violation|2
75555|NCT00092534|278482|P1|Base Study Follow Up Period|Protocol Violation|1
75556|NCT00092534|278480|P3|Base Study Follow Up Period|Pregnancy|0
75557|NCT00092534|278481|P2|Base Study Follow Up Period|Pregnancy|10
75558|NCT00092534|278482|P1|Base Study Follow Up Period|Pregnancy|6
75559|NCT00092534|278480|P3|Base Study Follow Up Period|Lost to Follow-up|0
75560|NCT00092534|278481|P2|Base Study Follow Up Period|Lost to Follow-up|146
75561|NCT00092534|278482|P1|Base Study Follow Up Period|Lost to Follow-up|120
75562|NCT00092534|278480|P3|Base Study Follow Up Period|Death|0
75563|NCT00092534|278481|P2|Base Study Follow Up Period|Death|1
75564|NCT00092534|278482|P1|Base Study Follow Up Period|Death|2
75565|NCT00092534|278480|P3|Base Study Follow Up Period|Adverse Event|0
75566|NCT00092534|278481|P2|Base Study Follow Up Period|Adverse Event|4
75567|NCT00092534|278482|P1|Base Study Follow Up Period|Adverse Event|2
75568|NCT00092534|278480|P3|Base Study Vaccination Period|Site Closed|0
75569|NCT00092534|278481|P2|Base Study Vaccination Period|Site Closed|1
75570|NCT00092534|278482|P1|Base Study Vaccination Period|Site Closed|0
75571|NCT00092534|278480|P3|Base Study Vaccination Period|Travel|0
75572|NCT00092534|278481|P2|Base Study Vaccination Period|Travel|0
75573|NCT00092534|278482|P1|Base Study Vaccination Period|Travel|1
75574|NCT00092534|278480|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
75575|NCT00092534|278481|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
75576|NCT00092534|278482|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
75577|NCT00092534|278480|P3|Base Study Vaccination Period|Moved|0
75578|NCT00092534|278481|P2|Base Study Vaccination Period|Moved|12
75579|NCT00092534|278482|P1|Base Study Vaccination Period|Moved|14
75580|NCT00092534|278480|P3|Base Study Vaccination Period|Withdrawal by Subject|0
75581|NCT00092534|278481|P2|Base Study Vaccination Period|Withdrawal by Subject|58
75582|NCT00092534|278482|P1|Base Study Vaccination Period|Withdrawal by Subject|85
75583|NCT00092534|278480|P3|Base Study Vaccination Period|Protocol Violation|0
75584|NCT00092534|278481|P2|Base Study Vaccination Period|Protocol Violation|1
75585|NCT00092534|278482|P1|Base Study Vaccination Period|Protocol Violation|2
75586|NCT00092534|278480|P3|Base Study Vaccination Period|Pregnancy|0
75587|NCT00092534|278481|P2|Base Study Vaccination Period|Pregnancy|7
75588|NCT00092534|278482|P1|Base Study Vaccination Period|Pregnancy|9
75589|NCT00092534|278480|P3|Base Study Vaccination Period|Physician Decision|0
75590|NCT00092534|278481|P2|Base Study Vaccination Period|Physician Decision|0
75591|NCT00092534|278482|P1|Base Study Vaccination Period|Physician Decision|1
75592|NCT00092534|278480|P3|Base Study Vaccination Period|Lost to Follow-up|0
75593|NCT00092534|278481|P2|Base Study Vaccination Period|Lost to Follow-up|37
75594|NCT00092534|278482|P1|Base Study Vaccination Period|Lost to Follow-up|41
75595|NCT00092534|278480|P3|Base Study Vaccination Period|Death|0
75596|NCT00092534|278481|P2|Base Study Vaccination Period|Death|4
75597|NCT00092534|278482|P1|Base Study Vaccination Period|Death|5
75598|NCT00092534|278480|P3|Base Study Vaccination Period|Adverse Event|0
75599|NCT00092534|278481|P2|Base Study Vaccination Period|Adverse Event|1
75600|NCT00092534|278482|P1|Base Study Vaccination Period|Adverse Event|3
75601|NCT00092534|278480|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
75602|NCT00092534|278481|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
75603|NCT00092534|278482|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
75604|NCT00092547|278499|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
75605|NCT00092547|278500|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
75606|NCT00092547|278501|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
75607|NCT00092547|278499|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
75608|NCT00092547|278500|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
75609|NCT00092547|278501|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
75610|NCT00092547|278499|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
75611|NCT00092547|278500|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
75612|NCT00092547|278501|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
75613|NCT00092547|278499|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
75614|NCT00092547|278500|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
75615|NCT00092547|278501|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
75616|NCT00092547|278499|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
75617|NCT00092547|278500|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
75618|NCT00092547|278501|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
75619|NCT00092547|278499|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
75620|NCT00092547|278500|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
75621|NCT00092547|278501|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
75622|NCT00092547|278499|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
75623|NCT00092547|278500|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
75624|NCT00092547|278501|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
75625|NCT00092547|278499|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
75626|NCT00092547|278500|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
75627|NCT00092547|278501|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
75628|NCT00092547|278499|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
75629|NCT00092547|278500|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
75630|NCT00092547|278501|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
75631|NCT00092547|278499|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
75632|NCT00092547|278500|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
75633|NCT00092547|278501|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
75634|NCT00092547|278499|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
75635|NCT00092547|278500|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
75636|NCT00092547|278501|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
75637|NCT00092547|278499|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
75638|NCT00092547|278500|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
75878|NCT00095498|278970|P3|Overall Study|Ineligibility determined|2
75639|NCT00092547|278501|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
75640|NCT00092547|278499|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
75641|NCT00092547|278500|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
75642|NCT00092547|278501|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
75643|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
75644|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
75645|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
75646|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
75647|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
75648|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
75649|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
75650|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
75651|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
75652|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
75653|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
75654|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
75655|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
75656|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
75657|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
75658|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
75659|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
75660|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
75661|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
75662|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
75663|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
75664|NCT00092547|278499|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
75665|NCT00092547|278500|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
75666|NCT00092547|278501|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
75667|NCT00092677|278545|P2|Overall Study|Adminstrative|9
75668|NCT00092677|278546|P1|Overall Study|Adminstrative|5
75669|NCT00092677|278545|P2|Overall Study|Lost to Follow-up|2
75670|NCT00092677|278546|P1|Overall Study|Lost to Follow-up|0
75671|NCT00084838|278588|P1|Overall Study|Ineligible|4
75672|NCT00084838|278588|P1|Overall Study|Pt Non-Compliance|1
75673|NCT00084838|278588|P1|Overall Study|Progressive Disease|4
75674|NCT00084838|278588|P1|Overall Study|Withdrawal by Subject|1
75675|NCT00084838|278588|P1|Overall Study|Adverse Event|2
75676|NCT00084838|278588|P1|Overall Study|Death|1
75677|NCT00084864|278614|P4|Overall Study|Adverse Event|0
75678|NCT00084864|278615|P3|Overall Study|Adverse Event|0
75679|NCT00084864|278616|P2|Overall Study|Adverse Event|0
75680|NCT00084864|278617|P1|Overall Study|Adverse Event|1
75681|NCT00085098|278645|P2|Overall Study|Ineligible|1
75682|NCT00085098|278646|P1|Overall Study|Ineligible|1
75683|NCT00085098|278645|P2|Overall Study|Withdrawal by Subject|1
75684|NCT00085098|278646|P1|Overall Study|Withdrawal by Subject|0
75685|NCT00093015|278654|P2|Overall Study|Death|385
75686|NCT00093015|278655|P1|Overall Study|Death|375
75687|NCT00093015|278654|P2|Overall Study|Lost to Follow-up|108
75688|NCT00093015|278655|P1|Overall Study|Lost to Follow-up|96
75689|NCT00093015|278654|P2|Overall Study|Withdrawal by Subject|171
75690|NCT00093015|278655|P1|Overall Study|Withdrawal by Subject|194
75691|NCT00093145|278712|P1|Overall Study|Other|1
75692|NCT00093145|278712|P1|Overall Study|Withdrawal by Subject|9
75693|NCT00093145|278712|P1|Overall Study|Physician Decision|5
75694|NCT00093145|278712|P1|Overall Study|Unacceptable Toxicity Only|2
75695|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Not Specified|8
75696|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Not Specified|6
75697|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Not Specified|4
75698|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Not Specified|0
75699|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Not Specified|0
75700|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Not Specified|0
75701|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
75702|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
75703|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
75704|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
75705|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
75706|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
75707|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
75708|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
75709|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
75710|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
75711|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
75712|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
75713|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
75714|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
75715|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
75716|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
75717|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
75718|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
75719|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
75720|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
75721|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
75722|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
75723|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
75724|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
75725|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
75726|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
75727|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
75728|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
75729|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
75730|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
75731|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
75732|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
75733|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
75734|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
75735|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
75736|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
75737|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
75738|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
75739|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
75740|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
75741|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
75742|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
75743|NCT00095173|278721|P6|Open-Label Extension Phase (Period C)|Death|1
75744|NCT00095173|278722|P5|Open-Label Extension Phase (Period C)|Death|0
75745|NCT00095173|278723|P4|Open-Label Extension Phase (Period C)|Death|0
75746|NCT00095173|278724|P3|Open-Label Extension Phase (Period C)|Death|0
75747|NCT00095173|278725|P2|Open-Label Extension Phase (Period C)|Death|0
75748|NCT00095173|278726|P1|Open-Label Extension Phase (Period C)|Death|0
75749|NCT00095173|278721|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
75750|NCT00095173|278722|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
75751|NCT00095173|278723|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
75752|NCT00095173|278724|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
75753|NCT00095173|278725|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
75754|NCT00095173|278726|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
75755|NCT00095173|278721|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
75756|NCT00095173|278722|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
75757|NCT00095173|278723|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
75758|NCT00095173|278724|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
75759|NCT00095173|278725|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
75760|NCT00095173|278726|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
75761|NCT00095173|278721|P6|Open-Label Lead-In Phase (Period A)|Not specified|0
75762|NCT00095173|278722|P5|Open-Label Lead-In Phase (Period A)|Not specified|0
75763|NCT00095173|278723|P4|Open-Label Lead-In Phase (Period A)|Not specified|0
75764|NCT00095173|278724|P3|Open-Label Lead-In Phase (Period A)|Not specified|0
75765|NCT00095173|278725|P2|Open-Label Lead-In Phase (Period A)|Not specified|0
75766|NCT00095173|278726|P1|Open-Label Lead-In Phase (Period A)|Not specified|1
75767|NCT00095173|278721|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
75768|NCT00095173|278722|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
75769|NCT00095173|278723|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
75770|NCT00095173|278724|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
75771|NCT00095173|278725|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
75772|NCT00095173|278726|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
75773|NCT00095173|278721|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
75774|NCT00095173|278722|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
75775|NCT00095173|278723|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
75776|NCT00095173|278724|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
75777|NCT00095173|278725|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
75778|NCT00095173|278726|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
75779|NCT00095173|278721|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
75780|NCT00095173|278722|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
75781|NCT00095173|278723|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
75782|NCT00095173|278724|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
75783|NCT00095173|278725|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
75784|NCT00095173|278726|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
75785|NCT00095199|278765|P4|Overall Study|Data inadvertently lost by site|0
75786|NCT00095199|278766|P3|Overall Study|Data inadvertently lost by site|0
75787|NCT00095199|278767|P2|Overall Study|Data inadvertently lost by site|0
75788|NCT00095199|278768|P1|Overall Study|Data inadvertently lost by site|1
75789|NCT00095199|278765|P4|Overall Study|Primary tumor removed in other surgery|0
75790|NCT00095199|278766|P3|Overall Study|Primary tumor removed in other surgery|0
75791|NCT00095199|278767|P2|Overall Study|Primary tumor removed in other surgery|1
75792|NCT00095199|278768|P1|Overall Study|Primary tumor removed in other surgery|0
75793|NCT00095199|278765|P4|Overall Study|Started radiotherapy regimen|0
75794|NCT00095199|278766|P3|Overall Study|Started radiotherapy regimen|0
75795|NCT00095199|278767|P2|Overall Study|Started radiotherapy regimen|1
75796|NCT00095199|278768|P1|Overall Study|Started radiotherapy regimen|0
75797|NCT00095199|278765|P4|Overall Study|Started Palliative Radiotherapy|0
75798|NCT00095199|278766|P3|Overall Study|Started Palliative Radiotherapy|0
75799|NCT00095199|278767|P2|Overall Study|Started Palliative Radiotherapy|0
75800|NCT00095199|278768|P1|Overall Study|Started Palliative Radiotherapy|1
75801|NCT00095199|278765|P4|Overall Study|Not eligible|1
75802|NCT00095199|278766|P3|Overall Study|Not eligible|0
75803|NCT00095199|278767|P2|Overall Study|Not eligible|7
75804|NCT00095199|278768|P1|Overall Study|Not eligible|1
75805|NCT00095199|278765|P4|Overall Study|Physician Decision|1
75806|NCT00095199|278766|P3|Overall Study|Physician Decision|1
75807|NCT00095199|278767|P2|Overall Study|Physician Decision|6
75808|NCT00095199|278768|P1|Overall Study|Physician Decision|5
75809|NCT00095199|278765|P4|Overall Study|Surgery needed could not start in 7 days|0
75810|NCT00095199|278766|P3|Overall Study|Surgery needed could not start in 7 days|1
75811|NCT00095199|278767|P2|Overall Study|Surgery needed could not start in 7 days|0
75812|NCT00095199|278768|P1|Overall Study|Surgery needed could not start in 7 days|0
75813|NCT00095199|278765|P4|Overall Study|Liver function test results elevated|1
75814|NCT00095199|278766|P3|Overall Study|Liver function test results elevated|1
75815|NCT00095199|278767|P2|Overall Study|Liver function test results elevated|0
75816|NCT00095199|278768|P1|Overall Study|Liver function test results elevated|0
75817|NCT00095199|278765|P4|Overall Study|Protocol Violation|0
75818|NCT00095199|278766|P3|Overall Study|Protocol Violation|2
75819|NCT00095199|278767|P2|Overall Study|Protocol Violation|4
75820|NCT00095199|278768|P1|Overall Study|Protocol Violation|4
75821|NCT00095199|278765|P4|Overall Study|Withdrawal by Subject|22
75822|NCT00095199|278766|P3|Overall Study|Withdrawal by Subject|13
75823|NCT00095199|278767|P2|Overall Study|Withdrawal by Subject|16
75824|NCT00095199|278768|P1|Overall Study|Withdrawal by Subject|21
75825|NCT00095199|278765|P4|Overall Study|Death|9
75826|NCT00095199|278766|P3|Overall Study|Death|11
75827|NCT00095199|278767|P2|Overall Study|Death|6
75828|NCT00095199|278768|P1|Overall Study|Death|10
75829|NCT00095199|278765|P4|Overall Study|Progressive disease|98
75830|NCT00095199|278766|P3|Overall Study|Progressive disease|105
75831|NCT00095199|278767|P2|Overall Study|Progressive disease|179
75832|NCT00095199|278768|P1|Overall Study|Progressive disease|213
75833|NCT00095199|278765|P4|Overall Study|Adverse Event|11
75834|NCT00095199|278766|P3|Overall Study|Adverse Event|26
75835|NCT00095199|278767|P2|Overall Study|Adverse Event|22
75836|NCT00095199|278768|P1|Overall Study|Adverse Event|40
75837|NCT00095212|278808|P2|Overall Study|Withdrawal by Subject|3
75838|NCT00095212|278809|P1|Overall Study|Withdrawal by Subject|1
75839|NCT00095238|278837|P2|Overall Study|Other Reasons|88
75840|NCT00095238|278838|P1|Overall Study|Other Reasons|87
75841|NCT00095238|278837|P2|Overall Study|Missing|0
75842|NCT00095238|278838|P1|Overall Study|Missing|1
75843|NCT00095238|278837|P2|Overall Study|Study terminated by sponsor|1
75844|NCT00095238|278838|P1|Overall Study|Study terminated by sponsor|0
75845|NCT00095238|278837|P2|Overall Study|No longer met study criteria|5
75846|NCT00095238|278838|P1|Overall Study|No longer met study criteria|4
75847|NCT00095238|278837|P2|Overall Study|Noncompliance|45
75848|NCT00095238|278838|P1|Overall Study|Noncompliance|44
75849|NCT00095238|278837|P2|Overall Study|Lost to Follow-up|24
75850|NCT00095238|278838|P1|Overall Study|Lost to Follow-up|19
75851|NCT00095238|278837|P2|Overall Study|Death|170
75852|NCT00095238|278838|P1|Overall Study|Death|154
75853|NCT00095238|278837|P2|Overall Study|Subject Withdrew Consent|223
75854|NCT00095238|278838|P1|Overall Study|Subject Withdrew Consent|208
75855|NCT00095238|278837|P2|Overall Study|Adverse Event|287
75856|NCT00095238|278838|P1|Overall Study|Adverse Event|331
75857|NCT00095238|278837|P2|Overall Study|Lack of Efficacy|9
75858|NCT00095238|278838|P1|Overall Study|Lack of Efficacy|9
75859|NCT00095303|278900|P2|Follow Up Study|Lost to Follow-up|58
75860|NCT00095303|278901|P1|Follow Up Study|Lost to Follow-up|59
75861|NCT00095303|278900|P2|Main Study|Lost to Follow-up|87
75862|NCT00095303|278901|P1|Main Study|Lost to Follow-up|91
75863|NCT00095498|278970|P3|Overall Study|Requirement for alternative therapy|2
75864|NCT00095498|278971|P2|Overall Study|Requirement for alternative therapy|0
75865|NCT00095498|278972|P1|Overall Study|Requirement for alternative therapy|1
75866|NCT00095498|278970|P3|Overall Study|Protocol Violation|1
75867|NCT00095498|278971|P2|Overall Study|Protocol Violation|0
75868|NCT00095498|278972|P1|Overall Study|Protocol Violation|0
75869|NCT00095498|278970|P3|Overall Study|Other|6
75870|NCT00095498|278971|P2|Overall Study|Other|7
75871|NCT00095498|278972|P1|Overall Study|Other|6
75872|NCT00095498|278970|P3|Overall Study|Noncompliance|1
75873|NCT00095498|278971|P2|Overall Study|Noncompliance|0
75874|NCT00095498|278972|P1|Overall Study|Noncompliance|1
75875|NCT00095498|278970|P3|Overall Study|Lost to Follow-up|2
75876|NCT00095498|278971|P2|Overall Study|Lost to Follow-up|1
75877|NCT00095498|278972|P1|Overall Study|Lost to Follow-up|1
75879|NCT00095498|278971|P2|Overall Study|Ineligibility determined|0
75880|NCT00095498|278972|P1|Overall Study|Ineligibility determined|3
75881|NCT00095498|278970|P3|Overall Study|Disease progression|1
75882|NCT00095498|278971|P2|Overall Study|Disease progression|1
75883|NCT00095498|278972|P1|Overall Study|Disease progression|0
75884|NCT00095498|278970|P3|Overall Study|Withdrawal by Subject|15
75885|NCT00095498|278971|P2|Overall Study|Withdrawal by Subject|16
75886|NCT00095498|278972|P1|Overall Study|Withdrawal by Subject|15
75887|NCT00095498|278970|P3|Overall Study|Adverse Event|1
75888|NCT00095498|278971|P2|Overall Study|Adverse Event|0
75889|NCT00095498|278972|P1|Overall Study|Adverse Event|1
75890|NCT00095498|278970|P3|Overall Study|Physician Decision|8
75891|NCT00095498|278971|P2|Overall Study|Physician Decision|10
75892|NCT00095498|278972|P1|Overall Study|Physician Decision|9
75893|NCT00095576|279408|P2|Overall Study|Subject moved|36
75894|NCT00095576|279409|P1|Overall Study|Subject moved|30
75895|NCT00095576|279408|P2|Overall Study|Site terminated|67
75896|NCT00095576|279409|P1|Overall Study|Site terminated|75
75897|NCT00095576|279408|P2|Overall Study|Option to switch to a rollover study|1099
75898|NCT00095576|279409|P1|Overall Study|Option to switch to a rollover study|1097
75899|NCT00095576|279408|P2|Overall Study|Withdrawal by Subject|47
75900|NCT00095576|279409|P1|Overall Study|Withdrawal by Subject|34
75901|NCT00095576|279408|P2|Overall Study|Protocol Violation|0
75902|NCT00095576|279409|P1|Overall Study|Protocol Violation|1
75903|NCT00095576|279408|P2|Overall Study|Lost to Follow-up|229
75904|NCT00095576|279409|P1|Overall Study|Lost to Follow-up|233
75905|NCT00095576|279408|P2|Overall Study|Adverse Event|3
75906|NCT00095576|279409|P1|Overall Study|Adverse Event|5
75907|NCT00095628|279421|P1|Overall Study|Disease progression prior to treatment|1
75908|NCT00095836|279453|P1|Overall Study|Death|2
75909|NCT00095836|279453|P1|Overall Study|Adverse Event|1
75910|NCT00095836|279453|P1|Overall Study|Lost to Follow-up|1
75911|NCT00095940|279478|P9|Lapatinib Continuation/Phase II|Adverse Event|0
75912|NCT00095940|279479|P8|Lapatinib Continuation/Phase II|Adverse Event|1
75913|NCT00095940|279480|P7|Lapatinib Continuation/Phase II|Adverse Event|0
75914|NCT00095940|279481|P6|Lapatinib Continuation/Phase II|Adverse Event|0
75915|NCT00095940|279482|P5|Lapatinib Continuation/Phase II|Adverse Event|0
75916|NCT00095940|279483|P4|Lapatinib Continuation/Phase II|Adverse Event|0
75917|NCT00095940|279484|P3|Lapatinib Continuation/Phase II|Adverse Event|0
75918|NCT00095940|279485|P2|Lapatinib Continuation/Phase II|Adverse Event|0
75919|NCT00095940|279486|P1|Lapatinib Continuation/Phase II|Adverse Event|0
75920|NCT00095940|279478|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
75921|NCT00095940|279479|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
75922|NCT00095940|279480|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
75923|NCT00095940|279481|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
75924|NCT00095940|279482|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
75925|NCT00095940|279483|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
75926|NCT00095940|279484|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
75927|NCT00095940|279485|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
75928|NCT00095940|279486|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
75929|NCT00095940|279478|P9|Lapatinib Continuation/Phase II|Disease Progression|12
75930|NCT00095940|279479|P8|Lapatinib Continuation/Phase II|Disease Progression|1
75931|NCT00095940|279480|P7|Lapatinib Continuation/Phase II|Disease Progression|2
75932|NCT00095940|279481|P6|Lapatinib Continuation/Phase II|Disease Progression|13
75933|NCT00095940|279482|P5|Lapatinib Continuation/Phase II|Disease Progression|0
75934|NCT00095940|279483|P4|Lapatinib Continuation/Phase II|Disease Progression|0
75935|NCT00095940|279484|P3|Lapatinib Continuation/Phase II|Disease Progression|15
75936|NCT00095940|279485|P2|Lapatinib Continuation/Phase II|Disease Progression|1
75937|NCT00095940|279486|P1|Lapatinib Continuation/Phase II|Disease Progression|1
75938|NCT00095979|279508|P1|Overall Study|Ineligible: Second primary cancer site|2
75939|NCT00096018|279516|P2|Overall Study|Miscellaneous|1
75940|NCT00096018|279517|P1|Overall Study|Miscellaneous|2
75941|NCT00096018|279516|P2|Overall Study|Withdrawal by Subject|2
75942|NCT00096018|279517|P1|Overall Study|Withdrawal by Subject|0
75943|NCT00096018|279516|P2|Overall Study|Death|1
75944|NCT00096018|279517|P1|Overall Study|Death|0
75945|NCT00096018|279516|P2|Overall Study|Adverse Event|5
75946|NCT00096018|279517|P1|Overall Study|Adverse Event|0
75947|NCT00096018|279516|P2|Overall Study|Miscellaneous (not treated)|2
75948|NCT00096018|279517|P1|Overall Study|Miscellaneous (not treated)|0
75949|NCT00096018|279516|P2|Overall Study|Became Ineligible (not treated)|3
75950|NCT00096018|279517|P1|Overall Study|Became Ineligible (not treated)|0
75951|NCT00096031|279525|P1|Overall Study|Not protocol specified|5
75952|NCT00096031|279525|P1|Overall Study|Ineligible|8
75953|NCT00096031|279525|P1|Overall Study|Withdrawal by Subject|1
75954|NCT00096031|279525|P1|Overall Study|Death|4
75955|NCT00096031|279525|P1|Overall Study|Lack of Efficacy|42
75956|NCT00096031|279525|P1|Overall Study|Adverse Event|3
75957|NCT00096044|279531|P1|Overall Study|Disease Progression|4
75958|NCT00096044|279531|P1|Overall Study|Adverse Event|21
75959|NCT00096044|279531|P1|Overall Study|Withdrawal by Subject|9
75960|NCT00096135|279552|P2|Overall Study|Ineligible|0
75961|NCT00096135|279553|P1|Overall Study|Ineligible|2
75962|NCT00096135|279552|P2|Overall Study|Other, specify|3
75963|NCT00096135|279553|P1|Overall Study|Other, specify|15
75964|NCT00096135|279552|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
75965|NCT00096135|279553|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
75966|NCT00096135|279552|P2|Overall Study|Refusal of further protocol therapy|1
75967|NCT00096135|279553|P1|Overall Study|Refusal of further protocol therapy|4
75968|NCT00096135|279552|P2|Overall Study|Physician Decision|4
75969|NCT00096135|279553|P1|Overall Study|Physician Decision|20
75970|NCT00096174|279596|P1|Overall Study|other reason|8
75971|NCT00096174|279596|P1|Overall Study|Ineligible|6
75972|NCT00096174|279596|P1|Overall Study|Not started protocol therapy|3
75973|NCT00096174|279596|P1|Overall Study|Withdrawal by Subject|15
75974|NCT00096174|279596|P1|Overall Study|Death|6
75975|NCT00096174|279596|P1|Overall Study|Adverse Event|15
75976|NCT00096174|279596|P1|Overall Study|Lack of Efficacy|9
75977|NCT00096200|279605|P3|Overall Study|Ineligible pathology|0
75978|NCT00096200|279606|P2|Overall Study|Ineligible pathology|1
75979|NCT00096200|279607|P1|Overall Study|Ineligible pathology|0
75980|NCT00096200|279605|P3|Overall Study|Withdrawal by Subject|0
75981|NCT00096200|279606|P2|Overall Study|Withdrawal by Subject|2
75982|NCT00096200|279607|P1|Overall Study|Withdrawal by Subject|1
75983|NCT00096200|279605|P3|Overall Study|Adverse Event|0
75984|NCT00096200|279606|P2|Overall Study|Adverse Event|4
75985|NCT00096200|279607|P1|Overall Study|Adverse Event|0
75986|NCT00096226|279615|P1|Overall Study|Surgery but inadequate nodal sampling|1
75987|NCT00096226|279615|P1|Overall Study|Surgical restaging not performed|13
75988|NCT00096226|279615|P1|Overall Study|Protocol treatment not started|1
75989|NCT00096226|279615|P1|Overall Study|Ineligible|2
75990|NCT00096265|279622|P3|Overall Study|Ineligible|0
75991|NCT00096265|279623|P2|Overall Study|Ineligible|0
75992|NCT00096265|279624|P1|Overall Study|Ineligible|1
75993|NCT00096278|279634|P2|Overall Study|Patient not at risk for primary endpoint|2
75994|NCT00096278|279635|P1|Overall Study|Patient not at risk for primary endpoint|3
75995|NCT00096278|279634|P2|Overall Study|No follow-up data|18
75996|NCT00096278|279635|P1|Overall Study|No follow-up data|15
75997|NCT00096356|279643|P2|Overall Study|multiple reasons|18
75998|NCT00096356|279644|P1|Overall Study|multiple reasons|10
75999|NCT00096356|279643|P2|Overall Study|Lack of Efficacy|0
76000|NCT00096356|279644|P1|Overall Study|Lack of Efficacy|1
76001|NCT00096356|279643|P2|Overall Study|Withdrawal by Subject|23
76002|NCT00096356|279644|P1|Overall Study|Withdrawal by Subject|17
76003|NCT00096356|279643|P2|Overall Study|Physician Decision|3
76004|NCT00096356|279644|P1|Overall Study|Physician Decision|5
76005|NCT00096356|279643|P2|Overall Study|Adverse Event|9
76006|NCT00096356|279644|P1|Overall Study|Adverse Event|11
76007|NCT00096382|279656|P2|Overall Study|Death during treatment|0
76008|NCT00096382|279657|P1|Overall Study|Death during treatment|1
76009|NCT00096382|279656|P2|Overall Study|Not treated|0
76010|NCT00096382|279657|P1|Overall Study|Not treated|1
76011|NCT00096447|279665|P1|Overall Study|Never treated|1
76012|NCT00096486|279684|P4|Overall Study|Not Treated|1
76013|NCT00096486|279685|P3|Overall Study|Not Treated|1
76014|NCT00096486|279686|P2|Overall Study|Not Treated|0
76015|NCT00096486|279687|P1|Overall Study|Not Treated|0
76016|NCT00096486|279684|P4|Overall Study|Withdrawal by Subject|1
76017|NCT00096486|279685|P3|Overall Study|Withdrawal by Subject|1
76018|NCT00096486|279686|P2|Overall Study|Withdrawal by Subject|0
76019|NCT00096486|279687|P1|Overall Study|Withdrawal by Subject|0
76020|NCT00096538|279697|P1|Overall Study|Withdrawal by Subject|1
76021|NCT00096785|279708|P2|Overall Study|Relocated|0
76022|NCT00096785|279709|P1|Overall Study|Relocated|1
76023|NCT00096785|279708|P2|Overall Study|Withdrawal by Subject|1
76024|NCT00096785|279709|P1|Overall Study|Withdrawal by Subject|0
76025|NCT00096785|279708|P2|Overall Study|Lost to Follow-up|0
76026|NCT00096785|279709|P1|Overall Study|Lost to Follow-up|1
76027|NCT00096941|279733|P1|Overall Study|disease progression|3
76028|NCT00096954|279740|P2|Overall Study|Lost to Follow-up|5
76029|NCT00096954|279741|P1|Overall Study|Lost to Follow-up|8
76030|NCT00096954|279740|P2|Overall Study|Non-compliance|3
76031|NCT00096954|279741|P1|Overall Study|Non-compliance|0
76032|NCT00096954|279740|P2|Overall Study|Initiation of immunotherapy|0
76033|NCT00096954|279741|P1|Overall Study|Initiation of immunotherapy|1
76034|NCT00096954|279740|P2|Overall Study|Pregnancy|1
76035|NCT00096954|279741|P1|Overall Study|Pregnancy|1
76036|NCT00096954|279740|P2|Overall Study|Sponsors Decision|1
76037|NCT00096954|279741|P1|Overall Study|Sponsors Decision|1
76038|NCT00096954|279740|P2|Overall Study|Physician Decision|1
76039|NCT00096954|279741|P1|Overall Study|Physician Decision|1
76040|NCT00096954|279740|P2|Overall Study|Withdrawal by Subject|8
76041|NCT00096954|279741|P1|Overall Study|Withdrawal by Subject|9
76042|NCT00096954|279740|P2|Overall Study|Adverse Event|1
76043|NCT00096954|279741|P1|Overall Study|Adverse Event|3
76044|NCT00096993|279755|P2|Overall Study|Other unspecified|1
76045|NCT00096993|279756|P1|Overall Study|Other unspecified|1
76046|NCT00096993|279755|P2|Overall Study|Non-compliance|1
76047|NCT00096993|279756|P1|Overall Study|Non-compliance|0
76048|NCT00096993|279755|P2|Overall Study|Physician Decision|1
76049|NCT00096993|279756|P1|Overall Study|Physician Decision|2
76050|NCT00096993|279755|P2|Overall Study|Subject's decision|1
76051|NCT00096993|279756|P1|Overall Study|Subject's decision|3
76052|NCT00096993|279755|P2|Overall Study|Adverse Event|8
76053|NCT00096993|279756|P1|Overall Study|Adverse Event|2
76054|NCT00096993|279755|P2|Overall Study|Disease progression|53
76055|NCT00096993|279756|P1|Overall Study|Disease progression|56
76056|NCT00096993|279755|P2|Overall Study|Death|0
76057|NCT00096993|279756|P1|Overall Study|Death|1
76058|NCT00097370|279785|P1|Stage 3|Lost to Follow-up|1
76059|NCT00097370|279785|P1|Stage 3|Sponsor Terminated Study|52
76060|NCT00097370|279785|P1|Stage 3|Lack of Efficacy|1
76061|NCT00097370|279785|P1|Stage 3|Withdrawal by Subject|3
76062|NCT00097370|279785|P1|Stage 3|Adverse Event|2
76063|NCT00097370|279785|P1|Stage 2|Lost to Follow-up|1
76064|NCT00097370|279785|P1|Stage 2|Sponsor Terminated Study|2
76065|NCT00097370|279785|P1|Stage 2|Pregnancy|1
76066|NCT00097370|279785|P1|Stage 2|Lack of Efficacy|3
76067|NCT00097370|279785|P1|Stage 2|Withdrawal by Subject|1
76068|NCT00097370|279785|P1|Stage 2|Adverse Event|5
76069|NCT00097370|279785|P1|Stage 1|Lack of Efficacy|2
76070|NCT00097370|279785|P1|Stage 1|Withdrawal by Subject|1
76071|NCT00097370|279785|P1|Stage 1|Adverse Event|3
76072|NCT00097500|279813|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
76073|NCT00097500|279814|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
76074|NCT00097500|279813|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
76075|NCT00097500|279814|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
76076|NCT00097500|279813|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
76077|NCT00097500|279814|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
76078|NCT00097500|279813|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
76079|NCT00097500|279814|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
76080|NCT00097500|279813|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
76081|NCT00097500|279814|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
76082|NCT00097500|279813|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
76083|NCT00097500|279814|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
76084|NCT00097500|279813|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
76085|NCT00097500|279814|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
76086|NCT00097539|279843|P7|Overall Study|Reason not Specified|2
76087|NCT00097539|279844|P6|Overall Study|Reason not Specified|40
76088|NCT00097539|279845|P5|Overall Study|Reason not Specified|11
76089|NCT00097539|279846|P4|Overall Study|Reason not Specified|21
76090|NCT00097539|279847|P3|Overall Study|Reason not Specified|53
76091|NCT00097539|279848|P2|Overall Study|Reason not Specified|49
76092|NCT00097539|279849|P1|Overall Study|Reason not Specified|111
76093|NCT00097539|279843|P7|Overall Study|Reasons Other Than Above|34
76094|NCT00097539|279844|P6|Overall Study|Reasons Other Than Above|1244
76095|NCT00097539|279845|P5|Overall Study|Reasons Other Than Above|361
76096|NCT00097539|279846|P4|Overall Study|Reasons Other Than Above|692
76097|NCT00097539|279847|P3|Overall Study|Reasons Other Than Above|1757
76098|NCT00097539|279848|P2|Overall Study|Reasons Other Than Above|1382
76099|NCT00097539|279849|P1|Overall Study|Reasons Other Than Above|3602
76100|NCT00097539|279843|P7|Overall Study|Death|0
76101|NCT00097539|279844|P6|Overall Study|Death|3
76102|NCT00097539|279845|P5|Overall Study|Death|1
76103|NCT00097539|279846|P4|Overall Study|Death|0
76104|NCT00097539|279847|P3|Overall Study|Death|0
76105|NCT00097539|279848|P2|Overall Study|Death|7
76106|NCT00097539|279849|P1|Overall Study|Death|2
76107|NCT00097539|279843|P7|Overall Study|Adverse Event|1
76108|NCT00097539|279844|P6|Overall Study|Adverse Event|59
76109|NCT00097539|279845|P5|Overall Study|Adverse Event|30
76110|NCT00097539|279846|P4|Overall Study|Adverse Event|27
76111|NCT00097539|279847|P3|Overall Study|Adverse Event|37
76112|NCT00097539|279848|P2|Overall Study|Adverse Event|133
76113|NCT00097539|279849|P1|Overall Study|Adverse Event|78
76114|NCT00097539|279843|P7|Overall Study|Lack of Efficacy|5
76115|NCT00097539|279844|P6|Overall Study|Lack of Efficacy|228
76116|NCT00097539|279845|P5|Overall Study|Lack of Efficacy|45
76117|NCT00097539|279846|P4|Overall Study|Lack of Efficacy|105
76118|NCT00097539|279847|P3|Overall Study|Lack of Efficacy|202
76119|NCT00097539|279848|P2|Overall Study|Lack of Efficacy|122
76120|NCT00097539|279849|P1|Overall Study|Lack of Efficacy|249
76121|NCT00097539|279843|P7|Overall Study|Participant Non-compliant|18
76122|NCT00097539|279844|P6|Overall Study|Participant Non-compliant|543
76123|NCT00097539|279845|P5|Overall Study|Participant Non-compliant|136
76124|NCT00097539|279846|P4|Overall Study|Participant Non-compliant|353
76125|NCT00097539|279847|P3|Overall Study|Participant Non-compliant|1067
76126|NCT00097539|279848|P2|Overall Study|Participant Non-compliant|567
76127|NCT00097539|279849|P1|Overall Study|Participant Non-compliant|2140
76128|NCT00097539|279843|P7|Overall Study|Withdrawal by Subject|3
76129|NCT00097539|279844|P6|Overall Study|Withdrawal by Subject|229
76130|NCT00097539|279845|P5|Overall Study|Withdrawal by Subject|68
76131|NCT00097539|279846|P4|Overall Study|Withdrawal by Subject|217
76132|NCT00097539|279847|P3|Overall Study|Withdrawal by Subject|346
76133|NCT00097539|279848|P2|Overall Study|Withdrawal by Subject|323
76134|NCT00097539|279849|P1|Overall Study|Withdrawal by Subject|925
76135|NCT00097539|279843|P7|Overall Study|Status Unknown (Or no final evaluation)|108
76136|NCT00097539|279844|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
76137|NCT00097539|279845|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
76138|NCT00097539|279846|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
76139|NCT00097539|279847|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
76140|NCT00097539|279848|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
76141|NCT00097539|279849|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
76142|NCT00097591|279895|P2|Overall Study|Other|3
76143|NCT00097591|279896|P1|Overall Study|Other|0
76144|NCT00097591|279895|P2|Overall Study|Lost to follow up|10
76145|NCT00097591|279896|P1|Overall Study|Lost to follow up|6
76146|NCT00097591|279895|P2|Overall Study|Unable to attend termination visit|51
76147|NCT00097591|279896|P1|Overall Study|Unable to attend termination visit|53
76148|NCT00097591|279895|P2|Overall Study|Less than 6 months on study drug|7
76149|NCT00097591|279896|P1|Overall Study|Less than 6 months on study drug|9
76150|NCT00097591|279895|P2|Overall Study|Withdrawal of consent|323
76151|NCT00097591|279896|P1|Overall Study|Withdrawal of consent|342
76152|NCT00097721|279948|P2|Overall Study|Reason not given|1
76153|NCT00097721|279949|P1|Overall Study|Reason not given|1
76154|NCT00097721|279948|P2|Overall Study|Physician Decision|3
76155|NCT00097721|279949|P1|Overall Study|Physician Decision|1
76156|NCT00097721|279948|P2|Overall Study|Progressive Disease|27
76157|NCT00097721|279949|P1|Overall Study|Progressive Disease|55
76158|NCT00097721|279948|P2|Overall Study|Withdrawal by Subject|1
76159|NCT00097721|279949|P1|Overall Study|Withdrawal by Subject|6
76160|NCT00097721|279948|P2|Overall Study|Adverse Event|1
76161|NCT00097721|279949|P1|Overall Study|Adverse Event|8
76162|NCT00088374|279963|P1|Overall Study|patient received <1 cycle only of 17AAG|1
76163|NCT00088374|279963|P1|Overall Study|patient did not receive any 17AAG|1
76164|NCT00088465|279972|P1|Overall Study|Death|11
76165|NCT00088465|279972|P1|Overall Study|Protocol Violation|17
76166|NCT00088465|279972|P1|Overall Study|Lack of Efficacy|27
76167|NCT00088465|279972|P1|Overall Study|Sponsor Decision|37
76168|NCT00088465|279972|P1|Overall Study|Physician Decision|45
76169|NCT00088465|279972|P1|Overall Study|Lost to Follow-up|57
76170|NCT00088465|279972|P1|Overall Study|Adverse Event|77
76171|NCT00088465|279972|P1|Overall Study|Withdrawal by Subject|290
76172|NCT00088530|279997|P2|Overall Study|Patient never treated|0
76173|NCT00088530|279998|P1|Overall Study|Patient never treated|1
76174|NCT00088530|279997|P2|Overall Study|Sponsor decision|1
76175|NCT00088530|279998|P1|Overall Study|Sponsor decision|0
76176|NCT00088530|279997|P2|Overall Study|Physician Decision|0
76177|NCT00088530|279998|P1|Overall Study|Physician Decision|2
76178|NCT00088530|279997|P2|Overall Study|Lost to Follow-up|0
76179|NCT00088530|279998|P1|Overall Study|Lost to Follow-up|2
76180|NCT00088530|279997|P2|Overall Study|Withdrawal by Subject|5
76181|NCT00088530|279998|P1|Overall Study|Withdrawal by Subject|2
76182|NCT00088530|279997|P2|Overall Study|Adverse Event|9
76183|NCT00088530|279998|P1|Overall Study|Adverse Event|15
76184|NCT00088530|279997|P2|Overall Study|Progressive/Relapsed Disease|39
76185|NCT00088530|279998|P1|Overall Study|Progressive/Relapsed Disease|28
76186|NCT00088595|280010|P1|Overall Study|New Cancer Therapy|2
76187|NCT00088595|280010|P1|Overall Study|Ongoing (After Core)|7
76188|NCT00088595|280010|P1|Overall Study|Withdrawal by Subject|8
76189|NCT00088595|280010|P1|Overall Study|Adverse Event|11
76190|NCT00088881|280045|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
76191|NCT00088881|280045|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
76192|NCT00088881|280045|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
76193|NCT00088881|280045|P1|Step 1 - R-CHOP|Physician Decision|1
76194|NCT00088881|280045|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
76195|NCT00088881|280045|P1|Step 1 - R-CHOP|Adverse Event|1
76196|NCT00088881|280045|P1|Step 1 - R-CHOP|Patient ineligible|9
76197|NCT00088907|280056|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
76198|NCT00088907|280057|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
76199|NCT00088907|280056|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
76200|NCT00088907|280057|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
76201|NCT00088907|280056|P2|Single Gefitinib Treatment (Step 2)|Death|0
76202|NCT00088907|280057|P1|Single Gefitinib Treatment (Step 2)|Death|1
76203|NCT00088907|280056|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
76204|NCT00088907|280057|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
76205|NCT00088907|280056|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
76206|NCT00088907|280057|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
76207|NCT00088907|280056|P2|Randomized Study (Step 1)|unknown/not specify|13
76208|NCT00088907|280057|P1|Randomized Study (Step 1)|unknown/not specify|24
76209|NCT00088907|280056|P2|Randomized Study (Step 1)|complicating disease|1
76210|NCT00088907|280057|P1|Randomized Study (Step 1)|complicating disease|3
76211|NCT00088907|280056|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
76212|NCT00088907|280057|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
76213|NCT00088907|280056|P2|Randomized Study (Step 1)|Death|12
76214|NCT00088907|280057|P1|Randomized Study (Step 1)|Death|11
76215|NCT00088907|280056|P2|Randomized Study (Step 1)|Adverse Event|19
76216|NCT00088907|280057|P1|Randomized Study (Step 1)|Adverse Event|14
76217|NCT00088907|280056|P2|Randomized Study (Step 1)|Lack of Efficacy|62
76218|NCT00088907|280057|P1|Randomized Study (Step 1)|Lack of Efficacy|55
76219|NCT00089076|280105|P1|Overall Study|Progression|7
76220|NCT00089076|280105|P1|Overall Study|Withdrawal by Subject|2
76221|NCT00089076|280105|P1|Overall Study|Alternate Therapy|1
76222|NCT00089141|280118|P2|Overall Study|Termination of trial|24
76223|NCT00089141|280119|P1|Overall Study|Termination of trial|18
76224|NCT00089297|280141|P1|Overall Study|Non-compliance|1
76225|NCT00089297|280141|P1|Overall Study|IRB approval not ready|1
76226|NCT00089297|280141|P1|Overall Study|Secondary malignancy|1
76227|NCT00089297|280141|P1|Overall Study|Ineligible|11
76228|NCT00089297|280141|P1|Overall Study|Disease progression|2
76229|NCT00089297|280141|P1|Overall Study|Withdrawal by Subject|12
76230|NCT00089297|280141|P1|Overall Study|Death|1
76231|NCT00089297|280141|P1|Overall Study|Adverse Event|9
76232|NCT00089479|280169|P2|Overall Study|Lost to Follow-up|107
76233|NCT00089479|280170|P1|Overall Study|Lost to Follow-up|137
76234|NCT00089479|280169|P2|Overall Study|Withdrawal by Subject|107
76235|NCT00089479|280170|P1|Overall Study|Withdrawal by Subject|86
76236|NCT00089479|280169|P2|Overall Study|Death|75
76237|NCT00089479|280170|P1|Overall Study|Death|108
76238|NCT00089505|280198|P4|Overall Study|Protocol Violation|0
76239|NCT00089505|280199|P3|Overall Study|Protocol Violation|1
76240|NCT00089505|280200|P2|Overall Study|Protocol Violation|0
76241|NCT00089505|280201|P1|Overall Study|Protocol Violation|0
76242|NCT00089505|280198|P4|Overall Study|Physician Decision|0
76243|NCT00089505|280199|P3|Overall Study|Physician Decision|0
76244|NCT00089505|280200|P2|Overall Study|Physician Decision|0
76245|NCT00089505|280201|P1|Overall Study|Physician Decision|1
76246|NCT00089505|280198|P4|Overall Study|Lost to Follow-up|7
76247|NCT00089505|280199|P3|Overall Study|Lost to Follow-up|9
76248|NCT00089505|280200|P2|Overall Study|Lost to Follow-up|1
76249|NCT00089505|280201|P1|Overall Study|Lost to Follow-up|1
76250|NCT00089505|280198|P4|Overall Study|Withdrawal by Subject|6
76251|NCT00089505|280199|P3|Overall Study|Withdrawal by Subject|6
76252|NCT00089505|280200|P2|Overall Study|Withdrawal by Subject|0
76253|NCT00089505|280201|P1|Overall Study|Withdrawal by Subject|3
76254|NCT00089505|280198|P4|Overall Study|Death|8
76255|NCT00089505|280199|P3|Overall Study|Death|5
76256|NCT00089505|280200|P2|Overall Study|Death|1
76257|NCT00089505|280201|P1|Overall Study|Death|4
76258|NCT00089544|280245|P2|Overall Study|Ineligible|0
76259|NCT00089544|280246|P1|Overall Study|Ineligible|1
76260|NCT00089583|280258|P2|Overall Study|Participant Incarcerated|1
76261|NCT00089583|280259|P1|Overall Study|Participant Incarcerated|0
76262|NCT00089583|280258|P2|Overall Study|Necessity to Use Prohibited Drug|0
76263|NCT00089583|280259|P1|Overall Study|Necessity to Use Prohibited Drug|1
76264|NCT00089583|280258|P2|Overall Study|Start of Disallowed Medication|1
76265|NCT00089583|280259|P1|Overall Study|Start of Disallowed Medication|0
76266|NCT00089583|280258|P2|Overall Study|Principal Investigator Decision|10
76267|NCT00089583|280259|P1|Overall Study|Principal Investigator Decision|0
76268|NCT00089583|280258|P2|Overall Study|Protocol Violation|3
76269|NCT00089583|280259|P1|Overall Study|Protocol Violation|0
76270|NCT00089583|280258|P2|Overall Study|Reason Not Provided|1
76271|NCT00089583|280259|P1|Overall Study|Reason Not Provided|0
76272|NCT00089583|280258|P2|Overall Study|Participant Management Criteria Met|1
76273|NCT00089583|280259|P1|Overall Study|Participant Management Criteria Met|0
76274|NCT00089583|280258|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
76275|NCT00089583|280259|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
76276|NCT00089583|280258|P2|Overall Study|Non-Compliance|4
76277|NCT00089583|280259|P1|Overall Study|Non-Compliance|0
76278|NCT00089583|280258|P2|Overall Study|Participant Refused Study Medication|2
76279|NCT00089583|280259|P1|Overall Study|Participant Refused Study Medication|0
76280|NCT00089583|280258|P2|Overall Study|Participant (Par) Didn't Take Medication|0
76281|NCT00089583|280259|P1|Overall Study|Participant (Par) Didn't Take Medication|1
76282|NCT00089583|280258|P2|Overall Study|Withdrawal by Subject|4
76283|NCT00089583|280259|P1|Overall Study|Withdrawal by Subject|0
76284|NCT00089583|280258|P2|Overall Study|Insufficient Viral Load Response|5
76285|NCT00089583|280259|P1|Overall Study|Insufficient Viral Load Response|5
76286|NCT00089583|280258|P2|Overall Study|Adverse Event|3
76287|NCT00089583|280259|P1|Overall Study|Adverse Event|0
76288|NCT00089609|280353|P2|Overall Study|Withdrawal by Subject|1
76289|NCT00089609|280354|P1|Overall Study|Withdrawal by Subject|3
76290|NCT00089635|280371|P1|Overall Study|Not specified|2
76291|NCT00089635|280371|P1|Overall Study|Ineligibility determined|1
76292|NCT00089635|280371|P1|Overall Study|Withdrawal by Subject|6
76293|NCT00089635|280371|P1|Overall Study|Lost to Follow-up|3
76294|NCT00089635|280371|P1|Overall Study|Disease Progression|12
76295|NCT00089635|280371|P1|Overall Study|Death|17
76296|NCT00089635|280371|P1|Overall Study|Adverse Event|2
76297|NCT00089648|280383|P1|Overall Study|Lack of Efficacy|33
76298|NCT00089648|280383|P1|Overall Study|Withdrawal by Subject|1
76299|NCT00089648|280383|P1|Overall Study|Adverse Event|7
76300|NCT00089661|280401|P2|Overall Study|Other|1
76301|NCT00089661|280402|P1|Overall Study|Other|2
76302|NCT00089661|280401|P2|Overall Study|Noncompliance|4
76303|NCT00089661|280402|P1|Overall Study|Noncompliance|2
76304|NCT00089661|280401|P2|Overall Study|Ineligibility determined|4
76305|NCT00089661|280402|P1|Overall Study|Ineligibility determined|4
76306|NCT00089661|280401|P2|Overall Study|Disease progression|3
76307|NCT00089661|280402|P1|Overall Study|Disease progression|1
76308|NCT00089661|280401|P2|Overall Study|Withdrawal by Subject|9
76309|NCT00089661|280402|P1|Overall Study|Withdrawal by Subject|11
76310|NCT00089661|280401|P2|Overall Study|Lost to Follow-up|3
76311|NCT00089661|280402|P1|Overall Study|Lost to Follow-up|0
76312|NCT00089661|280401|P2|Overall Study|Death|0
76313|NCT00089661|280402|P1|Overall Study|Death|1
76314|NCT00089661|280401|P2|Overall Study|Adverse Event|2
76315|NCT00089661|280402|P1|Overall Study|Adverse Event|0
76316|NCT00089674|280420|P2|Overall Study|Requirement for alternative therapy|4
76317|NCT00089674|280421|P1|Overall Study|Requirement for alternative therapy|14
76318|NCT00089674|280420|P2|Overall Study|Other|9
76319|NCT00089674|280421|P1|Overall Study|Other|5
76320|NCT00089674|280420|P2|Overall Study|Noncompliance|3
76321|NCT00089674|280421|P1|Overall Study|Noncompliance|7
76322|NCT00089674|280420|P2|Overall Study|Lost to Follow-up|17
76323|NCT00089674|280421|P1|Overall Study|Lost to Follow-up|21
76324|NCT00089674|280420|P2|Overall Study|Ineligibility determined|10
76325|NCT00089674|280421|P1|Overall Study|Ineligibility determined|8
76326|NCT00089674|280420|P2|Overall Study|Disease progression|23
76327|NCT00089674|280421|P1|Overall Study|Disease progression|21
76328|NCT00089674|280420|P2|Overall Study|Death|43
76329|NCT00089674|280421|P1|Overall Study|Death|43
76330|NCT00089674|280420|P2|Overall Study|Withdrawal by Subject|127
76331|NCT00089674|280421|P1|Overall Study|Withdrawal by Subject|143
76332|NCT00089674|280420|P2|Overall Study|Adverse Event|29
76333|NCT00089674|280421|P1|Overall Study|Adverse Event|23
76334|NCT00089674|280420|P2|Overall Study|Physician Decision|2
76335|NCT00089674|280421|P1|Overall Study|Physician Decision|4
76336|NCT00089778|280469|P3|Overall Study|Protocol Violation|1
76337|NCT00089778|280470|P2|Overall Study|Protocol Violation|0
76338|NCT00089778|280471|P1|Overall Study|Protocol Violation|0
76339|NCT00089791|280484|P2|Overall Study|Requirement for alternative therapy|4
76340|NCT00089791|280485|P1|Overall Study|Requirement for alternative therapy|7
76341|NCT00089791|280484|P2|Overall Study|Protocol deviation|10
76342|NCT00089791|280485|P1|Overall Study|Protocol deviation|12
76343|NCT00089791|280484|P2|Overall Study|Other|32
76344|NCT00089791|280485|P1|Overall Study|Other|20
76345|NCT00089791|280484|P2|Overall Study|Noncompliance|13
76346|NCT00089791|280485|P1|Overall Study|Noncompliance|17
76347|NCT00089791|280484|P2|Overall Study|Lost to Follow-up|57
76348|NCT00089791|280485|P1|Overall Study|Lost to Follow-up|57
76349|NCT00089791|280484|P2|Overall Study|Ineligibility determined|9
76350|NCT00089791|280485|P1|Overall Study|Ineligibility determined|12
76351|NCT00089791|280484|P2|Overall Study|Disease progression|3
76352|NCT00089791|280485|P1|Overall Study|Disease progression|7
76353|NCT00089791|280484|P2|Overall Study|Death|62
76354|NCT00089791|280485|P1|Overall Study|Death|78
76355|NCT00089791|280484|P2|Overall Study|Withdrawal by Subject|344
76356|NCT00089791|280485|P1|Overall Study|Withdrawal by Subject|403
76357|NCT00089791|280484|P2|Overall Study|Adverse Event|93
76358|NCT00089791|280485|P1|Overall Study|Adverse Event|81
76359|NCT00089791|280484|P2|Overall Study|Physician Decision|3
76360|NCT00089791|280485|P1|Overall Study|Physician Decision|6
76361|NCT00089843|280499|P4|Overall Study|Physician Decision|1
76362|NCT00089843|280500|P3|Overall Study|Physician Decision|0
76363|NCT00089843|280501|P2|Overall Study|Physician Decision|0
76364|NCT00089843|280502|P1|Overall Study|Physician Decision|1
76365|NCT00089843|280499|P4|Overall Study|Withdrawal by Subject|6
76366|NCT00089843|280500|P3|Overall Study|Withdrawal by Subject|5
76367|NCT00089843|280501|P2|Overall Study|Withdrawal by Subject|4
76368|NCT00089843|280502|P1|Overall Study|Withdrawal by Subject|1
76369|NCT00089895|280514|P2|Overall Study|Missing|2
76370|NCT00089895|280515|P1|Overall Study|Missing|4
76371|NCT00089895|280514|P2|Overall Study|Not otherwise specified|8
76372|NCT00089895|280515|P1|Overall Study|Not otherwise specified|4
76373|NCT00089895|280514|P2|Overall Study|Exclusion criteria met|6
76374|NCT00089895|280515|P1|Overall Study|Exclusion criteria met|6
76375|NCT00089895|280514|P2|Overall Study|Physician Decision|7
76376|NCT00089895|280515|P1|Overall Study|Physician Decision|3
76377|NCT00089895|280514|P2|Overall Study|Bleeding|2
76378|NCT00089895|280515|P1|Overall Study|Bleeding|0
76379|NCT00089895|280514|P2|Overall Study|Surgery|1
76380|NCT00089895|280515|P1|Overall Study|Surgery|0
76381|NCT00089895|280514|P2|Overall Study|Technical reason|2
76382|NCT00089895|280515|P1|Overall Study|Technical reason|7
76383|NCT00089895|280514|P2|Overall Study|Consent Withdrawn|14
76384|NCT00089895|280515|P1|Overall Study|Consent Withdrawn|11
76385|NCT00089986|280526|P3|Overall Study|Withdrawal by Subject|2
76386|NCT00089986|280527|P2|Overall Study|Withdrawal by Subject|6
76387|NCT00089986|280528|P1|Overall Study|Withdrawal by Subject|3
76388|NCT00089986|280526|P3|Overall Study|Do not resuscitate (DNR)|1
76389|NCT00089986|280527|P2|Overall Study|Do not resuscitate (DNR)|0
76390|NCT00089986|280528|P1|Overall Study|Do not resuscitate (DNR)|0
76391|NCT00089986|280526|P3|Overall Study|Family decision|0
76392|NCT00089986|280527|P2|Overall Study|Family decision|1
76393|NCT00089986|280528|P1|Overall Study|Family decision|0
76394|NCT00089986|280526|P3|Overall Study|Enrollment in another study|0
76395|NCT00089986|280527|P2|Overall Study|Enrollment in another study|1
76396|NCT00089986|280528|P1|Overall Study|Enrollment in another study|0
76397|NCT00089986|280526|P3|Overall Study|Investigator decision to withdrew|0
76398|NCT00089986|280527|P2|Overall Study|Investigator decision to withdrew|1
76399|NCT00089986|280528|P1|Overall Study|Investigator decision to withdrew|0
76400|NCT00089986|280526|P3|Overall Study|Hemohlobin stopping rule|0
76401|NCT00089986|280527|P2|Overall Study|Hemohlobin stopping rule|1
76402|NCT00089986|280528|P1|Overall Study|Hemohlobin stopping rule|0
76403|NCT00089986|280526|P3|Overall Study|Subject withdrew but agreed follow up|0
76404|NCT00089986|280527|P2|Overall Study|Subject withdrew but agreed follow up|2
76405|NCT00089986|280528|P1|Overall Study|Subject withdrew but agreed follow up|1
76406|NCT00089986|280526|P3|Overall Study|Patient transferred to another hospital|0
76407|NCT00089986|280527|P2|Overall Study|Patient transferred to another hospital|1
76408|NCT00089986|280528|P1|Overall Study|Patient transferred to another hospital|2
76409|NCT00089986|280526|P3|Overall Study|Protocol Violation|0
76410|NCT00089986|280527|P2|Overall Study|Protocol Violation|1
76411|NCT00089986|280528|P1|Overall Study|Protocol Violation|0
76412|NCT00089986|280526|P3|Overall Study|Lost to Follow-up|1
76413|NCT00089986|280527|P2|Overall Study|Lost to Follow-up|1
76414|NCT00089986|280528|P1|Overall Study|Lost to Follow-up|3
76415|NCT00089986|280526|P3|Overall Study|Adverse Event|6
76416|NCT00089986|280527|P2|Overall Study|Adverse Event|9
76417|NCT00089986|280528|P1|Overall Study|Adverse Event|6
76418|NCT00089999|280547|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
76419|NCT00089999|280548|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
76420|NCT00089999|280547|P2|Overall Study|Patient Underwent Surgery|0
76421|NCT00089999|280548|P1|Overall Study|Patient Underwent Surgery|2
76422|NCT00089999|280547|P2|Overall Study|Physician Decision|2
76423|NCT00089999|280548|P1|Overall Study|Physician Decision|2
76424|NCT00089999|280547|P2|Overall Study|Clinical Progression|2
76425|NCT00089999|280548|P1|Overall Study|Clinical Progression|1
76426|NCT00089999|280547|P2|Overall Study|Poor General Condition|0
76427|NCT00089999|280548|P1|Overall Study|Poor General Condition|1
76428|NCT00089999|280547|P2|Overall Study|Death|3
76429|NCT00089999|280548|P1|Overall Study|Death|3
76430|NCT00089999|280547|P2|Overall Study|Symptomatic Progression of Cancer|5
76431|NCT00089999|280548|P1|Overall Study|Symptomatic Progression of Cancer|2
76432|NCT00089999|280547|P2|Overall Study|Radiological Progression of Cancer|44
76433|NCT00089999|280548|P1|Overall Study|Radiological Progression of Cancer|52
76434|NCT00089999|280547|P2|Overall Study|Lost to Follow-up|1
76435|NCT00089999|280548|P1|Overall Study|Lost to Follow-up|2
76436|NCT00089999|280547|P2|Overall Study|Withdrawal by Subject|4
76437|NCT00089999|280548|P1|Overall Study|Withdrawal by Subject|0
76438|NCT00089999|280547|P2|Overall Study|Adverse Event|7
76439|NCT00089999|280548|P1|Overall Study|Adverse Event|4
76440|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Other|0
76441|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Other|1
76442|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Other|0
76443|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Jailed|0
76444|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Jailed|1
76445|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Jailed|0
76446|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
76447|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
76448|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
76449|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Depression|0
76450|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Depression|1
76451|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Depression|0
76452|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
76453|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
76454|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
76455|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
76456|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
76457|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
76458|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Back Pain|0
76459|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Back Pain|1
76460|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Back Pain|0
76461|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
76462|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
76463|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
76464|NCT00090103|280608|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
76465|NCT00090103|280609|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
76466|NCT00090103|280610|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
76467|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
76468|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
76469|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
76470|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Gyneomastia|0
76471|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Gyneomastia|0
76472|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Gyneomastia|1
76473|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Death|1
76474|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Death|0
76475|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Death|1
76476|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
76477|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
76478|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
76479|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Enrollment Error|2
76480|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Enrollment Error|0
76481|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Enrollment Error|1
76482|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Loss of Libido|0
76483|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Loss of Libido|0
76484|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Loss of Libido|1
76485|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
76486|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
76487|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
76488|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
76489|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
76490|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
76491|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
76492|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
76493|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
76494|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
76495|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
76496|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
76497|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Participant relocated|1
76498|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Participant relocated|3
76499|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Participant relocated|2
76500|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
76501|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
76502|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
76503|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Loss of Contact|2
76504|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Loss of Contact|0
76505|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Loss of Contact|4
76506|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
76507|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
76508|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
76509|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
76510|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
76511|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
76512|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Protocol Violation|17
76513|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Protocol Violation|18
76514|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Protocol Violation|18
76515|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
76516|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
76517|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
76518|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
76519|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
76520|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
76521|NCT00090103|280608|P3|16-Week Safety Follow-up Period|Adverse Event|44
76522|NCT00090103|280609|P2|16-Week Safety Follow-up Period|Adverse Event|39
76523|NCT00090103|280610|P1|16-Week Safety Follow-up Period|Adverse Event|34
76524|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
76525|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
76526|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
76527|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
76528|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
76529|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
76530|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
76531|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
76532|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
76533|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
76534|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
76535|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
76536|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
76537|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
76538|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
76539|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
76540|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
76541|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
76542|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
76543|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
76544|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
76545|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
76546|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
76547|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
76548|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
76549|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
76550|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
76551|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
76552|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
76553|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
76554|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
76555|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
76556|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
76557|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
76558|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
76559|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
76560|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
76561|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
76562|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
76563|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
76564|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
76565|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
76566|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
76567|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
76568|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
76569|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
76570|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
76571|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
76572|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
76573|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
76574|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
76575|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
76576|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
76577|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
76578|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
76579|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
76580|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
76581|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
76582|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
76583|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
76584|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
76585|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
76586|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
76587|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
76588|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
76589|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
76590|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
76591|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
76592|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
76593|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
76594|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
76595|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
76596|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
76597|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
76598|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
76599|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
76600|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
76601|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
76602|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
76603|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
76604|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
76605|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
76606|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
76607|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
76608|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
76609|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
76610|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
76611|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
76612|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
76613|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
76614|NCT00090103|280608|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
76615|NCT00090103|280609|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
76616|NCT00090103|280610|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
76617|NCT00090142|280708|P2|Treatment Period II|Not Specified|0
76618|NCT00090142|280709|P1|Treatment Period II|Not Specified|1
76619|NCT00090142|280708|P2|Treatment Period I|Not Specified|1
76620|NCT00090142|280709|P1|Treatment Period I|Not Specified|0
76621|NCT00090142|280708|P2|Treatment Period I|Withdrawal by Subject|0
76622|NCT00090142|280709|P1|Treatment Period I|Withdrawal by Subject|2
76623|NCT00090142|280708|P2|Treatment Period I|Protocol Violation|0
76624|NCT00090142|280709|P1|Treatment Period I|Protocol Violation|2
76625|NCT00090142|280708|P2|Treatment Period I|Lost to Follow-up|2
76626|NCT00090142|280709|P1|Treatment Period I|Lost to Follow-up|1
76627|NCT00097773|280741|P4|Overall Study|Other|0
76628|NCT00097773|280742|P3|Overall Study|Other|2
76629|NCT00097773|280743|P2|Overall Study|Other|0
76630|NCT00097773|280744|P1|Overall Study|Other|1
76631|NCT00097773|280741|P4|Overall Study|Adverse Event|0
76632|NCT00097773|280742|P3|Overall Study|Adverse Event|0
76633|NCT00097773|280743|P2|Overall Study|Adverse Event|1
76634|NCT00097773|280744|P1|Overall Study|Adverse Event|0
76635|NCT00097773|280741|P4|Overall Study|Withdrawal by Subject|1
76636|NCT00097773|280742|P3|Overall Study|Withdrawal by Subject|3
76637|NCT00097773|280743|P2|Overall Study|Withdrawal by Subject|3
76638|NCT00097773|280744|P1|Overall Study|Withdrawal by Subject|3
76639|NCT00097773|280741|P4|Overall Study|Physician Decision|1
76640|NCT00097773|280742|P3|Overall Study|Physician Decision|3
76641|NCT00097773|280743|P2|Overall Study|Physician Decision|2
76642|NCT00097773|280744|P1|Overall Study|Physician Decision|2
76643|NCT00097773|280741|P4|Overall Study|Lost to Follow-up|1
76644|NCT00097773|280742|P3|Overall Study|Lost to Follow-up|0
76645|NCT00097773|280743|P2|Overall Study|Lost to Follow-up|2
76646|NCT00097773|280744|P1|Overall Study|Lost to Follow-up|2
76647|NCT00097786|280766|P4|Overall Study|lost to follow-up for all-cause death|310
76648|NCT00097786|280767|P3|Overall Study|lost to follow-up for all-cause death|313
76649|NCT00097786|280768|P2|Overall Study|lost to follow-up for all-cause death|292
76650|NCT00097786|280769|P1|Overall Study|lost to follow-up for all-cause death|296
76651|NCT00097981|280789|P2|Overall Study|Other|13
76652|NCT00097981|280790|P1|Overall Study|Other|19
76653|NCT00097981|280789|P2|Overall Study|Transplant planned|27
76654|NCT00097981|280790|P1|Overall Study|Transplant planned|28
76655|NCT00097981|280789|P2|Overall Study|Disease Progression|2
76656|NCT00097981|280790|P1|Overall Study|Disease Progression|8
76657|NCT00097981|280789|P2|Overall Study|Physician Decision|1
76658|NCT00097981|280790|P1|Overall Study|Physician Decision|7
76659|NCT00097981|280789|P2|Overall Study|Death|4
76660|NCT00097981|280790|P1|Overall Study|Death|2
76661|NCT00097981|280789|P2|Overall Study|Protocol Violation|1
76662|NCT00097981|280790|P1|Overall Study|Protocol Violation|1
76663|NCT00097981|280789|P2|Overall Study|Withdrawal by Subject|8
76664|NCT00097981|280790|P1|Overall Study|Withdrawal by Subject|10
76665|NCT00097981|280789|P2|Overall Study|Adverse Event|44
76666|NCT00097981|280790|P1|Overall Study|Adverse Event|31
76667|NCT00100789|280907|P1|Overall Study|Never received treatment|1
76668|NCT00100789|280907|P1|Overall Study|Ineligible|3
76669|NCT00100789|280907|P1|Overall Study|Not protocol specified|5
76670|NCT00100789|280907|P1|Overall Study|Death|2
76671|NCT00100789|280907|P1|Overall Study|Progression/relapse|42
76672|NCT00100789|280907|P1|Overall Study|Withdrawal by Subject|1
76673|NCT00100789|280907|P1|Overall Study|Adverse Event|10
76674|NCT00100802|280914|P1|Overall Study|Ineligible|12
76675|NCT00100802|280914|P1|Overall Study|Withdrawal by Subject|5
76676|NCT00100802|280914|P1|Overall Study|Protocol Violation|1
76677|NCT00100802|280914|P1|Overall Study|Physician Decision|5
76678|NCT00100802|280914|P1|Overall Study|Lack of Efficacy|47
76679|NCT00100802|280914|P1|Overall Study|Death|1
76680|NCT00100802|280914|P1|Overall Study|Adverse Event|9
76681|NCT00100815|280919|P1|Overall Study|not specified|3
76682|NCT00100815|280919|P1|Overall Study|Death|4
76683|NCT00100815|280919|P1|Overall Study|Adverse Event|18
76684|NCT00100815|280919|P1|Overall Study|Progression|24
76685|NCT00100932|280934|P2|Overall Study|Not specified|2
76686|NCT00100932|280935|P1|Overall Study|Not specified|5
76687|NCT00100932|280934|P2|Overall Study|Physician Decision|5
76688|NCT00100932|280935|P1|Overall Study|Physician Decision|7
76689|NCT00100932|280934|P2|Overall Study|Progressive Disease|18
76690|NCT00100932|280935|P1|Overall Study|Progressive Disease|44
76691|NCT00100932|280934|P2|Overall Study|Withdrawal by Subject|0
76692|NCT00100932|280935|P1|Overall Study|Withdrawal by Subject|6
76693|NCT00100932|280934|P2|Overall Study|Adverse Event|2
76694|NCT00100932|280935|P1|Overall Study|Adverse Event|11
76695|NCT00101101|280958|P1|Overall Study|never received vaccine|20
76696|NCT00101166|280964|P1|Overall Study|progressive disease|10
76697|NCT00101192|280972|P1|Overall Study|Inevaluable|1
76698|NCT00101192|280972|P1|Overall Study|Ineligible|6
76699|NCT00101283|280978|P2|Overall Study|Prostate Cancer Recurrence|1
76700|NCT00101283|280979|P1|Overall Study|Prostate Cancer Recurrence|0
76701|NCT00101283|280978|P2|Overall Study|Insurance Refusal|1
76702|NCT00101283|280979|P1|Overall Study|Insurance Refusal|0
76703|NCT00101283|280978|P2|Overall Study|Withdrawal by Subject|1
76704|NCT00101283|280979|P1|Overall Study|Withdrawal by Subject|0
76705|NCT00101400|280998|P1|Survival Follow-Up|Alive|7
76706|NCT00101439|281017|P2|Period 2|Withdrawal by Subject|2
76707|NCT00101439|281018|P1|Period 2|Withdrawal by Subject|0
76708|NCT00101452|281029|P3|Overall Study|Other|12
76709|NCT00101452|281030|P2|Overall Study|Other|16
76710|NCT00101452|281031|P1|Overall Study|Other|15
76711|NCT00101452|281029|P3|Overall Study|Protocol Violation|3
76712|NCT00101452|281030|P2|Overall Study|Protocol Violation|1
76713|NCT00101452|281031|P1|Overall Study|Protocol Violation|2
76714|NCT00101452|281029|P3|Overall Study|Physician Decision|2
76715|NCT00101452|281030|P2|Overall Study|Physician Decision|3
76716|NCT00101452|281031|P1|Overall Study|Physician Decision|0
76717|NCT00101452|281029|P3|Overall Study|Baseline Fail|2
76718|NCT00101452|281030|P2|Overall Study|Baseline Fail|1
76719|NCT00101452|281031|P1|Overall Study|Baseline Fail|2
76720|NCT00101452|281029|P3|Overall Study|Withdrawal by Subject|9
76721|NCT00101452|281030|P2|Overall Study|Withdrawal by Subject|14
76722|NCT00101452|281031|P1|Overall Study|Withdrawal by Subject|10
76723|NCT00101452|281029|P3|Overall Study|Lost to Follow-up|14
76724|NCT00101452|281030|P2|Overall Study|Lost to Follow-up|8
76725|NCT00101452|281031|P1|Overall Study|Lost to Follow-up|13
76726|NCT00101452|281029|P3|Overall Study|Adverse Event|1
76727|NCT00101452|281030|P2|Overall Study|Adverse Event|0
76728|NCT00101452|281031|P1|Overall Study|Adverse Event|2
76729|NCT00101582|281045|P2|Overall Study|Other|1
76730|NCT00101582|281046|P1|Overall Study|Other|0
76731|NCT00101582|281045|P2|Overall Study|Death|5
76732|NCT00101582|281046|P1|Overall Study|Death|3
76733|NCT00101582|281045|P2|Overall Study|Physician Decision|0
76734|NCT00101582|281046|P1|Overall Study|Physician Decision|1
76735|NCT00101582|281045|P2|Overall Study|Withdrawal by Subject|4
76736|NCT00101582|281046|P1|Overall Study|Withdrawal by Subject|6
76737|NCT00101582|281045|P2|Overall Study|Adverse Event|4
76738|NCT00101582|281046|P1|Overall Study|Adverse Event|1
76739|NCT00101582|281045|P2|Overall Study|Ineligibility determined|1
76740|NCT00101582|281046|P1|Overall Study|Ineligibility determined|0
76741|NCT00101686|281146|P10|Overall Study|Withdrawal by Subject|9
76742|NCT00101686|281147|P9|Overall Study|Withdrawal by Subject|8
76743|NCT00101686|281148|P8|Overall Study|Withdrawal by Subject|7
76744|NCT00101686|281149|P7|Overall Study|Withdrawal by Subject|7
76745|NCT00101686|281150|P6|Overall Study|Withdrawal by Subject|7
76746|NCT00101686|281151|P5|Overall Study|Withdrawal by Subject|8
76747|NCT00101686|281152|P4|Overall Study|Withdrawal by Subject|8
76748|NCT00101686|281153|P3|Overall Study|Withdrawal by Subject|6
76749|NCT00101686|281154|P2|Overall Study|Withdrawal by Subject|8
76750|NCT00101686|281155|P1|Overall Study|Withdrawal by Subject|9
76751|NCT00101686|281146|P10|Overall Study|Other|3
76752|NCT00101686|281147|P9|Overall Study|Other|3
76753|NCT00101686|281148|P8|Overall Study|Other|5
76754|NCT00101686|281149|P7|Overall Study|Other|1
76755|NCT00101686|281150|P6|Overall Study|Other|12
76756|NCT00101686|281151|P5|Overall Study|Other|2
76757|NCT00101686|281152|P4|Overall Study|Other|6
76758|NCT00101686|281153|P3|Overall Study|Other|1
76759|NCT00101686|281154|P2|Overall Study|Other|4
76760|NCT00101686|281155|P1|Overall Study|Other|1
76761|NCT00101686|281146|P10|Overall Study|Physician Decision|1
76762|NCT00101686|281147|P9|Overall Study|Physician Decision|1
76763|NCT00101686|281148|P8|Overall Study|Physician Decision|5
76764|NCT00101686|281149|P7|Overall Study|Physician Decision|5
76765|NCT00101686|281150|P6|Overall Study|Physician Decision|9
76766|NCT00101686|281151|P5|Overall Study|Physician Decision|8
76767|NCT00101686|281152|P4|Overall Study|Physician Decision|7
76768|NCT00101686|281153|P3|Overall Study|Physician Decision|6
76769|NCT00101686|281154|P2|Overall Study|Physician Decision|13
76770|NCT00101686|281155|P1|Overall Study|Physician Decision|10
76771|NCT00101686|281146|P10|Overall Study|intercurrent non-cancer related illness|1
76772|NCT00101686|281147|P9|Overall Study|intercurrent non-cancer related illness|1
76773|NCT00101686|281148|P8|Overall Study|intercurrent non-cancer related illness|0
76774|NCT00101686|281149|P7|Overall Study|intercurrent non-cancer related illness|1
76775|NCT00101686|281150|P6|Overall Study|intercurrent non-cancer related illness|3
76776|NCT00101686|281151|P5|Overall Study|intercurrent non-cancer related illness|1
76777|NCT00101686|281152|P4|Overall Study|intercurrent non-cancer related illness|0
76778|NCT00101686|281153|P3|Overall Study|intercurrent non-cancer related illness|2
76779|NCT00101686|281154|P2|Overall Study|intercurrent non-cancer related illness|0
76780|NCT00101686|281155|P1|Overall Study|intercurrent non-cancer related illness|0
76781|NCT00101686|281146|P10|Overall Study|Randomized but did not receive treament|1
76782|NCT00101686|281147|P9|Overall Study|Randomized but did not receive treament|0
76783|NCT00101686|281148|P8|Overall Study|Randomized but did not receive treament|1
76784|NCT00101686|281149|P7|Overall Study|Randomized but did not receive treament|0
76785|NCT00101686|281150|P6|Overall Study|Randomized but did not receive treament|2
76786|NCT00101686|281151|P5|Overall Study|Randomized but did not receive treament|2
76787|NCT00101686|281152|P4|Overall Study|Randomized but did not receive treament|2
76788|NCT00101686|281153|P3|Overall Study|Randomized but did not receive treament|2
76789|NCT00101686|281154|P2|Overall Study|Randomized but did not receive treament|6
76790|NCT00101686|281155|P1|Overall Study|Randomized but did not receive treament|1
76791|NCT00101686|281146|P10|Overall Study|unacceptable toxicity|4
76792|NCT00101686|281147|P9|Overall Study|unacceptable toxicity|1
76793|NCT00101686|281148|P8|Overall Study|unacceptable toxicity|2
76794|NCT00101686|281149|P7|Overall Study|unacceptable toxicity|4
76795|NCT00101686|281150|P6|Overall Study|unacceptable toxicity|10
76796|NCT00101686|281151|P5|Overall Study|unacceptable toxicity|16
76797|NCT00101686|281152|P4|Overall Study|unacceptable toxicity|6
76798|NCT00101686|281153|P3|Overall Study|unacceptable toxicity|10
76799|NCT00101686|281154|P2|Overall Study|unacceptable toxicity|9
76800|NCT00101686|281155|P1|Overall Study|unacceptable toxicity|3
76801|NCT00101686|281146|P10|Overall Study|>3 week delay treatment due toxicity|0
76802|NCT00101686|281147|P9|Overall Study|>3 week delay treatment due toxicity|3
76803|NCT00101686|281148|P8|Overall Study|>3 week delay treatment due toxicity|1
76804|NCT00101686|281149|P7|Overall Study|>3 week delay treatment due toxicity|2
76805|NCT00101686|281150|P6|Overall Study|>3 week delay treatment due toxicity|3
76806|NCT00101686|281151|P5|Overall Study|>3 week delay treatment due toxicity|7
76807|NCT00101686|281152|P4|Overall Study|>3 week delay treatment due toxicity|2
76808|NCT00101686|281153|P3|Overall Study|>3 week delay treatment due toxicity|1
76809|NCT00101686|281154|P2|Overall Study|>3 week delay treatment due toxicity|2
76810|NCT00101686|281155|P1|Overall Study|>3 week delay treatment due toxicity|6
76811|NCT00101686|281146|P10|Overall Study|initiation other anti-cancer treatment|3
76812|NCT00101686|281147|P9|Overall Study|initiation other anti-cancer treatment|3
76813|NCT00101686|281148|P8|Overall Study|initiation other anti-cancer treatment|2
76814|NCT00101686|281149|P7|Overall Study|initiation other anti-cancer treatment|2
76815|NCT00101686|281150|P6|Overall Study|initiation other anti-cancer treatment|1
76816|NCT00101686|281151|P5|Overall Study|initiation other anti-cancer treatment|1
76817|NCT00101686|281152|P4|Overall Study|initiation other anti-cancer treatment|3
76818|NCT00101686|281153|P3|Overall Study|initiation other anti-cancer treatment|4
76819|NCT00101686|281154|P2|Overall Study|initiation other anti-cancer treatment|3
76820|NCT00101686|281155|P1|Overall Study|initiation other anti-cancer treatment|4
76821|NCT00101686|281146|P10|Overall Study|Progressive Disease|8
76822|NCT00101686|281147|P9|Overall Study|Progressive Disease|10
76823|NCT00101686|281148|P8|Overall Study|Progressive Disease|7
76824|NCT00101686|281149|P7|Overall Study|Progressive Disease|5
76825|NCT00101686|281150|P6|Overall Study|Progressive Disease|25
76826|NCT00101686|281151|P5|Overall Study|Progressive Disease|28
76827|NCT00101686|281152|P4|Overall Study|Progressive Disease|38
76828|NCT00101686|281153|P3|Overall Study|Progressive Disease|37
76829|NCT00101686|281154|P2|Overall Study|Progressive Disease|28
76830|NCT00101686|281155|P1|Overall Study|Progressive Disease|37
76831|NCT00101868|281252|P2|Overall Study|Lost to Follow-up|13
76832|NCT00101868|281253|P1|Overall Study|Lost to Follow-up|8
76833|NCT00101868|281252|P2|Overall Study|Protocol Violation|0
76834|NCT00101868|281253|P1|Overall Study|Protocol Violation|3
76835|NCT00101868|281252|P2|Overall Study|Withdrawal by Subject|9
76836|NCT00101868|281253|P1|Overall Study|Withdrawal by Subject|8
76837|NCT00101868|281252|P2|Overall Study|Death|10
76838|NCT00101868|281253|P1|Overall Study|Death|10
76839|NCT00101907|281269|P6|Overall Study|Withdrawal by Subject|0
76840|NCT00101907|281270|P5|Overall Study|Withdrawal by Subject|1
76841|NCT00101907|281271|P4|Overall Study|Withdrawal by Subject|0
76842|NCT00101907|281272|P3|Overall Study|Withdrawal by Subject|1
76843|NCT00101907|281273|P2|Overall Study|Withdrawal by Subject|0
76844|NCT00101907|281274|P1|Overall Study|Withdrawal by Subject|1
76845|NCT00101907|281269|P6|Overall Study|Physician Decision|0
76846|NCT00101907|281270|P5|Overall Study|Physician Decision|1
76847|NCT00101907|281271|P4|Overall Study|Physician Decision|1
76848|NCT00101907|281272|P3|Overall Study|Physician Decision|0
76849|NCT00101907|281273|P2|Overall Study|Physician Decision|0
76850|NCT00101907|281274|P1|Overall Study|Physician Decision|0
76851|NCT00101907|281269|P6|Overall Study|Death|0
76852|NCT00101907|281270|P5|Overall Study|Death|3
76853|NCT00101907|281271|P4|Overall Study|Death|0
76854|NCT00101907|281272|P3|Overall Study|Death|0
76855|NCT00101907|281273|P2|Overall Study|Death|1
76856|NCT00101907|281274|P1|Overall Study|Death|0
76857|NCT00101907|281269|P6|Overall Study|Adverse Event|0
76858|NCT00101907|281270|P5|Overall Study|Adverse Event|0
76859|NCT00101907|281271|P4|Overall Study|Adverse Event|0
76860|NCT00101907|281272|P3|Overall Study|Adverse Event|0
76861|NCT00101907|281273|P2|Overall Study|Adverse Event|0
76862|NCT00101907|281274|P1|Overall Study|Adverse Event|1
76863|NCT00102063|281340|P3|Overall Study|Protocol Violation|1
76864|NCT00102063|281341|P2|Overall Study|Protocol Violation|1
76865|NCT00102063|281342|P1|Overall Study|Protocol Violation|0
76866|NCT00102063|281340|P3|Overall Study|Lost to Follow-up|1
76867|NCT00102063|281341|P2|Overall Study|Lost to Follow-up|0
76868|NCT00102063|281342|P1|Overall Study|Lost to Follow-up|0
76869|NCT00102063|281340|P3|Overall Study|Withdrawal by Subject|5
76870|NCT00102063|281341|P2|Overall Study|Withdrawal by Subject|12
76871|NCT00102063|281342|P1|Overall Study|Withdrawal by Subject|4
76872|NCT00102063|281340|P3|Overall Study|Adverse Event|2
76873|NCT00102063|281341|P2|Overall Study|Adverse Event|4
76874|NCT00102063|281342|P1|Overall Study|Adverse Event|7
76875|NCT00102063|281340|P3|Overall Study|Lack of Efficacy|1
76876|NCT00102063|281341|P2|Overall Study|Lack of Efficacy|1
76877|NCT00102063|281342|P1|Overall Study|Lack of Efficacy|5
76878|NCT00102440|281374|P3|Overall Study|Protocol Violation|1
76879|NCT00102440|281375|P2|Overall Study|Protocol Violation|2
76880|NCT00102440|281376|P1|Overall Study|Protocol Violation|7
76881|NCT00102440|281374|P3|Overall Study|Other|14
76882|NCT00102440|281375|P2|Overall Study|Other|14
76883|NCT00102440|281376|P1|Overall Study|Other|11
76884|NCT00102440|281374|P3|Overall Study|Personal Reason(s)|13
76885|NCT00102440|281375|P2|Overall Study|Personal Reason(s)|13
76886|NCT00102440|281376|P1|Overall Study|Personal Reason(s)|19
76887|NCT00102440|281374|P3|Overall Study|Gout Flare|9
76888|NCT00102440|281375|P2|Overall Study|Gout Flare|28
76889|NCT00102440|281376|P1|Overall Study|Gout Flare|10
76890|NCT00102440|281374|P3|Overall Study|Adverse Event|8
76891|NCT00102440|281375|P2|Overall Study|Adverse Event|23
76892|NCT00102440|281376|P1|Overall Study|Adverse Event|16
76893|NCT00102440|281374|P3|Overall Study|Lost to Follow-up|21
76894|NCT00102440|281375|P2|Overall Study|Lost to Follow-up|18
76895|NCT00102440|281376|P1|Overall Study|Lost to Follow-up|25
76896|NCT00102531|281431|P2|Overall Study|Physician Decision|1
76897|NCT00102531|281432|P1|Overall Study|Physician Decision|0
76898|NCT00102531|281431|P2|Overall Study|Disease Progression|9
76899|NCT00102531|281432|P1|Overall Study|Disease Progression|5
76900|NCT00102531|281431|P2|Overall Study|Adverse Event|1
76901|NCT00102531|281432|P1|Overall Study|Adverse Event|0
76902|NCT00102596|281438|P2|Part A|Adverse Event|0
76903|NCT00102596|281439|P1|Part A|Adverse Event|1
76904|NCT00102596|281438|P2|Part A|Screen failures|0
76905|NCT00102596|281439|P1|Part A|Screen failures|6
76906|NCT00102687|281451|P5|Maintenance Period|Death|1
76907|NCT00102687|281452|P4|Maintenance Period|Death|1
76908|NCT00102687|281453|P3|Maintenance Period|Death|0
76909|NCT00102687|281454|P2|Maintenance Period|Death|0
76910|NCT00102687|281455|P1|Maintenance Period|Death|0
76911|NCT00102687|281451|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
76912|NCT00102687|281452|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
76913|NCT00102687|281453|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
76914|NCT00102687|281454|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
76915|NCT00102687|281455|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
76916|NCT00102687|281451|P5|Maintenance Period|Sponsor decision|0
76917|NCT00102687|281452|P4|Maintenance Period|Sponsor decision|0
76918|NCT00102687|281453|P3|Maintenance Period|Sponsor decision|0
76919|NCT00102687|281454|P2|Maintenance Period|Sponsor decision|0
76920|NCT00102687|281455|P1|Maintenance Period|Sponsor decision|0
76921|NCT00102687|281451|P5|Maintenance Period|Physician Decision|4
76922|NCT00102687|281452|P4|Maintenance Period|Physician Decision|0
76923|NCT00102687|281453|P3|Maintenance Period|Physician Decision|3
76924|NCT00102687|281454|P2|Maintenance Period|Physician Decision|2
76925|NCT00102687|281455|P1|Maintenance Period|Physician Decision|1
76926|NCT00102687|281451|P5|Maintenance Period|Protocol Violation|0
76927|NCT00102687|281452|P4|Maintenance Period|Protocol Violation|0
76928|NCT00102687|281453|P3|Maintenance Period|Protocol Violation|0
76929|NCT00102687|281454|P2|Maintenance Period|Protocol Violation|0
76930|NCT00102687|281455|P1|Maintenance Period|Protocol Violation|0
76931|NCT00102687|281451|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
76932|NCT00102687|281452|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
76933|NCT00102687|281453|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
76934|NCT00102687|281454|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
76935|NCT00102687|281455|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
76936|NCT00102687|281451|P5|Maintenance Period|Adverse Event|3
76937|NCT00102687|281452|P4|Maintenance Period|Adverse Event|1
76938|NCT00102687|281453|P3|Maintenance Period|Adverse Event|0
76939|NCT00102687|281454|P2|Maintenance Period|Adverse Event|0
76940|NCT00102687|281455|P1|Maintenance Period|Adverse Event|1
76941|NCT00102687|281451|P5|Maintenance Period|Withdrawal by Subject|1
76942|NCT00102687|281452|P4|Maintenance Period|Withdrawal by Subject|3
76943|NCT00102687|281453|P3|Maintenance Period|Withdrawal by Subject|2
76944|NCT00102687|281454|P2|Maintenance Period|Withdrawal by Subject|0
76945|NCT00102687|281455|P1|Maintenance Period|Withdrawal by Subject|4
76946|NCT00102687|281451|P5|Initial Period|Death|0
76947|NCT00102687|281452|P4|Initial Period|Death|0
76948|NCT00102687|281453|P3|Initial Period|Death|1
76949|NCT00102687|281454|P2|Initial Period|Death|1
76950|NCT00102687|281455|P1|Initial Period|Death|1
76951|NCT00102687|281451|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
76952|NCT00102687|281452|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
76953|NCT00102687|281453|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
76954|NCT00102687|281454|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
76955|NCT00102687|281455|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
76956|NCT00102687|281451|P5|Initial Period|Sponsor's decision|0
76957|NCT00102687|281452|P4|Initial Period|Sponsor's decision|0
76958|NCT00102687|281453|P3|Initial Period|Sponsor's decision|1
76959|NCT00102687|281454|P2|Initial Period|Sponsor's decision|1
76960|NCT00102687|281455|P1|Initial Period|Sponsor's decision|0
76961|NCT00102687|281451|P5|Initial Period|Physician Decision|0
76962|NCT00102687|281452|P4|Initial Period|Physician Decision|0
76963|NCT00102687|281453|P3|Initial Period|Physician Decision|6
76964|NCT00102687|281454|P2|Initial Period|Physician Decision|9
76965|NCT00102687|281455|P1|Initial Period|Physician Decision|2
76966|NCT00102687|281451|P5|Initial Period|Protocol Violation|0
76967|NCT00102687|281452|P4|Initial Period|Protocol Violation|0
76968|NCT00102687|281453|P3|Initial Period|Protocol Violation|2
76969|NCT00102687|281454|P2|Initial Period|Protocol Violation|0
76970|NCT00102687|281455|P1|Initial Period|Protocol Violation|0
76971|NCT00102687|281451|P5|Initial Period|Transformation to AML (blast > 30%)|0
76972|NCT00102687|281452|P4|Initial Period|Transformation to AML (blast > 30%)|0
76973|NCT00102687|281453|P3|Initial Period|Transformation to AML (blast > 30%)|0
76974|NCT00102687|281454|P2|Initial Period|Transformation to AML (blast > 30%)|3
76975|NCT00102687|281455|P1|Initial Period|Transformation to AML (blast > 30%)|1
76976|NCT00102687|281451|P5|Initial Period|Adverse Event|0
76977|NCT00102687|281452|P4|Initial Period|Adverse Event|0
76978|NCT00102687|281453|P3|Initial Period|Adverse Event|9
76979|NCT00102687|281454|P2|Initial Period|Adverse Event|7
76980|NCT00102687|281455|P1|Initial Period|Adverse Event|4
76981|NCT00102687|281451|P5|Initial Period|Withdrawal by Subject|0
76982|NCT00102687|281452|P4|Initial Period|Withdrawal by Subject|0
76983|NCT00102687|281453|P3|Initial Period|Withdrawal by Subject|5
76984|NCT00102687|281454|P2|Initial Period|Withdrawal by Subject|3
76985|NCT00102687|281455|P1|Initial Period|Withdrawal by Subject|6
76986|NCT00102804|281521|P2|Overall Study|Alive, Receiving Treatment|2
76987|NCT00102804|281522|P1|Overall Study|Alive, Receiving Treatment|7
76988|NCT00102804|281521|P2|Overall Study|Sponsor Decision|0
76989|NCT00102804|281522|P1|Overall Study|Sponsor Decision|1
76990|NCT00102804|281521|P2|Overall Study|Satisfactory Response|0
76991|NCT00102804|281522|P1|Overall Study|Satisfactory Response|2
76992|NCT00102804|281521|P2|Overall Study|Protocol Violation|1
76993|NCT00102804|281522|P1|Overall Study|Protocol Violation|2
76994|NCT00102804|281521|P2|Overall Study|Lost to Follow-up|1
76995|NCT00102804|281522|P1|Overall Study|Lost to Follow-up|4
76996|NCT00102804|281521|P2|Overall Study|Enrollment Criteria Not Met|0
76997|NCT00102804|281522|P1|Overall Study|Enrollment Criteria Not Met|6
76998|NCT00102804|281521|P2|Overall Study|Death|6
76999|NCT00102804|281522|P1|Overall Study|Death|5
77000|NCT00102804|281521|P2|Overall Study|Physician Decision|6
77001|NCT00102804|281522|P1|Overall Study|Physician Decision|24
77002|NCT00102804|281521|P2|Overall Study|Adverse Event|3
77003|NCT00102804|281522|P1|Overall Study|Adverse Event|37
77004|NCT00102804|281521|P2|Overall Study|Withdrawal by Subject|7
77005|NCT00102804|281522|P1|Overall Study|Withdrawal by Subject|46
77006|NCT00102804|281521|P2|Overall Study|Progressive Disease (PD)|196
77007|NCT00102804|281522|P1|Overall Study|Progressive Disease (PD)|307
77008|NCT00103012|281543|P3|Overall Study|Subject non-compliant with medications|1
77009|NCT00103012|281544|P2|Overall Study|Subject non-compliant with medications|0
77010|NCT00103012|281545|P1|Overall Study|Subject non-compliant with medications|0
77011|NCT00103012|281543|P3|Overall Study|Adverse Event|1
77012|NCT00103012|281544|P2|Overall Study|Adverse Event|0
77013|NCT00103012|281545|P1|Overall Study|Adverse Event|0
77014|NCT00103012|281543|P3|Overall Study|Pregnancy|0
77015|NCT00103012|281544|P2|Overall Study|Pregnancy|0
77016|NCT00103012|281545|P1|Overall Study|Pregnancy|1
77017|NCT00103012|281543|P3|Overall Study|Withdrawal by Subject|2
77018|NCT00103012|281544|P2|Overall Study|Withdrawal by Subject|1
77019|NCT00103012|281545|P1|Overall Study|Withdrawal by Subject|2
77020|NCT00103142|281560|P2|Overall Study|Progression of disease|1
77021|NCT00103142|281561|P1|Overall Study|Progression of disease|2
77022|NCT00103142|281560|P2|Overall Study|Adverse Event|0
77023|NCT00103142|281561|P1|Overall Study|Adverse Event|1
77024|NCT00093470|281577|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
77025|NCT00093470|281578|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
77026|NCT00093470|281577|P2|Overall Study|Never started treatment|0
77027|NCT00093470|281578|P1|Overall Study|Never started treatment|1
77028|NCT00093470|281577|P2|Overall Study|Physician Decision|0
77029|NCT00093470|281578|P1|Overall Study|Physician Decision|2
77030|NCT00093470|281577|P2|Overall Study|Other complicating disease|0
77031|NCT00093470|281578|P1|Overall Study|Other complicating disease|3
77032|NCT00093470|281577|P2|Overall Study|Alternative therapy|0
77033|NCT00093470|281578|P1|Overall Study|Alternative therapy|2
77034|NCT00093470|281577|P2|Overall Study|Withdrawal by Subject|0
77035|NCT00093470|281578|P1|Overall Study|Withdrawal by Subject|8
77036|NCT00093470|281577|P2|Overall Study|Death|0
77037|NCT00093470|281578|P1|Overall Study|Death|2
77038|NCT00093470|281577|P2|Overall Study|Adverse Event|0
77039|NCT00093470|281578|P1|Overall Study|Adverse Event|15
77040|NCT00093470|281577|P2|Overall Study|Disease progression|0
77041|NCT00093470|281578|P1|Overall Study|Disease progression|39
77042|NCT00093496|281588|P2|Overall Study|Protocol Violation|3
77043|NCT00093496|281589|P1|Overall Study|Protocol Violation|1
77044|NCT00093808|281618|P1|Overall Study|Protocol Violation|1
77045|NCT00093808|281618|P1|Overall Study|Cancel participation before receiving tx|1
77046|NCT00094055|281636|P1|Overall Study|Withdrawal by Subject|9
77047|NCT00094055|281636|P1|Overall Study|roll-over to another study|14
77048|NCT00094055|281636|P1|Overall Study|clinical progression|1
77049|NCT00094055|281636|P1|Overall Study|progressive disease|2
77050|NCT00094055|281636|P1|Overall Study|Lost to Follow-up|2
77051|NCT00094055|281636|P1|Overall Study|Lack of Efficacy|17
77052|NCT00094055|281636|P1|Overall Study|Death|4
77053|NCT00094055|281636|P1|Overall Study|Adverse Event|11
77054|NCT00094094|281645|P1|Overall Study|Adverse Event|7
77055|NCT00094094|281645|P1|Overall Study|Lack of Efficacy|23
77056|NCT00094094|281645|P1|Overall Study|Death|2
77057|NCT00094107|281654|P1|Overall Study|Withdrawal due to Disease Progression|1
77058|NCT00094107|281654|P1|Overall Study|Adverse Event|3
77059|NCT00094107|281654|P1|Overall Study|Death|5
77060|NCT00094107|281654|P1|Overall Study|Lack of Efficacy|23
77061|NCT00094172|281665|P2|Overall Study|Started other MS therapy due to disease|0
77062|NCT00094172|281666|P1|Overall Study|Started other MS therapy due to disease|1
77063|NCT00094172|281665|P2|Overall Study|Primary endpoint met.|0
77064|NCT00094172|281666|P1|Overall Study|Primary endpoint met.|1
77065|NCT00094172|281665|P2|Overall Study|Withdrawal by Subject|5
77066|NCT00094172|281666|P1|Overall Study|Withdrawal by Subject|10
77067|NCT00094172|281665|P2|Overall Study|Protocol Violation|1
77068|NCT00094172|281666|P1|Overall Study|Protocol Violation|0
77069|NCT00094172|281665|P2|Overall Study|Lost to Follow-up|0
77070|NCT00094172|281666|P1|Overall Study|Lost to Follow-up|2
77071|NCT00094172|281665|P2|Overall Study|Adverse Event|1
77072|NCT00094172|281666|P1|Overall Study|Adverse Event|0
77073|NCT00094302|281678|P2|Overall Study|Death|246
77074|NCT00094302|281679|P1|Overall Study|Death|266
77075|NCT00094302|281678|P2|Overall Study|Withdrawal by Subject|111
77076|NCT00094302|281679|P1|Overall Study|Withdrawal by Subject|103
77077|NCT00094302|281678|P2|Overall Study|Physician Decision|8
77078|NCT00094302|281679|P1|Overall Study|Physician Decision|5
77079|NCT00094302|281678|P2|Overall Study|Lost to Follow-up|41
77080|NCT00094302|281679|P1|Overall Study|Lost to Follow-up|43
77081|NCT00094328|281733|P1|Overall Study|Lost to Follow-up|1
77082|NCT00094458|281744|P6|OLE: Open-Label Extension|Patient decision|0
77083|NCT00094458|281745|P5|OLE: Open-Label Extension|Patient decision|1
77084|NCT00094458|281746|P4|OLE: Open-Label Extension|Patient decision|0
77085|NCT00094458|281747|P3|OLE: Open-Label Extension|Patient decision|0
77086|NCT00094458|281748|P2|OLE: Open-Label Extension|Patient decision|0
77087|NCT00094458|281749|P1|OLE: Open-Label Extension|Patient decision|0
77088|NCT00094458|281744|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
77089|NCT00094458|281745|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
77090|NCT00094458|281746|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
77091|NCT00094458|281747|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
77092|NCT00094458|281748|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
77093|NCT00094458|281749|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
77094|NCT00094458|281744|P6|OLE: Open-Label Extension|Adverse Event|4
77095|NCT00094458|281745|P5|OLE: Open-Label Extension|Adverse Event|3
77096|NCT00094458|281746|P4|OLE: Open-Label Extension|Adverse Event|0
77097|NCT00094458|281747|P3|OLE: Open-Label Extension|Adverse Event|0
77098|NCT00094458|281748|P2|OLE: Open-Label Extension|Adverse Event|0
77099|NCT00094458|281749|P1|OLE: Open-Label Extension|Adverse Event|0
77100|NCT00094458|281744|P6|Study Extension: Week 30 Through Week 50|Unspecified|0
77101|NCT00094458|281745|P5|Study Extension: Week 30 Through Week 50|Unspecified|0
77102|NCT00094458|281746|P4|Study Extension: Week 30 Through Week 50|Unspecified|0
77103|NCT00094458|281747|P3|Study Extension: Week 30 Through Week 50|Unspecified|3
77104|NCT00094458|281748|P2|Study Extension: Week 30 Through Week 50|Unspecified|2
77105|NCT00094458|281749|P1|Study Extension: Week 30 Through Week 50|Unspecified|1
77106|NCT00094458|281744|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
77107|NCT00094458|281745|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
77108|NCT00094458|281746|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
77109|NCT00094458|281747|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
77110|NCT00094458|281748|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
77111|NCT00094458|281749|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
77112|NCT00094458|281744|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
77113|NCT00094458|281745|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
77114|NCT00094458|281746|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
77115|NCT00094458|281747|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
77116|NCT00094458|281748|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
77117|NCT00094458|281749|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
77118|NCT00094458|281744|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
77119|NCT00094458|281745|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
77120|NCT00094458|281746|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
77121|NCT00094458|281747|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
77122|NCT00094458|281748|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
77123|NCT00094458|281749|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
77124|NCT00094458|281744|P6|Main Study: Through Week 30|Unspecified|0
77125|NCT00094458|281745|P5|Main Study: Through Week 30|Unspecified|0
77126|NCT00094458|281746|P4|Main Study: Through Week 30|Unspecified|0
77127|NCT00094458|281747|P3|Main Study: Through Week 30|Unspecified|9
77128|NCT00094458|281748|P2|Main Study: Through Week 30|Unspecified|16
77129|NCT00094458|281749|P1|Main Study: Through Week 30|Unspecified|19
77130|NCT00094458|281744|P6|Main Study: Through Week 30|Death|0
77131|NCT00094458|281745|P5|Main Study: Through Week 30|Death|0
77132|NCT00094458|281746|P4|Main Study: Through Week 30|Death|0
77133|NCT00094458|281747|P3|Main Study: Through Week 30|Death|0
77134|NCT00094458|281748|P2|Main Study: Through Week 30|Death|0
77135|NCT00094458|281749|P1|Main Study: Through Week 30|Death|1
77136|NCT00094458|281744|P6|Main Study: Through Week 30|Adverse Event|0
77137|NCT00094458|281745|P5|Main Study: Through Week 30|Adverse Event|0
77138|NCT00094458|281746|P4|Main Study: Through Week 30|Adverse Event|0
77139|NCT00094458|281747|P3|Main Study: Through Week 30|Adverse Event|28
77140|NCT00094458|281748|P2|Main Study: Through Week 30|Adverse Event|20
77141|NCT00094458|281749|P1|Main Study: Through Week 30|Adverse Event|38
77142|NCT00094458|281744|P6|Main Study: Through Week 30|Withdrawal by Subject|0
77143|NCT00094458|281745|P5|Main Study: Through Week 30|Withdrawal by Subject|0
77144|NCT00094458|281746|P4|Main Study: Through Week 30|Withdrawal by Subject|0
77145|NCT00094458|281747|P3|Main Study: Through Week 30|Withdrawal by Subject|7
77146|NCT00094458|281748|P2|Main Study: Through Week 30|Withdrawal by Subject|9
77147|NCT00094458|281749|P1|Main Study: Through Week 30|Withdrawal by Subject|18
77148|NCT00094458|281744|P6|Main Study: Through Week 30|Lost to Follow-up|0
77149|NCT00094458|281745|P5|Main Study: Through Week 30|Lost to Follow-up|0
77150|NCT00094458|281746|P4|Main Study: Through Week 30|Lost to Follow-up|0
77151|NCT00094458|281747|P3|Main Study: Through Week 30|Lost to Follow-up|2
77152|NCT00094458|281748|P2|Main Study: Through Week 30|Lost to Follow-up|5
77153|NCT00094458|281749|P1|Main Study: Through Week 30|Lost to Follow-up|5
77154|NCT00094458|281744|P6|Main Study: Through Week 30|Eligibility criteria not met|0
77155|NCT00094458|281745|P5|Main Study: Through Week 30|Eligibility criteria not met|0
77156|NCT00094458|281746|P4|Main Study: Through Week 30|Eligibility criteria not met|0
77157|NCT00094458|281747|P3|Main Study: Through Week 30|Eligibility criteria not met|2
77158|NCT00094458|281748|P2|Main Study: Through Week 30|Eligibility criteria not met|8
77159|NCT00094458|281749|P1|Main Study: Through Week 30|Eligibility criteria not met|3
77160|NCT00094536|281804|P1|Treatment and Follow-up|Unable to attend visits|1
77161|NCT00094536|281804|P1|Treatment and Follow-up|Subject non-compliance|9
77162|NCT00094536|281804|P1|Treatment and Follow-up|Withdrawal by Subject|1
77163|NCT00094536|281804|P1|Treatment and Follow-up|Lost to Follow-up|7
77164|NCT00094536|281804|P1|Treatment and Follow-up|Lack of Efficacy|9
77165|NCT00094536|281804|P1|Treatment and Follow-up|Adverse Event|4
77166|NCT00094536|281804|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
77167|NCT00094575|281810|P2|Overall Study|Death|146
77168|NCT00094575|281811|P1|Overall Study|Death|146
77169|NCT00094653|281834|P3|Overall Study|Protocol Violation|1
77170|NCT00094653|281835|P2|Overall Study|Protocol Violation|0
77171|NCT00094653|281836|P1|Overall Study|Protocol Violation|0
77172|NCT00094653|281834|P3|Overall Study|Lost to Follow-up|1
77173|NCT00094653|281835|P2|Overall Study|Lost to Follow-up|2
77174|NCT00094653|281836|P1|Overall Study|Lost to Follow-up|3
77175|NCT00094653|281834|P3|Overall Study|Not specified|2
77176|NCT00094653|281835|P2|Overall Study|Not specified|2
77177|NCT00094653|281836|P1|Overall Study|Not specified|2
77178|NCT00094653|281834|P3|Overall Study|Subject Withdrew Consent|3
77179|NCT00094653|281835|P2|Overall Study|Subject Withdrew Consent|2
77180|NCT00094653|281836|P1|Overall Study|Subject Withdrew Consent|10
77181|NCT00094653|281834|P3|Overall Study|Death|119
77182|NCT00094653|281835|P2|Overall Study|Death|100
77183|NCT00094653|281836|P1|Overall Study|Death|306
77184|NCT00094757|281900|P3|Overall Study|Protocol specified discontinuation|0
77185|NCT00094757|281901|P2|Overall Study|Protocol specified discontinuation|3
77186|NCT00094757|281902|P1|Overall Study|Protocol specified discontinuation|1
77187|NCT00094757|281900|P3|Overall Study|Unspecified|1
77188|NCT00094757|281901|P2|Overall Study|Unspecified|3
77189|NCT00094757|281902|P1|Overall Study|Unspecified|3
77190|NCT00094757|281900|P3|Overall Study|Withdrawal by Subject|5
77191|NCT00094757|281901|P2|Overall Study|Withdrawal by Subject|21
77192|NCT00094757|281902|P1|Overall Study|Withdrawal by Subject|14
77193|NCT00094757|281900|P3|Overall Study|Protocol Violation|3
77194|NCT00094757|281901|P2|Overall Study|Protocol Violation|5
77195|NCT00094757|281902|P1|Overall Study|Protocol Violation|8
77196|NCT00094757|281900|P3|Overall Study|Patient Moved|1
77197|NCT00094757|281901|P2|Overall Study|Patient Moved|1
77198|NCT00094757|281902|P1|Overall Study|Patient Moved|2
77199|NCT00094757|281900|P3|Overall Study|Lost to Follow-up|6
77200|NCT00094757|281901|P2|Overall Study|Lost to Follow-up|5
77201|NCT00094757|281902|P1|Overall Study|Lost to Follow-up|3
77202|NCT00094757|281900|P3|Overall Study|Lack of Efficacy|8
77203|NCT00094757|281901|P2|Overall Study|Lack of Efficacy|15
77204|NCT00094757|281902|P1|Overall Study|Lack of Efficacy|11
77205|NCT00094757|281900|P3|Overall Study|Adverse Event|6
77206|NCT00094757|281901|P2|Overall Study|Adverse Event|9
77207|NCT00094757|281902|P1|Overall Study|Adverse Event|11
77208|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Unspecified|23
77209|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Unspecified|15
77210|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
77211|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
77212|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
77213|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
77214|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
77215|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
77216|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
77217|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
77218|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
77219|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
77220|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
77221|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
77222|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
77223|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
77224|NCT00094770|281921|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
77225|NCT00094770|281922|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
77226|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Unspecified|11
77227|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Unspecified|10
77228|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
77229|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
77230|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
77231|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
77232|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
77233|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
77234|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
77235|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
77236|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
77237|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
77238|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
77239|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
77240|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
77241|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
77242|NCT00094770|281921|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
77243|NCT00094770|281922|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
77244|NCT00094809|281952|P2|Overall Study|Other|1
77245|NCT00094809|281953|P1|Overall Study|Other|1
77246|NCT00094809|281952|P2|Overall Study|Study drug not received|8
77247|NCT00094809|281953|P1|Overall Study|Study drug not received|2
77248|NCT00094809|281952|P2|Overall Study|Informed consent signed after treatment|0
77249|NCT00094809|281953|P1|Overall Study|Informed consent signed after treatment|1
77250|NCT00094809|281952|P2|Overall Study|Other|4
77251|NCT00094809|281953|P1|Overall Study|Other|2
77252|NCT00094809|281952|P2|Overall Study|Protocol-specified criteria|1
77253|NCT00094809|281953|P1|Overall Study|Protocol-specified criteria|1
77254|NCT00094809|281952|P2|Overall Study|Death|25
77255|NCT00094809|281953|P1|Overall Study|Death|19
77256|NCT00094809|281952|P2|Overall Study|Lost to Follow-up|6
77257|NCT00094809|281953|P1|Overall Study|Lost to Follow-up|6
77258|NCT00094809|281952|P2|Overall Study|Physician Decision|5
77259|NCT00094809|281953|P1|Overall Study|Physician Decision|3
77260|NCT00094809|281952|P2|Overall Study|Disease progression|3
77261|NCT00094809|281953|P1|Overall Study|Disease progression|3
77262|NCT00094809|281952|P2|Overall Study|Withdrawal by Subject|9
77263|NCT00094809|281953|P1|Overall Study|Withdrawal by Subject|8
77264|NCT00094809|281952|P2|Overall Study|Adverse Event|1
77265|NCT00094809|281953|P1|Overall Study|Adverse Event|3
77266|NCT00094809|281952|P2|Overall Study|Noncompliance|0
77267|NCT00094809|281953|P1|Overall Study|Noncompliance|1
77268|NCT00094809|281952|P2|Overall Study|Protocol deviation|2
77269|NCT00094809|281953|P1|Overall Study|Protocol deviation|2
77270|NCT00094835|281984|P7|Overall Study|Other|0
77271|NCT00094835|281985|P6|Overall Study|Other|0
77272|NCT00094835|281986|P5|Overall Study|Other|0
77273|NCT00094835|281987|P4|Overall Study|Other|1
77274|NCT00094835|281988|P3|Overall Study|Other|1
77275|NCT00094835|281989|P2|Overall Study|Other|1
77276|NCT00094835|281990|P1|Overall Study|Other|1
77277|NCT00094835|281984|P7|Overall Study|Non-compliance|1
77278|NCT00094835|281985|P6|Overall Study|Non-compliance|2
77279|NCT00094835|281986|P5|Overall Study|Non-compliance|2
77280|NCT00094835|281987|P4|Overall Study|Non-compliance|0
77281|NCT00094835|281988|P3|Overall Study|Non-compliance|2
77282|NCT00094835|281989|P2|Overall Study|Non-compliance|2
77283|NCT00094835|281990|P1|Overall Study|Non-compliance|1
77284|NCT00094835|281984|P7|Overall Study|Death|0
77285|NCT00094835|281985|P6|Overall Study|Death|0
77286|NCT00094835|281986|P5|Overall Study|Death|1
77287|NCT00094835|281987|P4|Overall Study|Death|0
77288|NCT00094835|281988|P3|Overall Study|Death|0
77289|NCT00094835|281989|P2|Overall Study|Death|0
77290|NCT00094835|281990|P1|Overall Study|Death|1
77291|NCT00094835|281984|P7|Overall Study|Lost to Follow-up|0
77292|NCT00094835|281985|P6|Overall Study|Lost to Follow-up|0
77293|NCT00094835|281986|P5|Overall Study|Lost to Follow-up|1
77294|NCT00094835|281987|P4|Overall Study|Lost to Follow-up|0
77295|NCT00094835|281988|P3|Overall Study|Lost to Follow-up|0
77296|NCT00094835|281989|P2|Overall Study|Lost to Follow-up|0
77297|NCT00094835|281990|P1|Overall Study|Lost to Follow-up|0
77298|NCT00094835|281984|P7|Overall Study|Withdrawal by Subject|1
77299|NCT00094835|281985|P6|Overall Study|Withdrawal by Subject|0
77300|NCT00094835|281986|P5|Overall Study|Withdrawal by Subject|0
77301|NCT00094835|281987|P4|Overall Study|Withdrawal by Subject|0
77302|NCT00094835|281988|P3|Overall Study|Withdrawal by Subject|0
77303|NCT00094835|281989|P2|Overall Study|Withdrawal by Subject|0
77304|NCT00094835|281990|P1|Overall Study|Withdrawal by Subject|0
77305|NCT00094835|281984|P7|Overall Study|Physician Decision|0
77306|NCT00094835|281985|P6|Overall Study|Physician Decision|1
77307|NCT00094835|281986|P5|Overall Study|Physician Decision|0
77308|NCT00094835|281987|P4|Overall Study|Physician Decision|0
77309|NCT00094835|281988|P3|Overall Study|Physician Decision|0
77310|NCT00094835|281989|P2|Overall Study|Physician Decision|0
77311|NCT00094835|281990|P1|Overall Study|Physician Decision|1
77312|NCT00094861|282068|P2|Overall Study|Other|0
77313|NCT00094861|282069|P1|Overall Study|Other|3
77314|NCT00094861|282068|P2|Overall Study|Death|2
77315|NCT00094861|282069|P1|Overall Study|Death|4
77316|NCT00094861|282068|P2|Overall Study|Lost to Follow-up|1
77317|NCT00094861|282069|P1|Overall Study|Lost to Follow-up|0
77318|NCT00094861|282068|P2|Overall Study|Physician Decision|1
77319|NCT00094861|282069|P1|Overall Study|Physician Decision|1
77320|NCT00094861|282068|P2|Overall Study|Withdrawal by Subject|3
77321|NCT00094861|282069|P1|Overall Study|Withdrawal by Subject|5
77322|NCT00094861|282068|P2|Overall Study|Adverse Event|2
77323|NCT00094861|282069|P1|Overall Study|Adverse Event|5
77324|NCT00094887|282091|P2|Overall Study|Physician Decision|2
77325|NCT00094887|282092|P1|Overall Study|Physician Decision|2
77326|NCT00094887|282091|P2|Overall Study|Family emergency, Subject noncompliance|4
77327|NCT00094887|282092|P1|Overall Study|Family emergency, Subject noncompliance|3
77328|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Protocol Violation|1
77329|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Protocol Violation|0
77330|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
77331|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
77332|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Death|1
77333|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Death|3
77334|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Patient Moved|0
77335|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Patient Moved|1
77336|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
77337|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
77338|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
77339|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
77340|NCT00095056|282200|P2|Phase B (Weeks 12-54)|Adverse Event|2
77341|NCT00095056|282201|P1|Phase B (Weeks 12-54)|Adverse Event|2
77342|NCT00095056|282200|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
77343|NCT00095056|282201|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
77344|NCT00095056|282200|P2|Phase A (Weeks 0-12)|Death|0
77345|NCT00095056|282201|P1|Phase A (Weeks 0-12)|Death|1
77346|NCT00095056|282200|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
77347|NCT00095056|282201|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
77348|NCT00095056|282200|P2|Phase A (Weeks 0-12)|Adverse Event|1
77349|NCT00095056|282201|P1|Phase A (Weeks 0-12)|Adverse Event|1
77350|NCT00095121|282211|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
77351|NCT00095121|282212|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
77352|NCT00095121|282211|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
77353|NCT00095121|282212|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
77354|NCT00095147|282259|P5|Long-term Extension Period|Leaving country|1
77355|NCT00095147|282260|P4|Long-term Extension Period|Leaving country|0
77356|NCT00095147|282261|P3|Long-term Extension Period|Leaving country|0
77357|NCT00095147|282262|P2|Long-term Extension Period|Leaving country|0
77358|NCT00095147|282263|P1|Long-term Extension Period|Leaving country|0
77359|NCT00095147|282259|P5|Long-term Extension Period|Participant chose to use Revellex|1
77360|NCT00095147|282260|P4|Long-term Extension Period|Participant chose to use Revellex|0
77361|NCT00095147|282261|P3|Long-term Extension Period|Participant chose to use Revellex|0
77362|NCT00095147|282262|P2|Long-term Extension Period|Participant chose to use Revellex|0
77363|NCT00095147|282263|P1|Long-term Extension Period|Participant chose to use Revellex|0
77364|NCT00095147|282259|P5|Long-term Extension Period|No longer meets study criteria|1
77365|NCT00095147|282260|P4|Long-term Extension Period|No longer meets study criteria|0
77366|NCT00095147|282261|P3|Long-term Extension Period|No longer meets study criteria|0
77367|NCT00095147|282262|P2|Long-term Extension Period|No longer meets study criteria|0
77368|NCT00095147|282263|P1|Long-term Extension Period|No longer meets study criteria|0
77369|NCT00095147|282259|P5|Long-term Extension Period|Pregnancy|1
77370|NCT00095147|282260|P4|Long-term Extension Period|Pregnancy|0
77371|NCT00095147|282261|P3|Long-term Extension Period|Pregnancy|0
77372|NCT00095147|282262|P2|Long-term Extension Period|Pregnancy|0
77373|NCT00095147|282263|P1|Long-term Extension Period|Pregnancy|0
77374|NCT00095147|282259|P5|Long-term Extension Period|Withdrawal of consent|12
77375|NCT00095147|282260|P4|Long-term Extension Period|Withdrawal of consent|0
77376|NCT00095147|282261|P3|Long-term Extension Period|Withdrawal of consent|0
77377|NCT00095147|282262|P2|Long-term Extension Period|Withdrawal of consent|0
77378|NCT00095147|282263|P1|Long-term Extension Period|Withdrawal of consent|0
77379|NCT00095147|282259|P5|Long-term Extension Period|Lost to Follow-up|6
77380|NCT00095147|282260|P4|Long-term Extension Period|Lost to Follow-up|0
77381|NCT00095147|282261|P3|Long-term Extension Period|Lost to Follow-up|0
77382|NCT00095147|282262|P2|Long-term Extension Period|Lost to Follow-up|0
77383|NCT00095147|282263|P1|Long-term Extension Period|Lost to Follow-up|0
77384|NCT00095147|282259|P5|Long-term Extension Period|Lack of Efficacy|9
77385|NCT00095147|282260|P4|Long-term Extension Period|Lack of Efficacy|0
77386|NCT00095147|282261|P3|Long-term Extension Period|Lack of Efficacy|0
77387|NCT00095147|282262|P2|Long-term Extension Period|Lack of Efficacy|0
77388|NCT00095147|282263|P1|Long-term Extension Period|Lack of Efficacy|0
77389|NCT00095147|282259|P5|Long-term Extension Period|Adverse Event|11
77390|NCT00095147|282260|P4|Long-term Extension Period|Adverse Event|0
77391|NCT00095147|282261|P3|Long-term Extension Period|Adverse Event|0
77392|NCT00095147|282262|P2|Long-term Extension Period|Adverse Event|0
77393|NCT00095147|282263|P1|Long-term Extension Period|Adverse Event|0
77394|NCT00095147|282259|P5|Long-term Extension Period|Death|3
77395|NCT00095147|282260|P4|Long-term Extension Period|Death|0
77396|NCT00095147|282261|P3|Long-term Extension Period|Death|0
77397|NCT00095147|282262|P2|Long-term Extension Period|Death|0
77398|NCT00095147|282263|P1|Long-term Extension Period|Death|0
77399|NCT00095147|282259|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
77400|NCT00095147|282260|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
77401|NCT00095147|282261|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
77402|NCT00095147|282262|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
77403|NCT00095147|282263|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
77404|NCT00095147|282259|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
77405|NCT00095147|282260|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
77406|NCT00095147|282261|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
77407|NCT00095147|282262|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
77408|NCT00095147|282263|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
77409|NCT00095147|282259|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
77410|NCT00095147|282260|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
77411|NCT00095147|282261|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
77412|NCT00095147|282262|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
77413|NCT00095147|282263|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
77414|NCT00095147|282259|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
77415|NCT00095147|282260|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
77416|NCT00095147|282261|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
77417|NCT00095147|282262|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
77418|NCT00095147|282263|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
77419|NCT00095147|282259|P5|Double-blind Period 2 (Days 198-365)|Death|0
77420|NCT00095147|282260|P4|Double-blind Period 2 (Days 198-365)|Death|1
77421|NCT00095147|282261|P3|Double-blind Period 2 (Days 198-365)|Death|0
77422|NCT00095147|282262|P2|Double-blind Period 2 (Days 198-365)|Death|1
77423|NCT00095147|282263|P1|Double-blind Period 2 (Days 198-365)|Death|0
77424|NCT00095147|282259|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
77425|NCT00095147|282260|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
77426|NCT00095147|282261|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
77427|NCT00095147|282262|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
77428|NCT00095147|282263|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
77429|NCT00095147|282259|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
77430|NCT00095147|282260|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
77431|NCT00095147|282261|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
77432|NCT00095147|282262|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
77433|NCT00095147|282263|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
77434|NCT00095147|282259|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
77435|NCT00095147|282260|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
77436|NCT00095147|282261|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
77437|NCT00095147|282262|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
77438|NCT00095147|282263|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
77439|NCT00095147|282259|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
77440|NCT00095147|282260|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
77441|NCT00095147|282261|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
77442|NCT00095147|282262|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
77443|NCT00095147|282263|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
77444|NCT00095147|282259|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
77445|NCT00095147|282260|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
77446|NCT00095147|282261|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
77447|NCT00095147|282262|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
77448|NCT00095147|282263|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
77449|NCT00095147|282259|P5|Double-blind Period 1 (Days 1-197)|Death|0
77450|NCT00095147|282260|P4|Double-blind Period 1 (Days 1-197)|Death|0
77451|NCT00095147|282261|P3|Double-blind Period 1 (Days 1-197)|Death|0
77452|NCT00095147|282262|P2|Double-blind Period 1 (Days 1-197)|Death|0
77453|NCT00095147|282263|P1|Double-blind Period 1 (Days 1-197)|Death|1
77454|NCT00103207|282463|P1|Overall Study|Diagnosis of BAC not confirmed|27
77455|NCT00103207|282463|P1|Overall Study|Ineligible|4
77456|NCT00103207|282463|P1|Overall Study|Other complicating disease|1
77457|NCT00103207|282463|P1|Overall Study|Withdrawal by Subject|2
77458|NCT00103207|282463|P1|Overall Study|Death|1
77459|NCT00103207|282463|P1|Overall Study|Adverse Event|3
77460|NCT00103259|282475|P2|Overall Study|ineligible/no protocol therapy|6
77461|NCT00103259|282476|P1|Overall Study|ineligible/no protocol therapy|4
77462|NCT00103259|282475|P2|Overall Study|other (reasons were not specified)|1
77463|NCT00103259|282476|P1|Overall Study|other (reasons were not specified)|2
77464|NCT00103259|282475|P2|Overall Study|alternative therapy|0
77465|NCT00103259|282476|P1|Overall Study|alternative therapy|1
77466|NCT00103259|282475|P2|Overall Study|Withdrawal by Subject|3
77467|NCT00103259|282476|P1|Overall Study|Withdrawal by Subject|2
77468|NCT00103259|282475|P2|Overall Study|Death|2
77469|NCT00103259|282476|P1|Overall Study|Death|3
77470|NCT00103311|282490|P2|Overall Study|Adverse Event|0
77471|NCT00103311|282491|P1|Overall Study|Adverse Event|1
77472|NCT00103311|282490|P2|Overall Study|Withdrawal by Subject|1
77473|NCT00103311|282491|P1|Overall Study|Withdrawal by Subject|2
77474|NCT00103311|282490|P2|Overall Study|Lost to Follow-up|0
77475|NCT00103311|282491|P1|Overall Study|Lost to Follow-up|1
77476|NCT00103506|282503|P2|Overall Study|Withdrawal by Subject|21
77477|NCT00103506|282504|P1|Overall Study|Withdrawal by Subject|18
77478|NCT00103506|282503|P2|Overall Study|Lost to Follow-up|13
77479|NCT00103506|282504|P1|Overall Study|Lost to Follow-up|13
77480|NCT00103506|282503|P2|Overall Study|Death|253
77481|NCT00103506|282504|P1|Overall Study|Death|257
77482|NCT00103506|282503|P2|Overall Study|Study closed by sponsor|37
77483|NCT00103506|282504|P1|Overall Study|Study closed by sponsor|34
77484|NCT00103857|282555|P7|50-Week Extension Study|reason unspecified|0
77485|NCT00103857|282556|P6|50-Week Extension Study|reason unspecified|0
77486|NCT00103857|282557|P5|50-Week Extension Study|reason unspecified|1
77487|NCT00103857|282558|P4|50-Week Extension Study|reason unspecified|0
77488|NCT00103857|282559|P3|50-Week Extension Study|reason unspecified|0
77489|NCT00103857|282560|P2|50-Week Extension Study|reason unspecified|0
77490|NCT00103857|282561|P1|50-Week Extension Study|reason unspecified|0
77491|NCT00103857|282555|P7|50-Week Extension Study|patient scheduled for elective surgery|0
77492|NCT00103857|282556|P6|50-Week Extension Study|patient scheduled for elective surgery|0
77493|NCT00103857|282557|P5|50-Week Extension Study|patient scheduled for elective surgery|0
77494|NCT00103857|282558|P4|50-Week Extension Study|patient scheduled for elective surgery|0
77495|NCT00103857|282559|P3|50-Week Extension Study|patient scheduled for elective surgery|1
77496|NCT00103857|282560|P2|50-Week Extension Study|patient scheduled for elective surgery|0
77497|NCT00103857|282561|P1|50-Week Extension Study|patient scheduled for elective surgery|0
77498|NCT00103857|282555|P7|50-Week Extension Study|patient moved|0
77499|NCT00103857|282556|P6|50-Week Extension Study|patient moved|0
77500|NCT00103857|282557|P5|50-Week Extension Study|patient moved|0
77501|NCT00103857|282558|P4|50-Week Extension Study|patient moved|2
77502|NCT00103857|282559|P3|50-Week Extension Study|patient moved|1
77503|NCT00103857|282560|P2|50-Week Extension Study|patient moved|0
77504|NCT00103857|282561|P1|50-Week Extension Study|patient moved|0
77505|NCT00103857|282555|P7|50-Week Extension Study|non-compliance with study procedures|0
77506|NCT00103857|282556|P6|50-Week Extension Study|non-compliance with study procedures|0
77507|NCT00103857|282557|P5|50-Week Extension Study|non-compliance with study procedures|1
77508|NCT00103857|282558|P4|50-Week Extension Study|non-compliance with study procedures|1
77509|NCT00103857|282559|P3|50-Week Extension Study|non-compliance with study procedures|0
77510|NCT00103857|282560|P2|50-Week Extension Study|non-compliance with study procedures|0
77511|NCT00103857|282561|P1|50-Week Extension Study|non-compliance with study procedures|1
77512|NCT00103857|282555|P7|50-Week Extension Study|protocol discontinuation criteria|0
77513|NCT00103857|282556|P6|50-Week Extension Study|protocol discontinuation criteria|3
77514|NCT00103857|282557|P5|50-Week Extension Study|protocol discontinuation criteria|3
77515|NCT00103857|282558|P4|50-Week Extension Study|protocol discontinuation criteria|2
77516|NCT00103857|282559|P3|50-Week Extension Study|protocol discontinuation criteria|3
77517|NCT00103857|282560|P2|50-Week Extension Study|protocol discontinuation criteria|2
77518|NCT00103857|282561|P1|50-Week Extension Study|protocol discontinuation criteria|2
77519|NCT00103857|282555|P7|50-Week Extension Study|Withdrawal by Subject|0
77520|NCT00103857|282556|P6|50-Week Extension Study|Withdrawal by Subject|3
77521|NCT00103857|282557|P5|50-Week Extension Study|Withdrawal by Subject|3
77522|NCT00103857|282558|P4|50-Week Extension Study|Withdrawal by Subject|8
77523|NCT00103857|282559|P3|50-Week Extension Study|Withdrawal by Subject|2
77524|NCT00103857|282560|P2|50-Week Extension Study|Withdrawal by Subject|5
77525|NCT00103857|282561|P1|50-Week Extension Study|Withdrawal by Subject|2
77526|NCT00103857|282555|P7|50-Week Extension Study|Protocol Violation|0
77527|NCT00103857|282556|P6|50-Week Extension Study|Protocol Violation|1
77528|NCT00103857|282557|P5|50-Week Extension Study|Protocol Violation|0
77529|NCT00103857|282558|P4|50-Week Extension Study|Protocol Violation|2
77530|NCT00103857|282559|P3|50-Week Extension Study|Protocol Violation|1
77531|NCT00103857|282560|P2|50-Week Extension Study|Protocol Violation|1
77532|NCT00103857|282561|P1|50-Week Extension Study|Protocol Violation|1
77533|NCT00103857|282555|P7|50-Week Extension Study|Pregnancy|0
77534|NCT00103857|282556|P6|50-Week Extension Study|Pregnancy|0
77535|NCT00103857|282557|P5|50-Week Extension Study|Pregnancy|1
77536|NCT00103857|282558|P4|50-Week Extension Study|Pregnancy|0
77537|NCT00103857|282559|P3|50-Week Extension Study|Pregnancy|1
77538|NCT00103857|282560|P2|50-Week Extension Study|Pregnancy|0
77539|NCT00103857|282561|P1|50-Week Extension Study|Pregnancy|0
77540|NCT00103857|282555|P7|50-Week Extension Study|Physician Decision|0
77541|NCT00103857|282556|P6|50-Week Extension Study|Physician Decision|0
77542|NCT00103857|282557|P5|50-Week Extension Study|Physician Decision|0
77543|NCT00103857|282558|P4|50-Week Extension Study|Physician Decision|0
77544|NCT00103857|282559|P3|50-Week Extension Study|Physician Decision|1
77545|NCT00103857|282560|P2|50-Week Extension Study|Physician Decision|1
77546|NCT00103857|282561|P1|50-Week Extension Study|Physician Decision|0
77547|NCT00103857|282555|P7|50-Week Extension Study|Lost to Follow-up|0
77548|NCT00103857|282556|P6|50-Week Extension Study|Lost to Follow-up|3
77549|NCT00103857|282557|P5|50-Week Extension Study|Lost to Follow-up|3
77550|NCT00103857|282558|P4|50-Week Extension Study|Lost to Follow-up|4
77551|NCT00103857|282559|P3|50-Week Extension Study|Lost to Follow-up|1
77552|NCT00103857|282560|P2|50-Week Extension Study|Lost to Follow-up|0
77553|NCT00103857|282561|P1|50-Week Extension Study|Lost to Follow-up|4
77554|NCT00103857|282555|P7|50-Week Extension Study|Lack of Efficacy|0
77555|NCT00103857|282556|P6|50-Week Extension Study|Lack of Efficacy|8
77556|NCT00103857|282557|P5|50-Week Extension Study|Lack of Efficacy|8
77557|NCT00103857|282558|P4|50-Week Extension Study|Lack of Efficacy|16
77558|NCT00103857|282559|P3|50-Week Extension Study|Lack of Efficacy|13
77559|NCT00103857|282560|P2|50-Week Extension Study|Lack of Efficacy|15
77560|NCT00103857|282561|P1|50-Week Extension Study|Lack of Efficacy|26
77561|NCT00103857|282555|P7|50-Week Extension Study|Death|0
77562|NCT00103857|282556|P6|50-Week Extension Study|Death|1
77563|NCT00103857|282557|P5|50-Week Extension Study|Death|0
77564|NCT00103857|282558|P4|50-Week Extension Study|Death|1
77565|NCT00103857|282559|P3|50-Week Extension Study|Death|0
77566|NCT00103857|282560|P2|50-Week Extension Study|Death|0
77567|NCT00103857|282561|P1|50-Week Extension Study|Death|0
77568|NCT00103857|282555|P7|50-Week Extension Study|Adverse Event|0
77569|NCT00103857|282556|P6|50-Week Extension Study|Adverse Event|1
77570|NCT00103857|282557|P5|50-Week Extension Study|Adverse Event|1
77571|NCT00103857|282558|P4|50-Week Extension Study|Adverse Event|0
77572|NCT00103857|282559|P3|50-Week Extension Study|Adverse Event|2
77573|NCT00103857|282560|P2|50-Week Extension Study|Adverse Event|3
77574|NCT00103857|282561|P1|50-Week Extension Study|Adverse Event|2
77575|NCT00103857|282555|P7|54-Week Base Study|patient intolerance to rescue therapy|0
77576|NCT00103857|282556|P6|54-Week Base Study|patient intolerance to rescue therapy|0
77577|NCT00103857|282557|P5|54-Week Base Study|patient intolerance to rescue therapy|0
77578|NCT00103857|282558|P4|54-Week Base Study|patient intolerance to rescue therapy|0
77579|NCT00103857|282559|P3|54-Week Base Study|patient intolerance to rescue therapy|0
77580|NCT00103857|282560|P2|54-Week Base Study|patient intolerance to rescue therapy|0
77663|NCT00103857|282559|P3|54-Week Base Study|Lack of Efficacy|8
77581|NCT00103857|282561|P1|54-Week Base Study|patient intolerance to rescue therapy|1
77582|NCT00103857|282555|P7|54-Week Base Study|site error|0
77583|NCT00103857|282556|P6|54-Week Base Study|site error|1
77584|NCT00103857|282557|P5|54-Week Base Study|site error|0
77585|NCT00103857|282558|P4|54-Week Base Study|site error|0
77586|NCT00103857|282559|P3|54-Week Base Study|site error|0
77587|NCT00103857|282560|P2|54-Week Base Study|site error|0
77588|NCT00103857|282561|P1|54-Week Base Study|site error|0
77589|NCT00103857|282555|P7|54-Week Base Study|laboratory reporting error|0
77590|NCT00103857|282556|P6|54-Week Base Study|laboratory reporting error|0
77591|NCT00103857|282557|P5|54-Week Base Study|laboratory reporting error|1
77592|NCT00103857|282558|P4|54-Week Base Study|laboratory reporting error|0
77593|NCT00103857|282559|P3|54-Week Base Study|laboratory reporting error|0
77594|NCT00103857|282560|P2|54-Week Base Study|laboratory reporting error|0
77595|NCT00103857|282561|P1|54-Week Base Study|laboratory reporting error|0
77596|NCT00103857|282555|P7|54-Week Base Study|patient incarcerated|0
77597|NCT00103857|282556|P6|54-Week Base Study|patient incarcerated|1
77598|NCT00103857|282557|P5|54-Week Base Study|patient incarcerated|1
77599|NCT00103857|282558|P4|54-Week Base Study|patient incarcerated|0
77600|NCT00103857|282559|P3|54-Week Base Study|patient incarcerated|0
77601|NCT00103857|282560|P2|54-Week Base Study|patient incarcerated|0
77602|NCT00103857|282561|P1|54-Week Base Study|patient incarcerated|0
77603|NCT00103857|282555|P7|54-Week Base Study|non-compliance with study procedures|0
77604|NCT00103857|282556|P6|54-Week Base Study|non-compliance with study procedures|2
77605|NCT00103857|282557|P5|54-Week Base Study|non-compliance with study procedures|0
77606|NCT00103857|282558|P4|54-Week Base Study|non-compliance with study procedures|0
77607|NCT00103857|282559|P3|54-Week Base Study|non-compliance with study procedures|0
77608|NCT00103857|282560|P2|54-Week Base Study|non-compliance with study procedures|2
77609|NCT00103857|282561|P1|54-Week Base Study|non-compliance with study procedures|1
77610|NCT00103857|282555|P7|54-Week Base Study|patient moved|0
77611|NCT00103857|282556|P6|54-Week Base Study|patient moved|1
77612|NCT00103857|282557|P5|54-Week Base Study|patient moved|3
77613|NCT00103857|282558|P4|54-Week Base Study|patient moved|2
77614|NCT00103857|282559|P3|54-Week Base Study|patient moved|1
77615|NCT00103857|282560|P2|54-Week Base Study|patient moved|1
77616|NCT00103857|282561|P1|54-Week Base Study|patient moved|0
77617|NCT00103857|282555|P7|54-Week Base Study|protocol discontinuation criteria|5
77618|NCT00103857|282556|P6|54-Week Base Study|protocol discontinuation criteria|3
77619|NCT00103857|282557|P5|54-Week Base Study|protocol discontinuation criteria|5
77620|NCT00103857|282558|P4|54-Week Base Study|protocol discontinuation criteria|6
77621|NCT00103857|282559|P3|54-Week Base Study|protocol discontinuation criteria|2
77622|NCT00103857|282560|P2|54-Week Base Study|protocol discontinuation criteria|5
77623|NCT00103857|282561|P1|54-Week Base Study|protocol discontinuation criteria|2
77624|NCT00103857|282555|P7|54-Week Base Study|Withdrawal by Subject|4
77625|NCT00103857|282556|P6|54-Week Base Study|Withdrawal by Subject|15
77626|NCT00103857|282557|P5|54-Week Base Study|Withdrawal by Subject|10
77627|NCT00103857|282558|P4|54-Week Base Study|Withdrawal by Subject|15
77628|NCT00103857|282559|P3|54-Week Base Study|Withdrawal by Subject|16
77629|NCT00103857|282560|P2|54-Week Base Study|Withdrawal by Subject|16
77630|NCT00103857|282561|P1|54-Week Base Study|Withdrawal by Subject|17
77631|NCT00103857|282555|P7|54-Week Base Study|Protocol Violation|3
77632|NCT00103857|282556|P6|54-Week Base Study|Protocol Violation|3
77633|NCT00103857|282557|P5|54-Week Base Study|Protocol Violation|0
77634|NCT00103857|282558|P4|54-Week Base Study|Protocol Violation|4
77635|NCT00103857|282559|P3|54-Week Base Study|Protocol Violation|2
77636|NCT00103857|282560|P2|54-Week Base Study|Protocol Violation|4
77637|NCT00103857|282561|P1|54-Week Base Study|Protocol Violation|6
77638|NCT00103857|282555|P7|54-Week Base Study|Pregnancy|1
77639|NCT00103857|282556|P6|54-Week Base Study|Pregnancy|0
77640|NCT00103857|282557|P5|54-Week Base Study|Pregnancy|1
77641|NCT00103857|282558|P4|54-Week Base Study|Pregnancy|0
77642|NCT00103857|282559|P3|54-Week Base Study|Pregnancy|0
77643|NCT00103857|282560|P2|54-Week Base Study|Pregnancy|0
77644|NCT00103857|282561|P1|54-Week Base Study|Pregnancy|1
77645|NCT00103857|282555|P7|54-Week Base Study|Physician Decision|0
77646|NCT00103857|282556|P6|54-Week Base Study|Physician Decision|0
77647|NCT00103857|282557|P5|54-Week Base Study|Physician Decision|1
77648|NCT00103857|282558|P4|54-Week Base Study|Physician Decision|0
77649|NCT00103857|282559|P3|54-Week Base Study|Physician Decision|0
77650|NCT00103857|282560|P2|54-Week Base Study|Physician Decision|1
77651|NCT00103857|282561|P1|54-Week Base Study|Physician Decision|1
77652|NCT00103857|282555|P7|54-Week Base Study|Lost to Follow-up|3
77653|NCT00103857|282556|P6|54-Week Base Study|Lost to Follow-up|9
77654|NCT00103857|282557|P5|54-Week Base Study|Lost to Follow-up|10
77655|NCT00103857|282558|P4|54-Week Base Study|Lost to Follow-up|5
77656|NCT00103857|282559|P3|54-Week Base Study|Lost to Follow-up|7
77657|NCT00103857|282560|P2|54-Week Base Study|Lost to Follow-up|4
77658|NCT00103857|282561|P1|54-Week Base Study|Lost to Follow-up|5
77659|NCT00103857|282555|P7|54-Week Base Study|Lack of Efficacy|19
77660|NCT00103857|282556|P6|54-Week Base Study|Lack of Efficacy|14
77661|NCT00103857|282557|P5|54-Week Base Study|Lack of Efficacy|3
77662|NCT00103857|282558|P4|54-Week Base Study|Lack of Efficacy|4
77664|NCT00103857|282560|P2|54-Week Base Study|Lack of Efficacy|14
77665|NCT00103857|282561|P1|54-Week Base Study|Lack of Efficacy|11
77666|NCT00103857|282555|P7|54-Week Base Study|Death|0
77667|NCT00103857|282556|P6|54-Week Base Study|Death|1
77668|NCT00103857|282557|P5|54-Week Base Study|Death|1
77669|NCT00103857|282558|P4|54-Week Base Study|Death|0
77670|NCT00103857|282559|P3|54-Week Base Study|Death|0
77671|NCT00103857|282560|P2|54-Week Base Study|Death|0
77672|NCT00103857|282561|P1|54-Week Base Study|Death|0
77673|NCT00103857|282555|P7|54-Week Base Study|Adverse Event|3
77674|NCT00103857|282556|P6|54-Week Base Study|Adverse Event|11
77675|NCT00103857|282557|P5|54-Week Base Study|Adverse Event|5
77676|NCT00103857|282558|P4|54-Week Base Study|Adverse Event|6
77677|NCT00103857|282559|P3|54-Week Base Study|Adverse Event|11
77678|NCT00103857|282560|P2|54-Week Base Study|Adverse Event|9
77679|NCT00103857|282561|P1|54-Week Base Study|Adverse Event|12
77680|NCT00104052|282624|P1|Overall Study|Discontinuation unrelated to treatment|2
77681|NCT00104052|282624|P1|Overall Study|Lack of Efficacy|26
77682|NCT00104052|282624|P1|Overall Study|Adverse Event|1
77683|NCT00104104|282630|P2|Overall Study|Death|6
77684|NCT00104104|282631|P1|Overall Study|Death|9
77685|NCT00104104|282630|P2|Overall Study|Administrative problems|13
77686|NCT00104104|282631|P1|Overall Study|Administrative problems|12
77687|NCT00104104|282630|P2|Overall Study|Lost to Follow-up|7
77688|NCT00104104|282631|P1|Overall Study|Lost to Follow-up|3
77689|NCT00104104|282630|P2|Overall Study|Withdrawal by Subject|15
77690|NCT00104104|282631|P1|Overall Study|Withdrawal by Subject|11
77691|NCT00104104|282630|P2|Overall Study|Protocol Violation|2
77692|NCT00104104|282631|P1|Overall Study|Protocol Violation|5
77693|NCT00104104|282630|P2|Overall Study|Condition no longer requires study drug|4
77694|NCT00104104|282631|P1|Overall Study|Condition no longer requires study drug|7
77695|NCT00104104|282630|P2|Overall Study|Lack of Efficacy|3
77696|NCT00104104|282631|P1|Overall Study|Lack of Efficacy|0
77697|NCT00104104|282630|P2|Overall Study|Abnormal laboratory value(s)|14
77698|NCT00104104|282631|P1|Overall Study|Abnormal laboratory value(s)|20
77699|NCT00104104|282630|P2|Overall Study|Adverse Event|8
77700|NCT00104104|282631|P1|Overall Study|Adverse Event|8
77701|NCT00104247|282658|P2|Overall Study|Noncompliant with dosing|1
77702|NCT00104247|282659|P1|Overall Study|Noncompliant with dosing|0
77703|NCT00104247|282658|P2|Overall Study|Withdrawal by Subject|0
77704|NCT00104247|282659|P1|Overall Study|Withdrawal by Subject|1
77705|NCT00104299|282667|P2|Overall Study|To have renal transplant|0
77706|NCT00104299|282668|P1|Overall Study|To have renal transplant|1
77707|NCT00104299|282667|P2|Overall Study|Physician Decision|1
77708|NCT00104299|282668|P1|Overall Study|Physician Decision|1
77709|NCT00104299|282667|P2|Overall Study|Withdrawal by Subject|6
77710|NCT00104299|282668|P1|Overall Study|Withdrawal by Subject|2
77711|NCT00104299|282667|P2|Overall Study|Death|2
77712|NCT00104299|282668|P1|Overall Study|Death|2
77713|NCT00104299|282667|P2|Overall Study|Adverse Event|1
77714|NCT00104299|282668|P1|Overall Study|Adverse Event|3
77715|NCT00104416|282690|P5|Continuation Phase|Non-compliance|1
77716|NCT00104416|282691|P4|Continuation Phase|Non-compliance|0
77717|NCT00104416|282692|P3|Continuation Phase|Non-compliance|0
77718|NCT00104416|282693|P2|Continuation Phase|Non-compliance|0
77719|NCT00104416|282694|P1|Continuation Phase|Non-compliance|0
77720|NCT00104416|282690|P5|Continuation Phase|Pregnancy|0
77721|NCT00104416|282691|P4|Continuation Phase|Pregnancy|1
77722|NCT00104416|282692|P3|Continuation Phase|Pregnancy|1
77723|NCT00104416|282693|P2|Continuation Phase|Pregnancy|0
77724|NCT00104416|282694|P1|Continuation Phase|Pregnancy|0
77725|NCT00104416|282690|P5|Continuation Phase|Withdrawal by Subject|1
77726|NCT00104416|282691|P4|Continuation Phase|Withdrawal by Subject|1
77727|NCT00104416|282692|P3|Continuation Phase|Withdrawal by Subject|2
77728|NCT00104416|282693|P2|Continuation Phase|Withdrawal by Subject|0
77729|NCT00104416|282694|P1|Continuation Phase|Withdrawal by Subject|0
77730|NCT00104416|282690|P5|Continuation Phase|Lost to Follow-up|1
77731|NCT00104416|282691|P4|Continuation Phase|Lost to Follow-up|0
77732|NCT00104416|282692|P3|Continuation Phase|Lost to Follow-up|1
77733|NCT00104416|282693|P2|Continuation Phase|Lost to Follow-up|0
77734|NCT00104416|282694|P1|Continuation Phase|Lost to Follow-up|0
77735|NCT00104416|282690|P5|Continuation Phase|Adverse Event|2
77736|NCT00104416|282691|P4|Continuation Phase|Adverse Event|0
77737|NCT00104416|282692|P3|Continuation Phase|Adverse Event|2
77738|NCT00104416|282693|P2|Continuation Phase|Adverse Event|0
77739|NCT00104416|282694|P1|Continuation Phase|Adverse Event|0
77740|NCT00104416|282690|P5|Double-Blind Phase|Participant Did Not Take Drug|0
77741|NCT00104416|282691|P4|Double-Blind Phase|Participant Did Not Take Drug|0
77742|NCT00104416|282692|P3|Double-Blind Phase|Participant Did Not Take Drug|0
77743|NCT00104416|282693|P2|Double-Blind Phase|Participant Did Not Take Drug|4
77744|NCT00104416|282694|P1|Double-Blind Phase|Participant Did Not Take Drug|3
77745|NCT00104416|282690|P5|Double-Blind Phase|Pregnancy|0
77746|NCT00104416|282691|P4|Double-Blind Phase|Pregnancy|0
77747|NCT00104416|282692|P3|Double-Blind Phase|Pregnancy|0
77748|NCT00104416|282693|P2|Double-Blind Phase|Pregnancy|0
77749|NCT00104416|282694|P1|Double-Blind Phase|Pregnancy|1
77750|NCT00104416|282690|P5|Double-Blind Phase|Withdrawal by Subject|0
77751|NCT00104416|282691|P4|Double-Blind Phase|Withdrawal by Subject|0
77752|NCT00104416|282692|P3|Double-Blind Phase|Withdrawal by Subject|0
77753|NCT00104416|282693|P2|Double-Blind Phase|Withdrawal by Subject|3
77754|NCT00104416|282694|P1|Double-Blind Phase|Withdrawal by Subject|2
77755|NCT00104416|282690|P5|Double-Blind Phase|Protocol Violation|0
77756|NCT00104416|282691|P4|Double-Blind Phase|Protocol Violation|0
77757|NCT00104416|282692|P3|Double-Blind Phase|Protocol Violation|0
77758|NCT00104416|282693|P2|Double-Blind Phase|Protocol Violation|1
77759|NCT00104416|282694|P1|Double-Blind Phase|Protocol Violation|0
77760|NCT00104416|282690|P5|Double-Blind Phase|Lost to Follow-up|0
77761|NCT00104416|282691|P4|Double-Blind Phase|Lost to Follow-up|0
77762|NCT00104416|282692|P3|Double-Blind Phase|Lost to Follow-up|0
77763|NCT00104416|282693|P2|Double-Blind Phase|Lost to Follow-up|1
77764|NCT00104416|282694|P1|Double-Blind Phase|Lost to Follow-up|0
77765|NCT00104416|282690|P5|Double-Blind Phase|Adverse Event|0
77766|NCT00104416|282691|P4|Double-Blind Phase|Adverse Event|0
77767|NCT00104416|282692|P3|Double-Blind Phase|Adverse Event|0
77768|NCT00104416|282693|P2|Double-Blind Phase|Adverse Event|1
77769|NCT00104416|282694|P1|Double-Blind Phase|Adverse Event|2
77770|NCT00104520|282739|P2|Overall Study|Other|5
77771|NCT00104520|282740|P1|Overall Study|Other|1
77772|NCT00104520|282739|P2|Overall Study|Personal/administrative|1
77773|NCT00104520|282740|P1|Overall Study|Personal/administrative|1
77774|NCT00104520|282739|P2|Overall Study|Noncompliance|2
77775|NCT00104520|282740|P1|Overall Study|Noncompliance|0
77776|NCT00104520|282739|P2|Overall Study|Lost to Follow-up|0
77777|NCT00104520|282740|P1|Overall Study|Lost to Follow-up|1
77778|NCT00104520|282739|P2|Overall Study|Related adverse event|15
77779|NCT00104520|282740|P1|Overall Study|Related adverse event|13
77780|NCT00104520|282739|P2|Overall Study|Study drug intolerance|1
77781|NCT00104520|282740|P1|Overall Study|Study drug intolerance|0
77782|NCT00104520|282739|P2|Overall Study|Unrelated adverse event|47
77783|NCT00104520|282740|P1|Overall Study|Unrelated adverse event|34
77784|NCT00104572|282761|P3|Overall Study|Withdrawal by Subject|0
77785|NCT00104572|282762|P2|Overall Study|Withdrawal by Subject|3
77786|NCT00104572|282763|P1|Overall Study|Withdrawal by Subject|3
77787|NCT00104637|282771|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
77788|NCT00104637|282772|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
77789|NCT00104650|282801|P3|Follow-up Period|Other|0
77790|NCT00104650|282802|P2|Follow-up Period|Other|1
77791|NCT00104650|282803|P1|Follow-up Period|Other|0
77792|NCT00104650|282801|P3|Follow-up Period|Lost to Follow-up|2
77793|NCT00104650|282802|P2|Follow-up Period|Lost to Follow-up|1
77794|NCT00104650|282803|P1|Follow-up Period|Lost to Follow-up|0
77795|NCT00104650|282801|P3|Follow-up Period|Disease progression|0
77796|NCT00104650|282802|P2|Follow-up Period|Disease progression|1
77797|NCT00104650|282803|P1|Follow-up Period|Disease progression|3
77798|NCT00104650|282801|P3|Follow-up Period|Death|4
77799|NCT00104650|282802|P2|Follow-up Period|Death|6
77800|NCT00104650|282803|P1|Follow-up Period|Death|6
77801|NCT00104650|282801|P3|Follow-up Period|Withdrawal by Subject|3
77802|NCT00104650|282802|P2|Follow-up Period|Withdrawal by Subject|3
77803|NCT00104650|282803|P1|Follow-up Period|Withdrawal by Subject|0
77804|NCT00104650|282801|P3|Follow-up Period|Adverse Event|1
77805|NCT00104650|282802|P2|Follow-up Period|Adverse Event|0
77806|NCT00104650|282803|P1|Follow-up Period|Adverse Event|1
77807|NCT00104650|282801|P3|Follow-up Period|Physician Decision|0
77808|NCT00104650|282802|P2|Follow-up Period|Physician Decision|1
77809|NCT00104650|282803|P1|Follow-up Period|Physician Decision|1
77810|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Protocol deviation|0
77811|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Protocol deviation|1
77812|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Protocol deviation|0
77813|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Other|0
77814|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Other|0
77815|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Other|1
77816|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
77817|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
77818|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
77819|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Disease progression|2
77820|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Disease progression|3
77821|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Disease progression|2
77822|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Death|6
77823|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Death|5
77824|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Death|7
77825|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
77826|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
77827|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
77828|NCT00104650|282801|P3|Treatment Period (25 Weeks)|Physician Decision|1
77829|NCT00104650|282802|P2|Treatment Period (25 Weeks)|Physician Decision|0
77830|NCT00104650|282803|P1|Treatment Period (25 Weeks)|Physician Decision|0
77831|NCT00104728|282835|P1|Overall Study|screen failures|19
77832|NCT00104871|282840|P1|Overall Study|Not evaluable|1
77833|NCT00104884|282845|P1|Overall Study|Disease progression|4
77834|NCT00105066|282901|P2|Overall Study|Adverse Event|5
77835|NCT00105066|282902|P1|Overall Study|Adverse Event|2
77836|NCT00105079|282914|P2|Overall Study|not specified|1
77837|NCT00105079|282915|P1|Overall Study|not specified|3
77838|NCT00105079|282914|P2|Overall Study|Protocol Violation|0
77839|NCT00105079|282915|P1|Overall Study|Protocol Violation|1
77840|NCT00105079|282914|P2|Overall Study|Violation of selection criteria at entry|2
77841|NCT00105079|282915|P1|Overall Study|Violation of selection criteria at entry|0
77842|NCT00105079|282914|P2|Overall Study|Refused treatment|4
77843|NCT00105079|282915|P1|Overall Study|Refused treatment|6
77844|NCT00105079|282914|P2|Overall Study|Lack of Efficacy|3
77845|NCT00105079|282915|P1|Overall Study|Lack of Efficacy|9
77846|NCT00105079|282914|P2|Overall Study|Lost to Follow-up|12
77847|NCT00105079|282915|P1|Overall Study|Lost to Follow-up|12
77848|NCT00105079|282914|P2|Overall Study|Death|1
77849|NCT00105079|282915|P1|Overall Study|Death|3
77850|NCT00105079|282914|P2|Overall Study|Adverse Event|12
77851|NCT00105079|282915|P1|Overall Study|Adverse Event|5
77852|NCT00105157|282935|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
77853|NCT00105157|282936|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
77854|NCT00105157|282937|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
77855|NCT00105157|282938|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
77856|NCT00105157|282935|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
77857|NCT00105157|282936|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
77858|NCT00105157|282937|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
77859|NCT00105157|282938|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
77860|NCT00105157|282935|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
77861|NCT00105157|282936|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
77862|NCT00105157|282937|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
77863|NCT00105157|282938|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
77864|NCT00105157|282935|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
77865|NCT00105157|282936|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
77866|NCT00105157|282937|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
77867|NCT00105157|282938|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
77868|NCT00105157|282935|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
77869|NCT00105157|282936|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
77870|NCT00105157|282937|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
77871|NCT00105157|282938|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
77872|NCT00105157|282935|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
77873|NCT00105157|282936|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
77874|NCT00105157|282937|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
77875|NCT00105157|282938|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
77876|NCT00105157|282935|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
77877|NCT00105157|282936|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
77878|NCT00105157|282937|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
77879|NCT00105157|282938|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
77880|NCT00105157|282935|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
77881|NCT00105157|282936|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
77882|NCT00105157|282937|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
77883|NCT00105157|282938|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
77884|NCT00105157|282935|P4|Open-Label Continuation of DB|Lost to Follow-up|0
77885|NCT00105157|282936|P3|Open-Label Continuation of DB|Lost to Follow-up|1
77886|NCT00105157|282937|P2|Open-Label Continuation of DB|Lost to Follow-up|1
77887|NCT00105157|282938|P1|Open-Label Continuation of DB|Lost to Follow-up|1
77888|NCT00105157|282935|P4|Open-Label Continuation of DB|Lack of Efficacy|1
77889|NCT00105157|282936|P3|Open-Label Continuation of DB|Lack of Efficacy|3
77890|NCT00105157|282937|P2|Open-Label Continuation of DB|Lack of Efficacy|4
77891|NCT00105157|282938|P1|Open-Label Continuation of DB|Lack of Efficacy|1
77892|NCT00105157|282935|P4|Open-Label Continuation of DB|Adverse Event|0
77893|NCT00105157|282936|P3|Open-Label Continuation of DB|Adverse Event|0
77894|NCT00105157|282937|P2|Open-Label Continuation of DB|Adverse Event|1
77895|NCT00105157|282938|P1|Open-Label Continuation of DB|Adverse Event|3
77896|NCT00105157|282935|P4|Double-Blind (DB)|Lack of Efficacy|38
77897|NCT00105157|282936|P3|Double-Blind (DB)|Lack of Efficacy|11
77898|NCT00105157|282937|P2|Double-Blind (DB)|Lack of Efficacy|14
77899|NCT00105157|282938|P1|Double-Blind (DB)|Lack of Efficacy|11
77900|NCT00105157|282935|P4|Double-Blind (DB)|Adverse Event|1
77901|NCT00105157|282936|P3|Double-Blind (DB)|Adverse Event|1
77902|NCT00105157|282937|P2|Double-Blind (DB)|Adverse Event|0
77903|NCT00105157|282938|P1|Double-Blind (DB)|Adverse Event|2
77904|NCT00105157|282935|P4|Double-Blind (DB)|Never Treated|0
77905|NCT00105157|282936|P3|Double-Blind (DB)|Never Treated|0
77906|NCT00105157|282937|P2|Double-Blind (DB)|Never Treated|0
77907|NCT00105157|282938|P1|Double-Blind (DB)|Never Treated|1
77908|NCT00105183|283133|P3|Overall Study|Other reason|0
77909|NCT00105183|283134|P2|Overall Study|Other reason|2
77910|NCT00105183|283135|P1|Overall Study|Other reason|1
77911|NCT00105183|283133|P3|Overall Study|Lost to Follow-up|1
77912|NCT00105183|283134|P2|Overall Study|Lost to Follow-up|1
77913|NCT00105183|283135|P1|Overall Study|Lost to Follow-up|0
77914|NCT00105183|283133|P3|Overall Study|Physician Decision|3
77915|NCT00105183|283134|P2|Overall Study|Physician Decision|2
77916|NCT00105183|283135|P1|Overall Study|Physician Decision|1
77917|NCT00105183|283133|P3|Overall Study|Withdrawal by Subject|4
77918|NCT00105183|283134|P2|Overall Study|Withdrawal by Subject|1
77919|NCT00105183|283135|P1|Overall Study|Withdrawal by Subject|1
77920|NCT00105183|283133|P3|Overall Study|Death|15
77921|NCT00105183|283134|P2|Overall Study|Death|13
77922|NCT00105183|283135|P1|Overall Study|Death|19
77923|NCT00105196|283169|P2|Overall Study|Subject became unblinded|1
77924|NCT00105196|283170|P1|Overall Study|Subject became unblinded|0
77925|NCT00105196|283169|P2|Overall Study|marijuana use|1
77926|NCT00105196|283170|P1|Overall Study|marijuana use|0
77927|NCT00105196|283169|P2|Overall Study|pending surgery|1
77928|NCT00105196|283170|P1|Overall Study|pending surgery|0
77929|NCT00105196|283169|P2|Overall Study|Protocol Violation|2
77930|NCT00105196|283170|P1|Overall Study|Protocol Violation|5
77931|NCT00105196|283169|P2|Overall Study|Poor/noncompliance|4
77932|NCT00105196|283170|P1|Overall Study|Poor/noncompliance|3
77933|NCT00105196|283169|P2|Overall Study|Lost to Follow-up|2
77934|NCT00105196|283170|P1|Overall Study|Lost to Follow-up|3
77935|NCT00105196|283169|P2|Overall Study|Withdrawal by Subject|6
77936|NCT00105196|283170|P1|Overall Study|Withdrawal by Subject|6
77937|NCT00105196|283169|P2|Overall Study|Adverse Event|3
77938|NCT00105196|283170|P1|Overall Study|Adverse Event|11
77939|NCT00105196|283169|P2|Overall Study|Lack of Efficacy|3
77940|NCT00105196|283170|P1|Overall Study|Lack of Efficacy|2
77941|NCT00105235|283190|P1|Overall Study|Withdrawal by Subject|2
77942|NCT00105235|283190|P1|Overall Study|Physician Decision|1
77943|NCT00105235|283190|P1|Overall Study|Death|4
77944|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
77945|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
77946|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
77947|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
77948|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
77949|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
77950|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
77951|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
78023|NCT00105469|283236|P1|Overall Study|Lack of Efficacy|2
77952|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
77953|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
77954|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
77955|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
77956|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
77957|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
77958|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
77959|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
77960|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
77961|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
77962|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
77963|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
77964|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
77965|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
77966|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
77967|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
77968|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
77969|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
77970|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
77971|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
77972|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
77973|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
77974|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
77975|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
77976|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
77977|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
77978|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
77979|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
77980|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
77981|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
77982|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
77983|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
77984|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
77985|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
77986|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
77987|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
77988|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
77989|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
77990|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
77991|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
77992|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
77993|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
77994|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
77995|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
77996|NCT00105443|283203|P4|Follow-up and/or Open Label Nexavar|Death|4
77997|NCT00105443|283204|P3|Follow-up and/or Open Label Nexavar|Death|219
77998|NCT00105443|283205|P2|Follow-up and/or Open Label Nexavar|Death|7
77999|NCT00105443|283206|P1|Follow-up and/or Open Label Nexavar|Death|180
78000|NCT00105443|283203|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
78001|NCT00105443|283204|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
78002|NCT00105443|283205|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
78003|NCT00105443|283206|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
78004|NCT00105443|283203|P4|Double-Blind Treatment|Physician Decision|0
78005|NCT00105443|283204|P3|Double-Blind Treatment|Physician Decision|2
78006|NCT00105443|283205|P2|Double-Blind Treatment|Physician Decision|0
78007|NCT00105443|283206|P1|Double-Blind Treatment|Physician Decision|1
78008|NCT00105443|283203|P4|Double-Blind Treatment|Withdrawal by Subject|0
78009|NCT00105443|283204|P3|Double-Blind Treatment|Withdrawal by Subject|7
78010|NCT00105443|283205|P2|Double-Blind Treatment|Withdrawal by Subject|0
78011|NCT00105443|283206|P1|Double-Blind Treatment|Withdrawal by Subject|8
78012|NCT00105443|283203|P4|Double-Blind Treatment|Lost to Follow-up|0
78013|NCT00105443|283204|P3|Double-Blind Treatment|Lost to Follow-up|1
78014|NCT00105443|283205|P2|Double-Blind Treatment|Lost to Follow-up|0
78015|NCT00105443|283206|P1|Double-Blind Treatment|Lost to Follow-up|0
78016|NCT00105443|283203|P4|Double-Blind Treatment|Adverse Event|0
78017|NCT00105443|283204|P3|Double-Blind Treatment|Adverse Event|0
78018|NCT00105443|283205|P2|Double-Blind Treatment|Adverse Event|0
78019|NCT00105443|283206|P1|Double-Blind Treatment|Adverse Event|1
78020|NCT00105469|283235|P2|Overall Study|Other Reason|0
78021|NCT00105469|283236|P1|Overall Study|Other Reason|4
78022|NCT00105469|283235|P2|Overall Study|Lack of Efficacy|0
78024|NCT00105469|283235|P2|Overall Study|Lost to Follow-up|0
78025|NCT00105469|283236|P1|Overall Study|Lost to Follow-up|1
78026|NCT00105469|283235|P2|Overall Study|Withdrawal by Subject|3
78027|NCT00105469|283236|P1|Overall Study|Withdrawal by Subject|2
78028|NCT00105469|283235|P2|Overall Study|Protocol Violation|0
78029|NCT00105469|283236|P1|Overall Study|Protocol Violation|4
78030|NCT00105469|283235|P2|Overall Study|Adverse Event|8
78031|NCT00105469|283236|P1|Overall Study|Adverse Event|9
78032|NCT00105482|283246|P2|Overall Study|Withdrawn by PI|1
78033|NCT00105482|283247|P1|Overall Study|Withdrawn by PI|1
78034|NCT00105482|283246|P2|Overall Study|Scheduling Conflict|3
78035|NCT00105482|283247|P1|Overall Study|Scheduling Conflict|2
78036|NCT00105482|283246|P2|Overall Study|Lost Interest|32
78037|NCT00105482|283247|P1|Overall Study|Lost Interest|29
78038|NCT00105482|283246|P2|Overall Study|Withdrawal by Subject|1
78039|NCT00105482|283247|P1|Overall Study|Withdrawal by Subject|0
78040|NCT00105482|283246|P2|Overall Study|Lost to Follow-up|17
78041|NCT00105482|283247|P1|Overall Study|Lost to Follow-up|26
78042|NCT00105482|283246|P2|Overall Study|Adverse Event|1
78043|NCT00105482|283247|P1|Overall Study|Adverse Event|1
78044|NCT00105534|283263|P2|Overall Study|Other Reason|2
78045|NCT00105534|283264|P1|Overall Study|Other Reason|0
78046|NCT00105534|283263|P2|Overall Study|Treatment unmasked|0
78047|NCT00105534|283264|P1|Overall Study|Treatment unmasked|1
78048|NCT00105534|283263|P2|Overall Study|Lack of Efficacy|15
78049|NCT00105534|283264|P1|Overall Study|Lack of Efficacy|7
78050|NCT00105534|283263|P2|Overall Study|Lost to Follow-up|1
78051|NCT00105534|283264|P1|Overall Study|Lost to Follow-up|5
78052|NCT00105534|283263|P2|Overall Study|Withdrawal by Subject|6
78053|NCT00105534|283264|P1|Overall Study|Withdrawal by Subject|6
78054|NCT00105534|283263|P2|Overall Study|Protocol Violation|4
78055|NCT00105534|283264|P1|Overall Study|Protocol Violation|1
78056|NCT00105534|283263|P2|Overall Study|Adverse Event|5
78057|NCT00105534|283264|P1|Overall Study|Adverse Event|2
78058|NCT00105560|283272|P1|Overall Study|Lost to Follow-up|1
78059|NCT00105586|283294|P2|Overall Study|Physician Decision|13
78060|NCT00105586|283295|P1|Overall Study|Physician Decision|13
78061|NCT00105586|283294|P2|Overall Study|Adverse Event|3
78062|NCT00105586|283295|P1|Overall Study|Adverse Event|4
78063|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
78064|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
78065|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
78066|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
78067|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Death|0
78068|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Death|0
78069|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
78070|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
78071|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
78072|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
78073|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
78074|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
78075|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
78076|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
78077|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
78078|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
78079|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
78080|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
78081|NCT00105989|283303|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
78082|NCT00105989|283304|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
78083|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
78084|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
78085|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
78086|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
78087|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Death|0
78088|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Death|0
78089|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
78090|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
78091|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
78092|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
78093|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
78094|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
78095|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
78096|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
78097|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
78098|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
78099|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
78100|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
78101|NCT00105989|283303|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
78102|NCT00105989|283304|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
78103|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
78104|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
78105|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
78106|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
78107|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Death|0
78108|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Death|1
78109|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Physician Decision|0
78110|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Physician Decision|0
78111|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
78112|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
78113|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
78114|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
78115|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
78116|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
78117|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
78118|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
78119|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
78120|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
78121|NCT00105989|283303|P2|Acute - Open Label: Week 0-10|Adverse Event|0
78122|NCT00105989|283304|P1|Acute - Open Label: Week 0-10|Adverse Event|33
78123|NCT00106002|283418|P1|Overall Study|Ineligible after Registration|1
78124|NCT00106002|283418|P1|Overall Study|Did not take any study drug|1
78125|NCT00106028|283428|P2|Overall Study|Lost to Follow-up|1
78126|NCT00106028|283429|P1|Overall Study|Lost to Follow-up|0
78127|NCT00106028|283428|P2|Overall Study|Withdrawal by Subject|8
78128|NCT00106028|283429|P1|Overall Study|Withdrawal by Subject|2
78129|NCT00106028|283428|P2|Overall Study|Protocol Violation|1
78130|NCT00106028|283429|P1|Overall Study|Protocol Violation|1
78131|NCT00106028|283428|P2|Overall Study|Adverse Event|2
78132|NCT00106028|283429|P1|Overall Study|Adverse Event|3
78133|NCT00106080|283525|P2|Overall Study|Withdrew/Loss to follow-up|27
78134|NCT00106080|283526|P1|Overall Study|Withdrew/Loss to follow-up|43
78135|NCT00106184|283566|P2|Overall Study|Withdrawal by Subject|2
78136|NCT00106184|283567|P1|Overall Study|Withdrawal by Subject|3
78137|NCT00106249|283579|P2|Overall Study|Lost to Follow-up|2
78138|NCT00106249|283580|P1|Overall Study|Lost to Follow-up|3
78139|NCT00106353|283592|P7|Part 2|Physician Decision|0
78140|NCT00106353|283593|P6|Part 2|Physician Decision|1
78141|NCT00106353|283594|P5|Part 2|Physician Decision|0
78142|NCT00106353|283595|P4|Part 2|Physician Decision|0
78143|NCT00106353|283596|P3|Part 2|Physician Decision|0
78144|NCT00106353|283597|P2|Part 2|Physician Decision|0
78145|NCT00106353|283598|P1|Part 2|Physician Decision|0
78146|NCT00106353|283592|P7|Part 2|Withdrawal by Subject|0
78147|NCT00106353|283593|P6|Part 2|Withdrawal by Subject|0
78148|NCT00106353|283594|P5|Part 2|Withdrawal by Subject|1
78149|NCT00106353|283595|P4|Part 2|Withdrawal by Subject|0
78150|NCT00106353|283596|P3|Part 2|Withdrawal by Subject|0
78151|NCT00106353|283597|P2|Part 2|Withdrawal by Subject|0
78152|NCT00106353|283598|P1|Part 2|Withdrawal by Subject|0
78153|NCT00106353|283592|P7|Part 2|Unspecified|1
78154|NCT00106353|283593|P6|Part 2|Unspecified|1
78155|NCT00106353|283594|P5|Part 2|Unspecified|1
78156|NCT00106353|283595|P4|Part 2|Unspecified|0
78157|NCT00106353|283596|P3|Part 2|Unspecified|0
78158|NCT00106353|283597|P2|Part 2|Unspecified|0
78159|NCT00106353|283598|P1|Part 2|Unspecified|0
78160|NCT00106353|283592|P7|Part 2|Adverse Event|1
78161|NCT00106353|283593|P6|Part 2|Adverse Event|2
78162|NCT00106353|283594|P5|Part 2|Adverse Event|0
78163|NCT00106353|283595|P4|Part 2|Adverse Event|0
78164|NCT00106353|283596|P3|Part 2|Adverse Event|0
78165|NCT00106353|283597|P2|Part 2|Adverse Event|0
78166|NCT00106353|283598|P1|Part 2|Adverse Event|0
78167|NCT00106353|283592|P7|Part 2|Symptomatic deterioration|0
78168|NCT00106353|283593|P6|Part 2|Symptomatic deterioration|0
78169|NCT00106353|283594|P5|Part 2|Symptomatic deterioration|3
78170|NCT00106353|283595|P4|Part 2|Symptomatic deterioration|0
78171|NCT00106353|283596|P3|Part 2|Symptomatic deterioration|0
78172|NCT00106353|283597|P2|Part 2|Symptomatic deterioration|0
78173|NCT00106353|283598|P1|Part 2|Symptomatic deterioration|0
78174|NCT00106353|283592|P7|Part 2|Death|1
78175|NCT00106353|283593|P6|Part 2|Death|0
78176|NCT00106353|283594|P5|Part 2|Death|3
78177|NCT00106353|283595|P4|Part 2|Death|0
78178|NCT00106353|283596|P3|Part 2|Death|0
78179|NCT00106353|283597|P2|Part 2|Death|0
78180|NCT00106353|283598|P1|Part 2|Death|0
78181|NCT00106353|283592|P7|Part 2|Disease progression|13
78182|NCT00106353|283593|P6|Part 2|Disease progression|14
78183|NCT00106353|283594|P5|Part 2|Disease progression|8
78184|NCT00106353|283595|P4|Part 2|Disease progression|0
78185|NCT00106353|283596|P3|Part 2|Disease progression|0
78186|NCT00106353|283597|P2|Part 2|Disease progression|0
78187|NCT00106353|283598|P1|Part 2|Disease progression|0
78188|NCT00106353|283592|P7|Part 1|Adverse Event|0
78189|NCT00106353|283593|P6|Part 1|Adverse Event|0
78190|NCT00106353|283594|P5|Part 1|Adverse Event|0
78191|NCT00106353|283595|P4|Part 1|Adverse Event|1
78192|NCT00106353|283596|P3|Part 1|Adverse Event|0
78193|NCT00106353|283597|P2|Part 1|Adverse Event|0
78194|NCT00106353|283598|P1|Part 1|Adverse Event|0
78195|NCT00106353|283592|P7|Part 1|Entered follow-up phase|0
78196|NCT00106353|283593|P6|Part 1|Entered follow-up phase|0
78197|NCT00106353|283594|P5|Part 1|Entered follow-up phase|0
78198|NCT00106353|283595|P4|Part 1|Entered follow-up phase|1
78199|NCT00106353|283596|P3|Part 1|Entered follow-up phase|0
78200|NCT00106353|283597|P2|Part 1|Entered follow-up phase|1
78201|NCT00106353|283598|P1|Part 1|Entered follow-up phase|1
78202|NCT00106353|283592|P7|Part 1|Symptomatic deterioration|0
78203|NCT00106353|283593|P6|Part 1|Symptomatic deterioration|0
78204|NCT00106353|283594|P5|Part 1|Symptomatic deterioration|0
78205|NCT00106353|283595|P4|Part 1|Symptomatic deterioration|0
78206|NCT00106353|283596|P3|Part 1|Symptomatic deterioration|1
78207|NCT00106353|283597|P2|Part 1|Symptomatic deterioration|0
78208|NCT00106353|283598|P1|Part 1|Symptomatic deterioration|0
78209|NCT00106353|283592|P7|Part 1|Withdrawal by Subject|0
78210|NCT00106353|283593|P6|Part 1|Withdrawal by Subject|0
78211|NCT00106353|283594|P5|Part 1|Withdrawal by Subject|0
78212|NCT00106353|283595|P4|Part 1|Withdrawal by Subject|2
78213|NCT00106353|283596|P3|Part 1|Withdrawal by Subject|1
78214|NCT00106353|283597|P2|Part 1|Withdrawal by Subject|0
78215|NCT00106353|283598|P1|Part 1|Withdrawal by Subject|0
78216|NCT00106353|283592|P7|Part 1|Disease progression|0
78217|NCT00106353|283593|P6|Part 1|Disease progression|0
78218|NCT00106353|283594|P5|Part 1|Disease progression|0
78219|NCT00106353|283595|P4|Part 1|Disease progression|3
78220|NCT00106353|283596|P3|Part 1|Disease progression|1
78221|NCT00106353|283597|P2|Part 1|Disease progression|4
78222|NCT00106353|283598|P1|Part 1|Disease progression|3
78223|NCT00098254|283742|P1|Overall Study|Death|1
78224|NCT00098254|283742|P1|Overall Study|Adverse Event|2
78225|NCT00098293|283764|P5|Supplemental Phase (SP)|Unspecified|22
78226|NCT00098293|283765|P4|Supplemental Phase (SP)|Unspecified|0
78227|NCT00098293|283766|P3|Supplemental Phase (SP)|Unspecified|0
78228|NCT00098293|283767|P2|Supplemental Phase (SP)|Unspecified|0
78229|NCT00098293|283768|P1|Supplemental Phase (SP)|Unspecified|0
78230|NCT00098293|283764|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
78231|NCT00098293|283765|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
78232|NCT00098293|283766|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
78233|NCT00098293|283767|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
78234|NCT00098293|283768|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
78235|NCT00098293|283764|P5|Supplemental Phase (SP)|Lost to Follow-up|2
78236|NCT00098293|283765|P4|Supplemental Phase (SP)|Lost to Follow-up|0
78237|NCT00098293|283766|P3|Supplemental Phase (SP)|Lost to Follow-up|0
78238|NCT00098293|283767|P2|Supplemental Phase (SP)|Lost to Follow-up|0
78239|NCT00098293|283768|P1|Supplemental Phase (SP)|Lost to Follow-up|0
78240|NCT00098293|283764|P5|Supplemental Phase (SP)|Death|1
78241|NCT00098293|283765|P4|Supplemental Phase (SP)|Death|0
78242|NCT00098293|283766|P3|Supplemental Phase (SP)|Death|0
78243|NCT00098293|283767|P2|Supplemental Phase (SP)|Death|0
78244|NCT00098293|283768|P1|Supplemental Phase (SP)|Death|0
78245|NCT00098293|283764|P5|Open-label (OL) Phase|Death|0
78246|NCT00098293|283765|P4|Open-label (OL) Phase|Death|0
78247|NCT00098293|283766|P3|Open-label (OL) Phase|Death|3
78248|NCT00098293|283767|P2|Open-label (OL) Phase|Death|2
78249|NCT00098293|283768|P1|Open-label (OL) Phase|Death|0
78250|NCT00098293|283764|P5|Open-label (OL) Phase|Participant Defaulted|0
78251|NCT00098293|283765|P4|Open-label (OL) Phase|Participant Defaulted|20
78252|NCT00098293|283766|P3|Open-label (OL) Phase|Participant Defaulted|16
78253|NCT00098293|283767|P2|Open-label (OL) Phase|Participant Defaulted|6
78254|NCT00098293|283768|P1|Open-label (OL) Phase|Participant Defaulted|0
78255|NCT00098293|283764|P5|Open-label (OL) Phase|Protocol Violation|0
78256|NCT00098293|283765|P4|Open-label (OL) Phase|Protocol Violation|16
78257|NCT00098293|283766|P3|Open-label (OL) Phase|Protocol Violation|13
78258|NCT00098293|283767|P2|Open-label (OL) Phase|Protocol Violation|6
78259|NCT00098293|283768|P1|Open-label (OL) Phase|Protocol Violation|0
78260|NCT00098293|283764|P5|Open-label (OL) Phase|Pregnancy|0
78261|NCT00098293|283765|P4|Open-label (OL) Phase|Pregnancy|3
78262|NCT00098293|283766|P3|Open-label (OL) Phase|Pregnancy|0
78263|NCT00098293|283767|P2|Open-label (OL) Phase|Pregnancy|1
78264|NCT00098293|283768|P1|Open-label (OL) Phase|Pregnancy|0
78265|NCT00098293|283764|P5|Open-label (OL) Phase|Lack of Efficacy|0
78266|NCT00098293|283765|P4|Open-label (OL) Phase|Lack of Efficacy|20
78267|NCT00098293|283766|P3|Open-label (OL) Phase|Lack of Efficacy|2
78268|NCT00098293|283767|P2|Open-label (OL) Phase|Lack of Efficacy|7
78269|NCT00098293|283768|P1|Open-label (OL) Phase|Lack of Efficacy|0
78270|NCT00098293|283764|P5|Open-label (OL) Phase|Adverse Event|0
78271|NCT00098293|283765|P4|Open-label (OL) Phase|Adverse Event|6
78272|NCT00098293|283766|P3|Open-label (OL) Phase|Adverse Event|7
78273|NCT00098293|283767|P2|Open-label (OL) Phase|Adverse Event|3
78274|NCT00098293|283768|P1|Open-label (OL) Phase|Adverse Event|0
78275|NCT00098293|283764|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
78276|NCT00098293|283765|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
78277|NCT00098293|283766|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
78278|NCT00098293|283767|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
78279|NCT00098293|283768|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
78280|NCT00098293|283764|P5|Double-blind (DB) Phase|Terminated by sponsor|0
78281|NCT00098293|283765|P4|Double-blind (DB) Phase|Terminated by sponsor|0
78282|NCT00098293|283766|P3|Double-blind (DB) Phase|Terminated by sponsor|0
78283|NCT00098293|283767|P2|Double-blind (DB) Phase|Terminated by sponsor|0
78284|NCT00098293|283768|P1|Double-blind (DB) Phase|Terminated by sponsor|135
78285|NCT00098293|283764|P5|Double-blind (DB) Phase|Protocol Violation|0
78286|NCT00098293|283765|P4|Double-blind (DB) Phase|Protocol Violation|0
78287|NCT00098293|283766|P3|Double-blind (DB) Phase|Protocol Violation|22
78288|NCT00098293|283767|P2|Double-blind (DB) Phase|Protocol Violation|18
78289|NCT00098293|283768|P1|Double-blind (DB) Phase|Protocol Violation|2
78290|NCT00098293|283764|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
78291|NCT00098293|283765|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
78292|NCT00098293|283766|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
78293|NCT00098293|283767|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
78294|NCT00098293|283768|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
78295|NCT00098293|283764|P5|Double-blind (DB) Phase|Death|0
78296|NCT00098293|283765|P4|Double-blind (DB) Phase|Death|0
78297|NCT00098293|283766|P3|Double-blind (DB) Phase|Death|2
78298|NCT00098293|283767|P2|Double-blind (DB) Phase|Death|2
78299|NCT00098293|283768|P1|Double-blind (DB) Phase|Death|1
78300|NCT00098293|283764|P5|Double-blind (DB) Phase|Lack of Efficacy|0
78301|NCT00098293|283765|P4|Double-blind (DB) Phase|Lack of Efficacy|0
78302|NCT00098293|283766|P3|Double-blind (DB) Phase|Lack of Efficacy|30
78303|NCT00098293|283767|P2|Double-blind (DB) Phase|Lack of Efficacy|64
78304|NCT00098293|283768|P1|Double-blind (DB) Phase|Lack of Efficacy|11
78305|NCT00098293|283764|P5|Double-blind (DB) Phase|Participant Defaulted|0
78306|NCT00098293|283765|P4|Double-blind (DB) Phase|Participant Defaulted|0
78307|NCT00098293|283766|P3|Double-blind (DB) Phase|Participant Defaulted|36
78308|NCT00098293|283767|P2|Double-blind (DB) Phase|Participant Defaulted|40
78309|NCT00098293|283768|P1|Double-blind (DB) Phase|Participant Defaulted|11
78310|NCT00098293|283764|P5|Double-blind (DB) Phase|Pregnancy|0
78311|NCT00098293|283765|P4|Double-blind (DB) Phase|Pregnancy|0
78312|NCT00098293|283766|P3|Double-blind (DB) Phase|Pregnancy|9
78313|NCT00098293|283767|P2|Double-blind (DB) Phase|Pregnancy|7
78314|NCT00098293|283768|P1|Double-blind (DB) Phase|Pregnancy|0
78315|NCT00098293|283764|P5|Double-blind (DB) Phase|Adverse Event|0
78316|NCT00098293|283765|P4|Double-blind (DB) Phase|Adverse Event|0
78317|NCT00098293|283766|P3|Double-blind (DB) Phase|Adverse Event|60
78318|NCT00098293|283767|P2|Double-blind (DB) Phase|Adverse Event|27
78319|NCT00098293|283768|P1|Double-blind (DB) Phase|Adverse Event|14
78320|NCT00098306|283824|P7|Observational Phase|Un-specified|4
78321|NCT00098306|283825|P6|Observational Phase|Un-specified|7
78322|NCT00098306|283826|P5|Observational Phase|Un-specified|0
78323|NCT00098306|283827|P4|Observational Phase|Un-specified|0
78324|NCT00098306|283828|P3|Observational Phase|Un-specified|0
78325|NCT00098306|283829|P2|Observational Phase|Un-specified|0
78326|NCT00098306|283830|P1|Observational Phase|Un-specified|0
78327|NCT00098306|283824|P7|Observational Phase|Participant defaulted|18
78328|NCT00098306|283825|P6|Observational Phase|Participant defaulted|34
78329|NCT00098306|283826|P5|Observational Phase|Participant defaulted|0
78330|NCT00098306|283827|P4|Observational Phase|Participant defaulted|0
78331|NCT00098306|283828|P3|Observational Phase|Participant defaulted|0
78332|NCT00098306|283829|P2|Observational Phase|Participant defaulted|0
78333|NCT00098306|283830|P1|Observational Phase|Participant defaulted|0
78334|NCT00098306|283824|P7|Observational Phase|Death|4
78335|NCT00098306|283825|P6|Observational Phase|Death|5
78336|NCT00098306|283826|P5|Observational Phase|Death|0
78337|NCT00098306|283827|P4|Observational Phase|Death|0
78338|NCT00098306|283828|P3|Observational Phase|Death|0
78339|NCT00098306|283829|P2|Observational Phase|Death|0
78340|NCT00098306|283830|P1|Observational Phase|Death|0
78341|NCT00098306|283824|P7|Open Label|Ongoing at cut-off date|0
78342|NCT00098306|283825|P6|Open Label|Ongoing at cut-off date|0
78343|NCT00098306|283826|P5|Open Label|Ongoing at cut-off date|62
78344|NCT00098306|283827|P4|Open Label|Ongoing at cut-off date|269
78345|NCT00098306|283828|P3|Open Label|Ongoing at cut-off date|0
78346|NCT00098306|283829|P2|Open Label|Ongoing at cut-off date|0
78347|NCT00098306|283830|P1|Open Label|Ongoing at cut-off date|0
78348|NCT00098306|283824|P7|Open Label|Un-specified|0
78349|NCT00098306|283825|P6|Open Label|Un-specified|0
78350|NCT00098306|283826|P5|Open Label|Un-specified|0
78351|NCT00098306|283827|P4|Open Label|Un-specified|15
78352|NCT00098306|283828|P3|Open Label|Un-specified|0
78353|NCT00098306|283829|P2|Open Label|Un-specified|0
78354|NCT00098306|283830|P1|Open Label|Un-specified|0
78355|NCT00098306|283824|P7|Open Label|Participant defaulted|0
78356|NCT00098306|283825|P6|Open Label|Participant defaulted|0
78357|NCT00098306|283826|P5|Open Label|Participant defaulted|0
78358|NCT00098306|283827|P4|Open Label|Participant defaulted|24
78359|NCT00098306|283828|P3|Open Label|Participant defaulted|0
78360|NCT00098306|283829|P2|Open Label|Participant defaulted|0
78361|NCT00098306|283830|P1|Open Label|Participant defaulted|0
78362|NCT00098306|283824|P7|Open Label|Death|0
78363|NCT00098306|283825|P6|Open Label|Death|0
78364|NCT00098306|283826|P5|Open Label|Death|0
78365|NCT00098306|283827|P4|Open Label|Death|4
78366|NCT00098306|283828|P3|Open Label|Death|0
78367|NCT00098306|283829|P2|Open Label|Death|0
78368|NCT00098306|283830|P1|Open Label|Death|0
78369|NCT00098306|283824|P7|Open Label|Adverse Event|0
78370|NCT00098306|283825|P6|Open Label|Adverse Event|0
78371|NCT00098306|283826|P5|Open Label|Adverse Event|0
78372|NCT00098306|283827|P4|Open Label|Adverse Event|2
78373|NCT00098306|283828|P3|Open Label|Adverse Event|0
78374|NCT00098306|283829|P2|Open Label|Adverse Event|0
78375|NCT00098306|283830|P1|Open Label|Adverse Event|0
78376|NCT00098306|283824|P7|Open Label|Lack of Efficacy|0
78377|NCT00098306|283825|P6|Open Label|Lack of Efficacy|0
78378|NCT00098306|283826|P5|Open Label|Lack of Efficacy|0
78379|NCT00098306|283827|P4|Open Label|Lack of Efficacy|13
78380|NCT00098306|283828|P3|Open Label|Lack of Efficacy|0
78381|NCT00098306|283829|P2|Open Label|Lack of Efficacy|0
78382|NCT00098306|283830|P1|Open Label|Lack of Efficacy|0
78383|NCT00098306|283824|P7|Double Blind|Un-specified|0
78384|NCT00098306|283825|P6|Double Blind|Un-specified|0
78385|NCT00098306|283826|P5|Double Blind|Un-specified|0
78386|NCT00098306|283827|P4|Double Blind|Un-specified|0
78387|NCT00098306|283828|P3|Double Blind|Un-specified|11
78388|NCT00098306|283829|P2|Double Blind|Un-specified|3
78389|NCT00098306|283830|P1|Double Blind|Un-specified|7
78390|NCT00098306|283824|P7|Double Blind|Participant defaulted|0
78391|NCT00098306|283825|P6|Double Blind|Participant defaulted|0
78392|NCT00098306|283826|P5|Double Blind|Participant defaulted|0
78393|NCT00098306|283827|P4|Double Blind|Participant defaulted|0
78394|NCT00098306|283828|P3|Double Blind|Participant defaulted|11
78395|NCT00098306|283829|P2|Double Blind|Participant defaulted|18
78396|NCT00098306|283830|P1|Double Blind|Participant defaulted|19
78397|NCT00098306|283824|P7|Double Blind|Death|0
78398|NCT00098306|283825|P6|Double Blind|Death|0
78399|NCT00098306|283826|P5|Double Blind|Death|0
78400|NCT00098306|283827|P4|Double Blind|Death|0
78401|NCT00098306|283828|P3|Double Blind|Death|1
78402|NCT00098306|283829|P2|Double Blind|Death|4
78403|NCT00098306|283830|P1|Double Blind|Death|1
78404|NCT00098306|283824|P7|Double Blind|Lack of Efficacy|0
78405|NCT00098306|283825|P6|Double Blind|Lack of Efficacy|0
78406|NCT00098306|283826|P5|Double Blind|Lack of Efficacy|0
78407|NCT00098306|283827|P4|Double Blind|Lack of Efficacy|0
78408|NCT00098306|283828|P3|Double Blind|Lack of Efficacy|17
78409|NCT00098306|283829|P2|Double Blind|Lack of Efficacy|34
78410|NCT00098306|283830|P1|Double Blind|Lack of Efficacy|43
78411|NCT00098306|283824|P7|Double Blind|Adverse Event|0
78412|NCT00098306|283825|P6|Double Blind|Adverse Event|0
78413|NCT00098306|283826|P5|Double Blind|Adverse Event|0
78414|NCT00098306|283827|P4|Double Blind|Adverse Event|0
78415|NCT00098306|283828|P3|Double Blind|Adverse Event|6
78416|NCT00098306|283829|P2|Double Blind|Adverse Event|10
78417|NCT00098306|283830|P1|Double Blind|Adverse Event|11
78418|NCT00098306|283824|P7|Double Blind|Ongoing at cut-off date|0
78419|NCT00098306|283825|P6|Double Blind|Ongoing at cut-off date|0
78420|NCT00098306|283826|P5|Double Blind|Ongoing at cut-off date|0
78421|NCT00098306|283827|P4|Double Blind|Ongoing at cut-off date|0
78422|NCT00098306|283828|P3|Double Blind|Ongoing at cut-off date|72
78423|NCT00098306|283829|P2|Double Blind|Ongoing at cut-off date|166
78424|NCT00098306|283830|P1|Double Blind|Ongoing at cut-off date|151
78425|NCT00098306|283824|P7|Double Blind|Randomized, not treated|0
78426|NCT00098306|283825|P6|Double Blind|Randomized, not treated|0
78427|NCT00098306|283826|P5|Double Blind|Randomized, not treated|0
78428|NCT00098306|283827|P4|Double Blind|Randomized, not treated|0
78429|NCT00098306|283828|P3|Double Blind|Randomized, not treated|2
78430|NCT00098306|283829|P2|Double Blind|Randomized, not treated|5
78431|NCT00098306|283830|P1|Double Blind|Randomized, not treated|9
78432|NCT00098345|283893|P1|Overall Study|progression|4
78433|NCT00098345|283893|P1|Overall Study|Withdrawal by Subject|2
78434|NCT00098345|283893|P1|Overall Study|Adverse Event|7
78435|NCT00098475|283930|P4|Step 2|Never started treatment|0
78436|NCT00098475|283931|P3|Step 2|Never started treatment|0
78437|NCT00098475|283932|P2|Step 2|Never started treatment|1
78438|NCT00098475|283933|P1|Step 2|Never started treatment|1
78439|NCT00098475|283930|P4|Step 2|Alternative therapy|0
78440|NCT00098475|283931|P3|Step 2|Alternative therapy|0
78441|NCT00098475|283932|P2|Step 2|Alternative therapy|2
78442|NCT00098475|283933|P1|Step 2|Alternative therapy|1
78443|NCT00098475|283930|P4|Step 2|Physician Decision|0
78444|NCT00098475|283931|P3|Step 2|Physician Decision|0
78445|NCT00098475|283932|P2|Step 2|Physician Decision|1
78446|NCT00098475|283933|P1|Step 2|Physician Decision|0
78447|NCT00098475|283930|P4|Step 2|Withdrawal by Subject|0
78448|NCT00098475|283931|P3|Step 2|Withdrawal by Subject|0
78449|NCT00098475|283932|P2|Step 2|Withdrawal by Subject|2
78450|NCT00098475|283933|P1|Step 2|Withdrawal by Subject|0
78451|NCT00098475|283930|P4|Step 2|Adverse Event|0
78452|NCT00098475|283931|P3|Step 2|Adverse Event|0
78453|NCT00098475|283932|P2|Step 2|Adverse Event|0
78454|NCT00098475|283933|P1|Step 2|Adverse Event|2
78455|NCT00098475|283930|P4|Step 2|Disease progression|0
78456|NCT00098475|283931|P3|Step 2|Disease progression|0
78457|NCT00098475|283932|P2|Step 2|Disease progression|4
78458|NCT00098475|283933|P1|Step 2|Disease progression|1
78459|NCT00098475|283930|P4|Step 1|Not documented|0
78460|NCT00098475|283931|P3|Step 1|Not documented|0
78461|NCT00098475|283932|P2|Step 1|Not documented|1
78462|NCT00098475|283933|P1|Step 1|Not documented|0
78463|NCT00098475|283930|P4|Step 1|Patient fell with fracture|0
78464|NCT00098475|283931|P3|Step 1|Patient fell with fracture|0
78465|NCT00098475|283932|P2|Step 1|Patient fell with fracture|0
78466|NCT00098475|283933|P1|Step 1|Patient fell with fracture|1
78467|NCT00098475|283930|P4|Step 1|Misinterpretation of lab data|0
78468|NCT00098475|283931|P3|Step 1|Misinterpretation of lab data|0
78469|NCT00098475|283932|P2|Step 1|Misinterpretation of lab data|1
78470|NCT00098475|283933|P1|Step 1|Misinterpretation of lab data|0
78471|NCT00098475|283930|P4|Step 1|Criteria to continue treatment not met|0
78472|NCT00098475|283931|P3|Step 1|Criteria to continue treatment not met|0
78473|NCT00098475|283932|P2|Step 1|Criteria to continue treatment not met|1
78474|NCT00098475|283933|P1|Step 1|Criteria to continue treatment not met|0
78475|NCT00098475|283930|P4|Step 1|Referred to other physicians|0
78476|NCT00098475|283931|P3|Step 1|Referred to other physicians|0
78477|NCT00098475|283932|P2|Step 1|Referred to other physicians|1
78478|NCT00098475|283933|P1|Step 1|Referred to other physicians|0
78479|NCT00098475|283930|P4|Step 1|Rising paraprotein|0
78480|NCT00098475|283931|P3|Step 1|Rising paraprotein|0
78481|NCT00098475|283932|P2|Step 1|Rising paraprotein|1
78482|NCT00098475|283933|P1|Step 1|Rising paraprotein|0
78483|NCT00098475|283930|P4|Step 1|Insurance issue|0
78484|NCT00098475|283931|P3|Step 1|Insurance issue|0
78485|NCT00098475|283932|P2|Step 1|Insurance issue|1
78486|NCT00098475|283933|P1|Step 1|Insurance issue|0
78487|NCT00098475|283930|P4|Step 1|Declining performance status|0
78488|NCT00098475|283931|P3|Step 1|Declining performance status|0
78489|NCT00098475|283932|P2|Step 1|Declining performance status|1
78490|NCT00098475|283933|P1|Step 1|Declining performance status|0
78491|NCT00098475|283930|P4|Step 1|Off treatment for > specified timeframe|0
78492|NCT00098475|283931|P3|Step 1|Off treatment for > specified timeframe|0
78493|NCT00098475|283932|P2|Step 1|Off treatment for > specified timeframe|1
78494|NCT00098475|283933|P1|Step 1|Off treatment for > specified timeframe|1
78495|NCT00098475|283930|P4|Step 1|Incorrect disease assessment|0
78496|NCT00098475|283931|P3|Step 1|Incorrect disease assessment|0
78497|NCT00098475|283932|P2|Step 1|Incorrect disease assessment|0
78498|NCT00098475|283933|P1|Step 1|Incorrect disease assessment|2
78499|NCT00098475|283930|P4|Step 1|Both patient and physician's decision|0
78500|NCT00098475|283931|P3|Step 1|Both patient and physician's decision|0
78501|NCT00098475|283932|P2|Step 1|Both patient and physician's decision|1
78502|NCT00098475|283933|P1|Step 1|Both patient and physician's decision|2
78503|NCT00098475|283930|P4|Step 1|Cannot comply due to other tx|0
78504|NCT00098475|283931|P3|Step 1|Cannot comply due to other tx|0
78505|NCT00098475|283932|P2|Step 1|Cannot comply due to other tx|1
78506|NCT00098475|283933|P1|Step 1|Cannot comply due to other tx|0
78507|NCT00098475|283930|P4|Step 1|Complications|0
78508|NCT00098475|283931|P3|Step 1|Complications|0
78509|NCT00098475|283932|P2|Step 1|Complications|0
78510|NCT00098475|283933|P1|Step 1|Complications|1
78511|NCT00098475|283930|P4|Step 1|Knee surgery|0
78512|NCT00098475|283931|P3|Step 1|Knee surgery|0
78513|NCT00098475|283932|P2|Step 1|Knee surgery|0
78514|NCT00098475|283933|P1|Step 1|Knee surgery|1
78515|NCT00098475|283930|P4|Step 1|Still on treatment as of this analysis|0
78516|NCT00098475|283931|P3|Step 1|Still on treatment as of this analysis|0
78517|NCT00098475|283932|P2|Step 1|Still on treatment as of this analysis|27
78518|NCT00098475|283933|P1|Step 1|Still on treatment as of this analysis|14
78519|NCT00098475|283930|P4|Step 1|Never started treatment|0
78520|NCT00098475|283931|P3|Step 1|Never started treatment|0
78521|NCT00098475|283932|P2|Step 1|Never started treatment|2
78522|NCT00098475|283933|P1|Step 1|Never started treatment|0
78523|NCT00098475|283930|P4|Step 1|Other disease|0
78524|NCT00098475|283931|P3|Step 1|Other disease|1
78525|NCT00098475|283932|P2|Step 1|Other disease|1
78526|NCT00098475|283933|P1|Step 1|Other disease|2
78527|NCT00098475|283930|P4|Step 1|Alternative therapy|0
78528|NCT00098475|283931|P3|Step 1|Alternative therapy|1
78529|NCT00098475|283932|P2|Step 1|Alternative therapy|43
78530|NCT00098475|283933|P1|Step 1|Alternative therapy|31
78531|NCT00098475|283930|P4|Step 1|Physician Decision|0
78532|NCT00098475|283931|P3|Step 1|Physician Decision|0
78533|NCT00098475|283932|P2|Step 1|Physician Decision|2
78534|NCT00098475|283933|P1|Step 1|Physician Decision|5
78535|NCT00098475|283930|P4|Step 1|Withdrawal by Subject|0
78536|NCT00098475|283931|P3|Step 1|Withdrawal by Subject|0
78537|NCT00098475|283932|P2|Step 1|Withdrawal by Subject|11
78538|NCT00098475|283933|P1|Step 1|Withdrawal by Subject|14
78539|NCT00098475|283930|P4|Step 1|Death|1
78540|NCT00098475|283931|P3|Step 1|Death|0
78541|NCT00098475|283932|P2|Step 1|Death|5
78542|NCT00098475|283933|P1|Step 1|Death|8
78543|NCT00098475|283930|P4|Step 1|Adverse Event|1
78544|NCT00098475|283931|P3|Step 1|Adverse Event|0
78545|NCT00098475|283932|P2|Step 1|Adverse Event|37
78546|NCT00098475|283933|P1|Step 1|Adverse Event|56
78547|NCT00098475|283930|P4|Step 1|Progressive disease|1
78548|NCT00098475|283931|P3|Step 1|Progressive disease|2
78549|NCT00098475|283932|P2|Step 1|Progressive disease|35
78550|NCT00098475|283933|P1|Step 1|Progressive disease|33
78551|NCT00098722|283957|P7|Observation Phase|Unspecified|10
78552|NCT00098722|283958|P6|Observation Phase|Unspecified|21
78553|NCT00098722|283959|P5|Observation Phase|Unspecified|0
78554|NCT00098722|283960|P4|Observation Phase|Unspecified|0
78555|NCT00098722|283961|P3|Observation Phase|Unspecified|0
78556|NCT00098722|283962|P2|Observation Phase|Unspecified|0
78557|NCT00098722|283963|P1|Observation Phase|Unspecified|0
78558|NCT00098722|283957|P7|Observation Phase|Participant defaulted|4
78559|NCT00098722|283958|P6|Observation Phase|Participant defaulted|17
78560|NCT00098722|283959|P5|Observation Phase|Participant defaulted|0
78561|NCT00098722|283960|P4|Observation Phase|Participant defaulted|0
78562|NCT00098722|283961|P3|Observation Phase|Participant defaulted|0
78563|NCT00098722|283962|P2|Observation Phase|Participant defaulted|0
78564|NCT00098722|283963|P1|Observation Phase|Participant defaulted|0
78565|NCT00098722|283957|P7|Observation Phase|Lack of Efficacy|0
78566|NCT00098722|283958|P6|Observation Phase|Lack of Efficacy|2
78567|NCT00098722|283959|P5|Observation Phase|Lack of Efficacy|0
78568|NCT00098722|283960|P4|Observation Phase|Lack of Efficacy|0
78569|NCT00098722|283961|P3|Observation Phase|Lack of Efficacy|0
78570|NCT00098722|283962|P2|Observation Phase|Lack of Efficacy|0
78571|NCT00098722|283963|P1|Observation Phase|Lack of Efficacy|0
78572|NCT00098722|283957|P7|Observation Phase|Death|3
78573|NCT00098722|283958|P6|Observation Phase|Death|5
78574|NCT00098722|283959|P5|Observation Phase|Death|0
78575|NCT00098722|283960|P4|Observation Phase|Death|0
78576|NCT00098722|283961|P3|Observation Phase|Death|0
78577|NCT00098722|283962|P2|Observation Phase|Death|0
78578|NCT00098722|283963|P1|Observation Phase|Death|0
78579|NCT00098722|283957|P7|Open Label Phase|Unspecified|0
78580|NCT00098722|283958|P6|Open Label Phase|Unspecified|0
78581|NCT00098722|283959|P5|Open Label Phase|Unspecified|0
78582|NCT00098722|283960|P4|Open Label Phase|Unspecified|18
78583|NCT00098722|283961|P3|Open Label Phase|Unspecified|0
78584|NCT00098722|283962|P2|Open Label Phase|Unspecified|0
78585|NCT00098722|283963|P1|Open Label Phase|Unspecified|0
78586|NCT00098722|283957|P7|Open Label Phase|Ongoing at cut-off date|0
78587|NCT00098722|283958|P6|Open Label Phase|Ongoing at cut-off date|0
78588|NCT00098722|283959|P5|Open Label Phase|Ongoing at cut-off date|50
78589|NCT00098722|283960|P4|Open Label Phase|Ongoing at cut-off date|220
78590|NCT00098722|283961|P3|Open Label Phase|Ongoing at cut-off date|0
78591|NCT00098722|283962|P2|Open Label Phase|Ongoing at cut-off date|0
78592|NCT00098722|283963|P1|Open Label Phase|Ongoing at cut-off date|0
78593|NCT00098722|283957|P7|Open Label Phase|Participant defaulted|0
78594|NCT00098722|283958|P6|Open Label Phase|Participant defaulted|0
78595|NCT00098722|283959|P5|Open Label Phase|Participant defaulted|0
78596|NCT00098722|283960|P4|Open Label Phase|Participant defaulted|18
78597|NCT00098722|283961|P3|Open Label Phase|Participant defaulted|0
78598|NCT00098722|283962|P2|Open Label Phase|Participant defaulted|0
78599|NCT00098722|283963|P1|Open Label Phase|Participant defaulted|0
78600|NCT00098722|283957|P7|Open Label Phase|Pregnancy|0
78601|NCT00098722|283958|P6|Open Label Phase|Pregnancy|0
78602|NCT00098722|283959|P5|Open Label Phase|Pregnancy|0
78603|NCT00098722|283960|P4|Open Label Phase|Pregnancy|1
78604|NCT00098722|283961|P3|Open Label Phase|Pregnancy|0
78605|NCT00098722|283962|P2|Open Label Phase|Pregnancy|0
78606|NCT00098722|283963|P1|Open Label Phase|Pregnancy|0
78607|NCT00098722|283957|P7|Open Label Phase|Lack of Efficacy|0
78608|NCT00098722|283958|P6|Open Label Phase|Lack of Efficacy|0
78609|NCT00098722|283959|P5|Open Label Phase|Lack of Efficacy|0
78610|NCT00098722|283960|P4|Open Label Phase|Lack of Efficacy|8
78611|NCT00098722|283961|P3|Open Label Phase|Lack of Efficacy|0
78612|NCT00098722|283962|P2|Open Label Phase|Lack of Efficacy|0
78613|NCT00098722|283963|P1|Open Label Phase|Lack of Efficacy|0
78614|NCT00098722|283957|P7|Open Label Phase|Death|0
78615|NCT00098722|283958|P6|Open Label Phase|Death|0
78616|NCT00098722|283959|P5|Open Label Phase|Death|0
78617|NCT00098722|283960|P4|Open Label Phase|Death|2
78618|NCT00098722|283961|P3|Open Label Phase|Death|0
78619|NCT00098722|283962|P2|Open Label Phase|Death|0
78620|NCT00098722|283963|P1|Open Label Phase|Death|0
78621|NCT00098722|283957|P7|Open Label Phase|Adverse Event|0
78622|NCT00098722|283958|P6|Open Label Phase|Adverse Event|0
78623|NCT00098722|283959|P5|Open Label Phase|Adverse Event|0
78624|NCT00098722|283960|P4|Open Label Phase|Adverse Event|5
78625|NCT00098722|283961|P3|Open Label Phase|Adverse Event|0
78626|NCT00098722|283962|P2|Open Label Phase|Adverse Event|0
78627|NCT00098722|283963|P1|Open Label Phase|Adverse Event|0
78628|NCT00098722|283957|P7|Double Blind Phase|Unspecified|0
78629|NCT00098722|283958|P6|Double Blind Phase|Unspecified|0
78630|NCT00098722|283959|P5|Double Blind Phase|Unspecified|0
78631|NCT00098722|283960|P4|Double Blind Phase|Unspecified|0
78632|NCT00098722|283961|P3|Double Blind Phase|Unspecified|7
78633|NCT00098722|283962|P2|Double Blind Phase|Unspecified|8
78634|NCT00098722|283963|P1|Double Blind Phase|Unspecified|7
78635|NCT00098722|283957|P7|Double Blind Phase|Ongoing at cut-off date|0
78636|NCT00098722|283958|P6|Double Blind Phase|Ongoing at cut-off date|0
78637|NCT00098722|283959|P5|Double Blind Phase|Ongoing at cut-off date|0
78638|NCT00098722|283960|P4|Double Blind Phase|Ongoing at cut-off date|0
78639|NCT00098722|283961|P3|Double Blind Phase|Ongoing at cut-off date|57
78640|NCT00098722|283962|P2|Double Blind Phase|Ongoing at cut-off date|137
78641|NCT00098722|283963|P1|Double Blind Phase|Ongoing at cut-off date|128
78642|NCT00098722|283957|P7|Double Blind Phase|Randomized, not treated|0
78643|NCT00098722|283958|P6|Double Blind Phase|Randomized, not treated|0
78644|NCT00098722|283959|P5|Double Blind Phase|Randomized, not treated|0
78645|NCT00098722|283960|P4|Double Blind Phase|Randomized, not treated|0
78646|NCT00098722|283961|P3|Double Blind Phase|Randomized, not treated|3
78647|NCT00098722|283962|P2|Double Blind Phase|Randomized, not treated|3
78648|NCT00098722|283963|P1|Double Blind Phase|Randomized, not treated|4
78649|NCT00098722|283957|P7|Double Blind Phase|Pregnancy|0
78650|NCT00098722|283958|P6|Double Blind Phase|Pregnancy|0
78651|NCT00098722|283959|P5|Double Blind Phase|Pregnancy|0
78652|NCT00098722|283960|P4|Double Blind Phase|Pregnancy|0
78653|NCT00098722|283961|P3|Double Blind Phase|Pregnancy|0
78654|NCT00098722|283962|P2|Double Blind Phase|Pregnancy|0
78655|NCT00098722|283963|P1|Double Blind Phase|Pregnancy|1
78656|NCT00098722|283957|P7|Double Blind Phase|Participant defaulted|0
78657|NCT00098722|283958|P6|Double Blind Phase|Participant defaulted|0
78658|NCT00098722|283959|P5|Double Blind Phase|Participant defaulted|0
78659|NCT00098722|283960|P4|Double Blind Phase|Participant defaulted|0
78660|NCT00098722|283961|P3|Double Blind Phase|Participant defaulted|9
78661|NCT00098722|283962|P2|Double Blind Phase|Participant defaulted|11
78662|NCT00098722|283963|P1|Double Blind Phase|Participant defaulted|16
78663|NCT00098722|283957|P7|Double Blind Phase|Lack of Efficacy|0
78664|NCT00098722|283958|P6|Double Blind Phase|Lack of Efficacy|0
78665|NCT00098722|283959|P5|Double Blind Phase|Lack of Efficacy|0
78666|NCT00098722|283960|P4|Double Blind Phase|Lack of Efficacy|0
78667|NCT00098722|283961|P3|Double Blind Phase|Lack of Efficacy|15
78668|NCT00098722|283962|P2|Double Blind Phase|Lack of Efficacy|23
78669|NCT00098722|283963|P1|Double Blind Phase|Lack of Efficacy|21
78670|NCT00098722|283957|P7|Double Blind Phase|Death|0
78671|NCT00098722|283958|P6|Double Blind Phase|Death|0
78672|NCT00098722|283959|P5|Double Blind Phase|Death|0
78673|NCT00098722|283960|P4|Double Blind Phase|Death|0
78674|NCT00098722|283961|P3|Double Blind Phase|Death|0
78675|NCT00098722|283962|P2|Double Blind Phase|Death|5
78676|NCT00098722|283963|P1|Double Blind Phase|Death|2
78677|NCT00098722|283957|P7|Double Blind Phase|Adverse Event|0
78678|NCT00098722|283958|P6|Double Blind Phase|Adverse Event|0
78679|NCT00098722|283959|P5|Double Blind Phase|Adverse Event|0
78680|NCT00098722|283960|P4|Double Blind Phase|Adverse Event|0
78681|NCT00098722|283961|P3|Double Blind Phase|Adverse Event|3
78682|NCT00098722|283962|P2|Double Blind Phase|Adverse Event|7
78683|NCT00098722|283963|P1|Double Blind Phase|Adverse Event|7
78684|NCT00098748|284029|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
78685|NCT00098748|284030|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
78686|NCT00098748|284031|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
78687|NCT00098748|284029|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
78688|NCT00098748|284030|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
78689|NCT00098748|284031|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
78690|NCT00098748|284029|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
78691|NCT00098748|284030|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
78692|NCT00098748|284031|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
78693|NCT00098748|284029|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
78694|NCT00098748|284030|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
78695|NCT00098748|284031|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
78696|NCT00098748|284029|P3|Continued on Open-Label Treatment|Adverse Event|0
78697|NCT00098748|284030|P2|Continued on Open-Label Treatment|Adverse Event|1
78698|NCT00098748|284031|P1|Continued on Open-Label Treatment|Adverse Event|0
78699|NCT00098748|284029|P3|Received Study Treatment|Subject defaulted|4
78700|NCT00098748|284030|P2|Received Study Treatment|Subject defaulted|4
78701|NCT00098748|284031|P1|Received Study Treatment|Subject defaulted|3
78702|NCT00098748|284029|P3|Received Study Treatment|Unspecified|6
78703|NCT00098748|284030|P2|Received Study Treatment|Unspecified|2
78704|NCT00098748|284031|P1|Received Study Treatment|Unspecified|2
78705|NCT00098748|284029|P3|Received Study Treatment|Lack of Efficacy|27
78706|NCT00098748|284030|P2|Received Study Treatment|Lack of Efficacy|27
78707|NCT00098748|284031|P1|Received Study Treatment|Lack of Efficacy|40
78708|NCT00098748|284029|P3|Received Study Treatment|Adverse Event|5
78709|NCT00098748|284030|P2|Received Study Treatment|Adverse Event|2
78710|NCT00098748|284031|P1|Received Study Treatment|Adverse Event|1
78711|NCT00098748|284029|P3|Received Study Treatment|Death|2
78712|NCT00098748|284030|P2|Received Study Treatment|Death|1
78713|NCT00098748|284031|P1|Received Study Treatment|Death|2
78714|NCT00098748|284029|P3|Assigned to Study Treatment|Randomized, but not treated|2
78715|NCT00098748|284030|P2|Assigned to Study Treatment|Randomized, but not treated|2
78716|NCT00098748|284031|P1|Assigned to Study Treatment|Randomized, but not treated|0
78717|NCT00098774|284084|P1|Overall Study|Physician Decision|2
78718|NCT00098774|284084|P1|Overall Study|Failed (to respond) during induction|4
78719|NCT00098774|284084|P1|Overall Study|Withdrawal by Subject|1
78720|NCT00098774|284084|P1|Overall Study|Disease Progression|9
78721|NCT00098774|284084|P1|Overall Study|Adverse Event|2
78722|NCT00098787|284094|P3|Overall Study|Other|9
78723|NCT00098787|284095|P2|Overall Study|Other|6
78724|NCT00098787|284096|P1|Overall Study|Other|7
78725|NCT00098787|284094|P3|Overall Study|Alternative therapy|13
78726|NCT00098787|284095|P2|Overall Study|Alternative therapy|13
78727|NCT00098787|284096|P1|Overall Study|Alternative therapy|8
78728|NCT00098787|284094|P3|Overall Study|Withdrawal by Subject|6
78729|NCT00098787|284095|P2|Overall Study|Withdrawal by Subject|12
78730|NCT00098787|284096|P1|Overall Study|Withdrawal by Subject|4
78731|NCT00098787|284094|P3|Overall Study|Death|0
78732|NCT00098787|284095|P2|Overall Study|Death|1
78733|NCT00098787|284096|P1|Overall Study|Death|6
78734|NCT00098787|284094|P3|Overall Study|Adverse Event|8
78735|NCT00098787|284095|P2|Overall Study|Adverse Event|17
78736|NCT00098787|284096|P1|Overall Study|Adverse Event|8
78737|NCT00098787|284094|P3|Overall Study|Disease progression|23
78738|NCT00098787|284095|P2|Overall Study|Disease progression|17
78739|NCT00098787|284096|P1|Overall Study|Disease progression|28
78740|NCT00098787|284094|P3|Overall Study|Ineligible|3
78741|NCT00098787|284095|P2|Overall Study|Ineligible|7
78742|NCT00098787|284096|P1|Overall Study|Ineligible|9
78743|NCT00098787|284094|P3|Overall Study|Never started treatment|1
78744|NCT00098787|284095|P2|Overall Study|Never started treatment|2
78745|NCT00098787|284096|P1|Overall Study|Never started treatment|3
78746|NCT00098813|284110|P1|Overall Study|Reversal of RAI resistance|1
78747|NCT00098813|284110|P1|Overall Study|Other complicating disease|1
78748|NCT00098813|284110|P1|Overall Study|Progression of Disease|1
78749|NCT00098813|284110|P1|Overall Study|Withdrawal by Subject|7
78750|NCT00098813|284110|P1|Overall Study|Protocol Violation|1
78751|NCT00098813|284110|P1|Overall Study|Death|8
78752|NCT00098839|284116|P2|Overall Study|Ineligible|0
78753|NCT00098839|284117|P1|Overall Study|Ineligible|2
78754|NCT00098839|284116|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
78755|NCT00098839|284117|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
78756|NCT00098839|284116|P2|Overall Study|Relapse|3
78757|NCT00098839|284117|P1|Overall Study|Relapse|6
78758|NCT00098839|284116|P2|Overall Study|Refusal of further protocol therapy|1
78759|NCT00098839|284117|P1|Overall Study|Refusal of further protocol therapy|3
78760|NCT00098839|284116|P2|Overall Study|Withdrawal by Subject|0
78761|NCT00098839|284117|P1|Overall Study|Withdrawal by Subject|1
78762|NCT00098839|284116|P2|Overall Study|Physician Decision|14
78763|NCT00098839|284117|P1|Overall Study|Physician Decision|4
78764|NCT00098839|284116|P2|Overall Study|Death|2
78765|NCT00098839|284117|P1|Overall Study|Death|1
78766|NCT00098839|284116|P2|Overall Study|Adverse Event|2
78767|NCT00098839|284117|P1|Overall Study|Adverse Event|5
78768|NCT00098865|284127|P1|Overall Study|Alternative Therapy|1
78769|NCT00098865|284127|P1|Overall Study|Adverse Event|2
78770|NCT00098865|284127|P1|Overall Study|Progressive Disease|6
78771|NCT00099268|284155|P2|Overall Study|Death|1
78772|NCT00099268|284156|P1|Overall Study|Death|3
78773|NCT00099268|284155|P2|Overall Study|Administrative problems|4
78774|NCT00099268|284156|P1|Overall Study|Administrative problems|4
78775|NCT00099268|284155|P2|Overall Study|Lack of Efficacy|18
78776|NCT00099268|284156|P1|Overall Study|Lack of Efficacy|5
78777|NCT00099268|284155|P2|Overall Study|Lost to Follow-up|4
78778|NCT00099268|284156|P1|Overall Study|Lost to Follow-up|6
78779|NCT00099268|284155|P2|Overall Study|Protocol Violation|8
78780|NCT00099268|284156|P1|Overall Study|Protocol Violation|9
78781|NCT00099268|284155|P2|Overall Study|Adverse Event|19
78782|NCT00099268|284156|P1|Overall Study|Adverse Event|19
78783|NCT00099268|284155|P2|Overall Study|Withdrawal by Subject|28
78784|NCT00099268|284156|P1|Overall Study|Withdrawal by Subject|46
78785|NCT00099359|284175|P3|Overall Study|moved out of area|4
78786|NCT00099359|284176|P2|Overall Study|moved out of area|7
78787|NCT00099359|284177|P1|Overall Study|moved out of area|9
78788|NCT00099359|284175|P3|Overall Study|Lost to Follow-up|24
78789|NCT00099359|284176|P2|Overall Study|Lost to Follow-up|24
78790|NCT00099359|284177|P1|Overall Study|Lost to Follow-up|15
78791|NCT00099359|284175|P3|Overall Study|Withdrawal by Subject|23
78792|NCT00099359|284176|P2|Overall Study|Withdrawal by Subject|19
78793|NCT00099359|284177|P1|Overall Study|Withdrawal by Subject|19
78794|NCT00099359|284175|P3|Overall Study|Death|17
78795|NCT00099359|284176|P2|Overall Study|Death|15
78796|NCT00099359|284177|P1|Overall Study|Death|11
78797|NCT00099437|284200|P2|Overall Study|Ongoing in FU but not on treatment|45
78798|NCT00099437|284201|P1|Overall Study|Ongoing in FU but not on treatment|37
78799|NCT00099437|284200|P2|Overall Study|Withdrawal by Subject|10
78800|NCT00099437|284201|P1|Overall Study|Withdrawal by Subject|6
78801|NCT00099437|284200|P2|Overall Study|Death|261
78802|NCT00099437|284201|P1|Overall Study|Death|293
78803|NCT00099437|284200|P2|Overall Study|Lost to Follow-up|33
78804|NCT00099437|284201|P1|Overall Study|Lost to Follow-up|30
78805|NCT00099632|284227|P6|Overall Study|Protocol Violation|1
78806|NCT00099632|284228|P5|Overall Study|Protocol Violation|0
78807|NCT00099632|284229|P4|Overall Study|Protocol Violation|0
78808|NCT00099632|284230|P3|Overall Study|Protocol Violation|0
78809|NCT00099632|284231|P2|Overall Study|Protocol Violation|0
78810|NCT00099632|284232|P1|Overall Study|Protocol Violation|0
78811|NCT00099632|284227|P6|Overall Study|Withdrawal by Subject|1
78812|NCT00099632|284228|P5|Overall Study|Withdrawal by Subject|0
78813|NCT00099632|284229|P4|Overall Study|Withdrawal by Subject|0
78814|NCT00099632|284230|P3|Overall Study|Withdrawal by Subject|0
78815|NCT00099632|284231|P2|Overall Study|Withdrawal by Subject|1
78816|NCT00099632|284232|P1|Overall Study|Withdrawal by Subject|0
78817|NCT00099632|284227|P6|Overall Study|Lost to Follow-up|0
78818|NCT00099632|284228|P5|Overall Study|Lost to Follow-up|1
78819|NCT00099632|284229|P4|Overall Study|Lost to Follow-up|1
78820|NCT00099632|284230|P3|Overall Study|Lost to Follow-up|3
78821|NCT00099632|284231|P2|Overall Study|Lost to Follow-up|0
78822|NCT00099632|284232|P1|Overall Study|Lost to Follow-up|1
78823|NCT00099983|284272|P2|Overall Study|Other issue|0
78824|NCT00099983|284273|P1|Overall Study|Other issue|1
78825|NCT00099983|284272|P2|Overall Study|Intolerant of burden of visits|1
78826|NCT00099983|284273|P1|Overall Study|Intolerant of burden of visits|0
78827|NCT00099983|284272|P2|Overall Study|Incarcerated|1
78828|NCT00099983|284273|P1|Overall Study|Incarcerated|0
78829|NCT00099983|284272|P2|Overall Study|Other psychiatric problem|0
78830|NCT00099983|284273|P1|Overall Study|Other psychiatric problem|1
78831|NCT00099983|284272|P2|Overall Study|Moved|0
78832|NCT00099983|284273|P1|Overall Study|Moved|1
78833|NCT00099983|284272|P2|Overall Study|Unable to return for appointments|1
78834|NCT00099983|284273|P1|Overall Study|Unable to return for appointments|1
78835|NCT00099983|284272|P2|Overall Study|Lack of Efficacy|1
78836|NCT00099983|284273|P1|Overall Study|Lack of Efficacy|0
78837|NCT00099983|284272|P2|Overall Study|Adverse Event|1
78838|NCT00099983|284273|P1|Overall Study|Adverse Event|1
78839|NCT00099983|284272|P2|Overall Study|Withdrawal by Subject|2
78840|NCT00099983|284273|P1|Overall Study|Withdrawal by Subject|3
78841|NCT00099983|284272|P2|Overall Study|Missing Source Documents|15
78842|NCT00099983|284273|P1|Overall Study|Missing Source Documents|14
78843|NCT00099983|284272|P2|Overall Study|Lost to Follow-up|3
78844|NCT00099983|284273|P1|Overall Study|Lost to Follow-up|2
78845|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
78846|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
78847|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
78848|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
78849|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
78850|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
78851|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
78852|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
78853|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
78854|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
78855|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
78856|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
78857|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
78858|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
78859|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
78860|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
78861|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
78862|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
78863|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
78864|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
78865|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
78866|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
78867|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
78868|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
78869|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
78870|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
78871|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
78872|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
78873|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
78874|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
78875|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
78876|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
78877|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
78878|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
78879|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
78880|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
78881|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
78882|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
78883|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
78884|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
78885|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
78886|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
78887|NCT00100048|284284|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
78888|NCT00100048|284285|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
78889|NCT00100048|284286|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
78890|NCT00100048|284287|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
78891|NCT00100048|284288|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
78892|NCT00100048|284289|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
78893|NCT00100178|284399|P3|Overall Study|Physician Decision|3
78894|NCT00100178|284400|P2|Overall Study|Physician Decision|1
78895|NCT00100178|284401|P1|Overall Study|Physician Decision|6
78896|NCT00100178|284399|P3|Overall Study|Withdrawal by Subject|1
78897|NCT00100178|284400|P2|Overall Study|Withdrawal by Subject|1
78898|NCT00100178|284401|P1|Overall Study|Withdrawal by Subject|1
78899|NCT00100178|284399|P3|Overall Study|Adverse Event|1
78900|NCT00100178|284400|P2|Overall Study|Adverse Event|2
78901|NCT00100178|284401|P1|Overall Study|Adverse Event|2
78902|NCT00100178|284399|P3|Overall Study|Lost to Follow-up|5
78903|NCT00100178|284400|P2|Overall Study|Lost to Follow-up|6
78904|NCT00100178|284401|P1|Overall Study|Lost to Follow-up|0
78905|NCT00106626|284735|P4|Overall Study|> 14 day delay in therapy start|0
78906|NCT00106626|284736|P3|Overall Study|> 14 day delay in therapy start|0
78907|NCT00106626|284737|P2|Overall Study|> 14 day delay in therapy start|1
78908|NCT00106626|284738|P1|Overall Study|> 14 day delay in therapy start|0
78909|NCT00106626|284735|P4|Overall Study|Received radiation on new therapy|0
78910|NCT00106626|284736|P3|Overall Study|Received radiation on new therapy|0
78911|NCT00106626|284737|P2|Overall Study|Received radiation on new therapy|0
78912|NCT00106626|284738|P1|Overall Study|Received radiation on new therapy|1
78913|NCT00106626|284735|P4|Overall Study|Progressive Disease|10
78914|NCT00106626|284736|P3|Overall Study|Progressive Disease|9
78915|NCT00106626|284737|P2|Overall Study|Progressive Disease|1
78916|NCT00106626|284738|P1|Overall Study|Progressive Disease|4
78917|NCT00106626|284735|P4|Overall Study|Adverse Event|3
78918|NCT00106626|284736|P3|Overall Study|Adverse Event|3
78919|NCT00106626|284737|P2|Overall Study|Adverse Event|4
78920|NCT00106626|284738|P1|Overall Study|Adverse Event|5
78921|NCT00106639|284756|P3|Overall Study|Participant defaulted|1
78922|NCT00106639|284757|P2|Overall Study|Participant defaulted|1
78923|NCT00106639|284758|P1|Overall Study|Participant defaulted|0
78924|NCT00106639|284756|P3|Overall Study|Withdrawal by Subject|0
78925|NCT00106639|284757|P2|Overall Study|Withdrawal by Subject|1
78926|NCT00106639|284758|P1|Overall Study|Withdrawal by Subject|0
78927|NCT00106639|284756|P3|Overall Study|Protocol Violation|0
78928|NCT00106639|284757|P2|Overall Study|Protocol Violation|1
78929|NCT00106639|284758|P1|Overall Study|Protocol Violation|0
78930|NCT00106639|284756|P3|Overall Study|Adverse Event|1
78931|NCT00106639|284757|P2|Overall Study|Adverse Event|4
78932|NCT00106639|284758|P1|Overall Study|Adverse Event|3
78933|NCT00106704|284883|P2|Overall Study|Laboratory test|1
78934|NCT00106704|284884|P1|Overall Study|Laboratory test|1
78935|NCT00106704|284883|P2|Overall Study|Unable to re-enter US|0
78936|NCT00106704|284884|P1|Overall Study|Unable to re-enter US|1
78937|NCT00106704|284883|P2|Overall Study|Patient Received Glycemic Medication|41
78938|NCT00106704|284884|P1|Overall Study|Patient Received Glycemic Medication|22
78939|NCT00106704|284883|P2|Overall Study|Planned major surgery|0
78940|NCT00106704|284884|P1|Overall Study|Planned major surgery|1
78941|NCT00106704|284883|P2|Overall Study|Site terminated|1
78942|NCT00106704|284884|P1|Overall Study|Site terminated|0
78943|NCT00106704|284883|P2|Overall Study|Patient moved|0
78944|NCT00106704|284884|P1|Overall Study|Patient moved|1
78945|NCT00106704|284883|P2|Overall Study|Withdrawal by Subject|21
78946|NCT00106704|284884|P1|Overall Study|Withdrawal by Subject|14
78947|NCT00106704|284883|P2|Overall Study|Protocol Violation|7
78948|NCT00106704|284884|P1|Overall Study|Protocol Violation|4
78949|NCT00106704|284883|P2|Overall Study|Pregnancy|0
78950|NCT00106704|284884|P1|Overall Study|Pregnancy|1
78951|NCT00106704|284883|P2|Overall Study|Lost to Follow-up|3
78952|NCT00106704|284884|P1|Overall Study|Lost to Follow-up|7
78953|NCT00106704|284883|P2|Overall Study|Lack of Efficacy|69
78954|NCT00106704|284884|P1|Overall Study|Lack of Efficacy|67
78955|NCT00106704|284883|P2|Overall Study|Death|1
78956|NCT00106704|284884|P1|Overall Study|Death|2
78957|NCT00106704|284883|P2|Overall Study|Adverse Event|7
78958|NCT00106704|284884|P1|Overall Study|Adverse Event|10
78959|NCT00109343|284895|P3|Overall Study|Unspecified|1
78960|NCT00109343|284896|P2|Overall Study|Unspecified|2
78961|NCT00109343|284897|P1|Overall Study|Unspecified|5
78962|NCT00109343|284895|P3|Overall Study|Subject Moved|1
78963|NCT00109343|284896|P2|Overall Study|Subject Moved|2
78964|NCT00109343|284897|P1|Overall Study|Subject Moved|6
78965|NCT00109343|284895|P3|Overall Study|Withdrawal by Subject|10
78966|NCT00109343|284896|P2|Overall Study|Withdrawal by Subject|11
78967|NCT00109343|284897|P1|Overall Study|Withdrawal by Subject|15
78968|NCT00109343|284895|P3|Overall Study|Protocol Violation|2
78969|NCT00109343|284896|P2|Overall Study|Protocol Violation|2
78970|NCT00109343|284897|P1|Overall Study|Protocol Violation|1
78971|NCT00109343|284895|P3|Overall Study|Lost to Follow-up|14
78972|NCT00109343|284896|P2|Overall Study|Lost to Follow-up|20
78973|NCT00109343|284897|P1|Overall Study|Lost to Follow-up|35
78974|NCT00109343|284895|P3|Overall Study|Lack of Efficacy|0
78975|NCT00109343|284896|P2|Overall Study|Lack of Efficacy|0
78976|NCT00109343|284897|P1|Overall Study|Lack of Efficacy|1
78977|NCT00109343|284895|P3|Overall Study|Adverse Event|2
78978|NCT00109343|284896|P2|Overall Study|Adverse Event|0
78979|NCT00109343|284897|P1|Overall Study|Adverse Event|1
78980|NCT00109577|284962|P2|Overall Study|Withdrawal by Subject|3
78981|NCT00109577|284963|P1|Overall Study|Withdrawal by Subject|3
78982|NCT00109590|284972|P3|Overall Study|Never Started Treatment|3
78983|NCT00109590|284973|P2|Overall Study|Never Started Treatment|2
78984|NCT00109590|284974|P1|Overall Study|Never Started Treatment|1
78985|NCT00109590|284972|P3|Overall Study|Lost to Follow-up|1
78986|NCT00109590|284973|P2|Overall Study|Lost to Follow-up|0
78987|NCT00109590|284974|P1|Overall Study|Lost to Follow-up|1
78988|NCT00109733|285016|P2|Overall Study|Could not commit time for study|1
78989|NCT00109733|285017|P1|Overall Study|Could not commit time for study|1
78990|NCT00109733|285016|P2|Overall Study|Non-compliant|1
78991|NCT00109733|285017|P1|Overall Study|Non-compliant|0
78992|NCT00109733|285016|P2|Overall Study|Stopped taking study drug|1
78993|NCT00109733|285017|P1|Overall Study|Stopped taking study drug|1
78994|NCT00109733|285016|P2|Overall Study|Protocol Violation|1
78995|NCT00109733|285017|P1|Overall Study|Protocol Violation|0
78996|NCT00109772|285033|P2|Open-label Extension|not specified|10
78997|NCT00109772|285034|P1|Open-label Extension|not specified|4
78998|NCT00109772|285033|P2|Open-label Extension|Protocol Violation|2
78999|NCT00109772|285034|P1|Open-label Extension|Protocol Violation|2
79000|NCT00109772|285033|P2|Open-label Extension|Death|1
79001|NCT00109772|285034|P1|Open-label Extension|Death|0
79002|NCT00109772|285033|P2|Open-label Extension|Lost to Follow-up|0
79003|NCT00109772|285034|P1|Open-label Extension|Lost to Follow-up|1
79004|NCT00109772|285033|P2|Open-label Extension|Withdrawal by Subject|6
79005|NCT00109772|285034|P1|Open-label Extension|Withdrawal by Subject|9
79006|NCT00109772|285033|P2|Open-label Extension|Lack of Efficacy|11
79007|NCT00109772|285034|P1|Open-label Extension|Lack of Efficacy|19
79008|NCT00109772|285033|P2|Open-label Extension|Adverse Event|19
79009|NCT00109772|285034|P1|Open-label Extension|Adverse Event|10
79010|NCT00109772|285033|P2|Double-blind Treatment|Withdrew prior to treatment|1
79011|NCT00109772|285034|P1|Double-blind Treatment|Withdrew prior to treatment|3
79012|NCT00109772|285033|P2|Double-blind Treatment|not specified|4
79013|NCT00109772|285034|P1|Double-blind Treatment|not specified|0
79014|NCT00109772|285033|P2|Double-blind Treatment|Protocol Violation|1
79015|NCT00109772|285034|P1|Double-blind Treatment|Protocol Violation|0
79016|NCT00109772|285033|P2|Double-blind Treatment|Lost to Follow-up|3
79017|NCT00109772|285034|P1|Double-blind Treatment|Lost to Follow-up|2
79018|NCT00109772|285033|P2|Double-blind Treatment|Withdrawal by Subject|1
79019|NCT00109772|285034|P1|Double-blind Treatment|Withdrawal by Subject|2
79020|NCT00109772|285033|P2|Double-blind Treatment|Lack of Efficacy|0
79021|NCT00109772|285034|P1|Double-blind Treatment|Lack of Efficacy|1
79022|NCT00109772|285033|P2|Double-blind Treatment|Adverse Event|5
79023|NCT00109772|285034|P1|Double-blind Treatment|Adverse Event|14
79024|NCT00109837|285072|P1|Overall Study|Ineligible|1
79025|NCT00109837|285072|P1|Overall Study|Not treated|1
79026|NCT00109837|285072|P1|Overall Study|BCR/ABL+ or Ph+|17
79027|NCT00109837|285072|P1|Overall Study|Death|1
79028|NCT00109837|285072|P1|Overall Study|Refusal unrelated to adverse effects|1
79029|NCT00109837|285072|P1|Overall Study|Adverse Event|2
79030|NCT00109850|285080|P1|Overall Study|Ineligible|1
79031|NCT00109850|285080|P1|Overall Study|Death|2
79032|NCT00109850|285080|P1|Overall Study|Adverse Event|1
79033|NCT00109928|285097|P1|Overall Study|not eligible|1
79034|NCT00109928|285097|P1|Overall Study|not protocol specified|2
79035|NCT00109928|285097|P1|Overall Study|Death|2
79036|NCT00109928|285097|P1|Overall Study|Progression|6
79037|NCT00109928|285097|P1|Overall Study|Adverse Event|2
79038|NCT00109967|285106|P2|Overall Study|Death|2
79039|NCT00109967|285107|P1|Overall Study|Death|0
79040|NCT00109967|285106|P2|Overall Study|Physician Decision|3
79041|NCT00109967|285107|P1|Overall Study|Physician Decision|1
79042|NCT00109967|285106|P2|Overall Study|Withdrawal by Subject|0
79043|NCT00109967|285107|P1|Overall Study|Withdrawal by Subject|5
79044|NCT00109967|285106|P2|Overall Study|Adverse Event|1
79045|NCT00109967|285107|P1|Overall Study|Adverse Event|12
79046|NCT00109967|285106|P2|Overall Study|Cancel Prior to Treatment|0
79047|NCT00109967|285107|P1|Overall Study|Cancel Prior to Treatment|2
79048|NCT00110019|285123|P2|Overall Study|other reasons|30
79049|NCT00110019|285124|P1|Overall Study|other reasons|22
79050|NCT00110019|285123|P2|Overall Study|Not start protocol therapy|16
79051|NCT00110019|285124|P1|Overall Study|Not start protocol therapy|17
79052|NCT00110019|285123|P2|Overall Study|symptom deterioration|16
79053|NCT00110019|285124|P1|Overall Study|symptom deterioration|13
79054|NCT00110019|285123|P2|Overall Study|complicating disease|1
79055|NCT00110019|285124|P1|Overall Study|complicating disease|1
79056|NCT00110019|285123|P2|Overall Study|alternative therapy|1
79057|NCT00110019|285124|P1|Overall Study|alternative therapy|5
79058|NCT00110019|285123|P2|Overall Study|Withdrawal by Subject|9
79059|NCT00110019|285124|P1|Overall Study|Withdrawal by Subject|21
79060|NCT00110019|285123|P2|Overall Study|Death|15
79061|NCT00110019|285124|P1|Overall Study|Death|13
79062|NCT00110019|285123|P2|Overall Study|Adverse Event|40
79063|NCT00110019|285124|P1|Overall Study|Adverse Event|61
79064|NCT00110019|285123|P2|Overall Study|Lack of Efficacy|285
79065|NCT00110019|285124|P1|Overall Study|Lack of Efficacy|253
79066|NCT00110084|285134|P1|Overall Study|Other|2
79067|NCT00110084|285134|P1|Overall Study|Intercurrent Illness|1
79068|NCT00110084|285134|P1|Overall Study|Alternate Therapy|5
79069|NCT00110084|285134|P1|Overall Study|Patient Refusal|10
79070|NCT00110084|285134|P1|Overall Study|Death|1
79071|NCT00110084|285134|P1|Overall Study|Adverse Event|9
79072|NCT00110214|285152|P2|Overall Study|Other (not specified)|75
79073|NCT00110214|285153|P1|Overall Study|Other (not specified)|61
79074|NCT00110214|285152|P2|Overall Study|Refused further treatment|65
79075|NCT00110214|285153|P1|Overall Study|Refused further treatment|52
79076|NCT00110214|285152|P2|Overall Study|Adverse Event|192
79077|NCT00110214|285153|P1|Overall Study|Adverse Event|115
79078|NCT00110214|285152|P2|Overall Study|Disease progression or death|151
79079|NCT00110214|285153|P1|Overall Study|Disease progression or death|260
79080|NCT00110214|285152|P2|Overall Study|Never started treatment|20
79081|NCT00110214|285153|P1|Overall Study|Never started treatment|21
79082|NCT00110305|285169|P2|Overall Study|Unspecified|2
79083|NCT00110305|285170|P1|Overall Study|Unspecified|8
79084|NCT00110305|285169|P2|Overall Study|Lost to Follow-up|3
79085|NCT00110305|285170|P1|Overall Study|Lost to Follow-up|20
79086|NCT00110305|285169|P2|Overall Study|Withdrawal by Subject|7
79087|NCT00110305|285170|P1|Overall Study|Withdrawal by Subject|7
79088|NCT00110305|285169|P2|Overall Study|Protocol Violation|1
79089|NCT00110305|285170|P1|Overall Study|Protocol Violation|0
79090|NCT00110305|285169|P2|Overall Study|Subject Reached A Virologic Endpoint|3
79091|NCT00110305|285170|P1|Overall Study|Subject Reached A Virologic Endpoint|21
79092|NCT00110305|285169|P2|Overall Study|Subject Ineligible To Continue The Trial|1
79093|NCT00110305|285170|P1|Overall Study|Subject Ineligible To Continue The Trial|2
79094|NCT00110305|285169|P2|Overall Study|Subject Non-Compliant|2
79095|NCT00110305|285170|P1|Overall Study|Subject Non-Compliant|9
79096|NCT00110305|285169|P2|Overall Study|Sponsors Decision|0
79097|NCT00110305|285170|P1|Overall Study|Sponsors Decision|1
79098|NCT00110305|285169|P2|Overall Study|Adverse Event|13
79099|NCT00110305|285170|P1|Overall Study|Adverse Event|46
79100|NCT00110357|285223|P2|Overall Study|Withdrawal by Subject|1
79101|NCT00110357|285224|P1|Overall Study|Withdrawal by Subject|3
79102|NCT00110357|285223|P2|Overall Study|Study Drug Toxicity|3
79103|NCT00110357|285224|P1|Overall Study|Study Drug Toxicity|1
79104|NCT00110357|285223|P2|Overall Study|Study Closure|0
79105|NCT00110357|285224|P1|Overall Study|Study Closure|1
79106|NCT00110357|285223|P2|Overall Study|Disease progression/relapse|15
79107|NCT00110357|285224|P1|Overall Study|Disease progression/relapse|20
79108|NCT00110357|285223|P2|Overall Study|Deterioration without progression|0
79109|NCT00110357|285224|P1|Overall Study|Deterioration without progression|2
79110|NCT00110396|285308|P1|Overall Study|Patient is to be administered copaxone|1
79111|NCT00110396|285308|P1|Overall Study|The patient has refused to visit site|1
79112|NCT00110396|285308|P1|Overall Study|The patient has refused|2
79113|NCT00110396|285308|P1|Overall Study|Patient refused to come back|1
79114|NCT00110396|285308|P1|Overall Study|Protocol Violation|2
79115|NCT00110396|285308|P1|Overall Study|Pregnancy (Protocol violation)|2
79116|NCT00110396|285308|P1|Overall Study|Pregnancy|1
79117|NCT00110396|285308|P1|Overall Study|Participation in MS vaccine study|1
79118|NCT00110396|285308|P1|Overall Study|Patient's decision|1
79119|NCT00110396|285308|P1|Overall Study|Patient will|1
79120|NCT00110396|285308|P1|Overall Study|Patient refused to participate|1
79121|NCT00110396|285308|P1|Overall Study|Patient refused to continue|1
79122|NCT00110396|285308|P1|Overall Study|Patient non-compliance|1
79123|NCT00110396|285308|P1|Overall Study|Decided not to continue treatment|1
79124|NCT00110396|285308|P1|Overall Study|Lack of Efficacy|1
79125|NCT00110396|285308|P1|Overall Study|Initiated mitoxantrone therapy|1
79126|NCT00110396|285308|P1|Overall Study|Administration of plasmapheresis|1
79127|NCT00110396|285308|P1|Overall Study|Lost to Follow-up|1
79128|NCT00110396|285308|P1|Overall Study|Adverse Event|15
79129|NCT00110617|285420|P2|Overall Study|Did not receive study drug|12
79130|NCT00110617|285421|P1|Overall Study|Did not receive study drug|0
79131|NCT00110617|285420|P2|Overall Study|Death|1
79132|NCT00110617|285421|P1|Overall Study|Death|1
79133|NCT00110617|285420|P2|Overall Study|Administrative problems|5
79134|NCT00110617|285421|P1|Overall Study|Administrative problems|6
79135|NCT00110617|285420|P2|Overall Study|Lost to Follow-up|1
79136|NCT00110617|285421|P1|Overall Study|Lost to Follow-up|9
79137|NCT00110617|285420|P2|Overall Study|Withdrawal by Subject|4
79138|NCT00110617|285421|P1|Overall Study|Withdrawal by Subject|10
79139|NCT00110617|285420|P2|Overall Study|Protocol Violation|0
79140|NCT00110617|285421|P1|Overall Study|Protocol Violation|5
79141|NCT00110617|285420|P2|Overall Study|Patient no longer requires study drug|0
79142|NCT00110617|285421|P1|Overall Study|Patient no longer requires study drug|1
79143|NCT00110617|285420|P2|Overall Study|Lack of Efficacy|0
79144|NCT00110617|285421|P1|Overall Study|Lack of Efficacy|1
79145|NCT00110617|285420|P2|Overall Study|Abnormal Laboratory Value|2
79146|NCT00110617|285421|P1|Overall Study|Abnormal Laboratory Value|4
79147|NCT00110617|285420|P2|Overall Study|Adverse Event|4
79148|NCT00110617|285421|P1|Overall Study|Adverse Event|2
79149|NCT00110812|285437|P3|Extended Follow-up|Lost to Follow-up|1
79150|NCT00110812|285438|P2|Extended Follow-up|Lost to Follow-up|3
79151|NCT00110812|285439|P1|Extended Follow-up|Lost to Follow-up|1
79152|NCT00110812|285437|P3|Extended Follow-up|Withdrawal by Subject|0
79153|NCT00110812|285438|P2|Extended Follow-up|Withdrawal by Subject|1
79154|NCT00110812|285439|P1|Extended Follow-up|Withdrawal by Subject|0
79155|NCT00110812|285437|P3|Extended Follow-up|Death|3
79156|NCT00110812|285438|P2|Extended Follow-up|Death|0
79157|NCT00110812|285439|P1|Extended Follow-up|Death|1
79158|NCT00110812|285437|P3|Main Study|Lost to Follow-up|10
79159|NCT00110812|285438|P2|Main Study|Lost to Follow-up|11
79160|NCT00110812|285439|P1|Main Study|Lost to Follow-up|8
79161|NCT00110812|285437|P3|Main Study|Withdrawal by Subject|1
79162|NCT00110812|285438|P2|Main Study|Withdrawal by Subject|0
79163|NCT00110812|285439|P1|Main Study|Withdrawal by Subject|0
79164|NCT00110812|285437|P3|Main Study|Death|2
79165|NCT00110812|285438|P2|Main Study|Death|0
79166|NCT00110812|285439|P1|Main Study|Death|0
79167|NCT00110890|285484|P2|Overall Study|Did not enter follow-up phase|4
79168|NCT00110890|285485|P1|Overall Study|Did not enter follow-up phase|10
79169|NCT00110890|285484|P2|Overall Study|Parathyroidectomy|1
79170|NCT00110890|285485|P1|Overall Study|Parathyroidectomy|0
79171|NCT00110890|285484|P2|Overall Study|Disease progression|1
79172|NCT00110890|285485|P1|Overall Study|Disease progression|0
79173|NCT00110890|285484|P2|Overall Study|Requirement for alternative therapy|1
79174|NCT00110890|285485|P1|Overall Study|Requirement for alternative therapy|0
79175|NCT00110890|285484|P2|Overall Study|Ineligibility determined|0
79176|NCT00110890|285485|P1|Overall Study|Ineligibility determined|3
79177|NCT00110890|285484|P2|Overall Study|Other|23
79178|NCT00110890|285485|P1|Overall Study|Other|34
79179|NCT00110890|285484|P2|Overall Study|Invest. Product Commercially Available|110
79180|NCT00110890|285485|P1|Overall Study|Invest. Product Commercially Available|217
79181|NCT00110890|285484|P2|Overall Study|Kidney Transplant|12
79182|NCT00110890|285485|P1|Overall Study|Kidney Transplant|16
79183|NCT00110890|285484|P2|Overall Study|Noncompliance|0
79184|NCT00110890|285485|P1|Overall Study|Noncompliance|10
79185|NCT00110890|285484|P2|Overall Study|Protocol Deviation|0
79186|NCT00110890|285485|P1|Overall Study|Protocol Deviation|1
79187|NCT00110890|285484|P2|Overall Study|Withdrawal by Subject|5
79188|NCT00110890|285485|P1|Overall Study|Withdrawal by Subject|17
79189|NCT00110890|285484|P2|Overall Study|Physician Decision|5
79190|NCT00110890|285485|P1|Overall Study|Physician Decision|4
79191|NCT00110890|285484|P2|Overall Study|Lost to Follow-up|1
79192|NCT00110890|285485|P1|Overall Study|Lost to Follow-up|3
79193|NCT00110890|285484|P2|Overall Study|Death|9
79194|NCT00110890|285485|P1|Overall Study|Death|16
79195|NCT00110890|285484|P2|Overall Study|Adverse Event|7
79196|NCT00110890|285485|P1|Overall Study|Adverse Event|30
79197|NCT00110994|285501|P2|Long Term Follow-up|Death|17
79198|NCT00110994|285502|P1|Long Term Follow-up|Death|19
79199|NCT00110994|285501|P2|Active Follow-up|Other reasons|2
79200|NCT00110994|285502|P1|Active Follow-up|Other reasons|0
79201|NCT00110994|285501|P2|Active Follow-up|Disease progression/recurrence/replace|0
79202|NCT00110994|285502|P1|Active Follow-up|Disease progression/recurrence/replace|1
79203|NCT00110994|285501|P2|Double-blind (DB) Treatment|other reasons|3
79204|NCT00110994|285502|P1|Double-blind (DB) Treatment|other reasons|2
79205|NCT00110994|285501|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
79206|NCT00110994|285502|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
79207|NCT00110994|285501|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
79208|NCT00110994|285502|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
79209|NCT00110994|285501|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
79210|NCT00110994|285502|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
79211|NCT00110994|285501|P2|Double-blind (DB) Treatment|Death|0
79212|NCT00110994|285502|P1|Double-blind (DB) Treatment|Death|1
79213|NCT00110994|285501|P2|Double-blind (DB) Treatment|Adverse Event|0
79214|NCT00110994|285502|P1|Double-blind (DB) Treatment|Adverse Event|3
79215|NCT00111007|285528|P2|Long Term Follow-up|Missing|3
79216|NCT00111007|285529|P1|Long Term Follow-up|Missing|10
79217|NCT00111007|285528|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
79218|NCT00111007|285529|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
79219|NCT00111007|285528|P2|Long Term Follow-up|Withdrawal by Subject|1
79220|NCT00111007|285529|P1|Long Term Follow-up|Withdrawal by Subject|0
79221|NCT00111007|285528|P2|Long Term Follow-up|Lost to Follow-up|1
79222|NCT00111007|285529|P1|Long Term Follow-up|Lost to Follow-up|1
79223|NCT00111007|285528|P2|Long Term Follow-up|Death|39
79224|NCT00111007|285529|P1|Long Term Follow-up|Death|34
79225|NCT00111007|285528|P2|Active Follow-up|Disease progression/recurrence/relapse|2
79226|NCT00111007|285529|P1|Active Follow-up|Disease progression/recurrence/relapse|3
79227|NCT00111007|285528|P2|Active Follow-up|Death|0
79228|NCT00111007|285529|P1|Active Follow-up|Death|2
79229|NCT00111007|285528|P2|Active Follow-up|Adverse Event|0
79230|NCT00111007|285529|P1|Active Follow-up|Adverse Event|1
79231|NCT00111007|285528|P2|Double-blind (DB) Treatment|Primary reason with other category|1
79232|NCT00111007|285529|P1|Double-blind (DB) Treatment|Primary reason with other category|0
79233|NCT00111007|285528|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
79577|NCT00107042|286712|P2|Overall Study|Inadvertent enrollment|1
79234|NCT00111007|285529|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
79235|NCT00111007|285528|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
79236|NCT00111007|285529|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
79237|NCT00111007|285528|P2|Double-blind (DB) Treatment|Relapse|0
79238|NCT00111007|285529|P1|Double-blind (DB) Treatment|Relapse|1
79239|NCT00111007|285528|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
79240|NCT00111007|285529|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
79241|NCT00111007|285528|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
79242|NCT00111007|285529|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
79243|NCT00111007|285528|P2|Double-blind (DB) Treatment|Protocol Violation|1
79244|NCT00111007|285529|P1|Double-blind (DB) Treatment|Protocol Violation|0
79245|NCT00111007|285528|P2|Double-blind (DB) Treatment|Death|2
79246|NCT00111007|285529|P1|Double-blind (DB) Treatment|Death|5
79247|NCT00111007|285528|P2|Double-blind (DB) Treatment|Adverse Event|4
79248|NCT00111007|285529|P1|Double-blind (DB) Treatment|Adverse Event|12
79249|NCT00111761|285555|P2|Part 2|Other|0
79250|NCT00111761|285556|P1|Part 2|Other|1
79251|NCT00111761|285555|P2|Part 2|Protocol-specified criteria|0
79252|NCT00111761|285556|P1|Part 2|Protocol-specified criteria|1
79253|NCT00111761|285555|P2|Part 2|Disease progression|0
79254|NCT00111761|285556|P1|Part 2|Disease progression|3
79255|NCT00111761|285555|P2|Part 2|Death|0
79256|NCT00111761|285556|P1|Part 2|Death|1
79257|NCT00111761|285555|P2|Part 2|Physician Decision|0
79258|NCT00111761|285556|P1|Part 2|Physician Decision|1
79259|NCT00111761|285555|P2|Part 2|Adverse Event|0
79260|NCT00111761|285556|P1|Part 2|Adverse Event|1
79261|NCT00111761|285555|P2|Part 1|Withdrawal by Subject|1
79262|NCT00111761|285556|P1|Part 1|Withdrawal by Subject|0
79263|NCT00111761|285555|P2|Part 1|Other|1
79264|NCT00111761|285556|P1|Part 1|Other|0
79265|NCT00111761|285555|P2|Part 1|Death|2
79266|NCT00111761|285556|P1|Part 1|Death|0
79267|NCT00111761|285555|P2|Part 1|Physician Decision|1
79268|NCT00111761|285556|P1|Part 1|Physician Decision|0
79269|NCT00111813|285573|P6|Overall Study|Not specified|0
79270|NCT00111813|285574|P5|Overall Study|Not specified|0
79271|NCT00111813|285575|P4|Overall Study|Not specified|0
79272|NCT00111813|285576|P3|Overall Study|Not specified|1
79273|NCT00111813|285577|P2|Overall Study|Not specified|0
79274|NCT00111813|285578|P1|Overall Study|Not specified|0
79275|NCT00111813|285573|P6|Overall Study|Lack of Efficacy|1
79276|NCT00111813|285574|P5|Overall Study|Lack of Efficacy|0
79277|NCT00111813|285575|P4|Overall Study|Lack of Efficacy|0
79278|NCT00111813|285576|P3|Overall Study|Lack of Efficacy|0
79279|NCT00111813|285577|P2|Overall Study|Lack of Efficacy|0
79280|NCT00111813|285578|P1|Overall Study|Lack of Efficacy|0
79281|NCT00111813|285573|P6|Overall Study|Progressive disease|3
79282|NCT00111813|285574|P5|Overall Study|Progressive disease|4
79283|NCT00111813|285575|P4|Overall Study|Progressive disease|3
79284|NCT00111813|285576|P3|Overall Study|Progressive disease|5
79285|NCT00111813|285577|P2|Overall Study|Progressive disease|1
79286|NCT00111813|285578|P1|Overall Study|Progressive disease|2
79287|NCT00111813|285573|P6|Overall Study|Adverse Event|2
79288|NCT00111813|285574|P5|Overall Study|Adverse Event|2
79289|NCT00111813|285575|P4|Overall Study|Adverse Event|2
79290|NCT00111813|285576|P3|Overall Study|Adverse Event|4
79291|NCT00111813|285577|P2|Overall Study|Adverse Event|2
79292|NCT00111813|285578|P1|Overall Study|Adverse Event|1
79293|NCT00103610|285613|P2|Overall Study|Noncompliance|1
79294|NCT00103610|285614|P1|Overall Study|Noncompliance|0
79295|NCT00103610|285613|P2|Overall Study|Failed mobilization|5
79296|NCT00103610|285614|P1|Overall Study|Failed mobilization|1
79297|NCT00103610|285613|P2|Overall Study|Other|7
79298|NCT00103610|285614|P1|Overall Study|Other|2
79299|NCT00103610|285613|P2|Overall Study|Adverse Event|2
79300|NCT00103610|285614|P1|Overall Study|Adverse Event|2
79301|NCT00103610|285613|P2|Overall Study|Lost to Follow-up|1
79302|NCT00103610|285614|P1|Overall Study|Lost to Follow-up|3
79303|NCT00103610|285613|P2|Overall Study|Elective Withdrawal|0
79304|NCT00103610|285614|P1|Overall Study|Elective Withdrawal|4
79305|NCT00103610|285613|P2|Overall Study|Death|12
79306|NCT00103610|285614|P1|Overall Study|Death|16
79307|NCT00103610|285613|P2|Overall Study|Entered Rescue Procedure|52
79308|NCT00103610|285614|P1|Overall Study|Entered Rescue Procedure|10
79309|NCT00103662|285638|P2|Overall Study|Intercurrent illness|0
79310|NCT00103662|285639|P1|Overall Study|Intercurrent illness|1
79311|NCT00103662|285638|P2|Overall Study|Failed mobilization|4
79312|NCT00103662|285639|P1|Overall Study|Failed mobilization|0
79313|NCT00103662|285638|P2|Overall Study|Other|9
79314|NCT00103662|285639|P1|Overall Study|Other|6
79315|NCT00103662|285638|P2|Overall Study|Lost to Follow-up|1
79316|NCT00103662|285639|P1|Overall Study|Lost to Follow-up|0
79317|NCT00103662|285638|P2|Overall Study|Elective Withdrawal|5
79318|NCT00103662|285639|P1|Overall Study|Elective Withdrawal|5
79319|NCT00103662|285638|P2|Overall Study|Death|7
79320|NCT00103662|285639|P1|Overall Study|Death|7
79321|NCT00103662|285638|P2|Overall Study|Entered Rescue Procedure|7
79322|NCT00103662|285639|P1|Overall Study|Entered Rescue Procedure|0
79323|NCT00103740|285665|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
79578|NCT00107042|286713|P1|Overall Study|Inadvertent enrollment|0
79324|NCT00103740|285666|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
79325|NCT00103740|285665|P2|Period 2 - Extended Observation Period|Death|2
79326|NCT00103740|285666|P1|Period 2 - Extended Observation Period|Death|6
79327|NCT00103740|285665|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
79328|NCT00103740|285666|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
79329|NCT00103740|285665|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
79330|NCT00103740|285666|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
79331|NCT00103740|285665|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
79332|NCT00103740|285666|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
79333|NCT00103740|285665|P2|Period 1 - Core|Patient withdrew consent|2
79334|NCT00103740|285666|P1|Period 1 - Core|Patient withdrew consent|3
79335|NCT00103740|285665|P2|Period 1 - Core|Protocol Violation|2
79336|NCT00103740|285666|P1|Period 1 - Core|Protocol Violation|3
79337|NCT00103740|285665|P2|Period 1 - Core|Adverse Event|0
79338|NCT00103740|285666|P1|Period 1 - Core|Adverse Event|1
79339|NCT00111917|285694|P2|Overall Study|Withdrawal by Subject|1
79340|NCT00111917|285695|P1|Overall Study|Withdrawal by Subject|1
79341|NCT00112047|285709|P2|Atripla Phase|Not specified|1
79342|NCT00112047|285710|P1|Atripla Phase|Not specified|3
79343|NCT00112047|285709|P2|Atripla Phase|Non-compliance|0
79344|NCT00112047|285710|P1|Atripla Phase|Non-compliance|1
79345|NCT00112047|285709|P2|Atripla Phase|Sub-optimal virological response|1
79346|NCT00112047|285710|P1|Atripla Phase|Sub-optimal virological response|0
79347|NCT00112047|285709|P2|Atripla Phase|Withdrew consent|7
79348|NCT00112047|285710|P1|Atripla Phase|Withdrew consent|7
79349|NCT00112047|285709|P2|Atripla Phase|Death|2
79350|NCT00112047|285710|P1|Atripla Phase|Death|0
79351|NCT00112047|285709|P2|Atripla Phase|Pregnancy|1
79352|NCT00112047|285710|P1|Atripla Phase|Pregnancy|0
79353|NCT00112047|285709|P2|Atripla Phase|Lost to Follow-up|7
79354|NCT00112047|285710|P1|Atripla Phase|Lost to Follow-up|5
79355|NCT00112047|285709|P2|Atripla Phase|Adverse Event|1
79356|NCT00112047|285710|P1|Atripla Phase|Adverse Event|2
79357|NCT00112047|285709|P2|Randomized Phase|High Hepatitis B DNA|1
79358|NCT00112047|285710|P1|Randomized Phase|High Hepatitis B DNA|0
79359|NCT00112047|285709|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
79360|NCT00112047|285710|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
79361|NCT00112047|285709|P2|Randomized Phase|Moved out of State|1
79362|NCT00112047|285710|P1|Randomized Phase|Moved out of State|0
79363|NCT00112047|285709|P2|Randomized Phase|Incarceration|2
79364|NCT00112047|285710|P1|Randomized Phase|Incarceration|3
79365|NCT00112047|285709|P2|Randomized Phase|Inability to swallow pills|1
79366|NCT00112047|285710|P1|Randomized Phase|Inability to swallow pills|0
79367|NCT00112047|285709|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
79368|NCT00112047|285710|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
79369|NCT00112047|285709|P2|Randomized Phase|Death|3
79370|NCT00112047|285710|P1|Randomized Phase|Death|1
79371|NCT00112047|285709|P2|Randomized Phase|Pregnancy|1
79372|NCT00112047|285710|P1|Randomized Phase|Pregnancy|3
79373|NCT00112047|285709|P2|Randomized Phase|Protocol Violation|0
79374|NCT00112047|285710|P1|Randomized Phase|Protocol Violation|2
79375|NCT00112047|285709|P2|Randomized Phase|Noncompliance|4
79376|NCT00112047|285710|P1|Randomized Phase|Noncompliance|8
79377|NCT00112047|285709|P2|Randomized Phase|Sub-optimal virological response|13
79378|NCT00112047|285710|P1|Randomized Phase|Sub-optimal virological response|3
79379|NCT00112047|285709|P2|Randomized Phase|Withrawal of consent|18
79380|NCT00112047|285710|P1|Randomized Phase|Withrawal of consent|10
79381|NCT00112047|285709|P2|Randomized Phase|Adverse Event|10
79382|NCT00112047|285710|P1|Randomized Phase|Adverse Event|10
79383|NCT00112047|285709|P2|Randomized Phase|Lost to Follow-up|33
79384|NCT00112047|285710|P1|Randomized Phase|Lost to Follow-up|26
79385|NCT00114530|286023|P2|Overall Study|Ineligible|0
79386|NCT00114530|286024|P1|Overall Study|Ineligible|1
79387|NCT00114530|286023|P2|Overall Study|Subject decision after endpoint failure|1
79388|NCT00114530|286024|P1|Overall Study|Subject decision after endpoint failure|0
79389|NCT00114530|286023|P2|Overall Study|Breast Cancer|0
79390|NCT00114530|286024|P1|Overall Study|Breast Cancer|1
79391|NCT00114530|286023|P2|Overall Study|Withdrawal by Subject|6
79392|NCT00114530|286024|P1|Overall Study|Withdrawal by Subject|2
79393|NCT00114530|286023|P2|Overall Study|Physician Decision|1
79394|NCT00114530|286024|P1|Overall Study|Physician Decision|1
79395|NCT00114530|286023|P2|Overall Study|Lost to Follow-up|1
79396|NCT00114530|286024|P1|Overall Study|Lost to Follow-up|1
79397|NCT00114530|286023|P2|Overall Study|Death|11
79398|NCT00114530|286024|P1|Overall Study|Death|3
79399|NCT00114634|286129|P1|Overall Study|failure to return forms|3
79400|NCT00114777|286146|P3|Long-Term Extension to Month 84|Not Specified|2
79401|NCT00114777|286147|P2|Long-Term Extension to Month 84|Not Specified|0
79402|NCT00114777|286148|P1|Long-Term Extension to Month 84|Not Specified|2
79403|NCT00114777|286146|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
79404|NCT00114777|286147|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
79405|NCT00114777|286148|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
79406|NCT00114777|286146|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
79407|NCT00114777|286147|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
79408|NCT00114777|286148|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
79409|NCT00114777|286146|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
79410|NCT00114777|286147|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
79411|NCT00114777|286148|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
79412|NCT00114777|286146|P3|Long-Term Extension to Month 84|Adverse Event|7
79413|NCT00114777|286147|P2|Long-Term Extension to Month 84|Adverse Event|14
79414|NCT00114777|286148|P1|Long-Term Extension to Month 84|Adverse Event|15
79415|NCT00114777|286146|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
79416|NCT00114777|286147|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
79417|NCT00114777|286148|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
79418|NCT00114777|286146|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
79419|NCT00114777|286147|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
79420|NCT00114777|286148|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
79421|NCT00114777|286146|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
79422|NCT00114777|286147|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
79423|NCT00114777|286148|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
79424|NCT00114777|286146|P3|Long-Term Extension to Month 84|Death|7
79425|NCT00114777|286147|P2|Long-Term Extension to Month 84|Death|13
79426|NCT00114777|286148|P1|Long-Term Extension to Month 84|Death|8
79427|NCT00114777|286146|P3|Randomization to Month 36|Not Specified|12
79428|NCT00114777|286147|P2|Randomization to Month 36|Not Specified|3
79429|NCT00114777|286148|P1|Randomization to Month 36|Not Specified|9
79430|NCT00114777|286146|P3|Randomization to Month 36|Withdrawal by Subject|5
79431|NCT00114777|286147|P2|Randomization to Month 36|Withdrawal by Subject|4
79432|NCT00114777|286148|P1|Randomization to Month 36|Withdrawal by Subject|3
79433|NCT00114777|286146|P3|Randomization to Month 36|Adverse Event|44
79434|NCT00114777|286147|P2|Randomization to Month 36|Adverse Event|35
79435|NCT00114777|286148|P1|Randomization to Month 36|Adverse Event|34
79436|NCT00114777|286146|P3|Randomization to Month 36|Poor or Non-Compliance|1
79437|NCT00114777|286147|P2|Randomization to Month 36|Poor or Non-Compliance|0
79438|NCT00114777|286148|P1|Randomization to Month 36|Poor or Non-Compliance|0
79439|NCT00114777|286146|P3|Randomization to Month 36|Lack of Efficacy|17
79440|NCT00114777|286147|P2|Randomization to Month 36|Lack of Efficacy|15
79441|NCT00114777|286148|P1|Randomization to Month 36|Lack of Efficacy|19
79442|NCT00114777|286146|P3|Randomization to Month 36|No Longer Met Study Criteria|2
79443|NCT00114777|286147|P2|Randomization to Month 36|No Longer Met Study Criteria|0
79444|NCT00114777|286148|P1|Randomization to Month 36|No Longer Met Study Criteria|0
79445|NCT00114777|286146|P3|Randomization to Month 36|Death|3
79446|NCT00114777|286147|P2|Randomization to Month 36|Death|4
79447|NCT00114777|286148|P1|Randomization to Month 36|Death|10
79448|NCT00114959|286222|P1|Overall Study|Death|1
79449|NCT00114959|286222|P1|Overall Study|Physician Decision|1
79450|NCT00114959|286222|P1|Overall Study|Lack of Efficacy|6
79451|NCT00114972|286231|P2|Overall Study|Lost to Follow-up|5
79452|NCT00114972|286232|P1|Overall Study|Lost to Follow-up|8
79453|NCT00114972|286231|P2|Overall Study|Withdrawal by Subject|7
79454|NCT00114972|286232|P1|Overall Study|Withdrawal by Subject|40
79455|NCT00115063|286254|P2|Overall Study|Death|0
79456|NCT00115063|286255|P1|Overall Study|Death|1
79457|NCT00115063|286254|P2|Overall Study|Lost to Follow-up|104
79458|NCT00115063|286255|P1|Overall Study|Lost to Follow-up|98
79459|NCT00115349|286286|P2|Overall Study|Study closed due to low enrollment.|9
79460|NCT00115349|286287|P1|Overall Study|Study closed due to low enrollment.|11
79461|NCT00115739|286293|P1|Overall Study|Lost to Follow-up|3
79462|NCT00115765|286304|P4|Overall Study|Not specified|2
79463|NCT00115765|286305|P3|Overall Study|Not specified|9
79464|NCT00115765|286306|P2|Overall Study|Not specified|12
79465|NCT00115765|286307|P1|Overall Study|Not specified|6
79466|NCT00115765|286304|P4|Overall Study|Lost to Follow-up|1
79467|NCT00115765|286305|P3|Overall Study|Lost to Follow-up|18
79468|NCT00115765|286306|P2|Overall Study|Lost to Follow-up|20
79469|NCT00115765|286307|P1|Overall Study|Lost to Follow-up|3
79470|NCT00115765|286304|P4|Overall Study|Physician Decision|13
79471|NCT00115765|286305|P3|Overall Study|Physician Decision|18
79472|NCT00115765|286306|P2|Overall Study|Physician Decision|15
79473|NCT00115765|286307|P1|Overall Study|Physician Decision|4
79474|NCT00115765|286304|P4|Overall Study|Withdrawal by Subject|15
79475|NCT00115765|286305|P3|Overall Study|Withdrawal by Subject|76
79476|NCT00115765|286306|P2|Overall Study|Withdrawal by Subject|53
79477|NCT00115765|286307|P1|Overall Study|Withdrawal by Subject|22
79478|NCT00115804|286345|P1|Overall Study|Adverse Event|2
79479|NCT00115934|286369|P2|Overall Study|Did not receive intervention|2
79480|NCT00115934|286370|P1|Overall Study|Did not receive intervention|3
79481|NCT00115934|286369|P2|Overall Study|Lost to Follow-up|0
79482|NCT00115934|286370|P1|Overall Study|Lost to Follow-up|1
79483|NCT00116168|286412|P4|Overall Study|Lost to Follow-up|0
79484|NCT00116168|286413|P3|Overall Study|Lost to Follow-up|0
79485|NCT00116168|286414|P2|Overall Study|Lost to Follow-up|5
79486|NCT00116168|286415|P1|Overall Study|Lost to Follow-up|6
79487|NCT00116272|286494|P2|Overall Study|Lost to Follow-up|6
79488|NCT00116272|286495|P1|Overall Study|Lost to Follow-up|11
79489|NCT00116428|286547|P2|Overall Study|Did not meet inclusion criteria|0
79490|NCT00116428|286548|P1|Overall Study|Did not meet inclusion criteria|1
79491|NCT00116428|286547|P2|Overall Study|Withdrawal by Subject|5
79492|NCT00116428|286548|P1|Overall Study|Withdrawal by Subject|2
79493|NCT00116649|286564|P1|Overall Study|Protocol Specified|7
79494|NCT00116649|286564|P1|Overall Study|Various Reasons|18
79495|NCT00116649|286564|P1|Overall Study|Local Skin Reaction|9
79496|NCT00116649|286564|P1|Overall Study|Withdrawal by Subject|68
79497|NCT00116649|286564|P1|Overall Study|Lost to Follow-up|32
79498|NCT00116649|286564|P1|Overall Study|Lack of Efficacy|1
79499|NCT00116649|286564|P1|Overall Study|Adverse Event|20
79500|NCT00116688|286571|P2|Overall Study|Other|0
79501|NCT00116688|286572|P1|Overall Study|Other|11
79502|NCT00116688|286571|P2|Overall Study|Pregnancy|0
79503|NCT00116688|286572|P1|Overall Study|Pregnancy|1
79504|NCT00116688|286571|P2|Overall Study|Protocol-specified criteria|0
79505|NCT00116688|286572|P1|Overall Study|Protocol-specified criteria|3
79506|NCT00116688|286571|P2|Overall Study|Death|0
79507|NCT00116688|286572|P1|Overall Study|Death|15
79508|NCT00116688|286571|P2|Overall Study|Lost to Follow-up|0
79509|NCT00116688|286572|P1|Overall Study|Lost to Follow-up|3
79510|NCT00116688|286571|P2|Overall Study|Physician Decision|0
79511|NCT00116688|286572|P1|Overall Study|Physician Decision|7
79512|NCT00116688|286571|P2|Overall Study|Requirement for alternative therapy|1
79513|NCT00116688|286572|P1|Overall Study|Requirement for alternative therapy|11
79514|NCT00116688|286571|P2|Overall Study|Withdrawal by Subject|2
79515|NCT00116688|286572|P1|Overall Study|Withdrawal by Subject|26
79516|NCT00116688|286571|P2|Overall Study|Adverse Event|0
79517|NCT00116688|286572|P1|Overall Study|Adverse Event|11
79518|NCT00116688|286571|P2|Overall Study|Noncompliance|1
79519|NCT00116688|286572|P1|Overall Study|Noncompliance|3
79520|NCT00116688|286571|P2|Overall Study|Protocol deviation|0
79521|NCT00116688|286572|P1|Overall Study|Protocol deviation|1
79522|NCT00116753|286590|P3|Overall Study|Dosing Error|0
79523|NCT00116753|286591|P2|Overall Study|Dosing Error|1
79524|NCT00116753|286592|P1|Overall Study|Dosing Error|0
79525|NCT00116753|286590|P3|Overall Study|Progressive Parkinson's Disease|0
79526|NCT00116753|286591|P2|Overall Study|Progressive Parkinson's Disease|0
79527|NCT00116753|286592|P1|Overall Study|Progressive Parkinson's Disease|1
79528|NCT00116753|286590|P3|Overall Study|Abnormal Echocardiogram|1
79529|NCT00116753|286591|P2|Overall Study|Abnormal Echocardiogram|0
79530|NCT00116753|286592|P1|Overall Study|Abnormal Echocardiogram|0
79531|NCT00116753|286590|P3|Overall Study|Disease Progression|3
79532|NCT00116753|286591|P2|Overall Study|Disease Progression|4
79533|NCT00116753|286592|P1|Overall Study|Disease Progression|3
79534|NCT00116753|286590|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
79535|NCT00116753|286591|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
79536|NCT00116753|286592|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
79537|NCT00116753|286590|P3|Overall Study|Protocol Violation|1
79538|NCT00116753|286591|P2|Overall Study|Protocol Violation|0
79539|NCT00116753|286592|P1|Overall Study|Protocol Violation|0
79540|NCT00116753|286590|P3|Overall Study|Lost to Follow-up|1
79541|NCT00116753|286591|P2|Overall Study|Lost to Follow-up|2
79542|NCT00116753|286592|P1|Overall Study|Lost to Follow-up|0
79543|NCT00116753|286590|P3|Overall Study|Withdrawal by Subject|8
79544|NCT00116753|286591|P2|Overall Study|Withdrawal by Subject|12
79545|NCT00116753|286592|P1|Overall Study|Withdrawal by Subject|11
79546|NCT00116753|286590|P3|Overall Study|Adverse Event|7
79547|NCT00116753|286591|P2|Overall Study|Adverse Event|10
79548|NCT00116753|286592|P1|Overall Study|Adverse Event|16
79549|NCT00106964|286685|P3|Overall Study|Required disallowed medication|0
79550|NCT00106964|286686|P2|Overall Study|Required disallowed medication|1
79551|NCT00106964|286687|P1|Overall Study|Required disallowed medication|0
79552|NCT00106964|286685|P3|Overall Study|Did not meet eligibility criteria|2
79553|NCT00106964|286686|P2|Overall Study|Did not meet eligibility criteria|2
79554|NCT00106964|286687|P1|Overall Study|Did not meet eligibility criteria|0
79555|NCT00106964|286685|P3|Overall Study|Failure to adhere|0
79556|NCT00106964|286686|P2|Overall Study|Failure to adhere|0
79557|NCT00106964|286687|P1|Overall Study|Failure to adhere|2
79558|NCT00106964|286685|P3|Overall Study|Site Funding Terminated|1
79559|NCT00106964|286686|P2|Overall Study|Site Funding Terminated|1
79560|NCT00106964|286687|P1|Overall Study|Site Funding Terminated|0
79561|NCT00106964|286685|P3|Overall Study|Incarceration|0
79562|NCT00106964|286686|P2|Overall Study|Incarceration|1
79563|NCT00106964|286687|P1|Overall Study|Incarceration|0
79564|NCT00106964|286685|P3|Overall Study|Death|0
79565|NCT00106964|286686|P2|Overall Study|Death|1
79566|NCT00106964|286687|P1|Overall Study|Death|1
79567|NCT00106964|286685|P3|Overall Study|Pregnancy|2
79568|NCT00106964|286686|P2|Overall Study|Pregnancy|3
79569|NCT00106964|286687|P1|Overall Study|Pregnancy|2
79570|NCT00106964|286685|P3|Overall Study|Lost to Follow-up|2
79571|NCT00106964|286686|P2|Overall Study|Lost to Follow-up|6
79572|NCT00106964|286687|P1|Overall Study|Lost to Follow-up|8
79573|NCT00107042|286712|P2|Overall Study|Disallowed medications|2
79574|NCT00107042|286713|P1|Overall Study|Disallowed medications|0
79575|NCT00107042|286712|P2|Overall Study|vaccinated outside window|1
79576|NCT00107042|286713|P1|Overall Study|vaccinated outside window|1
79579|NCT00107042|286712|P2|Overall Study|Pregnancy|1
79580|NCT00107042|286713|P1|Overall Study|Pregnancy|1
79581|NCT00107042|286712|P2|Overall Study|Moved out of area|3
79582|NCT00107042|286713|P1|Overall Study|Moved out of area|5
79583|NCT00107042|286712|P2|Overall Study|Withdrawal by Subject|1
79584|NCT00107042|286713|P1|Overall Study|Withdrawal by Subject|6
79585|NCT00107042|286712|P2|Overall Study|Lost to Follow-up|7
79586|NCT00107042|286713|P1|Overall Study|Lost to Follow-up|9
79587|NCT00107120|286778|P2|Overall Study|death of parent|1
79588|NCT00107120|286779|P1|Overall Study|death of parent|0
79589|NCT00107120|286778|P2|Overall Study|moving away from site|1
79590|NCT00107120|286779|P1|Overall Study|moving away from site|1
79591|NCT00107120|286778|P2|Overall Study|Pregnancy|1
79592|NCT00107120|286779|P1|Overall Study|Pregnancy|0
79593|NCT00107120|286778|P2|Overall Study|Lost to Follow-up|6
79594|NCT00107120|286779|P1|Overall Study|Lost to Follow-up|8
79595|NCT00107120|286778|P2|Overall Study|Withdrawal by Subject|9
79596|NCT00107120|286779|P1|Overall Study|Withdrawal by Subject|8
79597|NCT00107120|286778|P2|Overall Study|Protocol Violation|0
79598|NCT00107120|286779|P1|Overall Study|Protocol Violation|3
79599|NCT00107120|286778|P2|Overall Study|Lack of Efficacy|5
79600|NCT00107120|286779|P1|Overall Study|Lack of Efficacy|5
79601|NCT00107120|286778|P2|Overall Study|Adverse Event|1
79602|NCT00107120|286779|P1|Overall Study|Adverse Event|4
79603|NCT00107172|286791|P2|Overall Study|Other Reason|3
79604|NCT00107172|286792|P1|Overall Study|Other Reason|4
79605|NCT00107172|286791|P2|Overall Study|Death|2
79606|NCT00107172|286792|P1|Overall Study|Death|0
79607|NCT00107172|286791|P2|Overall Study|Withdrawal by Subject|0
79608|NCT00107172|286792|P1|Overall Study|Withdrawal by Subject|1
79609|NCT00107198|286820|P1|Overall Study|Ineligible|5
79610|NCT00107198|286820|P1|Overall Study|Withdrawal by Subject|6
79611|NCT00107198|286820|P1|Overall Study|Protocol Violation|1
79612|NCT00107198|286820|P1|Overall Study|Lost to Follow-up|12
79613|NCT00107198|286820|P1|Overall Study|Lack of Efficacy|28
79614|NCT00107276|286828|P1|Overall Study|Ineligible|16
79615|NCT00107276|286828|P1|Overall Study|Death|1
79616|NCT00107276|286828|P1|Overall Study|Patient refusal|1
79617|NCT00107276|286828|P1|Overall Study|M.D. decision|2
79618|NCT00107276|286828|P1|Overall Study|Adverse Event|6
79619|NCT00107276|286828|P1|Overall Study|Progression|46
79620|NCT00107315|286834|P1|Overall Study|Withdrawal by Subject|2
79621|NCT00107315|286834|P1|Overall Study|Adverse Event|4
79622|NCT00107315|286834|P1|Overall Study|Disease Progression|9
79623|NCT00107380|286841|P1|Overall Study|Ineligible|2
79624|NCT00107380|286841|P1|Overall Study|Other - not protocol specified|7
79625|NCT00107380|286841|P1|Overall Study|Death|3
79626|NCT00107380|286841|P1|Overall Study|Progression/relapse|4
79627|NCT00107380|286841|P1|Overall Study|Refusal Unrelated to Adverse Event|7
79628|NCT00107380|286841|P1|Overall Study|Adverse Event|7
79629|NCT00107614|286874|P1|Overall Study|Death|2
79630|NCT00107614|286874|P1|Overall Study|Physician Decision|10
79631|NCT00107653|286880|P2|Overall Study|Administrative Reasons|3
79632|NCT00107653|286881|P1|Overall Study|Administrative Reasons|3
79633|NCT00107653|286880|P2|Overall Study|Lost to Follow-up|5
79634|NCT00107653|286881|P1|Overall Study|Lost to Follow-up|13
79635|NCT00107653|286880|P2|Overall Study|Withdrawal by Subject|13
79636|NCT00107653|286881|P1|Overall Study|Withdrawal by Subject|12
79637|NCT00107653|286880|P2|Overall Study|Protocol Violation|0
79638|NCT00107653|286881|P1|Overall Study|Protocol Violation|1
79639|NCT00107653|286880|P2|Overall Study|Violation of Selection Criteria at Entry|1
79640|NCT00107653|286881|P1|Overall Study|Violation of Selection Criteria at Entry|1
79641|NCT00107653|286880|P2|Overall Study|Insufficient Therapeutic Response|11
79642|NCT00107653|286881|P1|Overall Study|Insufficient Therapeutic Response|25
79643|NCT00107653|286880|P2|Overall Study|Adverse Event|43
79644|NCT00107653|286881|P1|Overall Study|Adverse Event|24
79645|NCT00107783|286929|P2|Overall Study|Second hip replacement|1
79646|NCT00107783|286930|P1|Overall Study|Second hip replacement|1
79647|NCT00107783|286929|P2|Overall Study|Withdrawal by Subject|0
79648|NCT00107783|286930|P1|Overall Study|Withdrawal by Subject|2
79649|NCT00107783|286929|P2|Overall Study|Death|1
79650|NCT00107783|286930|P1|Overall Study|Death|0
79651|NCT00107783|286929|P2|Overall Study|Adverse Event|2
79652|NCT00107783|286930|P1|Overall Study|Adverse Event|0
79653|NCT00107900|286950|P6|Overall Study|Administrative Reasons|0
79654|NCT00107900|286951|P5|Overall Study|Administrative Reasons|2
79655|NCT00107900|286952|P4|Overall Study|Administrative Reasons|2
79656|NCT00107900|286953|P3|Overall Study|Administrative Reasons|2
79657|NCT00107900|286954|P2|Overall Study|Administrative Reasons|0
79658|NCT00107900|286955|P1|Overall Study|Administrative Reasons|1
79659|NCT00107900|286950|P6|Overall Study|Withdrawal by Subject|1
79660|NCT00107900|286951|P5|Overall Study|Withdrawal by Subject|1
79661|NCT00107900|286952|P4|Overall Study|Withdrawal by Subject|0
79662|NCT00107900|286953|P3|Overall Study|Withdrawal by Subject|5
79663|NCT00107900|286954|P2|Overall Study|Withdrawal by Subject|0
79664|NCT00107900|286955|P1|Overall Study|Withdrawal by Subject|1
79665|NCT00107900|286950|P6|Overall Study|Protocol Violation|0
79666|NCT00107900|286951|P5|Overall Study|Protocol Violation|7
79667|NCT00107900|286952|P4|Overall Study|Protocol Violation|5
79668|NCT00107900|286953|P3|Overall Study|Protocol Violation|5
79669|NCT00107900|286954|P2|Overall Study|Protocol Violation|0
79670|NCT00107900|286955|P1|Overall Study|Protocol Violation|1
79671|NCT00107900|286950|P6|Overall Study|Lost to Follow-up|5
79672|NCT00107900|286951|P5|Overall Study|Lost to Follow-up|5
79673|NCT00107900|286952|P4|Overall Study|Lost to Follow-up|2
79674|NCT00107900|286953|P3|Overall Study|Lost to Follow-up|3
79675|NCT00107900|286954|P2|Overall Study|Lost to Follow-up|1
79676|NCT00107900|286955|P1|Overall Study|Lost to Follow-up|4
79677|NCT00107900|286950|P6|Overall Study|Death|0
79678|NCT00107900|286951|P5|Overall Study|Death|1
79679|NCT00107900|286952|P4|Overall Study|Death|0
79680|NCT00107900|286953|P3|Overall Study|Death|0
79681|NCT00107900|286954|P2|Overall Study|Death|0
79682|NCT00107900|286955|P1|Overall Study|Death|0
79683|NCT00107900|286950|P6|Overall Study|Adverse Event|3
79684|NCT00107900|286951|P5|Overall Study|Adverse Event|5
79685|NCT00107900|286952|P4|Overall Study|Adverse Event|3
79686|NCT00107900|286953|P3|Overall Study|Adverse Event|10
79687|NCT00107900|286954|P2|Overall Study|Adverse Event|2
79688|NCT00107900|286955|P1|Overall Study|Adverse Event|3
79689|NCT00107952|286989|P2|Overall Study|Never received study treatment|6
79690|NCT00107952|286990|P1|Overall Study|Never received study treatment|9
79691|NCT00107952|286989|P2|Overall Study|Other|5
79692|NCT00107952|286990|P1|Overall Study|Other|2
79693|NCT00107952|286989|P2|Overall Study|Withdrawal by Subject|6
79694|NCT00107952|286990|P1|Overall Study|Withdrawal by Subject|9
79695|NCT00107952|286989|P2|Overall Study|Lost to Follow-up|3
79696|NCT00107952|286990|P1|Overall Study|Lost to Follow-up|0
79697|NCT00107952|286989|P2|Overall Study|Death|61
79698|NCT00107952|286990|P1|Overall Study|Death|75
79699|NCT00107978|286998|P2|Overall Study|Other|4
79700|NCT00107978|286999|P1|Overall Study|Other|5
79701|NCT00107978|286998|P2|Overall Study|Protocol Violation|1
79702|NCT00107978|286999|P1|Overall Study|Protocol Violation|0
79703|NCT00107978|286998|P2|Overall Study|Withdrawal by Subject|9
79704|NCT00107978|286999|P1|Overall Study|Withdrawal by Subject|4
79705|NCT00107978|286998|P2|Overall Study|Lost to Follow-up|28
79706|NCT00107978|286999|P1|Overall Study|Lost to Follow-up|20
79707|NCT00107978|286998|P2|Overall Study|Death|3
79708|NCT00107978|286999|P1|Overall Study|Death|3
79709|NCT00107978|286998|P2|Overall Study|Adverse Event|5
79710|NCT00107978|286999|P1|Overall Study|Adverse Event|1
79711|NCT00107991|287005|P1|18-Week Post Treatment Assessment|Adverse Event|2
79712|NCT00107991|287005|P1|12 Week Treatment Period|Incarcerated|1
79713|NCT00107991|287005|P1|12 Week Treatment Period|Protocol Violation|1
79714|NCT00107991|287005|P1|12 Week Treatment Period|Adverse Event|1
79715|NCT00107991|287005|P1|12 Week Treatment Period|Lack of Efficacy|2
79716|NCT00107991|287005|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
79717|NCT00107991|287005|P1|Eligibility Assessment|chronic uncontrolled asthma|1
79718|NCT00107991|287005|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
79719|NCT00107991|287005|P1|Eligibility Assessment|Abnormal labs|2
79720|NCT00107991|287005|P1|Eligibility Assessment|Postive PPD|4
79721|NCT00107991|287005|P1|Eligibility Assessment|Unwilling to participate|7
79722|NCT00107991|287005|P1|Eligibility Assessment|Disease not severe enough|7
79723|NCT00108069|287015|P2|Overall Study|Progessive disease|11
79724|NCT00108069|287016|P1|Overall Study|Progessive disease|27
79725|NCT00108069|287015|P2|Overall Study|Death|0
79726|NCT00108069|287016|P1|Overall Study|Death|1
79727|NCT00108069|287015|P2|Overall Study|Withdrawal by Subject|0
79728|NCT00108069|287016|P1|Overall Study|Withdrawal by Subject|1
79729|NCT00108069|287015|P2|Overall Study|Adverse Event|1
79730|NCT00108069|287016|P1|Overall Study|Adverse Event|1
79731|NCT00108069|287015|P2|Overall Study|Never rec'd study drug|1
79732|NCT00108069|287016|P1|Overall Study|Never rec'd study drug|0
79733|NCT00108082|287033|P3|Overall Study|Blood Pressure Not Controlled|0
79734|NCT00108082|287034|P2|Overall Study|Blood Pressure Not Controlled|0
79735|NCT00108082|287035|P1|Overall Study|Blood Pressure Not Controlled|1
79736|NCT00108082|287033|P3|Overall Study|Investigator Not at Site|0
79737|NCT00108082|287034|P2|Overall Study|Investigator Not at Site|0
79738|NCT00108082|287035|P1|Overall Study|Investigator Not at Site|1
79739|NCT00108082|287033|P3|Overall Study|Subject Left Site Location|0
79740|NCT00108082|287034|P2|Overall Study|Subject Left Site Location|0
79741|NCT00108082|287035|P1|Overall Study|Subject Left Site Location|1
79742|NCT00108082|287033|P3|Overall Study|Study Medication Not Tapered|0
79743|NCT00108082|287034|P2|Overall Study|Study Medication Not Tapered|1
79744|NCT00108082|287035|P1|Overall Study|Study Medication Not Tapered|0
79745|NCT00108082|287033|P3|Overall Study|Protocol Amendment|0
79746|NCT00108082|287034|P2|Overall Study|Protocol Amendment|1
79747|NCT00108082|287035|P1|Overall Study|Protocol Amendment|0
79748|NCT00108082|287033|P3|Overall Study|Site Closed Study|0
79749|NCT00108082|287034|P2|Overall Study|Site Closed Study|2
79750|NCT00108082|287035|P1|Overall Study|Site Closed Study|0
79751|NCT00108082|287033|P3|Overall Study|Stopped Study Medication|1
79752|NCT00108082|287034|P2|Overall Study|Stopped Study Medication|0
79753|NCT00108082|287035|P1|Overall Study|Stopped Study Medication|0
79754|NCT00108082|287033|P3|Overall Study|Non-compliance|2
79755|NCT00108082|287034|P2|Overall Study|Non-compliance|0
79756|NCT00108082|287035|P1|Overall Study|Non-compliance|1
79757|NCT00108082|287033|P3|Overall Study|Incorrectly Randomized|2
79758|NCT00108082|287034|P2|Overall Study|Incorrectly Randomized|0
79759|NCT00108082|287035|P1|Overall Study|Incorrectly Randomized|0
79760|NCT00108082|287033|P3|Overall Study|Woman of Child-bearing Potential|2
79761|NCT00108082|287034|P2|Overall Study|Woman of Child-bearing Potential|0
79762|NCT00108082|287035|P1|Overall Study|Woman of Child-bearing Potential|2
79763|NCT00108082|287033|P3|Overall Study|Amendment 4: > Month 12|5
79764|NCT00108082|287034|P2|Overall Study|Amendment 4: > Month 12|7
79765|NCT00108082|287035|P1|Overall Study|Amendment 4: > Month 12|5
79766|NCT00108082|287033|P3|Overall Study|Lack of Efficacy|2
79767|NCT00108082|287034|P2|Overall Study|Lack of Efficacy|1
79768|NCT00108082|287035|P1|Overall Study|Lack of Efficacy|3
79769|NCT00108082|287033|P3|Overall Study|Protocol Violation|0
79770|NCT00108082|287034|P2|Overall Study|Protocol Violation|2
79771|NCT00108082|287035|P1|Overall Study|Protocol Violation|1
79772|NCT00108082|287033|P3|Overall Study|Consent Withdrawn|5
79773|NCT00108082|287034|P2|Overall Study|Consent Withdrawn|3
79774|NCT00108082|287035|P1|Overall Study|Consent Withdrawn|3
79775|NCT00108082|287033|P3|Overall Study|Lost to Follow-up|7
79776|NCT00108082|287034|P2|Overall Study|Lost to Follow-up|3
79777|NCT00108082|287035|P1|Overall Study|Lost to Follow-up|6
79778|NCT00108082|287033|P3|Overall Study|Adverse Event|17
79779|NCT00108082|287034|P2|Overall Study|Adverse Event|12
79780|NCT00108082|287035|P1|Overall Study|Adverse Event|14
79781|NCT00108160|287084|P2|Overall Study|Protocol Violation|5
79782|NCT00108160|287085|P1|Overall Study|Protocol Violation|9
79783|NCT00108160|287084|P2|Overall Study|Withdrawal by Subject|2
79784|NCT00108160|287085|P1|Overall Study|Withdrawal by Subject|4
79785|NCT00108160|287084|P2|Overall Study|Death|2
79786|NCT00108160|287085|P1|Overall Study|Death|1
79787|NCT00108160|287084|P2|Overall Study|Lost to Follow-up|12
79788|NCT00108160|287085|P1|Overall Study|Lost to Follow-up|25
79789|NCT00108355|287136|P2|Overall Study|Loculated ascites, limiting paracentesis|1
79790|NCT00108355|287137|P1|Overall Study|Loculated ascites, limiting paracentesis|1
79791|NCT00108355|287136|P2|Overall Study|Peritonitis at index paracentesis|1
79792|NCT00108355|287137|P1|Overall Study|Peritonitis at index paracentesis|1
79793|NCT00108433|287147|P2|Overall Study|Unspecified|14
79794|NCT00108433|287148|P1|Overall Study|Unspecified|14
79795|NCT00108433|287147|P2|Overall Study|Adverse Event|1
79796|NCT00108433|287148|P1|Overall Study|Adverse Event|3
79797|NCT00108433|287147|P2|Overall Study|Death|0
79798|NCT00108433|287148|P1|Overall Study|Death|3
79799|NCT00108433|287147|P2|Overall Study|Lack of Efficacy|2
79800|NCT00108433|287148|P1|Overall Study|Lack of Efficacy|1
79801|NCT00108485|287164|P2|Overall Study|Lost to Follow-up|2
79802|NCT00108485|287165|P1|Overall Study|Lost to Follow-up|0
79803|NCT00108485|287164|P2|Overall Study|Withdrawal by Subject|0
79804|NCT00108485|287165|P1|Overall Study|Withdrawal by Subject|3
79805|NCT00108628|287197|P2|Overall Study|Death|0
79806|NCT00108628|287198|P1|Overall Study|Death|1
79807|NCT00108628|287197|P2|Overall Study|Lack of Efficacy|1
79808|NCT00108628|287198|P1|Overall Study|Lack of Efficacy|2
79809|NCT00108628|287197|P2|Overall Study|Withdrawal by Subject|9
79810|NCT00108628|287198|P1|Overall Study|Withdrawal by Subject|17
79811|NCT00108732|287222|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
79812|NCT00108732|287222|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
79813|NCT00108732|287222|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
79814|NCT00108732|287222|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
79815|NCT00108732|287222|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
79816|NCT00108732|287222|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
79817|NCT00108732|287222|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
79818|NCT00108862|287231|P2|Overall Study|Lost to Follow-up|19
79819|NCT00108862|287232|P1|Overall Study|Lost to Follow-up|27
79820|NCT00108862|287231|P2|Overall Study|Withdrawal by Subject|6
79821|NCT00108862|287232|P1|Overall Study|Withdrawal by Subject|10
79822|NCT00108862|287231|P2|Overall Study|Death|37
79823|NCT00108862|287232|P1|Overall Study|Death|31
79824|NCT00108953|287262|P2|Follow-up|Study terminated by sponsor|6
79825|NCT00108953|287263|P1|Follow-up|Study terminated by sponsor|10
79826|NCT00108953|287262|P2|Follow-up|Lost to Follow-up|1
79827|NCT00108953|287263|P1|Follow-up|Lost to Follow-up|1
79828|NCT00108953|287262|P2|Follow-up|Death|26
79829|NCT00108953|287263|P1|Follow-up|Death|18
79830|NCT00109031|287302|P4|Overall Study|Protocol Violation|0
79831|NCT00109031|287303|P3|Overall Study|Protocol Violation|1
79832|NCT00109031|287304|P2|Overall Study|Protocol Violation|0
79833|NCT00109031|287305|P1|Overall Study|Protocol Violation|0
79834|NCT00109031|287302|P4|Overall Study|Physician Decision|0
79835|NCT00109031|287303|P3|Overall Study|Physician Decision|0
79836|NCT00109031|287304|P2|Overall Study|Physician Decision|1
79837|NCT00109031|287305|P1|Overall Study|Physician Decision|0
79838|NCT00109031|287302|P4|Overall Study|Withdrawal by Subject|0
79839|NCT00109031|287303|P3|Overall Study|Withdrawal by Subject|0
79840|NCT00109031|287304|P2|Overall Study|Withdrawal by Subject|1
79841|NCT00109031|287305|P1|Overall Study|Withdrawal by Subject|0
79842|NCT00109031|287302|P4|Overall Study|Adverse Event|0
79843|NCT00109031|287303|P3|Overall Study|Adverse Event|1
79844|NCT00109031|287304|P2|Overall Study|Adverse Event|0
79845|NCT00109031|287305|P1|Overall Study|Adverse Event|0
79846|NCT00116779|287341|P2|Overall Study|Elevated PSA levels|2
79847|NCT00116779|287342|P1|Overall Study|Elevated PSA levels|2
79848|NCT00116779|287341|P2|Overall Study|Physician Decision|1
79849|NCT00116779|287342|P1|Overall Study|Physician Decision|3
79850|NCT00116779|287341|P2|Overall Study|Inadequate testosterone suppression|9
79851|NCT00116779|287342|P1|Overall Study|Inadequate testosterone suppression|7
79852|NCT00116779|287341|P2|Overall Study|Withdrawal by Subject|1
79853|NCT00116779|287342|P1|Overall Study|Withdrawal by Subject|4
79854|NCT00116779|287341|P2|Overall Study|Protocol Violation|4
79855|NCT00116779|287342|P1|Overall Study|Protocol Violation|1
79856|NCT00116779|287341|P2|Overall Study|Adverse Event|2
79857|NCT00116779|287342|P1|Overall Study|Adverse Event|4
79858|NCT00116805|287374|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
79859|NCT00116805|287375|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
79860|NCT00116805|287374|P2|Open-label Period Weeks 433 - 480|Investigator’s Discretion|0
79861|NCT00116805|287375|P1|Open-label Period Weeks 433 - 480|Investigator’s Discretion|1
79862|NCT00116805|287374|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
79863|NCT00116805|287375|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
79864|NCT00116805|287374|P2|Open-label Period Weeks 385 - 432|Investigator’s Discretion|0
79865|NCT00116805|287375|P1|Open-label Period Weeks 385 - 432|Investigator’s Discretion|1
79866|NCT00116805|287374|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
79867|NCT00116805|287375|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
79868|NCT00116805|287374|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
79869|NCT00116805|287375|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
79870|NCT00116805|287374|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
79871|NCT00116805|287375|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
79872|NCT00116805|287374|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
79873|NCT00116805|287375|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
79874|NCT00116805|287374|P2|Open-label Period Weeks 337 - 384|Completed Study|0
79875|NCT00116805|287375|P1|Open-label Period Weeks 337 - 384|Completed Study|1
79876|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
79877|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
79878|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
79879|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
79880|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
79881|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
79882|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
79883|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
79884|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
79885|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
79886|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
79887|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
79888|NCT00116805|287374|P2|Open-label Period Weeks 289 - 336|Completed Study|1
79889|NCT00116805|287375|P1|Open-label Period Weeks 289 - 336|Completed Study|0
80051|NCT00119379|288074|P1|Overall Study|Adverse Event|4
79890|NCT00116805|287374|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
79891|NCT00116805|287375|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
79892|NCT00116805|287374|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
79893|NCT00116805|287375|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
79894|NCT00116805|287374|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
79895|NCT00116805|287375|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
79896|NCT00116805|287374|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
79897|NCT00116805|287375|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
79898|NCT00116805|287374|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
79899|NCT00116805|287375|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
79900|NCT00116805|287374|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
79901|NCT00116805|287375|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
79902|NCT00116805|287374|P2|Open-label Period Weeks 193 - 240|Completed Study|1
79903|NCT00116805|287375|P1|Open-label Period Weeks 193 - 240|Completed Study|0
79904|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
79905|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
79906|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
79907|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
79908|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
79909|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
79910|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
79911|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
79912|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
79913|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
79914|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
79915|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
79916|NCT00116805|287374|P2|Open-label Period Weeks 145 - 192|Completed Study|1
79917|NCT00116805|287375|P1|Open-label Period Weeks 145 - 192|Completed Study|1
79918|NCT00116805|287374|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
79919|NCT00116805|287375|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
79920|NCT00116805|287374|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
79921|NCT00116805|287375|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
79922|NCT00116805|287374|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
79923|NCT00116805|287375|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
79924|NCT00116805|287374|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
79925|NCT00116805|287375|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
79926|NCT00116805|287374|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
79927|NCT00116805|287375|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
79928|NCT00116805|287374|P2|Open-label Period Weeks 97 - 144|Completed Study|0
79929|NCT00116805|287375|P1|Open-label Period Weeks 97 - 144|Completed Study|1
79930|NCT00116805|287374|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
79931|NCT00116805|287375|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
79932|NCT00116805|287374|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
79933|NCT00116805|287375|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
79934|NCT00116805|287374|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
79935|NCT00116805|287375|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
79936|NCT00116805|287374|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
79937|NCT00116805|287375|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
79938|NCT00116805|287374|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
79939|NCT00116805|287375|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
79940|NCT00116805|287374|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
79941|NCT00116805|287375|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
79942|NCT00116805|287374|P2|Double-blind Period Through Week 48|Withdrew Consent|2
79943|NCT00116805|287375|P1|Double-blind Period Through Week 48|Withdrew Consent|4
79944|NCT00116805|287374|P2|Double-blind Period Through Week 48|Protocol Violation|1
79945|NCT00116805|287375|P1|Double-blind Period Through Week 48|Protocol Violation|1
79946|NCT00116805|287374|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
79947|NCT00116805|287375|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
79948|NCT00116831|287468|P2|Overall Study|Missing data for participant|0
79949|NCT00116831|287469|P1|Overall Study|Missing data for participant|1
79950|NCT00116831|287468|P2|Overall Study|Insufficient therapeutic effect|1
79951|NCT00116831|287469|P1|Overall Study|Insufficient therapeutic effect|0
79952|NCT00116831|287468|P2|Overall Study|Withdrawal by Subject|32
79953|NCT00116831|287469|P1|Overall Study|Withdrawal by Subject|32
79954|NCT00116831|287468|P2|Overall Study|Withdrawn investigational product|0
79955|NCT00116831|287469|P1|Overall Study|Withdrawn investigational product|1
79956|NCT00116831|287468|P2|Overall Study|Low haemoglobin on screening|0
79957|NCT00116831|287469|P1|Overall Study|Low haemoglobin on screening|1
79958|NCT00116831|287468|P2|Overall Study|Hypoglycaemic events|0
79959|NCT00116831|287469|P1|Overall Study|Hypoglycaemic events|1
79960|NCT00116831|287468|P2|Overall Study|Protocol Violation|6
79961|NCT00116831|287469|P1|Overall Study|Protocol Violation|3
79962|NCT00116831|287468|P2|Overall Study|Lost to Follow-up|6
79963|NCT00116831|287469|P1|Overall Study|Lost to Follow-up|8
79964|NCT00116831|287468|P2|Overall Study|Baseline IVUS determined unevaluable|11
79965|NCT00116831|287469|P1|Overall Study|Baseline IVUS determined unevaluable|12
79966|NCT00116831|287468|P2|Overall Study|Adverse Event|16
79967|NCT00116831|287469|P1|Overall Study|Adverse Event|14
79968|NCT00118092|287554|P1|Overall Study|Protocol Violation|1
79969|NCT00118092|287554|P1|Overall Study|Withdrawal by Subject|1
79970|NCT00118157|287575|P1|Overall Study|Withdrawal by Subject|2
79971|NCT00118157|287575|P1|Overall Study|Death|8
79972|NCT00118157|287575|P1|Overall Study|Adverse Event|2
79973|NCT00118287|287595|P1|Overall Study|Muscle pain|1
79974|NCT00118287|287595|P1|Overall Study|Intracranial haemorrhage|1
79975|NCT00118417|287733|P2|Phase II (Weeks 6 to 12)|Remission|2
79976|NCT00118417|287734|P1|Phase II (Weeks 6 to 12)|Remission|1
79977|NCT00118417|287733|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
79978|NCT00118417|287734|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
79979|NCT00118417|287733|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
79980|NCT00118417|287734|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
79981|NCT00118417|287733|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
79982|NCT00118417|287734|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
79983|NCT00118417|287733|P2|Phase I (Weeks 0 to 6)|Remission|0
79984|NCT00118417|287734|P1|Phase I (Weeks 0 to 6)|Remission|8
79985|NCT00118430|287747|P3|Overall Study|Lost to Follow-up|28
79986|NCT00118430|287748|P2|Overall Study|Lost to Follow-up|22
79987|NCT00118430|287749|P1|Overall Study|Lost to Follow-up|15
79988|NCT00118430|287747|P3|Overall Study|Withdrawal by Subject|0
79989|NCT00118430|287748|P2|Overall Study|Withdrawal by Subject|2
79990|NCT00118430|287749|P1|Overall Study|Withdrawal by Subject|6
79991|NCT00118482|287766|P2|Overall Study|Withdrawal by Subject|22
79992|NCT00118482|287767|P1|Overall Study|Withdrawal by Subject|23
79993|NCT00118482|287766|P2|Overall Study|Lost to Follow-up|7
79994|NCT00118482|287767|P1|Overall Study|Lost to Follow-up|7
79995|NCT00118703|287862|P2|Overall Study|Lost to Follow-up|2
79996|NCT00118703|287863|P1|Overall Study|Lost to Follow-up|1
79997|NCT00118703|287862|P2|Overall Study|Withdrawal by Subject|5
79998|NCT00118703|287863|P1|Overall Study|Withdrawal by Subject|2
79999|NCT00118703|287862|P2|Overall Study|Participant took two different treatment|1
80000|NCT00118703|287863|P1|Overall Study|Participant took two different treatment|0
80001|NCT00118703|287862|P2|Overall Study|Adverse Event|1
80002|NCT00118703|287863|P1|Overall Study|Adverse Event|1
80003|NCT00118703|287862|P2|Overall Study|Protocol Violation|0
80004|NCT00118703|287863|P1|Overall Study|Protocol Violation|1
80005|NCT00118898|287907|P4|Overall Study|Not able to get to clinic|40
80006|NCT00118898|287908|P3|Overall Study|Not able to get to clinic|31
80007|NCT00118898|287909|P2|Overall Study|Not able to get to clinic|43
80008|NCT00118898|287910|P1|Overall Study|Not able to get to clinic|34
80009|NCT00118898|287907|P4|Overall Study|Not compliant with requirements|11
80010|NCT00118898|287908|P3|Overall Study|Not compliant with requirements|11
80011|NCT00118898|287909|P2|Overall Study|Not compliant with requirements|13
80012|NCT00118898|287910|P1|Overall Study|Not compliant with requirements|11
80013|NCT00118898|287907|P4|Overall Study|Severe debilitation|4
80014|NCT00118898|287908|P3|Overall Study|Severe debilitation|6
80015|NCT00118898|287909|P2|Overall Study|Severe debilitation|4
80016|NCT00118898|287910|P1|Overall Study|Severe debilitation|1
80017|NCT00118898|287907|P4|Overall Study|Site Closure|37
80018|NCT00118898|287908|P3|Overall Study|Site Closure|28
80019|NCT00118898|287909|P2|Overall Study|Site Closure|31
80020|NCT00118898|287910|P1|Overall Study|Site Closure|33
80021|NCT00118898|287907|P4|Overall Study|Withdrawal by Subject|8
80022|NCT00118898|287908|P3|Overall Study|Withdrawal by Subject|8
80023|NCT00118898|287909|P2|Overall Study|Withdrawal by Subject|5
80024|NCT00118898|287910|P1|Overall Study|Withdrawal by Subject|10
80025|NCT00118898|287907|P4|Overall Study|Lost to Follow-up|33
80026|NCT00118898|287908|P3|Overall Study|Lost to Follow-up|33
80027|NCT00118898|287909|P2|Overall Study|Lost to Follow-up|34
80028|NCT00118898|287910|P1|Overall Study|Lost to Follow-up|26
80029|NCT00118898|287907|P4|Overall Study|Death|8
80030|NCT00118898|287908|P3|Overall Study|Death|6
80031|NCT00118898|287909|P2|Overall Study|Death|11
80032|NCT00118898|287910|P1|Overall Study|Death|6
80033|NCT00118911|288006|P2|Overall Study|Withdrawal by Subject|5
80034|NCT00118911|288007|P1|Overall Study|Withdrawal by Subject|2
80035|NCT00119015|288017|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
80036|NCT00119015|288018|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
80037|NCT00119015|288019|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
80038|NCT00119262|288060|P2|Overall Study|others|5
80039|NCT00119262|288061|P1|Overall Study|others|0
80040|NCT00119262|288060|P2|Overall Study|ineligble|2
80041|NCT00119262|288061|P1|Overall Study|ineligble|1
80042|NCT00119262|288060|P2|Overall Study|other disease|2
80043|NCT00119262|288061|P1|Overall Study|other disease|0
80044|NCT00119262|288060|P2|Overall Study|Adverse Event|35
80045|NCT00119262|288061|P1|Overall Study|Adverse Event|33
80046|NCT00119262|288060|P2|Overall Study|Withdrawal by Subject|11
80047|NCT00119262|288061|P1|Overall Study|Withdrawal by Subject|12
80048|NCT00119262|288060|P2|Overall Study|Lack of Efficacy|3
80049|NCT00119262|288061|P1|Overall Study|Lack of Efficacy|0
80050|NCT00119379|288073|P2|Overall Study|Adverse Event|1
80052|NCT00119405|288098|P1|Overall Study|Withdrawal by Subject|1
80053|NCT00119678|288104|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
80054|NCT00119678|288105|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
80055|NCT00119678|288104|P2|Open-label Treatment Period|Pregnancy|0
80056|NCT00119678|288105|P1|Open-label Treatment Period|Pregnancy|1
80057|NCT00119678|288104|P2|Open-label Treatment Period|Participants not meeting study criteria|0
80058|NCT00119678|288105|P1|Open-label Treatment Period|Participants not meeting study criteria|2
80059|NCT00119678|288104|P2|Open-label Treatment Period|Participant withdrew consent|0
80060|NCT00119678|288105|P1|Open-label Treatment Period|Participant withdrew consent|4
80061|NCT00119678|288104|P2|Open-label Treatment Period|Lost to Follow-up|0
80062|NCT00119678|288105|P1|Open-label Treatment Period|Lost to Follow-up|3
80063|NCT00119678|288104|P2|Open-label Treatment Period|Lack of Efficacy|0
80064|NCT00119678|288105|P1|Open-label Treatment Period|Lack of Efficacy|9
80065|NCT00119678|288104|P2|Open-label Treatment Period|Adverse Event|0
80066|NCT00119678|288105|P1|Open-label Treatment Period|Adverse Event|3
80067|NCT00119678|288104|P2|Open-label Treatment Period|Death|0
80068|NCT00119678|288105|P1|Open-label Treatment Period|Death|1
80069|NCT00119678|288104|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
80070|NCT00119678|288105|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
80071|NCT00119678|288104|P2|Double-blind Treatment Period|Not treated|2
80072|NCT00119678|288105|P1|Double-blind Treatment Period|Not treated|1
80073|NCT00119678|288104|P2|Double-blind Treatment Period|Pregnancy|2
80074|NCT00119678|288105|P1|Double-blind Treatment Period|Pregnancy|0
80075|NCT00119678|288104|P2|Double-blind Treatment Period|Poor/Non-compliance|0
80076|NCT00119678|288105|P1|Double-blind Treatment Period|Poor/Non-compliance|3
80077|NCT00119678|288104|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
80078|NCT00119678|288105|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
80079|NCT00119678|288104|P2|Double-blind Treatment Period|Participant withdrew consent|4
80080|NCT00119678|288105|P1|Double-blind Treatment Period|Participant withdrew consent|4
80081|NCT00119678|288104|P2|Double-blind Treatment Period|Lost to Follow-up|2
80082|NCT00119678|288105|P1|Double-blind Treatment Period|Lost to Follow-up|1
80083|NCT00119678|288104|P2|Double-blind Treatment Period|Lack of Efficacy|12
80084|NCT00119678|288105|P1|Double-blind Treatment Period|Lack of Efficacy|21
80085|NCT00119678|288104|P2|Double-blind Treatment Period|Adverse Event|1
80086|NCT00119678|288105|P1|Double-blind Treatment Period|Adverse Event|7
80087|NCT00119678|288104|P2|Double-blind Treatment Period|Death|0
80088|NCT00119678|288105|P1|Double-blind Treatment Period|Death|1
80089|NCT00120042|288154|P3|Overall Study|all completed protocl|0
80090|NCT00120042|288155|P2|Overall Study|all completed protocl|0
80091|NCT00120042|288156|P1|Overall Study|all completed protocl|0
80092|NCT00120250|288164|P2|Overall Study|Protocol Violation|1
80093|NCT00120250|288165|P1|Overall Study|Protocol Violation|0
80094|NCT00120250|288164|P2|Overall Study|Lost to Follow-up|1
80095|NCT00120250|288165|P1|Overall Study|Lost to Follow-up|1
80096|NCT00120289|288180|P2|Overall Study|Withdrawal by Subject|13
80097|NCT00120289|288181|P1|Overall Study|Withdrawal by Subject|14
80098|NCT00120289|288180|P2|Overall Study|Lost to Follow-up|14
80099|NCT00120289|288181|P1|Overall Study|Lost to Follow-up|11
80100|NCT00120289|288180|P2|Overall Study|Death|82
80101|NCT00120289|288181|P1|Overall Study|Death|96
80102|NCT00120406|288195|P2|Overall Study|patient moved but has not withdrawn|1
80103|NCT00120406|288196|P1|Overall Study|patient moved but has not withdrawn|0
80104|NCT00120406|288195|P2|Overall Study|received non-study stent|2
80105|NCT00120406|288196|P1|Overall Study|received non-study stent|0
80106|NCT00120406|288195|P2|Overall Study|Lost to Follow-up|2
80107|NCT00120406|288196|P1|Overall Study|Lost to Follow-up|5
80108|NCT00120406|288195|P2|Overall Study|Withdrawal by Subject|7
80109|NCT00120406|288196|P1|Overall Study|Withdrawal by Subject|5
80110|NCT00120406|288195|P2|Overall Study|Death|4
80111|NCT00120406|288196|P1|Overall Study|Death|9
80112|NCT00120627|288231|P2|Overall Study|Withdrawal by Subject|5
80113|NCT00120627|288232|P1|Overall Study|Withdrawal by Subject|5
80114|NCT00112294|288258|P2|Overall Study|Still on study|0
80115|NCT00112294|288259|P1|Overall Study|Still on study|5
80116|NCT00112359|288299|P2|Overall Study|Other|0
80117|NCT00112359|288300|P1|Overall Study|Other|3
80118|NCT00112359|288299|P2|Overall Study|Personal/administrative|1
80119|NCT00112359|288300|P1|Overall Study|Personal/administrative|1
80120|NCT00112359|288299|P2|Overall Study|Lost to Follow-up|1
80121|NCT00112359|288300|P1|Overall Study|Lost to Follow-up|0
80122|NCT00112359|288299|P2|Overall Study|Related adverse event|3
80123|NCT00112359|288300|P1|Overall Study|Related adverse event|5
80124|NCT00112359|288299|P2|Overall Study|Trial drug intolerance (adverse event)|0
80125|NCT00112359|288300|P1|Overall Study|Trial drug intolerance (adverse event)|2
80126|NCT00112359|288299|P2|Overall Study|Unrelated adverse event|8
80127|NCT00112359|288300|P1|Overall Study|Unrelated adverse event|16
80128|NCT00112385|288326|P2|Overall Study|Withdrawal by Subject|1
80129|NCT00112385|288327|P1|Overall Study|Withdrawal by Subject|0
80130|NCT00112385|288326|P2|Overall Study|Lost to Follow-up|0
80131|NCT00112385|288327|P1|Overall Study|Lost to Follow-up|1
80132|NCT00112437|288420|P15|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80133|NCT00112437|288421|P14|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80134|NCT00112437|288422|P13|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80135|NCT00112437|288423|P12|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80136|NCT00112437|288424|P11|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80137|NCT00112437|288425|P10|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80138|NCT00112437|288426|P9|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80139|NCT00112437|288427|P8|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80140|NCT00112437|288428|P7|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
80141|NCT00112437|288429|P6|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|1
80142|NCT00112437|288430|P5|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80143|NCT00112437|288431|P4|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80144|NCT00112437|288432|P3|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80145|NCT00112437|288433|P2|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80146|NCT00112437|288434|P1|12 Month Extension (Year 3)|cortisone therapy, upcoming surgery|0
80147|NCT00112437|288420|P15|12 Month Extension (Year 3)|Withdrawal by Subject|0
80148|NCT00112437|288421|P14|12 Month Extension (Year 3)|Withdrawal by Subject|0
80149|NCT00112437|288422|P13|12 Month Extension (Year 3)|Withdrawal by Subject|0
80150|NCT00112437|288423|P12|12 Month Extension (Year 3)|Withdrawal by Subject|0
80151|NCT00112437|288424|P11|12 Month Extension (Year 3)|Withdrawal by Subject|0
80152|NCT00112437|288425|P10|12 Month Extension (Year 3)|Withdrawal by Subject|1
80153|NCT00112437|288426|P9|12 Month Extension (Year 3)|Withdrawal by Subject|0
80154|NCT00112437|288427|P8|12 Month Extension (Year 3)|Withdrawal by Subject|0
80155|NCT00112437|288428|P7|12 Month Extension (Year 3)|Withdrawal by Subject|3
80156|NCT00112437|288429|P6|12 Month Extension (Year 3)|Withdrawal by Subject|0
80157|NCT00112437|288430|P5|12 Month Extension (Year 3)|Withdrawal by Subject|0
80158|NCT00112437|288431|P4|12 Month Extension (Year 3)|Withdrawal by Subject|0
80159|NCT00112437|288432|P3|12 Month Extension (Year 3)|Withdrawal by Subject|0
80160|NCT00112437|288433|P2|12 Month Extension (Year 3)|Withdrawal by Subject|0
80161|NCT00112437|288434|P1|12 Month Extension (Year 3)|Withdrawal by Subject|0
80162|NCT00112437|288420|P15|12 Month Extension (Year 3)|Protocol Violation|0
80163|NCT00112437|288421|P14|12 Month Extension (Year 3)|Protocol Violation|0
80164|NCT00112437|288422|P13|12 Month Extension (Year 3)|Protocol Violation|0
80165|NCT00112437|288423|P12|12 Month Extension (Year 3)|Protocol Violation|0
80166|NCT00112437|288424|P11|12 Month Extension (Year 3)|Protocol Violation|1
80167|NCT00112437|288425|P10|12 Month Extension (Year 3)|Protocol Violation|0
80168|NCT00112437|288426|P9|12 Month Extension (Year 3)|Protocol Violation|0
80169|NCT00112437|288427|P8|12 Month Extension (Year 3)|Protocol Violation|0
80170|NCT00112437|288428|P7|12 Month Extension (Year 3)|Protocol Violation|0
80171|NCT00112437|288429|P6|12 Month Extension (Year 3)|Protocol Violation|0
80172|NCT00112437|288430|P5|12 Month Extension (Year 3)|Protocol Violation|0
80173|NCT00112437|288431|P4|12 Month Extension (Year 3)|Protocol Violation|0
80174|NCT00112437|288432|P3|12 Month Extension (Year 3)|Protocol Violation|0
80175|NCT00112437|288433|P2|12 Month Extension (Year 3)|Protocol Violation|0
80176|NCT00112437|288434|P1|12 Month Extension (Year 3)|Protocol Violation|0
80177|NCT00112437|288420|P15|12 Month Extension (Year 3)|Lost to Follow-up|0
80178|NCT00112437|288421|P14|12 Month Extension (Year 3)|Lost to Follow-up|0
80179|NCT00112437|288422|P13|12 Month Extension (Year 3)|Lost to Follow-up|0
80180|NCT00112437|288423|P12|12 Month Extension (Year 3)|Lost to Follow-up|0
80181|NCT00112437|288424|P11|12 Month Extension (Year 3)|Lost to Follow-up|1
80182|NCT00112437|288425|P10|12 Month Extension (Year 3)|Lost to Follow-up|0
80183|NCT00112437|288426|P9|12 Month Extension (Year 3)|Lost to Follow-up|0
80184|NCT00112437|288427|P8|12 Month Extension (Year 3)|Lost to Follow-up|0
80185|NCT00112437|288428|P7|12 Month Extension (Year 3)|Lost to Follow-up|0
80186|NCT00112437|288429|P6|12 Month Extension (Year 3)|Lost to Follow-up|0
80187|NCT00112437|288430|P5|12 Month Extension (Year 3)|Lost to Follow-up|0
80188|NCT00112437|288431|P4|12 Month Extension (Year 3)|Lost to Follow-up|0
80189|NCT00112437|288432|P3|12 Month Extension (Year 3)|Lost to Follow-up|0
80190|NCT00112437|288433|P2|12 Month Extension (Year 3)|Lost to Follow-up|0
80191|NCT00112437|288434|P1|12 Month Extension (Year 3)|Lost to Follow-up|0
80192|NCT00112437|288420|P15|12 Month Extension (Year 3)|Lack of Efficacy|0
80193|NCT00112437|288421|P14|12 Month Extension (Year 3)|Lack of Efficacy|2
80194|NCT00112437|288422|P13|12 Month Extension (Year 3)|Lack of Efficacy|0
80195|NCT00112437|288423|P12|12 Month Extension (Year 3)|Lack of Efficacy|0
80196|NCT00112437|288424|P11|12 Month Extension (Year 3)|Lack of Efficacy|1
80197|NCT00112437|288425|P10|12 Month Extension (Year 3)|Lack of Efficacy|0
80198|NCT00112437|288426|P9|12 Month Extension (Year 3)|Lack of Efficacy|1
80199|NCT00112437|288427|P8|12 Month Extension (Year 3)|Lack of Efficacy|0
80200|NCT00112437|288428|P7|12 Month Extension (Year 3)|Lack of Efficacy|1
80201|NCT00112437|288429|P6|12 Month Extension (Year 3)|Lack of Efficacy|0
80202|NCT00112437|288430|P5|12 Month Extension (Year 3)|Lack of Efficacy|0
80203|NCT00112437|288431|P4|12 Month Extension (Year 3)|Lack of Efficacy|0
80204|NCT00112437|288432|P3|12 Month Extension (Year 3)|Lack of Efficacy|0
80205|NCT00112437|288433|P2|12 Month Extension (Year 3)|Lack of Efficacy|0
80206|NCT00112437|288434|P1|12 Month Extension (Year 3)|Lack of Efficacy|0
80207|NCT00112437|288420|P15|12 Month Extension (Year 3)|Adverse Event|1
80208|NCT00112437|288421|P14|12 Month Extension (Year 3)|Adverse Event|0
80209|NCT00112437|288422|P13|12 Month Extension (Year 3)|Adverse Event|1
80210|NCT00112437|288423|P12|12 Month Extension (Year 3)|Adverse Event|3
80211|NCT00112437|288424|P11|12 Month Extension (Year 3)|Adverse Event|1
80212|NCT00112437|288425|P10|12 Month Extension (Year 3)|Adverse Event|0
80213|NCT00112437|288426|P9|12 Month Extension (Year 3)|Adverse Event|0
80214|NCT00112437|288427|P8|12 Month Extension (Year 3)|Adverse Event|0
80215|NCT00112437|288428|P7|12 Month Extension (Year 3)|Adverse Event|0
80216|NCT00112437|288429|P6|12 Month Extension (Year 3)|Adverse Event|1
80217|NCT00112437|288430|P5|12 Month Extension (Year 3)|Adverse Event|0
80218|NCT00112437|288431|P4|12 Month Extension (Year 3)|Adverse Event|0
80219|NCT00112437|288432|P3|12 Month Extension (Year 3)|Adverse Event|0
80220|NCT00112437|288433|P2|12 Month Extension (Year 3)|Adverse Event|0
80221|NCT00112437|288434|P1|12 Month Extension (Year 3)|Adverse Event|0
80222|NCT00112437|288420|P15|12 Month Extension|Moved|0
80223|NCT00112437|288421|P14|12 Month Extension|Moved|0
80224|NCT00112437|288422|P13|12 Month Extension|Moved|0
80225|NCT00112437|288423|P12|12 Month Extension|Moved|0
80226|NCT00112437|288424|P11|12 Month Extension|Moved|0
80227|NCT00112437|288425|P10|12 Month Extension|Moved|0
80228|NCT00112437|288426|P9|12 Month Extension|Moved|0
80229|NCT00112437|288427|P8|12 Month Extension|Moved|0
80230|NCT00112437|288428|P7|12 Month Extension|Moved|0
80231|NCT00112437|288429|P6|12 Month Extension|Moved|0
80232|NCT00112437|288430|P5|12 Month Extension|Moved|1
80233|NCT00112437|288431|P4|12 Month Extension|Moved|0
80234|NCT00112437|288432|P3|12 Month Extension|Moved|0
80235|NCT00112437|288433|P2|12 Month Extension|Moved|0
80236|NCT00112437|288434|P1|12 Month Extension|Moved|0
80237|NCT00112437|288420|P15|12 Month Extension|patient was out of windows|0
80238|NCT00112437|288421|P14|12 Month Extension|patient was out of windows|0
80239|NCT00112437|288422|P13|12 Month Extension|patient was out of windows|0
80240|NCT00112437|288423|P12|12 Month Extension|patient was out of windows|0
80241|NCT00112437|288424|P11|12 Month Extension|patient was out of windows|0
80242|NCT00112437|288425|P10|12 Month Extension|patient was out of windows|0
80243|NCT00112437|288426|P9|12 Month Extension|patient was out of windows|0
80244|NCT00112437|288427|P8|12 Month Extension|patient was out of windows|0
80245|NCT00112437|288428|P7|12 Month Extension|patient was out of windows|0
80246|NCT00112437|288429|P6|12 Month Extension|patient was out of windows|0
80247|NCT00112437|288430|P5|12 Month Extension|patient was out of windows|1
80248|NCT00112437|288431|P4|12 Month Extension|patient was out of windows|0
80249|NCT00112437|288432|P3|12 Month Extension|patient was out of windows|0
80250|NCT00112437|288433|P2|12 Month Extension|patient was out of windows|0
80251|NCT00112437|288434|P1|12 Month Extension|patient was out of windows|0
80252|NCT00112437|288420|P15|12 Month Extension|Patient stopped taking medication|0
80253|NCT00112437|288421|P14|12 Month Extension|Patient stopped taking medication|0
80254|NCT00112437|288422|P13|12 Month Extension|Patient stopped taking medication|0
80255|NCT00112437|288423|P12|12 Month Extension|Patient stopped taking medication|0
80256|NCT00112437|288424|P11|12 Month Extension|Patient stopped taking medication|0
80257|NCT00112437|288425|P10|12 Month Extension|Patient stopped taking medication|0
80258|NCT00112437|288426|P9|12 Month Extension|Patient stopped taking medication|0
80259|NCT00112437|288427|P8|12 Month Extension|Patient stopped taking medication|0
80260|NCT00112437|288428|P7|12 Month Extension|Patient stopped taking medication|0
80261|NCT00112437|288429|P6|12 Month Extension|Patient stopped taking medication|0
80262|NCT00112437|288430|P5|12 Month Extension|Patient stopped taking medication|1
80263|NCT00112437|288431|P4|12 Month Extension|Patient stopped taking medication|0
80264|NCT00112437|288432|P3|12 Month Extension|Patient stopped taking medication|0
80265|NCT00112437|288433|P2|12 Month Extension|Patient stopped taking medication|0
80266|NCT00112437|288434|P1|12 Month Extension|Patient stopped taking medication|0
80267|NCT00112437|288420|P15|12 Month Extension|Withdrawal by Subject|0
80268|NCT00112437|288421|P14|12 Month Extension|Withdrawal by Subject|0
80269|NCT00112437|288422|P13|12 Month Extension|Withdrawal by Subject|0
80270|NCT00112437|288423|P12|12 Month Extension|Withdrawal by Subject|0
80271|NCT00112437|288424|P11|12 Month Extension|Withdrawal by Subject|0
80272|NCT00112437|288425|P10|12 Month Extension|Withdrawal by Subject|0
80273|NCT00112437|288426|P9|12 Month Extension|Withdrawal by Subject|0
80274|NCT00112437|288427|P8|12 Month Extension|Withdrawal by Subject|0
80275|NCT00112437|288428|P7|12 Month Extension|Withdrawal by Subject|0
80276|NCT00112437|288429|P6|12 Month Extension|Withdrawal by Subject|0
80277|NCT00112437|288430|P5|12 Month Extension|Withdrawal by Subject|1
80278|NCT00112437|288431|P4|12 Month Extension|Withdrawal by Subject|4
80279|NCT00112437|288432|P3|12 Month Extension|Withdrawal by Subject|2
80280|NCT00112437|288433|P2|12 Month Extension|Withdrawal by Subject|1
80281|NCT00112437|288434|P1|12 Month Extension|Withdrawal by Subject|1
80282|NCT00112437|288420|P15|12 Month Extension|Protocol Violation|0
80283|NCT00112437|288421|P14|12 Month Extension|Protocol Violation|0
80284|NCT00112437|288422|P13|12 Month Extension|Protocol Violation|0
80285|NCT00112437|288423|P12|12 Month Extension|Protocol Violation|0
80286|NCT00112437|288424|P11|12 Month Extension|Protocol Violation|0
80287|NCT00112437|288425|P10|12 Month Extension|Protocol Violation|0
80288|NCT00112437|288426|P9|12 Month Extension|Protocol Violation|0
80289|NCT00112437|288427|P8|12 Month Extension|Protocol Violation|0
80290|NCT00112437|288428|P7|12 Month Extension|Protocol Violation|0
80291|NCT00112437|288429|P6|12 Month Extension|Protocol Violation|0
80292|NCT00112437|288430|P5|12 Month Extension|Protocol Violation|0
80293|NCT00112437|288431|P4|12 Month Extension|Protocol Violation|1
80294|NCT00112437|288432|P3|12 Month Extension|Protocol Violation|0
80295|NCT00112437|288433|P2|12 Month Extension|Protocol Violation|0
80296|NCT00112437|288434|P1|12 Month Extension|Protocol Violation|0
80297|NCT00112437|288420|P15|12 Month Extension|Lost to Follow-up|0
80298|NCT00112437|288421|P14|12 Month Extension|Lost to Follow-up|0
80299|NCT00112437|288422|P13|12 Month Extension|Lost to Follow-up|0
80300|NCT00112437|288423|P12|12 Month Extension|Lost to Follow-up|0
80301|NCT00112437|288424|P11|12 Month Extension|Lost to Follow-up|0
80302|NCT00112437|288425|P10|12 Month Extension|Lost to Follow-up|0
80303|NCT00112437|288426|P9|12 Month Extension|Lost to Follow-up|0
80304|NCT00112437|288427|P8|12 Month Extension|Lost to Follow-up|0
80305|NCT00112437|288428|P7|12 Month Extension|Lost to Follow-up|0
80306|NCT00112437|288429|P6|12 Month Extension|Lost to Follow-up|0
80307|NCT00112437|288430|P5|12 Month Extension|Lost to Follow-up|0
80308|NCT00112437|288431|P4|12 Month Extension|Lost to Follow-up|1
80309|NCT00112437|288432|P3|12 Month Extension|Lost to Follow-up|0
80310|NCT00112437|288433|P2|12 Month Extension|Lost to Follow-up|0
80311|NCT00112437|288434|P1|12 Month Extension|Lost to Follow-up|0
80312|NCT00112437|288420|P15|12 Month Extension|Lack of Efficacy|0
80313|NCT00112437|288421|P14|12 Month Extension|Lack of Efficacy|0
80314|NCT00112437|288422|P13|12 Month Extension|Lack of Efficacy|0
80315|NCT00112437|288423|P12|12 Month Extension|Lack of Efficacy|0
80316|NCT00112437|288424|P11|12 Month Extension|Lack of Efficacy|0
80317|NCT00112437|288425|P10|12 Month Extension|Lack of Efficacy|0
80318|NCT00112437|288426|P9|12 Month Extension|Lack of Efficacy|0
80319|NCT00112437|288427|P8|12 Month Extension|Lack of Efficacy|0
80320|NCT00112437|288428|P7|12 Month Extension|Lack of Efficacy|0
80321|NCT00112437|288429|P6|12 Month Extension|Lack of Efficacy|0
80322|NCT00112437|288430|P5|12 Month Extension|Lack of Efficacy|2
80323|NCT00112437|288431|P4|12 Month Extension|Lack of Efficacy|0
80324|NCT00112437|288432|P3|12 Month Extension|Lack of Efficacy|0
80325|NCT00112437|288433|P2|12 Month Extension|Lack of Efficacy|6
80326|NCT00112437|288434|P1|12 Month Extension|Lack of Efficacy|1
80327|NCT00112437|288420|P15|12 Month Extension|Adverse Event|0
80328|NCT00112437|288421|P14|12 Month Extension|Adverse Event|0
80329|NCT00112437|288422|P13|12 Month Extension|Adverse Event|0
80330|NCT00112437|288423|P12|12 Month Extension|Adverse Event|0
80331|NCT00112437|288424|P11|12 Month Extension|Adverse Event|0
80332|NCT00112437|288425|P10|12 Month Extension|Adverse Event|0
80333|NCT00112437|288426|P9|12 Month Extension|Adverse Event|0
80334|NCT00112437|288427|P8|12 Month Extension|Adverse Event|0
80335|NCT00112437|288428|P7|12 Month Extension|Adverse Event|0
80336|NCT00112437|288429|P6|12 Month Extension|Adverse Event|0
80337|NCT00112437|288430|P5|12 Month Extension|Adverse Event|7
80338|NCT00112437|288431|P4|12 Month Extension|Adverse Event|1
80339|NCT00112437|288432|P3|12 Month Extension|Adverse Event|6
80340|NCT00112437|288433|P2|12 Month Extension|Adverse Event|2
80341|NCT00112437|288434|P1|12 Month Extension|Adverse Event|1
80342|NCT00112437|288420|P15|12 Month Base Study|DXA was lower by more than 8%|0
80343|NCT00112437|288421|P14|12 Month Base Study|DXA was lower by more than 8%|0
80344|NCT00112437|288422|P13|12 Month Base Study|DXA was lower by more than 8%|0
80345|NCT00112437|288423|P12|12 Month Base Study|DXA was lower by more than 8%|0
80346|NCT00112437|288424|P11|12 Month Base Study|DXA was lower by more than 8%|0
80347|NCT00112437|288425|P10|12 Month Base Study|DXA was lower by more than 8%|0
80348|NCT00112437|288426|P9|12 Month Base Study|DXA was lower by more than 8%|0
80349|NCT00112437|288427|P8|12 Month Base Study|DXA was lower by more than 8%|0
80350|NCT00112437|288428|P7|12 Month Base Study|DXA was lower by more than 8%|0
80351|NCT00112437|288429|P6|12 Month Base Study|DXA was lower by more than 8%|0
80352|NCT00112437|288430|P5|12 Month Base Study|DXA was lower by more than 8%|1
80353|NCT00112437|288431|P4|12 Month Base Study|DXA was lower by more than 8%|0
80354|NCT00112437|288432|P3|12 Month Base Study|DXA was lower by more than 8%|0
80355|NCT00112437|288433|P2|12 Month Base Study|DXA was lower by more than 8%|0
80356|NCT00112437|288434|P1|12 Month Base Study|DXA was lower by more than 8%|0
80357|NCT00112437|288420|P15|12 Month Base Study|patient was unsure that they needed drug|0
80358|NCT00112437|288421|P14|12 Month Base Study|patient was unsure that they needed drug|0
80359|NCT00112437|288422|P13|12 Month Base Study|patient was unsure that they needed drug|0
80360|NCT00112437|288423|P12|12 Month Base Study|patient was unsure that they needed drug|0
80361|NCT00112437|288424|P11|12 Month Base Study|patient was unsure that they needed drug|0
80362|NCT00112437|288425|P10|12 Month Base Study|patient was unsure that they needed drug|0
80363|NCT00112437|288426|P9|12 Month Base Study|patient was unsure that they needed drug|0
80364|NCT00112437|288427|P8|12 Month Base Study|patient was unsure that they needed drug|0
80365|NCT00112437|288428|P7|12 Month Base Study|patient was unsure that they needed drug|0
80366|NCT00112437|288429|P6|12 Month Base Study|patient was unsure that they needed drug|0
80367|NCT00112437|288430|P5|12 Month Base Study|patient was unsure that they needed drug|0
80368|NCT00112437|288431|P4|12 Month Base Study|patient was unsure that they needed drug|2
80369|NCT00112437|288432|P3|12 Month Base Study|patient was unsure that they needed drug|0
80370|NCT00112437|288433|P2|12 Month Base Study|patient was unsure that they needed drug|0
80371|NCT00112437|288434|P1|12 Month Base Study|patient was unsure that they needed drug|0
80372|NCT00112437|288420|P15|12 Month Base Study|moved|0
80373|NCT00112437|288421|P14|12 Month Base Study|moved|0
80374|NCT00112437|288422|P13|12 Month Base Study|moved|0
80375|NCT00112437|288423|P12|12 Month Base Study|moved|0
80376|NCT00112437|288424|P11|12 Month Base Study|moved|0
80377|NCT00112437|288425|P10|12 Month Base Study|moved|0
80378|NCT00112437|288426|P9|12 Month Base Study|moved|0
80379|NCT00112437|288427|P8|12 Month Base Study|moved|0
80380|NCT00112437|288428|P7|12 Month Base Study|moved|0
80381|NCT00112437|288429|P6|12 Month Base Study|moved|0
80382|NCT00112437|288430|P5|12 Month Base Study|moved|0
80383|NCT00112437|288431|P4|12 Month Base Study|moved|0
80384|NCT00112437|288432|P3|12 Month Base Study|moved|1
80385|NCT00112437|288433|P2|12 Month Base Study|moved|1
80386|NCT00112437|288434|P1|12 Month Base Study|moved|0
80387|NCT00112437|288420|P15|12 Month Base Study|Withdrawal by Subject|0
80388|NCT00112437|288421|P14|12 Month Base Study|Withdrawal by Subject|0
80389|NCT00112437|288422|P13|12 Month Base Study|Withdrawal by Subject|0
80390|NCT00112437|288423|P12|12 Month Base Study|Withdrawal by Subject|0
80391|NCT00112437|288424|P11|12 Month Base Study|Withdrawal by Subject|0
80392|NCT00112437|288425|P10|12 Month Base Study|Withdrawal by Subject|0
80393|NCT00112437|288426|P9|12 Month Base Study|Withdrawal by Subject|0
80394|NCT00112437|288427|P8|12 Month Base Study|Withdrawal by Subject|0
80395|NCT00112437|288428|P7|12 Month Base Study|Withdrawal by Subject|0
80396|NCT00112437|288429|P6|12 Month Base Study|Withdrawal by Subject|0
80397|NCT00112437|288430|P5|12 Month Base Study|Withdrawal by Subject|7
80398|NCT00112437|288431|P4|12 Month Base Study|Withdrawal by Subject|1
80399|NCT00112437|288432|P3|12 Month Base Study|Withdrawal by Subject|2
80400|NCT00112437|288433|P2|12 Month Base Study|Withdrawal by Subject|5
80401|NCT00112437|288434|P1|12 Month Base Study|Withdrawal by Subject|5
80402|NCT00112437|288420|P15|12 Month Base Study|Protocol Violation|0
80403|NCT00112437|288421|P14|12 Month Base Study|Protocol Violation|0
80404|NCT00112437|288422|P13|12 Month Base Study|Protocol Violation|0
80405|NCT00112437|288423|P12|12 Month Base Study|Protocol Violation|0
80406|NCT00112437|288424|P11|12 Month Base Study|Protocol Violation|0
80407|NCT00112437|288425|P10|12 Month Base Study|Protocol Violation|0
80408|NCT00112437|288426|P9|12 Month Base Study|Protocol Violation|0
80409|NCT00112437|288427|P8|12 Month Base Study|Protocol Violation|0
80410|NCT00112437|288428|P7|12 Month Base Study|Protocol Violation|0
80411|NCT00112437|288429|P6|12 Month Base Study|Protocol Violation|0
80412|NCT00112437|288430|P5|12 Month Base Study|Protocol Violation|1
80413|NCT00112437|288431|P4|12 Month Base Study|Protocol Violation|1
80414|NCT00112437|288432|P3|12 Month Base Study|Protocol Violation|3
80415|NCT00112437|288433|P2|12 Month Base Study|Protocol Violation|0
80416|NCT00112437|288434|P1|12 Month Base Study|Protocol Violation|1
80417|NCT00112437|288420|P15|12 Month Base Study|Lost to Follow-up|0
80418|NCT00112437|288421|P14|12 Month Base Study|Lost to Follow-up|0
80419|NCT00112437|288422|P13|12 Month Base Study|Lost to Follow-up|0
80420|NCT00112437|288423|P12|12 Month Base Study|Lost to Follow-up|0
80421|NCT00112437|288424|P11|12 Month Base Study|Lost to Follow-up|0
80422|NCT00112437|288425|P10|12 Month Base Study|Lost to Follow-up|0
80423|NCT00112437|288426|P9|12 Month Base Study|Lost to Follow-up|0
80424|NCT00112437|288427|P8|12 Month Base Study|Lost to Follow-up|0
80425|NCT00112437|288428|P7|12 Month Base Study|Lost to Follow-up|0
80426|NCT00112437|288429|P6|12 Month Base Study|Lost to Follow-up|0
80427|NCT00112437|288430|P5|12 Month Base Study|Lost to Follow-up|0
80428|NCT00112437|288431|P4|12 Month Base Study|Lost to Follow-up|0
80429|NCT00112437|288432|P3|12 Month Base Study|Lost to Follow-up|0
80430|NCT00112437|288433|P2|12 Month Base Study|Lost to Follow-up|1
80431|NCT00112437|288434|P1|12 Month Base Study|Lost to Follow-up|0
80432|NCT00112437|288420|P15|12 Month Base Study|Lack of Efficacy|0
80433|NCT00112437|288421|P14|12 Month Base Study|Lack of Efficacy|0
80434|NCT00112437|288422|P13|12 Month Base Study|Lack of Efficacy|0
80435|NCT00112437|288423|P12|12 Month Base Study|Lack of Efficacy|0
80436|NCT00112437|288424|P11|12 Month Base Study|Lack of Efficacy|0
80437|NCT00112437|288425|P10|12 Month Base Study|Lack of Efficacy|0
80438|NCT00112437|288426|P9|12 Month Base Study|Lack of Efficacy|0
80439|NCT00112437|288427|P8|12 Month Base Study|Lack of Efficacy|0
80440|NCT00112437|288428|P7|12 Month Base Study|Lack of Efficacy|0
80441|NCT00112437|288429|P6|12 Month Base Study|Lack of Efficacy|0
80442|NCT00112437|288430|P5|12 Month Base Study|Lack of Efficacy|0
80443|NCT00112437|288431|P4|12 Month Base Study|Lack of Efficacy|0
80444|NCT00112437|288432|P3|12 Month Base Study|Lack of Efficacy|0
80445|NCT00112437|288433|P2|12 Month Base Study|Lack of Efficacy|1
80446|NCT00112437|288434|P1|12 Month Base Study|Lack of Efficacy|0
80447|NCT00112437|288420|P15|12 Month Base Study|Adverse Event|0
80448|NCT00112437|288421|P14|12 Month Base Study|Adverse Event|0
80449|NCT00112437|288422|P13|12 Month Base Study|Adverse Event|0
80450|NCT00112437|288423|P12|12 Month Base Study|Adverse Event|0
80451|NCT00112437|288424|P11|12 Month Base Study|Adverse Event|0
80452|NCT00112437|288425|P10|12 Month Base Study|Adverse Event|0
80453|NCT00112437|288426|P9|12 Month Base Study|Adverse Event|0
80454|NCT00112437|288427|P8|12 Month Base Study|Adverse Event|0
80455|NCT00112437|288428|P7|12 Month Base Study|Adverse Event|0
80456|NCT00112437|288429|P6|12 Month Base Study|Adverse Event|0
80457|NCT00112437|288430|P5|12 Month Base Study|Adverse Event|3
80458|NCT00112437|288431|P4|12 Month Base Study|Adverse Event|4
80459|NCT00112437|288432|P3|12 Month Base Study|Adverse Event|6
80460|NCT00112437|288433|P2|12 Month Base Study|Adverse Event|10
80461|NCT00112437|288434|P1|12 Month Base Study|Adverse Event|9
80462|NCT00112463|288691|P1|Overall Study|Never started treatment|2
80463|NCT00112463|288691|P1|Overall Study|Withdrawal by Subject|2
80464|NCT00112463|288691|P1|Overall Study|Toxicity|3
80465|NCT00112463|288691|P1|Overall Study|Second Primary|1
80466|NCT00112463|288691|P1|Overall Study|Progression|30
80467|NCT00112463|288691|P1|Overall Study|Physician Decision|1
80468|NCT00112489|288698|P1|Overall Study|Ineligible|7
80469|NCT00112489|288698|P1|Overall Study|Patient never treated|2
80470|NCT00112489|288698|P1|Overall Study|Other, Not Specified|9
80471|NCT00112489|288698|P1|Overall Study|Death|2
80472|NCT00112489|288698|P1|Overall Study|Adverse Event|12
80473|NCT00112489|288698|P1|Overall Study|Refused further treatment|8
80474|NCT00112736|288747|P2|Overall Study|1 pt never had had RX due rapid decline|0
80475|NCT00112736|288748|P1|Overall Study|1 pt never had had RX due rapid decline|1
80476|NCT00112840|288764|P3|Overall Study|Protocol Violation|5
80477|NCT00112840|288765|P2|Overall Study|Protocol Violation|0
80478|NCT00112840|288766|P1|Overall Study|Protocol Violation|0
80479|NCT00112840|288764|P3|Overall Study|Withdrawal by Subject|1
80480|NCT00112840|288765|P2|Overall Study|Withdrawal by Subject|0
80481|NCT00112840|288766|P1|Overall Study|Withdrawal by Subject|1
80482|NCT00112840|288764|P3|Overall Study|Physician Decision|0
80483|NCT00112840|288765|P2|Overall Study|Physician Decision|0
80484|NCT00112840|288766|P1|Overall Study|Physician Decision|1
80485|NCT00112866|288784|P2|Overall Study|did not start treatment post-op|2
80486|NCT00112866|288785|P1|Overall Study|did not start treatment post-op|1
80487|NCT00112866|288784|P2|Overall Study|Protocol Violation|0
80488|NCT00112866|288785|P1|Overall Study|Protocol Violation|1
80489|NCT00112905|288804|P1|Overall Study|performance status was deteiorating|1
80490|NCT00112905|288804|P1|Overall Study|Alternative treatment|1
80491|NCT00112905|288804|P1|Overall Study|Ineligibility|5
80492|NCT00112905|288804|P1|Overall Study|Death|1
80493|NCT00112905|288804|P1|Overall Study|Adverse Event|4
80494|NCT00113087|288850|P2|Overall Study|Family or MD withdrew subject|5
80495|NCT00113087|288851|P1|Overall Study|Family or MD withdrew subject|10
80496|NCT00113087|288850|P2|Overall Study|Death or Transplant|16
80497|NCT00113087|288851|P1|Overall Study|Death or Transplant|14
80498|NCT00113269|288925|P4|Overall Study|Unable to return for follow up|0
80499|NCT00113269|288926|P3|Overall Study|Unable to return for follow up|0
80500|NCT00113269|288927|P2|Overall Study|Unable to return for follow up|1
80501|NCT00113269|288928|P1|Overall Study|Unable to return for follow up|2
80502|NCT00113269|288925|P4|Overall Study|Did not meet eligibility criteria|1
80503|NCT00113269|288926|P3|Overall Study|Did not meet eligibility criteria|0
80504|NCT00113269|288927|P2|Overall Study|Did not meet eligibility criteria|0
80505|NCT00113269|288928|P1|Overall Study|Did not meet eligibility criteria|1
80506|NCT00113269|288925|P4|Overall Study|Withdrew consent, Prednisone initiated|1
80507|NCT00113269|288926|P3|Overall Study|Withdrew consent, Prednisone initiated|0
80508|NCT00113269|288927|P2|Overall Study|Withdrew consent, Prednisone initiated|0
80509|NCT00113269|288928|P1|Overall Study|Withdrew consent, Prednisone initiated|0
80510|NCT00113269|288925|P4|Overall Study|Received pancreas transplant|2
80511|NCT00113269|288926|P3|Overall Study|Received pancreas transplant|0
80512|NCT00113269|288927|P2|Overall Study|Received pancreas transplant|0
80513|NCT00113269|288928|P1|Overall Study|Received pancreas transplant|0
80514|NCT00113269|288925|P4|Overall Study|Moved|3
80515|NCT00113269|288926|P3|Overall Study|Moved|0
80516|NCT00113269|288927|P2|Overall Study|Moved|1
80517|NCT00113269|288928|P1|Overall Study|Moved|0
80518|NCT00113269|288925|P4|Overall Study|Discontinued due to rejection|0
80519|NCT00113269|288926|P3|Overall Study|Discontinued due to rejection|1
80520|NCT00113269|288927|P2|Overall Study|Discontinued due to rejection|0
80521|NCT00113269|288928|P1|Overall Study|Discontinued due to rejection|0
80522|NCT00113269|288925|P4|Overall Study|Sponsor elected to discontinue patient|1
80523|NCT00113269|288926|P3|Overall Study|Sponsor elected to discontinue patient|0
80524|NCT00113269|288927|P2|Overall Study|Sponsor elected to discontinue patient|0
80525|NCT00113269|288928|P1|Overall Study|Sponsor elected to discontinue patient|1
80526|NCT00113269|288925|P4|Overall Study|Lost to Follow-up|3
80527|NCT00113269|288926|P3|Overall Study|Lost to Follow-up|6
80528|NCT00113269|288927|P2|Overall Study|Lost to Follow-up|3
80529|NCT00113269|288928|P1|Overall Study|Lost to Follow-up|2
80530|NCT00113269|288925|P4|Overall Study|Protocol Violation|2
80531|NCT00113269|288926|P3|Overall Study|Protocol Violation|4
80532|NCT00113269|288927|P2|Overall Study|Protocol Violation|0
80533|NCT00113269|288928|P1|Overall Study|Protocol Violation|1
80534|NCT00113269|288925|P4|Overall Study|Graft loss|9
80535|NCT00113269|288926|P3|Overall Study|Graft loss|4
80536|NCT00113269|288927|P2|Overall Study|Graft loss|6
80537|NCT00113269|288928|P1|Overall Study|Graft loss|6
80538|NCT00113269|288925|P4|Overall Study|Withdrawal by Subject|2
80539|NCT00113269|288926|P3|Overall Study|Withdrawal by Subject|4
80540|NCT00113269|288927|P2|Overall Study|Withdrawal by Subject|3
80541|NCT00113269|288928|P1|Overall Study|Withdrawal by Subject|4
80542|NCT00113269|288925|P4|Overall Study|Adverse Event|7
80543|NCT00113269|288926|P3|Overall Study|Adverse Event|11
80544|NCT00113269|288927|P2|Overall Study|Adverse Event|7
80545|NCT00113269|288928|P1|Overall Study|Adverse Event|2
80546|NCT00113269|288925|P4|Overall Study|Did not meet eligibility – pre-treatment|2
80547|NCT00113269|288926|P3|Overall Study|Did not meet eligibility – pre-treatment|0
80548|NCT00113269|288927|P2|Overall Study|Did not meet eligibility – pre-treatment|0
80549|NCT00113269|288928|P1|Overall Study|Did not meet eligibility – pre-treatment|0
80550|NCT00113269|288925|P4|Overall Study|Death in operating room|1
80551|NCT00113269|288926|P3|Overall Study|Death in operating room|0
80552|NCT00113269|288927|P2|Overall Study|Death in operating room|0
80553|NCT00113269|288928|P1|Overall Study|Death in operating room|0
80554|NCT00113269|288925|P4|Overall Study|Early graft loss, technical|0
80555|NCT00113269|288926|P3|Overall Study|Early graft loss, technical|2
80556|NCT00113269|288927|P2|Overall Study|Early graft loss, technical|0
80557|NCT00113269|288928|P1|Overall Study|Early graft loss, technical|0
80558|NCT00113269|288925|P4|Overall Study|Not transplanted, recipient issues|4
80559|NCT00113269|288926|P3|Overall Study|Not transplanted, recipient issues|7
80560|NCT00113269|288927|P2|Overall Study|Not transplanted, recipient issues|1
80561|NCT00113269|288928|P1|Overall Study|Not transplanted, recipient issues|2
80562|NCT00113269|288925|P4|Overall Study|Not transplanted, donor issues|2
80563|NCT00113269|288926|P3|Overall Study|Not transplanted, donor issues|2
80564|NCT00113269|288927|P2|Overall Study|Not transplanted, donor issues|0
80565|NCT00113269|288928|P1|Overall Study|Not transplanted, donor issues|4
80566|NCT00113295|288980|P2|Overall Study|Unrelated Medical Illness|0
80567|NCT00113295|288981|P1|Overall Study|Unrelated Medical Illness|1
80568|NCT00113295|288980|P2|Overall Study|Adverse Event|1
80569|NCT00113295|288981|P1|Overall Study|Adverse Event|4
80570|NCT00113360|289004|P1|Overall Study|Did not meet eligibility criteria|3
80571|NCT00113360|289004|P1|Overall Study|Subject required surgery|1
80572|NCT00113360|289004|P1|Overall Study|Adverse Event|3
80573|NCT00113373|289008|P1|Overall Study|Never Treated|1
80574|NCT00113373|289008|P1|Overall Study|Ineligible: second primary|1
80575|NCT00113373|289008|P1|Overall Study|Ineligible: wrong primary|1
80576|NCT00113386|289016|P2|Overall Study|Unknown - Lost to Follow-Up|1
80577|NCT00113386|289017|P1|Overall Study|Unknown - Lost to Follow-Up|2
80578|NCT00113386|289016|P2|Overall Study|Ineligible|2
80579|NCT00113386|289017|P1|Overall Study|Ineligible|1
80580|NCT00113386|289016|P2|Overall Study|Toxicity|0
80581|NCT00113386|289017|P1|Overall Study|Toxicity|3
80582|NCT00113386|289016|P2|Overall Study|Physician Decision|1
80583|NCT00113386|289017|P1|Overall Study|Physician Decision|0
80584|NCT00113386|289016|P2|Overall Study|Withdrawal by Subject|0
80585|NCT00113386|289017|P1|Overall Study|Withdrawal by Subject|1
80586|NCT00113399|289025|P2|Overall Study|Other|1
80587|NCT00113399|289026|P1|Overall Study|Other|0
80588|NCT00113399|289025|P2|Overall Study|Complete Response|1
80589|NCT00113399|289026|P1|Overall Study|Complete Response|0
80590|NCT00113399|289025|P2|Overall Study|Withdrawal by Subject|2
80591|NCT00113399|289026|P1|Overall Study|Withdrawal by Subject|1
80592|NCT00113399|289025|P2|Overall Study|Death|1
80593|NCT00113399|289026|P1|Overall Study|Death|1
80594|NCT00113490|289052|P2|Overall Study|Lost to Follow-up|0
80595|NCT00113490|289053|P1|Overall Study|Lost to Follow-up|1
80596|NCT00113490|289052|P2|Overall Study|Withdrawal by Subject|3
80597|NCT00113490|289053|P1|Overall Study|Withdrawal by Subject|1
80598|NCT00113516|289066|P2|Part 2|Ongoing|1
80599|NCT00113516|289067|P1|Part 2|Ongoing|0
80600|NCT00113516|289066|P2|Part 2|Laboratory Abnormality|1
80601|NCT00113516|289067|P1|Part 2|Laboratory Abnormality|0
80602|NCT00113516|289066|P2|Part 2|Unspecified|3
80603|NCT00113516|289067|P1|Part 2|Unspecified|0
80604|NCT00113516|289066|P2|Part 2|Withdrawal by Subject|3
80605|NCT00113516|289067|P1|Part 2|Withdrawal by Subject|0
80606|NCT00113516|289066|P2|Part 2|Lack of Efficacy|37
80607|NCT00113516|289067|P1|Part 2|Lack of Efficacy|0
80608|NCT00113516|289066|P2|Part 2|Death|5
80609|NCT00113516|289067|P1|Part 2|Death|0
80610|NCT00113516|289066|P2|Part 2|Adverse Event|16
80611|NCT00113516|289067|P1|Part 2|Adverse Event|0
80612|NCT00113516|289066|P2|Part 1|Missing|0
80613|NCT00113516|289067|P1|Part 1|Missing|65
80614|NCT00113516|289066|P2|Part 1|Ongoing|0
80615|NCT00113516|289067|P1|Part 1|Ongoing|1
80616|NCT00113516|289066|P2|Part 1|Laboratory Abnormality|0
80617|NCT00113516|289067|P1|Part 1|Laboratory Abnormality|1
80618|NCT00113516|289066|P2|Part 1|Did Not Meet Entrance Criteria|0
80619|NCT00113516|289067|P1|Part 1|Did Not Meet Entrance Criteria|1
80620|NCT00113516|289066|P2|Part 1|Lack of Efficacy|0
80621|NCT00113516|289067|P1|Part 1|Lack of Efficacy|2
80622|NCT00113516|289066|P2|Part 1|Withdrawal by Subject|0
80623|NCT00113516|289067|P1|Part 1|Withdrawal by Subject|2
80624|NCT00113516|289066|P2|Part 1|Unspecified|0
80625|NCT00113516|289067|P1|Part 1|Unspecified|3
80626|NCT00113516|289066|P2|Part 1|Death|0
80627|NCT00113516|289067|P1|Part 1|Death|3
80628|NCT00113516|289066|P2|Part 1|Adverse Event|0
80629|NCT00113516|289067|P1|Part 1|Adverse Event|6
80630|NCT00113529|289108|P1|Overall Study|Withdrawal by Subject|4
80631|NCT00113529|289108|P1|Overall Study|Decision of sponsor|6
80632|NCT00113529|289108|P1|Overall Study|Lack of Efficacy|20
80633|NCT00113529|289108|P1|Overall Study|Adverse Event|4
80634|NCT00113568|289141|P1|Overall Study|Other|112
80635|NCT00113568|289141|P1|Overall Study|Withdrawal by Subject|117
80636|NCT00113568|289141|P1|Overall Study|Protocol Violation|32
80637|NCT00113568|289141|P1|Overall Study|Lost to Follow-up|156
80638|NCT00113568|289141|P1|Overall Study|Lack of Efficacy|30
80639|NCT00113568|289141|P1|Overall Study|Death|1
80640|NCT00113568|289141|P1|Overall Study|Adverse Event|97
80641|NCT00113607|289155|P2|Overall Study|Unspecified|32
80642|NCT00113607|289156|P1|Overall Study|Unspecified|43
80643|NCT00113607|289155|P2|Overall Study|Complete Response (Confirmed)|24
80644|NCT00113607|289156|P1|Overall Study|Complete Response (Confirmed)|14
80645|NCT00113607|289155|P2|Overall Study|Disease Progression|142
80646|NCT00113607|289156|P1|Overall Study|Disease Progression|180
80647|NCT00113607|289155|P2|Overall Study|Lost to Follow-up|2
80648|NCT00113607|289156|P1|Overall Study|Lost to Follow-up|0
80649|NCT00113607|289155|P2|Overall Study|Withdrawal by Subject|58
80650|NCT00113607|289156|P1|Overall Study|Withdrawal by Subject|50
80651|NCT00113607|289155|P2|Overall Study|Death|8
80652|NCT00113607|289156|P1|Overall Study|Death|8
80653|NCT00113607|289155|P2|Overall Study|Adverse Event|71
80654|NCT00113607|289156|P1|Overall Study|Adverse Event|40
80655|NCT00113763|289172|P2|Overall Study|Ongoing|0
80656|NCT00113763|289173|P1|Overall Study|Ongoing|1
80657|NCT00113763|289172|P2|Overall Study|Non-compliance|0
80658|NCT00113763|289173|P1|Overall Study|Non-compliance|1
80659|NCT00113763|289172|P2|Overall Study|Not specified|6
80660|NCT00113763|289173|P1|Overall Study|Not specified|27
80661|NCT00113763|289172|P2|Overall Study|Withdrawal by Subject|4
80662|NCT00113763|289173|P1|Overall Study|Withdrawal by Subject|1
80663|NCT00113763|289172|P2|Overall Study|Lost to Follow-up|0
80664|NCT00113763|289173|P1|Overall Study|Lost to Follow-up|10
80665|NCT00113763|289172|P2|Overall Study|Disease Progression|14
80666|NCT00113763|289173|P1|Overall Study|Disease Progression|28
80667|NCT00113763|289172|P2|Overall Study|Adverse Event|2
80668|NCT00113763|289173|P1|Overall Study|Adverse Event|5
80669|NCT00113841|289199|P2|Overall Study|Non-compliant|0
80670|NCT00113841|289200|P1|Overall Study|Non-compliant|1
80671|NCT00113841|289199|P2|Overall Study|Disease progression|2
80672|NCT00113841|289200|P1|Overall Study|Disease progression|0
80673|NCT00113919|289268|P1|Overall Study|Death|6
80674|NCT00113919|289268|P1|Overall Study|Physician Decision|8
80675|NCT00114127|289289|P2|Overall Study|Withdrawal by Subject|3
80676|NCT00114127|289290|P1|Overall Study|Withdrawal by Subject|1
80677|NCT00114127|289289|P2|Overall Study|Lost to Follow-up|0
80678|NCT00114127|289290|P1|Overall Study|Lost to Follow-up|1
80679|NCT00114127|289289|P2|Overall Study|Adverse Event|1
80680|NCT00114127|289290|P1|Overall Study|Adverse Event|2
80681|NCT00114166|289298|P1|Overall Study|Wrong primary|1
80682|NCT00114244|289306|P2|Overall Study|Withdrawal by Subject|2
80683|NCT00114244|289307|P1|Overall Study|Withdrawal by Subject|0
80684|NCT00114244|289306|P2|Overall Study|Adverse Event|5
80685|NCT00114244|289307|P1|Overall Study|Adverse Event|2
80686|NCT00120874|289319|P2|Overall Study|Death|1
80687|NCT00120874|289320|P1|Overall Study|Death|0
80688|NCT00121485|289369|P2|Overall Study|Crossover|2
80689|NCT00121485|289370|P1|Overall Study|Crossover|0
80690|NCT00121485|289369|P2|Overall Study|Not implanted|5
80691|NCT00121485|289370|P1|Overall Study|Not implanted|1
80692|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Other Reason|1
80693|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Other Reason|0
80694|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Other Reason|2
80695|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Other Reason|3
80696|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Other Reason|5
80697|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Missing|0
80698|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Missing|0
80699|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Missing|1
80700|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Missing|0
80701|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Missing|0
80702|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Death|0
80703|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Death|1
80704|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Death|0
80705|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Death|0
80706|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Death|0
80707|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
80708|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
80709|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
80710|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
80711|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
80712|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Pregnancy|0
80713|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Pregnancy|1
80714|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Pregnancy|0
80715|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Pregnancy|1
80716|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Pregnancy|0
80717|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
80718|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
80719|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
80720|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
80721|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
80722|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
80723|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
80724|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
80725|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
80726|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
80727|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
80728|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
80729|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
80730|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
80731|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
80732|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Adverse Event|5
80733|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Adverse Event|5
80734|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Adverse Event|10
80735|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Adverse Event|10
80736|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Adverse Event|9
80737|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
80738|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
80739|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
80740|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
80741|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
80742|NCT00121641|289408|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
80743|NCT00121641|289409|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
80744|NCT00121641|289410|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
80745|NCT00121641|289411|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
80746|NCT00121641|289412|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
80747|NCT00121641|289408|P5|24-week Short-term Treatment Period|Other Reason|0
80748|NCT00121641|289409|P4|24-week Short-term Treatment Period|Other Reason|0
80749|NCT00121641|289410|P3|24-week Short-term Treatment Period|Other Reason|0
80750|NCT00121641|289411|P2|24-week Short-term Treatment Period|Other Reason|0
80751|NCT00121641|289412|P1|24-week Short-term Treatment Period|Other Reason|1
80752|NCT00121641|289408|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
80753|NCT00121641|289409|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
80754|NCT00121641|289410|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
80755|NCT00121641|289411|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
80756|NCT00121641|289412|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
80757|NCT00121641|289408|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
80758|NCT00121641|289409|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
80759|NCT00121641|289410|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
80760|NCT00121641|289411|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
80761|NCT00121641|289412|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
80762|NCT00121641|289408|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
80763|NCT00121641|289409|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
80764|NCT00121641|289410|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
80765|NCT00121641|289411|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
80766|NCT00121641|289412|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
80767|NCT00121641|289408|P5|24-week Short-term Treatment Period|Adverse Event|2
80768|NCT00121641|289409|P4|24-week Short-term Treatment Period|Adverse Event|0
80769|NCT00121641|289410|P3|24-week Short-term Treatment Period|Adverse Event|4
80770|NCT00121641|289411|P2|24-week Short-term Treatment Period|Adverse Event|3
80771|NCT00121641|289412|P1|24-week Short-term Treatment Period|Adverse Event|3
80772|NCT00121641|289408|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
80773|NCT00121641|289409|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
80774|NCT00121641|289410|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
80775|NCT00121641|289411|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
80776|NCT00121641|289412|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
80777|NCT00121641|289408|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
80778|NCT00121641|289409|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
80779|NCT00121641|289410|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
80780|NCT00121641|289411|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
80781|NCT00121641|289412|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
80782|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Death|2
80783|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Death|0
80784|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Death|0
80785|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Death|1
80786|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
80787|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
80788|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
80789|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
80790|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
80791|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
80792|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
80793|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
80794|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
80795|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
80796|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
80797|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
80798|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
80799|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
80800|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
80801|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
80802|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
80803|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
80804|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
80805|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
80806|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
80807|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
80808|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
80809|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
80810|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
80811|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
80812|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
80813|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
80814|NCT00121667|289527|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
80815|NCT00121667|289528|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
80816|NCT00121667|289529|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
80817|NCT00121667|289530|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
80818|NCT00121667|289527|P4|Short Term (ST) Period|Pregnancy|1
80819|NCT00121667|289528|P3|Short Term (ST) Period|Pregnancy|0
80820|NCT00121667|289529|P2|Short Term (ST) Period|Pregnancy|0
80821|NCT00121667|289530|P1|Short Term (ST) Period|Pregnancy|0
80822|NCT00121667|289527|P4|Short Term (ST) Period|Death|1
80823|NCT00121667|289528|P3|Short Term (ST) Period|Death|0
80824|NCT00121667|289529|P2|Short Term (ST) Period|Death|0
80825|NCT00121667|289530|P1|Short Term (ST) Period|Death|0
80826|NCT00121667|289527|P4|Short Term (ST) Period|Other Reason|0
80827|NCT00121667|289528|P3|Short Term (ST) Period|Other Reason|0
80828|NCT00121667|289529|P2|Short Term (ST) Period|Other Reason|0
80829|NCT00121667|289530|P1|Short Term (ST) Period|Other Reason|3
80830|NCT00121667|289527|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
80831|NCT00121667|289528|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
80832|NCT00121667|289529|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
80833|NCT00121667|289530|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
80834|NCT00121667|289527|P4|Short Term (ST) Period|Poor / Non-compliance|2
80835|NCT00121667|289528|P3|Short Term (ST) Period|Poor / Non-compliance|1
80836|NCT00121667|289529|P2|Short Term (ST) Period|Poor / Non-compliance|1
80837|NCT00121667|289530|P1|Short Term (ST) Period|Poor / Non-compliance|0
80838|NCT00121667|289527|P4|Short Term (ST) Period|Lost to Follow-up|3
80839|NCT00121667|289528|P3|Short Term (ST) Period|Lost to Follow-up|4
80840|NCT00121667|289529|P2|Short Term (ST) Period|Lost to Follow-up|4
80841|NCT00121667|289530|P1|Short Term (ST) Period|Lost to Follow-up|3
80842|NCT00121667|289527|P4|Short Term (ST) Period|Adverse Event|3
80843|NCT00121667|289528|P3|Short Term (ST) Period|Adverse Event|5
80844|NCT00121667|289529|P2|Short Term (ST) Period|Adverse Event|6
80845|NCT00121667|289530|P1|Short Term (ST) Period|Adverse Event|5
80846|NCT00121667|289527|P4|Short Term (ST) Period|Subject Withdrew Consent|11
80847|NCT00121667|289528|P3|Short Term (ST) Period|Subject Withdrew Consent|4
80848|NCT00121667|289529|P2|Short Term (ST) Period|Subject Withdrew Consent|13
80849|NCT00121667|289530|P1|Short Term (ST) Period|Subject Withdrew Consent|8
80850|NCT00121667|289527|P4|Short Term (ST) Period|Lack of Efficacy|44
80851|NCT00121667|289528|P3|Short Term (ST) Period|Lack of Efficacy|27
80852|NCT00121667|289529|P2|Short Term (ST) Period|Lack of Efficacy|22
80853|NCT00121667|289530|P1|Short Term (ST) Period|Lack of Efficacy|25
80854|NCT00121719|289638|P14|Overall Study|Continuing/ongoing patients|0
80855|NCT00121719|289639|P13|Overall Study|Continuing/ongoing patients|3
80856|NCT00121719|289640|P12|Overall Study|Continuing/ongoing patients|1
80857|NCT00121719|289641|P11|Overall Study|Continuing/ongoing patients|1
80858|NCT00121719|289642|P10|Overall Study|Continuing/ongoing patients|0
80859|NCT00121719|289643|P9|Overall Study|Continuing/ongoing patients|0
80860|NCT00121719|289644|P8|Overall Study|Continuing/ongoing patients|1
80861|NCT00121719|289645|P7|Overall Study|Continuing/ongoing patients|0
80862|NCT00121719|289646|P6|Overall Study|Continuing/ongoing patients|0
80863|NCT00121719|289647|P5|Overall Study|Continuing/ongoing patients|0
80864|NCT00121719|289648|P4|Overall Study|Continuing/ongoing patients|0
80865|NCT00121719|289649|P3|Overall Study|Continuing/ongoing patients|0
80866|NCT00121719|289650|P2|Overall Study|Continuing/ongoing patients|0
80867|NCT00121719|289651|P1|Overall Study|Continuing/ongoing patients|0
80868|NCT00121719|289638|P14|Overall Study|Not specified|1
80869|NCT00121719|289639|P13|Overall Study|Not specified|1
80870|NCT00121719|289640|P12|Overall Study|Not specified|0
80871|NCT00121719|289641|P11|Overall Study|Not specified|0
80872|NCT00121719|289642|P10|Overall Study|Not specified|0
80873|NCT00121719|289643|P9|Overall Study|Not specified|1
80874|NCT00121719|289644|P8|Overall Study|Not specified|0
80875|NCT00121719|289645|P7|Overall Study|Not specified|1
80876|NCT00121719|289646|P6|Overall Study|Not specified|0
80877|NCT00121719|289647|P5|Overall Study|Not specified|0
80878|NCT00121719|289648|P4|Overall Study|Not specified|1
80879|NCT00121719|289649|P3|Overall Study|Not specified|1
80880|NCT00121719|289650|P2|Overall Study|Not specified|0
80881|NCT00121719|289651|P1|Overall Study|Not specified|0
80882|NCT00121719|289638|P14|Overall Study|Physician Decision|0
80883|NCT00121719|289639|P13|Overall Study|Physician Decision|1
80884|NCT00121719|289640|P12|Overall Study|Physician Decision|0
80885|NCT00121719|289641|P11|Overall Study|Physician Decision|0
80886|NCT00121719|289642|P10|Overall Study|Physician Decision|0
80887|NCT00121719|289643|P9|Overall Study|Physician Decision|0
80888|NCT00121719|289644|P8|Overall Study|Physician Decision|0
80889|NCT00121719|289645|P7|Overall Study|Physician Decision|0
80890|NCT00121719|289646|P6|Overall Study|Physician Decision|0
80891|NCT00121719|289647|P5|Overall Study|Physician Decision|0
80892|NCT00121719|289648|P4|Overall Study|Physician Decision|0
80893|NCT00121719|289649|P3|Overall Study|Physician Decision|0
80894|NCT00121719|289650|P2|Overall Study|Physician Decision|1
80895|NCT00121719|289651|P1|Overall Study|Physician Decision|0
80896|NCT00121719|289638|P14|Overall Study|Clinical deterioration|2
80897|NCT00121719|289639|P13|Overall Study|Clinical deterioration|2
80898|NCT00121719|289640|P12|Overall Study|Clinical deterioration|1
80899|NCT00121719|289641|P11|Overall Study|Clinical deterioration|0
80900|NCT00121719|289642|P10|Overall Study|Clinical deterioration|2
80901|NCT00121719|289643|P9|Overall Study|Clinical deterioration|2
80902|NCT00121719|289644|P8|Overall Study|Clinical deterioration|1
80903|NCT00121719|289645|P7|Overall Study|Clinical deterioration|2
80904|NCT00121719|289646|P6|Overall Study|Clinical deterioration|0
80905|NCT00121719|289647|P5|Overall Study|Clinical deterioration|1
80906|NCT00121719|289648|P4|Overall Study|Clinical deterioration|0
80907|NCT00121719|289649|P3|Overall Study|Clinical deterioration|1
80908|NCT00121719|289650|P2|Overall Study|Clinical deterioration|1
80909|NCT00121719|289651|P1|Overall Study|Clinical deterioration|0
80910|NCT00121719|289638|P14|Overall Study|Progressive disease|4
80911|NCT00121719|289639|P13|Overall Study|Progressive disease|13
80912|NCT00121719|289640|P12|Overall Study|Progressive disease|3
80913|NCT00121719|289641|P11|Overall Study|Progressive disease|4
80914|NCT00121719|289642|P10|Overall Study|Progressive disease|1
80915|NCT00121719|289643|P9|Overall Study|Progressive disease|3
80916|NCT00121719|289644|P8|Overall Study|Progressive disease|5
80917|NCT00121719|289645|P7|Overall Study|Progressive disease|7
80918|NCT00121719|289646|P6|Overall Study|Progressive disease|1
80919|NCT00121719|289647|P5|Overall Study|Progressive disease|2
80920|NCT00121719|289648|P4|Overall Study|Progressive disease|2
80921|NCT00121719|289649|P3|Overall Study|Progressive disease|0
80922|NCT00121719|289650|P2|Overall Study|Progressive disease|1
80923|NCT00121719|289651|P1|Overall Study|Progressive disease|2
80924|NCT00121719|289638|P14|Overall Study|Withdrawal by Subject|0
80925|NCT00121719|289639|P13|Overall Study|Withdrawal by Subject|0
80926|NCT00121719|289640|P12|Overall Study|Withdrawal by Subject|0
80927|NCT00121719|289641|P11|Overall Study|Withdrawal by Subject|0
80928|NCT00121719|289642|P10|Overall Study|Withdrawal by Subject|0
80929|NCT00121719|289643|P9|Overall Study|Withdrawal by Subject|0
80930|NCT00121719|289644|P8|Overall Study|Withdrawal by Subject|0
80931|NCT00121719|289645|P7|Overall Study|Withdrawal by Subject|0
80932|NCT00121719|289646|P6|Overall Study|Withdrawal by Subject|0
80933|NCT00121719|289647|P5|Overall Study|Withdrawal by Subject|0
80934|NCT00121719|289648|P4|Overall Study|Withdrawal by Subject|0
80935|NCT00121719|289649|P3|Overall Study|Withdrawal by Subject|0
80936|NCT00121719|289650|P2|Overall Study|Withdrawal by Subject|0
80937|NCT00121719|289651|P1|Overall Study|Withdrawal by Subject|1
80938|NCT00121719|289638|P14|Overall Study|Protocol deviation|0
80939|NCT00121719|289639|P13|Overall Study|Protocol deviation|0
80940|NCT00121719|289640|P12|Overall Study|Protocol deviation|0
80941|NCT00121719|289641|P11|Overall Study|Protocol deviation|0
80942|NCT00121719|289642|P10|Overall Study|Protocol deviation|0
80943|NCT00121719|289643|P9|Overall Study|Protocol deviation|0
80944|NCT00121719|289644|P8|Overall Study|Protocol deviation|0
80945|NCT00121719|289645|P7|Overall Study|Protocol deviation|0
80946|NCT00121719|289646|P6|Overall Study|Protocol deviation|0
80947|NCT00121719|289647|P5|Overall Study|Protocol deviation|0
80948|NCT00121719|289648|P4|Overall Study|Protocol deviation|0
80949|NCT00121719|289649|P3|Overall Study|Protocol deviation|1
80950|NCT00121719|289650|P2|Overall Study|Protocol deviation|0
80951|NCT00121719|289651|P1|Overall Study|Protocol deviation|0
80952|NCT00121719|289638|P14|Overall Study|Abnormal laboratory value|0
80953|NCT00121719|289639|P13|Overall Study|Abnormal laboratory value|1
80954|NCT00121719|289640|P12|Overall Study|Abnormal laboratory value|0
80955|NCT00121719|289641|P11|Overall Study|Abnormal laboratory value|0
80956|NCT00121719|289642|P10|Overall Study|Abnormal laboratory value|0
80957|NCT00121719|289643|P9|Overall Study|Abnormal laboratory value|0
80958|NCT00121719|289644|P8|Overall Study|Abnormal laboratory value|1
80959|NCT00121719|289645|P7|Overall Study|Abnormal laboratory value|0
80960|NCT00121719|289646|P6|Overall Study|Abnormal laboratory value|0
80961|NCT00121719|289647|P5|Overall Study|Abnormal laboratory value|0
80962|NCT00121719|289648|P4|Overall Study|Abnormal laboratory value|0
80963|NCT00121719|289649|P3|Overall Study|Abnormal laboratory value|0
80964|NCT00121719|289650|P2|Overall Study|Abnormal laboratory value|1
80965|NCT00121719|289651|P1|Overall Study|Abnormal laboratory value|1
80966|NCT00121719|289638|P14|Overall Study|Adverse Event|0
80967|NCT00121719|289639|P13|Overall Study|Adverse Event|3
80968|NCT00121719|289640|P12|Overall Study|Adverse Event|0
80969|NCT00121719|289641|P11|Overall Study|Adverse Event|1
80970|NCT00121719|289642|P10|Overall Study|Adverse Event|0
80971|NCT00121719|289643|P9|Overall Study|Adverse Event|0
80972|NCT00121719|289644|P8|Overall Study|Adverse Event|1
80973|NCT00121719|289645|P7|Overall Study|Adverse Event|2
80974|NCT00121719|289646|P6|Overall Study|Adverse Event|2
80975|NCT00121719|289647|P5|Overall Study|Adverse Event|0
80976|NCT00121719|289648|P4|Overall Study|Adverse Event|0
80977|NCT00121719|289649|P3|Overall Study|Adverse Event|1
80978|NCT00121719|289650|P2|Overall Study|Adverse Event|0
80979|NCT00121719|289651|P1|Overall Study|Adverse Event|0
80980|NCT00122109|289852|P2|Overall Study|Did not meet criteria|7
80981|NCT00122109|289853|P1|Overall Study|Did not meet criteria|6
80982|NCT00122135|289879|P2|Overall Study|Withdrawal by Subject|0
80983|NCT00122135|289880|P1|Overall Study|Withdrawal by Subject|3
80984|NCT00122187|289888|P2|Overall Study|Withdrew because of resource limitations|2
80985|NCT00122187|289889|P1|Overall Study|Withdrew because of resource limitations|2
80986|NCT00122317|289901|P1|Overall Study|Withdrawal by Subject|1
80987|NCT00122317|289901|P1|Overall Study|patient non-compliance|1
80988|NCT00122317|289901|P1|Overall Study|Physician Decision|2
80989|NCT00122317|289901|P1|Overall Study|Adverse Event|4
80990|NCT00122317|289901|P1|Overall Study|Death|3
80991|NCT00122382|290001|P3|Open-Label Study|Withdrawal of Consent|4
80992|NCT00122382|290002|P2|Open-Label Study|Withdrawal of Consent|0
80993|NCT00122382|290003|P1|Open-Label Study|Withdrawal of Consent|0
80994|NCT00122382|290001|P3|Open-Label Study|Poor/Non-Compliance|1
80995|NCT00122382|290002|P2|Open-Label Study|Poor/Non-Compliance|0
80996|NCT00122382|290003|P1|Open-Label Study|Poor/Non-Compliance|0
80997|NCT00122382|290001|P3|Open-Label Study|Pregnancy|2
80998|NCT00122382|290002|P2|Open-Label Study|Pregnancy|0
80999|NCT00122382|290003|P1|Open-Label Study|Pregnancy|0
81000|NCT00122382|290001|P3|Open-Label Study|Lost to Follow-up|3
81001|NCT00122382|290002|P2|Open-Label Study|Lost to Follow-up|0
81002|NCT00122382|290003|P1|Open-Label Study|Lost to Follow-up|0
81003|NCT00122382|290001|P3|Open-Label Study|Lack of Efficacy|3
81004|NCT00122382|290002|P2|Open-Label Study|Lack of Efficacy|0
81005|NCT00122382|290003|P1|Open-Label Study|Lack of Efficacy|0
81006|NCT00122382|290001|P3|Open-Label Study|Death|2
81007|NCT00122382|290002|P2|Open-Label Study|Death|0
81008|NCT00122382|290003|P1|Open-Label Study|Death|0
81009|NCT00122382|290001|P3|Open-Label Study|Adverse Event|11
81010|NCT00122382|290002|P2|Open-Label Study|Adverse Event|0
81011|NCT00122382|290003|P1|Open-Label Study|Adverse Event|0
81012|NCT00122382|290001|P3|Double-Blind Study|Randomized but not treated|0
81013|NCT00122382|290002|P2|Double-Blind Study|Randomized but not treated|2
81014|NCT00122382|290003|P1|Double-Blind Study|Randomized but not treated|0
81015|NCT00122382|290001|P3|Double-Blind Study|Methotrexate Discontinued|0
81016|NCT00122382|290002|P2|Double-Blind Study|Methotrexate Discontinued|1
81017|NCT00122382|290003|P1|Double-Blind Study|Methotrexate Discontinued|0
81018|NCT00122382|290001|P3|Double-Blind Study|Protocol Violation|0
81019|NCT00122382|290002|P2|Double-Blind Study|Protocol Violation|0
81020|NCT00122382|290003|P1|Double-Blind Study|Protocol Violation|1
81021|NCT00122382|290001|P3|Double-Blind Study|Withdrawal of Consent|0
81022|NCT00122382|290002|P2|Double-Blind Study|Withdrawal of Consent|3
81023|NCT00122382|290003|P1|Double-Blind Study|Withdrawal of Consent|7
81024|NCT00122382|290001|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
81025|NCT00122382|290002|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
81026|NCT00122382|290003|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
81027|NCT00122382|290001|P3|Double-Blind Study|Pregnancy|0
81028|NCT00122382|290002|P2|Double-Blind Study|Pregnancy|0
81029|NCT00122382|290003|P1|Double-Blind Study|Pregnancy|2
81030|NCT00122382|290001|P3|Double-Blind Study|Lost to Follow-up|0
81031|NCT00122382|290002|P2|Double-Blind Study|Lost to Follow-up|1
81032|NCT00122382|290003|P1|Double-Blind Study|Lost to Follow-up|2
81033|NCT00122382|290001|P3|Double-Blind Study|Lack of Efficacy|0
81034|NCT00122382|290002|P2|Double-Blind Study|Lack of Efficacy|8
81035|NCT00122382|290003|P1|Double-Blind Study|Lack of Efficacy|0
81036|NCT00122382|290001|P3|Double-Blind Study|Death|0
81037|NCT00122382|290002|P2|Double-Blind Study|Death|2
81038|NCT00122382|290003|P1|Double-Blind Study|Death|2
81039|NCT00122382|290001|P3|Double-Blind Study|Adverse Event|0
81040|NCT00122382|290002|P2|Double-Blind Study|Adverse Event|11
81041|NCT00122382|290003|P1|Double-Blind Study|Adverse Event|9
81042|NCT00122460|290080|P2|Overall Study|investigational study phase ongoing|1
81043|NCT00122460|290081|P1|Overall Study|investigational study phase ongoing|7
81044|NCT00122681|290105|P2|Overall Study|Personal reasons|147
81045|NCT00122681|290106|P1|Overall Study|Personal reasons|150
81046|NCT00122681|290105|P2|Overall Study|Withdrawal by Subject|251
81047|NCT00122681|290106|P1|Overall Study|Withdrawal by Subject|257
81048|NCT00122681|290105|P2|Overall Study|Protocol Violation|10
81049|NCT00122681|290106|P1|Overall Study|Protocol Violation|7
81050|NCT00122681|290105|P2|Overall Study|Lost to Follow-up|1097
81051|NCT00122681|290106|P1|Overall Study|Lost to Follow-up|1080
81052|NCT00122681|290105|P2|Overall Study|Adverse Event|16
81053|NCT00122681|290106|P1|Overall Study|Adverse Event|20
81054|NCT00122954|290180|P2|Overall Study|Protocol Violation|1
81055|NCT00122954|290181|P1|Overall Study|Protocol Violation|0
81056|NCT00122954|290180|P2|Overall Study|Withdrawal by Subject|2
81057|NCT00122954|290181|P1|Overall Study|Withdrawal by Subject|2
81058|NCT00122980|290191|P2|Overall Study|Study termination|35
81059|NCT00122980|290192|P1|Overall Study|Study termination|27
81060|NCT00122980|290191|P2|Overall Study|Adjudicated stroke (study endpoint)|0
81061|NCT00122980|290192|P1|Overall Study|Adjudicated stroke (study endpoint)|7
81062|NCT00122980|290191|P2|Overall Study|Withdrawal by Subject|3
81063|NCT00122980|290192|P1|Overall Study|Withdrawal by Subject|2
81064|NCT00122980|290191|P2|Overall Study|Protocol Violation|1
81065|NCT00122980|290192|P1|Overall Study|Protocol Violation|5
81066|NCT00122980|290191|P2|Overall Study|Physician Decision|0
81067|NCT00122980|290192|P1|Overall Study|Physician Decision|2
81068|NCT00122980|290191|P2|Overall Study|Death|1
81069|NCT00122980|290192|P1|Overall Study|Death|0
81070|NCT00123422|290255|P3|Overall Study|Lost to Follow-up|2
81071|NCT00123422|290256|P2|Overall Study|Lost to Follow-up|2
81072|NCT00123422|290257|P1|Overall Study|Lost to Follow-up|1
81073|NCT00123422|290255|P3|Overall Study|Withdrawal by Subject|2
81074|NCT00123422|290256|P2|Overall Study|Withdrawal by Subject|2
81075|NCT00123422|290257|P1|Overall Study|Withdrawal by Subject|1
81076|NCT00123422|290255|P3|Overall Study|Physician Decision|6
81077|NCT00123422|290256|P2|Overall Study|Physician Decision|2
81078|NCT00123422|290257|P1|Overall Study|Physician Decision|2
81079|NCT00123474|290272|P4|As Treated at Study Closure|Withdrawal by Subject|16
81080|NCT00123474|290273|P3|As Treated at Study Closure|Withdrawal by Subject|18
81081|NCT00123474|290274|P2|As Treated at Study Closure|Withdrawal by Subject|19
81082|NCT00123474|290275|P1|As Treated at Study Closure|Withdrawal by Subject|14
81083|NCT00123474|290272|P4|As Treated at Study Closure|Study Drug Toxicity|51
81084|NCT00123474|290273|P3|As Treated at Study Closure|Study Drug Toxicity|45
81085|NCT00123474|290274|P2|As Treated at Study Closure|Study Drug Toxicity|45
81086|NCT00123474|290275|P1|As Treated at Study Closure|Study Drug Toxicity|39
81087|NCT00123474|290272|P4|As Treated at Study Closure|non-specified|60
81088|NCT00123474|290273|P3|As Treated at Study Closure|non-specified|57
81089|NCT00123474|290274|P2|As Treated at Study Closure|non-specified|47
81090|NCT00123474|290275|P1|As Treated at Study Closure|non-specified|54
81091|NCT00123474|290272|P4|As Treated at Study Closure|Investigator Request|5
81092|NCT00123474|290273|P3|As Treated at Study Closure|Investigator Request|7
81093|NCT00123474|290274|P2|As Treated at Study Closure|Investigator Request|6
81094|NCT00123474|290275|P1|As Treated at Study Closure|Investigator Request|12
81095|NCT00123474|290272|P4|As Treated at Study Closure|Disease Progression|27
81096|NCT00123474|290273|P3|As Treated at Study Closure|Disease Progression|29
81097|NCT00123474|290274|P2|As Treated at Study Closure|Disease Progression|42
81098|NCT00123474|290275|P1|As Treated at Study Closure|Disease Progression|35
81099|NCT00123474|290272|P4|As Treated at Study Closure|Adverse Event|8
81100|NCT00123474|290273|P3|As Treated at Study Closure|Adverse Event|10
81101|NCT00123474|290274|P2|As Treated at Study Closure|Adverse Event|4
81102|NCT00123474|290275|P1|As Treated at Study Closure|Adverse Event|10
81103|NCT00123474|290272|P4|As Treated at Study Closure|not reported when site closed|0
81104|NCT00123474|290273|P3|As Treated at Study Closure|not reported when site closed|1
81105|NCT00123474|290274|P2|As Treated at Study Closure|not reported when site closed|0
81106|NCT00123474|290275|P1|As Treated at Study Closure|not reported when site closed|1
81107|NCT00123474|290272|P4|Randomized to Treatment|Randomized, never treated|1
81108|NCT00123474|290273|P3|Randomized to Treatment|Randomized, never treated|2
81109|NCT00123474|290274|P2|Randomized to Treatment|Randomized, never treated|4
81110|NCT00123474|290275|P1|Randomized to Treatment|Randomized, never treated|1
81111|NCT00123487|290368|P2|Treated With Study Drug|Unknown (case report form lost)|1
81112|NCT00123487|290369|P1|Treated With Study Drug|Unknown (case report form lost)|0
81113|NCT00123487|290368|P2|Treated With Study Drug|Withdrawal by Subject|13
81114|NCT00123487|290369|P1|Treated With Study Drug|Withdrawal by Subject|11
81115|NCT00123487|290368|P2|Treated With Study Drug|Study Drug Toxicity|80
81116|NCT00123487|290369|P1|Treated With Study Drug|Study Drug Toxicity|62
81117|NCT00123487|290368|P2|Treated With Study Drug|Not Specified|58
81118|NCT00123487|290369|P1|Treated With Study Drug|Not Specified|59
81119|NCT00123487|290368|P2|Treated With Study Drug|Physician Decision|9
81120|NCT00123487|290369|P1|Treated With Study Drug|Physician Decision|8
81121|NCT00123487|290368|P2|Treated With Study Drug|Disease Progression|122
81122|NCT00123487|290369|P1|Treated With Study Drug|Disease Progression|141
81123|NCT00123487|290368|P2|Treated With Study Drug|Adverse Event|22
81124|NCT00123487|290369|P1|Treated With Study Drug|Adverse Event|23
81125|NCT00123487|290368|P2|Randomized|SAE prior to starting treatment|0
81126|NCT00123487|290369|P1|Randomized|SAE prior to starting treatment|1
81127|NCT00123487|290368|P2|Randomized|Death prior to starting treatment|1
81128|NCT00123487|290369|P1|Randomized|Death prior to starting treatment|0
81129|NCT00123734|290461|P1|Overall Study|Withdrawal by Subject|1
81130|NCT00123734|290461|P1|Overall Study|Dropout|1
81131|NCT00123734|290461|P1|Overall Study|Lost to Follow-up|3
81132|NCT00123734|290461|P1|Overall Study|Death|3
81133|NCT00123955|290494|P2|Overall Study|Death|1
81134|NCT00123955|290495|P1|Overall Study|Death|0
81135|NCT00123955|290494|P2|Overall Study|Withdrawal by Subject|3
81136|NCT00123955|290495|P1|Overall Study|Withdrawal by Subject|4
81137|NCT00123955|290494|P2|Overall Study|Adverse Event|0
81138|NCT00123955|290495|P1|Overall Study|Adverse Event|1
81139|NCT00117156|290501|P1|Overall Study|Trt for Pre-Exist Second Primary|1
81140|NCT00117156|290501|P1|Overall Study|Physician Decision|1
81141|NCT00117156|290501|P1|Overall Study|Adverse Event|9
81142|NCT00117286|290511|P2|Overall Study|Research site closing|2
81143|NCT00117286|290512|P1|Overall Study|Research site closing|0
81144|NCT00117286|290511|P2|Overall Study|Lack of Efficacy|1
81145|NCT00117286|290512|P1|Overall Study|Lack of Efficacy|2
81146|NCT00117286|290511|P2|Overall Study|Physician Decision|7
81147|NCT00117286|290512|P1|Overall Study|Physician Decision|3
81148|NCT00117286|290511|P2|Overall Study|Withdrawal by Subject|2
81149|NCT00117286|290512|P1|Overall Study|Withdrawal by Subject|6
81150|NCT00117286|290511|P2|Overall Study|Protocol Violation|3
81151|NCT00117286|290512|P1|Overall Study|Protocol Violation|3
81152|NCT00117286|290511|P2|Overall Study|Lost to Follow-up|0
81153|NCT00117286|290512|P1|Overall Study|Lost to Follow-up|2
81154|NCT00117286|290511|P2|Overall Study|Adverse Event|6
81155|NCT00117286|290512|P1|Overall Study|Adverse Event|12
81156|NCT00117312|290524|P4|Overall Study|Withdrawal by Subject|0
81157|NCT00117312|290525|P3|Overall Study|Withdrawal by Subject|0
81158|NCT00117312|290526|P2|Overall Study|Withdrawal by Subject|2
81159|NCT00117312|290527|P1|Overall Study|Withdrawal by Subject|0
81160|NCT00117312|290524|P4|Overall Study|Hepatic abnormality|1
81161|NCT00117312|290525|P3|Overall Study|Hepatic abnormality|0
81162|NCT00117312|290526|P2|Overall Study|Hepatic abnormality|1
81163|NCT00117312|290527|P1|Overall Study|Hepatic abnormality|0
81164|NCT00117312|290524|P4|Overall Study|PSA increase >= 10ng/mL|0
81165|NCT00117312|290525|P3|Overall Study|PSA increase >= 10ng/mL|1
81166|NCT00117312|290526|P2|Overall Study|PSA increase >= 10ng/mL|1
81167|NCT00117312|290527|P1|Overall Study|PSA increase >= 10ng/mL|0
81168|NCT00117312|290524|P4|Overall Study|PSA decrease <=50%|4
81169|NCT00117312|290525|P3|Overall Study|PSA decrease <=50%|2
81170|NCT00117312|290526|P2|Overall Study|PSA decrease <=50%|2
81171|NCT00117312|290527|P1|Overall Study|PSA decrease <=50%|0
81172|NCT00117312|290524|P4|Overall Study|Protocol Violation|0
81173|NCT00117312|290525|P3|Overall Study|Protocol Violation|3
81174|NCT00117312|290526|P2|Overall Study|Protocol Violation|1
81175|NCT00117312|290527|P1|Overall Study|Protocol Violation|0
81176|NCT00117312|290524|P4|Overall Study|Adverse Event|0
81177|NCT00117312|290525|P3|Overall Study|Adverse Event|0
81178|NCT00117312|290526|P2|Overall Study|Adverse Event|2
81179|NCT00117312|290527|P1|Overall Study|Adverse Event|0
81180|NCT00117312|290524|P4|Overall Study|Patient choice|1
81181|NCT00117312|290525|P3|Overall Study|Patient choice|2
81182|NCT00117312|290526|P2|Overall Study|Patient choice|0
81183|NCT00117312|290527|P1|Overall Study|Patient choice|0
81184|NCT00117312|290524|P4|Overall Study|Not specified|1
81185|NCT00117312|290525|P3|Overall Study|Not specified|3
81186|NCT00117312|290526|P2|Overall Study|Not specified|1
81187|NCT00117312|290527|P1|Overall Study|Not specified|0
81188|NCT00117312|290524|P4|Overall Study|Prostate-specific antigen increase >=25%|3
81189|NCT00117312|290525|P3|Overall Study|Prostate-specific antigen increase >=25%|5
81190|NCT00117312|290526|P2|Overall Study|Prostate-specific antigen increase >=25%|1
81191|NCT00117312|290527|P1|Overall Study|Prostate-specific antigen increase >=25%|0
81192|NCT00117312|290524|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
81193|NCT00117312|290525|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
81194|NCT00117312|290526|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
81195|NCT00117312|290527|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
81196|NCT00117312|290524|P4|Overall Study|Testosterone >1.0 ng/mL|9
81197|NCT00117312|290525|P3|Overall Study|Testosterone >1.0 ng/mL|5
81198|NCT00117312|290526|P2|Overall Study|Testosterone >1.0 ng/mL|9
81199|NCT00117312|290527|P1|Overall Study|Testosterone >1.0 ng/mL|9
81200|NCT00117338|290543|P2|Overall Study|Lack of Efficacy|1
81201|NCT00117338|290544|P1|Overall Study|Lack of Efficacy|0
81202|NCT00117338|290543|P2|Overall Study|Did not meet Inclusion Criteria|0
81203|NCT00117338|290544|P1|Overall Study|Did not meet Inclusion Criteria|1
81204|NCT00117338|290543|P2|Overall Study|Withdrawal by Subject|0
81205|NCT00117338|290544|P1|Overall Study|Withdrawal by Subject|1
81206|NCT00117338|290543|P2|Overall Study|Protocol Violation|2
81207|NCT00117338|290544|P1|Overall Study|Protocol Violation|3
81208|NCT00117338|290543|P2|Overall Study|Adverse Event|1
81209|NCT00117338|290544|P1|Overall Study|Adverse Event|0
81210|NCT00117598|290578|P5|After Treament Cross Over|Unspecified|2
81211|NCT00117598|290579|P4|After Treament Cross Over|Unspecified|1
81212|NCT00117598|290580|P3|After Treament Cross Over|Unspecified|0
81213|NCT00117598|290581|P2|After Treament Cross Over|Unspecified|0
81214|NCT00117598|290582|P1|After Treament Cross Over|Unspecified|0
81215|NCT00117598|290578|P5|After Treament Cross Over|Withdrawal by Subject|0
81216|NCT00117598|290579|P4|After Treament Cross Over|Withdrawal by Subject|1
81217|NCT00117598|290580|P3|After Treament Cross Over|Withdrawal by Subject|0
81218|NCT00117598|290581|P2|After Treament Cross Over|Withdrawal by Subject|0
81219|NCT00117598|290582|P1|After Treament Cross Over|Withdrawal by Subject|0
81220|NCT00117598|290578|P5|After Treament Cross Over|Death|2
81221|NCT00117598|290579|P4|After Treament Cross Over|Death|1
81222|NCT00117598|290580|P3|After Treament Cross Over|Death|0
81223|NCT00117598|290581|P2|After Treament Cross Over|Death|0
81224|NCT00117598|290582|P1|After Treament Cross Over|Death|0
81225|NCT00117598|290578|P5|Prior to Treatment Cross Over|Unspecified|0
81226|NCT00117598|290579|P4|Prior to Treatment Cross Over|Unspecified|0
81227|NCT00117598|290580|P3|Prior to Treatment Cross Over|Unspecified|9
81228|NCT00117598|290581|P2|Prior to Treatment Cross Over|Unspecified|9
81229|NCT00117598|290582|P1|Prior to Treatment Cross Over|Unspecified|15
81230|NCT00117598|290578|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
81231|NCT00117598|290579|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
81232|NCT00117598|290580|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
81233|NCT00117598|290581|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
81234|NCT00117598|290582|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
81235|NCT00117598|290578|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
81236|NCT00117598|290579|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
81237|NCT00117598|290580|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
81238|NCT00117598|290581|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
81239|NCT00117598|290582|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
81240|NCT00117598|290578|P5|Prior to Treatment Cross Over|Death|0
81241|NCT00117598|290579|P4|Prior to Treatment Cross Over|Death|0
81242|NCT00117598|290580|P3|Prior to Treatment Cross Over|Death|37
81243|NCT00117598|290581|P2|Prior to Treatment Cross Over|Death|41
81244|NCT00117598|290582|P1|Prior to Treatment Cross Over|Death|40
81245|NCT00117637|290612|P2|Second Intervention (Period 2)|reason not reported|0
81246|NCT00117637|290613|P1|Second Intervention (Period 2)|reason not reported|1
81247|NCT00117637|290612|P2|Second Intervention (Period 2)|non compliant with study medication|1
81248|NCT00117637|290613|P1|Second Intervention (Period 2)|non compliant with study medication|1
81249|NCT00117637|290612|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
81250|NCT00117637|290613|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
81251|NCT00117637|290612|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
81252|NCT00117637|290613|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
81253|NCT00117637|290612|P2|Second Intervention (Period 2)|Protocol Violation|0
81254|NCT00117637|290613|P1|Second Intervention (Period 2)|Protocol Violation|1
81255|NCT00117637|290612|P2|Second Intervention (Period 2)|Lost to Follow-up|0
81256|NCT00117637|290613|P1|Second Intervention (Period 2)|Lost to Follow-up|1
81257|NCT00117637|290612|P2|Second Intervention (Period 2)|Adverse Event|9
81258|NCT00117637|290613|P1|Second Intervention (Period 2)|Adverse Event|0
81259|NCT00117637|290612|P2|First Intervention (Period 1)|reason not reported|1
81260|NCT00117637|290613|P1|First Intervention (Period 1)|reason not reported|0
81261|NCT00117637|290612|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
81262|NCT00117637|290613|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
81263|NCT00117637|290612|P2|First Intervention (Period 1)|protocol driven decision point|0
81264|NCT00117637|290613|P1|First Intervention (Period 1)|protocol driven decision point|1
81265|NCT00117637|290612|P2|First Intervention (Period 1)|study terminated by the sponsor|1
81266|NCT00117637|290613|P1|First Intervention (Period 1)|study terminated by the sponsor|3
81267|NCT00117637|290612|P2|First Intervention (Period 1)|Withdrawal by Subject|4
81268|NCT00117637|290613|P1|First Intervention (Period 1)|Withdrawal by Subject|2
81269|NCT00117637|290612|P2|First Intervention (Period 1)|Protocol Violation|0
81270|NCT00117637|290613|P1|First Intervention (Period 1)|Protocol Violation|1
81271|NCT00117637|290612|P2|First Intervention (Period 1)|Lost to Follow-up|2
81272|NCT00117637|290613|P1|First Intervention (Period 1)|Lost to Follow-up|0
81273|NCT00117637|290612|P2|First Intervention (Period 1)|Adverse Event|16
81274|NCT00117637|290613|P1|First Intervention (Period 1)|Adverse Event|11
81275|NCT00117676|290687|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
81276|NCT00117676|290688|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
81277|NCT00117676|290687|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
81278|NCT00117676|290688|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
81279|NCT00117676|290687|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
81280|NCT00117676|290688|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
81281|NCT00117676|290687|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
81282|NCT00117676|290688|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
81283|NCT00117676|290687|P2|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|1
81284|NCT00117676|290688|P1|Open-label Period: Weeks 385 - 432|Investigator’s Discretion|0
81285|NCT00117676|290687|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
81286|NCT00117676|290688|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
81287|NCT00117676|290687|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
81288|NCT00117676|290688|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
81289|NCT00117676|290687|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
81290|NCT00117676|290688|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
81291|NCT00117676|290687|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
81292|NCT00117676|290688|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
81293|NCT00117676|290687|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
81294|NCT00117676|290688|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
81295|NCT00117676|290687|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
81296|NCT00117676|290688|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
81297|NCT00117676|290687|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
81298|NCT00117676|290688|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
81299|NCT00117676|290687|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
81300|NCT00117676|290688|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
81301|NCT00117676|290687|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
81302|NCT00117676|290688|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
81303|NCT00117676|290687|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
81304|NCT00117676|290688|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
81305|NCT00117676|290687|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
81306|NCT00117676|290688|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
81307|NCT00117676|290687|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
81308|NCT00117676|290688|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
81309|NCT00117676|290687|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
81310|NCT00117676|290688|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
81311|NCT00117676|290687|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
81312|NCT00117676|290688|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
81313|NCT00117676|290687|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
81314|NCT00117676|290688|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
81315|NCT00117676|290687|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
81316|NCT00117676|290688|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
81317|NCT00117676|290687|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
81318|NCT00117676|290688|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
81319|NCT00117676|290687|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
81320|NCT00117676|290688|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
81321|NCT00117676|290687|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
81322|NCT00117676|290688|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
81323|NCT00117676|290687|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
81324|NCT00117676|290688|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
81325|NCT00117676|290687|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
81326|NCT00117676|290688|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
81327|NCT00117676|290687|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
81328|NCT00117676|290688|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
81329|NCT00117676|290687|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
81330|NCT00117676|290688|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
81331|NCT00117676|290687|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
81332|NCT00117676|290688|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
81333|NCT00117676|290687|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
81334|NCT00117676|290688|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
81335|NCT00117676|290687|P2|Double-blind Period Through Week 48|Withdrew Consent|1
81336|NCT00117676|290688|P1|Double-blind Period Through Week 48|Withdrew Consent|0
81337|NCT00117676|290687|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
81338|NCT00117676|290688|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
81339|NCT00117676|290687|P2|Double-blind Period Through Week 48|Protocol Violation|1
81340|NCT00117676|290688|P1|Double-blind Period Through Week 48|Protocol Violation|0
81341|NCT00117676|290687|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
81342|NCT00117676|290688|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
81343|NCT00117676|290687|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
81344|NCT00117676|290688|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
81345|NCT00117793|290781|P1|Overall Study|Withdrawal by Subject|12
81346|NCT00117845|290809|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
81347|NCT00117949|290818|P4|Overall Study|Hepatic abnormalities|1
81348|NCT00117949|290819|P3|Overall Study|Hepatic abnormalities|0
81349|NCT00117949|290820|P2|Overall Study|Hepatic abnormalities|1
81350|NCT00117949|290821|P1|Overall Study|Hepatic abnormalities|0
81351|NCT00117949|290818|P4|Overall Study|PSA reduction <=50%|4
81352|NCT00117949|290819|P3|Overall Study|PSA reduction <=50%|2
81353|NCT00117949|290820|P2|Overall Study|PSA reduction <=50%|2
81354|NCT00117949|290821|P1|Overall Study|PSA reduction <=50%|0
81355|NCT00117949|290818|P4|Overall Study|PSA increase >=10ng/mL|0
81356|NCT00117949|290819|P3|Overall Study|PSA increase >=10ng/mL|1
81357|NCT00117949|290820|P2|Overall Study|PSA increase >=10ng/mL|1
81358|NCT00117949|290821|P1|Overall Study|PSA increase >=10ng/mL|0
81359|NCT00117949|290818|P4|Overall Study|Prostate-specific antigen increase >=25%|2
81360|NCT00117949|290819|P3|Overall Study|Prostate-specific antigen increase >=25%|1
81361|NCT00117949|290820|P2|Overall Study|Prostate-specific antigen increase >=25%|1
81362|NCT00117949|290821|P1|Overall Study|Prostate-specific antigen increase >=25%|0
81363|NCT00117949|290818|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
81364|NCT00117949|290819|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
81365|NCT00117949|290820|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
81366|NCT00117949|290821|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
81367|NCT00117949|290818|P4|Overall Study|Testosterone >1.0 ng/mL|15
81368|NCT00117949|290819|P3|Overall Study|Testosterone >1.0 ng/mL|17
81369|NCT00117949|290820|P2|Overall Study|Testosterone >1.0 ng/mL|18
81370|NCT00117949|290821|P1|Overall Study|Testosterone >1.0 ng/mL|10
81371|NCT00117988|290870|P1|Overall Study|Adverse Event|1
81372|NCT00117988|290870|P1|Overall Study|Death|3
81373|NCT00118040|290877|P3|Overall Study|Other|1
81374|NCT00118040|290878|P2|Overall Study|Other|0
81375|NCT00118040|290879|P1|Overall Study|Other|0
81376|NCT00118040|290877|P3|Overall Study|Non-Compliant Participant|2
81377|NCT00118040|290878|P2|Overall Study|Non-Compliant Participant|1
81378|NCT00118040|290879|P1|Overall Study|Non-Compliant Participant|1
81379|NCT00118040|290877|P3|Overall Study|Medical Contraindication|1
81380|NCT00118040|290878|P2|Overall Study|Medical Contraindication|0
81381|NCT00118040|290879|P1|Overall Study|Medical Contraindication|0
81382|NCT00118040|290877|P3|Overall Study|Withdrawal by Subject|2
81383|NCT00118040|290878|P2|Overall Study|Withdrawal by Subject|0
81384|NCT00118040|290879|P1|Overall Study|Withdrawal by Subject|0
81385|NCT00118040|290877|P3|Overall Study|Adverse Event|0
81386|NCT00118040|290878|P2|Overall Study|Adverse Event|1
81387|NCT00118040|290879|P1|Overall Study|Adverse Event|0
81388|NCT00124020|290949|P2|Overall Study|Transfer to another hospital|0
81389|NCT00124020|290950|P1|Overall Study|Transfer to another hospital|2
81390|NCT00124020|290949|P2|Overall Study|Other|1
81391|NCT00124020|290950|P1|Overall Study|Other|1
81392|NCT00124020|290949|P2|Overall Study|Lost to Follow-up|8
81393|NCT00124020|290950|P1|Overall Study|Lost to Follow-up|5
81394|NCT00124020|290949|P2|Overall Study|Withdrawal by Subject|11
81395|NCT00124020|290950|P1|Overall Study|Withdrawal by Subject|13
81396|NCT00124020|290949|P2|Overall Study|Death|71
81397|NCT00124020|290950|P1|Overall Study|Death|67
81398|NCT00124072|290960|P4|Overall Study|Death|480
81399|NCT00124072|290961|P3|Overall Study|Death|471
81400|NCT00124072|290962|P2|Overall Study|Death|484
81401|NCT00124072|290963|P1|Overall Study|Death|499
81402|NCT00124072|290960|P4|Overall Study|Lost to Follow-up for Morbidity|18
81403|NCT00124072|290961|P3|Overall Study|Lost to Follow-up for Morbidity|19
81404|NCT00124072|290962|P2|Overall Study|Lost to Follow-up for Morbidity|25
81405|NCT00124072|290963|P1|Overall Study|Lost to Follow-up for Morbidity|15
81406|NCT00124072|290960|P4|Overall Study|Lost to Follow-up for Mortality|2
81407|NCT00124072|290961|P3|Overall Study|Lost to Follow-up for Mortality|2
81408|NCT00124072|290962|P2|Overall Study|Lost to Follow-up for Mortality|3
81409|NCT00124072|290963|P1|Overall Study|Lost to Follow-up for Mortality|0
81410|NCT00124618|290996|P1|Overall Study|Ineligible|1
81411|NCT00124657|291006|P3|Overall Study|Intercurrent illness|0
81412|NCT00124657|291007|P2|Overall Study|Intercurrent illness|0
81413|NCT00124657|291008|P1|Overall Study|Intercurrent illness|1
81414|NCT00124657|291006|P3|Overall Study|Progressive disease|27
81415|NCT00124657|291007|P2|Overall Study|Progressive disease|5
81416|NCT00124657|291008|P1|Overall Study|Progressive disease|14
81417|NCT00124657|291006|P3|Overall Study|Non-compliance|4
81418|NCT00124657|291007|P2|Overall Study|Non-compliance|0
81419|NCT00124657|291008|P1|Overall Study|Non-compliance|1
81420|NCT00124657|291006|P3|Overall Study|Toxicity|1
81421|NCT00124657|291007|P2|Overall Study|Toxicity|0
81422|NCT00124657|291008|P1|Overall Study|Toxicity|0
81423|NCT00124709|291045|P2|Overall Study|Lost to Follow-up|120
81424|NCT00124709|291046|P1|Overall Study|Lost to Follow-up|114
81425|NCT00124709|291045|P2|Overall Study|Withdrawal by Subject|136
81426|NCT00124709|291046|P1|Overall Study|Withdrawal by Subject|127
81427|NCT00124709|291045|P2|Overall Study|Protocol Violation|5
81428|NCT00124709|291046|P1|Overall Study|Protocol Violation|3
81429|NCT00124709|291045|P2|Overall Study|Lack of Efficacy|10
81430|NCT00124709|291046|P1|Overall Study|Lack of Efficacy|5
81431|NCT00124709|291045|P2|Overall Study|Adverse Event|0
81432|NCT00124709|291046|P1|Overall Study|Adverse Event|3
81433|NCT00124709|291045|P2|Overall Study|Randomized but did not take medication|1
81434|NCT00124709|291046|P1|Overall Study|Randomized but did not take medication|3
81435|NCT00124748|291125|P2|Overall Study|Death|3
81436|NCT00124748|291126|P1|Overall Study|Death|1
81437|NCT00124748|291125|P2|Overall Study|Administrative Problem(Study Terminated)|174
81438|NCT00124748|291126|P1|Overall Study|Administrative Problem(Study Terminated)|101
81439|NCT00124748|291125|P2|Overall Study|Lost to Follow-up|7
81440|NCT00124748|291126|P1|Overall Study|Lost to Follow-up|2
81441|NCT00124748|291125|P2|Overall Study|Withdrawal by Subject|15
81442|NCT00124748|291126|P1|Overall Study|Withdrawal by Subject|5
81443|NCT00124748|291125|P2|Overall Study|Protocol Violation|1
81444|NCT00124748|291126|P1|Overall Study|Protocol Violation|3
81445|NCT00124748|291125|P2|Overall Study|No longer requires study drug|1
81446|NCT00124748|291126|P1|Overall Study|No longer requires study drug|1
81447|NCT00124748|291125|P2|Overall Study|Lack of Efficacy|41
81448|NCT00124748|291126|P1|Overall Study|Lack of Efficacy|20
81449|NCT00124748|291125|P2|Overall Study|Abnormal Procedure|1
81450|NCT00124748|291126|P1|Overall Study|Abnormal Procedure|0
81451|NCT00124748|291125|P2|Overall Study|Abnormal laboratory Value|2
81452|NCT00124748|291126|P1|Overall Study|Abnormal laboratory Value|2
81453|NCT00124748|291125|P2|Overall Study|Adverse Event|39
81454|NCT00124748|291126|P1|Overall Study|Adverse Event|8
81455|NCT00124943|291172|P4|Phase II|Withdrawal by Subject|2
81456|NCT00124943|291173|P3|Phase II|Withdrawal by Subject|0
81457|NCT00124943|291174|P2|Phase II|Withdrawal by Subject|0
81458|NCT00124943|291175|P1|Phase II|Withdrawal by Subject|0
81459|NCT00124943|291172|P4|Phase II|Lost to Follow-up|1
81460|NCT00124943|291173|P3|Phase II|Lost to Follow-up|0
81461|NCT00124943|291174|P2|Phase II|Lost to Follow-up|0
81462|NCT00124943|291175|P1|Phase II|Lost to Follow-up|0
81463|NCT00124943|291172|P4|Phase II|Protocol Violation|1
81464|NCT00124943|291173|P3|Phase II|Protocol Violation|0
81465|NCT00124943|291174|P2|Phase II|Protocol Violation|0
81466|NCT00124943|291175|P1|Phase II|Protocol Violation|0
81467|NCT00124943|291172|P4|Phase II|Adverse Event|1
81468|NCT00124943|291173|P3|Phase II|Adverse Event|0
81469|NCT00124943|291174|P2|Phase II|Adverse Event|2
81470|NCT00124943|291175|P1|Phase II|Adverse Event|0
81471|NCT00124982|291215|P3|Long-term Period|Neurologist Recommendation|1
81472|NCT00124982|291216|P2|Long-term Period|Neurologist Recommendation|0
81473|NCT00124982|291217|P1|Long-term Period|Neurologist Recommendation|0
81474|NCT00124982|291215|P3|Long-term Period|Administrative Reason by Sponsor|1
81475|NCT00124982|291216|P2|Long-term Period|Administrative Reason by Sponsor|0
81476|NCT00124982|291217|P1|Long-term Period|Administrative Reason by Sponsor|0
81477|NCT00124982|291215|P3|Long-term Period|Poor/Non-compliance|2
81478|NCT00124982|291216|P2|Long-term Period|Poor/Non-compliance|0
81479|NCT00124982|291217|P1|Long-term Period|Poor/Non-compliance|0
81480|NCT00124982|291215|P3|Long-term Period|Pregnancy|1
81481|NCT00124982|291216|P2|Long-term Period|Pregnancy|0
81482|NCT00124982|291217|P1|Long-term Period|Pregnancy|0
81483|NCT00124982|291215|P3|Long-term Period|Withdrawal by Subject|16
81484|NCT00124982|291216|P2|Long-term Period|Withdrawal by Subject|0
81485|NCT00124982|291217|P1|Long-term Period|Withdrawal by Subject|0
81486|NCT00124982|291215|P3|Long-term Period|Lost to Follow-up|4
81487|NCT00124982|291216|P2|Long-term Period|Lost to Follow-up|0
81488|NCT00124982|291217|P1|Long-term Period|Lost to Follow-up|0
81489|NCT00124982|291215|P3|Long-term Period|Lack of Efficacy|46
81490|NCT00124982|291216|P2|Long-term Period|Lack of Efficacy|0
81491|NCT00124982|291217|P1|Long-term Period|Lack of Efficacy|0
81492|NCT00124982|291215|P3|Long-term Period|Adverse Event|17
81493|NCT00124982|291216|P2|Long-term Period|Adverse Event|0
81494|NCT00124982|291217|P1|Long-term Period|Adverse Event|0
81495|NCT00124982|291215|P3|Long-term Period|Death|1
81496|NCT00124982|291216|P2|Long-term Period|Death|0
81497|NCT00124982|291217|P1|Long-term Period|Death|0
81498|NCT00124982|291215|P3|Short-term Period|Participant Had Lymphopenia|0
81499|NCT00124982|291216|P2|Short-term Period|Participant Had Lymphopenia|0
81500|NCT00124982|291217|P1|Short-term Period|Participant Had Lymphopenia|1
81501|NCT00124982|291215|P3|Short-term Period|Investigator Decision-No Specific AE|0
81502|NCT00124982|291216|P2|Short-term Period|Investigator Decision-No Specific AE|0
81503|NCT00124982|291217|P1|Short-term Period|Investigator Decision-No Specific AE|1
81504|NCT00124982|291215|P3|Short-term Period|Participant Chose Own Doctor|0
81505|NCT00124982|291216|P2|Short-term Period|Participant Chose Own Doctor|1
81506|NCT00124982|291217|P1|Short-term Period|Participant Chose Own Doctor|0
81507|NCT00124982|291215|P3|Short-term Period|Participant Decision|0
81508|NCT00124982|291216|P2|Short-term Period|Participant Decision|0
81509|NCT00124982|291217|P1|Short-term Period|Participant Decision|1
81510|NCT00124982|291215|P3|Short-term Period|No Longer Meets Study Criteria|0
81511|NCT00124982|291216|P2|Short-term Period|No Longer Meets Study Criteria|2
81512|NCT00124982|291217|P1|Short-term Period|No Longer Meets Study Criteria|1
81513|NCT00124982|291215|P3|Short-term Period|Poor/Non-compliance|0
81514|NCT00124982|291216|P2|Short-term Period|Poor/Non-compliance|1
81515|NCT00124982|291217|P1|Short-term Period|Poor/Non-compliance|3
81516|NCT00124982|291215|P3|Short-term Period|Withdrawal of Consent|0
81517|NCT00124982|291216|P2|Short-term Period|Withdrawal of Consent|9
81518|NCT00124982|291217|P1|Short-term Period|Withdrawal of Consent|7
81519|NCT00124982|291215|P3|Short-term Period|Lost to Follow-up|0
81520|NCT00124982|291216|P2|Short-term Period|Lost to Follow-up|5
81521|NCT00124982|291217|P1|Short-term Period|Lost to Follow-up|8
81522|NCT00124982|291215|P3|Short-term Period|Lack of Efficacy|0
81523|NCT00124982|291216|P2|Short-term Period|Lack of Efficacy|73
81524|NCT00124982|291217|P1|Short-term Period|Lack of Efficacy|32
81525|NCT00124982|291215|P3|Short-term Period|Adverse Event|0
81526|NCT00124982|291216|P2|Short-term Period|Adverse Event|22
81527|NCT00124982|291217|P1|Short-term Period|Adverse Event|17
81528|NCT00124982|291215|P3|Short-term Period|Death|0
81529|NCT00124982|291216|P2|Short-term Period|Death|1
81530|NCT00124982|291217|P1|Short-term Period|Death|1
81531|NCT00125138|291332|P4|Overall Study|Sponsor decision-pt moved to assist care|1
81532|NCT00125138|291333|P3|Overall Study|Sponsor decision-pt moved to assist care|0
81533|NCT00125138|291334|P2|Overall Study|Sponsor decision-pt moved to assist care|0
81534|NCT00125138|291335|P1|Overall Study|Sponsor decision-pt moved to assist care|0
81535|NCT00125138|291332|P4|Overall Study|Lack of Efficacy|1
81536|NCT00125138|291333|P3|Overall Study|Lack of Efficacy|0
81537|NCT00125138|291334|P2|Overall Study|Lack of Efficacy|0
81538|NCT00125138|291335|P1|Overall Study|Lack of Efficacy|0
81539|NCT00125138|291332|P4|Overall Study|Withdrawal by Subject|1
81540|NCT00125138|291333|P3|Overall Study|Withdrawal by Subject|1
81541|NCT00125138|291334|P2|Overall Study|Withdrawal by Subject|3
81542|NCT00125138|291335|P1|Overall Study|Withdrawal by Subject|2
81543|NCT00125138|291332|P4|Overall Study|Adverse Event|2
81544|NCT00125138|291333|P3|Overall Study|Adverse Event|3
81545|NCT00125138|291334|P2|Overall Study|Adverse Event|0
81546|NCT00125138|291335|P1|Overall Study|Adverse Event|1
81547|NCT00125164|291353|P4|Overall Study|Withdrawal by Subject|1
81548|NCT00125164|291354|P3|Overall Study|Withdrawal by Subject|1
81549|NCT00125164|291355|P2|Overall Study|Withdrawal by Subject|0
81550|NCT00125164|291356|P1|Overall Study|Withdrawal by Subject|2
81551|NCT00125164|291353|P4|Overall Study|Lost to Follow-up|1
81552|NCT00125164|291354|P3|Overall Study|Lost to Follow-up|1
81553|NCT00125164|291355|P2|Overall Study|Lost to Follow-up|0
81554|NCT00125164|291356|P1|Overall Study|Lost to Follow-up|0
81555|NCT00125164|291353|P4|Overall Study|Adverse Event|4
81556|NCT00125164|291354|P3|Overall Study|Adverse Event|2
81557|NCT00125164|291355|P2|Overall Study|Adverse Event|0
81558|NCT00125164|291356|P1|Overall Study|Adverse Event|0
81559|NCT00125190|291406|P1|Overall Study|Non-compliance|2
81560|NCT00125190|291406|P1|Overall Study|other|1
81561|NCT00125190|291406|P1|Overall Study|Patient/Parent Decision|7
81562|NCT00125190|291406|P1|Overall Study|Lost to Follow-up|4
81563|NCT00125190|291406|P1|Overall Study|Adverse Event|1
81564|NCT00125242|291422|P2|Overall Study|did not qualify|2
81565|NCT00125242|291423|P1|Overall Study|did not qualify|7
81566|NCT00125268|291430|P2|Overall Study|Withdrawal by Subject|1
81567|NCT00125268|291431|P1|Overall Study|Withdrawal by Subject|1
81568|NCT00126126|291561|P2|Overall Study|Lost to Follow-up|2
81569|NCT00126126|291562|P1|Overall Study|Lost to Follow-up|0
81570|NCT00126191|291572|P2|Overall Study|Death|1
81571|NCT00126191|291573|P1|Overall Study|Death|0
81572|NCT00126191|291572|P2|Overall Study|Physician Decision|1
81573|NCT00126191|291573|P1|Overall Study|Physician Decision|0
81574|NCT00126425|291583|P2|Overall Study|Unspecified|0
81575|NCT00126425|291584|P1|Overall Study|Unspecified|5
81576|NCT00126425|291583|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
81577|NCT00126425|291584|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
81578|NCT00126425|291583|P2|Overall Study|Adverse Event|0
81579|NCT00126425|291584|P1|Overall Study|Adverse Event|1
81580|NCT00126425|291583|P2|Overall Study|Protocol Violation|6
81581|NCT00126425|291584|P1|Overall Study|Protocol Violation|9
81582|NCT00126425|291583|P2|Overall Study|Lost to Follow-up|4
81583|NCT00126425|291584|P1|Overall Study|Lost to Follow-up|8
81584|NCT00126425|291583|P2|Overall Study|Withdrawal by Subject|1
81585|NCT00126425|291584|P1|Overall Study|Withdrawal by Subject|17
81586|NCT00126438|291592|P2|Overall Study|Withdrawal by Subject|2
81587|NCT00126438|291593|P1|Overall Study|Withdrawal by Subject|3
81588|NCT00126438|291592|P2|Overall Study|Protocol Violation|8
81589|NCT00126438|291593|P1|Overall Study|Protocol Violation|8
81590|NCT00126438|291592|P2|Overall Study|Lost to Follow-up|0
81591|NCT00126438|291593|P1|Overall Study|Lost to Follow-up|22
81592|NCT00126438|291592|P2|Overall Study|Withdrawal due to adverse event|0
81593|NCT00126438|291593|P1|Overall Study|Withdrawal due to adverse event|1
81594|NCT00126490|291599|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
81595|NCT00126503|291609|P2|Overall Study|Physician Decision|1
81596|NCT00126503|291610|P1|Overall Study|Physician Decision|2
81597|NCT00126503|291609|P2|Overall Study|non-compliant|0
81598|NCT00126503|291610|P1|Overall Study|non-compliant|1
81599|NCT00126503|291609|P2|Overall Study|Adverse Event|3
81600|NCT00126503|291610|P1|Overall Study|Adverse Event|13
81601|NCT00126503|291609|P2|Overall Study|Death|0
81602|NCT00126503|291610|P1|Overall Study|Death|3
81603|NCT00126503|291609|P2|Overall Study|other complicating disease|1
81604|NCT00126503|291610|P1|Overall Study|other complicating disease|4
81605|NCT00126503|291609|P2|Overall Study|alternative therapy|1
81606|NCT00126503|291610|P1|Overall Study|alternative therapy|1
81607|NCT00126503|291609|P2|Overall Study|Withdrawal by Subject|1
81608|NCT00126503|291610|P1|Overall Study|Withdrawal by Subject|0
81609|NCT00126503|291609|P2|Overall Study|disease progression|14
81610|NCT00126503|291610|P1|Overall Study|disease progression|23
81611|NCT00126555|291622|P1|Overall Study|Progressive Disease|3
81612|NCT00126555|291622|P1|Overall Study|Adverse Event|2
81613|NCT00126555|291622|P1|Overall Study|Withdrawal by Subject|1
81614|NCT00126568|291636|P1|Overall Study|Death|2
81615|NCT00126581|291644|P2|Overall Study|Other illness/MD discretion|4
81616|NCT00126581|291645|P1|Overall Study|Other illness/MD discretion|3
81617|NCT00126581|291644|P2|Overall Study|Alternative therapy|3
81618|NCT00126581|291645|P1|Overall Study|Alternative therapy|3
81619|NCT00126581|291644|P2|Overall Study|Withdrawal by Subject|4
81620|NCT00126581|291645|P1|Overall Study|Withdrawal by Subject|1
81621|NCT00126581|291644|P2|Overall Study|Death|2
81622|NCT00126581|291645|P1|Overall Study|Death|3
81623|NCT00126581|291644|P2|Overall Study|Adverse Event|7
81624|NCT00126581|291645|P1|Overall Study|Adverse Event|3
81625|NCT00126594|291667|P2|Overall Study|Disease Progression|24
81626|NCT00126594|291668|P1|Overall Study|Disease Progression|29
81627|NCT00126594|291667|P2|Overall Study|Non-compliance|1
81628|NCT00126594|291668|P1|Overall Study|Non-compliance|0
81629|NCT00126594|291667|P2|Overall Study|Adverse Event|5
81630|NCT00126594|291668|P1|Overall Study|Adverse Event|7
81631|NCT00126594|291667|P2|Overall Study|Physician Decision|3
81632|NCT00126594|291668|P1|Overall Study|Physician Decision|1
81633|NCT00126594|291667|P2|Overall Study|Withdrawal by Subject|4
81634|NCT00126594|291668|P1|Overall Study|Withdrawal by Subject|0
81635|NCT00126594|291667|P2|Overall Study|Ineligible|0
81636|NCT00126594|291668|P1|Overall Study|Ineligible|2
81637|NCT00126659|291686|P3|Overall Study|Adverse Event|2
81638|NCT00126659|291687|P2|Overall Study|Adverse Event|0
81639|NCT00126659|291688|P1|Overall Study|Adverse Event|0
81640|NCT00126776|291738|P2|Overall Study|follow up complete on all patients|0
81641|NCT00126776|291739|P1|Overall Study|follow up complete on all patients|0
81642|NCT00127036|291745|P2|Overall Study|Screen Failure|0
81643|NCT00127036|291746|P1|Overall Study|Screen Failure|2
81644|NCT00127036|291745|P2|Overall Study|Insufficient Data for Analysis|11
81645|NCT00127036|291746|P1|Overall Study|Insufficient Data for Analysis|6
81646|NCT00127101|291762|P6|Continuation Phase|Withdrawal by Subject|1
81647|NCT00127101|291763|P5|Continuation Phase|Withdrawal by Subject|2
81648|NCT00127101|291764|P4|Continuation Phase|Withdrawal by Subject|0
81649|NCT00127101|291765|P3|Continuation Phase|Withdrawal by Subject|1
81650|NCT00127101|291766|P2|Continuation Phase|Withdrawal by Subject|0
81651|NCT00127101|291767|P1|Continuation Phase|Withdrawal by Subject|0
81652|NCT00127101|291762|P6|Continuation Phase|Lack of Efficacy|1
81653|NCT00127101|291763|P5|Continuation Phase|Lack of Efficacy|0
81654|NCT00127101|291764|P4|Continuation Phase|Lack of Efficacy|0
81655|NCT00127101|291765|P3|Continuation Phase|Lack of Efficacy|0
81656|NCT00127101|291766|P2|Continuation Phase|Lack of Efficacy|0
81657|NCT00127101|291767|P1|Continuation Phase|Lack of Efficacy|0
81658|NCT00127101|291762|P6|Continuation Phase|Adverse Event|1
81659|NCT00127101|291763|P5|Continuation Phase|Adverse Event|1
81660|NCT00127101|291764|P4|Continuation Phase|Adverse Event|0
81661|NCT00127101|291765|P3|Continuation Phase|Adverse Event|0
81662|NCT00127101|291766|P2|Continuation Phase|Adverse Event|0
81663|NCT00127101|291767|P1|Continuation Phase|Adverse Event|0
81664|NCT00127101|291762|P6|Base Protocol|Withdrawal by Subject|1
81665|NCT00127101|291763|P5|Base Protocol|Withdrawal by Subject|0
81666|NCT00127101|291764|P4|Base Protocol|Withdrawal by Subject|0
81667|NCT00127101|291765|P3|Base Protocol|Withdrawal by Subject|1
81668|NCT00127101|291766|P2|Base Protocol|Withdrawal by Subject|2
81669|NCT00127101|291767|P1|Base Protocol|Withdrawal by Subject|1
81670|NCT00127101|291762|P6|Base Protocol|Lack of Efficacy|0
81671|NCT00127101|291763|P5|Base Protocol|Lack of Efficacy|2
81672|NCT00127101|291764|P4|Base Protocol|Lack of Efficacy|0
81673|NCT00127101|291765|P3|Base Protocol|Lack of Efficacy|0
81674|NCT00127101|291766|P2|Base Protocol|Lack of Efficacy|0
81675|NCT00127101|291767|P1|Base Protocol|Lack of Efficacy|1
81676|NCT00127101|291762|P6|Base Protocol|Adverse Event|0
81677|NCT00127101|291763|P5|Base Protocol|Adverse Event|0
81678|NCT00127101|291764|P4|Base Protocol|Adverse Event|0
81679|NCT00127101|291765|P3|Base Protocol|Adverse Event|1
81680|NCT00127101|291766|P2|Base Protocol|Adverse Event|2
81681|NCT00127101|291767|P1|Base Protocol|Adverse Event|0
81682|NCT00121134|291791|P4|Overall Study|Patient Personal Reasons|0
81683|NCT00121134|291792|P3|Overall Study|Patient Personal Reasons|0
81684|NCT00121134|291793|P2|Overall Study|Patient Personal Reasons|1
81685|NCT00121134|291794|P1|Overall Study|Patient Personal Reasons|0
81686|NCT00121134|291791|P4|Overall Study|Intercurrent Illness|1
81687|NCT00121134|291792|P3|Overall Study|Intercurrent Illness|0
81688|NCT00121134|291793|P2|Overall Study|Intercurrent Illness|0
81689|NCT00121134|291794|P1|Overall Study|Intercurrent Illness|0
81690|NCT00121134|291791|P4|Overall Study|Treatment Delay|0
81691|NCT00121134|291792|P3|Overall Study|Treatment Delay|0
81692|NCT00121134|291793|P2|Overall Study|Treatment Delay|0
81693|NCT00121134|291794|P1|Overall Study|Treatment Delay|1
81694|NCT00121134|291791|P4|Overall Study|Physician Decision|1
81695|NCT00121134|291792|P3|Overall Study|Physician Decision|4
81696|NCT00121134|291793|P2|Overall Study|Physician Decision|4
81697|NCT00121134|291794|P1|Overall Study|Physician Decision|6
81698|NCT00121134|291791|P4|Overall Study|Toxicity|5
81699|NCT00121134|291792|P3|Overall Study|Toxicity|13
81700|NCT00121134|291793|P2|Overall Study|Toxicity|7
81701|NCT00121134|291794|P1|Overall Study|Toxicity|4
81702|NCT00121134|291791|P4|Overall Study|Progression of Disease|2
81703|NCT00121134|291792|P3|Overall Study|Progression of Disease|4
81704|NCT00121134|291793|P2|Overall Study|Progression of Disease|3
81705|NCT00121134|291794|P1|Overall Study|Progression of Disease|5
81706|NCT00121199|291809|P1|Overall Study|Ineligible|9
81707|NCT00121199|291809|P1|Overall Study|Other - Not Protocol Specified|3
81708|NCT00121199|291809|P1|Overall Study|Death|3
81709|NCT00121199|291809|P1|Overall Study|Progression/Relapse|1
81710|NCT00121199|291809|P1|Overall Study|Refusal Unrelated to Adverse Event|1
81711|NCT00121199|291809|P1|Overall Study|Adverse Event|11
81712|NCT00121238|291820|P1|Overall Study|Protocol Violation|2
81713|NCT00121238|291820|P1|Overall Study|disease progression before intervention|1
81714|NCT00127166|291830|P2|Period II|Patient did not perform Visit 6 exercise|0
81715|NCT00127166|291831|P1|Period II|Patient did not perform Visit 6 exercise|1
81716|NCT00127166|291830|P2|Period II|Withdrawal by Subject|0
81717|NCT00127166|291831|P1|Period II|Withdrawal by Subject|2
81718|NCT00127166|291830|P2|Washout Period|Patient did not meet inclusion criteria|1
81719|NCT00127166|291831|P1|Washout Period|Patient did not meet inclusion criteria|0
81720|NCT00127166|291830|P2|Period I|Patient did not meet inclusion criteria|0
81721|NCT00127166|291831|P1|Period I|Patient did not meet inclusion criteria|1
81722|NCT00127166|291830|P2|Period I|Withdrawal by Subject|0
81723|NCT00127166|291831|P1|Period I|Withdrawal by Subject|2
81724|NCT00127166|291830|P2|Period I|Protocol Violation|2
81725|NCT00127166|291831|P1|Period I|Protocol Violation|0
81726|NCT00127192|291850|P5|Overall Study|Adverse event in pre-treatment period|0
81727|NCT00127192|291851|P4|Overall Study|Adverse event in pre-treatment period|0
81728|NCT00127192|291852|P3|Overall Study|Adverse event in pre-treatment period|0
81729|NCT00127192|291853|P2|Overall Study|Adverse event in pre-treatment period|0
81730|NCT00127192|291854|P1|Overall Study|Adverse event in pre-treatment period|1
81731|NCT00127192|291850|P5|Overall Study|Withdrawal by Subject|3
81732|NCT00127192|291851|P4|Overall Study|Withdrawal by Subject|0
81733|NCT00127192|291852|P3|Overall Study|Withdrawal by Subject|1
81734|NCT00127192|291853|P2|Overall Study|Withdrawal by Subject|0
81735|NCT00127192|291854|P1|Overall Study|Withdrawal by Subject|0
81736|NCT00127192|291850|P5|Overall Study|Lack of Efficacy|2
81737|NCT00127192|291851|P4|Overall Study|Lack of Efficacy|0
81738|NCT00127192|291852|P3|Overall Study|Lack of Efficacy|0
81739|NCT00127192|291853|P2|Overall Study|Lack of Efficacy|0
81740|NCT00127192|291854|P1|Overall Study|Lack of Efficacy|2
81741|NCT00127192|291850|P5|Overall Study|Adverse Event|0
81742|NCT00127192|291851|P4|Overall Study|Adverse Event|1
81743|NCT00127192|291852|P3|Overall Study|Adverse Event|1
81744|NCT00127192|291853|P2|Overall Study|Adverse Event|1
81745|NCT00127192|291854|P1|Overall Study|Adverse Event|0
81746|NCT00127413|291889|P4|Overall Study|Lost to Follow-up|2
81747|NCT00127413|291890|P3|Overall Study|Lost to Follow-up|8
81748|NCT00127413|291891|P2|Overall Study|Lost to Follow-up|4
81749|NCT00127413|291892|P1|Overall Study|Lost to Follow-up|6
81750|NCT00129220|291905|P3|Study Period III|Reason Not Specified|2
81751|NCT00129220|291906|P2|Study Period III|Reason Not Specified|0
81752|NCT00129220|291907|P1|Study Period III|Reason Not Specified|9
81753|NCT00129220|291905|P3|Study Period III|Sponsor Decision|0
81754|NCT00129220|291906|P2|Study Period III|Sponsor Decision|0
81755|NCT00129220|291907|P1|Study Period III|Sponsor Decision|1
81756|NCT00129220|291905|P3|Study Period III|Withdrawal by Subject|3
81757|NCT00129220|291906|P2|Study Period III|Withdrawal by Subject|0
81758|NCT00129220|291907|P1|Study Period III|Withdrawal by Subject|1
81759|NCT00129220|291905|P3|Study Period III|Protocol Violation|2
81760|NCT00129220|291906|P2|Study Period III|Protocol Violation|1
81761|NCT00129220|291907|P1|Study Period III|Protocol Violation|1
81762|NCT00129220|291905|P3|Study Period III|Adverse Event|3
81763|NCT00129220|291906|P2|Study Period III|Adverse Event|0
81764|NCT00129220|291907|P1|Study Period III|Adverse Event|1
81765|NCT00129220|291905|P3|Study Period II|Reason Not Specified|5
81766|NCT00129220|291906|P2|Study Period II|Reason Not Specified|0
81767|NCT00129220|291907|P1|Study Period II|Reason Not Specified|2
81768|NCT00129220|291905|P3|Study Period II|Withdrawal by Subject|4
81769|NCT00129220|291906|P2|Study Period II|Withdrawal by Subject|3
81770|NCT00129220|291907|P1|Study Period II|Withdrawal by Subject|1
81771|NCT00129220|291905|P3|Study Period II|Physician Decision|0
81772|NCT00129220|291906|P2|Study Period II|Physician Decision|1
81773|NCT00129220|291907|P1|Study Period II|Physician Decision|0
81774|NCT00129220|291905|P3|Study Period II|Protocol Violation|1
81775|NCT00129220|291906|P2|Study Period II|Protocol Violation|2
81776|NCT00129220|291907|P1|Study Period II|Protocol Violation|4
81777|NCT00129220|291905|P3|Study Period II|Entry Criteria Not Met|2
81778|NCT00129220|291906|P2|Study Period II|Entry Criteria Not Met|0
81779|NCT00129220|291907|P1|Study Period II|Entry Criteria Not Met|2
81780|NCT00129220|291905|P3|Study Period II|Lack of Efficacy|28
81781|NCT00129220|291906|P2|Study Period II|Lack of Efficacy|1
81782|NCT00129220|291907|P1|Study Period II|Lack of Efficacy|15
81783|NCT00129220|291905|P3|Study Period II|Adverse Event|7
81784|NCT00129220|291906|P2|Study Period II|Adverse Event|5
81785|NCT00129220|291907|P1|Study Period II|Adverse Event|9
81786|NCT00129259|291961|P2|Overall Study|Only available minimal phone assessments|1
81787|NCT00129259|291962|P1|Overall Study|Only available minimal phone assessments|0
81788|NCT00129259|291961|P2|Overall Study|Withdrawal by Subject|1
81789|NCT00129259|291962|P1|Overall Study|Withdrawal by Subject|2
81790|NCT00129259|291961|P2|Overall Study|Lost to Follow-up|1
81791|NCT00129259|291962|P1|Overall Study|Lost to Follow-up|1
81792|NCT00129272|291974|P2|Overall Study|Withdrawal by Subject|11
81793|NCT00129272|291975|P1|Overall Study|Withdrawal by Subject|5
81794|NCT00129272|291974|P2|Overall Study|Lost to Follow-up|11
81795|NCT00129272|291975|P1|Overall Study|Lost to Follow-up|12
81796|NCT00129311|291985|P2|Overall Study|Withdrawal by Subject|19
81797|NCT00129311|291986|P1|Overall Study|Withdrawal by Subject|12
81798|NCT00129402|291996|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
81799|NCT00129402|291997|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
81800|NCT00129402|291998|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
81801|NCT00129402|291999|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
81802|NCT00129402|292000|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
81803|NCT00129402|292001|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
81804|NCT00129402|292002|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
81805|NCT00129402|291996|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
81806|NCT00129402|291997|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
81807|NCT00129402|291998|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
81808|NCT00129402|291999|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
81809|NCT00129402|292000|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
81810|NCT00129402|292001|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
81811|NCT00129402|292002|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
81812|NCT00129402|291996|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
81813|NCT00129402|291997|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
81814|NCT00129402|291998|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
81815|NCT00129402|291999|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
81816|NCT00129402|292000|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
81817|NCT00129402|292001|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
81818|NCT00129402|292002|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
81819|NCT00129402|291996|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
81820|NCT00129402|291997|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
81821|NCT00129402|291998|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
81822|NCT00129402|291999|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
81823|NCT00129402|292000|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
81824|NCT00129402|292001|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
81825|NCT00129402|292002|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
81826|NCT00129402|291996|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
81827|NCT00129402|291997|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
81828|NCT00129402|291998|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
81829|NCT00129402|291999|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
81830|NCT00129402|292000|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
81831|NCT00129402|292001|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
81832|NCT00129402|292002|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
81833|NCT00129402|291996|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
81834|NCT00129402|291997|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
81835|NCT00129402|291998|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
81836|NCT00129402|291999|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
81837|NCT00129402|292000|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
81838|NCT00129402|292001|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
81839|NCT00129402|292002|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
81840|NCT00129402|291996|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
81841|NCT00129402|291997|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
81842|NCT00129402|291998|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
81843|NCT00129402|291999|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
81844|NCT00129402|292000|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
81845|NCT00129402|292001|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
81846|NCT00129402|292002|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
81847|NCT00129402|291996|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
81848|NCT00129402|291997|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
81849|NCT00129402|291998|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
81850|NCT00129402|291999|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
81851|NCT00129402|292000|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
81852|NCT00129402|292001|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
81853|NCT00129402|292002|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
81854|NCT00129402|291996|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
81855|NCT00129402|291997|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
81856|NCT00129402|291998|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
81857|NCT00129402|291999|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
81858|NCT00129402|292000|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
81859|NCT00129402|292001|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
81860|NCT00129402|292002|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
81861|NCT00129402|291996|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
81862|NCT00129402|291997|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
81863|NCT00129402|291998|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
81864|NCT00129402|291999|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
81865|NCT00129402|292000|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
81866|NCT00129402|292001|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
81867|NCT00129402|292002|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
81868|NCT00129402|291996|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
81869|NCT00129402|291997|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
81870|NCT00129402|291998|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
81871|NCT00129402|291999|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
81872|NCT00129402|292000|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
81873|NCT00129402|292001|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
81874|NCT00129402|292002|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
81875|NCT00129402|291996|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
81876|NCT00129402|291997|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
81877|NCT00129402|291998|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
81878|NCT00129402|291999|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
81879|NCT00129402|292000|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
81880|NCT00129402|292001|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
81881|NCT00129402|292002|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
81882|NCT00129402|291996|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
81883|NCT00129402|291997|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
81884|NCT00129402|291998|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
81885|NCT00129402|291999|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
81886|NCT00129402|292000|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
81887|NCT00129402|292001|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
81888|NCT00129402|292002|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
81889|NCT00129467|292044|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
81890|NCT00129467|292045|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
81891|NCT00129467|292044|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
81892|NCT00129467|292045|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
81893|NCT00129467|292044|P2|Received Intervention|Dizzyness, fatigue|1
81894|NCT00129467|292045|P1|Received Intervention|Dizzyness, fatigue|0
81895|NCT00129467|292044|P2|Received Intervention|Intolerance to citalopram|1
81896|NCT00129467|292045|P1|Received Intervention|Intolerance to citalopram|0
81897|NCT00129467|292044|P2|Received Intervention|Nausea|0
81898|NCT00129467|292045|P1|Received Intervention|Nausea|1
81899|NCT00129467|292044|P2|Received Intervention|Withdrawal by Subject|0
81900|NCT00129467|292045|P1|Received Intervention|Withdrawal by Subject|1
81901|NCT00129467|292044|P2|Received Intervention|Delirium|0
81902|NCT00129467|292045|P1|Received Intervention|Delirium|2
81903|NCT00129467|292044|P2|Received Intervention|Cardiac SAE (hypertension)|1
81904|NCT00129467|292045|P1|Received Intervention|Cardiac SAE (hypertension)|1
81905|NCT00129467|292044|P2|Received Intervention|Death|1
81906|NCT00129467|292045|P1|Received Intervention|Death|1
81907|NCT00129545|292063|P3|Overall Study|Device not implanted|0
81908|NCT00129545|292064|P2|Overall Study|Device not implanted|61
81909|NCT00129545|292065|P1|Overall Study|Device not implanted|16
81910|NCT00129545|292063|P3|Overall Study|Physician Decision|10
81911|NCT00129545|292064|P2|Overall Study|Physician Decision|3
81912|NCT00129545|292065|P1|Overall Study|Physician Decision|0
81913|NCT00129545|292063|P3|Overall Study|Lost to Follow-up|13
81914|NCT00129545|292064|P2|Overall Study|Lost to Follow-up|22
81915|NCT00129545|292065|P1|Overall Study|Lost to Follow-up|2
81916|NCT00129545|292063|P3|Overall Study|Withdrawal by Subject|44
81917|NCT00129545|292064|P2|Overall Study|Withdrawal by Subject|18
81918|NCT00129545|292065|P1|Overall Study|Withdrawal by Subject|3
81919|NCT00129545|292063|P3|Overall Study|Death|44
81920|NCT00129545|292064|P2|Overall Study|Death|60
81921|NCT00129545|292065|P1|Overall Study|Death|5
81922|NCT00129623|292077|P2|Overall Study|Uncertainty to return|1
81923|NCT00129623|292078|P1|Overall Study|Uncertainty to return|0
81924|NCT00129623|292077|P2|Overall Study|Relocated job out of state|0
81925|NCT00129623|292078|P1|Overall Study|Relocated job out of state|1
81926|NCT00129623|292077|P2|Overall Study|Failure to Return|1
81927|NCT00129623|292078|P1|Overall Study|Failure to Return|1
81928|NCT00129623|292077|P2|Overall Study|Refused Treatment|3
81929|NCT00129623|292078|P1|Overall Study|Refused Treatment|5
81930|NCT00129623|292077|P2|Overall Study|Adverse Event|7
81931|NCT00129623|292078|P1|Overall Study|Adverse Event|3
81932|NCT00129766|292108|P2|Overall Study|Lost to Follow-up|21
81933|NCT00129766|292109|P1|Overall Study|Lost to Follow-up|26
81934|NCT00129766|292108|P2|Overall Study|Withdrawal of consent|30
81935|NCT00129766|292109|P1|Overall Study|Withdrawal of consent|31
81936|NCT00129766|292108|P2|Overall Study|Death|8
81937|NCT00129766|292109|P1|Overall Study|Death|3
81938|NCT00129961|292149|P2|Overall Study|Missing Record|1
81939|NCT00129961|292150|P1|Overall Study|Missing Record|0
81940|NCT00129961|292149|P2|Overall Study|Withdrawal by Subject|1
81941|NCT00129961|292150|P1|Overall Study|Withdrawal by Subject|2
81942|NCT00129961|292149|P2|Overall Study|Physician Decision|0
81943|NCT00129961|292150|P1|Overall Study|Physician Decision|1
81944|NCT00129961|292149|P2|Overall Study|Withdrawal by Sponsor|20
81945|NCT00129961|292150|P1|Overall Study|Withdrawal by Sponsor|14
81946|NCT00129961|292149|P2|Overall Study|Death|1
81947|NCT00129961|292150|P1|Overall Study|Death|1
81948|NCT00129961|292149|P2|Overall Study|Adverse Event|0
81949|NCT00129961|292150|P1|Overall Study|Adverse Event|1
81950|NCT00129974|292184|P1|Overall Study|Other|1
81951|NCT00130039|292191|P2|Overall Study|clinical events without follow up MRI|4
81952|NCT00130039|292192|P1|Overall Study|clinical events without follow up MRI|5
81953|NCT00130039|292191|P2|Overall Study|Physician Decision|0
81954|NCT00130039|292192|P1|Overall Study|Physician Decision|3
81955|NCT00130039|292191|P2|Overall Study|Adverse Event|2
81956|NCT00130039|292192|P1|Overall Study|Adverse Event|4
81957|NCT00130039|292191|P2|Overall Study|Lost to Follow-up|1
81958|NCT00130039|292192|P1|Overall Study|Lost to Follow-up|3
81959|NCT00130039|292191|P2|Overall Study|Withdrawal by Subject|11
81960|NCT00130039|292192|P1|Overall Study|Withdrawal by Subject|15
81961|NCT00130247|292234|P2|Overall Study|Not compliant with DOT|2
81962|NCT00130247|292235|P1|Overall Study|Not compliant with DOT|0
81963|NCT00130247|292234|P2|Overall Study|Post-randomization exclusion|2
81964|NCT00130247|292235|P1|Overall Study|Post-randomization exclusion|1
81965|NCT00130247|292234|P2|Overall Study|Pregnancy|0
81966|NCT00130247|292235|P1|Overall Study|Pregnancy|1
81967|NCT00130286|292255|P4|Overall Study|Missing lab specimens|0
81968|NCT00130286|292256|P3|Overall Study|Missing lab specimens|0
81969|NCT00130286|292257|P2|Overall Study|Missing lab specimens|2
81970|NCT00130286|292258|P1|Overall Study|Missing lab specimens|0
81971|NCT00130286|292255|P4|Overall Study|Adverse Event|0
81972|NCT00130286|292256|P3|Overall Study|Adverse Event|2
81973|NCT00130286|292257|P2|Overall Study|Adverse Event|0
81974|NCT00130286|292258|P1|Overall Study|Adverse Event|0
81975|NCT00130286|292255|P4|Overall Study|Withdrawal by Subject|2
81976|NCT00130286|292256|P3|Overall Study|Withdrawal by Subject|2
81977|NCT00130286|292257|P2|Overall Study|Withdrawal by Subject|1
81978|NCT00130286|292258|P1|Overall Study|Withdrawal by Subject|0
81979|NCT00130520|292276|P1|Overall Study|Did not meet re-treatment criteria|1
81980|NCT00130520|292276|P1|Overall Study|Protocol non-compliance|1
81981|NCT00130520|292276|P1|Overall Study|Disease Progression|23
81982|NCT00130520|292276|P1|Overall Study|Withdrawal by Subject|1
81983|NCT00130520|292276|P1|Overall Study|Physician Decision|1
81984|NCT00130520|292276|P1|Overall Study|Death|1
81985|NCT00130520|292276|P1|Overall Study|Adverse Event|11
81986|NCT00130637|292282|P1|Overall Study|Withdrawal by Subject|1
81987|NCT00130637|292282|P1|Overall Study|Adverse Event|2
81988|NCT00130689|292287|P1|Overall Study|Ineligible|6
81989|NCT00130689|292287|P1|Overall Study|Withdrawal by Subject|3
81990|NCT00130689|292287|P1|Overall Study|Clinical Deterioration|4
81991|NCT00130689|292287|P1|Overall Study|Death|1
81992|NCT00130689|292287|P1|Overall Study|Progressive Disease|29
81993|NCT00130728|292293|P2|Overall Study|Withdrawal by Subject|2
81994|NCT00130728|292294|P1|Overall Study|Withdrawal by Subject|0
81995|NCT00130728|292293|P2|Overall Study|Lost to Follow-up|0
81996|NCT00130728|292294|P1|Overall Study|Lost to Follow-up|4
81997|NCT00130728|292293|P2|Overall Study|Death|211
81998|NCT00130728|292294|P1|Overall Study|Death|207
81999|NCT00130793|292317|P2|Overall Study|Withdrew consent|0
82000|NCT00130793|292318|P1|Overall Study|Withdrew consent|2
82001|NCT00130793|292317|P2|Overall Study|Lost to Follow-up|4
82002|NCT00130793|292318|P1|Overall Study|Lost to Follow-up|1
82003|NCT00130832|292330|P2|Overall Study|Unspecified|3
82004|NCT00130832|292331|P1|Overall Study|Unspecified|0
82005|NCT00130832|292330|P2|Overall Study|Moved|2
82006|NCT00130832|292331|P1|Overall Study|Moved|2
82007|NCT00130832|292330|P2|Overall Study|Withdrawal by Subject|1
82008|NCT00130832|292331|P1|Overall Study|Withdrawal by Subject|6
82009|NCT00130832|292330|P2|Overall Study|Protocol Violation|8
82010|NCT00130832|292331|P1|Overall Study|Protocol Violation|6
82011|NCT00130832|292330|P2|Overall Study|Lost to Follow-up|2
82012|NCT00130832|292331|P1|Overall Study|Lost to Follow-up|1
82013|NCT00130832|292330|P2|Overall Study|Adverse Event|1
82014|NCT00130832|292331|P1|Overall Study|Adverse Event|1
82015|NCT00131248|292350|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
82016|NCT00131248|292351|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
82017|NCT00131352|292359|P2|Repeat Treatment Period|Unspecified|0
82018|NCT00131352|292360|P1|Repeat Treatment Period|Unspecified|1
82019|NCT00131352|292359|P2|Repeat Treatment Period|Adverse Event|0
82020|NCT00131352|292360|P1|Repeat Treatment Period|Adverse Event|1
82021|NCT00131352|292359|P2|Initial Treatment Period|Unspecified|2
82022|NCT00131352|292360|P1|Initial Treatment Period|Unspecified|0
82023|NCT00131352|292359|P2|Initial Treatment Period|Lack of Efficacy|4
82024|NCT00131352|292360|P1|Initial Treatment Period|Lack of Efficacy|6
82025|NCT00131352|292359|P2|Initial Treatment Period|Withdrawal by Subject|1
82026|NCT00131352|292360|P1|Initial Treatment Period|Withdrawal by Subject|1
82027|NCT00131352|292359|P2|Initial Treatment Period|Non-compliant|2
82028|NCT00131352|292360|P1|Initial Treatment Period|Non-compliant|1
82029|NCT00131352|292359|P2|Initial Treatment Period|Adverse Event|3
82030|NCT00131352|292360|P1|Initial Treatment Period|Adverse Event|1
82031|NCT00131508|292422|P2|Overall Study|Withdrawal by Subject|2
82032|NCT00131508|292423|P1|Overall Study|Withdrawal by Subject|1
82033|NCT00131508|292422|P2|Overall Study|Non-Compliance|4
82034|NCT00131508|292423|P1|Overall Study|Non-Compliance|2
82035|NCT00131508|292422|P2|Overall Study|Disease progression|2
82036|NCT00131508|292423|P1|Overall Study|Disease progression|0
82037|NCT00124449|292458|P2|18-Month Untreated Observation Period|Relocated|0
82038|NCT00124449|292459|P1|18-Month Untreated Observation Period|Relocated|1
82039|NCT00124449|292458|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
82040|NCT00124449|292459|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
82041|NCT00124449|292458|P2|18-Month Untreated Observation Period|Pregnancy|0
82042|NCT00124449|292459|P1|18-Month Untreated Observation Period|Pregnancy|1
82043|NCT00124449|292458|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
82044|NCT00124449|292459|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
82045|NCT00124449|292458|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
82046|NCT00124449|292459|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
82047|NCT00124449|292458|P2|18-Month Untreated Observation Period|Adverse Event|1
82048|NCT00124449|292459|P1|18-Month Untreated Observation Period|Adverse Event|0
82049|NCT00124449|292458|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
82050|NCT00124449|292459|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
82051|NCT00124449|292458|P2|6-month Double-Blind Treatment Period|Sponsor request|1
82052|NCT00124449|292459|P1|6-month Double-Blind Treatment Period|Sponsor request|0
82053|NCT00124449|292458|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
82054|NCT00124449|292459|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
82055|NCT00124449|292458|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
82056|NCT00124449|292459|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
82057|NCT00124449|292458|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
82058|NCT00124449|292459|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
82059|NCT00124449|292458|P2|6-month Double-Blind Treatment Period|Adverse Event|0
82060|NCT00124449|292459|P1|6-month Double-Blind Treatment Period|Adverse Event|1
82061|NCT00124462|292494|P2|Overall Study|Device fitting, n=2, other hlth issues|1
82062|NCT00124462|292495|P1|Overall Study|Device fitting, n=2, other hlth issues|1
82063|NCT00124462|292494|P2|Overall Study|Withdrawal by Subject|5
82064|NCT00124462|292495|P1|Overall Study|Withdrawal by Subject|4
82065|NCT00124462|292494|P2|Overall Study|Physician Decision|4
82066|NCT00124462|292495|P1|Overall Study|Physician Decision|3
82067|NCT00124462|292494|P2|Overall Study|Lost to Follow-up|3
82068|NCT00124462|292495|P1|Overall Study|Lost to Follow-up|3
82069|NCT00131664|292506|P6|Second Period (Additional Drug Added)|Administrative reasons|0
82070|NCT00131664|292507|P5|Second Period (Additional Drug Added)|Administrative reasons|1
82071|NCT00131664|292508|P4|Second Period (Additional Drug Added)|Administrative reasons|0
82072|NCT00131664|292509|P3|Second Period (Additional Drug Added)|Administrative reasons|0
82073|NCT00131664|292510|P2|Second Period (Additional Drug Added)|Administrative reasons|2
82074|NCT00131664|292511|P1|Second Period (Additional Drug Added)|Administrative reasons|4
82075|NCT00131664|292506|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
82076|NCT00131664|292507|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
82077|NCT00131664|292508|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
82078|NCT00131664|292509|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
82079|NCT00131664|292510|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
82080|NCT00131664|292511|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
82081|NCT00131664|292506|P6|Second Period (Additional Drug Added)|Adverse Event|1
82082|NCT00131664|292507|P5|Second Period (Additional Drug Added)|Adverse Event|0
82083|NCT00131664|292508|P4|Second Period (Additional Drug Added)|Adverse Event|0
82084|NCT00131664|292509|P3|Second Period (Additional Drug Added)|Adverse Event|0
82085|NCT00131664|292510|P2|Second Period (Additional Drug Added)|Adverse Event|1
82086|NCT00131664|292511|P1|Second Period (Additional Drug Added)|Adverse Event|0
82087|NCT00131664|292506|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
82088|NCT00131664|292507|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
82089|NCT00131664|292508|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
82090|NCT00131664|292509|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
82091|NCT00131664|292510|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
82092|NCT00131664|292511|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
82093|NCT00131664|292506|P6|Second Period (Additional Drug Added)|Protocol Violation|0
82094|NCT00131664|292507|P5|Second Period (Additional Drug Added)|Protocol Violation|0
82095|NCT00131664|292508|P4|Second Period (Additional Drug Added)|Protocol Violation|0
82096|NCT00131664|292509|P3|Second Period (Additional Drug Added)|Protocol Violation|1
82097|NCT00131664|292510|P2|Second Period (Additional Drug Added)|Protocol Violation|1
82098|NCT00131664|292511|P1|Second Period (Additional Drug Added)|Protocol Violation|0
82099|NCT00131664|292506|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
82100|NCT00131664|292507|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
82101|NCT00131664|292508|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
82102|NCT00131664|292509|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
82103|NCT00131664|292510|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
82104|NCT00131664|292511|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
82105|NCT00131664|292506|P6|First Period (First 6 Months)|Administrative reasons|0
82106|NCT00131664|292507|P5|First Period (First 6 Months)|Administrative reasons|0
82107|NCT00131664|292508|P4|First Period (First 6 Months)|Administrative reasons|0
82108|NCT00131664|292509|P3|First Period (First 6 Months)|Administrative reasons|5
82109|NCT00131664|292510|P2|First Period (First 6 Months)|Administrative reasons|0
82110|NCT00131664|292511|P1|First Period (First 6 Months)|Administrative reasons|2
82111|NCT00131664|292506|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
82112|NCT00131664|292507|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
82113|NCT00131664|292508|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
82114|NCT00131664|292509|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
82115|NCT00131664|292510|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
82116|NCT00131664|292511|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
82117|NCT00131664|292506|P6|First Period (First 6 Months)|Adverse Event|0
82118|NCT00131664|292507|P5|First Period (First 6 Months)|Adverse Event|0
82119|NCT00131664|292508|P4|First Period (First 6 Months)|Adverse Event|0
82120|NCT00131664|292509|P3|First Period (First 6 Months)|Adverse Event|5
82121|NCT00131664|292510|P2|First Period (First 6 Months)|Adverse Event|4
82122|NCT00131664|292511|P1|First Period (First 6 Months)|Adverse Event|9
82123|NCT00131664|292506|P6|First Period (First 6 Months)|Withdrawal by Subject|0
82124|NCT00131664|292507|P5|First Period (First 6 Months)|Withdrawal by Subject|0
82125|NCT00131664|292508|P4|First Period (First 6 Months)|Withdrawal by Subject|0
82126|NCT00131664|292509|P3|First Period (First 6 Months)|Withdrawal by Subject|2
82127|NCT00131664|292510|P2|First Period (First 6 Months)|Withdrawal by Subject|6
82128|NCT00131664|292511|P1|First Period (First 6 Months)|Withdrawal by Subject|4
82129|NCT00131664|292506|P6|First Period (First 6 Months)|Protocol Violation|0
82130|NCT00131664|292507|P5|First Period (First 6 Months)|Protocol Violation|0
82131|NCT00131664|292508|P4|First Period (First 6 Months)|Protocol Violation|0
82132|NCT00131664|292509|P3|First Period (First 6 Months)|Protocol Violation|1
82133|NCT00131664|292510|P2|First Period (First 6 Months)|Protocol Violation|2
82134|NCT00131664|292511|P1|First Period (First 6 Months)|Protocol Violation|2
82135|NCT00131664|292506|P6|First Period (First 6 Months)|Death|0
82136|NCT00131664|292507|P5|First Period (First 6 Months)|Death|0
82137|NCT00131664|292508|P4|First Period (First 6 Months)|Death|0
82138|NCT00131664|292509|P3|First Period (First 6 Months)|Death|0
82139|NCT00131664|292510|P2|First Period (First 6 Months)|Death|1
82140|NCT00131664|292511|P1|First Period (First 6 Months)|Death|0
82141|NCT00131664|292506|P6|First Period (First 6 Months)|Lost to Follow-up|0
82142|NCT00131664|292507|P5|First Period (First 6 Months)|Lost to Follow-up|0
82143|NCT00131664|292508|P4|First Period (First 6 Months)|Lost to Follow-up|0
82144|NCT00131664|292509|P3|First Period (First 6 Months)|Lost to Follow-up|3
82145|NCT00131664|292510|P2|First Period (First 6 Months)|Lost to Follow-up|3
82146|NCT00131664|292511|P1|First Period (First 6 Months)|Lost to Follow-up|7
82147|NCT00131911|292626|P2|Overall Study|Withdrawal by Subject|0
82148|NCT00131911|292627|P1|Overall Study|Withdrawal by Subject|1
82149|NCT00131937|292640|P1|Overall Study|Alternative therapy|1
82150|NCT00131937|292640|P1|Overall Study|Disease Progression|7
82151|NCT00131937|292640|P1|Overall Study|Physician Decision|1
82152|NCT00131937|292640|P1|Overall Study|Withdrawal by Subject|2
82153|NCT00131937|292640|P1|Overall Study|Adverse Event|3
82154|NCT00132314|292648|P2|Overall Study|Refused intervention at baseline|7
82155|NCT00132314|292649|P1|Overall Study|Refused intervention at baseline|2
82156|NCT00132314|292648|P2|Overall Study|Lacked SSN|3
82157|NCT00132314|292649|P1|Overall Study|Lacked SSN|1
82158|NCT00132314|292648|P2|Overall Study|Lost to Follow-up|62
82159|NCT00132314|292649|P1|Overall Study|Lost to Follow-up|70
82160|NCT00132496|292659|P2|Overall Study|Physician Decision|0
82161|NCT00132496|292660|P1|Overall Study|Physician Decision|1
82162|NCT00132496|292659|P2|Overall Study|Withdrawal by Subject|2
82163|NCT00132496|292660|P1|Overall Study|Withdrawal by Subject|1
82164|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
82165|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
82166|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
82167|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
82168|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
82169|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
82170|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
82171|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
82172|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
82173|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
82174|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
82175|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
82176|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
82177|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
82178|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
82179|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
82180|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
82181|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
82182|NCT00132678|292668|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
82183|NCT00132678|292669|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
82184|NCT00132678|292670|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
82185|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Pregnancy|0
82186|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Pregnancy|0
82187|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Pregnancy|2
82188|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Physician Decision|0
82189|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Physician Decision|0
82190|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Physician Decision|1
82191|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
82192|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
82193|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
82194|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
82195|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
82196|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
82197|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
82198|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
82199|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
82200|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
82201|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
82202|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
82203|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Non responder|0
82204|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Non responder|0
82205|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Non responder|107
82206|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Adverse Event|0
82207|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Adverse Event|0
82208|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Adverse Event|12
82209|NCT00132678|292668|P3|Period III (Open-Label Stabilization)|Death|0
82210|NCT00132678|292669|P2|Period III (Open-Label Stabilization)|Death|0
82211|NCT00132678|292670|P1|Period III (Open-Label Stabilization)|Death|2
82212|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
82213|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
82214|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
82215|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
82216|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
82217|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
82218|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
82219|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
82220|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
82221|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
82222|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
82223|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
82224|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
82225|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
82226|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
82227|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
82228|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
82229|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
82230|NCT00132678|292668|P3|Period II (Open-Label Oral Risperidone)|Death|1
82231|NCT00132678|292669|P2|Period II (Open-Label Oral Risperidone)|Death|0
82232|NCT00132678|292670|P1|Period II (Open-Label Oral Risperidone)|Death|0
82233|NCT00132691|292684|P2|Overall Study|Death|0
82234|NCT00132691|292685|P1|Overall Study|Death|2
82235|NCT00132691|292684|P2|Overall Study|Missed 2-year visit|4
82236|NCT00132691|292685|P1|Overall Study|Missed 2-year visit|4
82237|NCT00132691|292684|P2|Overall Study|Lost to Follow-up|8
82238|NCT00132691|292685|P1|Overall Study|Lost to Follow-up|5
82239|NCT00132730|292727|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
82240|NCT00132730|292728|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
82241|NCT00132730|292729|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
82242|NCT00132730|292730|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
82243|NCT00132730|292731|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
82244|NCT00132730|292732|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
82245|NCT00132730|292727|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
82246|NCT00132730|292728|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
82247|NCT00132730|292729|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
82248|NCT00132730|292730|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
82249|NCT00132730|292731|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
82250|NCT00132730|292732|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
82251|NCT00132730|292727|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
82252|NCT00132730|292728|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
82253|NCT00132730|292729|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
82254|NCT00132730|292730|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
82255|NCT00132730|292731|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
82256|NCT00132730|292732|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
82257|NCT00132730|292727|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
82258|NCT00132730|292728|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
82259|NCT00132730|292729|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
82260|NCT00132730|292730|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
82261|NCT00132730|292731|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
82262|NCT00132730|292732|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
82263|NCT00132730|292727|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
82264|NCT00132730|292728|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
82265|NCT00132730|292729|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
82266|NCT00132730|292730|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
82267|NCT00132730|292731|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
82268|NCT00132730|292732|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
82269|NCT00132730|292727|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
82270|NCT00132730|292728|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
82271|NCT00132730|292729|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
82272|NCT00132730|292730|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
82273|NCT00132730|292731|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
82274|NCT00132730|292732|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
82275|NCT00132730|292727|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
82276|NCT00132730|292728|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
82277|NCT00132730|292729|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
82278|NCT00132730|292730|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
82359|NCT00133952|292970|P2|Overall Study|Protocol Violation|1
82279|NCT00132730|292731|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
82280|NCT00132730|292732|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
82281|NCT00132730|292727|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
82282|NCT00132730|292728|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
82283|NCT00132730|292729|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
82284|NCT00132730|292730|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
82285|NCT00132730|292731|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
82286|NCT00132730|292732|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
82287|NCT00132730|292727|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
82288|NCT00132730|292728|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
82289|NCT00132730|292729|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
82290|NCT00132730|292730|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
82291|NCT00132730|292731|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
82292|NCT00132730|292732|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
82293|NCT00132730|292727|P6|Period II - 12-week Treatment (Base)|Other reasons|0
82294|NCT00132730|292728|P5|Period II - 12-week Treatment (Base)|Other reasons|0
82295|NCT00132730|292729|P4|Period II - 12-week Treatment (Base)|Other reasons|13
82296|NCT00132730|292730|P3|Period II - 12-week Treatment (Base)|Other reasons|9
82297|NCT00132730|292731|P2|Period II - 12-week Treatment (Base)|Other reasons|10
82298|NCT00132730|292732|P1|Period II - 12-week Treatment (Base)|Other reasons|11
82299|NCT00132730|292727|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
82300|NCT00132730|292728|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
82301|NCT00132730|292729|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
82302|NCT00132730|292730|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
82303|NCT00132730|292731|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
82304|NCT00132730|292732|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
82305|NCT00132730|292727|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
82306|NCT00132730|292728|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
82307|NCT00132730|292729|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
82308|NCT00132730|292730|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
82309|NCT00132730|292731|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
82310|NCT00132730|292732|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
82311|NCT00132769|292776|P2|Overall Study|Protocol Violation|1
82312|NCT00132769|292777|P1|Overall Study|Protocol Violation|1
82313|NCT00132769|292776|P2|Overall Study|Adverse Event|1
82314|NCT00132769|292777|P1|Overall Study|Adverse Event|2
82315|NCT00132769|292776|P2|Overall Study|Lack of Efficacy|6
82316|NCT00132769|292777|P1|Overall Study|Lack of Efficacy|7
82317|NCT00132769|292776|P2|Overall Study|Withdrawal by Subject|3
82318|NCT00132769|292777|P1|Overall Study|Withdrawal by Subject|1
82319|NCT00132808|292802|P3|Stratum II|Withdrawal by Subject|6
82320|NCT00132808|292803|P2|Stratum II|Withdrawal by Subject|9
82321|NCT00132808|292804|P1|Stratum II|Withdrawal by Subject|4
82322|NCT00132808|292802|P3|Stratum II|Protocol Violation|1
82323|NCT00132808|292803|P2|Stratum II|Protocol Violation|2
82324|NCT00132808|292804|P1|Stratum II|Protocol Violation|0
82325|NCT00132808|292802|P3|Stratum II|Lost to Follow-up|1
82326|NCT00132808|292803|P2|Stratum II|Lost to Follow-up|2
82327|NCT00132808|292804|P1|Stratum II|Lost to Follow-up|2
82328|NCT00132808|292802|P3|Stratum II|Death|0
82329|NCT00132808|292803|P2|Stratum II|Death|0
82330|NCT00132808|292804|P1|Stratum II|Death|1
82331|NCT00132808|292802|P3|Stratum II|Adverse Event|1
82332|NCT00132808|292803|P2|Stratum II|Adverse Event|2
82333|NCT00132808|292804|P1|Stratum II|Adverse Event|1
82334|NCT00132808|292802|P3|Stratum I|Abnormal test procedure result (s)|1
82335|NCT00132808|292803|P2|Stratum I|Abnormal test procedure result (s)|0
82336|NCT00132808|292804|P1|Stratum I|Abnormal test procedure result (s)|0
82337|NCT00132808|292802|P3|Stratum I|Withdrawal by Subject|3
82338|NCT00132808|292803|P2|Stratum I|Withdrawal by Subject|7
82339|NCT00132808|292804|P1|Stratum I|Withdrawal by Subject|4
82340|NCT00132808|292802|P3|Stratum I|Lost to Follow-up|1
82341|NCT00132808|292803|P2|Stratum I|Lost to Follow-up|4
82342|NCT00132808|292804|P1|Stratum I|Lost to Follow-up|3
82343|NCT00132808|292802|P3|Stratum I|Adverse Event|0
82344|NCT00132808|292803|P2|Stratum I|Adverse Event|1
82345|NCT00132808|292804|P1|Stratum I|Adverse Event|2
82346|NCT00132873|292827|P1|Overall Study|Planned Pregnancy|1
82347|NCT00132873|292827|P1|Overall Study|Withdrawal by Subject|3
82348|NCT00132873|292827|P1|Overall Study|Lack of Efficacy|1
82349|NCT00132873|292827|P1|Overall Study|Lost to Follow-up|1
82350|NCT00132873|292827|P1|Overall Study|Adverse Event|3
82351|NCT00133705|292954|P2|Overall Study|Withdrawal by Subject|3
82352|NCT00133705|292955|P1|Overall Study|Withdrawal by Subject|2
82353|NCT00133952|292970|P2|Overall Study|Sponsor Decision|1
82354|NCT00133952|292971|P1|Overall Study|Sponsor Decision|0
82355|NCT00133952|292970|P2|Overall Study|Physician Decision|3
82356|NCT00133952|292971|P1|Overall Study|Physician Decision|4
82357|NCT00133952|292970|P2|Overall Study|Withdrawal by Subject|4
82358|NCT00133952|292971|P1|Overall Study|Withdrawal by Subject|20
82360|NCT00133952|292971|P1|Overall Study|Protocol Violation|1
82361|NCT00133952|292970|P2|Overall Study|Protocol Entry Criteria Exclusion|1
82362|NCT00133952|292971|P1|Overall Study|Protocol Entry Criteria Exclusion|4
82363|NCT00133952|292970|P2|Overall Study|Lost to Follow-up|14
82364|NCT00133952|292971|P1|Overall Study|Lost to Follow-up|9
82365|NCT00133952|292970|P2|Overall Study|Death|2
82366|NCT00133952|292971|P1|Overall Study|Death|3
82367|NCT00133952|292970|P2|Overall Study|Adverse Event|2
82368|NCT00133952|292971|P1|Overall Study|Adverse Event|1
82369|NCT00134056|293040|P2|Eligible for Protocol Assigned Treatment|Not specified|56
82370|NCT00134056|293041|P1|Eligible for Protocol Assigned Treatment|Not specified|55
82371|NCT00134056|293040|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
82372|NCT00134056|293041|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
82373|NCT00134056|293040|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
82374|NCT00134056|293041|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
82375|NCT00134056|293040|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
82376|NCT00134056|293041|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
82377|NCT00134056|293040|P2|Randomization|Not eligible for assigned treatment|20
82378|NCT00134056|293041|P1|Randomization|Not eligible for assigned treatment|22
82379|NCT00134563|293064|P3|Overall Study|Reason other than above|5
82380|NCT00134563|293065|P2|Overall Study|Reason other than above|2
82381|NCT00134563|293066|P1|Overall Study|Reason other than above|0
82382|NCT00134563|293064|P3|Overall Study|did not wish to continue|26
82383|NCT00134563|293065|P2|Overall Study|did not wish to continue|32
82384|NCT00134563|293066|P1|Overall Study|did not wish to continue|33
82385|NCT00134563|293064|P3|Overall Study|progressive disease|2
82386|NCT00134563|293065|P2|Overall Study|progressive disease|4
82387|NCT00134563|293066|P1|Overall Study|progressive disease|11
82388|NCT00134563|293064|P3|Overall Study|Lost to Follow-up|2
82389|NCT00134563|293065|P2|Overall Study|Lost to Follow-up|0
82390|NCT00134563|293066|P1|Overall Study|Lost to Follow-up|4
82391|NCT00134563|293064|P3|Overall Study|Protocol Violation|5
82392|NCT00134563|293065|P2|Overall Study|Protocol Violation|2
82393|NCT00134563|293066|P1|Overall Study|Protocol Violation|3
82394|NCT00134563|293064|P3|Overall Study|Lack of Efficacy|17
82395|NCT00134563|293065|P2|Overall Study|Lack of Efficacy|14
82396|NCT00134563|293066|P1|Overall Study|Lack of Efficacy|24
82397|NCT00134563|293064|P3|Overall Study|Adverse Event|38
82398|NCT00134563|293065|P2|Overall Study|Adverse Event|37
82399|NCT00134563|293066|P1|Overall Study|Adverse Event|29
82400|NCT00134563|293064|P3|Overall Study|Not treated due to protocol violation|1
82401|NCT00134563|293065|P2|Overall Study|Not treated due to protocol violation|1
82402|NCT00134563|293066|P1|Overall Study|Not treated due to protocol violation|0
82403|NCT00134719|293092|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
82404|NCT00134719|293093|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
82494|NCT00128492|293947|P2|Overall Study|AE unrelated to study|9
82405|NCT00134719|293094|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
82406|NCT00134719|293092|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
82407|NCT00134719|293093|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
82408|NCT00134719|293094|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
82409|NCT00134719|293092|P3|Primary Vaccination Phase|Lost to Follow-up|3
82410|NCT00134719|293093|P2|Primary Vaccination Phase|Lost to Follow-up|3
82411|NCT00134719|293094|P1|Primary Vaccination Phase|Lost to Follow-up|7
82412|NCT00134719|293092|P3|Primary Vaccination Phase|Withdrawal by Subject|2
82413|NCT00134719|293093|P2|Primary Vaccination Phase|Withdrawal by Subject|3
82414|NCT00134719|293094|P1|Primary Vaccination Phase|Withdrawal by Subject|2
82415|NCT00134719|293092|P3|Primary Vaccination Phase|Protocol Violation|0
82416|NCT00134719|293093|P2|Primary Vaccination Phase|Protocol Violation|0
82417|NCT00134719|293094|P1|Primary Vaccination Phase|Protocol Violation|1
82418|NCT00134719|293092|P3|Primary Vaccination Phase|Adverse Event|0
82419|NCT00134719|293093|P2|Primary Vaccination Phase|Adverse Event|0
82420|NCT00134719|293094|P1|Primary Vaccination Phase|Adverse Event|4
82421|NCT00134784|293226|P4|Overall Study|Withdrawal by Subject|1
82422|NCT00134784|293227|P3|Overall Study|Withdrawal by Subject|2
82423|NCT00134784|293228|P2|Overall Study|Withdrawal by Subject|2
82424|NCT00134784|293229|P1|Overall Study|Withdrawal by Subject|2
82429|NCT00127712|293264|P2|Overall Study|Lack of GI access to continue|0
82430|NCT00127712|293265|P1|Overall Study|Lack of GI access to continue|2
82431|NCT00127712|293264|P2|Overall Study|Adverse Event|0
82432|NCT00127712|293265|P1|Overall Study|Adverse Event|3
82433|NCT00127803|293310|P4|Overall Study|Lost to Follow-up|1
82434|NCT00127803|293311|P3|Overall Study|Lost to Follow-up|0
82435|NCT00127803|293312|P2|Overall Study|Lost to Follow-up|0
82436|NCT00127803|293313|P1|Overall Study|Lost to Follow-up|0
82437|NCT00127803|293310|P4|Overall Study|Withdrawal by Subject|0
82438|NCT00127803|293311|P3|Overall Study|Withdrawal by Subject|0
82439|NCT00127803|293312|P2|Overall Study|Withdrawal by Subject|0
82440|NCT00127803|293313|P1|Overall Study|Withdrawal by Subject|1
82441|NCT00127803|293310|P4|Overall Study|Adverse Event|0
82442|NCT00127803|293311|P3|Overall Study|Adverse Event|0
82443|NCT00127803|293312|P2|Overall Study|Adverse Event|0
82444|NCT00127803|293313|P1|Overall Study|Adverse Event|2
82445|NCT00127842|293331|P1|Overall Study|Other|5
82446|NCT00127842|293331|P1|Overall Study|Protocol Violation|1
82447|NCT00127842|293331|P1|Overall Study|Noncompliance|2
82448|NCT00127842|293331|P1|Overall Study|Lack of Efficacy|12
82449|NCT00127842|293331|P1|Overall Study|Lost to Follow-up|1
82450|NCT00127842|293331|P1|Overall Study|Withdrawal by Subject|3
82451|NCT00127842|293331|P1|Overall Study|Adverse Event|15
82452|NCT00127855|293350|P5|Primary Vaccination Course|Unspecified|1
82453|NCT00127855|293351|P4|Primary Vaccination Course|Unspecified|0
82454|NCT00127855|293352|P3|Primary Vaccination Course|Unspecified|0
82455|NCT00127855|293353|P2|Primary Vaccination Course|Unspecified|0
82456|NCT00127855|293354|P1|Primary Vaccination Course|Unspecified|0
82457|NCT00127855|293350|P5|Primary Vaccination Course|Lost to Follow-up|2
82458|NCT00127855|293351|P4|Primary Vaccination Course|Lost to Follow-up|0
82459|NCT00127855|293352|P3|Primary Vaccination Course|Lost to Follow-up|1
82460|NCT00127855|293353|P2|Primary Vaccination Course|Lost to Follow-up|1
82461|NCT00127855|293354|P1|Primary Vaccination Course|Lost to Follow-up|1
82462|NCT00127855|293350|P5|Primary Vaccination Course|Withdrawal by Subject|1
82463|NCT00127855|293351|P4|Primary Vaccination Course|Withdrawal by Subject|0
82464|NCT00127855|293352|P3|Primary Vaccination Course|Withdrawal by Subject|0
82465|NCT00127855|293353|P2|Primary Vaccination Course|Withdrawal by Subject|0
82466|NCT00127855|293354|P1|Primary Vaccination Course|Withdrawal by Subject|1
82467|NCT00127855|293350|P5|Primary Vaccination Course|Adverse Event|0
82468|NCT00127855|293351|P4|Primary Vaccination Course|Adverse Event|0
82469|NCT00127855|293352|P3|Primary Vaccination Course|Adverse Event|1
82470|NCT00127855|293353|P2|Primary Vaccination Course|Adverse Event|0
82471|NCT00127855|293354|P1|Primary Vaccination Course|Adverse Event|0
82472|NCT00127933|293538|P2|Overall Study|Randomized but not dosed|0
82473|NCT00127933|293539|P1|Overall Study|Randomized but not dosed|1
82474|NCT00128206|293841|P2|Overall Study|Adverse Event|2
82475|NCT00128206|293842|P1|Overall Study|Adverse Event|0
82476|NCT00128206|293841|P2|Overall Study|Lost to Follow-up|118
82477|NCT00128206|293842|P1|Overall Study|Lost to Follow-up|137
82478|NCT00128492|293947|P2|Overall Study|Pregnancy|1
82479|NCT00128492|293948|P1|Overall Study|Pregnancy|0
82480|NCT00128492|293947|P2|Overall Study|Withdrawal by Subject|5
82481|NCT00128492|293948|P1|Overall Study|Withdrawal by Subject|3
82482|NCT00128492|293947|P2|Overall Study|Personal or administrative|22
82483|NCT00128492|293948|P1|Overall Study|Personal or administrative|10
82484|NCT00128492|293947|P2|Overall Study|Noncompliance|5
82485|NCT00128492|293948|P1|Overall Study|Noncompliance|0
82486|NCT00128492|293947|P2|Overall Study|Lost to Follow-up|5
82487|NCT00128492|293948|P1|Overall Study|Lost to Follow-up|1
82488|NCT00128492|293947|P2|Overall Study|Death|0
82489|NCT00128492|293948|P1|Overall Study|Death|1
82490|NCT00128492|293947|P2|Overall Study|AE related to study|4
82491|NCT00128492|293948|P1|Overall Study|AE related to study|1
82492|NCT00128492|293947|P2|Overall Study|Study drug intolerance (AE)|8
82493|NCT00128492|293948|P1|Overall Study|Study drug intolerance (AE)|2
82495|NCT00128492|293948|P1|Overall Study|AE unrelated to study|2
82496|NCT00128661|294008|P2|Overall Study|Unspecified|8
82497|NCT00128661|294009|P1|Overall Study|Unspecified|7
82498|NCT00128661|294008|P2|Overall Study|Withdrawal by Subject|232
82499|NCT00128661|294009|P1|Overall Study|Withdrawal by Subject|243
82500|NCT00128661|294008|P2|Overall Study|Lost to Follow-up|7
82501|NCT00128661|294009|P1|Overall Study|Lost to Follow-up|10
82502|NCT00128661|294008|P2|Overall Study|Adverse Event|11
82503|NCT00128661|294009|P1|Overall Study|Adverse Event|14
82504|NCT00128830|294078|P1|Overall Study|Unspecified|9
82505|NCT00128830|294078|P1|Overall Study|Discontinued or ineligible for study|2
82506|NCT00128830|294078|P1|Overall Study|Non-compliant|4
82507|NCT00128830|294078|P1|Overall Study|Reached a virologic endpoint|29
82508|NCT00128830|294078|P1|Overall Study|Lost to Follow-up|4
82509|NCT00128830|294078|P1|Overall Study|Withdrawal by Subject|14
82510|NCT00128830|294078|P1|Overall Study|Adverse Event|10
82511|NCT00129116|294120|P5|Booster Phase|Lost to Follow-up|1
82512|NCT00129116|294121|P4|Booster Phase|Lost to Follow-up|0
82513|NCT00129116|294122|P3|Booster Phase|Lost to Follow-up|0
82514|NCT00129116|294123|P2|Booster Phase|Lost to Follow-up|0
82515|NCT00129116|294124|P1|Booster Phase|Lost to Follow-up|2
82516|NCT00129116|294120|P5|Primary Phase|Unspecified|0
82517|NCT00129116|294121|P4|Primary Phase|Unspecified|0
82518|NCT00129116|294122|P3|Primary Phase|Unspecified|1
82519|NCT00129116|294123|P2|Primary Phase|Unspecified|0
82520|NCT00129116|294124|P1|Primary Phase|Unspecified|0
82521|NCT00129116|294120|P5|Primary Phase|Withdrawal by Subject|0
82522|NCT00129116|294121|P4|Primary Phase|Withdrawal by Subject|0
82523|NCT00129116|294122|P3|Primary Phase|Withdrawal by Subject|0
82524|NCT00129116|294123|P2|Primary Phase|Withdrawal by Subject|1
82525|NCT00129116|294124|P1|Primary Phase|Withdrawal by Subject|0
82526|NCT00129116|294120|P5|Primary Phase|Adverse Event|0
82527|NCT00129116|294121|P4|Primary Phase|Adverse Event|0
82528|NCT00129116|294122|P3|Primary Phase|Adverse Event|0
82529|NCT00129116|294123|P2|Primary Phase|Adverse Event|1
82530|NCT00129116|294124|P1|Primary Phase|Adverse Event|1
82531|NCT00129116|294120|P5|Primary Phase|Protocol Violation|0
82532|NCT00129116|294121|P4|Primary Phase|Protocol Violation|0
82533|NCT00129116|294122|P3|Primary Phase|Protocol Violation|0
82534|NCT00129116|294123|P2|Primary Phase|Protocol Violation|1
82535|NCT00129116|294124|P1|Primary Phase|Protocol Violation|0
82536|NCT00129116|294120|P5|Primary Phase|Lost to Follow-up|1
82537|NCT00129116|294121|P4|Primary Phase|Lost to Follow-up|1
82538|NCT00129116|294122|P3|Primary Phase|Lost to Follow-up|0
82539|NCT00129116|294123|P2|Primary Phase|Lost to Follow-up|1
82540|NCT00129116|294124|P1|Primary Phase|Lost to Follow-up|1
82541|NCT00129129|294389|P5|Fourth Dose Phase|Protocol Violation|0
82542|NCT00129129|294390|P4|Fourth Dose Phase|Protocol Violation|1
82543|NCT00129129|294391|P3|Fourth Dose Phase|Protocol Violation|0
82544|NCT00129129|294392|P2|Fourth Dose Phase|Protocol Violation|0
82545|NCT00129129|294393|P1|Fourth Dose Phase|Protocol Violation|0
82546|NCT00129129|294389|P5|Fourth Dose Phase|Unspecified|1
82547|NCT00129129|294390|P4|Fourth Dose Phase|Unspecified|1
82548|NCT00129129|294391|P3|Fourth Dose Phase|Unspecified|0
82549|NCT00129129|294392|P2|Fourth Dose Phase|Unspecified|0
82550|NCT00129129|294393|P1|Fourth Dose Phase|Unspecified|0
82551|NCT00129129|294389|P5|Fourth Dose Phase|Migration from study area|2
82552|NCT00129129|294390|P4|Fourth Dose Phase|Migration from study area|0
82553|NCT00129129|294391|P3|Fourth Dose Phase|Migration from study area|0
82554|NCT00129129|294392|P2|Fourth Dose Phase|Migration from study area|0
82555|NCT00129129|294393|P1|Fourth Dose Phase|Migration from study area|0
82556|NCT00129129|294389|P5|Fourth Dose Phase|Withdrawal by Subject|1
82557|NCT00129129|294390|P4|Fourth Dose Phase|Withdrawal by Subject|0
82558|NCT00129129|294391|P3|Fourth Dose Phase|Withdrawal by Subject|0
82559|NCT00129129|294392|P2|Fourth Dose Phase|Withdrawal by Subject|0
82560|NCT00129129|294393|P1|Fourth Dose Phase|Withdrawal by Subject|0
82561|NCT00129129|294389|P5|Fourth Dose Phase|Lost to Follow-up|2
82562|NCT00129129|294390|P4|Fourth Dose Phase|Lost to Follow-up|2
82563|NCT00129129|294391|P3|Fourth Dose Phase|Lost to Follow-up|0
82564|NCT00129129|294392|P2|Fourth Dose Phase|Lost to Follow-up|0
82565|NCT00129129|294393|P1|Fourth Dose Phase|Lost to Follow-up|4
82566|NCT00129129|294389|P5|Primary Phase|Unspecified|0
82567|NCT00129129|294390|P4|Primary Phase|Unspecified|0
82568|NCT00129129|294391|P3|Primary Phase|Unspecified|0
82569|NCT00129129|294392|P2|Primary Phase|Unspecified|5
82570|NCT00129129|294393|P1|Primary Phase|Unspecified|2
82571|NCT00129129|294389|P5|Primary Phase|Lost to Follow-up|0
82572|NCT00129129|294390|P4|Primary Phase|Lost to Follow-up|0
82573|NCT00129129|294391|P3|Primary Phase|Lost to Follow-up|0
82574|NCT00129129|294392|P2|Primary Phase|Lost to Follow-up|6
82575|NCT00129129|294393|P1|Primary Phase|Lost to Follow-up|8
82576|NCT00129129|294389|P5|Primary Phase|Migration from study area|0
82577|NCT00129129|294390|P4|Primary Phase|Migration from study area|0
82578|NCT00129129|294391|P3|Primary Phase|Migration from study area|0
82579|NCT00129129|294392|P2|Primary Phase|Migration from study area|3
82580|NCT00129129|294393|P1|Primary Phase|Migration from study area|1
82581|NCT00129129|294389|P5|Primary Phase|Withdrawal by Subject|0
82582|NCT00129129|294390|P4|Primary Phase|Withdrawal by Subject|0
82583|NCT00129129|294391|P3|Primary Phase|Withdrawal by Subject|0
82584|NCT00129129|294392|P2|Primary Phase|Withdrawal by Subject|10
82585|NCT00129129|294393|P1|Primary Phase|Withdrawal by Subject|12
82586|NCT00129129|294389|P5|Primary Phase|Adverse Event|0
82587|NCT00129129|294390|P4|Primary Phase|Adverse Event|0
82588|NCT00129129|294391|P3|Primary Phase|Adverse Event|0
82589|NCT00129129|294392|P2|Primary Phase|Adverse Event|1
82590|NCT00129129|294393|P1|Primary Phase|Adverse Event|2
82591|NCT00134901|294597|P2|Overall Study|discontinued intervention|10
82592|NCT00134901|294598|P1|Overall Study|discontinued intervention|12
82593|NCT00134901|294597|P2|Overall Study|Lost to Follow-up|5
82594|NCT00134901|294598|P1|Overall Study|Lost to Follow-up|5
82595|NCT00137267|294608|P2|Overall Study|Lost to Follow-up|21
82596|NCT00137267|294609|P1|Overall Study|Lost to Follow-up|15
82597|NCT00137423|294634|P2|Overall Study|Death|1
82598|NCT00137423|294635|P1|Overall Study|Death|0
82599|NCT00137423|294634|P2|Overall Study|Lack of Efficacy|33
82600|NCT00137423|294635|P1|Overall Study|Lack of Efficacy|31
82601|NCT00137423|294634|P2|Overall Study|consent withdrawn|1
82602|NCT00137423|294635|P1|Overall Study|consent withdrawn|1
82603|NCT00137423|294634|P2|Overall Study|Adverse Event|9
82604|NCT00137423|294635|P1|Overall Study|Adverse Event|7
82605|NCT00137436|294655|P1|Overall Study|Unspecified|5
82606|NCT00137436|294655|P1|Overall Study|Withdrawal by Subject|6
82607|NCT00137436|294655|P1|Overall Study|Lack of Efficacy|17
82608|NCT00137436|294655|P1|Overall Study|Death|2
82609|NCT00137436|294655|P1|Overall Study|Adverse Event|13
82610|NCT00137449|294674|P2|Overall Study|Withdrawal by Subject|1
82611|NCT00137449|294675|P1|Overall Study|Withdrawal by Subject|1
82612|NCT00137449|294674|P2|Overall Study|Adverse Event|1
82613|NCT00137449|294675|P1|Overall Study|Adverse Event|3
82614|NCT00137449|294674|P2|Overall Study|Death|3
82615|NCT00137449|294675|P1|Overall Study|Death|4
82616|NCT00137449|294674|P2|Overall Study|Disease Progression|13
82617|NCT00137449|294675|P1|Overall Study|Disease Progression|8
82618|NCT00137631|294714|P2|Overall Study|Lost to Follow-up|41
82619|NCT00137631|294715|P1|Overall Study|Lost to Follow-up|37
82620|NCT00138073|294763|P1|Overall Study|lack of resources|55
82621|NCT00138151|294772|P1|Overall Study|Physician Decision|1
82622|NCT00138151|294772|P1|Overall Study|Withdrawal by Subject|3
82623|NCT00138424|294798|P4|Overall Study|Physician Decision|0
82624|NCT00138424|294799|P3|Overall Study|Physician Decision|0
82625|NCT00138424|294800|P2|Overall Study|Physician Decision|1
82626|NCT00138424|294801|P1|Overall Study|Physician Decision|0
82627|NCT00138658|294876|P1|Overall Study|Withdrawal by Subject|5
82628|NCT00138658|294876|P1|Overall Study|Physician Decision|11
82629|NCT00138658|294876|P1|Overall Study|Disease Progression|21
82630|NCT00138658|294876|P1|Overall Study|Death|1
82631|NCT00138658|294876|P1|Overall Study|Adverse Event|23
82632|NCT00138671|294888|P2|Overall Study|Other|3
82633|NCT00138671|294889|P1|Overall Study|Other|3
82634|NCT00138671|294888|P2|Overall Study|Withdrawal by Subject|5
82635|NCT00138671|294889|P1|Overall Study|Withdrawal by Subject|3
82636|NCT00138671|294888|P2|Overall Study|Lost to Follow-up|2
82637|NCT00138671|294889|P1|Overall Study|Lost to Follow-up|1
82638|NCT00138671|294888|P2|Overall Study|Adverse Event|3
82639|NCT00138671|294889|P1|Overall Study|Adverse Event|6
82640|NCT00138671|294888|P2|Overall Study|Death|3
82641|NCT00138671|294889|P1|Overall Study|Death|0
82642|NCT00139477|294941|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
82643|NCT00139477|294942|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
82644|NCT00139477|294941|P2|Second Intervention -6Months to 12Months|Relocation|0
82645|NCT00139477|294942|P1|Second Intervention -6Months to 12Months|Relocation|1
82646|NCT00139477|294941|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
82647|NCT00139477|294942|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
82648|NCT00139477|294941|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
82649|NCT00139477|294942|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
82650|NCT00139477|294941|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
82651|NCT00139477|294942|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
82652|NCT00139477|294941|P2|First Intervention -Baseline to 6Months|Relocation|2
82653|NCT00139477|294942|P1|First Intervention -Baseline to 6Months|Relocation|1
82654|NCT00139477|294941|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
82655|NCT00139477|294942|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
82656|NCT00139659|294964|P2|Overall Study|Withdrawal by Subject|10
82657|NCT00139659|294965|P1|Overall Study|Withdrawal by Subject|14
82658|NCT00139659|294964|P2|Overall Study|Reason not Specified|3
82659|NCT00139659|294965|P1|Overall Study|Reason not Specified|6
82660|NCT00139659|294964|P2|Overall Study|Lost to Follow-up|3
82661|NCT00139659|294965|P1|Overall Study|Lost to Follow-up|7
82662|NCT00139659|294964|P2|Overall Study|Lack of Efficacy|1
82663|NCT00139659|294965|P1|Overall Study|Lack of Efficacy|1
82664|NCT00139659|294964|P2|Overall Study|Adverse Event|1
82665|NCT00139659|294965|P1|Overall Study|Adverse Event|12
82666|NCT00132028|295047|P1|Overall Study|Physician Decision|3
82667|NCT00132028|295047|P1|Overall Study|not eligible|2
82668|NCT00132028|295047|P1|Overall Study|Withdrawal by Subject|2
82669|NCT00132028|295047|P1|Overall Study|Lack of Efficacy|11
82670|NCT00132028|295047|P1|Overall Study|Death|2
82671|NCT00132028|295047|P1|Overall Study|Adverse Event|7
82672|NCT00132132|295055|P2|Overall Study|Lost to Follow-up|2
82673|NCT00132132|295056|P1|Overall Study|Lost to Follow-up|7
82674|NCT00139737|295064|P1|Overall Study|Screened, Not Treated|13
82675|NCT00139737|295064|P1|Overall Study|Did Not Meet Entrance Criteria|1
82676|NCT00139737|295064|P1|Overall Study|Withdrew During Screening Phase|8
82677|NCT00139737|295064|P1|Overall Study|Protocol Violation|18
82678|NCT00139737|295064|P1|Overall Study|Laboratory Abnormality|2
82679|NCT00139737|295064|P1|Overall Study|Death|3
82680|NCT00139737|295064|P1|Overall Study|Lost to Follow-up|8
82681|NCT00139737|295064|P1|Overall Study|Lack of Efficacy|40
82682|NCT00139737|295064|P1|Overall Study|Adverse Event|58
82683|NCT00139737|295064|P1|Overall Study|Withdrawal by Subject|190
82684|NCT00139776|295070|P4|Period III|Withdrawal by Subject|21
82685|NCT00139776|295071|P3|Period III|Withdrawal by Subject|16
82686|NCT00139776|295072|P2|Period III|Withdrawal by Subject|0
82687|NCT00139776|295073|P1|Period III|Withdrawal by Subject|0
82688|NCT00139776|295070|P4|Period III|Lost to Follow-up|4
82689|NCT00139776|295071|P3|Period III|Lost to Follow-up|5
82690|NCT00139776|295072|P2|Period III|Lost to Follow-up|0
82691|NCT00139776|295073|P1|Period III|Lost to Follow-up|0
82692|NCT00139776|295070|P4|Period III|Lack of Efficacy|24
82693|NCT00139776|295071|P3|Period III|Lack of Efficacy|10
82694|NCT00139776|295072|P2|Period III|Lack of Efficacy|0
82695|NCT00139776|295073|P1|Period III|Lack of Efficacy|0
82696|NCT00139776|295070|P4|Period III|Other|34
82697|NCT00139776|295071|P3|Period III|Other|23
82698|NCT00139776|295072|P2|Period III|Other|0
82699|NCT00139776|295073|P1|Period III|Other|0
82700|NCT00139776|295070|P4|Period III|Adverse Event|23
82701|NCT00139776|295071|P3|Period III|Adverse Event|22
82702|NCT00139776|295072|P2|Period III|Adverse Event|0
82703|NCT00139776|295073|P1|Period III|Adverse Event|0
82704|NCT00139776|295070|P4|Period II|Not Randomized into Period III|0
82705|NCT00139776|295071|P3|Period II|Not Randomized into Period III|0
82706|NCT00139776|295072|P2|Period II|Not Randomized into Period III|322
82707|NCT00139776|295073|P1|Period II|Not Randomized into Period III|0
82708|NCT00139776|295070|P4|Period I|Did not enter Period II|0
82709|NCT00139776|295071|P3|Period I|Did not enter Period II|0
82710|NCT00139776|295072|P2|Period I|Did not enter Period II|0
82711|NCT00139776|295073|P1|Period I|Did not enter Period II|575
82712|NCT00141037|295146|P2|Overall Study|Graft Failure|4
82713|NCT00141037|295147|P1|Overall Study|Graft Failure|3
82714|NCT00141037|295146|P2|Overall Study|Moved from area|7
82715|NCT00141037|295147|P1|Overall Study|Moved from area|1
82716|NCT00141037|295146|P2|Overall Study|Other|1
82717|NCT00141037|295147|P1|Overall Study|Other|0
82718|NCT00141037|295146|P2|Overall Study|Withdrawal by Subject|1
82719|NCT00141037|295147|P1|Overall Study|Withdrawal by Subject|2
82720|NCT00141037|295146|P2|Overall Study|Protocol Violation|2
82721|NCT00141037|295147|P1|Overall Study|Protocol Violation|0
82722|NCT00141037|295146|P2|Overall Study|Lost to Follow-up|1
82723|NCT00141037|295147|P1|Overall Study|Lost to Follow-up|3
82724|NCT00141037|295146|P2|Overall Study|Physician Decision|2
82725|NCT00141037|295147|P1|Overall Study|Physician Decision|1
82726|NCT00141102|295157|P2|Overall Study|Death|2
82727|NCT00141102|295158|P1|Overall Study|Death|2
82728|NCT00141102|295157|P2|Overall Study|Randomized But Did Not Receive Treatment|9
82729|NCT00141102|295158|P1|Overall Study|Randomized But Did Not Receive Treatment|15
82730|NCT00141102|295157|P2|Overall Study|Withdrawal by Subject|142
82731|NCT00141102|295158|P1|Overall Study|Withdrawal by Subject|112
82732|NCT00141102|295157|P2|Overall Study|Unspecified|76
82733|NCT00141102|295158|P1|Overall Study|Unspecified|87
82734|NCT00141102|295157|P2|Overall Study|Lost to Follow-up|32
82735|NCT00141102|295158|P1|Overall Study|Lost to Follow-up|29
82736|NCT00141102|295157|P2|Overall Study|Lack of Efficacy|26
82737|NCT00141102|295158|P1|Overall Study|Lack of Efficacy|21
82738|NCT00141102|295157|P2|Overall Study|Laboratory Abnormality|33
82739|NCT00141102|295158|P1|Overall Study|Laboratory Abnormality|9
82740|NCT00141102|295157|P2|Overall Study|Adverse Event|305
82741|NCT00141102|295158|P1|Overall Study|Adverse Event|233
82742|NCT00141219|295198|P2|Overall Study|Withdrawal by Subject|2
82743|NCT00141219|295199|P1|Overall Study|Withdrawal by Subject|6
82744|NCT00141219|295198|P2|Overall Study|Lack of Efficacy|4
82745|NCT00141219|295199|P1|Overall Study|Lack of Efficacy|5
82746|NCT00141219|295198|P2|Overall Study|Adverse Event|6
82747|NCT00141219|295199|P1|Overall Study|Adverse Event|8
82748|NCT00141219|295198|P2|Overall Study|Protocol violations|4
82749|NCT00141219|295199|P1|Overall Study|Protocol violations|5
82750|NCT00141271|295252|P3|Overall Study|Other|5
82751|NCT00141271|295253|P2|Overall Study|Other|12
82752|NCT00141271|295254|P1|Overall Study|Other|11
82753|NCT00141271|295252|P3|Overall Study|Withdrawal by Subject|10
82754|NCT00141271|295253|P2|Overall Study|Withdrawal by Subject|9
82755|NCT00141271|295254|P1|Overall Study|Withdrawal by Subject|14
82756|NCT00141271|295252|P3|Overall Study|Lost to Follow-up|21
82757|NCT00141271|295253|P2|Overall Study|Lost to Follow-up|15
82758|NCT00141271|295254|P1|Overall Study|Lost to Follow-up|15
82759|NCT00141271|295252|P3|Overall Study|Lack of Efficacy|3
82760|NCT00141271|295253|P2|Overall Study|Lack of Efficacy|7
82761|NCT00141271|295254|P1|Overall Study|Lack of Efficacy|7
82762|NCT00141271|295252|P3|Overall Study|Laboratory Abnormality|1
82763|NCT00141271|295253|P2|Overall Study|Laboratory Abnormality|1
82764|NCT00141271|295254|P1|Overall Study|Laboratory Abnormality|2
82765|NCT00141271|295252|P3|Overall Study|Adverse Event|17
82766|NCT00141271|295253|P2|Overall Study|Adverse Event|19
82767|NCT00141271|295254|P1|Overall Study|Adverse Event|31
82768|NCT00141297|295375|P10|Overall Study|Transitioned|0
82769|NCT00141297|295376|P9|Overall Study|Transitioned|0
82770|NCT00141297|295377|P8|Overall Study|Transitioned|0
82771|NCT00141297|295378|P7|Overall Study|Transitioned|0
82772|NCT00141297|295379|P6|Overall Study|Transitioned|0
82773|NCT00141297|295380|P5|Overall Study|Transitioned|1
82774|NCT00141297|295381|P4|Overall Study|Transitioned|0
82775|NCT00141297|295382|P3|Overall Study|Transitioned|0
82776|NCT00141297|295383|P2|Overall Study|Transitioned|0
82777|NCT00141297|295384|P1|Overall Study|Transitioned|0
82778|NCT00141297|295375|P10|Overall Study|Progressive Disease|6
82779|NCT00141297|295376|P9|Overall Study|Progressive Disease|15
82780|NCT00141297|295377|P8|Overall Study|Progressive Disease|3
82781|NCT00141297|295378|P7|Overall Study|Progressive Disease|3
82782|NCT00141297|295379|P6|Overall Study|Progressive Disease|2
82783|NCT00141297|295380|P5|Overall Study|Progressive Disease|15
82784|NCT00141297|295381|P4|Overall Study|Progressive Disease|2
82785|NCT00141297|295382|P3|Overall Study|Progressive Disease|6
82786|NCT00141297|295383|P2|Overall Study|Progressive Disease|3
82787|NCT00141297|295384|P1|Overall Study|Progressive Disease|2
82788|NCT00141297|295375|P10|Overall Study|Unspecified|0
82789|NCT00141297|295376|P9|Overall Study|Unspecified|2
82790|NCT00141297|295377|P8|Overall Study|Unspecified|0
82791|NCT00141297|295378|P7|Overall Study|Unspecified|0
82792|NCT00141297|295379|P6|Overall Study|Unspecified|0
82793|NCT00141297|295380|P5|Overall Study|Unspecified|5
82794|NCT00141297|295381|P4|Overall Study|Unspecified|1
82795|NCT00141297|295382|P3|Overall Study|Unspecified|0
82796|NCT00141297|295383|P2|Overall Study|Unspecified|0
82797|NCT00141297|295384|P1|Overall Study|Unspecified|0
82798|NCT00141297|295375|P10|Overall Study|Withdrawal by Subject|0
82799|NCT00141297|295376|P9|Overall Study|Withdrawal by Subject|1
82800|NCT00141297|295377|P8|Overall Study|Withdrawal by Subject|0
82801|NCT00141297|295378|P7|Overall Study|Withdrawal by Subject|0
82802|NCT00141297|295379|P6|Overall Study|Withdrawal by Subject|0
82803|NCT00141297|295380|P5|Overall Study|Withdrawal by Subject|0
82804|NCT00141297|295381|P4|Overall Study|Withdrawal by Subject|0
82805|NCT00141297|295382|P3|Overall Study|Withdrawal by Subject|0
82806|NCT00141297|295383|P2|Overall Study|Withdrawal by Subject|0
82807|NCT00141297|295384|P1|Overall Study|Withdrawal by Subject|0
82808|NCT00141297|295375|P10|Overall Study|Death|0
82809|NCT00141297|295376|P9|Overall Study|Death|1
82810|NCT00141297|295377|P8|Overall Study|Death|0
82811|NCT00141297|295378|P7|Overall Study|Death|0
82812|NCT00141297|295379|P6|Overall Study|Death|0
82813|NCT00141297|295380|P5|Overall Study|Death|0
82814|NCT00141297|295381|P4|Overall Study|Death|0
82815|NCT00141297|295382|P3|Overall Study|Death|0
82816|NCT00141297|295383|P2|Overall Study|Death|0
82817|NCT00141297|295384|P1|Overall Study|Death|1
82818|NCT00141297|295375|P10|Overall Study|Adverse Event|0
82819|NCT00141297|295376|P9|Overall Study|Adverse Event|1
82820|NCT00141297|295377|P8|Overall Study|Adverse Event|1
82821|NCT00141297|295378|P7|Overall Study|Adverse Event|0
82822|NCT00141297|295379|P6|Overall Study|Adverse Event|1
82823|NCT00141297|295380|P5|Overall Study|Adverse Event|1
82824|NCT00141297|295381|P4|Overall Study|Adverse Event|0
82825|NCT00141297|295382|P3|Overall Study|Adverse Event|1
82826|NCT00141297|295383|P2|Overall Study|Adverse Event|0
82827|NCT00141297|295384|P1|Overall Study|Adverse Event|0
82828|NCT00141453|295661|P2|Overall Study|Protocol Violation|5
82829|NCT00141453|295662|P1|Overall Study|Protocol Violation|6
82830|NCT00141518|295677|P3|Overall Study|Lack of Efficacy|0
82831|NCT00141518|295678|P2|Overall Study|Lack of Efficacy|0
82832|NCT00141518|295679|P1|Overall Study|Lack of Efficacy|5
82833|NCT00141518|295677|P3|Overall Study|Protocol Violation|2
82834|NCT00141518|295678|P2|Overall Study|Protocol Violation|1
82835|NCT00141518|295679|P1|Overall Study|Protocol Violation|1
82836|NCT00141518|295677|P3|Overall Study|Withdrawal by Subject|2
82837|NCT00141518|295678|P2|Overall Study|Withdrawal by Subject|0
82838|NCT00141518|295679|P1|Overall Study|Withdrawal by Subject|2
82839|NCT00141518|295677|P3|Overall Study|Adverse Event|2
82840|NCT00141518|295678|P2|Overall Study|Adverse Event|5
82841|NCT00141518|295679|P1|Overall Study|Adverse Event|7
82842|NCT00141518|295677|P3|Overall Study|Withdrew Consent Prior to Treatment|0
82843|NCT00141518|295678|P2|Overall Study|Withdrew Consent Prior to Treatment|0
82844|NCT00141518|295679|P1|Overall Study|Withdrew Consent Prior to Treatment|1
82845|NCT00141726|295866|P1|Overall Study|Completed <50% Scheduled Dosing|3
82846|NCT00141778|295889|P3|Started Study Medication|Chest Discomfort|1
82847|NCT00141778|295890|P2|Started Study Medication|Chest Discomfort|0
82848|NCT00141778|295891|P1|Started Study Medication|Chest Discomfort|0
82849|NCT00141778|295889|P3|Started Study Medication|Difficulty Swallowing|0
82850|NCT00141778|295890|P2|Started Study Medication|Difficulty Swallowing|1
82851|NCT00141778|295891|P1|Started Study Medication|Difficulty Swallowing|0
82852|NCT00141778|295889|P3|Started Study Medication|Withdrawal by Subject|0
82853|NCT00141778|295890|P2|Started Study Medication|Withdrawal by Subject|2
82854|NCT00141778|295891|P1|Started Study Medication|Withdrawal by Subject|0
82855|NCT00141778|295889|P3|Started Study Medication|Met safety criteria for discontinuation|3
82856|NCT00141778|295890|P2|Started Study Medication|Met safety criteria for discontinuation|4
82857|NCT00141778|295891|P1|Started Study Medication|Met safety criteria for discontinuation|2
82858|NCT00141778|295889|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
82859|NCT00141778|295890|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
82860|NCT00141778|295891|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
82861|NCT00141817|295933|P4|Overall Study|Parent request|0
82862|NCT00141817|295934|P3|Overall Study|Parent request|0
82863|NCT00141817|295935|P2|Overall Study|Parent request|0
82864|NCT00141817|295936|P1|Overall Study|Parent request|1
82865|NCT00141817|295933|P4|Overall Study|Protocol Violation|0
82866|NCT00141817|295934|P3|Overall Study|Protocol Violation|1
82867|NCT00141817|295935|P2|Overall Study|Protocol Violation|0
82868|NCT00141817|295936|P1|Overall Study|Protocol Violation|0
82869|NCT00141921|295974|P1|Overall Study|Other|8
82870|NCT00141921|295974|P1|Overall Study|Ineligibility Determined|2
82871|NCT00141921|295974|P1|Overall Study|Pregnancy|4
82872|NCT00141921|295974|P1|Overall Study|Administrative Decision|2
82873|NCT00141921|295974|P1|Overall Study|Adverse Event|5
82874|NCT00141921|295974|P1|Overall Study|Protocol Deviation|7
82875|NCT00141921|295974|P1|Overall Study|Disease Progression|7
82876|NCT00141921|295974|P1|Overall Study|Noncompliance|17
82877|NCT00141921|295974|P1|Overall Study|Lost to Follow-up|19
82878|NCT00141921|295974|P1|Overall Study|Withdrawal by Subject|42
82879|NCT00141921|295974|P1|Overall Study|Remain on Study|28
82880|NCT00142298|296018|P10|Overall Study|Treatment Failure|0
82881|NCT00142298|296019|P9|Overall Study|Treatment Failure|0
82882|NCT00142298|296020|P8|Overall Study|Treatment Failure|0
82883|NCT00142298|296021|P7|Overall Study|Treatment Failure|2
82884|NCT00142298|296022|P6|Overall Study|Treatment Failure|2
82885|NCT00142298|296023|P5|Overall Study|Treatment Failure|0
82886|NCT00142298|296024|P4|Overall Study|Treatment Failure|0
82887|NCT00142298|296025|P3|Overall Study|Treatment Failure|0
82888|NCT00142298|296026|P2|Overall Study|Treatment Failure|0
82889|NCT00142298|296027|P1|Overall Study|Treatment Failure|0
82890|NCT00142298|296018|P10|Overall Study|Lost to Follow-up|0
82891|NCT00142298|296019|P9|Overall Study|Lost to Follow-up|0
82892|NCT00142298|296020|P8|Overall Study|Lost to Follow-up|0
82893|NCT00142298|296021|P7|Overall Study|Lost to Follow-up|2
82894|NCT00142298|296022|P6|Overall Study|Lost to Follow-up|0
82895|NCT00142298|296023|P5|Overall Study|Lost to Follow-up|0
82896|NCT00142298|296024|P4|Overall Study|Lost to Follow-up|0
82897|NCT00142298|296025|P3|Overall Study|Lost to Follow-up|0
82898|NCT00142298|296026|P2|Overall Study|Lost to Follow-up|0
82899|NCT00142298|296027|P1|Overall Study|Lost to Follow-up|0
82900|NCT00142298|296018|P10|Overall Study|Other- not specified|0
82901|NCT00142298|296019|P9|Overall Study|Other- not specified|0
82902|NCT00142298|296020|P8|Overall Study|Other- not specified|0
82903|NCT00142298|296021|P7|Overall Study|Other- not specified|0
82904|NCT00142298|296022|P6|Overall Study|Other- not specified|0
82905|NCT00142298|296023|P5|Overall Study|Other- not specified|0
82906|NCT00142298|296024|P4|Overall Study|Other- not specified|1
82907|NCT00142298|296025|P3|Overall Study|Other- not specified|0
82908|NCT00142298|296026|P2|Overall Study|Other- not specified|3
82909|NCT00142298|296027|P1|Overall Study|Other- not specified|0
82910|NCT00142298|296018|P10|Overall Study|Virologic breakthrough|0
82911|NCT00142298|296019|P9|Overall Study|Virologic breakthrough|0
82912|NCT00142298|296020|P8|Overall Study|Virologic breakthrough|0
82913|NCT00142298|296021|P7|Overall Study|Virologic breakthrough|3
82914|NCT00142298|296022|P6|Overall Study|Virologic breakthrough|3
82915|NCT00142298|296023|P5|Overall Study|Virologic breakthrough|2
82916|NCT00142298|296024|P4|Overall Study|Virologic breakthrough|7
82917|NCT00142298|296025|P3|Overall Study|Virologic breakthrough|9
82918|NCT00142298|296026|P2|Overall Study|Virologic breakthrough|23
82919|NCT00142298|296027|P1|Overall Study|Virologic breakthrough|19
82920|NCT00142298|296018|P10|Overall Study|Pregnancy|0
82921|NCT00142298|296019|P9|Overall Study|Pregnancy|1
82922|NCT00142298|296020|P8|Overall Study|Pregnancy|0
82923|NCT00142298|296021|P7|Overall Study|Pregnancy|0
82924|NCT00142298|296022|P6|Overall Study|Pregnancy|0
82925|NCT00142298|296023|P5|Overall Study|Pregnancy|0
82926|NCT00142298|296024|P4|Overall Study|Pregnancy|3
82927|NCT00142298|296025|P3|Overall Study|Pregnancy|2
82928|NCT00142298|296026|P2|Overall Study|Pregnancy|4
82929|NCT00142298|296027|P1|Overall Study|Pregnancy|4
82930|NCT00142298|296018|P10|Overall Study|Patient, Investigator,or Sponsor request|0
82931|NCT00142298|296019|P9|Overall Study|Patient, Investigator,or Sponsor request|1
82932|NCT00142298|296020|P8|Overall Study|Patient, Investigator,or Sponsor request|4
82933|NCT00142298|296021|P7|Overall Study|Patient, Investigator,or Sponsor request|1
82934|NCT00142298|296022|P6|Overall Study|Patient, Investigator,or Sponsor request|3
82935|NCT00142298|296023|P5|Overall Study|Patient, Investigator,or Sponsor request|4
82936|NCT00142298|296024|P4|Overall Study|Patient, Investigator,or Sponsor request|51
82937|NCT00142298|296025|P3|Overall Study|Patient, Investigator,or Sponsor request|11
82938|NCT00142298|296026|P2|Overall Study|Patient, Investigator,or Sponsor request|60
82939|NCT00142298|296027|P1|Overall Study|Patient, Investigator,or Sponsor request|66
82940|NCT00142298|296018|P10|Overall Study|Non-compliance|0
82941|NCT00142298|296019|P9|Overall Study|Non-compliance|3
82942|NCT00142298|296020|P8|Overall Study|Non-compliance|3
82943|NCT00142298|296021|P7|Overall Study|Non-compliance|0
82944|NCT00142298|296022|P6|Overall Study|Non-compliance|0
82945|NCT00142298|296023|P5|Overall Study|Non-compliance|1
82946|NCT00142298|296024|P4|Overall Study|Non-compliance|6
82947|NCT00142298|296025|P3|Overall Study|Non-compliance|0
82948|NCT00142298|296026|P2|Overall Study|Non-compliance|13
82949|NCT00142298|296027|P1|Overall Study|Non-compliance|15
82950|NCT00142298|296018|P10|Overall Study|Lack of Efficacy|0
82951|NCT00142298|296019|P9|Overall Study|Lack of Efficacy|0
82952|NCT00142298|296020|P8|Overall Study|Lack of Efficacy|1
82953|NCT00142298|296021|P7|Overall Study|Lack of Efficacy|0
82954|NCT00142298|296022|P6|Overall Study|Lack of Efficacy|0
82955|NCT00142298|296023|P5|Overall Study|Lack of Efficacy|1
82956|NCT00142298|296024|P4|Overall Study|Lack of Efficacy|12
82957|NCT00142298|296025|P3|Overall Study|Lack of Efficacy|9
82958|NCT00142298|296026|P2|Overall Study|Lack of Efficacy|62
82959|NCT00142298|296027|P1|Overall Study|Lack of Efficacy|44
82960|NCT00142298|296018|P10|Overall Study|Death|0
82961|NCT00142298|296019|P9|Overall Study|Death|0
82962|NCT00142298|296020|P8|Overall Study|Death|0
82963|NCT00142298|296021|P7|Overall Study|Death|0
82964|NCT00142298|296022|P6|Overall Study|Death|6
82965|NCT00142298|296023|P5|Overall Study|Death|0
82966|NCT00142298|296024|P4|Overall Study|Death|0
82967|NCT00142298|296025|P3|Overall Study|Death|1
82968|NCT00142298|296026|P2|Overall Study|Death|1
82969|NCT00142298|296027|P1|Overall Study|Death|1
82970|NCT00142298|296018|P10|Overall Study|Clinical disease progression|0
82971|NCT00142298|296019|P9|Overall Study|Clinical disease progression|0
82972|NCT00142298|296020|P8|Overall Study|Clinical disease progression|0
82973|NCT00142298|296021|P7|Overall Study|Clinical disease progression|0
82974|NCT00142298|296022|P6|Overall Study|Clinical disease progression|0
82975|NCT00142298|296023|P5|Overall Study|Clinical disease progression|0
82976|NCT00142298|296024|P4|Overall Study|Clinical disease progression|0
82977|NCT00142298|296025|P3|Overall Study|Clinical disease progression|0
82978|NCT00142298|296026|P2|Overall Study|Clinical disease progression|0
82979|NCT00142298|296027|P1|Overall Study|Clinical disease progression|1
82980|NCT00142298|296018|P10|Overall Study|Adverse Event|0
82981|NCT00142298|296019|P9|Overall Study|Adverse Event|0
82982|NCT00142298|296020|P8|Overall Study|Adverse Event|0
82983|NCT00142298|296021|P7|Overall Study|Adverse Event|0
82984|NCT00142298|296022|P6|Overall Study|Adverse Event|2
82985|NCT00142298|296023|P5|Overall Study|Adverse Event|2
82986|NCT00142298|296024|P4|Overall Study|Adverse Event|5
82987|NCT00142298|296025|P3|Overall Study|Adverse Event|1
82988|NCT00142298|296026|P2|Overall Study|Adverse Event|10
82989|NCT00142298|296027|P1|Overall Study|Adverse Event|10
82990|NCT00142415|296055|P6|Overall Study|Physician Decision|2
82991|NCT00142415|296056|P5|Overall Study|Physician Decision|1
82992|NCT00142415|296057|P4|Overall Study|Physician Decision|0
82993|NCT00142415|296058|P3|Overall Study|Physician Decision|0
82994|NCT00142415|296059|P2|Overall Study|Physician Decision|0
82995|NCT00142415|296060|P1|Overall Study|Physician Decision|0
82996|NCT00142909|296116|P2|Medications Begin|Withdrawal by Subject|0
82997|NCT00142909|296117|P1|Medications Begin|Withdrawal by Subject|2
82998|NCT00142909|296116|P2|Medications Begin|Withdrawal by Subject|3
82999|NCT00142909|296117|P1|Medications Begin|Withdrawal by Subject|5
83000|NCT00142909|296116|P2|Medications Begin|Protocol Violation|0
83001|NCT00142909|296117|P1|Medications Begin|Protocol Violation|2
83002|NCT00142909|296116|P2|Randomization|Various Reasons|10
83003|NCT00142909|296117|P1|Randomization|Various Reasons|7
83004|NCT00142935|296136|P3|Overall Study|Death|1
83005|NCT00142935|296137|P2|Overall Study|Death|2
83006|NCT00142935|296138|P1|Overall Study|Death|0
83007|NCT00142935|296136|P3|Overall Study|Lost to Follow-up|5
83008|NCT00142935|296137|P2|Overall Study|Lost to Follow-up|5
83009|NCT00142935|296138|P1|Overall Study|Lost to Follow-up|2
83010|NCT00142935|296136|P3|Overall Study|Other reason|1
83011|NCT00142935|296137|P2|Overall Study|Other reason|1
83012|NCT00142935|296138|P1|Overall Study|Other reason|1
83013|NCT00135330|296169|P3|Overall Study|Sponsor Decision|0
83014|NCT00135330|296170|P2|Overall Study|Sponsor Decision|1
83015|NCT00135330|296171|P1|Overall Study|Sponsor Decision|0
83016|NCT00135330|296169|P3|Overall Study|Patient Decision|4
83017|NCT00135330|296170|P2|Overall Study|Patient Decision|1
83018|NCT00135330|296171|P1|Overall Study|Patient Decision|5
83019|NCT00135330|296169|P3|Overall Study|Protocol Violation|3
83020|NCT00135330|296170|P2|Overall Study|Protocol Violation|3
83021|NCT00135330|296171|P1|Overall Study|Protocol Violation|4
83022|NCT00135330|296169|P3|Overall Study|Physician Decision|0
83023|NCT00135330|296170|P2|Overall Study|Physician Decision|1
83024|NCT00135330|296171|P1|Overall Study|Physician Decision|1
83025|NCT00135330|296169|P3|Overall Study|Lost to Follow-up|3
83026|NCT00135330|296170|P2|Overall Study|Lost to Follow-up|2
83027|NCT00135330|296171|P1|Overall Study|Lost to Follow-up|0
83028|NCT00135330|296169|P3|Overall Study|Adverse Event|1
83029|NCT00135330|296170|P2|Overall Study|Adverse Event|5
83030|NCT00135330|296171|P1|Overall Study|Adverse Event|2
83031|NCT00135356|296265|P2|Overall Study|Withdrawal by Subject|4
83032|NCT00135356|296266|P1|Overall Study|Withdrawal by Subject|2
83033|NCT00135356|296265|P2|Overall Study|No longer meets study criteria|0
83034|NCT00135356|296266|P1|Overall Study|No longer meets study criteria|2
83035|NCT00135356|296265|P2|Overall Study|Poor/noncompliance|1
83036|NCT00135356|296266|P1|Overall Study|Poor/noncompliance|1
83037|NCT00135356|296265|P2|Overall Study|Change in antiviral regimen|1
83038|NCT00135356|296266|P1|Overall Study|Change in antiviral regimen|0
83039|NCT00135356|296265|P2|Overall Study|Surgery for abdominal fat|0
83040|NCT00135356|296266|P1|Overall Study|Surgery for abdominal fat|1
83041|NCT00135356|296265|P2|Overall Study|Lost to Follow-up|1
83042|NCT00135356|296266|P1|Overall Study|Lost to Follow-up|3
83043|NCT00135356|296265|P2|Overall Study|Lack of Efficacy|0
83044|NCT00135356|296266|P1|Overall Study|Lack of Efficacy|2
83045|NCT00135356|296265|P2|Overall Study|Adverse Event|2
83046|NCT00135356|296266|P1|Overall Study|Adverse Event|6
83047|NCT00135694|296309|P3|Overall Study|Ineligible for Random assignment|0
83048|NCT00135694|296310|P2|Overall Study|Ineligible for Random assignment|0
83049|NCT00135694|296311|P1|Overall Study|Ineligible for Random assignment|42
83050|NCT00135694|296309|P3|Overall Study|Hepatitis C related reasons|0
83051|NCT00135694|296310|P2|Overall Study|Hepatitis C related reasons|1
83052|NCT00135694|296311|P1|Overall Study|Hepatitis C related reasons|39
83053|NCT00135694|296309|P3|Overall Study|Protocol Violation|0
83054|NCT00135694|296310|P2|Overall Study|Protocol Violation|1
83055|NCT00135694|296311|P1|Overall Study|Protocol Violation|19
83056|NCT00135694|296309|P3|Overall Study|Withdrawal by Subject|4
83057|NCT00135694|296310|P2|Overall Study|Withdrawal by Subject|7
83058|NCT00135694|296311|P1|Overall Study|Withdrawal by Subject|41
83059|NCT00135694|296309|P3|Overall Study|Lost to Follow-up|1
83060|NCT00135694|296310|P2|Overall Study|Lost to Follow-up|7
83061|NCT00135694|296311|P1|Overall Study|Lost to Follow-up|8
83062|NCT00135694|296309|P3|Overall Study|Death|2
83063|NCT00135694|296310|P2|Overall Study|Death|1
83064|NCT00135694|296311|P1|Overall Study|Death|14
83065|NCT00135694|296309|P3|Overall Study|Adverse Event|0
83066|NCT00135694|296310|P2|Overall Study|Adverse Event|4
83067|NCT00135694|296311|P1|Overall Study|Adverse Event|17
83068|NCT00136084|296352|P2|Overall Study|Withdrawal by Subject|1
83069|NCT00136084|296353|P1|Overall Study|Withdrawal by Subject|5
83070|NCT00136084|296352|P2|Overall Study|No Response|2
83071|NCT00136084|296353|P1|Overall Study|No Response|1
83072|NCT00136084|296352|P2|Overall Study|Lost to Follow-up|0
83073|NCT00136084|296353|P1|Overall Study|Lost to Follow-up|2
83074|NCT00136084|296352|P2|Overall Study|Relapse|23
83075|NCT00136084|296353|P1|Overall Study|Relapse|20
83076|NCT00136084|296352|P2|Overall Study|Unacceptable toxicity|11
83077|NCT00136084|296353|P1|Overall Study|Unacceptable toxicity|8
83078|NCT00136084|296352|P2|Overall Study|Death|5
83079|NCT00136084|296353|P1|Overall Study|Death|12
83080|NCT00136318|296368|P2|Overall Study|Withdrawal by Subject|2
83081|NCT00136318|296369|P1|Overall Study|Withdrawal by Subject|2
83082|NCT00136318|296368|P2|Overall Study|Adverse Event|5
83083|NCT00136318|296369|P1|Overall Study|Adverse Event|5
83084|NCT00136357|296385|P2|Overall Study|Withdrawal by Subject|2
83085|NCT00136357|296386|P1|Overall Study|Withdrawal by Subject|3
83086|NCT00136916|296442|P2|Overall Study|Discontinued in follow up period|0
83087|NCT00136916|296443|P1|Overall Study|Discontinued in follow up period|3
83088|NCT00136916|296442|P2|Overall Study|Unspecified|24
83089|NCT00136916|296443|P1|Overall Study|Unspecified|22
83090|NCT00136916|296442|P2|Overall Study|Withdrawal by Subject|46
83091|NCT00136916|296443|P1|Overall Study|Withdrawal by Subject|44
83092|NCT00136916|296442|P2|Overall Study|Lost to Follow-up|14
83093|NCT00136916|296443|P1|Overall Study|Lost to Follow-up|12
83094|NCT00136916|296442|P2|Overall Study|Lack of Efficacy|3
83095|NCT00136916|296443|P1|Overall Study|Lack of Efficacy|13
83096|NCT00136916|296442|P2|Overall Study|Laboratory abnormality|1
83097|NCT00136916|296443|P1|Overall Study|Laboratory abnormality|0
83098|NCT00136916|296442|P2|Overall Study|Adverse Event|8
83099|NCT00136916|296443|P1|Overall Study|Adverse Event|27
83100|NCT00136916|296442|P2|Overall Study|Death|3
83101|NCT00136916|296443|P1|Overall Study|Death|1
83102|NCT00136916|296442|P2|Overall Study|Never received study treatment|5
83103|NCT00136916|296443|P1|Overall Study|Never received study treatment|3
83104|NCT00136955|296497|P1|Overall Study|Incl. prog. disease, protocol violation|12
83105|NCT00136955|296497|P1|Overall Study|Withdrawal by Subject|2
83106|NCT00136955|296497|P1|Overall Study|Lost to Follow-up|1
83107|NCT00136955|296497|P1|Overall Study|Adverse Event|8
83108|NCT00137046|296506|P2|Overall Study|Withdrew prior to study treatment|1
83109|NCT00137046|296507|P1|Overall Study|Withdrew prior to study treatment|1
83110|NCT00137046|296506|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
83111|NCT00137046|296507|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
83112|NCT00137046|296506|P2|Overall Study|Withdrawal by Subject|42
83113|NCT00137046|296507|P1|Overall Study|Withdrawal by Subject|33
83114|NCT00137046|296506|P2|Overall Study|Unspecified|19
83115|NCT00137046|296507|P1|Overall Study|Unspecified|23
83116|NCT00137046|296506|P2|Overall Study|Lost to Follow-up|24
83117|NCT00137046|296507|P1|Overall Study|Lost to Follow-up|8
83118|NCT00137046|296506|P2|Overall Study|Lack of Efficacy|1
83119|NCT00137046|296507|P1|Overall Study|Lack of Efficacy|13
83120|NCT00137046|296506|P2|Overall Study|Laboratory Abnormality|0
83121|NCT00137046|296507|P1|Overall Study|Laboratory Abnormality|2
83122|NCT00137046|296506|P2|Overall Study|Adverse Event|5
83123|NCT00137046|296507|P1|Overall Study|Adverse Event|16
83124|NCT00137046|296506|P2|Overall Study|Death|1
83125|NCT00137046|296507|P1|Overall Study|Death|2
83126|NCT00137111|296559|P4|Total Therapy|Non Compliance|0
83127|NCT00137111|296560|P3|Total Therapy|Non Compliance|0
83128|NCT00137111|296561|P2|Total Therapy|Non Compliance|0
83129|NCT00137111|296562|P1|Total Therapy|Non Compliance|5
83130|NCT00137111|296559|P4|Total Therapy|Death|0
83131|NCT00137111|296560|P3|Total Therapy|Death|0
83132|NCT00137111|296561|P2|Total Therapy|Death|0
83133|NCT00137111|296562|P1|Total Therapy|Death|35
83134|NCT00143247|296574|P1|Overall Study|Other|12
83135|NCT00143247|296574|P1|Overall Study|following inaccurate lab adverse event|1
83136|NCT00143247|296574|P1|Overall Study|Lost to Follow-up|12
83137|NCT00143247|296574|P1|Overall Study|Protocol Violation|15
83138|NCT00143247|296574|P1|Overall Study|Study terminated by sponsor|31
83139|NCT00143247|296574|P1|Overall Study|Withdrawal by Subject|55
83140|NCT00143247|296574|P1|Overall Study|Lack of Efficacy|3
83141|NCT00143247|296574|P1|Overall Study|Adverse Event|19
83142|NCT00143247|296574|P1|Overall Study|Death|8
83143|NCT00143312|296588|P1|Overall Study|Withdrawal by Subject|1
83144|NCT00143312|296588|P1|Overall Study|Other|1
83145|NCT00143312|296588|P1|Overall Study|Lost to Follow-up|1
83146|NCT00143312|296588|P1|Overall Study|Adverse Event|2
83147|NCT00143312|296588|P1|Overall Study|Death|11
83148|NCT00143455|296602|P4|Cohort 2|Randomized But Not Treated|1
83149|NCT00143455|296603|P3|Cohort 2|Randomized But Not Treated|1
83150|NCT00143455|296604|P2|Cohort 2|Randomized But Not Treated|0
83151|NCT00143455|296605|P1|Cohort 2|Randomized But Not Treated|0
83152|NCT00143455|296602|P4|Cohort 2|Unspecified|6
83153|NCT00143455|296603|P3|Cohort 2|Unspecified|7
83154|NCT00143455|296604|P2|Cohort 2|Unspecified|0
83155|NCT00143455|296605|P1|Cohort 2|Unspecified|0
83156|NCT00143455|296602|P4|Cohort 2|Withdrawal by Subject|12
83157|NCT00143455|296603|P3|Cohort 2|Withdrawal by Subject|13
83158|NCT00143455|296604|P2|Cohort 2|Withdrawal by Subject|0
83159|NCT00143455|296605|P1|Cohort 2|Withdrawal by Subject|0
83160|NCT00143455|296602|P4|Cohort 2|Progressive Disease|27
83161|NCT00143455|296603|P3|Cohort 2|Progressive Disease|20
83162|NCT00143455|296604|P2|Cohort 2|Progressive Disease|0
83163|NCT00143455|296605|P1|Cohort 2|Progressive Disease|0
83164|NCT00143455|296602|P4|Cohort 2|Death|12
83165|NCT00143455|296603|P3|Cohort 2|Death|20
83166|NCT00143455|296604|P2|Cohort 2|Death|0
83167|NCT00143455|296605|P1|Cohort 2|Death|0
83168|NCT00143455|296602|P4|Cohort 2|Lost to Follow-up|4
83169|NCT00143455|296603|P3|Cohort 2|Lost to Follow-up|1
83170|NCT00143455|296604|P2|Cohort 2|Lost to Follow-up|0
83171|NCT00143455|296605|P1|Cohort 2|Lost to Follow-up|0
83172|NCT00143455|296602|P4|Cohort 2|Protocol Violation|1
83173|NCT00143455|296603|P3|Cohort 2|Protocol Violation|1
83174|NCT00143455|296604|P2|Cohort 2|Protocol Violation|0
83175|NCT00143455|296605|P1|Cohort 2|Protocol Violation|0
83176|NCT00143455|296602|P4|Cohort 2|No Longer Required Study Treatment|0
83177|NCT00143455|296603|P3|Cohort 2|No Longer Required Study Treatment|1
83178|NCT00143455|296604|P2|Cohort 2|No Longer Required Study Treatment|0
83179|NCT00143455|296605|P1|Cohort 2|No Longer Required Study Treatment|0
83180|NCT00143455|296602|P4|Cohort 2|Adverse Event|30
83181|NCT00143455|296603|P3|Cohort 2|Adverse Event|42
83182|NCT00143455|296604|P2|Cohort 2|Adverse Event|0
83183|NCT00143455|296605|P1|Cohort 2|Adverse Event|0
83184|NCT00143455|296602|P4|Cohort 1|Randomized But Not Treated|0
83185|NCT00143455|296603|P3|Cohort 1|Randomized But Not Treated|0
83186|NCT00143455|296604|P2|Cohort 1|Randomized But Not Treated|1
83187|NCT00143455|296605|P1|Cohort 1|Randomized But Not Treated|0
83188|NCT00143455|296602|P4|Cohort 1|Withdrawal by Subject|0
83189|NCT00143455|296603|P3|Cohort 1|Withdrawal by Subject|0
83190|NCT00143455|296604|P2|Cohort 1|Withdrawal by Subject|4
83191|NCT00143455|296605|P1|Cohort 1|Withdrawal by Subject|1
83192|NCT00143455|296602|P4|Cohort 1|Progressive Disease|0
83193|NCT00143455|296603|P3|Cohort 1|Progressive Disease|0
83194|NCT00143455|296604|P2|Cohort 1|Progressive Disease|6
83195|NCT00143455|296605|P1|Cohort 1|Progressive Disease|0
83196|NCT00143455|296602|P4|Cohort 1|Death|0
83197|NCT00143455|296603|P3|Cohort 1|Death|0
83198|NCT00143455|296604|P2|Cohort 1|Death|2
83199|NCT00143455|296605|P1|Cohort 1|Death|5
83200|NCT00143455|296602|P4|Cohort 1|Adverse Event|0
83201|NCT00143455|296603|P3|Cohort 1|Adverse Event|0
83202|NCT00143455|296604|P2|Cohort 1|Adverse Event|4
83203|NCT00143455|296605|P1|Cohort 1|Adverse Event|8
83204|NCT00143507|296639|P2|Overall Study|Withdrawn by sponsor's decision|3
83205|NCT00143507|296640|P1|Overall Study|Withdrawn by sponsor's decision|0
83206|NCT00143507|296639|P2|Overall Study|Lost to Follow-up|0
83207|NCT00143507|296640|P1|Overall Study|Lost to Follow-up|1
83208|NCT00143507|296639|P2|Overall Study|Withdrawal by Subject|102
83209|NCT00143507|296640|P1|Overall Study|Withdrawal by Subject|114
83210|NCT00143507|296639|P2|Overall Study|Death|547
83211|NCT00143507|296640|P1|Overall Study|Death|572
83212|NCT00143598|296672|P2|Overall Study|Death|36
83213|NCT00143598|296673|P1|Overall Study|Death|36
83214|NCT00143598|296672|P2|Overall Study|Withdrawal by Subject|37
83215|NCT00143598|296673|P1|Overall Study|Withdrawal by Subject|33
83216|NCT00143598|296672|P2|Overall Study|Lost to Follow-up|21
83217|NCT00143598|296673|P1|Overall Study|Lost to Follow-up|23
83218|NCT00144027|296709|P2|Overall Study|did not complete baseline assessment|6
83219|NCT00144027|296710|P1|Overall Study|did not complete baseline assessment|0
83220|NCT00144027|296709|P2|Overall Study|Withdrawal by Subject|2
83221|NCT00144027|296710|P1|Overall Study|Withdrawal by Subject|2
83222|NCT00144027|296709|P2|Overall Study|Lost to Follow-up|3
83223|NCT00144027|296710|P1|Overall Study|Lost to Follow-up|1
83224|NCT00144170|296718|P2|Overall Study|Other reason not defined above|316
83225|NCT00144170|296719|P1|Overall Study|Other reason not defined above|211
83226|NCT00144170|296718|P2|Overall Study|Withdrawal by Subject|13
83227|NCT00144170|296719|P1|Overall Study|Withdrawal by Subject|29
83228|NCT00144170|296718|P2|Overall Study|Lost to Follow-up|10
83229|NCT00144170|296719|P1|Overall Study|Lost to Follow-up|5
83230|NCT00144170|296718|P2|Overall Study|Protocol Violation|16
83231|NCT00144170|296719|P1|Overall Study|Protocol Violation|23
83232|NCT00144170|296718|P2|Overall Study|Adverse Event|41
83233|NCT00144170|296719|P1|Overall Study|Adverse Event|84
83234|NCT00144300|296909|P2|Overall Study|Other reason (not specified)|3
83235|NCT00144300|296910|P1|Overall Study|Other reason (not specified)|1
83236|NCT00144300|296909|P2|Overall Study|Withdrawal by Subject|6
83237|NCT00144300|296910|P1|Overall Study|Withdrawal by Subject|6
83238|NCT00144300|296909|P2|Overall Study|Lost to Follow-up|0
83239|NCT00144300|296910|P1|Overall Study|Lost to Follow-up|3
83240|NCT00144300|296909|P2|Overall Study|Protocol Violation|3
83241|NCT00144300|296910|P1|Overall Study|Protocol Violation|1
83242|NCT00144300|296909|P2|Overall Study|Adverse Event|16
83243|NCT00144300|296910|P1|Overall Study|Adverse Event|18
83244|NCT00144339|296958|P2|Overall Study|Other|60
83245|NCT00144339|296959|P1|Overall Study|Other|58
83246|NCT00144339|296958|P2|Overall Study|Lost to Follow-up|64
83247|NCT00144339|296959|P1|Overall Study|Lost to Follow-up|76
83248|NCT00144339|296958|P2|Overall Study|Withdrawal by Subject|300
83249|NCT00144339|296959|P1|Overall Study|Withdrawal by Subject|403
83250|NCT00144339|296958|P2|Overall Study|Protocol Violation|48
83251|NCT00144339|296959|P1|Overall Study|Protocol Violation|75
83252|NCT00144339|296958|P2|Overall Study|Adverse Event|627
83253|NCT00144339|296959|P1|Overall Study|Adverse Event|746
83254|NCT00144781|297178|P4|Overall Study|Non-compliant|0
83255|NCT00144781|297179|P3|Overall Study|Non-compliant|0
83256|NCT00144781|297180|P2|Overall Study|Non-compliant|1
83257|NCT00144781|297181|P1|Overall Study|Non-compliant|0
83258|NCT00144781|297178|P4|Overall Study|Adverse Event|0
83259|NCT00144781|297179|P3|Overall Study|Adverse Event|0
83260|NCT00144781|297180|P2|Overall Study|Adverse Event|1
83261|NCT00144781|297181|P1|Overall Study|Adverse Event|0
83262|NCT00145119|297209|P1|Overall Study|Death|45
83263|NCT00145327|297262|P3|Overall Study|Missing – not stated|1
83264|NCT00145327|297263|P2|Overall Study|Missing – not stated|0
83265|NCT00145327|297264|P1|Overall Study|Missing – not stated|1
83266|NCT00145327|297262|P3|Overall Study|Abnormal laboratory value(s)|2
83267|NCT00145327|297263|P2|Overall Study|Abnormal laboratory value(s)|0
83268|NCT00145327|297264|P1|Overall Study|Abnormal laboratory value(s)|1
83269|NCT00145327|297262|P3|Overall Study|Protocol Violation|2
83270|NCT00145327|297263|P2|Overall Study|Protocol Violation|0
83271|NCT00145327|297264|P1|Overall Study|Protocol Violation|2
83272|NCT00145327|297262|P3|Overall Study|Administrative problems|13
83273|NCT00145327|297263|P2|Overall Study|Administrative problems|9
83274|NCT00145327|297264|P1|Overall Study|Administrative problems|12
83275|NCT00145327|297262|P3|Overall Study|Lost to Follow-up|14
83276|NCT00145327|297263|P2|Overall Study|Lost to Follow-up|14
83277|NCT00145327|297264|P1|Overall Study|Lost to Follow-up|9
83278|NCT00145327|297262|P3|Overall Study|Adverse Event|22
83279|NCT00145327|297263|P2|Overall Study|Adverse Event|11
83280|NCT00145327|297264|P1|Overall Study|Adverse Event|14
83281|NCT00145327|297262|P3|Overall Study|Death|30
83282|NCT00145327|297263|P2|Overall Study|Death|18
83283|NCT00145327|297264|P1|Overall Study|Death|26
83284|NCT00145327|297262|P3|Overall Study|Withdrawal by Subject|164
83285|NCT00145327|297263|P2|Overall Study|Withdrawal by Subject|72
83286|NCT00145327|297264|P1|Overall Study|Withdrawal by Subject|77
83287|NCT00145496|297326|P2|Overall Study|Other|13
83288|NCT00145496|297327|P1|Overall Study|Other|25
83289|NCT00145496|297326|P2|Overall Study|Lost to Follow-up|5
83290|NCT00145496|297327|P1|Overall Study|Lost to Follow-up|12
83291|NCT00145496|297326|P2|Overall Study|Withdrawal by Subject|26
83292|NCT00145496|297327|P1|Overall Study|Withdrawal by Subject|32
83293|NCT00145496|297326|P2|Overall Study|Lack of Efficacy|7
83294|NCT00145496|297327|P1|Overall Study|Lack of Efficacy|12
83295|NCT00145496|297326|P2|Overall Study|Adverse Event|30
83296|NCT00145496|297327|P1|Overall Study|Adverse Event|42
83297|NCT00145509|297339|P2|Overall Study|Reason not provided|1
83298|NCT00145509|297340|P1|Overall Study|Reason not provided|2
83299|NCT00145509|297339|P2|Overall Study|Withdrew Consent|7
83300|NCT00145509|297340|P1|Overall Study|Withdrew Consent|2
83301|NCT00145509|297339|P2|Overall Study|Lost to Follow-up|9
83302|NCT00145509|297340|P1|Overall Study|Lost to Follow-up|5
83303|NCT00145509|297339|P2|Overall Study|Lack of Efficacy|1
83304|NCT00145509|297340|P1|Overall Study|Lack of Efficacy|3
83305|NCT00145509|297339|P2|Overall Study|Adverse Event|3
83306|NCT00145509|297340|P1|Overall Study|Adverse Event|10
83307|NCT00145574|297355|P3|Open Label Long-term Extension|required restricted medicine|1
83308|NCT00145574|297356|P2|Open Label Long-term Extension|required restricted medicine|0
83309|NCT00145574|297357|P1|Open Label Long-term Extension|required restricted medicine|0
83310|NCT00145574|297355|P3|Open Label Long-term Extension|Withdrawal by Subject|4
83311|NCT00145574|297356|P2|Open Label Long-term Extension|Withdrawal by Subject|0
83312|NCT00145574|297357|P1|Open Label Long-term Extension|Withdrawal by Subject|0
83313|NCT00145574|297355|P3|Open Label Long-term Extension|Lost to Follow-up|1
83314|NCT00145574|297356|P2|Open Label Long-term Extension|Lost to Follow-up|0
83315|NCT00145574|297357|P1|Open Label Long-term Extension|Lost to Follow-up|0
83316|NCT00145574|297355|P3|Open Label Long-term Extension|Adverse Event|5
83317|NCT00145574|297356|P2|Open Label Long-term Extension|Adverse Event|0
83318|NCT00145574|297357|P1|Open Label Long-term Extension|Adverse Event|0
83319|NCT00145574|297355|P3|Double Blind|required restricted medicine|0
83320|NCT00145574|297356|P2|Double Blind|required restricted medicine|1
83321|NCT00145574|297357|P1|Double Blind|required restricted medicine|0
83322|NCT00145574|297355|P3|Double Blind|Withdrawal by Subject|1
83323|NCT00145574|297356|P2|Double Blind|Withdrawal by Subject|1
83324|NCT00145574|297357|P1|Double Blind|Withdrawal by Subject|1
83325|NCT00145574|297355|P3|Double Blind|Adverse Event|1
83326|NCT00145574|297356|P2|Double Blind|Adverse Event|3
83327|NCT00145574|297357|P1|Double Blind|Adverse Event|0
83328|NCT00145600|297425|P4|Overall Study|Withdrawal by Subject|1
83329|NCT00145600|297426|P3|Overall Study|Withdrawal by Subject|0
83330|NCT00145600|297427|P2|Overall Study|Withdrawal by Subject|2
83331|NCT00145600|297428|P1|Overall Study|Withdrawal by Subject|1
83332|NCT00145600|297425|P4|Overall Study|Noncompliance|0
83333|NCT00145600|297426|P3|Overall Study|Noncompliance|0
83334|NCT00145600|297427|P2|Overall Study|Noncompliance|0
83335|NCT00145600|297428|P1|Overall Study|Noncompliance|1
83336|NCT00145600|297425|P4|Overall Study|Lost to Follow-up|4
83337|NCT00145600|297426|P3|Overall Study|Lost to Follow-up|2
83338|NCT00145600|297427|P2|Overall Study|Lost to Follow-up|6
83339|NCT00145600|297428|P1|Overall Study|Lost to Follow-up|2
83340|NCT00145600|297425|P4|Overall Study|Ineligible|5
83341|NCT00145600|297426|P3|Overall Study|Ineligible|1
83342|NCT00145600|297427|P2|Overall Study|Ineligible|0
83343|NCT00145600|297428|P1|Overall Study|Ineligible|3
83344|NCT00145600|297425|P4|Overall Study|Death|6
83345|NCT00145600|297426|P3|Overall Study|Death|2
83346|NCT00145600|297427|P2|Overall Study|Death|2
83347|NCT00145600|297428|P1|Overall Study|Death|1
83348|NCT00145626|297542|P1|Overall Study|Withdrawal by Subject|1
83349|NCT00145626|297542|P1|Overall Study|Death|1
83350|NCT00145626|297542|P1|Overall Study|Turned 2 years old before treatment|1
83351|NCT00145626|297542|P1|Overall Study|Did not have NK infusions|2
83352|NCT00145795|297595|P2|Overall Study|Adverse Event|0
83353|NCT00145795|297596|P1|Overall Study|Adverse Event|1
83354|NCT00140140|297623|P3|Overall Study|Physician Decision|0
83355|NCT00140140|297624|P2|Overall Study|Physician Decision|1
83356|NCT00140140|297625|P1|Overall Study|Physician Decision|1
83357|NCT00140140|297623|P3|Overall Study|Unacceptable toxicity|2
83358|NCT00140140|297624|P2|Overall Study|Unacceptable toxicity|1
83359|NCT00140140|297625|P1|Overall Study|Unacceptable toxicity|1
83360|NCT00140413|297715|P2|Overall Study|Withdrawal by Subject|0
83361|NCT00140413|297716|P1|Overall Study|Withdrawal by Subject|2
83362|NCT00140413|297715|P2|Overall Study|Lost to Follow-up|0
83363|NCT00140413|297716|P1|Overall Study|Lost to Follow-up|1
83364|NCT00140426|297725|P2|Overall Study|Withdrawal by Subject|3
83365|NCT00140426|297726|P1|Overall Study|Withdrawal by Subject|0
83366|NCT00149630|297758|P2|Overall Study|Adverse Event|0
83367|NCT00149630|297759|P1|Overall Study|Adverse Event|2
83368|NCT00149630|297758|P2|Overall Study|Treatment Programs|5
83369|NCT00149630|297759|P1|Overall Study|Treatment Programs|4
83370|NCT00149630|297758|P2|Overall Study|Incarceration|0
83371|NCT00149630|297759|P1|Overall Study|Incarceration|2
83372|NCT00149747|297805|P2|Overall Study|Withdrawal by Subject|3
83373|NCT00149747|297806|P1|Overall Study|Withdrawal by Subject|3
83374|NCT00149747|297805|P2|Overall Study|Death|0
83375|NCT00149747|297806|P1|Overall Study|Death|1
83376|NCT00149825|297830|P2|Overall Study|Other|0
83377|NCT00149825|297831|P1|Overall Study|Other|1
83378|NCT00149825|297830|P2|Overall Study|Not liking insomnia therapy|0
83379|NCT00149825|297831|P1|Overall Study|Not liking insomnia therapy|1
83380|NCT00149825|297830|P2|Overall Study|Time commitments|1
83381|NCT00149825|297831|P1|Overall Study|Time commitments|2
83382|NCT00149825|297830|P2|Overall Study|Intolerance to medication side effects|2
83383|NCT00149825|297831|P1|Overall Study|Intolerance to medication side effects|1
83384|NCT00149890|297841|P2|Overall Study|Graft Loss|1
83385|NCT00149890|297842|P1|Overall Study|Graft Loss|2
83386|NCT00149890|297841|P2|Overall Study|Lost to Follow-up|0
83387|NCT00149890|297842|P1|Overall Study|Lost to Follow-up|1
83388|NCT00149890|297841|P2|Overall Study|Protocol Violation|0
83389|NCT00149890|297842|P1|Overall Study|Protocol Violation|1
83390|NCT00149890|297841|P2|Overall Study|Lack of Efficacy|9
83391|NCT00149890|297842|P1|Overall Study|Lack of Efficacy|8
83392|NCT00149890|297841|P2|Overall Study|Adverse Event|8
83393|NCT00149890|297842|P1|Overall Study|Adverse Event|1
83394|NCT00149994|297862|P2|Overall Study|Protocol Violation|1
83395|NCT00149994|297863|P1|Overall Study|Protocol Violation|0
83396|NCT00149994|297862|P2|Overall Study|Administrative problems:|0
83397|NCT00149994|297863|P1|Overall Study|Administrative problems:|1
83398|NCT00150176|297871|P2|Overall Study|OTHER|13
83399|NCT00150176|297872|P1|Overall Study|OTHER|11
83400|NCT00150176|297871|P2|Overall Study|Lost to Follow-up|3
83401|NCT00150176|297872|P1|Overall Study|Lost to Follow-up|3
83402|NCT00150176|297871|P2|Overall Study|Withdrawal by Subject|12
83403|NCT00150176|297872|P1|Overall Study|Withdrawal by Subject|19
83404|NCT00150176|297871|P2|Overall Study|Relapse/Impending relapse, non-AE|39
83405|NCT00150176|297872|P1|Overall Study|Relapse/Impending relapse, non-AE|10
83406|NCT00150176|297871|P2|Overall Study|Adverse Event|53
83407|NCT00150176|297872|P1|Overall Study|Adverse Event|16
83408|NCT00150345|297883|P2|Overall Study|Unspecified|14
83409|NCT00150345|297884|P1|Overall Study|Unspecified|12
83410|NCT00150345|297883|P2|Overall Study|Laboratory abnormality|2
83411|NCT00150345|297884|P1|Overall Study|Laboratory abnormality|1
83412|NCT00150345|297883|P2|Overall Study|Withdrawal by Subject|4
83413|NCT00150345|297884|P1|Overall Study|Withdrawal by Subject|3
83414|NCT00150345|297883|P2|Overall Study|Lack of Efficacy|4
83415|NCT00150345|297884|P1|Overall Study|Lack of Efficacy|5
83416|NCT00150345|297883|P2|Overall Study|Adverse Event|6
83417|NCT00150345|297884|P1|Overall Study|Adverse Event|8
83418|NCT00150345|297883|P2|Overall Study|Death|2
83419|NCT00150345|297884|P1|Overall Study|Death|5
83420|NCT00150462|297957|P11|Overall Study|Other|1
83421|NCT00150462|297958|P10|Overall Study|Other|1
83422|NCT00150462|297959|P9|Overall Study|Other|0
83423|NCT00150462|297960|P8|Overall Study|Other|0
83424|NCT00150462|297961|P7|Overall Study|Other|0
83425|NCT00150462|297962|P6|Overall Study|Other|0
83426|NCT00150462|297963|P5|Overall Study|Other|0
83427|NCT00150462|297964|P4|Overall Study|Other|0
83428|NCT00150462|297965|P3|Overall Study|Other|0
83429|NCT00150462|297966|P2|Overall Study|Other|0
83430|NCT00150462|297967|P1|Overall Study|Other|0
83431|NCT00150462|297957|P11|Overall Study|Physician Decision|0
83432|NCT00150462|297958|P10|Overall Study|Physician Decision|0
83433|NCT00150462|297959|P9|Overall Study|Physician Decision|0
83434|NCT00150462|297960|P8|Overall Study|Physician Decision|0
83435|NCT00150462|297961|P7|Overall Study|Physician Decision|0
83436|NCT00150462|297962|P6|Overall Study|Physician Decision|0
83437|NCT00150462|297963|P5|Overall Study|Physician Decision|0
83438|NCT00150462|297964|P4|Overall Study|Physician Decision|1
83439|NCT00150462|297965|P3|Overall Study|Physician Decision|1
83440|NCT00150462|297966|P2|Overall Study|Physician Decision|0
83441|NCT00150462|297967|P1|Overall Study|Physician Decision|0
83442|NCT00150462|297957|P11|Overall Study|Adverse Event|0
83443|NCT00150462|297958|P10|Overall Study|Adverse Event|1
83444|NCT00150462|297959|P9|Overall Study|Adverse Event|0
83445|NCT00150462|297960|P8|Overall Study|Adverse Event|2
83446|NCT00150462|297961|P7|Overall Study|Adverse Event|0
83447|NCT00150462|297962|P6|Overall Study|Adverse Event|0
83448|NCT00150462|297963|P5|Overall Study|Adverse Event|0
83449|NCT00150462|297964|P4|Overall Study|Adverse Event|1
83450|NCT00150462|297965|P3|Overall Study|Adverse Event|0
83451|NCT00150462|297966|P2|Overall Study|Adverse Event|0
83452|NCT00150462|297967|P1|Overall Study|Adverse Event|0
83453|NCT00150462|297957|P11|Overall Study|Death|0
83454|NCT00150462|297958|P10|Overall Study|Death|0
83455|NCT00150462|297959|P9|Overall Study|Death|1
83456|NCT00150462|297960|P8|Overall Study|Death|0
83457|NCT00150462|297961|P7|Overall Study|Death|0
83458|NCT00150462|297962|P6|Overall Study|Death|0
83459|NCT00150462|297963|P5|Overall Study|Death|0
83460|NCT00150462|297964|P4|Overall Study|Death|0
83461|NCT00150462|297965|P3|Overall Study|Death|0
83462|NCT00150462|297966|P2|Overall Study|Death|1
83463|NCT00150462|297967|P1|Overall Study|Death|0
83464|NCT00150462|297957|P11|Overall Study|Withdrawal by Subject|0
83465|NCT00150462|297958|P10|Overall Study|Withdrawal by Subject|1
83466|NCT00150462|297959|P9|Overall Study|Withdrawal by Subject|0
83467|NCT00150462|297960|P8|Overall Study|Withdrawal by Subject|1
83468|NCT00150462|297961|P7|Overall Study|Withdrawal by Subject|0
83469|NCT00150462|297962|P6|Overall Study|Withdrawal by Subject|2
83470|NCT00150462|297963|P5|Overall Study|Withdrawal by Subject|1
83471|NCT00150462|297964|P4|Overall Study|Withdrawal by Subject|0
83472|NCT00150462|297965|P3|Overall Study|Withdrawal by Subject|1
83473|NCT00150462|297966|P2|Overall Study|Withdrawal by Subject|1
83474|NCT00150462|297967|P1|Overall Study|Withdrawal by Subject|0
83475|NCT00150462|297957|P11|Overall Study|Disease Progression or Relapse|2
83476|NCT00150462|297958|P10|Overall Study|Disease Progression or Relapse|3
83477|NCT00150462|297959|P9|Overall Study|Disease Progression or Relapse|5
83478|NCT00150462|297960|P8|Overall Study|Disease Progression or Relapse|5
83479|NCT00150462|297961|P7|Overall Study|Disease Progression or Relapse|3
83480|NCT00150462|297962|P6|Overall Study|Disease Progression or Relapse|2
83481|NCT00150462|297963|P5|Overall Study|Disease Progression or Relapse|2
83482|NCT00150462|297964|P4|Overall Study|Disease Progression or Relapse|1
83483|NCT00150462|297965|P3|Overall Study|Disease Progression or Relapse|2
83484|NCT00150462|297966|P2|Overall Study|Disease Progression or Relapse|1
83485|NCT00150462|297967|P1|Overall Study|Disease Progression or Relapse|3
83486|NCT00150592|298077|P2|Overall Study|Non-compliance|0
83487|NCT00150592|298078|P1|Overall Study|Non-compliance|1
83488|NCT00150592|298077|P2|Overall Study|Withdrawal by Subject|2
83489|NCT00150592|298078|P1|Overall Study|Withdrawal by Subject|1
83490|NCT00150592|298077|P2|Overall Study|Protocol Violation|0
83491|NCT00150592|298078|P1|Overall Study|Protocol Violation|1
83492|NCT00150592|298077|P2|Overall Study|Adverse Event|1
83493|NCT00150592|298078|P1|Overall Study|Adverse Event|4
83494|NCT00150618|298103|P5|Overall Study|Sponsor's decision|0
83495|NCT00150618|298104|P4|Overall Study|Sponsor's decision|1
83496|NCT00150618|298105|P3|Overall Study|Sponsor's decision|0
83497|NCT00150618|298106|P2|Overall Study|Sponsor's decision|0
83498|NCT00150618|298107|P1|Overall Study|Sponsor's decision|0
83499|NCT00150618|298103|P5|Overall Study|Abnormal ECG|0
83500|NCT00150618|298104|P4|Overall Study|Abnormal ECG|0
83501|NCT00150618|298105|P3|Overall Study|Abnormal ECG|0
83502|NCT00150618|298106|P2|Overall Study|Abnormal ECG|0
83503|NCT00150618|298107|P1|Overall Study|Abnormal ECG|1
83504|NCT00150618|298103|P5|Overall Study|Lack of compliance|1
83505|NCT00150618|298104|P4|Overall Study|Lack of compliance|0
83506|NCT00150618|298105|P3|Overall Study|Lack of compliance|1
83507|NCT00150618|298106|P2|Overall Study|Lack of compliance|1
83508|NCT00150618|298107|P1|Overall Study|Lack of compliance|2
83509|NCT00150618|298103|P5|Overall Study|Physician Decision|1
83510|NCT00150618|298104|P4|Overall Study|Physician Decision|0
83511|NCT00150618|298105|P3|Overall Study|Physician Decision|0
83512|NCT00150618|298106|P2|Overall Study|Physician Decision|2
83513|NCT00150618|298107|P1|Overall Study|Physician Decision|0
83514|NCT00150618|298103|P5|Overall Study|No study meds|2
83515|NCT00150618|298104|P4|Overall Study|No study meds|0
83516|NCT00150618|298105|P3|Overall Study|No study meds|0
83517|NCT00150618|298106|P2|Overall Study|No study meds|0
83518|NCT00150618|298107|P1|Overall Study|No study meds|0
83519|NCT00150618|298103|P5|Overall Study|Lack of Efficacy|6
83520|NCT00150618|298104|P4|Overall Study|Lack of Efficacy|4
83521|NCT00150618|298105|P3|Overall Study|Lack of Efficacy|7
83522|NCT00150618|298106|P2|Overall Study|Lack of Efficacy|4
83523|NCT00150618|298107|P1|Overall Study|Lack of Efficacy|1
83524|NCT00150618|298103|P5|Overall Study|Protocol Violation|1
83525|NCT00150618|298104|P4|Overall Study|Protocol Violation|0
83526|NCT00150618|298105|P3|Overall Study|Protocol Violation|0
83527|NCT00150618|298106|P2|Overall Study|Protocol Violation|0
83528|NCT00150618|298107|P1|Overall Study|Protocol Violation|1
83529|NCT00150618|298103|P5|Overall Study|Lost to Follow-up|4
83530|NCT00150618|298104|P4|Overall Study|Lost to Follow-up|8
83531|NCT00150618|298105|P3|Overall Study|Lost to Follow-up|5
83532|NCT00150618|298106|P2|Overall Study|Lost to Follow-up|1
83533|NCT00150618|298107|P1|Overall Study|Lost to Follow-up|4
83534|NCT00150618|298103|P5|Overall Study|Withdrawal by Subject|5
83535|NCT00150618|298104|P4|Overall Study|Withdrawal by Subject|4
83536|NCT00150618|298105|P3|Overall Study|Withdrawal by Subject|8
83537|NCT00150618|298106|P2|Overall Study|Withdrawal by Subject|8
83538|NCT00150618|298107|P1|Overall Study|Withdrawal by Subject|6
83539|NCT00150618|298103|P5|Overall Study|Adverse Event|5
83540|NCT00150618|298104|P4|Overall Study|Adverse Event|9
83541|NCT00150618|298105|P3|Overall Study|Adverse Event|6
83542|NCT00150618|298106|P2|Overall Study|Adverse Event|2
83543|NCT00150618|298107|P1|Overall Study|Adverse Event|2
83544|NCT00150969|298141|P2|24-48 Month Extension|Other Reason|91
83545|NCT00150969|298142|P1|24-48 Month Extension|Other Reason|81
83546|NCT00150969|298141|P2|24-48 Month Extension|Adverse Event|3
83547|NCT00150969|298142|P1|24-48 Month Extension|Adverse Event|1
83548|NCT00150969|298141|P2|24-48 Month Extension|Lack of Efficacy|1
83549|NCT00150969|298142|P1|24-48 Month Extension|Lack of Efficacy|0
83550|NCT00150969|298141|P2|24-48 Month Extension|Withdrawal by Subject|5
83551|NCT00150969|298142|P1|24-48 Month Extension|Withdrawal by Subject|6
83552|NCT00150969|298141|P2|24 Month Main Study|Withdrawal by Subject|4
83553|NCT00150969|298142|P1|24 Month Main Study|Withdrawal by Subject|7
83554|NCT00150969|298141|P2|24 Month Main Study|Protocol Violation|2
83555|NCT00150969|298142|P1|24 Month Main Study|Protocol Violation|4
83556|NCT00150969|298141|P2|24 Month Main Study|Lost to Follow-up|2
83557|NCT00150969|298142|P1|24 Month Main Study|Lost to Follow-up|3
83558|NCT00150969|298141|P2|24 Month Main Study|Lack of Efficacy|8
83559|NCT00150969|298142|P1|24 Month Main Study|Lack of Efficacy|1
83560|NCT00150969|298141|P2|24 Month Main Study|Death|1
83561|NCT00150969|298142|P1|24 Month Main Study|Death|1
83562|NCT00150969|298141|P2|24 Month Main Study|Adverse Event|4
83563|NCT00150969|298142|P1|24 Month Main Study|Adverse Event|3
83564|NCT00151372|298183|P2|Overall Study|Withdrawal by Subject|7
83565|NCT00151372|298184|P1|Overall Study|Withdrawal by Subject|7
83566|NCT00151372|298183|P2|Overall Study|Too sick medically to continue|6
83567|NCT00151372|298184|P1|Overall Study|Too sick medically to continue|5
83568|NCT00151372|298183|P2|Overall Study|Lost to Follow-up|5
83569|NCT00151372|298184|P1|Overall Study|Lost to Follow-up|5
83570|NCT00151372|298183|P2|Overall Study|Death|11
83571|NCT00151372|298184|P1|Overall Study|Death|12
83572|NCT00151411|298194|P2|Overall Study|Pregnancy|4
83573|NCT00151411|298195|P1|Overall Study|Pregnancy|0
83574|NCT00151411|298194|P2|Overall Study|Adverse Event|0
83575|NCT00151411|298195|P1|Overall Study|Adverse Event|6
83576|NCT00151411|298194|P2|Overall Study|Withdrawal by Subject|20
83577|NCT00151411|298195|P1|Overall Study|Withdrawal by Subject|12
83578|NCT00151411|298194|P2|Overall Study|Lost to Follow-up|19
83579|NCT00151411|298195|P1|Overall Study|Lost to Follow-up|15
83580|NCT00151476|298204|P2|FAP Analyzed Subjects|Other study participation|1
83581|NCT00151476|298205|P1|FAP Analyzed Subjects|Other study participation|0
83582|NCT00151476|298204|P2|FAP Analyzed Subjects|Lost to Follow-up|2
83583|NCT00151476|298205|P1|FAP Analyzed Subjects|Lost to Follow-up|0
83584|NCT00151476|298204|P2|FAP Identified Subjects|Protocol Violation|1
83585|NCT00151476|298205|P1|FAP Identified Subjects|Protocol Violation|0
83586|NCT00143390|298262|P2|Overall Study|Other|2
83587|NCT00143390|298263|P1|Overall Study|Other|1
83588|NCT00143390|298262|P2|Overall Study|Adverse Event|8
83589|NCT00143390|298263|P1|Overall Study|Adverse Event|9
83590|NCT00143390|298262|P2|Overall Study|Study termination|15
83591|NCT00143390|298263|P1|Overall Study|Study termination|10
83592|NCT00143390|298262|P2|Overall Study|Protocol Violation|0
83593|NCT00143390|298263|P1|Overall Study|Protocol Violation|2
83594|NCT00143390|298262|P2|Overall Study|Progressive disease|115
83595|NCT00143390|298263|P1|Overall Study|Progressive disease|119
83596|NCT00143390|298262|P2|Overall Study|Withdrawal by Subject|4
83597|NCT00143390|298263|P1|Overall Study|Withdrawal by Subject|4
83598|NCT00143390|298262|P2|Overall Study|Not meeting entry criteria|5
83599|NCT00143390|298263|P1|Overall Study|Not meeting entry criteria|2
83600|NCT00143390|298262|P2|Overall Study|Death|0
83601|NCT00143390|298263|P1|Overall Study|Death|2
83602|NCT00143403|298281|P2|Overall Study|Randomized Not Treated|8
83603|NCT00143403|298282|P1|Overall Study|Randomized Not Treated|7
83604|NCT00143403|298281|P2|Overall Study|specified by site|9
83605|NCT00143403|298282|P1|Overall Study|specified by site|4
83606|NCT00143403|298281|P2|Overall Study|Protocol Violation|2
83607|NCT00143403|298282|P1|Overall Study|Protocol Violation|2
83608|NCT00143403|298281|P2|Overall Study|Relapse|7
83609|NCT00143403|298282|P1|Overall Study|Relapse|15
83610|NCT00143403|298281|P2|Overall Study|Withdrawal by Subject|12
83611|NCT00143403|298282|P1|Overall Study|Withdrawal by Subject|3
83612|NCT00143403|298281|P2|Overall Study|Death|0
83613|NCT00143403|298282|P1|Overall Study|Death|1
83614|NCT00143403|298281|P2|Overall Study|Adverse Event|8
83615|NCT00143403|298282|P1|Overall Study|Adverse Event|3
83616|NCT00151775|298295|P12|Period 4: Open Label|Protocol Violation|0
83617|NCT00151775|298296|P11|Period 4: Open Label|Protocol Violation|0
83618|NCT00151775|298297|P10|Period 4: Open Label|Protocol Violation|0
83619|NCT00151775|298298|P9|Period 4: Open Label|Protocol Violation|0
83620|NCT00151775|298299|P8|Period 4: Open Label|Protocol Violation|0
83621|NCT00151775|298300|P7|Period 4: Open Label|Protocol Violation|0
83622|NCT00151775|298301|P6|Period 4: Open Label|Protocol Violation|0
83623|NCT00151775|298302|P5|Period 4: Open Label|Protocol Violation|1
83624|NCT00151775|298303|P4|Period 4: Open Label|Protocol Violation|0
83625|NCT00151775|298304|P3|Period 4: Open Label|Protocol Violation|0
83626|NCT00151775|298305|P2|Period 4: Open Label|Protocol Violation|0
83627|NCT00151775|298306|P1|Period 4: Open Label|Protocol Violation|0
83628|NCT00151775|298295|P12|Period 4: Open Label|Physician Decision|0
83629|NCT00151775|298296|P11|Period 4: Open Label|Physician Decision|0
83630|NCT00151775|298297|P10|Period 4: Open Label|Physician Decision|2
83631|NCT00151775|298298|P9|Period 4: Open Label|Physician Decision|0
83632|NCT00151775|298299|P8|Period 4: Open Label|Physician Decision|0
83633|NCT00151775|298300|P7|Period 4: Open Label|Physician Decision|0
83634|NCT00151775|298301|P6|Period 4: Open Label|Physician Decision|0
83635|NCT00151775|298302|P5|Period 4: Open Label|Physician Decision|0
83636|NCT00151775|298303|P4|Period 4: Open Label|Physician Decision|0
83637|NCT00151775|298304|P3|Period 4: Open Label|Physician Decision|0
83638|NCT00151775|298305|P2|Period 4: Open Label|Physician Decision|0
83639|NCT00151775|298306|P1|Period 4: Open Label|Physician Decision|0
83640|NCT00151775|298295|P12|Period 4: Open Label|Other|0
83641|NCT00151775|298296|P11|Period 4: Open Label|Other|0
83642|NCT00151775|298297|P10|Period 4: Open Label|Other|3
83643|NCT00151775|298298|P9|Period 4: Open Label|Other|0
83644|NCT00151775|298299|P8|Period 4: Open Label|Other|0
83645|NCT00151775|298300|P7|Period 4: Open Label|Other|0
83646|NCT00151775|298301|P6|Period 4: Open Label|Other|0
83647|NCT00151775|298302|P5|Period 4: Open Label|Other|1
83648|NCT00151775|298303|P4|Period 4: Open Label|Other|0
83649|NCT00151775|298304|P3|Period 4: Open Label|Other|0
83650|NCT00151775|298305|P2|Period 4: Open Label|Other|0
83651|NCT00151775|298306|P1|Period 4: Open Label|Other|0
83652|NCT00151775|298295|P12|Period 4: Open Label|Non-compliance with protocol|0
83653|NCT00151775|298296|P11|Period 4: Open Label|Non-compliance with protocol|0
83654|NCT00151775|298297|P10|Period 4: Open Label|Non-compliance with protocol|4
83655|NCT00151775|298298|P9|Period 4: Open Label|Non-compliance with protocol|0
83656|NCT00151775|298299|P8|Period 4: Open Label|Non-compliance with protocol|0
83657|NCT00151775|298300|P7|Period 4: Open Label|Non-compliance with protocol|0
83658|NCT00151775|298301|P6|Period 4: Open Label|Non-compliance with protocol|0
83659|NCT00151775|298302|P5|Period 4: Open Label|Non-compliance with protocol|4
83660|NCT00151775|298303|P4|Period 4: Open Label|Non-compliance with protocol|0
83661|NCT00151775|298304|P3|Period 4: Open Label|Non-compliance with protocol|0
83662|NCT00151775|298305|P2|Period 4: Open Label|Non-compliance with protocol|0
83663|NCT00151775|298306|P1|Period 4: Open Label|Non-compliance with protocol|0
83664|NCT00151775|298295|P12|Period 4: Open Label|Lost to Follow-up|0
83665|NCT00151775|298296|P11|Period 4: Open Label|Lost to Follow-up|0
83666|NCT00151775|298297|P10|Period 4: Open Label|Lost to Follow-up|7
83667|NCT00151775|298298|P9|Period 4: Open Label|Lost to Follow-up|0
83668|NCT00151775|298299|P8|Period 4: Open Label|Lost to Follow-up|0
83669|NCT00151775|298300|P7|Period 4: Open Label|Lost to Follow-up|0
83670|NCT00151775|298301|P6|Period 4: Open Label|Lost to Follow-up|0
83671|NCT00151775|298302|P5|Period 4: Open Label|Lost to Follow-up|17
83672|NCT00151775|298303|P4|Period 4: Open Label|Lost to Follow-up|0
83673|NCT00151775|298304|P3|Period 4: Open Label|Lost to Follow-up|0
83674|NCT00151775|298305|P2|Period 4: Open Label|Lost to Follow-up|0
83675|NCT00151775|298306|P1|Period 4: Open Label|Lost to Follow-up|0
83676|NCT00151775|298295|P12|Period 4: Open Label|Adverse Event|0
83677|NCT00151775|298296|P11|Period 4: Open Label|Adverse Event|0
83678|NCT00151775|298297|P10|Period 4: Open Label|Adverse Event|2
83679|NCT00151775|298298|P9|Period 4: Open Label|Adverse Event|0
83680|NCT00151775|298299|P8|Period 4: Open Label|Adverse Event|0
83681|NCT00151775|298300|P7|Period 4: Open Label|Adverse Event|0
83682|NCT00151775|298301|P6|Period 4: Open Label|Adverse Event|0
83683|NCT00151775|298302|P5|Period 4: Open Label|Adverse Event|1
83684|NCT00151775|298303|P4|Period 4: Open Label|Adverse Event|0
83685|NCT00151775|298304|P3|Period 4: Open Label|Adverse Event|0
83686|NCT00151775|298305|P2|Period 4: Open Label|Adverse Event|0
83687|NCT00151775|298306|P1|Period 4: Open Label|Adverse Event|0
83688|NCT00151775|298295|P12|Period 4: Open Label|Withdrawal by Subject|0
83689|NCT00151775|298296|P11|Period 4: Open Label|Withdrawal by Subject|0
83690|NCT00151775|298297|P10|Period 4: Open Label|Withdrawal by Subject|2
83691|NCT00151775|298298|P9|Period 4: Open Label|Withdrawal by Subject|0
83692|NCT00151775|298299|P8|Period 4: Open Label|Withdrawal by Subject|0
83693|NCT00151775|298300|P7|Period 4: Open Label|Withdrawal by Subject|0
83694|NCT00151775|298301|P6|Period 4: Open Label|Withdrawal by Subject|0
83695|NCT00151775|298302|P5|Period 4: Open Label|Withdrawal by Subject|5
83696|NCT00151775|298303|P4|Period 4: Open Label|Withdrawal by Subject|0
83697|NCT00151775|298304|P3|Period 4: Open Label|Withdrawal by Subject|0
83698|NCT00151775|298305|P2|Period 4: Open Label|Withdrawal by Subject|0
83699|NCT00151775|298306|P1|Period 4: Open Label|Withdrawal by Subject|0
83700|NCT00151775|298295|P12|Period 4: Open Label|Increased blood pressure|0
83701|NCT00151775|298296|P11|Period 4: Open Label|Increased blood pressure|0
83702|NCT00151775|298297|P10|Period 4: Open Label|Increased blood pressure|1
83703|NCT00151775|298298|P9|Period 4: Open Label|Increased blood pressure|0
83704|NCT00151775|298299|P8|Period 4: Open Label|Increased blood pressure|0
83705|NCT00151775|298300|P7|Period 4: Open Label|Increased blood pressure|0
83706|NCT00151775|298301|P6|Period 4: Open Label|Increased blood pressure|0
83707|NCT00151775|298302|P5|Period 4: Open Label|Increased blood pressure|1
83708|NCT00151775|298303|P4|Period 4: Open Label|Increased blood pressure|0
83709|NCT00151775|298304|P3|Period 4: Open Label|Increased blood pressure|0
83710|NCT00151775|298305|P2|Period 4: Open Label|Increased blood pressure|0
83711|NCT00151775|298306|P1|Period 4: Open Label|Increased blood pressure|0
83712|NCT00151775|298295|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
83713|NCT00151775|298296|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83714|NCT00151775|298297|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83715|NCT00151775|298298|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83716|NCT00151775|298299|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83717|NCT00151775|298300|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83718|NCT00151775|298301|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83719|NCT00151775|298302|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83720|NCT00151775|298303|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83721|NCT00151775|298304|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83722|NCT00151775|298305|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83723|NCT00151775|298306|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
83724|NCT00151775|298295|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83725|NCT00151775|298296|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83726|NCT00151775|298297|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83727|NCT00151775|298298|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83728|NCT00151775|298299|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83729|NCT00151775|298300|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83730|NCT00151775|298301|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83731|NCT00151775|298302|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83732|NCT00151775|298303|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83733|NCT00151775|298304|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
83734|NCT00151775|298305|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83735|NCT00151775|298306|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
83736|NCT00151775|298295|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
83737|NCT00151775|298296|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
83738|NCT00151775|298297|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
83739|NCT00151775|298298|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
83740|NCT00151775|298299|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
83741|NCT00151775|298300|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
83742|NCT00151775|298301|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
83743|NCT00151775|298302|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
83744|NCT00151775|298303|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
83745|NCT00151775|298304|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
83746|NCT00151775|298305|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
83747|NCT00151775|298306|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
83748|NCT00151775|298295|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83749|NCT00151775|298296|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83750|NCT00151775|298297|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83751|NCT00151775|298298|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83752|NCT00151775|298299|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83753|NCT00151775|298300|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
83754|NCT00151775|298301|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83755|NCT00151775|298302|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83756|NCT00151775|298303|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83757|NCT00151775|298304|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83758|NCT00151775|298305|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83759|NCT00151775|298306|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
83760|NCT00151775|298295|P12|Period 3: Double-blind, Withdrawal|Other|0
83761|NCT00151775|298296|P11|Period 3: Double-blind, Withdrawal|Other|0
83762|NCT00151775|298297|P10|Period 3: Double-blind, Withdrawal|Other|0
83763|NCT00151775|298298|P9|Period 3: Double-blind, Withdrawal|Other|0
83764|NCT00151775|298299|P8|Period 3: Double-blind, Withdrawal|Other|1
83765|NCT00151775|298300|P7|Period 3: Double-blind, Withdrawal|Other|0
83766|NCT00151775|298301|P6|Period 3: Double-blind, Withdrawal|Other|0
83767|NCT00151775|298302|P5|Period 3: Double-blind, Withdrawal|Other|0
83768|NCT00151775|298303|P4|Period 3: Double-blind, Withdrawal|Other|0
83769|NCT00151775|298304|P3|Period 3: Double-blind, Withdrawal|Other|1
83770|NCT00151775|298305|P2|Period 3: Double-blind, Withdrawal|Other|0
83771|NCT00151775|298306|P1|Period 3: Double-blind, Withdrawal|Other|0
83772|NCT00151775|298295|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83773|NCT00151775|298296|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83774|NCT00151775|298297|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83775|NCT00151775|298298|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83776|NCT00151775|298299|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83777|NCT00151775|298300|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83778|NCT00151775|298301|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
83779|NCT00151775|298302|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83780|NCT00151775|298303|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83781|NCT00151775|298304|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83782|NCT00151775|298305|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83783|NCT00151775|298306|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
83784|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83785|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83786|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83787|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83788|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83789|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
83790|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83791|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83792|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83793|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83794|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83795|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
83796|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
83797|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
83798|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
83799|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
83800|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
83801|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
83802|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
83803|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
83804|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
83805|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
83806|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
83807|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
83808|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
83809|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
83810|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
83811|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
83812|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
83813|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
83814|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
83815|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
83816|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
83817|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
83818|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
83819|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
83820|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|Other|0
83821|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|Other|0
83822|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|Other|0
83823|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|Other|0
83824|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|Other|0
83825|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|Other|1
83826|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|Other|0
83827|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|Other|0
83828|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|Other|0
83829|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|Other|0
83830|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|Other|0
83831|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|Other|0
83832|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83833|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83834|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83835|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83836|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83837|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83838|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83839|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83840|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83841|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83842|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
83843|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
83844|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83845|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
83846|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83847|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83848|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83849|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
83850|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83851|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83852|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83853|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83854|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
83855|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
83856|NCT00151775|298295|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
83857|NCT00151775|298296|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
83858|NCT00151775|298297|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
83859|NCT00151775|298298|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
83860|NCT00151775|298299|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
83861|NCT00151775|298300|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
83862|NCT00151775|298301|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
83863|NCT00151775|298302|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
83864|NCT00151775|298303|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
83865|NCT00151775|298304|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
83866|NCT00151775|298305|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
83867|NCT00151775|298306|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
83868|NCT00151892|298375|P2|Overall Study|Lack of study medication at center|1
83869|NCT00151892|298376|P1|Overall Study|Lack of study medication at center|0
83870|NCT00151892|298375|P2|Overall Study|Used prohibited corticosteroids|0
83871|NCT00151892|298376|P1|Overall Study|Used prohibited corticosteroids|1
83872|NCT00151892|298375|P2|Overall Study|Did not return for a visit|0
83873|NCT00151892|298376|P1|Overall Study|Did not return for a visit|1
83874|NCT00151892|298375|P2|Overall Study|Pregnancy|1
83875|NCT00151892|298376|P1|Overall Study|Pregnancy|0
83876|NCT00151892|298375|P2|Overall Study|Non-compliance|1
83877|NCT00151892|298376|P1|Overall Study|Non-compliance|0
83878|NCT00151892|298375|P2|Overall Study|Protocol Violation|3
83879|NCT00151892|298376|P1|Overall Study|Protocol Violation|3
83880|NCT00151892|298375|P2|Overall Study|Adverse Event|3
83881|NCT00151892|298376|P1|Overall Study|Adverse Event|6
83882|NCT00151892|298375|P2|Overall Study|Lost to Follow-up|10
83883|NCT00151892|298376|P1|Overall Study|Lost to Follow-up|5
83884|NCT00151892|298375|P2|Overall Study|Patient request|7
83885|NCT00151892|298376|P1|Overall Study|Patient request|10
83886|NCT00151892|298375|P2|Overall Study|Lack of Efficacy|57
83887|NCT00151892|298376|P1|Overall Study|Lack of Efficacy|50
83888|NCT00151996|298392|P2|Overall Study|Sponsor's decision|2
83889|NCT00151996|298393|P1|Overall Study|Sponsor's decision|0
83890|NCT00151996|298392|P2|Overall Study|Protocol Violation|2
83891|NCT00151996|298393|P1|Overall Study|Protocol Violation|1
83892|NCT00151996|298392|P2|Overall Study|Withdrawal by Subject|1
83893|NCT00151996|298393|P1|Overall Study|Withdrawal by Subject|1
83894|NCT00151996|298392|P2|Overall Study|Adverse Event|2
83895|NCT00151996|298393|P1|Overall Study|Adverse Event|3
83896|NCT00152009|298411|P4|Overall Study|Sponsor's decision|3
83897|NCT00152009|298412|P3|Overall Study|Sponsor's decision|1
83898|NCT00152009|298413|P2|Overall Study|Sponsor's decision|3
83899|NCT00152009|298414|P1|Overall Study|Sponsor's decision|3
83900|NCT00152009|298411|P4|Overall Study|ECG abnormalities|1
83901|NCT00152009|298412|P3|Overall Study|ECG abnormalities|2
83902|NCT00152009|298413|P2|Overall Study|ECG abnormalities|2
83903|NCT00152009|298414|P1|Overall Study|ECG abnormalities|2
83904|NCT00152009|298411|P4|Overall Study|Lack of Efficacy|15
83905|NCT00152009|298412|P3|Overall Study|Lack of Efficacy|7
83906|NCT00152009|298413|P2|Overall Study|Lack of Efficacy|6
83907|NCT00152009|298414|P1|Overall Study|Lack of Efficacy|8
83908|NCT00152009|298411|P4|Overall Study|Lost to Follow-up|3
83909|NCT00152009|298412|P3|Overall Study|Lost to Follow-up|3
83910|NCT00152009|298413|P2|Overall Study|Lost to Follow-up|4
83911|NCT00152009|298414|P1|Overall Study|Lost to Follow-up|2
83912|NCT00152009|298411|P4|Overall Study|Withdrawal by Subject|9
83913|NCT00152009|298412|P3|Overall Study|Withdrawal by Subject|4
83914|NCT00152009|298413|P2|Overall Study|Withdrawal by Subject|3
83915|NCT00152009|298414|P1|Overall Study|Withdrawal by Subject|2
83916|NCT00152009|298411|P4|Overall Study|Protocol Violation|1
83917|NCT00152009|298412|P3|Overall Study|Protocol Violation|0
83918|NCT00152009|298413|P2|Overall Study|Protocol Violation|0
83919|NCT00152009|298414|P1|Overall Study|Protocol Violation|3
83920|NCT00152009|298411|P4|Overall Study|Adverse Event|1
83921|NCT00152009|298412|P3|Overall Study|Adverse Event|20
83922|NCT00152009|298413|P2|Overall Study|Adverse Event|13
83923|NCT00152009|298414|P1|Overall Study|Adverse Event|9
83924|NCT00153816|298450|P6|Overall Study|Follow-up exam done, histology missing|2
83925|NCT00153816|298451|P5|Overall Study|Follow-up exam done, histology missing|1
83926|NCT00153816|298452|P4|Overall Study|Follow-up exam done, histology missing|3
83927|NCT00153816|298453|P3|Overall Study|Follow-up exam done, histology missing|3
83928|NCT00153816|298454|P2|Overall Study|Follow-up exam done, histology missing|3
83929|NCT00153816|298455|P1|Overall Study|Follow-up exam done, histology missing|2
83930|NCT00153816|298450|P6|Overall Study|Follow-up exam not done|9
83931|NCT00153816|298451|P5|Overall Study|Follow-up exam not done|8
83932|NCT00153816|298452|P4|Overall Study|Follow-up exam not done|10
83933|NCT00153816|298453|P3|Overall Study|Follow-up exam not done|11
83934|NCT00153816|298454|P2|Overall Study|Follow-up exam not done|7
83935|NCT00153816|298455|P1|Overall Study|Follow-up exam not done|8
83936|NCT00153816|298450|P6|Overall Study|Withdrawal by Subject|5
83937|NCT00153816|298451|P5|Overall Study|Withdrawal by Subject|1
83938|NCT00153816|298452|P4|Overall Study|Withdrawal by Subject|4
83939|NCT00153816|298453|P3|Overall Study|Withdrawal by Subject|9
83940|NCT00153816|298454|P2|Overall Study|Withdrawal by Subject|9
83941|NCT00153816|298455|P1|Overall Study|Withdrawal by Subject|9
83942|NCT00153816|298450|P6|Overall Study|Lost to Follow-up|9
83943|NCT00153816|298451|P5|Overall Study|Lost to Follow-up|7
83944|NCT00153816|298452|P4|Overall Study|Lost to Follow-up|8
83945|NCT00153816|298453|P3|Overall Study|Lost to Follow-up|5
83946|NCT00153816|298454|P2|Overall Study|Lost to Follow-up|8
83947|NCT00153816|298455|P1|Overall Study|Lost to Follow-up|7
83948|NCT00153816|298450|P6|Overall Study|Death|2
83949|NCT00153816|298451|P5|Overall Study|Death|0
83950|NCT00153816|298452|P4|Overall Study|Death|6
83951|NCT00153816|298453|P3|Overall Study|Death|4
83952|NCT00153816|298454|P2|Overall Study|Death|5
83953|NCT00153816|298455|P1|Overall Study|Death|6
83954|NCT00153920|298475|P1|Overall Study|Progressive Disease before Trt|1
83955|NCT00153920|298475|P1|Overall Study|Withdrawal of Consent before Trt|1
83956|NCT00153920|298475|P1|Overall Study|Non-Protocol Therapy|1
83957|NCT00153920|298475|P1|Overall Study|Withdrawal by Subject|1
83958|NCT00153920|298475|P1|Overall Study|Death|2
83959|NCT00153920|298475|P1|Overall Study|Lack of Response|3
83960|NCT00153920|298475|P1|Overall Study|Physician Decision|3
83961|NCT00153920|298475|P1|Overall Study|Progressive Disease|9
83962|NCT00153920|298475|P1|Overall Study|Adverse Event|9
83963|NCT00154063|298492|P2|Overall Study|Not specified|3
83964|NCT00154063|298493|P1|Overall Study|Not specified|3
83965|NCT00154063|298492|P2|Overall Study|Withdrawal by Subject|9
83966|NCT00154063|298493|P1|Overall Study|Withdrawal by Subject|4
83967|NCT00154063|298492|P2|Overall Study|Investigator or Sponsor Request|1
83968|NCT00154063|298493|P1|Overall Study|Investigator or Sponsor Request|0
83969|NCT00154063|298492|P2|Overall Study|Protocol Violation|1
83970|NCT00154063|298493|P1|Overall Study|Protocol Violation|1
83971|NCT00154063|298492|P2|Overall Study|Adverse Event|8
83972|NCT00154063|298493|P1|Overall Study|Adverse Event|4
83973|NCT00154102|298551|P2|Overall Study|investigational study phase ongoing|2
83974|NCT00154102|298552|P1|Overall Study|investigational study phase ongoing|7
83975|NCT00154284|298588|P2|Overall Study|Protocol Violation|1
83976|NCT00154284|298589|P1|Overall Study|Protocol Violation|0
83977|NCT00154284|298588|P2|Overall Study|Lack of Efficacy|2
83978|NCT00154284|298589|P1|Overall Study|Lack of Efficacy|1
83979|NCT00154284|298588|P2|Overall Study|Abnormal laboratory value(s)|1
83980|NCT00154284|298589|P1|Overall Study|Abnormal laboratory value(s)|0
83981|NCT00154284|298588|P2|Overall Study|Adverse Event|9
83982|NCT00154284|298589|P1|Overall Study|Adverse Event|6
83983|NCT00154297|298603|P2|Overall Study|Lost to Follow-up|0
83984|NCT00154297|298604|P1|Overall Study|Lost to Follow-up|3
83985|NCT00154297|298603|P2|Overall Study|Withdrawal by Subject|5
83986|NCT00154297|298604|P1|Overall Study|Withdrawal by Subject|0
83987|NCT00154297|298603|P2|Overall Study|Death|2
83988|NCT00154297|298604|P1|Overall Study|Death|5
83989|NCT00154310|298622|P2|Overall Study|Death|1
83990|NCT00154310|298623|P1|Overall Study|Death|0
83991|NCT00154310|298622|P2|Overall Study|Administrative problems|1
83992|NCT00154310|298623|P1|Overall Study|Administrative problems|0
83993|NCT00154310|298622|P2|Overall Study|Lost to Follow-up|8
83994|NCT00154310|298623|P1|Overall Study|Lost to Follow-up|0
83995|NCT00154310|298622|P2|Overall Study|Withdrawal by Subject|3
83996|NCT00154310|298623|P1|Overall Study|Withdrawal by Subject|9
83997|NCT00154310|298622|P2|Overall Study|Protocol Violation|2
83998|NCT00154310|298623|P1|Overall Study|Protocol Violation|4
83999|NCT00154310|298622|P2|Overall Study|Lack of Efficacy|4
84000|NCT00154310|298623|P1|Overall Study|Lack of Efficacy|5
84001|NCT00154310|298622|P2|Overall Study|Adverse Event|9
84002|NCT00154310|298623|P1|Overall Study|Adverse Event|19
84003|NCT00154375|298639|P2|Overall Study|Suspected progression of disease|30
84004|NCT00154375|298640|P1|Overall Study|Suspected progression of disease|44
84005|NCT00154375|298639|P2|Overall Study|Protocol Violation|1
84006|NCT00154375|298640|P1|Overall Study|Protocol Violation|0
84007|NCT00154375|298639|P2|Overall Study|Abnormal laboratory value(s)|2
84008|NCT00154375|298640|P1|Overall Study|Abnormal laboratory value(s)|0
84009|NCT00154375|298639|P2|Overall Study|Lost to Follow-up|1
84010|NCT00154375|298640|P1|Overall Study|Lost to Follow-up|2
84011|NCT00154375|298639|P2|Overall Study|Study drug no longer required|3
84012|NCT00154375|298640|P1|Overall Study|Study drug no longer required|5
84013|NCT00154375|298639|P2|Overall Study|Death|13
84014|NCT00154375|298640|P1|Overall Study|Death|5
84015|NCT00154375|298639|P2|Overall Study|Withdrawal by Subject|10
84016|NCT00154375|298640|P1|Overall Study|Withdrawal by Subject|14
84017|NCT00154375|298639|P2|Overall Study|Adverse Event|20
84018|NCT00154375|298640|P1|Overall Study|Adverse Event|18
84019|NCT00154375|298639|P2|Overall Study|Unsatisfactory therapeutic effect|26
84020|NCT00154375|298640|P1|Overall Study|Unsatisfactory therapeutic effect|25
84021|NCT00156065|298671|P3|Overall Study|Unspecified|3
84022|NCT00156065|298672|P2|Overall Study|Unspecified|9
84023|NCT00156065|298673|P1|Overall Study|Unspecified|2
84024|NCT00156065|298671|P3|Overall Study|Lost to Follow-up|1
84025|NCT00156065|298672|P2|Overall Study|Lost to Follow-up|7
84026|NCT00156065|298673|P1|Overall Study|Lost to Follow-up|5
84027|NCT00156065|298671|P3|Overall Study|Withdrawal by Subject|16
84028|NCT00156065|298672|P2|Overall Study|Withdrawal by Subject|26
84029|NCT00156065|298673|P1|Overall Study|Withdrawal by Subject|13
84030|NCT00156065|298671|P3|Overall Study|Lack of Efficacy|3
84031|NCT00156065|298672|P2|Overall Study|Lack of Efficacy|9
84032|NCT00156065|298673|P1|Overall Study|Lack of Efficacy|2
84033|NCT00156065|298671|P3|Overall Study|Adverse Event|4
84034|NCT00156065|298672|P2|Overall Study|Adverse Event|11
84035|NCT00156065|298673|P1|Overall Study|Adverse Event|8
84036|NCT00156065|298671|P3|Overall Study|Enrolled But Never Received Treatment|0
84037|NCT00156065|298672|P2|Overall Study|Enrolled But Never Received Treatment|1
84038|NCT00156065|298673|P1|Overall Study|Enrolled But Never Received Treatment|1
84039|NCT00146328|298687|P3|Overall Study|Interaction with other medication|1
84040|NCT00146328|298688|P2|Overall Study|Interaction with other medication|0
84041|NCT00146328|298689|P1|Overall Study|Interaction with other medication|2
84042|NCT00146328|298687|P3|Overall Study|Moved|0
84043|NCT00146328|298688|P2|Overall Study|Moved|0
84044|NCT00146328|298689|P1|Overall Study|Moved|2
84045|NCT00146328|298687|P3|Overall Study|Death|1
84046|NCT00146328|298688|P2|Overall Study|Death|1
84047|NCT00146328|298689|P1|Overall Study|Death|0
84048|NCT00146328|298687|P3|Overall Study|Enroll into other trial|2
84049|NCT00146328|298688|P2|Overall Study|Enroll into other trial|4
84050|NCT00146328|298689|P1|Overall Study|Enroll into other trial|2
84051|NCT00146328|298687|P3|Overall Study|Patient decision to end|6
84052|NCT00146328|298688|P2|Overall Study|Patient decision to end|1
84053|NCT00146328|298689|P1|Overall Study|Patient decision to end|0
84054|NCT00146328|298687|P3|Overall Study|Trial ended/site closed|19
84055|NCT00146328|298688|P2|Overall Study|Trial ended/site closed|2
84056|NCT00146328|298689|P1|Overall Study|Trial ended/site closed|8
84057|NCT00146328|298687|P3|Overall Study|Virologic Failure/lack of efficacy|142
84058|NCT00146328|298688|P2|Overall Study|Virologic Failure/lack of efficacy|72
84059|NCT00146328|298689|P1|Overall Study|Virologic Failure/lack of efficacy|54
84060|NCT00146328|298687|P3|Overall Study|Withdrawal by Subject|22
84061|NCT00146328|298688|P2|Overall Study|Withdrawal by Subject|16
84062|NCT00146328|298689|P1|Overall Study|Withdrawal by Subject|16
84063|NCT00146328|298687|P3|Overall Study|Lost to Follow-up|7
84064|NCT00146328|298688|P2|Overall Study|Lost to Follow-up|4
84065|NCT00146328|298689|P1|Overall Study|Lost to Follow-up|7
84066|NCT00146328|298687|P3|Overall Study|Protocol Violation|12
84067|NCT00146328|298688|P2|Overall Study|Protocol Violation|6
84068|NCT00146328|298689|P1|Overall Study|Protocol Violation|11
84069|NCT00146328|298687|P3|Overall Study|Adverse Event|79
84070|NCT00146328|298688|P2|Overall Study|Adverse Event|48
84071|NCT00146328|298689|P1|Overall Study|Adverse Event|39
84072|NCT00146757|298772|P2|Overall Study|Adverse Event|0
84073|NCT00146757|298773|P1|Overall Study|Adverse Event|1
84074|NCT00146757|298772|P2|Overall Study|Death|0
84075|NCT00146757|298773|P1|Overall Study|Death|1
84076|NCT00146770|298792|P2|Overall Study|Withdrawal by Subject|0
84077|NCT00146770|298793|P1|Overall Study|Withdrawal by Subject|2
84078|NCT00146770|298792|P2|Overall Study|Pregnancy|0
84079|NCT00146770|298793|P1|Overall Study|Pregnancy|1
84080|NCT00146770|298792|P2|Overall Study|Adverse Event|0
84081|NCT00146770|298793|P1|Overall Study|Adverse Event|2
84082|NCT00146848|298814|P3|Post-randomization|Withdrawn|27
84083|NCT00146848|298815|P2|Post-randomization|Withdrawn|32
84084|NCT00146848|298816|P1|Post-randomization|Withdrawn|26
84085|NCT00146848|298814|P3|Post-randomization|Lost to Follow-up|12
84086|NCT00146848|298815|P2|Post-randomization|Lost to Follow-up|15
84087|NCT00146848|298816|P1|Post-randomization|Lost to Follow-up|12
84088|NCT00146848|298814|P3|Pre-randomization|Withdrawal by Subject|0
84089|NCT00146848|298815|P2|Pre-randomization|Withdrawal by Subject|0
84090|NCT00146848|298816|P1|Pre-randomization|Withdrawal by Subject|40
84091|NCT00146848|298814|P3|Pre-randomization|Protocol Violation|0
84092|NCT00146848|298815|P2|Pre-randomization|Protocol Violation|0
84093|NCT00146848|298816|P1|Pre-randomization|Protocol Violation|172
84094|NCT00146848|298814|P3|Pre-randomization|Physician Decision|0
84095|NCT00146848|298815|P2|Pre-randomization|Physician Decision|0
84096|NCT00146848|298816|P1|Pre-randomization|Physician Decision|8
84097|NCT00146848|298814|P3|Pre-randomization|Lost to Follow-up|0
84098|NCT00146848|298815|P2|Pre-randomization|Lost to Follow-up|0
84099|NCT00146848|298816|P1|Pre-randomization|Lost to Follow-up|70
84100|NCT00146848|298814|P3|Pre-randomization|Death|0
84101|NCT00146848|298815|P2|Pre-randomization|Death|0
84102|NCT00146848|298816|P1|Pre-randomization|Death|19
84103|NCT00147225|298916|P6|Overall Study|Chemotherapy Changed|1
84104|NCT00147225|298917|P5|Overall Study|Chemotherapy Changed|0
84105|NCT00147225|298918|P4|Overall Study|Chemotherapy Changed|0
84106|NCT00147225|298919|P3|Overall Study|Chemotherapy Changed|0
84107|NCT00147225|298920|P2|Overall Study|Chemotherapy Changed|0
84108|NCT00147225|298921|P1|Overall Study|Chemotherapy Changed|0
84109|NCT00147225|298916|P6|Overall Study|Screen Failure|0
84110|NCT00147225|298917|P5|Overall Study|Screen Failure|1
84111|NCT00147225|298918|P4|Overall Study|Screen Failure|0
84112|NCT00147225|298919|P3|Overall Study|Screen Failure|0
84113|NCT00147225|298920|P2|Overall Study|Screen Failure|0
84114|NCT00147225|298921|P1|Overall Study|Screen Failure|0
84115|NCT00147225|298916|P6|Overall Study|Adverse Event|0
84116|NCT00147225|298917|P5|Overall Study|Adverse Event|0
84117|NCT00147225|298918|P4|Overall Study|Adverse Event|1
84118|NCT00147225|298919|P3|Overall Study|Adverse Event|1
84119|NCT00147225|298920|P2|Overall Study|Adverse Event|0
84120|NCT00147225|298921|P1|Overall Study|Adverse Event|0
84121|NCT00147225|298916|P6|Overall Study|Withdrawal by Subject|1
84122|NCT00147225|298917|P5|Overall Study|Withdrawal by Subject|0
84123|NCT00147225|298918|P4|Overall Study|Withdrawal by Subject|0
84124|NCT00147225|298919|P3|Overall Study|Withdrawal by Subject|1
84125|NCT00147225|298920|P2|Overall Study|Withdrawal by Subject|0
84126|NCT00147225|298921|P1|Overall Study|Withdrawal by Subject|1
84127|NCT00147238|298941|P1|Overall Study|Inevaluable|8
84128|NCT00147498|298979|P4|Overall Study|Unspecified|3
84129|NCT00147498|298980|P3|Overall Study|Unspecified|3
84130|NCT00147498|298981|P2|Overall Study|Unspecified|1
84131|NCT00147498|298982|P1|Overall Study|Unspecified|1
84132|NCT00147498|298979|P4|Overall Study|Participant defaulted|3
84133|NCT00147498|298980|P3|Overall Study|Participant defaulted|4
84134|NCT00147498|298981|P2|Overall Study|Participant defaulted|1
84135|NCT00147498|298982|P1|Overall Study|Participant defaulted|0
84136|NCT00147498|298979|P4|Overall Study|Laboratory abnormality|0
84137|NCT00147498|298980|P3|Overall Study|Laboratory abnormality|2
84138|NCT00147498|298981|P2|Overall Study|Laboratory abnormality|0
84139|NCT00147498|298982|P1|Overall Study|Laboratory abnormality|0
84140|NCT00147498|298979|P4|Overall Study|Lack of Efficacy|8
84141|NCT00147498|298980|P3|Overall Study|Lack of Efficacy|1
84142|NCT00147498|298981|P2|Overall Study|Lack of Efficacy|1
84143|NCT00147498|298982|P1|Overall Study|Lack of Efficacy|1
84144|NCT00147498|298979|P4|Overall Study|Adverse Event|3
84145|NCT00147498|298980|P3|Overall Study|Adverse Event|7
84146|NCT00147498|298981|P2|Overall Study|Adverse Event|6
84147|NCT00147498|298982|P1|Overall Study|Adverse Event|1
84148|NCT00147537|299080|P11|Phase 2|Randomized but not treated|1
84149|NCT00147537|299081|P10|Phase 2|Randomized but not treated|1
84150|NCT00147537|299082|P9|Phase 2|Randomized but not treated|0
84151|NCT00147537|299083|P8|Phase 2|Randomized but not treated|0
84152|NCT00147537|299084|P7|Phase 2|Randomized but not treated|0
84153|NCT00147537|299085|P6|Phase 2|Randomized but not treated|0
84154|NCT00147537|299086|P5|Phase 2|Randomized but not treated|0
84155|NCT00147537|299087|P4|Phase 2|Randomized but not treated|0
84156|NCT00147537|299088|P3|Phase 2|Randomized but not treated|0
84157|NCT00147537|299089|P2|Phase 2|Randomized but not treated|0
84158|NCT00147537|299090|P1|Phase 2|Randomized but not treated|0
84159|NCT00147537|299080|P11|Phase 2|Withdrawal by Subject|4
84160|NCT00147537|299081|P10|Phase 2|Withdrawal by Subject|16
84161|NCT00147537|299082|P9|Phase 2|Withdrawal by Subject|0
84162|NCT00147537|299083|P8|Phase 2|Withdrawal by Subject|0
84163|NCT00147537|299084|P7|Phase 2|Withdrawal by Subject|0
84164|NCT00147537|299085|P6|Phase 2|Withdrawal by Subject|0
84165|NCT00147537|299086|P5|Phase 2|Withdrawal by Subject|0
84166|NCT00147537|299087|P4|Phase 2|Withdrawal by Subject|0
84167|NCT00147537|299088|P3|Phase 2|Withdrawal by Subject|0
84168|NCT00147537|299089|P2|Phase 2|Withdrawal by Subject|0
84169|NCT00147537|299090|P1|Phase 2|Withdrawal by Subject|0
84170|NCT00147537|299080|P11|Phase 2|unspecified|12
84171|NCT00147537|299081|P10|Phase 2|unspecified|47
84172|NCT00147537|299082|P9|Phase 2|unspecified|0
84173|NCT00147537|299083|P8|Phase 2|unspecified|0
84174|NCT00147537|299084|P7|Phase 2|unspecified|0
84175|NCT00147537|299085|P6|Phase 2|unspecified|0
84176|NCT00147537|299086|P5|Phase 2|unspecified|0
84177|NCT00147537|299087|P4|Phase 2|unspecified|0
84178|NCT00147537|299088|P3|Phase 2|unspecified|0
84179|NCT00147537|299089|P2|Phase 2|unspecified|0
84180|NCT00147537|299090|P1|Phase 2|unspecified|0
84181|NCT00147537|299080|P11|Phase 2|Lost to Follow-up|4
84182|NCT00147537|299081|P10|Phase 2|Lost to Follow-up|12
84183|NCT00147537|299082|P9|Phase 2|Lost to Follow-up|0
84184|NCT00147537|299083|P8|Phase 2|Lost to Follow-up|0
84185|NCT00147537|299084|P7|Phase 2|Lost to Follow-up|0
84186|NCT00147537|299085|P6|Phase 2|Lost to Follow-up|0
84187|NCT00147537|299086|P5|Phase 2|Lost to Follow-up|0
84188|NCT00147537|299087|P4|Phase 2|Lost to Follow-up|0
84189|NCT00147537|299088|P3|Phase 2|Lost to Follow-up|0
84190|NCT00147537|299089|P2|Phase 2|Lost to Follow-up|0
84191|NCT00147537|299090|P1|Phase 2|Lost to Follow-up|0
84192|NCT00147537|299080|P11|Phase 2|Death|31
84193|NCT00147537|299081|P10|Phase 2|Death|85
84194|NCT00147537|299082|P9|Phase 2|Death|0
84195|NCT00147537|299083|P8|Phase 2|Death|0
84196|NCT00147537|299084|P7|Phase 2|Death|0
84197|NCT00147537|299085|P6|Phase 2|Death|0
84198|NCT00147537|299086|P5|Phase 2|Death|0
84199|NCT00147537|299087|P4|Phase 2|Death|0
84200|NCT00147537|299088|P3|Phase 2|Death|0
84201|NCT00147537|299089|P2|Phase 2|Death|0
84202|NCT00147537|299090|P1|Phase 2|Death|0
84203|NCT00147537|299080|P11|Phase 1b|Randomized but not treated|0
84204|NCT00147537|299081|P10|Phase 1b|Randomized but not treated|0
84205|NCT00147537|299082|P9|Phase 1b|Randomized but not treated|1
84206|NCT00147537|299083|P8|Phase 1b|Randomized but not treated|0
84207|NCT00147537|299084|P7|Phase 1b|Randomized but not treated|1
84208|NCT00147537|299085|P6|Phase 1b|Randomized but not treated|0
84209|NCT00147537|299086|P5|Phase 1b|Randomized but not treated|0
84210|NCT00147537|299087|P4|Phase 1b|Randomized but not treated|0
84211|NCT00147537|299088|P3|Phase 1b|Randomized but not treated|0
84212|NCT00147537|299089|P2|Phase 1b|Randomized but not treated|0
84213|NCT00147537|299090|P1|Phase 1b|Randomized but not treated|0
84214|NCT00147537|299080|P11|Phase 1b|Withdrawal by Subject|0
84215|NCT00147537|299081|P10|Phase 1b|Withdrawal by Subject|0
84216|NCT00147537|299082|P9|Phase 1b|Withdrawal by Subject|2
84217|NCT00147537|299083|P8|Phase 1b|Withdrawal by Subject|0
84218|NCT00147537|299084|P7|Phase 1b|Withdrawal by Subject|0
84219|NCT00147537|299085|P6|Phase 1b|Withdrawal by Subject|0
84220|NCT00147537|299086|P5|Phase 1b|Withdrawal by Subject|0
84221|NCT00147537|299087|P4|Phase 1b|Withdrawal by Subject|0
84222|NCT00147537|299088|P3|Phase 1b|Withdrawal by Subject|0
84223|NCT00147537|299089|P2|Phase 1b|Withdrawal by Subject|0
84224|NCT00147537|299090|P1|Phase 1b|Withdrawal by Subject|0
84225|NCT00147537|299080|P11|Phase 1b|unspecified|0
84226|NCT00147537|299081|P10|Phase 1b|unspecified|0
84227|NCT00147537|299082|P9|Phase 1b|unspecified|4
84228|NCT00147537|299083|P8|Phase 1b|unspecified|4
84229|NCT00147537|299084|P7|Phase 1b|unspecified|14
84230|NCT00147537|299085|P6|Phase 1b|unspecified|1
84231|NCT00147537|299086|P5|Phase 1b|unspecified|1
84232|NCT00147537|299087|P4|Phase 1b|unspecified|1
84233|NCT00147537|299088|P3|Phase 1b|unspecified|2
84234|NCT00147537|299089|P2|Phase 1b|unspecified|0
84235|NCT00147537|299090|P1|Phase 1b|unspecified|0
84236|NCT00147537|299080|P11|Phase 1b|Lost to Follow-up|0
84237|NCT00147537|299081|P10|Phase 1b|Lost to Follow-up|0
84238|NCT00147537|299082|P9|Phase 1b|Lost to Follow-up|1
84239|NCT00147537|299083|P8|Phase 1b|Lost to Follow-up|0
84240|NCT00147537|299084|P7|Phase 1b|Lost to Follow-up|2
84241|NCT00147537|299085|P6|Phase 1b|Lost to Follow-up|0
84242|NCT00147537|299086|P5|Phase 1b|Lost to Follow-up|0
84243|NCT00147537|299087|P4|Phase 1b|Lost to Follow-up|0
84244|NCT00147537|299088|P3|Phase 1b|Lost to Follow-up|0
84245|NCT00147537|299089|P2|Phase 1b|Lost to Follow-up|1
84246|NCT00147537|299090|P1|Phase 1b|Lost to Follow-up|2
84247|NCT00147537|299080|P11|Phase 1b|Death|0
84248|NCT00147537|299081|P10|Phase 1b|Death|0
84249|NCT00147537|299082|P9|Phase 1b|Death|9
84250|NCT00147537|299083|P8|Phase 1b|Death|3
84251|NCT00147537|299084|P7|Phase 1b|Death|1
84252|NCT00147537|299085|P6|Phase 1b|Death|2
84253|NCT00147537|299086|P5|Phase 1b|Death|2
84254|NCT00147537|299087|P4|Phase 1b|Death|1
84255|NCT00147537|299088|P3|Phase 1b|Death|2
84256|NCT00147537|299089|P2|Phase 1b|Death|1
84257|NCT00147537|299090|P1|Phase 1b|Death|0
84258|NCT00147745|299272|P3|Overall Study|Withdrawal by Subject|0
84259|NCT00147745|299273|P2|Overall Study|Withdrawal by Subject|0
84260|NCT00147745|299274|P1|Overall Study|Withdrawal by Subject|1
84261|NCT00147823|299294|P2|Overall Study|Did not receive vitoss due to infection|2
84262|NCT00147823|299295|P1|Overall Study|Did not receive vitoss due to infection|6
84263|NCT00147823|299294|P2|Overall Study|Withdrawal by Subject|1
84264|NCT00147823|299295|P1|Overall Study|Withdrawal by Subject|0
84265|NCT00147823|299294|P2|Overall Study|Physician Decision|0
84266|NCT00147823|299295|P1|Overall Study|Physician Decision|1
84267|NCT00147823|299294|P2|Overall Study|Lost to Follow-up|12
84268|NCT00147823|299295|P1|Overall Study|Lost to Follow-up|6
84269|NCT00148109|299329|P2|Overall Study|Withdrawal by Subject|0
84270|NCT00148109|299330|P1|Overall Study|Withdrawal by Subject|2
84271|NCT00148109|299329|P2|Overall Study|Adverse Event|2
84272|NCT00148109|299330|P1|Overall Study|Adverse Event|0
84273|NCT00148109|299329|P2|Overall Study|Lack of Efficacy|18
84274|NCT00148109|299330|P1|Overall Study|Lack of Efficacy|10
84275|NCT00148122|299340|P1|Overall Study|Withdrawal by Subject|2
84276|NCT00148317|299346|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
84277|NCT00148317|299346|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
84278|NCT00148317|299346|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
84279|NCT00148759|299373|P2|Overall Study|Lost to Follow-up|0
84280|NCT00148759|299374|P1|Overall Study|Lost to Follow-up|1
84281|NCT00148759|299373|P2|Overall Study|Withdrawal by Subject|1
84282|NCT00148759|299374|P1|Overall Study|Withdrawal by Subject|1
84283|NCT00149214|299416|P2|Overall Study|Progressive Disease|3
84284|NCT00149214|299417|P1|Overall Study|Progressive Disease|7
84285|NCT00149214|299416|P2|Overall Study|Sponsor Decision|1
84286|NCT00149214|299417|P1|Overall Study|Sponsor Decision|0
84287|NCT00149214|299416|P2|Overall Study|Physician Decision|3
84288|NCT00149214|299417|P1|Overall Study|Physician Decision|3
84289|NCT00149214|299416|P2|Overall Study|Withdrawal by Subject|1
84290|NCT00149214|299417|P1|Overall Study|Withdrawal by Subject|4
84291|NCT00149214|299416|P2|Overall Study|Adverse Event|9
84292|NCT00149214|299417|P1|Overall Study|Adverse Event|12
84293|NCT00156819|299476|P3|Overall Study|Lost to Follow-up|3
84294|NCT00156819|299477|P2|Overall Study|Lost to Follow-up|1
84295|NCT00156819|299478|P1|Overall Study|Lost to Follow-up|1
84296|NCT00157014|299525|P4|Overall Study|Withdrawal by Subject|0
84297|NCT00157014|299526|P3|Overall Study|Withdrawal by Subject|0
84298|NCT00157014|299527|P2|Overall Study|Withdrawal by Subject|0
84299|NCT00157014|299528|P1|Overall Study|Withdrawal by Subject|1
84300|NCT00157014|299525|P4|Overall Study|Patient would not receive transplant|0
84301|NCT00157014|299526|P3|Overall Study|Patient would not receive transplant|0
84302|NCT00157014|299527|P2|Overall Study|Patient would not receive transplant|1
84303|NCT00157014|299528|P1|Overall Study|Patient would not receive transplant|0
84304|NCT00157014|299525|P4|Overall Study|Patient unable to return in nursing home|0
84305|NCT00157014|299526|P3|Overall Study|Patient unable to return in nursing home|0
84306|NCT00157014|299527|P2|Overall Study|Patient unable to return in nursing home|0
84307|NCT00157014|299528|P1|Overall Study|Patient unable to return in nursing home|1
84308|NCT00157014|299525|P4|Overall Study|Patient withdrawn by investigator|0
84309|NCT00157014|299526|P3|Overall Study|Patient withdrawn by investigator|0
84310|NCT00157014|299527|P2|Overall Study|Patient withdrawn by investigator|0
84311|NCT00157014|299528|P1|Overall Study|Patient withdrawn by investigator|1
84312|NCT00157014|299525|P4|Overall Study|Medications withdrawn on family request|0
84313|NCT00157014|299526|P3|Overall Study|Medications withdrawn on family request|0
84314|NCT00157014|299527|P2|Overall Study|Medications withdrawn on family request|1
84315|NCT00157014|299528|P1|Overall Study|Medications withdrawn on family request|0
84316|NCT00157014|299525|P4|Overall Study|Physician Decision|0
84317|NCT00157014|299526|P3|Overall Study|Physician Decision|0
84318|NCT00157014|299527|P2|Overall Study|Physician Decision|1
84319|NCT00157014|299528|P1|Overall Study|Physician Decision|0
84320|NCT00157014|299525|P4|Overall Study|Death|1
84321|NCT00157014|299526|P3|Overall Study|Death|1
84322|NCT00157014|299527|P2|Overall Study|Death|2
84323|NCT00157014|299528|P1|Overall Study|Death|4
84324|NCT00157157|299606|P1|Overall Study|Inclusion not met- baseline FVIII value|1
84325|NCT00157157|299606|P1|Overall Study|Met exclusion criteria|1
84326|NCT00157157|299606|P1|Overall Study|Enrolled in another study|1
84327|NCT00157157|299606|P1|Overall Study|Lost to Follow-up|1
84328|NCT00157157|299606|P1|Overall Study|Physician Decision|1
84329|NCT00157157|299606|P1|Overall Study|Withdrawal by Subject|6
84330|NCT00157196|299629|P1|Overall Study|Ongoing at data cut-off|9
84331|NCT00157209|299637|P2|Overall Study|Ongoing at data cut-off|0
84332|NCT00157209|299638|P1|Overall Study|Ongoing at data cut-off|10
84333|NCT00157248|299656|P4|Overall Study|site closures, subject moving|9
84334|NCT00157248|299657|P3|Overall Study|site closures, subject moving|3
84335|NCT00157248|299658|P2|Overall Study|site closures, subject moving|7
84336|NCT00157248|299659|P1|Overall Study|site closures, subject moving|7
84337|NCT00157248|299656|P4|Overall Study|Withdrawal by Subject|3
84338|NCT00157248|299657|P3|Overall Study|Withdrawal by Subject|3
84339|NCT00157248|299658|P2|Overall Study|Withdrawal by Subject|4
84340|NCT00157248|299659|P1|Overall Study|Withdrawal by Subject|1
84341|NCT00157248|299656|P4|Overall Study|Lost to Follow-up|0
84342|NCT00157248|299657|P3|Overall Study|Lost to Follow-up|0
84343|NCT00157248|299658|P2|Overall Study|Lost to Follow-up|1
84344|NCT00157248|299659|P1|Overall Study|Lost to Follow-up|0
84345|NCT00157248|299656|P4|Overall Study|Protocol Violation|2
84346|NCT00157248|299657|P3|Overall Study|Protocol Violation|2
84347|NCT00157248|299658|P2|Overall Study|Protocol Violation|0
84348|NCT00157248|299659|P1|Overall Study|Protocol Violation|4
84349|NCT00157248|299656|P4|Overall Study|Adverse Event|33
84350|NCT00157248|299657|P3|Overall Study|Adverse Event|13
84351|NCT00157248|299658|P2|Overall Study|Adverse Event|25
84352|NCT00157248|299659|P1|Overall Study|Adverse Event|36
84353|NCT00157755|299775|P6|Overall Study|Study completion|2
84354|NCT00157755|299776|P5|Overall Study|Study completion|1
84355|NCT00157755|299777|P4|Overall Study|Study completion|0
84356|NCT00157755|299778|P3|Overall Study|Study completion|0
84357|NCT00157755|299779|P2|Overall Study|Study completion|0
84358|NCT00157755|299780|P1|Overall Study|Study completion|0
84359|NCT00157755|299775|P6|Overall Study|Subject non-compliance|1
84360|NCT00157755|299776|P5|Overall Study|Subject non-compliance|0
84361|NCT00157755|299777|P4|Overall Study|Subject non-compliance|0
84362|NCT00157755|299778|P3|Overall Study|Subject non-compliance|0
84363|NCT00157755|299779|P2|Overall Study|Subject non-compliance|0
84364|NCT00157755|299780|P1|Overall Study|Subject non-compliance|0
84365|NCT00157755|299775|P6|Overall Study|Study site closure|0
84366|NCT00157755|299776|P5|Overall Study|Study site closure|0
84367|NCT00157755|299777|P4|Overall Study|Study site closure|0
84368|NCT00157755|299778|P3|Overall Study|Study site closure|0
84369|NCT00157755|299779|P2|Overall Study|Study site closure|1
84370|NCT00157755|299780|P1|Overall Study|Study site closure|0
84371|NCT00157755|299775|P6|Overall Study|Medical reason|0
84372|NCT00157755|299776|P5|Overall Study|Medical reason|0
84373|NCT00157755|299777|P4|Overall Study|Medical reason|1
84374|NCT00157755|299778|P3|Overall Study|Medical reason|1
84375|NCT00157755|299779|P2|Overall Study|Medical reason|0
84376|NCT00157755|299780|P1|Overall Study|Medical reason|0
84377|NCT00157755|299775|P6|Overall Study|Explant due to infection|0
84378|NCT00157755|299776|P5|Overall Study|Explant due to infection|0
84379|NCT00157755|299777|P4|Overall Study|Explant due to infection|0
84380|NCT00157755|299778|P3|Overall Study|Explant due to infection|1
84381|NCT00157755|299779|P2|Overall Study|Explant due to infection|0
84382|NCT00157755|299780|P1|Overall Study|Explant due to infection|0
84383|NCT00157755|299775|P6|Overall Study|Withdrawal by Subject|2
84384|NCT00157755|299776|P5|Overall Study|Withdrawal by Subject|1
84385|NCT00157755|299777|P4|Overall Study|Withdrawal by Subject|1
84386|NCT00157755|299778|P3|Overall Study|Withdrawal by Subject|1
84387|NCT00157755|299779|P2|Overall Study|Withdrawal by Subject|0
84388|NCT00157755|299780|P1|Overall Study|Withdrawal by Subject|0
84389|NCT00157755|299775|P6|Overall Study|Lost to Follow-up|0
84390|NCT00157755|299776|P5|Overall Study|Lost to Follow-up|0
84391|NCT00157755|299777|P4|Overall Study|Lost to Follow-up|0
84392|NCT00157755|299778|P3|Overall Study|Lost to Follow-up|1
84393|NCT00157755|299779|P2|Overall Study|Lost to Follow-up|0
84394|NCT00157755|299780|P1|Overall Study|Lost to Follow-up|0
84395|NCT00157755|299775|P6|Overall Study|Death|0
84396|NCT00157755|299776|P5|Overall Study|Death|0
84397|NCT00157755|299777|P4|Overall Study|Death|2
84398|NCT00157755|299778|P3|Overall Study|Death|3
84399|NCT00157755|299779|P2|Overall Study|Death|3
84400|NCT00157755|299780|P1|Overall Study|Death|2
84401|NCT00157820|299805|P3|2nd 8 Months|Premature cross-over|9
84402|NCT00157820|299806|P2|2nd 8 Months|Premature cross-over|7
84403|NCT00157820|299807|P1|2nd 8 Months|Premature cross-over|1
84404|NCT00157820|299805|P3|2nd 8 Months|Lost to Follow-up|2
84405|NCT00157820|299806|P2|2nd 8 Months|Lost to Follow-up|5
84406|NCT00157820|299807|P1|2nd 8 Months|Lost to Follow-up|1
84407|NCT00157820|299805|P3|2nd 8 Months|Death|3
84408|NCT00157820|299806|P2|2nd 8 Months|Death|1
84409|NCT00157820|299807|P1|2nd 8 Months|Death|3
84410|NCT00157820|299805|P3|1st 8 Month|Premature cross-over|2
84411|NCT00157820|299806|P2|1st 8 Month|Premature cross-over|2
84412|NCT00157820|299807|P1|1st 8 Month|Premature cross-over|0
84413|NCT00157820|299805|P3|1st 8 Month|Lost to Follow-up|1
84414|NCT00157820|299806|P2|1st 8 Month|Lost to Follow-up|2
84415|NCT00157820|299807|P1|1st 8 Month|Lost to Follow-up|1
84416|NCT00157820|299805|P3|1st 8 Month|Death|3
84417|NCT00157820|299806|P2|1st 8 Month|Death|8
84418|NCT00157820|299807|P1|1st 8 Month|Death|7
84419|NCT00157820|299805|P3|Randomized|Protocol Violation|2
84420|NCT00157820|299806|P2|Randomized|Protocol Violation|1
84421|NCT00157820|299807|P1|Randomized|Protocol Violation|2
84422|NCT00157820|299805|P3|Randomized|Withdrawal by Subject|3
84423|NCT00157820|299806|P2|Randomized|Withdrawal by Subject|2
84424|NCT00157820|299807|P1|Randomized|Withdrawal by Subject|1
84425|NCT00157820|299805|P3|Randomized|Physician Decision|3
84426|NCT00157820|299806|P2|Randomized|Physician Decision|2
84427|NCT00157820|299807|P1|Randomized|Physician Decision|4
84428|NCT00157950|299820|P2|Overall Study|Death|0
84429|NCT00157950|299821|P1|Overall Study|Death|1
84430|NCT00158054|299837|P2|Overall Study|Unavailable for follow up|3
84431|NCT00158054|299838|P1|Overall Study|Unavailable for follow up|7
84432|NCT00158054|299837|P2|Overall Study|Refused to continue|0
84433|NCT00158054|299838|P1|Overall Study|Refused to continue|3
84434|NCT00158184|299852|P2|Overall Study|Adverse Event|1
84435|NCT00158184|299853|P1|Overall Study|Adverse Event|1
84436|NCT00158184|299852|P2|Overall Study|failed for follow unit/study rules|0
84437|NCT00158184|299853|P1|Overall Study|failed for follow unit/study rules|2
84438|NCT00158184|299852|P2|Overall Study|personal issues|1
84439|NCT00158184|299853|P1|Overall Study|personal issues|3
84440|NCT00158262|299912|P2|Overall Study|Lost to Follow-up|1
84441|NCT00158262|299913|P1|Overall Study|Lost to Follow-up|1
84442|NCT00158600|299930|P2|Overall Study|Withdrawal by Subject|2
84443|NCT00158600|299931|P1|Overall Study|Withdrawal by Subject|2
84444|NCT00158600|299930|P2|Overall Study|Death|0
84445|NCT00158600|299931|P1|Overall Study|Death|1
84446|NCT00158600|299930|P2|Overall Study|Adverse Event|1
84447|NCT00158600|299931|P1|Overall Study|Adverse Event|2
84448|NCT00158600|299930|P2|Overall Study|unable to commit time to study|1
84449|NCT00158600|299931|P1|Overall Study|unable to commit time to study|0
84450|NCT00158756|299963|P5|Overall Study|Serious adverse event|0
84451|NCT00158756|299964|P4|Overall Study|Serious adverse event|0
84452|NCT00158756|299965|P3|Overall Study|Serious adverse event|1
84453|NCT00158756|299966|P2|Overall Study|Serious adverse event|0
84454|NCT00158756|299967|P1|Overall Study|Serious adverse event|0
84455|NCT00158756|299963|P5|Overall Study|Adverse Event|0
84456|NCT00158756|299964|P4|Overall Study|Adverse Event|0
84457|NCT00158756|299965|P3|Overall Study|Adverse Event|1
84458|NCT00158756|299966|P2|Overall Study|Adverse Event|0
84459|NCT00158756|299967|P1|Overall Study|Adverse Event|0
84460|NCT00158756|299963|P5|Overall Study|Withdrawal by Subject|3
84461|NCT00158756|299964|P4|Overall Study|Withdrawal by Subject|1
84462|NCT00158756|299965|P3|Overall Study|Withdrawal by Subject|6
84463|NCT00158756|299966|P2|Overall Study|Withdrawal by Subject|0
84464|NCT00158756|299967|P1|Overall Study|Withdrawal by Subject|5
84465|NCT00152516|300070|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
84466|NCT00152516|300070|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
84467|NCT00152516|300070|P1|Overall Study|Other: Moved Out Of State|1
84468|NCT00152516|300070|P1|Overall Study|Other: Primary Care Physician's Decision|1
84469|NCT00152516|300070|P1|Overall Study|Other: Non-Compliance|2
84470|NCT00152516|300070|P1|Overall Study|Other: Parents Withdrew Consent|2
84471|NCT00152516|300070|P1|Overall Study|Other: Given Commercial Drug in Error|2
84472|NCT00152516|300070|P1|Overall Study|Other: Mother Refused To Cooperate|1
84473|NCT00152516|300070|P1|Overall Study|Protocol Violation|3
84474|NCT00152516|300070|P1|Overall Study|Withdrawal by Subject|8
84475|NCT00152516|300070|P1|Overall Study|Lost to Follow-up|5
84476|NCT00152516|300070|P1|Overall Study|Lack and Loss of Efficacy|30
84477|NCT00152516|300070|P1|Overall Study|Adverse Event|18
84478|NCT00152763|300098|P4|Overall Study|Lost to Follow-up|13
84479|NCT00152763|300099|P3|Overall Study|Lost to Follow-up|2
84480|NCT00152763|300100|P2|Overall Study|Lost to Follow-up|4
84481|NCT00152763|300101|P1|Overall Study|Lost to Follow-up|6
84482|NCT00152763|300098|P4|Overall Study|Death|1
84483|NCT00152763|300099|P3|Overall Study|Death|2
84484|NCT00152763|300100|P2|Overall Study|Death|1
84485|NCT00152763|300101|P1|Overall Study|Death|4
84486|NCT00152971|300220|P3|Treatment|not specified|10
84487|NCT00152971|300221|P2|Treatment|not specified|11
84488|NCT00152971|300222|P1|Treatment|not specified|9
84489|NCT00152971|300220|P3|Treatment|Withdrawal by Subject|5
84490|NCT00152971|300221|P2|Treatment|Withdrawal by Subject|4
84491|NCT00152971|300222|P1|Treatment|Withdrawal by Subject|4
84492|NCT00152971|300220|P3|Treatment|Lost to Follow-up|1
84493|NCT00152971|300221|P2|Treatment|Lost to Follow-up|2
84494|NCT00152971|300222|P1|Treatment|Lost to Follow-up|1
84495|NCT00152971|300220|P3|Treatment|Protocol Violation|10
84496|NCT00152971|300221|P2|Treatment|Protocol Violation|6
84497|NCT00152971|300222|P1|Treatment|Protocol Violation|8
84498|NCT00152971|300220|P3|Treatment|Adverse Event|54
84499|NCT00152971|300221|P2|Treatment|Adverse Event|40
84500|NCT00152971|300222|P1|Treatment|Adverse Event|49
84501|NCT00152971|300220|P3|Overall Study|not specified|5
84502|NCT00152971|300221|P2|Overall Study|not specified|5
84503|NCT00152971|300222|P1|Overall Study|not specified|3
84504|NCT00152971|300220|P3|Overall Study|Withdrawal by Subject|14
84505|NCT00152971|300221|P2|Overall Study|Withdrawal by Subject|8
84506|NCT00152971|300222|P1|Overall Study|Withdrawal by Subject|9
84507|NCT00152971|300220|P3|Overall Study|Lost to Follow-up|13
84508|NCT00152971|300221|P2|Overall Study|Lost to Follow-up|14
84509|NCT00152971|300222|P1|Overall Study|Lost to Follow-up|17
84510|NCT00152971|300220|P3|Overall Study|Protocol Violation|8
84511|NCT00152971|300221|P2|Overall Study|Protocol Violation|11
84512|NCT00152971|300222|P1|Overall Study|Protocol Violation|10
84513|NCT00152971|300220|P3|Overall Study|Adverse Event|9
84514|NCT00152971|300221|P2|Overall Study|Adverse Event|10
84515|NCT00152971|300222|P1|Overall Study|Adverse Event|12
84516|NCT00153062|300258|P4|Overall Study|Other|0
84517|NCT00153062|300259|P3|Overall Study|Other|1
84518|NCT00153062|300260|P2|Overall Study|Other|0
84519|NCT00153062|300261|P1|Overall Study|Other|0
84520|NCT00153062|300258|P4|Overall Study|No disposition data available|1
84521|NCT00153062|300259|P3|Overall Study|No disposition data available|1
84522|NCT00153062|300260|P2|Overall Study|No disposition data available|1
84523|NCT00153062|300261|P1|Overall Study|No disposition data available|1
84524|NCT00153062|300258|P4|Overall Study|Protocol Violation|1
84525|NCT00153062|300259|P3|Overall Study|Protocol Violation|1
84526|NCT00153062|300260|P2|Overall Study|Protocol Violation|2
84527|NCT00153062|300261|P1|Overall Study|Protocol Violation|0
84528|NCT00153062|300258|P4|Overall Study|Adverse Event|0
84529|NCT00153062|300259|P3|Overall Study|Adverse Event|1
84530|NCT00153062|300260|P2|Overall Study|Adverse Event|1
84531|NCT00153062|300261|P1|Overall Study|Adverse Event|0
84532|NCT00153062|300258|P4|Overall Study|Lost to Follow-up|16
84533|NCT00153062|300259|P3|Overall Study|Lost to Follow-up|15
84534|NCT00153062|300260|P2|Overall Study|Lost to Follow-up|20
84535|NCT00153062|300261|P1|Overall Study|Lost to Follow-up|12
84536|NCT00153062|300258|P4|Overall Study|Withdrawal by Subject|28
84537|NCT00153062|300259|P3|Overall Study|Withdrawal by Subject|27
84538|NCT00153062|300260|P2|Overall Study|Withdrawal by Subject|30
84539|NCT00153062|300261|P1|Overall Study|Withdrawal by Subject|14
84540|NCT00153062|300258|P4|Overall Study|Death|365
84541|NCT00153062|300259|P3|Overall Study|Death|369
84542|NCT00153062|300260|P2|Overall Study|Death|352
84543|NCT00153062|300261|P1|Overall Study|Death|360
84544|NCT00153101|300282|P5|Overall Study|Withdrawal by Subject|5
84545|NCT00153101|300283|P4|Overall Study|Withdrawal by Subject|3
84546|NCT00153101|300284|P3|Overall Study|Withdrawal by Subject|3
84547|NCT00153101|300285|P2|Overall Study|Withdrawal by Subject|4
84548|NCT00153101|300286|P1|Overall Study|Withdrawal by Subject|3
84549|NCT00153101|300282|P5|Overall Study|Lost to Follow-up|5
84550|NCT00153101|300283|P4|Overall Study|Lost to Follow-up|5
84551|NCT00153101|300284|P3|Overall Study|Lost to Follow-up|12
84552|NCT00153101|300285|P2|Overall Study|Lost to Follow-up|14
84553|NCT00153101|300286|P1|Overall Study|Lost to Follow-up|14
84554|NCT00159432|300429|P1|Overall Study|Lack of Efficacy|8
84555|NCT00159432|300429|P1|Overall Study|Death|1
84556|NCT00159432|300429|P1|Overall Study|Adverse Event|1
84557|NCT00159822|300434|P1|Post-treatment Follow-up Period|Reason unspecified|1
84558|NCT00159822|300434|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
84559|NCT00159822|300434|P1|Post-treatment Follow-up Period|Death|1
84560|NCT00159822|300434|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
84561|NCT00159822|300434|P1|Voriconazole Treatment Period|Lost to Follow-up|2
84562|NCT00159822|300434|P1|Voriconazole Treatment Period|Protocol Violation|2
84563|NCT00159822|300434|P1|Voriconazole Treatment Period|Death|4
84564|NCT00159822|300434|P1|Voriconazole Treatment Period|Adverse Event|9
84565|NCT00159822|300434|P1|Voriconazole Treatment Period|Lack of Efficacy|3
84566|NCT00159861|300451|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
84567|NCT00159861|300452|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
84568|NCT00159861|300451|P2|Extension Study - up to 3 Years|Reason Unspecified|19
84569|NCT00159861|300452|P1|Extension Study - up to 3 Years|Reason Unspecified|12
84570|NCT00159861|300451|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
84571|NCT00159861|300452|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
84572|NCT00159861|300451|P2|Extension Study - up to 3 Years|Adverse Event|14
84573|NCT00159861|300452|P1|Extension Study - up to 3 Years|Adverse Event|14
84574|NCT00159861|300451|P2|Extension Study - up to 3 Years|Death|28
84575|NCT00159861|300452|P1|Extension Study - up to 3 Years|Death|24
84576|NCT00159861|300451|P2|Core Study - 16 Weeks|Randomized but not Treated|0
84577|NCT00159861|300452|P1|Core Study - 16 Weeks|Randomized but not Treated|2
84578|NCT00159861|300451|P2|Core Study - 16 Weeks|Subject Defaulted|0
84579|NCT00159861|300452|P1|Core Study - 16 Weeks|Subject Defaulted|1
84580|NCT00159861|300451|P2|Core Study - 16 Weeks|Reason Unspecified|3
84581|NCT00159861|300452|P1|Core Study - 16 Weeks|Reason Unspecified|5
84582|NCT00159861|300451|P2|Core Study - 16 Weeks|Lack of Efficacy|3
84583|NCT00159861|300452|P1|Core Study - 16 Weeks|Lack of Efficacy|2
84584|NCT00159861|300451|P2|Core Study - 16 Weeks|Adverse Event|6
84585|NCT00159861|300452|P1|Core Study - 16 Weeks|Adverse Event|12
84586|NCT00159861|300451|P2|Core Study - 16 Weeks|Death|0
84587|NCT00159861|300452|P1|Core Study - 16 Weeks|Death|3
84588|NCT00159874|300480|P7|Overall Study|Pregnancy|0
84589|NCT00159874|300481|P6|Overall Study|Pregnancy|0
84590|NCT00159874|300482|P5|Overall Study|Pregnancy|0
84591|NCT00159874|300483|P4|Overall Study|Pregnancy|0
84592|NCT00159874|300484|P3|Overall Study|Pregnancy|0
84593|NCT00159874|300485|P2|Overall Study|Pregnancy|1
84594|NCT00159874|300486|P1|Overall Study|Pregnancy|1
84595|NCT00159874|300480|P7|Overall Study|Withdrawal by Subject|1
84596|NCT00159874|300481|P6|Overall Study|Withdrawal by Subject|2
84597|NCT00159874|300482|P5|Overall Study|Withdrawal by Subject|3
84598|NCT00159874|300483|P4|Overall Study|Withdrawal by Subject|4
84599|NCT00159874|300484|P3|Overall Study|Withdrawal by Subject|8
84600|NCT00159874|300485|P2|Overall Study|Withdrawal by Subject|6
84601|NCT00159874|300486|P1|Overall Study|Withdrawal by Subject|2
84602|NCT00159874|300480|P7|Overall Study|Death|0
84603|NCT00159874|300481|P6|Overall Study|Death|2
84604|NCT00159874|300482|P5|Overall Study|Death|1
84605|NCT00159874|300483|P4|Overall Study|Death|0
84606|NCT00159874|300484|P3|Overall Study|Death|15
84607|NCT00159874|300485|P2|Overall Study|Death|8
84608|NCT00159874|300486|P1|Overall Study|Death|3
84609|NCT00159874|300480|P7|Overall Study|Protocol Violation|0
84610|NCT00159874|300481|P6|Overall Study|Protocol Violation|0
84611|NCT00159874|300482|P5|Overall Study|Protocol Violation|0
84612|NCT00159874|300483|P4|Overall Study|Protocol Violation|0
84613|NCT00159874|300484|P3|Overall Study|Protocol Violation|2
84614|NCT00159874|300485|P2|Overall Study|Protocol Violation|5
84615|NCT00159874|300486|P1|Overall Study|Protocol Violation|0
84616|NCT00159874|300480|P7|Overall Study|Not specified|3
84617|NCT00159874|300481|P6|Overall Study|Not specified|1
84618|NCT00159874|300482|P5|Overall Study|Not specified|2
84619|NCT00159874|300483|P4|Overall Study|Not specified|0
84620|NCT00159874|300484|P3|Overall Study|Not specified|8
84621|NCT00159874|300485|P2|Overall Study|Not specified|8
84622|NCT00159874|300486|P1|Overall Study|Not specified|8
84623|NCT00159874|300480|P7|Overall Study|Lost to Follow-up|1
84624|NCT00159874|300481|P6|Overall Study|Lost to Follow-up|2
84625|NCT00159874|300482|P5|Overall Study|Lost to Follow-up|1
84626|NCT00159874|300483|P4|Overall Study|Lost to Follow-up|0
84627|NCT00159874|300484|P3|Overall Study|Lost to Follow-up|3
84628|NCT00159874|300485|P2|Overall Study|Lost to Follow-up|0
84629|NCT00159874|300486|P1|Overall Study|Lost to Follow-up|1
84630|NCT00159874|300480|P7|Overall Study|Lack of Efficacy|0
84631|NCT00159874|300481|P6|Overall Study|Lack of Efficacy|3
84632|NCT00159874|300482|P5|Overall Study|Lack of Efficacy|0
84633|NCT00159874|300483|P4|Overall Study|Lack of Efficacy|1
84634|NCT00159874|300484|P3|Overall Study|Lack of Efficacy|1
84635|NCT00159874|300485|P2|Overall Study|Lack of Efficacy|0
84636|NCT00159874|300486|P1|Overall Study|Lack of Efficacy|2
84637|NCT00159874|300480|P7|Overall Study|Does Not Meet Entrance Criteria|0
84638|NCT00159874|300481|P6|Overall Study|Does Not Meet Entrance Criteria|0
84639|NCT00159874|300482|P5|Overall Study|Does Not Meet Entrance Criteria|0
84640|NCT00159874|300483|P4|Overall Study|Does Not Meet Entrance Criteria|0
84641|NCT00159874|300484|P3|Overall Study|Does Not Meet Entrance Criteria|1
84642|NCT00159874|300485|P2|Overall Study|Does Not Meet Entrance Criteria|0
84643|NCT00159874|300486|P1|Overall Study|Does Not Meet Entrance Criteria|1
84644|NCT00159874|300480|P7|Overall Study|Adverse Event|0
84645|NCT00159874|300481|P6|Overall Study|Adverse Event|2
84646|NCT00159874|300482|P5|Overall Study|Adverse Event|1
84647|NCT00159874|300483|P4|Overall Study|Adverse Event|1
84648|NCT00159874|300484|P3|Overall Study|Adverse Event|5
84649|NCT00159874|300485|P2|Overall Study|Adverse Event|2
84650|NCT00159874|300486|P1|Overall Study|Adverse Event|2
84651|NCT00159913|300658|P4|Overall Study|Protocol Violation|0
84652|NCT00159913|300659|P3|Overall Study|Protocol Violation|1
84653|NCT00159913|300660|P2|Overall Study|Protocol Violation|0
84654|NCT00159913|300661|P1|Overall Study|Protocol Violation|1
84655|NCT00159913|300658|P4|Overall Study|Lost to Follow-up|1
84656|NCT00159913|300659|P3|Overall Study|Lost to Follow-up|0
84657|NCT00159913|300660|P2|Overall Study|Lost to Follow-up|0
84658|NCT00159913|300661|P1|Overall Study|Lost to Follow-up|0
84659|NCT00159913|300658|P4|Overall Study|Withdrawal by Subject|1
84660|NCT00159913|300659|P3|Overall Study|Withdrawal by Subject|0
84661|NCT00159913|300660|P2|Overall Study|Withdrawal by Subject|0
84662|NCT00159913|300661|P1|Overall Study|Withdrawal by Subject|0
84663|NCT00159913|300658|P4|Overall Study|Adverse Event|0
84664|NCT00159913|300659|P3|Overall Study|Adverse Event|1
84665|NCT00159913|300660|P2|Overall Study|Adverse Event|0
84666|NCT00159913|300661|P1|Overall Study|Adverse Event|1
84667|NCT00160199|300765|P2|Overall Study|Protocol Violation|8
84668|NCT00160199|300766|P1|Overall Study|Protocol Violation|8
84669|NCT00160199|300765|P2|Overall Study|Administrative|1
84670|NCT00160199|300766|P1|Overall Study|Administrative|0
84671|NCT00160199|300765|P2|Overall Study|Withdrawal by Subject|6
84672|NCT00160199|300766|P1|Overall Study|Withdrawal by Subject|4
84673|NCT00160199|300765|P2|Overall Study|Lost to Follow-up|7
84674|NCT00160199|300766|P1|Overall Study|Lost to Follow-up|7
84675|NCT00160199|300765|P2|Overall Study|Lack of Efficacy|1
84676|NCT00160199|300766|P1|Overall Study|Lack of Efficacy|0
84677|NCT00160199|300765|P2|Overall Study|Adverse Event|14
84678|NCT00160199|300766|P1|Overall Study|Adverse Event|5
84679|NCT00160251|300790|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
84680|NCT00160251|300791|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84681|NCT00160251|300792|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84682|NCT00160251|300793|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84683|NCT00160251|300794|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84684|NCT00160251|300795|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84685|NCT00160251|300796|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84686|NCT00160251|300797|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
84687|NCT00160251|300790|P8|Post-amendment 2|Lack of Efficacy|24
84688|NCT00160251|300791|P7|Post-amendment 2|Lack of Efficacy|0
84689|NCT00160251|300792|P6|Post-amendment 2|Lack of Efficacy|0
84690|NCT00160251|300793|P5|Post-amendment 2|Lack of Efficacy|0
84691|NCT00160251|300794|P4|Post-amendment 2|Lack of Efficacy|0
84692|NCT00160251|300795|P3|Post-amendment 2|Lack of Efficacy|0
84693|NCT00160251|300796|P2|Post-amendment 2|Lack of Efficacy|0
84694|NCT00160251|300797|P1|Post-amendment 2|Lack of Efficacy|0
84695|NCT00160251|300790|P8|Post-amendment 2|Adverse Event|20
84696|NCT00160251|300791|P7|Post-amendment 2|Adverse Event|0
84697|NCT00160251|300792|P6|Post-amendment 2|Adverse Event|0
84698|NCT00160251|300793|P5|Post-amendment 2|Adverse Event|0
84699|NCT00160251|300794|P4|Post-amendment 2|Adverse Event|0
84700|NCT00160251|300795|P3|Post-amendment 2|Adverse Event|0
84701|NCT00160251|300796|P2|Post-amendment 2|Adverse Event|0
84702|NCT00160251|300797|P1|Post-amendment 2|Adverse Event|0
84703|NCT00160251|300790|P8|Prior to Amendment 2|Completed Treatment Phase|0
84704|NCT00160251|300791|P7|Prior to Amendment 2|Completed Treatment Phase|0
84705|NCT00160251|300792|P6|Prior to Amendment 2|Completed Treatment Phase|23
84706|NCT00160251|300793|P5|Prior to Amendment 2|Completed Treatment Phase|0
84707|NCT00160251|300794|P4|Prior to Amendment 2|Completed Treatment Phase|0
84708|NCT00160251|300795|P3|Prior to Amendment 2|Completed Treatment Phase|0
84709|NCT00160251|300796|P2|Prior to Amendment 2|Completed Treatment Phase|0
84710|NCT00160251|300797|P1|Prior to Amendment 2|Completed Treatment Phase|3
84711|NCT00160251|300790|P8|Prior to Amendment 2|Noncompliance with protocol|0
84712|NCT00160251|300791|P7|Prior to Amendment 2|Noncompliance with protocol|0
84713|NCT00160251|300792|P6|Prior to Amendment 2|Noncompliance with protocol|0
84714|NCT00160251|300793|P5|Prior to Amendment 2|Noncompliance with protocol|0
84715|NCT00160251|300794|P4|Prior to Amendment 2|Noncompliance with protocol|0
84716|NCT00160251|300795|P3|Prior to Amendment 2|Noncompliance with protocol|0
84717|NCT00160251|300796|P2|Prior to Amendment 2|Noncompliance with protocol|0
84718|NCT00160251|300797|P1|Prior to Amendment 2|Noncompliance with protocol|1
84719|NCT00160251|300790|P8|Prior to Amendment 2|Withdrawal by Subject|0
84720|NCT00160251|300791|P7|Prior to Amendment 2|Withdrawal by Subject|3
84721|NCT00160251|300792|P6|Prior to Amendment 2|Withdrawal by Subject|3
84722|NCT00160251|300793|P5|Prior to Amendment 2|Withdrawal by Subject|2
84723|NCT00160251|300794|P4|Prior to Amendment 2|Withdrawal by Subject|4
84724|NCT00160251|300795|P3|Prior to Amendment 2|Withdrawal by Subject|3
84725|NCT00160251|300796|P2|Prior to Amendment 2|Withdrawal by Subject|1
84726|NCT00160251|300797|P1|Prior to Amendment 2|Withdrawal by Subject|3
84727|NCT00160251|300790|P8|Prior to Amendment 2|Lost to Follow-up|0
84728|NCT00160251|300791|P7|Prior to Amendment 2|Lost to Follow-up|0
84729|NCT00160251|300792|P6|Prior to Amendment 2|Lost to Follow-up|1
84730|NCT00160251|300793|P5|Prior to Amendment 2|Lost to Follow-up|1
84731|NCT00160251|300794|P4|Prior to Amendment 2|Lost to Follow-up|0
84732|NCT00160251|300795|P3|Prior to Amendment 2|Lost to Follow-up|1
84733|NCT00160251|300796|P2|Prior to Amendment 2|Lost to Follow-up|0
84734|NCT00160251|300797|P1|Prior to Amendment 2|Lost to Follow-up|0
84735|NCT00160251|300790|P8|Prior to Amendment 2|Lack of Efficacy|0
84736|NCT00160251|300791|P7|Prior to Amendment 2|Lack of Efficacy|0
84737|NCT00160251|300792|P6|Prior to Amendment 2|Lack of Efficacy|55
84738|NCT00160251|300793|P5|Prior to Amendment 2|Lack of Efficacy|24
84739|NCT00160251|300794|P4|Prior to Amendment 2|Lack of Efficacy|35
84740|NCT00160251|300795|P3|Prior to Amendment 2|Lack of Efficacy|37
84741|NCT00160251|300796|P2|Prior to Amendment 2|Lack of Efficacy|4
84742|NCT00160251|300797|P1|Prior to Amendment 2|Lack of Efficacy|0
84743|NCT00160251|300790|P8|Prior to Amendment 2|Adverse Event|0
84744|NCT00160251|300791|P7|Prior to Amendment 2|Adverse Event|1
84745|NCT00160251|300792|P6|Prior to Amendment 2|Adverse Event|1
84746|NCT00160251|300793|P5|Prior to Amendment 2|Adverse Event|1
84747|NCT00160251|300794|P4|Prior to Amendment 2|Adverse Event|1
84748|NCT00160251|300795|P3|Prior to Amendment 2|Adverse Event|3
84749|NCT00160251|300796|P2|Prior to Amendment 2|Adverse Event|1
84750|NCT00160251|300797|P1|Prior to Amendment 2|Adverse Event|2
84751|NCT00160524|300871|P1|Overall Study|Other|20
84752|NCT00160524|300871|P1|Overall Study|Lack of Efficacy and Other|1
84753|NCT00160524|300871|P1|Overall Study|Lack of Efficacy|21
84754|NCT00160524|300871|P1|Overall Study|Lost to Follow-up and Other|1
84755|NCT00160524|300871|P1|Overall Study|Lost to Follow-up|13
84756|NCT00160524|300871|P1|Overall Study|Physician Decision and Other|6
84757|NCT00160524|300871|P1|Overall Study|Physician Decision|27
84758|NCT00160524|300871|P1|Overall Study|Withdrawal by Subject and Other|17
84759|NCT00160524|300871|P1|Overall Study|Withdrawal by Subject|141
84760|NCT00160524|300871|P1|Overall Study|Protocol Violation and Other|2
84761|NCT00160524|300871|P1|Overall Study|Protocol Violation|16
84762|NCT00160524|300871|P1|Overall Study|Adverse Event and Other|94
84763|NCT00160524|300871|P1|Overall Study|Adverse Event|119
84764|NCT00160563|300885|P3|Overall Study|Missing reason|0
84765|NCT00160563|300886|P2|Overall Study|Missing reason|1
84766|NCT00160563|300887|P1|Overall Study|Missing reason|0
84767|NCT00160563|300885|P3|Overall Study|Other (listed in the study report)|81
84768|NCT00160563|300886|P2|Overall Study|Other (listed in the study report)|40
84769|NCT00160563|300887|P1|Overall Study|Other (listed in the study report)|48
84770|NCT00160563|300885|P3|Overall Study|Withdrawal by Subject|3
84771|NCT00160563|300886|P2|Overall Study|Withdrawal by Subject|2
84772|NCT00160563|300887|P1|Overall Study|Withdrawal by Subject|1
84773|NCT00160563|300885|P3|Overall Study|Protocol Violation|3
84774|NCT00160563|300886|P2|Overall Study|Protocol Violation|0
84775|NCT00160563|300887|P1|Overall Study|Protocol Violation|0
84776|NCT00160563|300885|P3|Overall Study|Lost to Follow-up|2
84777|NCT00160563|300886|P2|Overall Study|Lost to Follow-up|1
84778|NCT00160563|300887|P1|Overall Study|Lost to Follow-up|1
84779|NCT00160563|300885|P3|Overall Study|Adverse Event|1
84780|NCT00160563|300886|P2|Overall Study|Adverse Event|1
84781|NCT00160563|300887|P1|Overall Study|Adverse Event|1
84782|NCT00160641|300899|P1|Overall Study|Unspecified|9
84783|NCT00160641|300899|P1|Overall Study|Protocol Violation|3
84784|NCT00160641|300899|P1|Overall Study|Lack of Efficacy|12
84785|NCT00160641|300899|P1|Overall Study|Lost to Follow-up|8
84786|NCT00160641|300899|P1|Overall Study|Withdrawal by Subject|87
84787|NCT00160641|300899|P1|Overall Study|Adverse Event|102
84788|NCT00160693|300930|P1|Overall Study|Study terminated by sponsor|15
84789|NCT00160693|300930|P1|Overall Study|Withdrawal by Subject|54
84790|NCT00160693|300930|P1|Overall Study|Lost to Follow-up|15
84791|NCT00160693|300930|P1|Overall Study|Protocol Violation|24
84792|NCT00160693|300930|P1|Overall Study|Lack of Efficacy|30
84793|NCT00160693|300930|P1|Overall Study|Adverse Event|97
84794|NCT00160706|300947|P1|Overall Study|Other Reason|11
84795|NCT00160706|300947|P1|Overall Study|Lack of Efficacy and Other|1
84796|NCT00160706|300947|P1|Overall Study|Lack of Efficacy|42
84797|NCT00160706|300947|P1|Overall Study|Lost to Follow-up and Other|1
84798|NCT00160706|300947|P1|Overall Study|Lost to Follow-up|4
84799|NCT00160706|300947|P1|Overall Study|Physician Decision and Other|3
84800|NCT00160706|300947|P1|Overall Study|Physician Decision|10
84801|NCT00160706|300947|P1|Overall Study|Withdrawal by Subject and Other|12
84802|NCT00160706|300947|P1|Overall Study|Withdrawal by Subject|41
84803|NCT00160706|300947|P1|Overall Study|Protocol Violation|3
84804|NCT00160706|300947|P1|Overall Study|Adverse Event and Other Reason|105
84805|NCT00160706|300947|P1|Overall Study|Adverse Event|53
84806|NCT00161213|300959|P1|Overall Study|Evaluable for toxicity but not response|1
84807|NCT00161213|300959|P1|Overall Study|Withdrawal by Subject|1
84808|NCT00161616|300992|P2|Overall Study|Protocol deviation|0
84809|NCT00161616|300993|P1|Overall Study|Protocol deviation|1
84810|NCT00161616|300992|P2|Overall Study|Lost to Follow-up|13
84811|NCT00161616|300993|P1|Overall Study|Lost to Follow-up|17
84812|NCT00161616|300992|P2|Overall Study|Death|1
84813|NCT00161616|300993|P1|Overall Study|Death|1
84814|NCT00161616|300992|P2|Overall Study|Physician Decision|0
84815|NCT00161616|300993|P1|Overall Study|Physician Decision|1
84816|NCT00161616|300992|P2|Overall Study|Withdrawal by Subject|5
84817|NCT00161616|300993|P1|Overall Study|Withdrawal by Subject|6
84818|NCT00162032|301003|P2|Overall Study|Reason not specified|0
84819|NCT00162032|301004|P1|Overall Study|Reason not specified|1
84820|NCT00162032|301003|P2|Overall Study|Lost to Follow-up|2
84821|NCT00162032|301004|P1|Overall Study|Lost to Follow-up|4
84822|NCT00162097|301016|P4|Overall Study|Participant no longer met study criteria|1
84823|NCT00162097|301017|P3|Overall Study|Participant no longer met study criteria|0
84824|NCT00162097|301018|P2|Overall Study|Participant no longer met study criteria|0
84825|NCT00162097|301019|P1|Overall Study|Participant no longer met study criteria|0
84826|NCT00162123|301087|P8|Overall Study|Follow-up only (not treated or assessed)|57
84827|NCT00162123|301088|P7|Overall Study|Follow-up only (not treated or assessed)|0
84828|NCT00162123|301089|P6|Overall Study|Follow-up only (not treated or assessed)|0
84829|NCT00162123|301090|P5|Overall Study|Follow-up only (not treated or assessed)|0
84830|NCT00162123|301091|P4|Overall Study|Follow-up only (not treated or assessed)|0
84831|NCT00162123|301092|P3|Overall Study|Follow-up only (not treated or assessed)|0
84832|NCT00162123|301093|P2|Overall Study|Follow-up only (not treated or assessed)|0
84833|NCT00162123|301094|P1|Overall Study|Follow-up only (not treated or assessed)|0
84834|NCT00162123|301087|P8|Overall Study|Tumor assessment only (not treated)|1
84835|NCT00162123|301088|P7|Overall Study|Tumor assessment only (not treated)|0
84836|NCT00162123|301089|P6|Overall Study|Tumor assessment only (not treated)|0
84837|NCT00162123|301090|P5|Overall Study|Tumor assessment only (not treated)|0
84838|NCT00162123|301091|P4|Overall Study|Tumor assessment only (not treated)|0
84839|NCT00162123|301092|P3|Overall Study|Tumor assessment only (not treated)|0
84840|NCT00162123|301093|P2|Overall Study|Tumor assessment only (not treated)|0
84841|NCT00162123|301094|P1|Overall Study|Tumor assessment only (not treated)|0
84842|NCT00162123|301087|P8|Overall Study|Physician Decision|0
84843|NCT00162123|301088|P7|Overall Study|Physician Decision|1
84844|NCT00162123|301089|P6|Overall Study|Physician Decision|1
84845|NCT00162123|301090|P5|Overall Study|Physician Decision|0
84846|NCT00162123|301091|P4|Overall Study|Physician Decision|0
84847|NCT00162123|301092|P3|Overall Study|Physician Decision|0
84848|NCT00162123|301093|P2|Overall Study|Physician Decision|2
84849|NCT00162123|301094|P1|Overall Study|Physician Decision|1
84850|NCT00162123|301087|P8|Overall Study|Not specified (after start of treatment)|0
84851|NCT00162123|301088|P7|Overall Study|Not specified (after start of treatment)|0
84852|NCT00162123|301089|P6|Overall Study|Not specified (after start of treatment)|0
84853|NCT00162123|301090|P5|Overall Study|Not specified (after start of treatment)|3
84854|NCT00162123|301091|P4|Overall Study|Not specified (after start of treatment)|0
84855|NCT00162123|301092|P3|Overall Study|Not specified (after start of treatment)|0
84856|NCT00162123|301093|P2|Overall Study|Not specified (after start of treatment)|0
84857|NCT00162123|301094|P1|Overall Study|Not specified (after start of treatment)|0
84858|NCT00162123|301087|P8|Overall Study|Not specified (before treatment)|0
84859|NCT00162123|301088|P7|Overall Study|Not specified (before treatment)|0
84860|NCT00162123|301089|P6|Overall Study|Not specified (before treatment)|1
84861|NCT00162123|301090|P5|Overall Study|Not specified (before treatment)|12
84862|NCT00162123|301091|P4|Overall Study|Not specified (before treatment)|0
84863|NCT00162123|301092|P3|Overall Study|Not specified (before treatment)|0
84864|NCT00162123|301093|P2|Overall Study|Not specified (before treatment)|0
84865|NCT00162123|301094|P1|Overall Study|Not specified (before treatment)|2
84866|NCT00162123|301087|P8|Overall Study|Adverse Event|0
84867|NCT00162123|301088|P7|Overall Study|Adverse Event|0
84868|NCT00162123|301089|P6|Overall Study|Adverse Event|0
84869|NCT00162123|301090|P5|Overall Study|Adverse Event|1
84870|NCT00162123|301091|P4|Overall Study|Adverse Event|2
84871|NCT00162123|301092|P3|Overall Study|Adverse Event|0
84872|NCT00162123|301093|P2|Overall Study|Adverse Event|2
84873|NCT00162123|301094|P1|Overall Study|Adverse Event|1
84874|NCT00162123|301087|P8|Overall Study|Deterioration without progression|0
84875|NCT00162123|301088|P7|Overall Study|Deterioration without progression|0
84876|NCT00162123|301089|P6|Overall Study|Deterioration without progression|0
84877|NCT00162123|301090|P5|Overall Study|Deterioration without progression|1
84878|NCT00162123|301091|P4|Overall Study|Deterioration without progression|0
84879|NCT00162123|301092|P3|Overall Study|Deterioration without progression|3
84880|NCT00162123|301093|P2|Overall Study|Deterioration without progression|2
84881|NCT00162123|301094|P1|Overall Study|Deterioration without progression|2
84882|NCT00162123|301087|P8|Overall Study|Withdrawal by Subject|0
84883|NCT00162123|301088|P7|Overall Study|Withdrawal by Subject|1
84884|NCT00162123|301089|P6|Overall Study|Withdrawal by Subject|2
84885|NCT00162123|301090|P5|Overall Study|Withdrawal by Subject|1
84886|NCT00162123|301091|P4|Overall Study|Withdrawal by Subject|1
84887|NCT00162123|301092|P3|Overall Study|Withdrawal by Subject|2
84888|NCT00162123|301093|P2|Overall Study|Withdrawal by Subject|0
84889|NCT00162123|301094|P1|Overall Study|Withdrawal by Subject|2
84890|NCT00162123|301087|P8|Overall Study|Death|0
84891|NCT00162123|301088|P7|Overall Study|Death|0
84892|NCT00162123|301089|P6|Overall Study|Death|1
84893|NCT00162123|301090|P5|Overall Study|Death|1
84894|NCT00162123|301091|P4|Overall Study|Death|1
84895|NCT00162123|301092|P3|Overall Study|Death|1
84896|NCT00162123|301093|P2|Overall Study|Death|3
84897|NCT00162123|301094|P1|Overall Study|Death|3
84898|NCT00162123|301087|P8|Overall Study|Study drug toxicity|0
84899|NCT00162123|301088|P7|Overall Study|Study drug toxicity|1
84900|NCT00162123|301089|P6|Overall Study|Study drug toxicity|1
84901|NCT00162123|301090|P5|Overall Study|Study drug toxicity|4
84902|NCT00162123|301091|P4|Overall Study|Study drug toxicity|0
84903|NCT00162123|301092|P3|Overall Study|Study drug toxicity|5
84904|NCT00162123|301093|P2|Overall Study|Study drug toxicity|1
84905|NCT00162123|301094|P1|Overall Study|Study drug toxicity|6
84906|NCT00162123|301087|P8|Overall Study|Disease progression|0
84907|NCT00162123|301088|P7|Overall Study|Disease progression|1
84908|NCT00162123|301089|P6|Overall Study|Disease progression|3
84909|NCT00162123|301090|P5|Overall Study|Disease progression|8
84910|NCT00162123|301091|P4|Overall Study|Disease progression|4
84911|NCT00162123|301092|P3|Overall Study|Disease progression|10
84912|NCT00162123|301093|P2|Overall Study|Disease progression|19
84913|NCT00162123|301094|P1|Overall Study|Disease progression|27
84914|NCT00162136|301129|P1|Overall Study|Withdrawal by Subject|1
84915|NCT00162136|301129|P1|Overall Study|Study Drug Toxicity|4
84916|NCT00162136|301129|P1|Overall Study|Investigator Request|5
84917|NCT00162136|301129|P1|Overall Study|Disease Progression/Relapse|23
84918|NCT00162136|301129|P1|Overall Study|Death|1
84919|NCT00162136|301129|P1|Overall Study|Adverse Event|1
84920|NCT00162266|301156|P4|Open-Label Period|Other Reasons|15
84921|NCT00162266|301157|P3|Open-Label Period|Other Reasons|0
84922|NCT00162266|301158|P2|Open-Label Period|Other Reasons|0
84923|NCT00162266|301159|P1|Open-Label Period|Other Reasons|0
84924|NCT00162266|301156|P4|Open-Label Period|Administrative Reason By Sponsor|9
84925|NCT00162266|301157|P3|Open-Label Period|Administrative Reason By Sponsor|0
84926|NCT00162266|301158|P2|Open-Label Period|Administrative Reason By Sponsor|0
84927|NCT00162266|301159|P1|Open-Label Period|Administrative Reason By Sponsor|0
84928|NCT00162266|301156|P4|Open-Label Period|Withdrawal by Subject|31
84929|NCT00162266|301157|P3|Open-Label Period|Withdrawal by Subject|0
84930|NCT00162266|301158|P2|Open-Label Period|Withdrawal by Subject|0
84931|NCT00162266|301159|P1|Open-Label Period|Withdrawal by Subject|0
84932|NCT00162266|301156|P4|Open-Label Period|Lost to Follow-up|3
84933|NCT00162266|301157|P3|Open-Label Period|Lost to Follow-up|0
84934|NCT00162266|301158|P2|Open-Label Period|Lost to Follow-up|0
84935|NCT00162266|301159|P1|Open-Label Period|Lost to Follow-up|0
84936|NCT00162266|301156|P4|Open-Label Period|Lack of Efficacy|26
84937|NCT00162266|301157|P3|Open-Label Period|Lack of Efficacy|0
84938|NCT00162266|301158|P2|Open-Label Period|Lack of Efficacy|0
84939|NCT00162266|301159|P1|Open-Label Period|Lack of Efficacy|0
84940|NCT00162266|301156|P4|Open-Label Period|Adverse Event|46
84941|NCT00162266|301157|P3|Open-Label Period|Adverse Event|0
84942|NCT00162266|301158|P2|Open-Label Period|Adverse Event|0
84943|NCT00162266|301159|P1|Open-Label Period|Adverse Event|0
84944|NCT00162266|301156|P4|Open-Label Period|Death|7
84945|NCT00162266|301157|P3|Open-Label Period|Death|0
84946|NCT00162266|301158|P2|Open-Label Period|Death|0
84947|NCT00162266|301159|P1|Open-Label Period|Death|0
84948|NCT00162266|301156|P4|Double-Blind Period|Withdrawal by Subject|0
84949|NCT00162266|301157|P3|Double-Blind Period|Withdrawal by Subject|6
84950|NCT00162266|301158|P2|Double-Blind Period|Withdrawal by Subject|2
84951|NCT00162266|301159|P1|Double-Blind Period|Withdrawal by Subject|5
84952|NCT00162266|301156|P4|Double-Blind Period|Lack of Efficacy|0
84953|NCT00162266|301157|P3|Double-Blind Period|Lack of Efficacy|30
84954|NCT00162266|301158|P2|Double-Blind Period|Lack of Efficacy|17
84955|NCT00162266|301159|P1|Double-Blind Period|Lack of Efficacy|13
84956|NCT00162266|301156|P4|Double-Blind Period|Other Reason|0
84957|NCT00162266|301157|P3|Double-Blind Period|Other Reason|1
84958|NCT00162266|301158|P2|Double-Blind Period|Other Reason|0
84959|NCT00162266|301159|P1|Double-Blind Period|Other Reason|1
84960|NCT00162266|301156|P4|Double-Blind Period|Lost to Follow-up|0
84961|NCT00162266|301157|P3|Double-Blind Period|Lost to Follow-up|0
84962|NCT00162266|301158|P2|Double-Blind Period|Lost to Follow-up|2
84963|NCT00162266|301159|P1|Double-Blind Period|Lost to Follow-up|1
84964|NCT00162266|301156|P4|Double-Blind Period|Death|0
84965|NCT00162266|301157|P3|Double-Blind Period|Death|0
84966|NCT00162266|301158|P2|Double-Blind Period|Death|1
84967|NCT00162266|301159|P1|Double-Blind Period|Death|0
84968|NCT00162266|301156|P4|Double-Blind Period|Adverse Event|0
84969|NCT00162266|301157|P3|Double-Blind Period|Adverse Event|11
84970|NCT00162266|301158|P2|Double-Blind Period|Adverse Event|9
84971|NCT00162266|301159|P1|Double-Blind Period|Adverse Event|5
84972|NCT00156533|301358|P4|Overall Study|Failed Screening|1
84973|NCT00156533|301359|P3|Overall Study|Failed Screening|1
84974|NCT00156533|301360|P2|Overall Study|Failed Screening|0
84975|NCT00156533|301361|P1|Overall Study|Failed Screening|1
84976|NCT00156533|301358|P4|Overall Study|Withdrawal by Subject|1
84977|NCT00156533|301359|P3|Overall Study|Withdrawal by Subject|0
84978|NCT00156533|301360|P2|Overall Study|Withdrawal by Subject|0
84979|NCT00156533|301361|P1|Overall Study|Withdrawal by Subject|1
84980|NCT00156533|301358|P4|Overall Study|Withdrawn - Medication Expiration|0
84981|NCT00156533|301359|P3|Overall Study|Withdrawn - Medication Expiration|1
84982|NCT00156533|301360|P2|Overall Study|Withdrawn - Medication Expiration|2
84983|NCT00156533|301361|P1|Overall Study|Withdrawn - Medication Expiration|0
84984|NCT00162370|301380|P1|Efficacy Population|Lost to Follow-up|51
84985|NCT00163657|301467|P3|Overall Study|Other reason|3
84986|NCT00163657|301468|P2|Overall Study|Other reason|1
84987|NCT00163657|301469|P1|Overall Study|Other reason|0
84988|NCT00163657|301467|P3|Overall Study|Lost to Follow-up|10
84989|NCT00163657|301468|P2|Overall Study|Lost to Follow-up|3
84990|NCT00163657|301469|P1|Overall Study|Lost to Follow-up|1
84991|NCT00163657|301467|P3|Overall Study|Non Compliance|0
84992|NCT00163657|301468|P2|Overall Study|Non Compliance|0
84993|NCT00163657|301469|P1|Overall Study|Non Compliance|1
84994|NCT00163657|301467|P3|Overall Study|Physician Decision|1
84995|NCT00163657|301468|P2|Overall Study|Physician Decision|1
84996|NCT00163657|301469|P1|Overall Study|Physician Decision|0
84997|NCT00163657|301467|P3|Overall Study|Withdrawal by Subject|2
84998|NCT00163657|301468|P2|Overall Study|Withdrawal by Subject|3
84999|NCT00163657|301469|P1|Overall Study|Withdrawal by Subject|2
85000|NCT00163657|301467|P3|Overall Study|graft loss|2
85001|NCT00163657|301468|P2|Overall Study|graft loss|1
85002|NCT00163657|301469|P1|Overall Study|graft loss|4
85003|NCT00163657|301467|P3|Overall Study|Death|19
85004|NCT00163657|301468|P2|Overall Study|Death|14
85005|NCT00163657|301469|P1|Overall Study|Death|12
85006|NCT00165503|301480|P1|Overall Study|Unresectable|3
85007|NCT00165503|301480|P1|Overall Study|Lost to Follow-up|12
85008|NCT00165503|301480|P1|Overall Study|Death|1
85009|NCT00165646|301487|P3|Overall Study|Protocol Violation|0
85010|NCT00165646|301488|P2|Overall Study|Protocol Violation|0
85011|NCT00165646|301489|P1|Overall Study|Protocol Violation|1
85012|NCT00165646|301487|P3|Overall Study|Physician Decision|2
85013|NCT00165646|301488|P2|Overall Study|Physician Decision|0
85014|NCT00165646|301489|P1|Overall Study|Physician Decision|2
85015|NCT00165646|301487|P3|Overall Study|Withdrawal by Subject|1
85016|NCT00165646|301488|P2|Overall Study|Withdrawal by Subject|2
85017|NCT00165646|301489|P1|Overall Study|Withdrawal by Subject|0
85018|NCT00165646|301487|P3|Overall Study|Lack of Efficacy|0
85019|NCT00165646|301488|P2|Overall Study|Lack of Efficacy|2
85020|NCT00165646|301489|P1|Overall Study|Lack of Efficacy|1
85021|NCT00165646|301487|P3|Overall Study|Adverse Event|1
85022|NCT00165646|301488|P2|Overall Study|Adverse Event|1
85023|NCT00165646|301489|P1|Overall Study|Adverse Event|1
85024|NCT00165672|301499|P2|Overall Study|Adverse Event|1
85025|NCT00165672|301500|P1|Overall Study|Adverse Event|0
85026|NCT00165698|301508|P2|Overall Study|Not Taken/Lost the medicine|2
85027|NCT00165698|301509|P1|Overall Study|Not Taken/Lost the medicine|1
85028|NCT00165698|301508|P2|Overall Study|Protocol Violation|0
85029|NCT00165698|301509|P1|Overall Study|Protocol Violation|1
85030|NCT00165698|301508|P2|Overall Study|Withdrawal by Subject|1
85031|NCT00165698|301509|P1|Overall Study|Withdrawal by Subject|2
85032|NCT00165698|301508|P2|Overall Study|Lost to Follow-up|2
85033|NCT00165698|301509|P1|Overall Study|Lost to Follow-up|2
85034|NCT00165698|301508|P2|Overall Study|Adverse Event|10
85035|NCT00165698|301509|P1|Overall Study|Adverse Event|2
85036|NCT00165776|301537|P4|Overall Study|Worsening of Cervical Dystonia|1
85037|NCT00165776|301538|P3|Overall Study|Worsening of Cervical Dystonia|0
85038|NCT00165776|301539|P2|Overall Study|Worsening of Cervical Dystonia|0
85039|NCT00165776|301540|P1|Overall Study|Worsening of Cervical Dystonia|0
85040|NCT00165776|301537|P4|Overall Study|Withdrawal by Subject|0
85041|NCT00165776|301538|P3|Overall Study|Withdrawal by Subject|2
85042|NCT00165776|301539|P2|Overall Study|Withdrawal by Subject|1
85043|NCT00165776|301540|P1|Overall Study|Withdrawal by Subject|4
85044|NCT00165776|301537|P4|Overall Study|Lack of Efficacy|1
85045|NCT00165776|301538|P3|Overall Study|Lack of Efficacy|0
85046|NCT00165776|301539|P2|Overall Study|Lack of Efficacy|0
85047|NCT00165776|301540|P1|Overall Study|Lack of Efficacy|0
85048|NCT00165789|301578|P4|Overall Study|Withdrawal by Subject|2
85049|NCT00165789|301579|P3|Overall Study|Withdrawal by Subject|1
85050|NCT00165789|301580|P2|Overall Study|Withdrawal by Subject|1
85051|NCT00165789|301581|P1|Overall Study|Withdrawal by Subject|0
85052|NCT00165789|301578|P4|Overall Study|Adverse Event|12
85053|NCT00165789|301579|P3|Overall Study|Adverse Event|0
85054|NCT00165789|301580|P2|Overall Study|Adverse Event|3
85055|NCT00165789|301581|P1|Overall Study|Adverse Event|0
85056|NCT00159783|301634|P3|Overall Study|not specified|4
85057|NCT00159783|301635|P2|Overall Study|not specified|2
85058|NCT00159783|301636|P1|Overall Study|not specified|0
85059|NCT00159783|301634|P3|Overall Study|Lost to Follow-up|11
85060|NCT00159783|301635|P2|Overall Study|Lost to Follow-up|5
85061|NCT00159783|301636|P1|Overall Study|Lost to Follow-up|6
85062|NCT00159783|301634|P3|Overall Study|Withdrawal by Subject|12
85063|NCT00159783|301635|P2|Overall Study|Withdrawal by Subject|11
85064|NCT00159783|301636|P1|Overall Study|Withdrawal by Subject|7
85065|NCT00159783|301634|P3|Overall Study|Lack of Efficacy|3
85066|NCT00159783|301635|P2|Overall Study|Lack of Efficacy|2
85067|NCT00159783|301636|P1|Overall Study|Lack of Efficacy|1
85068|NCT00159783|301634|P3|Overall Study|Adverse Event|9
85069|NCT00159783|301635|P2|Overall Study|Adverse Event|7
85070|NCT00159783|301636|P1|Overall Study|Adverse Event|5
85071|NCT00165841|301668|P2|Overall Study|Medication Noncompliance|1
85072|NCT00165841|301669|P1|Overall Study|Medication Noncompliance|1
85073|NCT00165841|301668|P2|Overall Study|Other|5
85074|NCT00165841|301669|P1|Overall Study|Other|3
85075|NCT00165841|301668|P2|Overall Study|Protocol Violation|8
85076|NCT00165841|301669|P1|Overall Study|Protocol Violation|6
85077|NCT00165841|301668|P2|Overall Study|Physician Decision|0
85078|NCT00165841|301669|P1|Overall Study|Physician Decision|1
85079|NCT00165841|301668|P2|Overall Study|Withdrawal by Subject|8
85080|NCT00165841|301669|P1|Overall Study|Withdrawal by Subject|7
85081|NCT00165841|301668|P2|Overall Study|Lost to Follow-up|4
85082|NCT00165841|301669|P1|Overall Study|Lost to Follow-up|4
85083|NCT00165841|301668|P2|Overall Study|Lack of Efficacy|33
85084|NCT00165841|301669|P1|Overall Study|Lack of Efficacy|6
85085|NCT00165841|301668|P2|Overall Study|Adverse Event|3
85086|NCT00165841|301669|P1|Overall Study|Adverse Event|2
85087|NCT00165984|301684|P1|Overall Study|Death|15
85088|NCT00166114|301704|P2|Overall Study|Adverse Event|1
85089|NCT00166114|301705|P1|Overall Study|Adverse Event|2
85090|NCT00166114|301704|P2|Overall Study|Withdrawal by Subject|4
85091|NCT00166114|301705|P1|Overall Study|Withdrawal by Subject|10
85092|NCT00166114|301704|P2|Overall Study|Protocol Violation|1
85093|NCT00166114|301705|P1|Overall Study|Protocol Violation|2
85094|NCT00168038|301711|P1|Overall Study|Therapy failure|1
85095|NCT00168038|301711|P1|Overall Study|Adverse Event|1
85096|NCT00168064|301725|P2|Overall Study|Various|3
85097|NCT00168064|301726|P1|Overall Study|Various|4
85098|NCT00168064|301725|P2|Overall Study|Subject's Best interest|2
85099|NCT00168064|301726|P1|Overall Study|Subject's Best interest|2
85100|NCT00168064|301725|P2|Overall Study|Concurrent Illness|3
85101|NCT00168064|301726|P1|Overall Study|Concurrent Illness|4
85102|NCT00168064|301725|P2|Overall Study|Non-compliance|3
85103|NCT00168064|301726|P1|Overall Study|Non-compliance|2
85104|NCT00168064|301725|P2|Overall Study|Lost to Follow-up|3
85105|NCT00168064|301726|P1|Overall Study|Lost to Follow-up|4
85106|NCT00168064|301725|P2|Overall Study|Lack of Efficacy|4
85107|NCT00168064|301726|P1|Overall Study|Lack of Efficacy|4
85108|NCT00168064|301725|P2|Overall Study|Withdrawal by Subject|4
85109|NCT00168064|301726|P1|Overall Study|Withdrawal by Subject|3
85110|NCT00168064|301725|P2|Overall Study|Adverse Event|22
85111|NCT00168064|301726|P1|Overall Study|Adverse Event|26
85112|NCT00168103|301737|P4|Overall Study|Lost to Follow-up|0
85113|NCT00168103|301738|P3|Overall Study|Lost to Follow-up|0
85114|NCT00168103|301739|P2|Overall Study|Lost to Follow-up|3
85115|NCT00168103|301740|P1|Overall Study|Lost to Follow-up|1
85116|NCT00168103|301737|P4|Overall Study|Withdrawal by Subject|0
85117|NCT00168103|301738|P3|Overall Study|Withdrawal by Subject|1
85118|NCT00168103|301739|P2|Overall Study|Withdrawal by Subject|2
85119|NCT00168103|301740|P1|Overall Study|Withdrawal by Subject|1
85120|NCT00168805|301955|P3|Treatment|not specified|17
85121|NCT00168805|301956|P2|Treatment|not specified|18
85122|NCT00168805|301957|P1|Treatment|not specified|18
85123|NCT00168805|301955|P3|Treatment|Withdrawal by Subject|8
85124|NCT00168805|301956|P2|Treatment|Withdrawal by Subject|7
85125|NCT00168805|301957|P1|Treatment|Withdrawal by Subject|3
85126|NCT00168805|301955|P3|Treatment|Protocol Violation|5
85127|NCT00168805|301956|P2|Treatment|Protocol Violation|5
85128|NCT00168805|301957|P1|Treatment|Protocol Violation|3
85129|NCT00168805|301955|P3|Treatment|Adverse Event|32
85130|NCT00168805|301956|P2|Treatment|Adverse Event|26
85131|NCT00168805|301957|P1|Treatment|Adverse Event|25
85132|NCT00168805|301955|P3|Overall Study|not specified|22
85133|NCT00168805|301956|P2|Overall Study|not specified|21
85134|NCT00168805|301957|P1|Overall Study|not specified|24
85135|NCT00168805|301955|P3|Overall Study|Withdrawal by Subject|21
85136|NCT00168805|301956|P2|Overall Study|Withdrawal by Subject|18
85137|NCT00168805|301957|P1|Overall Study|Withdrawal by Subject|16
85138|NCT00168805|301955|P3|Overall Study|Lost to Follow-up|11
85139|NCT00168805|301956|P2|Overall Study|Lost to Follow-up|17
85140|NCT00168805|301957|P1|Overall Study|Lost to Follow-up|12
85141|NCT00168805|301955|P3|Overall Study|Protocol Violation|8
85142|NCT00168805|301956|P2|Overall Study|Protocol Violation|11
85143|NCT00168805|301957|P1|Overall Study|Protocol Violation|12
85144|NCT00168805|301955|P3|Overall Study|Adverse Event|16
85145|NCT00168805|301956|P2|Overall Study|Adverse Event|11
85146|NCT00168805|301957|P1|Overall Study|Adverse Event|7
85147|NCT00168818|302001|P3|Treatment|not specified|31
85148|NCT00168818|302002|P2|Treatment|not specified|29
85149|NCT00168818|302003|P1|Treatment|not specified|23
85150|NCT00168818|302001|P3|Treatment|Withdrawal by Subject|22
85151|NCT00168818|302002|P2|Treatment|Withdrawal by Subject|20
85152|NCT00168818|302003|P1|Treatment|Withdrawal by Subject|25
85153|NCT00168818|302001|P3|Treatment|Lost to Follow-up|1
85154|NCT00168818|302002|P2|Treatment|Lost to Follow-up|2
85155|NCT00168818|302003|P1|Treatment|Lost to Follow-up|0
85156|NCT00168818|302001|P3|Treatment|Protocol Violation|11
85157|NCT00168818|302002|P2|Treatment|Protocol Violation|11
85158|NCT00168818|302003|P1|Treatment|Protocol Violation|8
85159|NCT00168818|302001|P3|Treatment|Adverse Event|68
85160|NCT00168818|302002|P2|Treatment|Adverse Event|89
85161|NCT00168818|302003|P1|Treatment|Adverse Event|77
85162|NCT00168818|302001|P3|Overall Study|not specified|30
85163|NCT00168818|302002|P2|Overall Study|not specified|24
85164|NCT00168818|302003|P1|Overall Study|not specified|22
85165|NCT00168818|302001|P3|Overall Study|Withdrawal by Subject|37
85166|NCT00168818|302002|P2|Overall Study|Withdrawal by Subject|41
85167|NCT00168818|302003|P1|Overall Study|Withdrawal by Subject|43
85168|NCT00168818|302001|P3|Overall Study|Lost to Follow-up|15
85169|NCT00168818|302002|P2|Overall Study|Lost to Follow-up|4
85170|NCT00168818|302003|P1|Overall Study|Lost to Follow-up|13
85171|NCT00168818|302001|P3|Overall Study|Protocol Violation|11
85172|NCT00168818|302002|P2|Overall Study|Protocol Violation|11
85173|NCT00168818|302003|P1|Overall Study|Protocol Violation|16
85174|NCT00168818|302001|P3|Overall Study|Adverse Event|31
85175|NCT00168818|302002|P2|Overall Study|Adverse Event|29
85176|NCT00168818|302003|P1|Overall Study|Adverse Event|23
85177|NCT00168831|302047|P3|Overall Study|Other|6
85178|NCT00168831|302048|P2|Overall Study|Other|3
85179|NCT00168831|302049|P1|Overall Study|Other|6
85180|NCT00168831|302047|P3|Overall Study|Protocol Violation|11
85181|NCT00168831|302048|P2|Overall Study|Protocol Violation|11
85182|NCT00168831|302049|P1|Overall Study|Protocol Violation|6
85183|NCT00168831|302047|P3|Overall Study|Withdrawal by Subject|19
85184|NCT00168831|302048|P2|Overall Study|Withdrawal by Subject|14
85185|NCT00168831|302049|P1|Overall Study|Withdrawal by Subject|7
85186|NCT00168831|302047|P3|Overall Study|Lost to Follow-up|4
85187|NCT00168831|302048|P2|Overall Study|Lost to Follow-up|6
85188|NCT00168831|302049|P1|Overall Study|Lost to Follow-up|5
85189|NCT00168831|302047|P3|Overall Study|Adverse Event|74
85190|NCT00168831|302048|P2|Overall Study|Adverse Event|47
85191|NCT00168831|302049|P1|Overall Study|Adverse Event|36
85192|NCT00168844|302231|P3|Overall Study|Other|9
85193|NCT00168844|302232|P2|Overall Study|Other|7
85194|NCT00168844|302233|P1|Overall Study|Other|6
85195|NCT00168844|302231|P3|Overall Study|Protocol Violation|4
85196|NCT00168844|302232|P2|Overall Study|Protocol Violation|2
85197|NCT00168844|302233|P1|Overall Study|Protocol Violation|2
85198|NCT00168844|302231|P3|Overall Study|Withdrawal by Subject|19
85199|NCT00168844|302232|P2|Overall Study|Withdrawal by Subject|9
85200|NCT00168844|302233|P1|Overall Study|Withdrawal by Subject|12
85201|NCT00168844|302231|P3|Overall Study|Lost to Follow-up|11
85202|NCT00168844|302232|P2|Overall Study|Lost to Follow-up|5
85203|NCT00168844|302233|P1|Overall Study|Lost to Follow-up|4
85204|NCT00168844|302231|P3|Overall Study|Adverse Event|48
85205|NCT00168844|302232|P2|Overall Study|Adverse Event|32
85206|NCT00168844|302233|P1|Overall Study|Adverse Event|31
85207|NCT00169442|302418|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
85208|NCT00169442|302419|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
85209|NCT00169442|302420|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
85210|NCT00169442|302421|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
85211|NCT00169442|302422|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
85212|NCT00169442|302423|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
85213|NCT00169442|302418|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
85214|NCT00169442|302419|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
85215|NCT00169442|302420|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
85216|NCT00169442|302421|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
85217|NCT00169442|302422|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
85218|NCT00169442|302423|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
85219|NCT00169442|302418|P6|Overall Study|Migrated/moved from study area|2
85220|NCT00169442|302419|P5|Overall Study|Migrated/moved from study area|0
85221|NCT00169442|302420|P4|Overall Study|Migrated/moved from study area|0
85222|NCT00169442|302421|P3|Overall Study|Migrated/moved from study area|0
85223|NCT00169442|302422|P2|Overall Study|Migrated/moved from study area|0
85224|NCT00169442|302423|P1|Overall Study|Migrated/moved from study area|0
85225|NCT00169442|302418|P6|Overall Study|Withdrawal by Subject|0
85226|NCT00169442|302419|P5|Overall Study|Withdrawal by Subject|0
85227|NCT00169442|302420|P4|Overall Study|Withdrawal by Subject|0
85228|NCT00169442|302421|P3|Overall Study|Withdrawal by Subject|1
85229|NCT00169442|302422|P2|Overall Study|Withdrawal by Subject|0
85230|NCT00169442|302423|P1|Overall Study|Withdrawal by Subject|0
85231|NCT00162773|302537|P1|Overall Study|P.I, Left institution. Study terminated|22
85232|NCT00162942|302543|P2|Overall Study|2 or more consecutive treatments missed|0
85233|NCT00162942|302544|P1|Overall Study|2 or more consecutive treatments missed|1
85234|NCT00162942|302543|P2|Overall Study|Flare During Active Treatment|3
85235|NCT00162942|302544|P1|Overall Study|Flare During Active Treatment|7
85236|NCT00162942|302543|P2|Overall Study|Lack of Efficacy|0
85237|NCT00162942|302544|P1|Overall Study|Lack of Efficacy|1
85238|NCT00162942|302543|P2|Overall Study|Alternate Therapy|2
85239|NCT00162942|302544|P1|Overall Study|Alternate Therapy|6
85240|NCT00162942|302543|P2|Overall Study|Enter Open-Label Study|35
85241|NCT00162942|302544|P1|Overall Study|Enter Open-Label Study|76
85242|NCT00162942|302543|P2|Overall Study|Physician Decision|0
85243|NCT00162942|302544|P1|Overall Study|Physician Decision|1
85244|NCT00162942|302543|P2|Overall Study|Withdrawal by Subject|6
85245|NCT00162942|302544|P1|Overall Study|Withdrawal by Subject|3
85246|NCT00162942|302543|P2|Overall Study|Death|0
85247|NCT00162942|302544|P1|Overall Study|Death|1
85248|NCT00162942|302543|P2|Overall Study|Adverse Event|6
85249|NCT00162942|302544|P1|Overall Study|Adverse Event|10
85250|NCT00162981|302594|P2|Overall Study|Physician Decision|0
85251|NCT00162981|302595|P1|Overall Study|Physician Decision|1
85252|NCT00162981|302594|P2|Overall Study|Withdrawal by Subject|1
85253|NCT00162981|302595|P1|Overall Study|Withdrawal by Subject|1
85254|NCT00162981|302594|P2|Overall Study|Adverse Event|5
85255|NCT00162981|302595|P1|Overall Study|Adverse Event|2
85256|NCT00163020|302611|P2|Overall Study|Lost to Follow-up|2
85257|NCT00163020|302612|P1|Overall Study|Lost to Follow-up|0
85258|NCT00163189|302650|P1|Overall Study|Did not meet continuation criterion|16
85259|NCT00163189|302650|P1|Overall Study|Withdrawal by Subject|11
85260|NCT00163189|302650|P1|Overall Study|Study terminated by sponsor|11
85261|NCT00163189|302650|P1|Overall Study|Lack of Efficacy|7
85262|NCT00163189|302650|P1|Overall Study|Adverse Event|6
85263|NCT00163189|302650|P1|Overall Study|Death|3
85264|NCT00163189|302650|P1|Overall Study|Protocol Violation|2
85265|NCT00163189|302650|P1|Overall Study|Lost to Follow-up|1
85266|NCT00163189|302650|P1|Overall Study|Unspecified|6
85267|NCT00163215|302672|P1|Overall Study|Unspecified|7
85268|NCT00163215|302672|P1|Overall Study|Withdrawal by Subject|5
85269|NCT00163215|302672|P1|Overall Study|Lack of Efficacy|3
85270|NCT00174187|302699|P3|Period 2 (After 3 Years)|Unspecified|5
85271|NCT00174187|302700|P2|Period 2 (After 3 Years)|Unspecified|0
85272|NCT00174187|302701|P1|Period 2 (After 3 Years)|Unspecified|0
85273|NCT00174187|302699|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
85274|NCT00174187|302700|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
85275|NCT00174187|302701|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
85276|NCT00174187|302699|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
85277|NCT00174187|302700|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
85278|NCT00174187|302701|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
85279|NCT00174187|302699|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
85280|NCT00174187|302700|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
85281|NCT00174187|302701|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
85282|NCT00174187|302699|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
85283|NCT00174187|302700|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
85284|NCT00174187|302701|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
85285|NCT00174187|302699|P3|Period 1 (up to 3 Years)|Unspecified|0
85286|NCT00174187|302700|P2|Period 1 (up to 3 Years)|Unspecified|1
85287|NCT00174187|302701|P1|Period 1 (up to 3 Years)|Unspecified|0
85288|NCT00174187|302699|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
85289|NCT00174187|302700|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
85290|NCT00174187|302701|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
85291|NCT00174187|302699|P3|Period 1 (up to 3 Years)|Non compliance|0
85292|NCT00174187|302700|P2|Period 1 (up to 3 Years)|Non compliance|1
85293|NCT00174187|302701|P1|Period 1 (up to 3 Years)|Non compliance|0
85294|NCT00174187|302699|P3|Period 1 (up to 3 Years)|Serious adverse event|0
85295|NCT00174187|302700|P2|Period 1 (up to 3 Years)|Serious adverse event|1
85296|NCT00174187|302701|P1|Period 1 (up to 3 Years)|Serious adverse event|0
85297|NCT00174252|302762|P1|Overall Study|Protocol Violation|2
85298|NCT00174265|302797|P2|Overall Study|Other (Not specified)|10
85299|NCT00174265|302798|P1|Overall Study|Other (Not specified)|16
85300|NCT00174265|302797|P2|Overall Study|Lost to Follow-up|0
85301|NCT00174265|302798|P1|Overall Study|Lost to Follow-up|1
85302|NCT00174265|302797|P2|Overall Study|Withdrawal by Subject|5
85303|NCT00174265|302798|P1|Overall Study|Withdrawal by Subject|3
85304|NCT00174265|302797|P2|Overall Study|Lack of Efficacy|2
85305|NCT00174265|302798|P1|Overall Study|Lack of Efficacy|2
85306|NCT00174265|302797|P2|Overall Study|Adverse Event|4
85307|NCT00174265|302798|P1|Overall Study|Adverse Event|7
85308|NCT00174291|302808|P2|Overall Study|Withdrawal by Subject|3
85309|NCT00174291|302809|P1|Overall Study|Withdrawal by Subject|3
85310|NCT00174291|302808|P2|Overall Study|Study terminated by sponsor|0
85311|NCT00174291|302809|P1|Overall Study|Study terminated by sponsor|1
85312|NCT00174291|302808|P2|Overall Study|Protocol Violation|2
85313|NCT00174291|302809|P1|Overall Study|Protocol Violation|0
85314|NCT00174291|302808|P2|Overall Study|Lost to Follow-up|1
85315|NCT00174291|302809|P1|Overall Study|Lost to Follow-up|1
85316|NCT00174382|302837|P1|Overall Study|Lost to Follow-up|1
85317|NCT00174382|302837|P1|Overall Study|Subject felt pill not effective enough|1
85318|NCT00174382|302837|P1|Overall Study|Arrived early for last visit in error|1
85319|NCT00174382|302837|P1|Overall Study|Protocol Violation|3
85320|NCT00174382|302837|P1|Overall Study|Withdrawal by Subject|6
85321|NCT00174382|302837|P1|Overall Study|Adverse Event|19
85322|NCT00174382|302837|P1|Overall Study|Death|2
85323|NCT00174447|302854|P1|Overall Study|Administrative reason/Other|2
85324|NCT00174447|302854|P1|Overall Study|Lack of Efficacy|1
85325|NCT00174447|302854|P1|Overall Study|Protocol Violation|1
85326|NCT00174447|302854|P1|Overall Study|Withdrawal by Subject|15
85327|NCT00174447|302854|P1|Overall Study|Adverse Event|19
85328|NCT00174460|302865|P2|Overall Study|Withdrawal by Subject|1
85329|NCT00174460|302866|P1|Overall Study|Withdrawal by Subject|0
85330|NCT00174785|302914|P2|Overall Study|Not pre-specified/Not coded|70
85331|NCT00174785|302915|P1|Overall Study|Not pre-specified/Not coded|56
85332|NCT00174785|302914|P2|Overall Study|Family request|8
85333|NCT00174785|302915|P1|Overall Study|Family request|6
85334|NCT00174785|302914|P2|Overall Study|Other prohibited medication|3
85335|NCT00174785|302915|P1|Overall Study|Other prohibited medication|5
85336|NCT00174785|302914|P2|Overall Study|Prohibited antiarrhythmic medication|88
85337|NCT00174785|302915|P1|Overall Study|Prohibited antiarrhythmic medication|39
85338|NCT00174785|302914|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
85339|NCT00174785|302915|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
85340|NCT00174785|302914|P2|Overall Study|Withdrawal by Subject|175
85341|NCT00174785|302915|P1|Overall Study|Withdrawal by Subject|173
85342|NCT00174785|302914|P2|Overall Study|Protocol Violation|14
85343|NCT00174785|302915|P1|Overall Study|Protocol Violation|14
85344|NCT00174785|302914|P2|Overall Study|Adverse Event|191
85345|NCT00174785|302915|P1|Overall Study|Adverse Event|293
85346|NCT00174915|302934|P5|Overall Study|Therapeutic Failure|3
85347|NCT00174915|302935|P4|Overall Study|Therapeutic Failure|1
85348|NCT00174915|302936|P3|Overall Study|Therapeutic Failure|2
85349|NCT00174915|302937|P2|Overall Study|Therapeutic Failure|3
85350|NCT00174915|302938|P1|Overall Study|Therapeutic Failure|6
85351|NCT00174915|302934|P5|Overall Study|Protocol Violation|3
85352|NCT00174915|302935|P4|Overall Study|Protocol Violation|6
85353|NCT00174915|302936|P3|Overall Study|Protocol Violation|3
85354|NCT00174915|302937|P2|Overall Study|Protocol Violation|3
85355|NCT00174915|302938|P1|Overall Study|Protocol Violation|6
85356|NCT00174915|302934|P5|Overall Study|Gout Flare|0
85357|NCT00174915|302935|P4|Overall Study|Gout Flare|1
85358|NCT00174915|302936|P3|Overall Study|Gout Flare|8
85359|NCT00174915|302937|P2|Overall Study|Gout Flare|6
85360|NCT00174915|302938|P1|Overall Study|Gout Flare|13
85361|NCT00174915|302934|P5|Overall Study|Other|3
85362|NCT00174915|302935|P4|Overall Study|Other|5
85363|NCT00174915|302936|P3|Overall Study|Other|6
85364|NCT00174915|302937|P2|Overall Study|Other|8
85365|NCT00174915|302938|P1|Overall Study|Other|15
85366|NCT00174915|302934|P5|Overall Study|Personal Reason(s)|9
85367|NCT00174915|302935|P4|Overall Study|Personal Reason(s)|9
85368|NCT00174915|302936|P3|Overall Study|Personal Reason(s)|9
85369|NCT00174915|302937|P2|Overall Study|Personal Reason(s)|16
85370|NCT00174915|302938|P1|Overall Study|Personal Reason(s)|16
85371|NCT00174915|302934|P5|Overall Study|Adverse Event|5
85372|NCT00174915|302935|P4|Overall Study|Adverse Event|18
85373|NCT00174915|302936|P3|Overall Study|Adverse Event|11
85374|NCT00174915|302937|P2|Overall Study|Adverse Event|16
85375|NCT00174915|302938|P1|Overall Study|Adverse Event|18
85376|NCT00174915|302934|P5|Overall Study|Lost to Follow-up|10
85377|NCT00174915|302935|P4|Overall Study|Lost to Follow-up|17
85378|NCT00174915|302936|P3|Overall Study|Lost to Follow-up|9
85379|NCT00174915|302937|P2|Overall Study|Lost to Follow-up|17
85380|NCT00174915|302938|P1|Overall Study|Lost to Follow-up|19
85381|NCT00174941|302998|P4|Overall Study|Reason Not Specified|9
85382|NCT00174941|302999|P3|Overall Study|Reason Not Specified|2
85383|NCT00174941|303000|P2|Overall Study|Reason Not Specified|6
85384|NCT00174941|303001|P1|Overall Study|Reason Not Specified|1
85385|NCT00174941|302998|P4|Overall Study|Gout Flare|8
85386|NCT00174941|302999|P3|Overall Study|Gout Flare|4
85387|NCT00174941|303000|P2|Overall Study|Gout Flare|4
85388|NCT00174941|303001|P1|Overall Study|Gout Flare|0
85389|NCT00174941|302998|P4|Overall Study|Personal Reason(s)|22
85390|NCT00174941|302999|P3|Overall Study|Personal Reason(s)|8
85391|NCT00174941|303000|P2|Overall Study|Personal Reason(s)|14
85392|NCT00174941|303001|P1|Overall Study|Personal Reason(s)|0
85393|NCT00174941|302998|P4|Overall Study|Lost to Follow-up|5
85394|NCT00174941|302999|P3|Overall Study|Lost to Follow-up|2
85395|NCT00174941|303000|P2|Overall Study|Lost to Follow-up|3
85396|NCT00174941|303001|P1|Overall Study|Lost to Follow-up|0
85397|NCT00174941|302998|P4|Overall Study|Protocol Violation|1
85398|NCT00174941|302999|P3|Overall Study|Protocol Violation|0
85399|NCT00174941|303000|P2|Overall Study|Protocol Violation|1
85400|NCT00174941|303001|P1|Overall Study|Protocol Violation|0
85401|NCT00174941|302998|P4|Overall Study|Adverse Event|13
85402|NCT00174941|302999|P3|Overall Study|Adverse Event|2
85403|NCT00174941|303000|P2|Overall Study|Adverse Event|10
85404|NCT00174941|303001|P1|Overall Study|Adverse Event|1
85405|NCT00174954|303071|P1|Overall Study|Physician Decision|1
85406|NCT00174954|303071|P1|Overall Study|No tophi found in MRI|1
85407|NCT00174954|303071|P1|Overall Study|Adverse Event|2
85408|NCT00174967|303080|P4|Overall Study|Not Specified|0
85409|NCT00174967|303081|P3|Overall Study|Not Specified|0
85410|NCT00174967|303082|P2|Overall Study|Not Specified|1
85411|NCT00174967|303083|P1|Overall Study|Not Specified|0
85412|NCT00174967|303080|P4|Overall Study|Gout Flare|1
85413|NCT00174967|303081|P3|Overall Study|Gout Flare|0
85414|NCT00174967|303082|P2|Overall Study|Gout Flare|0
85415|NCT00174967|303083|P1|Overall Study|Gout Flare|0
85416|NCT00174967|303080|P4|Overall Study|Adverse Event|1
85417|NCT00174967|303081|P3|Overall Study|Adverse Event|2
85418|NCT00174967|303082|P2|Overall Study|Adverse Event|2
85419|NCT00174967|303083|P1|Overall Study|Adverse Event|1
85420|NCT00175019|303137|P3|Overall Study|Reason Not Specified|11
85421|NCT00175019|303138|P2|Overall Study|Reason Not Specified|34
85422|NCT00175019|303139|P1|Overall Study|Reason Not Specified|40
85423|NCT00175019|303137|P3|Overall Study|Gout Flare|0
85424|NCT00175019|303138|P2|Overall Study|Gout Flare|3
85425|NCT00175019|303139|P1|Overall Study|Gout Flare|2
85426|NCT00175019|303137|P3|Overall Study|Therapeutic Failure|22
85427|NCT00175019|303138|P2|Overall Study|Therapeutic Failure|38
85428|NCT00175019|303139|P1|Overall Study|Therapeutic Failure|10
85429|NCT00175019|303137|P3|Overall Study|Personal Reason(s)|8
85430|NCT00175019|303138|P2|Overall Study|Personal Reason(s)|31
85431|NCT00175019|303139|P1|Overall Study|Personal Reason(s)|39
85432|NCT00175019|303137|P3|Overall Study|Did not continue under Amendment 4|2
85433|NCT00175019|303138|P2|Overall Study|Did not continue under Amendment 4|1
85434|NCT00175019|303139|P1|Overall Study|Did not continue under Amendment 4|1
85435|NCT00175019|303137|P3|Overall Study|Lost to Follow-up|9
85436|NCT00175019|303138|P2|Overall Study|Lost to Follow-up|39
85437|NCT00175019|303139|P1|Overall Study|Lost to Follow-up|42
85438|NCT00175019|303137|P3|Overall Study|Protocol Violation|3
85439|NCT00175019|303138|P2|Overall Study|Protocol Violation|3
85440|NCT00175019|303139|P1|Overall Study|Protocol Violation|6
85441|NCT00175019|303137|P3|Overall Study|Adverse Event|2
85442|NCT00175019|303138|P2|Overall Study|Adverse Event|22
85443|NCT00175019|303139|P1|Overall Study|Adverse Event|54
85444|NCT00175877|303183|P1|Overall Study|Withdrawal by subject & Other|1
85445|NCT00175877|303183|P1|Overall Study|AE & Other|1
85446|NCT00175877|303183|P1|Overall Study|Other Reason|20
85447|NCT00175877|303183|P1|Overall Study|Protocol Violation|15
85448|NCT00175877|303183|P1|Overall Study|Lack of Efficacy|26
85449|NCT00175877|303183|P1|Overall Study|Lost to Follow-up|9
85450|NCT00175877|303183|P1|Overall Study|Withdrawal by Subject|141
85451|NCT00175877|303183|P1|Overall Study|Adverse Event|136
85452|NCT00176254|303234|P1|Overall Study|Lost to Follow-up|1
85453|NCT00166296|303286|P2|Overall Study|Lost to Follow-up|2
85454|NCT00166296|303287|P1|Overall Study|Lost to Follow-up|4
85455|NCT00166296|303286|P2|Overall Study|Adverse Event|4
85456|NCT00166296|303287|P1|Overall Study|Adverse Event|2
85457|NCT00166296|303286|P2|Overall Study|Withdrawal by Subject|3
85458|NCT00166296|303287|P1|Overall Study|Withdrawal by Subject|1
85459|NCT00166504|303310|P2|Overall Study|Withdrawal by Subject|0
85460|NCT00166504|303311|P1|Overall Study|Withdrawal by Subject|1
85461|NCT00166504|303310|P2|Overall Study|Lost to Follow-up|1
85462|NCT00166504|303311|P1|Overall Study|Lost to Follow-up|1
85463|NCT00166504|303310|P2|Overall Study|Adverse Event|3
85464|NCT00166504|303311|P1|Overall Study|Adverse Event|3
85465|NCT00166517|303319|P2|Overall Study|Withdrawal by Subject|1
85466|NCT00166517|303320|P1|Overall Study|Withdrawal by Subject|0
85467|NCT00166517|303319|P2|Overall Study|Protocol Violation|1
85468|NCT00166517|303320|P1|Overall Study|Protocol Violation|4
85469|NCT00166517|303319|P2|Overall Study|Lost to Follow-up|0
85470|NCT00166517|303320|P1|Overall Study|Lost to Follow-up|1
85471|NCT00166712|303330|P2|Overall Study|Physician Decision|2
85472|NCT00166712|303331|P1|Overall Study|Physician Decision|0
85473|NCT00166712|303330|P2|Overall Study|Withdrawal by Subject|2
85474|NCT00166712|303331|P1|Overall Study|Withdrawal by Subject|1
85475|NCT00166712|303330|P2|Overall Study|Adverse Event|0
85476|NCT00166712|303331|P1|Overall Study|Adverse Event|1
85477|NCT00166712|303330|P2|Overall Study|Death|1
85478|NCT00166712|303331|P1|Overall Study|Death|0
85479|NCT00167245|303388|P2|Overall Study|Drowsy|0
85480|NCT00167245|303389|P1|Overall Study|Drowsy|1
85481|NCT00167245|303388|P2|Overall Study|Incarcerated|2
85482|NCT00167245|303389|P1|Overall Study|Incarcerated|3
85483|NCT00167245|303388|P2|Overall Study|Withdrawal by Subject|8
85484|NCT00167245|303389|P1|Overall Study|Withdrawal by Subject|5
85485|NCT00167245|303388|P2|Overall Study|Lost to Follow-up|31
85486|NCT00167245|303389|P1|Overall Study|Lost to Follow-up|20
85487|NCT00167310|303399|P2|Overall Study|Withdrawal by Subject|7
85488|NCT00167310|303400|P1|Overall Study|Withdrawal by Subject|3
85489|NCT00167310|303399|P2|Overall Study|Protocol Violation|3
85490|NCT00167310|303400|P1|Overall Study|Protocol Violation|5
85491|NCT00167778|303440|P1|Overall Study|Withdrawal by Subject|1
85492|NCT00176462|303500|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
85493|NCT00176462|303501|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
85494|NCT00176462|303500|P2|Intensive Continuation (8X8-week Cycles)|Death|0
85495|NCT00176462|303501|P1|Intensive Continuation (8X8-week Cycles)|Death|1
85496|NCT00176462|303500|P2|Consolidation (12 Weeks)|Not documented|1
85497|NCT00176462|303501|P1|Consolidation (12 Weeks)|Not documented|0
85498|NCT00176462|303500|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
85499|NCT00176462|303501|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
85500|NCT00176462|303500|P2|Consolidation (12 Weeks)|Adverse Event|1
85501|NCT00176462|303501|P1|Consolidation (12 Weeks)|Adverse Event|0
85502|NCT00176462|303500|P2|Consolidation (12 Weeks)|Patient moved to another state|1
85503|NCT00176462|303501|P1|Consolidation (12 Weeks)|Patient moved to another state|0
85504|NCT00176462|303500|P2|Induction (4 Weeks)|Lack of Efficacy|1
85505|NCT00176462|303501|P1|Induction (4 Weeks)|Lack of Efficacy|0
85506|NCT00176462|303500|P2|Induction (4 Weeks)|Death|2
85507|NCT00176462|303501|P1|Induction (4 Weeks)|Death|1
85508|NCT00176462|303500|P2|Induction (4 Weeks)|Withdrawal by Subject|2
85509|NCT00176462|303501|P1|Induction (4 Weeks)|Withdrawal by Subject|0
85510|NCT00176488|303508|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
85511|NCT00176605|303520|P1|Overall Study|Withdrawal by Subject|2
85512|NCT00176644|303530|P1|Overall Study|Withdrawal by Subject|1
85513|NCT00177164|303540|P2|Overall Study|Pregnancy|1
85514|NCT00177164|303541|P1|Overall Study|Pregnancy|0
85515|NCT00177164|303540|P2|Overall Study|Lack of Efficacy|1
85516|NCT00177164|303541|P1|Overall Study|Lack of Efficacy|2
85517|NCT00177164|303540|P2|Overall Study|discharge from hospital|0
85518|NCT00177164|303541|P1|Overall Study|discharge from hospital|1
85519|NCT00177164|303540|P2|Overall Study|Adverse Event|0
85520|NCT00177164|303541|P1|Overall Study|Adverse Event|1
85521|NCT00177164|303540|P2|Overall Study|increase in alcohol and drug use|2
85522|NCT00177164|303541|P1|Overall Study|increase in alcohol and drug use|1
85523|NCT00177164|303540|P2|Overall Study|Lost to Follow-up|5
85524|NCT00177164|303541|P1|Overall Study|Lost to Follow-up|4
85525|NCT00177164|303540|P2|Overall Study|Protocol Violation|7
85526|NCT00177164|303541|P1|Overall Study|Protocol Violation|0
85527|NCT00177216|303556|P3|Overall Study|Withdrawal by Subject|1
85528|NCT00177216|303557|P2|Overall Study|Withdrawal by Subject|3
85529|NCT00177216|303558|P1|Overall Study|Withdrawal by Subject|6
85530|NCT00177294|303579|P2|Overall Study|Withdrawal by Subject|5
85531|NCT00177294|303580|P1|Overall Study|Withdrawal by Subject|7
85532|NCT00177307|303586|P1|Overall Study|Withdrawal by Subject|1
85533|NCT00177671|303595|P2|Overall Study|Physician Decision|8
85534|NCT00177671|303596|P1|Overall Study|Physician Decision|12
85535|NCT00177671|303595|P2|Overall Study|Adverse Event|0
85536|NCT00177671|303596|P1|Overall Study|Adverse Event|6
85537|NCT00177671|303595|P2|Overall Study|medical complications|0
85538|NCT00177671|303596|P1|Overall Study|medical complications|2
85539|NCT00177671|303595|P2|Overall Study|Withdrawal by Subject|6
85540|NCT00177671|303596|P1|Overall Study|Withdrawal by Subject|5
85541|NCT00178126|303644|P2|Overall Study|did not receive intervention|6
85542|NCT00178126|303645|P1|Overall Study|did not receive intervention|4
85543|NCT00178126|303644|P2|Overall Study|Lost to Follow-up|21
85544|NCT00178126|303645|P1|Overall Study|Lost to Follow-up|21
85545|NCT00178256|303681|P4|Overall Study|Cancer progression|1
85546|NCT00178256|303682|P3|Overall Study|Cancer progression|0
85547|NCT00178256|303683|P2|Overall Study|Cancer progression|0
85548|NCT00178256|303684|P1|Overall Study|Cancer progression|2
85549|NCT00178256|303681|P4|Overall Study|Death|1
85550|NCT00178256|303682|P3|Overall Study|Death|0
85551|NCT00178256|303683|P2|Overall Study|Death|1
85552|NCT00178256|303684|P1|Overall Study|Death|0
85553|NCT00178256|303681|P4|Overall Study|Adverse Event|0
85554|NCT00178256|303682|P3|Overall Study|Adverse Event|0
85555|NCT00178256|303683|P2|Overall Study|Adverse Event|0
85556|NCT00178256|303684|P1|Overall Study|Adverse Event|2
85557|NCT00178464|303691|P1|Overall Study|Physician Decision|1
85558|NCT00178464|303691|P1|Overall Study|Withdrawal by Subject|1
85559|NCT00178633|303718|P1|Overall Study|Lost to Follow-up|6
85560|NCT00178685|303729|P3|Overall Study|Withdrawal by Subject|7
85561|NCT00178685|303730|P2|Overall Study|Withdrawal by Subject|14
85562|NCT00178685|303731|P1|Overall Study|Withdrawal by Subject|8
85563|NCT00178685|303729|P3|Overall Study|Lost to Follow-up|183
85564|NCT00178685|303730|P2|Overall Study|Lost to Follow-up|187
85565|NCT00178685|303731|P1|Overall Study|Lost to Follow-up|100
85566|NCT00178685|303729|P3|Overall Study|Death|6
85567|NCT00178685|303730|P2|Overall Study|Death|3
85568|NCT00178685|303731|P1|Overall Study|Death|3
85569|NCT00179309|303772|P2|Treatment|Allergy|0
85570|NCT00179309|303773|P1|Treatment|Allergy|1
85571|NCT00179309|303772|P2|Treatment|Withdrawal by Subject|2
85572|NCT00179309|303773|P1|Treatment|Withdrawal by Subject|1
85573|NCT00179309|303772|P2|Treatment|Toxicity|3
85574|NCT00179309|303773|P1|Treatment|Toxicity|2
85575|NCT00179413|303783|P2|Overall Study|Withdrawal by Subject|95
85576|NCT00179413|303784|P1|Overall Study|Withdrawal by Subject|87
85577|NCT00179413|303783|P2|Overall Study|Adverse Event|20
85578|NCT00179413|303784|P1|Overall Study|Adverse Event|38
85579|NCT00171704|303796|P2|Overall Study|Protocol Violation|1
85580|NCT00171704|303797|P1|Overall Study|Protocol Violation|0
85581|NCT00171704|303796|P2|Overall Study|Withdrawal by Subject|3
85582|NCT00171704|303797|P1|Overall Study|Withdrawal by Subject|1
85583|NCT00171704|303796|P2|Overall Study|Death|2
85584|NCT00171704|303797|P1|Overall Study|Death|2
85585|NCT00171704|303796|P2|Overall Study|Administrative Problems|1
85586|NCT00171704|303797|P1|Overall Study|Administrative Problems|2
85587|NCT00171704|303796|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
85588|NCT00171704|303797|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
85589|NCT00171704|303796|P2|Overall Study|Disease Progression|9
85590|NCT00171704|303797|P1|Overall Study|Disease Progression|14
85591|NCT00171704|303796|P2|Overall Study|Adverse Event|33
85592|NCT00171704|303797|P1|Overall Study|Adverse Event|24
85593|NCT00171834|303824|P7|Overall Study|Treatment Duration Completed|0
85594|NCT00171834|303825|P6|Overall Study|Treatment Duration Completed|1
85595|NCT00171834|303826|P5|Overall Study|Treatment Duration Completed|2
85596|NCT00171834|303827|P4|Overall Study|Treatment Duration Completed|0
85597|NCT00171834|303828|P3|Overall Study|Treatment Duration Completed|1
85598|NCT00171834|303829|P2|Overall Study|Treatment Duration Completed|0
85599|NCT00171834|303830|P1|Overall Study|Treatment Duration Completed|0
85600|NCT00171834|303824|P7|Overall Study|Disease Progression|3
85601|NCT00171834|303825|P6|Overall Study|Disease Progression|18
85602|NCT00171834|303826|P5|Overall Study|Disease Progression|2
85603|NCT00171834|303827|P4|Overall Study|Disease Progression|9
85604|NCT00171834|303828|P3|Overall Study|Disease Progression|8
85605|NCT00171834|303829|P2|Overall Study|Disease Progression|8
85606|NCT00171834|303830|P1|Overall Study|Disease Progression|4
85607|NCT00171834|303824|P7|Overall Study|Death from study indication|0
85608|NCT00171834|303825|P6|Overall Study|Death from study indication|0
85609|NCT00171834|303826|P5|Overall Study|Death from study indication|1
85610|NCT00171834|303827|P4|Overall Study|Death from study indication|0
85611|NCT00171834|303828|P3|Overall Study|Death from study indication|0
85612|NCT00171834|303829|P2|Overall Study|Death from study indication|1
85613|NCT00171834|303830|P1|Overall Study|Death from study indication|0
85614|NCT00171834|303824|P7|Overall Study|Withdrawal by Subject|0
85615|NCT00171834|303825|P6|Overall Study|Withdrawal by Subject|1
85616|NCT00171834|303826|P5|Overall Study|Withdrawal by Subject|1
85617|NCT00171834|303827|P4|Overall Study|Withdrawal by Subject|1
85618|NCT00171834|303828|P3|Overall Study|Withdrawal by Subject|0
85619|NCT00171834|303829|P2|Overall Study|Withdrawal by Subject|2
85620|NCT00171834|303830|P1|Overall Study|Withdrawal by Subject|0
85621|NCT00171834|303824|P7|Overall Study|Adverse Event|1
85622|NCT00171834|303825|P6|Overall Study|Adverse Event|15
85623|NCT00171834|303826|P5|Overall Study|Adverse Event|2
85624|NCT00171834|303827|P4|Overall Study|Adverse Event|2
85625|NCT00171834|303828|P3|Overall Study|Adverse Event|3
85626|NCT00171834|303829|P2|Overall Study|Adverse Event|1
85627|NCT00171834|303830|P1|Overall Study|Adverse Event|2
85628|NCT00171873|303870|P2|Overall Study|Switched to Octreotide|1
85629|NCT00171873|303871|P1|Overall Study|Switched to Octreotide|0
85630|NCT00171873|303870|P2|Overall Study|Adverse Event|0
85631|NCT00171873|303871|P1|Overall Study|Adverse Event|5
85632|NCT00171873|303870|P2|Overall Study|Withdrawal by Subject|2
85633|NCT00171873|303871|P1|Overall Study|Withdrawal by Subject|4
85634|NCT00171925|303879|P2|Overall Study|Death|2
85635|NCT00171925|303880|P1|Overall Study|Death|1
85636|NCT00171925|303879|P2|Overall Study|Administrative problems|11
85637|NCT00171925|303880|P1|Overall Study|Administrative problems|10
85638|NCT00171925|303879|P2|Overall Study|Lost to Follow-up|2
85639|NCT00171925|303880|P1|Overall Study|Lost to Follow-up|2
85640|NCT00171925|303879|P2|Overall Study|Withdrawal by Subject|9
85641|NCT00171925|303880|P1|Overall Study|Withdrawal by Subject|6
85642|NCT00171925|303879|P2|Overall Study|Protocol Violation|1
85643|NCT00171925|303880|P1|Overall Study|Protocol Violation|1
85644|NCT00171925|303879|P2|Overall Study|Adverse Event|6
85645|NCT00171925|303880|P1|Overall Study|Adverse Event|10
85646|NCT00172042|303892|P2|Overall Study|Death|42
85647|NCT00172042|303893|P1|Overall Study|Death|42
85648|NCT00172042|303892|P2|Overall Study|Administrative problems|10
85649|NCT00172042|303893|P1|Overall Study|Administrative problems|13
85650|NCT00172042|303892|P2|Overall Study|Lost to Follow-up|5
85651|NCT00172042|303893|P1|Overall Study|Lost to Follow-up|3
85652|NCT00172042|303892|P2|Overall Study|Withdrawal by Subject|25
85653|NCT00172042|303893|P1|Overall Study|Withdrawal by Subject|37
85654|NCT00172042|303892|P2|Overall Study|Protocol Violation|7
85655|NCT00172042|303893|P1|Overall Study|Protocol Violation|8
85656|NCT00172042|303892|P2|Overall Study|Patient no longer requires study drug|8
85657|NCT00172042|303893|P1|Overall Study|Patient no longer requires study drug|10
85658|NCT00172042|303892|P2|Overall Study|Unsatisfactory therapeutic effect|11
85659|NCT00172042|303893|P1|Overall Study|Unsatisfactory therapeutic effect|13
85660|NCT00172042|303892|P2|Overall Study|Abnormal test procedure(s)|3
85661|NCT00172042|303893|P1|Overall Study|Abnormal test procedure(s)|0
85662|NCT00172042|303892|P2|Overall Study|Abnormal laboratory value(s)|1
85663|NCT00172042|303893|P1|Overall Study|Abnormal laboratory value(s)|5
85664|NCT00172042|303892|P2|Overall Study|Adverse Event|13
85665|NCT00172042|303893|P1|Overall Study|Adverse Event|27
85666|NCT00172185|303917|P4|Overall Study|Withdrawal by Subject|0
85667|NCT00172185|303918|P3|Overall Study|Withdrawal by Subject|1
85668|NCT00172185|303919|P2|Overall Study|Withdrawal by Subject|0
85669|NCT00172185|303920|P1|Overall Study|Withdrawal by Subject|0
85670|NCT00172185|303917|P4|Overall Study|SPONSOR Decision|0
85671|NCT00172185|303918|P3|Overall Study|SPONSOR Decision|0
85672|NCT00172185|303919|P2|Overall Study|SPONSOR Decision|1
85673|NCT00172185|303920|P1|Overall Study|SPONSOR Decision|0
85674|NCT00172185|303917|P4|Overall Study|Physician Decision|0
85675|NCT00172185|303918|P3|Overall Study|Physician Decision|1
85676|NCT00172185|303919|P2|Overall Study|Physician Decision|0
85677|NCT00172185|303920|P1|Overall Study|Physician Decision|0
85678|NCT00172185|303917|P4|Overall Study|Adverse Event|4
85679|NCT00172185|303918|P3|Overall Study|Adverse Event|3
85680|NCT00172185|303919|P2|Overall Study|Adverse Event|1
85681|NCT00172185|303920|P1|Overall Study|Adverse Event|0
85682|NCT00179517|303936|P2|Overall Study|Withdrawal by Subject|1
85683|NCT00179517|303937|P1|Overall Study|Withdrawal by Subject|2
85684|NCT00179621|303962|P4|Open-Label Period|Unspecified|2
85685|NCT00179621|303963|P3|Open-Label Period|Unspecified|1
85686|NCT00179621|303964|P2|Open-Label Period|Unspecified|1
85687|NCT00179621|303965|P1|Open-Label Period|Unspecified|0
85688|NCT00179621|303962|P4|Open-Label Period|Death|2
85689|NCT00179621|303963|P3|Open-Label Period|Death|1
85690|NCT00179621|303964|P2|Open-Label Period|Death|0
85691|NCT00179621|303965|P1|Open-Label Period|Death|0
85692|NCT00179621|303962|P4|Open-Label Period|Withdrawal by Subject|2
85693|NCT00179621|303963|P3|Open-Label Period|Withdrawal by Subject|2
85694|NCT00179621|303964|P2|Open-Label Period|Withdrawal by Subject|2
85695|NCT00179621|303965|P1|Open-Label Period|Withdrawal by Subject|0
85696|NCT00179621|303962|P4|Open-Label Period|Adverse Event|6
85697|NCT00179621|303963|P3|Open-Label Period|Adverse Event|5
85698|NCT00179621|303964|P2|Open-Label Period|Adverse Event|6
85699|NCT00179621|303965|P1|Open-Label Period|Adverse Event|0
85700|NCT00179621|303962|P4|Open-Label Period|Lack of Therapeutic Effect|31
85701|NCT00179621|303963|P3|Open-Label Period|Lack of Therapeutic Effect|19
85702|NCT00179621|303964|P2|Open-Label Period|Lack of Therapeutic Effect|19
85703|NCT00179621|303965|P1|Open-Label Period|Lack of Therapeutic Effect|0
85704|NCT00179621|303962|P4|Double-Blind Period|Unspecified|0
85705|NCT00179621|303963|P3|Double-Blind Period|Unspecified|2
85706|NCT00179621|303964|P2|Double-Blind Period|Unspecified|2
85707|NCT00179621|303965|P1|Double-Blind Period|Unspecified|0
85708|NCT00179621|303962|P4|Double-Blind Period|Protocol Violation|0
85709|NCT00179621|303963|P3|Double-Blind Period|Protocol Violation|0
85710|NCT00179621|303964|P2|Double-Blind Period|Protocol Violation|0
85711|NCT00179621|303965|P1|Double-Blind Period|Protocol Violation|1
85712|NCT00179621|303962|P4|Double-Blind Period|Death|0
85713|NCT00179621|303963|P3|Double-Blind Period|Death|2
85714|NCT00179621|303964|P2|Double-Blind Period|Death|1
85715|NCT00179621|303965|P1|Double-Blind Period|Death|0
85716|NCT00179621|303962|P4|Double-Blind Period|Withdrawal by Subject|0
85717|NCT00179621|303963|P3|Double-Blind Period|Withdrawal by Subject|3
85718|NCT00179621|303964|P2|Double-Blind Period|Withdrawal by Subject|1
85719|NCT00179621|303965|P1|Double-Blind Period|Withdrawal by Subject|2
85720|NCT00179621|303962|P4|Double-Blind Period|Adverse Event|0
85721|NCT00179621|303963|P3|Double-Blind Period|Adverse Event|4
85722|NCT00179621|303964|P2|Double-Blind Period|Adverse Event|7
85723|NCT00179621|303965|P1|Double-Blind Period|Adverse Event|2
85724|NCT00179621|303962|P4|Double-Blind Period|Lack of Therapeutic Effect|0
85725|NCT00179621|303963|P3|Double-Blind Period|Lack of Therapeutic Effect|19
85726|NCT00179621|303964|P2|Double-Blind Period|Lack of Therapeutic Effect|35
85727|NCT00179621|303965|P1|Double-Blind Period|Lack of Therapeutic Effect|59
85728|NCT00179647|304016|P1|Overall Study|Not specified|960
85729|NCT00179647|304016|P1|Overall Study|Death|94
85730|NCT00179647|304016|P1|Overall Study|Lost to Follow-up|4
85731|NCT00179647|304016|P1|Overall Study|Withdrawal by Subject|83
85732|NCT00179647|304016|P1|Overall Study|Lack of Efficacy|478
85733|NCT00179647|304016|P1|Overall Study|Adverse Event|294
85734|NCT00179660|304020|P1|Overall Study|Other - Unspecified|9
85735|NCT00179660|304020|P1|Overall Study|Death|3
85736|NCT00179660|304020|P1|Overall Study|Lost to Follow-up|1
85737|NCT00179660|304020|P1|Overall Study|Withdrawal by Subject|2
85738|NCT00179660|304020|P1|Overall Study|Lack of therapeutic effect|28
85739|NCT00179660|304020|P1|Overall Study|Adverse Event|7
85740|NCT00179673|304029|P1|Overall Study|Other Observations and options|14
85741|NCT00179673|304029|P1|Overall Study|Death|4
85742|NCT00179673|304029|P1|Overall Study|Withdrawal by Subject|3
85743|NCT00179673|304029|P1|Overall Study|Lack of Efficacy|15
85744|NCT00179673|304029|P1|Overall Study|Adverse Event|7
85745|NCT00181155|304066|P2|Overall Study|Withdrawal by Subject|0
85746|NCT00181155|304067|P1|Overall Study|Withdrawal by Subject|1
85747|NCT00181155|304066|P2|Overall Study|Physician Decision|0
85748|NCT00181155|304067|P1|Overall Study|Physician Decision|1
85749|NCT00181766|304096|P1|Overall Study|non-compliance|2
85750|NCT00181766|304096|P1|Overall Study|Adverse Event|4
85751|NCT00181766|304096|P1|Overall Study|Lost to Follow-up|6
85752|NCT00181844|304101|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
85753|NCT00181844|304101|P1|Exposed to Study Medication|Withdrawal by Subject|1
85754|NCT00181844|304101|P1|Exposed to Study Medication|Non-compliance|2
85755|NCT00181844|304101|P1|Exposed to Study Medication|Lack of Efficacy|2
85756|NCT00181844|304101|P1|Exposed to Study Medication|Adverse Event|10
85757|NCT00181844|304101|P1|Signed Consent|Did not meet entrance criteria|7
85758|NCT00181844|304101|P1|Signed Consent|Withdrawal by Subject|5
85759|NCT00181883|304105|P1|Overall Study|Lost to Follow-up|1
85760|NCT00181883|304105|P1|Overall Study|Withdrawal by Subject|4
85761|NCT00181883|304105|P1|Overall Study|Treatment Limiting AEs|3
85762|NCT00181883|304105|P1|Overall Study|Lack of Efficacy|2
85763|NCT00182078|304120|P2|Overall Study|Withdrawal by Subject|0
85764|NCT00182078|304121|P1|Overall Study|Withdrawal by Subject|1
85765|NCT00182091|304135|P4|Overall Study|Withdrawal by Subject|0
85766|NCT00182091|304136|P3|Overall Study|Withdrawal by Subject|0
85767|NCT00182091|304137|P2|Overall Study|Withdrawal by Subject|0
85768|NCT00182091|304138|P1|Overall Study|Withdrawal by Subject|1
85769|NCT00182637|304152|P1|Overall Study|Disease Progression|1
85770|NCT00182637|304152|P1|Overall Study|Adverse Event|2
85771|NCT00182689|304160|P2|Overall Study|Never received treatment|0
85772|NCT00182689|304161|P1|Overall Study|Never received treatment|1
85773|NCT00182689|304160|P2|Overall Study|Ineligible|4
85774|NCT00182689|304161|P1|Overall Study|Ineligible|1
85775|NCT00182689|304160|P2|Overall Study|not protocol specified|3
85776|NCT00182689|304161|P1|Overall Study|not protocol specified|0
85777|NCT00182689|304160|P2|Overall Study|Death|0
85778|NCT00182689|304161|P1|Overall Study|Death|1
85779|NCT00182689|304160|P2|Overall Study|Progression|29
85780|NCT00182689|304161|P1|Overall Study|Progression|27
85781|NCT00182689|304160|P2|Overall Study|Withdrawal by Subject|2
85782|NCT00182689|304161|P1|Overall Study|Withdrawal by Subject|2
85783|NCT00182689|304160|P2|Overall Study|Adverse Event|11
85784|NCT00182689|304161|P1|Overall Study|Adverse Event|8
85785|NCT00183196|304247|P3|Overall Study|Required more intensive care|2
85786|NCT00183196|304248|P2|Overall Study|Required more intensive care|1
85787|NCT00183196|304249|P1|Overall Study|Required more intensive care|0
85788|NCT00183196|304247|P3|Overall Study|Legal event|1
85789|NCT00183196|304248|P2|Overall Study|Legal event|1
85790|NCT00183196|304249|P1|Overall Study|Legal event|1
85791|NCT00183196|304247|P3|Overall Study|Adverse Event|2
85792|NCT00183196|304248|P2|Overall Study|Adverse Event|2
85793|NCT00183196|304249|P1|Overall Study|Adverse Event|1
85794|NCT00183196|304247|P3|Overall Study|Withdrawal by Subject|13
85795|NCT00183196|304248|P2|Overall Study|Withdrawal by Subject|11
85796|NCT00183196|304249|P1|Overall Study|Withdrawal by Subject|18
85797|NCT00183248|304259|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
85798|NCT00183248|304260|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
85799|NCT00183248|304259|P2|Overall Study|Lost to Follow-up|1
85800|NCT00183248|304260|P1|Overall Study|Lost to Follow-up|0
85801|NCT00183274|304278|P6|Phase 3: Double-Blind|Relapsed|2
85802|NCT00183274|304279|P5|Phase 3: Double-Blind|Relapsed|11
85803|NCT00183274|304280|P4|Phase 3: Double-Blind|Relapsed|1
85804|NCT00183274|304281|P3|Phase 3: Double-Blind|Relapsed|0
85805|NCT00183274|304282|P2|Phase 3: Double-Blind|Relapsed|0
85806|NCT00183274|304283|P1|Phase 3: Double-Blind|Relapsed|0
85807|NCT00183274|304278|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
85808|NCT00183274|304279|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
85809|NCT00183274|304280|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
85810|NCT00183274|304281|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
85811|NCT00183274|304282|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
85812|NCT00183274|304283|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
85813|NCT00183274|304278|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
85814|NCT00183274|304279|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
85815|NCT00183274|304280|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
85816|NCT00183274|304281|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
85817|NCT00183274|304282|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
85818|NCT00183274|304283|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
85819|NCT00183274|304278|P6|Phase 2: Double-Blind|Relapsed|0
85820|NCT00183274|304279|P5|Phase 2: Double-Blind|Relapsed|0
85821|NCT00183274|304280|P4|Phase 2: Double-Blind|Relapsed|0
85822|NCT00183274|304281|P3|Phase 2: Double-Blind|Relapsed|29
85823|NCT00183274|304282|P2|Phase 2: Double-Blind|Relapsed|8
85824|NCT00183274|304283|P1|Phase 2: Double-Blind|Relapsed|0
85825|NCT00183274|304278|P6|Phase 1: Open-Label|Other|0
85826|NCT00183274|304279|P5|Phase 1: Open-Label|Other|0
85827|NCT00183274|304280|P4|Phase 1: Open-Label|Other|0
85828|NCT00183274|304281|P3|Phase 1: Open-Label|Other|0
85829|NCT00183274|304282|P2|Phase 1: Open-Label|Other|0
85830|NCT00183274|304283|P1|Phase 1: Open-Label|Other|9
85831|NCT00183274|304278|P6|Phase 1: Open-Label|Lost to Follow-up|0
85832|NCT00183274|304279|P5|Phase 1: Open-Label|Lost to Follow-up|0
85833|NCT00183274|304280|P4|Phase 1: Open-Label|Lost to Follow-up|0
85834|NCT00183274|304281|P3|Phase 1: Open-Label|Lost to Follow-up|0
85835|NCT00183274|304282|P2|Phase 1: Open-Label|Lost to Follow-up|0
85836|NCT00183274|304283|P1|Phase 1: Open-Label|Lost to Follow-up|33
85837|NCT00183274|304278|P6|Phase 1: Open-Label|Withdrawal by Subject|0
85838|NCT00183274|304279|P5|Phase 1: Open-Label|Withdrawal by Subject|0
85839|NCT00183274|304280|P4|Phase 1: Open-Label|Withdrawal by Subject|0
85840|NCT00183274|304281|P3|Phase 1: Open-Label|Withdrawal by Subject|0
85841|NCT00183274|304282|P2|Phase 1: Open-Label|Withdrawal by Subject|0
85842|NCT00183274|304283|P1|Phase 1: Open-Label|Withdrawal by Subject|13
85843|NCT00183274|304278|P6|Phase 1: Open-Label|Protocol Violation|0
85844|NCT00183274|304279|P5|Phase 1: Open-Label|Protocol Violation|0
85845|NCT00183274|304280|P4|Phase 1: Open-Label|Protocol Violation|0
85846|NCT00183274|304281|P3|Phase 1: Open-Label|Protocol Violation|0
85847|NCT00183274|304282|P2|Phase 1: Open-Label|Protocol Violation|0
85848|NCT00183274|304283|P1|Phase 1: Open-Label|Protocol Violation|11
85849|NCT00183274|304278|P6|Phase 1: Open-Label|Lack of Efficacy|0
85850|NCT00183274|304279|P5|Phase 1: Open-Label|Lack of Efficacy|0
85851|NCT00183274|304280|P4|Phase 1: Open-Label|Lack of Efficacy|0
85852|NCT00183274|304281|P3|Phase 1: Open-Label|Lack of Efficacy|0
85853|NCT00183274|304282|P2|Phase 1: Open-Label|Lack of Efficacy|0
85854|NCT00183274|304283|P1|Phase 1: Open-Label|Lack of Efficacy|13
85855|NCT00183274|304278|P6|Phase 1: Open-Label|Adverse Event|0
85856|NCT00183274|304279|P5|Phase 1: Open-Label|Adverse Event|0
85857|NCT00183274|304280|P4|Phase 1: Open-Label|Adverse Event|0
85858|NCT00183274|304281|P3|Phase 1: Open-Label|Adverse Event|0
85859|NCT00183274|304282|P2|Phase 1: Open-Label|Adverse Event|0
85860|NCT00183274|304283|P1|Phase 1: Open-Label|Adverse Event|31
85861|NCT00170846|304301|P3|Overall Study|Reason Missing|0
85862|NCT00170846|304302|P2|Overall Study|Reason Missing|1
85863|NCT00170846|304303|P1|Overall Study|Reason Missing|0
85864|NCT00170846|304301|P3|Overall Study|Death|3
85865|NCT00170846|304302|P2|Overall Study|Death|3
85866|NCT00170846|304303|P1|Overall Study|Death|0
85867|NCT00170846|304301|P3|Overall Study|Lost to Follow-up|2
85868|NCT00170846|304302|P2|Overall Study|Lost to Follow-up|3
85869|NCT00170846|304303|P1|Overall Study|Lost to Follow-up|6
85870|NCT00170846|304301|P3|Overall Study|Subject withdrew Informed Consent|8
85871|NCT00170846|304302|P2|Overall Study|Subject withdrew Informed Consent|12
85872|NCT00170846|304303|P1|Overall Study|Subject withdrew Informed Consent|5
85873|NCT00170950|304319|P2|Overall Study|Termination Data Not Recorded|22
85874|NCT00170950|304320|P1|Overall Study|Termination Data Not Recorded|17
85875|NCT00170950|304319|P2|Overall Study|Missing|1
85876|NCT00170950|304320|P1|Overall Study|Missing|2
85877|NCT00170950|304319|P2|Overall Study|Lost to Follow-up|115
85878|NCT00170950|304320|P1|Overall Study|Lost to Follow-up|134
85879|NCT00170950|304319|P2|Overall Study|Withdrawal by Subject|498
85880|NCT00170950|304320|P1|Overall Study|Withdrawal by Subject|496
85881|NCT00170950|304319|P2|Overall Study|Death|274
85882|NCT00170950|304320|P1|Overall Study|Death|236
85883|NCT00171054|304332|P2|Overall Study|Condition no longer required study drug|1
85884|NCT00171054|304333|P1|Overall Study|Condition no longer required study drug|0
85885|NCT00171054|304332|P2|Overall Study|Adverse Event|8
85886|NCT00171054|304333|P1|Overall Study|Adverse Event|8
85887|NCT00171054|304332|P2|Overall Study|Lost to Follow-up|1
85888|NCT00171054|304333|P1|Overall Study|Lost to Follow-up|0
85889|NCT00171054|304332|P2|Overall Study|Patient withdrew consent|0
85890|NCT00171054|304333|P1|Overall Study|Patient withdrew consent|1
85891|NCT00171054|304332|P2|Overall Study|Protocol Violation|2
85892|NCT00171054|304333|P1|Overall Study|Protocol Violation|1
85893|NCT00171210|304365|P2|Overall Study|Stopped at end of extension 1|1
85894|NCT00171210|304366|P1|Overall Study|Stopped at end of extension 1|0
85895|NCT00171210|304365|P2|Overall Study|Stopped at end of core|32
85896|NCT00171210|304366|P1|Overall Study|Stopped at end of core|0
85897|NCT00171210|304365|P2|Overall Study|Death|3
85898|NCT00171210|304366|P1|Overall Study|Death|2
85899|NCT00171210|304365|P2|Overall Study|Administrative problems|1
85900|NCT00171210|304366|P1|Overall Study|Administrative problems|1
85901|NCT00171210|304365|P2|Overall Study|Lost to Follow-up|0
85902|NCT00171210|304366|P1|Overall Study|Lost to Follow-up|1
85903|NCT00171210|304365|P2|Overall Study|Withdrawal by Subject|30
85904|NCT00171210|304366|P1|Overall Study|Withdrawal by Subject|32
85905|NCT00171210|304365|P2|Overall Study|Protocol Violation|2
85906|NCT00171210|304366|P1|Overall Study|Protocol Violation|0
85907|NCT00171210|304365|P2|Overall Study|Unsatisfactory therapeutic effect|15
85908|NCT00171210|304366|P1|Overall Study|Unsatisfactory therapeutic effect|11
85909|NCT00171210|304365|P2|Overall Study|Abnormal test procedure result(s)|1
85910|NCT00171210|304366|P1|Overall Study|Abnormal test procedure result(s)|0
85911|NCT00171210|304365|P2|Overall Study|Abnormal laboratory value(s)|3
85912|NCT00171210|304366|P1|Overall Study|Abnormal laboratory value(s)|6
85913|NCT00171210|304365|P2|Overall Study|Adverse Event|27
85914|NCT00171210|304366|P1|Overall Study|Adverse Event|16
85915|NCT00171301|304396|P2|Overall Study|Withdrawal by Subject|1
85916|NCT00171301|304397|P1|Overall Study|Withdrawal by Subject|0
85917|NCT00171301|304396|P2|Overall Study|Protocol Violation|2
85918|NCT00171301|304397|P1|Overall Study|Protocol Violation|0
85919|NCT00171301|304396|P2|Overall Study|Lost to Follow-up|2
85920|NCT00171301|304397|P1|Overall Study|Lost to Follow-up|6
85921|NCT00171301|304396|P2|Overall Study|Adverse Event|2
85922|NCT00171301|304397|P1|Overall Study|Adverse Event|1
85923|NCT00171301|304396|P2|Overall Study|Death|2
85924|NCT00171301|304397|P1|Overall Study|Death|1
85925|NCT00171314|304410|P2|Overall Study|Death|1
85926|NCT00171314|304411|P1|Overall Study|Death|2
85927|NCT00171314|304410|P2|Overall Study|Lost to Follow-up|3
85928|NCT00171314|304411|P1|Overall Study|Lost to Follow-up|1
85929|NCT00171314|304410|P2|Overall Study|Administrative Problems|3
85930|NCT00171314|304411|P1|Overall Study|Administrative Problems|4
85931|NCT00171314|304410|P2|Overall Study|Protocol Violation|7
85932|NCT00171314|304411|P1|Overall Study|Protocol Violation|3
85933|NCT00171314|304410|P2|Overall Study|Abnormal Test Procedure Results|3
85934|NCT00171314|304411|P1|Overall Study|Abnormal Test Procedure Results|9
85935|NCT00171314|304410|P2|Overall Study|Withdrawal by Subject|6
85936|NCT00171314|304411|P1|Overall Study|Withdrawal by Subject|9
85937|NCT00171314|304410|P2|Overall Study|Lack of Efficacy|14
85938|NCT00171314|304411|P1|Overall Study|Lack of Efficacy|19
85939|NCT00171314|304410|P2|Overall Study|Adverse Event|41
85940|NCT00171314|304411|P1|Overall Study|Adverse Event|44
85941|NCT00171340|304427|P2|Overall Study|Death|6
85942|NCT00171340|304428|P1|Overall Study|Death|6
85943|NCT00171340|304427|P2|Overall Study|Administrative Problems|2
85944|NCT00171340|304428|P1|Overall Study|Administrative Problems|5
85945|NCT00171340|304427|P2|Overall Study|No Longer Required Study Drug|1
85946|NCT00171340|304428|P1|Overall Study|No Longer Required Study Drug|1
85947|NCT00171340|304427|P2|Overall Study|Abnormal Test Procedure Results|11
85948|NCT00171340|304428|P1|Overall Study|Abnormal Test Procedure Results|6
85949|NCT00171340|304427|P2|Overall Study|Abnormal Laboratory Results|0
85950|NCT00171340|304428|P1|Overall Study|Abnormal Laboratory Results|2
85951|NCT00171340|304427|P2|Overall Study|Lost to Follow-up|5
85952|NCT00171340|304428|P1|Overall Study|Lost to Follow-up|0
85953|NCT00171340|304427|P2|Overall Study|Withdrawal by Subject|19
85954|NCT00171340|304428|P1|Overall Study|Withdrawal by Subject|22
85955|NCT00171340|304427|P2|Overall Study|Protocol Violation|8
85956|NCT00171340|304428|P1|Overall Study|Protocol Violation|7
85957|NCT00171340|304427|P2|Overall Study|Lack of Efficacy|41
85958|NCT00171340|304428|P1|Overall Study|Lack of Efficacy|29
85959|NCT00171340|304427|P2|Overall Study|Adverse Event|42
85960|NCT00171340|304428|P1|Overall Study|Adverse Event|46
85961|NCT00183430|304612|P2|Overall Study|Withdrawal by Subject|0
85962|NCT00183430|304613|P1|Overall Study|Withdrawal by Subject|1
85963|NCT00183430|304612|P2|Overall Study|did not meet inclusion criteria|0
85964|NCT00183430|304613|P1|Overall Study|did not meet inclusion criteria|1
85965|NCT00183430|304612|P2|Overall Study|Lost to Follow-up|0
85966|NCT00183430|304613|P1|Overall Study|Lost to Follow-up|3
85967|NCT00183430|304612|P2|Overall Study|Adverse Event|0
85968|NCT00183430|304613|P1|Overall Study|Adverse Event|1
85969|NCT00183625|304687|P4|Overall Study|Withdrawal by Subject|14
85970|NCT00183625|304688|P3|Overall Study|Withdrawal by Subject|19
85971|NCT00183625|304689|P2|Overall Study|Withdrawal by Subject|18
85972|NCT00183625|304690|P1|Overall Study|Withdrawal by Subject|18
85973|NCT00189202|304732|P1|Overall Study|Physician Decision|5
85974|NCT00189306|304741|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
85975|NCT00189306|304741|P1|Long-Term Follow-up|Lost to Follow-up|9
85976|NCT00189306|304741|P1|Long-Term Follow-up|Intercurrent disease|2
85977|NCT00189306|304741|P1|Long-Term Follow-up|Withdrawal by Subject|1
85978|NCT00189306|304741|P1|Long-Term Follow-up|Death|4
85979|NCT00189306|304741|P1|Long-Term Follow-up|Adverse Event|2
85980|NCT00189306|304741|P1|Posttreatment Period|Local skin reaction/sign|1
85981|NCT00189306|304741|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
85982|NCT00189306|304741|P1|Posttreatment Period|Protocol Violation|1
85983|NCT00189306|304741|P1|Posttreatment Period|Target lesion excised|1
85984|NCT00189306|304741|P1|Posttreatment Period|Noncompliance|1
85985|NCT00189306|304741|P1|Posttreatment Period|Withdrawal by Subject|2
85986|NCT00189306|304741|P1|Posttreatment Period|Death|1
85987|NCT00189306|304741|P1|Treatment Period|Protocol Violation|1
85988|NCT00189306|304741|P1|Treatment Period|Adverse Event|2
85989|NCT00189306|304741|P1|Treatment Period|Withdrawal by Subject|2
85990|NCT00189423|304748|P2|Overall Study|Lost to Follow-up|10
85991|NCT00189423|304749|P1|Overall Study|Lost to Follow-up|10
85992|NCT00189423|304748|P2|Overall Study|Withdrawal by Subject|9
85993|NCT00189423|304749|P1|Overall Study|Withdrawal by Subject|9
85994|NCT00189423|304748|P2|Overall Study|Death|747
85995|NCT00189423|304749|P1|Overall Study|Death|746
85996|NCT00189462|304780|P2|Overall Study|Lost to Follow-up|20
85997|NCT00189462|304781|P1|Overall Study|Lost to Follow-up|18
85998|NCT00189462|304780|P2|Overall Study|Lack of Efficacy|1
85999|NCT00189462|304781|P1|Overall Study|Lack of Efficacy|5
86000|NCT00189488|304798|P2|Overall Study|Other|0
86001|NCT00189488|304799|P1|Overall Study|Other|1
86002|NCT00189488|304798|P2|Overall Study|Death|8
86003|NCT00189488|304799|P1|Overall Study|Death|5
86004|NCT00189488|304798|P2|Overall Study|Administrative Decision|2
86005|NCT00189488|304799|P1|Overall Study|Administrative Decision|0
86006|NCT00189488|304798|P2|Overall Study|Disease progression|4
86007|NCT00189488|304799|P1|Overall Study|Disease progression|2
86008|NCT00189488|304798|P2|Overall Study|Withdrawal by Subject|6
86009|NCT00189488|304799|P1|Overall Study|Withdrawal by Subject|2
86010|NCT00189488|304798|P2|Overall Study|Adverse Event|1
86011|NCT00189488|304799|P1|Overall Study|Adverse Event|2
86012|NCT00189488|304798|P2|Overall Study|Protocol deviation|1
86013|NCT00189488|304799|P1|Overall Study|Protocol deviation|2
86014|NCT00189488|304798|P2|Overall Study|Ineligibility determined|0
86015|NCT00189488|304799|P1|Overall Study|Ineligibility determined|1
86016|NCT00189540|304821|P2|Overall Study|Death|1
86017|NCT00189540|304822|P1|Overall Study|Death|4
86018|NCT00189540|304821|P2|Overall Study|Withdrawal by Subject|0
86019|NCT00189540|304822|P1|Overall Study|Withdrawal by Subject|3
86020|NCT00190671|304840|P2|Overall Study|Withdrawal by Subject|2
86021|NCT00190671|304841|P1|Overall Study|Withdrawal by Subject|0
86022|NCT00190671|304840|P2|Overall Study|Protocol Violation|1
86023|NCT00190671|304841|P1|Overall Study|Protocol Violation|0
86024|NCT00190671|304840|P2|Overall Study|Death from Other Causes|2
86025|NCT00190671|304841|P1|Overall Study|Death from Other Causes|0
86026|NCT00190671|304840|P2|Overall Study|Death from Study-Drug Toxicity|2
86027|NCT00190671|304841|P1|Overall Study|Death from Study-Drug Toxicity|0
86028|NCT00190671|304840|P2|Overall Study|Clinical Relapse|1
86029|NCT00190671|304841|P1|Overall Study|Clinical Relapse|0
86030|NCT00190671|304840|P2|Overall Study|Adverse Event|2
86031|NCT00190671|304841|P1|Overall Study|Adverse Event|3
86032|NCT00190671|304840|P2|Overall Study|Death from Study Disease|1
86033|NCT00190671|304841|P1|Overall Study|Death from Study Disease|1
86034|NCT00190671|304840|P2|Overall Study|Lack of Efficacy|24
86035|NCT00190671|304841|P1|Overall Study|Lack of Efficacy|19
86036|NCT00190671|304840|P2|Overall Study|Satisfactory Response|7
86037|NCT00190671|304841|P1|Overall Study|Satisfactory Response|4
86038|NCT00190684|304859|P1|Overall Study|Study Period V Completed|1
86039|NCT00190684|304859|P1|Overall Study|Study Period III Completed|103
86040|NCT00190684|304859|P1|Overall Study|Protocol Violation|123
86041|NCT00190684|304859|P1|Overall Study|Physician Decision|84
86042|NCT00190684|304859|P1|Overall Study|Sponsor's decision|17
86043|NCT00190684|304859|P1|Overall Study|Clinical relapse|67
86044|NCT00190684|304859|P1|Overall Study|Patient Decision|432
86045|NCT00190684|304859|P1|Overall Study|Patient moved|60
86046|NCT00190684|304859|P1|Overall Study|Lost to Follow-up|232
86047|NCT00190684|304859|P1|Overall Study|Lack of efficacy|204
86048|NCT00190684|304859|P1|Overall Study|Satisfactory response|80
86049|NCT00190684|304859|P1|Overall Study|Adverse Event|86
86050|NCT00190749|304880|P2|Overall Study|Sponsor Decision|0
86051|NCT00190749|304881|P1|Overall Study|Sponsor Decision|1
86052|NCT00190749|304880|P2|Overall Study|Reason Not Specified|2
86053|NCT00190749|304881|P1|Overall Study|Reason Not Specified|0
86054|NCT00190749|304880|P2|Overall Study|Lack of Efficacy|3
86055|NCT00190749|304881|P1|Overall Study|Lack of Efficacy|2
86056|NCT00190749|304880|P2|Overall Study|Adverse Event|5
86057|NCT00190749|304881|P1|Overall Study|Adverse Event|0
86058|NCT00190749|304880|P2|Overall Study|Protocol Violation|4
86059|NCT00190749|304881|P1|Overall Study|Protocol Violation|5
86060|NCT00190749|304880|P2|Overall Study|Withdrawal by Subject|6
86061|NCT00190749|304881|P1|Overall Study|Withdrawal by Subject|10
86062|NCT00190749|304880|P2|Overall Study|Lost to Follow-up|11
86063|NCT00190749|304881|P1|Overall Study|Lost to Follow-up|8
86064|NCT00190775|304947|P2|Overall Study|Exclusion Criteria Met|3
86065|NCT00190775|304948|P1|Overall Study|Exclusion Criteria Met|1
86066|NCT00190775|304947|P2|Overall Study|Protocol Violation|1
86067|NCT00190775|304948|P1|Overall Study|Protocol Violation|0
86068|NCT00190775|304947|P2|Overall Study|Noncompliance|5
86069|NCT00190775|304948|P1|Overall Study|Noncompliance|3
86070|NCT00190775|304947|P2|Overall Study|Physician Decision|0
86071|NCT00190775|304948|P1|Overall Study|Physician Decision|3
86072|NCT00190775|304947|P2|Overall Study|Sponsor Decision|0
86073|NCT00190775|304948|P1|Overall Study|Sponsor Decision|1
86074|NCT00190775|304947|P2|Overall Study|Withdrawal by Subject|13
86075|NCT00190775|304948|P1|Overall Study|Withdrawal by Subject|24
86076|NCT00190775|304947|P2|Overall Study|Participant Moved|1
86077|NCT00190775|304948|P1|Overall Study|Participant Moved|0
86078|NCT00190775|304947|P2|Overall Study|Lost to Follow-up|23
86079|NCT00190775|304948|P1|Overall Study|Lost to Follow-up|31
86080|NCT00190775|304947|P2|Overall Study|Lack of Efficacy|32
86081|NCT00190775|304948|P1|Overall Study|Lack of Efficacy|28
86082|NCT00190775|304947|P2|Overall Study|Satisfactory Response|0
86083|NCT00190775|304948|P1|Overall Study|Satisfactory Response|1
86084|NCT00190775|304947|P2|Overall Study|Adverse Event|22
86085|NCT00190775|304948|P1|Overall Study|Adverse Event|57
86086|NCT00190983|305017|P1|Overall Study|Inevaluable (never treated)|2
86087|NCT00191100|305026|P2|Overall Study|Reason Not Specified|1
86088|NCT00191100|305027|P1|Overall Study|Reason Not Specified|0
86089|NCT00191100|305026|P2|Overall Study|Death from Other Cause|0
86090|NCT00191100|305027|P1|Overall Study|Death from Other Cause|1
86091|NCT00191100|305026|P2|Overall Study|Protocol Violation|1
86092|NCT00191100|305027|P1|Overall Study|Protocol Violation|1
86093|NCT00191100|305026|P2|Overall Study|Death from Study Drug Toxicity|0
86094|NCT00191100|305027|P1|Overall Study|Death from Study Drug Toxicity|2
86095|NCT00191100|305026|P2|Overall Study|Physician Decision|1
86096|NCT00191100|305027|P1|Overall Study|Physician Decision|3
86097|NCT00191100|305026|P2|Overall Study|Lack of Efficacy, Stable Disease|0
86098|NCT00191100|305027|P1|Overall Study|Lack of Efficacy, Stable Disease|1
86099|NCT00191100|305026|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
86100|NCT00191100|305027|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
86101|NCT00191100|305026|P2|Overall Study|Clinical Relapse|1
86102|NCT00191100|305027|P1|Overall Study|Clinical Relapse|2
86103|NCT00191100|305026|P2|Overall Study|Protocol Entry Criteria Not Met|1
86104|NCT00191100|305027|P1|Overall Study|Protocol Entry Criteria Not Met|2
86105|NCT00191100|305026|P2|Overall Study|Withdrawal by Subject|3
86106|NCT00191100|305027|P1|Overall Study|Withdrawal by Subject|9
86107|NCT00191100|305026|P2|Overall Study|Patient Moved|1
86108|NCT00191100|305027|P1|Overall Study|Patient Moved|0
86109|NCT00191100|305026|P2|Overall Study|Lost to Follow-up|0
86110|NCT00191100|305027|P1|Overall Study|Lost to Follow-up|2
86111|NCT00191100|305026|P2|Overall Study|Adverse Event|1
86112|NCT00191100|305027|P1|Overall Study|Adverse Event|18
86113|NCT00191113|305045|P2|Core Study|Death|0
86114|NCT00191113|305046|P1|Core Study|Death|1
86115|NCT00191113|305045|P2|Core Study|Lack of Efficacy|2
86116|NCT00191113|305046|P1|Core Study|Lack of Efficacy|0
86117|NCT00191113|305045|P2|Core Study|Adverse Event|2
86118|NCT00191113|305046|P1|Core Study|Adverse Event|0
86119|NCT00191113|305045|P2|Core Study|Lost to Follow-up|0
86120|NCT00191113|305046|P1|Core Study|Lost to Follow-up|3
86121|NCT00191113|305045|P2|Core Study|Protocol Violation|2
86122|NCT00191113|305046|P1|Core Study|Protocol Violation|6
86123|NCT00191113|305045|P2|Core Study|Withdrawal by Subject|9
86124|NCT00191113|305046|P1|Core Study|Withdrawal by Subject|25
86125|NCT00191139|305088|P2|Overall Study|Other|2
86126|NCT00191139|305089|P1|Overall Study|Other|1
86127|NCT00191139|305088|P2|Overall Study|Disease Progression|1
86128|NCT00191139|305089|P1|Overall Study|Disease Progression|0
86129|NCT00191139|305088|P2|Overall Study|Withdrawal by Subject|3
86130|NCT00191139|305089|P1|Overall Study|Withdrawal by Subject|0
86131|NCT00191139|305088|P2|Overall Study|Death|0
86132|NCT00191139|305089|P1|Overall Study|Death|2
86133|NCT00191139|305088|P2|Overall Study|Adverse Event|6
86134|NCT00191139|305089|P1|Overall Study|Adverse Event|2
86135|NCT00191152|305105|P2|Crossover Treatment|Not Specified|3
86136|NCT00191152|305106|P1|Crossover Treatment|Not Specified|4
86137|NCT00191152|305105|P2|Crossover Treatment|Lost to Follow-up|1
86138|NCT00191152|305106|P1|Crossover Treatment|Lost to Follow-up|2
86139|NCT00191152|305105|P2|Crossover Treatment|Withdrawal by Subject|9
86140|NCT00191152|305106|P1|Crossover Treatment|Withdrawal by Subject|6
86141|NCT00191152|305105|P2|Crossover Treatment|Physician Decision|7
86142|NCT00191152|305106|P1|Crossover Treatment|Physician Decision|7
86143|NCT00191152|305105|P2|Crossover Treatment|Adverse Event|8
86144|NCT00191152|305106|P1|Crossover Treatment|Adverse Event|8
86145|NCT00191152|305105|P2|Initial Treatment|not specified|21
86146|NCT00191152|305106|P1|Initial Treatment|not specified|18
86147|NCT00191152|305105|P2|Initial Treatment|Lost to Follow-up|6
86148|NCT00191152|305106|P1|Initial Treatment|Lost to Follow-up|0
86149|NCT00191152|305105|P2|Initial Treatment|Withdrawal by Subject|28
86150|NCT00191152|305106|P1|Initial Treatment|Withdrawal by Subject|40
86151|NCT00191152|305105|P2|Initial Treatment|Physician Decision|31
86152|NCT00191152|305106|P1|Initial Treatment|Physician Decision|40
86153|NCT00191152|305105|P2|Initial Treatment|Adverse Event|67
86154|NCT00191152|305106|P1|Initial Treatment|Adverse Event|43
86155|NCT00191165|305138|P2|Overall Study|Participant Moved Away|1
86156|NCT00191165|305139|P1|Overall Study|Participant Moved Away|0
86157|NCT00191165|305138|P2|Overall Study|Protocol Violation|1
86158|NCT00191165|305139|P1|Overall Study|Protocol Violation|0
86159|NCT00191165|305138|P2|Overall Study|Adverse Event|0
86160|NCT00191165|305139|P1|Overall Study|Adverse Event|2
86161|NCT00191191|305151|P2|Overall Study|Good Clinical Practice Violation|1
86162|NCT00191191|305152|P1|Overall Study|Good Clinical Practice Violation|0
86163|NCT00191191|305151|P2|Overall Study|Physician Decision|2
86164|NCT00191191|305152|P1|Overall Study|Physician Decision|3
86165|NCT00191191|305151|P2|Overall Study|Lost to Follow-up|0
86166|NCT00191191|305152|P1|Overall Study|Lost to Follow-up|1
86167|NCT00191191|305151|P2|Overall Study|Family/Caregiver Decision|7
86168|NCT00191191|305152|P1|Overall Study|Family/Caregiver Decision|5
86169|NCT00191191|305151|P2|Overall Study|Toxicity After Dose Reduction|8
86170|NCT00191191|305152|P1|Overall Study|Toxicity After Dose Reduction|7
86171|NCT00191191|305151|P2|Overall Study|Progressive Disease|72
86172|NCT00191191|305152|P1|Overall Study|Progressive Disease|84
86173|NCT00191191|305151|P2|Overall Study|Adverse Event|21
86174|NCT00191191|305152|P1|Overall Study|Adverse Event|11
86175|NCT00191191|305151|P2|Overall Study|Treated with Another Systemic Agent|1
86176|NCT00191191|305152|P1|Overall Study|Treated with Another Systemic Agent|1
86177|NCT00191191|305151|P2|Overall Study|Entry Criteria Exclusion|0
86178|NCT00191191|305152|P1|Overall Study|Entry Criteria Exclusion|2
86179|NCT00191269|305168|P2|Overall Study|Physician Decision|3
86180|NCT00191269|305169|P1|Overall Study|Physician Decision|0
86181|NCT00191269|305168|P2|Overall Study|Pathologic Aggrevation|1
86182|NCT00191269|305169|P1|Overall Study|Pathologic Aggrevation|0
86183|NCT00191269|305168|P2|Overall Study|Withdrawal by Subject|1
86184|NCT00191269|305169|P1|Overall Study|Withdrawal by Subject|0
86185|NCT00191269|305168|P2|Overall Study|Lack of Efficacy|5
86186|NCT00191269|305169|P1|Overall Study|Lack of Efficacy|1
86187|NCT00191269|305168|P2|Overall Study|Progression of Disease|42
86188|NCT00191269|305169|P1|Overall Study|Progression of Disease|4
86189|NCT00191269|305168|P2|Overall Study|Adverse Event|4
86190|NCT00191269|305169|P1|Overall Study|Adverse Event|1
86191|NCT00191269|305168|P2|Overall Study|Protocol Violation|2
86192|NCT00191269|305169|P1|Overall Study|Protocol Violation|0
86193|NCT00191282|305185|P2|Overall Study|Lost to Follow-up|31
86194|NCT00191282|305186|P1|Overall Study|Lost to Follow-up|24
86195|NCT00191282|305185|P2|Overall Study|Sponsor's decision|2
86196|NCT00191282|305186|P1|Overall Study|Sponsor's decision|2
86197|NCT00191282|305185|P2|Overall Study|Severity of outcome|5
86198|NCT00191282|305186|P1|Overall Study|Severity of outcome|2
86199|NCT00191282|305185|P2|Overall Study|Protocol Violation|12
86200|NCT00191282|305186|P1|Overall Study|Protocol Violation|9
86201|NCT00191282|305185|P2|Overall Study|Protocol entry criteria not met|9
86202|NCT00191282|305186|P1|Overall Study|Protocol entry criteria not met|14
86203|NCT00191282|305185|P2|Overall Study|Physician Decision|15
86204|NCT00191282|305186|P1|Overall Study|Physician Decision|18
86205|NCT00191282|305185|P2|Overall Study|Withdrawal by Subject|44
86206|NCT00191282|305186|P1|Overall Study|Withdrawal by Subject|59
86207|NCT00191282|305185|P2|Overall Study|Patient moved|14
86208|NCT00191282|305186|P1|Overall Study|Patient moved|11
86209|NCT00191282|305185|P2|Overall Study|Noncompliance|17
86210|NCT00191282|305186|P1|Overall Study|Noncompliance|14
86211|NCT00191282|305185|P2|Overall Study|Lack of Efficacy|6
86212|NCT00191282|305186|P1|Overall Study|Lack of Efficacy|11
86213|NCT00191282|305185|P2|Overall Study|Death|51
86214|NCT00191282|305186|P1|Overall Study|Death|51
86215|NCT00191282|305185|P2|Overall Study|Adverse Event|6
86216|NCT00191282|305186|P1|Overall Study|Adverse Event|5
86217|NCT00191308|305244|P1|Overall Study|Adverse Event|1
86218|NCT00179959|305254|P2|Overall Study|Withdrawal by Subject|2
86219|NCT00179959|305255|P1|Overall Study|Withdrawal by Subject|3
86220|NCT00179959|305254|P2|Overall Study|Lost to Follow-up|1
86221|NCT00179959|305255|P1|Overall Study|Lost to Follow-up|3
86222|NCT00180479|305279|P2|Overall Study|Informed consent not signed|1
86223|NCT00180479|305280|P1|Overall Study|Informed consent not signed|0
86224|NCT00180479|305279|P2|Overall Study|Withdrawal by Subject|3
86225|NCT00180479|305280|P1|Overall Study|Withdrawal by Subject|3
86226|NCT00180479|305279|P2|Overall Study|Lost to Follow-up|7
86227|NCT00180479|305280|P1|Overall Study|Lost to Follow-up|9
86228|NCT00180479|305279|P2|Overall Study|Death|2
86229|NCT00180479|305280|P1|Overall Study|Death|4
86230|NCT00191334|305372|P1|Overall Study|Withdrawal by Subject|4
86231|NCT00191334|305372|P1|Overall Study|Physician Decision|1
86232|NCT00191334|305372|P1|Overall Study|Disease Progression or Relapse|8
86233|NCT00191334|305372|P1|Overall Study|Adverse Event|4
86234|NCT00191386|305380|P1|Overall Study|Lack of Efficacy|15
86235|NCT00191386|305380|P1|Overall Study|Physician Decision|11
86236|NCT00191386|305380|P1|Overall Study|Withdrawal by Subject|96
86237|NCT00191386|305380|P1|Overall Study|Protocol Violation|18
86238|NCT00191386|305380|P1|Overall Study|Entry Criteria Exclusion|3
86239|NCT00191386|305380|P1|Overall Study|Lost to Follow-up|1
86240|NCT00191386|305380|P1|Overall Study|Adverse Event|16
86241|NCT00191451|305390|P3|Overall Study|Reason Not Specified|3
86242|NCT00191451|305391|P2|Overall Study|Reason Not Specified|1
86243|NCT00191451|305392|P1|Overall Study|Reason Not Specified|2
86244|NCT00191451|305390|P3|Overall Study|Ineligible|0
86245|NCT00191451|305391|P2|Overall Study|Ineligible|1
86246|NCT00191451|305392|P1|Overall Study|Ineligible|0
86247|NCT00191451|305390|P3|Overall Study|Sponsor Decision|0
86248|NCT00191451|305391|P2|Overall Study|Sponsor Decision|0
86249|NCT00191451|305392|P1|Overall Study|Sponsor Decision|1
86250|NCT00191451|305390|P3|Overall Study|Physician Decision|6
86251|NCT00191451|305391|P2|Overall Study|Physician Decision|9
86252|NCT00191451|305392|P1|Overall Study|Physician Decision|2
86253|NCT00191451|305390|P3|Overall Study|Withdrawal by Subject|5
86254|NCT00191451|305391|P2|Overall Study|Withdrawal by Subject|3
86255|NCT00191451|305392|P1|Overall Study|Withdrawal by Subject|2
86256|NCT00191477|305414|P2|Overall Study|Discontinued Prior to Instillation|14
86257|NCT00191477|305415|P1|Overall Study|Discontinued Prior to Instillation|13
86258|NCT00191477|305414|P2|Overall Study|Pathological Specimen Lost|0
86259|NCT00191477|305415|P1|Overall Study|Pathological Specimen Lost|1
86260|NCT00191477|305414|P2|Overall Study|Not Eligible|38
86261|NCT00191477|305415|P1|Overall Study|Not Eligible|41
86262|NCT00191477|305414|P2|Overall Study|Unspecified|0
86263|NCT00191477|305415|P1|Overall Study|Unspecified|2
86264|NCT00191477|305414|P2|Overall Study|Withdrawal by Subject|0
86265|NCT00191477|305415|P1|Overall Study|Withdrawal by Subject|2
86266|NCT00191477|305414|P2|Overall Study|Treatment Change|0
86267|NCT00191477|305415|P1|Overall Study|Treatment Change|2
86268|NCT00191477|305414|P2|Overall Study|Protocol Violation|1
86269|NCT00191477|305415|P1|Overall Study|Protocol Violation|1
86270|NCT00191477|305414|P2|Overall Study|Lost to Follow-up|21
86271|NCT00191477|305415|P1|Overall Study|Lost to Follow-up|23
86272|NCT00191477|305414|P2|Overall Study|Death, Other Cause|6
86273|NCT00191477|305415|P1|Overall Study|Death, Other Cause|3
86274|NCT00191477|305414|P2|Overall Study|Death, Study Disease|1
86275|NCT00191477|305415|P1|Overall Study|Death, Study Disease|1
86276|NCT00191477|305414|P2|Overall Study|Tumor Recurrence|48
86277|NCT00191477|305415|P1|Overall Study|Tumor Recurrence|49
86278|NCT00191646|305433|P2|Overall Study|Missing Data|11
86279|NCT00191646|305434|P1|Overall Study|Missing Data|18
86280|NCT00191646|305433|P2|Overall Study|Other|34
86281|NCT00191646|305434|P1|Overall Study|Other|33
86282|NCT00191646|305433|P2|Overall Study|Death|8
86283|NCT00191646|305434|P1|Overall Study|Death|6
86284|NCT00191646|305433|P2|Overall Study|Protocol Violation|7
86285|NCT00191646|305434|P1|Overall Study|Protocol Violation|5
86286|NCT00191646|305433|P2|Overall Study|Withdrawal by Subject|39
86287|NCT00191646|305434|P1|Overall Study|Withdrawal by Subject|58
86288|NCT00191646|305433|P2|Overall Study|Physician Decision|11
86289|NCT00191646|305434|P1|Overall Study|Physician Decision|20
86290|NCT00191646|305433|P2|Overall Study|Disease Progression|6
86291|NCT00191646|305434|P1|Overall Study|Disease Progression|5
86292|NCT00191646|305433|P2|Overall Study|Toxicity|37
86293|NCT00191646|305434|P1|Overall Study|Toxicity|26
86294|NCT00194675|305474|P2|Overall Study|Death|0
86295|NCT00194675|305475|P1|Overall Study|Death|1
86296|NCT00194675|305474|P2|Overall Study|Protocol Violation|0
86297|NCT00194675|305475|P1|Overall Study|Protocol Violation|1
86298|NCT00194675|305474|P2|Overall Study|"withdrew due to edgy feeling"|0
86299|NCT00194675|305475|P1|Overall Study|"withdrew due to edgy feeling"|1
86300|NCT00194675|305474|P2|Overall Study|lack of interest|1
86301|NCT00194675|305475|P1|Overall Study|lack of interest|1
86302|NCT00194675|305474|P2|Overall Study|Lost to Follow-up|1
86303|NCT00194675|305475|P1|Overall Study|Lost to Follow-up|1
86304|NCT00194792|305491|P1|Overall Study|Withdrawal by Subject|1
86305|NCT00195260|305533|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|3
86306|NCT00195260|305534|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|4
86307|NCT00195260|305535|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|6
86308|NCT00195260|305536|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86309|NCT00195260|305537|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86310|NCT00195260|305538|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86311|NCT00195260|305539|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86312|NCT00195260|305540|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86313|NCT00195260|305541|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86314|NCT00195260|305542|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86315|NCT00195260|305543|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Unspecified|0
86316|NCT00195260|305533|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
86317|NCT00195260|305534|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
86318|NCT00195260|305535|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
86319|NCT00195260|305536|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86320|NCT00195260|305537|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86321|NCT00195260|305538|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86322|NCT00195260|305539|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86323|NCT00195260|305540|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86324|NCT00195260|305541|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86325|NCT00195260|305542|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86326|NCT00195260|305543|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
86327|NCT00195260|305533|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
86328|NCT00195260|305534|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
86329|NCT00195260|305535|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
86330|NCT00195260|305536|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86331|NCT00195260|305537|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86332|NCT00195260|305538|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86333|NCT00195260|305539|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86334|NCT00195260|305540|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86335|NCT00195260|305541|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86336|NCT00195260|305542|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86337|NCT00195260|305543|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
86338|NCT00195260|305533|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
86339|NCT00195260|305534|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
86340|NCT00195260|305535|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
86341|NCT00195260|305536|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86342|NCT00195260|305537|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86343|NCT00195260|305538|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86344|NCT00195260|305539|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86345|NCT00195260|305540|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86346|NCT00195260|305541|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86347|NCT00195260|305542|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86348|NCT00195260|305543|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
86349|NCT00195260|305533|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
86350|NCT00195260|305534|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
86351|NCT00195260|305535|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
86352|NCT00195260|305536|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
86353|NCT00195260|305537|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
86354|NCT00195260|305538|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
86355|NCT00195260|305539|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
86356|NCT00195260|305540|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
86357|NCT00195260|305541|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
86358|NCT00195260|305542|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
86359|NCT00195260|305543|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
86360|NCT00195260|305533|P11|Part 1: Dose Escalation|Disease Progression|0
86361|NCT00195260|305534|P10|Part 1: Dose Escalation|Disease Progression|0
86362|NCT00195260|305535|P9|Part 1: Dose Escalation|Disease Progression|0
86363|NCT00195260|305536|P8|Part 1: Dose Escalation|Disease Progression|4
86364|NCT00195260|305537|P7|Part 1: Dose Escalation|Disease Progression|7
86365|NCT00195260|305538|P6|Part 1: Dose Escalation|Disease Progression|6
86366|NCT00195260|305539|P5|Part 1: Dose Escalation|Disease Progression|4
86367|NCT00195260|305540|P4|Part 1: Dose Escalation|Disease Progression|6
86368|NCT00195260|305541|P3|Part 1: Dose Escalation|Disease Progression|5
86369|NCT00195260|305542|P2|Part 1: Dose Escalation|Disease Progression|2
86370|NCT00195260|305543|P1|Part 1: Dose Escalation|Disease Progression|3
86371|NCT00195260|305533|P11|Part 1: Dose Escalation|Death|0
86372|NCT00195260|305534|P10|Part 1: Dose Escalation|Death|0
86373|NCT00195260|305535|P9|Part 1: Dose Escalation|Death|0
86374|NCT00195260|305536|P8|Part 1: Dose Escalation|Death|1
86375|NCT00195260|305537|P7|Part 1: Dose Escalation|Death|0
86376|NCT00195260|305538|P6|Part 1: Dose Escalation|Death|0
86377|NCT00195260|305539|P5|Part 1: Dose Escalation|Death|0
86378|NCT00195260|305540|P4|Part 1: Dose Escalation|Death|0
86379|NCT00195260|305541|P3|Part 1: Dose Escalation|Death|0
86380|NCT00195260|305542|P2|Part 1: Dose Escalation|Death|0
86381|NCT00195260|305543|P1|Part 1: Dose Escalation|Death|0
86382|NCT00195260|305533|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
86383|NCT00195260|305534|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
86384|NCT00195260|305535|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
86385|NCT00195260|305536|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
86386|NCT00195260|305537|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
86387|NCT00195260|305538|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
86388|NCT00195260|305539|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
86389|NCT00195260|305540|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
86390|NCT00195260|305541|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
86391|NCT00195260|305542|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
86392|NCT00195260|305543|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
86393|NCT00195260|305533|P11|Part 1: Dose Escalation|Adverse Event|0
86394|NCT00195260|305534|P10|Part 1: Dose Escalation|Adverse Event|0
86395|NCT00195260|305535|P9|Part 1: Dose Escalation|Adverse Event|0
86396|NCT00195260|305536|P8|Part 1: Dose Escalation|Adverse Event|0
86397|NCT00195260|305537|P7|Part 1: Dose Escalation|Adverse Event|3
86398|NCT00195260|305538|P6|Part 1: Dose Escalation|Adverse Event|0
86399|NCT00195260|305539|P5|Part 1: Dose Escalation|Adverse Event|1
86400|NCT00195260|305540|P4|Part 1: Dose Escalation|Adverse Event|1
86401|NCT00195260|305541|P3|Part 1: Dose Escalation|Adverse Event|0
86402|NCT00195260|305542|P2|Part 1: Dose Escalation|Adverse Event|1
86403|NCT00195260|305543|P1|Part 1: Dose Escalation|Adverse Event|0
86404|NCT00195273|305691|P2|Overall Study|Procedural complications|3
86405|NCT00195273|305692|P1|Overall Study|Procedural complications|9
86406|NCT00195273|305691|P2|Overall Study|Lack of Efficacy|1
86407|NCT00195273|305692|P1|Overall Study|Lack of Efficacy|3
86408|NCT00195273|305691|P2|Overall Study|Protocol deviation|1
86409|NCT00195273|305692|P1|Overall Study|Protocol deviation|0
86410|NCT00195273|305691|P2|Overall Study|Adverse Event|9
86411|NCT00195273|305692|P1|Overall Study|Adverse Event|9
86412|NCT00195338|305704|P1|Overall Study|Early closure of the site|4
86413|NCT00195338|305704|P1|Overall Study|Lack of Efficacy|1
86414|NCT00195338|305704|P1|Overall Study|Adverse Event|5
86415|NCT00195338|305704|P1|Overall Study|Lost to Follow-up|2
86416|NCT00195351|305714|P2|Overall Study|Lack of Efficacy|1
86417|NCT00195351|305715|P1|Overall Study|Lack of Efficacy|0
86418|NCT00195351|305714|P2|Overall Study|Death|1
86419|NCT00195351|305715|P1|Overall Study|Death|3
86420|NCT00195351|305714|P2|Overall Study|Protocol Deviation|2
86421|NCT00195351|305715|P1|Overall Study|Protocol Deviation|3
86422|NCT00195351|305714|P2|Overall Study|Withdrawal by Subject|3
86423|NCT00195351|305715|P1|Overall Study|Withdrawal by Subject|6
86424|NCT00195351|305714|P2|Overall Study|Lost to Follow-up|9
86425|NCT00195351|305715|P1|Overall Study|Lost to Follow-up|9
86426|NCT00195429|305733|P2|Overall Study|Lost to Follow-up|0
86427|NCT00195429|305734|P1|Overall Study|Lost to Follow-up|1
86428|NCT00195429|305733|P2|Overall Study|Lack of Efficacy|1
86429|NCT00195429|305734|P1|Overall Study|Lack of Efficacy|2
86430|NCT00195429|305733|P2|Overall Study|Adverse Event|4
86431|NCT00195429|305734|P1|Overall Study|Adverse Event|2
86432|NCT00195442|305742|P1|Overall Study|Other|14
86433|NCT00195442|305742|P1|Overall Study|Poor cooperation|2
86434|NCT00195442|305742|P1|Overall Study|No reason specified|4
86435|NCT00195442|305742|P1|Overall Study|Death|7
86436|NCT00195442|305742|P1|Overall Study|Intermittent product shortage|21
86437|NCT00195442|305742|P1|Overall Study|Switch to other Factor VIII preparation|23
86438|NCT00195442|305742|P1|Overall Study|Lost to Follow-up|27
86439|NCT00195442|305742|P1|Overall Study|Less than expected therapeutic effect|38
86440|NCT00195494|305761|P6|Year 2|System toxicity|0
86441|NCT00195494|305762|P5|Year 2|System toxicity|0
86442|NCT00195494|305763|P4|Year 2|System toxicity|1
86443|NCT00195494|305764|P3|Year 2|System toxicity|0
86444|NCT00195494|305765|P2|Year 2|System toxicity|0
86445|NCT00195494|305766|P1|Year 2|System toxicity|0
86446|NCT00195494|305761|P6|Year 2|Withdrawal by Subject|0
86447|NCT00195494|305762|P5|Year 2|Withdrawal by Subject|0
86448|NCT00195494|305763|P4|Year 2|Withdrawal by Subject|3
86449|NCT00195494|305764|P3|Year 2|Withdrawal by Subject|4
86450|NCT00195494|305765|P2|Year 2|Withdrawal by Subject|5
86451|NCT00195494|305766|P1|Year 2|Withdrawal by Subject|1
86452|NCT00195494|305761|P6|Year 2|Physician Decision|0
86453|NCT00195494|305762|P5|Year 2|Physician Decision|0
86454|NCT00195494|305763|P4|Year 2|Physician Decision|0
86455|NCT00195494|305764|P3|Year 2|Physician Decision|0
86456|NCT00195494|305765|P2|Year 2|Physician Decision|1
86457|NCT00195494|305766|P1|Year 2|Physician Decision|1
86458|NCT00195494|305761|P6|Year 2|Protocol deviation|0
86459|NCT00195494|305762|P5|Year 2|Protocol deviation|0
86460|NCT00195494|305763|P4|Year 2|Protocol deviation|0
86461|NCT00195494|305764|P3|Year 2|Protocol deviation|0
86462|NCT00195494|305765|P2|Year 2|Protocol deviation|1
86463|NCT00195494|305766|P1|Year 2|Protocol deviation|0
86464|NCT00195494|305761|P6|Year 2|Missed >4 consecutive doses|0
86465|NCT00195494|305762|P5|Year 2|Missed >4 consecutive doses|0
86466|NCT00195494|305763|P4|Year 2|Missed >4 consecutive doses|0
86467|NCT00195494|305764|P3|Year 2|Missed >4 consecutive doses|1
86468|NCT00195494|305765|P2|Year 2|Missed >4 consecutive doses|1
86469|NCT00195494|305766|P1|Year 2|Missed >4 consecutive doses|1
86470|NCT00195494|305761|P6|Year 2|Lost to Follow-up|0
86471|NCT00195494|305762|P5|Year 2|Lost to Follow-up|0
86472|NCT00195494|305763|P4|Year 2|Lost to Follow-up|1
86473|NCT00195494|305764|P3|Year 2|Lost to Follow-up|1
86474|NCT00195494|305765|P2|Year 2|Lost to Follow-up|0
86475|NCT00195494|305766|P1|Year 2|Lost to Follow-up|0
86476|NCT00195494|305761|P6|Year 2|Compliance|0
86477|NCT00195494|305762|P5|Year 2|Compliance|0
86478|NCT00195494|305763|P4|Year 2|Compliance|2
86479|NCT00195494|305764|P3|Year 2|Compliance|0
86480|NCT00195494|305765|P2|Year 2|Compliance|0
86481|NCT00195494|305766|P1|Year 2|Compliance|1
86482|NCT00195494|305761|P6|Year 2|Lack of Efficacy|0
86483|NCT00195494|305762|P5|Year 2|Lack of Efficacy|0
86484|NCT00195494|305763|P4|Year 2|Lack of Efficacy|7
86485|NCT00195494|305764|P3|Year 2|Lack of Efficacy|7
86486|NCT00195494|305765|P2|Year 2|Lack of Efficacy|1
86487|NCT00195494|305766|P1|Year 2|Lack of Efficacy|0
86488|NCT00195494|305761|P6|Year 2|Adverse Event|0
86489|NCT00195494|305762|P5|Year 2|Adverse Event|0
86490|NCT00195494|305763|P4|Year 2|Adverse Event|9
86491|NCT00195494|305764|P3|Year 2|Adverse Event|5
86492|NCT00195494|305765|P2|Year 2|Adverse Event|7
86493|NCT00195494|305766|P1|Year 2|Adverse Event|3
86494|NCT00195494|305761|P6|Year 1|Protocol Violation|1
86495|NCT00195494|305762|P5|Year 1|Protocol Violation|1
86496|NCT00195494|305763|P4|Year 1|Protocol Violation|0
86497|NCT00195494|305764|P3|Year 1|Protocol Violation|0
86498|NCT00195494|305765|P2|Year 1|Protocol Violation|0
86499|NCT00195494|305766|P1|Year 1|Protocol Violation|0
86500|NCT00195494|305761|P6|Year 1|Withdrawal by Subject|9
86501|NCT00195494|305762|P5|Year 1|Withdrawal by Subject|8
86502|NCT00195494|305763|P4|Year 1|Withdrawal by Subject|0
86503|NCT00195494|305764|P3|Year 1|Withdrawal by Subject|0
86504|NCT00195494|305765|P2|Year 1|Withdrawal by Subject|0
86505|NCT00195494|305766|P1|Year 1|Withdrawal by Subject|0
86506|NCT00195494|305761|P6|Year 1|Physician Decision|0
86507|NCT00195494|305762|P5|Year 1|Physician Decision|1
86508|NCT00195494|305763|P4|Year 1|Physician Decision|0
86509|NCT00195494|305764|P3|Year 1|Physician Decision|0
86510|NCT00195494|305765|P2|Year 1|Physician Decision|0
86511|NCT00195494|305766|P1|Year 1|Physician Decision|0
86512|NCT00195494|305761|P6|Year 1|Protocol deviation|3
86513|NCT00195494|305762|P5|Year 1|Protocol deviation|2
86514|NCT00195494|305763|P4|Year 1|Protocol deviation|0
86515|NCT00195494|305764|P3|Year 1|Protocol deviation|0
86516|NCT00195494|305765|P2|Year 1|Protocol deviation|0
86517|NCT00195494|305766|P1|Year 1|Protocol deviation|0
86518|NCT00195494|305761|P6|Year 1|Missed >4 consecutive doses|2
86519|NCT00195494|305762|P5|Year 1|Missed >4 consecutive doses|3
86520|NCT00195494|305763|P4|Year 1|Missed >4 consecutive doses|0
86521|NCT00195494|305764|P3|Year 1|Missed >4 consecutive doses|0
86522|NCT00195494|305765|P2|Year 1|Missed >4 consecutive doses|0
86523|NCT00195494|305766|P1|Year 1|Missed >4 consecutive doses|0
86524|NCT00195494|305761|P6|Year 1|Lost to Follow-up|0
86525|NCT00195494|305762|P5|Year 1|Lost to Follow-up|1
86526|NCT00195494|305763|P4|Year 1|Lost to Follow-up|0
86527|NCT00195494|305764|P3|Year 1|Lost to Follow-up|0
86528|NCT00195494|305765|P2|Year 1|Lost to Follow-up|0
86529|NCT00195494|305766|P1|Year 1|Lost to Follow-up|0
86530|NCT00195494|305761|P6|Year 1|Compliance|1
86531|NCT00195494|305762|P5|Year 1|Compliance|5
86532|NCT00195494|305763|P4|Year 1|Compliance|0
86533|NCT00195494|305764|P3|Year 1|Compliance|0
86534|NCT00195494|305765|P2|Year 1|Compliance|0
86535|NCT00195494|305766|P1|Year 1|Compliance|0
86536|NCT00195494|305761|P6|Year 1|Lack of Efficacy|9
86537|NCT00195494|305762|P5|Year 1|Lack of Efficacy|24
86538|NCT00195494|305763|P4|Year 1|Lack of Efficacy|0
86539|NCT00195494|305764|P3|Year 1|Lack of Efficacy|0
86540|NCT00195494|305765|P2|Year 1|Lack of Efficacy|0
86541|NCT00195494|305766|P1|Year 1|Lack of Efficacy|0
86542|NCT00195494|305761|P6|Year 1|System Toxicity|1
86543|NCT00195494|305762|P5|Year 1|System Toxicity|0
86544|NCT00195494|305763|P4|Year 1|System Toxicity|0
86545|NCT00195494|305764|P3|Year 1|System Toxicity|0
86546|NCT00195494|305765|P2|Year 1|System Toxicity|0
86547|NCT00195494|305766|P1|Year 1|System Toxicity|0
86548|NCT00195494|305761|P6|Year 1|Adverse Event|27
86549|NCT00195494|305762|P5|Year 1|Adverse Event|34
86550|NCT00195494|305763|P4|Year 1|Adverse Event|0
86551|NCT00195494|305764|P3|Year 1|Adverse Event|0
86552|NCT00195494|305765|P2|Year 1|Adverse Event|0
86553|NCT00195494|305766|P1|Year 1|Adverse Event|0
86554|NCT00195507|305786|P2|Overall Study|Protocol Deviation|3
86555|NCT00195507|305787|P1|Overall Study|Protocol Deviation|6
86556|NCT00195507|305786|P2|Overall Study|Withdrawal by Subject|23
86557|NCT00195507|305787|P1|Overall Study|Withdrawal by Subject|16
86558|NCT00195507|305786|P2|Overall Study|Lack of Efficacy|67
86559|NCT00195507|305787|P1|Overall Study|Lack of Efficacy|40
86560|NCT00195507|305786|P2|Overall Study|Protocol Violation|4
86561|NCT00195507|305787|P1|Overall Study|Protocol Violation|5
86562|NCT00195507|305786|P2|Overall Study|Lost to Follow-up|2
86563|NCT00195507|305787|P1|Overall Study|Lost to Follow-up|3
86564|NCT00195507|305786|P2|Overall Study|Physician Decision|2
86565|NCT00195507|305787|P1|Overall Study|Physician Decision|1
86566|NCT00195507|305786|P2|Overall Study|Failed to Return|3
86567|NCT00195507|305787|P1|Overall Study|Failed to Return|4
86568|NCT00195507|305786|P2|Overall Study|Death|1
86569|NCT00195507|305787|P1|Overall Study|Death|0
86570|NCT00195507|305786|P2|Overall Study|Adverse Event|13
86571|NCT00195507|305787|P1|Overall Study|Adverse Event|24
86572|NCT00195650|305799|P1|Overall Study|Administrative reasons|83
86573|NCT00195650|305799|P1|Overall Study|Protocol Violation|15
86574|NCT00195650|305799|P1|Overall Study|Death|23
86575|NCT00195650|305799|P1|Overall Study|Lost to Follow-up|44
86576|NCT00195650|305799|P1|Overall Study|Withdrawal by Subject|67
86577|NCT00195650|305799|P1|Overall Study|Lack of Efficacy|99
86578|NCT00195650|305799|P1|Overall Study|Adverse Event|194
86579|NCT00195663|305816|P3|Open-Label Extension Period|Administrative reasons|13
86580|NCT00195663|305817|P2|Open-Label Extension Period|Administrative reasons|11
86581|NCT00195663|305818|P1|Open-Label Extension Period|Administrative reasons|11
86582|NCT00195663|305816|P3|Open-Label Extension Period|Lack of Efficacy|12
86583|NCT00195663|305817|P2|Open-Label Extension Period|Lack of Efficacy|6
86584|NCT00195663|305818|P1|Open-Label Extension Period|Lack of Efficacy|14
86585|NCT00195663|305816|P3|Open-Label Extension Period|Withdrawal by Subject|22
86586|NCT00195663|305817|P2|Open-Label Extension Period|Withdrawal by Subject|15
86587|NCT00195663|305818|P1|Open-Label Extension Period|Withdrawal by Subject|16
86588|NCT00195663|305816|P3|Open-Label Extension Period|Death|2
86589|NCT00195663|305817|P2|Open-Label Extension Period|Death|2
86590|NCT00195663|305818|P1|Open-Label Extension Period|Death|2
86591|NCT00195663|305816|P3|Open-Label Extension Period|Protocol Violation|4
86592|NCT00195663|305817|P2|Open-Label Extension Period|Protocol Violation|4
86593|NCT00195663|305818|P1|Open-Label Extension Period|Protocol Violation|3
86594|NCT00195663|305816|P3|Open-Label Extension Period|Recovery|2
86595|NCT00195663|305817|P2|Open-Label Extension Period|Recovery|2
86596|NCT00195663|305818|P1|Open-Label Extension Period|Recovery|0
86597|NCT00195663|305816|P3|Open-Label Extension Period|Lost to Follow-up|6
86598|NCT00195663|305817|P2|Open-Label Extension Period|Lost to Follow-up|2
86599|NCT00195663|305818|P1|Open-Label Extension Period|Lost to Follow-up|9
86600|NCT00195663|305816|P3|Open-Label Extension Period|Adverse Event|36
86601|NCT00195663|305817|P2|Open-Label Extension Period|Adverse Event|32
86602|NCT00195663|305818|P1|Open-Label Extension Period|Adverse Event|21
86603|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Administrative reasons|9
86604|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Administrative reasons|2
86605|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Administrative reasons|3
86606|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Recovery|1
86607|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Recovery|0
86608|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Recovery|1
86609|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
86610|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
86611|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
86612|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Protocol Violation|4
86613|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Protocol Violation|6
86614|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Protocol Violation|6
86615|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
86616|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
86617|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
86618|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
86619|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
86620|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
86621|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
86622|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
86623|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
86624|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Death|0
86625|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Death|2
86626|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Death|0
86627|NCT00195663|305816|P3|2-year Double-blind Treatment Period|Adverse Event|32
86628|NCT00195663|305817|P2|2-year Double-blind Treatment Period|Adverse Event|27
86629|NCT00195663|305818|P1|2-year Double-blind Treatment Period|Adverse Event|21
86630|NCT00195676|305912|P1|Period R - Retreatment 16 Weeks|Other reasons|6
86631|NCT00195676|305912|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
86632|NCT00195676|305912|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
86633|NCT00195676|305912|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
86634|NCT00195676|305912|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
86635|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
86636|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
86637|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
86638|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
86639|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
86640|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
86641|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Death|2
86642|NCT00195676|305912|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
86643|NCT00195676|305912|P1|Period O - Open-label Treatment|Other reasons|68
86644|NCT00195676|305912|P1|Period O - Open-label Treatment|Administrative reasons|2
86645|NCT00195676|305912|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
86646|NCT00195676|305912|P1|Period O - Open-label Treatment|Protocol Violation|12
86647|NCT00195676|305912|P1|Period O - Open-label Treatment|Lost to Follow-up|91
86648|NCT00195676|305912|P1|Period O - Open-label Treatment|Lack of Efficacy|198
86649|NCT00195676|305912|P1|Period O - Open-label Treatment|Death|6
86650|NCT00195676|305912|P1|Period O - Open-label Treatment|Adverse Event|82
86651|NCT00195715|305995|P1|Overall Study|Sponsor discretion - trial ended early|1
86652|NCT00195715|305995|P1|Overall Study|Sponsor discontinued trial|1
86653|NCT00195715|305995|P1|Overall Study|Colonic stricture|1
86654|NCT00195715|305995|P1|Overall Study|Ineligible|1
86655|NCT00195715|305995|P1|Overall Study|Increased infection rate|1
86656|NCT00195715|305995|P1|Overall Study|Planned surgery|2
86657|NCT00195715|305995|P1|Overall Study|Use of prohibited medication|2
86658|NCT00195715|305995|P1|Overall Study|Subject wants to get pregnant|4
86659|NCT00195715|305995|P1|Overall Study|Investigator's decision|2
86660|NCT00195715|305995|P1|Overall Study|Administrative reasons|2
86661|NCT00195715|305995|P1|Overall Study|Sponsor stopped study|1
86662|NCT00195715|305995|P1|Overall Study|Loss of response/no improvement|3
86663|NCT00195715|305995|P1|Overall Study|Subject choice|3
86664|NCT00195715|305995|P1|Overall Study|Subject started commercial Humira|5
86665|NCT00195715|305995|P1|Overall Study|Subject non-compliance|6
86666|NCT00195715|305995|P1|Overall Study|Subject moved/relocated|7
86667|NCT00195715|305995|P1|Overall Study|Investigative site closure|8
86668|NCT00195715|305995|P1|Overall Study|Pregnancy|14
86669|NCT00195715|305995|P1|Overall Study|Lack of Efficacy|93
86670|NCT00195715|305995|P1|Overall Study|Protocol Violation|13
86671|NCT00195715|305995|P1|Overall Study|Lost to Follow-up|27
86672|NCT00195715|305995|P1|Overall Study|Withdrawal by Subject|58
86673|NCT00195715|305995|P1|Overall Study|Adverse Event|122
86674|NCT00195819|306023|P2|Open-label|Withdrawal by Subject|5
86675|NCT00195819|306024|P1|Open-label|Withdrawal by Subject|0
86676|NCT00195819|306023|P2|Open-label|Moved|1
86677|NCT00195819|306024|P1|Open-label|Moved|0
86678|NCT00195819|306023|P2|Open-label|Protocol Violation|2
86679|NCT00195819|306024|P1|Open-label|Protocol Violation|0
86680|NCT00195819|306023|P2|Open-label|Pregnancy|1
86681|NCT00195819|306024|P1|Open-label|Pregnancy|0
86682|NCT00195819|306023|P2|Open-label|Lack of Efficacy|2
86683|NCT00195819|306024|P1|Open-label|Lack of Efficacy|0
86684|NCT00195819|306023|P2|Open-label|Adverse Event|9
86685|NCT00195819|306024|P1|Open-label|Adverse Event|0
86686|NCT00195819|306023|P2|Double-Blind|Moved|0
86687|NCT00195819|306024|P1|Double-Blind|Moved|1
86688|NCT00195819|306023|P2|Double-Blind|Withdrawal by Subject|0
86689|NCT00195819|306024|P1|Double-Blind|Withdrawal by Subject|1
86690|NCT00196105|306077|P3|Overall Study|Lost to Follow-up|7
86691|NCT00196105|306078|P2|Overall Study|Lost to Follow-up|5
86692|NCT00196105|306079|P1|Overall Study|Lost to Follow-up|4
86693|NCT00196196|306099|P1|Overall Study|Did not have required condition (hydroce|5
86694|NCT00196196|306099|P1|Overall Study|Withdrawal by Subject|2
86695|NCT00196313|306106|P2|Overall Study|Lost to Follow-up|2
86696|NCT00196313|306107|P1|Overall Study|Lost to Follow-up|2
86697|NCT00196313|306106|P2|Overall Study|Subject Pregnant|1
86698|NCT00196313|306107|P1|Overall Study|Subject Pregnant|1
86699|NCT00196313|306106|P2|Overall Study|Adverse Event|1
86700|NCT00196313|306107|P1|Overall Study|Adverse Event|3
86701|NCT00196313|306106|P2|Overall Study|Withdrawal by Subject|1
86702|NCT00196313|306107|P1|Overall Study|Withdrawal by Subject|3
86703|NCT00196313|306106|P2|Overall Study|Protocol Violation|3
86704|NCT00196313|306107|P1|Overall Study|Protocol Violation|2
86705|NCT00196326|306121|P1|Overall Study|Not specified|22
86706|NCT00196326|306121|P1|Overall Study|Lost to Follow-up|304
86707|NCT00196326|306121|P1|Overall Study|Pregnancy|34
86708|NCT00196326|306121|P1|Overall Study|Adverse Event|253
86709|NCT00196326|306121|P1|Overall Study|Withdrawal by Subject|225
86710|NCT00196326|306121|P1|Overall Study|Physician Decision|3
86711|NCT00196326|306121|P1|Overall Study|Non-compliance with the protocol|81
86712|NCT00196326|306121|P1|Overall Study|Did not meet protocol requirements|64
86713|NCT00184002|306162|P1|Overall Study|Withdrawal by Subject|4
86714|NCT00184002|306162|P1|Overall Study|Physician Decision|1
86715|NCT00184002|306162|P1|Overall Study|Death|3
86716|NCT00184002|306162|P1|Overall Study|Adverse Event|9
86717|NCT00184028|306167|P1|Overall Study|Non-compliance|2
86718|NCT00184028|306167|P1|Overall Study|Withdrawal by Subject|1
86719|NCT00184028|306167|P1|Overall Study|Adverse Event|2
86720|NCT00184028|306167|P1|Overall Study|Lack of Efficacy|4
86721|NCT00184028|306167|P1|Overall Study|Death|1
86722|NCT00184054|306172|P1|Overall Study|Adverse Event|1
86723|NCT00184093|306177|P1|Overall Study|Withdrawal by Subject|2
86724|NCT00184093|306177|P1|Overall Study|Physician Decision|1
86725|NCT00184093|306177|P1|Overall Study|Lost to Follow-up|3
86726|NCT00184093|306177|P1|Overall Study|Adverse Event|3
86727|NCT00184600|306226|P3|Overall Study|Unclassified|3
86728|NCT00184600|306227|P2|Overall Study|Unclassified|5
86729|NCT00184600|306228|P1|Overall Study|Unclassified|4
86730|NCT00184600|306226|P3|Overall Study|Withdrawal by Subject|12
86731|NCT00184600|306227|P2|Overall Study|Withdrawal by Subject|28
86732|NCT00184600|306228|P1|Overall Study|Withdrawal by Subject|20
86733|NCT00184600|306226|P3|Overall Study|Protocol Violation|3
86734|NCT00184600|306227|P2|Overall Study|Protocol Violation|2
86735|NCT00184600|306228|P1|Overall Study|Protocol Violation|2
86736|NCT00184600|306226|P3|Overall Study|Lost to Follow-up|1
86737|NCT00184600|306227|P2|Overall Study|Lost to Follow-up|6
86738|NCT00184600|306228|P1|Overall Study|Lost to Follow-up|4
86739|NCT00184600|306226|P3|Overall Study|Lack of Efficacy|3
86740|NCT00184600|306227|P2|Overall Study|Lack of Efficacy|1
86741|NCT00184600|306228|P1|Overall Study|Lack of Efficacy|3
86742|NCT00184600|306226|P3|Overall Study|Death|7
86743|NCT00184600|306227|P2|Overall Study|Death|9
86744|NCT00184600|306228|P1|Overall Study|Death|3
86745|NCT00184600|306226|P3|Overall Study|Adverse Event|5
86746|NCT00184600|306227|P2|Overall Study|Adverse Event|0
86747|NCT00184600|306228|P1|Overall Study|Adverse Event|9
86748|NCT00186485|306329|P1|Overall Study|Lost to Follow-up|3
86749|NCT00186537|306338|P3|Overall Study|ALT > 1.5 x ULN|0
86750|NCT00186537|306339|P2|Overall Study|ALT > 1.5 x ULN|0
86751|NCT00186537|306340|P1|Overall Study|ALT > 1.5 x ULN|3
86752|NCT00186537|306338|P3|Overall Study|Withdrawal by Subject|3
86753|NCT00186537|306339|P2|Overall Study|Withdrawal by Subject|0
86754|NCT00186537|306340|P1|Overall Study|Withdrawal by Subject|4
86755|NCT00186888|306374|P3|Overall Study|Relapse or progression of disease|0
86756|NCT00186888|306375|P2|Overall Study|Relapse or progression of disease|2
86757|NCT00186888|306376|P1|Overall Study|Relapse or progression of disease|4
86758|NCT00186888|306374|P3|Overall Study|Toxicity|0
86759|NCT00186888|306375|P2|Overall Study|Toxicity|1
86760|NCT00186888|306376|P1|Overall Study|Toxicity|0
86761|NCT00186901|306443|P3|Overall Study|Bone Mineral Density > 0|149
86762|NCT00186901|306444|P2|Overall Study|Bone Mineral Density > 0|0
86763|NCT00186901|306445|P1|Overall Study|Bone Mineral Density > 0|0
86764|NCT00186901|306443|P3|Overall Study|Limited adherence to study requirements|0
86765|NCT00186901|306444|P2|Overall Study|Limited adherence to study requirements|23
86766|NCT00186901|306445|P1|Overall Study|Limited adherence to study requirements|20
86767|NCT00186901|306443|P3|Overall Study|Open label|0
86768|NCT00186901|306444|P2|Overall Study|Open label|2
86769|NCT00186901|306445|P1|Overall Study|Open label|3
86770|NCT00186901|306443|P3|Overall Study|Withdrawal by Subject|0
86771|NCT00186901|306444|P2|Overall Study|Withdrawal by Subject|5
86772|NCT00186901|306445|P1|Overall Study|Withdrawal by Subject|4
86773|NCT00186901|306443|P3|Overall Study|ALL relapse or second malignancy|0
86774|NCT00186901|306444|P2|Overall Study|ALL relapse or second malignancy|2
86775|NCT00186901|306445|P1|Overall Study|ALL relapse or second malignancy|1
86776|NCT00186901|306443|P3|Overall Study|Bone Mineral Density dropped > 5%|0
86777|NCT00186901|306444|P2|Overall Study|Bone Mineral Density dropped > 5%|7
86778|NCT00186901|306445|P1|Overall Study|Bone Mineral Density dropped > 5%|9
86779|NCT00186901|306443|P3|Overall Study|Lost to Follow-up|0
86780|NCT00186901|306444|P2|Overall Study|Lost to Follow-up|3
86781|NCT00186901|306445|P1|Overall Study|Lost to Follow-up|6
86782|NCT00186901|306443|P3|Overall Study|Pregnancy|0
86783|NCT00186901|306444|P2|Overall Study|Pregnancy|3
86784|NCT00186901|306445|P1|Overall Study|Pregnancy|6
86785|NCT00187096|306485|P3|Overall Study|unacceptable toxicity|1
86786|NCT00187096|306486|P2|Overall Study|unacceptable toxicity|0
86787|NCT00187096|306487|P1|Overall Study|unacceptable toxicity|0
86788|NCT00187135|306528|P6|Visit Three|Study Discontinued|6
86789|NCT00187135|306529|P5|Visit Three|Study Discontinued|7
86790|NCT00187135|306530|P4|Visit Three|Study Discontinued|7
86791|NCT00187135|306531|P3|Visit Three|Study Discontinued|7
86792|NCT00187135|306532|P2|Visit Three|Study Discontinued|6
86793|NCT00187135|306533|P1|Visit Three|Study Discontinued|7
86794|NCT00187135|306528|P6|Visit Three|Withdrawal by Subject|0
86795|NCT00187135|306529|P5|Visit Three|Withdrawal by Subject|0
86796|NCT00187135|306530|P4|Visit Three|Withdrawal by Subject|2
86797|NCT00187135|306531|P3|Visit Three|Withdrawal by Subject|1
86798|NCT00187135|306532|P2|Visit Three|Withdrawal by Subject|1
86799|NCT00187135|306533|P1|Visit Three|Withdrawal by Subject|0
86800|NCT00187135|306528|P6|Visit Three|Death|0
86801|NCT00187135|306529|P5|Visit Three|Death|1
86802|NCT00187135|306530|P4|Visit Three|Death|0
86803|NCT00187135|306531|P3|Visit Three|Death|1
86804|NCT00187135|306532|P2|Visit Three|Death|0
86805|NCT00187135|306533|P1|Visit Three|Death|0
86806|NCT00187135|306528|P6|Visit Two|Study Discontinued|6
86807|NCT00187135|306529|P5|Visit Two|Study Discontinued|5
86808|NCT00187135|306530|P4|Visit Two|Study Discontinued|7
86809|NCT00187135|306531|P3|Visit Two|Study Discontinued|1
86810|NCT00187135|306532|P2|Visit Two|Study Discontinued|2
86811|NCT00187135|306533|P1|Visit Two|Study Discontinued|3
86812|NCT00187135|306528|P6|Visit Two|Withdrawal by Subject|1
86813|NCT00187135|306529|P5|Visit Two|Withdrawal by Subject|1
86814|NCT00187135|306530|P4|Visit Two|Withdrawal by Subject|0
86815|NCT00187135|306531|P3|Visit Two|Withdrawal by Subject|1
86816|NCT00187135|306532|P2|Visit Two|Withdrawal by Subject|1
86817|NCT00187135|306533|P1|Visit Two|Withdrawal by Subject|1
86818|NCT00187135|306528|P6|Visit Two|Physician Decision|0
86819|NCT00187135|306529|P5|Visit Two|Physician Decision|0
86820|NCT00187135|306530|P4|Visit Two|Physician Decision|0
86821|NCT00187135|306531|P3|Visit Two|Physician Decision|0
86822|NCT00187135|306532|P2|Visit Two|Physician Decision|0
86823|NCT00187135|306533|P1|Visit Two|Physician Decision|1
86824|NCT00187135|306528|P6|Visit Two|Death|1
86825|NCT00187135|306529|P5|Visit Two|Death|0
86826|NCT00187135|306530|P4|Visit Two|Death|1
86827|NCT00187135|306531|P3|Visit Two|Death|0
86828|NCT00187135|306532|P2|Visit Two|Death|0
86829|NCT00187135|306533|P1|Visit Two|Death|0
86830|NCT00187135|306528|P6|Visit One|Physician Decision|1
86831|NCT00187135|306529|P5|Visit One|Physician Decision|0
86832|NCT00187135|306530|P4|Visit One|Physician Decision|0
86833|NCT00187135|306531|P3|Visit One|Physician Decision|0
86834|NCT00187135|306532|P2|Visit One|Physician Decision|1
86835|NCT00187135|306533|P1|Visit One|Physician Decision|3
86836|NCT00187135|306528|P6|Visit One|Withdrawal by Subject|1
86837|NCT00187135|306529|P5|Visit One|Withdrawal by Subject|0
86838|NCT00187135|306530|P4|Visit One|Withdrawal by Subject|0
86839|NCT00187135|306531|P3|Visit One|Withdrawal by Subject|0
86840|NCT00187135|306532|P2|Visit One|Withdrawal by Subject|0
86841|NCT00187135|306533|P1|Visit One|Withdrawal by Subject|1
86842|NCT00187486|306593|P1|Overall Study|Protocol Violation|1
86843|NCT00187889|306634|P2|Overall Study|Withdrawal by Subject|4
86844|NCT00187889|306635|P1|Overall Study|Withdrawal by Subject|6
86845|NCT00196937|306656|P3|Overall Study|Withdrawal by Subject|3
86846|NCT00196937|306657|P2|Overall Study|Withdrawal by Subject|0
86847|NCT00196937|306658|P1|Overall Study|Withdrawal by Subject|0
86848|NCT00196937|306656|P3|Overall Study|Lost to Follow-up|3
86849|NCT00196937|306657|P2|Overall Study|Lost to Follow-up|3
86850|NCT00196937|306658|P1|Overall Study|Lost to Follow-up|4
86851|NCT00196937|306656|P3|Overall Study|Subject did not come due to holidays|0
86852|NCT00196937|306657|P2|Overall Study|Subject did not come due to holidays|1
86853|NCT00196937|306658|P1|Overall Study|Subject did not come due to holidays|3
86854|NCT00196937|306656|P3|Overall Study|Adverse Event|1
86855|NCT00196937|306657|P2|Overall Study|Adverse Event|1
86856|NCT00196937|306658|P1|Overall Study|Adverse Event|2
86857|NCT00196976|306710|P14|Booster Study|Lost to Follow-up|0
86858|NCT00196976|306711|P13|Booster Study|Lost to Follow-up|0
86859|NCT00196976|306712|P12|Booster Study|Lost to Follow-up|2
86860|NCT00196976|306713|P11|Booster Study|Lost to Follow-up|1
86861|NCT00196976|306714|P10|Booster Study|Lost to Follow-up|0
86862|NCT00196976|306715|P9|Booster Study|Lost to Follow-up|0
86863|NCT00196976|306716|P8|Booster Study|Lost to Follow-up|0
86864|NCT00196976|306717|P7|Booster Study|Lost to Follow-up|0
86865|NCT00196976|306718|P6|Booster Study|Lost to Follow-up|0
86866|NCT00196976|306719|P5|Booster Study|Lost to Follow-up|0
86867|NCT00196976|306720|P4|Booster Study|Lost to Follow-up|0
86868|NCT00196976|306721|P3|Booster Study|Lost to Follow-up|0
86869|NCT00196976|306722|P2|Booster Study|Lost to Follow-up|0
86870|NCT00196976|306723|P1|Booster Study|Lost to Follow-up|0
86871|NCT00196976|306710|P14|Booster Study|Withdrawal by Subject|0
86872|NCT00196976|306711|P13|Booster Study|Withdrawal by Subject|0
86873|NCT00196976|306712|P12|Booster Study|Withdrawal by Subject|0
86874|NCT00196976|306713|P11|Booster Study|Withdrawal by Subject|1
86875|NCT00196976|306714|P10|Booster Study|Withdrawal by Subject|0
86876|NCT00196976|306715|P9|Booster Study|Withdrawal by Subject|0
86877|NCT00196976|306716|P8|Booster Study|Withdrawal by Subject|0
86878|NCT00196976|306717|P7|Booster Study|Withdrawal by Subject|0
86879|NCT00196976|306718|P6|Booster Study|Withdrawal by Subject|0
86880|NCT00196976|306719|P5|Booster Study|Withdrawal by Subject|0
86881|NCT00196976|306720|P4|Booster Study|Withdrawal by Subject|0
86882|NCT00196976|306721|P3|Booster Study|Withdrawal by Subject|0
86883|NCT00196976|306722|P2|Booster Study|Withdrawal by Subject|0
86884|NCT00196976|306723|P1|Booster Study|Withdrawal by Subject|0
86885|NCT00196976|306710|P14|Primary Study|Unspecified|0
86886|NCT00196976|306711|P13|Primary Study|Unspecified|0
86887|NCT00196976|306712|P12|Primary Study|Unspecified|0
86888|NCT00196976|306713|P11|Primary Study|Unspecified|0
86889|NCT00196976|306714|P10|Primary Study|Unspecified|0
86890|NCT00196976|306715|P9|Primary Study|Unspecified|0
86891|NCT00196976|306716|P8|Primary Study|Unspecified|0
86892|NCT00196976|306717|P7|Primary Study|Unspecified|0
86893|NCT00196976|306718|P6|Primary Study|Unspecified|0
86894|NCT00196976|306719|P5|Primary Study|Unspecified|0
86895|NCT00196976|306720|P4|Primary Study|Unspecified|0
86896|NCT00196976|306721|P3|Primary Study|Unspecified|2
86897|NCT00196976|306722|P2|Primary Study|Unspecified|0
86898|NCT00196976|306723|P1|Primary Study|Unspecified|0
86899|NCT00196976|306710|P14|Primary Study|Lost to Follow-up|0
86900|NCT00196976|306711|P13|Primary Study|Lost to Follow-up|0
86901|NCT00196976|306712|P12|Primary Study|Lost to Follow-up|0
86902|NCT00196976|306713|P11|Primary Study|Lost to Follow-up|0
86903|NCT00196976|306714|P10|Primary Study|Lost to Follow-up|0
86904|NCT00196976|306715|P9|Primary Study|Lost to Follow-up|0
86905|NCT00196976|306716|P8|Primary Study|Lost to Follow-up|2
86906|NCT00196976|306717|P7|Primary Study|Lost to Follow-up|0
86907|NCT00196976|306718|P6|Primary Study|Lost to Follow-up|1
86908|NCT00196976|306719|P5|Primary Study|Lost to Follow-up|1
86909|NCT00196976|306720|P4|Primary Study|Lost to Follow-up|0
86910|NCT00196976|306721|P3|Primary Study|Lost to Follow-up|0
86911|NCT00196976|306722|P2|Primary Study|Lost to Follow-up|0
86912|NCT00196976|306723|P1|Primary Study|Lost to Follow-up|0
86913|NCT00196976|306710|P14|Primary Study|Withdrawal by Subject|0
86914|NCT00196976|306711|P13|Primary Study|Withdrawal by Subject|0
86915|NCT00196976|306712|P12|Primary Study|Withdrawal by Subject|0
86916|NCT00196976|306713|P11|Primary Study|Withdrawal by Subject|0
86917|NCT00196976|306714|P10|Primary Study|Withdrawal by Subject|1
86918|NCT00196976|306715|P9|Primary Study|Withdrawal by Subject|0
86919|NCT00196976|306716|P8|Primary Study|Withdrawal by Subject|0
86920|NCT00196976|306717|P7|Primary Study|Withdrawal by Subject|0
86921|NCT00196976|306718|P6|Primary Study|Withdrawal by Subject|1
86922|NCT00196976|306719|P5|Primary Study|Withdrawal by Subject|2
86923|NCT00196976|306720|P4|Primary Study|Withdrawal by Subject|1
86924|NCT00196976|306721|P3|Primary Study|Withdrawal by Subject|1
86925|NCT00196976|306722|P2|Primary Study|Withdrawal by Subject|0
86926|NCT00196976|306723|P1|Primary Study|Withdrawal by Subject|1
86927|NCT00196976|306710|P14|Primary Study|Protocol Violation|0
86928|NCT00196976|306711|P13|Primary Study|Protocol Violation|0
86929|NCT00196976|306712|P12|Primary Study|Protocol Violation|0
86930|NCT00196976|306713|P11|Primary Study|Protocol Violation|0
86931|NCT00196976|306714|P10|Primary Study|Protocol Violation|0
86932|NCT00196976|306715|P9|Primary Study|Protocol Violation|0
86933|NCT00196976|306716|P8|Primary Study|Protocol Violation|0
86934|NCT00196976|306717|P7|Primary Study|Protocol Violation|0
86935|NCT00196976|306718|P6|Primary Study|Protocol Violation|0
86936|NCT00196976|306719|P5|Primary Study|Protocol Violation|0
86937|NCT00196976|306720|P4|Primary Study|Protocol Violation|0
86938|NCT00196976|306721|P3|Primary Study|Protocol Violation|1
86939|NCT00196976|306722|P2|Primary Study|Protocol Violation|1
86940|NCT00196976|306723|P1|Primary Study|Protocol Violation|0
86941|NCT00196976|306710|P14|Primary Study|Migrated from study area|0
86942|NCT00196976|306711|P13|Primary Study|Migrated from study area|0
86943|NCT00196976|306712|P12|Primary Study|Migrated from study area|0
86944|NCT00196976|306713|P11|Primary Study|Migrated from study area|0
86945|NCT00196976|306714|P10|Primary Study|Migrated from study area|0
86946|NCT00196976|306715|P9|Primary Study|Migrated from study area|0
86947|NCT00196976|306716|P8|Primary Study|Migrated from study area|1
86948|NCT00196976|306717|P7|Primary Study|Migrated from study area|0
86949|NCT00196976|306718|P6|Primary Study|Migrated from study area|0
86950|NCT00196976|306719|P5|Primary Study|Migrated from study area|0
86951|NCT00196976|306720|P4|Primary Study|Migrated from study area|0
86952|NCT00196976|306721|P3|Primary Study|Migrated from study area|0
86953|NCT00196976|306722|P2|Primary Study|Migrated from study area|0
86954|NCT00196976|306723|P1|Primary Study|Migrated from study area|0
86955|NCT00197002|306919|P3|Overall Study|Others|1
86956|NCT00197002|306920|P2|Overall Study|Others|1
86957|NCT00197002|306921|P1|Overall Study|Others|3
86958|NCT00197002|306919|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
86959|NCT00197002|306920|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
86960|NCT00197002|306921|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
86961|NCT00197002|306919|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
86962|NCT00197002|306920|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
86963|NCT00197002|306921|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
86964|NCT00197002|306919|P3|Overall Study|Migrated/moved from study area|1
86965|NCT00197002|306920|P2|Overall Study|Migrated/moved from study area|5
86966|NCT00197002|306921|P1|Overall Study|Migrated/moved from study area|3
86967|NCT00197002|306919|P3|Overall Study|Withdrawal by Subject|7
86968|NCT00197002|306920|P2|Overall Study|Withdrawal by Subject|5
86969|NCT00197002|306921|P1|Overall Study|Withdrawal by Subject|9
86970|NCT00197002|306919|P3|Overall Study|Protocol Violation|2
86971|NCT00197002|306920|P2|Overall Study|Protocol Violation|0
86972|NCT00197002|306921|P1|Overall Study|Protocol Violation|1
86973|NCT00197002|306919|P3|Overall Study|Adverse Event|0
86974|NCT00197002|306920|P2|Overall Study|Adverse Event|1
86975|NCT00197002|306921|P1|Overall Study|Adverse Event|0
86976|NCT00197015|306961|P3|Overall Study|Other|2
86977|NCT00197015|306962|P2|Overall Study|Other|3
86978|NCT00197015|306963|P1|Overall Study|Other|2
86979|NCT00197015|306961|P3|Overall Study|Lost to Follow-up|37
86980|NCT00197015|306962|P2|Overall Study|Lost to Follow-up|46
86981|NCT00197015|306963|P1|Overall Study|Lost to Follow-up|28
86982|NCT00197015|306961|P3|Overall Study|Withdrawal by Subject|34
86983|NCT00197015|306962|P2|Overall Study|Withdrawal by Subject|37
86984|NCT00197015|306963|P1|Overall Study|Withdrawal by Subject|17
86985|NCT00197015|306961|P3|Overall Study|Protocol Violation|3
86986|NCT00197015|306962|P2|Overall Study|Protocol Violation|3
86987|NCT00197015|306963|P1|Overall Study|Protocol Violation|0
86988|NCT00197015|306961|P3|Overall Study|Adverse Event|1
86989|NCT00197015|306962|P2|Overall Study|Adverse Event|0
86990|NCT00197015|306963|P1|Overall Study|Adverse Event|3
86991|NCT00197028|307021|P2|Overall Study|Unspecified|6
86992|NCT00197028|307022|P1|Overall Study|Unspecified|3
86993|NCT00197028|307021|P2|Overall Study|Lost to Follow-up|0
86994|NCT00197028|307022|P1|Overall Study|Lost to Follow-up|1
86995|NCT00197028|307021|P2|Overall Study|Withdrawal by Subject|12
86996|NCT00197028|307022|P1|Overall Study|Withdrawal by Subject|8
86997|NCT00197028|307021|P2|Overall Study|Protocol Violation|1
86998|NCT00197028|307022|P1|Overall Study|Protocol Violation|2
86999|NCT00197028|307021|P2|Overall Study|Adverse Event|2
87000|NCT00197028|307022|P1|Overall Study|Adverse Event|2
87001|NCT00199381|307062|P1|Overall Study|Study termination by Sponsor|323
87002|NCT00199381|307062|P1|Overall Study|Not including due to early termination|37
87003|NCT00199381|307062|P1|Overall Study|Lack of Efficacy|27
87004|NCT00199381|307062|P1|Overall Study|Protocol Violation|6
87005|NCT00199381|307062|P1|Overall Study|Adverse Event|73
87006|NCT00199381|307062|P1|Overall Study|Withdrawal by Subject|38
87007|NCT00200057|307075|P1|Overall Study|Death|1
87008|NCT00200057|307075|P1|Overall Study|Infection|1
87009|NCT00200057|307075|P1|Overall Study|Change in medical condition|1
87010|NCT00200057|307075|P1|Overall Study|Withdrawal by Subject|1
87011|NCT00200057|307075|P1|Overall Study|Exited due to terminal illness of PI|2
87012|NCT00200057|307075|P1|Overall Study|Lack of Efficacy|3
87013|NCT00200356|307115|P2|Overall Study|Nontreatment|0
87014|NCT00200356|307116|P1|Overall Study|Nontreatment|1
87015|NCT00200356|307115|P2|Overall Study|Protocol Violation|4
87016|NCT00200356|307116|P1|Overall Study|Protocol Violation|4
87017|NCT00200356|307115|P2|Overall Study|Lack of Efficacy|3
87018|NCT00200356|307116|P1|Overall Study|Lack of Efficacy|3
87019|NCT00200967|307153|P2|Run-out Period|Lost to Follow-up|0
87020|NCT00200967|307154|P1|Run-out Period|Lost to Follow-up|1
87021|NCT00200967|307153|P2|Second Treatment Period|Withdrawal by Subject|2
87022|NCT00200967|307154|P1|Second Treatment Period|Withdrawal by Subject|1
87023|NCT00200967|307153|P2|Wash-out Period|Lost to Follow-up|1
87024|NCT00200967|307154|P1|Wash-out Period|Lost to Follow-up|0
87025|NCT00200967|307153|P2|First Treatment Period|Pregnancy|0
87026|NCT00200967|307154|P1|First Treatment Period|Pregnancy|1
87027|NCT00200967|307153|P2|First Treatment Period|Withdrawal by Subject|1
87028|NCT00200967|307154|P1|First Treatment Period|Withdrawal by Subject|5
87029|NCT00201006|307185|P3|Overall Study|Adverse Event|1
87030|NCT00201006|307186|P2|Overall Study|Adverse Event|0
87031|NCT00201006|307187|P1|Overall Study|Adverse Event|1
87032|NCT00201006|307185|P3|Overall Study|Withdrawal by Subject|3
87033|NCT00201006|307186|P2|Overall Study|Withdrawal by Subject|2
87034|NCT00201006|307187|P1|Overall Study|Withdrawal by Subject|7
87035|NCT00201201|307216|P2|Overall Study|Withdrawal by Subject|5
87036|NCT00201201|307217|P1|Overall Study|Withdrawal by Subject|5
87037|NCT00201201|307216|P2|Overall Study|Death|2
87038|NCT00201201|307217|P1|Overall Study|Death|0
87039|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
87040|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
87041|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
87042|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
87043|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
87044|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
87045|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
87046|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
87131|NCT00191906|307380|P3|Study Period II|Withdrawal by Subject|0
87047|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
87048|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
87049|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
87050|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
87051|NCT00185211|307264|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
87052|NCT00185211|307265|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
87053|NCT00185211|307264|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
87054|NCT00185211|307265|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
87055|NCT00185211|307264|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
87056|NCT00185211|307265|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
87057|NCT00185211|307264|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
87058|NCT00185211|307265|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
87059|NCT00185211|307264|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
87060|NCT00185211|307265|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
87061|NCT00185211|307264|P2|Placebo-controlled Study (92012)|Adverse Event|0
87062|NCT00185211|307265|P1|Placebo-controlled Study (92012)|Adverse Event|8
87063|NCT00191724|307295|P5|Overall Study|Withdrawal by Subject|0
87064|NCT00191724|307296|P4|Overall Study|Withdrawal by Subject|1
87065|NCT00191724|307297|P3|Overall Study|Withdrawal by Subject|0
87066|NCT00191724|307298|P2|Overall Study|Withdrawal by Subject|0
87067|NCT00191724|307299|P1|Overall Study|Withdrawal by Subject|0
87068|NCT00191724|307295|P5|Overall Study|Lost to Follow-up|3
87069|NCT00191724|307296|P4|Overall Study|Lost to Follow-up|2
87070|NCT00191724|307297|P3|Overall Study|Lost to Follow-up|0
87071|NCT00191724|307298|P2|Overall Study|Lost to Follow-up|1
87072|NCT00191724|307299|P1|Overall Study|Lost to Follow-up|1
87073|NCT00191724|307295|P5|Overall Study|Adverse Event|0
87074|NCT00191724|307296|P4|Overall Study|Adverse Event|0
87075|NCT00191724|307297|P3|Overall Study|Adverse Event|1
87076|NCT00191724|307298|P2|Overall Study|Adverse Event|0
87077|NCT00191724|307299|P1|Overall Study|Adverse Event|0
87078|NCT00191789|307326|P1|Overall Study|Death - Not Study-Drug Related|1
87079|NCT00191789|307326|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
87080|NCT00191789|307326|P1|Overall Study|Death - Possibly Study Drug Related|4
87081|NCT00191789|307326|P1|Overall Study|Withdrawal by Subject|4
87082|NCT00191789|307326|P1|Overall Study|Patient/Physician: Satisfactory Response|4
87083|NCT00191789|307326|P1|Overall Study|Patient: Satisfactory Response|5
87084|NCT00191789|307326|P1|Overall Study|Adverse Event|5
87085|NCT00191815|307338|P1|Overall Study|Withdrawal by Subject|7
87086|NCT00191815|307338|P1|Overall Study|Physician Decision|2
87087|NCT00191815|307338|P1|Overall Study|Protocol Violation|3
87088|NCT00191815|307338|P1|Overall Study|Death|2
87089|NCT00191815|307338|P1|Overall Study|Disease progression or relapse|24
87090|NCT00191815|307338|P1|Overall Study|Adverse Event|2
87091|NCT00191854|307353|P3|Overall Study|Screen Failure|1
87092|NCT00191854|307354|P2|Overall Study|Screen Failure|0
87093|NCT00191854|307355|P1|Overall Study|Screen Failure|0
87094|NCT00191854|307353|P3|Overall Study|Sponsor Decision|1
87095|NCT00191854|307354|P2|Overall Study|Sponsor Decision|0
87096|NCT00191854|307355|P1|Overall Study|Sponsor Decision|0
87097|NCT00191854|307353|P3|Overall Study|Withdrawal by Subject|3
87098|NCT00191854|307354|P2|Overall Study|Withdrawal by Subject|2
87099|NCT00191854|307355|P1|Overall Study|Withdrawal by Subject|4
87100|NCT00191854|307353|P3|Overall Study|Lost to Follow-up|5
87101|NCT00191854|307354|P2|Overall Study|Lost to Follow-up|5
87102|NCT00191854|307355|P1|Overall Study|Lost to Follow-up|7
87103|NCT00191854|307353|P3|Overall Study|Death|29
87104|NCT00191854|307354|P2|Overall Study|Death|23
87105|NCT00191854|307355|P1|Overall Study|Death|26
87106|NCT00191906|307379|P4|Study Period III|Lack of Efficacy|0
87107|NCT00191906|307380|P3|Study Period III|Lack of Efficacy|0
87108|NCT00191906|307381|P2|Study Period III|Lack of Efficacy|3
87109|NCT00191906|307382|P1|Study Period III|Lack of Efficacy|3
87110|NCT00191906|307379|P4|Study Period III|Parent/Caregiver Decision|0
87111|NCT00191906|307380|P3|Study Period III|Parent/Caregiver Decision|0
87112|NCT00191906|307381|P2|Study Period III|Parent/Caregiver Decision|0
87113|NCT00191906|307382|P1|Study Period III|Parent/Caregiver Decision|1
87114|NCT00191906|307379|P4|Study Period III|Lost to Follow-up|0
87115|NCT00191906|307380|P3|Study Period III|Lost to Follow-up|0
87116|NCT00191906|307381|P2|Study Period III|Lost to Follow-up|1
87117|NCT00191906|307382|P1|Study Period III|Lost to Follow-up|0
87118|NCT00191906|307379|P4|Study Period III|Adverse Event|0
87119|NCT00191906|307380|P3|Study Period III|Adverse Event|0
87120|NCT00191906|307381|P2|Study Period III|Adverse Event|0
87121|NCT00191906|307382|P1|Study Period III|Adverse Event|1
87122|NCT00191906|307379|P4|Study Period II|Entry Criteria Exclusion|0
87123|NCT00191906|307380|P3|Study Period II|Entry Criteria Exclusion|1
87124|NCT00191906|307381|P2|Study Period II|Entry Criteria Exclusion|0
87125|NCT00191906|307382|P1|Study Period II|Entry Criteria Exclusion|0
87126|NCT00191906|307379|P4|Study Period II|Parent/Caregiver Decision|0
87127|NCT00191906|307380|P3|Study Period II|Parent/Caregiver Decision|0
87128|NCT00191906|307381|P2|Study Period II|Parent/Caregiver Decision|1
87129|NCT00191906|307382|P1|Study Period II|Parent/Caregiver Decision|0
87130|NCT00191906|307379|P4|Study Period II|Withdrawal by Subject|0
87132|NCT00191906|307381|P2|Study Period II|Withdrawal by Subject|3
87133|NCT00191906|307382|P1|Study Period II|Withdrawal by Subject|0
87134|NCT00191906|307379|P4|Study Period II|Adverse Event|0
87135|NCT00191906|307380|P3|Study Period II|Adverse Event|0
87136|NCT00191906|307381|P2|Study Period II|Adverse Event|1
87137|NCT00191906|307382|P1|Study Period II|Adverse Event|0
87138|NCT00191945|307424|P2|Double-Blind Acute Treatment|Physician Decision|2
87139|NCT00191945|307425|P1|Double-Blind Acute Treatment|Physician Decision|0
87140|NCT00191945|307424|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
87141|NCT00191945|307425|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
87142|NCT00191945|307424|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
87143|NCT00191945|307425|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
87144|NCT00191945|307424|P2|Double-Blind Acute Treatment|Parent's Decision|0
87145|NCT00191945|307425|P1|Double-Blind Acute Treatment|Parent's Decision|3
87146|NCT00191984|307457|P1|Overall Study|Physician Decision|4
87147|NCT00191984|307457|P1|Overall Study|Withdrawal by Subject|7
87148|NCT00191984|307457|P1|Overall Study|Entry Criteria Exclusion|1
87149|NCT00191984|307457|P1|Overall Study|Death|2
87150|NCT00191984|307457|P1|Overall Study|Adverse Event|4
87151|NCT00191984|307457|P1|Overall Study|Disease Progression|21
87152|NCT00192023|307467|P2|Period IV - Optional Open-Label|Physician Decision|0
87153|NCT00192023|307468|P1|Period IV - Optional Open-Label|Physician Decision|9
87154|NCT00192023|307467|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
87155|NCT00192023|307468|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
87156|NCT00192023|307467|P2|Period IV - Optional Open-Label|Protocol Violation|0
87157|NCT00192023|307468|P1|Period IV - Optional Open-Label|Protocol Violation|1
87158|NCT00192023|307467|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
87159|NCT00192023|307468|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
87160|NCT00192023|307467|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
87161|NCT00192023|307468|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
87162|NCT00192023|307467|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
87163|NCT00192023|307468|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
87164|NCT00192023|307467|P2|Period IV - Optional Open-Label|Adverse Event|0
87165|NCT00192023|307468|P1|Period IV - Optional Open-Label|Adverse Event|6
87166|NCT00192023|307467|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
87167|NCT00192023|307468|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
87168|NCT00192023|307467|P2|Period III - Double-Blind|Physician Decision|0
87169|NCT00192023|307468|P1|Period III - Double-Blind|Physician Decision|2
87170|NCT00192023|307467|P2|Period III - Double-Blind|Adverse Event|0
87171|NCT00192023|307468|P1|Period III - Double-Blind|Adverse Event|3
87172|NCT00192036|307490|P1|Overall Study|Unknown or Not Specified|5
87173|NCT00192036|307490|P1|Overall Study|Death|1
87174|NCT00192036|307490|P1|Overall Study|Clinical Disease Progression|1
87175|NCT00192036|307490|P1|Overall Study|Objective Tumor Progression|4
87176|NCT00192036|307490|P1|Overall Study|Patient/Physician Perception|1
87177|NCT00192036|307490|P1|Overall Study|Adverse Event|6
87178|NCT00192036|307490|P1|Overall Study|Protocol Violation|3
87179|NCT00192075|307500|P2|Overall Study|Other|2
87180|NCT00192075|307501|P1|Overall Study|Other|5
87181|NCT00192075|307500|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
87182|NCT00192075|307501|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
87183|NCT00192075|307500|P2|Overall Study|Patient Non-Compliance|1
87184|NCT00192075|307501|P1|Overall Study|Patient Non-Compliance|0
87185|NCT00192075|307500|P2|Overall Study|Withdrawal by Subject|5
87186|NCT00192075|307501|P1|Overall Study|Withdrawal by Subject|5
87187|NCT00192075|307500|P2|Overall Study|Physician Decision|0
87188|NCT00192075|307501|P1|Overall Study|Physician Decision|3
87189|NCT00192075|307500|P2|Overall Study|Lack of Efficacy|0
87190|NCT00192075|307501|P1|Overall Study|Lack of Efficacy|0
87191|NCT00192075|307500|P2|Overall Study|Death|1
87192|NCT00192075|307501|P1|Overall Study|Death|0
87193|NCT00192075|307500|P2|Overall Study|Adverse Event|3
87194|NCT00192075|307501|P1|Overall Study|Adverse Event|1
87195|NCT00192075|307500|P2|Overall Study|Disease Progression|6
87196|NCT00192075|307501|P1|Overall Study|Disease Progression|23
87197|NCT00192296|307530|P4|Overall Study|Withdrawal by Subject|0
87198|NCT00192296|307531|P3|Overall Study|Withdrawal by Subject|0
87199|NCT00192296|307532|P2|Overall Study|Withdrawal by Subject|1
87200|NCT00192296|307533|P1|Overall Study|Withdrawal by Subject|0
87201|NCT00192647|307589|P2|Overall Study|Other/Administrative|3
87202|NCT00192647|307590|P1|Overall Study|Other/Administrative|5
87203|NCT00192647|307589|P2|Overall Study|Failure to Return|13
87204|NCT00192647|307590|P1|Overall Study|Failure to Return|11
87205|NCT00192647|307589|P2|Overall Study|Refused Treatment/Did not Cooperate|8
87206|NCT00192647|307590|P1|Overall Study|Refused Treatment/Did not Cooperate|10
87207|NCT00192647|307589|P2|Overall Study|Protocol Violation|1
87208|NCT00192647|307590|P1|Overall Study|Protocol Violation|3
87209|NCT00192647|307589|P2|Overall Study|Entry Criteria Violation|6
87210|NCT00192647|307590|P1|Overall Study|Entry Criteria Violation|6
87211|NCT00192647|307589|P2|Overall Study|Insufficient Therapeutic Response|83
87212|NCT00192647|307590|P1|Overall Study|Insufficient Therapeutic Response|53
87213|NCT00192647|307589|P2|Overall Study|Laboratory Test Abnormality|2
87214|NCT00192647|307590|P1|Overall Study|Laboratory Test Abnormality|4
87215|NCT00192647|307589|P2|Overall Study|Adverse Event|29
87216|NCT00192647|307590|P1|Overall Study|Adverse Event|35
87217|NCT00192647|307589|P2|Overall Study|Death|1
87218|NCT00192647|307590|P1|Overall Study|Death|1
87219|NCT00193050|307617|P1|Adjuvant|Lack of Efficacy|2
87220|NCT00193050|307617|P1|Adjuvant|Intercurrent Hospitalization|3
87221|NCT00193050|307617|P1|Adjuvant|Physician Decision|5
87222|NCT00193050|307617|P1|Neoadjuvant Treatment|Adverse Event|2
87223|NCT00193050|307617|P1|Neoadjuvant Treatment|Physician Decision|2
87224|NCT00193050|307617|P1|Neoadjuvant Treatment|Intercurrent Illness|3
87225|NCT00193050|307617|P1|Neoadjuvant Treatment|Lack of Efficacy|2
87226|NCT00193063|307621|P1|Overall Study|Adverse Event|1
87227|NCT00193063|307621|P1|Overall Study|Lack of Efficacy|3
87228|NCT00193180|307636|P1|Overall Study|Protocol Violation|1
87229|NCT00193180|307636|P1|Overall Study|Adverse Event|8
87230|NCT00193180|307636|P1|Overall Study|Lack of Efficacy|1
87231|NCT00193206|307642|P1|Postoperative Therapy|Protocol Violation|1
87232|NCT00193206|307642|P1|Postoperative Therapy|Lack of Efficacy|1
87233|NCT00193206|307642|P1|Postoperative Therapy|Intercurrent Illness|2
87234|NCT00193206|307642|P1|Postoperative Therapy|Physician Decision|3
87235|NCT00193206|307642|P1|Postoperative Therapy|Withdrawal by Subject|7
87236|NCT00193206|307642|P1|Preoperative Therapy|False Positive Pregnancy Test|1
87237|NCT00193206|307642|P1|Preoperative Therapy|Withdrawal by Subject|2
87238|NCT00193206|307642|P1|Preoperative Therapy|Adverse Event|2
87239|NCT00193206|307642|P1|Preoperative Therapy|Lack of Efficacy|2
87240|NCT00193479|307683|P1|Induction Chemotherapy|Disease Progression|1
87241|NCT00193479|307683|P1|Induction Chemotherapy|Adverse Event|2
87242|NCT00193609|307709|P1|Overall Study|Adverse Event|2
87243|NCT00193609|307709|P1|Overall Study|Lack of Efficacy|2
87244|NCT00194012|307716|P2|Open Label Extension (OLE)|Lack of Efficacy|0
87245|NCT00194012|307717|P1|Open Label Extension (OLE)|Lack of Efficacy|1
87246|NCT00194012|307716|P2|Open Label Extension (OLE)|Lost to Follow-up|5
87247|NCT00194012|307717|P1|Open Label Extension (OLE)|Lost to Follow-up|3
87248|NCT00194012|307716|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
87249|NCT00194012|307717|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
87250|NCT00194012|307716|P2|Open Label Extension (OLE)|Weight Gain|0
87251|NCT00194012|307717|P1|Open Label Extension (OLE)|Weight Gain|1
87252|NCT00194012|307716|P2|Randomized Phase|Oral/nasal twitching|1
87253|NCT00194012|307717|P1|Randomized Phase|Oral/nasal twitching|0
87254|NCT00194012|307716|P2|Randomized Phase|Emesis and enuresis|1
87255|NCT00194012|307717|P1|Randomized Phase|Emesis and enuresis|0
87256|NCT00194012|307716|P2|Randomized Phase|Participant reported having a rash|0
87257|NCT00194012|307717|P1|Randomized Phase|Participant reported having a rash|1
87258|NCT00194012|307716|P2|Randomized Phase|Adverse Event|1
87259|NCT00194012|307717|P1|Randomized Phase|Adverse Event|2
87260|NCT00194012|307716|P2|Randomized Phase|Withdrawal by Subject|3
87261|NCT00194012|307717|P1|Randomized Phase|Withdrawal by Subject|3
87262|NCT00194012|307716|P2|Randomized Phase|Study nonadherence|1
87263|NCT00194012|307717|P1|Randomized Phase|Study nonadherence|2
87264|NCT00194012|307716|P2|Randomized Phase|Lack of Efficacy|18
87265|NCT00194012|307717|P1|Randomized Phase|Lack of Efficacy|8
87266|NCT00194025|307753|P1|Overall Study|non-adherence with study medication|4
87267|NCT00194025|307753|P1|Overall Study|Adverse Event|1
87268|NCT00194077|307768|P2|Overall Study|Withdrawal by Subject|1
87269|NCT00194077|307769|P1|Overall Study|Withdrawal by Subject|1
87270|NCT00194077|307768|P2|Overall Study|Study nonadherence|0
87271|NCT00194077|307769|P1|Overall Study|Study nonadherence|1
87272|NCT00194077|307768|P2|Overall Study|Lack of Efficacy|29
87273|NCT00194077|307769|P1|Overall Study|Lack of Efficacy|22
87274|NCT00201643|307797|P2|Overall Study|Withdrawal by Subject|4
87275|NCT00201643|307798|P1|Overall Study|Withdrawal by Subject|5
87276|NCT00202839|307871|P2|Overall Study|Lost to Follow-up|2
87277|NCT00202839|307872|P1|Overall Study|Lost to Follow-up|3
87278|NCT00202839|307871|P2|Overall Study|Protocol Violation|1
87279|NCT00202839|307872|P1|Overall Study|Protocol Violation|2
87280|NCT00202839|307871|P2|Overall Study|Withdrawal by Subject|2
87281|NCT00202839|307872|P1|Overall Study|Withdrawal by Subject|6
87282|NCT00202839|307871|P2|Overall Study|Physician Decision|0
87283|NCT00202839|307872|P1|Overall Study|Physician Decision|12
87284|NCT00202839|307871|P2|Overall Study|Adverse Event|5
87285|NCT00202839|307872|P1|Overall Study|Adverse Event|1
87286|NCT00202878|307882|P2|Overall Study|Withdrawal by Subject|808
87287|NCT00202878|307883|P1|Overall Study|Withdrawal by Subject|795
87288|NCT00202878|307882|P2|Overall Study|Site Closure|36
87289|NCT00202878|307883|P1|Overall Study|Site Closure|39
87290|NCT00202878|307882|P2|Overall Study|Lost to Follow-up|49
87291|NCT00202878|307883|P1|Overall Study|Lost to Follow-up|44
87292|NCT00202878|307882|P2|Overall Study|Only Vital Status Known|356
87293|NCT00202878|307883|P1|Overall Study|Only Vital Status Known|357
87294|NCT00202878|307882|P2|Overall Study|Death|968
87295|NCT00202878|307883|P1|Overall Study|Death|964
87296|NCT00203047|307897|P2|Overall Study|Not specified|5
87297|NCT00203047|307898|P1|Overall Study|Not specified|5
87298|NCT00203047|307897|P2|Overall Study|Pregnancy|0
87299|NCT00203047|307898|P1|Overall Study|Pregnancy|3
87300|NCT00203047|307897|P2|Overall Study|Death|2
87301|NCT00203047|307898|P1|Overall Study|Death|1
87302|NCT00203047|307897|P2|Overall Study|Adverse Event|18
87303|NCT00203047|307898|P1|Overall Study|Adverse Event|8
87304|NCT00203047|307897|P2|Overall Study|Lost to Follow-up|5
87305|NCT00203047|307898|P1|Overall Study|Lost to Follow-up|11
87306|NCT00203047|307897|P2|Overall Study|Protocol Violation|0
87307|NCT00203047|307898|P1|Overall Study|Protocol Violation|1
87308|NCT00203047|307897|P2|Overall Study|Non-compliance|8
87309|NCT00203047|307898|P1|Overall Study|Non-compliance|4
87310|NCT00203047|307897|P2|Overall Study|Physician Decision|7
87311|NCT00203047|307898|P1|Overall Study|Physician Decision|8
87312|NCT00203047|307897|P2|Overall Study|Teva requested participant withdrawal|1
87313|NCT00203047|307898|P1|Overall Study|Teva requested participant withdrawal|1
87314|NCT00203047|307897|P2|Overall Study|Withdrawal by Subject|47
87315|NCT00203047|307898|P1|Overall Study|Withdrawal by Subject|13
87316|NCT00203047|307897|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
87317|NCT00203047|307898|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
87318|NCT00203047|307897|P2|Overall Study|Ongoing: in database - January 29, 2009|109
87319|NCT00203047|307898|P1|Overall Study|Ongoing: in database - January 29, 2009|131
87320|NCT00203242|307956|P1|Overall Study|Lost to Follow-up|1
87321|NCT00203268|307960|P1|Early Treatment|Withdrawal by Subject|1
87322|NCT00203268|307960|P1|Early Treatment|Lost to Follow-up|1
87323|NCT00203268|307960|P1|Early Treatment|only treated one headache|2
87324|NCT00203294|307968|P2|Overall Study|Withdrawal by Subject|13
87325|NCT00203294|307969|P1|Overall Study|Withdrawal by Subject|8
87326|NCT00203307|307977|P2|First Intervention|Adverse Event|0
87327|NCT00203307|307978|P1|First Intervention|Adverse Event|2
87328|NCT00203411|307984|P1|Follow-up|Progressive Disease|4
87329|NCT00203424|307991|P1|Follow-up Period|Lost to Follow-up|1
87330|NCT00203424|307991|P1|Follow-up Period|progressive disease|4
87331|NCT00203424|307991|P1|Follow-up Period|Withdrawal by Subject|1
87332|NCT00203424|307991|P1|Treatment Period|progressive disease|2
87333|NCT00203424|307991|P1|Treatment Period|Adverse Event|5
87334|NCT00203424|307991|P1|Treatment Period|Withdrawal by Subject|4
87335|NCT00203476|308001|P3|Overall Study|Withdrawal by Subject|0
87336|NCT00203476|308002|P2|Overall Study|Withdrawal by Subject|1
87337|NCT00203476|308003|P1|Overall Study|Withdrawal by Subject|0
87338|NCT00203476|308001|P3|Overall Study|Lost to Follow-up|0
87339|NCT00203476|308002|P2|Overall Study|Lost to Follow-up|0
87340|NCT00203476|308003|P1|Overall Study|Lost to Follow-up|1
87341|NCT00203502|308020|P1|Overall Study|Death|1
87342|NCT00203892|308031|P3|Overall Study|Death|0
87343|NCT00203892|308032|P2|Overall Study|Death|0
87344|NCT00203892|308033|P1|Overall Study|Death|1
87345|NCT00203892|308031|P3|Overall Study|Physician Decision|0
87346|NCT00203892|308032|P2|Overall Study|Physician Decision|2
87347|NCT00203892|308033|P1|Overall Study|Physician Decision|1
87348|NCT00203996|308067|P10|Overall Study|Scheduling issue|0
87349|NCT00203996|308068|P9|Overall Study|Scheduling issue|0
87350|NCT00203996|308069|P8|Overall Study|Scheduling issue|2
87351|NCT00203996|308070|P7|Overall Study|Scheduling issue|0
87352|NCT00203996|308071|P6|Overall Study|Scheduling issue|0
87353|NCT00203996|308072|P5|Overall Study|Scheduling issue|0
87354|NCT00203996|308073|P4|Overall Study|Scheduling issue|0
87355|NCT00203996|308074|P3|Overall Study|Scheduling issue|0
87356|NCT00203996|308075|P2|Overall Study|Scheduling issue|0
87357|NCT00203996|308076|P1|Overall Study|Scheduling issue|0
87358|NCT00203996|308067|P10|Overall Study|CPAP machine malfunction|0
87359|NCT00203996|308068|P9|Overall Study|CPAP machine malfunction|0
87360|NCT00203996|308069|P8|Overall Study|CPAP machine malfunction|0
87361|NCT00203996|308070|P7|Overall Study|CPAP machine malfunction|0
87362|NCT00203996|308071|P6|Overall Study|CPAP machine malfunction|0
87363|NCT00203996|308072|P5|Overall Study|CPAP machine malfunction|0
87364|NCT00203996|308073|P4|Overall Study|CPAP machine malfunction|1
87365|NCT00203996|308074|P3|Overall Study|CPAP machine malfunction|0
87366|NCT00203996|308075|P2|Overall Study|CPAP machine malfunction|0
87367|NCT00203996|308076|P1|Overall Study|CPAP machine malfunction|0
87368|NCT00203996|308067|P10|Overall Study|Physician Decision|1
87369|NCT00203996|308068|P9|Overall Study|Physician Decision|0
87370|NCT00203996|308069|P8|Overall Study|Physician Decision|0
87371|NCT00203996|308070|P7|Overall Study|Physician Decision|0
87372|NCT00203996|308071|P6|Overall Study|Physician Decision|0
87373|NCT00203996|308072|P5|Overall Study|Physician Decision|0
87374|NCT00203996|308073|P4|Overall Study|Physician Decision|2
87375|NCT00203996|308074|P3|Overall Study|Physician Decision|0
87376|NCT00203996|308075|P2|Overall Study|Physician Decision|0
87377|NCT00203996|308076|P1|Overall Study|Physician Decision|0
87378|NCT00203996|308067|P10|Overall Study|Protocol Violation|0
87379|NCT00203996|308068|P9|Overall Study|Protocol Violation|0
87380|NCT00203996|308069|P8|Overall Study|Protocol Violation|0
87381|NCT00203996|308070|P7|Overall Study|Protocol Violation|0
87382|NCT00203996|308071|P6|Overall Study|Protocol Violation|0
87383|NCT00203996|308072|P5|Overall Study|Protocol Violation|1
87384|NCT00203996|308073|P4|Overall Study|Protocol Violation|6
87385|NCT00203996|308074|P3|Overall Study|Protocol Violation|0
87386|NCT00203996|308075|P2|Overall Study|Protocol Violation|0
87387|NCT00203996|308076|P1|Overall Study|Protocol Violation|0
87388|NCT00203996|308067|P10|Overall Study|Lost to Follow-up|0
87389|NCT00203996|308068|P9|Overall Study|Lost to Follow-up|0
87390|NCT00203996|308069|P8|Overall Study|Lost to Follow-up|0
87391|NCT00203996|308070|P7|Overall Study|Lost to Follow-up|0
87392|NCT00203996|308071|P6|Overall Study|Lost to Follow-up|0
87393|NCT00203996|308072|P5|Overall Study|Lost to Follow-up|0
87394|NCT00203996|308073|P4|Overall Study|Lost to Follow-up|1
87395|NCT00203996|308074|P3|Overall Study|Lost to Follow-up|0
87396|NCT00203996|308075|P2|Overall Study|Lost to Follow-up|0
87397|NCT00203996|308076|P1|Overall Study|Lost to Follow-up|0
87398|NCT00185588|308132|P4|Overall Study|Physician Decision|0
87399|NCT00185588|308133|P3|Overall Study|Physician Decision|1
87400|NCT00185588|308134|P2|Overall Study|Physician Decision|0
87401|NCT00185588|308135|P1|Overall Study|Physician Decision|0
87402|NCT00185588|308132|P4|Overall Study|Withdrawal by Subject|0
87403|NCT00185588|308133|P3|Overall Study|Withdrawal by Subject|0
87404|NCT00185588|308134|P2|Overall Study|Withdrawal by Subject|1
87405|NCT00185588|308135|P1|Overall Study|Withdrawal by Subject|0
87406|NCT00185588|308132|P4|Overall Study|Lost to Follow-up|2
87407|NCT00185588|308133|P3|Overall Study|Lost to Follow-up|1
87408|NCT00185588|308134|P2|Overall Study|Lost to Follow-up|0
87409|NCT00185588|308135|P1|Overall Study|Lost to Follow-up|0
87410|NCT00185588|308132|P4|Overall Study|Adverse Event|2
87411|NCT00185588|308133|P3|Overall Study|Adverse Event|4
87412|NCT00185588|308134|P2|Overall Study|Adverse Event|1
87413|NCT00185588|308135|P1|Overall Study|Adverse Event|3
87414|NCT00185965|308162|P2|Overall Study|Adverse Event|1
87415|NCT00185965|308163|P1|Overall Study|Adverse Event|0
87416|NCT00186186|308206|P1|Overall Study|Not reported as to reason|2
87417|NCT00186186|308206|P1|Overall Study|Withdrawal by Subject|3
87418|NCT00186186|308206|P1|Overall Study|Lack of Efficacy|3
87419|NCT00197106|308213|P3|Overall Treatment Period|Withdrawal by Subject|2
87420|NCT00197106|308214|P2|Overall Treatment Period|Withdrawal by Subject|0
87421|NCT00197106|308215|P1|Overall Treatment Period|Withdrawal by Subject|0
87422|NCT00197106|308213|P3|Overall Treatment Period|Protocol Violation|2
87423|NCT00197106|308214|P2|Overall Treatment Period|Protocol Violation|0
87424|NCT00197106|308215|P1|Overall Treatment Period|Protocol Violation|0
87425|NCT00197106|308213|P3|Overall Treatment Period|Lost to Follow-up|2
87426|NCT00197106|308214|P2|Overall Treatment Period|Lost to Follow-up|0
87427|NCT00197106|308215|P1|Overall Treatment Period|Lost to Follow-up|0
87428|NCT00197106|308213|P3|Overall Treatment Period|Lack of Efficacy|0
87429|NCT00197106|308214|P2|Overall Treatment Period|Lack of Efficacy|1
87430|NCT00197106|308215|P1|Overall Treatment Period|Lack of Efficacy|0
87431|NCT00197106|308213|P3|4-Week Run-In Period|Did not meet entry criteria|0
87432|NCT00197106|308214|P2|4-Week Run-In Period|Did not meet entry criteria|0
87433|NCT00197106|308215|P1|4-Week Run-In Period|Did not meet entry criteria|99
87434|NCT00197236|308290|P3|Overall Study|Returned out of specified time window|1
87435|NCT00197236|308291|P2|Overall Study|Returned out of specified time window|0
87436|NCT00197236|308292|P1|Overall Study|Returned out of specified time window|0
87437|NCT00197236|308290|P3|Overall Study|Study drug/medication expiration|3
87438|NCT00197236|308291|P2|Overall Study|Study drug/medication expiration|0
87439|NCT00197236|308292|P1|Overall Study|Study drug/medication expiration|1
87440|NCT00197236|308290|P3|Overall Study|Withdrawal by Subject|11
87441|NCT00197236|308291|P2|Overall Study|Withdrawal by Subject|3
87442|NCT00197236|308292|P1|Overall Study|Withdrawal by Subject|7
87443|NCT00197236|308290|P3|Overall Study|Protocol Violation|1
87444|NCT00197236|308291|P2|Overall Study|Protocol Violation|0
87445|NCT00197236|308292|P1|Overall Study|Protocol Violation|0
87446|NCT00197236|308290|P3|Overall Study|Lost to Follow-up|6
87447|NCT00197236|308291|P2|Overall Study|Lost to Follow-up|14
87448|NCT00197236|308292|P1|Overall Study|Lost to Follow-up|5
87449|NCT00197236|308290|P3|Overall Study|Adverse Event|1
87450|NCT00197236|308291|P2|Overall Study|Adverse Event|0
87451|NCT00197236|308292|P1|Overall Study|Adverse Event|1
87452|NCT00197496|308373|P2|Follow-up|Lost to Follow-up|1
87453|NCT00197496|308374|P1|Follow-up|Lost to Follow-up|2
87454|NCT00197496|308373|P2|Baseline to Discharge|Protocol Violation|1
87455|NCT00197496|308374|P1|Baseline to Discharge|Protocol Violation|0
87456|NCT00197496|308373|P2|Baseline to Discharge|Physician Decision|1
87457|NCT00197496|308374|P1|Baseline to Discharge|Physician Decision|0
87458|NCT00197496|308373|P2|Baseline to Discharge|MRSA|0
87459|NCT00197496|308374|P1|Baseline to Discharge|MRSA|1
87460|NCT00197496|308373|P2|Baseline to Discharge|not interested|0
87461|NCT00197496|308374|P1|Baseline to Discharge|not interested|1
87462|NCT00198029|308387|P1|Overall Study|Withdrawal by Subject|4
87463|NCT00198133|308427|P2|Overall Study|Physician Decision|0
87464|NCT00198133|308428|P1|Overall Study|Physician Decision|1
87465|NCT00198133|308427|P2|Overall Study|Withdrawal by Subject|0
87466|NCT00198133|308428|P1|Overall Study|Withdrawal by Subject|1
87467|NCT00198133|308427|P2|Overall Study|Adverse Event|3
87468|NCT00198133|308428|P1|Overall Study|Adverse Event|1
87469|NCT00198133|308427|P2|Overall Study|Disease progression|5
87470|NCT00198133|308428|P1|Overall Study|Disease progression|2
87471|NCT00198822|308441|P3|Overall Study|Lost to Follow-up|21
87472|NCT00198822|308442|P2|Overall Study|Lost to Follow-up|20
87473|NCT00198822|308443|P1|Overall Study|Lost to Follow-up|14
87474|NCT00209339|308478|P1|At 5 Years Follow-up|Death|1
87475|NCT00209339|308478|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
87476|NCT00209339|308478|P1|At 5 Years Follow-up|Withdrawal by Subject|2
87477|NCT00209339|308478|P1|At 4 Years Follow-up|Death|1
87478|NCT00209339|308478|P1|At 4 Years Follow-up|Withdrawal by Subject|4
87479|NCT00209339|308478|P1|At 3 Years Follow-up|Withdrawal by Subject|1
87480|NCT00209339|308478|P1|At 24 Months Follow-up|Death|1
87481|NCT00209339|308478|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
87482|NCT00209339|308478|P1|At 24 Months Follow-up|Withdrawal by Subject|4
87483|NCT00209339|308478|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
87484|NCT00209339|308478|P1|At 12 Months Follow-up|Death|1
87485|NCT00209339|308478|P1|At 12 Months Follow-up|Withdrawal by Subject|8
87486|NCT00209560|308573|P2|Overall Study|Lack of Efficacy|0
87487|NCT00209560|308574|P1|Overall Study|Lack of Efficacy|1
87488|NCT00210470|308582|P1|Overall Study|Subject did not continue to surgery|1
87489|NCT00210626|308588|P2|Overall Study|Not Specified|5
87490|NCT00210626|308589|P1|Overall Study|Not Specified|4
87491|NCT00210626|308588|P2|Overall Study|Sponser Request|0
87492|NCT00210626|308589|P1|Overall Study|Sponser Request|1
87493|NCT00210626|308588|P2|Overall Study|Physician Decision|2
87494|NCT00210626|308589|P1|Overall Study|Physician Decision|0
87495|NCT00210626|308588|P2|Overall Study|Withdrawal by Subject|20
87496|NCT00210626|308589|P1|Overall Study|Withdrawal by Subject|29
87497|NCT00210626|308588|P2|Overall Study|Death|0
87498|NCT00210626|308589|P1|Overall Study|Death|1
87499|NCT00210626|308588|P2|Overall Study|Lost to Follow-up|11
87500|NCT00210626|308589|P1|Overall Study|Lost to Follow-up|11
87501|NCT00210626|308588|P2|Overall Study|Protocol Violation|5
87502|NCT00210626|308589|P1|Overall Study|Protocol Violation|1
87503|NCT00210626|308588|P2|Overall Study|Adverse Event|2
87504|NCT00210626|308589|P1|Overall Study|Adverse Event|1
87505|NCT00210639|308599|P2|Overall Study|Not specified|12
87506|NCT00210639|308600|P1|Overall Study|Not specified|18
87507|NCT00210639|308599|P2|Overall Study|Withdrawal by Subject|1
87508|NCT00210639|308600|P1|Overall Study|Withdrawal by Subject|8
87509|NCT00210639|308599|P2|Overall Study|Lost to Follow-up|29
87510|NCT00210639|308600|P1|Overall Study|Lost to Follow-up|37
87511|NCT00211081|308606|P1|Overall Study|Withdrawal by Subject|2
87512|NCT00211172|308612|P2|Overall Study|Died or lost health plan eligibility|32
87513|NCT00211172|308613|P1|Overall Study|Died or lost health plan eligibility|39
87514|NCT00211237|308621|P3|12 Months|unrelated medical problem|1
87515|NCT00211237|308622|P2|12 Months|unrelated medical problem|0
87516|NCT00211237|308623|P1|12 Months|unrelated medical problem|0
87517|NCT00211237|308621|P3|12 Months|Withdrew|1
87518|NCT00211237|308622|P2|12 Months|Withdrew|0
87519|NCT00211237|308623|P1|12 Months|Withdrew|0
87520|NCT00211237|308621|P3|12 Months|Lost to Follow-up|1
87521|NCT00211237|308622|P2|12 Months|Lost to Follow-up|0
87522|NCT00211237|308623|P1|12 Months|Lost to Follow-up|1
87523|NCT00211237|308621|P3|12 Months|Death|3
87524|NCT00211237|308622|P2|12 Months|Death|2
87525|NCT00211237|308623|P1|12 Months|Death|8
87526|NCT00211237|308621|P3|6 Months|Could not comply with protocol|0
87527|NCT00211237|308622|P2|6 Months|Could not comply with protocol|2
87528|NCT00211237|308623|P1|6 Months|Could not comply with protocol|0
87529|NCT00211237|308621|P3|6 Months|Lost to Follow-up|0
87530|NCT00211237|308622|P2|6 Months|Lost to Follow-up|0
87531|NCT00211237|308623|P1|6 Months|Lost to Follow-up|2
87532|NCT00211237|308621|P3|6 Months|Death|3
87533|NCT00211237|308622|P2|6 Months|Death|0
87534|NCT00211237|308623|P1|6 Months|Death|6
87535|NCT00211237|308621|P3|3 Months|Non-medical problem|1
87536|NCT00211237|308622|P2|3 Months|Non-medical problem|0
87537|NCT00211237|308623|P1|3 Months|Non-medical problem|0
87538|NCT00211237|308621|P3|3 Months|Withdrew|0
87539|NCT00211237|308622|P2|3 Months|Withdrew|1
87540|NCT00211237|308623|P1|3 Months|Withdrew|0
87541|NCT00211237|308621|P3|3 Months|Could not comply with protocol|0
87542|NCT00211237|308622|P2|3 Months|Could not comply with protocol|0
87543|NCT00211237|308623|P1|3 Months|Could not comply with protocol|1
87544|NCT00211237|308621|P3|3 Months|Death|0
87545|NCT00211237|308622|P2|3 Months|Death|3
87546|NCT00211237|308623|P1|3 Months|Death|7
87547|NCT00211237|308621|P3|1 Month|Non-medical problem|0
87548|NCT00211237|308622|P2|1 Month|Non-medical problem|2
87549|NCT00211237|308623|P1|1 Month|Non-medical problem|0
87550|NCT00211237|308621|P3|1 Month|Additional surgery needed|0
87551|NCT00211237|308622|P2|1 Month|Additional surgery needed|0
87552|NCT00211237|308623|P1|1 Month|Additional surgery needed|1
87553|NCT00211237|308621|P3|1 Month|Withdrew|0
87554|NCT00211237|308622|P2|1 Month|Withdrew|4
87555|NCT00211237|308623|P1|1 Month|Withdrew|0
87556|NCT00211237|308621|P3|1 Month|Lost to Follow-up|0
87557|NCT00211237|308622|P2|1 Month|Lost to Follow-up|2
87558|NCT00211237|308623|P1|1 Month|Lost to Follow-up|0
87559|NCT00211237|308621|P3|1 Month|Death|0
87560|NCT00211237|308622|P2|1 Month|Death|1
87561|NCT00211237|308623|P1|1 Month|Death|2
87562|NCT00211237|308621|P3|Baseline|Refused random assignment|0
87563|NCT00211237|308622|P2|Baseline|Refused random assignment|0
87564|NCT00211237|308623|P1|Baseline|Refused random assignment|1
87565|NCT00211237|308621|P3|Baseline|Withdrew|0
87566|NCT00211237|308622|P2|Baseline|Withdrew|3
87567|NCT00211237|308623|P1|Baseline|Withdrew|1
87568|NCT00211510|308715|P2|Overall Study|Withdrawal by Subject|1
87569|NCT00211510|308716|P1|Overall Study|Withdrawal by Subject|3
87570|NCT00211510|308715|P2|Overall Study|Physician Decision|1
87571|NCT00211510|308716|P1|Overall Study|Physician Decision|3
87572|NCT00211536|308734|P2|Overall Study|Adverse Event|0
87573|NCT00211536|308735|P1|Overall Study|Adverse Event|2
87574|NCT00211536|308734|P2|Overall Study|Physician Decision|5
87575|NCT00211536|308735|P1|Overall Study|Physician Decision|0
87576|NCT00211536|308734|P2|Overall Study|Withdrawal by Subject|2
87577|NCT00211536|308735|P1|Overall Study|Withdrawal by Subject|2
87578|NCT00185380|308763|P3|Overall Study|personal reason|1
87579|NCT00185380|308764|P2|Overall Study|personal reason|1
87580|NCT00185380|308765|P1|Overall Study|personal reason|6
87581|NCT00185380|308763|P3|Overall Study|Could not attend visits|4
87582|NCT00185380|308764|P2|Overall Study|Could not attend visits|0
87583|NCT00185380|308765|P1|Overall Study|Could not attend visits|2
87584|NCT00185380|308763|P3|Overall Study|No need for contraception|3
87585|NCT00185380|308764|P2|Overall Study|No need for contraception|3
87586|NCT00185380|308765|P1|Overall Study|No need for contraception|3
87587|NCT00185380|308763|P3|Overall Study|Planned pregnancy|12
87588|NCT00185380|308764|P2|Overall Study|Planned pregnancy|12
87589|NCT00185380|308765|P1|Overall Study|Planned pregnancy|9
87590|NCT00185380|308763|P3|Overall Study|Failed insertion|2
87591|NCT00185380|308764|P2|Overall Study|Failed insertion|1
87592|NCT00185380|308765|P1|Overall Study|Failed insertion|1
87593|NCT00185380|308763|P3|Overall Study|Withdrawal by Subject|0
87594|NCT00185380|308764|P2|Overall Study|Withdrawal by Subject|2
87595|NCT00185380|308765|P1|Overall Study|Withdrawal by Subject|1
87596|NCT00185380|308763|P3|Overall Study|Protocol Violation|1
87597|NCT00185380|308764|P2|Overall Study|Protocol Violation|2
87598|NCT00185380|308765|P1|Overall Study|Protocol Violation|2
87599|NCT00185380|308763|P3|Overall Study|Pregnancy|0
87600|NCT00185380|308764|P2|Overall Study|Pregnancy|4
87601|NCT00185380|308765|P1|Overall Study|Pregnancy|1
87602|NCT00185380|308763|P3|Overall Study|Lost to Follow-up|3
87603|NCT00185380|308764|P2|Overall Study|Lost to Follow-up|4
87604|NCT00185380|308765|P1|Overall Study|Lost to Follow-up|0
87605|NCT00185380|308763|P3|Overall Study|Adverse Event|48
87606|NCT00185380|308764|P2|Overall Study|Adverse Event|43
87607|NCT00185380|308765|P1|Overall Study|Adverse Event|41
87608|NCT00185458|308791|P1|HRT Phase|Withdrawal by Subject|3
87609|NCT00185458|308791|P1|HRT Phase|Protocol Violation|2
87610|NCT00185458|308791|P1|HRT Phase|Lost to Follow-up|4
87611|NCT00185458|308791|P1|HRT Phase|Adverse Event|18
87612|NCT00185458|308791|P1|Contraception Phase|Withdrawal by Subject|7
87613|NCT00185458|308791|P1|Contraception Phase|Physician Decision|2
87614|NCT00185458|308791|P1|Contraception Phase|Protocol Violation|2
87615|NCT00185458|308791|P1|Contraception Phase|Lost to Follow-up|10
87616|NCT00185458|308791|P1|Contraception Phase|Adverse Event|37
87617|NCT00201851|308878|P3|Overall Study|Ineligible post enrollment|1
87618|NCT00201851|308879|P2|Overall Study|Ineligible post enrollment|1
87619|NCT00201851|308880|P1|Overall Study|Ineligible post enrollment|6
87620|NCT00201851|308878|P3|Overall Study|Lost to Follow-up|0
87621|NCT00201851|308879|P2|Overall Study|Lost to Follow-up|1
87622|NCT00201851|308880|P1|Overall Study|Lost to Follow-up|2
87623|NCT00211809|308902|P1|Overall Study|side effects|2
87624|NCT00211809|308902|P1|Overall Study|Pregnancy|1
87625|NCT00211809|308902|P1|Overall Study|Lost to Follow-up|2
87626|NCT00211809|308902|P1|Overall Study|Lack of Efficacy|1
87627|NCT00211887|308919|P3|Overall Study|Side effects|5
87628|NCT00211887|308920|P2|Overall Study|Side effects|13
87629|NCT00211887|308921|P1|Overall Study|Side effects|19
87630|NCT00211887|308919|P3|Overall Study|Other medical reason|7
87631|NCT00211887|308920|P2|Overall Study|Other medical reason|11
87632|NCT00211887|308921|P1|Overall Study|Other medical reason|15
87633|NCT00211887|308919|P3|Overall Study|Non-medical reason|8
87634|NCT00211887|308920|P2|Overall Study|Non-medical reason|14
87635|NCT00211887|308921|P1|Overall Study|Non-medical reason|31
87636|NCT00211887|308919|P3|Overall Study|Lost to Follow-up|9
87637|NCT00211887|308920|P2|Overall Study|Lost to Follow-up|13
87638|NCT00211887|308921|P1|Overall Study|Lost to Follow-up|28
87639|NCT00211887|308919|P3|Overall Study|Death|1
87640|NCT00211887|308920|P2|Overall Study|Death|1
87641|NCT00211887|308921|P1|Overall Study|Death|1
87642|NCT00211887|308919|P3|Overall Study|Adverse Event|6
87643|NCT00211887|308920|P2|Overall Study|Adverse Event|4
87644|NCT00211887|308921|P1|Overall Study|Adverse Event|8
87645|NCT00212758|308959|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
87646|NCT00212758|308960|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
87647|NCT00212758|308959|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
87648|NCT00212758|308960|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
87649|NCT00213135|308969|P3|Overall Study|Unspecified|15
87650|NCT00213135|308970|P2|Overall Study|Unspecified|12
87651|NCT00213135|308971|P1|Overall Study|Unspecified|21
87652|NCT00213135|308969|P3|Overall Study|Disease progression|21
87653|NCT00213135|308970|P2|Overall Study|Disease progression|5
87654|NCT00213135|308971|P1|Overall Study|Disease progression|4
87655|NCT00213135|308969|P3|Overall Study|Death|2
87656|NCT00213135|308970|P2|Overall Study|Death|1
87657|NCT00213135|308971|P1|Overall Study|Death|1
87658|NCT00213135|308969|P3|Overall Study|Protocol Violation|10
87659|NCT00213135|308970|P2|Overall Study|Protocol Violation|4
87660|NCT00213135|308971|P1|Overall Study|Protocol Violation|4
87661|NCT00213135|308969|P3|Overall Study|Lost to Follow-up|4
87662|NCT00213135|308970|P2|Overall Study|Lost to Follow-up|8
87663|NCT00213135|308971|P1|Overall Study|Lost to Follow-up|11
87664|NCT00213135|308969|P3|Overall Study|Adverse Event|5
87665|NCT00213135|308970|P2|Overall Study|Adverse Event|5
87666|NCT00213135|308971|P1|Overall Study|Adverse Event|9
87667|NCT00214019|308988|P1|Overall Study|Screen failed|17
87668|NCT00214019|308988|P1|Overall Study|Withdrawal by Subject|2
87669|NCT00214019|308988|P1|Overall Study|Lost to Follow-up|11
87670|NCT00214201|308997|P2|Overall Study|Death|2
87671|NCT00214201|308998|P1|Overall Study|Death|0
87672|NCT00214201|308997|P2|Overall Study|Withdrawal by Subject|0
87673|NCT00214201|308998|P1|Overall Study|Withdrawal by Subject|2
87674|NCT00214383|309010|P2|Overall Study|Lost to Follow-up|26
87675|NCT00214383|309011|P1|Overall Study|Lost to Follow-up|16
87676|NCT00214461|309025|P4|Overall Study|Withdrawal by Subject|0
87677|NCT00214461|309026|P3|Overall Study|Withdrawal by Subject|1
87678|NCT00214461|309027|P2|Overall Study|Withdrawal by Subject|0
87679|NCT00214461|309028|P1|Overall Study|Withdrawal by Subject|0
87680|NCT00214461|309025|P4|Overall Study|Adverse Event|1
87681|NCT00214461|309026|P3|Overall Study|Adverse Event|1
87682|NCT00214461|309027|P2|Overall Study|Adverse Event|0
87683|NCT00214461|309028|P1|Overall Study|Adverse Event|0
87684|NCT00205712|309181|P2|Overall Study|Lost to Follow-up|1
87685|NCT00205712|309182|P1|Overall Study|Lost to Follow-up|0
87686|NCT00205777|309196|P6|Study Extension II|Enrolled but not treated|131
87687|NCT00205777|309197|P5|Study Extension II|Enrolled but not treated|0
87688|NCT00205777|309198|P4|Study Extension II|Enrolled but not treated|71
87689|NCT00205777|309199|P3|Study Extension II|Enrolled but not treated|0
87690|NCT00205777|309200|P2|Study Extension II|Enrolled but not treated|0
87691|NCT00205777|309201|P1|Study Extension II|Enrolled but not treated|0
87692|NCT00205777|309196|P6|Study Extension II|Other Event|20
87693|NCT00205777|309197|P5|Study Extension II|Other Event|0
87694|NCT00205777|309198|P4|Study Extension II|Other Event|12
87695|NCT00205777|309199|P3|Study Extension II|Other Event|0
87696|NCT00205777|309200|P2|Study Extension II|Other Event|0
87697|NCT00205777|309201|P1|Study Extension II|Other Event|0
87698|NCT00205777|309196|P6|Study Extension II|Failed to return|26
87699|NCT00205777|309197|P5|Study Extension II|Failed to return|0
87700|NCT00205777|309198|P4|Study Extension II|Failed to return|14
87701|NCT00205777|309199|P3|Study Extension II|Failed to return|0
87702|NCT00205777|309200|P2|Study Extension II|Failed to return|0
87703|NCT00205777|309201|P1|Study Extension II|Failed to return|0
87704|NCT00205777|309196|P6|Study Extension II|Lack of Efficacy|1
87705|NCT00205777|309197|P5|Study Extension II|Lack of Efficacy|0
87706|NCT00205777|309198|P4|Study Extension II|Lack of Efficacy|0
87707|NCT00205777|309199|P3|Study Extension II|Lack of Efficacy|0
87708|NCT00205777|309200|P2|Study Extension II|Lack of Efficacy|0
87709|NCT00205777|309201|P1|Study Extension II|Lack of Efficacy|0
87710|NCT00205777|309196|P6|Study Extension II|Protocol Violation|10
87711|NCT00205777|309197|P5|Study Extension II|Protocol Violation|0
87712|NCT00205777|309198|P4|Study Extension II|Protocol Violation|1
87713|NCT00205777|309199|P3|Study Extension II|Protocol Violation|0
87714|NCT00205777|309200|P2|Study Extension II|Protocol Violation|0
87715|NCT00205777|309201|P1|Study Extension II|Protocol Violation|0
87716|NCT00205777|309196|P6|Study Extension II|Withdrawal by Subject|59
87717|NCT00205777|309197|P5|Study Extension II|Withdrawal by Subject|0
87718|NCT00205777|309198|P4|Study Extension II|Withdrawal by Subject|35
87719|NCT00205777|309199|P3|Study Extension II|Withdrawal by Subject|0
87720|NCT00205777|309200|P2|Study Extension II|Withdrawal by Subject|0
87721|NCT00205777|309201|P1|Study Extension II|Withdrawal by Subject|0
87722|NCT00205777|309196|P6|Study Extension II|Death|5
87723|NCT00205777|309197|P5|Study Extension II|Death|0
87724|NCT00205777|309198|P4|Study Extension II|Death|2
87725|NCT00205777|309199|P3|Study Extension II|Death|0
87726|NCT00205777|309200|P2|Study Extension II|Death|0
87727|NCT00205777|309201|P1|Study Extension II|Death|0
87728|NCT00205777|309196|P6|Study Extension II|Adverse Event|30
87729|NCT00205777|309197|P5|Study Extension II|Adverse Event|0
87730|NCT00205777|309198|P4|Study Extension II|Adverse Event|14
87731|NCT00205777|309199|P3|Study Extension II|Adverse Event|0
87732|NCT00205777|309200|P2|Study Extension II|Adverse Event|0
87733|NCT00205777|309201|P1|Study Extension II|Adverse Event|0
87734|NCT00205777|309196|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
87735|NCT00205777|309197|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
87736|NCT00205777|309198|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
87737|NCT00205777|309199|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
87738|NCT00205777|309200|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
87739|NCT00205777|309201|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
87740|NCT00205777|309196|P6|Study Extension I|Withdrawn as per protocol|0
87741|NCT00205777|309197|P5|Study Extension I|Withdrawn as per protocol|0
87742|NCT00205777|309198|P4|Study Extension I|Withdrawn as per protocol|0
87743|NCT00205777|309199|P3|Study Extension I|Withdrawn as per protocol|1070
87744|NCT00205777|309200|P2|Study Extension I|Withdrawn as per protocol|0
87745|NCT00205777|309201|P1|Study Extension I|Withdrawn as per protocol|0
87746|NCT00205777|309196|P6|Study Extension I|Other Event|0
87747|NCT00205777|309197|P5|Study Extension I|Other Event|29
87748|NCT00205777|309198|P4|Study Extension I|Other Event|34
87749|NCT00205777|309199|P3|Study Extension I|Other Event|0
87750|NCT00205777|309200|P2|Study Extension I|Other Event|0
87751|NCT00205777|309201|P1|Study Extension I|Other Event|34
87752|NCT00205777|309196|P6|Study Extension I|Failed to return|0
87753|NCT00205777|309197|P5|Study Extension I|Failed to return|13
87754|NCT00205777|309198|P4|Study Extension I|Failed to return|17
87755|NCT00205777|309199|P3|Study Extension I|Failed to return|0
87756|NCT00205777|309200|P2|Study Extension I|Failed to return|0
87757|NCT00205777|309201|P1|Study Extension I|Failed to return|15
87758|NCT00205777|309196|P6|Study Extension I|Lack of Efficacy|0
87759|NCT00205777|309197|P5|Study Extension I|Lack of Efficacy|2
87760|NCT00205777|309198|P4|Study Extension I|Lack of Efficacy|1
87761|NCT00205777|309199|P3|Study Extension I|Lack of Efficacy|0
87762|NCT00205777|309200|P2|Study Extension I|Lack of Efficacy|0
87763|NCT00205777|309201|P1|Study Extension I|Lack of Efficacy|0
87764|NCT00205777|309196|P6|Study Extension I|Protocol Violation|0
87765|NCT00205777|309197|P5|Study Extension I|Protocol Violation|8
87766|NCT00205777|309198|P4|Study Extension I|Protocol Violation|8
87767|NCT00205777|309199|P3|Study Extension I|Protocol Violation|0
87768|NCT00205777|309200|P2|Study Extension I|Protocol Violation|0
87769|NCT00205777|309201|P1|Study Extension I|Protocol Violation|4
87770|NCT00205777|309196|P6|Study Extension I|Withdrawal by Subject|0
87771|NCT00205777|309197|P5|Study Extension I|Withdrawal by Subject|89
87772|NCT00205777|309198|P4|Study Extension I|Withdrawal by Subject|106
87773|NCT00205777|309199|P3|Study Extension I|Withdrawal by Subject|0
87774|NCT00205777|309200|P2|Study Extension I|Withdrawal by Subject|0
87775|NCT00205777|309201|P1|Study Extension I|Withdrawal by Subject|99
87776|NCT00205777|309196|P6|Study Extension I|Death|0
87777|NCT00205777|309197|P5|Study Extension I|Death|2
87778|NCT00205777|309198|P4|Study Extension I|Death|1
87779|NCT00205777|309199|P3|Study Extension I|Death|0
87780|NCT00205777|309200|P2|Study Extension I|Death|0
87781|NCT00205777|309201|P1|Study Extension I|Death|5
87782|NCT00205777|309196|P6|Study Extension I|Adverse Event|0
87783|NCT00205777|309197|P5|Study Extension I|Adverse Event|58
87784|NCT00205777|309198|P4|Study Extension I|Adverse Event|61
87785|NCT00205777|309199|P3|Study Extension I|Adverse Event|0
87786|NCT00205777|309200|P2|Study Extension I|Adverse Event|0
87787|NCT00205777|309201|P1|Study Extension I|Adverse Event|57
87788|NCT00205777|309196|P6|Completed Core Study, Entered SE I|Other Event|0
87789|NCT00205777|309197|P5|Completed Core Study, Entered SE I|Other Event|0
87790|NCT00205777|309198|P4|Completed Core Study, Entered SE I|Other Event|50
87791|NCT00205777|309199|P3|Completed Core Study, Entered SE I|Other Event|47
87792|NCT00205777|309200|P2|Completed Core Study, Entered SE I|Other Event|46
87793|NCT00205777|309201|P1|Completed Core Study, Entered SE I|Other Event|52
87794|NCT00205777|309196|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
87795|NCT00205777|309197|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
87796|NCT00205777|309198|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
87797|NCT00205777|309199|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
87798|NCT00205777|309200|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
87799|NCT00205777|309201|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
87800|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
87801|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
87802|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
87803|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
87804|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
87805|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
87806|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
87807|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
87808|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
87809|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
87810|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
87811|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
87812|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Protocol Violation|0
87813|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Protocol Violation|0
87814|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Protocol Violation|42
87815|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Protocol Violation|50
87816|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Protocol Violation|55
87817|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Protocol Violation|53
87818|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
87819|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
87820|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
87821|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
87822|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
87823|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
87824|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Other Event|0
87825|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Other Event|0
87826|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Other Event|58
87827|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Other Event|41
87828|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Other Event|52
87829|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Other Event|49
87830|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Failed to return|0
87831|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Failed to return|0
87832|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Failed to return|27
87833|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Failed to return|27
87834|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Failed to return|25
87835|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Failed to return|40
87836|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Death|0
87837|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Death|0
87838|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Death|7
87839|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Death|14
87840|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Death|7
87841|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Death|9
87842|NCT00205777|309196|P6|Core Study (Up to 3 Years)|Adverse Event|0
87843|NCT00205777|309197|P5|Core Study (Up to 3 Years)|Adverse Event|0
87844|NCT00205777|309198|P4|Core Study (Up to 3 Years)|Adverse Event|232
87845|NCT00205777|309199|P3|Core Study (Up to 3 Years)|Adverse Event|252
87846|NCT00205777|309200|P2|Core Study (Up to 3 Years)|Adverse Event|267
87847|NCT00205777|309201|P1|Core Study (Up to 3 Years)|Adverse Event|260
87848|NCT00205803|309410|P2|Toddler Dose|Lost to Follow-up|3
87849|NCT00205803|309411|P1|Toddler Dose|Lost to Follow-up|2
87850|NCT00205803|309410|P2|After Infant Series|Unspecified|4
87851|NCT00205803|309411|P1|After Infant Series|Unspecified|10
87852|NCT00205803|309410|P2|After Infant Series|Withdrawal by Subject|4
87853|NCT00205803|309411|P1|After Infant Series|Withdrawal by Subject|1
87854|NCT00205803|309410|P2|After Infant Series|Physician Decision|2
87855|NCT00205803|309411|P1|After Infant Series|Physician Decision|3
87856|NCT00205803|309410|P2|After Infant Series|Lost to Follow-up|1
87857|NCT00205803|309411|P1|After Infant Series|Lost to Follow-up|2
87858|NCT00205803|309410|P2|After Infant Series|Protocol Violation|1
87859|NCT00205803|309411|P1|After Infant Series|Protocol Violation|1
87860|NCT00205803|309410|P2|After Infant Series|Adverse Event|1
87861|NCT00205803|309411|P1|After Infant Series|Adverse Event|1
87862|NCT00205803|309410|P2|Infant Series|Sponsor request|0
87863|NCT00205803|309411|P1|Infant Series|Sponsor request|1
87864|NCT00205803|309410|P2|Infant Series|Non-compliant|0
87865|NCT00205803|309411|P1|Infant Series|Non-compliant|1
87866|NCT00205803|309410|P2|Infant Series|Lost Kaiser coverage|1
87867|NCT00205803|309411|P1|Infant Series|Lost Kaiser coverage|0
87868|NCT00205803|309410|P2|Infant Series|Protocol Violation|0
87869|NCT00205803|309411|P1|Infant Series|Protocol Violation|1
87870|NCT00205803|309410|P2|Infant Series|Physician Decision|1
87871|NCT00205803|309411|P1|Infant Series|Physician Decision|3
87872|NCT00205803|309410|P2|Infant Series|Withdrawal by Subject|5
87873|NCT00205803|309411|P1|Infant Series|Withdrawal by Subject|2
87874|NCT00205803|309410|P2|Infant Series|Lost to Follow-up|4
87875|NCT00205803|309411|P1|Infant Series|Lost to Follow-up|10
87876|NCT00205855|309463|P1|Overall Study|Withdrawal by Subject|5
87877|NCT00205855|309463|P1|Overall Study|Only received temporary implants|16
87878|NCT00205881|309467|P1|Overall Study|Withdrawal by Subject|16
87879|NCT00206076|309474|P2|Overall Study|Withdrawal by Subject|1
87880|NCT00206076|309475|P1|Overall Study|Withdrawal by Subject|1
87881|NCT00206076|309474|P2|Overall Study|Physician Decision|0
87882|NCT00206076|309475|P1|Overall Study|Physician Decision|2
87883|NCT00206102|309487|P2|Overall Study|None of those categories|36
87884|NCT00206102|309488|P1|Overall Study|None of those categories|42
87885|NCT00206102|309487|P2|Overall Study|Study-specific discontinuation criteria|17
87886|NCT00206102|309488|P1|Overall Study|Study-specific discontinuation criteria|18
87887|NCT00206102|309487|P2|Overall Study|Withdrawal by Subject|101
87888|NCT00206102|309488|P1|Overall Study|Withdrawal by Subject|118
87889|NCT00206102|309487|P2|Overall Study|Lost to Follow-up|66
87890|NCT00206102|309488|P1|Overall Study|Lost to Follow-up|95
87891|NCT00206102|309487|P2|Overall Study|Lack of therapeutic response|11
87892|NCT00206102|309488|P1|Overall Study|Lack of therapeutic response|16
87893|NCT00206102|309487|P2|Overall Study|Protocol Violation|2
87894|NCT00206102|309488|P1|Overall Study|Protocol Violation|0
87895|NCT00206102|309487|P2|Overall Study|Adverse Event|82
87896|NCT00206102|309488|P1|Overall Study|Adverse Event|119
87897|NCT00207090|309522|P1|Overall Study|Physician Decision|1
87898|NCT00207090|309522|P1|Overall Study|Disease progression/relapse|2
87899|NCT00207090|309522|P1|Overall Study|Chest wall mass larger|1
87900|NCT00207090|309522|P1|Overall Study|Study drug toxicity|3
87901|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
87902|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
87903|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
87904|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
87905|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Death|1
87906|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Death|0
87907|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Death|0
87908|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Death|0
87909|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
87910|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
87911|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
87912|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
87913|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
87914|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
87915|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
87916|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
87917|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
87918|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
87919|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
87920|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
87921|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
87922|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
87923|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
87924|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
87925|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
87926|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
87927|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
87928|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
87929|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
87930|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
87931|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
87932|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
87933|NCT00207142|309554|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
87934|NCT00207142|309555|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
87935|NCT00207142|309556|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
87936|NCT00207142|309557|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
87937|NCT00207142|309554|P4|Induction Phase|Missing lab data|0
87938|NCT00207142|309555|P3|Induction Phase|Missing lab data|0
87939|NCT00207142|309556|P2|Induction Phase|Missing lab data|0
87940|NCT00207142|309557|P1|Induction Phase|Missing lab data|1
87941|NCT00207142|309554|P4|Induction Phase|Incarceration|0
87942|NCT00207142|309555|P3|Induction Phase|Incarceration|0
87943|NCT00207142|309556|P2|Induction Phase|Incarceration|0
87944|NCT00207142|309557|P1|Induction Phase|Incarceration|1
87945|NCT00207142|309554|P4|Induction Phase|Withdrawal by Subject|0
87946|NCT00207142|309555|P3|Induction Phase|Withdrawal by Subject|0
87947|NCT00207142|309556|P2|Induction Phase|Withdrawal by Subject|0
87948|NCT00207142|309557|P1|Induction Phase|Withdrawal by Subject|4
87949|NCT00207142|309554|P4|Induction Phase|Subject no longer meets study criteria|0
87950|NCT00207142|309555|P3|Induction Phase|Subject no longer meets study criteria|0
87951|NCT00207142|309556|P2|Induction Phase|Subject no longer meets study criteria|0
87952|NCT00207142|309557|P1|Induction Phase|Subject no longer meets study criteria|3
87953|NCT00207142|309554|P4|Induction Phase|Pregnancy|0
87954|NCT00207142|309555|P3|Induction Phase|Pregnancy|0
87955|NCT00207142|309556|P2|Induction Phase|Pregnancy|0
87956|NCT00207142|309557|P1|Induction Phase|Pregnancy|1
87957|NCT00207142|309554|P4|Induction Phase|Poor/noncompliance|0
87958|NCT00207142|309555|P3|Induction Phase|Poor/noncompliance|0
87959|NCT00207142|309556|P2|Induction Phase|Poor/noncompliance|0
87960|NCT00207142|309557|P1|Induction Phase|Poor/noncompliance|2
87961|NCT00207142|309554|P4|Induction Phase|Physician Decision|0
87962|NCT00207142|309555|P3|Induction Phase|Physician Decision|0
87963|NCT00207142|309556|P2|Induction Phase|Physician Decision|0
87964|NCT00207142|309557|P1|Induction Phase|Physician Decision|2
87965|NCT00207142|309554|P4|Induction Phase|Lost to Follow-up|0
87966|NCT00207142|309555|P3|Induction Phase|Lost to Follow-up|0
87967|NCT00207142|309556|P2|Induction Phase|Lost to Follow-up|0
87968|NCT00207142|309557|P1|Induction Phase|Lost to Follow-up|5
87969|NCT00207142|309554|P4|Induction Phase|Lack of Efficacy|0
87970|NCT00207142|309555|P3|Induction Phase|Lack of Efficacy|0
87971|NCT00207142|309556|P2|Induction Phase|Lack of Efficacy|0
87972|NCT00207142|309557|P1|Induction Phase|Lack of Efficacy|1
87973|NCT00207142|309554|P4|Induction Phase|Death|0
87974|NCT00207142|309555|P3|Induction Phase|Death|0
87975|NCT00207142|309556|P2|Induction Phase|Death|0
87976|NCT00207142|309557|P1|Induction Phase|Death|1
87977|NCT00207142|309554|P4|Induction Phase|Adverse Event|0
87978|NCT00207142|309555|P3|Induction Phase|Adverse Event|0
87979|NCT00207142|309556|P2|Induction Phase|Adverse Event|0
87980|NCT00207142|309557|P1|Induction Phase|Adverse Event|9
87981|NCT00207714|309599|P5|Overall Study|Unspecified|0
87982|NCT00207714|309600|P4|Overall Study|Unspecified|1
87983|NCT00207714|309601|P3|Overall Study|Unspecified|5
87984|NCT00207714|309602|P2|Overall Study|Unspecified|2
87985|NCT00207714|309603|P1|Overall Study|Unspecified|3
87986|NCT00207714|309599|P5|Overall Study|Unsatisfactory therapeutic effect|4
87987|NCT00207714|309600|P4|Overall Study|Unsatisfactory therapeutic effect|4
87988|NCT00207714|309601|P3|Overall Study|Unsatisfactory therapeutic effect|1
87989|NCT00207714|309602|P2|Overall Study|Unsatisfactory therapeutic effect|3
87990|NCT00207714|309603|P1|Overall Study|Unsatisfactory therapeutic effect|5
87991|NCT00207714|309599|P5|Overall Study|Adverse Event|1
87992|NCT00207714|309600|P4|Overall Study|Adverse Event|3
87993|NCT00207714|309601|P3|Overall Study|Adverse Event|4
87994|NCT00207714|309602|P2|Overall Study|Adverse Event|2
87995|NCT00207714|309603|P1|Overall Study|Adverse Event|6
87996|NCT00207727|309627|P5|Overall Study|Not specified|33
87997|NCT00207727|309628|P4|Overall Study|Not specified|37
87998|NCT00207727|309629|P3|Overall Study|Not specified|41
87999|NCT00207727|309630|P2|Overall Study|Not specified|41
88000|NCT00207727|309631|P1|Overall Study|Not specified|38
88001|NCT00207727|309627|P5|Overall Study|Lost to Follow-up|0
88002|NCT00207727|309628|P4|Overall Study|Lost to Follow-up|0
88003|NCT00207727|309629|P3|Overall Study|Lost to Follow-up|0
88004|NCT00207727|309630|P2|Overall Study|Lost to Follow-up|1
88005|NCT00207727|309631|P1|Overall Study|Lost to Follow-up|0
88006|NCT00207727|309627|P5|Overall Study|Withdrawal by Subject|1
88007|NCT00207727|309628|P4|Overall Study|Withdrawal by Subject|0
88008|NCT00207727|309629|P3|Overall Study|Withdrawal by Subject|0
88009|NCT00207727|309630|P2|Overall Study|Withdrawal by Subject|0
88010|NCT00207727|309631|P1|Overall Study|Withdrawal by Subject|0
88011|NCT00207740|309657|P4|Overall Study|Not Specified|5
88012|NCT00207740|309658|P3|Overall Study|Not Specified|7
88013|NCT00207740|309659|P2|Overall Study|Not Specified|10
88014|NCT00207740|309660|P1|Overall Study|Not Specified|2
88015|NCT00207740|309657|P4|Overall Study|Sponsor Directive|21
88016|NCT00207740|309658|P3|Overall Study|Sponsor Directive|16
88017|NCT00207740|309659|P2|Overall Study|Sponsor Directive|15
88018|NCT00207740|309660|P1|Overall Study|Sponsor Directive|22
88019|NCT00207740|309657|P4|Overall Study|Death|1
88020|NCT00207740|309658|P3|Overall Study|Death|0
88021|NCT00207740|309659|P2|Overall Study|Death|0
88022|NCT00207740|309660|P1|Overall Study|Death|0
88023|NCT00207740|309657|P4|Overall Study|Lost to Follow-up|1
88024|NCT00207740|309658|P3|Overall Study|Lost to Follow-up|1
88025|NCT00207740|309659|P2|Overall Study|Lost to Follow-up|2
88026|NCT00207740|309660|P1|Overall Study|Lost to Follow-up|0
88027|NCT00207740|309657|P4|Overall Study|Unsatisfactory therapeutic effect|4
88028|NCT00207740|309658|P3|Overall Study|Unsatisfactory therapeutic effect|2
88029|NCT00207740|309659|P2|Overall Study|Unsatisfactory therapeutic effect|0
88030|NCT00207740|309660|P1|Overall Study|Unsatisfactory therapeutic effect|1
88031|NCT00207740|309657|P4|Overall Study|Adverse Event|11
88032|NCT00207740|309658|P3|Overall Study|Adverse Event|14
88033|NCT00207740|309659|P2|Overall Study|Adverse Event|14
88034|NCT00207740|309660|P1|Overall Study|Adverse Event|4
88035|NCT00208325|309728|P4|Overall Study|Mis-Randomized|0
88036|NCT00208325|309729|P3|Overall Study|Mis-Randomized|0
88037|NCT00208325|309730|P2|Overall Study|Mis-Randomized|20
88038|NCT00208325|309731|P1|Overall Study|Mis-Randomized|17
88039|NCT00208325|309728|P4|Overall Study|Other|0
88040|NCT00208325|309729|P3|Overall Study|Other|1
88041|NCT00208325|309730|P2|Overall Study|Other|1
88042|NCT00208325|309731|P1|Overall Study|Other|2
88043|NCT00208325|309728|P4|Overall Study|Does not wish to Continue in Study|2
88044|NCT00208325|309729|P3|Overall Study|Does not wish to Continue in Study|3
88045|NCT00208325|309730|P2|Overall Study|Does not wish to Continue in Study|8
88046|NCT00208325|309731|P1|Overall Study|Does not wish to Continue in Study|5
88047|NCT00208325|309728|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
88048|NCT00208325|309729|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
88049|NCT00208325|309730|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
88050|NCT00208325|309731|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
88051|NCT00208325|309728|P4|Overall Study|Lost to Follow-up|0
88052|NCT00208325|309729|P3|Overall Study|Lost to Follow-up|2
88053|NCT00208325|309730|P2|Overall Study|Lost to Follow-up|0
88054|NCT00208325|309731|P1|Overall Study|Lost to Follow-up|1
88055|NCT00208325|309728|P4|Overall Study|Revision|4
88056|NCT00208325|309729|P3|Overall Study|Revision|0
88057|NCT00208325|309730|P2|Overall Study|Revision|1
88058|NCT00208325|309731|P1|Overall Study|Revision|4
88059|NCT00208325|309728|P4|Overall Study|Withdrawal by Subject|0
88060|NCT00208325|309729|P3|Overall Study|Withdrawal by Subject|0
88061|NCT00208325|309730|P2|Overall Study|Withdrawal by Subject|1
88062|NCT00208325|309731|P1|Overall Study|Withdrawal by Subject|0
88063|NCT00208325|309728|P4|Overall Study|Death|5
88064|NCT00208325|309729|P3|Overall Study|Death|7
88065|NCT00208325|309730|P2|Overall Study|Death|19
88066|NCT00208325|309731|P1|Overall Study|Death|18
88067|NCT00208767|309859|P2|Overall Study|Lost to Follow-up|3
88068|NCT00208767|309860|P1|Overall Study|Lost to Follow-up|3
88069|NCT00208767|309859|P2|Overall Study|Death|0
88070|NCT00208767|309860|P1|Overall Study|Death|1
88071|NCT00208767|309859|P2|Overall Study|Withdrawal by Subject|3
88072|NCT00208767|309860|P1|Overall Study|Withdrawal by Subject|14
88073|NCT00208767|309859|P2|Overall Study|Adverse Event|1
88074|NCT00208767|309860|P1|Overall Study|Adverse Event|9
88075|NCT00209027|309884|P2|Overall Study|study terminated|0
88076|NCT00209027|309885|P1|Overall Study|study terminated|10
88077|NCT00209092|309893|P2|Overall Study|Withdrawal by Subject|0
88078|NCT00209092|309894|P1|Overall Study|Withdrawal by Subject|1
88079|NCT00209092|309893|P2|Overall Study|Adverse Event|1
88080|NCT00209092|309894|P1|Overall Study|Adverse Event|0
88081|NCT00209092|309893|P2|Overall Study|Progression of disease|1
88082|NCT00209092|309894|P1|Overall Study|Progression of disease|7
88083|NCT00209131|309904|P2|Overall Study|Lack of personnel due to turnovers.|11
88084|NCT00209131|309905|P1|Overall Study|Lack of personnel due to turnovers.|15
88085|NCT00209170|309915|P2|Overall Study|Lack of Efficacy|1
88086|NCT00209170|309916|P1|Overall Study|Lack of Efficacy|0
88087|NCT00209170|309915|P2|Overall Study|Withdrawal by Subject|1
88088|NCT00209170|309916|P1|Overall Study|Withdrawal by Subject|2
88089|NCT00209170|309915|P2|Overall Study|Adverse Event|1
88090|NCT00209170|309916|P1|Overall Study|Adverse Event|0
88091|NCT00215137|309922|P3|Randomization Period|Withdrawal by Subject|0
88092|NCT00215137|309923|P2|Randomization Period|Withdrawal by Subject|1
88093|NCT00215137|309924|P1|Randomization Period|Withdrawal by Subject|0
88094|NCT00215137|309922|P3|Randomization Period|Lost to Follow-up|0
88095|NCT00215137|309923|P2|Randomization Period|Lost to Follow-up|1
88096|NCT00215137|309924|P1|Randomization Period|Lost to Follow-up|0
88097|NCT00215137|309922|P3|Open Label Escitalopram|Lack of Efficacy|0
88098|NCT00215137|309923|P2|Open Label Escitalopram|Lack of Efficacy|0
88099|NCT00215137|309924|P1|Open Label Escitalopram|Lack of Efficacy|1
88100|NCT00215150|309932|P1|Randomization Phase Placebo|Withdrawal by Subject|1
88101|NCT00215150|309932|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
88102|NCT00215150|309932|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
88103|NCT00215150|309932|P1|Open Label Phase|Did not meet randomization criteria|9
88104|NCT00215150|309932|P1|Open Label Phase|Did not complete a post base visit|13
88105|NCT00215150|309932|P1|Open Label Phase|Withdrawal by Subject|1
88106|NCT00215150|309932|P1|Open Label Phase|Lost to Follow-up|7
88107|NCT00215943|309948|P2|Overall Study|Other complications|1
88108|NCT00215943|309949|P1|Overall Study|Other complications|3
88109|NCT00215943|309948|P2|Overall Study|Other disease|1
88110|NCT00215943|309949|P1|Overall Study|Other disease|0
88111|NCT00215943|309948|P2|Overall Study|Adverse Event|6
88112|NCT00215943|309949|P1|Overall Study|Adverse Event|3
88113|NCT00215943|309948|P2|Overall Study|Alternate therapy|1
88114|NCT00215943|309949|P1|Overall Study|Alternate therapy|0
88115|NCT00215943|309948|P2|Overall Study|Disease Progression|5
88116|NCT00215943|309949|P1|Overall Study|Disease Progression|3
88117|NCT00216086|309984|P1|Overall Study|Social Reasons|2
88118|NCT00216086|309984|P1|Overall Study|Diagnosis of Metastatic Disease|1
88119|NCT00216086|309984|P1|Overall Study|Protocol Violation|1
88120|NCT00216203|310013|P1|Overall Study|Withdrawal by Subject|2
88121|NCT00216476|310043|P3|Overall Study|Patient Moved|0
88122|NCT00216476|310044|P2|Overall Study|Patient Moved|2
88123|NCT00216476|310045|P1|Overall Study|Patient Moved|2
88124|NCT00216476|310043|P3|Overall Study|Protocol Deviation|0
88125|NCT00216476|310044|P2|Overall Study|Protocol Deviation|1
88126|NCT00216476|310045|P1|Overall Study|Protocol Deviation|5
88127|NCT00216476|310043|P3|Overall Study|Administrative Reasons|0
88128|NCT00216476|310044|P2|Overall Study|Administrative Reasons|1
88129|NCT00216476|310045|P1|Overall Study|Administrative Reasons|1
88130|NCT00216476|310043|P3|Overall Study|Higher dose/Extra Medication Required|2
88131|NCT00216476|310044|P2|Overall Study|Higher dose/Extra Medication Required|0
88132|NCT00216476|310045|P1|Overall Study|Higher dose/Extra Medication Required|2
88133|NCT00216476|310043|P3|Overall Study|Non-compliance|1
88134|NCT00216476|310044|P2|Overall Study|Non-compliance|4
88135|NCT00216476|310045|P1|Overall Study|Non-compliance|0
88136|NCT00216476|310043|P3|Overall Study|No Further Need for Treatment|1
88137|NCT00216476|310044|P2|Overall Study|No Further Need for Treatment|4
88138|NCT00216476|310045|P1|Overall Study|No Further Need for Treatment|3
88139|NCT00216476|310043|P3|Overall Study|Refuses Injection|0
88140|NCT00216476|310044|P2|Overall Study|Refuses Injection|0
88141|NCT00216476|310045|P1|Overall Study|Refuses Injection|11
88142|NCT00216476|310043|P3|Overall Study|Other|1
88143|NCT00216476|310044|P2|Overall Study|Other|0
88144|NCT00216476|310045|P1|Overall Study|Other|0
88145|NCT00216476|310043|P3|Overall Study|Pregnancy|1
88146|NCT00216476|310044|P2|Overall Study|Pregnancy|1
88147|NCT00216476|310045|P1|Overall Study|Pregnancy|0
88148|NCT00216476|310043|P3|Overall Study|Death|0
88149|NCT00216476|310044|P2|Overall Study|Death|0
88150|NCT00216476|310045|P1|Overall Study|Death|2
88151|NCT00216476|310043|P3|Overall Study|Lack of Efficacy|0
88152|NCT00216476|310044|P2|Overall Study|Lack of Efficacy|3
88153|NCT00216476|310045|P1|Overall Study|Lack of Efficacy|4
88154|NCT00216476|310043|P3|Overall Study|Adverse Event|1
88155|NCT00216476|310044|P2|Overall Study|Adverse Event|10
88156|NCT00216476|310045|P1|Overall Study|Adverse Event|6
88157|NCT00216476|310043|P3|Overall Study|Lost to Follow-up|1
88158|NCT00216476|310044|P2|Overall Study|Lost to Follow-up|9
88159|NCT00216476|310045|P1|Overall Study|Lost to Follow-up|10
88160|NCT00216476|310043|P3|Overall Study|Withdrawal by Subject|9
88161|NCT00216476|310044|P2|Overall Study|Withdrawal by Subject|72
88162|NCT00216476|310045|P1|Overall Study|Withdrawal by Subject|59
88163|NCT00216671|310064|P2|Overall Study|Insufficient Response Adverse Event|1
88164|NCT00216671|310065|P1|Overall Study|Insufficient Response Adverse Event|2
88165|NCT00216671|310064|P2|Overall Study|Ineligible, no efficacy data|2
88166|NCT00216671|310065|P1|Overall Study|Ineligible, no efficacy data|2
88167|NCT00216671|310064|P2|Overall Study|Patient Moved|1
88168|NCT00216671|310065|P1|Overall Study|Patient Moved|0
88169|NCT00216671|310064|P2|Overall Study|Investigator Illness|1
88170|NCT00216671|310065|P1|Overall Study|Investigator Illness|0
88171|NCT00216671|310064|P2|Overall Study|Relapse|0
88172|NCT00216671|310065|P1|Overall Study|Relapse|1
88173|NCT00216671|310064|P2|Overall Study|Protocol Violation|5
88174|NCT00216671|310065|P1|Overall Study|Protocol Violation|3
88175|NCT00216671|310064|P2|Overall Study|Physician Decision|1
88176|NCT00216671|310065|P1|Overall Study|Physician Decision|1
88177|NCT00216671|310064|P2|Overall Study|Ineligible|2
88178|NCT00216671|310065|P1|Overall Study|Ineligible|0
88179|NCT00216671|310064|P2|Overall Study|Non compliant|2
88180|NCT00216671|310065|P1|Overall Study|Non compliant|2
88181|NCT00216671|310064|P2|Overall Study|Lost to Follow-up|5
88182|NCT00216671|310065|P1|Overall Study|Lost to Follow-up|3
88183|NCT00216671|310064|P2|Overall Study|Insufficient Response|4
88184|NCT00216671|310065|P1|Overall Study|Insufficient Response|9
88185|NCT00216671|310064|P2|Overall Study|No Need to Continue Medication|1
88186|NCT00216671|310065|P1|Overall Study|No Need to Continue Medication|1
88187|NCT00216671|310064|P2|Overall Study|Refused Injections|13
88188|NCT00216671|310065|P1|Overall Study|Refused Injections|3
88189|NCT00216671|310064|P2|Overall Study|Withdrawal by Subject|2
88190|NCT00216671|310065|P1|Overall Study|Withdrawal by Subject|4
88191|NCT00216671|310064|P2|Overall Study|Pregnancy|1
88192|NCT00216671|310065|P1|Overall Study|Pregnancy|0
88193|NCT00216671|310064|P2|Overall Study|Adverse Event|9
88194|NCT00216671|310065|P1|Overall Study|Adverse Event|4
88195|NCT00216736|310083|P2|Overall Study|Lost to Follow-up|1
88196|NCT00216736|310084|P1|Overall Study|Lost to Follow-up|1
88197|NCT00217022|310098|P2|Overall Study|Withdrawal by Subject|1
88198|NCT00217022|310099|P1|Overall Study|Withdrawal by Subject|1
88199|NCT00217087|310109|P2|Overall Study|completed less than 12 months return|18
88200|NCT00217087|310110|P1|Overall Study|completed less than 12 months return|10
88201|NCT00217087|310109|P2|Overall Study|decided to have esophagectomy|2
88202|NCT00217087|310110|P1|Overall Study|decided to have esophagectomy|1
88203|NCT00217425|310128|P1|Overall Study|Other|4
88204|NCT00217425|310128|P1|Overall Study|Other complicating disease|1
88205|NCT00217425|310128|P1|Overall Study|Withdrawal by Subject|4
88206|NCT00217425|310128|P1|Overall Study|Adverse Event|8
88207|NCT00217425|310128|P1|Overall Study|Lack of Efficacy|13
88208|NCT00217425|310128|P1|Overall Study|Patient ineligible|5
88209|NCT00217425|310128|P1|Overall Study|Never started treatment|2
88210|NCT00217464|310145|P1|Overall Study|not specified|2
88211|NCT00217464|310145|P1|Overall Study|Progression|15
88212|NCT00217581|310171|P1|Overall Study|Withdrawal by Subject|1
88213|NCT00217620|310175|P1|Overall Study|Never received treatment|1
88214|NCT00217620|310175|P1|Overall Study|Ineligible|13
88215|NCT00217620|310175|P1|Overall Study|Not Protocol Specified|4
88216|NCT00217620|310175|P1|Overall Study|Progression|31
88217|NCT00217620|310175|P1|Overall Study|Adverse Event|2
88218|NCT00217672|310186|P2|Follow-up|Lost to Follow-up|0
88219|NCT00217672|310187|P1|Follow-up|Lost to Follow-up|1
88220|NCT00217672|310186|P2|Follow-up|Withdrawal by Subject|0
88221|NCT00217672|310187|P1|Follow-up|Withdrawal by Subject|4
88222|NCT00217672|310186|P2|Treatment|secondary malignancy|0
88223|NCT00217672|310187|P1|Treatment|secondary malignancy|1
88224|NCT00217672|310186|P2|Treatment|Death|0
88225|NCT00217672|310187|P1|Treatment|Death|2
88226|NCT00217672|310186|P2|Treatment|insurance issues|1
88227|NCT00217672|310187|P1|Treatment|insurance issues|1
88228|NCT00217672|310186|P2|Treatment|Physician Decision|0
88229|NCT00217672|310187|P1|Treatment|Physician Decision|6
88230|NCT00217672|310186|P2|Treatment|reqd treatment not permitted by protocol|0
88231|NCT00217672|310187|P1|Treatment|reqd treatment not permitted by protocol|6
88232|NCT00217672|310186|P2|Treatment|Adverse Event|2
88233|NCT00217672|310187|P1|Treatment|Adverse Event|18
88234|NCT00217672|310186|P2|Treatment|disease progression|4
88235|NCT00217672|310187|P1|Treatment|disease progression|33
88236|NCT00217672|310186|P2|Allocation|Ineligible|0
88237|NCT00217672|310187|P1|Allocation|Ineligible|2
88238|NCT00217971|310204|P2|Overall Study|non compliant|0
88239|NCT00217971|310205|P1|Overall Study|non compliant|1
88240|NCT00217971|310204|P2|Overall Study|Withdrawal by Subject|12
88241|NCT00217971|310205|P1|Overall Study|Withdrawal by Subject|7
88242|NCT00217971|310204|P2|Overall Study|Physician Decision|1
88243|NCT00217971|310205|P1|Overall Study|Physician Decision|0
88244|NCT00217971|310204|P2|Overall Study|Lost to Follow-up|19
88245|NCT00217971|310205|P1|Overall Study|Lost to Follow-up|15
88246|NCT00217971|310204|P2|Overall Study|Adverse Event|1
88247|NCT00217971|310205|P1|Overall Study|Adverse Event|1
88248|NCT00218296|310267|P2|Overall Study|Randomized but did not enter treatment|67
88249|NCT00218296|310268|P1|Overall Study|Randomized but did not enter treatment|66
88250|NCT00218296|310267|P2|Overall Study|Withdrawal by Subject|47
88251|NCT00218296|310268|P1|Overall Study|Withdrawal by Subject|36
88252|NCT00218296|310267|P2|Overall Study|Lost to Follow-up|7
88253|NCT00218296|310268|P1|Overall Study|Lost to Follow-up|9
88254|NCT00206427|310353|P1|Overall Study|Adverse Event|2
88255|NCT00206440|310359|P2|Overall Study|Adverse Event|2
88256|NCT00206440|310360|P1|Overall Study|Adverse Event|4
88257|NCT00206440|310359|P2|Overall Study|Protocol Violation|2
88258|NCT00206440|310360|P1|Overall Study|Protocol Violation|1
88259|NCT00206518|310368|P2|Overall Study|Protocol Violation|1
88260|NCT00206518|310369|P1|Overall Study|Protocol Violation|1
88261|NCT00206518|310368|P2|Overall Study|Physician Decision|0
88262|NCT00206518|310369|P1|Overall Study|Physician Decision|1
88263|NCT00206518|310368|P2|Overall Study|Adverse Event|1
88264|NCT00206518|310369|P1|Overall Study|Adverse Event|2
88265|NCT00206518|310368|P2|Overall Study|Lack of Efficacy|4
88266|NCT00206518|310369|P1|Overall Study|Lack of Efficacy|6
88267|NCT00206726|310379|P1|Overall Study|Withdrawal by Subject|8
88268|NCT00206726|310379|P1|Overall Study|Protocol Violation|1
88269|NCT00206726|310379|P1|Overall Study|Death|4
88270|NCT00206726|310379|P1|Overall Study|Adverse Event|17
88271|NCT00206726|310379|P1|Overall Study|Bone marrow transplant|1
88272|NCT00206726|310379|P1|Overall Study|Placed on new protocol|1
88273|NCT00206726|310379|P1|Overall Study|Progressive disease or relapsed disease|18
88274|NCT00206726|310379|P1|Overall Study|Delayed recovery of blood counts|1
88275|NCT00212355|310403|P1|Overall Study|A change of address|1
88276|NCT00212355|310403|P1|Overall Study|Withdrawal by Subject|1
88277|NCT00212355|310403|P1|Overall Study|Adverse Event|1
88278|NCT00218543|310437|P1|Overall Study|Adverse Event|2
88279|NCT00218543|310437|P1|Overall Study|Physician Decision|3
88280|NCT00218543|310437|P1|Overall Study|Withdrawal by Subject|1
88281|NCT00218543|310437|P1|Overall Study|relocated|1
88282|NCT00218543|310437|P1|Overall Study|Lost to Follow-up|8
88283|NCT00218634|310444|P2|Overall Study|Lost to Follow-up|15
88284|NCT00218634|310445|P1|Overall Study|Lost to Follow-up|8
88285|NCT00222105|310465|P1|Overall Study|Death|2
88286|NCT00222105|310465|P1|Overall Study|Treatment delays|2
88287|NCT00222105|310465|P1|Overall Study|Adverse Event|8
88288|NCT00222105|310465|P1|Overall Study|Withdrawal by Subject|1
88289|NCT00222105|310465|P1|Overall Study|Removed due to wrong diagnosis|1
88290|NCT00222729|310470|P1|Overall Study|Adverse Event|3
88291|NCT00223496|310492|P1|Overall Study|Physician Decision|2
88292|NCT00223496|310492|P1|Overall Study|Withdrawal by Subject|1
88293|NCT00223496|310492|P1|Overall Study|Lack of Efficacy|6
88294|NCT00223496|310492|P1|Overall Study|Lost to Follow-up|4
88295|NCT00223496|310492|P1|Overall Study|screen failure|9
88296|NCT00223795|310549|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
88297|NCT00223795|310550|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
88298|NCT00223795|310549|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
88299|NCT00223795|310550|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
88300|NCT00223808|310560|P3|Overall Study|<5 hrs therapy before discharge|5
88301|NCT00223808|310561|P2|Overall Study|<5 hrs therapy before discharge|5
88302|NCT00223808|310562|P1|Overall Study|<5 hrs therapy before discharge|3
88303|NCT00223977|310593|P3|Overall Study|not specified|0
88304|NCT00223977|310594|P2|Overall Study|not specified|0
88305|NCT00223977|310595|P1|Overall Study|not specified|1
88306|NCT00223977|310593|P3|Overall Study|Withdrawal by Subject|2
88307|NCT00223977|310594|P2|Overall Study|Withdrawal by Subject|1
88308|NCT00223977|310595|P1|Overall Study|Withdrawal by Subject|1
88309|NCT00223977|310593|P3|Overall Study|Protocol Violation|1
88310|NCT00223977|310594|P2|Overall Study|Protocol Violation|0
88311|NCT00223977|310595|P1|Overall Study|Protocol Violation|0
88312|NCT00223977|310593|P3|Overall Study|Adverse Event|0
88313|NCT00223977|310594|P2|Overall Study|Adverse Event|10
88314|NCT00223977|310595|P1|Overall Study|Adverse Event|7
88315|NCT00224003|310615|P1|Overall Study|unk|3
88316|NCT00224003|310615|P1|Overall Study|Withdrawal by Subject|1
88317|NCT00224003|310615|P1|Overall Study|Protocol Violation|2
88318|NCT00224003|310615|P1|Overall Study|Adverse Event|1
88319|NCT00224016|310621|P2|Maintenance Period|Lost to Follow-up|1
88320|NCT00224016|310622|P1|Maintenance Period|Lost to Follow-up|0
88321|NCT00224016|310621|P2|Maintenance Period|Withdrawal by Subject|0
88322|NCT00224016|310622|P1|Maintenance Period|Withdrawal by Subject|2
88323|NCT00224016|310621|P2|Titration Period|Lost to Follow-up|0
88324|NCT00224016|310622|P1|Titration Period|Lost to Follow-up|1
88325|NCT00224016|310621|P2|Titration Period|Withdrawal by Subject|1
88326|NCT00224016|310622|P1|Titration Period|Withdrawal by Subject|0
88327|NCT00224029|310630|P1|Overall Study|Other|1
88328|NCT00224029|310630|P1|Overall Study|Withdrawal by Subject|4
88329|NCT00224029|310630|P1|Overall Study|Lost to Follow-up|1
88330|NCT00224042|310636|P2|Overall Study|Not specified|0
88331|NCT00224042|310637|P1|Overall Study|Not specified|2
88332|NCT00224042|310636|P2|Overall Study|Did not meet lab incusion criteria|3
88333|NCT00224042|310637|P1|Overall Study|Did not meet lab incusion criteria|2
88334|NCT00224042|310636|P2|Overall Study|Physician Decision|1
88335|NCT00224042|310637|P1|Overall Study|Physician Decision|0
88336|NCT00224042|310636|P2|Overall Study|Protocol Violation|1
88337|NCT00224042|310637|P1|Overall Study|Protocol Violation|0
88338|NCT00224042|310636|P2|Overall Study|Adverse Event|1
88339|NCT00224042|310637|P1|Overall Study|Adverse Event|2
88340|NCT00224055|310651|P2|Overall Study|Not Specified|0
88341|NCT00224055|310652|P1|Overall Study|Not Specified|1
88342|NCT00224055|310651|P2|Overall Study|Withdrawal by Subject|2
88343|NCT00224055|310652|P1|Overall Study|Withdrawal by Subject|0
88344|NCT00224055|310651|P2|Overall Study|Inclusion Violation|6
88345|NCT00224055|310652|P1|Overall Study|Inclusion Violation|3
88346|NCT00224055|310651|P2|Overall Study|Protocol Violation|1
88347|NCT00224055|310652|P1|Overall Study|Protocol Violation|1
88348|NCT00224055|310651|P2|Overall Study|Lost to Follow-up|2
88349|NCT00224055|310652|P1|Overall Study|Lost to Follow-up|1
88350|NCT00224055|310651|P2|Overall Study|Adverse Event|3
88351|NCT00224055|310652|P1|Overall Study|Adverse Event|9
88352|NCT00224107|310662|P2|Overall Study|Not specified|1
88353|NCT00224107|310663|P1|Overall Study|Not specified|1
88354|NCT00224107|310662|P2|Overall Study|Physician Decision|0
88355|NCT00224107|310663|P1|Overall Study|Physician Decision|1
88356|NCT00224107|310662|P2|Overall Study|Lost to Follow-up|0
88357|NCT00224107|310663|P1|Overall Study|Lost to Follow-up|4
88358|NCT00224107|310662|P2|Overall Study|Lack of Efficacy|0
88359|NCT00224107|310663|P1|Overall Study|Lack of Efficacy|2
88360|NCT00224107|310662|P2|Overall Study|Withdrawal by Subject|4
88361|NCT00224107|310663|P1|Overall Study|Withdrawal by Subject|1
88362|NCT00224107|310662|P2|Overall Study|Protocol Violation|3
88363|NCT00224107|310663|P1|Overall Study|Protocol Violation|2
88364|NCT00224107|310662|P2|Overall Study|Adverse Event|6
88365|NCT00224107|310663|P1|Overall Study|Adverse Event|20
88366|NCT00215540|310674|P3|Overall Study|Withdrew from study medication|0
88367|NCT00215540|310675|P2|Overall Study|Withdrew from study medication|0
88368|NCT00215540|310676|P1|Overall Study|Withdrew from study medication|1
88369|NCT00215657|310762|P8|Overall Study|Not specified|1
88370|NCT00215657|310763|P7|Overall Study|Not specified|6
88371|NCT00215657|310764|P6|Overall Study|Not specified|4
88372|NCT00215657|310765|P5|Overall Study|Not specified|5
88373|NCT00215657|310766|P4|Overall Study|Not specified|3
88374|NCT00215657|310767|P3|Overall Study|Not specified|2
88375|NCT00215657|310768|P2|Overall Study|Not specified|1
88376|NCT00215657|310769|P1|Overall Study|Not specified|3
88377|NCT00215657|310762|P8|Overall Study|Insufficient testosterone response|7
88378|NCT00215657|310763|P7|Overall Study|Insufficient testosterone response|4
88379|NCT00215657|310764|P6|Overall Study|Insufficient testosterone response|12
88380|NCT00215657|310765|P5|Overall Study|Insufficient testosterone response|8
88381|NCT00215657|310766|P4|Overall Study|Insufficient testosterone response|12
88382|NCT00215657|310767|P3|Overall Study|Insufficient testosterone response|1
88383|NCT00215657|310768|P2|Overall Study|Insufficient testosterone response|4
88384|NCT00215657|310769|P1|Overall Study|Insufficient testosterone response|5
88385|NCT00215657|310762|P8|Overall Study|Insuff prostate specific antigen resp|2
88386|NCT00215657|310763|P7|Overall Study|Insuff prostate specific antigen resp|3
88387|NCT00215657|310764|P6|Overall Study|Insuff prostate specific antigen resp|2
88388|NCT00215657|310765|P5|Overall Study|Insuff prostate specific antigen resp|1
88389|NCT00215657|310766|P4|Overall Study|Insuff prostate specific antigen resp|2
88390|NCT00215657|310767|P3|Overall Study|Insuff prostate specific antigen resp|2
88391|NCT00215657|310768|P2|Overall Study|Insuff prostate specific antigen resp|2
88392|NCT00215657|310769|P1|Overall Study|Insuff prostate specific antigen resp|3
88393|NCT00215657|310762|P8|Overall Study|Withdrawal by Subject|3
88394|NCT00215657|310763|P7|Overall Study|Withdrawal by Subject|10
88395|NCT00215657|310764|P6|Overall Study|Withdrawal by Subject|1
88396|NCT00215657|310765|P5|Overall Study|Withdrawal by Subject|6
88397|NCT00215657|310766|P4|Overall Study|Withdrawal by Subject|1
88398|NCT00215657|310767|P3|Overall Study|Withdrawal by Subject|3
88399|NCT00215657|310768|P2|Overall Study|Withdrawal by Subject|3
88400|NCT00215657|310769|P1|Overall Study|Withdrawal by Subject|6
88401|NCT00215657|310762|P8|Overall Study|Adverse Event|3
88402|NCT00215657|310763|P7|Overall Study|Adverse Event|0
88403|NCT00215657|310764|P6|Overall Study|Adverse Event|1
88404|NCT00215657|310765|P5|Overall Study|Adverse Event|3
88405|NCT00215657|310766|P4|Overall Study|Adverse Event|0
88406|NCT00215657|310767|P3|Overall Study|Adverse Event|3
88407|NCT00215657|310768|P2|Overall Study|Adverse Event|1
88408|NCT00215657|310769|P1|Overall Study|Adverse Event|5
88409|NCT00215683|310798|P3|Overall Study|Intermittent therapy required|0
88410|NCT00215683|310799|P2|Overall Study|Intermittent therapy required|1
88411|NCT00215683|310800|P1|Overall Study|Intermittent therapy required|0
88412|NCT00215683|310798|P3|Overall Study|No study drug available|0
88413|NCT00215683|310799|P2|Overall Study|No study drug available|1
88414|NCT00215683|310800|P1|Overall Study|No study drug available|0
88415|NCT00215683|310798|P3|Overall Study|Difficult to attend visits|0
88416|NCT00215683|310799|P2|Overall Study|Difficult to attend visits|1
88417|NCT00215683|310800|P1|Overall Study|Difficult to attend visits|0
88418|NCT00215683|310798|P3|Overall Study|Physician Decision|1
88419|NCT00215683|310799|P2|Overall Study|Physician Decision|0
88420|NCT00215683|310800|P1|Overall Study|Physician Decision|0
88421|NCT00215683|310798|P3|Overall Study|Withdrawal by Subject|13
88422|NCT00215683|310799|P2|Overall Study|Withdrawal by Subject|4
88423|NCT00215683|310800|P1|Overall Study|Withdrawal by Subject|9
88424|NCT00215683|310798|P3|Overall Study|Lost to Follow-up|1
88425|NCT00215683|310799|P2|Overall Study|Lost to Follow-up|2
88426|NCT00215683|310800|P1|Overall Study|Lost to Follow-up|0
88427|NCT00215683|310798|P3|Overall Study|Lack of Efficacy|2
88428|NCT00215683|310799|P2|Overall Study|Lack of Efficacy|1
88429|NCT00215683|310800|P1|Overall Study|Lack of Efficacy|5
88430|NCT00215683|310798|P3|Overall Study|Adverse Event|15
88431|NCT00215683|310799|P2|Overall Study|Adverse Event|16
88432|NCT00215683|310800|P1|Overall Study|Adverse Event|15
88433|NCT00224120|310817|P2|Overall Study|Not specified|5
88434|NCT00224120|310818|P1|Overall Study|Not specified|4
88435|NCT00224120|310817|P2|Overall Study|Lost to Follow-up|3
88436|NCT00224120|310818|P1|Overall Study|Lost to Follow-up|2
88437|NCT00224120|310817|P2|Overall Study|Lack of Efficacy|2
88438|NCT00224120|310818|P1|Overall Study|Lack of Efficacy|0
88439|NCT00224120|310817|P2|Overall Study|Withdrawal by Subject|10
88440|NCT00224120|310818|P1|Overall Study|Withdrawal by Subject|5
88441|NCT00224120|310817|P2|Overall Study|Protocol Violation|0
88442|NCT00224120|310818|P1|Overall Study|Protocol Violation|1
88443|NCT00224120|310817|P2|Overall Study|Adverse Event|4
88444|NCT00224120|310818|P1|Overall Study|Adverse Event|10
88445|NCT00224133|310826|P1|Overall Study|Not specified|14
88446|NCT00224133|310826|P1|Overall Study|Physician Decision|1
88447|NCT00224133|310826|P1|Overall Study|Lost to Follow-up|21
88448|NCT00224133|310826|P1|Overall Study|Lack of Efficacy|58
88449|NCT00224133|310826|P1|Overall Study|Withdrawal by Subject|33
88450|NCT00224133|310826|P1|Overall Study|Protocol Violation|6
88451|NCT00224133|310826|P1|Overall Study|Adverse Event|93
88452|NCT00226655|310859|P1|Overall Study|Clinical deterioration|10
88453|NCT00226655|310859|P1|Overall Study|Physician Decision|6
88454|NCT00226655|310859|P1|Overall Study|Adverse Event|35
88455|NCT00226655|310859|P1|Overall Study|Withdrawal by Subject|15
88456|NCT00226655|310859|P1|Overall Study|Death|13
88457|NCT00226811|310863|P1|Overall Study|Withdrawal by Subject|2
88458|NCT00226811|310863|P1|Overall Study|Lack of Efficacy|55
88459|NCT00226811|310863|P1|Overall Study|Adverse Event|11
88460|NCT00226811|310863|P1|Overall Study|Death|8
88461|NCT00227266|310882|P3|Overall Study|Excessive weight gain|2
88462|NCT00227266|310883|P2|Overall Study|Excessive weight gain|0
88463|NCT00227266|310884|P1|Overall Study|Excessive weight gain|0
88464|NCT00227266|310882|P3|Overall Study|Protocol Violation|1
88465|NCT00227266|310883|P2|Overall Study|Protocol Violation|0
88466|NCT00227266|310884|P1|Overall Study|Protocol Violation|1
88467|NCT00227266|310882|P3|Overall Study|Withdrawal by Subject|1
88468|NCT00227266|310883|P2|Overall Study|Withdrawal by Subject|0
88469|NCT00227266|310884|P1|Overall Study|Withdrawal by Subject|0
88470|NCT00227305|310904|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
88471|NCT00227305|310904|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
88472|NCT00227305|310904|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
88473|NCT00227305|310904|P1|Overall Study|Physician Decision|3
88474|NCT00227305|310904|P1|Overall Study|Lack of Efficacy|7
88475|NCT00227305|310904|P1|Overall Study|MOVED OUT OF AREA|3
88476|NCT00227305|310904|P1|Overall Study|Study specific discontinuation|13
88477|NCT00227305|310904|P1|Overall Study|Lost to Follow-up|33
88478|NCT00227305|310904|P1|Overall Study|Withdrawal by Subject|42
88479|NCT00227305|310904|P1|Overall Study|Adverse Event|40
88480|NCT00227344|310920|P2|Overall Study|study terminated early|5
88481|NCT00227344|310921|P1|Overall Study|study terminated early|12
88482|NCT00227370|310943|P2|Overall Study|Other reasons|1
88483|NCT00227370|310944|P1|Overall Study|Other reasons|2
88484|NCT00227370|310943|P2|Overall Study|Physician Decision|6
88485|NCT00227370|310944|P1|Overall Study|Physician Decision|9
88486|NCT00227370|310943|P2|Overall Study|Adverse Event|11
88487|NCT00227370|310944|P1|Overall Study|Adverse Event|6
88488|NCT00227370|310943|P2|Overall Study|Death|4
88489|NCT00227370|310944|P1|Overall Study|Death|3
88490|NCT00227370|310943|P2|Overall Study|Withdrawal by Subject|2
88491|NCT00227370|310944|P1|Overall Study|Withdrawal by Subject|1
88492|NCT00227539|310962|P1|Overall Study|Protocol Violation|1
88493|NCT00227591|310968|P1|Overall Study|Withdrawal by Subject|1
88494|NCT00227721|310972|P1|Overall Study|On study, but never treated.|1
88495|NCT00227903|310984|P2|Overall Study|Miscarriage|0
88496|NCT00227903|310985|P1|Overall Study|Miscarriage|1
88497|NCT00227903|310984|P2|Overall Study|Lost to Follow-up|3
88498|NCT00227903|310985|P1|Overall Study|Lost to Follow-up|1
88499|NCT00227903|310984|P2|Overall Study|Subject moved out of area|2
88500|NCT00227903|310985|P1|Overall Study|Subject moved out of area|1
88501|NCT00227903|310984|P2|Overall Study|Withdrawal by Subject|5
88502|NCT00227903|310985|P1|Overall Study|Withdrawal by Subject|2
88503|NCT00228384|311058|P2|Overall Study|Physician Decision|1
88504|NCT00228384|311059|P1|Overall Study|Physician Decision|0
88505|NCT00228384|311058|P2|Overall Study|Withdrawal by Subject|10
88506|NCT00228384|311059|P1|Overall Study|Withdrawal by Subject|9
88507|NCT00228384|311058|P2|Overall Study|Surgical Intervention (bypass)|5
88508|NCT00228384|311059|P1|Overall Study|Surgical Intervention (bypass)|5
88509|NCT00228384|311058|P2|Overall Study|Lost to Follow-up|10
88510|NCT00228384|311059|P1|Overall Study|Lost to Follow-up|6
88511|NCT00228384|311058|P2|Overall Study|Death|3
88512|NCT00228384|311059|P1|Overall Study|Death|9
88513|NCT00228553|311097|P1|Overall Study|Miscellaneous|46
88514|NCT00228553|311097|P1|Overall Study|Pregnancy|2
88515|NCT00228553|311097|P1|Overall Study|Withdrawal by Subject|115
88516|NCT00228553|311097|P1|Overall Study|Protocol Violation|6
88517|NCT00228553|311097|P1|Overall Study|Physician Decision|48
88518|NCT00228553|311097|P1|Overall Study|Lost to Follow-up|67
88519|NCT00228553|311097|P1|Overall Study|Lack of Efficacy|34
88520|NCT00228553|311097|P1|Overall Study|Adverse Event|112
88521|NCT00228566|311101|P1|Overall Study|Miscellaneous|1
88522|NCT00228566|311101|P1|Overall Study|Withdrawal by Subject|4
88523|NCT00228566|311101|P1|Overall Study|Physician Decision|5
88524|NCT00228566|311101|P1|Overall Study|Lost to Follow-up|16
88525|NCT00228566|311101|P1|Overall Study|Lack of Efficacy|14
88526|NCT00228566|311101|P1|Overall Study|Adverse Event|31
88527|NCT00219141|311108|P3|Overall Study|Condition no longer requires study drug|0
88528|NCT00219141|311109|P2|Overall Study|Condition no longer requires study drug|0
88529|NCT00219141|311110|P1|Overall Study|Condition no longer requires study drug|1
88530|NCT00219141|311108|P3|Overall Study|Withdrawal by Subject|5
88531|NCT00219141|311109|P2|Overall Study|Withdrawal by Subject|3
88532|NCT00219141|311110|P1|Overall Study|Withdrawal by Subject|1
88533|NCT00219141|311108|P3|Overall Study|Protocol Violation|1
88534|NCT00219141|311109|P2|Overall Study|Protocol Violation|1
88535|NCT00219141|311110|P1|Overall Study|Protocol Violation|3
88536|NCT00219141|311108|P3|Overall Study|Lost to Follow-up|1
88537|NCT00219141|311109|P2|Overall Study|Lost to Follow-up|4
88538|NCT00219141|311110|P1|Overall Study|Lost to Follow-up|2
88539|NCT00219141|311108|P3|Overall Study|Administrative problems|0
88540|NCT00219141|311109|P2|Overall Study|Administrative problems|1
88541|NCT00219141|311110|P1|Overall Study|Administrative problems|0
88542|NCT00219141|311108|P3|Overall Study|Lack of Efficacy|0
88543|NCT00219141|311109|P2|Overall Study|Lack of Efficacy|2
88544|NCT00219141|311110|P1|Overall Study|Lack of Efficacy|3
88545|NCT00219141|311108|P3|Overall Study|Adverse Event|5
88546|NCT00219141|311109|P2|Overall Study|Adverse Event|10
88547|NCT00219141|311110|P1|Overall Study|Adverse Event|4
88548|NCT00219284|311156|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
88549|NCT00219284|311157|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
88550|NCT00219284|311156|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
88551|NCT00219284|311157|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
88552|NCT00219284|311156|P2|Extension Phase - 8 Weeks|Adverse Event|3
88553|NCT00219284|311157|P1|Extension Phase - 8 Weeks|Adverse Event|2
88554|NCT00219284|311156|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
88555|NCT00219284|311157|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
88556|NCT00219284|311156|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
88557|NCT00219284|311157|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
88558|NCT00219284|311156|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
88559|NCT00219284|311157|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
88560|NCT00219284|311156|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
88561|NCT00219284|311157|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
88562|NCT00219284|311156|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
88563|NCT00219284|311157|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
88564|NCT00219284|311156|P2|Treatment Phase - 16 Weeks|Adverse Event|24
88565|NCT00219284|311157|P1|Treatment Phase - 16 Weeks|Adverse Event|26
88566|NCT00219349|311179|P1|Escitalopram Phase|Physician Decision|7
88567|NCT00219349|311179|P1|Escitalopram Phase|Withdrawal by Subject|4
88568|NCT00219349|311179|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
88569|NCT00219349|311179|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
88570|NCT00219349|311179|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
88571|NCT00219544|311183|P2|Single Blind Treatment Period|Withdrawal by Subject|0
88572|NCT00219544|311184|P1|Single Blind Treatment Period|Withdrawal by Subject|1
88573|NCT00219544|311183|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
88574|NCT00219544|311184|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
88575|NCT00219544|311183|P2|Single Blind Treatment Period|Lost to Follow-up|0
88576|NCT00219544|311184|P1|Single Blind Treatment Period|Lost to Follow-up|2
88577|NCT00219544|311183|P2|Single Blind Treatment Period|Protocol Violation|0
88578|NCT00219544|311184|P1|Single Blind Treatment Period|Protocol Violation|4
88579|NCT00219544|311183|P2|Single Blind Treatment Period|Adverse Event|0
88580|NCT00219544|311184|P1|Single Blind Treatment Period|Adverse Event|9
88581|NCT00219544|311183|P2|Single Blind Treatment Period|Lack of Efficacy|0
88582|NCT00219544|311184|P1|Single Blind Treatment Period|Lack of Efficacy|5
88583|NCT00219557|311225|P3|Phase 2|Treatment not received|3
88584|NCT00219557|311226|P2|Phase 2|Treatment not received|1
88585|NCT00219557|311227|P1|Phase 2|Treatment not received|0
88586|NCT00219557|311225|P3|Phase 2|Withdrawal by Subject|5
88587|NCT00219557|311226|P2|Phase 2|Withdrawal by Subject|9
88588|NCT00219557|311227|P1|Phase 2|Withdrawal by Subject|0
88589|NCT00219557|311225|P3|Phase 2|Unspecified|6
88590|NCT00219557|311226|P2|Phase 2|Unspecified|8
88591|NCT00219557|311227|P1|Phase 2|Unspecified|0
88592|NCT00219557|311225|P3|Phase 2|Death|2
88593|NCT00219557|311226|P2|Phase 2|Death|8
88594|NCT00219557|311227|P1|Phase 2|Death|0
88595|NCT00219557|311225|P3|Phase 2|Adverse Event|2
88596|NCT00219557|311226|P2|Phase 2|Adverse Event|22
88597|NCT00219557|311227|P1|Phase 2|Adverse Event|0
88598|NCT00219557|311225|P3|Phase 2|Lack of Efficacy|15
88599|NCT00219557|311226|P2|Phase 2|Lack of Efficacy|21
88600|NCT00219557|311227|P1|Phase 2|Lack of Efficacy|0
88601|NCT00219557|311225|P3|Phase 1|Started chemotherapy at other institute|0
88602|NCT00219557|311226|P2|Phase 1|Started chemotherapy at other institute|0
88603|NCT00219557|311227|P1|Phase 1|Started chemotherapy at other institute|1
88604|NCT00219557|311225|P3|Phase 1|Withdrawal by Subject|0
88605|NCT00219557|311226|P2|Phase 1|Withdrawal by Subject|0
88606|NCT00219557|311227|P1|Phase 1|Withdrawal by Subject|1
88607|NCT00219557|311225|P3|Phase 1|Adverse Event|0
88608|NCT00219557|311226|P2|Phase 1|Adverse Event|0
88609|NCT00219557|311227|P1|Phase 1|Adverse Event|2
88610|NCT00219557|311225|P3|Phase 1|Lack of Efficacy|0
88611|NCT00219557|311226|P2|Phase 1|Lack of Efficacy|0
88612|NCT00219557|311227|P1|Phase 1|Lack of Efficacy|3
88613|NCT00220636|311255|P1|Overall Study|Withdrawal by Subject|4
88614|NCT00220701|311264|P2|Overall Study|Lost to Follow-up|4
88615|NCT00220701|311265|P1|Overall Study|Lost to Follow-up|5
88616|NCT00220727|311283|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
88617|NCT00220727|311284|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
88618|NCT00220740|311300|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
88619|NCT00220740|311301|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
88620|NCT00220740|311300|P2|Efficacy Period|Protocol Violation|0
88621|NCT00220740|311301|P1|Efficacy Period|Protocol Violation|1
88622|NCT00220740|311300|P2|Efficacy Period|Withdrawal by Subject|0
88623|NCT00220740|311301|P1|Efficacy Period|Withdrawal by Subject|1
88624|NCT00220740|311300|P2|Efficacy Period|Adverse Event|1
88625|NCT00220740|311301|P1|Efficacy Period|Adverse Event|1
88626|NCT00220740|311300|P2|Efficacy Period|Entered rescue treatment with placebo|0
88627|NCT00220740|311301|P1|Efficacy Period|Entered rescue treatment with placebo|23
88628|NCT00220779|311316|P3|Overall Study|Lack of Efficacy|1
88629|NCT00220779|311317|P2|Overall Study|Lack of Efficacy|0
88630|NCT00220779|311318|P1|Overall Study|Lack of Efficacy|3
88631|NCT00220779|311316|P3|Overall Study|Pregnancy|2
88632|NCT00220779|311317|P2|Overall Study|Pregnancy|0
88633|NCT00220779|311318|P1|Overall Study|Pregnancy|0
88634|NCT00220779|311316|P3|Overall Study|Too time consuming|0
88635|NCT00220779|311317|P2|Overall Study|Too time consuming|0
88636|NCT00220779|311318|P1|Overall Study|Too time consuming|1
88637|NCT00220779|311316|P3|Overall Study|Non-compliance|0
88638|NCT00220779|311317|P2|Overall Study|Non-compliance|0
88639|NCT00220779|311318|P1|Overall Study|Non-compliance|1
88640|NCT00220779|311316|P3|Overall Study|Withdrawal by Subject|1
88641|NCT00220779|311317|P2|Overall Study|Withdrawal by Subject|4
88642|NCT00220779|311318|P1|Overall Study|Withdrawal by Subject|1
88643|NCT00220779|311316|P3|Overall Study|Adverse Event|0
88644|NCT00220779|311317|P2|Overall Study|Adverse Event|0
88645|NCT00220779|311318|P1|Overall Study|Adverse Event|1
88646|NCT00220805|311328|P2|Overall Study|Develop. of choroidal neovascularization|8
88647|NCT00220805|311329|P1|Overall Study|Develop. of choroidal neovascularization|3
88648|NCT00220805|311328|P2|Overall Study|Lack of Efficacy|0
88649|NCT00220805|311329|P1|Overall Study|Lack of Efficacy|1
88650|NCT00220805|311328|P2|Overall Study|Withdrawal by Subject|0
88651|NCT00220805|311329|P1|Overall Study|Withdrawal by Subject|3
88652|NCT00220805|311328|P2|Overall Study|Adverse Event|3
88653|NCT00220805|311329|P1|Overall Study|Adverse Event|1
88654|NCT00221195|311366|P2|Overall Study|Lost to Follow-up|1
88655|NCT00221195|311367|P1|Overall Study|Lost to Follow-up|0
88656|NCT00221195|311366|P2|Overall Study|Death|1
88657|NCT00221195|311367|P1|Overall Study|Death|1
88658|NCT00221195|311366|P2|Overall Study|Withdrawal by Subject|1
88659|NCT00221195|311367|P1|Overall Study|Withdrawal by Subject|4
88660|NCT00228813|311388|P1|Overall Study|Death|4
88661|NCT00228917|311398|P4|Overall Study|Migrated/moved from study area|0
88662|NCT00228917|311399|P3|Overall Study|Migrated/moved from study area|0
88663|NCT00228917|311400|P2|Overall Study|Migrated/moved from study area|3
88664|NCT00228917|311401|P1|Overall Study|Migrated/moved from study area|0
88665|NCT00228917|311398|P4|Overall Study|Lost to Follow-up|0
88666|NCT00228917|311399|P3|Overall Study|Lost to Follow-up|0
88667|NCT00228917|311400|P2|Overall Study|Lost to Follow-up|0
88668|NCT00228917|311401|P1|Overall Study|Lost to Follow-up|1
88669|NCT00229658|311441|P2|Overall Study|Withdrawal of consent|39
88670|NCT00229658|311442|P1|Overall Study|Withdrawal of consent|46
88671|NCT00229658|311441|P2|Overall Study|Serious Adverse Event|2
88672|NCT00229658|311442|P1|Overall Study|Serious Adverse Event|2
88673|NCT00229658|311441|P2|Overall Study|Lost to Follow-up|55
88674|NCT00229658|311442|P1|Overall Study|Lost to Follow-up|82
88675|NCT00229658|311441|P2|Overall Study|Other|60
88676|NCT00229658|311442|P1|Overall Study|Other|80
88677|NCT00229658|311441|P2|Overall Study|Investigator decision|10
88678|NCT00229658|311442|P1|Overall Study|Investigator decision|13
88679|NCT00229658|311441|P2|Overall Study|Administrative|1
88680|NCT00229658|311442|P1|Overall Study|Administrative|2
88681|NCT00229723|311477|P7|Maintenance Phase|Unspecified|1
88682|NCT00229723|311478|P6|Maintenance Phase|Unspecified|3
88683|NCT00229723|311479|P5|Maintenance Phase|Unspecified|3
88684|NCT00229723|311480|P4|Maintenance Phase|Unspecified|2
88685|NCT00229723|311481|P3|Maintenance Phase|Unspecified|1
88686|NCT00229723|311482|P2|Maintenance Phase|Unspecified|4
88687|NCT00229723|311483|P1|Maintenance Phase|Unspecified|5
88688|NCT00229723|311477|P7|Maintenance Phase|Severe non-compliance|0
88689|NCT00229723|311478|P6|Maintenance Phase|Severe non-compliance|0
88690|NCT00229723|311479|P5|Maintenance Phase|Severe non-compliance|1
88691|NCT00229723|311480|P4|Maintenance Phase|Severe non-compliance|0
88692|NCT00229723|311481|P3|Maintenance Phase|Severe non-compliance|0
88693|NCT00229723|311482|P2|Maintenance Phase|Severe non-compliance|1
88694|NCT00229723|311483|P1|Maintenance Phase|Severe non-compliance|3
88695|NCT00229723|311477|P7|Maintenance Phase|Informed consent withdrawn|0
88696|NCT00229723|311478|P6|Maintenance Phase|Informed consent withdrawn|1
88697|NCT00229723|311479|P5|Maintenance Phase|Informed consent withdrawn|1
88698|NCT00229723|311480|P4|Maintenance Phase|Informed consent withdrawn|1
88699|NCT00229723|311481|P3|Maintenance Phase|Informed consent withdrawn|0
88700|NCT00229723|311482|P2|Maintenance Phase|Informed consent withdrawn|0
88701|NCT00229723|311483|P1|Maintenance Phase|Informed consent withdrawn|1
88702|NCT00229723|311477|P7|Maintenance Phase|Lost to Follow-up|1
88703|NCT00229723|311478|P6|Maintenance Phase|Lost to Follow-up|0
88704|NCT00229723|311479|P5|Maintenance Phase|Lost to Follow-up|0
88705|NCT00229723|311480|P4|Maintenance Phase|Lost to Follow-up|2
88706|NCT00229723|311481|P3|Maintenance Phase|Lost to Follow-up|2
88707|NCT00229723|311482|P2|Maintenance Phase|Lost to Follow-up|1
88708|NCT00229723|311483|P1|Maintenance Phase|Lost to Follow-up|0
88709|NCT00229723|311477|P7|Maintenance Phase|Clinical progression|1
88710|NCT00229723|311478|P6|Maintenance Phase|Clinical progression|1
88711|NCT00229723|311479|P5|Maintenance Phase|Clinical progression|1
88712|NCT00229723|311480|P4|Maintenance Phase|Clinical progression|2
88713|NCT00229723|311481|P3|Maintenance Phase|Clinical progression|2
88714|NCT00229723|311482|P2|Maintenance Phase|Clinical progression|1
88715|NCT00229723|311483|P1|Maintenance Phase|Clinical progression|4
88716|NCT00229723|311477|P7|Maintenance Phase|Objective disease progression|5
88717|NCT00229723|311478|P6|Maintenance Phase|Objective disease progression|9
88718|NCT00229723|311479|P5|Maintenance Phase|Objective disease progression|2
88719|NCT00229723|311480|P4|Maintenance Phase|Objective disease progression|6
88720|NCT00229723|311481|P3|Maintenance Phase|Objective disease progression|3
88721|NCT00229723|311482|P2|Maintenance Phase|Objective disease progression|5
88722|NCT00229723|311483|P1|Maintenance Phase|Objective disease progression|5
88723|NCT00229723|311477|P7|Maintenance Phase|Adverse Event|2
88724|NCT00229723|311478|P6|Maintenance Phase|Adverse Event|5
88725|NCT00229723|311479|P5|Maintenance Phase|Adverse Event|7
88726|NCT00229723|311480|P4|Maintenance Phase|Adverse Event|4
88727|NCT00229723|311481|P3|Maintenance Phase|Adverse Event|1
88728|NCT00229723|311482|P2|Maintenance Phase|Adverse Event|2
88729|NCT00229723|311483|P1|Maintenance Phase|Adverse Event|7
88730|NCT00229723|311477|P7|Concomitant Phase|Unspecified|0
88731|NCT00229723|311478|P6|Concomitant Phase|Unspecified|2
88732|NCT00229723|311479|P5|Concomitant Phase|Unspecified|0
88733|NCT00229723|311480|P4|Concomitant Phase|Unspecified|1
88734|NCT00229723|311481|P3|Concomitant Phase|Unspecified|1
88735|NCT00229723|311482|P2|Concomitant Phase|Unspecified|0
88736|NCT00229723|311483|P1|Concomitant Phase|Unspecified|3
88737|NCT00229723|311477|P7|Concomitant Phase|Severe non-compliance|0
88738|NCT00229723|311478|P6|Concomitant Phase|Severe non-compliance|0
88739|NCT00229723|311479|P5|Concomitant Phase|Severe non-compliance|1
88740|NCT00229723|311480|P4|Concomitant Phase|Severe non-compliance|0
88741|NCT00229723|311481|P3|Concomitant Phase|Severe non-compliance|0
88742|NCT00229723|311482|P2|Concomitant Phase|Severe non-compliance|1
88743|NCT00229723|311483|P1|Concomitant Phase|Severe non-compliance|0
88744|NCT00229723|311477|P7|Concomitant Phase|Informed consent withdrawn|0
88745|NCT00229723|311478|P6|Concomitant Phase|Informed consent withdrawn|0
88746|NCT00229723|311479|P5|Concomitant Phase|Informed consent withdrawn|0
88747|NCT00229723|311480|P4|Concomitant Phase|Informed consent withdrawn|2
88748|NCT00229723|311481|P3|Concomitant Phase|Informed consent withdrawn|0
88749|NCT00229723|311482|P2|Concomitant Phase|Informed consent withdrawn|2
88750|NCT00229723|311483|P1|Concomitant Phase|Informed consent withdrawn|3
88751|NCT00229723|311477|P7|Concomitant Phase|Lost to Follow-up|0
88752|NCT00229723|311478|P6|Concomitant Phase|Lost to Follow-up|0
88753|NCT00229723|311479|P5|Concomitant Phase|Lost to Follow-up|1
88754|NCT00229723|311480|P4|Concomitant Phase|Lost to Follow-up|0
88755|NCT00229723|311481|P3|Concomitant Phase|Lost to Follow-up|0
88756|NCT00229723|311482|P2|Concomitant Phase|Lost to Follow-up|0
88757|NCT00229723|311483|P1|Concomitant Phase|Lost to Follow-up|0
88758|NCT00229723|311477|P7|Concomitant Phase|Clinical progression|1
88759|NCT00229723|311478|P6|Concomitant Phase|Clinical progression|0
88760|NCT00229723|311479|P5|Concomitant Phase|Clinical progression|0
88761|NCT00229723|311480|P4|Concomitant Phase|Clinical progression|0
88762|NCT00229723|311481|P3|Concomitant Phase|Clinical progression|0
88763|NCT00229723|311482|P2|Concomitant Phase|Clinical progression|0
88764|NCT00229723|311483|P1|Concomitant Phase|Clinical progression|0
88765|NCT00229723|311477|P7|Concomitant Phase|Objective disease progression|0
88766|NCT00229723|311478|P6|Concomitant Phase|Objective disease progression|0
88767|NCT00229723|311479|P5|Concomitant Phase|Objective disease progression|0
88768|NCT00229723|311480|P4|Concomitant Phase|Objective disease progression|0
88769|NCT00229723|311481|P3|Concomitant Phase|Objective disease progression|0
88770|NCT00229723|311482|P2|Concomitant Phase|Objective disease progression|0
88771|NCT00229723|311483|P1|Concomitant Phase|Objective disease progression|0
88772|NCT00229723|311477|P7|Concomitant Phase|Adverse Event|2
88773|NCT00229723|311478|P6|Concomitant Phase|Adverse Event|1
88774|NCT00229723|311479|P5|Concomitant Phase|Adverse Event|0
88775|NCT00229723|311480|P4|Concomitant Phase|Adverse Event|2
88776|NCT00229723|311481|P3|Concomitant Phase|Adverse Event|5
88777|NCT00229723|311482|P2|Concomitant Phase|Adverse Event|2
88778|NCT00229723|311483|P1|Concomitant Phase|Adverse Event|4
88779|NCT00229931|311536|P2|Overall Study|Lost to Follow-up|2
88780|NCT00229931|311537|P1|Overall Study|Lost to Follow-up|3
88781|NCT00229931|311536|P2|Overall Study|Death|0
88782|NCT00229931|311537|P1|Overall Study|Death|1
88783|NCT00230048|311595|P2|Overall Study|Lost to Follow-up|18
88784|NCT00230048|311596|P1|Overall Study|Lost to Follow-up|13
88785|NCT00230178|311643|P3|Overall Study|Various other reasons|4
88786|NCT00230178|311644|P2|Overall Study|Various other reasons|2
88787|NCT00230178|311645|P1|Overall Study|Various other reasons|3
88788|NCT00230178|311643|P3|Overall Study|Withdrawal by Subject|1
88789|NCT00230178|311644|P2|Overall Study|Withdrawal by Subject|0
88790|NCT00230178|311645|P1|Overall Study|Withdrawal by Subject|0
88791|NCT00230178|311643|P3|Overall Study|Adverse Event|2
88792|NCT00230178|311644|P2|Overall Study|Adverse Event|5
88793|NCT00230178|311645|P1|Overall Study|Adverse Event|1
88794|NCT00230282|311659|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
88795|NCT00230282|311659|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
88796|NCT00230282|311659|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
88797|NCT00230282|311659|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
88798|NCT00230971|311692|P2|Baseline Participants|Reintervention|0
88799|NCT00230971|311693|P1|Baseline Participants|Reintervention|1
88800|NCT00230971|311692|P2|Baseline Participants|Failure to return|1
88801|NCT00230971|311693|P1|Baseline Participants|Failure to return|1
88802|NCT00230971|311692|P2|Baseline Participants|No bacteria observed|0
88803|NCT00230971|311693|P1|Baseline Participants|No bacteria observed|1
88804|NCT00230971|311692|P2|Baseline Participants|Adverse Event|0
88805|NCT00230971|311693|P1|Baseline Participants|Adverse Event|1
88806|NCT00230971|311692|P2|Baseline Participants|Withdrawal by Subject|1
88807|NCT00230971|311693|P1|Baseline Participants|Withdrawal by Subject|7
88808|NCT00230971|311692|P2|Baseline Participants|Death|5
88809|NCT00230971|311693|P1|Baseline Participants|Death|6
88810|NCT00230971|311692|P2|Baseline Participants|Lost to Follow-up|12
88811|NCT00230971|311693|P1|Baseline Participants|Lost to Follow-up|5
88812|NCT00230971|311692|P2|Randomization|No study drug administered|3
88813|NCT00230971|311693|P1|Randomization|No study drug administered|3
88814|NCT00231062|311705|P1|Overall Study|Physician Decision|6
88815|NCT00231114|311713|P2|Post-Treatment Period|Withdrawal by Subject|0
88816|NCT00231114|311714|P1|Post-Treatment Period|Withdrawal by Subject|1
88817|NCT00231114|311713|P2|Post-Treatment Period|Physician Decision|0
88818|NCT00231114|311714|P1|Post-Treatment Period|Physician Decision|1
88819|NCT00231114|311713|P2|Post-Treatment Period|Lost to Follow-up|1
88820|NCT00231114|311714|P1|Post-Treatment Period|Lost to Follow-up|6
88821|NCT00231114|311713|P2|Treatment Period|Death: Motor Vehicle Accident|0
88822|NCT00231114|311714|P1|Treatment Period|Death: Motor Vehicle Accident|1
88823|NCT00231114|311713|P2|Randomized|Withdrawal by Subject|3
88824|NCT00231114|311714|P1|Randomized|Withdrawal by Subject|6
88825|NCT00231179|311763|P2|Overall Study|Withdrawal by Subject|3
88826|NCT00231179|311764|P1|Overall Study|Withdrawal by Subject|3
88827|NCT00231179|311763|P2|Overall Study|Lost to Follow-up|21
88828|NCT00231179|311764|P1|Overall Study|Lost to Follow-up|21
88829|NCT00231465|311790|P1|Overall Study|Did not have follow up CT scans|1
88830|NCT00231465|311790|P1|Overall Study|Completed only one cycle|1
88831|NCT00231478|311798|P2|Overall Study|Administrative|2
88832|NCT00231478|311799|P1|Overall Study|Administrative|3
88833|NCT00231478|311798|P2|Overall Study|Adverse Event|1
88834|NCT00231478|311799|P1|Overall Study|Adverse Event|0
88835|NCT00231478|311798|P2|Overall Study|Withdrawal by Subject|0
88836|NCT00231478|311799|P1|Overall Study|Withdrawal by Subject|1
88837|NCT00231478|311798|P2|Overall Study|Refused Treatment|1
88838|NCT00231478|311799|P1|Overall Study|Refused Treatment|1
88839|NCT00231478|311798|P2|Overall Study|Protocol Violation|2
88840|NCT00231478|311799|P1|Overall Study|Protocol Violation|3
88841|NCT00231777|311813|P2|Overall Study|Unspecified|2
88842|NCT00231777|311814|P1|Overall Study|Unspecified|3
88843|NCT00231777|311813|P2|Overall Study|Lost to Follow-up|0
88844|NCT00231777|311814|P1|Overall Study|Lost to Follow-up|3
88845|NCT00224484|311829|P3|Overall Study|Reaon not specified|2
88846|NCT00224484|311830|P2|Overall Study|Reaon not specified|4
88847|NCT00224484|311831|P1|Overall Study|Reaon not specified|5
88848|NCT00224484|311829|P3|Overall Study|Lost to Follow-up|36
88849|NCT00224484|311830|P2|Overall Study|Lost to Follow-up|28
88850|NCT00224484|311831|P1|Overall Study|Lost to Follow-up|66
88851|NCT00224484|311829|P3|Overall Study|Migrated/moved from study area|5
88852|NCT00224484|311830|P2|Overall Study|Migrated/moved from study area|5
88853|NCT00224484|311831|P1|Overall Study|Migrated/moved from study area|18
88854|NCT00224484|311829|P3|Overall Study|Withdrawal by Subject|16
88855|NCT00224484|311830|P2|Overall Study|Withdrawal by Subject|18
88856|NCT00224484|311831|P1|Overall Study|Withdrawal by Subject|49
88857|NCT00224484|311829|P3|Overall Study|Protocol Violation|0
88858|NCT00224484|311830|P2|Overall Study|Protocol Violation|2
88859|NCT00224484|311831|P1|Overall Study|Protocol Violation|2
88860|NCT00224484|311829|P3|Overall Study|Non-Serious Adverse Event|3
88861|NCT00224484|311830|P2|Overall Study|Non-Serious Adverse Event|7
88862|NCT00224484|311831|P1|Overall Study|Non-Serious Adverse Event|5
88863|NCT00224484|311829|P3|Overall Study|Serious Adverse Event|0
88864|NCT00224484|311830|P2|Overall Study|Serious Adverse Event|1
88865|NCT00224484|311831|P1|Overall Study|Serious Adverse Event|1
88866|NCT00224770|311893|P3|Overall Study|Lost to Follow-up|0
88867|NCT00224770|311894|P2|Overall Study|Lost to Follow-up|2
88868|NCT00224770|311895|P1|Overall Study|Lost to Follow-up|4
88869|NCT00224874|311931|P4|Overall Study|Withdrawal by Subject|0
88870|NCT00224874|311932|P3|Overall Study|Withdrawal by Subject|1
88871|NCT00224874|311933|P2|Overall Study|Withdrawal by Subject|0
88872|NCT00224874|311934|P1|Overall Study|Withdrawal by Subject|0
88873|NCT00225147|312009|P4|Open-label Phase|Withdrawal by Subject|6
88874|NCT00225147|312010|P3|Open-label Phase|Withdrawal by Subject|0
88875|NCT00225147|312011|P2|Open-label Phase|Withdrawal by Subject|0
88876|NCT00225147|312012|P1|Open-label Phase|Withdrawal by Subject|0
88877|NCT00225147|312009|P4|Open-label Phase|Lost to Follow-up|4
88878|NCT00225147|312010|P3|Open-label Phase|Lost to Follow-up|0
88879|NCT00225147|312011|P2|Open-label Phase|Lost to Follow-up|0
88880|NCT00225147|312012|P1|Open-label Phase|Lost to Follow-up|0
88881|NCT00225212|312026|P1|Overall Study|Intercurrent illness|1
88882|NCT00225212|312026|P1|Overall Study|Adverse Event|2
88883|NCT00225212|312026|P1|Overall Study|Death|1
88884|NCT00225212|312026|P1|Overall Study|Disease progression|2
88885|NCT00225251|312033|P2|Overall Study|Withdrawal by Subject|1
88886|NCT00225251|312034|P1|Overall Study|Withdrawal by Subject|1
88887|NCT00225277|312050|P2|Overall Study|Other|9
88888|NCT00225277|312051|P1|Overall Study|Other|7
88889|NCT00225277|312050|P2|Overall Study|Withdrawal by Subject|34
88890|NCT00225277|312051|P1|Overall Study|Withdrawal by Subject|40
88891|NCT00225277|312050|P2|Overall Study|Protocol Violation|3
88892|NCT00225277|312051|P1|Overall Study|Protocol Violation|6
88893|NCT00225277|312050|P2|Overall Study|Physician Decision|8
88894|NCT00225277|312051|P1|Overall Study|Physician Decision|6
88895|NCT00225277|312050|P2|Overall Study|Lost to Follow-up|6
88896|NCT00225277|312051|P1|Overall Study|Lost to Follow-up|4
88897|NCT00225277|312050|P2|Overall Study|Lack of Efficacy|1
88898|NCT00225277|312051|P1|Overall Study|Lack of Efficacy|4
88899|NCT00225277|312050|P2|Overall Study|Adverse Event|34
88900|NCT00225277|312051|P1|Overall Study|Adverse Event|30
88901|NCT00231816|312102|P2|Overall Study|Not Specified|1
88902|NCT00231816|312103|P1|Overall Study|Not Specified|2
88903|NCT00231816|312102|P2|Overall Study|Withdrawal by Subject|3
88904|NCT00231816|312103|P1|Overall Study|Withdrawal by Subject|3
88905|NCT00231816|312102|P2|Overall Study|Protocol Violation|3
88906|NCT00231816|312103|P1|Overall Study|Protocol Violation|2
88907|NCT00231816|312102|P2|Overall Study|Lost to Follow-up|5
88908|NCT00231816|312103|P1|Overall Study|Lost to Follow-up|8
88909|NCT00231816|312102|P2|Overall Study|Adverse Event|0
88910|NCT00231816|312103|P1|Overall Study|Adverse Event|1
88911|NCT00233064|312118|P2|Overall Study|Moved to Dom. Republic|0
88912|NCT00233064|312119|P1|Overall Study|Moved to Dom. Republic|1
88913|NCT00233064|312118|P2|Overall Study|Protocol Violation|0
88914|NCT00233064|312119|P1|Overall Study|Protocol Violation|1
88915|NCT00233064|312118|P2|Overall Study|Relocation|1
88916|NCT00233064|312119|P1|Overall Study|Relocation|0
88917|NCT00233064|312118|P2|Overall Study|Death|1
88918|NCT00233064|312119|P1|Overall Study|Death|0
88919|NCT00233064|312118|P2|Overall Study|Withdrawal by Subject|3
88920|NCT00233064|312119|P1|Overall Study|Withdrawal by Subject|5
88921|NCT00233064|312118|P2|Overall Study|Lost to Follow-up|7
88922|NCT00233064|312119|P1|Overall Study|Lost to Follow-up|7
88923|NCT00233324|312168|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
88924|NCT00233324|312169|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
88925|NCT00233324|312170|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
88926|NCT00233324|312171|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
88927|NCT00233324|312168|P4|Follow up at 18-22 Months Corrected Age|Death|4
88928|NCT00233324|312169|P3|Follow up at 18-22 Months Corrected Age|Death|5
88929|NCT00233324|312170|P2|Follow up at 18-22 Months Corrected Age|Death|7
88930|NCT00233324|312171|P1|Follow up at 18-22 Months Corrected Age|Death|5
88931|NCT00233324|312168|P4|Main Study|Death|47
88932|NCT00233324|312169|P3|Main Study|Death|62
88933|NCT00233324|312170|P2|Main Study|Death|60
88934|NCT00233324|312171|P1|Main Study|Death|68
88935|NCT00233402|312187|P2|Overall Study|Lost to follow up etc|21
88936|NCT00233402|312188|P1|Overall Study|Lost to follow up etc|3
88937|NCT00233402|312187|P2|Overall Study|No Ta/T1|94
88938|NCT00233402|312188|P1|Overall Study|No Ta/T1|89
88939|NCT00233402|312187|P2|Overall Study|No pathology data|9
88940|NCT00233402|312188|P1|Overall Study|No pathology data|12
88941|NCT00233454|312199|P1|Overall Study|Death|6
88942|NCT00233948|312215|P6|Overall Study|Adverse Event|0
88943|NCT00233948|312216|P5|Overall Study|Adverse Event|0
88944|NCT00233948|312217|P4|Overall Study|Adverse Event|0
88945|NCT00233948|312218|P3|Overall Study|Adverse Event|0
88946|NCT00233948|312219|P2|Overall Study|Adverse Event|0
88947|NCT00233948|312220|P1|Overall Study|Adverse Event|1
88948|NCT00233987|312235|P1|Overall Study|Ineligible|4
88949|NCT00233987|312235|P1|Overall Study|Eligible but No Treatment Received|2
88950|NCT00233987|312235|P1|Overall Study|Other - Not Protocol Specified|5
88951|NCT00233987|312235|P1|Overall Study|Reason Under Review|1
88952|NCT00233987|312235|P1|Overall Study|Lack of Efficacy|2
88953|NCT00233987|312235|P1|Overall Study|Withdrawal by Subject|1
88954|NCT00234039|312242|P1|Overall Study|No Protocol Treatment Received|2
88955|NCT00234039|312242|P1|Overall Study|Ineligible|9
88956|NCT00234039|312242|P1|Overall Study|Other - Not Protocol Specified|3
88957|NCT00234039|312242|P1|Overall Study|Progression/relapse|34
88958|NCT00234039|312242|P1|Overall Study|Adverse Event|2
88959|NCT00234065|312251|P2|Overall Study|Not Classified|112
88960|NCT00234065|312252|P1|Overall Study|Not Classified|111
88961|NCT00234065|312251|P2|Overall Study|Physician Decision|22
88962|NCT00234065|312252|P1|Overall Study|Physician Decision|23
88963|NCT00234065|312251|P2|Overall Study|Withdrawal by Subject|56
88964|NCT00234065|312252|P1|Overall Study|Withdrawal by Subject|73
88965|NCT00234065|312251|P2|Overall Study|Adverse Event|166
88966|NCT00234065|312252|P1|Overall Study|Adverse Event|268
88967|NCT00234104|312301|P4|Overall Study|Physician Decision|2
88968|NCT00234104|312302|P3|Overall Study|Physician Decision|2
88969|NCT00234104|312303|P2|Overall Study|Physician Decision|1
88970|NCT00234104|312304|P1|Overall Study|Physician Decision|0
88971|NCT00234104|312301|P4|Overall Study|Protocol Violation|1
88972|NCT00234104|312302|P3|Overall Study|Protocol Violation|0
88973|NCT00234104|312303|P2|Overall Study|Protocol Violation|0
88974|NCT00234104|312304|P1|Overall Study|Protocol Violation|0
88975|NCT00234104|312301|P4|Overall Study|Adverse Event|5
88976|NCT00234104|312302|P3|Overall Study|Adverse Event|3
88977|NCT00234104|312303|P2|Overall Study|Adverse Event|0
88978|NCT00234104|312304|P1|Overall Study|Adverse Event|4
88979|NCT00234494|312349|P1|Overall Study|Protocol Violation|2
88980|NCT00235326|312394|P2|Overall Study|Lost to Follow-up|1400
88981|NCT00235326|312395|P1|Overall Study|Lost to Follow-up|746
88982|NCT00235391|312405|P6|Overall Study|Death|0
88983|NCT00235391|312406|P5|Overall Study|Death|0
88984|NCT00235391|312407|P4|Overall Study|Death|4
88985|NCT00235391|312408|P3|Overall Study|Death|1
88986|NCT00235391|312409|P2|Overall Study|Death|0
88987|NCT00235391|312410|P1|Overall Study|Death|0
88988|NCT00235391|312405|P6|Overall Study|Administrative problems|0
88989|NCT00235391|312406|P5|Overall Study|Administrative problems|0
88990|NCT00235391|312407|P4|Overall Study|Administrative problems|1
88991|NCT00235391|312408|P3|Overall Study|Administrative problems|0
88992|NCT00235391|312409|P2|Overall Study|Administrative problems|0
88993|NCT00235391|312410|P1|Overall Study|Administrative problems|0
88994|NCT00235391|312405|P6|Overall Study|Lost to Follow-up|0
88995|NCT00235391|312406|P5|Overall Study|Lost to Follow-up|0
88996|NCT00235391|312407|P4|Overall Study|Lost to Follow-up|16
88997|NCT00235391|312408|P3|Overall Study|Lost to Follow-up|3
88998|NCT00235391|312409|P2|Overall Study|Lost to Follow-up|3
88999|NCT00235391|312410|P1|Overall Study|Lost to Follow-up|0
89000|NCT00235391|312405|P6|Overall Study|Withdrawal by Subject|0
89001|NCT00235391|312406|P5|Overall Study|Withdrawal by Subject|5
89002|NCT00235391|312407|P4|Overall Study|Withdrawal by Subject|61
89003|NCT00235391|312408|P3|Overall Study|Withdrawal by Subject|3
89004|NCT00235391|312409|P2|Overall Study|Withdrawal by Subject|3
89005|NCT00235391|312410|P1|Overall Study|Withdrawal by Subject|2
89006|NCT00235391|312405|P6|Overall Study|Protocol deviation|0
89007|NCT00235391|312406|P5|Overall Study|Protocol deviation|0
89008|NCT00235391|312407|P4|Overall Study|Protocol deviation|11
89009|NCT00235391|312408|P3|Overall Study|Protocol deviation|1
89010|NCT00235391|312409|P2|Overall Study|Protocol deviation|0
89011|NCT00235391|312410|P1|Overall Study|Protocol deviation|0
89012|NCT00235391|312405|P6|Overall Study|Condition no longer requires treatment|0
89013|NCT00235391|312406|P5|Overall Study|Condition no longer requires treatment|1
89014|NCT00235391|312407|P4|Overall Study|Condition no longer requires treatment|11
89015|NCT00235391|312408|P3|Overall Study|Condition no longer requires treatment|0
89016|NCT00235391|312409|P2|Overall Study|Condition no longer requires treatment|0
89017|NCT00235391|312410|P1|Overall Study|Condition no longer requires treatment|3
89018|NCT00235391|312405|P6|Overall Study|Unsatisfactory therapeutic effect|0
89019|NCT00235391|312406|P5|Overall Study|Unsatisfactory therapeutic effect|0
89020|NCT00235391|312407|P4|Overall Study|Unsatisfactory therapeutic effect|17
89021|NCT00235391|312408|P3|Overall Study|Unsatisfactory therapeutic effect|2
89022|NCT00235391|312409|P2|Overall Study|Unsatisfactory therapeutic effect|2
89023|NCT00235391|312410|P1|Overall Study|Unsatisfactory therapeutic effect|0
89024|NCT00235391|312405|P6|Overall Study|Abnormal laboratory value(s)|2
89025|NCT00235391|312406|P5|Overall Study|Abnormal laboratory value(s)|1
89026|NCT00235391|312407|P4|Overall Study|Abnormal laboratory value(s)|27
89027|NCT00235391|312408|P3|Overall Study|Abnormal laboratory value(s)|4
89028|NCT00235391|312409|P2|Overall Study|Abnormal laboratory value(s)|5
89029|NCT00235391|312410|P1|Overall Study|Abnormal laboratory value(s)|3
89030|NCT00235391|312405|P6|Overall Study|Adverse Event|2
89031|NCT00235391|312406|P5|Overall Study|Adverse Event|5
89032|NCT00235391|312407|P4|Overall Study|Adverse Event|72
89033|NCT00235391|312408|P3|Overall Study|Adverse Event|10
89034|NCT00235391|312409|P2|Overall Study|Adverse Event|5
89035|NCT00235391|312410|P1|Overall Study|Adverse Event|4
89036|NCT00235443|312431|P6|Overall Study|Other reasons for premature termination|6
89037|NCT00235443|312432|P5|Overall Study|Other reasons for premature termination|3
89038|NCT00235443|312433|P4|Overall Study|Other reasons for premature termination|7
89039|NCT00235443|312434|P3|Overall Study|Other reasons for premature termination|6
89040|NCT00235443|312435|P2|Overall Study|Other reasons for premature termination|6
89041|NCT00235443|312436|P1|Overall Study|Other reasons for premature termination|1
89042|NCT00235443|312431|P6|Overall Study|Unsatisfactory compliance|0
89043|NCT00235443|312432|P5|Overall Study|Unsatisfactory compliance|1
89044|NCT00235443|312433|P4|Overall Study|Unsatisfactory compliance|4
89045|NCT00235443|312434|P3|Overall Study|Unsatisfactory compliance|3
89046|NCT00235443|312435|P2|Overall Study|Unsatisfactory compliance|2
89047|NCT00235443|312436|P1|Overall Study|Unsatisfactory compliance|0
89048|NCT00235443|312431|P6|Overall Study|Lost to Follow-up|3
89049|NCT00235443|312432|P5|Overall Study|Lost to Follow-up|4
89050|NCT00235443|312433|P4|Overall Study|Lost to Follow-up|6
89051|NCT00235443|312434|P3|Overall Study|Lost to Follow-up|6
89052|NCT00235443|312435|P2|Overall Study|Lost to Follow-up|8
89053|NCT00235443|312436|P1|Overall Study|Lost to Follow-up|0
89054|NCT00235443|312431|P6|Overall Study|Withdrawal by Subject|12
89055|NCT00235443|312432|P5|Overall Study|Withdrawal by Subject|10
89056|NCT00235443|312433|P4|Overall Study|Withdrawal by Subject|24
89057|NCT00235443|312434|P3|Overall Study|Withdrawal by Subject|25
89058|NCT00235443|312435|P2|Overall Study|Withdrawal by Subject|9
89059|NCT00235443|312436|P1|Overall Study|Withdrawal by Subject|3
89060|NCT00235443|312431|P6|Overall Study|Lack of Efficacy|9
89061|NCT00235443|312432|P5|Overall Study|Lack of Efficacy|2
89062|NCT00235443|312433|P4|Overall Study|Lack of Efficacy|12
89063|NCT00235443|312434|P3|Overall Study|Lack of Efficacy|5
89064|NCT00235443|312435|P2|Overall Study|Lack of Efficacy|1
89065|NCT00235443|312436|P1|Overall Study|Lack of Efficacy|0
89066|NCT00235443|312431|P6|Overall Study|Adverse Event|15
89067|NCT00235443|312432|P5|Overall Study|Adverse Event|10
89068|NCT00235443|312433|P4|Overall Study|Adverse Event|44
89069|NCT00235443|312434|P3|Overall Study|Adverse Event|17
89070|NCT00235443|312435|P2|Overall Study|Adverse Event|12
89071|NCT00235443|312436|P1|Overall Study|Adverse Event|4
89072|NCT00229203|312592|P2|Overall Study|Withdrawal by Subject|4
89073|NCT00229203|312593|P1|Overall Study|Withdrawal by Subject|1
89074|NCT00229203|312592|P2|Overall Study|Other|3
89075|NCT00229203|312593|P1|Overall Study|Other|3
89076|NCT00229203|312592|P2|Overall Study|Death|2
89077|NCT00229203|312593|P1|Overall Study|Death|4
89078|NCT00229203|312592|P2|Overall Study|Toxicity|1
89079|NCT00229203|312593|P1|Overall Study|Toxicity|6
89080|NCT00229203|312592|P2|Overall Study|Progressive disease|9
89081|NCT00229203|312593|P1|Overall Study|Progressive disease|18
89082|NCT00235716|312613|P4|Overall Study|Physician Decision|3
89083|NCT00235716|312614|P3|Overall Study|Physician Decision|1
89084|NCT00235716|312615|P2|Overall Study|Physician Decision|1
89085|NCT00235716|312616|P1|Overall Study|Physician Decision|0
89086|NCT00235716|312613|P4|Overall Study|Adverse Event|0
89087|NCT00235716|312614|P3|Overall Study|Adverse Event|1
89088|NCT00235716|312615|P2|Overall Study|Adverse Event|1
89089|NCT00235716|312616|P1|Overall Study|Adverse Event|1
89090|NCT00235716|312613|P4|Overall Study|Lost to Follow-up|10
89091|NCT00235716|312614|P3|Overall Study|Lost to Follow-up|14
89092|NCT00235716|312615|P2|Overall Study|Lost to Follow-up|7
89093|NCT00235716|312616|P1|Overall Study|Lost to Follow-up|12
89094|NCT00235716|312613|P4|Overall Study|Withdrawal by Subject|18
89095|NCT00235716|312614|P3|Overall Study|Withdrawal by Subject|17
89096|NCT00235716|312615|P2|Overall Study|Withdrawal by Subject|19
89097|NCT00235716|312616|P1|Overall Study|Withdrawal by Subject|23
89098|NCT00235716|312613|P4|Overall Study|Death|31
89099|NCT00235716|312614|P3|Overall Study|Death|32
89100|NCT00235716|312615|P2|Overall Study|Death|39
89101|NCT00235716|312616|P1|Overall Study|Death|26
89102|NCT00235755|312653|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
89103|NCT00235755|312654|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
89104|NCT00235755|312655|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
89105|NCT00235755|312653|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
89106|NCT00235755|312654|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
89107|NCT00235755|312655|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
89108|NCT00235755|312653|P3|12-Week Maintenance Phase|Protocol Violation|2
89109|NCT00235755|312654|P2|12-Week Maintenance Phase|Protocol Violation|4
89110|NCT00235755|312655|P1|12-Week Maintenance Phase|Protocol Violation|0
89111|NCT00235755|312653|P3|12-Week Maintenance Phase|Lack of Efficacy|0
89112|NCT00235755|312654|P2|12-Week Maintenance Phase|Lack of Efficacy|0
89113|NCT00235755|312655|P1|12-Week Maintenance Phase|Lack of Efficacy|5
89114|NCT00235755|312653|P3|12-Week Maintenance Phase|Lost to Follow-up|0
89115|NCT00235755|312654|P2|12-Week Maintenance Phase|Lost to Follow-up|3
89116|NCT00235755|312655|P1|12-Week Maintenance Phase|Lost to Follow-up|2
89117|NCT00235755|312653|P3|12-Week Maintenance Phase|Adverse Event|26
89118|NCT00235755|312654|P2|12-Week Maintenance Phase|Adverse Event|12
89119|NCT00235755|312655|P1|12-Week Maintenance Phase|Adverse Event|8
89120|NCT00235755|312653|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
89121|NCT00235755|312654|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
89122|NCT00235755|312655|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
89123|NCT00235755|312653|P3|4-Week Titration Phase|Randomization Occurred in Error|0
89124|NCT00235755|312654|P2|4-Week Titration Phase|Randomization Occurred in Error|0
89125|NCT00235755|312655|P1|4-Week Titration Phase|Randomization Occurred in Error|1
89126|NCT00235755|312653|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
89127|NCT00235755|312654|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
89128|NCT00235755|312655|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
89129|NCT00235755|312653|P3|4-Week Titration Phase|Withdrawal by Subject|3
89130|NCT00235755|312654|P2|4-Week Titration Phase|Withdrawal by Subject|2
89131|NCT00235755|312655|P1|4-Week Titration Phase|Withdrawal by Subject|1
89132|NCT00235755|312653|P3|4-Week Titration Phase|Protocol Violation|1
89133|NCT00235755|312654|P2|4-Week Titration Phase|Protocol Violation|2
89134|NCT00235755|312655|P1|4-Week Titration Phase|Protocol Violation|2
89135|NCT00235755|312653|P3|4-Week Titration Phase|Lost to Follow-up|1
89136|NCT00235755|312654|P2|4-Week Titration Phase|Lost to Follow-up|1
89137|NCT00235755|312655|P1|4-Week Titration Phase|Lost to Follow-up|0
89138|NCT00235755|312653|P3|4-Week Titration Phase|Adverse Event|20
89139|NCT00235755|312654|P2|4-Week Titration Phase|Adverse Event|14
89140|NCT00235755|312655|P1|4-Week Titration Phase|Adverse Event|6
89141|NCT00235872|312742|P1|Overall Study|Administrative reason|61
89142|NCT00235872|312742|P1|Overall Study|Withdrawal by Subject|50
89143|NCT00235872|312742|P1|Overall Study|Lost to Follow-up|1
89144|NCT00235872|312742|P1|Overall Study|Death|1
89145|NCT00235872|312742|P1|Overall Study|Adverse Event|34
89146|NCT00236080|312762|P5|Overall Study|Miscellaneous|0
89147|NCT00236080|312763|P4|Overall Study|Miscellaneous|0
89148|NCT00236080|312764|P3|Overall Study|Miscellaneous|1
89149|NCT00236080|312765|P2|Overall Study|Miscellaneous|0
89150|NCT00236080|312766|P1|Overall Study|Miscellaneous|0
89151|NCT00236080|312762|P5|Overall Study|Withdrawal by Subject|0
89152|NCT00236080|312763|P4|Overall Study|Withdrawal by Subject|0
89153|NCT00236080|312764|P3|Overall Study|Withdrawal by Subject|0
89154|NCT00236080|312765|P2|Overall Study|Withdrawal by Subject|0
89155|NCT00236080|312766|P1|Overall Study|Withdrawal by Subject|1
89156|NCT00236080|312762|P5|Overall Study|Physician Decision|1
89157|NCT00236080|312763|P4|Overall Study|Physician Decision|1
89158|NCT00236080|312764|P3|Overall Study|Physician Decision|1
89159|NCT00236080|312765|P2|Overall Study|Physician Decision|0
89160|NCT00236080|312766|P1|Overall Study|Physician Decision|1
89161|NCT00236080|312762|P5|Overall Study|Lost to Follow-up|0
89162|NCT00236080|312763|P4|Overall Study|Lost to Follow-up|0
89163|NCT00236080|312764|P3|Overall Study|Lost to Follow-up|0
89164|NCT00236080|312765|P2|Overall Study|Lost to Follow-up|1
89165|NCT00236080|312766|P1|Overall Study|Lost to Follow-up|0
89166|NCT00236080|312762|P5|Overall Study|Adverse Event|0
89167|NCT00236080|312763|P4|Overall Study|Adverse Event|1
89168|NCT00236080|312764|P3|Overall Study|Adverse Event|3
89169|NCT00236080|312765|P2|Overall Study|Adverse Event|0
89170|NCT00236080|312766|P1|Overall Study|Adverse Event|0
89171|NCT00236184|312785|P2|Overall Study|other|2
89172|NCT00236184|312786|P1|Overall Study|other|1
89173|NCT00236184|312785|P2|Overall Study|non-compliance with study drug|1
89174|NCT00236184|312786|P1|Overall Study|non-compliance with study drug|2
89175|NCT00236184|312785|P2|Overall Study|Protocol Violation|0
89176|NCT00236184|312786|P1|Overall Study|Protocol Violation|3
89177|NCT00236184|312785|P2|Overall Study|Withdrawal by Subject|0
89178|NCT00236184|312786|P1|Overall Study|Withdrawal by Subject|3
89179|NCT00236184|312785|P2|Overall Study|Physician Decision|1
89180|NCT00236184|312786|P1|Overall Study|Physician Decision|1
89181|NCT00236184|312785|P2|Overall Study|Lost to Follow-up|4
89182|NCT00236184|312786|P1|Overall Study|Lost to Follow-up|3
89183|NCT00236184|312785|P2|Overall Study|Lack of Efficacy|1
89184|NCT00236184|312786|P1|Overall Study|Lack of Efficacy|0
89185|NCT00236184|312785|P2|Overall Study|Adverse Event|2
89186|NCT00236184|312786|P1|Overall Study|Adverse Event|5
89187|NCT00236197|312794|P2|Overall Study|Other|2
89188|NCT00236197|312795|P1|Overall Study|Other|0
89189|NCT00236197|312794|P2|Overall Study|Medication non-compliance|2
89190|NCT00236197|312795|P1|Overall Study|Medication non-compliance|1
89191|NCT00236197|312794|P2|Overall Study|Protocol Violation|3
89192|NCT00236197|312795|P1|Overall Study|Protocol Violation|0
89193|NCT00236197|312794|P2|Overall Study|Lost to Follow-up|5
89194|NCT00236197|312795|P1|Overall Study|Lost to Follow-up|1
89195|NCT00236197|312794|P2|Overall Study|Withdrawal by Subject|2
89196|NCT00236197|312795|P1|Overall Study|Withdrawal by Subject|3
89197|NCT00236899|312805|P4|Overall Study|Lack of Efficacy|23
89198|NCT00236899|312806|P3|Overall Study|Lack of Efficacy|25
89199|NCT00236899|312807|P2|Overall Study|Lack of Efficacy|18
89200|NCT00236899|312808|P1|Overall Study|Lack of Efficacy|18
89201|NCT00236899|312805|P4|Overall Study|Satisfactory Response|1
89202|NCT00236899|312806|P3|Overall Study|Satisfactory Response|0
89203|NCT00236899|312807|P2|Overall Study|Satisfactory Response|0
89204|NCT00236899|312808|P1|Overall Study|Satisfactory Response|2
89205|NCT00236899|312805|P4|Overall Study|Physician Decision|6
89206|NCT00236899|312806|P3|Overall Study|Physician Decision|7
89207|NCT00236899|312807|P2|Overall Study|Physician Decision|8
89208|NCT00236899|312808|P1|Overall Study|Physician Decision|7
89209|NCT00236899|312805|P4|Overall Study|Withdrawal by Subject|2
89210|NCT00236899|312806|P3|Overall Study|Withdrawal by Subject|5
89211|NCT00236899|312807|P2|Overall Study|Withdrawal by Subject|4
89212|NCT00236899|312808|P1|Overall Study|Withdrawal by Subject|6
89213|NCT00236899|312805|P4|Overall Study|Protocol Violation|0
89214|NCT00236899|312806|P3|Overall Study|Protocol Violation|0
89215|NCT00236899|312807|P2|Overall Study|Protocol Violation|0
89216|NCT00236899|312808|P1|Overall Study|Protocol Violation|1
89217|NCT00236899|312805|P4|Overall Study|Entry Criteria Exclusion|0
89218|NCT00236899|312806|P3|Overall Study|Entry Criteria Exclusion|1
89219|NCT00236899|312807|P2|Overall Study|Entry Criteria Exclusion|1
89220|NCT00236899|312808|P1|Overall Study|Entry Criteria Exclusion|0
89221|NCT00236899|312805|P4|Overall Study|Lost to Follow-up|0
89222|NCT00236899|312806|P3|Overall Study|Lost to Follow-up|0
89223|NCT00236899|312807|P2|Overall Study|Lost to Follow-up|1
89224|NCT00236899|312808|P1|Overall Study|Lost to Follow-up|0
89225|NCT00236899|312805|P4|Overall Study|Death (Study Drug Toxicity)|0
89226|NCT00236899|312806|P3|Overall Study|Death (Study Drug Toxicity)|0
89227|NCT00236899|312807|P2|Overall Study|Death (Study Drug Toxicity)|0
89228|NCT00236899|312808|P1|Overall Study|Death (Study Drug Toxicity)|1
89229|NCT00236899|312805|P4|Overall Study|Death (Not Study Related)|0
89230|NCT00236899|312806|P3|Overall Study|Death (Not Study Related)|0
89231|NCT00236899|312807|P2|Overall Study|Death (Not Study Related)|0
89232|NCT00236899|312808|P1|Overall Study|Death (Not Study Related)|2
89233|NCT00236899|312805|P4|Overall Study|Death (Study Disease)|0
89234|NCT00236899|312806|P3|Overall Study|Death (Study Disease)|0
89235|NCT00236899|312807|P2|Overall Study|Death (Study Disease)|4
89236|NCT00236899|312808|P1|Overall Study|Death (Study Disease)|1
89237|NCT00236899|312805|P4|Overall Study|Adverse Event (Not Study Related)|7
89238|NCT00236899|312806|P3|Overall Study|Adverse Event (Not Study Related)|4
89239|NCT00236899|312807|P2|Overall Study|Adverse Event (Not Study Related)|3
89240|NCT00236899|312808|P1|Overall Study|Adverse Event (Not Study Related)|3
89241|NCT00236899|312805|P4|Overall Study|Adverse Event (Study Related)|1
89242|NCT00236899|312806|P3|Overall Study|Adverse Event (Study Related)|2
89243|NCT00236899|312807|P2|Overall Study|Adverse Event (Study Related)|1
89244|NCT00236899|312808|P1|Overall Study|Adverse Event (Study Related)|1
89245|NCT00237042|312894|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
89246|NCT00237042|312895|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
89247|NCT00237042|312896|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
89248|NCT00237042|312894|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
89249|NCT00237042|312895|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
89250|NCT00237042|312896|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
89251|NCT00237042|312894|P3|Treatment|Completed no treatment|21
89252|NCT00237042|312895|P2|Treatment|Completed no treatment|5
89253|NCT00237042|312896|P1|Treatment|Completed no treatment|5
89254|NCT00237042|312894|P3|Treatment|Moved out of state|1
89255|NCT00237042|312895|P2|Treatment|Moved out of state|1
89256|NCT00237042|312896|P1|Treatment|Moved out of state|1
89257|NCT00237042|312894|P3|Treatment|Became ineligible post-randomization|16
89258|NCT00237042|312895|P2|Treatment|Became ineligible post-randomization|1
89259|NCT00237042|312896|P1|Treatment|Became ineligible post-randomization|0
89260|NCT00237185|312915|P2|Extension|Death|1
89261|NCT00237185|312916|P1|Extension|Death|1
89262|NCT00237185|312915|P2|Extension|Administrative problems|0
89263|NCT00237185|312916|P1|Extension|Administrative problems|1
89264|NCT00237185|312915|P2|Extension|Lost to Follow-up|0
89265|NCT00237185|312916|P1|Extension|Lost to Follow-up|1
89266|NCT00237185|312915|P2|Extension|Withdrawal by Subject|2
89267|NCT00237185|312916|P1|Extension|Withdrawal by Subject|3
89268|NCT00237185|312915|P2|Extension|Condition no longer required study drug|1
89269|NCT00237185|312916|P1|Extension|Condition no longer required study drug|0
89270|NCT00237185|312915|P2|Extension|Lack of Efficacy|14
89271|NCT00237185|312916|P1|Extension|Lack of Efficacy|9
89272|NCT00237185|312915|P2|Extension|Abnormal laboratory value|1
89273|NCT00237185|312916|P1|Extension|Abnormal laboratory value|0
89274|NCT00237185|312915|P2|Extension|Adverse Event|0
89275|NCT00237185|312916|P1|Extension|Adverse Event|1
89276|NCT00237185|312915|P2|Core|Determined ineligible post randomization|0
89277|NCT00237185|312916|P1|Core|Determined ineligible post randomization|1
89278|NCT00237185|312915|P2|Core|Death|0
89279|NCT00237185|312916|P1|Core|Death|4
89280|NCT00237185|312915|P2|Core|Administrative problems|1
89281|NCT00237185|312916|P1|Core|Administrative problems|0
89282|NCT00237185|312915|P2|Core|Withdrawal by Subject|4
89283|NCT00237185|312916|P1|Core|Withdrawal by Subject|4
89284|NCT00237185|312915|P2|Core|Protocol Violation|1
89285|NCT00237185|312916|P1|Core|Protocol Violation|1
89286|NCT00237185|312915|P2|Core|Lack of Efficacy|23
89287|NCT00237185|312916|P1|Core|Lack of Efficacy|30
89288|NCT00237185|312915|P2|Core|Abnormal test procedure results|0
89289|NCT00237185|312916|P1|Core|Abnormal test procedure results|1
89290|NCT00237185|312915|P2|Core|Abnormal laboratory value|4
89291|NCT00237185|312916|P1|Core|Abnormal laboratory value|0
89292|NCT00237185|312915|P2|Core|Adverse Event|4
89293|NCT00237185|312916|P1|Core|Adverse Event|3
89294|NCT00237458|312944|P1|Overall Study|Withdrawal by Subject|1
89295|NCT00237458|312944|P1|Overall Study|Adverse Event|1
89296|NCT00237458|312944|P1|Overall Study|Lack of Efficacy|1
89297|NCT00237692|312974|P4|Overall Study|Withdrawal by Subject|4
89298|NCT00237692|312975|P3|Overall Study|Withdrawal by Subject|10
89299|NCT00237692|312976|P2|Overall Study|Withdrawal by Subject|6
89300|NCT00237692|312977|P1|Overall Study|Withdrawal by Subject|4
89301|NCT00237692|312974|P4|Overall Study|Excluded - did not meet criteria|9
89302|NCT00237692|312975|P3|Overall Study|Excluded - did not meet criteria|5
89303|NCT00237692|312976|P2|Overall Study|Excluded - did not meet criteria|3
89304|NCT00237692|312977|P1|Overall Study|Excluded - did not meet criteria|4
89305|NCT00237692|312974|P4|Overall Study|Death|3
89306|NCT00237692|312975|P3|Overall Study|Death|2
89307|NCT00237692|312976|P2|Overall Study|Death|2
89308|NCT00237692|312977|P1|Overall Study|Death|1
89309|NCT00237692|312974|P4|Overall Study|Lost to Follow-up|3
89310|NCT00237692|312975|P3|Overall Study|Lost to Follow-up|5
89311|NCT00237692|312976|P2|Overall Study|Lost to Follow-up|3
89312|NCT00237692|312977|P1|Overall Study|Lost to Follow-up|9
89313|NCT00237744|313021|P3|Overall Study|Withdrawal by Subject|0
89314|NCT00237744|313022|P2|Overall Study|Withdrawal by Subject|1
89315|NCT00237744|313023|P1|Overall Study|Withdrawal by Subject|3
89316|NCT00237796|313049|P2|Overall Study|Baseline and one other ILSS required|5
89317|NCT00237796|313050|P1|Overall Study|Baseline and one other ILSS required|10
89318|NCT00237809|313072|P4|Overall Study|Lost to Follow-up|9
89319|NCT00237809|313073|P3|Overall Study|Lost to Follow-up|9
89320|NCT00237809|313074|P2|Overall Study|Lost to Follow-up|10
89321|NCT00237809|313075|P1|Overall Study|Lost to Follow-up|11
89322|NCT00238121|313120|P2|Overall Study|Adverse Event|1
89323|NCT00238121|313121|P1|Overall Study|Adverse Event|2
89324|NCT00238121|313120|P2|Overall Study|Withdrawal by Subject|1
89325|NCT00238121|313121|P1|Overall Study|Withdrawal by Subject|1
89326|NCT00238238|313135|P3|Overall Study|Withdrawal by Subject|0
89327|NCT00238238|313136|P2|Overall Study|Withdrawal by Subject|3
89328|NCT00238238|313137|P1|Overall Study|Withdrawal by Subject|0
89329|NCT00238264|313148|P1|Overall Study|Ineligible|7
89330|NCT00238264|313148|P1|Overall Study|Withdrawal by Subject|4
89331|NCT00238264|313148|P1|Overall Study|Lost to Follow-up|18
89332|NCT00238264|313148|P1|Overall Study|Death|7
89333|NCT00238303|313161|P3|Overall Study|Adverse Event|3
89334|NCT00238303|313162|P2|Overall Study|Adverse Event|1
89335|NCT00238303|313163|P1|Overall Study|Adverse Event|0
89336|NCT00238303|313161|P3|Overall Study|Poor tolerance of study treatment|1
89337|NCT00238303|313162|P2|Overall Study|Poor tolerance of study treatment|0
89338|NCT00238303|313163|P1|Overall Study|Poor tolerance of study treatment|1
89339|NCT00238303|313161|P3|Overall Study|Other Medical Problems|2
89340|NCT00238303|313162|P2|Overall Study|Other Medical Problems|0
89341|NCT00238303|313163|P1|Overall Study|Other Medical Problems|2
89342|NCT00238303|313161|P3|Overall Study|Death|1
89343|NCT00238303|313162|P2|Overall Study|Death|0
89344|NCT00238303|313163|P1|Overall Study|Death|1
89345|NCT00238303|313161|P3|Overall Study|Withdrawal by Subject|2
89346|NCT00238303|313162|P2|Overall Study|Withdrawal by Subject|1
89347|NCT00238303|313163|P1|Overall Study|Withdrawal by Subject|11
89348|NCT00238420|313186|P2|Overall Study|Protocol Violation|1
89349|NCT00238420|313187|P1|Overall Study|Protocol Violation|1
89350|NCT00238433|313197|P1|Overall Study|Death|1
89351|NCT00238433|313197|P1|Overall Study|Lost to Follow-up|1
89352|NCT00238433|313197|P1|Overall Study|Screen failure|1
89353|NCT00232141|313204|P2|Overall Study|Withdrawal by Subject|3
89354|NCT00232141|313205|P1|Overall Study|Withdrawal by Subject|5
89355|NCT00232141|313204|P2|Overall Study|Other|10
89356|NCT00232141|313205|P1|Overall Study|Other|8
89357|NCT00232141|313204|P2|Overall Study|Lost to Follow-up|6
89358|NCT00232141|313205|P1|Overall Study|Lost to Follow-up|9
89359|NCT00232141|313204|P2|Overall Study|Lack of Efficacy|3
89360|NCT00232141|313205|P1|Overall Study|Lack of Efficacy|0
89361|NCT00232141|313204|P2|Overall Study|Adverse Event|4
89362|NCT00232141|313205|P1|Overall Study|Adverse Event|9
89363|NCT00232180|313275|P3|Open Label Phase|Randomized but not treated|1
89364|NCT00232180|313276|P2|Open Label Phase|Randomized but not treated|0
89365|NCT00232180|313277|P1|Open Label Phase|Randomized but not treated|0
89366|NCT00232180|313275|P3|Open Label Phase|Laboratory abnormality|10
89367|NCT00232180|313276|P2|Open Label Phase|Laboratory abnormality|0
89368|NCT00232180|313277|P1|Open Label Phase|Laboratory abnormality|0
89369|NCT00232180|313275|P3|Open Label Phase|Adverse Event|25
89370|NCT00232180|313276|P2|Open Label Phase|Adverse Event|0
89371|NCT00232180|313277|P1|Open Label Phase|Adverse Event|0
89372|NCT00232180|313275|P3|Open Label Phase|Unspecified|16
89373|NCT00232180|313276|P2|Open Label Phase|Unspecified|0
89374|NCT00232180|313277|P1|Open Label Phase|Unspecified|0
89375|NCT00232180|313275|P3|Open Label Phase|Withdrawal by Subject|37
89376|NCT00232180|313276|P2|Open Label Phase|Withdrawal by Subject|0
89377|NCT00232180|313277|P1|Open Label Phase|Withdrawal by Subject|0
89378|NCT00232180|313275|P3|Open Label Phase|Study terminated by sponsor|3
89379|NCT00232180|313276|P2|Open Label Phase|Study terminated by sponsor|0
89380|NCT00232180|313277|P1|Open Label Phase|Study terminated by sponsor|0
89381|NCT00232180|313275|P3|Open Label Phase|Protocol Violation|3
89382|NCT00232180|313276|P2|Open Label Phase|Protocol Violation|0
89383|NCT00232180|313277|P1|Open Label Phase|Protocol Violation|0
89384|NCT00232180|313275|P3|Open Label Phase|Lost to Follow-up|5
89385|NCT00232180|313276|P2|Open Label Phase|Lost to Follow-up|0
89386|NCT00232180|313277|P1|Open Label Phase|Lost to Follow-up|0
89387|NCT00232180|313275|P3|Open Label Phase|Death|48
89388|NCT00232180|313276|P2|Open Label Phase|Death|0
89389|NCT00232180|313277|P1|Open Label Phase|Death|0
89390|NCT00232180|313275|P3|Double-blind (DB) Phase|Laboratory abnormality|0
89391|NCT00232180|313276|P2|Double-blind (DB) Phase|Laboratory abnormality|7
89392|NCT00232180|313277|P1|Double-blind (DB) Phase|Laboratory abnormality|6
89393|NCT00232180|313275|P3|Double-blind (DB) Phase|Randomized but not treated|0
89394|NCT00232180|313276|P2|Double-blind (DB) Phase|Randomized but not treated|4
89395|NCT00232180|313277|P1|Double-blind (DB) Phase|Randomized but not treated|3
89396|NCT00232180|313275|P3|Double-blind (DB) Phase|Unspecified|0
89397|NCT00232180|313276|P2|Double-blind (DB) Phase|Unspecified|75
89398|NCT00232180|313277|P1|Double-blind (DB) Phase|Unspecified|70
89399|NCT00232180|313275|P3|Double-blind (DB) Phase|Adverse Event|0
89400|NCT00232180|313276|P2|Double-blind (DB) Phase|Adverse Event|100
89401|NCT00232180|313277|P1|Double-blind (DB) Phase|Adverse Event|83
89402|NCT00232180|313275|P3|Double-blind (DB) Phase|Protocol Violation|0
89403|NCT00232180|313276|P2|Double-blind (DB) Phase|Protocol Violation|21
89404|NCT00232180|313277|P1|Double-blind (DB) Phase|Protocol Violation|28
89405|NCT00232180|313275|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
89406|NCT00232180|313276|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
89407|NCT00232180|313277|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
89408|NCT00232180|313275|P3|Double-blind (DB) Phase|Lost to Follow-up|0
89409|NCT00232180|313276|P2|Double-blind (DB) Phase|Lost to Follow-up|28
89410|NCT00232180|313277|P1|Double-blind (DB) Phase|Lost to Follow-up|34
89411|NCT00232180|313275|P3|Double-blind (DB) Phase|Death|0
89412|NCT00232180|313276|P2|Double-blind (DB) Phase|Death|222
89413|NCT00232180|313277|P1|Double-blind (DB) Phase|Death|186
89414|NCT00232544|313343|P2|Overall Study|Lost to Follow-up|15
89415|NCT00232544|313344|P1|Overall Study|Lost to Follow-up|20
89416|NCT00232557|313354|P2|Overall Study|Lost to Follow-up|5
89417|NCT00232557|313355|P1|Overall Study|Lost to Follow-up|3
89418|NCT00232596|313374|P2|12-Week Maintenance Phase|Other|3
89419|NCT00232596|313375|P1|12-Week Maintenance Phase|Other|1
89420|NCT00232596|313374|P2|12-Week Maintenance Phase|Protocol Violation|1
89421|NCT00232596|313375|P1|12-Week Maintenance Phase|Protocol Violation|3
89422|NCT00232596|313374|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
89423|NCT00232596|313375|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
89424|NCT00232596|313374|P2|12-Week Maintenance Phase|Adverse Event|22
89425|NCT00232596|313375|P1|12-Week Maintenance Phase|Adverse Event|7
89426|NCT00232596|313374|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
89427|NCT00232596|313375|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
89428|NCT00232596|313374|P2|6-Week Titration Phase|Other|3
89429|NCT00232596|313375|P1|6-Week Titration Phase|Other|3
89430|NCT00232596|313374|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
89431|NCT00232596|313375|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
89432|NCT00232596|313374|P2|6-Week Titration Phase|Protocol Violation|3
89433|NCT00232596|313375|P1|6-Week Titration Phase|Protocol Violation|1
89434|NCT00232596|313374|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
89435|NCT00232596|313375|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
89436|NCT00232596|313374|P2|6-Week Titration Phase|Failed to Return|1
89437|NCT00232596|313375|P1|6-Week Titration Phase|Failed to Return|2
89438|NCT00232596|313374|P2|6-Week Titration Phase|Adverse Event|19
89439|NCT00232596|313375|P1|6-Week Titration Phase|Adverse Event|6
89440|NCT00240994|313577|P1|Overall Study|Graft failure|1
89441|NCT00240994|313577|P1|Overall Study|Protocol Violation|1
89442|NCT00240994|313577|P1|Overall Study|Lost to Follow-up|1
89443|NCT00241280|313590|P2|Overall Study|Excessive Dryness|1
89444|NCT00241280|313591|P1|Overall Study|Excessive Dryness|0
89445|NCT00241280|313590|P2|Overall Study|Coating on Lens|0
89446|NCT00241280|313591|P1|Overall Study|Coating on Lens|1
89447|NCT00241280|313590|P2|Overall Study|History of Ocular Surgery|1
89448|NCT00241280|313591|P1|Overall Study|History of Ocular Surgery|0
89449|NCT00241280|313590|P2|Overall Study|Scheduling Conflict|2
89450|NCT00241280|313591|P1|Overall Study|Scheduling Conflict|0
89451|NCT00241280|313590|P2|Overall Study|Unacceptable Fit|1
89452|NCT00241280|313591|P1|Overall Study|Unacceptable Fit|0
89453|NCT00241280|313590|P2|Overall Study|Dispensed incorrect test article|2
89454|NCT00241280|313591|P1|Overall Study|Dispensed incorrect test article|1
89455|NCT00241280|313590|P2|Overall Study|Subject Ineligible/Dispensed|6
89456|NCT00241280|313591|P1|Overall Study|Subject Ineligible/Dispensed|9
89457|NCT00241280|313590|P2|Overall Study|Diabetic|0
89458|NCT00241280|313591|P1|Overall Study|Diabetic|1
89459|NCT00241280|313590|P2|Overall Study|Unsatisfactory Visual Response|1
89460|NCT00241280|313591|P1|Overall Study|Unsatisfactory Visual Response|1
89461|NCT00241280|313590|P2|Overall Study|Unsatisfactory Physiological Response|1
89462|NCT00241280|313591|P1|Overall Study|Unsatisfactory Physiological Response|1
89463|NCT00241280|313590|P2|Overall Study|Relocation|4
89464|NCT00241280|313591|P1|Overall Study|Relocation|4
89465|NCT00241280|313590|P2|Overall Study|Protocol Violation|10
89466|NCT00241280|313591|P1|Overall Study|Protocol Violation|4
89467|NCT00241280|313590|P2|Overall Study|Withdrawal by Subject|4
89468|NCT00241280|313591|P1|Overall Study|Withdrawal by Subject|7
89469|NCT00241280|313590|P2|Overall Study|Lost to Follow-up|8
89470|NCT00241280|313591|P1|Overall Study|Lost to Follow-up|5
89471|NCT00241280|313590|P2|Overall Study|Pregnancy|5
89472|NCT00241280|313591|P1|Overall Study|Pregnancy|1
89473|NCT00241280|313590|P2|Overall Study|Discomfort|16
89474|NCT00241280|313591|P1|Overall Study|Discomfort|11
89475|NCT00241280|313590|P2|Overall Study|Adverse Event|6
89476|NCT00241280|313591|P1|Overall Study|Adverse Event|2
89477|NCT00241358|313602|P3|Overall Study|Determined to be not ineligible|1
89478|NCT00241358|313603|P2|Overall Study|Determined to be not ineligible|1
89479|NCT00241358|313604|P1|Overall Study|Determined to be not ineligible|0
89480|NCT00241644|313639|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
89481|NCT00241644|313640|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
89482|NCT00241644|313641|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
89483|NCT00241644|313642|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
89484|NCT00241644|313639|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
89485|NCT00241644|313640|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
89486|NCT00241644|313641|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
89487|NCT00241644|313642|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
89488|NCT00241644|313639|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
89489|NCT00241644|313640|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
89490|NCT00241644|313641|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
89491|NCT00241644|313642|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
89492|NCT00241644|313639|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
89493|NCT00241644|313640|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
89494|NCT00241644|313641|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
89495|NCT00241644|313642|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
89496|NCT00241644|313639|P4|Second Efficacy Period (Year 2)|Adverse Event|20
89497|NCT00241644|313640|P3|Second Efficacy Period (Year 2)|Adverse Event|12
89498|NCT00241644|313641|P2|Second Efficacy Period (Year 2)|Adverse Event|9
89499|NCT00241644|313642|P1|Second Efficacy Period (Year 2)|Adverse Event|11
89500|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
89501|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
89502|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
89503|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
89504|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
89505|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
89506|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
89507|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
89508|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
89509|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
89510|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
89511|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
89512|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Non-compliance|3
89513|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Non-compliance|2
89514|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Non-compliance|1
89515|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Non-compliance|2
89516|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
89517|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
89518|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
89519|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
89520|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
89521|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
89522|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
89523|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
89524|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Protocol Violation|8
89525|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Protocol Violation|4
89526|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Protocol Violation|5
89527|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Protocol Violation|3
89528|NCT00241644|313639|P4|First Efficacy Period (Year 1)|Adverse Event|91
89529|NCT00241644|313640|P3|First Efficacy Period (Year 1)|Adverse Event|45
89530|NCT00241644|313641|P2|First Efficacy Period (Year 1)|Adverse Event|45
89531|NCT00241644|313642|P1|First Efficacy Period (Year 1)|Adverse Event|46
89532|NCT00241839|313726|P2|Overall Study|Adverse Event|1
89533|NCT00241839|313727|P1|Overall Study|Adverse Event|1
89534|NCT00241839|313726|P2|Overall Study|Withdrawal by Subject|17
89535|NCT00241839|313727|P1|Overall Study|Withdrawal by Subject|18
89536|NCT00242216|313741|P2|Overall Study|no medicaiton dispensed|1
89537|NCT00242216|313742|P1|Overall Study|no medicaiton dispensed|1
89538|NCT00242216|313741|P2|Overall Study|Lack of Efficacy|2
89539|NCT00242216|313742|P1|Overall Study|Lack of Efficacy|1
89540|NCT00242216|313741|P2|Overall Study|Death|2
89541|NCT00242216|313742|P1|Overall Study|Death|4
89542|NCT00242216|313741|P2|Overall Study|Lost to Follow-up|17
89543|NCT00242216|313742|P1|Overall Study|Lost to Follow-up|12
89544|NCT00242567|313781|P2|Overall Study|Other|9
89545|NCT00242567|313782|P1|Overall Study|Other|14
89546|NCT00242567|313781|P2|Overall Study|Use of an inhibitor of bone resorption|2
89547|NCT00242567|313782|P1|Overall Study|Use of an inhibitor of bone resorption|0
89548|NCT00242567|313781|P2|Overall Study|Protocol Violation|12
89549|NCT00242567|313782|P1|Overall Study|Protocol Violation|12
89550|NCT00242567|313781|P2|Overall Study|Withdrawal by Subject|28
89551|NCT00242567|313782|P1|Overall Study|Withdrawal by Subject|33
89552|NCT00242567|313781|P2|Overall Study|Lost to Follow-up|19
89553|NCT00242567|313782|P1|Overall Study|Lost to Follow-up|9
89554|NCT00242567|313781|P2|Overall Study|Lack of Efficacy|2
89555|NCT00242567|313782|P1|Overall Study|Lack of Efficacy|2
89556|NCT00242567|313781|P2|Overall Study|Symptomatic deterioration|3
89557|NCT00242567|313782|P1|Overall Study|Symptomatic deterioration|9
89558|NCT00242567|313781|P2|Overall Study|Disease Progression|22
89559|NCT00242567|313782|P1|Overall Study|Disease Progression|17
89560|NCT00242567|313781|P2|Overall Study|Adverse Event|43
89561|NCT00242567|313782|P1|Overall Study|Adverse Event|70
89562|NCT00242580|313801|P3|Overall Study|Death|1
89563|NCT00242580|313802|P2|Overall Study|Death|2
89564|NCT00242580|313803|P1|Overall Study|Death|1
89565|NCT00242580|313801|P3|Overall Study|Lost to Follow-up|0
89566|NCT00242580|313802|P2|Overall Study|Lost to Follow-up|3
89567|NCT00242580|313803|P1|Overall Study|Lost to Follow-up|0
89568|NCT00242580|313801|P3|Overall Study|Subject withdrew consent|5
89569|NCT00242580|313802|P2|Overall Study|Subject withdrew consent|2
89570|NCT00242580|313803|P1|Overall Study|Subject withdrew consent|2
89571|NCT00242580|313801|P3|Overall Study|Protocol Violation|1
89572|NCT00242580|313802|P2|Overall Study|Protocol Violation|0
89573|NCT00242580|313803|P1|Overall Study|Protocol Violation|0
89574|NCT00242580|313801|P3|Overall Study|Unsatisfactory therapeutic effect|5
89575|NCT00242580|313802|P2|Overall Study|Unsatisfactory therapeutic effect|5
89576|NCT00242580|313803|P1|Overall Study|Unsatisfactory therapeutic effect|4
89577|NCT00242580|313801|P3|Overall Study|Adverse Event|2
89578|NCT00242580|313802|P2|Overall Study|Adverse Event|0
89579|NCT00242580|313803|P1|Overall Study|Adverse Event|3
89580|NCT00242658|313848|P2|Overall Study|Lost to Follow-up|19
89581|NCT00242658|313849|P1|Overall Study|Lost to Follow-up|22
89582|NCT00242710|313866|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
89583|NCT00242710|313867|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
89584|NCT00242710|313868|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
89661|NCT00242710|313869|P1|Core Study (up to Year 1)|Death|0
89585|NCT00242710|313869|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
89586|NCT00242710|313866|P4|Study Extension (up to Year 2)|Protocol Violation|1
89587|NCT00242710|313867|P3|Study Extension (up to Year 2)|Protocol Violation|0
89588|NCT00242710|313868|P2|Study Extension (up to Year 2)|Protocol Violation|2
89589|NCT00242710|313869|P1|Study Extension (up to Year 2)|Protocol Violation|0
89590|NCT00242710|313866|P4|Study Extension (up to Year 2)|Unspecified|3
89591|NCT00242710|313867|P3|Study Extension (up to Year 2)|Unspecified|4
89592|NCT00242710|313868|P2|Study Extension (up to Year 2)|Unspecified|5
89593|NCT00242710|313869|P1|Study Extension (up to Year 2)|Unspecified|3
89594|NCT00242710|313866|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
89595|NCT00242710|313867|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
89596|NCT00242710|313868|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
89597|NCT00242710|313869|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
89598|NCT00242710|313866|P4|Study Extension (up to Year 2)|Death|1
89599|NCT00242710|313867|P3|Study Extension (up to Year 2)|Death|0
89600|NCT00242710|313868|P2|Study Extension (up to Year 2)|Death|0
89601|NCT00242710|313869|P1|Study Extension (up to Year 2)|Death|0
89602|NCT00242710|313866|P4|Study Extension (up to Year 2)|Adverse Event|4
89603|NCT00242710|313867|P3|Study Extension (up to Year 2)|Adverse Event|2
89604|NCT00242710|313868|P2|Study Extension (up to Year 2)|Adverse Event|9
89605|NCT00242710|313869|P1|Study Extension (up to Year 2)|Adverse Event|7
89606|NCT00242710|313866|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
89607|NCT00242710|313867|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
89608|NCT00242710|313868|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
89609|NCT00242710|313869|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
89610|NCT00242710|313866|P4|Period Between Core Study and Extension|Protocol Violation|1
89611|NCT00242710|313867|P3|Period Between Core Study and Extension|Protocol Violation|2
89612|NCT00242710|313868|P2|Period Between Core Study and Extension|Protocol Violation|0
89613|NCT00242710|313869|P1|Period Between Core Study and Extension|Protocol Violation|0
89614|NCT00242710|313866|P4|Period Between Core Study and Extension|Extension not Available|7
89615|NCT00242710|313867|P3|Period Between Core Study and Extension|Extension not Available|8
89616|NCT00242710|313868|P2|Period Between Core Study and Extension|Extension not Available|21
89617|NCT00242710|313869|P1|Period Between Core Study and Extension|Extension not Available|17
89618|NCT00242710|313866|P4|Period Between Core Study and Extension|Unspecified|11
89619|NCT00242710|313867|P3|Period Between Core Study and Extension|Unspecified|9
89620|NCT00242710|313868|P2|Period Between Core Study and Extension|Unspecified|24
89621|NCT00242710|313869|P1|Period Between Core Study and Extension|Unspecified|24
89622|NCT00242710|313866|P4|Period Between Core Study and Extension|Physician Decision|0
89623|NCT00242710|313867|P3|Period Between Core Study and Extension|Physician Decision|0
89624|NCT00242710|313868|P2|Period Between Core Study and Extension|Physician Decision|1
89625|NCT00242710|313869|P1|Period Between Core Study and Extension|Physician Decision|1
89626|NCT00242710|313866|P4|Period Between Core Study and Extension|Adverse Event|2
89627|NCT00242710|313867|P3|Period Between Core Study and Extension|Adverse Event|5
89628|NCT00242710|313868|P2|Period Between Core Study and Extension|Adverse Event|3
89629|NCT00242710|313869|P1|Period Between Core Study and Extension|Adverse Event|2
89630|NCT00242710|313866|P4|Core Study (up to Year 1)|Randomized but not Treated|2
89631|NCT00242710|313867|P3|Core Study (up to Year 1)|Randomized but not Treated|4
89632|NCT00242710|313868|P2|Core Study (up to Year 1)|Randomized but not Treated|4
89633|NCT00242710|313869|P1|Core Study (up to Year 1)|Randomized but not Treated|12
89634|NCT00242710|313866|P4|Core Study (up to Year 1)|Lack of Efficacy|0
89635|NCT00242710|313867|P3|Core Study (up to Year 1)|Lack of Efficacy|0
89636|NCT00242710|313868|P2|Core Study (up to Year 1)|Lack of Efficacy|0
89637|NCT00242710|313869|P1|Core Study (up to Year 1)|Lack of Efficacy|1
89638|NCT00242710|313866|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
89639|NCT00242710|313867|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
89640|NCT00242710|313868|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
89641|NCT00242710|313869|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
89642|NCT00242710|313866|P4|Core Study (up to Year 1)|Protocol Violation|3
89643|NCT00242710|313867|P3|Core Study (up to Year 1)|Protocol Violation|1
89644|NCT00242710|313868|P2|Core Study (up to Year 1)|Protocol Violation|9
89645|NCT00242710|313869|P1|Core Study (up to Year 1)|Protocol Violation|2
89646|NCT00242710|313866|P4|Core Study (up to Year 1)|Unspecified|2
89647|NCT00242710|313867|P3|Core Study (up to Year 1)|Unspecified|0
89648|NCT00242710|313868|P2|Core Study (up to Year 1)|Unspecified|1
89649|NCT00242710|313869|P1|Core Study (up to Year 1)|Unspecified|6
89650|NCT00242710|313866|P4|Core Study (up to Year 1)|Lost to Follow-up|3
89651|NCT00242710|313867|P3|Core Study (up to Year 1)|Lost to Follow-up|7
89652|NCT00242710|313868|P2|Core Study (up to Year 1)|Lost to Follow-up|8
89653|NCT00242710|313869|P1|Core Study (up to Year 1)|Lost to Follow-up|8
89654|NCT00242710|313866|P4|Core Study (up to Year 1)|Physician Decision|1
89655|NCT00242710|313867|P3|Core Study (up to Year 1)|Physician Decision|0
89656|NCT00242710|313868|P2|Core Study (up to Year 1)|Physician Decision|1
89657|NCT00242710|313869|P1|Core Study (up to Year 1)|Physician Decision|0
89658|NCT00242710|313866|P4|Core Study (up to Year 1)|Death|0
89659|NCT00242710|313867|P3|Core Study (up to Year 1)|Death|1
89660|NCT00242710|313868|P2|Core Study (up to Year 1)|Death|0
89662|NCT00242710|313866|P4|Core Study (up to Year 1)|Adverse Event|14
89663|NCT00242710|313867|P3|Core Study (up to Year 1)|Adverse Event|23
89664|NCT00242710|313868|P2|Core Study (up to Year 1)|Adverse Event|25
89665|NCT00242710|313869|P1|Core Study (up to Year 1)|Adverse Event|30
89666|NCT00235989|313923|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
89667|NCT00235989|313924|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
89668|NCT00235989|313925|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
89669|NCT00235989|313926|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
89670|NCT00235989|313927|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
89671|NCT00235989|313928|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
89672|NCT00235989|313923|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
89673|NCT00235989|313924|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
89674|NCT00235989|313925|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
89675|NCT00235989|313926|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
89676|NCT00235989|313927|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
89677|NCT00235989|313928|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
89678|NCT00235989|313923|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
89679|NCT00235989|313924|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
89680|NCT00235989|313925|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
89681|NCT00235989|313926|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
89682|NCT00235989|313927|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
89683|NCT00235989|313928|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
89684|NCT00235989|313923|P6|Extension Treatment Period (ET)|Adverse Event|0
89685|NCT00235989|313924|P5|Extension Treatment Period (ET)|Adverse Event|0
89686|NCT00235989|313925|P4|Extension Treatment Period (ET)|Adverse Event|0
89687|NCT00235989|313926|P3|Extension Treatment Period (ET)|Adverse Event|2
89688|NCT00235989|313927|P2|Extension Treatment Period (ET)|Adverse Event|0
89689|NCT00235989|313928|P1|Extension Treatment Period (ET)|Adverse Event|3
89690|NCT00235989|313923|P6|Core Treatment Period (CT)|Lost to Follow-up|2
89691|NCT00235989|313924|P5|Core Treatment Period (CT)|Lost to Follow-up|0
89692|NCT00235989|313925|P4|Core Treatment Period (CT)|Lost to Follow-up|0
89693|NCT00235989|313926|P3|Core Treatment Period (CT)|Lost to Follow-up|0
89694|NCT00235989|313927|P2|Core Treatment Period (CT)|Lost to Follow-up|0
89695|NCT00235989|313928|P1|Core Treatment Period (CT)|Lost to Follow-up|0
89696|NCT00243022|313944|P2|Overall Study|Difficult Travel Distance|1
89697|NCT00243022|313945|P1|Overall Study|Difficult Travel Distance|0
89698|NCT00243022|313944|P2|Overall Study|Death|0
89699|NCT00243022|313945|P1|Overall Study|Death|1
89700|NCT00243022|313944|P2|Overall Study|Withdrawal by Subject|0
89701|NCT00243022|313945|P1|Overall Study|Withdrawal by Subject|1
89702|NCT00243074|313972|P1|Overall Study|Did not receive any treatment|1
89703|NCT00243074|313972|P1|Overall Study|not protocol specified|1
89704|NCT00243074|313972|P1|Overall Study|Death|2
89705|NCT00243074|313972|P1|Overall Study|Lack of Efficacy|36
89706|NCT00243074|313972|P1|Overall Study|Withdrawal by Subject|2
89707|NCT00243074|313972|P1|Overall Study|Adverse Event|6
89708|NCT00243074|313972|P1|Overall Study|Ineligible|6
89709|NCT00243269|313998|P4|Overall Study|Lost to Follow-up|3
89710|NCT00243269|313999|P3|Overall Study|Lost to Follow-up|1
89711|NCT00243269|314000|P2|Overall Study|Lost to Follow-up|0
89712|NCT00243269|314001|P1|Overall Study|Lost to Follow-up|1
89713|NCT00243269|313998|P4|Overall Study|Protocol Violation|1
89714|NCT00243269|313999|P3|Overall Study|Protocol Violation|0
89715|NCT00243269|314000|P2|Overall Study|Protocol Violation|1
89716|NCT00243269|314001|P1|Overall Study|Protocol Violation|2
89717|NCT00243919|314018|P3|Overall Study|Physician Decision|0
89718|NCT00243919|314019|P2|Overall Study|Physician Decision|1
89719|NCT00243919|314020|P1|Overall Study|Physician Decision|1
89720|NCT00243919|314018|P3|Overall Study|Administrative Error|0
89721|NCT00243919|314019|P2|Overall Study|Administrative Error|0
89722|NCT00243919|314020|P1|Overall Study|Administrative Error|1
89723|NCT00243919|314018|P3|Overall Study|Lost to Follow-up|3
89724|NCT00243919|314019|P2|Overall Study|Lost to Follow-up|7
89725|NCT00243919|314020|P1|Overall Study|Lost to Follow-up|6
89726|NCT00243919|314018|P3|Overall Study|Withdrawal by Subject|2
89727|NCT00243919|314019|P2|Overall Study|Withdrawal by Subject|6
89728|NCT00243919|314020|P1|Overall Study|Withdrawal by Subject|6
89729|NCT00243919|314018|P3|Overall Study|Death|6
89730|NCT00243919|314019|P2|Overall Study|Death|4
89731|NCT00243919|314020|P1|Overall Study|Death|3
89732|NCT00243932|314064|P3|Stage 1: Dose Selection|Lost to Follow-up|0
89733|NCT00243932|314065|P2|Stage 1: Dose Selection|Lost to Follow-up|0
89734|NCT00243932|314066|P1|Stage 1: Dose Selection|Lost to Follow-up|2
89735|NCT00244374|314111|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
89736|NCT00244374|314112|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
89737|NCT00244374|314113|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
89738|NCT00244374|314114|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
89739|NCT00244374|314115|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
89740|NCT00244374|314111|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
89806|NCT00244712|314155|P2|Overall Study|Withdrawal by Subject|23
89741|NCT00244374|314112|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
89742|NCT00244374|314113|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
89743|NCT00244374|314114|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
89744|NCT00244374|314115|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
89745|NCT00244374|314111|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
89746|NCT00244374|314112|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
89747|NCT00244374|314113|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
89748|NCT00244374|314114|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
89749|NCT00244374|314115|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
89750|NCT00244374|314111|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
89751|NCT00244374|314112|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
89752|NCT00244374|314113|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
89753|NCT00244374|314114|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
89754|NCT00244374|314115|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
89755|NCT00244374|314111|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
89756|NCT00244374|314112|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
89757|NCT00244374|314113|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
89758|NCT00244374|314114|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
89759|NCT00244374|314115|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
89760|NCT00244374|314111|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
89761|NCT00244374|314112|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
89762|NCT00244374|314113|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
89763|NCT00244374|314114|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
89764|NCT00244374|314115|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
89765|NCT00244374|314111|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
89766|NCT00244374|314112|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
89767|NCT00244374|314113|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
89768|NCT00244374|314114|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
89769|NCT00244374|314115|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
89770|NCT00244374|314111|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
89771|NCT00244374|314112|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
89772|NCT00244374|314113|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
89773|NCT00244374|314114|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
89774|NCT00244374|314115|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
89775|NCT00244374|314111|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
89776|NCT00244374|314112|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
89777|NCT00244374|314113|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
89778|NCT00244374|314114|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
89779|NCT00244374|314115|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
89780|NCT00244621|314134|P3|Open-label Treatment Period|Moved abroad|1
89781|NCT00244621|314135|P2|Open-label Treatment Period|Moved abroad|0
89782|NCT00244621|314136|P1|Open-label Treatment Period|Moved abroad|0
89783|NCT00244621|314134|P3|Open-label Treatment Period|Adverse Event|1
89784|NCT00244621|314135|P2|Open-label Treatment Period|Adverse Event|0
89785|NCT00244621|314136|P1|Open-label Treatment Period|Adverse Event|0
89786|NCT00244621|314134|P3|Open-label Treatment Period|Withdrawal by Subject|0
89787|NCT00244621|314135|P2|Open-label Treatment Period|Withdrawal by Subject|0
89788|NCT00244621|314136|P1|Open-label Treatment Period|Withdrawal by Subject|1
89789|NCT00244621|314134|P3|Open-label Treatment Period|Lost to Follow-up|0
89790|NCT00244621|314135|P2|Open-label Treatment Period|Lost to Follow-up|1
89791|NCT00244621|314136|P1|Open-label Treatment Period|Lost to Follow-up|0
89792|NCT00244621|314134|P3|Double-blind Treatment Period|Multiple Reasons|1
89793|NCT00244621|314135|P2|Double-blind Treatment Period|Multiple Reasons|1
89794|NCT00244621|314136|P1|Double-blind Treatment Period|Multiple Reasons|2
89795|NCT00244621|314134|P3|Double-blind Treatment Period|Lack of Efficacy|0
89796|NCT00244621|314135|P2|Double-blind Treatment Period|Lack of Efficacy|1
89797|NCT00244621|314136|P1|Double-blind Treatment Period|Lack of Efficacy|0
89798|NCT00244621|314134|P3|Double-blind Treatment Period|Withdrawal by Subject|0
89799|NCT00244621|314135|P2|Double-blind Treatment Period|Withdrawal by Subject|1
89800|NCT00244621|314136|P1|Double-blind Treatment Period|Withdrawal by Subject|0
89801|NCT00244621|314134|P3|Double-blind Treatment Period|Lost to Follow-up|1
89802|NCT00244621|314135|P2|Double-blind Treatment Period|Lost to Follow-up|0
89803|NCT00244621|314136|P1|Double-blind Treatment Period|Lost to Follow-up|0
89804|NCT00244712|314155|P2|Overall Study|Protocol Violation, disease progression|11
89805|NCT00244712|314156|P1|Overall Study|Protocol Violation, disease progression|13
89807|NCT00244712|314156|P1|Overall Study|Withdrawal by Subject|13
89808|NCT00244712|314155|P2|Overall Study|Lost to Follow-up|52
89809|NCT00244712|314156|P1|Overall Study|Lost to Follow-up|45
89810|NCT00244712|314155|P2|Overall Study|Lack of Compliance|11
89811|NCT00244712|314156|P1|Overall Study|Lack of Compliance|10
89812|NCT00244712|314155|P2|Overall Study|Protocol-Defined Virologic Failure|6
89813|NCT00244712|314156|P1|Overall Study|Protocol-Defined Virologic Failure|8
89814|NCT00244712|314155|P2|Overall Study|Adverse Event|21
89815|NCT00244712|314156|P1|Overall Study|Adverse Event|20
89816|NCT00244725|314192|P4|Overall Study|Failed to follow-up|1
89817|NCT00244725|314193|P3|Overall Study|Failed to follow-up|1
89818|NCT00244725|314194|P2|Overall Study|Failed to follow-up|0
89819|NCT00244725|314195|P1|Overall Study|Failed to follow-up|0
89820|NCT00244725|314192|P4|Overall Study|Vomit|0
89821|NCT00244725|314193|P3|Overall Study|Vomit|1
89822|NCT00244725|314194|P2|Overall Study|Vomit|0
89823|NCT00244725|314195|P1|Overall Study|Vomit|0
89824|NCT00244725|314192|P4|Overall Study|Administrative reason|0
89825|NCT00244725|314193|P3|Overall Study|Administrative reason|1
89826|NCT00244725|314194|P2|Overall Study|Administrative reason|0
89827|NCT00244725|314195|P1|Overall Study|Administrative reason|0
89828|NCT00244725|314192|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
89829|NCT00244725|314193|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
89830|NCT00244725|314194|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
89831|NCT00244725|314195|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
89832|NCT00244725|314192|P4|Overall Study|Received prohibited medication|1
89833|NCT00244725|314193|P3|Overall Study|Received prohibited medication|0
89834|NCT00244725|314194|P2|Overall Study|Received prohibited medication|1
89835|NCT00244725|314195|P1|Overall Study|Received prohibited medication|0
89836|NCT00244725|314192|P4|Overall Study|Headache|0
89837|NCT00244725|314193|P3|Overall Study|Headache|0
89838|NCT00244725|314194|P2|Overall Study|Headache|1
89839|NCT00244725|314195|P1|Overall Study|Headache|0
89840|NCT00244725|314192|P4|Overall Study|Rehab Refused to allow participantion|0
89841|NCT00244725|314193|P3|Overall Study|Rehab Refused to allow participantion|0
89842|NCT00244725|314194|P2|Overall Study|Rehab Refused to allow participantion|1
89843|NCT00244725|314195|P1|Overall Study|Rehab Refused to allow participantion|0
89844|NCT00244725|314192|P4|Overall Study|Mediciation Error|0
89845|NCT00244725|314193|P3|Overall Study|Mediciation Error|0
89846|NCT00244725|314194|P2|Overall Study|Mediciation Error|1
89847|NCT00244725|314195|P1|Overall Study|Mediciation Error|0
89848|NCT00244725|314192|P4|Overall Study|Sponsor withdrew the participant|1
89849|NCT00244725|314193|P3|Overall Study|Sponsor withdrew the participant|0
89850|NCT00244725|314194|P2|Overall Study|Sponsor withdrew the participant|0
89851|NCT00244725|314195|P1|Overall Study|Sponsor withdrew the participant|1
89852|NCT00244725|314192|P4|Overall Study|Liver function test abnormality|1
89853|NCT00244725|314193|P3|Overall Study|Liver function test abnormality|0
89854|NCT00244725|314194|P2|Overall Study|Liver function test abnormality|0
89855|NCT00244725|314195|P1|Overall Study|Liver function test abnormality|2
89856|NCT00244725|314192|P4|Overall Study|Withdrwal by participant|1
89857|NCT00244725|314193|P3|Overall Study|Withdrwal by participant|0
89858|NCT00244725|314194|P2|Overall Study|Withdrwal by participant|0
89859|NCT00244725|314195|P1|Overall Study|Withdrwal by participant|1
89860|NCT00244725|314192|P4|Overall Study|Adverse Events|4
89861|NCT00244725|314193|P3|Overall Study|Adverse Events|4
89862|NCT00244725|314194|P2|Overall Study|Adverse Events|1
89863|NCT00244725|314195|P1|Overall Study|Adverse Events|3
89864|NCT00244725|314192|P4|Overall Study|Physician Decision|2
89865|NCT00244725|314193|P3|Overall Study|Physician Decision|1
89866|NCT00244725|314194|P2|Overall Study|Physician Decision|0
89867|NCT00244725|314195|P1|Overall Study|Physician Decision|3
89868|NCT00244725|314192|P4|Overall Study|Not meet treatment eligibility criteria|0
89869|NCT00244725|314193|P3|Overall Study|Not meet treatment eligibility criteria|0
89870|NCT00244725|314194|P2|Overall Study|Not meet treatment eligibility criteria|2
89871|NCT00244725|314195|P1|Overall Study|Not meet treatment eligibility criteria|1
89872|NCT00244725|314192|P4|Overall Study|Withdrawal by Subject|8
89873|NCT00244725|314193|P3|Overall Study|Withdrawal by Subject|7
89874|NCT00244725|314194|P2|Overall Study|Withdrawal by Subject|7
89875|NCT00244725|314195|P1|Overall Study|Withdrawal by Subject|9
89876|NCT00244725|314192|P4|Overall Study|Lost to Follow-up|2
89877|NCT00244725|314193|P3|Overall Study|Lost to Follow-up|9
89878|NCT00244725|314194|P2|Overall Study|Lost to Follow-up|4
89879|NCT00244725|314195|P1|Overall Study|Lost to Follow-up|3
89880|NCT00244764|314249|P1|Overall Study|Developed Secondary Malignancy|1
89881|NCT00244764|314249|P1|Overall Study|Sponsor Terminated Study|2
89882|NCT00244764|314249|P1|Overall Study|Primary Investigator Discretion|2
89883|NCT00244764|314249|P1|Overall Study|Participant was Hospitalized until Death|1
89884|NCT00244764|314249|P1|Overall Study|Declining Performance Status|1
89885|NCT00244764|314249|P1|Overall Study|Off Study Medication for >21 Days|1
89886|NCT00244764|314249|P1|Overall Study|Death|1
89887|NCT00244764|314249|P1|Overall Study|Protocol Violation|2
89888|NCT00244764|314249|P1|Overall Study|Disease Progression|13
89889|NCT00244764|314249|P1|Overall Study|Withdrawal by Subject|12
89890|NCT00244764|314249|P1|Overall Study|Lost to Follow-up|23
89891|NCT00244764|314249|P1|Overall Study|Adverse Event|37
89892|NCT00244855|314258|P2|Overall Study|Withdrawal by Subject|1
89893|NCT00244855|314259|P1|Overall Study|Withdrawal by Subject|0
89894|NCT00244881|314267|P1|Overall Study|Withdrawal by Subject|3
89895|NCT00244933|314273|P1|Overall Study|Not response evaluable|2
89896|NCT00245011|314285|P1|Overall Study|Lack of Efficacy|1
89897|NCT00245037|314289|P1|Overall Study|Death|17
89898|NCT00245050|314301|P2|Overall Study|Adverse Event|2
89899|NCT00245050|314302|P1|Overall Study|Adverse Event|3
89900|NCT00245063|314312|P2|Overall Study|Death|0
89901|NCT00245063|314313|P1|Overall Study|Death|1
89902|NCT00245063|314312|P2|Overall Study|Adverse Event|5
89903|NCT00245063|314313|P1|Overall Study|Adverse Event|6
89904|NCT00245102|314325|P6|Overall Study|Clinical progression|0
89905|NCT00245102|314326|P5|Overall Study|Clinical progression|0
89906|NCT00245102|314327|P4|Overall Study|Clinical progression|0
89907|NCT00245102|314328|P3|Overall Study|Clinical progression|0
89908|NCT00245102|314329|P2|Overall Study|Clinical progression|0
89909|NCT00245102|314330|P1|Overall Study|Clinical progression|1
89910|NCT00245102|314325|P6|Overall Study|Participant needed surgery|0
89911|NCT00245102|314326|P5|Overall Study|Participant needed surgery|0
89912|NCT00245102|314327|P4|Overall Study|Participant needed surgery|0
89913|NCT00245102|314328|P3|Overall Study|Participant needed surgery|1
89914|NCT00245102|314329|P2|Overall Study|Participant needed surgery|0
89915|NCT00245102|314330|P1|Overall Study|Participant needed surgery|0
89916|NCT00245102|314325|P6|Overall Study|Decline in performance|2
89917|NCT00245102|314326|P5|Overall Study|Decline in performance|0
89918|NCT00245102|314327|P4|Overall Study|Decline in performance|1
89919|NCT00245102|314328|P3|Overall Study|Decline in performance|0
89920|NCT00245102|314329|P2|Overall Study|Decline in performance|2
89921|NCT00245102|314330|P1|Overall Study|Decline in performance|0
89922|NCT00245102|314325|P6|Overall Study|Adverse Event|2
89923|NCT00245102|314326|P5|Overall Study|Adverse Event|0
89924|NCT00245102|314327|P4|Overall Study|Adverse Event|1
89925|NCT00245102|314328|P3|Overall Study|Adverse Event|5
89926|NCT00245102|314329|P2|Overall Study|Adverse Event|2
89927|NCT00245102|314330|P1|Overall Study|Adverse Event|4
89928|NCT00245102|314325|P6|Overall Study|Death|0
89929|NCT00245102|314326|P5|Overall Study|Death|0
89930|NCT00245102|314327|P4|Overall Study|Death|1
89931|NCT00245102|314328|P3|Overall Study|Death|0
89932|NCT00245102|314329|P2|Overall Study|Death|0
89933|NCT00245102|314330|P1|Overall Study|Death|0
89934|NCT00245102|314325|P6|Overall Study|Protocol Violation|0
89935|NCT00245102|314326|P5|Overall Study|Protocol Violation|0
89936|NCT00245102|314327|P4|Overall Study|Protocol Violation|0
89937|NCT00245102|314328|P3|Overall Study|Protocol Violation|0
89938|NCT00245102|314329|P2|Overall Study|Protocol Violation|0
89939|NCT00245102|314330|P1|Overall Study|Protocol Violation|1
89940|NCT00245102|314325|P6|Overall Study|Not Treated|0
89941|NCT00245102|314326|P5|Overall Study|Not Treated|0
89942|NCT00245102|314327|P4|Overall Study|Not Treated|0
89943|NCT00245102|314328|P3|Overall Study|Not Treated|1
89944|NCT00245102|314329|P2|Overall Study|Not Treated|0
89945|NCT00245102|314330|P1|Overall Study|Not Treated|1
89946|NCT00245466|314370|P3|Overall Study|Administrative reasons|0
89947|NCT00245466|314371|P2|Overall Study|Administrative reasons|1
89948|NCT00245466|314372|P1|Overall Study|Administrative reasons|0
89949|NCT00245466|314370|P3|Overall Study|Death|0
89950|NCT00245466|314371|P2|Overall Study|Death|2
89951|NCT00245466|314372|P1|Overall Study|Death|0
89952|NCT00245466|314370|P3|Overall Study|Protocol Violation|2
89953|NCT00245466|314371|P2|Overall Study|Protocol Violation|2
89954|NCT00245466|314372|P1|Overall Study|Protocol Violation|1
89955|NCT00245466|314370|P3|Overall Study|Disease progression|1
89956|NCT00245466|314371|P2|Overall Study|Disease progression|3
89957|NCT00245466|314372|P1|Overall Study|Disease progression|0
89958|NCT00245466|314370|P3|Overall Study|Lost to Follow-up|0
89959|NCT00245466|314371|P2|Overall Study|Lost to Follow-up|0
89960|NCT00245466|314372|P1|Overall Study|Lost to Follow-up|3
89961|NCT00245466|314370|P3|Overall Study|Withdrawal by Subject|1
89962|NCT00245466|314371|P2|Overall Study|Withdrawal by Subject|2
89963|NCT00245466|314372|P1|Overall Study|Withdrawal by Subject|2
89964|NCT00245466|314370|P3|Overall Study|Insufficient PSA and testosterone suppr|3
89965|NCT00245466|314371|P2|Overall Study|Insufficient PSA and testosterone suppr|0
89966|NCT00245466|314372|P1|Overall Study|Insufficient PSA and testosterone suppr|0
89967|NCT00245466|314370|P3|Overall Study|Insufficient testosterone suppr|21
89968|NCT00245466|314371|P2|Overall Study|Insufficient testosterone suppr|12
89969|NCT00245466|314372|P1|Overall Study|Insufficient testosterone suppr|12
89970|NCT00245466|314370|P3|Overall Study|Low prostate specific antigen suppr|5
89971|NCT00245466|314371|P2|Overall Study|Low prostate specific antigen suppr|14
89972|NCT00245466|314372|P1|Overall Study|Low prostate specific antigen suppr|16
89973|NCT00245466|314370|P3|Overall Study|Adverse Event|4
89974|NCT00245466|314371|P2|Overall Study|Adverse Event|8
89975|NCT00245466|314372|P1|Overall Study|Adverse Event|2
89976|NCT00245570|314400|P6|Washout Between Periods III and IV|Adverse Event|0
89977|NCT00245570|314401|P5|Washout Between Periods III and IV|Adverse Event|0
89978|NCT00245570|314402|P4|Washout Between Periods III and IV|Adverse Event|0
89979|NCT00245570|314403|P3|Washout Between Periods III and IV|Adverse Event|0
89980|NCT00245570|314404|P2|Washout Between Periods III and IV|Adverse Event|1
89981|NCT00245570|314405|P1|Washout Between Periods III and IV|Adverse Event|0
89982|NCT00245856|314458|P2|Period Two|Withdrawal by Subject|1
89983|NCT00245856|314459|P1|Period Two|Withdrawal by Subject|0
89984|NCT00245960|314468|P2|Overall Study|Lack of Efficacy|6
89985|NCT00245960|314469|P1|Overall Study|Lack of Efficacy|4
89986|NCT00245960|314468|P2|Overall Study|Withdrawal by Subject|7
89987|NCT00245960|314469|P1|Overall Study|Withdrawal by Subject|5
89988|NCT00245960|314468|P2|Overall Study|Protocol Violation|3
89989|NCT00245960|314469|P1|Overall Study|Protocol Violation|4
89990|NCT00245960|314468|P2|Overall Study|Lost to Follow-up|2
89991|NCT00245960|314469|P1|Overall Study|Lost to Follow-up|2
89992|NCT00245960|314468|P2|Overall Study|Adverse Event|10
89993|NCT00245960|314469|P1|Overall Study|Adverse Event|14
89994|NCT00246012|314486|P9|Overall Study|Randomly assigned but not treated|0
89995|NCT00246012|314487|P8|Overall Study|Randomly assigned but not treated|0
89996|NCT00246012|314488|P7|Overall Study|Randomly assigned but not treated|1
89997|NCT00246012|314489|P6|Overall Study|Randomly assigned but not treated|1
89998|NCT00246012|314490|P5|Overall Study|Randomly assigned but not treated|0
89999|NCT00246012|314491|P4|Overall Study|Randomly assigned but not treated|0
90000|NCT00246012|314492|P3|Overall Study|Randomly assigned but not treated|0
90001|NCT00246012|314493|P2|Overall Study|Randomly assigned but not treated|0
90002|NCT00246012|314494|P1|Overall Study|Randomly assigned but not treated|0
90003|NCT00246012|314486|P9|Overall Study|unspecified|0
90004|NCT00246012|314487|P8|Overall Study|unspecified|1
90005|NCT00246012|314488|P7|Overall Study|unspecified|0
90006|NCT00246012|314489|P6|Overall Study|unspecified|0
90007|NCT00246012|314490|P5|Overall Study|unspecified|0
90008|NCT00246012|314491|P4|Overall Study|unspecified|0
90009|NCT00246012|314492|P3|Overall Study|unspecified|0
90010|NCT00246012|314493|P2|Overall Study|unspecified|0
90011|NCT00246012|314494|P1|Overall Study|unspecified|0
90012|NCT00246012|314486|P9|Overall Study|Disease progression|26
90013|NCT00246012|314487|P8|Overall Study|Disease progression|27
90014|NCT00246012|314488|P7|Overall Study|Disease progression|30
90015|NCT00246012|314489|P6|Overall Study|Disease progression|25
90016|NCT00246012|314490|P5|Overall Study|Disease progression|3
90017|NCT00246012|314491|P4|Overall Study|Disease progression|3
90018|NCT00246012|314492|P3|Overall Study|Disease progression|2
90019|NCT00246012|314493|P2|Overall Study|Disease progression|1
90020|NCT00246012|314494|P1|Overall Study|Disease progression|3
90021|NCT00246012|314486|P9|Overall Study|Withdrawal by Subject|0
90022|NCT00246012|314487|P8|Overall Study|Withdrawal by Subject|0
90023|NCT00246012|314488|P7|Overall Study|Withdrawal by Subject|0
90024|NCT00246012|314489|P6|Overall Study|Withdrawal by Subject|1
90025|NCT00246012|314490|P5|Overall Study|Withdrawal by Subject|0
90026|NCT00246012|314491|P4|Overall Study|Withdrawal by Subject|0
90027|NCT00246012|314492|P3|Overall Study|Withdrawal by Subject|0
90028|NCT00246012|314493|P2|Overall Study|Withdrawal by Subject|0
90029|NCT00246012|314494|P1|Overall Study|Withdrawal by Subject|0
90030|NCT00246012|314486|P9|Overall Study|Adverse Event|2
90031|NCT00246012|314487|P8|Overall Study|Adverse Event|0
90032|NCT00246012|314488|P7|Overall Study|Adverse Event|0
90033|NCT00246012|314489|P6|Overall Study|Adverse Event|1
90034|NCT00246012|314490|P5|Overall Study|Adverse Event|0
90035|NCT00246012|314491|P4|Overall Study|Adverse Event|0
90036|NCT00246012|314492|P3|Overall Study|Adverse Event|0
90037|NCT00246012|314493|P2|Overall Study|Adverse Event|0
90038|NCT00246012|314494|P1|Overall Study|Adverse Event|0
90039|NCT00246025|314591|P4|Overall Study|unsuitable medical history was found|1
90040|NCT00246025|314592|P3|Overall Study|unsuitable medical history was found|0
90041|NCT00246025|314593|P2|Overall Study|unsuitable medical history was found|0
90042|NCT00246025|314594|P1|Overall Study|unsuitable medical history was found|0
90043|NCT00246025|314591|P4|Overall Study|Withdrawal by Subject|2
90044|NCT00246025|314592|P3|Overall Study|Withdrawal by Subject|1
90045|NCT00246025|314593|P2|Overall Study|Withdrawal by Subject|0
90046|NCT00246025|314594|P1|Overall Study|Withdrawal by Subject|3
90047|NCT00246025|314591|P4|Overall Study|Adverse Event|10
90048|NCT00246025|314592|P3|Overall Study|Adverse Event|9
90049|NCT00246025|314593|P2|Overall Study|Adverse Event|9
90050|NCT00246025|314594|P1|Overall Study|Adverse Event|7
90051|NCT00246090|314644|P1|Overall Study|Not Otherwise Specified|10
90052|NCT00246090|314644|P1|Overall Study|Physician Decision|11
90053|NCT00246090|314644|P1|Overall Study|Clinical Progression|30
90054|NCT00246090|314644|P1|Overall Study|Progressive Disease|212
90055|NCT00246090|314644|P1|Overall Study|Withdrawal by Subject|7
90056|NCT00246090|314644|P1|Overall Study|Adverse Event|25
90057|NCT00246259|314651|P2|Overall Study|randomly assigned, not eligible for ITT|6
90058|NCT00246259|314652|P1|Overall Study|randomly assigned, not eligible for ITT|2
90059|NCT00246259|314651|P2|Overall Study|Withdrawal by Subject|1
90060|NCT00246259|314652|P1|Overall Study|Withdrawal by Subject|5
90061|NCT00246259|314651|P2|Overall Study|Lost to Follow-up|4
90062|NCT00246259|314652|P1|Overall Study|Lost to Follow-up|3
90063|NCT00246259|314651|P2|Overall Study|Adverse Event|0
90064|NCT00246259|314652|P1|Overall Study|Adverse Event|5
90065|NCT00246259|314651|P2|Overall Study|Investigator withdrew participant|0
90066|NCT00246259|314652|P1|Overall Study|Investigator withdrew participant|2
90067|NCT00246259|314651|P2|Overall Study|Lack of Efficacy|2
90068|NCT00246259|314652|P1|Overall Study|Lack of Efficacy|2
90069|NCT00246259|314651|P2|Overall Study|Participant non-compliant|9
90070|NCT00246259|314652|P1|Overall Study|Participant non-compliant|4
90071|NCT00246259|314651|P2|Overall Study|Not stable by Week 18|1
90072|NCT00246259|314652|P1|Overall Study|Not stable by Week 18|2
90073|NCT00246259|314651|P2|Overall Study|Unspecified|3
90074|NCT00246259|314652|P1|Overall Study|Unspecified|3
90075|NCT00246324|314686|P1|Overall Study|Withdrawal by Subject|1
90076|NCT00246337|314700|P9|Overall Study|Reported as completing trial in error|0
90077|NCT00246337|314701|P8|Overall Study|Reported as completing trial in error|1
90078|NCT00246337|314702|P7|Overall Study|Reported as completing trial in error|0
90079|NCT00246337|314703|P6|Overall Study|Reported as completing trial in error|0
90080|NCT00246337|314704|P5|Overall Study|Reported as completing trial in error|0
90081|NCT00246337|314705|P4|Overall Study|Reported as completing trial in error|0
90082|NCT00246337|314706|P3|Overall Study|Reported as completing trial in error|0
90083|NCT00246337|314707|P2|Overall Study|Reported as completing trial in error|0
90084|NCT00246337|314708|P1|Overall Study|Reported as completing trial in error|0
90085|NCT00246337|314700|P9|Overall Study|Protocol Violator|0
90086|NCT00246337|314701|P8|Overall Study|Protocol Violator|0
90087|NCT00246337|314702|P7|Overall Study|Protocol Violator|0
90088|NCT00246337|314703|P6|Overall Study|Protocol Violator|0
90089|NCT00246337|314704|P5|Overall Study|Protocol Violator|0
90090|NCT00246337|314705|P4|Overall Study|Protocol Violator|0
90091|NCT00246337|314706|P3|Overall Study|Protocol Violator|0
90092|NCT00246337|314707|P2|Overall Study|Protocol Violator|0
90093|NCT00246337|314708|P1|Overall Study|Protocol Violator|1
90094|NCT00246337|314700|P9|Overall Study|Overwhelmed|0
90095|NCT00246337|314701|P8|Overall Study|Overwhelmed|0
90096|NCT00246337|314702|P7|Overall Study|Overwhelmed|0
90097|NCT00246337|314703|P6|Overall Study|Overwhelmed|1
90098|NCT00246337|314704|P5|Overall Study|Overwhelmed|0
90099|NCT00246337|314705|P4|Overall Study|Overwhelmed|0
90100|NCT00246337|314706|P3|Overall Study|Overwhelmed|0
90101|NCT00246337|314707|P2|Overall Study|Overwhelmed|0
90102|NCT00246337|314708|P1|Overall Study|Overwhelmed|0
90103|NCT00246337|314700|P9|Overall Study|Abnormal baseline lab values|4
90104|NCT00246337|314701|P8|Overall Study|Abnormal baseline lab values|0
90105|NCT00246337|314702|P7|Overall Study|Abnormal baseline lab values|2
90106|NCT00246337|314703|P6|Overall Study|Abnormal baseline lab values|2
90107|NCT00246337|314704|P5|Overall Study|Abnormal baseline lab values|0
90108|NCT00246337|314705|P4|Overall Study|Abnormal baseline lab values|0
90109|NCT00246337|314706|P3|Overall Study|Abnormal baseline lab values|2
90110|NCT00246337|314707|P2|Overall Study|Abnormal baseline lab values|0
90111|NCT00246337|314708|P1|Overall Study|Abnormal baseline lab values|7
90112|NCT00246337|314700|P9|Overall Study|Site Terminated|2
90113|NCT00246337|314701|P8|Overall Study|Site Terminated|6
90114|NCT00246337|314702|P7|Overall Study|Site Terminated|1
90115|NCT00246337|314703|P6|Overall Study|Site Terminated|7
90116|NCT00246337|314704|P5|Overall Study|Site Terminated|0
90117|NCT00246337|314705|P4|Overall Study|Site Terminated|0
90118|NCT00246337|314706|P3|Overall Study|Site Terminated|0
90119|NCT00246337|314707|P2|Overall Study|Site Terminated|0
90120|NCT00246337|314708|P1|Overall Study|Site Terminated|10
90121|NCT00246337|314700|P9|Overall Study|Lack of Qualifying Event|5
90122|NCT00246337|314701|P8|Overall Study|Lack of Qualifying Event|2
90123|NCT00246337|314702|P7|Overall Study|Lack of Qualifying Event|3
90124|NCT00246337|314703|P6|Overall Study|Lack of Qualifying Event|3
90125|NCT00246337|314704|P5|Overall Study|Lack of Qualifying Event|1
90126|NCT00246337|314705|P4|Overall Study|Lack of Qualifying Event|1
90127|NCT00246337|314706|P3|Overall Study|Lack of Qualifying Event|1
90128|NCT00246337|314707|P2|Overall Study|Lack of Qualifying Event|2
90129|NCT00246337|314708|P1|Overall Study|Lack of Qualifying Event|8
90130|NCT00246337|314700|P9|Overall Study|Withdrawal by Subject|0
90131|NCT00246337|314701|P8|Overall Study|Withdrawal by Subject|1
90132|NCT00246337|314702|P7|Overall Study|Withdrawal by Subject|1
90133|NCT00246337|314703|P6|Overall Study|Withdrawal by Subject|0
90134|NCT00246337|314704|P5|Overall Study|Withdrawal by Subject|0
90135|NCT00246337|314705|P4|Overall Study|Withdrawal by Subject|0
90136|NCT00246337|314706|P3|Overall Study|Withdrawal by Subject|0
90137|NCT00246337|314707|P2|Overall Study|Withdrawal by Subject|0
90138|NCT00246337|314708|P1|Overall Study|Withdrawal by Subject|2
90139|NCT00246337|314700|P9|Overall Study|Protocol Violation|0
90140|NCT00246337|314701|P8|Overall Study|Protocol Violation|1
90141|NCT00246337|314702|P7|Overall Study|Protocol Violation|1
90142|NCT00246337|314703|P6|Overall Study|Protocol Violation|0
90143|NCT00246337|314704|P5|Overall Study|Protocol Violation|1
90144|NCT00246337|314705|P4|Overall Study|Protocol Violation|0
90145|NCT00246337|314706|P3|Overall Study|Protocol Violation|0
90146|NCT00246337|314707|P2|Overall Study|Protocol Violation|0
90147|NCT00246337|314708|P1|Overall Study|Protocol Violation|1
90148|NCT00246337|314700|P9|Overall Study|Lost to Follow-up|0
90149|NCT00246337|314701|P8|Overall Study|Lost to Follow-up|2
90150|NCT00246337|314702|P7|Overall Study|Lost to Follow-up|1
90151|NCT00246337|314703|P6|Overall Study|Lost to Follow-up|2
90152|NCT00246337|314704|P5|Overall Study|Lost to Follow-up|2
90153|NCT00246337|314705|P4|Overall Study|Lost to Follow-up|0
90154|NCT00246337|314706|P3|Overall Study|Lost to Follow-up|0
90155|NCT00246337|314707|P2|Overall Study|Lost to Follow-up|0
90156|NCT00246337|314708|P1|Overall Study|Lost to Follow-up|3
90157|NCT00239005|314757|P2|Overall Study|Lost to Follow-up|1
90158|NCT00239005|314758|P1|Overall Study|Lost to Follow-up|0
90159|NCT00239005|314757|P2|Overall Study|Subj. cond. no longer needs study drug|1
90160|NCT00239005|314758|P1|Overall Study|Subj. cond. no longer needs study drug|0
90161|NCT00239005|314757|P2|Overall Study|Protocol Violation|0
90162|NCT00239005|314758|P1|Overall Study|Protocol Violation|1
90163|NCT00239005|314757|P2|Overall Study|Unsatisfactory Therapeutic effect|0
90164|NCT00239005|314758|P1|Overall Study|Unsatisfactory Therapeutic effect|2
90165|NCT00239005|314757|P2|Overall Study|Withdrawal by Subject|4
90166|NCT00239005|314758|P1|Overall Study|Withdrawal by Subject|3
90167|NCT00239005|314757|P2|Overall Study|Adverse Event|6
90168|NCT00239005|314758|P1|Overall Study|Adverse Event|6
90169|NCT00239226|314772|P4|Overall Study|Lost to Follow-up|0
90170|NCT00239226|314773|P3|Overall Study|Lost to Follow-up|1
90171|NCT00239226|314774|P2|Overall Study|Lost to Follow-up|0
90172|NCT00239226|314775|P1|Overall Study|Lost to Follow-up|1
90173|NCT00239226|314772|P4|Overall Study|permAF during stabilization period|3
90174|NCT00239226|314773|P3|Overall Study|permAF during stabilization period|0
90175|NCT00239226|314774|P2|Overall Study|permAF during stabilization period|0
90176|NCT00239226|314775|P1|Overall Study|permAF during stabilization period|0
90177|NCT00239356|314787|P2|Overall Study|Drug available on market|2
90178|NCT00239356|314788|P1|Overall Study|Drug available on market|11
90179|NCT00239356|314787|P2|Overall Study|Administrative reason|1
90180|NCT00239356|314788|P1|Overall Study|Administrative reason|0
90181|NCT00239356|314787|P2|Overall Study|Pregnancy|0
90182|NCT00239356|314788|P1|Overall Study|Pregnancy|1
90183|NCT00239356|314787|P2|Overall Study|poor/non-compliance|0
90184|NCT00239356|314788|P1|Overall Study|poor/non-compliance|2
90185|NCT00239356|314787|P2|Overall Study|Lost to Follow-up|0
90186|NCT00239356|314788|P1|Overall Study|Lost to Follow-up|3
90187|NCT00239356|314787|P2|Overall Study|Withdrawal by Subject|6
90188|NCT00239356|314788|P1|Overall Study|Withdrawal by Subject|15
90189|NCT00239356|314787|P2|Overall Study|Adverse Event|0
90190|NCT00239356|314788|P1|Overall Study|Adverse Event|6
90191|NCT00239356|314787|P2|Overall Study|Lack of Efficacy|0
90192|NCT00239356|314788|P1|Overall Study|Lack of Efficacy|1
90193|NCT00239681|314845|P2|Overall Study|No information chacked on CaseReportForm|84
90194|NCT00239681|314846|P1|Overall Study|No information chacked on CaseReportForm|90
90195|NCT00239681|314845|P2|Overall Study|Physician Decision|17
90196|NCT00239681|314846|P1|Overall Study|Physician Decision|13
90197|NCT00239681|314845|P2|Overall Study|Protocol Violation|4
90198|NCT00239681|314846|P1|Overall Study|Protocol Violation|4
90199|NCT00239681|314845|P2|Overall Study|Lost to Follow-up|22
90200|NCT00239681|314846|P1|Overall Study|Lost to Follow-up|28
90201|NCT00239681|314845|P2|Overall Study|Withdrawal by Subject|489
90202|NCT00239681|314846|P1|Overall Study|Withdrawal by Subject|458
90203|NCT00239681|314845|P2|Overall Study|Adverse Event|99
90204|NCT00239681|314846|P1|Overall Study|Adverse Event|100
90205|NCT00239720|314864|P2|Overall Study|Lost to Follow-up|1
90206|NCT00239720|314865|P1|Overall Study|Lost to Follow-up|0
90207|NCT00239720|314864|P2|Overall Study|Adverse Event|0
90208|NCT00239720|314865|P1|Overall Study|Adverse Event|1
90209|NCT00239837|314878|P2|Overall Study|Lost to Follow-up|7
90210|NCT00239837|314879|P1|Overall Study|Lost to Follow-up|3
90211|NCT00239928|314899|P1|Overall Study|Withdrawal by Subject|2
90212|NCT00239928|314899|P1|Overall Study|Not need to continue study|3
90213|NCT00239928|314899|P1|Overall Study|Adverse Event|4
90214|NCT00239928|314899|P1|Overall Study|Lack of Efficacy|1
90215|NCT00240071|314909|P1|Overall Study|Withdrawal by Subject|3
90216|NCT00240097|314913|P1|Part II|did not continue from Part I|23
90217|NCT00240097|314913|P1|Part I|unevaluable|1
90218|NCT00240097|314913|P1|Part I|histology|1
90219|NCT00240097|314913|P1|Part I|Death|1
90220|NCT00240097|314913|P1|Part I|Adverse Event|1
90221|NCT00240110|314925|P2|Overall Study|Lost to Follow-up|7
90222|NCT00240110|314926|P1|Overall Study|Lost to Follow-up|6
90223|NCT00240331|314949|P2|Overall Study|Option selected by investigator|2
90224|NCT00240331|314950|P1|Overall Study|Option selected by investigator|1
90225|NCT00240331|314949|P2|Overall Study|Withdrawal by Subject|132
90226|NCT00240331|314950|P1|Overall Study|Withdrawal by Subject|125
90227|NCT00246376|314973|P5|Overall Study|Lost to Follow-up|13
90228|NCT00246376|314974|P4|Overall Study|Lost to Follow-up|16
90229|NCT00246376|314975|P3|Overall Study|Lost to Follow-up|11
90230|NCT00246376|314976|P2|Overall Study|Lost to Follow-up|11
90231|NCT00246376|314977|P1|Overall Study|Lost to Follow-up|2
90232|NCT00246376|314973|P5|Overall Study|Adverse Event|1
90233|NCT00246376|314974|P4|Overall Study|Adverse Event|3
90234|NCT00246376|314975|P3|Overall Study|Adverse Event|1
90235|NCT00246376|314976|P2|Overall Study|Adverse Event|3
90236|NCT00246376|314977|P1|Overall Study|Adverse Event|2
90237|NCT00246376|314973|P5|Overall Study|Dropped/withdrew during dietary run-in|3
90238|NCT00246376|314974|P4|Overall Study|Dropped/withdrew during dietary run-in|7
90239|NCT00246376|314975|P3|Overall Study|Dropped/withdrew during dietary run-in|4
90240|NCT00246376|314976|P2|Overall Study|Dropped/withdrew during dietary run-in|5
90241|NCT00246376|314977|P1|Overall Study|Dropped/withdrew during dietary run-in|11
90242|NCT00246571|315030|P2|Overall Study|Crossover participants|74
90243|NCT00246571|315031|P1|Overall Study|Crossover participants|0
90244|NCT00246571|315030|P2|Overall Study|Laboratory abnormalities|0
90245|NCT00246571|315031|P1|Overall Study|Laboratory abnormalities|1
90246|NCT00246571|315030|P2|Overall Study|Did not meet entrance criteria|1
90247|NCT00246571|315031|P1|Overall Study|Did not meet entrance criteria|2
90248|NCT00246571|315030|P2|Overall Study|Sponsor|1
90249|NCT00246571|315031|P1|Overall Study|Sponsor|0
90250|NCT00246571|315030|P2|Overall Study|Death|3
90251|NCT00246571|315031|P1|Overall Study|Death|17
90252|NCT00246571|315030|P2|Overall Study|Lack of Efficacy|21
90253|NCT00246571|315031|P1|Overall Study|Lack of Efficacy|84
90254|NCT00246571|315030|P2|Overall Study|Withdrawal by Subject|3
90255|NCT00246571|315031|P1|Overall Study|Withdrawal by Subject|2
90256|NCT00246571|315030|P2|Overall Study|Protocol Violation|1
90257|NCT00246571|315031|P1|Overall Study|Protocol Violation|0
90258|NCT00246571|315030|P2|Overall Study|Adverse Event|0
90259|NCT00246571|315031|P1|Overall Study|Adverse Event|7
90260|NCT00247611|315071|P2|Baselined|Completed baseline only|8
90261|NCT00247611|315072|P1|Baselined|Completed baseline only|9
90262|NCT00247611|315071|P2|Baselined|Completed baseline, never placed on ARVs|5
90263|NCT00247611|315072|P1|Baselined|Completed baseline, never placed on ARVs|8
90264|NCT00247676|315088|P1|Overall Study|Withdrawal by Subject|2
90265|NCT00247676|315088|P1|Overall Study|Unspecified|3
90266|NCT00247676|315088|P1|Overall Study|Lack of Efficacy|15
90267|NCT00247676|315088|P1|Overall Study|Adverse Event|11
90268|NCT00247676|315088|P1|Overall Study|Death|5
90269|NCT00247962|315118|P2|Overall Study|Lack of Efficacy|2
90270|NCT00247962|315119|P1|Overall Study|Lack of Efficacy|4
90271|NCT00247962|315118|P2|Overall Study|Withdrawal by Subject|2
90272|NCT00247962|315119|P1|Overall Study|Withdrawal by Subject|3
90273|NCT00247962|315118|P2|Overall Study|Protocol Violation|1
90274|NCT00247962|315119|P1|Overall Study|Protocol Violation|1
90275|NCT00247962|315118|P2|Overall Study|Physician Decision|1
90276|NCT00247962|315119|P1|Overall Study|Physician Decision|0
90277|NCT00247962|315118|P2|Overall Study|Lost to Follow-up|1
90278|NCT00247962|315119|P1|Overall Study|Lost to Follow-up|3
90279|NCT00247962|315118|P2|Overall Study|Adverse Event|12
90280|NCT00247962|315119|P1|Overall Study|Adverse Event|15
90281|NCT00248170|315129|P2|Overall Study|Protocol deviation|19
90282|NCT00248170|315130|P1|Overall Study|Protocol deviation|17
90283|NCT00248170|315129|P2|Overall Study|Abnormal laboratory values|0
90284|NCT00248170|315130|P1|Overall Study|Abnormal laboratory values|4
90285|NCT00248170|315129|P2|Overall Study|Abnormal test procedure(s) result|61
90286|NCT00248170|315130|P1|Overall Study|Abnormal test procedure(s) result|49
90287|NCT00248170|315129|P2|Overall Study|Administrative problems|25
90288|NCT00248170|315130|P1|Overall Study|Administrative problems|22
90289|NCT00248170|315129|P2|Overall Study|Adverse Event|296
90290|NCT00248170|315130|P1|Overall Study|Adverse Event|311
90291|NCT00248170|315129|P2|Overall Study|Death|47
90292|NCT00248170|315130|P1|Overall Study|Death|28
90293|NCT00248170|315129|P2|Overall Study|Disease progression|216
90294|NCT00248170|315130|P1|Overall Study|Disease progression|196
90295|NCT00248170|315129|P2|Overall Study|Lost to Follow-up|35
90296|NCT00248170|315130|P1|Overall Study|Lost to Follow-up|28
90297|NCT00248170|315129|P2|Overall Study|Protocol Violation|30
90298|NCT00248170|315130|P1|Overall Study|Protocol Violation|35
90299|NCT00248170|315129|P2|Overall Study|Withdrawal by Subject|79
90300|NCT00248170|315130|P1|Overall Study|Withdrawal by Subject|71
90301|NCT00248287|315152|P2|Overall Study|Other|2
90302|NCT00248287|315153|P1|Overall Study|Other|3
90303|NCT00248287|315152|P2|Overall Study|Patient Request|3
90304|NCT00248287|315153|P1|Overall Study|Patient Request|5
90305|NCT00248287|315152|P2|Overall Study|Investigator Request|3
90306|NCT00248287|315153|P1|Overall Study|Investigator Request|4
90307|NCT00248287|315152|P2|Overall Study|Lost to Follow-up|1
90308|NCT00248287|315153|P1|Overall Study|Lost to Follow-up|0
90309|NCT00248287|315152|P2|Overall Study|Death|0
90310|NCT00248287|315153|P1|Overall Study|Death|1
90311|NCT00248287|315152|P2|Overall Study|Adverse Event|10
90312|NCT00248287|315153|P1|Overall Study|Adverse Event|11
90313|NCT00248495|315165|P1|Overall Study|Withdrawal by Subject|1
90314|NCT00248625|315238|P2|Overall Study|Withdrawal by Subject|2
90315|NCT00248625|315239|P1|Overall Study|Withdrawal by Subject|0
90316|NCT00248651|315273|P3|Overall Study|Withdrawal by Subject|32
90317|NCT00248651|315274|P2|Overall Study|Withdrawal by Subject|40
90318|NCT00248651|315275|P1|Overall Study|Withdrawal by Subject|28
90319|NCT00248794|315322|P3|Overall Study|Lost to Follow-up|3
90320|NCT00248794|315323|P2|Overall Study|Lost to Follow-up|8
90321|NCT00248794|315324|P1|Overall Study|Lost to Follow-up|6
90322|NCT00249002|315361|P1|Overall Study|Unspecified|2
90323|NCT00249002|315361|P1|Overall Study|Study cancellation|3
90324|NCT00249002|315361|P1|Overall Study|Adverse Event|2
90325|NCT00249288|315440|P2|Overall Study|Withdrawal by Subject|2
90326|NCT00249288|315441|P1|Overall Study|Withdrawal by Subject|2
90327|NCT00249288|315440|P2|Overall Study|Lost to Follow-up|3
90328|NCT00249288|315441|P1|Overall Study|Lost to Follow-up|3
90329|NCT00249613|315490|P2|12 Month Follow-up|Lost to Follow-up|8
90330|NCT00249613|315491|P1|12 Month Follow-up|Lost to Follow-up|10
90331|NCT00249613|315490|P2|12 Month Follow-up|Withdrawal by Subject|6
90332|NCT00249613|315491|P1|12 Month Follow-up|Withdrawal by Subject|6
90333|NCT00249613|315490|P2|12 Month Follow-up|Death|1
90334|NCT00249613|315491|P1|12 Month Follow-up|Death|1
90335|NCT00249795|315502|P2|Overall Study|Missing|1
90336|NCT00249795|315503|P1|Overall Study|Missing|0
90337|NCT00249795|315502|P2|Overall Study|Lost to Follow-up|2
90338|NCT00249795|315503|P1|Overall Study|Lost to Follow-up|0
90339|NCT00249795|315502|P2|Overall Study|Site not agree to continue after May08|1
90340|NCT00249795|315503|P1|Overall Study|Site not agree to continue after May08|1
90341|NCT00249795|315502|P2|Overall Study|Patient not wish to continue after May08|6
90342|NCT00249795|315503|P1|Overall Study|Patient not wish to continue after May08|4
90343|NCT00249795|315502|P2|Overall Study|Event related to cardiac condition|16
90344|NCT00249795|315503|P1|Overall Study|Event related to cardiac condition|17
90345|NCT00249795|315502|P2|Overall Study|Other contraindicated medication|1
90346|NCT00249795|315503|P1|Overall Study|Other contraindicated medication|1
90347|NCT00249795|315502|P2|Overall Study|Hypotension (non-symptomatic)|5
90348|NCT00249795|315503|P1|Overall Study|Hypotension (non-symptomatic)|5
90349|NCT00249795|315502|P2|Overall Study|Lightheadedness / dizziness|11
90350|NCT00249795|315503|P1|Overall Study|Lightheadedness / dizziness|15
90351|NCT00249795|315502|P2|Overall Study|Angiotensin II receptor blocker required|58
90352|NCT00249795|315503|P1|Overall Study|Angiotensin II receptor blocker required|35
90353|NCT00249795|315502|P2|Overall Study|Surgery / procedure|5
90354|NCT00249795|315503|P1|Overall Study|Surgery / procedure|4
90355|NCT00249795|315502|P2|Overall Study|Physician withdrew consent|63
90356|NCT00249795|315503|P1|Overall Study|Physician withdrew consent|71
90357|NCT00249795|315502|P2|Overall Study|Other adverse events (non-serious)|159
90358|NCT00249795|315503|P1|Overall Study|Other adverse events (non-serious)|188
90359|NCT00249795|315502|P2|Overall Study|Study drug intolerance|3
90360|NCT00249795|315503|P1|Overall Study|Study drug intolerance|3
90361|NCT00249795|315502|P2|Overall Study|Non-compliance|69
90362|NCT00249795|315503|P1|Overall Study|Non-compliance|71
90363|NCT00249795|315502|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
90364|NCT00249795|315503|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
90365|NCT00249795|315502|P2|Overall Study|Oral anticoagulant required|0
90366|NCT00249795|315503|P1|Overall Study|Oral anticoagulant required|2
90367|NCT00249795|315502|P2|Overall Study|Thromboembolic / outcome event|45
90368|NCT00249795|315503|P1|Overall Study|Thromboembolic / outcome event|39
90369|NCT00249795|315502|P2|Overall Study|Withdrawal by Subject|742
90370|NCT00249795|315503|P1|Overall Study|Withdrawal by Subject|678
90371|NCT00249795|315502|P2|Overall Study|Qualifying condition not present|29
90372|NCT00249795|315503|P1|Overall Study|Qualifying condition not present|26
90373|NCT00249795|315502|P2|Overall Study|Other Serious Adverse Event|93
90374|NCT00249795|315503|P1|Overall Study|Other Serious Adverse Event|84
90375|NCT00249795|315502|P2|Overall Study|Symptomatic hypotension|64
90376|NCT00249795|315503|P1|Overall Study|Symptomatic hypotension|127
90377|NCT00249795|315502|P2|Overall Study|Not treated|14
90378|NCT00249795|315503|P1|Overall Study|Not treated|16
90379|NCT00249821|315523|P2|Overall Study|Technical problem|1
90380|NCT00249821|315524|P1|Overall Study|Technical problem|0
90381|NCT00249873|315546|P2|Overall Study|Thromboembolic/outcome event|122
90382|NCT00249873|315547|P1|Overall Study|Thromboembolic/outcome event|82
90383|NCT00249873|315546|P2|Overall Study|Event related to cardiac condition|21
90384|NCT00249873|315547|P1|Overall Study|Event related to cardiac condition|12
90385|NCT00249873|315546|P2|Overall Study|Surgery/ procedure|9
90386|NCT00249873|315547|P1|Overall Study|Surgery/ procedure|9
90387|NCT00249873|315546|P2|Overall Study|Study drug intolerance|0
90388|NCT00249873|315547|P1|Overall Study|Study drug intolerance|5
90389|NCT00249873|315546|P2|Overall Study|Oral anticoagulant required|157
90390|NCT00249873|315547|P1|Overall Study|Oral anticoagulant required|159
90391|NCT00249873|315546|P2|Overall Study|Angiotensin II receptor blocker required|0
90392|NCT00249873|315547|P1|Overall Study|Angiotensin II receptor blocker required|1
90393|NCT00249873|315546|P2|Overall Study|Open label clopidogrel required|42
90394|NCT00249873|315547|P1|Overall Study|Open label clopidogrel required|31
90395|NCT00249873|315546|P2|Overall Study|Physician withdrew consent|60
90396|NCT00249873|315547|P1|Overall Study|Physician withdrew consent|59
90397|NCT00249873|315546|P2|Overall Study|Patient not wish to continue after May08|4
90398|NCT00249873|315547|P1|Overall Study|Patient not wish to continue after May08|3
90399|NCT00249873|315546|P2|Overall Study|Other contraindicated medication|0
90400|NCT00249873|315547|P1|Overall Study|Other contraindicated medication|1
90401|NCT00249873|315546|P2|Overall Study|Other non serious Adverse Event|108
90402|NCT00249873|315547|P1|Overall Study|Other non serious Adverse Event|112
90403|NCT00249873|315546|P2|Overall Study|Non-compliance|46
90404|NCT00249873|315547|P1|Overall Study|Non-compliance|41
90405|NCT00249873|315546|P2|Overall Study|Minor bleeding|37
90406|NCT00249873|315547|P1|Overall Study|Minor bleeding|99
90407|NCT00249873|315546|P2|Overall Study|Lost to Follow-up|7
90408|NCT00249873|315547|P1|Overall Study|Lost to Follow-up|4
90409|NCT00249873|315546|P2|Overall Study|Withdrawal by Subject|466
90410|NCT00249873|315547|P1|Overall Study|Withdrawal by Subject|504
90411|NCT00249873|315546|P2|Overall Study|Contraindication to oral anticoagulant|8
90412|NCT00249873|315547|P1|Overall Study|Contraindication to oral anticoagulant|4
90413|NCT00249873|315546|P2|Overall Study|Qualifying condition not present|23
90414|NCT00249873|315547|P1|Overall Study|Qualifying condition not present|20
90415|NCT00249873|315546|P2|Overall Study|Other Serious Adverse Event|97
90416|NCT00249873|315547|P1|Overall Study|Other Serious Adverse Event|86
90417|NCT00249873|315546|P2|Overall Study|Serious haemorrhagic Adverse Event|30
90418|NCT00249873|315547|P1|Overall Study|Serious haemorrhagic Adverse Event|74
90419|NCT00249873|315546|P2|Overall Study|Severe allergic reaction|1
90420|NCT00249873|315547|P1|Overall Study|Severe allergic reaction|8
90421|NCT00249873|315546|P2|Overall Study|Significant thrombocytopenia|8
90422|NCT00249873|315547|P1|Overall Study|Significant thrombocytopenia|9
90423|NCT00249873|315546|P2|Overall Study|Not treated|8
90424|NCT00249873|315547|P1|Overall Study|Not treated|7
90425|NCT00243347|315559|P1|Overall Study|Condition worsened|7
90426|NCT00243347|315559|P1|Overall Study|Withdrawal by Subject|5
90427|NCT00243347|315559|P1|Overall Study|Death|1
90428|NCT00243347|315559|P1|Overall Study|Adverse Event|2
90429|NCT00243347|315559|P1|Overall Study|Lack of Efficacy|4
90430|NCT00243386|315564|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
90431|NCT00243386|315565|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
90432|NCT00243386|315566|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
90433|NCT00243386|315564|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
90434|NCT00243386|315565|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
90435|NCT00243386|315566|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
90436|NCT00243386|315564|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
90437|NCT00243386|315565|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
90438|NCT00243386|315566|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
90439|NCT00243386|315564|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
90440|NCT00243386|315565|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
90441|NCT00243386|315566|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
90442|NCT00243386|315564|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
90443|NCT00243386|315565|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
90444|NCT00243386|315566|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
90445|NCT00243386|315564|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
90446|NCT00243386|315565|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
90447|NCT00243386|315566|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
90448|NCT00243386|315564|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
90449|NCT00243386|315565|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
90450|NCT00243386|315566|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
90451|NCT00243386|315564|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
90452|NCT00243386|315565|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
90453|NCT00243386|315566|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
90454|NCT00243412|315633|P2|Overall Study|not specified|1
90455|NCT00243412|315634|P1|Overall Study|not specified|1
90456|NCT00243412|315633|P2|Overall Study|Withdrawal by Subject|5
90457|NCT00243412|315634|P1|Overall Study|Withdrawal by Subject|4
90458|NCT00243412|315633|P2|Overall Study|Physician Decision|1
90459|NCT00243412|315634|P1|Overall Study|Physician Decision|1
90460|NCT00243412|315633|P2|Overall Study|Lost to Follow-up|1
90461|NCT00243412|315634|P1|Overall Study|Lost to Follow-up|0
90462|NCT00243412|315633|P2|Overall Study|Adverse Event|2
90463|NCT00243412|315634|P1|Overall Study|Adverse Event|4
90464|NCT00243412|315633|P2|Overall Study|Death|1
90465|NCT00243412|315634|P1|Overall Study|Death|0
90466|NCT00243503|315660|P1|Overall Study|Unspecified|1
90467|NCT00243503|315660|P1|Overall Study|Death|1
90468|NCT00243503|315660|P1|Overall Study|Lack of Efficacy|44
90469|NCT00243503|315660|P1|Overall Study|Withdrawal by Subject|1
90470|NCT00243503|315660|P1|Overall Study|Adverse Event|11
90471|NCT00243659|315677|P2|Overall Study|Protocol Violation|2
90472|NCT00243659|315678|P1|Overall Study|Protocol Violation|1
90473|NCT00243659|315677|P2|Overall Study|Withdrawal by Subject|1
90474|NCT00243659|315678|P1|Overall Study|Withdrawal by Subject|1
90475|NCT00250276|315690|P4|Overall Study|Lost to Follow-up|8
90476|NCT00250276|315691|P3|Overall Study|Lost to Follow-up|13
90477|NCT00250276|315692|P2|Overall Study|Lost to Follow-up|18
90478|NCT00250276|315693|P1|Overall Study|Lost to Follow-up|11
90479|NCT00250276|315690|P4|Overall Study|Migrated/moved from study area|7
90480|NCT00250276|315691|P3|Overall Study|Migrated/moved from study area|2
90481|NCT00250276|315692|P2|Overall Study|Migrated/moved from study area|0
90482|NCT00250276|315693|P1|Overall Study|Migrated/moved from study area|3
90483|NCT00250276|315690|P4|Overall Study|Withdrawal by Subject|2
90484|NCT00250276|315691|P3|Overall Study|Withdrawal by Subject|3
90485|NCT00250276|315692|P2|Overall Study|Withdrawal by Subject|2
90486|NCT00250276|315693|P1|Overall Study|Withdrawal by Subject|1
90487|NCT00250276|315690|P4|Overall Study|Protocol Violation|0
90488|NCT00250276|315691|P3|Overall Study|Protocol Violation|0
90489|NCT00250276|315692|P2|Overall Study|Protocol Violation|1
90490|NCT00250276|315693|P1|Overall Study|Protocol Violation|0
90491|NCT00250276|315690|P4|Overall Study|Non-serious Adverse Event|2
90492|NCT00250276|315691|P3|Overall Study|Non-serious Adverse Event|0
90493|NCT00250276|315692|P2|Overall Study|Non-serious Adverse Event|0
90494|NCT00250276|315693|P1|Overall Study|Non-serious Adverse Event|2
90495|NCT00250276|315690|P4|Overall Study|Serious Adverse Event|0
90496|NCT00250276|315691|P3|Overall Study|Serious Adverse Event|1
90497|NCT00250276|315692|P2|Overall Study|Serious Adverse Event|0
90498|NCT00250276|315693|P1|Overall Study|Serious Adverse Event|0
90499|NCT00250432|315773|P2|Overall Study|Pt was considered untreatable|1
90500|NCT00250432|315774|P1|Overall Study|Pt was considered untreatable|0
90501|NCT00250432|315773|P2|Overall Study|Pt died out of posttherapy report period|5
90502|NCT00250432|315774|P1|Overall Study|Pt died out of posttherapy report period|6
90503|NCT00250432|315773|P2|Overall Study|Withdrawal by Subject|2
90504|NCT00250432|315774|P1|Overall Study|Withdrawal by Subject|6
90505|NCT00250432|315773|P2|Overall Study|Protocol Violation|3
90506|NCT00250432|315774|P1|Overall Study|Protocol Violation|0
90507|NCT00250432|315773|P2|Overall Study|Patient Moved|1
90508|NCT00250432|315774|P1|Overall Study|Patient Moved|0
90509|NCT00250432|315773|P2|Overall Study|Lost to Follow-up|5
90510|NCT00250432|315774|P1|Overall Study|Lost to Follow-up|6
90511|NCT00250432|315773|P2|Overall Study|Lack of Efficacy|1
90512|NCT00250432|315774|P1|Overall Study|Lack of Efficacy|2
90513|NCT00250432|315773|P2|Overall Study|Adverse Event|29
90514|NCT00250432|315774|P1|Overall Study|Adverse Event|25
90515|NCT00250458|315784|P2|Overall Study|Not Specified|0
90516|NCT00250458|315785|P1|Overall Study|Not Specified|1
90517|NCT00250458|315784|P2|Overall Study|Qualifying migraine but did not treat|3
90518|NCT00250458|315785|P1|Overall Study|Qualifying migraine but did not treat|3
90519|NCT00250458|315784|P2|Overall Study|Lack of Migraine Attack|9
90520|NCT00250458|315785|P1|Overall Study|Lack of Migraine Attack|20
90521|NCT00250458|315784|P2|Overall Study|Withdrawal by Subject|2
90522|NCT00250458|315785|P1|Overall Study|Withdrawal by Subject|4
90523|NCT00250458|315784|P2|Overall Study|Protocol Violation|1
90524|NCT00250458|315785|P1|Overall Study|Protocol Violation|0
90525|NCT00250458|315784|P2|Overall Study|Lost to Follow-up|2
90526|NCT00250458|315785|P1|Overall Study|Lost to Follow-up|4
90527|NCT00250588|315826|P3|Overall Study|Lost to Follow-up|13
90528|NCT00250588|315827|P2|Overall Study|Lost to Follow-up|13
90529|NCT00250588|315828|P1|Overall Study|Lost to Follow-up|6
90530|NCT00250588|315826|P3|Overall Study|Withdrawal by Subject|0
90531|NCT00250588|315827|P2|Overall Study|Withdrawal by Subject|6
90532|NCT00250588|315828|P1|Overall Study|Withdrawal by Subject|3
90533|NCT00250679|315845|P3|Overall Study|various single events: hip surgery,diary|1
90534|NCT00250679|315846|P2|Overall Study|various single events: hip surgery,diary|1
90535|NCT00250679|315847|P1|Overall Study|various single events: hip surgery,diary|3
90536|NCT00250679|315845|P3|Overall Study|Non-compliance|0
90537|NCT00250679|315846|P2|Overall Study|Non-compliance|1
90538|NCT00250679|315847|P1|Overall Study|Non-compliance|1
90539|NCT00250679|315845|P3|Overall Study|Moved|0
90540|NCT00250679|315846|P2|Overall Study|Moved|1
90541|NCT00250679|315847|P1|Overall Study|Moved|1
90542|NCT00250679|315845|P3|Overall Study|Technical Holter issues|2
90543|NCT00250679|315846|P2|Overall Study|Technical Holter issues|0
90544|NCT00250679|315847|P1|Overall Study|Technical Holter issues|1
90545|NCT00250679|315845|P3|Overall Study|Lack of Efficacy|3
90546|NCT00250679|315846|P2|Overall Study|Lack of Efficacy|1
90547|NCT00250679|315847|P1|Overall Study|Lack of Efficacy|0
90548|NCT00250679|315845|P3|Overall Study|Does Not Meet Entry Criteria|2
90549|NCT00250679|315846|P2|Overall Study|Does Not Meet Entry Criteria|4
90550|NCT00250679|315847|P1|Overall Study|Does Not Meet Entry Criteria|1
90551|NCT00250679|315845|P3|Overall Study|Lost to Follow-up|2
90552|NCT00250679|315846|P2|Overall Study|Lost to Follow-up|4
90553|NCT00250679|315847|P1|Overall Study|Lost to Follow-up|3
90554|NCT00250679|315845|P3|Overall Study|Withdrawal by Subject|15
90555|NCT00250679|315846|P2|Overall Study|Withdrawal by Subject|18
90556|NCT00250679|315847|P1|Overall Study|Withdrawal by Subject|15
90557|NCT00250679|315845|P3|Overall Study|Protocol Violation|3
90558|NCT00250679|315846|P2|Overall Study|Protocol Violation|4
90559|NCT00250679|315847|P1|Overall Study|Protocol Violation|2
90560|NCT00250679|315845|P3|Overall Study|Adverse Event|16
90561|NCT00250679|315846|P2|Overall Study|Adverse Event|15
90562|NCT00250679|315847|P1|Overall Study|Adverse Event|12
90563|NCT00250705|315945|P1|Overall Study|Lack of Efficacy|2
90564|NCT00250718|315953|P1|Overall Study|Withdrawal by Subject|1
90565|NCT00250718|315953|P1|Overall Study|Adverse Event|1
90566|NCT00250718|315953|P1|Overall Study|Death|1
90567|NCT00250835|315958|P1|Overall Study|Withdrawal by Subject|1
90568|NCT00251004|315977|P3|Overall Study|Graft Loss|8
90569|NCT00251004|315978|P2|Overall Study|Graft Loss|13
90570|NCT00251004|315979|P1|Overall Study|Graft Loss|12
90571|NCT00251004|315977|P3|Overall Study|Lost to Follow-up|1
90572|NCT00251004|315978|P2|Overall Study|Lost to Follow-up|2
90573|NCT00251004|315979|P1|Overall Study|Lost to Follow-up|1
90574|NCT00251004|315977|P3|Overall Study|Death|8
90575|NCT00251004|315978|P2|Overall Study|Death|10
90576|NCT00251004|315979|P1|Overall Study|Death|9
90577|NCT00251004|315977|P3|Overall Study|Withdrawal by Subject|14
90578|NCT00251004|315978|P2|Overall Study|Withdrawal by Subject|16
90579|NCT00251004|315979|P1|Overall Study|Withdrawal by Subject|23
90580|NCT00251316|316028|P2|Overall Study|Physician Decision|3
90581|NCT00251316|316029|P1|Overall Study|Physician Decision|2
90582|NCT00251589|316039|P4|Overall Study|Discontinued due to progressive disease|1
90583|NCT00251589|316040|P3|Overall Study|Discontinued due to progressive disease|0
90584|NCT00251589|316041|P2|Overall Study|Discontinued due to progressive disease|1
90585|NCT00251589|316042|P1|Overall Study|Discontinued due to progressive disease|9
90586|NCT00251589|316039|P4|Overall Study|Withdrawal by Subject|0
90587|NCT00251589|316040|P3|Overall Study|Withdrawal by Subject|0
90588|NCT00251589|316041|P2|Overall Study|Withdrawal by Subject|1
90589|NCT00251589|316042|P1|Overall Study|Withdrawal by Subject|1
90590|NCT00251589|316039|P4|Overall Study|Adverse Event|1
90591|NCT00251589|316040|P3|Overall Study|Adverse Event|2
90592|NCT00251589|316041|P2|Overall Study|Adverse Event|1
90593|NCT00251589|316042|P1|Overall Study|Adverse Event|5
90594|NCT00251641|316079|P2|Overall Study|Switched Treatment|63
90595|NCT00251641|316080|P1|Overall Study|Switched Treatment|9
90596|NCT00251641|316079|P2|Overall Study|Did not Meet protocol Eligibility|1
90597|NCT00251641|316080|P1|Overall Study|Did not Meet protocol Eligibility|2
90598|NCT00251641|316079|P2|Overall Study|Protocol Violation|2
90599|NCT00251641|316080|P1|Overall Study|Protocol Violation|10
90600|NCT00251641|316079|P2|Overall Study|Withdrawal by Subject|8
90601|NCT00251641|316080|P1|Overall Study|Withdrawal by Subject|6
90602|NCT00251641|316079|P2|Overall Study|Lost to Follow-up|3
90603|NCT00251641|316080|P1|Overall Study|Lost to Follow-up|3
90604|NCT00251641|316079|P2|Overall Study|Progression of Disease|2
90605|NCT00251641|316080|P1|Overall Study|Progression of Disease|0
90606|NCT00251641|316079|P2|Overall Study|Lack of Efficacy|1
90607|NCT00251641|316080|P1|Overall Study|Lack of Efficacy|2
90608|NCT00251641|316079|P2|Overall Study|Adverse Event|8
90609|NCT00251641|316080|P1|Overall Study|Adverse Event|80
90610|NCT00251693|316097|P3|Overall Study|Abnormal laboratory findings|1
90611|NCT00251693|316098|P2|Overall Study|Abnormal laboratory findings|0
90612|NCT00251693|316099|P1|Overall Study|Abnormal laboratory findings|0
90613|NCT00251693|316097|P3|Overall Study|Subject request/subject unavailable|0
90614|NCT00251693|316098|P2|Overall Study|Subject request/subject unavailable|2
90615|NCT00251693|316099|P1|Overall Study|Subject request/subject unavailable|1
90616|NCT00251693|316097|P3|Overall Study|Possible Barrett's esophagus|2
90617|NCT00251693|316098|P2|Overall Study|Possible Barrett's esophagus|5
90618|NCT00251693|316099|P1|Overall Study|Possible Barrett's esophagus|3
90619|NCT00251693|316097|P3|Overall Study|Noncompliant|2
90620|NCT00251693|316098|P2|Overall Study|Noncompliant|0
90621|NCT00251693|316099|P1|Overall Study|Noncompliant|0
90622|NCT00251693|316097|P3|Overall Study|Inclusion/exclusion criteria not met|8
90623|NCT00251693|316098|P2|Overall Study|Inclusion/exclusion criteria not met|3
90624|NCT00251693|316099|P1|Overall Study|Inclusion/exclusion criteria not met|5
90625|NCT00251693|316097|P3|Overall Study|Lack of Efficacy|0
90626|NCT00251693|316098|P2|Overall Study|Lack of Efficacy|1
90627|NCT00251693|316099|P1|Overall Study|Lack of Efficacy|0
90628|NCT00251693|316097|P3|Overall Study|Withdrawal by Subject|14
90629|NCT00251693|316098|P2|Overall Study|Withdrawal by Subject|17
90630|NCT00251693|316099|P1|Overall Study|Withdrawal by Subject|11
90631|NCT00251693|316097|P3|Overall Study|Lost to Follow-up|8
90632|NCT00251693|316098|P2|Overall Study|Lost to Follow-up|7
90633|NCT00251693|316099|P1|Overall Study|Lost to Follow-up|12
90634|NCT00251693|316097|P3|Overall Study|Protocol Violation|2
90635|NCT00251693|316098|P2|Overall Study|Protocol Violation|0
90636|NCT00251693|316099|P1|Overall Study|Protocol Violation|2
90637|NCT00251693|316097|P3|Overall Study|Adverse Event|9
90638|NCT00251693|316098|P2|Overall Study|Adverse Event|9
90639|NCT00251693|316099|P1|Overall Study|Adverse Event|17
90640|NCT00251719|316125|P3|Overall Study|Barrett's esophagus|0
90641|NCT00251719|316126|P2|Overall Study|Barrett's esophagus|2
90642|NCT00251719|316127|P1|Overall Study|Barrett's esophagus|2
90643|NCT00251719|316125|P3|Overall Study|Noncompliance|1
90644|NCT00251719|316126|P2|Overall Study|Noncompliance|3
90645|NCT00251719|316127|P1|Overall Study|Noncompliance|2
90646|NCT00251719|316125|P3|Overall Study|Investigator decision|0
90647|NCT00251719|316126|P2|Overall Study|Investigator decision|1
90648|NCT00251719|316127|P1|Overall Study|Investigator decision|1
90649|NCT00251719|316125|P3|Overall Study|Inclusion/exclusion criteria not met|2
90650|NCT00251719|316126|P2|Overall Study|Inclusion/exclusion criteria not met|6
90651|NCT00251719|316127|P1|Overall Study|Inclusion/exclusion criteria not met|12
90652|NCT00251719|316125|P3|Overall Study|Lack of Efficacy|0
90653|NCT00251719|316126|P2|Overall Study|Lack of Efficacy|1
90654|NCT00251719|316127|P1|Overall Study|Lack of Efficacy|2
90655|NCT00251719|316125|P3|Overall Study|Withdrawal by Subject|11
90656|NCT00251719|316126|P2|Overall Study|Withdrawal by Subject|12
90657|NCT00251719|316127|P1|Overall Study|Withdrawal by Subject|14
90658|NCT00251719|316125|P3|Overall Study|Lost to Follow-up|8
90659|NCT00251719|316126|P2|Overall Study|Lost to Follow-up|11
90660|NCT00251719|316127|P1|Overall Study|Lost to Follow-up|5
90661|NCT00251719|316125|P3|Overall Study|Protocol Violation|1
90662|NCT00251719|316126|P2|Overall Study|Protocol Violation|1
90663|NCT00251719|316127|P1|Overall Study|Protocol Violation|1
90664|NCT00251719|316125|P3|Overall Study|Adverse Event|7
90665|NCT00251719|316126|P2|Overall Study|Adverse Event|8
90666|NCT00251719|316127|P1|Overall Study|Adverse Event|14
90667|NCT00251745|316153|P3|Overall Study|Per Investigator Request|0
90668|NCT00251745|316154|P2|Overall Study|Per Investigator Request|0
90669|NCT00251745|316155|P1|Overall Study|Per Investigator Request|1
90670|NCT00251745|316153|P3|Overall Study|Per Subject Request|1
90671|NCT00251745|316154|P2|Overall Study|Per Subject Request|0
90672|NCT00251745|316155|P1|Overall Study|Per Subject Request|0
90673|NCT00251745|316153|P3|Overall Study|Pregnancy|0
90674|NCT00251745|316154|P2|Overall Study|Pregnancy|1
90675|NCT00251745|316155|P1|Overall Study|Pregnancy|0
90676|NCT00251745|316153|P3|Overall Study|Noncompliant|2
90677|NCT00251745|316154|P2|Overall Study|Noncompliant|2
90678|NCT00251745|316155|P1|Overall Study|Noncompliant|0
90679|NCT00251745|316153|P3|Overall Study|Lack of Efficacy|0
90680|NCT00251745|316154|P2|Overall Study|Lack of Efficacy|0
90681|NCT00251745|316155|P1|Overall Study|Lack of Efficacy|3
90682|NCT00251745|316153|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
90683|NCT00251745|316154|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
90684|NCT00251745|316155|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
90685|NCT00251745|316153|P3|Overall Study|Withdrawal by Subject|3
90686|NCT00251745|316154|P2|Overall Study|Withdrawal by Subject|7
90687|NCT00251745|316155|P1|Overall Study|Withdrawal by Subject|13
90688|NCT00251745|316153|P3|Overall Study|Lost to Follow-up|5
90689|NCT00251745|316154|P2|Overall Study|Lost to Follow-up|2
90690|NCT00251745|316155|P1|Overall Study|Lost to Follow-up|4
90691|NCT00251745|316153|P3|Overall Study|Adverse Event|11
90692|NCT00251745|316154|P2|Overall Study|Adverse Event|9
90693|NCT00251745|316155|P1|Overall Study|Adverse Event|7
90694|NCT00251758|316175|P3|Overall Study|Per Investigator Request|0
90695|NCT00251758|316176|P2|Overall Study|Per Investigator Request|0
90696|NCT00251758|316177|P1|Overall Study|Per Investigator Request|1
90697|NCT00251758|316175|P3|Overall Study|Per Subject Request|1
90698|NCT00251758|316176|P2|Overall Study|Per Subject Request|0
90699|NCT00251758|316177|P1|Overall Study|Per Subject Request|0
90700|NCT00251758|316175|P3|Overall Study|Pregnancy|0
90701|NCT00251758|316176|P2|Overall Study|Pregnancy|1
90702|NCT00251758|316177|P1|Overall Study|Pregnancy|0
90703|NCT00251758|316175|P3|Overall Study|Noncompliant|2
90704|NCT00251758|316176|P2|Overall Study|Noncompliant|2
90705|NCT00251758|316177|P1|Overall Study|Noncompliant|0
90706|NCT00251758|316175|P3|Overall Study|Lack of Efficacy|0
90707|NCT00251758|316176|P2|Overall Study|Lack of Efficacy|0
90708|NCT00251758|316177|P1|Overall Study|Lack of Efficacy|3
90709|NCT00251758|316175|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
90710|NCT00251758|316176|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
90711|NCT00251758|316177|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
90712|NCT00251758|316175|P3|Overall Study|Withdrawal by Subject|3
90713|NCT00251758|316176|P2|Overall Study|Withdrawal by Subject|7
90714|NCT00251758|316177|P1|Overall Study|Withdrawal by Subject|13
90715|NCT00251758|316175|P3|Overall Study|Lost to Follow-up|5
90716|NCT00251758|316176|P2|Overall Study|Lost to Follow-up|2
90717|NCT00251758|316177|P1|Overall Study|Lost to Follow-up|4
90718|NCT00251758|316175|P3|Overall Study|Adverse Event|11
90719|NCT00251758|316176|P2|Overall Study|Adverse Event|9
90720|NCT00251758|316177|P1|Overall Study|Adverse Event|7
90721|NCT00251927|316218|P2|Overall Study|Study procedure non-compliance|6
90722|NCT00251927|316219|P1|Overall Study|Study procedure non-compliance|5
90723|NCT00251927|316218|P2|Overall Study|Study-specific discont. achieved|2
90724|NCT00251927|316219|P1|Overall Study|Study-specific discont. achieved|13
90725|NCT00251927|316218|P2|Overall Study|Withdrawal by Subject|25
90726|NCT00251927|316219|P1|Overall Study|Withdrawal by Subject|40
90727|NCT00251927|316218|P2|Overall Study|Pregnancy|0
90728|NCT00251927|316219|P1|Overall Study|Pregnancy|2
90729|NCT00251927|316218|P2|Overall Study|Protocol Violation|2
90730|NCT00251927|316219|P1|Overall Study|Protocol Violation|1
90731|NCT00251927|316218|P2|Overall Study|Lost to Follow-up|8
90732|NCT00251927|316219|P1|Overall Study|Lost to Follow-up|22
90733|NCT00251927|316218|P2|Overall Study|Lack of Efficacy|16
90734|NCT00251927|316219|P1|Overall Study|Lack of Efficacy|22
90735|NCT00251927|316218|P2|Overall Study|Adverse Event|15
90736|NCT00251927|316219|P1|Overall Study|Adverse Event|3
90737|NCT00251979|316248|P2|Overall Study|Death|5
90738|NCT00251979|316249|P1|Overall Study|Death|3
90739|NCT00251979|316248|P2|Overall Study|Lost to Follow-up|6
90740|NCT00251979|316249|P1|Overall Study|Lost to Follow-up|8
90741|NCT00251979|316248|P2|Overall Study|Withdrawal by Subject|7
90742|NCT00251979|316249|P1|Overall Study|Withdrawal by Subject|13
90743|NCT00251979|316248|P2|Overall Study|Adverse Event|17
90744|NCT00251979|316249|P1|Overall Study|Adverse Event|11
90745|NCT00251979|316248|P2|Overall Study|Protocol Violation|5
90746|NCT00251979|316249|P1|Overall Study|Protocol Violation|3
90747|NCT00252057|316281|P2|Overall Study|Participant previously enrolled|1
90748|NCT00252057|316282|P1|Overall Study|Participant previously enrolled|0
90749|NCT00252057|316281|P2|Overall Study|Death|2
90750|NCT00252057|316282|P1|Overall Study|Death|1
90751|NCT00252057|316281|P2|Overall Study|Withdrawal by Subject|5
90752|NCT00252057|316282|P1|Overall Study|Withdrawal by Subject|2
90753|NCT00252174|316291|P3|Overall Study|Withdrawal by Subject|0
90754|NCT00252174|316292|P2|Overall Study|Withdrawal by Subject|1
90755|NCT00252174|316293|P1|Overall Study|Withdrawal by Subject|0
90756|NCT00252187|316330|P2|Overall Study|Withdrawal by Subject|0
90757|NCT00252187|316331|P1|Overall Study|Withdrawal by Subject|1
90758|NCT00252187|316330|P2|Overall Study|Adverse Event|1
90759|NCT00252187|316331|P1|Overall Study|Adverse Event|3
90760|NCT00252239|316355|P4|Overall Study|Lost to Follow-up|0
90761|NCT00252239|316356|P3|Overall Study|Lost to Follow-up|2
90762|NCT00252239|316357|P2|Overall Study|Lost to Follow-up|0
90763|NCT00252239|316358|P1|Overall Study|Lost to Follow-up|0
90764|NCT00252239|316355|P4|Overall Study|Withdrawal by Subject|1
90765|NCT00252239|316356|P3|Overall Study|Withdrawal by Subject|0
90766|NCT00252239|316357|P2|Overall Study|Withdrawal by Subject|0
90767|NCT00252239|316358|P1|Overall Study|Withdrawal by Subject|1
90768|NCT00252499|316376|P3|Overall Study|Lost to Follow-up|0
90769|NCT00252499|316377|P2|Overall Study|Lost to Follow-up|0
90770|NCT00252499|316378|P1|Overall Study|Lost to Follow-up|1
90771|NCT00252564|316418|P2|Overall Study|Withdrawal by Subject|2
90772|NCT00252564|316419|P1|Overall Study|Withdrawal by Subject|0
90773|NCT00252564|316418|P2|Overall Study|Patient Request|5
90774|NCT00252564|316419|P1|Overall Study|Patient Request|4
90775|NCT00252564|316418|P2|Overall Study|Lost to Follow-up|0
90776|NCT00252564|316419|P1|Overall Study|Lost to Follow-up|1
90777|NCT00252564|316418|P2|Overall Study|Physician Decision|0
90778|NCT00252564|316419|P1|Overall Study|Physician Decision|1
90779|NCT00252564|316418|P2|Overall Study|Protocol Violation|0
90780|NCT00252564|316419|P1|Overall Study|Protocol Violation|0
90781|NCT00252564|316418|P2|Overall Study|Death|3
90782|NCT00252564|316419|P1|Overall Study|Death|0
90783|NCT00252564|316418|P2|Overall Study|Disease Progression|20
90784|NCT00252564|316419|P1|Overall Study|Disease Progression|14
90785|NCT00252564|316418|P2|Overall Study|Unrelated Complication|1
90786|NCT00252564|316419|P1|Overall Study|Unrelated Complication|2
90787|NCT00252564|316418|P2|Overall Study|Adverse Event|13
90788|NCT00252564|316419|P1|Overall Study|Adverse Event|17
90789|NCT00252694|316467|P2|Overall Study|Patient Moving|16
90790|NCT00252694|316468|P1|Overall Study|Patient Moving|17
90791|NCT00252694|316467|P2|Overall Study|Mostly Lost to Follow Up|13
90792|NCT00252694|316468|P1|Overall Study|Mostly Lost to Follow Up|8
90793|NCT00252694|316467|P2|Overall Study|Death|34
90794|NCT00252694|316468|P1|Overall Study|Death|36
90795|NCT00252694|316467|P2|Overall Study|Withdrawal by Subject|91
90796|NCT00252694|316468|P1|Overall Study|Withdrawal by Subject|83
90797|NCT00252720|316482|P2|Overall Study|Mainly patients lost to follow-up|18
90798|NCT00252720|316483|P1|Overall Study|Mainly patients lost to follow-up|7
90799|NCT00252720|316482|P2|Overall Study|Moving|42
90800|NCT00252720|316483|P1|Overall Study|Moving|23
90801|NCT00252720|316482|P2|Overall Study|Death|8
90802|NCT00252720|316483|P1|Overall Study|Death|7
90803|NCT00252720|316482|P2|Overall Study|Withdrawal by Subject|97
90804|NCT00252720|316483|P1|Overall Study|Withdrawal by Subject|95
90805|NCT00252733|316497|P2|Overall Study|Multiple Reasons|14
90806|NCT00252733|316498|P1|Overall Study|Multiple Reasons|14
90807|NCT00252733|316497|P2|Overall Study|Lost to Follow-up|6
90808|NCT00252733|316498|P1|Overall Study|Lost to Follow-up|12
90809|NCT00252733|316497|P2|Overall Study|Death|5
90810|NCT00252733|316498|P1|Overall Study|Death|7
90811|NCT00252733|316497|P2|Overall Study|Withdrawal by Subject|67
90812|NCT00252733|316498|P1|Overall Study|Withdrawal by Subject|73
90813|NCT00246753|316544|P1|Overall Study|Unacceptable toxicity|2
90814|NCT00246753|316544|P1|Overall Study|Adverse Event|2
90815|NCT00246753|316544|P1|Overall Study|Physician Decision|2
90816|NCT00246753|316544|P1|Overall Study|Withdrawal by Subject|2
90817|NCT00246805|316552|P2|Phase 1|Lost to Follow-up|0
90818|NCT00246805|316553|P1|Phase 1|Lost to Follow-up|1
90819|NCT00247273|316561|P2|Overall Study|Did not take any study drug|0
90820|NCT00247273|316562|P1|Overall Study|Did not take any study drug|2
90821|NCT00247273|316561|P2|Overall Study|Withdrawal by Subject|47
90822|NCT00247273|316562|P1|Overall Study|Withdrawal by Subject|46
90823|NCT00247273|316561|P2|Overall Study|Lost to Follow-up|7
90824|NCT00247273|316562|P1|Overall Study|Lost to Follow-up|7
90825|NCT00247273|316561|P2|Overall Study|Physician Decision|3
90826|NCT00247273|316562|P1|Overall Study|Physician Decision|6
90827|NCT00247273|316561|P2|Overall Study|Adverse Event|80
90828|NCT00247273|316562|P1|Overall Study|Adverse Event|85
90829|NCT00247416|316635|P2|Overall Study|3 patients were found to be ineligible|2
90830|NCT00247416|316636|P1|Overall Study|3 patients were found to be ineligible|1
90831|NCT00253747|316650|P2|Overall Study|Administrative Discharge (1), Other (2)|2
90832|NCT00253747|316651|P1|Overall Study|Administrative Discharge (1), Other (2)|1
90833|NCT00253747|316650|P2|Overall Study|Withdrawal by Subject|11
90834|NCT00253747|316651|P1|Overall Study|Withdrawal by Subject|10
90835|NCT00253747|316650|P2|Overall Study|Lost to Follow-up|14
90836|NCT00253747|316651|P1|Overall Study|Lost to Follow-up|13
90837|NCT00254163|316698|P2|Overall Study|Other|8
90838|NCT00254163|316699|P1|Overall Study|Other|8
90839|NCT00254163|316698|P2|Overall Study|Death|1
90840|NCT00254163|316699|P1|Overall Study|Death|0
90841|NCT00254163|316698|P2|Overall Study|Progressive disease|1
90842|NCT00254163|316699|P1|Overall Study|Progressive disease|0
90843|NCT00254163|316698|P2|Overall Study|Failed entry|3
90844|NCT00254163|316699|P1|Overall Study|Failed entry|1
90845|NCT00254163|316698|P2|Overall Study|Investigator request|3
90846|NCT00254163|316699|P1|Overall Study|Investigator request|1
90847|NCT00254163|316698|P2|Overall Study|Patient request/withdrew consent|4
90848|NCT00254163|316699|P1|Overall Study|Patient request/withdrew consent|6
90849|NCT00254163|316698|P2|Overall Study|Adverse Event|26
90850|NCT00254163|316699|P1|Overall Study|Adverse Event|29
90851|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|not specified|1
90852|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|not specified|0
90853|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|not specified|0
90854|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|not specified|0
90855|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|not specified|0
90856|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|not specified|0
90857|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|not specified|0
90858|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
90859|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
90860|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
90861|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
90862|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
90863|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
90864|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
90865|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
90866|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
90867|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
90868|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
90869|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
90870|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
90871|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
90872|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
90873|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
90874|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
90875|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
90876|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
90877|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
90878|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
90879|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
90880|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
90881|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
90882|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
90883|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
90884|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
90885|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
90886|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|Adverse Event|1
90887|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|Adverse Event|0
90888|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|Adverse Event|0
90889|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|Adverse Event|0
90890|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|Adverse Event|0
90891|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|Adverse Event|0
90892|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|Adverse Event|0
90893|NCT00254293|316727|P7|LTE Open Label Fixed Dosing|Death|3
90894|NCT00254293|316728|P6|LTE Open Label Fixed Dosing|Death|0
90895|NCT00254293|316729|P5|LTE Open Label Fixed Dosing|Death|0
90896|NCT00254293|316730|P4|LTE Open Label Fixed Dosing|Death|0
90897|NCT00254293|316731|P3|LTE Open Label Fixed Dosing|Death|0
90898|NCT00254293|316732|P2|LTE Open Label Fixed Dosing|Death|0
90899|NCT00254293|316733|P1|LTE Open Label Fixed Dosing|Death|0
90900|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|not specified|0
90901|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|not specified|0
90902|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|not specified|0
90903|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|not specified|0
90904|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|not specified|2
90905|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|not specified|0
90906|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|not specified|0
90907|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
90908|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
90909|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
90910|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
90911|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
90912|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
90913|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
90914|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
90915|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
90916|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
90917|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
90918|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
90919|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
90920|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
90921|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
91001|NCT00254982|316902|P1|Overall Study|Protocol deviation|1
90922|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
90923|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
90924|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
90925|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
90926|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
90927|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
90928|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
90929|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
90930|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
90931|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
90932|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
90933|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
90934|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
90935|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
90936|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
90937|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
90938|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
90939|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
90940|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
90941|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
90942|NCT00254293|316727|P7|LTE Open Label Variable SC Dosing|Death|0
90943|NCT00254293|316728|P6|LTE Open Label Variable SC Dosing|Death|0
90944|NCT00254293|316729|P5|LTE Open Label Variable SC Dosing|Death|0
90945|NCT00254293|316730|P4|LTE Open Label Variable SC Dosing|Death|0
90946|NCT00254293|316731|P3|LTE Open Label Variable SC Dosing|Death|1
90947|NCT00254293|316732|P2|LTE Open Label Variable SC Dosing|Death|0
90948|NCT00254293|316733|P1|LTE Open Label Variable SC Dosing|Death|0
90949|NCT00254293|316727|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
90950|NCT00254293|316728|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
90951|NCT00254293|316729|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
90952|NCT00254293|316730|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
90953|NCT00254293|316731|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
90954|NCT00254293|316732|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
90955|NCT00254293|316733|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
90956|NCT00254293|316727|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
90957|NCT00254293|316728|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
90958|NCT00254293|316729|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
90959|NCT00254293|316730|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
90960|NCT00254293|316731|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
90961|NCT00254293|316732|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
90962|NCT00254293|316733|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
90963|NCT00254293|316727|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
90964|NCT00254293|316728|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
90965|NCT00254293|316729|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
90966|NCT00254293|316730|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
90967|NCT00254293|316731|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
90968|NCT00254293|316732|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
90969|NCT00254293|316733|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
90970|NCT00254501|316827|P2|Overall Study|Lost to Follow-up|1
90971|NCT00254501|316828|P1|Overall Study|Lost to Follow-up|1
90972|NCT00254540|316842|P2|Overall Study|Laboratory Test Abnormality|1
90973|NCT00254540|316843|P1|Overall Study|Laboratory Test Abnormality|0
90974|NCT00254540|316842|P2|Overall Study|Death|1
90975|NCT00254540|316843|P1|Overall Study|Death|0
90976|NCT00254540|316842|P2|Overall Study|Lack of Efficacy|13
90977|NCT00254540|316843|P1|Overall Study|Lack of Efficacy|13
90978|NCT00254540|316842|P2|Overall Study|Adverse Event|7
90979|NCT00254540|316843|P1|Overall Study|Adverse Event|6
90980|NCT00254566|316872|P2|Overall Study|Lost to Follow-up|2
90981|NCT00254566|316873|P1|Overall Study|Lost to Follow-up|7
90982|NCT00254566|316872|P2|Overall Study|Withdrawal by Subject|6
90983|NCT00254566|316873|P1|Overall Study|Withdrawal by Subject|5
90984|NCT00254566|316872|P2|Overall Study|Other|5
90985|NCT00254566|316873|P1|Overall Study|Other|1
90986|NCT00254566|316872|P2|Overall Study|Lack of Efficacy|9
90987|NCT00254566|316873|P1|Overall Study|Lack of Efficacy|12
90988|NCT00254566|316872|P2|Overall Study|Adverse Event|4
90989|NCT00254566|316873|P1|Overall Study|Adverse Event|5
90990|NCT00254566|316872|P2|Overall Study|Death|0
90991|NCT00254566|316873|P1|Overall Study|Death|1
90992|NCT00254982|316901|P2|Overall Study|Abnormal liver function tests|1
90993|NCT00254982|316902|P1|Overall Study|Abnormal liver function tests|2
90994|NCT00254982|316901|P2|Overall Study|Opportunistic infection|0
90995|NCT00254982|316902|P1|Overall Study|Opportunistic infection|1
90996|NCT00254982|316901|P2|Overall Study|Malignancy|2
90997|NCT00254982|316902|P1|Overall Study|Malignancy|0
90998|NCT00254982|316901|P2|Overall Study|Diagnosis of Tuberculosis|1
90999|NCT00254982|316902|P1|Overall Study|Diagnosis of Tuberculosis|1
91000|NCT00254982|316901|P2|Overall Study|Protocol deviation|1
91002|NCT00254982|316901|P2|Overall Study|Inclusion/exclusion criteria violation|2
91003|NCT00254982|316902|P1|Overall Study|Inclusion/exclusion criteria violation|0
91004|NCT00254982|316901|P2|Overall Study|Withdrawal by Subject|1
91005|NCT00254982|316902|P1|Overall Study|Withdrawal by Subject|1
91006|NCT00254982|316901|P2|Overall Study|Adverse Event|16
91007|NCT00254982|316902|P1|Overall Study|Adverse Event|18
91008|NCT00254982|316901|P2|Overall Study|Lost to Follow-up|3
91009|NCT00254982|316902|P1|Overall Study|Lost to Follow-up|5
91010|NCT00254982|316901|P2|Overall Study|Lack of Efficacy|3
91011|NCT00254982|316902|P1|Overall Study|Lack of Efficacy|5
91012|NCT00254982|316901|P2|Overall Study|Not specified|1
91013|NCT00254982|316902|P1|Overall Study|Not specified|2
91014|NCT00255008|316936|P4|Overall Study|Other|2
91015|NCT00255008|316937|P3|Overall Study|Other|3
91016|NCT00255008|316938|P2|Overall Study|Other|0
91017|NCT00255008|316939|P1|Overall Study|Other|7
91018|NCT00255008|316936|P4|Overall Study|Adverse lab experience|0
91019|NCT00255008|316937|P3|Overall Study|Adverse lab experience|0
91020|NCT00255008|316938|P2|Overall Study|Adverse lab experience|0
91021|NCT00255008|316939|P1|Overall Study|Adverse lab experience|1
91022|NCT00255008|316936|P4|Overall Study|Sponsor request|17
91023|NCT00255008|316937|P3|Overall Study|Sponsor request|8
91024|NCT00255008|316938|P2|Overall Study|Sponsor request|3
91025|NCT00255008|316939|P1|Overall Study|Sponsor request|18
91026|NCT00255008|316936|P4|Overall Study|Withdrew consent|0
91027|NCT00255008|316937|P3|Overall Study|Withdrew consent|2
91028|NCT00255008|316938|P2|Overall Study|Withdrew consent|0
91029|NCT00255008|316939|P1|Overall Study|Withdrew consent|0
91030|NCT00255008|316936|P4|Overall Study|Did not meet viral reduction criteria|1
91031|NCT00255008|316937|P3|Overall Study|Did not meet viral reduction criteria|0
91032|NCT00255008|316938|P2|Overall Study|Did not meet viral reduction criteria|5
91033|NCT00255008|316939|P1|Overall Study|Did not meet viral reduction criteria|4
91034|NCT00255008|316936|P4|Overall Study|Lost to Follow-up|2
91035|NCT00255008|316937|P3|Overall Study|Lost to Follow-up|1
91036|NCT00255008|316938|P2|Overall Study|Lost to Follow-up|0
91037|NCT00255008|316939|P1|Overall Study|Lost to Follow-up|1
91038|NCT00255008|316936|P4|Overall Study|Adverse Event|0
91039|NCT00255008|316937|P3|Overall Study|Adverse Event|2
91040|NCT00255008|316938|P2|Overall Study|Adverse Event|1
91041|NCT00255008|316939|P1|Overall Study|Adverse Event|1
91042|NCT00255034|316951|P2|Overall Study|Withdrawal by Subject|38
91043|NCT00255034|316952|P1|Overall Study|Withdrawal by Subject|15
91044|NCT00255047|316962|P4|Overall Study|Withdrawal by Subject|18
91045|NCT00255047|316963|P3|Overall Study|Withdrawal by Subject|25
91046|NCT00255047|316964|P2|Overall Study|Withdrawal by Subject|23
91047|NCT00255047|316965|P1|Overall Study|Withdrawal by Subject|24
91048|NCT00255047|316962|P4|Overall Study|Lost to Follow-up|6
91049|NCT00255047|316963|P3|Overall Study|Lost to Follow-up|5
91050|NCT00255047|316964|P2|Overall Study|Lost to Follow-up|8
91051|NCT00255047|316965|P1|Overall Study|Lost to Follow-up|9
91052|NCT00255047|316962|P4|Overall Study|Protocol Violation|20
91053|NCT00255047|316963|P3|Overall Study|Protocol Violation|16
91054|NCT00255047|316964|P2|Overall Study|Protocol Violation|13
91055|NCT00255047|316965|P1|Overall Study|Protocol Violation|13
91056|NCT00255047|316962|P4|Overall Study|Adverse Event|1
91057|NCT00255047|316963|P3|Overall Study|Adverse Event|2
91058|NCT00255047|316964|P2|Overall Study|Adverse Event|3
91059|NCT00255047|316965|P1|Overall Study|Adverse Event|0
91060|NCT00255047|316962|P4|Overall Study|Serious Adverse Events|1
91061|NCT00255047|316963|P3|Overall Study|Serious Adverse Events|2
91062|NCT00255047|316964|P2|Overall Study|Serious Adverse Events|1
91063|NCT00255047|316965|P1|Overall Study|Serious Adverse Events|2
91064|NCT00255086|316989|P2|Overall Study|Protocol Violation|1
91065|NCT00255086|316990|P1|Overall Study|Protocol Violation|1
91066|NCT00255086|316989|P2|Overall Study|Adverse Event|1
91067|NCT00255086|316990|P1|Overall Study|Adverse Event|1
91068|NCT00255151|317010|P3|Overall Study|Therapeutic Failure|3
91069|NCT00255151|317011|P2|Overall Study|Therapeutic Failure|2
91070|NCT00255151|317012|P1|Overall Study|Therapeutic Failure|11
91071|NCT00255151|317010|P3|Overall Study|Esophageal Stricture|1
91072|NCT00255151|317011|P2|Overall Study|Esophageal Stricture|0
91073|NCT00255151|317012|P1|Overall Study|Esophageal Stricture|0
91074|NCT00255151|317010|P3|Overall Study|Possible Barrett's Esophagus|8
91075|NCT00255151|317011|P2|Overall Study|Possible Barrett's Esophagus|3
91076|NCT00255151|317012|P1|Overall Study|Possible Barrett's Esophagus|1
91077|NCT00255151|317010|P3|Overall Study|Relapse of Erosive Esophagitis|12
91078|NCT00255151|317011|P2|Overall Study|Relapse of Erosive Esophagitis|16
91079|NCT00255151|317012|P1|Overall Study|Relapse of Erosive Esophagitis|78
91080|NCT00255151|317010|P3|Overall Study|Subject Request/Subject Unavailable|2
91081|NCT00255151|317011|P2|Overall Study|Subject Request/Subject Unavailable|1
91082|NCT00255151|317012|P1|Overall Study|Subject Request/Subject Unavailable|1
91083|NCT00255151|317010|P3|Overall Study|Noncompliance|2
91084|NCT00255151|317011|P2|Overall Study|Noncompliance|1
91085|NCT00255151|317012|P1|Overall Study|Noncompliance|0
91086|NCT00255151|317010|P3|Overall Study|Withdrawal by Subject|8
91087|NCT00255151|317011|P2|Overall Study|Withdrawal by Subject|17
91088|NCT00255151|317012|P1|Overall Study|Withdrawal by Subject|18
91089|NCT00255151|317010|P3|Overall Study|Lost to Follow-up|4
91090|NCT00255151|317011|P2|Overall Study|Lost to Follow-up|3
91091|NCT00255151|317012|P1|Overall Study|Lost to Follow-up|4
91092|NCT00255151|317010|P3|Overall Study|Adverse Event|9
91093|NCT00255151|317011|P2|Overall Study|Adverse Event|6
91094|NCT00255151|317012|P1|Overall Study|Adverse Event|10
91095|NCT00255164|317038|P3|Overall Study|Therapeutic Failure|3
91096|NCT00255164|317039|P2|Overall Study|Therapeutic Failure|2
91097|NCT00255164|317040|P1|Overall Study|Therapeutic Failure|11
91098|NCT00255164|317038|P3|Overall Study|Esophageal Stricture|1
91099|NCT00255164|317039|P2|Overall Study|Esophageal Stricture|0
91100|NCT00255164|317040|P1|Overall Study|Esophageal Stricture|0
91101|NCT00255164|317038|P3|Overall Study|Possible Barrett's Esophagus|8
91102|NCT00255164|317039|P2|Overall Study|Possible Barrett's Esophagus|3
91103|NCT00255164|317040|P1|Overall Study|Possible Barrett's Esophagus|1
91104|NCT00255164|317038|P3|Overall Study|Relapse of Erosive Esophagitis|12
91105|NCT00255164|317039|P2|Overall Study|Relapse of Erosive Esophagitis|16
91106|NCT00255164|317040|P1|Overall Study|Relapse of Erosive Esophagitis|78
91107|NCT00255164|317038|P3|Overall Study|Subject Request/Subject Unavailable|2
91108|NCT00255164|317039|P2|Overall Study|Subject Request/Subject Unavailable|1
91109|NCT00255164|317040|P1|Overall Study|Subject Request/Subject Unavailable|1
91110|NCT00255164|317038|P3|Overall Study|Noncompliance|2
91111|NCT00255164|317039|P2|Overall Study|Noncompliance|1
91112|NCT00255164|317040|P1|Overall Study|Noncompliance|0
91113|NCT00255164|317038|P3|Overall Study|Withdrawal by Subject|8
91114|NCT00255164|317039|P2|Overall Study|Withdrawal by Subject|17
91115|NCT00255164|317040|P1|Overall Study|Withdrawal by Subject|18
91116|NCT00255164|317038|P3|Overall Study|Lost to Follow-up|4
91117|NCT00255164|317039|P2|Overall Study|Lost to Follow-up|3
91118|NCT00255164|317040|P1|Overall Study|Lost to Follow-up|4
91119|NCT00255164|317038|P3|Overall Study|Adverse Event|9
91120|NCT00255164|317039|P2|Overall Study|Adverse Event|6
91121|NCT00255164|317040|P1|Overall Study|Adverse Event|10
91122|NCT00255190|317082|P2|Overall Study|Various|23
91123|NCT00255190|317083|P1|Overall Study|Various|4
91124|NCT00255190|317082|P2|Overall Study|Erosive esophagitis not healed|20
91125|NCT00255190|317083|P1|Overall Study|Erosive esophagitis not healed|0
91126|NCT00255190|317082|P2|Overall Study|Inclusion/Exclusion criteria not met|1
91127|NCT00255190|317083|P1|Overall Study|Inclusion/Exclusion criteria not met|0
91128|NCT00255190|317082|P2|Overall Study|Withdrew Consent|48
91129|NCT00255190|317083|P1|Overall Study|Withdrew Consent|17
91130|NCT00255190|317082|P2|Overall Study|Lost to Follow-up|27
91131|NCT00255190|317083|P1|Overall Study|Lost to Follow-up|10
91132|NCT00255190|317082|P2|Overall Study|Protocol Violation|2
91133|NCT00255190|317083|P1|Overall Study|Protocol Violation|2
91134|NCT00255190|317082|P2|Overall Study|Adverse Event|36
91135|NCT00255190|317083|P1|Overall Study|Adverse Event|17
91136|NCT00255723|317154|P2|Overall Study|Response Data Not Available|0
91137|NCT00255723|317155|P1|Overall Study|Response Data Not Available|1
91138|NCT00255723|317154|P2|Overall Study|Death|1
91139|NCT00255723|317155|P1|Overall Study|Death|0
91140|NCT00255723|317154|P2|Overall Study|Adverse Event|1
91141|NCT00255723|317155|P1|Overall Study|Adverse Event|1
91142|NCT00255840|317163|P2|Overall Study|Discontinued intervention|56
91143|NCT00255840|317164|P1|Overall Study|Discontinued intervention|53
91144|NCT00255840|317163|P2|Overall Study|Lost to Follow-up|14
91145|NCT00255840|317164|P1|Overall Study|Lost to Follow-up|10
91146|NCT00256204|317195|P4|Overall Study|Need for additional prohibited treatment|25
91147|NCT00256204|317196|P3|Overall Study|Need for additional prohibited treatment|27
91148|NCT00256204|317197|P2|Overall Study|Need for additional prohibited treatment|28
91149|NCT00256204|317198|P1|Overall Study|Need for additional prohibited treatment|38
91150|NCT00256204|317195|P4|Overall Study|Withdrawal by Subject|5
91151|NCT00256204|317196|P3|Overall Study|Withdrawal by Subject|7
91152|NCT00256204|317197|P2|Overall Study|Withdrawal by Subject|6
91153|NCT00256204|317198|P1|Overall Study|Withdrawal by Subject|17
91154|NCT00256204|317195|P4|Overall Study|Physician Decision|2
91155|NCT00256204|317196|P3|Overall Study|Physician Decision|1
91156|NCT00256204|317197|P2|Overall Study|Physician Decision|0
91157|NCT00256204|317198|P1|Overall Study|Physician Decision|0
91158|NCT00256204|317195|P4|Overall Study|Protocol Violation|1
91159|NCT00256204|317196|P3|Overall Study|Protocol Violation|2
91160|NCT00256204|317197|P2|Overall Study|Protocol Violation|0
91161|NCT00256204|317198|P1|Overall Study|Protocol Violation|1
91162|NCT00256204|317195|P4|Overall Study|Lost to Follow-up|2
91163|NCT00256204|317196|P3|Overall Study|Lost to Follow-up|1
91164|NCT00256204|317197|P2|Overall Study|Lost to Follow-up|1
91165|NCT00256204|317198|P1|Overall Study|Lost to Follow-up|1
91166|NCT00256204|317195|P4|Overall Study|Death|0
91167|NCT00256204|317196|P3|Overall Study|Death|0
91168|NCT00256204|317197|P2|Overall Study|Death|1
91169|NCT00256204|317198|P1|Overall Study|Death|0
91170|NCT00256204|317195|P4|Overall Study|Adverse Event|14
91171|NCT00256204|317196|P3|Overall Study|Adverse Event|16
91172|NCT00256204|317197|P2|Overall Study|Adverse Event|14
91173|NCT00256204|317198|P1|Overall Study|Adverse Event|10
91174|NCT00256243|317211|P1|Overall Study|Not treated|1
91175|NCT00256243|317211|P1|Overall Study|Death|7
91176|NCT00256243|317211|P1|Overall Study|Lost to Follow-up|2
91177|NCT00256295|317216|P1|Overall Study|Death|1
91178|NCT00256295|317216|P1|Overall Study|Withdrawal by Subject|3
91179|NCT00257556|317240|P2|Overall Study|other reason|6
91180|NCT00257556|317241|P1|Overall Study|other reason|4
91181|NCT00257556|317240|P2|Overall Study|Did not meet hCG criterion|0
91182|NCT00257556|317241|P1|Overall Study|Did not meet hCG criterion|3
91183|NCT00257556|317240|P2|Overall Study|Physician Decision|0
91184|NCT00257556|317241|P1|Overall Study|Physician Decision|6
91185|NCT00257556|317240|P2|Overall Study|Adverse Event|4
91186|NCT00257556|317241|P1|Overall Study|Adverse Event|1
91187|NCT00257608|317269|P3|Post Chemotherapy Phase|Not treated|7
91188|NCT00257608|317270|P2|Post Chemotherapy Phase|Not treated|4
91189|NCT00257608|317271|P1|Post Chemotherapy Phase|Not treated|0
91190|NCT00257608|317269|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
91191|NCT00257608|317270|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
91192|NCT00257608|317271|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
91193|NCT00257608|317269|P3|Post Chemotherapy Phase|Physician Decision|11
91194|NCT00257608|317270|P2|Post Chemotherapy Phase|Physician Decision|8
91195|NCT00257608|317271|P1|Post Chemotherapy Phase|Physician Decision|0
91196|NCT00257608|317269|P3|Post Chemotherapy Phase|Lost to Follow-up|1
91197|NCT00257608|317270|P2|Post Chemotherapy Phase|Lost to Follow-up|0
91198|NCT00257608|317271|P1|Post Chemotherapy Phase|Lost to Follow-up|0
91199|NCT00257608|317269|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
91200|NCT00257608|317270|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
91201|NCT00257608|317271|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
91202|NCT00257608|317269|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
91203|NCT00257608|317270|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
91204|NCT00257608|317271|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
91205|NCT00257608|317269|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
91206|NCT00257608|317270|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
91207|NCT00257608|317271|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
91208|NCT00257608|317269|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
91209|NCT00257608|317270|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
91210|NCT00257608|317271|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
91211|NCT00257608|317269|P3|Post Chemotherapy Phase|Disease progression|168
91212|NCT00257608|317270|P2|Post Chemotherapy Phase|Disease progression|204
91213|NCT00257608|317271|P1|Post Chemotherapy Phase|Disease progression|0
91214|NCT00257608|317269|P3|Post Chemotherapy Phase|Adverse Event|38
91215|NCT00257608|317270|P2|Post Chemotherapy Phase|Adverse Event|34
91216|NCT00257608|317271|P1|Post Chemotherapy Phase|Adverse Event|0
91217|NCT00257608|317269|P3|Chemotherapy Phase|Physician Decision|0
91218|NCT00257608|317270|P2|Chemotherapy Phase|Physician Decision|0
91219|NCT00257608|317271|P1|Chemotherapy Phase|Physician Decision|28
91220|NCT00257608|317269|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
91221|NCT00257608|317270|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
91222|NCT00257608|317271|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
91223|NCT00257608|317269|P3|Chemotherapy Phase|Patient's decision to discontinue|0
91224|NCT00257608|317270|P2|Chemotherapy Phase|Patient's decision to discontinue|0
91225|NCT00257608|317271|P1|Chemotherapy Phase|Patient's decision to discontinue|35
91226|NCT00257608|317269|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
91227|NCT00257608|317270|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
91228|NCT00257608|317271|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
91229|NCT00257608|317269|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
91230|NCT00257608|317270|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
91231|NCT00257608|317271|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
91232|NCT00257608|317269|P3|Chemotherapy Phase|Disease progression|0
91233|NCT00257608|317270|P2|Chemotherapy Phase|Disease progression|0
91234|NCT00257608|317271|P1|Chemotherapy Phase|Disease progression|139
91235|NCT00257608|317269|P3|Chemotherapy Phase|Adverse Event|0
91236|NCT00257608|317270|P2|Chemotherapy Phase|Adverse Event|0
91237|NCT00257608|317271|P1|Chemotherapy Phase|Adverse Event|138
91238|NCT00257660|317297|P2|Overall Study|No longer wanted to do blood draws|0
91239|NCT00257660|317298|P1|Overall Study|No longer wanted to do blood draws|1
91240|NCT00257660|317297|P2|Overall Study|PI & Subject Schedule Conflicts|0
91241|NCT00257660|317298|P1|Overall Study|PI & Subject Schedule Conflicts|1
91242|NCT00257660|317297|P2|Overall Study|Lost to Follow-up|0
91243|NCT00257660|317298|P1|Overall Study|Lost to Follow-up|1
91244|NCT00257660|317297|P2|Overall Study|Withdrawal by Subject|0
91245|NCT00257660|317298|P1|Overall Study|Withdrawal by Subject|2
91246|NCT00257660|317297|P2|Overall Study|Lack of Efficacy|23
91247|NCT00257660|317298|P1|Overall Study|Lack of Efficacy|5
91248|NCT00257920|317374|P2|Period: Second Intervention|Other|1
91249|NCT00257920|317375|P1|Period: Second Intervention|Other|2
91250|NCT00257920|317374|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
91251|NCT00257920|317375|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
91252|NCT00258154|317399|P2|Overall Study|Patient Moved|1
91253|NCT00258154|317400|P1|Overall Study|Patient Moved|3
91254|NCT00258154|317399|P2|Overall Study|Withdrawal by Subject|4
91255|NCT00258154|317400|P1|Overall Study|Withdrawal by Subject|3
91256|NCT00258154|317399|P2|Overall Study|Protocol Violation|1
91257|NCT00258154|317400|P1|Overall Study|Protocol Violation|2
91258|NCT00258154|317399|P2|Overall Study|Lost to Follow-up|1
91259|NCT00258154|317400|P1|Overall Study|Lost to Follow-up|0
91260|NCT00258154|317399|P2|Overall Study|Adverse Event|0
91261|NCT00258154|317400|P1|Overall Study|Adverse Event|1
91262|NCT00258440|317491|P3|Overall Study|Withdrawal by Subject|1
91263|NCT00258440|317492|P2|Overall Study|Withdrawal by Subject|0
91264|NCT00258440|317493|P1|Overall Study|Withdrawal by Subject|0
91265|NCT00258674|317507|P3|Overall Study|Death|34
91266|NCT00258674|317508|P2|Overall Study|Death|53
91267|NCT00258674|317509|P1|Overall Study|Death|32
91268|NCT00258856|317597|P4|Overall Study|Non-compliance|1
91269|NCT00258856|317598|P3|Overall Study|Non-compliance|0
91270|NCT00258856|317599|P2|Overall Study|Non-compliance|0
91271|NCT00258856|317600|P1|Overall Study|Non-compliance|2
91272|NCT00258856|317597|P4|Overall Study|Lost to Follow-up|0
91273|NCT00258856|317598|P3|Overall Study|Lost to Follow-up|2
91274|NCT00258856|317599|P2|Overall Study|Lost to Follow-up|0
91275|NCT00258856|317600|P1|Overall Study|Lost to Follow-up|1
91276|NCT00258895|317630|P2|Overall Study|Withdrawal by Subject|0
91277|NCT00258895|317631|P1|Overall Study|Withdrawal by Subject|1
91278|NCT00258895|317630|P2|Overall Study|Protocol Violation|2
91279|NCT00258895|317631|P1|Overall Study|Protocol Violation|6
91280|NCT00258895|317630|P2|Overall Study|Lost to Follow-up|1
91281|NCT00258895|317631|P1|Overall Study|Lost to Follow-up|3
91282|NCT00259012|317653|P2|Overall Study|Protocol Violation|1
91283|NCT00259012|317654|P1|Overall Study|Protocol Violation|1
91284|NCT00259012|317653|P2|Overall Study|Lost to Follow-up|1
91285|NCT00259012|317654|P1|Overall Study|Lost to Follow-up|0
91286|NCT00259012|317653|P2|Overall Study|Physician Decision|1
91287|NCT00259012|317654|P1|Overall Study|Physician Decision|0
91288|NCT00259012|317653|P2|Overall Study|Withdrawal by Subject|0
91289|NCT00259012|317654|P1|Overall Study|Withdrawal by Subject|1
91290|NCT00259012|317653|P2|Overall Study|Adverse Event|1
91291|NCT00259012|317654|P1|Overall Study|Adverse Event|0
91292|NCT00259272|317709|P4|Overall Study|Lost to Follow-up|1
91293|NCT00259272|317710|P3|Overall Study|Lost to Follow-up|0
91294|NCT00259272|317711|P2|Overall Study|Lost to Follow-up|0
91295|NCT00259272|317712|P1|Overall Study|Lost to Follow-up|1
91296|NCT00259272|317709|P4|Overall Study|Withdrawal by Subject|7
91297|NCT00259272|317710|P3|Overall Study|Withdrawal by Subject|2
91298|NCT00259272|317711|P2|Overall Study|Withdrawal by Subject|2
91299|NCT00259272|317712|P1|Overall Study|Withdrawal by Subject|4
91300|NCT00259272|317709|P4|Overall Study|Sponsor Decision|0
91301|NCT00259272|317710|P3|Overall Study|Sponsor Decision|0
91302|NCT00259272|317711|P2|Overall Study|Sponsor Decision|1
91303|NCT00259272|317712|P1|Overall Study|Sponsor Decision|0
91304|NCT00259272|317709|P4|Overall Study|Protocol Violation|1
91305|NCT00259272|317710|P3|Overall Study|Protocol Violation|0
91306|NCT00259272|317711|P2|Overall Study|Protocol Violation|0
91307|NCT00259272|317712|P1|Overall Study|Protocol Violation|2
91308|NCT00259272|317709|P4|Overall Study|Physician Decision|3
91309|NCT00259272|317710|P3|Overall Study|Physician Decision|1
91310|NCT00259272|317711|P2|Overall Study|Physician Decision|2
91311|NCT00259272|317712|P1|Overall Study|Physician Decision|1
91312|NCT00259272|317709|P4|Overall Study|Lack of Efficacy|6
91313|NCT00259272|317710|P3|Overall Study|Lack of Efficacy|2
91314|NCT00259272|317711|P2|Overall Study|Lack of Efficacy|1
91315|NCT00259272|317712|P1|Overall Study|Lack of Efficacy|5
91316|NCT00259272|317709|P4|Overall Study|Adverse Event|3
91317|NCT00259272|317710|P3|Overall Study|Adverse Event|0
91318|NCT00259272|317711|P2|Overall Study|Adverse Event|1
91319|NCT00259272|317712|P1|Overall Study|Adverse Event|2
91320|NCT00259298|317793|P1|Overall Study|Physician Decision|2
91321|NCT00259298|317793|P1|Overall Study|Withdrawal by Subject|1
91322|NCT00259610|317805|P4|Overall Study|Serious Adverse Event|2
91323|NCT00259610|317806|P3|Overall Study|Serious Adverse Event|2
91324|NCT00259610|317807|P2|Overall Study|Serious Adverse Event|2
91325|NCT00259610|317808|P1|Overall Study|Serious Adverse Event|8
91326|NCT00259610|317805|P4|Overall Study|Adverse Event|2
91327|NCT00259610|317806|P3|Overall Study|Adverse Event|5
91328|NCT00259610|317807|P2|Overall Study|Adverse Event|4
91329|NCT00259610|317808|P1|Overall Study|Adverse Event|3
91330|NCT00259610|317805|P4|Overall Study|non medical reason|3
91331|NCT00259610|317806|P3|Overall Study|non medical reason|10
91332|NCT00259610|317807|P2|Overall Study|non medical reason|2
91333|NCT00259610|317808|P1|Overall Study|non medical reason|6
91334|NCT00259610|317805|P4|Overall Study|Death|0
91335|NCT00259610|317806|P3|Overall Study|Death|2
91336|NCT00259610|317807|P2|Overall Study|Death|1
91337|NCT00259610|317808|P1|Overall Study|Death|1
91338|NCT00259610|317805|P4|Overall Study|Physician Decision|2
91339|NCT00259610|317806|P3|Overall Study|Physician Decision|7
91340|NCT00259610|317807|P2|Overall Study|Physician Decision|4
91341|NCT00259610|317808|P1|Overall Study|Physician Decision|6
91342|NCT00259610|317805|P4|Overall Study|Lost to Follow-up|15
91343|NCT00259610|317806|P3|Overall Study|Lost to Follow-up|18
91344|NCT00259610|317807|P2|Overall Study|Lost to Follow-up|8
91345|NCT00259610|317808|P1|Overall Study|Lost to Follow-up|19
91346|NCT00259610|317805|P4|Overall Study|Withdrawal by Subject|19
91347|NCT00259610|317806|P3|Overall Study|Withdrawal by Subject|29
91348|NCT00259610|317807|P2|Overall Study|Withdrawal by Subject|25
91349|NCT00259610|317808|P1|Overall Study|Withdrawal by Subject|33
91350|NCT00259649|317822|P1|Overall Study|irregular menses|3
91351|NCT00259649|317822|P1|Overall Study|Lost to Follow-up|7
91352|NCT00259740|317828|P2|Overall Study|Requirement for alternative therapy|4
91353|NCT00259740|317829|P1|Overall Study|Requirement for alternative therapy|0
91354|NCT00259740|317828|P2|Overall Study|Other|0
91355|NCT00259740|317829|P1|Overall Study|Other|3
91356|NCT00259740|317828|P2|Overall Study|Ongoing|3
91357|NCT00259740|317829|P1|Overall Study|Ongoing|17
91358|NCT00259740|317828|P2|Overall Study|Disease progression|36
91359|NCT00259740|317829|P1|Overall Study|Disease progression|19
91360|NCT00259740|317828|P2|Overall Study|Death|1
91361|NCT00259740|317829|P1|Overall Study|Death|1
91362|NCT00259740|317828|P2|Overall Study|Withdrawal by Subject|6
91363|NCT00259740|317829|P1|Overall Study|Withdrawal by Subject|2
91364|NCT00259740|317828|P2|Overall Study|Adverse Event|2
91365|NCT00259740|317829|P1|Overall Study|Adverse Event|0
91366|NCT00259740|317828|P2|Overall Study|Physician Decision|1
91367|NCT00259740|317829|P1|Overall Study|Physician Decision|1
91368|NCT00253370|317839|P1|Overall Study|Abdominal pain due to disease|1
91369|NCT00253370|317839|P1|Overall Study|Protocol Violation|1
91370|NCT00253370|317839|P1|Overall Study|Physician Decision|1
91371|NCT00253370|317839|P1|Overall Study|Non-protocol therapy|1
91372|NCT00253370|317839|P1|Overall Study|Withdrawal by Subject|6
91373|NCT00253370|317839|P1|Overall Study|Death|2
91374|NCT00253370|317839|P1|Overall Study|Disease progression|13
91375|NCT00253370|317839|P1|Overall Study|Adverse Event|18
91376|NCT00253448|317860|P1|Overall Study|Withdrawal by Subject|1
91377|NCT00253643|317875|P4|Overall Study|Non-Compliance|2
91378|NCT00253643|317876|P3|Overall Study|Non-Compliance|0
91379|NCT00253643|317877|P2|Overall Study|Non-Compliance|0
91380|NCT00253643|317878|P1|Overall Study|Non-Compliance|0
91381|NCT00253643|317875|P4|Overall Study|Withdrawal by Subject|1
91382|NCT00253643|317876|P3|Overall Study|Withdrawal by Subject|1
91383|NCT00253643|317877|P2|Overall Study|Withdrawal by Subject|0
91384|NCT00253643|317878|P1|Overall Study|Withdrawal by Subject|0
91385|NCT00259857|317925|P2|24 Months Treatment|Lost to Follow-up|3
91386|NCT00259857|317926|P1|24 Months Treatment|Lost to Follow-up|0
91387|NCT00259857|317925|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
91388|NCT00259857|317926|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
91389|NCT00260065|317942|P1|Overall Study|Medication Noncompliance|1
91390|NCT00260065|317942|P1|Overall Study|Not otherwise specified|8
91391|NCT00260065|317942|P1|Overall Study|Physician Decision|19
91392|NCT00260065|317942|P1|Overall Study|Withdrawal by Subject|13
91393|NCT00260065|317942|P1|Overall Study|Death|13
91394|NCT00260065|317942|P1|Overall Study|Adverse Event|17
91395|NCT00260065|317942|P1|Overall Study|Progressive Disease|22
91396|NCT00262743|317953|P2|Overall Study|Disease progression|3
91397|NCT00262743|317954|P1|Overall Study|Disease progression|0
91398|NCT00262743|317953|P2|Overall Study|Adverse Event|9
91399|NCT00262743|317954|P1|Overall Study|Adverse Event|0
91400|NCT00262821|317963|P2|Overall Study|Inevaluable - inadequate data|4
91401|NCT00262821|317964|P1|Overall Study|Inevaluable - inadequate data|0
91402|NCT00262821|317963|P2|Overall Study|Ineligible - required test not done|4
91403|NCT00262821|317964|P1|Overall Study|Ineligible - required test not done|1
91404|NCT00262821|317963|P2|Overall Study|Ineligible - elevated creatinine|2
91405|NCT00262821|317964|P1|Overall Study|Ineligible - elevated creatinine|0
91406|NCT00262821|317963|P2|Overall Study|Ineligible - inadequate pathology|3
91407|NCT00262821|317964|P1|Overall Study|Ineligible - inadequate pathology|1
91408|NCT00262821|317963|P2|Overall Study|Ineligible - wrong primary|1
91409|NCT00262821|317964|P1|Overall Study|Ineligible - wrong primary|0
91410|NCT00262821|317963|P2|Overall Study|Ineligible - wrong cell type|2
91411|NCT00262821|317964|P1|Overall Study|Ineligible - wrong cell type|2
91412|NCT00262821|317963|P2|Overall Study|Ineligible - wrong stage|3
91413|NCT00262821|317964|P1|Overall Study|Ineligible - wrong stage|0
91414|NCT00262834|317976|P2|Overall Study|Surgery delayed/tissue not collected|4
91415|NCT00262834|317977|P1|Overall Study|Surgery delayed/tissue not collected|1
91416|NCT00262847|317988|P3|Overall Study|Did not receive study treatment|4
91417|NCT00262847|317989|P2|Overall Study|Did not receive study treatment|1
91418|NCT00262847|317990|P1|Overall Study|Did not receive study treatment|4
91419|NCT00262847|317988|P3|Overall Study|Other Reasons|27
91420|NCT00262847|317989|P2|Overall Study|Other Reasons|88
91421|NCT00262847|317990|P1|Overall Study|Other Reasons|79
91422|NCT00262847|317988|P3|Overall Study|Concomitant disease|4
91423|NCT00262847|317989|P2|Overall Study|Concomitant disease|2
91424|NCT00262847|317990|P1|Overall Study|Concomitant disease|3
91425|NCT00262847|317988|P3|Overall Study|Death|11
91426|NCT00262847|317989|P2|Overall Study|Death|8
91427|NCT00262847|317990|P1|Overall Study|Death|8
91428|NCT00262847|317988|P3|Overall Study|Adverse Event|108
91429|NCT00262847|317989|P2|Overall Study|Adverse Event|88
91430|NCT00262847|317990|P1|Overall Study|Adverse Event|74
91431|NCT00262847|317988|P3|Overall Study|Patient Refusal|47
91432|NCT00262847|317989|P2|Overall Study|Patient Refusal|52
91433|NCT00262847|317990|P1|Overall Study|Patient Refusal|41
91434|NCT00262847|317988|P3|Overall Study|Disease Progression|195
91435|NCT00262847|317989|P2|Overall Study|Disease Progression|274
91436|NCT00262847|317990|P1|Overall Study|Disease Progression|309
91437|NCT00262860|318004|P1|Overall Study|Adverse Event|2
91438|NCT00262873|318010|P1|Overall Study|Withdrawal by Subject|5
91439|NCT00262873|318010|P1|Overall Study|Adverse Event|3
91440|NCT00262925|318021|P1|Overall Study|Other|1
91441|NCT00262925|318021|P1|Overall Study|alternative therapy|1
91442|NCT00262925|318021|P1|Overall Study|Death|2
91443|NCT00262925|318021|P1|Overall Study|Adverse Event|4
91444|NCT00262925|318021|P1|Overall Study|Lack of Efficacy|3
91445|NCT00262951|318027|P1|Overall Study|Off treatment for other disease|1
91446|NCT00262951|318027|P1|Overall Study|Alternative treatment|3
91447|NCT00262951|318027|P1|Overall Study|Withdrawal by Subject|1
91448|NCT00262951|318027|P1|Overall Study|Death|1
91449|NCT00262951|318027|P1|Overall Study|Adverse Event|7
91450|NCT00262951|318027|P1|Overall Study|Progressive disease/relapse|3
91451|NCT00263211|318069|P2|Overall Study|Disease Progression|1
91452|NCT00263211|318070|P1|Overall Study|Disease Progression|0
91453|NCT00263211|318069|P2|Overall Study|Protocol Violation|0
91454|NCT00263211|318070|P1|Overall Study|Protocol Violation|1
91455|NCT00263211|318069|P2|Overall Study|Withdrawal by Subject|0
91456|NCT00263211|318070|P1|Overall Study|Withdrawal by Subject|3
91457|NCT00263211|318069|P2|Overall Study|Death|0
91458|NCT00263211|318070|P1|Overall Study|Death|1
91459|NCT00263328|318089|P3|Overall Study|Adverse Event|4
91460|NCT00263328|318090|P2|Overall Study|Adverse Event|1
91461|NCT00263328|318091|P1|Overall Study|Adverse Event|1
91462|NCT00263328|318089|P3|Overall Study|Not specified|1
91463|NCT00263328|318090|P2|Overall Study|Not specified|0
91464|NCT00263328|318091|P1|Overall Study|Not specified|3
91465|NCT00263328|318089|P3|Overall Study|Withdrawal by Subject|1
91466|NCT00263328|318090|P2|Overall Study|Withdrawal by Subject|0
91467|NCT00263328|318091|P1|Overall Study|Withdrawal by Subject|3
91468|NCT00263328|318089|P3|Overall Study|Lost to Follow-up|0
91469|NCT00263328|318090|P2|Overall Study|Lost to Follow-up|1
91470|NCT00263328|318091|P1|Overall Study|Lost to Follow-up|1
91471|NCT00263328|318089|P3|Overall Study|Death|1
91472|NCT00263328|318090|P2|Overall Study|Death|0
91473|NCT00263328|318091|P1|Overall Study|Death|0
91474|NCT00263666|318249|P2|Overall Study|Withdrawal by Subject|1
91475|NCT00263666|318250|P1|Overall Study|Withdrawal by Subject|0
91476|NCT00263666|318249|P2|Overall Study|Lost to Follow-up|2
91477|NCT00263666|318250|P1|Overall Study|Lost to Follow-up|1
91478|NCT00263666|318249|P2|Overall Study|Adverse Event|8
91479|NCT00263666|318250|P1|Overall Study|Adverse Event|6
91480|NCT00263757|318303|P2|Overall Study|Adverse Event|3
91481|NCT00263757|318304|P1|Overall Study|Adverse Event|3
91482|NCT00263757|318303|P2|Overall Study|Screen failure|1
91483|NCT00263757|318304|P1|Overall Study|Screen failure|0
91484|NCT00263757|318303|P2|Overall Study|Withdrawal by Subject|4
91485|NCT00263757|318304|P1|Overall Study|Withdrawal by Subject|5
91486|NCT00263887|318316|P2|Overall Study|Lack of Efficacy|1
91487|NCT00263887|318317|P1|Overall Study|Lack of Efficacy|0
91488|NCT00263887|318316|P2|Overall Study|Disease progression|1
91489|NCT00263887|318317|P1|Overall Study|Disease progression|0
91490|NCT00263887|318316|P2|Overall Study|Adverse Event|2
91491|NCT00263887|318317|P1|Overall Study|Adverse Event|0
91492|NCT00263887|318316|P2|Overall Study|Too ill to attend visit|0
91493|NCT00263887|318317|P1|Overall Study|Too ill to attend visit|1
91494|NCT00263887|318316|P2|Overall Study|Lung transplantation|2
91495|NCT00263887|318317|P1|Overall Study|Lung transplantation|1
91496|NCT00263887|318316|P2|Overall Study|Withdrawal by Subject|1
91497|NCT00263887|318317|P1|Overall Study|Withdrawal by Subject|1
91498|NCT00264004|318327|P4|Overall Study|Not treated|2
91499|NCT00264004|318328|P3|Overall Study|Not treated|2
91500|NCT00264004|318329|P2|Overall Study|Not treated|0
91501|NCT00264004|318330|P1|Overall Study|Not treated|3
91502|NCT00264004|318327|P4|Overall Study|Cond. under inv. worsened|4
91503|NCT00264004|318328|P3|Overall Study|Cond. under inv. worsened|3
91504|NCT00264004|318329|P2|Overall Study|Cond. under inv. worsened|5
91505|NCT00264004|318330|P1|Overall Study|Cond. under inv. worsened|9
91506|NCT00264004|318327|P4|Overall Study|Development study specific disc. crit.|0
91507|NCT00264004|318328|P3|Overall Study|Development study specific disc. crit.|1
91508|NCT00264004|318329|P2|Overall Study|Development study specific disc. crit.|0
91509|NCT00264004|318330|P1|Overall Study|Development study specific disc. crit.|1
91510|NCT00264004|318327|P4|Overall Study|Not specified|3
91511|NCT00264004|318328|P3|Overall Study|Not specified|0
91512|NCT00264004|318329|P2|Overall Study|Not specified|2
91513|NCT00264004|318330|P1|Overall Study|Not specified|2
91514|NCT00264004|318327|P4|Overall Study|Withdrawal by Subject|2
91515|NCT00264004|318328|P3|Overall Study|Withdrawal by Subject|2
91516|NCT00264004|318329|P2|Overall Study|Withdrawal by Subject|1
91517|NCT00264004|318330|P1|Overall Study|Withdrawal by Subject|0
91518|NCT00264004|318327|P4|Overall Study|Adverse Event|4
91519|NCT00264004|318328|P3|Overall Study|Adverse Event|6
91520|NCT00264004|318329|P2|Overall Study|Adverse Event|3
91521|NCT00264004|318330|P1|Overall Study|Adverse Event|2
91522|NCT00264147|318361|P6|Treatment II Period|Pre-scheduled total hip replacement|1
91523|NCT00264147|318362|P5|Treatment II Period|Pre-scheduled total hip replacement|0
91524|NCT00264147|318363|P4|Treatment II Period|Pre-scheduled total hip replacement|0
91525|NCT00264147|318364|P3|Treatment II Period|Pre-scheduled total hip replacement|0
91526|NCT00264147|318365|P2|Treatment II Period|Pre-scheduled total hip replacement|0
91527|NCT00264147|318366|P1|Treatment II Period|Pre-scheduled total hip replacement|0
91528|NCT00264147|318361|P6|Treatment II Period|Withdrawal by Subject|2
91529|NCT00264147|318362|P5|Treatment II Period|Withdrawal by Subject|3
91530|NCT00264147|318363|P4|Treatment II Period|Withdrawal by Subject|0
91531|NCT00264147|318364|P3|Treatment II Period|Withdrawal by Subject|0
91532|NCT00264147|318365|P2|Treatment II Period|Withdrawal by Subject|0
91533|NCT00264147|318366|P1|Treatment II Period|Withdrawal by Subject|0
91534|NCT00264147|318361|P6|Treatment II Period|Lost to Follow-up|1
91535|NCT00264147|318362|P5|Treatment II Period|Lost to Follow-up|1
91536|NCT00264147|318363|P4|Treatment II Period|Lost to Follow-up|0
91537|NCT00264147|318364|P3|Treatment II Period|Lost to Follow-up|0
91538|NCT00264147|318365|P2|Treatment II Period|Lost to Follow-up|0
91539|NCT00264147|318366|P1|Treatment II Period|Lost to Follow-up|0
91540|NCT00264147|318361|P6|Treatment II Period|Lack of Efficacy|19
91541|NCT00264147|318362|P5|Treatment II Period|Lack of Efficacy|20
91542|NCT00264147|318363|P4|Treatment II Period|Lack of Efficacy|0
91543|NCT00264147|318364|P3|Treatment II Period|Lack of Efficacy|0
91544|NCT00264147|318365|P2|Treatment II Period|Lack of Efficacy|0
91545|NCT00264147|318366|P1|Treatment II Period|Lack of Efficacy|0
91546|NCT00264147|318361|P6|Treatment II Period|Laboratory Adverse Event|1
91547|NCT00264147|318362|P5|Treatment II Period|Laboratory Adverse Event|0
91548|NCT00264147|318363|P4|Treatment II Period|Laboratory Adverse Event|0
91549|NCT00264147|318364|P3|Treatment II Period|Laboratory Adverse Event|0
91550|NCT00264147|318365|P2|Treatment II Period|Laboratory Adverse Event|0
91551|NCT00264147|318366|P1|Treatment II Period|Laboratory Adverse Event|0
91552|NCT00264147|318361|P6|Treatment II Period|Adverse Event|9
91553|NCT00264147|318362|P5|Treatment II Period|Adverse Event|9
91554|NCT00264147|318363|P4|Treatment II Period|Adverse Event|0
91555|NCT00264147|318364|P3|Treatment II Period|Adverse Event|0
91556|NCT00264147|318365|P2|Treatment II Period|Adverse Event|0
91557|NCT00264147|318366|P1|Treatment II Period|Adverse Event|0
91558|NCT00264147|318361|P6|Treatment I Period|Reassigned to Treatment II Period|0
91559|NCT00264147|318362|P5|Treatment I Period|Reassigned to Treatment II Period|45
91560|NCT00264147|318363|P4|Treatment I Period|Reassigned to Treatment II Period|63
91561|NCT00264147|318364|P3|Treatment I Period|Reassigned to Treatment II Period|65
91562|NCT00264147|318365|P2|Treatment I Period|Reassigned to Treatment II Period|72
91563|NCT00264147|318366|P1|Treatment I Period|Reassigned to Treatment II Period|84
91564|NCT00264147|318361|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
91565|NCT00264147|318362|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
91566|NCT00264147|318363|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
91567|NCT00264147|318364|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
91568|NCT00264147|318365|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
91569|NCT00264147|318366|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
91570|NCT00264147|318361|P6|Treatment I Period|Patient out of town for an extended time|0
91571|NCT00264147|318362|P5|Treatment I Period|Patient out of town for an extended time|0
91572|NCT00264147|318363|P4|Treatment I Period|Patient out of town for an extended time|0
91573|NCT00264147|318364|P3|Treatment I Period|Patient out of town for an extended time|0
91574|NCT00264147|318365|P2|Treatment I Period|Patient out of town for an extended time|1
91575|NCT00264147|318366|P1|Treatment I Period|Patient out of town for an extended time|0
91576|NCT00264147|318361|P6|Treatment I Period|Withdrawal by Subject|0
91577|NCT00264147|318362|P5|Treatment I Period|Withdrawal by Subject|2
91578|NCT00264147|318363|P4|Treatment I Period|Withdrawal by Subject|2
91579|NCT00264147|318364|P3|Treatment I Period|Withdrawal by Subject|0
91580|NCT00264147|318365|P2|Treatment I Period|Withdrawal by Subject|0
91581|NCT00264147|318366|P1|Treatment I Period|Withdrawal by Subject|2
91582|NCT00264147|318361|P6|Treatment I Period|Protocol Violation|0
91583|NCT00264147|318362|P5|Treatment I Period|Protocol Violation|0
91584|NCT00264147|318363|P4|Treatment I Period|Protocol Violation|0
91585|NCT00264147|318364|P3|Treatment I Period|Protocol Violation|0
91586|NCT00264147|318365|P2|Treatment I Period|Protocol Violation|2
91587|NCT00264147|318366|P1|Treatment I Period|Protocol Violation|2
91588|NCT00264147|318361|P6|Treatment I Period|Lost to Follow-up|0
91589|NCT00264147|318362|P5|Treatment I Period|Lost to Follow-up|1
91590|NCT00264147|318363|P4|Treatment I Period|Lost to Follow-up|1
91591|NCT00264147|318364|P3|Treatment I Period|Lost to Follow-up|0
91592|NCT00264147|318365|P2|Treatment I Period|Lost to Follow-up|0
91593|NCT00264147|318366|P1|Treatment I Period|Lost to Follow-up|1
91594|NCT00264147|318361|P6|Treatment I Period|Lack of Efficacy|0
91595|NCT00264147|318362|P5|Treatment I Period|Lack of Efficacy|1
91596|NCT00264147|318363|P4|Treatment I Period|Lack of Efficacy|0
91597|NCT00264147|318364|P3|Treatment I Period|Lack of Efficacy|8
91598|NCT00264147|318365|P2|Treatment I Period|Lack of Efficacy|2
91599|NCT00264147|318366|P1|Treatment I Period|Lack of Efficacy|6
91600|NCT00264147|318361|P6|Treatment I Period|Laboratory Adverse Event|0
91601|NCT00264147|318362|P5|Treatment I Period|Laboratory Adverse Event|0
91602|NCT00264147|318363|P4|Treatment I Period|Laboratory Adverse Event|1
91603|NCT00264147|318364|P3|Treatment I Period|Laboratory Adverse Event|0
91604|NCT00264147|318365|P2|Treatment I Period|Laboratory Adverse Event|0
91605|NCT00264147|318366|P1|Treatment I Period|Laboratory Adverse Event|0
91606|NCT00264147|318361|P6|Treatment I Period|Adverse Event|0
91607|NCT00264147|318362|P5|Treatment I Period|Adverse Event|7
91608|NCT00264147|318363|P4|Treatment I Period|Adverse Event|5
91609|NCT00264147|318364|P3|Treatment I Period|Adverse Event|3
91610|NCT00264147|318365|P2|Treatment I Period|Adverse Event|6
91611|NCT00264147|318366|P1|Treatment I Period|Adverse Event|3
91612|NCT00264238|318405|P1|Overall Study|Protocol Violation|1
91613|NCT00264290|318414|P2|Intervention (8 Weeks)|Adverse Event|0
91614|NCT00264290|318415|P1|Intervention (8 Weeks)|Adverse Event|1
91615|NCT00264303|318423|P2|Overall Study|Various reasons listed in study report|7
91616|NCT00264303|318424|P1|Overall Study|Various reasons listed in study report|6
91617|NCT00264303|318423|P2|Overall Study|Withdrawal by Subject|3
91618|NCT00264303|318424|P1|Overall Study|Withdrawal by Subject|2
91619|NCT00264303|318423|P2|Overall Study|Lost to Follow-up|3
91620|NCT00264303|318424|P1|Overall Study|Lost to Follow-up|3
91621|NCT00264303|318423|P2|Overall Study|Lack of Efficacy|13
91622|NCT00264303|318424|P1|Overall Study|Lack of Efficacy|10
91623|NCT00264303|318423|P2|Overall Study|Adverse Event|3
91624|NCT00264303|318424|P1|Overall Study|Adverse Event|4
91625|NCT00264498|318457|P2|Crossover Treatment|Withdrawal by Subject|0
91626|NCT00264498|318458|P1|Crossover Treatment|Withdrawal by Subject|1
91627|NCT00264498|318457|P2|Crossover Treatment|Study closure|1
91628|NCT00264498|318458|P1|Crossover Treatment|Study closure|0
91629|NCT00264498|318457|P2|Crossover Treatment|Objective disease progression|5
91630|NCT00264498|318458|P1|Crossover Treatment|Objective disease progression|4
91631|NCT00264498|318457|P2|Crossover Treatment|Death|3
91632|NCT00264498|318458|P1|Crossover Treatment|Death|1
91633|NCT00264498|318457|P2|Randomized Treatment|Protocol Violation|0
91634|NCT00264498|318458|P1|Randomized Treatment|Protocol Violation|1
91635|NCT00264498|318457|P2|Randomized Treatment|Study Closure|0
91636|NCT00264498|318458|P1|Randomized Treatment|Study Closure|1
91637|NCT00264498|318457|P2|Randomized Treatment|Incorrectly randomized|0
91638|NCT00264498|318458|P1|Randomized Treatment|Incorrectly randomized|1
91639|NCT00264498|318457|P2|Randomized Treatment|Physician Decision|0
91640|NCT00264498|318458|P1|Randomized Treatment|Physician Decision|1
91641|NCT00264498|318457|P2|Randomized Treatment|Objective disease Progression|14
91642|NCT00264498|318458|P1|Randomized Treatment|Objective disease Progression|13
91643|NCT00264498|318457|P2|Randomized Treatment|Withdrawal by Subject|1
91644|NCT00264498|318458|P1|Randomized Treatment|Withdrawal by Subject|0
91645|NCT00264498|318457|P2|Randomized Treatment|Death|3
91646|NCT00264498|318458|P1|Randomized Treatment|Death|0
91647|NCT00264537|318468|P4|Overall Study|Not treated|0
91648|NCT00264537|318469|P3|Overall Study|Not treated|1
91649|NCT00264537|318470|P2|Overall Study|Not treated|2
91650|NCT00264537|318471|P1|Overall Study|Not treated|0
91651|NCT00264537|318468|P4|Overall Study|Not specified|11
91652|NCT00264537|318469|P3|Overall Study|Not specified|10
91653|NCT00264537|318470|P2|Overall Study|Not specified|11
91654|NCT00264537|318471|P1|Overall Study|Not specified|21
91655|NCT00264537|318468|P4|Overall Study|Unsatisfactory therapeutic effect|7
91656|NCT00264537|318469|P3|Overall Study|Unsatisfactory therapeutic effect|5
91657|NCT00264537|318470|P2|Overall Study|Unsatisfactory therapeutic effect|6
91658|NCT00264537|318471|P1|Overall Study|Unsatisfactory therapeutic effect|5
91659|NCT00264537|318468|P4|Overall Study|Adverse Event|34
91660|NCT00264537|318469|P3|Overall Study|Adverse Event|24
91661|NCT00264537|318470|P2|Overall Study|Adverse Event|32
91662|NCT00264537|318471|P1|Overall Study|Adverse Event|21
91663|NCT00264537|318468|P4|Overall Study|Lost to Follow-up|6
91664|NCT00264537|318469|P3|Overall Study|Lost to Follow-up|7
91665|NCT00264537|318470|P2|Overall Study|Lost to Follow-up|4
91666|NCT00264537|318471|P1|Overall Study|Lost to Follow-up|3
91667|NCT00264537|318468|P4|Overall Study|Death|2
91668|NCT00264537|318469|P3|Overall Study|Death|3
91669|NCT00264537|318470|P2|Overall Study|Death|3
91670|NCT00264537|318471|P1|Overall Study|Death|0
91671|NCT00264550|318505|P4|Overall Study|Not specified|9
91672|NCT00264550|318506|P3|Overall Study|Not specified|3
91673|NCT00264550|318507|P2|Overall Study|Not specified|7
91674|NCT00264550|318508|P1|Overall Study|Not specified|13
91675|NCT00264550|318505|P4|Overall Study|Discontinued oral study agent|0
91676|NCT00264550|318506|P3|Overall Study|Discontinued oral study agent|0
91677|NCT00264550|318507|P2|Overall Study|Discontinued oral study agent|1
91678|NCT00264550|318508|P1|Overall Study|Discontinued oral study agent|0
91679|NCT00264550|318505|P4|Overall Study|Unsatisfactory therapeutic effect|6
91680|NCT00264550|318506|P3|Overall Study|Unsatisfactory therapeutic effect|4
91681|NCT00264550|318507|P2|Overall Study|Unsatisfactory therapeutic effect|11
91682|NCT00264550|318508|P1|Overall Study|Unsatisfactory therapeutic effect|4
91683|NCT00264550|318505|P4|Overall Study|Adverse Event|14
91684|NCT00264550|318506|P3|Overall Study|Adverse Event|9
91685|NCT00264550|318507|P2|Overall Study|Adverse Event|18
91686|NCT00264550|318508|P1|Overall Study|Adverse Event|23
91687|NCT00264550|318505|P4|Overall Study|Lost to Follow-up|1
91688|NCT00264550|318506|P3|Overall Study|Lost to Follow-up|1
91689|NCT00264550|318507|P2|Overall Study|Lost to Follow-up|1
91690|NCT00264550|318508|P1|Overall Study|Lost to Follow-up|3
91691|NCT00264550|318505|P4|Overall Study|Death|0
91692|NCT00264550|318506|P3|Overall Study|Death|0
91693|NCT00264550|318507|P2|Overall Study|Death|3
91694|NCT00264550|318508|P1|Overall Study|Death|0
91695|NCT00264576|318545|P2|Overall Study|Lost to Follow-up|1
91696|NCT00264576|318546|P1|Overall Study|Lost to Follow-up|1
91697|NCT00264797|318576|P2|Overall Study|Other|4
91698|NCT00264797|318577|P1|Overall Study|Other|3
91699|NCT00264797|318576|P2|Overall Study|Feels treatment not necessary, not worki|1
91700|NCT00264797|318577|P1|Overall Study|Feels treatment not necessary, not worki|0
91701|NCT00264797|318576|P2|Overall Study|Pressure/advice from Outsiders|1
91702|NCT00264797|318577|P1|Overall Study|Pressure/advice from Outsiders|1
91703|NCT00264797|318576|P2|Overall Study|Incarceration|5
91704|NCT00264797|318577|P1|Overall Study|Incarceration|4
91705|NCT00264797|318576|P2|Overall Study|Practical Problems|3
91706|NCT00264797|318577|P1|Overall Study|Practical Problems|2
91707|NCT00264797|318576|P2|Overall Study|Moved from area|1
91708|NCT00264797|318577|P1|Overall Study|Moved from area|3
91709|NCT00264797|318576|P2|Overall Study|Lost to Follow-up|17
91710|NCT00264797|318577|P1|Overall Study|Lost to Follow-up|9
91711|NCT00264797|318576|P2|Overall Study|Withdrawal by Subject|11
91712|NCT00264797|318577|P1|Overall Study|Withdrawal by Subject|11
91713|NCT00264810|318591|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
91714|NCT00264810|318592|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
91715|NCT00264810|318591|P2|Open Label Evaluation Period|Death|2
91716|NCT00264810|318592|P1|Open Label Evaluation Period|Death|3
91717|NCT00264810|318591|P2|Open Label Evaluation Period|Explant due to infection|1
91718|NCT00264810|318592|P1|Open Label Evaluation Period|Explant due to infection|1
91719|NCT00264810|318591|P2|Blinded Evaluation Period|Explant due to infection|1
91720|NCT00264810|318592|P1|Blinded Evaluation Period|Explant due to infection|1
91721|NCT00264810|318591|P2|Stimulation Optimization Period|Death|1
91722|NCT00264810|318592|P1|Stimulation Optimization Period|Death|0
91723|NCT00264810|318591|P2|Stimulation Optimization Period|Withdrawal by Subject|0
91724|NCT00264810|318592|P1|Stimulation Optimization Period|Withdrawal by Subject|1
91725|NCT00264810|318591|P2|Baseline|Other|1
91726|NCT00264810|318592|P1|Baseline|Other|0
91727|NCT00264810|318591|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
91728|NCT00264810|318592|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
91729|NCT00264810|318591|P2|Baseline|Insufficient Seizure Frequency|2
91730|NCT00264810|318592|P1|Baseline|Insufficient Seizure Frequency|2
91731|NCT00264810|318591|P2|Baseline|Subject Compliance Failure|3
91732|NCT00264810|318592|P1|Baseline|Subject Compliance Failure|3
91733|NCT00264810|318591|P2|Baseline|Physician Decision|8
91734|NCT00264810|318592|P1|Baseline|Physician Decision|7
91735|NCT00264810|318591|P2|Baseline|Withdrawal by Subject|10
91736|NCT00264810|318592|P1|Baseline|Withdrawal by Subject|10
91737|NCT00264849|318602|P2|Overall Study|Administrative Problems|0
91738|NCT00264849|318603|P1|Overall Study|Administrative Problems|2
91739|NCT00264849|318602|P2|Overall Study|Death|1
91740|NCT00264849|318603|P1|Overall Study|Death|0
91741|NCT00264849|318602|P2|Overall Study|Lost to Follow-up|2
91742|NCT00264849|318603|P1|Overall Study|Lost to Follow-up|0
91743|NCT00264849|318602|P2|Overall Study|Lack of Efficacy|6
91744|NCT00264849|318603|P1|Overall Study|Lack of Efficacy|1
91745|NCT00264849|318602|P2|Overall Study|Protocol Violation|3
91746|NCT00264849|318603|P1|Overall Study|Protocol Violation|5
91747|NCT00264849|318602|P2|Overall Study|Withdrawal by Subject|11
91748|NCT00264849|318603|P1|Overall Study|Withdrawal by Subject|7
91749|NCT00264849|318602|P2|Overall Study|Adverse Event|2
91750|NCT00264849|318603|P1|Overall Study|Adverse Event|7
91751|NCT00264875|318637|P1|Overall Study|Withdrawal by Subject|7
91752|NCT00264875|318637|P1|Overall Study|Protocol Violation|11
91753|NCT00264875|318637|P1|Overall Study|Lost to Follow-up|6
91754|NCT00264875|318637|P1|Overall Study|Adverse Event|6
91755|NCT00265083|318644|P3|Overall Study|Not specified|9
91756|NCT00265083|318645|P2|Overall Study|Not specified|12
91757|NCT00265083|318646|P1|Overall Study|Not specified|1
91758|NCT00265083|318644|P3|Overall Study|Unsatisfactory therapeutic effect|14
91759|NCT00265083|318645|P2|Overall Study|Unsatisfactory therapeutic effect|13
91760|NCT00265083|318646|P1|Overall Study|Unsatisfactory therapeutic effect|8
91761|NCT00265083|318644|P3|Overall Study|Lost to Follow-up|4
91762|NCT00265083|318645|P2|Overall Study|Lost to Follow-up|4
91763|NCT00265083|318646|P1|Overall Study|Lost to Follow-up|3
91764|NCT00265083|318644|P3|Overall Study|Adverse Event|15
91765|NCT00265083|318645|P2|Overall Study|Adverse Event|13
91766|NCT00265083|318646|P1|Overall Study|Adverse Event|5
91767|NCT00265096|318670|P3|Overall Study|Not Specified|10
91768|NCT00265096|318671|P2|Overall Study|Not Specified|19
91769|NCT00265096|318672|P1|Overall Study|Not Specified|11
91770|NCT00265096|318670|P3|Overall Study|Unsatisfactory therapeutic effect|6
91771|NCT00265096|318671|P2|Overall Study|Unsatisfactory therapeutic effect|8
91772|NCT00265096|318672|P1|Overall Study|Unsatisfactory therapeutic effect|9
91773|NCT00265096|318670|P3|Overall Study|Death|2
91774|NCT00265096|318671|P2|Overall Study|Death|1
91775|NCT00265096|318672|P1|Overall Study|Death|0
91776|NCT00265096|318670|P3|Overall Study|Lost to Follow-up|3
91777|NCT00265096|318671|P2|Overall Study|Lost to Follow-up|5
91778|NCT00265096|318672|P1|Overall Study|Lost to Follow-up|2
91779|NCT00265096|318670|P3|Overall Study|Adverse Event|18
91780|NCT00265096|318671|P2|Overall Study|Adverse Event|18
91781|NCT00265096|318672|P1|Overall Study|Adverse Event|14
91782|NCT00265109|318701|P1|Overall Study|Adverse Event|1
91783|NCT00265109|318701|P1|Overall Study|Withdrawal by Subject|5
91784|NCT00265122|318711|P6|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
91785|NCT00265122|318712|P5|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
91786|NCT00265122|318713|P4|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
91787|NCT00265122|318714|P3|Intervention Period 2 (Weeks 8 to 28):|Not specified|1
91788|NCT00265122|318715|P2|Intervention Period 2 (Weeks 8 to 28):|Not specified|0
91789|NCT00265122|318716|P1|Intervention Period 2 (Weeks 8 to 28):|Not specified|4
91790|NCT00265122|318711|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
91791|NCT00265122|318712|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
91792|NCT00265122|318713|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
91793|NCT00265122|318714|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
91794|NCT00265122|318715|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
91795|NCT00265122|318716|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
91796|NCT00265122|318711|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
91797|NCT00265122|318712|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
91798|NCT00265122|318713|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
91799|NCT00265122|318714|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
91800|NCT00265122|318715|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
91801|NCT00265122|318716|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
91802|NCT00265122|318711|P6|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
91803|NCT00265122|318712|P5|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
91804|NCT00265122|318713|P4|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
91805|NCT00265122|318714|P3|Intervention Period 1 (Weeks 0 to 8):|Not specified|2
91806|NCT00265122|318715|P2|Intervention Period 1 (Weeks 0 to 8):|Not specified|1
91807|NCT00265122|318716|P1|Intervention Period 1 (Weeks 0 to 8):|Not specified|0
91808|NCT00265122|318711|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
91809|NCT00265122|318712|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
91810|NCT00265122|318713|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
91811|NCT00265122|318714|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
91812|NCT00265122|318715|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
91813|NCT00265122|318716|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
91814|NCT00265122|318711|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
91815|NCT00265122|318712|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
91816|NCT00265122|318713|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
91817|NCT00265122|318714|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
91818|NCT00265122|318715|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
91819|NCT00265122|318716|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
91820|NCT00265239|318744|P2|Overall Study|Adverse Event|1
91821|NCT00265239|318745|P1|Overall Study|Adverse Event|2
91822|NCT00256698|318759|P2|Overall Study|Prematurely Discontinued|0
91823|NCT00256698|318760|P1|Overall Study|Prematurely Discontinued|1
91824|NCT00256698|318759|P2|Overall Study|withdrawn due to osteoporosis|0
91825|NCT00256698|318760|P1|Overall Study|withdrawn due to osteoporosis|1
91826|NCT00256698|318759|P2|Overall Study|still ongoing at data cut-off|46
91827|NCT00256698|318760|P1|Overall Study|still ongoing at data cut-off|41
91828|NCT00256698|318759|P2|Overall Study|disease progression|105
91829|NCT00256698|318760|P1|Overall Study|disease progression|97
91830|NCT00256698|318759|P2|Overall Study|Lost to Follow-up|3
91831|NCT00256698|318760|P1|Overall Study|Lost to Follow-up|1
91832|NCT00256698|318759|P2|Overall Study|Protocol Violation|5
91833|NCT00256698|318760|P1|Overall Study|Protocol Violation|6
91834|NCT00256698|318759|P2|Overall Study|Adverse Event|6
91835|NCT00256698|318760|P1|Overall Study|Adverse Event|13
91836|NCT00256698|318759|P2|Overall Study|Withdrawal by Subject|7
91837|NCT00256698|318760|P1|Overall Study|Withdrawal by Subject|7
91838|NCT00256724|318780|P2|Overall Study|Protocol Violation|3
91839|NCT00256724|318781|P1|Overall Study|Protocol Violation|3
91840|NCT00256724|318780|P2|Overall Study|Physician Decision|5
91841|NCT00256724|318781|P1|Overall Study|Physician Decision|2
91842|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Not Specified|5
91843|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Not Specified|4
91844|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Not Specified|5
91845|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
91846|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
91847|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
91848|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
91849|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
91850|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
91851|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
91852|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
91853|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
91854|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
91855|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
91856|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
91857|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Death|4
91858|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Death|4
91859|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Death|9
91860|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
91861|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
91862|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
91863|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
91864|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
91865|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
91866|NCT00256750|318792|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
91867|NCT00256750|318793|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
91868|NCT00256750|318794|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
91869|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Not specified|1
91870|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Not specified|1
91871|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Not specified|0
91872|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
91873|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
91874|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
91875|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
91876|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
91877|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
91878|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
91879|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
91880|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
91881|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Death|1
91882|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Death|2
91883|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Death|0
91884|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
91885|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
91886|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
91887|NCT00256750|318792|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
91888|NCT00256750|318793|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
91889|NCT00256750|318794|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
91890|NCT00256750|318792|P3|Post-Transplant Treated (24 Months)|Not Specified|1
91891|NCT00256750|318793|P2|Post-Transplant Treated (24 Months)|Not Specified|0
91892|NCT00256750|318794|P1|Post-Transplant Treated (24 Months)|Not Specified|2
91893|NCT00256750|318792|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
91894|NCT00256750|318793|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
91895|NCT00256750|318794|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
91896|NCT00256750|318792|P3|Post-Transplant Treated (24 Months)|Death|0
91897|NCT00256750|318793|P2|Post-Transplant Treated (24 Months)|Death|0
91898|NCT00256750|318794|P1|Post-Transplant Treated (24 Months)|Death|3
91899|NCT00256750|318792|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
91982|NCT00257192|318992|P1|Overall Study|Withdrawal by Subject|14
91900|NCT00256750|318793|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
91901|NCT00256750|318794|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
91902|NCT00256750|318792|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
91903|NCT00256750|318793|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
91904|NCT00256750|318794|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
91905|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
91906|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
91907|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
91908|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
91909|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
91910|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
91911|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Not Specified|2
91912|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Not Specified|4
91913|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Not Specified|5
91914|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
91915|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
91916|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
91917|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
91918|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
91919|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
91920|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Death|4
91921|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Death|2
91922|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Death|3
91923|NCT00256750|318792|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
91924|NCT00256750|318793|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
91925|NCT00256750|318794|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
91926|NCT00256750|318792|P3|Transplanted Pre-Treatment|Death|0
91927|NCT00256750|318793|P2|Transplanted Pre-Treatment|Death|0
91928|NCT00256750|318794|P1|Transplanted Pre-Treatment|Death|1
91929|NCT00256750|318792|P3|Transplanted Pre-Treatment|Not Specified|0
91930|NCT00256750|318793|P2|Transplanted Pre-Treatment|Not Specified|0
91931|NCT00256750|318794|P1|Transplanted Pre-Treatment|Not Specified|2
91932|NCT00256750|318792|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
91933|NCT00256750|318793|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
91934|NCT00256750|318794|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
91935|NCT00256997|318940|P2|Overall Study|Investigator Withdrew Participant|1
91936|NCT00256997|318941|P1|Overall Study|Investigator Withdrew Participant|2
91937|NCT00256997|318940|P2|Overall Study|Participant Non-compliant|6
91938|NCT00256997|318941|P1|Overall Study|Participant Non-compliant|3
91939|NCT00256997|318940|P2|Overall Study|End of Study (As Per Sponsor)|24
91940|NCT00256997|318941|P1|Overall Study|End of Study (As Per Sponsor)|12
91941|NCT00256997|318940|P2|Overall Study|Unspecified|8
91942|NCT00256997|318941|P1|Overall Study|Unspecified|5
91943|NCT00256997|318940|P2|Overall Study|Started but not treated|0
91944|NCT00256997|318941|P1|Overall Study|Started but not treated|2
91945|NCT00256997|318940|P2|Overall Study|Withdrawal by Subject|3
91946|NCT00256997|318941|P1|Overall Study|Withdrawal by Subject|13
91947|NCT00256997|318940|P2|Overall Study|Lost to Follow-up|5
91948|NCT00256997|318941|P1|Overall Study|Lost to Follow-up|3
91949|NCT00256997|318940|P2|Overall Study|Adverse Event|0
91950|NCT00256997|318941|P1|Overall Study|Adverse Event|4
91951|NCT00256997|318940|P2|Overall Study|Death|0
91952|NCT00256997|318941|P1|Overall Study|Death|2
91953|NCT00256997|318940|P2|Overall Study|Lack of Efficacy|4
91954|NCT00256997|318941|P1|Overall Study|Lack of Efficacy|1
91955|NCT00256997|318940|P2|Overall Study|Protocol Violation|4
91956|NCT00256997|318941|P1|Overall Study|Protocol Violation|1
91957|NCT00257010|318965|P1|Overall Study|no headache reported|9
91958|NCT00257010|318965|P1|Overall Study|various|11
91959|NCT00257010|318965|P1|Overall Study|Adverse Event|10
91960|NCT00257010|318965|P1|Overall Study|Withdrawal by Subject|34
91961|NCT00257010|318965|P1|Overall Study|Lost to Follow-up|53
91962|NCT00257010|318965|P1|Overall Study|Lack of Efficacy|11
91963|NCT00257166|318976|P2|Overall Study|Randomized, but not treated|0
91964|NCT00257166|318977|P1|Overall Study|Randomized, but not treated|1
91965|NCT00257166|318976|P2|Overall Study|Unspecified|21
91966|NCT00257166|318977|P1|Overall Study|Unspecified|16
91967|NCT00257166|318976|P2|Overall Study|Withdrawal by Subject|2
91968|NCT00257166|318977|P1|Overall Study|Withdrawal by Subject|9
91969|NCT00257166|318976|P2|Overall Study|Lost to Follow-up|1
91970|NCT00257166|318977|P1|Overall Study|Lost to Follow-up|8
91971|NCT00257166|318976|P2|Overall Study|Laboratory abnormality|0
91972|NCT00257166|318977|P1|Overall Study|Laboratory abnormality|1
91973|NCT00257166|318976|P2|Overall Study|Adverse Event|13
91974|NCT00257166|318977|P1|Overall Study|Adverse Event|18
91975|NCT00257192|318991|P2|Overall Study|Miscellaneous|4
91976|NCT00257192|318992|P1|Overall Study|Miscellaneous|0
91977|NCT00257192|318991|P2|Overall Study|Study terminated by sponsor|0
91978|NCT00257192|318992|P1|Overall Study|Study terminated by sponsor|1
91979|NCT00257192|318991|P2|Overall Study|Randomized but not treated|1
91980|NCT00257192|318992|P1|Overall Study|Randomized but not treated|0
91981|NCT00257192|318991|P2|Overall Study|Withdrawal by Subject|2
91983|NCT00257192|318991|P2|Overall Study|Insufficient clinical response|18
91984|NCT00257192|318992|P1|Overall Study|Insufficient clinical response|18
91985|NCT00257192|318991|P2|Overall Study|Lost to Follow-up|3
91986|NCT00257192|318992|P1|Overall Study|Lost to Follow-up|3
91987|NCT00257192|318991|P2|Overall Study|Laboratory abnormality|1
91988|NCT00257192|318992|P1|Overall Study|Laboratory abnormality|1
91989|NCT00257192|318991|P2|Overall Study|Adverse Event|10
91990|NCT00257192|318992|P1|Overall Study|Adverse Event|21
91991|NCT00265317|319038|P4|Phase 2|Unspecified|1
91992|NCT00265317|319039|P3|Phase 2|Unspecified|1
91993|NCT00265317|319040|P2|Phase 2|Unspecified|0
91994|NCT00265317|319041|P1|Phase 2|Unspecified|0
91995|NCT00265317|319038|P4|Phase 2|Study terminated by sponsor|0
91996|NCT00265317|319039|P3|Phase 2|Study terminated by sponsor|1
91997|NCT00265317|319040|P2|Phase 2|Study terminated by sponsor|0
91998|NCT00265317|319041|P1|Phase 2|Study terminated by sponsor|0
91999|NCT00265317|319038|P4|Phase 2|Withdrawal/other than adverse event|1
92000|NCT00265317|319039|P3|Phase 2|Withdrawal/other than adverse event|2
92001|NCT00265317|319040|P2|Phase 2|Withdrawal/other than adverse event|0
92002|NCT00265317|319041|P1|Phase 2|Withdrawal/other than adverse event|0
92003|NCT00265317|319038|P4|Phase 2|Lost to Follow-up|1
92004|NCT00265317|319039|P3|Phase 2|Lost to Follow-up|0
92005|NCT00265317|319040|P2|Phase 2|Lost to Follow-up|0
92006|NCT00265317|319041|P1|Phase 2|Lost to Follow-up|0
92007|NCT00265317|319038|P4|Phase 2|Protocol Violation|4
92008|NCT00265317|319039|P3|Phase 2|Protocol Violation|1
92009|NCT00265317|319040|P2|Phase 2|Protocol Violation|0
92010|NCT00265317|319041|P1|Phase 2|Protocol Violation|0
92011|NCT00265317|319038|P4|Phase 2|Death|15
92012|NCT00265317|319039|P3|Phase 2|Death|12
92013|NCT00265317|319040|P2|Phase 2|Death|0
92014|NCT00265317|319041|P1|Phase 2|Death|0
92015|NCT00265317|319038|P4|Phase 2|Adverse Event|5
92016|NCT00265317|319039|P3|Phase 2|Adverse Event|7
92017|NCT00265317|319040|P2|Phase 2|Adverse Event|0
92018|NCT00265317|319041|P1|Phase 2|Adverse Event|0
92019|NCT00265317|319038|P4|Phase 2|Global deterioration of health status|0
92192|NCT00267202|319428|P2|Overall Study|Protocol Violation|3
92020|NCT00265317|319039|P3|Phase 2|Global deterioration of health status|3
92021|NCT00265317|319040|P2|Phase 2|Global deterioration of health status|0
92022|NCT00265317|319041|P1|Phase 2|Global deterioration of health status|0
92023|NCT00265317|319038|P4|Phase 2|Objective progression or relapse|38
92024|NCT00265317|319039|P3|Phase 2|Objective progression or relapse|37
92025|NCT00265317|319040|P2|Phase 2|Objective progression or relapse|0
92026|NCT00265317|319041|P1|Phase 2|Objective progression or relapse|0
92027|NCT00265317|319038|P4|Lead-In|Withdrawal/other than adverse event|0
92028|NCT00265317|319039|P3|Lead-In|Withdrawal/other than adverse event|0
92029|NCT00265317|319040|P2|Lead-In|Withdrawal/other than adverse event|0
92030|NCT00265317|319041|P1|Lead-In|Withdrawal/other than adverse event|1
92031|NCT00265317|319038|P4|Lead-In|Death|0
92032|NCT00265317|319039|P3|Lead-In|Death|0
92033|NCT00265317|319040|P2|Lead-In|Death|5
92034|NCT00265317|319041|P1|Lead-In|Death|3
92035|NCT00265317|319038|P4|Lead-In|Adverse Event|0
92036|NCT00265317|319039|P3|Lead-In|Adverse Event|0
92037|NCT00265317|319040|P2|Lead-In|Adverse Event|1
92038|NCT00265317|319041|P1|Lead-In|Adverse Event|2
92039|NCT00265317|319038|P4|Lead-In|Objective progression or relapse|0
92040|NCT00265317|319039|P3|Lead-In|Objective progression or relapse|0
92041|NCT00265317|319040|P2|Lead-In|Objective progression or relapse|11
92042|NCT00265317|319041|P1|Lead-In|Objective progression or relapse|6
92043|NCT00265330|319154|P1|Overall Study|Protocol Violation|1
92044|NCT00265330|319154|P1|Overall Study|Withdrew Consent|1
92045|NCT00265330|319154|P1|Overall Study|Principal Investigators Request|1
92046|NCT00265330|319154|P1|Overall Study|Site Closed by Sponsor|1
92047|NCT00265330|319154|P1|Overall Study|Discharged from Unit for Long Term Care|1
92048|NCT00265330|319154|P1|Overall Study|Began Taking Formulary Geodon|1
92049|NCT00265330|319154|P1|Overall Study|Family Scheduling Conflicts|1
92050|NCT00265330|319154|P1|Overall Study|Lack of Efficacy|4
92051|NCT00265330|319154|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
92052|NCT00265330|319154|P1|Overall Study|Withdrawal by Subject|34
92053|NCT00265330|319154|P1|Overall Study|Lost to Follow-up|8
92054|NCT00265330|319154|P1|Overall Study|Adverse Event|41
92055|NCT00265343|319178|P2|Overall Study|Other|3
92056|NCT00265343|319179|P1|Overall Study|Other|8
92057|NCT00265343|319178|P2|Overall Study|Withdrawal by Subject|9
92058|NCT00265343|319179|P1|Overall Study|Withdrawal by Subject|3
92059|NCT00265343|319178|P2|Overall Study|Adverse Event|7
92060|NCT00265343|319179|P1|Overall Study|Adverse Event|10
92061|NCT00265382|319187|P1|Overall Study|Death|1
92062|NCT00265382|319187|P1|Overall Study|Study terminated by sponsor|94
92063|NCT00265382|319187|P1|Overall Study|Withdrawal by Subject|13
92064|NCT00265382|319187|P1|Overall Study|Miscellaneous|6
92065|NCT00265382|319187|P1|Overall Study|Lack of Efficacy|6
92066|NCT00265382|319187|P1|Overall Study|Lost to Follow-up|3
92067|NCT00265382|319187|P1|Overall Study|Laboratory Abnormality|1
92068|NCT00265382|319187|P1|Overall Study|Adverse Event|21
92069|NCT00265395|319207|P2|Overall Study|Administrative|1
92070|NCT00265395|319208|P1|Overall Study|Administrative|0
92071|NCT00265395|319207|P2|Overall Study|Lack of Efficacy|1
92072|NCT00265395|319208|P1|Overall Study|Lack of Efficacy|0
92073|NCT00265395|319207|P2|Overall Study|Protocol Violation|2
92074|NCT00265395|319208|P1|Overall Study|Protocol Violation|2
92075|NCT00265395|319207|P2|Overall Study|Withdrawal by Subject|6
92076|NCT00265395|319208|P1|Overall Study|Withdrawal by Subject|1
92077|NCT00265395|319207|P2|Overall Study|Lost to Follow-up|1
92078|NCT00265395|319208|P1|Overall Study|Lost to Follow-up|2
92079|NCT00265395|319207|P2|Overall Study|Adverse Event|6
92080|NCT00265395|319208|P1|Overall Study|Adverse Event|3
92081|NCT00267046|319232|P2|Overall Study|Radiation|1
92082|NCT00267046|319233|P1|Overall Study|Radiation|0
92083|NCT00267046|319232|P2|Overall Study|Withdrawal by Subject|0
92084|NCT00267046|319233|P1|Overall Study|Withdrawal by Subject|1
92085|NCT00267046|319232|P2|Overall Study|Surgery|1
92086|NCT00267046|319233|P1|Overall Study|Surgery|3
92087|NCT00267046|319232|P2|Overall Study|Open-label palifermin|7
92088|NCT00267046|319233|P1|Overall Study|Open-label palifermin|2
92089|NCT00267046|319232|P2|Overall Study|Chemotoxicity|0
92090|NCT00267046|319233|P1|Overall Study|Chemotoxicity|2
92091|NCT00267046|319232|P2|Overall Study|Disease progression|2
92092|NCT00267046|319233|P1|Overall Study|Disease progression|4
92093|NCT00267098|319257|P8|Overall Study|Sponsor withdrew subject|0
92094|NCT00267098|319258|P7|Overall Study|Sponsor withdrew subject|0
92095|NCT00267098|319259|P6|Overall Study|Sponsor withdrew subject|0
92096|NCT00267098|319260|P5|Overall Study|Sponsor withdrew subject|0
92097|NCT00267098|319261|P4|Overall Study|Sponsor withdrew subject|1
92098|NCT00267098|319262|P3|Overall Study|Sponsor withdrew subject|0
92099|NCT00267098|319263|P2|Overall Study|Sponsor withdrew subject|0
92100|NCT00267098|319264|P1|Overall Study|Sponsor withdrew subject|0
92101|NCT00267098|319257|P8|Overall Study|Subject listed for heart transplant|0
92102|NCT00267098|319258|P7|Overall Study|Subject listed for heart transplant|1
92103|NCT00267098|319259|P6|Overall Study|Subject listed for heart transplant|0
92104|NCT00267098|319260|P5|Overall Study|Subject listed for heart transplant|0
92105|NCT00267098|319261|P4|Overall Study|Subject listed for heart transplant|0
92106|NCT00267098|319262|P3|Overall Study|Subject listed for heart transplant|0
92107|NCT00267098|319263|P2|Overall Study|Subject listed for heart transplant|0
92108|NCT00267098|319264|P1|Overall Study|Subject listed for heart transplant|0
92109|NCT00267098|319257|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
92110|NCT00267098|319258|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
92111|NCT00267098|319259|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
92112|NCT00267098|319260|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
92113|NCT00267098|319261|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
92114|NCT00267098|319262|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
92115|NCT00267098|319263|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
92116|NCT00267098|319264|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
92117|NCT00267098|319257|P8|Overall Study|Explanted Medtronic device|0
92118|NCT00267098|319258|P7|Overall Study|Explanted Medtronic device|0
92119|NCT00267098|319259|P6|Overall Study|Explanted Medtronic device|0
92120|NCT00267098|319260|P5|Overall Study|Explanted Medtronic device|0
92121|NCT00267098|319261|P4|Overall Study|Explanted Medtronic device|1
92122|NCT00267098|319262|P3|Overall Study|Explanted Medtronic device|0
92123|NCT00267098|319263|P2|Overall Study|Explanted Medtronic device|0
92124|NCT00267098|319264|P1|Overall Study|Explanted Medtronic device|0
92125|NCT00267098|319257|P8|Overall Study|Site closure|0
92126|NCT00267098|319258|P7|Overall Study|Site closure|1
92127|NCT00267098|319259|P6|Overall Study|Site closure|1
92128|NCT00267098|319260|P5|Overall Study|Site closure|0
92129|NCT00267098|319261|P4|Overall Study|Site closure|1
92130|NCT00267098|319262|P3|Overall Study|Site closure|0
92131|NCT00267098|319263|P2|Overall Study|Site closure|0
92132|NCT00267098|319264|P1|Overall Study|Site closure|0
92133|NCT00267098|319257|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92134|NCT00267098|319258|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92135|NCT00267098|319259|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92136|NCT00267098|319260|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92137|NCT00267098|319261|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92138|NCT00267098|319262|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92139|NCT00267098|319263|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
92140|NCT00267098|319264|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
92141|NCT00267098|319257|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
92142|NCT00267098|319258|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
92143|NCT00267098|319259|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
92144|NCT00267098|319260|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
92145|NCT00267098|319261|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
92146|NCT00267098|319262|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
92147|NCT00267098|319263|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
92148|NCT00267098|319264|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
92149|NCT00267098|319257|P8|Overall Study|Physician Decision|0
92150|NCT00267098|319258|P7|Overall Study|Physician Decision|3
92151|NCT00267098|319259|P6|Overall Study|Physician Decision|4
92152|NCT00267098|319260|P5|Overall Study|Physician Decision|5
92153|NCT00267098|319261|P4|Overall Study|Physician Decision|11
92154|NCT00267098|319262|P3|Overall Study|Physician Decision|7
92155|NCT00267098|319263|P2|Overall Study|Physician Decision|0
92156|NCT00267098|319264|P1|Overall Study|Physician Decision|5
92157|NCT00267098|319257|P8|Overall Study|Withdrawal by Subject|5
92158|NCT00267098|319258|P7|Overall Study|Withdrawal by Subject|12
92159|NCT00267098|319259|P6|Overall Study|Withdrawal by Subject|9
92160|NCT00267098|319260|P5|Overall Study|Withdrawal by Subject|12
92161|NCT00267098|319261|P4|Overall Study|Withdrawal by Subject|21
92162|NCT00267098|319262|P3|Overall Study|Withdrawal by Subject|24
92163|NCT00267098|319263|P2|Overall Study|Withdrawal by Subject|0
92164|NCT00267098|319264|P1|Overall Study|Withdrawal by Subject|8
92165|NCT00267098|319257|P8|Overall Study|Lost to Follow-up|1
92166|NCT00267098|319258|P7|Overall Study|Lost to Follow-up|1
92167|NCT00267098|319259|P6|Overall Study|Lost to Follow-up|3
92168|NCT00267098|319260|P5|Overall Study|Lost to Follow-up|2
92169|NCT00267098|319261|P4|Overall Study|Lost to Follow-up|5
92170|NCT00267098|319262|P3|Overall Study|Lost to Follow-up|6
92171|NCT00267098|319263|P2|Overall Study|Lost to Follow-up|0
92172|NCT00267098|319264|P1|Overall Study|Lost to Follow-up|0
92173|NCT00267098|319257|P8|Overall Study|Death|9
92174|NCT00267098|319258|P7|Overall Study|Death|28
92175|NCT00267098|319259|P6|Overall Study|Death|23
92176|NCT00267098|319260|P5|Overall Study|Death|14
92177|NCT00267098|319261|P4|Overall Study|Death|66
92178|NCT00267098|319262|P3|Overall Study|Death|57
92179|NCT00267098|319263|P2|Overall Study|Death|0
92180|NCT00267098|319264|P1|Overall Study|Death|0
92181|NCT00267150|319408|P1|Overall Study|Adverse Event|1
92182|NCT00267189|319415|P2|Overall Study|Missing|0
92183|NCT00267189|319416|P1|Overall Study|Missing|3
92184|NCT00267189|319415|P2|Overall Study|Death|0
92185|NCT00267189|319416|P1|Overall Study|Death|1
92186|NCT00267189|319415|P2|Overall Study|Patient withdrew consent|1
92187|NCT00267189|319416|P1|Overall Study|Patient withdrew consent|1
92188|NCT00267202|319428|P2|Overall Study|Lost to Follow-up|0
92189|NCT00267202|319429|P1|Overall Study|Lost to Follow-up|3
92190|NCT00267202|319428|P2|Overall Study|Administrative problems|1
92191|NCT00267202|319429|P1|Overall Study|Administrative problems|2
92193|NCT00267202|319429|P1|Overall Study|Protocol Violation|2
92194|NCT00267202|319428|P2|Overall Study|Adverse Event|7
92195|NCT00267202|319429|P1|Overall Study|Adverse Event|13
92196|NCT00267202|319428|P2|Overall Study|Withdrawal by Subject|15
92197|NCT00267202|319429|P1|Overall Study|Withdrawal by Subject|12
92198|NCT00267202|319428|P2|Overall Study|Unsatisfactory therapeutic effect|8
92199|NCT00267202|319429|P1|Overall Study|Unsatisfactory therapeutic effect|21
92200|NCT00267488|319461|P1|Overall Study|Other (Disease Progression)|1
92201|NCT00267488|319461|P1|Overall Study|Protocol Violation|1
92202|NCT00267488|319461|P1|Overall Study|Sponsor Terminated Study|9
92203|NCT00267748|319513|P3|Randomized Period|randomized but not treated|3
92204|NCT00267748|319514|P2|Randomized Period|randomized but not treated|0
92205|NCT00267748|319515|P1|Randomized Period|randomized but not treated|0
92206|NCT00267748|319513|P3|Randomized Period|Unspecified|6
92207|NCT00267748|319514|P2|Randomized Period|Unspecified|9
92208|NCT00267748|319515|P1|Randomized Period|Unspecified|0
92209|NCT00267748|319513|P3|Randomized Period|Withdrawal by Subject|2
92210|NCT00267748|319514|P2|Randomized Period|Withdrawal by Subject|9
92211|NCT00267748|319515|P1|Randomized Period|Withdrawal by Subject|0
92212|NCT00267748|319513|P3|Randomized Period|Objective progression or relapse|86
92213|NCT00267748|319514|P2|Randomized Period|Objective progression or relapse|77
92214|NCT00267748|319515|P1|Randomized Period|Objective progression or relapse|0
92215|NCT00267748|319513|P3|Randomized Period|Lost to Follow-up|0
92216|NCT00267748|319514|P2|Randomized Period|Lost to Follow-up|1
92217|NCT00267748|319515|P1|Randomized Period|Lost to Follow-up|0
92218|NCT00267748|319513|P3|Randomized Period|Global deterioration of health status|7
92219|NCT00267748|319514|P2|Randomized Period|Global deterioration of health status|6
92220|NCT00267748|319515|P1|Randomized Period|Global deterioration of health status|0
92221|NCT00267748|319513|P3|Randomized Period|Adverse Event|25
92222|NCT00267748|319514|P2|Randomized Period|Adverse Event|23
92223|NCT00267748|319515|P1|Randomized Period|Adverse Event|0
92224|NCT00267748|319513|P3|Randomized Period|Death|3
92225|NCT00267748|319514|P2|Randomized Period|Death|2
92226|NCT00267748|319515|P1|Randomized Period|Death|0
92227|NCT00267748|319513|P3|Non-randomized Period|Unspecified|0
92228|NCT00267748|319514|P2|Non-randomized Period|Unspecified|0
92229|NCT00267748|319515|P1|Non-randomized Period|Unspecified|3
92230|NCT00267748|319513|P3|Non-randomized Period|Participant not willing to participate|0
92231|NCT00267748|319514|P2|Non-randomized Period|Participant not willing to participate|0
92232|NCT00267748|319515|P1|Non-randomized Period|Participant not willing to participate|1
92233|NCT00267748|319513|P3|Non-randomized Period|Death|0
92234|NCT00267748|319514|P2|Non-randomized Period|Death|0
92235|NCT00267748|319515|P1|Non-randomized Period|Death|1
92236|NCT00267748|319513|P3|Non-randomized Period|Adverse Event|0
92237|NCT00267748|319514|P2|Non-randomized Period|Adverse Event|0
92238|NCT00267748|319515|P1|Non-randomized Period|Adverse Event|8
92239|NCT00267748|319513|P3|Non-randomized Period|Progressive disease|0
92240|NCT00267748|319514|P2|Non-randomized Period|Progressive disease|0
92241|NCT00267748|319515|P1|Non-randomized Period|Progressive disease|10
92242|NCT00267956|319543|P4|After Controlled Period|Withdrew consent|0
92243|NCT00267956|319544|P3|After Controlled Period|Withdrew consent|1
92244|NCT00267956|319545|P2|After Controlled Period|Withdrew consent|0
92245|NCT00267956|319546|P1|After Controlled Period|Withdrew consent|0
92246|NCT00267956|319543|P4|After Controlled Period|Lost to Follow-up|0
92247|NCT00267956|319544|P3|After Controlled Period|Lost to Follow-up|1
92248|NCT00267956|319545|P2|After Controlled Period|Lost to Follow-up|0
92249|NCT00267956|319546|P1|After Controlled Period|Lost to Follow-up|0
92250|NCT00267956|319543|P4|After Controlled Period|Lack of Efficacy|1
92251|NCT00267956|319544|P3|After Controlled Period|Lack of Efficacy|1
92252|NCT00267956|319545|P2|After Controlled Period|Lack of Efficacy|0
92253|NCT00267956|319546|P1|After Controlled Period|Lack of Efficacy|0
92254|NCT00267956|319543|P4|After Controlled Period|Adverse Event|1
92255|NCT00267956|319544|P3|After Controlled Period|Adverse Event|2
92256|NCT00267956|319545|P2|After Controlled Period|Adverse Event|0
92257|NCT00267956|319546|P1|After Controlled Period|Adverse Event|0
92258|NCT00267956|319543|P4|Controlled Period|Withdrew consent|0
92259|NCT00267956|319544|P3|Controlled Period|Withdrew consent|0
92260|NCT00267956|319545|P2|Controlled Period|Withdrew consent|1
92261|NCT00267956|319546|P1|Controlled Period|Withdrew consent|3
92262|NCT00267956|319543|P4|Controlled Period|Lost to Follow-up|0
92263|NCT00267956|319544|P3|Controlled Period|Lost to Follow-up|0
92264|NCT00267956|319545|P2|Controlled Period|Lost to Follow-up|0
92265|NCT00267956|319546|P1|Controlled Period|Lost to Follow-up|2
92266|NCT00267956|319543|P4|Controlled Period|Lack of Efficacy|0
92267|NCT00267956|319544|P3|Controlled Period|Lack of Efficacy|0
92268|NCT00267956|319545|P2|Controlled Period|Lack of Efficacy|2
92269|NCT00267956|319546|P1|Controlled Period|Lack of Efficacy|4
92270|NCT00267956|319543|P4|Controlled Period|Adverse Event|0
92271|NCT00267956|319544|P3|Controlled Period|Adverse Event|0
92272|NCT00267956|319545|P2|Controlled Period|Adverse Event|1
92273|NCT00267956|319546|P1|Controlled Period|Adverse Event|4
92274|NCT00267969|319567|P7|After Controlled Period|Not specified|25
92275|NCT00267969|319568|P6|After Controlled Period|Not specified|22
92276|NCT00267969|319569|P5|After Controlled Period|Not specified|11
92277|NCT00267969|319570|P4|After Controlled Period|Not specified|13
92278|NCT00267969|319571|P3|After Controlled Period|Not specified|0
92279|NCT00267969|319572|P2|After Controlled Period|Not specified|0
92280|NCT00267969|319573|P1|After Controlled Period|Not specified|0
92281|NCT00267969|319567|P7|After Controlled Period|Lost to Follow-up|10
92282|NCT00267969|319568|P6|After Controlled Period|Lost to Follow-up|9
92283|NCT00267969|319569|P5|After Controlled Period|Lost to Follow-up|8
92284|NCT00267969|319570|P4|After Controlled Period|Lost to Follow-up|5
92285|NCT00267969|319571|P3|After Controlled Period|Lost to Follow-up|0
92286|NCT00267969|319572|P2|After Controlled Period|Lost to Follow-up|0
92287|NCT00267969|319573|P1|After Controlled Period|Lost to Follow-up|0
92288|NCT00267969|319567|P7|After Controlled Period|Lack of Efficacy|15
92289|NCT00267969|319568|P6|After Controlled Period|Lack of Efficacy|28
92290|NCT00267969|319569|P5|After Controlled Period|Lack of Efficacy|6
92291|NCT00267969|319570|P4|After Controlled Period|Lack of Efficacy|10
92292|NCT00267969|319571|P3|After Controlled Period|Lack of Efficacy|0
92293|NCT00267969|319572|P2|After Controlled Period|Lack of Efficacy|0
92294|NCT00267969|319573|P1|After Controlled Period|Lack of Efficacy|0
92295|NCT00267969|319567|P7|After Controlled Period|Death|1
92296|NCT00267969|319568|P6|After Controlled Period|Death|0
92297|NCT00267969|319569|P5|After Controlled Period|Death|2
92298|NCT00267969|319570|P4|After Controlled Period|Death|1
92299|NCT00267969|319571|P3|After Controlled Period|Death|0
92300|NCT00267969|319572|P2|After Controlled Period|Death|0
92301|NCT00267969|319573|P1|After Controlled Period|Death|0
92302|NCT00267969|319567|P7|After Controlled Period|Adverse Event|21
92303|NCT00267969|319568|P6|After Controlled Period|Adverse Event|23
92304|NCT00267969|319569|P5|After Controlled Period|Adverse Event|8
92305|NCT00267969|319570|P4|After Controlled Period|Adverse Event|7
92306|NCT00267969|319571|P3|After Controlled Period|Adverse Event|0
92307|NCT00267969|319572|P2|After Controlled Period|Adverse Event|0
92308|NCT00267969|319573|P1|After Controlled Period|Adverse Event|0
92309|NCT00267969|319567|P7|Controlled Period|Not specified|0
92310|NCT00267969|319568|P6|Controlled Period|Not specified|0
92311|NCT00267969|319569|P5|Controlled Period|Not specified|0
92312|NCT00267969|319570|P4|Controlled Period|Not specified|0
92313|NCT00267969|319571|P3|Controlled Period|Not specified|6
92314|NCT00267969|319572|P2|Controlled Period|Not specified|1
92315|NCT00267969|319573|P1|Controlled Period|Not specified|2
92316|NCT00267969|319567|P7|Controlled Period|Randomized but not treated|0
92317|NCT00267969|319568|P6|Controlled Period|Randomized but not treated|0
92318|NCT00267969|319569|P5|Controlled Period|Randomized but not treated|0
92319|NCT00267969|319570|P4|Controlled Period|Randomized but not treated|0
92320|NCT00267969|319571|P3|Controlled Period|Randomized but not treated|1
92321|NCT00267969|319572|P2|Controlled Period|Randomized but not treated|0
92322|NCT00267969|319573|P1|Controlled Period|Randomized but not treated|0
92323|NCT00267969|319567|P7|Controlled Period|Lost to Follow-up|0
92324|NCT00267969|319568|P6|Controlled Period|Lost to Follow-up|0
92325|NCT00267969|319569|P5|Controlled Period|Lost to Follow-up|0
92326|NCT00267969|319570|P4|Controlled Period|Lost to Follow-up|0
92327|NCT00267969|319571|P3|Controlled Period|Lost to Follow-up|1
92328|NCT00267969|319572|P2|Controlled Period|Lost to Follow-up|0
92329|NCT00267969|319573|P1|Controlled Period|Lost to Follow-up|1
92330|NCT00267969|319567|P7|Controlled Period|Lack of Efficacy|0
92331|NCT00267969|319568|P6|Controlled Period|Lack of Efficacy|0
92332|NCT00267969|319569|P5|Controlled Period|Lack of Efficacy|0
92333|NCT00267969|319570|P4|Controlled Period|Lack of Efficacy|0
92334|NCT00267969|319571|P3|Controlled Period|Lack of Efficacy|1
92335|NCT00267969|319572|P2|Controlled Period|Lack of Efficacy|0
92336|NCT00267969|319573|P1|Controlled Period|Lack of Efficacy|3
92337|NCT00267969|319567|P7|Controlled Period|Adverse Event|0
92338|NCT00267969|319568|P6|Controlled Period|Adverse Event|0
92339|NCT00267969|319569|P5|Controlled Period|Adverse Event|0
92340|NCT00267969|319570|P4|Controlled Period|Adverse Event|0
92341|NCT00267969|319571|P3|Controlled Period|Adverse Event|2
92342|NCT00267969|319572|P2|Controlled Period|Adverse Event|0
92343|NCT00267969|319573|P1|Controlled Period|Adverse Event|6
92344|NCT00268203|319597|P1|Overall Study|Completed 2 Years of Follow-up|62
92345|NCT00268203|319597|P1|Overall Study|Reason Not Specified|34
92346|NCT00268203|319597|P1|Overall Study|Death|84
92347|NCT00268203|319597|P1|Overall Study|Progressive Disease|359
92348|NCT00268203|319597|P1|Overall Study|Received Other NHL Therapy|7
92349|NCT00268203|319597|P1|Overall Study|Withdrawal by Subject|9
92350|NCT00268203|319597|P1|Overall Study|Lost to Follow-up|92
92351|NCT00268242|319608|P1|Overall Study|Death|1
92352|NCT00268346|319619|P2|Overall Study|Withdrawal by Subject|1
92353|NCT00268346|319620|P1|Overall Study|Withdrawal by Subject|0
92354|NCT00268346|319619|P2|Overall Study|Death|1
92355|NCT00268346|319620|P1|Overall Study|Death|0
92356|NCT00268346|319619|P2|Overall Study|Adverse Event|1
92357|NCT00268346|319620|P1|Overall Study|Adverse Event|0
92358|NCT00268437|319626|P1|Overall Study|Ineligible|1
92359|NCT00268463|319633|P2|Overall Study|study terminated due to low accrual|12
92360|NCT00268463|319634|P1|Overall Study|study terminated due to low accrual|10
92361|NCT00268892|319649|P3|Overall Study|Trial Site Closed|2
92362|NCT00268892|319650|P2|Overall Study|Trial Site Closed|2
92363|NCT00268892|319651|P1|Overall Study|Trial Site Closed|4
92364|NCT00268892|319649|P3|Overall Study|Disease Progression|0
92365|NCT00268892|319650|P2|Overall Study|Disease Progression|1
92366|NCT00268892|319651|P1|Overall Study|Disease Progression|1
92367|NCT00268892|319649|P3|Overall Study|Protocol Violation|0
92368|NCT00268892|319650|P2|Overall Study|Protocol Violation|1
92369|NCT00268892|319651|P1|Overall Study|Protocol Violation|0
92370|NCT00268892|319649|P3|Overall Study|Lost to Follow-up|4
92371|NCT00268892|319650|P2|Overall Study|Lost to Follow-up|2
92372|NCT00268892|319651|P1|Overall Study|Lost to Follow-up|5
92373|NCT00268892|319649|P3|Overall Study|Physician Decision|0
92374|NCT00268892|319650|P2|Overall Study|Physician Decision|1
92375|NCT00268892|319651|P1|Overall Study|Physician Decision|0
92376|NCT00268892|319649|P3|Overall Study|Withdrawal by Subject|13
92377|NCT00268892|319650|P2|Overall Study|Withdrawal by Subject|15
92378|NCT00268892|319651|P1|Overall Study|Withdrawal by Subject|14
92379|NCT00268892|319649|P3|Overall Study|Lack of Efficacy|0
92380|NCT00268892|319650|P2|Overall Study|Lack of Efficacy|3
92381|NCT00268892|319651|P1|Overall Study|Lack of Efficacy|1
92382|NCT00268892|319649|P3|Overall Study|Adverse Event|20
92383|NCT00268892|319650|P2|Overall Study|Adverse Event|17
92384|NCT00268892|319651|P1|Overall Study|Adverse Event|14
92385|NCT00268905|319665|P3|Overall Study|Clinical Progression|1
92386|NCT00268905|319666|P2|Overall Study|Clinical Progression|4
92387|NCT00268905|319667|P1|Overall Study|Clinical Progression|9
92388|NCT00268905|319665|P3|Overall Study|Physician Decision|1
92389|NCT00268905|319666|P2|Overall Study|Physician Decision|0
92390|NCT00268905|319667|P1|Overall Study|Physician Decision|3
92391|NCT00268905|319665|P3|Overall Study|Progressive Disease|3
92392|NCT00268905|319666|P2|Overall Study|Progressive Disease|4
92393|NCT00268905|319667|P1|Overall Study|Progressive Disease|28
92394|NCT00268905|319665|P3|Overall Study|Withdrawal by Subject|3
92395|NCT00268905|319666|P2|Overall Study|Withdrawal by Subject|0
92396|NCT00268905|319667|P1|Overall Study|Withdrawal by Subject|0
92397|NCT00268905|319665|P3|Overall Study|Lost to Follow-up|0
92398|NCT00268905|319666|P2|Overall Study|Lost to Follow-up|1
92399|NCT00268905|319667|P1|Overall Study|Lost to Follow-up|0
92400|NCT00268905|319665|P3|Overall Study|Adverse Event|4
92401|NCT00268905|319666|P2|Overall Study|Adverse Event|0
92402|NCT00268905|319667|P1|Overall Study|Adverse Event|3
92403|NCT00268983|319683|P2|Overall Study|Death|0
92404|NCT00268983|319684|P1|Overall Study|Death|3
92405|NCT00269113|319726|P2|Overall Study|Not specified|2
92406|NCT00269113|319727|P1|Overall Study|Not specified|0
92407|NCT00269113|319726|P2|Overall Study|Protocol Violation|5
92408|NCT00269113|319727|P1|Overall Study|Protocol Violation|15
92409|NCT00269113|319726|P2|Overall Study|Lost to Follow-up|1
92410|NCT00269113|319727|P1|Overall Study|Lost to Follow-up|2
92411|NCT00269113|319726|P2|Overall Study|Death|2
92412|NCT00269113|319727|P1|Overall Study|Death|6
92413|NCT00269113|319726|P2|Overall Study|Withdrawal by Subject|2
92414|NCT00269113|319727|P1|Overall Study|Withdrawal by Subject|0
92415|NCT00269113|319726|P2|Overall Study|Early Improvement|0
92416|NCT00269113|319727|P1|Overall Study|Early Improvement|2
92417|NCT00269113|319726|P2|Overall Study|Lack of Efficacy|18
92418|NCT00269113|319727|P1|Overall Study|Lack of Efficacy|35
92419|NCT00269113|319726|P2|Overall Study|Adverse Event|7
92420|NCT00269113|319727|P1|Overall Study|Adverse Event|14
92421|NCT00269152|319747|P2|Overall Study|Protocol Violation|1
92422|NCT00269152|319748|P1|Overall Study|Protocol Violation|0
92423|NCT00269152|319747|P2|Overall Study|Physician Decision|3
92424|NCT00269152|319748|P1|Overall Study|Physician Decision|2
92425|NCT00269152|319747|P2|Overall Study|Withdrawal by Subject|3
92426|NCT00269152|319748|P1|Overall Study|Withdrawal by Subject|7
92427|NCT00269152|319747|P2|Overall Study|Adverse Event|3
92428|NCT00269152|319748|P1|Overall Study|Adverse Event|9
92429|NCT00269477|319766|P4|Overall Study|Missed post-vaccination blood draw|0
92430|NCT00269477|319767|P3|Overall Study|Missed post-vaccination blood draw|0
92431|NCT00269477|319768|P2|Overall Study|Missed post-vaccination blood draw|1
92432|NCT00269477|319769|P1|Overall Study|Missed post-vaccination blood draw|0
92433|NCT00269477|319766|P4|Overall Study|Protocol Violation|0
92434|NCT00269477|319767|P3|Overall Study|Protocol Violation|1
92435|NCT00269477|319768|P2|Overall Study|Protocol Violation|5
92436|NCT00269477|319769|P1|Overall Study|Protocol Violation|5
92437|NCT00260208|319800|P2|Overall Study|Missing|16
92438|NCT00260208|319801|P1|Overall Study|Missing|18
92439|NCT00260208|319800|P2|Overall Study|Death|10
92440|NCT00260208|319801|P1|Overall Study|Death|12
92441|NCT00260208|319800|P2|Overall Study|Lost to Follow-up|1
92442|NCT00260208|319801|P1|Overall Study|Lost to Follow-up|6
92443|NCT00260208|319800|P2|Overall Study|Subject withdrew consent|7
92444|NCT00260208|319801|P1|Overall Study|Subject withdrew consent|11
92445|NCT00260429|319831|P2|Overall Study|scheduled hand surgery|0
92446|NCT00260429|319832|P1|Overall Study|scheduled hand surgery|1
92447|NCT00260429|319831|P2|Overall Study|failure to follow appointments|0
92448|NCT00260429|319832|P1|Overall Study|failure to follow appointments|1
92449|NCT00260533|319840|P2|Overall Study|Not Known|3
92450|NCT00260533|319841|P1|Overall Study|Not Known|3
92451|NCT00260832|319868|P2|Overall Study|Protocol Violation|1
92452|NCT00260832|319869|P1|Overall Study|Protocol Violation|3
92453|NCT00260832|319868|P2|Overall Study|Not Specified|7
92454|NCT00260832|319869|P1|Overall Study|Not Specified|10
92455|NCT00260832|319868|P2|Overall Study|Death|62
92456|NCT00260832|319869|P1|Overall Study|Death|43
92457|NCT00260832|319868|P2|Overall Study|Physician Decision|9
92458|NCT00260832|319869|P1|Overall Study|Physician Decision|15
92459|NCT00260832|319868|P2|Overall Study|Withdrawal by Subject|17
92460|NCT00260832|319869|P1|Overall Study|Withdrawal by Subject|15
92461|NCT00260832|319868|P2|Overall Study|Progression|96
92462|NCT00260832|319869|P1|Overall Study|Progression|116
92463|NCT00260832|319868|P2|Overall Study|Adverse Event|19
92464|NCT00260832|319869|P1|Overall Study|Adverse Event|26
92465|NCT00261443|319888|P3|4: Extension Phase|Lost to Follow-up|0
92466|NCT00261443|319889|P2|4: Extension Phase|Lost to Follow-up|1
92467|NCT00261443|319890|P1|4: Extension Phase|Lost to Follow-up|0
92468|NCT00261443|319888|P3|4: Extension Phase|Withdrawal by Subject|2
92469|NCT00261443|319889|P2|4: Extension Phase|Withdrawal by Subject|1
92470|NCT00261443|319890|P1|4: Extension Phase|Withdrawal by Subject|0
92471|NCT00261443|319888|P3|4: Extension Phase|Adverse Event|0
92472|NCT00261443|319889|P2|4: Extension Phase|Adverse Event|1
92473|NCT00261443|319890|P1|4: Extension Phase|Adverse Event|0
92474|NCT00261443|319888|P3|3: Assessment of Relapse|Other Reasons|3
92475|NCT00261443|319889|P2|3: Assessment of Relapse|Other Reasons|4
92476|NCT00261443|319890|P1|3: Assessment of Relapse|Other Reasons|0
92477|NCT00261443|319888|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
92478|NCT00261443|319889|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
92479|NCT00261443|319890|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
92480|NCT00261443|319888|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
92481|NCT00261443|319889|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
92482|NCT00261443|319890|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
92483|NCT00261443|319888|P3|3: Assessment of Relapse|Pregnancy|1
92484|NCT00261443|319889|P2|3: Assessment of Relapse|Pregnancy|2
92485|NCT00261443|319890|P1|3: Assessment of Relapse|Pregnancy|0
92486|NCT00261443|319888|P3|3: Assessment of Relapse|Poor/Noncompliance|3
92487|NCT00261443|319889|P2|3: Assessment of Relapse|Poor/Noncompliance|5
92488|NCT00261443|319890|P1|3: Assessment of Relapse|Poor/Noncompliance|0
92489|NCT00261443|319888|P3|3: Assessment of Relapse|Lost to Follow-up|6
92490|NCT00261443|319889|P2|3: Assessment of Relapse|Lost to Follow-up|7
92491|NCT00261443|319890|P1|3: Assessment of Relapse|Lost to Follow-up|0
92492|NCT00261443|319888|P3|3: Assessment of Relapse|Death|1
92493|NCT00261443|319889|P2|3: Assessment of Relapse|Death|0
92494|NCT00261443|319890|P1|3: Assessment of Relapse|Death|0
92495|NCT00261443|319888|P3|3: Assessment of Relapse|Withdrawal by Subject|15
92496|NCT00261443|319889|P2|3: Assessment of Relapse|Withdrawal by Subject|14
92497|NCT00261443|319890|P1|3: Assessment of Relapse|Withdrawal by Subject|0
92498|NCT00261443|319888|P3|3: Assessment of Relapse|Adverse Event|19
92499|NCT00261443|319889|P2|3: Assessment of Relapse|Adverse Event|15
92500|NCT00261443|319890|P1|3: Assessment of Relapse|Adverse Event|0
92501|NCT00261443|319888|P3|3: Assessment of Relapse|Lack of Efficacy|14
92502|NCT00261443|319889|P2|3: Assessment of Relapse|Lack of Efficacy|31
92503|NCT00261443|319890|P1|3: Assessment of Relapse|Lack of Efficacy|0
92504|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Other Reasons|0
92505|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Other Reasons|0
92506|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Other Reasons|13
92507|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
92508|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
92509|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
92510|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
92511|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
92512|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
92513|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Pregnancy|0
92514|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Pregnancy|0
92515|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Pregnancy|1
92516|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
92517|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
92518|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
92519|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
92520|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
92521|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
92522|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
92523|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
92524|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
92525|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Adverse Event|0
92526|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Adverse Event|0
92527|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Adverse Event|93
92528|NCT00261443|319888|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
92529|NCT00261443|319889|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
92530|NCT00261443|319890|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
92531|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
92532|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
92533|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
92534|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
92535|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
92536|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
92537|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
92538|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
92539|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
92540|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
92541|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
92542|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
92543|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
92544|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
92545|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
92546|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
92547|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
92548|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
92549|NCT00261443|319888|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
92550|NCT00261443|319889|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
92551|NCT00261443|319890|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
92552|NCT00261495|320147|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
92553|NCT00261495|320148|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
92554|NCT00261495|320147|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
92555|NCT00261495|320148|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
92556|NCT00261495|320147|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
92557|NCT00261495|320148|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
92558|NCT00261495|320147|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
92559|NCT00261495|320148|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
92560|NCT00261495|320147|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
92561|NCT00261495|320148|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
92562|NCT00261495|320147|P2|Extension Phase (Weeks 24 to 52)|Other|2
92563|NCT00261495|320148|P1|Extension Phase (Weeks 24 to 52)|Other|4
92564|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
92565|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
92566|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
92567|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
92568|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
92569|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
92570|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
92571|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
92572|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
92573|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
92574|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
92575|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
92576|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
92577|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
92578|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
92579|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
92580|NCT00261495|320147|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
92581|NCT00261495|320148|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
92582|NCT00261495|320147|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
92583|NCT00261495|320148|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
92584|NCT00261495|320147|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
92585|NCT00261495|320148|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
92586|NCT00261495|320147|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
92587|NCT00261495|320148|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
92588|NCT00261495|320147|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
92589|NCT00261495|320148|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
92590|NCT00261495|320147|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
92591|NCT00261495|320148|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
92592|NCT00261495|320147|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
92593|NCT00261495|320148|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
92594|NCT00261716|320312|P2|Overall Study|Lost to Follow-up|2
92595|NCT00261716|320313|P1|Overall Study|Lost to Follow-up|0
92596|NCT00261716|320312|P2|Overall Study|Withdrawal by Subject|8
92597|NCT00261716|320313|P1|Overall Study|Withdrawal by Subject|6
92598|NCT00261833|320333|P2|Overall Study|Not interested in being participant|1
92599|NCT00261833|320334|P1|Overall Study|Not interested in being participant|0
92600|NCT00261833|320333|P2|Overall Study|Missing reason|0
92601|NCT00261833|320334|P1|Overall Study|Missing reason|1
92602|NCT00261833|320333|P2|Overall Study|Lung transplantation|1
92603|NCT00261833|320334|P1|Overall Study|Lung transplantation|1
92604|NCT00261833|320333|P2|Overall Study|Suspicion of pulmonary cancer|1
92605|NCT00261833|320334|P1|Overall Study|Suspicion of pulmonary cancer|0
92606|NCT00261833|320333|P2|Overall Study|Protocol Violation|1
92607|NCT00261833|320334|P1|Overall Study|Protocol Violation|0
92608|NCT00261833|320333|P2|Overall Study|Withdrawal by Subject|7
92609|NCT00261833|320334|P1|Overall Study|Withdrawal by Subject|5
92610|NCT00261833|320333|P2|Overall Study|Adverse Event|4
92611|NCT00261833|320334|P1|Overall Study|Adverse Event|1
92612|NCT00261833|320333|P2|Overall Study|Death|3
92613|NCT00261833|320334|P1|Overall Study|Death|1
92614|NCT00261846|320375|P12|Period 2: Part 2 (Efficacy)|Extension study|1
92615|NCT00261846|320376|P11|Period 2: Part 2 (Efficacy)|Extension study|1
92616|NCT00261846|320377|P10|Period 2: Part 2 (Efficacy)|Extension study|9
92617|NCT00261846|320378|P9|Period 2: Part 2 (Efficacy)|Extension study|5
92618|NCT00261846|320379|P8|Period 2: Part 2 (Efficacy)|Extension study|9
92619|NCT00261846|320380|P7|Period 2: Part 2 (Efficacy)|Extension study|4
92620|NCT00261846|320381|P6|Period 2: Part 2 (Efficacy)|Extension study|0
92621|NCT00261846|320382|P5|Period 2: Part 2 (Efficacy)|Extension study|27
92622|NCT00261846|320383|P4|Period 2: Part 2 (Efficacy)|Extension study|61
92623|NCT00261846|320384|P3|Period 2: Part 2 (Efficacy)|Extension study|0
92624|NCT00261846|320385|P2|Period 2: Part 2 (Efficacy)|Extension study|0
92625|NCT00261846|320386|P1|Period 2: Part 2 (Efficacy)|Extension study|0
92626|NCT00261846|320375|P12|Period 2: Part 2 (Efficacy)|Death|22
92627|NCT00261846|320376|P11|Period 2: Part 2 (Efficacy)|Death|44
92628|NCT00261846|320377|P10|Period 2: Part 2 (Efficacy)|Death|30
92629|NCT00261846|320378|P9|Period 2: Part 2 (Efficacy)|Death|3
92630|NCT00261846|320379|P8|Period 2: Part 2 (Efficacy)|Death|12
92631|NCT00261846|320380|P7|Period 2: Part 2 (Efficacy)|Death|10
92632|NCT00261846|320381|P6|Period 2: Part 2 (Efficacy)|Death|1
92633|NCT00261846|320382|P5|Period 2: Part 2 (Efficacy)|Death|7
92634|NCT00261846|320383|P4|Period 2: Part 2 (Efficacy)|Death|37
92635|NCT00261846|320384|P3|Period 2: Part 2 (Efficacy)|Death|0
92636|NCT00261846|320385|P2|Period 2: Part 2 (Efficacy)|Death|0
92637|NCT00261846|320386|P1|Period 2: Part 2 (Efficacy)|Death|0
92638|NCT00261846|320375|P12|Period 2: Part 2 (Efficacy)|Unspecified|0
92639|NCT00261846|320376|P11|Period 2: Part 2 (Efficacy)|Unspecified|0
92640|NCT00261846|320377|P10|Period 2: Part 2 (Efficacy)|Unspecified|4
92641|NCT00261846|320378|P9|Period 2: Part 2 (Efficacy)|Unspecified|4
92642|NCT00261846|320379|P8|Period 2: Part 2 (Efficacy)|Unspecified|5
92643|NCT00261846|320380|P7|Period 2: Part 2 (Efficacy)|Unspecified|1
92644|NCT00261846|320381|P6|Period 2: Part 2 (Efficacy)|Unspecified|0
92645|NCT00261846|320382|P5|Period 2: Part 2 (Efficacy)|Unspecified|4
92646|NCT00261846|320383|P4|Period 2: Part 2 (Efficacy)|Unspecified|15
92647|NCT00261846|320384|P3|Period 2: Part 2 (Efficacy)|Unspecified|0
92648|NCT00261846|320385|P2|Period 2: Part 2 (Efficacy)|Unspecified|0
92649|NCT00261846|320386|P1|Period 2: Part 2 (Efficacy)|Unspecified|0
92650|NCT00261846|320375|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
92651|NCT00261846|320376|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
92652|NCT00261846|320377|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
92653|NCT00261846|320378|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
92654|NCT00261846|320379|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
92655|NCT00261846|320380|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
92656|NCT00261846|320381|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
92657|NCT00261846|320382|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
92658|NCT00261846|320383|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
92659|NCT00261846|320384|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
92660|NCT00261846|320385|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
92661|NCT00261846|320386|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
92662|NCT00261846|320375|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
92663|NCT00261846|320376|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
92664|NCT00261846|320377|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
92665|NCT00261846|320378|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
92666|NCT00261846|320379|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
92667|NCT00261846|320380|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
92668|NCT00261846|320381|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
92669|NCT00261846|320382|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
92670|NCT00261846|320383|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
92671|NCT00261846|320384|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
92672|NCT00261846|320385|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
92673|NCT00261846|320386|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
92674|NCT00261846|320375|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92675|NCT00261846|320376|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92676|NCT00261846|320377|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92677|NCT00261846|320378|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
92678|NCT00261846|320379|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92679|NCT00261846|320380|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92680|NCT00261846|320381|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92681|NCT00261846|320382|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92682|NCT00261846|320383|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
92683|NCT00261846|320384|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92684|NCT00261846|320385|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92685|NCT00261846|320386|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
92686|NCT00261846|320375|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92687|NCT00261846|320376|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92688|NCT00261846|320377|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92689|NCT00261846|320378|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92690|NCT00261846|320379|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92691|NCT00261846|320380|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92692|NCT00261846|320381|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92693|NCT00261846|320382|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92694|NCT00261846|320383|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
92695|NCT00261846|320384|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
92696|NCT00261846|320385|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
92697|NCT00261846|320386|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
92698|NCT00261950|320643|P1|Overall Study|Protocol specified Criteria|11
92699|NCT00261950|320643|P1|Overall Study|Physician Decision|1
92700|NCT00261950|320643|P1|Overall Study|not specified|1
92701|NCT00261950|320643|P1|Overall Study|Withdrawal by Subject|5
92702|NCT00261950|320643|P1|Overall Study|Death|6
92703|NCT00261950|320643|P1|Overall Study|Lost to Follow-up|2
92704|NCT00262002|320666|P7|Overall Study|Unable to classify|2
92705|NCT00262002|320667|P6|Overall Study|Unable to classify|0
92706|NCT00262002|320668|P5|Overall Study|Unable to classify|0
92707|NCT00262002|320669|P4|Overall Study|Unable to classify|0
92708|NCT00262002|320670|P3|Overall Study|Unable to classify|0
92709|NCT00262002|320671|P2|Overall Study|Unable to classify|0
92710|NCT00262002|320672|P1|Overall Study|Unable to classify|0
92711|NCT00262002|320666|P7|Overall Study|Protocol Violation|2
92712|NCT00262002|320667|P6|Overall Study|Protocol Violation|3
92713|NCT00262002|320668|P5|Overall Study|Protocol Violation|5
92714|NCT00262002|320669|P4|Overall Study|Protocol Violation|2
92715|NCT00262002|320670|P3|Overall Study|Protocol Violation|0
92716|NCT00262002|320671|P2|Overall Study|Protocol Violation|2
92717|NCT00262002|320672|P1|Overall Study|Protocol Violation|3
92718|NCT00262002|320666|P7|Overall Study|Inapropriate enrollment|0
92719|NCT00262002|320667|P6|Overall Study|Inapropriate enrollment|0
92720|NCT00262002|320668|P5|Overall Study|Inapropriate enrollment|0
92721|NCT00262002|320669|P4|Overall Study|Inapropriate enrollment|0
92722|NCT00262002|320670|P3|Overall Study|Inapropriate enrollment|0
92723|NCT00262002|320671|P2|Overall Study|Inapropriate enrollment|1
92724|NCT00262002|320672|P1|Overall Study|Inapropriate enrollment|0
92725|NCT00262002|320666|P7|Overall Study|Lost to Follow-up|0
92726|NCT00262002|320667|P6|Overall Study|Lost to Follow-up|1
92727|NCT00262002|320668|P5|Overall Study|Lost to Follow-up|0
92728|NCT00262002|320669|P4|Overall Study|Lost to Follow-up|2
92729|NCT00262002|320670|P3|Overall Study|Lost to Follow-up|0
92730|NCT00262002|320671|P2|Overall Study|Lost to Follow-up|0
92731|NCT00262002|320672|P1|Overall Study|Lost to Follow-up|2
92732|NCT00262002|320666|P7|Overall Study|Withdrawal by Subject|2
92733|NCT00262002|320667|P6|Overall Study|Withdrawal by Subject|2
92734|NCT00262002|320668|P5|Overall Study|Withdrawal by Subject|2
92735|NCT00262002|320669|P4|Overall Study|Withdrawal by Subject|1
92736|NCT00262002|320670|P3|Overall Study|Withdrawal by Subject|0
92737|NCT00262002|320671|P2|Overall Study|Withdrawal by Subject|2
92738|NCT00262002|320672|P1|Overall Study|Withdrawal by Subject|4
92739|NCT00262002|320666|P7|Overall Study|Adverse Event|0
92740|NCT00262002|320667|P6|Overall Study|Adverse Event|1
92741|NCT00262002|320668|P5|Overall Study|Adverse Event|0
92742|NCT00262002|320669|P4|Overall Study|Adverse Event|0
92743|NCT00262002|320670|P3|Overall Study|Adverse Event|0
92744|NCT00262002|320671|P2|Overall Study|Adverse Event|1
92745|NCT00262002|320672|P1|Overall Study|Adverse Event|2
92746|NCT00262028|320774|P9|Overall Study|Unable to classify|1
92747|NCT00262028|320775|P8|Overall Study|Unable to classify|0
92748|NCT00262028|320776|P7|Overall Study|Unable to classify|0
92749|NCT00262028|320777|P6|Overall Study|Unable to classify|0
92750|NCT00262028|320778|P5|Overall Study|Unable to classify|0
92751|NCT00262028|320779|P4|Overall Study|Unable to classify|0
92752|NCT00262028|320780|P3|Overall Study|Unable to classify|0
92753|NCT00262028|320781|P2|Overall Study|Unable to classify|3
92754|NCT00262028|320782|P1|Overall Study|Unable to classify|0
92755|NCT00262028|320774|P9|Overall Study|Protocol Violation|0
92756|NCT00262028|320775|P8|Overall Study|Protocol Violation|0
92757|NCT00262028|320776|P7|Overall Study|Protocol Violation|0
92758|NCT00262028|320777|P6|Overall Study|Protocol Violation|0
92759|NCT00262028|320778|P5|Overall Study|Protocol Violation|0
92760|NCT00262028|320779|P4|Overall Study|Protocol Violation|1
92761|NCT00262028|320780|P3|Overall Study|Protocol Violation|0
92762|NCT00262028|320781|P2|Overall Study|Protocol Violation|0
92763|NCT00262028|320782|P1|Overall Study|Protocol Violation|0
92764|NCT00262028|320774|P9|Overall Study|Administrative Reason|10
92765|NCT00262028|320775|P8|Overall Study|Administrative Reason|6
92766|NCT00262028|320776|P7|Overall Study|Administrative Reason|4
92767|NCT00262028|320777|P6|Overall Study|Administrative Reason|7
92768|NCT00262028|320778|P5|Overall Study|Administrative Reason|6
92769|NCT00262028|320779|P4|Overall Study|Administrative Reason|12
92770|NCT00262028|320780|P3|Overall Study|Administrative Reason|9
92771|NCT00262028|320781|P2|Overall Study|Administrative Reason|14
92772|NCT00262028|320782|P1|Overall Study|Administrative Reason|11
92773|NCT00262028|320774|P9|Overall Study|Lost to Follow-up|6
92774|NCT00262028|320775|P8|Overall Study|Lost to Follow-up|5
92775|NCT00262028|320776|P7|Overall Study|Lost to Follow-up|3
92776|NCT00262028|320777|P6|Overall Study|Lost to Follow-up|3
92777|NCT00262028|320778|P5|Overall Study|Lost to Follow-up|4
92778|NCT00262028|320779|P4|Overall Study|Lost to Follow-up|5
92779|NCT00262028|320780|P3|Overall Study|Lost to Follow-up|5
92780|NCT00262028|320781|P2|Overall Study|Lost to Follow-up|7
92781|NCT00262028|320782|P1|Overall Study|Lost to Follow-up|7
92782|NCT00262028|320774|P9|Overall Study|Withdrawal by Subject|2
92783|NCT00262028|320775|P8|Overall Study|Withdrawal by Subject|7
92784|NCT00262028|320776|P7|Overall Study|Withdrawal by Subject|5
92785|NCT00262028|320777|P6|Overall Study|Withdrawal by Subject|3
92786|NCT00262028|320778|P5|Overall Study|Withdrawal by Subject|2
92787|NCT00262028|320779|P4|Overall Study|Withdrawal by Subject|5
92788|NCT00262028|320780|P3|Overall Study|Withdrawal by Subject|6
92789|NCT00262028|320781|P2|Overall Study|Withdrawal by Subject|3
92790|NCT00262028|320782|P1|Overall Study|Withdrawal by Subject|6
92791|NCT00262041|320841|P3|Overall Study|Unable to classify|0
92792|NCT00262041|320842|P2|Overall Study|Unable to classify|0
92793|NCT00262041|320843|P1|Overall Study|Unable to classify|1
92794|NCT00262041|320841|P3|Overall Study|Lost to Follow-up|5
92795|NCT00262041|320842|P2|Overall Study|Lost to Follow-up|1
92796|NCT00262041|320843|P1|Overall Study|Lost to Follow-up|1
92797|NCT00262041|320841|P3|Overall Study|Withdrawal by Subject|1
92798|NCT00262041|320842|P2|Overall Study|Withdrawal by Subject|3
92799|NCT00262041|320843|P1|Overall Study|Withdrawal by Subject|0
92800|NCT00262067|320867|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
92801|NCT00262067|320868|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
92802|NCT00262067|320869|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
92803|NCT00262067|320870|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
92804|NCT00262067|320867|P4|Overall Study|Sponsor's Decision to Terminate Study|0
92805|NCT00262067|320868|P3|Overall Study|Sponsor's Decision to Terminate Study|0
92806|NCT00262067|320869|P2|Overall Study|Sponsor's Decision to Terminate Study|0
92807|NCT00262067|320870|P1|Overall Study|Sponsor's Decision to Terminate Study|1
92808|NCT00262067|320867|P4|Overall Study|Lost to Follow-up|5
92809|NCT00262067|320868|P3|Overall Study|Lost to Follow-up|7
92810|NCT00262067|320869|P2|Overall Study|Lost to Follow-up|4
92811|NCT00262067|320870|P1|Overall Study|Lost to Follow-up|5
92812|NCT00262067|320867|P4|Overall Study|Death|99
92813|NCT00262067|320868|P3|Overall Study|Death|186
92814|NCT00262067|320869|P2|Overall Study|Death|89
92815|NCT00262067|320870|P1|Overall Study|Death|190
92816|NCT00262080|320903|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
92817|NCT00262080|320904|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
92818|NCT00262080|320905|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
92819|NCT00262080|320903|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
92820|NCT00262080|320904|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
92821|NCT00262080|320905|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
92822|NCT00262080|320903|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
92823|NCT00262080|320904|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
92824|NCT00262080|320905|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
92825|NCT00262080|320903|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
92826|NCT00262080|320904|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
92827|NCT00262080|320905|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
92828|NCT00262080|320903|P3|Repeat Dose Treatment Period|Adverse Event|0
92829|NCT00262080|320904|P2|Repeat Dose Treatment Period|Adverse Event|0
92830|NCT00262080|320905|P1|Repeat Dose Treatment Period|Adverse Event|1
92831|NCT00262080|320903|P3|Double Blind Treatment Period|Lost to Follow-up|0
92832|NCT00262080|320904|P2|Double Blind Treatment Period|Lost to Follow-up|0
92833|NCT00262080|320905|P1|Double Blind Treatment Period|Lost to Follow-up|1
92834|NCT00262119|320924|P3|Overall Study|Death|16
92835|NCT00262119|320925|P2|Overall Study|Death|19
92836|NCT00262119|320926|P1|Overall Study|Death|20
92837|NCT00262119|320924|P3|Overall Study|Lost to Follow-up|42
92838|NCT00262119|320925|P2|Overall Study|Lost to Follow-up|51
92839|NCT00262119|320926|P1|Overall Study|Lost to Follow-up|38
92840|NCT00262223|320945|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
92841|NCT00262223|320946|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
92842|NCT00262223|320945|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
92843|NCT00262223|320946|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
92844|NCT00262223|320945|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
92845|NCT00262223|320946|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
92846|NCT00262223|320945|P2|Treatment Phase|Adverse Event|2
92847|NCT00262223|320946|P1|Treatment Phase|Adverse Event|1
92848|NCT00262223|320945|P2|Treatment Phase|Withdrawal by Subject|6
92849|NCT00262223|320946|P1|Treatment Phase|Withdrawal by Subject|3
92850|NCT00262301|320957|P3|Double-blind Phase|"worsening of HAE symptoms"|0
92851|NCT00262301|320958|P2|Double-blind Phase|"worsening of HAE symptoms"|1
92852|NCT00262301|320959|P1|Double-blind Phase|"worsening of HAE symptoms"|0
92853|NCT00262301|320957|P3|Double-blind Phase|Lost to Follow-up|0
92854|NCT00262301|320958|P2|Double-blind Phase|Lost to Follow-up|0
92855|NCT00262301|320959|P1|Double-blind Phase|Lost to Follow-up|1
92856|NCT00262314|320970|P1|Overall Study|Administrative withdrawal|30
92857|NCT00262314|320970|P1|Overall Study|Lost to Follow-up|70
92858|NCT00262314|320970|P1|Overall Study|Not specified|95
92859|NCT00262314|320970|P1|Overall Study|Patient's decision|92
92860|NCT00262314|320970|P1|Overall Study|Death|12
92861|NCT00262314|320970|P1|Overall Study|Changing physicians|38
92862|NCT00262522|320998|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
92863|NCT00262522|320999|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
92864|NCT00262522|321000|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
92865|NCT00262522|321001|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
92866|NCT00262522|320998|P4|Study Start Through 96 Weeks|Virologic failure|0
92867|NCT00262522|320999|P3|Study Start Through 96 Weeks|Virologic failure|8
92868|NCT00262522|321000|P2|Study Start Through 96 Weeks|Virologic failure|0
92869|NCT00262522|321001|P1|Study Start Through 96 Weeks|Virologic failure|5
92870|NCT00262522|320998|P4|Study Start Through 96 Weeks|Death|0
92871|NCT00262522|320999|P3|Study Start Through 96 Weeks|Death|2
92872|NCT00262522|321000|P2|Study Start Through 96 Weeks|Death|0
92873|NCT00262522|321001|P1|Study Start Through 96 Weeks|Death|2
92874|NCT00262522|320998|P4|Study Start Through 96 Weeks|Noncompliance|0
92875|NCT00262522|320999|P3|Study Start Through 96 Weeks|Noncompliance|11
92876|NCT00262522|321000|P2|Study Start Through 96 Weeks|Noncompliance|0
92877|NCT00262522|321001|P1|Study Start Through 96 Weeks|Noncompliance|6
92878|NCT00262522|320998|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
92879|NCT00262522|320999|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
92880|NCT00262522|321000|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
92881|NCT00262522|321001|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
92882|NCT00262522|320998|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
92883|NCT00262522|320999|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
92884|NCT00262522|321000|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
92885|NCT00262522|321001|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
92886|NCT00262522|320998|P4|Study Start Through 96 Weeks|Adverse Event|0
92887|NCT00262522|320999|P3|Study Start Through 96 Weeks|Adverse Event|16
92888|NCT00262522|321000|P2|Study Start Through 96 Weeks|Adverse Event|0
92889|NCT00262522|321001|P1|Study Start Through 96 Weeks|Adverse Event|20
92890|NCT00262522|320998|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
92891|NCT00262522|320999|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
92892|NCT00262522|321000|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
92893|NCT00262522|321001|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
92894|NCT00262522|320998|P4|Study Start Through 48 Weeks|Virologic failure|0
92895|NCT00262522|320999|P3|Study Start Through 48 Weeks|Virologic failure|4
92896|NCT00262522|321000|P2|Study Start Through 48 Weeks|Virologic failure|0
92897|NCT00262522|321001|P1|Study Start Through 48 Weeks|Virologic failure|2
92898|NCT00262522|320998|P4|Study Start Through 48 Weeks|Death|0
92899|NCT00262522|320999|P3|Study Start Through 48 Weeks|Death|1
92900|NCT00262522|321000|P2|Study Start Through 48 Weeks|Death|0
92901|NCT00262522|321001|P1|Study Start Through 48 Weeks|Death|2
92902|NCT00262522|320998|P4|Study Start Through 48 Weeks|Noncompliance|0
92903|NCT00262522|320999|P3|Study Start Through 48 Weeks|Noncompliance|8
92904|NCT00262522|321000|P2|Study Start Through 48 Weeks|Noncompliance|0
92905|NCT00262522|321001|P1|Study Start Through 48 Weeks|Noncompliance|3
92906|NCT00262522|320998|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
92907|NCT00262522|320999|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
92908|NCT00262522|321000|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
92909|NCT00262522|321001|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
92910|NCT00262522|320998|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
92911|NCT00262522|320999|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
92912|NCT00262522|321000|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
92913|NCT00262522|321001|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
92914|NCT00262522|320998|P4|Study Start Through 48 Weeks|Adverse Event|0
92915|NCT00262522|320999|P3|Study Start Through 48 Weeks|Adverse Event|10
92916|NCT00262522|321000|P2|Study Start Through 48 Weeks|Adverse Event|0
92917|NCT00262522|321001|P1|Study Start Through 48 Weeks|Adverse Event|16
92918|NCT00262522|320998|P4|Study Start Through 8 Weeks|Death|0
92919|NCT00262522|320999|P3|Study Start Through 8 Weeks|Death|0
92920|NCT00262522|321000|P2|Study Start Through 8 Weeks|Death|0
92921|NCT00262522|321001|P1|Study Start Through 8 Weeks|Death|1
92922|NCT00262522|320998|P4|Study Start Through 8 Weeks|Noncompliance|2
92923|NCT00262522|320999|P3|Study Start Through 8 Weeks|Noncompliance|2
92924|NCT00262522|321000|P2|Study Start Through 8 Weeks|Noncompliance|0
92925|NCT00262522|321001|P1|Study Start Through 8 Weeks|Noncompliance|0
92926|NCT00262522|320998|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
92927|NCT00262522|320999|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
92928|NCT00262522|321000|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
92929|NCT00262522|321001|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
92930|NCT00262522|320998|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
92931|NCT00262522|320999|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
92932|NCT00262522|321000|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
92933|NCT00262522|321001|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
92934|NCT00262522|320998|P4|Study Start Through 8 Weeks|Adverse Event|1
92935|NCT00262522|320999|P3|Study Start Through 8 Weeks|Adverse Event|3
92936|NCT00262522|321000|P2|Study Start Through 8 Weeks|Adverse Event|2
92937|NCT00262522|321001|P1|Study Start Through 8 Weeks|Adverse Event|1
92938|NCT00262600|321024|P3|Overall Study|Not Specified|62
92939|NCT00262600|321025|P2|Overall Study|Not Specified|59
92940|NCT00262600|321026|P1|Overall Study|Not Specified|58
92941|NCT00262600|321024|P3|Overall Study|Not Treated|24
92942|NCT00262600|321025|P2|Overall Study|Not Treated|17
92943|NCT00262600|321026|P1|Overall Study|Not Treated|32
92944|NCT00262600|321024|P3|Overall Study|Withdrawal by Subject|139
92945|NCT00262600|321025|P2|Overall Study|Withdrawal by Subject|145
92946|NCT00262600|321026|P1|Overall Study|Withdrawal by Subject|128
92947|NCT00262600|321024|P3|Overall Study|Lost to Follow-up|41
92948|NCT00262600|321025|P2|Overall Study|Lost to Follow-up|31
92949|NCT00262600|321026|P1|Overall Study|Lost to Follow-up|17
92950|NCT00269633|321072|P2|Overall Study|Withdrawal by Subject|0
92951|NCT00269633|321073|P1|Overall Study|Withdrawal by Subject|1
92952|NCT00269919|321079|P1|Overall Study|Started but not treated|1
92953|NCT00269919|321079|P1|Overall Study|Unspecified|26
92954|NCT00272779|321098|P2|Baseline Through Week 96|Continuing on treatment|38
92955|NCT00272779|321099|P1|Baseline Through Week 96|Continuing on treatment|61
92956|NCT00272779|321098|P2|Baseline Through Week 96|Never treated|3
92957|NCT00272779|321099|P1|Baseline Through Week 96|Never treated|2
92958|NCT00272779|321098|P2|Baseline Through Week 96|Pregnancy at Week 96|0
92959|NCT00272779|321099|P1|Baseline Through Week 96|Pregnancy at Week 96|1
92960|NCT00272779|321098|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
92961|NCT00272779|321099|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
92962|NCT00272779|321098|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
92963|NCT00272779|321099|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
92964|NCT00272779|321098|P2|Baseline Through Week 96|Changed address before Week 96|1
92965|NCT00272779|321099|P1|Baseline Through Week 96|Changed address before Week 96|0
92966|NCT00272779|321098|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
92967|NCT00272779|321099|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
92968|NCT00272779|321098|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
92969|NCT00272779|321099|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
92970|NCT00272779|321098|P2|Baseline Through Week 96|Pregnancy before Week 96|7
92971|NCT00272779|321099|P1|Baseline Through Week 96|Pregnancy before Week 96|5
92972|NCT00272779|321098|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
92973|NCT00272779|321099|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
92974|NCT00272779|321098|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
92975|NCT00272779|321099|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
92976|NCT00272779|321098|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
92977|NCT00272779|321099|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
92978|NCT00272779|321098|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
92979|NCT00272779|321099|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
92980|NCT00272779|321098|P2|Baseline Through Week 96|Death before Week 96|5
92981|NCT00272779|321099|P1|Baseline Through Week 96|Death before Week 96|6
92982|NCT00272779|321098|P2|Baseline Through Week 96|Adverse event before Week 96|22
92983|NCT00272779|321099|P1|Baseline Through Week 96|Adverse event before Week 96|13
92984|NCT00272779|321098|P2|Baseline Through Week 48|Never treated|3
92985|NCT00272779|321099|P1|Baseline Through Week 48|Never treated|2
92986|NCT00272779|321098|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
92987|NCT00272779|321099|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
92988|NCT00272779|321098|P2|Baseline Through Week 48|Continuing treatment|368
92989|NCT00272779|321099|P1|Baseline Through Week 48|Continuing treatment|385
92990|NCT00272779|321098|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
92991|NCT00272779|321099|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
92992|NCT00272779|321098|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
92993|NCT00272779|321099|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
92994|NCT00272779|321098|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
92995|NCT00272779|321099|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
92996|NCT00272779|321098|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
92997|NCT00272779|321099|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
92998|NCT00272779|321098|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
92999|NCT00272779|321099|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
93000|NCT00272779|321098|P2|Baseline Through Week 48|Death on/after Week 48|1
93001|NCT00272779|321099|P1|Baseline Through Week 48|Death on/after Week 48|1
93002|NCT00272779|321098|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
93003|NCT00272779|321099|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
93004|NCT00272779|321098|P2|Baseline Through Week 48|Chose different site before wk 48|1
93005|NCT00272779|321099|P1|Baseline Through Week 48|Chose different site before wk 48|0
93006|NCT00272779|321098|P2|Baseline Through Week 48|Participant's decision before wk 48|1
93007|NCT00272779|321099|P1|Baseline Through Week 48|Participant's decision before wk 48|0
93008|NCT00272779|321098|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
93009|NCT00272779|321099|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
93010|NCT00272779|321098|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
93011|NCT00272779|321099|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
93012|NCT00272779|321098|P2|Baseline Through Week 48|Pregnancy before Week 48|2
93013|NCT00272779|321099|P1|Baseline Through Week 48|Pregnancy before Week 48|2
93014|NCT00272779|321098|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
93015|NCT00272779|321099|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
93016|NCT00272779|321098|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
93017|NCT00272779|321099|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
93018|NCT00272779|321098|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
93019|NCT00272779|321099|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
93020|NCT00272779|321098|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
93021|NCT00272779|321099|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
93022|NCT00272779|321098|P2|Baseline Through Week 48|Death before Week 48|4
93023|NCT00272779|321099|P1|Baseline Through Week 48|Death before Week 48|4
93024|NCT00272779|321098|P2|Baseline Through Week 48|Adverse event before Week 48|14
93025|NCT00272779|321099|P1|Baseline Through Week 48|Adverse event before Week 48|10
93026|NCT00272792|321280|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
93027|NCT00272792|321281|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
93028|NCT00272792|321280|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
93029|NCT00272792|321281|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
93030|NCT00272792|321280|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
93031|NCT00272792|321281|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
93032|NCT00272792|321280|P2|Part 1: Responsiveness|Lost to Follow-up|0
93033|NCT00272792|321281|P1|Part 1: Responsiveness|Lost to Follow-up|1
93034|NCT00272961|321294|P5|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
93035|NCT00272961|321295|P4|Treatment Phase: Week 3 Up to Week 12|Unspecified|2
93036|NCT00272961|321296|P3|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
93037|NCT00272961|321297|P2|Treatment Phase: Week 3 Up to Week 12|Unspecified|3
93038|NCT00272961|321298|P1|Treatment Phase: Week 3 Up to Week 12|Unspecified|1
93039|NCT00272961|321294|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
93040|NCT00272961|321295|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
93041|NCT00272961|321296|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
93042|NCT00272961|321297|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
93043|NCT00272961|321298|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
93044|NCT00272961|321294|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
93045|NCT00272961|321295|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
93046|NCT00272961|321296|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
93047|NCT00272961|321297|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
93048|NCT00272961|321298|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
93049|NCT00272961|321294|P5|Placebo Run-in Phase: Up to Week 2|Unspecified|0
93050|NCT00272961|321295|P4|Placebo Run-in Phase: Up to Week 2|Unspecified|0
93051|NCT00272961|321296|P3|Placebo Run-in Phase: Up to Week 2|Unspecified|0
93052|NCT00272961|321297|P2|Placebo Run-in Phase: Up to Week 2|Unspecified|0
93053|NCT00272961|321298|P1|Placebo Run-in Phase: Up to Week 2|Unspecified|2
93054|NCT00272961|321294|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
93055|NCT00272961|321295|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
93056|NCT00272961|321296|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
93057|NCT00272961|321297|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
93058|NCT00272961|321298|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
93059|NCT00272961|321294|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
93060|NCT00272961|321295|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
93061|NCT00272961|321296|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
93062|NCT00272961|321297|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
93063|NCT00272961|321298|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
93064|NCT00272961|321294|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
93065|NCT00272961|321295|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
93066|NCT00272961|321296|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
93067|NCT00272961|321297|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
93068|NCT00272961|321298|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
93069|NCT00272961|321294|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
93070|NCT00272961|321295|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
93071|NCT00272961|321296|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
93072|NCT00272961|321297|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
93073|NCT00272961|321298|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
93074|NCT00272987|321358|P3|Overall Study|Ongoing|15
93075|NCT00272987|321359|P2|Overall Study|Ongoing|14
93076|NCT00272987|321360|P1|Overall Study|Ongoing|20
93077|NCT00272987|321358|P3|Overall Study|Missed >3 Visits|1
93078|NCT00272987|321359|P2|Overall Study|Missed >3 Visits|0
93079|NCT00272987|321360|P1|Overall Study|Missed >3 Visits|0
93080|NCT00272987|321358|P3|Overall Study|Withdrawal by Subject|3
93081|NCT00272987|321359|P2|Overall Study|Withdrawal by Subject|0
93082|NCT00272987|321360|P1|Overall Study|Withdrawal by Subject|0
93083|NCT00272987|321358|P3|Overall Study|Adverse Event|0
93084|NCT00272987|321359|P2|Overall Study|Adverse Event|0
93085|NCT00272987|321360|P1|Overall Study|Adverse Event|1
93086|NCT00273052|321421|P2|Overall Study|Worsening serum lipid levels|2
93087|NCT00273052|321422|P1|Overall Study|Worsening serum lipid levels|0
93088|NCT00273052|321421|P2|Overall Study|Not specified|0
93089|NCT00273052|321422|P1|Overall Study|Not specified|2
93090|NCT00273052|321421|P2|Overall Study|Non-Compliance|1
93091|NCT00273052|321422|P1|Overall Study|Non-Compliance|3
93092|NCT00273052|321421|P2|Overall Study|Lack of Efficacy|4
93093|NCT00273052|321422|P1|Overall Study|Lack of Efficacy|6
93094|NCT00273052|321421|P2|Overall Study|Lost to Follow-up|25
93095|NCT00273052|321422|P1|Overall Study|Lost to Follow-up|7
93096|NCT00273052|321421|P2|Overall Study|Protocol Violation|18
93097|NCT00273052|321422|P1|Overall Study|Protocol Violation|14
93098|NCT00273052|321421|P2|Overall Study|Adverse Event|19
93099|NCT00273052|321422|P1|Overall Study|Adverse Event|21
93100|NCT00273052|321421|P2|Overall Study|Withdrawal by Subject|19
93101|NCT00273052|321422|P1|Overall Study|Withdrawal by Subject|16
93102|NCT00273182|321454|P1|Overall Study|Site exit, system change, 36 m FU missed|36
93103|NCT00273182|321454|P1|Overall Study|Device/System Explant|154
93104|NCT00273182|321454|P1|Overall Study|Withdrawal by Subject|257
93105|NCT00273182|321454|P1|Overall Study|Lost to Follow-up|88
93106|NCT00273182|321454|P1|Overall Study|Death|450
93107|NCT00273858|321512|P1|Overall Study|Adverse Event|81
93108|NCT00273858|321512|P1|Overall Study|Withdrawal by Subject|21
93109|NCT00273858|321512|P1|Overall Study|Lost to Follow-up|101
93110|NCT00273858|321512|P1|Overall Study|Not completed 24 month observation time|334
93111|NCT00274261|321554|P2|Overall Study|Lost to Follow-up|75
93112|NCT00274261|321555|P1|Overall Study|Lost to Follow-up|106
93113|NCT00274261|321554|P2|Overall Study|Protocol Violation|42
93114|NCT00274261|321555|P1|Overall Study|Protocol Violation|71
93115|NCT00274261|321554|P2|Overall Study|Withdrawal by Subject|126
93116|NCT00274261|321555|P1|Overall Study|Withdrawal by Subject|179
93117|NCT00274261|321554|P2|Overall Study|Pregnancy|83
93118|NCT00274261|321555|P1|Overall Study|Pregnancy|114
93119|NCT00274261|321554|P2|Overall Study|Adverse Event|11
93120|NCT00274261|321555|P1|Overall Study|Adverse Event|19
93121|NCT00274287|321561|P1|Overall Study|subject non-compliance|1
93122|NCT00274287|321561|P1|Overall Study|Withdrawal by Subject|1
93123|NCT00274456|321569|P4|Overall Study|Withdrawal by Subject|13
93124|NCT00274456|321570|P3|Overall Study|Withdrawal by Subject|9
93125|NCT00274456|321571|P2|Overall Study|Withdrawal by Subject|13
93126|NCT00274456|321572|P1|Overall Study|Withdrawal by Subject|18
93127|NCT00274456|321569|P4|Overall Study|Lost to Follow-up|0
93128|NCT00274456|321570|P3|Overall Study|Lost to Follow-up|1
93129|NCT00274456|321571|P2|Overall Study|Lost to Follow-up|0
93130|NCT00274456|321572|P1|Overall Study|Lost to Follow-up|0
93131|NCT00274456|321569|P4|Overall Study|Physician Decision|13
93132|NCT00274456|321570|P3|Overall Study|Physician Decision|6
93133|NCT00274456|321571|P2|Overall Study|Physician Decision|5
93134|NCT00274456|321572|P1|Overall Study|Physician Decision|7
93135|NCT00274456|321569|P4|Overall Study|Adverse Event|2
93136|NCT00274456|321570|P3|Overall Study|Adverse Event|2
93137|NCT00274456|321571|P2|Overall Study|Adverse Event|1
93138|NCT00274456|321572|P1|Overall Study|Adverse Event|0
93139|NCT00274456|321569|P4|Overall Study|Unacceptable toxicity|16
93140|NCT00274456|321570|P3|Overall Study|Unacceptable toxicity|12
93141|NCT00274456|321571|P2|Overall Study|Unacceptable toxicity|5
93142|NCT00274456|321572|P1|Overall Study|Unacceptable toxicity|10
93143|NCT00274456|321569|P4|Overall Study|Still on treatment|1
93144|NCT00274456|321570|P3|Overall Study|Still on treatment|5
93145|NCT00274456|321571|P2|Overall Study|Still on treatment|3
93146|NCT00274456|321572|P1|Overall Study|Still on treatment|2
93147|NCT00274469|321616|P2|Overall Study|Reasons not specified|8
93148|NCT00274469|321617|P1|Overall Study|Reasons not specified|5
93149|NCT00274469|321616|P2|Overall Study|Withdrawal by Subject|0
93150|NCT00274469|321617|P1|Overall Study|Withdrawal by Subject|2
93151|NCT00274469|321616|P2|Overall Study|Condition under investigation worsened|38
93152|NCT00274469|321617|P1|Overall Study|Condition under investigation worsened|28
93153|NCT00274469|321616|P2|Overall Study|Adverse Event|3
93154|NCT00274469|321617|P1|Overall Study|Adverse Event|2
93155|NCT00274469|321616|P2|Overall Study|Death|1
93156|NCT00274469|321617|P1|Overall Study|Death|1
93157|NCT00274625|321633|P2|Overall Study|Excluded from analysis|8
93158|NCT00274625|321634|P1|Overall Study|Excluded from analysis|14
93159|NCT00274625|321633|P2|Overall Study|Lost to Follow-up|54
93160|NCT00274625|321634|P1|Overall Study|Lost to Follow-up|46
93161|NCT00274651|321642|P2|Overall Study|Physician Decision|7
93162|NCT00274651|321643|P1|Overall Study|Physician Decision|8
93163|NCT00274651|321642|P2|Overall Study|Withdrawal by Subject|1
93164|NCT00274651|321643|P1|Overall Study|Withdrawal by Subject|0
93165|NCT00274651|321642|P2|Overall Study|Death|3
93166|NCT00274651|321643|P1|Overall Study|Death|1
93167|NCT00274651|321642|P2|Overall Study|Lack of Efficacy|6
93168|NCT00274651|321643|P1|Overall Study|Lack of Efficacy|13
93169|NCT00274651|321642|P2|Overall Study|Adverse Event|3
93170|NCT00274651|321643|P1|Overall Study|Adverse Event|6
93171|NCT00274716|321662|P6|Phase B|Lost to Follow-up|0
93172|NCT00274716|321663|P5|Phase B|Lost to Follow-up|0
93173|NCT00274716|321664|P4|Phase B|Lost to Follow-up|0
93174|NCT00274716|321665|P3|Phase B|Lost to Follow-up|0
93175|NCT00274716|321666|P2|Phase B|Lost to Follow-up|1
93176|NCT00274716|321667|P1|Phase B|Lost to Follow-up|0
93177|NCT00274716|321662|P6|Phase B|Other non-reported reason|0
93178|NCT00274716|321663|P5|Phase B|Other non-reported reason|0
93179|NCT00274716|321664|P4|Phase B|Other non-reported reason|1
93180|NCT00274716|321665|P3|Phase B|Other non-reported reason|1
93181|NCT00274716|321666|P2|Phase B|Other non-reported reason|0
93182|NCT00274716|321667|P1|Phase B|Other non-reported reason|0
93183|NCT00274716|321662|P6|Phase B|Participant moved|0
93184|NCT00274716|321663|P5|Phase B|Participant moved|0
93185|NCT00274716|321664|P4|Phase B|Participant moved|0
93186|NCT00274716|321665|P3|Phase B|Participant moved|0
93187|NCT00274716|321666|P2|Phase B|Participant moved|0
93188|NCT00274716|321667|P1|Phase B|Participant moved|1
93189|NCT00274716|321662|P6|Phase B|Withdrawal by Subject|0
93190|NCT00274716|321663|P5|Phase B|Withdrawal by Subject|0
93191|NCT00274716|321664|P4|Phase B|Withdrawal by Subject|0
93192|NCT00274716|321665|P3|Phase B|Withdrawal by Subject|0
93193|NCT00274716|321666|P2|Phase B|Withdrawal by Subject|1
93194|NCT00274716|321667|P1|Phase B|Withdrawal by Subject|0
93195|NCT00274716|321662|P6|Phase B|Protocol Violation|0
93196|NCT00274716|321663|P5|Phase B|Protocol Violation|0
93197|NCT00274716|321664|P4|Phase B|Protocol Violation|0
93198|NCT00274716|321665|P3|Phase B|Protocol Violation|0
93199|NCT00274716|321666|P2|Phase B|Protocol Violation|2
93200|NCT00274716|321667|P1|Phase B|Protocol Violation|0
93201|NCT00274716|321662|P6|Phase B|Adverse Event|1
93202|NCT00274716|321663|P5|Phase B|Adverse Event|0
93203|NCT00274716|321664|P4|Phase B|Adverse Event|0
93204|NCT00274716|321665|P3|Phase B|Adverse Event|2
93205|NCT00274716|321666|P2|Phase B|Adverse Event|0
93206|NCT00274716|321667|P1|Phase B|Adverse Event|0
93207|NCT00274716|321662|P6|Phase A|Completed but did not enter Phase B|1
93208|NCT00274716|321663|P5|Phase A|Completed but did not enter Phase B|1
93209|NCT00274716|321664|P4|Phase A|Completed but did not enter Phase B|2
93210|NCT00274716|321665|P3|Phase A|Completed but did not enter Phase B|2
93211|NCT00274716|321666|P2|Phase A|Completed but did not enter Phase B|2
93212|NCT00274716|321667|P1|Phase A|Completed but did not enter Phase B|1
93213|NCT00274716|321662|P6|Phase A|Adverse Event|0
93214|NCT00274716|321663|P5|Phase A|Adverse Event|2
93215|NCT00274716|321664|P4|Phase A|Adverse Event|0
93216|NCT00274716|321665|P3|Phase A|Adverse Event|3
93217|NCT00274716|321666|P2|Phase A|Adverse Event|3
93218|NCT00274716|321667|P1|Phase A|Adverse Event|2
93219|NCT00274716|321662|P6|Phase A|Withdrawal by Subject|1
93220|NCT00274716|321663|P5|Phase A|Withdrawal by Subject|0
93221|NCT00274716|321664|P4|Phase A|Withdrawal by Subject|3
93222|NCT00274716|321665|P3|Phase A|Withdrawal by Subject|1
93223|NCT00274716|321666|P2|Phase A|Withdrawal by Subject|2
93224|NCT00274716|321667|P1|Phase A|Withdrawal by Subject|2
93225|NCT00274716|321662|P6|Phase A|Met criteria for discontinuation|0
93226|NCT00274716|321663|P5|Phase A|Met criteria for discontinuation|0
93227|NCT00274716|321664|P4|Phase A|Met criteria for discontinuation|0
93228|NCT00274716|321665|P3|Phase A|Met criteria for discontinuation|0
93229|NCT00274716|321666|P2|Phase A|Met criteria for discontinuation|1
93230|NCT00274716|321667|P1|Phase A|Met criteria for discontinuation|1
93231|NCT00274716|321662|P6|Phase A|Protocol Violation|0
93232|NCT00274716|321663|P5|Phase A|Protocol Violation|0
93233|NCT00274716|321664|P4|Phase A|Protocol Violation|1
93234|NCT00274716|321665|P3|Phase A|Protocol Violation|0
93235|NCT00274716|321666|P2|Phase A|Protocol Violation|0
93236|NCT00274716|321667|P1|Phase A|Protocol Violation|1
93237|NCT00274716|321662|P6|Phase A|Site Terminated|0
93238|NCT00274716|321663|P5|Phase A|Site Terminated|0
93239|NCT00274716|321664|P4|Phase A|Site Terminated|1
93240|NCT00274716|321665|P3|Phase A|Site Terminated|0
93241|NCT00274716|321666|P2|Phase A|Site Terminated|0
93242|NCT00274716|321667|P1|Phase A|Site Terminated|0
93243|NCT00274716|321662|P6|Phase A|Participant moved|1
93244|NCT00274716|321663|P5|Phase A|Participant moved|0
93245|NCT00274716|321664|P4|Phase A|Participant moved|0
93246|NCT00274716|321665|P3|Phase A|Participant moved|1
93247|NCT00274716|321666|P2|Phase A|Participant moved|0
93248|NCT00274716|321667|P1|Phase A|Participant moved|0
93249|NCT00274716|321662|P6|Phase A|Other non-reported reason|1
93250|NCT00274716|321663|P5|Phase A|Other non-reported reason|0
93251|NCT00274716|321664|P4|Phase A|Other non-reported reason|2
93252|NCT00274716|321665|P3|Phase A|Other non-reported reason|1
93253|NCT00274716|321666|P2|Phase A|Other non-reported reason|2
93254|NCT00274716|321667|P1|Phase A|Other non-reported reason|4
93255|NCT00274742|321733|P6|Overall Study|Other|0
93256|NCT00274742|321734|P5|Overall Study|Other|2
93257|NCT00274742|321735|P4|Overall Study|Other|0
93258|NCT00274742|321736|P3|Overall Study|Other|0
93259|NCT00274742|321737|P2|Overall Study|Other|3
93260|NCT00274742|321738|P1|Overall Study|Other|0
93261|NCT00274742|321733|P6|Overall Study|Disease Progression|0
93262|NCT00274742|321734|P5|Overall Study|Disease Progression|1
93263|NCT00274742|321735|P4|Overall Study|Disease Progression|0
93264|NCT00274742|321736|P3|Overall Study|Disease Progression|1
93265|NCT00274742|321737|P2|Overall Study|Disease Progression|1
93266|NCT00274742|321738|P1|Overall Study|Disease Progression|0
93267|NCT00274742|321733|P6|Overall Study|End of Study|0
93268|NCT00274742|321734|P5|Overall Study|End of Study|0
93269|NCT00274742|321735|P4|Overall Study|End of Study|1
93270|NCT00274742|321736|P3|Overall Study|End of Study|0
93271|NCT00274742|321737|P2|Overall Study|End of Study|0
93272|NCT00274742|321738|P1|Overall Study|End of Study|0
93273|NCT00274742|321733|P6|Overall Study|Lost to Follow-up|0
93274|NCT00274742|321734|P5|Overall Study|Lost to Follow-up|1
93275|NCT00274742|321735|P4|Overall Study|Lost to Follow-up|0
93276|NCT00274742|321736|P3|Overall Study|Lost to Follow-up|0
93277|NCT00274742|321737|P2|Overall Study|Lost to Follow-up|0
93278|NCT00274742|321738|P1|Overall Study|Lost to Follow-up|0
93279|NCT00274742|321733|P6|Overall Study|Adverse Event|3
93280|NCT00274742|321734|P5|Overall Study|Adverse Event|12
93281|NCT00274742|321735|P4|Overall Study|Adverse Event|4
93282|NCT00274742|321736|P3|Overall Study|Adverse Event|1
93283|NCT00274742|321737|P2|Overall Study|Adverse Event|4
93284|NCT00274742|321738|P1|Overall Study|Adverse Event|0
93285|NCT00274846|321780|P1|Overall Study|Did not receive adequate NK cells|1
93286|NCT00265759|321813|P4|Overall Study|Discontinued due to intolerability|1
93287|NCT00265759|321814|P3|Overall Study|Discontinued due to intolerability|0
93288|NCT00265759|321815|P2|Overall Study|Discontinued due to intolerability|0
93289|NCT00265759|321816|P1|Overall Study|Discontinued due to intolerability|0
93290|NCT00265759|321813|P4|Overall Study|Bilateral disease|2
93291|NCT00265759|321814|P3|Overall Study|Bilateral disease|0
93292|NCT00265759|321815|P2|Overall Study|Bilateral disease|0
93293|NCT00265759|321816|P1|Overall Study|Bilateral disease|0
93294|NCT00265759|321813|P4|Overall Study|Ineligible|1
93295|NCT00265759|321814|P3|Overall Study|Ineligible|0
93296|NCT00265759|321815|P2|Overall Study|Ineligible|0
93297|NCT00265759|321816|P1|Overall Study|Ineligible|0
93298|NCT00265759|321813|P4|Overall Study|Cancel|3
93299|NCT00265759|321814|P3|Overall Study|Cancel|0
93300|NCT00265759|321815|P2|Overall Study|Cancel|0
93301|NCT00265759|321816|P1|Overall Study|Cancel|0
93302|NCT00265759|321813|P4|Overall Study|Withdrawal by Subject|2
93303|NCT00265759|321814|P3|Overall Study|Withdrawal by Subject|2
93304|NCT00265759|321815|P2|Overall Study|Withdrawal by Subject|1
93305|NCT00265759|321816|P1|Overall Study|Withdrawal by Subject|0
93306|NCT00265785|321845|P1|Overall Study|Did not receive protocol treatment|2
93307|NCT00265785|321845|P1|Overall Study|Ineligible|1
93308|NCT00265785|321845|P1|Overall Study|Not protocol specified|2
93309|NCT00265785|321845|P1|Overall Study|Progression/Relapse|15
93310|NCT00265785|321845|P1|Overall Study|Withdrawal by Subject|3
93311|NCT00265785|321845|P1|Overall Study|Adverse Event|4
93312|NCT00265889|321873|P1|Overall Study|Insurance denied the request|3
93313|NCT00265889|321873|P1|Overall Study|Protocol Violation|1
93314|NCT00265889|321873|P1|Overall Study|Physician Decision|1
93315|NCT00266032|321882|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
93316|NCT00266032|321883|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
93317|NCT00266032|321884|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
93318|NCT00266032|321882|P3|Open-label Safety Extension|Withdrawal by Subject|12
93319|NCT00266032|321883|P2|Open-label Safety Extension|Withdrawal by Subject|3
93320|NCT00266032|321884|P1|Open-label Safety Extension|Withdrawal by Subject|19
93321|NCT00266032|321882|P3|Open-label Safety Extension|Protocol Violation|2
93322|NCT00266032|321883|P2|Open-label Safety Extension|Protocol Violation|3
93323|NCT00266032|321884|P1|Open-label Safety Extension|Protocol Violation|1
93324|NCT00266032|321882|P3|Open-label Safety Extension|Pregnancy|2
93325|NCT00266032|321883|P2|Open-label Safety Extension|Pregnancy|1
93326|NCT00266032|321884|P1|Open-label Safety Extension|Pregnancy|4
93327|NCT00266032|321882|P3|Open-label Safety Extension|Lost to Follow-up|4
93328|NCT00266032|321883|P2|Open-label Safety Extension|Lost to Follow-up|5
93329|NCT00266032|321884|P1|Open-label Safety Extension|Lost to Follow-up|2
93330|NCT00266032|321882|P3|Open-label Safety Extension|Adverse Event|4
93331|NCT00266032|321883|P2|Open-label Safety Extension|Adverse Event|0
93332|NCT00266032|321884|P1|Open-label Safety Extension|Adverse Event|5
93333|NCT00266032|321882|P3|Treatment|patient moved/wish for pregnancy/no need|8
93334|NCT00266032|321883|P2|Treatment|patient moved/wish for pregnancy/no need|5
93335|NCT00266032|321884|P1|Treatment|patient moved/wish for pregnancy/no need|13
93336|NCT00266032|321882|P3|Treatment|Withdrawal by Subject|12
93337|NCT00266032|321883|P2|Treatment|Withdrawal by Subject|13
93338|NCT00266032|321884|P1|Treatment|Withdrawal by Subject|28
93339|NCT00266032|321882|P3|Treatment|Protocol Violation|13
93340|NCT00266032|321883|P2|Treatment|Protocol Violation|14
93341|NCT00266032|321884|P1|Treatment|Protocol Violation|6
93342|NCT00266032|321882|P3|Treatment|Pregnancy|2
93343|NCT00266032|321883|P2|Treatment|Pregnancy|2
93344|NCT00266032|321884|P1|Treatment|Pregnancy|3
93345|NCT00266032|321882|P3|Treatment|Lost to Follow-up|2
93346|NCT00266032|321883|P2|Treatment|Lost to Follow-up|4
93347|NCT00266032|321884|P1|Treatment|Lost to Follow-up|19
93348|NCT00266032|321882|P3|Treatment|Adverse Event|10
93349|NCT00266032|321883|P2|Treatment|Adverse Event|26
93350|NCT00266032|321884|P1|Treatment|Adverse Event|42
93351|NCT00266227|321918|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
93352|NCT00266227|321919|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
93353|NCT00266227|321920|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
93354|NCT00266227|321918|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
93355|NCT00266227|321919|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
93356|NCT00266227|321920|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
93357|NCT00266227|321918|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
93358|NCT00266227|321919|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
93359|NCT00266227|321920|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
93360|NCT00266227|321918|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
93361|NCT00266227|321919|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
93362|NCT00266227|321920|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
93363|NCT00266227|321918|P3|Retreatment: Week 48 to Week 72|Death|0
93364|NCT00266227|321919|P2|Retreatment: Week 48 to Week 72|Death|1
93365|NCT00266227|321920|P1|Retreatment: Week 48 to Week 72|Death|1
93366|NCT00266227|321918|P3|Retreatment: Up to Week 48|Pregnancy|0
93367|NCT00266227|321919|P2|Retreatment: Up to Week 48|Pregnancy|0
93368|NCT00266227|321920|P1|Retreatment: Up to Week 48|Pregnancy|1
93369|NCT00266227|321918|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
93370|NCT00266227|321919|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
93371|NCT00266227|321920|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
93372|NCT00266227|321918|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
93373|NCT00266227|321919|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
93374|NCT00266227|321920|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
93375|NCT00266227|321918|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
93376|NCT00266227|321919|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
93377|NCT00266227|321920|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
93378|NCT00266227|321918|P3|Retreatment: Up to Week 48|Adverse Event|0
93379|NCT00266227|321919|P2|Retreatment: Up to Week 48|Adverse Event|7
93380|NCT00266227|321920|P1|Retreatment: Up to Week 48|Adverse Event|7
93381|NCT00266227|321918|P3|Retreatment: Up to Week 48|Death|0
93382|NCT00266227|321919|P2|Retreatment: Up to Week 48|Death|0
93383|NCT00266227|321920|P1|Retreatment: Up to Week 48|Death|1
93384|NCT00266227|321918|P3|Initial Treatment|Pregnancy|1
93385|NCT00266227|321919|P2|Initial Treatment|Pregnancy|0
93386|NCT00266227|321920|P1|Initial Treatment|Pregnancy|0
93387|NCT00266227|321918|P3|Initial Treatment|Physician decision to withdraw|12
93388|NCT00266227|321919|P2|Initial Treatment|Physician decision to withdraw|0
93389|NCT00266227|321920|P1|Initial Treatment|Physician decision to withdraw|0
93390|NCT00266227|321918|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
93391|NCT00266227|321919|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
93392|NCT00266227|321920|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
93393|NCT00266227|321918|P3|Initial Treatment|Lost to Follow-up|6
93394|NCT00266227|321919|P2|Initial Treatment|Lost to Follow-up|0
93395|NCT00266227|321920|P1|Initial Treatment|Lost to Follow-up|0
93396|NCT00266227|321918|P3|Initial Treatment|Adverse Event|13
93397|NCT00266227|321919|P2|Initial Treatment|Adverse Event|0
93398|NCT00266227|321920|P1|Initial Treatment|Adverse Event|0
93399|NCT00266409|321973|P4|Overall Study|unspecified|0
93400|NCT00266409|321974|P3|Overall Study|unspecified|2
93401|NCT00266409|321975|P2|Overall Study|unspecified|4
93402|NCT00266409|321976|P1|Overall Study|unspecified|7
93403|NCT00266409|321973|P4|Overall Study|Protocol Violation|2
93404|NCT00266409|321974|P3|Overall Study|Protocol Violation|4
93405|NCT00266409|321975|P2|Overall Study|Protocol Violation|3
93406|NCT00266409|321976|P1|Overall Study|Protocol Violation|5
93407|NCT00266409|321973|P4|Overall Study|Withdrawal by Subject|9
93408|NCT00266409|321974|P3|Overall Study|Withdrawal by Subject|3
93409|NCT00266409|321975|P2|Overall Study|Withdrawal by Subject|10
93410|NCT00266409|321976|P1|Overall Study|Withdrawal by Subject|6
93411|NCT00266409|321973|P4|Overall Study|Lost to Follow-up|8
93412|NCT00266409|321974|P3|Overall Study|Lost to Follow-up|6
93413|NCT00266409|321975|P2|Overall Study|Lost to Follow-up|21
93414|NCT00266409|321976|P1|Overall Study|Lost to Follow-up|18
93415|NCT00266409|321973|P4|Overall Study|Adverse Event|1
93416|NCT00266409|321974|P3|Overall Study|Adverse Event|1
93417|NCT00266409|321975|P2|Overall Study|Adverse Event|2
93418|NCT00266409|321976|P1|Overall Study|Adverse Event|7
93419|NCT00266409|321973|P4|Overall Study|Lack of Efficacy|2
93420|NCT00266409|321974|P3|Overall Study|Lack of Efficacy|1
93421|NCT00266409|321975|P2|Overall Study|Lack of Efficacy|6
93422|NCT00266409|321976|P1|Overall Study|Lack of Efficacy|2
93423|NCT00266630|322260|P2|Overall Study|Not Specified|11
93424|NCT00266630|322261|P1|Overall Study|Not Specified|19
93425|NCT00266630|322260|P2|Overall Study|Lost to Follow-up|0
93426|NCT00266630|322261|P1|Overall Study|Lost to Follow-up|1
93427|NCT00266630|322260|P2|Overall Study|Withdrawal by Subject|2
93428|NCT00266630|322261|P1|Overall Study|Withdrawal by Subject|10
93429|NCT00266630|322260|P2|Overall Study|Physician Decision|2
93430|NCT00266630|322261|P1|Overall Study|Physician Decision|1
93431|NCT00266630|322260|P2|Overall Study|Protocol Violation|3
93432|NCT00266630|322261|P1|Overall Study|Protocol Violation|1
93433|NCT00266630|322260|P2|Overall Study|Entry Criteria not met|0
93434|NCT00266630|322261|P1|Overall Study|Entry Criteria not met|1
93435|NCT00266630|322260|P2|Overall Study|Lack of Efficacy|4
93436|NCT00266630|322261|P1|Overall Study|Lack of Efficacy|1
93437|NCT00266630|322260|P2|Overall Study|Adverse Event|6
93438|NCT00266630|322261|P1|Overall Study|Adverse Event|8
93439|NCT00266656|322301|P2|Overall Study|Parent/Caregiver Decision|2
93440|NCT00266656|322302|P1|Overall Study|Parent/Caregiver Decision|1
93441|NCT00266656|322301|P2|Overall Study|Did Not Reach Final Height|8
93442|NCT00266656|322302|P1|Overall Study|Did Not Reach Final Height|4
93443|NCT00266656|322301|P2|Overall Study|Withdrawal by Subject|2
93444|NCT00266656|322302|P1|Overall Study|Withdrawal by Subject|4
93445|NCT00266656|322301|P2|Overall Study|Lost to Follow-up|1
93446|NCT00266656|322302|P1|Overall Study|Lost to Follow-up|4
93447|NCT00266656|322301|P2|Overall Study|Death|0
93448|NCT00266656|322302|P1|Overall Study|Death|1
93449|NCT00266695|322324|P1|Overall Study|Withdrawal by Subject|15
93450|NCT00266695|322324|P1|Overall Study|Lost to Follow-up|3
93451|NCT00266695|322324|P1|Overall Study|Physician Decision|1
93452|NCT00266695|322324|P1|Overall Study|Death|9
93453|NCT00266695|322324|P1|Overall Study|Adverse Event|1
93454|NCT00266812|322353|P2|Overall Study|Discontinued before starting study drug|0
93455|NCT00266812|322354|P1|Overall Study|Discontinued before starting study drug|4
93456|NCT00266812|322353|P2|Overall Study|Withdrawal by Subject|2
93457|NCT00266812|322354|P1|Overall Study|Withdrawal by Subject|0
93458|NCT00266812|322353|P2|Overall Study|Protocol Violation|1
93459|NCT00266812|322354|P1|Overall Study|Protocol Violation|0
93460|NCT00266812|322353|P2|Overall Study|Adverse Event|1
93461|NCT00266812|322354|P1|Overall Study|Adverse Event|3
93462|NCT00266812|322353|P2|Overall Study|Death|4
93463|NCT00266812|322354|P1|Overall Study|Death|5
93464|NCT00266812|322353|P2|Overall Study|Disease Progression|3
93465|NCT00266812|322354|P1|Overall Study|Disease Progression|9
93466|NCT00266825|322362|P2|Completed Follow-Up|Withdrawal by Subject|5
93467|NCT00266825|322363|P1|Completed Follow-Up|Withdrawal by Subject|11
93468|NCT00266825|322362|P2|Completed Follow-Up|Lost to Follow-up|19
93469|NCT00266825|322363|P1|Completed Follow-Up|Lost to Follow-up|14
93470|NCT00266864|322389|P2|Overall Study|Withdrawal by Subject|1
93471|NCT00266864|322390|P1|Overall Study|Withdrawal by Subject|1
93472|NCT00266864|322389|P2|Overall Study|Lost to Follow-up|1
93473|NCT00266864|322390|P1|Overall Study|Lost to Follow-up|4
93474|NCT00267007|322399|P2|Overall Study|Adverse Event|0
93475|NCT00267007|322400|P1|Overall Study|Adverse Event|1
93476|NCT00267007|322399|P2|Overall Study|Non-compliance|1
93477|NCT00267007|322400|P1|Overall Study|Non-compliance|0
93478|NCT00267007|322399|P2|Overall Study|Lost to Follow-up|0
93479|NCT00267007|322400|P1|Overall Study|Lost to Follow-up|1
93480|NCT00267007|322399|P2|Overall Study|Withdrawal by Subject|0
93481|NCT00267007|322400|P1|Overall Study|Withdrawal by Subject|6
93482|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
93483|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
93484|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
93485|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
93486|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
93487|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
93488|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
93489|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
93490|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
93491|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
93492|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
93493|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
93494|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
93495|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
93496|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
93497|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
93498|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
93499|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
93500|NCT00274924|322411|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
93501|NCT00274924|322412|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
93502|NCT00274924|322413|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
93503|NCT00274924|322411|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
93504|NCT00274924|322412|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
93505|NCT00274924|322413|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
93506|NCT00274924|322411|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
93507|NCT00274924|322412|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
93508|NCT00274924|322413|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
93509|NCT00274924|322411|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
93510|NCT00274924|322412|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
93511|NCT00274924|322413|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
93512|NCT00274924|322411|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
93513|NCT00274924|322412|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
93514|NCT00274924|322413|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
93515|NCT00274924|322411|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
93516|NCT00274924|322412|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
93517|NCT00274924|322413|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
93518|NCT00274924|322411|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
93519|NCT00274924|322412|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
93520|NCT00274924|322413|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
93521|NCT00274937|322422|P1|Overall Study|Progressive Disease|4
93522|NCT00274937|322422|P1|Overall Study|Withdrawal by Subject|6
93523|NCT00274937|322422|P1|Overall Study|Physician Decision|10
93524|NCT00275002|322431|P2|Overall Study|Adverse Event|1
93525|NCT00275002|322432|P1|Overall Study|Adverse Event|0
93526|NCT00275002|322431|P2|Overall Study|Disease progression|15
93527|NCT00275002|322432|P1|Overall Study|Disease progression|21
93528|NCT00275002|322431|P2|Overall Study|Death|0
93529|NCT00275002|322432|P1|Overall Study|Death|1
93530|NCT00275028|322440|P1|Overall Study|Physician Decision|2
93531|NCT00275028|322440|P1|Overall Study|Progressive Disease|30
93532|NCT00275028|322440|P1|Overall Study|Adverse Event|9
93533|NCT00275028|322440|P1|Overall Study|Withdrawal by Subject|5
93534|NCT00275028|322440|P1|Overall Study|Withdrew consent before treatment began|1
93535|NCT00276016|322451|P6|Intervention 1|Withdrawal by Subject|0
93536|NCT00276016|322452|P5|Intervention 1|Withdrawal by Subject|0
93537|NCT00276016|322453|P4|Intervention 1|Withdrawal by Subject|0
93538|NCT00276016|322454|P3|Intervention 1|Withdrawal by Subject|0
93539|NCT00276016|322455|P2|Intervention 1|Withdrawal by Subject|1
93540|NCT00276016|322456|P1|Intervention 1|Withdrawal by Subject|0
93541|NCT00276094|322468|P3|Overall Study|Other-Study medication lost|1
93542|NCT00276094|322469|P2|Overall Study|Other-Study medication lost|0
93543|NCT00276094|322470|P1|Overall Study|Other-Study medication lost|0
93544|NCT00276094|322468|P3|Overall Study|Other-Relocation|0
93545|NCT00276094|322469|P2|Overall Study|Other-Relocation|1
93546|NCT00276094|322470|P1|Overall Study|Other-Relocation|0
93547|NCT00276094|322468|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
93548|NCT00276094|322469|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
93549|NCT00276094|322470|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
93550|NCT00276094|322468|P3|Overall Study|Other-Refused follow-up visit|0
93551|NCT00276094|322469|P2|Overall Study|Other-Refused follow-up visit|0
93552|NCT00276094|322470|P1|Overall Study|Other-Refused follow-up visit|1
93553|NCT00276094|322468|P3|Overall Study|Other-Lack of efficacy|0
93554|NCT00276094|322469|P2|Overall Study|Other-Lack of efficacy|0
93555|NCT00276094|322470|P1|Overall Study|Other-Lack of efficacy|1
93556|NCT00276094|322468|P3|Overall Study|Other-Scheduled gastroplasty|0
93557|NCT00276094|322469|P2|Overall Study|Other-Scheduled gastroplasty|0
93558|NCT00276094|322470|P1|Overall Study|Other-Scheduled gastroplasty|1
93559|NCT00276094|322468|P3|Overall Study|Other-Subject moved out of country|0
93560|NCT00276094|322469|P2|Overall Study|Other-Subject moved out of country|0
93561|NCT00276094|322470|P1|Overall Study|Other-Subject moved out of country|1
93562|NCT00276094|322468|P3|Overall Study|Lost to Follow-up|4
93563|NCT00276094|322469|P2|Overall Study|Lost to Follow-up|6
93564|NCT00276094|322470|P1|Overall Study|Lost to Follow-up|8
93565|NCT00276094|322468|P3|Overall Study|Protocol Violation|10
93566|NCT00276094|322469|P2|Overall Study|Protocol Violation|7
93567|NCT00276094|322470|P1|Overall Study|Protocol Violation|16
93568|NCT00276094|322468|P3|Overall Study|Withdrawal by Subject|12
93569|NCT00276094|322469|P2|Overall Study|Withdrawal by Subject|14
93570|NCT00276094|322470|P1|Overall Study|Withdrawal by Subject|14
93571|NCT00276094|322468|P3|Overall Study|Adverse Event|11
93572|NCT00276094|322469|P2|Overall Study|Adverse Event|13
93573|NCT00276094|322470|P1|Overall Study|Adverse Event|15
93574|NCT00276159|322517|P1|Overall Study|Did not receive all 24 doses of 852A|6
93575|NCT00276419|322594|P2|First Intervention|Withdrawal by Subject|2
93576|NCT00276419|322595|P1|First Intervention|Withdrawal by Subject|0
93577|NCT00276419|322594|P2|First Intervention|Adverse Event|0
93578|NCT00276419|322595|P1|First Intervention|Adverse Event|1
93579|NCT00276458|322607|P2|Overall Study|Protocol Violation|3
93580|NCT00276458|322608|P1|Overall Study|Protocol Violation|4
93581|NCT00276458|322607|P2|Overall Study|Lost to Follow-up|2
93582|NCT00276458|322608|P1|Overall Study|Lost to Follow-up|2
93583|NCT00276458|322607|P2|Overall Study|Adverse Event|2
93584|NCT00276458|322608|P1|Overall Study|Adverse Event|0
93585|NCT00276484|322642|P2|Overall Study|Could not take time off work|1
93586|NCT00276484|322643|P1|Overall Study|Could not take time off work|0
93587|NCT00276484|322642|P2|Overall Study|Withdrawal by Subject|3
93588|NCT00276484|322643|P1|Overall Study|Withdrawal by Subject|4
93589|NCT00276484|322642|P2|Overall Study|Protocol Violation|1
93590|NCT00276484|322643|P1|Overall Study|Protocol Violation|0
93591|NCT00276484|322642|P2|Overall Study|Lost to Follow-up|1
93592|NCT00276484|322643|P1|Overall Study|Lost to Follow-up|1
93593|NCT00276484|322642|P2|Overall Study|Adverse Event|7
93594|NCT00276484|322643|P1|Overall Study|Adverse Event|4
93595|NCT00276614|322678|P1|Overall Study|Progression of disease under study|3
93596|NCT00277095|322687|P1|Overall Study|Physician Decision|1
93597|NCT00277095|322687|P1|Overall Study|Missed Follow-up|9
93598|NCT00277095|322687|P1|Overall Study|Lost to Follow-up|2
93599|NCT00277095|322687|P1|Overall Study|Explanted|7
93600|NCT00277095|322687|P1|Overall Study|Death|2
93601|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
93602|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
93603|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
93604|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
93605|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
93606|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
93607|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
93608|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
93609|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
93610|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
93611|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
93612|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
93613|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
93614|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
93615|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
93616|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
93617|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
93618|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
93619|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
93620|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
93621|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
93622|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
93623|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
93624|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
93625|NCT00277212|322691|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
93626|NCT00277212|322692|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
93627|NCT00277212|322693|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
93628|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
93629|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
93630|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
93631|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
93632|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
93633|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
93634|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
93635|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
93636|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
93637|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
93638|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
93639|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
93640|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
93641|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
93642|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
93643|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
93644|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
93645|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
93646|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
93647|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
93648|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
93649|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
93650|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
93651|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
93652|NCT00277212|322691|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
93653|NCT00277212|322692|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
93654|NCT00277212|322693|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
93655|NCT00277355|322733|P2|Overall Study|Physician Decision|0
93656|NCT00277355|322734|P1|Overall Study|Physician Decision|1
93657|NCT00277355|322733|P2|Overall Study|Death|0
93658|NCT00277355|322734|P1|Overall Study|Death|3
93659|NCT00277355|322733|P2|Overall Study|Adverse Event|0
93660|NCT00277355|322734|P1|Overall Study|Adverse Event|5
93661|NCT00277355|322733|P2|Overall Study|Lost to Follow-up|2
93662|NCT00277355|322734|P1|Overall Study|Lost to Follow-up|2
93663|NCT00277355|322733|P2|Overall Study|Withdrawal by Subject|3
93664|NCT00277355|322734|P1|Overall Study|Withdrawal by Subject|3
93665|NCT00278395|322789|P1|Overall Study|Nonevaluable|1
93666|NCT00278395|322789|P1|Overall Study|Adverse Event|2
93667|NCT00278473|322795|P2|Overall Study|drop out|3
93668|NCT00278473|322796|P1|Overall Study|drop out|4
93669|NCT00270205|322816|P4|Overall Study|Lost to Follow-up|1
93670|NCT00270205|322817|P3|Overall Study|Lost to Follow-up|0
93671|NCT00270205|322818|P2|Overall Study|Lost to Follow-up|0
93672|NCT00270205|322819|P1|Overall Study|Lost to Follow-up|1
93673|NCT00270231|322929|P2|Second Intervention|Lost to Follow-up|1
93674|NCT00270231|322930|P1|Second Intervention|Lost to Follow-up|0
93675|NCT00270231|322929|P2|Washout Period|Lost to Follow-up|0
93676|NCT00270231|322930|P1|Washout Period|Lost to Follow-up|1
93677|NCT00270231|322929|P2|First Intervention|Lost to Follow-up|1
93678|NCT00270231|322930|P1|First Intervention|Lost to Follow-up|1
93679|NCT00270257|322938|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
93680|NCT00270257|322939|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
93681|NCT00270894|323035|P1|Overall Study|Withdrawal by Subject|1
93682|NCT00270894|323035|P1|Overall Study|Adverse Event|1
93683|NCT00270998|323048|P3|12 Month Follow-up|Received/desired alternate treatment|1
93684|NCT00270998|323049|P2|12 Month Follow-up|Received/desired alternate treatment|4
93685|NCT00270998|323050|P1|12 Month Follow-up|Received/desired alternate treatment|1
93686|NCT00270998|323048|P3|12 Month Follow-up|Personal/family health|1
93687|NCT00270998|323049|P2|12 Month Follow-up|Personal/family health|5
93688|NCT00270998|323050|P1|12 Month Follow-up|Personal/family health|0
93689|NCT00270998|323048|P3|12 Month Follow-up|Pessary did not fit|0
93690|NCT00270998|323049|P2|12 Month Follow-up|Pessary did not fit|0
93691|NCT00270998|323050|P1|12 Month Follow-up|Pessary did not fit|1
93692|NCT00270998|323048|P3|12 Month Follow-up|Withdrawal by Subject|16
93693|NCT00270998|323049|P2|12 Month Follow-up|Withdrawal by Subject|12
93694|NCT00270998|323050|P1|12 Month Follow-up|Withdrawal by Subject|7
93695|NCT00270998|323048|P3|12 Month Follow-up|Lack of Efficacy|3
93696|NCT00270998|323049|P2|12 Month Follow-up|Lack of Efficacy|4
93697|NCT00270998|323050|P1|12 Month Follow-up|Lack of Efficacy|5
93698|NCT00270998|323048|P3|3 Month Follow-up|Received/desired alternate treatment|2
93699|NCT00270998|323049|P2|3 Month Follow-up|Received/desired alternate treatment|5
93700|NCT00270998|323050|P1|3 Month Follow-up|Received/desired alternate treatment|13
93701|NCT00270998|323048|P3|3 Month Follow-up|Personal/family health|0
93702|NCT00270998|323049|P2|3 Month Follow-up|Personal/family health|1
93703|NCT00270998|323050|P1|3 Month Follow-up|Personal/family health|1
93704|NCT00270998|323048|P3|3 Month Follow-up|Pessary did not fit|0
93705|NCT00270998|323049|P2|3 Month Follow-up|Pessary did not fit|0
93706|NCT00270998|323050|P1|3 Month Follow-up|Pessary did not fit|12
93707|NCT00270998|323048|P3|3 Month Follow-up|Withdrawal by Subject|15
93708|NCT00270998|323049|P2|3 Month Follow-up|Withdrawal by Subject|14
93709|NCT00270998|323050|P1|3 Month Follow-up|Withdrawal by Subject|11
93710|NCT00270998|323048|P3|3 Month Follow-up|Lack of Efficacy|1
93711|NCT00270998|323049|P2|3 Month Follow-up|Lack of Efficacy|2
93712|NCT00270998|323050|P1|3 Month Follow-up|Lack of Efficacy|1
93713|NCT00270998|323048|P3|3 Month Follow-up|Adverse Event|0
93714|NCT00270998|323049|P2|3 Month Follow-up|Adverse Event|0
93715|NCT00270998|323050|P1|3 Month Follow-up|Adverse Event|1
93716|NCT00271024|323088|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
93717|NCT00271024|323089|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
93718|NCT00271024|323090|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
93719|NCT00271024|323091|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
93720|NCT00271024|323088|P4|Overall Study|Unpleasant Reaction To Tablet|2
93721|NCT00271024|323089|P3|Overall Study|Unpleasant Reaction To Tablet|4
93722|NCT00271024|323090|P2|Overall Study|Unpleasant Reaction To Tablet|3
93723|NCT00271024|323091|P1|Overall Study|Unpleasant Reaction To Tablet|1
93724|NCT00271024|323088|P4|Overall Study|Protocol Violation|11
93725|NCT00271024|323089|P3|Overall Study|Protocol Violation|5
93726|NCT00271024|323090|P2|Overall Study|Protocol Violation|6
93727|NCT00271024|323091|P1|Overall Study|Protocol Violation|1
93728|NCT00271024|323088|P4|Overall Study|Unknown/Unspecified|4
93729|NCT00271024|323089|P3|Overall Study|Unknown/Unspecified|8
93730|NCT00271024|323090|P2|Overall Study|Unknown/Unspecified|11
93731|NCT00271024|323091|P1|Overall Study|Unknown/Unspecified|11
93732|NCT00271024|323088|P4|Overall Study|Lost Interest|3
93733|NCT00271024|323089|P3|Overall Study|Lost Interest|2
93734|NCT00271024|323090|P2|Overall Study|Lost Interest|4
93735|NCT00271024|323091|P1|Overall Study|Lost Interest|3
93736|NCT00271544|323213|P1|Overall Study|Implant not attempted|4
93737|NCT00271544|323213|P1|Overall Study|Model 4196 lead not attempted|9
93738|NCT00271544|323213|P1|Overall Study|Subjects did not receive a 4196 lead|7
93739|NCT00271596|323247|P2|Overall Study|Withdrawal by Subject|1
93740|NCT00271596|323248|P1|Overall Study|Withdrawal by Subject|0
93741|NCT00271596|323247|P2|Overall Study|Protocol Violation|0
93742|NCT00271596|323248|P1|Overall Study|Protocol Violation|1
93743|NCT00271609|323274|P2|Overall Study|Withdrawal by Subject|0
93744|NCT00271609|323275|P1|Overall Study|Withdrawal by Subject|2
93745|NCT00271609|323274|P2|Overall Study|Adverse Event|3
93746|NCT00271609|323275|P1|Overall Study|Adverse Event|11
93747|NCT00271817|323299|P3|Part 2|LDL < 50 mg/dL|4
93748|NCT00271817|323300|P2|Part 2|LDL < 50 mg/dL|3
93749|NCT00271817|323301|P1|Part 2|LDL < 50 mg/dL|0
93750|NCT00271817|323299|P3|Part 2|Withdrawal by Subject|13
93751|NCT00271817|323300|P2|Part 2|Withdrawal by Subject|2
93752|NCT00271817|323301|P1|Part 2|Withdrawal by Subject|0
93753|NCT00271817|323299|P3|Part 2|Patient Moved|5
93754|NCT00271817|323300|P2|Part 2|Patient Moved|0
93755|NCT00271817|323301|P1|Part 2|Patient Moved|0
93756|NCT00271817|323299|P3|Part 2|Protocol Violation|5
93757|NCT00271817|323300|P2|Part 2|Protocol Violation|3
93758|NCT00271817|323301|P1|Part 2|Protocol Violation|0
93759|NCT00271817|323299|P3|Part 2|Lost to Follow-up|18
93760|NCT00271817|323300|P2|Part 2|Lost to Follow-up|6
93761|NCT00271817|323301|P1|Part 2|Lost to Follow-up|0
93762|NCT00271817|323299|P3|Part 2|Lack of Efficacy|6
93763|NCT00271817|323300|P2|Part 2|Lack of Efficacy|1
93764|NCT00271817|323301|P1|Part 2|Lack of Efficacy|0
93765|NCT00271817|323299|P3|Part 2|Adverse Event|33
93766|NCT00271817|323300|P2|Part 2|Adverse Event|17
93767|NCT00271817|323301|P1|Part 2|Adverse Event|0
93768|NCT00271817|323299|P3|Part 1|LDL < 50 mg/dL|48
93769|NCT00271817|323300|P2|Part 1|LDL < 50 mg/dL|4
93770|NCT00271817|323301|P1|Part 1|LDL < 50 mg/dL|1
93771|NCT00271817|323299|P3|Part 1|Withdrawal by Subject|45
93772|NCT00271817|323300|P2|Part 1|Withdrawal by Subject|17
93773|NCT00271817|323301|P1|Part 1|Withdrawal by Subject|23
93774|NCT00271817|323299|P3|Part 1|Patient Moved|5
93775|NCT00271817|323300|P2|Part 1|Patient Moved|1
93776|NCT00271817|323301|P1|Part 1|Patient Moved|3
93777|NCT00271817|323299|P3|Part 1|Protocol Violation|7
93778|NCT00271817|323300|P2|Part 1|Protocol Violation|4
93779|NCT00271817|323301|P1|Part 1|Protocol Violation|5
93780|NCT00271817|323299|P3|Part 1|Lost to Follow-up|24
93781|NCT00271817|323300|P2|Part 1|Lost to Follow-up|8
93782|NCT00271817|323301|P1|Part 1|Lost to Follow-up|6
93783|NCT00271817|323299|P3|Part 1|Adverse Event|156
93784|NCT00271817|323300|P2|Part 1|Adverse Event|25
93785|NCT00271817|323301|P1|Part 1|Adverse Event|68
93786|NCT00271856|323330|P2|Overall Study|Lost to Follow-up|11
93787|NCT00271856|323331|P1|Overall Study|Lost to Follow-up|10
93788|NCT00271856|323330|P2|Overall Study|Withdrawal by Subject|7
93789|NCT00271856|323331|P1|Overall Study|Withdrawal by Subject|1
93790|NCT00271947|323347|P1|Overall Study|Lost to Follow-up|1
93791|NCT00272038|323351|P1|Overall Study|withdrew before they received 2 cycles|7
93792|NCT00282867|323465|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
93793|NCT00282867|323466|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
93794|NCT00282867|323467|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
93795|NCT00282919|323481|P1|Overall Study|Asymptomatic Parasitemia|2
93796|NCT00282919|323481|P1|Overall Study|Withdrawal by Subject|1
93797|NCT00282919|323481|P1|Overall Study|Lack of Efficacy|4
93798|NCT00282984|323508|P2|Overall Study|Protocol Violation|0
93799|NCT00282984|323509|P1|Overall Study|Protocol Violation|2
93800|NCT00282984|323508|P2|Overall Study|in prison|1
93801|NCT00282984|323509|P1|Overall Study|in prison|0
93802|NCT00282984|323508|P2|Overall Study|lack of motivation|0
93803|NCT00282984|323509|P1|Overall Study|lack of motivation|1
93804|NCT00282984|323508|P2|Overall Study|Participant used antipsychosis meds|1
93805|NCT00282984|323509|P1|Overall Study|Participant used antipsychosis meds|0
93806|NCT00282984|323508|P2|Overall Study|Participant only allowed phone follow-up|1
93807|NCT00282984|323509|P1|Overall Study|Participant only allowed phone follow-up|0
93808|NCT00282984|323508|P2|Overall Study|Participant stopped study medication|2
93809|NCT00282984|323509|P1|Overall Study|Participant stopped study medication|2
93810|NCT00282984|323508|P2|Overall Study|Withdrawal by Participant|34
93811|NCT00282984|323509|P1|Overall Study|Withdrawal by Participant|22
93812|NCT00282984|323508|P2|Overall Study|Lost to Follow-up|10
93813|NCT00282984|323509|P1|Overall Study|Lost to Follow-up|14
93814|NCT00282984|323508|P2|Overall Study|Lack of Efficacy|2
93815|NCT00282984|323509|P1|Overall Study|Lack of Efficacy|0
93816|NCT00282984|323508|P2|Overall Study|Adverse Event|5
93817|NCT00282984|323509|P1|Overall Study|Adverse Event|8
93818|NCT00282984|323508|P2|Overall Study|Death|5
93819|NCT00282984|323509|P1|Overall Study|Death|2
93820|NCT00283049|323536|P3|Overall Study|No longer requires study treatment|1
93821|NCT00283049|323537|P2|Overall Study|No longer requires study treatment|0
93822|NCT00283049|323538|P1|Overall Study|No longer requires study treatment|0
93823|NCT00283049|323536|P3|Overall Study|Discontinuation of Study|20
93824|NCT00283049|323537|P2|Overall Study|Discontinuation of Study|16
93825|NCT00283049|323538|P1|Overall Study|Discontinuation of Study|18
93826|NCT00283049|323536|P3|Overall Study|Withdrawal by Subject|19
93827|NCT00283049|323537|P2|Overall Study|Withdrawal by Subject|24
93828|NCT00283049|323538|P1|Overall Study|Withdrawal by Subject|26
93829|NCT00283049|323536|P3|Overall Study|Lost to Follow-up|5
93830|NCT00283049|323537|P2|Overall Study|Lost to Follow-up|2
93831|NCT00283049|323538|P1|Overall Study|Lost to Follow-up|4
93832|NCT00283049|323536|P3|Overall Study|Lack of Efficacy|1
93833|NCT00283049|323537|P2|Overall Study|Lack of Efficacy|1
93834|NCT00283049|323538|P1|Overall Study|Lack of Efficacy|0
93835|NCT00283049|323536|P3|Overall Study|Death|1
93836|NCT00283049|323537|P2|Overall Study|Death|1
93837|NCT00283049|323538|P1|Overall Study|Death|1
93838|NCT00283049|323536|P3|Overall Study|Protocol Violation|3
93839|NCT00283049|323537|P2|Overall Study|Protocol Violation|0
93840|NCT00283049|323538|P1|Overall Study|Protocol Violation|3
93841|NCT00283049|323536|P3|Overall Study|Adverse Event|4
93842|NCT00283049|323537|P2|Overall Study|Adverse Event|1
93843|NCT00283049|323538|P1|Overall Study|Adverse Event|6
93844|NCT00283062|323568|P4|Overall Study|chemotherapy not completed (cycle 6)|0
93845|NCT00283062|323569|P3|Overall Study|chemotherapy not completed (cycle 6)|0
93846|NCT00283062|323570|P2|Overall Study|chemotherapy not completed (cycle 6)|0
93847|NCT00283062|323571|P1|Overall Study|chemotherapy not completed (cycle 6)|1
93848|NCT00283062|323568|P4|Overall Study|Undefined|4
93849|NCT00283062|323569|P3|Overall Study|Undefined|1
93850|NCT00283062|323570|P2|Overall Study|Undefined|1
93851|NCT00283062|323571|P1|Overall Study|Undefined|0
93852|NCT00283062|323568|P4|Overall Study|Participant did not wish to continue|0
93853|NCT00283062|323569|P3|Overall Study|Participant did not wish to continue|1
93854|NCT00283062|323570|P2|Overall Study|Participant did not wish to continue|2
93855|NCT00283062|323571|P1|Overall Study|Participant did not wish to continue|3
93856|NCT00283062|323568|P4|Overall Study|Progressive disease|0
93857|NCT00283062|323569|P3|Overall Study|Progressive disease|1
93858|NCT00283062|323570|P2|Overall Study|Progressive disease|0
93859|NCT00283062|323571|P1|Overall Study|Progressive disease|0
93860|NCT00283062|323568|P4|Overall Study|Lost to Follow-up|0
93861|NCT00283062|323569|P3|Overall Study|Lost to Follow-up|1
93862|NCT00283062|323570|P2|Overall Study|Lost to Follow-up|0
93863|NCT00283062|323571|P1|Overall Study|Lost to Follow-up|1
93864|NCT00283062|323568|P4|Overall Study|Adverse Event|0
93865|NCT00283062|323569|P3|Overall Study|Adverse Event|1
93866|NCT00283062|323570|P2|Overall Study|Adverse Event|0
93867|NCT00283062|323571|P1|Overall Study|Adverse Event|2
93868|NCT00283062|323568|P4|Overall Study|Did not receive any study medication|45
93869|NCT00283062|323569|P3|Overall Study|Did not receive any study medication|36
93870|NCT00283062|323570|P2|Overall Study|Did not receive any study medication|4
93871|NCT00283062|323571|P1|Overall Study|Did not receive any study medication|5
93872|NCT00283244|323616|P3|Overall Study|Clinical deterioration|3
93873|NCT00283244|323617|P2|Overall Study|Clinical deterioration|3
93874|NCT00283244|323618|P1|Overall Study|Clinical deterioration|1
93875|NCT00283244|323616|P3|Overall Study|Medical illness (other complicating dz)|6
93876|NCT00283244|323617|P2|Overall Study|Medical illness (other complicating dz)|3
93877|NCT00283244|323618|P1|Overall Study|Medical illness (other complicating dz)|4
93878|NCT00283244|323616|P3|Overall Study|Physician Decision|1
93879|NCT00283244|323617|P2|Overall Study|Physician Decision|0
93880|NCT00283244|323618|P1|Overall Study|Physician Decision|0
93881|NCT00283244|323616|P3|Overall Study|Withdrawal by Subject|2
93882|NCT00283244|323617|P2|Overall Study|Withdrawal by Subject|2
93883|NCT00283244|323618|P1|Overall Study|Withdrawal by Subject|1
93884|NCT00283244|323616|P3|Overall Study|Lack of Efficacy|26
93885|NCT00283244|323617|P2|Overall Study|Lack of Efficacy|32
93886|NCT00283244|323618|P1|Overall Study|Lack of Efficacy|8
93887|NCT00283244|323616|P3|Overall Study|Death|2
93888|NCT00283244|323617|P2|Overall Study|Death|3
93889|NCT00283244|323618|P1|Overall Study|Death|4
93890|NCT00283244|323616|P3|Overall Study|Adverse Event|11
93891|NCT00283244|323617|P2|Overall Study|Adverse Event|8
93892|NCT00283244|323618|P1|Overall Study|Adverse Event|0
93893|NCT00283296|323638|P1|Overall Study|in-home trial not completed|5
93894|NCT00283387|323644|P2|First Intervention|Withdrawal by Subject|1
93895|NCT00283387|323645|P1|First Intervention|Withdrawal by Subject|0
93896|NCT00283387|323644|P2|First Intervention|Subject non-compliant|1
93897|NCT00283387|323645|P1|First Intervention|Subject non-compliant|1
93898|NCT00283400|323655|P4|Overall Study|Death|0
93899|NCT00283400|323656|P3|Overall Study|Death|1
93900|NCT00283400|323657|P2|Overall Study|Death|0
93901|NCT00283400|323658|P1|Overall Study|Death|1
93902|NCT00283400|323655|P4|Overall Study|Withdrawal by Subject|0
93903|NCT00283400|323656|P3|Overall Study|Withdrawal by Subject|0
93904|NCT00283400|323657|P2|Overall Study|Withdrawal by Subject|1
93905|NCT00283400|323658|P1|Overall Study|Withdrawal by Subject|1
93906|NCT00283439|323680|P4|Overall Study|Not specified|0
93907|NCT00283439|323681|P3|Overall Study|Not specified|0
93908|NCT00283439|323682|P2|Overall Study|Not specified|0
93909|NCT00283439|323683|P1|Overall Study|Not specified|1
93910|NCT00283439|323680|P4|Overall Study|Treatment discontinued|3
93911|NCT00283439|323681|P3|Overall Study|Treatment discontinued|1
93912|NCT00283439|323682|P2|Overall Study|Treatment discontinued|2
93913|NCT00283439|323683|P1|Overall Study|Treatment discontinued|0
93914|NCT00283439|323680|P4|Overall Study|Stem cell transplant|3
93915|NCT00283439|323681|P3|Overall Study|Stem cell transplant|4
93916|NCT00283439|323682|P2|Overall Study|Stem cell transplant|6
93917|NCT00283439|323683|P1|Overall Study|Stem cell transplant|6
93918|NCT00283439|323680|P4|Overall Study|Requirement for alternative therapy|2
93919|NCT00283439|323681|P3|Overall Study|Requirement for alternative therapy|5
93920|NCT00283439|323682|P2|Overall Study|Requirement for alternative therapy|2
93921|NCT00283439|323683|P1|Overall Study|Requirement for alternative therapy|1
93922|NCT00283439|323680|P4|Overall Study|Disease progression|0
93923|NCT00283439|323681|P3|Overall Study|Disease progression|0
93924|NCT00283439|323682|P2|Overall Study|Disease progression|1
93925|NCT00283439|323683|P1|Overall Study|Disease progression|0
93926|NCT00283439|323680|P4|Overall Study|Death|0
93927|NCT00283439|323681|P3|Overall Study|Death|1
93928|NCT00283439|323682|P2|Overall Study|Death|0
93929|NCT00283439|323683|P1|Overall Study|Death|0
93930|NCT00283439|323680|P4|Overall Study|Adverse Event|1
93931|NCT00283439|323681|P3|Overall Study|Adverse Event|0
93932|NCT00283439|323682|P2|Overall Study|Adverse Event|0
93933|NCT00283439|323683|P1|Overall Study|Adverse Event|0
93934|NCT00283595|323707|P2|Overall Study|Withdrawal by Subject|2
93935|NCT00283595|323708|P1|Overall Study|Withdrawal by Subject|1
93936|NCT00283686|323720|P4|Overall Study|Less than full participation|12
93937|NCT00283686|323721|P3|Overall Study|Less than full participation|6
93938|NCT00283686|323722|P2|Overall Study|Less than full participation|9
93939|NCT00283686|323723|P1|Overall Study|Less than full participation|7
93940|NCT00283686|323720|P4|Overall Study|Lost to Follow-up|20
93941|NCT00283686|323721|P3|Overall Study|Lost to Follow-up|26
93942|NCT00283686|323722|P2|Overall Study|Lost to Follow-up|31
93943|NCT00283686|323723|P1|Overall Study|Lost to Follow-up|21
93944|NCT00283686|323720|P4|Overall Study|Death|0
93945|NCT00283686|323721|P3|Overall Study|Death|1
93946|NCT00283686|323722|P2|Overall Study|Death|1
93947|NCT00283686|323723|P1|Overall Study|Death|1
93948|NCT00283712|323767|P2|Overall Study|Death|1
93949|NCT00283712|323768|P1|Overall Study|Death|0
93950|NCT00283842|323822|P5|Overall Study|Lost to Follow-up|1
93951|NCT00283842|323823|P4|Overall Study|Lost to Follow-up|1
93952|NCT00283842|323824|P3|Overall Study|Lost to Follow-up|4
93953|NCT00283842|323825|P2|Overall Study|Lost to Follow-up|2
93954|NCT00283842|323826|P1|Overall Study|Lost to Follow-up|0
93955|NCT00283842|323822|P5|Overall Study|Lack of Efficacy|3
93956|NCT00283842|323823|P4|Overall Study|Lack of Efficacy|0
93957|NCT00283842|323824|P3|Overall Study|Lack of Efficacy|1
93958|NCT00283842|323825|P2|Overall Study|Lack of Efficacy|3
93959|NCT00283842|323826|P1|Overall Study|Lack of Efficacy|1
93960|NCT00283842|323822|P5|Overall Study|Withdrawal by Subject|4
93961|NCT00283842|323823|P4|Overall Study|Withdrawal by Subject|5
93962|NCT00283842|323824|P3|Overall Study|Withdrawal by Subject|1
93963|NCT00283842|323825|P2|Overall Study|Withdrawal by Subject|1
93964|NCT00283842|323826|P1|Overall Study|Withdrawal by Subject|2
93965|NCT00283842|323822|P5|Overall Study|Protocol deviation|2
93966|NCT00283842|323823|P4|Overall Study|Protocol deviation|0
93967|NCT00283842|323824|P3|Overall Study|Protocol deviation|0
93968|NCT00283842|323825|P2|Overall Study|Protocol deviation|0
93969|NCT00283842|323826|P1|Overall Study|Protocol deviation|0
93970|NCT00283842|323822|P5|Overall Study|Protocol Violation|0
93971|NCT00283842|323823|P4|Overall Study|Protocol Violation|0
93972|NCT00283842|323824|P3|Overall Study|Protocol Violation|4
93973|NCT00283842|323825|P2|Overall Study|Protocol Violation|5
93974|NCT00283842|323826|P1|Overall Study|Protocol Violation|1
93975|NCT00283842|323822|P5|Overall Study|Adverse Event|5
93976|NCT00283842|323823|P4|Overall Study|Adverse Event|21
93977|NCT00283842|323824|P3|Overall Study|Adverse Event|21
93978|NCT00283842|323825|P2|Overall Study|Adverse Event|7
93979|NCT00283842|323826|P1|Overall Study|Adverse Event|8
93980|NCT00283868|323845|P2|Overall Study|Lost to Follow-up|8
93981|NCT00283868|323846|P1|Overall Study|Lost to Follow-up|7
93982|NCT00284050|323861|P3|Overall Study|Death|0
93983|NCT00284050|323862|P2|Overall Study|Death|0
93984|NCT00284050|323863|P1|Overall Study|Death|1
93985|NCT00284050|323861|P3|Overall Study|Lost to Follow-up|1
93986|NCT00284050|323862|P2|Overall Study|Lost to Follow-up|0
93987|NCT00284050|323863|P1|Overall Study|Lost to Follow-up|1
93988|NCT00284050|323861|P3|Overall Study|Withdrawal by Subject|2
93989|NCT00284050|323862|P2|Overall Study|Withdrawal by Subject|2
93990|NCT00284050|323863|P1|Overall Study|Withdrawal by Subject|2
93991|NCT00284050|323861|P3|Overall Study|Protocol Violation|2
93992|NCT00284050|323862|P2|Overall Study|Protocol Violation|1
93993|NCT00284050|323863|P1|Overall Study|Protocol Violation|0
93994|NCT00284050|323861|P3|Overall Study|Lack of Efficacy|3
93995|NCT00284050|323862|P2|Overall Study|Lack of Efficacy|1
93996|NCT00284050|323863|P1|Overall Study|Lack of Efficacy|0
93997|NCT00284050|323861|P3|Overall Study|Adverse Event|1
93998|NCT00284050|323862|P2|Overall Study|Adverse Event|1
93999|NCT00284050|323863|P1|Overall Study|Adverse Event|1
94000|NCT00284089|323881|P4|Extension Phase|Withdrawal by Subject|3
94001|NCT00284089|323882|P3|Extension Phase|Withdrawal by Subject|1
94002|NCT00284089|323883|P2|Extension Phase|Withdrawal by Subject|0
94003|NCT00284089|323884|P1|Extension Phase|Withdrawal by Subject|0
94004|NCT00284089|323881|P4|Extension Phase|Protocol Violation|0
94005|NCT00284089|323882|P3|Extension Phase|Protocol Violation|1
94006|NCT00284089|323883|P2|Extension Phase|Protocol Violation|0
94007|NCT00284089|323884|P1|Extension Phase|Protocol Violation|0
94008|NCT00284089|323881|P4|Extension Phase|condition no longer requires study drug|7
94009|NCT00284089|323882|P3|Extension Phase|condition no longer requires study drug|2
94010|NCT00284089|323883|P2|Extension Phase|condition no longer requires study drug|0
94011|NCT00284089|323884|P1|Extension Phase|condition no longer requires study drug|2
94012|NCT00284089|323881|P4|Extension Phase|Adverse Event|2
94013|NCT00284089|323882|P3|Extension Phase|Adverse Event|2
94014|NCT00284089|323883|P2|Extension Phase|Adverse Event|0
94015|NCT00284089|323884|P1|Extension Phase|Adverse Event|0
94016|NCT00284089|323881|P4|Multiple Dose Phase|Death|1
94017|NCT00284089|323882|P3|Multiple Dose Phase|Death|1
94018|NCT00284089|323883|P2|Multiple Dose Phase|Death|0
94019|NCT00284089|323884|P1|Multiple Dose Phase|Death|0
94020|NCT00284089|323881|P4|Multiple Dose Phase|Withdrawal by Subject|2
94021|NCT00284089|323882|P3|Multiple Dose Phase|Withdrawal by Subject|1
94022|NCT00284089|323883|P2|Multiple Dose Phase|Withdrawal by Subject|0
94023|NCT00284089|323884|P1|Multiple Dose Phase|Withdrawal by Subject|0
94024|NCT00284089|323881|P4|Multiple Dose Phase|Protocol Violation|0
94025|NCT00284089|323882|P3|Multiple Dose Phase|Protocol Violation|1
94026|NCT00284089|323883|P2|Multiple Dose Phase|Protocol Violation|0
94027|NCT00284089|323884|P1|Multiple Dose Phase|Protocol Violation|0
94028|NCT00284089|323881|P4|Multiple Dose Phase|Adverse Event|1
94029|NCT00284089|323882|P3|Multiple Dose Phase|Adverse Event|1
94030|NCT00284089|323883|P2|Multiple Dose Phase|Adverse Event|0
94031|NCT00284089|323884|P1|Multiple Dose Phase|Adverse Event|1
94032|NCT00284141|323910|P1|Overall Study|Ongoing treatment|2
94033|NCT00284141|323910|P1|Overall Study|Did not take study medication|2
94034|NCT00284141|323910|P1|Overall Study|Pneumonia|1
94035|NCT00284141|323910|P1|Overall Study|General decline|1
94036|NCT00284141|323910|P1|Overall Study|Clinical deterioration / death|2
94037|NCT00284141|323910|P1|Overall Study|Symptomatic / Clinical Progression|11
94038|NCT00284141|323910|P1|Overall Study|Participant's request|9
94039|NCT00284141|323910|P1|Overall Study|Adverse Event|19
94040|NCT00284141|323910|P1|Overall Study|Disease Progression / Lack of efficacy|51
94041|NCT00284856|324017|P3|Overall Study|Unspecified|4
94042|NCT00284856|324018|P2|Overall Study|Unspecified|5
94043|NCT00284856|324019|P1|Overall Study|Unspecified|4
94044|NCT00284856|324017|P3|Overall Study|Withdrawal by Subject|18
94045|NCT00284856|324018|P2|Overall Study|Withdrawal by Subject|16
94046|NCT00284856|324019|P1|Overall Study|Withdrawal by Subject|12
94047|NCT00284856|324017|P3|Overall Study|Protocol Violation|5
94048|NCT00284856|324018|P2|Overall Study|Protocol Violation|4
94049|NCT00284856|324019|P1|Overall Study|Protocol Violation|5
94050|NCT00284856|324017|P3|Overall Study|Lost to Follow-up|22
94051|NCT00284856|324018|P2|Overall Study|Lost to Follow-up|21
94052|NCT00284856|324019|P1|Overall Study|Lost to Follow-up|25
94053|NCT00284856|324017|P3|Overall Study|Lack of Efficacy|8
94054|NCT00284856|324018|P2|Overall Study|Lack of Efficacy|1
94055|NCT00284856|324019|P1|Overall Study|Lack of Efficacy|2
94056|NCT00284856|324017|P3|Overall Study|Adverse Event|3
94057|NCT00284856|324018|P2|Overall Study|Adverse Event|3
94058|NCT00284856|324019|P1|Overall Study|Adverse Event|3
94059|NCT00284934|324035|P2|Overall Study|Other reasons|1
94060|NCT00284934|324036|P1|Overall Study|Other reasons|3
94061|NCT00284934|324035|P2|Overall Study|Adverse Event|2
94062|NCT00284934|324036|P1|Overall Study|Adverse Event|1
94063|NCT00285012|324050|P2|Received Study Tx|Other|5
94064|NCT00285012|324051|P1|Received Study Tx|Other|5
94065|NCT00285012|324050|P2|Received Study Tx|Withdrawal by Subject|43
94066|NCT00285012|324051|P1|Received Study Tx|Withdrawal by Subject|31
94067|NCT00285012|324050|P2|Received Study Tx|Lost to Follow-up|31
94068|NCT00285012|324051|P1|Received Study Tx|Lost to Follow-up|29
94069|NCT00285012|324050|P2|Received Study Tx|Lack of Efficacy|3
94070|NCT00285012|324051|P1|Received Study Tx|Lack of Efficacy|0
94071|NCT00285012|324050|P2|Received Study Tx|Adverse Event|11
94072|NCT00285012|324051|P1|Received Study Tx|Adverse Event|5
94073|NCT00285012|324050|P2|Received Study Tx|Death|1
94074|NCT00285012|324051|P1|Received Study Tx|Death|2
94075|NCT00285012|324050|P2|Assigned to Study Treatment (Tx)|Other|3
94076|NCT00285012|324051|P1|Assigned to Study Treatment (Tx)|Other|2
94077|NCT00285207|324077|P2|Overall Study|non-compliance|1
94078|NCT00285207|324078|P1|Overall Study|non-compliance|0
94079|NCT00285207|324077|P2|Overall Study|Pregnancy|1
94080|NCT00285207|324078|P1|Overall Study|Pregnancy|1
94081|NCT00285207|324077|P2|Overall Study|Withdrawal by Subject|2
94082|NCT00285207|324078|P1|Overall Study|Withdrawal by Subject|5
94083|NCT00285207|324077|P2|Overall Study|Lost to Follow-up|2
94084|NCT00285207|324078|P1|Overall Study|Lost to Follow-up|3
94085|NCT00275262|324086|P2|Overall Study|Started Chemotherapy|0
94086|NCT00275262|324087|P1|Overall Study|Started Chemotherapy|1
94087|NCT00275262|324086|P2|Overall Study|Death|0
94088|NCT00275262|324087|P1|Overall Study|Death|1
94089|NCT00275262|324086|P2|Overall Study|Protocol Violation|2
94090|NCT00275262|324087|P1|Overall Study|Protocol Violation|0
94091|NCT00275262|324086|P2|Overall Study|Lost to Follow-up|2
94092|NCT00275262|324087|P1|Overall Study|Lost to Follow-up|0
94093|NCT00275262|324086|P2|Overall Study|Disease progression|5
94094|NCT00275262|324087|P1|Overall Study|Disease progression|2
94095|NCT00275262|324086|P2|Overall Study|Adverse Event|0
94096|NCT00275262|324087|P1|Overall Study|Adverse Event|2
94097|NCT00275301|324114|P1|Overall Study|Adverse Event|5
94098|NCT00275340|324120|P2|Overall Study|Lost to Follow-up|4
94099|NCT00275340|324121|P1|Overall Study|Lost to Follow-up|2
94100|NCT00275561|324138|P2|Overall Study|Family Issues|2
94101|NCT00275561|324139|P1|Overall Study|Family Issues|0
94102|NCT00275561|324138|P2|Overall Study|Scheduling|2
94103|NCT00275561|324139|P1|Overall Study|Scheduling|1
94104|NCT00275561|324138|P2|Overall Study|Travel|1
94105|NCT00275561|324139|P1|Overall Study|Travel|1
94106|NCT00275561|324138|P2|Overall Study|Withdrawal by Subject|1
94107|NCT00275561|324139|P1|Overall Study|Withdrawal by Subject|0
94108|NCT00275821|324152|P3|Overall Study|Protocol Violation|0
94109|NCT00275821|324153|P2|Overall Study|Protocol Violation|1
94110|NCT00275821|324154|P1|Overall Study|Protocol Violation|5
94111|NCT00275821|324152|P3|Overall Study|Lack of Efficacy|0
94112|NCT00275821|324153|P2|Overall Study|Lack of Efficacy|1
94113|NCT00275821|324154|P1|Overall Study|Lack of Efficacy|2
94114|NCT00275821|324152|P3|Overall Study|Death|1
94115|NCT00275821|324153|P2|Overall Study|Death|2
94116|NCT00275821|324154|P1|Overall Study|Death|0
94117|NCT00275821|324152|P3|Overall Study|Lost to Follow-up|1
94118|NCT00275821|324153|P2|Overall Study|Lost to Follow-up|1
94119|NCT00275821|324154|P1|Overall Study|Lost to Follow-up|0
94120|NCT00275821|324152|P3|Overall Study|Withdrawal by Subject|1
94121|NCT00275821|324153|P2|Overall Study|Withdrawal by Subject|2
94122|NCT00275821|324154|P1|Overall Study|Withdrawal by Subject|0
94123|NCT00275821|324152|P3|Overall Study|Administrative problems|4
94124|NCT00275821|324153|P2|Overall Study|Administrative problems|4
94125|NCT00275821|324154|P1|Overall Study|Administrative problems|3
94126|NCT00275821|324152|P3|Overall Study|Adverse Event|5
94127|NCT00275821|324153|P2|Overall Study|Adverse Event|12
94128|NCT00275821|324154|P1|Overall Study|Adverse Event|4
94129|NCT00285584|324225|P2|Month 6|Lost to Follow-up|1
94130|NCT00285584|324226|P1|Month 6|Lost to Follow-up|0
94131|NCT00285584|324225|P2|Month 3|Withdrawal by Subject|0
94132|NCT00285584|324226|P1|Month 3|Withdrawal by Subject|1
94133|NCT00285584|324225|P2|Month 3|Lost to Follow-up|3
94134|NCT00285584|324226|P1|Month 3|Lost to Follow-up|3
94135|NCT00285818|324249|P2|Overall Study|Lost to Follow-up|0
94136|NCT00285818|324250|P1|Overall Study|Lost to Follow-up|1
94137|NCT00285818|324249|P2|Overall Study|Withdrawal by Subject|2
94138|NCT00285818|324250|P1|Overall Study|Withdrawal by Subject|3
94139|NCT00285857|324256|P1|Overall Study|Adverse Event|1
94140|NCT00285857|324256|P1|Overall Study|Inadequate initial breast cytology|1
94141|NCT00285857|324256|P1|Overall Study|Withdrawal by Subject|2
94142|NCT00286091|324280|P2|Open-label Treatment Phase|Missing End of Study Information|1
94143|NCT00286091|324281|P1|Open-label Treatment Phase|Missing End of Study Information|0
94144|NCT00286091|324280|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
94145|NCT00286091|324281|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
94146|NCT00286091|324280|P2|Open-label Treatment Phase|Lost to Follow-up|1
94147|NCT00286091|324281|P1|Open-label Treatment Phase|Lost to Follow-up|0
94148|NCT00286091|324280|P2|Open-label Treatment Phase|Noncompliance|1
94149|NCT00286091|324281|P1|Open-label Treatment Phase|Noncompliance|3
94150|NCT00286091|324280|P2|Open-label Treatment Phase|Disease Progression|3
94151|NCT00286091|324281|P1|Open-label Treatment Phase|Disease Progression|9
94152|NCT00286091|324280|P2|Open-label Treatment Phase|Death|7
94153|NCT00286091|324281|P1|Open-label Treatment Phase|Death|10
94154|NCT00286091|324280|P2|Open-label Treatment Phase|Withdrawal by Subject|10
94155|NCT00286091|324281|P1|Open-label Treatment Phase|Withdrawal by Subject|14
94156|NCT00286091|324280|P2|Open-label Treatment Phase|Other|11
94157|NCT00286091|324281|P1|Open-label Treatment Phase|Other|11
94158|NCT00286091|324280|P2|Open-label Treatment Phase|Adverse Event|16
94159|NCT00286091|324281|P1|Open-label Treatment Phase|Adverse Event|5
94160|NCT00286091|324280|P2|Open-label Treatment Phase|Physician Decision|21
94161|NCT00286091|324281|P1|Open-label Treatment Phase|Physician Decision|24
94162|NCT00286091|324280|P2|Double-blind Treatment Phase|Ineligibility Determined|2
94163|NCT00286091|324281|P1|Double-blind Treatment Phase|Ineligibility Determined|1
94164|NCT00286091|324280|P2|Double-blind Treatment Phase|Protocol Deviation|3
94165|NCT00286091|324281|P1|Double-blind Treatment Phase|Protocol Deviation|1
94166|NCT00286091|324280|P2|Double-blind Treatment Phase|Lost to Follow-up|4
94167|NCT00286091|324281|P1|Double-blind Treatment Phase|Lost to Follow-up|11
94168|NCT00286091|324280|P2|Double-blind Treatment Phase|Noncompliance|8
94169|NCT00286091|324281|P1|Double-blind Treatment Phase|Noncompliance|8
94170|NCT00286091|324280|P2|Double-blind Treatment Phase|Administrative Decision|21
94171|NCT00286091|324281|P1|Double-blind Treatment Phase|Administrative Decision|20
94172|NCT00286091|324280|P2|Double-blind Treatment Phase|Other|33
94173|NCT00286091|324281|P1|Double-blind Treatment Phase|Other|25
94174|NCT00286091|324280|P2|Double-blind Treatment Phase|Disease Progression|35
94175|NCT00286091|324281|P1|Double-blind Treatment Phase|Disease Progression|22
94176|NCT00286091|324280|P2|Double-blind Treatment Phase|Adverse Event|40
94177|NCT00286091|324281|P1|Double-blind Treatment Phase|Adverse Event|28
94178|NCT00286091|324280|P2|Double-blind Treatment Phase|Death|65
94179|NCT00286091|324281|P1|Double-blind Treatment Phase|Death|58
94180|NCT00286091|324280|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
94181|NCT00286091|324281|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
94182|NCT00286091|324280|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
94183|NCT00286091|324281|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
94184|NCT00286156|324296|P3|Overall Study|AE: pneumonia|0
94185|NCT00286156|324297|P2|Overall Study|AE: pneumonia|0
94186|NCT00286156|324298|P1|Overall Study|AE: pneumonia|1
94187|NCT00286156|324296|P3|Overall Study|AE: nephrotic-range proteinuruia|0
94188|NCT00286156|324297|P2|Overall Study|AE: nephrotic-range proteinuruia|0
94189|NCT00286156|324298|P1|Overall Study|AE: nephrotic-range proteinuruia|1
94190|NCT00286156|324296|P3|Overall Study|AE: pulmonary embolus|0
94191|NCT00286156|324297|P2|Overall Study|AE: pulmonary embolus|1
94192|NCT00286156|324298|P1|Overall Study|AE: pulmonary embolus|0
94193|NCT00286156|324296|P3|Overall Study|Missed 12 month visit|1
94194|NCT00286156|324297|P2|Overall Study|Missed 12 month visit|0
94195|NCT00286156|324298|P1|Overall Study|Missed 12 month visit|0
94196|NCT00286429|324329|P3|Overall Study|Administrative Decision|0
94197|NCT00286429|324330|P2|Overall Study|Administrative Decision|1
94198|NCT00286429|324331|P1|Overall Study|Administrative Decision|0
94199|NCT00286429|324329|P3|Overall Study|Administrative Error|1
94200|NCT00286429|324330|P2|Overall Study|Administrative Error|1
94201|NCT00286429|324331|P1|Overall Study|Administrative Error|1
94202|NCT00286429|324329|P3|Overall Study|Withdrawal by Subject|6
94203|NCT00286429|324330|P2|Overall Study|Withdrawal by Subject|2
94204|NCT00286429|324331|P1|Overall Study|Withdrawal by Subject|3
94205|NCT00286429|324329|P3|Overall Study|Protocol Violation|4
94206|NCT00286429|324330|P2|Overall Study|Protocol Violation|5
94207|NCT00286429|324331|P1|Overall Study|Protocol Violation|3
94208|NCT00286429|324329|P3|Overall Study|Physician Decision|7
94209|NCT00286429|324330|P2|Overall Study|Physician Decision|7
94210|NCT00286429|324331|P1|Overall Study|Physician Decision|10
94211|NCT00286429|324329|P3|Overall Study|Lost to Follow-up|3
94212|NCT00286429|324330|P2|Overall Study|Lost to Follow-up|4
94213|NCT00286429|324331|P1|Overall Study|Lost to Follow-up|2
94214|NCT00286429|324329|P3|Overall Study|Lack of Efficacy|25
94215|NCT00286429|324330|P2|Overall Study|Lack of Efficacy|27
94216|NCT00286429|324331|P1|Overall Study|Lack of Efficacy|52
94217|NCT00286429|324329|P3|Overall Study|Adverse Event|6
94218|NCT00286429|324330|P2|Overall Study|Adverse Event|1
94219|NCT00286429|324331|P1|Overall Study|Adverse Event|4
94220|NCT00286442|324438|P3|Overall Study|Withdrawal by Subject|2
94221|NCT00286442|324439|P2|Overall Study|Withdrawal by Subject|14
94222|NCT00286442|324440|P1|Overall Study|Withdrawal by Subject|2
94223|NCT00286442|324438|P3|Overall Study|Administrative Error|0
94224|NCT00286442|324439|P2|Overall Study|Administrative Error|1
94225|NCT00286442|324440|P1|Overall Study|Administrative Error|1
94226|NCT00286442|324438|P3|Overall Study|Physician Decision|1
94227|NCT00286442|324439|P2|Overall Study|Physician Decision|1
94228|NCT00286442|324440|P1|Overall Study|Physician Decision|1
94229|NCT00286442|324438|P3|Overall Study|Lost to Follow-up|1
94230|NCT00286442|324439|P2|Overall Study|Lost to Follow-up|2
94231|NCT00286442|324440|P1|Overall Study|Lost to Follow-up|5
94232|NCT00286442|324438|P3|Overall Study|Protocol Violation|2
94233|NCT00286442|324439|P2|Overall Study|Protocol Violation|4
94234|NCT00286442|324440|P1|Overall Study|Protocol Violation|2
94235|NCT00286442|324438|P3|Overall Study|Adverse Event|1
94236|NCT00286442|324439|P2|Overall Study|Adverse Event|6
94237|NCT00286442|324440|P1|Overall Study|Adverse Event|7
94238|NCT00286442|324438|P3|Overall Study|Hyperglycemic Rescue|25
94239|NCT00286442|324439|P2|Overall Study|Hyperglycemic Rescue|17
94240|NCT00286442|324440|P1|Overall Study|Hyperglycemic Rescue|19
94241|NCT00286455|324601|P3|Overall Study|Withdrawal by Subject|7
94242|NCT00286455|324602|P2|Overall Study|Withdrawal by Subject|8
94243|NCT00286455|324603|P1|Overall Study|Withdrawal by Subject|0
94244|NCT00286455|324601|P3|Overall Study|Participant Non-compliance|0
94245|NCT00286455|324602|P2|Overall Study|Participant Non-compliance|0
94246|NCT00286455|324603|P1|Overall Study|Participant Non-compliance|1
94247|NCT00286455|324601|P3|Overall Study|Protocol Violation|0
94248|NCT00286455|324602|P2|Overall Study|Protocol Violation|1
94249|NCT00286455|324603|P1|Overall Study|Protocol Violation|1
94250|NCT00286455|324601|P3|Overall Study|Physician Decision|2
94251|NCT00286455|324602|P2|Overall Study|Physician Decision|0
94252|NCT00286455|324603|P1|Overall Study|Physician Decision|3
94253|NCT00286455|324601|P3|Overall Study|Lost to Follow-up|3
94254|NCT00286455|324602|P2|Overall Study|Lost to Follow-up|3
94255|NCT00286455|324603|P1|Overall Study|Lost to Follow-up|0
94256|NCT00286455|324601|P3|Overall Study|Adverse Event|2
94257|NCT00286455|324602|P2|Overall Study|Adverse Event|3
94258|NCT00286455|324603|P1|Overall Study|Adverse Event|1
94259|NCT00286455|324601|P3|Overall Study|Hyperglycemia rescue|10
94260|NCT00286455|324602|P2|Overall Study|Hyperglycemia rescue|13
94261|NCT00286455|324603|P1|Overall Study|Hyperglycemia rescue|19
94262|NCT00286468|324782|P3|Overall Study|Physician Decision|1
94263|NCT00286468|324783|P2|Overall Study|Physician Decision|2
94264|NCT00286468|324784|P1|Overall Study|Physician Decision|3
94265|NCT00286468|324782|P3|Overall Study|Withdrawal by Subject|11
94266|NCT00286468|324783|P2|Overall Study|Withdrawal by Subject|8
94267|NCT00286468|324784|P1|Overall Study|Withdrawal by Subject|3
94268|NCT00286468|324782|P3|Overall Study|Lost to Follow-up|2
94269|NCT00286468|324783|P2|Overall Study|Lost to Follow-up|1
94270|NCT00286468|324784|P1|Overall Study|Lost to Follow-up|1
94271|NCT00286468|324782|P3|Overall Study|Protocol Violation|1
94272|NCT00286468|324783|P2|Overall Study|Protocol Violation|3
94273|NCT00286468|324784|P1|Overall Study|Protocol Violation|0
94274|NCT00286468|324782|P3|Overall Study|Adverse Event|4
94275|NCT00286468|324783|P2|Overall Study|Adverse Event|6
94276|NCT00286468|324784|P1|Overall Study|Adverse Event|2
94277|NCT00286468|324782|P3|Overall Study|Hyperglycemic Rescue|31
94278|NCT00286468|324783|P2|Overall Study|Hyperglycemic Rescue|30
94279|NCT00286468|324784|P1|Overall Study|Hyperglycemic Rescue|28
94280|NCT00286494|324945|P3|Overall Study|Protocol Violation|2
94281|NCT00286494|324946|P2|Overall Study|Protocol Violation|1
94282|NCT00286494|324947|P1|Overall Study|Protocol Violation|1
94283|NCT00286494|324945|P3|Overall Study|Lost to Follow-up|3
94284|NCT00286494|324946|P2|Overall Study|Lost to Follow-up|1
94285|NCT00286494|324947|P1|Overall Study|Lost to Follow-up|3
94286|NCT00286494|324945|P3|Overall Study|Physician Decision|1
94287|NCT00286494|324946|P2|Overall Study|Physician Decision|5
94288|NCT00286494|324947|P1|Overall Study|Physician Decision|5
94289|NCT00286494|324945|P3|Overall Study|Adverse Event|6
94290|NCT00286494|324946|P2|Overall Study|Adverse Event|8
94291|NCT00286494|324947|P1|Overall Study|Adverse Event|3
94292|NCT00286494|324945|P3|Overall Study|Withdrawal by Subject|9
94293|NCT00286494|324946|P2|Overall Study|Withdrawal by Subject|10
94294|NCT00286494|324947|P1|Overall Study|Withdrawal by Subject|2
94295|NCT00286494|324945|P3|Overall Study|Hyperglycemic rescue|18
94296|NCT00286494|324946|P2|Overall Study|Hyperglycemic rescue|19
94297|NCT00286494|324947|P1|Overall Study|Hyperglycemic rescue|12
94298|NCT00286754|325128|P3|Overall Study|Moved out of state|1
94299|NCT00286754|325129|P2|Overall Study|Moved out of state|0
94300|NCT00286754|325130|P1|Overall Study|Moved out of state|0
94301|NCT00286754|325128|P3|Overall Study|Lost to Follow-up|6
94302|NCT00286754|325129|P2|Overall Study|Lost to Follow-up|14
94303|NCT00286754|325130|P1|Overall Study|Lost to Follow-up|12
94304|NCT00286754|325128|P3|Overall Study|Withdrawal by Subject|0
94305|NCT00286754|325129|P2|Overall Study|Withdrawal by Subject|2
94306|NCT00286754|325130|P1|Overall Study|Withdrawal by Subject|6
94307|NCT00286754|325128|P3|Overall Study|Adverse Event|3
94308|NCT00286754|325129|P2|Overall Study|Adverse Event|2
94309|NCT00286754|325130|P1|Overall Study|Adverse Event|2
94310|NCT00287079|325173|P2|Overall Study|Unspecified|0
94311|NCT00287079|325174|P1|Overall Study|Unspecified|3
94312|NCT00287079|325173|P2|Overall Study|Protocol Violation|0
94313|NCT00287079|325174|P1|Overall Study|Protocol Violation|1
94314|NCT00287079|325173|P2|Overall Study|Adverse Event|0
94315|NCT00287079|325174|P1|Overall Study|Adverse Event|5
94316|NCT00287079|325173|P2|Overall Study|Non-qualifying relapse|0
94317|NCT00287079|325174|P1|Overall Study|Non-qualifying relapse|1
94318|NCT00287079|325173|P2|Overall Study|Qualifying relapse|1
94319|NCT00287079|325174|P1|Overall Study|Qualifying relapse|12
94320|NCT00287365|325197|P1|Overall Study|sample not acquired|13
94321|NCT00287586|325206|P2|Overall Study|Recurrent Melanoma|1
94322|NCT00287586|325207|P1|Overall Study|Recurrent Melanoma|0
94323|NCT00287586|325206|P2|Overall Study|Itchy Swollen Eyes|1
94324|NCT00287586|325207|P1|Overall Study|Itchy Swollen Eyes|0
94325|NCT00287586|325206|P2|Overall Study|Bradycardia|1
94326|NCT00287586|325207|P1|Overall Study|Bradycardia|0
94327|NCT00287586|325206|P2|Overall Study|Mood Swings and Irritability|1
94328|NCT00287586|325207|P1|Overall Study|Mood Swings and Irritability|0
94329|NCT00287586|325206|P2|Overall Study|Mastodynia and Gynecomastia|1
94330|NCT00287586|325207|P1|Overall Study|Mastodynia and Gynecomastia|0
94331|NCT00287586|325206|P2|Overall Study|Retroperitoneal Cancer|1
94332|NCT00287586|325207|P1|Overall Study|Retroperitoneal Cancer|0
94333|NCT00287586|325206|P2|Overall Study|Elevated IPSS Score|1
94334|NCT00287586|325207|P1|Overall Study|Elevated IPSS Score|0
94335|NCT00287586|325206|P2|Overall Study|Lung Cancer|2
94336|NCT00287586|325207|P1|Overall Study|Lung Cancer|0
94337|NCT00287586|325206|P2|Overall Study|Major Depression|2
94338|NCT00287586|325207|P1|Overall Study|Major Depression|0
94339|NCT00287586|325206|P2|Overall Study|Enrolled in Another Study|0
94340|NCT00287586|325207|P1|Overall Study|Enrolled in Another Study|1
94341|NCT00287586|325206|P2|Overall Study|Nonadherence|1
94342|NCT00287586|325207|P1|Overall Study|Nonadherence|1
94343|NCT00287586|325206|P2|Overall Study|Inappropriate Behaviour with Staff|0
94344|NCT00287586|325207|P1|Overall Study|Inappropriate Behaviour with Staff|1
94345|NCT00287586|325206|P2|Overall Study|Shoulder Pain|0
94346|NCT00287586|325207|P1|Overall Study|Shoulder Pain|1
94347|NCT00287586|325206|P2|Overall Study|Sleep Apnea|0
94348|NCT00287586|325207|P1|Overall Study|Sleep Apnea|1
94349|NCT00287586|325206|P2|Overall Study|Pancreatic Cancer|3
94350|NCT00287586|325207|P1|Overall Study|Pancreatic Cancer|1
94351|NCT00287586|325206|P2|Overall Study|Cognitive Impairment|0
94352|NCT00287586|325207|P1|Overall Study|Cognitive Impairment|1
94353|NCT00287586|325206|P2|Overall Study|Lower Urinary Tract Symptoms|0
94354|NCT00287586|325207|P1|Overall Study|Lower Urinary Tract Symptoms|1
94355|NCT00287586|325206|P2|Overall Study|Myocardial Infarction|0
94356|NCT00287586|325207|P1|Overall Study|Myocardial Infarction|1
94357|NCT00287586|325206|P2|Overall Study|Stroke|0
94358|NCT00287586|325207|P1|Overall Study|Stroke|2
94359|NCT00287586|325206|P2|Overall Study|Elevated Prostate Specific Antigen|0
94360|NCT00287586|325207|P1|Overall Study|Elevated Prostate Specific Antigen|2
94361|NCT00287586|325206|P2|Overall Study|Rash|0
94362|NCT00287586|325207|P1|Overall Study|Rash|3
94363|NCT00287586|325206|P2|Overall Study|Elevated Hematocrit|0
94364|NCT00287586|325207|P1|Overall Study|Elevated Hematocrit|3
94365|NCT00287586|325206|P2|Overall Study|Death|3
94366|NCT00287586|325207|P1|Overall Study|Death|2
94367|NCT00287586|325206|P2|Overall Study|Lost to Follow-up|4
94368|NCT00287586|325207|P1|Overall Study|Lost to Follow-up|5
94369|NCT00287586|325206|P2|Overall Study|Withdrew Consent|30
94370|NCT00287586|325207|P1|Overall Study|Withdrew Consent|19
94371|NCT00288054|325305|P1|Overall Study|Not protocol specified|2
94372|NCT00288054|325305|P1|Overall Study|Withdrawal by Subject|1
94373|NCT00288054|325305|P1|Overall Study|Adverse Event|3
94374|NCT00288054|325305|P1|Overall Study|Lack of Efficacy|16
94375|NCT00288054|325305|P1|Overall Study|Protocol Violation|2
94376|NCT00288080|325321|P2|Overall Study|Protocol Violation|20
94377|NCT00288080|325322|P1|Overall Study|Protocol Violation|25
94378|NCT00288080|325321|P2|Overall Study|Withdrawal by Subject|3
94379|NCT00288080|325322|P1|Overall Study|Withdrawal by Subject|1
94380|NCT00278889|325358|P3|Overall Study|Death|17
94381|NCT00278889|325359|P2|Overall Study|Death|21
94382|NCT00278889|325360|P1|Overall Study|Death|24
94383|NCT00278889|325358|P3|Overall Study|Lost to Follow-up|0
94384|NCT00278889|325359|P2|Overall Study|Lost to Follow-up|1
94385|NCT00278889|325360|P1|Overall Study|Lost to Follow-up|1
94386|NCT00278889|325358|P3|Overall Study|Withdrawal by Subject|3
94387|NCT00278889|325359|P2|Overall Study|Withdrawal by Subject|5
94388|NCT00278889|325360|P1|Overall Study|Withdrawal by Subject|0
94389|NCT00278915|325386|P1|Overall Study|Lack of Efficacy|1
94390|NCT00278954|325419|P1|Overall Study|Withdrawal by Subject|1
94391|NCT00278954|325419|P1|Overall Study|Lost to Follow-up|1
94392|NCT00278954|325419|P1|Overall Study|Adverse Event|3
94393|NCT00278993|325427|P1|Overall Study|Not Otherwise Specified|4
94394|NCT00278993|325427|P1|Overall Study|Physician Decision|9
94395|NCT00278993|325427|P1|Overall Study|Progressive Disease|65
94396|NCT00278993|325427|P1|Overall Study|Withdrawal by Subject|5
94397|NCT00278993|325427|P1|Overall Study|Adverse Event|24
94398|NCT00279201|325437|P6|Intensification Addendum|Death|0
94399|NCT00279201|325438|P5|Intensification Addendum|Death|1
94400|NCT00279201|325439|P4|Intensification Addendum|Death|0
94401|NCT00279201|325440|P3|Intensification Addendum|Death|0
94402|NCT00279201|325441|P2|Intensification Addendum|Death|0
94403|NCT00279201|325442|P1|Intensification Addendum|Death|0
94404|NCT00279201|325437|P6|Intensification Addendum|Lack of Efficacy|0
94405|NCT00279201|325438|P5|Intensification Addendum|Lack of Efficacy|1
94406|NCT00279201|325439|P4|Intensification Addendum|Lack of Efficacy|1
94407|NCT00279201|325440|P3|Intensification Addendum|Lack of Efficacy|0
94408|NCT00279201|325441|P2|Intensification Addendum|Lack of Efficacy|0
94409|NCT00279201|325442|P1|Intensification Addendum|Lack of Efficacy|0
94410|NCT00279201|325437|P6|Intensification Addendum|Entry Criteria Exclusion|0
94411|NCT00279201|325438|P5|Intensification Addendum|Entry Criteria Exclusion|0
94412|NCT00279201|325439|P4|Intensification Addendum|Entry Criteria Exclusion|0
94413|NCT00279201|325440|P3|Intensification Addendum|Entry Criteria Exclusion|1
94414|NCT00279201|325441|P2|Intensification Addendum|Entry Criteria Exclusion|0
94415|NCT00279201|325442|P1|Intensification Addendum|Entry Criteria Exclusion|0
94416|NCT00279201|325437|P6|Intensification Addendum|Sponsor Decision|1
94417|NCT00279201|325438|P5|Intensification Addendum|Sponsor Decision|1
94418|NCT00279201|325439|P4|Intensification Addendum|Sponsor Decision|0
94419|NCT00279201|325440|P3|Intensification Addendum|Sponsor Decision|0
94420|NCT00279201|325441|P2|Intensification Addendum|Sponsor Decision|0
94421|NCT00279201|325442|P1|Intensification Addendum|Sponsor Decision|0
94422|NCT00279201|325437|P6|Intensification Addendum|Physician Decision|2
94423|NCT00279201|325438|P5|Intensification Addendum|Physician Decision|3
94424|NCT00279201|325439|P4|Intensification Addendum|Physician Decision|1
94425|NCT00279201|325440|P3|Intensification Addendum|Physician Decision|4
94426|NCT00279201|325441|P2|Intensification Addendum|Physician Decision|0
94427|NCT00279201|325442|P1|Intensification Addendum|Physician Decision|0
94428|NCT00279201|325437|P6|Intensification Addendum|Adverse Event|3
94429|NCT00279201|325438|P5|Intensification Addendum|Adverse Event|1
94430|NCT00279201|325439|P4|Intensification Addendum|Adverse Event|4
94431|NCT00279201|325440|P3|Intensification Addendum|Adverse Event|0
94432|NCT00279201|325441|P2|Intensification Addendum|Adverse Event|0
94433|NCT00279201|325442|P1|Intensification Addendum|Adverse Event|0
94434|NCT00279201|325437|P6|Intensification Addendum|Protocol Violation|6
94435|NCT00279201|325438|P5|Intensification Addendum|Protocol Violation|6
94436|NCT00279201|325439|P4|Intensification Addendum|Protocol Violation|2
94437|NCT00279201|325440|P3|Intensification Addendum|Protocol Violation|2
94438|NCT00279201|325441|P2|Intensification Addendum|Protocol Violation|0
94439|NCT00279201|325442|P1|Intensification Addendum|Protocol Violation|0
94440|NCT00279201|325437|P6|Intensification Addendum|Lost to Follow-up|7
94441|NCT00279201|325438|P5|Intensification Addendum|Lost to Follow-up|7
94442|NCT00279201|325439|P4|Intensification Addendum|Lost to Follow-up|6
94443|NCT00279201|325440|P3|Intensification Addendum|Lost to Follow-up|4
94444|NCT00279201|325441|P2|Intensification Addendum|Lost to Follow-up|0
94445|NCT00279201|325442|P1|Intensification Addendum|Lost to Follow-up|0
94446|NCT00279201|325437|P6|Intensification Addendum|Withdrawal by Subject|18
94447|NCT00279201|325438|P5|Intensification Addendum|Withdrawal by Subject|9
94448|NCT00279201|325439|P4|Intensification Addendum|Withdrawal by Subject|14
94449|NCT00279201|325440|P3|Intensification Addendum|Withdrawal by Subject|12
94450|NCT00279201|325441|P2|Intensification Addendum|Withdrawal by Subject|0
94451|NCT00279201|325442|P1|Intensification Addendum|Withdrawal by Subject|0
94452|NCT00279201|325437|P6|Maintenance|HbA1c>7.5%|0
94453|NCT00279201|325438|P5|Maintenance|HbA1c>7.5%|0
94454|NCT00279201|325439|P4|Maintenance|HbA1c>7.5%|0
94455|NCT00279201|325440|P3|Maintenance|HbA1c>7.5%|0
94456|NCT00279201|325441|P2|Maintenance|HbA1c>7.5%|126
94457|NCT00279201|325442|P1|Maintenance|HbA1c>7.5%|123
94458|NCT00279201|325437|P6|Maintenance|Sponsor Decision|0
94459|NCT00279201|325438|P5|Maintenance|Sponsor Decision|0
94460|NCT00279201|325439|P4|Maintenance|Sponsor Decision|0
94461|NCT00279201|325440|P3|Maintenance|Sponsor Decision|0
94462|NCT00279201|325441|P2|Maintenance|Sponsor Decision|0
94463|NCT00279201|325442|P1|Maintenance|Sponsor Decision|4
94464|NCT00279201|325437|P6|Maintenance|Physician Decision|0
94465|NCT00279201|325438|P5|Maintenance|Physician Decision|0
94466|NCT00279201|325439|P4|Maintenance|Physician Decision|0
94467|NCT00279201|325440|P3|Maintenance|Physician Decision|0
94468|NCT00279201|325441|P2|Maintenance|Physician Decision|9
94469|NCT00279201|325442|P1|Maintenance|Physician Decision|9
94470|NCT00279201|325437|P6|Maintenance|Withdrawal by Subject|0
94471|NCT00279201|325438|P5|Maintenance|Withdrawal by Subject|0
94472|NCT00279201|325439|P4|Maintenance|Withdrawal by Subject|0
94473|NCT00279201|325440|P3|Maintenance|Withdrawal by Subject|0
94474|NCT00279201|325441|P2|Maintenance|Withdrawal by Subject|18
94475|NCT00279201|325442|P1|Maintenance|Withdrawal by Subject|18
94476|NCT00279201|325437|P6|Maintenance|Protocol Violation|0
94477|NCT00279201|325438|P5|Maintenance|Protocol Violation|0
94478|NCT00279201|325439|P4|Maintenance|Protocol Violation|0
94479|NCT00279201|325440|P3|Maintenance|Protocol Violation|0
94480|NCT00279201|325441|P2|Maintenance|Protocol Violation|24
94481|NCT00279201|325442|P1|Maintenance|Protocol Violation|16
94482|NCT00279201|325437|P6|Maintenance|Entry Criteria Exclusion|0
94483|NCT00279201|325438|P5|Maintenance|Entry Criteria Exclusion|0
94484|NCT00279201|325439|P4|Maintenance|Entry Criteria Exclusion|0
94485|NCT00279201|325440|P3|Maintenance|Entry Criteria Exclusion|0
94486|NCT00279201|325441|P2|Maintenance|Entry Criteria Exclusion|4
94487|NCT00279201|325442|P1|Maintenance|Entry Criteria Exclusion|1
94488|NCT00279201|325437|P6|Maintenance|Lost to Follow-up|0
94489|NCT00279201|325438|P5|Maintenance|Lost to Follow-up|0
94490|NCT00279201|325439|P4|Maintenance|Lost to Follow-up|0
94491|NCT00279201|325440|P3|Maintenance|Lost to Follow-up|0
94492|NCT00279201|325441|P2|Maintenance|Lost to Follow-up|13
94493|NCT00279201|325442|P1|Maintenance|Lost to Follow-up|17
94494|NCT00279201|325437|P6|Maintenance|Death|0
94495|NCT00279201|325438|P5|Maintenance|Death|0
94496|NCT00279201|325439|P4|Maintenance|Death|0
94497|NCT00279201|325440|P3|Maintenance|Death|0
94498|NCT00279201|325441|P2|Maintenance|Death|4
94499|NCT00279201|325442|P1|Maintenance|Death|4
94500|NCT00279201|325437|P6|Maintenance|Adverse Event|0
94501|NCT00279201|325438|P5|Maintenance|Adverse Event|0
94502|NCT00279201|325439|P4|Maintenance|Adverse Event|0
94503|NCT00279201|325440|P3|Maintenance|Adverse Event|0
94504|NCT00279201|325441|P2|Maintenance|Adverse Event|4
94505|NCT00279201|325442|P1|Maintenance|Adverse Event|4
94506|NCT00279201|325437|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
94507|NCT00279201|325438|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
94508|NCT00279201|325439|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
94509|NCT00279201|325440|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
94510|NCT00279201|325441|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
94511|NCT00279201|325442|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
94512|NCT00279201|325437|P6|Maintenance|Lack of Efficacy|0
94513|NCT00279201|325438|P5|Maintenance|Lack of Efficacy|0
94514|NCT00279201|325439|P4|Maintenance|Lack of Efficacy|0
94515|NCT00279201|325440|P3|Maintenance|Lack of Efficacy|0
94516|NCT00279201|325441|P2|Maintenance|Lack of Efficacy|30
94517|NCT00279201|325442|P1|Maintenance|Lack of Efficacy|32
94518|NCT00279201|325437|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
94519|NCT00279201|325438|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
94520|NCT00279201|325439|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
94521|NCT00279201|325440|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
94522|NCT00279201|325441|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
94523|NCT00279201|325442|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
94524|NCT00279201|325437|P6|Initiation|Sponsor Decision|0
94525|NCT00279201|325438|P5|Initiation|Sponsor Decision|0
94526|NCT00279201|325439|P4|Initiation|Sponsor Decision|0
94527|NCT00279201|325440|P3|Initiation|Sponsor Decision|0
94528|NCT00279201|325441|P2|Initiation|Sponsor Decision|5
94529|NCT00279201|325442|P1|Initiation|Sponsor Decision|13
94530|NCT00279201|325437|P6|Initiation|Physician Decision|0
94531|NCT00279201|325438|P5|Initiation|Physician Decision|0
94532|NCT00279201|325439|P4|Initiation|Physician Decision|0
94533|NCT00279201|325440|P3|Initiation|Physician Decision|0
94534|NCT00279201|325441|P2|Initiation|Physician Decision|18
94535|NCT00279201|325442|P1|Initiation|Physician Decision|15
94536|NCT00279201|325437|P6|Initiation|Withdrawal by Subject|0
94537|NCT00279201|325438|P5|Initiation|Withdrawal by Subject|0
94538|NCT00279201|325439|P4|Initiation|Withdrawal by Subject|0
94539|NCT00279201|325440|P3|Initiation|Withdrawal by Subject|0
94540|NCT00279201|325441|P2|Initiation|Withdrawal by Subject|41
94541|NCT00279201|325442|P1|Initiation|Withdrawal by Subject|35
94542|NCT00279201|325437|P6|Initiation|Protocol Violation|0
94543|NCT00279201|325438|P5|Initiation|Protocol Violation|0
94544|NCT00279201|325439|P4|Initiation|Protocol Violation|0
94545|NCT00279201|325440|P3|Initiation|Protocol Violation|0
94546|NCT00279201|325441|P2|Initiation|Protocol Violation|10
94547|NCT00279201|325442|P1|Initiation|Protocol Violation|9
94548|NCT00279201|325437|P6|Initiation|Entry Criteria Exclusion|0
94549|NCT00279201|325438|P5|Initiation|Entry Criteria Exclusion|0
94550|NCT00279201|325439|P4|Initiation|Entry Criteria Exclusion|0
94551|NCT00279201|325440|P3|Initiation|Entry Criteria Exclusion|0
94552|NCT00279201|325441|P2|Initiation|Entry Criteria Exclusion|9
94553|NCT00279201|325442|P1|Initiation|Entry Criteria Exclusion|7
94554|NCT00279201|325437|P6|Initiation|Lost to Follow-up|0
94555|NCT00279201|325438|P5|Initiation|Lost to Follow-up|0
94556|NCT00279201|325439|P4|Initiation|Lost to Follow-up|0
94557|NCT00279201|325440|P3|Initiation|Lost to Follow-up|0
94558|NCT00279201|325441|P2|Initiation|Lost to Follow-up|41
94559|NCT00279201|325442|P1|Initiation|Lost to Follow-up|42
94560|NCT00279201|325437|P6|Initiation|Adverse Event|0
94561|NCT00279201|325438|P5|Initiation|Adverse Event|0
94562|NCT00279201|325439|P4|Initiation|Adverse Event|0
94563|NCT00279201|325440|P3|Initiation|Adverse Event|0
94564|NCT00279201|325441|P2|Initiation|Adverse Event|15
94565|NCT00279201|325442|P1|Initiation|Adverse Event|6
94566|NCT00279201|325437|P6|Initiation|Death|0
94567|NCT00279201|325438|P5|Initiation|Death|0
94568|NCT00279201|325439|P4|Initiation|Death|0
94569|NCT00279201|325440|P3|Initiation|Death|0
94570|NCT00279201|325441|P2|Initiation|Death|5
94571|NCT00279201|325442|P1|Initiation|Death|1
94572|NCT00279214|325588|P2|Overall Study|Physician Decision|2
94573|NCT00279214|325589|P1|Overall Study|Physician Decision|3
94574|NCT00279305|325619|P2|Overall Study|FDA Safety Alert|1
94575|NCT00279305|325620|P1|Overall Study|FDA Safety Alert|4
94576|NCT00279305|325619|P2|Overall Study|Dificulting establishing IV|0
94577|NCT00279305|325620|P1|Overall Study|Dificulting establishing IV|1
94578|NCT00279305|325619|P2|Overall Study|Withdrawal by Subject|0
94579|NCT00279305|325620|P1|Overall Study|Withdrawal by Subject|2
94580|NCT00279305|325619|P2|Overall Study|Pregnancy|0
94581|NCT00279305|325620|P1|Overall Study|Pregnancy|1
94582|NCT00279708|325645|P2|Overall Study|Adverse Event|1
94583|NCT00279708|325646|P1|Overall Study|Adverse Event|1
94584|NCT00279708|325645|P2|Overall Study|Withdrawal by Subject|3
94585|NCT00279708|325646|P1|Overall Study|Withdrawal by Subject|2
94586|NCT00279916|325654|P2|Overall Study|Lost to Follow-up|2
94587|NCT00279916|325655|P1|Overall Study|Lost to Follow-up|3
94588|NCT00279916|325654|P2|Overall Study|Withdrawal by Subject|3
94589|NCT00279916|325655|P1|Overall Study|Withdrawal by Subject|4
94590|NCT00280293|325684|P2|Overall Study|Adverse Event|1
94591|NCT00280293|325685|P1|Overall Study|Adverse Event|0
94592|NCT00280293|325684|P2|Overall Study|Incarceration/Legal Reasons|1
94593|NCT00280293|325685|P1|Overall Study|Incarceration/Legal Reasons|1
94594|NCT00280293|325684|P2|Overall Study|Withdrawal by Subject|5
94595|NCT00280293|325685|P1|Overall Study|Withdrawal by Subject|3
94596|NCT00280293|325684|P2|Overall Study|Lost to Follow-up|12
94597|NCT00280293|325685|P1|Overall Study|Lost to Follow-up|14
94598|NCT00280293|325684|P2|Overall Study|Physician Decision|4
94599|NCT00280293|325685|P1|Overall Study|Physician Decision|5
94600|NCT00280293|325684|P2|Overall Study|Protocol Violation|0
94601|NCT00280293|325685|P1|Overall Study|Protocol Violation|3
94602|NCT00280397|325754|P1|Overall Study|Adverse Event|1
94603|NCT00280566|325763|P3|Period 2 Double Blind|miscellaneous|5
94604|NCT00280566|325764|P2|Period 2 Double Blind|miscellaneous|10
94605|NCT00280566|325765|P1|Period 2 Double Blind|miscellaneous|0
94606|NCT00280566|325763|P3|Period 2 Double Blind|Withdrawal by Subject|9
94607|NCT00280566|325764|P2|Period 2 Double Blind|Withdrawal by Subject|9
94608|NCT00280566|325765|P1|Period 2 Double Blind|Withdrawal by Subject|0
94609|NCT00280566|325763|P3|Period 2 Double Blind|Lost to Follow-up|6
94610|NCT00280566|325764|P2|Period 2 Double Blind|Lost to Follow-up|3
94611|NCT00280566|325765|P1|Period 2 Double Blind|Lost to Follow-up|0
94612|NCT00280566|325763|P3|Period 2 Double Blind|Adverse Event|15
94613|NCT00280566|325764|P2|Period 2 Double Blind|Adverse Event|11
94614|NCT00280566|325765|P1|Period 2 Double Blind|Adverse Event|0
94615|NCT00280566|325763|P3|Period 2 Double Blind|Laboratory Abnormality|0
94616|NCT00280566|325764|P2|Period 2 Double Blind|Laboratory Abnormality|1
94617|NCT00280566|325765|P1|Period 2 Double Blind|Laboratory Abnormality|0
94618|NCT00280566|325763|P3|Period 2 Double Blind|Lack of Efficacy|22
94619|NCT00280566|325764|P2|Period 2 Double Blind|Lack of Efficacy|9
94620|NCT00280566|325765|P1|Period 2 Double Blind|Lack of Efficacy|0
94621|NCT00280566|325763|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
94622|NCT00280566|325764|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
94623|NCT00280566|325765|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
94624|NCT00280566|325763|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
94625|NCT00280566|325764|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
94626|NCT00280566|325765|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
94627|NCT00280566|325763|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
94628|NCT00280566|325764|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
94629|NCT00280566|325765|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
94630|NCT00280566|325763|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
94631|NCT00280566|325764|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
94632|NCT00280566|325765|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
94633|NCT00280566|325763|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
94634|NCT00280566|325764|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
94635|NCT00280566|325765|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
94636|NCT00280566|325763|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
94637|NCT00280566|325764|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
94638|NCT00280566|325765|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
94639|NCT00280683|325792|P2|Overall Study|Adverse Event|1
94640|NCT00280683|325793|P1|Overall Study|Adverse Event|1
94641|NCT00280683|325792|P2|Overall Study|Withdrawal by Subject|2
94642|NCT00280683|325793|P1|Overall Study|Withdrawal by Subject|1
94643|NCT00280735|325801|P1|Overall Study|Intercurrent Illness|2
94644|NCT00280735|325801|P1|Overall Study|Withdrawal by Subject|8
94645|NCT00280735|325801|P1|Overall Study|Lack of Efficacy|3
94646|NCT00280735|325801|P1|Overall Study|Adverse Event|5
94647|NCT00280748|325811|P1|Overall Study|Extra-cranial disease progression|1
94648|NCT00280748|325811|P1|Overall Study|Decline in performance|3
94649|NCT00280917|325838|P4|Overall Study|Noncompliance|0
94650|NCT00280917|325839|P3|Overall Study|Noncompliance|2
94651|NCT00280917|325840|P2|Overall Study|Noncompliance|1
94652|NCT00280917|325841|P1|Overall Study|Noncompliance|0
94653|NCT00280917|325838|P4|Overall Study|Withdrawal by Subject|1
94654|NCT00280917|325839|P3|Overall Study|Withdrawal by Subject|0
94655|NCT00280917|325840|P2|Overall Study|Withdrawal by Subject|2
94656|NCT00280917|325841|P1|Overall Study|Withdrawal by Subject|0
94657|NCT00280917|325838|P4|Overall Study|Change Therapy|0
94658|NCT00280917|325839|P3|Overall Study|Change Therapy|0
94659|NCT00280917|325840|P2|Overall Study|Change Therapy|2
94660|NCT00280917|325841|P1|Overall Study|Change Therapy|1
94661|NCT00280917|325838|P4|Overall Study|Adverse Event|1
94662|NCT00280917|325839|P3|Overall Study|Adverse Event|4
94663|NCT00280917|325840|P2|Overall Study|Adverse Event|1
94664|NCT00280917|325841|P1|Overall Study|Adverse Event|1
94665|NCT00281099|325857|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
94666|NCT00281099|325858|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
94667|NCT00281099|325857|P2|Overall Study|Physician Decision|72
94668|NCT00281099|325858|P1|Overall Study|Physician Decision|79
94669|NCT00281099|325857|P2|Overall Study|Withdrawal by Subject|70
94670|NCT00281099|325858|P1|Overall Study|Withdrawal by Subject|65
94671|NCT00281099|325857|P2|Overall Study|Lost to Follow-up|19
94672|NCT00281099|325858|P1|Overall Study|Lost to Follow-up|10
94673|NCT00281099|325857|P2|Overall Study|Death|57
94674|NCT00281099|325858|P1|Overall Study|Death|46
94675|NCT00281320|325901|P2|Overall Study|Not specified|1
94676|NCT00281320|325902|P1|Overall Study|Not specified|3
94677|NCT00281320|325901|P2|Overall Study|Lost to Follow-up|2
94678|NCT00281320|325902|P1|Overall Study|Lost to Follow-up|1
94679|NCT00281320|325901|P2|Overall Study|Withdrawal by Subject|6
94680|NCT00281320|325902|P1|Overall Study|Withdrawal by Subject|5
94681|NCT00281320|325901|P2|Overall Study|Lack of Efficacy|3
94682|NCT00281320|325902|P1|Overall Study|Lack of Efficacy|4
94683|NCT00281320|325901|P2|Overall Study|Adverse Event|9
94684|NCT00281320|325902|P1|Overall Study|Adverse Event|12
94685|NCT00281528|325930|P3|Overall Study|Unspecified|5
94686|NCT00281528|325931|P2|Overall Study|Unspecified|3
94687|NCT00281528|325932|P1|Overall Study|Unspecified|6
94688|NCT00281528|325930|P3|Overall Study|Withdrawal by Subject|7
94689|NCT00281528|325931|P2|Overall Study|Withdrawal by Subject|5
94690|NCT00281528|325932|P1|Overall Study|Withdrawal by Subject|5
94691|NCT00281528|325930|P3|Overall Study|Protocol Violation|1
94692|NCT00281528|325931|P2|Overall Study|Protocol Violation|0
94693|NCT00281528|325932|P1|Overall Study|Protocol Violation|1
94694|NCT00281528|325930|P3|Overall Study|Physician Decision|5
94695|NCT00281528|325931|P2|Overall Study|Physician Decision|4
94696|NCT00281528|325932|P1|Overall Study|Physician Decision|11
94697|NCT00281528|325930|P3|Overall Study|Adverse Event-unrelated to treatment|2
94698|NCT00281528|325931|P2|Overall Study|Adverse Event-unrelated to treatment|0
94699|NCT00281528|325932|P1|Overall Study|Adverse Event-unrelated to treatment|3
94700|NCT00281528|325930|P3|Overall Study|Unacceptable Toxicity-related to trt|32
94701|NCT00281528|325931|P2|Overall Study|Unacceptable Toxicity-related to trt|24
94702|NCT00281528|325932|P1|Overall Study|Unacceptable Toxicity-related to trt|21
94703|NCT00281528|325930|P3|Overall Study|Progressive Disease|27
94704|NCT00281528|325931|P2|Overall Study|Progressive Disease|18
94705|NCT00281528|325932|P1|Overall Study|Progressive Disease|28
94706|NCT00281580|325992|P16|Overall Study|Randomised in error; pregnancy; moving|2
94707|NCT00281580|325993|P15|Overall Study|Randomised in error; pregnancy; moving|1
94708|NCT00281580|325994|P14|Overall Study|Randomised in error; pregnancy; moving|0
94709|NCT00281580|325995|P13|Overall Study|Randomised in error; pregnancy; moving|2
94710|NCT00281580|325996|P12|Overall Study|Randomised in error; pregnancy; moving|1
94711|NCT00281580|325997|P11|Overall Study|Randomised in error; pregnancy; moving|1
94712|NCT00281580|325998|P10|Overall Study|Randomised in error; pregnancy; moving|1
94713|NCT00281580|325999|P9|Overall Study|Randomised in error; pregnancy; moving|2
94714|NCT00281580|326000|P8|Overall Study|Randomised in error; pregnancy; moving|0
94715|NCT00281580|326001|P7|Overall Study|Randomised in error; pregnancy; moving|1
94716|NCT00281580|326002|P6|Overall Study|Randomised in error; pregnancy; moving|0
94717|NCT00281580|326003|P5|Overall Study|Randomised in error; pregnancy; moving|0
94718|NCT00281580|326004|P4|Overall Study|Randomised in error; pregnancy; moving|2
94719|NCT00281580|326005|P3|Overall Study|Randomised in error; pregnancy; moving|0
94720|NCT00281580|326006|P2|Overall Study|Randomised in error; pregnancy; moving|0
94721|NCT00281580|326007|P1|Overall Study|Randomised in error; pregnancy; moving|0
94722|NCT00281580|325992|P16|Overall Study|Lost to Follow-up|0
94723|NCT00281580|325993|P15|Overall Study|Lost to Follow-up|0
94724|NCT00281580|325994|P14|Overall Study|Lost to Follow-up|0
94725|NCT00281580|325995|P13|Overall Study|Lost to Follow-up|1
94726|NCT00281580|325996|P12|Overall Study|Lost to Follow-up|0
94727|NCT00281580|325997|P11|Overall Study|Lost to Follow-up|1
94728|NCT00281580|325998|P10|Overall Study|Lost to Follow-up|1
94729|NCT00281580|325999|P9|Overall Study|Lost to Follow-up|2
94730|NCT00281580|326000|P8|Overall Study|Lost to Follow-up|1
94731|NCT00281580|326001|P7|Overall Study|Lost to Follow-up|0
94732|NCT00281580|326002|P6|Overall Study|Lost to Follow-up|1
94733|NCT00281580|326003|P5|Overall Study|Lost to Follow-up|0
94734|NCT00281580|326004|P4|Overall Study|Lost to Follow-up|3
94735|NCT00281580|326005|P3|Overall Study|Lost to Follow-up|0
94736|NCT00281580|326006|P2|Overall Study|Lost to Follow-up|0
94737|NCT00281580|326007|P1|Overall Study|Lost to Follow-up|0
94738|NCT00281580|325992|P16|Overall Study|Lack of Efficacy|0
94739|NCT00281580|325993|P15|Overall Study|Lack of Efficacy|1
94740|NCT00281580|325994|P14|Overall Study|Lack of Efficacy|2
94741|NCT00281580|325995|P13|Overall Study|Lack of Efficacy|0
94742|NCT00281580|325996|P12|Overall Study|Lack of Efficacy|1
94743|NCT00281580|325997|P11|Overall Study|Lack of Efficacy|0
94744|NCT00281580|325998|P10|Overall Study|Lack of Efficacy|0
94745|NCT00281580|325999|P9|Overall Study|Lack of Efficacy|0
94746|NCT00281580|326000|P8|Overall Study|Lack of Efficacy|0
94747|NCT00281580|326001|P7|Overall Study|Lack of Efficacy|0
94748|NCT00281580|326002|P6|Overall Study|Lack of Efficacy|0
94749|NCT00281580|326003|P5|Overall Study|Lack of Efficacy|2
94750|NCT00281580|326004|P4|Overall Study|Lack of Efficacy|6
94751|NCT00281580|326005|P3|Overall Study|Lack of Efficacy|1
94752|NCT00281580|326006|P2|Overall Study|Lack of Efficacy|1
94753|NCT00281580|326007|P1|Overall Study|Lack of Efficacy|2
94754|NCT00281580|325992|P16|Overall Study|Withdrawal by Subject|5
94755|NCT00281580|325993|P15|Overall Study|Withdrawal by Subject|1
94756|NCT00281580|325994|P14|Overall Study|Withdrawal by Subject|2
94757|NCT00281580|325995|P13|Overall Study|Withdrawal by Subject|2
94758|NCT00281580|325996|P12|Overall Study|Withdrawal by Subject|1
94759|NCT00281580|325997|P11|Overall Study|Withdrawal by Subject|1
94760|NCT00281580|325998|P10|Overall Study|Withdrawal by Subject|4
94761|NCT00281580|325999|P9|Overall Study|Withdrawal by Subject|1
94762|NCT00281580|326000|P8|Overall Study|Withdrawal by Subject|0
94763|NCT00281580|326001|P7|Overall Study|Withdrawal by Subject|2
94764|NCT00281580|326002|P6|Overall Study|Withdrawal by Subject|2
94765|NCT00281580|326003|P5|Overall Study|Withdrawal by Subject|1
94766|NCT00281580|326004|P4|Overall Study|Withdrawal by Subject|1
94767|NCT00281580|326005|P3|Overall Study|Withdrawal by Subject|1
94768|NCT00281580|326006|P2|Overall Study|Withdrawal by Subject|0
94769|NCT00281580|326007|P1|Overall Study|Withdrawal by Subject|3
94770|NCT00281580|325992|P16|Overall Study|Protocol Violation|3
94771|NCT00281580|325993|P15|Overall Study|Protocol Violation|1
94772|NCT00281580|325994|P14|Overall Study|Protocol Violation|1
94773|NCT00281580|325995|P13|Overall Study|Protocol Violation|0
94774|NCT00281580|325996|P12|Overall Study|Protocol Violation|2
94775|NCT00281580|325997|P11|Overall Study|Protocol Violation|1
94776|NCT00281580|325998|P10|Overall Study|Protocol Violation|0
94777|NCT00281580|325999|P9|Overall Study|Protocol Violation|2
94778|NCT00281580|326000|P8|Overall Study|Protocol Violation|0
94779|NCT00281580|326001|P7|Overall Study|Protocol Violation|1
94780|NCT00281580|326002|P6|Overall Study|Protocol Violation|0
94781|NCT00281580|326003|P5|Overall Study|Protocol Violation|0
94782|NCT00281580|326004|P4|Overall Study|Protocol Violation|1
94783|NCT00281580|326005|P3|Overall Study|Protocol Violation|1
94784|NCT00281580|326006|P2|Overall Study|Protocol Violation|0
94785|NCT00281580|326007|P1|Overall Study|Protocol Violation|0
94786|NCT00281580|325992|P16|Overall Study|Adverse Event|3
94787|NCT00281580|325993|P15|Overall Study|Adverse Event|3
94788|NCT00281580|325994|P14|Overall Study|Adverse Event|2
94789|NCT00281580|325995|P13|Overall Study|Adverse Event|8
94790|NCT00281580|325996|P12|Overall Study|Adverse Event|5
94791|NCT00281580|325997|P11|Overall Study|Adverse Event|0
94792|NCT00281580|325998|P10|Overall Study|Adverse Event|6
94793|NCT00281580|325999|P9|Overall Study|Adverse Event|1
94794|NCT00281580|326000|P8|Overall Study|Adverse Event|0
94795|NCT00281580|326001|P7|Overall Study|Adverse Event|1
94796|NCT00281580|326002|P6|Overall Study|Adverse Event|0
94797|NCT00281580|326003|P5|Overall Study|Adverse Event|1
94798|NCT00281580|326004|P4|Overall Study|Adverse Event|4
94799|NCT00281580|326005|P3|Overall Study|Adverse Event|2
94800|NCT00281580|326006|P2|Overall Study|Adverse Event|0
94801|NCT00281580|326007|P1|Overall Study|Adverse Event|2
94802|NCT00281632|326351|P1|Overall Study|Ongoing|3
94803|NCT00281632|326351|P1|Overall Study|Physician Decision|1
94804|NCT00281632|326351|P1|Overall Study|Death|1
94805|NCT00281632|326351|P1|Overall Study|Disease Progression|22
94806|NCT00281632|326351|P1|Overall Study|Withdrawal by Subject|2
94807|NCT00281632|326351|P1|Overall Study|Adverse Event|7
94808|NCT00281658|326379|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
94809|NCT00281658|326380|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
94810|NCT00281658|326381|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
94811|NCT00281658|326379|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
94812|NCT00281658|326380|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
94813|NCT00281658|326381|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
94814|NCT00281658|326379|P3|Open-label Monotherapy Extension Phase|Death|97
94815|NCT00281658|326380|P2|Open-label Monotherapy Extension Phase|Death|0
94816|NCT00281658|326381|P1|Open-label Monotherapy Extension Phase|Death|0
94817|NCT00281658|326379|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
94818|NCT00281658|326380|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
94819|NCT00281658|326381|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
94820|NCT00281658|326379|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
94821|NCT00281658|326380|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
94822|NCT00281658|326381|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
94823|NCT00281658|326379|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
94824|NCT00281658|326380|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
94825|NCT00281658|326381|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
94826|NCT00281658|326379|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
94827|NCT00281658|326380|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
94828|NCT00281658|326381|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
94829|NCT00281658|326379|P3|Double-blind, Randomized Phase|Death|0
94830|NCT00281658|326380|P2|Double-blind, Randomized Phase|Death|46
94831|NCT00281658|326381|P1|Double-blind, Randomized Phase|Death|120
94832|NCT00281697|326400|P2|Overall Study|Did not receive study drug|2
94833|NCT00281697|326401|P1|Overall Study|Did not receive study drug|3
94834|NCT00281697|326400|P2|Overall Study|Subject/guardian's decision to withdraw|6
94835|NCT00281697|326401|P1|Overall Study|Subject/guardian's decision to withdraw|33
94836|NCT00281697|326400|P2|Overall Study|Physician's decision to withdraw|12
94837|NCT00281697|326401|P1|Overall Study|Physician's decision to withdraw|15
94838|NCT00281697|326400|P2|Overall Study|Not specified|6
94839|NCT00281697|326401|P1|Overall Study|Not specified|5
94840|NCT00281697|326400|P2|Overall Study|Disease progression|149
94841|NCT00281697|326401|P1|Overall Study|Disease progression|279
94842|NCT00281697|326400|P2|Overall Study|Death|3
94843|NCT00281697|326401|P1|Overall Study|Death|8
94844|NCT00281697|326400|P2|Overall Study|Adverse Event|15
94845|NCT00281697|326401|P1|Overall Study|Adverse Event|54
94846|NCT00281697|326400|P2|Overall Study|> 60 days since last dose of study drug|4
94847|NCT00281697|326401|P1|Overall Study|> 60 days since last dose of study drug|4
94848|NCT00281840|326426|P1|Overall Study|Complicating Disease|1
94849|NCT00281840|326426|P1|Overall Study|exceed maximum delay in treatment|1
94850|NCT00281840|326426|P1|Overall Study|Disease Progression|2
94851|NCT00281840|326426|P1|Overall Study|Withdrawal by Subject|3
94852|NCT00281840|326426|P1|Overall Study|Physician Decision|6
94853|NCT00281840|326426|P1|Overall Study|Adverse Event|12
94854|NCT00281957|326495|P2|Overall Study|Refusal unrelated to adverse events|1
94855|NCT00281957|326496|P1|Overall Study|Refusal unrelated to adverse events|0
94856|NCT00281957|326495|P2|Overall Study|Did not start treatment|1
94857|NCT00281957|326496|P1|Overall Study|Did not start treatment|3
94858|NCT00281957|326495|P2|Overall Study|Not eligible|2
94859|NCT00281957|326496|P1|Overall Study|Not eligible|1
94860|NCT00281957|326495|P2|Overall Study|Not protocol specified|1
94861|NCT00281957|326496|P1|Overall Study|Not protocol specified|8
94862|NCT00281957|326495|P2|Overall Study|Progression/relapse|35
94863|NCT00281957|326496|P1|Overall Study|Progression/relapse|47
94864|NCT00281957|326495|P2|Overall Study|Death|0
94865|NCT00281957|326496|P1|Overall Study|Death|1
94866|NCT00281957|326495|P2|Overall Study|Adverse Event|2
94867|NCT00281957|326496|P1|Overall Study|Adverse Event|7
94868|NCT00282048|326508|P1|Overall Study|Ongoing|1
94869|NCT00282048|326508|P1|Overall Study|Unspecified|8
94870|NCT00282048|326508|P1|Overall Study|Withdrawal by Subject|1
94871|NCT00282048|326508|P1|Overall Study|Adverse Event|22
94872|NCT00282048|326508|P1|Overall Study|Lack of Efficacy|30
94873|NCT00282087|326520|P1|Overall Study|Death|1
94874|NCT00282113|326536|P3|Overall Study|Removed at parents request|0
94875|NCT00282113|326537|P2|Overall Study|Removed at parents request|0
94876|NCT00282113|326538|P1|Overall Study|Removed at parents request|1
94877|NCT00282152|326554|P2|Overall Study|Withdrawal by Subject|0
94878|NCT00282152|326555|P1|Overall Study|Withdrawal by Subject|1
94879|NCT00282243|326573|P1|Extension Treatment Period|Physician Decision|1
94880|NCT00282243|326573|P1|Extension Treatment Period|Non-compliance|2
94881|NCT00282243|326573|P1|Extension Treatment Period|Withdrawal by Subject|4
94882|NCT00282243|326573|P1|Extension Treatment Period|Adverse Event|15
94883|NCT00282243|326573|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
94884|NCT00282243|326573|P1|Pharmacokinetic Treatment Period|Adverse Event|3
94885|NCT00282256|326597|P1|Extension Treatment Period|Adverse Event|2
94886|NCT00282256|326597|P1|Pharmacokinetic Treatment Period|Poor venous access|1
94887|NCT00282295|326627|P3|Overall Study|Unspecified|0
94888|NCT00282295|326628|P2|Overall Study|Unspecified|1
94889|NCT00282295|326629|P1|Overall Study|Unspecified|0
94890|NCT00282295|326627|P3|Overall Study|Lost to Follow-up|2
94891|NCT00282295|326628|P2|Overall Study|Lost to Follow-up|7
94892|NCT00282295|326629|P1|Overall Study|Lost to Follow-up|1
94893|NCT00282295|326627|P3|Overall Study|Withdrawal by Subject|4
94894|NCT00282295|326628|P2|Overall Study|Withdrawal by Subject|6
94895|NCT00282295|326629|P1|Overall Study|Withdrawal by Subject|2
94896|NCT00282295|326627|P3|Overall Study|Protocol Violation|1
94897|NCT00282295|326628|P2|Overall Study|Protocol Violation|2
94898|NCT00282295|326629|P1|Overall Study|Protocol Violation|0
94899|NCT00282295|326627|P3|Overall Study|Serious Adverse Events|1
94900|NCT00282295|326628|P2|Overall Study|Serious Adverse Events|0
94901|NCT00282295|326629|P1|Overall Study|Serious Adverse Events|0
94902|NCT00282295|326627|P3|Overall Study|Adverse Event|0
94903|NCT00282295|326628|P2|Overall Study|Adverse Event|1
94904|NCT00282295|326629|P1|Overall Study|Adverse Event|0
94905|NCT00282308|326680|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
94906|NCT00282308|326681|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
94907|NCT00282308|326682|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
94908|NCT00282308|326680|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
94909|NCT00282308|326681|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
94910|NCT00282308|326682|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
94911|NCT00282308|326680|P3|Safety Follow-up Period|Lost to Follow-up|5
94912|NCT00282308|326681|P2|Safety Follow-up Period|Lost to Follow-up|0
94913|NCT00282308|326682|P1|Safety Follow-up Period|Lost to Follow-up|0
94914|NCT00282308|326680|P3|Safety Follow-up Period|Adverse Event|1
94915|NCT00282308|326681|P2|Safety Follow-up Period|Adverse Event|0
94916|NCT00282308|326682|P1|Safety Follow-up Period|Adverse Event|0
94917|NCT00282308|326680|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
94918|NCT00282308|326681|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
94919|NCT00282308|326682|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
94920|NCT00282308|326680|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
94921|NCT00282308|326681|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
94922|NCT00282308|326682|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
94923|NCT00282308|326680|P3|Optional Extension Re-treatment Period|Adverse Event|4
94924|NCT00282308|326681|P2|Optional Extension Re-treatment Period|Adverse Event|0
94925|NCT00282308|326682|P1|Optional Extension Re-treatment Period|Adverse Event|0
94926|NCT00282308|326680|P3|Treatment Period|Not Treated with Study Drug|0
94927|NCT00282308|326681|P2|Treatment Period|Not Treated with Study Drug|0
94928|NCT00282308|326682|P1|Treatment Period|Not Treated with Study Drug|1
94929|NCT00282308|326680|P3|Treatment Period|Adverse Event|0
94930|NCT00282308|326681|P2|Treatment Period|Adverse Event|2
94931|NCT00282308|326682|P1|Treatment Period|Adverse Event|0
94932|NCT00282308|326680|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
94933|NCT00282308|326681|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
94934|NCT00282308|326682|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
94935|NCT00282308|326680|P3|Treatment Period|Lost to Follow-up|0
94936|NCT00282308|326681|P2|Treatment Period|Lost to Follow-up|0
94937|NCT00282308|326682|P1|Treatment Period|Lost to Follow-up|1
94938|NCT00282334|326711|P2|Overall Study|Withdrawal by Subject|5
94939|NCT00282334|326712|P1|Overall Study|Withdrawal by Subject|8
94940|NCT00282347|326720|P2|B Cell Follow-up Period|Reason Not Specified|0
94941|NCT00282347|326721|P1|B Cell Follow-up Period|Reason Not Specified|2
94942|NCT00282347|326720|P2|B Cell Follow-up Period|Physician Decision|0
94943|NCT00282347|326721|P1|B Cell Follow-up Period|Physician Decision|1
94944|NCT00282347|326720|P2|B Cell Follow-up Period|Withdrawal by Subject|0
94945|NCT00282347|326721|P1|B Cell Follow-up Period|Withdrawal by Subject|2
94946|NCT00282347|326720|P2|Safety Follow-up Period|Protocol Deviation|2
94947|NCT00282347|326721|P1|Safety Follow-up Period|Protocol Deviation|0
94948|NCT00282347|326720|P2|Safety Follow-up Period|Physician Decision|1
94949|NCT00282347|326721|P1|Safety Follow-up Period|Physician Decision|1
94950|NCT00282347|326720|P2|Safety Follow-up Period|Withdrawal by Subject|1
94951|NCT00282347|326721|P1|Safety Follow-up Period|Withdrawal by Subject|2
94952|NCT00282347|326720|P2|Safety Follow-up Period|Lost to Follow-up|2
94953|NCT00282347|326721|P1|Safety Follow-up Period|Lost to Follow-up|0
94954|NCT00282347|326720|P2|Treatment Period|Physician Decision|1
94955|NCT00282347|326721|P1|Treatment Period|Physician Decision|0
94956|NCT00282347|326720|P2|Treatment Period|Withdrawal by Subject|3
94957|NCT00282347|326721|P1|Treatment Period|Withdrawal by Subject|1
94958|NCT00282347|326720|P2|Treatment Period|Lost to Follow-up|5
94959|NCT00282347|326721|P1|Treatment Period|Lost to Follow-up|2
94960|NCT00282347|326720|P2|Treatment Period|Death|0
94961|NCT00282347|326721|P1|Treatment Period|Death|2
94962|NCT00282438|326747|P2|Overall Study|Death|1
94963|NCT00282438|326748|P1|Overall Study|Death|0
94964|NCT00282438|326747|P2|Overall Study|Lack of Efficacy|0
94965|NCT00282438|326748|P1|Overall Study|Lack of Efficacy|1
94966|NCT00282464|326756|P2|Overall Study|dropped due to missed visits|1
94967|NCT00282464|326757|P1|Overall Study|dropped due to missed visits|0
94968|NCT00282464|326756|P2|Overall Study|dispensed wrong kit|1
94969|NCT00282464|326757|P1|Overall Study|dispensed wrong kit|0
94970|NCT00282464|326756|P2|Overall Study|family crisis|1
94971|NCT00282464|326757|P1|Overall Study|family crisis|0
94972|NCT00282464|326756|P2|Overall Study|patient incarcerated|1
94973|NCT00282464|326757|P1|Overall Study|patient incarcerated|0
94974|NCT00282464|326756|P2|Overall Study|patient no show|1
94975|NCT00282464|326757|P1|Overall Study|patient no show|0
94976|NCT00282464|326756|P2|Overall Study|patient non-compliant|0
94977|NCT00282464|326757|P1|Overall Study|patient non-compliant|3
94978|NCT00282464|326756|P2|Overall Study|Patient moved|0
94979|NCT00282464|326757|P1|Overall Study|Patient moved|1
94980|NCT00282464|326756|P2|Overall Study|Protocol Violation|7
94981|NCT00282464|326757|P1|Overall Study|Protocol Violation|0
94982|NCT00282464|326756|P2|Overall Study|laboratory abnormality|2
94983|NCT00282464|326757|P1|Overall Study|laboratory abnormality|1
94984|NCT00282464|326756|P2|Overall Study|Withdrawal by Subject|10
94985|NCT00282464|326757|P1|Overall Study|Withdrawal by Subject|24
94986|NCT00282464|326756|P2|Overall Study|Lost to Follow-up|10
94987|NCT00282464|326757|P1|Overall Study|Lost to Follow-up|10
94988|NCT00282464|326756|P2|Overall Study|Lack of Efficacy|8
94989|NCT00282464|326757|P1|Overall Study|Lack of Efficacy|8
94990|NCT00282464|326756|P2|Overall Study|Adverse Event|20
94991|NCT00282464|326757|P1|Overall Study|Adverse Event|26
94992|NCT00282568|326805|P1|Extended Treatment Period|Lost to Follow-up|2
94993|NCT00282568|326805|P1|Extended Treatment Period|Physician Decision|1
94994|NCT00282568|326805|P1|Extended Treatment Period|Non-compliance|4
94995|NCT00282568|326805|P1|Extended Treatment Period|Adverse Event|17
94996|NCT00282568|326805|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
94997|NCT00282568|326805|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
94998|NCT00288509|326882|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
94999|NCT00288509|326882|P1|Treatment Cycle 4|Physician Decision|4
95000|NCT00288509|326882|P1|Treatment Cycle 4|Withdrawal by Subject|3
95001|NCT00288509|326882|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
95002|NCT00288509|326882|P1|Treatment Cycle 3|Lost to Follow-up|2
95003|NCT00288509|326882|P1|Treatment Cycle 3|Withdrawal by Subject|1
95004|NCT00288509|326882|P1|Treatment Cycle 3|Lack of Efficacy|1
95005|NCT00288509|326882|P1|Treatment Cycle 2|Withdrawal by Subject|2
95006|NCT00288509|326882|P1|Treatment Cycle 2|Lack of Efficacy|1
95007|NCT00288509|326882|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
95008|NCT00288509|326882|P1|Treatment Cycle 1|Lost to Follow-up|2
95009|NCT00288509|326882|P1|Treatment Cycle 1|Withdrawal by Subject|1
95010|NCT00288509|326882|P1|Treatment Cycle 1|Lack of Efficacy|1
95011|NCT00288509|326882|P1|Treatment Cycle 1|Adverse Event|1
95012|NCT00291187|326921|P4|Overall Study|Protocol Violation- No Drug Administered|0
95013|NCT00291187|326922|P3|Overall Study|Protocol Violation- No Drug Administered|1
95014|NCT00291187|326923|P2|Overall Study|Protocol Violation- No Drug Administered|0
95015|NCT00291187|326924|P1|Overall Study|Protocol Violation- No Drug Administered|0
95016|NCT00291330|326964|P2|Overall Study|Other|1
95017|NCT00291330|326965|P1|Overall Study|Other|3
95018|NCT00291330|326964|P2|Overall Study|Withdrawal by Subject|25
95019|NCT00291330|326965|P1|Overall Study|Withdrawal by Subject|22
95020|NCT00291330|326964|P2|Overall Study|Lost to Follow-up|11
95021|NCT00291330|326965|P1|Overall Study|Lost to Follow-up|16
95022|NCT00291330|326964|P2|Overall Study|Protocol Violation|20
95023|NCT00291330|326965|P1|Overall Study|Protocol Violation|13
95024|NCT00291330|326964|P2|Overall Study|Adverse Event|40
95025|NCT00291330|326965|P1|Overall Study|Adverse Event|47
95026|NCT00291551|327018|P1|Overall Study|Withdrawal by Subject|6
95027|NCT00291551|327018|P1|Overall Study|Death|7
95028|NCT00291577|327033|P1|Overall Study|Lack of Efficacy|14
95029|NCT00291577|327033|P1|Overall Study|Withdrawal by Subject|2
95030|NCT00291577|327033|P1|Overall Study|Other|4
95031|NCT00291577|327033|P1|Overall Study|Adverse Event|1
95032|NCT00292188|327107|P3|Double-Blind|Laboratory Abnormality|1
95033|NCT00292188|327108|P2|Double-Blind|Laboratory Abnormality|0
95034|NCT00292188|327109|P1|Double-Blind|Laboratory Abnormality|0
95035|NCT00292188|327107|P3|Double-Blind|Withdrawal by Subject|3
95036|NCT00292188|327108|P2|Double-Blind|Withdrawal by Subject|0
95037|NCT00292188|327109|P1|Double-Blind|Withdrawal by Subject|0
95038|NCT00292188|327107|P3|Double-Blind|Other|4
95039|NCT00292188|327108|P2|Double-Blind|Other|3
95040|NCT00292188|327109|P1|Double-Blind|Other|0
95041|NCT00292188|327107|P3|Double-Blind|Lost to Follow-up|0
95042|NCT00292188|327108|P2|Double-Blind|Lost to Follow-up|1
95043|NCT00292188|327109|P1|Double-Blind|Lost to Follow-up|0
95044|NCT00292188|327107|P3|Double-Blind|Lack of Efficacy|12
95045|NCT00292188|327108|P2|Double-Blind|Lack of Efficacy|2
95046|NCT00292188|327109|P1|Double-Blind|Lack of Efficacy|0
95047|NCT00292188|327107|P3|Double-Blind|Adverse Event|9
95048|NCT00292188|327108|P2|Double-Blind|Adverse Event|25
95049|NCT00292188|327109|P1|Double-Blind|Adverse Event|0
95050|NCT00292188|327107|P3|Single-Blind|Did not receive treatment|0
95051|NCT00292188|327108|P2|Single-Blind|Did not receive treatment|0
95052|NCT00292188|327109|P1|Single-Blind|Did not receive treatment|1
95053|NCT00292188|327107|P3|Single-Blind|Withdrawal by Subject|0
95054|NCT00292188|327108|P2|Single-Blind|Withdrawal by Subject|0
95055|NCT00292188|327109|P1|Single-Blind|Withdrawal by Subject|12
95056|NCT00292188|327107|P3|Single-Blind|Other|0
95057|NCT00292188|327108|P2|Single-Blind|Other|0
95058|NCT00292188|327109|P1|Single-Blind|Other|77
95059|NCT00292188|327107|P3|Single-Blind|Lost to Follow-up|0
95060|NCT00292188|327108|P2|Single-Blind|Lost to Follow-up|0
95061|NCT00292188|327109|P1|Single-Blind|Lost to Follow-up|3
95062|NCT00292188|327107|P3|Single-Blind|Laboratory Abnormality|0
95063|NCT00292188|327108|P2|Single-Blind|Laboratory Abnormality|0
95064|NCT00292188|327109|P1|Single-Blind|Laboratory Abnormality|5
95065|NCT00292188|327107|P3|Single-Blind|Lack of Efficacy|0
95066|NCT00292188|327108|P2|Single-Blind|Lack of Efficacy|0
95067|NCT00292188|327109|P1|Single-Blind|Lack of Efficacy|2
95068|NCT00292188|327107|P3|Single-Blind|Adverse Event|0
95069|NCT00292188|327108|P2|Single-Blind|Adverse Event|0
95070|NCT00292188|327109|P1|Single-Blind|Adverse Event|14
95071|NCT00292227|327170|P3|Patch Period|Withdrawal by Subject|1
95072|NCT00292227|327171|P2|Patch Period|Withdrawal by Subject|0
95073|NCT00292227|327172|P1|Patch Period|Withdrawal by Subject|0
95074|NCT00292227|327170|P3|Patch Period|Adverse Event|2
95075|NCT00292227|327171|P2|Patch Period|Adverse Event|0
95076|NCT00292227|327172|P1|Patch Period|Adverse Event|1
95077|NCT00292318|327254|P2|Overall Study|Study terminated by officials|1
95078|NCT00292318|327255|P1|Overall Study|Study terminated by officials|2
95079|NCT00292370|327266|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
95080|NCT00292370|327267|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
95081|NCT00292370|327268|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
95082|NCT00292370|327266|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
95083|NCT00292370|327267|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
95084|NCT00292370|327268|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
95085|NCT00292370|327266|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
95086|NCT00292370|327267|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
95087|NCT00292370|327268|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
95088|NCT00292370|327266|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
95089|NCT00292370|327267|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
95090|NCT00292370|327268|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
95091|NCT00292370|327266|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
95092|NCT00292370|327267|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
95093|NCT00292370|327268|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
95094|NCT00292370|327266|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
95095|NCT00292370|327267|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
95096|NCT00292370|327268|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
95097|NCT00292461|327277|P2|Overall Study|Lost to Follow-up|0
95098|NCT00292461|327278|P1|Overall Study|Lost to Follow-up|1
95099|NCT00292461|327277|P2|Overall Study|Protocol Violation|3
95100|NCT00292461|327278|P1|Overall Study|Protocol Violation|4
95101|NCT00292461|327277|P2|Overall Study|Withdrawal by Subject|1
95102|NCT00292461|327278|P1|Overall Study|Withdrawal by Subject|0
95103|NCT00292461|327277|P2|Overall Study|Lack of Efficacy|0
95104|NCT00292461|327278|P1|Overall Study|Lack of Efficacy|1
95105|NCT00292461|327277|P2|Overall Study|Adverse Event|2
95106|NCT00292461|327278|P1|Overall Study|Adverse Event|4
95107|NCT00292981|327303|P1|Overall Study|Not specified|3
95108|NCT00292981|327303|P1|Overall Study|Withdrawal by Subject|22
95109|NCT00292981|327303|P1|Overall Study|Lost to Follow-up|13
95110|NCT00292981|327303|P1|Overall Study|Adverse Event|1
95111|NCT00293020|327310|P1|Overall Study|No dose taken|1
95112|NCT00293020|327310|P1|Overall Study|Other Reason|22
95113|NCT00293020|327310|P1|Overall Study|Physician Decision|21
95114|NCT00293020|327310|P1|Overall Study|Protocol Violation|6
95115|NCT00293020|327310|P1|Overall Study|Lost to Follow-up|4
95116|NCT00293020|327310|P1|Overall Study|Lack of Efficacy|12
95117|NCT00293020|327310|P1|Overall Study|Death|32
95118|NCT00293020|327310|P1|Overall Study|Adverse Event|30
95119|NCT00293020|327310|P1|Overall Study|Withdrawal by Subject|34
95120|NCT00293059|327316|P2|Overall Study|missing|5
95121|NCT00293059|327317|P1|Overall Study|missing|3
95122|NCT00293059|327316|P2|Overall Study|Noncompliant - sanitary pads collection|1
95123|NCT00293059|327317|P1|Overall Study|Noncompliant - sanitary pads collection|0
95124|NCT00293059|327316|P2|Overall Study|Participant stopped study drug|0
95125|NCT00293059|327317|P1|Overall Study|Participant stopped study drug|1
95126|NCT00293059|327316|P2|Overall Study|Participant moved out of state|0
95127|NCT00293059|327317|P1|Overall Study|Participant moved out of state|1
95128|NCT00293059|327316|P2|Overall Study|Withdrawal by Subject|5
95129|NCT00293059|327317|P1|Overall Study|Withdrawal by Subject|11
95130|NCT00293059|327316|P2|Overall Study|Protocol Violation|0
95131|NCT00293059|327317|P1|Overall Study|Protocol Violation|2
95132|NCT00293059|327316|P2|Overall Study|Pregnancy|1
95133|NCT00293059|327317|P1|Overall Study|Pregnancy|1
95134|NCT00293059|327316|P2|Overall Study|Lost to Follow-up|3
95135|NCT00293059|327317|P1|Overall Study|Lost to Follow-up|2
95136|NCT00293059|327316|P2|Overall Study|Lack of Efficacy|0
95137|NCT00293059|327317|P1|Overall Study|Lack of Efficacy|2
95138|NCT00293059|327316|P2|Overall Study|Adverse Event|4
95139|NCT00293059|327317|P1|Overall Study|Adverse Event|12
95140|NCT00293241|327431|P2|Overall Study|Withdrawal by Subject|8
95141|NCT00293241|327432|P1|Overall Study|Withdrawal by Subject|4
95142|NCT00293241|327431|P2|Overall Study|Physician Decision|17
95143|NCT00293241|327432|P1|Overall Study|Physician Decision|23
95144|NCT00293241|327431|P2|Overall Study|Lost to Follow-up|16
95145|NCT00293241|327432|P1|Overall Study|Lost to Follow-up|9
95146|NCT00293254|327476|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
95147|NCT00293254|327477|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
95148|NCT00293254|327476|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
95295|NCT00293462|327595|P3|Overall Study|Lost to Follow-up|0
95149|NCT00293254|327477|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
95150|NCT00293254|327476|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
95151|NCT00293254|327477|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
95152|NCT00293254|327476|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
95153|NCT00293254|327477|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
95154|NCT00293254|327476|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
95155|NCT00293254|327477|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
95156|NCT00293254|327476|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
95157|NCT00293254|327477|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
95158|NCT00293254|327476|P2|Extension - Open-Label Week 157-240|Other Reason|0
95159|NCT00293254|327477|P1|Extension - Open-Label Week 157-240|Other Reason|4
95160|NCT00293254|327476|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
95161|NCT00293254|327477|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
95162|NCT00293254|327476|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
95163|NCT00293254|327477|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
95164|NCT00293254|327476|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
95165|NCT00293254|327477|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
95166|NCT00293254|327476|P2|Extension - Open-Label Week 157-240|Adverse Event|1
95167|NCT00293254|327477|P1|Extension - Open-Label Week 157-240|Adverse Event|2
95168|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
95169|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
95170|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Other Reason|2
95171|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Other Reason|10
95172|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
95173|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
95174|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
95175|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
95176|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
95177|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
95178|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
95179|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
95180|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Death|1
95181|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Death|4
95182|NCT00293254|327476|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
95183|NCT00293254|327477|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
95184|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
95185|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
95186|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
95187|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
95188|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
95189|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
95190|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
95191|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
95192|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
95193|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
95194|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Death|2
95195|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Death|5
95196|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
95197|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
95198|NCT00293254|327476|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
95199|NCT00293254|327477|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
95200|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
95201|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
95202|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
95203|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
95204|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
95205|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
95206|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
95207|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
95208|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
95209|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
95210|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
95211|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
95212|NCT00293267|327517|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
95213|NCT00293267|327518|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
95214|NCT00293267|327517|P2|Extension - Open-Label Week 157-240|Other Reason|1
95215|NCT00293267|327518|P1|Extension - Open-Label Week 157-240|Other Reason|3
95216|NCT00293267|327517|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
95217|NCT00293267|327518|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
95218|NCT00293267|327517|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
95219|NCT00293267|327518|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
95220|NCT00293267|327517|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
95221|NCT00293267|327518|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
95222|NCT00293267|327517|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
95223|NCT00293267|327518|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
95224|NCT00293267|327517|P2|Extension - Open-Label Week 157-240|Adverse Event|0
95225|NCT00293267|327518|P1|Extension - Open-Label Week 157-240|Adverse Event|5
95226|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
95227|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
95228|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Other Reason|0
95229|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Other Reason|7
95230|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
95231|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
95232|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Death|0
95233|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Death|3
95234|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
95235|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
95236|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
95237|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
95238|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
95239|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
95240|NCT00293267|327517|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
95241|NCT00293267|327518|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
95242|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
95243|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
95244|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
95245|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
95246|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
95247|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
95248|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
95249|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
95250|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Death|3
95251|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Death|3
95252|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
95253|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
95254|NCT00293267|327517|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
95255|NCT00293267|327518|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
95256|NCT00293293|327558|P2|Overall Study|Patient discontinued chemotherapy|1
95257|NCT00293293|327559|P1|Overall Study|Patient discontinued chemotherapy|0
95258|NCT00293293|327558|P2|Overall Study|"Patient too anxious to complete trial"|0
95259|NCT00293293|327559|P1|Overall Study|"Patient too anxious to complete trial"|1
95260|NCT00293293|327558|P2|Overall Study|Withdrawal by Subject|1
95261|NCT00293293|327559|P1|Overall Study|Withdrawal by Subject|1
95262|NCT00293384|327585|P1|Overall Study|Ineligible|2
95263|NCT00293384|327585|P1|Overall Study|Missed dosage/study drug|1
95264|NCT00293384|327585|P1|Overall Study|Non-compliance|2
95265|NCT00293462|327595|P3|Overall Study|Physician Decision|0
95266|NCT00293462|327596|P2|Overall Study|Physician Decision|1
95267|NCT00293462|327597|P1|Overall Study|Physician Decision|0
95268|NCT00293462|327595|P3|Overall Study|Low radiation dose in oral cavity|0
95269|NCT00293462|327596|P2|Overall Study|Low radiation dose in oral cavity|1
95270|NCT00293462|327597|P1|Overall Study|Low radiation dose in oral cavity|0
95271|NCT00293462|327595|P3|Overall Study|Possible Tracheostomy leakage|0
95272|NCT00293462|327596|P2|Overall Study|Possible Tracheostomy leakage|1
95273|NCT00293462|327597|P1|Overall Study|Possible Tracheostomy leakage|0
95274|NCT00293462|327595|P3|Overall Study|Ischemic stroke after chemotherapy|1
95275|NCT00293462|327596|P2|Overall Study|Ischemic stroke after chemotherapy|0
95276|NCT00293462|327597|P1|Overall Study|Ischemic stroke after chemotherapy|0
95277|NCT00293462|327595|P3|Overall Study|Blood clot after chemotherapy|1
95278|NCT00293462|327596|P2|Overall Study|Blood clot after chemotherapy|0
95279|NCT00293462|327597|P1|Overall Study|Blood clot after chemotherapy|0
95280|NCT00293462|327595|P3|Overall Study|Went back to his home country|1
95281|NCT00293462|327596|P2|Overall Study|Went back to his home country|0
95282|NCT00293462|327597|P1|Overall Study|Went back to his home country|0
95283|NCT00293462|327595|P3|Overall Study|No Show|1
95284|NCT00293462|327596|P2|Overall Study|No Show|0
95285|NCT00293462|327597|P1|Overall Study|No Show|0
95286|NCT00293462|327595|P3|Overall Study|Refuse Radiation Treatment|0
95287|NCT00293462|327596|P2|Overall Study|Refuse Radiation Treatment|0
95288|NCT00293462|327597|P1|Overall Study|Refuse Radiation Treatment|1
95289|NCT00293462|327595|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
95290|NCT00293462|327596|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
95291|NCT00293462|327597|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
95292|NCT00293462|327595|P3|Overall Study|Change Treatment Regimen (ineligible)|0
95293|NCT00293462|327596|P2|Overall Study|Change Treatment Regimen (ineligible)|0
95294|NCT00293462|327597|P1|Overall Study|Change Treatment Regimen (ineligible)|1
95296|NCT00293462|327596|P2|Overall Study|Lost to Follow-up|1
95297|NCT00293462|327597|P1|Overall Study|Lost to Follow-up|0
95298|NCT00293462|327595|P3|Overall Study|Death|0
95299|NCT00293462|327596|P2|Overall Study|Death|0
95300|NCT00293462|327597|P1|Overall Study|Death|1
95301|NCT00293462|327595|P3|Overall Study|Withdrawal by Subject|6
95302|NCT00293462|327596|P2|Overall Study|Withdrawal by Subject|3
95303|NCT00293462|327597|P1|Overall Study|Withdrawal by Subject|4
95304|NCT00293579|327625|P1|Overall Study|Withdrawal by Subject|1
95305|NCT00280059|327650|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
95306|NCT00280059|327651|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
95307|NCT00280059|327650|P2|Efficacy Assessment Phase|Unspecified|8
95308|NCT00280059|327651|P1|Efficacy Assessment Phase|Unspecified|7
95309|NCT00280059|327650|P2|Efficacy Assessment Phase|Lost to Follow-up|13
95310|NCT00280059|327651|P1|Efficacy Assessment Phase|Lost to Follow-up|6
95311|NCT00280059|327650|P2|Efficacy Assessment Phase|Lack of Efficacy|3
95312|NCT00280059|327651|P1|Efficacy Assessment Phase|Lack of Efficacy|19
95313|NCT00280059|327650|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
95314|NCT00280059|327651|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
95315|NCT00280059|327650|P2|Efficacy Assessment Phase|Adverse Event|31
95316|NCT00280059|327651|P1|Efficacy Assessment Phase|Adverse Event|33
95317|NCT00280059|327650|P2|Efficacy Assessment Phase|Death|0
95318|NCT00280059|327651|P1|Efficacy Assessment Phase|Death|2
95319|NCT00280150|327701|P4|Overall Study|Declining Performance Status|1
95320|NCT00280150|327702|P3|Overall Study|Declining Performance Status|0
95321|NCT00280150|327703|P2|Overall Study|Declining Performance Status|0
95322|NCT00280150|327704|P1|Overall Study|Declining Performance Status|0
95323|NCT00280150|327701|P4|Overall Study|Did not get consolidation therapy|0
95324|NCT00280150|327702|P3|Overall Study|Did not get consolidation therapy|3
95325|NCT00280150|327703|P2|Overall Study|Did not get consolidation therapy|0
95326|NCT00280150|327704|P1|Overall Study|Did not get consolidation therapy|3
95327|NCT00280150|327701|P4|Overall Study|Withdrawal by Subject|1
95328|NCT00280150|327702|P3|Overall Study|Withdrawal by Subject|0
95329|NCT00280150|327703|P2|Overall Study|Withdrawal by Subject|0
95330|NCT00280150|327704|P1|Overall Study|Withdrawal by Subject|0
95331|NCT00280150|327701|P4|Overall Study|Protocol Violation|1
95332|NCT00280150|327702|P3|Overall Study|Protocol Violation|0
95333|NCT00280150|327703|P2|Overall Study|Protocol Violation|0
95334|NCT00280150|327704|P1|Overall Study|Protocol Violation|0
95335|NCT00280150|327701|P4|Overall Study|Physician Decision|1
95336|NCT00280150|327702|P3|Overall Study|Physician Decision|0
95337|NCT00280150|327703|P2|Overall Study|Physician Decision|0
95338|NCT00280150|327704|P1|Overall Study|Physician Decision|0
95339|NCT00280150|327701|P4|Overall Study|Lack of Efficacy|3
95340|NCT00280150|327702|P3|Overall Study|Lack of Efficacy|0
95341|NCT00280150|327703|P2|Overall Study|Lack of Efficacy|0
95342|NCT00280150|327704|P1|Overall Study|Lack of Efficacy|0
95343|NCT00280150|327701|P4|Overall Study|Adverse Event|3
95344|NCT00280150|327702|P3|Overall Study|Adverse Event|2
95345|NCT00280150|327703|P2|Overall Study|Adverse Event|1
95346|NCT00280150|327704|P1|Overall Study|Adverse Event|0
95347|NCT00285649|327720|P3|Overall Study|Withdrawal by Subject|2
95348|NCT00285649|327721|P2|Overall Study|Withdrawal by Subject|2
95349|NCT00285649|327722|P1|Overall Study|Withdrawal by Subject|3
95350|NCT00285649|327720|P3|Overall Study|Lost to Follow-up|4
95351|NCT00285649|327721|P2|Overall Study|Lost to Follow-up|4
95352|NCT00285649|327722|P1|Overall Study|Lost to Follow-up|6
95353|NCT00293709|327730|P1|Overall Study|Unspecified|47
95354|NCT00293722|327744|P1|Overall Study|Unspecified|427
95355|NCT00293813|327761|P3|Overall Study|Noncompliance|0
95356|NCT00293813|327762|P2|Overall Study|Noncompliance|1
95357|NCT00293813|327763|P1|Overall Study|Noncompliance|0
95358|NCT00293813|327761|P3|Overall Study|Lost to Follow-up|3
95359|NCT00293813|327762|P2|Overall Study|Lost to Follow-up|2
95360|NCT00293813|327763|P1|Overall Study|Lost to Follow-up|3
95361|NCT00293813|327761|P3|Overall Study|Withdrawal by Subject|4
95362|NCT00293813|327762|P2|Overall Study|Withdrawal by Subject|4
95363|NCT00293813|327763|P1|Overall Study|Withdrawal by Subject|7
95364|NCT00293813|327761|P3|Overall Study|Adverse Event|1
95365|NCT00293813|327762|P2|Overall Study|Adverse Event|1
95366|NCT00293813|327763|P1|Overall Study|Adverse Event|3
95367|NCT00293813|327761|P3|Overall Study|Physician Decision|0
95368|NCT00293813|327762|P2|Overall Study|Physician Decision|1
95369|NCT00293813|327763|P1|Overall Study|Physician Decision|0
95370|NCT00294398|327776|P2|Overall Study|Lost to Follow-up|26
95371|NCT00294398|327777|P1|Overall Study|Lost to Follow-up|21
95372|NCT00294645|327804|P2|Overall Study|Other|10
95373|NCT00294645|327805|P1|Overall Study|Other|4
95374|NCT00294645|327804|P2|Overall Study|Physician Decision|20
95375|NCT00294645|327805|P1|Overall Study|Physician Decision|15
95376|NCT00294645|327804|P2|Overall Study|Withdrawal by Subject|34
95377|NCT00294645|327805|P1|Overall Study|Withdrawal by Subject|18
95378|NCT00294645|327804|P2|Overall Study|Lost to Follow-up|10
95379|NCT00294645|327805|P1|Overall Study|Lost to Follow-up|1
95380|NCT00294645|327804|P2|Overall Study|Death|18
95381|NCT00294645|327805|P1|Overall Study|Death|10
95382|NCT00294658|327839|P2|Overall Study|Patient and family were not satisfied|1
95383|NCT00294658|327840|P1|Overall Study|Patient and family were not satisfied|0
95384|NCT00294658|327839|P2|Overall Study|Found to have invasive thymoma|0
95385|NCT00294658|327840|P1|Overall Study|Found to have invasive thymoma|1
95386|NCT00294658|327839|P2|Overall Study|Withdrawal by Subject|4
95387|NCT00294658|327840|P1|Overall Study|Withdrawal by Subject|0
95388|NCT00294658|327839|P2|Overall Study|Pregnancy|1
95389|NCT00294658|327840|P1|Overall Study|Pregnancy|0
95390|NCT00294658|327839|P2|Overall Study|Physician Decision|2
95391|NCT00294658|327840|P1|Overall Study|Physician Decision|1
95392|NCT00294658|327839|P2|Overall Study|Lost to Follow-up|0
95393|NCT00294658|327840|P1|Overall Study|Lost to Follow-up|4
95394|NCT00294658|327839|P2|Overall Study|Death|1
95395|NCT00294658|327840|P1|Overall Study|Death|0
95396|NCT00294671|327904|P2|Overall Study|Death|1
95397|NCT00294671|327905|P1|Overall Study|Death|0
95398|NCT00294671|327904|P2|Overall Study|Non-compliance|0
95399|NCT00294671|327905|P1|Overall Study|Non-compliance|1
95400|NCT00294671|327904|P2|Overall Study|Lost to Follow-up|3
95401|NCT00294671|327905|P1|Overall Study|Lost to Follow-up|1
95402|NCT00294671|327904|P2|Overall Study|Non-drug related AE|2
95403|NCT00294671|327905|P1|Overall Study|Non-drug related AE|3
95404|NCT00294671|327904|P2|Overall Study|Drug related adverse event (AE)|2
95405|NCT00294671|327905|P1|Overall Study|Drug related adverse event (AE)|4
95406|NCT00294671|327904|P2|Overall Study|Liver transplant|9
95407|NCT00294671|327905|P1|Overall Study|Liver transplant|7
95408|NCT00294671|327904|P2|Overall Study|Lack of Efficacy|23
95409|NCT00294671|327905|P1|Overall Study|Lack of Efficacy|11
95410|NCT00294684|327921|P2|Overall Study|Lost to Follow-up|8
95411|NCT00294684|327922|P1|Overall Study|Lost to Follow-up|5
95412|NCT00294723|327963|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
95413|NCT00294723|327964|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
95414|NCT00294723|327965|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
95415|NCT00294723|327963|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
95416|NCT00294723|327964|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
95417|NCT00294723|327965|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
95418|NCT00294723|327963|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
95419|NCT00294723|327964|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
95420|NCT00294723|327965|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
95421|NCT00294723|327963|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
95422|NCT00294723|327964|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
95423|NCT00294723|327965|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
95424|NCT00294723|327963|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
95425|NCT00294723|327964|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
95426|NCT00294723|327965|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
95427|NCT00294723|327963|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
95428|NCT00294723|327964|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
95429|NCT00294723|327965|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
95430|NCT00294723|327963|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
95431|NCT00294723|327964|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
95432|NCT00294723|327965|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
95433|NCT00294723|327963|P3|Open-Label Extension 52 Weeks|Adverse Event|2
95434|NCT00294723|327964|P2|Open-Label Extension 52 Weeks|Adverse Event|5
95435|NCT00294723|327965|P1|Open-Label Extension 52 Weeks|Adverse Event|5
95436|NCT00294723|327963|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
95437|NCT00294723|327964|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
95438|NCT00294723|327965|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
95439|NCT00294723|327963|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
95440|NCT00294723|327964|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
95441|NCT00294723|327965|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
95442|NCT00294723|327963|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
95443|NCT00294723|327964|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
95444|NCT00294723|327965|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
95445|NCT00294723|327963|P3|Double-Blind Period 52 Weeks|Adverse Event|15
95446|NCT00294723|327964|P2|Double-Blind Period 52 Weeks|Adverse Event|25
95447|NCT00294723|327965|P1|Double-Blind Period 52 Weeks|Adverse Event|18
95448|NCT00294762|328026|P2|Overall Study|Did not receive study treatment|3
95449|NCT00294762|328027|P1|Overall Study|Did not receive study treatment|3
95450|NCT00295490|328087|P4|Overall Study|Other|1
95451|NCT00295490|328088|P3|Overall Study|Other|0
95452|NCT00295490|328089|P2|Overall Study|Other|2
95453|NCT00295490|328090|P1|Overall Study|Other|0
95454|NCT00295490|328087|P4|Overall Study|Adverse Event|0
95455|NCT00295490|328088|P3|Overall Study|Adverse Event|0
95456|NCT00295490|328089|P2|Overall Study|Adverse Event|0
95457|NCT00295490|328090|P1|Overall Study|Adverse Event|1
95458|NCT00295490|328087|P4|Overall Study|Lost to Follow-up|0
95459|NCT00295490|328088|P3|Overall Study|Lost to Follow-up|1
95460|NCT00295490|328089|P2|Overall Study|Lost to Follow-up|0
95461|NCT00295490|328090|P1|Overall Study|Lost to Follow-up|0
95462|NCT00295490|328087|P4|Overall Study|Withdrawal by Subject|1
95463|NCT00295490|328088|P3|Overall Study|Withdrawal by Subject|0
95464|NCT00295490|328089|P2|Overall Study|Withdrawal by Subject|2
95465|NCT00295490|328090|P1|Overall Study|Withdrawal by Subject|0
95466|NCT00295490|328087|P4|Overall Study|Protocol Violation|3
95467|NCT00295490|328088|P3|Overall Study|Protocol Violation|3
95468|NCT00295490|328089|P2|Overall Study|Protocol Violation|0
95469|NCT00295490|328090|P1|Overall Study|Protocol Violation|0
95470|NCT00295633|328137|P3|Overall Study|Administrative reason by sponsor|1
95471|NCT00295633|328138|P2|Overall Study|Administrative reason by sponsor|0
95472|NCT00295633|328139|P1|Overall Study|Administrative reason by sponsor|0
95473|NCT00295633|328137|P3|Overall Study|Death|0
95474|NCT00295633|328138|P2|Overall Study|Death|1
95475|NCT00295633|328139|P1|Overall Study|Death|1
95476|NCT00295633|328137|P3|Overall Study|Subject No Longer Meets Study Criteria|3
95477|NCT00295633|328138|P2|Overall Study|Subject No Longer Meets Study Criteria|3
95478|NCT00295633|328139|P1|Overall Study|Subject No Longer Meets Study Criteria|0
95479|NCT00295633|328137|P3|Overall Study|Poor/Noncompliance|6
95480|NCT00295633|328138|P2|Overall Study|Poor/Noncompliance|2
95481|NCT00295633|328139|P1|Overall Study|Poor/Noncompliance|2
95482|NCT00295633|328137|P3|Overall Study|Physician Decision|8
95483|NCT00295633|328138|P2|Overall Study|Physician Decision|10
95484|NCT00295633|328139|P1|Overall Study|Physician Decision|9
95485|NCT00295633|328137|P3|Overall Study|Lost to Follow-up|7
95486|NCT00295633|328138|P2|Overall Study|Lost to Follow-up|11
95487|NCT00295633|328139|P1|Overall Study|Lost to Follow-up|6
95488|NCT00295633|328137|P3|Overall Study|Adverse Event|9
95489|NCT00295633|328138|P2|Overall Study|Adverse Event|17
95490|NCT00295633|328139|P1|Overall Study|Adverse Event|9
95491|NCT00295633|328137|P3|Overall Study|Withdrawal of consent by subject|26
95492|NCT00295633|328138|P2|Overall Study|Withdrawal of consent by subject|16
95493|NCT00295633|328139|P1|Overall Study|Withdrawal of consent by subject|16
95494|NCT00295633|328137|P3|Overall Study|Lack of Efficacy|16
95495|NCT00295633|328138|P2|Overall Study|Lack of Efficacy|7
95496|NCT00295633|328139|P1|Overall Study|Lack of Efficacy|19
95497|NCT00295750|328159|P3|Overall Study|Protocol Violation|2
95498|NCT00295750|328160|P2|Overall Study|Protocol Violation|4
95499|NCT00295750|328161|P1|Overall Study|Protocol Violation|2
95500|NCT00295750|328159|P3|Overall Study|Withdrawal by Subject|7
95501|NCT00295750|328160|P2|Overall Study|Withdrawal by Subject|4
95502|NCT00295750|328161|P1|Overall Study|Withdrawal by Subject|9
95503|NCT00295750|328159|P3|Overall Study|Randomized but never received trial drug|3
95504|NCT00295750|328160|P2|Overall Study|Randomized but never received trial drug|3
95505|NCT00295750|328161|P1|Overall Study|Randomized but never received trial drug|4
95506|NCT00295750|328159|P3|Overall Study|Personal reasons|0
95507|NCT00295750|328160|P2|Overall Study|Personal reasons|1
95508|NCT00295750|328161|P1|Overall Study|Personal reasons|0
95509|NCT00295750|328159|P3|Overall Study|Disease progression|0
95510|NCT00295750|328160|P2|Overall Study|Disease progression|1
95511|NCT00295750|328161|P1|Overall Study|Disease progression|2
95512|NCT00295750|328159|P3|Overall Study|Trial drug errors|0
95513|NCT00295750|328160|P2|Overall Study|Trial drug errors|1
95514|NCT00295750|328161|P1|Overall Study|Trial drug errors|1
95515|NCT00295750|328159|P3|Overall Study|Administrative errors|5
95516|NCT00295750|328160|P2|Overall Study|Administrative errors|4
95517|NCT00295750|328161|P1|Overall Study|Administrative errors|2
95518|NCT00295750|328159|P3|Overall Study|Taking prohibited therapy|2
95519|NCT00295750|328160|P2|Overall Study|Taking prohibited therapy|3
95520|NCT00295750|328161|P1|Overall Study|Taking prohibited therapy|2
95521|NCT00295750|328159|P3|Overall Study|Lost to Follow-up|1
95522|NCT00295750|328160|P2|Overall Study|Lost to Follow-up|4
95523|NCT00295750|328161|P1|Overall Study|Lost to Follow-up|1
95524|NCT00295750|328159|P3|Overall Study|Lack of Efficacy|0
95525|NCT00295750|328160|P2|Overall Study|Lack of Efficacy|1
95526|NCT00295750|328161|P1|Overall Study|Lack of Efficacy|1
95527|NCT00295750|328159|P3|Overall Study|Adverse Event|12
95528|NCT00295750|328160|P2|Overall Study|Adverse Event|15
95529|NCT00295750|328161|P1|Overall Study|Adverse Event|19
95530|NCT00295854|328196|P3|Overall Study|not specified|1
95531|NCT00295854|328197|P2|Overall Study|not specified|5
95532|NCT00295854|328198|P1|Overall Study|not specified|3
95533|NCT00295854|328196|P3|Overall Study|required a prohibited medication|0
95534|NCT00295854|328197|P2|Overall Study|required a prohibited medication|0
95535|NCT00295854|328198|P1|Overall Study|required a prohibited medication|1
95536|NCT00295854|328196|P3|Overall Study|did not continue to meet criteria|2
95537|NCT00295854|328197|P2|Overall Study|did not continue to meet criteria|1
95538|NCT00295854|328198|P1|Overall Study|did not continue to meet criteria|1
95539|NCT00295854|328196|P3|Overall Study|Withdrawal by Subject|4
95540|NCT00295854|328197|P2|Overall Study|Withdrawal by Subject|7
95541|NCT00295854|328198|P1|Overall Study|Withdrawal by Subject|3
95542|NCT00295854|328196|P3|Overall Study|Lost to Follow-up|1
95543|NCT00295854|328197|P2|Overall Study|Lost to Follow-up|0
95544|NCT00295854|328198|P1|Overall Study|Lost to Follow-up|2
95545|NCT00295854|328196|P3|Overall Study|Protocol Violation|1
95546|NCT00295854|328197|P2|Overall Study|Protocol Violation|1
95547|NCT00295854|328198|P1|Overall Study|Protocol Violation|1
95548|NCT00295854|328196|P3|Overall Study|Adverse Event|6
95549|NCT00295854|328197|P2|Overall Study|Adverse Event|7
95550|NCT00295854|328198|P1|Overall Study|Adverse Event|7
95551|NCT00295880|328209|P1|Overall Study|Unit randomization did not occur|1
95552|NCT00295880|328209|P1|Overall Study|IBMI unit could not be volume reduced|1
95553|NCT00296036|328222|P6|Overall Study|Protocol Violation|3
95554|NCT00296036|328223|P5|Overall Study|Protocol Violation|0
95555|NCT00296036|328224|P4|Overall Study|Protocol Violation|0
95556|NCT00296036|328225|P3|Overall Study|Protocol Violation|0
95557|NCT00296036|328226|P2|Overall Study|Protocol Violation|0
95558|NCT00296036|328227|P1|Overall Study|Protocol Violation|0
95559|NCT00296036|328222|P6|Overall Study|Withdrawal by Subject|1
95560|NCT00296036|328223|P5|Overall Study|Withdrawal by Subject|2
95561|NCT00296036|328224|P4|Overall Study|Withdrawal by Subject|1
95562|NCT00296036|328225|P3|Overall Study|Withdrawal by Subject|2
95563|NCT00296036|328226|P2|Overall Study|Withdrawal by Subject|0
95564|NCT00296036|328227|P1|Overall Study|Withdrawal by Subject|1
95565|NCT00296244|328301|P2|Overall Study|Underwent retransplant|1
95566|NCT00296244|328302|P1|Overall Study|Underwent retransplant|0
95567|NCT00296335|328333|P2|Overall Study|Physician Decision|11
95568|NCT00296335|328334|P1|Overall Study|Physician Decision|3
95569|NCT00296335|328333|P2|Overall Study|Lost to Follow-up|33
95570|NCT00296335|328334|P1|Overall Study|Lost to Follow-up|7
95571|NCT00296335|328333|P2|Overall Study|Adverse Event|27
95572|NCT00296335|328334|P1|Overall Study|Adverse Event|17
95573|NCT00296335|328333|P2|Overall Study|Recurrence|51
95574|NCT00296335|328334|P1|Overall Study|Recurrence|3
95575|NCT00296374|328347|P3|Overall Study|Not specified|1
95576|NCT00296374|328348|P2|Overall Study|Not specified|0
95577|NCT00296374|328349|P1|Overall Study|Not specified|0
95578|NCT00296374|328347|P3|Overall Study|Pregnancy|2
95579|NCT00296374|328348|P2|Overall Study|Pregnancy|0
95580|NCT00296374|328349|P1|Overall Study|Pregnancy|0
95581|NCT00296374|328347|P3|Overall Study|Nephrologist introduced ACE|0
95582|NCT00296374|328348|P2|Overall Study|Nephrologist introduced ACE|1
95583|NCT00296374|328349|P1|Overall Study|Nephrologist introduced ACE|0
95584|NCT00296374|328347|P3|Overall Study|Stopped drug before end of study visit|0
95585|NCT00296374|328348|P2|Overall Study|Stopped drug before end of study visit|1
95586|NCT00296374|328349|P1|Overall Study|Stopped drug before end of study visit|0
95587|NCT00296374|328347|P3|Overall Study|Relocated to another state|0
95588|NCT00296374|328348|P2|Overall Study|Relocated to another state|0
95589|NCT00296374|328349|P1|Overall Study|Relocated to another state|1
95590|NCT00296374|328347|P3|Overall Study|Lost to Follow-up|1
95591|NCT00296374|328348|P2|Overall Study|Lost to Follow-up|1
95592|NCT00296374|328349|P1|Overall Study|Lost to Follow-up|3
95593|NCT00296374|328347|P3|Overall Study|Protocol Violation|3
95594|NCT00296374|328348|P2|Overall Study|Protocol Violation|2
95595|NCT00296374|328349|P1|Overall Study|Protocol Violation|1
95596|NCT00296374|328347|P3|Overall Study|Incorrect enrollment|4
95597|NCT00296374|328348|P2|Overall Study|Incorrect enrollment|3
95598|NCT00296374|328349|P1|Overall Study|Incorrect enrollment|3
95599|NCT00296374|328347|P3|Overall Study|Withdrawal by Subject|11
95600|NCT00296374|328348|P2|Overall Study|Withdrawal by Subject|5
95601|NCT00296374|328349|P1|Overall Study|Withdrawal by Subject|3
95602|NCT00296374|328347|P3|Overall Study|Adverse Event|7
95603|NCT00296374|328348|P2|Overall Study|Adverse Event|10
95604|NCT00296374|328349|P1|Overall Study|Adverse Event|14
95605|NCT00296400|328573|P3|Overall Study|Pregnancy|0
95606|NCT00296400|328574|P2|Overall Study|Pregnancy|2
95607|NCT00296400|328575|P1|Overall Study|Pregnancy|1
95608|NCT00296400|328573|P3|Overall Study|Visit 10 was performed earlier|0
95609|NCT00296400|328574|P2|Overall Study|Visit 10 was performed earlier|1
95610|NCT00296400|328575|P1|Overall Study|Visit 10 was performed earlier|0
95611|NCT00296400|328573|P3|Overall Study|Study specific discontinuation criteria|1
95612|NCT00296400|328574|P2|Overall Study|Study specific discontinuation criteria|0
95613|NCT00296400|328575|P1|Overall Study|Study specific discontinuation criteria|0
95614|NCT00296400|328573|P3|Overall Study|Lost to Follow-up|2
95615|NCT00296400|328574|P2|Overall Study|Lost to Follow-up|1
95616|NCT00296400|328575|P1|Overall Study|Lost to Follow-up|1
95617|NCT00296400|328573|P3|Overall Study|Protocol Violation|1
95618|NCT00296400|328574|P2|Overall Study|Protocol Violation|1
95619|NCT00296400|328575|P1|Overall Study|Protocol Violation|1
95620|NCT00296400|328573|P3|Overall Study|Incorrect enrollment|0
95621|NCT00296400|328574|P2|Overall Study|Incorrect enrollment|0
95622|NCT00296400|328575|P1|Overall Study|Incorrect enrollment|2
95623|NCT00296400|328573|P3|Overall Study|Withdrawal by Subject|2
95624|NCT00296400|328574|P2|Overall Study|Withdrawal by Subject|6
95625|NCT00296400|328575|P1|Overall Study|Withdrawal by Subject|5
95626|NCT00296400|328573|P3|Overall Study|Adverse Event|7
95627|NCT00296400|328574|P2|Overall Study|Adverse Event|7
95628|NCT00296400|328575|P1|Overall Study|Adverse Event|7
95629|NCT00296491|328800|P4|Overall Study|Lost to Follow-up|0
95630|NCT00296491|328801|P3|Overall Study|Lost to Follow-up|2
95631|NCT00296491|328802|P2|Overall Study|Lost to Follow-up|2
95632|NCT00296491|328803|P1|Overall Study|Lost to Follow-up|0
95633|NCT00296491|328800|P4|Overall Study|Non-Compliance|14
95634|NCT00296491|328801|P3|Overall Study|Non-Compliance|10
95635|NCT00296491|328802|P2|Overall Study|Non-Compliance|13
95636|NCT00296491|328803|P1|Overall Study|Non-Compliance|12
95637|NCT00296491|328800|P4|Overall Study|Withdrawal by Subject|2
95638|NCT00296491|328801|P3|Overall Study|Withdrawal by Subject|3
95639|NCT00296491|328802|P2|Overall Study|Withdrawal by Subject|3
95640|NCT00296491|328803|P1|Overall Study|Withdrawal by Subject|7
95641|NCT00296491|328800|P4|Overall Study|Withdrawn due to Asthma|4
95642|NCT00296491|328801|P3|Overall Study|Withdrawn due to Asthma|0
95643|NCT00296491|328802|P2|Overall Study|Withdrawn due to Asthma|0
95644|NCT00296491|328803|P1|Overall Study|Withdrawn due to Asthma|0
95645|NCT00296491|328800|P4|Overall Study|Adverse Event|4
95646|NCT00296491|328801|P3|Overall Study|Adverse Event|1
95647|NCT00296491|328802|P2|Overall Study|Adverse Event|3
95648|NCT00296491|328803|P1|Overall Study|Adverse Event|1
95649|NCT00296491|328800|P4|Overall Study|Protocol Violation|3
95650|NCT00296491|328801|P3|Overall Study|Protocol Violation|2
95651|NCT00296491|328802|P2|Overall Study|Protocol Violation|6
95652|NCT00296491|328803|P1|Overall Study|Protocol Violation|4
95653|NCT00296491|328800|P4|Overall Study|Low Pollen Counts|16
95654|NCT00296491|328801|P3|Overall Study|Low Pollen Counts|25
95655|NCT00296491|328802|P2|Overall Study|Low Pollen Counts|26
95656|NCT00296491|328803|P1|Overall Study|Low Pollen Counts|18
95657|NCT00296504|328837|P9|Final Analysis|Poor Adherence|1
95658|NCT00296504|328838|P8|Final Analysis|Poor Adherence|0
95659|NCT00296504|328839|P7|Final Analysis|Poor Adherence|0
95660|NCT00296504|328840|P6|Final Analysis|Poor Adherence|0
95661|NCT00296504|328841|P5|Final Analysis|Poor Adherence|0
95662|NCT00296504|328842|P4|Final Analysis|Poor Adherence|0
95663|NCT00296504|328843|P3|Final Analysis|Poor Adherence|0
95664|NCT00296504|328844|P2|Final Analysis|Poor Adherence|0
95665|NCT00296504|328845|P1|Final Analysis|Poor Adherence|0
95666|NCT00296504|328837|P9|Final Analysis|Participant Moved to Another Country|1
95667|NCT00296504|328838|P8|Final Analysis|Participant Moved to Another Country|0
95668|NCT00296504|328839|P7|Final Analysis|Participant Moved to Another Country|0
95669|NCT00296504|328840|P6|Final Analysis|Participant Moved to Another Country|0
95670|NCT00296504|328841|P5|Final Analysis|Participant Moved to Another Country|0
95671|NCT00296504|328842|P4|Final Analysis|Participant Moved to Another Country|0
95672|NCT00296504|328843|P3|Final Analysis|Participant Moved to Another Country|0
95673|NCT00296504|328844|P2|Final Analysis|Participant Moved to Another Country|0
95674|NCT00296504|328845|P1|Final Analysis|Participant Moved to Another Country|0
95675|NCT00296504|328837|P9|Final Analysis|Tuberculosis|1
95676|NCT00296504|328838|P8|Final Analysis|Tuberculosis|0
95677|NCT00296504|328839|P7|Final Analysis|Tuberculosis|0
95678|NCT00296504|328840|P6|Final Analysis|Tuberculosis|0
95679|NCT00296504|328841|P5|Final Analysis|Tuberculosis|0
95680|NCT00296504|328842|P4|Final Analysis|Tuberculosis|0
95681|NCT00296504|328843|P3|Final Analysis|Tuberculosis|0
95682|NCT00296504|328844|P2|Final Analysis|Tuberculosis|0
95683|NCT00296504|328845|P1|Final Analysis|Tuberculosis|0
95684|NCT00296504|328837|P9|Final Analysis|Pregnancy|4
95685|NCT00296504|328838|P8|Final Analysis|Pregnancy|0
95686|NCT00296504|328839|P7|Final Analysis|Pregnancy|0
95687|NCT00296504|328840|P6|Final Analysis|Pregnancy|0
95688|NCT00296504|328841|P5|Final Analysis|Pregnancy|0
95689|NCT00296504|328842|P4|Final Analysis|Pregnancy|0
95690|NCT00296504|328843|P3|Final Analysis|Pregnancy|0
95691|NCT00296504|328844|P2|Final Analysis|Pregnancy|0
95692|NCT00296504|328845|P1|Final Analysis|Pregnancy|0
95693|NCT00296504|328837|P9|Final Analysis|Adverse Event|2
95694|NCT00296504|328838|P8|Final Analysis|Adverse Event|0
95695|NCT00296504|328839|P7|Final Analysis|Adverse Event|0
95696|NCT00296504|328840|P6|Final Analysis|Adverse Event|0
95697|NCT00296504|328841|P5|Final Analysis|Adverse Event|0
95698|NCT00296504|328842|P4|Final Analysis|Adverse Event|0
95699|NCT00296504|328843|P3|Final Analysis|Adverse Event|0
95700|NCT00296504|328844|P2|Final Analysis|Adverse Event|0
95701|NCT00296504|328845|P1|Final Analysis|Adverse Event|0
95702|NCT00296504|328837|P9|Final Analysis|Insufficient Viral Load Response|6
95703|NCT00296504|328838|P8|Final Analysis|Insufficient Viral Load Response|0
95704|NCT00296504|328839|P7|Final Analysis|Insufficient Viral Load Response|0
95705|NCT00296504|328840|P6|Final Analysis|Insufficient Viral Load Response|0
95706|NCT00296504|328841|P5|Final Analysis|Insufficient Viral Load Response|0
95707|NCT00296504|328842|P4|Final Analysis|Insufficient Viral Load Response|0
95708|NCT00296504|328843|P3|Final Analysis|Insufficient Viral Load Response|0
95709|NCT00296504|328844|P2|Final Analysis|Insufficient Viral Load Response|0
95710|NCT00296504|328845|P1|Final Analysis|Insufficient Viral Load Response|0
95711|NCT00296504|328837|P9|Final Analysis|Lost to Follow-up|5
95712|NCT00296504|328838|P8|Final Analysis|Lost to Follow-up|0
95713|NCT00296504|328839|P7|Final Analysis|Lost to Follow-up|0
95714|NCT00296504|328840|P6|Final Analysis|Lost to Follow-up|0
95715|NCT00296504|328841|P5|Final Analysis|Lost to Follow-up|0
95716|NCT00296504|328842|P4|Final Analysis|Lost to Follow-up|0
95717|NCT00296504|328843|P3|Final Analysis|Lost to Follow-up|0
95718|NCT00296504|328844|P2|Final Analysis|Lost to Follow-up|0
95719|NCT00296504|328845|P1|Final Analysis|Lost to Follow-up|0
95720|NCT00296504|328837|P9|Final Analysis|Withdrawal by Subject|1
95721|NCT00296504|328838|P8|Final Analysis|Withdrawal by Subject|0
95722|NCT00296504|328839|P7|Final Analysis|Withdrawal by Subject|0
95723|NCT00296504|328840|P6|Final Analysis|Withdrawal by Subject|0
95724|NCT00296504|328841|P5|Final Analysis|Withdrawal by Subject|0
95725|NCT00296504|328842|P4|Final Analysis|Withdrawal by Subject|0
95726|NCT00296504|328843|P3|Final Analysis|Withdrawal by Subject|0
95727|NCT00296504|328844|P2|Final Analysis|Withdrawal by Subject|0
95728|NCT00296504|328845|P1|Final Analysis|Withdrawal by Subject|0
95729|NCT00296504|328837|P9|Interim Analysis|Ongoing|0
95730|NCT00296504|328838|P8|Interim Analysis|Ongoing|1
95731|NCT00296504|328839|P7|Interim Analysis|Ongoing|30
95732|NCT00296504|328840|P6|Interim Analysis|Ongoing|0
95733|NCT00296504|328841|P5|Interim Analysis|Ongoing|0
95734|NCT00296504|328842|P4|Interim Analysis|Ongoing|22
95735|NCT00296504|328843|P3|Interim Analysis|Ongoing|16
95736|NCT00296504|328844|P2|Interim Analysis|Ongoing|12
95737|NCT00296504|328845|P1|Interim Analysis|Ongoing|32
95738|NCT00296504|328837|P9|Interim Analysis|Participant Needed Interferon|0
95739|NCT00296504|328838|P8|Interim Analysis|Participant Needed Interferon|1
95740|NCT00296504|328839|P7|Interim Analysis|Participant Needed Interferon|0
95741|NCT00296504|328840|P6|Interim Analysis|Participant Needed Interferon|0
95742|NCT00296504|328841|P5|Interim Analysis|Participant Needed Interferon|0
95743|NCT00296504|328842|P4|Interim Analysis|Participant Needed Interferon|0
95744|NCT00296504|328843|P3|Interim Analysis|Participant Needed Interferon|0
95745|NCT00296504|328844|P2|Interim Analysis|Participant Needed Interferon|0
95746|NCT00296504|328845|P1|Interim Analysis|Participant Needed Interferon|0
95747|NCT00296504|328837|P9|Interim Analysis|Study Ended|0
95748|NCT00296504|328838|P8|Interim Analysis|Study Ended|0
95749|NCT00296504|328839|P7|Interim Analysis|Study Ended|1
95750|NCT00296504|328840|P6|Interim Analysis|Study Ended|0
95751|NCT00296504|328841|P5|Interim Analysis|Study Ended|0
95752|NCT00296504|328842|P4|Interim Analysis|Study Ended|0
95753|NCT00296504|328843|P3|Interim Analysis|Study Ended|0
95754|NCT00296504|328844|P2|Interim Analysis|Study Ended|0
95755|NCT00296504|328845|P1|Interim Analysis|Study Ended|0
95756|NCT00296504|328837|P9|Interim Analysis|Participant Stopped HIV Medications|0
95757|NCT00296504|328838|P8|Interim Analysis|Participant Stopped HIV Medications|0
95758|NCT00296504|328839|P7|Interim Analysis|Participant Stopped HIV Medications|1
95759|NCT00296504|328840|P6|Interim Analysis|Participant Stopped HIV Medications|0
95760|NCT00296504|328841|P5|Interim Analysis|Participant Stopped HIV Medications|0
95761|NCT00296504|328842|P4|Interim Analysis|Participant Stopped HIV Medications|0
95762|NCT00296504|328843|P3|Interim Analysis|Participant Stopped HIV Medications|0
95763|NCT00296504|328844|P2|Interim Analysis|Participant Stopped HIV Medications|0
95764|NCT00296504|328845|P1|Interim Analysis|Participant Stopped HIV Medications|0
95765|NCT00296504|328837|P9|Interim Analysis|Physician and Participant Decision|0
95766|NCT00296504|328838|P8|Interim Analysis|Physician and Participant Decision|0
95767|NCT00296504|328839|P7|Interim Analysis|Physician and Participant Decision|0
95768|NCT00296504|328840|P6|Interim Analysis|Physician and Participant Decision|1
95769|NCT00296504|328841|P5|Interim Analysis|Physician and Participant Decision|0
95770|NCT00296504|328842|P4|Interim Analysis|Physician and Participant Decision|0
95771|NCT00296504|328843|P3|Interim Analysis|Physician and Participant Decision|0
95772|NCT00296504|328844|P2|Interim Analysis|Physician and Participant Decision|0
95773|NCT00296504|328845|P1|Interim Analysis|Physician and Participant Decision|0
95774|NCT00296504|328837|P9|Interim Analysis|Participant Stopped|0
95775|NCT00296504|328838|P8|Interim Analysis|Participant Stopped|0
95776|NCT00296504|328839|P7|Interim Analysis|Participant Stopped|0
95777|NCT00296504|328840|P6|Interim Analysis|Participant Stopped|0
95778|NCT00296504|328841|P5|Interim Analysis|Participant Stopped|1
95779|NCT00296504|328842|P4|Interim Analysis|Participant Stopped|0
95780|NCT00296504|328843|P3|Interim Analysis|Participant Stopped|0
95781|NCT00296504|328844|P2|Interim Analysis|Participant Stopped|0
95782|NCT00296504|328845|P1|Interim Analysis|Participant Stopped|0
95783|NCT00296504|328837|P9|Interim Analysis|Inclusion in Other Protocol|0
95784|NCT00296504|328838|P8|Interim Analysis|Inclusion in Other Protocol|0
95785|NCT00296504|328839|P7|Interim Analysis|Inclusion in Other Protocol|0
95786|NCT00296504|328840|P6|Interim Analysis|Inclusion in Other Protocol|0
95787|NCT00296504|328841|P5|Interim Analysis|Inclusion in Other Protocol|0
95788|NCT00296504|328842|P4|Interim Analysis|Inclusion in Other Protocol|1
95789|NCT00296504|328843|P3|Interim Analysis|Inclusion in Other Protocol|0
95790|NCT00296504|328844|P2|Interim Analysis|Inclusion in Other Protocol|0
95791|NCT00296504|328845|P1|Interim Analysis|Inclusion in Other Protocol|0
95792|NCT00296504|328837|P9|Interim Analysis|Missed Schedule Date|0
95793|NCT00296504|328838|P8|Interim Analysis|Missed Schedule Date|0
95794|NCT00296504|328839|P7|Interim Analysis|Missed Schedule Date|0
95795|NCT00296504|328840|P6|Interim Analysis|Missed Schedule Date|0
95796|NCT00296504|328841|P5|Interim Analysis|Missed Schedule Date|0
95797|NCT00296504|328842|P4|Interim Analysis|Missed Schedule Date|0
95798|NCT00296504|328843|P3|Interim Analysis|Missed Schedule Date|0
95799|NCT00296504|328844|P2|Interim Analysis|Missed Schedule Date|0
95800|NCT00296504|328845|P1|Interim Analysis|Missed Schedule Date|1
95801|NCT00296504|328837|P9|Interim Analysis|Lack of Personnel at Site|0
95802|NCT00296504|328838|P8|Interim Analysis|Lack of Personnel at Site|0
95803|NCT00296504|328839|P7|Interim Analysis|Lack of Personnel at Site|0
95804|NCT00296504|328840|P6|Interim Analysis|Lack of Personnel at Site|0
95805|NCT00296504|328841|P5|Interim Analysis|Lack of Personnel at Site|0
95806|NCT00296504|328842|P4|Interim Analysis|Lack of Personnel at Site|0
95807|NCT00296504|328843|P3|Interim Analysis|Lack of Personnel at Site|0
95808|NCT00296504|328844|P2|Interim Analysis|Lack of Personnel at Site|0
95809|NCT00296504|328845|P1|Interim Analysis|Lack of Personnel at Site|1
95810|NCT00296504|328837|P9|Interim Analysis|Site Closing|0
95811|NCT00296504|328838|P8|Interim Analysis|Site Closing|0
95812|NCT00296504|328839|P7|Interim Analysis|Site Closing|2
95813|NCT00296504|328840|P6|Interim Analysis|Site Closing|1
95814|NCT00296504|328841|P5|Interim Analysis|Site Closing|0
95815|NCT00296504|328842|P4|Interim Analysis|Site Closing|0
95816|NCT00296504|328843|P3|Interim Analysis|Site Closing|0
95817|NCT00296504|328844|P2|Interim Analysis|Site Closing|0
95818|NCT00296504|328845|P1|Interim Analysis|Site Closing|1
95819|NCT00296504|328837|P9|Interim Analysis|Non-adherence|0
95820|NCT00296504|328838|P8|Interim Analysis|Non-adherence|1
95821|NCT00296504|328839|P7|Interim Analysis|Non-adherence|0
95822|NCT00296504|328840|P6|Interim Analysis|Non-adherence|0
95823|NCT00296504|328841|P5|Interim Analysis|Non-adherence|1
95824|NCT00296504|328842|P4|Interim Analysis|Non-adherence|0
95825|NCT00296504|328843|P3|Interim Analysis|Non-adherence|0
95826|NCT00296504|328844|P2|Interim Analysis|Non-adherence|0
95827|NCT00296504|328845|P1|Interim Analysis|Non-adherence|2
95828|NCT00296504|328837|P9|Interim Analysis|Principle Investigator Terminated Study|0
95829|NCT00296504|328838|P8|Interim Analysis|Principle Investigator Terminated Study|0
95830|NCT00296504|328839|P7|Interim Analysis|Principle Investigator Terminated Study|0
95831|NCT00296504|328840|P6|Interim Analysis|Principle Investigator Terminated Study|0
95832|NCT00296504|328841|P5|Interim Analysis|Principle Investigator Terminated Study|0
95833|NCT00296504|328842|P4|Interim Analysis|Principle Investigator Terminated Study|0
95834|NCT00296504|328843|P3|Interim Analysis|Principle Investigator Terminated Study|1
95835|NCT00296504|328844|P2|Interim Analysis|Principle Investigator Terminated Study|0
95836|NCT00296504|328845|P1|Interim Analysis|Principle Investigator Terminated Study|0
95837|NCT00296504|328837|P9|Interim Analysis|Principle Investigator Discretion|0
95838|NCT00296504|328838|P8|Interim Analysis|Principle Investigator Discretion|0
95839|NCT00296504|328839|P7|Interim Analysis|Principle Investigator Discretion|0
95840|NCT00296504|328840|P6|Interim Analysis|Principle Investigator Discretion|0
95841|NCT00296504|328841|P5|Interim Analysis|Principle Investigator Discretion|0
95842|NCT00296504|328842|P4|Interim Analysis|Principle Investigator Discretion|1
95843|NCT00296504|328843|P3|Interim Analysis|Principle Investigator Discretion|1
95844|NCT00296504|328844|P2|Interim Analysis|Principle Investigator Discretion|0
95845|NCT00296504|328845|P1|Interim Analysis|Principle Investigator Discretion|2
95846|NCT00296504|328837|P9|Interim Analysis|Physician Decision|0
95847|NCT00296504|328838|P8|Interim Analysis|Physician Decision|0
95848|NCT00296504|328839|P7|Interim Analysis|Physician Decision|0
95849|NCT00296504|328840|P6|Interim Analysis|Physician Decision|0
95850|NCT00296504|328841|P5|Interim Analysis|Physician Decision|0
95851|NCT00296504|328842|P4|Interim Analysis|Physician Decision|0
95852|NCT00296504|328843|P3|Interim Analysis|Physician Decision|1
95853|NCT00296504|328844|P2|Interim Analysis|Physician Decision|0
95854|NCT00296504|328845|P1|Interim Analysis|Physician Decision|0
95855|NCT00296504|328837|P9|Interim Analysis|Resistance to FPV|0
95856|NCT00296504|328838|P8|Interim Analysis|Resistance to FPV|0
95857|NCT00296504|328839|P7|Interim Analysis|Resistance to FPV|0
95858|NCT00296504|328840|P6|Interim Analysis|Resistance to FPV|0
95859|NCT00296504|328841|P5|Interim Analysis|Resistance to FPV|0
95860|NCT00296504|328842|P4|Interim Analysis|Resistance to FPV|0
95861|NCT00296504|328843|P3|Interim Analysis|Resistance to FPV|1
95862|NCT00296504|328844|P2|Interim Analysis|Resistance to FPV|0
95863|NCT00296504|328845|P1|Interim Analysis|Resistance to FPV|0
95864|NCT00296504|328837|P9|Interim Analysis|Participant Was Incarcerated|0
95865|NCT00296504|328838|P8|Interim Analysis|Participant Was Incarcerated|0
95866|NCT00296504|328839|P7|Interim Analysis|Participant Was Incarcerated|0
95867|NCT00296504|328840|P6|Interim Analysis|Participant Was Incarcerated|0
95868|NCT00296504|328841|P5|Interim Analysis|Participant Was Incarcerated|0
95869|NCT00296504|328842|P4|Interim Analysis|Participant Was Incarcerated|0
95870|NCT00296504|328843|P3|Interim Analysis|Participant Was Incarcerated|1
95871|NCT00296504|328844|P2|Interim Analysis|Participant Was Incarcerated|0
95872|NCT00296504|328845|P1|Interim Analysis|Participant Was Incarcerated|2
95873|NCT00296504|328837|P9|Interim Analysis|Participant Moved|0
95874|NCT00296504|328838|P8|Interim Analysis|Participant Moved|0
95875|NCT00296504|328839|P7|Interim Analysis|Participant Moved|1
95876|NCT00296504|328840|P6|Interim Analysis|Participant Moved|1
95877|NCT00296504|328841|P5|Interim Analysis|Participant Moved|0
95878|NCT00296504|328842|P4|Interim Analysis|Participant Moved|0
95879|NCT00296504|328843|P3|Interim Analysis|Participant Moved|1
95880|NCT00296504|328844|P2|Interim Analysis|Participant Moved|0
95881|NCT00296504|328845|P1|Interim Analysis|Participant Moved|1
95882|NCT00296504|328837|P9|Interim Analysis|Participant Had Problems with Alcohol|0
95883|NCT00296504|328838|P8|Interim Analysis|Participant Had Problems with Alcohol|0
95884|NCT00296504|328839|P7|Interim Analysis|Participant Had Problems with Alcohol|0
95885|NCT00296504|328840|P6|Interim Analysis|Participant Had Problems with Alcohol|0
95886|NCT00296504|328841|P5|Interim Analysis|Participant Had Problems with Alcohol|0
95887|NCT00296504|328842|P4|Interim Analysis|Participant Had Problems with Alcohol|0
95888|NCT00296504|328843|P3|Interim Analysis|Participant Had Problems with Alcohol|1
95889|NCT00296504|328844|P2|Interim Analysis|Participant Had Problems with Alcohol|0
95890|NCT00296504|328845|P1|Interim Analysis|Participant Had Problems with Alcohol|0
95891|NCT00296504|328837|P9|Interim Analysis|To Simplify Treatment|0
95892|NCT00296504|328838|P8|Interim Analysis|To Simplify Treatment|0
95893|NCT00296504|328839|P7|Interim Analysis|To Simplify Treatment|2
95894|NCT00296504|328840|P6|Interim Analysis|To Simplify Treatment|0
95895|NCT00296504|328841|P5|Interim Analysis|To Simplify Treatment|0
95896|NCT00296504|328842|P4|Interim Analysis|To Simplify Treatment|0
95897|NCT00296504|328843|P3|Interim Analysis|To Simplify Treatment|1
95898|NCT00296504|328844|P2|Interim Analysis|To Simplify Treatment|0
95899|NCT00296504|328845|P1|Interim Analysis|To Simplify Treatment|0
95900|NCT00296504|328837|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
95901|NCT00296504|328838|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
95902|NCT00296504|328839|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
95903|NCT00296504|328840|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
95904|NCT00296504|328841|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
95905|NCT00296504|328842|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
95906|NCT00296504|328843|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
95907|NCT00296504|328844|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
95908|NCT00296504|328845|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
95909|NCT00296504|328837|P9|Interim Analysis|Participant Non-compliant|0
95910|NCT00296504|328838|P8|Interim Analysis|Participant Non-compliant|2
95911|NCT00296504|328839|P7|Interim Analysis|Participant Non-compliant|6
95912|NCT00296504|328840|P6|Interim Analysis|Participant Non-compliant|3
95913|NCT00296504|328841|P5|Interim Analysis|Participant Non-compliant|1
95914|NCT00296504|328842|P4|Interim Analysis|Participant Non-compliant|1
95915|NCT00296504|328843|P3|Interim Analysis|Participant Non-compliant|2
95916|NCT00296504|328844|P2|Interim Analysis|Participant Non-compliant|1
95917|NCT00296504|328845|P1|Interim Analysis|Participant Non-compliant|0
95918|NCT00296504|328837|P9|Interim Analysis|Death|0
95919|NCT00296504|328838|P8|Interim Analysis|Death|0
95920|NCT00296504|328839|P7|Interim Analysis|Death|0
95921|NCT00296504|328840|P6|Interim Analysis|Death|0
95922|NCT00296504|328841|P5|Interim Analysis|Death|0
95923|NCT00296504|328842|P4|Interim Analysis|Death|0
95924|NCT00296504|328843|P3|Interim Analysis|Death|3
95925|NCT00296504|328844|P2|Interim Analysis|Death|0
95926|NCT00296504|328845|P1|Interim Analysis|Death|1
95927|NCT00296504|328837|P9|Interim Analysis|Pregnancy|0
95928|NCT00296504|328838|P8|Interim Analysis|Pregnancy|1
95929|NCT00296504|328839|P7|Interim Analysis|Pregnancy|1
95930|NCT00296504|328840|P6|Interim Analysis|Pregnancy|1
95931|NCT00296504|328841|P5|Interim Analysis|Pregnancy|0
95932|NCT00296504|328842|P4|Interim Analysis|Pregnancy|2
95933|NCT00296504|328843|P3|Interim Analysis|Pregnancy|4
95934|NCT00296504|328844|P2|Interim Analysis|Pregnancy|1
95935|NCT00296504|328845|P1|Interim Analysis|Pregnancy|4
95936|NCT00296504|328837|P9|Interim Analysis|Switched to Commercially Available Drug|0
95937|NCT00296504|328838|P8|Interim Analysis|Switched to Commercially Available Drug|4
95938|NCT00296504|328839|P7|Interim Analysis|Switched to Commercially Available Drug|3
95939|NCT00296504|328840|P6|Interim Analysis|Switched to Commercially Available Drug|5
95940|NCT00296504|328841|P5|Interim Analysis|Switched to Commercially Available Drug|0
95941|NCT00296504|328842|P4|Interim Analysis|Switched to Commercially Available Drug|1
95942|NCT00296504|328843|P3|Interim Analysis|Switched to Commercially Available Drug|4
95943|NCT00296504|328844|P2|Interim Analysis|Switched to Commercially Available Drug|0
95944|NCT00296504|328845|P1|Interim Analysis|Switched to Commercially Available Drug|2
95945|NCT00296504|328837|P9|Interim Analysis|Insufficient CD4 Response|0
95946|NCT00296504|328838|P8|Interim Analysis|Insufficient CD4 Response|0
95947|NCT00296504|328839|P7|Interim Analysis|Insufficient CD4 Response|0
95948|NCT00296504|328840|P6|Interim Analysis|Insufficient CD4 Response|1
95949|NCT00296504|328841|P5|Interim Analysis|Insufficient CD4 Response|1
95950|NCT00296504|328842|P4|Interim Analysis|Insufficient CD4 Response|0
95951|NCT00296504|328843|P3|Interim Analysis|Insufficient CD4 Response|0
95952|NCT00296504|328844|P2|Interim Analysis|Insufficient CD4 Response|0
95953|NCT00296504|328845|P1|Interim Analysis|Insufficient CD4 Response|0
95954|NCT00296504|328837|P9|Interim Analysis|Protocol Violation|0
95955|NCT00296504|328838|P8|Interim Analysis|Protocol Violation|1
95956|NCT00296504|328839|P7|Interim Analysis|Protocol Violation|0
95957|NCT00296504|328840|P6|Interim Analysis|Protocol Violation|0
95958|NCT00296504|328841|P5|Interim Analysis|Protocol Violation|1
95959|NCT00296504|328842|P4|Interim Analysis|Protocol Violation|0
95960|NCT00296504|328843|P3|Interim Analysis|Protocol Violation|2
95961|NCT00296504|328844|P2|Interim Analysis|Protocol Violation|0
95962|NCT00296504|328845|P1|Interim Analysis|Protocol Violation|0
95963|NCT00296504|328837|P9|Interim Analysis|Adverse Event|0
95964|NCT00296504|328838|P8|Interim Analysis|Adverse Event|5
95965|NCT00296504|328839|P7|Interim Analysis|Adverse Event|4
95966|NCT00296504|328840|P6|Interim Analysis|Adverse Event|3
95967|NCT00296504|328841|P5|Interim Analysis|Adverse Event|6
95968|NCT00296504|328842|P4|Interim Analysis|Adverse Event|4
95969|NCT00296504|328843|P3|Interim Analysis|Adverse Event|13
95970|NCT00296504|328844|P2|Interim Analysis|Adverse Event|0
95971|NCT00296504|328845|P1|Interim Analysis|Adverse Event|0
95972|NCT00296504|328837|P9|Interim Analysis|Insufficient Viral Load Response|0
96141|NCT00289289|329296|P2|Overall Study|Lost to Follow-up|0
95973|NCT00296504|328838|P8|Interim Analysis|Insufficient Viral Load Response|24
95974|NCT00296504|328839|P7|Interim Analysis|Insufficient Viral Load Response|2
95975|NCT00296504|328840|P6|Interim Analysis|Insufficient Viral Load Response|9
95976|NCT00296504|328841|P5|Interim Analysis|Insufficient Viral Load Response|7
95977|NCT00296504|328842|P4|Interim Analysis|Insufficient Viral Load Response|2
95978|NCT00296504|328843|P3|Interim Analysis|Insufficient Viral Load Response|12
95979|NCT00296504|328844|P2|Interim Analysis|Insufficient Viral Load Response|1
95980|NCT00296504|328845|P1|Interim Analysis|Insufficient Viral Load Response|5
95981|NCT00296504|328837|P9|Interim Analysis|Clinical Progression|0
95982|NCT00296504|328838|P8|Interim Analysis|Clinical Progression|2
95983|NCT00296504|328839|P7|Interim Analysis|Clinical Progression|1
95984|NCT00296504|328840|P6|Interim Analysis|Clinical Progression|2
95985|NCT00296504|328841|P5|Interim Analysis|Clinical Progression|0
95986|NCT00296504|328842|P4|Interim Analysis|Clinical Progression|1
95987|NCT00296504|328843|P3|Interim Analysis|Clinical Progression|1
95988|NCT00296504|328844|P2|Interim Analysis|Clinical Progression|0
95989|NCT00296504|328845|P1|Interim Analysis|Clinical Progression|1
95990|NCT00296504|328837|P9|Interim Analysis|Lost to Follow-up|0
95991|NCT00296504|328838|P8|Interim Analysis|Lost to Follow-up|4
95992|NCT00296504|328839|P7|Interim Analysis|Lost to Follow-up|11
95993|NCT00296504|328840|P6|Interim Analysis|Lost to Follow-up|4
95994|NCT00296504|328841|P5|Interim Analysis|Lost to Follow-up|14
95995|NCT00296504|328842|P4|Interim Analysis|Lost to Follow-up|8
95996|NCT00296504|328843|P3|Interim Analysis|Lost to Follow-up|26
95997|NCT00296504|328844|P2|Interim Analysis|Lost to Follow-up|3
95998|NCT00296504|328845|P1|Interim Analysis|Lost to Follow-up|13
95999|NCT00296504|328837|P9|Interim Analysis|Withdrawal by Subject|0
96000|NCT00296504|328838|P8|Interim Analysis|Withdrawal by Subject|3
96001|NCT00296504|328839|P7|Interim Analysis|Withdrawal by Subject|9
96002|NCT00296504|328840|P6|Interim Analysis|Withdrawal by Subject|5
96003|NCT00296504|328841|P5|Interim Analysis|Withdrawal by Subject|5
96004|NCT00296504|328842|P4|Interim Analysis|Withdrawal by Subject|0
96005|NCT00296504|328843|P3|Interim Analysis|Withdrawal by Subject|12
96006|NCT00296504|328844|P2|Interim Analysis|Withdrawal by Subject|0
96007|NCT00296504|328845|P1|Interim Analysis|Withdrawal by Subject|8
96008|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Not specified|2
96009|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Not specified|0
96010|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
96011|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
96012|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
96013|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
96014|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
96015|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
96016|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
96017|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
96018|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
96019|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
96020|NCT00296517|328936|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
96021|NCT00296517|328937|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
96022|NCT00296517|328936|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
96023|NCT00296517|328937|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
96024|NCT00296517|328936|P2|Dose Level 2 - Week 2|Adverse Event|5
96025|NCT00296517|328937|P1|Dose Level 2 - Week 2|Adverse Event|1
96026|NCT00296647|328970|P5|Overall Study|Withdrawal by Subject|19
96027|NCT00296647|328971|P4|Overall Study|Withdrawal by Subject|16
96028|NCT00296647|328972|P3|Overall Study|Withdrawal by Subject|32
96029|NCT00296647|328973|P2|Overall Study|Withdrawal by Subject|27
96030|NCT00296647|328974|P1|Overall Study|Withdrawal by Subject|28
96031|NCT00296647|328970|P5|Overall Study|Death|1
96032|NCT00296647|328971|P4|Overall Study|Death|1
96033|NCT00296647|328972|P3|Overall Study|Death|2
96034|NCT00296647|328973|P2|Overall Study|Death|1
96035|NCT00296647|328974|P1|Overall Study|Death|4
96036|NCT00288587|328988|P2|Overall Study|Severe Aortic Stenosis|0
96037|NCT00288587|328989|P1|Overall Study|Severe Aortic Stenosis|1
96038|NCT00288587|328988|P2|Overall Study|Physician Decision|2
96039|NCT00288587|328989|P1|Overall Study|Physician Decision|0
96040|NCT00288587|328988|P2|Overall Study|Adverse Event|1
96041|NCT00288587|328989|P1|Overall Study|Adverse Event|0
96042|NCT00288587|328988|P2|Overall Study|Transplant|3
96043|NCT00288587|328989|P1|Overall Study|Transplant|0
96044|NCT00288587|328988|P2|Overall Study|Death|4
96045|NCT00288587|328989|P1|Overall Study|Death|4
96046|NCT00288626|329012|P1|Overall Study|Withdrawal by Subject|4
96047|NCT00288626|329012|P1|Overall Study|Death|3
96048|NCT00288639|329035|P1|Overall Study|Other|1
96049|NCT00288639|329035|P1|Overall Study|Withdrawal by Subject|2
96050|NCT00288639|329035|P1|Overall Study|Lack of Efficacy|4
96051|NCT00288639|329035|P1|Overall Study|Adverse Event|5
96052|NCT00288704|329055|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
96053|NCT00288704|329056|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
96054|NCT00288704|329057|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
96055|NCT00288704|329055|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
96056|NCT00288704|329056|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
96142|NCT00289289|329297|P1|Overall Study|Lost to Follow-up|1
96057|NCT00288704|329057|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
96058|NCT00288704|329055|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
96059|NCT00288704|329056|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
96060|NCT00288704|329057|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
96061|NCT00288704|329055|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
96062|NCT00288704|329056|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
96063|NCT00288704|329057|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
96064|NCT00288704|329055|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
96065|NCT00288704|329056|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
96066|NCT00288704|329057|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
96067|NCT00288704|329055|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
96068|NCT00288704|329056|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
96069|NCT00288704|329057|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
96070|NCT00288704|329055|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
96071|NCT00288704|329056|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
96072|NCT00288704|329057|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
96073|NCT00288860|329086|P2|Overall Study|Lost to Follow-up|71
96074|NCT00288860|329087|P1|Overall Study|Lost to Follow-up|74
96075|NCT00288860|329086|P2|Overall Study|Withdrawal by Subject|15
96076|NCT00288860|329087|P1|Overall Study|Withdrawal by Subject|20
96077|NCT00288860|329086|P2|Overall Study|Death|3
96078|NCT00288860|329087|P1|Overall Study|Death|4
96079|NCT00288860|329086|P2|Overall Study|Did not complete intake|8
96080|NCT00288860|329087|P1|Overall Study|Did not complete intake|4
96081|NCT00288912|329121|P3|Overall Study|Withdrawal by Subject|12
96082|NCT00288912|329122|P2|Overall Study|Withdrawal by Subject|5
96083|NCT00288912|329123|P1|Overall Study|Withdrawal by Subject|4
96084|NCT00288912|329121|P3|Overall Study|Lost to Follow-up|9
96085|NCT00288912|329122|P2|Overall Study|Lost to Follow-up|6
96086|NCT00288912|329123|P1|Overall Study|Lost to Follow-up|9
96087|NCT00288912|329121|P3|Overall Study|Developed exclusion criterion|7
96088|NCT00288912|329122|P2|Overall Study|Developed exclusion criterion|6
96089|NCT00288912|329123|P1|Overall Study|Developed exclusion criterion|4
96090|NCT00289016|329140|P1|Overall Study|Other|1
96091|NCT00289016|329140|P1|Overall Study|Adverse Event|1
96092|NCT00289016|329140|P1|Overall Study|Withdrawal by Subject|2
96093|NCT00289016|329140|P1|Overall Study|Unrelated Medical Condition or Accident|2
96094|NCT00289016|329140|P1|Overall Study|Death|2
96095|NCT00289016|329140|P1|Overall Study|Disease Progression|29
96096|NCT00289133|329185|P2|Overall Study|Lost to Follow-up|115
96097|NCT00289133|329186|P1|Overall Study|Lost to Follow-up|92
96098|NCT00289133|329185|P2|Overall Study|Revision|6
96099|NCT00289133|329186|P1|Overall Study|Revision|8
96100|NCT00289133|329185|P2|Overall Study|Physician Decision|45
96101|NCT00289133|329186|P1|Overall Study|Physician Decision|41
96102|NCT00289133|329185|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
96103|NCT00289133|329186|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
96104|NCT00289133|329185|P2|Overall Study|Death|10
96105|NCT00289133|329186|P1|Overall Study|Death|5
96106|NCT00289133|329185|P2|Overall Study|Withdrawal by Subject|10
96107|NCT00289133|329186|P1|Overall Study|Withdrawal by Subject|9
96108|NCT00289133|329185|P2|Overall Study|Protocol Violation|38
96109|NCT00289133|329186|P1|Overall Study|Protocol Violation|32
96110|NCT00289133|329185|P2|Overall Study|Non-study device implanted|0
96111|NCT00289133|329186|P1|Overall Study|Non-study device implanted|12
96112|NCT00289185|329210|P2|Overall Study|Death|1
96113|NCT00289185|329211|P1|Overall Study|Death|1
96114|NCT00289185|329210|P2|Overall Study|Lost to Follow-up|17
96115|NCT00289185|329211|P1|Overall Study|Lost to Follow-up|23
96116|NCT00289185|329210|P2|Overall Study|Withdrawal by Subject|8
96117|NCT00289185|329211|P1|Overall Study|Withdrawal by Subject|4
96118|NCT00289276|329279|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
96119|NCT00289276|329280|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
96120|NCT00289276|329279|P2|Second Part of FAST Study (Expansion)|Death|2
96121|NCT00289276|329280|P1|Second Part of FAST Study (Expansion)|Death|0
96122|NCT00289289|329295|P3|Overall Study|Other Exit Reason|12
96123|NCT00289289|329296|P2|Overall Study|Other Exit Reason|4
96124|NCT00289289|329297|P1|Overall Study|Other Exit Reason|6
96125|NCT00289289|329295|P3|Overall Study|Did not meet inclusion/exclusion|6
96126|NCT00289289|329296|P2|Overall Study|Did not meet inclusion/exclusion|0
96127|NCT00289289|329297|P1|Overall Study|Did not meet inclusion/exclusion|0
96128|NCT00289289|329295|P3|Overall Study|Non-study device implanted|3
96129|NCT00289289|329296|P2|Overall Study|Non-study device implanted|1
96130|NCT00289289|329297|P1|Overall Study|Non-study device implanted|2
96131|NCT00289289|329295|P3|Overall Study|Physician Decision|6
96132|NCT00289289|329296|P2|Overall Study|Physician Decision|0
96133|NCT00289289|329297|P1|Overall Study|Physician Decision|1
96134|NCT00289289|329295|P3|Overall Study|No implant attempted|1
96135|NCT00289289|329296|P2|Overall Study|No implant attempted|0
96136|NCT00289289|329297|P1|Overall Study|No implant attempted|0
96137|NCT00289289|329295|P3|Overall Study|Death|5
96138|NCT00289289|329296|P2|Overall Study|Death|2
96139|NCT00289289|329297|P1|Overall Study|Death|4
96140|NCT00289289|329295|P3|Overall Study|Lost to Follow-up|1
96143|NCT00289289|329295|P3|Overall Study|Withdrawal by Subject|15
96144|NCT00289289|329296|P2|Overall Study|Withdrawal by Subject|3
96145|NCT00289289|329297|P1|Overall Study|Withdrawal by Subject|5
96146|NCT00289458|329326|P3|Overall Study|Withdrawal by Subject|4
96147|NCT00289458|329327|P2|Overall Study|Withdrawal by Subject|2
96148|NCT00289458|329328|P1|Overall Study|Withdrawal by Subject|2
96149|NCT00289458|329326|P3|Overall Study|Physician Decision|2
96150|NCT00289458|329327|P2|Overall Study|Physician Decision|4
96151|NCT00289458|329328|P1|Overall Study|Physician Decision|3
96152|NCT00289458|329326|P3|Overall Study|Death|0
96153|NCT00289458|329327|P2|Overall Study|Death|0
96154|NCT00289458|329328|P1|Overall Study|Death|1
96155|NCT00289536|329355|P3|Period 3|Lost to Follow-up|1
96156|NCT00289536|329356|P2|Period 3|Lost to Follow-up|0
96157|NCT00289536|329357|P1|Period 3|Lost to Follow-up|0
96158|NCT00289770|329439|P1|Year 15|Withdrawal by Subject|1
96159|NCT00289783|329453|P2|Fourth Dose Phase|Unspecified|10
96160|NCT00289783|329454|P1|Fourth Dose Phase|Unspecified|22
96161|NCT00289783|329453|P2|Fourth Dose Phase|Migration from the study area|1
96162|NCT00289783|329454|P1|Fourth Dose Phase|Migration from the study area|1
96163|NCT00289783|329453|P2|Fourth Dose Phase|Lost to Follow-up|12
96164|NCT00289783|329454|P1|Fourth Dose Phase|Lost to Follow-up|53
96165|NCT00289783|329453|P2|Fourth Dose Phase|Withdrawal by Subject|1
96166|NCT00289783|329454|P1|Fourth Dose Phase|Withdrawal by Subject|10
96167|NCT00289783|329453|P2|Fourth Dose Phase|Adverse Event|0
96168|NCT00289783|329454|P1|Fourth Dose Phase|Adverse Event|1
96169|NCT00289783|329453|P2|Primary Phase|Unspecified|12
96170|NCT00289783|329454|P1|Primary Phase|Unspecified|32
96171|NCT00289783|329453|P2|Primary Phase|Migration from the study area|10
96172|NCT00289783|329454|P1|Primary Phase|Migration from the study area|26
96173|NCT00289783|329453|P2|Primary Phase|Lost to Follow-up|14
96174|NCT00289783|329454|P1|Primary Phase|Lost to Follow-up|60
96175|NCT00289783|329453|P2|Primary Phase|Withdrawal by Subject|40
96176|NCT00289783|329454|P1|Primary Phase|Withdrawal by Subject|93
96177|NCT00289783|329453|P2|Primary Phase|Protocol Violation|6
96178|NCT00289783|329454|P1|Primary Phase|Protocol Violation|27
96179|NCT00289783|329453|P2|Primary Phase|Adverse Event|1
96180|NCT00289783|329454|P1|Primary Phase|Adverse Event|10
96181|NCT00289848|329634|P2|Overall Study|Open-Label AHA Treatment Requested|1
96182|NCT00289848|329635|P1|Overall Study|Open-Label AHA Treatment Requested|0
96183|NCT00289848|329634|P2|Overall Study|Patient Moved|2
96184|NCT00289848|329635|P1|Overall Study|Patient Moved|6
96185|NCT00289848|329634|P2|Overall Study|Withdrawal by Subject|11
96186|NCT00289848|329635|P1|Overall Study|Withdrawal by Subject|5
96187|NCT00289848|329634|P2|Overall Study|Protocol Violation|2
96188|NCT00289848|329635|P1|Overall Study|Protocol Violation|5
96189|NCT00289848|329634|P2|Overall Study|Lost to Follow-up|1
96190|NCT00289848|329635|P1|Overall Study|Lost to Follow-up|3
96191|NCT00289848|329634|P2|Overall Study|Lack of Efficacy|24
96192|NCT00289848|329635|P1|Overall Study|Lack of Efficacy|20
96193|NCT00289848|329634|P2|Overall Study|Death|0
96194|NCT00289848|329635|P1|Overall Study|Death|1
96195|NCT00289848|329634|P2|Overall Study|Adverse Event|4
96196|NCT00289848|329635|P1|Overall Study|Adverse Event|6
96197|NCT00289874|329647|P2|Overall Study|Did not meet eligibility|0
96198|NCT00289874|329648|P1|Overall Study|Did not meet eligibility|1
96199|NCT00289874|329647|P2|Overall Study|Protocol Violation|2
96200|NCT00289874|329648|P1|Overall Study|Protocol Violation|3
96201|NCT00289874|329647|P2|Overall Study|Lost to Follow-up|1
96202|NCT00289874|329648|P1|Overall Study|Lost to Follow-up|1
96203|NCT00289874|329647|P2|Overall Study|Adverse Event|5
96204|NCT00289874|329648|P1|Overall Study|Adverse Event|1
96205|NCT00289887|329658|P2|Overall Study|Unspecified|3
96206|NCT00289887|329659|P1|Overall Study|Unspecified|7
96207|NCT00289887|329658|P2|Overall Study|Withdrawal by Subject|8
96208|NCT00289887|329659|P1|Overall Study|Withdrawal by Subject|3
96209|NCT00289887|329658|P2|Overall Study|Protocol Violation|1
96210|NCT00289887|329659|P1|Overall Study|Protocol Violation|3
96211|NCT00289887|329658|P2|Overall Study|Lost to Follow-up|3
96212|NCT00289887|329659|P1|Overall Study|Lost to Follow-up|3
96213|NCT00289887|329658|P2|Overall Study|Lack of Efficacy|11
96214|NCT00289887|329659|P1|Overall Study|Lack of Efficacy|3
96215|NCT00289887|329658|P2|Overall Study|Adverse Event|3
96216|NCT00289887|329659|P1|Overall Study|Adverse Event|3
96217|NCT00289900|329681|P6|Overall Study|Not treated|0
96218|NCT00289900|329682|P5|Overall Study|Not treated|0
96219|NCT00289900|329683|P4|Overall Study|Not treated|0
96220|NCT00289900|329684|P3|Overall Study|Not treated|0
96221|NCT00289900|329685|P2|Overall Study|Not treated|1
96222|NCT00289900|329686|P1|Overall Study|Not treated|0
96223|NCT00289900|329681|P6|Overall Study|site terminated|0
96224|NCT00289900|329682|P5|Overall Study|site terminated|0
96225|NCT00289900|329683|P4|Overall Study|site terminated|0
96226|NCT00289900|329684|P3|Overall Study|site terminated|1
96227|NCT00289900|329685|P2|Overall Study|site terminated|0
96228|NCT00289900|329686|P1|Overall Study|site terminated|1
96229|NCT00289900|329681|P6|Overall Study|Protocol Violation|4
96230|NCT00289900|329682|P5|Overall Study|Protocol Violation|7
96231|NCT00289900|329683|P4|Overall Study|Protocol Violation|6
96232|NCT00289900|329684|P3|Overall Study|Protocol Violation|2
96233|NCT00289900|329685|P2|Overall Study|Protocol Violation|9
96234|NCT00289900|329686|P1|Overall Study|Protocol Violation|3
96235|NCT00289900|329681|P6|Overall Study|Withdrawal by Subject|11
96236|NCT00289900|329682|P5|Overall Study|Withdrawal by Subject|12
96237|NCT00289900|329683|P4|Overall Study|Withdrawal by Subject|18
96238|NCT00289900|329684|P3|Overall Study|Withdrawal by Subject|8
96239|NCT00289900|329685|P2|Overall Study|Withdrawal by Subject|21
96240|NCT00289900|329686|P1|Overall Study|Withdrawal by Subject|10
96241|NCT00289900|329681|P6|Overall Study|Participant moved|1
96242|NCT00289900|329682|P5|Overall Study|Participant moved|1
96243|NCT00289900|329683|P4|Overall Study|Participant moved|1
96244|NCT00289900|329684|P3|Overall Study|Participant moved|0
96245|NCT00289900|329685|P2|Overall Study|Participant moved|0
96246|NCT00289900|329686|P1|Overall Study|Participant moved|1
96247|NCT00289900|329681|P6|Overall Study|Other|0
96248|NCT00289900|329682|P5|Overall Study|Other|1
96249|NCT00289900|329683|P4|Overall Study|Other|5
96250|NCT00289900|329684|P3|Overall Study|Other|0
96251|NCT00289900|329685|P2|Overall Study|Other|0
96252|NCT00289900|329686|P1|Overall Study|Other|0
96253|NCT00289900|329681|P6|Overall Study|Participant had flushing|4
96254|NCT00289900|329682|P5|Overall Study|Participant had flushing|0
96255|NCT00289900|329683|P4|Overall Study|Participant had flushing|2
96256|NCT00289900|329684|P3|Overall Study|Participant had flushing|1
96257|NCT00289900|329685|P2|Overall Study|Participant had flushing|42
96258|NCT00289900|329686|P1|Overall Study|Participant had flushing|18
96259|NCT00289900|329681|P6|Overall Study|Lost to Follow-up|8
96260|NCT00289900|329682|P5|Overall Study|Lost to Follow-up|4
96261|NCT00289900|329683|P4|Overall Study|Lost to Follow-up|8
96262|NCT00289900|329684|P3|Overall Study|Lost to Follow-up|8
96263|NCT00289900|329685|P2|Overall Study|Lost to Follow-up|7
96264|NCT00289900|329686|P1|Overall Study|Lost to Follow-up|7
96265|NCT00289900|329681|P6|Overall Study|Adverse Event|33
96266|NCT00289900|329682|P5|Overall Study|Adverse Event|20
96267|NCT00289900|329683|P4|Overall Study|Adverse Event|19
96268|NCT00289900|329684|P3|Overall Study|Adverse Event|13
96269|NCT00289900|329685|P2|Overall Study|Adverse Event|40
96270|NCT00289900|329686|P1|Overall Study|Adverse Event|28
96271|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
96272|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
96273|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
96274|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
96275|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
96276|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
96277|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
96278|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
96279|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
96280|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
96281|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
96282|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
96283|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
96284|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
96285|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
96286|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
96287|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
96288|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
96289|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
96290|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
96291|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
96292|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
96293|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
96294|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
96295|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
96296|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96297|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
96298|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96299|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96300|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96301|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
96302|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
96303|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
96304|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
96305|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
96306|NCT00289913|329793|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96307|NCT00289913|329794|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96308|NCT00289913|329795|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96309|NCT00289913|329796|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
96310|NCT00289913|329797|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96311|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
96312|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
96313|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
96314|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
96315|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
96316|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
96317|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
96318|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
96319|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
96320|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
96321|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
96322|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
96323|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
96324|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
96325|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
96326|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
96327|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
96328|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
96329|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
96330|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
96331|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
96332|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
96333|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
96334|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
96335|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
96336|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
96337|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
96338|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
96339|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
96340|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
96341|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
96342|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
96343|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
96344|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
96345|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
96346|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
96347|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
96348|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
96349|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
96350|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
96351|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
96352|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
96353|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
96354|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
96355|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
96356|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
96357|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
96358|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
96359|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
96360|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
96361|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96362|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96363|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
96364|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
96365|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
96366|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
96367|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
96368|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
96369|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
96370|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
96371|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
96372|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
96373|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
96374|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
96375|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
96376|NCT00289913|329793|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96377|NCT00289913|329794|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96378|NCT00289913|329795|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
96379|NCT00289913|329796|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96380|NCT00289913|329797|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96381|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
96382|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
96383|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
96384|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
96385|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
96386|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
96387|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
96388|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
96389|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
96390|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
96391|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
96392|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
96393|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
96394|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
96395|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
96396|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
96397|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
96398|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
96399|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
96400|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
96401|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
96402|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
96403|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
96404|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
96405|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
96406|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
96407|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
96408|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
96409|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
96410|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
96411|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
96412|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
96413|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
96414|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
96415|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
96416|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
96417|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
96418|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
96419|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
96420|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
96421|NCT00289913|329793|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96422|NCT00289913|329794|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96423|NCT00289913|329795|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96424|NCT00289913|329796|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
96425|NCT00289913|329797|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
96426|NCT00289978|329825|P3|Overall Study|Death|2
96427|NCT00289978|329826|P2|Overall Study|Death|0
96428|NCT00289978|329827|P1|Overall Study|Death|1
96429|NCT00289978|329825|P3|Overall Study|Abnormal test procedure result(s)|1
96430|NCT00289978|329826|P2|Overall Study|Abnormal test procedure result(s)|1
96431|NCT00289978|329827|P1|Overall Study|Abnormal test procedure result(s)|2
96432|NCT00289978|329825|P3|Overall Study|Protocol Violation|4
96433|NCT00289978|329826|P2|Overall Study|Protocol Violation|5
96434|NCT00289978|329827|P1|Overall Study|Protocol Violation|5
96435|NCT00289978|329825|P3|Overall Study|Lost to Follow-up|7
96436|NCT00289978|329826|P2|Overall Study|Lost to Follow-up|5
96437|NCT00289978|329827|P1|Overall Study|Lost to Follow-up|3
96438|NCT00289978|329825|P3|Overall Study|Abnormal laboratory value(s)|1
96439|NCT00289978|329826|P2|Overall Study|Abnormal laboratory value(s)|9
96440|NCT00289978|329827|P1|Overall Study|Abnormal laboratory value(s)|20
96441|NCT00289978|329825|P3|Overall Study|Lack of Efficacy|25
96442|NCT00289978|329826|P2|Overall Study|Lack of Efficacy|6
96443|NCT00289978|329827|P1|Overall Study|Lack of Efficacy|13
96444|NCT00289978|329825|P3|Overall Study|Adverse Event|18
96445|NCT00289978|329826|P2|Overall Study|Adverse Event|13
96446|NCT00289978|329827|P1|Overall Study|Adverse Event|22
96447|NCT00289978|329825|P3|Overall Study|Withdrawal by Subject|28
96448|NCT00289978|329826|P2|Overall Study|Withdrawal by Subject|17
96449|NCT00289978|329827|P1|Overall Study|Withdrawal by Subject|31
96450|NCT00289991|329843|P2|Overall Study|Unspecified|14
96451|NCT00289991|329844|P1|Overall Study|Unspecified|5
96452|NCT00289991|329843|P2|Overall Study|Withdrawal by Subject|12
96453|NCT00289991|329844|P1|Overall Study|Withdrawal by Subject|2
96454|NCT00289991|329843|P2|Overall Study|Lost to Follow-up|1
96455|NCT00289991|329844|P1|Overall Study|Lost to Follow-up|0
96456|NCT00289991|329843|P2|Overall Study|Fungal breakthrough infection|1
96457|NCT00289991|329844|P1|Overall Study|Fungal breakthrough infection|0
96458|NCT00289991|329843|P2|Overall Study|Failure of prophylaxis|1
96459|NCT00289991|329844|P1|Overall Study|Failure of prophylaxis|1
96460|NCT00289991|329843|P2|Overall Study|Adverse Event|13
96461|NCT00289991|329844|P1|Overall Study|Adverse Event|15
96462|NCT00289991|329843|P2|Overall Study|Death|38
96463|NCT00289991|329844|P1|Overall Study|Death|35
96464|NCT00290186|329879|P2|Overall Study|Withdrawal by Subject|1
96465|NCT00290186|329880|P1|Overall Study|Withdrawal by Subject|0
96466|NCT00290186|329879|P2|Overall Study|Study was terminated prior to 3-month te|1
96467|NCT00290186|329880|P1|Overall Study|Study was terminated prior to 3-month te|1
96468|NCT00290186|329879|P2|Overall Study|Lost to Follow-up|2
96469|NCT00290186|329880|P1|Overall Study|Lost to Follow-up|3
96470|NCT00290186|329879|P2|Overall Study|Adverse Event|1
96471|NCT00290186|329880|P1|Overall Study|Adverse Event|1
96472|NCT00290238|329935|P2|Overall Study|Withdrawal by Subject|13
96473|NCT00290238|329936|P1|Overall Study|Withdrawal by Subject|15
96474|NCT00290238|329935|P2|Overall Study|Lost to Follow-up|1
96475|NCT00290238|329936|P1|Overall Study|Lost to Follow-up|0
96476|NCT00290238|329935|P2|Overall Study|Study terminated|27
96477|NCT00290238|329936|P1|Overall Study|Study terminated|27
96478|NCT00290251|329944|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
96479|NCT00290251|329945|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
96480|NCT00290251|329946|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
96481|NCT00290251|329944|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
96482|NCT00290251|329945|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
96483|NCT00290251|329946|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
96484|NCT00290251|329944|P3|Treatment 1 (Months 1 - 3)|headache|0
96485|NCT00290251|329945|P2|Treatment 1 (Months 1 - 3)|headache|1
96486|NCT00290251|329946|P1|Treatment 1 (Months 1 - 3)|headache|0
96487|NCT00290251|329944|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
96488|NCT00290251|329945|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
96489|NCT00290251|329946|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
96490|NCT00290290|329958|P2|Overall Study|Underwent clean surgical procedure|12
96491|NCT00290290|329959|P1|Overall Study|Underwent clean surgical procedure|13
96492|NCT00290290|329958|P2|Overall Study|Withdrawal by Subject|2
96493|NCT00290290|329959|P1|Overall Study|Withdrawal by Subject|2
96494|NCT00290290|329958|P2|Overall Study|Death|4
96495|NCT00290290|329959|P1|Overall Study|Death|3
96496|NCT00290732|330042|P5|Overall Study|Inability to instill drug intraductally.|0
96497|NCT00290732|330043|P4|Overall Study|Inability to instill drug intraductally.|0
96498|NCT00290732|330044|P3|Overall Study|Inability to instill drug intraductally.|1
96499|NCT00290732|330045|P2|Overall Study|Inability to instill drug intraductally.|1
96500|NCT00290732|330046|P1|Overall Study|Inability to instill drug intraductally.|0
96501|NCT00290758|330066|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
96502|NCT00290758|330067|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
96503|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
96504|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
96505|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
96506|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
96507|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
96508|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
96509|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
96510|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
96511|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
96512|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
96513|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
96514|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
96515|NCT00290758|330066|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
96516|NCT00290758|330067|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
96517|NCT00290771|330089|P2|Overall Study|Lost to Follow-up|1
96518|NCT00290771|330090|P1|Overall Study|Lost to Follow-up|0
96519|NCT00290771|330089|P2|Overall Study|Protocol Violation|0
96520|NCT00290771|330090|P1|Overall Study|Protocol Violation|2
96521|NCT00290771|330089|P2|Overall Study|Administrative problems|1
96522|NCT00290771|330090|P1|Overall Study|Administrative problems|2
96523|NCT00290771|330089|P2|Overall Study|Withdrawal by Subject|6
96524|NCT00290771|330090|P1|Overall Study|Withdrawal by Subject|5
96525|NCT00290771|330089|P2|Overall Study|Adverse Event|6
96526|NCT00290771|330090|P1|Overall Study|Adverse Event|12
96527|NCT00290771|330089|P2|Overall Study|Death|10
96528|NCT00290771|330090|P1|Overall Study|Death|11
96529|NCT00290771|330089|P2|Overall Study|Disease progression|73
96530|NCT00290771|330090|P1|Overall Study|Disease progression|95
96531|NCT00290888|330121|P2|Overall Study|Physician Decision|1
96532|NCT00290888|330122|P1|Overall Study|Physician Decision|3
96533|NCT00291018|330133|P3|Overall Study|Lost to Follow-up|18
96534|NCT00291018|330134|P2|Overall Study|Lost to Follow-up|4
96535|NCT00291018|330135|P1|Overall Study|Lost to Follow-up|3
96536|NCT00291018|330133|P3|Overall Study|Failures|5
96537|NCT00291018|330134|P2|Overall Study|Failures|12
96538|NCT00291018|330135|P1|Overall Study|Failures|5
96539|NCT00291018|330133|P3|Overall Study|Withdrawal by Subject|1
96540|NCT00291018|330134|P2|Overall Study|Withdrawal by Subject|8
96541|NCT00291018|330135|P1|Overall Study|Withdrawal by Subject|2
96542|NCT00291018|330133|P3|Overall Study|Death|4
96543|NCT00291018|330134|P2|Overall Study|Death|3
96544|NCT00291018|330135|P1|Overall Study|Death|3
96545|NCT00291018|330133|P3|Overall Study|Not Consented or Declined PAS|15
96546|NCT00291018|330134|P2|Overall Study|Not Consented or Declined PAS|15
96547|NCT00291018|330135|P1|Overall Study|Not Consented or Declined PAS|12
96548|NCT00296816|330175|P1|Overall Study|ineligibility due to radiation treatment|1
96549|NCT00296816|330175|P1|Overall Study|Proteinuria|1
96550|NCT00296816|330175|P1|Overall Study|Neuropathy/patient preference|1
96551|NCT00296816|330175|P1|Overall Study|Urine protein/creatinine ratio delay|1
96552|NCT00296816|330175|P1|Overall Study|Noncompliance/decision to discontinue|1
96553|NCT00296816|330175|P1|Overall Study|Relocation to Florida|1
96554|NCT00296816|330175|P1|Overall Study|Poor performance status|1
96555|NCT00296816|330175|P1|Overall Study|Progression based on CA-125 (biomarker)|2
96556|NCT00296816|330175|P1|Overall Study|Missing for end of treatment|4
96557|NCT00296816|330175|P1|Overall Study|Non-compliance|1
96558|NCT00296816|330175|P1|Overall Study|Investigator/Participant request|5
96559|NCT00296816|330175|P1|Overall Study|Adverse Event|18
96560|NCT00296816|330175|P1|Overall Study|Disease Progression|37
96561|NCT00297037|330189|P2|Overall Study|Withdrawal by Subject|0
96562|NCT00297037|330190|P1|Overall Study|Withdrawal by Subject|2
96563|NCT00300755|330237|P3|Overall Study|Protocol Violation|1
96564|NCT00300755|330238|P2|Overall Study|Protocol Violation|0
96565|NCT00300755|330239|P1|Overall Study|Protocol Violation|0
96566|NCT00300755|330237|P3|Overall Study|Withdrawal by Subject|0
96567|NCT00300755|330238|P2|Overall Study|Withdrawal by Subject|2
96568|NCT00300755|330239|P1|Overall Study|Withdrawal by Subject|0
96569|NCT00300755|330237|P3|Overall Study|Adverse Event|1
96570|NCT00300755|330238|P2|Overall Study|Adverse Event|2
96571|NCT00300755|330239|P1|Overall Study|Adverse Event|1
96572|NCT00300885|330258|P2|Follow-up|Withdrawal by Subject|25
96573|NCT00300885|330259|P1|Follow-up|Withdrawal by Subject|26
96574|NCT00300885|330258|P2|Follow-up|Lost to Follow-up|7
96575|NCT00300885|330259|P1|Follow-up|Lost to Follow-up|11
96576|NCT00300885|330258|P2|Follow-up|Death|163
96577|NCT00300885|330259|P1|Follow-up|Death|141
96578|NCT00300885|330258|P2|Treatment|Non-compliant with study medication|4
96579|NCT00300885|330259|P1|Treatment|Non-compliant with study medication|3
96580|NCT00300885|330258|P2|Treatment|Random code broken (subject died)|1
96581|NCT00300885|330259|P1|Treatment|Random code broken (subject died)|0
96582|NCT00300885|330258|P2|Treatment|Disease progression|238
96583|NCT00300885|330259|P1|Treatment|Disease progression|171
96584|NCT00300885|330258|P2|Treatment|Withdrawal by Subject|23
96585|NCT00300885|330259|P1|Treatment|Withdrawal by Subject|26
96586|NCT00300885|330258|P2|Treatment|Protocol Violation|11
96587|NCT00300885|330259|P1|Treatment|Protocol Violation|11
96588|NCT00300885|330258|P2|Treatment|Physician Decision|5
96589|NCT00300885|330259|P1|Treatment|Physician Decision|4
96590|NCT00300885|330258|P2|Treatment|Lost to Follow-up|2
96591|NCT00300885|330259|P1|Treatment|Lost to Follow-up|3
96592|NCT00300885|330258|P2|Treatment|Lack of Efficacy|1
96593|NCT00300885|330259|P1|Treatment|Lack of Efficacy|1
96594|NCT00300885|330258|P2|Treatment|Death|7
96595|NCT00300885|330259|P1|Treatment|Death|20
96596|NCT00300885|330258|P2|Treatment|Adverse Event|82
96597|NCT00300885|330259|P1|Treatment|Adverse Event|134
96598|NCT00301080|330279|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
96599|NCT00301080|330280|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
96600|NCT00301080|330281|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
96601|NCT00301080|330282|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
96602|NCT00301080|330283|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
96603|NCT00301262|330314|P2|Open Label Phase (OL)|Other|0
96604|NCT00301262|330315|P1|Open Label Phase (OL)|Other|2
96605|NCT00301262|330314|P2|Open Label Phase (OL)|Lost to Follow-up|2
96606|NCT00301262|330315|P1|Open Label Phase (OL)|Lost to Follow-up|1
96607|NCT00301262|330314|P2|Open Label Phase (OL)|Adverse Event|0
96608|NCT00301262|330315|P1|Open Label Phase (OL)|Adverse Event|1
96609|NCT00301262|330314|P2|Double Blind Phase (DB)|Other|4
96610|NCT00301262|330315|P1|Double Blind Phase (DB)|Other|1
96611|NCT00301262|330314|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
96612|NCT00301262|330315|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
96613|NCT00301262|330314|P2|Double Blind Phase (DB)|Lost to Follow-up|3
96614|NCT00301262|330315|P1|Double Blind Phase (DB)|Lost to Follow-up|3
96615|NCT00301262|330314|P2|Double Blind Phase (DB)|Lack of Efficacy|1
96616|NCT00301262|330315|P1|Double Blind Phase (DB)|Lack of Efficacy|0
96617|NCT00301262|330314|P2|Double Blind Phase (DB)|Adverse Event|0
96618|NCT00301262|330315|P1|Double Blind Phase (DB)|Adverse Event|1
96619|NCT00301366|330473|P1|Overall Study|Adverse Event|1
96620|NCT00301808|330492|P1|Overall Study|Lack of Efficacy|4
96621|NCT00301808|330492|P1|Overall Study|Death|3
96622|NCT00301808|330492|P1|Overall Study|Adverse Event|5
96623|NCT00301821|330496|P1|Overall Study|Cancel|1
96624|NCT00301821|330496|P1|Overall Study|Ineligible|25
96625|NCT00301834|330503|P1|Overall Study|Death|1
96626|NCT00301964|330518|P1|Overall Study|Inadequate pathology|1
96627|NCT00301964|330518|P1|Overall Study|Wrong primary|1
96628|NCT00301964|330518|P1|Overall Study|Second primary|2
96629|NCT00302003|330523|P1|Overall Study|Protocol Violation|1
96630|NCT00302003|330523|P1|Overall Study|Ineligible|9
96631|NCT00302003|330523|P1|Overall Study|Withdrawal by Subject|5
96632|NCT00302003|330523|P1|Overall Study|Physician Decision|2
96633|NCT00302003|330523|P1|Overall Study|Lost to Follow-up|1
96634|NCT00302003|330523|P1|Overall Study|Lack of Efficacy|62
96635|NCT00302081|330582|P3|Overall Study|Other|5
96636|NCT00302081|330583|P2|Overall Study|Other|6
96637|NCT00302081|330584|P1|Overall Study|Other|13
96638|NCT00302081|330582|P3|Overall Study|Death|0
96639|NCT00302081|330583|P2|Overall Study|Death|1
96640|NCT00302081|330584|P1|Overall Study|Death|2
96641|NCT00302081|330582|P3|Overall Study|Lack of Efficacy|5
96642|NCT00302081|330583|P2|Overall Study|Lack of Efficacy|0
96643|NCT00302081|330584|P1|Overall Study|Lack of Efficacy|1
96644|NCT00302081|330582|P3|Overall Study|Protocol Violation|2
96645|NCT00302081|330583|P2|Overall Study|Protocol Violation|1
96646|NCT00302081|330584|P1|Overall Study|Protocol Violation|5
96647|NCT00302081|330582|P3|Overall Study|Withdrawal by Subject|8
96648|NCT00302081|330583|P2|Overall Study|Withdrawal by Subject|12
96649|NCT00302081|330584|P1|Overall Study|Withdrawal by Subject|8
96650|NCT00302081|330582|P3|Overall Study|Lost to Follow-up|28
96651|NCT00302081|330583|P2|Overall Study|Lost to Follow-up|18
96652|NCT00302081|330584|P1|Overall Study|Lost to Follow-up|21
96653|NCT00302081|330582|P3|Overall Study|Adverse Event|4
96654|NCT00302081|330583|P2|Overall Study|Adverse Event|5
96655|NCT00302081|330584|P1|Overall Study|Adverse Event|6
96656|NCT00302107|330594|P2|Overall Study|Adverse Event|0
96657|NCT00302107|330595|P1|Overall Study|Adverse Event|1
96658|NCT00302107|330594|P2|Overall Study|Withdrawal by Subject|3
96659|NCT00302107|330595|P1|Overall Study|Withdrawal by Subject|0
96660|NCT00302107|330594|P2|Overall Study|Relocation|1
96661|NCT00302107|330595|P1|Overall Study|Relocation|0
96662|NCT00302107|330594|P2|Overall Study|Protocol Violation|0
96663|NCT00302107|330595|P1|Overall Study|Protocol Violation|1
96664|NCT00302107|330594|P2|Overall Study|Lost to Follow-up|5
96665|NCT00302107|330595|P1|Overall Study|Lost to Follow-up|6
96666|NCT00302159|330612|P1|Overall Study|pt started Avastin|1
96667|NCT00302159|330612|P1|Overall Study|pt declined before treatment started|1
96668|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
96669|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
96670|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
96671|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
96672|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
96673|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
96674|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
96675|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
96676|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
96677|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
96678|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
96679|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
96680|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
96681|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
96682|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
96683|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Death|1
96684|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Death|1
96685|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Death|0
96686|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Death|0
96687|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Death|0
96688|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Disease progression|2
96689|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Disease progression|1
96690|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Disease progression|0
96691|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Disease progression|0
96692|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Disease progression|0
96693|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
96694|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
96695|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
96696|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
96697|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
96698|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Adverse Event|0
96699|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Adverse Event|1
96700|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Adverse Event|0
96701|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Adverse Event|0
96702|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Adverse Event|0
96703|NCT00302211|330624|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
96704|NCT00302211|330625|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
96705|NCT00302211|330626|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
96706|NCT00302211|330627|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
96707|NCT00302211|330628|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
96708|NCT00302211|330624|P5|Double Blind Period (New Patients)|Disease progression|0
96709|NCT00302211|330625|P4|Double Blind Period (New Patients)|Disease progression|0
96710|NCT00302211|330626|P3|Double Blind Period (New Patients)|Disease progression|1
96711|NCT00302211|330627|P2|Double Blind Period (New Patients)|Disease progression|1
96712|NCT00302211|330628|P1|Double Blind Period (New Patients)|Disease progression|0
96713|NCT00302211|330624|P5|Double Blind Period (New Patients)|Investigator's judgement|0
96714|NCT00302211|330625|P4|Double Blind Period (New Patients)|Investigator's judgement|0
96715|NCT00302211|330626|P3|Double Blind Period (New Patients)|Investigator's judgement|0
96716|NCT00302211|330627|P2|Double Blind Period (New Patients)|Investigator's judgement|0
96717|NCT00302211|330628|P1|Double Blind Period (New Patients)|Investigator's judgement|1
96718|NCT00302211|330624|P5|Double Blind Period (New Patients)|Adverse Event|0
96719|NCT00302211|330625|P4|Double Blind Period (New Patients)|Adverse Event|0
96720|NCT00302211|330626|P3|Double Blind Period (New Patients)|Adverse Event|3
96721|NCT00302211|330627|P2|Double Blind Period (New Patients)|Adverse Event|0
96722|NCT00302211|330628|P1|Double Blind Period (New Patients)|Adverse Event|0
96723|NCT00302211|330624|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
96724|NCT00302211|330625|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
96725|NCT00302211|330626|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
96726|NCT00302211|330627|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
96727|NCT00302211|330628|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
96728|NCT00302328|330643|P3|Overall Study|Physician Decision|0
96729|NCT00302328|330644|P2|Overall Study|Physician Decision|1
96730|NCT00302328|330645|P1|Overall Study|Physician Decision|0
96731|NCT00302458|330659|P1|Overall Study|Withdrawal by Subject|1
96732|NCT00302458|330659|P1|Overall Study|Ineligible after screening|1
96733|NCT00302458|330659|P1|Overall Study|Lost to Follow-up|1
96734|NCT00302718|330671|P4|Overall Study|Participant left primary care setting|1
96735|NCT00302718|330672|P3|Overall Study|Participant left primary care setting|2
96736|NCT00302718|330673|P2|Overall Study|Participant left primary care setting|0
96737|NCT00302718|330674|P1|Overall Study|Participant left primary care setting|0
96738|NCT00302718|330671|P4|Overall Study|Withdrawal by Subject|0
96739|NCT00302718|330672|P3|Overall Study|Withdrawal by Subject|0
96740|NCT00302718|330673|P2|Overall Study|Withdrawal by Subject|1
96741|NCT00302718|330674|P1|Overall Study|Withdrawal by Subject|0
96742|NCT00302718|330671|P4|Overall Study|Participant left the hospital|1
96743|NCT00302718|330672|P3|Overall Study|Participant left the hospital|0
96744|NCT00302718|330673|P2|Overall Study|Participant left the hospital|0
96745|NCT00302718|330674|P1|Overall Study|Participant left the hospital|1
96746|NCT00302952|330720|P2|Overall Study|Elevated SGOT (AST) lab value|1
96747|NCT00302952|330721|P1|Overall Study|Elevated SGOT (AST) lab value|0
96748|NCT00302952|330720|P2|Overall Study|Withdrawal by Subject|3
96749|NCT00302952|330721|P1|Overall Study|Withdrawal by Subject|2
96750|NCT00302952|330720|P2|Overall Study|Physician Decision|1
96751|NCT00302952|330721|P1|Overall Study|Physician Decision|1
96752|NCT00303069|330759|P4|Overall Study|Recruitment into Army Reserves|0
96753|NCT00303069|330760|P3|Overall Study|Recruitment into Army Reserves|1
96754|NCT00303069|330761|P2|Overall Study|Recruitment into Army Reserves|0
96755|NCT00303069|330762|P1|Overall Study|Recruitment into Army Reserves|0
96756|NCT00303069|330759|P4|Overall Study|subject moved|0
96757|NCT00303069|330760|P3|Overall Study|subject moved|0
96758|NCT00303069|330761|P2|Overall Study|subject moved|0
96759|NCT00303069|330762|P1|Overall Study|subject moved|1
96760|NCT00303069|330759|P4|Overall Study|Lost to Follow-up|2
96761|NCT00303069|330760|P3|Overall Study|Lost to Follow-up|0
96762|NCT00303069|330761|P2|Overall Study|Lost to Follow-up|0
96763|NCT00303069|330762|P1|Overall Study|Lost to Follow-up|1
96764|NCT00294047|330782|P2|Month 84|No consent for Month 84 Follow-up|754
96765|NCT00294047|330783|P1|Month 84|No consent for Month 84 Follow-up|731
96766|NCT00294047|330782|P2|Month 84|Visit missed|1
96767|NCT00294047|330783|P1|Month 84|Visit missed|0
96768|NCT00294047|330782|P2|Month 84|Under investigation locally|0
96769|NCT00294047|330783|P1|Month 84|Under investigation locally|1
96770|NCT00294047|330782|P2|Month 84|Unable to reach study site|0
96771|NCT00294047|330783|P1|Month 84|Unable to reach study site|1
96772|NCT00294047|330782|P2|Month 84|Transport reimbursement delayed|1
96773|NCT00294047|330783|P1|Month 84|Transport reimbursement delayed|0
96774|NCT00294047|330782|P2|Month 84|Subject does not want male physician|0
96775|NCT00294047|330783|P1|Month 84|Subject does not want male physician|1
96776|NCT00294047|330782|P2|Month 84|Personal reason|4
96777|NCT00294047|330783|P1|Month 84|Personal reason|2
96778|NCT00294047|330782|P2|Month 84|Lack of time|1
96779|NCT00294047|330783|P1|Month 84|Lack of time|3
96780|NCT00294047|330782|P2|Month 84|Family problems|2
96781|NCT00294047|330783|P1|Month 84|Family problems|2
96782|NCT00294047|330782|P2|Month 84|Center closed, subject did not transfer|0
96783|NCT00294047|330783|P1|Month 84|Center closed, subject did not transfer|1
96784|NCT00294047|330782|P2|Month 84|Work related reasons|2
96785|NCT00294047|330783|P1|Month 84|Work related reasons|4
96786|NCT00294047|330782|P2|Month 84|Absent Cervix|0
96787|NCT00294047|330783|P1|Month 84|Absent Cervix|2
96788|NCT00294047|330782|P2|Month 84|Lost to Follow-up|190
96789|NCT00294047|330783|P1|Month 84|Lost to Follow-up|187
96790|NCT00294047|330782|P2|Month 84|Withdrawal by Subject|31
96791|NCT00294047|330783|P1|Month 84|Withdrawal by Subject|33
96792|NCT00294047|330782|P2|Month 84|Protocol Violation|1
96793|NCT00294047|330783|P1|Month 84|Protocol Violation|1
96794|NCT00294047|330782|P2|Month 84|Adverse Event|2
96795|NCT00294047|330783|P1|Month 84|Adverse Event|4
96796|NCT00294047|330782|P2|Month 48|Unspecified|14
96797|NCT00294047|330783|P1|Month 48|Unspecified|10
96798|NCT00294047|330782|P2|Month 48|Lost to Follow-up|287
96799|NCT00294047|330783|P1|Month 48|Lost to Follow-up|272
96800|NCT00294047|330782|P2|Month 48|Withdrawal by Subject|115
96801|NCT00294047|330783|P1|Month 48|Withdrawal by Subject|111
96802|NCT00294047|330782|P2|Month 48|Protocol Violation|4
96803|NCT00294047|330783|P1|Month 48|Protocol Violation|4
96804|NCT00294047|330782|P2|Month 48|Adverse Event|13
96805|NCT00294047|330783|P1|Month 48|Adverse Event|28
96806|NCT00294060|330885|P1|Overall Study|Device explanted/not replaced|23
96807|NCT00294060|330885|P1|Overall Study|Medical condition|3
96808|NCT00294060|330885|P1|Overall Study|Physician Decision|797
96809|NCT00294060|330885|P1|Overall Study|Withdrawal by Subject|11
96810|NCT00294060|330885|P1|Overall Study|Lost to Follow-up|55
96811|NCT00294060|330885|P1|Overall Study|Other|59
96812|NCT00294060|330885|P1|Overall Study|Death|225
96813|NCT00303108|330894|P3|Overall Study|ineligible|0
96814|NCT00303108|330895|P2|Overall Study|ineligible|1
96815|NCT00303108|330896|P1|Overall Study|ineligible|2
96816|NCT00303108|330894|P3|Overall Study|Failed Entry|1
96817|NCT00303108|330895|P2|Overall Study|Failed Entry|0
96818|NCT00303108|330896|P1|Overall Study|Failed Entry|1
96819|NCT00303108|330894|P3|Overall Study|Patient Request|8
96820|NCT00303108|330895|P2|Overall Study|Patient Request|2
96821|NCT00303108|330896|P1|Overall Study|Patient Request|4
96822|NCT00303108|330894|P3|Overall Study|Adverse Event|7
96823|NCT00303108|330895|P2|Overall Study|Adverse Event|6
96824|NCT00303108|330896|P1|Overall Study|Adverse Event|5
96825|NCT00303186|330912|P1|Overall Study|Unspecified|52
96826|NCT00303316|330945|P2|Overall Study|Withdrawal by Subject|2
96827|NCT00303316|330946|P1|Overall Study|Withdrawal by Subject|1
96828|NCT00303316|330945|P2|Overall Study|Lost to Follow-up|1
96829|NCT00303316|330946|P1|Overall Study|Lost to Follow-up|0
96830|NCT00303316|330945|P2|Overall Study|Protocol Violation|0
96831|NCT00303316|330946|P1|Overall Study|Protocol Violation|1
96832|NCT00303329|330960|P2|Overall Study|Stopped at end of extension 1|0
96833|NCT00303329|330961|P1|Overall Study|Stopped at end of extension 1|1
96834|NCT00303329|330960|P2|Overall Study|Stopped at end of core|9
96835|NCT00303329|330961|P1|Overall Study|Stopped at end of core|3
96836|NCT00303329|330960|P2|Overall Study|Death|12
96837|NCT00303329|330961|P1|Overall Study|Death|2
96838|NCT00303329|330960|P2|Overall Study|Administrative problems|0
96839|NCT00303329|330961|P1|Overall Study|Administrative problems|1
96840|NCT00303329|330960|P2|Overall Study|Lost to Follow-up|1
96841|NCT00303329|330961|P1|Overall Study|Lost to Follow-up|0
96842|NCT00303329|330960|P2|Overall Study|Withdrawal by Subject|15
96843|NCT00303329|330961|P1|Overall Study|Withdrawal by Subject|9
96844|NCT00303329|330960|P2|Overall Study|Protocol Violation|0
96845|NCT00303329|330961|P1|Overall Study|Protocol Violation|3
96846|NCT00303329|330960|P2|Overall Study|Condition no longer requires study drug|8
96847|NCT00303329|330961|P1|Overall Study|Condition no longer requires study drug|0
96848|NCT00303329|330960|P2|Overall Study|Unsatisfactory therapeutic effect|2
96849|NCT00303329|330961|P1|Overall Study|Unsatisfactory therapeutic effect|9
96850|NCT00303329|330960|P2|Overall Study|Abnormal Laboratory Values|1
96851|NCT00303329|330961|P1|Overall Study|Abnormal Laboratory Values|0
96852|NCT00303329|330960|P2|Overall Study|Adverse Event|14
96853|NCT00303329|330961|P1|Overall Study|Adverse Event|7
96854|NCT00304915|330975|P2|Overall Study|Withdrawal by Subject|0
96855|NCT00304915|330976|P1|Overall Study|Withdrawal by Subject|3
96856|NCT00304915|330975|P2|Overall Study|Death|5
96857|NCT00304915|330976|P1|Overall Study|Death|4
96858|NCT00304915|330975|P2|Overall Study|Lost to Follow-up|11
96859|NCT00304915|330976|P1|Overall Study|Lost to Follow-up|11
96860|NCT00304954|330986|P4|Overall Study|Adverse Event|0
96861|NCT00304954|330987|P3|Overall Study|Adverse Event|0
96862|NCT00304954|330988|P2|Overall Study|Adverse Event|0
96863|NCT00304954|330989|P1|Overall Study|Adverse Event|1
96864|NCT00304954|330986|P4|Overall Study|Withdrawal by Subject|0
96865|NCT00304954|330987|P3|Overall Study|Withdrawal by Subject|1
96866|NCT00304954|330988|P2|Overall Study|Withdrawal by Subject|0
96867|NCT00304954|330989|P1|Overall Study|Withdrawal by Subject|0
96868|NCT00305227|331050|P2|Overall Study|Lost to Follow-up|6
96869|NCT00305227|331051|P1|Overall Study|Lost to Follow-up|7
96870|NCT00305253|331059|P2|Overall Study|Withdrawal by Subject|1
96871|NCT00305253|331060|P1|Overall Study|Withdrawal by Subject|0
96872|NCT00305448|331077|P3|Overall Study|Tumor Marker Elevation|1
96873|NCT00305448|331078|P2|Overall Study|Tumor Marker Elevation|0
96874|NCT00305448|331079|P1|Overall Study|Tumor Marker Elevation|0
96875|NCT00305448|331077|P3|Overall Study|Subjective Disease Progression|2
96876|NCT00305448|331078|P2|Overall Study|Subjective Disease Progression|2
96877|NCT00305448|331079|P1|Overall Study|Subjective Disease Progression|1
96878|NCT00305448|331077|P3|Overall Study|Disease Progression|28
96879|NCT00305448|331078|P2|Overall Study|Disease Progression|31
96880|NCT00305448|331079|P1|Overall Study|Disease Progression|27
96881|NCT00305448|331077|P3|Overall Study|Adverse Event|1
96882|NCT00305448|331078|P2|Overall Study|Adverse Event|0
96883|NCT00305448|331079|P1|Overall Study|Adverse Event|1
96884|NCT00305448|331077|P3|Overall Study|Withdrawal by Subject|1
96885|NCT00305448|331078|P2|Overall Study|Withdrawal by Subject|0
96886|NCT00305448|331079|P1|Overall Study|Withdrawal by Subject|2
96887|NCT00305448|331077|P3|Overall Study|Protocol Violation|0
96888|NCT00305448|331078|P2|Overall Study|Protocol Violation|1
96889|NCT00305448|331079|P1|Overall Study|Protocol Violation|0
96890|NCT00305604|331226|P2|Overall Study|Patient moved|0
96891|NCT00305604|331227|P1|Overall Study|Patient moved|1
96892|NCT00305604|331226|P2|Overall Study|Withdrawal by Subject|21
96893|NCT00305604|331227|P1|Overall Study|Withdrawal by Subject|12
96894|NCT00305604|331226|P2|Overall Study|Protocol Violation|1
96895|NCT00305604|331227|P1|Overall Study|Protocol Violation|2
96896|NCT00305604|331226|P2|Overall Study|Lost to Follow-up|4
96897|NCT00305604|331227|P1|Overall Study|Lost to Follow-up|0
96898|NCT00305604|331226|P2|Overall Study|Lack of Efficacy|18
96899|NCT00305604|331227|P1|Overall Study|Lack of Efficacy|11
96900|NCT00305604|331226|P2|Overall Study|Adverse Event|3
96901|NCT00305604|331227|P1|Overall Study|Adverse Event|6
96902|NCT00305773|331256|P2|Overall Study|All other reasons|2
96903|NCT00305773|331257|P1|Overall Study|All other reasons|3
96904|NCT00305773|331256|P2|Overall Study|Disease Progression|3
96905|NCT00305773|331257|P1|Overall Study|Disease Progression|1
96906|NCT00305773|331256|P2|Overall Study|Withdrawal by Subject|4
96907|NCT00305773|331257|P1|Overall Study|Withdrawal by Subject|1
96908|NCT00305773|331256|P2|Overall Study|Physician Decision|1
96909|NCT00305773|331257|P1|Overall Study|Physician Decision|1
96910|NCT00305773|331256|P2|Overall Study|Alternative Treatment|4
96911|NCT00305773|331257|P1|Overall Study|Alternative Treatment|4
96912|NCT00305773|331256|P2|Overall Study|Adverse Event|2
96913|NCT00305773|331257|P1|Overall Study|Adverse Event|1
96914|NCT00305773|331256|P2|Overall Study|Death|2
96915|NCT00305773|331257|P1|Overall Study|Death|3
96916|NCT00305864|331275|P4|Overall Study|Ineligible / No protocol treatment|13
96917|NCT00305864|331276|P3|Overall Study|Ineligible / No protocol treatment|1
96918|NCT00305864|331277|P2|Overall Study|Ineligible / No protocol treatment|1
96919|NCT00305864|331278|P1|Overall Study|Ineligible / No protocol treatment|0
96920|NCT00305877|331290|P2|Overall Study|Transportation issue with daily RT|1
96921|NCT00305877|331291|P1|Overall Study|Transportation issue with daily RT|0
96922|NCT00305877|331290|P2|Overall Study|Ineligible|1
96923|NCT00305877|331291|P1|Overall Study|Ineligible|2
96924|NCT00305877|331290|P2|Overall Study|Never start treatment|5
96925|NCT00305877|331291|P1|Overall Study|Never start treatment|2
96926|NCT00305877|331290|P2|Overall Study|Physician Decision|1
96927|NCT00305877|331291|P1|Overall Study|Physician Decision|1
96928|NCT00305877|331290|P2|Overall Study|Withdrawal by Subject|2
96929|NCT00305877|331291|P1|Overall Study|Withdrawal by Subject|4
96930|NCT00305877|331290|P2|Overall Study|Death|1
96931|NCT00305877|331291|P1|Overall Study|Death|0
96932|NCT00305877|331290|P2|Overall Study|Adverse Event|14
96933|NCT00305877|331291|P1|Overall Study|Adverse Event|9
96934|NCT00305877|331290|P2|Overall Study|Lack of Efficacy|9
96935|NCT00305877|331291|P1|Overall Study|Lack of Efficacy|6
96936|NCT00306189|331320|P4|Overall Study|Other|0
96937|NCT00306189|331321|P3|Overall Study|Other|0
96938|NCT00306189|331322|P2|Overall Study|Other|0
96939|NCT00306189|331323|P1|Overall Study|Other|1
96940|NCT00306189|331320|P4|Overall Study|Ineligibility determined|1
96941|NCT00306189|331321|P3|Overall Study|Ineligibility determined|1
96942|NCT00306189|331322|P2|Overall Study|Ineligibility determined|1
96943|NCT00306189|331323|P1|Overall Study|Ineligibility determined|1
96944|NCT00306189|331320|P4|Overall Study|Withdrawal by Subject|1
96945|NCT00306189|331321|P3|Overall Study|Withdrawal by Subject|8
96946|NCT00306189|331322|P2|Overall Study|Withdrawal by Subject|2
96947|NCT00306189|331323|P1|Overall Study|Withdrawal by Subject|4
96948|NCT00306189|331320|P4|Overall Study|Adverse Event|2
96949|NCT00306189|331321|P3|Overall Study|Adverse Event|2
96950|NCT00306189|331322|P2|Overall Study|Adverse Event|3
96951|NCT00306189|331323|P1|Overall Study|Adverse Event|3
96952|NCT00306189|331320|P4|Overall Study|Physician Decision|1
96953|NCT00306189|331321|P3|Overall Study|Physician Decision|0
96954|NCT00306189|331322|P2|Overall Study|Physician Decision|0
96955|NCT00306189|331323|P1|Overall Study|Physician Decision|0
96956|NCT00306202|331336|P3|Overall Study|Still on treatment|0
96957|NCT00306202|331337|P2|Overall Study|Still on treatment|1
96958|NCT00306202|331338|P1|Overall Study|Still on treatment|6
96959|NCT00306384|331497|P3|Overall Study|Site closure|0
96960|NCT00306384|331498|P2|Overall Study|Site closure|0
96961|NCT00306384|331499|P1|Overall Study|Site closure|2
96962|NCT00306384|331497|P3|Overall Study|Other|32
96963|NCT00306384|331498|P2|Overall Study|Other|70
96964|NCT00306384|331499|P1|Overall Study|Other|80
96965|NCT00306384|331497|P3|Overall Study|Investigator discretion|21
96966|NCT00306384|331498|P2|Overall Study|Investigator discretion|31
96967|NCT00306384|331499|P1|Overall Study|Investigator discretion|28
96968|NCT00306384|331497|P3|Overall Study|Lack of Efficacy|38
96969|NCT00306384|331498|P2|Overall Study|Lack of Efficacy|40
96970|NCT00306384|331499|P1|Overall Study|Lack of Efficacy|26
96971|NCT00306384|331497|P3|Overall Study|Pregnancy|1
96972|NCT00306384|331498|P2|Overall Study|Pregnancy|1
96973|NCT00306384|331499|P1|Overall Study|Pregnancy|3
96974|NCT00306384|331497|P3|Overall Study|Study termination|1
96975|NCT00306384|331498|P2|Overall Study|Study termination|0
96976|NCT00306384|331499|P1|Overall Study|Study termination|1
96977|NCT00306384|331497|P3|Overall Study|Voluntary withdrawal|91
96978|NCT00306384|331498|P2|Overall Study|Voluntary withdrawal|187
96979|NCT00306384|331499|P1|Overall Study|Voluntary withdrawal|199
96980|NCT00306384|331497|P3|Overall Study|Lost to Follow-up|35
96981|NCT00306384|331498|P2|Overall Study|Lost to Follow-up|41
96982|NCT00306384|331499|P1|Overall Study|Lost to Follow-up|57
96983|NCT00306384|331497|P3|Overall Study|Major protocol deviation|18
96984|NCT00306384|331498|P2|Overall Study|Major protocol deviation|51
96985|NCT00306384|331499|P1|Overall Study|Major protocol deviation|43
96986|NCT00306384|331497|P3|Overall Study|Adverse Event|40
96987|NCT00306384|331498|P2|Overall Study|Adverse Event|87
96988|NCT00306384|331499|P1|Overall Study|Adverse Event|103
96989|NCT00306527|331547|P4|Overall Study|Death|2
96990|NCT00306527|331548|P3|Overall Study|Death|1
96991|NCT00306527|331549|P2|Overall Study|Death|0
96992|NCT00306527|331550|P1|Overall Study|Death|1
96993|NCT00306527|331547|P4|Overall Study|Adverse Event|1
96994|NCT00306527|331548|P3|Overall Study|Adverse Event|1
96995|NCT00306527|331549|P2|Overall Study|Adverse Event|0
96996|NCT00306527|331550|P1|Overall Study|Adverse Event|0
96997|NCT00306527|331547|P4|Overall Study|Withdrawal by Subject|3
96998|NCT00306527|331548|P3|Overall Study|Withdrawal by Subject|0
96999|NCT00306527|331549|P2|Overall Study|Withdrawal by Subject|3
97000|NCT00306527|331550|P1|Overall Study|Withdrawal by Subject|2
97001|NCT00306527|331547|P4|Overall Study|Lost to Follow-up|0
97002|NCT00306527|331548|P3|Overall Study|Lost to Follow-up|3
97003|NCT00306527|331549|P2|Overall Study|Lost to Follow-up|4
97004|NCT00306527|331550|P1|Overall Study|Lost to Follow-up|3
97005|NCT00306592|331604|P2|Overall Study|48-week Treatment Period Ongoing|20
97006|NCT00306592|331605|P1|Overall Study|48-week Treatment Period Ongoing|0
97007|NCT00306592|331604|P2|Overall Study|Other|2
97008|NCT00306592|331605|P1|Overall Study|Other|1
97009|NCT00306592|331604|P2|Overall Study|Not Specified|10
97010|NCT00306592|331605|P1|Overall Study|Not Specified|5
97011|NCT00306592|331604|P2|Overall Study|Voluntary|6
97012|NCT00306592|331605|P1|Overall Study|Voluntary|10
97013|NCT00306592|331604|P2|Overall Study|Persistent Antibodies|3
97014|NCT00306592|331605|P1|Overall Study|Persistent Antibodies|6
97015|NCT00306592|331604|P2|Overall Study|Noncompliance|2
97016|NCT00306592|331605|P1|Overall Study|Noncompliance|0
97017|NCT00306592|331604|P2|Overall Study|Lost to Follow-up|0
97018|NCT00306592|331605|P1|Overall Study|Lost to Follow-up|1
97019|NCT00306592|331604|P2|Overall Study|Adverse Event|15
97020|NCT00306592|331605|P1|Overall Study|Adverse Event|8
97021|NCT00306670|331613|P2|Overall Study|patients recruited; Genentech, the st|2
97022|NCT00306670|331614|P1|Overall Study|patients recruited; Genentech, the st|0
97023|NCT00306787|331622|P2|Overall Study|Abnormal laboratory value(s)|0
97024|NCT00306787|331623|P1|Overall Study|Abnormal laboratory value(s)|1
97025|NCT00306787|331622|P2|Overall Study|Administrative problems|0
97026|NCT00306787|331623|P1|Overall Study|Administrative problems|4
97027|NCT00306787|331622|P2|Overall Study|Lost to Follow-up|6
97028|NCT00306787|331623|P1|Overall Study|Lost to Follow-up|9
97029|NCT00306787|331622|P2|Overall Study|Withdrawal by Subject|9
97030|NCT00306787|331623|P1|Overall Study|Withdrawal by Subject|2
97031|NCT00306787|331622|P2|Overall Study|Protocol Violation|10
97032|NCT00306787|331623|P1|Overall Study|Protocol Violation|8
97033|NCT00306787|331622|P2|Overall Study|Lack of Efficacy|0
97034|NCT00306787|331623|P1|Overall Study|Lack of Efficacy|1
97035|NCT00306787|331622|P2|Overall Study|Adverse Event|1
97036|NCT00306787|331623|P1|Overall Study|Adverse Event|1
97037|NCT00306787|331622|P2|Overall Study|Discontinued without taking study drug|215
97038|NCT00306787|331623|P1|Overall Study|Discontinued without taking study drug|208
97039|NCT00306852|331641|P2|Overall Study|Lost to Follow-up|24
97040|NCT00306852|331642|P1|Overall Study|Lost to Follow-up|15
97041|NCT00306852|331641|P2|Overall Study|Death|14
97042|NCT00306852|331642|P1|Overall Study|Death|14
97043|NCT00306891|331662|P4|Part B|Development of study specific disc crit.|1
97044|NCT00306891|331663|P3|Part B|Development of study specific disc crit.|0
97045|NCT00306891|331664|P2|Part B|Development of study specific disc crit.|0
97046|NCT00306891|331665|P1|Part B|Development of study specific disc crit.|0
97047|NCT00306891|331662|P4|Part B|Condition under investigation worsened|8
97048|NCT00306891|331663|P3|Part B|Condition under investigation worsened|2
97049|NCT00306891|331664|P2|Part B|Condition under investigation worsened|0
97050|NCT00306891|331665|P1|Part B|Condition under investigation worsened|0
97051|NCT00306891|331662|P4|Part B|Withdrawal by Subject|1
97052|NCT00306891|331663|P3|Part B|Withdrawal by Subject|3
97053|NCT00306891|331664|P2|Part B|Withdrawal by Subject|0
97054|NCT00306891|331665|P1|Part B|Withdrawal by Subject|0
97055|NCT00306891|331662|P4|Part B|Adverse Event|5
97056|NCT00306891|331663|P3|Part B|Adverse Event|5
97057|NCT00306891|331664|P2|Part B|Adverse Event|0
97058|NCT00306891|331665|P1|Part B|Adverse Event|0
97059|NCT00306891|331662|P4|Part B|Death|2
97060|NCT00306891|331663|P3|Part B|Death|1
97061|NCT00306891|331664|P2|Part B|Death|0
97062|NCT00306891|331665|P1|Part B|Death|0
97063|NCT00306891|331662|P4|Part A|QTC interval outwith elig. criteria|0
97064|NCT00306891|331663|P3|Part A|QTC interval outwith elig. criteria|0
97065|NCT00306891|331664|P2|Part A|QTC interval outwith elig. criteria|0
97066|NCT00306891|331665|P1|Part A|QTC interval outwith elig. criteria|1
97067|NCT00306891|331662|P4|Part A|Suspicion of second malignancy|0
97068|NCT00306891|331663|P3|Part A|Suspicion of second malignancy|0
97069|NCT00306891|331664|P2|Part A|Suspicion of second malignancy|1
97070|NCT00306891|331665|P1|Part A|Suspicion of second malignancy|0
97071|NCT00306891|331662|P4|Part A|Reaccumul. of ascites following drainage|0
97072|NCT00306891|331663|P3|Part A|Reaccumul. of ascites following drainage|0
97073|NCT00306891|331664|P2|Part A|Reaccumul. of ascites following drainage|1
97074|NCT00306891|331665|P1|Part A|Reaccumul. of ascites following drainage|0
97075|NCT00306891|331662|P4|Part A|Partial bowel obstruction|0
97076|NCT00306891|331663|P3|Part A|Partial bowel obstruction|0
97077|NCT00306891|331664|P2|Part A|Partial bowel obstruction|0
97078|NCT00306891|331665|P1|Part A|Partial bowel obstruction|1
97079|NCT00306891|331662|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
97080|NCT00306891|331663|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
97081|NCT00306891|331664|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
97082|NCT00306891|331665|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
97083|NCT00306891|331662|P4|Part A|Condition under investigation worsened|0
97084|NCT00306891|331663|P3|Part A|Condition under investigation worsened|0
97085|NCT00306891|331664|P2|Part A|Condition under investigation worsened|2
97086|NCT00306891|331665|P1|Part A|Condition under investigation worsened|2
97087|NCT00306891|331662|P4|Part A|Withdrawal by Subject|0
97088|NCT00306891|331663|P3|Part A|Withdrawal by Subject|0
97089|NCT00306891|331664|P2|Part A|Withdrawal by Subject|1
97090|NCT00306891|331665|P1|Part A|Withdrawal by Subject|1
97091|NCT00307034|331697|P2|Overall Study|Lost to Follow-up|3
97092|NCT00307034|331698|P1|Overall Study|Lost to Follow-up|0
97093|NCT00307034|331697|P2|Overall Study|Withdrawal by Subject|2
97094|NCT00307034|331698|P1|Overall Study|Withdrawal by Subject|1
97095|NCT00307034|331697|P2|Overall Study|Adverse Event|2
97096|NCT00307034|331698|P1|Overall Study|Adverse Event|1
97097|NCT00307047|331738|P2|Overall Study|All death, all MI, all Revascularization|16
97098|NCT00307047|331739|P1|Overall Study|All death, all MI, all Revascularization|27
97099|NCT00307047|331738|P2|Overall Study|Lost to follow-up for other reasons|1
97100|NCT00307047|331739|P1|Overall Study|Lost to follow-up for other reasons|0
97101|NCT00307047|331738|P2|Overall Study|Physician Decision|2
97102|NCT00307047|331739|P1|Overall Study|Physician Decision|1
97103|NCT00307047|331738|P2|Overall Study|Withdrawal by Subject|6
97104|NCT00307047|331739|P1|Overall Study|Withdrawal by Subject|6
97105|NCT00307047|331738|P2|Overall Study|Lost to Follow-up|24
97106|NCT00307047|331739|P1|Overall Study|Lost to Follow-up|35
97107|NCT00307086|331875|P1|Overall Study|ineligible|5
97108|NCT00307125|331881|P3|Pilot Phase|Withdrawal by Subject|1
97109|NCT00307125|331882|P2|Pilot Phase|Withdrawal by Subject|1
97110|NCT00307125|331883|P1|Pilot Phase|Withdrawal by Subject|0
97111|NCT00307125|331881|P3|Pilot Phase|Lost to Follow-up|0
97112|NCT00307125|331882|P2|Pilot Phase|Lost to Follow-up|1
97113|NCT00307125|331883|P1|Pilot Phase|Lost to Follow-up|0
97114|NCT00307125|331881|P3|Screening Phase|Coronary artery bypass|0
97115|NCT00307125|331882|P2|Screening Phase|Coronary artery bypass|0
97116|NCT00307125|331883|P1|Screening Phase|Coronary artery bypass|1
97117|NCT00307125|331881|P3|Screening Phase|AMR and treated with rituximab|0
97118|NCT00307125|331882|P2|Screening Phase|AMR and treated with rituximab|0
97119|NCT00307125|331883|P1|Screening Phase|AMR and treated with rituximab|1
97120|NCT00307125|331881|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
97121|NCT00307125|331882|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
97122|NCT00307125|331883|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
97123|NCT00307125|331881|P3|Screening Phase|Screen Error|0
97124|NCT00307125|331882|P2|Screening Phase|Screen Error|0
97125|NCT00307125|331883|P1|Screening Phase|Screen Error|1
97126|NCT00307125|331881|P3|Screening Phase|Ineligible|0
97127|NCT00307125|331882|P2|Screening Phase|Ineligible|0
97128|NCT00307125|331883|P1|Screening Phase|Ineligible|1
97129|NCT00307125|331881|P3|Screening Phase|PAK|0
97130|NCT00307125|331882|P2|Screening Phase|PAK|0
97131|NCT00307125|331883|P1|Screening Phase|PAK|1
97132|NCT00307125|331881|P3|Screening Phase|Malignancy|0
97133|NCT00307125|331882|P2|Screening Phase|Malignancy|0
97134|NCT00307125|331883|P1|Screening Phase|Malignancy|1
97135|NCT00307125|331881|P3|Screening Phase|Metastatic colon cancer|0
97136|NCT00307125|331882|P2|Screening Phase|Metastatic colon cancer|0
97137|NCT00307125|331883|P1|Screening Phase|Metastatic colon cancer|1
97138|NCT00307125|331881|P3|Screening Phase|Developed acute leukemia|0
97139|NCT00307125|331882|P2|Screening Phase|Developed acute leukemia|0
97140|NCT00307125|331883|P1|Screening Phase|Developed acute leukemia|1
97141|NCT00307125|331881|P3|Screening Phase|Try to get pregnant|0
97142|NCT00307125|331882|P2|Screening Phase|Try to get pregnant|0
97143|NCT00307125|331883|P1|Screening Phase|Try to get pregnant|1
97144|NCT00307125|331881|P3|Screening Phase|Ineligible for pilot|0
97145|NCT00307125|331882|P2|Screening Phase|Ineligible for pilot|0
97146|NCT00307125|331883|P1|Screening Phase|Ineligible for pilot|4
97147|NCT00307125|331881|P3|Screening Phase|Received Pancreas Transplant|0
97148|NCT00307125|331882|P2|Screening Phase|Received Pancreas Transplant|0
97149|NCT00307125|331883|P1|Screening Phase|Received Pancreas Transplant|8
97150|NCT00307125|331881|P3|Screening Phase|Moved or transferred facilities|0
97151|NCT00307125|331882|P2|Screening Phase|Moved or transferred facilities|0
97152|NCT00307125|331883|P1|Screening Phase|Moved or transferred facilities|34
97153|NCT00307125|331881|P3|Screening Phase|Scheduling issues/Non-compliance|0
97154|NCT00307125|331882|P2|Screening Phase|Scheduling issues/Non-compliance|0
97155|NCT00307125|331883|P1|Screening Phase|Scheduling issues/Non-compliance|55
97156|NCT00307125|331881|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
97157|NCT00307125|331882|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
97158|NCT00307125|331883|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
97159|NCT00307125|331881|P3|Screening Phase|Graft Failure|0
97160|NCT00307125|331882|P2|Screening Phase|Graft Failure|0
97161|NCT00307125|331883|P1|Screening Phase|Graft Failure|8
97162|NCT00307125|331881|P3|Screening Phase|Graft Loss|0
97163|NCT00307125|331882|P2|Screening Phase|Graft Loss|0
97164|NCT00307125|331883|P1|Screening Phase|Graft Loss|3
97165|NCT00307125|331881|P3|Screening Phase|Study Terminated|0
97166|NCT00307125|331882|P2|Screening Phase|Study Terminated|0
97167|NCT00307125|331883|P1|Screening Phase|Study Terminated|17
97168|NCT00307125|331881|P3|Screening Phase|Sponsor Decision|0
97169|NCT00307125|331882|P2|Screening Phase|Sponsor Decision|0
97170|NCT00307125|331883|P1|Screening Phase|Sponsor Decision|4
97171|NCT00307125|331881|P3|Screening Phase|Physician Decision|0
97172|NCT00307125|331882|P2|Screening Phase|Physician Decision|0
97173|NCT00307125|331883|P1|Screening Phase|Physician Decision|26
97174|NCT00307125|331881|P3|Screening Phase|Withdrawal by Subject|0
97175|NCT00307125|331882|P2|Screening Phase|Withdrawal by Subject|0
97176|NCT00307125|331883|P1|Screening Phase|Withdrawal by Subject|77
97177|NCT00307125|331881|P3|Screening Phase|Death|0
97178|NCT00307125|331882|P2|Screening Phase|Death|0
97179|NCT00307125|331883|P1|Screening Phase|Death|10
97180|NCT00307125|331881|P3|Screening Phase|Lost to Follow-up|0
97181|NCT00307125|331882|P2|Screening Phase|Lost to Follow-up|0
97182|NCT00307125|331883|P1|Screening Phase|Lost to Follow-up|87
97183|NCT00307125|331881|P3|Screening Phase|Protocol Violation|0
97184|NCT00307125|331882|P2|Screening Phase|Protocol Violation|0
97185|NCT00307125|331883|P1|Screening Phase|Protocol Violation|27
97186|NCT00307125|331881|P3|Screening Phase|Adverse Event|0
97187|NCT00307125|331882|P2|Screening Phase|Adverse Event|0
97188|NCT00307125|331883|P1|Screening Phase|Adverse Event|1
97189|NCT00307151|331909|P4|Overall Study|Clinic unable to contact subject|1
97190|NCT00307151|331910|P3|Overall Study|Clinic unable to contact subject|1
97191|NCT00307151|331911|P2|Overall Study|Clinic unable to contact subject|3
97192|NCT00307151|331912|P1|Overall Study|Clinic unable to contact subject|3
97193|NCT00307151|331909|P4|Overall Study|Not willing to adhere to study reqs|2
97194|NCT00307151|331910|P3|Overall Study|Not willing to adhere to study reqs|2
97195|NCT00307151|331911|P2|Overall Study|Not willing to adhere to study reqs|0
97196|NCT00307151|331912|P1|Overall Study|Not willing to adhere to study reqs|2
97197|NCT00307151|331909|P4|Overall Study|Withdrew consent|3
97198|NCT00307151|331910|P3|Overall Study|Withdrew consent|1
97199|NCT00307151|331911|P2|Overall Study|Withdrew consent|1
97200|NCT00307151|331912|P1|Overall Study|Withdrew consent|0
97201|NCT00307151|331909|P4|Overall Study|Subject unable to get to clinic|2
97202|NCT00307151|331910|P3|Overall Study|Subject unable to get to clinic|6
97203|NCT00307151|331911|P2|Overall Study|Subject unable to get to clinic|0
97204|NCT00307151|331912|P1|Overall Study|Subject unable to get to clinic|1
97205|NCT00307151|331909|P4|Overall Study|Severe debilitation, unable to continue|0
97206|NCT00307151|331910|P3|Overall Study|Severe debilitation, unable to continue|0
97207|NCT00307151|331911|P2|Overall Study|Severe debilitation, unable to continue|0
97208|NCT00307151|331912|P1|Overall Study|Severe debilitation, unable to continue|1
97209|NCT00307151|331909|P4|Overall Study|Death|3
97210|NCT00307151|331910|P3|Overall Study|Death|10
97211|NCT00307151|331911|P2|Overall Study|Death|3
97212|NCT00307151|331912|P1|Overall Study|Death|4
97213|NCT00307164|331956|P2|Overall Study|Lost to Follow-up|1
97214|NCT00307164|331957|P1|Overall Study|Lost to Follow-up|6
97215|NCT00307164|331956|P2|Overall Study|Not compliant with requirements|4
97216|NCT00307164|331957|P1|Overall Study|Not compliant with requirements|4
97217|NCT00307164|331956|P2|Overall Study|Withdrawal by Subject|8
97218|NCT00307164|331957|P1|Overall Study|Withdrawal by Subject|1
97219|NCT00307164|331956|P2|Overall Study|Subject/parent not able to get to clinic|1
97220|NCT00307164|331957|P1|Overall Study|Subject/parent not able to get to clinic|2
97221|NCT00307164|331956|P2|Overall Study|Severe debilitation, unable to continue|0
97222|NCT00307164|331957|P1|Overall Study|Severe debilitation, unable to continue|1
97223|NCT00307164|331956|P2|Overall Study|Death|0
97224|NCT00307164|331957|P1|Overall Study|Death|1
97225|NCT00297167|332016|P3|Second Double-blind Intervention Period|Protocol Violation|0
97226|NCT00297167|332017|P2|Second Double-blind Intervention Period|Protocol Violation|0
97227|NCT00297167|332018|P1|Second Double-blind Intervention Period|Protocol Violation|1
97228|NCT00297167|332016|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
97229|NCT00297167|332017|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
97230|NCT00297167|332018|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
97231|NCT00297232|332042|P1|Overall Study|Other|1
97232|NCT00297232|332042|P1|Overall Study|No data available after Week 264|161
97233|NCT00297232|332042|P1|Overall Study|Did Not Enroll to Week 480|17
97234|NCT00297232|332042|P1|Overall Study|Did Not Enroll to Week 264|34
97235|NCT00297232|332042|P1|Overall Study|Investigator Withdrew From Program|19
97236|NCT00297232|332042|P1|Overall Study|Persistently Positive Antibodies|11
97237|NCT00297232|332042|P1|Overall Study|Subject Withdrew Consent|37
97238|NCT00297232|332042|P1|Overall Study|Subject Relocated|7
97239|NCT00297232|332042|P1|Overall Study|Sponsor Decision|34
97240|NCT00297232|332042|P1|Overall Study|Miscellaneous|5
97241|NCT00297232|332042|P1|Overall Study|Anti-JCV Antibody Positive|13
97242|NCT00297232|332042|P1|Overall Study|Fear of PML|10
97243|NCT00297232|332042|P1|Overall Study|Disease Progression|8
97244|NCT00297232|332042|P1|Overall Study|Switched to Commercial Tysabri|22
97245|NCT00297232|332042|P1|Overall Study|Anti-natalizumab Positive|8
97246|NCT00297232|332042|P1|Overall Study|Death|9
97247|NCT00297232|332042|P1|Overall Study|Subject was Noncompliant|9
97248|NCT00297232|332042|P1|Overall Study|Voluntary Withdrawal|120
97249|NCT00297232|332042|P1|Overall Study|Adverse Event|63
97250|NCT00297232|332042|P1|Overall Study|Lost to Follow-up|10
97251|NCT00297232|332042|P1|Overall Study|Lack of Efficacy|7
97252|NCT00297258|332048|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
97253|NCT00297258|332048|P1|Overall Study|Switch to Commercial Treatment|1
97254|NCT00297258|332048|P1|Overall Study|Surgery Performed on Target Lesion|1
97255|NCT00297258|332048|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
97256|NCT00297258|332048|P1|Overall Study|Deteriorization of General Condition|1
97257|NCT00297258|332048|P1|Overall Study|Intercurrent Death|2
97258|NCT00297258|332048|P1|Overall Study|Intercurrent Illness|3
97259|NCT00297258|332048|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
97260|NCT00297258|332048|P1|Overall Study|Toxicity (or Toxic Death)|10
97261|NCT00297258|332048|P1|Overall Study|Disease Progression, Relapse, Death|120
97262|NCT00297427|332069|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
97263|NCT00297427|332070|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
97264|NCT00297427|332069|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
97265|NCT00297427|332070|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
97266|NCT00297427|332069|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
97267|NCT00297427|332070|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
97268|NCT00297427|332069|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
97269|NCT00297427|332070|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
97270|NCT00297427|332069|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
97271|NCT00297427|332070|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
97272|NCT00297427|332069|P2|Phase 1: Initial Intervention|Death|1
97273|NCT00297427|332070|P1|Phase 1: Initial Intervention|Death|0
97274|NCT00297427|332069|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
97275|NCT00297427|332070|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
97276|NCT00297427|332069|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
97277|NCT00297427|332070|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
97278|NCT00297492|332114|P3|6 Month Follow-up|Lost to Follow-up|27
97279|NCT00297492|332115|P2|6 Month Follow-up|Lost to Follow-up|49
97280|NCT00297492|332116|P1|6 Month Follow-up|Lost to Follow-up|63
97281|NCT00297492|332114|P3|Set Quit Date|Lost to Follow-up|5
97282|NCT00297492|332115|P2|Set Quit Date|Lost to Follow-up|13
97283|NCT00297492|332116|P1|Set Quit Date|Lost to Follow-up|7
97284|NCT00298272|332171|P2|Safety Follow-up Phase|Administrative/Other Reason|1
97285|NCT00298272|332172|P1|Safety Follow-up Phase|Administrative/Other Reason|1
97286|NCT00298272|332171|P2|Safety Follow-up Phase|Withdrawal by Subject|2
97287|NCT00298272|332172|P1|Safety Follow-up Phase|Withdrawal by Subject|2
97288|NCT00298272|332171|P2|Safety Follow-up Phase|Failure to Return|1
97289|NCT00298272|332172|P1|Safety Follow-up Phase|Failure to Return|1
97290|NCT00298272|332171|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
97291|NCT00298272|332172|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
97292|NCT00298272|332171|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
97293|NCT00298272|332172|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
97294|NCT00298272|332171|P2|Open Label Retreatment Phase|Protocol Violation|1
97295|NCT00298272|332172|P1|Open Label Retreatment Phase|Protocol Violation|2
97296|NCT00298272|332171|P2|Open Label Retreatment Phase|Failure to Return|0
97297|NCT00298272|332172|P1|Open Label Retreatment Phase|Failure to Return|1
97298|NCT00298272|332171|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
97299|NCT00298272|332172|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
97300|NCT00298272|332171|P2|Open Label Retreatment Phase|Adverse Event|2
97301|NCT00298272|332172|P1|Open Label Retreatment Phase|Adverse Event|1
97302|NCT00298272|332171|P2|Double-blind Phase|Withdrawal by Subject|0
97303|NCT00298272|332172|P1|Double-blind Phase|Withdrawal by Subject|2
97304|NCT00298272|332171|P2|Double-blind Phase|Protocol Violation|0
97305|NCT00298272|332172|P1|Double-blind Phase|Protocol Violation|2
97306|NCT00298272|332171|P2|Double-blind Phase|Failure to Return|0
97307|NCT00298272|332172|P1|Double-blind Phase|Failure to Return|2
97308|NCT00298272|332171|P2|Double-blind Phase|Adverse Event|0
97309|NCT00298272|332172|P1|Double-blind Phase|Adverse Event|2
97310|NCT00298363|332196|P3|Overall Study|Lack of Efficacy|0
97311|NCT00298363|332197|P2|Overall Study|Lack of Efficacy|3
97312|NCT00298363|332198|P1|Overall Study|Lack of Efficacy|2
97313|NCT00298363|332196|P3|Overall Study|Adverse Event|2
97314|NCT00298363|332197|P2|Overall Study|Adverse Event|2
97315|NCT00298363|332198|P1|Overall Study|Adverse Event|5
97316|NCT00298363|332196|P3|Overall Study|Withdrawal by Subject|3
97317|NCT00298363|332197|P2|Overall Study|Withdrawal by Subject|1
97318|NCT00298363|332198|P1|Overall Study|Withdrawal by Subject|5
97319|NCT00298363|332196|P3|Overall Study|Protocol Violation|0
97320|NCT00298363|332197|P2|Overall Study|Protocol Violation|1
97321|NCT00298363|332198|P1|Overall Study|Protocol Violation|1
97322|NCT00298363|332196|P3|Overall Study|Physician Decision|0
97323|NCT00298363|332197|P2|Overall Study|Physician Decision|1
97324|NCT00298363|332198|P1|Overall Study|Physician Decision|4
97325|NCT00298363|332196|P3|Overall Study|Lost to Follow-up|1
97326|NCT00298363|332197|P2|Overall Study|Lost to Follow-up|0
97327|NCT00298363|332198|P1|Overall Study|Lost to Follow-up|0
97328|NCT00298766|332401|P1|Overall Study|Other|4
97329|NCT00298766|332401|P1|Overall Study|Subjects overall condition deterioration|4
97330|NCT00298766|332401|P1|Overall Study|Deterioration in KPS and organ function|1
97331|NCT00298766|332401|P1|Overall Study|Progression of amyloid markers|4
97332|NCT00298766|332401|P1|Overall Study|Treatment ongoing|4
97333|NCT00298766|332401|P1|Overall Study|Withdrawal by Subject|9
97334|NCT00298766|332401|P1|Overall Study|Death|2
97335|NCT00298766|332401|P1|Overall Study|Adverse Event|18
97336|NCT00299104|332428|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
97337|NCT00299104|332429|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
97338|NCT00299104|332430|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
97339|NCT00299104|332428|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
97340|NCT00299104|332429|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
97341|NCT00299104|332430|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
97342|NCT00299104|332428|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
97343|NCT00299104|332429|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
97344|NCT00299104|332430|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
97345|NCT00299104|332428|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
97346|NCT00299104|332429|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
97347|NCT00299104|332430|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
97348|NCT00299104|332428|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
97349|NCT00299104|332429|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
97350|NCT00299104|332430|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
97351|NCT00299104|332428|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
97352|NCT00299104|332429|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
97353|NCT00299104|332430|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
97354|NCT00299104|332428|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
97355|NCT00299104|332429|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
97356|NCT00299104|332430|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
97357|NCT00299104|332428|P3|Safety Follow-Up (SFU) Period|Death|1
97358|NCT00299104|332429|P2|Safety Follow-Up (SFU) Period|Death|2
97359|NCT00299104|332430|P1|Safety Follow-Up (SFU) Period|Death|3
97360|NCT00299104|332428|P3|Treatment Period|Administrative reasons|137
97361|NCT00299104|332429|P2|Treatment Period|Administrative reasons|120
97362|NCT00299104|332430|P1|Treatment Period|Administrative reasons|106
97363|NCT00299104|332428|P3|Treatment Period|Withdrew consent|9
97364|NCT00299104|332429|P2|Treatment Period|Withdrew consent|19
97365|NCT00299104|332430|P1|Treatment Period|Withdrew consent|14
97366|NCT00299104|332428|P3|Treatment Period|Refused treatment|2
97367|NCT00299104|332429|P2|Treatment Period|Refused treatment|2
97368|NCT00299104|332430|P1|Treatment Period|Refused treatment|9
97369|NCT00299104|332428|P3|Treatment Period|Protocol Violation|0
97370|NCT00299104|332429|P2|Treatment Period|Protocol Violation|1
97371|NCT00299104|332430|P1|Treatment Period|Protocol Violation|1
97372|NCT00299104|332428|P3|Treatment Period|Violation of selection criteria|0
97373|NCT00299104|332429|P2|Treatment Period|Violation of selection criteria|2
97374|NCT00299104|332430|P1|Treatment Period|Violation of selection criteria|1
97375|NCT00299104|332428|P3|Treatment Period|Failure to return|8
97376|NCT00299104|332429|P2|Treatment Period|Failure to return|8
97377|NCT00299104|332430|P1|Treatment Period|Failure to return|9
97378|NCT00299104|332428|P3|Treatment Period|Insufficient therapeutic response|8
97379|NCT00299104|332429|P2|Treatment Period|Insufficient therapeutic response|13
97380|NCT00299104|332430|P1|Treatment Period|Insufficient therapeutic response|34
97381|NCT00299104|332428|P3|Treatment Period|Death|1
97382|NCT00299104|332429|P2|Treatment Period|Death|1
97383|NCT00299104|332430|P1|Treatment Period|Death|1
97384|NCT00299104|332428|P3|Treatment Period|Adverse Event|7
97385|NCT00299104|332429|P2|Treatment Period|Adverse Event|9
97386|NCT00299104|332430|P1|Treatment Period|Adverse Event|14
97387|NCT00299130|332528|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
97388|NCT00299130|332529|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
97389|NCT00299130|332530|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
97390|NCT00299130|332528|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
97391|NCT00299130|332529|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
97392|NCT00299130|332530|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
97393|NCT00299130|332528|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
97394|NCT00299130|332529|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
97395|NCT00299130|332530|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
97396|NCT00299130|332528|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
97397|NCT00299130|332529|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
97398|NCT00299130|332530|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
97399|NCT00299130|332528|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
97400|NCT00299130|332529|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
97401|NCT00299130|332530|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
97402|NCT00299130|332528|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
97403|NCT00299130|332529|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
97404|NCT00299130|332530|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
97405|NCT00299130|332528|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
97406|NCT00299130|332529|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
97407|NCT00299130|332530|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
97408|NCT00299130|332528|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
97409|NCT00299130|332529|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
97410|NCT00299130|332530|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
97411|NCT00299130|332528|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
97412|NCT00299130|332529|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
97413|NCT00299130|332530|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
97414|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
97415|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
97416|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
97417|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
97418|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
97419|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
97420|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Failure to Return|6
97421|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Failure to Return|6
97422|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Failure to Return|4
97423|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
97424|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
97425|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
97426|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
97427|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
97428|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
97429|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
97430|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
97431|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
97432|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Death|1
97433|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Death|3
97434|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Death|1
97435|NCT00299130|332528|P3|Treatment Period (up to 5 Years)|Adverse Event|13
97436|NCT00299130|332529|P2|Treatment Period (up to 5 Years)|Adverse Event|8
97437|NCT00299130|332530|P1|Treatment Period (up to 5 Years)|Adverse Event|13
97438|NCT00299156|332635|P3|Period 2 (Randomized)|Screen Failure|0
97439|NCT00299156|332636|P2|Period 2 (Randomized)|Screen Failure|1
97440|NCT00299156|332637|P1|Period 2 (Randomized)|Screen Failure|0
97441|NCT00299546|332671|P3|Overall Study|Not treated|1
97442|NCT00299546|332672|P2|Overall Study|Not treated|1
97443|NCT00299546|332673|P1|Overall Study|Not treated|0
97444|NCT00299546|332671|P3|Overall Study|Not specified|19
97445|NCT00299546|332672|P2|Overall Study|Not specified|26
97446|NCT00299546|332673|P1|Overall Study|Not specified|24
97447|NCT00299546|332671|P3|Overall Study|Unsatisfactory therapeutic effect|34
97448|NCT00299546|332672|P2|Overall Study|Unsatisfactory therapeutic effect|39
97449|NCT00299546|332673|P1|Overall Study|Unsatisfactory therapeutic effect|34
97450|NCT00299546|332671|P3|Overall Study|Adverse Event|27
97451|NCT00299546|332672|P2|Overall Study|Adverse Event|22
97452|NCT00299546|332673|P1|Overall Study|Adverse Event|37
97453|NCT00299546|332671|P3|Overall Study|Lost to Follow-up|5
97454|NCT00299546|332672|P2|Overall Study|Lost to Follow-up|2
97455|NCT00299546|332673|P1|Overall Study|Lost to Follow-up|2
97456|NCT00299546|332671|P3|Overall Study|Death|0
97457|NCT00299546|332672|P2|Overall Study|Death|2
97458|NCT00299546|332673|P1|Overall Study|Death|3
97459|NCT00299702|332704|P2|Overall Study|Admin issues, sponsor decision, etc.|9
97460|NCT00299702|332705|P1|Overall Study|Admin issues, sponsor decision, etc.|5
97461|NCT00299702|332704|P2|Overall Study|Insufficient Response|3
97462|NCT00299702|332705|P1|Overall Study|Insufficient Response|4
97463|NCT00299702|332704|P2|Overall Study|Pregnancy|1
97464|NCT00299702|332705|P1|Overall Study|Pregnancy|0
97465|NCT00299702|332704|P2|Overall Study|Withdrawal by Subject|23
97466|NCT00299702|332705|P1|Overall Study|Withdrawal by Subject|25
97467|NCT00299702|332704|P2|Overall Study|Lost to Follow-up|10
97468|NCT00299702|332705|P1|Overall Study|Lost to Follow-up|18
97469|NCT00299702|332704|P2|Overall Study|Adverse Event|4
97470|NCT00299702|332705|P1|Overall Study|Adverse Event|0
97471|NCT00299702|332704|P2|Overall Study|Death|0
97472|NCT00299702|332705|P1|Overall Study|Death|1
97473|NCT00299975|332721|P3|Overall Study|Physician Decision|1
97474|NCT00299975|332722|P2|Overall Study|Physician Decision|0
97475|NCT00299975|332723|P1|Overall Study|Physician Decision|0
97476|NCT00299975|332721|P3|Overall Study|Withdrawal by Subject|3
97477|NCT00299975|332722|P2|Overall Study|Withdrawal by Subject|1
97478|NCT00299975|332723|P1|Overall Study|Withdrawal by Subject|0
97479|NCT00299975|332721|P3|Overall Study|Lost to Follow-up|0
97480|NCT00299975|332722|P2|Overall Study|Lost to Follow-up|0
97481|NCT00299975|332723|P1|Overall Study|Lost to Follow-up|1
97482|NCT00299975|332721|P3|Overall Study|Lack of Efficacy|1
97483|NCT00299975|332722|P2|Overall Study|Lack of Efficacy|0
97484|NCT00299975|332723|P1|Overall Study|Lack of Efficacy|1
97485|NCT00299975|332721|P3|Overall Study|Pregnancy|1
97486|NCT00299975|332722|P2|Overall Study|Pregnancy|0
97487|NCT00299975|332723|P1|Overall Study|Pregnancy|0
97488|NCT00299975|332721|P3|Overall Study|Adverse Event|2
97489|NCT00299975|332722|P2|Overall Study|Adverse Event|0
97490|NCT00299975|332723|P1|Overall Study|Adverse Event|1
97491|NCT00300274|332797|P3|Overall Study|Re-transplant|1
97492|NCT00300274|332798|P2|Overall Study|Re-transplant|0
97493|NCT00300274|332799|P1|Overall Study|Re-transplant|0
97494|NCT00300274|332797|P3|Overall Study|Death|25
97495|NCT00300274|332798|P2|Overall Study|Death|20
97496|NCT00300274|332799|P1|Overall Study|Death|31
97497|NCT00300274|332797|P3|Overall Study|Lost to Follow-up|5
97498|NCT00300274|332798|P2|Overall Study|Lost to Follow-up|4
97499|NCT00300274|332799|P1|Overall Study|Lost to Follow-up|3
97500|NCT00300274|332797|P3|Overall Study|Withdrawal by Subject|14
97501|NCT00300274|332798|P2|Overall Study|Withdrawal by Subject|3
97502|NCT00300274|332799|P1|Overall Study|Withdrawal by Subject|12
97503|NCT00300365|332836|P2|Overall Study|Adverse Event|2
97504|NCT00300365|332837|P1|Overall Study|Adverse Event|0
97505|NCT00300365|332836|P2|Overall Study|Withdrawal by Subject|0
97506|NCT00300365|332837|P1|Overall Study|Withdrawal by Subject|1
97507|NCT00300365|332836|P2|Overall Study|Physician Decision|0
97508|NCT00300365|332837|P1|Overall Study|Physician Decision|2
97509|NCT00300365|332836|P2|Overall Study|Lost to Follow-up|0
97510|NCT00300365|332837|P1|Overall Study|Lost to Follow-up|1
97511|NCT00300495|333083|P2|Overall Study|Protocol Violation|1
97512|NCT00300495|333084|P1|Overall Study|Protocol Violation|4
97513|NCT00307333|333094|P2|Overall Study|Lost to Follow-up|3
97514|NCT00307333|333095|P1|Overall Study|Lost to Follow-up|11
97515|NCT00307437|333110|P7|After Controlled Period|Unspecified|28
97516|NCT00307437|333111|P6|After Controlled Period|Unspecified|40
97517|NCT00307437|333112|P5|After Controlled Period|Unspecified|9
97518|NCT00307437|333113|P4|After Controlled Period|Unspecified|15
97519|NCT00307437|333114|P3|After Controlled Period|Unspecified|0
97520|NCT00307437|333115|P2|After Controlled Period|Unspecified|0
97521|NCT00307437|333116|P1|After Controlled Period|Unspecified|0
97522|NCT00307437|333110|P7|After Controlled Period|Lost to Follow-up|18
97523|NCT00307437|333111|P6|After Controlled Period|Lost to Follow-up|13
97524|NCT00307437|333112|P5|After Controlled Period|Lost to Follow-up|12
97525|NCT00307437|333113|P4|After Controlled Period|Lost to Follow-up|7
97526|NCT00307437|333114|P3|After Controlled Period|Lost to Follow-up|0
97527|NCT00307437|333115|P2|After Controlled Period|Lost to Follow-up|0
97528|NCT00307437|333116|P1|After Controlled Period|Lost to Follow-up|0
97529|NCT00307437|333110|P7|After Controlled Period|Lack of Efficacy|24
97530|NCT00307437|333111|P6|After Controlled Period|Lack of Efficacy|37
97531|NCT00307437|333112|P5|After Controlled Period|Lack of Efficacy|17
97532|NCT00307437|333113|P4|After Controlled Period|Lack of Efficacy|15
97533|NCT00307437|333114|P3|After Controlled Period|Lack of Efficacy|0
97534|NCT00307437|333115|P2|After Controlled Period|Lack of Efficacy|0
97535|NCT00307437|333116|P1|After Controlled Period|Lack of Efficacy|0
97536|NCT00307437|333110|P7|After Controlled Period|Death|3
97537|NCT00307437|333111|P6|After Controlled Period|Death|1
97538|NCT00307437|333112|P5|After Controlled Period|Death|1
97539|NCT00307437|333113|P4|After Controlled Period|Death|3
97540|NCT00307437|333114|P3|After Controlled Period|Death|0
97541|NCT00307437|333115|P2|After Controlled Period|Death|0
97542|NCT00307437|333116|P1|After Controlled Period|Death|0
97543|NCT00307437|333110|P7|After Controlled Period|Adverse Event|40
97544|NCT00307437|333111|P6|After Controlled Period|Adverse Event|31
97545|NCT00307437|333112|P5|After Controlled Period|Adverse Event|16
97546|NCT00307437|333113|P4|After Controlled Period|Adverse Event|18
97547|NCT00307437|333114|P3|After Controlled Period|Adverse Event|0
97548|NCT00307437|333115|P2|After Controlled Period|Adverse Event|0
97549|NCT00307437|333116|P1|After Controlled Period|Adverse Event|0
97550|NCT00307437|333110|P7|Controlled Period|Unspecified|0
97551|NCT00307437|333111|P6|Controlled Period|Unspecified|0
97552|NCT00307437|333112|P5|Controlled Period|Unspecified|0
97553|NCT00307437|333113|P4|Controlled Period|Unspecified|0
97554|NCT00307437|333114|P3|Controlled Period|Unspecified|3
97555|NCT00307437|333115|P2|Controlled Period|Unspecified|1
97556|NCT00307437|333116|P1|Controlled Period|Unspecified|5
97557|NCT00307437|333110|P7|Controlled Period|Lost to Follow-up|0
97558|NCT00307437|333111|P6|Controlled Period|Lost to Follow-up|0
97559|NCT00307437|333112|P5|Controlled Period|Lost to Follow-up|0
97560|NCT00307437|333113|P4|Controlled Period|Lost to Follow-up|0
97561|NCT00307437|333114|P3|Controlled Period|Lost to Follow-up|0
97562|NCT00307437|333115|P2|Controlled Period|Lost to Follow-up|3
97563|NCT00307437|333116|P1|Controlled Period|Lost to Follow-up|2
97564|NCT00307437|333110|P7|Controlled Period|Lack of Efficacy|0
97565|NCT00307437|333111|P6|Controlled Period|Lack of Efficacy|0
97566|NCT00307437|333112|P5|Controlled Period|Lack of Efficacy|0
97567|NCT00307437|333113|P4|Controlled Period|Lack of Efficacy|0
97568|NCT00307437|333114|P3|Controlled Period|Lack of Efficacy|0
97569|NCT00307437|333115|P2|Controlled Period|Lack of Efficacy|0
97570|NCT00307437|333116|P1|Controlled Period|Lack of Efficacy|2
97571|NCT00307437|333110|P7|Controlled Period|Death|0
97572|NCT00307437|333111|P6|Controlled Period|Death|0
97573|NCT00307437|333112|P5|Controlled Period|Death|0
97574|NCT00307437|333113|P4|Controlled Period|Death|0
97575|NCT00307437|333114|P3|Controlled Period|Death|1
97576|NCT00307437|333115|P2|Controlled Period|Death|0
97577|NCT00307437|333116|P1|Controlled Period|Death|0
97578|NCT00307437|333110|P7|Controlled Period|Adverse Event|0
97579|NCT00307437|333111|P6|Controlled Period|Adverse Event|0
97580|NCT00307437|333112|P5|Controlled Period|Adverse Event|0
97581|NCT00307437|333113|P4|Controlled Period|Adverse Event|0
97582|NCT00307437|333114|P3|Controlled Period|Adverse Event|5
97583|NCT00307437|333115|P2|Controlled Period|Adverse Event|2
97584|NCT00307437|333116|P1|Controlled Period|Adverse Event|7
97585|NCT00307489|333142|P2|Week 48 Through Week 168|Seroconversion|0
97586|NCT00307489|333143|P1|Week 48 Through Week 168|Seroconversion|1
97587|NCT00307489|333142|P2|Week 48 Through Week 168|Lost to Follow-up|1
97588|NCT00307489|333143|P1|Week 48 Through Week 168|Lost to Follow-up|0
97589|NCT00307489|333142|P2|Week 48 Through Week 168|Death|1
97590|NCT00307489|333143|P1|Week 48 Through Week 168|Death|0
97591|NCT00307489|333142|P2|Week 48 Through Week 168|Lack of Efficacy|2
97592|NCT00307489|333143|P1|Week 48 Through Week 168|Lack of Efficacy|2
97593|NCT00307489|333142|P2|Week 48 Through Week 168|Withdrawal by Subject|2
97594|NCT00307489|333143|P1|Week 48 Through Week 168|Withdrawal by Subject|1
97595|NCT00307489|333142|P2|Week 48 Through Week 168|Physician Decision|0
97596|NCT00307489|333143|P1|Week 48 Through Week 168|Physician Decision|1
97597|NCT00307489|333142|P2|Week 48 Through Week 168|Adverse Event|0
97598|NCT00307489|333143|P1|Week 48 Through Week 168|Adverse Event|1
97599|NCT00307489|333142|P2|Baseline Through Week 48|Withdrawal by Subject|1
97600|NCT00307489|333143|P1|Baseline Through Week 48|Withdrawal by Subject|0
97601|NCT00307489|333142|P2|Baseline Through Week 48|Physician Decision|0
97602|NCT00307489|333143|P1|Baseline Through Week 48|Physician Decision|1
97603|NCT00307489|333142|P2|Baseline Through Week 48|Lost to Follow-up|1
97604|NCT00307489|333143|P1|Baseline Through Week 48|Lost to Follow-up|0
97605|NCT00308113|333189|P4|Overall Study|Protocol closure|1
97606|NCT00308113|333190|P3|Overall Study|Protocol closure|0
97607|NCT00308113|333191|P2|Overall Study|Protocol closure|0
97608|NCT00308113|333192|P1|Overall Study|Protocol closure|0
97609|NCT00308139|333212|P2|Overall Study|Other|0
97610|NCT00308139|333213|P1|Overall Study|Other|1
97611|NCT00308139|333212|P2|Overall Study|Administrative|4
97612|NCT00308139|333213|P1|Overall Study|Administrative|1
97613|NCT00308139|333212|P2|Overall Study|Loss of Glucose Control|7
97614|NCT00308139|333213|P1|Overall Study|Loss of Glucose Control|5
97615|NCT00308139|333212|P2|Overall Study|Investigator Decision|10
97616|NCT00308139|333213|P1|Overall Study|Investigator Decision|11
97617|NCT00308139|333212|P2|Overall Study|Withdrawal of Consent|42
97618|NCT00308139|333213|P1|Overall Study|Withdrawal of Consent|40
97619|NCT00308139|333212|P2|Overall Study|Protocol Violation|2
97620|NCT00308139|333213|P1|Overall Study|Protocol Violation|3
97621|NCT00308139|333212|P2|Overall Study|Lost to Follow-up|8
97622|NCT00308139|333213|P1|Overall Study|Lost to Follow-up|13
97623|NCT00308139|333212|P2|Overall Study|Adverse Event|14
97624|NCT00308139|333213|P1|Overall Study|Adverse Event|20
97625|NCT00308308|333298|P2|Overall Study|Other|0
97626|NCT00308308|333299|P1|Overall Study|Other|1
97627|NCT00308308|333298|P2|Overall Study|Randomized but not dosed|16
97628|NCT00308308|333299|P1|Overall Study|Randomized but not dosed|8
97629|NCT00308308|333298|P2|Overall Study|Various|5
97630|NCT00308308|333299|P1|Overall Study|Various|7
97631|NCT00308308|333298|P2|Overall Study|Withdrawal by Subject|19
97632|NCT00308308|333299|P1|Overall Study|Withdrawal by Subject|47
97633|NCT00308308|333298|P2|Overall Study|Protocol Violation|14
97634|NCT00308308|333299|P1|Overall Study|Protocol Violation|3
97635|NCT00308308|333298|P2|Overall Study|Physician Decision|7
97636|NCT00308308|333299|P1|Overall Study|Physician Decision|15
97637|NCT00308308|333298|P2|Overall Study|Lost to Follow-up|5
97638|NCT00308308|333299|P1|Overall Study|Lost to Follow-up|5
97639|NCT00308308|333298|P2|Overall Study|Adverse Event|2
97640|NCT00308308|333299|P1|Overall Study|Adverse Event|17
97641|NCT00308555|333330|P2|Overall Study|Physician Decision|0
97642|NCT00308555|333331|P1|Overall Study|Physician Decision|2
97643|NCT00308555|333330|P2|Overall Study|Withdrawal by Subject|0
97644|NCT00308555|333331|P1|Overall Study|Withdrawal by Subject|1
97645|NCT00308581|333337|P3|Randomized Maintenance Phase|Unknown reason|0
97646|NCT00308581|333338|P2|Randomized Maintenance Phase|Unknown reason|0
97647|NCT00308581|333339|P1|Randomized Maintenance Phase|Unknown reason|3
97648|NCT00308581|333337|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
97649|NCT00308581|333338|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
97650|NCT00308581|333339|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
97651|NCT00308581|333337|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
97652|NCT00308581|333338|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
97653|NCT00308581|333339|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
97654|NCT00308581|333337|P3|Randomized Maintenance Phase|Lost to Follow-up|0
97655|NCT00308581|333338|P2|Randomized Maintenance Phase|Lost to Follow-up|2
97656|NCT00308581|333339|P1|Randomized Maintenance Phase|Lost to Follow-up|0
97657|NCT00308581|333337|P3|Randomized Maintenance Phase|Lack of Efficacy|0
97658|NCT00308581|333338|P2|Randomized Maintenance Phase|Lack of Efficacy|21
97659|NCT00308581|333339|P1|Randomized Maintenance Phase|Lack of Efficacy|9
97660|NCT00308581|333337|P3|Randomized Maintenance Phase|Adverse Event|0
97661|NCT00308581|333338|P2|Randomized Maintenance Phase|Adverse Event|17
97662|NCT00308581|333339|P1|Randomized Maintenance Phase|Adverse Event|10
97663|NCT00308581|333337|P3|Induction Phase|Unknown reason|3
97664|NCT00308581|333338|P2|Induction Phase|Unknown reason|0
97665|NCT00308581|333339|P1|Induction Phase|Unknown reason|0
97666|NCT00308581|333337|P3|Induction Phase|Withdrawal by Subject|5
97667|NCT00308581|333338|P2|Induction Phase|Withdrawal by Subject|0
97668|NCT00308581|333339|P1|Induction Phase|Withdrawal by Subject|0
97669|NCT00308581|333337|P3|Induction Phase|Lack of Efficacy|121
97670|NCT00308581|333338|P2|Induction Phase|Lack of Efficacy|0
97671|NCT00308581|333339|P1|Induction Phase|Lack of Efficacy|0
97672|NCT00308581|333337|P3|Induction Phase|Adverse Event|37
97673|NCT00308581|333338|P2|Induction Phase|Adverse Event|0
97674|NCT00308581|333339|P1|Induction Phase|Adverse Event|0
97675|NCT00308620|333466|P3|Overall Study|Lost to Follow-up|1
97676|NCT00308620|333467|P2|Overall Study|Lost to Follow-up|0
97677|NCT00308620|333468|P1|Overall Study|Lost to Follow-up|0
97678|NCT00308620|333466|P3|Overall Study|Death|0
97679|NCT00308620|333467|P2|Overall Study|Death|1
97680|NCT00308620|333468|P1|Overall Study|Death|1
97681|NCT00308711|333480|P3|Overall Study|Subject incarcerated, data not allowed|1
97682|NCT00308711|333481|P2|Overall Study|Subject incarcerated, data not allowed|0
97683|NCT00308711|333482|P1|Overall Study|Subject incarcerated, data not allowed|0
97684|NCT00308711|333480|P3|Overall Study|Baby not born within 7 days of treatment|2
97685|NCT00308711|333481|P2|Overall Study|Baby not born within 7 days of treatment|2
97686|NCT00308711|333482|P1|Overall Study|Baby not born within 7 days of treatment|1
97687|NCT00308711|333480|P3|Overall Study|Lost to Follow-up|0
97688|NCT00308711|333481|P2|Overall Study|Lost to Follow-up|1
97689|NCT00308711|333482|P1|Overall Study|Lost to Follow-up|0
97690|NCT00308711|333480|P3|Overall Study|Protocol Violation|1
97691|NCT00308711|333481|P2|Overall Study|Protocol Violation|1
97692|NCT00308711|333482|P1|Overall Study|Protocol Violation|0
97693|NCT00308711|333480|P3|Overall Study|Withdrawal by Subject|1
97694|NCT00308711|333481|P2|Overall Study|Withdrawal by Subject|0
97695|NCT00308711|333482|P1|Overall Study|Withdrawal by Subject|1
97696|NCT00308737|333517|P3|Overall Study|Various|8
97697|NCT00308737|333518|P2|Overall Study|Various|20
97698|NCT00308737|333519|P1|Overall Study|Various|32
97699|NCT00308737|333517|P3|Overall Study|Withdrawal by Subject|18
97700|NCT00308737|333518|P2|Overall Study|Withdrawal by Subject|166
97701|NCT00308737|333519|P1|Overall Study|Withdrawal by Subject|218
97702|NCT00308737|333517|P3|Overall Study|Protocol Violation|5
97703|NCT00308737|333518|P2|Overall Study|Protocol Violation|9
97704|NCT00308737|333519|P1|Overall Study|Protocol Violation|34
97705|NCT00308737|333517|P3|Overall Study|Physician Decision|1
97706|NCT00308737|333518|P2|Overall Study|Physician Decision|2
97707|NCT00308737|333519|P1|Overall Study|Physician Decision|15
97708|NCT00308737|333517|P3|Overall Study|Lost to Follow-up|5
97709|NCT00308737|333518|P2|Overall Study|Lost to Follow-up|80
97710|NCT00308737|333519|P1|Overall Study|Lost to Follow-up|56
97711|NCT00308737|333517|P3|Overall Study|Death|0
97712|NCT00308737|333518|P2|Overall Study|Death|3
97713|NCT00308737|333519|P1|Overall Study|Death|4
97714|NCT00308737|333517|P3|Overall Study|Adverse Event|0
97715|NCT00308737|333518|P2|Overall Study|Adverse Event|9
97716|NCT00308737|333519|P1|Overall Study|Adverse Event|104
97717|NCT00308997|333558|P2|Overall Study|Unable to tolerate intervention|0
97718|NCT00308997|333559|P1|Overall Study|Unable to tolerate intervention|1
97719|NCT00308997|333558|P2|Overall Study|Subject feigned clinical data|1
97720|NCT00308997|333559|P1|Overall Study|Subject feigned clinical data|0
97721|NCT00309244|333577|P2|Overall Study|Death|1
97722|NCT00309244|333578|P1|Overall Study|Death|4
97723|NCT00309244|333577|P2|Overall Study|Randomized but not dosed|12
97724|NCT00309244|333578|P1|Overall Study|Randomized but not dosed|11
97725|NCT00309244|333577|P2|Overall Study|Various|7
97726|NCT00309244|333578|P1|Overall Study|Various|7
97727|NCT00309244|333577|P2|Overall Study|Withdrawal by Subject|32
97728|NCT00309244|333578|P1|Overall Study|Withdrawal by Subject|50
97729|NCT00309244|333577|P2|Overall Study|Protocol Violation|3
97730|NCT00309244|333578|P1|Overall Study|Protocol Violation|6
97731|NCT00309244|333577|P2|Overall Study|Physician Decision|8
97732|NCT00309244|333578|P1|Overall Study|Physician Decision|5
97733|NCT00309244|333577|P2|Overall Study|Lost to Follow-up|22
97734|NCT00309244|333578|P1|Overall Study|Lost to Follow-up|6
97735|NCT00309244|333577|P2|Overall Study|Adverse Event|12
97736|NCT00309244|333578|P1|Overall Study|Adverse Event|29
97737|NCT00309387|333600|P2|Overall Study|Lost to Follow-up|86
97738|NCT00309387|333601|P1|Overall Study|Lost to Follow-up|70
97739|NCT00309387|333600|P2|Overall Study|Death|73
97740|NCT00309387|333601|P1|Overall Study|Death|72
97741|NCT00309452|333619|P2|Overall Study|Withdrawal by Subject|0
97742|NCT00309452|333620|P1|Overall Study|Withdrawal by Subject|3
97743|NCT00309608|333676|P5|Overall Study|Other incl. Lack of efficacy|0
97744|NCT00309608|333677|P4|Overall Study|Other incl. Lack of efficacy|4
97745|NCT00309608|333678|P3|Overall Study|Other incl. Lack of efficacy|3
97746|NCT00309608|333679|P2|Overall Study|Other incl. Lack of efficacy|4
97747|NCT00309608|333680|P1|Overall Study|Other incl. Lack of efficacy|10
97748|NCT00309608|333676|P5|Overall Study|Withdrawal by Subject|0
97749|NCT00309608|333677|P4|Overall Study|Withdrawal by Subject|0
97750|NCT00309608|333678|P3|Overall Study|Withdrawal by Subject|2
97751|NCT00309608|333679|P2|Overall Study|Withdrawal by Subject|4
97752|NCT00309608|333680|P1|Overall Study|Withdrawal by Subject|1
97753|NCT00309608|333676|P5|Overall Study|Lost to Follow-up|1
97754|NCT00309608|333677|P4|Overall Study|Lost to Follow-up|0
97755|NCT00309608|333678|P3|Overall Study|Lost to Follow-up|2
97756|NCT00309608|333679|P2|Overall Study|Lost to Follow-up|0
97757|NCT00309608|333680|P1|Overall Study|Lost to Follow-up|0
97758|NCT00309608|333676|P5|Overall Study|Protocol Violation|0
97759|NCT00309608|333677|P4|Overall Study|Protocol Violation|0
97760|NCT00309608|333678|P3|Overall Study|Protocol Violation|0
97761|NCT00309608|333679|P2|Overall Study|Protocol Violation|0
97762|NCT00309608|333680|P1|Overall Study|Protocol Violation|2
97763|NCT00309608|333676|P5|Overall Study|Adverse Event|3
97764|NCT00309608|333677|P4|Overall Study|Adverse Event|2
97765|NCT00309608|333678|P3|Overall Study|Adverse Event|3
97766|NCT00309608|333679|P2|Overall Study|Adverse Event|5
97767|NCT00309608|333680|P1|Overall Study|Adverse Event|1
97768|NCT00309777|333727|P4|Overall Study|Death|0
97769|NCT00309777|333728|P3|Overall Study|Death|0
97770|NCT00309777|333729|P2|Overall Study|Death|1
97771|NCT00309777|333730|P1|Overall Study|Death|0
97772|NCT00309777|333727|P4|Overall Study|Lost to Follow-up|0
97773|NCT00309777|333728|P3|Overall Study|Lost to Follow-up|1
97774|NCT00309777|333729|P2|Overall Study|Lost to Follow-up|0
97775|NCT00309777|333730|P1|Overall Study|Lost to Follow-up|0
97776|NCT00309777|333727|P4|Overall Study|Withdrawal by Subject|2
97777|NCT00309777|333728|P3|Overall Study|Withdrawal by Subject|7
97778|NCT00309777|333729|P2|Overall Study|Withdrawal by Subject|5
97779|NCT00309777|333730|P1|Overall Study|Withdrawal by Subject|6
97780|NCT00309777|333727|P4|Overall Study|Protocol Violation|1
97781|NCT00309777|333728|P3|Overall Study|Protocol Violation|3
97782|NCT00309777|333729|P2|Overall Study|Protocol Violation|1
97783|NCT00309777|333730|P1|Overall Study|Protocol Violation|4
97784|NCT00309777|333727|P4|Overall Study|Adverse Event|1
97785|NCT00309777|333728|P3|Overall Study|Adverse Event|8
97786|NCT00309777|333729|P2|Overall Study|Adverse Event|2
97787|NCT00309777|333730|P1|Overall Study|Adverse Event|13
97788|NCT00309907|333744|P1|Overall Study|Major infectious event|4
97789|NCT00309907|333744|P1|Overall Study|Ineligible|11
97790|NCT00309907|333744|P1|Overall Study|Physician Decision|1
97791|NCT00309907|333744|P1|Overall Study|Death|4
97792|NCT00309946|333748|P1|Overall Study|Withdrawal by Subject|1
97793|NCT00309985|333756|P2|Overall Study|Chemotherapy discontinued only|0
97794|NCT00309985|333757|P1|Overall Study|Chemotherapy discontinued only|1
97795|NCT00309985|333756|P2|Overall Study|Non-compliance|0
97796|NCT00309985|333757|P1|Overall Study|Non-compliance|1
97797|NCT00309985|333756|P2|Overall Study|Complicating disease|0
97798|NCT00309985|333757|P1|Overall Study|Complicating disease|1
97799|NCT00309985|333756|P2|Overall Study|Never started treatment|0
97800|NCT00309985|333757|P1|Overall Study|Never started treatment|7
97801|NCT00309985|333756|P2|Overall Study|Physician Decision|0
97802|NCT00309985|333757|P1|Overall Study|Physician Decision|3
97803|NCT00309985|333756|P2|Overall Study|Withdrawal by Subject|1
97804|NCT00309985|333757|P1|Overall Study|Withdrawal by Subject|5
97805|NCT00309985|333756|P2|Overall Study|Death|0
97806|NCT00309985|333757|P1|Overall Study|Death|2
97807|NCT00309985|333756|P2|Overall Study|Adverse Event|0
97808|NCT00309985|333757|P1|Overall Study|Adverse Event|30
97809|NCT00309985|333756|P2|Overall Study|Disease progression|0
97810|NCT00309985|333757|P1|Overall Study|Disease progression|12
97811|NCT00310375|333819|P2|Overall Study|Request of Ethics Committee|1
97812|NCT00310375|333820|P1|Overall Study|Request of Ethics Committee|0
97813|NCT00310375|333819|P2|Overall Study|Par. switched to commercial product|1
97814|NCT00310375|333820|P1|Overall Study|Par. switched to commercial product|0
97815|NCT00310375|333819|P2|Overall Study|Missed study drug for 2 months|0
97816|NCT00310375|333820|P1|Overall Study|Missed study drug for 2 months|1
97817|NCT00310375|333819|P2|Overall Study|Site closure|0
97818|NCT00310375|333820|P1|Overall Study|Site closure|3
97819|NCT00310375|333819|P2|Overall Study|Missed study drug >5 days|0
97820|NCT00310375|333820|P1|Overall Study|Missed study drug >5 days|1
97821|NCT00310375|333819|P2|Overall Study|Going for temporal lobectomy|0
97822|NCT00310375|333820|P1|Overall Study|Going for temporal lobectomy|1
97823|NCT00310375|333819|P2|Overall Study|Participant request unrelated to study|2
97824|NCT00310375|333820|P1|Overall Study|Participant request unrelated to study|1
97825|NCT00310375|333819|P2|Overall Study|Failed to return|3
97826|NCT00310375|333820|P1|Overall Study|Failed to return|1
97827|NCT00310375|333819|P2|Overall Study|Request of the sponsor|2
97828|NCT00310375|333820|P1|Overall Study|Request of the sponsor|2
97829|NCT00310375|333819|P2|Overall Study|Physician Decision|3
97830|NCT00310375|333820|P1|Overall Study|Physician Decision|5
97831|NCT00310375|333819|P2|Overall Study|Transaminase >5 upper limit of normal|1
97832|NCT00310375|333820|P1|Overall Study|Transaminase >5 upper limit of normal|2
97833|NCT00310375|333819|P2|Overall Study|Change in Par medical condition|0
97834|NCT00310375|333820|P1|Overall Study|Change in Par medical condition|2
97835|NCT00310375|333819|P2|Overall Study|Protocol Violation|5
97836|NCT00310375|333820|P1|Overall Study|Protocol Violation|8
97837|NCT00310375|333819|P2|Overall Study|Withdrawal by Subject|7
97838|NCT00310375|333820|P1|Overall Study|Withdrawal by Subject|10
97839|NCT00310375|333819|P2|Overall Study|Pregnancy|2
97840|NCT00310375|333820|P1|Overall Study|Pregnancy|2
97841|NCT00310375|333819|P2|Overall Study|Lack of Efficacy|19
97842|NCT00310375|333820|P1|Overall Study|Lack of Efficacy|24
97843|NCT00310375|333819|P2|Overall Study|Adverse Event|22
97844|NCT00310375|333820|P1|Overall Study|Adverse Event|28
97845|NCT00310440|333892|P2|Overall Study|Missed 12 Month Visit|4
97846|NCT00310440|333893|P1|Overall Study|Missed 12 Month Visit|7
97847|NCT00310440|333892|P2|Overall Study|Withdrawal by Subject|1
97848|NCT00310440|333893|P1|Overall Study|Withdrawal by Subject|2
97849|NCT00310440|333892|P2|Overall Study|Lost to Follow-up|8
97850|NCT00310440|333893|P1|Overall Study|Lost to Follow-up|17
97851|NCT00297648|333932|P1|Overall Study|Other: Incompliance|1
97852|NCT00297648|333932|P1|Overall Study|Withdrawal by Subject|3
97853|NCT00297648|333932|P1|Overall Study|Lost to Follow-up|1
97854|NCT00297648|333932|P1|Overall Study|Lack of Efficacy|18
97855|NCT00297648|333932|P1|Overall Study|Adverse Event|13
97856|NCT00297778|333973|P2|Overall Study|Other|1
97857|NCT00297778|333974|P1|Overall Study|Other|0
97858|NCT00297778|333973|P2|Overall Study|Non-compliant with trial protocol|3
97859|NCT00297778|333974|P1|Overall Study|Non-compliant with trial protocol|0
97860|NCT00297778|333973|P2|Overall Study|Lack of Efficacy|1
97861|NCT00297778|333974|P1|Overall Study|Lack of Efficacy|2
97862|NCT00297778|333973|P2|Overall Study|Withdrawal by Subject|5
97863|NCT00297778|333974|P1|Overall Study|Withdrawal by Subject|1
97864|NCT00297778|333973|P2|Overall Study|Adverse Event|10
97865|NCT00297778|333974|P1|Overall Study|Adverse Event|16
97866|NCT00297830|334011|P3|12 Month Visit|Withdrawal by Subject|0
97867|NCT00297830|334012|P2|12 Month Visit|Withdrawal by Subject|3
97868|NCT00297830|334013|P1|12 Month Visit|Withdrawal by Subject|0
97869|NCT00297830|334011|P3|12 Month Visit|Adverse Event|0
97870|NCT00297830|334012|P2|12 Month Visit|Adverse Event|3
97871|NCT00297830|334013|P1|12 Month Visit|Adverse Event|0
97872|NCT00297830|334011|P3|12 Month Visit|Lost to Follow-up|0
97873|NCT00297830|334012|P2|12 Month Visit|Lost to Follow-up|0
97874|NCT00297830|334013|P1|12 Month Visit|Lost to Follow-up|1
97875|NCT00297830|334011|P3|6 Month Visit|Adverse Event|0
97876|NCT00297830|334012|P2|6 Month Visit|Adverse Event|1
97877|NCT00297830|334013|P1|6 Month Visit|Adverse Event|0
97878|NCT00297830|334011|P3|6 Month Visit|Withdrawal by Subject|1
97879|NCT00297830|334012|P2|6 Month Visit|Withdrawal by Subject|1
97880|NCT00297830|334013|P1|6 Month Visit|Withdrawal by Subject|2
97881|NCT00297830|334011|P3|6 Month Visit|Death|2
97882|NCT00297830|334012|P2|6 Month Visit|Death|0
97883|NCT00297830|334013|P1|6 Month Visit|Death|1
97884|NCT00303446|334032|P2|Overall Study|Physician Decision|1
97885|NCT00303446|334033|P1|Overall Study|Physician Decision|0
97886|NCT00303446|334032|P2|Overall Study|Death|1
97887|NCT00303446|334033|P1|Overall Study|Death|0
97888|NCT00303446|334032|P2|Overall Study|Withdrawal by Subject|2
97889|NCT00303446|334033|P1|Overall Study|Withdrawal by Subject|2
97890|NCT00303459|334069|P2|Overall Study|Lung transplantation|1
97891|NCT00303459|334070|P1|Overall Study|Lung transplantation|1
97892|NCT00303459|334069|P2|Overall Study|Decision by the investigator|7
97893|NCT00303459|334070|P1|Overall Study|Decision by the investigator|5
97894|NCT00303459|334069|P2|Overall Study|Administrative reason|7
97895|NCT00303459|334070|P1|Overall Study|Administrative reason|7
97896|NCT00303459|334069|P2|Overall Study|Lost to Follow-up|4
97897|NCT00303459|334070|P1|Overall Study|Lost to Follow-up|5
97898|NCT00303459|334069|P2|Overall Study|Withdrawal of consent|26
97899|NCT00303459|334070|P1|Overall Study|Withdrawal of consent|32
97900|NCT00303459|334069|P2|Overall Study|Death|44
97901|NCT00303459|334070|P1|Overall Study|Death|33
97902|NCT00303472|334101|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
97903|NCT00303472|334102|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
97904|NCT00303472|334103|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
97905|NCT00303472|334104|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
97906|NCT00303472|334105|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
97907|NCT00303472|334106|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
97908|NCT00303472|334107|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
97909|NCT00303472|334101|P7|Treatment Extension (Optional)|Not specified|0
97910|NCT00303472|334102|P6|Treatment Extension (Optional)|Not specified|0
97911|NCT00303472|334103|P5|Treatment Extension (Optional)|Not specified|1
97912|NCT00303472|334104|P4|Treatment Extension (Optional)|Not specified|2
97913|NCT00303472|334105|P3|Treatment Extension (Optional)|Not specified|4
97914|NCT00303472|334106|P2|Treatment Extension (Optional)|Not specified|2
97915|NCT00303472|334107|P1|Treatment Extension (Optional)|Not specified|0
97916|NCT00303472|334101|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
97917|NCT00303472|334102|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
97918|NCT00303472|334103|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
97919|NCT00303472|334104|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
97920|NCT00303472|334105|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
97921|NCT00303472|334106|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
97922|NCT00303472|334107|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
97923|NCT00303472|334101|P7|Treatment Extension (Optional)|Physician Decision|0
97924|NCT00303472|334102|P6|Treatment Extension (Optional)|Physician Decision|0
97925|NCT00303472|334103|P5|Treatment Extension (Optional)|Physician Decision|2
97926|NCT00303472|334104|P4|Treatment Extension (Optional)|Physician Decision|3
97927|NCT00303472|334105|P3|Treatment Extension (Optional)|Physician Decision|2
97928|NCT00303472|334106|P2|Treatment Extension (Optional)|Physician Decision|4
97929|NCT00303472|334107|P1|Treatment Extension (Optional)|Physician Decision|0
97930|NCT00303472|334101|P7|Treatment Extension (Optional)|Lost to Follow-up|0
97931|NCT00303472|334102|P6|Treatment Extension (Optional)|Lost to Follow-up|0
97932|NCT00303472|334103|P5|Treatment Extension (Optional)|Lost to Follow-up|0
97933|NCT00303472|334104|P4|Treatment Extension (Optional)|Lost to Follow-up|1
97934|NCT00303472|334105|P3|Treatment Extension (Optional)|Lost to Follow-up|0
97935|NCT00303472|334106|P2|Treatment Extension (Optional)|Lost to Follow-up|0
97936|NCT00303472|334107|P1|Treatment Extension (Optional)|Lost to Follow-up|0
97937|NCT00303472|334101|P7|Treatment Extension (Optional)|Death|0
97938|NCT00303472|334102|P6|Treatment Extension (Optional)|Death|0
97939|NCT00303472|334103|P5|Treatment Extension (Optional)|Death|0
97940|NCT00303472|334104|P4|Treatment Extension (Optional)|Death|0
97941|NCT00303472|334105|P3|Treatment Extension (Optional)|Death|1
97942|NCT00303472|334106|P2|Treatment Extension (Optional)|Death|0
97943|NCT00303472|334107|P1|Treatment Extension (Optional)|Death|2
97944|NCT00303472|334101|P7|Treatment Extension (Optional)|Adverse Event|0
97945|NCT00303472|334102|P6|Treatment Extension (Optional)|Adverse Event|0
97946|NCT00303472|334103|P5|Treatment Extension (Optional)|Adverse Event|0
97947|NCT00303472|334104|P4|Treatment Extension (Optional)|Adverse Event|0
97948|NCT00303472|334105|P3|Treatment Extension (Optional)|Adverse Event|1
97949|NCT00303472|334106|P2|Treatment Extension (Optional)|Adverse Event|0
97950|NCT00303472|334107|P1|Treatment Extension (Optional)|Adverse Event|1
97951|NCT00303472|334101|P7|Treatment Period|Disease Progression (to AML)|0
97952|NCT00303472|334102|P6|Treatment Period|Disease Progression (to AML)|0
97953|NCT00303472|334103|P5|Treatment Period|Disease Progression (to AML)|1
97954|NCT00303472|334104|P4|Treatment Period|Disease Progression (to AML)|0
97955|NCT00303472|334105|P3|Treatment Period|Disease Progression (to AML)|0
97956|NCT00303472|334106|P2|Treatment Period|Disease Progression (to AML)|0
97957|NCT00303472|334107|P1|Treatment Period|Disease Progression (to AML)|0
97958|NCT00303472|334101|P7|Treatment Period|Not specified|1
97959|NCT00303472|334102|P6|Treatment Period|Not specified|0
97960|NCT00303472|334103|P5|Treatment Period|Not specified|1
97961|NCT00303472|334104|P4|Treatment Period|Not specified|0
97962|NCT00303472|334105|P3|Treatment Period|Not specified|0
97963|NCT00303472|334106|P2|Treatment Period|Not specified|0
97964|NCT00303472|334107|P1|Treatment Period|Not specified|0
97965|NCT00303472|334101|P7|Treatment Period|Withdrawal by Subject|0
97966|NCT00303472|334102|P6|Treatment Period|Withdrawal by Subject|1
97967|NCT00303472|334103|P5|Treatment Period|Withdrawal by Subject|0
97968|NCT00303472|334104|P4|Treatment Period|Withdrawal by Subject|1
97969|NCT00303472|334105|P3|Treatment Period|Withdrawal by Subject|0
97970|NCT00303472|334106|P2|Treatment Period|Withdrawal by Subject|0
97971|NCT00303472|334107|P1|Treatment Period|Withdrawal by Subject|0
97972|NCT00303472|334101|P7|Treatment Period|Death|1
97973|NCT00303472|334102|P6|Treatment Period|Death|0
97974|NCT00303472|334103|P5|Treatment Period|Death|0
97975|NCT00303472|334104|P4|Treatment Period|Death|1
97976|NCT00303472|334105|P3|Treatment Period|Death|0
97977|NCT00303472|334106|P2|Treatment Period|Death|0
97978|NCT00303472|334107|P1|Treatment Period|Death|0
97979|NCT00303472|334101|P7|Treatment Period|Adverse Event|0
97980|NCT00303472|334102|P6|Treatment Period|Adverse Event|0
97981|NCT00303472|334103|P5|Treatment Period|Adverse Event|1
97982|NCT00303472|334104|P4|Treatment Period|Adverse Event|0
97983|NCT00303472|334105|P3|Treatment Period|Adverse Event|0
97984|NCT00303472|334106|P2|Treatment Period|Adverse Event|0
97985|NCT00303472|334107|P1|Treatment Period|Adverse Event|0
97986|NCT00303485|334167|P2|Overall Study|Withdrawal by Subject|0
97987|NCT00303485|334168|P1|Overall Study|Withdrawal by Subject|1
97988|NCT00303485|334167|P2|Overall Study|Failure to return|1
97989|NCT00303485|334168|P1|Overall Study|Failure to return|0
97990|NCT00303485|334167|P2|Overall Study|Adverse Event/Intercurrent Illness|1
97991|NCT00303485|334168|P1|Overall Study|Adverse Event/Intercurrent Illness|0
97992|NCT00303602|334198|P2|Overall Study|Protocol Violation|0
97993|NCT00303602|334199|P1|Overall Study|Protocol Violation|1
97994|NCT00303602|334198|P2|Overall Study|Noncompliance|2
97995|NCT00303602|334199|P1|Overall Study|Noncompliance|2
97996|NCT00303602|334198|P2|Overall Study|Physician Decision|1
97997|NCT00303602|334199|P1|Overall Study|Physician Decision|2
97998|NCT00303602|334198|P2|Overall Study|Protocol entry criteria not met|2
97999|NCT00303602|334199|P1|Overall Study|Protocol entry criteria not met|2
98000|NCT00303602|334198|P2|Overall Study|Lost to Follow-up|2
98001|NCT00303602|334199|P1|Overall Study|Lost to Follow-up|5
98002|NCT00303602|334198|P2|Overall Study|Withdrawal by Subject|6
98003|NCT00303602|334199|P1|Overall Study|Withdrawal by Subject|5
98004|NCT00303602|334198|P2|Overall Study|Adverse Event|2
98005|NCT00303602|334199|P1|Overall Study|Adverse Event|2
98006|NCT00303628|334241|P2|Overall Study|Other|9
98007|NCT00303628|334242|P1|Overall Study|Other|8
98008|NCT00303628|334241|P2|Overall Study|Not start protocol therapy|5
98009|NCT00303628|334242|P1|Overall Study|Not start protocol therapy|3
98010|NCT00303628|334241|P2|Overall Study|Other complicating disease|1
98011|NCT00303628|334242|P1|Overall Study|Other complicating disease|0
98012|NCT00303628|334241|P2|Overall Study|Alternative therapy|0
98013|NCT00303628|334242|P1|Overall Study|Alternative therapy|2
98014|NCT00303628|334241|P2|Overall Study|Withdrawal by Subject|20
98015|NCT00303628|334242|P1|Overall Study|Withdrawal by Subject|11
98016|NCT00303628|334241|P2|Overall Study|Death|1
98017|NCT00303628|334242|P1|Overall Study|Death|0
98018|NCT00303628|334241|P2|Overall Study|Adverse Event|36
98019|NCT00303628|334242|P1|Overall Study|Adverse Event|26
98020|NCT00303628|334241|P2|Overall Study|Disease progression|1
98021|NCT00303628|334242|P1|Overall Study|Disease progression|0
98022|NCT00303667|334260|P2|Overall Study|Death|4
98023|NCT00303667|334261|P1|Overall Study|Death|0
98024|NCT00303953|334310|P1|Overall Study|Physician Decision|1
98025|NCT00303953|334310|P1|Overall Study|Lack of Efficacy|12
98026|NCT00303953|334310|P1|Overall Study|Adverse Event|4
98027|NCT00303953|334310|P1|Overall Study|Death|1
98028|NCT00303953|334310|P1|Overall Study|Ineligible|1
98029|NCT00304031|334343|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
98030|NCT00304031|334344|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
98031|NCT00304031|334345|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
98032|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
98033|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|0
98034|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Other, not otherwise specified|37
98035|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
98036|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Other complicating disease|0
98037|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Other complicating disease|1
98038|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Toxicity|0
98039|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Toxicity|0
98040|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Toxicity|10
98041|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Physician preference|0
98042|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Physician preference|0
98043|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Physician preference|15
98044|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Death|0
98045|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Death|0
98046|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Death|18
98047|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Patient refusal|0
98048|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Patient refusal|0
98049|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Patient refusal|19
98050|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Disease progression|0
98051|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Disease progression|0
98052|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Disease progression|48
98053|NCT00304031|334343|P3|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
98054|NCT00304031|334344|P2|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|0
98055|NCT00304031|334345|P1|Concomitant Radiation Therapy and TMZ|Ineligible due to insufficient tissue|144
98056|NCT00304031|334343|P3|Registration|Ineligible|0
98057|NCT00304031|334344|P2|Registration|Ineligible|0
98058|NCT00304031|334345|P1|Registration|Ineligible|48
98059|NCT00304070|334355|P3|Overall Study|Progressive Disease|4
98060|NCT00304070|334356|P2|Overall Study|Progressive Disease|7
98061|NCT00304070|334357|P1|Overall Study|Progressive Disease|3
98062|NCT00304070|334355|P3|Overall Study|Withdrawal by Subject|1
98063|NCT00304070|334356|P2|Overall Study|Withdrawal by Subject|0
98064|NCT00304070|334357|P1|Overall Study|Withdrawal by Subject|0
98065|NCT00304070|334355|P3|Overall Study|Physician Decision|3
98066|NCT00304070|334356|P2|Overall Study|Physician Decision|0
98067|NCT00304070|334357|P1|Overall Study|Physician Decision|0
98068|NCT00304070|334355|P3|Overall Study|Lost to Follow-up|1
98069|NCT00304070|334356|P2|Overall Study|Lost to Follow-up|0
98070|NCT00304070|334357|P1|Overall Study|Lost to Follow-up|0
98071|NCT00304070|334355|P3|Overall Study|Death|3
98072|NCT00304070|334356|P2|Overall Study|Death|0
98073|NCT00304070|334357|P1|Overall Study|Death|0
98074|NCT00304278|334409|P1|Overall Study|PT had medical condition preventing TX|1
98075|NCT00304278|334409|P1|Overall Study|lack of insurance coverage for chemoRT|1
98076|NCT00310804|334445|P2|Overall Study|Withdrawal by Subject|0
98077|NCT00310804|334446|P1|Overall Study|Withdrawal by Subject|3
98078|NCT00310804|334445|P2|Overall Study|Lost to Follow-up|0
98079|NCT00310804|334446|P1|Overall Study|Lost to Follow-up|2
98080|NCT00310817|334483|P4|Overall Study|Unable to classify|0
98081|NCT00310817|334484|P3|Overall Study|Unable to classify|0
98082|NCT00310817|334485|P2|Overall Study|Unable to classify|1
98083|NCT00310817|334486|P1|Overall Study|Unable to classify|3
98084|NCT00310817|334483|P4|Overall Study|Protocol Violation|1
98085|NCT00310817|334484|P3|Overall Study|Protocol Violation|1
98086|NCT00310817|334485|P2|Overall Study|Protocol Violation|1
98087|NCT00310817|334486|P1|Overall Study|Protocol Violation|1
98088|NCT00310817|334483|P4|Overall Study|Inappropriate Enrollment|0
98089|NCT00310817|334484|P3|Overall Study|Inappropriate Enrollment|1
98090|NCT00310817|334485|P2|Overall Study|Inappropriate Enrollment|0
98091|NCT00310817|334486|P1|Overall Study|Inappropriate Enrollment|1
98092|NCT00310817|334483|P4|Overall Study|Lost to Follow-up|0
98093|NCT00310817|334484|P3|Overall Study|Lost to Follow-up|0
98094|NCT00310817|334485|P2|Overall Study|Lost to Follow-up|1
98095|NCT00310817|334486|P1|Overall Study|Lost to Follow-up|2
98096|NCT00310817|334483|P4|Overall Study|Withdrawal by Subject|7
98097|NCT00310817|334484|P3|Overall Study|Withdrawal by Subject|6
98098|NCT00310817|334485|P2|Overall Study|Withdrawal by Subject|4
98099|NCT00310817|334486|P1|Overall Study|Withdrawal by Subject|1
98100|NCT00310817|334483|P4|Overall Study|AE or Death|0
98101|NCT00310817|334484|P3|Overall Study|AE or Death|0
98102|NCT00310817|334485|P2|Overall Study|AE or Death|1
98103|NCT00310817|334486|P1|Overall Study|AE or Death|3
98104|NCT00310856|334575|P3|Overall Study|Unable to classify|0
98105|NCT00310856|334576|P2|Overall Study|Unable to classify|0
98106|NCT00310856|334577|P1|Overall Study|Unable to classify|1
98107|NCT00310856|334575|P3|Overall Study|Inappropriate enrollment|0
98108|NCT00310856|334576|P2|Overall Study|Inappropriate enrollment|1
98109|NCT00310856|334577|P1|Overall Study|Inappropriate enrollment|1
98110|NCT00310856|334575|P3|Overall Study|Lost to Follow-up|6
98111|NCT00310856|334576|P2|Overall Study|Lost to Follow-up|2
98112|NCT00310856|334577|P1|Overall Study|Lost to Follow-up|1
98113|NCT00310856|334575|P3|Overall Study|Withdrawal by Subject|2
98114|NCT00310856|334576|P2|Overall Study|Withdrawal by Subject|2
98115|NCT00310856|334577|P1|Overall Study|Withdrawal by Subject|2
98116|NCT00319020|334616|P2|Overall Study|Adverse Event|1
98117|NCT00319020|334617|P1|Overall Study|Adverse Event|0
98118|NCT00319020|334616|P2|Overall Study|Treatment failure|1
98119|NCT00319020|334617|P1|Overall Study|Treatment failure|0
98120|NCT00319020|334616|P2|Overall Study|Transplant|1
98121|NCT00319020|334617|P1|Overall Study|Transplant|0
98122|NCT00319020|334616|P2|Overall Study|Disease progression|2
98123|NCT00319020|334617|P1|Overall Study|Disease progression|0
98124|NCT00319020|334616|P2|Overall Study|Administrative reason|5
98125|NCT00319020|334617|P1|Overall Study|Administrative reason|0
98126|NCT00319020|334616|P2|Overall Study|F-1 completed but not enrolled in F-2|0
98127|NCT00319020|334617|P1|Overall Study|F-1 completed but not enrolled in F-2|1
98128|NCT00319020|334616|P2|Overall Study|Withdrawal by Subject|1
98129|NCT00319020|334617|P1|Overall Study|Withdrawal by Subject|4
98130|NCT00319020|334616|P2|Overall Study|Death|2
98131|NCT00319020|334617|P1|Overall Study|Death|2
98132|NCT00319046|334646|P1|Overall Study|administrative reason|1
98133|NCT00319046|334646|P1|Overall Study|withdrawal of subject's consent|7
98134|NCT00319098|334657|P2|Overall Study|Protocol Violation|1
98135|NCT00319098|334658|P1|Overall Study|Protocol Violation|3
98136|NCT00319098|334657|P2|Overall Study|Others|8
98137|NCT00319098|334658|P1|Overall Study|Others|33
98138|NCT00319098|334657|P2|Overall Study|Lost to Follow-up|13
98139|NCT00319098|334658|P1|Overall Study|Lost to Follow-up|37
98140|NCT00319098|334657|P2|Overall Study|Migrated/moved from study area|1
98141|NCT00319098|334658|P1|Overall Study|Migrated/moved from study area|2
98142|NCT00319098|334657|P2|Overall Study|Withdrawal by Subject|8
98143|NCT00319098|334658|P1|Overall Study|Withdrawal by Subject|37
98144|NCT00319098|334657|P2|Overall Study|Adverse Event|1
98145|NCT00319098|334658|P1|Overall Study|Adverse Event|20
98146|NCT00319098|334657|P2|Overall Study|Serious adverse event|0
98147|NCT00319098|334658|P1|Overall Study|Serious adverse event|3
98148|NCT00319111|334716|P1|Overall Study|Treatment failure|1
98149|NCT00319111|334716|P1|Overall Study|Administrative|2
98150|NCT00319111|334716|P1|Overall Study|Lack of clinical improvement|4
98151|NCT00319111|334716|P1|Overall Study|Death|9
98152|NCT00319111|334716|P1|Overall Study|Withdrawal of consent|11
98153|NCT00319111|334716|P1|Overall Study|Adverse Event|20
98154|NCT00319254|334726|P1|Overall Study|Enrolled, Not Treated|2
98155|NCT00319254|334726|P1|Overall Study|Lost to Follow-up|2
98156|NCT00319254|334726|P1|Overall Study|Death|46
98157|NCT00319254|334726|P1|Overall Study|Withdrawal by Subject|4
98158|NCT00319436|334741|P2|Overall Study|Withdrawal by Subject|7
98159|NCT00319436|334742|P1|Overall Study|Withdrawal by Subject|6
98160|NCT00319449|334762|P2|Overall Study|Noncompliance with the protocol|0
98161|NCT00319449|334763|P1|Overall Study|Noncompliance with the protocol|1
98162|NCT00319449|334762|P2|Overall Study|Subject did not wish to continue|0
98163|NCT00319449|334763|P1|Overall Study|Subject did not wish to continue|1
98164|NCT00319501|334775|P2|Open-label Extension Period|Withdrawal by Subject|0
98165|NCT00319501|334776|P1|Open-label Extension Period|Withdrawal by Subject|2
98166|NCT00319501|334775|P2|Open-label Extension Period|Sponsor request|0
98167|NCT00319501|334776|P1|Open-label Extension Period|Sponsor request|26
98168|NCT00319501|334775|P2|Open-label Extension Period|Principal investigator decision|0
98169|NCT00319501|334776|P1|Open-label Extension Period|Principal investigator decision|2
98170|NCT00319501|334775|P2|Open-label Extension Period|Not specified|0
98171|NCT00319501|334776|P1|Open-label Extension Period|Not specified|1
98172|NCT00319501|334775|P2|Open-label Extension Period|Did not receive treatment|0
98173|NCT00319501|334776|P1|Open-label Extension Period|Did not receive treatment|18
98174|NCT00319501|334775|P2|Open-label Extension Period|Adverse Event|0
98175|NCT00319501|334776|P1|Open-label Extension Period|Adverse Event|2
98176|NCT00319501|334775|P2|Open-label Period|Not specified|0
98177|NCT00319501|334776|P1|Open-label Period|Not specified|11
98178|NCT00319501|334775|P2|Open-label Period|Did not receive treatment|0
98179|NCT00319501|334776|P1|Open-label Period|Did not receive treatment|33
98180|NCT00319501|334775|P2|Open-label Period|Lost to Follow-up|0
98181|NCT00319501|334776|P1|Open-label Period|Lost to Follow-up|5
98182|NCT00319501|334775|P2|Open-label Period|Sponsor request|0
98183|NCT00319501|334776|P1|Open-label Period|Sponsor request|12
98184|NCT00319501|334775|P2|Open-label Period|Principal Investigator decision|0
98185|NCT00319501|334776|P1|Open-label Period|Principal Investigator decision|6
98186|NCT00319501|334775|P2|Open-label Period|Withdrawal by Subject|0
98187|NCT00319501|334776|P1|Open-label Period|Withdrawal by Subject|38
98188|NCT00319501|334775|P2|Open-label Period|Protocol Violation|0
98189|NCT00319501|334776|P1|Open-label Period|Protocol Violation|6
98190|NCT00319501|334775|P2|Open-label Period|Adverse Event|0
98191|NCT00319501|334776|P1|Open-label Period|Adverse Event|5
98192|NCT00319501|334775|P2|Double-blind Period|Did not receive treatment|29
98193|NCT00319501|334776|P1|Double-blind Period|Did not receive treatment|42
98194|NCT00319501|334775|P2|Double-blind Period|Sponsor Request|0
98195|NCT00319501|334776|P1|Double-blind Period|Sponsor Request|1
98196|NCT00319501|334775|P2|Double-blind Period|Withdrawal by Subject|3
98197|NCT00319501|334776|P1|Double-blind Period|Withdrawal by Subject|0
98198|NCT00319553|334802|P2|Overall Study|Withdrawal by Subject|1
98199|NCT00319553|334803|P1|Overall Study|Withdrawal by Subject|1
98200|NCT00319553|334802|P2|Overall Study|Lost to Follow-up|1
98201|NCT00319553|334803|P1|Overall Study|Lost to Follow-up|2
98202|NCT00319553|334802|P2|Overall Study|Protocol Violation|2
98203|NCT00319553|334803|P1|Overall Study|Protocol Violation|1
98204|NCT00319592|334817|P2|Overall Study|Physician Decision|1
98205|NCT00319592|334818|P1|Overall Study|Physician Decision|0
98206|NCT00319592|334817|P2|Overall Study|Protocol Violation|0
98207|NCT00319592|334818|P1|Overall Study|Protocol Violation|1
98208|NCT00319696|334843|P1|Overall Study|Lost to Follow-up|3
98209|NCT00319696|334843|P1|Overall Study|administrative|7
98210|NCT00319696|334843|P1|Overall Study|withdrawal of consent|14
98211|NCT00319696|334843|P1|Overall Study|Adverse Event|36
98212|NCT00319735|334867|P1|Overall Study|Death|2
98213|NCT00319982|334892|P2|Overall Study|Withdrawal by Subject|0
98214|NCT00319982|334893|P1|Overall Study|Withdrawal by Subject|1
98215|NCT00320112|334913|P2|Overall Study|Death|1
98216|NCT00320112|334914|P1|Overall Study|Death|2
98217|NCT00320112|334913|P2|Overall Study|Withdrawal by Subject|0
98218|NCT00320112|334914|P1|Overall Study|Withdrawal by Subject|3
98219|NCT00320112|334913|P2|Overall Study|Lost to Follow-up|4
98220|NCT00320112|334914|P1|Overall Study|Lost to Follow-up|3
98221|NCT00320190|334928|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
98222|NCT00320190|334929|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
98223|NCT00320190|334928|P2|Long-term (12-month) Extension|Lack of major molecular response|2
98224|NCT00320190|334929|P1|Long-term (12-month) Extension|Lack of major molecular response|1
98225|NCT00320190|334928|P2|Long-term (12-month) Extension|Sponsor terminated study|0
98226|NCT00320190|334929|P1|Long-term (12-month) Extension|Sponsor terminated study|7
98227|NCT00320190|334928|P2|First 12 Months|Withdrawal by Subject|1
98228|NCT00320190|334929|P1|First 12 Months|Withdrawal by Subject|0
98229|NCT00320190|334928|P2|First 12 Months|Study drug toxicity|1
98230|NCT00320190|334929|P1|First 12 Months|Study drug toxicity|0
98231|NCT00320190|334928|P2|First 12 Months|Investigator request|1
98232|NCT00320190|334929|P1|First 12 Months|Investigator request|0
98233|NCT00320190|334928|P2|First 12 Months|Adverse event unrelated to study drug|0
98234|NCT00320190|334929|P1|First 12 Months|Adverse event unrelated to study drug|1
98235|NCT00320190|334928|P2|First 12 Months|Enrollment failure|1
98236|NCT00320190|334929|P1|First 12 Months|Enrollment failure|0
98237|NCT00320190|334928|P2|First 12 Months|Lost to Follow-up|1
98238|NCT00320190|334929|P1|First 12 Months|Lost to Follow-up|0
98239|NCT00320190|334928|P2|First 12 Months|Sponsor terminated study|2
98240|NCT00320190|334929|P1|First 12 Months|Sponsor terminated study|2
98241|NCT00320190|334928|P2|First 12 Months|Completed but did not enter extension|3
98242|NCT00320190|334929|P1|First 12 Months|Completed but did not enter extension|5
98243|NCT00320216|334952|P5|Overall Study|Other|3
98244|NCT00320216|334953|P4|Overall Study|Other|1
98245|NCT00320216|334954|P3|Overall Study|Other|5
98246|NCT00320216|334955|P2|Overall Study|Other|2
98247|NCT00320216|334956|P1|Overall Study|Other|7
98248|NCT00320216|334952|P5|Overall Study|Lost to Follow-up|0
98249|NCT00320216|334953|P4|Overall Study|Lost to Follow-up|0
98250|NCT00320216|334954|P3|Overall Study|Lost to Follow-up|0
98251|NCT00320216|334955|P2|Overall Study|Lost to Follow-up|0
98252|NCT00320216|334956|P1|Overall Study|Lost to Follow-up|3
98253|NCT00320216|334952|P5|Overall Study|Lack of Efficacy|1
98254|NCT00320216|334953|P4|Overall Study|Lack of Efficacy|0
98255|NCT00320216|334954|P3|Overall Study|Lack of Efficacy|1
98256|NCT00320216|334955|P2|Overall Study|Lack of Efficacy|2
98257|NCT00320216|334956|P1|Overall Study|Lack of Efficacy|6
98258|NCT00320216|334952|P5|Overall Study|Adverse Event|2
98259|NCT00320216|334953|P4|Overall Study|Adverse Event|2
98260|NCT00320216|334954|P3|Overall Study|Adverse Event|0
98261|NCT00320216|334955|P2|Overall Study|Adverse Event|6
98262|NCT00320216|334956|P1|Overall Study|Adverse Event|0
98263|NCT00320255|335002|P6|Overall Study|Not specified|0
98264|NCT00320255|335003|P5|Overall Study|Not specified|0
98265|NCT00320255|335004|P4|Overall Study|Not specified|0
98266|NCT00320255|335005|P3|Overall Study|Not specified|1
98267|NCT00320255|335006|P2|Overall Study|Not specified|2
98268|NCT00320255|335007|P1|Overall Study|Not specified|3
98269|NCT00320255|335002|P6|Overall Study|No longer meets study criteria|0
98270|NCT00320255|335003|P5|Overall Study|No longer meets study criteria|0
98271|NCT00320255|335004|P4|Overall Study|No longer meets study criteria|1
98272|NCT00320255|335005|P3|Overall Study|No longer meets study criteria|0
98273|NCT00320255|335006|P2|Overall Study|No longer meets study criteria|0
98274|NCT00320255|335007|P1|Overall Study|No longer meets study criteria|0
98275|NCT00320255|335002|P6|Overall Study|Poor compliance/noncompliance|0
98276|NCT00320255|335003|P5|Overall Study|Poor compliance/noncompliance|0
98277|NCT00320255|335004|P4|Overall Study|Poor compliance/noncompliance|1
98278|NCT00320255|335005|P3|Overall Study|Poor compliance/noncompliance|0
98279|NCT00320255|335006|P2|Overall Study|Poor compliance/noncompliance|1
98280|NCT00320255|335007|P1|Overall Study|Poor compliance/noncompliance|1
98281|NCT00320255|335002|P6|Overall Study|Withdrawal by Subject|0
98282|NCT00320255|335003|P5|Overall Study|Withdrawal by Subject|0
98283|NCT00320255|335004|P4|Overall Study|Withdrawal by Subject|4
98284|NCT00320255|335005|P3|Overall Study|Withdrawal by Subject|2
98285|NCT00320255|335006|P2|Overall Study|Withdrawal by Subject|2
98286|NCT00320255|335007|P1|Overall Study|Withdrawal by Subject|1
98287|NCT00320255|335002|P6|Overall Study|Adverse Event|0
98288|NCT00320255|335003|P5|Overall Study|Adverse Event|0
98289|NCT00320255|335004|P4|Overall Study|Adverse Event|2
98290|NCT00320255|335005|P3|Overall Study|Adverse Event|3
98291|NCT00320255|335006|P2|Overall Study|Adverse Event|2
98292|NCT00320255|335007|P1|Overall Study|Adverse Event|5
98293|NCT00320255|335002|P6|Overall Study|Lack of Efficacy|0
98294|NCT00320255|335003|P5|Overall Study|Lack of Efficacy|0
98295|NCT00320255|335004|P4|Overall Study|Lack of Efficacy|0
98296|NCT00320255|335005|P3|Overall Study|Lack of Efficacy|0
98297|NCT00320255|335006|P2|Overall Study|Lack of Efficacy|0
98298|NCT00320255|335007|P1|Overall Study|Lack of Efficacy|1
98299|NCT00320372|335099|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
98300|NCT00320372|335100|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
98301|NCT00320372|335099|P2|Overall Study|Did not Meet (I/E)|1
98302|NCT00320372|335100|P1|Overall Study|Did not Meet (I/E)|3
98303|NCT00320372|335099|P2|Overall Study|Non-Compliance|39
98304|NCT00320372|335100|P1|Overall Study|Non-Compliance|40
98305|NCT00320372|335099|P2|Overall Study|Withdrawal by Subject|37
98306|NCT00320372|335100|P1|Overall Study|Withdrawal by Subject|55
98307|NCT00320372|335099|P2|Overall Study|Death|8
98308|NCT00320372|335100|P1|Overall Study|Death|7
98309|NCT00320372|335099|P2|Overall Study|Physician Decision|7
98310|NCT00320372|335100|P1|Overall Study|Physician Decision|4
98311|NCT00320385|335127|P2|Overall Study|Adverse Event|1
98312|NCT00320385|335128|P1|Overall Study|Adverse Event|0
98313|NCT00320385|335127|P2|Overall Study|Withdrew Consent|0
98314|NCT00320385|335128|P1|Overall Study|Withdrew Consent|1
98315|NCT00320385|335127|P2|Overall Study|Serious Adverse Event|0
98316|NCT00320385|335128|P1|Overall Study|Serious Adverse Event|1
98317|NCT00320385|335127|P2|Overall Study|Death|2
98318|NCT00320385|335128|P1|Overall Study|Death|1
98319|NCT00320385|335127|P2|Overall Study|Investigator Decision|1
98320|NCT00320385|335128|P1|Overall Study|Investigator Decision|0
98321|NCT00320385|335127|P2|Overall Study|Sponsor Terminated Study|1
98322|NCT00320385|335128|P1|Overall Study|Sponsor Terminated Study|2
98323|NCT00320385|335127|P2|Overall Study|Withdrawal by Subject|7
98324|NCT00320385|335128|P1|Overall Study|Withdrawal by Subject|6
98325|NCT00320385|335127|P2|Overall Study|Lost to Follow-up|10
98326|NCT00320385|335128|P1|Overall Study|Lost to Follow-up|7
98327|NCT00320411|335148|P1|Overall Study|No investigational product admin.|4
98328|NCT00320489|335171|P2|Overall Study|Withdrawal by Subject|41
98329|NCT00320489|335172|P1|Overall Study|Withdrawal by Subject|39
98330|NCT00320489|335171|P2|Overall Study|Sponsor Decision|3
98331|NCT00320489|335172|P1|Overall Study|Sponsor Decision|3
98332|NCT00320489|335171|P2|Overall Study|Protocol Violation|4
98333|NCT00320489|335172|P1|Overall Study|Protocol Violation|4
98334|NCT00320489|335171|P2|Overall Study|Physician Decision|8
98335|NCT00320489|335172|P1|Overall Study|Physician Decision|8
98336|NCT00320489|335171|P2|Overall Study|Lost to Follow-up|22
98337|NCT00320489|335172|P1|Overall Study|Lost to Follow-up|21
98338|NCT00320489|335171|P2|Overall Study|Lack of Efficacy|7
98339|NCT00320489|335172|P1|Overall Study|Lack of Efficacy|16
98340|NCT00320489|335171|P2|Overall Study|Entry Criteria Exclusion|4
98341|NCT00320489|335172|P1|Overall Study|Entry Criteria Exclusion|2
98342|NCT00320489|335171|P2|Overall Study|Death|2
98343|NCT00320489|335172|P1|Overall Study|Death|0
98344|NCT00320489|335171|P2|Overall Study|Clinical Relapse|20
98345|NCT00320489|335172|P1|Overall Study|Clinical Relapse|26
98346|NCT00320489|335171|P2|Overall Study|Adverse Event|25
98347|NCT00320489|335172|P1|Overall Study|Adverse Event|26
98348|NCT00320515|335228|P1|Overall Study|Withdrawal by Subject|8
98349|NCT00320515|335228|P1|Overall Study|Physician Decision|2
98350|NCT00320515|335228|P1|Overall Study|Lost to Follow-up|6
98351|NCT00320515|335228|P1|Overall Study|Death|33
98352|NCT00320528|335238|P3|Study Period III|Atomoxetine Commercially Available|90
98353|NCT00320528|335239|P2|Study Period III|Atomoxetine Commercially Available|25
98354|NCT00320528|335240|P1|Study Period III|Atomoxetine Commercially Available|68
98355|NCT00320528|335238|P3|Study Period III|Sponsor Decision|1
98356|NCT00320528|335239|P2|Study Period III|Sponsor Decision|0
98357|NCT00320528|335240|P1|Study Period III|Sponsor Decision|0
98358|NCT00320528|335238|P3|Study Period III|Physician Decision|2
98359|NCT00320528|335239|P2|Study Period III|Physician Decision|1
98360|NCT00320528|335240|P1|Study Period III|Physician Decision|0
98361|NCT00320528|335238|P3|Study Period III|Protocol Violation|0
98362|NCT00320528|335239|P2|Study Period III|Protocol Violation|1
98363|NCT00320528|335240|P1|Study Period III|Protocol Violation|0
98364|NCT00320528|335238|P3|Study Period III|Parent/Caregiver Decision|11
98365|NCT00320528|335239|P2|Study Period III|Parent/Caregiver Decision|3
98366|NCT00320528|335240|P1|Study Period III|Parent/Caregiver Decision|14
98367|NCT00320528|335238|P3|Study Period III|Lack of Efficacy|0
98368|NCT00320528|335239|P2|Study Period III|Lack of Efficacy|0
98369|NCT00320528|335240|P1|Study Period III|Lack of Efficacy|2
98370|NCT00320528|335238|P3|Study Period III|Withdrawal by Subject|2
98371|NCT00320528|335239|P2|Study Period III|Withdrawal by Subject|1
98372|NCT00320528|335240|P1|Study Period III|Withdrawal by Subject|1
98373|NCT00320528|335238|P3|Study Period III|Lost to Follow-up|0
98374|NCT00320528|335239|P2|Study Period III|Lost to Follow-up|0
98375|NCT00320528|335240|P1|Study Period III|Lost to Follow-up|1
98376|NCT00320528|335238|P3|Study Period III|Adverse Event|0
98377|NCT00320528|335239|P2|Study Period III|Adverse Event|0
98378|NCT00320528|335240|P1|Study Period III|Adverse Event|1
98379|NCT00320528|335238|P3|Study Period II|Entry Criteria Exclusion|2
98380|NCT00320528|335239|P2|Study Period II|Entry Criteria Exclusion|2
98381|NCT00320528|335240|P1|Study Period II|Entry Criteria Exclusion|0
98382|NCT00320528|335238|P3|Study Period II|Withdrawal by Subject|1
98383|NCT00320528|335239|P2|Study Period II|Withdrawal by Subject|1
98384|NCT00320528|335240|P1|Study Period II|Withdrawal by Subject|0
98385|NCT00320528|335238|P3|Study Period II|Parent/Caregiver Decision|11
98386|NCT00320528|335239|P2|Study Period II|Parent/Caregiver Decision|3
98387|NCT00320528|335240|P1|Study Period II|Parent/Caregiver Decision|8
98388|NCT00320528|335238|P3|Study Period II|Adverse Event|8
98389|NCT00320528|335239|P2|Study Period II|Adverse Event|4
98390|NCT00320528|335240|P1|Study Period II|Adverse Event|3
98391|NCT00320541|335277|P2|Overall Study|Protocol Entry Criterion Not Met|0
98392|NCT00320541|335278|P1|Overall Study|Protocol Entry Criterion Not Met|1
98393|NCT00320541|335277|P2|Overall Study|Death due to Adverse Event(s)|0
98394|NCT00320541|335278|P1|Overall Study|Death due to Adverse Event(s)|1
98395|NCT00320541|335277|P2|Overall Study|Death due to Study Disease|3
98396|NCT00320541|335278|P1|Overall Study|Death due to Study Disease|1
98397|NCT00320541|335277|P2|Overall Study|Sponsor Decision|1
98398|NCT00320541|335278|P1|Overall Study|Sponsor Decision|2
98399|NCT00320541|335277|P2|Overall Study|Other|4
98400|NCT00320541|335278|P1|Overall Study|Other|3
98401|NCT00320541|335277|P2|Overall Study|Physician Decision|13
98402|NCT00320541|335278|P1|Overall Study|Physician Decision|9
98403|NCT00320541|335277|P2|Overall Study|Withdrawal by Subject|16
98404|NCT00320541|335278|P1|Overall Study|Withdrawal by Subject|12
98405|NCT00320541|335277|P2|Overall Study|Protocol Violation|1
98406|NCT00320541|335278|P1|Overall Study|Protocol Violation|0
98407|NCT00320541|335277|P2|Overall Study|Adverse Event|19
98408|NCT00320541|335278|P1|Overall Study|Adverse Event|21
98409|NCT00320593|335304|P2|Overall Study|Withdrawal by clinical center|0
98410|NCT00320593|335305|P1|Overall Study|Withdrawal by clinical center|1
98411|NCT00320593|335304|P2|Overall Study|Withdrawal by Subject|1
98412|NCT00320593|335305|P1|Overall Study|Withdrawal by Subject|2
98413|NCT00320593|335304|P2|Overall Study|Moved to another state|0
98414|NCT00320593|335305|P1|Overall Study|Moved to another state|1
98415|NCT00320593|335304|P2|Overall Study|Lost to Follow-up|0
98416|NCT00320593|335305|P1|Overall Study|Lost to Follow-up|3
98417|NCT00320606|335327|P1|Overall Study|Ongoing in study|12
98418|NCT00320606|335327|P1|Overall Study|Protocol Violation|1
98419|NCT00320606|335327|P1|Overall Study|Adverse Event|1
98420|NCT00320710|335343|P3|Overall Study|Lost to Follow-up|0
98421|NCT00320710|335344|P2|Overall Study|Lost to Follow-up|0
98422|NCT00320710|335345|P1|Overall Study|Lost to Follow-up|1
98423|NCT00320710|335343|P3|Overall Study|Adverse Event|1
98424|NCT00320710|335344|P2|Overall Study|Adverse Event|14
98425|NCT00320710|335345|P1|Overall Study|Adverse Event|18
98426|NCT00320710|335343|P3|Overall Study|Abnormal laboratory value(s)|0
98427|NCT00320710|335344|P2|Overall Study|Abnormal laboratory value(s)|3
98428|NCT00320710|335345|P1|Overall Study|Abnormal laboratory value(s)|12
98429|NCT00320710|335343|P3|Overall Study|Abnormal test procedure result(s)|0
98430|NCT00320710|335344|P2|Overall Study|Abnormal test procedure result(s)|0
98431|NCT00320710|335345|P1|Overall Study|Abnormal test procedure result(s)|2
98432|NCT00320710|335343|P3|Overall Study|Protocol Violation|0
98433|NCT00320710|335344|P2|Overall Study|Protocol Violation|5
98434|NCT00320710|335345|P1|Overall Study|Protocol Violation|6
98435|NCT00320710|335343|P3|Overall Study|Withdrawal by Subject|1
98436|NCT00320710|335344|P2|Overall Study|Withdrawal by Subject|26
98437|NCT00320710|335345|P1|Overall Study|Withdrawal by Subject|20
98438|NCT00320710|335343|P3|Overall Study|Administrative problems|0
98439|NCT00320710|335344|P2|Overall Study|Administrative problems|2
98440|NCT00320710|335345|P1|Overall Study|Administrative problems|1
98441|NCT00320710|335343|P3|Overall Study|Death|1
98442|NCT00320710|335344|P2|Overall Study|Death|7
98443|NCT00320710|335345|P1|Overall Study|Death|10
98444|NCT00320710|335343|P3|Overall Study|Disease progression|2
98445|NCT00320710|335344|P2|Overall Study|Disease progression|19
98446|NCT00320710|335345|P1|Overall Study|Disease progression|24
98447|NCT00320788|335379|P5|Overall Study|Withdrawal by Subject|1
98448|NCT00320788|335380|P4|Overall Study|Withdrawal by Subject|3
98449|NCT00320788|335381|P3|Overall Study|Withdrawal by Subject|0
98450|NCT00320788|335382|P2|Overall Study|Withdrawal by Subject|0
98451|NCT00320788|335383|P1|Overall Study|Withdrawal by Subject|3
98452|NCT00320788|335379|P5|Overall Study|Protocol Violation|1
98453|NCT00320788|335380|P4|Overall Study|Protocol Violation|0
98454|NCT00320788|335381|P3|Overall Study|Protocol Violation|0
98455|NCT00320788|335382|P2|Overall Study|Protocol Violation|0
98456|NCT00320788|335383|P1|Overall Study|Protocol Violation|0
98457|NCT00320788|335379|P5|Overall Study|Physician Decision|0
98458|NCT00320788|335380|P4|Overall Study|Physician Decision|0
98459|NCT00320788|335381|P3|Overall Study|Physician Decision|0
98460|NCT00320788|335382|P2|Overall Study|Physician Decision|1
98461|NCT00320788|335383|P1|Overall Study|Physician Decision|1
98462|NCT00320788|335379|P5|Overall Study|Other|1
98463|NCT00320788|335380|P4|Overall Study|Other|1
98464|NCT00320788|335381|P3|Overall Study|Other|1
98465|NCT00320788|335382|P2|Overall Study|Other|2
98466|NCT00320788|335383|P1|Overall Study|Other|1
98467|NCT00320788|335379|P5|Overall Study|Decision by the Sponsor|1
98468|NCT00320788|335380|P4|Overall Study|Decision by the Sponsor|0
98469|NCT00320788|335381|P3|Overall Study|Decision by the Sponsor|0
98470|NCT00320788|335382|P2|Overall Study|Decision by the Sponsor|1
98471|NCT00320788|335383|P1|Overall Study|Decision by the Sponsor|1
98472|NCT00320788|335379|P5|Overall Study|Lost to Follow-up|0
98473|NCT00320788|335380|P4|Overall Study|Lost to Follow-up|0
98474|NCT00320788|335381|P3|Overall Study|Lost to Follow-up|1
98475|NCT00320788|335382|P2|Overall Study|Lost to Follow-up|2
98476|NCT00320788|335383|P1|Overall Study|Lost to Follow-up|0
98477|NCT00320788|335379|P5|Overall Study|Death|1
98478|NCT00320788|335380|P4|Overall Study|Death|0
98479|NCT00320788|335381|P3|Overall Study|Death|1
98480|NCT00320788|335382|P2|Overall Study|Death|0
98481|NCT00320788|335383|P1|Overall Study|Death|0
98482|NCT00320788|335379|P5|Overall Study|Adverse Event|0
98483|NCT00320788|335380|P4|Overall Study|Adverse Event|1
98484|NCT00320788|335381|P3|Overall Study|Adverse Event|0
98485|NCT00320788|335382|P2|Overall Study|Adverse Event|0
98486|NCT00320788|335383|P1|Overall Study|Adverse Event|0
98487|NCT00320801|335428|P4|Extension Phase|Lost to Follow-up|3
98488|NCT00320801|335429|P3|Extension Phase|Lost to Follow-up|0
98489|NCT00320801|335430|P2|Extension Phase|Lost to Follow-up|0
98490|NCT00320801|335431|P1|Extension Phase|Lost to Follow-up|0
98491|NCT00320801|335428|P4|Extension Phase|Lack of Efficacy|2
98492|NCT00320801|335429|P3|Extension Phase|Lack of Efficacy|0
98493|NCT00320801|335430|P2|Extension Phase|Lack of Efficacy|0
98494|NCT00320801|335431|P1|Extension Phase|Lack of Efficacy|0
98495|NCT00320801|335428|P4|Extension Phase|Administrative|29
98496|NCT00320801|335429|P3|Extension Phase|Administrative|0
98497|NCT00320801|335430|P2|Extension Phase|Administrative|0
98498|NCT00320801|335431|P1|Extension Phase|Administrative|0
98499|NCT00320801|335428|P4|Extension Phase|Adverse Event|8
98500|NCT00320801|335429|P3|Extension Phase|Adverse Event|0
98501|NCT00320801|335430|P2|Extension Phase|Adverse Event|0
98502|NCT00320801|335431|P1|Extension Phase|Adverse Event|0
98503|NCT00320801|335428|P4|Extension Phase|Withdrawal by Subject|6
98504|NCT00320801|335429|P3|Extension Phase|Withdrawal by Subject|0
98505|NCT00320801|335430|P2|Extension Phase|Withdrawal by Subject|0
98506|NCT00320801|335431|P1|Extension Phase|Withdrawal by Subject|0
98507|NCT00320801|335428|P4|Double-blind Phase|Lack of Efficacy|0
98508|NCT00320801|335429|P3|Double-blind Phase|Lack of Efficacy|1
98509|NCT00320801|335430|P2|Double-blind Phase|Lack of Efficacy|9
98510|NCT00320801|335431|P1|Double-blind Phase|Lack of Efficacy|0
98511|NCT00320801|335428|P4|Double-blind Phase|Administrative|0
98512|NCT00320801|335429|P3|Double-blind Phase|Administrative|4
98513|NCT00320801|335430|P2|Double-blind Phase|Administrative|0
98514|NCT00320801|335431|P1|Double-blind Phase|Administrative|0
98515|NCT00320801|335428|P4|Double-blind Phase|Adverse Event|0
98516|NCT00320801|335429|P3|Double-blind Phase|Adverse Event|8
98517|NCT00320801|335430|P2|Double-blind Phase|Adverse Event|2
98518|NCT00320801|335431|P1|Double-blind Phase|Adverse Event|0
98519|NCT00320801|335428|P4|Double-blind Phase|Withdrawal by Subject|0
98520|NCT00320801|335429|P3|Double-blind Phase|Withdrawal by Subject|1
98521|NCT00320801|335430|P2|Double-blind Phase|Withdrawal by Subject|0
98522|NCT00320801|335431|P1|Double-blind Phase|Withdrawal by Subject|0
98523|NCT00320801|335428|P4|Open-label Run-in Period|Did not qualify|0
98524|NCT00320801|335429|P3|Open-label Run-in Period|Did not qualify|0
98525|NCT00320801|335430|P2|Open-label Run-in Period|Did not qualify|0
98526|NCT00320801|335431|P1|Open-label Run-in Period|Did not qualify|1
98527|NCT00320801|335428|P4|Open-label Run-in Period|Lost to Follow-up|0
98528|NCT00320801|335429|P3|Open-label Run-in Period|Lost to Follow-up|0
98529|NCT00320801|335430|P2|Open-label Run-in Period|Lost to Follow-up|0
98530|NCT00320801|335431|P1|Open-label Run-in Period|Lost to Follow-up|2
98531|NCT00320801|335428|P4|Open-label Run-in Period|Lack of Efficacy|0
98532|NCT00320801|335429|P3|Open-label Run-in Period|Lack of Efficacy|0
98533|NCT00320801|335430|P2|Open-label Run-in Period|Lack of Efficacy|0
98534|NCT00320801|335431|P1|Open-label Run-in Period|Lack of Efficacy|44
98535|NCT00320801|335428|P4|Open-label Run-in Period|Administrative|0
98536|NCT00320801|335429|P3|Open-label Run-in Period|Administrative|0
98537|NCT00320801|335430|P2|Open-label Run-in Period|Administrative|0
98538|NCT00320801|335431|P1|Open-label Run-in Period|Administrative|10
98539|NCT00320801|335428|P4|Open-label Run-in Period|Adverse Event|0
98540|NCT00320801|335429|P3|Open-label Run-in Period|Adverse Event|0
98541|NCT00320801|335430|P2|Open-label Run-in Period|Adverse Event|0
98542|NCT00320801|335431|P1|Open-label Run-in Period|Adverse Event|33
98543|NCT00320801|335428|P4|Open-label Run-in Period|Withdrawal by Subject|0
98544|NCT00320801|335429|P3|Open-label Run-in Period|Withdrawal by Subject|0
98545|NCT00320801|335430|P2|Open-label Run-in Period|Withdrawal by Subject|0
98546|NCT00320801|335431|P1|Open-label Run-in Period|Withdrawal by Subject|2
98547|NCT00307684|335452|P3|Double Blind Phase|Lack of Efficacy|0
98548|NCT00307684|335453|P2|Double Blind Phase|Lack of Efficacy|5
98549|NCT00307684|335454|P1|Double Blind Phase|Lack of Efficacy|2
98550|NCT00307684|335452|P3|Open Label Phase|other|6
98551|NCT00307684|335453|P2|Open Label Phase|other|0
98552|NCT00307684|335454|P1|Open Label Phase|other|0
98553|NCT00307684|335452|P3|Open Label Phase|non compliance|5
98554|NCT00307684|335453|P2|Open Label Phase|non compliance|0
98555|NCT00307684|335454|P1|Open Label Phase|non compliance|0
98556|NCT00307684|335452|P3|Open Label Phase|Lost to Follow-up|11
98557|NCT00307684|335453|P2|Open Label Phase|Lost to Follow-up|0
98558|NCT00307684|335454|P1|Open Label Phase|Lost to Follow-up|0
98559|NCT00307684|335452|P3|Open Label Phase|Withdrawal by Subject|15
98560|NCT00307684|335453|P2|Open Label Phase|Withdrawal by Subject|0
98561|NCT00307684|335454|P1|Open Label Phase|Withdrawal by Subject|0
98562|NCT00307684|335452|P3|Open Label Phase|Adverse Event|16
98563|NCT00307684|335453|P2|Open Label Phase|Adverse Event|0
98564|NCT00307684|335454|P1|Open Label Phase|Adverse Event|0
98565|NCT00307684|335452|P3|Open Label Phase|Lack of Efficacy|3
98566|NCT00307684|335453|P2|Open Label Phase|Lack of Efficacy|0
98567|NCT00307684|335454|P1|Open Label Phase|Lack of Efficacy|0
98568|NCT00307736|335480|P4|Overall Study|Withdrawal by Subject|0
98569|NCT00307736|335481|P3|Overall Study|Withdrawal by Subject|2
98570|NCT00307736|335482|P2|Overall Study|Withdrawal by Subject|0
98571|NCT00307736|335483|P1|Overall Study|Withdrawal by Subject|0
98572|NCT00307736|335480|P4|Overall Study|Adverse Event|3
98573|NCT00307736|335481|P3|Overall Study|Adverse Event|1
98574|NCT00307736|335482|P2|Overall Study|Adverse Event|0
98575|NCT00307736|335483|P1|Overall Study|Adverse Event|0
98576|NCT00307801|335496|P2|Overall Study|Pregnancy|1
98577|NCT00307801|335497|P1|Overall Study|Pregnancy|0
98578|NCT00307801|335496|P2|Overall Study|No reason specified|0
98579|NCT00307801|335497|P1|Overall Study|No reason specified|2
98580|NCT00307801|335496|P2|Overall Study|Protocol Violation|2
98581|NCT00307801|335497|P1|Overall Study|Protocol Violation|3
98582|NCT00307801|335496|P2|Overall Study|Frustration with e-diary|0
98583|NCT00307801|335497|P1|Overall Study|Frustration with e-diary|1
98584|NCT00307801|335496|P2|Overall Study|Lost to Follow-up, moved abroad|1
98585|NCT00307801|335497|P1|Overall Study|Lost to Follow-up, moved abroad|1
98586|NCT00307801|335496|P2|Overall Study|Lack of Efficacy|2
98587|NCT00307801|335497|P1|Overall Study|Lack of Efficacy|0
98588|NCT00307801|335496|P2|Overall Study|Wrong Randomization|0
98589|NCT00307801|335497|P1|Overall Study|Wrong Randomization|1
98590|NCT00307801|335496|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
98591|NCT00307801|335497|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
98592|NCT00307801|335496|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
98593|NCT00307801|335497|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
98594|NCT00307801|335496|P2|Overall Study|Non-compliance, not taken all tablets|2
98595|NCT00307801|335497|P1|Overall Study|Non-compliance, not taken all tablets|1
98596|NCT00307801|335496|P2|Overall Study|Withdrawal by Subject|4
98597|NCT00307801|335497|P1|Overall Study|Withdrawal by Subject|9
98598|NCT00307801|335496|P2|Overall Study|Adverse Event|4
98599|NCT00307801|335497|P1|Overall Study|Adverse Event|12
98600|NCT00307931|335609|P1|Overall Study|Adverse Event|1
98601|NCT00308074|335634|P1|Overall Study|Withdrawal by Subject|1
98602|NCT00308087|335643|P2|Overall Study|Not Specified|3
98603|NCT00308087|335644|P1|Overall Study|Not Specified|4
98604|NCT00308087|335643|P2|Overall Study|Withdrawal by Subject|1
98605|NCT00308087|335644|P1|Overall Study|Withdrawal by Subject|2
98606|NCT00308087|335643|P2|Overall Study|Study Closure|12
98607|NCT00308087|335644|P1|Overall Study|Study Closure|11
98608|NCT00308087|335643|P2|Overall Study|Progressive Disease|21
98609|NCT00308087|335644|P1|Overall Study|Progressive Disease|19
98610|NCT00321373|335667|P3|Overall Study|Unspecified|1
98611|NCT00321373|335668|P2|Overall Study|Unspecified|0
98612|NCT00321373|335669|P1|Overall Study|Unspecified|0
98613|NCT00321373|335667|P3|Overall Study|Withdrawal by Subject|0
98614|NCT00321373|335668|P2|Overall Study|Withdrawal by Subject|0
98615|NCT00321373|335669|P1|Overall Study|Withdrawal by Subject|1
98616|NCT00321373|335667|P3|Overall Study|Lost to Follow-up|1
98617|NCT00321373|335668|P2|Overall Study|Lost to Follow-up|0
98618|NCT00321373|335669|P1|Overall Study|Lost to Follow-up|1
98619|NCT00321373|335667|P3|Overall Study|Adverse Event|1
98620|NCT00321373|335668|P2|Overall Study|Adverse Event|0
98621|NCT00321373|335669|P1|Overall Study|Adverse Event|0
98622|NCT00321464|335694|P2|Overall Study|Other|18
98623|NCT00321464|335695|P1|Overall Study|Other|21
98624|NCT00321464|335694|P2|Overall Study|Ineligibility determined|1
98625|NCT00321464|335695|P1|Overall Study|Ineligibility determined|2
98626|NCT00321464|335694|P2|Overall Study|Protocol deviation|2
98627|NCT00321464|335695|P1|Overall Study|Protocol deviation|0
98628|NCT00321464|335694|P2|Overall Study|Lost to Follow-up|8
98629|NCT00321464|335695|P1|Overall Study|Lost to Follow-up|7
98630|NCT00321464|335694|P2|Overall Study|Noncompliance|10
98631|NCT00321464|335695|P1|Overall Study|Noncompliance|4
98632|NCT00321464|335694|P2|Overall Study|Physician Decision|14
98633|NCT00321464|335695|P1|Overall Study|Physician Decision|15
98634|NCT00321464|335694|P2|Overall Study|Adverse Event|28
98635|NCT00321464|335695|P1|Overall Study|Adverse Event|43
98636|NCT00321464|335694|P2|Overall Study|Participant request|61
98637|NCT00321464|335695|P1|Overall Study|Participant request|57
98638|NCT00321464|335694|P2|Overall Study|Withdrawal by Subject|118
98639|NCT00321464|335695|P1|Overall Study|Withdrawal by Subject|117
98640|NCT00321464|335694|P2|Overall Study|Disease progression|124
98641|NCT00321464|335695|P1|Overall Study|Disease progression|124
98642|NCT00321464|335694|P2|Overall Study|Death|174
98643|NCT00321464|335695|P1|Overall Study|Death|169
98644|NCT00321620|335707|P2|Overall Study|Other|33
98645|NCT00321620|335708|P1|Overall Study|Other|42
98646|NCT00321620|335707|P2|Overall Study|Participant request|52
98647|NCT00321620|335708|P1|Overall Study|Participant request|75
98648|NCT00321620|335707|P2|Overall Study|Ineligibility determined|3
98649|NCT00321620|335708|P1|Overall Study|Ineligibility determined|2
98650|NCT00321620|335707|P2|Overall Study|Protocol deviation|3
98651|NCT00321620|335708|P1|Overall Study|Protocol deviation|4
98652|NCT00321620|335707|P2|Overall Study|Noncompliance|7
98653|NCT00321620|335708|P1|Overall Study|Noncompliance|14
98654|NCT00321620|335707|P2|Overall Study|Physician Decision|1
98655|NCT00321620|335708|P1|Overall Study|Physician Decision|4
98656|NCT00321620|335707|P2|Overall Study|Lost to Follow-up|9
98657|NCT00321620|335708|P1|Overall Study|Lost to Follow-up|13
98658|NCT00321620|335707|P2|Overall Study|Adverse Event|56
98659|NCT00321620|335708|P1|Overall Study|Adverse Event|43
98660|NCT00321620|335707|P2|Overall Study|Disease progression|117
98661|NCT00321620|335708|P1|Overall Study|Disease progression|113
98662|NCT00321620|335707|P2|Overall Study|Withdrawal by Subject|147
98663|NCT00321620|335708|P1|Overall Study|Withdrawal by Subject|164
98664|NCT00321620|335707|P2|Overall Study|Death|294
98665|NCT00321620|335708|P1|Overall Study|Death|269
98666|NCT00327444|335724|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
98667|NCT00327444|335725|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
98668|NCT00327444|335724|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
98669|NCT00327444|335725|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
98670|NCT00327444|335724|P2|Open Label Treatment (OL) Period|Adverse Event|2
98671|NCT00327444|335725|P1|Open Label Treatment (OL) Period|Adverse Event|2
98672|NCT00327444|335724|P2|Open Label Treatment (OL) Period|Disease progression|7
98673|NCT00327444|335725|P1|Open Label Treatment (OL) Period|Disease progression|8
98674|NCT00327444|335724|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
98675|NCT00327444|335725|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
98676|NCT00327444|335724|P2|Double Blind Treatment (DB) Period|Subject request|1
98677|NCT00327444|335725|P1|Double Blind Treatment (DB) Period|Subject request|0
98678|NCT00327444|335724|P2|Double Blind Treatment (DB) Period|Adverse Event|5
98679|NCT00327444|335725|P1|Double Blind Treatment (DB) Period|Adverse Event|5
98680|NCT00327444|335724|P2|Double Blind Treatment (DB) Period|Disease progression|13
98681|NCT00327444|335725|P1|Double Blind Treatment (DB) Period|Disease progression|10
98682|NCT00327470|335739|P2|Overall Study|Death|4
98683|NCT00327470|335740|P1|Overall Study|Death|1
98684|NCT00327470|335739|P2|Overall Study|Withdrawal by Subject|12
98685|NCT00327470|335740|P1|Overall Study|Withdrawal by Subject|6
98686|NCT00327470|335739|P2|Overall Study|Lost to Follow-up|3
98687|NCT00327470|335740|P1|Overall Study|Lost to Follow-up|1
98688|NCT00327470|335739|P2|Overall Study|Other|9
98689|NCT00327470|335740|P1|Overall Study|Other|5
98690|NCT00327470|335739|P2|Overall Study|Lack of Efficacy|19
98691|NCT00327470|335740|P1|Overall Study|Lack of Efficacy|7
98692|NCT00327470|335739|P2|Overall Study|Adverse Event|14
98693|NCT00327470|335740|P1|Overall Study|Adverse Event|9
98694|NCT00327470|335739|P2|Overall Study|Randomized, but not treated|2
98695|NCT00327470|335740|P1|Overall Study|Randomized, but not treated|0
98696|NCT00327717|335760|P2|Overall Study|Withdrawal by Subject|7
98697|NCT00327717|335761|P1|Overall Study|Withdrawal by Subject|3
98698|NCT00327717|335760|P2|Overall Study|Lack of Efficacy|1
98699|NCT00327717|335761|P1|Overall Study|Lack of Efficacy|0
98700|NCT00327717|335760|P2|Overall Study|Adverse Event|6
98701|NCT00327717|335761|P1|Overall Study|Adverse Event|6
98702|NCT00328094|335811|P2|Overall Study|Physician Decision|3
98703|NCT00328094|335812|P1|Overall Study|Physician Decision|3
98704|NCT00328172|335825|P5|Overall Study|Other reason (not specified)|0
98705|NCT00328172|335826|P4|Overall Study|Other reason (not specified)|0
98706|NCT00328172|335827|P3|Overall Study|Other reason (not specified)|1
98707|NCT00328172|335828|P2|Overall Study|Other reason (not specified)|0
98708|NCT00328172|335829|P1|Overall Study|Other reason (not specified)|3
98709|NCT00328172|335825|P5|Overall Study|Lack of Efficacy|3
98710|NCT00328172|335826|P4|Overall Study|Lack of Efficacy|4
98711|NCT00328172|335827|P3|Overall Study|Lack of Efficacy|4
98712|NCT00328172|335828|P2|Overall Study|Lack of Efficacy|9
98713|NCT00328172|335829|P1|Overall Study|Lack of Efficacy|14
98714|NCT00328172|335825|P5|Overall Study|Withdrawal by Subject|0
98715|NCT00328172|335826|P4|Overall Study|Withdrawal by Subject|6
98716|NCT00328172|335827|P3|Overall Study|Withdrawal by Subject|1
98717|NCT00328172|335828|P2|Overall Study|Withdrawal by Subject|1
98718|NCT00328172|335829|P1|Overall Study|Withdrawal by Subject|1
98719|NCT00328172|335825|P5|Overall Study|Lost to Follow-up|1
98720|NCT00328172|335826|P4|Overall Study|Lost to Follow-up|1
98721|NCT00328172|335827|P3|Overall Study|Lost to Follow-up|2
98722|NCT00328172|335828|P2|Overall Study|Lost to Follow-up|1
98723|NCT00328172|335829|P1|Overall Study|Lost to Follow-up|1
98724|NCT00328172|335825|P5|Overall Study|Protocol Violation|0
98725|NCT00328172|335826|P4|Overall Study|Protocol Violation|0
98726|NCT00328172|335827|P3|Overall Study|Protocol Violation|1
98727|NCT00328172|335828|P2|Overall Study|Protocol Violation|1
98728|NCT00328172|335829|P1|Overall Study|Protocol Violation|0
98729|NCT00328172|335825|P5|Overall Study|Adverse Event|1
98730|NCT00328172|335826|P4|Overall Study|Adverse Event|2
98731|NCT00328172|335827|P3|Overall Study|Adverse Event|1
98732|NCT00328172|335828|P2|Overall Study|Adverse Event|2
98733|NCT00328172|335829|P1|Overall Study|Adverse Event|3
98734|NCT00328198|335851|P1|Follow-up|Death|31
98735|NCT00328198|335851|P1|Follow-up|Lost to Follow-up|4
98736|NCT00328198|335851|P1|Treatment|Confirmed complete response, MRD -|3
98737|NCT00328198|335851|P1|Treatment|Non-compliance|1
98738|NCT00328198|335851|P1|Treatment|Evidence of disease progression|2
98739|NCT00328198|335851|P1|Treatment|Withdrawal by Subject|5
98740|NCT00328198|335851|P1|Treatment|Physician Decision|5
98741|NCT00328198|335851|P1|Treatment|Death|1
98742|NCT00328198|335851|P1|Treatment|Adverse Event|21
98743|NCT00328510|335872|P2|Overall Study|Treatment changed to a single fraction|1
98744|NCT00328510|335873|P1|Overall Study|Treatment changed to a single fraction|1
98745|NCT00328510|335872|P2|Overall Study|Severe kyphosis, could not use mask|1
98746|NCT00328510|335873|P1|Overall Study|Severe kyphosis, could not use mask|0
98747|NCT00328510|335872|P2|Overall Study|Withdrawal by Subject|2
98748|NCT00328510|335873|P1|Overall Study|Withdrawal by Subject|4
98749|NCT00328510|335872|P2|Overall Study|Dentition problems, could not use frame|0
98750|NCT00328510|335873|P1|Overall Study|Dentition problems, could not use frame|1
98751|NCT00328510|335872|P2|Overall Study|Gag disorder, could not use frame|0
98752|NCT00328510|335873|P1|Overall Study|Gag disorder, could not use frame|4
98753|NCT00328562|335879|P1|Overall Study|Disease progression|1
98754|NCT00328627|335918|P12|Overall Study|Other|0
98755|NCT00328627|335919|P11|Overall Study|Other|1
98756|NCT00328627|335920|P10|Overall Study|Other|1
98757|NCT00328627|335921|P9|Overall Study|Other|0
98758|NCT00328627|335922|P8|Overall Study|Other|0
98759|NCT00328627|335923|P7|Overall Study|Other|1
98760|NCT00328627|335924|P6|Overall Study|Other|0
98761|NCT00328627|335925|P5|Overall Study|Other|0
98762|NCT00328627|335926|P4|Overall Study|Other|1
98763|NCT00328627|335927|P3|Overall Study|Other|0
98764|NCT00328627|335928|P2|Overall Study|Other|0
98765|NCT00328627|335929|P1|Overall Study|Other|0
98766|NCT00328627|335918|P12|Overall Study|Physician Decision|0
98767|NCT00328627|335919|P11|Overall Study|Physician Decision|1
98768|NCT00328627|335920|P10|Overall Study|Physician Decision|2
98769|NCT00328627|335921|P9|Overall Study|Physician Decision|3
98770|NCT00328627|335922|P8|Overall Study|Physician Decision|0
98771|NCT00328627|335923|P7|Overall Study|Physician Decision|1
98772|NCT00328627|335924|P6|Overall Study|Physician Decision|1
98773|NCT00328627|335925|P5|Overall Study|Physician Decision|1
98774|NCT00328627|335926|P4|Overall Study|Physician Decision|2
98775|NCT00328627|335927|P3|Overall Study|Physician Decision|1
98776|NCT00328627|335928|P2|Overall Study|Physician Decision|3
98777|NCT00328627|335929|P1|Overall Study|Physician Decision|4
98778|NCT00328627|335918|P12|Overall Study|Pregnancy|0
98779|NCT00328627|335919|P11|Overall Study|Pregnancy|0
98780|NCT00328627|335920|P10|Overall Study|Pregnancy|0
98781|NCT00328627|335921|P9|Overall Study|Pregnancy|0
98782|NCT00328627|335922|P8|Overall Study|Pregnancy|0
98783|NCT00328627|335923|P7|Overall Study|Pregnancy|0
98784|NCT00328627|335924|P6|Overall Study|Pregnancy|0
98785|NCT00328627|335925|P5|Overall Study|Pregnancy|0
98786|NCT00328627|335926|P4|Overall Study|Pregnancy|0
98787|NCT00328627|335927|P3|Overall Study|Pregnancy|0
98788|NCT00328627|335928|P2|Overall Study|Pregnancy|1
98789|NCT00328627|335929|P1|Overall Study|Pregnancy|0
98790|NCT00328627|335918|P12|Overall Study|Withdrawal by Subject|7
98791|NCT00328627|335919|P11|Overall Study|Withdrawal by Subject|2
98792|NCT00328627|335920|P10|Overall Study|Withdrawal by Subject|5
98793|NCT00328627|335921|P9|Overall Study|Withdrawal by Subject|4
98794|NCT00328627|335922|P8|Overall Study|Withdrawal by Subject|4
98795|NCT00328627|335923|P7|Overall Study|Withdrawal by Subject|4
98796|NCT00328627|335924|P6|Overall Study|Withdrawal by Subject|5
98797|NCT00328627|335925|P5|Overall Study|Withdrawal by Subject|2
98798|NCT00328627|335926|P4|Overall Study|Withdrawal by Subject|6
98799|NCT00328627|335927|P3|Overall Study|Withdrawal by Subject|5
98800|NCT00328627|335928|P2|Overall Study|Withdrawal by Subject|4
98801|NCT00328627|335929|P1|Overall Study|Withdrawal by Subject|5
98802|NCT00328627|335918|P12|Overall Study|Lost to Follow-up|1
98803|NCT00328627|335919|P11|Overall Study|Lost to Follow-up|0
98804|NCT00328627|335920|P10|Overall Study|Lost to Follow-up|2
98805|NCT00328627|335921|P9|Overall Study|Lost to Follow-up|3
98806|NCT00328627|335922|P8|Overall Study|Lost to Follow-up|0
98807|NCT00328627|335923|P7|Overall Study|Lost to Follow-up|3
98808|NCT00328627|335924|P6|Overall Study|Lost to Follow-up|2
98809|NCT00328627|335925|P5|Overall Study|Lost to Follow-up|0
98810|NCT00328627|335926|P4|Overall Study|Lost to Follow-up|4
98811|NCT00328627|335927|P3|Overall Study|Lost to Follow-up|2
98812|NCT00328627|335928|P2|Overall Study|Lost to Follow-up|2
98813|NCT00328627|335929|P1|Overall Study|Lost to Follow-up|4
98814|NCT00328627|335918|P12|Overall Study|Protocol Violation|2
98815|NCT00328627|335919|P11|Overall Study|Protocol Violation|6
98816|NCT00328627|335920|P10|Overall Study|Protocol Violation|4
98817|NCT00328627|335921|P9|Overall Study|Protocol Violation|1
98818|NCT00328627|335922|P8|Overall Study|Protocol Violation|2
98819|NCT00328627|335923|P7|Overall Study|Protocol Violation|6
98820|NCT00328627|335924|P6|Overall Study|Protocol Violation|5
98821|NCT00328627|335925|P5|Overall Study|Protocol Violation|5
98822|NCT00328627|335926|P4|Overall Study|Protocol Violation|8
98823|NCT00328627|335927|P3|Overall Study|Protocol Violation|2
98824|NCT00328627|335928|P2|Overall Study|Protocol Violation|2
98825|NCT00328627|335929|P1|Overall Study|Protocol Violation|2
98826|NCT00328627|335918|P12|Overall Study|Adverse Event|4
98827|NCT00328627|335919|P11|Overall Study|Adverse Event|5
98828|NCT00328627|335920|P10|Overall Study|Adverse Event|7
98829|NCT00328627|335921|P9|Overall Study|Adverse Event|0
98830|NCT00328627|335922|P8|Overall Study|Adverse Event|2
98831|NCT00328627|335923|P7|Overall Study|Adverse Event|1
98832|NCT00328627|335924|P6|Overall Study|Adverse Event|2
98833|NCT00328627|335925|P5|Overall Study|Adverse Event|1
98834|NCT00328627|335926|P4|Overall Study|Adverse Event|3
98835|NCT00328627|335927|P3|Overall Study|Adverse Event|2
98836|NCT00328627|335928|P2|Overall Study|Adverse Event|1
98837|NCT00328627|335929|P1|Overall Study|Adverse Event|3
98838|NCT00328627|335918|P12|Overall Study|Hyperglycemic Rescue|2
98839|NCT00328627|335919|P11|Overall Study|Hyperglycemic Rescue|3
98840|NCT00328627|335920|P10|Overall Study|Hyperglycemic Rescue|11
98841|NCT00328627|335921|P9|Overall Study|Hyperglycemic Rescue|6
98842|NCT00328627|335922|P8|Overall Study|Hyperglycemic Rescue|6
98843|NCT00328627|335923|P7|Overall Study|Hyperglycemic Rescue|19
98844|NCT00328627|335924|P6|Overall Study|Hyperglycemic Rescue|5
98845|NCT00328627|335925|P5|Overall Study|Hyperglycemic Rescue|6
98846|NCT00328627|335926|P4|Overall Study|Hyperglycemic Rescue|13
98847|NCT00328627|335927|P3|Overall Study|Hyperglycemic Rescue|16
98848|NCT00328627|335928|P2|Overall Study|Hyperglycemic Rescue|18
98849|NCT00328627|335929|P1|Overall Study|Hyperglycemic Rescue|41
98850|NCT00328783|337452|P1|Overall Study|Withdrawal by Subject|1
98851|NCT00328783|337452|P1|Overall Study|No heart in RT field|4
98852|NCT00328783|337452|P1|Overall Study|Could not tolerate ABC|21
98853|NCT00328926|337471|P3|Overall Study|Lack of ovarian response|0
98854|NCT00328926|337472|P2|Overall Study|Lack of ovarian response|1
98855|NCT00328926|337473|P1|Overall Study|Lack of ovarian response|0
98856|NCT00328926|337471|P3|Overall Study|In vitro fertilization treatment|1
98857|NCT00328926|337472|P2|Overall Study|In vitro fertilization treatment|0
98858|NCT00328926|337473|P1|Overall Study|In vitro fertilization treatment|0
98859|NCT00328926|337471|P3|Overall Study|Death|1
98860|NCT00328926|337472|P2|Overall Study|Death|0
98861|NCT00328926|337473|P1|Overall Study|Death|0
98862|NCT00328926|337471|P3|Overall Study|Lost to Follow-up|0
98863|NCT00328926|337472|P2|Overall Study|Lost to Follow-up|1
98864|NCT00328926|337473|P1|Overall Study|Lost to Follow-up|0
98865|NCT00328926|337471|P3|Overall Study|Pregnancy|0
98866|NCT00328926|337472|P2|Overall Study|Pregnancy|1
98867|NCT00328926|337473|P1|Overall Study|Pregnancy|2
98868|NCT00329030|337489|P2|Overall Study|Ineligible Pathology|1
98869|NCT00329030|337490|P1|Overall Study|Ineligible Pathology|1
98870|NCT00329030|337489|P2|Overall Study|Progressive Disease|2
98871|NCT00329030|337490|P1|Overall Study|Progressive Disease|6
98872|NCT00329030|337489|P2|Overall Study|Withdrawal by Subject|3
98873|NCT00329030|337490|P1|Overall Study|Withdrawal by Subject|1
98874|NCT00329108|337520|P2|Overall Study|Protocol Violation|2
98875|NCT00329108|337521|P1|Overall Study|Protocol Violation|0
98876|NCT00329108|337520|P2|Overall Study|withdrew patient after SAE resolved|0
98877|NCT00329108|337521|P1|Overall Study|withdrew patient after SAE resolved|1
98878|NCT00329108|337520|P2|Overall Study|study terminated by sponsor|0
98879|NCT00329108|337521|P1|Overall Study|study terminated by sponsor|1
98880|NCT00329108|337520|P2|Overall Study|Subject no longer willing to participate|2
98881|NCT00329108|337521|P1|Overall Study|Subject no longer willing to participate|2
98882|NCT00329108|337520|P2|Overall Study|symptomatic deterioration|1
98883|NCT00329108|337521|P1|Overall Study|symptomatic deterioration|1
98884|NCT00329108|337520|P2|Overall Study|Withdrawal by Subject|2
98885|NCT00329108|337521|P1|Overall Study|Withdrawal by Subject|0
98886|NCT00329108|337520|P2|Overall Study|Lack of Efficacy|3
98887|NCT00329108|337521|P1|Overall Study|Lack of Efficacy|3
98888|NCT00329108|337520|P2|Overall Study|Adverse Event|2
98889|NCT00329108|337521|P1|Overall Study|Adverse Event|2
98890|NCT00329160|337527|P1|Overall Study|Incomplete IVUS|45
98891|NCT00329160|337527|P1|Overall Study|Did not Receive Study Drug|1
98892|NCT00329160|337527|P1|Overall Study|Protocol Violation|2
98893|NCT00329160|337527|P1|Overall Study|Withdrawal by Subject|13
98894|NCT00329160|337527|P1|Overall Study|Adverse Event|27
98895|NCT00329238|337536|P2|Overall Study|Other reason (not specified)|54
98896|NCT00329238|337537|P1|Overall Study|Other reason (not specified)|40
98897|NCT00329238|337536|P2|Overall Study|Withdrawal by Subject|58
98898|NCT00329238|337537|P1|Overall Study|Withdrawal by Subject|64
98899|NCT00329238|337536|P2|Overall Study|Lost to Follow-up|6
98900|NCT00329238|337537|P1|Overall Study|Lost to Follow-up|2
98901|NCT00329238|337536|P2|Overall Study|Protocol Violation|34
98902|NCT00329238|337537|P1|Overall Study|Protocol Violation|23
98903|NCT00329238|337536|P2|Overall Study|Adverse Event|129
98904|NCT00329238|337537|P1|Overall Study|Adverse Event|147
98905|NCT00329407|337573|P1|Overall Study|Withdrawal by Subject|1
98906|NCT00329420|337581|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
98907|NCT00329420|337582|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
98908|NCT00329420|337583|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
98909|NCT00329420|337581|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
98910|NCT00329420|337582|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
98911|NCT00329420|337583|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
98912|NCT00329420|337581|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
98913|NCT00329420|337582|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
98914|NCT00329420|337583|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
98915|NCT00329420|337581|P3|Re-induction Phase|Did not respond to re-induction|7
98916|NCT00329420|337582|P2|Re-induction Phase|Did not respond to re-induction|5
98917|NCT00329420|337583|P1|Re-induction Phase|Did not respond to re-induction|6
98918|NCT00329420|337581|P3|Re-induction Phase|Withdrawal of Consent|1
98919|NCT00329420|337582|P2|Re-induction Phase|Withdrawal of Consent|0
98920|NCT00329420|337583|P1|Re-induction Phase|Withdrawal of Consent|0
98921|NCT00329420|337581|P3|Re-induction Phase|Lack of Efficacy|0
98922|NCT00329420|337582|P2|Re-induction Phase|Lack of Efficacy|1
98923|NCT00329420|337583|P1|Re-induction Phase|Lack of Efficacy|0
98924|NCT00329550|337980|P3|Overall Study|Due to Relocation|1
98925|NCT00329550|337981|P2|Overall Study|Due to Relocation|0
98926|NCT00329550|337982|P1|Overall Study|Due to Relocation|0
98927|NCT00329550|337980|P3|Overall Study|Withdrawal of Consent|1
98928|NCT00329550|337981|P2|Overall Study|Withdrawal of Consent|0
98929|NCT00329550|337982|P1|Overall Study|Withdrawal of Consent|1
98930|NCT00329550|337980|P3|Overall Study|Adverse Event|2
98931|NCT00329550|337981|P2|Overall Study|Adverse Event|4
98932|NCT00329550|337982|P1|Overall Study|Adverse Event|3
98933|NCT00329602|338231|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
98934|NCT00329602|338232|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
98935|NCT00329602|338233|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
98936|NCT00329602|338231|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
98937|NCT00329602|338232|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
98938|NCT00329602|338233|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
98939|NCT00329602|338231|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
98940|NCT00329602|338232|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
98941|NCT00329602|338233|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
98942|NCT00329602|338231|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
98943|NCT00329602|338232|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
98944|NCT00329602|338233|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
98945|NCT00329602|338231|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
98946|NCT00329602|338232|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
98947|NCT00329602|338233|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
98948|NCT00329602|338231|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
98949|NCT00329602|338232|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
98950|NCT00329602|338233|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
98951|NCT00329641|338268|P1|Overall Study|Other reason, not protocol specified|1
98952|NCT00329641|338268|P1|Overall Study|Adverse Event|3
98953|NCT00329641|338268|P1|Overall Study|Not eligible|1
98954|NCT00329641|338268|P1|Overall Study|Did not start treatment|1
98955|NCT00329719|338279|P4|Overall Study|Lost to Follow-up|1
98956|NCT00329719|338280|P3|Overall Study|Lost to Follow-up|0
98957|NCT00329719|338281|P2|Overall Study|Lost to Follow-up|0
98958|NCT00329719|338282|P1|Overall Study|Lost to Follow-up|0
98959|NCT00329745|338314|P2|Overall Study|Lost to Follow-up|101
98960|NCT00329745|338315|P1|Overall Study|Lost to Follow-up|86
98961|NCT00329745|338314|P2|Overall Study|Withdrawal by Subject|1
98962|NCT00329745|338315|P1|Overall Study|Withdrawal by Subject|0
98963|NCT00329745|338314|P2|Overall Study|Protocol Violation|0
98964|NCT00329745|338315|P1|Overall Study|Protocol Violation|1
98965|NCT00329784|338331|P4|Overall Study|Unspecified|0
98966|NCT00329784|338332|P3|Overall Study|Unspecified|0
98967|NCT00329784|338333|P2|Overall Study|Unspecified|2
98968|NCT00329784|338334|P1|Overall Study|Unspecified|1
98969|NCT00329784|338331|P4|Overall Study|Withdrawal by Subject|0
98970|NCT00329784|338332|P3|Overall Study|Withdrawal by Subject|0
98971|NCT00329784|338333|P2|Overall Study|Withdrawal by Subject|2
98972|NCT00329784|338334|P1|Overall Study|Withdrawal by Subject|4
98973|NCT00329784|338331|P4|Overall Study|Lost to Follow-up|0
98974|NCT00329784|338332|P3|Overall Study|Lost to Follow-up|0
98975|NCT00329784|338333|P2|Overall Study|Lost to Follow-up|1
98976|NCT00329784|338334|P1|Overall Study|Lost to Follow-up|0
98977|NCT00329849|338362|P2|Overall Study|Withdrawal by Subject|4
98978|NCT00329849|338363|P1|Overall Study|Withdrawal by Subject|6
98979|NCT00329901|338386|P3|Overall Study|Unable to classify|0
98980|NCT00329901|338387|P2|Overall Study|Unable to classify|2
98981|NCT00329901|338388|P1|Overall Study|Unable to classify|2
98982|NCT00329901|338386|P3|Overall Study|Protocol Violation|1
98983|NCT00329901|338387|P2|Overall Study|Protocol Violation|0
98984|NCT00329901|338388|P1|Overall Study|Protocol Violation|1
98985|NCT00329901|338386|P3|Overall Study|Lost to Follow-up|1
98986|NCT00329901|338387|P2|Overall Study|Lost to Follow-up|0
98987|NCT00329901|338388|P1|Overall Study|Lost to Follow-up|2
98988|NCT00329901|338386|P3|Overall Study|Withdrawal by Subject|2
98989|NCT00329901|338387|P2|Overall Study|Withdrawal by Subject|3
98990|NCT00329901|338388|P1|Overall Study|Withdrawal by Subject|4
98991|NCT00311155|338416|P1|Overall Study|Did not meet entry criteria|55
98992|NCT00311155|338416|P1|Overall Study|Withdrawal by Subject|17
98993|NCT00311155|338416|P1|Overall Study|Adverse Event|21
98994|NCT00311181|338425|P1|Overall Study|Final DFTs were not obtained|96
98995|NCT00311311|338433|P2|Overall Study|Lack of ancillary assistance|1
98996|NCT00311311|338434|P1|Overall Study|Lack of ancillary assistance|0
98997|NCT00311311|338433|P2|Overall Study|Death|0
98998|NCT00311311|338434|P1|Overall Study|Death|1
98999|NCT00311311|338433|P2|Overall Study|Study Termination by Sponsor|4
99000|NCT00311311|338434|P1|Overall Study|Study Termination by Sponsor|3
99001|NCT00311311|338433|P2|Overall Study|Noncompliance|1
99002|NCT00311311|338434|P1|Overall Study|Noncompliance|0
99003|NCT00311311|338433|P2|Overall Study|Withdrawal by Subject|1
99004|NCT00311311|338434|P1|Overall Study|Withdrawal by Subject|1
99005|NCT00311311|338433|P2|Overall Study|Adverse Event|2
99006|NCT00311311|338434|P1|Overall Study|Adverse Event|3
99007|NCT00311363|338487|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
99008|NCT00311363|338488|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
99009|NCT00311363|338489|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
99010|NCT00311363|338487|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
99011|NCT00311363|338488|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
99012|NCT00311363|338489|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
99013|NCT00311363|338487|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
99014|NCT00311363|338488|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
99015|NCT00311363|338489|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
99016|NCT00311363|338487|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
99017|NCT00311363|338488|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
99018|NCT00311363|338489|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
99019|NCT00311363|338487|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
99020|NCT00311363|338488|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
99021|NCT00311363|338489|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
99022|NCT00311363|338487|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
99023|NCT00311363|338488|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
99024|NCT00311363|338489|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
99025|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Death|0
99026|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Death|0
99027|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Death|1
99028|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
99029|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
99030|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
99031|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
99032|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
99033|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
99034|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
99035|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
99036|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
99037|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
99038|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
99039|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
99040|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
99041|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
99042|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
99043|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
99044|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
99045|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
99046|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
99047|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
99048|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
99049|NCT00311363|338487|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
99050|NCT00311363|338488|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
99051|NCT00311363|338489|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
99052|NCT00311402|338571|P2|Overall Study|IRB's rejection etc.|3
99053|NCT00311402|338572|P1|Overall Study|IRB's rejection etc.|10
99054|NCT00311402|338571|P2|Overall Study|Protocol Violation|6
99055|NCT00311402|338572|P1|Overall Study|Protocol Violation|7
99056|NCT00311402|338571|P2|Overall Study|Lack of Efficacy|42
99057|NCT00311402|338572|P1|Overall Study|Lack of Efficacy|58
99058|NCT00311402|338571|P2|Overall Study|Withdrawal by Subject|18
99059|NCT00311402|338572|P1|Overall Study|Withdrawal by Subject|17
99060|NCT00311402|338571|P2|Overall Study|Lost to Follow-up|3
99061|NCT00311402|338572|P1|Overall Study|Lost to Follow-up|0
99062|NCT00311402|338571|P2|Overall Study|Adverse Event|105
99063|NCT00311402|338572|P1|Overall Study|Adverse Event|118
99064|NCT00311584|338598|P2|Overall Study|ineligible|2
99065|NCT00311584|338599|P1|Overall Study|ineligible|2
99066|NCT00311584|338598|P2|Overall Study|Withdrawal by Subject|1
99067|NCT00311584|338599|P1|Overall Study|Withdrawal by Subject|1
99068|NCT00311584|338598|P2|Overall Study|Physician Decision|5
99069|NCT00311584|338599|P1|Overall Study|Physician Decision|4
99070|NCT00311584|338598|P2|Overall Study|Lack of Efficacy|15
99071|NCT00311584|338599|P1|Overall Study|Lack of Efficacy|12
99072|NCT00311584|338598|P2|Overall Study|Death|0
99073|NCT00311584|338599|P1|Overall Study|Death|1
99074|NCT00312195|338618|P2|Overall Study|Protocol Violation|0
99075|NCT00312195|338619|P1|Overall Study|Protocol Violation|1
99076|NCT00312195|338618|P2|Overall Study|Lost to Follow-up|0
99077|NCT00312195|338619|P1|Overall Study|Lost to Follow-up|1
99078|NCT00312195|338618|P2|Overall Study|Adverse Event|6
99079|NCT00312195|338619|P1|Overall Study|Adverse Event|4
99080|NCT00312208|338635|P2|Overall Study|Not specified|7
99081|NCT00312208|338636|P1|Overall Study|Not specified|5
99082|NCT00312208|338635|P2|Overall Study|Withdrawal by Subject|42
99083|NCT00312208|338636|P1|Overall Study|Withdrawal by Subject|53
99084|NCT00312208|338635|P2|Overall Study|Lost to Follow-up|5
99085|NCT00312208|338636|P1|Overall Study|Lost to Follow-up|3
99086|NCT00312208|338635|P2|Overall Study|Lack of Efficacy|4
99087|NCT00312208|338636|P1|Overall Study|Lack of Efficacy|7
99088|NCT00312208|338635|P2|Overall Study|Death|1
99089|NCT00312208|338636|P1|Overall Study|Death|2
99090|NCT00312208|338635|P2|Overall Study|Protocol Violation|3
99091|NCT00312208|338636|P1|Overall Study|Protocol Violation|5
99092|NCT00312208|338635|P2|Overall Study|Adverse Event|61
99093|NCT00312208|338636|P1|Overall Study|Adverse Event|97
99094|NCT00312221|338647|P4|Double-blind Phase|Lack of Efficacy|10
99095|NCT00312221|338648|P3|Double-blind Phase|Lack of Efficacy|6
99096|NCT00312221|338649|P2|Double-blind Phase|Lack of Efficacy|17
99097|NCT00312221|338650|P1|Double-blind Phase|Lack of Efficacy|0
99098|NCT00312221|338647|P4|Double-blind Phase|Administrative|33
99099|NCT00312221|338648|P3|Double-blind Phase|Administrative|37
99100|NCT00312221|338649|P2|Double-blind Phase|Administrative|26
99101|NCT00312221|338650|P1|Double-blind Phase|Administrative|0
99102|NCT00312221|338647|P4|Double-blind Phase|Lost to Follow-up|2
99103|NCT00312221|338648|P3|Double-blind Phase|Lost to Follow-up|2
99104|NCT00312221|338649|P2|Double-blind Phase|Lost to Follow-up|0
99105|NCT00312221|338650|P1|Double-blind Phase|Lost to Follow-up|0
99106|NCT00312221|338647|P4|Double-blind Phase|Adverse Event|18
99107|NCT00312221|338648|P3|Double-blind Phase|Adverse Event|19
99108|NCT00312221|338649|P2|Double-blind Phase|Adverse Event|10
99109|NCT00312221|338650|P1|Double-blind Phase|Adverse Event|0
99110|NCT00312221|338647|P4|Double-blind Phase|Withdrawal by Subject|7
99111|NCT00312221|338648|P3|Double-blind Phase|Withdrawal by Subject|8
99112|NCT00312221|338649|P2|Double-blind Phase|Withdrawal by Subject|6
99113|NCT00312221|338650|P1|Double-blind Phase|Withdrawal by Subject|0
99114|NCT00312221|338647|P4|Open-label Run-in Period|Did not qualify|0
99115|NCT00312221|338648|P3|Open-label Run-in Period|Did not qualify|0
99116|NCT00312221|338649|P2|Open-label Run-in Period|Did not qualify|0
99117|NCT00312221|338650|P1|Open-label Run-in Period|Did not qualify|5
99118|NCT00312221|338647|P4|Open-label Run-in Period|Lack of Efficacy|0
99119|NCT00312221|338648|P3|Open-label Run-in Period|Lack of Efficacy|0
99120|NCT00312221|338649|P2|Open-label Run-in Period|Lack of Efficacy|0
99121|NCT00312221|338650|P1|Open-label Run-in Period|Lack of Efficacy|102
99122|NCT00312221|338647|P4|Open-label Run-in Period|Administrative|0
99123|NCT00312221|338648|P3|Open-label Run-in Period|Administrative|0
99124|NCT00312221|338649|P2|Open-label Run-in Period|Administrative|0
99125|NCT00312221|338650|P1|Open-label Run-in Period|Administrative|42
99126|NCT00312221|338647|P4|Open-label Run-in Period|Lost to Follow-up|0
99127|NCT00312221|338648|P3|Open-label Run-in Period|Lost to Follow-up|0
99128|NCT00312221|338649|P2|Open-label Run-in Period|Lost to Follow-up|0
99129|NCT00312221|338650|P1|Open-label Run-in Period|Lost to Follow-up|5
99130|NCT00312221|338647|P4|Open-label Run-in Period|Adverse Event|0
99131|NCT00312221|338648|P3|Open-label Run-in Period|Adverse Event|0
99132|NCT00312221|338649|P2|Open-label Run-in Period|Adverse Event|0
99133|NCT00312221|338650|P1|Open-label Run-in Period|Adverse Event|74
99134|NCT00312221|338647|P4|Open-label Run-in Period|Withdrawal by Subject|0
99135|NCT00312221|338648|P3|Open-label Run-in Period|Withdrawal by Subject|0
99136|NCT00312221|338649|P2|Open-label Run-in Period|Withdrawal by Subject|0
99137|NCT00312221|338650|P1|Open-label Run-in Period|Withdrawal by Subject|6
99138|NCT00313300|338673|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
99139|NCT00313300|338674|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
99140|NCT00313300|338675|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
99141|NCT00313300|338676|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
99142|NCT00313300|338677|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
99143|NCT00313300|338673|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
99144|NCT00313300|338674|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
99145|NCT00313300|338675|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
99146|NCT00313300|338676|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
99147|NCT00313300|338677|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
99148|NCT00313300|338673|P5|Follow-Up(30days)-Randomized Phase B|Death|0
99149|NCT00313300|338674|P4|Follow-Up(30days)-Randomized Phase B|Death|0
99150|NCT00313300|338675|P3|Follow-Up(30days)-Randomized Phase B|Death|0
99151|NCT00313300|338676|P2|Follow-Up(30days)-Randomized Phase B|Death|0
99152|NCT00313300|338677|P1|Follow-Up(30days)-Randomized Phase B|Death|1
99153|NCT00313300|338673|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
99154|NCT00313300|338674|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
99155|NCT00313300|338675|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
99156|NCT00313300|338676|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
99157|NCT00313300|338677|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
99158|NCT00313300|338673|P5|Follow-Up(30days)-Randomized Phase A|Death|0
99159|NCT00313300|338674|P4|Follow-Up(30days)-Randomized Phase A|Death|0
99160|NCT00313300|338675|P3|Follow-Up(30days)-Randomized Phase A|Death|0
99161|NCT00313300|338676|P2|Follow-Up(30days)-Randomized Phase A|Death|1
99162|NCT00313300|338677|P1|Follow-Up(30days)-Randomized Phase A|Death|0
99163|NCT00313300|338673|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
99164|NCT00313300|338674|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
99165|NCT00313300|338675|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
99166|NCT00313300|338676|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
99167|NCT00313300|338677|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
99168|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|non-specified|0
99169|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|non-specified|0
99170|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|non-specified|0
99171|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|non-specified|0
99172|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|non-specified|1
99173|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
99174|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
99175|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
99176|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
99177|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
99178|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
99179|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
99180|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
99181|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
99182|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
99183|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
99184|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
99185|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
99186|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
99187|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
99188|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
99189|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
99190|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
99191|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
99192|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
99193|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|Death|1
99194|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|Death|0
99195|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|Death|1
99196|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|Death|3
99197|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|Death|5
99198|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
99199|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
99200|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
99201|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
99202|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
99203|NCT00313300|338673|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
99204|NCT00313300|338674|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
99205|NCT00313300|338675|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
99206|NCT00313300|338676|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
99207|NCT00313300|338677|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
99208|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
99209|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
99210|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
99211|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
99212|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
99213|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
99214|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
99215|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
99216|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
99217|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
99218|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
99219|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
99220|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
99221|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
99222|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
99223|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
99224|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
99225|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
99226|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
99227|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
99228|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|Death|0
99229|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|Death|0
99230|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|Death|0
99231|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|Death|4
99232|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|Death|3
99233|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
99234|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
99235|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
99236|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
99237|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
99238|NCT00313300|338673|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
99239|NCT00313300|338674|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
99240|NCT00313300|338675|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
99241|NCT00313300|338676|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
99242|NCT00313300|338677|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
99243|NCT00313313|338730|P3|Overall Study|Subject No Longer Meets Study Criteria|2
99244|NCT00313313|338731|P2|Overall Study|Subject No Longer Meets Study Criteria|3
99245|NCT00313313|338732|P1|Overall Study|Subject No Longer Meets Study Criteria|0
99246|NCT00313313|338730|P3|Overall Study|Death|2
99247|NCT00313313|338731|P2|Overall Study|Death|0
99248|NCT00313313|338732|P1|Overall Study|Death|0
99249|NCT00313313|338730|P3|Overall Study|Pregnancy|0
99250|NCT00313313|338731|P2|Overall Study|Pregnancy|2
99251|NCT00313313|338732|P1|Overall Study|Pregnancy|1
99252|NCT00313313|338730|P3|Overall Study|Poor/Noncompliance|2
99253|NCT00313313|338731|P2|Overall Study|Poor/Noncompliance|6
99254|NCT00313313|338732|P1|Overall Study|Poor/Noncompliance|3
99255|NCT00313313|338730|P3|Overall Study|Physician Decision|4
99256|NCT00313313|338731|P2|Overall Study|Physician Decision|6
99257|NCT00313313|338732|P1|Overall Study|Physician Decision|2
99258|NCT00313313|338730|P3|Overall Study|Adverse Event|12
99259|NCT00313313|338731|P2|Overall Study|Adverse Event|16
99260|NCT00313313|338732|P1|Overall Study|Adverse Event|15
99261|NCT00313313|338730|P3|Overall Study|Lost to Follow-up|9
99262|NCT00313313|338731|P2|Overall Study|Lost to Follow-up|7
99263|NCT00313313|338732|P1|Overall Study|Lost to Follow-up|10
99264|NCT00313313|338730|P3|Overall Study|Withdrawal of consent by subject|31
99265|NCT00313313|338731|P2|Overall Study|Withdrawal of consent by subject|17
99266|NCT00313313|338732|P1|Overall Study|Withdrawal of consent by subject|18
99267|NCT00313313|338730|P3|Overall Study|Lack of Efficacy|20
99268|NCT00313313|338731|P2|Overall Study|Lack of Efficacy|9
99269|NCT00313313|338732|P1|Overall Study|Lack of Efficacy|14
99270|NCT00313586|338761|P4|Overall Study|Death before starting treatment|0
99271|NCT00313586|338762|P3|Overall Study|Death before starting treatment|0
99272|NCT00313586|338763|P2|Overall Study|Death before starting treatment|0
99273|NCT00313586|338764|P1|Overall Study|Death before starting treatment|1
99274|NCT00313586|338761|P4|Overall Study|Moved|0
99275|NCT00313586|338762|P3|Overall Study|Moved|0
99276|NCT00313586|338763|P2|Overall Study|Moved|1
99277|NCT00313586|338764|P1|Overall Study|Moved|0
99278|NCT00313586|338761|P4|Overall Study|Lost insurance|0
99279|NCT00313586|338762|P3|Overall Study|Lost insurance|0
99280|NCT00313586|338763|P2|Overall Study|Lost insurance|1
99281|NCT00313586|338764|P1|Overall Study|Lost insurance|0
99282|NCT00313586|338761|P4|Overall Study|Absolute neutrophil count not recovered|0
99283|NCT00313586|338762|P3|Overall Study|Absolute neutrophil count not recovered|0
99284|NCT00313586|338763|P2|Overall Study|Absolute neutrophil count not recovered|1
99285|NCT00313586|338764|P1|Overall Study|Absolute neutrophil count not recovered|2
99286|NCT00313586|338761|P4|Overall Study|Physician Decision|0
99287|NCT00313586|338762|P3|Overall Study|Physician Decision|0
99288|NCT00313586|338763|P2|Overall Study|Physician Decision|1
99289|NCT00313586|338764|P1|Overall Study|Physician Decision|2
99290|NCT00313586|338761|P4|Overall Study|Did not achieve HI-major/better response|1
99291|NCT00313586|338762|P3|Overall Study|Did not achieve HI-major/better response|2
99292|NCT00313586|338763|P2|Overall Study|Did not achieve HI-major/better response|7
99293|NCT00313586|338764|P1|Overall Study|Did not achieve HI-major/better response|10
99294|NCT00313586|338761|P4|Overall Study|Other complicating disease|0
99295|NCT00313586|338762|P3|Overall Study|Other complicating disease|0
99296|NCT00313586|338763|P2|Overall Study|Other complicating disease|2
99297|NCT00313586|338764|P1|Overall Study|Other complicating disease|2
99298|NCT00313586|338761|P4|Overall Study|Alternative therapy|0
99299|NCT00313586|338762|P3|Overall Study|Alternative therapy|2
99300|NCT00313586|338763|P2|Overall Study|Alternative therapy|6
99301|NCT00313586|338764|P1|Overall Study|Alternative therapy|3
99302|NCT00313586|338761|P4|Overall Study|Withdrawal by Subject|2
99303|NCT00313586|338762|P3|Overall Study|Withdrawal by Subject|6
99304|NCT00313586|338763|P2|Overall Study|Withdrawal by Subject|6
99305|NCT00313586|338764|P1|Overall Study|Withdrawal by Subject|13
99306|NCT00313586|338761|P4|Overall Study|Death|7
99307|NCT00313586|338762|P3|Overall Study|Death|1
99308|NCT00313586|338763|P2|Overall Study|Death|8
99309|NCT00313586|338764|P1|Overall Study|Death|11
99310|NCT00313586|338761|P4|Overall Study|Adverse Event|10
99311|NCT00313586|338762|P3|Overall Study|Adverse Event|3
99312|NCT00313586|338763|P2|Overall Study|Adverse Event|18
99313|NCT00313586|338764|P1|Overall Study|Adverse Event|12
99314|NCT00313586|338761|P4|Overall Study|Disease progression|3
99315|NCT00313586|338762|P3|Overall Study|Disease progression|10
99316|NCT00313586|338763|P2|Overall Study|Disease progression|19
99317|NCT00313586|338764|P1|Overall Study|Disease progression|14
99318|NCT00313612|338774|P2|Overall Study|Patient never received treatment|1
99319|NCT00313612|338775|P1|Overall Study|Patient never received treatment|0
99320|NCT00313703|338787|P4|Overall Study|Lost to Follow-up|12
99321|NCT00313703|338788|P3|Overall Study|Lost to Follow-up|5
99322|NCT00313703|338789|P2|Overall Study|Lost to Follow-up|2
99323|NCT00313703|338790|P1|Overall Study|Lost to Follow-up|11
99324|NCT00313716|338810|P6|Overall Study|Withdrawal by Subject|0
99325|NCT00313716|338811|P5|Overall Study|Withdrawal by Subject|1
99326|NCT00313716|338812|P4|Overall Study|Withdrawal by Subject|0
99327|NCT00313716|338813|P3|Overall Study|Withdrawal by Subject|1
99328|NCT00313716|338814|P2|Overall Study|Withdrawal by Subject|1
99329|NCT00313716|338815|P1|Overall Study|Withdrawal by Subject|0
99330|NCT00313716|338810|P6|Overall Study|Lost to Follow-up|4
99331|NCT00313716|338811|P5|Overall Study|Lost to Follow-up|0
99332|NCT00313716|338812|P4|Overall Study|Lost to Follow-up|1
99333|NCT00313716|338813|P3|Overall Study|Lost to Follow-up|2
99334|NCT00313716|338814|P2|Overall Study|Lost to Follow-up|5
99335|NCT00313716|338815|P1|Overall Study|Lost to Follow-up|2
99336|NCT00313716|338810|P6|Overall Study|Death|9
99337|NCT00313716|338811|P5|Overall Study|Death|5
99338|NCT00313716|338812|P4|Overall Study|Death|3
99339|NCT00313716|338813|P3|Overall Study|Death|9
99340|NCT00313716|338814|P2|Overall Study|Death|2
99341|NCT00313716|338815|P1|Overall Study|Death|3
99342|NCT00313781|338840|P3|After Crossover|Unspecified|18
99343|NCT00313781|338841|P2|After Crossover|Unspecified|0
99344|NCT00313781|338842|P1|After Crossover|Unspecified|0
99345|NCT00313781|338840|P3|After Crossover|Withdrawal by Subject|3
99346|NCT00313781|338841|P2|After Crossover|Withdrawal by Subject|0
99347|NCT00313781|338842|P1|After Crossover|Withdrawal by Subject|0
99348|NCT00313781|338840|P3|After Crossover|Death|6
99349|NCT00313781|338841|P2|After Crossover|Death|0
99350|NCT00313781|338842|P1|After Crossover|Death|0
99351|NCT00313781|338840|P3|Before Crossover|Randomized, not treated|0
99352|NCT00313781|338841|P2|Before Crossover|Randomized, not treated|0
99353|NCT00313781|338842|P1|Before Crossover|Randomized, not treated|5
99354|NCT00313781|338840|P3|Before Crossover|Crossover|0
99355|NCT00313781|338841|P2|Before Crossover|Crossover|37
99356|NCT00313781|338842|P1|Before Crossover|Crossover|0
99357|NCT00313781|338840|P3|Before Crossover|Unspecified|0
99358|NCT00313781|338841|P2|Before Crossover|Unspecified|30
99359|NCT00313781|338842|P1|Before Crossover|Unspecified|45
99360|NCT00313781|338840|P3|Before Crossover|Withdrawal by Subject|0
99361|NCT00313781|338841|P2|Before Crossover|Withdrawal by Subject|1
99362|NCT00313781|338842|P1|Before Crossover|Withdrawal by Subject|3
99363|NCT00313781|338840|P3|Before Crossover|Lost to Follow-up|0
99364|NCT00313781|338841|P2|Before Crossover|Lost to Follow-up|3
99365|NCT00313781|338842|P1|Before Crossover|Lost to Follow-up|0
99366|NCT00313781|338840|P3|Before Crossover|Death|0
99367|NCT00313781|338841|P2|Before Crossover|Death|8
99368|NCT00313781|338842|P1|Before Crossover|Death|22
99369|NCT00313820|338878|P2|Pregabalin or Placebo Treatment Period|Other|3
99370|NCT00313820|338879|P1|Pregabalin or Placebo Treatment Period|Other|2
99371|NCT00313820|338878|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
99372|NCT00313820|338879|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
99373|NCT00313820|338878|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
99374|NCT00313820|338879|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
99375|NCT00313820|338878|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
99376|NCT00313820|338879|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
99377|NCT00313820|338878|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
99378|NCT00313820|338879|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
99379|NCT00313820|338878|P2|Assigned to Treatment|Other|0
99380|NCT00313820|338879|P1|Assigned to Treatment|Other|1
99381|NCT00313846|338917|P2|Overall Study|Administrative|3
99382|NCT00313846|338918|P1|Overall Study|Administrative|2
99383|NCT00313846|338917|P2|Overall Study|Adverse Event|8
99384|NCT00313846|338918|P1|Overall Study|Adverse Event|1
99385|NCT00313846|338917|P2|Overall Study|Withdrawal by Subject|0
99386|NCT00313846|338918|P1|Overall Study|Withdrawal by Subject|2
99387|NCT00313911|338929|P2|Overall Study|Did not meet age criteria|1
99388|NCT00313911|338930|P1|Overall Study|Did not meet age criteria|1
99389|NCT00313911|338929|P2|Overall Study|Withdrawal by Subject|12
99390|NCT00313911|338930|P1|Overall Study|Withdrawal by Subject|39
99391|NCT00313911|338929|P2|Overall Study|Lost to Follow-up|14
99392|NCT00313911|338930|P1|Overall Study|Lost to Follow-up|27
99393|NCT00313911|338929|P2|Overall Study|Protocol Violation|10
99394|NCT00313911|338930|P1|Overall Study|Protocol Violation|19
99395|NCT00313911|338929|P2|Overall Study|Adverse Event|3
99396|NCT00313911|338930|P1|Overall Study|Adverse Event|2
99397|NCT00313911|338929|P2|Overall Study|Serious adverse event|1
99398|NCT00313911|338930|P1|Overall Study|Serious adverse event|6
99399|NCT00314132|338955|P2|Overall Study|Physician Decision|0
99400|NCT00314132|338956|P1|Overall Study|Physician Decision|1
99401|NCT00314132|338955|P2|Overall Study|Adverse Event|0
99402|NCT00314132|338956|P1|Overall Study|Adverse Event|1
99403|NCT00314132|338955|P2|Overall Study|Withdrawal by Subject|5
99404|NCT00314132|338956|P1|Overall Study|Withdrawal by Subject|3
99405|NCT00314132|338955|P2|Overall Study|Lost to Follow-up|13
99406|NCT00314132|338956|P1|Overall Study|Lost to Follow-up|3
99407|NCT00314145|338966|P2|Overall Study|Sponsor Decision|0
99408|NCT00314145|338967|P1|Overall Study|Sponsor Decision|2
99409|NCT00314145|338966|P2|Overall Study|Protocol Violation|0
99410|NCT00314145|338967|P1|Overall Study|Protocol Violation|3
99411|NCT00314145|338966|P2|Overall Study|Adverse Event|3
99412|NCT00314145|338967|P1|Overall Study|Adverse Event|0
99413|NCT00314145|338966|P2|Overall Study|Physician Decision|4
99414|NCT00314145|338967|P1|Overall Study|Physician Decision|3
99415|NCT00314145|338966|P2|Overall Study|Lost to Follow-up|12
99416|NCT00314145|338967|P1|Overall Study|Lost to Follow-up|5
99417|NCT00314145|338966|P2|Overall Study|Withdrawal by Subject|10
99418|NCT00314145|338967|P1|Overall Study|Withdrawal by Subject|8
99419|NCT00314249|338996|P2|Overall Study|Non-Compliant|6
99420|NCT00314249|338997|P1|Overall Study|Non-Compliant|5
99421|NCT00314249|338996|P2|Overall Study|Withdrawn for other reasons|1
99422|NCT00314249|338997|P1|Overall Study|Withdrawn for other reasons|4
99423|NCT00314249|338996|P2|Overall Study|Physician Decision|1
99424|NCT00314249|338997|P1|Overall Study|Physician Decision|1
99425|NCT00314249|338996|P2|Overall Study|Lost to Follow-up|9
99426|NCT00314249|338997|P1|Overall Study|Lost to Follow-up|15
99427|NCT00314249|338996|P2|Overall Study|Withdrawal by Subject|28
99428|NCT00314249|338997|P1|Overall Study|Withdrawal by Subject|21
99429|NCT00314249|338996|P2|Overall Study|Lack of Efficacy|24
99430|NCT00314249|338997|P1|Overall Study|Lack of Efficacy|33
99431|NCT00314249|338996|P2|Overall Study|Adverse Event|94
99432|NCT00314249|338997|P1|Overall Study|Adverse Event|73
99433|NCT00314262|339013|P1|Overall Study|Physician Decision|1
99434|NCT00314262|339013|P1|Overall Study|Withdrawal by Subject|2
99435|NCT00314262|339013|P1|Overall Study|Adverse Event|2
99436|NCT00314327|339019|P1|Overall Study|Withdrawal by Subject|1
99437|NCT00314340|339023|P1|Overall Study|lost interest|1
99438|NCT00314366|339040|P2|Overall Study|not treated due to patient medical condi|0
99439|NCT00314366|339041|P1|Overall Study|not treated due to patient medical condi|1
99440|NCT00314574|339071|P2|Overall Study|Data unknown at database lock|1
99441|NCT00314574|339072|P1|Overall Study|Data unknown at database lock|0
99442|NCT00314574|339071|P2|Overall Study|Pregnancy|4
99443|NCT00314574|339072|P1|Overall Study|Pregnancy|6
99444|NCT00314574|339071|P2|Overall Study|Physician Decision|15
99445|NCT00314574|339072|P1|Overall Study|Physician Decision|22
99446|NCT00314574|339071|P2|Overall Study|Withdrawal by Subject|22
99447|NCT00314574|339072|P1|Overall Study|Withdrawal by Subject|33
99448|NCT00314574|339071|P2|Overall Study|Lost to Follow-up|25
99449|NCT00314574|339072|P1|Overall Study|Lost to Follow-up|19
99450|NCT00314574|339071|P2|Overall Study|Adverse Event|16
99451|NCT00314574|339072|P1|Overall Study|Adverse Event|11
99452|NCT00314574|339071|P2|Overall Study|Death|0
99453|NCT00314574|339072|P1|Overall Study|Death|3
99454|NCT00314808|339086|P1|Overall Study|Withdrawal by Subject/PI without AE|4
99455|NCT00314808|339086|P1|Overall Study|Disease Progression without AE|4
99456|NCT00314951|339096|P2|Follow-up|mITT failure|34
99457|NCT00314951|339097|P1|Follow-up|mITT failure|44
99458|NCT00314951|339096|P2|Treatment|Didn't meet criteria for mITT population|11
99459|NCT00314951|339097|P1|Treatment|Didn't meet criteria for mITT population|16
99460|NCT00315055|339109|P2|Overall Study|Lost to Follow-up|1
99461|NCT00315055|339110|P1|Overall Study|Lost to Follow-up|1
99462|NCT00315055|339109|P2|Overall Study|Protocol Violation|4
99463|NCT00315055|339110|P1|Overall Study|Protocol Violation|2
99464|NCT00315445|339346|P3|Overall Study|Other|0
99465|NCT00315445|339347|P2|Overall Study|Other|3
99466|NCT00315445|339348|P1|Overall Study|Other|1
99467|NCT00315445|339346|P3|Overall Study|Protocol Violation|1
99468|NCT00315445|339347|P2|Overall Study|Protocol Violation|0
99469|NCT00315445|339348|P1|Overall Study|Protocol Violation|2
99470|NCT00315445|339346|P3|Overall Study|Lost to Follow-up|1
99471|NCT00315445|339347|P2|Overall Study|Lost to Follow-up|0
99472|NCT00315445|339348|P1|Overall Study|Lost to Follow-up|1
99473|NCT00315445|339346|P3|Overall Study|Lack of Efficacy|7
99474|NCT00315445|339347|P2|Overall Study|Lack of Efficacy|1
99475|NCT00315445|339348|P1|Overall Study|Lack of Efficacy|16
99476|NCT00315445|339346|P3|Overall Study|Adverse Event|15
99477|NCT00315445|339347|P2|Overall Study|Adverse Event|12
99478|NCT00315445|339348|P1|Overall Study|Adverse Event|7
99479|NCT00315458|339421|P4|Overall Study|Did not qualify|0
99480|NCT00315458|339422|P3|Overall Study|Did not qualify|1
99481|NCT00315458|339423|P2|Overall Study|Did not qualify|0
99482|NCT00315458|339424|P1|Overall Study|Did not qualify|0
99483|NCT00315458|339421|P4|Overall Study|Lack of Efficacy|1
99484|NCT00315458|339422|P3|Overall Study|Lack of Efficacy|20
99485|NCT00315458|339423|P2|Overall Study|Lack of Efficacy|0
99486|NCT00315458|339424|P1|Overall Study|Lack of Efficacy|0
99487|NCT00315458|339421|P4|Overall Study|Withdrawal by Subject|2
99488|NCT00315458|339422|P3|Overall Study|Withdrawal by Subject|0
99489|NCT00315458|339423|P2|Overall Study|Withdrawal by Subject|3
99490|NCT00315458|339424|P1|Overall Study|Withdrawal by Subject|0
99491|NCT00315458|339421|P4|Overall Study|Lost to Follow-up|2
99492|NCT00315458|339422|P3|Overall Study|Lost to Follow-up|0
99493|NCT00315458|339423|P2|Overall Study|Lost to Follow-up|2
99494|NCT00315458|339424|P1|Overall Study|Lost to Follow-up|1
99495|NCT00315458|339421|P4|Overall Study|Adverse Event|3
99496|NCT00315458|339422|P3|Overall Study|Adverse Event|23
99497|NCT00315458|339423|P2|Overall Study|Adverse Event|4
99498|NCT00315458|339424|P1|Overall Study|Adverse Event|2
99499|NCT00315458|339421|P4|Overall Study|Administrative|21
99500|NCT00315458|339422|P3|Overall Study|Administrative|8
99501|NCT00315458|339423|P2|Overall Study|Administrative|3
99502|NCT00315458|339424|P1|Overall Study|Administrative|0
99503|NCT00315705|339458|P1|Phase 2|Death|7
99504|NCT00315705|339458|P1|Phase 2|Unspecified|1
99505|NCT00315705|339458|P1|Phase 2|Scheduled for transplant|8
99506|NCT00315705|339458|P1|Phase 2|Disease relapse|1
99507|NCT00315705|339458|P1|Phase 2|Failure to achieve response|3
99508|NCT00315705|339458|P1|Phase 2|Adverse Event|1
99509|NCT00315705|339458|P1|Phase 2|Physician Decision|4
99510|NCT00315705|339458|P1|Phase 1|Death|3
99511|NCT00315705|339458|P1|Phase 1|Scheduled for transplant|9
99512|NCT00315705|339458|P1|Phase 1|Disease relapse|4
99513|NCT00315705|339458|P1|Phase 1|Failure to achieve response|8
99514|NCT00315705|339458|P1|Phase 1|Refused further treatment|1
99515|NCT00315731|339495|P1|Overall Study|Death|5
99516|NCT00315731|339495|P1|Overall Study|Lost to Follow-up|1
99517|NCT00316004|339542|P3|Overall Study|Subject was not given study fluid.|21
99518|NCT00316004|339543|P2|Overall Study|Subject was not given study fluid.|14
99519|NCT00316004|339544|P1|Overall Study|Subject was not given study fluid.|14
99520|NCT00316017|339600|P3|Overall Study|Protocol Violation|19
99521|NCT00316017|339601|P2|Overall Study|Protocol Violation|13
99522|NCT00316017|339602|P1|Overall Study|Protocol Violation|11
99523|NCT00316303|339675|P2|Overall Study|Lost to Follow-up|16
99524|NCT00316303|339676|P1|Overall Study|Lost to Follow-up|11
99525|NCT00316693|339703|P2|Overall Study|Other|44
99526|NCT00316693|339704|P1|Overall Study|Other|38
99527|NCT00316693|339703|P2|Overall Study|Lost to Follow-up|34
99528|NCT00316693|339704|P1|Overall Study|Lost to Follow-up|26
99529|NCT00316693|339703|P2|Overall Study|Withdrawal by Subject|6
99530|NCT00316693|339704|P1|Overall Study|Withdrawal by Subject|6
99531|NCT00316693|339703|P2|Overall Study|Protocol Violation|0
99532|NCT00316693|339704|P1|Overall Study|Protocol Violation|1
99533|NCT00316693|339703|P2|Overall Study|Adverse Event|1
99534|NCT00316693|339704|P1|Overall Study|Adverse Event|6
99535|NCT00316706|339746|P2|Overall Study|Lost to Follow-up|48
99536|NCT00316706|339747|P1|Overall Study|Lost to Follow-up|38
99537|NCT00316719|339763|P2|Overall Study|Consent withdrawn|0
99538|NCT00316719|339764|P1|Overall Study|Consent withdrawn|2
99539|NCT00316719|339763|P2|Overall Study|Adverse Event|6
99540|NCT00316719|339764|P1|Overall Study|Adverse Event|0
99541|NCT00316888|339796|P2|Overall Study|Not start protocol therapy|1
99542|NCT00316888|339797|P1|Overall Study|Not start protocol therapy|0
99543|NCT00316888|339796|P2|Overall Study|Withdrawal by Subject|2
99544|NCT00316888|339797|P1|Overall Study|Withdrawal by Subject|2
99545|NCT00316888|339796|P2|Overall Study|Adverse Event|5
99546|NCT00316888|339797|P1|Overall Study|Adverse Event|4
99547|NCT00316914|339813|P2|Overall Study|Missing end of treatment documentation|15
99548|NCT00316914|339814|P1|Overall Study|Missing end of treatment documentation|14
99549|NCT00316914|339813|P2|Overall Study|Other Problems|11
99550|NCT00316914|339814|P1|Overall Study|Other Problems|6
99551|NCT00316914|339813|P2|Overall Study|Adverse Event|7
99552|NCT00316914|339814|P1|Overall Study|Adverse Event|8
99553|NCT00316914|339813|P2|Overall Study|Withdrawal by Subject|3
99554|NCT00316914|339814|P1|Overall Study|Withdrawal by Subject|5
99555|NCT00317044|339845|P3|Overall Study|Multiple Reasons|6
99556|NCT00317044|339846|P2|Overall Study|Multiple Reasons|2
99557|NCT00317044|339847|P1|Overall Study|Multiple Reasons|6
99558|NCT00317044|339845|P3|Overall Study|Lost to Follow-up|3
99559|NCT00317044|339846|P2|Overall Study|Lost to Follow-up|2
99560|NCT00317044|339847|P1|Overall Study|Lost to Follow-up|0
99561|NCT00317044|339845|P3|Overall Study|Withdrawal by Subject|12
99562|NCT00317044|339846|P2|Overall Study|Withdrawal by Subject|7
99563|NCT00317044|339847|P1|Overall Study|Withdrawal by Subject|10
99564|NCT00317044|339845|P3|Overall Study|Adverse Event|4
99565|NCT00317044|339846|P2|Overall Study|Adverse Event|7
99566|NCT00317044|339847|P1|Overall Study|Adverse Event|4
99567|NCT00317044|339845|P3|Overall Study|Protocol Violation|20
99568|NCT00317044|339846|P2|Overall Study|Protocol Violation|22
99569|NCT00317044|339847|P1|Overall Study|Protocol Violation|28
99570|NCT00317109|339893|P2|Overall Study|Migated/moved from study area|0
99571|NCT00317109|339894|P1|Overall Study|Migated/moved from study area|1
99572|NCT00317109|339893|P2|Overall Study|Withdrawal by Subject|0
99573|NCT00317109|339894|P1|Overall Study|Withdrawal by Subject|2
99574|NCT00317642|339943|P2|Overall Study|AML Not Centrally Confirmed|5
99575|NCT00317642|339944|P1|Overall Study|AML Not Centrally Confirmed|1
99576|NCT00317642|339943|P2|Overall Study|Referred For Transplantation|0
99577|NCT00317642|339944|P1|Overall Study|Referred For Transplantation|1
99578|NCT00317642|339943|P2|Overall Study|Withdrawal by Subject|1
99579|NCT00317642|339944|P1|Overall Study|Withdrawal by Subject|0
99580|NCT00317642|339943|P2|Overall Study|Not Continue to Consolidation|0
99581|NCT00317642|339944|P1|Overall Study|Not Continue to Consolidation|2
99582|NCT00317642|339943|P2|Overall Study|Death|7
99583|NCT00317642|339944|P1|Overall Study|Death|14
99584|NCT00317642|339943|P2|Overall Study|Disease Recurrence|2
99585|NCT00317642|339944|P1|Overall Study|Disease Recurrence|1
99586|NCT00317642|339943|P2|Overall Study|Treatment Failure|102
99587|NCT00317642|339944|P1|Overall Study|Treatment Failure|56
99588|NCT00317642|339943|P2|Overall Study|Adverse Event|5
99589|NCT00317642|339944|P1|Overall Study|Adverse Event|17
99590|NCT00317642|339943|P2|Overall Study|Participant declined treatment|3
99591|NCT00317642|339944|P1|Overall Study|Participant declined treatment|14
99592|NCT00317642|339943|P2|Overall Study|Physician Decision|7
99593|NCT00317642|339944|P1|Overall Study|Physician Decision|15
99594|NCT00317642|339943|P2|Overall Study|Not Received Either Study Drug|3
99595|NCT00317642|339944|P1|Overall Study|Not Received Either Study Drug|1
99596|NCT00318370|340084|P3|Period 3|Other|3
99597|NCT00318370|340085|P2|Period 3|Other|0
99598|NCT00318370|340086|P1|Period 3|Other|0
99599|NCT00318370|340084|P3|Period 3|Withdrawal by Subject|3
99600|NCT00318370|340085|P2|Period 3|Withdrawal by Subject|0
99601|NCT00318370|340086|P1|Period 3|Withdrawal by Subject|0
99602|NCT00318370|340084|P3|Period 3|Physician Decision|1
99603|NCT00318370|340085|P2|Period 3|Physician Decision|0
99604|NCT00318370|340086|P1|Period 3|Physician Decision|0
99605|NCT00318370|340084|P3|Period 3|Death|1
99606|NCT00318370|340085|P2|Period 3|Death|0
99607|NCT00318370|340086|P1|Period 3|Death|0
99608|NCT00318370|340084|P3|Period 3|Lack of Efficacy|24
99609|NCT00318370|340085|P2|Period 3|Lack of Efficacy|0
99610|NCT00318370|340086|P1|Period 3|Lack of Efficacy|0
99611|NCT00318370|340084|P3|Period 3|Adverse Event|1
99612|NCT00318370|340085|P2|Period 3|Adverse Event|0
99613|NCT00318370|340086|P1|Period 3|Adverse Event|0
99614|NCT00318370|340084|P3|Period 2|Other|0
99615|NCT00318370|340085|P2|Period 2|Other|1
99616|NCT00318370|340086|P1|Period 2|Other|0
99617|NCT00318370|340084|P3|Period 2|Withdrawal by Subject|0
99618|NCT00318370|340085|P2|Period 2|Withdrawal by Subject|1
99619|NCT00318370|340086|P1|Period 2|Withdrawal by Subject|0
99620|NCT00318370|340084|P3|Period 2|Physician Decision|0
99621|NCT00318370|340085|P2|Period 2|Physician Decision|1
99622|NCT00318370|340086|P1|Period 2|Physician Decision|0
99623|NCT00318370|340084|P3|Period 2|Lack of Efficacy|0
99624|NCT00318370|340085|P2|Period 2|Lack of Efficacy|5
99625|NCT00318370|340086|P1|Period 2|Lack of Efficacy|0
99626|NCT00318370|340084|P3|Period 2|Adverse Event|0
99627|NCT00318370|340085|P2|Period 2|Adverse Event|3
99628|NCT00318370|340086|P1|Period 2|Adverse Event|0
99629|NCT00318370|340084|P3|Period 1|Withdrawal by Subject|0
99630|NCT00318370|340085|P2|Period 1|Withdrawal by Subject|0
99631|NCT00318370|340086|P1|Period 1|Withdrawal by Subject|1
99632|NCT00318370|340084|P3|Period 1|Physician Decision|0
99633|NCT00318370|340085|P2|Period 1|Physician Decision|0
99634|NCT00318370|340086|P1|Period 1|Physician Decision|1
99635|NCT00318370|340084|P3|Period 1|Lack of Efficacy|0
99636|NCT00318370|340085|P2|Period 1|Lack of Efficacy|0
99637|NCT00318370|340086|P1|Period 1|Lack of Efficacy|5
99638|NCT00318461|340123|P5|Open-Label Extension, 18 Months|Protocol Violation|6
99639|NCT00318461|340124|P4|Open-Label Extension, 18 Months|Protocol Violation|4
99640|NCT00318461|340125|P3|Open-Label Extension, 18 Months|Protocol Violation|3
99641|NCT00318461|340126|P2|Open-Label Extension, 18 Months|Protocol Violation|5
99642|NCT00318461|340127|P1|Open-Label Extension, 18 Months|Protocol Violation|7
99643|NCT00318461|340123|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
99644|NCT00318461|340124|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
99645|NCT00318461|340125|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
99646|NCT00318461|340126|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
99647|NCT00318461|340127|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
99648|NCT00318461|340123|P5|Open-Label Extension, 18 Months|Adverse Event|6
99649|NCT00318461|340124|P4|Open-Label Extension, 18 Months|Adverse Event|1
99650|NCT00318461|340125|P3|Open-Label Extension, 18 Months|Adverse Event|6
99651|NCT00318461|340126|P2|Open-Label Extension, 18 Months|Adverse Event|8
99652|NCT00318461|340127|P1|Open-Label Extension, 18 Months|Adverse Event|11
99653|NCT00318461|340123|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
99654|NCT00318461|340124|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
99655|NCT00318461|340125|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
99656|NCT00318461|340126|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
99657|NCT00318461|340127|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
99658|NCT00318461|340123|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
99659|NCT00318461|340124|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
99660|NCT00318461|340125|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
99661|NCT00318461|340126|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
99662|NCT00318461|340127|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
99663|NCT00318461|340123|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
99664|NCT00318461|340124|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
99665|NCT00318461|340125|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
99666|NCT00318461|340126|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
99667|NCT00318461|340127|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
99668|NCT00318461|340123|P5|Double-Blind, 6 Months|Hyperglicaemia|0
99669|NCT00318461|340124|P4|Double-Blind, 6 Months|Hyperglicaemia|1
99670|NCT00318461|340125|P3|Double-Blind, 6 Months|Hyperglicaemia|0
99671|NCT00318461|340126|P2|Double-Blind, 6 Months|Hyperglicaemia|0
99672|NCT00318461|340127|P1|Double-Blind, 6 Months|Hyperglicaemia|0
99673|NCT00318461|340123|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
99674|NCT00318461|340124|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
99675|NCT00318461|340125|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
99676|NCT00318461|340126|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
99677|NCT00318461|340127|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
99678|NCT00318461|340123|P5|Double-Blind, 6 Months|Lack of time|0
99679|NCT00318461|340124|P4|Double-Blind, 6 Months|Lack of time|0
99680|NCT00318461|340125|P3|Double-Blind, 6 Months|Lack of time|0
99681|NCT00318461|340126|P2|Double-Blind, 6 Months|Lack of time|0
99682|NCT00318461|340127|P1|Double-Blind, 6 Months|Lack of time|1
99683|NCT00318461|340123|P5|Double-Blind, 6 Months|Investigator decision|1
99684|NCT00318461|340124|P4|Double-Blind, 6 Months|Investigator decision|0
99685|NCT00318461|340125|P3|Double-Blind, 6 Months|Investigator decision|0
99686|NCT00318461|340126|P2|Double-Blind, 6 Months|Investigator decision|0
99687|NCT00318461|340127|P1|Double-Blind, 6 Months|Investigator decision|0
99688|NCT00318461|340123|P5|Double-Blind, 6 Months|Work commitment|1
99689|NCT00318461|340124|P4|Double-Blind, 6 Months|Work commitment|0
99690|NCT00318461|340125|P3|Double-Blind, 6 Months|Work commitment|0
99691|NCT00318461|340126|P2|Double-Blind, 6 Months|Work commitment|0
99692|NCT00318461|340127|P1|Double-Blind, 6 Months|Work commitment|0
99693|NCT00318461|340123|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
99694|NCT00318461|340124|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
99695|NCT00318461|340125|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
99696|NCT00318461|340126|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
99697|NCT00318461|340127|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
99698|NCT00318461|340123|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
99699|NCT00318461|340124|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
99700|NCT00318461|340125|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
99701|NCT00318461|340126|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
99702|NCT00318461|340127|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
99703|NCT00318461|340123|P5|Double-Blind, 6 Months|Move|0
99704|NCT00318461|340124|P4|Double-Blind, 6 Months|Move|0
99705|NCT00318461|340125|P3|Double-Blind, 6 Months|Move|0
99706|NCT00318461|340126|P2|Double-Blind, 6 Months|Move|1
99707|NCT00318461|340127|P1|Double-Blind, 6 Months|Move|0
99708|NCT00318461|340123|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
99709|NCT00318461|340124|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
99710|NCT00318461|340125|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
99711|NCT00318461|340126|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
99712|NCT00318461|340127|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
99713|NCT00318461|340123|P5|Double-Blind, 6 Months|Consent withdrawn|4
99714|NCT00318461|340124|P4|Double-Blind, 6 Months|Consent withdrawn|10
99715|NCT00318461|340125|P3|Double-Blind, 6 Months|Consent withdrawn|4
99716|NCT00318461|340126|P2|Double-Blind, 6 Months|Consent withdrawn|3
99717|NCT00318461|340127|P1|Double-Blind, 6 Months|Consent withdrawn|0
99718|NCT00318461|340123|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
99719|NCT00318461|340124|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
99720|NCT00318461|340125|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
99721|NCT00318461|340126|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
99722|NCT00318461|340127|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
99723|NCT00318461|340123|P5|Double-Blind, 6 Months|Lost to follow up|0
99724|NCT00318461|340124|P4|Double-Blind, 6 Months|Lost to follow up|0
99725|NCT00318461|340125|P3|Double-Blind, 6 Months|Lost to follow up|0
99726|NCT00318461|340126|P2|Double-Blind, 6 Months|Lost to follow up|1
99727|NCT00318461|340127|P1|Double-Blind, 6 Months|Lost to follow up|0
99728|NCT00318461|340123|P5|Double-Blind, 6 Months|Protocol Violation|5
99729|NCT00318461|340124|P4|Double-Blind, 6 Months|Protocol Violation|4
99730|NCT00318461|340125|P3|Double-Blind, 6 Months|Protocol Violation|4
99731|NCT00318461|340126|P2|Double-Blind, 6 Months|Protocol Violation|4
99732|NCT00318461|340127|P1|Double-Blind, 6 Months|Protocol Violation|2
99733|NCT00318461|340123|P5|Double-Blind, 6 Months|Lack of Efficacy|9
99734|NCT00318461|340124|P4|Double-Blind, 6 Months|Lack of Efficacy|29
99735|NCT00318461|340125|P3|Double-Blind, 6 Months|Lack of Efficacy|13
99736|NCT00318461|340126|P2|Double-Blind, 6 Months|Lack of Efficacy|8
99737|NCT00318461|340127|P1|Double-Blind, 6 Months|Lack of Efficacy|19
99738|NCT00318461|340123|P5|Double-Blind, 6 Months|Adverse Event|8
99739|NCT00318461|340124|P4|Double-Blind, 6 Months|Adverse Event|2
99740|NCT00318461|340125|P3|Double-Blind, 6 Months|Adverse Event|29
99741|NCT00318461|340126|P2|Double-Blind, 6 Months|Adverse Event|23
99742|NCT00318461|340127|P1|Double-Blind, 6 Months|Adverse Event|11
99743|NCT00318474|340206|P2|Overall Study|Trial terminated|7
99744|NCT00318474|340207|P1|Overall Study|Trial terminated|10
99745|NCT00318474|340206|P2|Overall Study|Post-therapy hyperflycemia|1
99746|NCT00318474|340207|P1|Overall Study|Post-therapy hyperflycemia|0
99747|NCT00318474|340206|P2|Overall Study|Fall in GFR|3
99748|NCT00318474|340207|P1|Overall Study|Fall in GFR|3
99749|NCT00318474|340206|P2|Overall Study|Withdrawal by Subject|2
99750|NCT00318474|340207|P1|Overall Study|Withdrawal by Subject|3
99751|NCT00318474|340206|P2|Overall Study|Protocol Violation|0
99752|NCT00318474|340207|P1|Overall Study|Protocol Violation|1
99753|NCT00318474|340206|P2|Overall Study|Pregnancy|2
99754|NCT00318474|340207|P1|Overall Study|Pregnancy|0
99755|NCT00318474|340206|P2|Overall Study|Lost to Follow-up|1
99756|NCT00318474|340207|P1|Overall Study|Lost to Follow-up|0
99757|NCT00318474|340206|P2|Overall Study|Adverse Event|1
99758|NCT00318474|340207|P1|Overall Study|Adverse Event|1
99759|NCT00318565|340213|P1|Overall Study|Excluded per protocol|24
99760|NCT00318656|340241|P2|Overall Study|Did not receive any treatment|1
99761|NCT00318656|340242|P1|Overall Study|Did not receive any treatment|0
99762|NCT00318656|340241|P2|Overall Study|Took Avandamet instead of Glim/Met|1
99763|NCT00318656|340242|P1|Overall Study|Took Avandamet instead of Glim/Met|0
99764|NCT00312338|340289|P2|Overall Study|Subsequent infection|0
99765|NCT00312338|340290|P1|Overall Study|Subsequent infection|2
99766|NCT00312338|340289|P2|Overall Study|Withdrawal by Subject|0
99767|NCT00312338|340290|P1|Overall Study|Withdrawal by Subject|4
99768|NCT00312338|340289|P2|Overall Study|Lost to Follow-up|1
99769|NCT00312338|340290|P1|Overall Study|Lost to Follow-up|9
99770|NCT00312338|340289|P2|Overall Study|Adverse Event|2
99771|NCT00312338|340290|P1|Overall Study|Adverse Event|7
99772|NCT00312377|340302|P2|Overall Study|Site ended participation in study|0
99773|NCT00312377|340303|P1|Overall Study|Site ended participation in study|1
99774|NCT00312377|340302|P2|Overall Study|Discontinue treatment survival follow up|200
99775|NCT00312377|340303|P1|Overall Study|Discontinue treatment survival follow up|202
99776|NCT00312377|340302|P2|Overall Study|Randomised but never received treatment|6
99777|NCT00312377|340303|P1|Overall Study|Randomised but never received treatment|6
99778|NCT00312377|340302|P2|Overall Study|Non-compliance|2
99779|NCT00312377|340303|P1|Overall Study|Non-compliance|0
99780|NCT00312377|340302|P2|Overall Study|Lost to Follow-up|12
99781|NCT00312377|340303|P1|Overall Study|Lost to Follow-up|9
99782|NCT00312377|340302|P2|Overall Study|Withdrawal by Subject|30
99783|NCT00312377|340303|P1|Overall Study|Withdrawal by Subject|23
99784|NCT00312377|340302|P2|Overall Study|Death|418
99785|NCT00312377|340303|P1|Overall Study|Death|403
99786|NCT00312494|340328|P3|Overall Study|Unspecified|1
99787|NCT00312494|340329|P2|Overall Study|Unspecified|10
99788|NCT00312494|340330|P1|Overall Study|Unspecified|10
99789|NCT00312494|340328|P3|Overall Study|Withdrawal by Subject|10
99790|NCT00312494|340329|P2|Overall Study|Withdrawal by Subject|9
99791|NCT00312494|340330|P1|Overall Study|Withdrawal by Subject|6
99792|NCT00312494|340328|P3|Overall Study|Lost to Follow-up|8
99793|NCT00312494|340329|P2|Overall Study|Lost to Follow-up|8
99794|NCT00312494|340330|P1|Overall Study|Lost to Follow-up|8
99795|NCT00312494|340328|P3|Overall Study|Laboratory abnormality|0
99796|NCT00312494|340329|P2|Overall Study|Laboratory abnormality|0
99797|NCT00312494|340330|P1|Overall Study|Laboratory abnormality|1
99798|NCT00312494|340328|P3|Overall Study|Lack of Efficacy|8
99799|NCT00312494|340329|P2|Overall Study|Lack of Efficacy|6
99800|NCT00312494|340330|P1|Overall Study|Lack of Efficacy|4
99801|NCT00312494|340328|P3|Overall Study|Adverse Event|11
99802|NCT00312494|340329|P2|Overall Study|Adverse Event|15
99803|NCT00312494|340330|P1|Overall Study|Adverse Event|33
99804|NCT00312494|340328|P3|Overall Study|Randomized; not treated with study drug|5
99805|NCT00312494|340329|P2|Overall Study|Randomized; not treated with study drug|10
99806|NCT00312494|340330|P1|Overall Study|Randomized; not treated with study drug|9
99807|NCT00312572|340364|P2|Overall Study|Lack of Efficacy|2
99808|NCT00312572|340365|P1|Overall Study|Lack of Efficacy|1
99809|NCT00312572|340364|P2|Overall Study|Administrative|2
99810|NCT00312572|340365|P1|Overall Study|Administrative|4
99811|NCT00312572|340364|P2|Overall Study|Lost to Follow-up|1
99812|NCT00312572|340365|P1|Overall Study|Lost to Follow-up|1
99813|NCT00312572|340364|P2|Overall Study|Adverse Event|16
99814|NCT00312572|340365|P1|Overall Study|Adverse Event|10
99815|NCT00312728|340373|P1|Overall Study|Other|1
99816|NCT00312728|340373|P1|Overall Study|Other|10
99817|NCT00312728|340373|P1|Overall Study|Protocol Violation|2
99818|NCT00312728|340373|P1|Overall Study|Required non-protocol cancer treatment|2
99819|NCT00312728|340373|P1|Overall Study|Withdrawal by Subject|10
99820|NCT00312728|340373|P1|Overall Study|Adverse Event|32
99821|NCT00312728|340373|P1|Overall Study|Progressive disease|53
99822|NCT00312845|340384|P2|Overall Study|Other|5
99823|NCT00312845|340385|P1|Overall Study|Other|6
99824|NCT00312845|340384|P2|Overall Study|Lost to Follow-up|0
99825|NCT00312845|340385|P1|Overall Study|Lost to Follow-up|2
99826|NCT00312845|340384|P2|Overall Study|Disease Progression|77
99827|NCT00312845|340385|P1|Overall Study|Disease Progression|56
99828|NCT00312845|340384|P2|Overall Study|Withdrawal by Subject|6
99829|NCT00312845|340385|P1|Overall Study|Withdrawal by Subject|14
99830|NCT00312845|340384|P2|Overall Study|Death|2
99831|NCT00312845|340385|P1|Overall Study|Death|2
99832|NCT00312845|340384|P2|Overall Study|Adverse Event|5
99833|NCT00312845|340385|P1|Overall Study|Adverse Event|19
99834|NCT00312858|340395|P2|Overall Study|Unspecified|12
99835|NCT00312858|340396|P1|Overall Study|Unspecified|9
99836|NCT00312858|340395|P2|Overall Study|Participant Moved|10
99837|NCT00312858|340396|P1|Overall Study|Participant Moved|11
99838|NCT00312858|340395|P2|Overall Study|Withdraw by Participant|20
99839|NCT00312858|340396|P1|Overall Study|Withdraw by Participant|20
99840|NCT00312858|340395|P2|Overall Study|Protocol Violation|8
99841|NCT00312858|340396|P1|Overall Study|Protocol Violation|3
99842|NCT00312858|340395|P2|Overall Study|Lost to Follow-up|42
99843|NCT00312858|340396|P1|Overall Study|Lost to Follow-up|25
99844|NCT00312858|340395|P2|Overall Study|Adverse Event|1
99845|NCT00312858|340396|P1|Overall Study|Adverse Event|0
99846|NCT00313014|340477|P3|Overall Study|Lack of Efficacy|16
99847|NCT00313014|340478|P2|Overall Study|Lack of Efficacy|25
99848|NCT00313014|340479|P1|Overall Study|Lack of Efficacy|52
99849|NCT00313014|340477|P3|Overall Study|Administrative|14
99850|NCT00313014|340478|P2|Overall Study|Administrative|6
99851|NCT00313014|340479|P1|Overall Study|Administrative|9
99852|NCT00313014|340477|P3|Overall Study|Lost to Follow-up|10
99853|NCT00313014|340478|P2|Overall Study|Lost to Follow-up|6
99854|NCT00313014|340479|P1|Overall Study|Lost to Follow-up|7
99855|NCT00313014|340477|P3|Overall Study|Adverse Event|16
99856|NCT00313014|340478|P2|Overall Study|Adverse Event|29
99857|NCT00313014|340479|P1|Overall Study|Adverse Event|14
99858|NCT00313014|340477|P3|Overall Study|Withdrawal by Subject|5
99859|NCT00313014|340478|P2|Overall Study|Withdrawal by Subject|7
99860|NCT00313014|340479|P1|Overall Study|Withdrawal by Subject|11
99861|NCT00313144|340497|P1|Overall Study|Due to termination of the study|66
99862|NCT00313144|340497|P1|Overall Study|Change to different product|1
99863|NCT00313144|340497|P1|Overall Study|Insurance (homecare provider) change|1
99864|NCT00313144|340497|P1|Overall Study|Liver transplant|1
99865|NCT00313144|340497|P1|Overall Study|Adverse event - transient|5
99866|NCT00313144|340497|P1|Overall Study|Physician Decision|4
99867|NCT00313144|340497|P1|Overall Study|Terminated by sponsor/ homecare provider|4
99868|NCT00313144|340497|P1|Overall Study|Withdrawal by Subject|4
99869|NCT00313144|340497|P1|Overall Study|Lost to Follow-up|5
99870|NCT00313144|340497|P1|Overall Study|Death|7
99871|NCT00313144|340497|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
99872|NCT00313170|340584|P3|Overall Study|brain mets. after randomisation|1
99873|NCT00313170|340585|P2|Overall Study|brain mets. after randomisation|0
99874|NCT00313170|340586|P1|Overall Study|brain mets. after randomisation|0
99875|NCT00313170|340584|P3|Overall Study|dosing error|1
99876|NCT00313170|340585|P2|Overall Study|dosing error|0
99877|NCT00313170|340586|P1|Overall Study|dosing error|0
99878|NCT00313170|340584|P3|Overall Study|Clinical progression|0
99879|NCT00313170|340585|P2|Overall Study|Clinical progression|0
99880|NCT00313170|340586|P1|Overall Study|Clinical progression|1
99881|NCT00313170|340584|P3|Overall Study|Lost to Follow-up|1
99882|NCT00313170|340585|P2|Overall Study|Lost to Follow-up|0
99883|NCT00313170|340586|P1|Overall Study|Lost to Follow-up|0
99884|NCT00313170|340584|P3|Overall Study|Incorrect enrollment|1
99885|NCT00313170|340585|P2|Overall Study|Incorrect enrollment|2
99886|NCT00313170|340586|P1|Overall Study|Incorrect enrollment|0
99887|NCT00313170|340584|P3|Overall Study|Withdrawal by Subject|1
99888|NCT00313170|340585|P2|Overall Study|Withdrawal by Subject|1
99889|NCT00313170|340586|P1|Overall Study|Withdrawal by Subject|1
99890|NCT00313170|340584|P3|Overall Study|Disease progression|27
99891|NCT00313170|340585|P2|Overall Study|Disease progression|26
99892|NCT00313170|340586|P1|Overall Study|Disease progression|31
99893|NCT00313170|340584|P3|Overall Study|Adverse Event|0
99894|NCT00313170|340585|P2|Overall Study|Adverse Event|2
99895|NCT00313170|340586|P1|Overall Study|Adverse Event|2
99896|NCT00313170|340584|P3|Overall Study|Death|0
99897|NCT00313170|340585|P2|Overall Study|Death|4
99898|NCT00313170|340586|P1|Overall Study|Death|1
99899|NCT00330174|340630|P2|Overall Study|Miscellaneous reasons|1
99900|NCT00330174|340631|P1|Overall Study|Miscellaneous reasons|7
99901|NCT00330174|340630|P2|Overall Study|Excessive missed visits|8
99902|NCT00330174|340631|P1|Overall Study|Excessive missed visits|3
99903|NCT00330174|340630|P2|Overall Study|Clinical deterioration|2
99904|NCT00330174|340631|P1|Overall Study|Clinical deterioration|1
99905|NCT00330174|340630|P2|Overall Study|Lost to Follow-up|1
99906|NCT00330174|340631|P1|Overall Study|Lost to Follow-up|4
99907|NCT00330174|340630|P2|Overall Study|Withdrawal by Subject|7
99908|NCT00330174|340631|P1|Overall Study|Withdrawal by Subject|7
99909|NCT00330460|340650|P2|Overall Study|Other|0
99910|NCT00330460|340651|P1|Overall Study|Other|1
99911|NCT00330460|340650|P2|Overall Study|Noncompliance|1
99912|NCT00330460|340651|P1|Overall Study|Noncompliance|2
99913|NCT00330460|340650|P2|Overall Study|Lost to Follow-up|3
99914|NCT00330460|340651|P1|Overall Study|Lost to Follow-up|8
99915|NCT00330460|340650|P2|Overall Study|Ineligibility determined|3
99916|NCT00330460|340651|P1|Overall Study|Ineligibility determined|1
99917|NCT00330460|340650|P2|Overall Study|Death|1
99918|NCT00330460|340651|P1|Overall Study|Death|1
99919|NCT00330460|340650|P2|Overall Study|Withdrawal by Subject|17
99920|NCT00330460|340651|P1|Overall Study|Withdrawal by Subject|18
99921|NCT00330460|340650|P2|Overall Study|Adverse Event|8
99922|NCT00330460|340651|P1|Overall Study|Adverse Event|10
99923|NCT00330460|340650|P2|Overall Study|Physician Decision|0
99924|NCT00330460|340651|P1|Overall Study|Physician Decision|1
99925|NCT00330616|340670|P1|Overall Study|Not specified|1
99926|NCT00330616|340670|P1|Overall Study|Withdrawal by Subject|4
99927|NCT00330616|340670|P1|Overall Study|Lost to Follow-up|2
99928|NCT00330616|340670|P1|Overall Study|Lack of Efficacy|1
99929|NCT00330616|340670|P1|Overall Study|Adverse Event|13
99930|NCT00330668|340689|P1|Overall Study|Patient started Lupron|1
99931|NCT00330668|340689|P1|Overall Study|Use of exclusionary medication|1
99932|NCT00330668|340689|P1|Overall Study|Lack of Efficacy|1
99933|NCT00330668|340689|P1|Overall Study|Sponsor's decision|76
99934|NCT00330668|340689|P1|Overall Study|Withdrawal by Subject|20
99935|NCT00330668|340689|P1|Overall Study|Non-Compliance|5
99936|NCT00330668|340689|P1|Overall Study|Lost to Follow-up|9
99937|NCT00330668|340689|P1|Overall Study|Adverse Event|1
99938|NCT00330681|340698|P2|Overall Study|Tracheotomy due to worsening of ALS|2
99939|NCT00330681|340699|P1|Overall Study|Tracheotomy due to worsening of ALS|1
99940|NCT00330681|340698|P2|Overall Study|Withdrawal by Subject|5
99941|NCT00330681|340699|P1|Overall Study|Withdrawal by Subject|5
99942|NCT00330681|340698|P2|Overall Study|Protocol Violation|1
99943|NCT00330681|340699|P1|Overall Study|Protocol Violation|0
99944|NCT00330681|340698|P2|Overall Study|Adverse Event|6
99945|NCT00330681|340699|P1|Overall Study|Adverse Event|3
99946|NCT00330759|340732|P2|Overall Study|Other|44
99947|NCT00330759|340733|P1|Overall Study|Other|36
99948|NCT00330759|340732|P2|Overall Study|Ineligibility determined|1
99949|NCT00330759|340733|P1|Overall Study|Ineligibility determined|2
99950|NCT00330759|340732|P2|Overall Study|Protocol deviation|2
99951|NCT00330759|340733|P1|Overall Study|Protocol deviation|0
99952|NCT00330759|340732|P2|Overall Study|Physician Decision|2
99953|NCT00330759|340733|P1|Overall Study|Physician Decision|1
99954|NCT00330759|340732|P2|Overall Study|Noncompliance|17
99955|NCT00330759|340733|P1|Overall Study|Noncompliance|15
99956|NCT00330759|340732|P2|Overall Study|Lost to Follow-up|22
99957|NCT00330759|340733|P1|Overall Study|Lost to Follow-up|16
99958|NCT00330759|340732|P2|Overall Study|Participant request|22
99959|NCT00330759|340733|P1|Overall Study|Participant request|31
99960|NCT00330759|340732|P2|Overall Study|Adverse Event|36
99961|NCT00330759|340733|P1|Overall Study|Adverse Event|48
99962|NCT00330759|340732|P2|Overall Study|Withdrawal by Subject|124
99963|NCT00330759|340733|P1|Overall Study|Withdrawal by Subject|143
99964|NCT00330759|340732|P2|Overall Study|Disease progression|126
99965|NCT00330759|340733|P1|Overall Study|Disease progression|104
99966|NCT00330759|340732|P2|Overall Study|Death|310
99967|NCT00330759|340733|P1|Overall Study|Death|316
99968|NCT00330928|340759|P1|Overall Study|IVUS could not be performed.|1
99969|NCT00330928|340759|P1|Overall Study|Death|1
99970|NCT00330928|340759|P1|Overall Study|Physician Decision|9
99971|NCT00330928|340759|P1|Overall Study|Lost to Follow-up|6
99972|NCT00330967|340766|P2|Overall Study|Physician Decision|9
99973|NCT00330967|340767|P1|Overall Study|Physician Decision|0
99974|NCT00330967|340766|P2|Overall Study|Withdrawal by Subject|5
99975|NCT00330967|340767|P1|Overall Study|Withdrawal by Subject|0
99976|NCT00331006|340778|P1|Follow-Up Phase II|Lost to Follow-up|3
99977|NCT00331006|340778|P1|Follow-Up Phase I|Lost to Follow-up|1
99978|NCT00331006|340778|P1|Treatment Phase|Withdrawal by Subject|1
99979|NCT00331006|340778|P1|Screening Phase|Ineligible for treatment phase|4
99980|NCT00331006|340778|P1|Screening Phase|Lost to Follow-up|1
99981|NCT00331006|340778|P1|Screening Phase|enrollment halted|1
99982|NCT00331006|340778|P1|Screening Phase|Withdrawal by Subject|1
99983|NCT00331409|340789|P1|Overall Study|Lack of Efficacy|4
99984|NCT00331422|340796|P1|Overall Study|Did not receive entire study regimen|5
99985|NCT00331552|340807|P2|Period 3: Phase II|Severe Nausea|0
99986|NCT00331552|340808|P1|Period 3: Phase II|Severe Nausea|1
99987|NCT00331552|340807|P2|Period 3: Phase II|Neurological Symptoms|0
99988|NCT00331552|340808|P1|Period 3: Phase II|Neurological Symptoms|1
99989|NCT00331682|340822|P1|Overall Study|Adverse Event|1
99990|NCT00331760|340830|P2|Overall Study|Ineligible / no protocol treatment|8
99991|NCT00331760|340831|P1|Overall Study|Ineligible / no protocol treatment|15
99992|NCT00331773|340839|P2|Overall Study|Protocol Violation|3
99993|NCT00331773|340840|P1|Overall Study|Protocol Violation|10
99994|NCT00331773|340839|P2|Overall Study|Withdrawal by Subject|4
99995|NCT00331773|340840|P1|Overall Study|Withdrawal by Subject|6
99996|NCT00331799|340866|P1|Overall Study|Sedation|1
99997|NCT00331799|340866|P1|Overall Study|Withdrawal by Subject|2
99998|NCT00331864|340872|P2|Overall Study|Death|0
99999|NCT00331864|340873|P1|Overall Study|Death|6
100000|NCT00331864|340872|P2|Overall Study|Administrative Problems|0
100001|NCT00331864|340873|P1|Overall Study|Administrative Problems|1
100002|NCT00331864|340872|P2|Overall Study|Lost to Follow-up|3
100003|NCT00331864|340873|P1|Overall Study|Lost to Follow-up|4
100004|NCT00331864|340872|P2|Overall Study|Withdrawal by Subject|0
100005|NCT00331864|340873|P1|Overall Study|Withdrawal by Subject|10
100006|NCT00331864|340872|P2|Overall Study|Protocol Violation|0
100007|NCT00331864|340873|P1|Overall Study|Protocol Violation|3
100008|NCT00331864|340872|P2|Overall Study|Lack of Efficacy|0
100009|NCT00331864|340873|P1|Overall Study|Lack of Efficacy|4
100010|NCT00331864|340872|P2|Overall Study|Adverse Event|1
100011|NCT00331864|340873|P1|Overall Study|Adverse Event|30
100012|NCT00332189|340927|P1|Overall Study|Moved out of country|2
100013|NCT00332189|340927|P1|Overall Study|Lack of Efficacy|4
100014|NCT00332189|340927|P1|Overall Study|Withdrawal by Subject|9
100015|NCT00332189|340927|P1|Overall Study|Uncooperative/Noncompliant|3
100016|NCT00332189|340927|P1|Overall Study|Adverse Event|3
100017|NCT00332241|340934|P2|Overall Study|Lost to Follow-up|1
100018|NCT00332241|340935|P1|Overall Study|Lost to Follow-up|4
100019|NCT00332241|340934|P2|Overall Study|Withdrawal by Subject|1
100020|NCT00332241|340935|P1|Overall Study|Withdrawal by Subject|2
100021|NCT00332241|340934|P2|Overall Study|Adverse Event|5
100022|NCT00332241|340935|P1|Overall Study|Adverse Event|3
100023|NCT00332241|340934|P2|Overall Study|Lack of Efficacy|1
100024|NCT00332241|340935|P1|Overall Study|Lack of Efficacy|6
100025|NCT00332332|340955|P1|Overall Study|Did not receive study treatment|16
100026|NCT00332332|340955|P1|Overall Study|Not specified|18
100027|NCT00332332|340955|P1|Overall Study|Disease progression|2
100028|NCT00332332|340955|P1|Overall Study|Noncompliance|2
100029|NCT00332332|340955|P1|Overall Study|Protocol deviation|4
100030|NCT00332332|340955|P1|Overall Study|Lost to Follow-up|3
100031|NCT00332332|340955|P1|Overall Study|Physician Decision|1
100032|NCT00332332|340955|P1|Overall Study|Withdrawal by Subject|8
100033|NCT00332332|340955|P1|Overall Study|Death|1
100034|NCT00332332|340955|P1|Overall Study|Adverse Event|13
100035|NCT00332462|340962|P1|Overall Study|Graft Loss|2
100036|NCT00332462|340962|P1|Overall Study|Death|3
100037|NCT00332462|340962|P1|Overall Study|no longer requires study drug|1
100038|NCT00332462|340962|P1|Overall Study|Unsatisfactory therapeutic effect|4
100039|NCT00332462|340962|P1|Overall Study|Abnormal Lab Value|1
100040|NCT00332462|340962|P1|Overall Study|Adverse Event|5
100041|NCT00332488|340972|P3|Transfer Treatment Phase (Weeks 12 – 24)|Various|5
100042|NCT00332488|340973|P2|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
100043|NCT00332488|340974|P1|Transfer Treatment Phase (Weeks 12 – 24)|Various|0
100044|NCT00332488|340972|P3|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|8
100045|NCT00332488|340973|P2|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
100046|NCT00332488|340974|P1|Transfer Treatment Phase (Weeks 12 – 24)|Withdrawal by Subject|2
100047|NCT00332488|340972|P3|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|1
100048|NCT00332488|340973|P2|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
100049|NCT00332488|340974|P1|Transfer Treatment Phase (Weeks 12 – 24)|Protocol Violation|0
100050|NCT00332488|340972|P3|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|3
100051|NCT00332488|340973|P2|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
100052|NCT00332488|340974|P1|Transfer Treatment Phase (Weeks 12 – 24)|Physician Decision|0
100053|NCT00332488|340972|P3|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|1
100054|NCT00332488|340973|P2|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
100055|NCT00332488|340974|P1|Transfer Treatment Phase (Weeks 12 – 24)|Lost to Follow-up|0
100056|NCT00332488|340972|P3|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|3
100057|NCT00332488|340973|P2|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
100058|NCT00332488|340974|P1|Transfer Treatment Phase (Weeks 12 – 24)|Adverse Event|0
100059|NCT00332488|340972|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
100060|NCT00332488|340973|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
100061|NCT00332488|340974|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
100062|NCT00332488|340972|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
100063|NCT00332488|340973|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
100064|NCT00332488|340974|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
100065|NCT00332488|340972|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
100066|NCT00332488|340973|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
100067|NCT00332488|340974|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
100068|NCT00332488|340972|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
100069|NCT00332488|340973|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
100070|NCT00332488|340974|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
100071|NCT00332488|340972|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
100072|NCT00332488|340973|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
100073|NCT00332488|340974|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
100074|NCT00332488|340972|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
100075|NCT00332488|340973|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
100076|NCT00332488|340974|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
100077|NCT00332696|341035|P2|Overall Study|Withdrawal by Subject|0
100078|NCT00332696|341036|P1|Overall Study|Withdrawal by Subject|1
100079|NCT00332696|341035|P2|Overall Study|Lost to Follow-up|1
100080|NCT00332696|341036|P1|Overall Study|Lost to Follow-up|0
100081|NCT00332696|341035|P2|Overall Study|Condition does not justify treatment|2
100082|NCT00332696|341036|P1|Overall Study|Condition does not justify treatment|0
100083|NCT00332696|341035|P2|Overall Study|Adverse Event|2
100084|NCT00332696|341036|P1|Overall Study|Adverse Event|1
100085|NCT00332696|341035|P2|Overall Study|Insufficient therapeutic effect|11
100086|NCT00332696|341036|P1|Overall Study|Insufficient therapeutic effect|4
100087|NCT00332696|341035|P2|Overall Study|Death|14
100088|NCT00332696|341036|P1|Overall Study|Death|24
100089|NCT00332709|341064|P2|Overall Study|Abnormal test procedure result|0
100090|NCT00332709|341065|P1|Overall Study|Abnormal test procedure result|1
100091|NCT00332709|341064|P2|Overall Study|Administrative Problems|3
100092|NCT00332709|341065|P1|Overall Study|Administrative Problems|0
100093|NCT00332709|341064|P2|Overall Study|Lost to Follow-up|0
100094|NCT00332709|341065|P1|Overall Study|Lost to Follow-up|2
100095|NCT00332709|341064|P2|Overall Study|Withdrawal by Subject|3
100096|NCT00332709|341065|P1|Overall Study|Withdrawal by Subject|2
100097|NCT00332709|341064|P2|Overall Study|Adverse Event|14
100098|NCT00332709|341065|P1|Overall Study|Adverse Event|11
100099|NCT00332839|341100|P2|Follow-up (Months 12 - 60)|Death|1
100100|NCT00332839|341101|P1|Follow-up (Months 12 - 60)|Death|1
100101|NCT00332839|341100|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
100102|NCT00332839|341101|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
100103|NCT00332839|341100|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
100104|NCT00332839|341101|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
100105|NCT00332839|341100|P2|Core (Months 0 - 12)|Adverse Event|15
100106|NCT00332839|341101|P1|Core (Months 0 - 12)|Adverse Event|5
100107|NCT00332839|341100|P2|Core (Months 0 - 12)|Protocol deviation|1
100108|NCT00332839|341101|P1|Core (Months 0 - 12)|Protocol deviation|1
100109|NCT00332839|341100|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
100110|NCT00332839|341101|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
100111|NCT00332839|341100|P2|Core (Months 0 - 12)|Administrative problems|1
100112|NCT00332839|341101|P1|Core (Months 0 - 12)|Administrative problems|1
100113|NCT00316082|341124|P5|Overall Study|Administrative reason by sponsor|0
100114|NCT00316082|341125|P4|Overall Study|Administrative reason by sponsor|0
100115|NCT00316082|341126|P3|Overall Study|Administrative reason by sponsor|1
100116|NCT00316082|341127|P2|Overall Study|Administrative reason by sponsor|0
100117|NCT00316082|341128|P1|Overall Study|Administrative reason by sponsor|0
100118|NCT00316082|341124|P5|Overall Study|Death|0
100119|NCT00316082|341125|P4|Overall Study|Death|0
100120|NCT00316082|341126|P3|Overall Study|Death|1
100121|NCT00316082|341127|P2|Overall Study|Death|0
100122|NCT00316082|341128|P1|Overall Study|Death|0
100123|NCT00316082|341124|P5|Overall Study|Physician Decision|1
100124|NCT00316082|341125|P4|Overall Study|Physician Decision|1
100125|NCT00316082|341126|P3|Overall Study|Physician Decision|2
100126|NCT00316082|341127|P2|Overall Study|Physician Decision|1
100127|NCT00316082|341128|P1|Overall Study|Physician Decision|1
100128|NCT00316082|341124|P5|Overall Study|Subject no longer meets study criteria|1
100129|NCT00316082|341125|P4|Overall Study|Subject no longer meets study criteria|2
100130|NCT00316082|341126|P3|Overall Study|Subject no longer meets study criteria|2
100131|NCT00316082|341127|P2|Overall Study|Subject no longer meets study criteria|1
100132|NCT00316082|341128|P1|Overall Study|Subject no longer meets study criteria|3
100133|NCT00316082|341124|P5|Overall Study|Adverse Event|3
100134|NCT00316082|341125|P4|Overall Study|Adverse Event|1
100135|NCT00316082|341126|P3|Overall Study|Adverse Event|5
100136|NCT00316082|341127|P2|Overall Study|Adverse Event|2
100137|NCT00316082|341128|P1|Overall Study|Adverse Event|4
100138|NCT00316082|341124|P5|Overall Study|Poor/noncompliance|4
100139|NCT00316082|341125|P4|Overall Study|Poor/noncompliance|1
100140|NCT00316082|341126|P3|Overall Study|Poor/noncompliance|4
100141|NCT00316082|341127|P2|Overall Study|Poor/noncompliance|1
100142|NCT00316082|341128|P1|Overall Study|Poor/noncompliance|6
100143|NCT00316082|341124|P5|Overall Study|Lost to Follow-up|6
100144|NCT00316082|341125|P4|Overall Study|Lost to Follow-up|8
100145|NCT00316082|341126|P3|Overall Study|Lost to Follow-up|7
100146|NCT00316082|341127|P2|Overall Study|Lost to Follow-up|6
100147|NCT00316082|341128|P1|Overall Study|Lost to Follow-up|7
100148|NCT00316082|341124|P5|Overall Study|Withdrawal of Consent by Subject|5
100149|NCT00316082|341125|P4|Overall Study|Withdrawal of Consent by Subject|9
100150|NCT00316082|341126|P3|Overall Study|Withdrawal of Consent by Subject|2
100151|NCT00316082|341127|P2|Overall Study|Withdrawal of Consent by Subject|8
100152|NCT00316082|341128|P1|Overall Study|Withdrawal of Consent by Subject|10
100153|NCT00316082|341124|P5|Overall Study|Lack of Efficacy|6
100154|NCT00316082|341125|P4|Overall Study|Lack of Efficacy|4
100155|NCT00316082|341126|P3|Overall Study|Lack of Efficacy|3
100156|NCT00316082|341127|P2|Overall Study|Lack of Efficacy|3
100157|NCT00316082|341128|P1|Overall Study|Lack of Efficacy|2
100158|NCT00316121|341158|P2|Overall Study|Subject did not have 24 month visit|0
100159|NCT00316121|341159|P1|Overall Study|Subject did not have 24 month visit|1
100160|NCT00316121|341158|P2|Overall Study|Subject no show for visit x 3|0
100161|NCT00316121|341159|P1|Overall Study|Subject no show for visit x 3|1
100162|NCT00316121|341158|P2|Overall Study|Subject refused to return|0
100163|NCT00316121|341159|P1|Overall Study|Subject refused to return|1
100164|NCT00316121|341158|P2|Overall Study|Subject relocated|1
100165|NCT00316121|341159|P1|Overall Study|Subject relocated|1
100166|NCT00316121|341158|P2|Overall Study|Reason is missing|0
100167|NCT00316121|341159|P1|Overall Study|Reason is missing|1
100168|NCT00316121|341158|P2|Overall Study|Withdrawal by Subject|0
100169|NCT00316121|341159|P1|Overall Study|Withdrawal by Subject|2
100170|NCT00316121|341158|P2|Overall Study|Lost to Follow-up|8
100171|NCT00316121|341159|P1|Overall Study|Lost to Follow-up|14
100172|NCT00316121|341158|P2|Overall Study|Death|0
100173|NCT00316121|341159|P1|Overall Study|Death|1
100174|NCT00316173|341167|P2|Treatment Phase|Study Follow-up Stopped|34
100175|NCT00316173|341168|P1|Treatment Phase|Study Follow-up Stopped|0
100176|NCT00316173|341167|P2|Treatment Phase|Withdrawal by Subject|1
100177|NCT00316173|341168|P1|Treatment Phase|Withdrawal by Subject|0
100178|NCT00316173|341167|P2|Treatment Phase|Lost to Follow-up|3
100179|NCT00316173|341168|P1|Treatment Phase|Lost to Follow-up|0
100180|NCT00316173|341167|P2|Treatment Phase|Lack of Efficacy|3
100181|NCT00316173|341168|P1|Treatment Phase|Lack of Efficacy|0
100182|NCT00316173|341167|P2|Treatment Phase|Adverse Event|1
100183|NCT00316173|341168|P1|Treatment Phase|Adverse Event|0
100184|NCT00316173|341167|P2|Run-in Phase|Study Follow-up Stopped|0
100185|NCT00316173|341168|P1|Run-in Phase|Study Follow-up Stopped|5
100186|NCT00316173|341167|P2|Run-in Phase|Protocol Violation|0
100187|NCT00316173|341168|P1|Run-in Phase|Protocol Violation|1
100188|NCT00316173|341167|P2|Run-in Phase|Adverse Event|0
100189|NCT00316173|341168|P1|Run-in Phase|Adverse Event|1
100190|NCT00316186|341179|P1|Overall Study|Other|1
100191|NCT00316186|341179|P1|Overall Study|Lost to Follow-up|1
100192|NCT00316186|341179|P1|Overall Study|Disease Progression|4
100193|NCT00316186|341179|P1|Overall Study|Adverse Event|6
100194|NCT00316199|341191|P1|Overall Study|Lost to Follow-up|2
100195|NCT00316199|341191|P1|Overall Study|Death|8
100196|NCT00316199|341191|P1|Overall Study|Adverse Event|2
100197|NCT00316225|341199|P1|Overall Study|Death|2
100198|NCT00316225|341199|P1|Overall Study|Withdrawal by Subject|3
100199|NCT00316225|341199|P1|Overall Study|Progressive Disease|15
100200|NCT00316225|341199|P1|Overall Study|Physician Decision|3
100201|NCT00316225|341199|P1|Overall Study|Adverse Event|2
100202|NCT00316264|341211|P3|Overall Study|not specified|0
100203|NCT00316264|341212|P2|Overall Study|not specified|1
100204|NCT00316264|341213|P1|Overall Study|not specified|1
100205|NCT00316264|341211|P3|Overall Study|Death|0
100206|NCT00316264|341212|P2|Overall Study|Death|0
100207|NCT00316264|341213|P1|Overall Study|Death|2
100208|NCT00316264|341211|P3|Overall Study|Withdrawal of Consent|6
100209|NCT00316264|341212|P2|Overall Study|Withdrawal of Consent|5
100210|NCT00316264|341213|P1|Overall Study|Withdrawal of Consent|3
100211|NCT00316264|341211|P3|Overall Study|Lost to Follow-up|0
100212|NCT00316264|341212|P2|Overall Study|Lost to Follow-up|1
100213|NCT00316264|341213|P1|Overall Study|Lost to Follow-up|0
100214|NCT00316277|341283|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
100215|NCT00316277|341284|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
100216|NCT00316277|341283|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
100217|NCT00316277|341284|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
100218|NCT00316277|341283|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
100219|NCT00316277|341284|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
100220|NCT00316277|341283|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
100221|NCT00316277|341284|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
100222|NCT00316277|341283|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
100223|NCT00316277|341284|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
100224|NCT00321646|341302|P1|Neoadjuvant Chemotherapy|Disease progression|1
100225|NCT00321646|341302|P1|Neoadjuvant Chemotherapy|Adverse Event|2
100226|NCT00321646|341302|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
100227|NCT00321672|341311|P4|Overall Study|Extensive travel required for new job|0
100228|NCT00321672|341312|P3|Overall Study|Extensive travel required for new job|0
100229|NCT00321672|341313|P2|Overall Study|Extensive travel required for new job|1
100230|NCT00321672|341314|P1|Overall Study|Extensive travel required for new job|0
100231|NCT00321672|341311|P4|Overall Study|Diagnosis of testicular cancer|0
100232|NCT00321672|341312|P3|Overall Study|Diagnosis of testicular cancer|0
100233|NCT00321672|341313|P2|Overall Study|Diagnosis of testicular cancer|1
100234|NCT00321672|341314|P1|Overall Study|Diagnosis of testicular cancer|0
100235|NCT00321672|341311|P4|Overall Study|Protocol Violation|0
100236|NCT00321672|341312|P3|Overall Study|Protocol Violation|1
100237|NCT00321672|341313|P2|Overall Study|Protocol Violation|0
100238|NCT00321672|341314|P1|Overall Study|Protocol Violation|0
100239|NCT00321672|341311|P4|Overall Study|Moved out of state|0
100240|NCT00321672|341312|P3|Overall Study|Moved out of state|1
100241|NCT00321672|341313|P2|Overall Study|Moved out of state|1
100242|NCT00321672|341314|P1|Overall Study|Moved out of state|0
100243|NCT00321672|341311|P4|Overall Study|Incarcerated|0
100244|NCT00321672|341312|P3|Overall Study|Incarcerated|2
100245|NCT00321672|341313|P2|Overall Study|Incarcerated|0
100246|NCT00321672|341314|P1|Overall Study|Incarcerated|0
100247|NCT00321672|341311|P4|Overall Study|Too far to travel for visits|0
100248|NCT00321672|341312|P3|Overall Study|Too far to travel for visits|0
100249|NCT00321672|341313|P2|Overall Study|Too far to travel for visits|0
100250|NCT00321672|341314|P1|Overall Study|Too far to travel for visits|1
100251|NCT00321672|341311|P4|Overall Study|Death|0
100252|NCT00321672|341312|P3|Overall Study|Death|0
100253|NCT00321672|341313|P2|Overall Study|Death|0
100254|NCT00321672|341314|P1|Overall Study|Death|1
100255|NCT00321672|341311|P4|Overall Study|Lost to Follow-up|2
100256|NCT00321672|341312|P3|Overall Study|Lost to Follow-up|4
100257|NCT00321672|341313|P2|Overall Study|Lost to Follow-up|0
100258|NCT00321672|341314|P1|Overall Study|Lost to Follow-up|2
100259|NCT00321672|341311|P4|Overall Study|Lack of Efficacy|0
100260|NCT00321672|341312|P3|Overall Study|Lack of Efficacy|0
100261|NCT00321672|341313|P2|Overall Study|Lack of Efficacy|1
100262|NCT00321672|341314|P1|Overall Study|Lack of Efficacy|1
100263|NCT00321672|341311|P4|Overall Study|Adverse Event|0
100264|NCT00321672|341312|P3|Overall Study|Adverse Event|0
100265|NCT00321672|341313|P2|Overall Study|Adverse Event|1
100266|NCT00321672|341314|P1|Overall Study|Adverse Event|1
100267|NCT00321672|341311|P4|Overall Study|Noncompliance|0
100268|NCT00321672|341312|P3|Overall Study|Noncompliance|1
100269|NCT00321672|341313|P2|Overall Study|Noncompliance|2
100270|NCT00321672|341314|P1|Overall Study|Noncompliance|1
100271|NCT00321672|341311|P4|Overall Study|Withdrawal by Subject|0
100272|NCT00321672|341312|P3|Overall Study|Withdrawal by Subject|2
100273|NCT00321672|341313|P2|Overall Study|Withdrawal by Subject|1
100274|NCT00321672|341314|P1|Overall Study|Withdrawal by Subject|5
100275|NCT00321685|341340|P1|Overall Study|Ineligible|2
100276|NCT00321685|341340|P1|Overall Study|Not start protocol therapy|2
100277|NCT00321685|341340|P1|Overall Study|Other|5
100278|NCT00321685|341340|P1|Overall Study|Complicating disese|1
100279|NCT00321685|341340|P1|Overall Study|Alternative therapy|1
100280|NCT00321685|341340|P1|Overall Study|Withdrawal by Subject|8
100281|NCT00321685|341340|P1|Overall Study|Death|2
100282|NCT00321685|341340|P1|Overall Study|Adverse Event|18
100283|NCT00321711|341376|P5|Part B|Death|1
100284|NCT00321711|341377|P4|Part B|Death|2
100285|NCT00321711|341378|P3|Part B|Death|0
100286|NCT00321711|341379|P2|Part B|Death|0
100287|NCT00321711|341380|P1|Part B|Death|0
100288|NCT00321711|341376|P5|Part B|Physician Decision|2
100289|NCT00321711|341377|P4|Part B|Physician Decision|1
100290|NCT00321711|341378|P3|Part B|Physician Decision|0
100291|NCT00321711|341379|P2|Part B|Physician Decision|0
100292|NCT00321711|341380|P1|Part B|Physician Decision|0
100293|NCT00321711|341376|P5|Part B|Disease progression|0
100294|NCT00321711|341377|P4|Part B|Disease progression|1
100295|NCT00321711|341378|P3|Part B|Disease progression|0
100296|NCT00321711|341379|P2|Part B|Disease progression|0
100297|NCT00321711|341380|P1|Part B|Disease progression|0
100298|NCT00321711|341376|P5|Part B|Adverse Event|1
100299|NCT00321711|341377|P4|Part B|Adverse Event|2
100300|NCT00321711|341378|P3|Part B|Adverse Event|0
100301|NCT00321711|341379|P2|Part B|Adverse Event|0
100302|NCT00321711|341380|P1|Part B|Adverse Event|0
100303|NCT00321711|341376|P5|Part B|Noncompliance|1
100304|NCT00321711|341377|P4|Part B|Noncompliance|0
100305|NCT00321711|341378|P3|Part B|Noncompliance|0
100306|NCT00321711|341379|P2|Part B|Noncompliance|0
100307|NCT00321711|341380|P1|Part B|Noncompliance|0
100308|NCT00321711|341376|P5|Part A|Protocol deviation|0
100309|NCT00321711|341377|P4|Part A|Protocol deviation|0
100310|NCT00321711|341378|P3|Part A|Protocol deviation|1
100311|NCT00321711|341379|P2|Part A|Protocol deviation|0
100312|NCT00321711|341380|P1|Part A|Protocol deviation|0
100313|NCT00321711|341376|P5|Part A|Other|0
100314|NCT00321711|341377|P4|Part A|Other|0
100315|NCT00321711|341378|P3|Part A|Other|3
100316|NCT00321711|341379|P2|Part A|Other|2
100317|NCT00321711|341380|P1|Part A|Other|1
100318|NCT00321711|341376|P5|Part A|Physician Decision|0
100319|NCT00321711|341377|P4|Part A|Physician Decision|0
100320|NCT00321711|341378|P3|Part A|Physician Decision|3
100321|NCT00321711|341379|P2|Part A|Physician Decision|1
100322|NCT00321711|341380|P1|Part A|Physician Decision|0
100323|NCT00321711|341376|P5|Part A|Requirement for alternative therapy|0
100324|NCT00321711|341377|P4|Part A|Requirement for alternative therapy|0
100325|NCT00321711|341378|P3|Part A|Requirement for alternative therapy|1
100326|NCT00321711|341379|P2|Part A|Requirement for alternative therapy|2
100327|NCT00321711|341380|P1|Part A|Requirement for alternative therapy|0
100328|NCT00321711|341376|P5|Part A|Disease progression|0
100329|NCT00321711|341377|P4|Part A|Disease progression|0
100330|NCT00321711|341378|P3|Part A|Disease progression|0
100331|NCT00321711|341379|P2|Part A|Disease progression|1
100332|NCT00321711|341380|P1|Part A|Disease progression|0
100333|NCT00321711|341376|P5|Part A|Withdrawal by Subject|0
100334|NCT00321711|341377|P4|Part A|Withdrawal by Subject|0
100335|NCT00321711|341378|P3|Part A|Withdrawal by Subject|1
100336|NCT00321711|341379|P2|Part A|Withdrawal by Subject|1
100337|NCT00321711|341380|P1|Part A|Withdrawal by Subject|1
100338|NCT00321711|341376|P5|Part A|Adverse Event|0
100339|NCT00321711|341377|P4|Part A|Adverse Event|0
100340|NCT00321711|341378|P3|Part A|Adverse Event|2
100341|NCT00321711|341379|P2|Part A|Adverse Event|3
100342|NCT00321711|341380|P1|Part A|Adverse Event|3
100343|NCT00321737|341410|P3|Overall Study|Subject Request/ Subject Unavailable|2
100344|NCT00321737|341411|P2|Overall Study|Subject Request/ Subject Unavailable|0
100345|NCT00321737|341412|P1|Overall Study|Subject Request/ Subject Unavailable|0
100346|NCT00321737|341410|P3|Overall Study|Noncompliance|0
100347|NCT00321737|341411|P2|Overall Study|Noncompliance|0
100348|NCT00321737|341412|P1|Overall Study|Noncompliance|2
100349|NCT00321737|341410|P3|Overall Study|Pregnancy|0
100350|NCT00321737|341411|P2|Overall Study|Pregnancy|2
100351|NCT00321737|341412|P1|Overall Study|Pregnancy|0
100352|NCT00321737|341410|P3|Overall Study|Therapeutic Failure|2
100353|NCT00321737|341411|P2|Overall Study|Therapeutic Failure|0
100354|NCT00321737|341412|P1|Overall Study|Therapeutic Failure|6
100355|NCT00321737|341410|P3|Overall Study|Possible Barrett's Esophagus|1
100356|NCT00321737|341411|P2|Overall Study|Possible Barrett's Esophagus|1
100357|NCT00321737|341412|P1|Overall Study|Possible Barrett's Esophagus|2
100358|NCT00321737|341410|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
100359|NCT00321737|341411|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
100360|NCT00321737|341412|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
100361|NCT00321737|341410|P3|Overall Study|Protocol Violation|1
100362|NCT00321737|341411|P2|Overall Study|Protocol Violation|0
100363|NCT00321737|341412|P1|Overall Study|Protocol Violation|0
100364|NCT00321737|341410|P3|Overall Study|Withdrawal by Subject|17
100365|NCT00321737|341411|P2|Overall Study|Withdrawal by Subject|12
100366|NCT00321737|341412|P1|Overall Study|Withdrawal by Subject|19
100367|NCT00321737|341410|P3|Overall Study|Lost to Follow-up|6
100368|NCT00321737|341411|P2|Overall Study|Lost to Follow-up|5
100369|NCT00321737|341412|P1|Overall Study|Lost to Follow-up|5
100370|NCT00321737|341410|P3|Overall Study|Adverse Event|6
100371|NCT00321737|341411|P2|Overall Study|Adverse Event|3
100372|NCT00321737|341412|P1|Overall Study|Adverse Event|11
100373|NCT00321737|341410|P3|Overall Study|Relapse of Erosive Esophagitis|19
100374|NCT00321737|341411|P2|Overall Study|Relapse of Erosive Esophagitis|25
100375|NCT00321737|341412|P1|Overall Study|Relapse of Erosive Esophagitis|76
100376|NCT00321763|341439|P4|Overall Study|Lost to Follow-up|4
100377|NCT00321763|341440|P3|Overall Study|Lost to Follow-up|5
100378|NCT00321763|341441|P2|Overall Study|Lost to Follow-up|1
100379|NCT00321763|341442|P1|Overall Study|Lost to Follow-up|3
100380|NCT00321763|341439|P4|Overall Study|Withdrawal by Subject|0
100381|NCT00321763|341440|P3|Overall Study|Withdrawal by Subject|1
100382|NCT00321763|341441|P2|Overall Study|Withdrawal by Subject|0
100383|NCT00321763|341442|P1|Overall Study|Withdrawal by Subject|2
100384|NCT00321763|341439|P4|Overall Study|Adverse Event|1
100385|NCT00321763|341440|P3|Overall Study|Adverse Event|0
100386|NCT00321763|341441|P2|Overall Study|Adverse Event|1
100387|NCT00321763|341442|P1|Overall Study|Adverse Event|1
100388|NCT00321789|341501|P2|Overall Study|Protocol Violation|3
100389|NCT00321789|341502|P1|Overall Study|Protocol Violation|5
100390|NCT00321789|341501|P2|Overall Study|Withdrawal by Subject|6
100391|NCT00321789|341502|P1|Overall Study|Withdrawal by Subject|6
100392|NCT00321789|341501|P2|Overall Study|Lost to Follow-up|7
100393|NCT00321789|341502|P1|Overall Study|Lost to Follow-up|4
100394|NCT00321828|341530|P1|Overall Study|No follow up data|1
100395|NCT00321828|341530|P1|Overall Study|Ineligible|3
100396|NCT00321854|341536|P2|Overall Study|Other|1
100397|NCT00321854|341537|P1|Overall Study|Other|1
100398|NCT00321854|341536|P2|Overall Study|Withdrawal by Subject|17
100399|NCT00321854|341537|P1|Overall Study|Withdrawal by Subject|6
100400|NCT00321854|341536|P2|Overall Study|Lost to Follow-up|2
100401|NCT00321854|341537|P1|Overall Study|Lost to Follow-up|0
100402|NCT00321854|341536|P2|Overall Study|Protocol Violation|5
100403|NCT00321854|341537|P1|Overall Study|Protocol Violation|6
100404|NCT00321854|341536|P2|Overall Study|Lack of Efficacy|14
100405|NCT00321854|341537|P1|Overall Study|Lack of Efficacy|9
100406|NCT00321854|341536|P2|Overall Study|Adverse Event|43
100407|NCT00321854|341537|P1|Overall Study|Adverse Event|41
100408|NCT00321893|341657|P2|Overall Study|Adverse Event|3
100409|NCT00321893|341658|P1|Overall Study|Adverse Event|6
100410|NCT00321893|341657|P2|Overall Study|Lost to Follow-up|1
100411|NCT00321893|341658|P1|Overall Study|Lost to Follow-up|2
100412|NCT00321893|341657|P2|Overall Study|Non-Compliance/Refusal|10
100413|NCT00321893|341658|P1|Overall Study|Non-Compliance/Refusal|16
100414|NCT00321906|341672|P2|Overall Study|Withdrawal by Subject|4
100415|NCT00321906|341673|P1|Overall Study|Withdrawal by Subject|0
100416|NCT00321906|341672|P2|Overall Study|Lost to Follow-up|2
100417|NCT00321906|341673|P1|Overall Study|Lost to Follow-up|1
100418|NCT00321906|341672|P2|Overall Study|Death|6
100419|NCT00321906|341673|P1|Overall Study|Death|9
100420|NCT00321906|341672|P2|Overall Study|Adverse Event|44
100421|NCT00321906|341673|P1|Overall Study|Adverse Event|36
100422|NCT00321919|341695|P2|Overall Study|Other withdrawal reason|6
100423|NCT00321919|341696|P1|Overall Study|Other withdrawal reason|7
100424|NCT00321919|341695|P2|Overall Study|Failure to Return|1
100425|NCT00321919|341696|P1|Overall Study|Failure to Return|3
100426|NCT00321919|341695|P2|Overall Study|Other Protocol Violation|3
100427|NCT00321919|341696|P1|Overall Study|Other Protocol Violation|2
100428|NCT00321919|341695|P2|Overall Study|Refused Treatment|14
100429|NCT00321919|341696|P1|Overall Study|Refused Treatment|23
100430|NCT00321919|341695|P2|Overall Study|Violation of Selection Criteria at Entry|1
100431|NCT00321919|341696|P1|Overall Study|Violation of Selection Criteria at Entry|1
100432|NCT00321919|341695|P2|Overall Study|Insufficient Therapeutic Response|0
100433|NCT00321919|341696|P1|Overall Study|Insufficient Therapeutic Response|1
100434|NCT00321919|341695|P2|Overall Study|Death|17
100435|NCT00321919|341696|P1|Overall Study|Death|21
100436|NCT00321919|341695|P2|Overall Study|Adverse Event|10
100437|NCT00321919|341696|P1|Overall Study|Adverse Event|17
100438|NCT00321932|341738|P2|Overall Study|Missing data|1
100439|NCT00321932|341739|P1|Overall Study|Missing data|2
100440|NCT00321932|341738|P2|Overall Study|Early relapse|8
100441|NCT00321932|341739|P1|Overall Study|Early relapse|2
100442|NCT00321932|341738|P2|Overall Study|Withdrawal by Subject|6
100443|NCT00321932|341739|P1|Overall Study|Withdrawal by Subject|3
100444|NCT00321932|341738|P2|Overall Study|Death|6
100445|NCT00321932|341739|P1|Overall Study|Death|3
100446|NCT00321984|341764|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
100447|NCT00321984|341765|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
100448|NCT00321984|341766|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
100449|NCT00321984|341764|P3|Overall Study|Per Investigator Request|0
100450|NCT00321984|341765|P2|Overall Study|Per Investigator Request|0
100451|NCT00321984|341766|P1|Overall Study|Per Investigator Request|1
100452|NCT00321984|341764|P3|Overall Study|Per Subject Request|0
100453|NCT00321984|341765|P2|Overall Study|Per Subject Request|0
100454|NCT00321984|341766|P1|Overall Study|Per Subject Request|1
100455|NCT00321984|341764|P3|Overall Study|Pregnancy|0
100456|NCT00321984|341765|P2|Overall Study|Pregnancy|1
100457|NCT00321984|341766|P1|Overall Study|Pregnancy|0
100458|NCT00321984|341764|P3|Overall Study|Noncompliant|2
100459|NCT00321984|341765|P2|Overall Study|Noncompliant|0
100460|NCT00321984|341766|P1|Overall Study|Noncompliant|0
100461|NCT00321984|341764|P3|Overall Study|Lack of Efficacy|3
100462|NCT00321984|341765|P2|Overall Study|Lack of Efficacy|1
100463|NCT00321984|341766|P1|Overall Study|Lack of Efficacy|3
100464|NCT00321984|341764|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
100465|NCT00321984|341765|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
100466|NCT00321984|341766|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
100467|NCT00321984|341764|P3|Overall Study|Withdrawal by Subject|5
100468|NCT00321984|341765|P2|Overall Study|Withdrawal by Subject|6
100469|NCT00321984|341766|P1|Overall Study|Withdrawal by Subject|8
100470|NCT00321984|341764|P3|Overall Study|Lost to Follow-up|2
100471|NCT00321984|341765|P2|Overall Study|Lost to Follow-up|4
100472|NCT00321984|341766|P1|Overall Study|Lost to Follow-up|2
100473|NCT00321984|341764|P3|Overall Study|Protocol Violation|1
100474|NCT00321984|341765|P2|Overall Study|Protocol Violation|1
100475|NCT00321984|341766|P1|Overall Study|Protocol Violation|0
100476|NCT00321984|341764|P3|Overall Study|Adverse Event|8
100477|NCT00321984|341765|P2|Overall Study|Adverse Event|6
100478|NCT00321984|341766|P1|Overall Study|Adverse Event|9
100479|NCT00322049|341787|P4|Overall Study|Infected with Dengue during study|0
100480|NCT00322049|341788|P3|Overall Study|Infected with Dengue during study|0
100481|NCT00322049|341789|P2|Overall Study|Infected with Dengue during study|1
100482|NCT00322049|341790|P1|Overall Study|Infected with Dengue during study|0
100483|NCT00322049|341787|P4|Overall Study|Moved out of area|1
100484|NCT00322049|341788|P3|Overall Study|Moved out of area|0
100485|NCT00322049|341789|P2|Overall Study|Moved out of area|0
100486|NCT00322049|341790|P1|Overall Study|Moved out of area|0
100487|NCT00322153|341841|P2|Overall Study|Withdrawn for other reasons|4
100488|NCT00322153|341842|P1|Overall Study|Withdrawn for other reasons|5
100489|NCT00322153|341841|P2|Overall Study|Lost to Follow-up|4
100490|NCT00322153|341842|P1|Overall Study|Lost to Follow-up|5
100491|NCT00322153|341841|P2|Overall Study|Lack of Efficacy|3
100492|NCT00322153|341842|P1|Overall Study|Lack of Efficacy|8
100493|NCT00322153|341841|P2|Overall Study|Withdrawal by Subject|10
100494|NCT00322153|341842|P1|Overall Study|Withdrawal by Subject|18
100495|NCT00322153|341841|P2|Overall Study|Protocol Violation|14
100496|NCT00322153|341842|P1|Overall Study|Protocol Violation|6
100497|NCT00322153|341841|P2|Overall Study|Adverse Event|34
100498|NCT00322153|341842|P1|Overall Study|Adverse Event|21
100499|NCT00322348|341927|P2|Overall Study|Reasons not specified|1
100500|NCT00322348|341928|P1|Overall Study|Reasons not specified|5
100501|NCT00322348|341927|P2|Overall Study|Disease Progression|25
100502|NCT00322348|341928|P1|Overall Study|Disease Progression|30
100503|NCT00322348|341927|P2|Overall Study|Death|2
100504|NCT00322348|341928|P1|Overall Study|Death|0
100505|NCT00322348|341927|P2|Overall Study|Lost to Follow-up|0
100506|NCT00322348|341928|P1|Overall Study|Lost to Follow-up|1
100507|NCT00322348|341927|P2|Overall Study|Withdrawal by Subject|4
100508|NCT00322348|341928|P1|Overall Study|Withdrawal by Subject|1
100509|NCT00322348|341927|P2|Overall Study|Adverse Event|1
100510|NCT00322348|341928|P1|Overall Study|Adverse Event|0
100511|NCT00322374|341947|P4|Second Escalation|Study Drug Toxicity|0
100512|NCT00322374|341948|P3|Second Escalation|Study Drug Toxicity|1
100513|NCT00322374|341949|P2|Second Escalation|Study Drug Toxicity|0
100514|NCT00322374|341950|P1|Second Escalation|Study Drug Toxicity|0
100515|NCT00322374|341947|P4|Second Escalation|Physician Decision|0
100516|NCT00322374|341948|P3|Second Escalation|Physician Decision|5
100517|NCT00322374|341949|P2|Second Escalation|Physician Decision|0
100518|NCT00322374|341950|P1|Second Escalation|Physician Decision|0
100519|NCT00322374|341947|P4|First Escalation|Participant Request|0
100520|NCT00322374|341948|P3|First Escalation|Participant Request|0
100521|NCT00322374|341949|P2|First Escalation|Participant Request|1
100522|NCT00322374|341950|P1|First Escalation|Participant Request|0
100523|NCT00322374|341947|P4|First Escalation|Study Drug Toxicity|0
100524|NCT00322374|341948|P3|First Escalation|Study Drug Toxicity|0
100525|NCT00322374|341949|P2|First Escalation|Study Drug Toxicity|11
100526|NCT00322374|341950|P1|First Escalation|Study Drug Toxicity|0
100527|NCT00322374|341947|P4|First Escalation|Physician Decision|0
100528|NCT00322374|341948|P3|First Escalation|Physician Decision|0
100529|NCT00322374|341949|P2|First Escalation|Physician Decision|12
100530|NCT00322374|341950|P1|First Escalation|Physician Decision|0
100531|NCT00322374|341947|P4|First Escalation|Documented Disease Progression|0
100532|NCT00322374|341948|P3|First Escalation|Documented Disease Progression|0
100533|NCT00322374|341949|P2|First Escalation|Documented Disease Progression|6
100534|NCT00322374|341950|P1|First Escalation|Documented Disease Progression|0
100535|NCT00322374|341947|P4|Starting Dose|Study Drug Toxicity|0
100536|NCT00322374|341948|P3|Starting Dose|Study Drug Toxicity|0
100537|NCT00322374|341949|P2|Starting Dose|Study Drug Toxicity|0
100538|NCT00322374|341950|P1|Starting Dose|Study Drug Toxicity|4
100539|NCT00322374|341947|P4|Starting Dose|Physician Decision|0
100540|NCT00322374|341948|P3|Starting Dose|Physician Decision|0
100541|NCT00322374|341949|P2|Starting Dose|Physician Decision|0
100542|NCT00322374|341950|P1|Starting Dose|Physician Decision|2
100543|NCT00322387|342000|P2|Follow-up Period|Death|0
100544|NCT00322387|342001|P1|Follow-up Period|Death|1
100545|NCT00322387|342000|P2|Follow-up Period|Final assessment not done|3
100546|NCT00322387|342001|P1|Follow-up Period|Final assessment not done|1
100547|NCT00322387|342000|P2|Treatment Period|Adverse Event|1
100548|NCT00322387|342001|P1|Treatment Period|Adverse Event|0
100549|NCT00322452|342047|P2|Overall Study|Death|227
100550|NCT00322452|342048|P1|Overall Study|Death|223
100551|NCT00322452|342047|P2|Overall Study|Withdrawal by Subject|46
100552|NCT00322452|342048|P1|Overall Study|Withdrawal by Subject|19
100553|NCT00322452|342047|P2|Overall Study|Lost to Follow-up|2
100554|NCT00322452|342048|P1|Overall Study|Lost to Follow-up|5
100555|NCT00322452|342047|P2|Overall Study|Eligibility criteria not fulfilled|1
100556|NCT00322452|342048|P1|Overall Study|Eligibility criteria not fulfilled|0
100557|NCT00322491|342152|P2|Overall Study|Death|2
100558|NCT00322491|342153|P1|Overall Study|Death|1
100559|NCT00322491|342152|P2|Overall Study|Adverse Event|0
100560|NCT00322491|342153|P1|Overall Study|Adverse Event|1
100561|NCT00322556|342175|P1|Overall Study|Other Reason|7
100562|NCT00322556|342175|P1|Overall Study|Lost to Follow-up|3
100563|NCT00322556|342175|P1|Overall Study|Withdrawal by Subject|1
100564|NCT00322556|342175|P1|Overall Study|Adverse Event|1
100565|NCT00322621|342189|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
100566|NCT00322621|342190|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
100567|NCT00322621|342191|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
100568|NCT00322621|342189|P3|Period III - Maintenance / Rescue Phase|Death|0
100569|NCT00322621|342190|P2|Period III - Maintenance / Rescue Phase|Death|1
100570|NCT00322621|342191|P1|Period III - Maintenance / Rescue Phase|Death|0
100571|NCT00322621|342189|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
100572|NCT00322621|342190|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
100573|NCT00322621|342191|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
100574|NCT00322621|342189|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
100575|NCT00322621|342190|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
100576|NCT00322621|342191|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
100577|NCT00322621|342189|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
100578|NCT00322621|342190|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
100579|NCT00322621|342191|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
100580|NCT00322621|342189|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
100581|NCT00322621|342190|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
100582|NCT00322621|342191|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
100583|NCT00322621|342189|P3|Period II - Acute Therapy Phase|Physician Decision|0
100584|NCT00322621|342190|P2|Period II - Acute Therapy Phase|Physician Decision|0
100585|NCT00322621|342191|P1|Period II - Acute Therapy Phase|Physician Decision|1
100586|NCT00322621|342189|P3|Period II - Acute Therapy Phase|Protocol Violation|0
100587|NCT00322621|342190|P2|Period II - Acute Therapy Phase|Protocol Violation|0
100588|NCT00322621|342191|P1|Period II - Acute Therapy Phase|Protocol Violation|2
100589|NCT00322621|342189|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
100590|NCT00322621|342190|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
100591|NCT00322621|342191|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
100592|NCT00322621|342189|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
100593|NCT00322621|342190|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
100594|NCT00322621|342191|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
100595|NCT00322621|342189|P3|Period II - Acute Therapy Phase|Adverse Event|0
100596|NCT00322621|342190|P2|Period II - Acute Therapy Phase|Adverse Event|0
100597|NCT00322621|342191|P1|Period II - Acute Therapy Phase|Adverse Event|20
100598|NCT00322712|342243|P1|Overall Study|treated with bevacizumab not cetuximab|1
100599|NCT00322842|342262|P2|Overall Study|Death|0
100600|NCT00322842|342263|P1|Overall Study|Death|1
100601|NCT00322842|342262|P2|Overall Study|Refused transplant|0
100602|NCT00322842|342263|P1|Overall Study|Refused transplant|1
100603|NCT00322842|342262|P2|Overall Study|Lost to Follow-up|1
100604|NCT00322842|342263|P1|Overall Study|Lost to Follow-up|0
100605|NCT00322842|342262|P2|Overall Study|Withdrawal by Subject|1
100606|NCT00322842|342263|P1|Overall Study|Withdrawal by Subject|0
100607|NCT00322881|342292|P1|Overall Study|Disease Progression|2
100608|NCT00322881|342292|P1|Overall Study|Adverse Event|1
100609|NCT00322881|342292|P1|Overall Study|Death|2
100610|NCT00323115|342303|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
100611|NCT00323115|342303|P1|Vaccine Administration|Adverse Event|1
100612|NCT00323258|342321|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
100613|NCT00323258|342322|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
100614|NCT00323258|342321|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
100615|NCT00323258|342322|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
100616|NCT00323258|342321|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
100617|NCT00323258|342322|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
100618|NCT00323258|342321|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
100619|NCT00323258|342322|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
100620|NCT00323258|342321|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
100621|NCT00323258|342322|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
100622|NCT00323258|342321|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
100623|NCT00323258|342322|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
100624|NCT00323258|342321|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
100625|NCT00323258|342322|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
100626|NCT00323297|342360|P2|Part B (Open-label)|Protocol Violation|1
100627|NCT00323297|342361|P1|Part B (Open-label)|Protocol Violation|0
100628|NCT00323297|342360|P2|Part B (Open-label)|Adverse Event|5
100629|NCT00323297|342361|P1|Part B (Open-label)|Adverse Event|5
100630|NCT00323297|342360|P2|Part B (Open-label)|Lack of Efficacy|1
100631|NCT00323297|342361|P1|Part B (Open-label)|Lack of Efficacy|3
100632|NCT00323297|342360|P2|Part B (Open-label)|Withdrawal by Subject|3
100633|NCT00323297|342361|P1|Part B (Open-label)|Withdrawal by Subject|1
100634|NCT00323297|342360|P2|Part B (Open-label)|Reason unspecified|1
100635|NCT00323297|342361|P1|Part B (Open-label)|Reason unspecified|0
100636|NCT00323297|342360|P2|Part B (Open-label)|Death|1
100637|NCT00323297|342361|P1|Part B (Open-label)|Death|0
100638|NCT00323297|342360|P2|Part A (Double Blind Randomized)|Related adverse event|2
100639|NCT00323297|342361|P1|Part A (Double Blind Randomized)|Related adverse event|2
100640|NCT00323297|342360|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
100641|NCT00323297|342361|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
100642|NCT00323297|342360|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
100643|NCT00323297|342361|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
100644|NCT00323297|342360|P2|Part A (Double Blind Randomized)|Protocol Violation|3
100645|NCT00323297|342361|P1|Part A (Double Blind Randomized)|Protocol Violation|1
100646|NCT00323297|342360|P2|Part A (Double Blind Randomized)|Death|1
100647|NCT00323297|342361|P1|Part A (Double Blind Randomized)|Death|0
100648|NCT00323297|342360|P2|Part A (Double Blind Randomized)|Reason unspecified|1
100649|NCT00323297|342361|P1|Part A (Double Blind Randomized)|Reason unspecified|0
100650|NCT00323310|342377|P1|Overall Study|did not complete the 24-hr f-up visit|1
100651|NCT00323310|342377|P1|Overall Study|a parent refused blood draw|1
100652|NCT00323310|342377|P1|Overall Study|Withdrawal by Subject|1
100653|NCT00323479|342409|P1|Overall Study|house moving|1
100654|NCT00323479|342409|P1|Overall Study|Protocol Violation|3
100655|NCT00323479|342409|P1|Overall Study|Withdrawal by Subject|2
100656|NCT00323479|342409|P1|Overall Study|Adverse Event|2
100657|NCT00323492|342420|P3|Study Phase 2|Protocol Violation|0
100658|NCT00323492|342421|P2|Study Phase 2|Protocol Violation|0
100659|NCT00323492|342422|P1|Study Phase 2|Protocol Violation|1
100660|NCT00323492|342420|P3|Study Phase 2|Noncompliance with study schedule|1
100661|NCT00323492|342421|P2|Study Phase 2|Noncompliance with study schedule|0
100662|NCT00323492|342422|P1|Study Phase 2|Noncompliance with study schedule|0
100663|NCT00323492|342420|P3|Study Phase 2|Withdrawal by Subject|0
100664|NCT00323492|342421|P2|Study Phase 2|Withdrawal by Subject|1
100665|NCT00323492|342422|P1|Study Phase 2|Withdrawal by Subject|0
100666|NCT00323492|342420|P3|Study Phase 2|Lost to Follow-up|0
100667|NCT00323492|342421|P2|Study Phase 2|Lost to Follow-up|0
100668|NCT00323492|342422|P1|Study Phase 2|Lost to Follow-up|1
100669|NCT00323492|342420|P3|Study Phase 2|Physician Decision|0
100670|NCT00323492|342421|P2|Study Phase 2|Physician Decision|0
100671|NCT00323492|342422|P1|Study Phase 2|Physician Decision|1
100672|NCT00323492|342420|P3|Study Phase 2|Adverse Event|0
100673|NCT00323492|342421|P2|Study Phase 2|Adverse Event|0
100674|NCT00323492|342422|P1|Study Phase 2|Adverse Event|1
100675|NCT00323492|342420|P3|Study Phase 1|Adverse Event|0
100676|NCT00323492|342421|P2|Study Phase 1|Adverse Event|0
100677|NCT00323492|342422|P1|Study Phase 1|Adverse Event|2
100678|NCT00323557|342455|P2|Overall Study|Physician Decision|0
100679|NCT00323557|342456|P1|Overall Study|Physician Decision|1
100680|NCT00323609|342465|P4|Overall Study|Other reason|9
100681|NCT00323609|342466|P3|Overall Study|Other reason|4
100682|NCT00323609|342467|P2|Overall Study|Other reason|8
100683|NCT00323609|342468|P1|Overall Study|Other reason|11
100684|NCT00323609|342465|P4|Overall Study|Logistical withdrawal|1
100685|NCT00323609|342466|P3|Overall Study|Logistical withdrawal|0
100686|NCT00323609|342467|P2|Overall Study|Logistical withdrawal|5
100687|NCT00323609|342468|P1|Overall Study|Logistical withdrawal|9
100688|NCT00323609|342465|P4|Overall Study|Unrelenting or severe back pain|0
100689|NCT00323609|342466|P3|Overall Study|Unrelenting or severe back pain|0
100690|NCT00323609|342467|P2|Overall Study|Unrelenting or severe back pain|1
100691|NCT00323609|342468|P1|Overall Study|Unrelenting or severe back pain|1
100692|NCT00323609|342465|P4|Overall Study|Sponsor discontinued trial|0
100693|NCT00323609|342466|P3|Overall Study|Sponsor discontinued trial|0
100694|NCT00323609|342467|P2|Overall Study|Sponsor discontinued trial|29
100695|NCT00323609|342468|P1|Overall Study|Sponsor discontinued trial|29
100696|NCT00323609|342465|P4|Overall Study|Other non-VCF-related medical condition|0
100697|NCT00323609|342466|P3|Overall Study|Other non-VCF-related medical condition|0
100698|NCT00323609|342467|P2|Overall Study|Other non-VCF-related medical condition|2
100699|NCT00323609|342468|P1|Overall Study|Other non-VCF-related medical condition|3
100700|NCT00323609|342465|P4|Overall Study|Withdrawal by Subject|4
100701|NCT00323609|342466|P3|Overall Study|Withdrawal by Subject|4
100702|NCT00323609|342467|P2|Overall Study|Withdrawal by Subject|23
100703|NCT00323609|342468|P1|Overall Study|Withdrawal by Subject|11
100704|NCT00323609|342465|P4|Overall Study|Physician Decision|1
100705|NCT00323609|342466|P3|Overall Study|Physician Decision|0
100706|NCT00323609|342467|P2|Overall Study|Physician Decision|0
100707|NCT00323609|342468|P1|Overall Study|Physician Decision|2
100708|NCT00323609|342465|P4|Overall Study|Lost to Follow-up|0
100709|NCT00323609|342466|P3|Overall Study|Lost to Follow-up|0
100710|NCT00323609|342467|P2|Overall Study|Lost to Follow-up|10
100711|NCT00323609|342468|P1|Overall Study|Lost to Follow-up|9
100712|NCT00323609|342465|P4|Overall Study|Death|0
100713|NCT00323609|342466|P3|Overall Study|Death|0
100714|NCT00323609|342467|P2|Overall Study|Death|21
100715|NCT00323609|342468|P1|Overall Study|Death|16
100716|NCT00323622|342510|P8|Overall Study|Death|2
100717|NCT00323622|342511|P7|Overall Study|Death|0
100718|NCT00323622|342512|P6|Overall Study|Death|0
100719|NCT00323622|342513|P5|Overall Study|Death|7
100720|NCT00323622|342514|P4|Overall Study|Death|0
100721|NCT00323622|342515|P3|Overall Study|Death|0
100722|NCT00323622|342516|P2|Overall Study|Death|1
100723|NCT00323622|342517|P1|Overall Study|Death|1
100724|NCT00323622|342510|P8|Overall Study|Unspecified|13
100725|NCT00323622|342511|P7|Overall Study|Unspecified|5
100726|NCT00323622|342512|P6|Overall Study|Unspecified|74
100727|NCT00323622|342513|P5|Overall Study|Unspecified|32
100728|NCT00323622|342514|P4|Overall Study|Unspecified|12
100729|NCT00323622|342515|P3|Overall Study|Unspecified|4
100730|NCT00323622|342516|P2|Overall Study|Unspecified|91
100731|NCT00323622|342517|P1|Overall Study|Unspecified|30
100732|NCT00324961|342613|P1|Overall Study|Other|2
100733|NCT00324961|342613|P1|Overall Study|Protocol Violation|3
100734|NCT00324961|342613|P1|Overall Study|Lost to Follow-up|22
100735|NCT00324961|342613|P1|Overall Study|Consent Withdrawn|11
100736|NCT00324961|342613|P1|Overall Study|Adverse Event|5
100737|NCT00325039|342628|P2|Overall Study|Lost to Follow-up|14
100738|NCT00325039|342629|P1|Overall Study|Lost to Follow-up|18
100739|NCT00325130|342660|P2|Overall Study|Patient Discontinued for Other|0
100740|NCT00325130|342661|P1|Overall Study|Patient Discontinued for Other|1
100741|NCT00325130|342660|P2|Overall Study|Moved|1
100742|NCT00325130|342661|P1|Overall Study|Moved|0
100743|NCT00325130|342660|P2|Overall Study|Protocol Deviation|1
100744|NCT00325130|342661|P1|Overall Study|Protocol Deviation|0
100745|NCT00325130|342660|P2|Overall Study|Withdrawal by Subject|14
100746|NCT00325130|342661|P1|Overall Study|Withdrawal by Subject|12
100747|NCT00325130|342660|P2|Overall Study|Lost to Follow-up|14
100748|NCT00325130|342661|P1|Overall Study|Lost to Follow-up|6
100749|NCT00325143|342701|P1|Overall Study|Withdrawal by Subject|8
100750|NCT00325143|342701|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
100751|NCT00325143|342701|P1|Overall Study|Migrated/moved from study area|1
100752|NCT00325143|342701|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
100753|NCT00325156|342708|P1|Overall Study|Withdrawal by Subject|31
100754|NCT00325156|342708|P1|Overall Study|Unspecified|1
100755|NCT00325156|342708|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
100756|NCT00325156|342708|P1|Overall Study|Adverse event, non-fatal|3
100757|NCT00325156|342708|P1|Overall Study|Migrated/moved from study area|12
100758|NCT00325156|342708|P1|Overall Study|Lost to follow-up (complete vaccination)|41
100759|NCT00325156|342708|P1|Overall Study|Protocol Violation|8
100760|NCT00325195|342718|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
100761|NCT00325195|342719|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
100762|NCT00325195|342720|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
100763|NCT00325195|342718|P3|Received Intervention: ITT Population|Lost to Follow-up|2
100764|NCT00325195|342719|P2|Received Intervention: ITT Population|Lost to Follow-up|0
100765|NCT00325195|342720|P1|Received Intervention: ITT Population|Lost to Follow-up|0
100766|NCT00325195|342718|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
100767|NCT00325195|342719|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
100768|NCT00325195|342720|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
100769|NCT00325195|342718|P3|Received Intervention: ITT Population|Death|0
100770|NCT00325195|342719|P2|Received Intervention: ITT Population|Death|1
100771|NCT00325195|342720|P1|Received Intervention: ITT Population|Death|3
100772|NCT00325195|342718|P3|Received Intervention: ITT Population|Adverse Event|1
100773|NCT00325195|342719|P2|Received Intervention: ITT Population|Adverse Event|17
100774|NCT00325195|342720|P1|Received Intervention: ITT Population|Adverse Event|15
100775|NCT00325195|342718|P3|Randomized|Not dosed|3
100776|NCT00325195|342719|P2|Randomized|Not dosed|5
100777|NCT00325195|342720|P1|Randomized|Not dosed|5
100778|NCT00325234|342745|P2|Overall Study|Progressive Disease|37
100779|NCT00325234|342746|P1|Overall Study|Progressive Disease|34
100780|NCT00325234|342745|P2|Overall Study|Physician Decision|12
100781|NCT00325234|342746|P1|Overall Study|Physician Decision|17
100782|NCT00325234|342745|P2|Overall Study|Subject Decision|8
100783|NCT00325234|342746|P1|Overall Study|Subject Decision|6
100784|NCT00325234|342745|P2|Overall Study|Entry Criteria Not Met|2
100785|NCT00325234|342746|P1|Overall Study|Entry Criteria Not Met|1
100786|NCT00325234|342745|P2|Overall Study|Death due to Study Disease|0
100787|NCT00325234|342746|P1|Overall Study|Death due to Study Disease|1
100788|NCT00325234|342745|P2|Overall Study|Adverse Event|7
100789|NCT00325234|342746|P1|Overall Study|Adverse Event|10
100790|NCT00325416|342803|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
100791|NCT00325416|342804|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
100792|NCT00325416|342803|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
100793|NCT00325416|342804|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
100794|NCT00325416|342803|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
100795|NCT00325416|342804|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
100796|NCT00325416|342803|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
100797|NCT00325416|342804|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
100798|NCT00325416|342803|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
100799|NCT00325416|342804|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
100800|NCT00325416|342803|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
100801|NCT00325416|342804|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
100802|NCT00325468|342869|P5|Overall Study|site closure etc|1
100803|NCT00325468|342870|P4|Overall Study|site closure etc|8
100804|NCT00325468|342871|P3|Overall Study|site closure etc|1
100805|NCT00325468|342872|P2|Overall Study|site closure etc|2
100806|NCT00325468|342873|P1|Overall Study|site closure etc|4
100807|NCT00325468|342869|P5|Overall Study|Withdrawal by Subject|4
100808|NCT00325468|342870|P4|Overall Study|Withdrawal by Subject|14
100809|NCT00325468|342871|P3|Overall Study|Withdrawal by Subject|0
100810|NCT00325468|342872|P2|Overall Study|Withdrawal by Subject|1
100811|NCT00325468|342873|P1|Overall Study|Withdrawal by Subject|3
100812|NCT00325468|342869|P5|Overall Study|Physician Decision|0
100813|NCT00325468|342870|P4|Overall Study|Physician Decision|1
100814|NCT00325468|342871|P3|Overall Study|Physician Decision|0
100815|NCT00325468|342872|P2|Overall Study|Physician Decision|1
100816|NCT00325468|342873|P1|Overall Study|Physician Decision|1
100817|NCT00325468|342869|P5|Overall Study|Lost to Follow-up|2
100818|NCT00325468|342870|P4|Overall Study|Lost to Follow-up|2
100819|NCT00325468|342871|P3|Overall Study|Lost to Follow-up|1
100820|NCT00325468|342872|P2|Overall Study|Lost to Follow-up|0
100821|NCT00325468|342873|P1|Overall Study|Lost to Follow-up|0
100822|NCT00325468|342869|P5|Overall Study|Death|0
100823|NCT00325468|342870|P4|Overall Study|Death|4
100824|NCT00325468|342871|P3|Overall Study|Death|2
100825|NCT00325468|342872|P2|Overall Study|Death|0
100826|NCT00325468|342873|P1|Overall Study|Death|2
100827|NCT00325468|342869|P5|Overall Study|Adverse Event|1
100828|NCT00325468|342870|P4|Overall Study|Adverse Event|5
100829|NCT00325468|342871|P3|Overall Study|Adverse Event|0
100830|NCT00325468|342872|P2|Overall Study|Adverse Event|1
100831|NCT00325468|342873|P1|Overall Study|Adverse Event|1
100832|NCT00325754|342921|P2|Overall Study|Adverse Event|1
100833|NCT00325754|342922|P1|Overall Study|Adverse Event|4
100834|NCT00325819|342943|P2|Overall Study|Lost to Follow-up|3
100835|NCT00325819|342944|P1|Overall Study|Lost to Follow-up|3
100836|NCT00325819|342943|P2|Overall Study|Did not take a dose of study product|9
100837|NCT00325819|342944|P1|Overall Study|Did not take a dose of study product|4
100838|NCT00325819|342943|P2|Overall Study|Study product lost in mail|1
100839|NCT00325819|342944|P1|Overall Study|Study product lost in mail|2
100840|NCT00325897|342966|P2|Overall Study|Lost to Follow-up|13
100841|NCT00325897|342967|P1|Overall Study|Lost to Follow-up|12
100842|NCT00326001|342987|P2|Overall Study|Physician Decision|3
100843|NCT00326001|342988|P1|Overall Study|Physician Decision|3
100844|NCT00326001|342987|P2|Overall Study|Adverse Event|5
100845|NCT00326001|342988|P1|Overall Study|Adverse Event|4
100846|NCT00326118|343002|P2|Active Phase|Withdrawal by Subject|1
100847|NCT00326118|343003|P1|Active Phase|Withdrawal by Subject|4
100848|NCT00326183|343043|P2|Overall Study|Adverse Event|0
100849|NCT00326183|343044|P1|Overall Study|Adverse Event|1
100850|NCT00326183|343043|P2|Overall Study|Unspecified|13
100851|NCT00326183|343044|P1|Overall Study|Unspecified|47
100852|NCT00326183|343043|P2|Overall Study|Subject Moved|4
100853|NCT00326183|343044|P1|Overall Study|Subject Moved|7
100854|NCT00326183|343043|P2|Overall Study|Withdrawal by Subject|7
100855|NCT00326183|343044|P1|Overall Study|Withdrawal by Subject|35
100856|NCT00326183|343043|P2|Overall Study|Protocol Violation|3
100857|NCT00326183|343044|P1|Overall Study|Protocol Violation|6
100858|NCT00326183|343043|P2|Overall Study|Lost to Follow-up|56
100859|NCT00326183|343044|P1|Overall Study|Lost to Follow-up|104
100860|NCT00326417|343081|P4|Overall Study|Death|0
100861|NCT00326417|343082|P3|Overall Study|Death|0
100862|NCT00326417|343083|P2|Overall Study|Death|0
100863|NCT00326417|343084|P1|Overall Study|Death|7
100864|NCT00326417|343081|P4|Overall Study|Arm Closed|3
100865|NCT00326417|343082|P3|Overall Study|Arm Closed|0
100866|NCT00326417|343083|P2|Overall Study|Arm Closed|0
100867|NCT00326417|343084|P1|Overall Study|Arm Closed|7
100868|NCT00326417|343081|P4|Overall Study|Withdrawal by Subject|0
100869|NCT00326417|343082|P3|Overall Study|Withdrawal by Subject|1
100870|NCT00326417|343083|P2|Overall Study|Withdrawal by Subject|0
100871|NCT00326417|343084|P1|Overall Study|Withdrawal by Subject|0
100872|NCT00326495|343100|P1|Overall Study|Subject off study before assessment|1
100873|NCT00326495|343100|P1|Overall Study|Refused further treatment|2
100874|NCT00326495|343100|P1|Overall Study|Disease progression before treatment|1
100875|NCT00326495|343100|P1|Overall Study|Switched to alternative treatment|1
100876|NCT00326599|343109|P4|Overall Study|Other Unspecified Reason|1
100877|NCT00326599|343110|P3|Overall Study|Other Unspecified Reason|2
100878|NCT00326599|343111|P2|Overall Study|Other Unspecified Reason|0
100879|NCT00326599|343112|P1|Overall Study|Other Unspecified Reason|0
100880|NCT00326599|343109|P4|Overall Study|Death|2
100881|NCT00326599|343110|P3|Overall Study|Death|1
100882|NCT00326599|343111|P2|Overall Study|Death|0
100883|NCT00326599|343112|P1|Overall Study|Death|0
100884|NCT00326599|343109|P4|Overall Study|Alternate Treatment|0
100885|NCT00326599|343110|P3|Overall Study|Alternate Treatment|0
100886|NCT00326599|343111|P2|Overall Study|Alternate Treatment|0
100887|NCT00326599|343112|P1|Overall Study|Alternate Treatment|1
100888|NCT00326599|343109|P4|Overall Study|Disease Progression|11
100889|NCT00326599|343110|P3|Overall Study|Disease Progression|13
100890|NCT00326599|343111|P2|Overall Study|Disease Progression|1
100891|NCT00326599|343112|P1|Overall Study|Disease Progression|3
100892|NCT00326599|343109|P4|Overall Study|Adverse Event|3
100893|NCT00326599|343110|P3|Overall Study|Adverse Event|32
100894|NCT00326599|343111|P2|Overall Study|Adverse Event|0
100895|NCT00326599|343112|P1|Overall Study|Adverse Event|1
100896|NCT00326599|343109|P4|Overall Study|Withdrawal by Subject|2
100897|NCT00326599|343110|P3|Overall Study|Withdrawal by Subject|5
100898|NCT00326599|343111|P2|Overall Study|Withdrawal by Subject|0
100899|NCT00326599|343112|P1|Overall Study|Withdrawal by Subject|1
100900|NCT00326612|343133|P2|Overall Study|They did not have a seizure requiring tx|137
100901|NCT00326612|343134|P1|Overall Study|They did not have a seizure requiring tx|129
100902|NCT00326716|343154|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
100903|NCT00326716|343155|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
100904|NCT00326716|343156|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
100905|NCT00326716|343157|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
100906|NCT00326885|343247|P1|Overall Study|Hospice withdrew consent|2
100907|NCT00326885|343247|P1|Overall Study|Physician Decision|1
100908|NCT00326885|343247|P1|Overall Study|Withdrawal by Subject|3
100909|NCT00326885|343247|P1|Overall Study|Adverse Event|1
100910|NCT00326898|343259|P3|Overall Study|Other/Missing/Unknown|32
100911|NCT00326898|343260|P2|Overall Study|Other/Missing/Unknown|28
100912|NCT00326898|343261|P1|Overall Study|Other/Missing/Unknown|33
100913|NCT00326898|343259|P3|Overall Study|Other complicating disease|4
100914|NCT00326898|343260|P2|Overall Study|Other complicating disease|5
100915|NCT00326898|343261|P1|Overall Study|Other complicating disease|5
100916|NCT00326898|343259|P3|Overall Study|Alternative therapy|0
100917|NCT00326898|343260|P2|Overall Study|Alternative therapy|0
100918|NCT00326898|343261|P1|Overall Study|Alternative therapy|1
100919|NCT00326898|343259|P3|Overall Study|Withdrawal by Subject|32
100920|NCT00326898|343260|P2|Overall Study|Withdrawal by Subject|128
100921|NCT00326898|343261|P1|Overall Study|Withdrawal by Subject|134
100922|NCT00326898|343259|P3|Overall Study|Death|0
100923|NCT00326898|343260|P2|Overall Study|Death|0
100924|NCT00326898|343261|P1|Overall Study|Death|2
100925|NCT00326898|343259|P3|Overall Study|Adverse Event|33
100926|NCT00326898|343260|P2|Overall Study|Adverse Event|128
100927|NCT00326898|343261|P1|Overall Study|Adverse Event|124
100928|NCT00326898|343259|P3|Overall Study|Disease progression|102
100929|NCT00326898|343260|P2|Overall Study|Disease progression|54
100930|NCT00326898|343261|P1|Overall Study|Disease progression|52
100931|NCT00326911|343280|P2|Overall Study|Withdrawal by subject prior to treatment|1
100932|NCT00326911|343281|P1|Overall Study|Withdrawal by subject prior to treatment|0
100933|NCT00326911|343280|P2|Overall Study|Physician decision prior to treatment|0
100934|NCT00326911|343281|P1|Overall Study|Physician decision prior to treatment|1
100935|NCT00326911|343280|P2|Overall Study|Hospitalization prior to treatment|1
100936|NCT00326911|343281|P1|Overall Study|Hospitalization prior to treatment|0
100937|NCT00326950|343331|P1|Overall Study|Progressive Disease|1
100938|NCT00326963|343336|P1|Overall Study|Administrative / other|1
100939|NCT00326963|343336|P1|Overall Study|Other protocol violation|1
100940|NCT00326963|343336|P1|Overall Study|Violation of selection criteria at entry|2
100941|NCT00326963|343336|P1|Overall Study|Refused treatment / did not cooperate|5
100942|NCT00326963|343336|P1|Overall Study|Withdrawal by Subject|10
100943|NCT00326963|343336|P1|Overall Study|Failure to return|10
100944|NCT00326963|343336|P1|Overall Study|Death|1
100945|NCT00326963|343336|P1|Overall Study|Injection site reaction|1
100946|NCT00326963|343336|P1|Overall Study|Adverse Event|2
100947|NCT00327015|343360|P4|Overall Study|Administrative Reason by Sponsor|1
100948|NCT00327015|343361|P3|Overall Study|Administrative Reason by Sponsor|2
100949|NCT00327015|343362|P2|Overall Study|Administrative Reason by Sponsor|2
100950|NCT00327015|343363|P1|Overall Study|Administrative Reason by Sponsor|1
100951|NCT00327015|343360|P4|Overall Study|Pregnancy|1
100952|NCT00327015|343361|P3|Overall Study|Pregnancy|1
100953|NCT00327015|343362|P2|Overall Study|Pregnancy|2
100954|NCT00327015|343363|P1|Overall Study|Pregnancy|0
100955|NCT00327015|343360|P4|Overall Study|Death|3
100956|NCT00327015|343361|P3|Overall Study|Death|2
100957|NCT00327015|343362|P2|Overall Study|Death|2
100958|NCT00327015|343363|P1|Overall Study|Death|1
100959|NCT00327015|343360|P4|Overall Study|Physician Decision|2
100960|NCT00327015|343361|P3|Overall Study|Physician Decision|3
100961|NCT00327015|343362|P2|Overall Study|Physician Decision|1
100962|NCT00327015|343363|P1|Overall Study|Physician Decision|0
100963|NCT00327015|343360|P4|Overall Study|Poor/Noncompliance|5
100964|NCT00327015|343361|P3|Overall Study|Poor/Noncompliance|4
100965|NCT00327015|343362|P2|Overall Study|Poor/Noncompliance|8
100966|NCT00327015|343363|P1|Overall Study|Poor/Noncompliance|11
100967|NCT00327015|343360|P4|Overall Study|Subject no longer meets study criteria|7
100968|NCT00327015|343361|P3|Overall Study|Subject no longer meets study criteria|8
100969|NCT00327015|343362|P2|Overall Study|Subject no longer meets study criteria|2
100970|NCT00327015|343363|P1|Overall Study|Subject no longer meets study criteria|4
100971|NCT00327015|343360|P4|Overall Study|Adverse Event|14
100972|NCT00327015|343361|P3|Overall Study|Adverse Event|14
100973|NCT00327015|343362|P2|Overall Study|Adverse Event|10
100974|NCT00327015|343363|P1|Overall Study|Adverse Event|14
100975|NCT00327015|343360|P4|Overall Study|Lost to Follow-up|22
100976|NCT00327015|343361|P3|Overall Study|Lost to Follow-up|29
100977|NCT00327015|343362|P2|Overall Study|Lost to Follow-up|23
100978|NCT00327015|343363|P1|Overall Study|Lost to Follow-up|22
100979|NCT00327015|343360|P4|Overall Study|Withdrawal of Consent by Subject|25
100980|NCT00327015|343361|P3|Overall Study|Withdrawal of Consent by Subject|28
100981|NCT00327015|343362|P2|Overall Study|Withdrawal of Consent by Subject|24
100982|NCT00327015|343363|P1|Overall Study|Withdrawal of Consent by Subject|20
100983|NCT00327015|343360|P4|Overall Study|Lack of Efficacy|29
100984|NCT00327015|343361|P3|Overall Study|Lack of Efficacy|35
100985|NCT00327015|343362|P2|Overall Study|Lack of Efficacy|18
100986|NCT00327015|343363|P1|Overall Study|Lack of Efficacy|18
100987|NCT00327171|343407|P2|Overall Study|Unspecified|0
100988|NCT00327171|343408|P1|Overall Study|Unspecified|1
100989|NCT00327171|343407|P2|Overall Study|Undisclosed history of ischemia|1
100990|NCT00327171|343408|P1|Overall Study|Undisclosed history of ischemia|0
100991|NCT00327171|343407|P2|Overall Study|Clinical progression|8
100992|NCT00327171|343408|P1|Overall Study|Clinical progression|12
100993|NCT00327171|343407|P2|Overall Study|Investigator/participant request|8
100994|NCT00327171|343408|P1|Overall Study|Investigator/participant request|1
100995|NCT00327171|343407|P2|Overall Study|Disease progression/lack of efficacy|69
100996|NCT00327171|343408|P1|Overall Study|Disease progression/lack of efficacy|68
100997|NCT00327171|343407|P2|Overall Study|Adverse Event|23
100998|NCT00327171|343408|P1|Overall Study|Adverse Event|23
100999|NCT00327171|343407|P2|Overall Study|Did not receive study medication|0
101000|NCT00327171|343408|P1|Overall Study|Did not receive study medication|3
101001|NCT00327340|343438|P2|Overall Study|Adverse Event|3
101002|NCT00327340|343439|P1|Overall Study|Adverse Event|3
101003|NCT00327340|343438|P2|Overall Study|Symptomatic Disease|2
101004|NCT00327340|343439|P1|Overall Study|Symptomatic Disease|0
101005|NCT00327340|343438|P2|Overall Study|Disease Progression|19
101006|NCT00327340|343439|P1|Overall Study|Disease Progression|10
101007|NCT00327340|343438|P2|Overall Study|Physician Decision|1
101008|NCT00327340|343439|P1|Overall Study|Physician Decision|1
101009|NCT00327340|343438|P2|Overall Study|Withdrawal by Subject|5
101010|NCT00327340|343439|P1|Overall Study|Withdrawal by Subject|1
101011|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Death|0
101012|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Death|1
101013|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Death|0
101014|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
101015|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
101016|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
101017|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
101018|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
101019|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
101020|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
101021|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
101022|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
101023|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
101024|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
101025|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
101026|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
101027|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
101028|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
101029|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
101030|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
101031|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
101032|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
101033|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
101034|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
101035|NCT00333138|343454|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
101036|NCT00333138|343455|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
101037|NCT00333138|343456|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
101038|NCT00333138|343454|P3|Core Study (6 Months)|Laboratory abnormality|1
101039|NCT00333138|343455|P2|Core Study (6 Months)|Laboratory abnormality|0
101040|NCT00333138|343456|P1|Core Study (6 Months)|Laboratory abnormality|0
101041|NCT00333138|343454|P3|Core Study (6 Months)|Protocol Violation|1
101042|NCT00333138|343455|P2|Core Study (6 Months)|Protocol Violation|0
101043|NCT00333138|343456|P1|Core Study (6 Months)|Protocol Violation|1
101044|NCT00333138|343454|P3|Core Study (6 Months)|Lack of Efficacy|0
101045|NCT00333138|343455|P2|Core Study (6 Months)|Lack of Efficacy|0
101046|NCT00333138|343456|P1|Core Study (6 Months)|Lack of Efficacy|1
101047|NCT00333138|343454|P3|Core Study (6 Months)|Withdrawal by Subject|2
101048|NCT00333138|343455|P2|Core Study (6 Months)|Withdrawal by Subject|1
101049|NCT00333138|343456|P1|Core Study (6 Months)|Withdrawal by Subject|1
101050|NCT00333138|343454|P3|Core Study (6 Months)|Adverse Event|8
101051|NCT00333138|343455|P2|Core Study (6 Months)|Adverse Event|5
101052|NCT00333138|343456|P1|Core Study (6 Months)|Adverse Event|4
101053|NCT00333229|343495|P2|Overall Study|Lack of Efficacy|1
101054|NCT00333229|343496|P1|Overall Study|Lack of Efficacy|0
101055|NCT00333359|343512|P2|Overall Study|Withdrew before Receiving One Dose|6
101056|NCT00333359|343513|P1|Overall Study|Withdrew before Receiving One Dose|2
101057|NCT00333359|343512|P2|Overall Study|Treatment Failure|8
101058|NCT00333359|343513|P1|Overall Study|Treatment Failure|3
101059|NCT00333359|343512|P2|Overall Study|Termination or Withdrawal by Sponsor|1
101060|NCT00333359|343513|P1|Overall Study|Termination or Withdrawal by Sponsor|1
101061|NCT00333359|343512|P2|Overall Study|Lost to Follow-up|25
101062|NCT00333359|343513|P1|Overall Study|Lost to Follow-up|15
101063|NCT00333359|343512|P2|Overall Study|Protocol Non-compliance|8
101064|NCT00333359|343513|P1|Overall Study|Protocol Non-compliance|2
101065|NCT00333359|343512|P2|Overall Study|Physician Decision|2
101066|NCT00333359|343513|P1|Overall Study|Physician Decision|2
101067|NCT00333359|343512|P2|Overall Study|Withdrawal by Subject|37
101068|NCT00333359|343513|P1|Overall Study|Withdrawal by Subject|19
101069|NCT00333359|343512|P2|Overall Study|Adverse Event|35
101070|NCT00333359|343513|P1|Overall Study|Adverse Event|29
101071|NCT00334113|343570|P2|Overall Study|Withdrawal by Subject|1
101072|NCT00334113|343571|P1|Overall Study|Withdrawal by Subject|0
101073|NCT00334113|343570|P2|Overall Study|Lost to Follow-up|2
101074|NCT00334113|343571|P1|Overall Study|Lost to Follow-up|2
101075|NCT00334282|343585|P2|Overall Study|Death|100
101076|NCT00334282|343586|P1|Overall Study|Death|194
101077|NCT00334282|343585|P2|Overall Study|Withdrawal by Subject|3
101078|NCT00334282|343586|P1|Overall Study|Withdrawal by Subject|17
101079|NCT00334282|343585|P2|Overall Study|Lost to Follow-up|5
101080|NCT00334282|343586|P1|Overall Study|Lost to Follow-up|11
101081|NCT00334295|343609|P1|Overall Study|Patients received fewer than 3 injection|5
101082|NCT00334542|343617|P1|Overall Study|New cancer diagnosis|1
101083|NCT00334542|343617|P1|Overall Study|Withdrawal by Subject|1
101084|NCT00334542|343617|P1|Overall Study|Adverse Event|3
101085|NCT00334802|343637|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
101086|NCT00334802|343638|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
101087|NCT00334802|343637|P2|Overall Study|Adverse Event|3
101088|NCT00334802|343638|P1|Overall Study|Adverse Event|0
101089|NCT00334802|343637|P2|Overall Study|Withdrawal by Subject|4
101090|NCT00334802|343638|P1|Overall Study|Withdrawal by Subject|0
101091|NCT00334802|343637|P2|Overall Study|Physician Decision|0
101092|NCT00334802|343638|P1|Overall Study|Physician Decision|1
101093|NCT00334802|343637|P2|Overall Study|Patient Condition Aggrevated|0
101094|NCT00334802|343638|P1|Overall Study|Patient Condition Aggrevated|1
101095|NCT00334802|343637|P2|Overall Study|Lack of Efficacy|3
101096|NCT00334802|343638|P1|Overall Study|Lack of Efficacy|1
101097|NCT00334802|343637|P2|Overall Study|Toxicity|5
101098|NCT00334802|343638|P1|Overall Study|Toxicity|1
101099|NCT00334802|343637|P2|Overall Study|Progressive Disease|24
101100|NCT00334802|343638|P1|Overall Study|Progressive Disease|2
101101|NCT00334815|343657|P2|Overall Study|Physician Decision|4
101102|NCT00334815|343658|P1|Overall Study|Physician Decision|2
101103|NCT00334815|343657|P2|Overall Study|patient refused treatment|1
101104|NCT00334815|343658|P1|Overall Study|patient refused treatment|0
101105|NCT00334815|343657|P2|Overall Study|ineligible|1
101106|NCT00334815|343658|P1|Overall Study|ineligible|1
101107|NCT00334815|343657|P2|Overall Study|Progression|0
101108|NCT00334815|343658|P1|Overall Study|Progression|1
101109|NCT00334815|343657|P2|Overall Study|Death|2
101110|NCT00334815|343658|P1|Overall Study|Death|0
101111|NCT00334815|343657|P2|Overall Study|Adverse Event|2
101112|NCT00334815|343658|P1|Overall Study|Adverse Event|3
101113|NCT00334893|343672|P2|Overall Study|Not Treated|0
101114|NCT00334893|343673|P1|Overall Study|Not Treated|1
101115|NCT00334958|343681|P2|Overall Study|Not specified|2
101116|NCT00334958|343682|P1|Overall Study|Not specified|1
101117|NCT00334958|343681|P2|Overall Study|Adverse Event|12
101118|NCT00334958|343682|P1|Overall Study|Adverse Event|27
101119|NCT00334958|343681|P2|Overall Study|Withdrawal by Subject|4
101120|NCT00334958|343682|P1|Overall Study|Withdrawal by Subject|7
101121|NCT00334958|343681|P2|Overall Study|Request of the investigator or sponsor|1
101122|NCT00334958|343682|P1|Overall Study|Request of the investigator or sponsor|0
101123|NCT00334958|343681|P2|Overall Study|Protocol Violation|2
101124|NCT00334958|343682|P1|Overall Study|Protocol Violation|2
101125|NCT00334958|343681|P2|Overall Study|Medication Noncompliance|3
101126|NCT00334958|343682|P1|Overall Study|Medication Noncompliance|0
101127|NCT00335140|343694|P1|Overall Study|Ineligible|1
101128|NCT00335153|343698|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
101129|NCT00335153|343698|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
101130|NCT00335153|343698|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
101131|NCT00335153|343698|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
101132|NCT00335153|343698|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
101133|NCT00335153|343698|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
101134|NCT00335153|343698|P1|Nasojejunal (NJ) Test Period|Administrative|1
101135|NCT00335153|343698|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
101136|NCT00335153|343698|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
101137|NCT00335153|343698|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
101138|NCT00335322|343775|P3|Overall Study|Randomised but withdrew prior to ART sta|2
101139|NCT00335322|343776|P2|Overall Study|Randomised but withdrew prior to ART sta|2
101140|NCT00335322|343777|P1|Overall Study|Randomised but withdrew prior to ART sta|1
101141|NCT00335452|343789|P4|Overall Study|Lost to Follow-up|2
101142|NCT00335452|343790|P3|Overall Study|Lost to Follow-up|1
101143|NCT00335452|343791|P2|Overall Study|Lost to Follow-up|3
101144|NCT00335452|343792|P1|Overall Study|Lost to Follow-up|2
101145|NCT00335452|343789|P4|Overall Study|Death|129
101146|NCT00335452|343790|P3|Overall Study|Death|158
101147|NCT00335452|343791|P2|Overall Study|Death|144
101148|NCT00335452|343792|P1|Overall Study|Death|156
101149|NCT00335556|343857|P6|Overall Study|Refusal of further protocol therapy|0
101150|NCT00335556|343858|P5|Overall Study|Refusal of further protocol therapy|0
101151|NCT00335556|343859|P4|Overall Study|Refusal of further protocol therapy|1
101152|NCT00335556|343860|P3|Overall Study|Refusal of further protocol therapy|0
101153|NCT00335556|343861|P2|Overall Study|Refusal of further protocol therapy|4
101154|NCT00335556|343862|P1|Overall Study|Refusal of further protocol therapy|0
101155|NCT00335556|343857|P6|Overall Study|Ineligible|0
101156|NCT00335556|343858|P5|Overall Study|Ineligible|0
101157|NCT00335556|343859|P4|Overall Study|Ineligible|0
101158|NCT00335556|343860|P3|Overall Study|Ineligible|0
101159|NCT00335556|343861|P2|Overall Study|Ineligible|0
101160|NCT00335556|343862|P1|Overall Study|Ineligible|2
101161|NCT00335556|343857|P6|Overall Study|Physician Decision|0
101162|NCT00335556|343858|P5|Overall Study|Physician Decision|0
101163|NCT00335556|343859|P4|Overall Study|Physician Decision|1
101164|NCT00335556|343860|P3|Overall Study|Physician Decision|2
101165|NCT00335556|343861|P2|Overall Study|Physician Decision|6
101166|NCT00335556|343862|P1|Overall Study|Physician Decision|0
101167|NCT00335556|343857|P6|Overall Study|Lack of Efficacy|1
101168|NCT00335556|343858|P5|Overall Study|Lack of Efficacy|0
101169|NCT00335556|343859|P4|Overall Study|Lack of Efficacy|3
101170|NCT00335556|343860|P3|Overall Study|Lack of Efficacy|3
101171|NCT00335556|343861|P2|Overall Study|Lack of Efficacy|19
101172|NCT00335556|343862|P1|Overall Study|Lack of Efficacy|0
101173|NCT00335556|343857|P6|Overall Study|Death|0
101174|NCT00335556|343858|P5|Overall Study|Death|1
101175|NCT00335556|343859|P4|Overall Study|Death|0
101176|NCT00335556|343860|P3|Overall Study|Death|0
101177|NCT00335556|343861|P2|Overall Study|Death|5
101178|NCT00335556|343862|P1|Overall Study|Death|0
101179|NCT00335777|343894|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
101180|NCT00335777|343894|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
101181|NCT00335777|343894|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
101182|NCT00335777|343894|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
101183|NCT00335777|343894|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
101184|NCT00335829|343899|P1|Overall Study|Adverse Event|1
101185|NCT00335829|343899|P1|Overall Study|Lost to Follow-up|1
101186|NCT00335829|343899|P1|Overall Study|Withdrawal by Subject|1
101187|NCT00335959|343913|P1|Overall Study|Ineligible|1
101188|NCT00335959|343913|P1|Overall Study|Adverse Event|2
101189|NCT00335972|343920|P2|Overall Study|not given treatments|3
101190|NCT00335972|343921|P1|Overall Study|not given treatments|0
101191|NCT00336284|343937|P2|Overall Study|Withdrawal by Physician or Subject|64
101192|NCT00336284|343938|P1|Overall Study|Withdrawal by Physician or Subject|102
101193|NCT00336284|343937|P2|Overall Study|Lost to Follow-up|61
101194|NCT00336284|343938|P1|Overall Study|Lost to Follow-up|82
101195|NCT00336284|343937|P2|Overall Study|Death|26
101196|NCT00336284|343938|P1|Overall Study|Death|52
101197|NCT00336479|344018|P4|Overall Study|Virologic Stopping Rule|0
101198|NCT00336479|344019|P3|Overall Study|Virologic Stopping Rule|0
101199|NCT00336479|344020|P2|Overall Study|Virologic Stopping Rule|0
101200|NCT00336479|344021|P1|Overall Study|Virologic Stopping Rule|20
101201|NCT00336479|344018|P4|Overall Study|Unspecified|0
101202|NCT00336479|344019|P3|Overall Study|Unspecified|1
101203|NCT00336479|344020|P2|Overall Study|Unspecified|0
101204|NCT00336479|344021|P1|Overall Study|Unspecified|0
101205|NCT00336479|344018|P4|Overall Study|Withdrawal by Subject|0
101206|NCT00336479|344019|P3|Overall Study|Withdrawal by Subject|3
101207|NCT00336479|344020|P2|Overall Study|Withdrawal by Subject|2
101208|NCT00336479|344021|P1|Overall Study|Withdrawal by Subject|3
101209|NCT00336479|344018|P4|Overall Study|Lost to Follow-up|0
101210|NCT00336479|344019|P3|Overall Study|Lost to Follow-up|0
101211|NCT00336479|344020|P2|Overall Study|Lost to Follow-up|2
101212|NCT00336479|344021|P1|Overall Study|Lost to Follow-up|3
101213|NCT00336479|344018|P4|Overall Study|Physician Decision|0
101214|NCT00336479|344019|P3|Overall Study|Physician Decision|1
101215|NCT00336479|344020|P2|Overall Study|Physician Decision|3
101216|NCT00336479|344021|P1|Overall Study|Physician Decision|2
101217|NCT00336479|344018|P4|Overall Study|Noncompliant|0
101218|NCT00336479|344019|P3|Overall Study|Noncompliant|3
101219|NCT00336479|344020|P2|Overall Study|Noncompliant|7
101220|NCT00336479|344021|P1|Overall Study|Noncompliant|1
101221|NCT00336479|344018|P4|Overall Study|Adverse Event|4
101222|NCT00336479|344019|P3|Overall Study|Adverse Event|18
101223|NCT00336479|344020|P2|Overall Study|Adverse Event|11
101224|NCT00336479|344021|P1|Overall Study|Adverse Event|8
101225|NCT00336492|344047|P3|Overall Study|Other|1
101226|NCT00336492|344048|P2|Overall Study|Other|0
101227|NCT00336492|344049|P1|Overall Study|Other|5
101228|NCT00336492|344047|P3|Overall Study|Lack of Efficacy|4
101229|NCT00336492|344048|P2|Overall Study|Lack of Efficacy|1
101230|NCT00336492|344049|P1|Overall Study|Lack of Efficacy|6
101231|NCT00336492|344047|P3|Overall Study|Adverse Event|6
101232|NCT00336492|344048|P2|Overall Study|Adverse Event|3
101233|NCT00336492|344049|P1|Overall Study|Adverse Event|4
101234|NCT00336505|344059|P2|Overall Study|Other|7
101235|NCT00336505|344060|P1|Overall Study|Other|7
101236|NCT00336505|344059|P2|Overall Study|Withdrawal by Subject|3
101237|NCT00336505|344060|P1|Overall Study|Withdrawal by Subject|5
101238|NCT00336505|344059|P2|Overall Study|Lost to Follow-up|4
101239|NCT00336505|344060|P1|Overall Study|Lost to Follow-up|7
101240|NCT00336505|344059|P2|Overall Study|Lack of Efficacy|4
101241|NCT00336505|344060|P1|Overall Study|Lack of Efficacy|8
101242|NCT00336505|344059|P2|Overall Study|Adverse Event|9
101243|NCT00336505|344060|P1|Overall Study|Adverse Event|10
101244|NCT00336544|344074|P2|Overall Study|Other|5
101245|NCT00336544|344075|P1|Overall Study|Other|3
101246|NCT00336544|344074|P2|Overall Study|Withdrawal by Subject|3
101247|NCT00336544|344075|P1|Overall Study|Withdrawal by Subject|4
101248|NCT00336544|344074|P2|Overall Study|Adverse Event|9
101249|NCT00336544|344075|P1|Overall Study|Adverse Event|4
101250|NCT00336544|344074|P2|Overall Study|Lack of Efficacy|5
101251|NCT00336544|344075|P1|Overall Study|Lack of Efficacy|8
101252|NCT00336583|344087|P1|Overall Study|Death|1
101253|NCT00336583|344087|P1|Overall Study|Lost to Follow-up|1
101254|NCT00323869|344092|P1|Overall Study|Death|1
101255|NCT00323882|344109|P5|Overall Study|Not Specified|1
101256|NCT00323882|344110|P4|Overall Study|Not Specified|1
101257|NCT00323882|344111|P3|Overall Study|Not Specified|0
101258|NCT00323882|344112|P2|Overall Study|Not Specified|0
101259|NCT00323882|344113|P1|Overall Study|Not Specified|0
101260|NCT00323882|344109|P5|Overall Study|Lost to Follow-up|1
101261|NCT00323882|344110|P4|Overall Study|Lost to Follow-up|0
101262|NCT00323882|344111|P3|Overall Study|Lost to Follow-up|1
101263|NCT00323882|344112|P2|Overall Study|Lost to Follow-up|0
101264|NCT00323882|344113|P1|Overall Study|Lost to Follow-up|0
101265|NCT00323882|344109|P5|Overall Study|Death|5
101266|NCT00323882|344110|P4|Overall Study|Death|0
101267|NCT00323882|344111|P3|Overall Study|Death|1
101268|NCT00323882|344112|P2|Overall Study|Death|1
101269|NCT00323882|344113|P1|Overall Study|Death|0
101270|NCT00323882|344109|P5|Overall Study|Disease Progression|22
101271|NCT00323882|344110|P4|Overall Study|Disease Progression|5
101272|NCT00323882|344111|P3|Overall Study|Disease Progression|10
101273|NCT00323882|344112|P2|Overall Study|Disease Progression|4
101274|NCT00323882|344113|P1|Overall Study|Disease Progression|6
101275|NCT00323882|344109|P5|Overall Study|Adverse Event|3
101276|NCT00323882|344110|P4|Overall Study|Adverse Event|1
101277|NCT00323882|344111|P3|Overall Study|Adverse Event|1
101278|NCT00323882|344112|P2|Overall Study|Adverse Event|1
101279|NCT00323882|344113|P1|Overall Study|Adverse Event|2
101280|NCT00324038|344186|P2|Overall Study|Other|13
101281|NCT00324038|344187|P1|Overall Study|Other|6
101282|NCT00324038|344186|P2|Overall Study|Lost to Follow-up|2
101283|NCT00324038|344187|P1|Overall Study|Lost to Follow-up|0
101284|NCT00324038|344186|P2|Overall Study|Lack of Efficacy|13
101285|NCT00324038|344187|P1|Overall Study|Lack of Efficacy|5
101286|NCT00324038|344186|P2|Overall Study|Adverse Event|23
101287|NCT00324038|344187|P1|Overall Study|Adverse Event|38
101288|NCT00324116|344193|P1|Overall Study|Other|5
101289|NCT00324116|344193|P1|Overall Study|Withdrawal by Subject|5
101290|NCT00324116|344193|P1|Overall Study|Lack of Efficacy|17
101291|NCT00324116|344193|P1|Overall Study|Adverse Event|5
101292|NCT00324155|344205|P2|Follow-up Phase|On-going participants still on drug|6
101293|NCT00324155|344206|P1|Follow-up Phase|On-going participants still on drug|11
101294|NCT00324155|344205|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
101295|NCT00324155|344206|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
101296|NCT00324155|344205|P2|Received Treatment in Maintenance Phase|Adverse Event|3
101297|NCT00324155|344206|P1|Received Treatment in Maintenance Phase|Adverse Event|0
101298|NCT00324155|344205|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
101299|NCT00324155|344206|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
101300|NCT00324155|344205|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
101301|NCT00324155|344206|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
101302|NCT00324155|344205|P2|Received Treatment in Maintenance Phase|Disease Progression|41
101303|NCT00324155|344206|P1|Received Treatment in Maintenance Phase|Disease Progression|26
101304|NCT00324155|344205|P2|Received Treatment in Induction Phase|Physician Decision|0
101305|NCT00324155|344206|P1|Received Treatment in Induction Phase|Physician Decision|2
101306|NCT00324155|344205|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
101307|NCT00324155|344206|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
101308|NCT00324155|344205|P2|Received Treatment in Induction Phase|Adverse Event|7
101309|NCT00324155|344206|P1|Received Treatment in Induction Phase|Adverse Event|6
101310|NCT00324155|344205|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
101311|NCT00324155|344206|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
101312|NCT00324155|344205|P2|Received Treatment in Induction Phase|Death|15
101313|NCT00324155|344206|P1|Received Treatment in Induction Phase|Death|8
101314|NCT00324155|344205|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
101315|NCT00324155|344206|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
101316|NCT00324155|344205|P2|Received Treatment in Induction Phase|Disease Progression|152
101317|NCT00324155|344206|P1|Received Treatment in Induction Phase|Disease Progression|88
101318|NCT00324155|344205|P2|Enrolled and Randomized|Lost to Follow-up|1
101319|NCT00324155|344206|P1|Enrolled and Randomized|Lost to Follow-up|0
101320|NCT00324155|344205|P2|Enrolled and Randomized|No longer met study criteria|0
101321|NCT00324155|344206|P1|Enrolled and Randomized|No longer met study criteria|3
101322|NCT00324168|344238|P2|Overall Study|Patient did not visit in f/u window|9
101323|NCT00324168|344239|P1|Overall Study|Patient did not visit in f/u window|6
101324|NCT00324168|344238|P2|Overall Study|Death|3
101325|NCT00324168|344239|P1|Overall Study|Death|3
101326|NCT00324168|344238|P2|Overall Study|Lost to Follow-up|18
101327|NCT00324168|344239|P1|Overall Study|Lost to Follow-up|19
101328|NCT00324233|344267|P2|Second Period|Protocol Violation|6
101329|NCT00324233|344268|P1|Second Period|Protocol Violation|4
101330|NCT00324233|344267|P2|Second Period|unable to insert catheter|1
101331|NCT00324233|344268|P1|Second Period|unable to insert catheter|1
101332|NCT00324233|344267|P2|First Period|unable to insert catheter|0
101333|NCT00324233|344268|P1|First Period|unable to insert catheter|1
101334|NCT00324649|344365|P2|Overall Study|Noncompliance|0
101335|NCT00324649|344366|P1|Overall Study|Noncompliance|1
101336|NCT00324649|344365|P2|Overall Study|Withdrawal by Subject|1
101337|NCT00324649|344366|P1|Overall Study|Withdrawal by Subject|0
101338|NCT00324649|344365|P2|Overall Study|Adverse Event|4
101339|NCT00324649|344366|P1|Overall Study|Adverse Event|1
101340|NCT00324675|344408|P2|Overall Study|Adverse Event|0
101341|NCT00324675|344409|P1|Overall Study|Adverse Event|1
101342|NCT00324740|344426|P3|Overall Study|Withdrawal by Subject|1
101343|NCT00324740|344427|P2|Overall Study|Withdrawal by Subject|0
101344|NCT00324740|344428|P1|Overall Study|Withdrawal by Subject|1
101345|NCT00330343|344435|P1|Overall Study|Lost to Follow-up|5
101346|NCT00336856|344505|P1|Overall Study|Found ineligible at time of analysis|1
101347|NCT00336856|344505|P1|Overall Study|Withdrawal by Subject|3
101348|NCT00336895|344511|P1|Overall Study|screen failed|1
101349|NCT00336895|344511|P1|Overall Study|Physician Decision|1
101350|NCT00336895|344511|P1|Overall Study|nausea and upset stomach|1
101351|NCT00336895|344511|P1|Overall Study|diarrhea|1
101352|NCT00342628|344564|P3|Overall Study|moved residence|1
101353|NCT00342628|344565|P2|Overall Study|moved residence|1
101354|NCT00342628|344566|P1|Overall Study|moved residence|0
101355|NCT00342628|344564|P3|Overall Study|Death|0
101356|NCT00342628|344565|P2|Overall Study|Death|1
101357|NCT00342628|344566|P1|Overall Study|Death|1
101358|NCT00342628|344564|P3|Overall Study|Withdrawal by Subject|18
101359|NCT00342628|344565|P2|Overall Study|Withdrawal by Subject|19
101360|NCT00342628|344566|P1|Overall Study|Withdrawal by Subject|19
101361|NCT00343252|344601|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
101362|NCT00343252|344602|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
101363|NCT00343252|344601|P2|18 Months (All Treated Participants)|Sponsor Decision|5
101364|NCT00343252|344602|P1|18 Months (All Treated Participants)|Sponsor Decision|8
101365|NCT00343252|344601|P2|18 Months (All Treated Participants)|Protocol Violation|3
101366|NCT00343252|344602|P1|18 Months (All Treated Participants)|Protocol Violation|3
101367|NCT00343252|344601|P2|18 Months (All Treated Participants)|Physician Decision|7
101368|NCT00343252|344602|P1|18 Months (All Treated Participants)|Physician Decision|4
101369|NCT00343252|344601|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
101370|NCT00343252|344602|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
101371|NCT00343252|344601|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
101372|NCT00343252|344602|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
101373|NCT00343252|344601|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
101374|NCT00343252|344602|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
101375|NCT00343252|344601|P2|18 Months (All Treated Participants)|Death|5
101376|NCT00343252|344602|P1|18 Months (All Treated Participants)|Death|4
101377|NCT00343252|344601|P2|18 Months (All Treated Participants)|Adverse Event|23
101378|NCT00343252|344602|P1|18 Months (All Treated Participants)|Adverse Event|31
101379|NCT00343252|344601|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
101380|NCT00343252|344602|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
101381|NCT00343252|344601|P2|12 Months (All Treated Participants)|Sponsor Decision|6
101382|NCT00343252|344602|P1|12 Months (All Treated Participants)|Sponsor Decision|9
101383|NCT00343252|344601|P2|12 Months (All Treated Participants)|Protocol Violation|2
101384|NCT00343252|344602|P1|12 Months (All Treated Participants)|Protocol Violation|3
101385|NCT00343252|344601|P2|12 Months (All Treated Participants)|Physician Decision|5
101386|NCT00343252|344602|P1|12 Months (All Treated Participants)|Physician Decision|4
101387|NCT00343252|344601|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
101388|NCT00343252|344602|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
101389|NCT00343252|344601|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
101390|NCT00343252|344602|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
101391|NCT00343252|344601|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
101392|NCT00343252|344602|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
101393|NCT00343252|344601|P2|12 Months (All Treated Participants)|Death|3
101394|NCT00343252|344602|P1|12 Months (All Treated Participants)|Death|3
101395|NCT00343252|344601|P2|12 Months (All Treated Participants)|Adverse Event|20
101396|NCT00343252|344602|P1|12 Months (All Treated Participants)|Adverse Event|22
101397|NCT00343252|344601|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
101398|NCT00343252|344602|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
101399|NCT00343252|344601|P2|6 Months (All Treated Participants)|Sponsor Decision|4
101400|NCT00343252|344602|P1|6 Months (All Treated Participants)|Sponsor Decision|7
101401|NCT00343252|344601|P2|6 Months (All Treated Participants)|Protocol Violation|2
101402|NCT00343252|344602|P1|6 Months (All Treated Participants)|Protocol Violation|2
101403|NCT00343252|344601|P2|6 Months (All Treated Participants)|Physician Decision|3
101404|NCT00343252|344602|P1|6 Months (All Treated Participants)|Physician Decision|1
101405|NCT00343252|344601|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
101406|NCT00343252|344602|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
101407|NCT00343252|344601|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
101408|NCT00343252|344602|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
101409|NCT00343252|344601|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
101410|NCT00343252|344602|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
101411|NCT00343252|344601|P2|6 Months (All Treated Participants)|Death|2
101412|NCT00343252|344602|P1|6 Months (All Treated Participants)|Death|0
101413|NCT00343252|344601|P2|6 Months (All Treated Participants)|Adverse Event|11
101414|NCT00343252|344602|P1|6 Months (All Treated Participants)|Adverse Event|17
101415|NCT00343291|344650|P2|Overall Study|Other|5
101416|NCT00343291|344651|P1|Overall Study|Other|8
101417|NCT00343291|344650|P2|Overall Study|Withdrawal by Subject|2
101418|NCT00343291|344651|P1|Overall Study|Withdrawal by Subject|0
101419|NCT00343291|344650|P2|Overall Study|Progressive disease|34
101420|NCT00343291|344651|P1|Overall Study|Progressive disease|33
101421|NCT00343291|344650|P2|Overall Study|Death|2
101422|NCT00343291|344651|P1|Overall Study|Death|3
101423|NCT00343291|344650|P2|Overall Study|Adverse Event|13
101424|NCT00343291|344651|P1|Overall Study|Adverse Event|13
101425|NCT00343382|344668|P3|Overall Study|Other Reason Not Specified|4
101426|NCT00343382|344669|P2|Overall Study|Other Reason Not Specified|2
101427|NCT00343382|344670|P1|Overall Study|Other Reason Not Specified|1
101428|NCT00343382|344668|P3|Overall Study|Withdrawal by Subject|6
101429|NCT00343382|344669|P2|Overall Study|Withdrawal by Subject|2
101430|NCT00343382|344670|P1|Overall Study|Withdrawal by Subject|1
101431|NCT00343382|344668|P3|Overall Study|Adverse Event|7
101432|NCT00343382|344669|P2|Overall Study|Adverse Event|10
101433|NCT00343382|344670|P1|Overall Study|Adverse Event|2
101434|NCT00343512|344766|P1|Overall Study|Withdrawal by Subject|2
101435|NCT00343889|344841|P2|Overall Study|Protocol Violation|0
101436|NCT00343889|344842|P1|Overall Study|Protocol Violation|1
101437|NCT00343889|344841|P2|Overall Study|Withdrawal by Subject|1
101438|NCT00343889|344842|P1|Overall Study|Withdrawal by Subject|0
101439|NCT00343889|344841|P2|Overall Study|Lost to Follow-up|0
101440|NCT00343889|344842|P1|Overall Study|Lost to Follow-up|2
101441|NCT00343915|344860|P2|Primary Study|Unspecified|0
101442|NCT00343915|344861|P1|Primary Study|Unspecified|1
101443|NCT00343915|344860|P2|Primary Study|Lost to Follow-up|3
101444|NCT00343915|344861|P1|Primary Study|Lost to Follow-up|2
101445|NCT00343915|344860|P2|Primary Study|Withdrawal by Subject|0
101446|NCT00343915|344861|P1|Primary Study|Withdrawal by Subject|1
101447|NCT00344019|344888|P3|Overall Study|did not meet final inclusion criteria|74
101448|NCT00344019|344889|P2|Overall Study|did not meet final inclusion criteria|0
101449|NCT00344019|344890|P1|Overall Study|did not meet final inclusion criteria|0
101450|NCT00344032|344899|P2|Overall Study|Physician Decision|1
101451|NCT00344032|344900|P1|Overall Study|Physician Decision|4
101452|NCT00344032|344899|P2|Overall Study|Lost to Follow-up|6
101453|NCT00344032|344900|P1|Overall Study|Lost to Follow-up|4
101454|NCT00344032|344899|P2|Overall Study|Withdrawal by Subject|2
101455|NCT00344032|344900|P1|Overall Study|Withdrawal by Subject|6
101456|NCT00344032|344899|P2|Overall Study|Adverse Event|1
101457|NCT00344032|344900|P1|Overall Study|Adverse Event|0
101458|NCT00333619|344939|P2|Overall Study|Lost to Follow-up|3
101459|NCT00333619|344940|P1|Overall Study|Lost to Follow-up|3
101460|NCT00333619|344939|P2|Overall Study|Withdrawal by Subject|1
101461|NCT00333619|344940|P1|Overall Study|Withdrawal by Subject|6
101462|NCT00333619|344939|P2|Overall Study|Death|6
101463|NCT00333619|344940|P1|Overall Study|Death|12
101464|NCT00333775|344968|P3|Overall Study|Lost to Follow-up|8
101465|NCT00333775|344969|P2|Overall Study|Lost to Follow-up|7
101466|NCT00333775|344970|P1|Overall Study|Lost to Follow-up|10
101467|NCT00333775|344968|P3|Overall Study|In Follow−up When Study Stopped|96
101468|NCT00333775|344969|P2|Overall Study|In Follow−up When Study Stopped|92
101469|NCT00333775|344970|P1|Overall Study|In Follow−up When Study Stopped|87
101470|NCT00333775|344968|P3|Overall Study|Death|143
101471|NCT00333775|344969|P2|Overall Study|Death|149
101472|NCT00333775|344970|P1|Overall Study|Death|144
101473|NCT00333788|344990|P1|Overall Study|Other: Signed consent for another study|1
101474|NCT00333788|344990|P1|Overall Study|Other: Physician decision|1
101475|NCT00333788|344990|P1|Overall Study|Other: Medical monitor decision|1
101476|NCT00333788|344990|P1|Overall Study|Other: Subject in need of an Entocort|1
101477|NCT00333788|344990|P1|Overall Study|Other: Sponsor decision|1
101478|NCT00333788|344990|P1|Overall Study|Other: Quality of life concern|1
101479|NCT00333788|344990|P1|Overall Study|Other: Investigator decision|1
101480|NCT00333788|344990|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
101481|NCT00333788|344990|P1|Overall Study|Other: Moved|2
101482|NCT00333788|344990|P1|Overall Study|Other: Non-compliance|2
101483|NCT00333788|344990|P1|Overall Study|Withdrawal by Subject|24
101484|NCT00333788|344990|P1|Overall Study|Lost to Follow-up|2
101485|NCT00333788|344990|P1|Overall Study|Lack of Efficacy|80
101486|NCT00333788|344990|P1|Overall Study|Adverse Event|44
101487|NCT00333801|345019|P2|Overall Study|Withdrawal by Subject|1
101488|NCT00333801|345020|P1|Overall Study|Withdrawal by Subject|0
101489|NCT00333801|345019|P2|Overall Study|Incarcerated|2
101490|NCT00333801|345020|P1|Overall Study|Incarcerated|1
101491|NCT00333801|345019|P2|Overall Study|Lost to Follow-up|0
101492|NCT00333801|345020|P1|Overall Study|Lost to Follow-up|2
101493|NCT00333801|345019|P2|Overall Study|Moved to another state|3
101494|NCT00333801|345020|P1|Overall Study|Moved to another state|5
101495|NCT00333840|345059|P4|Second-line Treatment Period|Death|9
101496|NCT00333840|345060|P3|Second-line Treatment Period|Death|0
101497|NCT00333840|345061|P2|Second-line Treatment Period|Death|0
101498|NCT00333840|345062|P1|Second-line Treatment Period|Death|0
101499|NCT00333840|345059|P4|Second-line Treatment Period|Administrative problems|7
101500|NCT00333840|345060|P3|Second-line Treatment Period|Administrative problems|0
101501|NCT00333840|345061|P2|Second-line Treatment Period|Administrative problems|0
101502|NCT00333840|345062|P1|Second-line Treatment Period|Administrative problems|0
101503|NCT00333840|345059|P4|Second-line Treatment Period|Lost to Follow-up|6
101504|NCT00333840|345060|P3|Second-line Treatment Period|Lost to Follow-up|0
101505|NCT00333840|345061|P2|Second-line Treatment Period|Lost to Follow-up|0
101506|NCT00333840|345062|P1|Second-line Treatment Period|Lost to Follow-up|0
101507|NCT00333840|345059|P4|Second-line Treatment Period|Subject withdrew consent|34
101508|NCT00333840|345060|P3|Second-line Treatment Period|Subject withdrew consent|0
101509|NCT00333840|345061|P2|Second-line Treatment Period|Subject withdrew consent|0
101510|NCT00333840|345062|P1|Second-line Treatment Period|Subject withdrew consent|0
101511|NCT00333840|345059|P4|Second-line Treatment Period|Protocol Violation|10
101512|NCT00333840|345060|P3|Second-line Treatment Period|Protocol Violation|1
101513|NCT00333840|345061|P2|Second-line Treatment Period|Protocol Violation|0
101514|NCT00333840|345062|P1|Second-line Treatment Period|Protocol Violation|0
101515|NCT00333840|345059|P4|Second-line Treatment Period|No longer required study drug|14
101516|NCT00333840|345060|P3|Second-line Treatment Period|No longer required study drug|1
101517|NCT00333840|345061|P2|Second-line Treatment Period|No longer required study drug|0
101518|NCT00333840|345062|P1|Second-line Treatment Period|No longer required study drug|0
101519|NCT00333840|345059|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
101520|NCT00333840|345060|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
101521|NCT00333840|345061|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
101522|NCT00333840|345062|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
101523|NCT00333840|345059|P4|Second-line Treatment Period|Abnormal procedure|1
101524|NCT00333840|345060|P3|Second-line Treatment Period|Abnormal procedure|0
101525|NCT00333840|345061|P2|Second-line Treatment Period|Abnormal procedure|0
101526|NCT00333840|345062|P1|Second-line Treatment Period|Abnormal procedure|0
101527|NCT00333840|345059|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
101528|NCT00333840|345060|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
101529|NCT00333840|345061|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
101530|NCT00333840|345062|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
101531|NCT00333840|345059|P4|Second-line Treatment Period|Adverse Event|34
101532|NCT00333840|345060|P3|Second-line Treatment Period|Adverse Event|3
101533|NCT00333840|345061|P2|Second-line Treatment Period|Adverse Event|0
101534|NCT00333840|345062|P1|Second-line Treatment Period|Adverse Event|0
101535|NCT00333840|345059|P4|First-line Treatment Period|Crossed over to other treatment arm|0
101536|NCT00333840|345060|P3|First-line Treatment Period|Crossed over to other treatment arm|0
101537|NCT00333840|345061|P2|First-line Treatment Period|Crossed over to other treatment arm|363
101538|NCT00333840|345062|P1|First-line Treatment Period|Crossed over to other treatment arm|14
101539|NCT00333840|345059|P4|First-line Treatment Period|Death|0
101540|NCT00333840|345060|P3|First-line Treatment Period|Death|0
101541|NCT00333840|345061|P2|First-line Treatment Period|Death|2
101542|NCT00333840|345062|P1|First-line Treatment Period|Death|19
101543|NCT00333840|345059|P4|First-line Treatment Period|Administrative problems|0
101544|NCT00333840|345060|P3|First-line Treatment Period|Administrative problems|0
101545|NCT00333840|345061|P2|First-line Treatment Period|Administrative problems|6
101546|NCT00333840|345062|P1|First-line Treatment Period|Administrative problems|12
101547|NCT00333840|345059|P4|First-line Treatment Period|Lost to Follow-up|0
101548|NCT00333840|345060|P3|First-line Treatment Period|Lost to Follow-up|0
101549|NCT00333840|345061|P2|First-line Treatment Period|Lost to Follow-up|6
101550|NCT00333840|345062|P1|First-line Treatment Period|Lost to Follow-up|15
101551|NCT00333840|345059|P4|First-line Treatment Period|Subject withdrew consent|0
101552|NCT00333840|345060|P3|First-line Treatment Period|Subject withdrew consent|0
101553|NCT00333840|345061|P2|First-line Treatment Period|Subject withdrew consent|77
101554|NCT00333840|345062|P1|First-line Treatment Period|Subject withdrew consent|57
101555|NCT00333840|345059|P4|First-line Treatment Period|Protocol Violation|0
101556|NCT00333840|345060|P3|First-line Treatment Period|Protocol Violation|0
101557|NCT00333840|345061|P2|First-line Treatment Period|Protocol Violation|17
101558|NCT00333840|345062|P1|First-line Treatment Period|Protocol Violation|17
101559|NCT00333840|345059|P4|First-line Treatment Period|No longer required study drug|0
101560|NCT00333840|345060|P3|First-line Treatment Period|No longer required study drug|0
101561|NCT00333840|345061|P2|First-line Treatment Period|No longer required study drug|8
101562|NCT00333840|345062|P1|First-line Treatment Period|No longer required study drug|21
101563|NCT00333840|345059|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
101564|NCT00333840|345060|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
101565|NCT00333840|345061|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
101566|NCT00333840|345062|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
101567|NCT00333840|345059|P4|First-line Treatment Period|Abnormal procedure|0
101568|NCT00333840|345060|P3|First-line Treatment Period|Abnormal procedure|0
101569|NCT00333840|345061|P2|First-line Treatment Period|Abnormal procedure|0
101570|NCT00333840|345062|P1|First-line Treatment Period|Abnormal procedure|2
101571|NCT00333840|345059|P4|First-line Treatment Period|Abnormal laboratory values|0
101572|NCT00333840|345060|P3|First-line Treatment Period|Abnormal laboratory values|0
101573|NCT00333840|345061|P2|First-line Treatment Period|Abnormal laboratory values|1
101574|NCT00333840|345062|P1|First-line Treatment Period|Abnormal laboratory values|3
101575|NCT00333840|345059|P4|First-line Treatment Period|Adverse Event|0
101576|NCT00333840|345060|P3|First-line Treatment Period|Adverse Event|0
101577|NCT00333840|345061|P2|First-line Treatment Period|Adverse Event|37
101578|NCT00333840|345062|P1|First-line Treatment Period|Adverse Event|38
101579|NCT00333866|345091|P4|Overall Study|Randomized but not Treated|1
101580|NCT00333866|345092|P3|Overall Study|Randomized but not Treated|2
101581|NCT00333866|345093|P2|Overall Study|Randomized but not Treated|3
101582|NCT00333866|345094|P1|Overall Study|Randomized but not Treated|5
101583|NCT00333866|345091|P4|Overall Study|Withdrawal by Subject|9
101584|NCT00333866|345092|P3|Overall Study|Withdrawal by Subject|4
101585|NCT00333866|345093|P2|Overall Study|Withdrawal by Subject|14
101586|NCT00333866|345094|P1|Overall Study|Withdrawal by Subject|8
101587|NCT00333866|345091|P4|Overall Study|Lost to Follow-up|2
101588|NCT00333866|345092|P3|Overall Study|Lost to Follow-up|2
101589|NCT00333866|345093|P2|Overall Study|Lost to Follow-up|2
101590|NCT00333866|345094|P1|Overall Study|Lost to Follow-up|1
101591|NCT00333866|345091|P4|Overall Study|Lack of Efficacy|5
101592|NCT00333866|345092|P3|Overall Study|Lack of Efficacy|3
101593|NCT00333866|345093|P2|Overall Study|Lack of Efficacy|6
101594|NCT00333866|345094|P1|Overall Study|Lack of Efficacy|8
101595|NCT00333866|345091|P4|Overall Study|Unspecified|2
101596|NCT00333866|345092|P3|Overall Study|Unspecified|2
101597|NCT00333866|345093|P2|Overall Study|Unspecified|2
101598|NCT00333866|345094|P1|Overall Study|Unspecified|3
101599|NCT00333866|345091|P4|Overall Study|Adverse Event|47
101600|NCT00333866|345092|P3|Overall Study|Adverse Event|38
101601|NCT00333866|345093|P2|Overall Study|Adverse Event|37
101602|NCT00333866|345094|P1|Overall Study|Adverse Event|23
101603|NCT00333970|345159|P2|Overall Study|Withdrawal by Subject|7
101604|NCT00333970|345160|P1|Overall Study|Withdrawal by Subject|13
101605|NCT00333983|345169|P3|Overall Study|Withdrawal by Subject|1
101606|NCT00333983|345170|P2|Overall Study|Withdrawal by Subject|3
101607|NCT00333983|345171|P1|Overall Study|Withdrawal by Subject|0
101608|NCT00333983|345169|P3|Overall Study|Adverse Event|1
101609|NCT00333983|345170|P2|Overall Study|Adverse Event|1
101610|NCT00333983|345171|P1|Overall Study|Adverse Event|1
101611|NCT00333983|345169|P3|Overall Study|Lost to Follow-up|0
101612|NCT00333983|345170|P2|Overall Study|Lost to Follow-up|1
101613|NCT00333983|345171|P1|Overall Study|Lost to Follow-up|2
101614|NCT00344305|345181|P2|Overall Study|Participant was not contacted in window|1
101615|NCT00344305|345182|P1|Overall Study|Participant was not contacted in window|0
101616|NCT00344305|345181|P2|Overall Study|Lost to Follow-up|0
101617|NCT00344305|345182|P1|Overall Study|Lost to Follow-up|2
101618|NCT00344448|345230|P2|Open Label|Study terminated|0
101619|NCT00344448|345231|P1|Open Label|Study terminated|1
101620|NCT00344448|345230|P2|Open Label|Withdrawal by Subject|1
101621|NCT00344448|345231|P1|Open Label|Withdrawal by Subject|1
101622|NCT00344448|345230|P2|Double Blind, Placebo Controlled|Study terminated|0
101623|NCT00344448|345231|P1|Double Blind, Placebo Controlled|Study terminated|1
101624|NCT00344448|345230|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
101625|NCT00344448|345231|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
101626|NCT00344448|345230|P2|Screening|Withdrawal by Subject|1
101627|NCT00344448|345231|P1|Screening|Withdrawal by Subject|0
101628|NCT00344487|345237|P1|Overall Study|immunologic failure|1
101629|NCT00344500|345243|P3|Overall Study|Not Noted|0
101630|NCT00344500|345244|P2|Overall Study|Not Noted|3
101631|NCT00344500|345245|P1|Overall Study|Not Noted|1
101632|NCT00344500|345243|P3|Overall Study|Protocol Violation|1
101633|NCT00344500|345244|P2|Overall Study|Protocol Violation|7
101634|NCT00344500|345245|P1|Overall Study|Protocol Violation|4
101635|NCT00344500|345243|P3|Overall Study|Withdrawal by Subject|0
101636|NCT00344500|345244|P2|Overall Study|Withdrawal by Subject|10
101637|NCT00344500|345245|P1|Overall Study|Withdrawal by Subject|7
101638|NCT00344500|345243|P3|Overall Study|Lost to Follow-up|1
101639|NCT00344500|345244|P2|Overall Study|Lost to Follow-up|13
101640|NCT00344500|345245|P1|Overall Study|Lost to Follow-up|5
101641|NCT00344500|345243|P3|Overall Study|Adverse Event|0
101642|NCT00344500|345244|P2|Overall Study|Adverse Event|2
101643|NCT00344500|345245|P1|Overall Study|Adverse Event|6
101644|NCT00345631|345259|P3|Overall Study|Other reasons|1
101645|NCT00345631|345260|P2|Overall Study|Other reasons|0
101646|NCT00345631|345261|P1|Overall Study|Other reasons|0
101647|NCT00345631|345259|P3|Overall Study|Lost to Follow-up|4
101648|NCT00345631|345260|P2|Overall Study|Lost to Follow-up|7
101649|NCT00345631|345261|P1|Overall Study|Lost to Follow-up|3
101650|NCT00345631|345259|P3|Overall Study|Adverse Event|0
101651|NCT00345631|345260|P2|Overall Study|Adverse Event|1
101652|NCT00345631|345261|P1|Overall Study|Adverse Event|0
101653|NCT00345631|345259|P3|Overall Study|Withdrawal by Subject|1
101654|NCT00345631|345260|P2|Overall Study|Withdrawal by Subject|0
101655|NCT00345631|345261|P1|Overall Study|Withdrawal by Subject|1
101656|NCT00345683|345295|P2|Overall Study|Unspecified|2
101657|NCT00345683|345296|P1|Overall Study|Unspecified|6
101658|NCT00345683|345295|P2|Overall Study|Lost to Follow-up|7
101659|NCT00345683|345296|P1|Overall Study|Lost to Follow-up|19
101660|NCT00345839|345318|P2|Overall Study|Lost to Follow-up|61
101661|NCT00345839|345319|P1|Overall Study|Lost to Follow-up|58
101662|NCT00345839|345318|P2|Overall Study|Withdrawal by Subject|98
101663|NCT00345839|345319|P1|Overall Study|Withdrawal by Subject|91
101664|NCT00345878|345345|P2|Overall Study|Other|0
101665|NCT00345878|345346|P1|Overall Study|Other|1
101666|NCT00345878|345345|P2|Overall Study|Lost to Follow-up|1
101667|NCT00345878|345346|P1|Overall Study|Lost to Follow-up|2
101668|NCT00345878|345345|P2|Overall Study|Adverse Event|0
101669|NCT00345878|345346|P1|Overall Study|Adverse Event|1
101670|NCT00346034|345362|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
101671|NCT00346034|345362|P1|Overall Study|Patient Stopped Taking Study Drug|1
101672|NCT00346034|345362|P1|Overall Study|Withdrawal by Subject|13
101673|NCT00346034|345362|P1|Overall Study|Lack of Efficacy|8
101674|NCT00346034|345362|P1|Overall Study|Adverse Event|34
101675|NCT00346151|345367|P1|Overall Study|Withdrawal by Subject|3
101676|NCT00346216|345388|P3|Overall Study|Missing Subject Summary Status|62
101677|NCT00346216|345389|P2|Overall Study|Missing Subject Summary Status|61
101678|NCT00346216|345390|P1|Overall Study|Missing Subject Summary Status|62
101679|NCT00346216|345388|P3|Overall Study|Study terminated by sponsor|8
101680|NCT00346216|345389|P2|Overall Study|Study terminated by sponsor|4
101681|NCT00346216|345390|P1|Overall Study|Study terminated by sponsor|11
101682|NCT00346216|345388|P3|Overall Study|Death|228
101683|NCT00346216|345389|P2|Overall Study|Death|192
101684|NCT00346216|345390|P1|Overall Study|Death|189
101685|NCT00346216|345388|P3|Overall Study|Does not meet entrance criteria|8
101686|NCT00346216|345389|P2|Overall Study|Does not meet entrance criteria|10
101687|NCT00346216|345390|P1|Overall Study|Does not meet entrance criteria|13
101688|NCT00346216|345388|P3|Overall Study|Physician Decision|59
101689|NCT00346216|345389|P2|Overall Study|Physician Decision|76
101690|NCT00346216|345390|P1|Overall Study|Physician Decision|80
101691|NCT00346216|345388|P3|Overall Study|Lost to Follow-up|542
101692|NCT00346216|345389|P2|Overall Study|Lost to Follow-up|588
101693|NCT00346216|345390|P1|Overall Study|Lost to Follow-up|611
101694|NCT00346216|345388|P3|Overall Study|Withdrawal by Subject|651
101695|NCT00346216|345389|P2|Overall Study|Withdrawal by Subject|692
101696|NCT00346216|345390|P1|Overall Study|Withdrawal by Subject|661
101697|NCT00346216|345388|P3|Overall Study|No longer willing to participate|585
101698|NCT00346216|345389|P2|Overall Study|No longer willing to participate|606
101699|NCT00346216|345390|P1|Overall Study|No longer willing to participate|600
101700|NCT00346216|345388|P3|Overall Study|Not specified|205
101701|NCT00346216|345389|P2|Overall Study|Not specified|231
101702|NCT00346216|345390|P1|Overall Study|Not specified|181
101703|NCT00346268|345409|P2|Overall Study|Participant refused|3
101704|NCT00346268|345410|P1|Overall Study|Participant refused|0
101705|NCT00346268|345409|P2|Overall Study|Protocol Violation|0
101706|NCT00346268|345410|P1|Overall Study|Protocol Violation|1
101707|NCT00346268|345409|P2|Overall Study|Adverse Event|0
101708|NCT00346268|345410|P1|Overall Study|Adverse Event|1
101709|NCT00346333|345444|P2|Overall Study|unwilling or unable to continue|8
101710|NCT00346333|345445|P1|Overall Study|unwilling or unable to continue|4
101711|NCT00346333|345444|P2|Overall Study|Death|0
101712|NCT00346333|345445|P1|Overall Study|Death|1
101713|NCT00346398|345461|P2|Overall Study|Withdrawal by Subject|2
101714|NCT00346398|345462|P1|Overall Study|Withdrawal by Subject|0
101715|NCT00346398|345461|P2|Overall Study|Lost to Follow-up|0
101716|NCT00346398|345462|P1|Overall Study|Lost to Follow-up|3
101717|NCT00346632|345479|P10|Overall Study|Not Stated|1
101718|NCT00346632|345480|P9|Overall Study|Not Stated|2
101719|NCT00346632|345481|P8|Overall Study|Not Stated|2
101720|NCT00346632|345482|P7|Overall Study|Not Stated|0
101721|NCT00346632|345483|P6|Overall Study|Not Stated|0
101722|NCT00346632|345484|P5|Overall Study|Not Stated|0
101723|NCT00346632|345485|P4|Overall Study|Not Stated|0
101724|NCT00346632|345486|P3|Overall Study|Not Stated|0
101725|NCT00346632|345487|P2|Overall Study|Not Stated|1
101726|NCT00346632|345488|P1|Overall Study|Not Stated|1
101727|NCT00346632|345479|P10|Overall Study|Switched to alternative treatment|0
101728|NCT00346632|345480|P9|Overall Study|Switched to alternative treatment|0
101729|NCT00346632|345481|P8|Overall Study|Switched to alternative treatment|0
101730|NCT00346632|345482|P7|Overall Study|Switched to alternative treatment|0
101731|NCT00346632|345483|P6|Overall Study|Switched to alternative treatment|0
101732|NCT00346632|345484|P5|Overall Study|Switched to alternative treatment|0
101733|NCT00346632|345485|P4|Overall Study|Switched to alternative treatment|0
101734|NCT00346632|345486|P3|Overall Study|Switched to alternative treatment|1
101735|NCT00346632|345487|P2|Overall Study|Switched to alternative treatment|0
101736|NCT00346632|345488|P1|Overall Study|Switched to alternative treatment|0
101737|NCT00346632|345479|P10|Overall Study|Withdrawal by Subject|0
101738|NCT00346632|345480|P9|Overall Study|Withdrawal by Subject|0
101739|NCT00346632|345481|P8|Overall Study|Withdrawal by Subject|0
101740|NCT00346632|345482|P7|Overall Study|Withdrawal by Subject|1
101741|NCT00346632|345483|P6|Overall Study|Withdrawal by Subject|0
101742|NCT00346632|345484|P5|Overall Study|Withdrawal by Subject|0
101743|NCT00346632|345485|P4|Overall Study|Withdrawal by Subject|0
101744|NCT00346632|345486|P3|Overall Study|Withdrawal by Subject|0
101745|NCT00346632|345487|P2|Overall Study|Withdrawal by Subject|0
101746|NCT00346632|345488|P1|Overall Study|Withdrawal by Subject|0
101747|NCT00346632|345479|P10|Overall Study|Protocol Violation|0
101748|NCT00346632|345480|P9|Overall Study|Protocol Violation|0
101749|NCT00346632|345481|P8|Overall Study|Protocol Violation|0
101750|NCT00346632|345482|P7|Overall Study|Protocol Violation|1
101751|NCT00346632|345483|P6|Overall Study|Protocol Violation|0
101752|NCT00346632|345484|P5|Overall Study|Protocol Violation|0
101753|NCT00346632|345485|P4|Overall Study|Protocol Violation|0
101754|NCT00346632|345486|P3|Overall Study|Protocol Violation|0
101755|NCT00346632|345487|P2|Overall Study|Protocol Violation|0
101756|NCT00346632|345488|P1|Overall Study|Protocol Violation|0
101757|NCT00346632|345479|P10|Overall Study|Death|0
101758|NCT00346632|345480|P9|Overall Study|Death|0
101759|NCT00346632|345481|P8|Overall Study|Death|0
101760|NCT00346632|345482|P7|Overall Study|Death|0
101761|NCT00346632|345483|P6|Overall Study|Death|0
101762|NCT00346632|345484|P5|Overall Study|Death|0
101763|NCT00346632|345485|P4|Overall Study|Death|0
101764|NCT00346632|345486|P3|Overall Study|Death|1
101765|NCT00346632|345487|P2|Overall Study|Death|0
101766|NCT00346632|345488|P1|Overall Study|Death|0
101767|NCT00346632|345479|P10|Overall Study|Adverse Event|0
101768|NCT00346632|345480|P9|Overall Study|Adverse Event|0
101769|NCT00346632|345481|P8|Overall Study|Adverse Event|0
101770|NCT00346632|345482|P7|Overall Study|Adverse Event|1
101771|NCT00346632|345483|P6|Overall Study|Adverse Event|1
101772|NCT00346632|345484|P5|Overall Study|Adverse Event|1
101773|NCT00346632|345485|P4|Overall Study|Adverse Event|0
101774|NCT00346632|345486|P3|Overall Study|Adverse Event|0
101775|NCT00346632|345487|P2|Overall Study|Adverse Event|0
101776|NCT00346632|345488|P1|Overall Study|Adverse Event|0
101777|NCT00346632|345479|P10|Overall Study|Progressive Disease|2
101778|NCT00346632|345480|P9|Overall Study|Progressive Disease|2
101779|NCT00346632|345481|P8|Overall Study|Progressive Disease|2
101780|NCT00346632|345482|P7|Overall Study|Progressive Disease|2
101781|NCT00346632|345483|P6|Overall Study|Progressive Disease|1
101782|NCT00346632|345484|P5|Overall Study|Progressive Disease|3
101783|NCT00346632|345485|P4|Overall Study|Progressive Disease|3
101784|NCT00346632|345486|P3|Overall Study|Progressive Disease|4
101785|NCT00346632|345487|P2|Overall Study|Progressive Disease|2
101786|NCT00346632|345488|P1|Overall Study|Progressive Disease|2
101787|NCT00346697|345633|P2|Overall Study|Lost to Follow-up|1
101788|NCT00346697|345634|P1|Overall Study|Lost to Follow-up|0
101789|NCT00347009|345672|P1|Overall Study|Serious Adverse Event|1
101790|NCT00347009|345672|P1|Overall Study|Increased ALT/HBV DNA|1
101791|NCT00347009|345672|P1|Overall Study|Insufficient Viral Suppression|3
101792|NCT00347009|345672|P1|Overall Study|Adverse Laboratory Experience|1
101793|NCT00347009|345672|P1|Overall Study|Protocol Violation|2
101794|NCT00347009|345672|P1|Overall Study|Lost to Follow-up|4
101795|NCT00347009|345672|P1|Overall Study|Physician Decision|5
101796|NCT00347009|345672|P1|Overall Study|Withdrawal by Subject|3
101797|NCT00347009|345672|P1|Overall Study|Adverse Event|6
101798|NCT00347009|345672|P1|Overall Study|Death|1
101799|NCT00347269|345700|P2|Overall Study|Death|3
101800|NCT00347269|345701|P1|Overall Study|Death|2
101801|NCT00347269|345700|P2|Overall Study|Withdrawal by Subject|38
101802|NCT00347269|345701|P1|Overall Study|Withdrawal by Subject|18
101803|NCT00347269|345700|P2|Overall Study|Lost to Follow-up|65
101804|NCT00347269|345701|P1|Overall Study|Lost to Follow-up|74
101805|NCT00347360|345726|P15|Overall Study|Visits conflicted with new job|0
101806|NCT00347360|345727|P14|Overall Study|Visits conflicted with new job|0
101807|NCT00347360|345728|P13|Overall Study|Visits conflicted with new job|0
101808|NCT00347360|345729|P12|Overall Study|Visits conflicted with new job|0
101809|NCT00347360|345730|P11|Overall Study|Visits conflicted with new job|0
101810|NCT00347360|345731|P10|Overall Study|Visits conflicted with new job|0
101811|NCT00347360|345732|P9|Overall Study|Visits conflicted with new job|0
101812|NCT00347360|345733|P8|Overall Study|Visits conflicted with new job|0
101813|NCT00347360|345734|P7|Overall Study|Visits conflicted with new job|1
101814|NCT00347360|345735|P6|Overall Study|Visits conflicted with new job|0
101815|NCT00347360|345736|P5|Overall Study|Visits conflicted with new job|0
101816|NCT00347360|345737|P4|Overall Study|Visits conflicted with new job|0
101817|NCT00347360|345738|P3|Overall Study|Visits conflicted with new job|0
101818|NCT00347360|345739|P2|Overall Study|Visits conflicted with new job|0
101819|NCT00347360|345740|P1|Overall Study|Visits conflicted with new job|0
101820|NCT00347360|345726|P15|Overall Study|Subject refuse to sign updated consent|1
101821|NCT00347360|345727|P14|Overall Study|Subject refuse to sign updated consent|0
101822|NCT00347360|345728|P13|Overall Study|Subject refuse to sign updated consent|0
101823|NCT00347360|345729|P12|Overall Study|Subject refuse to sign updated consent|0
101824|NCT00347360|345730|P11|Overall Study|Subject refuse to sign updated consent|0
101825|NCT00347360|345731|P10|Overall Study|Subject refuse to sign updated consent|0
101826|NCT00347360|345732|P9|Overall Study|Subject refuse to sign updated consent|0
101827|NCT00347360|345733|P8|Overall Study|Subject refuse to sign updated consent|0
101828|NCT00347360|345734|P7|Overall Study|Subject refuse to sign updated consent|0
101829|NCT00347360|345735|P6|Overall Study|Subject refuse to sign updated consent|0
101830|NCT00347360|345736|P5|Overall Study|Subject refuse to sign updated consent|0
101831|NCT00347360|345737|P4|Overall Study|Subject refuse to sign updated consent|0
101832|NCT00347360|345738|P3|Overall Study|Subject refuse to sign updated consent|0
101833|NCT00347360|345739|P2|Overall Study|Subject refuse to sign updated consent|0
101834|NCT00347360|345740|P1|Overall Study|Subject refuse to sign updated consent|0
101835|NCT00347360|345726|P15|Overall Study|Subject left town, ran out of study drug|0
101836|NCT00347360|345727|P14|Overall Study|Subject left town, ran out of study drug|1
101837|NCT00347360|345728|P13|Overall Study|Subject left town, ran out of study drug|0
101838|NCT00347360|345729|P12|Overall Study|Subject left town, ran out of study drug|0
101839|NCT00347360|345730|P11|Overall Study|Subject left town, ran out of study drug|0
101840|NCT00347360|345731|P10|Overall Study|Subject left town, ran out of study drug|0
101841|NCT00347360|345732|P9|Overall Study|Subject left town, ran out of study drug|0
101842|NCT00347360|345733|P8|Overall Study|Subject left town, ran out of study drug|0
101843|NCT00347360|345734|P7|Overall Study|Subject left town, ran out of study drug|0
101844|NCT00347360|345735|P6|Overall Study|Subject left town, ran out of study drug|0
101845|NCT00347360|345736|P5|Overall Study|Subject left town, ran out of study drug|0
101846|NCT00347360|345737|P4|Overall Study|Subject left town, ran out of study drug|0
101847|NCT00347360|345738|P3|Overall Study|Subject left town, ran out of study drug|0
101848|NCT00347360|345739|P2|Overall Study|Subject left town, ran out of study drug|0
101849|NCT00347360|345740|P1|Overall Study|Subject left town, ran out of study drug|0
101850|NCT00347360|345726|P15|Overall Study|Prolonged duration between visits|0
101851|NCT00347360|345727|P14|Overall Study|Prolonged duration between visits|0
101852|NCT00347360|345728|P13|Overall Study|Prolonged duration between visits|1
101853|NCT00347360|345729|P12|Overall Study|Prolonged duration between visits|0
101854|NCT00347360|345730|P11|Overall Study|Prolonged duration between visits|0
101855|NCT00347360|345731|P10|Overall Study|Prolonged duration between visits|0
101856|NCT00347360|345732|P9|Overall Study|Prolonged duration between visits|0
101857|NCT00347360|345733|P8|Overall Study|Prolonged duration between visits|0
101858|NCT00347360|345734|P7|Overall Study|Prolonged duration between visits|0
101859|NCT00347360|345735|P6|Overall Study|Prolonged duration between visits|0
101860|NCT00347360|345736|P5|Overall Study|Prolonged duration between visits|0
101861|NCT00347360|345737|P4|Overall Study|Prolonged duration between visits|0
101862|NCT00347360|345738|P3|Overall Study|Prolonged duration between visits|0
101863|NCT00347360|345739|P2|Overall Study|Prolonged duration between visits|0
101864|NCT00347360|345740|P1|Overall Study|Prolonged duration between visits|0
101865|NCT00347360|345726|P15|Overall Study|Failed inclusion criteria #4|0
101866|NCT00347360|345727|P14|Overall Study|Failed inclusion criteria #4|0
101867|NCT00347360|345728|P13|Overall Study|Failed inclusion criteria #4|0
101868|NCT00347360|345729|P12|Overall Study|Failed inclusion criteria #4|1
101869|NCT00347360|345730|P11|Overall Study|Failed inclusion criteria #4|0
101870|NCT00347360|345731|P10|Overall Study|Failed inclusion criteria #4|0
101871|NCT00347360|345732|P9|Overall Study|Failed inclusion criteria #4|0
101872|NCT00347360|345733|P8|Overall Study|Failed inclusion criteria #4|0
101873|NCT00347360|345734|P7|Overall Study|Failed inclusion criteria #4|0
101874|NCT00347360|345735|P6|Overall Study|Failed inclusion criteria #4|0
101875|NCT00347360|345736|P5|Overall Study|Failed inclusion criteria #4|0
101876|NCT00347360|345737|P4|Overall Study|Failed inclusion criteria #4|0
101877|NCT00347360|345738|P3|Overall Study|Failed inclusion criteria #4|0
101878|NCT00347360|345739|P2|Overall Study|Failed inclusion criteria #4|0
101879|NCT00347360|345740|P1|Overall Study|Failed inclusion criteria #4|0
101880|NCT00347360|345726|P15|Overall Study|Randomized in error|0
101881|NCT00347360|345727|P14|Overall Study|Randomized in error|0
101882|NCT00347360|345728|P13|Overall Study|Randomized in error|0
101883|NCT00347360|345729|P12|Overall Study|Randomized in error|1
101884|NCT00347360|345730|P11|Overall Study|Randomized in error|0
101885|NCT00347360|345731|P10|Overall Study|Randomized in error|0
101886|NCT00347360|345732|P9|Overall Study|Randomized in error|0
101887|NCT00347360|345733|P8|Overall Study|Randomized in error|0
101888|NCT00347360|345734|P7|Overall Study|Randomized in error|0
101889|NCT00347360|345735|P6|Overall Study|Randomized in error|0
101890|NCT00347360|345736|P5|Overall Study|Randomized in error|0
101891|NCT00347360|345737|P4|Overall Study|Randomized in error|0
101892|NCT00347360|345738|P3|Overall Study|Randomized in error|0
101893|NCT00347360|345739|P2|Overall Study|Randomized in error|0
101894|NCT00347360|345740|P1|Overall Study|Randomized in error|0
101895|NCT00347360|345726|P15|Overall Study|Did not meet criteria before ABPM|0
101896|NCT00347360|345727|P14|Overall Study|Did not meet criteria before ABPM|0
101897|NCT00347360|345728|P13|Overall Study|Did not meet criteria before ABPM|0
101898|NCT00347360|345729|P12|Overall Study|Did not meet criteria before ABPM|0
101899|NCT00347360|345730|P11|Overall Study|Did not meet criteria before ABPM|1
101900|NCT00347360|345731|P10|Overall Study|Did not meet criteria before ABPM|0
101901|NCT00347360|345732|P9|Overall Study|Did not meet criteria before ABPM|0
101902|NCT00347360|345733|P8|Overall Study|Did not meet criteria before ABPM|0
101903|NCT00347360|345734|P7|Overall Study|Did not meet criteria before ABPM|0
101904|NCT00347360|345735|P6|Overall Study|Did not meet criteria before ABPM|0
101905|NCT00347360|345736|P5|Overall Study|Did not meet criteria before ABPM|0
101906|NCT00347360|345737|P4|Overall Study|Did not meet criteria before ABPM|0
101907|NCT00347360|345738|P3|Overall Study|Did not meet criteria before ABPM|0
101908|NCT00347360|345739|P2|Overall Study|Did not meet criteria before ABPM|0
101909|NCT00347360|345740|P1|Overall Study|Did not meet criteria before ABPM|0
101910|NCT00347360|345726|P15|Overall Study|PI recommended early withdrawal|0
101911|NCT00347360|345727|P14|Overall Study|PI recommended early withdrawal|0
101912|NCT00347360|345728|P13|Overall Study|PI recommended early withdrawal|0
101913|NCT00347360|345729|P12|Overall Study|PI recommended early withdrawal|0
101914|NCT00347360|345730|P11|Overall Study|PI recommended early withdrawal|0
101915|NCT00347360|345731|P10|Overall Study|PI recommended early withdrawal|1
101916|NCT00347360|345732|P9|Overall Study|PI recommended early withdrawal|0
101917|NCT00347360|345733|P8|Overall Study|PI recommended early withdrawal|0
101918|NCT00347360|345734|P7|Overall Study|PI recommended early withdrawal|0
101919|NCT00347360|345735|P6|Overall Study|PI recommended early withdrawal|0
101920|NCT00347360|345736|P5|Overall Study|PI recommended early withdrawal|0
101921|NCT00347360|345737|P4|Overall Study|PI recommended early withdrawal|0
101922|NCT00347360|345738|P3|Overall Study|PI recommended early withdrawal|0
101923|NCT00347360|345739|P2|Overall Study|PI recommended early withdrawal|0
101924|NCT00347360|345740|P1|Overall Study|PI recommended early withdrawal|0
101925|NCT00347360|345726|P15|Overall Study|Abnormal lab values|0
101926|NCT00347360|345727|P14|Overall Study|Abnormal lab values|0
101927|NCT00347360|345728|P13|Overall Study|Abnormal lab values|0
101928|NCT00347360|345729|P12|Overall Study|Abnormal lab values|0
101929|NCT00347360|345730|P11|Overall Study|Abnormal lab values|0
101930|NCT00347360|345731|P10|Overall Study|Abnormal lab values|0
101931|NCT00347360|345732|P9|Overall Study|Abnormal lab values|0
101932|NCT00347360|345733|P8|Overall Study|Abnormal lab values|0
101933|NCT00347360|345734|P7|Overall Study|Abnormal lab values|1
101934|NCT00347360|345735|P6|Overall Study|Abnormal lab values|0
101935|NCT00347360|345736|P5|Overall Study|Abnormal lab values|0
101936|NCT00347360|345737|P4|Overall Study|Abnormal lab values|0
101937|NCT00347360|345738|P3|Overall Study|Abnormal lab values|0
101938|NCT00347360|345739|P2|Overall Study|Abnormal lab values|0
101939|NCT00347360|345740|P1|Overall Study|Abnormal lab values|0
101940|NCT00347360|345726|P15|Overall Study|Subject did not meet end of study ABPM|0
101941|NCT00347360|345727|P14|Overall Study|Subject did not meet end of study ABPM|1
102022|NCT00347360|345733|P8|Overall Study|Withdrawal by Subject|1
101942|NCT00347360|345728|P13|Overall Study|Subject did not meet end of study ABPM|1
101943|NCT00347360|345729|P12|Overall Study|Subject did not meet end of study ABPM|0
101944|NCT00347360|345730|P11|Overall Study|Subject did not meet end of study ABPM|1
101945|NCT00347360|345731|P10|Overall Study|Subject did not meet end of study ABPM|0
101946|NCT00347360|345732|P9|Overall Study|Subject did not meet end of study ABPM|0
101947|NCT00347360|345733|P8|Overall Study|Subject did not meet end of study ABPM|0
101948|NCT00347360|345734|P7|Overall Study|Subject did not meet end of study ABPM|1
101949|NCT00347360|345735|P6|Overall Study|Subject did not meet end of study ABPM|0
101950|NCT00347360|345736|P5|Overall Study|Subject did not meet end of study ABPM|0
101951|NCT00347360|345737|P4|Overall Study|Subject did not meet end of study ABPM|0
101952|NCT00347360|345738|P3|Overall Study|Subject did not meet end of study ABPM|0
101953|NCT00347360|345739|P2|Overall Study|Subject did not meet end of study ABPM|0
101954|NCT00347360|345740|P1|Overall Study|Subject did not meet end of study ABPM|0
101955|NCT00347360|345726|P15|Overall Study|P.I. recommended due to blood pressure|0
101956|NCT00347360|345727|P14|Overall Study|P.I. recommended due to blood pressure|0
101957|NCT00347360|345728|P13|Overall Study|P.I. recommended due to blood pressure|0
101958|NCT00347360|345729|P12|Overall Study|P.I. recommended due to blood pressure|0
101959|NCT00347360|345730|P11|Overall Study|P.I. recommended due to blood pressure|0
101960|NCT00347360|345731|P10|Overall Study|P.I. recommended due to blood pressure|0
101961|NCT00347360|345732|P9|Overall Study|P.I. recommended due to blood pressure|0
101962|NCT00347360|345733|P8|Overall Study|P.I. recommended due to blood pressure|0
101963|NCT00347360|345734|P7|Overall Study|P.I. recommended due to blood pressure|0
101964|NCT00347360|345735|P6|Overall Study|P.I. recommended due to blood pressure|0
101965|NCT00347360|345736|P5|Overall Study|P.I. recommended due to blood pressure|1
101966|NCT00347360|345737|P4|Overall Study|P.I. recommended due to blood pressure|0
101967|NCT00347360|345738|P3|Overall Study|P.I. recommended due to blood pressure|0
101968|NCT00347360|345739|P2|Overall Study|P.I. recommended due to blood pressure|0
101969|NCT00347360|345740|P1|Overall Study|P.I. recommended due to blood pressure|0
101970|NCT00347360|345726|P15|Overall Study|Per sponsors instruction|0
101971|NCT00347360|345727|P14|Overall Study|Per sponsors instruction|0
101972|NCT00347360|345728|P13|Overall Study|Per sponsors instruction|0
101973|NCT00347360|345729|P12|Overall Study|Per sponsors instruction|0
101974|NCT00347360|345730|P11|Overall Study|Per sponsors instruction|0
101975|NCT00347360|345731|P10|Overall Study|Per sponsors instruction|0
101976|NCT00347360|345732|P9|Overall Study|Per sponsors instruction|0
101977|NCT00347360|345733|P8|Overall Study|Per sponsors instruction|0
101978|NCT00347360|345734|P7|Overall Study|Per sponsors instruction|0
101979|NCT00347360|345735|P6|Overall Study|Per sponsors instruction|0
101980|NCT00347360|345736|P5|Overall Study|Per sponsors instruction|0
101981|NCT00347360|345737|P4|Overall Study|Per sponsors instruction|0
101982|NCT00347360|345738|P3|Overall Study|Per sponsors instruction|0
101983|NCT00347360|345739|P2|Overall Study|Per sponsors instruction|1
101984|NCT00347360|345740|P1|Overall Study|Per sponsors instruction|0
101985|NCT00347360|345726|P15|Overall Study|Reason not listed/blank|0
101986|NCT00347360|345727|P14|Overall Study|Reason not listed/blank|1
101987|NCT00347360|345728|P13|Overall Study|Reason not listed/blank|0
101988|NCT00347360|345729|P12|Overall Study|Reason not listed/blank|0
101989|NCT00347360|345730|P11|Overall Study|Reason not listed/blank|0
101990|NCT00347360|345731|P10|Overall Study|Reason not listed/blank|0
101991|NCT00347360|345732|P9|Overall Study|Reason not listed/blank|0
101992|NCT00347360|345733|P8|Overall Study|Reason not listed/blank|0
101993|NCT00347360|345734|P7|Overall Study|Reason not listed/blank|1
101994|NCT00347360|345735|P6|Overall Study|Reason not listed/blank|0
101995|NCT00347360|345736|P5|Overall Study|Reason not listed/blank|0
101996|NCT00347360|345737|P4|Overall Study|Reason not listed/blank|0
101997|NCT00347360|345738|P3|Overall Study|Reason not listed/blank|0
101998|NCT00347360|345739|P2|Overall Study|Reason not listed/blank|0
101999|NCT00347360|345740|P1|Overall Study|Reason not listed/blank|1
102000|NCT00347360|345726|P15|Overall Study|Lack of Efficacy|0
102001|NCT00347360|345727|P14|Overall Study|Lack of Efficacy|0
102002|NCT00347360|345728|P13|Overall Study|Lack of Efficacy|0
102003|NCT00347360|345729|P12|Overall Study|Lack of Efficacy|0
102004|NCT00347360|345730|P11|Overall Study|Lack of Efficacy|0
102005|NCT00347360|345731|P10|Overall Study|Lack of Efficacy|0
102006|NCT00347360|345732|P9|Overall Study|Lack of Efficacy|1
102007|NCT00347360|345733|P8|Overall Study|Lack of Efficacy|1
102008|NCT00347360|345734|P7|Overall Study|Lack of Efficacy|0
102009|NCT00347360|345735|P6|Overall Study|Lack of Efficacy|1
102010|NCT00347360|345736|P5|Overall Study|Lack of Efficacy|0
102011|NCT00347360|345737|P4|Overall Study|Lack of Efficacy|1
102012|NCT00347360|345738|P3|Overall Study|Lack of Efficacy|3
102013|NCT00347360|345739|P2|Overall Study|Lack of Efficacy|1
102014|NCT00347360|345740|P1|Overall Study|Lack of Efficacy|1
102015|NCT00347360|345726|P15|Overall Study|Withdrawal by Subject|1
102016|NCT00347360|345727|P14|Overall Study|Withdrawal by Subject|2
102017|NCT00347360|345728|P13|Overall Study|Withdrawal by Subject|4
102018|NCT00347360|345729|P12|Overall Study|Withdrawal by Subject|3
102019|NCT00347360|345730|P11|Overall Study|Withdrawal by Subject|0
102020|NCT00347360|345731|P10|Overall Study|Withdrawal by Subject|1
102021|NCT00347360|345732|P9|Overall Study|Withdrawal by Subject|1
102023|NCT00347360|345734|P7|Overall Study|Withdrawal by Subject|1
102024|NCT00347360|345735|P6|Overall Study|Withdrawal by Subject|2
102025|NCT00347360|345736|P5|Overall Study|Withdrawal by Subject|1
102026|NCT00347360|345737|P4|Overall Study|Withdrawal by Subject|4
102027|NCT00347360|345738|P3|Overall Study|Withdrawal by Subject|2
102028|NCT00347360|345739|P2|Overall Study|Withdrawal by Subject|1
102029|NCT00347360|345740|P1|Overall Study|Withdrawal by Subject|0
102030|NCT00347360|345726|P15|Overall Study|Protocol Violation|0
102031|NCT00347360|345727|P14|Overall Study|Protocol Violation|1
102032|NCT00347360|345728|P13|Overall Study|Protocol Violation|0
102033|NCT00347360|345729|P12|Overall Study|Protocol Violation|0
102034|NCT00347360|345730|P11|Overall Study|Protocol Violation|0
102035|NCT00347360|345731|P10|Overall Study|Protocol Violation|2
102036|NCT00347360|345732|P9|Overall Study|Protocol Violation|1
102037|NCT00347360|345733|P8|Overall Study|Protocol Violation|0
102038|NCT00347360|345734|P7|Overall Study|Protocol Violation|0
102039|NCT00347360|345735|P6|Overall Study|Protocol Violation|2
102040|NCT00347360|345736|P5|Overall Study|Protocol Violation|1
102041|NCT00347360|345737|P4|Overall Study|Protocol Violation|2
102042|NCT00347360|345738|P3|Overall Study|Protocol Violation|1
102043|NCT00347360|345739|P2|Overall Study|Protocol Violation|3
102044|NCT00347360|345740|P1|Overall Study|Protocol Violation|2
102045|NCT00347360|345726|P15|Overall Study|Lost to Follow-up|0
102046|NCT00347360|345727|P14|Overall Study|Lost to Follow-up|0
102047|NCT00347360|345728|P13|Overall Study|Lost to Follow-up|1
102048|NCT00347360|345729|P12|Overall Study|Lost to Follow-up|0
102049|NCT00347360|345730|P11|Overall Study|Lost to Follow-up|0
102050|NCT00347360|345731|P10|Overall Study|Lost to Follow-up|2
102051|NCT00347360|345732|P9|Overall Study|Lost to Follow-up|1
102052|NCT00347360|345733|P8|Overall Study|Lost to Follow-up|1
102053|NCT00347360|345734|P7|Overall Study|Lost to Follow-up|0
102054|NCT00347360|345735|P6|Overall Study|Lost to Follow-up|1
102055|NCT00347360|345736|P5|Overall Study|Lost to Follow-up|1
102056|NCT00347360|345737|P4|Overall Study|Lost to Follow-up|2
102057|NCT00347360|345738|P3|Overall Study|Lost to Follow-up|0
102058|NCT00347360|345739|P2|Overall Study|Lost to Follow-up|0
102059|NCT00347360|345740|P1|Overall Study|Lost to Follow-up|0
102060|NCT00347360|345726|P15|Overall Study|Adverse Event|2
102061|NCT00347360|345727|P14|Overall Study|Adverse Event|2
102062|NCT00347360|345728|P13|Overall Study|Adverse Event|3
102063|NCT00347360|345729|P12|Overall Study|Adverse Event|1
102064|NCT00347360|345730|P11|Overall Study|Adverse Event|3
102065|NCT00347360|345731|P10|Overall Study|Adverse Event|3
102066|NCT00347360|345732|P9|Overall Study|Adverse Event|2
102067|NCT00347360|345733|P8|Overall Study|Adverse Event|0
102068|NCT00347360|345734|P7|Overall Study|Adverse Event|2
102069|NCT00347360|345735|P6|Overall Study|Adverse Event|2
102070|NCT00347360|345736|P5|Overall Study|Adverse Event|1
102071|NCT00347360|345737|P4|Overall Study|Adverse Event|4
102072|NCT00347360|345738|P3|Overall Study|Adverse Event|0
102073|NCT00347360|345739|P2|Overall Study|Adverse Event|2
102074|NCT00347360|345740|P1|Overall Study|Adverse Event|1
102075|NCT00347438|345922|P1|Overall Study|Physician Decision|1
102076|NCT00347438|345922|P1|Overall Study|Withdrawal by Subject|1
102077|NCT00347776|345932|P3|12 Month Follow-up|Reached endpoint|9
102078|NCT00347776|345933|P2|12 Month Follow-up|Reached endpoint|6
102079|NCT00347776|345934|P1|12 Month Follow-up|Reached endpoint|13
102080|NCT00347776|345932|P3|12 Month Follow-up|Death|4
102081|NCT00347776|345933|P2|12 Month Follow-up|Death|4
102082|NCT00347776|345934|P1|12 Month Follow-up|Death|3
102083|NCT00347776|345932|P3|12 Month Follow-up|Lost to Follow-up|6
102084|NCT00347776|345933|P2|12 Month Follow-up|Lost to Follow-up|6
102085|NCT00347776|345934|P1|12 Month Follow-up|Lost to Follow-up|7
102086|NCT00347776|345932|P3|6 Month Follow-up|reached endpont|15
102087|NCT00347776|345933|P2|6 Month Follow-up|reached endpont|12
102088|NCT00347776|345934|P1|6 Month Follow-up|reached endpont|20
102089|NCT00347776|345932|P3|6 Month Follow-up|Death|3
102090|NCT00347776|345933|P2|6 Month Follow-up|Death|1
102091|NCT00347776|345934|P1|6 Month Follow-up|Death|2
102092|NCT00347776|345932|P3|1.5 Month Follow-up|reached the endpoint|12
102093|NCT00347776|345933|P2|1.5 Month Follow-up|reached the endpoint|8
102094|NCT00347776|345934|P1|1.5 Month Follow-up|reached the endpoint|12
102095|NCT00347776|345932|P3|1.5 Month Follow-up|Death|0
102096|NCT00347776|345933|P2|1.5 Month Follow-up|Death|0
102097|NCT00347776|345934|P1|1.5 Month Follow-up|Death|2
102098|NCT00347919|345949|P3|Overall Study|Missing|2
102099|NCT00347919|345950|P2|Overall Study|Missing|1
102100|NCT00347919|345951|P1|Overall Study|Missing|2
102101|NCT00347919|345949|P3|Overall Study|Par. Started Other Treatment|1
102102|NCT00347919|345950|P2|Overall Study|Par. Started Other Treatment|1
102103|NCT00347919|345951|P1|Overall Study|Par. Started Other Treatment|1
102104|NCT00347919|345949|P3|Overall Study|Death|19
102105|NCT00347919|345950|P2|Overall Study|Death|42
102106|NCT00347919|345951|P1|Overall Study|Death|35
102107|NCT00347919|345949|P3|Overall Study|Sponsor terminated study|16
102108|NCT00347919|345950|P2|Overall Study|Sponsor terminated study|10
102109|NCT00347919|345951|P1|Overall Study|Sponsor terminated study|15
102110|NCT00347919|345949|P3|Overall Study|Physician Decision|0
102111|NCT00347919|345950|P2|Overall Study|Physician Decision|1
102112|NCT00347919|345951|P1|Overall Study|Physician Decision|1
102113|NCT00347919|345949|P3|Overall Study|Withdrawal by Subject|0
102114|NCT00347919|345950|P2|Overall Study|Withdrawal by Subject|8
102115|NCT00347919|345951|P1|Overall Study|Withdrawal by Subject|6
102116|NCT00347919|345949|P3|Overall Study|Lost to Follow-up|0
102117|NCT00347919|345950|P2|Overall Study|Lost to Follow-up|13
102118|NCT00347919|345951|P1|Overall Study|Lost to Follow-up|11
102119|NCT00347932|345973|P2|Overall Study|Did not meet inclusion criteria|8
102120|NCT00347932|345974|P1|Overall Study|Did not meet inclusion criteria|4
102121|NCT00347932|345973|P2|Overall Study|Withdrawal by Subject|16
102122|NCT00347932|345974|P1|Overall Study|Withdrawal by Subject|10
102123|NCT00347932|345973|P2|Overall Study|Lost to Follow-up|9
102124|NCT00347932|345974|P1|Overall Study|Lost to Follow-up|10
102125|NCT00347932|345973|P2|Overall Study|Lack of Efficacy|14
102126|NCT00347932|345974|P1|Overall Study|Lack of Efficacy|3
102127|NCT00347932|345973|P2|Overall Study|Adverse Event|5
102128|NCT00347932|345974|P1|Overall Study|Adverse Event|4
102129|NCT00347958|345986|P1|Overall Study|Withdrawal by Subject|1
102130|NCT00347958|345986|P1|Overall Study|Protocol Violation|2
102131|NCT00347958|345986|P1|Overall Study|Adverse Event|1
102132|NCT00337077|346002|P3|Overall Study|Ineligible|1
102133|NCT00337077|346003|P2|Overall Study|Ineligible|1
102134|NCT00337077|346004|P1|Overall Study|Ineligible|1
102135|NCT00337077|346002|P3|Overall Study|Never started treatment|0
102136|NCT00337077|346003|P2|Overall Study|Never started treatment|1
102137|NCT00337077|346004|P1|Overall Study|Never started treatment|1
102138|NCT00337077|346002|P3|Overall Study|Physician Decision|2
102139|NCT00337077|346003|P2|Overall Study|Physician Decision|4
102140|NCT00337077|346004|P1|Overall Study|Physician Decision|1
102141|NCT00337077|346002|P3|Overall Study|Alternative therapy|0
102142|NCT00337077|346003|P2|Overall Study|Alternative therapy|0
102143|NCT00337077|346004|P1|Overall Study|Alternative therapy|1
102144|NCT00337077|346002|P3|Overall Study|Withdrawal by Subject|2
102145|NCT00337077|346003|P2|Overall Study|Withdrawal by Subject|2
102146|NCT00337077|346004|P1|Overall Study|Withdrawal by Subject|7
102147|NCT00337077|346002|P3|Overall Study|Death|0
102148|NCT00337077|346003|P2|Overall Study|Death|1
102149|NCT00337077|346004|P1|Overall Study|Death|0
102150|NCT00337077|346002|P3|Overall Study|Adverse Event|1
102151|NCT00337077|346003|P2|Overall Study|Adverse Event|7
102152|NCT00337077|346004|P1|Overall Study|Adverse Event|7
102153|NCT00337077|346002|P3|Overall Study|Progressive disease|19
102154|NCT00337077|346003|P2|Overall Study|Progressive disease|37
102155|NCT00337077|346004|P1|Overall Study|Progressive disease|25
102156|NCT00337103|346015|P2|Overall Study|Death|0
102157|NCT00337103|346016|P1|Overall Study|Death|1
102158|NCT00337103|346015|P2|Overall Study|Lost to Follow-up|2
102159|NCT00337103|346016|P1|Overall Study|Lost to Follow-up|1
102160|NCT00337103|346015|P2|Overall Study|Entry Criteria Not Met|1
102161|NCT00337103|346016|P1|Overall Study|Entry Criteria Not Met|4
102162|NCT00337103|346015|P2|Overall Study|Not specified|6
102163|NCT00337103|346016|P1|Overall Study|Not specified|5
102164|NCT00337103|346015|P2|Overall Study|Withdrawal by Subject|5
102165|NCT00337103|346016|P1|Overall Study|Withdrawal by Subject|8
102166|NCT00337103|346015|P2|Overall Study|Physician Decision|14
102167|NCT00337103|346016|P1|Overall Study|Physician Decision|15
102168|NCT00337103|346015|P2|Overall Study|Clinical Progression|24
102169|NCT00337103|346016|P1|Overall Study|Clinical Progression|27
102170|NCT00337103|346015|P2|Overall Study|Subject Choice|27
102171|NCT00337103|346016|P1|Overall Study|Subject Choice|34
102172|NCT00337103|346015|P2|Overall Study|Adverse Event|59
102173|NCT00337103|346016|P1|Overall Study|Adverse Event|45
102174|NCT00337103|346015|P2|Overall Study|Progressive Disease|405
102175|NCT00337103|346016|P1|Overall Study|Progressive Disease|409
102176|NCT00337129|346024|P1|Overall Study|not protocol specified|1
102177|NCT00337129|346024|P1|Overall Study|Death|2
102178|NCT00337129|346024|P1|Overall Study|Lack of Efficacy|32
102179|NCT00337129|346024|P1|Overall Study|Withdrawal by Subject|1
102180|NCT00337129|346024|P1|Overall Study|Adverse Event|4
102181|NCT00337168|346031|P1|Overall Study|Did not start therapy|1
102182|NCT00337168|346031|P1|Overall Study|Not protocol specified|2
102183|NCT00337168|346031|P1|Overall Study|Death|5
102184|NCT00337194|346040|P2|Overall Study|Subsequent non-protocol therapy|1
102185|NCT00337194|346041|P1|Overall Study|Subsequent non-protocol therapy|3
102186|NCT00337194|346040|P2|Overall Study|Disease progression|2
102187|NCT00337194|346041|P1|Overall Study|Disease progression|1
102188|NCT00337194|346040|P2|Overall Study|Withdrawal by Subject|0
102189|NCT00337194|346041|P1|Overall Study|Withdrawal by Subject|1
102190|NCT00337194|346040|P2|Overall Study|Death|0
102191|NCT00337194|346041|P1|Overall Study|Death|2
102192|NCT00337194|346040|P2|Overall Study|Adverse Event|1
102193|NCT00337194|346041|P1|Overall Study|Adverse Event|5
102194|NCT00337207|346056|P1|Overall Study|Withdrawal by Subject|3
102195|NCT00337272|346062|P2|Withdrawal Period|Non-compliance|1
102196|NCT00337272|346063|P1|Withdrawal Period|Non-compliance|0
102197|NCT00337272|346062|P2|Treatment Period|Withdrawal by Subject|1
102198|NCT00337272|346063|P1|Treatment Period|Withdrawal by Subject|0
102199|NCT00337272|346062|P2|Treatment Period|Non-compliance|1
102200|NCT00337272|346063|P1|Treatment Period|Non-compliance|1
102201|NCT00337272|346062|P2|Screening Period (Pre-randomization)|Screen failure|0
102202|NCT00337272|346063|P1|Screening Period (Pre-randomization)|Screen failure|3
102203|NCT00337272|346062|P2|Screening Period (Pre-randomization)|Non-compliance|0
102204|NCT00337272|346063|P1|Screening Period (Pre-randomization)|Non-compliance|1
102205|NCT00337272|346062|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
102206|NCT00337272|346063|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
102207|NCT00337285|346083|P1|Overall Study|Lack of protocol compliance|7
102208|NCT00337285|346083|P1|Overall Study|Physician Decision|1
102209|NCT00337285|346083|P1|Overall Study|Death|1
102210|NCT00337285|346083|P1|Overall Study|Lack of Efficacy|11
102211|NCT00337285|346083|P1|Overall Study|Protocol Violation|27
102212|NCT00337285|346083|P1|Overall Study|Adverse Event|28
102213|NCT00337285|346083|P1|Overall Study|Lost to Follow-up|41
102214|NCT00337285|346083|P1|Overall Study|Withdrawal by Subject|42
102215|NCT00337428|346104|P2|Overall Study|Anorexia|0
102216|NCT00337428|346105|P1|Overall Study|Anorexia|1
102217|NCT00337428|346104|P2|Overall Study|Unwilling to Continue|0
102218|NCT00337428|346105|P1|Overall Study|Unwilling to Continue|1
102219|NCT00337428|346104|P2|Overall Study|Lack of Time|1
102220|NCT00337428|346105|P1|Overall Study|Lack of Time|1
102221|NCT00337428|346104|P2|Overall Study|Withdrawal by Subject|2
102222|NCT00337428|346105|P1|Overall Study|Withdrawal by Subject|1
102223|NCT00337467|346143|P1|Overall Study|Subject No Longer Met Study Criteria|2
102224|NCT00337467|346143|P1|Overall Study|Lost to Follow-up|2
102225|NCT00337467|346143|P1|Overall Study|Pregnancy|1
102226|NCT00337467|346143|P1|Overall Study|Subject Withdrew Consent|2
102227|NCT00337467|346143|P1|Overall Study|Adverse Event|3
102228|NCT00337571|346164|P4|Overall Study|High Potassium level|1
102229|NCT00337571|346165|P3|Overall Study|High Potassium level|0
102230|NCT00337571|346166|P2|Overall Study|High Potassium level|0
102231|NCT00337571|346167|P1|Overall Study|High Potassium level|0
102232|NCT00337571|346164|P4|Overall Study|No longer met study criteria|0
102233|NCT00337571|346165|P3|Overall Study|No longer met study criteria|0
102234|NCT00337571|346166|P2|Overall Study|No longer met study criteria|0
102235|NCT00337571|346167|P1|Overall Study|No longer met study criteria|1
102236|NCT00337571|346164|P4|Overall Study|Poor/noncompliance|1
102237|NCT00337571|346165|P3|Overall Study|Poor/noncompliance|1
102238|NCT00337571|346166|P2|Overall Study|Poor/noncompliance|1
102239|NCT00337571|346167|P1|Overall Study|Poor/noncompliance|1
102240|NCT00337571|346164|P4|Overall Study|Lost to Follow-up|1
102241|NCT00337571|346165|P3|Overall Study|Lost to Follow-up|0
102242|NCT00337571|346166|P2|Overall Study|Lost to Follow-up|1
102243|NCT00337571|346167|P1|Overall Study|Lost to Follow-up|3
102244|NCT00337571|346164|P4|Overall Study|Withdrawal by Subject|0
102245|NCT00337571|346165|P3|Overall Study|Withdrawal by Subject|1
102246|NCT00337571|346166|P2|Overall Study|Withdrawal by Subject|2
102247|NCT00337571|346167|P1|Overall Study|Withdrawal by Subject|2
102248|NCT00337571|346164|P4|Overall Study|Adverse Event|4
102249|NCT00337571|346165|P3|Overall Study|Adverse Event|8
102250|NCT00337571|346166|P2|Overall Study|Adverse Event|5
102251|NCT00337571|346167|P1|Overall Study|Adverse Event|4
102252|NCT00337571|346164|P4|Overall Study|Lack of Efficacy|0
102253|NCT00337571|346165|P3|Overall Study|Lack of Efficacy|0
102254|NCT00337571|346166|P2|Overall Study|Lack of Efficacy|0
102255|NCT00337571|346167|P1|Overall Study|Lack of Efficacy|3
102256|NCT00337610|346207|P2|Overall Study|Withdrawal by Subject|5
102257|NCT00337610|346208|P1|Overall Study|Withdrawal by Subject|6
102258|NCT00337610|346207|P2|Overall Study|Lost to Follow-up|3
102259|NCT00337610|346208|P1|Overall Study|Lost to Follow-up|3
102260|NCT00337610|346207|P2|Overall Study|Lack of Efficacy|3
102261|NCT00337610|346208|P1|Overall Study|Lack of Efficacy|6
102262|NCT00337610|346207|P2|Overall Study|Death|1
102263|NCT00337610|346208|P1|Overall Study|Death|0
102264|NCT00337610|346207|P2|Overall Study|Adverse Event|2
102265|NCT00337610|346208|P1|Overall Study|Adverse Event|2
102266|NCT00337662|346223|P4|Study Period III|Clinical Relapse|0
102267|NCT00337662|346224|P3|Study Period III|Clinical Relapse|0
102268|NCT00337662|346225|P2|Study Period III|Clinical Relapse|0
102269|NCT00337662|346226|P1|Study Period III|Clinical Relapse|1
102270|NCT00337662|346223|P4|Study Period III|Sponsor Decision|0
102271|NCT00337662|346224|P3|Study Period III|Sponsor Decision|1
102272|NCT00337662|346225|P2|Study Period III|Sponsor Decision|0
102273|NCT00337662|346226|P1|Study Period III|Sponsor Decision|1
102274|NCT00337662|346223|P4|Study Period III|Parent/Caregiver Decision|0
102275|NCT00337662|346224|P3|Study Period III|Parent/Caregiver Decision|2
102276|NCT00337662|346225|P2|Study Period III|Parent/Caregiver Decision|0
102277|NCT00337662|346226|P1|Study Period III|Parent/Caregiver Decision|0
102278|NCT00337662|346223|P4|Study Period III|Lack of Efficacy|0
102279|NCT00337662|346224|P3|Study Period III|Lack of Efficacy|2
102280|NCT00337662|346225|P2|Study Period III|Lack of Efficacy|4
102281|NCT00337662|346226|P1|Study Period III|Lack of Efficacy|4
102282|NCT00337662|346223|P4|Study Period III|Entry Criteria Not Met|0
102283|NCT00337662|346224|P3|Study Period III|Entry Criteria Not Met|3
102284|NCT00337662|346225|P2|Study Period III|Entry Criteria Not Met|1
102285|NCT00337662|346226|P1|Study Period III|Entry Criteria Not Met|4
102286|NCT00337662|346223|P4|Study Period III|Physician Decision|0
102287|NCT00337662|346224|P3|Study Period III|Physician Decision|0
102288|NCT00337662|346225|P2|Study Period III|Physician Decision|5
102289|NCT00337662|346226|P1|Study Period III|Physician Decision|6
102290|NCT00337662|346223|P4|Study Period III|Protocol Violation|0
102291|NCT00337662|346224|P3|Study Period III|Protocol Violation|2
102292|NCT00337662|346225|P2|Study Period III|Protocol Violation|8
102293|NCT00337662|346226|P1|Study Period III|Protocol Violation|3
102294|NCT00337662|346223|P4|Study Period III|Adverse Event|0
102295|NCT00337662|346224|P3|Study Period III|Adverse Event|8
102296|NCT00337662|346225|P2|Study Period III|Adverse Event|10
102297|NCT00337662|346226|P1|Study Period III|Adverse Event|9
102298|NCT00337662|346223|P4|Study Period III|Withdrawal by Subject|0
102299|NCT00337662|346224|P3|Study Period III|Withdrawal by Subject|12
102300|NCT00337662|346225|P2|Study Period III|Withdrawal by Subject|14
102301|NCT00337662|346226|P1|Study Period III|Withdrawal by Subject|18
102302|NCT00337662|346223|P4|Study Period III|Lost to Follow-up|0
102303|NCT00337662|346224|P3|Study Period III|Lost to Follow-up|14
102304|NCT00337662|346225|P2|Study Period III|Lost to Follow-up|16
102305|NCT00337662|346226|P1|Study Period III|Lost to Follow-up|14
102306|NCT00337662|346223|P4|Study Period II|Parent/Caregiver Decision|1
102307|NCT00337662|346224|P3|Study Period II|Parent/Caregiver Decision|0
102308|NCT00337662|346225|P2|Study Period II|Parent/Caregiver Decision|0
102309|NCT00337662|346226|P1|Study Period II|Parent/Caregiver Decision|0
102310|NCT00337662|346223|P4|Study Period II|Sponsor Decision|2
102311|NCT00337662|346224|P3|Study Period II|Sponsor Decision|0
102312|NCT00337662|346225|P2|Study Period II|Sponsor Decision|0
102313|NCT00337662|346226|P1|Study Period II|Sponsor Decision|0
102314|NCT00337662|346223|P4|Study Period II|Lack of Efficacy|7
102315|NCT00337662|346224|P3|Study Period II|Lack of Efficacy|0
102316|NCT00337662|346225|P2|Study Period II|Lack of Efficacy|0
102317|NCT00337662|346226|P1|Study Period II|Lack of Efficacy|0
102318|NCT00337662|346223|P4|Study Period II|Protocol Violation|6
102319|NCT00337662|346224|P3|Study Period II|Protocol Violation|0
102320|NCT00337662|346225|P2|Study Period II|Protocol Violation|0
102321|NCT00337662|346226|P1|Study Period II|Protocol Violation|0
102322|NCT00337662|346223|P4|Study Period II|Entry Criteria Not Met|6
102323|NCT00337662|346224|P3|Study Period II|Entry Criteria Not Met|0
102324|NCT00337662|346225|P2|Study Period II|Entry Criteria Not Met|0
102325|NCT00337662|346226|P1|Study Period II|Entry Criteria Not Met|0
102326|NCT00337662|346223|P4|Study Period II|Physician Decision|13
102327|NCT00337662|346224|P3|Study Period II|Physician Decision|0
102328|NCT00337662|346225|P2|Study Period II|Physician Decision|0
102329|NCT00337662|346226|P1|Study Period II|Physician Decision|0
102330|NCT00337662|346223|P4|Study Period II|Adverse Event|16
102331|NCT00337662|346224|P3|Study Period II|Adverse Event|0
102332|NCT00337662|346225|P2|Study Period II|Adverse Event|0
102333|NCT00337662|346226|P1|Study Period II|Adverse Event|0
102334|NCT00337662|346223|P4|Study Period II|Withdrawal by Subject|20
102335|NCT00337662|346224|P3|Study Period II|Withdrawal by Subject|0
102336|NCT00337662|346225|P2|Study Period II|Withdrawal by Subject|0
102337|NCT00337662|346226|P1|Study Period II|Withdrawal by Subject|0
102338|NCT00337662|346223|P4|Study Period II|Lost to Follow-up|35
102339|NCT00337662|346224|P3|Study Period II|Lost to Follow-up|0
102340|NCT00337662|346225|P2|Study Period II|Lost to Follow-up|0
102341|NCT00337662|346226|P1|Study Period II|Lost to Follow-up|0
102342|NCT00337675|346281|P3|Overall Study|Trial Terminated|2
102343|NCT00337675|346282|P2|Overall Study|Trial Terminated|0
102344|NCT00337675|346283|P1|Overall Study|Trial Terminated|0
102345|NCT00337675|346281|P3|Overall Study|Progressive Disease|0
102346|NCT00337675|346282|P2|Overall Study|Progressive Disease|2
102347|NCT00337675|346283|P1|Overall Study|Progressive Disease|0
102348|NCT00337675|346281|P3|Overall Study|Withdrawal by Subject|19
102349|NCT00337675|346282|P2|Overall Study|Withdrawal by Subject|25
102350|NCT00337675|346283|P1|Overall Study|Withdrawal by Subject|25
102351|NCT00337675|346281|P3|Overall Study|Protocol Violation|19
102352|NCT00337675|346282|P2|Overall Study|Protocol Violation|24
102353|NCT00337675|346283|P1|Overall Study|Protocol Violation|21
102354|NCT00337675|346281|P3|Overall Study|Physician Decision|14
102355|NCT00337675|346282|P2|Overall Study|Physician Decision|17
102356|NCT00337675|346283|P1|Overall Study|Physician Decision|9
102357|NCT00337675|346281|P3|Overall Study|Lost to Follow-up|17
102358|NCT00337675|346282|P2|Overall Study|Lost to Follow-up|19
102359|NCT00337675|346283|P1|Overall Study|Lost to Follow-up|22
102360|NCT00337675|346281|P3|Overall Study|Lack of Efficacy|9
102361|NCT00337675|346282|P2|Overall Study|Lack of Efficacy|7
102362|NCT00337675|346283|P1|Overall Study|Lack of Efficacy|10
102363|NCT00337675|346281|P3|Overall Study|Adverse Event|19
102364|NCT00337675|346282|P2|Overall Study|Adverse Event|9
102365|NCT00337675|346283|P1|Overall Study|Adverse Event|10
102366|NCT00337727|346299|P2|Overall Study|Withdrawal by Subject|5
102367|NCT00337727|346300|P1|Overall Study|Withdrawal by Subject|3
102368|NCT00337727|346299|P2|Overall Study|Protocol Violation|0
102369|NCT00337727|346300|P1|Overall Study|Protocol Violation|4
102370|NCT00337727|346299|P2|Overall Study|Physician Decision|0
102371|NCT00337727|346300|P1|Overall Study|Physician Decision|1
102372|NCT00337727|346299|P2|Overall Study|Lost to Follow-up|4
102373|NCT00337727|346300|P1|Overall Study|Lost to Follow-up|5
102374|NCT00337727|346299|P2|Overall Study|Adverse Event|3
102375|NCT00337727|346300|P1|Overall Study|Adverse Event|5
102376|NCT00337779|346310|P2|Overall Study|Death|1
102377|NCT00337779|346311|P1|Overall Study|Death|0
102378|NCT00337779|346310|P2|Overall Study|Pregnancy|2
102379|NCT00337779|346311|P1|Overall Study|Pregnancy|3
102380|NCT00337779|346310|P2|Overall Study|Adverse Event|51
102381|NCT00337779|346311|P1|Overall Study|Adverse Event|28
102382|NCT00337779|346310|P2|Overall Study|Lost to Follow-up|5
102383|NCT00337779|346311|P1|Overall Study|Lost to Follow-up|6
102384|NCT00337779|346310|P2|Overall Study|Protocol Violation|1
102385|NCT00337779|346311|P1|Overall Study|Protocol Violation|1
102386|NCT00337779|346310|P2|Overall Study|Physician Decision|6
102387|NCT00337779|346311|P1|Overall Study|Physician Decision|3
102388|NCT00337779|346310|P2|Overall Study|Sponsor decision|1
102389|NCT00337779|346311|P1|Overall Study|Sponsor decision|1
102390|NCT00337779|346310|P2|Overall Study|Withdrawal by Subject|12
102391|NCT00337779|346311|P1|Overall Study|Withdrawal by Subject|10
102392|NCT00337818|346324|P3|Overall Study|Lost to Follow-up|107
102393|NCT00337818|346325|P2|Overall Study|Lost to Follow-up|91
102394|NCT00337818|346326|P1|Overall Study|Lost to Follow-up|289
102395|NCT00337935|346348|P2|Overall Study|Lack of Efficacy|1
102396|NCT00337935|346349|P1|Overall Study|Lack of Efficacy|0
102397|NCT00337935|346348|P2|Overall Study|Other|1
102398|NCT00337935|346349|P1|Overall Study|Other|0
102399|NCT00337935|346348|P2|Overall Study|Withdrawal by Subject|7
102400|NCT00337935|346349|P1|Overall Study|Withdrawal by Subject|1
102401|NCT00337935|346348|P2|Overall Study|Protocol Violation|3
102402|NCT00337935|346349|P1|Overall Study|Protocol Violation|4
102403|NCT00337935|346348|P2|Overall Study|Lost to Follow-up|1
102404|NCT00337935|346349|P1|Overall Study|Lost to Follow-up|0
102405|NCT00337935|346348|P2|Overall Study|Physician Decision|1
102406|NCT00337935|346349|P1|Overall Study|Physician Decision|1
102407|NCT00337935|346348|P2|Overall Study|Death|8
102408|NCT00337935|346349|P1|Overall Study|Death|2
102409|NCT00337935|346348|P2|Overall Study|Adverse Event|5
102410|NCT00337935|346349|P1|Overall Study|Adverse Event|2
102411|NCT00338104|346372|P3|Overall Study|Protocol Violation|3
102412|NCT00338104|346373|P2|Overall Study|Protocol Violation|1
102413|NCT00338104|346374|P1|Overall Study|Protocol Violation|2
102414|NCT00338286|346387|P2|Overall Study|undefined|4
102415|NCT00338286|346388|P1|Overall Study|undefined|3
102416|NCT00338286|346387|P2|Overall Study|ongoing|272
102417|NCT00338286|346388|P1|Overall Study|ongoing|297
102418|NCT00338286|346387|P2|Overall Study|Lost to Follow-up|50
102419|NCT00338286|346388|P1|Overall Study|Lost to Follow-up|53
102420|NCT00338286|346387|P2|Overall Study|Withdrawal by Subject|44
102421|NCT00338286|346388|P1|Overall Study|Withdrawal by Subject|40
102422|NCT00338962|346406|P4|Overall Study|Poor Compliance|0
102423|NCT00338962|346407|P3|Overall Study|Poor Compliance|2
102424|NCT00338962|346408|P2|Overall Study|Poor Compliance|0
102425|NCT00338962|346409|P1|Overall Study|Poor Compliance|0
102426|NCT00338962|346406|P4|Overall Study|Adverse Event|0
102427|NCT00338962|346407|P3|Overall Study|Adverse Event|2
102428|NCT00338962|346408|P2|Overall Study|Adverse Event|0
102429|NCT00338962|346409|P1|Overall Study|Adverse Event|0
102430|NCT00338962|346406|P4|Overall Study|Moved|0
102431|NCT00338962|346407|P3|Overall Study|Moved|0
102432|NCT00338962|346408|P2|Overall Study|Moved|1
102433|NCT00338962|346409|P1|Overall Study|Moved|0
102434|NCT00338962|346406|P4|Overall Study|Time Constraint|0
102435|NCT00338962|346407|P3|Overall Study|Time Constraint|0
102436|NCT00338962|346408|P2|Overall Study|Time Constraint|0
102437|NCT00338962|346409|P1|Overall Study|Time Constraint|2
102438|NCT00338962|346406|P4|Overall Study|No Transportation|0
102439|NCT00338962|346407|P3|Overall Study|No Transportation|0
102440|NCT00338962|346408|P2|Overall Study|No Transportation|0
102441|NCT00338962|346409|P1|Overall Study|No Transportation|2
102442|NCT00338962|346406|P4|Overall Study|Withdrawal by Subject|0
102443|NCT00338962|346407|P3|Overall Study|Withdrawal by Subject|0
102444|NCT00338962|346408|P2|Overall Study|Withdrawal by Subject|0
102445|NCT00338962|346409|P1|Overall Study|Withdrawal by Subject|1
102446|NCT00338962|346406|P4|Overall Study|Lost to Follow-up|3
102447|NCT00338962|346407|P3|Overall Study|Lost to Follow-up|2
102448|NCT00338962|346408|P2|Overall Study|Lost to Follow-up|3
102449|NCT00338962|346409|P1|Overall Study|Lost to Follow-up|3
102450|NCT00339040|346438|P2|Stage II|Site closing|0
102451|NCT00339040|346439|P1|Stage II|Site closing|2
102452|NCT00339040|346438|P2|Stage II|Not able to attend clinic|0
102453|NCT00339040|346439|P1|Stage II|Not able to attend clinic|1
102454|NCT00339040|346438|P2|Stage II|Protocol Violation|0
102455|NCT00339040|346439|P1|Stage II|Protocol Violation|3
102456|NCT00339040|346438|P2|Stage II|Withdrawal by Subject|2
102457|NCT00339040|346439|P1|Stage II|Withdrawal by Subject|1
102458|NCT00339040|346438|P2|Stage II|Lost to Follow-up|0
102459|NCT00339040|346439|P1|Stage II|Lost to Follow-up|3
102460|NCT00339040|346438|P2|Stage I|Protocol Violation|1
102461|NCT00339040|346439|P1|Stage I|Protocol Violation|1
102462|NCT00339040|346438|P2|Stage I|Not able to attend clinic|0
102463|NCT00339040|346439|P1|Stage I|Not able to attend clinic|1
102464|NCT00339144|346481|P3|Overall Study|Participant's request to discontinuation|1
102465|NCT00339144|346482|P2|Overall Study|Participant's request to discontinuation|0
102466|NCT00339144|346483|P1|Overall Study|Participant's request to discontinuation|1
102467|NCT00339144|346481|P3|Overall Study|Study drug toxicity|1
102468|NCT00339144|346482|P2|Overall Study|Study drug toxicity|1
102469|NCT00339144|346483|P1|Overall Study|Study drug toxicity|3
102470|NCT00339144|346481|P3|Overall Study|Disease progression|2
102471|NCT00339144|346482|P2|Overall Study|Disease progression|2
102472|NCT00339144|346483|P1|Overall Study|Disease progression|5
102473|NCT00339183|346567|P2|Overall Study|Ongoing|13
102474|NCT00339183|346568|P1|Overall Study|Ongoing|20
102475|NCT00339183|346567|P2|Overall Study|Other|40
102476|NCT00339183|346568|P1|Overall Study|Other|46
102477|NCT00339183|346567|P2|Overall Study|Missing reason|1
102478|NCT00339183|346568|P1|Overall Study|Missing reason|3
102479|NCT00339183|346567|P2|Overall Study|Protocol-specified criteria|8
102480|NCT00339183|346568|P1|Overall Study|Protocol-specified criteria|12
102481|NCT00339183|346567|P2|Overall Study|Lost to Follow-up|17
102482|NCT00339183|346568|P1|Overall Study|Lost to Follow-up|17
102483|NCT00339183|346567|P2|Overall Study|Physician Decision|4
102484|NCT00339183|346568|P1|Overall Study|Physician Decision|2
102485|NCT00339183|346567|P2|Overall Study|Withdrawal by Subject|19
102486|NCT00339183|346568|P1|Overall Study|Withdrawal by Subject|16
102487|NCT00339183|346567|P2|Overall Study|Adverse Event|3
102488|NCT00339183|346568|P1|Overall Study|Adverse Event|5
102489|NCT00339833|346596|P2|Overall Study|Error in data records|0
102490|NCT00339833|346597|P1|Overall Study|Error in data records|1
102491|NCT00339833|346596|P2|Overall Study|anaemia or excess drop in glycaemia|0
102492|NCT00339833|346597|P1|Overall Study|anaemia or excess drop in glycaemia|2
102493|NCT00339833|346596|P2|Overall Study|Poor venous access|2
102494|NCT00339833|346597|P1|Overall Study|Poor venous access|2
102495|NCT00339833|346596|P2|Overall Study|minor infection|1
102496|NCT00339833|346597|P1|Overall Study|minor infection|0
102497|NCT00339833|346596|P2|Overall Study|Chest pain|1
102498|NCT00339833|346597|P1|Overall Study|Chest pain|0
102499|NCT00339833|346596|P2|Overall Study|indigestion|1
102500|NCT00339833|346597|P1|Overall Study|indigestion|0
102501|NCT00339833|346596|P2|Overall Study|toothache|1
102502|NCT00339833|346597|P1|Overall Study|toothache|0
102503|NCT00339833|346596|P2|Overall Study|Withdrawal by Subject|2
102504|NCT00339833|346597|P1|Overall Study|Withdrawal by Subject|1
102505|NCT00340678|346622|P4|Overall Study|Lost to Follow-up|0
102506|NCT00340678|346623|P3|Overall Study|Lost to Follow-up|0
102507|NCT00340678|346624|P2|Overall Study|Lost to Follow-up|0
102508|NCT00340678|346625|P1|Overall Study|Lost to Follow-up|1
102509|NCT00340704|346646|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
102510|NCT00340704|346647|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
102511|NCT00340704|346648|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
102512|NCT00340704|346649|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
102513|NCT00340704|346650|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
102514|NCT00340704|346651|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
102515|NCT00340704|346652|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
102516|NCT00340704|346653|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
102517|NCT00340704|346654|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
102518|NCT00340704|346646|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102519|NCT00340704|346647|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102520|NCT00340704|346648|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102521|NCT00340704|346649|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
102522|NCT00340704|346650|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
102523|NCT00340704|346651|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102524|NCT00340704|346652|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102525|NCT00340704|346653|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102526|NCT00340704|346654|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
102527|NCT00340704|346646|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102528|NCT00340704|346647|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102529|NCT00340704|346648|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102530|NCT00340704|346649|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
102531|NCT00340704|346650|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102532|NCT00340704|346651|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102533|NCT00340704|346652|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102534|NCT00340704|346653|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102535|NCT00340704|346654|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
102536|NCT00340704|346646|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
102537|NCT00340704|346647|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
102538|NCT00340704|346648|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
102539|NCT00340704|346649|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
102540|NCT00340704|346650|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
102541|NCT00340704|346651|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
102542|NCT00340704|346652|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
102543|NCT00340704|346653|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
102544|NCT00340704|346654|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
102545|NCT00340704|346646|P9|PK Study|Not treated|0
102546|NCT00340704|346647|P8|PK Study|Not treated|0
102547|NCT00340704|346648|P7|PK Study|Not treated|0
102548|NCT00340704|346649|P6|PK Study|Not treated|0
102549|NCT00340704|346650|P5|PK Study|Not treated|0
102550|NCT00340704|346651|P4|PK Study|Not treated|0
102551|NCT00340704|346652|P3|PK Study|Not treated|1
102552|NCT00340704|346653|P2|PK Study|Not treated|0
102553|NCT00340704|346654|P1|PK Study|Not treated|0
102554|NCT00340704|346646|P9|PK Study|Adverse Event|0
102555|NCT00340704|346647|P8|PK Study|Adverse Event|0
102556|NCT00340704|346648|P7|PK Study|Adverse Event|0
102557|NCT00340704|346649|P6|PK Study|Adverse Event|0
102558|NCT00340704|346650|P5|PK Study|Adverse Event|0
102559|NCT00340704|346651|P4|PK Study|Adverse Event|0
102560|NCT00340704|346652|P3|PK Study|Adverse Event|0
102561|NCT00340704|346653|P2|PK Study|Adverse Event|1
102562|NCT00340704|346654|P1|PK Study|Adverse Event|0
102563|NCT00340834|346761|P5|Extension Phase of Study|Death|1
102564|NCT00340834|346762|P4|Extension Phase of Study|Death|0
102565|NCT00340834|346763|P3|Extension Phase of Study|Death|0
102566|NCT00340834|346764|P2|Extension Phase of Study|Death|0
102567|NCT00340834|346765|P1|Extension Phase of Study|Death|0
102568|NCT00340834|346761|P5|Extension Phase of Study|Protocol Violation|0
102569|NCT00340834|346762|P4|Extension Phase of Study|Protocol Violation|0
102570|NCT00340834|346763|P3|Extension Phase of Study|Protocol Violation|0
102571|NCT00340834|346764|P2|Extension Phase of Study|Protocol Violation|0
102572|NCT00340834|346765|P1|Extension Phase of Study|Protocol Violation|3
102573|NCT00340834|346761|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
102574|NCT00340834|346762|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
102575|NCT00340834|346763|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
102576|NCT00340834|346764|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
102577|NCT00340834|346765|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
102578|NCT00340834|346761|P5|Extension Phase of Study|Administrative problems|1
102579|NCT00340834|346762|P4|Extension Phase of Study|Administrative problems|1
102580|NCT00340834|346763|P3|Extension Phase of Study|Administrative problems|0
102581|NCT00340834|346764|P2|Extension Phase of Study|Administrative problems|0
102582|NCT00340834|346765|P1|Extension Phase of Study|Administrative problems|3
102583|NCT00340834|346761|P5|Extension Phase of Study|Subject no longer requires study drug|2
102584|NCT00340834|346762|P4|Extension Phase of Study|Subject no longer requires study drug|0
102585|NCT00340834|346763|P3|Extension Phase of Study|Subject no longer requires study drug|0
102586|NCT00340834|346764|P2|Extension Phase of Study|Subject no longer requires study drug|0
102587|NCT00340834|346765|P1|Extension Phase of Study|Subject no longer requires study drug|4
102588|NCT00340834|346761|P5|Extension Phase of Study|Lost to Follow-up|3
102589|NCT00340834|346762|P4|Extension Phase of Study|Lost to Follow-up|2
102590|NCT00340834|346763|P3|Extension Phase of Study|Lost to Follow-up|0
102591|NCT00340834|346764|P2|Extension Phase of Study|Lost to Follow-up|1
102592|NCT00340834|346765|P1|Extension Phase of Study|Lost to Follow-up|1
102593|NCT00340834|346761|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
102594|NCT00340834|346762|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
102595|NCT00340834|346763|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
102596|NCT00340834|346764|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
102597|NCT00340834|346765|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
102598|NCT00340834|346761|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
102599|NCT00340834|346762|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
102600|NCT00340834|346763|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
102601|NCT00340834|346764|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
102602|NCT00340834|346765|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
102603|NCT00340834|346761|P5|Extension Phase of Study|Adverse Event|7
102604|NCT00340834|346762|P4|Extension Phase of Study|Adverse Event|19
102605|NCT00340834|346763|P3|Extension Phase of Study|Adverse Event|0
102606|NCT00340834|346764|P2|Extension Phase of Study|Adverse Event|22
102607|NCT00340834|346765|P1|Extension Phase of Study|Adverse Event|21
102608|NCT00340834|346761|P5|Extension Phase of Study|Subject withdrew consent|15
102609|NCT00340834|346762|P4|Extension Phase of Study|Subject withdrew consent|12
102610|NCT00340834|346763|P3|Extension Phase of Study|Subject withdrew consent|0
102611|NCT00340834|346764|P2|Extension Phase of Study|Subject withdrew consent|31
102612|NCT00340834|346765|P1|Extension Phase of Study|Subject withdrew consent|26
102613|NCT00340834|346761|P5|Extension Phase of Study|Subject did not receive study drug|0
102614|NCT00340834|346762|P4|Extension Phase of Study|Subject did not receive study drug|2
102615|NCT00340834|346763|P3|Extension Phase of Study|Subject did not receive study drug|0
102616|NCT00340834|346764|P2|Extension Phase of Study|Subject did not receive study drug|1
102617|NCT00340834|346765|P1|Extension Phase of Study|Subject did not receive study drug|0
102618|NCT00340834|346761|P5|Core Phase of Study|Protocol Violation|0
102619|NCT00340834|346762|P4|Core Phase of Study|Protocol Violation|0
102620|NCT00340834|346763|P3|Core Phase of Study|Protocol Violation|2
102621|NCT00340834|346764|P2|Core Phase of Study|Protocol Violation|0
102622|NCT00340834|346765|P1|Core Phase of Study|Protocol Violation|0
102623|NCT00340834|346761|P5|Core Phase of Study|Death|0
102624|NCT00340834|346762|P4|Core Phase of Study|Death|0
102625|NCT00340834|346763|P3|Core Phase of Study|Death|0
102626|NCT00340834|346764|P2|Core Phase of Study|Death|0
102627|NCT00340834|346765|P1|Core Phase of Study|Death|2
102628|NCT00340834|346761|P5|Core Phase of Study|Lost to Follow-up|0
102629|NCT00340834|346762|P4|Core Phase of Study|Lost to Follow-up|0
102630|NCT00340834|346763|P3|Core Phase of Study|Lost to Follow-up|4
102631|NCT00340834|346764|P2|Core Phase of Study|Lost to Follow-up|1
102632|NCT00340834|346765|P1|Core Phase of Study|Lost to Follow-up|1
102633|NCT00340834|346761|P5|Core Phase of Study|Abnormal test procedure result(s)|0
102634|NCT00340834|346762|P4|Core Phase of Study|Abnormal test procedure result(s)|0
102635|NCT00340834|346763|P3|Core Phase of Study|Abnormal test procedure result(s)|3
102636|NCT00340834|346764|P2|Core Phase of Study|Abnormal test procedure result(s)|3
102637|NCT00340834|346765|P1|Core Phase of Study|Abnormal test procedure result(s)|4
102638|NCT00340834|346761|P5|Core Phase of Study|Abnormal laboratory value(s)|0
102639|NCT00340834|346762|P4|Core Phase of Study|Abnormal laboratory value(s)|0
102640|NCT00340834|346763|P3|Core Phase of Study|Abnormal laboratory value(s)|1
102641|NCT00340834|346764|P2|Core Phase of Study|Abnormal laboratory value(s)|6
102642|NCT00340834|346765|P1|Core Phase of Study|Abnormal laboratory value(s)|4
102643|NCT00340834|346761|P5|Core Phase of Study|Lack of Efficacy|0
102644|NCT00340834|346762|P4|Core Phase of Study|Lack of Efficacy|0
102645|NCT00340834|346763|P3|Core Phase of Study|Lack of Efficacy|7
102646|NCT00340834|346764|P2|Core Phase of Study|Lack of Efficacy|3
102647|NCT00340834|346765|P1|Core Phase of Study|Lack of Efficacy|3
102648|NCT00340834|346761|P5|Core Phase of Study|Administrative Problems|0
102649|NCT00340834|346762|P4|Core Phase of Study|Administrative Problems|0
102650|NCT00340834|346763|P3|Core Phase of Study|Administrative Problems|7
102651|NCT00340834|346764|P2|Core Phase of Study|Administrative Problems|2
102652|NCT00340834|346765|P1|Core Phase of Study|Administrative Problems|6
102653|NCT00340834|346761|P5|Core Phase of Study|Withdrawal by Subject|0
102654|NCT00340834|346762|P4|Core Phase of Study|Withdrawal by Subject|0
102655|NCT00340834|346763|P3|Core Phase of Study|Withdrawal by Subject|16
102656|NCT00340834|346764|P2|Core Phase of Study|Withdrawal by Subject|9
102657|NCT00340834|346765|P1|Core Phase of Study|Withdrawal by Subject|11
102658|NCT00340834|346761|P5|Core Phase of Study|Adverse Event|0
102659|NCT00340834|346762|P4|Core Phase of Study|Adverse Event|0
102660|NCT00340834|346763|P3|Core Phase of Study|Adverse Event|9
102661|NCT00340834|346764|P2|Core Phase of Study|Adverse Event|9
102662|NCT00340834|346765|P1|Core Phase of Study|Adverse Event|26
102663|NCT00348283|346792|P2|Open Label|Sponsor decision|1
102664|NCT00348283|346793|P1|Open Label|Sponsor decision|0
102665|NCT00348283|346792|P2|Open Label|Pregnancy|1
102666|NCT00348283|346793|P1|Open Label|Pregnancy|0
102667|NCT00348283|346792|P2|Open Label|Subject moved to the United States|1
102668|NCT00348283|346793|P1|Open Label|Subject moved to the United States|0
102669|NCT00348283|346792|P2|Open Label|Administrative reasons|5
102670|NCT00348283|346793|P1|Open Label|Administrative reasons|0
102671|NCT00348283|346792|P2|Open Label|Lack of Efficacy|13
102672|NCT00348283|346793|P1|Open Label|Lack of Efficacy|0
102673|NCT00348283|346792|P2|Open Label|Lost to Follow-up|1
102674|NCT00348283|346793|P1|Open Label|Lost to Follow-up|0
102675|NCT00348283|346792|P2|Open Label|Withdrawal by Subject|4
102676|NCT00348283|346793|P1|Open Label|Withdrawal by Subject|0
102677|NCT00348283|346792|P2|Open Label|Adverse Event|8
102678|NCT00348283|346793|P1|Open Label|Adverse Event|0
102679|NCT00348283|346792|P2|Double Blind|Pregnancy|1
102680|NCT00348283|346793|P1|Double Blind|Pregnancy|0
102681|NCT00348283|346792|P2|Double Blind|Lack of Efficacy|2
102682|NCT00348283|346793|P1|Double Blind|Lack of Efficacy|2
102683|NCT00348283|346792|P2|Double Blind|Protocol Violation|1
102684|NCT00348283|346793|P1|Double Blind|Protocol Violation|0
102685|NCT00348283|346792|P2|Double Blind|Withdrawal by Subject|1
102686|NCT00348283|346793|P1|Double Blind|Withdrawal by Subject|1
102687|NCT00348283|346792|P2|Double Blind|Adverse Event|5
102688|NCT00348283|346793|P1|Double Blind|Adverse Event|2
102689|NCT00348283|346792|P2|Induction|Protocol Violation|4
102690|NCT00348283|346793|P1|Induction|Protocol Violation|0
102691|NCT00348283|346792|P2|Induction|Adverse Event|2
102692|NCT00348283|346793|P1|Induction|Adverse Event|0
102693|NCT00348348|346811|P2|Overall Study|Adverse event probably related to study|0
102694|NCT00348348|346812|P1|Overall Study|Adverse event probably related to study|1
102695|NCT00348348|346811|P2|Overall Study|Worsening of BC - Unlikely related|2
102696|NCT00348348|346812|P1|Overall Study|Worsening of BC - Unlikely related|1
102697|NCT00348348|346811|P2|Overall Study|Worsening of BC - Unrelated to study|3
102698|NCT00348348|346812|P1|Overall Study|Worsening of BC - Unrelated to study|0
102699|NCT00348348|346811|P2|Overall Study|Dissallowed Meds - possibly releated|1
102700|NCT00348348|346812|P1|Overall Study|Dissallowed Meds - possibly releated|1
102701|NCT00348348|346811|P2|Overall Study|Dissallowed Meds - unlikley related|1
102702|NCT00348348|346812|P1|Overall Study|Dissallowed Meds - unlikley related|1
102703|NCT00348348|346811|P2|Overall Study|Dissallowed Meds - unrelated to study|3
102704|NCT00348348|346812|P1|Overall Study|Dissallowed Meds - unrelated to study|1
102705|NCT00348348|346811|P2|Overall Study|Not specified|4
102706|NCT00348348|346812|P1|Overall Study|Not specified|7
102707|NCT00348348|346811|P2|Overall Study|Withdrawal by Subject|1
102708|NCT00348348|346812|P1|Overall Study|Withdrawal by Subject|4
102709|NCT00348348|346811|P2|Overall Study|Lost to Follow-up|10
102710|NCT00348348|346812|P1|Overall Study|Lost to Follow-up|8
102711|NCT00348348|346811|P2|Overall Study|Lack of Efficacy|1
102712|NCT00348348|346812|P1|Overall Study|Lack of Efficacy|1
102713|NCT00348348|346811|P2|Overall Study|Adverse event - unrelated to study drug|1
102714|NCT00348348|346812|P1|Overall Study|Adverse event - unrelated to study drug|0
102715|NCT00348374|346826|P2|Overall Study|randomized but did not receive treatment|7
102716|NCT00348374|346827|P1|Overall Study|randomized but did not receive treatment|0
102717|NCT00348374|346826|P2|Overall Study|ongoing at date of cutoff|1
102718|NCT00348374|346827|P1|Overall Study|ongoing at date of cutoff|1
102719|NCT00348374|346826|P2|Overall Study|Other|12
102720|NCT00348374|346827|P1|Overall Study|Other|11
102721|NCT00348374|346826|P2|Overall Study|Withdrawal by Subject|5
102722|NCT00348374|346827|P1|Overall Study|Withdrawal by Subject|5
102723|NCT00348374|346826|P2|Overall Study|Lost to Follow-up|3
102724|NCT00348374|346827|P1|Overall Study|Lost to Follow-up|1
102725|NCT00348374|346826|P2|Overall Study|Adverse Event|4
102726|NCT00348374|346827|P1|Overall Study|Adverse Event|1
102727|NCT00349349|346900|P3|Overall Study|New Malignancy (Bladder Cancer)|0
102728|NCT00349349|346901|P2|Overall Study|New Malignancy (Bladder Cancer)|1
102729|NCT00349349|346902|P1|Overall Study|New Malignancy (Bladder Cancer)|0
102730|NCT00349349|346900|P3|Overall Study|No Response|0
102731|NCT00349349|346901|P2|Overall Study|No Response|3
102732|NCT00349349|346902|P1|Overall Study|No Response|0
102733|NCT00349349|346900|P3|Overall Study|Physician Decision|1
102734|NCT00349349|346901|P2|Overall Study|Physician Decision|2
102735|NCT00349349|346902|P1|Overall Study|Physician Decision|1
102736|NCT00349349|346900|P3|Overall Study|Participant Reduced General Condition|0
102737|NCT00349349|346901|P2|Overall Study|Participant Reduced General Condition|1
102738|NCT00349349|346902|P1|Overall Study|Participant Reduced General Condition|0
102739|NCT00349349|346900|P3|Overall Study|Other Treatment Selected|0
102740|NCT00349349|346901|P2|Overall Study|Other Treatment Selected|0
102741|NCT00349349|346902|P1|Overall Study|Other Treatment Selected|2
102742|NCT00349349|346900|P3|Overall Study|Death|1
102743|NCT00349349|346901|P2|Overall Study|Death|10
102744|NCT00349349|346902|P1|Overall Study|Death|13
102745|NCT00349349|346900|P3|Overall Study|Withdrawn due to Disease Progression|1
102746|NCT00349349|346901|P2|Overall Study|Withdrawn due to Disease Progression|37
102747|NCT00349349|346902|P1|Overall Study|Withdrawn due to Disease Progression|27
102748|NCT00349349|346900|P3|Overall Study|Withdrawal by Subject|1
102749|NCT00349349|346901|P2|Overall Study|Withdrawal by Subject|2
102750|NCT00349349|346902|P1|Overall Study|Withdrawal by Subject|5
102751|NCT00349349|346900|P3|Overall Study|Adverse Event|2
102752|NCT00349349|346901|P2|Overall Study|Adverse Event|6
102753|NCT00349349|346902|P1|Overall Study|Adverse Event|5
102754|NCT00349622|346986|P2|Overall Study|Withdrawal by Subject|9
102755|NCT00349622|346987|P1|Overall Study|Withdrawal by Subject|5
102756|NCT00349622|346986|P2|Overall Study|Lost to Follow-up|1
102757|NCT00349622|346987|P1|Overall Study|Lost to Follow-up|5
102758|NCT00349622|346986|P2|Overall Study|Death|86
102759|NCT00349622|346987|P1|Overall Study|Death|168
102760|NCT00349752|347030|P2|Overall Study|Other:History of squamous cell carcinoma|0
102761|NCT00349752|347031|P1|Overall Study|Other:History of squamous cell carcinoma|1
102762|NCT00349752|347030|P2|Overall Study|Other: Inadvertently unblinded|0
102763|NCT00349752|347031|P1|Overall Study|Other: Inadvertently unblinded|1
102764|NCT00349752|347030|P2|Overall Study|Other: Ineligible|0
102765|NCT00349752|347031|P1|Overall Study|Other: Ineligible|1
102766|NCT00349752|347030|P2|Overall Study|Other: Patient's steroid use|0
102767|NCT00349752|347031|P1|Overall Study|Other: Patient's steroid use|1
102768|NCT00349752|347030|P2|Overall Study|Other: Patient stopped steroids|1
102769|NCT00349752|347031|P1|Overall Study|Other: Patient stopped steroids|0
102770|NCT00349752|347030|P2|Overall Study|Other: Non compliance|1
102771|NCT00349752|347031|P1|Overall Study|Other: Non compliance|0
102772|NCT00349752|347030|P2|Overall Study|Other: Required exclusionary medication|1
102773|NCT00349752|347031|P1|Overall Study|Other: Required exclusionary medication|0
102774|NCT00349752|347030|P2|Overall Study|Personal reasons|5
102775|NCT00349752|347031|P1|Overall Study|Personal reasons|6
102776|NCT00349752|347030|P2|Overall Study|Lost to Follow-up|2
102777|NCT00349752|347031|P1|Overall Study|Lost to Follow-up|4
102778|NCT00349752|347030|P2|Overall Study|Lack of Efficacy|42
102779|NCT00349752|347031|P1|Overall Study|Lack of Efficacy|37
102780|NCT00349752|347030|P2|Overall Study|Adverse Event|12
102781|NCT00349752|347031|P1|Overall Study|Adverse Event|8
102782|NCT00349908|347059|P2|Overall Study|Withdrawal by Subject|4
102783|NCT00349908|347060|P1|Overall Study|Withdrawal by Subject|0
102784|NCT00349921|347082|P4|First Spinal Injection|Adverse Event|0
102785|NCT00349921|347083|P3|First Spinal Injection|Adverse Event|1
102786|NCT00349921|347084|P2|First Spinal Injection|Adverse Event|0
102787|NCT00349921|347085|P1|First Spinal Injection|Adverse Event|0
102788|NCT00349921|347082|P4|First Spinal Injection|Physician Decision|0
102789|NCT00349921|347083|P3|First Spinal Injection|Physician Decision|0
102790|NCT00349921|347084|P2|First Spinal Injection|Physician Decision|0
102791|NCT00349921|347085|P1|First Spinal Injection|Physician Decision|1
102792|NCT00350207|347113|P3|Overall Study|Other|1
102793|NCT00350207|347114|P2|Overall Study|Other|3
102794|NCT00350207|347115|P1|Overall Study|Other|1
102795|NCT00350207|347113|P3|Overall Study|Withdrawal by Subject|1
102796|NCT00350207|347114|P2|Overall Study|Withdrawal by Subject|1
102797|NCT00350207|347115|P1|Overall Study|Withdrawal by Subject|0
102798|NCT00350207|347113|P3|Overall Study|Lost to Follow-up|1
102799|NCT00350207|347114|P2|Overall Study|Lost to Follow-up|0
102800|NCT00350207|347115|P1|Overall Study|Lost to Follow-up|1
102801|NCT00350207|347113|P3|Overall Study|Lack of Efficacy|2
102802|NCT00350207|347114|P2|Overall Study|Lack of Efficacy|0
102803|NCT00350207|347115|P1|Overall Study|Lack of Efficacy|1
102804|NCT00350207|347113|P3|Overall Study|Adverse Event|2
102805|NCT00350207|347114|P2|Overall Study|Adverse Event|2
102806|NCT00350207|347115|P1|Overall Study|Adverse Event|5
102807|NCT00350272|347322|P2|Open-Label 84 Week Treatment|Sponsor decision|1
102808|NCT00350272|347323|P1|Open-Label 84 Week Treatment|Sponsor decision|2
102809|NCT00350272|347322|P2|Open-Label 84 Week Treatment|Physician Decision|2
102810|NCT00350272|347323|P1|Open-Label 84 Week Treatment|Physician Decision|1
102811|NCT00350272|347322|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
102812|NCT00350272|347323|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
102813|NCT00350272|347322|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
102814|NCT00350272|347323|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
102815|NCT00350272|347322|P2|Open-Label 84 Week Treatment|Adverse Event|1
102816|NCT00350272|347323|P1|Open-Label 84 Week Treatment|Adverse Event|2
102817|NCT00350272|347322|P2|Blinded 12 Week Treatment|Sponsor decision|1
102818|NCT00350272|347323|P1|Blinded 12 Week Treatment|Sponsor decision|0
102819|NCT00350272|347322|P2|Blinded 12 Week Treatment|Physician Decision|1
102820|NCT00350272|347323|P1|Blinded 12 Week Treatment|Physician Decision|2
102821|NCT00350272|347322|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
102822|NCT00350272|347323|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
102823|NCT00350272|347322|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
102824|NCT00350272|347323|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
102825|NCT00350272|347322|P2|Blinded 12 Week Treatment|Death|0
102826|NCT00350272|347323|P1|Blinded 12 Week Treatment|Death|1
102827|NCT00350272|347322|P2|Blinded 12 Week Treatment|Adverse Event|0
102828|NCT00350272|347323|P1|Blinded 12 Week Treatment|Adverse Event|1
102829|NCT00350402|347337|P2|Overall Study|Lost to Follow-up|1
102830|NCT00350402|347338|P1|Overall Study|Lost to Follow-up|1
102831|NCT00350519|347352|P2|Overall Study|Withdrawal by Subject|2
102832|NCT00350519|347353|P1|Overall Study|Withdrawal by Subject|3
102833|NCT00350519|347352|P2|Overall Study|Protocol Violation|2
102834|NCT00350519|347353|P1|Overall Study|Protocol Violation|1
102835|NCT00350519|347352|P2|Overall Study|Physician Decision|1
102836|NCT00350519|347353|P1|Overall Study|Physician Decision|0
102837|NCT00350519|347352|P2|Overall Study|Death|1
102838|NCT00350519|347353|P1|Overall Study|Death|0
102839|NCT00350623|347377|P3|Overall Study|patient traveling outside the country|1
102840|NCT00350623|347378|P2|Overall Study|patient traveling outside the country|0
102841|NCT00350623|347379|P1|Overall Study|patient traveling outside the country|0
102842|NCT00350623|347377|P3|Overall Study|Withdrawal by Subject|1
102843|NCT00350623|347378|P2|Overall Study|Withdrawal by Subject|1
102844|NCT00350623|347379|P1|Overall Study|Withdrawal by Subject|0
102845|NCT00350623|347377|P3|Overall Study|Lost to Follow-up|4
102846|NCT00350623|347378|P2|Overall Study|Lost to Follow-up|3
102847|NCT00350623|347379|P1|Overall Study|Lost to Follow-up|8
102848|NCT00350636|347389|P2|Overall Study|Other|2
102849|NCT00350636|347390|P1|Overall Study|Other|1
102850|NCT00350636|347389|P2|Overall Study|Physician Decision|2
102851|NCT00350636|347390|P1|Overall Study|Physician Decision|0
102852|NCT00350636|347389|P2|Overall Study|Lost to Follow-up|8
102853|NCT00350636|347390|P1|Overall Study|Lost to Follow-up|9
102854|NCT00350636|347389|P2|Overall Study|Withdrawal by Subject|17
102855|NCT00350636|347390|P1|Overall Study|Withdrawal by Subject|13
102856|NCT00350636|347389|P2|Overall Study|Protocol Violation|3
102857|NCT00350636|347390|P1|Overall Study|Protocol Violation|1
102858|NCT00350636|347389|P2|Overall Study|Adverse Event|13
102859|NCT00350636|347390|P1|Overall Study|Adverse Event|19
102860|NCT00350727|347409|P3|Phase II|Enrolled in Rollover Study|1
102861|NCT00350727|347410|P2|Phase II|Enrolled in Rollover Study|0
102862|NCT00350727|347411|P1|Phase II|Enrolled in Rollover Study|0
102863|NCT00350727|347409|P3|Phase II|Sponsor Terminated Study|1
102864|NCT00350727|347410|P2|Phase II|Sponsor Terminated Study|0
102865|NCT00350727|347411|P1|Phase II|Sponsor Terminated Study|0
102866|NCT00350727|347409|P3|Phase II|Death|2
102867|NCT00350727|347410|P2|Phase II|Death|0
102868|NCT00350727|347411|P1|Phase II|Death|0
102869|NCT00350727|347409|P3|Phase II|Adverse Event|1
102870|NCT00350727|347410|P2|Phase II|Adverse Event|1
102871|NCT00350727|347411|P1|Phase II|Adverse Event|0
102872|NCT00350727|347409|P3|Phase II|Withdrawal by Subject|1
102873|NCT00350727|347410|P2|Phase II|Withdrawal by Subject|2
102874|NCT00350727|347411|P1|Phase II|Withdrawal by Subject|0
102875|NCT00350727|347409|P3|Phase II|Clinical Deterioration|0
102876|NCT00350727|347410|P2|Phase II|Clinical Deterioration|1
102877|NCT00350727|347411|P1|Phase II|Clinical Deterioration|0
102878|NCT00350727|347409|P3|Phase II|Disease Progression|16
102879|NCT00350727|347410|P2|Phase II|Disease Progression|15
102880|NCT00350727|347411|P1|Phase II|Disease Progression|0
102881|NCT00350727|347409|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
102882|NCT00350727|347410|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
102883|NCT00350727|347411|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
102884|NCT00350727|347409|P3|Phase I: Dose Escalation|Physician Decision|0
102885|NCT00350727|347410|P2|Phase I: Dose Escalation|Physician Decision|0
102886|NCT00350727|347411|P1|Phase I: Dose Escalation|Physician Decision|1
102887|NCT00350727|347409|P3|Phase I: Dose Escalation|Death|0
102888|NCT00350727|347410|P2|Phase I: Dose Escalation|Death|0
102889|NCT00350727|347411|P1|Phase I: Dose Escalation|Death|1
102890|NCT00350727|347409|P3|Phase I: Dose Escalation|Lack of Efficacy|0
102891|NCT00350727|347410|P2|Phase I: Dose Escalation|Lack of Efficacy|0
102892|NCT00350727|347411|P1|Phase I: Dose Escalation|Lack of Efficacy|25
102893|NCT00350727|347409|P3|Phase I: Dose Escalation|Adverse Event|0
102894|NCT00350727|347410|P2|Phase I: Dose Escalation|Adverse Event|0
102895|NCT00350727|347411|P1|Phase I: Dose Escalation|Adverse Event|4
102896|NCT00350779|347555|P2|Overall Study|Non-compliance with study procedures|1
102897|NCT00350779|347556|P1|Overall Study|Non-compliance with study procedures|0
102898|NCT00350779|347555|P2|Overall Study|Patient Moved|1
102899|NCT00350779|347556|P1|Overall Study|Patient Moved|2
102900|NCT00350779|347555|P2|Overall Study|Withdrawal by Subject|8
102901|NCT00350779|347556|P1|Overall Study|Withdrawal by Subject|9
102902|NCT00350779|347555|P2|Overall Study|Protocol Violation|1
102903|NCT00350779|347556|P1|Overall Study|Protocol Violation|3
102904|NCT00350779|347555|P2|Overall Study|Physician Decision|4
102905|NCT00350779|347556|P1|Overall Study|Physician Decision|2
102906|NCT00350779|347555|P2|Overall Study|Lost to Follow-up|0
102907|NCT00350779|347556|P1|Overall Study|Lost to Follow-up|2
102908|NCT00350779|347555|P2|Overall Study|Lack of Efficacy|4
102909|NCT00350779|347556|P1|Overall Study|Lack of Efficacy|0
102910|NCT00350779|347555|P2|Overall Study|Adverse Event|2
102911|NCT00350779|347556|P1|Overall Study|Adverse Event|4
102912|NCT00350792|347574|P1|Overall Study|Lack of Efficacy|11
102913|NCT00350792|347574|P1|Overall Study|Physician Decision|2
102914|NCT00350792|347574|P1|Overall Study|Withdrawal by Subject|4
102915|NCT00350792|347574|P1|Overall Study|Protocol Violation|1
102916|NCT00350792|347574|P1|Overall Study|Death Not Study Drug Related|2
102917|NCT00350792|347574|P1|Overall Study|Death from Study Drug Toxicity|1
102918|NCT00350792|347574|P1|Overall Study|Death from Study Disease|1
102919|NCT00350792|347574|P1|Overall Study|Adverse Event|11
102920|NCT00350844|347582|P1|Overall Study|Lost to Follow-up|1
102921|NCT00350870|347590|P4|Overall Study|Physician Decision|1
102922|NCT00350870|347591|P3|Overall Study|Physician Decision|1
102923|NCT00350870|347592|P2|Overall Study|Physician Decision|0
102924|NCT00350870|347593|P1|Overall Study|Physician Decision|1
102925|NCT00350870|347590|P4|Overall Study|Withdrawal by Subject|14
102926|NCT00350870|347591|P3|Overall Study|Withdrawal by Subject|15
102927|NCT00350870|347592|P2|Overall Study|Withdrawal by Subject|17
102928|NCT00350870|347593|P1|Overall Study|Withdrawal by Subject|21
102929|NCT00351273|347626|P3|Overall Study|Lost to Follow-up|5
102930|NCT00351273|347627|P2|Overall Study|Lost to Follow-up|2
102931|NCT00351273|347628|P1|Overall Study|Lost to Follow-up|1
102932|NCT00351351|347655|P2|Overall Study|surgical access pbs; device issues|4
102933|NCT00351351|347656|P1|Overall Study|surgical access pbs; device issues|9
102934|NCT00351377|347662|P1|Overall Study|Unsatisfactory therapeutic effect|1
102935|NCT00351377|347662|P1|Overall Study|Death|1
102936|NCT00351377|347662|P1|Overall Study|Adverse Event|5
102937|NCT00351468|347683|P1|Overall Study|Protocol Violation|3
102938|NCT00351468|347683|P1|Overall Study|Lost to Follow-up|4
102939|NCT00351468|347683|P1|Overall Study|Non-compliance|8
102940|NCT00351468|347683|P1|Overall Study|Lack of Efficacy|32
102941|NCT00351468|347683|P1|Overall Study|Various -follow up w clinical team|39
102942|NCT00351468|347683|P1|Overall Study|Withdrawal by Subject|39
102943|NCT00351468|347683|P1|Overall Study|Adverse Event|42
102944|NCT00351533|347700|P2|Overall Study|Withdrawal by Subject|1
102945|NCT00351533|347701|P1|Overall Study|Withdrawal by Subject|0
102946|NCT00351533|347700|P2|Overall Study|Physician Decision|1
102947|NCT00351533|347701|P1|Overall Study|Physician Decision|0
102948|NCT00351533|347700|P2|Overall Study|Lost to Follow-up|3
102949|NCT00351533|347701|P1|Overall Study|Lost to Follow-up|1
102950|NCT00351533|347700|P2|Overall Study|Extubated before first BAL|0
102951|NCT00351533|347701|P1|Overall Study|Extubated before first BAL|1
102952|NCT00338455|347763|P2|Overall Study|Physician Decision|0
102953|NCT00338455|347764|P1|Overall Study|Physician Decision|1
102954|NCT00338455|347763|P2|Overall Study|Death|1
102955|NCT00338455|347764|P1|Overall Study|Death|2
102956|NCT00338741|347799|P2|Overall Study|Lost to Follow-up|0
102957|NCT00338741|347800|P1|Overall Study|Lost to Follow-up|2
102958|NCT00338806|347810|P2|Follow-up|Lost to Follow-up|3
102959|NCT00338806|347811|P1|Follow-up|Lost to Follow-up|1
102960|NCT00338806|347810|P2|Acute Phase|Withdrawal by Subject|1
102961|NCT00338806|347811|P1|Acute Phase|Withdrawal by Subject|0
102962|NCT00338884|347871|P1|Overall Study|Randomized But Did Not Receive Treatment|1
102963|NCT00338884|347871|P1|Overall Study|Lost to Follow-up|1
102964|NCT00338884|347871|P1|Overall Study|Withdrawal by Subject|3
102965|NCT00338884|347871|P1|Overall Study|Global Deterioration of Health Status|3
102966|NCT00338884|347871|P1|Overall Study|Unspecified|4
102967|NCT00338884|347871|P1|Overall Study|Death|8
102968|NCT00338884|347871|P1|Overall Study|Adverse Event|14
102969|NCT00338884|347871|P1|Overall Study|Objective Disease Progression or Relapse|44
102970|NCT00344773|347918|P1|Overall Study|Not Eligible for the study|2
102971|NCT00344773|347918|P1|Overall Study|Withdrawal by Subject|1
102972|NCT00344773|347918|P1|Overall Study|Objective Disease Progression|16
102973|NCT00344773|347918|P1|Overall Study|Adverse Event|2
102974|NCT00344968|347927|P3|Overall Study|Other|0
102975|NCT00344968|347928|P2|Overall Study|Other|1
102976|NCT00344968|347929|P1|Overall Study|Other|0
102977|NCT00344968|347927|P3|Overall Study|Death|31
102978|NCT00344968|347928|P2|Overall Study|Death|27
102979|NCT00344968|347929|P1|Overall Study|Death|11
102980|NCT00344968|347927|P3|Overall Study|Lost to Follow-up|37
102981|NCT00344968|347928|P2|Overall Study|Lost to Follow-up|37
102982|NCT00344968|347929|P1|Overall Study|Lost to Follow-up|24
102983|NCT00344968|347927|P3|Overall Study|Withdrawal by Subject|27
102984|NCT00344968|347928|P2|Overall Study|Withdrawal by Subject|31
102985|NCT00344968|347929|P1|Overall Study|Withdrawal by Subject|14
102986|NCT00344968|347927|P3|Overall Study|Protocol Violation|5
102987|NCT00344968|347928|P2|Overall Study|Protocol Violation|2
102988|NCT00344968|347929|P1|Overall Study|Protocol Violation|2
102989|NCT00344968|347927|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
102990|NCT00344968|347928|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
102991|NCT00344968|347929|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
102992|NCT00344968|347927|P3|Overall Study|Adverse Event|15
102993|NCT00344968|347928|P2|Overall Study|Adverse Event|4
102994|NCT00344968|347929|P1|Overall Study|Adverse Event|5
102995|NCT00345046|347962|P3|Overall Study|Protocol Violation|2
102996|NCT00345046|347963|P2|Overall Study|Protocol Violation|1
102997|NCT00345046|347964|P1|Overall Study|Protocol Violation|1
102998|NCT00345293|348008|P2|Overall Study|Withdrawal by Subject|0
102999|NCT00345293|348009|P1|Overall Study|Withdrawal by Subject|1
103000|NCT00345293|348008|P2|Overall Study|Unable to access line for sample|0
103001|NCT00345293|348009|P1|Overall Study|Unable to access line for sample|1
103002|NCT00345397|348049|P1|Overall Study|Death|1
103003|NCT00345540|348054|P1|Overall Study|Withdrawal by Subject|1
103004|NCT00345579|348062|P2|Overall Study|Unspecified|1
103005|NCT00345579|348063|P1|Overall Study|Unspecified|9
103006|NCT00345579|348062|P2|Overall Study|Lost to Follow-up|36
103007|NCT00345579|348063|P1|Overall Study|Lost to Follow-up|82
103008|NCT00345579|348062|P2|Overall Study|Withdrawal by Subject|17
103009|NCT00345579|348063|P1|Overall Study|Withdrawal by Subject|50
103010|NCT00345579|348062|P2|Overall Study|Protocol Violation|5
103011|NCT00345579|348063|P1|Overall Study|Protocol Violation|14
103012|NCT00345579|348062|P2|Overall Study|Adverse Event|6
103013|NCT00345579|348063|P1|Overall Study|Adverse Event|9
103014|NCT00345592|348085|P2|Overall Study|Withdrawal by Subject|8
103015|NCT00345592|348086|P1|Overall Study|Withdrawal by Subject|11
103016|NCT00345592|348085|P2|Overall Study|Death|16
103017|NCT00345592|348086|P1|Overall Study|Death|14
103018|NCT00345605|348092|P2|Arm 2, Opposite Treatment|Adverse Event|0
103019|NCT00345605|348093|P1|Arm 2, Opposite Treatment|Adverse Event|1
103020|NCT00345605|348092|P2|Arm 1|Adverse Event|1
103021|NCT00345605|348093|P1|Arm 1|Adverse Event|0
103022|NCT00351819|348134|P2|Overall Study|Enrolled in another trial|1
103023|NCT00351819|348135|P1|Overall Study|Enrolled in another trial|0
103024|NCT00351819|348134|P2|Overall Study|Incarcerated|1
103025|NCT00351819|348135|P1|Overall Study|Incarcerated|0
103026|NCT00351819|348134|P2|Overall Study|Non-compliance|1
103027|NCT00351819|348135|P1|Overall Study|Non-compliance|0
103028|NCT00351819|348134|P2|Overall Study|Unprofessional behavior|0
103029|NCT00351819|348135|P1|Overall Study|Unprofessional behavior|1
103030|NCT00351819|348134|P2|Overall Study|Traumatic ankle fracture|0
103031|NCT00351819|348135|P1|Overall Study|Traumatic ankle fracture|1
103032|NCT00351819|348134|P2|Overall Study|Elevated PSA|1
103033|NCT00351819|348135|P1|Overall Study|Elevated PSA|1
103034|NCT00351819|348134|P2|Overall Study|Withdrawal by Subject|4
103035|NCT00351819|348135|P1|Overall Study|Withdrawal by Subject|0
103036|NCT00351819|348134|P2|Overall Study|Lost to Follow-up|4
103037|NCT00351819|348135|P1|Overall Study|Lost to Follow-up|4
103038|NCT00352365|348183|P1|Maintenance Therapy|Not eligible|4
103039|NCT00352365|348183|P1|Maintenance Therapy|Not protocol specified|3
103040|NCT00352365|348183|P1|Maintenance Therapy|Death|2
103041|NCT00352365|348183|P1|Maintenance Therapy|Progression/Relapse|3
103042|NCT00352365|348183|P1|Induction Therapy|Death before starting protocol therapy|1
103043|NCT00352365|348183|P1|Induction Therapy|Not eligible|3
103044|NCT00352365|348183|P1|Induction Therapy|Not protocol specified|1
103045|NCT00352365|348183|P1|Induction Therapy|Death|7
103046|NCT00352365|348183|P1|Induction Therapy|Progression/Relapse|8
103047|NCT00352365|348183|P1|Induction Therapy|Adverse Event|7
103048|NCT00352417|348195|P2|Overall Study|Schedule Change|1
103049|NCT00352417|348196|P1|Overall Study|Schedule Change|2
103050|NCT00352417|348195|P2|Overall Study|Lost to Follow-up|0
103051|NCT00352417|348196|P1|Overall Study|Lost to Follow-up|1
103052|NCT00352417|348195|P2|Overall Study|Withdrawal by Subject|2
103053|NCT00352417|348196|P1|Overall Study|Withdrawal by Subject|1
103054|NCT00352417|348195|P2|Overall Study|Protocol Violation|2
103055|NCT00352417|348196|P1|Overall Study|Protocol Violation|0
103056|NCT00352417|348195|P2|Overall Study|Adverse Event|0
103057|NCT00352417|348196|P1|Overall Study|Adverse Event|1
103058|NCT00352534|348212|P7|Final Risk Group Assignment|Death|0
103059|NCT00352534|348213|P6|Final Risk Group Assignment|Death|2
103060|NCT00352534|348214|P5|Final Risk Group Assignment|Death|0
103061|NCT00352534|348215|P4|Final Risk Group Assignment|Death|0
103062|NCT00352534|348216|P3|Final Risk Group Assignment|Death|0
103063|NCT00352534|348217|P2|Final Risk Group Assignment|Death|0
103064|NCT00352534|348218|P1|Final Risk Group Assignment|Death|0
103065|NCT00352534|348212|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
103066|NCT00352534|348213|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
103067|NCT00352534|348214|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
103068|NCT00352534|348215|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
103069|NCT00352534|348216|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
103070|NCT00352534|348217|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
103071|NCT00352534|348218|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
103072|NCT00352534|348212|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
103073|NCT00352534|348213|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
103074|NCT00352534|348214|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
103075|NCT00352534|348215|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
103076|NCT00352534|348216|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
103077|NCT00352534|348217|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
103078|NCT00352534|348218|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
103079|NCT00352534|348212|P7|Final Risk Group Assignment|Ineligible|0
103080|NCT00352534|348213|P6|Final Risk Group Assignment|Ineligible|13
103081|NCT00352534|348214|P5|Final Risk Group Assignment|Ineligible|0
103082|NCT00352534|348215|P4|Final Risk Group Assignment|Ineligible|1
103083|NCT00352534|348216|P3|Final Risk Group Assignment|Ineligible|3
103084|NCT00352534|348217|P2|Final Risk Group Assignment|Ineligible|0
103085|NCT00352534|348218|P1|Final Risk Group Assignment|Ineligible|0
103086|NCT00352534|348212|P7|Final Risk Group Assignment|Withdrawal by Subject|0
103087|NCT00352534|348213|P6|Final Risk Group Assignment|Withdrawal by Subject|3
103088|NCT00352534|348214|P5|Final Risk Group Assignment|Withdrawal by Subject|0
103089|NCT00352534|348215|P4|Final Risk Group Assignment|Withdrawal by Subject|0
103090|NCT00352534|348216|P3|Final Risk Group Assignment|Withdrawal by Subject|0
103091|NCT00352534|348217|P2|Final Risk Group Assignment|Withdrawal by Subject|0
103092|NCT00352534|348218|P1|Final Risk Group Assignment|Withdrawal by Subject|0
103093|NCT00352534|348212|P7|Final Risk Group Assignment|Physician Decision|0
103094|NCT00352534|348213|P6|Final Risk Group Assignment|Physician Decision|8
103095|NCT00352534|348214|P5|Final Risk Group Assignment|Physician Decision|0
103096|NCT00352534|348215|P4|Final Risk Group Assignment|Physician Decision|0
103097|NCT00352534|348216|P3|Final Risk Group Assignment|Physician Decision|0
103098|NCT00352534|348217|P2|Final Risk Group Assignment|Physician Decision|0
103099|NCT00352534|348218|P1|Final Risk Group Assignment|Physician Decision|0
103100|NCT00352534|348212|P7|Final Risk Group Assignment|Lack of Efficacy|0
103101|NCT00352534|348213|P6|Final Risk Group Assignment|Lack of Efficacy|19
103102|NCT00352534|348214|P5|Final Risk Group Assignment|Lack of Efficacy|1
103103|NCT00352534|348215|P4|Final Risk Group Assignment|Lack of Efficacy|2
103104|NCT00352534|348216|P3|Final Risk Group Assignment|Lack of Efficacy|0
103105|NCT00352534|348217|P2|Final Risk Group Assignment|Lack of Efficacy|0
103106|NCT00352534|348218|P1|Final Risk Group Assignment|Lack of Efficacy|0
103107|NCT00352534|348212|P7|Initial Staging|Ineligible|0
103108|NCT00352534|348213|P6|Initial Staging|Ineligible|0
103109|NCT00352534|348214|P5|Initial Staging|Ineligible|0
103110|NCT00352534|348215|P4|Initial Staging|Ineligible|0
103111|NCT00352534|348216|P3|Initial Staging|Ineligible|0
103112|NCT00352534|348217|P2|Initial Staging|Ineligible|9
103113|NCT00352534|348218|P1|Initial Staging|Ineligible|8
103114|NCT00352664|348244|P2|Overall Study|Withdrawal by Subject|0
103115|NCT00352664|348245|P1|Overall Study|Withdrawal by Subject|7
103116|NCT00352690|348253|P2|Overall Study|Determined to be ineligible|0
103117|NCT00352690|348254|P1|Overall Study|Determined to be ineligible|2
103118|NCT00352755|348272|P1|Overall Study|Adverse Event|1
103119|NCT00352755|348272|P1|Overall Study|Physician Decision|1
103120|NCT00352846|348287|P2|Overall Study|Death|1
103121|NCT00352846|348288|P1|Overall Study|Death|0
103122|NCT00352846|348287|P2|Overall Study|Non-compliance|0
103123|NCT00352846|348288|P1|Overall Study|Non-compliance|2
103124|NCT00352846|348287|P2|Overall Study|Ineligible|2
103125|NCT00352846|348288|P1|Overall Study|Ineligible|3
103126|NCT00352846|348287|P2|Overall Study|Withdrawal by Subject|8
103127|NCT00352846|348288|P1|Overall Study|Withdrawal by Subject|3
103128|NCT00352846|348287|P2|Overall Study|Disease progression|2
103129|NCT00352846|348288|P1|Overall Study|Disease progression|0
103130|NCT00353262|348325|P1|Overall Study|Break from Chemotherapy|1
103131|NCT00353262|348325|P1|Overall Study|Surgery|4
103132|NCT00353262|348325|P1|Overall Study|Progression|1
103133|NCT00353262|348325|P1|Overall Study|Insufficient Therapeutic Response|13
103134|NCT00353262|348325|P1|Overall Study|Withdrawal by Subject|2
103135|NCT00353262|348325|P1|Overall Study|Adverse Event|8
103136|NCT00353366|348356|P1|Overall Study|Unspecified|135
103137|NCT00353366|348356|P1|Overall Study|Adverse Event|8
103138|NCT00353496|348403|P2|Overall Study|Not otherwise specified|2
103139|NCT00353496|348404|P1|Overall Study|Not otherwise specified|4
103140|NCT00353496|348403|P2|Overall Study|Physician Decision|9
103141|NCT00353496|348404|P1|Overall Study|Physician Decision|6
103142|NCT00353496|348403|P2|Overall Study|Withdrawal by Subject|4
103143|NCT00353496|348404|P1|Overall Study|Withdrawal by Subject|3
103144|NCT00353496|348403|P2|Overall Study|Protocol Violation|2
103145|NCT00353496|348404|P1|Overall Study|Protocol Violation|2
103146|NCT00353496|348403|P2|Overall Study|Adverse Event|0
103147|NCT00353496|348404|P1|Overall Study|Adverse Event|1
103148|NCT00353704|348446|P2|Overall Study|Protocol Violation|1
103149|NCT00353704|348447|P1|Overall Study|Protocol Violation|3
103150|NCT00353873|348461|P2|Overall Study|Withdrawal by Subject|1
103151|NCT00353873|348462|P1|Overall Study|Withdrawal by Subject|1
103152|NCT00353873|348461|P2|Overall Study|Physician Decision|0
103153|NCT00353873|348462|P1|Overall Study|Physician Decision|2
103154|NCT00353873|348461|P2|Overall Study|Adverse Event|0
103155|NCT00353873|348462|P1|Overall Study|Adverse Event|1
103156|NCT00353873|348461|P2|Overall Study|Exacerbation|0
103157|NCT00353873|348462|P1|Overall Study|Exacerbation|1
103158|NCT00353873|348461|P2|Overall Study|Protocol Violation|2
103159|NCT00353873|348462|P1|Overall Study|Protocol Violation|1
103160|NCT00354029|348480|P2|Overall Study|Protocol Violation|2
103161|NCT00354029|348481|P1|Overall Study|Protocol Violation|4
103162|NCT00354107|348487|P1|Overall Study|Withdrawal by Subject|1
103163|NCT00354107|348487|P1|Overall Study|Physician Decision|2
103164|NCT00354107|348487|P1|Overall Study|Adverse Event|2
103165|NCT00354159|348493|P2|Long-term Follow-up|Study Closed|34
103166|NCT00354159|348494|P1|Long-term Follow-up|Study Closed|29
103167|NCT00354159|348493|P2|Long-term Follow-up|Death|11
103168|NCT00354159|348494|P1|Long-term Follow-up|Death|14
103169|NCT00354159|348493|P2|Long-term Follow-up|Lost to Follow-up|0
103170|NCT00354159|348494|P1|Long-term Follow-up|Lost to Follow-up|1
103171|NCT00354159|348493|P2|Long-term Follow-up|Physician Decision|122
103172|NCT00354159|348494|P1|Long-term Follow-up|Physician Decision|127
103173|NCT00354159|348493|P2|Long-term Follow-up|Withdrawal by Subject|9
103174|NCT00354159|348494|P1|Long-term Follow-up|Withdrawal by Subject|9
103175|NCT00354159|348493|P2|Randomized Study Period|Death|9
103176|NCT00354159|348494|P1|Randomized Study Period|Death|7
103177|NCT00354159|348493|P2|Randomized Study Period|Lost to Follow-up|0
103178|NCT00354159|348494|P1|Randomized Study Period|Lost to Follow-up|4
103179|NCT00354159|348493|P2|Randomized Study Period|Physician Decision|10
103180|NCT00354159|348494|P1|Randomized Study Period|Physician Decision|6
103181|NCT00354159|348493|P2|Randomized Study Period|Withdrawal by Subject|3
103182|NCT00354159|348494|P1|Randomized Study Period|Withdrawal by Subject|5
103183|NCT00354172|348537|P1|Overall Study|Did not receive transplant|1
103184|NCT00354341|348557|P2|Overall Study|Unspecified|2
103185|NCT00354341|348558|P1|Overall Study|Unspecified|1
103186|NCT00354341|348557|P2|Overall Study|Failure to return|1
103187|NCT00354341|348558|P1|Overall Study|Failure to return|0
103188|NCT00354341|348557|P2|Overall Study|Refused treatment|2
103189|NCT00354341|348558|P1|Overall Study|Refused treatment|1
103190|NCT00354341|348557|P2|Overall Study|Death|2
103191|NCT00354341|348558|P1|Overall Study|Death|0
103192|NCT00354341|348557|P2|Overall Study|Adverse Event|0
103193|NCT00354341|348558|P1|Overall Study|Adverse Event|1
103194|NCT00354432|348578|P4|Overall Study|Off/Toxicity|5
103195|NCT00354432|348579|P3|Overall Study|Off/Toxicity|5
103196|NCT00354432|348580|P2|Overall Study|Off/Toxicity|7
103197|NCT00354432|348581|P1|Overall Study|Off/Toxicity|3
103198|NCT00354432|348578|P4|Overall Study|Adverse Event|5
103199|NCT00354432|348579|P3|Overall Study|Adverse Event|5
103200|NCT00354432|348580|P2|Overall Study|Adverse Event|1
103201|NCT00354432|348581|P1|Overall Study|Adverse Event|3
103202|NCT00354601|348604|P1|Overall Study|progression|1
103203|NCT00354601|348604|P1|Overall Study|Protocol Violation|1
103204|NCT00354614|348611|P1|Overall Study|Lack of Efficacy|28
103205|NCT00354679|348620|P1|Overall Study|Patient Not Treated|1
103206|NCT00348556|348624|P1|Overall Study|Adverse Event|1
103207|NCT00348673|348637|P9|Stage 1|Randomized but not Treated|0
103208|NCT00348673|348638|P8|Stage 1|Randomized but not Treated|0
103209|NCT00348673|348639|P7|Stage 1|Randomized but not Treated|0
103210|NCT00348673|348640|P6|Stage 1|Randomized but not Treated|0
103211|NCT00348673|348641|P5|Stage 1|Randomized but not Treated|0
103212|NCT00348673|348642|P4|Stage 1|Randomized but not Treated|0
103213|NCT00348673|348643|P3|Stage 1|Randomized but not Treated|1
103214|NCT00348673|348644|P2|Stage 1|Randomized but not Treated|0
103215|NCT00348673|348645|P1|Stage 1|Randomized but not Treated|0
103216|NCT00348686|348692|P1|Overall Study|Multiple Reasons|8
103217|NCT00348686|348692|P1|Overall Study|Lost to Follow-up|2
103218|NCT00348686|348692|P1|Overall Study|Protocol Violation|6
103219|NCT00348686|348692|P1|Overall Study|Adverse Event|5
103220|NCT00348686|348692|P1|Overall Study|Withdrawal by Subject|45
103221|NCT00348790|348701|P1|Completed Treatment|Unable to travel to study site|1
103222|NCT00348790|348701|P1|Completed Treatment|Required surgery|2
103223|NCT00348790|348701|P1|Completed Treatment|Adverse Event|4
103224|NCT00348790|348701|P1|Completed Treatment|Disease progression|14
103225|NCT00348790|348701|P1|Completed Treatment|Withdrawal by Subject|4
103226|NCT00348816|348706|P1|Overall Study|Noncompliance with radiation treatment|1
103227|NCT00348881|348713|P2|Overall Study|Serious Adverse Event|2
103228|NCT00348881|348714|P1|Overall Study|Serious Adverse Event|0
103229|NCT00348881|348713|P2|Overall Study|Adverse Event|0
103230|NCT00348881|348714|P1|Overall Study|Adverse Event|2
103231|NCT00348881|348713|P2|Overall Study|Withdrawal by Subject|4
103232|NCT00348881|348714|P1|Overall Study|Withdrawal by Subject|3
103233|NCT00348881|348713|P2|Overall Study|Lost to Follow-up|6
103234|NCT00348881|348714|P1|Overall Study|Lost to Follow-up|12
103235|NCT00348933|348726|P1|Overall Study|Adverse Event|7
103236|NCT00348933|348726|P1|Overall Study|Protocol Violation|2
103237|NCT00348933|348726|P1|Overall Study|Lost to Follow-up|6
103238|NCT00348933|348726|P1|Overall Study|Withdrawal by Subject|10
103239|NCT00354744|348732|P1|Overall Study|Withdrawal by Subject|14
103240|NCT00354744|348732|P1|Overall Study|Physician Decision|11
103241|NCT00354744|348732|P1|Overall Study|Lost to Follow-up|2
103242|NCT00354744|348732|P1|Overall Study|Lack of Efficacy|11
103243|NCT00354744|348732|P1|Overall Study|Death|2
103244|NCT00354744|348732|P1|Overall Study|Adverse Event|2
103245|NCT00354835|348748|P2|Overall Study|Refusal of further therapy|8
103246|NCT00354835|348749|P1|Overall Study|Refusal of further therapy|3
103247|NCT00354835|348748|P2|Overall Study|Adverse Event|0
103248|NCT00354835|348749|P1|Overall Study|Adverse Event|6
103249|NCT00354835|348748|P2|Overall Study|Disease progression or relapse|22
103250|NCT00354835|348749|P1|Overall Study|Disease progression or relapse|15
103251|NCT00354835|348748|P2|Overall Study|Ineligible|16
103252|NCT00354835|348749|P1|Overall Study|Ineligible|17
103253|NCT00354835|348748|P2|Overall Study|Withdrawal by Subject|1
103254|NCT00354835|348749|P1|Overall Study|Withdrawal by Subject|2
103255|NCT00354835|348748|P2|Overall Study|Physician Decision|13
103256|NCT00354835|348749|P1|Overall Study|Physician Decision|8
103257|NCT00354835|348748|P2|Overall Study|Death|1
103258|NCT00354835|348749|P1|Overall Study|Death|1
103259|NCT00355030|348796|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
103260|NCT00355030|348797|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
103261|NCT00355030|348796|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
103262|NCT00355030|348797|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
103263|NCT00355030|348796|P2|Study Period 1 Treatment|Other|6
103264|NCT00355030|348797|P1|Study Period 1 Treatment|Other|2
103265|NCT00355030|348796|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
103266|NCT00355030|348797|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
103267|NCT00355030|348796|P2|Study Period 1 Treatment|Sponsor Decision|32
103268|NCT00355030|348797|P1|Study Period 1 Treatment|Sponsor Decision|34
103269|NCT00355030|348796|P2|Study Period 1 Treatment|Physician Decision|1
103270|NCT00355030|348797|P1|Study Period 1 Treatment|Physician Decision|0
103271|NCT00355030|348796|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
103272|NCT00355030|348797|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
103273|NCT00355030|348796|P2|Study Period 1 Treatment|Withdrawal by Subject|1
103274|NCT00355030|348797|P1|Study Period 1 Treatment|Withdrawal by Subject|4
103275|NCT00355030|348796|P2|Study Period 1 Treatment|Lost to Follow-up|0
103276|NCT00355030|348797|P1|Study Period 1 Treatment|Lost to Follow-up|3
103277|NCT00355030|348796|P2|Study Period 1 Treatment|Adverse Event|1
103278|NCT00355030|348797|P1|Study Period 1 Treatment|Adverse Event|1
103279|NCT00357110|348821|P2|Overall Study|Early study termination|5
103280|NCT00357110|348822|P1|Overall Study|Early study termination|5
103281|NCT00357370|348852|P3|Cohort 2|Withdrawal by Subject|0
103282|NCT00357370|348853|P2|Cohort 2|Withdrawal by Subject|2
103283|NCT00357370|348854|P1|Cohort 2|Withdrawal by Subject|0
103284|NCT00357370|348852|P3|Cohort 2|non-compliance, not met criteria, etc|0
103285|NCT00357370|348853|P2|Cohort 2|non-compliance, not met criteria, etc|1
103286|NCT00357370|348854|P1|Cohort 2|non-compliance, not met criteria, etc|1
103287|NCT00357370|348852|P3|Cohort 2|Lost to Follow-up|0
103288|NCT00357370|348853|P2|Cohort 2|Lost to Follow-up|1
103289|NCT00357370|348854|P1|Cohort 2|Lost to Follow-up|0
103290|NCT00357370|348852|P3|Cohort 2|Adverse Event|1
103291|NCT00357370|348853|P2|Cohort 2|Adverse Event|1
103292|NCT00357370|348854|P1|Cohort 2|Adverse Event|1
103293|NCT00357370|348852|P3|Cohort 2|Lack of Efficacy|1
103294|NCT00357370|348853|P2|Cohort 2|Lack of Efficacy|2
103295|NCT00357370|348854|P1|Cohort 2|Lack of Efficacy|0
103296|NCT00357396|348879|P2|Overall Study|Adverse Event|0
103297|NCT00357396|348880|P1|Overall Study|Adverse Event|1
103298|NCT00357500|348885|P1|Overall Study|Not Started Protocol Therapy|4
103299|NCT00357500|348885|P1|Overall Study|Progressive Disease|65
103300|NCT00357500|348885|P1|Overall Study|Withdrawal by Subject|5
103301|NCT00357500|348885|P1|Overall Study|Adverse Event|3
103302|NCT00357552|348892|P1|Weeks 24 to 104|Not able to get to clinic|2
103303|NCT00357552|348892|P1|Weeks 24 to 104|Death|3
103304|NCT00357552|348892|P1|Weeks 0 to 24|Death|1
103305|NCT00357552|348892|P1|Screening|Did not meet eligibility criteria|84
103306|NCT00357656|348909|P2|Overall Study|Other, No surgery performed|3
103307|NCT00357656|348910|P1|Overall Study|Other, No surgery performed|0
103308|NCT00357760|348972|P2|Overall Study|To receive hospice care|1
103309|NCT00357760|348973|P1|Overall Study|To receive hospice care|0
103310|NCT00357760|348972|P2|Overall Study|Protocol Violation|1
103311|NCT00357760|348973|P1|Overall Study|Protocol Violation|0
103312|NCT00357760|348972|P2|Overall Study|Physician Decision|1
103313|NCT00357760|348973|P1|Overall Study|Physician Decision|2
103314|NCT00357760|348972|P2|Overall Study|Ineligible|2
103315|NCT00357760|348973|P1|Overall Study|Ineligible|0
103316|NCT00357760|348972|P2|Overall Study|Never started treatment|1
103317|NCT00357760|348973|P1|Overall Study|Never started treatment|2
103318|NCT00357760|348972|P2|Overall Study|Withdrawal by Subject|2
103319|NCT00357760|348973|P1|Overall Study|Withdrawal by Subject|0
103320|NCT00357760|348972|P2|Overall Study|Alternative therapy|0
103321|NCT00357760|348973|P1|Overall Study|Alternative therapy|1
103322|NCT00357760|348972|P2|Overall Study|Death|3
103323|NCT00357760|348973|P1|Overall Study|Death|0
103324|NCT00357760|348972|P2|Overall Study|Adverse Event|7
103325|NCT00357760|348973|P1|Overall Study|Adverse Event|10
103326|NCT00357760|348972|P2|Overall Study|Disease progression|17
103327|NCT00357760|348973|P1|Overall Study|Disease progression|44
103328|NCT00357877|348985|P2|Overall Study|Other|2
103329|NCT00357877|348986|P1|Overall Study|Other|0
103330|NCT00357877|348985|P2|Overall Study|Administrative withdrawal|1
103331|NCT00357877|348986|P1|Overall Study|Administrative withdrawal|1
103332|NCT00357877|348985|P2|Overall Study|Withdrawal by Subject|3
103333|NCT00357877|348986|P1|Overall Study|Withdrawal by Subject|3
103334|NCT00357877|348985|P2|Overall Study|Lost to Follow-up|23
103335|NCT00357877|348986|P1|Overall Study|Lost to Follow-up|20
103336|NCT00357877|348985|P2|Overall Study|Death|1
103337|NCT00357877|348986|P1|Overall Study|Death|2
103338|NCT00357903|349000|P2|Overall Study|Other|10
103339|NCT00357903|349001|P1|Overall Study|Other|49
103340|NCT00357903|349000|P2|Overall Study|Response status|9
103341|NCT00357903|349001|P1|Overall Study|Response status|61
103342|NCT00357903|349000|P2|Overall Study|Protocol issues|3
103343|NCT00357903|349001|P1|Overall Study|Protocol issues|14
103344|NCT00357903|349000|P2|Overall Study|Completed month 12 only|1
103345|NCT00357903|349001|P1|Overall Study|Completed month 12 only|0
103346|NCT00357903|349000|P2|Overall Study|Withdrawal by Subject|7
103347|NCT00357903|349001|P1|Overall Study|Withdrawal by Subject|57
103348|NCT00357903|349000|P2|Overall Study|Physician Decision|5
103349|NCT00357903|349001|P1|Overall Study|Physician Decision|39
103350|NCT00357903|349000|P2|Overall Study|Lost to Follow-up|4
103351|NCT00357903|349001|P1|Overall Study|Lost to Follow-up|23
103352|NCT00357903|349000|P2|Overall Study|Death|0
103353|NCT00357903|349001|P1|Overall Study|Death|33
103354|NCT00357903|349000|P2|Overall Study|Adverse Event|4
103355|NCT00357903|349001|P1|Overall Study|Adverse Event|87
103356|NCT00357968|349050|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
103445|NCT00358670|349432|P1|Overall Study|Lost to Follow-up|4
103357|NCT00357968|349051|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
103358|NCT00357968|349050|P2|First Maintenance Dose Phase|Not a PCI patient|42
103359|NCT00357968|349051|P1|First Maintenance Dose Phase|Not a PCI patient|47
103360|NCT00357994|349095|P2|Overall Study|Protocol Violation|0
103361|NCT00357994|349096|P1|Overall Study|Protocol Violation|1
103362|NCT00357994|349095|P2|Overall Study|Lack of Efficacy|1
103363|NCT00357994|349096|P1|Overall Study|Lack of Efficacy|0
103364|NCT00357994|349095|P2|Overall Study|Adverse Event|2
103365|NCT00357994|349096|P1|Overall Study|Adverse Event|1
103366|NCT00358150|349153|P1|Overall Study|Undefined|3
103367|NCT00358150|349153|P1|Overall Study|Withdrawal by Subject|1
103368|NCT00358150|349153|P1|Overall Study|Adverse Event|3
103369|NCT00358215|349177|P2|Overall Study|Did not receive investigational product|3
103370|NCT00358215|349178|P1|Overall Study|Did not receive investigational product|2
103371|NCT00358215|349177|P2|Overall Study|Other|14
103372|NCT00358215|349178|P1|Overall Study|Other|21
103373|NCT00358215|349177|P2|Overall Study|Pregnancy|0
103374|NCT00358215|349178|P1|Overall Study|Pregnancy|1
103375|NCT00358215|349177|P2|Overall Study|Protocol Violation|59
103376|NCT00358215|349178|P1|Overall Study|Protocol Violation|64
103377|NCT00358215|349177|P2|Overall Study|Death|281
103378|NCT00358215|349178|P1|Overall Study|Death|265
103379|NCT00358215|349177|P2|Overall Study|Lost to Follow-up|22
103380|NCT00358215|349178|P1|Overall Study|Lost to Follow-up|16
103381|NCT00358215|349177|P2|Overall Study|Physician Decision|39
103382|NCT00358215|349178|P1|Overall Study|Physician Decision|47
103383|NCT00358215|349177|P2|Overall Study|Participant request|64
103384|NCT00358215|349178|P1|Overall Study|Participant request|65
103385|NCT00358215|349177|P2|Overall Study|Withdrawal by Subject|102
103386|NCT00358215|349178|P1|Overall Study|Withdrawal by Subject|111
103387|NCT00358215|349177|P2|Overall Study|Adverse Event|65
103388|NCT00358215|349178|P1|Overall Study|Adverse Event|83
103389|NCT00358215|349177|P2|Overall Study|Ineligibility determined|3
103390|NCT00358215|349178|P1|Overall Study|Ineligibility determined|4
103391|NCT00358436|349251|P2|Overall Study|Other|1
103392|NCT00358436|349252|P1|Overall Study|Other|6
103393|NCT00358436|349251|P2|Overall Study|COPD exacerbation|10
103394|NCT00358436|349252|P1|Overall Study|COPD exacerbation|22
103395|NCT00358436|349251|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
103396|NCT00358436|349252|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
103397|NCT00358436|349251|P2|Overall Study|Withdrawal by Subject|17
103398|NCT00358436|349252|P1|Overall Study|Withdrawal by Subject|40
103399|NCT00358436|349251|P2|Overall Study|Protocol Violation|3
103400|NCT00358436|349252|P1|Overall Study|Protocol Violation|8
103401|NCT00358436|349251|P2|Overall Study|Lost to Follow-up|6
103402|NCT00358436|349252|P1|Overall Study|Lost to Follow-up|11
103403|NCT00358436|349251|P2|Overall Study|Lack of Efficacy|36
103404|NCT00358436|349252|P1|Overall Study|Lack of Efficacy|34
103405|NCT00358436|349251|P2|Overall Study|Adverse Event|13
103406|NCT00358436|349252|P1|Overall Study|Adverse Event|29
103407|NCT00358449|349267|P3|Overall Study|Steriod Inhaler was Increased|1
103408|NCT00358449|349268|P2|Overall Study|Steriod Inhaler was Increased|0
103409|NCT00358449|349269|P1|Overall Study|Steriod Inhaler was Increased|0
103410|NCT00358449|349267|P3|Overall Study|Lack of Efficacy|0
103411|NCT00358449|349268|P2|Overall Study|Lack of Efficacy|1
103412|NCT00358449|349269|P1|Overall Study|Lack of Efficacy|0
103413|NCT00358449|349267|P3|Overall Study|Withdrawal by Subject|0
103414|NCT00358449|349268|P2|Overall Study|Withdrawal by Subject|0
103415|NCT00358449|349269|P1|Overall Study|Withdrawal by Subject|2
103416|NCT00358449|349267|P3|Overall Study|Lost to Follow-up|0
103417|NCT00358449|349268|P2|Overall Study|Lost to Follow-up|0
103418|NCT00358449|349269|P1|Overall Study|Lost to Follow-up|1
103419|NCT00358449|349267|P3|Overall Study|Adverse Event|1
103420|NCT00358449|349268|P2|Overall Study|Adverse Event|0
103421|NCT00358449|349269|P1|Overall Study|Adverse Event|1
103422|NCT00358527|349399|P2|Overall Study|Administrative|1
103423|NCT00358527|349400|P1|Overall Study|Administrative|2
103424|NCT00358527|349399|P2|Overall Study|Non-compliance with protocol|1
103425|NCT00358527|349400|P1|Overall Study|Non-compliance with protocol|6
103426|NCT00358527|349399|P2|Overall Study|Withdrawal by Subject|1
103427|NCT00358527|349400|P1|Overall Study|Withdrawal by Subject|1
103428|NCT00358527|349399|P2|Overall Study|Adverse Event|0
103429|NCT00358527|349400|P1|Overall Study|Adverse Event|4
103430|NCT00358644|349425|P1|Overall Study|Patient not eligible for study|1
103431|NCT00358644|349425|P1|Overall Study|Physician Decision|6
103432|NCT00358644|349425|P1|Overall Study|Withdrawal by Subject|4
103433|NCT00358644|349425|P1|Overall Study|Death|11
103434|NCT00358644|349425|P1|Overall Study|Adverse Event|7
103435|NCT00358644|349425|P1|Overall Study|Progressive Disease|21
103436|NCT00358670|349431|P2|Overall Study|Administrative|125
103437|NCT00358670|349432|P1|Overall Study|Administrative|153
103438|NCT00358670|349431|P2|Overall Study|Did Not Meet Protocol Eligibility|3
103439|NCT00358670|349432|P1|Overall Study|Did Not Meet Protocol Eligibility|0
103440|NCT00358670|349431|P2|Overall Study|Protocol Defined Clinical Event|1
103441|NCT00358670|349432|P1|Overall Study|Protocol Defined Clinical Event|0
103442|NCT00358670|349431|P2|Overall Study|Withdrawal by Subject|24
103443|NCT00358670|349432|P1|Overall Study|Withdrawal by Subject|13
103444|NCT00358670|349431|P2|Overall Study|Lost to Follow-up|5
103446|NCT00358670|349431|P2|Overall Study|Protocol Violation|9
103447|NCT00358670|349432|P1|Overall Study|Protocol Violation|6
103448|NCT00358670|349431|P2|Overall Study|Lack of Efficacy|23
103449|NCT00358670|349432|P1|Overall Study|Lack of Efficacy|20
103450|NCT00358670|349431|P2|Overall Study|Adverse Event|29
103451|NCT00358670|349432|P1|Overall Study|Adverse Event|26
103452|NCT00358826|349481|P8|MDCT Substudy|Withdrawal by Subject|0
103453|NCT00358826|349482|P7|MDCT Substudy|Withdrawal by Subject|0
103454|NCT00358826|349483|P6|MDCT Substudy|Withdrawal by Subject|1
103455|NCT00358826|349484|P5|MDCT Substudy|Withdrawal by Subject|0
103456|NCT00358826|349485|P4|MDCT Substudy|Withdrawal by Subject|0
103457|NCT00358826|349486|P3|MDCT Substudy|Withdrawal by Subject|0
103458|NCT00358826|349487|P2|MDCT Substudy|Withdrawal by Subject|0
103459|NCT00358826|349488|P1|MDCT Substudy|Withdrawal by Subject|0
103460|NCT00358826|349481|P8|MDCT Substudy|Lost to Follow-up|0
103461|NCT00358826|349482|P7|MDCT Substudy|Lost to Follow-up|0
103462|NCT00358826|349483|P6|MDCT Substudy|Lost to Follow-up|1
103463|NCT00358826|349484|P5|MDCT Substudy|Lost to Follow-up|0
103464|NCT00358826|349485|P4|MDCT Substudy|Lost to Follow-up|0
103465|NCT00358826|349486|P3|MDCT Substudy|Lost to Follow-up|0
103466|NCT00358826|349487|P2|MDCT Substudy|Lost to Follow-up|0
103467|NCT00358826|349488|P1|MDCT Substudy|Lost to Follow-up|0
103468|NCT00358826|349481|P8|MDCT Substudy|Adverse Event|0
103469|NCT00358826|349482|P7|MDCT Substudy|Adverse Event|0
103470|NCT00358826|349483|P6|MDCT Substudy|Adverse Event|0
103471|NCT00358826|349484|P5|MDCT Substudy|Adverse Event|1
103472|NCT00358826|349485|P4|MDCT Substudy|Adverse Event|0
103473|NCT00358826|349486|P3|MDCT Substudy|Adverse Event|0
103474|NCT00358826|349487|P2|MDCT Substudy|Adverse Event|0
103475|NCT00358826|349488|P1|MDCT Substudy|Adverse Event|0
103476|NCT00358826|349481|P8|Core Study|Physician Decision|0
103477|NCT00358826|349482|P7|Core Study|Physician Decision|0
103478|NCT00358826|349483|P6|Core Study|Physician Decision|0
103479|NCT00358826|349484|P5|Core Study|Physician Decision|0
103480|NCT00358826|349485|P4|Core Study|Physician Decision|0
103481|NCT00358826|349486|P3|Core Study|Physician Decision|1
103482|NCT00358826|349487|P2|Core Study|Physician Decision|0
103483|NCT00358826|349488|P1|Core Study|Physician Decision|0
103484|NCT00358826|349481|P8|Core Study|Lost to Follow-up|0
103485|NCT00358826|349482|P7|Core Study|Lost to Follow-up|0
103486|NCT00358826|349483|P6|Core Study|Lost to Follow-up|0
103487|NCT00358826|349484|P5|Core Study|Lost to Follow-up|0
103488|NCT00358826|349485|P4|Core Study|Lost to Follow-up|1
103489|NCT00358826|349486|P3|Core Study|Lost to Follow-up|0
103490|NCT00358826|349487|P2|Core Study|Lost to Follow-up|0
103491|NCT00358826|349488|P1|Core Study|Lost to Follow-up|0
103492|NCT00358826|349481|P8|Core Study|Withdrawal by Subject|0
103493|NCT00358826|349482|P7|Core Study|Withdrawal by Subject|0
103494|NCT00358826|349483|P6|Core Study|Withdrawal by Subject|0
103495|NCT00358826|349484|P5|Core Study|Withdrawal by Subject|0
103496|NCT00358826|349485|P4|Core Study|Withdrawal by Subject|0
103497|NCT00358826|349486|P3|Core Study|Withdrawal by Subject|0
103498|NCT00358826|349487|P2|Core Study|Withdrawal by Subject|2
103499|NCT00358826|349488|P1|Core Study|Withdrawal by Subject|2
103500|NCT00358826|349481|P8|Core Study|Adverse Event|0
103501|NCT00358826|349482|P7|Core Study|Adverse Event|0
103502|NCT00358826|349483|P6|Core Study|Adverse Event|0
103503|NCT00358826|349484|P5|Core Study|Adverse Event|0
103504|NCT00358826|349485|P4|Core Study|Adverse Event|1
103505|NCT00358826|349486|P3|Core Study|Adverse Event|1
103506|NCT00358826|349487|P2|Core Study|Adverse Event|3
103507|NCT00358826|349488|P1|Core Study|Adverse Event|1
103508|NCT00358917|349524|P2|Overall Study|Unable to Continue Participation|2
103509|NCT00358917|349525|P1|Overall Study|Unable to Continue Participation|2
103510|NCT00358917|349524|P2|Overall Study|Virologic failure|8
103511|NCT00358917|349525|P1|Overall Study|Virologic failure|11
103512|NCT00358917|349524|P2|Overall Study|Death|3
103513|NCT00358917|349525|P1|Overall Study|Death|2
103514|NCT00358917|349524|P2|Overall Study|Noncompliance|11
103515|NCT00358917|349525|P1|Overall Study|Noncompliance|12
103516|NCT00358917|349524|P2|Overall Study|Lost to Follow-up|17
103517|NCT00358917|349525|P1|Overall Study|Lost to Follow-up|20
103518|NCT00358917|349524|P2|Overall Study|Withdrawal by Subject|7
103519|NCT00358917|349525|P1|Overall Study|Withdrawal by Subject|5
103520|NCT00358917|349524|P2|Overall Study|Adverse Event|21
103521|NCT00358917|349525|P1|Overall Study|Adverse Event|14
103522|NCT00358956|349539|P1|Overall Study|Withdrawal by Subject|1
103523|NCT00358956|349539|P1|Overall Study|condition under investigation worsened|4
103524|NCT00358956|349539|P1|Overall Study|Adverse Event|3
103525|NCT00359021|349551|P2|Overall Study|Pregnancy|0
103526|NCT00359021|349552|P1|Overall Study|Pregnancy|1
103527|NCT00359021|349551|P2|Overall Study|Not specified|1
103528|NCT00359021|349552|P1|Overall Study|Not specified|4
103529|NCT00359021|349551|P2|Overall Study|Lost to Follow-up|0
103530|NCT00359021|349552|P1|Overall Study|Lost to Follow-up|1
103531|NCT00359021|349551|P2|Overall Study|Withdrawal by Subject|9
103532|NCT00359021|349552|P1|Overall Study|Withdrawal by Subject|2
103533|NCT00359021|349551|P2|Overall Study|Subject Reached A Virologic Endpoint|32
103534|NCT00359021|349552|P1|Overall Study|Subject Reached A Virologic Endpoint|45
103535|NCT00359021|349551|P2|Overall Study|Subject Ineligible To Continue The Trial|0
103536|NCT00359021|349552|P1|Overall Study|Subject Ineligible To Continue The Trial|1
103537|NCT00359021|349551|P2|Overall Study|Subject Non-Compliant|2
103538|NCT00359021|349552|P1|Overall Study|Subject Non-Compliant|1
103539|NCT00359021|349551|P2|Overall Study|Adverse Event|8
103540|NCT00359021|349552|P1|Overall Study|Adverse Event|26
103541|NCT00359281|349604|P9|Overall Study|Withdrawal by Subject|0
103542|NCT00359281|349605|P8|Overall Study|Withdrawal by Subject|0
103543|NCT00359281|349606|P7|Overall Study|Withdrawal by Subject|1
103544|NCT00359281|349607|P6|Overall Study|Withdrawal by Subject|0
103545|NCT00359281|349608|P5|Overall Study|Withdrawal by Subject|0
103546|NCT00359281|349609|P4|Overall Study|Withdrawal by Subject|0
103547|NCT00359281|349610|P3|Overall Study|Withdrawal by Subject|0
103548|NCT00359281|349611|P2|Overall Study|Withdrawal by Subject|0
103549|NCT00359281|349612|P1|Overall Study|Withdrawal by Subject|0
103550|NCT00359281|349604|P9|Overall Study|Adverse Event|0
103551|NCT00359281|349605|P8|Overall Study|Adverse Event|0
103552|NCT00359281|349606|P7|Overall Study|Adverse Event|1
103553|NCT00359281|349607|P6|Overall Study|Adverse Event|0
103554|NCT00359281|349608|P5|Overall Study|Adverse Event|0
103555|NCT00359281|349609|P4|Overall Study|Adverse Event|0
103556|NCT00359281|349610|P3|Overall Study|Adverse Event|0
103557|NCT00359281|349611|P2|Overall Study|Adverse Event|0
103558|NCT00359281|349612|P1|Overall Study|Adverse Event|1
103559|NCT00359424|349644|P2|Overall Study|follow up not conducted|0
103560|NCT00359424|349645|P1|Overall Study|follow up not conducted|2
103561|NCT00359424|349644|P2|Overall Study|Withdrawal by Subject|2
103562|NCT00359424|349645|P1|Overall Study|Withdrawal by Subject|10
103563|NCT00359424|349644|P2|Overall Study|Lost to Follow-up|7
103564|NCT00359424|349645|P1|Overall Study|Lost to Follow-up|19
103565|NCT00359424|349644|P2|Overall Study|Death|58
103566|NCT00359424|349645|P1|Overall Study|Death|99
103567|NCT00352027|349692|P1|Overall Study|Progressive disease|3
103568|NCT00352053|349963|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
103569|NCT00352053|349964|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
103570|NCT00352053|349963|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
103571|NCT00352053|349964|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
103572|NCT00352053|349963|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
103573|NCT00352053|349964|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
103574|NCT00352053|349963|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
103575|NCT00352053|349964|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
103576|NCT00352053|349963|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
103577|NCT00352053|349964|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
103578|NCT00352053|349963|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
103579|NCT00352053|349964|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
103580|NCT00352053|349963|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
103581|NCT00352053|349964|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
103582|NCT00352053|349963|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
103583|NCT00352053|349964|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
103584|NCT00352053|349963|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
103585|NCT00352053|349964|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
103586|NCT00352053|349963|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
103587|NCT00352053|349964|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
103588|NCT00352053|349963|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
103589|NCT00352053|349964|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
103590|NCT00352053|349963|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
103591|NCT00352053|349964|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
103592|NCT00352053|349963|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
103593|NCT00352053|349964|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
103594|NCT00352105|350131|P1|Overall Study|Protocol Violation|2
103595|NCT00352105|350131|P1|Overall Study|Adverse Event|19
103596|NCT00352105|350131|P1|Overall Study|Lack of Efficacy|9
103597|NCT00352105|350131|P1|Overall Study|Withdrawal by Subject|5
103598|NCT00352105|350131|P1|Overall Study|Death|5
103599|NCT00352118|350140|P1|Overall Study|Physician Decision|4
103600|NCT00359619|350157|P7|Overall Study|Lost to Follow-up|0
103601|NCT00359619|350158|P6|Overall Study|Lost to Follow-up|5
103602|NCT00359619|350159|P5|Overall Study|Lost to Follow-up|1
103603|NCT00359619|350160|P4|Overall Study|Lost to Follow-up|1
103604|NCT00359619|350161|P3|Overall Study|Lost to Follow-up|2
103605|NCT00359619|350162|P2|Overall Study|Lost to Follow-up|4
103606|NCT00359619|350163|P1|Overall Study|Lost to Follow-up|4
103607|NCT00359619|350157|P7|Overall Study|Unspecified|0
103608|NCT00359619|350158|P6|Overall Study|Unspecified|0
103609|NCT00359619|350159|P5|Overall Study|Unspecified|0
103610|NCT00359619|350160|P4|Overall Study|Unspecified|0
103611|NCT00359619|350161|P3|Overall Study|Unspecified|0
103612|NCT00359619|350162|P2|Overall Study|Unspecified|0
103613|NCT00359619|350163|P1|Overall Study|Unspecified|1
103614|NCT00359619|350157|P7|Overall Study|Withdrawal by Subject|3
103615|NCT00359619|350158|P6|Overall Study|Withdrawal by Subject|0
103616|NCT00359619|350159|P5|Overall Study|Withdrawal by Subject|2
103617|NCT00359619|350160|P4|Overall Study|Withdrawal by Subject|2
103618|NCT00359619|350161|P3|Overall Study|Withdrawal by Subject|4
103619|NCT00359619|350162|P2|Overall Study|Withdrawal by Subject|1
103620|NCT00359619|350163|P1|Overall Study|Withdrawal by Subject|3
103621|NCT00359619|350157|P7|Overall Study|Adverse Event|1
103622|NCT00359619|350158|P6|Overall Study|Adverse Event|0
103623|NCT00359619|350159|P5|Overall Study|Adverse Event|0
103624|NCT00359619|350160|P4|Overall Study|Adverse Event|0
103625|NCT00359619|350161|P3|Overall Study|Adverse Event|1
103626|NCT00359619|350162|P2|Overall Study|Adverse Event|0
103627|NCT00359619|350163|P1|Overall Study|Adverse Event|0
103628|NCT00359632|350293|P2|Overall Study|Non-compliance with visit schedule|0
103629|NCT00359632|350294|P1|Overall Study|Non-compliance with visit schedule|1
103630|NCT00359632|350293|P2|Overall Study|Adverse Event|0
103631|NCT00359632|350294|P1|Overall Study|Adverse Event|1
103632|NCT00359632|350293|P2|Overall Study|Death|0
103633|NCT00359632|350294|P1|Overall Study|Death|2
103634|NCT00359762|350314|P5|Period III|Subject Decision|0
103635|NCT00359762|350315|P4|Period III|Subject Decision|20
103636|NCT00359762|350316|P3|Period III|Subject Decision|8
103637|NCT00359762|350317|P2|Period III|Subject Decision|7
103638|NCT00359762|350318|P1|Period III|Subject Decision|0
103639|NCT00359762|350314|P5|Period III|Entry Criteria Not Met|0
103640|NCT00359762|350315|P4|Period III|Entry Criteria Not Met|1
103641|NCT00359762|350316|P3|Period III|Entry Criteria Not Met|0
103642|NCT00359762|350317|P2|Period III|Entry Criteria Not Met|1
103643|NCT00359762|350318|P1|Period III|Entry Criteria Not Met|0
103644|NCT00359762|350314|P5|Period III|Lost to follow up|0
103645|NCT00359762|350315|P4|Period III|Lost to follow up|2
103646|NCT00359762|350316|P3|Period III|Lost to follow up|1
103647|NCT00359762|350317|P2|Period III|Lost to follow up|1
103648|NCT00359762|350318|P1|Period III|Lost to follow up|0
103649|NCT00359762|350314|P5|Period III|Lack of Efficacy|0
103650|NCT00359762|350315|P4|Period III|Lack of Efficacy|9
103651|NCT00359762|350316|P3|Period III|Lack of Efficacy|5
103652|NCT00359762|350317|P2|Period III|Lack of Efficacy|7
103653|NCT00359762|350318|P1|Period III|Lack of Efficacy|0
103654|NCT00359762|350314|P5|Period III|Physician Decision|0
103655|NCT00359762|350315|P4|Period III|Physician Decision|15
103656|NCT00359762|350316|P3|Period III|Physician Decision|9
103657|NCT00359762|350317|P2|Period III|Physician Decision|5
103658|NCT00359762|350318|P1|Period III|Physician Decision|0
103659|NCT00359762|350314|P5|Period III|Adverse Event|0
103660|NCT00359762|350315|P4|Period III|Adverse Event|10
103661|NCT00359762|350316|P3|Period III|Adverse Event|4
103662|NCT00359762|350317|P2|Period III|Adverse Event|3
103663|NCT00359762|350318|P1|Period III|Adverse Event|0
103664|NCT00359762|350314|P5|Period III|Protocol Violation|0
103665|NCT00359762|350315|P4|Period III|Protocol Violation|8
103666|NCT00359762|350316|P3|Period III|Protocol Violation|3
103667|NCT00359762|350317|P2|Period III|Protocol Violation|5
103668|NCT00359762|350318|P1|Period III|Protocol Violation|0
103669|NCT00359762|350314|P5|Period II|Subject Decision|70
103670|NCT00359762|350315|P4|Period II|Subject Decision|0
103671|NCT00359762|350316|P3|Period II|Subject Decision|0
103672|NCT00359762|350317|P2|Period II|Subject Decision|0
103673|NCT00359762|350318|P1|Period II|Subject Decision|50
103674|NCT00359762|350314|P5|Period II|Entry Criteria Not Met|4
103675|NCT00359762|350315|P4|Period II|Entry Criteria Not Met|0
103676|NCT00359762|350316|P3|Period II|Entry Criteria Not Met|0
103677|NCT00359762|350317|P2|Period II|Entry Criteria Not Met|0
103678|NCT00359762|350318|P1|Period II|Entry Criteria Not Met|8
103679|NCT00359762|350314|P5|Period II|Lost to follow up|5
103680|NCT00359762|350315|P4|Period II|Lost to follow up|0
103681|NCT00359762|350316|P3|Period II|Lost to follow up|0
103682|NCT00359762|350317|P2|Period II|Lost to follow up|0
103683|NCT00359762|350318|P1|Period II|Lost to follow up|5
103684|NCT00359762|350314|P5|Period II|Lack of Efficacy|8
103685|NCT00359762|350315|P4|Period II|Lack of Efficacy|0
103686|NCT00359762|350316|P3|Period II|Lack of Efficacy|0
103687|NCT00359762|350317|P2|Period II|Lack of Efficacy|0
103688|NCT00359762|350318|P1|Period II|Lack of Efficacy|11
103689|NCT00359762|350314|P5|Period II|Death|4
103690|NCT00359762|350315|P4|Period II|Death|0
103691|NCT00359762|350316|P3|Period II|Death|0
103692|NCT00359762|350317|P2|Period II|Death|0
103693|NCT00359762|350318|P1|Period II|Death|2
103694|NCT00359762|350314|P5|Period II|Physician Decision|23
103695|NCT00359762|350315|P4|Period II|Physician Decision|0
103696|NCT00359762|350316|P3|Period II|Physician Decision|0
103697|NCT00359762|350317|P2|Period II|Physician Decision|0
103698|NCT00359762|350318|P1|Period II|Physician Decision|17
103699|NCT00359762|350314|P5|Period II|Protocol Violation|11
103700|NCT00359762|350315|P4|Period II|Protocol Violation|0
103701|NCT00359762|350316|P3|Period II|Protocol Violation|0
103702|NCT00359762|350317|P2|Period II|Protocol Violation|0
103703|NCT00359762|350318|P1|Period II|Protocol Violation|18
103704|NCT00359762|350314|P5|Period II|Adverse Event|49
103705|NCT00359762|350315|P4|Period II|Adverse Event|0
103706|NCT00359762|350316|P3|Period II|Adverse Event|0
103707|NCT00359762|350317|P2|Period II|Adverse Event|0
103708|NCT00359762|350318|P1|Period II|Adverse Event|17
103709|NCT00359788|350381|P2|Overall Study|Protocol Violation|2
103710|NCT00359788|350382|P1|Overall Study|Protocol Violation|4
103711|NCT00359788|350381|P2|Overall Study|Withdrawal by Subject|1
103712|NCT00359788|350382|P1|Overall Study|Withdrawal by Subject|4
103713|NCT00359788|350381|P2|Overall Study|Lost to Follow-up|2
103714|NCT00359788|350382|P1|Overall Study|Lost to Follow-up|3
103715|NCT00359788|350381|P2|Overall Study|Lack of Efficacy|2
103716|NCT00359788|350382|P1|Overall Study|Lack of Efficacy|1
103717|NCT00359788|350381|P2|Overall Study|Adverse Event|10
103718|NCT00359788|350382|P1|Overall Study|Adverse Event|11
103719|NCT00359801|350616|P2|Overall Study|Sponsor Decision|16
103720|NCT00359801|350617|P1|Overall Study|Sponsor Decision|17
103721|NCT00359801|350616|P2|Overall Study|Final Status Unknown: missing data|4
103722|NCT00359801|350617|P1|Overall Study|Final Status Unknown: missing data|7
103723|NCT00359801|350616|P2|Overall Study|Unspecified|46
103724|NCT00359801|350617|P1|Overall Study|Unspecified|66
103725|NCT00359801|350616|P2|Overall Study|Withdrawal by Subject|96
103726|NCT00359801|350617|P1|Overall Study|Withdrawal by Subject|143
103727|NCT00359801|350616|P2|Overall Study|Lost to Follow-up|58
103728|NCT00359801|350617|P1|Overall Study|Lost to Follow-up|72
103729|NCT00362115|350686|P7|Overall Study|Other|0
103730|NCT00362115|350687|P6|Overall Study|Other|1
103731|NCT00362115|350688|P5|Overall Study|Other|0
103732|NCT00362115|350689|P4|Overall Study|Other|1
103733|NCT00362115|350690|P3|Overall Study|Other|0
103734|NCT00362115|350691|P2|Overall Study|Other|1
103735|NCT00362115|350692|P1|Overall Study|Other|0
103736|NCT00362115|350686|P7|Overall Study|Physician Decision|3
103737|NCT00362115|350687|P6|Overall Study|Physician Decision|0
103738|NCT00362115|350688|P5|Overall Study|Physician Decision|0
103739|NCT00362115|350689|P4|Overall Study|Physician Decision|0
103740|NCT00362115|350690|P3|Overall Study|Physician Decision|0
103741|NCT00362115|350691|P2|Overall Study|Physician Decision|0
103742|NCT00362115|350692|P1|Overall Study|Physician Decision|0
103743|NCT00362115|350686|P7|Overall Study|Lack of Efficacy|3
103744|NCT00362115|350687|P6|Overall Study|Lack of Efficacy|0
103745|NCT00362115|350688|P5|Overall Study|Lack of Efficacy|2
103746|NCT00362115|350689|P4|Overall Study|Lack of Efficacy|2
103747|NCT00362115|350690|P3|Overall Study|Lack of Efficacy|5
103748|NCT00362115|350691|P2|Overall Study|Lack of Efficacy|0
103749|NCT00362115|350692|P1|Overall Study|Lack of Efficacy|1
103750|NCT00362115|350686|P7|Overall Study|Withdrawal by Subject|4
103751|NCT00362115|350687|P6|Overall Study|Withdrawal by Subject|3
103752|NCT00362115|350688|P5|Overall Study|Withdrawal by Subject|1
103753|NCT00362115|350689|P4|Overall Study|Withdrawal by Subject|0
103754|NCT00362115|350690|P3|Overall Study|Withdrawal by Subject|1
103755|NCT00362115|350691|P2|Overall Study|Withdrawal by Subject|3
103756|NCT00362115|350692|P1|Overall Study|Withdrawal by Subject|1
103757|NCT00362115|350686|P7|Overall Study|Lost to Follow-up|1
103758|NCT00362115|350687|P6|Overall Study|Lost to Follow-up|0
103759|NCT00362115|350688|P5|Overall Study|Lost to Follow-up|2
103760|NCT00362115|350689|P4|Overall Study|Lost to Follow-up|0
103761|NCT00362115|350690|P3|Overall Study|Lost to Follow-up|0
103762|NCT00362115|350691|P2|Overall Study|Lost to Follow-up|1
103763|NCT00362115|350692|P1|Overall Study|Lost to Follow-up|0
103764|NCT00362115|350686|P7|Overall Study|Protocol Violation|0
103765|NCT00362115|350687|P6|Overall Study|Protocol Violation|1
103766|NCT00362115|350688|P5|Overall Study|Protocol Violation|0
103767|NCT00362115|350689|P4|Overall Study|Protocol Violation|0
103768|NCT00362115|350690|P3|Overall Study|Protocol Violation|0
103769|NCT00362115|350691|P2|Overall Study|Protocol Violation|0
103770|NCT00362115|350692|P1|Overall Study|Protocol Violation|0
103771|NCT00362115|350686|P7|Overall Study|Adverse Event|1
103772|NCT00362115|350687|P6|Overall Study|Adverse Event|2
103773|NCT00362115|350688|P5|Overall Study|Adverse Event|2
103774|NCT00362115|350689|P4|Overall Study|Adverse Event|1
103775|NCT00362115|350690|P3|Overall Study|Adverse Event|1
103776|NCT00362115|350691|P2|Overall Study|Adverse Event|1
103777|NCT00362115|350692|P1|Overall Study|Adverse Event|0
103778|NCT00362180|350854|P9|Treated Period|Adverse Event|0
103779|NCT00362180|350855|P8|Treated Period|Adverse Event|1
103780|NCT00362180|350856|P7|Treated Period|Adverse Event|0
103781|NCT00362180|350857|P6|Treated Period|Adverse Event|1
103782|NCT00362180|350858|P5|Treated Period|Adverse Event|0
103783|NCT00362180|350859|P4|Treated Period|Adverse Event|0
103784|NCT00362180|350860|P3|Treated Period|Adverse Event|0
103785|NCT00362180|350861|P2|Treated Period|Adverse Event|0
103786|NCT00362180|350862|P1|Treated Period|Adverse Event|0
103787|NCT00362180|350854|P9|Treated Period|Withdrawal by Subject|0
103788|NCT00362180|350855|P8|Treated Period|Withdrawal by Subject|0
103789|NCT00362180|350856|P7|Treated Period|Withdrawal by Subject|0
103790|NCT00362180|350857|P6|Treated Period|Withdrawal by Subject|0
103791|NCT00362180|350858|P5|Treated Period|Withdrawal by Subject|0
103792|NCT00362180|350859|P4|Treated Period|Withdrawal by Subject|0
103793|NCT00362180|350860|P3|Treated Period|Withdrawal by Subject|0
103794|NCT00362180|350861|P2|Treated Period|Withdrawal by Subject|0
103795|NCT00362180|350862|P1|Treated Period|Withdrawal by Subject|1
103796|NCT00362232|350925|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
103797|NCT00362232|350926|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
103798|NCT00362232|350925|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
103799|NCT00362232|350926|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
103800|NCT00362232|350925|P2|Follow-up (30 (+ 5) Days)|Death|1
103801|NCT00362232|350926|P1|Follow-up (30 (+ 5) Days)|Death|1
103802|NCT00362232|350925|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
103803|NCT00362232|350926|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
103804|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
103805|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
103806|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
103807|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
103808|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
103809|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
103810|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
103811|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
103812|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
103813|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
103814|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
103815|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
103816|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
103817|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
103818|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Death|3
103819|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Death|1
103820|NCT00362232|350925|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
103821|NCT00362232|350926|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
103822|NCT00362297|350964|P2|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|4
103823|NCT00362297|350965|P1|Arm 1 (Initial Drug Assignment)|Lost to Follow-up|0
103824|NCT00362336|350974|P3|Overall Study|Withdrawal by Subject|1
103825|NCT00362336|350975|P2|Overall Study|Withdrawal by Subject|3
103826|NCT00362336|350976|P1|Overall Study|Withdrawal by Subject|3
103827|NCT00362336|350974|P3|Overall Study|Lost to Follow-up|0
103828|NCT00362336|350975|P2|Overall Study|Lost to Follow-up|4
103829|NCT00362336|350976|P1|Overall Study|Lost to Follow-up|6
103830|NCT00362336|350974|P3|Overall Study|Protocol Violation|1
103831|NCT00362336|350975|P2|Overall Study|Protocol Violation|0
103832|NCT00362336|350976|P1|Overall Study|Protocol Violation|0
103833|NCT00362336|350974|P3|Overall Study|Serious Adverse Event|1
103834|NCT00362336|350975|P2|Overall Study|Serious Adverse Event|0
103835|NCT00362336|350976|P1|Overall Study|Serious Adverse Event|1
103836|NCT00362375|351004|P2|Overall Study|Lost to Follow-up|35
103837|NCT00362375|351005|P1|Overall Study|Lost to Follow-up|40
103838|NCT00362414|351029|P1|Overall Study|Adverse Event|1
103839|NCT00362414|351029|P1|Overall Study|Death|2
103840|NCT00362609|351117|P2|Overall Study|Protocol Violation|1
103841|NCT00362609|351118|P1|Overall Study|Protocol Violation|0
103842|NCT00362609|351117|P2|Overall Study|Withdrawal by Subject|1
103843|NCT00362609|351118|P1|Overall Study|Withdrawal by Subject|0
103844|NCT00362648|351134|P4|Overall Study|Withdrawal by Subject|6
103845|NCT00362648|351135|P3|Overall Study|Withdrawal by Subject|2
103846|NCT00362648|351136|P2|Overall Study|Withdrawal by Subject|42
103847|NCT00362648|351137|P1|Overall Study|Withdrawal by Subject|48
103848|NCT00362648|351134|P4|Overall Study|Protocol Violation|2
103849|NCT00362648|351135|P3|Overall Study|Protocol Violation|2
103850|NCT00362648|351136|P2|Overall Study|Protocol Violation|2
103851|NCT00362648|351137|P1|Overall Study|Protocol Violation|4
103852|NCT00362648|351134|P4|Overall Study|Lost to Follow-up|3
103853|NCT00362648|351135|P3|Overall Study|Lost to Follow-up|4
103854|NCT00362648|351136|P2|Overall Study|Lost to Follow-up|69
103855|NCT00362648|351137|P1|Overall Study|Lost to Follow-up|62
103856|NCT00362648|351134|P4|Overall Study|Adverse Event|0
103857|NCT00362648|351135|P3|Overall Study|Adverse Event|1
103858|NCT00362648|351136|P2|Overall Study|Adverse Event|21
103859|NCT00362648|351137|P1|Overall Study|Adverse Event|12
103860|NCT00363051|351181|P2|Overall Study|Death|2
103861|NCT00363051|351182|P1|Overall Study|Death|3
103862|NCT00363051|351181|P2|Overall Study|Protocol Violation|2
103863|NCT00363051|351182|P1|Overall Study|Protocol Violation|0
103864|NCT00363051|351181|P2|Overall Study|Lost to Follow-up|1
103865|NCT00363051|351182|P1|Overall Study|Lost to Follow-up|0
103866|NCT00363051|351181|P2|Overall Study|Withdrawal by Subject|3
103867|NCT00363051|351182|P1|Overall Study|Withdrawal by Subject|11
103868|NCT00363051|351181|P2|Overall Study|New Cancer Therapy|1
103869|NCT00363051|351182|P1|Overall Study|New Cancer Therapy|2
103870|NCT00363051|351181|P2|Overall Study|Adverse Event|12
103871|NCT00363051|351182|P1|Overall Study|Adverse Event|21
103872|NCT00363051|351181|P2|Overall Study|Adminstrative problems|1
103873|NCT00363051|351182|P1|Overall Study|Adminstrative problems|1
103874|NCT00363129|351228|P2|Overall Study|Other Reasons|3
103875|NCT00363129|351229|P1|Overall Study|Other Reasons|6
103876|NCT00363129|351228|P2|Overall Study|Death|1
103877|NCT00363129|351229|P1|Overall Study|Death|0
103878|NCT00363129|351228|P2|Overall Study|Other Medical Problems|4
103879|NCT00363129|351229|P1|Overall Study|Other Medical Problems|2
103880|NCT00363129|351228|P2|Overall Study|Alternate Treatment|4
103881|NCT00363129|351229|P1|Overall Study|Alternate Treatment|2
103882|NCT00363129|351228|P2|Overall Study|Adverse Event|3
103883|NCT00363129|351229|P1|Overall Study|Adverse Event|8
103884|NCT00363129|351228|P2|Overall Study|Withdrawal by Subject|18
103885|NCT00363129|351229|P1|Overall Study|Withdrawal by Subject|11
103886|NCT00363142|351245|P2|Overall Study|Withdrawal by Subject|1
103887|NCT00363142|351246|P1|Overall Study|Withdrawal by Subject|3
103888|NCT00363142|351245|P2|Overall Study|Non-compliance|1
103889|NCT00363142|351246|P1|Overall Study|Non-compliance|1
103890|NCT00363142|351245|P2|Overall Study|Lost to Follow-up|0
103891|NCT00363142|351246|P1|Overall Study|Lost to Follow-up|1
103892|NCT00363142|351245|P2|Overall Study|Lack of Efficacy|1
103893|NCT00363142|351246|P1|Overall Study|Lack of Efficacy|0
103894|NCT00363142|351245|P2|Overall Study|Adverse Event|0
103895|NCT00363142|351246|P1|Overall Study|Adverse Event|2
103896|NCT00363246|351284|P1|Overall Study|Eligibility changed due to Hospice move|5
103897|NCT00363246|351284|P1|Overall Study|Subject expressed security concerns|2
103898|NCT00363246|351284|P1|Overall Study|Stopped using wheelchair|11
103899|NCT00363246|351284|P1|Overall Study|Bad health|6
103900|NCT00363246|351284|P1|Overall Study|Lost to Follow-up|14
103901|NCT00363246|351284|P1|Overall Study|Withdrawal by Subject|19
103902|NCT00363246|351284|P1|Overall Study|Death|40
103903|NCT00363298|351291|P2|4-week Study Continuation Phase|Lack of Efficacy|0
103904|NCT00363298|351292|P1|4-week Study Continuation Phase|Lack of Efficacy|1
103905|NCT00363298|351291|P2|First Study Week|Lack of Efficacy|5
103906|NCT00363298|351292|P1|First Study Week|Lack of Efficacy|6
103907|NCT00363311|351302|P2|Overall Study|Participant Moved to Louisiana|1
103908|NCT00363311|351303|P1|Overall Study|Participant Moved to Louisiana|0
103909|NCT00363311|351302|P2|Overall Study|Withdrawn per Instructions of Monitor|1
103910|NCT00363311|351303|P1|Overall Study|Withdrawn per Instructions of Monitor|0
103911|NCT00363311|351302|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
103912|NCT00363311|351303|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
103913|NCT00363311|351302|P2|Overall Study|Participant Moved to Another Country|0
103914|NCT00363311|351303|P1|Overall Study|Participant Moved to Another Country|1
103915|NCT00363311|351302|P2|Overall Study|Participant Opted for Treatment|0
103916|NCT00363311|351303|P1|Overall Study|Participant Opted for Treatment|1
103917|NCT00363311|351302|P2|Overall Study|Prostate Volume/PSA Doubled|0
103918|NCT00363311|351303|P1|Overall Study|Prostate Volume/PSA Doubled|1
103919|NCT00363311|351302|P2|Overall Study|Participant Refused Biopsy|0
103920|NCT00363311|351303|P1|Overall Study|Participant Refused Biopsy|1
103921|NCT00363311|351302|P2|Overall Study|Non-Compliance|1
103922|NCT00363311|351303|P1|Overall Study|Non-Compliance|1
103923|NCT00363311|351302|P2|Overall Study|Disease Progression|26
103924|NCT00363311|351303|P1|Overall Study|Disease Progression|46
103925|NCT00363311|351302|P2|Overall Study|Sponsor Terminated Study|2
103926|NCT00363311|351303|P1|Overall Study|Sponsor Terminated Study|2
103927|NCT00363311|351302|P2|Overall Study|Physician Decision|1
103928|NCT00363311|351303|P1|Overall Study|Physician Decision|1
103929|NCT00363311|351302|P2|Overall Study|Withdrawal by Subject|6
103930|NCT00363311|351303|P1|Overall Study|Withdrawal by Subject|12
103931|NCT00363311|351302|P2|Overall Study|Protocol Violation|2
103932|NCT00363311|351303|P1|Overall Study|Protocol Violation|1
103933|NCT00363311|351302|P2|Overall Study|Lost to Follow-up|0
103934|NCT00363311|351303|P1|Overall Study|Lost to Follow-up|3
103935|NCT00363311|351302|P2|Overall Study|Adverse Event|4
103936|NCT00363311|351303|P1|Overall Study|Adverse Event|6
103937|NCT00363415|351369|P2|Overall Study|Protocol Violation|4
103938|NCT00363415|351370|P1|Overall Study|Protocol Violation|1
103939|NCT00363415|351369|P2|Overall Study|Lost to Follow-up|3
103940|NCT00363415|351370|P1|Overall Study|Lost to Follow-up|3
103941|NCT00363415|351369|P2|Overall Study|Withdrawal by Subject|15
103942|NCT00363415|351370|P1|Overall Study|Withdrawal by Subject|9
103943|NCT00363415|351369|P2|Overall Study|Entry Criteria Not Met|10
103944|NCT00363415|351370|P1|Overall Study|Entry Criteria Not Met|11
103945|NCT00363415|351369|P2|Overall Study|Physician Decision|35
103946|NCT00363415|351370|P1|Overall Study|Physician Decision|18
103947|NCT00363415|351369|P2|Overall Study|Adverse Event|15
103948|NCT00363415|351370|P1|Overall Study|Adverse Event|24
103949|NCT00363415|351369|P2|Overall Study|Death|29
103950|NCT00363415|351370|P1|Overall Study|Death|32
103951|NCT00363415|351369|P2|Overall Study|Sponsor Decision|31
103952|NCT00363415|351370|P1|Overall Study|Sponsor Decision|67
103953|NCT00363415|351369|P2|Overall Study|Progressive Disease|107
103954|NCT00363415|351370|P1|Overall Study|Progressive Disease|196
103955|NCT00363467|351386|P1|Overall Study|Physician Decision|1
103956|NCT00363545|351396|P2|Overall Study|Others|0
103957|NCT00363545|351397|P1|Overall Study|Others|1
103958|NCT00363545|351396|P2|Overall Study|Lost to follow-up (complete vaccination)|17
103959|NCT00363545|351397|P1|Overall Study|Lost to follow-up (complete vaccination)|14
103960|NCT00363545|351396|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
103961|NCT00363545|351397|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
103962|NCT00363545|351396|P2|Overall Study|Migrated/moved from study area|6
103963|NCT00363545|351397|P1|Overall Study|Migrated/moved from study area|3
103964|NCT00363545|351396|P2|Overall Study|Withdrawal by Subject|15
103965|NCT00363545|351397|P1|Overall Study|Withdrawal by Subject|12
103966|NCT00363545|351396|P2|Overall Study|Serious Adverse Event|1
103967|NCT00363545|351397|P1|Overall Study|Serious Adverse Event|0
103968|NCT00363896|351451|P2|Overall Study|Other|2
103969|NCT00363896|351452|P1|Overall Study|Other|1
103970|NCT00363896|351451|P2|Overall Study|Non-fulfilment of entry criteria|0
103971|NCT00363896|351452|P1|Overall Study|Non-fulfilment of entry criteria|1
103972|NCT00363896|351451|P2|Overall Study|Lost to Follow-up|0
103973|NCT00363896|351452|P1|Overall Study|Lost to Follow-up|3
103974|NCT00363896|351451|P2|Overall Study|Protocol Violation|1
103975|NCT00363896|351452|P1|Overall Study|Protocol Violation|6
103976|NCT00363896|351451|P2|Overall Study|Lack of Efficacy|8
103977|NCT00363896|351452|P1|Overall Study|Lack of Efficacy|12
103978|NCT00363896|351451|P2|Overall Study|COPD exacerbation|7
103979|NCT00363896|351452|P1|Overall Study|COPD exacerbation|13
103980|NCT00363896|351451|P2|Overall Study|Adverse Event|13
103981|NCT00363896|351452|P1|Overall Study|Adverse Event|24
103982|NCT00363896|351451|P2|Overall Study|Withdrawal by Subject|16
103983|NCT00363896|351452|P1|Overall Study|Withdrawal by Subject|29
103984|NCT00364013|351466|P2|Overall Study|Ongoing|13
103985|NCT00364013|351467|P1|Overall Study|Ongoing|20
103986|NCT00364013|351466|P2|Overall Study|Other|47
103987|NCT00364013|351467|P1|Overall Study|Other|41
103988|NCT00364013|351466|P2|Overall Study|Protocol-specified criteria|6
103989|NCT00364013|351467|P1|Overall Study|Protocol-specified criteria|6
103990|NCT00364013|351466|P2|Overall Study|Lost to Follow-up|3
103991|NCT00364013|351467|P1|Overall Study|Lost to Follow-up|10
103992|NCT00364013|351466|P2|Overall Study|Physician Decision|3
103993|NCT00364013|351467|P1|Overall Study|Physician Decision|3
103994|NCT00364013|351466|P2|Overall Study|Withdrawal by Subject|18
103995|NCT00364013|351467|P1|Overall Study|Withdrawal by Subject|13
103996|NCT00364013|351466|P2|Overall Study|Adverse Event|3
103997|NCT00364013|351467|P1|Overall Study|Adverse Event|4
103998|NCT00364013|351466|P2|Overall Study|Ineligibility determined|2
103999|NCT00364013|351467|P1|Overall Study|Ineligibility determined|4
104000|NCT00364130|351495|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
104001|NCT00364130|351496|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
104002|NCT00364130|351495|P2|Intervention Period|Withdrawal by Subject|5
104003|NCT00364130|351496|P1|Intervention Period|Withdrawal by Subject|4
104004|NCT00364130|351495|P2|Intervention Period|Pregnancy|0
104005|NCT00364130|351496|P1|Intervention Period|Pregnancy|1
104006|NCT00364130|351495|P2|Intervention Period|Lost to Follow-up|3
104007|NCT00364130|351496|P1|Intervention Period|Lost to Follow-up|4
104008|NCT00364156|351518|P2|Overall Study|Protocol Violation|1
104009|NCT00364156|351519|P1|Overall Study|Protocol Violation|6
104010|NCT00364156|351518|P2|Overall Study|Withdrawal by Subject|80
104011|NCT00364156|351519|P1|Overall Study|Withdrawal by Subject|73
104012|NCT00364182|351528|P3|Third Intervention|Lost to Follow-up|1
104013|NCT00364182|351529|P2|Third Intervention|Lost to Follow-up|0
104014|NCT00364182|351530|P1|Third Intervention|Lost to Follow-up|0
104015|NCT00364182|351528|P3|Third Intervention|non-compliance|0
104016|NCT00364182|351529|P2|Third Intervention|non-compliance|1
104017|NCT00364182|351530|P1|Third Intervention|non-compliance|0
104018|NCT00364182|351528|P3|Second Intervention|Adverse Event|1
104019|NCT00364182|351529|P2|Second Intervention|Adverse Event|0
104020|NCT00364182|351530|P1|Second Intervention|Adverse Event|0
104021|NCT00364182|351528|P3|Second Intervention|Protocol Violation|0
104022|NCT00364182|351529|P2|Second Intervention|Protocol Violation|1
104023|NCT00364182|351530|P1|Second Intervention|Protocol Violation|0
104024|NCT00364182|351528|P3|Second Intervention|non-compliance|1
104025|NCT00364182|351529|P2|Second Intervention|non-compliance|1
104026|NCT00364182|351530|P1|Second Intervention|non-compliance|0
104027|NCT00364182|351528|P3|First Intervention|Withdrawal by Subject|0
104028|NCT00364182|351529|P2|First Intervention|Withdrawal by Subject|0
104029|NCT00364182|351530|P1|First Intervention|Withdrawal by Subject|2
104030|NCT00364182|351528|P3|First Intervention|Secondary prophylaxis|0
104031|NCT00364182|351529|P2|First Intervention|Secondary prophylaxis|0
104032|NCT00364182|351530|P1|First Intervention|Secondary prophylaxis|1
104033|NCT00355082|351568|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
104034|NCT00355082|351569|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
104035|NCT00355082|351570|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
104036|NCT00355082|351568|P3|Continuation Phase|Scheduling Error|0
104037|NCT00355082|351569|P2|Continuation Phase|Scheduling Error|0
104038|NCT00355082|351570|P1|Continuation Phase|Scheduling Error|1
104039|NCT00355082|351568|P3|Continuation Phase|Site Closed by Sponsor|0
104040|NCT00355082|351569|P2|Continuation Phase|Site Closed by Sponsor|0
104041|NCT00355082|351570|P1|Continuation Phase|Site Closed by Sponsor|8
104042|NCT00355082|351568|P3|Continuation Phase|Lack of Efficacy|0
104043|NCT00355082|351569|P2|Continuation Phase|Lack of Efficacy|0
104044|NCT00355082|351570|P1|Continuation Phase|Lack of Efficacy|5
104045|NCT00355082|351568|P3|Continuation Phase|Withdrawal by Subject|0
104046|NCT00355082|351569|P2|Continuation Phase|Withdrawal by Subject|0
104047|NCT00355082|351570|P1|Continuation Phase|Withdrawal by Subject|4
104048|NCT00355082|351568|P3|Continuation Phase|Protocol Violation|1
104049|NCT00355082|351569|P2|Continuation Phase|Protocol Violation|0
104050|NCT00355082|351570|P1|Continuation Phase|Protocol Violation|1
104051|NCT00355082|351568|P3|Continuation Phase|Lost to Follow-up|1
104052|NCT00355082|351569|P2|Continuation Phase|Lost to Follow-up|0
104053|NCT00355082|351570|P1|Continuation Phase|Lost to Follow-up|2
104054|NCT00355082|351568|P3|Continuation Phase|Adverse Event|1
104055|NCT00355082|351569|P2|Continuation Phase|Adverse Event|0
104056|NCT00355082|351570|P1|Continuation Phase|Adverse Event|2
104057|NCT00355082|351568|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
104058|NCT00355082|351569|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
104059|NCT00355082|351570|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
104060|NCT00355082|351568|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
104061|NCT00355082|351569|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
104062|NCT00355082|351570|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
104063|NCT00355082|351568|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
104064|NCT00355082|351569|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
104065|NCT00355082|351570|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
104066|NCT00355082|351568|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
104067|NCT00355082|351569|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
104068|NCT00355082|351570|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
104069|NCT00355082|351568|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
104070|NCT00355082|351569|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
104071|NCT00355082|351570|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
104072|NCT00355082|351568|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
104073|NCT00355082|351569|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
104074|NCT00355082|351570|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
104075|NCT00355121|351593|P3|Overall Study|Serious adverse events|0
104076|NCT00355121|351594|P2|Overall Study|Serious adverse events|2
104077|NCT00355121|351595|P1|Overall Study|Serious adverse events|0
104078|NCT00355121|351593|P3|Overall Study|Withdrawal by Subject|2
104079|NCT00355121|351594|P2|Overall Study|Withdrawal by Subject|10
104080|NCT00355121|351595|P1|Overall Study|Withdrawal by Subject|9
104081|NCT00355121|351593|P3|Overall Study|Lost to Follow-up|1
104082|NCT00355121|351594|P2|Overall Study|Lost to Follow-up|7
104083|NCT00355121|351595|P1|Overall Study|Lost to Follow-up|4
104084|NCT00355121|351593|P3|Overall Study|Protocol Violation|1
104085|NCT00355121|351594|P2|Overall Study|Protocol Violation|9
104086|NCT00355121|351595|P1|Overall Study|Protocol Violation|7
104087|NCT00355121|351593|P3|Overall Study|Adverse Event|0
104088|NCT00355121|351594|P2|Overall Study|Adverse Event|1
104089|NCT00355121|351595|P1|Overall Study|Adverse Event|0
104090|NCT00355121|351593|P3|Overall Study|Did not receive study vaccine|1
104091|NCT00355121|351594|P2|Overall Study|Did not receive study vaccine|0
104092|NCT00355121|351595|P1|Overall Study|Did not receive study vaccine|1
104093|NCT00355134|351629|P5|Extension Phase|Protocol Violation|0
104094|NCT00355134|351630|P4|Extension Phase|Protocol Violation|1
104095|NCT00355134|351631|P3|Extension Phase|Protocol Violation|0
104096|NCT00355134|351632|P2|Extension Phase|Protocol Violation|0
104097|NCT00355134|351633|P1|Extension Phase|Protocol Violation|0
104098|NCT00355134|351629|P5|Extension Phase|Abnormal test procedure result(s)|1
104099|NCT00355134|351630|P4|Extension Phase|Abnormal test procedure result(s)|0
104100|NCT00355134|351631|P3|Extension Phase|Abnormal test procedure result(s)|0
104101|NCT00355134|351632|P2|Extension Phase|Abnormal test procedure result(s)|1
104102|NCT00355134|351633|P1|Extension Phase|Abnormal test procedure result(s)|0
104103|NCT00355134|351629|P5|Extension Phase|Unsatisfactory therapeutic effect|1
104104|NCT00355134|351630|P4|Extension Phase|Unsatisfactory therapeutic effect|0
104105|NCT00355134|351631|P3|Extension Phase|Unsatisfactory therapeutic effect|0
104106|NCT00355134|351632|P2|Extension Phase|Unsatisfactory therapeutic effect|4
104107|NCT00355134|351633|P1|Extension Phase|Unsatisfactory therapeutic effect|3
104108|NCT00355134|351629|P5|Extension Phase|Administrative problems|1
104109|NCT00355134|351630|P4|Extension Phase|Administrative problems|1
104110|NCT00355134|351631|P3|Extension Phase|Administrative problems|0
104111|NCT00355134|351632|P2|Extension Phase|Administrative problems|4
104112|NCT00355134|351633|P1|Extension Phase|Administrative problems|2
104113|NCT00355134|351629|P5|Extension Phase|Abnormal laboratory value(s)|2
104114|NCT00355134|351630|P4|Extension Phase|Abnormal laboratory value(s)|2
104115|NCT00355134|351631|P3|Extension Phase|Abnormal laboratory value(s)|0
104116|NCT00355134|351632|P2|Extension Phase|Abnormal laboratory value(s)|2
104117|NCT00355134|351633|P1|Extension Phase|Abnormal laboratory value(s)|4
104118|NCT00355134|351629|P5|Extension Phase|Lost to Follow-up|4
104119|NCT00355134|351630|P4|Extension Phase|Lost to Follow-up|2
104120|NCT00355134|351631|P3|Extension Phase|Lost to Follow-up|0
104121|NCT00355134|351632|P2|Extension Phase|Lost to Follow-up|6
104122|NCT00355134|351633|P1|Extension Phase|Lost to Follow-up|2
104123|NCT00355134|351629|P5|Extension Phase|Adverse Event|5
104124|NCT00355134|351630|P4|Extension Phase|Adverse Event|3
104125|NCT00355134|351631|P3|Extension Phase|Adverse Event|0
104126|NCT00355134|351632|P2|Extension Phase|Adverse Event|9
104127|NCT00355134|351633|P1|Extension Phase|Adverse Event|13
104128|NCT00355134|351629|P5|Extension Phase|Withdrawal by Subject|5
104129|NCT00355134|351630|P4|Extension Phase|Withdrawal by Subject|7
104130|NCT00355134|351631|P3|Extension Phase|Withdrawal by Subject|0
104131|NCT00355134|351632|P2|Extension Phase|Withdrawal by Subject|11
104132|NCT00355134|351633|P1|Extension Phase|Withdrawal by Subject|7
104133|NCT00355134|351629|P5|Core Phase|Condition no longer requires study drug|0
104134|NCT00355134|351630|P4|Core Phase|Condition no longer requires study drug|0
104135|NCT00355134|351631|P3|Core Phase|Condition no longer requires study drug|1
104136|NCT00355134|351632|P2|Core Phase|Condition no longer requires study drug|0
104137|NCT00355134|351633|P1|Core Phase|Condition no longer requires study drug|1
104138|NCT00355134|351629|P5|Core Phase|Abnormal test procedure result(s)|0
104139|NCT00355134|351630|P4|Core Phase|Abnormal test procedure result(s)|0
104140|NCT00355134|351631|P3|Core Phase|Abnormal test procedure result(s)|1
104141|NCT00355134|351632|P2|Core Phase|Abnormal test procedure result(s)|2
104142|NCT00355134|351633|P1|Core Phase|Abnormal test procedure result(s)|1
104143|NCT00355134|351629|P5|Core Phase|Protocol Violation|0
104144|NCT00355134|351630|P4|Core Phase|Protocol Violation|0
104145|NCT00355134|351631|P3|Core Phase|Protocol Violation|2
104146|NCT00355134|351632|P2|Core Phase|Protocol Violation|2
104147|NCT00355134|351633|P1|Core Phase|Protocol Violation|3
104148|NCT00355134|351629|P5|Core Phase|Administrative problems|0
104149|NCT00355134|351630|P4|Core Phase|Administrative problems|0
104150|NCT00355134|351631|P3|Core Phase|Administrative problems|5
104151|NCT00355134|351632|P2|Core Phase|Administrative problems|3
104152|NCT00355134|351633|P1|Core Phase|Administrative problems|5
104153|NCT00355134|351629|P5|Core Phase|Unsatisfactory therapeutic effect|0
104154|NCT00355134|351630|P4|Core Phase|Unsatisfactory therapeutic effect|0
104155|NCT00355134|351631|P3|Core Phase|Unsatisfactory therapeutic effect|17
104156|NCT00355134|351632|P2|Core Phase|Unsatisfactory therapeutic effect|6
104157|NCT00355134|351633|P1|Core Phase|Unsatisfactory therapeutic effect|10
104158|NCT00355134|351629|P5|Core Phase|Abnormal laboratory value(s)|0
104159|NCT00355134|351630|P4|Core Phase|Abnormal laboratory value(s)|0
104160|NCT00355134|351631|P3|Core Phase|Abnormal laboratory value(s)|2
104161|NCT00355134|351632|P2|Core Phase|Abnormal laboratory value(s)|14
104162|NCT00355134|351633|P1|Core Phase|Abnormal laboratory value(s)|19
104163|NCT00355134|351629|P5|Core Phase|Lost to Follow-up|0
104164|NCT00355134|351630|P4|Core Phase|Lost to Follow-up|0
104165|NCT00355134|351631|P3|Core Phase|Lost to Follow-up|21
104166|NCT00355134|351632|P2|Core Phase|Lost to Follow-up|13
104167|NCT00355134|351633|P1|Core Phase|Lost to Follow-up|17
104168|NCT00355134|351629|P5|Core Phase|Adverse Event|0
104169|NCT00355134|351630|P4|Core Phase|Adverse Event|0
104170|NCT00355134|351631|P3|Core Phase|Adverse Event|16
104171|NCT00355134|351632|P2|Core Phase|Adverse Event|22
104172|NCT00355134|351633|P1|Core Phase|Adverse Event|28
104173|NCT00355134|351629|P5|Core Phase|Withdrawal by Subject|0
104174|NCT00355134|351630|P4|Core Phase|Withdrawal by Subject|0
104175|NCT00355134|351631|P3|Core Phase|Withdrawal by Subject|35
104176|NCT00355134|351632|P2|Core Phase|Withdrawal by Subject|24
104177|NCT00355134|351633|P1|Core Phase|Withdrawal by Subject|35
104178|NCT00355147|351675|P2|Overall Study|Withdrawal by Subject|12
104179|NCT00355147|351676|P1|Overall Study|Withdrawal by Subject|8
104180|NCT00355147|351675|P2|Overall Study|Lost to Follow-up|8
104181|NCT00355147|351676|P1|Overall Study|Lost to Follow-up|10
104182|NCT00355368|351709|P2|Overall Study|cardiac arrest prior to intubation|2
104183|NCT00355368|351710|P1|Overall Study|cardiac arrest prior to intubation|2
104184|NCT00355368|351709|P2|Overall Study|Protocol Violation|7
104185|NCT00355368|351710|P1|Overall Study|Protocol Violation|8
104186|NCT00355472|351741|P1|Overall Study|Physician Decision|1
104187|NCT00355615|351770|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
104188|NCT00355615|351771|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
104189|NCT00355615|351772|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
104190|NCT00355615|351773|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
104191|NCT00355615|351774|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
104192|NCT00355615|351770|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
104193|NCT00355615|351771|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
104194|NCT00355615|351772|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
104195|NCT00355615|351773|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
104196|NCT00355615|351774|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
104197|NCT00355615|351770|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
104198|NCT00355615|351771|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
104199|NCT00355615|351772|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
104200|NCT00355615|351773|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
104201|NCT00355615|351774|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
104202|NCT00355615|351770|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
104203|NCT00355615|351771|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
104204|NCT00355615|351772|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
104205|NCT00355615|351773|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
104206|NCT00355615|351774|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
104207|NCT00355615|351770|P5|Randomized Double Blind Period|Protocol Violation|0
104208|NCT00355615|351771|P4|Randomized Double Blind Period|Protocol Violation|1
104209|NCT00355615|351772|P3|Randomized Double Blind Period|Protocol Violation|1
104210|NCT00355615|351773|P2|Randomized Double Blind Period|Protocol Violation|0
104211|NCT00355615|351774|P1|Randomized Double Blind Period|Protocol Violation|0
104212|NCT00355615|351770|P5|Randomized Double Blind Period|Adverse Event|0
104213|NCT00355615|351771|P4|Randomized Double Blind Period|Adverse Event|0
104214|NCT00355615|351772|P3|Randomized Double Blind Period|Adverse Event|0
104215|NCT00355615|351773|P2|Randomized Double Blind Period|Adverse Event|0
104216|NCT00355615|351774|P1|Randomized Double Blind Period|Adverse Event|1
104217|NCT00355784|351849|P3|Overall Study|Withdrawal by Subject|2
104218|NCT00355784|351850|P2|Overall Study|Withdrawal by Subject|0
104219|NCT00355784|351851|P1|Overall Study|Withdrawal by Subject|0
104220|NCT00356122|351948|P1|FOLLOW-UP|Other|2
104221|NCT00356122|351948|P1|FOLLOW-UP|Lost to Follow-up|2
104222|NCT00356122|351948|P1|FOLLOW-UP|Death|37
104223|NCT00356122|351948|P1|TREATMENT|Did not receive study medication|1
104224|NCT00356122|351948|P1|TREATMENT|Other|4
104225|NCT00356122|351948|P1|TREATMENT|Subject's request|4
104226|NCT00356122|351948|P1|TREATMENT|Adverse Event|10
104227|NCT00356122|351948|P1|TREATMENT|Lack of Efficacy|26
104228|NCT00356135|351959|P3|Overall Study|Subject non-compliance|3
104229|NCT00356135|351960|P2|Overall Study|Subject non-compliance|1
104230|NCT00356135|351961|P1|Overall Study|Subject non-compliance|1
104231|NCT00356135|351959|P3|Overall Study|Physician Decision|1
104232|NCT00356135|351960|P2|Overall Study|Physician Decision|1
104233|NCT00356135|351961|P1|Overall Study|Physician Decision|1
104234|NCT00356135|351959|P3|Overall Study|Lost to Follow-up|1
104235|NCT00356135|351960|P2|Overall Study|Lost to Follow-up|0
104236|NCT00356135|351961|P1|Overall Study|Lost to Follow-up|0
104237|NCT00356135|351959|P3|Overall Study|Adverse Event|0
104238|NCT00356135|351960|P2|Overall Study|Adverse Event|0
104239|NCT00356135|351961|P1|Overall Study|Adverse Event|1
104240|NCT00356135|351959|P3|Overall Study|Protocol Violation|0
104241|NCT00356135|351960|P2|Overall Study|Protocol Violation|0
104242|NCT00356135|351961|P1|Overall Study|Protocol Violation|1
104243|NCT00356148|351985|P2|Overall Study|Reoperation within 30 days|1
104244|NCT00356148|351986|P1|Overall Study|Reoperation within 30 days|2
104245|NCT00356200|351996|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
104246|NCT00356200|351997|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
104247|NCT00356200|351996|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
104248|NCT00356200|351997|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
104249|NCT00356278|352012|P3|Overall Study|Withdrawal by Subject|19
104250|NCT00356278|352013|P2|Overall Study|Withdrawal by Subject|15
104251|NCT00356278|352014|P1|Overall Study|Withdrawal by Subject|25
104252|NCT00356408|352064|P1|Overall Study|Other: Subject chose commerical dosing|1
104253|NCT00356408|352064|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
104254|NCT00356408|352064|P1|Overall Study|Other: Azathioprine stopped|1
104255|NCT00356408|352064|P1|Overall Study|Other: Sponsor request|1
104256|NCT00356408|352064|P1|Overall Study|Other: Principal investigator discretion|3
104257|NCT00356408|352064|P1|Overall Study|Withdrawal by Subject|6
104258|NCT00356408|352064|P1|Overall Study|Lost to Follow-up|2
104259|NCT00356408|352064|P1|Overall Study|Lack of Efficacy|36
104260|NCT00356408|352064|P1|Overall Study|Adverse Event|9
104261|NCT00356421|352081|P2|Overall Study|Not related to study drug|3
104262|NCT00356421|352082|P1|Overall Study|Not related to study drug|5
104263|NCT00356421|352081|P2|Overall Study|Related to study drug|12
104264|NCT00356421|352082|P1|Overall Study|Related to study drug|15
104265|NCT00356421|352081|P2|Overall Study|Withdrawal by Subject|2
104266|NCT00356421|352082|P1|Overall Study|Withdrawal by Subject|9
104267|NCT00356421|352081|P2|Overall Study|Lack of Efficacy|0
104268|NCT00356421|352082|P1|Overall Study|Lack of Efficacy|3
104269|NCT00356525|352135|P4|Overall Study|Sponsor Decision|1
104270|NCT00356525|352136|P3|Overall Study|Sponsor Decision|0
104271|NCT00356525|352137|P2|Overall Study|Sponsor Decision|0
104272|NCT00356525|352138|P1|Overall Study|Sponsor Decision|0
104273|NCT00356525|352135|P4|Overall Study|Death|1
104274|NCT00356525|352136|P3|Overall Study|Death|0
104275|NCT00356525|352137|P2|Overall Study|Death|0
104276|NCT00356525|352138|P1|Overall Study|Death|0
104277|NCT00356525|352135|P4|Overall Study|Withdrawal by Subject|3
104278|NCT00356525|352136|P3|Overall Study|Withdrawal by Subject|0
104279|NCT00356525|352137|P2|Overall Study|Withdrawal by Subject|1
104280|NCT00356525|352138|P1|Overall Study|Withdrawal by Subject|1
104281|NCT00356525|352135|P4|Overall Study|Protocol Entry Criteria Not Met|0
104282|NCT00356525|352136|P3|Overall Study|Protocol Entry Criteria Not Met|0
104283|NCT00356525|352137|P2|Overall Study|Protocol Entry Criteria Not Met|0
104284|NCT00356525|352138|P1|Overall Study|Protocol Entry Criteria Not Met|1
104285|NCT00356525|352135|P4|Overall Study|Physician Decision|1
104286|NCT00356525|352136|P3|Overall Study|Physician Decision|2
104287|NCT00356525|352137|P2|Overall Study|Physician Decision|2
104288|NCT00356525|352138|P1|Overall Study|Physician Decision|2
104289|NCT00356525|352135|P4|Overall Study|Lost to Follow-up|0
104290|NCT00356525|352136|P3|Overall Study|Lost to Follow-up|0
104291|NCT00356525|352137|P2|Overall Study|Lost to Follow-up|0
104292|NCT00356525|352138|P1|Overall Study|Lost to Follow-up|1
104293|NCT00356525|352135|P4|Overall Study|Adverse Event|1
104294|NCT00356525|352136|P3|Overall Study|Adverse Event|1
104295|NCT00356525|352137|P2|Overall Study|Adverse Event|3
104296|NCT00356525|352138|P1|Overall Study|Adverse Event|1
104297|NCT00356525|352135|P4|Overall Study|Progressive Disease|2
104298|NCT00356525|352136|P3|Overall Study|Progressive Disease|4
104299|NCT00356525|352137|P2|Overall Study|Progressive Disease|5
104300|NCT00356525|352138|P1|Overall Study|Progressive Disease|8
104301|NCT00356590|352164|P1|Overall Study|Other|52
104302|NCT00356590|352164|P1|Overall Study|Response status|28
104303|NCT00356590|352164|P1|Overall Study|Protocol issues|6
104304|NCT00356590|352164|P1|Overall Study|Completed month 12 only|2
104305|NCT00356590|352164|P1|Overall Study|Withdrawal by Subject|41
104306|NCT00356590|352164|P1|Overall Study|Physician Decision|46
104307|NCT00356590|352164|P1|Overall Study|Lost to Follow-up|35
104308|NCT00356590|352164|P1|Overall Study|Death|10
104309|NCT00356590|352164|P1|Overall Study|Adverse Event|54
104310|NCT00356811|352196|P1|Overall Study|Site Closed during Follow-up|2
104311|NCT00356811|352196|P1|Overall Study|Study Is Terminating|3
104312|NCT00356811|352196|P1|Overall Study|Participant Could Not Make a Checkup|1
104313|NCT00356811|352196|P1|Overall Study|Withdrawal by Subject|6
104314|NCT00356811|352196|P1|Overall Study|Lost to Follow-up|2
104315|NCT00356811|352196|P1|Overall Study|Death|35
104316|NCT00356863|352211|P2|Overall Study|Lost to Follow-up|43
104317|NCT00356863|352212|P1|Overall Study|Lost to Follow-up|76
104318|NCT00356863|352211|P2|Overall Study|Death|32
104319|NCT00356863|352212|P1|Overall Study|Death|16
104320|NCT00356889|352238|P1|Overall Study|Adverse Event|1
104321|NCT00356889|352238|P1|Overall Study|Protocol Violation|2
104322|NCT00356915|352248|P3|Overall Study|Miscellaneous reasons|3
104323|NCT00356915|352249|P2|Overall Study|Miscellaneous reasons|8
104324|NCT00356915|352250|P1|Overall Study|Miscellaneous reasons|11
104325|NCT00356915|352248|P3|Overall Study|Adverse Event|8
104326|NCT00356915|352249|P2|Overall Study|Adverse Event|31
104327|NCT00356915|352250|P1|Overall Study|Adverse Event|21
104328|NCT00356915|352248|P3|Overall Study|Physician Decision|0
104329|NCT00356915|352249|P2|Overall Study|Physician Decision|2
104330|NCT00356915|352250|P1|Overall Study|Physician Decision|0
104331|NCT00356915|352248|P3|Overall Study|Administrative Decision|1
104332|NCT00356915|352249|P2|Overall Study|Administrative Decision|0
104333|NCT00356915|352250|P1|Overall Study|Administrative Decision|0
104334|NCT00356915|352248|P3|Overall Study|Lost to Follow-up|14
104335|NCT00356915|352249|P2|Overall Study|Lost to Follow-up|34
104336|NCT00356915|352250|P1|Overall Study|Lost to Follow-up|27
104337|NCT00356915|352248|P3|Overall Study|Lack of Efficacy|3
104338|NCT00356915|352249|P2|Overall Study|Lack of Efficacy|0
104339|NCT00356915|352250|P1|Overall Study|Lack of Efficacy|0
104340|NCT00356915|352248|P3|Overall Study|Withdrawal by Subject|10
104341|NCT00356915|352249|P2|Overall Study|Withdrawal by Subject|14
104342|NCT00356915|352250|P1|Overall Study|Withdrawal by Subject|14
104343|NCT00356915|352248|P3|Overall Study|Protocol Violation|2
104344|NCT00356915|352249|P2|Overall Study|Protocol Violation|3
104345|NCT00356915|352250|P1|Overall Study|Protocol Violation|2
104346|NCT00356915|352248|P3|Overall Study|Non compliance|1
104347|NCT00356915|352249|P2|Overall Study|Non compliance|2
104348|NCT00356915|352250|P1|Overall Study|Non compliance|1
104349|NCT00357006|352270|P3|Overall Study|Withdrawal by Subject|2
104350|NCT00357006|352271|P2|Overall Study|Withdrawal by Subject|3
104351|NCT00357006|352272|P1|Overall Study|Withdrawal by Subject|1
104352|NCT00357006|352270|P3|Overall Study|Lost to Follow-up|1
104353|NCT00357006|352271|P2|Overall Study|Lost to Follow-up|2
104354|NCT00357006|352272|P1|Overall Study|Lost to Follow-up|1
104355|NCT00357097|352287|P2|Overall Study|Increase of RLS Symptoms|1
104356|NCT00357097|352288|P1|Overall Study|Increase of RLS Symptoms|0
104357|NCT00357097|352287|P2|Overall Study|Other|1
104358|NCT00357097|352288|P1|Overall Study|Other|1
104359|NCT00357097|352287|P2|Overall Study|Met Exclusion Criteria|1
104360|NCT00357097|352288|P1|Overall Study|Met Exclusion Criteria|3
104361|NCT00357097|352287|P2|Overall Study|Lack of Efficacy|8
104362|NCT00357097|352288|P1|Overall Study|Lack of Efficacy|2
104363|NCT00357097|352287|P2|Overall Study|Non-compliance|2
104364|NCT00357097|352288|P1|Overall Study|Non-compliance|1
104365|NCT00357097|352287|P2|Overall Study|Withdrawal by Subject|7
104366|NCT00357097|352288|P1|Overall Study|Withdrawal by Subject|8
104367|NCT00357097|352287|P2|Overall Study|Adverse Event|6
104368|NCT00357097|352288|P1|Overall Study|Adverse Event|34
104369|NCT00357097|352287|P2|Overall Study|Did not meet inclusion criteria|3
104370|NCT00357097|352288|P1|Overall Study|Did not meet inclusion criteria|5
104371|NCT00364351|352334|P2|Overall Study|Randomised treatment not started|3
104372|NCT00364351|352335|P1|Overall Study|Randomised treatment not started|0
104373|NCT00364351|352334|P2|Overall Study|Patient could not travel to site|1
104374|NCT00364351|352335|P1|Overall Study|Patient could not travel to site|0
104375|NCT00364351|352334|P2|Overall Study|Investigator error|2
104376|NCT00364351|352335|P1|Overall Study|Investigator error|0
104377|NCT00364351|352334|P2|Overall Study|Poor treatment compliance|3
104378|NCT00364351|352335|P1|Overall Study|Poor treatment compliance|0
104379|NCT00364351|352334|P2|Overall Study|Sponsor decision|0
104380|NCT00364351|352335|P1|Overall Study|Sponsor decision|1
104381|NCT00364351|352334|P2|Overall Study|Incorrect enrollment|1
104382|NCT00364351|352335|P1|Overall Study|Incorrect enrollment|1
104383|NCT00364351|352334|P2|Overall Study|Withdrawal by Subject|29
104384|NCT00364351|352335|P1|Overall Study|Withdrawal by Subject|30
104385|NCT00364351|352334|P2|Overall Study|Lost to Follow-up|1
104386|NCT00364351|352335|P1|Overall Study|Lost to Follow-up|1
104387|NCT00364351|352334|P2|Overall Study|Prohibited concomitant medication|2
104388|NCT00364351|352335|P1|Overall Study|Prohibited concomitant medication|0
104389|NCT00364351|352334|P2|Overall Study|Condition under investigation worsened|497
104390|NCT00364351|352335|P1|Overall Study|Condition under investigation worsened|469
104391|NCT00364351|352334|P2|Overall Study|Adverse Event|44
104392|NCT00364351|352335|P1|Overall Study|Adverse Event|90
104393|NCT00364533|352367|P5|Overall Study|Protocol Violation|0
104394|NCT00364533|352368|P4|Overall Study|Protocol Violation|0
104395|NCT00364533|352369|P3|Overall Study|Protocol Violation|0
104396|NCT00364533|352370|P2|Overall Study|Protocol Violation|1
104397|NCT00364533|352371|P1|Overall Study|Protocol Violation|1
104398|NCT00364533|352367|P5|Overall Study|Non-compliance|0
104399|NCT00364533|352368|P4|Overall Study|Non-compliance|0
104400|NCT00364533|352369|P3|Overall Study|Non-compliance|0
104401|NCT00364533|352370|P2|Overall Study|Non-compliance|0
104402|NCT00364533|352371|P1|Overall Study|Non-compliance|1
104403|NCT00364533|352367|P5|Overall Study|Variations in drug compliance|0
104404|NCT00364533|352368|P4|Overall Study|Variations in drug compliance|0
104405|NCT00364533|352369|P3|Overall Study|Variations in drug compliance|1
104406|NCT00364533|352370|P2|Overall Study|Variations in drug compliance|1
104407|NCT00364533|352371|P1|Overall Study|Variations in drug compliance|2
104408|NCT00364533|352367|P5|Overall Study|Subject discharged from hospital|1
104409|NCT00364533|352368|P4|Overall Study|Subject discharged from hospital|3
104410|NCT00364533|352369|P3|Overall Study|Subject discharged from hospital|2
104411|NCT00364533|352370|P2|Overall Study|Subject discharged from hospital|1
104412|NCT00364533|352371|P1|Overall Study|Subject discharged from hospital|4
104413|NCT00364533|352367|P5|Overall Study|Lack of Efficacy|42
104414|NCT00364533|352368|P4|Overall Study|Lack of Efficacy|17
104415|NCT00364533|352369|P3|Overall Study|Lack of Efficacy|21
104416|NCT00364533|352370|P2|Overall Study|Lack of Efficacy|22
104417|NCT00364533|352371|P1|Overall Study|Lack of Efficacy|22
104418|NCT00364533|352367|P5|Overall Study|Withdrawal by Subject|6
104419|NCT00364533|352368|P4|Overall Study|Withdrawal by Subject|6
104420|NCT00364533|352369|P3|Overall Study|Withdrawal by Subject|6
104421|NCT00364533|352370|P2|Overall Study|Withdrawal by Subject|8
104422|NCT00364533|352371|P1|Overall Study|Withdrawal by Subject|4
104423|NCT00364533|352367|P5|Overall Study|Adverse Event|2
104424|NCT00364533|352368|P4|Overall Study|Adverse Event|5
104425|NCT00364533|352369|P3|Overall Study|Adverse Event|15
104426|NCT00364533|352370|P2|Overall Study|Adverse Event|7
104427|NCT00364533|352371|P1|Overall Study|Adverse Event|8
104428|NCT00364611|352395|P2|Overall Study|Receiving Liver Ablation|1
104429|NCT00364611|352396|P1|Overall Study|Receiving Liver Ablation|0
104430|NCT00364611|352395|P2|Overall Study|Presumed CR on Study|1
104431|NCT00364611|352396|P1|Overall Study|Presumed CR on Study|0
104432|NCT00364611|352395|P2|Overall Study|Found Ineligible|0
104433|NCT00364611|352396|P1|Overall Study|Found Ineligible|1
104434|NCT00364611|352395|P2|Overall Study|Investigator decision|2
104435|NCT00364611|352396|P1|Overall Study|Investigator decision|2
104436|NCT00364611|352395|P2|Overall Study|Disease Progression|8
104437|NCT00364611|352396|P1|Overall Study|Disease Progression|38
104438|NCT00364611|352395|P2|Overall Study|Participant's Request|4
104439|NCT00364611|352396|P1|Overall Study|Participant's Request|3
104440|NCT00364611|352395|P2|Overall Study|Adverse Event|4
104441|NCT00364611|352396|P1|Overall Study|Adverse Event|7
104442|NCT00364611|352395|P2|Overall Study|Did not receive study medication|1
104443|NCT00364611|352396|P1|Overall Study|Did not receive study medication|0
104444|NCT00365716|352419|P7|Extension 2|Withdrawal by Subject|5
104445|NCT00365716|352420|P6|Extension 2|Withdrawal by Subject|0
104446|NCT00365716|352421|P5|Extension 2|Withdrawal by Subject|0
104447|NCT00365716|352422|P4|Extension 2|Withdrawal by Subject|0
104448|NCT00365716|352423|P3|Extension 2|Withdrawal by Subject|0
104449|NCT00365716|352424|P2|Extension 2|Withdrawal by Subject|0
104450|NCT00365716|352425|P1|Extension 2|Withdrawal by Subject|0
104451|NCT00365716|352419|P7|Extension 2|Unspecified|3
104452|NCT00365716|352420|P6|Extension 2|Unspecified|0
104453|NCT00365716|352421|P5|Extension 2|Unspecified|0
104454|NCT00365716|352422|P4|Extension 2|Unspecified|0
104455|NCT00365716|352423|P3|Extension 2|Unspecified|0
104456|NCT00365716|352424|P2|Extension 2|Unspecified|0
104457|NCT00365716|352425|P1|Extension 2|Unspecified|0
104458|NCT00365716|352419|P7|Extension 2|Lost to Follow-up|2
104459|NCT00365716|352420|P6|Extension 2|Lost to Follow-up|0
104460|NCT00365716|352421|P5|Extension 2|Lost to Follow-up|0
104461|NCT00365716|352422|P4|Extension 2|Lost to Follow-up|0
104462|NCT00365716|352423|P3|Extension 2|Lost to Follow-up|0
104463|NCT00365716|352424|P2|Extension 2|Lost to Follow-up|0
104464|NCT00365716|352425|P1|Extension 2|Lost to Follow-up|0
104465|NCT00365716|352419|P7|Extension 1|Protocol Violation|0
104466|NCT00365716|352420|P6|Extension 1|Protocol Violation|1
104467|NCT00365716|352421|P5|Extension 1|Protocol Violation|0
104468|NCT00365716|352422|P4|Extension 1|Protocol Violation|0
104469|NCT00365716|352423|P3|Extension 1|Protocol Violation|0
104470|NCT00365716|352424|P2|Extension 1|Protocol Violation|0
104471|NCT00365716|352425|P1|Extension 1|Protocol Violation|0
104472|NCT00365716|352419|P7|Extension 1|Pregnancy|0
104473|NCT00365716|352420|P6|Extension 1|Pregnancy|4
104474|NCT00365716|352421|P5|Extension 1|Pregnancy|0
104475|NCT00365716|352422|P4|Extension 1|Pregnancy|0
104476|NCT00365716|352423|P3|Extension 1|Pregnancy|0
104477|NCT00365716|352424|P2|Extension 1|Pregnancy|0
104478|NCT00365716|352425|P1|Extension 1|Pregnancy|0
104479|NCT00365716|352419|P7|Extension 1|Withdrawal by Subject|0
104480|NCT00365716|352420|P6|Extension 1|Withdrawal by Subject|3
104481|NCT00365716|352421|P5|Extension 1|Withdrawal by Subject|0
104482|NCT00365716|352422|P4|Extension 1|Withdrawal by Subject|0
104483|NCT00365716|352423|P3|Extension 1|Withdrawal by Subject|0
104484|NCT00365716|352424|P2|Extension 1|Withdrawal by Subject|0
104485|NCT00365716|352425|P1|Extension 1|Withdrawal by Subject|0
104486|NCT00365716|352419|P7|Extension 1|Moved|0
104487|NCT00365716|352420|P6|Extension 1|Moved|4
104488|NCT00365716|352421|P5|Extension 1|Moved|0
104489|NCT00365716|352422|P4|Extension 1|Moved|0
104490|NCT00365716|352423|P3|Extension 1|Moved|0
104491|NCT00365716|352424|P2|Extension 1|Moved|0
104492|NCT00365716|352425|P1|Extension 1|Moved|0
104493|NCT00365716|352419|P7|Extension 1|Unspecified|0
104494|NCT00365716|352420|P6|Extension 1|Unspecified|9
104495|NCT00365716|352421|P5|Extension 1|Unspecified|0
104496|NCT00365716|352422|P4|Extension 1|Unspecified|0
104497|NCT00365716|352423|P3|Extension 1|Unspecified|0
104498|NCT00365716|352424|P2|Extension 1|Unspecified|0
104499|NCT00365716|352425|P1|Extension 1|Unspecified|0
104500|NCT00365716|352419|P7|Extension 1|Lost to Follow-up|0
104501|NCT00365716|352420|P6|Extension 1|Lost to Follow-up|1
104502|NCT00365716|352421|P5|Extension 1|Lost to Follow-up|0
104503|NCT00365716|352422|P4|Extension 1|Lost to Follow-up|0
104504|NCT00365716|352423|P3|Extension 1|Lost to Follow-up|0
104505|NCT00365716|352424|P2|Extension 1|Lost to Follow-up|0
104506|NCT00365716|352425|P1|Extension 1|Lost to Follow-up|0
104507|NCT00365716|352419|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
104508|NCT00365716|352420|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
104509|NCT00365716|352421|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
104510|NCT00365716|352422|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
104511|NCT00365716|352423|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
104512|NCT00365716|352424|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
104513|NCT00365716|352425|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
104514|NCT00365716|352419|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
104515|NCT00365716|352420|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
104516|NCT00365716|352421|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
104517|NCT00365716|352422|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
104518|NCT00365716|352423|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
104519|NCT00365716|352424|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
104520|NCT00365716|352425|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
104521|NCT00365716|352419|P7|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
104522|NCT00365716|352420|P6|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
104523|NCT00365716|352421|P5|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|1
104524|NCT00365716|352422|P4|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
104525|NCT00365716|352423|P3|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
104526|NCT00365716|352424|P2|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|0
104527|NCT00365716|352425|P1|Long Term Follow-up (Month 7 toMonth 36)|Unspecified|2
104528|NCT00365716|352419|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
104529|NCT00365716|352420|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
104530|NCT00365716|352421|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
104531|NCT00365716|352422|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
104532|NCT00365716|352423|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
104533|NCT00365716|352424|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
104534|NCT00365716|352425|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
104535|NCT00365716|352419|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
104536|NCT00365716|352420|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
104537|NCT00365716|352421|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
104538|NCT00365716|352422|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
104539|NCT00365716|352423|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
104540|NCT00365716|352424|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
104541|NCT00365716|352425|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
104542|NCT00365716|352419|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
104543|NCT00365716|352420|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
104544|NCT00365716|352421|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
104545|NCT00365716|352422|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
104546|NCT00365716|352423|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
104547|NCT00365716|352424|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
104548|NCT00365716|352425|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
104549|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
104550|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
104551|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
104552|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
104553|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
104554|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
104555|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
104556|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
104557|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
104558|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
104559|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
104560|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
104561|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
104562|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
104563|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
104564|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
104565|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
104566|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
104567|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
104568|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
104569|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
104570|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Unspecified|0
104571|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Unspecified|0
104572|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Unspecified|0
104573|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Unspecified|0
104574|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Unspecified|0
104575|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Unspecified|1
104576|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Unspecified|0
104577|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
104578|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
104579|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
104580|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
104581|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
104582|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
104583|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
104584|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
104585|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
104586|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
104587|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
104588|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
104589|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
104590|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
104591|NCT00365716|352419|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
104592|NCT00365716|352420|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
104593|NCT00365716|352421|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
104594|NCT00365716|352422|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
104595|NCT00365716|352423|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
104596|NCT00365716|352424|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
104597|NCT00365716|352425|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
104598|NCT00365846|352451|P1|Overall Study|Lost to Follow-up|1
104599|NCT00365976|352572|P2|Overall Study|Withdrawal by Subject|5
104600|NCT00365976|352573|P1|Overall Study|Withdrawal by Subject|1
104601|NCT00366249|352621|P2|Overall Study|Most due to osteomylitis status|20
104602|NCT00366249|352622|P1|Overall Study|Most due to osteomylitis status|31
104603|NCT00366249|352621|P2|Overall Study|Lack of Efficacy|21
104604|NCT00366249|352622|P1|Overall Study|Lack of Efficacy|21
104605|NCT00366249|352621|P2|Overall Study|Withdrawal by Subject|4
104606|NCT00366249|352622|P1|Overall Study|Withdrawal by Subject|18
104607|NCT00366249|352621|P2|Overall Study|Protocol Violation|2
104608|NCT00366249|352622|P1|Overall Study|Protocol Violation|1
104609|NCT00366249|352621|P2|Overall Study|Lost to Follow-up|0
104610|NCT00366249|352622|P1|Overall Study|Lost to Follow-up|2
104611|NCT00366249|352621|P2|Overall Study|Physician Decision|2
104612|NCT00366249|352622|P1|Overall Study|Physician Decision|5
104613|NCT00366249|352621|P2|Overall Study|Death|1
104614|NCT00366249|352622|P1|Overall Study|Death|0
104615|NCT00366249|352621|P2|Overall Study|Adverse Event|28
104616|NCT00366249|352622|P1|Overall Study|Adverse Event|53
104617|NCT00366301|352644|P4|Overall Study|Withdrawal by Subject|1
104618|NCT00366301|352645|P3|Overall Study|Withdrawal by Subject|1
104619|NCT00366301|352646|P2|Overall Study|Withdrawal by Subject|2
104620|NCT00366301|352647|P1|Overall Study|Withdrawal by Subject|4
104621|NCT00366301|352644|P4|Overall Study|Lost to Follow-up|7
104622|NCT00366301|352645|P3|Overall Study|Lost to Follow-up|3
104623|NCT00366301|352646|P2|Overall Study|Lost to Follow-up|4
104624|NCT00366301|352647|P1|Overall Study|Lost to Follow-up|4
104625|NCT00366340|352659|P2|Toddler Dose|Parent/legal guardian request|1
104626|NCT00366340|352660|P1|Toddler Dose|Parent/legal guardian request|0
104627|NCT00366340|352659|P2|Toddler Dose|Failed to return|0
104628|NCT00366340|352660|P1|Toddler Dose|Failed to return|1
104629|NCT00366340|352659|P2|After the Infant Series|Lost to Follow-up|1
104630|NCT00366340|352660|P1|After the Infant Series|Lost to Follow-up|0
104631|NCT00366340|352659|P2|After the Infant Series|Adverse Event|1
104632|NCT00366340|352660|P1|After the Infant Series|Adverse Event|0
104633|NCT00366340|352659|P2|After the Infant Series|Protocol Violation|2
104634|NCT00366340|352660|P1|After the Infant Series|Protocol Violation|2
104635|NCT00366340|352659|P2|After the Infant Series|Failed to return|1
104636|NCT00366340|352660|P1|After the Infant Series|Failed to return|0
104637|NCT00366340|352659|P2|After the Infant Series|Parent/legal guardian request|1
104638|NCT00366340|352660|P1|After the Infant Series|Parent/legal guardian request|1
104639|NCT00366340|352659|P2|Infant Series|Failure to return|0
104640|NCT00366340|352660|P1|Infant Series|Failure to return|1
104641|NCT00366340|352659|P2|Infant Series|Lost to Follow-up|1
104642|NCT00366340|352660|P1|Infant Series|Lost to Follow-up|1
104643|NCT00366340|352659|P2|Infant Series|Adverse Event|2
104644|NCT00366340|352660|P1|Infant Series|Adverse Event|0
104645|NCT00366340|352659|P2|Infant Series|Withdrawal by Subject|3
104646|NCT00366340|352660|P1|Infant Series|Withdrawal by Subject|3
104647|NCT00366340|352659|P2|Infant Series|Protocol Violation|4
104648|NCT00366340|352660|P1|Infant Series|Protocol Violation|3
104649|NCT00366444|352716|P2|Overall Study|Lack of Efficacy|1
104650|NCT00366444|352717|P1|Overall Study|Lack of Efficacy|0
104651|NCT00366444|352716|P2|Overall Study|Withdrawal by Subject|1
104652|NCT00366444|352717|P1|Overall Study|Withdrawal by Subject|1
104653|NCT00366457|352743|P1|Overall Study|never began study therapy|2
104654|NCT00366548|352752|P2|After Infant Series|Lost to Follow-up|0
104655|NCT00366548|352753|P1|After Infant Series|Lost to Follow-up|1
104656|NCT00366548|352752|P2|After Infant Series|Adverse Event|0
104657|NCT00366548|352753|P1|After Infant Series|Adverse Event|2
104658|NCT00366548|352752|P2|After Infant Series|Withdrawal by Subject|1
104659|NCT00366548|352753|P1|After Infant Series|Withdrawal by Subject|3
104660|NCT00366548|352752|P2|Infant Series|Withdrawal by Subject|1
104661|NCT00366548|352753|P1|Infant Series|Withdrawal by Subject|3
104662|NCT00366548|352752|P2|Infant Series|Protocol Violation|1
104663|NCT00366548|352753|P1|Infant Series|Protocol Violation|0
104664|NCT00366548|352752|P2|Infant Series|Adverse Event|3
104665|NCT00366548|352753|P1|Infant Series|Adverse Event|1
104666|NCT00366678|352804|P3|Toddler Dose|protocol deviation|0
104667|NCT00366678|352805|P2|Toddler Dose|protocol deviation|0
104668|NCT00366678|352806|P1|Toddler Dose|protocol deviation|1
104669|NCT00366678|352804|P3|Toddler Dose|Withdrawal by Subject|0
104670|NCT00366678|352805|P2|Toddler Dose|Withdrawal by Subject|0
104671|NCT00366678|352806|P1|Toddler Dose|Withdrawal by Subject|1
104672|NCT00366678|352804|P3|Toddler Dose|Failed to return|0
104673|NCT00366678|352805|P2|Toddler Dose|Failed to return|0
104674|NCT00366678|352806|P1|Toddler Dose|Failed to return|1
104675|NCT00366678|352804|P3|Toddler Dose|Protocol Violation|0
104676|NCT00366678|352805|P2|Toddler Dose|Protocol Violation|1
104677|NCT00366678|352806|P1|Toddler Dose|Protocol Violation|2
104678|NCT00366678|352804|P3|After Infant|Protocol Violation|0
104679|NCT00366678|352805|P2|After Infant|Protocol Violation|0
104680|NCT00366678|352806|P1|After Infant|Protocol Violation|1
104681|NCT00366678|352804|P3|After Infant|Adverse Event|0
104682|NCT00366678|352805|P2|After Infant|Adverse Event|0
104683|NCT00366678|352806|P1|After Infant|Adverse Event|1
104684|NCT00366678|352804|P3|After Infant|Failed to return|0
104685|NCT00366678|352805|P2|After Infant|Failed to return|5
104686|NCT00366678|352806|P1|After Infant|Failed to return|5
104687|NCT00366678|352804|P3|After Infant|Lost to Follow-up|0
104688|NCT00366678|352805|P2|After Infant|Lost to Follow-up|1
104689|NCT00366678|352806|P1|After Infant|Lost to Follow-up|2
104690|NCT00366678|352804|P3|After Infant|Withdrawal by Subject|0
104691|NCT00366678|352805|P2|After Infant|Withdrawal by Subject|4
104692|NCT00366678|352806|P1|After Infant|Withdrawal by Subject|8
104693|NCT00366678|352804|P3|Infant Series|Adverse Event|0
104694|NCT00366678|352805|P2|Infant Series|Adverse Event|0
104695|NCT00366678|352806|P1|Infant Series|Adverse Event|1
104696|NCT00366678|352804|P3|Infant Series|Failed to return|0
104697|NCT00366678|352805|P2|Infant Series|Failed to return|1
104698|NCT00366678|352806|P1|Infant Series|Failed to return|1
104699|NCT00366678|352804|P3|Infant Series|Protocol Violation|0
104700|NCT00366678|352805|P2|Infant Series|Protocol Violation|3
104701|NCT00366678|352806|P1|Infant Series|Protocol Violation|4
104702|NCT00366678|352804|P3|Infant Series|Withdrawal by Subject|0
104703|NCT00366678|352805|P2|Infant Series|Withdrawal by Subject|6
104704|NCT00366678|352806|P1|Infant Series|Withdrawal by Subject|8
104705|NCT00366899|352873|P2|Toddler Dose|Protocol Violation|0
104706|NCT00366899|352874|P1|Toddler Dose|Protocol Violation|1
104707|NCT00366899|352873|P2|Toddler Dose|Withdrawal by Subject|1
104708|NCT00366899|352874|P1|Toddler Dose|Withdrawal by Subject|1
104709|NCT00366899|352873|P2|After Infant Series|Protocol Violation|0
104710|NCT00366899|352874|P1|After Infant Series|Protocol Violation|1
104711|NCT00366899|352873|P2|After Infant Series|Adverse Event|2
104712|NCT00366899|352874|P1|After Infant Series|Adverse Event|1
104713|NCT00366899|352873|P2|After Infant Series|Withdrawal by Subject|4
104714|NCT00366899|352874|P1|After Infant Series|Withdrawal by Subject|1
104715|NCT00366899|352873|P2|After Infant Series|Lost to Follow-up|3
104716|NCT00366899|352874|P1|After Infant Series|Lost to Follow-up|4
104717|NCT00366899|352873|P2|Infant Series|Randomized but not consented|0
104718|NCT00366899|352874|P1|Infant Series|Randomized but not consented|1
104719|NCT00366899|352873|P2|Infant Series|Physician Decision|0
104720|NCT00366899|352874|P1|Infant Series|Physician Decision|1
104721|NCT00366899|352873|P2|Infant Series|Adverse Event|1
104722|NCT00366899|352874|P1|Infant Series|Adverse Event|0
104723|NCT00366899|352873|P2|Infant Series|Lost to Follow-up|2
104724|NCT00366899|352874|P1|Infant Series|Lost to Follow-up|0
104725|NCT00366899|352873|P2|Infant Series|Failed to return|1
104726|NCT00366899|352874|P1|Infant Series|Failed to return|1
104727|NCT00366899|352873|P2|Infant Series|Protocol Violation|1
104728|NCT00366899|352874|P1|Infant Series|Protocol Violation|2
104729|NCT00366899|352873|P2|Infant Series|Withdrawal by Subject|7
104730|NCT00366899|352874|P1|Infant Series|Withdrawal by Subject|4
104731|NCT00367055|352934|P2|Overall Study|Participant Living too Far from Hospital|1
104732|NCT00367055|352935|P1|Overall Study|Participant Living too Far from Hospital|0
104733|NCT00367055|352934|P2|Overall Study|Stopping Criterion Met|1
104734|NCT00367055|352935|P1|Overall Study|Stopping Criterion Met|0
104735|NCT00367055|352934|P2|Overall Study|Protocol Violation|1
104736|NCT00367055|352935|P1|Overall Study|Protocol Violation|0
104737|NCT00367055|352934|P2|Overall Study|Lost to Follow-up|1
104738|NCT00367055|352935|P1|Overall Study|Lost to Follow-up|1
104739|NCT00367055|352934|P2|Overall Study|Lack of Efficacy|2
104740|NCT00367055|352935|P1|Overall Study|Lack of Efficacy|1
104741|NCT00367055|352934|P2|Overall Study|Patient's Willing|2
104742|NCT00367055|352935|P1|Overall Study|Patient's Willing|3
104743|NCT00367055|352934|P2|Overall Study|Adverse Event|3
104744|NCT00367055|352935|P1|Overall Study|Adverse Event|6
104745|NCT00367133|352952|P3|2 Years|Missed visit|4
104746|NCT00367133|352953|P2|2 Years|Missed visit|5
104747|NCT00367133|352954|P1|2 Years|Missed visit|4
104748|NCT00367133|352952|P3|2 Years|Dropped|33
104749|NCT00367133|352953|P2|2 Years|Dropped|19
104750|NCT00367133|352954|P1|2 Years|Dropped|34
104751|NCT00367133|352952|P3|2 Years|Death|12
104752|NCT00367133|352953|P2|2 Years|Death|12
104753|NCT00367133|352954|P1|2 Years|Death|20
104754|NCT00367237|353006|P2|Overall Study|Protocol Violation|5
104755|NCT00367237|353007|P1|Overall Study|Protocol Violation|2
104756|NCT00367237|353006|P2|Overall Study|Withdrawal by Subject|4
104757|NCT00367237|353007|P1|Overall Study|Withdrawal by Subject|0
104758|NCT00367237|353006|P2|Overall Study|Lost to Follow-up|0
104759|NCT00367237|353007|P1|Overall Study|Lost to Follow-up|1
104760|NCT00367237|353006|P2|Overall Study|Adverse Event|2
104761|NCT00367237|353007|P1|Overall Study|Adverse Event|7
104762|NCT00367341|353015|P2|Overall Study|Protocol Violation|0
104763|NCT00367341|353016|P1|Overall Study|Protocol Violation|1
104764|NCT00367341|353015|P2|Overall Study|Physician Decision|0
104765|NCT00367341|353016|P1|Overall Study|Physician Decision|1
104766|NCT00367432|353037|P2|Second Period (up to 54 Months)|Other Reason|2
104767|NCT00367432|353038|P1|Second Period (up to 54 Months)|Other Reason|6
104768|NCT00367432|353037|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
104769|NCT00367432|353038|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
104770|NCT00367432|353037|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
104771|NCT00367432|353038|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
104772|NCT00367432|353037|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
104773|NCT00367432|353038|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
104774|NCT00367432|353037|P2|Second Period (up to 54 Months)|Adverse Event|3
104775|NCT00367432|353038|P1|Second Period (up to 54 Months)|Adverse Event|14
104776|NCT00367432|353037|P2|First Period (16 Weeks)|Other Reason|0
104777|NCT00367432|353038|P1|First Period (16 Weeks)|Other Reason|2
104778|NCT00367432|353037|P2|First Period (16 Weeks)|Withdrawal by Subject|0
104779|NCT00367432|353038|P1|First Period (16 Weeks)|Withdrawal by Subject|6
104780|NCT00367432|353037|P2|First Period (16 Weeks)|Lack of Efficacy|0
104781|NCT00367432|353038|P1|First Period (16 Weeks)|Lack of Efficacy|24
104782|NCT00367432|353037|P2|First Period (16 Weeks)|Adverse Event|0
104783|NCT00367432|353038|P1|First Period (16 Weeks)|Adverse Event|6
104784|NCT00367484|353050|P1|Overall Study|Lack of Efficacy|1
104785|NCT00367484|353050|P1|Overall Study|The choice of the patient|1
104786|NCT00367484|353050|P1|Overall Study|Protocol Violation|1
104787|NCT00367484|353050|P1|Overall Study|Lost to Follow-up|1
104788|NCT00367484|353050|P1|Overall Study|Travel to USA|1
104789|NCT00367484|353050|P1|Overall Study|Withdrew informed consent|5
104790|NCT00367484|353050|P1|Overall Study|Adverse Event|7
104791|NCT00367640|353064|P4|Overall Study|Any other reason not above-mentioned|4
104792|NCT00367640|353065|P3|Overall Study|Any other reason not above-mentioned|3
104793|NCT00367640|353066|P2|Overall Study|Any other reason not above-mentioned|5
104794|NCT00367640|353067|P1|Overall Study|Any other reason not above-mentioned|7
104795|NCT00367640|353064|P4|Overall Study|Withdrawal by Subject|6
104796|NCT00367640|353065|P3|Overall Study|Withdrawal by Subject|8
104797|NCT00367640|353066|P2|Overall Study|Withdrawal by Subject|11
104798|NCT00367640|353067|P1|Overall Study|Withdrawal by Subject|8
104799|NCT00367640|353064|P4|Overall Study|Adverse Event|0
104800|NCT00367640|353065|P3|Overall Study|Adverse Event|8
104801|NCT00367640|353066|P2|Overall Study|Adverse Event|6
104802|NCT00367640|353067|P1|Overall Study|Adverse Event|3
104803|NCT00367744|353096|P2|Overall Study|Lost to Follow-up|5
104804|NCT00367744|353097|P1|Overall Study|Lost to Follow-up|4
104805|NCT00367770|353105|P1|Overall Study|Withdrawal by Subject|1
104806|NCT00367770|353105|P1|Overall Study|Adverse Event|1
104807|NCT00367835|353113|P2|Overall Study|History of lead poisoning|1
104808|NCT00367835|353114|P1|Overall Study|History of lead poisoning|0
104809|NCT00367835|353113|P2|Overall Study|Did not respond to calls|0
104810|NCT00367835|353114|P1|Overall Study|Did not respond to calls|1
104811|NCT00367835|353113|P2|Overall Study|refused blood collection|0
104812|NCT00367835|353114|P1|Overall Study|refused blood collection|1
104813|NCT00367835|353113|P2|Overall Study|Subject in juvenile detention center|0
104814|NCT00367835|353114|P1|Overall Study|Subject in juvenile detention center|1
104815|NCT00367835|353113|P2|Overall Study|Lack of Efficacy|12
104816|NCT00367835|353114|P1|Overall Study|Lack of Efficacy|3
104817|NCT00367835|353113|P2|Overall Study|Lost to Follow-up|4
104818|NCT00367835|353114|P1|Overall Study|Lost to Follow-up|1
104819|NCT00367835|353113|P2|Overall Study|Withdrawal by Subject|6
104820|NCT00367835|353114|P1|Overall Study|Withdrawal by Subject|7
104821|NCT00367835|353113|P2|Overall Study|Protocol Violation|7
104822|NCT00367835|353114|P1|Overall Study|Protocol Violation|1
104823|NCT00367835|353113|P2|Overall Study|Adverse Event|1
104824|NCT00367835|353114|P1|Overall Study|Adverse Event|14
104825|NCT00367991|353142|P2|Overall Study|Adverse Event|1
104826|NCT00367991|353143|P1|Overall Study|Adverse Event|1
104827|NCT00367991|353142|P2|Overall Study|Withdrawal by Subject|1
104828|NCT00367991|353143|P1|Overall Study|Withdrawal by Subject|1
104829|NCT00368069|353151|P2|Overall Study|no blood sampling possible|1
104830|NCT00368069|353152|P1|Overall Study|no blood sampling possible|0
104831|NCT00368069|353151|P2|Overall Study|Withdrawal of Consent|1
104832|NCT00368069|353152|P1|Overall Study|Withdrawal of Consent|2
104833|NCT00368069|353151|P2|Overall Study|Protocol Violation|2
104834|NCT00368069|353152|P1|Overall Study|Protocol Violation|0
104835|NCT00368069|353151|P2|Overall Study|Lost to Follow-up|0
104836|NCT00368069|353152|P1|Overall Study|Lost to Follow-up|1
104837|NCT00368069|353151|P2|Overall Study|Lack of Efficacy|1
104838|NCT00368069|353152|P1|Overall Study|Lack of Efficacy|0
104839|NCT00368069|353151|P2|Overall Study|Adverse Event|2
104840|NCT00368069|353152|P1|Overall Study|Adverse Event|5
104841|NCT00368108|353171|P3|Overall Study|Not Specified|1
104842|NCT00368108|353172|P2|Overall Study|Not Specified|7
104843|NCT00368108|353173|P1|Overall Study|Not Specified|3
104844|NCT00368108|353171|P3|Overall Study|Physician Decision|1
104845|NCT00368108|353172|P2|Overall Study|Physician Decision|0
104846|NCT00368108|353173|P1|Overall Study|Physician Decision|2
104847|NCT00368108|353171|P3|Overall Study|Lack of Efficacy|5
104848|NCT00368108|353172|P2|Overall Study|Lack of Efficacy|8
104849|NCT00368108|353173|P1|Overall Study|Lack of Efficacy|7
104850|NCT00368108|353171|P3|Overall Study|Withdrawal by Subject|5
104851|NCT00368108|353172|P2|Overall Study|Withdrawal by Subject|3
104852|NCT00368108|353173|P1|Overall Study|Withdrawal by Subject|9
104853|NCT00368108|353171|P3|Overall Study|Protocol Violation|9
104854|NCT00368108|353172|P2|Overall Study|Protocol Violation|9
104855|NCT00368108|353173|P1|Overall Study|Protocol Violation|5
104856|NCT00368108|353171|P3|Overall Study|Abnormal Laboratory Value|3
104857|NCT00368108|353172|P2|Overall Study|Abnormal Laboratory Value|0
104858|NCT00368108|353173|P1|Overall Study|Abnormal Laboratory Value|0
104859|NCT00368108|353171|P3|Overall Study|Adverse Event|44
104860|NCT00368108|353172|P2|Overall Study|Adverse Event|26
104861|NCT00368108|353173|P1|Overall Study|Adverse Event|38
104862|NCT00360269|353297|P2|Overall Study|Withdrawal by Subject|1
104863|NCT00360269|353298|P1|Overall Study|Withdrawal by Subject|1
104864|NCT00360269|353297|P2|Overall Study|Adverse Event|0
104865|NCT00360269|353298|P1|Overall Study|Adverse Event|1
104866|NCT00360269|353297|P2|Overall Study|Physician Decision|2
104867|NCT00360269|353298|P1|Overall Study|Physician Decision|1
104868|NCT00360269|353297|P2|Overall Study|Lost to Follow-up|9
104869|NCT00360269|353298|P1|Overall Study|Lost to Follow-up|7
104870|NCT00360282|353312|P4|Second Intervention|Adverse Event|0
104871|NCT00360282|353313|P3|Second Intervention|Adverse Event|0
104872|NCT00360282|353314|P2|Second Intervention|Adverse Event|1
104873|NCT00360282|353315|P1|Second Intervention|Adverse Event|0
104874|NCT00360282|353312|P4|Washout 1-3 Weeks|Lost to Follow-up|0
104875|NCT00360282|353313|P3|Washout 1-3 Weeks|Lost to Follow-up|1
104876|NCT00360282|353314|P2|Washout 1-3 Weeks|Lost to Follow-up|0
104877|NCT00360282|353315|P1|Washout 1-3 Weeks|Lost to Follow-up|0
104878|NCT00360308|353328|P3|Overall Study|Study termination by sponsor|44
104879|NCT00360308|353329|P2|Overall Study|Study termination by sponsor|55
104880|NCT00360308|353330|P1|Overall Study|Study termination by sponsor|43
104881|NCT00360308|353328|P3|Overall Study|Not Specified|1
104882|NCT00360308|353329|P2|Overall Study|Not Specified|1
104883|NCT00360308|353330|P1|Overall Study|Not Specified|2
104884|NCT00360308|353328|P3|Overall Study|Lack of Efficacy|2
104885|NCT00360308|353329|P2|Overall Study|Lack of Efficacy|0
104886|NCT00360308|353330|P1|Overall Study|Lack of Efficacy|3
104887|NCT00360308|353328|P3|Overall Study|Withdrawal by Subject|14
104888|NCT00360308|353329|P2|Overall Study|Withdrawal by Subject|7
104889|NCT00360308|353330|P1|Overall Study|Withdrawal by Subject|11
104890|NCT00360308|353328|P3|Overall Study|Protocol Violation|2
104891|NCT00360308|353329|P2|Overall Study|Protocol Violation|1
104892|NCT00360308|353330|P1|Overall Study|Protocol Violation|2
104893|NCT00360308|353328|P3|Overall Study|Abnormal Laboratory Value(s)|0
104894|NCT00360308|353329|P2|Overall Study|Abnormal Laboratory Value(s)|1
104895|NCT00360308|353330|P1|Overall Study|Abnormal Laboratory Value(s)|0
104896|NCT00360308|353328|P3|Overall Study|Adverse Event|25
104897|NCT00360308|353329|P2|Overall Study|Adverse Event|14
104898|NCT00360308|353330|P1|Overall Study|Adverse Event|15
104899|NCT00360334|353349|P2|Overall Study|Subject decision|2
104900|NCT00360334|353350|P1|Overall Study|Subject decision|8
104901|NCT00360334|353349|P2|Overall Study|Entry criterion not met|2
104902|NCT00360334|353350|P1|Overall Study|Entry criterion not met|1
104903|NCT00360334|353349|P2|Overall Study|Lack of Efficacy|1
104904|NCT00360334|353350|P1|Overall Study|Lack of Efficacy|0
104905|NCT00360334|353349|P2|Overall Study|Physician Decision|3
104906|NCT00360334|353350|P1|Overall Study|Physician Decision|2
104907|NCT00360334|353349|P2|Overall Study|Protocol Violation|1
104908|NCT00360334|353350|P1|Overall Study|Protocol Violation|1
104909|NCT00360334|353349|P2|Overall Study|Adverse Event|4
104910|NCT00360334|353350|P1|Overall Study|Adverse Event|7
104911|NCT00360412|353445|P2|Overall Study|Study termination by Sponsor|469
104912|NCT00360412|353446|P1|Overall Study|Study termination by Sponsor|214
104913|NCT00360412|353445|P2|Overall Study|Not specified|6
104914|NCT00360412|353446|P1|Overall Study|Not specified|5
104915|NCT00360412|353445|P2|Overall Study|Physician Decision|4
104916|NCT00360412|353446|P1|Overall Study|Physician Decision|2
104917|NCT00360412|353445|P2|Overall Study|Lack of therapeutic efficacy|61
104918|NCT00360412|353446|P1|Overall Study|Lack of therapeutic efficacy|46
104919|NCT00360412|353445|P2|Overall Study|Patient withdrew consent|52
104920|NCT00360412|353446|P1|Overall Study|Patient withdrew consent|27
104921|NCT00360412|353445|P2|Overall Study|Protocol Violation|5
104922|NCT00360412|353446|P1|Overall Study|Protocol Violation|2
104923|NCT00360412|353445|P2|Overall Study|Adverse Event|65
104924|NCT00360412|353446|P1|Overall Study|Adverse Event|37
104925|NCT00360490|353460|P2|Overall Study|Withdrawal by Subject|3
104926|NCT00360490|353461|P1|Overall Study|Withdrawal by Subject|1
104927|NCT00360490|353460|P2|Overall Study|Protocol Violation|4
104928|NCT00360490|353461|P1|Overall Study|Protocol Violation|0
104929|NCT00360490|353460|P2|Overall Study|Physician Decision|1
104930|NCT00360490|353461|P1|Overall Study|Physician Decision|2
104931|NCT00360490|353460|P2|Overall Study|Lost to Follow-up|1
104932|NCT00360490|353461|P1|Overall Study|Lost to Follow-up|2
104933|NCT00360490|353460|P2|Overall Study|Adverse Event|2
104934|NCT00360490|353461|P1|Overall Study|Adverse Event|4
104935|NCT00360529|353497|P3|Overall Study|Reason discontinued not explained above|11
104936|NCT00360529|353498|P2|Overall Study|Reason discontinued not explained above|9
104937|NCT00360529|353499|P1|Overall Study|Reason discontinued not explained above|4
104938|NCT00360529|353497|P3|Overall Study|Lack of Efficacy|5
104939|NCT00360529|353498|P2|Overall Study|Lack of Efficacy|6
104940|NCT00360529|353499|P1|Overall Study|Lack of Efficacy|8
104941|NCT00360529|353497|P3|Overall Study|Withdrawal by Subject|18
104942|NCT00360529|353498|P2|Overall Study|Withdrawal by Subject|14
104943|NCT00360529|353499|P1|Overall Study|Withdrawal by Subject|22
104944|NCT00360529|353497|P3|Overall Study|Lost to Follow-up|13
104945|NCT00360529|353498|P2|Overall Study|Lost to Follow-up|10
104946|NCT00360529|353499|P1|Overall Study|Lost to Follow-up|14
104947|NCT00360529|353497|P3|Overall Study|Protocol Violation|11
104948|NCT00360529|353498|P2|Overall Study|Protocol Violation|3
104949|NCT00360529|353499|P1|Overall Study|Protocol Violation|3
104950|NCT00360529|353497|P3|Overall Study|Adverse Event|33
104951|NCT00360529|353498|P2|Overall Study|Adverse Event|23
104952|NCT00360529|353499|P1|Overall Study|Adverse Event|10
104953|NCT00360568|353548|P2|Overall Study|Withdrawal by Subject|3
104954|NCT00360568|353549|P1|Overall Study|Withdrawal by Subject|0
104955|NCT00360568|353548|P2|Overall Study|Lack of Efficacy|0
104956|NCT00360568|353549|P1|Overall Study|Lack of Efficacy|1
104957|NCT00360568|353548|P2|Overall Study|Adverse Event|2
104958|NCT00360568|353549|P1|Overall Study|Adverse Event|1
104959|NCT00360698|353675|P2|Treatment Period|Early termination by error|1
104960|NCT00360698|353676|P1|Treatment Period|Early termination by error|0
104961|NCT00360698|353675|P2|Treatment Period|Non compliance with treatment procedure|0
104962|NCT00360698|353676|P1|Treatment Period|Non compliance with treatment procedure|1
104963|NCT00360698|353675|P2|Run-In|Need of insulin with meals|1
104964|NCT00360698|353676|P1|Run-In|Need of insulin with meals|0
104965|NCT00360698|353675|P2|Run-In|Patient personal reasons|2
104966|NCT00360698|353676|P1|Run-In|Patient personal reasons|0
104967|NCT00360698|353675|P2|Run-In|Patient did not meet inclusion criteria|1
104968|NCT00360698|353676|P1|Run-In|Patient did not meet inclusion criteria|0
104969|NCT00360698|353675|P2|Run-In|Sponsor request|2
104970|NCT00360698|353676|P1|Run-In|Sponsor request|0
104971|NCT00360698|353675|P2|Run-In|Non compliance with treatment procedure|1
104972|NCT00360698|353676|P1|Run-In|Non compliance with treatment procedure|0
104973|NCT00360698|353675|P2|Run-In|Withdrawal by Subject|2
104974|NCT00360698|353676|P1|Run-In|Withdrawal by Subject|0
104975|NCT00360698|353675|P2|Run-In|Physician Decision|1
104976|NCT00360698|353676|P1|Run-In|Physician Decision|0
104977|NCT00361218|353764|P1|Overall Study|terminated / withdrawn due to toxicity /|5
104978|NCT00361218|353764|P1|Overall Study|Personal Reasons|7
104979|NCT00361218|353764|P1|Overall Study|Lost to Follow-up|11
104980|NCT00361231|353768|P1|Overall Study|Adverse Event|6
104981|NCT00361231|353768|P1|Overall Study|Withdrawal by Subject|4
104982|NCT00361231|353768|P1|Overall Study|Radiographic disease progression|16
104983|NCT00361231|353768|P1|Overall Study|Symptomatic deterioration|5
104984|NCT00361231|353768|P1|Overall Study|Physician Decision|3
104985|NCT00361270|353832|P4|Overall Study|Adverse Event|0
104986|NCT00361270|353833|P3|Overall Study|Adverse Event|1
104987|NCT00361270|353834|P2|Overall Study|Adverse Event|1
104988|NCT00361270|353835|P1|Overall Study|Adverse Event|0
104989|NCT00361270|353832|P4|Overall Study|Problems with Transportation|0
104990|NCT00361270|353833|P3|Overall Study|Problems with Transportation|0
104991|NCT00361270|353834|P2|Overall Study|Problems with Transportation|0
104992|NCT00361270|353835|P1|Overall Study|Problems with Transportation|4
104993|NCT00361270|353832|P4|Overall Study|Afraid of Hypnosis|0
104994|NCT00361270|353833|P3|Overall Study|Afraid of Hypnosis|0
104995|NCT00361270|353834|P2|Overall Study|Afraid of Hypnosis|2
104996|NCT00361270|353835|P1|Overall Study|Afraid of Hypnosis|1
104997|NCT00361270|353832|P4|Overall Study|Withdrawal by Subject|7
104998|NCT00361270|353833|P3|Overall Study|Withdrawal by Subject|3
104999|NCT00361270|353834|P2|Overall Study|Withdrawal by Subject|6
105000|NCT00361270|353835|P1|Overall Study|Withdrawal by Subject|6
105001|NCT00361270|353832|P4|Overall Study|Protocol Violation|4
105002|NCT00361270|353833|P3|Overall Study|Protocol Violation|5
105003|NCT00361270|353834|P2|Overall Study|Protocol Violation|4
105004|NCT00361270|353835|P1|Overall Study|Protocol Violation|9
105005|NCT00361270|353832|P4|Overall Study|Physician Decision|0
105006|NCT00361270|353833|P3|Overall Study|Physician Decision|1
105007|NCT00361270|353834|P2|Overall Study|Physician Decision|0
105008|NCT00361270|353835|P1|Overall Study|Physician Decision|0
105009|NCT00361270|353832|P4|Overall Study|Lost to Follow-up|0
105010|NCT00361270|353833|P3|Overall Study|Lost to Follow-up|0
105011|NCT00361270|353834|P2|Overall Study|Lost to Follow-up|1
105012|NCT00361270|353835|P1|Overall Study|Lost to Follow-up|4
105013|NCT00361270|353832|P4|Overall Study|Death|2
105014|NCT00361270|353833|P3|Overall Study|Death|0
105015|NCT00361270|353834|P2|Overall Study|Death|0
105016|NCT00361270|353835|P1|Overall Study|Death|0
105017|NCT00361283|353853|P1|Overall Study|Lost to Follow-up|27
105018|NCT00361335|353862|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
105019|NCT00361335|353863|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
105020|NCT00361335|353864|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
105021|NCT00361335|353865|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
105022|NCT00361335|353866|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
105023|NCT00361335|353867|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
105024|NCT00361335|353868|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
105025|NCT00361335|353862|P7|SC Period: Week E0 to Week E24|Not specified|2
105026|NCT00361335|353863|P6|SC Period: Week E0 to Week E24|Not specified|1
105027|NCT00361335|353864|P5|SC Period: Week E0 to Week E24|Not specified|0
105028|NCT00361335|353865|P4|SC Period: Week E0 to Week E24|Not specified|1
105029|NCT00361335|353866|P3|SC Period: Week E0 to Week E24|Not specified|0
105030|NCT00361335|353867|P2|SC Period: Week E0 to Week E24|Not specified|0
105031|NCT00361335|353868|P1|SC Period: Week E0 to Week E24|Not specified|1
105032|NCT00361335|353862|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
105033|NCT00361335|353863|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
105034|NCT00361335|353864|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
105035|NCT00361335|353865|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
105036|NCT00361335|353866|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
105037|NCT00361335|353867|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
105038|NCT00361335|353868|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
105039|NCT00361335|353862|P7|SC Period: Week E0 to Week E24|Death|1
105040|NCT00361335|353863|P6|SC Period: Week E0 to Week E24|Death|0
105041|NCT00361335|353864|P5|SC Period: Week E0 to Week E24|Death|0
105042|NCT00361335|353865|P4|SC Period: Week E0 to Week E24|Death|0
105043|NCT00361335|353866|P3|SC Period: Week E0 to Week E24|Death|0
105044|NCT00361335|353867|P2|SC Period: Week E0 to Week E24|Death|0
105045|NCT00361335|353868|P1|SC Period: Week E0 to Week E24|Death|0
105046|NCT00361335|353862|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
105047|NCT00361335|353863|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
105048|NCT00361335|353864|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
105049|NCT00361335|353865|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
105050|NCT00361335|353866|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
105051|NCT00361335|353867|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
105052|NCT00361335|353868|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
105053|NCT00361335|353862|P7|SC Period: Week E0 to Week E24|Adverse Event|2
105054|NCT00361335|353863|P6|SC Period: Week E0 to Week E24|Adverse Event|0
105055|NCT00361335|353864|P5|SC Period: Week E0 to Week E24|Adverse Event|0
105056|NCT00361335|353865|P4|SC Period: Week E0 to Week E24|Adverse Event|2
105057|NCT00361335|353866|P3|SC Period: Week E0 to Week E24|Adverse Event|1
105058|NCT00361335|353867|P2|SC Period: Week E0 to Week E24|Adverse Event|2
105059|NCT00361335|353868|P1|SC Period: Week E0 to Week E24|Adverse Event|0
105060|NCT00361335|353862|P7|IV Period: Baseline to E0|Lack of Efficacy|0
105061|NCT00361335|353863|P6|IV Period: Baseline to E0|Lack of Efficacy|0
105062|NCT00361335|353864|P5|IV Period: Baseline to E0|Lack of Efficacy|8
105063|NCT00361335|353865|P4|IV Period: Baseline to E0|Lack of Efficacy|7
105064|NCT00361335|353866|P3|IV Period: Baseline to E0|Lack of Efficacy|3
105065|NCT00361335|353867|P2|IV Period: Baseline to E0|Lack of Efficacy|9
105066|NCT00361335|353868|P1|IV Period: Baseline to E0|Lack of Efficacy|5
105067|NCT00361335|353862|P7|IV Period: Baseline to E0|Not specified|0
105068|NCT00361335|353863|P6|IV Period: Baseline to E0|Not specified|0
105069|NCT00361335|353864|P5|IV Period: Baseline to E0|Not specified|2
105070|NCT00361335|353865|P4|IV Period: Baseline to E0|Not specified|3
105071|NCT00361335|353866|P3|IV Period: Baseline to E0|Not specified|9
105072|NCT00361335|353867|P2|IV Period: Baseline to E0|Not specified|9
105073|NCT00361335|353868|P1|IV Period: Baseline to E0|Not specified|2
105074|NCT00361335|353862|P7|IV Period: Baseline to E0|Worsening of RA|0
105075|NCT00361335|353863|P6|IV Period: Baseline to E0|Worsening of RA|0
105076|NCT00361335|353864|P5|IV Period: Baseline to E0|Worsening of RA|2
105077|NCT00361335|353865|P4|IV Period: Baseline to E0|Worsening of RA|4
105078|NCT00361335|353866|P3|IV Period: Baseline to E0|Worsening of RA|1
105079|NCT00361335|353867|P2|IV Period: Baseline to E0|Worsening of RA|5
105080|NCT00361335|353868|P1|IV Period: Baseline to E0|Worsening of RA|0
105081|NCT00361335|353862|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
105082|NCT00361335|353863|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
105083|NCT00361335|353864|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
105084|NCT00361335|353865|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
105085|NCT00361335|353866|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
105086|NCT00361335|353867|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
105087|NCT00361335|353868|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
105088|NCT00361335|353862|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
105089|NCT00361335|353863|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
105090|NCT00361335|353864|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
105091|NCT00361335|353865|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
105092|NCT00361335|353866|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
105093|NCT00361335|353867|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
105094|NCT00361335|353868|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
105095|NCT00361335|353862|P7|IV Period: Baseline to E0|Death|0
105096|NCT00361335|353863|P6|IV Period: Baseline to E0|Death|0
105097|NCT00361335|353864|P5|IV Period: Baseline to E0|Death|0
105098|NCT00361335|353865|P4|IV Period: Baseline to E0|Death|1
105099|NCT00361335|353866|P3|IV Period: Baseline to E0|Death|1
105100|NCT00361335|353867|P2|IV Period: Baseline to E0|Death|1
105101|NCT00361335|353868|P1|IV Period: Baseline to E0|Death|1
105102|NCT00361335|353862|P7|IV Period: Baseline to E0|Lost to Follow-up|0
105103|NCT00361335|353863|P6|IV Period: Baseline to E0|Lost to Follow-up|0
105104|NCT00361335|353864|P5|IV Period: Baseline to E0|Lost to Follow-up|2
105105|NCT00361335|353865|P4|IV Period: Baseline to E0|Lost to Follow-up|2
105106|NCT00361335|353866|P3|IV Period: Baseline to E0|Lost to Follow-up|0
105107|NCT00361335|353867|P2|IV Period: Baseline to E0|Lost to Follow-up|0
105108|NCT00361335|353868|P1|IV Period: Baseline to E0|Lost to Follow-up|1
105109|NCT00361335|353862|P7|IV Period: Baseline to E0|Adverse Event|0
105110|NCT00361335|353863|P6|IV Period: Baseline to E0|Adverse Event|0
105111|NCT00361335|353864|P5|IV Period: Baseline to E0|Adverse Event|8
105112|NCT00361335|353865|P4|IV Period: Baseline to E0|Adverse Event|9
105113|NCT00361335|353866|P3|IV Period: Baseline to E0|Adverse Event|5
105114|NCT00361335|353867|P2|IV Period: Baseline to E0|Adverse Event|4
105115|NCT00361335|353868|P1|IV Period: Baseline to E0|Adverse Event|9
105116|NCT00361504|353942|P2|Overall Study|All other|3
105117|NCT00361504|353943|P1|Overall Study|All other|28
105118|NCT00361504|353942|P2|Overall Study|Study medication non compliant|15
105119|NCT00361504|353943|P1|Overall Study|Study medication non compliant|42
105120|NCT00361504|353942|P2|Overall Study|Resolution of Pain|0
105121|NCT00361504|353943|P1|Overall Study|Resolution of Pain|2
105122|NCT00361504|353942|P2|Overall Study|Lack of Efficacy|7
105123|NCT00361504|353943|P1|Overall Study|Lack of Efficacy|72
105124|NCT00361504|353942|P2|Overall Study|Adverse Event|82
105125|NCT00361504|353943|P1|Overall Study|Adverse Event|203
105126|NCT00361504|353942|P2|Overall Study|Lost to Follow-up|7
105127|NCT00361504|353943|P1|Overall Study|Lost to Follow-up|40
105128|NCT00361504|353942|P2|Overall Study|Withdrawal by Subject|31
105129|NCT00361504|353943|P1|Overall Study|Withdrawal by Subject|94
105130|NCT00361569|353955|P4|Overall Study|Not specified by investigator|1
105131|NCT00361569|353956|P3|Overall Study|Not specified by investigator|0
105132|NCT00361569|353957|P2|Overall Study|Not specified by investigator|0
105133|NCT00361569|353958|P1|Overall Study|Not specified by investigator|2
105134|NCT00361569|353955|P4|Overall Study|Lost to Follow-up|2
105135|NCT00361569|353956|P3|Overall Study|Lost to Follow-up|3
105136|NCT00361569|353957|P2|Overall Study|Lost to Follow-up|3
105137|NCT00361569|353958|P1|Overall Study|Lost to Follow-up|2
105138|NCT00361569|353955|P4|Overall Study|Adverse Event|2
105139|NCT00361569|353956|P3|Overall Study|Adverse Event|2
105140|NCT00361569|353957|P2|Overall Study|Adverse Event|5
105141|NCT00361569|353958|P1|Overall Study|Adverse Event|3
105142|NCT00361569|353955|P4|Overall Study|Withdrawal by Subject|14
105143|NCT00361569|353956|P3|Overall Study|Withdrawal by Subject|9
105144|NCT00361569|353957|P2|Overall Study|Withdrawal by Subject|1
105145|NCT00361569|353958|P1|Overall Study|Withdrawal by Subject|2
105146|NCT00361569|353955|P4|Overall Study|Protocol Violation|2
105147|NCT00361569|353956|P3|Overall Study|Protocol Violation|4
105148|NCT00361569|353957|P2|Overall Study|Protocol Violation|2
105149|NCT00361569|353958|P1|Overall Study|Protocol Violation|3
105150|NCT00361634|353987|P1|Overall Study|Withdrawal by Subject|1
105151|NCT00361634|353987|P1|Overall Study|Lost to Follow-up|1
105152|NCT00368251|354008|P3|Overall Study|AE, non-serious non-fatal|1
105153|NCT00368251|354009|P2|Overall Study|AE, non-serious non-fatal|0
105154|NCT00368251|354010|P1|Overall Study|AE, non-serious non-fatal|0
105155|NCT00368251|354008|P3|Overall Study|SAE, non-fatal|0
105156|NCT00368251|354009|P2|Overall Study|SAE, non-fatal|0
105157|NCT00368251|354010|P1|Overall Study|SAE, non-fatal|1
105158|NCT00368277|354032|P2|Overall Study|Lost to Follow-up|6
105159|NCT00368277|354033|P1|Overall Study|Lost to Follow-up|8
105160|NCT00368277|354032|P2|Overall Study|Patient withdrew consent|28
105161|NCT00368277|354033|P1|Overall Study|Patient withdrew consent|32
105162|NCT00368277|354032|P2|Overall Study|Protocol deviation|0
105163|NCT00368277|354033|P1|Overall Study|Protocol deviation|7
105164|NCT00368277|354032|P2|Overall Study|Unsatisfactory therapeutic effect|24
105165|NCT00368277|354033|P1|Overall Study|Unsatisfactory therapeutic effect|31
105166|NCT00368277|354032|P2|Overall Study|Death|1
105167|NCT00368277|354033|P1|Overall Study|Death|2
105168|NCT00368277|354032|P2|Overall Study|Adverse Event|49
105169|NCT00368277|354033|P1|Overall Study|Adverse Event|33
105170|NCT00369681|354069|P1|Overall Study|Inevaluable|1
105171|NCT00369785|354090|P2|Overall Study|Multiple reasons|5
105172|NCT00369785|354091|P1|Overall Study|Multiple reasons|6
105173|NCT00369785|354090|P2|Overall Study|Progression|4
105174|NCT00369785|354091|P1|Overall Study|Progression|4
105175|NCT00369785|354090|P2|Overall Study|Never started|2
105176|NCT00369785|354091|P1|Overall Study|Never started|0
105177|NCT00369785|354090|P2|Overall Study|Toxicity|4
105178|NCT00369785|354091|P1|Overall Study|Toxicity|6
105179|NCT00369785|354090|P2|Overall Study|Withdrawal by Subject|6
105180|NCT00369785|354091|P1|Overall Study|Withdrawal by Subject|7
105181|NCT00369785|354090|P2|Overall Study|Death|2
105182|NCT00369785|354091|P1|Overall Study|Death|1
105183|NCT00369785|354090|P2|Overall Study|Physician Decision|2
105184|NCT00369785|354091|P1|Overall Study|Physician Decision|3
105185|NCT00369824|354105|P6|Overall Study|Other|3
105186|NCT00369824|354106|P5|Overall Study|Other|1
105187|NCT00369824|354107|P4|Overall Study|Other|2
105188|NCT00369824|354108|P3|Overall Study|Other|0
105189|NCT00369824|354109|P2|Overall Study|Other|0
105190|NCT00369824|354110|P1|Overall Study|Other|0
105191|NCT00369824|354105|P6|Overall Study|Lost to Follow-up|6
105192|NCT00369824|354106|P5|Overall Study|Lost to Follow-up|9
105193|NCT00369824|354107|P4|Overall Study|Lost to Follow-up|8
105194|NCT00369824|354108|P3|Overall Study|Lost to Follow-up|7
105195|NCT00369824|354109|P2|Overall Study|Lost to Follow-up|11
105196|NCT00369824|354110|P1|Overall Study|Lost to Follow-up|6
105197|NCT00369824|354105|P6|Overall Study|Withdrawal by Subject|2
105198|NCT00369824|354106|P5|Overall Study|Withdrawal by Subject|6
105199|NCT00369824|354107|P4|Overall Study|Withdrawal by Subject|4
105200|NCT00369824|354108|P3|Overall Study|Withdrawal by Subject|5
105201|NCT00369824|354109|P2|Overall Study|Withdrawal by Subject|5
105202|NCT00369824|354110|P1|Overall Study|Withdrawal by Subject|9
105203|NCT00369824|354105|P6|Overall Study|Protocol Violation|0
105204|NCT00369824|354106|P5|Overall Study|Protocol Violation|1
105205|NCT00369824|354107|P4|Overall Study|Protocol Violation|1
105206|NCT00369824|354108|P3|Overall Study|Protocol Violation|0
105207|NCT00369824|354109|P2|Overall Study|Protocol Violation|1
105208|NCT00369824|354110|P1|Overall Study|Protocol Violation|0
105209|NCT00369824|354105|P6|Overall Study|Adverse Event|0
105210|NCT00369824|354106|P5|Overall Study|Adverse Event|1
105211|NCT00369824|354107|P4|Overall Study|Adverse Event|0
105212|NCT00369824|354108|P3|Overall Study|Adverse Event|0
105213|NCT00369824|354109|P2|Overall Study|Adverse Event|2
105214|NCT00369824|354110|P1|Overall Study|Adverse Event|0
105215|NCT00369915|354210|P2|Overall Study|W/drawl by investigators|1
105216|NCT00369915|354211|P1|Overall Study|W/drawl by investigators|0
105217|NCT00369915|354210|P2|Overall Study|Withdrawal by Subject|1
105218|NCT00369915|354211|P1|Overall Study|Withdrawal by Subject|4
105219|NCT00369915|354210|P2|Overall Study|expected side effects|1
105220|NCT00369915|354211|P1|Overall Study|expected side effects|2
105221|NCT00369941|354234|P2|Overall Study|Miscellaneous|3
105222|NCT00369941|354235|P1|Overall Study|Miscellaneous|3
105223|NCT00369941|354234|P2|Overall Study|Study Site Terminated|0
105224|NCT00369941|354235|P1|Overall Study|Study Site Terminated|2
105225|NCT00369941|354234|P2|Overall Study|Employment Interfered with Study Visits|0
105226|NCT00369941|354235|P1|Overall Study|Employment Interfered with Study Visits|1
105227|NCT00369941|354234|P2|Overall Study|Treatment with Prohibited Medication|1
105228|NCT00369941|354235|P1|Overall Study|Treatment with Prohibited Medication|3
105229|NCT00369941|354234|P2|Overall Study|Moved|5
105230|NCT00369941|354235|P1|Overall Study|Moved|11
105231|NCT00369941|354234|P2|Overall Study|Completed, Did Not Enter Extension|6
105232|NCT00369941|354235|P1|Overall Study|Completed, Did Not Enter Extension|5
105233|NCT00369941|354234|P2|Overall Study|Pregnancy|2
105234|NCT00369941|354235|P1|Overall Study|Pregnancy|4
105235|NCT00369941|354234|P2|Overall Study|Withdrawal by Subject|18
105236|NCT00369941|354235|P1|Overall Study|Withdrawal by Subject|5
105237|NCT00369941|354234|P2|Overall Study|Protocol Violation|3
105238|NCT00369941|354235|P1|Overall Study|Protocol Violation|5
105239|NCT00369941|354234|P2|Overall Study|Lost to Follow-up|22
105240|NCT00369941|354235|P1|Overall Study|Lost to Follow-up|12
105241|NCT00369941|354234|P2|Overall Study|Lack of Efficacy|10
105242|NCT00369941|354235|P1|Overall Study|Lack of Efficacy|6
105243|NCT00369941|354234|P2|Overall Study|Adverse Event|28
105244|NCT00369941|354235|P1|Overall Study|Adverse Event|14
105245|NCT00369941|354234|P2|Overall Study|Never Treated|2
105246|NCT00369941|354235|P1|Overall Study|Never Treated|1
105247|NCT00369967|354387|P2|Overall Study|Lost to Follow-up|12
105248|NCT00369967|354388|P1|Overall Study|Lost to Follow-up|23
105249|NCT00370032|354406|P2|Follow-up Period|Withdrawal by Subject|0
105250|NCT00370032|354407|P1|Follow-up Period|Withdrawal by Subject|1
105251|NCT00370032|354406|P2|Washout Period|Adverse Event|0
105252|NCT00370032|354407|P1|Washout Period|Adverse Event|1
105253|NCT00370032|354406|P2|Washout Period|Lost to Follow-up|1
105254|NCT00370032|354407|P1|Washout Period|Lost to Follow-up|0
105255|NCT00370032|354406|P2|Washout Period|Withdrawal by Subject|1
105256|NCT00370032|354407|P1|Washout Period|Withdrawal by Subject|0
105257|NCT00370032|354406|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
105258|NCT00370032|354407|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
105259|NCT00370071|354425|P1|Overall Study|Withdrawal by Subject|2
105260|NCT00370149|354442|P2|Overall Study|Antibiotic coated dressing placed|1
105261|NCT00370149|354443|P1|Overall Study|Antibiotic coated dressing placed|0
105262|NCT00370149|354442|P2|Overall Study|Pre-existing infection|1
105263|NCT00370149|354443|P1|Overall Study|Pre-existing infection|0
105264|NCT00370149|354442|P2|Overall Study|Catheter inserted in wrong vessel-|1
105265|NCT00370149|354443|P1|Overall Study|Catheter inserted in wrong vessel-|2
105266|NCT00370149|354442|P2|Overall Study|Protocol Violation|0
105267|NCT00370149|354443|P1|Overall Study|Protocol Violation|1
105268|NCT00370149|354442|P2|Overall Study|Physician Decision|16
105269|NCT00370149|354443|P1|Overall Study|Physician Decision|16
105270|NCT00370292|354455|P1|Overall Study|Physician Decision|2
105271|NCT00370292|354455|P1|Overall Study|Adverse Event|7
105272|NCT00370292|354455|P1|Overall Study|Disease Progression|4
105273|NCT00370331|354468|P2|Overall Study|Protocol Violation|1
105274|NCT00370331|354469|P1|Overall Study|Protocol Violation|1
105275|NCT00370331|354468|P2|Overall Study|Non-compliance|1
105276|NCT00370331|354469|P1|Overall Study|Non-compliance|0
105277|NCT00370331|354468|P2|Overall Study|Lack of Efficacy|1
105278|NCT00370331|354469|P1|Overall Study|Lack of Efficacy|0
105279|NCT00370331|354468|P2|Overall Study|Lost to Follow-up|3
105280|NCT00370331|354469|P1|Overall Study|Lost to Follow-up|0
105281|NCT00370331|354468|P2|Overall Study|Withdrawal by Subject|4
105282|NCT00370331|354469|P1|Overall Study|Withdrawal by Subject|2
105283|NCT00370331|354468|P2|Overall Study|Adverse Event|13
105284|NCT00370331|354469|P1|Overall Study|Adverse Event|4
105285|NCT00370552|354496|P3|Overall Study|Planned radiation for palliation|0
105286|NCT00370552|354497|P2|Overall Study|Planned radiation for palliation|1
105287|NCT00370552|354498|P1|Overall Study|Planned radiation for palliation|0
105288|NCT00370552|354496|P3|Overall Study|High risk of allergic reaction|0
105289|NCT00370552|354497|P2|Overall Study|High risk of allergic reaction|1
105290|NCT00370552|354498|P1|Overall Study|High risk of allergic reaction|0
105291|NCT00370552|354496|P3|Overall Study|Investigator decision|0
105292|NCT00370552|354497|P2|Overall Study|Investigator decision|1
105293|NCT00370552|354498|P1|Overall Study|Investigator decision|2
105294|NCT00370552|354496|P3|Overall Study|Physician Decision|0
105295|NCT00370552|354497|P2|Overall Study|Physician Decision|1
105296|NCT00370552|354498|P1|Overall Study|Physician Decision|1
105297|NCT00370552|354496|P3|Overall Study|Never treated|0
105298|NCT00370552|354497|P2|Overall Study|Never treated|0
105299|NCT00370552|354498|P1|Overall Study|Never treated|1
105300|NCT00370552|354496|P3|Overall Study|Still on treatment|2
105301|NCT00370552|354497|P2|Overall Study|Still on treatment|3
105302|NCT00370552|354498|P1|Overall Study|Still on treatment|1
105303|NCT00370552|354496|P3|Overall Study|Withdrawal by Subject|1
105304|NCT00370552|354497|P2|Overall Study|Withdrawal by Subject|0
105305|NCT00370552|354498|P1|Overall Study|Withdrawal by Subject|2
105306|NCT00370552|354496|P3|Overall Study|Study drug toxicity|6
105307|NCT00370552|354497|P2|Overall Study|Study drug toxicity|8
105308|NCT00370552|354498|P1|Overall Study|Study drug toxicity|11
105309|NCT00370552|354496|P3|Overall Study|Poor or noncompliance|1
105310|NCT00370552|354497|P2|Overall Study|Poor or noncompliance|0
105311|NCT00370552|354498|P1|Overall Study|Poor or noncompliance|0
105312|NCT00370552|354496|P3|Overall Study|Maximum clinical benefit|5
105313|NCT00370552|354497|P2|Overall Study|Maximum clinical benefit|5
105314|NCT00370552|354498|P1|Overall Study|Maximum clinical benefit|3
105315|NCT00370552|354496|P3|Overall Study|Disease progression|15
105316|NCT00370552|354497|P2|Overall Study|Disease progression|23
105317|NCT00370552|354498|P1|Overall Study|Disease progression|23
105318|NCT00370552|354496|P3|Overall Study|Adverse Event|2
105319|NCT00370552|354497|P2|Overall Study|Adverse Event|2
105320|NCT00370552|354498|P1|Overall Study|Adverse Event|2
105321|NCT00370682|354539|P3|Overall Study|Lost to Follow-up|1
105322|NCT00370682|354540|P2|Overall Study|Lost to Follow-up|1
105323|NCT00370682|354541|P1|Overall Study|Lost to Follow-up|0
105324|NCT00370682|354539|P3|Overall Study|Moved from area|0
105325|NCT00370682|354540|P2|Overall Study|Moved from area|2
105326|NCT00370682|354541|P1|Overall Study|Moved from area|0
105327|NCT00371137|354615|P3|Overall Study|Protocol Violation|1
105328|NCT00371137|354616|P2|Overall Study|Protocol Violation|1
105329|NCT00371137|354617|P1|Overall Study|Protocol Violation|2
105330|NCT00371137|354615|P3|Overall Study|Physician Decision|1
105331|NCT00371137|354616|P2|Overall Study|Physician Decision|1
105332|NCT00371137|354617|P1|Overall Study|Physician Decision|1
105333|NCT00371137|354615|P3|Overall Study|Sponsor Decision|2
105334|NCT00371137|354616|P2|Overall Study|Sponsor Decision|1
105335|NCT00371137|354617|P1|Overall Study|Sponsor Decision|2
105336|NCT00371137|354615|P3|Overall Study|Lack of Efficacy|13
105337|NCT00371137|354616|P2|Overall Study|Lack of Efficacy|12
105338|NCT00371137|354617|P1|Overall Study|Lack of Efficacy|30
105339|NCT00371137|354615|P3|Overall Study|Lost to Follow-up|5
105340|NCT00371137|354616|P2|Overall Study|Lost to Follow-up|3
105341|NCT00371137|354617|P1|Overall Study|Lost to Follow-up|6
105342|NCT00371137|354615|P3|Overall Study|Withdrawal by Subject|15
105343|NCT00371137|354616|P2|Overall Study|Withdrawal by Subject|10
105344|NCT00371137|354617|P1|Overall Study|Withdrawal by Subject|11
105345|NCT00371137|354615|P3|Overall Study|Adverse Event|42
105346|NCT00371137|354616|P2|Overall Study|Adverse Event|35
105347|NCT00371137|354617|P1|Overall Study|Adverse Event|20
105348|NCT00371150|354627|P2|Overall Study|Lost to Follow-up|2
105349|NCT00371150|354628|P1|Overall Study|Lost to Follow-up|3
105350|NCT00371254|354693|P2|Overall Study|Withdrawal by Subject|1
105351|NCT00371254|354694|P1|Overall Study|Withdrawal by Subject|0
105352|NCT00371254|354693|P2|Overall Study|Lost to Follow-up|1
105353|NCT00371254|354694|P1|Overall Study|Lost to Follow-up|0
105354|NCT00371254|354693|P2|Overall Study|Adverse event unrelated to study drug|1
105355|NCT00371254|354694|P1|Overall Study|Adverse event unrelated to study drug|0
105356|NCT00371254|354693|P2|Overall Study|Investigator Decision|0
105357|NCT00371254|354694|P1|Overall Study|Investigator Decision|2
105358|NCT00371254|354693|P2|Overall Study|Subject request|0
105359|NCT00371254|354694|P1|Overall Study|Subject request|5
105360|NCT00371254|354693|P2|Overall Study|Study drug toxicity|5
105361|NCT00371254|354694|P1|Overall Study|Study drug toxicity|3
105362|NCT00371254|354693|P2|Overall Study|Disease progression|13
105363|NCT00371254|354694|P1|Overall Study|Disease progression|13
105364|NCT00371345|354788|P2|Overall Study|Participant Withdrew Consent|1
105365|NCT00371345|354789|P1|Overall Study|Participant Withdrew Consent|0
105366|NCT00371345|354788|P2|Overall Study|Participant Request|1
105367|NCT00371345|354789|P1|Overall Study|Participant Request|1
105368|NCT00371345|354788|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
105369|NCT00371345|354789|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
105370|NCT00371345|354788|P2|Overall Study|Study Drug Toxicity|7
105371|NCT00371345|354789|P1|Overall Study|Study Drug Toxicity|1
105372|NCT00371345|354788|P2|Overall Study|Disease Progression|35
105373|NCT00371345|354789|P1|Overall Study|Disease Progression|21
105374|NCT00371397|354846|P12|Session 1|Withdrawal by Subject|0
105375|NCT00371397|354847|P11|Session 1|Withdrawal by Subject|0
105376|NCT00371397|354848|P10|Session 1|Withdrawal by Subject|0
105377|NCT00371397|354849|P9|Session 1|Withdrawal by Subject|0
105378|NCT00371397|354850|P8|Session 1|Withdrawal by Subject|1
105379|NCT00371397|354851|P7|Session 1|Withdrawal by Subject|0
105380|NCT00371397|354852|P6|Session 1|Withdrawal by Subject|0
105381|NCT00371397|354853|P5|Session 1|Withdrawal by Subject|0
105382|NCT00371397|354854|P4|Session 1|Withdrawal by Subject|0
105383|NCT00371397|354855|P3|Session 1|Withdrawal by Subject|0
105384|NCT00371397|354856|P2|Session 1|Withdrawal by Subject|0
105385|NCT00371397|354857|P1|Session 1|Withdrawal by Subject|1
105386|NCT00371462|354883|P2|Overall Study|Other|8
105387|NCT00371462|354884|P1|Overall Study|Other|7
105388|NCT00371462|354883|P2|Overall Study|Withdrawal by Subject|0
105389|NCT00371462|354884|P1|Overall Study|Withdrawal by Subject|1
105390|NCT00371566|354905|P2|Follow Up Phase|Lost to Follow-up|0
105391|NCT00371566|354906|P1|Follow Up Phase|Lost to Follow-up|1
105392|NCT00371566|354905|P2|Follow Up Phase|Physician Decision|1
105393|NCT00371566|354906|P1|Follow Up Phase|Physician Decision|1
105394|NCT00371566|354905|P2|Follow Up Phase|Withdrawal by Subject|1
105395|NCT00371566|354906|P1|Follow Up Phase|Withdrawal by Subject|0
105396|NCT00371566|354905|P2|Follow Up Phase|Disease progression|0
105397|NCT00371566|354906|P1|Follow Up Phase|Disease progression|1
105398|NCT00371566|354905|P2|Follow Up Phase|Death|5
105399|NCT00371566|354906|P1|Follow Up Phase|Death|0
105400|NCT00371566|354905|P2|Chemoradiation Phase|Death|0
105401|NCT00371566|354906|P1|Chemoradiation Phase|Death|2
105402|NCT00371566|354905|P2|Chemoradiation Phase|Progressive Disease|1
105403|NCT00371566|354906|P1|Chemoradiation Phase|Progressive Disease|1
105404|NCT00371566|354905|P2|Chemoradiation Phase|Non compliant|1
105405|NCT00371566|354906|P1|Chemoradiation Phase|Non compliant|0
105406|NCT00371566|354905|P2|Chemoradiation Phase|Withdrawal by Subject|1
105407|NCT00371566|354906|P1|Chemoradiation Phase|Withdrawal by Subject|0
105408|NCT00371566|354905|P2|Chemoradiation Phase|Physician Decision|0
105409|NCT00371566|354906|P1|Chemoradiation Phase|Physician Decision|2
105410|NCT00371566|354905|P2|Treatment Phase|Protocol Violation|1
105411|NCT00371566|354906|P1|Treatment Phase|Protocol Violation|0
105412|NCT00371566|354905|P2|Treatment Phase|Adverse Event|1
105413|NCT00371566|354906|P1|Treatment Phase|Adverse Event|0
105414|NCT00371566|354905|P2|Treatment Phase|Withdrawal by Subject|1
105415|NCT00371566|354906|P1|Treatment Phase|Withdrawal by Subject|0
105416|NCT00371683|354992|P2|Follow-Up Period - Randomized Patients|non-specified|12
105417|NCT00371683|354993|P1|Follow-Up Period - Randomized Patients|non-specified|6
105418|NCT00371683|354992|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
105419|NCT00371683|354993|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
105420|NCT00371683|354992|P2|Follow-Up Period - Randomized Patients|Death|2
105421|NCT00371683|354993|P1|Follow-Up Period - Randomized Patients|Death|0
105422|NCT00371683|354992|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
105423|NCT00371683|354993|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
105424|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|non-specified|8
105425|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|non-specified|9
105426|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
105593|NCT00364858|355494|P2|Overall Study|Discontinuation at baseline|0
105427|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
105428|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
105429|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
105430|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
105431|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
105432|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
105433|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
105434|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
105435|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
105436|NCT00371683|354992|P2|DB Treatment Period-Randomized Patients|Death|1
105437|NCT00371683|354993|P1|DB Treatment Period-Randomized Patients|Death|1
105438|NCT00371761|355047|P2|Overall Study|Study termination|3
105439|NCT00371761|355048|P1|Overall Study|Study termination|4
105440|NCT00371761|355047|P2|Overall Study|Investigator Judgment|3
105441|NCT00371761|355048|P1|Overall Study|Investigator Judgment|2
105442|NCT00371761|355047|P2|Overall Study|Withdrawal by Subject|3
105443|NCT00371761|355048|P1|Overall Study|Withdrawal by Subject|1
105444|NCT00371761|355047|P2|Overall Study|Adverse Event|1
105445|NCT00371761|355048|P1|Overall Study|Adverse Event|1
105446|NCT00371787|355056|P2|Overall Study|Withdrawal by Subject|1
105447|NCT00371787|355057|P1|Overall Study|Withdrawal by Subject|3
105448|NCT00371826|355072|P3|Extension Phase (24 Months)|Administrative problems|2
105449|NCT00371826|355073|P2|Extension Phase (24 Months)|Administrative problems|0
105450|NCT00371826|355074|P1|Extension Phase (24 Months)|Administrative problems|0
105451|NCT00371826|355072|P3|Extension Phase (24 Months)|Subject withdrew consent|0
105452|NCT00371826|355073|P2|Extension Phase (24 Months)|Subject withdrew consent|2
105453|NCT00371826|355074|P1|Extension Phase (24 Months)|Subject withdrew consent|1
105454|NCT00371826|355072|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
105455|NCT00371826|355073|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
105456|NCT00371826|355074|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
105457|NCT00371826|355072|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
105458|NCT00371826|355073|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
105459|NCT00371826|355074|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
105460|NCT00371826|355072|P3|Extension Phase (24 Months)|Adverse Event|0
105461|NCT00371826|355073|P2|Extension Phase (24 Months)|Adverse Event|5
105462|NCT00371826|355074|P1|Extension Phase (24 Months)|Adverse Event|4
105463|NCT00371826|355072|P3|Core Phase (12 Months)|Graft Loss|0
105464|NCT00371826|355073|P2|Core Phase (12 Months)|Graft Loss|1
105465|NCT00371826|355074|P1|Core Phase (12 Months)|Graft Loss|0
105466|NCT00371826|355072|P3|Core Phase (12 Months)|Administrative problems|8
105467|NCT00371826|355073|P2|Core Phase (12 Months)|Administrative problems|0
105468|NCT00371826|355074|P1|Core Phase (12 Months)|Administrative problems|1
105469|NCT00371826|355072|P3|Core Phase (12 Months)|Subject withdrew consent|3
105470|NCT00371826|355073|P2|Core Phase (12 Months)|Subject withdrew consent|0
105471|NCT00371826|355074|P1|Core Phase (12 Months)|Subject withdrew consent|0
105472|NCT00371826|355072|P3|Core Phase (12 Months)|Protocol Violation|1
105473|NCT00371826|355073|P2|Core Phase (12 Months)|Protocol Violation|0
105474|NCT00371826|355074|P1|Core Phase (12 Months)|Protocol Violation|1
105475|NCT00371826|355072|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
105476|NCT00371826|355073|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
105477|NCT00371826|355074|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
105478|NCT00371826|355072|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
105479|NCT00371826|355073|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
105480|NCT00371826|355074|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
105481|NCT00371826|355072|P3|Core Phase (12 Months)|Adverse Event|9
105482|NCT00371826|355073|P2|Core Phase (12 Months)|Adverse Event|4
105483|NCT00371826|355074|P1|Core Phase (12 Months)|Adverse Event|15
105484|NCT00371839|355199|P3|Overall Study|Lost to Follow-up|2
105485|NCT00371839|355200|P2|Overall Study|Lost to Follow-up|3
105486|NCT00371839|355201|P1|Overall Study|Lost to Follow-up|6
105487|NCT00371839|355199|P3|Overall Study|Withdrawal by Subject|0
105488|NCT00371839|355200|P2|Overall Study|Withdrawal by Subject|4
105489|NCT00371839|355201|P1|Overall Study|Withdrawal by Subject|7
105490|NCT00371839|355199|P3|Overall Study|Death|0
105491|NCT00371839|355200|P2|Overall Study|Death|0
105492|NCT00371839|355201|P1|Overall Study|Death|4
105493|NCT00371865|355209|P2|Overall Study|Withdrawal by Subject|10
105494|NCT00371865|355210|P1|Overall Study|Withdrawal by Subject|12
105495|NCT00371865|355209|P2|Overall Study|Protocol Violation|2
105496|NCT00371865|355210|P1|Overall Study|Protocol Violation|3
105497|NCT00371865|355209|P2|Overall Study|Lack of Efficacy|2
105498|NCT00371865|355210|P1|Overall Study|Lack of Efficacy|0
105499|NCT00372060|355226|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
105500|NCT00372060|355227|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
105501|NCT00372060|355226|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
105502|NCT00372060|355227|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
105503|NCT00372060|355226|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
105504|NCT00372060|355227|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
105505|NCT00372060|355226|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
105506|NCT00372060|355227|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
105507|NCT00372060|355226|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
105508|NCT00372060|355227|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
105509|NCT00372060|355226|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
105510|NCT00372060|355227|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
105511|NCT00372190|355242|P2|Overall Study|Lost to Follow-up|1
105512|NCT00372190|355243|P1|Overall Study|Lost to Follow-up|3
105513|NCT00364793|355259|P4|Overall Study|Withdrawal by Subject|0
105514|NCT00364793|355260|P3|Overall Study|Withdrawal by Subject|0
105515|NCT00364793|355261|P2|Overall Study|Withdrawal by Subject|1
105516|NCT00364793|355262|P1|Overall Study|Withdrawal by Subject|0
105517|NCT00364793|355259|P4|Overall Study|No longer meets criteria|1
105518|NCT00364793|355260|P3|Overall Study|No longer meets criteria|0
105519|NCT00364793|355261|P2|Overall Study|No longer meets criteria|0
105520|NCT00364793|355262|P1|Overall Study|No longer meets criteria|0
105521|NCT00364793|355259|P4|Overall Study|Poor or non-compliance|1
105522|NCT00364793|355260|P3|Overall Study|Poor or non-compliance|0
105523|NCT00364793|355261|P2|Overall Study|Poor or non-compliance|1
105524|NCT00364793|355262|P1|Overall Study|Poor or non-compliance|1
105525|NCT00364793|355259|P4|Overall Study|Lost to Follow-up|0
105526|NCT00364793|355260|P3|Overall Study|Lost to Follow-up|2
105527|NCT00364793|355261|P2|Overall Study|Lost to Follow-up|0
105528|NCT00364793|355262|P1|Overall Study|Lost to Follow-up|1
105529|NCT00364793|355259|P4|Overall Study|Lack of Efficacy|1
105530|NCT00364793|355260|P3|Overall Study|Lack of Efficacy|1
105531|NCT00364793|355261|P2|Overall Study|Lack of Efficacy|3
105532|NCT00364793|355262|P1|Overall Study|Lack of Efficacy|3
105533|NCT00364793|355259|P4|Overall Study|Death|0
105534|NCT00364793|355260|P3|Overall Study|Death|1
105535|NCT00364793|355261|P2|Overall Study|Death|0
105536|NCT00364793|355262|P1|Overall Study|Death|1
105537|NCT00364793|355259|P4|Overall Study|Adverse Event|0
105538|NCT00364793|355260|P3|Overall Study|Adverse Event|0
105539|NCT00364793|355261|P2|Overall Study|Adverse Event|0
105540|NCT00364793|355262|P1|Overall Study|Adverse Event|2
105541|NCT00364832|355413|P12|Extension Year 2|Early Withdrawals|3
105542|NCT00364832|355414|P11|Extension Year 2|Early Withdrawals|5
105543|NCT00364832|355415|P10|Extension Year 2|Early Withdrawals|5
105544|NCT00364832|355416|P9|Extension Year 2|Early Withdrawals|0
105545|NCT00364832|355417|P8|Extension Year 2|Early Withdrawals|0
105546|NCT00364832|355418|P7|Extension Year 2|Early Withdrawals|0
105547|NCT00364832|355419|P6|Extension Year 2|Early Withdrawals|0
105548|NCT00364832|355420|P5|Extension Year 2|Early Withdrawals|0
105549|NCT00364832|355421|P4|Extension Year 2|Early Withdrawals|0
105550|NCT00364832|355422|P3|Extension Year 2|Early Withdrawals|0
105551|NCT00364832|355423|P2|Extension Year 2|Early Withdrawals|0
105552|NCT00364832|355424|P1|Extension Year 2|Early Withdrawals|0
105553|NCT00364832|355413|P12|Extension Year 1|Early Withdrawals|10
105554|NCT00364832|355414|P11|Extension Year 1|Early Withdrawals|2
105555|NCT00364832|355415|P10|Extension Year 1|Early Withdrawals|4
105556|NCT00364832|355416|P9|Extension Year 1|Early Withdrawals|0
105557|NCT00364832|355417|P8|Extension Year 1|Early Withdrawals|0
105558|NCT00364832|355418|P7|Extension Year 1|Early Withdrawals|0
105559|NCT00364832|355419|P6|Extension Year 1|Early Withdrawals|0
105560|NCT00364832|355420|P5|Extension Year 1|Early Withdrawals|0
105561|NCT00364832|355421|P4|Extension Year 1|Early Withdrawals|0
105562|NCT00364832|355422|P3|Extension Year 1|Early Withdrawals|0
105563|NCT00364832|355423|P2|Extension Year 1|Early Withdrawals|0
105564|NCT00364832|355424|P1|Extension Year 1|Early Withdrawals|0
105565|NCT00364832|355413|P12|Core Period|Early Withdrawals|0
105566|NCT00364832|355414|P11|Core Period|Early Withdrawals|0
105567|NCT00364832|355415|P10|Core Period|Early Withdrawals|0
105568|NCT00364832|355416|P9|Core Period|Early Withdrawals|0
105569|NCT00364832|355417|P8|Core Period|Early Withdrawals|1
105570|NCT00364832|355418|P7|Core Period|Early Withdrawals|4
105571|NCT00364832|355419|P6|Core Period|Early Withdrawals|0
105572|NCT00364832|355420|P5|Core Period|Early Withdrawals|0
105573|NCT00364832|355421|P4|Core Period|Early Withdrawals|1
105574|NCT00364832|355422|P3|Core Period|Early Withdrawals|1
105575|NCT00364832|355423|P2|Core Period|Early Withdrawals|2
105576|NCT00364832|355424|P1|Core Period|Early Withdrawals|2
105577|NCT00364845|355479|P2|Overall Study|Death|1
105578|NCT00364845|355480|P1|Overall Study|Death|0
105579|NCT00364845|355479|P2|Overall Study|Lost to Follow-up|1
105580|NCT00364845|355480|P1|Overall Study|Lost to Follow-up|0
105581|NCT00364845|355479|P2|Overall Study|Physician Decision|8
105582|NCT00364845|355480|P1|Overall Study|Physician Decision|8
105583|NCT00364845|355479|P2|Overall Study|Withdrawal by Subject|1
105584|NCT00364845|355480|P1|Overall Study|Withdrawal by Subject|2
105585|NCT00364845|355479|P2|Overall Study|Adverse Event|0
105586|NCT00364845|355480|P1|Overall Study|Adverse Event|1
105587|NCT00364858|355494|P2|Overall Study|Clinical baseline issue|1
105588|NCT00364858|355495|P1|Overall Study|Clinical baseline issue|0
105589|NCT00364858|355494|P2|Overall Study|Return to Q2 regimen|1
105590|NCT00364858|355495|P1|Overall Study|Return to Q2 regimen|0
105591|NCT00364858|355494|P2|Overall Study|Non-compliant|0
105592|NCT00364858|355495|P1|Overall Study|Non-compliant|1
105594|NCT00364858|355495|P1|Overall Study|Discontinuation at baseline|1
105595|NCT00364858|355494|P2|Overall Study|Clinical failure|13
105596|NCT00364858|355495|P1|Overall Study|Clinical failure|2
105597|NCT00364858|355494|P2|Overall Study|Pregnancy|1
105598|NCT00364858|355495|P1|Overall Study|Pregnancy|1
105599|NCT00364858|355494|P2|Overall Study|Withdrawal by Subject|1
105600|NCT00364858|355495|P1|Overall Study|Withdrawal by Subject|1
105601|NCT00364858|355494|P2|Overall Study|Adverse Event|5
105602|NCT00364858|355495|P1|Overall Study|Adverse Event|1
105603|NCT00364923|355508|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
105604|NCT00364923|355508|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
105605|NCT00365105|355544|P2|Overall Study|Lost to Follow-up|0
105606|NCT00365105|355545|P1|Overall Study|Lost to Follow-up|1
105607|NCT00365105|355544|P2|Overall Study|Withdrawal by Subject|1
105608|NCT00365105|355545|P1|Overall Study|Withdrawal by Subject|1
105609|NCT00365105|355544|P2|Overall Study|Protocol Violation|3
105610|NCT00365105|355545|P1|Overall Study|Protocol Violation|4
105611|NCT00365300|355605|P2|Double-blind Phase|Lack of Efficacy|6
105612|NCT00365300|355606|P1|Double-blind Phase|Lack of Efficacy|6
105613|NCT00365300|355605|P2|Double-blind Phase|Protocol Violation|1
105614|NCT00365300|355606|P1|Double-blind Phase|Protocol Violation|3
105615|NCT00365300|355605|P2|Double-blind Phase|Withdrawal by Subject|1
105616|NCT00365300|355606|P1|Double-blind Phase|Withdrawal by Subject|0
105617|NCT00365300|355605|P2|Double-blind Phase|Noncompliance|1
105618|NCT00365300|355606|P1|Double-blind Phase|Noncompliance|1
105619|NCT00365300|355605|P2|Double-blind Phase|Failed to return|0
105620|NCT00365300|355606|P1|Double-blind Phase|Failed to return|1
105621|NCT00365300|355605|P2|Open-label Phase|Patient skipped open label phase|0
105622|NCT00365300|355606|P1|Open-label Phase|Patient skipped open label phase|1
105623|NCT00365300|355605|P2|Open-label Phase|Lack of Efficacy|0
105624|NCT00365300|355606|P1|Open-label Phase|Lack of Efficacy|1
105625|NCT00365300|355605|P2|Open-label Phase|Protocol Violation|0
105626|NCT00365300|355606|P1|Open-label Phase|Protocol Violation|1
105627|NCT00365300|355605|P2|Open-label Phase|Parent/Legal Guardian Request|0
105628|NCT00365300|355606|P1|Open-label Phase|Parent/Legal Guardian Request|4
105629|NCT00365300|355605|P2|Open-label Phase|Noncompliance|0
105630|NCT00365300|355606|P1|Open-label Phase|Noncompliance|9
105631|NCT00365300|355605|P2|Open-label Phase|Physician Decision|0
105632|NCT00365300|355606|P1|Open-label Phase|Physician Decision|1
105633|NCT00365300|355605|P2|Open-label Phase|Failed to Return|0
105634|NCT00365300|355606|P1|Open-label Phase|Failed to Return|1
105635|NCT00365300|355605|P2|Open-label Phase|Adverse Event|0
105636|NCT00365300|355606|P1|Open-label Phase|Adverse Event|4
105637|NCT00365352|355618|P3|Overall Study|Withdrawal of Participant by Sponsor|0
105638|NCT00365352|355619|P2|Overall Study|Withdrawal of Participant by Sponsor|0
105639|NCT00365352|355620|P1|Overall Study|Withdrawal of Participant by Sponsor|1
105640|NCT00365352|355618|P3|Overall Study|Lost to Follow-up|0
105641|NCT00365352|355619|P2|Overall Study|Lost to Follow-up|1
105642|NCT00365352|355620|P1|Overall Study|Lost to Follow-up|1
105643|NCT00365352|355618|P3|Overall Study|Non-Compliance (after Randomization)|1
105644|NCT00365352|355619|P2|Overall Study|Non-Compliance (after Randomization)|0
105645|NCT00365352|355620|P1|Overall Study|Non-Compliance (after Randomization)|1
105646|NCT00365352|355618|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
105647|NCT00365352|355619|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
105648|NCT00365352|355620|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
105649|NCT00365352|355618|P3|Overall Study|Lack of Efficacy|0
105650|NCT00365352|355619|P2|Overall Study|Lack of Efficacy|0
105651|NCT00365352|355620|P1|Overall Study|Lack of Efficacy|3
105652|NCT00365352|355618|P3|Overall Study|Participant Withdrew Consent|4
105653|NCT00365352|355619|P2|Overall Study|Participant Withdrew Consent|3
105654|NCT00365352|355620|P1|Overall Study|Participant Withdrew Consent|8
105655|NCT00365352|355618|P3|Overall Study|Adverse Event|8
105656|NCT00365352|355619|P2|Overall Study|Adverse Event|7
105657|NCT00365352|355620|P1|Overall Study|Adverse Event|6
105658|NCT00365365|355705|P3|Overall Study|Patient/physician decision|1
105659|NCT00365365|355706|P2|Overall Study|Patient/physician decision|0
105660|NCT00365365|355707|P1|Overall Study|Patient/physician decision|0
105661|NCT00365365|355705|P3|Overall Study|Second malignancy|0
105662|NCT00365365|355706|P2|Overall Study|Second malignancy|1
105663|NCT00365365|355707|P1|Overall Study|Second malignancy|0
105664|NCT00365365|355705|P3|Overall Study|Withdrew consent|0
105665|NCT00365365|355706|P2|Overall Study|Withdrew consent|1
105666|NCT00365365|355707|P1|Overall Study|Withdrew consent|1
105667|NCT00365365|355705|P3|Overall Study|New cancer|0
105668|NCT00365365|355706|P2|Overall Study|New cancer|0
105669|NCT00365365|355707|P1|Overall Study|New cancer|1
105670|NCT00365365|355705|P3|Overall Study|Moved|0
105671|NCT00365365|355706|P2|Overall Study|Moved|0
105672|NCT00365365|355707|P1|Overall Study|Moved|2
105673|NCT00365365|355705|P3|Overall Study|Adverse Event|3
105674|NCT00365365|355706|P2|Overall Study|Adverse Event|6
105675|NCT00365365|355707|P1|Overall Study|Adverse Event|6
105676|NCT00365365|355705|P3|Overall Study|Disease progression/relapse|7
105677|NCT00365365|355706|P2|Overall Study|Disease progression/relapse|6
105678|NCT00365365|355707|P1|Overall Study|Disease progression/relapse|9
105679|NCT00365365|355705|P3|Overall Study|Subject's request|1
105680|NCT00365365|355706|P2|Overall Study|Subject's request|13
105681|NCT00365365|355707|P1|Overall Study|Subject's request|11
105682|NCT00365365|355705|P3|Overall Study|Death|0
105683|NCT00365365|355706|P2|Overall Study|Death|3
105684|NCT00365365|355707|P1|Overall Study|Death|1
105685|NCT00365365|355705|P3|Overall Study|Lost to Follow-up|3
105686|NCT00365365|355706|P2|Overall Study|Lost to Follow-up|3
105687|NCT00365365|355707|P1|Overall Study|Lost to Follow-up|3
105688|NCT00365365|355705|P3|Overall Study|Poor compliance to protocol|0
105689|NCT00365365|355706|P2|Overall Study|Poor compliance to protocol|1
105690|NCT00365365|355707|P1|Overall Study|Poor compliance to protocol|0
105691|NCT00365365|355705|P3|Overall Study|Randomized but not treated|0
105692|NCT00365365|355706|P2|Overall Study|Randomized but not treated|2
105693|NCT00365365|355707|P1|Overall Study|Randomized but not treated|0
105694|NCT00365378|355723|P3|Extension|Unspecified|31
105695|NCT00365378|355724|P2|Extension|Unspecified|0
105696|NCT00365378|355725|P1|Extension|Unspecified|0
105697|NCT00365378|355723|P3|Extension|Withdrawal by Subject|98
105698|NCT00365378|355724|P2|Extension|Withdrawal by Subject|0
105699|NCT00365378|355725|P1|Extension|Withdrawal by Subject|0
105700|NCT00365378|355723|P3|Extension|Protocol Violation|2
105701|NCT00365378|355724|P2|Extension|Protocol Violation|0
105702|NCT00365378|355725|P1|Extension|Protocol Violation|0
105703|NCT00365378|355723|P3|Extension|Lost to Follow-up|57
105704|NCT00365378|355724|P2|Extension|Lost to Follow-up|0
105705|NCT00365378|355725|P1|Extension|Lost to Follow-up|0
105706|NCT00365378|355723|P3|Extension|Moved|8
105707|NCT00365378|355724|P2|Extension|Moved|0
105708|NCT00365378|355725|P1|Extension|Moved|0
105709|NCT00365378|355723|P3|Extension|Adverse Event|1
105710|NCT00365378|355724|P2|Extension|Adverse Event|0
105711|NCT00365378|355725|P1|Extension|Adverse Event|0
105712|NCT00365378|355723|P3|Follow-up (Month 7 Though Month 48)|Unspecified|0
105713|NCT00365378|355724|P2|Follow-up (Month 7 Though Month 48)|Unspecified|21
105714|NCT00365378|355725|P1|Follow-up (Month 7 Though Month 48)|Unspecified|11
105715|NCT00365378|355723|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
105716|NCT00365378|355724|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
105717|NCT00365378|355725|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
105718|NCT00365378|355723|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
105719|NCT00365378|355724|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
105720|NCT00365378|355725|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
105721|NCT00365378|355723|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
105722|NCT00365378|355724|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
105723|NCT00365378|355725|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
105724|NCT00365378|355723|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
105725|NCT00365378|355724|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
105726|NCT00365378|355725|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
105727|NCT00365378|355723|P3|Follow-up (Month 7 Though Month 48)|Moved|0
105728|NCT00365378|355724|P2|Follow-up (Month 7 Though Month 48)|Moved|5
105729|NCT00365378|355725|P1|Follow-up (Month 7 Though Month 48)|Moved|6
105730|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Unspecified|0
105731|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Unspecified|9
105732|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Unspecified|17
105733|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
105734|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
105735|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
105736|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
105737|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
105738|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
105739|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
105740|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
105741|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
105742|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
105743|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
105744|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
105745|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
105746|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
105747|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
105748|NCT00365378|355723|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
105749|NCT00365378|355724|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
105750|NCT00365378|355725|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
105751|NCT00365456|355750|P2|Trial Period III (12 Months)|Other|1
105752|NCT00365456|355751|P1|Trial Period III (12 Months)|Other|1
105753|NCT00365456|355750|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
105754|NCT00365456|355751|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
105755|NCT00365456|355750|P2|Trial Period III (12 Months)|Adverse Event|3
105756|NCT00365456|355751|P1|Trial Period III (12 Months)|Adverse Event|13
105757|NCT00365456|355750|P2|Trial Period II (12 Months)|Other|1
105758|NCT00365456|355751|P1|Trial Period II (12 Months)|Other|0
105759|NCT00365456|355750|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
105760|NCT00365456|355751|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
105761|NCT00365456|355750|P2|Trial Period II (12 Months)|Non-compliance|2
105762|NCT00365456|355751|P1|Trial Period II (12 Months)|Non-compliance|0
105763|NCT00365456|355750|P2|Trial Period II (12 Months)|Adverse Event|6
105764|NCT00365456|355751|P1|Trial Period II (12 Months)|Adverse Event|0
105765|NCT00365456|355750|P2|Trial Period I (12 Months)|Other|0
105766|NCT00365456|355751|P1|Trial Period I (12 Months)|Other|11
105767|NCT00365456|355750|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
105768|NCT00365456|355751|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
105769|NCT00365456|355750|P2|Trial Period I (12 Months)|Non-compliance|0
105770|NCT00365456|355751|P1|Trial Period I (12 Months)|Non-compliance|3
105771|NCT00365456|355750|P2|Trial Period I (12 Months)|Adverse Event|0
105772|NCT00365456|355751|P1|Trial Period I (12 Months)|Adverse Event|84
105773|NCT00365508|355759|P2|Overall Study|Lost to Follow-up|154
105774|NCT00365508|355760|P1|Overall Study|Lost to Follow-up|139
105775|NCT00365547|355768|P1|Overall Study|Withdrawal by Subject|1
105776|NCT00365547|355768|P1|Overall Study|Screen failure|1
105777|NCT00365547|355768|P1|Overall Study|Insurance did not cover Avastin|1
105778|NCT00372385|355786|P4|Overall Study|Virologic Stopping Rule|0
105779|NCT00372385|355787|P3|Overall Study|Virologic Stopping Rule|0
105780|NCT00372385|355788|P2|Overall Study|Virologic Stopping Rule|0
105781|NCT00372385|355789|P1|Overall Study|Virologic Stopping Rule|17
105782|NCT00372385|355786|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
105783|NCT00372385|355787|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
105784|NCT00372385|355788|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
105785|NCT00372385|355789|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
105786|NCT00372385|355786|P4|Overall Study|No Response|0
105787|NCT00372385|355787|P3|Overall Study|No Response|0
105788|NCT00372385|355788|P2|Overall Study|No Response|1
105789|NCT00372385|355789|P1|Overall Study|No Response|1
105790|NCT00372385|355786|P4|Overall Study|Refusal of Treatment|0
105791|NCT00372385|355787|P3|Overall Study|Refusal of Treatment|0
105792|NCT00372385|355788|P2|Overall Study|Refusal of Treatment|6
105793|NCT00372385|355789|P1|Overall Study|Refusal of Treatment|3
105794|NCT00372385|355786|P4|Overall Study|Withdrawal by Subject|0
105795|NCT00372385|355787|P3|Overall Study|Withdrawal by Subject|0
105796|NCT00372385|355788|P2|Overall Study|Withdrawal by Subject|1
105797|NCT00372385|355789|P1|Overall Study|Withdrawal by Subject|2
105798|NCT00372385|355786|P4|Overall Study|Lost to Follow-up|0
105799|NCT00372385|355787|P3|Overall Study|Lost to Follow-up|0
105800|NCT00372385|355788|P2|Overall Study|Lost to Follow-up|0
105801|NCT00372385|355789|P1|Overall Study|Lost to Follow-up|2
105802|NCT00372385|355786|P4|Overall Study|Physician Decision|0
105803|NCT00372385|355787|P3|Overall Study|Physician Decision|0
105804|NCT00372385|355788|P2|Overall Study|Physician Decision|0
105805|NCT00372385|355789|P1|Overall Study|Physician Decision|1
105806|NCT00372385|355786|P4|Overall Study|Noncompliance|1
105807|NCT00372385|355787|P3|Overall Study|Noncompliance|1
105808|NCT00372385|355788|P2|Overall Study|Noncompliance|1
105809|NCT00372385|355789|P1|Overall Study|Noncompliance|0
105810|NCT00372385|355786|P4|Overall Study|Adverse Event|7
105811|NCT00372385|355787|P3|Overall Study|Adverse Event|9
105812|NCT00372385|355788|P2|Overall Study|Adverse Event|11
105813|NCT00372385|355789|P1|Overall Study|Adverse Event|6
105814|NCT00372411|355819|P3|Overall Study|Adverse Event|0
105815|NCT00372411|355820|P2|Overall Study|Adverse Event|1
105816|NCT00372411|355821|P1|Overall Study|Adverse Event|1
105817|NCT00372411|355819|P3|Overall Study|Lost to Follow-up|1
105818|NCT00372411|355820|P2|Overall Study|Lost to Follow-up|1
105819|NCT00372411|355821|P1|Overall Study|Lost to Follow-up|1
105820|NCT00372411|355819|P3|Overall Study|Death|1
105821|NCT00372411|355820|P2|Overall Study|Death|2
105822|NCT00372411|355821|P1|Overall Study|Death|0
105823|NCT00372411|355819|P3|Overall Study|Withdrawal by Subject|1
105824|NCT00372411|355820|P2|Overall Study|Withdrawal by Subject|4
105825|NCT00372411|355821|P1|Overall Study|Withdrawal by Subject|3
105826|NCT00372424|355841|P1|Overall Study|Enrolled, Not Treated|1
105827|NCT00372424|355841|P1|Overall Study|Unspecified|7
105828|NCT00372424|355841|P1|Overall Study|Objective Progression or Relapse|14
105829|NCT00372424|355841|P1|Overall Study|Death|1
105830|NCT00372424|355841|P1|Overall Study|Withdrawal by Subject|1
105831|NCT00372424|355841|P1|Overall Study|Adverse Event|2
105832|NCT00372489|355852|P1|Overall Study|Sponsor Decision to Terminate Study|41
105833|NCT00372489|355852|P1|Overall Study|Renal transplant|6
105834|NCT00372489|355852|P1|Overall Study|Patient Relocation|2
105835|NCT00372489|355852|P1|Overall Study|Withdrawal by Subject|5
105836|NCT00372489|355852|P1|Overall Study|Physician Decision|3
105837|NCT00372489|355852|P1|Overall Study|Lost to Follow-up|3
105838|NCT00372489|355852|P1|Overall Study|Lack of Efficacy|1
105839|NCT00372489|355852|P1|Overall Study|Adverse Event|18
105840|NCT00372528|355856|P1|Overall Study|Unspecified|1
105841|NCT00372528|355856|P1|Overall Study|Study Terminated by Sponsor|18
105842|NCT00372528|355856|P1|Overall Study|Adverse Event|1
105843|NCT00372528|355856|P1|Overall Study|Lack of Efficacy|1
105844|NCT00372593|355864|P3|Overall Study|Ineligible|1
105845|NCT00372593|355865|P2|Overall Study|Ineligible|21
105846|NCT00372593|355866|P1|Overall Study|Ineligible|20
105847|NCT00372593|355864|P3|Overall Study|Physician Decision|0
105848|NCT00372593|355865|P2|Overall Study|Physician Decision|41
105849|NCT00372593|355866|P1|Overall Study|Physician Decision|42
105850|NCT00372593|355864|P3|Overall Study|Lost to Follow-up|0
105851|NCT00372593|355865|P2|Overall Study|Lost to Follow-up|0
105852|NCT00372593|355866|P1|Overall Study|Lost to Follow-up|1
105853|NCT00372593|355864|P3|Overall Study|Lack of Efficacy|2
105854|NCT00372593|355865|P2|Overall Study|Lack of Efficacy|71
105855|NCT00372593|355866|P1|Overall Study|Lack of Efficacy|82
105856|NCT00372593|355864|P3|Overall Study|Death|1
105857|NCT00372593|355865|P2|Overall Study|Death|20
105858|NCT00372593|355866|P1|Overall Study|Death|16
105859|NCT00372593|355864|P3|Overall Study|Adverse Event|0
105860|NCT00372593|355865|P2|Overall Study|Adverse Event|45
105861|NCT00372593|355866|P1|Overall Study|Adverse Event|43
105862|NCT00372619|355899|P7|Overall Study|Inevaluable|0
105863|NCT00372619|355900|P6|Overall Study|Inevaluable|1
105864|NCT00372619|355901|P5|Overall Study|Inevaluable|0
105865|NCT00372619|355902|P4|Overall Study|Inevaluable|0
105866|NCT00372619|355903|P3|Overall Study|Inevaluable|0
105867|NCT00372619|355904|P2|Overall Study|Inevaluable|0
105868|NCT00372619|355905|P1|Overall Study|Inevaluable|0
105869|NCT00372619|355899|P7|Overall Study|Ineligible|0
105870|NCT00372619|355900|P6|Overall Study|Ineligible|2
105871|NCT00372619|355901|P5|Overall Study|Ineligible|0
105872|NCT00372619|355902|P4|Overall Study|Ineligible|0
105873|NCT00372619|355903|P3|Overall Study|Ineligible|0
105874|NCT00372619|355904|P2|Overall Study|Ineligible|0
105875|NCT00372619|355905|P1|Overall Study|Ineligible|0
105876|NCT00372697|355937|P2|Overall Study|Protocol Violation|1
105877|NCT00372697|355938|P1|Overall Study|Protocol Violation|1
105878|NCT00372775|355956|P1|Overall Study|Not Treated|2
105879|NCT00372775|355956|P1|Overall Study|Not specified|1
105880|NCT00372775|355956|P1|Overall Study|Withdrawal by Subject|1
105881|NCT00372775|355956|P1|Overall Study|Global deterioration of health status|6
105882|NCT00372775|355956|P1|Overall Study|Objective progression or relapse|30
105883|NCT00372775|355956|P1|Overall Study|Death|15
105884|NCT00372775|355956|P1|Overall Study|Adverse Event|8
105885|NCT00372996|355987|P4|Overall Study|Not specified|7
105886|NCT00372996|355988|P3|Overall Study|Not specified|7
105887|NCT00372996|355989|P2|Overall Study|Not specified|2
105888|NCT00372996|355990|P1|Overall Study|Not specified|10
105889|NCT00372996|355987|P4|Overall Study|Study Terminated by Sponsor|0
105890|NCT00372996|355988|P3|Overall Study|Study Terminated by Sponsor|4
105891|NCT00372996|355989|P2|Overall Study|Study Terminated by Sponsor|0
105892|NCT00372996|355990|P1|Overall Study|Study Terminated by Sponsor|4
105893|NCT00372996|355987|P4|Overall Study|Withdrawal by Subject|5
105894|NCT00372996|355988|P3|Overall Study|Withdrawal by Subject|9
105895|NCT00372996|355989|P2|Overall Study|Withdrawal by Subject|6
105896|NCT00372996|355990|P1|Overall Study|Withdrawal by Subject|12
105897|NCT00372996|355987|P4|Overall Study|Lost to Follow-up|1
105898|NCT00372996|355988|P3|Overall Study|Lost to Follow-up|0
105899|NCT00372996|355989|P2|Overall Study|Lost to Follow-up|2
105900|NCT00372996|355990|P1|Overall Study|Lost to Follow-up|0
105901|NCT00372996|355987|P4|Overall Study|Death|7
105902|NCT00372996|355988|P3|Overall Study|Death|8
105903|NCT00372996|355989|P2|Overall Study|Death|4
105904|NCT00372996|355990|P1|Overall Study|Death|11
105905|NCT00373113|356016|P2|Overall Study|Withdrawal by Subject|15
105906|NCT00373113|356017|P1|Overall Study|Withdrawal by Subject|10
105907|NCT00373113|356016|P2|Overall Study|Protocol Violation|1
105908|NCT00373113|356017|P1|Overall Study|Protocol Violation|5
105909|NCT00373113|356016|P2|Overall Study|Unspecified|17
105910|NCT00373113|356017|P1|Overall Study|Unspecified|14
105911|NCT00373113|356016|P2|Overall Study|Objective progression or relapse|169
105912|NCT00373113|356017|P1|Overall Study|Objective progression or relapse|150
105913|NCT00373113|356016|P2|Overall Study|Lost to Follow-up|3
105914|NCT00373113|356017|P1|Overall Study|Lost to Follow-up|1
105915|NCT00373113|356016|P2|Overall Study|Global deterioration of health status|7
105916|NCT00373113|356017|P1|Overall Study|Global deterioration of health status|10
105917|NCT00373113|356016|P2|Overall Study|Study terminated by sponsor|1
105918|NCT00373113|356017|P1|Overall Study|Study terminated by sponsor|9
105919|NCT00373113|356016|P2|Overall Study|Adverse Event|24
105920|NCT00373113|356017|P1|Overall Study|Adverse Event|38
105921|NCT00373113|356016|P2|Overall Study|Death|7
105922|NCT00373113|356017|P1|Overall Study|Death|1
105923|NCT00373256|356039|P2|Overall Study|Study Terminated by Sponsor|13
105924|NCT00373256|356040|P1|Overall Study|Study Terminated by Sponsor|41
105925|NCT00373256|356039|P2|Overall Study|Protocol Violation|2
105926|NCT00373256|356040|P1|Overall Study|Protocol Violation|0
105927|NCT00373256|356039|P2|Overall Study|Unspecified|107
105928|NCT00373256|356040|P1|Overall Study|Unspecified|73
105929|NCT00373256|356039|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
105930|NCT00373256|356040|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
105931|NCT00373256|356039|P2|Overall Study|Objective Progression or Relapse|104
105932|NCT00373256|356040|P1|Overall Study|Objective Progression or Relapse|111
105933|NCT00373256|356039|P2|Overall Study|Death|8
105934|NCT00373256|356040|P1|Overall Study|Death|9
105935|NCT00373256|356039|P2|Overall Study|Lost to Follow-up|1
105936|NCT00373256|356040|P1|Overall Study|Lost to Follow-up|2
105937|NCT00373256|356039|P2|Overall Study|Adverse Event (AE)|5
105938|NCT00373256|356040|P1|Overall Study|Adverse Event (AE)|1
105939|NCT00373295|356075|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
105940|NCT00373295|356076|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
105941|NCT00373295|356077|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
105942|NCT00373295|356078|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
105943|NCT00373295|356079|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
105944|NCT00373295|356080|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
105945|NCT00373425|356140|P5|Overall Study|Death|0
105946|NCT00373425|356141|P4|Overall Study|Death|1
105947|NCT00373425|356142|P3|Overall Study|Death|3
105948|NCT00373425|356143|P2|Overall Study|Death|0
105949|NCT00373425|356144|P1|Overall Study|Death|7
105950|NCT00373425|356140|P5|Overall Study|Medical/ethical/noncompliance reason|5
105951|NCT00373425|356141|P4|Overall Study|Medical/ethical/noncompliance reason|2
105952|NCT00373425|356142|P3|Overall Study|Medical/ethical/noncompliance reason|10
105953|NCT00373425|356143|P2|Overall Study|Medical/ethical/noncompliance reason|9
105954|NCT00373425|356144|P1|Overall Study|Medical/ethical/noncompliance reason|21
105955|NCT00373425|356140|P5|Overall Study|Patient request|7
105956|NCT00373425|356141|P4|Overall Study|Patient request|6
105957|NCT00373425|356142|P3|Overall Study|Patient request|43
105958|NCT00373425|356143|P2|Overall Study|Patient request|18
105959|NCT00373425|356144|P1|Overall Study|Patient request|35
105960|NCT00373425|356140|P5|Overall Study|Adverse Event|34
105961|NCT00373425|356141|P4|Overall Study|Adverse Event|0
105962|NCT00373425|356142|P3|Overall Study|Adverse Event|59
105963|NCT00373425|356143|P2|Overall Study|Adverse Event|22
105964|NCT00373425|356144|P1|Overall Study|Adverse Event|191
105965|NCT00373425|356140|P5|Overall Study|Relapse of NSCLC|26
105966|NCT00373425|356141|P4|Overall Study|Relapse of NSCLC|2
105967|NCT00373425|356142|P3|Overall Study|Relapse of NSCLC|19
105968|NCT00373425|356143|P2|Overall Study|Relapse of NSCLC|104
105969|NCT00373425|356144|P1|Overall Study|Relapse of NSCLC|116
105970|NCT00373490|356171|P2|Overall Study|Withdrawal by Subject|1
105971|NCT00373490|356172|P1|Overall Study|Withdrawal by Subject|0
105972|NCT00373490|356171|P2|Overall Study|Lack of Efficacy|4
105973|NCT00373490|356172|P1|Overall Study|Lack of Efficacy|9
105974|NCT00373490|356171|P2|Overall Study|Adverse Event|1
105975|NCT00373490|356172|P1|Overall Study|Adverse Event|0
105976|NCT00373529|356190|P1|Overall Study|Consent violation|1
105977|NCT00373529|356190|P1|Overall Study|Failed independent confirmation of AML|3
105978|NCT00373529|356190|P1|Overall Study|Not specified|8
105979|NCT00373529|356190|P1|Overall Study|Need for treatment prohibited by study|1
105980|NCT00373529|356190|P1|Overall Study|Death|16
105981|NCT00373529|356190|P1|Overall Study|Disease recurrence|10
105982|NCT00373529|356190|P1|Overall Study|Treatment failure|36
105983|NCT00373529|356190|P1|Overall Study|Adverse Event|7
105984|NCT00373529|356190|P1|Overall Study|Withdrawal by Subject|7
105985|NCT00373529|356190|P1|Overall Study|Physician Decision|19
105986|NCT00373685|356202|P2|Overall Study|Randomized, not treated|77
105987|NCT00373685|356203|P1|Overall Study|Randomized, not treated|51
105988|NCT00373685|356202|P2|Overall Study|Final Status Unknown|4
105989|NCT00373685|356203|P1|Overall Study|Final Status Unknown|12
105990|NCT00373685|356202|P2|Overall Study|Protocol Violation|182
105991|NCT00373685|356203|P1|Overall Study|Protocol Violation|191
105992|NCT00373685|356202|P2|Overall Study|Unspecified|146
105993|NCT00373685|356203|P1|Overall Study|Unspecified|149
105994|NCT00373685|356202|P2|Overall Study|No longer willing to participate|352
105995|NCT00373685|356203|P1|Overall Study|No longer willing to participate|337
105996|NCT00373685|356202|P2|Overall Study|Lost to follow up|103
105997|NCT00373685|356203|P1|Overall Study|Lost to follow up|83
105998|NCT00373685|356202|P2|Overall Study|Did not meet entrance criteria|184
105999|NCT00373685|356203|P1|Overall Study|Did not meet entrance criteria|167
106000|NCT00373685|356202|P2|Overall Study|Insufficient clinical response|119
106001|NCT00373685|356203|P1|Overall Study|Insufficient clinical response|169
106002|NCT00373685|356202|P2|Overall Study|Adverse Event|253
106003|NCT00373685|356203|P1|Overall Study|Adverse Event|278
106004|NCT00373685|356202|P2|Overall Study|Death|1
106005|NCT00373685|356203|P1|Overall Study|Death|2
106006|NCT00373958|356254|P2|Toddler Dose|Withdrawn after infant series|25
106007|NCT00373958|356255|P1|Toddler Dose|Withdrawn after infant series|22
106008|NCT00373958|356254|P2|Toddler Dose|Protocol Violation|1
106009|NCT00373958|356255|P1|Toddler Dose|Protocol Violation|0
106010|NCT00373958|356254|P2|Toddler Dose|Failed to return|2
106011|NCT00373958|356255|P1|Toddler Dose|Failed to return|1
106012|NCT00373958|356254|P2|Toddler Dose|Withdrawal by Subject|2
106013|NCT00373958|356255|P1|Toddler Dose|Withdrawal by Subject|2
106014|NCT00373958|356254|P2|Toddler Dose|Lost to Follow-up|8
106015|NCT00373958|356255|P1|Toddler Dose|Lost to Follow-up|5
106016|NCT00373958|356254|P2|Infant Series|Physician Decision|1
106017|NCT00373958|356255|P1|Infant Series|Physician Decision|1
106018|NCT00373958|356254|P2|Infant Series|Adverse Event|1
106019|NCT00373958|356255|P1|Infant Series|Adverse Event|3
106020|NCT00373958|356254|P2|Infant Series|Consent was not received|0
106021|NCT00373958|356255|P1|Infant Series|Consent was not received|1
106022|NCT00373958|356254|P2|Infant Series|Child relocated|0
106023|NCT00373958|356255|P1|Infant Series|Child relocated|1
106024|NCT00373958|356254|P2|Infant Series|Lost Kaiser coverage|0
106025|NCT00373958|356255|P1|Infant Series|Lost Kaiser coverage|4
106026|NCT00373958|356254|P2|Infant Series|Protocol Violation|7
106027|NCT00373958|356255|P1|Infant Series|Protocol Violation|3
106028|NCT00373958|356254|P2|Infant Series|Lost to Follow-up|5
106029|NCT00373958|356255|P1|Infant Series|Lost to Follow-up|6
106030|NCT00373958|356254|P2|Infant Series|Failed to return|13
106031|NCT00373958|356255|P1|Infant Series|Failed to return|8
106032|NCT00373958|356254|P2|Infant Series|Withdrawal by Subject|15
106033|NCT00373958|356255|P1|Infant Series|Withdrawal by Subject|13
106034|NCT00374140|356316|P1|Overall Study|Protocol Violation|1
106035|NCT00374140|356316|P1|Overall Study|Lost to Follow-up|1
106036|NCT00374322|356377|P2|Overall Study|Did Not Receive Study Medication|6
106037|NCT00374322|356378|P1|Overall Study|Did Not Receive Study Medication|8
106038|NCT00374322|356377|P2|Overall Study|Withdrew Consent During Follow-up|5
106039|NCT00374322|356378|P1|Overall Study|Withdrew Consent During Follow-up|0
106040|NCT00374322|356377|P2|Overall Study|Noncompliance with Study Requirements|1
106041|NCT00374322|356378|P1|Overall Study|Noncompliance with Study Requirements|0
106042|NCT00374322|356377|P2|Overall Study|Started Another Chemotherapy Regimen|1
106043|NCT00374322|356378|P1|Overall Study|Started Another Chemotherapy Regimen|0
106044|NCT00374322|356377|P2|Overall Study|Participant Changed Physician|0
106045|NCT00374322|356378|P1|Overall Study|Participant Changed Physician|1
106046|NCT00374322|356377|P2|Overall Study|Site Closed|2
106047|NCT00374322|356378|P1|Overall Study|Site Closed|2
106048|NCT00374322|356377|P2|Overall Study|Severe Toxicity|0
106049|NCT00374322|356378|P1|Overall Study|Severe Toxicity|1
106050|NCT00374322|356377|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
106051|NCT00374322|356378|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
106052|NCT00374322|356377|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
106053|NCT00374322|356378|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
106054|NCT00374322|356377|P2|Overall Study|Sponsor Decision|3
106055|NCT00374322|356378|P1|Overall Study|Sponsor Decision|2
106056|NCT00374322|356377|P2|Overall Study|Par. Consented to Survival FU Only|1
106057|NCT00374322|356378|P1|Overall Study|Par. Consented to Survival FU Only|3
106058|NCT00374322|356377|P2|Overall Study|Physician Decision|32
106059|NCT00374322|356378|P1|Overall Study|Physician Decision|36
106060|NCT00374322|356377|P2|Overall Study|Sponsor Terminated Study|990
106061|NCT00374322|356378|P1|Overall Study|Sponsor Terminated Study|866
106062|NCT00374322|356377|P2|Overall Study|Withdrawal by Subject|167
106063|NCT00374322|356378|P1|Overall Study|Withdrawal by Subject|235
106064|NCT00374322|356377|P2|Overall Study|Protocol Violation|3
106065|NCT00374322|356378|P1|Overall Study|Protocol Violation|8
106066|NCT00374322|356377|P2|Overall Study|Lost to Follow-up|90
106067|NCT00374322|356378|P1|Overall Study|Lost to Follow-up|92
106068|NCT00374868|356479|P1|Overall Study|Other - Not Specified|1
106069|NCT00374868|356479|P1|Overall Study|Death|2
106070|NCT00374868|356479|P1|Overall Study|Lost to Follow-up|1
106071|NCT00374868|356479|P1|Overall Study|Physician Decision|13
106072|NCT00374868|356479|P1|Overall Study|Progressive Disease|7
106073|NCT00374868|356479|P1|Overall Study|Adverse Event|12
106074|NCT00374907|356492|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
106075|NCT00374907|356493|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
106076|NCT00374907|356492|P2|116-Week Short-term + Long-term Period|Adverse Event|2
106077|NCT00374907|356493|P1|116-Week Short-term + Long-term Period|Adverse Event|0
106078|NCT00374907|356492|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
106079|NCT00374907|356493|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
106080|NCT00374907|356492|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
106081|NCT00374907|356493|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
106082|NCT00374907|356492|P2|12-Week Short-term Period|Subject Withdrew Consent|1
106083|NCT00374907|356493|P1|12-Week Short-term Period|Subject Withdrew Consent|3
106084|NCT00368472|356532|P1|Overall Study|Missing Final Disposition Date|1
106085|NCT00368472|356532|P1|Overall Study|Not Specified|32
106086|NCT00368472|356532|P1|Overall Study|Diary non-compliance|1
106087|NCT00368472|356532|P1|Overall Study|Withdrawal by Subject|40
106088|NCT00368472|356532|P1|Overall Study|Request of Investigator or Sponsor|3
106089|NCT00368472|356532|P1|Overall Study|Protocol Violation|2
106090|NCT00368472|356532|P1|Overall Study|Medication non-compliance|4
106091|NCT00368472|356532|P1|Overall Study|Adverse Event|22
106092|NCT00368537|356540|P2|Baseline Participants|Patient uncompliant|1
106093|NCT00368537|356541|P1|Baseline Participants|Patient uncompliant|0
106094|NCT00368537|356540|P2|Baseline Participants|No susceptibility|0
106095|NCT00368537|356541|P1|Baseline Participants|No susceptibility|1
106096|NCT00368537|356540|P2|Baseline Participants|Death|2
106097|NCT00368537|356541|P1|Baseline Participants|Death|1
106098|NCT00368537|356540|P2|Baseline Participants|Withdrawal by Subject|4
106099|NCT00368537|356541|P1|Baseline Participants|Withdrawal by Subject|6
106100|NCT00368537|356540|P2|Baseline Participants|Lost to Follow-up|17
106101|NCT00368537|356541|P1|Baseline Participants|Lost to Follow-up|16
106102|NCT00368537|356540|P2|Randomization|No study drug dosed|6
106103|NCT00368537|356541|P1|Randomization|No study drug dosed|13
106104|NCT00368550|356557|P2|Overall Study|Withdrawal by Subject|10
106105|NCT00368550|356558|P1|Overall Study|Withdrawal by Subject|17
106106|NCT00368550|356557|P2|Overall Study|Lack of Efficacy|9
106107|NCT00368550|356558|P1|Overall Study|Lack of Efficacy|4
106108|NCT00368550|356557|P2|Overall Study|Adverse Event|4
106109|NCT00368550|356558|P1|Overall Study|Adverse Event|7
106110|NCT00368641|356570|P2|Overall Study|Sponsor decision to terminate study|5
106111|NCT00368641|356571|P1|Overall Study|Sponsor decision to terminate study|2
106112|NCT00368641|356570|P2|Overall Study|Withdrawal by Subject|0
106113|NCT00368641|356571|P1|Overall Study|Withdrawal by Subject|1
106114|NCT00368641|356570|P2|Overall Study|Death|0
106115|NCT00368641|356571|P1|Overall Study|Death|1
106116|NCT00368641|356570|P2|Overall Study|Adverse Event|1
106117|NCT00368641|356571|P1|Overall Study|Adverse Event|2
106118|NCT00368745|356579|P2|Double-blind Treatment Period|Other|6
106119|NCT00368745|356580|P1|Double-blind Treatment Period|Other|7
106120|NCT00368745|356579|P2|Double-blind Treatment Period|Withdrawal by Subject|3
106121|NCT00368745|356580|P1|Double-blind Treatment Period|Withdrawal by Subject|5
106122|NCT00368745|356579|P2|Double-blind Treatment Period|Lost to Follow-up|0
106123|NCT00368745|356580|P1|Double-blind Treatment Period|Lost to Follow-up|1
106124|NCT00368745|356579|P2|Double-blind Treatment Period|Lack of Efficacy|16
106125|NCT00368745|356580|P1|Double-blind Treatment Period|Lack of Efficacy|7
106126|NCT00368745|356579|P2|Double-blind Treatment Period|Adverse Event|6
106127|NCT00368745|356580|P1|Double-blind Treatment Period|Adverse Event|6
106128|NCT00368849|356610|P2|Overall Study|Physician Decision|1
106129|NCT00368849|356611|P1|Overall Study|Physician Decision|0
106130|NCT00368849|356610|P2|Overall Study|Withdrawal by Subject|1
106131|NCT00368849|356611|P1|Overall Study|Withdrawal by Subject|0
106132|NCT00368875|356625|P2|Overall Study|Alternative Therapy|1
106133|NCT00368875|356626|P1|Overall Study|Alternative Therapy|1
106134|NCT00368875|356625|P2|Overall Study|Other Reason|2
106135|NCT00368875|356626|P1|Overall Study|Other Reason|0
106136|NCT00368875|356625|P2|Overall Study|Withdrawal by Subject|6
106137|NCT00368875|356626|P1|Overall Study|Withdrawal by Subject|2
106138|NCT00368875|356625|P2|Overall Study|Progressive disease|27
106139|NCT00368875|356626|P1|Overall Study|Progressive disease|3
106140|NCT00368875|356625|P2|Overall Study|Adverse Event|12
106141|NCT00368875|356626|P1|Overall Study|Adverse Event|0
106142|NCT00368927|356636|P2|Overall Study|Physician Decision|0
106143|NCT00368927|356637|P1|Overall Study|Physician Decision|1
106144|NCT00368927|356636|P2|Overall Study|Withdrawal by Subject|2
106145|NCT00368927|356637|P1|Overall Study|Withdrawal by Subject|1
106146|NCT00368927|356636|P2|Overall Study|Adverse Event|1
106147|NCT00368927|356637|P1|Overall Study|Adverse Event|1
106148|NCT00368927|356636|P2|Overall Study|Lost to Follow-up|0
106149|NCT00368927|356637|P1|Overall Study|Lost to Follow-up|2
106150|NCT00368966|356662|P2|Toddler Dose|Lost to Follow-up|2
106151|NCT00368966|356663|P1|Toddler Dose|Lost to Follow-up|0
106152|NCT00368966|356662|P2|Toddler Dose|Withdrawal by Subject|1
106153|NCT00368966|356663|P1|Toddler Dose|Withdrawal by Subject|1
106154|NCT00368966|356662|P2|After Infant|Lost to Follow-up|1
106155|NCT00368966|356663|P1|After Infant|Lost to Follow-up|0
106156|NCT00368966|356662|P2|After Infant|Death|0
106157|NCT00368966|356663|P1|After Infant|Death|1
106158|NCT00368966|356662|P2|After Infant|Withdrawal by Subject|1
106159|NCT00368966|356663|P1|After Infant|Withdrawal by Subject|1
106160|NCT00368966|356662|P2|After Infant|Adverse Event|2
106161|NCT00368966|356663|P1|After Infant|Adverse Event|1
106162|NCT00368966|356662|P2|After Infant|Failed to return|1
106163|NCT00368966|356663|P1|After Infant|Failed to return|3
106164|NCT00368966|356662|P2|Infant Series|Failed to return|0
106165|NCT00368966|356663|P1|Infant Series|Failed to return|1
106166|NCT00368966|356662|P2|Infant Series|Adverse Event|1
106167|NCT00368966|356663|P1|Infant Series|Adverse Event|0
106168|NCT00368966|356662|P2|Infant Series|Failed to meet eligibility criteria|1
106169|NCT00368966|356663|P1|Infant Series|Failed to meet eligibility criteria|0
106170|NCT00368966|356662|P2|Infant Series|Randomization error|1
106171|NCT00368966|356663|P1|Infant Series|Randomization error|0
106172|NCT00368966|356662|P2|Infant Series|Lost to Follow-up|0
106173|NCT00368966|356663|P1|Infant Series|Lost to Follow-up|2
106174|NCT00368966|356662|P2|Infant Series|Protocol Violation|1
106175|NCT00368966|356663|P1|Infant Series|Protocol Violation|2
106176|NCT00368966|356662|P2|Infant Series|Withdrawal by Subject|6
106177|NCT00368966|356663|P1|Infant Series|Withdrawal by Subject|11
106178|NCT00368979|356719|P2|Overall Study|Withdrawal by Subject|9
106179|NCT00368979|356720|P1|Overall Study|Withdrawal by Subject|5
106180|NCT00368979|356719|P2|Overall Study|Protocol Violation|1
106181|NCT00368979|356720|P1|Overall Study|Protocol Violation|2
106182|NCT00368979|356719|P2|Overall Study|Lost to Follow-up|0
106183|NCT00368979|356720|P1|Overall Study|Lost to Follow-up|1
106184|NCT00368979|356719|P2|Overall Study|Not specified|1
106185|NCT00368979|356720|P1|Overall Study|Not specified|3
106186|NCT00368979|356719|P2|Overall Study|Lack of Efficacy|3
106187|NCT00368979|356720|P1|Overall Study|Lack of Efficacy|5
106188|NCT00368979|356719|P2|Overall Study|Adverse Event|16
106189|NCT00368979|356720|P1|Overall Study|Adverse Event|9
106190|NCT00368992|356734|P1|Overall Study|Not Specified|9
106191|NCT00368992|356734|P1|Overall Study|Death|4
106192|NCT00368992|356734|P1|Overall Study|Adverse Event|26
106193|NCT00368992|356734|P1|Overall Study|Lack of Efficacy|63
106194|NCT00368992|356734|P1|Overall Study|Refused treatment|3
106195|NCT00368992|356734|P1|Overall Study|Ineligible|5
106196|NCT00369122|356741|P1|Overall Study|No protocol treatment|1
106197|NCT00369122|356741|P1|Overall Study|Ineligible|10
106198|NCT00369161|356747|P2|Overall Study|Administrative Problem|2
106199|NCT00369161|356748|P1|Overall Study|Administrative Problem|2
106200|NCT00369161|356747|P2|Overall Study|Graft loss|0
106201|NCT00369161|356748|P1|Overall Study|Graft loss|4
106202|NCT00369161|356747|P2|Overall Study|Death|2
106203|NCT00369161|356748|P1|Overall Study|Death|1
106204|NCT00369161|356747|P2|Overall Study|Withdrawal by Subject|3
106205|NCT00369161|356748|P1|Overall Study|Withdrawal by Subject|2
106206|NCT00369161|356747|P2|Overall Study|Protocol Violation|2
106207|NCT00369161|356748|P1|Overall Study|Protocol Violation|0
106208|NCT00369161|356747|P2|Overall Study|Lack of Efficacy|1
106209|NCT00369161|356748|P1|Overall Study|Lack of Efficacy|3
106210|NCT00369161|356747|P2|Overall Study|Abnormal laboratory value|1
106211|NCT00369161|356748|P1|Overall Study|Abnormal laboratory value|0
106212|NCT00369161|356747|P2|Overall Study|Adverse Event|13
106213|NCT00369161|356748|P1|Overall Study|Adverse Event|15
106214|NCT00369265|356773|P2|Overall Study|Study terminated|7
106215|NCT00369265|356774|P1|Overall Study|Study terminated|4
106216|NCT00369278|356782|P2|Overall Study|Graft loss|2
106217|NCT00369278|356783|P1|Overall Study|Graft loss|1
106218|NCT00369278|356782|P2|Overall Study|Lost to Follow-up|0
106219|NCT00369278|356783|P1|Overall Study|Lost to Follow-up|1
106220|NCT00369278|356782|P2|Overall Study|Withdrawal by Subject|2
106221|NCT00369278|356783|P1|Overall Study|Withdrawal by Subject|2
106222|NCT00369278|356782|P2|Overall Study|Protocol Violation|1
106223|NCT00369278|356783|P1|Overall Study|Protocol Violation|2
106224|NCT00369278|356782|P2|Overall Study|Unsatisfactory therapeutic effect|5
106225|NCT00369278|356783|P1|Overall Study|Unsatisfactory therapeutic effect|4
106226|NCT00369278|356782|P2|Overall Study|Adverse Event|11
106227|NCT00369278|356783|P1|Overall Study|Adverse Event|14
106228|NCT00369317|356797|P1|Overall Study|Ineligible|1
106229|NCT00369317|356797|P1|Overall Study|Withdrawal by Subject|8
106230|NCT00369317|356797|P1|Overall Study|Physician Decision|2
106231|NCT00369317|356797|P1|Overall Study|Lack of Efficacy|5
106232|NCT00369317|356797|P1|Overall Study|Death|1
106233|NCT00369317|356797|P1|Overall Study|Adverse Event|3
106234|NCT00369343|356813|P2|Open-label Phase|did not take study drug|2
106235|NCT00369343|356814|P1|Open-label Phase|did not take study drug|1
106236|NCT00369343|356813|P2|Open-label Phase|Lack of continuance tolerability|4
106237|NCT00369343|356814|P1|Open-label Phase|Lack of continuance tolerability|3
106238|NCT00369343|356813|P2|Open-label Phase|Lack of Efficacy|3
106239|NCT00369343|356814|P1|Open-label Phase|Lack of Efficacy|4
106240|NCT00369343|356813|P2|Open-label Phase|Withdrawal by Subject|6
106241|NCT00369343|356814|P1|Open-label Phase|Withdrawal by Subject|15
106242|NCT00369343|356813|P2|Open-label Phase|Protocol Violation|3
106243|NCT00369343|356814|P1|Open-label Phase|Protocol Violation|1
106244|NCT00369343|356813|P2|Open-label Phase|inadvertently reported study completers|2
106245|NCT00369343|356814|P1|Open-label Phase|inadvertently reported study completers|3
106246|NCT00369343|356813|P2|Open-label Phase|Lost to Follow-up|3
106247|NCT00369343|356814|P1|Open-label Phase|Lost to Follow-up|5
106248|NCT00369343|356813|P2|Open-label Phase|Physician Decision|0
106249|NCT00369343|356814|P1|Open-label Phase|Physician Decision|2
106250|NCT00369343|356813|P2|Open-label Phase|Failed to return|0
106251|NCT00369343|356814|P1|Open-label Phase|Failed to return|4
106252|NCT00369343|356813|P2|Open-label Phase|Adverse Event|7
106253|NCT00369343|356814|P1|Open-label Phase|Adverse Event|19
106254|NCT00369343|356813|P2|Double-blind Phase|Protocol deviation|0
106255|NCT00369343|356814|P1|Double-blind Phase|Protocol deviation|4
106256|NCT00369343|356813|P2|Double-blind Phase|Lack of Efficacy|4
106257|NCT00369343|356814|P1|Double-blind Phase|Lack of Efficacy|0
106258|NCT00369343|356813|P2|Double-blind Phase|Withdrawal by Subject|6
106259|NCT00369343|356814|P1|Double-blind Phase|Withdrawal by Subject|8
106260|NCT00369343|356813|P2|Double-blind Phase|Protocol Violation|0
106261|NCT00369343|356814|P1|Double-blind Phase|Protocol Violation|2
106262|NCT00369343|356813|P2|Double-blind Phase|Lost to Follow-up|2
106263|NCT00369343|356814|P1|Double-blind Phase|Lost to Follow-up|9
106264|NCT00369343|356813|P2|Double-blind Phase|Failed to return|0
106265|NCT00369343|356814|P1|Double-blind Phase|Failed to return|2
106266|NCT00369343|356813|P2|Double-blind Phase|Adverse Event|4
106267|NCT00369343|356814|P1|Double-blind Phase|Adverse Event|19
106268|NCT00369382|356849|P2|Overall Study|Unspecified|0
106269|NCT00369382|356850|P1|Overall Study|Unspecified|1
106270|NCT00369382|356849|P2|Overall Study|Randomized, not treated|0
106271|NCT00369382|356850|P1|Overall Study|Randomized, not treated|2
106272|NCT00369382|356849|P2|Overall Study|Withdrawal by Subject|0
106273|NCT00369382|356850|P1|Overall Study|Withdrawal by Subject|5
106274|NCT00369382|356849|P2|Overall Study|Physician Decision|1
106275|NCT00369382|356850|P1|Overall Study|Physician Decision|2
106276|NCT00369382|356849|P2|Overall Study|Death|2
106277|NCT00369382|356850|P1|Overall Study|Death|0
106278|NCT00369486|356886|P5|34-Week Visit|Dropped|3
106279|NCT00369486|356887|P4|34-Week Visit|Dropped|3
106280|NCT00369486|356888|P3|34-Week Visit|Dropped|1
106281|NCT00369486|356889|P2|34-Week Visit|Dropped|1
106282|NCT00369486|356890|P1|34-Week Visit|Dropped|0
106283|NCT00369486|356886|P5|17-Week Visit|Missed visit|1
106284|NCT00369486|356887|P4|17-Week Visit|Missed visit|1
106285|NCT00369486|356888|P3|17-Week Visit|Missed visit|1
106286|NCT00369486|356889|P2|17-Week Visit|Missed visit|0
106287|NCT00369486|356890|P1|17-Week Visit|Missed visit|0
106288|NCT00369486|356886|P5|8-Week Visit|Dropped|0
106289|NCT00369486|356887|P4|8-Week Visit|Dropped|1
106290|NCT00369486|356888|P3|8-Week Visit|Dropped|0
106291|NCT00369486|356889|P2|8-Week Visit|Dropped|0
106292|NCT00369486|356890|P1|8-Week Visit|Dropped|0
106293|NCT00369486|356886|P5|8-Week Visit|Missed visit|1
106294|NCT00369486|356887|P4|8-Week Visit|Missed visit|0
106295|NCT00369486|356888|P3|8-Week Visit|Missed visit|0
106296|NCT00369486|356889|P2|8-Week Visit|Missed visit|1
106297|NCT00369486|356890|P1|8-Week Visit|Missed visit|0
106298|NCT00369486|356886|P5|4-Week Visit|Dropped|0
106299|NCT00369486|356887|P4|4-Week Visit|Dropped|0
106300|NCT00369486|356888|P3|4-Week Visit|Dropped|1
106301|NCT00369486|356889|P2|4-Week Visit|Dropped|0
106302|NCT00369486|356890|P1|4-Week Visit|Dropped|0
106303|NCT00369486|356886|P5|4-Week Visit|Missed visit|1
106304|NCT00369486|356887|P4|4-Week Visit|Missed visit|2
106305|NCT00369486|356888|P3|4-Week Visit|Missed visit|0
106306|NCT00369486|356889|P2|4-Week Visit|Missed visit|2
106307|NCT00369486|356890|P1|4-Week Visit|Missed visit|2
106308|NCT00369655|356960|P1|Overall Study|Refusal of further treatment|2
106309|NCT00369668|356972|P3|Overall Study|Lack of Efficacy|7
106310|NCT00369668|356973|P2|Overall Study|Lack of Efficacy|5
106311|NCT00369668|356974|P1|Overall Study|Lack of Efficacy|4
106312|NCT00375219|356991|P3|Overall Study|Withdrawal by Subject|0
106313|NCT00375219|356992|P2|Overall Study|Withdrawal by Subject|0
106314|NCT00375219|356993|P1|Overall Study|Withdrawal by Subject|1
106315|NCT00375219|356991|P3|Overall Study|Cord blood transplantation|0
106316|NCT00375219|356992|P2|Overall Study|Cord blood transplantation|0
106317|NCT00375219|356993|P1|Overall Study|Cord blood transplantation|1
106318|NCT00375219|356991|P3|Overall Study|Allograft|0
106319|NCT00375219|356992|P2|Overall Study|Allograft|0
106320|NCT00375219|356993|P1|Overall Study|Allograft|2
106321|NCT00375219|356991|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
106322|NCT00375219|356992|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
106323|NCT00375219|356993|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
106324|NCT00375219|356991|P3|Overall Study|Hematologic resistance|0
106325|NCT00375219|356992|P2|Overall Study|Hematologic resistance|0
106326|NCT00375219|356993|P1|Overall Study|Hematologic resistance|1
106327|NCT00375219|356991|P3|Overall Study|Death|7
106328|NCT00375219|356992|P2|Overall Study|Death|3
106329|NCT00375219|356993|P1|Overall Study|Death|4
106330|NCT00375219|356991|P3|Overall Study|Disease progression|12
106331|NCT00375219|356992|P2|Overall Study|Disease progression|9
106332|NCT00375219|356993|P1|Overall Study|Disease progression|18
106333|NCT00375219|356991|P3|Overall Study|Lost to Follow-up|0
106334|NCT00375219|356992|P2|Overall Study|Lost to Follow-up|1
106335|NCT00375219|356993|P1|Overall Study|Lost to Follow-up|1
106336|NCT00375219|356991|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
106337|NCT00375219|356992|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
106338|NCT00375219|356993|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
106339|NCT00375219|356991|P3|Overall Study|Protocol Violation|1
106340|NCT00375219|356992|P2|Overall Study|Protocol Violation|0
106341|NCT00375219|356993|P1|Overall Study|Protocol Violation|1
106342|NCT00375219|356991|P3|Overall Study|Adverse Event|1
106343|NCT00375219|356992|P2|Overall Study|Adverse Event|2
106344|NCT00375219|356993|P1|Overall Study|Adverse Event|8
106345|NCT00375219|356991|P3|Overall Study|Failure to achieve a response|0
106346|NCT00375219|356992|P2|Overall Study|Failure to achieve a response|2
106347|NCT00375219|356993|P1|Overall Study|Failure to achieve a response|16
106348|NCT00375674|357061|P2|Overall Study|Lost to Follow-up|12
106349|NCT00375674|357062|P1|Overall Study|Lost to Follow-up|14
106350|NCT00375674|357061|P2|Overall Study|Subject refused further follow-up|23
106351|NCT00375674|357062|P1|Overall Study|Subject refused further follow-up|24
106352|NCT00375674|357061|P2|Overall Study|Death|64
106353|NCT00375674|357062|P1|Overall Study|Death|61
106354|NCT00375674|357061|P2|Overall Study|Not specified|16
106355|NCT00375674|357062|P1|Overall Study|Not specified|24
106356|NCT00375752|357105|P2|Overall Study|Administrative Problems|1
106357|NCT00375752|357106|P1|Overall Study|Administrative Problems|0
106358|NCT00375752|357105|P2|Overall Study|Protocol Violation|2
106359|NCT00375752|357106|P1|Overall Study|Protocol Violation|0
106360|NCT00375752|357105|P2|Overall Study|Abnormal Laboratory Value(s)|1
106361|NCT00375752|357106|P1|Overall Study|Abnormal Laboratory Value(s)|1
106362|NCT00375752|357105|P2|Overall Study|Withdrawal by Subject|1
106363|NCT00375752|357106|P1|Overall Study|Withdrawal by Subject|6
106364|NCT00375752|357105|P2|Overall Study|Adverse Event|6
106365|NCT00375752|357106|P1|Overall Study|Adverse Event|1
106366|NCT00375752|357105|P2|Overall Study|Lack of Efficacy|4
106367|NCT00375752|357106|P1|Overall Study|Lack of Efficacy|4
106368|NCT00375934|357122|P2|Overall Study|Physician Decision|1
106369|NCT00375934|357123|P1|Overall Study|Physician Decision|0
106370|NCT00375934|357122|P2|Overall Study|Lack of Efficacy|2
106371|NCT00375934|357123|P1|Overall Study|Lack of Efficacy|0
106372|NCT00375934|357122|P2|Overall Study|Withdrawal by Subject|2
106373|NCT00375934|357123|P1|Overall Study|Withdrawal by Subject|2
106374|NCT00375934|357122|P2|Overall Study|Adverse Event|1
106375|NCT00375934|357123|P1|Overall Study|Adverse Event|1
106376|NCT00376168|357176|P2|Overall Study|Pregnancy|0
106377|NCT00376168|357177|P1|Overall Study|Pregnancy|1
106378|NCT00376168|357176|P2|Overall Study|Adverse Event|1
106379|NCT00376168|357177|P1|Overall Study|Adverse Event|1
106380|NCT00376220|357193|P2|Overall Study|Withdrawal by Subject|2
106381|NCT00376220|357194|P1|Overall Study|Withdrawal by Subject|3
106382|NCT00376220|357193|P2|Overall Study|Lost to Follow-up|10
106383|NCT00376220|357194|P1|Overall Study|Lost to Follow-up|7
106384|NCT00376259|357202|P2|Overall Study|Patient request|0
106385|NCT00376259|357203|P1|Overall Study|Patient request|1
106386|NCT00376259|357202|P2|Overall Study|Sponsor request - study termination|21
106387|NCT00376259|357203|P1|Overall Study|Sponsor request - study termination|21
106388|NCT00376506|357230|P2|Overall Study|Death|2
106389|NCT00376506|357231|P1|Overall Study|Death|0
106390|NCT00376532|357249|P2|Overall Study|Lack sufficient blood sample|6
106391|NCT00376532|357250|P1|Overall Study|Lack sufficient blood sample|6
106392|NCT00376675|357270|P2|Overall Study|Other Reason|7
106393|NCT00376675|357271|P1|Overall Study|Other Reason|1
106394|NCT00376675|357270|P2|Overall Study|Adverse Event|5
106395|NCT00376675|357271|P1|Overall Study|Adverse Event|10
106396|NCT00376675|357270|P2|Overall Study|Withdrawal by Subject|2
106397|NCT00376675|357271|P1|Overall Study|Withdrawal by Subject|9
106398|NCT00376688|357293|P1|Overall Study|Death|1
106399|NCT00376688|357293|P1|Overall Study|Adverse Event|3
106400|NCT00376961|357354|P2|Maintenance|Ineligible|3
106401|NCT00376961|357355|P1|Maintenance|Ineligible|0
106402|NCT00376961|357354|P2|Maintenance|Progression/relapse|18
106403|NCT00376961|357355|P1|Maintenance|Progression/relapse|0
106404|NCT00376961|357354|P2|Maintenance|Refusal Unrelated to Adverse Event|1
106405|NCT00376961|357355|P1|Maintenance|Refusal Unrelated to Adverse Event|0
106406|NCT00376961|357354|P2|Maintenance|Adverse Event|1
106407|NCT00376961|357355|P1|Maintenance|Adverse Event|0
106408|NCT00376961|357354|P2|Initial Registration|Ineligible|0
106409|NCT00376961|357355|P1|Initial Registration|Ineligible|3
106410|NCT00376961|357354|P2|Initial Registration|Progression/relapse|0
106411|NCT00376961|357355|P1|Initial Registration|Progression/relapse|1
106412|NCT00376961|357354|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
106413|NCT00376961|357355|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
106414|NCT00376961|357354|P2|Initial Registration|Adverse Event|0
106415|NCT00376961|357355|P1|Initial Registration|Adverse Event|1
106416|NCT00377156|357366|P2|Overall Study|Other|2
106417|NCT00377156|357367|P1|Overall Study|Other|5
106418|NCT00377156|357366|P2|Overall Study|Disability or language problem|1
106419|NCT00377156|357367|P1|Overall Study|Disability or language problem|0
106420|NCT00377156|357366|P2|Overall Study|Ineligible|1
106421|NCT00377156|357367|P1|Overall Study|Ineligible|0
106422|NCT00377156|357366|P2|Overall Study|Refused testing|1
106423|NCT00377156|357367|P1|Overall Study|Refused testing|0
106424|NCT00377156|357366|P2|Overall Study|Cancellation|0
106425|NCT00377156|357367|P1|Overall Study|Cancellation|1
106426|NCT00377156|357366|P2|Overall Study|Had follow-up <90 d|6
106427|NCT00377156|357367|P1|Overall Study|Had follow-up <90 d|3
106428|NCT00377156|357366|P2|Overall Study|Withdrawal by Subject|24
106429|NCT00377156|357367|P1|Overall Study|Withdrawal by Subject|16
106430|NCT00377156|357366|P2|Overall Study|Death|19
106431|NCT00377156|357367|P1|Overall Study|Death|23
106432|NCT00377234|357383|P2|Overall Study|Not assigned|2
106433|NCT00377234|357384|P1|Overall Study|Not assigned|3
106434|NCT00377234|357383|P2|Overall Study|Administrative|1
106435|NCT00377234|357384|P1|Overall Study|Administrative|2
106436|NCT00377234|357383|P2|Overall Study|Lost to Follow-up|2
106437|NCT00377234|357384|P1|Overall Study|Lost to Follow-up|4
106438|NCT00377234|357383|P2|Overall Study|Withdrawal by Subject|9
106439|NCT00377234|357384|P1|Overall Study|Withdrawal by Subject|11
106440|NCT00377234|357383|P2|Overall Study|Adverse Event|17
106441|NCT00377234|357384|P1|Overall Study|Adverse Event|14
106442|NCT00377260|357402|P2|Overall Study|Withdrawal by Subject|4
106443|NCT00377260|357403|P1|Overall Study|Withdrawal by Subject|2
106444|NCT00377260|357402|P2|Overall Study|Lost to Follow-up|1
106445|NCT00377260|357403|P1|Overall Study|Lost to Follow-up|0
106446|NCT00377299|357457|P2|Overall Study|Withdrawal by Subject|4
106447|NCT00377299|357458|P1|Overall Study|Withdrawal by Subject|5
106448|NCT00377299|357457|P2|Overall Study|Adverse Event|1
106449|NCT00377299|357458|P1|Overall Study|Adverse Event|0
106450|NCT00377299|357457|P2|Overall Study|Lost to Follow-up|19
106451|NCT00377299|357458|P1|Overall Study|Lost to Follow-up|14
106452|NCT00377312|357474|P2|Overall Study|Adverse Event|1
106453|NCT00377312|357475|P1|Overall Study|Adverse Event|1
106454|NCT00377364|357507|P2|Overall Study|Withdrawal by Subject|0
106455|NCT00377364|357508|P1|Overall Study|Withdrawal by Subject|1
106456|NCT00377364|357507|P2|Overall Study|Lost to Follow-up|0
106457|NCT00377364|357508|P1|Overall Study|Lost to Follow-up|1
106458|NCT00377403|357534|P2|Overall Study|Unable to contact for telephone intervie|7
106459|NCT00377403|357535|P1|Overall Study|Unable to contact for telephone intervie|4
106460|NCT00377429|357541|P1|Overall Study|Patient non-compliance|1
106461|NCT00377429|357541|P1|Overall Study|Physician Decision|1
106462|NCT00377429|357541|P1|Overall Study|Adverse Event|8
106463|NCT00377429|357541|P1|Overall Study|Withdrawal by Subject|5
106464|NCT00377455|357550|P1|Overall Study|Withdrawal by Subject|1
106465|NCT00377520|357554|P1|Overall Study|Ineligible (Prior radiation)|1
106466|NCT00377637|357604|P4|Maintenance Phase|Death|1
106467|NCT00377637|357605|P3|Maintenance Phase|Death|0
106468|NCT00377637|357606|P2|Maintenance Phase|Death|0
106469|NCT00377637|357607|P1|Maintenance Phase|Death|0
106470|NCT00377637|357604|P4|Maintenance Phase|Study medication stopped > 14 days|1
106471|NCT00377637|357605|P3|Maintenance Phase|Study medication stopped > 14 days|0
106472|NCT00377637|357606|P2|Maintenance Phase|Study medication stopped > 14 days|0
106473|NCT00377637|357607|P1|Maintenance Phase|Study medication stopped > 14 days|0
106474|NCT00377637|357604|P4|Maintenance Phase|Non-compliance|1
106475|NCT00377637|357605|P3|Maintenance Phase|Non-compliance|1
106476|NCT00377637|357606|P2|Maintenance Phase|Non-compliance|0
106477|NCT00377637|357607|P1|Maintenance Phase|Non-compliance|0
106478|NCT00377637|357604|P4|Maintenance Phase|Sponsor decision|3
106479|NCT00377637|357605|P3|Maintenance Phase|Sponsor decision|2
106480|NCT00377637|357606|P2|Maintenance Phase|Sponsor decision|0
106481|NCT00377637|357607|P1|Maintenance Phase|Sponsor decision|0
106482|NCT00377637|357604|P4|Maintenance Phase|Withdrawal by Subject|3
106483|NCT00377637|357605|P3|Maintenance Phase|Withdrawal by Subject|3
106484|NCT00377637|357606|P2|Maintenance Phase|Withdrawal by Subject|0
106485|NCT00377637|357607|P1|Maintenance Phase|Withdrawal by Subject|0
106486|NCT00377637|357604|P4|Maintenance Phase|Lost to Follow-up|1
106487|NCT00377637|357605|P3|Maintenance Phase|Lost to Follow-up|3
106488|NCT00377637|357606|P2|Maintenance Phase|Lost to Follow-up|0
106489|NCT00377637|357607|P1|Maintenance Phase|Lost to Follow-up|0
106490|NCT00377637|357604|P4|Maintenance Phase|Physician Decision|4
106491|NCT00377637|357605|P3|Maintenance Phase|Physician Decision|5
106492|NCT00377637|357606|P2|Maintenance Phase|Physician Decision|0
106493|NCT00377637|357607|P1|Maintenance Phase|Physician Decision|0
106494|NCT00377637|357604|P4|Maintenance Phase|Adverse Event|43
106495|NCT00377637|357605|P3|Maintenance Phase|Adverse Event|29
106496|NCT00377637|357606|P2|Maintenance Phase|Adverse Event|0
106497|NCT00377637|357607|P1|Maintenance Phase|Adverse Event|0
106498|NCT00377637|357604|P4|Induction Phase|Reason for withdrawal is not noted|0
106499|NCT00377637|357605|P3|Induction Phase|Reason for withdrawal is not noted|0
106500|NCT00377637|357606|P2|Induction Phase|Reason for withdrawal is not noted|0
106501|NCT00377637|357607|P1|Induction Phase|Reason for withdrawal is not noted|2
106502|NCT00377637|357604|P4|Induction Phase|Non-Compliance|0
106503|NCT00377637|357605|P3|Induction Phase|Non-Compliance|0
106504|NCT00377637|357606|P2|Induction Phase|Non-Compliance|0
106505|NCT00377637|357607|P1|Induction Phase|Non-Compliance|1
106506|NCT00377637|357604|P4|Induction Phase|Sponsor decision|0
106507|NCT00377637|357605|P3|Induction Phase|Sponsor decision|0
106508|NCT00377637|357606|P2|Induction Phase|Sponsor decision|2
106509|NCT00377637|357607|P1|Induction Phase|Sponsor decision|1
106510|NCT00377637|357604|P4|Induction Phase|Physician Decision|0
106511|NCT00377637|357605|P3|Induction Phase|Physician Decision|0
106512|NCT00377637|357606|P2|Induction Phase|Physician Decision|1
106513|NCT00377637|357607|P1|Induction Phase|Physician Decision|3
106514|NCT00377637|357604|P4|Induction Phase|Withdrawal by Subject|0
106515|NCT00377637|357605|P3|Induction Phase|Withdrawal by Subject|0
106516|NCT00377637|357606|P2|Induction Phase|Withdrawal by Subject|6
106517|NCT00377637|357607|P1|Induction Phase|Withdrawal by Subject|5
106518|NCT00377637|357604|P4|Induction Phase|Death|0
106519|NCT00377637|357605|P3|Induction Phase|Death|0
106520|NCT00377637|357606|P2|Induction Phase|Death|3
106521|NCT00377637|357607|P1|Induction Phase|Death|1
106522|NCT00377637|357604|P4|Induction Phase|Lost to Follow-up|0
106523|NCT00377637|357605|P3|Induction Phase|Lost to Follow-up|0
106524|NCT00377637|357606|P2|Induction Phase|Lost to Follow-up|1
106525|NCT00377637|357607|P1|Induction Phase|Lost to Follow-up|2
106526|NCT00377637|357604|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
106527|NCT00377637|357605|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
106528|NCT00377637|357606|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
106529|NCT00377637|357607|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
106530|NCT00377637|357604|P4|Induction Phase|Deterioration/serum creatinine|0
106531|NCT00377637|357605|P3|Induction Phase|Deterioration/serum creatinine|0
106532|NCT00377637|357606|P2|Induction Phase|Deterioration/serum creatinine|0
106533|NCT00377637|357607|P1|Induction Phase|Deterioration/serum creatinine|2
106534|NCT00377637|357604|P4|Induction Phase|Adverse Event|0
106535|NCT00377637|357605|P3|Induction Phase|Adverse Event|0
106536|NCT00377637|357606|P2|Induction Phase|Adverse Event|21
106537|NCT00377637|357607|P1|Induction Phase|Adverse Event|12
106538|NCT00377676|357643|P2|Overall Study|not specified|58
106539|NCT00377676|357644|P1|Overall Study|not specified|118
106540|NCT00377676|357643|P2|Overall Study|Lost to Follow-up|56
106541|NCT00377676|357644|P1|Overall Study|Lost to Follow-up|120
106542|NCT00377676|357643|P2|Overall Study|Withdrawal by Subject|72
106543|NCT00377676|357644|P1|Overall Study|Withdrawal by Subject|187
106544|NCT00377676|357643|P2|Overall Study|Death|2
106545|NCT00377676|357644|P1|Overall Study|Death|5
106546|NCT00377676|357643|P2|Overall Study|Protocol Violation|27
106547|NCT00377676|357644|P1|Overall Study|Protocol Violation|33
106548|NCT00377676|357643|P2|Overall Study|Adverse Event|107
106549|NCT00377676|357644|P1|Overall Study|Adverse Event|498
106550|NCT00377819|357675|P2|Overall Study|Protocol Violation|1
106551|NCT00377819|357676|P1|Overall Study|Protocol Violation|1
106552|NCT00377819|357675|P2|Overall Study|Lost to Follow-up|1
106553|NCT00377819|357676|P1|Overall Study|Lost to Follow-up|0
106554|NCT00377819|357675|P2|Overall Study|Death|1
106555|NCT00377819|357676|P1|Overall Study|Death|0
106556|NCT00377819|357675|P2|Overall Study|Withdrawal by Subject|4
106557|NCT00377819|357676|P1|Overall Study|Withdrawal by Subject|10
106558|NCT00377819|357675|P2|Overall Study|Adverse Event|3
106559|NCT00377819|357676|P1|Overall Study|Adverse Event|2
106560|NCT00377858|357711|P2|Overall Study|Death|3
106561|NCT00377858|357712|P1|Overall Study|Death|0
106562|NCT00377858|357711|P2|Overall Study|Sponsor Decision|2
106563|NCT00377858|357712|P1|Overall Study|Sponsor Decision|1
106564|NCT00377858|357711|P2|Overall Study|Entry Criteria Not Met|0
106565|NCT00377858|357712|P1|Overall Study|Entry Criteria Not Met|2
106566|NCT00377858|357711|P2|Overall Study|Adverse Event|1
106567|NCT00377858|357712|P1|Overall Study|Adverse Event|2
106568|NCT00377858|357711|P2|Overall Study|Protocol Violation|4
106569|NCT00377858|357712|P1|Overall Study|Protocol Violation|3
106570|NCT00377858|357711|P2|Overall Study|Physician Decision|5
106571|NCT00377858|357712|P1|Overall Study|Physician Decision|5
106572|NCT00377858|357711|P2|Overall Study|Lost to Follow-up|1
106573|NCT00377858|357712|P1|Overall Study|Lost to Follow-up|6
106574|NCT00377858|357711|P2|Overall Study|Withdrawal by Subject|11
106575|NCT00377858|357712|P1|Overall Study|Withdrawal by Subject|12
106576|NCT00377962|357742|P2|Extension Study: 12-24 Months|Unspecified reason|3
106577|NCT00377962|357743|P1|Extension Study: 12-24 Months|Unspecified reason|0
106578|NCT00377962|357742|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
106579|NCT00377962|357743|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
106580|NCT00377962|357742|P2|Extension Study: 12-24 Months|Adverse Event|0
106581|NCT00377962|357743|P1|Extension Study: 12-24 Months|Adverse Event|8
106582|NCT00377962|357742|P2|Extension Study: 12-24 Months|Death|1
106583|NCT00377962|357743|P1|Extension Study: 12-24 Months|Death|1
106584|NCT00377962|357742|P2|Core Study: 0-12 Months|Unspecified reasons|4
106585|NCT00377962|357743|P1|Core Study: 0-12 Months|Unspecified reasons|1
106586|NCT00377962|357742|P2|Core Study: 0-12 Months|Administrative Reason|1
106587|NCT00377962|357743|P1|Core Study: 0-12 Months|Administrative Reason|1
106588|NCT00377962|357742|P2|Core Study: 0-12 Months|Withdrew Consent|2
106589|NCT00377962|357743|P1|Core Study: 0-12 Months|Withdrew Consent|5
106590|NCT00377962|357742|P2|Core Study: 0-12 Months|Death|0
106591|NCT00377962|357743|P1|Core Study: 0-12 Months|Death|3
106592|NCT00377962|357742|P2|Core Study: 0-12 Months|Adverse Event|2
106593|NCT00377962|357743|P1|Core Study: 0-12 Months|Adverse Event|18
106594|NCT00378014|357779|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
106595|NCT00378014|357780|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
106596|NCT00378014|357779|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
106597|NCT00378014|357780|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
106598|NCT00378014|357779|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
106599|NCT00378014|357780|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
106600|NCT00378014|357779|P2|Extension (Month 12 to Month 59)|Administrative problems|0
106601|NCT00378014|357780|P1|Extension (Month 12 to Month 59)|Administrative problems|1
106602|NCT00378014|357779|P2|Extension (Month 12 to Month 59)|Death|2
106603|NCT00378014|357780|P1|Extension (Month 12 to Month 59)|Death|1
106604|NCT00378014|357779|P2|Extension (Month 12 to Month 59)|Adverse Event|7
106605|NCT00378014|357780|P1|Extension (Month 12 to Month 59)|Adverse Event|8
106606|NCT00378014|357779|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
106607|NCT00378014|357780|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
106608|NCT00378014|357779|P2|Core (Randomization to Month 11)|Protocol deviation|1
106609|NCT00378014|357780|P1|Core (Randomization to Month 11)|Protocol deviation|0
106610|NCT00378014|357779|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
106611|NCT00378014|357780|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
106612|NCT00378014|357779|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
106613|NCT00378014|357780|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
106614|NCT00378014|357779|P2|Core (Randomization to Month 11)|Administrative Problems|2
106615|NCT00378014|357780|P1|Core (Randomization to Month 11)|Administrative Problems|2
106616|NCT00378014|357779|P2|Core (Randomization to Month 11)|Death|3
106617|NCT00378014|357780|P1|Core (Randomization to Month 11)|Death|5
106618|NCT00378014|357779|P2|Core (Randomization to Month 11)|Graft loss|2
106619|NCT00378014|357780|P1|Core (Randomization to Month 11)|Graft loss|1
106620|NCT00378014|357779|P2|Core (Randomization to Month 11)|Adverse Event|0
106621|NCT00378014|357780|P1|Core (Randomization to Month 11)|Adverse Event|1
106622|NCT00378079|357807|P3|Overall Study|Lost to Follow-up|0
106623|NCT00378079|357808|P2|Overall Study|Lost to Follow-up|1
106624|NCT00378079|357809|P1|Overall Study|Lost to Follow-up|6
106625|NCT00378105|357831|P2|Overall Study|necessity to increase lenalidomide dose|1
106626|NCT00378105|357832|P1|Overall Study|necessity to increase lenalidomide dose|0
106627|NCT00378105|357831|P2|Overall Study|Going non-protocol therapy|1
106628|NCT00378105|357832|P1|Overall Study|Going non-protocol therapy|0
106629|NCT00378105|357831|P2|Overall Study|Physician Decision|2
106630|NCT00378105|357832|P1|Overall Study|Physician Decision|0
106631|NCT00378105|357831|P2|Overall Study|remain on study|11
106632|NCT00378105|357832|P1|Overall Study|remain on study|3
106633|NCT00378105|357831|P2|Overall Study|Progressive disease|3
106634|NCT00378105|357832|P1|Overall Study|Progressive disease|3
106635|NCT00378105|357831|P2|Overall Study|Going to transplant|8
106636|NCT00378105|357832|P1|Overall Study|Going to transplant|7
106637|NCT00378105|357831|P2|Overall Study|Death|0
106638|NCT00378105|357832|P1|Overall Study|Death|1
106639|NCT00378105|357831|P2|Overall Study|Withdrawal by Subject|3
106640|NCT00378105|357832|P1|Overall Study|Withdrawal by Subject|3
106641|NCT00378105|357831|P2|Overall Study|Adverse Event|1
106642|NCT00378105|357832|P1|Overall Study|Adverse Event|3
106643|NCT00372567|357844|P3|Phase 3 Study|study terminated by sponsor|5
106644|NCT00372567|357845|P2|Phase 3 Study|study terminated by sponsor|8
106645|NCT00372567|357846|P1|Phase 3 Study|study terminated by sponsor|13
106646|NCT00372567|357844|P3|Phase 3 Study|not specified|1
106647|NCT00372567|357845|P2|Phase 3 Study|not specified|2
106648|NCT00372567|357846|P1|Phase 3 Study|not specified|2
106649|NCT00372567|357844|P3|Phase 3 Study|Global deterioration of health status|0
106650|NCT00372567|357845|P2|Phase 3 Study|Global deterioration of health status|1
106651|NCT00372567|357846|P1|Phase 3 Study|Global deterioration of health status|0
106652|NCT00372567|357844|P3|Phase 3 Study|Objective progression or relapse|4
106653|NCT00372567|357845|P2|Phase 3 Study|Objective progression or relapse|13
106654|NCT00372567|357846|P1|Phase 3 Study|Objective progression or relapse|10
106655|NCT00372567|357844|P3|Phase 3 Study|Protocol Violation|1
106656|NCT00372567|357845|P2|Phase 3 Study|Protocol Violation|0
106657|NCT00372567|357846|P1|Phase 3 Study|Protocol Violation|0
106658|NCT00372567|357844|P3|Phase 3 Study|Death|0
106659|NCT00372567|357845|P2|Phase 3 Study|Death|1
106660|NCT00372567|357846|P1|Phase 3 Study|Death|1
106661|NCT00372567|357844|P3|Phase 3 Study|Adverse Event|1
106662|NCT00372567|357845|P2|Phase 3 Study|Adverse Event|1
106663|NCT00372567|357846|P1|Phase 3 Study|Adverse Event|5
106664|NCT00378209|357874|P1|Overall Study|Treatment delay|1
106665|NCT00378209|357874|P1|Overall Study|Death|1
106666|NCT00378209|357874|P1|Overall Study|Physician Decision|3
106667|NCT00378209|357874|P1|Overall Study|Initiation of non-protocol therapy|3
106668|NCT00378209|357874|P1|Overall Study|Adverse Event|3
106669|NCT00378209|357874|P1|Overall Study|Progressive disease|11
106670|NCT00378378|357920|P3|Overall Study|Non-compliance with protocol|1
106671|NCT00378378|357921|P2|Overall Study|Non-compliance with protocol|0
106672|NCT00378378|357922|P1|Overall Study|Non-compliance with protocol|0
106673|NCT00378378|357920|P3|Overall Study|Treatment Failure|1
106674|NCT00378378|357921|P2|Overall Study|Treatment Failure|0
106675|NCT00378378|357922|P1|Overall Study|Treatment Failure|0
106676|NCT00378378|357920|P3|Overall Study|Withdrawal by Subject|0
106677|NCT00378378|357921|P2|Overall Study|Withdrawal by Subject|1
106678|NCT00378378|357922|P1|Overall Study|Withdrawal by Subject|0
106679|NCT00378703|357937|P4|Overall Study|Other|3
106680|NCT00378703|357938|P3|Overall Study|Other|2
106681|NCT00378703|357939|P2|Overall Study|Other|1
106682|NCT00378703|357940|P1|Overall Study|Other|1
106683|NCT00378703|357937|P4|Overall Study|Never started treatment|0
106684|NCT00378703|357938|P3|Overall Study|Never started treatment|0
106685|NCT00378703|357939|P2|Overall Study|Never started treatment|4
106686|NCT00378703|357940|P1|Overall Study|Never started treatment|1
106687|NCT00378703|357937|P4|Overall Study|Ineligible|7
106688|NCT00378703|357938|P3|Overall Study|Ineligible|7
106689|NCT00378703|357939|P2|Overall Study|Ineligible|7
106690|NCT00378703|357940|P1|Overall Study|Ineligible|4
106691|NCT00378703|357937|P4|Overall Study|Relocation|0
106692|NCT00378703|357938|P3|Overall Study|Relocation|1
106693|NCT00378703|357939|P2|Overall Study|Relocation|0
106694|NCT00378703|357940|P1|Overall Study|Relocation|0
106695|NCT00378703|357937|P4|Overall Study|Adverse events and progressive disease|1
106696|NCT00378703|357938|P3|Overall Study|Adverse events and progressive disease|0
106697|NCT00378703|357939|P2|Overall Study|Adverse events and progressive disease|0
106698|NCT00378703|357940|P1|Overall Study|Adverse events and progressive disease|0
106699|NCT00378703|357937|P4|Overall Study|Joint decision of physician and patient|0
106700|NCT00378703|357938|P3|Overall Study|Joint decision of physician and patient|0
106701|NCT00378703|357939|P2|Overall Study|Joint decision of physician and patient|0
106702|NCT00378703|357940|P1|Overall Study|Joint decision of physician and patient|1
106703|NCT00378703|357937|P4|Overall Study|Surgery|1
106704|NCT00378703|357938|P3|Overall Study|Surgery|0
106705|NCT00378703|357939|P2|Overall Study|Surgery|0
106706|NCT00378703|357940|P1|Overall Study|Surgery|1
106707|NCT00378703|357937|P4|Overall Study|Symptomatic deterioration|2
106708|NCT00378703|357938|P3|Overall Study|Symptomatic deterioration|0
106709|NCT00378703|357939|P2|Overall Study|Symptomatic deterioration|1
106710|NCT00378703|357940|P1|Overall Study|Symptomatic deterioration|0
106711|NCT00378703|357937|P4|Overall Study|Other complicated disease|0
106712|NCT00378703|357938|P3|Overall Study|Other complicated disease|2
106713|NCT00378703|357939|P2|Overall Study|Other complicated disease|2
106714|NCT00378703|357940|P1|Overall Study|Other complicated disease|0
106715|NCT00378703|357937|P4|Overall Study|Alternative therapy|0
106716|NCT00378703|357938|P3|Overall Study|Alternative therapy|0
106717|NCT00378703|357939|P2|Overall Study|Alternative therapy|2
106718|NCT00378703|357940|P1|Overall Study|Alternative therapy|4
106719|NCT00378703|357937|P4|Overall Study|Physician Decision|0
106720|NCT00378703|357938|P3|Overall Study|Physician Decision|1
106721|NCT00378703|357939|P2|Overall Study|Physician Decision|4
106722|NCT00378703|357940|P1|Overall Study|Physician Decision|1
106723|NCT00378703|357937|P4|Overall Study|Withdrawal by Subject|7
106724|NCT00378703|357938|P3|Overall Study|Withdrawal by Subject|5
106725|NCT00378703|357939|P2|Overall Study|Withdrawal by Subject|8
106726|NCT00378703|357940|P1|Overall Study|Withdrawal by Subject|4
106727|NCT00378703|357937|P4|Overall Study|Death|3
106728|NCT00378703|357938|P3|Overall Study|Death|4
106729|NCT00378703|357939|P2|Overall Study|Death|2
106730|NCT00378703|357940|P1|Overall Study|Death|2
106731|NCT00378703|357937|P4|Overall Study|Adverse Event|18
106732|NCT00378703|357938|P3|Overall Study|Adverse Event|20
106733|NCT00378703|357939|P2|Overall Study|Adverse Event|17
106734|NCT00378703|357940|P1|Overall Study|Adverse Event|11
106735|NCT00378703|357937|P4|Overall Study|Disease progression|49
106736|NCT00378703|357938|P3|Overall Study|Disease progression|48
106737|NCT00378703|357939|P2|Overall Study|Disease progression|43
106738|NCT00378703|357940|P1|Overall Study|Disease progression|59
106739|NCT00378898|357964|P2|Overall Study|Protocol Violation|1
106740|NCT00378898|357965|P1|Overall Study|Protocol Violation|1
106741|NCT00378898|357964|P2|Overall Study|Withdrawal by Subject|5
106742|NCT00378898|357965|P1|Overall Study|Withdrawal by Subject|10
106743|NCT00379080|357976|P3|Overall Study|Withdrawal by Subject|0
106744|NCT00379080|357977|P2|Overall Study|Withdrawal by Subject|4
106745|NCT00379080|357978|P1|Overall Study|Withdrawal by Subject|0
106746|NCT00379210|358028|P2|Overall Study|Withdrawal by Subject|7
106747|NCT00379210|358029|P1|Overall Study|Withdrawal by Subject|10
106748|NCT00379236|358037|P3|Open-label Extension|Not specified|7
106749|NCT00379236|358038|P2|Open-label Extension|Not specified|0
106750|NCT00379236|358039|P1|Open-label Extension|Not specified|0
106751|NCT00379236|358037|P3|Open-label Extension|Use of exclusionary medication|3
106752|NCT00379236|358038|P2|Open-label Extension|Use of exclusionary medication|0
106753|NCT00379236|358039|P1|Open-label Extension|Use of exclusionary medication|0
106754|NCT00379236|358037|P3|Open-label Extension|Lost to Follow-up|12
106755|NCT00379236|358038|P2|Open-label Extension|Lost to Follow-up|0
106756|NCT00379236|358039|P1|Open-label Extension|Lost to Follow-up|0
106757|NCT00379236|358037|P3|Open-label Extension|Withdrawal by Subject|13
106758|NCT00379236|358038|P2|Open-label Extension|Withdrawal by Subject|0
106759|NCT00379236|358039|P1|Open-label Extension|Withdrawal by Subject|0
106760|NCT00379236|358037|P3|Open-label Extension|Protocol Violation|7
106761|NCT00379236|358038|P2|Open-label Extension|Protocol Violation|0
106762|NCT00379236|358039|P1|Open-label Extension|Protocol Violation|0
106763|NCT00379236|358037|P3|Open-label Extension|Adverse Event|13
106764|NCT00379236|358038|P2|Open-label Extension|Adverse Event|0
106765|NCT00379236|358039|P1|Open-label Extension|Adverse Event|0
106766|NCT00379236|358037|P3|Double-blind|Data could not be retrieved|0
106767|NCT00379236|358038|P2|Double-blind|Data could not be retrieved|2
106768|NCT00379236|358039|P1|Double-blind|Data could not be retrieved|2
106769|NCT00379236|358037|P3|Double-blind|Not specified|0
106770|NCT00379236|358038|P2|Double-blind|Not specified|7
106771|NCT00379236|358039|P1|Double-blind|Not specified|3
106772|NCT00379236|358037|P3|Double-blind|Use of exclusionary medication|0
106773|NCT00379236|358038|P2|Double-blind|Use of exclusionary medication|2
106774|NCT00379236|358039|P1|Double-blind|Use of exclusionary medication|1
106775|NCT00379236|358037|P3|Double-blind|Lost to Follow-up|0
106776|NCT00379236|358038|P2|Double-blind|Lost to Follow-up|3
106777|NCT00379236|358039|P1|Double-blind|Lost to Follow-up|4
106778|NCT00379236|358037|P3|Double-blind|Withdrawal by Subject|0
106779|NCT00379236|358038|P2|Double-blind|Withdrawal by Subject|13
106780|NCT00379236|358039|P1|Double-blind|Withdrawal by Subject|12
106781|NCT00379236|358037|P3|Double-blind|Protocol Violation|0
106782|NCT00379236|358038|P2|Double-blind|Protocol Violation|3
106783|NCT00379236|358039|P1|Double-blind|Protocol Violation|3
106784|NCT00379236|358037|P3|Double-blind|Adverse Event|0
106785|NCT00379236|358038|P2|Double-blind|Adverse Event|6
106786|NCT00379236|358039|P1|Double-blind|Adverse Event|11
106787|NCT00379288|358086|P4|Overall Study|Administrative|1
106788|NCT00379288|358087|P3|Overall Study|Administrative|0
106789|NCT00379288|358088|P2|Overall Study|Administrative|2
106790|NCT00379288|358089|P1|Overall Study|Administrative|2
106791|NCT00379288|358086|P4|Overall Study|Did not meet protocol eligibility|2
106792|NCT00379288|358087|P3|Overall Study|Did not meet protocol eligibility|0
106793|NCT00379288|358088|P2|Overall Study|Did not meet protocol eligibility|1
106794|NCT00379288|358089|P1|Overall Study|Did not meet protocol eligibility|0
106795|NCT00379288|358086|P4|Overall Study|Noncompliance with protocol|1
106796|NCT00379288|358087|P3|Overall Study|Noncompliance with protocol|2
106797|NCT00379288|358088|P2|Overall Study|Noncompliance with protocol|6
106798|NCT00379288|358089|P1|Overall Study|Noncompliance with protocol|8
106799|NCT00379288|358086|P4|Overall Study|Subject withdrew-related to study drug|1
106800|NCT00379288|358087|P3|Overall Study|Subject withdrew-related to study drug|0
106801|NCT00379288|358088|P2|Overall Study|Subject withdrew-related to study drug|0
106802|NCT00379288|358089|P1|Overall Study|Subject withdrew-related to study drug|1
106803|NCT00379288|358086|P4|Overall Study|Subject withdrew-unrelated to study drug|2
106804|NCT00379288|358087|P3|Overall Study|Subject withdrew-unrelated to study drug|4
106805|NCT00379288|358088|P2|Overall Study|Subject withdrew-unrelated to study drug|3
106806|NCT00379288|358089|P1|Overall Study|Subject withdrew-unrelated to study drug|0
106807|NCT00379288|358086|P4|Overall Study|Lost to Follow-up|0
106808|NCT00379288|358087|P3|Overall Study|Lost to Follow-up|2
106809|NCT00379288|358088|P2|Overall Study|Lost to Follow-up|3
106810|NCT00379288|358089|P1|Overall Study|Lost to Follow-up|3
106811|NCT00379288|358086|P4|Overall Study|Treatment Failure|1
106812|NCT00379288|358087|P3|Overall Study|Treatment Failure|0
106813|NCT00379288|358088|P2|Overall Study|Treatment Failure|1
106814|NCT00379288|358089|P1|Overall Study|Treatment Failure|0
106815|NCT00379288|358086|P4|Overall Study|Adverse Event|0
106816|NCT00379288|358087|P3|Overall Study|Adverse Event|2
106817|NCT00379288|358088|P2|Overall Study|Adverse Event|6
106818|NCT00379288|358089|P1|Overall Study|Adverse Event|5
106819|NCT00379340|358104|P5|Overall Study|Delayed nephrectomy and anaplasia|1
106820|NCT00379340|358105|P4|Overall Study|Delayed nephrectomy and anaplasia|1
106821|NCT00379340|358106|P3|Overall Study|Delayed nephrectomy and anaplasia|0
106822|NCT00379340|358107|P2|Overall Study|Delayed nephrectomy and anaplasia|0
106823|NCT00379340|358108|P1|Overall Study|Delayed nephrectomy and anaplasia|0
106824|NCT00379340|358104|P5|Overall Study|On more than 1 tumor therapeutic study|0
106825|NCT00379340|358105|P4|Overall Study|On more than 1 tumor therapeutic study|2
106826|NCT00379340|358106|P3|Overall Study|On more than 1 tumor therapeutic study|0
106827|NCT00379340|358107|P2|Overall Study|On more than 1 tumor therapeutic study|0
106828|NCT00379340|358108|P1|Overall Study|On more than 1 tumor therapeutic study|0
106829|NCT00379340|358104|P5|Overall Study|Refusal of further protocol therapy|7
106830|NCT00379340|358105|P4|Overall Study|Refusal of further protocol therapy|1
106831|NCT00379340|358106|P3|Overall Study|Refusal of further protocol therapy|1
106832|NCT00379340|358107|P2|Overall Study|Refusal of further protocol therapy|0
106833|NCT00379340|358108|P1|Overall Study|Refusal of further protocol therapy|1
106834|NCT00379340|358104|P5|Overall Study|Withdrawal by Subject|0
106835|NCT00379340|358105|P4|Overall Study|Withdrawal by Subject|1
106836|NCT00379340|358106|P3|Overall Study|Withdrawal by Subject|0
106837|NCT00379340|358107|P2|Overall Study|Withdrawal by Subject|0
106838|NCT00379340|358108|P1|Overall Study|Withdrawal by Subject|0
106839|NCT00379340|358104|P5|Overall Study|Physician Decision|3
106840|NCT00379340|358105|P4|Overall Study|Physician Decision|2
106841|NCT00379340|358106|P3|Overall Study|Physician Decision|1
106842|NCT00379340|358107|P2|Overall Study|Physician Decision|2
106843|NCT00379340|358108|P1|Overall Study|Physician Decision|6
106844|NCT00379340|358104|P5|Overall Study|Lack of Efficacy|3
106845|NCT00379340|358105|P4|Overall Study|Lack of Efficacy|4
106846|NCT00379340|358106|P3|Overall Study|Lack of Efficacy|0
106847|NCT00379340|358107|P2|Overall Study|Lack of Efficacy|1
106848|NCT00379340|358108|P1|Overall Study|Lack of Efficacy|6
106849|NCT00379340|358104|P5|Overall Study|Death|0
106850|NCT00379340|358105|P4|Overall Study|Death|2
106851|NCT00379340|358106|P3|Overall Study|Death|0
106852|NCT00379340|358107|P2|Overall Study|Death|0
106853|NCT00379340|358108|P1|Overall Study|Death|0
106854|NCT00379353|358123|P2|Overall Study|Conflicting drug treatment|1
106855|NCT00379353|358124|P1|Overall Study|Conflicting drug treatment|0
106856|NCT00379353|358123|P2|Overall Study|Non-compliance|0
106857|NCT00379353|358124|P1|Overall Study|Non-compliance|1
106858|NCT00379353|358123|P2|Overall Study|Cardiac Tamponade|0
106859|NCT00379353|358124|P1|Overall Study|Cardiac Tamponade|1
106860|NCT00379353|358123|P2|Overall Study|Death|0
106861|NCT00379353|358124|P1|Overall Study|Death|1
106862|NCT00379353|358123|P2|Overall Study|Withdrawal by Subject|2
106863|NCT00379353|358124|P1|Overall Study|Withdrawal by Subject|5
106864|NCT00379353|358123|P2|Overall Study|Hospitalization|3
106865|NCT00379353|358124|P1|Overall Study|Hospitalization|3
106866|NCT00379587|358159|P1|Overall Study|Lost to Follow-up|2
106867|NCT00379639|358171|P5|Overall Study|Other|0
106868|NCT00379639|358172|P4|Overall Study|Other|0
106869|NCT00379639|358173|P3|Overall Study|Other|3
106870|NCT00379639|358174|P2|Overall Study|Other|0
106871|NCT00379639|358175|P1|Overall Study|Other|0
106872|NCT00379639|358171|P5|Overall Study|Lost to Follow-up|0
106873|NCT00379639|358172|P4|Overall Study|Lost to Follow-up|1
106874|NCT00379639|358173|P3|Overall Study|Lost to Follow-up|0
106875|NCT00379639|358174|P2|Overall Study|Lost to Follow-up|0
106876|NCT00379639|358175|P1|Overall Study|Lost to Follow-up|0
106877|NCT00379639|358171|P5|Overall Study|Adverse Event|1
106878|NCT00379639|358172|P4|Overall Study|Adverse Event|0
106879|NCT00379639|358173|P3|Overall Study|Adverse Event|1
106880|NCT00379639|358174|P2|Overall Study|Adverse Event|0
106881|NCT00379639|358175|P1|Overall Study|Adverse Event|0
106882|NCT00379639|358171|P5|Overall Study|Symptomatic Deterioration|1
106883|NCT00379639|358172|P4|Overall Study|Symptomatic Deterioration|0
106884|NCT00379639|358173|P3|Overall Study|Symptomatic Deterioration|1
106885|NCT00379639|358174|P2|Overall Study|Symptomatic Deterioration|0
106886|NCT00379639|358175|P1|Overall Study|Symptomatic Deterioration|0
106887|NCT00379639|358171|P5|Overall Study|Physician Decision|0
106888|NCT00379639|358172|P4|Overall Study|Physician Decision|1
106889|NCT00379639|358173|P3|Overall Study|Physician Decision|1
106890|NCT00379639|358174|P2|Overall Study|Physician Decision|2
106891|NCT00379639|358175|P1|Overall Study|Physician Decision|0
106892|NCT00379639|358171|P5|Overall Study|Disease Progression|4
106893|NCT00379639|358172|P4|Overall Study|Disease Progression|4
106894|NCT00379639|358173|P3|Overall Study|Disease Progression|3
106895|NCT00379639|358174|P2|Overall Study|Disease Progression|3
106896|NCT00379639|358175|P1|Overall Study|Disease Progression|3
106897|NCT00379769|358201|P6|Observational Follow-up|Unknown; Reason Not Provided|1
106898|NCT00379769|358202|P5|Observational Follow-up|Unknown; Reason Not Provided|1
106899|NCT00379769|358203|P4|Observational Follow-up|Unknown; Reason Not Provided|0
106900|NCT00379769|358204|P3|Observational Follow-up|Unknown; Reason Not Provided|0
106901|NCT00379769|358205|P2|Observational Follow-up|Unknown; Reason Not Provided|0
106902|NCT00379769|358206|P1|Observational Follow-up|Unknown; Reason Not Provided|0
106903|NCT00379769|358201|P6|Observational Follow-up|Participant Moved|1
106904|NCT00379769|358202|P5|Observational Follow-up|Participant Moved|0
106905|NCT00379769|358203|P4|Observational Follow-up|Participant Moved|0
106906|NCT00379769|358204|P3|Observational Follow-up|Participant Moved|0
106907|NCT00379769|358205|P2|Observational Follow-up|Participant Moved|0
106908|NCT00379769|358206|P1|Observational Follow-up|Participant Moved|0
106909|NCT00379769|358201|P6|Observational Follow-up|Site Closed Early|7
106910|NCT00379769|358202|P5|Observational Follow-up|Site Closed Early|6
106911|NCT00379769|358203|P4|Observational Follow-up|Site Closed Early|0
106912|NCT00379769|358204|P3|Observational Follow-up|Site Closed Early|0
106913|NCT00379769|358205|P2|Observational Follow-up|Site Closed Early|0
106914|NCT00379769|358206|P1|Observational Follow-up|Site Closed Early|0
106915|NCT00379769|358201|P6|Observational Follow-up|Physician Decision|8
106916|NCT00379769|358202|P5|Observational Follow-up|Physician Decision|8
106917|NCT00379769|358203|P4|Observational Follow-up|Physician Decision|0
106918|NCT00379769|358204|P3|Observational Follow-up|Physician Decision|0
106919|NCT00379769|358205|P2|Observational Follow-up|Physician Decision|0
106920|NCT00379769|358206|P1|Observational Follow-up|Physician Decision|0
106921|NCT00379769|358201|P6|Observational Follow-up|Entered into Another Clinical Trial|22
106922|NCT00379769|358202|P5|Observational Follow-up|Entered into Another Clinical Trial|18
106923|NCT00379769|358203|P4|Observational Follow-up|Entered into Another Clinical Trial|0
106924|NCT00379769|358204|P3|Observational Follow-up|Entered into Another Clinical Trial|0
106925|NCT00379769|358205|P2|Observational Follow-up|Entered into Another Clinical Trial|0
106926|NCT00379769|358206|P1|Observational Follow-up|Entered into Another Clinical Trial|0
106927|NCT00379769|358201|P6|Observational Follow-up|Withdrawal by Subject|12
106928|NCT00379769|358202|P5|Observational Follow-up|Withdrawal by Subject|12
106929|NCT00379769|358203|P4|Observational Follow-up|Withdrawal by Subject|0
106930|NCT00379769|358204|P3|Observational Follow-up|Withdrawal by Subject|0
106931|NCT00379769|358205|P2|Observational Follow-up|Withdrawal by Subject|0
106932|NCT00379769|358206|P1|Observational Follow-up|Withdrawal by Subject|0
106933|NCT00379769|358201|P6|Observational Follow-up|Lost to Follow-up|27
106934|NCT00379769|358202|P5|Observational Follow-up|Lost to Follow-up|25
106935|NCT00379769|358203|P4|Observational Follow-up|Lost to Follow-up|0
106936|NCT00379769|358204|P3|Observational Follow-up|Lost to Follow-up|0
106937|NCT00379769|358205|P2|Observational Follow-up|Lost to Follow-up|0
106938|NCT00379769|358206|P1|Observational Follow-up|Lost to Follow-up|0
106939|NCT00379769|358201|P6|Observational Follow-up|Adverse Event|0
106940|NCT00379769|358202|P5|Observational Follow-up|Adverse Event|1
106941|NCT00379769|358203|P4|Observational Follow-up|Adverse Event|0
106942|NCT00379769|358204|P3|Observational Follow-up|Adverse Event|0
106943|NCT00379769|358205|P2|Observational Follow-up|Adverse Event|0
106944|NCT00379769|358206|P1|Observational Follow-up|Adverse Event|0
106945|NCT00379769|358201|P6|Observational Follow-up|Death|70
106946|NCT00379769|358202|P5|Observational Follow-up|Death|78
106947|NCT00379769|358203|P4|Observational Follow-up|Death|0
106948|NCT00379769|358204|P3|Observational Follow-up|Death|0
106949|NCT00379769|358205|P2|Observational Follow-up|Death|0
106950|NCT00379769|358206|P1|Observational Follow-up|Death|0
106951|NCT00379769|358201|P6|Main Study|Reason unspecified|0
106952|NCT00379769|358202|P5|Main Study|Reason unspecified|0
106953|NCT00379769|358203|P4|Main Study|Reason unspecified|0
106954|NCT00379769|358204|P3|Main Study|Reason unspecified|1
106955|NCT00379769|358205|P2|Main Study|Reason unspecified|0
106956|NCT00379769|358206|P1|Main Study|Reason unspecified|0
106957|NCT00379769|358201|P6|Main Study|Investigator refused to log temperature|0
106958|NCT00379769|358202|P5|Main Study|Investigator refused to log temperature|0
106959|NCT00379769|358203|P4|Main Study|Investigator refused to log temperature|0
106960|NCT00379769|358204|P3|Main Study|Investigator refused to log temperature|1
106961|NCT00379769|358205|P2|Main Study|Investigator refused to log temperature|0
106962|NCT00379769|358206|P1|Main Study|Investigator refused to log temperature|0
106963|NCT00379769|358201|P6|Main Study|Risk of heart failure|0
106964|NCT00379769|358202|P5|Main Study|Risk of heart failure|0
106965|NCT00379769|358203|P4|Main Study|Risk of heart failure|0
106966|NCT00379769|358204|P3|Main Study|Risk of heart failure|0
106967|NCT00379769|358205|P2|Main Study|Risk of heart failure|1
106968|NCT00379769|358206|P1|Main Study|Risk of heart failure|0
106969|NCT00379769|358201|P6|Main Study|Personal reasons|0
106970|NCT00379769|358202|P5|Main Study|Personal reasons|0
106971|NCT00379769|358203|P4|Main Study|Personal reasons|0
106972|NCT00379769|358204|P3|Main Study|Personal reasons|0
106973|NCT00379769|358205|P2|Main Study|Personal reasons|0
106974|NCT00379769|358206|P1|Main Study|Personal reasons|1
106975|NCT00379769|358201|P6|Main Study|Participant completed study at visit 27|0
106976|NCT00379769|358202|P5|Main Study|Participant completed study at visit 27|0
106977|NCT00379769|358203|P4|Main Study|Participant completed study at visit 27|0
106978|NCT00379769|358204|P3|Main Study|Participant completed study at visit 27|0
106979|NCT00379769|358205|P2|Main Study|Participant completed study at visit 27|0
106980|NCT00379769|358206|P1|Main Study|Participant completed study at visit 27|1
106981|NCT00379769|358201|P6|Main Study|Physician Decision|0
106982|NCT00379769|358202|P5|Main Study|Physician Decision|0
106983|NCT00379769|358203|P4|Main Study|Physician Decision|1
106984|NCT00379769|358204|P3|Main Study|Physician Decision|1
106985|NCT00379769|358205|P2|Main Study|Physician Decision|2
106986|NCT00379769|358206|P1|Main Study|Physician Decision|2
106987|NCT00379769|358201|P6|Main Study|Participant did not take study drug|0
106988|NCT00379769|358202|P5|Main Study|Participant did not take study drug|0
106989|NCT00379769|358203|P4|Main Study|Participant did not take study drug|0
106990|NCT00379769|358204|P3|Main Study|Participant did not take study drug|1
106991|NCT00379769|358205|P2|Main Study|Participant did not take study drug|0
106992|NCT00379769|358206|P1|Main Study|Participant did not take study drug|0
106993|NCT00379769|358201|P6|Main Study|Entry criteria violation|0
106994|NCT00379769|358202|P5|Main Study|Entry criteria violation|0
106995|NCT00379769|358203|P4|Main Study|Entry criteria violation|1
106996|NCT00379769|358204|P3|Main Study|Entry criteria violation|1
106997|NCT00379769|358205|P2|Main Study|Entry criteria violation|0
106998|NCT00379769|358206|P1|Main Study|Entry criteria violation|0
106999|NCT00379769|358201|P6|Main Study|Site closed|0
107000|NCT00379769|358202|P5|Main Study|Site closed|0
107001|NCT00379769|358203|P4|Main Study|Site closed|8
107002|NCT00379769|358204|P3|Main Study|Site closed|4
107003|NCT00379769|358205|P2|Main Study|Site closed|4
107004|NCT00379769|358206|P1|Main Study|Site closed|4
107005|NCT00379769|358201|P6|Main Study|Prohibited glucose lowering medication|0
107006|NCT00379769|358202|P5|Main Study|Prohibited glucose lowering medication|0
107007|NCT00379769|358203|P4|Main Study|Prohibited glucose lowering medication|1
107008|NCT00379769|358204|P3|Main Study|Prohibited glucose lowering medication|0
107009|NCT00379769|358205|P2|Main Study|Prohibited glucose lowering medication|3
107010|NCT00379769|358206|P1|Main Study|Prohibited glucose lowering medication|0
107011|NCT00379769|358201|P6|Main Study|Poor compliance|0
107012|NCT00379769|358202|P5|Main Study|Poor compliance|0
107013|NCT00379769|358203|P4|Main Study|Poor compliance|1
107014|NCT00379769|358204|P3|Main Study|Poor compliance|2
107015|NCT00379769|358205|P2|Main Study|Poor compliance|2
107016|NCT00379769|358206|P1|Main Study|Poor compliance|3
107017|NCT00379769|358201|P6|Main Study|Participant moved|0
107018|NCT00379769|358202|P5|Main Study|Participant moved|0
107019|NCT00379769|358203|P4|Main Study|Participant moved|3
107020|NCT00379769|358204|P3|Main Study|Participant moved|3
107021|NCT00379769|358205|P2|Main Study|Participant moved|2
107022|NCT00379769|358206|P1|Main Study|Participant moved|3
107023|NCT00379769|358201|P6|Main Study|Moved to survival status follow-up only|0
107024|NCT00379769|358202|P5|Main Study|Moved to survival status follow-up only|0
107025|NCT00379769|358203|P4|Main Study|Moved to survival status follow-up only|36
107026|NCT00379769|358204|P3|Main Study|Moved to survival status follow-up only|32
107027|NCT00379769|358205|P2|Main Study|Moved to survival status follow-up only|25
107028|NCT00379769|358206|P1|Main Study|Moved to survival status follow-up only|27
107029|NCT00379769|358201|P6|Main Study|Withdrawal by Subject|0
107030|NCT00379769|358202|P5|Main Study|Withdrawal by Subject|0
107031|NCT00379769|358203|P4|Main Study|Withdrawal by Subject|70
107032|NCT00379769|358204|P3|Main Study|Withdrawal by Subject|72
107033|NCT00379769|358205|P2|Main Study|Withdrawal by Subject|56
107034|NCT00379769|358206|P1|Main Study|Withdrawal by Subject|46
107035|NCT00379769|358201|P6|Main Study|Lost to Follow-up|0
107036|NCT00379769|358202|P5|Main Study|Lost to Follow-up|0
107037|NCT00379769|358203|P4|Main Study|Lost to Follow-up|26
107038|NCT00379769|358204|P3|Main Study|Lost to Follow-up|25
107039|NCT00379769|358205|P2|Main Study|Lost to Follow-up|29
107040|NCT00379769|358206|P1|Main Study|Lost to Follow-up|29
107041|NCT00379769|358201|P6|Main Study|Adverse Event|0
107042|NCT00379769|358202|P5|Main Study|Adverse Event|0
107043|NCT00379769|358203|P4|Main Study|Adverse Event|11
107044|NCT00379769|358204|P3|Main Study|Adverse Event|10
107045|NCT00379769|358205|P2|Main Study|Adverse Event|8
107046|NCT00379769|358206|P1|Main Study|Adverse Event|5
107047|NCT00379769|358201|P6|Main Study|Death|0
107048|NCT00379769|358202|P5|Main Study|Death|0
107049|NCT00379769|358203|P4|Main Study|Death|72
107050|NCT00379769|358204|P3|Main Study|Death|54
107051|NCT00379769|358205|P2|Main Study|Death|67
107052|NCT00379769|358206|P1|Main Study|Death|57
107053|NCT00379795|358365|P5|Overall Study|Sponsor's decision|10
107054|NCT00379795|358366|P4|Overall Study|Sponsor's decision|47
107055|NCT00379795|358367|P3|Overall Study|Sponsor's decision|54
107056|NCT00379795|358368|P2|Overall Study|Sponsor's decision|17
107057|NCT00379795|358369|P1|Overall Study|Sponsor's decision|257
107058|NCT00379795|358365|P5|Overall Study|Subjects condition mandated intervention|7
107059|NCT00379795|358366|P4|Overall Study|Subjects condition mandated intervention|5
107060|NCT00379795|358367|P3|Overall Study|Subjects condition mandated intervention|7
107061|NCT00379795|358368|P2|Overall Study|Subjects condition mandated intervention|9
107062|NCT00379795|358369|P1|Overall Study|Subjects condition mandated intervention|34
107063|NCT00379795|358365|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
107152|NCT00380250|358709|P2|Overall Study|Protocol Violation|5
107064|NCT00379795|358366|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
107065|NCT00379795|358367|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
107066|NCT00379795|358368|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
107067|NCT00379795|358369|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
107068|NCT00379795|358365|P5|Overall Study|Subject non-compliance|1
107069|NCT00379795|358366|P4|Overall Study|Subject non-compliance|0
107070|NCT00379795|358367|P3|Overall Study|Subject non-compliance|0
107071|NCT00379795|358368|P2|Overall Study|Subject non-compliance|2
107072|NCT00379795|358369|P1|Overall Study|Subject non-compliance|7
107073|NCT00379795|358365|P5|Overall Study|Withdrawal by Subject|14
107074|NCT00379795|358366|P4|Overall Study|Withdrawal by Subject|7
107075|NCT00379795|358367|P3|Overall Study|Withdrawal by Subject|19
107076|NCT00379795|358368|P2|Overall Study|Withdrawal by Subject|11
107077|NCT00379795|358369|P1|Overall Study|Withdrawal by Subject|94
107078|NCT00379795|358365|P5|Overall Study|Physician Decision|2
107079|NCT00379795|358366|P4|Overall Study|Physician Decision|2
107080|NCT00379795|358367|P3|Overall Study|Physician Decision|2
107081|NCT00379795|358368|P2|Overall Study|Physician Decision|0
107082|NCT00379795|358369|P1|Overall Study|Physician Decision|25
107083|NCT00379795|358365|P5|Overall Study|Lost to Follow-up|4
107084|NCT00379795|358366|P4|Overall Study|Lost to Follow-up|1
107085|NCT00379795|358367|P3|Overall Study|Lost to Follow-up|2
107086|NCT00379795|358368|P2|Overall Study|Lost to Follow-up|1
107087|NCT00379795|358369|P1|Overall Study|Lost to Follow-up|8
107088|NCT00379795|358365|P5|Overall Study|Adverse Event|4
107089|NCT00379795|358366|P4|Overall Study|Adverse Event|1
107090|NCT00379795|358367|P3|Overall Study|Adverse Event|3
107091|NCT00379795|358368|P2|Overall Study|Adverse Event|3
107092|NCT00379795|358369|P1|Overall Study|Adverse Event|17
107093|NCT00379795|358365|P5|Overall Study|Death|7
107094|NCT00379795|358366|P4|Overall Study|Death|4
107095|NCT00379795|358367|P3|Overall Study|Death|6
107096|NCT00379795|358368|P2|Overall Study|Death|8
107097|NCT00379795|358369|P1|Overall Study|Death|31
107098|NCT00379808|358395|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
107099|NCT00379808|358396|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
107100|NCT00379834|358560|P1|Overall Study|Time constraints|2
107101|NCT00379899|358566|P2|Overall Study|Other|1
107102|NCT00379899|358567|P1|Overall Study|Other|3
107103|NCT00379899|358566|P2|Overall Study|Other protocol-specified criteria|4
107104|NCT00379899|358567|P1|Overall Study|Other protocol-specified criteria|3
107105|NCT00379899|358566|P2|Overall Study|Coronary artery bypass graft|1
107106|NCT00379899|358567|P1|Overall Study|Coronary artery bypass graft|1
107107|NCT00379899|358566|P2|Overall Study|Renal transplantation|4
107108|NCT00379899|358567|P1|Overall Study|Renal transplantation|5
107109|NCT00379899|358566|P2|Overall Study|Parathyroidectomy|2
107110|NCT00379899|358567|P1|Overall Study|Parathyroidectomy|0
107111|NCT00379899|358566|P2|Overall Study|Noncompliance|1
107112|NCT00379899|358567|P1|Overall Study|Noncompliance|1
107113|NCT00379899|358566|P2|Overall Study|Ineligibility determined|1
107114|NCT00379899|358567|P1|Overall Study|Ineligibility determined|0
107115|NCT00379899|358566|P2|Overall Study|Withdrawal by Subject|5
107116|NCT00379899|358567|P1|Overall Study|Withdrawal by Subject|5
107117|NCT00379899|358566|P2|Overall Study|Physician Decision|4
107118|NCT00379899|358567|P1|Overall Study|Physician Decision|3
107119|NCT00379899|358566|P2|Overall Study|Lost to Follow-up|4
107120|NCT00379899|358567|P1|Overall Study|Lost to Follow-up|2
107121|NCT00379899|358566|P2|Overall Study|Death|10
107122|NCT00379899|358567|P1|Overall Study|Death|10
107123|NCT00379899|358566|P2|Overall Study|Adverse Event|3
107124|NCT00379899|358567|P1|Overall Study|Adverse Event|7
107125|NCT00379912|358597|P2|Overall Study|Lack of Efficacy|0
107126|NCT00379912|358598|P1|Overall Study|Lack of Efficacy|1
107127|NCT00380068|358626|P1|Overall Study|Lack of Efficacy|5
107128|NCT00380068|358626|P1|Overall Study|Partipant moved away|1
107129|NCT00380068|358626|P1|Overall Study|Physician Decision|2
107130|NCT00380068|358626|P1|Overall Study|Lung transplant|3
107131|NCT00380068|358626|P1|Overall Study|Addition of other PAH therapeutic agent|1
107132|NCT00380068|358626|P1|Overall Study|Lost to Follow-up|1
107133|NCT00380068|358626|P1|Overall Study|Not compliant|6
107134|NCT00380068|358626|P1|Overall Study|Withdrawal by Subject|10
107135|NCT00380068|358626|P1|Overall Study|Adverse Event|40
107136|NCT00380081|358652|P6|Overall Study|Family Emergency|1
107137|NCT00380081|358653|P5|Overall Study|Family Emergency|0
107138|NCT00380081|358654|P4|Overall Study|Family Emergency|0
107139|NCT00380081|358655|P3|Overall Study|Family Emergency|0
107140|NCT00380081|358656|P2|Overall Study|Family Emergency|0
107141|NCT00380081|358657|P1|Overall Study|Family Emergency|0
107142|NCT00380081|358652|P6|Overall Study|Withdrawal by Subject|0
107143|NCT00380081|358653|P5|Overall Study|Withdrawal by Subject|1
107144|NCT00380081|358654|P4|Overall Study|Withdrawal by Subject|0
107145|NCT00380081|358655|P3|Overall Study|Withdrawal by Subject|0
107146|NCT00380081|358656|P2|Overall Study|Withdrawal by Subject|0
107147|NCT00380081|358657|P1|Overall Study|Withdrawal by Subject|0
107148|NCT00380250|358709|P2|Overall Study|Physician Decision|0
107149|NCT00380250|358710|P1|Overall Study|Physician Decision|1
107150|NCT00380250|358709|P2|Overall Study|Lost to Follow-up|5
107151|NCT00380250|358710|P1|Overall Study|Lost to Follow-up|14
107153|NCT00380250|358710|P1|Overall Study|Protocol Violation|15
107154|NCT00380250|358709|P2|Overall Study|Lack of Efficacy|8
107155|NCT00380250|358710|P1|Overall Study|Lack of Efficacy|10
107156|NCT00380250|358709|P2|Overall Study|Adverse Event|9
107157|NCT00380250|358710|P1|Overall Study|Adverse Event|20
107158|NCT00380250|358709|P2|Overall Study|Withdrawal by Subject|28
107159|NCT00380250|358710|P1|Overall Study|Withdrawal by Subject|39
107160|NCT00380367|358772|P1|Overall Study|Withdrawal by Subject|1
107161|NCT00380367|358772|P1|Overall Study|Lost to Follow-up|1
107162|NCT00380588|358779|P2|Overall Study|Physician Decision|0
107163|NCT00380588|358780|P1|Overall Study|Physician Decision|2
107164|NCT00380588|358779|P2|Overall Study|Withdrawal by Subject|3
107165|NCT00380588|358780|P1|Overall Study|Withdrawal by Subject|1
107166|NCT00380588|358779|P2|Overall Study|Adverse Event|3
107167|NCT00380588|358780|P1|Overall Study|Adverse Event|7
107168|NCT00380588|358779|P2|Overall Study|Next Cycle Not Started|0
107169|NCT00380588|358780|P1|Overall Study|Next Cycle Not Started|4
107170|NCT00380588|358779|P2|Overall Study|Unequivocal Disease Progression|34
107171|NCT00380588|358780|P1|Overall Study|Unequivocal Disease Progression|25
107172|NCT00380692|358794|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
107173|NCT00380692|358795|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
107174|NCT00380692|358794|P2|Study Period III - Open Label|Lack of Efficacy|4
107175|NCT00380692|358795|P1|Study Period III - Open Label|Lack of Efficacy|0
107176|NCT00380692|358794|P2|Study Period III - Open Label|Physician Decision|3
107177|NCT00380692|358795|P1|Study Period III - Open Label|Physician Decision|0
107178|NCT00380692|358794|P2|Study Period III - Open Label|Withdrawal by Subject|1
107179|NCT00380692|358795|P1|Study Period III - Open Label|Withdrawal by Subject|0
107180|NCT00380692|358794|P2|Study Period III - Open Label|Protocol Violation|0
107181|NCT00380692|358795|P1|Study Period III - Open Label|Protocol Violation|0
107182|NCT00380692|358794|P2|Study Period III - Open Label|Adverse Event|3
107183|NCT00380692|358795|P1|Study Period III - Open Label|Adverse Event|5
107184|NCT00380692|358794|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
107185|NCT00380692|358795|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
107186|NCT00380692|358794|P2|Study Period II - Double Blind|Lack of Efficacy|0
107187|NCT00380692|358795|P1|Study Period II - Double Blind|Lack of Efficacy|1
107188|NCT00380692|358794|P2|Study Period II - Double Blind|Physician Decision|1
107189|NCT00380692|358795|P1|Study Period II - Double Blind|Physician Decision|0
107190|NCT00380692|358794|P2|Study Period II - Double Blind|Withdrawal by Subject|0
107191|NCT00380692|358795|P1|Study Period II - Double Blind|Withdrawal by Subject|0
107192|NCT00380692|358794|P2|Study Period II - Double Blind|Protocol Violation|2
107193|NCT00380692|358795|P1|Study Period II - Double Blind|Protocol Violation|2
107194|NCT00380692|358794|P2|Study Period II - Double Blind|Adverse Event|0
107195|NCT00380692|358795|P1|Study Period II - Double Blind|Adverse Event|1
107196|NCT00380718|358841|P1|Overall Study|Death after 30-day post-therapy followup|17
107197|NCT00380718|358841|P1|Overall Study|Adverse Event|1
107198|NCT00380874|358862|P2|Overall Study|Not related to study drug|2
107199|NCT00380874|358863|P1|Overall Study|Not related to study drug|3
107200|NCT00380874|358862|P2|Overall Study|Withdrawal by Subject|1
107201|NCT00380874|358863|P1|Overall Study|Withdrawal by Subject|2
107202|NCT00380874|358862|P2|Overall Study|Death|0
107203|NCT00380874|358863|P1|Overall Study|Death|1
107204|NCT00380874|358862|P2|Overall Study|Adverse Event|7
107205|NCT00380874|358863|P1|Overall Study|Adverse Event|7
107206|NCT00380978|358881|P2|Overall Study|Parous patient|0
107207|NCT00380978|358882|P1|Overall Study|Parous patient|1
107208|NCT00380978|358881|P2|Overall Study|Allocation prior to analgesia request|2
107209|NCT00380978|358882|P1|Overall Study|Allocation prior to analgesia request|1
107210|NCT00380978|358881|P2|Overall Study|Wrong study envelope|2
107211|NCT00380978|358882|P1|Overall Study|Wrong study envelope|0
107212|NCT00380978|358881|P2|Overall Study|Refused allocated intervention|6
107213|NCT00380978|358882|P1|Overall Study|Refused allocated intervention|0
107214|NCT00381043|358910|P2|Overall Study|incarcerated|0
107215|NCT00381043|358911|P1|Overall Study|incarcerated|1
107216|NCT00381043|358910|P2|Overall Study|wanted more care|1
107217|NCT00381043|358911|P1|Overall Study|wanted more care|0
107218|NCT00381043|358910|P2|Overall Study|Withdrawal by Subject|1
107219|NCT00381043|358911|P1|Overall Study|Withdrawal by Subject|3
107220|NCT00381043|358910|P2|Overall Study|Lost to Follow-up|6
107221|NCT00381043|358911|P1|Overall Study|Lost to Follow-up|8
107222|NCT00381095|358931|P2|Overall Study|Adverse Event|7
107223|NCT00381095|358932|P1|Overall Study|Adverse Event|2
107224|NCT00381095|358931|P2|Overall Study|Withdrawal by Subject|3
107225|NCT00381095|358932|P1|Overall Study|Withdrawal by Subject|3
107226|NCT00381095|358931|P2|Overall Study|Protocol Violation|1
107227|NCT00381095|358932|P1|Overall Study|Protocol Violation|1
107228|NCT00381095|358931|P2|Overall Study|Unspecified|2
107229|NCT00381095|358932|P1|Overall Study|Unspecified|2
107230|NCT00381095|358931|P2|Overall Study|Lack of Efficacy|4
107231|NCT00381095|358932|P1|Overall Study|Lack of Efficacy|2
107232|NCT00381095|358931|P2|Overall Study|Death|4
107233|NCT00381095|358932|P1|Overall Study|Death|3
107234|NCT00375427|358964|P2|Overall Study|Death|10
107235|NCT00375427|358965|P1|Overall Study|Death|11
107236|NCT00375427|358964|P2|Overall Study|Administrative reasons|1
107237|NCT00375427|358965|P1|Overall Study|Administrative reasons|0
107238|NCT00375427|358964|P2|Overall Study|Lost to Follow-up|1
107239|NCT00375427|358965|P1|Overall Study|Lost to Follow-up|1
107240|NCT00375427|358964|P2|Overall Study|Withdrawal by Subject|13
107241|NCT00375427|358965|P1|Overall Study|Withdrawal by Subject|9
107242|NCT00375427|358964|P2|Overall Study|Protocol Violation|8
107243|NCT00375427|358965|P1|Overall Study|Protocol Violation|10
107244|NCT00375427|358964|P2|Overall Study|Patient no longer requires study drug|7
107245|NCT00375427|358965|P1|Overall Study|Patient no longer requires study drug|3
107246|NCT00375427|358964|P2|Overall Study|Unsatisfactory therapeutic effect|4
107247|NCT00375427|358965|P1|Overall Study|Unsatisfactory therapeutic effect|4
107248|NCT00375427|358964|P2|Overall Study|Abnormal laboratory value(s)|2
107249|NCT00375427|358965|P1|Overall Study|Abnormal laboratory value(s)|1
107250|NCT00375427|358964|P2|Overall Study|Abnormal test procedure result(s)|1
107251|NCT00375427|358965|P1|Overall Study|Abnormal test procedure result(s)|0
107252|NCT00375427|358964|P2|Overall Study|Adverse Event|27
107253|NCT00375427|358965|P1|Overall Study|Adverse Event|21
107254|NCT00375492|358989|P2|Overall Study|Withdrawal by Subject|6
107255|NCT00375492|358990|P1|Overall Study|Withdrawal by Subject|6
107256|NCT00375492|358989|P2|Overall Study|Sponsor Decision|1
107257|NCT00375492|358990|P1|Overall Study|Sponsor Decision|0
107258|NCT00375492|358989|P2|Overall Study|Protocol Violation|3
107259|NCT00375492|358990|P1|Overall Study|Protocol Violation|6
107260|NCT00375492|358989|P2|Overall Study|Physician Decision|4
107261|NCT00375492|358990|P1|Overall Study|Physician Decision|0
107262|NCT00375492|358989|P2|Overall Study|Lost to Follow-up|5
107263|NCT00375492|358990|P1|Overall Study|Lost to Follow-up|10
107264|NCT00375492|358989|P2|Overall Study|Loss of Glucose Control|1
107265|NCT00375492|358990|P1|Overall Study|Loss of Glucose Control|0
107266|NCT00375492|358989|P2|Overall Study|Entry Criteria Not Met|1
107267|NCT00375492|358990|P1|Overall Study|Entry Criteria Not Met|0
107268|NCT00375492|358989|P2|Overall Study|Adverse Event|5
107269|NCT00375492|358990|P1|Overall Study|Adverse Event|4
107270|NCT00375505|359020|P2|Overall Study|Adverse Event|2
107271|NCT00375505|359021|P1|Overall Study|Adverse Event|1
107272|NCT00375518|359065|P2|Overall Study|Death|1
107273|NCT00375518|359066|P1|Overall Study|Death|0
107274|NCT00375518|359065|P2|Overall Study|Patient Not Treated|6
107275|NCT00375518|359066|P1|Overall Study|Patient Not Treated|6
107276|NCT00375518|359065|P2|Overall Study|Withdrawal by Subject|10
107277|NCT00375518|359066|P1|Overall Study|Withdrawal by Subject|2
107278|NCT00381238|359072|P1|Overall Study|Disease progression|1
107279|NCT00381238|359072|P1|Overall Study|Withdrew by physician|1
107280|NCT00381238|359072|P1|Overall Study|Lack of Efficacy|2
107281|NCT00381238|359072|P1|Overall Study|Withdrawal by Subject|4
107282|NCT00381238|359072|P1|Overall Study|Protocol Violation|1
107283|NCT00381238|359072|P1|Overall Study|Adverse Event|3
107284|NCT00381303|359088|P2|Overall Study|Subject primary physician's decision|0
107285|NCT00381303|359089|P1|Overall Study|Subject primary physician's decision|1
107286|NCT00381303|359088|P2|Overall Study|Subject did not continue visits|0
107287|NCT00381303|359089|P1|Overall Study|Subject did not continue visits|1
107288|NCT00381303|359088|P2|Overall Study|Subject was too busy for appointments|0
107289|NCT00381303|359089|P1|Overall Study|Subject was too busy for appointments|1
107290|NCT00381303|359088|P2|Overall Study|No virologic response by week 12|0
107291|NCT00381303|359089|P1|Overall Study|No virologic response by week 12|1
107292|NCT00381303|359088|P2|Overall Study|Subject taking too many different meds|0
107293|NCT00381303|359089|P1|Overall Study|Subject taking too many different meds|1
107294|NCT00381303|359088|P2|Overall Study|Subject moved out of state|0
107295|NCT00381303|359089|P1|Overall Study|Subject moved out of state|2
107296|NCT00381303|359088|P2|Overall Study|Physician's decision to close the site|1
107297|NCT00381303|359089|P1|Overall Study|Physician's decision to close the site|3
107298|NCT00381303|359088|P2|Overall Study|Physician Decision|0
107299|NCT00381303|359089|P1|Overall Study|Physician Decision|1
107300|NCT00381303|359088|P2|Overall Study|Pregnancy|0
107301|NCT00381303|359089|P1|Overall Study|Pregnancy|2
107302|NCT00381303|359088|P2|Overall Study|Ineligible to continue the trial|1
107303|NCT00381303|359089|P1|Overall Study|Ineligible to continue the trial|2
107304|NCT00381303|359088|P2|Overall Study|Virologic failure|4
107305|NCT00381303|359089|P1|Overall Study|Virologic failure|6
107306|NCT00381303|359088|P2|Overall Study|Withdrawal by Subject|6
107307|NCT00381303|359089|P1|Overall Study|Withdrawal by Subject|13
107308|NCT00381303|359088|P2|Overall Study|Non-Adherence|6
107309|NCT00381303|359089|P1|Overall Study|Non-Adherence|13
107310|NCT00381303|359088|P2|Overall Study|AE/HIV-related event|6
107311|NCT00381303|359089|P1|Overall Study|AE/HIV-related event|22
107312|NCT00381303|359088|P2|Overall Study|Lost to Follow-up|9
107313|NCT00381303|359089|P1|Overall Study|Lost to Follow-up|25
107314|NCT00381381|359149|P1|Overall Study|Withdrawal by Subject|9
107315|NCT00381381|359149|P1|Overall Study|Lost to Follow-up|52
107316|NCT00381381|359149|P1|Overall Study|Adverse Event|3
107317|NCT00382291|359159|P3|Overall Study|Lack of Efficacy|1
107318|NCT00382291|359160|P2|Overall Study|Lack of Efficacy|0
107319|NCT00382291|359161|P1|Overall Study|Lack of Efficacy|0
107320|NCT00382291|359159|P3|Overall Study|Physician Decision|0
107321|NCT00382291|359160|P2|Overall Study|Physician Decision|1
107322|NCT00382291|359161|P1|Overall Study|Physician Decision|0
107323|NCT00382291|359159|P3|Overall Study|Withdrawal by Subject|0
107324|NCT00382291|359160|P2|Overall Study|Withdrawal by Subject|2
107325|NCT00382291|359161|P1|Overall Study|Withdrawal by Subject|0
107326|NCT00382291|359159|P3|Overall Study|Temporary study suspension|5
107327|NCT00382291|359160|P2|Overall Study|Temporary study suspension|2
107328|NCT00382291|359161|P1|Overall Study|Temporary study suspension|2
107329|NCT00382291|359159|P3|Overall Study|Protocol Violation|0
107330|NCT00382291|359160|P2|Overall Study|Protocol Violation|0
107331|NCT00382291|359161|P1|Overall Study|Protocol Violation|1
107332|NCT00382291|359159|P3|Overall Study|Adverse Event|2
107333|NCT00382291|359160|P2|Overall Study|Adverse Event|2
107334|NCT00382291|359161|P1|Overall Study|Adverse Event|1
107335|NCT00382408|359174|P2|Overall Study|Not specified|35
107336|NCT00382408|359175|P1|Overall Study|Not specified|100
107337|NCT00382408|359174|P2|Overall Study|Lost to Follow-up|8
107338|NCT00382408|359175|P1|Overall Study|Lost to Follow-up|19
107339|NCT00382408|359174|P2|Overall Study|Pregnancy|0
107340|NCT00382408|359175|P1|Overall Study|Pregnancy|2
107341|NCT00382408|359174|P2|Overall Study|Withdrawal by Subject|6
107342|NCT00382408|359175|P1|Overall Study|Withdrawal by Subject|17
107343|NCT00382408|359174|P2|Overall Study|Physician Decision|0
107344|NCT00382408|359175|P1|Overall Study|Physician Decision|1
107345|NCT00382408|359174|P2|Overall Study|Protocol Violation|2
107346|NCT00382408|359175|P1|Overall Study|Protocol Violation|2
107347|NCT00382408|359174|P2|Overall Study|Did not meet protocol requirement|3
107348|NCT00382408|359175|P1|Overall Study|Did not meet protocol requirement|3
107349|NCT00382720|359211|P3|Overall Study|Discontinued at end of study|2
107350|NCT00382720|359212|P2|Overall Study|Discontinued at end of study|1
107351|NCT00382720|359213|P1|Overall Study|Discontinued at end of study|0
107352|NCT00382720|359211|P3|Overall Study|Investigator/Clinical decision|6
107353|NCT00382720|359212|P2|Overall Study|Investigator/Clinical decision|6
107354|NCT00382720|359213|P1|Overall Study|Investigator/Clinical decision|5
107355|NCT00382720|359211|P3|Overall Study|Good prognosis|0
107356|NCT00382720|359212|P2|Overall Study|Good prognosis|1
107357|NCT00382720|359213|P1|Overall Study|Good prognosis|0
107358|NCT00382720|359211|P3|Overall Study|Clinically progressive disease|0
107359|NCT00382720|359212|P2|Overall Study|Clinically progressive disease|1
107360|NCT00382720|359213|P1|Overall Study|Clinically progressive disease|0
107361|NCT00382720|359211|P3|Overall Study|Patient did not receive study medication|4
107362|NCT00382720|359212|P2|Overall Study|Patient did not receive study medication|1
107363|NCT00382720|359213|P1|Overall Study|Patient did not receive study medication|1
107364|NCT00382720|359211|P3|Overall Study|Surgery|4
107365|NCT00382720|359212|P2|Overall Study|Surgery|1
107366|NCT00382720|359213|P1|Overall Study|Surgery|1
107367|NCT00382720|359211|P3|Overall Study|Withdrawal by Subject|12
107368|NCT00382720|359212|P2|Overall Study|Withdrawal by Subject|20
107369|NCT00382720|359213|P1|Overall Study|Withdrawal by Subject|11
107370|NCT00382720|359211|P3|Overall Study|Withdrew consent|2
107371|NCT00382720|359212|P2|Overall Study|Withdrew consent|1
107372|NCT00382720|359213|P1|Overall Study|Withdrew consent|1
107373|NCT00382720|359211|P3|Overall Study|Progressive disease|38
107374|NCT00382720|359212|P2|Overall Study|Progressive disease|28
107375|NCT00382720|359213|P1|Overall Study|Progressive disease|37
107376|NCT00382720|359211|P3|Overall Study|Death|2
107377|NCT00382720|359212|P2|Overall Study|Death|1
107378|NCT00382720|359213|P1|Overall Study|Death|0
107379|NCT00382720|359211|P3|Overall Study|Protocol Violation|1
107380|NCT00382720|359212|P2|Overall Study|Protocol Violation|5
107381|NCT00382720|359213|P1|Overall Study|Protocol Violation|2
107382|NCT00382720|359211|P3|Overall Study|Adverse Event|15
107383|NCT00382720|359212|P2|Overall Study|Adverse Event|23
107384|NCT00382720|359213|P1|Overall Study|Adverse Event|21
107385|NCT00382733|359227|P5|Overall Study|Withdrawal by Subject|0
107386|NCT00382733|359228|P4|Overall Study|Withdrawal by Subject|0
107387|NCT00382733|359229|P3|Overall Study|Withdrawal by Subject|0
107388|NCT00382733|359230|P2|Overall Study|Withdrawal by Subject|1
107389|NCT00382733|359231|P1|Overall Study|Withdrawal by Subject|0
107390|NCT00382863|359264|P2|Overall Study|Withdrawal by Subject|25
107391|NCT00382863|359265|P1|Overall Study|Withdrawal by Subject|5
107392|NCT00382863|359264|P2|Overall Study|Lost to Follow-up|2
107393|NCT00382863|359265|P1|Overall Study|Lost to Follow-up|1
107394|NCT00382863|359264|P2|Overall Study|Death|9
107395|NCT00382863|359265|P1|Overall Study|Death|9
107396|NCT00382967|359336|P2|Overall Study|Protocol Violation|1
107397|NCT00382967|359337|P1|Overall Study|Protocol Violation|1
107398|NCT00382993|359345|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
107399|NCT00382993|359346|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
107400|NCT00382993|359345|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
107401|NCT00382993|359346|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
107402|NCT00382993|359345|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
107403|NCT00382993|359346|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
107404|NCT00382993|359345|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
107405|NCT00382993|359346|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
107406|NCT00382993|359345|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
107407|NCT00382993|359346|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
107408|NCT00382993|359345|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
107409|NCT00382993|359346|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
107410|NCT00382993|359345|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
107411|NCT00382993|359346|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
107412|NCT00382993|359345|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
107413|NCT00382993|359346|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
107414|NCT00382993|359345|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
107415|NCT00382993|359346|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
107416|NCT00382993|359345|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
107417|NCT00382993|359346|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
107418|NCT00383019|359390|P2|Overall Study|Withdrawal by Subject|1
107419|NCT00383019|359391|P1|Overall Study|Withdrawal by Subject|0
107420|NCT00383019|359390|P2|Overall Study|Adverse Event|1
107421|NCT00383019|359391|P1|Overall Study|Adverse Event|5
107422|NCT00383084|359432|P2|Overall Study|Withdrawal by Subject|10
107423|NCT00383084|359433|P1|Overall Study|Withdrawal by Subject|12
107424|NCT00383123|359466|P2|Overall Study|Other reason|6
107425|NCT00383123|359467|P1|Overall Study|Other reason|10
107426|NCT00383123|359466|P2|Overall Study|Withdrawal by Subject|18
107427|NCT00383123|359467|P1|Overall Study|Withdrawal by Subject|27
107428|NCT00383123|359466|P2|Overall Study|Protocol Violation|1
107429|NCT00383123|359467|P1|Overall Study|Protocol Violation|5
107430|NCT00383123|359466|P2|Overall Study|Lost to Follow-up|61
107431|NCT00383123|359467|P1|Overall Study|Lost to Follow-up|68
107432|NCT00383123|359466|P2|Overall Study|Adverse Event|0
107433|NCT00383123|359467|P1|Overall Study|Adverse Event|1
107434|NCT00383149|359487|P1|Overall Study|Participant Withdrew Consent|1
107435|NCT00383149|359487|P1|Overall Study|Request to Discontinue Treatment|4
107436|NCT00383149|359487|P1|Overall Study|Study Drug Toxicity|4
107437|NCT00383149|359487|P1|Overall Study|Other|1
107438|NCT00383149|359487|P1|Overall Study|Lost to Follow-up|1
107439|NCT00383149|359487|P1|Overall Study|Disease Progression|38
107440|NCT00383149|359487|P1|Overall Study|Death|2
107441|NCT00383149|359487|P1|Overall Study|Adverse Event not Related to Study Drug|3
107442|NCT00383162|359504|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
107443|NCT00383162|359505|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
107444|NCT00383162|359504|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
107445|NCT00383162|359505|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
107446|NCT00383162|359504|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
107447|NCT00383162|359505|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
107448|NCT00383162|359504|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
107449|NCT00383162|359505|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
107450|NCT00383162|359504|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
107451|NCT00383162|359505|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
107452|NCT00383162|359504|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
107453|NCT00383162|359505|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
107454|NCT00383162|359504|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
107455|NCT00383162|359505|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
107456|NCT00383162|359504|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
107457|NCT00383162|359505|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
107458|NCT00383162|359504|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
107459|NCT00383162|359505|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
107460|NCT00383240|359551|P4|Overall Study|Administrative|0
107461|NCT00383240|359552|P3|Overall Study|Administrative|0
107462|NCT00383240|359553|P2|Overall Study|Administrative|1
107463|NCT00383240|359554|P1|Overall Study|Administrative|1
107464|NCT00383240|359551|P4|Overall Study|Did not meet protocol eligibility|3
107465|NCT00383240|359552|P3|Overall Study|Did not meet protocol eligibility|9
107466|NCT00383240|359553|P2|Overall Study|Did not meet protocol eligibility|4
107467|NCT00383240|359554|P1|Overall Study|Did not meet protocol eligibility|9
107468|NCT00383240|359551|P4|Overall Study|Protocol Violation|6
107469|NCT00383240|359552|P3|Overall Study|Protocol Violation|9
107470|NCT00383240|359553|P2|Overall Study|Protocol Violation|5
107471|NCT00383240|359554|P1|Overall Study|Protocol Violation|4
107472|NCT00383240|359551|P4|Overall Study|Withdrawal by subjects, reasons related|5
107473|NCT00383240|359552|P3|Overall Study|Withdrawal by subjects, reasons related|3
107474|NCT00383240|359553|P2|Overall Study|Withdrawal by subjects, reasons related|1
107475|NCT00383240|359554|P1|Overall Study|Withdrawal by subjects, reasons related|0
107476|NCT00383240|359551|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
107477|NCT00383240|359552|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
107478|NCT00383240|359553|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
107479|NCT00383240|359554|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
107480|NCT00383240|359551|P4|Overall Study|Lost to Follow-up|2
107481|NCT00383240|359552|P3|Overall Study|Lost to Follow-up|0
107482|NCT00383240|359553|P2|Overall Study|Lost to Follow-up|0
107483|NCT00383240|359554|P1|Overall Study|Lost to Follow-up|3
107484|NCT00383240|359551|P4|Overall Study|Treatment Failure|46
107485|NCT00383240|359552|P3|Overall Study|Treatment Failure|47
107486|NCT00383240|359553|P2|Overall Study|Treatment Failure|13
107487|NCT00383240|359554|P1|Overall Study|Treatment Failure|8
107488|NCT00383240|359551|P4|Overall Study|Adverse Event|7
107489|NCT00383240|359552|P3|Overall Study|Adverse Event|9
107490|NCT00383240|359553|P2|Overall Study|Adverse Event|6
107491|NCT00383240|359554|P1|Overall Study|Adverse Event|4
107492|NCT00383331|359596|P2|Overall Study|Protocol Violation|1
107493|NCT00383331|359597|P1|Overall Study|Protocol Violation|0
107494|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Administrative|0
107495|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Administrative|1
107496|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Administrative|0
107497|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Administrative|1
107498|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Administrative|1
107499|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
107500|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
107501|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
107502|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
107503|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
107504|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
107505|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
107506|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
107507|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
107508|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
107509|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
107510|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
107511|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
107512|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
107513|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
107514|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
107515|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
107516|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
107517|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
107518|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
107519|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
107520|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
107521|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
107522|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
107523|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
107524|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
107525|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
107526|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
107527|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
107528|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
107529|NCT00383435|359618|P5|26-Week Treatment Safety Extension|Adverse Event|1
107530|NCT00383435|359619|P4|26-Week Treatment Safety Extension|Adverse Event|5
107531|NCT00383435|359620|P3|26-Week Treatment Safety Extension|Adverse Event|5
107532|NCT00383435|359621|P2|26-Week Treatment Safety Extension|Adverse Event|2
107533|NCT00383435|359622|P1|26-Week Treatment Safety Extension|Adverse Event|4
107534|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Administrative|1
107535|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Administrative|1
107536|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Administrative|1
107537|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Administrative|3
107538|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Administrative|5
107539|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
107540|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
107541|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
107542|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
107543|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
107544|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
107545|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
107546|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
107547|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
107548|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
107549|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
107550|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
107551|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
107552|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
107553|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
107554|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
107555|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
107556|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
107557|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
107705|NCT00384033|359861|P2|Overall Study|Randomized but not treated|7
107558|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
107559|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
107560|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
107561|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
107562|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
107563|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
107564|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
107565|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
107566|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
107567|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
107568|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
107569|NCT00383435|359618|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
107570|NCT00383435|359619|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
107571|NCT00383435|359620|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
107572|NCT00383435|359621|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
107573|NCT00383435|359622|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
107574|NCT00383500|359662|P3|Overall Study|Lost to Follow-up|2
107575|NCT00383500|359663|P2|Overall Study|Lost to Follow-up|0
107576|NCT00383500|359664|P1|Overall Study|Lost to Follow-up|0
107577|NCT00383500|359662|P3|Overall Study|Withdrawal by Subject|0
107578|NCT00383500|359663|P2|Overall Study|Withdrawal by Subject|3
107579|NCT00383500|359664|P1|Overall Study|Withdrawal by Subject|8
107580|NCT00383552|359679|P4|Overall Study|Administrative|1
107581|NCT00383552|359680|P3|Overall Study|Administrative|1
107582|NCT00383552|359681|P2|Overall Study|Administrative|0
107583|NCT00383552|359682|P1|Overall Study|Administrative|1
107584|NCT00383552|359679|P4|Overall Study|Did not meet protocol eligibility|3
107585|NCT00383552|359680|P3|Overall Study|Did not meet protocol eligibility|2
107586|NCT00383552|359681|P2|Overall Study|Did not meet protocol eligibility|6
107587|NCT00383552|359682|P1|Overall Study|Did not meet protocol eligibility|8
107588|NCT00383552|359679|P4|Overall Study|Noncompliance with the protocol|10
107589|NCT00383552|359680|P3|Overall Study|Noncompliance with the protocol|8
107590|NCT00383552|359681|P2|Overall Study|Noncompliance with the protocol|6
107591|NCT00383552|359682|P1|Overall Study|Noncompliance with the protocol|11
107592|NCT00383552|359679|P4|Overall Study|Did not wish to continue (related)|3
107593|NCT00383552|359680|P3|Overall Study|Did not wish to continue (related)|2
107594|NCT00383552|359681|P2|Overall Study|Did not wish to continue (related)|0
107595|NCT00383552|359682|P1|Overall Study|Did not wish to continue (related)|1
107596|NCT00383552|359679|P4|Overall Study|Did not wish to continue (unrelated)|6
107597|NCT00383552|359680|P3|Overall Study|Did not wish to continue (unrelated)|5
107598|NCT00383552|359681|P2|Overall Study|Did not wish to continue (unrelated)|9
107599|NCT00383552|359682|P1|Overall Study|Did not wish to continue (unrelated)|4
107600|NCT00383552|359679|P4|Overall Study|Lost to Follow-up|1
107601|NCT00383552|359680|P3|Overall Study|Lost to Follow-up|5
107602|NCT00383552|359681|P2|Overall Study|Lost to Follow-up|1
107603|NCT00383552|359682|P1|Overall Study|Lost to Follow-up|0
107604|NCT00383552|359679|P4|Overall Study|Lack of Efficacy|42
107605|NCT00383552|359680|P3|Overall Study|Lack of Efficacy|29
107606|NCT00383552|359681|P2|Overall Study|Lack of Efficacy|13
107607|NCT00383552|359682|P1|Overall Study|Lack of Efficacy|4
107608|NCT00383552|359679|P4|Overall Study|Adverse Event|6
107609|NCT00383552|359680|P3|Overall Study|Adverse Event|9
107610|NCT00383552|359681|P2|Overall Study|Adverse Event|6
107611|NCT00383552|359682|P1|Overall Study|Adverse Event|7
107612|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Administrative|0
107613|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Administrative|1
107614|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Administrative|3
107615|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Administrative|2
107616|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Administrative|1
107617|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
107618|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
107619|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
107620|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
107621|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
107622|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
107623|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
107624|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
107625|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
107626|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
107627|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
107628|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
107629|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
107630|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
107631|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
107632|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
107633|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
107634|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
107635|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
107636|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
107637|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
107638|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
107639|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
107640|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
107641|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
107642|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
107643|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
107644|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
107645|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
107646|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
107647|NCT00383721|359757|P5|26-Week Treatment Safety Extension|Adverse Event|0
107648|NCT00383721|359758|P4|26-Week Treatment Safety Extension|Adverse Event|1
107649|NCT00383721|359759|P3|26-Week Treatment Safety Extension|Adverse Event|10
107650|NCT00383721|359760|P2|26-Week Treatment Safety Extension|Adverse Event|7
107651|NCT00383721|359761|P1|26-Week Treatment Safety Extension|Adverse Event|6
107652|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Ongoing|0
107653|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Ongoing|0
107654|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Ongoing|0
107655|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Ongoing|0
107656|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Ongoing|1
107657|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Administrative|3
107658|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Administrative|3
107659|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Administrative|3
107660|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Administrative|3
107661|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Administrative|1
107662|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
107663|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
107664|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
107665|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
107666|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
107667|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
107668|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
107669|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
107670|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
107671|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
107672|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
107673|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
107674|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
107675|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
107676|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
107677|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
107678|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
107679|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
107680|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
107681|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
107682|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
107683|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
107684|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
107685|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
107686|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
107687|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
107688|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
107689|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
107690|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
107691|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
107692|NCT00383721|359757|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
107693|NCT00383721|359758|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
107694|NCT00383721|359759|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
107695|NCT00383721|359760|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
107696|NCT00383721|359761|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
107697|NCT00383786|359839|P2|Overall Study|Physician Decision|1
107698|NCT00383786|359840|P1|Overall Study|Physician Decision|0
107699|NCT00383786|359839|P2|Overall Study|Withdrawal by Subject|5
107700|NCT00383786|359840|P1|Overall Study|Withdrawal by Subject|2
107701|NCT00383786|359839|P2|Overall Study|Protocol Violation|6
107702|NCT00383786|359840|P1|Overall Study|Protocol Violation|2
107703|NCT00384033|359859|P4|Overall Study|Randomized but not treated|2
107704|NCT00384033|359860|P3|Overall Study|Randomized but not treated|10
107706|NCT00384033|359862|P1|Overall Study|Randomized but not treated|3
107707|NCT00384033|359859|P4|Overall Study|Lack of Efficacy|1
107708|NCT00384033|359860|P3|Overall Study|Lack of Efficacy|3
107709|NCT00384033|359861|P2|Overall Study|Lack of Efficacy|3
107710|NCT00384033|359862|P1|Overall Study|Lack of Efficacy|7
107711|NCT00384033|359859|P4|Overall Study|Withdrawal by Subject|2
107712|NCT00384033|359860|P3|Overall Study|Withdrawal by Subject|5
107713|NCT00384033|359861|P2|Overall Study|Withdrawal by Subject|2
107714|NCT00384033|359862|P1|Overall Study|Withdrawal by Subject|6
107715|NCT00384033|359859|P4|Overall Study|Protocol Violation|6
107716|NCT00384033|359860|P3|Overall Study|Protocol Violation|5
107717|NCT00384033|359861|P2|Overall Study|Protocol Violation|0
107718|NCT00384033|359862|P1|Overall Study|Protocol Violation|5
107719|NCT00384033|359859|P4|Overall Study|Unspecified|0
107720|NCT00384033|359860|P3|Overall Study|Unspecified|0
107721|NCT00384033|359861|P2|Overall Study|Unspecified|0
107722|NCT00384033|359862|P1|Overall Study|Unspecified|2
107723|NCT00384033|359859|P4|Overall Study|Lost to Follow-up|7
107724|NCT00384033|359860|P3|Overall Study|Lost to Follow-up|7
107725|NCT00384033|359861|P2|Overall Study|Lost to Follow-up|12
107726|NCT00384033|359862|P1|Overall Study|Lost to Follow-up|6
107727|NCT00384033|359859|P4|Overall Study|Physician Decision|0
107728|NCT00384033|359860|P3|Overall Study|Physician Decision|0
107729|NCT00384033|359861|P2|Overall Study|Physician Decision|0
107730|NCT00384033|359862|P1|Overall Study|Physician Decision|1
107731|NCT00384033|359859|P4|Overall Study|Failed to return|2
107732|NCT00384033|359860|P3|Overall Study|Failed to return|2
107733|NCT00384033|359861|P2|Overall Study|Failed to return|3
107734|NCT00384033|359862|P1|Overall Study|Failed to return|1
107735|NCT00384033|359859|P4|Overall Study|Adverse Event|20
107736|NCT00384033|359860|P3|Overall Study|Adverse Event|11
107737|NCT00384033|359861|P2|Overall Study|Adverse Event|8
107738|NCT00384033|359862|P1|Overall Study|Adverse Event|10
107739|NCT00384059|359906|P2|Toddler Dose|Failed to return|1
107740|NCT00384059|359907|P1|Toddler Dose|Failed to return|0
107741|NCT00384059|359906|P2|Toddler Dose|Lost to Follow-up|1
107742|NCT00384059|359907|P1|Toddler Dose|Lost to Follow-up|1
107743|NCT00384059|359906|P2|After Infant Series|Lost to Follow-up|1
107744|NCT00384059|359907|P1|After Infant Series|Lost to Follow-up|0
107745|NCT00384059|359906|P2|After Infant Series|Physician Decision|1
107746|NCT00384059|359907|P1|After Infant Series|Physician Decision|0
107747|NCT00384059|359906|P2|After Infant Series|Adverse Event|1
107748|NCT00384059|359907|P1|After Infant Series|Adverse Event|0
107749|NCT00384059|359906|P2|After Infant Series|Failed to Return|2
107750|NCT00384059|359907|P1|After Infant Series|Failed to Return|0
107751|NCT00384059|359906|P2|After Infant Series|Withdrawal by Subject|2
107752|NCT00384059|359907|P1|After Infant Series|Withdrawal by Subject|2
107753|NCT00384059|359906|P2|After Infant Series|Protocol Violation|3
107754|NCT00384059|359907|P1|After Infant Series|Protocol Violation|2
107755|NCT00384059|359906|P2|Infant Series|Lost to Follow-up|1
107756|NCT00384059|359907|P1|Infant Series|Lost to Follow-up|0
107757|NCT00384059|359906|P2|Infant Series|Protocol Violation|2
107758|NCT00384059|359907|P1|Infant Series|Protocol Violation|1
107759|NCT00384059|359906|P2|Infant Series|Adverse Event|2
107760|NCT00384059|359907|P1|Infant Series|Adverse Event|1
107761|NCT00384059|359906|P2|Infant Series|Withdrawal by Subject|2
107762|NCT00384059|359907|P1|Infant Series|Withdrawal by Subject|2
107763|NCT00384059|359906|P2|Infant Series|Not consented|6
107764|NCT00384059|359907|P1|Infant Series|Not consented|2
107765|NCT00384085|359956|P3|Overall Study|Patient required surgery|0
107766|NCT00384085|359957|P2|Overall Study|Patient required surgery|1
107767|NCT00384085|359958|P1|Overall Study|Patient required surgery|0
107768|NCT00384085|359956|P3|Overall Study|Patient moved|1
107769|NCT00384085|359957|P2|Overall Study|Patient moved|0
107770|NCT00384085|359958|P1|Overall Study|Patient moved|1
107771|NCT00384085|359956|P3|Overall Study|Sponsor decision|1
107772|NCT00384085|359957|P2|Overall Study|Sponsor decision|2
107773|NCT00384085|359958|P1|Overall Study|Sponsor decision|1
107774|NCT00384085|359956|P3|Overall Study|Loss of site personnel|1
107775|NCT00384085|359957|P2|Overall Study|Loss of site personnel|0
107776|NCT00384085|359958|P1|Overall Study|Loss of site personnel|1
107777|NCT00384085|359956|P3|Overall Study|Physician Decision|0
107778|NCT00384085|359957|P2|Overall Study|Physician Decision|0
107779|NCT00384085|359958|P1|Overall Study|Physician Decision|1
107780|NCT00384085|359956|P3|Overall Study|Patient non-compliant|5
107781|NCT00384085|359957|P2|Overall Study|Patient non-compliant|4
107782|NCT00384085|359958|P1|Overall Study|Patient non-compliant|4
107783|NCT00384085|359956|P3|Overall Study|Withdrawal by Subject|29
107784|NCT00384085|359957|P2|Overall Study|Withdrawal by Subject|19
107785|NCT00384085|359958|P1|Overall Study|Withdrawal by Subject|14
107786|NCT00384085|359956|P3|Overall Study|Progressive Disease|0
107787|NCT00384085|359957|P2|Overall Study|Progressive Disease|1
107788|NCT00384085|359958|P1|Overall Study|Progressive Disease|0
107789|NCT00384085|359956|P3|Overall Study|Lost to Follow-up|10
107790|NCT00384085|359957|P2|Overall Study|Lost to Follow-up|9
107791|NCT00384085|359958|P1|Overall Study|Lost to Follow-up|9
107792|NCT00384085|359956|P3|Overall Study|Protocol Violation|2
107793|NCT00384085|359957|P2|Overall Study|Protocol Violation|2
107794|NCT00384085|359958|P1|Overall Study|Protocol Violation|2
107795|NCT00384085|359956|P3|Overall Study|No longer Requires Study Treatment|1
107796|NCT00384085|359957|P2|Overall Study|No longer Requires Study Treatment|0
107797|NCT00384085|359958|P1|Overall Study|No longer Requires Study Treatment|1
107798|NCT00384085|359956|P3|Overall Study|Lack of Efficacy|2
107799|NCT00384085|359957|P2|Overall Study|Lack of Efficacy|3
107800|NCT00384085|359958|P1|Overall Study|Lack of Efficacy|0
107801|NCT00384085|359956|P3|Overall Study|Adverse Event|4
107802|NCT00384085|359957|P2|Overall Study|Adverse Event|5
107803|NCT00384085|359958|P1|Overall Study|Adverse Event|5
107804|NCT00384176|359985|P3|Overall Study|Liver metastases, colon resec. planned|0
107805|NCT00384176|359986|P2|Overall Study|Liver metastases, colon resec. planned|0
107806|NCT00384176|359987|P1|Overall Study|Liver metastases, colon resec. planned|1
107807|NCT00384176|359985|P3|Overall Study|Physician Decision|0
107808|NCT00384176|359986|P2|Overall Study|Physician Decision|2
107809|NCT00384176|359987|P1|Overall Study|Physician Decision|0
107810|NCT00384176|359985|P3|Overall Study|Did not receive study treatment|1
107811|NCT00384176|359986|P2|Overall Study|Did not receive study treatment|1
107812|NCT00384176|359987|P1|Overall Study|Did not receive study treatment|0
107813|NCT00384176|359985|P3|Overall Study|Toxicity of treatment|0
107814|NCT00384176|359986|P2|Overall Study|Toxicity of treatment|0
107815|NCT00384176|359987|P1|Overall Study|Toxicity of treatment|1
107816|NCT00384176|359985|P3|Overall Study|Longer QTC as Visit 1|0
107817|NCT00384176|359986|P2|Overall Study|Longer QTC as Visit 1|0
107818|NCT00384176|359987|P1|Overall Study|Longer QTC as Visit 1|1
107819|NCT00384176|359985|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
107820|NCT00384176|359986|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
107821|NCT00384176|359987|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
107822|NCT00384176|359985|P3|Overall Study|Lost to Follow-up|4
107823|NCT00384176|359986|P2|Overall Study|Lost to Follow-up|18
107824|NCT00384176|359987|P1|Overall Study|Lost to Follow-up|16
107825|NCT00384176|359985|P3|Overall Study|Withdrawal by Subject|22
107826|NCT00384176|359986|P2|Overall Study|Withdrawal by Subject|48
107827|NCT00384176|359987|P1|Overall Study|Withdrawal by Subject|52
107828|NCT00384176|359985|P3|Overall Study|Death|105
107829|NCT00384176|359986|P2|Overall Study|Death|247
107830|NCT00384176|359987|P1|Overall Study|Death|239
107831|NCT00384189|360014|P4|Overall Study|Reason Not Specified|40
107832|NCT00384189|360015|P3|Overall Study|Reason Not Specified|58
107833|NCT00384189|360016|P2|Overall Study|Reason Not Specified|57
107834|NCT00384189|360017|P1|Overall Study|Reason Not Specified|50
107835|NCT00384293|360086|P3|Post-randomization Period|Patient Randomized in Error|1
107836|NCT00384293|360087|P2|Post-randomization Period|Patient Randomized in Error|0
107837|NCT00384293|360088|P1|Post-randomization Period|Patient Randomized in Error|0
107838|NCT00384293|360086|P3|Post-randomization Period|Trial Termination|204
107839|NCT00384293|360087|P2|Post-randomization Period|Trial Termination|180
107840|NCT00384293|360088|P1|Post-randomization Period|Trial Termination|0
107841|NCT00384293|360086|P3|Post-randomization Period|Withdrawal by Subject|6
107842|NCT00384293|360087|P2|Post-randomization Period|Withdrawal by Subject|8
107843|NCT00384293|360088|P1|Post-randomization Period|Withdrawal by Subject|0
107844|NCT00384293|360086|P3|Post-randomization Period|Protocol Violation|0
107845|NCT00384293|360087|P2|Post-randomization Period|Protocol Violation|1
107846|NCT00384293|360088|P1|Post-randomization Period|Protocol Violation|0
107847|NCT00384293|360086|P3|Post-randomization Period|Lost to Follow-up|1
107848|NCT00384293|360087|P2|Post-randomization Period|Lost to Follow-up|2
107849|NCT00384293|360088|P1|Post-randomization Period|Lost to Follow-up|0
107850|NCT00384293|360086|P3|Post-randomization Period|Adverse Event|7
107851|NCT00384293|360087|P2|Post-randomization Period|Adverse Event|23
107852|NCT00384293|360088|P1|Post-randomization Period|Adverse Event|0
107853|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
107854|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
107855|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
107856|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
107857|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
107858|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
107859|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
107860|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
107861|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
107862|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
107863|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
107864|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
107865|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
107866|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
107867|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
107868|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
107869|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
107870|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
107871|NCT00384293|360086|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
107872|NCT00384293|360087|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
107873|NCT00384293|360088|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
107874|NCT00384332|360101|P2|Overall Study|Lost to Follow-up|0
107875|NCT00384332|360102|P1|Overall Study|Lost to Follow-up|4
107876|NCT00384397|360113|P3|Overall Study|Withdrawal by Subject|15
107877|NCT00384397|360114|P2|Overall Study|Withdrawal by Subject|17
107878|NCT00384397|360115|P1|Overall Study|Withdrawal by Subject|14
107879|NCT00384397|360113|P3|Overall Study|Lost to Follow-up|3
107880|NCT00384397|360114|P2|Overall Study|Lost to Follow-up|13
107881|NCT00384397|360115|P1|Overall Study|Lost to Follow-up|11
107882|NCT00384397|360113|P3|Overall Study|Protocol Violation|13
107883|NCT00384397|360114|P2|Overall Study|Protocol Violation|15
107884|NCT00384397|360115|P1|Overall Study|Protocol Violation|7
107885|NCT00384397|360113|P3|Overall Study|Adverse Event|2
107886|NCT00384397|360114|P2|Overall Study|Adverse Event|1
107887|NCT00384397|360115|P1|Overall Study|Adverse Event|0
107888|NCT00378508|360144|P2|Overall Study|Lost to Follow-up|0
107889|NCT00378508|360145|P1|Overall Study|Lost to Follow-up|1
107890|NCT00378508|360144|P2|Overall Study|Withdrawal by Subject|3
107891|NCT00378508|360145|P1|Overall Study|Withdrawal by Subject|1
107892|NCT00378534|360161|P1|Overall Study|Subjects did not receive a transplant|3
107893|NCT00378534|360161|P1|Overall Study|Donors|57
107894|NCT00378560|360167|P2|Overall Study|Laboratory test values abnormal|0
107895|NCT00378560|360168|P1|Overall Study|Laboratory test values abnormal|1
107896|NCT00378560|360167|P2|Overall Study|Pregnancy|5
107897|NCT00378560|360168|P1|Overall Study|Pregnancy|7
107898|NCT00378560|360167|P2|Overall Study|Moved|3
107899|NCT00378560|360168|P1|Overall Study|Moved|4
107900|NCT00378560|360167|P2|Overall Study|Withdrawal by Subject|21
107901|NCT00378560|360168|P1|Overall Study|Withdrawal by Subject|17
107902|NCT00378560|360167|P2|Overall Study|Protocol Violation|0
107903|NCT00378560|360168|P1|Overall Study|Protocol Violation|2
107904|NCT00378560|360167|P2|Overall Study|Lost to Follow-up|29
107905|NCT00378560|360168|P1|Overall Study|Lost to Follow-up|24
107906|NCT00378560|360167|P2|Overall Study|Adverse Event|0
107907|NCT00378560|360168|P1|Overall Study|Adverse Event|1
107908|NCT00378573|360182|P1|Follow-up|Withdrawal by Subject|1
107909|NCT00378573|360182|P1|Follow-up|Lost to Follow-up|1
107910|NCT00378573|360182|P1|Follow-up|Death|12
107911|NCT00378573|360182|P1|Treatment Period|Sponsor decision to close study|1
107912|NCT00378573|360182|P1|Treatment Period|Disease Progression|4
107913|NCT00378573|360182|P1|Treatment Period|Withdrawal by Subject|2
107914|NCT00378573|360182|P1|Treatment Period|Physician Decision|1
107915|NCT00378573|360182|P1|Treatment Period|Adverse Event|9
107916|NCT00378599|360188|P1|Overall Study|Withdrawal by Subject|5
107917|NCT00378599|360188|P1|Overall Study|Treatment failure|7
107918|NCT00378599|360188|P1|Overall Study|Protocol Violation|2
107919|NCT00378599|360188|P1|Overall Study|Adverse Event|38
107920|NCT00384930|360240|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
107921|NCT00384930|360241|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
107922|NCT00384930|360242|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
107923|NCT00384930|360243|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
107924|NCT00384930|360244|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
107925|NCT00384930|360240|P5|Overall Study|Withdrawal by Subject|16
107926|NCT00384930|360241|P4|Overall Study|Withdrawal by Subject|6
107927|NCT00384930|360242|P3|Overall Study|Withdrawal by Subject|7
107928|NCT00384930|360243|P2|Overall Study|Withdrawal by Subject|7
107929|NCT00384930|360244|P1|Overall Study|Withdrawal by Subject|9
107930|NCT00384930|360240|P5|Overall Study|Sponsor Decision|0
107931|NCT00384930|360241|P4|Overall Study|Sponsor Decision|5
107932|NCT00384930|360242|P3|Overall Study|Sponsor Decision|0
107933|NCT00384930|360243|P2|Overall Study|Sponsor Decision|4
107934|NCT00384930|360244|P1|Overall Study|Sponsor Decision|3
107935|NCT00384930|360240|P5|Overall Study|Protocol Violation|4
107936|NCT00384930|360241|P4|Overall Study|Protocol Violation|6
107937|NCT00384930|360242|P3|Overall Study|Protocol Violation|1
107938|NCT00384930|360243|P2|Overall Study|Protocol Violation|0
107939|NCT00384930|360244|P1|Overall Study|Protocol Violation|1
107940|NCT00384930|360240|P5|Overall Study|Physician Decision|1
107941|NCT00384930|360241|P4|Overall Study|Physician Decision|0
107942|NCT00384930|360242|P3|Overall Study|Physician Decision|1
107943|NCT00384930|360243|P2|Overall Study|Physician Decision|1
107944|NCT00384930|360244|P1|Overall Study|Physician Decision|0
107945|NCT00384930|360240|P5|Overall Study|Lost to Follow-up|6
107946|NCT00384930|360241|P4|Overall Study|Lost to Follow-up|4
107947|NCT00384930|360242|P3|Overall Study|Lost to Follow-up|0
107948|NCT00384930|360243|P2|Overall Study|Lost to Follow-up|3
107949|NCT00384930|360244|P1|Overall Study|Lost to Follow-up|5
107950|NCT00384930|360240|P5|Overall Study|Lack of Efficacy|2
107951|NCT00384930|360241|P4|Overall Study|Lack of Efficacy|1
107952|NCT00384930|360242|P3|Overall Study|Lack of Efficacy|2
107953|NCT00384930|360243|P2|Overall Study|Lack of Efficacy|1
107954|NCT00384930|360244|P1|Overall Study|Lack of Efficacy|1
107955|NCT00384930|360240|P5|Overall Study|Entry Criteria Not Met|4
107956|NCT00384930|360241|P4|Overall Study|Entry Criteria Not Met|8
107957|NCT00384930|360242|P3|Overall Study|Entry Criteria Not Met|7
107958|NCT00384930|360243|P2|Overall Study|Entry Criteria Not Met|6
107959|NCT00384930|360244|P1|Overall Study|Entry Criteria Not Met|2
107960|NCT00384930|360240|P5|Overall Study|Adverse Event|14
107961|NCT00384930|360241|P4|Overall Study|Adverse Event|11
107962|NCT00384930|360242|P3|Overall Study|Adverse Event|12
107963|NCT00384930|360243|P2|Overall Study|Adverse Event|4
107964|NCT00384930|360244|P1|Overall Study|Adverse Event|5
107965|NCT00384956|360298|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
107966|NCT00385541|360321|P2|Overall Study|severe pain, clinician requested unblind|1
107967|NCT00385541|360322|P1|Overall Study|severe pain, clinician requested unblind|0
107968|NCT00385593|360430|P2|Overall Study|Incorrect randomization|1
107969|NCT00385593|360431|P1|Overall Study|Incorrect randomization|0
107970|NCT00385593|360430|P2|Overall Study|Incorrect inclusion|0
107971|NCT00385593|360431|P1|Overall Study|Incorrect inclusion|2
107972|NCT00385593|360430|P2|Overall Study|Several reasons|15
107973|NCT00385593|360431|P1|Overall Study|Several reasons|17
107974|NCT00385593|360430|P2|Overall Study|Protocol Violation|4
107975|NCT00385593|360431|P1|Overall Study|Protocol Violation|7
107976|NCT00385593|360430|P2|Overall Study|Lost to Follow-up|8
107977|NCT00385593|360431|P1|Overall Study|Lost to Follow-up|12
107978|NCT00385593|360430|P2|Overall Study|Withdrawal by Subject|7
107979|NCT00385593|360431|P1|Overall Study|Withdrawal by Subject|17
107980|NCT00385593|360430|P2|Overall Study|Adverse Event|2
107981|NCT00385593|360431|P1|Overall Study|Adverse Event|3
107982|NCT00385671|360450|P3|Overall Study|Withdrawal by Subject|4
107983|NCT00385671|360451|P2|Overall Study|Withdrawal by Subject|4
107984|NCT00385671|360452|P1|Overall Study|Withdrawal by Subject|4
107985|NCT00385671|360450|P3|Overall Study|Sponsor Decision|1
107986|NCT00385671|360451|P2|Overall Study|Sponsor Decision|2
107987|NCT00385671|360452|P1|Overall Study|Sponsor Decision|2
107988|NCT00385671|360450|P3|Overall Study|Protocol Violation|1
107989|NCT00385671|360451|P2|Overall Study|Protocol Violation|2
107990|NCT00385671|360452|P1|Overall Study|Protocol Violation|5
107991|NCT00385671|360450|P3|Overall Study|Physician Decision|2
107992|NCT00385671|360451|P2|Overall Study|Physician Decision|1
107993|NCT00385671|360452|P1|Overall Study|Physician Decision|2
107994|NCT00385671|360450|P3|Overall Study|Lost to Follow-up|5
107995|NCT00385671|360451|P2|Overall Study|Lost to Follow-up|6
107996|NCT00385671|360452|P1|Overall Study|Lost to Follow-up|6
107997|NCT00385671|360450|P3|Overall Study|Lack of Efficacy|5
107998|NCT00385671|360451|P2|Overall Study|Lack of Efficacy|9
107999|NCT00385671|360452|P1|Overall Study|Lack of Efficacy|5
108000|NCT00385671|360450|P3|Overall Study|Adverse Event|18
108001|NCT00385671|360451|P2|Overall Study|Adverse Event|27
108002|NCT00385671|360452|P1|Overall Study|Adverse Event|14
108003|NCT00385684|360606|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
108004|NCT00385684|360607|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
108005|NCT00385684|360606|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
108006|NCT00385684|360607|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
108007|NCT00385684|360606|P2|FIRST INTERVENTION OF PHASE A|Death|0
108008|NCT00385684|360607|P1|FIRST INTERVENTION OF PHASE A|Death|1
108009|NCT00385723|360616|P3|Overall Study|Withdrawal by Subject|2
108010|NCT00385723|360617|P2|Overall Study|Withdrawal by Subject|0
108011|NCT00385723|360618|P1|Overall Study|Withdrawal by Subject|1
108012|NCT00385723|360616|P3|Overall Study|Lost to Follow-up|0
108013|NCT00385723|360617|P2|Overall Study|Lost to Follow-up|1
108014|NCT00385723|360618|P1|Overall Study|Lost to Follow-up|1
108015|NCT00385736|360635|P3|Safety Analysis Set|Other|4
108016|NCT00385736|360636|P2|Safety Analysis Set|Other|4
108017|NCT00385736|360637|P1|Safety Analysis Set|Other|1
108018|NCT00385736|360635|P3|Safety Analysis Set|Protocol Violation|6
108019|NCT00385736|360636|P2|Safety Analysis Set|Protocol Violation|1
108020|NCT00385736|360637|P1|Safety Analysis Set|Protocol Violation|2
108021|NCT00385736|360635|P3|Safety Analysis Set|Lack of Efficacy|31
108022|NCT00385736|360636|P2|Safety Analysis Set|Lack of Efficacy|16
108023|NCT00385736|360637|P1|Safety Analysis Set|Lack of Efficacy|38
108024|NCT00385736|360635|P3|Safety Analysis Set|Lost to Follow-up|2
108025|NCT00385736|360636|P2|Safety Analysis Set|Lost to Follow-up|2
108026|NCT00385736|360637|P1|Safety Analysis Set|Lost to Follow-up|0
108027|NCT00385736|360635|P3|Safety Analysis Set|Withdrawal by Subject|14
108028|NCT00385736|360636|P2|Safety Analysis Set|Withdrawal by Subject|6
108029|NCT00385736|360637|P1|Safety Analysis Set|Withdrawal by Subject|6
108030|NCT00385736|360635|P3|Safety Analysis Set|Adverse Event|23
108031|NCT00385736|360636|P2|Safety Analysis Set|Adverse Event|15
108032|NCT00385736|360637|P1|Safety Analysis Set|Adverse Event|23
108033|NCT00385736|360635|P3|Efficacy Analysis Set - Maintenance|Other|4
108034|NCT00385736|360636|P2|Efficacy Analysis Set - Maintenance|Other|4
108035|NCT00385736|360637|P1|Efficacy Analysis Set - Maintenance|Other|0
108036|NCT00385736|360635|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
108037|NCT00385736|360636|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
108038|NCT00385736|360637|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
108039|NCT00385736|360635|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
108040|NCT00385736|360636|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
108041|NCT00385736|360637|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
108042|NCT00385736|360635|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
108043|NCT00385736|360636|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
108044|NCT00385736|360637|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
108045|NCT00385736|360635|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
108046|NCT00385736|360636|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
108047|NCT00385736|360637|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
108048|NCT00385736|360635|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
108049|NCT00385736|360636|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
108050|NCT00385736|360637|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
108051|NCT00385736|360635|P3|Efficacy Analysis Set - Induction|Other|1
108052|NCT00385736|360636|P2|Efficacy Analysis Set - Induction|Other|0
108053|NCT00385736|360637|P1|Efficacy Analysis Set - Induction|Other|0
108054|NCT00385736|360635|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
108055|NCT00385736|360636|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
108056|NCT00385736|360637|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
108057|NCT00385736|360635|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
108058|NCT00385736|360636|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
108059|NCT00385736|360637|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
108060|NCT00385736|360635|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
108061|NCT00385736|360636|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
108062|NCT00385736|360637|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
108063|NCT00385736|360635|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
108064|NCT00385736|360636|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
108065|NCT00385736|360637|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
108066|NCT00385736|360635|P3|Efficacy Analysis Set - Induction|Adverse Event|4
108067|NCT00385736|360636|P2|Efficacy Analysis Set - Induction|Adverse Event|6
108068|NCT00385736|360637|P1|Efficacy Analysis Set - Induction|Adverse Event|5
108069|NCT00385762|360679|P1|Overall Study|Lost to Follow-up|1
108070|NCT00385762|360679|P1|Overall Study|Adverse Event|1
108071|NCT00385827|360704|P3|Part 2|Unspecified|21
108072|NCT00385827|360705|P2|Part 2|Unspecified|11
108073|NCT00385827|360706|P1|Part 2|Unspecified|0
108074|NCT00385827|360704|P3|Part 2|Randomized but not treated|2
108075|NCT00385827|360705|P2|Part 2|Randomized but not treated|2
108076|NCT00385827|360706|P1|Part 2|Randomized but not treated|0
108077|NCT00385827|360704|P3|Part 2|Lack of Efficacy|13
108078|NCT00385827|360705|P2|Part 2|Lack of Efficacy|14
108079|NCT00385827|360706|P1|Part 2|Lack of Efficacy|0
108080|NCT00385827|360704|P3|Part 2|Death|2
108081|NCT00385827|360705|P2|Part 2|Death|0
108082|NCT00385827|360706|P1|Part 2|Death|0
108083|NCT00385827|360704|P3|Part 2|Adverse Event|10
108084|NCT00385827|360705|P2|Part 2|Adverse Event|6
108085|NCT00385827|360706|P1|Part 2|Adverse Event|0
108086|NCT00385827|360704|P3|Part 1|Unspecified|0
108087|NCT00385827|360705|P2|Part 1|Unspecified|0
108088|NCT00385827|360706|P1|Part 1|Unspecified|1
108089|NCT00385827|360704|P3|Part 1|Lack of Efficacy|0
108090|NCT00385827|360705|P2|Part 1|Lack of Efficacy|0
108091|NCT00385827|360706|P1|Part 1|Lack of Efficacy|5
108092|NCT00385827|360704|P3|Part 1|Death|0
108093|NCT00385827|360705|P2|Part 1|Death|0
108094|NCT00385827|360706|P1|Part 1|Death|2
108095|NCT00385827|360704|P3|Part 1|Adverse Event|0
108096|NCT00385827|360705|P2|Part 1|Adverse Event|0
108097|NCT00385827|360706|P1|Part 1|Adverse Event|1
108098|NCT00385840|360728|P2|Overall Study|Lost to Follow-up|13
108099|NCT00385840|360729|P1|Overall Study|Lost to Follow-up|3
108100|NCT00385840|360728|P2|Overall Study|Adverse Event|1
108101|NCT00385840|360729|P1|Overall Study|Adverse Event|1
108102|NCT00385918|360751|P3|Intervention Phase After Randomization|Lost to Follow-up|0
108103|NCT00385918|360752|P2|Intervention Phase After Randomization|Lost to Follow-up|0
108104|NCT00385918|360753|P1|Intervention Phase After Randomization|Lost to Follow-up|1
108105|NCT00385918|360751|P3|Intervention Phase After Randomization|Physician Decision|0
108106|NCT00385918|360752|P2|Intervention Phase After Randomization|Physician Decision|0
108107|NCT00385918|360753|P1|Intervention Phase After Randomization|Physician Decision|1
108108|NCT00385918|360751|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
108109|NCT00385918|360752|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
108110|NCT00385918|360753|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
108111|NCT00385918|360751|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
108112|NCT00385918|360752|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
108113|NCT00385918|360753|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
108114|NCT00385918|360751|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
108115|NCT00385918|360752|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
108116|NCT00385918|360753|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
108117|NCT00385918|360751|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
108118|NCT00385918|360752|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
108119|NCT00385918|360753|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
108120|NCT00385944|360777|P3|2nd Maintenance Dose Period|Invalid PD Data|0
108121|NCT00385944|360778|P2|2nd Maintenance Dose Period|Invalid PD Data|3
108122|NCT00385944|360779|P1|2nd Maintenance Dose Period|Invalid PD Data|2
108123|NCT00385944|360777|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
108124|NCT00385944|360778|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
108125|NCT00385944|360779|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
108126|NCT00385944|360777|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
108127|NCT00385944|360778|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
108128|NCT00385944|360779|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
108129|NCT00385944|360777|P3|1st Maintenance Dose Period|Physician Decision|0
108130|NCT00385944|360778|P2|1st Maintenance Dose Period|Physician Decision|0
108131|NCT00385944|360779|P1|1st Maintenance Dose Period|Physician Decision|1
108132|NCT00386009|360827|P2|Overall Study|Withdrawal by Subject|4
108133|NCT00386009|360828|P1|Overall Study|Withdrawal by Subject|5
108134|NCT00386009|360827|P2|Overall Study|Sponsor Decision|1
108135|NCT00386009|360828|P1|Overall Study|Sponsor Decision|1
108136|NCT00386009|360827|P2|Overall Study|Protocol Violation|0
108137|NCT00386009|360828|P1|Overall Study|Protocol Violation|1
108138|NCT00386009|360827|P2|Overall Study|Lost to Follow-up|1
108139|NCT00386009|360828|P1|Overall Study|Lost to Follow-up|1
108140|NCT00386009|360827|P2|Overall Study|Entry Criteria Not Met|2
108141|NCT00386009|360828|P1|Overall Study|Entry Criteria Not Met|0
108142|NCT00386009|360827|P2|Overall Study|Death|0
108143|NCT00386009|360828|P1|Overall Study|Death|1
108144|NCT00386009|360827|P2|Overall Study|Adverse Event|2
108145|NCT00386009|360828|P1|Overall Study|Adverse Event|0
108146|NCT00386022|360868|P2|Plus Estrogen|Adverse Event|1
108147|NCT00386022|360869|P1|Plus Estrogen|Adverse Event|0
108148|NCT00386022|360868|P2|Plus Estrogen|Lost to Follow-up|0
108149|NCT00386022|360869|P1|Plus Estrogen|Lost to Follow-up|2
108150|NCT00386100|360879|P2|Overall Study|Participant randomized in error|0
108151|NCT00386100|360880|P1|Overall Study|Participant randomized in error|1
108152|NCT00386100|360879|P2|Overall Study|Hb1Ac >8%|1
108153|NCT00386100|360880|P1|Overall Study|Hb1Ac >8%|0
108154|NCT00386100|360879|P2|Overall Study|Out of country for 5 months|0
108155|NCT00386100|360880|P1|Overall Study|Out of country for 5 months|1
108156|NCT00386100|360879|P2|Overall Study|Positive pregnancy test|3
108157|NCT00386100|360880|P1|Overall Study|Positive pregnancy test|1
108158|NCT00386100|360879|P2|Overall Study|Osteoporosis|1
108159|NCT00386100|360880|P1|Overall Study|Osteoporosis|0
108160|NCT00386100|360879|P2|Overall Study|7.6% bone loss|0
108161|NCT00386100|360880|P1|Overall Study|7.6% bone loss|1
108162|NCT00386100|360879|P2|Overall Study|DBP 93 mmHg at randomization|0
108163|NCT00386100|360880|P1|Overall Study|DBP 93 mmHg at randomization|1
108164|NCT00386100|360879|P2|Overall Study|Bone loss by DXA bone scan|0
108165|NCT00386100|360880|P1|Overall Study|Bone loss by DXA bone scan|1
108166|NCT00386100|360879|P2|Overall Study|Bad metabolic control & patient security|0
108167|NCT00386100|360880|P1|Overall Study|Bad metabolic control & patient security|1
108168|NCT00386100|360879|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
108169|NCT00386100|360880|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
108170|NCT00386100|360879|P2|Overall Study|Participant's PCP wanted to stop drug|0
108171|NCT00386100|360880|P1|Overall Study|Participant's PCP wanted to stop drug|1
108172|NCT00386100|360879|P2|Overall Study|Didn't meet entry criteria|1
108173|NCT00386100|360880|P1|Overall Study|Didn't meet entry criteria|1
108174|NCT00386100|360879|P2|Overall Study|Excessive bone loss vs. baseline value|1
108175|NCT00386100|360880|P1|Overall Study|Excessive bone loss vs. baseline value|0
108176|NCT00386100|360879|P2|Overall Study|Participant moving out of state|0
108177|NCT00386100|360880|P1|Overall Study|Participant moving out of state|2
108178|NCT00386100|360879|P2|Overall Study|Participant's concern due to CPK levels|0
108179|NCT00386100|360880|P1|Overall Study|Participant's concern due to CPK levels|1
108180|NCT00386100|360879|P2|Overall Study|Laboratory findings|0
108181|NCT00386100|360880|P1|Overall Study|Laboratory findings|1
108182|NCT00386100|360879|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
108183|NCT00386100|360880|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
108184|NCT00386100|360879|P2|Overall Study|Consecutive elevated Hba1C|0
108185|NCT00386100|360880|P1|Overall Study|Consecutive elevated Hba1C|1
108186|NCT00386100|360879|P2|Overall Study|BMD <2.5|0
108187|NCT00386100|360880|P1|Overall Study|BMD <2.5|1
108188|NCT00386100|360879|P2|Overall Study|Bone mass density (BMD) loss >6%|4
108189|NCT00386100|360880|P1|Overall Study|Bone mass density (BMD) loss >6%|4
108190|NCT00386100|360879|P2|Overall Study|Withdrawal by Subject|31
108191|NCT00386100|360880|P1|Overall Study|Withdrawal by Subject|32
108192|NCT00386100|360879|P2|Overall Study|Protocol Violation|3
108193|NCT00386100|360880|P1|Overall Study|Protocol Violation|5
108194|NCT00386100|360879|P2|Overall Study|Non-compliance|19
108195|NCT00386100|360880|P1|Overall Study|Non-compliance|18
108196|NCT00386100|360879|P2|Overall Study|Lost to Follow-up|29
108197|NCT00386100|360880|P1|Overall Study|Lost to Follow-up|29
108198|NCT00386100|360879|P2|Overall Study|Insufficient therapeutic effect|6
108199|NCT00386100|360880|P1|Overall Study|Insufficient therapeutic effect|30
108200|NCT00386100|360879|P2|Overall Study|Death|1
108201|NCT00386100|360880|P1|Overall Study|Death|0
108202|NCT00386100|360879|P2|Overall Study|Adverse Event|25
108203|NCT00386100|360880|P1|Overall Study|Adverse Event|15
108204|NCT00386100|360879|P2|Overall Study|Did not receive study medication|4
108205|NCT00386100|360880|P1|Overall Study|Did not receive study medication|6
108206|NCT00386152|360945|P3|Overall Study|Withdrawal by Subject|10
108207|NCT00386152|360946|P2|Overall Study|Withdrawal by Subject|6
108208|NCT00386152|360947|P1|Overall Study|Withdrawal by Subject|3
108209|NCT00386152|360945|P3|Overall Study|Protocol Violation|2
108210|NCT00386152|360946|P2|Overall Study|Protocol Violation|5
108211|NCT00386152|360947|P1|Overall Study|Protocol Violation|3
108212|NCT00386152|360945|P3|Overall Study|Completed chemotherapy|1
108213|NCT00386152|360946|P2|Overall Study|Completed chemotherapy|5
108214|NCT00386152|360947|P1|Overall Study|Completed chemotherapy|4
108215|NCT00386152|360945|P3|Overall Study|Lost to Follow-up|0
108216|NCT00386152|360946|P2|Overall Study|Lost to Follow-up|0
108217|NCT00386152|360947|P1|Overall Study|Lost to Follow-up|1
108218|NCT00386152|360945|P3|Overall Study|Physician Decision|4
108219|NCT00386152|360946|P2|Overall Study|Physician Decision|10
108220|NCT00386152|360947|P1|Overall Study|Physician Decision|13
108221|NCT00386152|360945|P3|Overall Study|Disease progression|5
108222|NCT00386152|360946|P2|Overall Study|Disease progression|4
108223|NCT00386152|360947|P1|Overall Study|Disease progression|7
108224|NCT00386152|360945|P3|Overall Study|Death|1
108225|NCT00386152|360946|P2|Overall Study|Death|0
108226|NCT00386152|360947|P1|Overall Study|Death|3
108227|NCT00386152|360945|P3|Overall Study|Chang from original chemo stratification|6
108228|NCT00386152|360946|P2|Overall Study|Chang from original chemo stratification|5
108229|NCT00386152|360947|P1|Overall Study|Chang from original chemo stratification|4
108230|NCT00386152|360945|P3|Overall Study|Adverse Event|4
108231|NCT00386152|360946|P2|Overall Study|Adverse Event|5
108232|NCT00386152|360947|P1|Overall Study|Adverse Event|6
108233|NCT00386308|360998|P2|Overall Study|Other Event|1
108234|NCT00386308|360999|P1|Overall Study|Other Event|8
108235|NCT00386308|360998|P2|Overall Study|Withdrawal by Subject|2
108236|NCT00386308|360999|P1|Overall Study|Withdrawal by Subject|6
108237|NCT00386308|360998|P2|Overall Study|Lost to Follow-up|6
108238|NCT00386308|360999|P1|Overall Study|Lost to Follow-up|10
108239|NCT00386308|360998|P2|Overall Study|Lack of Efficacy|2
108240|NCT00386308|360999|P1|Overall Study|Lack of Efficacy|0
108241|NCT00386308|360998|P2|Overall Study|Protocol Violation|5
108242|NCT00386308|360999|P1|Overall Study|Protocol Violation|2
108243|NCT00386308|360998|P2|Overall Study|Adverse Event|3
108244|NCT00386308|360999|P1|Overall Study|Adverse Event|3
108245|NCT00386334|361013|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
108246|NCT00386334|361014|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
108247|NCT00386334|361013|P2|Double Blind Period|Other|3
108248|NCT00386334|361014|P1|Double Blind Period|Other|3
108249|NCT00386334|361013|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
108250|NCT00386334|361014|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
108251|NCT00386334|361013|P2|Double Blind Period|Lack of Efficacy|11
108252|NCT00386334|361014|P1|Double Blind Period|Lack of Efficacy|20
108253|NCT00386334|361013|P2|Double Blind Period|Withdrawal by Subject|13
108254|NCT00386334|361014|P1|Double Blind Period|Withdrawal by Subject|9
108255|NCT00386334|361013|P2|Double Blind Period|Protocol Violation|1
108256|NCT00386334|361014|P1|Double Blind Period|Protocol Violation|1
108257|NCT00386334|361013|P2|Double Blind Period|Adverse Event|14
108258|NCT00386334|361014|P1|Double Blind Period|Adverse Event|9
108259|NCT00386360|361158|P2|Overall Study|Did not take any study medication|2
108260|NCT00386360|361159|P1|Overall Study|Did not take any study medication|0
108261|NCT00386360|361158|P2|Overall Study|Withdrawal by Subject|6
108262|NCT00386360|361159|P1|Overall Study|Withdrawal by Subject|3
108263|NCT00386360|361158|P2|Overall Study|Protocol Violation|3
108264|NCT00386360|361159|P1|Overall Study|Protocol Violation|0
108265|NCT00386360|361158|P2|Overall Study|Lost to Follow-up|2
108266|NCT00386360|361159|P1|Overall Study|Lost to Follow-up|0
108267|NCT00386360|361158|P2|Overall Study|Physician Decision|2
108268|NCT00386360|361159|P1|Overall Study|Physician Decision|2
108269|NCT00386360|361158|P2|Overall Study|Adverse Event|2
108270|NCT00386360|361159|P1|Overall Study|Adverse Event|4
108271|NCT00386425|361194|P3|Overall Study|Withdrawal by Subject|0
108272|NCT00386425|361195|P2|Overall Study|Withdrawal by Subject|1
108273|NCT00386425|361196|P1|Overall Study|Withdrawal by Subject|0
108274|NCT00386425|361194|P3|Overall Study|Physician Decision|0
108275|NCT00386425|361195|P2|Overall Study|Physician Decision|0
108276|NCT00386425|361196|P1|Overall Study|Physician Decision|3
108277|NCT00386607|361229|P2|Extension|Unsatisfactory therapeutic effect|1
108278|NCT00386607|361230|P1|Extension|Unsatisfactory therapeutic effect|0
108279|NCT00386607|361229|P2|Extension|Patient withdrew consent|5
108280|NCT00386607|361230|P1|Extension|Patient withdrew consent|0
108281|NCT00386607|361229|P2|Extension|Lost to Follow-up|3
108282|NCT00386607|361230|P1|Extension|Lost to Follow-up|0
108283|NCT00386607|361229|P2|Extension|Administrative problems|1
108284|NCT00386607|361230|P1|Extension|Administrative problems|0
108285|NCT00386607|361229|P2|Extension|Abnormal laboratory value(s)|1
108286|NCT00386607|361230|P1|Extension|Abnormal laboratory value(s)|0
108287|NCT00386607|361229|P2|Extension|Adverse Event|6
108288|NCT00386607|361230|P1|Extension|Adverse Event|0
108289|NCT00386607|361229|P2|Core|Protocol Deviation|0
108290|NCT00386607|361230|P1|Core|Protocol Deviation|6
108291|NCT00386607|361229|P2|Core|Administrative problems|0
108292|NCT00386607|361230|P1|Core|Administrative problems|1
108293|NCT00386607|361229|P2|Core|Lost to Follow-up|0
108294|NCT00386607|361230|P1|Core|Lost to Follow-up|23
108295|NCT00386607|361229|P2|Core|Patient withdrew consent|0
108296|NCT00386607|361230|P1|Core|Patient withdrew consent|15
108297|NCT00386607|361229|P2|Core|Condition no longer requires study drug|0
108298|NCT00386607|361230|P1|Core|Condition no longer requires study drug|4
108299|NCT00386607|361229|P2|Core|Unsatisfactory therapeutic effect|0
108300|NCT00386607|361230|P1|Core|Unsatisfactory therapeutic effect|23
108301|NCT00386607|361229|P2|Core|Abnormal laboratory value(s)|0
108302|NCT00386607|361230|P1|Core|Abnormal laboratory value(s)|3
108303|NCT00386607|361229|P2|Core|Adverse Event|0
108304|NCT00386607|361230|P1|Core|Adverse Event|40
108305|NCT00386776|361246|P1|Overall Study|Withdrawal by Subject|8
108306|NCT00387010|361262|P1|Treatment Period|Participant reported study drug stolen|1
108307|NCT00387010|361262|P1|Treatment Period|Noncompliance with study procedures|3
108308|NCT00387010|361262|P1|Treatment Period|Noncompliance with study medication|2
108309|NCT00387010|361262|P1|Treatment Period|Withdrawal by Subject|1
108310|NCT00387010|361262|P1|Treatment Period|Adverse Event|4
108311|NCT00387010|361262|P1|Dose Titration Period|Noncompliance with study procedures|7
108312|NCT00387010|361262|P1|Dose Titration Period|Noncompliance with study medication|8
108313|NCT00387010|361262|P1|Dose Titration Period|Lost to Follow-up|2
108314|NCT00387010|361262|P1|Dose Titration Period|Protocol Violation|1
108315|NCT00387010|361262|P1|Dose Titration Period|Withdrawal by Subject|3
108316|NCT00387010|361262|P1|Dose Titration Period|Lack of Efficacy|5
108317|NCT00387010|361262|P1|Dose Titration Period|Adverse Event|12
108318|NCT00387088|361298|P2|Overall Study|Other|52
108319|NCT00387088|361299|P1|Overall Study|Other|58
108320|NCT00387088|361298|P2|Overall Study|Lost to Follow-up|28
108321|NCT00387088|361299|P1|Overall Study|Lost to Follow-up|22
108322|NCT00387088|361298|P2|Overall Study|Lack of Efficacy|67
108323|NCT00387088|361299|P1|Overall Study|Lack of Efficacy|28
108324|NCT00387088|361298|P2|Overall Study|Withdrawal by Subject|35
108325|NCT00387088|361299|P1|Overall Study|Withdrawal by Subject|20
108326|NCT00387088|361298|P2|Overall Study|Protocol Violation|35
108327|NCT00387088|361299|P1|Overall Study|Protocol Violation|47
108328|NCT00387088|361298|P2|Overall Study|Adverse Event|156
108329|NCT00387088|361299|P1|Overall Study|Adverse Event|143
108330|NCT00387127|361345|P2|Overall Study|Sponsor Unblinded|0
108331|NCT00387127|361346|P1|Overall Study|Sponsor Unblinded|1
108332|NCT00387127|361345|P2|Overall Study|Serious Adverse Event|1
108333|NCT00387127|361346|P1|Overall Study|Serious Adverse Event|1
108334|NCT00387127|361345|P2|Overall Study|Required by Protocol Amendment #4|10
108335|NCT00387127|361346|P1|Overall Study|Required by Protocol Amendment #4|12
108336|NCT00387127|361345|P2|Overall Study|Withdrawal by Subject|2
108337|NCT00387127|361346|P1|Overall Study|Withdrawal by Subject|3
108338|NCT00387127|361345|P2|Overall Study|Physician Decision|1
108339|NCT00387127|361346|P1|Overall Study|Physician Decision|0
108340|NCT00387127|361345|P2|Overall Study|Death|16
108341|NCT00387127|361346|P1|Overall Study|Death|16
108342|NCT00387127|361345|P2|Overall Study|Lost to Follow-up|4
108343|NCT00387127|361346|P1|Overall Study|Lost to Follow-up|0
108344|NCT00387153|361386|P1|Overall Study|Lack of Response|4
108345|NCT00387153|361386|P1|Overall Study|Disease Progression|3
108346|NCT00387153|361386|P1|Overall Study|Adverse Event|1
108347|NCT00387348|361408|P3|Overall Study|Adverse Event|1
108348|NCT00387348|361409|P2|Overall Study|Adverse Event|0
108349|NCT00387348|361410|P1|Overall Study|Adverse Event|1
108350|NCT00387348|361408|P3|Overall Study|Withdrawal by Subject|2
108351|NCT00387348|361409|P2|Overall Study|Withdrawal by Subject|2
108352|NCT00387348|361410|P1|Overall Study|Withdrawal by Subject|0
108353|NCT00387348|361408|P3|Overall Study|Physician Decision|1
108354|NCT00387348|361409|P2|Overall Study|Physician Decision|0
108355|NCT00387348|361410|P1|Overall Study|Physician Decision|1
108356|NCT00387348|361408|P3|Overall Study|Death|0
108357|NCT00387348|361409|P2|Overall Study|Death|1
108358|NCT00387348|361410|P1|Overall Study|Death|1
108359|NCT00387426|361424|P1|Overall Study|Disease Progression|3
108360|NCT00387426|361424|P1|Overall Study|Toxicities|4
108361|NCT00387426|361424|P1|Overall Study|Lack of Response|7
108362|NCT00387647|361462|P1|Overall Study|Death|18
108363|NCT00387725|361493|P4|Overall Study|Parent/legal guardian request|1
108364|NCT00387725|361494|P3|Overall Study|Parent/legal guardian request|1
108365|NCT00387725|361495|P2|Overall Study|Parent/legal guardian request|0
108366|NCT00387725|361496|P1|Overall Study|Parent/legal guardian request|0
108367|NCT00387725|361493|P4|Overall Study|Withdrawal by Subject|0
108368|NCT00387725|361494|P3|Overall Study|Withdrawal by Subject|1
108369|NCT00387725|361495|P2|Overall Study|Withdrawal by Subject|0
108370|NCT00387725|361496|P1|Overall Study|Withdrawal by Subject|1
108371|NCT00387725|361493|P4|Overall Study|Protocol Violation|0
108372|NCT00387725|361494|P3|Overall Study|Protocol Violation|0
108373|NCT00387725|361495|P2|Overall Study|Protocol Violation|1
108374|NCT00387725|361496|P1|Overall Study|Protocol Violation|0
108375|NCT00387725|361493|P4|Overall Study|Adverse Event|1
108376|NCT00387725|361494|P3|Overall Study|Adverse Event|0
108377|NCT00387725|361495|P2|Overall Study|Adverse Event|0
108378|NCT00387725|361496|P1|Overall Study|Adverse Event|0
108379|NCT00387764|361518|P1|Overall Study|Death|7
108380|NCT00387764|361518|P1|Overall Study|Other|2
108381|NCT00387764|361518|P1|Overall Study|Physician Decision|1
108382|NCT00387764|361518|P1|Overall Study|Sponsor Terminated Study|1
108383|NCT00387764|361518|P1|Overall Study|Withdrawal by Subject|8
108384|NCT00387764|361518|P1|Overall Study|Adverse Event|12
108385|NCT00387790|361536|P1|Overall Study|Ineligible for study|2
108386|NCT00387790|361536|P1|Overall Study|Withdrawal by Subject|3
108387|NCT00387790|361536|P1|Overall Study|Physician Decision|2
108388|NCT00387790|361536|P1|Overall Study|Lack of Efficacy|2
108389|NCT00387790|361536|P1|Overall Study|Adverse Event|5
108390|NCT00387881|361553|P2|Overall Study|Not otherwise specified|7
108391|NCT00387881|361554|P1|Overall Study|Not otherwise specified|11
108392|NCT00387881|361553|P2|Overall Study|No opportunity to treat headache|34
108393|NCT00387881|361554|P1|Overall Study|No opportunity to treat headache|32
108394|NCT00387881|361553|P2|Overall Study|Not eligible|7
108395|NCT00387881|361554|P1|Overall Study|Not eligible|6
108396|NCT00387881|361553|P2|Overall Study|Sponsor terminated Study|1
108397|NCT00387881|361554|P1|Overall Study|Sponsor terminated Study|0
108398|NCT00387881|361553|P2|Overall Study|Withdrawal by Subject|18
108399|NCT00387881|361554|P1|Overall Study|Withdrawal by Subject|15
108400|NCT00387881|361553|P2|Overall Study|Protocol Violation|12
108401|NCT00387881|361554|P1|Overall Study|Protocol Violation|2
108402|NCT00387881|361553|P2|Overall Study|Lost to Follow-up|23
108403|NCT00387881|361554|P1|Overall Study|Lost to Follow-up|23
108404|NCT00387894|361576|P1|Overall Study|Withdrawal by Subject|1
108405|NCT00388037|361585|P1|Overall Study|Protocol Violation|1
108406|NCT00381485|361592|P4|Double-Blind Treatment Period|Administrative|1
108407|NCT00381485|361593|P3|Double-Blind Treatment Period|Administrative|0
108408|NCT00381485|361594|P2|Double-Blind Treatment Period|Administrative|1
108409|NCT00381485|361595|P1|Double-Blind Treatment Period|Administrative|0
108410|NCT00381485|361592|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
108411|NCT00381485|361593|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
108412|NCT00381485|361594|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
108413|NCT00381485|361595|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
108414|NCT00381485|361592|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
108415|NCT00381485|361593|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
108416|NCT00381485|361594|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
108417|NCT00381485|361595|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
108418|NCT00381485|361592|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
108419|NCT00381485|361593|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
108420|NCT00381485|361594|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
108421|NCT00381485|361595|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
108422|NCT00381485|361592|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
108423|NCT00381485|361593|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
108424|NCT00381485|361594|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
108425|NCT00381485|361595|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
108426|NCT00381485|361592|P4|Double-Blind Treatment Period|Lost to Follow-up|1
108427|NCT00381485|361593|P3|Double-Blind Treatment Period|Lost to Follow-up|1
108428|NCT00381485|361594|P2|Double-Blind Treatment Period|Lost to Follow-up|0
108429|NCT00381485|361595|P1|Double-Blind Treatment Period|Lost to Follow-up|0
108430|NCT00381485|361592|P4|Double-Blind Treatment Period|Lack of Efficacy|13
108431|NCT00381485|361593|P3|Double-Blind Treatment Period|Lack of Efficacy|11
108432|NCT00381485|361594|P2|Double-Blind Treatment Period|Lack of Efficacy|8
108433|NCT00381485|361595|P1|Double-Blind Treatment Period|Lack of Efficacy|0
108434|NCT00381485|361592|P4|Double-Blind Treatment Period|Adverse Event|5
108435|NCT00381485|361593|P3|Double-Blind Treatment Period|Adverse Event|2
108436|NCT00381485|361594|P2|Double-Blind Treatment Period|Adverse Event|2
108437|NCT00381485|361595|P1|Double-Blind Treatment Period|Adverse Event|0
108438|NCT00381485|361592|P4|Open-Label Run-In Period|Treatment failure|0
108439|NCT00381485|361593|P3|Open-Label Run-In Period|Treatment failure|0
108440|NCT00381485|361594|P2|Open-Label Run-In Period|Treatment failure|0
108441|NCT00381485|361595|P1|Open-Label Run-In Period|Treatment failure|1
108442|NCT00381485|361592|P4|Open-Label Run-In Period|Lost to Follow-up|0
108443|NCT00381485|361593|P3|Open-Label Run-In Period|Lost to Follow-up|0
108444|NCT00381485|361594|P2|Open-Label Run-In Period|Lost to Follow-up|0
108445|NCT00381485|361595|P1|Open-Label Run-In Period|Lost to Follow-up|3
108446|NCT00381485|361592|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
108447|NCT00381485|361593|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
108448|NCT00381485|361594|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
108449|NCT00381485|361595|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
108450|NCT00381485|361592|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
108451|NCT00381485|361593|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
108452|NCT00381485|361594|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
108453|NCT00381485|361595|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
108454|NCT00381485|361592|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
108455|NCT00381485|361593|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
108456|NCT00381485|361594|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
108457|NCT00381485|361595|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
108458|NCT00381485|361592|P4|Open-Label Run-In Period|Adverse Event|0
108459|NCT00381485|361593|P3|Open-Label Run-In Period|Adverse Event|0
108460|NCT00381485|361594|P2|Open-Label Run-In Period|Adverse Event|0
108461|NCT00381485|361595|P1|Open-Label Run-In Period|Adverse Event|9
108462|NCT00381563|361620|P2|Overall Study|Protocol Violation|1
108463|NCT00381563|361621|P1|Overall Study|Protocol Violation|0
108464|NCT00381563|361620|P2|Overall Study|Lost to Follow-up|0
108465|NCT00381563|361621|P1|Overall Study|Lost to Follow-up|2
108466|NCT00381563|361620|P2|Overall Study|Withdrawal by Subject|5
108467|NCT00381563|361621|P1|Overall Study|Withdrawal by Subject|5
108468|NCT00381615|361632|P4|Overall Study|Protocol Violation|0
108469|NCT00381615|361633|P3|Overall Study|Protocol Violation|1
108470|NCT00381615|361634|P2|Overall Study|Protocol Violation|0
108471|NCT00381615|361635|P1|Overall Study|Protocol Violation|0
108472|NCT00381615|361632|P4|Overall Study|Lost to Follow-up|1
108473|NCT00381615|361633|P3|Overall Study|Lost to Follow-up|0
108474|NCT00381615|361634|P2|Overall Study|Lost to Follow-up|2
108475|NCT00381615|361635|P1|Overall Study|Lost to Follow-up|3
108476|NCT00381615|361632|P4|Overall Study|Withdrawal by Subject|1
108477|NCT00381615|361633|P3|Overall Study|Withdrawal by Subject|0
108478|NCT00381615|361634|P2|Overall Study|Withdrawal by Subject|3
108479|NCT00381615|361635|P1|Overall Study|Withdrawal by Subject|1
108480|NCT00381680|361704|P2|Overall Study|Ineligible|1
108481|NCT00381680|361705|P1|Overall Study|Ineligible|3
108482|NCT00381680|361704|P2|Overall Study|Other not otherwise specified|2
108483|NCT00381680|361705|P1|Overall Study|Other not otherwise specified|7
108484|NCT00381680|361704|P2|Overall Study|Progression|1
108485|NCT00381680|361705|P1|Overall Study|Progression|1
108486|NCT00381680|361704|P2|Overall Study|Induction Failure|1
108487|NCT00381680|361705|P1|Overall Study|Induction Failure|4
108488|NCT00381680|361704|P2|Overall Study|Relapse|9
108489|NCT00381680|361705|P1|Overall Study|Relapse|18
108490|NCT00381680|361704|P2|Overall Study|Stem Cell Transplant|10
108491|NCT00381680|361705|P1|Overall Study|Stem Cell Transplant|26
108492|NCT00381680|361704|P2|Overall Study|Delay initiation|0
108493|NCT00381680|361705|P1|Overall Study|Delay initiation|1
108494|NCT00381680|361704|P2|Overall Study|Secondary Malignancy|0
108495|NCT00381680|361705|P1|Overall Study|Secondary Malignancy|3
108496|NCT00381680|361704|P2|Overall Study|Alternative Therapy|5
108497|NCT00381680|361705|P1|Overall Study|Alternative Therapy|11
108498|NCT00381680|361704|P2|Overall Study|Entry onto another COG Trial|2
108499|NCT00381680|361705|P1|Overall Study|Entry onto another COG Trial|1
108500|NCT00381680|361704|P2|Overall Study|Withdrawal by Subject|1
108501|NCT00381680|361705|P1|Overall Study|Withdrawal by Subject|3
108502|NCT00381680|361704|P2|Overall Study|Physician Decision|6
108503|NCT00381680|361705|P1|Overall Study|Physician Decision|25
108504|NCT00381680|361704|P2|Overall Study|Lost to Follow-up|2
108505|NCT00381680|361705|P1|Overall Study|Lost to Follow-up|3
108506|NCT00381680|361704|P2|Overall Study|Death|7
108507|NCT00381680|361705|P1|Overall Study|Death|10
108508|NCT00381680|361704|P2|Overall Study|Adverse Event|3
108509|NCT00381680|361705|P1|Overall Study|Adverse Event|9
108510|NCT00381693|361720|P1|Overall Study|Progression|2
108511|NCT00381693|361720|P1|Overall Study|Patient Choice|1
108512|NCT00381693|361720|P1|Overall Study|Adverse Event|4
108513|NCT00381693|361720|P1|Overall Study|Death|1
108514|NCT00381706|361733|P3|Overall Study|Never treated|1
108515|NCT00381706|361734|P2|Overall Study|Never treated|2
108516|NCT00381706|361735|P1|Overall Study|Never treated|7
108517|NCT00381797|361763|P5|Overall Study|Ineligible|0
108518|NCT00381797|361764|P4|Overall Study|Ineligible|1
108519|NCT00381797|361765|P3|Overall Study|Ineligible|0
108520|NCT00381797|361766|P2|Overall Study|Ineligible|0
108521|NCT00381797|361767|P1|Overall Study|Ineligible|0
108522|NCT00381797|361763|P5|Overall Study|Withdrawal by Subject|2
108523|NCT00381797|361764|P4|Overall Study|Withdrawal by Subject|0
108524|NCT00381797|361765|P3|Overall Study|Withdrawal by Subject|0
108525|NCT00381797|361766|P2|Overall Study|Withdrawal by Subject|1
108526|NCT00381797|361767|P1|Overall Study|Withdrawal by Subject|1
108527|NCT00381849|361823|P2|Wash Out|Withdrawal by Subject|1
108528|NCT00381849|361824|P1|Wash Out|Withdrawal by Subject|0
108529|NCT00381888|361846|P1|Overall Study|Adverse Event|1
108530|NCT00381888|361846|P1|Overall Study|Surgery was cancelled|2
108531|NCT00381888|361846|P1|Overall Study|Had laparoscopic surgery|2
108532|NCT00381888|361846|P1|Overall Study|Protocol Violation|9
108533|NCT00381888|361846|P1|Overall Study|Physician Decision|1
108534|NCT00381888|361846|P1|Overall Study|Withdrawal by Subject|1
108535|NCT00381888|361846|P1|Overall Study|Death|1
108536|NCT00381940|361851|P1|Overall Study|Ineligible|1
108537|NCT00381940|361851|P1|Overall Study|Protocol Violation|1
108538|NCT00381940|361851|P1|Overall Study|Lack of Efficacy|3
108539|NCT00382018|361859|P4|Overall Study|Other, not protocol specified|1
108540|NCT00382018|361860|P3|Overall Study|Other, not protocol specified|3
108541|NCT00382018|361861|P2|Overall Study|Other, not protocol specified|16
108542|NCT00382018|361862|P1|Overall Study|Other, not protocol specified|0
108543|NCT00382018|361859|P4|Overall Study|Withdrawal by Subject|4
108544|NCT00382018|361860|P3|Overall Study|Withdrawal by Subject|3
108545|NCT00382018|361861|P2|Overall Study|Withdrawal by Subject|4
108546|NCT00382018|361862|P1|Overall Study|Withdrawal by Subject|0
108547|NCT00382018|361859|P4|Overall Study|Death|11
108548|NCT00382018|361860|P3|Overall Study|Death|7
108549|NCT00382018|361861|P2|Overall Study|Death|9
108550|NCT00382018|361862|P1|Overall Study|Death|0
108551|NCT00382018|361859|P4|Overall Study|Progression|43
108552|NCT00382018|361860|P3|Overall Study|Progression|51
108553|NCT00382018|361861|P2|Overall Study|Progression|136
108554|NCT00382018|361862|P1|Overall Study|Progression|0
108555|NCT00382109|361897|P2|Overall Study|consent withdrawal|1
108556|NCT00382109|361898|P1|Overall Study|consent withdrawal|0
108557|NCT00382109|361897|P2|Overall Study|Other|2
108558|NCT00382109|361898|P1|Overall Study|Other|0
108559|NCT00382109|361897|P2|Overall Study|ineligible|0
108560|NCT00382109|361898|P1|Overall Study|ineligible|2
108561|NCT00382109|361897|P2|Overall Study|Withdrawal by Subject|0
108562|NCT00382109|361898|P1|Overall Study|Withdrawal by Subject|1
108563|NCT00382109|361897|P2|Overall Study|Physician Decision|1
108564|NCT00382109|361898|P1|Overall Study|Physician Decision|6
108565|NCT00382109|361897|P2|Overall Study|Adverse Event|0
108566|NCT00382109|361898|P1|Overall Study|Adverse Event|3
108567|NCT00382174|361935|P3|Overall Study|Wounds merged|2
108568|NCT00382174|361936|P2|Overall Study|Wounds merged|2
108569|NCT00382174|361937|P1|Overall Study|Wounds merged|0
108570|NCT00382174|361935|P3|Overall Study|Failed to meet criteria|1
108571|NCT00382174|361936|P2|Overall Study|Failed to meet criteria|1
108572|NCT00382174|361937|P1|Overall Study|Failed to meet criteria|0
108573|NCT00382174|361935|P3|Overall Study|Physician Decision|2
108574|NCT00382174|361936|P2|Overall Study|Physician Decision|2
108575|NCT00382174|361937|P1|Overall Study|Physician Decision|0
108576|NCT00382174|361935|P3|Overall Study|Non compliance|1
108577|NCT00382174|361936|P2|Overall Study|Non compliance|0
108578|NCT00382174|361937|P1|Overall Study|Non compliance|1
108579|NCT00382174|361935|P3|Overall Study|Withdrawal by Subject|5
108580|NCT00382174|361936|P2|Overall Study|Withdrawal by Subject|4
108581|NCT00382174|361937|P1|Overall Study|Withdrawal by Subject|1
108582|NCT00382174|361935|P3|Overall Study|Adverse Event|5
108583|NCT00382174|361936|P2|Overall Study|Adverse Event|4
108584|NCT00382174|361937|P1|Overall Study|Adverse Event|1
108585|NCT00382174|361935|P3|Overall Study|Lost to Follow-up|5
108586|NCT00382174|361936|P2|Overall Study|Lost to Follow-up|4
108587|NCT00382174|361937|P1|Overall Study|Lost to Follow-up|1
108588|NCT00388154|361948|P1|Overall Study|Withdrawal by Subject|1
108589|NCT00388349|361953|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
108590|NCT00388349|361954|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
108591|NCT00388362|361963|P1|Remained on Study Median of 514 Days|Death|2
108592|NCT00388362|361963|P1|Enrolled|Withdrawal by Subject|1
108593|NCT00388362|361963|P1|Enrolled|Loss insurance|1
108594|NCT00388362|361963|P1|Enrolled|Death|1
108595|NCT00388362|361963|P1|Enrolled|Adverse Event|9
108596|NCT00388362|361963|P1|Enrolled|Ineligible|1
108597|NCT00388505|361970|P2|Overall Study|Unable to classify|3
108598|NCT00388505|361971|P1|Overall Study|Unable to classify|4
108599|NCT00388505|361970|P2|Overall Study|Protocol Violation|5
108600|NCT00388505|361971|P1|Overall Study|Protocol Violation|6
108601|NCT00388505|361970|P2|Overall Study|Administrative Reason|0
108602|NCT00388505|361971|P1|Overall Study|Administrative Reason|1
108603|NCT00388505|361970|P2|Overall Study|Inappropriate Enrollment|1
108604|NCT00388505|361971|P1|Overall Study|Inappropriate Enrollment|0
108605|NCT00388505|361970|P2|Overall Study|Lost to Follow-up|3
108606|NCT00388505|361971|P1|Overall Study|Lost to Follow-up|5
108607|NCT00388505|361970|P2|Overall Study|Withdrawal by Subject|9
108608|NCT00388505|361971|P1|Overall Study|Withdrawal by Subject|24
108609|NCT00388505|361970|P2|Overall Study|Adverse Event or Death|17
108610|NCT00388505|361971|P1|Overall Study|Adverse Event or Death|43
108611|NCT00388583|361995|P2|Overall Study|Did not receive vaccine|1
108612|NCT00388583|361996|P1|Overall Study|Did not receive vaccine|0
108613|NCT00388583|361995|P2|Overall Study|Serious Adverse Event|0
108614|NCT00388583|361996|P1|Overall Study|Serious Adverse Event|2
108615|NCT00388583|361995|P2|Overall Study|Withdrawal by Subject|3
108616|NCT00388583|361996|P1|Overall Study|Withdrawal by Subject|3
108617|NCT00388583|361995|P2|Overall Study|Protocol Violation|0
108618|NCT00388583|361996|P1|Overall Study|Protocol Violation|1
108619|NCT00388726|362010|P2|Overall Study|Death|2
108620|NCT00388726|362011|P1|Overall Study|Death|3
108621|NCT00388726|362010|P2|Overall Study|Physician Decision|13
108622|NCT00388726|362011|P1|Overall Study|Physician Decision|18
108623|NCT00388726|362010|P2|Overall Study|Administrative|9
108624|NCT00388726|362011|P1|Overall Study|Administrative|6
108625|NCT00388726|362010|P2|Overall Study|Withdrawal by Subject|7
108626|NCT00388726|362011|P1|Overall Study|Withdrawal by Subject|10
108627|NCT00388726|362010|P2|Overall Study|Clinical Progression|36
108628|NCT00388726|362011|P1|Overall Study|Clinical Progression|61
108629|NCT00388726|362010|P2|Overall Study|Progressive Disease|153
108630|NCT00388726|362011|P1|Overall Study|Progressive Disease|336
108631|NCT00388726|362010|P2|Overall Study|Adverse Event|24
108632|NCT00388726|362011|P1|Overall Study|Adverse Event|50
108633|NCT00388947|362032|P1|Overall Study|Protocol Violation|47
108634|NCT00388973|362039|P2|Overall Study|Did not complete 2-week follow-up visit|17
108635|NCT00388973|362040|P1|Overall Study|Did not complete 2-week follow-up visit|17
108636|NCT00388973|362039|P2|Overall Study|Left region|1
108637|NCT00388973|362040|P1|Overall Study|Left region|0
108638|NCT00388973|362039|P2|Overall Study|Did not complete 61 days of treatment|4
108639|NCT00388973|362040|P1|Overall Study|Did not complete 61 days of treatment|5
108640|NCT00388973|362039|P2|Overall Study|Study specific Discontinuation Criteria|1
108641|NCT00388973|362040|P1|Overall Study|Study specific Discontinuation Criteria|0
108642|NCT00388973|362039|P2|Overall Study|Withdrawal by Subject|17
108643|NCT00388973|362040|P1|Overall Study|Withdrawal by Subject|14
108644|NCT00388973|362039|P2|Overall Study|Protocol Violation|0
108645|NCT00388973|362040|P1|Overall Study|Protocol Violation|3
108646|NCT00388973|362039|P2|Overall Study|Lack of Efficacy|12
108647|NCT00388973|362040|P1|Overall Study|Lack of Efficacy|1
108648|NCT00388973|362039|P2|Overall Study|Adverse Event|6
108649|NCT00388973|362040|P1|Overall Study|Adverse Event|16
108650|NCT00389064|362062|P2|Overall Study|Multiple Reasons|11
108651|NCT00389064|362063|P1|Overall Study|Multiple Reasons|9
108652|NCT00389064|362062|P2|Overall Study|Protocol Violation|0
108653|NCT00389064|362063|P1|Overall Study|Protocol Violation|2
108654|NCT00389064|362062|P2|Overall Study|Lost to Follow-up|2
108655|NCT00389064|362063|P1|Overall Study|Lost to Follow-up|1
108656|NCT00389064|362062|P2|Overall Study|Physician Decision|2
108657|NCT00389064|362063|P1|Overall Study|Physician Decision|2
108658|NCT00389064|362062|P2|Overall Study|Withdrawal by Subject|27
108659|NCT00389064|362063|P1|Overall Study|Withdrawal by Subject|17
108660|NCT00389064|362062|P2|Overall Study|Lack of Efficacy|14
108661|NCT00389064|362063|P1|Overall Study|Lack of Efficacy|3
108662|NCT00389064|362062|P2|Overall Study|Adverse Event|3
108663|NCT00389064|362063|P1|Overall Study|Adverse Event|11
108664|NCT00389207|362111|P3|Overall Study|Not specified|9
108665|NCT00389207|362112|P2|Overall Study|Not specified|23
108666|NCT00389207|362113|P1|Overall Study|Not specified|17
108667|NCT00389207|362111|P3|Overall Study|Withdrawal by Subject|11
108668|NCT00389207|362112|P2|Overall Study|Withdrawal by Subject|7
108669|NCT00389207|362113|P1|Overall Study|Withdrawal by Subject|5
108670|NCT00389207|362111|P3|Overall Study|Lost to Follow-up|7
108671|NCT00389207|362112|P2|Overall Study|Lost to Follow-up|9
108672|NCT00389207|362113|P1|Overall Study|Lost to Follow-up|12
108673|NCT00389207|362111|P3|Overall Study|Protocol Violation|4
108674|NCT00389207|362112|P2|Overall Study|Protocol Violation|1
108675|NCT00389207|362113|P1|Overall Study|Protocol Violation|3
108676|NCT00389207|362111|P3|Overall Study|Adverse Event|10
108677|NCT00389207|362112|P2|Overall Study|Adverse Event|32
108678|NCT00389207|362113|P1|Overall Study|Adverse Event|26
108679|NCT00389324|362215|P1|Subcutaneous Phase|Lost to Follow-up|1
108680|NCT00389324|362215|P1|Subcutaneous Phase|Withdrawal by Subject|2
108681|NCT00389324|362215|P1|Subcutaneous Phase|Non-compliance with study medication|2
108682|NCT00389324|362215|P1|Subcutaneous Phase|Adverse Event|2
108683|NCT00389324|362215|P1|Run-In Phase|Withdrawal by Subject|1
108684|NCT00389324|362215|P1|Run-In Phase|Lost to Follow-up|1
108685|NCT00389324|362215|P1|Run-In Phase|Adverse Event|1
108686|NCT00389441|362222|P1|Overall Study|Clinical progression|1
108687|NCT00389441|362222|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
108688|NCT00389441|362222|P1|Overall Study|Objective progression or relapse|26
108689|NCT00389441|362222|P1|Overall Study|Global deterioration of health status|4
108690|NCT00389441|362222|P1|Overall Study|Protocol Violation|1
108691|NCT00389441|362222|P1|Overall Study|Physician Decision|1
108692|NCT00389441|362222|P1|Overall Study|Withdrawal by Subject|4
108693|NCT00389441|362222|P1|Overall Study|Lost to Follow-up|2
108694|NCT00389441|362222|P1|Overall Study|Death|4
108695|NCT00389441|362222|P1|Overall Study|Adverse Event|7
108696|NCT00389519|362286|P4|Treated|Reason not specified|2
108697|NCT00389519|362287|P3|Treated|Reason not specified|0
108698|NCT00389519|362288|P2|Treated|Reason not specified|1
108699|NCT00389519|362289|P1|Treated|Reason not specified|1
108700|NCT00389519|362286|P4|Treated|Adverse Event|2
108701|NCT00389519|362287|P3|Treated|Adverse Event|0
108702|NCT00389519|362288|P2|Treated|Adverse Event|0
108703|NCT00389519|362289|P1|Treated|Adverse Event|1
108704|NCT00389519|362286|P4|Randomized|Did not receive study drug|0
108705|NCT00389519|362287|P3|Randomized|Did not receive study drug|0
108706|NCT00389519|362288|P2|Randomized|Did not receive study drug|0
108707|NCT00389519|362289|P1|Randomized|Did not receive study drug|2
108708|NCT00389519|362286|P4|Placebo Run-In|Reason not specified|0
108709|NCT00389519|362287|P3|Placebo Run-In|Reason not specified|0
108710|NCT00389519|362288|P2|Placebo Run-In|Reason not specified|0
108711|NCT00389519|362289|P1|Placebo Run-In|Reason not specified|40
108712|NCT00389519|362286|P4|Placebo Run-In|Withdrawal by Subject|0
108713|NCT00389519|362287|P3|Placebo Run-In|Withdrawal by Subject|0
108714|NCT00389519|362288|P2|Placebo Run-In|Withdrawal by Subject|0
108715|NCT00389519|362289|P1|Placebo Run-In|Withdrawal by Subject|19
108716|NCT00389519|362286|P4|Placebo Run-In|Did not meet blood pressure criteria|0
108717|NCT00389519|362287|P3|Placebo Run-In|Did not meet blood pressure criteria|0
108718|NCT00389519|362288|P2|Placebo Run-In|Did not meet blood pressure criteria|0
108719|NCT00389519|362289|P1|Placebo Run-In|Did not meet blood pressure criteria|119
108720|NCT00389597|362330|P4|Overall Study|Lost to Follow-up|6
108721|NCT00389597|362331|P3|Overall Study|Lost to Follow-up|4
108722|NCT00389597|362332|P2|Overall Study|Lost to Follow-up|6
108723|NCT00389597|362333|P1|Overall Study|Lost to Follow-up|8
108724|NCT00389831|362378|P2|Overall Study|Lost to Follow-up|1
108725|NCT00389831|362379|P1|Overall Study|Lost to Follow-up|0
108726|NCT00389831|362378|P2|Overall Study|Other reasons|2
108727|NCT00389831|362379|P1|Overall Study|Other reasons|0
108728|NCT00389831|362378|P2|Overall Study|Did not receive treatment.|2
108729|NCT00389831|362379|P1|Overall Study|Did not receive treatment.|0
108730|NCT00389831|362378|P2|Overall Study|Lack of Efficacy|2
108731|NCT00389831|362379|P1|Overall Study|Lack of Efficacy|0
108732|NCT00390013|362425|P4|Phase 2 First Treatment|Withdrawal by Subject|0
108733|NCT00390013|362426|P3|Phase 2 First Treatment|Withdrawal by Subject|0
108734|NCT00390013|362427|P2|Phase 2 First Treatment|Withdrawal by Subject|1
108735|NCT00390013|362428|P1|Phase 2 First Treatment|Withdrawal by Subject|0
108736|NCT00390013|362425|P4|Phase 2 First Treatment|tired|0
108737|NCT00390013|362426|P3|Phase 2 First Treatment|tired|0
108738|NCT00390013|362427|P2|Phase 2 First Treatment|tired|0
108739|NCT00390013|362428|P1|Phase 2 First Treatment|tired|1
108740|NCT00390013|362425|P4|Phase 1|tired|1
108741|NCT00390013|362426|P3|Phase 1|tired|0
108742|NCT00390013|362427|P2|Phase 1|tired|0
108743|NCT00390013|362428|P1|Phase 1|tired|0
108744|NCT00390221|362443|P3|Overall Study|Not Specified|2
108745|NCT00390221|362444|P2|Overall Study|Not Specified|4
108746|NCT00390221|362445|P1|Overall Study|Not Specified|3
108747|NCT00390221|362443|P3|Overall Study|Subject Non-compliance|2
108748|NCT00390221|362444|P2|Overall Study|Subject Non-compliance|0
108749|NCT00390221|362445|P1|Overall Study|Subject Non-compliance|1
108750|NCT00390221|362443|P3|Overall Study|Withdrawal by Subject|7
108751|NCT00390221|362444|P2|Overall Study|Withdrawal by Subject|9
108752|NCT00390221|362445|P1|Overall Study|Withdrawal by Subject|13
108753|NCT00390221|362443|P3|Overall Study|Investigator Decision|1
108754|NCT00390221|362444|P2|Overall Study|Investigator Decision|0
108755|NCT00390221|362445|P1|Overall Study|Investigator Decision|0
108756|NCT00390221|362443|P3|Overall Study|Adverse Event|3
108757|NCT00390221|362444|P2|Overall Study|Adverse Event|4
108758|NCT00390221|362445|P1|Overall Study|Adverse Event|1
108759|NCT00390221|362443|P3|Overall Study|Lost to Follow-up|0
108760|NCT00390221|362444|P2|Overall Study|Lost to Follow-up|3
108761|NCT00390221|362445|P1|Overall Study|Lost to Follow-up|0
108762|NCT00390416|362478|P1|Overall Study|Not treated|3
108763|NCT00390416|362478|P1|Overall Study|Withdrawal by Subject|1
108764|NCT00390455|362486|P2|Overall Study|Other Medical Reasons|11
108765|NCT00390455|362487|P1|Overall Study|Other Medical Reasons|7
108766|NCT00390455|362486|P2|Overall Study|Alternate Treatment|1
108767|NCT00390455|362487|P1|Overall Study|Alternate Treatment|0
108768|NCT00390455|362486|P2|Overall Study|Withdrawal by Subject|8
108769|NCT00390455|362487|P1|Overall Study|Withdrawal by Subject|8
108770|NCT00390455|362486|P2|Overall Study|Adverse Event|3
108771|NCT00390455|362487|P1|Overall Study|Adverse Event|17
108772|NCT00390468|362505|P1|Overall Study|Lack of Efficacy|1
108773|NCT00390468|362505|P1|Overall Study|Protocol Violation|2
108774|NCT00390546|362511|P2|Overall Study|Physician Decision|5
108775|NCT00390546|362512|P1|Overall Study|Physician Decision|5
108776|NCT00390546|362511|P2|Overall Study|Renal impairment|0
108777|NCT00390546|362512|P1|Overall Study|Renal impairment|1
108778|NCT00390572|362534|P2|Overall Study|health condition|1
108779|NCT00390572|362535|P1|Overall Study|health condition|0
108780|NCT00390572|362534|P2|Overall Study|Lost to Follow-up|4
108781|NCT00390572|362535|P1|Overall Study|Lost to Follow-up|8
108782|NCT00390689|362567|P3|Overall Study|Investigator's judgement|0
108783|NCT00390689|362568|P2|Overall Study|Investigator's judgement|0
108784|NCT00390689|362569|P1|Overall Study|Investigator's judgement|2
108785|NCT00390689|362567|P3|Overall Study|Protocol Violation|0
108786|NCT00390689|362568|P2|Overall Study|Protocol Violation|0
108787|NCT00390689|362569|P1|Overall Study|Protocol Violation|1
108788|NCT00390689|362567|P3|Overall Study|Lack of Efficacy|1
108789|NCT00390689|362568|P2|Overall Study|Lack of Efficacy|0
108790|NCT00390689|362569|P1|Overall Study|Lack of Efficacy|0
108791|NCT00390689|362567|P3|Overall Study|Adverse Event|2
108792|NCT00390689|362568|P2|Overall Study|Adverse Event|5
108793|NCT00390689|362569|P1|Overall Study|Adverse Event|2
108794|NCT00390780|362629|P2|Overall Study|SAE, death|1
108795|NCT00390780|362630|P1|Overall Study|SAE, death|0
108796|NCT00390780|362629|P2|Overall Study|Investigator decision, SAE, other reason|1
108797|NCT00390780|362630|P1|Overall Study|Investigator decision, SAE, other reason|0
108798|NCT00390780|362629|P2|Overall Study|Lost to follow up and other reasons|1
108799|NCT00390780|362630|P1|Overall Study|Lost to follow up and other reasons|0
108800|NCT00390780|362629|P2|Overall Study|Inclusion criteria not satisfied|2
108801|NCT00390780|362630|P1|Overall Study|Inclusion criteria not satisfied|0
108802|NCT00390780|362629|P2|Overall Study|Withdrawal by Subject|2
108803|NCT00390780|362630|P1|Overall Study|Withdrawal by Subject|1
108804|NCT00390780|362629|P2|Overall Study|Death|3
108805|NCT00390780|362630|P1|Overall Study|Death|1
108806|NCT00390780|362629|P2|Overall Study|Adverse Event|3
108807|NCT00390780|362630|P1|Overall Study|Adverse Event|2
108808|NCT00390780|362629|P2|Overall Study|Lost to Follow-up|6
108809|NCT00390780|362630|P1|Overall Study|Lost to Follow-up|3
108810|NCT00390780|362629|P2|Overall Study|Protocol Violation|4
108811|NCT00390780|362630|P1|Overall Study|Protocol Violation|6
108812|NCT00390780|362629|P2|Overall Study|Not completed|4
108813|NCT00390780|362630|P1|Overall Study|Not completed|10
108814|NCT00390806|362662|P2|Overall Study|Ongoing|2
108815|NCT00390806|362663|P1|Overall Study|Ongoing|4
108816|NCT00390806|362662|P2|Overall Study|Physician Decision|1
108817|NCT00390806|362663|P1|Overall Study|Physician Decision|0
108818|NCT00390806|362662|P2|Overall Study|Death|0
108819|NCT00390806|362663|P1|Overall Study|Death|1
108820|NCT00390806|362662|P2|Overall Study|Investigator Decision|6
108821|NCT00390806|362663|P1|Overall Study|Investigator Decision|4
108822|NCT00390806|362662|P2|Overall Study|Withdrawal by Subject|15
108823|NCT00390806|362663|P1|Overall Study|Withdrawal by Subject|12
108824|NCT00390806|362662|P2|Overall Study|Protocol Violation|2
108825|NCT00390806|362663|P1|Overall Study|Protocol Violation|2
108826|NCT00390806|362662|P2|Overall Study|Lost to Follow-up|6
108827|NCT00390806|362663|P1|Overall Study|Lost to Follow-up|7
108828|NCT00390858|362731|P2|Overall Study|Withdrawal by Subject|4
108829|NCT00390858|362732|P1|Overall Study|Withdrawal by Subject|3
108830|NCT00390858|362731|P2|Overall Study|Lack of Efficacy|1
108831|NCT00390858|362732|P1|Overall Study|Lack of Efficacy|0
108832|NCT00390858|362731|P2|Overall Study|Adverse Event|2
108833|NCT00390858|362732|P1|Overall Study|Adverse Event|6
108834|NCT00390884|362746|P2|Overall Study|Withdrawal by Subject|2
108835|NCT00390884|362747|P1|Overall Study|Withdrawal by Subject|2
108836|NCT00385203|362806|P2|Overall Study|Incorrect enrollment|0
108837|NCT00385203|362807|P1|Overall Study|Incorrect enrollment|2
108838|NCT00385203|362806|P2|Overall Study|Condition under investigation worsened|3
108839|NCT00385203|362807|P1|Overall Study|Condition under investigation worsened|18
108840|NCT00385203|362806|P2|Overall Study|Death|0
108841|NCT00385203|362807|P1|Overall Study|Death|1
108842|NCT00385203|362806|P2|Overall Study|Adverse Event|4
108843|NCT00385203|362807|P1|Overall Study|Adverse Event|5
108844|NCT00391027|362849|P2|Overall Study|Other|3
108845|NCT00391027|362850|P1|Overall Study|Other|4
108846|NCT00391027|362849|P2|Overall Study|Withdrawal by Subject|1
108847|NCT00391027|362850|P1|Overall Study|Withdrawal by Subject|10
108848|NCT00391027|362849|P2|Overall Study|Lack of Efficacy|0
108849|NCT00391027|362850|P1|Overall Study|Lack of Efficacy|3
108850|NCT00391027|362849|P2|Overall Study|Adverse Event|8
108851|NCT00391027|362850|P1|Overall Study|Adverse Event|8
108852|NCT00391053|362892|P4|Overall Study|Withdrawal by Subject|1
108853|NCT00391053|362893|P3|Overall Study|Withdrawal by Subject|1
108854|NCT00391053|362894|P2|Overall Study|Withdrawal by Subject|1
108855|NCT00391053|362895|P1|Overall Study|Withdrawal by Subject|5
108856|NCT00391053|362892|P4|Overall Study|Lost to Follow-up|5
108857|NCT00391053|362893|P3|Overall Study|Lost to Follow-up|0
108858|NCT00391053|362894|P2|Overall Study|Lost to Follow-up|0
108859|NCT00391053|362895|P1|Overall Study|Lost to Follow-up|1
108860|NCT00391053|362892|P4|Overall Study|Protocol Violation|0
108861|NCT00391053|362893|P3|Overall Study|Protocol Violation|0
108862|NCT00391053|362894|P2|Overall Study|Protocol Violation|0
108863|NCT00391053|362895|P1|Overall Study|Protocol Violation|2
108864|NCT00391053|362892|P4|Overall Study|Serious Adverse Events|4
108865|NCT00391053|362893|P3|Overall Study|Serious Adverse Events|1
108866|NCT00391053|362894|P2|Overall Study|Serious Adverse Events|0
108867|NCT00391053|362895|P1|Overall Study|Serious Adverse Events|1
108868|NCT00391092|362940|P2|Overall Study|Alive in follow-up|84
108869|NCT00391092|362941|P1|Overall Study|Alive in follow-up|88
108870|NCT00391092|362940|P2|Overall Study|Alive on treatment|33
108871|NCT00391092|362941|P1|Overall Study|Alive on treatment|29
108872|NCT00391092|362940|P2|Overall Study|Lost to Follow-up|18
108873|NCT00391092|362941|P1|Overall Study|Lost to Follow-up|13
108874|NCT00391092|362940|P2|Overall Study|Death|81
108875|NCT00391092|362941|P1|Overall Study|Death|78
108876|NCT00391222|362962|P4|Period III (Double-Blind Treatment)|Other|0
108877|NCT00391222|362963|P3|Period III (Double-Blind Treatment)|Other|6
108878|NCT00391222|362964|P2|Period III (Double-Blind Treatment)|Other|1
108879|NCT00391222|362965|P1|Period III (Double-Blind Treatment)|Other|6
108880|NCT00391222|362962|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
108881|NCT00391222|362963|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
108882|NCT00391222|362964|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
108883|NCT00391222|362965|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
108884|NCT00391222|362962|P4|Period III (Double-Blind Treatment)|Pregnancy|0
108885|NCT00391222|362963|P3|Period III (Double-Blind Treatment)|Pregnancy|0
108886|NCT00391222|362964|P2|Period III (Double-Blind Treatment)|Pregnancy|2
108887|NCT00391222|362965|P1|Period III (Double-Blind Treatment)|Pregnancy|0
108888|NCT00391222|362962|P4|Period III (Double-Blind Treatment)|Adverse Event|0
108889|NCT00391222|362963|P3|Period III (Double-Blind Treatment)|Adverse Event|4
108890|NCT00391222|362964|P2|Period III (Double-Blind Treatment)|Adverse Event|2
108891|NCT00391222|362965|P1|Period III (Double-Blind Treatment)|Adverse Event|5
108892|NCT00391222|362962|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
108893|NCT00391222|362963|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
108894|NCT00391222|362964|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
108895|NCT00391222|362965|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
108896|NCT00391222|362962|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
108897|NCT00391222|362963|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
108898|NCT00391222|362964|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
108899|NCT00391222|362965|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
108900|NCT00391222|362962|P4|Period II (Open-label Risperidone LAI)|Other|24
108901|NCT00391222|362963|P3|Period II (Open-label Risperidone LAI)|Other|0
108902|NCT00391222|362964|P2|Period II (Open-label Risperidone LAI)|Other|0
108903|NCT00391222|362965|P1|Period II (Open-label Risperidone LAI)|Other|0
108904|NCT00391222|362962|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
108905|NCT00391222|362963|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
108906|NCT00391222|362964|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
108907|NCT00391222|362965|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
108908|NCT00391222|362962|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
108909|NCT00391222|362963|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
108910|NCT00391222|362964|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
108911|NCT00391222|362965|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
108912|NCT00391222|362962|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
108913|NCT00391222|362963|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
108914|NCT00391222|362964|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
108915|NCT00391222|362965|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
108916|NCT00391222|362962|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
108917|NCT00391222|362963|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
108918|NCT00391222|362964|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
108919|NCT00391222|362965|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
108920|NCT00391274|362991|P2|Overall Study|Death Not Study Related|1
108921|NCT00391274|362992|P1|Overall Study|Death Not Study Related|0
108922|NCT00391274|362991|P2|Overall Study|Death Due to Indeterminate Cause|0
108923|NCT00391274|362992|P1|Overall Study|Death Due to Indeterminate Cause|1
108924|NCT00391274|362991|P2|Overall Study|Death Due to Adverse Event|3
108925|NCT00391274|362992|P1|Overall Study|Death Due to Adverse Event|1
108926|NCT00391274|362991|P2|Overall Study|Withdrawal by Subject|3
108927|NCT00391274|362992|P1|Overall Study|Withdrawal by Subject|0
108928|NCT00391274|362991|P2|Overall Study|Physician Decision|2
108929|NCT00391274|362992|P1|Overall Study|Physician Decision|4
108930|NCT00391274|362991|P2|Overall Study|Lost to Follow-up|3
108931|NCT00391274|362992|P1|Overall Study|Lost to Follow-up|0
108932|NCT00391274|362991|P2|Overall Study|Death Due to Study Disease|45
108933|NCT00391274|362992|P1|Overall Study|Death Due to Study Disease|55
108934|NCT00391625|363008|P1|Month 50|Physician Decision|1
108935|NCT00391625|363008|P1|Month 14|Withdrawal by Subject|1
108936|NCT00391768|363077|P7|Overall Study|Lost to Follow-up|3
108937|NCT00391768|363078|P6|Overall Study|Lost to Follow-up|2
108938|NCT00391768|363079|P5|Overall Study|Lost to Follow-up|2
108939|NCT00391768|363080|P4|Overall Study|Lost to Follow-up|1
108940|NCT00391768|363081|P3|Overall Study|Lost to Follow-up|0
108941|NCT00391768|363082|P2|Overall Study|Lost to Follow-up|0
108942|NCT00391768|363083|P1|Overall Study|Lost to Follow-up|0
108943|NCT00391768|363077|P7|Overall Study|Withdrawal by Subject|1
108944|NCT00391768|363078|P6|Overall Study|Withdrawal by Subject|1
108945|NCT00391768|363079|P5|Overall Study|Withdrawal by Subject|0
108946|NCT00391768|363080|P4|Overall Study|Withdrawal by Subject|0
108947|NCT00391768|363081|P3|Overall Study|Withdrawal by Subject|1
108948|NCT00391768|363082|P2|Overall Study|Withdrawal by Subject|0
108949|NCT00391768|363083|P1|Overall Study|Withdrawal by Subject|0
108950|NCT00391807|363148|P1|Overall Study|Various|96
108951|NCT00391807|363148|P1|Overall Study|Protocol Violation|20
108952|NCT00391807|363148|P1|Overall Study|Withdrawal by Subject|147
108953|NCT00391807|363148|P1|Overall Study|Lost to Follow-up|227
108954|NCT00391807|363148|P1|Overall Study|Pregnancy|25
108955|NCT00391807|363148|P1|Overall Study|Adverse Event|177
108956|NCT00391807|363148|P1|Overall Study|Did not receive study medication|23
108957|NCT00391846|363170|P2|Overall Study|Developed study specific DC criteria|1
108958|NCT00391846|363171|P1|Overall Study|Developed study specific DC criteria|0
108959|NCT00391846|363170|P2|Overall Study|Withdrawal by Subject|3
108960|NCT00391846|363171|P1|Overall Study|Withdrawal by Subject|2
108961|NCT00391846|363170|P2|Overall Study|Did not meet the required elig. crit|2
108962|NCT00391846|363171|P1|Overall Study|Did not meet the required elig. crit|2
108963|NCT00391846|363170|P2|Overall Study|Adverse Event|1
108964|NCT00391846|363171|P1|Overall Study|Adverse Event|4
108965|NCT00391872|363193|P2|Overall Study|Lost to Follow-up|0
108966|NCT00391872|363194|P1|Overall Study|Lost to Follow-up|2
108967|NCT00391872|363193|P2|Overall Study|Reason unknown|4
108968|NCT00391872|363194|P1|Overall Study|Reason unknown|2
108969|NCT00391872|363193|P2|Overall Study|Withdrawal by Subject|249
108970|NCT00391872|363194|P1|Overall Study|Withdrawal by Subject|296
108971|NCT00391872|363193|P2|Overall Study|Protocol Violation|2
108972|NCT00391872|363194|P1|Overall Study|Protocol Violation|7
108973|NCT00391898|363232|P2|Overall Study|Other|10
108974|NCT00391898|363233|P1|Overall Study|Other|8
108975|NCT00391898|363232|P2|Overall Study|Adverse Event|0
108976|NCT00391898|363233|P1|Overall Study|Adverse Event|3
108977|NCT00391976|363254|P3|Overall Study|Positive P. aeruginosa antibody test|31
108978|NCT00391976|363255|P2|Overall Study|Positive P. aeruginosa antibody test|0
108979|NCT00391976|363256|P1|Overall Study|Positive P. aeruginosa antibody test|0
108980|NCT00391976|363254|P3|Overall Study|Unable to classify|1
108981|NCT00391976|363255|P2|Overall Study|Unable to classify|0
108982|NCT00391976|363256|P1|Overall Study|Unable to classify|0
108983|NCT00391976|363254|P3|Overall Study|Recurrence/no eradication of infection|0
108984|NCT00391976|363255|P2|Overall Study|Recurrence/no eradication of infection|19
108985|NCT00391976|363256|P1|Overall Study|Recurrence/no eradication of infection|21
108986|NCT00391976|363254|P3|Overall Study|Protocol deviation/violation|1
108987|NCT00391976|363255|P2|Overall Study|Protocol deviation/violation|2
108988|NCT00391976|363256|P1|Overall Study|Protocol deviation/violation|4
108989|NCT00391976|363254|P3|Overall Study|Inappropriate enrollment|0
108990|NCT00391976|363255|P2|Overall Study|Inappropriate enrollment|1
108991|NCT00391976|363256|P1|Overall Study|Inappropriate enrollment|1
108992|NCT00391976|363254|P3|Overall Study|Lost to Follow-up|0
108993|NCT00391976|363255|P2|Overall Study|Lost to Follow-up|2
108994|NCT00391976|363256|P1|Overall Study|Lost to Follow-up|1
108995|NCT00391976|363254|P3|Overall Study|Withdrawal of consent|1
108996|NCT00391976|363255|P2|Overall Study|Withdrawal of consent|1
108997|NCT00391976|363256|P1|Overall Study|Withdrawal of consent|0
108998|NCT00391976|363254|P3|Overall Study|Adverse Event|1
108999|NCT00391976|363255|P2|Overall Study|Adverse Event|0
109000|NCT00391976|363256|P1|Overall Study|Adverse Event|0
109001|NCT00392171|363282|P1|Overall Study|Disease progression|101
109002|NCT00392171|363282|P1|Overall Study|Did not meet inclusion criteria|4
109003|NCT00392197|363288|P2|Overall Study|Withdrawal by Subject|6
109004|NCT00392197|363289|P1|Overall Study|Withdrawal by Subject|4
109005|NCT00392197|363288|P2|Overall Study|Protocol Violation|5
109006|NCT00392197|363289|P1|Overall Study|Protocol Violation|7
109007|NCT00392197|363288|P2|Overall Study|Physician Decision|2
109008|NCT00392197|363289|P1|Overall Study|Physician Decision|3
109009|NCT00392197|363288|P2|Overall Study|Lost to Follow-up|1
109010|NCT00392197|363289|P1|Overall Study|Lost to Follow-up|0
109011|NCT00392197|363288|P2|Overall Study|Lack of Efficacy|4
109012|NCT00392197|363289|P1|Overall Study|Lack of Efficacy|3
109013|NCT00392197|363288|P2|Overall Study|Adverse Event|12
109014|NCT00392197|363289|P1|Overall Study|Adverse Event|4
109015|NCT00392210|363299|P2|First Voiding Trial|Physician Decision|2
109016|NCT00392210|363300|P1|First Voiding Trial|Physician Decision|2
109017|NCT00392223|363308|P2|Overall Study|Withdrawal by Subject|2
109018|NCT00392223|363309|P1|Overall Study|Withdrawal by Subject|3
109019|NCT00392223|363308|P2|Overall Study|Protocol Violation|3
109020|NCT00392223|363309|P1|Overall Study|Protocol Violation|0
109021|NCT00392223|363308|P2|Overall Study|Lost to Follow-up|4
109022|NCT00392223|363309|P1|Overall Study|Lost to Follow-up|1
109023|NCT00392223|363308|P2|Overall Study|Adverse Event|4
109024|NCT00392223|363309|P1|Overall Study|Adverse Event|5
109025|NCT00392288|363337|P3|Overall Study|Other|1
109026|NCT00392288|363338|P2|Overall Study|Other|4
109027|NCT00392288|363339|P1|Overall Study|Other|3
109028|NCT00392288|363337|P3|Overall Study|Parent/legal guardian withdrawal|1
109029|NCT00392288|363338|P2|Overall Study|Parent/legal guardian withdrawal|2
109030|NCT00392288|363339|P1|Overall Study|Parent/legal guardian withdrawal|1
109031|NCT00392288|363337|P3|Overall Study|Withdrawal by Subject|2
109032|NCT00392288|363338|P2|Overall Study|Withdrawal by Subject|0
109033|NCT00392288|363339|P1|Overall Study|Withdrawal by Subject|1
109034|NCT00392288|363337|P3|Overall Study|Lost to Follow-up|1
109035|NCT00392288|363338|P2|Overall Study|Lost to Follow-up|1
109036|NCT00392288|363339|P1|Overall Study|Lost to Follow-up|1
109037|NCT00392288|363337|P3|Overall Study|Protocol Violation|1
109038|NCT00392288|363338|P2|Overall Study|Protocol Violation|3
109039|NCT00392288|363339|P1|Overall Study|Protocol Violation|1
109040|NCT00392288|363337|P3|Overall Study|Lack of Efficacy|3
109041|NCT00392288|363338|P2|Overall Study|Lack of Efficacy|5
109042|NCT00392288|363339|P1|Overall Study|Lack of Efficacy|8
109043|NCT00392288|363337|P3|Overall Study|Adverse Event|8
109044|NCT00392288|363338|P2|Overall Study|Adverse Event|7
109045|NCT00392288|363339|P1|Overall Study|Adverse Event|17
109046|NCT00392379|363355|P2|Overall Study|Adverse Event|1
109047|NCT00392379|363356|P1|Overall Study|Adverse Event|1
109048|NCT00392379|363355|P2|Overall Study|Lost to Follow-up|9
109049|NCT00392379|363356|P1|Overall Study|Lost to Follow-up|4
109050|NCT00392379|363355|P2|Overall Study|Withdrawal by Subject|28
109051|NCT00392379|363356|P1|Overall Study|Withdrawal by Subject|17
109052|NCT00392665|363380|P2|Overall Study|Lost to Follow-up|1
109053|NCT00392665|363381|P1|Overall Study|Lost to Follow-up|1
109054|NCT00392665|363380|P2|Overall Study|Death|14
109055|NCT00392665|363381|P1|Overall Study|Death|16
109056|NCT00392769|363439|P1|Overall Study|Adverse Event|1
109057|NCT00392769|363439|P1|Overall Study|Clinical Deterioration|9
109058|NCT00392808|363457|P4|Overall Study|Unable to withdraw blood|2
109059|NCT00392808|363458|P3|Overall Study|Unable to withdraw blood|1
109060|NCT00392808|363459|P2|Overall Study|Unable to withdraw blood|1
109061|NCT00392808|363460|P1|Overall Study|Unable to withdraw blood|3
109062|NCT00392808|363457|P4|Overall Study|Lost to Follow-up|2
109063|NCT00392808|363458|P3|Overall Study|Lost to Follow-up|1
109064|NCT00392808|363459|P2|Overall Study|Lost to Follow-up|2
109065|NCT00392808|363460|P1|Overall Study|Lost to Follow-up|3
109066|NCT00392925|363502|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
109067|NCT00392925|363503|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
109068|NCT00392925|363504|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
109069|NCT00392925|363505|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
109070|NCT00392925|363502|P4|Randomization to Treatment Group Period|Protocol Violation|1
109071|NCT00392925|363503|P3|Randomization to Treatment Group Period|Protocol Violation|2
109072|NCT00392925|363504|P2|Randomization to Treatment Group Period|Protocol Violation|0
109073|NCT00392925|363505|P1|Randomization to Treatment Group Period|Protocol Violation|0
109074|NCT00392925|363502|P4|Randomization to Treatment Group Period|Adverse Event|5
109075|NCT00392925|363503|P3|Randomization to Treatment Group Period|Adverse Event|3
109076|NCT00392925|363504|P2|Randomization to Treatment Group Period|Adverse Event|3
109077|NCT00392925|363505|P1|Randomization to Treatment Group Period|Adverse Event|0
109078|NCT00392925|363502|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
109079|NCT00392925|363503|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
109080|NCT00392925|363504|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
109081|NCT00392925|363505|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
109082|NCT00392925|363502|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
109083|NCT00392925|363503|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
109084|NCT00392925|363504|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
109085|NCT00392925|363505|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
109086|NCT00392925|363502|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
109087|NCT00392925|363503|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
109088|NCT00392925|363504|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
109089|NCT00392925|363505|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
109090|NCT00392925|363502|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
109091|NCT00392925|363503|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
109092|NCT00392925|363504|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
109093|NCT00392925|363505|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
109094|NCT00392925|363502|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
109095|NCT00392925|363503|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
109096|NCT00392925|363504|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
109097|NCT00392925|363505|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
109098|NCT00392925|363502|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
109099|NCT00392925|363503|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
109100|NCT00392925|363504|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
109101|NCT00392925|363505|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
109102|NCT00393029|363593|P2|Overall Study|Not treated|1
109103|NCT00393029|363594|P1|Overall Study|Not treated|0
109104|NCT00393042|363603|P2|Second Intervetion|Protocol Violation|1
109105|NCT00393042|363604|P1|Second Intervetion|Protocol Violation|1
109106|NCT00393042|363603|P2|Second Intervetion|Lost to Follow-up|2
109107|NCT00393042|363604|P1|Second Intervetion|Lost to Follow-up|0
109108|NCT00393042|363603|P2|Second Intervetion|Lack of Efficacy|0
109109|NCT00393042|363604|P1|Second Intervetion|Lack of Efficacy|1
109110|NCT00393042|363603|P2|Second Intervetion|Withdrawal by Subject|2
109111|NCT00393042|363604|P1|Second Intervetion|Withdrawal by Subject|0
109112|NCT00393042|363603|P2|Second Intervetion|Adverse Event|3
109113|NCT00393042|363604|P1|Second Intervetion|Adverse Event|0
109114|NCT00393042|363603|P2|First Intervention|Adverse Event|1
109115|NCT00393042|363604|P1|First Intervention|Adverse Event|0
109116|NCT00393042|363603|P2|First Intervention|Protocol Violation|0
109117|NCT00393042|363604|P1|First Intervention|Protocol Violation|1
109118|NCT00393042|363603|P2|First Intervention|Lost to Follow-up|3
109119|NCT00393042|363604|P1|First Intervention|Lost to Follow-up|3
109120|NCT00393042|363603|P2|First Intervention|Withdrawal by Subject|2
109121|NCT00393042|363604|P1|First Intervention|Withdrawal by Subject|1
109122|NCT00393094|363678|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
109123|NCT00393094|363678|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
109124|NCT00393367|363687|P2|Overall Study|Withdrawal by Subject|2
109125|NCT00393367|363688|P1|Overall Study|Withdrawal by Subject|0
109126|NCT00393367|363687|P2|Overall Study|Protocol Violation|5
109127|NCT00393367|363688|P1|Overall Study|Protocol Violation|2
109128|NCT00393458|363731|P4|Overall Study|Subject no longer requires study drug|0
109129|NCT00393458|363732|P3|Overall Study|Subject no longer requires study drug|0
109130|NCT00393458|363733|P2|Overall Study|Subject no longer requires study drug|1
109131|NCT00393458|363734|P1|Overall Study|Subject no longer requires study drug|0
109132|NCT00393458|363731|P4|Overall Study|Abnormal test procedure result(s)|2
109133|NCT00393458|363732|P3|Overall Study|Abnormal test procedure result(s)|1
109134|NCT00393458|363733|P2|Overall Study|Abnormal test procedure result(s)|1
109135|NCT00393458|363734|P1|Overall Study|Abnormal test procedure result(s)|0
109136|NCT00393458|363731|P4|Overall Study|Death|5
109137|NCT00393458|363732|P3|Overall Study|Death|5
109138|NCT00393458|363733|P2|Overall Study|Death|1
109139|NCT00393458|363734|P1|Overall Study|Death|1
109140|NCT00393458|363731|P4|Overall Study|Abnormal laboratory value(s)|0
109141|NCT00393458|363732|P3|Overall Study|Abnormal laboratory value(s)|0
109142|NCT00393458|363733|P2|Overall Study|Abnormal laboratory value(s)|1
109143|NCT00393458|363734|P1|Overall Study|Abnormal laboratory value(s)|1
109144|NCT00393458|363731|P4|Overall Study|Lost to Follow-up|3
109145|NCT00393458|363732|P3|Overall Study|Lost to Follow-up|5
109146|NCT00393458|363733|P2|Overall Study|Lost to Follow-up|6
109147|NCT00393458|363734|P1|Overall Study|Lost to Follow-up|5
109148|NCT00393458|363731|P4|Overall Study|Administrative problems|2
109149|NCT00393458|363732|P3|Overall Study|Administrative problems|5
109150|NCT00393458|363733|P2|Overall Study|Administrative problems|8
109151|NCT00393458|363734|P1|Overall Study|Administrative problems|7
109152|NCT00393458|363731|P4|Overall Study|Protocol deviation|10
109153|NCT00393458|363732|P3|Overall Study|Protocol deviation|11
109154|NCT00393458|363733|P2|Overall Study|Protocol deviation|11
109155|NCT00393458|363734|P1|Overall Study|Protocol deviation|11
109156|NCT00393458|363731|P4|Overall Study|Unsatisfactory therapeutic effect|30
109157|NCT00393458|363732|P3|Overall Study|Unsatisfactory therapeutic effect|12
109158|NCT00393458|363733|P2|Overall Study|Unsatisfactory therapeutic effect|9
109159|NCT00393458|363734|P1|Overall Study|Unsatisfactory therapeutic effect|12
109160|NCT00393458|363731|P4|Overall Study|Subject withdrew consent|50
109161|NCT00393458|363732|P3|Overall Study|Subject withdrew consent|33
109162|NCT00393458|363733|P2|Overall Study|Subject withdrew consent|40
109163|NCT00393458|363734|P1|Overall Study|Subject withdrew consent|27
109164|NCT00393458|363731|P4|Overall Study|Adverse Event|35
109165|NCT00393458|363732|P3|Overall Study|Adverse Event|40
109166|NCT00393458|363733|P2|Overall Study|Adverse Event|24
109167|NCT00393458|363734|P1|Overall Study|Adverse Event|35
109168|NCT00393484|363750|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
109169|NCT00393484|363751|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
109170|NCT00393484|363750|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
109171|NCT00393484|363751|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
109172|NCT00393484|363750|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
109173|NCT00393484|363751|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
109174|NCT00393484|363750|P2|Open-label Period (Weeks 96 to 240)|Death|0
109175|NCT00393484|363751|P1|Open-label Period (Weeks 96 to 240)|Death|1
109176|NCT00393484|363750|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
109177|NCT00393484|363751|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
109178|NCT00393484|363750|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
109179|NCT00393484|363751|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
109180|NCT00393484|363750|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
109181|NCT00393484|363751|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
109182|NCT00393484|363750|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
109183|NCT00393484|363751|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
109184|NCT00393484|363750|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
109185|NCT00393484|363751|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
109186|NCT00393484|363750|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
109187|NCT00393484|363751|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
109188|NCT00393510|363785|P2|Overall Study|Physician Decision|9
109189|NCT00393510|363786|P1|Overall Study|Physician Decision|3
109190|NCT00393523|363801|P5|Overall Study|Vaccine supply issue|0
109191|NCT00393523|363802|P4|Overall Study|Vaccine supply issue|0
109192|NCT00393523|363803|P3|Overall Study|Vaccine supply issue|1
109193|NCT00393523|363804|P2|Overall Study|Vaccine supply issue|0
109194|NCT00393523|363805|P1|Overall Study|Vaccine supply issue|0
109195|NCT00393523|363801|P5|Overall Study|Difficulties in specimen collection|0
109196|NCT00393523|363802|P4|Overall Study|Difficulties in specimen collection|0
109197|NCT00393523|363803|P3|Overall Study|Difficulties in specimen collection|1
109198|NCT00393523|363804|P2|Overall Study|Difficulties in specimen collection|0
109199|NCT00393523|363805|P1|Overall Study|Difficulties in specimen collection|0
109200|NCT00393523|363801|P5|Overall Study|Withdrawal by Subject|0
109201|NCT00393523|363802|P4|Overall Study|Withdrawal by Subject|3
109202|NCT00393523|363803|P3|Overall Study|Withdrawal by Subject|2
109203|NCT00393523|363804|P2|Overall Study|Withdrawal by Subject|7
109204|NCT00393523|363805|P1|Overall Study|Withdrawal by Subject|6
109205|NCT00393523|363801|P5|Overall Study|Protocol Violation|0
109206|NCT00393523|363802|P4|Overall Study|Protocol Violation|1
109207|NCT00393523|363803|P3|Overall Study|Protocol Violation|0
109208|NCT00393523|363804|P2|Overall Study|Protocol Violation|2
109209|NCT00393523|363805|P1|Overall Study|Protocol Violation|6
109210|NCT00393523|363801|P5|Overall Study|Lost to Follow-up|1
109211|NCT00393523|363802|P4|Overall Study|Lost to Follow-up|2
109212|NCT00393523|363803|P3|Overall Study|Lost to Follow-up|0
109213|NCT00393523|363804|P2|Overall Study|Lost to Follow-up|0
109214|NCT00393523|363805|P1|Overall Study|Lost to Follow-up|0
109215|NCT00393705|363822|P2|Overall Study|Physician Decision|2
109216|NCT00393705|363823|P1|Overall Study|Physician Decision|2
109217|NCT00393705|363822|P2|Overall Study|Withdrawal by Subject|3
109218|NCT00393705|363823|P1|Overall Study|Withdrawal by Subject|5
109219|NCT00393705|363822|P2|Overall Study|Protocol Violation|3
109220|NCT00393705|363823|P1|Overall Study|Protocol Violation|4
109221|NCT00393705|363822|P2|Overall Study|Entry Criteria Not Met|10
109222|NCT00393705|363823|P1|Overall Study|Entry Criteria Not Met|10
109223|NCT00393705|363822|P2|Overall Study|Lost to Follow-up|2
109224|NCT00393705|363823|P1|Overall Study|Lost to Follow-up|2
109225|NCT00393705|363822|P2|Overall Study|Death|1
109226|NCT00393705|363823|P1|Overall Study|Death|0
109227|NCT00393705|363822|P2|Overall Study|Adverse Event|2
109228|NCT00393705|363823|P1|Overall Study|Adverse Event|0
109229|NCT00393718|363849|P2|Overall Study|Move|0
109230|NCT00393718|363850|P1|Overall Study|Move|1
109231|NCT00393718|363849|P2|Overall Study|Missed measurement|0
109232|NCT00393718|363850|P1|Overall Study|Missed measurement|1
109233|NCT00393718|363849|P2|Overall Study|Withdrawal of consent|1
109234|NCT00393718|363850|P1|Overall Study|Withdrawal of consent|2
109235|NCT00393718|363849|P2|Overall Study|Subject decision|0
109236|NCT00393718|363850|P1|Overall Study|Subject decision|5
109237|NCT00393718|363849|P2|Overall Study|Hypoglycaemia|2
109238|NCT00393718|363850|P1|Overall Study|Hypoglycaemia|3
109239|NCT00393718|363849|P2|Overall Study|Lack of Efficacy|9
109240|NCT00393718|363850|P1|Overall Study|Lack of Efficacy|10
109241|NCT00393718|363849|P2|Overall Study|Protocol Violation|2
109242|NCT00393718|363850|P1|Overall Study|Protocol Violation|1
109243|NCT00393718|363849|P2|Overall Study|Adverse Event|8
109244|NCT00393718|363850|P1|Overall Study|Adverse Event|20
109245|NCT00393848|363893|P4|Overall Study|Personal reasons|0
109246|NCT00393848|363894|P3|Overall Study|Personal reasons|2
109247|NCT00393848|363895|P2|Overall Study|Personal reasons|0
109248|NCT00393848|363896|P1|Overall Study|Personal reasons|0
109249|NCT00393848|363893|P4|Overall Study|Surgical schedule|1
109250|NCT00393848|363894|P3|Overall Study|Surgical schedule|0
109251|NCT00393848|363895|P2|Overall Study|Surgical schedule|0
109252|NCT00393848|363896|P1|Overall Study|Surgical schedule|0
109253|NCT00393861|363908|P1|Overall Study|Disease Progression|24
109254|NCT00393861|363908|P1|Overall Study|Adverse Event|2
109255|NCT00393887|363939|P2|Overall Study|Lost to Follow-up|9
109256|NCT00393887|363940|P1|Overall Study|Lost to Follow-up|11
109257|NCT00393887|363939|P2|Overall Study|Physician Decision|0
109258|NCT00393887|363940|P1|Overall Study|Physician Decision|5
109259|NCT00393913|363946|P1|CPAP|TEchnical problem with CPAP|3
109260|NCT00393913|363946|P1|CPAP|Physician Decision|1
109261|NCT00393913|363946|P1|CPAP|Withdrawal by Subject|3
109262|NCT00393913|363946|P1|Initial Assessment|Withdrawal by Subject|16
109263|NCT00393913|363946|P1|Initial Assessment|diagnosed with other sleep disorder|21
109264|NCT00393939|363954|P2|Overall Study|Not specified|45
109265|NCT00393939|363955|P1|Overall Study|Not specified|37
109266|NCT00393939|363954|P2|Overall Study|Withdrawal by Subject|7
109267|NCT00393939|363955|P1|Overall Study|Withdrawal by Subject|2
109268|NCT00393939|363954|P2|Overall Study|Objective progression or relapse|223
109269|NCT00393939|363955|P1|Overall Study|Objective progression or relapse|239
109270|NCT00393939|363954|P2|Overall Study|Sponsor|13
109271|NCT00393939|363955|P1|Overall Study|Sponsor|5
109272|NCT00393939|363954|P2|Overall Study|Death|4
109273|NCT00393939|363955|P1|Overall Study|Death|10
109274|NCT00393939|363954|P2|Overall Study|Lost to Follow-up|4
109275|NCT00393939|363955|P1|Overall Study|Lost to Follow-up|2
109276|NCT00393939|363954|P2|Overall Study|Protocol Violation|1
109277|NCT00393939|363955|P1|Overall Study|Protocol Violation|1
109278|NCT00394082|363984|P1|Overall Study|Not specified|1
109279|NCT00394082|363984|P1|Overall Study|Withdrawal by Subject|2
109280|NCT00394082|363984|P1|Overall Study|Physician Decision|4
109281|NCT00394082|363984|P1|Overall Study|Adverse Event|4
109282|NCT00394082|363984|P1|Overall Study|Unacceptable toxicity|15
109283|NCT00394095|363995|P2|Overall Study|Adverse Event|0
109284|NCT00394095|363996|P1|Overall Study|Adverse Event|1
109285|NCT00394212|364028|P2|Overall Study|Withdrawal by Subject|1
109286|NCT00394212|364029|P1|Overall Study|Withdrawal by Subject|4
109287|NCT00394212|364028|P2|Overall Study|Lost to Follow-up|0
109288|NCT00394212|364029|P1|Overall Study|Lost to Follow-up|3
109289|NCT00394251|364043|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
109290|NCT00394251|364044|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
109291|NCT00394251|364043|P2|Overall Study|Withdrawal by Subject|11
109292|NCT00394251|364044|P1|Overall Study|Withdrawal by Subject|7
109293|NCT00394251|364043|P2|Overall Study|Protocol Violation|1
109294|NCT00394251|364044|P1|Overall Study|Protocol Violation|0
109295|NCT00394251|364043|P2|Overall Study|Physician Decision|1
109296|NCT00394251|364044|P1|Overall Study|Physician Decision|1
109297|NCT00394251|364043|P2|Overall Study|Unacceptable Toxicity|18
109298|NCT00394251|364044|P1|Overall Study|Unacceptable Toxicity|20
109299|NCT00394251|364043|P2|Overall Study|Adverse Event|5
109300|NCT00394251|364044|P1|Overall Study|Adverse Event|7
109301|NCT00394355|364120|P4|Overall Study|Lack of Efficacy|3
109302|NCT00394355|364121|P3|Overall Study|Lack of Efficacy|2
109303|NCT00394355|364122|P2|Overall Study|Lack of Efficacy|0
109304|NCT00394355|364123|P1|Overall Study|Lack of Efficacy|0
109305|NCT00394355|364120|P4|Overall Study|Administrative|1
109306|NCT00394355|364121|P3|Overall Study|Administrative|1
109307|NCT00394355|364122|P2|Overall Study|Administrative|1
109308|NCT00394355|364123|P1|Overall Study|Administrative|0
109309|NCT00394355|364120|P4|Overall Study|Noncompliance with protocol|8
109310|NCT00394355|364121|P3|Overall Study|Noncompliance with protocol|10
109311|NCT00394355|364122|P2|Overall Study|Noncompliance with protocol|3
109312|NCT00394355|364123|P1|Overall Study|Noncompliance with protocol|4
109313|NCT00394355|364120|P4|Overall Study|Lost to Follow-up|3
109314|NCT00394355|364121|P3|Overall Study|Lost to Follow-up|4
109315|NCT00394355|364122|P2|Overall Study|Lost to Follow-up|5
109316|NCT00394355|364123|P1|Overall Study|Lost to Follow-up|7
109317|NCT00394355|364120|P4|Overall Study|Subject withdrawal - related to drug|0
109318|NCT00394355|364121|P3|Overall Study|Subject withdrawal - related to drug|0
109319|NCT00394355|364122|P2|Overall Study|Subject withdrawal - related to drug|0
109320|NCT00394355|364123|P1|Overall Study|Subject withdrawal - related to drug|1
109321|NCT00394355|364120|P4|Overall Study|Subject withdrawal - unrelated to drug|6
109322|NCT00394355|364121|P3|Overall Study|Subject withdrawal - unrelated to drug|10
109323|NCT00394355|364122|P2|Overall Study|Subject withdrawal - unrelated to drug|14
109324|NCT00394355|364123|P1|Overall Study|Subject withdrawal - unrelated to drug|12
109325|NCT00394355|364120|P4|Overall Study|Did not meet protocol eligibility|2
109326|NCT00394355|364121|P3|Overall Study|Did not meet protocol eligibility|4
109327|NCT00394355|364122|P2|Overall Study|Did not meet protocol eligibility|5
109328|NCT00394355|364123|P1|Overall Study|Did not meet protocol eligibility|1
109329|NCT00394355|364120|P4|Overall Study|Adverse Event|8
109330|NCT00394355|364121|P3|Overall Study|Adverse Event|7
109331|NCT00394355|364122|P2|Overall Study|Adverse Event|6
109332|NCT00394355|364123|P1|Overall Study|Adverse Event|10
109333|NCT00394433|364145|P1|Overall Study|Alternative Therapy|1
109334|NCT00394433|364145|P1|Overall Study|Adverse Event|2
109335|NCT00394472|364154|P2|Overall Study|Lost to Follow-up|1
109336|NCT00394472|364155|P1|Overall Study|Lost to Follow-up|0
109337|NCT00394472|364154|P2|Overall Study|Physician Decision|1
109338|NCT00394472|364155|P1|Overall Study|Physician Decision|0
109339|NCT00394472|364154|P2|Overall Study|Withdrawal by Subject|2
109340|NCT00394472|364155|P1|Overall Study|Withdrawal by Subject|0
109341|NCT00394472|364154|P2|Overall Study|Adverse Event|2
109342|NCT00394472|364155|P1|Overall Study|Adverse Event|4
109343|NCT00394472|364154|P2|Overall Study|incorrect enrolment|2
109344|NCT00394472|364155|P1|Overall Study|incorrect enrolment|4
109345|NCT00394472|364154|P2|Overall Study|Protocol Violation|3
109346|NCT00394472|364155|P1|Overall Study|Protocol Violation|1
109347|NCT00397488|364179|P1|Overall Study|Death|1
109348|NCT00397488|364179|P1|Overall Study|Adverse Event|3
109349|NCT00397488|364179|P1|Overall Study|Withdrawal by Subject|3
109350|NCT00397514|364183|P1|Overall Study|poor echocardiographic windows|1
109351|NCT00397514|364183|P1|Overall Study|early extubation|2
109352|NCT00397514|364183|P1|Overall Study|Not able to capture & pace LV intraoper.|4
109353|NCT00397514|364183|P1|Overall Study|Pacing wire malfunction|1
109354|NCT00397514|364183|P1|Overall Study|Withdrawal by Subject|1
109355|NCT00397540|364195|P2|Overall Study|short follow-up duration < 12 months|0
109356|NCT00397540|364196|P1|Overall Study|short follow-up duration < 12 months|1
109357|NCT00397631|364204|P2|Overall Study|protocol discontinuation criteria|4
109358|NCT00397631|364205|P1|Overall Study|protocol discontinuation criteria|1
109359|NCT00397631|364204|P2|Overall Study|Withdrawal by Subject|14
109360|NCT00397631|364205|P1|Overall Study|Withdrawal by Subject|7
109361|NCT00397631|364204|P2|Overall Study|Protocol Violation|1
109362|NCT00397631|364205|P1|Overall Study|Protocol Violation|0
109363|NCT00397631|364204|P2|Overall Study|Physician Decision|0
109364|NCT00397631|364205|P1|Overall Study|Physician Decision|2
109365|NCT00397631|364204|P2|Overall Study|Lost to Follow-up|9
109366|NCT00397631|364205|P1|Overall Study|Lost to Follow-up|8
109367|NCT00397631|364204|P2|Overall Study|Lack of Efficacy|10
109368|NCT00397631|364205|P1|Overall Study|Lack of Efficacy|7
109369|NCT00397631|364204|P2|Overall Study|Adverse Event|6
109370|NCT00397631|364205|P1|Overall Study|Adverse Event|5
109371|NCT00397891|364241|P5|Overall Study|Withdrawal by Subject|1
109372|NCT00397891|364242|P4|Overall Study|Withdrawal by Subject|0
109373|NCT00397891|364243|P3|Overall Study|Withdrawal by Subject|0
109374|NCT00397891|364244|P2|Overall Study|Withdrawal by Subject|0
109375|NCT00397891|364245|P1|Overall Study|Withdrawal by Subject|1
109376|NCT00397930|364349|P2|Overall Study|Missing data|4
109377|NCT00397930|364350|P1|Overall Study|Missing data|0
109378|NCT00397930|364349|P2|Overall Study|Withdrawal by Subject|8
109379|NCT00397930|364350|P1|Overall Study|Withdrawal by Subject|0
109380|NCT00397930|364349|P2|Overall Study|Did not want to be in control group|1
109381|NCT00397930|364350|P1|Overall Study|Did not want to be in control group|0
109382|NCT00397930|364349|P2|Overall Study|Started own yoga program|1
109383|NCT00397930|364350|P1|Overall Study|Started own yoga program|1
109384|NCT00397930|364349|P2|Overall Study|Too time-consuming|9
109385|NCT00397930|364350|P1|Overall Study|Too time-consuming|2
109386|NCT00397930|364349|P2|Overall Study|Noncompliant|2
109387|NCT00397930|364350|P1|Overall Study|Noncompliant|3
109388|NCT00397930|364349|P2|Overall Study|Unknown reasons|14
109389|NCT00397930|364350|P1|Overall Study|Unknown reasons|9
109390|NCT00397930|364349|P2|Overall Study|Other medical|4
109391|NCT00397930|364350|P1|Overall Study|Other medical|9
109392|NCT00397930|364349|P2|Overall Study|Personal reasons|8
109393|NCT00397930|364350|P1|Overall Study|Personal reasons|14
109394|NCT00397982|364356|P1|Overall Study|Unrelated health issues|1
109395|NCT00397982|364356|P1|Overall Study|noncompliance|1
109396|NCT00397982|364356|P1|Overall Study|Adverse Event|1
109397|NCT00397982|364356|P1|Overall Study|Withdrawal by Subject|1
109398|NCT00398047|364365|P1|Overall Study|all patient progressed before completion|3
109399|NCT00398073|364377|P2|Overall Study|Withdrawal by Subject|0
109400|NCT00398073|364378|P1|Overall Study|Withdrawal by Subject|1
109401|NCT00398086|364391|P3|Overall Study|Withdrawal by Subject|0
109402|NCT00398086|364392|P2|Overall Study|Withdrawal by Subject|7
109403|NCT00398086|364393|P1|Overall Study|Withdrawal by Subject|5
109404|NCT00398086|364391|P3|Overall Study|Physician Decision|0
109405|NCT00398086|364392|P2|Overall Study|Physician Decision|4
109406|NCT00398086|364393|P1|Overall Study|Physician Decision|1
109407|NCT00398086|364391|P3|Overall Study|Adverse Event|0
109408|NCT00398086|364392|P2|Overall Study|Adverse Event|4
109409|NCT00398086|364393|P1|Overall Study|Adverse Event|1
109410|NCT00398086|364391|P3|Overall Study|Unacceptable Toxicity|2
109411|NCT00398086|364392|P2|Overall Study|Unacceptable Toxicity|8
109412|NCT00398086|364393|P1|Overall Study|Unacceptable Toxicity|2
109413|NCT00398112|364425|P1|Overall Study|Death|1
109414|NCT00398112|364425|P1|Overall Study|Withdrawal by Subject|3
109415|NCT00398112|364425|P1|Overall Study|Alternative treatment|1
109416|NCT00398112|364425|P1|Overall Study|Disease progression|9
109417|NCT00398112|364425|P1|Overall Study|Adverse Event|4
109418|NCT00398138|364433|P1|Overall Study|Adverse Event|2
109419|NCT00398216|364443|P5|Overall Study|entrance criteria|2
109420|NCT00398216|364444|P4|Overall Study|entrance criteria|0
109421|NCT00398216|364445|P3|Overall Study|entrance criteria|0
109422|NCT00398216|364446|P2|Overall Study|entrance criteria|0
109423|NCT00398216|364447|P1|Overall Study|entrance criteria|0
109424|NCT00398216|364443|P5|Overall Study|administrative reasons|3
109425|NCT00398216|364444|P4|Overall Study|administrative reasons|3
109426|NCT00398216|364445|P3|Overall Study|administrative reasons|4
109427|NCT00398216|364446|P2|Overall Study|administrative reasons|4
109428|NCT00398216|364447|P1|Overall Study|administrative reasons|3
109429|NCT00398216|364443|P5|Overall Study|Withdrawal by Subject|2
109430|NCT00398216|364444|P4|Overall Study|Withdrawal by Subject|1
109431|NCT00398216|364445|P3|Overall Study|Withdrawal by Subject|3
109432|NCT00398216|364446|P2|Overall Study|Withdrawal by Subject|0
109433|NCT00398216|364447|P1|Overall Study|Withdrawal by Subject|1
109434|NCT00398216|364443|P5|Overall Study|Death|0
109435|NCT00398216|364444|P4|Overall Study|Death|0
109436|NCT00398216|364445|P3|Overall Study|Death|0
109437|NCT00398216|364446|P2|Overall Study|Death|3
109438|NCT00398216|364447|P1|Overall Study|Death|0
109439|NCT00398216|364443|P5|Overall Study|Lost to Follow-up|1
109440|NCT00398216|364444|P4|Overall Study|Lost to Follow-up|4
109441|NCT00398216|364445|P3|Overall Study|Lost to Follow-up|4
109442|NCT00398216|364446|P2|Overall Study|Lost to Follow-up|6
109443|NCT00398216|364447|P1|Overall Study|Lost to Follow-up|1
109444|NCT00398216|364443|P5|Overall Study|Protocol Violation|5
109445|NCT00398216|364444|P4|Overall Study|Protocol Violation|7
109446|NCT00398216|364445|P3|Overall Study|Protocol Violation|5
109447|NCT00398216|364446|P2|Overall Study|Protocol Violation|4
109448|NCT00398216|364447|P1|Overall Study|Protocol Violation|2
109449|NCT00398216|364443|P5|Overall Study|Adverse Event|2
109450|NCT00398216|364444|P4|Overall Study|Adverse Event|7
109451|NCT00398216|364445|P3|Overall Study|Adverse Event|5
109452|NCT00398216|364446|P2|Overall Study|Adverse Event|2
109453|NCT00398216|364447|P1|Overall Study|Adverse Event|4
109454|NCT00398320|364474|P1|Overall Study|Physician Decision|1
109455|NCT00398320|364474|P1|Overall Study|Adverse Event|4
109456|NCT00398320|364474|P1|Overall Study|Death|1
109457|NCT00398411|364491|P2|Overall Study|Death|1
109458|NCT00398411|364492|P1|Overall Study|Death|0
109459|NCT00398632|364508|P1|Overall Study|Lack of Efficacy|1
109460|NCT00398632|364508|P1|Overall Study|Withdrawal by Subject|1
109549|NCT00391586|364845|P1|Overall Study|Progressive disease|13
109461|NCT00398866|364515|P3|Overall Study|Unable to complete requirements of study|1
109462|NCT00398866|364516|P2|Overall Study|Unable to complete requirements of study|1
109463|NCT00398866|364517|P1|Overall Study|Unable to complete requirements of study|1
109464|NCT00398866|364515|P3|Overall Study|Withdrawal by Subject|2
109465|NCT00398866|364516|P2|Overall Study|Withdrawal by Subject|1
109466|NCT00398866|364517|P1|Overall Study|Withdrawal by Subject|5
109467|NCT00398866|364515|P3|Overall Study|Lost to Follow-up|4
109468|NCT00398866|364516|P2|Overall Study|Lost to Follow-up|6
109469|NCT00398866|364517|P1|Overall Study|Lost to Follow-up|7
109470|NCT00398866|364515|P3|Overall Study|Lack of Efficacy|1
109471|NCT00398866|364516|P2|Overall Study|Lack of Efficacy|0
109472|NCT00398866|364517|P1|Overall Study|Lack of Efficacy|0
109473|NCT00398866|364515|P3|Overall Study|Adverse Event|0
109474|NCT00398866|364516|P2|Overall Study|Adverse Event|0
109475|NCT00398866|364517|P1|Overall Study|Adverse Event|1
109476|NCT00399035|364545|P3|Overall Study|Severe non-compliance with protocol|0
109477|NCT00399035|364546|P2|Overall Study|Severe non-compliance with protocol|1
109478|NCT00399035|364547|P1|Overall Study|Severe non-compliance with protocol|2
109479|NCT00399035|364545|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
109480|NCT00399035|364546|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
109481|NCT00399035|364547|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
109482|NCT00399035|364545|P3|Overall Study|Withdrawal by Subject|12
109483|NCT00399035|364546|P2|Overall Study|Withdrawal by Subject|15
109484|NCT00399035|364547|P1|Overall Study|Withdrawal by Subject|19
109485|NCT00399035|364545|P3|Overall Study|Lost to Follow-up|5
109486|NCT00399035|364546|P2|Overall Study|Lost to Follow-up|1
109487|NCT00399035|364547|P1|Overall Study|Lost to Follow-up|2
109488|NCT00399035|364545|P3|Overall Study|Death|234
109489|NCT00399035|364546|P2|Overall Study|Death|141
109490|NCT00399035|364547|P1|Overall Study|Death|289
109491|NCT00399360|364592|P4|Overall Study|Withdrawal by Subject|2
109492|NCT00399360|364593|P3|Overall Study|Withdrawal by Subject|0
109493|NCT00399360|364594|P2|Overall Study|Withdrawal by Subject|2
109494|NCT00399360|364595|P1|Overall Study|Withdrawal by Subject|0
109495|NCT00399360|364592|P4|Overall Study|Adverse Event|0
109496|NCT00399360|364593|P3|Overall Study|Adverse Event|1
109497|NCT00399360|364594|P2|Overall Study|Adverse Event|0
109498|NCT00399360|364595|P1|Overall Study|Adverse Event|0
109499|NCT00399360|364592|P4|Overall Study|Lost to Follow-up|4
109500|NCT00399360|364593|P3|Overall Study|Lost to Follow-up|2
109501|NCT00399360|364594|P2|Overall Study|Lost to Follow-up|1
109502|NCT00399360|364595|P1|Overall Study|Lost to Follow-up|2
109503|NCT00399516|364641|P1|Overall Study|Lost to Follow-up|2
109504|NCT00399542|364647|P2|Overall Study|Physician Decision|1
109505|NCT00399542|364648|P1|Overall Study|Physician Decision|0
109506|NCT00399542|364647|P2|Overall Study|Unspecified|0
109507|NCT00399542|364648|P1|Overall Study|Unspecified|1
109508|NCT00399542|364647|P2|Overall Study|Lost to Follow-up|6
109509|NCT00399542|364648|P1|Overall Study|Lost to Follow-up|6
109510|NCT00399542|364647|P2|Overall Study|Lack of Efficacy|8
109511|NCT00399542|364648|P1|Overall Study|Lack of Efficacy|18
109512|NCT00399542|364647|P2|Overall Study|Withdrawal by Subject|10
109513|NCT00399542|364648|P1|Overall Study|Withdrawal by Subject|28
109514|NCT00399542|364647|P2|Overall Study|Protocol Violation|3
109515|NCT00399542|364648|P1|Overall Study|Protocol Violation|13
109516|NCT00399542|364647|P2|Overall Study|Adverse Event|15
109517|NCT00399542|364648|P1|Overall Study|Adverse Event|18
109518|NCT00399568|364712|P2|Overall Study|Lost to Follow-up|2
109519|NCT00399568|364713|P1|Overall Study|Lost to Follow-up|2
109520|NCT00399568|364712|P2|Overall Study|Protocol non-compliance|2
109521|NCT00399568|364713|P1|Overall Study|Protocol non-compliance|2
109522|NCT00399568|364712|P2|Overall Study|Withdrawal by Subject|3
109523|NCT00399568|364713|P1|Overall Study|Withdrawal by Subject|7
109524|NCT00399568|364712|P2|Overall Study|Adverse Event|2
109525|NCT00399568|364713|P1|Overall Study|Adverse Event|1
109526|NCT00399763|364727|P2|Overall Study|Lost to Follow-up|3
109527|NCT00399763|364728|P1|Overall Study|Lost to Follow-up|2
109528|NCT00399893|364740|P2|Overall Study|Withdrawal by Subject|0
109529|NCT00399893|364741|P1|Overall Study|Withdrawal by Subject|1
109530|NCT00391391|364784|P4|Overall Study|Withdrawal by Subject|7
109531|NCT00391391|364785|P3|Overall Study|Withdrawal by Subject|10
109532|NCT00391391|364786|P2|Overall Study|Withdrawal by Subject|4
109533|NCT00391391|364787|P1|Overall Study|Withdrawal by Subject|6
109534|NCT00391391|364784|P4|Overall Study|Protocol Violation|7
109535|NCT00391391|364785|P3|Overall Study|Protocol Violation|6
109536|NCT00391391|364786|P2|Overall Study|Protocol Violation|3
109537|NCT00391391|364787|P1|Overall Study|Protocol Violation|2
109538|NCT00391391|364784|P4|Overall Study|Lost to Follow-up|4
109539|NCT00391391|364785|P3|Overall Study|Lost to Follow-up|7
109540|NCT00391391|364786|P2|Overall Study|Lost to Follow-up|3
109541|NCT00391391|364787|P1|Overall Study|Lost to Follow-up|1
109542|NCT00391391|364784|P4|Overall Study|Adverse Event|1
109543|NCT00391391|364785|P3|Overall Study|Adverse Event|0
109544|NCT00391391|364786|P2|Overall Study|Adverse Event|0
109545|NCT00391391|364787|P1|Overall Study|Adverse Event|0
109546|NCT00391586|364845|P1|Overall Study|Death|4
109547|NCT00391586|364845|P1|Overall Study|Physician Decision|2
109548|NCT00391586|364845|P1|Overall Study|Adverse Event|5
109550|NCT00400153|364866|P3|Overall Study|Other reasons - not mentioned above|3
109551|NCT00400153|364867|P2|Overall Study|Other reasons - not mentioned above|5
109552|NCT00400153|364868|P1|Overall Study|Other reasons - not mentioned above|8
109553|NCT00400153|364866|P3|Overall Study|Withdrawal by Subject|10
109554|NCT00400153|364867|P2|Overall Study|Withdrawal by Subject|11
109555|NCT00400153|364868|P1|Overall Study|Withdrawal by Subject|12
109556|NCT00400153|364866|P3|Overall Study|Lost to Follow-up|4
109557|NCT00400153|364867|P2|Overall Study|Lost to Follow-up|1
109558|NCT00400153|364868|P1|Overall Study|Lost to Follow-up|2
109559|NCT00400153|364866|P3|Overall Study|Protocol Violation|9
109560|NCT00400153|364867|P2|Overall Study|Protocol Violation|4
109561|NCT00400153|364868|P1|Overall Study|Protocol Violation|7
109562|NCT00400153|364866|P3|Overall Study|AE due to other condition|15
109563|NCT00400153|364867|P2|Overall Study|AE due to other condition|14
109564|NCT00400153|364868|P1|Overall Study|AE due to other condition|3
109565|NCT00400153|364866|P3|Overall Study|AE due to other disease worsening|0
109566|NCT00400153|364867|P2|Overall Study|AE due to other disease worsening|1
109567|NCT00400153|364868|P1|Overall Study|AE due to other disease worsening|2
109568|NCT00400153|364866|P3|Overall Study|AE due to study disease worsening|20
109569|NCT00400153|364867|P2|Overall Study|AE due to study disease worsening|19
109570|NCT00400153|364868|P1|Overall Study|AE due to study disease worsening|14
109571|NCT00400179|365115|P2|Overall Study|Randomization error/patient ineligible|6
109572|NCT00400179|365116|P1|Overall Study|Randomization error/patient ineligible|1
109573|NCT00400179|365115|P2|Overall Study|Investigator judgment|1
109574|NCT00400179|365116|P1|Overall Study|Investigator judgment|0
109575|NCT00400179|365115|P2|Overall Study|Intercurrent illness|1
109576|NCT00400179|365116|P1|Overall Study|Intercurrent illness|0
109577|NCT00400179|365115|P2|Overall Study|Disease progression|1
109578|NCT00400179|365116|P1|Overall Study|Disease progression|1
109579|NCT00400179|365115|P2|Overall Study|Withdrew Consent|5
109580|NCT00400179|365116|P1|Overall Study|Withdrew Consent|1
109581|NCT00400179|365115|P2|Overall Study|Death|2
109582|NCT00400179|365116|P1|Overall Study|Death|1
109583|NCT00400179|365115|P2|Overall Study|Adverse Event|2
109584|NCT00400179|365116|P1|Overall Study|Adverse Event|2
109585|NCT00401973|365137|P3|Overall Study|Withdrawal by Subject|9
109586|NCT00401973|365138|P2|Overall Study|Withdrawal by Subject|12
109587|NCT00401973|365139|P1|Overall Study|Withdrawal by Subject|4
109588|NCT00401973|365137|P3|Overall Study|Sponsor Decision|0
109589|NCT00401973|365138|P2|Overall Study|Sponsor Decision|1
109590|NCT00401973|365139|P1|Overall Study|Sponsor Decision|0
109591|NCT00401973|365137|P3|Overall Study|Protocol Violation|3
109592|NCT00401973|365138|P2|Overall Study|Protocol Violation|2
109593|NCT00401973|365139|P1|Overall Study|Protocol Violation|1
109594|NCT00401973|365137|P3|Overall Study|Physician Decision|1
109595|NCT00401973|365138|P2|Overall Study|Physician Decision|0
109596|NCT00401973|365139|P1|Overall Study|Physician Decision|2
109597|NCT00401973|365137|P3|Overall Study|Lost to Follow-up|2
109598|NCT00401973|365138|P2|Overall Study|Lost to Follow-up|2
109599|NCT00401973|365139|P1|Overall Study|Lost to Follow-up|2
109600|NCT00401973|365137|P3|Overall Study|Lack of Efficacy|3
109601|NCT00401973|365138|P2|Overall Study|Lack of Efficacy|0
109602|NCT00401973|365139|P1|Overall Study|Lack of Efficacy|0
109603|NCT00401973|365137|P3|Overall Study|Clinical Relapse|1
109604|NCT00401973|365138|P2|Overall Study|Clinical Relapse|1
109605|NCT00401973|365139|P1|Overall Study|Clinical Relapse|0
109606|NCT00401973|365137|P3|Overall Study|Adverse Event|4
109607|NCT00401973|365138|P2|Overall Study|Adverse Event|8
109608|NCT00401973|365139|P1|Overall Study|Adverse Event|2
109609|NCT00402025|365179|P3|Overall Study|Participant Decision|1
109610|NCT00402025|365180|P2|Overall Study|Participant Decision|0
109611|NCT00402025|365181|P1|Overall Study|Participant Decision|0
109612|NCT00402025|365179|P3|Overall Study|Physician Decision|0
109613|NCT00402025|365180|P2|Overall Study|Physician Decision|1
109614|NCT00402025|365181|P1|Overall Study|Physician Decision|1
109615|NCT00402025|365179|P3|Overall Study|Disease Progression|2
109616|NCT00402025|365180|P2|Overall Study|Disease Progression|1
109617|NCT00402025|365181|P1|Overall Study|Disease Progression|1
109618|NCT00402025|365179|P3|Overall Study|Death|5
109619|NCT00402025|365180|P2|Overall Study|Death|1
109620|NCT00402025|365181|P1|Overall Study|Death|0
109621|NCT00402025|365179|P3|Overall Study|Adverse Event|2
109622|NCT00402025|365180|P2|Overall Study|Adverse Event|0
109623|NCT00402025|365181|P1|Overall Study|Adverse Event|0
109624|NCT00402051|365206|P2|Overall Study|Lost to Follow-up|0
109625|NCT00402051|365207|P1|Overall Study|Lost to Follow-up|1
109626|NCT00402051|365206|P2|Overall Study|Death Due to Adverse Event|2
109627|NCT00402051|365207|P1|Overall Study|Death Due to Adverse Event|0
109628|NCT00402051|365206|P2|Overall Study|Death Due to Study Disease|1
109629|NCT00402051|365207|P1|Overall Study|Death Due to Study Disease|2
109630|NCT00402051|365206|P2|Overall Study|Death - Related to Study Drug|2
109631|NCT00402051|365207|P1|Overall Study|Death - Related to Study Drug|1
109632|NCT00402051|365206|P2|Overall Study|Withdrawal by Subject|3
109633|NCT00402051|365207|P1|Overall Study|Withdrawal by Subject|3
109634|NCT00402051|365206|P2|Overall Study|Physician Decision|3
109635|NCT00402051|365207|P1|Overall Study|Physician Decision|7
109636|NCT00402051|365206|P2|Overall Study|Adverse Event|4
109637|NCT00402051|365207|P1|Overall Study|Adverse Event|11
109638|NCT00402051|365206|P2|Overall Study|Progressive Disease|20
109639|NCT00402051|365207|P1|Overall Study|Progressive Disease|13
109640|NCT00402103|365223|P2|Overall Study|Administrative problems|0
109641|NCT00402103|365224|P1|Overall Study|Administrative problems|2
109642|NCT00402103|365223|P2|Overall Study|Lost to Follow-up|3
109643|NCT00402103|365224|P1|Overall Study|Lost to Follow-up|6
109644|NCT00402103|365223|P2|Overall Study|Patient withdrew consent|1
109645|NCT00402103|365224|P1|Overall Study|Patient withdrew consent|12
109646|NCT00402103|365223|P2|Overall Study|Protocol Deviation|0
109647|NCT00402103|365224|P1|Overall Study|Protocol Deviation|8
109648|NCT00402103|365223|P2|Overall Study|Condition no longer requires study drug|0
109649|NCT00402103|365224|P1|Overall Study|Condition no longer requires study drug|2
109650|NCT00402103|365223|P2|Overall Study|Unsatisfactory therapeutic effect|2
109651|NCT00402103|365224|P1|Overall Study|Unsatisfactory therapeutic effect|1
109652|NCT00402103|365223|P2|Overall Study|Adverse Event|7
109653|NCT00402103|365224|P1|Overall Study|Adverse Event|60
109654|NCT00402168|365240|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
109655|NCT00402168|365241|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
109656|NCT00402168|365240|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
109657|NCT00402168|365241|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
109658|NCT00402168|365240|P2|Long Term (LT)|non-specified|2
109659|NCT00402168|365241|P1|Long Term (LT)|non-specified|1
109660|NCT00402168|365240|P2|Long Term (LT)|Lack of Efficacy|2
109661|NCT00402168|365241|P1|Long Term (LT)|Lack of Efficacy|0
109662|NCT00402168|365240|P2|Long Term (LT)|Death|0
109663|NCT00402168|365241|P1|Long Term (LT)|Death|4
109664|NCT00402168|365240|P2|Long Term (LT)|Lost to Follow-up|0
109665|NCT00402168|365241|P1|Long Term (LT)|Lost to Follow-up|1
109666|NCT00402168|365240|P2|Long Term (LT)|Pregnancy|1
109667|NCT00402168|365241|P1|Long Term (LT)|Pregnancy|0
109668|NCT00402168|365240|P2|Long Term (LT)|Withdrawal by Subject|7
109669|NCT00402168|365241|P1|Long Term (LT)|Withdrawal by Subject|4
109670|NCT00402168|365240|P2|Long Term (LT)|Adverse Event|5
109671|NCT00402168|365241|P1|Long Term (LT)|Adverse Event|1
109672|NCT00402168|365240|P2|Treatment (up to 12 Months)|non-specified|1
109673|NCT00402168|365241|P1|Treatment (up to 12 Months)|non-specified|0
109674|NCT00402168|365240|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
109675|NCT00402168|365241|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
109676|NCT00402168|365240|P2|Treatment (up to 12 Months)|Death|1
109677|NCT00402168|365241|P1|Treatment (up to 12 Months)|Death|0
109678|NCT00402168|365240|P2|Randomized|Withdrawal by Subject|1
109679|NCT00402168|365241|P1|Randomized|Withdrawal by Subject|0
109680|NCT00402168|365240|P2|Randomized|Lost to Follow-up|0
109681|NCT00402168|365241|P1|Randomized|Lost to Follow-up|1
109682|NCT00402233|365311|P4|Overall Study|Worsening of other pre-existing disease|0
109683|NCT00402233|365312|P3|Overall Study|Worsening of other pre-existing disease|0
109684|NCT00402233|365313|P2|Overall Study|Worsening of other pre-existing disease|1
109685|NCT00402233|365314|P1|Overall Study|Worsening of other pre-existing disease|0
109686|NCT00402233|365311|P4|Overall Study|Worsening of disease under study|0
109687|NCT00402233|365312|P3|Overall Study|Worsening of disease under study|0
109688|NCT00402233|365313|P2|Overall Study|Worsening of disease under study|0
109689|NCT00402233|365314|P1|Overall Study|Worsening of disease under study|2
109690|NCT00402233|365311|P4|Overall Study|Withdrawal by Subject|2
109691|NCT00402233|365312|P3|Overall Study|Withdrawal by Subject|2
109692|NCT00402233|365313|P2|Overall Study|Withdrawal by Subject|1
109693|NCT00402233|365314|P1|Overall Study|Withdrawal by Subject|2
109694|NCT00402233|365311|P4|Overall Study|Protocol Violation|0
109695|NCT00402233|365312|P3|Overall Study|Protocol Violation|0
109696|NCT00402233|365313|P2|Overall Study|Protocol Violation|1
109697|NCT00402233|365314|P1|Overall Study|Protocol Violation|0
109698|NCT00402233|365311|P4|Overall Study|Adverse Event|9
109699|NCT00402233|365312|P3|Overall Study|Adverse Event|9
109700|NCT00402233|365313|P2|Overall Study|Adverse Event|7
109701|NCT00402233|365314|P1|Overall Study|Adverse Event|1
109702|NCT00402246|365338|P2|Overall Study|Deterioriating Condition|2
109703|NCT00402246|365339|P1|Overall Study|Deterioriating Condition|3
109704|NCT00402246|365338|P2|Overall Study|Center Closure|3
109705|NCT00402246|365339|P1|Overall Study|Center Closure|5
109706|NCT00402246|365338|P2|Overall Study|Patient's device explanted|2
109707|NCT00402246|365339|P1|Overall Study|Patient's device explanted|6
109708|NCT00402246|365338|P2|Overall Study|Heart Transplant|1
109709|NCT00402246|365339|P1|Overall Study|Heart Transplant|0
109710|NCT00402246|365338|P2|Overall Study|Insurance Issues|1
109711|NCT00402246|365339|P1|Overall Study|Insurance Issues|2
109712|NCT00402246|365338|P2|Overall Study|Missed Final Visit|2
109713|NCT00402246|365339|P1|Overall Study|Missed Final Visit|1
109714|NCT00402246|365338|P2|Overall Study|Protocol Violation|24
109715|NCT00402246|365339|P1|Overall Study|Protocol Violation|25
109716|NCT00402246|365338|P2|Overall Study|Physician Decision|26
109717|NCT00402246|365339|P1|Overall Study|Physician Decision|24
109718|NCT00402246|365338|P2|Overall Study|Withdrawal by Subject|87
109719|NCT00402246|365339|P1|Overall Study|Withdrawal by Subject|72
109720|NCT00402246|365338|P2|Overall Study|Lost to Follow-up|28
109721|NCT00402246|365339|P1|Overall Study|Lost to Follow-up|20
109722|NCT00402246|365338|P2|Overall Study|Death|58
109723|NCT00402246|365339|P1|Overall Study|Death|62
109724|NCT00402285|365372|P3|Overall Study|insufficient RNA quality|2
109725|NCT00402285|365373|P2|Overall Study|insufficient RNA quality|6
109726|NCT00402285|365374|P1|Overall Study|insufficient RNA quality|7
109727|NCT00402324|365382|P2|Overall Study|Death|0
109728|NCT00402324|365383|P1|Overall Study|Death|1
109729|NCT00402324|365382|P2|Overall Study|Adverse Event|4
109730|NCT00402324|365383|P1|Overall Study|Adverse Event|6
109731|NCT00402324|365382|P2|Overall Study|Lack of Efficacy|4
109732|NCT00402324|365383|P1|Overall Study|Lack of Efficacy|1
109733|NCT00402324|365382|P2|Overall Study|Sponsor Decision|5
109734|NCT00402324|365383|P1|Overall Study|Sponsor Decision|4
109735|NCT00402324|365382|P2|Overall Study|Physician Decision|4
109736|NCT00402324|365383|P1|Overall Study|Physician Decision|2
109737|NCT00402324|365382|P2|Overall Study|Withdrawal by Subject|2
109738|NCT00402324|365383|P1|Overall Study|Withdrawal by Subject|5
109739|NCT00402324|365382|P2|Overall Study|Protocol Violation|7
109740|NCT00402324|365383|P1|Overall Study|Protocol Violation|8
109741|NCT00402324|365382|P2|Overall Study|Protocol Entry Criteria Not Met|4
109742|NCT00402324|365383|P1|Overall Study|Protocol Entry Criteria Not Met|5
109743|NCT00402324|365382|P2|Overall Study|Lost to Follow-up|11
109744|NCT00402324|365383|P1|Overall Study|Lost to Follow-up|11
109745|NCT00402337|365418|P5|Overall Study|Other Reason|0
109746|NCT00402337|365419|P4|Overall Study|Other Reason|0
109747|NCT00402337|365420|P3|Overall Study|Other Reason|0
109748|NCT00402337|365421|P2|Overall Study|Other Reason|1
109749|NCT00402337|365422|P1|Overall Study|Other Reason|0
109750|NCT00402337|365418|P5|Overall Study|Physician Decision|0
109751|NCT00402337|365419|P4|Overall Study|Physician Decision|1
109752|NCT00402337|365420|P3|Overall Study|Physician Decision|0
109753|NCT00402337|365421|P2|Overall Study|Physician Decision|0
109754|NCT00402337|365422|P1|Overall Study|Physician Decision|0
109755|NCT00402337|365418|P5|Overall Study|Lost to Follow-up|0
109756|NCT00402337|365419|P4|Overall Study|Lost to Follow-up|2
109757|NCT00402337|365420|P3|Overall Study|Lost to Follow-up|1
109758|NCT00402337|365421|P2|Overall Study|Lost to Follow-up|0
109759|NCT00402337|365422|P1|Overall Study|Lost to Follow-up|0
109760|NCT00402337|365418|P5|Overall Study|Withdrawal by Subject|4
109761|NCT00402337|365419|P4|Overall Study|Withdrawal by Subject|6
109762|NCT00402337|365420|P3|Overall Study|Withdrawal by Subject|1
109763|NCT00402337|365421|P2|Overall Study|Withdrawal by Subject|3
109764|NCT00402337|365422|P1|Overall Study|Withdrawal by Subject|5
109765|NCT00402337|365418|P5|Overall Study|Noncompliance|2
109766|NCT00402337|365419|P4|Overall Study|Noncompliance|0
109767|NCT00402337|365420|P3|Overall Study|Noncompliance|0
109768|NCT00402337|365421|P2|Overall Study|Noncompliance|0
109769|NCT00402337|365422|P1|Overall Study|Noncompliance|0
109770|NCT00402337|365418|P5|Overall Study|Adverse Event|2
109771|NCT00402337|365419|P4|Overall Study|Adverse Event|3
109772|NCT00402337|365420|P3|Overall Study|Adverse Event|2
109773|NCT00402337|365421|P2|Overall Study|Adverse Event|2
109774|NCT00402337|365422|P1|Overall Study|Adverse Event|0
109775|NCT00402363|365463|P4|Overall Study|"Captured as Other"|2
109776|NCT00402363|365464|P3|Overall Study|"Captured as Other"|2
109777|NCT00402363|365465|P2|Overall Study|"Captured as Other"|2
109778|NCT00402363|365466|P1|Overall Study|"Captured as Other"|6
109779|NCT00402363|365463|P4|Overall Study|Lost to Follow-up|2
109780|NCT00402363|365464|P3|Overall Study|Lost to Follow-up|0
109781|NCT00402363|365465|P2|Overall Study|Lost to Follow-up|4
109782|NCT00402363|365466|P1|Overall Study|Lost to Follow-up|5
109783|NCT00402363|365463|P4|Overall Study|Protocol Violation|3
109784|NCT00402363|365464|P3|Overall Study|Protocol Violation|0
109785|NCT00402363|365465|P2|Overall Study|Protocol Violation|5
109786|NCT00402363|365466|P1|Overall Study|Protocol Violation|3
109787|NCT00402363|365463|P4|Overall Study|Withdrew Consent|1
109788|NCT00402363|365464|P3|Overall Study|Withdrew Consent|2
109789|NCT00402363|365465|P2|Overall Study|Withdrew Consent|5
109790|NCT00402363|365466|P1|Overall Study|Withdrew Consent|10
109791|NCT00402363|365463|P4|Overall Study|Adverse Event|2
109792|NCT00402363|365464|P3|Overall Study|Adverse Event|2
109793|NCT00402363|365465|P2|Overall Study|Adverse Event|14
109794|NCT00402363|365466|P1|Overall Study|Adverse Event|9
109795|NCT00402597|365529|P5|Overall Study|reason not specified|20
109796|NCT00402597|365530|P4|Overall Study|reason not specified|14
109797|NCT00402597|365531|P3|Overall Study|reason not specified|27
109798|NCT00402597|365532|P2|Overall Study|reason not specified|4
109799|NCT00402597|365533|P1|Overall Study|reason not specified|30
109800|NCT00402597|365529|P5|Overall Study|Withdrawal by Subject|24
109801|NCT00402597|365530|P4|Overall Study|Withdrawal by Subject|15
109802|NCT00402597|365531|P3|Overall Study|Withdrawal by Subject|65
109803|NCT00402597|365532|P2|Overall Study|Withdrawal by Subject|16
109804|NCT00402597|365533|P1|Overall Study|Withdrawal by Subject|57
109805|NCT00402597|365529|P5|Overall Study|Lost to Follow-up|3
109806|NCT00402597|365530|P4|Overall Study|Lost to Follow-up|2
109807|NCT00402597|365531|P3|Overall Study|Lost to Follow-up|8
109808|NCT00402597|365532|P2|Overall Study|Lost to Follow-up|1
109809|NCT00402597|365533|P1|Overall Study|Lost to Follow-up|8
109810|NCT00402597|365529|P5|Overall Study|Adverse Event|71
109811|NCT00402597|365530|P4|Overall Study|Adverse Event|39
109812|NCT00402597|365531|P3|Overall Study|Adverse Event|106
109813|NCT00402597|365532|P2|Overall Study|Adverse Event|18
109814|NCT00402597|365533|P1|Overall Study|Adverse Event|81
109815|NCT00402597|365529|P5|Overall Study|Death|6
109816|NCT00402597|365530|P4|Overall Study|Death|4
109817|NCT00402597|365531|P3|Overall Study|Death|6
109818|NCT00402597|365532|P2|Overall Study|Death|7
109819|NCT00402597|365533|P1|Overall Study|Death|15
109820|NCT00402649|365570|P1|Overall Study|Withdrawal by Subject|1
109821|NCT00402649|365570|P1|Overall Study|Lost to Follow-up|1
109822|NCT00402688|365583|P3|Overall Study|Patient Left Town and Forgot Medication|1
109823|NCT00402688|365584|P2|Overall Study|Patient Left Town and Forgot Medication|0
109824|NCT00402688|365585|P1|Overall Study|Patient Left Town and Forgot Medication|0
109825|NCT00402688|365583|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
109826|NCT00402688|365584|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
109827|NCT00402688|365585|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
109828|NCT00402688|365583|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
109829|NCT00402688|365584|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
109830|NCT00402688|365585|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
109831|NCT00402688|365583|P3|Overall Study|Lost to Follow-up|2
109832|NCT00402688|365584|P2|Overall Study|Lost to Follow-up|0
109833|NCT00402688|365585|P1|Overall Study|Lost to Follow-up|1
109834|NCT00402688|365583|P3|Overall Study|Protocol Violation|1
109835|NCT00402688|365584|P2|Overall Study|Protocol Violation|1
109836|NCT00402688|365585|P1|Overall Study|Protocol Violation|1
109837|NCT00402688|365583|P3|Overall Study|Lack of Efficacy|5
109838|NCT00402688|365584|P2|Overall Study|Lack of Efficacy|4
109839|NCT00402688|365585|P1|Overall Study|Lack of Efficacy|4
109840|NCT00402688|365583|P3|Overall Study|Physician Decision|1
109841|NCT00402688|365584|P2|Overall Study|Physician Decision|0
109842|NCT00402688|365585|P1|Overall Study|Physician Decision|0
109843|NCT00402688|365583|P3|Overall Study|Withdrawal by Subject|1
109844|NCT00402688|365584|P2|Overall Study|Withdrawal by Subject|1
109845|NCT00402688|365585|P1|Overall Study|Withdrawal by Subject|3
109846|NCT00402688|365583|P3|Overall Study|Adverse Event|3
109847|NCT00402688|365584|P2|Overall Study|Adverse Event|9
109848|NCT00402688|365585|P1|Overall Study|Adverse Event|12
109849|NCT00402727|365621|P2|Overall Study|non-compliance|1
109850|NCT00402727|365622|P1|Overall Study|non-compliance|0
109851|NCT00402727|365621|P2|Overall Study|supply problems|1
109852|NCT00402727|365622|P1|Overall Study|supply problems|2
109853|NCT00402727|365621|P2|Overall Study|Withdrawal by Subject|7
109854|NCT00402727|365622|P1|Overall Study|Withdrawal by Subject|3
109855|NCT00402727|365621|P2|Overall Study|Protocol Violation|4
109856|NCT00402727|365622|P1|Overall Study|Protocol Violation|0
109857|NCT00402727|365621|P2|Overall Study|Physician Decision|1
109858|NCT00402727|365622|P1|Overall Study|Physician Decision|1
109859|NCT00402727|365621|P2|Overall Study|Lost to Follow-up|11
109860|NCT00402727|365622|P1|Overall Study|Lost to Follow-up|24
109861|NCT00402727|365621|P2|Overall Study|Lack of Efficacy|3
109862|NCT00402727|365622|P1|Overall Study|Lack of Efficacy|1
109863|NCT00402727|365621|P2|Overall Study|Death|0
109864|NCT00402727|365622|P1|Overall Study|Death|1
109865|NCT00402727|365621|P2|Overall Study|Adverse Event|6
109866|NCT00402727|365622|P1|Overall Study|Adverse Event|10
109867|NCT00402740|365650|P1|Overall Study|Subject disposition unknown.|1
109868|NCT00402740|365650|P1|Overall Study|No stent. Completed FU at 30 days.|5
109869|NCT00402740|365650|P1|Overall Study|Lost to Follow-up|6
109870|NCT00402740|365650|P1|Overall Study|Death|50
109871|NCT00402740|365650|P1|Overall Study|Withdrawal by Subject|18
109872|NCT00402987|365672|P4|Overall Study|Lack of Efficacy|0
109873|NCT00402987|365673|P3|Overall Study|Lack of Efficacy|1
109874|NCT00402987|365674|P2|Overall Study|Lack of Efficacy|0
109875|NCT00402987|365675|P1|Overall Study|Lack of Efficacy|0
109876|NCT00403130|365837|P1|Overall Study|Withdrawal by Subject|1
109877|NCT00403130|365837|P1|Overall Study|Lost to Follow up|1
109878|NCT00403130|365837|P1|Overall Study|Not Eligible|3
109879|NCT00403234|365848|P4|Overall Study|Adverse Event|0
109880|NCT00403234|365849|P3|Overall Study|Adverse Event|1
109881|NCT00403234|365850|P2|Overall Study|Adverse Event|0
109882|NCT00403234|365851|P1|Overall Study|Adverse Event|1
109883|NCT00403234|365848|P4|Overall Study|Withdrawal by Subject|0
109884|NCT00403234|365849|P3|Overall Study|Withdrawal by Subject|0
109885|NCT00403234|365850|P2|Overall Study|Withdrawal by Subject|1
109886|NCT00403234|365851|P1|Overall Study|Withdrawal by Subject|0
109887|NCT00403273|365863|P2|Overall Study|pt. wanted to have a surgical procedure|1
109888|NCT00403273|365864|P1|Overall Study|pt. wanted to have a surgical procedure|0
109889|NCT00403273|365863|P2|Overall Study|Physician Decision|1
109890|NCT00403273|365864|P1|Overall Study|Physician Decision|0
109891|NCT00403273|365863|P2|Overall Study|Lost to Follow-up|2
109892|NCT00403273|365864|P1|Overall Study|Lost to Follow-up|3
109893|NCT00403455|365907|P1|Overall Study|Withdrawal by Subject|1
109894|NCT00403481|365911|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
109895|NCT00403481|365911|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
109896|NCT00403481|365911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
109897|NCT00403481|365911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
109898|NCT00403481|365911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
109899|NCT00403481|365911|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
109900|NCT00403481|365911|P1|Olm 40 mg|Other|1
109901|NCT00403481|365911|P1|Olm 40 mg|Withdrawal by Subject|1
109902|NCT00403481|365911|P1|Olm 40 mg|Protocol Violation|1
109903|NCT00403481|365911|P1|Olm 40 mg|Adverse Event|2
109904|NCT00403481|365911|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
109905|NCT00403481|365911|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
109906|NCT00403481|365911|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
109907|NCT00403481|365911|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
109908|NCT00403546|365928|P3|Randomized Trial|Early Terminations|16
109909|NCT00403546|365929|P2|Randomized Trial|Early Terminations|17
109910|NCT00403546|365930|P1|Randomized Trial|Early Terminations|0
109911|NCT00403546|365928|P3|Screening Phase|Terminated Prior to Randomization|0
109912|NCT00403546|365929|P2|Screening Phase|Terminated Prior to Randomization|0
109913|NCT00403546|365930|P1|Screening Phase|Terminated Prior to Randomization|5
109914|NCT00403546|365928|P3|Screening Phase|Adverse Event|0
109915|NCT00403546|365929|P2|Screening Phase|Adverse Event|0
109916|NCT00403546|365930|P1|Screening Phase|Adverse Event|1
109917|NCT00403546|365928|P3|Screening Phase|Screening Failure|0
109918|NCT00403546|365929|P2|Screening Phase|Screening Failure|0
109919|NCT00403546|365930|P1|Screening Phase|Screening Failure|22
109920|NCT00403546|365928|P3|Signed Informed Consent/Open-Label|Adverse Event|0
109921|NCT00403546|365929|P2|Signed Informed Consent/Open-Label|Adverse Event|0
109922|NCT00403546|365930|P1|Signed Informed Consent/Open-Label|Adverse Event|5
109923|NCT00403546|365928|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
109924|NCT00403546|365929|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
109925|NCT00403546|365930|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
109926|NCT00403546|365928|P3|Signed Informed Consent/Open-Label|Early Termination|0
109927|NCT00403546|365929|P2|Signed Informed Consent/Open-Label|Early Termination|0
109928|NCT00403546|365930|P1|Signed Informed Consent/Open-Label|Early Termination|8
109929|NCT00403546|365928|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
109930|NCT00403546|365929|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
109931|NCT00403546|365930|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
109932|NCT00403585|365970|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
109933|NCT00403585|365970|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
109934|NCT00403585|365970|P1|Initial Treatment Phase|Lost to Follow-up|2
109935|NCT00403754|365979|P4|Core Treatment Period 2|Lack of Efficacy|0
109936|NCT00403754|365980|P3|Core Treatment Period 2|Lack of Efficacy|1
109937|NCT00403754|365981|P2|Core Treatment Period 2|Lack of Efficacy|0
109938|NCT00403754|365982|P1|Core Treatment Period 2|Lack of Efficacy|0
109939|NCT00403754|365979|P4|Core Treatment Period 1|Withdrawal by Subject|0
109940|NCT00403754|365980|P3|Core Treatment Period 1|Withdrawal by Subject|0
109941|NCT00403754|365981|P2|Core Treatment Period 1|Withdrawal by Subject|1
109942|NCT00403754|365982|P1|Core Treatment Period 1|Withdrawal by Subject|0
109943|NCT00403767|366011|P2|Overall Study|Missing/incomplete data|1
109944|NCT00403767|366012|P1|Overall Study|Missing/incomplete data|1
109945|NCT00403767|366011|P2|Overall Study|Study terminated by sponsor|69
109946|NCT00403767|366012|P1|Overall Study|Study terminated by sponsor|82
109947|NCT00403767|366011|P2|Overall Study|Clinical efficacy endpoint reached|332
109948|NCT00403767|366012|P1|Overall Study|Clinical efficacy endpoint reached|300
109949|NCT00403767|366011|P2|Overall Study|Protocol Violation|124
109950|NCT00403767|366012|P1|Overall Study|Protocol Violation|142
109951|NCT00403767|366011|P2|Overall Study|Lost to Follow-up|8
109952|NCT00403767|366012|P1|Overall Study|Lost to Follow-up|6
109953|NCT00403767|366011|P2|Overall Study|Investigator dec./not protocol-related|178
109954|NCT00403767|366012|P1|Overall Study|Investigator dec./not protocol-related|191
109955|NCT00403767|366011|P2|Overall Study|Consent withdrawn|673
109956|NCT00403767|366012|P1|Overall Study|Consent withdrawn|671
109957|NCT00403767|366011|P2|Overall Study|Non-compliant with study medication|164
109958|NCT00403767|366012|P1|Overall Study|Non-compliant with study medication|134
109959|NCT00403767|366011|P2|Overall Study|Adverse Event|919
109960|NCT00403767|366012|P1|Overall Study|Adverse Event|993
109961|NCT00403845|366036|P4|Treatment Period 3|Adverse Event|1
109962|NCT00403845|366037|P3|Treatment Period 3|Adverse Event|0
109963|NCT00403845|366038|P2|Treatment Period 3|Adverse Event|0
109964|NCT00403845|366039|P1|Treatment Period 3|Adverse Event|0
109965|NCT00403845|366036|P4|Treatment Period 3|Subject withdrew consent|1
109966|NCT00403845|366037|P3|Treatment Period 3|Subject withdrew consent|0
109967|NCT00403845|366038|P2|Treatment Period 3|Subject withdrew consent|0
109968|NCT00403845|366039|P1|Treatment Period 3|Subject withdrew consent|0
109969|NCT00403845|366036|P4|Treatment Period 2|Subject withdrew consent|0
109970|NCT00403845|366037|P3|Treatment Period 2|Subject withdrew consent|0
109971|NCT00403845|366038|P2|Treatment Period 2|Subject withdrew consent|0
109972|NCT00403845|366039|P1|Treatment Period 2|Subject withdrew consent|1
109973|NCT00403845|366036|P4|Treatment Period 1|Subject no longer needs study drug|1
109974|NCT00403845|366037|P3|Treatment Period 1|Subject no longer needs study drug|0
109975|NCT00403845|366038|P2|Treatment Period 1|Subject no longer needs study drug|0
109976|NCT00403845|366039|P1|Treatment Period 1|Subject no longer needs study drug|0
109977|NCT00403845|366036|P4|Treatment Period 1|Subject withdrew consent|0
109978|NCT00403845|366037|P3|Treatment Period 1|Subject withdrew consent|0
109979|NCT00403845|366038|P2|Treatment Period 1|Subject withdrew consent|0
109980|NCT00403845|366039|P1|Treatment Period 1|Subject withdrew consent|1
109981|NCT00404079|366063|P2|Overall Study|Lost to follow up, adverse event etc|20
109982|NCT00404079|366064|P1|Overall Study|Lost to follow up, adverse event etc|22
109983|NCT00404092|366074|P4|Overall Study|Adverse Event|0
109984|NCT00404092|366075|P3|Overall Study|Adverse Event|1
109985|NCT00404092|366076|P2|Overall Study|Adverse Event|0
109986|NCT00404092|366077|P1|Overall Study|Adverse Event|0
109987|NCT00404092|366074|P4|Overall Study|Death|0
109988|NCT00404092|366075|P3|Overall Study|Death|0
109989|NCT00404092|366076|P2|Overall Study|Death|0
109990|NCT00404092|366077|P1|Overall Study|Death|1
109991|NCT00404248|366094|P9|Overall Study|pts declining status|0
109992|NCT00404248|366095|P8|Overall Study|pts declining status|0
109993|NCT00404248|366096|P7|Overall Study|pts declining status|0
109994|NCT00404248|366097|P6|Overall Study|pts declining status|0
109995|NCT00404248|366098|P5|Overall Study|pts declining status|0
109996|NCT00404248|366099|P4|Overall Study|pts declining status|0
109997|NCT00404248|366100|P3|Overall Study|pts declining status|0
109998|NCT00404248|366101|P2|Overall Study|pts declining status|1
109999|NCT00404248|366102|P1|Overall Study|pts declining status|0
110000|NCT00404352|366136|P9|Open Label Extension (up to 36 Months)|unspecified|2
110001|NCT00404352|366137|P8|Open Label Extension (up to 36 Months)|unspecified|0
110002|NCT00404352|366138|P7|Open Label Extension (up to 36 Months)|unspecified|0
110003|NCT00404352|366139|P6|Open Label Extension (up to 36 Months)|unspecified|0
110004|NCT00404352|366140|P5|Open Label Extension (up to 36 Months)|unspecified|0
110005|NCT00404352|366141|P4|Open Label Extension (up to 36 Months)|unspecified|0
110006|NCT00404352|366142|P3|Open Label Extension (up to 36 Months)|unspecified|0
110007|NCT00404352|366143|P2|Open Label Extension (up to 36 Months)|unspecified|0
110008|NCT00404352|366144|P1|Open Label Extension (up to 36 Months)|unspecified|0
110009|NCT00404352|366136|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
110010|NCT00404352|366137|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
110011|NCT00404352|366138|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
110012|NCT00404352|366139|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
110013|NCT00404352|366140|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
110014|NCT00404352|366141|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
110015|NCT00404352|366142|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
110016|NCT00404352|366143|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
110017|NCT00404352|366144|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
110018|NCT00404352|366136|P9|Open Label (up to 24 Month)|Disease progression|0
110019|NCT00404352|366137|P8|Open Label (up to 24 Month)|Disease progression|0
110020|NCT00404352|366138|P7|Open Label (up to 24 Month)|Disease progression|0
110021|NCT00404352|366139|P6|Open Label (up to 24 Month)|Disease progression|0
110022|NCT00404352|366140|P5|Open Label (up to 24 Month)|Disease progression|0
110023|NCT00404352|366141|P4|Open Label (up to 24 Month)|Disease progression|1
110024|NCT00404352|366142|P3|Open Label (up to 24 Month)|Disease progression|0
110025|NCT00404352|366143|P2|Open Label (up to 24 Month)|Disease progression|0
110026|NCT00404352|366144|P1|Open Label (up to 24 Month)|Disease progression|0
110027|NCT00404352|366136|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
110028|NCT00404352|366137|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
110029|NCT00404352|366138|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
110030|NCT00404352|366139|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
110031|NCT00404352|366140|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
110032|NCT00404352|366141|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
110033|NCT00404352|366142|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
110034|NCT00404352|366143|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
110035|NCT00404352|366144|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
110036|NCT00404352|366136|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
110037|NCT00404352|366137|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
110038|NCT00404352|366138|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
110039|NCT00404352|366139|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
110040|NCT00404352|366140|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
110041|NCT00404352|366141|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
110042|NCT00404352|366142|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
110043|NCT00404352|366143|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
110044|NCT00404352|366144|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
110045|NCT00404352|366136|P9|Open Label (up to 24 Month)|Pregnancy|0
110046|NCT00404352|366137|P8|Open Label (up to 24 Month)|Pregnancy|0
110047|NCT00404352|366138|P7|Open Label (up to 24 Month)|Pregnancy|0
110048|NCT00404352|366139|P6|Open Label (up to 24 Month)|Pregnancy|1
110049|NCT00404352|366140|P5|Open Label (up to 24 Month)|Pregnancy|0
110050|NCT00404352|366141|P4|Open Label (up to 24 Month)|Pregnancy|0
110051|NCT00404352|366142|P3|Open Label (up to 24 Month)|Pregnancy|0
110052|NCT00404352|366143|P2|Open Label (up to 24 Month)|Pregnancy|0
110053|NCT00404352|366144|P1|Open Label (up to 24 Month)|Pregnancy|0
110054|NCT00404352|366136|P9|Open Label (up to 24 Month)|Adverse Event|0
110055|NCT00404352|366137|P8|Open Label (up to 24 Month)|Adverse Event|0
110056|NCT00404352|366138|P7|Open Label (up to 24 Month)|Adverse Event|0
110057|NCT00404352|366139|P6|Open Label (up to 24 Month)|Adverse Event|1
110058|NCT00404352|366140|P5|Open Label (up to 24 Month)|Adverse Event|1
110059|NCT00404352|366141|P4|Open Label (up to 24 Month)|Adverse Event|2
110060|NCT00404352|366142|P3|Open Label (up to 24 Month)|Adverse Event|0
110061|NCT00404352|366143|P2|Open Label (up to 24 Month)|Adverse Event|0
110062|NCT00404352|366144|P1|Open Label (up to 24 Month)|Adverse Event|0
110063|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Unspecified|0
110064|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Unspecified|0
110065|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Unspecified|0
110066|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Unspecified|0
110067|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Unspecified|0
110068|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Unspecified|0
110069|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Unspecified|0
110070|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Unspecified|1
110071|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Unspecified|0
110072|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Physician Decision|0
110073|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Physician Decision|0
110074|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Physician Decision|0
110075|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Physician Decision|0
110076|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Physician Decision|0
110077|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Physician Decision|0
110078|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Physician Decision|1
110079|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Physician Decision|0
110080|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Physician Decision|0
110081|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
110082|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
110083|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
110084|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
110085|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
110086|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
110087|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
110088|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
110089|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
110090|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
110091|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
110092|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
110093|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
110094|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
110095|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
110096|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
110097|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
110098|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
110099|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Poor compliance|0
110100|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Poor compliance|0
110101|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Poor compliance|0
110102|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Poor compliance|0
110103|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Poor compliance|0
110104|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Poor compliance|0
110105|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Poor compliance|0
110106|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Poor compliance|0
110107|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Poor compliance|1
110108|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Disease progression|0
110109|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Disease progression|0
110110|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Disease progression|0
110111|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Disease progression|0
110112|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Disease progression|0
110113|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Disease progression|0
110114|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Disease progression|2
110115|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Disease progression|0
110116|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Disease progression|3
110117|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
110118|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
110119|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
110120|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
110121|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
110122|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
110123|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
110124|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
110125|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
110126|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
110127|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
110128|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
110129|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
110130|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
110131|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
110132|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
110133|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
110134|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
110135|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Death|0
110136|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Death|0
110137|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Death|0
110138|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Death|0
110139|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Death|0
110140|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Death|0
110141|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Death|1
110142|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Death|0
110143|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Death|0
110144|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Pregnancy|0
110145|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Pregnancy|0
110146|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Pregnancy|0
110147|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Pregnancy|0
110148|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Pregnancy|0
110149|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Pregnancy|0
110150|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Pregnancy|2
110151|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Pregnancy|0
110152|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Pregnancy|0
110153|NCT00404352|366136|P9|Double Blind (up to 24 Month)|Adverse Event|0
110154|NCT00404352|366137|P8|Double Blind (up to 24 Month)|Adverse Event|0
110155|NCT00404352|366138|P7|Double Blind (up to 24 Month)|Adverse Event|0
110156|NCT00404352|366139|P6|Double Blind (up to 24 Month)|Adverse Event|0
110157|NCT00404352|366140|P5|Double Blind (up to 24 Month)|Adverse Event|0
110158|NCT00404352|366141|P4|Double Blind (up to 24 Month)|Adverse Event|0
110159|NCT00404352|366142|P3|Double Blind (up to 24 Month)|Adverse Event|6
110160|NCT00404352|366143|P2|Double Blind (up to 24 Month)|Adverse Event|4
110161|NCT00404352|366144|P1|Double Blind (up to 24 Month)|Adverse Event|5
110162|NCT00394524|366178|P2|Overall Study|Withdrawal by Subject|10
110163|NCT00394524|366179|P1|Overall Study|Withdrawal by Subject|11
110164|NCT00394914|366191|P3|Treatment Period|Did not meet protocol eligibility|1
110165|NCT00394914|366192|P2|Treatment Period|Did not meet protocol eligibility|1
110166|NCT00394914|366193|P1|Treatment Period|Did not meet protocol eligibility|0
110167|NCT00394914|366191|P3|Treatment Period|Noncompliance with protocol|2
110168|NCT00394914|366192|P2|Treatment Period|Noncompliance with protocol|3
110169|NCT00394914|366193|P1|Treatment Period|Noncompliance with protocol|0
110170|NCT00394914|366191|P3|Treatment Period|Withdrawal by Subject|2
110171|NCT00394914|366192|P2|Treatment Period|Withdrawal by Subject|2
110172|NCT00394914|366193|P1|Treatment Period|Withdrawal by Subject|0
110173|NCT00394914|366191|P3|Treatment Period|Lost to Follow-up|0
110174|NCT00394914|366192|P2|Treatment Period|Lost to Follow-up|1
110175|NCT00394914|366193|P1|Treatment Period|Lost to Follow-up|0
110176|NCT00394914|366191|P3|Treatment Period|Adverse Event|1
110177|NCT00394914|366192|P2|Treatment Period|Adverse Event|3
110178|NCT00394914|366193|P1|Treatment Period|Adverse Event|0
110179|NCT00394953|366219|P2|Second Treatment Period|Not defined|8
110180|NCT00394953|366220|P1|Second Treatment Period|Not defined|3
110181|NCT00394953|366219|P2|Second Treatment Period|Renal transplant|6
110182|NCT00394953|366220|P1|Second Treatment Period|Renal transplant|4
110183|NCT00394953|366219|P2|Second Treatment Period|Lost to Follow-up|1
110184|NCT00394953|366220|P1|Second Treatment Period|Lost to Follow-up|0
110185|NCT00394953|366219|P2|Second Treatment Period|Withdrawal by Subject|3
110186|NCT00394953|366220|P1|Second Treatment Period|Withdrawal by Subject|3
110187|NCT00394953|366219|P2|Second Treatment Period|Lack of Efficacy|47
110188|NCT00394953|366220|P1|Second Treatment Period|Lack of Efficacy|9
110189|NCT00394953|366219|P2|Second Treatment Period|Death|4
110190|NCT00394953|366220|P1|Second Treatment Period|Death|8
110191|NCT00394953|366219|P2|Second Treatment Period|Adverse Event|5
110192|NCT00394953|366220|P1|Second Treatment Period|Adverse Event|2
110193|NCT00394953|366219|P2|First Treatment Period|Not defined|1
110194|NCT00394953|366220|P1|First Treatment Period|Not defined|4
110195|NCT00394953|366219|P2|First Treatment Period|Renal transplant|7
110196|NCT00394953|366220|P1|First Treatment Period|Renal transplant|11
110197|NCT00394953|366219|P2|First Treatment Period|Lost to Follow-up|1
110198|NCT00394953|366220|P1|First Treatment Period|Lost to Follow-up|0
110199|NCT00394953|366219|P2|First Treatment Period|Withdrawal by Subject|3
110200|NCT00394953|366220|P1|First Treatment Period|Withdrawal by Subject|6
110201|NCT00394953|366219|P2|First Treatment Period|Lack of Efficacy|1
110202|NCT00394953|366220|P1|First Treatment Period|Lack of Efficacy|1
110203|NCT00394953|366219|P2|First Treatment Period|Death|7
110204|NCT00394953|366220|P1|First Treatment Period|Death|6
110205|NCT00394953|366219|P2|First Treatment Period|Adverse Event|2
110206|NCT00394953|366220|P1|First Treatment Period|Adverse Event|1
110207|NCT00395018|366236|P1|Off-Treatment Follow-up|Poor/non-compliance|1
110208|NCT00395018|366236|P1|Off-Treatment Follow-up|Lost to Follow-up|2
110209|NCT00395018|366236|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
110210|NCT00395018|366236|P1|On-Treatment|Subject no longer meets study criteria|2
110211|NCT00395018|366236|P1|On-Treatment|Poor/non-compliance|2
110212|NCT00395018|366236|P1|On-Treatment|Other Reason|2
110213|NCT00395018|366236|P1|On-Treatment|Death|4
110214|NCT00395083|366311|P2|Overall Study|Developed another disease|3
110215|NCT00395083|366312|P1|Overall Study|Developed another disease|4
110216|NCT00395083|366311|P2|Overall Study|Withdrawal by Subject|5
110217|NCT00395083|366312|P1|Overall Study|Withdrawal by Subject|6
110218|NCT00395226|366365|P2|Overall Study|Lost to Follow-up|1
110219|NCT00395226|366366|P1|Overall Study|Lost to Follow-up|0
110220|NCT00395226|366365|P2|Overall Study|Withdrawal by Subject|1
110221|NCT00395226|366366|P1|Overall Study|Withdrawal by Subject|0
110222|NCT00395226|366365|P2|Overall Study|Adverse Event|3
110223|NCT00395226|366366|P1|Overall Study|Adverse Event|4
110224|NCT00395304|366403|P6|Treatment Period 3|Other|0
110225|NCT00395304|366404|P5|Treatment Period 3|Other|0
110226|NCT00395304|366405|P4|Treatment Period 3|Other|1
110227|NCT00395304|366406|P3|Treatment Period 3|Other|0
110228|NCT00395304|366407|P2|Treatment Period 3|Other|0
110229|NCT00395304|366408|P1|Treatment Period 3|Other|0
110230|NCT00395304|366403|P6|Treatment Period 3|Physician Decision|0
110231|NCT00395304|366404|P5|Treatment Period 3|Physician Decision|0
110232|NCT00395304|366405|P4|Treatment Period 3|Physician Decision|0
110233|NCT00395304|366406|P3|Treatment Period 3|Physician Decision|0
110234|NCT00395304|366407|P2|Treatment Period 3|Physician Decision|1
110235|NCT00395304|366408|P1|Treatment Period 3|Physician Decision|0
110236|NCT00395304|366403|P6|Treatment Period 3|Lost to Follow-up|0
110237|NCT00395304|366404|P5|Treatment Period 3|Lost to Follow-up|0
110238|NCT00395304|366405|P4|Treatment Period 3|Lost to Follow-up|0
110239|NCT00395304|366406|P3|Treatment Period 3|Lost to Follow-up|0
110240|NCT00395304|366407|P2|Treatment Period 3|Lost to Follow-up|1
110241|NCT00395304|366408|P1|Treatment Period 3|Lost to Follow-up|1
110242|NCT00395304|366403|P6|Treatment Period 3|Withdrawal by Subject|1
110243|NCT00395304|366404|P5|Treatment Period 3|Withdrawal by Subject|0
110244|NCT00395304|366405|P4|Treatment Period 3|Withdrawal by Subject|1
110245|NCT00395304|366406|P3|Treatment Period 3|Withdrawal by Subject|0
110246|NCT00395304|366407|P2|Treatment Period 3|Withdrawal by Subject|0
110247|NCT00395304|366408|P1|Treatment Period 3|Withdrawal by Subject|0
110248|NCT00395304|366403|P6|Treatment Period 2|Other|0
110249|NCT00395304|366404|P5|Treatment Period 2|Other|0
110250|NCT00395304|366405|P4|Treatment Period 2|Other|0
110251|NCT00395304|366406|P3|Treatment Period 2|Other|0
110252|NCT00395304|366407|P2|Treatment Period 2|Other|1
110253|NCT00395304|366408|P1|Treatment Period 2|Other|0
110254|NCT00395304|366403|P6|Treatment Period 2|Physician Decision|0
110255|NCT00395304|366404|P5|Treatment Period 2|Physician Decision|0
110256|NCT00395304|366405|P4|Treatment Period 2|Physician Decision|0
110257|NCT00395304|366406|P3|Treatment Period 2|Physician Decision|1
110258|NCT00395304|366407|P2|Treatment Period 2|Physician Decision|0
110259|NCT00395304|366408|P1|Treatment Period 2|Physician Decision|0
110260|NCT00395304|366403|P6|Treatment Period 2|Lost to Follow-up|0
110261|NCT00395304|366404|P5|Treatment Period 2|Lost to Follow-up|0
110262|NCT00395304|366405|P4|Treatment Period 2|Lost to Follow-up|0
110263|NCT00395304|366406|P3|Treatment Period 2|Lost to Follow-up|0
110264|NCT00395304|366407|P2|Treatment Period 2|Lost to Follow-up|3
110265|NCT00395304|366408|P1|Treatment Period 2|Lost to Follow-up|0
110266|NCT00395304|366403|P6|Treatment Period 2|Withdrawal by Subject|2
110267|NCT00395304|366404|P5|Treatment Period 2|Withdrawal by Subject|0
110268|NCT00395304|366405|P4|Treatment Period 2|Withdrawal by Subject|1
110269|NCT00395304|366406|P3|Treatment Period 2|Withdrawal by Subject|0
110270|NCT00395304|366407|P2|Treatment Period 2|Withdrawal by Subject|0
110271|NCT00395304|366408|P1|Treatment Period 2|Withdrawal by Subject|0
110272|NCT00395304|366403|P6|Treatment Period 1|Physician Decision|0
110273|NCT00395304|366404|P5|Treatment Period 1|Physician Decision|0
110274|NCT00395304|366405|P4|Treatment Period 1|Physician Decision|0
110275|NCT00395304|366406|P3|Treatment Period 1|Physician Decision|0
110276|NCT00395304|366407|P2|Treatment Period 1|Physician Decision|1
110277|NCT00395304|366408|P1|Treatment Period 1|Physician Decision|0
110278|NCT00395304|366403|P6|Treatment Period 1|Lost to Follow-up|1
110279|NCT00395304|366404|P5|Treatment Period 1|Lost to Follow-up|0
110280|NCT00395304|366405|P4|Treatment Period 1|Lost to Follow-up|1
110281|NCT00395304|366406|P3|Treatment Period 1|Lost to Follow-up|0
110282|NCT00395304|366407|P2|Treatment Period 1|Lost to Follow-up|0
110283|NCT00395304|366408|P1|Treatment Period 1|Lost to Follow-up|1
110284|NCT00395304|366403|P6|Treatment Period 1|Withdrawal by Subject|1
110285|NCT00395304|366404|P5|Treatment Period 1|Withdrawal by Subject|1
110286|NCT00395304|366405|P4|Treatment Period 1|Withdrawal by Subject|2
110287|NCT00395304|366406|P3|Treatment Period 1|Withdrawal by Subject|0
110288|NCT00395304|366407|P2|Treatment Period 1|Withdrawal by Subject|3
110289|NCT00395304|366408|P1|Treatment Period 1|Withdrawal by Subject|0
110290|NCT00395343|366414|P2|Overall Study|Unspecified|2
110291|NCT00395343|366415|P1|Overall Study|Unspecified|5
110292|NCT00395343|366414|P2|Overall Study|Withdrawal by Subject|12
110293|NCT00395343|366415|P1|Overall Study|Withdrawal by Subject|11
110294|NCT00395343|366414|P2|Overall Study|Protocol Violation|8
110295|NCT00395343|366415|P1|Overall Study|Protocol Violation|6
110296|NCT00395343|366414|P2|Overall Study|Physician Decision|4
110297|NCT00395343|366415|P1|Overall Study|Physician Decision|2
110298|NCT00395343|366414|P2|Overall Study|Lost to Follow-up|4
110299|NCT00395343|366415|P1|Overall Study|Lost to Follow-up|4
110300|NCT00395343|366414|P2|Overall Study|Lack of Efficacy|1
110301|NCT00395343|366415|P1|Overall Study|Lack of Efficacy|0
110302|NCT00395343|366414|P2|Overall Study|Adverse Event|5
110303|NCT00395343|366415|P1|Overall Study|Adverse Event|13
110304|NCT00395447|366435|P2|Overall Study|Withdrawl - Other (not subject)|17
110305|NCT00395447|366436|P1|Overall Study|Withdrawl - Other (not subject)|8
110306|NCT00395447|366435|P2|Overall Study|Withdrawal by Subject|19
110307|NCT00395447|366436|P1|Overall Study|Withdrawal by Subject|24
110308|NCT00395447|366435|P2|Overall Study|Lost to Follow-up|43
110309|NCT00395447|366436|P1|Overall Study|Lost to Follow-up|52
110310|NCT00395447|366435|P2|Overall Study|Death|32
110311|NCT00395447|366436|P1|Overall Study|Death|37
110312|NCT00395460|366444|P2|Overall Study|Withdrawal by Subject|0
110313|NCT00395460|366445|P1|Overall Study|Withdrawal by Subject|1
110314|NCT00395486|366469|P2|Overall Study|Lost to Follow-up|1
110315|NCT00395486|366470|P1|Overall Study|Lost to Follow-up|0
110316|NCT00395486|366469|P2|Overall Study|Withdrawal by Subject|2
110317|NCT00395486|366470|P1|Overall Study|Withdrawal by Subject|5
110318|NCT00395486|366469|P2|Overall Study|Adverse Event|2
110319|NCT00395486|366470|P1|Overall Study|Adverse Event|1
110320|NCT00395512|366502|P4|Overall Study|Hyperglycemic Rescue|6
110321|NCT00395512|366503|P3|Overall Study|Hyperglycemic Rescue|4
110322|NCT00395512|366504|P2|Overall Study|Hyperglycemic Rescue|10
110323|NCT00395512|366505|P1|Overall Study|Hyperglycemic Rescue|18
110324|NCT00395512|366502|P4|Overall Study|Other|0
110325|NCT00395512|366503|P3|Overall Study|Other|0
110326|NCT00395512|366504|P2|Overall Study|Other|1
110327|NCT00395512|366505|P1|Overall Study|Other|1
110328|NCT00395512|366502|P4|Overall Study|Physician Decision|2
110329|NCT00395512|366503|P3|Overall Study|Physician Decision|2
110330|NCT00395512|366504|P2|Overall Study|Physician Decision|4
110331|NCT00395512|366505|P1|Overall Study|Physician Decision|6
110332|NCT00395512|366502|P4|Overall Study|Withdrawal by Subject|12
110333|NCT00395512|366503|P3|Overall Study|Withdrawal by Subject|5
110334|NCT00395512|366504|P2|Overall Study|Withdrawal by Subject|5
110335|NCT00395512|366505|P1|Overall Study|Withdrawal by Subject|6
110336|NCT00395512|366502|P4|Overall Study|Lost to Follow-up|5
110337|NCT00395512|366503|P3|Overall Study|Lost to Follow-up|5
110338|NCT00395512|366504|P2|Overall Study|Lost to Follow-up|6
110339|NCT00395512|366505|P1|Overall Study|Lost to Follow-up|2
110340|NCT00395512|366502|P4|Overall Study|Protocol Violation|7
110341|NCT00395512|366503|P3|Overall Study|Protocol Violation|6
110342|NCT00395512|366504|P2|Overall Study|Protocol Violation|3
110343|NCT00395512|366505|P1|Overall Study|Protocol Violation|2
110344|NCT00395512|366502|P4|Overall Study|Adverse Event|6
110345|NCT00395512|366503|P3|Overall Study|Adverse Event|6
110346|NCT00395512|366504|P2|Overall Study|Adverse Event|8
110347|NCT00395512|366505|P1|Overall Study|Adverse Event|3
110348|NCT00395629|366678|P3|Extension Study|Administrative problems|1
110349|NCT00395629|366679|P2|Extension Study|Administrative problems|0
110350|NCT00395629|366680|P1|Extension Study|Administrative problems|0
110351|NCT00395629|366678|P3|Extension Study|Adverse Event|2
110352|NCT00395629|366679|P2|Extension Study|Adverse Event|0
110353|NCT00395629|366680|P1|Extension Study|Adverse Event|0
110354|NCT00395629|366678|P3|Core Study|Lost to Follow-up|1
110355|NCT00395629|366679|P2|Core Study|Lost to Follow-up|0
110356|NCT00395629|366680|P1|Core Study|Lost to Follow-up|0
110357|NCT00395629|366678|P3|Core Study|Withdrawal by Subject|1
110358|NCT00395629|366679|P2|Core Study|Withdrawal by Subject|1
110359|NCT00395629|366680|P1|Core Study|Withdrawal by Subject|0
110360|NCT00395629|366678|P3|Core Study|Protocol Violation|0
110361|NCT00395629|366679|P2|Core Study|Protocol Violation|0
110362|NCT00395629|366680|P1|Core Study|Protocol Violation|1
110363|NCT00395629|366678|P3|Core Study|Abnormal laboratory value(s)|1
110364|NCT00395629|366679|P2|Core Study|Abnormal laboratory value(s)|0
110365|NCT00395629|366680|P1|Core Study|Abnormal laboratory value(s)|0
110366|NCT00395629|366678|P3|Core Study|Adverse Event|4
110367|NCT00395629|366679|P2|Core Study|Adverse Event|3
110368|NCT00395629|366680|P1|Core Study|Adverse Event|0
110369|NCT00395642|366694|P1|Overall Study|Withdrawal by Subject|1
110370|NCT00395642|366694|P1|Overall Study|Physician Decision|7
110371|NCT00395642|366694|P1|Overall Study|Lost to Follow-up|1
110372|NCT00395642|366694|P1|Overall Study|Death|4
110373|NCT00395694|366700|P2|Continuation Phase|Withdrawal by Subject|2
110374|NCT00395694|366701|P1|Continuation Phase|Withdrawal by Subject|0
110375|NCT00395694|366700|P2|Continuation Phase|Poor Compliance|0
110376|NCT00395694|366701|P1|Continuation Phase|Poor Compliance|1
110377|NCT00395694|366700|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
110378|NCT00395694|366701|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
110379|NCT00395694|366700|P2|Continuation Phase|Lack of Efficacy|11
110380|NCT00395694|366701|P1|Continuation Phase|Lack of Efficacy|12
110381|NCT00395694|366700|P2|Continuation Phase|Adverse Event|0
110382|NCT00395694|366701|P1|Continuation Phase|Adverse Event|1
110383|NCT00395694|366700|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
110384|NCT00395694|366701|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
110385|NCT00395733|366734|P2|Period 2|Technical problems|0
110386|NCT00395733|366735|P1|Period 2|Technical problems|1
110387|NCT00395733|366734|P2|Period 2|Adverse Event|2
110388|NCT00395733|366735|P1|Period 2|Adverse Event|0
110389|NCT00395733|366734|P2|Period 2|Protocol Violation|1
110390|NCT00395733|366735|P1|Period 2|Protocol Violation|0
110391|NCT00395733|366734|P2|Period 2|Withdrawal by Subject|2
110392|NCT00395733|366735|P1|Period 2|Withdrawal by Subject|1
110393|NCT00395746|366760|P3|Overall Study|Unable to visit site on schedule|0
110394|NCT00395746|366761|P2|Overall Study|Unable to visit site on schedule|0
110395|NCT00395746|366762|P1|Overall Study|Unable to visit site on schedule|1
110396|NCT00395746|366760|P3|Overall Study|Difficultulty in use of device|1
110397|NCT00395746|366761|P2|Overall Study|Difficultulty in use of device|0
110398|NCT00395746|366762|P1|Overall Study|Difficultulty in use of device|0
110399|NCT00395746|366760|P3|Overall Study|Withdrawal of consent|1
110400|NCT00395746|366761|P2|Overall Study|Withdrawal of consent|0
110401|NCT00395746|366762|P1|Overall Study|Withdrawal of consent|0
110402|NCT00395746|366760|P3|Overall Study|Subject decision|1
110403|NCT00395746|366761|P2|Overall Study|Subject decision|0
110404|NCT00395746|366762|P1|Overall Study|Subject decision|0
110405|NCT00395746|366760|P3|Overall Study|Hypoglycaemia|0
110406|NCT00395746|366761|P2|Overall Study|Hypoglycaemia|1
110407|NCT00395746|366762|P1|Overall Study|Hypoglycaemia|2
110408|NCT00395746|366760|P3|Overall Study|Lack of Efficacy|17
110409|NCT00395746|366761|P2|Overall Study|Lack of Efficacy|0
110410|NCT00395746|366762|P1|Overall Study|Lack of Efficacy|2
110411|NCT00395746|366760|P3|Overall Study|Protocol Violation|0
110412|NCT00395746|366761|P2|Overall Study|Protocol Violation|1
110413|NCT00395746|366762|P1|Overall Study|Protocol Violation|0
110414|NCT00395746|366760|P3|Overall Study|Adverse Event|2
110415|NCT00395746|366761|P2|Overall Study|Adverse Event|2
110416|NCT00395746|366762|P1|Overall Study|Adverse Event|5
110417|NCT00395850|366810|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
110418|NCT00395850|366811|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
110419|NCT00395850|366812|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
110420|NCT00395850|366813|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
110421|NCT00395850|366810|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
110422|NCT00395850|366811|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
110423|NCT00395850|366812|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
110424|NCT00395850|366813|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
110425|NCT00395850|366810|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
110426|NCT00395850|366811|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
110509|NCT00396409|367220|P1|Period 1 - 2007|Lack of Efficacy|0
110427|NCT00395850|366812|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
110428|NCT00395850|366813|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
110429|NCT00395850|366810|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
110430|NCT00395850|366811|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
110431|NCT00395850|366812|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
110432|NCT00395850|366813|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
110433|NCT00395850|366810|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
110434|NCT00395850|366811|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
110435|NCT00395850|366812|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
110436|NCT00395850|366813|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
110437|NCT00395850|366810|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
110438|NCT00395850|366811|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
110439|NCT00395850|366812|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
110440|NCT00395850|366813|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
110441|NCT00395850|366810|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
110442|NCT00395850|366811|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
110443|NCT00395850|366812|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
110444|NCT00395850|366813|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
110445|NCT00395863|366829|P2|Overall Study|Patients did not complete both exams|3
110446|NCT00395863|366830|P1|Overall Study|Patients did not complete both exams|2
110447|NCT00395967|366890|P1|Follow-up Period|Lost to Follow-up|1
110448|NCT00395967|366890|P1|Follow-up Period|Death|1
110449|NCT00395967|366890|P1|Treatment Period|Failed Mobilization|1
110450|NCT00396084|366946|P6|Overall Study|Withdrawal by Subject|0
110451|NCT00396084|366947|P5|Overall Study|Withdrawal by Subject|0
110452|NCT00396084|366948|P4|Overall Study|Withdrawal by Subject|1
110453|NCT00396084|366949|P3|Overall Study|Withdrawal by Subject|0
110454|NCT00396084|366950|P2|Overall Study|Withdrawal by Subject|0
110455|NCT00396084|366951|P1|Overall Study|Withdrawal by Subject|0
110456|NCT00396084|366946|P6|Overall Study|Adverse Event|2
110457|NCT00396084|366947|P5|Overall Study|Adverse Event|1
110458|NCT00396084|366948|P4|Overall Study|Adverse Event|0
110459|NCT00396084|366949|P3|Overall Study|Adverse Event|0
110460|NCT00396084|366950|P2|Overall Study|Adverse Event|0
110461|NCT00396084|366951|P1|Overall Study|Adverse Event|0
110462|NCT00396097|367026|P2|Overall Study|Insufficient Clinical Response|4
110463|NCT00396097|367027|P1|Overall Study|Insufficient Clinical Response|1
110464|NCT00396097|367026|P2|Overall Study|Adverse Event|5
110465|NCT00396097|367027|P1|Overall Study|Adverse Event|1
110466|NCT00396097|367026|P2|Overall Study|Protocol Violation|6
110467|NCT00396097|367027|P1|Overall Study|Protocol Violation|0
110468|NCT00396097|367026|P2|Overall Study|Not specified|5
110469|NCT00396097|367027|P1|Overall Study|Not specified|3
110470|NCT00396097|367026|P2|Overall Study|Lost to Follow-up|9
110471|NCT00396097|367027|P1|Overall Study|Lost to Follow-up|4
110472|NCT00396097|367026|P2|Overall Study|Withdrawal by Subject|17
110473|NCT00396097|367027|P1|Overall Study|Withdrawal by Subject|17
110474|NCT00396136|367049|P1|Overall Study|Study device explanted|8
110475|NCT00396136|367049|P1|Overall Study|Lost to Follow-up|15
110476|NCT00396136|367049|P1|Overall Study|Withdrawal by Subject|59
110477|NCT00396136|367049|P1|Overall Study|Death|43
110478|NCT00396162|367056|P2|Overall Study|Withdrawal by Subject|3
110479|NCT00396162|367057|P1|Overall Study|Withdrawal by Subject|2
110480|NCT00396253|367086|P1|Overall Study|Change in eligibility status|1
110481|NCT00396253|367086|P1|Overall Study|Physician Decision|1
110482|NCT00396253|367086|P1|Overall Study|Death|3
110483|NCT00396253|367086|P1|Overall Study|Withdrawal by Subject|7
110484|NCT00396253|367086|P1|Overall Study|Protocol Violation|1
110485|NCT00396279|367122|P1|Overall Study|Physician Decision|1
110486|NCT00396279|367122|P1|Overall Study|Withdrawal by Subject|1
110487|NCT00396279|367122|P1|Overall Study|Disease progression|2
110488|NCT00396279|367122|P1|Overall Study|Ongoing in study|26
110489|NCT00396318|367140|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
110490|NCT00396331|367155|P1|Overall Study|Death|16
110491|NCT00396331|367155|P1|Overall Study|Lost to Follow-up|3
110492|NCT00396331|367155|P1|Overall Study|Did not go on to transplant|5
110493|NCT00396331|367155|P1|Overall Study|Failed to mobilize - no transplant|8
110494|NCT00396383|367208|P1|Overall Study|Lost to Follow-up|1
110495|NCT00396383|367208|P1|Overall Study|Death|2
110496|NCT00396409|367219|P2|Period 2 - 2008|Lost to Follow-up|1
110497|NCT00396409|367220|P1|Period 2 - 2008|Lost to Follow-up|3
110498|NCT00396409|367219|P2|Period 2 - 2008|Withdrawal by Subject|1
110499|NCT00396409|367220|P1|Period 2 - 2008|Withdrawal by Subject|3
110500|NCT00396409|367219|P2|Period 2 - 2008|Protocol Violation|0
110501|NCT00396409|367220|P1|Period 2 - 2008|Protocol Violation|1
110502|NCT00396409|367219|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
110503|NCT00396409|367220|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
110504|NCT00396409|367219|P2|Period 1 - 2007|Lost to Follow-up|3
110505|NCT00396409|367220|P1|Period 1 - 2007|Lost to Follow-up|2
110506|NCT00396409|367219|P2|Period 1 - 2007|Withdrawal by Subject|1
110507|NCT00396409|367220|P1|Period 1 - 2007|Withdrawal by Subject|1
110508|NCT00396409|367219|P2|Period 1 - 2007|Lack of Efficacy|1
110510|NCT00396409|367219|P2|Period 1 - 2007|Adverse Event|1
110511|NCT00396409|367220|P1|Period 1 - 2007|Adverse Event|0
110512|NCT00396565|367253|P3|Overall Study|Lack of Efficacy|11
110513|NCT00396565|367254|P2|Overall Study|Lack of Efficacy|64
110514|NCT00396565|367255|P1|Overall Study|Lack of Efficacy|32
110515|NCT00396565|367253|P3|Overall Study|Withdrawal by Subject|1
110516|NCT00396565|367254|P2|Overall Study|Withdrawal by Subject|13
110517|NCT00396565|367255|P1|Overall Study|Withdrawal by Subject|8
110518|NCT00396565|367253|P3|Overall Study|Adverse Event|3
110519|NCT00396565|367254|P2|Overall Study|Adverse Event|13
110520|NCT00396565|367255|P1|Overall Study|Adverse Event|5
110521|NCT00396565|367253|P3|Overall Study|Physician Decision|2
110522|NCT00396565|367254|P2|Overall Study|Physician Decision|1
110523|NCT00396565|367255|P1|Overall Study|Physician Decision|3
110524|NCT00396591|367278|P1|Overall Study|Participant request|1
110525|NCT00396591|367278|P1|Overall Study|Adverse Event|2
110526|NCT00396591|367278|P1|Overall Study|Disease Progression|13
110527|NCT00396630|367290|P2|Overall Study|Not vaccinated at Visit 3|3
110528|NCT00396630|367291|P1|Overall Study|Not vaccinated at Visit 3|3
110529|NCT00396630|367290|P2|Overall Study|Withdrawal by Subject|1
110530|NCT00396630|367291|P1|Overall Study|Withdrawal by Subject|1
110531|NCT00396630|367290|P2|Overall Study|Lost to Follow-up|1
110532|NCT00396630|367291|P1|Overall Study|Lost to Follow-up|1
110533|NCT00396656|367308|P2|Second Treatment Period|Adverse Event|1
110534|NCT00396656|367309|P1|Second Treatment Period|Adverse Event|0
110535|NCT00396656|367308|P2|First Treatment Period|Withdrawal by Subject|2
110536|NCT00396656|367309|P1|First Treatment Period|Withdrawal by Subject|0
110537|NCT00396812|367325|P1|Overall Study|Physician Decision|1
110538|NCT00396877|367339|P2|Overall Study|Parent(s)/guardian(s)'s request|7
110539|NCT00396877|367340|P1|Overall Study|Parent(s)/guardian(s)'s request|4
110540|NCT00396877|367339|P2|Overall Study|Lost to Follow-up|1
110541|NCT00396877|367340|P1|Overall Study|Lost to Follow-up|2
110542|NCT00397033|367374|P3|Overall Study|Other|2
110543|NCT00397033|367375|P2|Overall Study|Other|5
110544|NCT00397033|367376|P1|Overall Study|Other|0
110545|NCT00397033|367374|P3|Overall Study|Withdrawal by Subject|5
110546|NCT00397033|367375|P2|Overall Study|Withdrawal by Subject|7
110547|NCT00397033|367376|P1|Overall Study|Withdrawal by Subject|12
110548|NCT00397033|367374|P3|Overall Study|Lost to Follow-up|3
110549|NCT00397033|367375|P2|Overall Study|Lost to Follow-up|3
110550|NCT00397033|367376|P1|Overall Study|Lost to Follow-up|3
110551|NCT00397033|367374|P3|Overall Study|Lack of Efficacy|9
110552|NCT00397033|367375|P2|Overall Study|Lack of Efficacy|12
110553|NCT00397033|367376|P1|Overall Study|Lack of Efficacy|22
110554|NCT00397033|367374|P3|Overall Study|Adverse Event|4
110555|NCT00397033|367375|P2|Overall Study|Adverse Event|10
110556|NCT00397033|367376|P1|Overall Study|Adverse Event|7
110557|NCT00397189|367452|P2|3 Weeks Period|Other|2
110558|NCT00397189|367453|P1|3 Weeks Period|Other|0
110559|NCT00397189|367452|P2|3 Weeks Period|Protocol Violation|3
110560|NCT00397189|367453|P1|3 Weeks Period|Protocol Violation|0
110561|NCT00397189|367452|P2|3 Weeks Period|Physician Decision|2
110562|NCT00397189|367453|P1|3 Weeks Period|Physician Decision|0
110563|NCT00397189|367452|P2|3 Weeks Period|Withdrawal by Subject|9
110564|NCT00397189|367453|P1|3 Weeks Period|Withdrawal by Subject|13
110565|NCT00397189|367452|P2|3 Weeks Period|Adverse Event|2
110566|NCT00397189|367453|P1|3 Weeks Period|Adverse Event|3
110567|NCT00397189|367452|P2|3 Weeks Period|Lost to Follow-up|4
110568|NCT00397189|367453|P1|3 Weeks Period|Lost to Follow-up|5
110569|NCT00397215|367463|P4|Month 6 (Day 180)|Unspecified|0
110570|NCT00397215|367464|P3|Month 6 (Day 180)|Unspecified|3
110571|NCT00397215|367465|P2|Month 6 (Day 180)|Unspecified|0
110572|NCT00397215|367466|P1|Month 6 (Day 180)|Unspecified|2
110573|NCT00397215|367463|P4|Month 6 (Day 180)|Adverse Event|0
110574|NCT00397215|367464|P3|Month 6 (Day 180)|Adverse Event|2
110575|NCT00397215|367465|P2|Month 6 (Day 180)|Adverse Event|3
110576|NCT00397215|367466|P1|Month 6 (Day 180)|Adverse Event|0
110577|NCT00397215|367463|P4|Month 0 (Day 0)|Unspecified|3
110578|NCT00397215|367464|P3|Month 0 (Day 0)|Unspecified|3
110579|NCT00397215|367465|P2|Month 0 (Day 0)|Unspecified|1
110580|NCT00397215|367466|P1|Month 0 (Day 0)|Unspecified|4
110581|NCT00397215|367463|P4|Month 0 (Day 0)|Withdrawal by Subject|1
110582|NCT00397215|367464|P3|Month 0 (Day 0)|Withdrawal by Subject|3
110583|NCT00397215|367465|P2|Month 0 (Day 0)|Withdrawal by Subject|3
110584|NCT00397215|367466|P1|Month 0 (Day 0)|Withdrawal by Subject|3
110585|NCT00397215|367463|P4|Month 0 (Day 0)|Adverse Event|0
110586|NCT00397215|367464|P3|Month 0 (Day 0)|Adverse Event|0
110587|NCT00397215|367465|P2|Month 0 (Day 0)|Adverse Event|1
110588|NCT00397215|367466|P1|Month 0 (Day 0)|Adverse Event|0
110589|NCT00397254|367600|P2|Overall Study|Lost to Follow-up|2
110590|NCT00397254|367601|P1|Overall Study|Lost to Follow-up|2
110591|NCT00404495|367621|P2|Overall Study|Withdrawal by Subject|0
110592|NCT00404495|367622|P1|Overall Study|Withdrawal by Subject|1
110593|NCT00404495|367621|P2|Overall Study|Not specified|0
110594|NCT00404495|367622|P1|Overall Study|Not specified|1
110595|NCT00404495|367621|P2|Overall Study|Lost to Follow-up|0
110596|NCT00404495|367622|P1|Overall Study|Lost to Follow-up|5
110597|NCT00404495|367621|P2|Overall Study|Death|11
110598|NCT00404495|367622|P1|Overall Study|Death|37
110599|NCT00404547|367640|P2|Overall Study|Reason not stated|6
110600|NCT00404547|367641|P1|Overall Study|Reason not stated|3
110601|NCT00404547|367640|P2|Overall Study|Not known|0
110602|NCT00404547|367641|P1|Overall Study|Not known|4
110603|NCT00404547|367640|P2|Overall Study|Lack of compliance|1
110604|NCT00404547|367641|P1|Overall Study|Lack of compliance|5
110605|NCT00404547|367640|P2|Overall Study|Lost to Follow-up|9
110606|NCT00404547|367641|P1|Overall Study|Lost to Follow-up|20
110607|NCT00404547|367640|P2|Overall Study|Protocol Violation|1
110608|NCT00404547|367641|P1|Overall Study|Protocol Violation|0
110609|NCT00404547|367640|P2|Overall Study|Withdrawal by Subject|2
110610|NCT00404547|367641|P1|Overall Study|Withdrawal by Subject|19
110611|NCT00404547|367640|P2|Overall Study|Adverse Event|6
110612|NCT00404547|367641|P1|Overall Study|Adverse Event|39
110613|NCT00404651|367653|P4|Overall Study|Withdrawal by Subject|6
110614|NCT00404651|367654|P3|Overall Study|Withdrawal by Subject|16
110615|NCT00404651|367655|P2|Overall Study|Withdrawal by Subject|12
110616|NCT00404651|367656|P1|Overall Study|Withdrawal by Subject|14
110617|NCT00404651|367653|P4|Overall Study|Lost to Follow-up|10
110618|NCT00404651|367654|P3|Overall Study|Lost to Follow-up|13
110619|NCT00404651|367655|P2|Overall Study|Lost to Follow-up|11
110620|NCT00404651|367656|P1|Overall Study|Lost to Follow-up|15
110621|NCT00404651|367653|P4|Overall Study|Protocol Violation|5
110622|NCT00404651|367654|P3|Overall Study|Protocol Violation|14
110623|NCT00404651|367655|P2|Overall Study|Protocol Violation|5
110624|NCT00404651|367656|P1|Overall Study|Protocol Violation|10
110625|NCT00404651|367653|P4|Overall Study|Serious Adverse Event|0
110626|NCT00404651|367654|P3|Overall Study|Serious Adverse Event|2
110627|NCT00404651|367655|P2|Overall Study|Serious Adverse Event|0
110628|NCT00404651|367656|P1|Overall Study|Serious Adverse Event|0
110629|NCT00405548|367701|P2|Overall Study|Withdrawal by Subject|0
110630|NCT00405548|367702|P1|Overall Study|Withdrawal by Subject|1
110631|NCT00405548|367701|P2|Overall Study|Venous access failed during study day|0
110632|NCT00405548|367702|P1|Overall Study|Venous access failed during study day|1
110633|NCT00405548|367701|P2|Overall Study|Unable to self-administer shots|0
110634|NCT00405548|367702|P1|Overall Study|Unable to self-administer shots|1
110635|NCT00405548|367701|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
110636|NCT00405548|367702|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
110637|NCT00405548|367701|P2|Overall Study|Cognitive Memory problems on study day|0
110638|NCT00405548|367702|P1|Overall Study|Cognitive Memory problems on study day|1
110639|NCT00405587|367718|P4|Overall Study|Participant not dosed|0
110640|NCT00405587|367719|P3|Overall Study|Participant not dosed|0
110641|NCT00405587|367720|P2|Overall Study|Participant not dosed|1
110642|NCT00405587|367721|P1|Overall Study|Participant not dosed|0
110643|NCT00405587|367718|P4|Overall Study|Withdrawal by Subject|2
110644|NCT00405587|367719|P3|Overall Study|Withdrawal by Subject|0
110645|NCT00405587|367720|P2|Overall Study|Withdrawal by Subject|0
110646|NCT00405587|367721|P1|Overall Study|Withdrawal by Subject|0
110647|NCT00405587|367718|P4|Overall Study|Radiation induced necrosis|0
110648|NCT00405587|367719|P3|Overall Study|Radiation induced necrosis|0
110649|NCT00405587|367720|P2|Overall Study|Radiation induced necrosis|1
110650|NCT00405587|367721|P1|Overall Study|Radiation induced necrosis|0
110651|NCT00405587|367718|P4|Overall Study|Lost to Follow-up|0
110652|NCT00405587|367719|P3|Overall Study|Lost to Follow-up|1
110653|NCT00405587|367720|P2|Overall Study|Lost to Follow-up|1
110654|NCT00405587|367721|P1|Overall Study|Lost to Follow-up|0
110655|NCT00405587|367718|P4|Overall Study|Adverse Event|0
110656|NCT00405587|367719|P3|Overall Study|Adverse Event|0
110657|NCT00405587|367720|P2|Overall Study|Adverse Event|0
110658|NCT00405587|367721|P1|Overall Study|Adverse Event|1
110659|NCT00405587|367718|P4|Overall Study|Physician Decision|0
110660|NCT00405587|367719|P3|Overall Study|Physician Decision|0
110661|NCT00405587|367720|P2|Overall Study|Physician Decision|2
110662|NCT00405587|367721|P1|Overall Study|Physician Decision|3
110663|NCT00405587|367718|P4|Overall Study|Disease Progression|17
110664|NCT00405587|367719|P3|Overall Study|Disease Progression|21
110665|NCT00405587|367720|P2|Overall Study|Disease Progression|23
110666|NCT00405587|367721|P1|Overall Study|Disease Progression|22
110667|NCT00405587|367718|P4|Overall Study|Death|1
110668|NCT00405587|367719|P3|Overall Study|Death|0
110669|NCT00405587|367720|P2|Overall Study|Death|0
110670|NCT00405587|367721|P1|Overall Study|Death|0
110671|NCT00405639|367839|P2|Overall Study|Seizure prior to receiving BNP|0
110672|NCT00405639|367840|P1|Overall Study|Seizure prior to receiving BNP|1
110673|NCT00405639|367839|P2|Overall Study|Adverse Event|0
110674|NCT00405639|367840|P1|Overall Study|Adverse Event|1
110675|NCT00405639|367839|P2|Overall Study|Withdrawal by Subject|0
110676|NCT00405639|367840|P1|Overall Study|Withdrawal by Subject|1
110677|NCT00405652|367852|P1|Overall Study|Adverse Event|4
110678|NCT00405756|367883|P3|Follow-up|Lost to Follow-up|4
110679|NCT00405756|367884|P2|Follow-up|Lost to Follow-up|8
110680|NCT00405756|367885|P1|Follow-up|Lost to Follow-up|2
110681|NCT00405756|367883|P3|Follow-up|Death|24
110682|NCT00405756|367884|P2|Follow-up|Death|31
110683|NCT00405756|367885|P1|Follow-up|Death|21
110684|NCT00405756|367883|P3|Follow-up|Ongoing in Follow-up Period|60
110685|NCT00405756|367884|P2|Follow-up|Ongoing in Follow-up Period|51
110686|NCT00405756|367885|P1|Follow-up|Ongoing in Follow-up Period|52
110687|NCT00405756|367883|P3|Open-label Extension|Unspecified|7
110688|NCT00405756|367884|P2|Open-label Extension|Unspecified|1
110689|NCT00405756|367885|P1|Open-label Extension|Unspecified|0
110690|NCT00405756|367883|P3|Open-label Extension|Death|4
110691|NCT00405756|367884|P2|Open-label Extension|Death|2
110692|NCT00405756|367885|P1|Open-label Extension|Death|1
110693|NCT00405756|367883|P3|Open-label Extension|Withdrawal by Subject|3
110694|NCT00405756|367884|P2|Open-label Extension|Withdrawal by Subject|3
110695|NCT00405756|367885|P1|Open-label Extension|Withdrawal by Subject|2
110696|NCT00405756|367883|P3|Open-label Extension|Disease Progression|26
110697|NCT00405756|367884|P2|Open-label Extension|Disease Progression|23
110698|NCT00405756|367885|P1|Open-label Extension|Disease Progression|8
110699|NCT00405756|367883|P3|Open-label Extension|Adverse Event|7
110700|NCT00405756|367884|P2|Open-label Extension|Adverse Event|3
110701|NCT00405756|367885|P1|Open-label Extension|Adverse Event|1
110702|NCT00405756|367883|P3|Open-label Extension|Ongoing in Open Label Period|25
110703|NCT00405756|367884|P2|Open-label Extension|Ongoing in Open Label Period|15
110704|NCT00405756|367885|P1|Open-label Extension|Ongoing in Open Label Period|7
110705|NCT00405756|367883|P3|Double-blind Treatment|Not Specified|4
110706|NCT00405756|367884|P2|Double-blind Treatment|Not Specified|4
110707|NCT00405756|367885|P1|Double-blind Treatment|Not Specified|7
110708|NCT00405756|367883|P3|Double-blind Treatment|Protocol Violation|2
110709|NCT00405756|367884|P2|Double-blind Treatment|Protocol Violation|0
110710|NCT00405756|367885|P1|Double-blind Treatment|Protocol Violation|1
110711|NCT00405756|367883|P3|Double-blind Treatment|Death|4
110712|NCT00405756|367884|P2|Double-blind Treatment|Death|4
110713|NCT00405756|367885|P1|Double-blind Treatment|Death|4
110714|NCT00405756|367883|P3|Double-blind Treatment|Lost to Follow-up|0
110715|NCT00405756|367884|P2|Double-blind Treatment|Lost to Follow-up|0
110716|NCT00405756|367885|P1|Double-blind Treatment|Lost to Follow-up|1
110717|NCT00405756|367883|P3|Double-blind Treatment|Withdrawal by Subject|10
110718|NCT00405756|367884|P2|Double-blind Treatment|Withdrawal by Subject|9
110719|NCT00405756|367885|P1|Double-blind Treatment|Withdrawal by Subject|15
110720|NCT00405756|367883|P3|Double-blind Treatment|Lack of Efficacy|2
110721|NCT00405756|367884|P2|Double-blind Treatment|Lack of Efficacy|4
110722|NCT00405756|367885|P1|Double-blind Treatment|Lack of Efficacy|1
110723|NCT00405756|367883|P3|Double-blind Treatment|Disease Progression|102
110724|NCT00405756|367884|P2|Double-blind Treatment|Disease Progression|81
110725|NCT00405756|367885|P1|Double-blind Treatment|Disease Progression|47
110726|NCT00405756|367883|P3|Double-blind Treatment|Adverse Event|12
110727|NCT00405756|367884|P2|Double-blind Treatment|Adverse Event|27
110728|NCT00405756|367885|P1|Double-blind Treatment|Adverse Event|31
110729|NCT00405756|367883|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
110730|NCT00405756|367884|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
110731|NCT00405756|367885|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
110732|NCT00405821|367975|P2|Overall Study|initiated ART|8
110733|NCT00405821|367976|P1|Overall Study|initiated ART|9
110734|NCT00405821|367975|P2|Overall Study|Protocol Violation|0
110735|NCT00405821|367976|P1|Overall Study|Protocol Violation|1
110736|NCT00405821|367975|P2|Overall Study|Lost to Follow-up|7
110737|NCT00405821|367976|P1|Overall Study|Lost to Follow-up|7
110738|NCT00405821|367975|P2|Overall Study|Death|7
110739|NCT00405821|367976|P1|Overall Study|Death|5
110740|NCT00405912|367989|P3|Overall Study|Lost to Follow-up|4
110741|NCT00405912|367990|P2|Overall Study|Lost to Follow-up|8
110742|NCT00405912|367991|P1|Overall Study|Lost to Follow-up|4
110743|NCT00405912|367989|P3|Overall Study|Withdrawal by Subject|12
110744|NCT00405912|367990|P2|Overall Study|Withdrawal by Subject|11
110745|NCT00405912|367991|P1|Overall Study|Withdrawal by Subject|12
110746|NCT00405964|368013|P2|Overall Study|Protocol Violation|6
110747|NCT00405964|368014|P1|Overall Study|Protocol Violation|11
110748|NCT00405964|368013|P2|Overall Study|Withdrawal by Subject|23
110749|NCT00405964|368014|P1|Overall Study|Withdrawal by Subject|19
110750|NCT00405964|368013|P2|Overall Study|Lost to Follow-up|5
110751|NCT00405964|368014|P1|Overall Study|Lost to Follow-up|5
110752|NCT00405964|368013|P2|Overall Study|Adverse Event|16
110753|NCT00405964|368014|P1|Overall Study|Adverse Event|7
110754|NCT00405964|368013|P2|Overall Study|Treatment Failure|45
110755|NCT00405964|368014|P1|Overall Study|Treatment Failure|17
110756|NCT00406029|368029|P5|Overall Study|Randomized in Error|1
110757|NCT00406029|368030|P4|Overall Study|Randomized in Error|3
110758|NCT00406029|368031|P3|Overall Study|Randomized in Error|2
110759|NCT00406029|368032|P2|Overall Study|Randomized in Error|0
110760|NCT00406029|368033|P1|Overall Study|Randomized in Error|0
110761|NCT00406029|368029|P5|Overall Study|Did Not Meet Eligibility Criteria|0
110762|NCT00406029|368030|P4|Overall Study|Did Not Meet Eligibility Criteria|0
110763|NCT00406029|368031|P3|Overall Study|Did Not Meet Eligibility Criteria|1
110764|NCT00406029|368032|P2|Overall Study|Did Not Meet Eligibility Criteria|0
110765|NCT00406029|368033|P1|Overall Study|Did Not Meet Eligibility Criteria|0
110766|NCT00406029|368029|P5|Overall Study|Protocol Violation|0
110767|NCT00406029|368030|P4|Overall Study|Protocol Violation|2
110768|NCT00406029|368031|P3|Overall Study|Protocol Violation|0
110769|NCT00406029|368032|P2|Overall Study|Protocol Violation|2
110770|NCT00406029|368033|P1|Overall Study|Protocol Violation|1
110771|NCT00406029|368029|P5|Overall Study|Withdrawal by Subject|0
110772|NCT00406029|368030|P4|Overall Study|Withdrawal by Subject|2
110773|NCT00406029|368031|P3|Overall Study|Withdrawal by Subject|2
110774|NCT00406029|368032|P2|Overall Study|Withdrawal by Subject|4
110775|NCT00406029|368033|P1|Overall Study|Withdrawal by Subject|3
110776|NCT00406029|368029|P5|Overall Study|Adverse Event|7
110777|NCT00406029|368030|P4|Overall Study|Adverse Event|10
110778|NCT00406029|368031|P3|Overall Study|Adverse Event|5
110779|NCT00406029|368032|P2|Overall Study|Adverse Event|2
110780|NCT00406029|368033|P1|Overall Study|Adverse Event|12
110781|NCT00406315|368222|P1|Overall Study|Withdrawal by Subject|30
110782|NCT00406315|368222|P1|Overall Study|Lost to Follow-up|21
110783|NCT00406315|368222|P1|Overall Study|Unspecified|33
110784|NCT00406315|368222|P1|Overall Study|Lack of Efficacy|13
110785|NCT00406315|368222|P1|Overall Study|Laboratory Abnormality|4
110786|NCT00406315|368222|P1|Overall Study|Adverse Event|39
110787|NCT00406315|368222|P1|Overall Study|Death|1
110788|NCT00406354|368243|P3|All Randomized and Treated Patients|Physician Decision|1
110789|NCT00406354|368244|P2|All Randomized and Treated Patients|Physician Decision|0
110790|NCT00406354|368245|P1|All Randomized and Treated Patients|Physician Decision|0
110791|NCT00406354|368243|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
110792|NCT00406354|368244|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
110793|NCT00406354|368245|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
110794|NCT00406354|368243|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
110795|NCT00406354|368244|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
110796|NCT00406354|368245|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
110797|NCT00406354|368243|P3|All Randomized and Treated Patients|Adverse Event|1
110798|NCT00406354|368244|P2|All Randomized and Treated Patients|Adverse Event|2
110799|NCT00406354|368245|P1|All Randomized and Treated Patients|Adverse Event|6
110800|NCT00406354|368243|P3|All Randomized and Treated Patients|Lack of Efficacy|17
110801|NCT00406354|368244|P2|All Randomized and Treated Patients|Lack of Efficacy|4
110802|NCT00406354|368245|P1|All Randomized and Treated Patients|Lack of Efficacy|7
110803|NCT00406354|368243|P3|All Randomized Patients|Protocol Violation|1
110804|NCT00406354|368244|P2|All Randomized Patients|Protocol Violation|0
110805|NCT00406354|368245|P1|All Randomized Patients|Protocol Violation|0
110806|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
110807|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
110808|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
110809|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
110810|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
110811|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
110812|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
110813|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
110814|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
110815|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
110816|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
110817|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
110818|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
110819|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
110820|NCT00406367|368318|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
110821|NCT00406367|368319|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
110822|NCT00406367|368318|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
110823|NCT00406367|368319|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
110824|NCT00406367|368318|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
110825|NCT00406367|368319|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
110826|NCT00406367|368318|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
110827|NCT00406367|368319|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
110828|NCT00406367|368318|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
110829|NCT00406367|368319|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
110830|NCT00406393|368333|P2|Overall Study|Did not undergo transplantation|1
110831|NCT00406393|368334|P1|Overall Study|Did not undergo transplantation|2
110832|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
110833|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
110834|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
110835|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
110836|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|non-compliance|2
110837|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|non-compliance|3
110838|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
110839|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
110840|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|Physician Decision|0
110841|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|Physician Decision|1
110842|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|Failed to Return|0
110843|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|Failed to Return|1
110844|NCT00406640|368364|P2|OL Extension Phase for Non-Responders|Adverse Event|6
110845|NCT00406640|368365|P1|OL Extension Phase for Non-Responders|Adverse Event|6
110846|NCT00406640|368364|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
110847|NCT00406640|368365|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
110928|NCT00406653|368405|P1|Open-Label Period|Withdrawal of Consent|0
110848|NCT00406640|368364|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
110849|NCT00406640|368365|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
110850|NCT00406640|368364|P2|DB Continuation Phase for Responders|Protocol Violation|2
110851|NCT00406640|368365|P1|DB Continuation Phase for Responders|Protocol Violation|2
110852|NCT00406640|368364|P2|DB Continuation Phase for Responders|non-compliance|5
110853|NCT00406640|368365|P1|DB Continuation Phase for Responders|non-compliance|7
110854|NCT00406640|368364|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
110855|NCT00406640|368365|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
110856|NCT00406640|368364|P2|DB Continuation Phase for Responders|Physician Decision|3
110857|NCT00406640|368365|P1|DB Continuation Phase for Responders|Physician Decision|2
110858|NCT00406640|368364|P2|DB Continuation Phase for Responders|Failed to Return|2
110859|NCT00406640|368365|P1|DB Continuation Phase for Responders|Failed to Return|0
110860|NCT00406640|368364|P2|DB Continuation Phase for Responders|Death|0
110861|NCT00406640|368365|P1|DB Continuation Phase for Responders|Death|1
110862|NCT00406640|368364|P2|DB Continuation Phase for Responders|Adverse Event|11
110863|NCT00406640|368365|P1|DB Continuation Phase for Responders|Adverse Event|11
110864|NCT00406640|368364|P2|Acute Phase|Lack of Efficacy|3
110865|NCT00406640|368365|P1|Acute Phase|Lack of Efficacy|3
110866|NCT00406640|368364|P2|Acute Phase|Withdrawal by Subject|9
110867|NCT00406640|368365|P1|Acute Phase|Withdrawal by Subject|11
110868|NCT00406640|368364|P2|Acute Phase|Protocol Violation|2
110869|NCT00406640|368365|P1|Acute Phase|Protocol Violation|3
110870|NCT00406640|368364|P2|Acute Phase|Protocol deviation|10
110871|NCT00406640|368365|P1|Acute Phase|Protocol deviation|4
110872|NCT00406640|368364|P2|Acute Phase|Lost to Follow-up|4
110873|NCT00406640|368365|P1|Acute Phase|Lost to Follow-up|7
110874|NCT00406640|368364|P2|Acute Phase|Physician Decision|1
110875|NCT00406640|368365|P1|Acute Phase|Physician Decision|0
110876|NCT00406640|368364|P2|Acute Phase|Failed to Return|1
110877|NCT00406640|368365|P1|Acute Phase|Failed to Return|5
110878|NCT00406640|368364|P2|Acute Phase|Adverse Event|13
110879|NCT00406640|368365|P1|Acute Phase|Adverse Event|18
110880|NCT00406653|368399|P7|Open-Label Period|Refused followup|1
110881|NCT00406653|368400|P6|Open-Label Period|Refused followup|0
110882|NCT00406653|368401|P5|Open-Label Period|Refused followup|0
110883|NCT00406653|368402|P4|Open-Label Period|Refused followup|0
110884|NCT00406653|368403|P3|Open-Label Period|Refused followup|0
110885|NCT00406653|368404|P2|Open-Label Period|Refused followup|0
110886|NCT00406653|368405|P1|Open-Label Period|Refused followup|0
110887|NCT00406653|368399|P7|Open-Label Period|Discontinued by Sponsor|1
110888|NCT00406653|368400|P6|Open-Label Period|Discontinued by Sponsor|0
110889|NCT00406653|368401|P5|Open-Label Period|Discontinued by Sponsor|0
110890|NCT00406653|368402|P4|Open-Label Period|Discontinued by Sponsor|0
110891|NCT00406653|368403|P3|Open-Label Period|Discontinued by Sponsor|0
110892|NCT00406653|368404|P2|Open-Label Period|Discontinued by Sponsor|0
110893|NCT00406653|368405|P1|Open-Label Period|Discontinued by Sponsor|0
110894|NCT00406653|368399|P7|Open-Label Period|Declined participation but followup done|8
110895|NCT00406653|368400|P6|Open-Label Period|Declined participation but followup done|0
110896|NCT00406653|368401|P5|Open-Label Period|Declined participation but followup done|0
110897|NCT00406653|368402|P4|Open-Label Period|Declined participation but followup done|0
110898|NCT00406653|368403|P3|Open-Label Period|Declined participation but followup done|0
110899|NCT00406653|368404|P2|Open-Label Period|Declined participation but followup done|0
110900|NCT00406653|368405|P1|Open-Label Period|Declined participation but followup done|0
110901|NCT00406653|368399|P7|Open-Label Period|Administrative Reason By Sponsor|115
110902|NCT00406653|368400|P6|Open-Label Period|Administrative Reason By Sponsor|0
110903|NCT00406653|368401|P5|Open-Label Period|Administrative Reason By Sponsor|0
110904|NCT00406653|368402|P4|Open-Label Period|Administrative Reason By Sponsor|0
110905|NCT00406653|368403|P3|Open-Label Period|Administrative Reason By Sponsor|0
110906|NCT00406653|368404|P2|Open-Label Period|Administrative Reason By Sponsor|0
110907|NCT00406653|368405|P1|Open-Label Period|Administrative Reason By Sponsor|0
110908|NCT00406653|368399|P7|Open-Label Period|Pregnancy|2
110909|NCT00406653|368400|P6|Open-Label Period|Pregnancy|0
110910|NCT00406653|368401|P5|Open-Label Period|Pregnancy|0
110911|NCT00406653|368402|P4|Open-Label Period|Pregnancy|0
110912|NCT00406653|368403|P3|Open-Label Period|Pregnancy|0
110913|NCT00406653|368404|P2|Open-Label Period|Pregnancy|0
110914|NCT00406653|368405|P1|Open-Label Period|Pregnancy|0
110915|NCT00406653|368399|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
110916|NCT00406653|368400|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
110917|NCT00406653|368401|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
110918|NCT00406653|368402|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
110919|NCT00406653|368403|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
110920|NCT00406653|368404|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
110921|NCT00406653|368405|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
110922|NCT00406653|368399|P7|Open-Label Period|Withdrawal of Consent|11
110923|NCT00406653|368400|P6|Open-Label Period|Withdrawal of Consent|0
110924|NCT00406653|368401|P5|Open-Label Period|Withdrawal of Consent|0
110925|NCT00406653|368402|P4|Open-Label Period|Withdrawal of Consent|0
110926|NCT00406653|368403|P3|Open-Label Period|Withdrawal of Consent|0
110927|NCT00406653|368404|P2|Open-Label Period|Withdrawal of Consent|0
110929|NCT00406653|368399|P7|Open-Label Period|Lost to Follow-up|6
110930|NCT00406653|368400|P6|Open-Label Period|Lost to Follow-up|0
110931|NCT00406653|368401|P5|Open-Label Period|Lost to Follow-up|0
110932|NCT00406653|368402|P4|Open-Label Period|Lost to Follow-up|0
110933|NCT00406653|368403|P3|Open-Label Period|Lost to Follow-up|0
110934|NCT00406653|368404|P2|Open-Label Period|Lost to Follow-up|0
110935|NCT00406653|368405|P1|Open-Label Period|Lost to Follow-up|0
110936|NCT00406653|368399|P7|Open-Label Period|Lack of Efficacy|160
110937|NCT00406653|368400|P6|Open-Label Period|Lack of Efficacy|0
110938|NCT00406653|368401|P5|Open-Label Period|Lack of Efficacy|0
110939|NCT00406653|368402|P4|Open-Label Period|Lack of Efficacy|0
110940|NCT00406653|368403|P3|Open-Label Period|Lack of Efficacy|0
110941|NCT00406653|368404|P2|Open-Label Period|Lack of Efficacy|0
110942|NCT00406653|368405|P1|Open-Label Period|Lack of Efficacy|0
110943|NCT00406653|368399|P7|Open-Label Period|Adverse Event|18
110944|NCT00406653|368400|P6|Open-Label Period|Adverse Event|0
110945|NCT00406653|368401|P5|Open-Label Period|Adverse Event|0
110946|NCT00406653|368402|P4|Open-Label Period|Adverse Event|0
110947|NCT00406653|368403|P3|Open-Label Period|Adverse Event|0
110948|NCT00406653|368404|P2|Open-Label Period|Adverse Event|0
110949|NCT00406653|368405|P1|Open-Label Period|Adverse Event|0
110950|NCT00406653|368399|P7|Open-Label Period|Death|1
110951|NCT00406653|368400|P6|Open-Label Period|Death|0
110952|NCT00406653|368401|P5|Open-Label Period|Death|0
110953|NCT00406653|368402|P4|Open-Label Period|Death|0
110954|NCT00406653|368403|P3|Open-Label Period|Death|0
110955|NCT00406653|368404|P2|Open-Label Period|Death|0
110956|NCT00406653|368405|P1|Open-Label Period|Death|0
110957|NCT00406653|368399|P7|Maintenance Period|Error in disease score evaluation|0
110958|NCT00406653|368400|P6|Maintenance Period|Error in disease score evaluation|0
110959|NCT00406653|368401|P5|Maintenance Period|Error in disease score evaluation|1
110960|NCT00406653|368402|P4|Maintenance Period|Error in disease score evaluation|0
110961|NCT00406653|368403|P3|Maintenance Period|Error in disease score evaluation|0
110962|NCT00406653|368404|P2|Maintenance Period|Error in disease score evaluation|0
110963|NCT00406653|368405|P1|Maintenance Period|Error in disease score evaluation|0
110964|NCT00406653|368399|P7|Maintenance Period|Administrative Reason By Sponsor|0
110965|NCT00406653|368400|P6|Maintenance Period|Administrative Reason By Sponsor|7
110966|NCT00406653|368401|P5|Maintenance Period|Administrative Reason By Sponsor|4
110967|NCT00406653|368402|P4|Maintenance Period|Administrative Reason By Sponsor|0
110968|NCT00406653|368403|P3|Maintenance Period|Administrative Reason By Sponsor|0
110969|NCT00406653|368404|P2|Maintenance Period|Administrative Reason By Sponsor|0
110970|NCT00406653|368405|P1|Maintenance Period|Administrative Reason By Sponsor|0
110971|NCT00406653|368399|P7|Maintenance Period|Pregnancy|0
110972|NCT00406653|368400|P6|Maintenance Period|Pregnancy|1
110973|NCT00406653|368401|P5|Maintenance Period|Pregnancy|0
110974|NCT00406653|368402|P4|Maintenance Period|Pregnancy|0
110975|NCT00406653|368403|P3|Maintenance Period|Pregnancy|0
110976|NCT00406653|368404|P2|Maintenance Period|Pregnancy|0
110977|NCT00406653|368405|P1|Maintenance Period|Pregnancy|0
110978|NCT00406653|368399|P7|Maintenance Period|Withdrawal of Consent|0
110979|NCT00406653|368400|P6|Maintenance Period|Withdrawal of Consent|0
110980|NCT00406653|368401|P5|Maintenance Period|Withdrawal of Consent|2
110981|NCT00406653|368402|P4|Maintenance Period|Withdrawal of Consent|0
110982|NCT00406653|368403|P3|Maintenance Period|Withdrawal of Consent|0
110983|NCT00406653|368404|P2|Maintenance Period|Withdrawal of Consent|0
110984|NCT00406653|368405|P1|Maintenance Period|Withdrawal of Consent|0
110985|NCT00406653|368399|P7|Maintenance Period|Lost to Follow-up|0
110986|NCT00406653|368400|P6|Maintenance Period|Lost to Follow-up|1
110987|NCT00406653|368401|P5|Maintenance Period|Lost to Follow-up|2
110988|NCT00406653|368402|P4|Maintenance Period|Lost to Follow-up|0
110989|NCT00406653|368403|P3|Maintenance Period|Lost to Follow-up|0
110990|NCT00406653|368404|P2|Maintenance Period|Lost to Follow-up|0
110991|NCT00406653|368405|P1|Maintenance Period|Lost to Follow-up|0
110992|NCT00406653|368399|P7|Maintenance Period|Lack of Efficacy|0
110993|NCT00406653|368400|P6|Maintenance Period|Lack of Efficacy|26
110994|NCT00406653|368401|P5|Maintenance Period|Lack of Efficacy|20
110995|NCT00406653|368402|P4|Maintenance Period|Lack of Efficacy|0
110996|NCT00406653|368403|P3|Maintenance Period|Lack of Efficacy|0
110997|NCT00406653|368404|P2|Maintenance Period|Lack of Efficacy|0
110998|NCT00406653|368405|P1|Maintenance Period|Lack of Efficacy|0
110999|NCT00406653|368399|P7|Maintenance Period|Adverse Event|0
111000|NCT00406653|368400|P6|Maintenance Period|Adverse Event|1
111001|NCT00406653|368401|P5|Maintenance Period|Adverse Event|1
111002|NCT00406653|368402|P4|Maintenance Period|Adverse Event|0
111003|NCT00406653|368403|P3|Maintenance Period|Adverse Event|0
111004|NCT00406653|368404|P2|Maintenance Period|Adverse Event|0
111005|NCT00406653|368405|P1|Maintenance Period|Adverse Event|0
111006|NCT00406653|368399|P7|Induction Period|Patient relocated|0
111007|NCT00406653|368400|P6|Induction Period|Patient relocated|0
111008|NCT00406653|368401|P5|Induction Period|Patient relocated|0
111009|NCT00406653|368402|P4|Induction Period|Patient relocated|0
111010|NCT00406653|368403|P3|Induction Period|Patient relocated|1
111011|NCT00406653|368404|P2|Induction Period|Patient relocated|0
111012|NCT00406653|368405|P1|Induction Period|Patient relocated|0
111013|NCT00406653|368399|P7|Induction Period|Incarcerated|0
111014|NCT00406653|368400|P6|Induction Period|Incarcerated|0
111015|NCT00406653|368401|P5|Induction Period|Incarcerated|0
111016|NCT00406653|368402|P4|Induction Period|Incarcerated|0
111017|NCT00406653|368403|P3|Induction Period|Incarcerated|1
111018|NCT00406653|368404|P2|Induction Period|Incarcerated|0
111019|NCT00406653|368405|P1|Induction Period|Incarcerated|0
111020|NCT00406653|368399|P7|Induction Period|Given prohibited drug|0
111021|NCT00406653|368400|P6|Induction Period|Given prohibited drug|0
111022|NCT00406653|368401|P5|Induction Period|Given prohibited drug|0
111023|NCT00406653|368402|P4|Induction Period|Given prohibited drug|0
111024|NCT00406653|368403|P3|Induction Period|Given prohibited drug|2
111025|NCT00406653|368404|P2|Induction Period|Given prohibited drug|1
111026|NCT00406653|368405|P1|Induction Period|Given prohibited drug|0
111027|NCT00406653|368399|P7|Induction Period|Declined participation but followup done|0
111028|NCT00406653|368400|P6|Induction Period|Declined participation but followup done|0
111029|NCT00406653|368401|P5|Induction Period|Declined participation but followup done|0
111030|NCT00406653|368402|P4|Induction Period|Declined participation but followup done|1
111031|NCT00406653|368403|P3|Induction Period|Declined participation but followup done|1
111032|NCT00406653|368404|P2|Induction Period|Declined participation but followup done|2
111033|NCT00406653|368405|P1|Induction Period|Declined participation but followup done|0
111034|NCT00406653|368399|P7|Induction Period|Pregnancy|0
111035|NCT00406653|368400|P6|Induction Period|Pregnancy|0
111036|NCT00406653|368401|P5|Induction Period|Pregnancy|0
111037|NCT00406653|368402|P4|Induction Period|Pregnancy|0
111038|NCT00406653|368403|P3|Induction Period|Pregnancy|0
111039|NCT00406653|368404|P2|Induction Period|Pregnancy|0
111040|NCT00406653|368405|P1|Induction Period|Pregnancy|1
111041|NCT00406653|368399|P7|Induction Period|Subject No Longer Meets Study Criteria|0
111042|NCT00406653|368400|P6|Induction Period|Subject No Longer Meets Study Criteria|0
111043|NCT00406653|368401|P5|Induction Period|Subject No Longer Meets Study Criteria|0
111044|NCT00406653|368402|P4|Induction Period|Subject No Longer Meets Study Criteria|2
111045|NCT00406653|368403|P3|Induction Period|Subject No Longer Meets Study Criteria|0
111046|NCT00406653|368404|P2|Induction Period|Subject No Longer Meets Study Criteria|0
111047|NCT00406653|368405|P1|Induction Period|Subject No Longer Meets Study Criteria|0
111048|NCT00406653|368399|P7|Induction Period|Withdrawal of Consent|0
111049|NCT00406653|368400|P6|Induction Period|Withdrawal of Consent|0
111050|NCT00406653|368401|P5|Induction Period|Withdrawal of Consent|0
111051|NCT00406653|368402|P4|Induction Period|Withdrawal of Consent|2
111052|NCT00406653|368403|P3|Induction Period|Withdrawal of Consent|1
111053|NCT00406653|368404|P2|Induction Period|Withdrawal of Consent|5
111054|NCT00406653|368405|P1|Induction Period|Withdrawal of Consent|2
111055|NCT00406653|368399|P7|Induction Period|Lost to Follow-up|0
111056|NCT00406653|368400|P6|Induction Period|Lost to Follow-up|0
111057|NCT00406653|368401|P5|Induction Period|Lost to Follow-up|0
111058|NCT00406653|368402|P4|Induction Period|Lost to Follow-up|0
111059|NCT00406653|368403|P3|Induction Period|Lost to Follow-up|0
111060|NCT00406653|368404|P2|Induction Period|Lost to Follow-up|2
111061|NCT00406653|368405|P1|Induction Period|Lost to Follow-up|0
111062|NCT00406653|368399|P7|Induction Period|Lack of Efficacy|0
111063|NCT00406653|368400|P6|Induction Period|Lack of Efficacy|0
111064|NCT00406653|368401|P5|Induction Period|Lack of Efficacy|0
111065|NCT00406653|368402|P4|Induction Period|Lack of Efficacy|10
111066|NCT00406653|368403|P3|Induction Period|Lack of Efficacy|8
111067|NCT00406653|368404|P2|Induction Period|Lack of Efficacy|14
111068|NCT00406653|368405|P1|Induction Period|Lack of Efficacy|11
111069|NCT00406653|368399|P7|Induction Period|Adverse Event|0
111070|NCT00406653|368400|P6|Induction Period|Adverse Event|0
111071|NCT00406653|368401|P5|Induction Period|Adverse Event|0
111072|NCT00406653|368402|P4|Induction Period|Adverse Event|11
111073|NCT00406653|368403|P3|Induction Period|Adverse Event|4
111074|NCT00406653|368404|P2|Induction Period|Adverse Event|10
111075|NCT00406653|368405|P1|Induction Period|Adverse Event|1
111076|NCT00406692|368484|P1|Overall Study|Lack of Efficacy|1
111077|NCT00406692|368484|P1|Overall Study|Adverse Event|1
111078|NCT00406692|368484|P1|Overall Study|Physician Decision|1
111079|NCT00406692|368484|P1|Overall Study|Withdrawal by Subject|4
111080|NCT00406718|368493|P3|Overall Study|Lost to Follow-up|4
111081|NCT00406718|368494|P2|Overall Study|Lost to Follow-up|5
111082|NCT00406718|368495|P1|Overall Study|Lost to Follow-up|2
111083|NCT00406718|368493|P3|Overall Study|Withdrawal by Subject|4
111084|NCT00406718|368494|P2|Overall Study|Withdrawal by Subject|9
111085|NCT00406718|368495|P1|Overall Study|Withdrawal by Subject|2
111086|NCT00406783|368511|P2|Overall Study|Protocol Violation|4
111087|NCT00406783|368512|P1|Overall Study|Protocol Violation|4
111088|NCT00406783|368511|P2|Overall Study|Withdrawal by Subject|4
111089|NCT00406783|368512|P1|Overall Study|Withdrawal by Subject|1
111090|NCT00406783|368511|P2|Overall Study|Lost to Follow-up|0
111091|NCT00406783|368512|P1|Overall Study|Lost to Follow-up|3
111092|NCT00406783|368511|P2|Overall Study|Treatment Failure|3
111093|NCT00406783|368512|P1|Overall Study|Treatment Failure|2
111094|NCT00406783|368511|P2|Overall Study|Adverse Event|4
111095|NCT00406783|368512|P1|Overall Study|Adverse Event|4
111096|NCT00406848|368526|P2|Overall Study|Sponsor Decision|1
111097|NCT00406848|368527|P1|Overall Study|Sponsor Decision|1
111098|NCT00406848|368526|P2|Overall Study|Physician Decision|2
111099|NCT00406848|368527|P1|Overall Study|Physician Decision|2
111100|NCT00406848|368526|P2|Overall Study|Lost to Follow-up|2
111101|NCT00406848|368527|P1|Overall Study|Lost to Follow-up|6
111102|NCT00406848|368526|P2|Overall Study|Protocol Violation|6
111103|NCT00406848|368527|P1|Overall Study|Protocol Violation|10
111104|NCT00406848|368526|P2|Overall Study|Lack of Efficacy|14
111105|NCT00406848|368527|P1|Overall Study|Lack of Efficacy|9
111106|NCT00406848|368526|P2|Overall Study|Adverse Event|7
111107|NCT00406848|368527|P1|Overall Study|Adverse Event|38
111108|NCT00406848|368526|P2|Overall Study|Withdrawal by Subject|22
111109|NCT00406848|368527|P1|Overall Study|Withdrawal by Subject|27
111110|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Physician Decision|0
111111|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Physician Decision|2
111112|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Physician Decision|1
111113|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Patient Decision|0
111114|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Patient Decision|2
111115|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Patient Decision|1
111116|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
111117|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
111118|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
111119|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
111120|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
111121|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
111122|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Adverse Event|0
111123|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Adverse Event|0
111124|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Adverse Event|1
111125|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
111126|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
111127|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
111128|NCT00407030|368592|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
111129|NCT00407030|368593|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
111130|NCT00407030|368594|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
111131|NCT00407030|368592|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
111132|NCT00407030|368593|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
111133|NCT00407030|368594|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
111134|NCT00407030|368592|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
111135|NCT00407030|368593|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
111136|NCT00407030|368594|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
111137|NCT00407030|368592|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
111138|NCT00407030|368593|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
111139|NCT00407030|368594|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
111140|NCT00407030|368592|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
111141|NCT00407030|368593|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
111142|NCT00407030|368594|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
111143|NCT00407030|368592|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
111144|NCT00407030|368593|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
111145|NCT00407030|368594|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
111146|NCT00407030|368592|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
111147|NCT00407030|368593|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
111148|NCT00407030|368594|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
111149|NCT00407511|368649|P1|Overall Study|Withdrawal by Subject|4
111150|NCT00407511|368649|P1|Overall Study|Other|5
111151|NCT00407511|368649|P1|Overall Study|Lost to Follow-up|4
111152|NCT00407511|368649|P1|Overall Study|Adverse Event|9
111153|NCT00407537|368665|P2|Overall Study|Withdrawal by Subject|16
111154|NCT00407537|368666|P1|Overall Study|Withdrawal by Subject|34
111155|NCT00407537|368665|P2|Overall Study|Unspecified|7
111156|NCT00407537|368666|P1|Overall Study|Unspecified|6
111157|NCT00407537|368665|P2|Overall Study|Lost to Follow-up|19
111158|NCT00407537|368666|P1|Overall Study|Lost to Follow-up|12
111159|NCT00407537|368665|P2|Overall Study|Adverse Event|0
111160|NCT00407537|368666|P1|Overall Study|Adverse Event|36
111161|NCT00407537|368665|P2|Overall Study|Death|2
111162|NCT00407537|368666|P1|Overall Study|Death|5
111163|NCT00407550|368716|P2|Overall Study|Insurance or Other medical condition|1
111164|NCT00407550|368717|P1|Overall Study|Insurance or Other medical condition|2
111165|NCT00407550|368716|P2|Overall Study|Death|0
111166|NCT00407550|368717|P1|Overall Study|Death|1
111167|NCT00407550|368716|P2|Overall Study|Withdrawal by Subject|2
111168|NCT00407550|368717|P1|Overall Study|Withdrawal by Subject|0
111169|NCT00407550|368716|P2|Overall Study|Adverse Event|1
111170|NCT00407550|368717|P1|Overall Study|Adverse Event|0
111171|NCT00407563|368723|P1|Overall Study|Patient continues on treatment|1
111172|NCT00407745|368745|P2|Overall Study|Randomized, unknown if treated|1
111173|NCT00407745|368746|P1|Overall Study|Randomized, unknown if treated|0
111174|NCT00407745|368745|P2|Overall Study|Unspecified|0
111175|NCT00407745|368746|P1|Overall Study|Unspecified|2
111176|NCT00407745|368745|P2|Overall Study|Adverse Event|8
111177|NCT00407745|368746|P1|Overall Study|Adverse Event|8
111178|NCT00407745|368745|P2|Overall Study|Protocol Violation|3
111179|NCT00407745|368746|P1|Overall Study|Protocol Violation|5
111180|NCT00407745|368745|P2|Overall Study|Withdrawal by Subject|3
111181|NCT00407745|368746|P1|Overall Study|Withdrawal by Subject|3
111182|NCT00407745|368745|P2|Overall Study|Lack of Efficacy|2
111183|NCT00407745|368746|P1|Overall Study|Lack of Efficacy|1
111184|NCT00394589|368821|P3|Overall Study|Protocol Violation|2
111185|NCT00394589|368822|P2|Overall Study|Protocol Violation|0
111186|NCT00394589|368823|P1|Overall Study|Protocol Violation|4
111187|NCT00394589|368821|P3|Overall Study|Lack of Efficacy|3
111188|NCT00394589|368822|P2|Overall Study|Lack of Efficacy|2
111189|NCT00394589|368823|P1|Overall Study|Lack of Efficacy|2
111190|NCT00394589|368821|P3|Overall Study|Adverse Event|2
111191|NCT00394589|368822|P2|Overall Study|Adverse Event|1
111192|NCT00394589|368823|P1|Overall Study|Adverse Event|2
111193|NCT00394654|368833|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
111194|NCT00394654|368834|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
111195|NCT00394654|368833|P2|Overall Study|Lost to Follow-up|0
111196|NCT00394654|368834|P1|Overall Study|Lost to Follow-up|1
111197|NCT00394706|368904|P8|Overall Study|Lost to Follow-up|0
111198|NCT00394706|368905|P7|Overall Study|Lost to Follow-up|2
111199|NCT00394706|368906|P6|Overall Study|Lost to Follow-up|5
111200|NCT00394706|368907|P5|Overall Study|Lost to Follow-up|2
111201|NCT00394706|368908|P4|Overall Study|Lost to Follow-up|1
111202|NCT00394706|368909|P3|Overall Study|Lost to Follow-up|8
111203|NCT00394706|368910|P2|Overall Study|Lost to Follow-up|2
111204|NCT00394706|368911|P1|Overall Study|Lost to Follow-up|2
111205|NCT00394706|368904|P8|Overall Study|Withdrawal by Subject|0
111206|NCT00394706|368905|P7|Overall Study|Withdrawal by Subject|1
111207|NCT00394706|368906|P6|Overall Study|Withdrawal by Subject|2
111208|NCT00394706|368907|P5|Overall Study|Withdrawal by Subject|0
111209|NCT00394706|368908|P4|Overall Study|Withdrawal by Subject|0
111210|NCT00394706|368909|P3|Overall Study|Withdrawal by Subject|1
111211|NCT00394706|368910|P2|Overall Study|Withdrawal by Subject|0
111212|NCT00394706|368911|P1|Overall Study|Withdrawal by Subject|2
111213|NCT00394771|368933|P4|Overall Study|Not specified|0
111214|NCT00394771|368934|P3|Overall Study|Not specified|1
111215|NCT00394771|368935|P2|Overall Study|Not specified|3
111216|NCT00394771|368936|P1|Overall Study|Not specified|3
111217|NCT00394771|368933|P4|Overall Study|Lost to Follow-up|10
111218|NCT00394771|368934|P3|Overall Study|Lost to Follow-up|13
111219|NCT00394771|368935|P2|Overall Study|Lost to Follow-up|15
111220|NCT00394771|368936|P1|Overall Study|Lost to Follow-up|15
111221|NCT00394771|368933|P4|Overall Study|Participant pregnant|2
111222|NCT00394771|368934|P3|Overall Study|Participant pregnant|2
111223|NCT00394771|368935|P2|Overall Study|Participant pregnant|1
111224|NCT00394771|368936|P1|Overall Study|Participant pregnant|0
111225|NCT00394771|368933|P4|Overall Study|Adverse Event|8
111226|NCT00394771|368934|P3|Overall Study|Adverse Event|12
111227|NCT00394771|368935|P2|Overall Study|Adverse Event|5
111228|NCT00394771|368936|P1|Overall Study|Adverse Event|10
111229|NCT00394771|368933|P4|Overall Study|Withdrawal by Subject|12
111230|NCT00394771|368934|P3|Overall Study|Withdrawal by Subject|8
111231|NCT00394771|368935|P2|Overall Study|Withdrawal by Subject|6
111232|NCT00394771|368936|P1|Overall Study|Withdrawal by Subject|10
111233|NCT00394771|368933|P4|Overall Study|Protocol Violation|7
111234|NCT00394771|368934|P3|Overall Study|Protocol Violation|9
111235|NCT00394771|368935|P2|Overall Study|Protocol Violation|4
111236|NCT00394771|368936|P1|Overall Study|Protocol Violation|2
111237|NCT00394771|368933|P4|Overall Study|Did not meet protocol requirements|0
111238|NCT00394771|368934|P3|Overall Study|Did not meet protocol requirements|2
111239|NCT00394771|368935|P2|Overall Study|Did not meet protocol requirements|0
111240|NCT00394771|368936|P1|Overall Study|Did not meet protocol requirements|1
111241|NCT00394836|369000|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
111242|NCT00394836|369001|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
111243|NCT00394836|369000|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
111244|NCT00394836|369001|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
111245|NCT00394836|369000|P2|Extended Follow-up Phase (2-5 Years)|Death|1
111246|NCT00394836|369001|P1|Extended Follow-up Phase (2-5 Years)|Death|0
111247|NCT00394836|369000|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
111248|NCT00394836|369001|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
111249|NCT00394836|369000|P2|Teatment or Follow-up Phase|Non compliance|1
111250|NCT00394836|369001|P1|Teatment or Follow-up Phase|Non compliance|0
111251|NCT00394836|369000|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
111252|NCT00394836|369001|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
111253|NCT00394836|369000|P2|Teatment or Follow-up Phase|Physician Decision|1
111254|NCT00394836|369001|P1|Teatment or Follow-up Phase|Physician Decision|0
111255|NCT00394836|369000|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
111256|NCT00394836|369001|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
111257|NCT00394836|369000|P2|Teatment or Follow-up Phase|Started alternative treatment|6
111258|NCT00394836|369001|P1|Teatment or Follow-up Phase|Started alternative treatment|0
111259|NCT00394836|369000|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
111260|NCT00394836|369001|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
111261|NCT00394836|369000|P2|Teatment or Follow-up Phase|Death|1
111262|NCT00394836|369001|P1|Teatment or Follow-up Phase|Death|0
111263|NCT00394836|369000|P2|Teatment or Follow-up Phase|Patient Refusal|2
111264|NCT00394836|369001|P1|Teatment or Follow-up Phase|Patient Refusal|1
111265|NCT00394836|369000|P2|Teatment or Follow-up Phase|Disease Progression|60
111266|NCT00394836|369001|P1|Teatment or Follow-up Phase|Disease Progression|27
111267|NCT00394836|369000|P2|Teatment or Follow-up Phase|Protocol Violation|2
111268|NCT00394836|369001|P1|Teatment or Follow-up Phase|Protocol Violation|0
111269|NCT00394836|369000|P2|Teatment or Follow-up Phase|Adverse Event|2
111270|NCT00394836|369001|P1|Teatment or Follow-up Phase|Adverse Event|0
111271|NCT00394901|369063|P4|Double-blind Phase|Found not to meet entrance criteria|1
111272|NCT00394901|369064|P3|Double-blind Phase|Found not to meet entrance criteria|0
111273|NCT00394901|369065|P2|Double-blind Phase|Found not to meet entrance criteria|0
111274|NCT00394901|369066|P1|Double-blind Phase|Found not to meet entrance criteria|0
111275|NCT00394901|369063|P4|Double-blind Phase|Entry into another study was found|0
111276|NCT00394901|369064|P3|Double-blind Phase|Entry into another study was found|1
111277|NCT00394901|369065|P2|Double-blind Phase|Entry into another study was found|0
111278|NCT00394901|369066|P1|Double-blind Phase|Entry into another study was found|0
111279|NCT00394901|369063|P4|Double-blind Phase|Lack of Compliance|0
111280|NCT00394901|369064|P3|Double-blind Phase|Lack of Compliance|0
111281|NCT00394901|369065|P2|Double-blind Phase|Lack of Compliance|3
111282|NCT00394901|369066|P1|Double-blind Phase|Lack of Compliance|0
111283|NCT00394901|369063|P4|Double-blind Phase|Subject's Personal Reason|1
111284|NCT00394901|369064|P3|Double-blind Phase|Subject's Personal Reason|0
111285|NCT00394901|369065|P2|Double-blind Phase|Subject's Personal Reason|0
111286|NCT00394901|369066|P1|Double-blind Phase|Subject's Personal Reason|1
111287|NCT00394901|369063|P4|Double-blind Phase|Death|0
111288|NCT00394901|369064|P3|Double-blind Phase|Death|0
111289|NCT00394901|369065|P2|Double-blind Phase|Death|0
111290|NCT00394901|369066|P1|Double-blind Phase|Death|1
111291|NCT00394901|369063|P4|Double-blind Phase|Protocol Violation|1
111292|NCT00394901|369064|P3|Double-blind Phase|Protocol Violation|0
111293|NCT00394901|369065|P2|Double-blind Phase|Protocol Violation|0
111294|NCT00394901|369066|P1|Double-blind Phase|Protocol Violation|0
111295|NCT00394901|369063|P4|Double-blind Phase|Lost to Follow-up|1
111296|NCT00394901|369064|P3|Double-blind Phase|Lost to Follow-up|0
111297|NCT00394901|369065|P2|Double-blind Phase|Lost to Follow-up|0
111298|NCT00394901|369066|P1|Double-blind Phase|Lost to Follow-up|0
111299|NCT00394901|369063|P4|Double-blind Phase|Withdrawal by Subject|0
111300|NCT00394901|369064|P3|Double-blind Phase|Withdrawal by Subject|0
111301|NCT00394901|369065|P2|Double-blind Phase|Withdrawal by Subject|0
111302|NCT00394901|369066|P1|Double-blind Phase|Withdrawal by Subject|2
111303|NCT00394901|369063|P4|Double-blind Phase|Lack of Efficacy|3
111304|NCT00394901|369064|P3|Double-blind Phase|Lack of Efficacy|1
111305|NCT00394901|369065|P2|Double-blind Phase|Lack of Efficacy|4
111306|NCT00394901|369066|P1|Double-blind Phase|Lack of Efficacy|6
111307|NCT00394901|369063|P4|Double-blind Phase|Adverse Event|20
111308|NCT00394901|369064|P3|Double-blind Phase|Adverse Event|16
111309|NCT00394901|369065|P2|Double-blind Phase|Adverse Event|7
111310|NCT00394901|369066|P1|Double-blind Phase|Adverse Event|5
111311|NCT00394901|369063|P4|Baseline Phase|Protocol Violation|0
111312|NCT00394901|369064|P3|Baseline Phase|Protocol Violation|1
111313|NCT00394901|369065|P2|Baseline Phase|Protocol Violation|0
111314|NCT00394901|369066|P1|Baseline Phase|Protocol Violation|0
111315|NCT00400400|369293|P2|Overall Study|Did not receive study drug|3
111316|NCT00400400|369294|P1|Overall Study|Did not receive study drug|1
111317|NCT00400400|369293|P2|Overall Study|Lost to Follow-up|1
111318|NCT00400400|369294|P1|Overall Study|Lost to Follow-up|0
111319|NCT00400400|369293|P2|Overall Study|Administrative Problem|0
111320|NCT00400400|369294|P1|Overall Study|Administrative Problem|1
111321|NCT00400400|369293|P2|Overall Study|Withdrawal by Subject|3
111322|NCT00400400|369294|P1|Overall Study|Withdrawal by Subject|1
111323|NCT00400400|369293|P2|Overall Study|Protocol Violation|0
111324|NCT00400400|369294|P1|Overall Study|Protocol Violation|2
111325|NCT00400400|369293|P2|Overall Study|Adverse Event|8
111326|NCT00400400|369294|P1|Overall Study|Adverse Event|9
111327|NCT00400569|369312|P1|Overall Study|Death|1
111328|NCT00400712|369342|P2|Overall Study|Physician Decision|4
111329|NCT00400712|369343|P1|Overall Study|Physician Decision|5
111330|NCT00400712|369342|P2|Overall Study|Withdrawal by Subject|12
111331|NCT00400712|369343|P1|Overall Study|Withdrawal by Subject|11
111332|NCT00400712|369342|P2|Overall Study|Death|0
111333|NCT00400712|369343|P1|Overall Study|Death|1
111334|NCT00400764|369366|P5|Phase II|Withdrawal by Subject|0
111335|NCT00400764|369367|P4|Phase II|Withdrawal by Subject|1
111336|NCT00400764|369368|P3|Phase II|Withdrawal by Subject|1
111337|NCT00400764|369369|P2|Phase II|Withdrawal by Subject|0
111338|NCT00400764|369370|P1|Phase II|Withdrawal by Subject|0
111339|NCT00400764|369366|P5|Phase II|Patient began new, non-protocol, therapy|0
111340|NCT00400764|369367|P4|Phase II|Patient began new, non-protocol, therapy|0
111341|NCT00400764|369368|P3|Phase II|Patient began new, non-protocol, therapy|1
111342|NCT00400764|369369|P2|Phase II|Patient began new, non-protocol, therapy|0
111343|NCT00400764|369370|P1|Phase II|Patient began new, non-protocol, therapy|0
111344|NCT00400764|369366|P5|Phase II|Sponsor’s decision to terminate|11
111345|NCT00400764|369367|P4|Phase II|Sponsor’s decision to terminate|22
111346|NCT00400764|369368|P3|Phase II|Sponsor’s decision to terminate|18
111347|NCT00400764|369369|P2|Phase II|Sponsor’s decision to terminate|0
111348|NCT00400764|369370|P1|Phase II|Sponsor’s decision to terminate|0
111349|NCT00400764|369366|P5|Phase II|Physician Decision|0
111350|NCT00400764|369367|P4|Phase II|Physician Decision|1
111351|NCT00400764|369368|P3|Phase II|Physician Decision|1
111352|NCT00400764|369369|P2|Phase II|Physician Decision|0
111353|NCT00400764|369370|P1|Phase II|Physician Decision|0
111354|NCT00400764|369366|P5|Phase II|Lost to Follow-up|0
111355|NCT00400764|369367|P4|Phase II|Lost to Follow-up|0
111356|NCT00400764|369368|P3|Phase II|Lost to Follow-up|1
111357|NCT00400764|369369|P2|Phase II|Lost to Follow-up|0
111358|NCT00400764|369370|P1|Phase II|Lost to Follow-up|0
111359|NCT00400764|369366|P5|Phase II|Death|0
111360|NCT00400764|369367|P4|Phase II|Death|2
111361|NCT00400764|369368|P3|Phase II|Death|1
111362|NCT00400764|369369|P2|Phase II|Death|0
111363|NCT00400764|369370|P1|Phase II|Death|0
111364|NCT00400764|369366|P5|Phase Ib|Disease Progression|0
111365|NCT00400764|369367|P4|Phase Ib|Disease Progression|0
111366|NCT00400764|369368|P3|Phase Ib|Disease Progression|0
111367|NCT00400764|369369|P2|Phase Ib|Disease Progression|4
111368|NCT00400764|369370|P1|Phase Ib|Disease Progression|4
111369|NCT00400764|369366|P5|Phase Ib|Death|0
111370|NCT00400764|369367|P4|Phase Ib|Death|0
111371|NCT00400764|369368|P3|Phase Ib|Death|0
111372|NCT00400764|369369|P2|Phase Ib|Death|0
111373|NCT00400764|369370|P1|Phase Ib|Death|1
111374|NCT00400764|369366|P5|Phase Ib|Adverse Event|0
111375|NCT00400764|369367|P4|Phase Ib|Adverse Event|0
111376|NCT00400764|369368|P3|Phase Ib|Adverse Event|0
111377|NCT00400764|369369|P2|Phase Ib|Adverse Event|0
111378|NCT00400764|369370|P1|Phase Ib|Adverse Event|1
111379|NCT00400946|369454|P5|Overall Study|Other|1
111380|NCT00400946|369455|P4|Overall Study|Other|0
111381|NCT00400946|369456|P3|Overall Study|Other|0
111382|NCT00400946|369457|P2|Overall Study|Other|0
111383|NCT00400946|369458|P1|Overall Study|Other|0
111384|NCT00400946|369454|P5|Overall Study|Clinical|9
111385|NCT00400946|369455|P4|Overall Study|Clinical|2
111386|NCT00400946|369456|P3|Overall Study|Clinical|0
111387|NCT00400946|369457|P2|Overall Study|Clinical|2
111388|NCT00400946|369458|P1|Overall Study|Clinical|1
111389|NCT00400946|369454|P5|Overall Study|Withdrawal by Subject|8
111390|NCT00400946|369455|P4|Overall Study|Withdrawal by Subject|5
111391|NCT00400946|369456|P3|Overall Study|Withdrawal by Subject|1
111392|NCT00400946|369457|P2|Overall Study|Withdrawal by Subject|5
111393|NCT00400946|369458|P1|Overall Study|Withdrawal by Subject|2
111394|NCT00400946|369454|P5|Overall Study|Transplant in CR1|1
111395|NCT00400946|369455|P4|Overall Study|Transplant in CR1|10
111396|NCT00400946|369456|P3|Overall Study|Transplant in CR1|0
111397|NCT00400946|369457|P2|Overall Study|Transplant in CR1|0
111398|NCT00400946|369458|P1|Overall Study|Transplant in CR1|0
111399|NCT00400946|369454|P5|Overall Study|Relapse|5
111400|NCT00400946|369455|P4|Overall Study|Relapse|1
111401|NCT00400946|369456|P3|Overall Study|Relapse|1
111402|NCT00400946|369457|P2|Overall Study|Relapse|2
111403|NCT00400946|369458|P1|Overall Study|Relapse|9
111404|NCT00400946|369454|P5|Overall Study|Remission Death|1
111405|NCT00400946|369455|P4|Overall Study|Remission Death|0
111406|NCT00400946|369456|P3|Overall Study|Remission Death|0
111407|NCT00400946|369457|P2|Overall Study|Remission Death|1
111408|NCT00400946|369458|P1|Overall Study|Remission Death|1
111409|NCT00400946|369454|P5|Overall Study|Lost to Follow-up|1
111410|NCT00400946|369455|P4|Overall Study|Lost to Follow-up|0
111411|NCT00400946|369456|P3|Overall Study|Lost to Follow-up|0
111412|NCT00400946|369457|P2|Overall Study|Lost to Follow-up|1
111413|NCT00400946|369458|P1|Overall Study|Lost to Follow-up|1
111414|NCT00400946|369454|P5|Overall Study|Induction Death|3
111415|NCT00400946|369455|P4|Overall Study|Induction Death|13
111416|NCT00400946|369456|P3|Overall Study|Induction Death|0
111417|NCT00400946|369457|P2|Overall Study|Induction Death|0
111418|NCT00400946|369458|P1|Overall Study|Induction Death|0
111419|NCT00400946|369454|P5|Overall Study|Induction Failure|8
111420|NCT00400946|369455|P4|Overall Study|Induction Failure|11
111421|NCT00400946|369456|P3|Overall Study|Induction Failure|0
111422|NCT00400946|369457|P2|Overall Study|Induction Failure|0
111423|NCT00400946|369458|P1|Overall Study|Induction Failure|0
111424|NCT00400946|369454|P5|Overall Study|Ineligible|1
111425|NCT00400946|369455|P4|Overall Study|Ineligible|5
111426|NCT00400946|369456|P3|Overall Study|Ineligible|0
111427|NCT00400946|369457|P2|Overall Study|Ineligible|0
111428|NCT00400946|369458|P1|Overall Study|Ineligible|0
111429|NCT00401193|369491|P3|Overall Study|Other Event|2
111430|NCT00401193|369492|P2|Overall Study|Other Event|2
111431|NCT00401193|369493|P1|Overall Study|Other Event|3
111432|NCT00401193|369491|P3|Overall Study|Withdrawal by Subject|1
111433|NCT00401193|369492|P2|Overall Study|Withdrawal by Subject|0
111434|NCT00401193|369493|P1|Overall Study|Withdrawal by Subject|2
111435|NCT00401193|369491|P3|Overall Study|Lost to Follow-up|1
111436|NCT00401193|369492|P2|Overall Study|Lost to Follow-up|5
111437|NCT00401193|369493|P1|Overall Study|Lost to Follow-up|6
111438|NCT00401193|369491|P3|Overall Study|Protocol Violation|1
111439|NCT00401193|369492|P2|Overall Study|Protocol Violation|1
111440|NCT00401193|369493|P1|Overall Study|Protocol Violation|3
111441|NCT00401193|369491|P3|Overall Study|Adverse Event|1
111442|NCT00401193|369492|P2|Overall Study|Adverse Event|3
111443|NCT00401193|369493|P1|Overall Study|Adverse Event|1
111444|NCT00401245|369511|P8|Double Blind Tapering Phase|Lack of Efficacy|0
111445|NCT00401245|369512|P7|Double Blind Tapering Phase|Lack of Efficacy|0
111446|NCT00401245|369513|P6|Double Blind Tapering Phase|Lack of Efficacy|1
111447|NCT00401245|369514|P5|Double Blind Tapering Phase|Lack of Efficacy|0
111448|NCT00401245|369515|P4|Double Blind Tapering Phase|Lack of Efficacy|0
111449|NCT00401245|369516|P3|Double Blind Tapering Phase|Lack of Efficacy|0
111450|NCT00401245|369517|P2|Double Blind Tapering Phase|Lack of Efficacy|0
111451|NCT00401245|369518|P1|Double Blind Tapering Phase|Lack of Efficacy|0
111452|NCT00401245|369511|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
111453|NCT00401245|369512|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
111454|NCT00401245|369513|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
111455|NCT00401245|369514|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
111456|NCT00401245|369515|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
111457|NCT00401245|369516|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
111458|NCT00401245|369517|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
111459|NCT00401245|369518|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
111460|NCT00401245|369511|P8|Double Blind Tapering Phase|Unspecified|2
111461|NCT00401245|369512|P7|Double Blind Tapering Phase|Unspecified|2
111462|NCT00401245|369513|P6|Double Blind Tapering Phase|Unspecified|0
111463|NCT00401245|369514|P5|Double Blind Tapering Phase|Unspecified|1
111464|NCT00401245|369515|P4|Double Blind Tapering Phase|Unspecified|0
111465|NCT00401245|369516|P3|Double Blind Tapering Phase|Unspecified|0
111466|NCT00401245|369517|P2|Double Blind Tapering Phase|Unspecified|0
111467|NCT00401245|369518|P1|Double Blind Tapering Phase|Unspecified|0
111468|NCT00401245|369511|P8|Double Blind Tapering Phase|Investigator request|1
111469|NCT00401245|369512|P7|Double Blind Tapering Phase|Investigator request|0
111470|NCT00401245|369513|P6|Double Blind Tapering Phase|Investigator request|0
111471|NCT00401245|369514|P5|Double Blind Tapering Phase|Investigator request|0
111472|NCT00401245|369515|P4|Double Blind Tapering Phase|Investigator request|0
111473|NCT00401245|369516|P3|Double Blind Tapering Phase|Investigator request|0
111474|NCT00401245|369517|P2|Double Blind Tapering Phase|Investigator request|0
111475|NCT00401245|369518|P1|Double Blind Tapering Phase|Investigator request|0
111476|NCT00401245|369511|P8|Double Blind Tapering Phase|Adverse Event|4
111477|NCT00401245|369512|P7|Double Blind Tapering Phase|Adverse Event|2
111478|NCT00401245|369513|P6|Double Blind Tapering Phase|Adverse Event|1
111479|NCT00401245|369514|P5|Double Blind Tapering Phase|Adverse Event|1
111480|NCT00401245|369515|P4|Double Blind Tapering Phase|Adverse Event|0
111481|NCT00401245|369516|P3|Double Blind Tapering Phase|Adverse Event|0
111482|NCT00401245|369517|P2|Double Blind Tapering Phase|Adverse Event|0
111483|NCT00401245|369518|P1|Double Blind Tapering Phase|Adverse Event|0
111484|NCT00401245|369511|P8|Open Label Phase|Lack of Efficacy|0
111485|NCT00401245|369512|P7|Open Label Phase|Lack of Efficacy|0
111486|NCT00401245|369513|P6|Open Label Phase|Lack of Efficacy|0
111487|NCT00401245|369514|P5|Open Label Phase|Lack of Efficacy|0
111488|NCT00401245|369515|P4|Open Label Phase|Lack of Efficacy|0
111489|NCT00401245|369516|P3|Open Label Phase|Lack of Efficacy|3
111490|NCT00401245|369517|P2|Open Label Phase|Lack of Efficacy|2
111491|NCT00401245|369518|P1|Open Label Phase|Lack of Efficacy|4
111492|NCT00401245|369511|P8|Open Label Phase|Withdrawal by Subject|0
111493|NCT00401245|369512|P7|Open Label Phase|Withdrawal by Subject|0
111494|NCT00401245|369513|P6|Open Label Phase|Withdrawal by Subject|0
111495|NCT00401245|369514|P5|Open Label Phase|Withdrawal by Subject|0
111496|NCT00401245|369515|P4|Open Label Phase|Withdrawal by Subject|1
111497|NCT00401245|369516|P3|Open Label Phase|Withdrawal by Subject|2
111498|NCT00401245|369517|P2|Open Label Phase|Withdrawal by Subject|3
111499|NCT00401245|369518|P1|Open Label Phase|Withdrawal by Subject|3
111500|NCT00401245|369511|P8|Open Label Phase|Protocol Violation|0
111501|NCT00401245|369512|P7|Open Label Phase|Protocol Violation|0
111502|NCT00401245|369513|P6|Open Label Phase|Protocol Violation|0
111503|NCT00401245|369514|P5|Open Label Phase|Protocol Violation|0
111504|NCT00401245|369515|P4|Open Label Phase|Protocol Violation|1
111505|NCT00401245|369516|P3|Open Label Phase|Protocol Violation|0
111506|NCT00401245|369517|P2|Open Label Phase|Protocol Violation|1
111507|NCT00401245|369518|P1|Open Label Phase|Protocol Violation|0
111508|NCT00401245|369511|P8|Open Label Phase|Unspecified|0
111509|NCT00401245|369512|P7|Open Label Phase|Unspecified|0
111510|NCT00401245|369513|P6|Open Label Phase|Unspecified|0
111511|NCT00401245|369514|P5|Open Label Phase|Unspecified|0
111512|NCT00401245|369515|P4|Open Label Phase|Unspecified|8
111513|NCT00401245|369516|P3|Open Label Phase|Unspecified|7
111514|NCT00401245|369517|P2|Open Label Phase|Unspecified|8
111515|NCT00401245|369518|P1|Open Label Phase|Unspecified|4
111516|NCT00401245|369511|P8|Open Label Phase|Lost to Follow-up|0
111517|NCT00401245|369512|P7|Open Label Phase|Lost to Follow-up|0
111518|NCT00401245|369513|P6|Open Label Phase|Lost to Follow-up|0
111519|NCT00401245|369514|P5|Open Label Phase|Lost to Follow-up|0
111520|NCT00401245|369515|P4|Open Label Phase|Lost to Follow-up|4
111521|NCT00401245|369516|P3|Open Label Phase|Lost to Follow-up|5
111522|NCT00401245|369517|P2|Open Label Phase|Lost to Follow-up|7
111523|NCT00401245|369518|P1|Open Label Phase|Lost to Follow-up|5
111524|NCT00401245|369511|P8|Open Label Phase|Adverse Event|0
111525|NCT00401245|369512|P7|Open Label Phase|Adverse Event|0
111526|NCT00401245|369513|P6|Open Label Phase|Adverse Event|0
111527|NCT00401245|369514|P5|Open Label Phase|Adverse Event|0
111528|NCT00401245|369515|P4|Open Label Phase|Adverse Event|7
111529|NCT00401245|369516|P3|Open Label Phase|Adverse Event|6
111530|NCT00401245|369517|P2|Open Label Phase|Adverse Event|14
111531|NCT00401245|369518|P1|Open Label Phase|Adverse Event|5
111532|NCT00401245|369511|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
111533|NCT00401245|369512|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
111534|NCT00401245|369513|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
111535|NCT00401245|369514|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
111536|NCT00401245|369515|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
111537|NCT00401245|369516|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
111538|NCT00401245|369517|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
111539|NCT00401245|369518|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
111540|NCT00401245|369511|P8|Double Blind Titration Phase|Withdrawal by Subject|0
111541|NCT00401245|369512|P7|Double Blind Titration Phase|Withdrawal by Subject|0
111542|NCT00401245|369513|P6|Double Blind Titration Phase|Withdrawal by Subject|0
111543|NCT00401245|369514|P5|Double Blind Titration Phase|Withdrawal by Subject|0
111544|NCT00401245|369515|P4|Double Blind Titration Phase|Withdrawal by Subject|2
111545|NCT00401245|369516|P3|Double Blind Titration Phase|Withdrawal by Subject|0
111546|NCT00401245|369517|P2|Double Blind Titration Phase|Withdrawal by Subject|1
111547|NCT00401245|369518|P1|Double Blind Titration Phase|Withdrawal by Subject|1
111548|NCT00401245|369511|P8|Double Blind Titration Phase|Protocol Violation|0
111549|NCT00401245|369512|P7|Double Blind Titration Phase|Protocol Violation|0
111550|NCT00401245|369513|P6|Double Blind Titration Phase|Protocol Violation|0
111551|NCT00401245|369514|P5|Double Blind Titration Phase|Protocol Violation|0
111552|NCT00401245|369515|P4|Double Blind Titration Phase|Protocol Violation|1
111553|NCT00401245|369516|P3|Double Blind Titration Phase|Protocol Violation|0
111554|NCT00401245|369517|P2|Double Blind Titration Phase|Protocol Violation|0
111555|NCT00401245|369518|P1|Double Blind Titration Phase|Protocol Violation|0
111556|NCT00401245|369511|P8|Double Blind Titration Phase|Unspecified|0
111557|NCT00401245|369512|P7|Double Blind Titration Phase|Unspecified|0
111558|NCT00401245|369513|P6|Double Blind Titration Phase|Unspecified|0
111559|NCT00401245|369514|P5|Double Blind Titration Phase|Unspecified|0
111560|NCT00401245|369515|P4|Double Blind Titration Phase|Unspecified|0
111561|NCT00401245|369516|P3|Double Blind Titration Phase|Unspecified|1
111562|NCT00401245|369517|P2|Double Blind Titration Phase|Unspecified|0
111563|NCT00401245|369518|P1|Double Blind Titration Phase|Unspecified|0
111564|NCT00401245|369511|P8|Double Blind Titration Phase|Adverse Event|0
111565|NCT00401245|369512|P7|Double Blind Titration Phase|Adverse Event|0
111566|NCT00401245|369513|P6|Double Blind Titration Phase|Adverse Event|0
111567|NCT00401245|369514|P5|Double Blind Titration Phase|Adverse Event|0
111568|NCT00401245|369515|P4|Double Blind Titration Phase|Adverse Event|12
111569|NCT00401245|369516|P3|Double Blind Titration Phase|Adverse Event|5
111570|NCT00401245|369517|P2|Double Blind Titration Phase|Adverse Event|2
111571|NCT00401245|369518|P1|Double Blind Titration Phase|Adverse Event|3
111572|NCT00401258|369583|P1|Overall Study|Adverse Event|7
111573|NCT00401531|369643|P2|Overall Study|Withdrawal by Subject|2
111574|NCT00401531|369644|P1|Overall Study|Withdrawal by Subject|3
111575|NCT00401531|369643|P2|Overall Study|Lost to Follow-up|1
111576|NCT00401531|369644|P1|Overall Study|Lost to Follow-up|1
111577|NCT00401531|369643|P2|Overall Study|Protocol Violation|7
111578|NCT00401531|369644|P1|Overall Study|Protocol Violation|3
111579|NCT00401531|369643|P2|Overall Study|Adverse Event|0
111580|NCT00401531|369644|P1|Overall Study|Adverse Event|2
111581|NCT00401544|369664|P4|Overall Study|Other|2
111582|NCT00401544|369665|P3|Overall Study|Other|2
111583|NCT00401544|369666|P2|Overall Study|Other|0
111584|NCT00401544|369667|P1|Overall Study|Other|0
111585|NCT00401544|369664|P4|Overall Study|Disease progression|0
111586|NCT00401544|369665|P3|Overall Study|Disease progression|0
111587|NCT00401544|369666|P2|Overall Study|Disease progression|1
111588|NCT00401544|369667|P1|Overall Study|Disease progression|0
111589|NCT00401544|369664|P4|Overall Study|Ineligibility determined|2
111590|NCT00401544|369665|P3|Overall Study|Ineligibility determined|0
111591|NCT00401544|369666|P2|Overall Study|Ineligibility determined|1
111592|NCT00401544|369667|P1|Overall Study|Ineligibility determined|0
111593|NCT00401544|369664|P4|Overall Study|Physician Decision|0
111594|NCT00401544|369665|P3|Overall Study|Physician Decision|0
111595|NCT00401544|369666|P2|Overall Study|Physician Decision|3
111596|NCT00401544|369667|P1|Overall Study|Physician Decision|1
111597|NCT00401544|369664|P4|Overall Study|Withdrawal by Subject|5
111598|NCT00401544|369665|P3|Overall Study|Withdrawal by Subject|6
111599|NCT00401544|369666|P2|Overall Study|Withdrawal by Subject|6
111600|NCT00401544|369667|P1|Overall Study|Withdrawal by Subject|7
111601|NCT00401544|369664|P4|Overall Study|Lost to Follow-up|1
111602|NCT00401544|369665|P3|Overall Study|Lost to Follow-up|1
111603|NCT00401544|369666|P2|Overall Study|Lost to Follow-up|0
111604|NCT00401544|369667|P1|Overall Study|Lost to Follow-up|2
111605|NCT00401544|369664|P4|Overall Study|Death|5
111606|NCT00401544|369665|P3|Overall Study|Death|2
111607|NCT00401544|369666|P2|Overall Study|Death|6
111608|NCT00401544|369667|P1|Overall Study|Death|3
111609|NCT00401544|369664|P4|Overall Study|Adverse Event|1
111610|NCT00401544|369665|P3|Overall Study|Adverse Event|1
111611|NCT00401544|369666|P2|Overall Study|Adverse Event|1
111612|NCT00401544|369667|P1|Overall Study|Adverse Event|5
111613|NCT00401726|369718|P2|Overall Study|Protocol Deviation|4
111614|NCT00401726|369719|P1|Overall Study|Protocol Deviation|9
111615|NCT00401726|369718|P2|Overall Study|Lack of Efficacy|6
111616|NCT00401726|369719|P1|Overall Study|Lack of Efficacy|4
111617|NCT00401726|369718|P2|Overall Study|Withdrawal by Subject|24
111618|NCT00401726|369719|P1|Overall Study|Withdrawal by Subject|18
111619|NCT00401726|369718|P2|Overall Study|Protocol Violation|3
111620|NCT00401726|369719|P1|Overall Study|Protocol Violation|6
111621|NCT00401726|369718|P2|Overall Study|Lost to Follow-up|20
111622|NCT00401726|369719|P1|Overall Study|Lost to Follow-up|23
111623|NCT00401726|369718|P2|Overall Study|Physician Decision|6
111624|NCT00401726|369719|P1|Overall Study|Physician Decision|3
111625|NCT00401726|369718|P2|Overall Study|Sponsor Request|1
111626|NCT00401726|369719|P1|Overall Study|Sponsor Request|0
111627|NCT00401726|369718|P2|Overall Study|Death|3
111628|NCT00401726|369719|P1|Overall Study|Death|0
111629|NCT00401726|369718|P2|Overall Study|Adverse Event|45
111630|NCT00401726|369719|P1|Overall Study|Adverse Event|34
111631|NCT00401752|369741|P2|Overall Study|Physician Decision|1
111632|NCT00401752|369742|P1|Overall Study|Physician Decision|1
111633|NCT00401752|369741|P2|Overall Study|Development of any exclusion criteria|2
111634|NCT00401752|369742|P1|Overall Study|Development of any exclusion criteria|4
111635|NCT00401752|369741|P2|Overall Study|Lost to Follow-up|4
111636|NCT00401752|369742|P1|Overall Study|Lost to Follow-up|1
111637|NCT00401752|369741|P2|Overall Study|Withdrawal by Subject|6
111638|NCT00401752|369742|P1|Overall Study|Withdrawal by Subject|2
111639|NCT00401752|369741|P2|Overall Study|Adverse Event|5
111640|NCT00401752|369742|P1|Overall Study|Adverse Event|2
111641|NCT00401830|369777|P2|Overall Study|Other: Personal / Family problems|0
111642|NCT00401830|369778|P1|Overall Study|Other: Personal / Family problems|1
111643|NCT00401830|369777|P2|Overall Study|Lost to Follow-up|3
111644|NCT00401830|369778|P1|Overall Study|Lost to Follow-up|1
111645|NCT00401830|369777|P2|Overall Study|Non-compliance with drug study|0
111646|NCT00401830|369778|P1|Overall Study|Non-compliance with drug study|1
111647|NCT00401830|369777|P2|Overall Study|Protocol Violation|3
111648|NCT00401830|369778|P1|Overall Study|Protocol Violation|3
111649|NCT00401830|369777|P2|Overall Study|Withdrawal by Subject|3
111650|NCT00401830|369778|P1|Overall Study|Withdrawal by Subject|4
111651|NCT00401830|369777|P2|Overall Study|Lack of Efficacy|5
111652|NCT00401830|369778|P1|Overall Study|Lack of Efficacy|11
111653|NCT00401830|369777|P2|Overall Study|Adverse Event|18
111654|NCT00401830|369778|P1|Overall Study|Adverse Event|10
111655|NCT00401843|369813|P3|Overall Study|Received incorrect treatment|0
111656|NCT00401843|369814|P2|Overall Study|Received incorrect treatment|3
111657|NCT00401843|369815|P1|Overall Study|Received incorrect treatment|0
111658|NCT00401843|369813|P3|Overall Study|Randomized but not Treated|3
111659|NCT00401843|369814|P2|Overall Study|Randomized but not Treated|2
111660|NCT00401843|369815|P1|Overall Study|Randomized but not Treated|0
111661|NCT00401843|369813|P3|Overall Study|Withdrawal of consent to study agent|17
111662|NCT00401843|369814|P2|Overall Study|Withdrawal of consent to study agent|15
111663|NCT00401843|369815|P1|Overall Study|Withdrawal of consent to study agent|1
111664|NCT00401843|369813|P3|Overall Study|Withdrawal by Subject|5
111665|NCT00401843|369814|P2|Overall Study|Withdrawal by Subject|5
111666|NCT00401843|369815|P1|Overall Study|Withdrawal by Subject|1
111667|NCT00401843|369813|P3|Overall Study|Protocol Violation|1
111668|NCT00401843|369814|P2|Overall Study|Protocol Violation|0
111669|NCT00401843|369815|P1|Overall Study|Protocol Violation|0
111670|NCT00401843|369813|P3|Overall Study|Physician Decision|10
111671|NCT00401843|369814|P2|Overall Study|Physician Decision|16
111672|NCT00401843|369815|P1|Overall Study|Physician Decision|0
111673|NCT00401843|369813|P3|Overall Study|Other Unspecified|5
111674|NCT00401843|369814|P2|Overall Study|Other Unspecified|3
111675|NCT00401843|369815|P1|Overall Study|Other Unspecified|0
111676|NCT00401843|369813|P3|Overall Study|Lost to Follow-up|2
111677|NCT00401843|369814|P2|Overall Study|Lost to Follow-up|0
111678|NCT00401843|369815|P1|Overall Study|Lost to Follow-up|0
111679|NCT00401843|369813|P3|Overall Study|End of Study|2
111680|NCT00401843|369814|P2|Overall Study|End of Study|1
111681|NCT00401843|369815|P1|Overall Study|End of Study|1
111682|NCT00401843|369813|P3|Overall Study|Disease progression|49
111683|NCT00401843|369814|P2|Overall Study|Disease progression|60
111684|NCT00401843|369815|P1|Overall Study|Disease progression|10
111685|NCT00401843|369813|P3|Overall Study|Death|10
111686|NCT00401843|369814|P2|Overall Study|Death|8
111687|NCT00401843|369815|P1|Overall Study|Death|0
111688|NCT00401843|369813|P3|Overall Study|Adverse Event|27
111689|NCT00401843|369814|P2|Overall Study|Adverse Event|26
111690|NCT00401843|369815|P1|Overall Study|Adverse Event|7
111691|NCT00401843|369813|P3|Overall Study|Achieved Complete Response|11
111692|NCT00401843|369814|P2|Overall Study|Achieved Complete Response|5
111693|NCT00401843|369815|P1|Overall Study|Achieved Complete Response|1
111694|NCT00401960|369852|P2|Overall Study|Death|0
111695|NCT00401960|369853|P1|Overall Study|Death|2
111696|NCT00401960|369852|P2|Overall Study|Lost to Follow-up|0
111697|NCT00401960|369853|P1|Overall Study|Lost to Follow-up|3
111698|NCT00407797|369861|P1|Overall Study|Withdrawal by Subject|3
111699|NCT00407797|369861|P1|Overall Study|Unspecified|7
111700|NCT00407797|369861|P1|Overall Study|Adverse Event|6
111701|NCT00407797|369861|P1|Overall Study|Lost to Follow-up|2
111702|NCT00408876|369896|P4|Overall Study|Physician Decision|0
111703|NCT00408876|369897|P3|Overall Study|Physician Decision|3
111704|NCT00408876|369898|P2|Overall Study|Physician Decision|0
111705|NCT00408876|369899|P1|Overall Study|Physician Decision|1
111706|NCT00408876|369896|P4|Overall Study|Protocol Violation|3
111707|NCT00408876|369897|P3|Overall Study|Protocol Violation|4
111708|NCT00408876|369898|P2|Overall Study|Protocol Violation|3
111709|NCT00408876|369899|P1|Overall Study|Protocol Violation|0
111710|NCT00408876|369896|P4|Overall Study|Lost to Follow-up|2
111711|NCT00408876|369897|P3|Overall Study|Lost to Follow-up|5
111712|NCT00408876|369898|P2|Overall Study|Lost to Follow-up|6
111713|NCT00408876|369899|P1|Overall Study|Lost to Follow-up|1
111714|NCT00408876|369896|P4|Overall Study|Lack of Efficacy|6
111715|NCT00408876|369897|P3|Overall Study|Lack of Efficacy|5
111716|NCT00408876|369898|P2|Overall Study|Lack of Efficacy|4
111717|NCT00408876|369899|P1|Overall Study|Lack of Efficacy|2
111718|NCT00408876|369896|P4|Overall Study|Withdrawal by Subject|14
111719|NCT00408876|369897|P3|Overall Study|Withdrawal by Subject|6
111720|NCT00408876|369898|P2|Overall Study|Withdrawal by Subject|6
111721|NCT00408876|369899|P1|Overall Study|Withdrawal by Subject|3
111722|NCT00408876|369896|P4|Overall Study|Adverse Event|10
111723|NCT00408876|369897|P3|Overall Study|Adverse Event|27
111724|NCT00408876|369898|P2|Overall Study|Adverse Event|17
111725|NCT00408876|369899|P1|Overall Study|Adverse Event|9
111726|NCT00408902|370149|P1|Overall Study|Adverse Event|3
111727|NCT00408902|370149|P1|Overall Study|Lack of Efficacy|7
111728|NCT00408928|370154|P1|Overall Study|Infection indistinguishable from GVHD|1
111729|NCT00408928|370154|P1|Overall Study|Death|1
111730|NCT00408928|370154|P1|Overall Study|Withdrawal by Subject|1
111731|NCT00408993|370161|P2|Overall Study|Withdrawal by Subject|3
111732|NCT00408993|370162|P1|Overall Study|Withdrawal by Subject|2
111733|NCT00408993|370161|P2|Overall Study|Lack of Efficacy|4
111734|NCT00408993|370162|P1|Overall Study|Lack of Efficacy|1
111735|NCT00408993|370161|P2|Overall Study|Protocol Violation|6
111736|NCT00408993|370162|P1|Overall Study|Protocol Violation|1
111737|NCT00408993|370161|P2|Overall Study|Adverse Event|4
111738|NCT00408993|370162|P1|Overall Study|Adverse Event|15
111739|NCT00409006|370196|P2|Overall Study|Physician Decision|2
111740|NCT00409006|370197|P1|Overall Study|Physician Decision|1
111741|NCT00409006|370196|P2|Overall Study|Withdrawal by Subject|2
111742|NCT00409006|370197|P1|Overall Study|Withdrawal by Subject|3
111743|NCT00409006|370196|P2|Overall Study|Lost to Follow-up|2
111744|NCT00409006|370197|P1|Overall Study|Lost to Follow-up|1
111745|NCT00409006|370196|P2|Overall Study|Death|6
111746|NCT00409006|370197|P1|Overall Study|Death|15
111747|NCT00409175|370213|P2|Overall Study|Liver transplantation|13
111748|NCT00409175|370214|P1|Overall Study|Liver transplantation|13
111749|NCT00409175|370213|P2|Overall Study|Negative genotype|1
111750|NCT00409175|370214|P1|Overall Study|Negative genotype|0
111751|NCT00409175|370213|P2|Overall Study|Withdrawal by Subject|2
111752|NCT00409175|370214|P1|Overall Study|Withdrawal by Subject|1
111753|NCT00409175|370213|P2|Overall Study|Adverse Event|3
111754|NCT00409175|370214|P1|Overall Study|Adverse Event|4
111755|NCT00409188|370240|P2|Overall Study|Ongoing at data cut-off|175
111756|NCT00409188|370241|P1|Overall Study|Ongoing at data cut-off|383
111757|NCT00409331|370271|P1|Overall Study|Physician Decision|1
111758|NCT00409344|370277|P2|Overall Study|no enrollment|0
111759|NCT00409344|370278|P1|Overall Study|no enrollment|0
111760|NCT00409409|370298|P2|Overall Study|Any other reason not above-mentioned|1
111761|NCT00409409|370299|P1|Overall Study|Any other reason not above-mentioned|0
111762|NCT00409409|370298|P2|Overall Study|Withdrawal by Subject|1
111763|NCT00409409|370299|P1|Overall Study|Withdrawal by Subject|1
111764|NCT00409409|370298|P2|Overall Study|Adverse Event|2
111765|NCT00409409|370299|P1|Overall Study|Adverse Event|7
111766|NCT00409578|370343|P4|Overall Study|Missing|1
111767|NCT00409578|370344|P3|Overall Study|Missing|0
111768|NCT00409578|370345|P2|Overall Study|Missing|1
111769|NCT00409578|370346|P1|Overall Study|Missing|0
111770|NCT00409578|370343|P4|Overall Study|Protocol Violation|1
111771|NCT00409578|370344|P3|Overall Study|Protocol Violation|3
111772|NCT00409578|370345|P2|Overall Study|Protocol Violation|2
111773|NCT00409578|370346|P1|Overall Study|Protocol Violation|3
111774|NCT00409578|370343|P4|Overall Study|Death|2
111775|NCT00409578|370344|P3|Overall Study|Death|4
111776|NCT00409578|370345|P2|Overall Study|Death|4
111777|NCT00409578|370346|P1|Overall Study|Death|2
111778|NCT00409578|370343|P4|Overall Study|Administrative problems|4
111779|NCT00409578|370344|P3|Overall Study|Administrative problems|2
111780|NCT00409578|370345|P2|Overall Study|Administrative problems|9
111781|NCT00409578|370346|P1|Overall Study|Administrative problems|8
111782|NCT00409578|370343|P4|Overall Study|Lost to Follow-up|2
111783|NCT00409578|370344|P3|Overall Study|Lost to Follow-up|2
111784|NCT00409578|370345|P2|Overall Study|Lost to Follow-up|0
111785|NCT00409578|370346|P1|Overall Study|Lost to Follow-up|2
111786|NCT00409578|370343|P4|Overall Study|Withdrawal by Subject|17
111787|NCT00409578|370344|P3|Overall Study|Withdrawal by Subject|16
111788|NCT00409578|370345|P2|Overall Study|Withdrawal by Subject|15
111789|NCT00409578|370346|P1|Overall Study|Withdrawal by Subject|8
111790|NCT00409578|370343|P4|Overall Study|Subject no longer requires study drug|1
111791|NCT00409578|370344|P3|Overall Study|Subject no longer requires study drug|0
111792|NCT00409578|370345|P2|Overall Study|Subject no longer requires study drug|0
111793|NCT00409578|370346|P1|Overall Study|Subject no longer requires study drug|0
111794|NCT00409578|370343|P4|Overall Study|Lack of Efficacy|2
111795|NCT00409578|370344|P3|Overall Study|Lack of Efficacy|0
111796|NCT00409578|370345|P2|Overall Study|Lack of Efficacy|0
111797|NCT00409578|370346|P1|Overall Study|Lack of Efficacy|0
111798|NCT00409578|370343|P4|Overall Study|Abnormal laboratory value(s)|4
111799|NCT00409578|370344|P3|Overall Study|Abnormal laboratory value(s)|2
111800|NCT00409578|370345|P2|Overall Study|Abnormal laboratory value(s)|2
111801|NCT00409578|370346|P1|Overall Study|Abnormal laboratory value(s)|2
111802|NCT00409578|370343|P4|Overall Study|Adverse Event|33
111803|NCT00409578|370344|P3|Overall Study|Adverse Event|25
111804|NCT00409578|370345|P2|Overall Study|Adverse Event|37
111805|NCT00409578|370346|P1|Overall Study|Adverse Event|27
111806|NCT00409617|370368|P1|Overall Study|Not described|14
111807|NCT00409617|370368|P1|Overall Study|Administrative reasons|1
111808|NCT00409617|370368|P1|Overall Study|Withdrawal by Subject|8
111809|NCT00409617|370368|P1|Overall Study|Protocol Violation|24
111810|NCT00409617|370368|P1|Overall Study|Lost to Follow-up|2
111811|NCT00409617|370368|P1|Overall Study|Lack of Efficacy|54
111812|NCT00409617|370368|P1|Overall Study|Adverse Event|57
111813|NCT00409682|370383|P3|EOW Double-blind Maintenance Period|Non-compliance|1
111814|NCT00409682|370384|P2|EOW Double-blind Maintenance Period|Non-compliance|0
111815|NCT00409682|370385|P1|EOW Double-blind Maintenance Period|Non-compliance|0
111816|NCT00409682|370383|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
111817|NCT00409682|370384|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
111818|NCT00409682|370385|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
111819|NCT00409682|370383|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
111820|NCT00409682|370384|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
111821|NCT00409682|370385|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
111822|NCT00409682|370383|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
111823|NCT00409682|370384|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
111824|NCT00409682|370385|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
111825|NCT00409682|370383|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
111826|NCT00409682|370384|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
111827|NCT00409682|370385|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
111828|NCT00409682|370383|P3|EOW Double-blind Maintenance Period|Adverse Event|12
111829|NCT00409682|370384|P2|EOW Double-blind Maintenance Period|Adverse Event|10
111830|NCT00409682|370385|P1|EOW Double-blind Maintenance Period|Adverse Event|0
111831|NCT00409682|370383|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
111832|NCT00409682|370384|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
111833|NCT00409682|370385|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
111834|NCT00409682|370383|P3|Open-label Induction Period|Protocol Violation|0
111835|NCT00409682|370384|P2|Open-label Induction Period|Protocol Violation|0
111836|NCT00409682|370385|P1|Open-label Induction Period|Protocol Violation|1
111837|NCT00409682|370383|P3|Open-label Induction Period|Lack of Efficacy|0
111838|NCT00409682|370384|P2|Open-label Induction Period|Lack of Efficacy|0
111839|NCT00409682|370385|P1|Open-label Induction Period|Lack of Efficacy|1
111840|NCT00409682|370383|P3|Open-label Induction Period|Adverse Event|0
111841|NCT00409682|370384|P2|Open-label Induction Period|Adverse Event|0
111842|NCT00409682|370385|P1|Open-label Induction Period|Adverse Event|1
111843|NCT00409708|370404|P2|Washout|Lost to Follow-up|3
111844|NCT00409708|370405|P1|Washout|Lost to Follow-up|1
111845|NCT00409708|370404|P2|Washout|Withdrawal by Subject|5
111846|NCT00409708|370405|P1|Washout|Withdrawal by Subject|11
111847|NCT00409708|370404|P2|Washout|Protocol Violation|1
111848|NCT00409708|370405|P1|Washout|Protocol Violation|0
111849|NCT00409708|370404|P2|Washout|Lack of Efficacy|1
111850|NCT00409708|370405|P1|Washout|Lack of Efficacy|9
111851|NCT00409708|370404|P2|Treatment|Administrative problems|0
111852|NCT00409708|370405|P1|Treatment|Administrative problems|5
111853|NCT00409708|370404|P2|Treatment|Lost to Follow-up|6
111854|NCT00409708|370405|P1|Treatment|Lost to Follow-up|0
111855|NCT00409708|370404|P2|Treatment|Withdrawal by Subject|8
111856|NCT00409708|370405|P1|Treatment|Withdrawal by Subject|3
111857|NCT00409708|370404|P2|Treatment|Protocol Violation|2
111858|NCT00409708|370405|P1|Treatment|Protocol Violation|6
111859|NCT00409708|370404|P2|Treatment|Lack of Efficacy|1
111860|NCT00409708|370405|P1|Treatment|Lack of Efficacy|0
111861|NCT00409708|370404|P2|Treatment|Abnormal test procedure result(s)|0
111862|NCT00409708|370405|P1|Treatment|Abnormal test procedure result(s)|1
111863|NCT00409747|370423|P1|Overall Study|Withdrawal by Subject|1
111864|NCT00409773|370433|P5|Overall Study|Lack of Eligibility|1
111865|NCT00409773|370434|P4|Overall Study|Lack of Eligibility|0
111866|NCT00409773|370435|P3|Overall Study|Lack of Eligibility|0
111867|NCT00409773|370436|P2|Overall Study|Lack of Eligibility|0
111868|NCT00409773|370437|P1|Overall Study|Lack of Eligibility|0
111869|NCT00409773|370433|P5|Overall Study|Withdrawal by Subject|1
111870|NCT00409773|370434|P4|Overall Study|Withdrawal by Subject|2
111871|NCT00409773|370435|P3|Overall Study|Withdrawal by Subject|0
111872|NCT00409773|370436|P2|Overall Study|Withdrawal by Subject|0
111873|NCT00409773|370437|P1|Overall Study|Withdrawal by Subject|0
111874|NCT00409773|370433|P5|Overall Study|Protocol Violation|1
111875|NCT00409773|370434|P4|Overall Study|Protocol Violation|3
111876|NCT00409773|370435|P3|Overall Study|Protocol Violation|3
111877|NCT00409773|370436|P2|Overall Study|Protocol Violation|2
111878|NCT00409773|370437|P1|Overall Study|Protocol Violation|0
111879|NCT00409773|370433|P5|Overall Study|Physician Decision|0
111880|NCT00409773|370434|P4|Overall Study|Physician Decision|2
111881|NCT00409773|370435|P3|Overall Study|Physician Decision|0
111882|NCT00409773|370436|P2|Overall Study|Physician Decision|0
111883|NCT00409773|370437|P1|Overall Study|Physician Decision|0
111884|NCT00409773|370433|P5|Overall Study|Lost to Follow-up|1
111885|NCT00409773|370434|P4|Overall Study|Lost to Follow-up|3
111886|NCT00409773|370435|P3|Overall Study|Lost to Follow-up|2
111887|NCT00409773|370436|P2|Overall Study|Lost to Follow-up|1
111888|NCT00409773|370437|P1|Overall Study|Lost to Follow-up|6
111889|NCT00409773|370433|P5|Overall Study|Adverse Event|6
111890|NCT00409773|370434|P4|Overall Study|Adverse Event|2
111891|NCT00409773|370435|P3|Overall Study|Adverse Event|4
111892|NCT00409773|370436|P2|Overall Study|Adverse Event|4
111893|NCT00409773|370437|P1|Overall Study|Adverse Event|3
111894|NCT00409786|370519|P1|Overall Study|Withdrawal by Subject|3
111895|NCT00409838|370529|P2|Long-term Extension Period|Pregnancy|0
111896|NCT00409838|370530|P1|Long-term Extension Period|Pregnancy|1
111897|NCT00409838|370529|P2|Long-term Extension Period|Poor compliance/noncompliance|0
111898|NCT00409838|370530|P1|Long-term Extension Period|Poor compliance/noncompliance|1
111899|NCT00409838|370529|P2|Long-term Extension Period|Withdrawal by Subject|0
111900|NCT00409838|370530|P1|Long-term Extension Period|Withdrawal by Subject|3
111901|NCT00409838|370529|P2|Long-term Extension Period|Lack of Efficacy|0
111902|NCT00409838|370530|P1|Long-term Extension Period|Lack of Efficacy|2
111903|NCT00409838|370529|P2|Long-term Extension Period|Death|0
111904|NCT00409838|370530|P1|Long-term Extension Period|Death|1
111905|NCT00409838|370529|P2|Long-term Extension Period|Adverse Event|0
111906|NCT00409838|370530|P1|Long-term Extension Period|Adverse Event|10
111907|NCT00409838|370529|P2|Short-term Period|Never Treated|0
111908|NCT00409838|370530|P1|Short-term Period|Never Treated|1
111909|NCT00409838|370529|P2|Short-term Period|Withdrawal by Subject|3
111910|NCT00409838|370530|P1|Short-term Period|Withdrawal by Subject|2
111911|NCT00409838|370529|P2|Short-term Period|Lost to Follow-up|1
111912|NCT00409838|370530|P1|Short-term Period|Lost to Follow-up|0
111913|NCT00409838|370529|P2|Short-term Period|Adverse Event|1
111914|NCT00409838|370530|P1|Short-term Period|Adverse Event|0
111915|NCT00410046|370591|P1|Overall Study|Lost to Follow-up|1
111916|NCT00410046|370591|P1|Overall Study|Withdrawal by Subject|1
111917|NCT00410046|370591|P1|Overall Study|Adverse Event|3
111918|NCT00410072|370626|P2|After Week 48 to Week 96|Withdrawal by Subject|1
111919|NCT00410072|370627|P1|After Week 48 to Week 96|Withdrawal by Subject|0
111920|NCT00410072|370626|P2|After Week 48 to Week 96|Pregnancy|2
111921|NCT00410072|370627|P1|After Week 48 to Week 96|Pregnancy|0
111922|NCT00410072|370626|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
111923|NCT00410072|370627|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
111924|NCT00410072|370626|P2|After Week 48 to Week 96|Not specified|0
111925|NCT00410072|370627|P1|After Week 48 to Week 96|Not specified|2
111926|NCT00410072|370626|P2|After Week 48 to Week 96|Lost to Follow-up|4
111927|NCT00410072|370627|P1|After Week 48 to Week 96|Lost to Follow-up|2
111928|NCT00410072|370626|P2|After Week 48 to Week 96|Lack of Efficacy|0
111929|NCT00410072|370627|P1|After Week 48 to Week 96|Lack of Efficacy|1
111930|NCT00410072|370626|P2|After Week 48 to Week 96|Death|1
111931|NCT00410072|370627|P1|After Week 48 to Week 96|Death|0
111932|NCT00410072|370626|P2|After Week 48 to Week 96|Adverse Event|2
111933|NCT00410072|370627|P1|After Week 48 to Week 96|Adverse Event|1
111934|NCT00410072|370626|P2|Day 1 to Week 48|Withdrawal by Subject|2
111935|NCT00410072|370627|P1|Day 1 to Week 48|Withdrawal by Subject|0
111936|NCT00410072|370626|P2|Day 1 to Week 48|Pregnancy|2
111937|NCT00410072|370627|P1|Day 1 to Week 48|Pregnancy|0
111938|NCT00410072|370626|P2|Day 1 to Week 48|poor compliance/noncompliance|3
111939|NCT00410072|370627|P1|Day 1 to Week 48|poor compliance/noncompliance|0
111940|NCT00410072|370626|P2|Day 1 to Week 48|Not specified|1
111941|NCT00410072|370627|P1|Day 1 to Week 48|Not specified|0
111942|NCT00410072|370626|P2|Day 1 to Week 48|Lost to Follow-up|2
111943|NCT00410072|370627|P1|Day 1 to Week 48|Lost to Follow-up|5
111944|NCT00410072|370626|P2|Day 1 to Week 48|Adverse Event|2
111945|NCT00410072|370627|P1|Day 1 to Week 48|Adverse Event|1
111946|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
111947|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
111948|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
111949|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
111950|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
111951|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
111952|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Death|10
111953|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Death|2
111954|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
111955|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
111956|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
111957|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
111958|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
111959|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
111960|NCT00410124|370665|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
111961|NCT00410124|370666|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
111962|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
111963|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
111964|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Death|4
111965|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Death|7
111966|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
111967|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
111968|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
111969|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
111970|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
111971|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
111972|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
111973|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
111974|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
111975|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
111976|NCT00410124|370665|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
111977|NCT00410124|370666|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
111978|NCT00410163|370706|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
111979|NCT00410163|370707|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
111980|NCT00410163|370706|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
111981|NCT00410163|370707|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
111982|NCT00410163|370706|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
111983|NCT00410163|370707|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
111984|NCT00410163|370706|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
111985|NCT00410163|370707|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
111986|NCT00410163|370706|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
111987|NCT00410163|370707|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
111988|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
111989|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
111990|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
111991|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
111992|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
111993|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
111994|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
111995|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
111996|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
111997|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
111998|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
111999|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
112000|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
112001|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
112002|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Death|1
112003|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Death|1
112004|NCT00410163|370706|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
112005|NCT00410163|370707|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
112006|NCT00410202|370757|P3|Off-treatment Follow up|Lost to Follow-up|0
112007|NCT00410202|370758|P2|Off-treatment Follow up|Lost to Follow-up|0
112008|NCT00410202|370759|P1|Off-treatment Follow up|Lost to Follow-up|1
112009|NCT00410202|370757|P3|Off-treatment Follow up|Follow up not required per protocol|1
112010|NCT00410202|370758|P2|Off-treatment Follow up|Follow up not required per protocol|0
112011|NCT00410202|370759|P1|Off-treatment Follow up|Follow up not required per protocol|3
112012|NCT00410202|370757|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
112013|NCT00410202|370758|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
112014|NCT00410202|370759|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
112015|NCT00410202|370757|P3|On-Treatment|Other Reason|1
112016|NCT00410202|370758|P2|On-Treatment|Other Reason|0
112017|NCT00410202|370759|P1|On-Treatment|Other Reason|0
112018|NCT00410202|370757|P3|On-Treatment|Withdrawal by Subject|1
112019|NCT00410202|370758|P2|On-Treatment|Withdrawal by Subject|1
112020|NCT00410202|370759|P1|On-Treatment|Withdrawal by Subject|2
112021|NCT00410202|370757|P3|On-Treatment|Lack of Efficacy|0
112022|NCT00410202|370758|P2|On-Treatment|Lack of Efficacy|4
112023|NCT00410202|370759|P1|On-Treatment|Lack of Efficacy|1
112024|NCT00410202|370757|P3|On-Treatment|Lost to Follow-up|1
112025|NCT00410202|370758|P2|On-Treatment|Lost to Follow-up|0
112026|NCT00410202|370759|P1|On-Treatment|Lost to Follow-up|1
112027|NCT00410202|370757|P3|On-Treatment|Death|0
112028|NCT00410202|370758|P2|On-Treatment|Death|0
112029|NCT00410202|370759|P1|On-Treatment|Death|1
112030|NCT00410202|370757|P3|On-Treatment|Adverse Event|2
112031|NCT00410202|370758|P2|On-Treatment|Adverse Event|3
112032|NCT00410202|370759|P1|On-Treatment|Adverse Event|1
112033|NCT00410202|370757|P3|On-Treatment|Continuing treatment|66
112034|NCT00410202|370758|P2|On-Treatment|Continuing treatment|71
112035|NCT00410202|370759|P1|On-Treatment|Continuing treatment|69
112036|NCT00410384|370886|P3|Overall Study|Other|4
112037|NCT00410384|370887|P2|Overall Study|Other|8
112038|NCT00410384|370888|P1|Overall Study|Other|3
112039|NCT00410384|370886|P3|Overall Study|Physician Decision|4
112040|NCT00410384|370887|P2|Overall Study|Physician Decision|3
112041|NCT00410384|370888|P1|Overall Study|Physician Decision|3
112042|NCT00410384|370886|P3|Overall Study|Protocol Violation|6
112043|NCT00410384|370887|P2|Overall Study|Protocol Violation|6
112044|NCT00410384|370888|P1|Overall Study|Protocol Violation|6
112045|NCT00410384|370886|P3|Overall Study|Lost to Follow-up|6
112046|NCT00410384|370887|P2|Overall Study|Lost to Follow-up|6
112047|NCT00410384|370888|P1|Overall Study|Lost to Follow-up|4
112048|NCT00410384|370886|P3|Overall Study|Lack of Compliance|2
112049|NCT00410384|370887|P2|Overall Study|Lack of Compliance|2
112050|NCT00410384|370888|P1|Overall Study|Lack of Compliance|2
112051|NCT00410384|370886|P3|Overall Study|Lack of Efficacy|17
112052|NCT00410384|370887|P2|Overall Study|Lack of Efficacy|12
112053|NCT00410384|370888|P1|Overall Study|Lack of Efficacy|20
112054|NCT00410384|370886|P3|Overall Study|Adverse Event|23
112055|NCT00410384|370887|P2|Overall Study|Adverse Event|18
112056|NCT00410384|370888|P1|Overall Study|Adverse Event|23
112057|NCT00410384|370886|P3|Overall Study|Withdrawal by Subject|20
112058|NCT00410384|370887|P2|Overall Study|Withdrawal by Subject|17
112059|NCT00410384|370888|P1|Overall Study|Withdrawal by Subject|28
112060|NCT00410410|370920|P9|Open-Label Period (OL)|not specified|7
112061|NCT00410410|370921|P8|Open-Label Period (OL)|not specified|0
112062|NCT00410410|370922|P7|Open-Label Period (OL)|not specified|0
112063|NCT00410410|370923|P6|Open-Label Period (OL)|not specified|0
112064|NCT00410410|370924|P5|Open-Label Period (OL)|not specified|0
112065|NCT00410410|370925|P4|Open-Label Period (OL)|not specified|0
112066|NCT00410410|370926|P3|Open-Label Period (OL)|not specified|0
112067|NCT00410410|370927|P2|Open-Label Period (OL)|not specified|0
112068|NCT00410410|370928|P1|Open-Label Period (OL)|not specified|0
112069|NCT00410410|370920|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
112070|NCT00410410|370921|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112071|NCT00410410|370922|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112072|NCT00410410|370923|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112073|NCT00410410|370924|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112074|NCT00410410|370925|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112075|NCT00410410|370926|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112076|NCT00410410|370927|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112077|NCT00410410|370928|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
112078|NCT00410410|370920|P9|Open-Label Period (OL)|Pregnancy|1
112079|NCT00410410|370921|P8|Open-Label Period (OL)|Pregnancy|0
112080|NCT00410410|370922|P7|Open-Label Period (OL)|Pregnancy|0
112081|NCT00410410|370923|P6|Open-Label Period (OL)|Pregnancy|0
112082|NCT00410410|370924|P5|Open-Label Period (OL)|Pregnancy|0
112083|NCT00410410|370925|P4|Open-Label Period (OL)|Pregnancy|0
112084|NCT00410410|370926|P3|Open-Label Period (OL)|Pregnancy|0
112085|NCT00410410|370927|P2|Open-Label Period (OL)|Pregnancy|0
112086|NCT00410410|370928|P1|Open-Label Period (OL)|Pregnancy|0
112087|NCT00410410|370920|P9|Open-Label Period (OL)|Withdrawal by Subject|20
112088|NCT00410410|370921|P8|Open-Label Period (OL)|Withdrawal by Subject|0
112089|NCT00410410|370922|P7|Open-Label Period (OL)|Withdrawal by Subject|0
112090|NCT00410410|370923|P6|Open-Label Period (OL)|Withdrawal by Subject|0
112091|NCT00410410|370924|P5|Open-Label Period (OL)|Withdrawal by Subject|0
112092|NCT00410410|370925|P4|Open-Label Period (OL)|Withdrawal by Subject|0
112093|NCT00410410|370926|P3|Open-Label Period (OL)|Withdrawal by Subject|0
112094|NCT00410410|370927|P2|Open-Label Period (OL)|Withdrawal by Subject|0
112095|NCT00410410|370928|P1|Open-Label Period (OL)|Withdrawal by Subject|0
112096|NCT00410410|370920|P9|Open-Label Period (OL)|Lost to Follow-up|4
112097|NCT00410410|370921|P8|Open-Label Period (OL)|Lost to Follow-up|0
112098|NCT00410410|370922|P7|Open-Label Period (OL)|Lost to Follow-up|0
112099|NCT00410410|370923|P6|Open-Label Period (OL)|Lost to Follow-up|0
112100|NCT00410410|370924|P5|Open-Label Period (OL)|Lost to Follow-up|0
112101|NCT00410410|370925|P4|Open-Label Period (OL)|Lost to Follow-up|0
112102|NCT00410410|370926|P3|Open-Label Period (OL)|Lost to Follow-up|0
112103|NCT00410410|370927|P2|Open-Label Period (OL)|Lost to Follow-up|0
112104|NCT00410410|370928|P1|Open-Label Period (OL)|Lost to Follow-up|0
112105|NCT00410410|370920|P9|Open-Label Period (OL)|Lack of Efficacy|161
112106|NCT00410410|370921|P8|Open-Label Period (OL)|Lack of Efficacy|0
112107|NCT00410410|370922|P7|Open-Label Period (OL)|Lack of Efficacy|0
112108|NCT00410410|370923|P6|Open-Label Period (OL)|Lack of Efficacy|0
112109|NCT00410410|370924|P5|Open-Label Period (OL)|Lack of Efficacy|0
112110|NCT00410410|370925|P4|Open-Label Period (OL)|Lack of Efficacy|0
112111|NCT00410410|370926|P3|Open-Label Period (OL)|Lack of Efficacy|0
112112|NCT00410410|370927|P2|Open-Label Period (OL)|Lack of Efficacy|0
112113|NCT00410410|370928|P1|Open-Label Period (OL)|Lack of Efficacy|0
112114|NCT00410410|370920|P9|Open-Label Period (OL)|Adverse Event|10
112115|NCT00410410|370921|P8|Open-Label Period (OL)|Adverse Event|0
112116|NCT00410410|370922|P7|Open-Label Period (OL)|Adverse Event|0
112117|NCT00410410|370923|P6|Open-Label Period (OL)|Adverse Event|0
112118|NCT00410410|370924|P5|Open-Label Period (OL)|Adverse Event|0
112119|NCT00410410|370925|P4|Open-Label Period (OL)|Adverse Event|0
112120|NCT00410410|370926|P3|Open-Label Period (OL)|Adverse Event|0
112121|NCT00410410|370927|P2|Open-Label Period (OL)|Adverse Event|0
112122|NCT00410410|370928|P1|Open-Label Period (OL)|Adverse Event|0
112123|NCT00410410|370920|P9|Open-Label Period (OL)|Death|1
112124|NCT00410410|370921|P8|Open-Label Period (OL)|Death|0
112125|NCT00410410|370922|P7|Open-Label Period (OL)|Death|0
112126|NCT00410410|370923|P6|Open-Label Period (OL)|Death|0
112127|NCT00410410|370924|P5|Open-Label Period (OL)|Death|0
112128|NCT00410410|370925|P4|Open-Label Period (OL)|Death|0
112129|NCT00410410|370926|P3|Open-Label Period (OL)|Death|0
112130|NCT00410410|370927|P2|Open-Label Period (OL)|Death|0
112131|NCT00410410|370928|P1|Open-Label Period (OL)|Death|0
112132|NCT00410410|370920|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112133|NCT00410410|370921|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
112134|NCT00410410|370922|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
112135|NCT00410410|370923|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112136|NCT00410410|370924|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112137|NCT00410410|370925|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112138|NCT00410410|370926|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112139|NCT00410410|370927|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112140|NCT00410410|370928|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
112141|NCT00410410|370920|P9|Maintenance Period (MP)|Withdrawal by Subject|0
112142|NCT00410410|370921|P8|Maintenance Period (MP)|Withdrawal by Subject|1
112143|NCT00410410|370922|P7|Maintenance Period (MP)|Withdrawal by Subject|1
112144|NCT00410410|370923|P6|Maintenance Period (MP)|Withdrawal by Subject|0
112145|NCT00410410|370924|P5|Maintenance Period (MP)|Withdrawal by Subject|0
112146|NCT00410410|370925|P4|Maintenance Period (MP)|Withdrawal by Subject|0
112147|NCT00410410|370926|P3|Maintenance Period (MP)|Withdrawal by Subject|0
112148|NCT00410410|370927|P2|Maintenance Period (MP)|Withdrawal by Subject|0
112149|NCT00410410|370928|P1|Maintenance Period (MP)|Withdrawal by Subject|0
112150|NCT00410410|370920|P9|Maintenance Period (MP)|Lost to Follow-up|0
112151|NCT00410410|370921|P8|Maintenance Period (MP)|Lost to Follow-up|2
112152|NCT00410410|370922|P7|Maintenance Period (MP)|Lost to Follow-up|1
112153|NCT00410410|370923|P6|Maintenance Period (MP)|Lost to Follow-up|0
112154|NCT00410410|370924|P5|Maintenance Period (MP)|Lost to Follow-up|0
112155|NCT00410410|370925|P4|Maintenance Period (MP)|Lost to Follow-up|0
112156|NCT00410410|370926|P3|Maintenance Period (MP)|Lost to Follow-up|0
112157|NCT00410410|370927|P2|Maintenance Period (MP)|Lost to Follow-up|0
112158|NCT00410410|370928|P1|Maintenance Period (MP)|Lost to Follow-up|0
112159|NCT00410410|370920|P9|Maintenance Period (MP)|Lack of Efficacy|0
112160|NCT00410410|370921|P8|Maintenance Period (MP)|Lack of Efficacy|24
112161|NCT00410410|370922|P7|Maintenance Period (MP)|Lack of Efficacy|25
112162|NCT00410410|370923|P6|Maintenance Period (MP)|Lack of Efficacy|0
112163|NCT00410410|370924|P5|Maintenance Period (MP)|Lack of Efficacy|0
112164|NCT00410410|370925|P4|Maintenance Period (MP)|Lack of Efficacy|0
112165|NCT00410410|370926|P3|Maintenance Period (MP)|Lack of Efficacy|0
112166|NCT00410410|370927|P2|Maintenance Period (MP)|Lack of Efficacy|0
112167|NCT00410410|370928|P1|Maintenance Period (MP)|Lack of Efficacy|0
112168|NCT00410410|370920|P9|Maintenance Period (MP)|Adverse Event|0
112169|NCT00410410|370921|P8|Maintenance Period (MP)|Adverse Event|3
112170|NCT00410410|370922|P7|Maintenance Period (MP)|Adverse Event|1
112171|NCT00410410|370923|P6|Maintenance Period (MP)|Adverse Event|0
112172|NCT00410410|370924|P5|Maintenance Period (MP)|Adverse Event|0
112173|NCT00410410|370925|P4|Maintenance Period (MP)|Adverse Event|0
112174|NCT00410410|370926|P3|Maintenance Period (MP)|Adverse Event|0
112175|NCT00410410|370927|P2|Maintenance Period (MP)|Adverse Event|0
112176|NCT00410410|370928|P1|Maintenance Period (MP)|Adverse Event|0
112177|NCT00410410|370920|P9|Maintenance Period (MP)|Death|0
112178|NCT00410410|370921|P8|Maintenance Period (MP)|Death|0
112179|NCT00410410|370922|P7|Maintenance Period (MP)|Death|1
112180|NCT00410410|370923|P6|Maintenance Period (MP)|Death|0
112181|NCT00410410|370924|P5|Maintenance Period (MP)|Death|0
112182|NCT00410410|370925|P4|Maintenance Period (MP)|Death|0
112183|NCT00410410|370926|P3|Maintenance Period (MP)|Death|0
112184|NCT00410410|370927|P2|Maintenance Period (MP)|Death|0
112185|NCT00410410|370928|P1|Maintenance Period (MP)|Death|0
112186|NCT00410410|370920|P9|Induction Period (IP)|not specified|0
112187|NCT00410410|370921|P8|Induction Period (IP)|not specified|0
112188|NCT00410410|370922|P7|Induction Period (IP)|not specified|0
112189|NCT00410410|370923|P6|Induction Period (IP)|not specified|0
112190|NCT00410410|370924|P5|Induction Period (IP)|not specified|0
112191|NCT00410410|370925|P4|Induction Period (IP)|not specified|0
112192|NCT00410410|370926|P3|Induction Period (IP)|not specified|1
112193|NCT00410410|370927|P2|Induction Period (IP)|not specified|0
112194|NCT00410410|370928|P1|Induction Period (IP)|not specified|0
112195|NCT00410410|370920|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
112196|NCT00410410|370921|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
112197|NCT00410410|370922|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
112198|NCT00410410|370923|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
112199|NCT00410410|370924|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
112200|NCT00410410|370925|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
112201|NCT00410410|370926|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
112202|NCT00410410|370927|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
112203|NCT00410410|370928|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
112204|NCT00410410|370920|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112205|NCT00410410|370921|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112206|NCT00410410|370922|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112207|NCT00410410|370923|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112208|NCT00410410|370924|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112209|NCT00410410|370925|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112210|NCT00410410|370926|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
112211|NCT00410410|370927|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112212|NCT00410410|370928|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
112213|NCT00410410|370920|P9|Induction Period (IP)|Withdrawal by Subject|0
112214|NCT00410410|370921|P8|Induction Period (IP)|Withdrawal by Subject|0
112215|NCT00410410|370922|P7|Induction Period (IP)|Withdrawal by Subject|0
112216|NCT00410410|370923|P6|Induction Period (IP)|Withdrawal by Subject|0
112217|NCT00410410|370924|P5|Induction Period (IP)|Withdrawal by Subject|2
112218|NCT00410410|370925|P4|Induction Period (IP)|Withdrawal by Subject|5
112219|NCT00410410|370926|P3|Induction Period (IP)|Withdrawal by Subject|3
112220|NCT00410410|370927|P2|Induction Period (IP)|Withdrawal by Subject|5
112221|NCT00410410|370928|P1|Induction Period (IP)|Withdrawal by Subject|3
112222|NCT00410410|370920|P9|Induction Period (IP)|Lost to Follow-up|0
112223|NCT00410410|370921|P8|Induction Period (IP)|Lost to Follow-up|0
112224|NCT00410410|370922|P7|Induction Period (IP)|Lost to Follow-up|0
112225|NCT00410410|370923|P6|Induction Period (IP)|Lost to Follow-up|1
112226|NCT00410410|370924|P5|Induction Period (IP)|Lost to Follow-up|0
112227|NCT00410410|370925|P4|Induction Period (IP)|Lost to Follow-up|3
112228|NCT00410410|370926|P3|Induction Period (IP)|Lost to Follow-up|2
112229|NCT00410410|370927|P2|Induction Period (IP)|Lost to Follow-up|2
112230|NCT00410410|370928|P1|Induction Period (IP)|Lost to Follow-up|2
112231|NCT00410410|370920|P9|Induction Period (IP)|Lack of Efficacy|0
112232|NCT00410410|370921|P8|Induction Period (IP)|Lack of Efficacy|0
112233|NCT00410410|370922|P7|Induction Period (IP)|Lack of Efficacy|0
112234|NCT00410410|370923|P6|Induction Period (IP)|Lack of Efficacy|7
112235|NCT00410410|370924|P5|Induction Period (IP)|Lack of Efficacy|7
112236|NCT00410410|370925|P4|Induction Period (IP)|Lack of Efficacy|8
112237|NCT00410410|370926|P3|Induction Period (IP)|Lack of Efficacy|8
112238|NCT00410410|370927|P2|Induction Period (IP)|Lack of Efficacy|24
112239|NCT00410410|370928|P1|Induction Period (IP)|Lack of Efficacy|26
112240|NCT00410410|370920|P9|Induction Period (IP)|Adverse Event|0
112241|NCT00410410|370921|P8|Induction Period (IP)|Adverse Event|0
112242|NCT00410410|370922|P7|Induction Period (IP)|Adverse Event|0
112243|NCT00410410|370923|P6|Induction Period (IP)|Adverse Event|0
112244|NCT00410410|370924|P5|Induction Period (IP)|Adverse Event|1
112245|NCT00410410|370925|P4|Induction Period (IP)|Adverse Event|4
112246|NCT00410410|370926|P3|Induction Period (IP)|Adverse Event|2
112247|NCT00410410|370927|P2|Induction Period (IP)|Adverse Event|4
112248|NCT00410410|370928|P1|Induction Period (IP)|Adverse Event|3
112249|NCT00410410|370920|P9|Induction Period (IP)|Death|0
112250|NCT00410410|370921|P8|Induction Period (IP)|Death|0
112251|NCT00410410|370922|P7|Induction Period (IP)|Death|0
112252|NCT00410410|370923|P6|Induction Period (IP)|Death|0
112253|NCT00410410|370924|P5|Induction Period (IP)|Death|0
112254|NCT00410410|370925|P4|Induction Period (IP)|Death|0
112255|NCT00410410|370926|P3|Induction Period (IP)|Death|0
112256|NCT00410410|370927|P2|Induction Period (IP)|Death|0
112257|NCT00410410|370928|P1|Induction Period (IP)|Death|1
112258|NCT00410514|371097|P3|Overall Study|Non-compliant with study procedures|2
112259|NCT00410514|371098|P2|Overall Study|Non-compliant with study procedures|0
112260|NCT00410514|371099|P1|Overall Study|Non-compliant with study procedures|0
112261|NCT00410514|371097|P3|Overall Study|Lost to Follow-up|2
112262|NCT00410514|371098|P2|Overall Study|Lost to Follow-up|0
112263|NCT00410514|371099|P1|Overall Study|Lost to Follow-up|0
112264|NCT00410514|371097|P3|Overall Study|Protocol Violation|1
112265|NCT00410514|371098|P2|Overall Study|Protocol Violation|1
112266|NCT00410514|371099|P1|Overall Study|Protocol Violation|0
112267|NCT00410514|371097|P3|Overall Study|Adverse Event|2
112268|NCT00410514|371098|P2|Overall Study|Adverse Event|2
112269|NCT00410514|371099|P1|Overall Study|Adverse Event|2
112270|NCT00410761|371160|P2|Overall Study|Never received randomised treatment|1
112271|NCT00410761|371161|P1|Overall Study|Never received randomised treatment|0
112272|NCT00410761|371160|P2|Overall Study|Other|9
112273|NCT00410761|371161|P1|Overall Study|Other|12
112274|NCT00410761|371160|P2|Overall Study|Withdrawal by Subject|4
112275|NCT00410761|371161|P1|Overall Study|Withdrawal by Subject|8
112276|NCT00410761|371160|P2|Overall Study|objective disease progression|55
112277|NCT00410761|371161|P1|Overall Study|objective disease progression|71
112278|NCT00410761|371160|P2|Overall Study|Adverse Event|3
112279|NCT00410761|371161|P1|Overall Study|Adverse Event|29
112280|NCT00410813|371183|P2|Overall Study|Death|2
112281|NCT00410813|371184|P1|Overall Study|Death|0
112282|NCT00410813|371183|P2|Overall Study|Ineligible|4
112283|NCT00410813|371184|P1|Overall Study|Ineligible|2
112284|NCT00410813|371183|P2|Overall Study|Not protocol specified|4
112285|NCT00410813|371184|P1|Overall Study|Not protocol specified|3
112286|NCT00410813|371183|P2|Overall Study|Progression|21
112287|NCT00410813|371184|P1|Overall Study|Progression|32
112288|NCT00410813|371183|P2|Overall Study|Adverse Event|11
112289|NCT00410813|371184|P1|Overall Study|Adverse Event|6
112290|NCT00411151|371243|P1|Overall Study|Trial prematurely closed|4
112291|NCT00411151|371243|P1|Overall Study|Protocol Violation|1
112292|NCT00411151|371243|P1|Overall Study|Lost to Follow-up|2
112293|NCT00411151|371243|P1|Overall Study|Withdrawal by Subject|2
112294|NCT00411151|371243|P1|Overall Study|Death|38
112295|NCT00411216|371255|P2|Overall Study|Ten participants were entered into the c|2
112296|NCT00411216|371256|P1|Overall Study|Ten participants were entered into the c|0
112297|NCT00404820|371264|P2|Overall Study|Other|2
112298|NCT00404820|371265|P1|Overall Study|Other|0
112299|NCT00404820|371264|P2|Overall Study|Death|0
112300|NCT00404820|371265|P1|Overall Study|Death|1
112301|NCT00404820|371264|P2|Overall Study|Administrative problems|0
112302|NCT00404820|371265|P1|Overall Study|Administrative problems|2
112303|NCT00404820|371264|P2|Overall Study|Lost to Follow-up|3
112304|NCT00404820|371265|P1|Overall Study|Lost to Follow-up|7
112305|NCT00404820|371264|P2|Overall Study|Withdrawal by Subject|3
112306|NCT00404820|371265|P1|Overall Study|Withdrawal by Subject|5
112307|NCT00404820|371264|P2|Overall Study|Adverse Event|16
112308|NCT00404820|371265|P1|Overall Study|Adverse Event|4
112309|NCT00404924|371285|P2|Overall Study|Randomised but not received treatment|1
112310|NCT00404924|371286|P1|Overall Study|Randomised but not received treatment|1
112311|NCT00404924|371285|P2|Overall Study|Not Specified|11
112312|NCT00404924|371286|P1|Overall Study|Not Specified|25
112313|NCT00404924|371285|P2|Overall Study|Withdrawal by Subject|13
112314|NCT00404924|371286|P1|Overall Study|Withdrawal by Subject|26
112315|NCT00404924|371285|P2|Overall Study|Lost to Follow-up|1
112316|NCT00404924|371286|P1|Overall Study|Lost to Follow-up|1
112317|NCT00404924|371285|P2|Overall Study|Condition under investigation worsened|264
112318|NCT00404924|371286|P1|Overall Study|Condition under investigation worsened|475
112319|NCT00404924|371285|P2|Overall Study|Adverse Event|16
112320|NCT00404924|371286|P1|Overall Study|Adverse Event|75
112321|NCT00405067|371305|P3|Overall Study|Lost to Follow-up|1
112322|NCT00405067|371306|P2|Overall Study|Lost to Follow-up|0
112323|NCT00405067|371307|P1|Overall Study|Lost to Follow-up|0
112324|NCT00405067|371305|P3|Overall Study|Adverse Event|4
112325|NCT00405067|371306|P2|Overall Study|Adverse Event|9
112326|NCT00405067|371307|P1|Overall Study|Adverse Event|4
112327|NCT00405275|371344|P2|Overall Study|Unwilling to continue|9
112328|NCT00405275|371345|P1|Overall Study|Unwilling to continue|10
112329|NCT00405275|371344|P2|Overall Study|Withdrawal by Subject|9
112330|NCT00405275|371345|P1|Overall Study|Withdrawal by Subject|7
112331|NCT00405275|371344|P2|Overall Study|Lost to Follow-up|1
112332|NCT00405275|371345|P1|Overall Study|Lost to Follow-up|5
112333|NCT00405275|371344|P2|Overall Study|Death|0
112334|NCT00405275|371345|P1|Overall Study|Death|1
112335|NCT00411450|371397|P1|Overall Study|Ongoing at time of data cut-off.|3
112336|NCT00411554|371441|P2|Overall Study|Patient Moved|0
112337|NCT00411554|371442|P1|Overall Study|Patient Moved|1
112338|NCT00411554|371441|P2|Overall Study|Withdrawal by Subject|0
112339|NCT00411554|371442|P1|Overall Study|Withdrawal by Subject|3
112340|NCT00411554|371441|P2|Overall Study|Lack of Efficacy|5
112341|NCT00411554|371442|P1|Overall Study|Lack of Efficacy|2
112342|NCT00411554|371441|P2|Overall Study|Adverse Event|4
112343|NCT00411554|371442|P1|Overall Study|Adverse Event|2
112344|NCT00411645|371459|P2|Overall Study|Lost to Follow-up|0
112345|NCT00411645|371460|P1|Overall Study|Lost to Follow-up|2
112346|NCT00411645|371459|P2|Overall Study|Investigator/Sponsor Decision|7
112347|NCT00411645|371460|P1|Overall Study|Investigator/Sponsor Decision|10
112348|NCT00411645|371459|P2|Overall Study|Death|135
112349|NCT00411645|371460|P1|Overall Study|Death|56
112350|NCT00411645|371459|P2|Overall Study|Consent Withdrawn|22
112351|NCT00411645|371460|P1|Overall Study|Consent Withdrawn|13
112352|NCT00411671|371484|P1|Overall Study|Lost to Follow-up|3
112353|NCT00411671|371484|P1|Overall Study|Death|2
112354|NCT00411671|371484|P1|Overall Study|Adverse Event|15
112355|NCT00412737|371492|P2|Overall Study|Failure to Return|2
112356|NCT00412737|371493|P1|Overall Study|Failure to Return|6
112357|NCT00412737|371492|P2|Overall Study|Refused Treatment|2
112358|NCT00412737|371493|P1|Overall Study|Refused Treatment|6
112359|NCT00412737|371492|P2|Overall Study|Adverse Event|2
112360|NCT00412737|371493|P1|Overall Study|Adverse Event|3
112361|NCT00412737|371492|P2|Overall Study|Death|0
112362|NCT00412737|371493|P1|Overall Study|Death|1
112363|NCT00412750|371514|P3|Overall Study|Lack of Efficacy|3
112364|NCT00412750|371515|P2|Overall Study|Lack of Efficacy|0
112365|NCT00412750|371516|P1|Overall Study|Lack of Efficacy|0
112366|NCT00412750|371514|P3|Overall Study|Withdrawal by Subject|2
112367|NCT00412750|371515|P2|Overall Study|Withdrawal by Subject|1
112368|NCT00412750|371516|P1|Overall Study|Withdrawal by Subject|0
112369|NCT00412750|371514|P3|Overall Study|Lost to Follow-up|1
112370|NCT00412750|371515|P2|Overall Study|Lost to Follow-up|0
112371|NCT00412750|371516|P1|Overall Study|Lost to Follow-up|1
112372|NCT00412750|371514|P3|Overall Study|Adverse Event|3
112373|NCT00412750|371515|P2|Overall Study|Adverse Event|3
112374|NCT00412750|371516|P1|Overall Study|Adverse Event|8
112375|NCT00412750|371514|P3|Overall Study|Administrative problems|14
112376|NCT00412750|371515|P2|Overall Study|Administrative problems|17
112377|NCT00412750|371516|P1|Overall Study|Administrative problems|21
112378|NCT00412750|371514|P3|Overall Study|Abnormal laboratory value(s)|0
112379|NCT00412750|371515|P2|Overall Study|Abnormal laboratory value(s)|0
112380|NCT00412750|371516|P1|Overall Study|Abnormal laboratory value(s)|1
112381|NCT00412854|371552|P2|Overall Study|Withdrawn for other reasons|11
112382|NCT00412854|371553|P1|Overall Study|Withdrawn for other reasons|13
112383|NCT00412854|371552|P2|Overall Study|Withdrawn due to adverse events|5
112384|NCT00412854|371553|P1|Overall Study|Withdrawn due to adverse events|1
112385|NCT00412893|371588|P2|Overall Study|Randomized but Never Received Study Drug|6
112386|NCT00412893|371589|P1|Overall Study|Randomized but Never Received Study Drug|5
112387|NCT00412893|371588|P2|Overall Study|Administrative Reason|15
112388|NCT00412893|371589|P1|Overall Study|Administrative Reason|12
112389|NCT00412893|371588|P2|Overall Study|Did Not Cooperate|9
112390|NCT00412893|371589|P1|Overall Study|Did Not Cooperate|12
112391|NCT00412893|371588|P2|Overall Study|Other Protocol Violation|6
112392|NCT00412893|371589|P1|Overall Study|Other Protocol Violation|10
112393|NCT00412893|371588|P2|Overall Study|Violation of Selection at Entry|10
112394|NCT00412893|371589|P1|Overall Study|Violation of Selection at Entry|17
112395|NCT00412893|371588|P2|Overall Study|Lost to Follow-up|1
112396|NCT00412893|371589|P1|Overall Study|Lost to Follow-up|2
112397|NCT00412893|371588|P2|Overall Study|Insufficient Therapeutic Response|23
112398|NCT00412893|371589|P1|Overall Study|Insufficient Therapeutic Response|39
112399|NCT00412893|371588|P2|Overall Study|Death|21
112400|NCT00412893|371589|P1|Overall Study|Death|17
112401|NCT00412893|371588|P2|Overall Study|Adverse Event|53
112402|NCT00412893|371589|P1|Overall Study|Adverse Event|31
112403|NCT00412932|371615|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
112404|NCT00412932|371615|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
112405|NCT00412932|371615|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
112406|NCT00412932|371615|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
112407|NCT00412932|371615|P1|Olmesartan 40 mg|Withdrawal by Subject|1
112408|NCT00412932|371615|P1|Olmesartan 40 mg|Lack of Efficacy|3
112409|NCT00412932|371615|P1|Olmesartan 40 mg|Adverse Event|4
112410|NCT00412932|371615|P1|Olmesartan (Olm) 20 mg|Other|1
112411|NCT00412932|371615|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
112412|NCT00412932|371615|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
112413|NCT00412932|371615|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
112414|NCT00412932|371615|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
112415|NCT00412958|371628|P4|Overall Study|Transport issue|0
112416|NCT00412958|371629|P3|Overall Study|Transport issue|0
112417|NCT00412958|371630|P2|Overall Study|Transport issue|1
112418|NCT00412958|371631|P1|Overall Study|Transport issue|0
112419|NCT00412958|371628|P4|Overall Study|Death|0
112420|NCT00412958|371629|P3|Overall Study|Death|0
112421|NCT00412958|371630|P2|Overall Study|Death|1
112422|NCT00412958|371631|P1|Overall Study|Death|0
112423|NCT00412958|371628|P4|Overall Study|Lost to Follow-up|0
112424|NCT00412958|371629|P3|Overall Study|Lost to Follow-up|0
112425|NCT00412958|371630|P2|Overall Study|Lost to Follow-up|1
112426|NCT00412958|371631|P1|Overall Study|Lost to Follow-up|0
112427|NCT00412958|371628|P4|Overall Study|Adverse Event|0
112428|NCT00412958|371629|P3|Overall Study|Adverse Event|0
112429|NCT00412958|371630|P2|Overall Study|Adverse Event|1
112430|NCT00412958|371631|P1|Overall Study|Adverse Event|0
112431|NCT00412958|371628|P4|Overall Study|Withdrawal by Subject|1
112432|NCT00412958|371629|P3|Overall Study|Withdrawal by Subject|0
112433|NCT00412958|371630|P2|Overall Study|Withdrawal by Subject|0
112434|NCT00412958|371631|P1|Overall Study|Withdrawal by Subject|3
112435|NCT00412971|371643|P2|Overall Study|Protocol Violation|1
112436|NCT00412971|371644|P1|Overall Study|Protocol Violation|13
112437|NCT00412971|371643|P2|Overall Study|Lost to Follow-up|9
112438|NCT00412971|371644|P1|Overall Study|Lost to Follow-up|17
112439|NCT00412984|371655|P2|Overall Study|Not Reported|12
112440|NCT00412984|371656|P1|Overall Study|Not Reported|11
112441|NCT00412984|371655|P2|Overall Study|Other Reason|92
112442|NCT00412984|371656|P1|Overall Study|Other Reason|80
112443|NCT00412984|371655|P2|Overall Study|Physician Refused to Continue Treatment|89
112444|NCT00412984|371656|P1|Overall Study|Physician Refused to Continue Treatment|81
112445|NCT00412984|371655|P2|Overall Study|Administrative Reason by Sponsor|8
112446|NCT00412984|371656|P1|Overall Study|Administrative Reason by Sponsor|11
112447|NCT00412984|371655|P2|Overall Study|Subject No Longer Meets Study Criteria|100
112448|NCT00412984|371656|P1|Overall Study|Subject No Longer Meets Study Criteria|87
112449|NCT00412984|371655|P2|Overall Study|Pregnancy|0
112450|NCT00412984|371656|P1|Overall Study|Pregnancy|1
112451|NCT00412984|371655|P2|Overall Study|Poor/Noncompliance|77
112452|NCT00412984|371656|P1|Overall Study|Poor/Noncompliance|57
112453|NCT00412984|371655|P2|Overall Study|Lost to Follow-up|39
112454|NCT00412984|371656|P1|Overall Study|Lost to Follow-up|51
112455|NCT00412984|371655|P2|Overall Study|Withdrawal by Subject|989
112456|NCT00412984|371656|P1|Overall Study|Withdrawal by Subject|921
112457|NCT00412984|371655|P2|Overall Study|Adverse Event|738
112458|NCT00412984|371656|P1|Overall Study|Adverse Event|679
112459|NCT00412984|371655|P2|Overall Study|Death|349
112460|NCT00412984|371656|P1|Overall Study|Death|331
112461|NCT00413010|371700|P2|Overall Study|Due to termination of the study|52
112462|NCT00413010|371701|P1|Overall Study|Due to termination of the study|54
112463|NCT00413010|371700|P2|Overall Study|Withdrawal by Subject|2
112464|NCT00413010|371701|P1|Overall Study|Withdrawal by Subject|7
112465|NCT00413010|371700|P2|Overall Study|Lost to Follow-up|0
112466|NCT00413010|371701|P1|Overall Study|Lost to Follow-up|3
112467|NCT00413010|371700|P2|Overall Study|Lack of Efficacy|3
112468|NCT00413010|371701|P1|Overall Study|Lack of Efficacy|0
112469|NCT00413010|371700|P2|Overall Study|Laboratory abnormality|2
112470|NCT00413010|371701|P1|Overall Study|Laboratory abnormality|0
112471|NCT00413010|371700|P2|Overall Study|Adverse Event|4
112472|NCT00413010|371701|P1|Overall Study|Adverse Event|8
112473|NCT00413036|371721|P1|Overall Study|Missing|2
112474|NCT00413036|371721|P1|Overall Study|Unspecified|26
112475|NCT00413036|371721|P1|Overall Study|Death|9
112476|NCT00413036|371721|P1|Overall Study|Withdrawal by Subject|7
112477|NCT00413036|371721|P1|Overall Study|Lack of Efficacy|129
112478|NCT00413036|371721|P1|Overall Study|Adverse Event|44
112479|NCT00413049|371731|P2|Overall Study|Lack of Efficacy|0
112480|NCT00413049|371732|P1|Overall Study|Lack of Efficacy|1
112481|NCT00413049|371731|P2|Overall Study|Abnormal laboratory value(s)|0
112482|NCT00413049|371732|P1|Overall Study|Abnormal laboratory value(s)|1
112483|NCT00413049|371731|P2|Overall Study|Subject no longer requires study drug|1
112484|NCT00413049|371732|P1|Overall Study|Subject no longer requires study drug|0
112485|NCT00413049|371731|P2|Overall Study|Protocol Violation|1
112486|NCT00413049|371732|P1|Overall Study|Protocol Violation|3
112487|NCT00413049|371731|P2|Overall Study|Lost to Follow-up|3
112488|NCT00413049|371732|P1|Overall Study|Lost to Follow-up|2
112489|NCT00413049|371731|P2|Overall Study|Withdrawal by Subject|5
112490|NCT00413049|371732|P1|Overall Study|Withdrawal by Subject|7
112491|NCT00413049|371731|P2|Overall Study|Adverse Event|8
112492|NCT00413049|371732|P1|Overall Study|Adverse Event|10
112493|NCT00413062|371750|P2|Overall Study|Other reason|34
112494|NCT00413062|371751|P1|Overall Study|Other reason|70
112495|NCT00413062|371750|P2|Overall Study|Lost to Follow-up|73
112496|NCT00413062|371751|P1|Overall Study|Lost to Follow-up|175
112497|NCT00413062|371750|P2|Overall Study|Pregnancy wish|6
112498|NCT00413062|371751|P1|Overall Study|Pregnancy wish|17
112499|NCT00413062|371750|P2|Overall Study|Pregnancy|5
112500|NCT00413062|371751|P1|Overall Study|Pregnancy|15
112501|NCT00413062|371750|P2|Overall Study|Withdrawal of informed consent|36
112502|NCT00413062|371751|P1|Overall Study|Withdrawal of informed consent|111
112503|NCT00413062|371750|P2|Overall Study|Pre-treatment (serious) adverse event|0
112504|NCT00413062|371751|P1|Overall Study|Pre-treatment (serious) adverse event|1
112505|NCT00413062|371750|P2|Overall Study|Adverse event/serious adverse event|56
112506|NCT00413062|371751|P1|Overall Study|Adverse event/serious adverse event|289
112507|NCT00413153|371777|P2|Overall Study|Adverse Event|0
112508|NCT00413153|371778|P1|Overall Study|Adverse Event|1
112509|NCT00413153|371777|P2|Overall Study|Withdrawal by Subject|1
112510|NCT00413153|371778|P1|Overall Study|Withdrawal by Subject|1
112511|NCT00413192|371804|P4|Overall Study|Not treated|1
112512|NCT00413192|371805|P3|Overall Study|Not treated|0
112513|NCT00413192|371806|P2|Overall Study|Not treated|0
112514|NCT00413192|371807|P1|Overall Study|Not treated|0
112515|NCT00413192|371804|P4|Overall Study|Not specified|2
112516|NCT00413192|371805|P3|Overall Study|Not specified|1
112517|NCT00413192|371806|P2|Overall Study|Not specified|1
112518|NCT00413192|371807|P1|Overall Study|Not specified|5
112519|NCT00413192|371804|P4|Overall Study|Intercurrent death|0
112520|NCT00413192|371805|P3|Overall Study|Intercurrent death|0
112521|NCT00413192|371806|P2|Overall Study|Intercurrent death|1
112522|NCT00413192|371807|P1|Overall Study|Intercurrent death|0
112523|NCT00413192|371804|P4|Overall Study|Intercurrent illness|1
112524|NCT00413192|371805|P3|Overall Study|Intercurrent illness|0
112525|NCT00413192|371806|P2|Overall Study|Intercurrent illness|0
112526|NCT00413192|371807|P1|Overall Study|Intercurrent illness|0
112527|NCT00413192|371804|P4|Overall Study|Withdrawal by Subject|1
112528|NCT00413192|371805|P3|Overall Study|Withdrawal by Subject|0
112529|NCT00413192|371806|P2|Overall Study|Withdrawal by Subject|5
112530|NCT00413192|371807|P1|Overall Study|Withdrawal by Subject|3
112531|NCT00413192|371804|P4|Overall Study|Toxicity|2
112532|NCT00413192|371805|P3|Overall Study|Toxicity|2
112533|NCT00413192|371806|P2|Overall Study|Toxicity|2
112534|NCT00413192|371807|P1|Overall Study|Toxicity|3
112535|NCT00413192|371804|P4|Overall Study|Disease progression|25
112536|NCT00413192|371805|P3|Overall Study|Disease progression|16
112537|NCT00413192|371806|P2|Overall Study|Disease progression|31
112538|NCT00413192|371807|P1|Overall Study|Disease progression|26
112539|NCT00413218|371847|P2|Overall Study|Withdrawal by Subject|1
112540|NCT00413218|371848|P1|Overall Study|Withdrawal by Subject|9
112541|NCT00413218|371847|P2|Overall Study|Missing|0
112542|NCT00413218|371848|P1|Overall Study|Missing|1
112543|NCT00413218|371847|P2|Overall Study|Admin|14
112544|NCT00413218|371848|P1|Overall Study|Admin|20
112545|NCT00413218|371847|P2|Overall Study|Lost to Follow-up|17
112546|NCT00413218|371848|P1|Overall Study|Lost to Follow-up|14
112547|NCT00413218|371847|P2|Overall Study|Death|56
112548|NCT00413218|371848|P1|Overall Study|Death|57
112549|NCT00413218|371847|P2|Overall Study|Randomized but didn't receive study drug|8
112550|NCT00413218|371848|P1|Overall Study|Randomized but didn't receive study drug|2
112551|NCT00413231|371870|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
112552|NCT00413231|371870|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
112553|NCT00413231|371870|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
112554|NCT00413231|371870|P1|365-day to 60-month Post Treatment|Death|36
112555|NCT00413231|371870|P1|30-day to 365-day Post Treatment|Death|13
112556|NCT00413231|371870|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
112557|NCT00413231|371870|P1|0 to 30-day Post Treatment|Death|5
112558|NCT00413244|371902|P2|Overall Study|Withdrawal by Subject|1
112559|NCT00413244|371903|P1|Overall Study|Withdrawal by Subject|10
112560|NCT00413283|371935|P4|Overall Study|Not specified|0
112561|NCT00413283|371936|P3|Overall Study|Not specified|1
112562|NCT00413283|371937|P2|Overall Study|Not specified|0
112563|NCT00413283|371938|P1|Overall Study|Not specified|0
112564|NCT00413283|371935|P4|Overall Study|Requirement for alternative therapy|0
112565|NCT00413283|371936|P3|Overall Study|Requirement for alternative therapy|0
112566|NCT00413283|371937|P2|Overall Study|Requirement for alternative therapy|2
112567|NCT00413283|371938|P1|Overall Study|Requirement for alternative therapy|0
112568|NCT00413283|371935|P4|Overall Study|Protocol deviation|0
112569|NCT00413283|371936|P3|Overall Study|Protocol deviation|0
112570|NCT00413283|371937|P2|Overall Study|Protocol deviation|1
112571|NCT00413283|371938|P1|Overall Study|Protocol deviation|0
112572|NCT00413283|371935|P4|Overall Study|Ineligibility determined|1
112573|NCT00413283|371936|P3|Overall Study|Ineligibility determined|0
112574|NCT00413283|371937|P2|Overall Study|Ineligibility determined|0
112575|NCT00413283|371938|P1|Overall Study|Ineligibility determined|0
112576|NCT00413283|371935|P4|Overall Study|Adverse Event|1
112577|NCT00413283|371936|P3|Overall Study|Adverse Event|0
112578|NCT00413283|371937|P2|Overall Study|Adverse Event|0
112579|NCT00413283|371938|P1|Overall Study|Adverse Event|0
112580|NCT00413283|371935|P4|Overall Study|Death|1
112581|NCT00413283|371936|P3|Overall Study|Death|1
112582|NCT00413283|371937|P2|Overall Study|Death|0
112583|NCT00413283|371938|P1|Overall Study|Death|0
112584|NCT00413283|371935|P4|Overall Study|Withdrawal by Subject|1
112585|NCT00413283|371936|P3|Overall Study|Withdrawal by Subject|0
112586|NCT00413283|371937|P2|Overall Study|Withdrawal by Subject|0
112587|NCT00413283|371938|P1|Overall Study|Withdrawal by Subject|1
112588|NCT00413374|371985|P1|Overall Study|Surgery|1
112589|NCT00413374|371985|P1|Overall Study|Lost to Follow-up|1
112590|NCT00413374|371985|P1|Overall Study|Adverse Event|1
112591|NCT00413374|371985|P1|Overall Study|Ineligible due to screening criteria.|3
112592|NCT00413413|372024|P3|Double-Blind|Lost to Follow-up|2
112593|NCT00413413|372025|P2|Double-Blind|Lost to Follow-up|4
112594|NCT00413413|372026|P1|Double-Blind|Lost to Follow-up|3
112595|NCT00413413|372024|P3|Double-Blind|Subject withdrew consent|9
112596|NCT00413413|372025|P2|Double-Blind|Subject withdrew consent|6
112597|NCT00413413|372026|P1|Double-Blind|Subject withdrew consent|4
112598|NCT00413413|372024|P3|Double-Blind|Protocol deviation|1
112599|NCT00413413|372025|P2|Double-Blind|Protocol deviation|2
112600|NCT00413413|372026|P1|Double-Blind|Protocol deviation|1
112601|NCT00413413|372024|P3|Double-Blind|Unsatisfactory therapeutic effect|1
112602|NCT00413413|372025|P2|Double-Blind|Unsatisfactory therapeutic effect|2
112603|NCT00413413|372026|P1|Double-Blind|Unsatisfactory therapeutic effect|1
112604|NCT00413413|372024|P3|Double-Blind|Adverse Event|5
112605|NCT00413413|372025|P2|Double-Blind|Adverse Event|0
112606|NCT00413413|372026|P1|Double-Blind|Adverse Event|6
112607|NCT00413413|372024|P3|Single-Blind|Lost to Follow-up|0
112608|NCT00413413|372025|P2|Single-Blind|Lost to Follow-up|8
112609|NCT00413413|372026|P1|Single-Blind|Lost to Follow-up|0
112610|NCT00413413|372024|P3|Single-Blind|Withdrawal by Subject|0
112611|NCT00413413|372025|P2|Single-Blind|Withdrawal by Subject|27
112612|NCT00413413|372026|P1|Single-Blind|Withdrawal by Subject|0
112613|NCT00413413|372024|P3|Single-Blind|Protocol Violation|0
112614|NCT00413413|372025|P2|Single-Blind|Protocol Violation|16
112615|NCT00413413|372026|P1|Single-Blind|Protocol Violation|0
112616|NCT00413413|372024|P3|Single-Blind|Subject no longer requires study drug|0
112617|NCT00413413|372025|P2|Single-Blind|Subject no longer requires study drug|151
112618|NCT00413413|372026|P1|Single-Blind|Subject no longer requires study drug|0
112619|NCT00413413|372024|P3|Single-Blind|Lack of Efficacy|0
112620|NCT00413413|372025|P2|Single-Blind|Lack of Efficacy|5
112621|NCT00413413|372026|P1|Single-Blind|Lack of Efficacy|0
112622|NCT00413413|372024|P3|Single-Blind|Adverse Event|0
112623|NCT00413413|372025|P2|Single-Blind|Adverse Event|9
112624|NCT00413413|372026|P1|Single-Blind|Adverse Event|0
112625|NCT00413660|372107|P11|Post Week 12|Unspecified|0
112626|NCT00413660|372108|P10|Post Week 12|Unspecified|0
112627|NCT00413660|372109|P9|Post Week 12|Unspecified|0
112628|NCT00413660|372110|P8|Post Week 12|Unspecified|0
112629|NCT00413660|372111|P7|Post Week 12|Unspecified|1
112630|NCT00413660|372112|P6|Post Week 12|Unspecified|1
112631|NCT00413660|372113|P5|Post Week 12|Unspecified|1
112632|NCT00413660|372114|P4|Post Week 12|Unspecified|0
112633|NCT00413660|372115|P3|Post Week 12|Unspecified|3
112634|NCT00413660|372116|P2|Post Week 12|Unspecified|2
112635|NCT00413660|372117|P1|Post Week 12|Unspecified|1
112636|NCT00413660|372107|P11|Post Week 12|Withdrawal by Subject|1
112637|NCT00413660|372108|P10|Post Week 12|Withdrawal by Subject|0
112638|NCT00413660|372109|P9|Post Week 12|Withdrawal by Subject|0
112639|NCT00413660|372110|P8|Post Week 12|Withdrawal by Subject|0
112640|NCT00413660|372111|P7|Post Week 12|Withdrawal by Subject|0
112641|NCT00413660|372112|P6|Post Week 12|Withdrawal by Subject|0
112642|NCT00413660|372113|P5|Post Week 12|Withdrawal by Subject|1
112643|NCT00413660|372114|P4|Post Week 12|Withdrawal by Subject|0
112644|NCT00413660|372115|P3|Post Week 12|Withdrawal by Subject|1
112645|NCT00413660|372116|P2|Post Week 12|Withdrawal by Subject|1
112646|NCT00413660|372117|P1|Post Week 12|Withdrawal by Subject|0
112647|NCT00413660|372107|P11|Post Week 12|Lost to Follow-up|0
112648|NCT00413660|372108|P10|Post Week 12|Lost to Follow-up|0
112649|NCT00413660|372109|P9|Post Week 12|Lost to Follow-up|0
112650|NCT00413660|372110|P8|Post Week 12|Lost to Follow-up|0
112651|NCT00413660|372111|P7|Post Week 12|Lost to Follow-up|0
112652|NCT00413660|372112|P6|Post Week 12|Lost to Follow-up|0
112653|NCT00413660|372113|P5|Post Week 12|Lost to Follow-up|0
112654|NCT00413660|372114|P4|Post Week 12|Lost to Follow-up|0
112655|NCT00413660|372115|P3|Post Week 12|Lost to Follow-up|1
112656|NCT00413660|372116|P2|Post Week 12|Lost to Follow-up|1
112657|NCT00413660|372117|P1|Post Week 12|Lost to Follow-up|0
112658|NCT00413660|372107|P11|Post Week 12|Lack of Efficacy|0
112659|NCT00413660|372108|P10|Post Week 12|Lack of Efficacy|1
112660|NCT00413660|372109|P9|Post Week 12|Lack of Efficacy|0
112661|NCT00413660|372110|P8|Post Week 12|Lack of Efficacy|0
112662|NCT00413660|372111|P7|Post Week 12|Lack of Efficacy|0
112663|NCT00413660|372112|P6|Post Week 12|Lack of Efficacy|0
112664|NCT00413660|372113|P5|Post Week 12|Lack of Efficacy|0
112665|NCT00413660|372114|P4|Post Week 12|Lack of Efficacy|0
112666|NCT00413660|372115|P3|Post Week 12|Lack of Efficacy|1
112667|NCT00413660|372116|P2|Post Week 12|Lack of Efficacy|0
112668|NCT00413660|372117|P1|Post Week 12|Lack of Efficacy|0
112669|NCT00413660|372107|P11|Post Week 12|Adverse Event|0
112670|NCT00413660|372108|P10|Post Week 12|Adverse Event|0
112671|NCT00413660|372109|P9|Post Week 12|Adverse Event|0
112672|NCT00413660|372110|P8|Post Week 12|Adverse Event|0
112673|NCT00413660|372111|P7|Post Week 12|Adverse Event|2
112674|NCT00413660|372112|P6|Post Week 12|Adverse Event|2
112675|NCT00413660|372113|P5|Post Week 12|Adverse Event|4
112676|NCT00413660|372114|P4|Post Week 12|Adverse Event|1
112677|NCT00413660|372115|P3|Post Week 12|Adverse Event|2
112678|NCT00413660|372116|P2|Post Week 12|Adverse Event|0
112679|NCT00413660|372117|P1|Post Week 12|Adverse Event|2
112680|NCT00413660|372107|P11|Up To Week 12|Unspecified|0
112681|NCT00413660|372108|P10|Up To Week 12|Unspecified|0
112682|NCT00413660|372109|P9|Up To Week 12|Unspecified|0
112683|NCT00413660|372110|P8|Up To Week 12|Unspecified|0
112684|NCT00413660|372111|P7|Up To Week 12|Unspecified|3
112685|NCT00413660|372112|P6|Up To Week 12|Unspecified|4
112686|NCT00413660|372113|P5|Up To Week 12|Unspecified|2
112687|NCT00413660|372114|P4|Up To Week 12|Unspecified|1
112688|NCT00413660|372115|P3|Up To Week 12|Unspecified|6
112689|NCT00413660|372116|P2|Up To Week 12|Unspecified|1
112690|NCT00413660|372117|P1|Up To Week 12|Unspecified|3
112691|NCT00413660|372107|P11|Up To Week 12|Randomized, Not Treated|0
112692|NCT00413660|372108|P10|Up To Week 12|Randomized, Not Treated|0
112693|NCT00413660|372109|P9|Up To Week 12|Randomized, Not Treated|0
112694|NCT00413660|372110|P8|Up To Week 12|Randomized, Not Treated|0
112695|NCT00413660|372111|P7|Up To Week 12|Randomized, Not Treated|0
112696|NCT00413660|372112|P6|Up To Week 12|Randomized, Not Treated|0
112697|NCT00413660|372113|P5|Up To Week 12|Randomized, Not Treated|0
112698|NCT00413660|372114|P4|Up To Week 12|Randomized, Not Treated|1
112699|NCT00413660|372115|P3|Up To Week 12|Randomized, Not Treated|0
112700|NCT00413660|372116|P2|Up To Week 12|Randomized, Not Treated|0
112701|NCT00413660|372117|P1|Up To Week 12|Randomized, Not Treated|1
112702|NCT00413660|372107|P11|Up To Week 12|Withdrawal by Subject|0
112703|NCT00413660|372108|P10|Up To Week 12|Withdrawal by Subject|0
112704|NCT00413660|372109|P9|Up To Week 12|Withdrawal by Subject|0
112705|NCT00413660|372110|P8|Up To Week 12|Withdrawal by Subject|0
112706|NCT00413660|372111|P7|Up To Week 12|Withdrawal by Subject|2
112707|NCT00413660|372112|P6|Up To Week 12|Withdrawal by Subject|2
112708|NCT00413660|372113|P5|Up To Week 12|Withdrawal by Subject|0
112709|NCT00413660|372114|P4|Up To Week 12|Withdrawal by Subject|2
112710|NCT00413660|372115|P3|Up To Week 12|Withdrawal by Subject|0
112711|NCT00413660|372116|P2|Up To Week 12|Withdrawal by Subject|2
112712|NCT00413660|372117|P1|Up To Week 12|Withdrawal by Subject|0
112713|NCT00413660|372107|P11|Up To Week 12|Lost to Follow-up|0
112714|NCT00413660|372108|P10|Up To Week 12|Lost to Follow-up|0
112715|NCT00413660|372109|P9|Up To Week 12|Lost to Follow-up|0
112716|NCT00413660|372110|P8|Up To Week 12|Lost to Follow-up|0
112717|NCT00413660|372111|P7|Up To Week 12|Lost to Follow-up|0
112718|NCT00413660|372112|P6|Up To Week 12|Lost to Follow-up|0
112719|NCT00413660|372113|P5|Up To Week 12|Lost to Follow-up|1
112720|NCT00413660|372114|P4|Up To Week 12|Lost to Follow-up|0
112721|NCT00413660|372115|P3|Up To Week 12|Lost to Follow-up|0
112722|NCT00413660|372116|P2|Up To Week 12|Lost to Follow-up|1
112723|NCT00413660|372117|P1|Up To Week 12|Lost to Follow-up|0
112724|NCT00413660|372107|P11|Up To Week 12|Lack of Efficacy|0
112725|NCT00413660|372108|P10|Up To Week 12|Lack of Efficacy|0
112726|NCT00413660|372109|P9|Up To Week 12|Lack of Efficacy|0
112727|NCT00413660|372110|P8|Up To Week 12|Lack of Efficacy|0
112728|NCT00413660|372111|P7|Up To Week 12|Lack of Efficacy|5
112729|NCT00413660|372112|P6|Up To Week 12|Lack of Efficacy|0
112730|NCT00413660|372113|P5|Up To Week 12|Lack of Efficacy|0
112731|NCT00413660|372114|P4|Up To Week 12|Lack of Efficacy|0
112732|NCT00413660|372115|P3|Up To Week 12|Lack of Efficacy|0
112733|NCT00413660|372116|P2|Up To Week 12|Lack of Efficacy|0
112734|NCT00413660|372117|P1|Up To Week 12|Lack of Efficacy|2
112735|NCT00413660|372107|P11|Up To Week 12|Adverse Event|0
112736|NCT00413660|372108|P10|Up To Week 12|Adverse Event|0
112737|NCT00413660|372109|P9|Up To Week 12|Adverse Event|0
112738|NCT00413660|372110|P8|Up To Week 12|Adverse Event|0
112739|NCT00413660|372111|P7|Up To Week 12|Adverse Event|1
112740|NCT00413660|372112|P6|Up To Week 12|Adverse Event|4
112741|NCT00413660|372113|P5|Up To Week 12|Adverse Event|6
112742|NCT00413660|372114|P4|Up To Week 12|Adverse Event|4
112743|NCT00413660|372115|P3|Up To Week 12|Adverse Event|1
112744|NCT00413660|372116|P2|Up To Week 12|Adverse Event|3
112745|NCT00413660|372117|P1|Up To Week 12|Adverse Event|1
112746|NCT00413777|372465|P2|Fixed-dose Period|Withdrew Consent|1
112747|NCT00413777|372466|P1|Fixed-dose Period|Withdrew Consent|0
112748|NCT00413777|372465|P2|Fixed-dose Period|Met Withdrawal Criteria|0
112749|NCT00413777|372466|P1|Fixed-dose Period|Met Withdrawal Criteria|1
112750|NCT00413777|372465|P2|Fixed-dose Period|Adverse Event|1
112751|NCT00413777|372466|P1|Fixed-dose Period|Adverse Event|2
112752|NCT00413777|372465|P2|Fixed-dose Period|Lost to Follow-up|1
112753|NCT00413777|372466|P1|Fixed-dose Period|Lost to Follow-up|1
112754|NCT00413894|372512|P1|Overall Study|Unspecified|18
112755|NCT00413894|372512|P1|Overall Study|Protocol Violation|11
112756|NCT00413894|372512|P1|Overall Study|Adverse Event|28
112757|NCT00413894|372512|P1|Overall Study|Hb <10 grams/deciliter|12
112758|NCT00413894|372512|P1|Overall Study|Administrative Reasons|1
112759|NCT00413894|372512|P1|Overall Study|Withdrawal by Subject|10
112760|NCT00413920|372529|P2|Overall Study|Graft Loss|3
112761|NCT00413920|372530|P1|Overall Study|Graft Loss|5
112762|NCT00413920|372529|P2|Overall Study|Death|5
112763|NCT00413920|372530|P1|Overall Study|Death|3
112764|NCT00413920|372529|P2|Overall Study|Lack of Efficacy|9
112765|NCT00413920|372530|P1|Overall Study|Lack of Efficacy|11
112766|NCT00413920|372529|P2|Overall Study|Adverse Event|11
112767|NCT00413920|372530|P1|Overall Study|Adverse Event|9
112768|NCT00413959|372545|P1|Overall Study|Pt had only one cycle.|1
112769|NCT00413972|372554|P4|Overall Study|Not Specified|1
112770|NCT00413972|372555|P3|Overall Study|Not Specified|0
112771|NCT00413972|372556|P2|Overall Study|Not Specified|0
112772|NCT00413972|372557|P1|Overall Study|Not Specified|0
112773|NCT00413972|372554|P4|Overall Study|Protocol Violation|0
112774|NCT00413972|372555|P3|Overall Study|Protocol Violation|2
112775|NCT00413972|372556|P2|Overall Study|Protocol Violation|0
112776|NCT00413972|372557|P1|Overall Study|Protocol Violation|0
112777|NCT00413972|372554|P4|Overall Study|Withdrawal by Subject|2
112778|NCT00413972|372555|P3|Overall Study|Withdrawal by Subject|7
112779|NCT00413972|372556|P2|Overall Study|Withdrawal by Subject|5
112780|NCT00413972|372557|P1|Overall Study|Withdrawal by Subject|4
112781|NCT00413972|372554|P4|Overall Study|Lost to Follow-up|0
112782|NCT00413972|372555|P3|Overall Study|Lost to Follow-up|1
112783|NCT00413972|372556|P2|Overall Study|Lost to Follow-up|2
112784|NCT00413972|372557|P1|Overall Study|Lost to Follow-up|1
112785|NCT00413972|372554|P4|Overall Study|Adverse Event|0
112786|NCT00413972|372555|P3|Overall Study|Adverse Event|0
112787|NCT00413972|372556|P2|Overall Study|Adverse Event|1
112788|NCT00413972|372557|P1|Overall Study|Adverse Event|2
112789|NCT00414011|372567|P1|Overall Study|Withdrawal by Subject|2
112790|NCT00414011|372567|P1|Overall Study|Physician Decision|3
112791|NCT00414050|372576|P4|Overall Study|Subject Moved|1
112792|NCT00414050|372577|P3|Overall Study|Subject Moved|0
112793|NCT00414050|372578|P2|Overall Study|Subject Moved|0
112794|NCT00414050|372579|P1|Overall Study|Subject Moved|0
112795|NCT00414050|372576|P4|Overall Study|Subject discontinued for other reason|1
112796|NCT00414050|372577|P3|Overall Study|Subject discontinued for other reason|2
112797|NCT00414050|372578|P2|Overall Study|Subject discontinued for other reason|2
112798|NCT00414050|372579|P1|Overall Study|Subject discontinued for other reason|1
112799|NCT00414050|372576|P4|Overall Study|Withdrawal by Subject|4
112800|NCT00414050|372577|P3|Overall Study|Withdrawal by Subject|2
112801|NCT00414050|372578|P2|Overall Study|Withdrawal by Subject|3
112802|NCT00414050|372579|P1|Overall Study|Withdrawal by Subject|5
112803|NCT00414050|372576|P4|Overall Study|Lost to Follow-up|1
112804|NCT00414050|372577|P3|Overall Study|Lost to Follow-up|1
112805|NCT00414050|372578|P2|Overall Study|Lost to Follow-up|2
112806|NCT00414050|372579|P1|Overall Study|Lost to Follow-up|2
112807|NCT00414050|372576|P4|Overall Study|Adverse Event|1
112808|NCT00414050|372577|P3|Overall Study|Adverse Event|1
112809|NCT00414050|372578|P2|Overall Study|Adverse Event|1
112810|NCT00414050|372579|P1|Overall Study|Adverse Event|1
112811|NCT00414310|372619|P2|Overall Study|Not treated|0
112812|NCT00414310|372620|P1|Overall Study|Not treated|1
112813|NCT00414388|372626|P1|Overall Study|Adverse Event|1
112814|NCT00414440|372634|P2|Extension Period|Not included in follow up period|8
112815|NCT00414440|372635|P1|Extension Period|Not included in follow up period|18
112816|NCT00414440|372634|P2|Extension Period|Withdrawal by Subject|7
112817|NCT00414440|372635|P1|Extension Period|Withdrawal by Subject|9
112818|NCT00414440|372634|P2|Extension Period|Death|2
112819|NCT00414440|372635|P1|Extension Period|Death|1
112820|NCT00414440|372634|P2|Extension Period|Administrative|16
112821|NCT00414440|372635|P1|Extension Period|Administrative|16
112822|NCT00414440|372634|P2|Extension Period|Other|1
112823|NCT00414440|372635|P1|Extension Period|Other|1
112824|NCT00414440|372634|P2|Extension Period|Did not consent to continue follow up|54
112825|NCT00414440|372635|P1|Extension Period|Did not consent to continue follow up|61
112826|NCT00414440|372634|P2|Extension Period|Lost to Follow-up|52
112827|NCT00414440|372635|P1|Extension Period|Lost to Follow-up|44
112828|NCT00414440|372634|P2|Core Period|Withdrawal by Subject|32
112829|NCT00414440|372635|P1|Core Period|Withdrawal by Subject|70
112830|NCT00414453|372649|P1|Overall Study|Abnormal lab work|16
112831|NCT00414466|372699|P4|Overall Study|Withdrawn by Sponsor|0
112832|NCT00414466|372700|P3|Overall Study|Withdrawn by Sponsor|0
112833|NCT00414466|372701|P2|Overall Study|Withdrawn by Sponsor|0
112834|NCT00414466|372702|P1|Overall Study|Withdrawn by Sponsor|1
112835|NCT00414466|372699|P4|Overall Study|Lack of Efficacy|0
112836|NCT00414466|372700|P3|Overall Study|Lack of Efficacy|0
112837|NCT00414466|372701|P2|Overall Study|Lack of Efficacy|0
112838|NCT00414466|372702|P1|Overall Study|Lack of Efficacy|1
112839|NCT00414466|372699|P4|Overall Study|Adverse Event|1
112840|NCT00414466|372700|P3|Overall Study|Adverse Event|1
112841|NCT00414466|372701|P2|Overall Study|Adverse Event|0
112842|NCT00414466|372702|P1|Overall Study|Adverse Event|0
112843|NCT00414544|372733|P1|Overall Study|Lost to Follow-up|14
112844|NCT00414596|372739|P1|Overall Study|Protocol Violation|2
112845|NCT00414609|372750|P3|Extension Study|Death|17
112846|NCT00414609|372751|P2|Extension Study|Death|0
112847|NCT00414609|372752|P1|Extension Study|Death|0
112848|NCT00414609|372750|P3|Extension Study|Administrative problems|1
112849|NCT00414609|372751|P2|Extension Study|Administrative problems|0
112850|NCT00414609|372752|P1|Extension Study|Administrative problems|0
112851|NCT00414609|372750|P3|Extension Study|Lost to Follow-up|10
112852|NCT00414609|372751|P2|Extension Study|Lost to Follow-up|0
112853|NCT00414609|372752|P1|Extension Study|Lost to Follow-up|0
112854|NCT00414609|372750|P3|Extension Study|Withdrawal by Subject|13
112855|NCT00414609|372751|P2|Extension Study|Withdrawal by Subject|0
112856|NCT00414609|372752|P1|Extension Study|Withdrawal by Subject|0
112857|NCT00414609|372750|P3|Extension Study|Unsatisfactory therapeutic effect|2
112858|NCT00414609|372751|P2|Extension Study|Unsatisfactory therapeutic effect|0
112859|NCT00414609|372752|P1|Extension Study|Unsatisfactory therapeutic effect|0
112860|NCT00414609|372750|P3|Extension Study|Adverse Event|14
112861|NCT00414609|372751|P2|Extension Study|Adverse Event|0
112862|NCT00414609|372752|P1|Extension Study|Adverse Event|0
112863|NCT00414609|372750|P3|Core Study|Death|0
112864|NCT00414609|372751|P2|Core Study|Death|14
112865|NCT00414609|372752|P1|Core Study|Death|7
112866|NCT00414609|372750|P3|Core Study|Administrative problems|0
112867|NCT00414609|372751|P2|Core Study|Administrative problems|2
112868|NCT00414609|372752|P1|Core Study|Administrative problems|0
112869|NCT00414609|372750|P3|Core Study|Lost to Follow-up|0
112870|NCT00414609|372751|P2|Core Study|Lost to Follow-up|4
112871|NCT00414609|372752|P1|Core Study|Lost to Follow-up|7
112872|NCT00414609|372750|P3|Core Study|Patient withdrew consent|0
112873|NCT00414609|372751|P2|Core Study|Patient withdrew consent|11
112874|NCT00414609|372752|P1|Core Study|Patient withdrew consent|10
112875|NCT00414609|372750|P3|Core Study|Protocol deviation|0
112876|NCT00414609|372751|P2|Core Study|Protocol deviation|1
112877|NCT00414609|372752|P1|Core Study|Protocol deviation|0
112878|NCT00414609|372750|P3|Core Study|Abnormal test procedure results|0
112879|NCT00414609|372751|P2|Core Study|Abnormal test procedure results|1
112880|NCT00414609|372752|P1|Core Study|Abnormal test procedure results|1
112881|NCT00414609|372750|P3|Core Study|Abnormal laboratory values|0
112882|NCT00414609|372751|P2|Core Study|Abnormal laboratory values|1
112883|NCT00414609|372752|P1|Core Study|Abnormal laboratory values|0
112884|NCT00414609|372750|P3|Core Study|Adverse Event|0
112885|NCT00414609|372751|P2|Core Study|Adverse Event|11
112886|NCT00414609|372752|P1|Core Study|Adverse Event|9
112887|NCT00414661|372800|P4|Overall Study|Unspecified|0
112888|NCT00414661|372801|P3|Overall Study|Unspecified|0
112889|NCT00414661|372802|P2|Overall Study|Unspecified|3
112890|NCT00414661|372803|P1|Overall Study|Unspecified|6
112891|NCT00414661|372800|P4|Overall Study|Withdrawal by Subject|2
112892|NCT00414661|372801|P3|Overall Study|Withdrawal by Subject|2
112893|NCT00414661|372802|P2|Overall Study|Withdrawal by Subject|2
112894|NCT00414661|372803|P1|Overall Study|Withdrawal by Subject|5
112895|NCT00414661|372800|P4|Overall Study|Lost to Follow-up|1
112896|NCT00414661|372801|P3|Overall Study|Lost to Follow-up|0
112897|NCT00414661|372802|P2|Overall Study|Lost to Follow-up|4
112898|NCT00414661|372803|P1|Overall Study|Lost to Follow-up|1
112899|NCT00414661|372800|P4|Overall Study|Death|0
112900|NCT00414661|372801|P3|Overall Study|Death|0
112901|NCT00414661|372802|P2|Overall Study|Death|5
112902|NCT00414661|372803|P1|Overall Study|Death|2
112903|NCT00414726|372850|P2|Overall Study|Withdrawal by Subject|1
112904|NCT00414726|372851|P1|Overall Study|Withdrawal by Subject|0
112905|NCT00414908|372874|P2|Overall Study|Protocol Violation|1
112906|NCT00414908|372875|P1|Overall Study|Protocol Violation|1
112907|NCT00414973|372901|P4|Overall Study|Death|0
112908|NCT00414973|372902|P3|Overall Study|Death|1
112909|NCT00414973|372903|P2|Overall Study|Death|0
112910|NCT00414973|372904|P1|Overall Study|Death|0
112911|NCT00414973|372901|P4|Overall Study|Sponsor Decision|0
112912|NCT00414973|372902|P3|Overall Study|Sponsor Decision|0
112913|NCT00414973|372903|P2|Overall Study|Sponsor Decision|0
112914|NCT00414973|372904|P1|Overall Study|Sponsor Decision|1
112915|NCT00414973|372901|P4|Overall Study|Lost to Follow-up|0
112916|NCT00414973|372902|P3|Overall Study|Lost to Follow-up|0
112917|NCT00414973|372903|P2|Overall Study|Lost to Follow-up|2
112918|NCT00414973|372904|P1|Overall Study|Lost to Follow-up|0
112919|NCT00414973|372901|P4|Overall Study|Protocol Violation|0
112920|NCT00414973|372902|P3|Overall Study|Protocol Violation|0
112921|NCT00414973|372903|P2|Overall Study|Protocol Violation|4
112922|NCT00414973|372904|P1|Overall Study|Protocol Violation|3
112923|NCT00414973|372901|P4|Overall Study|Adverse Event|0
112924|NCT00414973|372902|P3|Overall Study|Adverse Event|1
112925|NCT00414973|372903|P2|Overall Study|Adverse Event|0
112926|NCT00414973|372904|P1|Overall Study|Adverse Event|10
112927|NCT00414973|372901|P4|Overall Study|Withdrawal by Subject|0
112928|NCT00414973|372902|P3|Overall Study|Withdrawal by Subject|1
112929|NCT00414973|372903|P2|Overall Study|Withdrawal by Subject|4
112930|NCT00414973|372904|P1|Overall Study|Withdrawal by Subject|14
112931|NCT00415051|372922|P1|Overall Study|Protocol Violation|1
112932|NCT00415168|372929|P1|Overall Study|Withdrawal by Subject|6
112933|NCT00415168|372929|P1|Overall Study|Sponsor Decision|4
112934|NCT00415168|372929|P1|Overall Study|Physician Decision|13
112935|NCT00415168|372929|P1|Overall Study|Lost to Follow-up|3
112936|NCT00415168|372929|P1|Overall Study|Death|26
112937|NCT00415194|372941|P2|Overall Study|Death Due to AE (Other Causes)|15
112938|NCT00415194|372942|P1|Overall Study|Death Due to AE (Other Causes)|27
112939|NCT00415194|372941|P2|Overall Study|Death Due to Procedural Related AE|1
112940|NCT00415194|372942|P1|Overall Study|Death Due to Procedural Related AE|0
112941|NCT00415194|372941|P2|Overall Study|Death Due to Study Drug Related AE|1
112942|NCT00415194|372942|P1|Overall Study|Death Due to Study Drug Related AE|11
112943|NCT00415194|372941|P2|Overall Study|Death Due to Study Disease|29
112944|NCT00415194|372942|P1|Overall Study|Death Due to Study Disease|26
112945|NCT00415194|372941|P2|Overall Study|Withdrawal by Subject|21
112946|NCT00415194|372942|P1|Overall Study|Withdrawal by Subject|28
112947|NCT00415194|372941|P2|Overall Study|Protocol Violation|2
112948|NCT00415194|372942|P1|Overall Study|Protocol Violation|4
112949|NCT00415194|372941|P2|Overall Study|Progressive Disease|217
112950|NCT00415194|372942|P1|Overall Study|Progressive Disease|180
112951|NCT00415194|372941|P2|Overall Study|Physician Decision|16
112952|NCT00415194|372942|P1|Overall Study|Physician Decision|10
112953|NCT00415194|372941|P2|Overall Study|Lost to Follow-up|0
112954|NCT00415194|372942|P1|Overall Study|Lost to Follow-up|1
112955|NCT00415194|372941|P2|Overall Study|Entry Criteria Not Met|8
112956|NCT00415194|372942|P1|Overall Study|Entry Criteria Not Met|4
112957|NCT00415194|372941|P2|Overall Study|Adverse Event|32
112958|NCT00415194|372942|P1|Overall Study|Adverse Event|37
112959|NCT00408317|372969|P2|Second Intervention Period|Withdrawal of consent|1
112960|NCT00408317|372970|P1|Second Intervention Period|Withdrawal of consent|0
112961|NCT00408317|372969|P2|Second Intervention Period|Protocol Violation|1
112962|NCT00408317|372970|P1|Second Intervention Period|Protocol Violation|0
112963|NCT00408317|372969|P2|Second Intervention Period|Adverse Event|0
112964|NCT00408317|372970|P1|Second Intervention Period|Adverse Event|2
112965|NCT00408317|372969|P2|First Intervention Period|Adverse Event|1
112966|NCT00408317|372970|P1|First Intervention Period|Adverse Event|0
112967|NCT00408421|372984|P3|Treatment Re-Randomization|Withdrawal by Subject|0
112968|NCT00408421|372985|P2|Treatment Re-Randomization|Withdrawal by Subject|1
112969|NCT00408421|372986|P1|Treatment Re-Randomization|Withdrawal by Subject|2
112970|NCT00408421|372984|P3|Treatment Re-Randomization|Protocol Violation|0
112971|NCT00408421|372985|P2|Treatment Re-Randomization|Protocol Violation|1
112972|NCT00408421|372986|P1|Treatment Re-Randomization|Protocol Violation|1
112973|NCT00408421|372984|P3|Treatment Re-Randomization|Physician Decision|0
112974|NCT00408421|372985|P2|Treatment Re-Randomization|Physician Decision|3
112975|NCT00408421|372986|P1|Treatment Re-Randomization|Physician Decision|1
112976|NCT00408421|372984|P3|Treatment Re-Randomization|Lost to Follow-up|1
112977|NCT00408421|372985|P2|Treatment Re-Randomization|Lost to Follow-up|0
112978|NCT00408421|372986|P1|Treatment Re-Randomization|Lost to Follow-up|0
112979|NCT00408421|372984|P3|Treatment Re-Randomization|Lack of Efficacy|0
112980|NCT00408421|372985|P2|Treatment Re-Randomization|Lack of Efficacy|0
112981|NCT00408421|372986|P1|Treatment Re-Randomization|Lack of Efficacy|1
112982|NCT00408421|372984|P3|Treatment Re-Randomization|Adverse Event|4
112983|NCT00408421|372985|P2|Treatment Re-Randomization|Adverse Event|2
112984|NCT00408421|372986|P1|Treatment Re-Randomization|Adverse Event|2
112985|NCT00408421|372984|P3|Treatment Initial Randomization|Sponsor Decision|0
112986|NCT00408421|372985|P2|Treatment Initial Randomization|Sponsor Decision|0
112987|NCT00408421|372986|P1|Treatment Initial Randomization|Sponsor Decision|1
112988|NCT00408421|372984|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
112989|NCT00408421|372985|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
112990|NCT00408421|372986|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
112991|NCT00408421|372984|P3|Treatment Initial Randomization|Withdrawal by Subject|0
112992|NCT00408421|372985|P2|Treatment Initial Randomization|Withdrawal by Subject|7
112993|NCT00408421|372986|P1|Treatment Initial Randomization|Withdrawal by Subject|7
112994|NCT00408421|372984|P3|Treatment Initial Randomization|Protocol Violation|0
112995|NCT00408421|372985|P2|Treatment Initial Randomization|Protocol Violation|1
112996|NCT00408421|372986|P1|Treatment Initial Randomization|Protocol Violation|0
112997|NCT00408421|372984|P3|Treatment Initial Randomization|Physician Decision|0
112998|NCT00408421|372985|P2|Treatment Initial Randomization|Physician Decision|0
112999|NCT00408421|372986|P1|Treatment Initial Randomization|Physician Decision|1
113000|NCT00408421|372984|P3|Treatment Initial Randomization|Lost to Follow-up|0
113001|NCT00408421|372985|P2|Treatment Initial Randomization|Lost to Follow-up|3
113002|NCT00408421|372986|P1|Treatment Initial Randomization|Lost to Follow-up|0
113003|NCT00408421|372984|P3|Treatment Initial Randomization|Lack of Efficacy|0
113004|NCT00408421|372985|P2|Treatment Initial Randomization|Lack of Efficacy|2
113005|NCT00408421|372986|P1|Treatment Initial Randomization|Lack of Efficacy|2
113006|NCT00408421|372984|P3|Treatment Initial Randomization|Adverse Event|0
113007|NCT00408421|372985|P2|Treatment Initial Randomization|Adverse Event|9
113008|NCT00408421|372986|P1|Treatment Initial Randomization|Adverse Event|5
113009|NCT00408499|373066|P5|Phase II- MTD Expansion|treatment delay|3
113010|NCT00408499|373067|P4|Phase II- MTD Expansion|treatment delay|0
113011|NCT00408499|373068|P3|Phase II- MTD Expansion|treatment delay|0
113012|NCT00408499|373069|P2|Phase II- MTD Expansion|treatment delay|0
113013|NCT00408499|373070|P1|Phase II- MTD Expansion|treatment delay|0
113014|NCT00408499|373066|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
113015|NCT00408499|373067|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
113016|NCT00408499|373068|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
113017|NCT00408499|373069|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
113018|NCT00408499|373070|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
113019|NCT00408499|373066|P5|Phase II- MTD Expansion|Physician Decision|1
113020|NCT00408499|373067|P4|Phase II- MTD Expansion|Physician Decision|0
113021|NCT00408499|373068|P3|Phase II- MTD Expansion|Physician Decision|0
113022|NCT00408499|373069|P2|Phase II- MTD Expansion|Physician Decision|0
113023|NCT00408499|373070|P1|Phase II- MTD Expansion|Physician Decision|0
113024|NCT00408499|373066|P5|Phase II- MTD Expansion|Death|2
113025|NCT00408499|373067|P4|Phase II- MTD Expansion|Death|0
113026|NCT00408499|373068|P3|Phase II- MTD Expansion|Death|0
113027|NCT00408499|373069|P2|Phase II- MTD Expansion|Death|0
113028|NCT00408499|373070|P1|Phase II- MTD Expansion|Death|0
113029|NCT00408499|373066|P5|Phase II- MTD Expansion|Adverse Event|9
113030|NCT00408499|373067|P4|Phase II- MTD Expansion|Adverse Event|0
113031|NCT00408499|373068|P3|Phase II- MTD Expansion|Adverse Event|0
113032|NCT00408499|373069|P2|Phase II- MTD Expansion|Adverse Event|0
113033|NCT00408499|373070|P1|Phase II- MTD Expansion|Adverse Event|0
113034|NCT00408499|373066|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
113035|NCT00408499|373067|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
113036|NCT00408499|373068|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
113037|NCT00408499|373069|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
113038|NCT00408499|373070|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
113039|NCT00408499|373066|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
113040|NCT00408499|373067|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
113041|NCT00408499|373068|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
113042|NCT00408499|373069|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
113043|NCT00408499|373070|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
113044|NCT00408499|373066|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
113045|NCT00408499|373067|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
113046|NCT00408499|373068|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
113047|NCT00408499|373069|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
113048|NCT00408499|373070|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
113049|NCT00408629|373100|P2|Overall Study|Miscellaneous|15
113050|NCT00408629|373101|P1|Overall Study|Miscellaneous|11
113051|NCT00408629|373100|P2|Overall Study|Protocol Violation|5
113052|NCT00408629|373101|P1|Overall Study|Protocol Violation|1
113053|NCT00408629|373100|P2|Overall Study|Lack of Efficacy|73
113054|NCT00408629|373101|P1|Overall Study|Lack of Efficacy|63
113055|NCT00408629|373100|P2|Overall Study|Lost to Follow-up|1
113056|NCT00408629|373101|P1|Overall Study|Lost to Follow-up|1
113057|NCT00408629|373100|P2|Overall Study|Withdrawal by Subject|4
113058|NCT00408629|373101|P1|Overall Study|Withdrawal by Subject|8
113059|NCT00408629|373100|P2|Overall Study|Adverse Event|27
113060|NCT00408629|373101|P1|Overall Study|Adverse Event|13
113061|NCT00408681|373140|P1|Overall Study|Adverse Event|7
113062|NCT00408681|373140|P1|Overall Study|Lack of Efficacy|2
113063|NCT00408694|373157|P1|Overall Study|No protocol treatment|1
113064|NCT00408694|373157|P1|Overall Study|Ineligible|1
113065|NCT00415532|373183|P2|Safety Follow Up Period|Requirement for alternative therapy|1
113066|NCT00415532|373184|P1|Safety Follow Up Period|Requirement for alternative therapy|0
113067|NCT00415532|373183|P2|Safety Follow Up Period|Noncompliance|0
113068|NCT00415532|373184|P1|Safety Follow Up Period|Noncompliance|1
113069|NCT00415532|373183|P2|Safety Follow Up Period|Ineligibility determined|1
113070|NCT00415532|373184|P1|Safety Follow Up Period|Ineligibility determined|1
113071|NCT00415532|373183|P2|Safety Follow Up Period|Other|4
113072|NCT00415532|373184|P1|Safety Follow Up Period|Other|1
113073|NCT00415532|373183|P2|Safety Follow Up Period|Withdrawal by Subject|3
113074|NCT00415532|373184|P1|Safety Follow Up Period|Withdrawal by Subject|2
113075|NCT00415532|373183|P2|Safety Follow Up Period|Death|0
113076|NCT00415532|373184|P1|Safety Follow Up Period|Death|3
113077|NCT00415532|373183|P2|Safety Follow Up Period|Adverse Event|3
113078|NCT00415532|373184|P1|Safety Follow Up Period|Adverse Event|1
113079|NCT00415532|373183|P2|Treatment Period|Requirement for alternative therapy|0
113080|NCT00415532|373184|P1|Treatment Period|Requirement for alternative therapy|1
113081|NCT00415532|373183|P2|Treatment Period|Noncompliance|1
113082|NCT00415532|373184|P1|Treatment Period|Noncompliance|1
113083|NCT00415532|373183|P2|Treatment Period|Ineligibility determined|1
113084|NCT00415532|373184|P1|Treatment Period|Ineligibility determined|1
113085|NCT00415532|373183|P2|Treatment Period|Other|2
113086|NCT00415532|373184|P1|Treatment Period|Other|2
113087|NCT00415532|373183|P2|Treatment Period|Withdrawal by Subject|6
113088|NCT00415532|373184|P1|Treatment Period|Withdrawal by Subject|6
113089|NCT00415532|373183|P2|Treatment Period|Protocol Violation|0
113090|NCT00415532|373184|P1|Treatment Period|Protocol Violation|1
113091|NCT00415532|373183|P2|Treatment Period|Lost to Follow-up|1
113092|NCT00415532|373184|P1|Treatment Period|Lost to Follow-up|1
113093|NCT00415532|373183|P2|Treatment Period|Death|1
113094|NCT00415532|373184|P1|Treatment Period|Death|2
113095|NCT00415532|373183|P2|Treatment Period|Adverse Event|3
113096|NCT00415532|373184|P1|Treatment Period|Adverse Event|2
113097|NCT00418938|373206|P2|Overall Study|Ineligibility Determined|0
113098|NCT00418938|373207|P1|Overall Study|Ineligibility Determined|1
113099|NCT00418938|373206|P2|Overall Study|On-going|1
113100|NCT00418938|373207|P1|Overall Study|On-going|1
113101|NCT00418938|373206|P2|Overall Study|Adverse Event|1
113102|NCT00418938|373207|P1|Overall Study|Adverse Event|1
113103|NCT00418938|373206|P2|Overall Study|Lost to Follow-up|3
113104|NCT00418938|373207|P1|Overall Study|Lost to Follow-up|1
113105|NCT00418938|373206|P2|Overall Study|Withdrawal by Subject|15
113106|NCT00418938|373207|P1|Overall Study|Withdrawal by Subject|16
113107|NCT00418938|373206|P2|Overall Study|Administrative decision|3
113108|NCT00418938|373207|P1|Overall Study|Administrative decision|3
113109|NCT00418938|373206|P2|Overall Study|Reimbursement|0
113110|NCT00418938|373207|P1|Overall Study|Reimbursement|1
113111|NCT00419003|373270|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
113112|NCT00419003|373271|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
113113|NCT00419003|373270|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
113114|NCT00419003|373271|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
113115|NCT00419094|373282|P2|Overall Study|Other: No contact for extended period|1
113116|NCT00419094|373283|P1|Overall Study|Other: No contact for extended period|0
113117|NCT00419094|373282|P2|Overall Study|Other: Patient non-compliant|1
113118|NCT00419094|373283|P1|Overall Study|Other: Patient non-compliant|0
113119|NCT00419094|373282|P2|Overall Study|Other: Error determining exit criteria|0
113120|NCT00419094|373283|P1|Overall Study|Other: Error determining exit criteria|1
113121|NCT00419094|373282|P2|Overall Study|Withdrawal of consent|5
113122|NCT00419094|373283|P1|Overall Study|Withdrawal of consent|1
113123|NCT00419094|373282|P2|Overall Study|Protocol Violation|14
113124|NCT00419094|373283|P1|Overall Study|Protocol Violation|1
113125|NCT00419094|373282|P2|Overall Study|Lost to Follow-up|2
113126|NCT00419094|373283|P1|Overall Study|Lost to Follow-up|0
113127|NCT00419094|373282|P2|Overall Study|Lack of Efficacy|0
113128|NCT00419094|373283|P1|Overall Study|Lack of Efficacy|1
113129|NCT00419094|373282|P2|Overall Study|Adverse Event|7
113130|NCT00419094|373283|P1|Overall Study|Adverse Event|3
113131|NCT00419120|373295|P1|Long Term Follow up Period|study ongoing|10
113132|NCT00419159|373302|P2|Overall Study|Disease progression|76
113133|NCT00419159|373303|P1|Overall Study|Disease progression|79
113134|NCT00419159|373302|P2|Overall Study|Death|2
113135|NCT00419159|373303|P1|Overall Study|Death|2
113136|NCT00419159|373302|P2|Overall Study|Lost to Follow-up|1
113137|NCT00419159|373303|P1|Overall Study|Lost to Follow-up|0
113138|NCT00419159|373302|P2|Overall Study|Withdrawal by Subject|3
113139|NCT00419159|373303|P1|Overall Study|Withdrawal by Subject|10
113140|NCT00419159|373302|P2|Overall Study|Protocol Violation|0
113141|NCT00419159|373303|P1|Overall Study|Protocol Violation|1
113142|NCT00419159|373302|P2|Overall Study|Subject's no longer requires study drug|1
113143|NCT00419159|373303|P1|Overall Study|Subject's no longer requires study drug|0
113144|NCT00419159|373302|P2|Overall Study|Abnormal laboratory value(s)|2
113145|NCT00419159|373303|P1|Overall Study|Abnormal laboratory value(s)|0
113146|NCT00419159|373302|P2|Overall Study|Adverse Event|15
113147|NCT00419159|373303|P1|Overall Study|Adverse Event|7
113148|NCT00419263|373320|P3|Overall Study|Withdrawal by Subject|1
113149|NCT00419263|373321|P2|Overall Study|Withdrawal by Subject|0
113150|NCT00419263|373322|P1|Overall Study|Withdrawal by Subject|0
113151|NCT00419263|373320|P3|Overall Study|Adverse Event|1
113152|NCT00419263|373321|P2|Overall Study|Adverse Event|0
113153|NCT00419263|373322|P1|Overall Study|Adverse Event|0
113154|NCT00419263|373320|P3|Overall Study|Randomized in Error, Not Treated|0
113155|NCT00419263|373321|P2|Overall Study|Randomized in Error, Not Treated|1
113156|NCT00419263|373322|P1|Overall Study|Randomized in Error, Not Treated|1
113157|NCT00419263|373320|P3|Overall Study|Lost to Follow-up|1
113158|NCT00419263|373321|P2|Overall Study|Lost to Follow-up|1
113159|NCT00419263|373322|P1|Overall Study|Lost to Follow-up|2
113160|NCT00419341|373360|P1|Efficacy Period|Termination of study site|1
113161|NCT00419341|373360|P1|Efficacy Period|Non-compliance|1
113162|NCT00419341|373360|P1|Efficacy Period|Lost to Follow-up|1
113163|NCT00419341|373360|P1|Efficacy Period|Protocol Violation|1
113164|NCT00419341|373360|P1|Efficacy Period|Withdrawal by Subject|6
113165|NCT00419341|373360|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
113166|NCT00419341|373360|P1|Wash in/Wash Out Period|Adverse Event|2
113167|NCT00419341|373360|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
113168|NCT00419380|373383|P2|Overall Study|Withdrawal by Subject|1
113169|NCT00419380|373384|P1|Overall Study|Withdrawal by Subject|0
113170|NCT00419380|373383|P2|Overall Study|Lost to Follow-up|1
113171|NCT00419380|373384|P1|Overall Study|Lost to Follow-up|0
113172|NCT00419380|373383|P2|Overall Study|Physician Decision|1
113173|NCT00419380|373384|P1|Overall Study|Physician Decision|0
113174|NCT00419380|373383|P2|Overall Study|Lack of Efficacy|7
113175|NCT00419380|373384|P1|Overall Study|Lack of Efficacy|1
113176|NCT00419393|373392|P1|Overall Study|Other: Investigator decision|1
113177|NCT00419393|373392|P1|Overall Study|Other: Other health problems|1
113178|NCT00419393|373392|P1|Overall Study|Other: Site closure|1
113179|NCT00419393|373392|P1|Overall Study|Other: Subject had temporal lobectomy|1
113180|NCT00419393|373392|P1|Overall Study|Other: Sponsor request|3
113181|NCT00419393|373392|P1|Overall Study|Withdrawal by Subject|7
113182|NCT00419393|373392|P1|Overall Study|Protocol Violation|5
113183|NCT00419393|373392|P1|Overall Study|Adverse Event|5
113184|NCT00419744|373416|P3|Overall Study|Incorrect medication kit dispensed|1
113185|NCT00419744|373417|P2|Overall Study|Incorrect medication kit dispensed|0
113186|NCT00419744|373418|P1|Overall Study|Incorrect medication kit dispensed|0
113187|NCT00419744|373416|P3|Overall Study|Spirometry mouthpiece issues|2
113188|NCT00419744|373417|P2|Overall Study|Spirometry mouthpiece issues|1
113189|NCT00419744|373418|P1|Overall Study|Spirometry mouthpiece issues|0
113190|NCT00419744|373416|P3|Overall Study|Physician Decision|6
113191|NCT00419744|373417|P2|Overall Study|Physician Decision|5
113192|NCT00419744|373418|P1|Overall Study|Physician Decision|10
113193|NCT00419744|373416|P3|Overall Study|Moving out of state|1
113194|NCT00419744|373417|P2|Overall Study|Moving out of state|0
113195|NCT00419744|373418|P1|Overall Study|Moving out of state|2
113196|NCT00419744|373416|P3|Overall Study|Randomized in error|7
113197|NCT00419744|373417|P2|Overall Study|Randomized in error|6
113198|NCT00419744|373418|P1|Overall Study|Randomized in error|9
113199|NCT00419744|373416|P3|Overall Study|Protocol Violation|8
113200|NCT00419744|373417|P2|Overall Study|Protocol Violation|7
113201|NCT00419744|373418|P1|Overall Study|Protocol Violation|4
113202|NCT00419744|373416|P3|Overall Study|Lost to Follow-up|6
113203|NCT00419744|373417|P2|Overall Study|Lost to Follow-up|10
113204|NCT00419744|373418|P1|Overall Study|Lost to Follow-up|8
113205|NCT00419744|373416|P3|Overall Study|Withdrawal by Subject|52
113206|NCT00419744|373417|P2|Overall Study|Withdrawal by Subject|49
113207|NCT00419744|373418|P1|Overall Study|Withdrawal by Subject|45
113208|NCT00419744|373416|P3|Overall Study|Adverse Event|50
113209|NCT00419744|373417|P2|Overall Study|Adverse Event|40
113210|NCT00419744|373418|P1|Overall Study|Adverse Event|39
113211|NCT00419757|373449|P2|Overall Study|Multiple reasons|1
113212|NCT00419757|373450|P1|Overall Study|Multiple reasons|3
113213|NCT00419757|373449|P2|Overall Study|Study specific discontinuation criteria|8
113214|NCT00419757|373450|P1|Overall Study|Study specific discontinuation criteria|4
113215|NCT00419757|373449|P2|Overall Study|Protocol Violation|3
113216|NCT00419757|373450|P1|Overall Study|Protocol Violation|2
113217|NCT00419757|373449|P2|Overall Study|Withdrawal by Subject|1
113218|NCT00419757|373450|P1|Overall Study|Withdrawal by Subject|7
113219|NCT00419757|373449|P2|Overall Study|Lost to Follow-up|4
113220|NCT00419757|373450|P1|Overall Study|Lost to Follow-up|1
113221|NCT00419757|373449|P2|Overall Study|Adverse Event|4
113222|NCT00419757|373450|P1|Overall Study|Adverse Event|1
113223|NCT00419770|373488|P2|Overall Study|Withdrawal by Subject|1
113224|NCT00419770|373489|P1|Overall Study|Withdrawal by Subject|5
113225|NCT00419926|373497|P2|Overall Study|Death|1
113226|NCT00419926|373498|P1|Overall Study|Death|2
113227|NCT00419926|373497|P2|Overall Study|Lost to Follow-up|2
113228|NCT00419926|373498|P1|Overall Study|Lost to Follow-up|1
113229|NCT00419926|373497|P2|Overall Study|Administrative Problem|4
113230|NCT00419926|373498|P1|Overall Study|Administrative Problem|4
113231|NCT00419926|373497|P2|Overall Study|Withdrawal by Subject|3
113232|NCT00419926|373498|P1|Overall Study|Withdrawal by Subject|7
113233|NCT00419952|373514|P2|Overall Study|Abnormal ECG|0
113234|NCT00419952|373515|P1|Overall Study|Abnormal ECG|1
113235|NCT00419952|373514|P2|Overall Study|Diary or medication non-compliance|4
113236|NCT00419952|373515|P1|Overall Study|Diary or medication non-compliance|2
113237|NCT00419952|373514|P2|Overall Study|Occurence of 2 or more exacerbations|0
113238|NCT00419952|373515|P1|Overall Study|Occurence of 2 or more exacerbations|2
113239|NCT00419952|373514|P2|Overall Study|Intake of prohibited medication|2
113240|NCT00419952|373515|P1|Overall Study|Intake of prohibited medication|2
113241|NCT00419952|373514|P2|Overall Study|Incorrectly enrolled|3
113242|NCT00419952|373515|P1|Overall Study|Incorrectly enrolled|10
113243|NCT00419952|373514|P2|Overall Study|Physician Decision|3
113244|NCT00419952|373515|P1|Overall Study|Physician Decision|1
113245|NCT00419952|373514|P2|Overall Study|Pregnancy|2
113246|NCT00419952|373515|P1|Overall Study|Pregnancy|4
113247|NCT00419952|373514|P2|Overall Study|Protocol Violation|24
113248|NCT00419952|373515|P1|Overall Study|Protocol Violation|32
113249|NCT00419952|373514|P2|Overall Study|Lost to Follow-up|34
113250|NCT00419952|373515|P1|Overall Study|Lost to Follow-up|43
113251|NCT00419952|373514|P2|Overall Study|Withdrawal by Subject|43
113252|NCT00419952|373515|P1|Overall Study|Withdrawal by Subject|44
113253|NCT00419952|373514|P2|Overall Study|Adverse Event|10
113254|NCT00419952|373515|P1|Overall Study|Adverse Event|8
113255|NCT00420056|373562|P1|Overall Study|Objective progression or relapse|17
113256|NCT00420095|373586|P2|Overall Study|Lost to Follow-up|0
113257|NCT00420095|373587|P1|Overall Study|Lost to Follow-up|1
113258|NCT00420095|373586|P2|Overall Study|Protocol Violation|1
113259|NCT00420095|373587|P1|Overall Study|Protocol Violation|1
113260|NCT00420095|373586|P2|Overall Study|Adverse Event|0
113261|NCT00420095|373587|P1|Overall Study|Adverse Event|1
113262|NCT00420199|373618|P2|Overall Study|Participant no longer met study criteria|0
113263|NCT00420199|373619|P1|Overall Study|Participant no longer met study criteria|1
113264|NCT00420212|373675|P3|Overall Study|Other-Unspecified|18
113265|NCT00420212|373676|P2|Overall Study|Other-Unspecified|14
113266|NCT00420212|373677|P1|Overall Study|Other-Unspecified|21
113267|NCT00420212|373675|P3|Overall Study|Death|1
113268|NCT00420212|373676|P2|Overall Study|Death|0
113269|NCT00420212|373677|P1|Overall Study|Death|0
113270|NCT00420212|373675|P3|Overall Study|Protocol Violation|8
113271|NCT00420212|373676|P2|Overall Study|Protocol Violation|4
113272|NCT00420212|373677|P1|Overall Study|Protocol Violation|4
113273|NCT00420212|373675|P3|Overall Study|Physician Decision|3
113274|NCT00420212|373676|P2|Overall Study|Physician Decision|4
113275|NCT00420212|373677|P1|Overall Study|Physician Decision|4
113276|NCT00420212|373675|P3|Overall Study|Withdrawal by Subject|19
113277|NCT00420212|373676|P2|Overall Study|Withdrawal by Subject|22
113278|NCT00420212|373677|P1|Overall Study|Withdrawal by Subject|31
113279|NCT00420212|373675|P3|Overall Study|Lost to Follow-up|11
113280|NCT00420212|373676|P2|Overall Study|Lost to Follow-up|11
113281|NCT00420212|373677|P1|Overall Study|Lost to Follow-up|9
113282|NCT00420212|373675|P3|Overall Study|Adverse Event|36
113283|NCT00420212|373676|P2|Overall Study|Adverse Event|40
113284|NCT00420212|373677|P1|Overall Study|Adverse Event|22
113285|NCT00420238|373703|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
113286|NCT00420238|373704|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
113287|NCT00420238|373703|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
113288|NCT00420238|373704|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
113289|NCT00420238|373703|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
113290|NCT00420238|373704|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
113291|NCT00420238|373703|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
113292|NCT00420238|373704|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
113293|NCT00420238|373703|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
113294|NCT00420238|373704|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
113295|NCT00420238|373703|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
113296|NCT00420238|373704|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
113297|NCT00420290|373842|P2|Overall Study|did not meet inclusion/exclusion|1
113298|NCT00420290|373843|P1|Overall Study|did not meet inclusion/exclusion|1
113299|NCT00420290|373842|P2|Overall Study|Withdrawal by Subject|2
113300|NCT00420290|373843|P1|Overall Study|Withdrawal by Subject|0
113301|NCT00420290|373842|P2|Overall Study|Adverse Event|1
113302|NCT00420290|373843|P1|Overall Study|Adverse Event|3
113303|NCT00420303|373859|P2|Overall Study|Physician Decision|1
113304|NCT00420303|373860|P1|Overall Study|Physician Decision|0
113305|NCT00420303|373859|P2|Overall Study|Lack of Efficacy|3
113306|NCT00420303|373860|P1|Overall Study|Lack of Efficacy|0
113307|NCT00420303|373859|P2|Overall Study|Serious Adverse Event|0
113308|NCT00420303|373860|P1|Overall Study|Serious Adverse Event|1
113309|NCT00420316|373872|P2|Overall Study|Lost to Follow-up|8
113310|NCT00420316|373873|P1|Overall Study|Lost to Follow-up|12
113311|NCT00420316|373872|P2|Overall Study|Withdrawal by Subject|1
113312|NCT00420316|373873|P1|Overall Study|Withdrawal by Subject|0
113313|NCT00420342|373898|P3|Overall Study|Withdrawal by Subject|0
113314|NCT00420342|373899|P2|Overall Study|Withdrawal by Subject|2
113315|NCT00420342|373900|P1|Overall Study|Withdrawal by Subject|0
113316|NCT00420342|373898|P3|Overall Study|Lost to Follow-up|1
113317|NCT00420342|373899|P2|Overall Study|Lost to Follow-up|0
113318|NCT00420342|373900|P1|Overall Study|Lost to Follow-up|1
113319|NCT00420407|373943|P2|Overall Study|Withdrawal by Subject|2
113320|NCT00420407|373944|P1|Overall Study|Withdrawal by Subject|0
113321|NCT00420407|373943|P2|Overall Study|subject identified as Jehovah's witness|0
113322|NCT00420407|373944|P1|Overall Study|subject identified as Jehovah's witness|1
113323|NCT00420407|373943|P2|Overall Study|subject identified as detainee|0
113324|NCT00420407|373944|P1|Overall Study|subject identified as detainee|1
113325|NCT00420407|373943|P2|Overall Study|Physician Decision|1
113326|NCT00420407|373944|P1|Overall Study|Physician Decision|2
113327|NCT00420407|373943|P2|Overall Study|Lost to Follow-up|3
113328|NCT00420407|373944|P1|Overall Study|Lost to Follow-up|0
113329|NCT00420420|373952|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
113330|NCT00420420|373953|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
113331|NCT00420420|373952|P2|Overall Study|Withdrawal by Subject|0
113332|NCT00420420|373953|P1|Overall Study|Withdrawal by Subject|1
113333|NCT00420420|373952|P2|Overall Study|Protocol Violation|1
113334|NCT00420420|373953|P1|Overall Study|Protocol Violation|1
113335|NCT00420420|373952|P2|Overall Study|Adverse Event|3
113336|NCT00420420|373953|P1|Overall Study|Adverse Event|5
113337|NCT00420511|373980|P2|Overall Study|Lost to Follow-up|0
113338|NCT00420511|373981|P1|Overall Study|Lost to Follow-up|1
113339|NCT00420511|373980|P2|Overall Study|Adverse Event|1
113340|NCT00420511|373981|P1|Overall Study|Adverse Event|1
113341|NCT00420628|373993|P2|Overall Study|Adverse Event|0
113342|NCT00420628|373994|P1|Overall Study|Adverse Event|1
113343|NCT00420628|373993|P2|Overall Study|Lost to Follow-up|2
113344|NCT00420628|373994|P1|Overall Study|Lost to Follow-up|3
113345|NCT00420628|373993|P2|Overall Study|Withdrawn by parent or gaurdian|2
113346|NCT00420628|373994|P1|Overall Study|Withdrawn by parent or gaurdian|5
113347|NCT00420745|374010|P2|Overall Study|Age limit exceeded for Dose 2|0
113348|NCT00420745|374011|P1|Overall Study|Age limit exceeded for Dose 2|1
113349|NCT00420745|374010|P2|Overall Study|Recurrent pneumonia & bronchitis|1
113350|NCT00420745|374011|P1|Overall Study|Recurrent pneumonia & bronchitis|0
113351|NCT00420745|374010|P2|Overall Study|Physician Decision|1
113352|NCT00420745|374011|P1|Overall Study|Physician Decision|1
113353|NCT00420745|374010|P2|Overall Study|Protocol Violation|0
113354|NCT00420745|374011|P1|Overall Study|Protocol Violation|1
113355|NCT00420745|374010|P2|Overall Study|Lost to Follow-up|2
113356|NCT00420745|374011|P1|Overall Study|Lost to Follow-up|10
113357|NCT00420745|374010|P2|Overall Study|Adverse Event|2
113358|NCT00420745|374011|P1|Overall Study|Adverse Event|2
113359|NCT00420784|374031|P4|Overall Study|Unspecified|5
113360|NCT00420784|374032|P3|Overall Study|Unspecified|0
113361|NCT00420784|374033|P2|Overall Study|Unspecified|2
113362|NCT00420784|374034|P1|Overall Study|Unspecified|1
113363|NCT00420784|374031|P4|Overall Study|Virologic Stopping Rule|67
113364|NCT00420784|374032|P3|Overall Study|Virologic Stopping Rule|41
113365|NCT00420784|374033|P2|Overall Study|Virologic Stopping Rule|26
113366|NCT00420784|374034|P1|Overall Study|Virologic Stopping Rule|17
113367|NCT00420784|374031|P4|Overall Study|Lost to Follow-up|1
113368|NCT00420784|374032|P3|Overall Study|Lost to Follow-up|2
113369|NCT00420784|374033|P2|Overall Study|Lost to Follow-up|0
113370|NCT00420784|374034|P1|Overall Study|Lost to Follow-up|0
113371|NCT00420784|374031|P4|Overall Study|Withdrawal by Subject|0
113372|NCT00420784|374032|P3|Overall Study|Withdrawal by Subject|0
113373|NCT00420784|374033|P2|Overall Study|Withdrawal by Subject|1
113374|NCT00420784|374034|P1|Overall Study|Withdrawal by Subject|0
113375|NCT00420784|374031|P4|Overall Study|Adverse Event|5
113376|NCT00420784|374032|P3|Overall Study|Adverse Event|10
113377|NCT00420784|374033|P2|Overall Study|Adverse Event|29
113378|NCT00420784|374034|P1|Overall Study|Adverse Event|11
113379|NCT00420849|374061|P1|Overall Study|Lost to Follow-up|1
113380|NCT00420849|374061|P1|Overall Study|Protocol Violation|1
113381|NCT00420849|374061|P1|Overall Study|Transplant|8
113382|NCT00420849|374061|P1|Overall Study|Not specified|14
113383|NCT00420849|374061|P1|Overall Study|Death|18
113384|NCT00420849|374061|P1|Overall Study|Withdrawal by Subject|28
113385|NCT00420849|374061|P1|Overall Study|Adverse Event|107
113386|NCT00420849|374061|P1|Overall Study|Lack of Efficacy|154
113387|NCT00420927|374133|P7|Period 2|Took prohibited medication|0
113388|NCT00420927|374134|P6|Period 2|Took prohibited medication|0
113389|NCT00420927|374135|P5|Period 2|Took prohibited medication|1
113390|NCT00420927|374136|P4|Period 2|Took prohibited medication|0
113391|NCT00420927|374137|P3|Period 2|Took prohibited medication|0
113392|NCT00420927|374138|P2|Period 2|Took prohibited medication|0
113393|NCT00420927|374139|P1|Period 2|Took prohibited medication|0
113394|NCT00420927|374133|P7|Period 2|Methotrexate intolerance|1
113395|NCT00420927|374134|P6|Period 2|Methotrexate intolerance|0
113396|NCT00420927|374135|P5|Period 2|Methotrexate intolerance|0
113397|NCT00420927|374136|P4|Period 2|Methotrexate intolerance|0
113398|NCT00420927|374137|P3|Period 2|Methotrexate intolerance|0
113399|NCT00420927|374138|P2|Period 2|Methotrexate intolerance|0
113400|NCT00420927|374139|P1|Period 2|Methotrexate intolerance|0
113401|NCT00420927|374133|P7|Period 2|Noncompliant with study drug|2
113402|NCT00420927|374134|P6|Period 2|Noncompliant with study drug|0
113403|NCT00420927|374135|P5|Period 2|Noncompliant with study drug|0
113404|NCT00420927|374136|P4|Period 2|Noncompliant with study drug|1
113405|NCT00420927|374137|P3|Period 2|Noncompliant with study drug|0
113406|NCT00420927|374138|P2|Period 2|Noncompliant with study drug|0
113407|NCT00420927|374139|P1|Period 2|Noncompliant with study drug|0
113408|NCT00420927|374133|P7|Period 2|Randomization error|0
113409|NCT00420927|374134|P6|Period 2|Randomization error|1
113410|NCT00420927|374135|P5|Period 2|Randomization error|1
113411|NCT00420927|374136|P4|Period 2|Randomization error|0
113412|NCT00420927|374137|P3|Period 2|Randomization error|0
113413|NCT00420927|374138|P2|Period 2|Randomization error|0
113414|NCT00420927|374139|P1|Period 2|Randomization error|0
113415|NCT00420927|374133|P7|Period 2|Sponsor decision|1
113416|NCT00420927|374134|P6|Period 2|Sponsor decision|0
113417|NCT00420927|374135|P5|Period 2|Sponsor decision|0
113418|NCT00420927|374136|P4|Period 2|Sponsor decision|0
113419|NCT00420927|374137|P3|Period 2|Sponsor decision|1
113420|NCT00420927|374138|P2|Period 2|Sponsor decision|0
113421|NCT00420927|374139|P1|Period 2|Sponsor decision|0
113422|NCT00420927|374133|P7|Period 2|Physician Decision|0
113423|NCT00420927|374134|P6|Period 2|Physician Decision|1
113424|NCT00420927|374135|P5|Period 2|Physician Decision|1
113425|NCT00420927|374136|P4|Period 2|Physician Decision|0
113426|NCT00420927|374137|P3|Period 2|Physician Decision|0
113427|NCT00420927|374138|P2|Period 2|Physician Decision|0
113428|NCT00420927|374139|P1|Period 2|Physician Decision|0
113429|NCT00420927|374133|P7|Period 2|Subject unable to find transportation|1
113430|NCT00420927|374134|P6|Period 2|Subject unable to find transportation|0
113431|NCT00420927|374135|P5|Period 2|Subject unable to find transportation|0
113432|NCT00420927|374136|P4|Period 2|Subject unable to find transportation|0
113433|NCT00420927|374137|P3|Period 2|Subject unable to find transportation|0
113434|NCT00420927|374138|P2|Period 2|Subject unable to find transportation|0
113435|NCT00420927|374139|P1|Period 2|Subject unable to find transportation|0
113436|NCT00420927|374133|P7|Period 2|Received wrong treatment/incorrect dose|1
113437|NCT00420927|374134|P6|Period 2|Received wrong treatment/incorrect dose|0
113438|NCT00420927|374135|P5|Period 2|Received wrong treatment/incorrect dose|0
113439|NCT00420927|374136|P4|Period 2|Received wrong treatment/incorrect dose|0
113440|NCT00420927|374137|P3|Period 2|Received wrong treatment/incorrect dose|0
113441|NCT00420927|374138|P2|Period 2|Received wrong treatment/incorrect dose|0
113442|NCT00420927|374139|P1|Period 2|Received wrong treatment/incorrect dose|0
113443|NCT00420927|374133|P7|Period 2|Lack of efficacy/Loss of efficacy|6
113444|NCT00420927|374134|P6|Period 2|Lack of efficacy/Loss of efficacy|2
113445|NCT00420927|374135|P5|Period 2|Lack of efficacy/Loss of efficacy|6
113446|NCT00420927|374136|P4|Period 2|Lack of efficacy/Loss of efficacy|1
113447|NCT00420927|374137|P3|Period 2|Lack of efficacy/Loss of efficacy|2
113448|NCT00420927|374138|P2|Period 2|Lack of efficacy/Loss of efficacy|0
113449|NCT00420927|374139|P1|Period 2|Lack of efficacy/Loss of efficacy|0
113450|NCT00420927|374133|P7|Period 2|Lost to Follow-up|9
113451|NCT00420927|374134|P6|Period 2|Lost to Follow-up|3
113452|NCT00420927|374135|P5|Period 2|Lost to Follow-up|6
113453|NCT00420927|374136|P4|Period 2|Lost to Follow-up|2
113454|NCT00420927|374137|P3|Period 2|Lost to Follow-up|2
113455|NCT00420927|374138|P2|Period 2|Lost to Follow-up|0
113456|NCT00420927|374139|P1|Period 2|Lost to Follow-up|0
113457|NCT00420927|374133|P7|Period 2|Withdrawal by Subject|12
113458|NCT00420927|374134|P6|Period 2|Withdrawal by Subject|2
113459|NCT00420927|374135|P5|Period 2|Withdrawal by Subject|11
113460|NCT00420927|374136|P4|Period 2|Withdrawal by Subject|3
113461|NCT00420927|374137|P3|Period 2|Withdrawal by Subject|1
113462|NCT00420927|374138|P2|Period 2|Withdrawal by Subject|0
113463|NCT00420927|374139|P1|Period 2|Withdrawal by Subject|0
113464|NCT00420927|374133|P7|Period 2|Adverse Event|20
113465|NCT00420927|374134|P6|Period 2|Adverse Event|6
113466|NCT00420927|374135|P5|Period 2|Adverse Event|17
113467|NCT00420927|374136|P4|Period 2|Adverse Event|3
113468|NCT00420927|374137|P3|Period 2|Adverse Event|7
113469|NCT00420927|374138|P2|Period 2|Adverse Event|0
113470|NCT00420927|374139|P1|Period 2|Adverse Event|0
113471|NCT00420927|374133|P7|Period 1|Took prohibited medication|0
113472|NCT00420927|374134|P6|Period 1|Took prohibited medication|0
113473|NCT00420927|374135|P5|Period 1|Took prohibited medication|0
113474|NCT00420927|374136|P4|Period 1|Took prohibited medication|0
113475|NCT00420927|374137|P3|Period 1|Took prohibited medication|0
113476|NCT00420927|374138|P2|Period 1|Took prohibited medication|3
113477|NCT00420927|374139|P1|Period 1|Took prohibited medication|1
113478|NCT00420927|374133|P7|Period 1|Failed to meet entry criteria|0
113479|NCT00420927|374134|P6|Period 1|Failed to meet entry criteria|0
113480|NCT00420927|374135|P5|Period 1|Failed to meet entry criteria|0
113481|NCT00420927|374136|P4|Period 1|Failed to meet entry criteria|0
113482|NCT00420927|374137|P3|Period 1|Failed to meet entry criteria|0
113483|NCT00420927|374138|P2|Period 1|Failed to meet entry criteria|7
113484|NCT00420927|374139|P1|Period 1|Failed to meet entry criteria|8
113485|NCT00420927|374133|P7|Period 1|Received wrong treatment/incorrect dose|0
113486|NCT00420927|374134|P6|Period 1|Received wrong treatment/incorrect dose|0
113487|NCT00420927|374135|P5|Period 1|Received wrong treatment/incorrect dose|0
113488|NCT00420927|374136|P4|Period 1|Received wrong treatment/incorrect dose|0
113489|NCT00420927|374137|P3|Period 1|Received wrong treatment/incorrect dose|0
113490|NCT00420927|374138|P2|Period 1|Received wrong treatment/incorrect dose|1
113491|NCT00420927|374139|P1|Period 1|Received wrong treatment/incorrect dose|0
113492|NCT00420927|374133|P7|Period 1|Subject received new diagnosis|0
113493|NCT00420927|374134|P6|Period 1|Subject received new diagnosis|0
113494|NCT00420927|374135|P5|Period 1|Subject received new diagnosis|0
113495|NCT00420927|374136|P4|Period 1|Subject received new diagnosis|0
113496|NCT00420927|374137|P3|Period 1|Subject received new diagnosis|0
113497|NCT00420927|374138|P2|Period 1|Subject received new diagnosis|2
113498|NCT00420927|374139|P1|Period 1|Subject received new diagnosis|0
113499|NCT00420927|374133|P7|Period 1|Study site closure|0
113500|NCT00420927|374134|P6|Period 1|Study site closure|0
113501|NCT00420927|374135|P5|Period 1|Study site closure|0
113502|NCT00420927|374136|P4|Period 1|Study site closure|0
113503|NCT00420927|374137|P3|Period 1|Study site closure|0
113504|NCT00420927|374138|P2|Period 1|Study site closure|1
113505|NCT00420927|374139|P1|Period 1|Study site closure|0
113506|NCT00420927|374133|P7|Period 1|Suspected tuberculosis/positive test|0
113507|NCT00420927|374134|P6|Period 1|Suspected tuberculosis/positive test|0
113508|NCT00420927|374135|P5|Period 1|Suspected tuberculosis/positive test|0
113509|NCT00420927|374136|P4|Period 1|Suspected tuberculosis/positive test|0
113510|NCT00420927|374137|P3|Period 1|Suspected tuberculosis/positive test|0
113511|NCT00420927|374138|P2|Period 1|Suspected tuberculosis/positive test|1
113512|NCT00420927|374139|P1|Period 1|Suspected tuberculosis/positive test|1
113513|NCT00420927|374133|P7|Period 1|Randomization error|0
113514|NCT00420927|374134|P6|Period 1|Randomization error|0
113515|NCT00420927|374135|P5|Period 1|Randomization error|0
113516|NCT00420927|374136|P4|Period 1|Randomization error|0
113517|NCT00420927|374137|P3|Period 1|Randomization error|0
113518|NCT00420927|374138|P2|Period 1|Randomization error|0
113519|NCT00420927|374139|P1|Period 1|Randomization error|1
113520|NCT00420927|374133|P7|Period 1|Noncompliant with study drug|0
113521|NCT00420927|374134|P6|Period 1|Noncompliant with study drug|0
113522|NCT00420927|374135|P5|Period 1|Noncompliant with study drug|0
113523|NCT00420927|374136|P4|Period 1|Noncompliant with study drug|0
113524|NCT00420927|374137|P3|Period 1|Noncompliant with study drug|0
113525|NCT00420927|374138|P2|Period 1|Noncompliant with study drug|1
113526|NCT00420927|374139|P1|Period 1|Noncompliant with study drug|1
113527|NCT00420927|374133|P7|Period 1|Subject moved/relocated|0
113528|NCT00420927|374134|P6|Period 1|Subject moved/relocated|0
113529|NCT00420927|374135|P5|Period 1|Subject moved/relocated|0
113530|NCT00420927|374136|P4|Period 1|Subject moved/relocated|0
113531|NCT00420927|374137|P3|Period 1|Subject moved/relocated|0
113532|NCT00420927|374138|P2|Period 1|Subject moved/relocated|2
113533|NCT00420927|374139|P1|Period 1|Subject moved/relocated|0
113534|NCT00420927|374133|P7|Period 1|Death|0
113535|NCT00420927|374134|P6|Period 1|Death|0
113536|NCT00420927|374135|P5|Period 1|Death|0
113537|NCT00420927|374136|P4|Period 1|Death|0
113538|NCT00420927|374137|P3|Period 1|Death|0
113539|NCT00420927|374138|P2|Period 1|Death|0
113540|NCT00420927|374139|P1|Period 1|Death|2
113541|NCT00420927|374133|P7|Period 1|Lack of efficacy/Loss of efficacy|0
113542|NCT00420927|374134|P6|Period 1|Lack of efficacy/Loss of efficacy|0
113543|NCT00420927|374135|P5|Period 1|Lack of efficacy/Loss of efficacy|0
113544|NCT00420927|374136|P4|Period 1|Lack of efficacy/Loss of efficacy|0
113545|NCT00420927|374137|P3|Period 1|Lack of efficacy/Loss of efficacy|0
113546|NCT00420927|374138|P2|Period 1|Lack of efficacy/Loss of efficacy|6
113547|NCT00420927|374139|P1|Period 1|Lack of efficacy/Loss of efficacy|1
113548|NCT00420927|374133|P7|Period 1|Lost to Follow-up|0
113549|NCT00420927|374134|P6|Period 1|Lost to Follow-up|0
113550|NCT00420927|374135|P5|Period 1|Lost to Follow-up|0
113551|NCT00420927|374136|P4|Period 1|Lost to Follow-up|0
113552|NCT00420927|374137|P3|Period 1|Lost to Follow-up|0
113553|NCT00420927|374138|P2|Period 1|Lost to Follow-up|6
113554|NCT00420927|374139|P1|Period 1|Lost to Follow-up|8
113555|NCT00420927|374133|P7|Period 1|Withdrawal by Subject|0
113556|NCT00420927|374134|P6|Period 1|Withdrawal by Subject|0
113557|NCT00420927|374135|P5|Period 1|Withdrawal by Subject|0
113558|NCT00420927|374136|P4|Period 1|Withdrawal by Subject|0
113559|NCT00420927|374137|P3|Period 1|Withdrawal by Subject|0
113560|NCT00420927|374138|P2|Period 1|Withdrawal by Subject|12
113561|NCT00420927|374139|P1|Period 1|Withdrawal by Subject|7
113562|NCT00420927|374133|P7|Period 1|Adverse Event|0
113563|NCT00420927|374134|P6|Period 1|Adverse Event|0
113564|NCT00420927|374135|P5|Period 1|Adverse Event|0
113565|NCT00420927|374136|P4|Period 1|Adverse Event|0
113566|NCT00420927|374137|P3|Period 1|Adverse Event|0
113567|NCT00420927|374138|P2|Period 1|Adverse Event|15
113568|NCT00420927|374139|P1|Period 1|Adverse Event|19
113569|NCT00421174|374255|P2|Overall Study|Ineligible due to infection|0
113570|NCT00421174|374256|P1|Overall Study|Ineligible due to infection|2
113571|NCT00421174|374255|P2|Overall Study|Withdrawal by Subject|1
113572|NCT00421174|374256|P1|Overall Study|Withdrawal by Subject|0
113573|NCT00421343|374284|P1|Overall Study|Lost to follow-up|3
113574|NCT00421343|374284|P1|Overall Study|Withdrawal by Subject|2
113575|NCT00421343|374284|P1|Overall Study|Death|1
113576|NCT00421408|374290|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
113577|NCT00421408|374291|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
113578|NCT00421408|374290|P2|Overall Study|Lost to Follow-up|20
113579|NCT00421408|374291|P1|Overall Study|Lost to Follow-up|30
113580|NCT00411762|374328|P1|Overall Study|Withdrawal by Subject|5
113581|NCT00411788|374333|P1|Overall Study|Adverse Event|1
113582|NCT00411788|374333|P1|Overall Study|Protocol Violation|1
113583|NCT00412061|374344|P2|Open Label Phase|New Cancer Therapy|1
113584|NCT00412061|374345|P1|Open Label Phase|New Cancer Therapy|0
113585|NCT00412061|374344|P2|Open Label Phase|Lost to Follow-up|2
113586|NCT00412061|374345|P1|Open Label Phase|Lost to Follow-up|0
113587|NCT00412061|374344|P2|Open Label Phase|Death|7
113588|NCT00412061|374345|P1|Open Label Phase|Death|0
113589|NCT00412061|374344|P2|Open Label Phase|Administrative Problems|13
113590|NCT00412061|374345|P1|Open Label Phase|Administrative Problems|0
113591|NCT00412061|374344|P2|Open Label Phase|Withdrawal by Subject|15
113592|NCT00412061|374345|P1|Open Label Phase|Withdrawal by Subject|0
113593|NCT00412061|374344|P2|Open Label Phase|Adverse Event|46
113594|NCT00412061|374345|P1|Open Label Phase|Adverse Event|0
113595|NCT00412061|374344|P2|Open Label Phase|Disease Progression|86
113596|NCT00412061|374345|P1|Open Label Phase|Disease Progression|0
113597|NCT00412061|374344|P2|Double Blind Phase|Lost to Follow-up|1
113598|NCT00412061|374345|P1|Double Blind Phase|Lost to Follow-up|0
113599|NCT00412061|374344|P2|Double Blind Phase|New Cander Therapy|1
113600|NCT00412061|374345|P1|Double Blind Phase|New Cander Therapy|1
113601|NCT00412061|374344|P2|Double Blind Phase|Protocol Violation|4
113602|NCT00412061|374345|P1|Double Blind Phase|Protocol Violation|3
113603|NCT00412061|374344|P2|Double Blind Phase|Death|3
113604|NCT00412061|374345|P1|Double Blind Phase|Death|6
113605|NCT00412061|374344|P2|Double Blind Phase|Withdrawal by Subject|20
113606|NCT00412061|374345|P1|Double Blind Phase|Withdrawal by Subject|18
113607|NCT00412061|374344|P2|Double Blind Phase|Final Primary Analysis|14
113608|NCT00412061|374345|P1|Double Blind Phase|Final Primary Analysis|26
113609|NCT00412061|374344|P2|Double Blind Phase|Adverse Event|16
113610|NCT00412061|374345|P1|Double Blind Phase|Adverse Event|61
113611|NCT00412061|374344|P2|Double Blind Phase|Disease Progression|154
113612|NCT00412061|374345|P1|Double Blind Phase|Disease Progression|101
113613|NCT00412113|374395|P2|Overall Study|did not receive treatment|0
113614|NCT00412113|374396|P1|Overall Study|did not receive treatment|1
113615|NCT00412113|374395|P2|Overall Study|Adverse Event|15
113616|NCT00412113|374396|P1|Overall Study|Adverse Event|11
113617|NCT00412217|374450|P2|Overall Study|Not Specified|1
113618|NCT00412217|374451|P1|Overall Study|Not Specified|1
113619|NCT00412217|374450|P2|Overall Study|Study Terminated by Sponsor|33
113620|NCT00412217|374451|P1|Overall Study|Study Terminated by Sponsor|26
113621|NCT00412217|374450|P2|Overall Study|Lost to Follow-up|4
113622|NCT00412217|374451|P1|Overall Study|Lost to Follow-up|1
113623|NCT00412217|374450|P2|Overall Study|Withdrawal by Subject|0
113624|NCT00412217|374451|P1|Overall Study|Withdrawal by Subject|2
113625|NCT00412217|374450|P2|Overall Study|Investigator Decision|0
113626|NCT00412217|374451|P1|Overall Study|Investigator Decision|1
113627|NCT00412217|374450|P2|Overall Study|Disease Progression|3
113628|NCT00412217|374451|P1|Overall Study|Disease Progression|2
113629|NCT00412217|374450|P2|Overall Study|Death|4
113630|NCT00412217|374451|P1|Overall Study|Death|5
113631|NCT00412217|374450|P2|Overall Study|Insufficient Data Available|3
113632|NCT00412217|374451|P1|Overall Study|Insufficient Data Available|8
113633|NCT00412373|374496|P2|Overall Study|Not Specified|2
113634|NCT00412373|374497|P1|Overall Study|Not Specified|2
113635|NCT00412373|374496|P2|Overall Study|Withdrawal by Subject|27
113636|NCT00412373|374497|P1|Overall Study|Withdrawal by Subject|8
113637|NCT00412373|374496|P2|Overall Study|Lost to Follow-up|13
113638|NCT00412373|374497|P1|Overall Study|Lost to Follow-up|7
113639|NCT00412373|374496|P2|Overall Study|Lack of Efficacy|22
113640|NCT00412373|374497|P1|Overall Study|Lack of Efficacy|16
113641|NCT00412373|374496|P2|Overall Study|Adverse Event|13
113642|NCT00412373|374497|P1|Overall Study|Adverse Event|8
113643|NCT00412542|374618|P2|Overall Study|Not Eligible|1
113644|NCT00412542|374619|P1|Overall Study|Not Eligible|0
113645|NCT00412542|374618|P2|Overall Study|Withdrawal by Subject|2
113646|NCT00412542|374619|P1|Overall Study|Withdrawal by Subject|0
113647|NCT00412607|374623|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
113648|NCT00412607|374623|P1|Overall Study|Death|61
113649|NCT00412607|374623|P1|Overall Study|Lost to Follow-up|19
113650|NCT00412607|374623|P1|Overall Study|Withdrawal by Subject|9
113651|NCT00421733|374646|P3|Overall Study|Protocol deviation|2
113652|NCT00421733|374647|P2|Overall Study|Protocol deviation|7
113653|NCT00421733|374648|P1|Overall Study|Protocol deviation|4
113654|NCT00421733|374646|P3|Overall Study|Sponsor request|3
113655|NCT00421733|374647|P2|Overall Study|Sponsor request|0
113656|NCT00421733|374648|P1|Overall Study|Sponsor request|1
113657|NCT00421733|374646|P3|Overall Study|Did not satisfy entry criteria|2
113658|NCT00421733|374647|P2|Overall Study|Did not satisfy entry criteria|3
113659|NCT00421733|374648|P1|Overall Study|Did not satisfy entry criteria|1
113660|NCT00421733|374646|P3|Overall Study|Administrative|0
113661|NCT00421733|374647|P2|Overall Study|Administrative|0
113662|NCT00421733|374648|P1|Overall Study|Administrative|2
113663|NCT00421733|374646|P3|Overall Study|Required dialysis|0
113664|NCT00421733|374647|P2|Overall Study|Required dialysis|0
113665|NCT00421733|374648|P1|Overall Study|Required dialysis|1
113666|NCT00421733|374646|P3|Overall Study|Death|0
113667|NCT00421733|374647|P2|Overall Study|Death|3
113668|NCT00421733|374648|P1|Overall Study|Death|0
113669|NCT00421733|374646|P3|Overall Study|Withdrawal by Subject|7
113670|NCT00421733|374647|P2|Overall Study|Withdrawal by Subject|2
113671|NCT00421733|374648|P1|Overall Study|Withdrawal by Subject|1
113672|NCT00421733|374646|P3|Overall Study|Lost to Follow-up|4
113673|NCT00421733|374647|P2|Overall Study|Lost to Follow-up|2
113674|NCT00421733|374648|P1|Overall Study|Lost to Follow-up|1
113675|NCT00421733|374646|P3|Overall Study|Adverse Event|2
113676|NCT00421733|374647|P2|Overall Study|Adverse Event|9
113677|NCT00421733|374648|P1|Overall Study|Adverse Event|4
113678|NCT00424255|374668|P2|Overall Study|Sponsor Terminated Study|167
113679|NCT00424255|374669|P1|Overall Study|Sponsor Terminated Study|161
113680|NCT00424255|374668|P2|Overall Study|Disease Progression|2
113681|NCT00424255|374669|P1|Overall Study|Disease Progression|0
113682|NCT00424255|374668|P2|Overall Study|Fatigue|0
113683|NCT00424255|374669|P1|Overall Study|Fatigue|1
113684|NCT00424255|374668|P2|Overall Study|Non-compliance by Participants|0
113685|NCT00424255|374669|P1|Overall Study|Non-compliance by Participants|1
113686|NCT00424255|374668|P2|Overall Study|Cognitive Disturbance|0
113687|NCT00424255|374669|P1|Overall Study|Cognitive Disturbance|1
113688|NCT00424255|374668|P2|Overall Study|Physician Decision|7
113689|NCT00424255|374669|P1|Overall Study|Physician Decision|3
113690|NCT00424255|374668|P2|Overall Study|Withdrawal by Subject|38
113691|NCT00424255|374669|P1|Overall Study|Withdrawal by Subject|34
113692|NCT00424255|374668|P2|Overall Study|Protocol Violation|1
113693|NCT00424255|374669|P1|Overall Study|Protocol Violation|0
113694|NCT00424255|374668|P2|Overall Study|Lost to Follow-up|20
113695|NCT00424255|374669|P1|Overall Study|Lost to Follow-up|26
113696|NCT00424255|374668|P2|Overall Study|Death|111
113697|NCT00424255|374669|P1|Overall Study|Death|115
113698|NCT00424294|374734|P2|Overall Study|Randomized but not Treated|0
113699|NCT00424294|374735|P1|Overall Study|Randomized but not Treated|1
113700|NCT00424294|374734|P2|Overall Study|Unspecified|2
113701|NCT00424294|374735|P1|Overall Study|Unspecified|0
113702|NCT00424294|374734|P2|Overall Study|Withdrawal by Subject|2
113703|NCT00424294|374735|P1|Overall Study|Withdrawal by Subject|1
113704|NCT00424294|374734|P2|Overall Study|Lack of Efficacy|1
113705|NCT00424294|374735|P1|Overall Study|Lack of Efficacy|2
113706|NCT00424294|374734|P2|Overall Study|Adverse Event|10
113707|NCT00424294|374735|P1|Overall Study|Adverse Event|4
113708|NCT00424346|374787|P4|Extension Phase|Protocol Violation|0
113709|NCT00424346|374788|P3|Extension Phase|Protocol Violation|1
113710|NCT00424346|374789|P2|Extension Phase|Protocol Violation|1
113711|NCT00424346|374790|P1|Extension Phase|Protocol Violation|0
113712|NCT00424346|374787|P4|Extension Phase|Death|1
113713|NCT00424346|374788|P3|Extension Phase|Death|0
113714|NCT00424346|374789|P2|Extension Phase|Death|0
113715|NCT00424346|374790|P1|Extension Phase|Death|0
113716|NCT00424346|374787|P4|Extension Phase|Administrative Problems|35
113717|NCT00424346|374788|P3|Extension Phase|Administrative Problems|32
113718|NCT00424346|374789|P2|Extension Phase|Administrative Problems|69
113719|NCT00424346|374790|P1|Extension Phase|Administrative Problems|0
113720|NCT00424346|374787|P4|Extension Phase|Lost to Follow-up|0
113721|NCT00424346|374788|P3|Extension Phase|Lost to Follow-up|0
113722|NCT00424346|374789|P2|Extension Phase|Lost to Follow-up|2
113723|NCT00424346|374790|P1|Extension Phase|Lost to Follow-up|0
113724|NCT00424346|374787|P4|Extension Phase|Withdrawal by Subject|4
113725|NCT00424346|374788|P3|Extension Phase|Withdrawal by Subject|3
113726|NCT00424346|374789|P2|Extension Phase|Withdrawal by Subject|5
113727|NCT00424346|374790|P1|Extension Phase|Withdrawal by Subject|0
113728|NCT00424346|374787|P4|Extension Phase|Lack of Efficacy|11
113729|NCT00424346|374788|P3|Extension Phase|Lack of Efficacy|14
113730|NCT00424346|374789|P2|Extension Phase|Lack of Efficacy|16
113731|NCT00424346|374790|P1|Extension Phase|Lack of Efficacy|0
113732|NCT00424346|374787|P4|Extension Phase|Adverse Event|4
113733|NCT00424346|374788|P3|Extension Phase|Adverse Event|5
113734|NCT00424346|374789|P2|Extension Phase|Adverse Event|9
113735|NCT00424346|374790|P1|Extension Phase|Adverse Event|0
113736|NCT00424346|374787|P4|Core Study|Protocol Violation|0
113737|NCT00424346|374788|P3|Core Study|Protocol Violation|2
113738|NCT00424346|374789|P2|Core Study|Protocol Violation|0
113739|NCT00424346|374790|P1|Core Study|Protocol Violation|0
113740|NCT00424346|374787|P4|Core Study|Administrative Problems|0
113741|NCT00424346|374788|P3|Core Study|Administrative Problems|1
113742|NCT00424346|374789|P2|Core Study|Administrative Problems|0
113743|NCT00424346|374790|P1|Core Study|Administrative Problems|1
113744|NCT00424346|374787|P4|Core Study|Lost to Follow-up|0
113745|NCT00424346|374788|P3|Core Study|Lost to Follow-up|0
113746|NCT00424346|374789|P2|Core Study|Lost to Follow-up|1
113747|NCT00424346|374790|P1|Core Study|Lost to Follow-up|1
113748|NCT00424346|374787|P4|Core Study|Withdrawal by Subject|2
113749|NCT00424346|374788|P3|Core Study|Withdrawal by Subject|0
113750|NCT00424346|374789|P2|Core Study|Withdrawal by Subject|0
113751|NCT00424346|374790|P1|Core Study|Withdrawal by Subject|1
113752|NCT00424346|374787|P4|Core Study|Lack of Efficacy|4
113753|NCT00424346|374788|P3|Core Study|Lack of Efficacy|0
113754|NCT00424346|374789|P2|Core Study|Lack of Efficacy|3
113755|NCT00424346|374790|P1|Core Study|Lack of Efficacy|1
113756|NCT00424346|374787|P4|Core Study|Abnormal Laboratory Values|0
113757|NCT00424346|374788|P3|Core Study|Abnormal Laboratory Values|0
113758|NCT00424346|374789|P2|Core Study|Abnormal Laboratory Values|1
113759|NCT00424346|374790|P1|Core Study|Abnormal Laboratory Values|0
113760|NCT00424346|374787|P4|Core Study|Adverse Event|1
113761|NCT00424346|374788|P3|Core Study|Adverse Event|1
113762|NCT00424346|374789|P2|Core Study|Adverse Event|3
113763|NCT00424346|374790|P1|Core Study|Adverse Event|5
113764|NCT00424372|374903|P1|Overall Study|Lack of Efficacy|6
113765|NCT00424372|374903|P1|Overall Study|Protocol Violation|1
113766|NCT00424372|374903|P1|Overall Study|Withdrawal by Subject|4
113767|NCT00424372|374903|P1|Overall Study|Health deterioration|1
113768|NCT00424372|374903|P1|Overall Study|Adverse Event|18
113769|NCT00424372|374903|P1|Overall Study|Death|1
113770|NCT00424385|374911|P1|Cohort 1|Withdrawal by Subject|1
113771|NCT00424385|374911|P1|Cohort 0|Physician Decision|1
113772|NCT00424385|374911|P1|Cohort 0|Withdrawal by Subject|5
113773|NCT00424398|374921|P3|Overall Study|Subject met exclusion criteria|0
113774|NCT00424398|374922|P2|Overall Study|Subject met exclusion criteria|0
113775|NCT00424398|374923|P1|Overall Study|Subject met exclusion criteria|1
113776|NCT00424398|374921|P3|Overall Study|Withdrawal by Subject|0
113777|NCT00424398|374922|P2|Overall Study|Withdrawal by Subject|1
113778|NCT00424398|374923|P1|Overall Study|Withdrawal by Subject|2
113779|NCT00424476|374970|P3|Overall Study|Other|9
113780|NCT00424476|374971|P2|Overall Study|Other|3
113781|NCT00424476|374972|P1|Overall Study|Other|4
113782|NCT00424476|374970|P3|Overall Study|Physician Decision|3
113783|NCT00424476|374971|P2|Overall Study|Physician Decision|2
113784|NCT00424476|374972|P1|Overall Study|Physician Decision|3
113785|NCT00424476|374970|P3|Overall Study|Protocol Violation|3
113786|NCT00424476|374971|P2|Overall Study|Protocol Violation|2
113787|NCT00424476|374972|P1|Overall Study|Protocol Violation|7
113788|NCT00424476|374970|P3|Overall Study|Lost to Follow-up|3
113789|NCT00424476|374971|P2|Overall Study|Lost to Follow-up|6
113790|NCT00424476|374972|P1|Overall Study|Lost to Follow-up|4
113791|NCT00424476|374970|P3|Overall Study|Lack of Compliance|1
113792|NCT00424476|374971|P2|Overall Study|Lack of Compliance|1
113793|NCT00424476|374972|P1|Overall Study|Lack of Compliance|1
113794|NCT00424476|374970|P3|Overall Study|Lack of Efficacy|12
113795|NCT00424476|374971|P2|Overall Study|Lack of Efficacy|12
113796|NCT00424476|374972|P1|Overall Study|Lack of Efficacy|16
113797|NCT00424476|374970|P3|Overall Study|Adverse Event|15
113798|NCT00424476|374971|P2|Overall Study|Adverse Event|16
113799|NCT00424476|374972|P1|Overall Study|Adverse Event|19
113800|NCT00424476|374970|P3|Overall Study|Withdrawal by Subject|3
113801|NCT00424476|374971|P2|Overall Study|Withdrawal by Subject|6
113802|NCT00424476|374972|P1|Overall Study|Withdrawal by Subject|7
113803|NCT00424515|375006|P2|Overall Study|Withdrawal by Subject|0
113804|NCT00424515|375007|P1|Overall Study|Withdrawal by Subject|1
113805|NCT00424515|375006|P2|Overall Study|Intercurrent Illness|1
113806|NCT00424515|375007|P1|Overall Study|Intercurrent Illness|0
113807|NCT00424515|375006|P2|Overall Study|Adverse Event|1
113808|NCT00424515|375007|P1|Overall Study|Adverse Event|0
113809|NCT00424515|375006|P2|Overall Study|Progressive Disease|11
113810|NCT00424515|375007|P1|Overall Study|Progressive Disease|10
113811|NCT00424528|375020|P3|Overall Study|noncompliance with study requirements|2
113812|NCT00424528|375021|P2|Overall Study|noncompliance with study requirements|1
113813|NCT00424528|375022|P1|Overall Study|noncompliance with study requirements|2
113814|NCT00424528|375020|P3|Overall Study|Lost to Follow-up|0
113815|NCT00424528|375021|P2|Overall Study|Lost to Follow-up|1
113816|NCT00424528|375022|P1|Overall Study|Lost to Follow-up|0
113817|NCT00424528|375020|P3|Overall Study|Protocol Violation|0
113818|NCT00424528|375021|P2|Overall Study|Protocol Violation|1
113819|NCT00424528|375022|P1|Overall Study|Protocol Violation|1
113820|NCT00424528|375020|P3|Overall Study|Adverse Event|2
113821|NCT00424528|375021|P2|Overall Study|Adverse Event|1
113822|NCT00424528|375022|P1|Overall Study|Adverse Event|2
113823|NCT00424593|375094|P2|Dose-Blind Extension Period|Physician Decision|0
113824|NCT00424593|375095|P1|Dose-Blind Extension Period|Physician Decision|3
113825|NCT00424593|375094|P2|Dose-Blind Extension Period|Lost to Follow-up|0
113826|NCT00424593|375095|P1|Dose-Blind Extension Period|Lost to Follow-up|6
113827|NCT00424593|375094|P2|Dose-Blind Extension Period|Protocol Violation|0
113828|NCT00424593|375095|P1|Dose-Blind Extension Period|Protocol Violation|9
113829|NCT00424593|375094|P2|Dose-Blind Extension Period|Lack of Efficacy|0
113830|NCT00424593|375095|P1|Dose-Blind Extension Period|Lack of Efficacy|9
113831|NCT00424593|375094|P2|Dose-Blind Extension Period|Adverse Event|0
113832|NCT00424593|375095|P1|Dose-Blind Extension Period|Adverse Event|18
113833|NCT00424593|375094|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
113834|NCT00424593|375095|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
113835|NCT00424593|375094|P2|Acute Double-Blind Period|Lack of Efficacy|1
113836|NCT00424593|375095|P1|Acute Double-Blind Period|Lack of Efficacy|0
113837|NCT00424593|375094|P2|Acute Double-Blind Period|Lost to Follow-up|1
113838|NCT00424593|375095|P1|Acute Double-Blind Period|Lost to Follow-up|1
113839|NCT00424593|375094|P2|Acute Double-Blind Period|Physician Decision|2
113840|NCT00424593|375095|P1|Acute Double-Blind Period|Physician Decision|1
113841|NCT00424593|375094|P2|Acute Double-Blind Period|Protocol Violation|2
113842|NCT00424593|375095|P1|Acute Double-Blind Period|Protocol Violation|2
113843|NCT00424593|375094|P2|Acute Double-Blind Period|Withdrawal by Subject|10
113933|NCT00425061|375372|P4|Overall Study|Withdrawal by Subject|0
113844|NCT00424593|375095|P1|Acute Double-Blind Period|Withdrawal by Subject|11
113845|NCT00424593|375094|P2|Acute Double-Blind Period|Adverse Event|7
113846|NCT00424593|375095|P1|Acute Double-Blind Period|Adverse Event|16
113847|NCT00424632|375178|P10|Overall Study|Unspecified|0
113848|NCT00424632|375179|P9|Overall Study|Unspecified|1
113849|NCT00424632|375180|P8|Overall Study|Unspecified|0
113850|NCT00424632|375181|P7|Overall Study|Unspecified|0
113851|NCT00424632|375182|P6|Overall Study|Unspecified|0
113852|NCT00424632|375183|P5|Overall Study|Unspecified|0
113853|NCT00424632|375184|P4|Overall Study|Unspecified|1
113854|NCT00424632|375185|P3|Overall Study|Unspecified|0
113855|NCT00424632|375186|P2|Overall Study|Unspecified|0
113856|NCT00424632|375187|P1|Overall Study|Unspecified|0
113857|NCT00424632|375178|P10|Overall Study|Objective progression or relapse|4
113858|NCT00424632|375179|P9|Overall Study|Objective progression or relapse|12
113859|NCT00424632|375180|P8|Overall Study|Objective progression or relapse|3
113860|NCT00424632|375181|P7|Overall Study|Objective progression or relapse|7
113861|NCT00424632|375182|P6|Overall Study|Objective progression or relapse|13
113862|NCT00424632|375183|P5|Overall Study|Objective progression or relapse|2
113863|NCT00424632|375184|P4|Overall Study|Objective progression or relapse|2
113864|NCT00424632|375185|P3|Overall Study|Objective progression or relapse|1
113865|NCT00424632|375186|P2|Overall Study|Objective progression or relapse|1
113866|NCT00424632|375187|P1|Overall Study|Objective progression or relapse|1
113867|NCT00424632|375178|P10|Overall Study|Global deterioration of health status|0
113868|NCT00424632|375179|P9|Overall Study|Global deterioration of health status|0
113869|NCT00424632|375180|P8|Overall Study|Global deterioration of health status|0
113870|NCT00424632|375181|P7|Overall Study|Global deterioration of health status|0
113871|NCT00424632|375182|P6|Overall Study|Global deterioration of health status|0
113872|NCT00424632|375183|P5|Overall Study|Global deterioration of health status|1
113873|NCT00424632|375184|P4|Overall Study|Global deterioration of health status|1
113874|NCT00424632|375185|P3|Overall Study|Global deterioration of health status|0
113875|NCT00424632|375186|P2|Overall Study|Global deterioration of health status|0
113876|NCT00424632|375187|P1|Overall Study|Global deterioration of health status|0
113877|NCT00424632|375178|P10|Overall Study|Adverse Event|2
113878|NCT00424632|375179|P9|Overall Study|Adverse Event|3
113879|NCT00424632|375180|P8|Overall Study|Adverse Event|0
113880|NCT00424632|375181|P7|Overall Study|Adverse Event|0
113881|NCT00424632|375182|P6|Overall Study|Adverse Event|0
113882|NCT00424632|375183|P5|Overall Study|Adverse Event|0
113883|NCT00424632|375184|P4|Overall Study|Adverse Event|0
113884|NCT00424632|375185|P3|Overall Study|Adverse Event|0
113885|NCT00424632|375186|P2|Overall Study|Adverse Event|0
113886|NCT00424632|375187|P1|Overall Study|Adverse Event|0
113887|NCT00424632|375178|P10|Overall Study|Death|0
113888|NCT00424632|375179|P9|Overall Study|Death|0
113889|NCT00424632|375180|P8|Overall Study|Death|0
113890|NCT00424632|375181|P7|Overall Study|Death|0
113891|NCT00424632|375182|P6|Overall Study|Death|2
113892|NCT00424632|375183|P5|Overall Study|Death|0
113893|NCT00424632|375184|P4|Overall Study|Death|0
113894|NCT00424632|375185|P3|Overall Study|Death|0
113895|NCT00424632|375186|P2|Overall Study|Death|0
113896|NCT00424632|375187|P1|Overall Study|Death|0
113897|NCT00424645|375320|P2|Overall Study|Death|0
113898|NCT00424645|375321|P1|Overall Study|Death|1
113899|NCT00424749|375327|P1|Overall Study|Withdrawal by Subject|1
113900|NCT00424762|375334|P2|Overall Study|Lost to Follow-up|3
113901|NCT00424762|375335|P1|Overall Study|Lost to Follow-up|2
113902|NCT00424762|375334|P2|Overall Study|Withdrawal by Subject|19
113903|NCT00424762|375335|P1|Overall Study|Withdrawal by Subject|18
113904|NCT00424775|375345|P2|Overall Study|Lack of Efficacy|0
113905|NCT00424775|375346|P1|Overall Study|Lack of Efficacy|1
113906|NCT00424775|375345|P2|Overall Study|Adverse Event|0
113907|NCT00424775|375346|P1|Overall Study|Adverse Event|2
113908|NCT00424827|375354|P1|Overall Study|Adverse Event|1
113909|NCT00425061|375369|P7|Overall Study|Unspecified|1
113910|NCT00425061|375370|P6|Overall Study|Unspecified|0
113911|NCT00425061|375371|P5|Overall Study|Unspecified|3
113912|NCT00425061|375372|P4|Overall Study|Unspecified|0
113913|NCT00425061|375373|P3|Overall Study|Unspecified|0
113914|NCT00425061|375374|P2|Overall Study|Unspecified|0
113915|NCT00425061|375375|P1|Overall Study|Unspecified|0
113916|NCT00425061|375369|P7|Overall Study|Physician Decision|0
113917|NCT00425061|375370|P6|Overall Study|Physician Decision|0
113918|NCT00425061|375371|P5|Overall Study|Physician Decision|1
113919|NCT00425061|375372|P4|Overall Study|Physician Decision|0
113920|NCT00425061|375373|P3|Overall Study|Physician Decision|0
113921|NCT00425061|375374|P2|Overall Study|Physician Decision|0
113922|NCT00425061|375375|P1|Overall Study|Physician Decision|0
113923|NCT00425061|375369|P7|Overall Study|Sponsor's request|15
113924|NCT00425061|375370|P6|Overall Study|Sponsor's request|4
113925|NCT00425061|375371|P5|Overall Study|Sponsor's request|19
113926|NCT00425061|375372|P4|Overall Study|Sponsor's request|0
113927|NCT00425061|375373|P3|Overall Study|Sponsor's request|0
113928|NCT00425061|375374|P2|Overall Study|Sponsor's request|0
113929|NCT00425061|375375|P1|Overall Study|Sponsor's request|0
113930|NCT00425061|375369|P7|Overall Study|Withdrawal by Subject|3
113931|NCT00425061|375370|P6|Overall Study|Withdrawal by Subject|0
113932|NCT00425061|375371|P5|Overall Study|Withdrawal by Subject|1
113934|NCT00425061|375373|P3|Overall Study|Withdrawal by Subject|0
113935|NCT00425061|375374|P2|Overall Study|Withdrawal by Subject|1
113936|NCT00425061|375375|P1|Overall Study|Withdrawal by Subject|0
113937|NCT00425061|375369|P7|Overall Study|Protocol Violation|0
113938|NCT00425061|375370|P6|Overall Study|Protocol Violation|0
113939|NCT00425061|375371|P5|Overall Study|Protocol Violation|0
113940|NCT00425061|375372|P4|Overall Study|Protocol Violation|0
113941|NCT00425061|375373|P3|Overall Study|Protocol Violation|0
113942|NCT00425061|375374|P2|Overall Study|Protocol Violation|0
113943|NCT00425061|375375|P1|Overall Study|Protocol Violation|1
113944|NCT00425061|375369|P7|Overall Study|Lost to Follow-up|0
113945|NCT00425061|375370|P6|Overall Study|Lost to Follow-up|0
113946|NCT00425061|375371|P5|Overall Study|Lost to Follow-up|0
113947|NCT00425061|375372|P4|Overall Study|Lost to Follow-up|0
113948|NCT00425061|375373|P3|Overall Study|Lost to Follow-up|0
113949|NCT00425061|375374|P2|Overall Study|Lost to Follow-up|1
113950|NCT00425061|375375|P1|Overall Study|Lost to Follow-up|0
113951|NCT00425061|375369|P7|Overall Study|Adverse Event|0
113952|NCT00425061|375370|P6|Overall Study|Adverse Event|0
113953|NCT00425061|375371|P5|Overall Study|Adverse Event|2
113954|NCT00425061|375372|P4|Overall Study|Adverse Event|2
113955|NCT00425061|375373|P3|Overall Study|Adverse Event|0
113956|NCT00425061|375374|P2|Overall Study|Adverse Event|0
113957|NCT00425061|375375|P1|Overall Study|Adverse Event|1
113958|NCT00425100|375491|P1|Overall Study|Withdrawal by Subject|7
113959|NCT00425100|375491|P1|Overall Study|Protocol Violation|4
113960|NCT00425100|375491|P1|Overall Study|Lost to Follow-up|2
113961|NCT00425100|375491|P1|Overall Study|Lack of Efficacy|4
113962|NCT00425100|375491|P1|Overall Study|Adverse Event|36
113963|NCT00425113|375530|P2|Overall Study|Withdrawal by Subject|0
113964|NCT00425113|375531|P1|Overall Study|Withdrawal by Subject|1
113965|NCT00425113|375530|P2|Overall Study|missing study drug more than 14 days|1
113966|NCT00425113|375531|P1|Overall Study|missing study drug more than 14 days|0
113967|NCT00425113|375530|P2|Overall Study|diagnosis of abdominal TB|1
113968|NCT00425113|375531|P1|Overall Study|diagnosis of abdominal TB|0
113969|NCT00425113|375530|P2|Overall Study|uncontrolled diabetes mellitus|0
113970|NCT00425113|375531|P1|Overall Study|uncontrolled diabetes mellitus|1
113971|NCT00425269|375541|P2|Overall Study|moved or medical reason|4
113972|NCT00425269|375542|P1|Overall Study|moved or medical reason|5
113973|NCT00425269|375541|P2|Overall Study|Lost to Follow-up|9
113974|NCT00425269|375542|P1|Overall Study|Lost to Follow-up|9
113975|NCT00425269|375541|P2|Overall Study|Pregnancy|7
113976|NCT00425269|375542|P1|Overall Study|Pregnancy|5
113977|NCT00425308|375620|P2|Overall Study|Death|0
113978|NCT00425308|375621|P1|Overall Study|Death|1
113979|NCT00425308|375620|P2|Overall Study|Withdrawal by Subject|0
113980|NCT00425308|375621|P1|Overall Study|Withdrawal by Subject|1
113981|NCT00425308|375620|P2|Overall Study|Adverse Event|1
113982|NCT00425308|375621|P1|Overall Study|Adverse Event|2
113983|NCT00425373|375658|P9|Overall Study|Lack of Efficacy|5
113984|NCT00425373|375659|P8|Overall Study|Lack of Efficacy|0
113985|NCT00425373|375660|P7|Overall Study|Lack of Efficacy|3
113986|NCT00425373|375661|P6|Overall Study|Lack of Efficacy|3
113987|NCT00425373|375662|P5|Overall Study|Lack of Efficacy|1
113988|NCT00425373|375663|P4|Overall Study|Lack of Efficacy|0
113989|NCT00425373|375664|P3|Overall Study|Lack of Efficacy|0
113990|NCT00425373|375665|P2|Overall Study|Lack of Efficacy|0
113991|NCT00425373|375666|P1|Overall Study|Lack of Efficacy|0
113992|NCT00425373|375658|P9|Overall Study|Withdrawal by Subject|2
113993|NCT00425373|375659|P8|Overall Study|Withdrawal by Subject|2
113994|NCT00425373|375660|P7|Overall Study|Withdrawal by Subject|2
113995|NCT00425373|375661|P6|Overall Study|Withdrawal by Subject|0
113996|NCT00425373|375662|P5|Overall Study|Withdrawal by Subject|4
113997|NCT00425373|375663|P4|Overall Study|Withdrawal by Subject|1
113998|NCT00425373|375664|P3|Overall Study|Withdrawal by Subject|2
113999|NCT00425373|375665|P2|Overall Study|Withdrawal by Subject|0
114000|NCT00425373|375666|P1|Overall Study|Withdrawal by Subject|2
114001|NCT00425373|375658|P9|Overall Study|Protocol Violation|3
114002|NCT00425373|375659|P8|Overall Study|Protocol Violation|5
114003|NCT00425373|375660|P7|Overall Study|Protocol Violation|0
114004|NCT00425373|375661|P6|Overall Study|Protocol Violation|0
114005|NCT00425373|375662|P5|Overall Study|Protocol Violation|0
114006|NCT00425373|375663|P4|Overall Study|Protocol Violation|0
114007|NCT00425373|375664|P3|Overall Study|Protocol Violation|1
114008|NCT00425373|375665|P2|Overall Study|Protocol Violation|0
114009|NCT00425373|375666|P1|Overall Study|Protocol Violation|1
114010|NCT00425373|375658|P9|Overall Study|Lost to Follow-up|0
114011|NCT00425373|375659|P8|Overall Study|Lost to Follow-up|0
114012|NCT00425373|375660|P7|Overall Study|Lost to Follow-up|0
114013|NCT00425373|375661|P6|Overall Study|Lost to Follow-up|0
114014|NCT00425373|375662|P5|Overall Study|Lost to Follow-up|1
114015|NCT00425373|375663|P4|Overall Study|Lost to Follow-up|0
114016|NCT00425373|375664|P3|Overall Study|Lost to Follow-up|0
114017|NCT00425373|375665|P2|Overall Study|Lost to Follow-up|1
114018|NCT00425373|375666|P1|Overall Study|Lost to Follow-up|0
114019|NCT00425373|375658|P9|Overall Study|Adverse Event|8
114020|NCT00425373|375659|P8|Overall Study|Adverse Event|3
114021|NCT00425373|375660|P7|Overall Study|Adverse Event|2
114022|NCT00425373|375661|P6|Overall Study|Adverse Event|6
114023|NCT00425373|375662|P5|Overall Study|Adverse Event|4
114024|NCT00425373|375663|P4|Overall Study|Adverse Event|1
114025|NCT00425373|375664|P3|Overall Study|Adverse Event|0
114026|NCT00425373|375665|P2|Overall Study|Adverse Event|2
114027|NCT00425373|375666|P1|Overall Study|Adverse Event|2
114028|NCT00425438|375733|P2|Overall Study|Termination by Sponsor|27
114029|NCT00425438|375734|P1|Overall Study|Termination by Sponsor|25
114030|NCT00425503|375750|P1|Overall Study|Protocol Violation|1
114031|NCT00425503|375750|P1|Overall Study|Adverse Event|2
114032|NCT00425607|375754|P1|Overall Study|Withdrawal by Subject|1
114033|NCT00425607|375754|P1|Overall Study|Death|1
114034|NCT00425698|375769|P2|Overall Study|Withdrawal by Subject|1
114035|NCT00425698|375770|P1|Overall Study|Withdrawal by Subject|0
114036|NCT00425698|375769|P2|Overall Study|Adverse Event|1
114037|NCT00425698|375770|P1|Overall Study|Adverse Event|3
114038|NCT00425750|375776|P1|Overall Study|Progression of disease|18
114039|NCT00425750|375776|P1|Overall Study|Adverse Event|3
114040|NCT00425750|375776|P1|Overall Study|Withdrawal by Subject|3
114041|NCT00425750|375776|P1|Overall Study|Death|1
114042|NCT00425854|375784|P2|Overall Study|Other Adverse Event|2
114043|NCT00425854|375785|P1|Overall Study|Other Adverse Event|2
114044|NCT00425854|375784|P2|Overall Study|Dose reduction toxicity AE|7
114045|NCT00425854|375785|P1|Overall Study|Dose reduction toxicity AE|8
114046|NCT00425854|375784|P2|Overall Study|Progressive Disease|12
114047|NCT00425854|375785|P1|Overall Study|Progressive Disease|19
114048|NCT00425945|375808|P2|Overall Study|Moved from area|1
114049|NCT00425945|375809|P1|Overall Study|Moved from area|0
114050|NCT00425945|375808|P2|Overall Study|Began cancer treatments|0
114051|NCT00425945|375809|P1|Overall Study|Began cancer treatments|1
114052|NCT00425945|375808|P2|Overall Study|Began hypertension medication|0
114053|NCT00425945|375809|P1|Overall Study|Began hypertension medication|1
114054|NCT00425945|375808|P2|Overall Study|Lost to Follow-up|2
114055|NCT00425945|375809|P1|Overall Study|Lost to Follow-up|0
114056|NCT00425945|375808|P2|Overall Study|Inconvenience|2
114057|NCT00425945|375809|P1|Overall Study|Inconvenience|0
114058|NCT00425945|375808|P2|Overall Study|Concern about Supplement|0
114059|NCT00425945|375809|P1|Overall Study|Concern about Supplement|2
114060|NCT00426127|375845|P1|Overall Study|Removed due to disease progression|1
114061|NCT00426127|375845|P1|Overall Study|Adverse Event|1
114062|NCT00426231|375868|P2|Overall Study|Withdrawal by Subject|12
114063|NCT00426231|375869|P1|Overall Study|Withdrawal by Subject|9
114064|NCT00426270|375877|P1|Overall Study|Adverse Event|5
114065|NCT00426270|375877|P1|Overall Study|Incorrectly Enrolled in the Study|1
114066|NCT00426361|375897|P3|Overall Study|Withdrawal by Subject|0
114067|NCT00426361|375898|P2|Overall Study|Withdrawal by Subject|3
114068|NCT00426361|375899|P1|Overall Study|Withdrawal by Subject|1
114069|NCT00426361|375897|P3|Overall Study|Lost to Follow-up|5
114070|NCT00426361|375898|P2|Overall Study|Lost to Follow-up|2
114071|NCT00426361|375899|P1|Overall Study|Lost to Follow-up|3
114072|NCT00426556|375953|P4|Phase II - Extension Phase|Adverse Event|2
114073|NCT00426556|375954|P3|Phase II - Extension Phase|Adverse Event|0
114074|NCT00426556|375955|P2|Phase II - Extension Phase|Adverse Event|0
114075|NCT00426556|375956|P1|Phase II - Extension Phase|Adverse Event|0
114076|NCT00426556|375953|P4|Phase II - Extension Phase|Disease Progression|21
114077|NCT00426556|375954|P3|Phase II - Extension Phase|Disease Progression|0
114078|NCT00426556|375955|P2|Phase II - Extension Phase|Disease Progression|0
114079|NCT00426556|375956|P1|Phase II - Extension Phase|Disease Progression|0
114080|NCT00426556|375953|P4|Phase II - Core Phase|Adverse Event|8
114081|NCT00426556|375954|P3|Phase II - Core Phase|Adverse Event|0
114082|NCT00426556|375955|P2|Phase II - Core Phase|Adverse Event|0
114083|NCT00426556|375956|P1|Phase II - Core Phase|Adverse Event|0
114084|NCT00426556|375953|P4|Phase II - Core Phase|Disease Progression|16
114085|NCT00426556|375954|P3|Phase II - Core Phase|Disease Progression|0
114086|NCT00426556|375955|P2|Phase II - Core Phase|Disease Progression|0
114087|NCT00426556|375956|P1|Phase II - Core Phase|Disease Progression|0
114088|NCT00426556|375953|P4|Phase II - Core Phase|Withdrawal by Subject|3
114089|NCT00426556|375954|P3|Phase II - Core Phase|Withdrawal by Subject|0
114090|NCT00426556|375955|P2|Phase II - Core Phase|Withdrawal by Subject|0
114091|NCT00426556|375956|P1|Phase II - Core Phase|Withdrawal by Subject|0
114092|NCT00426556|375953|P4|Phase I - Extension Phase|Disease Progression|0
114093|NCT00426556|375954|P3|Phase I - Extension Phase|Disease Progression|6
114094|NCT00426556|375955|P2|Phase I - Extension Phase|Disease Progression|5
114095|NCT00426556|375956|P1|Phase I - Extension Phase|Disease Progression|5
114096|NCT00426556|375953|P4|Phase I - Extension Phase|Adverse Event|0
114097|NCT00426556|375954|P3|Phase I - Extension Phase|Adverse Event|1
114098|NCT00426556|375955|P2|Phase I - Extension Phase|Adverse Event|1
114099|NCT00426556|375956|P1|Phase I - Extension Phase|Adverse Event|0
114100|NCT00426556|375953|P4|Phase I - Core Phase|Death|0
114101|NCT00426556|375954|P3|Phase I - Core Phase|Death|0
114102|NCT00426556|375955|P2|Phase I - Core Phase|Death|1
114103|NCT00426556|375956|P1|Phase I - Core Phase|Death|0
114104|NCT00426556|375953|P4|Phase I - Core Phase|Adverse Event|0
114105|NCT00426556|375954|P3|Phase I - Core Phase|Adverse Event|1
114106|NCT00426556|375955|P2|Phase I - Core Phase|Adverse Event|3
114107|NCT00426556|375956|P1|Phase I - Core Phase|Adverse Event|1
114108|NCT00426556|375953|P4|Phase I - Core Phase|Disease Progression|0
114109|NCT00426556|375954|P3|Phase I - Core Phase|Disease Progression|2
114110|NCT00426556|375955|P2|Phase I - Core Phase|Disease Progression|6
114111|NCT00426556|375956|P1|Phase I - Core Phase|Disease Progression|0
114112|NCT00426660|375978|P1|Overall Study|Enrolled Not Treated|15
114113|NCT00426660|375978|P1|Overall Study|Protocol Violation|1
114114|NCT00426660|375978|P1|Overall Study|Withdrawal by Subject|18
114115|NCT00426660|375978|P1|Overall Study|Unspecified|23
114116|NCT00426660|375978|P1|Overall Study|Lost to Follow-up|15
114117|NCT00426660|375978|P1|Overall Study|Insufficient Clinical Response|22
114118|NCT00426660|375978|P1|Overall Study|Adverse Event|23
114119|NCT00426660|375978|P1|Overall Study|Death|14
114120|NCT00426751|376007|P2|Overall Study|Other Reasons|12
114121|NCT00426751|376008|P1|Overall Study|Other Reasons|7
114122|NCT00426751|376007|P2|Overall Study|Consent Withdrawn|1
114123|NCT00426751|376008|P1|Overall Study|Consent Withdrawn|0
114124|NCT00426751|376007|P2|Overall Study|Lost to Follow-up|6
114125|NCT00426751|376008|P1|Overall Study|Lost to Follow-up|7
114126|NCT00426751|376007|P2|Overall Study|Adverse Event|1
114127|NCT00426751|376008|P1|Overall Study|Adverse Event|8
114128|NCT00426764|376052|P1|Overall Study|Other|2
114129|NCT00426764|376052|P1|Overall Study|Protocol Violation|1
114130|NCT00426764|376052|P1|Overall Study|Physician Decision|1
114131|NCT00426764|376052|P1|Overall Study|Withdrawal by Subject|3
114132|NCT00426764|376052|P1|Overall Study|Adverse Event|19
114133|NCT00426764|376052|P1|Overall Study|Progressive disease|72
114134|NCT00416455|376068|P2|Overall Study|Inadequate pathology|2
114135|NCT00416455|376069|P1|Overall Study|Inadequate pathology|11
114136|NCT00416455|376068|P2|Overall Study|PET / CT poor quality|1
114137|NCT00416455|376069|P1|Overall Study|PET / CT poor quality|2
114138|NCT00416455|376068|P2|Overall Study|PET / CT not done|5
114139|NCT00416455|376069|P1|Overall Study|PET / CT not done|3
114140|NCT00416520|376100|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
114141|NCT00416520|376101|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
114142|NCT00416520|376102|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
114143|NCT00416520|376103|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
114144|NCT00416520|376100|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
114145|NCT00416520|376101|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
114146|NCT00416520|376102|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
114147|NCT00416520|376103|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
114148|NCT00416520|376100|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
114149|NCT00416520|376101|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
114150|NCT00416520|376102|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
114151|NCT00416520|376103|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
114152|NCT00416520|376100|P4|Open-label Period|Other Reasons|0
114153|NCT00416520|376101|P3|Open-label Period|Other Reasons|0
114154|NCT00416520|376102|P2|Open-label Period|Other Reasons|12
114155|NCT00416520|376103|P1|Open-label Period|Other Reasons|3
114156|NCT00416520|376100|P4|Open-label Period|Withdrawal by Subject|0
114157|NCT00416520|376101|P3|Open-label Period|Withdrawal by Subject|0
114158|NCT00416520|376102|P2|Open-label Period|Withdrawal by Subject|5
114159|NCT00416520|376103|P1|Open-label Period|Withdrawal by Subject|16
114160|NCT00416520|376100|P4|Open-label Period|Protocol Violation|0
114161|NCT00416520|376101|P3|Open-label Period|Protocol Violation|0
114162|NCT00416520|376102|P2|Open-label Period|Protocol Violation|3
114163|NCT00416520|376103|P1|Open-label Period|Protocol Violation|3
114164|NCT00416520|376100|P4|Open-label Period|Lack of Efficacy|0
114165|NCT00416520|376101|P3|Open-label Period|Lack of Efficacy|0
114166|NCT00416520|376102|P2|Open-label Period|Lack of Efficacy|1
114167|NCT00416520|376103|P1|Open-label Period|Lack of Efficacy|8
114168|NCT00416520|376100|P4|Open-label Period|Death|0
114169|NCT00416520|376101|P3|Open-label Period|Death|0
114170|NCT00416520|376102|P2|Open-label Period|Death|1
114171|NCT00416520|376103|P1|Open-label Period|Death|2
114172|NCT00416520|376100|P4|Open-label Period|Adverse Event|0
114173|NCT00416520|376101|P3|Open-label Period|Adverse Event|0
114174|NCT00416520|376102|P2|Open-label Period|Adverse Event|10
114175|NCT00416520|376103|P1|Open-label Period|Adverse Event|28
114176|NCT00416598|376132|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
114177|NCT00416598|376132|P1|Decitabine Maintenance|Alternative treatment|2
114178|NCT00416598|376132|P1|Decitabine Maintenance|Progression/relapse|38
114179|NCT00416598|376132|P1|Decitabine Maintenance|Withdrawal by Subject|18
114180|NCT00416598|376132|P1|Decitabine Maintenance|Adverse Event|5
114181|NCT00416598|376132|P1|Induction & Intensification|Failed induction|87
114182|NCT00416598|376132|P1|Induction & Intensification|Relapse/progression|29
114183|NCT00416598|376132|P1|Induction & Intensification|Physician discretion/other medical issue|45
114184|NCT00416598|376132|P1|Induction & Intensification|Alternative Treatment|135
114185|NCT00416598|376132|P1|Induction & Intensification|Withdrawal by Subject|46
114186|NCT00416598|376132|P1|Induction & Intensification|Death|32
114187|NCT00416598|376132|P1|Induction & Intensification|Adverse Event|38
114188|NCT00416624|376141|P4|Overall Study|Cancel|0
114189|NCT00416624|376142|P3|Overall Study|Cancel|0
114190|NCT00416624|376143|P2|Overall Study|Cancel|0
114191|NCT00416624|376144|P1|Overall Study|Cancel|1
114192|NCT00416624|376141|P4|Overall Study|Not Specified|5
114193|NCT00416624|376142|P3|Overall Study|Not Specified|5
114194|NCT00416624|376143|P2|Overall Study|Not Specified|11
114195|NCT00416624|376144|P1|Overall Study|Not Specified|8
114196|NCT00416624|376141|P4|Overall Study|Adverse Event|2
114197|NCT00416624|376142|P3|Overall Study|Adverse Event|2
114198|NCT00416624|376143|P2|Overall Study|Adverse Event|3
114199|NCT00416624|376144|P1|Overall Study|Adverse Event|8
114200|NCT00416624|376141|P4|Overall Study|Death|1
114201|NCT00416624|376142|P3|Overall Study|Death|7
114202|NCT00416624|376143|P2|Overall Study|Death|7
114203|NCT00416624|376144|P1|Overall Study|Death|4
114204|NCT00416624|376141|P4|Overall Study|Withdrawal by Subject|9
114205|NCT00416624|376142|P3|Overall Study|Withdrawal by Subject|4
114206|NCT00416624|376143|P2|Overall Study|Withdrawal by Subject|6
114207|NCT00416624|376144|P1|Overall Study|Withdrawal by Subject|1
114208|NCT00416715|376198|P1|Overall Study|Vitamin D levels not evaluable|8
114209|NCT00416715|376198|P1|Overall Study|Not evaluable for joint aches|7
114210|NCT00416884|376209|P1|Overall Study|Study terminated due to low accrual|1
114211|NCT00417027|376216|P3|Overall Study|Protocol Violation|5
114212|NCT00417027|376217|P2|Overall Study|Protocol Violation|5
114213|NCT00417027|376218|P1|Overall Study|Protocol Violation|0
114214|NCT00417079|376246|P2|Overall Study|abnormal liver function tests|1
114215|NCT00417079|376247|P1|Overall Study|abnormal liver function tests|0
114216|NCT00417079|376246|P2|Overall Study|Patient unable to come to the clinic|1
114217|NCT00417079|376247|P1|Overall Study|Patient unable to come to the clinic|0
114218|NCT00417079|376246|P2|Overall Study|Withdrawal by subject's family|1
114219|NCT00417079|376247|P1|Overall Study|Withdrawal by subject's family|0
114220|NCT00417079|376246|P2|Overall Study|Screening error|1
114221|NCT00417079|376247|P1|Overall Study|Screening error|2
114222|NCT00417079|376246|P2|Overall Study|Clinical deterioration|0
114223|NCT00417079|376247|P1|Overall Study|Clinical deterioration|1
114224|NCT00417079|376246|P2|Overall Study|Non-confirmed Disease progression|1
114225|NCT00417079|376247|P1|Overall Study|Non-confirmed Disease progression|1
114226|NCT00417079|376246|P2|Overall Study|Investigator's decision|4
114227|NCT00417079|376247|P1|Overall Study|Investigator's decision|1
114228|NCT00417079|376246|P2|Overall Study|Screened failure|1
114229|NCT00417079|376247|P1|Overall Study|Screened failure|2
114230|NCT00417079|376246|P2|Overall Study|Not treated|7
114231|NCT00417079|376247|P1|Overall Study|Not treated|6
114232|NCT00417079|376246|P2|Overall Study|Withdrawal by Subject|8
114233|NCT00417079|376247|P1|Overall Study|Withdrawal by Subject|17
114234|NCT00417079|376246|P2|Overall Study|Lost to Follow-up|0
114235|NCT00417079|376247|P1|Overall Study|Lost to Follow-up|2
114236|NCT00417079|376246|P2|Overall Study|Non-compliance to protocol|1
114237|NCT00417079|376247|P1|Overall Study|Non-compliance to protocol|0
114238|NCT00417079|376246|P2|Overall Study|Adverse Event|67
114239|NCT00417079|376247|P1|Overall Study|Adverse Event|32
114240|NCT00417079|376246|P2|Overall Study|Disease progression|180
114241|NCT00417079|376247|P1|Overall Study|Disease progression|267
114242|NCT00417170|376269|P2|Overall Study|Lost to Follow-up|1
114243|NCT00417170|376270|P1|Overall Study|Lost to Follow-up|0
114244|NCT00417170|376269|P2|Overall Study|Withdrawal by Subject|1
114245|NCT00417170|376270|P1|Overall Study|Withdrawal by Subject|1
114246|NCT00417170|376269|P2|Overall Study|Adverse Event|1
114247|NCT00417170|376270|P1|Overall Study|Adverse Event|1
114248|NCT00417248|376284|P1|Overall Study|Lack of Efficacy|1
114249|NCT00417248|376284|P1|Overall Study|Death|1
114250|NCT00417248|376284|P1|Overall Study|Study Terminated|6
114251|NCT00417482|376307|P3|Phase B 2nd 16 Weeks|Death|0
114252|NCT00417482|376308|P2|Phase B 2nd 16 Weeks|Death|1
114253|NCT00417482|376309|P1|Phase B 2nd 16 Weeks|Death|1
114254|NCT00417482|376307|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
114255|NCT00417482|376308|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
114256|NCT00417482|376309|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
114257|NCT00417482|376307|P3|Phase B 2nd 16 Weeks|Adverse Event|1
114258|NCT00417482|376308|P2|Phase B 2nd 16 Weeks|Adverse Event|0
114259|NCT00417482|376309|P1|Phase B 2nd 16 Weeks|Adverse Event|0
114260|NCT00417482|376307|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
114261|NCT00417482|376308|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
114262|NCT00417482|376309|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
114263|NCT00417482|376307|P3|Phase B 1st 16 Weeks|Death|0
114264|NCT00417482|376308|P2|Phase B 1st 16 Weeks|Death|0
114265|NCT00417482|376309|P1|Phase B 1st 16 Weeks|Death|1
114266|NCT00417482|376307|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
114267|NCT00417482|376308|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
114268|NCT00417482|376309|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
114269|NCT00417482|376307|P3|Phase B 1st 16 Weeks|Adverse Event|1
114270|NCT00417482|376308|P2|Phase B 1st 16 Weeks|Adverse Event|0
114271|NCT00417482|376309|P1|Phase B 1st 16 Weeks|Adverse Event|2
114272|NCT00417482|376307|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
114273|NCT00417482|376308|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
114274|NCT00417482|376309|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
114275|NCT00417612|376335|P2|Overall Study|Lost to Follow-up|0
114276|NCT00417612|376336|P1|Overall Study|Lost to Follow-up|1
114277|NCT00417612|376335|P2|Overall Study|Protocol Violation|2
114278|NCT00417612|376336|P1|Overall Study|Protocol Violation|0
114279|NCT00417612|376335|P2|Overall Study|Adverse Event|0
114280|NCT00417612|376336|P1|Overall Study|Adverse Event|2
114281|NCT00417612|376335|P2|Overall Study|Errant diagnosis|1
114282|NCT00417612|376336|P1|Overall Study|Errant diagnosis|0
114283|NCT00417885|376359|P1|Overall Study|Transferred to Another Sunitinib Study|2
114284|NCT00417885|376359|P1|Overall Study|Objective Progression or Relapse|3
114285|NCT00417885|376359|P1|Overall Study|Adverse Event|1
114286|NCT00417963|376368|P1|Overall Study|Study device could not be deployed|3
114287|NCT00417963|376368|P1|Overall Study|Death|17
114288|NCT00417963|376368|P1|Overall Study|Withdrawal by Subject|18
114289|NCT00417963|376368|P1|Overall Study|Lost to Follow-up|3
114290|NCT00417976|376385|P1|Overall Study|Treatment -related toxicity|2
114291|NCT00417976|376385|P1|Overall Study|Non compliance unrelated to toxicity|1
114292|NCT00417989|376392|P2|Overall Study|Physician Decision|2
114293|NCT00417989|376393|P1|Overall Study|Physician Decision|5
114294|NCT00417989|376392|P2|Overall Study|Death|1
114295|NCT00417989|376393|P1|Overall Study|Death|0
114296|NCT00417989|376392|P2|Overall Study|Protocol Violation|0
114297|NCT00417989|376393|P1|Overall Study|Protocol Violation|1
114298|NCT00417989|376392|P2|Overall Study|Lost to Follow-up|6
114299|NCT00417989|376393|P1|Overall Study|Lost to Follow-up|1
114300|NCT00417989|376392|P2|Overall Study|Withdrawal by Subject|13
114301|NCT00417989|376393|P1|Overall Study|Withdrawal by Subject|13
114302|NCT00418145|376453|P1|Overall Study|study terminated|6
114303|NCT00418184|376467|P2|Double-blind Phase|Poor compliance|1
114304|NCT00418184|376468|P1|Double-blind Phase|Poor compliance|3
114305|NCT00418184|376467|P2|Double-blind Phase|Adverse Event|1
114306|NCT00418184|376468|P1|Double-blind Phase|Adverse Event|2
114307|NCT00418184|376467|P2|Double-blind Phase|Withdrawal by Subject|9
114308|NCT00418184|376468|P1|Double-blind Phase|Withdrawal by Subject|22
114309|NCT00418314|376496|P2|Overall Study|Withdrawal by Subject|2
114310|NCT00418314|376497|P1|Overall Study|Withdrawal by Subject|1
114311|NCT00418379|376510|P3|Year 5|Any other reason not above-mentioned|3
114312|NCT00418379|376511|P2|Year 5|Any other reason not above-mentioned|4
114313|NCT00418379|376512|P1|Year 5|Any other reason not above-mentioned|2
114314|NCT00418379|376510|P3|Year 5|Adverse Event|0
114315|NCT00418379|376511|P2|Year 5|Adverse Event|1
114316|NCT00418379|376512|P1|Year 5|Adverse Event|0
114317|NCT00418379|376510|P3|Year 4|Any other reason not above-mentioned|0
114318|NCT00418379|376511|P2|Year 4|Any other reason not above-mentioned|1
114319|NCT00418379|376512|P1|Year 4|Any other reason not above-mentioned|1
114320|NCT00418379|376510|P3|Year 4|Withdrawal by Subject|2
114321|NCT00418379|376511|P2|Year 4|Withdrawal by Subject|3
114322|NCT00418379|376512|P1|Year 4|Withdrawal by Subject|2
114323|NCT00418379|376510|P3|Year 4|Adverse Event|0
114324|NCT00418379|376511|P2|Year 4|Adverse Event|1
114325|NCT00418379|376512|P1|Year 4|Adverse Event|0
114326|NCT00418379|376510|P3|Year 3|Any other reason not above-mentioned|1
114327|NCT00418379|376511|P2|Year 3|Any other reason not above-mentioned|1
114328|NCT00418379|376512|P1|Year 3|Any other reason not above-mentioned|2
114329|NCT00418379|376510|P3|Year 3|Withdrawal by Subject|2
114330|NCT00418379|376511|P2|Year 3|Withdrawal by Subject|1
114331|NCT00418379|376512|P1|Year 3|Withdrawal by Subject|1
114332|NCT00418379|376510|P3|Year 2|Any other reason not above-mentioned|6
114333|NCT00418379|376511|P2|Year 2|Any other reason not above-mentioned|1
114334|NCT00418379|376512|P1|Year 2|Any other reason not above-mentioned|2
114335|NCT00418379|376510|P3|Year 2|Withdrawal by Subject|3
114336|NCT00418379|376511|P2|Year 2|Withdrawal by Subject|1
114337|NCT00418379|376512|P1|Year 2|Withdrawal by Subject|1
114338|NCT00418379|376510|P3|Year 2|Adverse Event|1
114339|NCT00418379|376511|P2|Year 2|Adverse Event|2
114340|NCT00418379|376512|P1|Year 2|Adverse Event|5
114341|NCT00418379|376510|P3|Year 1|Any other reason not above-mentioned|7
114342|NCT00418379|376511|P2|Year 1|Any other reason not above-mentioned|5
114343|NCT00418379|376512|P1|Year 1|Any other reason not above-mentioned|2
114344|NCT00418379|376510|P3|Year 1|Withdrawal by Subject|5
114345|NCT00418379|376511|P2|Year 1|Withdrawal by Subject|8
114346|NCT00418379|376512|P1|Year 1|Withdrawal by Subject|7
114347|NCT00418379|376510|P3|Year 1|Adverse Event|3
114348|NCT00418379|376511|P2|Year 1|Adverse Event|15
114349|NCT00418379|376512|P1|Year 1|Adverse Event|9
114350|NCT00418522|376522|P2|Overall Study|Randomized but did not receive treatment|4
114351|NCT00418522|376523|P1|Overall Study|Randomized but did not receive treatment|7
114352|NCT00418522|376522|P2|Overall Study|Other|23
114353|NCT00418522|376523|P1|Overall Study|Other|27
114354|NCT00418522|376522|P2|Overall Study|Withdrawal by Subject|7
114355|NCT00418522|376523|P1|Overall Study|Withdrawal by Subject|31
114356|NCT00418522|376522|P2|Overall Study|Lost to Follow-up|4
114357|NCT00418522|376523|P1|Overall Study|Lost to Follow-up|10
114358|NCT00418522|376522|P2|Overall Study|Lack of Efficacy|3
114359|NCT00418522|376523|P1|Overall Study|Lack of Efficacy|1
114360|NCT00418522|376522|P2|Overall Study|Adverse Event|1
114361|NCT00418522|376523|P1|Overall Study|Adverse Event|7
114362|NCT00418561|376570|P3|Overall Study|Participant's (guardian's) decision|0
114363|NCT00418561|376571|P2|Overall Study|Participant's (guardian's) decision|1
114364|NCT00418561|376572|P1|Overall Study|Participant's (guardian's) decision|0
114365|NCT00418665|376657|P3|Treatment Extension|Death|1
114366|NCT00418665|376658|P2|Treatment Extension|Death|0
114367|NCT00418665|376659|P1|Treatment Extension|Death|0
114368|NCT00418665|376657|P3|Treatment Extension|Physician Decision|1
114369|NCT00418665|376658|P2|Treatment Extension|Physician Decision|2
114370|NCT00418665|376659|P1|Treatment Extension|Physician Decision|2
114371|NCT00418665|376657|P3|Treatment Extension|Requirement for alternative therapy|0
114372|NCT00418665|376658|P2|Treatment Extension|Requirement for alternative therapy|2
114373|NCT00418665|376659|P1|Treatment Extension|Requirement for alternative therapy|2
114374|NCT00418665|376657|P3|Treatment Extension|Withdrawal by Subject|0
114375|NCT00418665|376658|P2|Treatment Extension|Withdrawal by Subject|0
114376|NCT00418665|376659|P1|Treatment Extension|Withdrawal by Subject|1
114377|NCT00418665|376657|P3|Treatment Extension|Adverse Event|0
114378|NCT00418665|376658|P2|Treatment Extension|Adverse Event|0
114379|NCT00418665|376659|P1|Treatment Extension|Adverse Event|1
114380|NCT00418665|376657|P3|Treatment Period|Physician Decision|3
114381|NCT00418665|376658|P2|Treatment Period|Physician Decision|0
114382|NCT00418665|376659|P1|Treatment Period|Physician Decision|1
114383|NCT00418665|376657|P3|Treatment Period|Requirement for alternative therapy|0
114384|NCT00418665|376658|P2|Treatment Period|Requirement for alternative therapy|0
114385|NCT00418665|376659|P1|Treatment Period|Requirement for alternative therapy|1
114386|NCT00418665|376657|P3|Treatment Period|Withdrawal by Subject|1
114387|NCT00418665|376658|P2|Treatment Period|Withdrawal by Subject|3
114388|NCT00418665|376659|P1|Treatment Period|Withdrawal by Subject|0
114389|NCT00418665|376657|P3|Treatment Period|Adverse Event|0
114390|NCT00418665|376658|P2|Treatment Period|Adverse Event|2
114391|NCT00418665|376659|P1|Treatment Period|Adverse Event|2
114392|NCT00418665|376657|P3|Treatment Period|Ineligibility determined|0
114393|NCT00418665|376658|P2|Treatment Period|Ineligibility determined|1
114394|NCT00418665|376659|P1|Treatment Period|Ineligibility determined|1
114395|NCT00418691|376679|P3|Overall Study|Progressive Disease|1
114396|NCT00418691|376680|P2|Overall Study|Progressive Disease|0
114397|NCT00418691|376681|P1|Overall Study|Progressive Disease|1
114398|NCT00418691|376679|P3|Overall Study|Started new medication voiding entry|1
114399|NCT00418691|376680|P2|Overall Study|Started new medication voiding entry|0
114400|NCT00418691|376681|P1|Overall Study|Started new medication voiding entry|0
114401|NCT00418691|376679|P3|Overall Study|Lost to Follow-up|3
114402|NCT00418691|376680|P2|Overall Study|Lost to Follow-up|2
114403|NCT00418691|376681|P1|Overall Study|Lost to Follow-up|1
114404|NCT00418717|376689|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
114405|NCT00418717|376689|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
114406|NCT00418834|376696|P2|Overall Study|Withdrawal by Subject|7
114407|NCT00418834|376697|P1|Overall Study|Withdrawal by Subject|3
114408|NCT00418834|376696|P2|Overall Study|Protocol Violation|3
114409|NCT00418834|376697|P1|Overall Study|Protocol Violation|4
114410|NCT00418834|376696|P2|Overall Study|Lost to Follow-up|1
114411|NCT00418834|376697|P1|Overall Study|Lost to Follow-up|0
114412|NCT00418834|376696|P2|Overall Study|Adverse Event|9
114413|NCT00418834|376697|P1|Overall Study|Adverse Event|16
114414|NCT00418886|376759|P2|Overall Study|randomised but no treatment received|1
114415|NCT00418886|376760|P1|Overall Study|randomised but no treatment received|0
114416|NCT00418886|376759|P2|Overall Study|withdrawn due to other reason|0
114417|NCT00418886|376760|P1|Overall Study|withdrawn due to other reason|1
114418|NCT00418886|376759|P2|Overall Study|Lost to Follow-up|6
114419|NCT00418886|376760|P1|Overall Study|Lost to Follow-up|4
114420|NCT00418886|376759|P2|Overall Study|Withdrawal by Subject|10
114421|NCT00418886|376760|P1|Overall Study|Withdrawal by Subject|9
114422|NCT00418886|376759|P2|Overall Study|Death|147
114423|NCT00418886|376760|P1|Overall Study|Death|122
114424|NCT00418886|376759|P2|Overall Study|discontinue treatment survival follow up|91
114425|NCT00418886|376760|P1|Overall Study|discontinue treatment survival follow up|90
114426|NCT00426842|376784|P1|Overall Study|Lost to Follow-up|1
114427|NCT00427011|376794|P1|Overall Study|Not specified|12
114428|NCT00427011|376794|P1|Overall Study|Lack of Efficacy|2
114429|NCT00427011|376794|P1|Overall Study|Withdrawal by Subject|1
114430|NCT00427011|376794|P1|Overall Study|Adverse Event|10
114431|NCT00427349|376820|P1|Overall Study|Never started therapy|1
114432|NCT00427349|376820|P1|Overall Study|Ineligible|1
114433|NCT00427349|376820|P1|Overall Study|Other|2
114434|NCT00427349|376820|P1|Overall Study|Alternative therapy|1
114435|NCT00427349|376820|P1|Overall Study|Withdrawal by Subject|3
114436|NCT00427349|376820|P1|Overall Study|Death|1
114437|NCT00427349|376820|P1|Overall Study|Adverse Event|14
114438|NCT00427349|376820|P1|Overall Study|Lack of Efficacy|23
114439|NCT00427635|376832|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
114440|NCT00427635|376833|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
114441|NCT00427635|376832|P2|Treatment Phase|Withdrawal by Subject|0
114442|NCT00427635|376833|P1|Treatment Phase|Withdrawal by Subject|1
114443|NCT00427700|376869|P2|Overall Study|Pregnancy|2
114444|NCT00427700|376870|P1|Overall Study|Pregnancy|0
114445|NCT00427700|376869|P2|Overall Study|no induction of menses|4
114446|NCT00427700|376870|P1|Overall Study|no induction of menses|1
114447|NCT00427700|376869|P2|Overall Study|Lost to Follow-up|5
114448|NCT00427700|376870|P1|Overall Study|Lost to Follow-up|2
114449|NCT00427895|376906|P8|Vax 2/Year 3 to 4|Failed to Return|0
114450|NCT00427895|376907|P7|Vax 2/Year 3 to 4|Failed to Return|0
114451|NCT00427895|376908|P6|Vax 2/Year 3 to 4|Failed to Return|0
114452|NCT00427895|376909|P5|Vax 2/Year 3 to 4|Failed to Return|1
114453|NCT00427895|376910|P4|Vax 2/Year 3 to 4|Failed to Return|0
114454|NCT00427895|376911|P3|Vax 2/Year 3 to 4|Failed to Return|0
114455|NCT00427895|376912|P2|Vax 2/Year 3 to 4|Failed to Return|0
114456|NCT00427895|376913|P1|Vax 2/Year 3 to 4|Failed to Return|0
114457|NCT00427895|376906|P8|Vax 2/Year 3 to 4|Protocol Violation|1
114458|NCT00427895|376907|P7|Vax 2/Year 3 to 4|Protocol Violation|0
114459|NCT00427895|376908|P6|Vax 2/Year 3 to 4|Protocol Violation|0
114460|NCT00427895|376909|P5|Vax 2/Year 3 to 4|Protocol Violation|0
114461|NCT00427895|376910|P4|Vax 2/Year 3 to 4|Protocol Violation|0
114462|NCT00427895|376911|P3|Vax 2/Year 3 to 4|Protocol Violation|0
114463|NCT00427895|376912|P2|Vax 2/Year 3 to 4|Protocol Violation|0
114464|NCT00427895|376913|P1|Vax 2/Year 3 to 4|Protocol Violation|0
114465|NCT00427895|376906|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
114466|NCT00427895|376907|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
114467|NCT00427895|376908|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
114468|NCT00427895|376909|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
114469|NCT00427895|376910|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
114470|NCT00427895|376911|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
114471|NCT00427895|376912|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
114472|NCT00427895|376913|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
114473|NCT00427895|376906|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
114474|NCT00427895|376907|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
114475|NCT00427895|376908|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
114476|NCT00427895|376909|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
114477|NCT00427895|376910|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
114478|NCT00427895|376911|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
114479|NCT00427895|376912|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
114480|NCT00427895|376913|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
114481|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Unspecified|0
114482|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Unspecified|0
114483|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Unspecified|0
114484|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Unspecified|0
114485|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Unspecified|2
114486|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Unspecified|0
114487|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Unspecified|0
114488|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Unspecified|0
114489|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
114490|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
114491|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
114492|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
114493|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
114494|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
114495|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
114496|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
114497|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Death|0
114498|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Death|0
114499|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Death|0
114500|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Death|0
114501|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Death|0
114502|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Death|0
114503|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Death|0
114504|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Death|1
114505|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
114506|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
114507|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
114508|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
114509|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
114510|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
114511|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
114512|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
114513|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
114514|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
114515|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
114516|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
114517|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
114518|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
114519|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
114520|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
114521|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
114522|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
114523|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
114524|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
114525|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
114526|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
114527|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
114528|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
114529|NCT00427895|376906|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
114530|NCT00427895|376907|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
114531|NCT00427895|376908|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
114532|NCT00427895|376909|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
114533|NCT00427895|376910|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
114534|NCT00427895|376911|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
114535|NCT00427895|376912|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
114536|NCT00427895|376913|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
114537|NCT00427895|376906|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114538|NCT00427895|376907|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114539|NCT00427895|376908|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114540|NCT00427895|376909|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114541|NCT00427895|376910|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
114542|NCT00427895|376911|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114543|NCT00427895|376912|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114544|NCT00427895|376913|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
114545|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
114546|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
114547|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
114548|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
114549|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Unspecified|2
114550|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Unspecified|1
114551|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
114552|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Unspecified|0
114553|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
114554|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
114555|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
114556|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
114557|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
114558|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
114559|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
114560|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
114561|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114562|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114563|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114564|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114565|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
114566|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114567|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114568|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
114569|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
114570|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
114571|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
114572|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
114573|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
114574|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
114575|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
114576|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
114577|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
114578|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
114579|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
114580|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
114581|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
114582|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
114583|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
114584|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
114585|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
114586|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
114587|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
114588|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
114589|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
114590|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
114591|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
114592|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
114593|NCT00427895|376906|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
114594|NCT00427895|376907|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
114595|NCT00427895|376908|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
114596|NCT00427895|376909|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
114597|NCT00427895|376910|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
114598|NCT00427895|376911|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
114599|NCT00427895|376912|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
114600|NCT00427895|376913|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
114601|NCT00427921|376968|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
114602|NCT00427921|376968|P1|Overall Study|Adverse Event + Withdrawn from Study|1
114603|NCT00427921|376968|P1|Overall Study|Adverse Event + Lost Response|1
114604|NCT00427921|376968|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
114605|NCT00427921|376968|P1|Overall Study|Adverse Event + Worsening of CD|1
114606|NCT00427921|376968|P1|Overall Study|Adverse Event + No Response|1
114607|NCT00427921|376968|P1|Overall Study|Adverse Event + Withdrew Consent|1
114608|NCT00427921|376968|P1|Overall Study|Adverse Event + Hospitalization|1
114609|NCT00427921|376968|P1|Overall Study|Other reason not specified|10
114610|NCT00427921|376968|P1|Overall Study|Lost to Follow-up|2
114611|NCT00427921|376968|P1|Overall Study|Withdrawal by Subject|4
114612|NCT00427921|376968|P1|Overall Study|Adverse Event|26
114613|NCT00427934|376991|P4|Overall Study|Withdrawal by Subject|3
114614|NCT00427934|376992|P3|Overall Study|Withdrawal by Subject|1
114615|NCT00427934|376993|P2|Overall Study|Withdrawal by Subject|0
114616|NCT00427934|376994|P1|Overall Study|Withdrawal by Subject|0
114617|NCT00427934|376991|P4|Overall Study|Other|5
114618|NCT00427934|376992|P3|Overall Study|Other|11
114619|NCT00427934|376993|P2|Overall Study|Other|0
114620|NCT00427934|376994|P1|Overall Study|Other|0
114621|NCT00427934|376991|P4|Overall Study|Randomized But Did Not Receive Treatment|1
114622|NCT00427934|376992|P3|Overall Study|Randomized But Did Not Receive Treatment|1
114623|NCT00427934|376993|P2|Overall Study|Randomized But Did Not Receive Treatment|0
114624|NCT00427934|376994|P1|Overall Study|Randomized But Did Not Receive Treatment|0
114625|NCT00427934|376991|P4|Overall Study|Lack of Efficacy|2
114626|NCT00427934|376992|P3|Overall Study|Lack of Efficacy|5
114627|NCT00427934|376993|P2|Overall Study|Lack of Efficacy|0
114628|NCT00427934|376994|P1|Overall Study|Lack of Efficacy|0
114629|NCT00427934|376991|P4|Overall Study|Adverse Event|4
114630|NCT00427934|376992|P3|Overall Study|Adverse Event|5
114631|NCT00427934|376993|P2|Overall Study|Adverse Event|0
114632|NCT00427934|376994|P1|Overall Study|Adverse Event|1
114633|NCT00427960|377064|P2|Overall Study|Not Specified|1
114634|NCT00427960|377065|P1|Overall Study|Not Specified|0
114635|NCT00427960|377064|P2|Overall Study|Withdrawal by Subject|3
114636|NCT00427960|377065|P1|Overall Study|Withdrawal by Subject|0
114637|NCT00427960|377064|P2|Overall Study|Adverse Event|0
114638|NCT00427960|377065|P1|Overall Study|Adverse Event|2
114639|NCT00427999|377106|P1|Overall Study|Death|1
114640|NCT00427999|377106|P1|Overall Study|Withdrawal by Subject|9
114641|NCT00427999|377106|P1|Overall Study|Protocol Violation|2
114642|NCT00427999|377106|P1|Overall Study|Unsatisfactory therapeutic effect|13
114643|NCT00427999|377106|P1|Overall Study|Abnormal laboratory values|1
114644|NCT00427999|377106|P1|Overall Study|Adverse Event|6
114645|NCT00428090|377123|P4|Overall Study|Raised Creatinine Value|1
114646|NCT00428090|377124|P3|Overall Study|Raised Creatinine Value|0
114647|NCT00428090|377125|P2|Overall Study|Raised Creatinine Value|0
114648|NCT00428090|377126|P1|Overall Study|Raised Creatinine Value|0
114649|NCT00428090|377123|P4|Overall Study|Excluded for heart insufficiency|0
114650|NCT00428090|377124|P3|Overall Study|Excluded for heart insufficiency|1
114651|NCT00428090|377125|P2|Overall Study|Excluded for heart insufficiency|0
114652|NCT00428090|377126|P1|Overall Study|Excluded for heart insufficiency|0
114653|NCT00428090|377123|P4|Overall Study|Serious adverse event|0
114654|NCT00428090|377124|P3|Overall Study|Serious adverse event|1
114655|NCT00428090|377125|P2|Overall Study|Serious adverse event|0
114656|NCT00428090|377126|P1|Overall Study|Serious adverse event|0
114657|NCT00428090|377123|P4|Overall Study|Deterioration of cognitive status|0
114658|NCT00428090|377124|P3|Overall Study|Deterioration of cognitive status|1
114659|NCT00428090|377125|P2|Overall Study|Deterioration of cognitive status|0
114660|NCT00428090|377126|P1|Overall Study|Deterioration of cognitive status|0
114661|NCT00428090|377123|P4|Overall Study|High MMSE scores|0
114662|NCT00428090|377124|P3|Overall Study|High MMSE scores|1
114663|NCT00428090|377125|P2|Overall Study|High MMSE scores|0
114664|NCT00428090|377126|P1|Overall Study|High MMSE scores|0
114665|NCT00428090|377123|P4|Overall Study|Insufficient AD documentation|0
114666|NCT00428090|377124|P3|Overall Study|Insufficient AD documentation|1
114667|NCT00428090|377125|P2|Overall Study|Insufficient AD documentation|0
114668|NCT00428090|377126|P1|Overall Study|Insufficient AD documentation|0
114669|NCT00428090|377123|P4|Overall Study|Excluded for concerning QTc value|0
114670|NCT00428090|377124|P3|Overall Study|Excluded for concerning QTc value|1
114671|NCT00428090|377125|P2|Overall Study|Excluded for concerning QTc value|0
114672|NCT00428090|377126|P1|Overall Study|Excluded for concerning QTc value|0
114673|NCT00428090|377123|P4|Overall Study|Worsening of AD|0
114674|NCT00428090|377124|P3|Overall Study|Worsening of AD|1
114675|NCT00428090|377125|P2|Overall Study|Worsening of AD|0
114676|NCT00428090|377126|P1|Overall Study|Worsening of AD|0
114677|NCT00428090|377123|P4|Overall Study|Mental status of par. was|0
114678|NCT00428090|377124|P3|Overall Study|Mental status of par. was|0
114679|NCT00428090|377125|P2|Overall Study|Mental status of par. was|1
114680|NCT00428090|377126|P1|Overall Study|Mental status of par. was|0
114681|NCT00428090|377123|P4|Overall Study|Medical monitor terminated par.|0
114682|NCT00428090|377124|P3|Overall Study|Medical monitor terminated par.|0
114683|NCT00428090|377125|P2|Overall Study|Medical monitor terminated par.|1
114684|NCT00428090|377126|P1|Overall Study|Medical monitor terminated par.|0
114685|NCT00428090|377123|P4|Overall Study|Visit 7 exceed the visit window|0
114686|NCT00428090|377124|P3|Overall Study|Visit 7 exceed the visit window|0
114687|NCT00428090|377125|P2|Overall Study|Visit 7 exceed the visit window|1
114688|NCT00428090|377126|P1|Overall Study|Visit 7 exceed the visit window|0
114689|NCT00428090|377123|P4|Overall Study|Death of par.|0
114690|NCT00428090|377124|P3|Overall Study|Death of par.|1
114691|NCT00428090|377125|P2|Overall Study|Death of par.|0
114692|NCT00428090|377126|P1|Overall Study|Death of par.|1
114693|NCT00428090|377123|P4|Overall Study|Prohibited medication used for SAE|0
114694|NCT00428090|377124|P3|Overall Study|Prohibited medication used for SAE|0
114695|NCT00428090|377125|P2|Overall Study|Prohibited medication used for SAE|0
114696|NCT00428090|377126|P1|Overall Study|Prohibited medication used for SAE|1
114697|NCT00428090|377123|P4|Overall Study|Follow-Up visit not possible|0
114698|NCT00428090|377124|P3|Overall Study|Follow-Up visit not possible|0
114699|NCT00428090|377125|P2|Overall Study|Follow-Up visit not possible|0
114700|NCT00428090|377126|P1|Overall Study|Follow-Up visit not possible|1
114701|NCT00428090|377123|P4|Overall Study|Par. did not returned to visit|1
114702|NCT00428090|377124|P3|Overall Study|Par. did not returned to visit|0
114703|NCT00428090|377125|P2|Overall Study|Par. did not returned to visit|0
114704|NCT00428090|377126|P1|Overall Study|Par. did not returned to visit|1
114705|NCT00428090|377123|P4|Overall Study|Non-compliance|3
114706|NCT00428090|377124|P3|Overall Study|Non-compliance|1
114707|NCT00428090|377125|P2|Overall Study|Non-compliance|0
114708|NCT00428090|377126|P1|Overall Study|Non-compliance|4
114709|NCT00428090|377123|P4|Overall Study|Sponsor terminated study|0
114710|NCT00428090|377124|P3|Overall Study|Sponsor terminated study|0
114711|NCT00428090|377125|P2|Overall Study|Sponsor terminated study|1
114712|NCT00428090|377126|P1|Overall Study|Sponsor terminated study|0
114713|NCT00428090|377123|P4|Overall Study|Withdrawal by Subject|5
114714|NCT00428090|377124|P3|Overall Study|Withdrawal by Subject|15
114715|NCT00428090|377125|P2|Overall Study|Withdrawal by Subject|12
114716|NCT00428090|377126|P1|Overall Study|Withdrawal by Subject|10
114717|NCT00428090|377123|P4|Overall Study|Protocol Violation|3
114718|NCT00428090|377124|P3|Overall Study|Protocol Violation|3
114719|NCT00428090|377125|P2|Overall Study|Protocol Violation|1
114720|NCT00428090|377126|P1|Overall Study|Protocol Violation|3
114721|NCT00428090|377123|P4|Overall Study|Lost to Follow-up|4
114722|NCT00428090|377124|P3|Overall Study|Lost to Follow-up|1
114723|NCT00428090|377125|P2|Overall Study|Lost to Follow-up|6
114724|NCT00428090|377126|P1|Overall Study|Lost to Follow-up|3
114725|NCT00428090|377123|P4|Overall Study|Adverse Event|11
114726|NCT00428090|377124|P3|Overall Study|Adverse Event|10
114727|NCT00428090|377125|P2|Overall Study|Adverse Event|8
114728|NCT00428090|377126|P1|Overall Study|Adverse Event|10
114729|NCT00428116|377242|P2|Overall Study|Lost to Follow-up|0
114730|NCT00428116|377243|P1|Overall Study|Lost to Follow-up|1
114731|NCT00428116|377242|P2|Overall Study|Withdrawal by Subject|0
114732|NCT00428116|377243|P1|Overall Study|Withdrawal by Subject|1
114733|NCT00428116|377242|P2|Overall Study|Death|0
114734|NCT00428116|377243|P1|Overall Study|Death|1
114735|NCT00428220|377258|P1|Overall Study|Other|23
114736|NCT00428220|377258|P1|Overall Study|Adverse Event|51
114737|NCT00428220|377258|P1|Overall Study|Participant refused continued treatment|7
114738|NCT00428220|377258|P1|Overall Study|Objective progression or relapse|123
114739|NCT00428220|377258|P1|Overall Study|Lost to Follow-up|4
114740|NCT00428220|377258|P1|Overall Study|Global deterioration of health status|7
114741|NCT00428220|377258|P1|Overall Study|Participant died|8
114742|NCT00428246|377277|P3|Overall Study|Adverse Event|0
114743|NCT00428246|377278|P2|Overall Study|Adverse Event|0
114744|NCT00428246|377279|P1|Overall Study|Adverse Event|1
114745|NCT00428246|377277|P3|Overall Study|Withdrawal by Subject|1
114746|NCT00428246|377278|P2|Overall Study|Withdrawal by Subject|0
114747|NCT00428246|377279|P1|Overall Study|Withdrawal by Subject|0
114748|NCT00428389|377302|P2|Extension Phase|Administrative problems|1
114749|NCT00428389|377303|P1|Extension Phase|Administrative problems|1
114750|NCT00428389|377302|P2|Extension Phase|Protocol Violation|2
114751|NCT00428389|377303|P1|Extension Phase|Protocol Violation|3
114752|NCT00428389|377302|P2|Extension Phase|Death|0
114753|NCT00428389|377303|P1|Extension Phase|Death|1
114754|NCT00428389|377302|P2|Extension Phase|Lost to Follow-up|3
114755|NCT00428389|377303|P1|Extension Phase|Lost to Follow-up|0
114756|NCT00428389|377302|P2|Extension Phase|Withdrawal by Subject|6
114757|NCT00428389|377303|P1|Extension Phase|Withdrawal by Subject|6
114758|NCT00428389|377302|P2|Extension Phase|Lack of Efficacy|3
114759|NCT00428389|377303|P1|Extension Phase|Lack of Efficacy|4
114760|NCT00428389|377302|P2|Extension Phase|Adverse Event|11
114761|NCT00428389|377303|P1|Extension Phase|Adverse Event|17
114762|NCT00428389|377302|P2|Core Phase|Protocol deviation|2
114763|NCT00428389|377303|P1|Core Phase|Protocol deviation|0
114764|NCT00428389|377302|P2|Core Phase|Withdrawal by Subject|4
114765|NCT00428389|377303|P1|Core Phase|Withdrawal by Subject|3
114766|NCT00428389|377302|P2|Core Phase|Abnormal test procedure result(s)|1
114767|NCT00428389|377303|P1|Core Phase|Abnormal test procedure result(s)|0
114768|NCT00428389|377302|P2|Core Phase|Lack of Efficacy|0
114769|NCT00428389|377303|P1|Core Phase|Lack of Efficacy|2
114770|NCT00428389|377302|P2|Core Phase|Adverse Event|4
114771|NCT00428389|377303|P1|Core Phase|Adverse Event|6
114772|NCT00428441|377321|P1|Overall Study|Lost to Follow-up|1
114773|NCT00428597|377354|P2|Overall Study|Death|3
114774|NCT00428597|377355|P1|Overall Study|Death|1
114775|NCT00428597|377354|P2|Overall Study|Pregnancy|0
114776|NCT00428597|377355|P1|Overall Study|Pregnancy|1
114777|NCT00428597|377354|P2|Overall Study|Lost to Follow-up|1
114778|NCT00428597|377355|P1|Overall Study|Lost to Follow-up|0
114779|NCT00428597|377354|P2|Overall Study|Other|1
114780|NCT00428597|377355|P1|Overall Study|Other|1
114781|NCT00428597|377354|P2|Overall Study|Withdrawal by Subject|1
114782|NCT00428597|377355|P1|Overall Study|Withdrawal by Subject|2
114783|NCT00428597|377354|P2|Overall Study|Protocol Violation|1
114784|NCT00428597|377355|P1|Overall Study|Protocol Violation|2
114785|NCT00428597|377354|P2|Overall Study|Global Deterioration of Health Status|5
114786|NCT00428597|377355|P1|Overall Study|Global Deterioration of Health Status|1
114787|NCT00428597|377354|P2|Overall Study|Adverse Event|7
114788|NCT00428597|377355|P1|Overall Study|Adverse Event|15
114789|NCT00428597|377354|P2|Overall Study|Study Terminated by Sponsor|16
114790|NCT00428597|377355|P1|Overall Study|Study Terminated by Sponsor|41
114791|NCT00428597|377354|P2|Overall Study|Objective Progression or Relapse|47
114792|NCT00428597|377355|P1|Overall Study|Objective Progression or Relapse|19
114793|NCT00428597|377354|P2|Overall Study|Randomized but not treated|3
114794|NCT00428597|377355|P1|Overall Study|Randomized but not treated|3
114795|NCT00428792|377397|P2|Overall Study|Lost to Follow-up|1
114796|NCT00428792|377398|P1|Overall Study|Lost to Follow-up|0
114797|NCT00428792|377397|P2|Overall Study|Lack of Efficacy|3
114798|NCT00428792|377398|P1|Overall Study|Lack of Efficacy|1
114799|NCT00428844|377425|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
114800|NCT00428844|377426|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
114801|NCT00428844|377427|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
114802|NCT00428844|377425|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
114803|NCT00428844|377426|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
114804|NCT00428844|377427|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
114805|NCT00428844|377425|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
114806|NCT00428844|377426|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
114807|NCT00428844|377427|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
114808|NCT00428844|377425|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
114809|NCT00428844|377426|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
114810|NCT00428844|377427|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
114811|NCT00428844|377425|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
114812|NCT00428844|377426|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
114813|NCT00428844|377427|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
114814|NCT00428844|377425|P3|Completed Study Drug Treatment|Randomized Not Treated|1
114815|NCT00428844|377426|P2|Completed Study Drug Treatment|Randomized Not Treated|0
114816|NCT00428844|377427|P1|Completed Study Drug Treatment|Randomized Not Treated|0
114817|NCT00428844|377425|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
114818|NCT00428844|377426|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
114819|NCT00428844|377427|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
114820|NCT00428844|377425|P3|Completed Study Drug Treatment|Protocol Violation|1
114821|NCT00428844|377426|P2|Completed Study Drug Treatment|Protocol Violation|1
114822|NCT00428844|377427|P1|Completed Study Drug Treatment|Protocol Violation|0
114823|NCT00428844|377425|P3|Completed Study Drug Treatment|Adverse Event|4
114824|NCT00428844|377426|P2|Completed Study Drug Treatment|Adverse Event|4
114825|NCT00428844|377427|P1|Completed Study Drug Treatment|Adverse Event|2
114826|NCT00428948|377457|P2|Overall Study|Protocol Deviation|1
114827|NCT00428948|377458|P1|Overall Study|Protocol Deviation|1
114828|NCT00428948|377457|P2|Overall Study|Subject Withdrew Consent|30
114829|NCT00428948|377458|P1|Overall Study|Subject Withdrew Consent|50
114830|NCT00428948|377457|P2|Overall Study|Investigator Withdrew Subject|4
114831|NCT00428948|377458|P1|Overall Study|Investigator Withdrew Subject|3
114832|NCT00428948|377457|P2|Overall Study|Subject Met Withdrawal Criteria|0
114833|NCT00428948|377458|P1|Overall Study|Subject Met Withdrawal Criteria|4
114834|NCT00428948|377457|P2|Overall Study|Adverse Event|24
114835|NCT00428948|377458|P1|Overall Study|Adverse Event|148
114836|NCT00428948|377457|P2|Overall Study|Lost to Follow-up|8
114837|NCT00428948|377458|P1|Overall Study|Lost to Follow-up|15
114838|NCT00429026|377497|P1|Overall Study|Inevaluable for response.|40
114839|NCT00429104|377501|P1|Overall Study|Protocol Violation|1
114840|NCT00429169|377516|P2|Overall Study|Ineligibility discovered after entry|1
114841|NCT00429169|377517|P1|Overall Study|Ineligibility discovered after entry|2
114842|NCT00429169|377516|P2|Overall Study|Lost to Follow-up|1
114843|NCT00429169|377517|P1|Overall Study|Lost to Follow-up|0
114844|NCT00429182|377527|P1|Overall Study|Not eligible|5
114845|NCT00429182|377527|P1|Overall Study|Not evaluable, Disease Progression|2
114846|NCT00429273|377535|P3|Overall Study|Adverse Event|2
114847|NCT00429273|377536|P2|Overall Study|Adverse Event|1
114848|NCT00429273|377537|P1|Overall Study|Adverse Event|1
114849|NCT00429273|377535|P3|Overall Study|Physician Decision|5
114850|NCT00429273|377536|P2|Overall Study|Physician Decision|5
114851|NCT00429273|377537|P1|Overall Study|Physician Decision|6
114852|NCT00429273|377535|P3|Overall Study|Lost to Follow-up|2
114853|NCT00429273|377536|P2|Overall Study|Lost to Follow-up|2
114854|NCT00429273|377537|P1|Overall Study|Lost to Follow-up|1
114855|NCT00429299|377548|P3|Overall Study|Withdrawal by Subject|3
114856|NCT00429299|377549|P2|Overall Study|Withdrawal by Subject|1
114857|NCT00429299|377550|P1|Overall Study|Withdrawal by Subject|0
114858|NCT00429299|377548|P3|Overall Study|Protocol Violation|0
114859|NCT00429299|377549|P2|Overall Study|Protocol Violation|0
114860|NCT00429299|377550|P1|Overall Study|Protocol Violation|1
114861|NCT00429299|377548|P3|Overall Study|Adverse Event|1
114862|NCT00429299|377549|P2|Overall Study|Adverse Event|5
114863|NCT00429299|377550|P1|Overall Study|Adverse Event|2
114864|NCT00429299|377548|P3|Overall Study|Disease Progression|0
114865|NCT00429299|377549|P2|Overall Study|Disease Progression|1
114866|NCT00429299|377550|P1|Overall Study|Disease Progression|1
114867|NCT00429364|377581|P2|Overall Study|Pregnancy|1
114868|NCT00429364|377582|P1|Overall Study|Pregnancy|0
114869|NCT00429364|377581|P2|Overall Study|Underwent aortic root surgery|18
114870|NCT00429364|377582|P1|Overall Study|Underwent aortic root surgery|10
114871|NCT00429364|377581|P2|Overall Study|Death|1
114872|NCT00429364|377582|P1|Overall Study|Death|0
114873|NCT00429364|377581|P2|Overall Study|Lost to Follow-up|6
114874|NCT00429364|377582|P1|Overall Study|Lost to Follow-up|7
114875|NCT00429364|377581|P2|Overall Study|Physician Decision|2
114876|NCT00429364|377582|P1|Overall Study|Physician Decision|4
114877|NCT00429364|377581|P2|Overall Study|Withdrawal by Subject|5
114878|NCT00429364|377582|P1|Overall Study|Withdrawal by Subject|11
114879|NCT00429416|377647|P1|Overall Study|Death|1
114880|NCT00429494|377655|P1|Overall Study|Death|6
114881|NCT00429494|377655|P1|Overall Study|Withdrawal by Subject|9
114882|NCT00429572|377663|P1|Overall Study|Disease progression|1
114883|NCT00429663|377673|P2|Overall Study|Death|0
114884|NCT00429663|377674|P1|Overall Study|Death|4
114885|NCT00429663|377673|P2|Overall Study|Withdrawal by Subject|5
114886|NCT00429663|377674|P1|Overall Study|Withdrawal by Subject|2
114887|NCT00429663|377673|P2|Overall Study|Physician Decision|3
114888|NCT00429663|377674|P1|Overall Study|Physician Decision|6
114889|NCT00429663|377673|P2|Overall Study|Lost to Follow-up|31
114890|NCT00429663|377674|P1|Overall Study|Lost to Follow-up|24
114891|NCT00429793|377699|P1|Overall Study|Non-measurable|1
114892|NCT00429793|377699|P1|Overall Study|Never treated|1
114893|NCT00429793|377699|P1|Overall Study|Required test not done|1
114894|NCT00429793|377699|P1|Overall Study|Improper pre-protocol treatment|3
114895|NCT00421889|377715|P9|Overall Study|Lost to Follow-up|1
114896|NCT00421889|377716|P8|Overall Study|Lost to Follow-up|0
114897|NCT00421889|377717|P7|Overall Study|Lost to Follow-up|0
114898|NCT00421889|377718|P6|Overall Study|Lost to Follow-up|0
114899|NCT00421889|377719|P5|Overall Study|Lost to Follow-up|0
114900|NCT00421889|377720|P4|Overall Study|Lost to Follow-up|0
114901|NCT00421889|377721|P3|Overall Study|Lost to Follow-up|0
114902|NCT00421889|377722|P2|Overall Study|Lost to Follow-up|0
114903|NCT00421889|377723|P1|Overall Study|Lost to Follow-up|0
114904|NCT00421889|377715|P9|Overall Study|Patient/Investigator request|3
114905|NCT00421889|377716|P8|Overall Study|Patient/Investigator request|1
114906|NCT00421889|377717|P7|Overall Study|Patient/Investigator request|0
114907|NCT00421889|377718|P6|Overall Study|Patient/Investigator request|9
114908|NCT00421889|377719|P5|Overall Study|Patient/Investigator request|0
114909|NCT00421889|377720|P4|Overall Study|Patient/Investigator request|0
114910|NCT00421889|377721|P3|Overall Study|Patient/Investigator request|0
114911|NCT00421889|377722|P2|Overall Study|Patient/Investigator request|0
114912|NCT00421889|377723|P1|Overall Study|Patient/Investigator request|0
114913|NCT00421889|377715|P9|Overall Study|Progressive disease|5
114914|NCT00421889|377716|P8|Overall Study|Progressive disease|1
114915|NCT00421889|377717|P7|Overall Study|Progressive disease|3
114916|NCT00421889|377718|P6|Overall Study|Progressive disease|21
114917|NCT00421889|377719|P5|Overall Study|Progressive disease|2
114918|NCT00421889|377720|P4|Overall Study|Progressive disease|3
114919|NCT00421889|377721|P3|Overall Study|Progressive disease|2
114920|NCT00421889|377722|P2|Overall Study|Progressive disease|2
114921|NCT00421889|377723|P1|Overall Study|Progressive disease|3
114922|NCT00421889|377715|P9|Overall Study|Death|0
114923|NCT00421889|377716|P8|Overall Study|Death|0
114924|NCT00421889|377717|P7|Overall Study|Death|0
114925|NCT00421889|377718|P6|Overall Study|Death|1
114926|NCT00421889|377719|P5|Overall Study|Death|1
114927|NCT00421889|377720|P4|Overall Study|Death|0
114928|NCT00421889|377721|P3|Overall Study|Death|0
114929|NCT00421889|377722|P2|Overall Study|Death|0
114930|NCT00421889|377723|P1|Overall Study|Death|0
114931|NCT00421889|377715|P9|Overall Study|Withdrawal by Subject|0
114932|NCT00421889|377716|P8|Overall Study|Withdrawal by Subject|0
114933|NCT00421889|377717|P7|Overall Study|Withdrawal by Subject|0
114934|NCT00421889|377718|P6|Overall Study|Withdrawal by Subject|0
114935|NCT00421889|377719|P5|Overall Study|Withdrawal by Subject|2
114936|NCT00421889|377720|P4|Overall Study|Withdrawal by Subject|0
114937|NCT00421889|377721|P3|Overall Study|Withdrawal by Subject|0
114938|NCT00421889|377722|P2|Overall Study|Withdrawal by Subject|3
114939|NCT00421889|377723|P1|Overall Study|Withdrawal by Subject|1
114940|NCT00421889|377715|P9|Overall Study|Adverse Event|2
114941|NCT00421889|377716|P8|Overall Study|Adverse Event|0
114942|NCT00421889|377717|P7|Overall Study|Adverse Event|1
114943|NCT00421889|377718|P6|Overall Study|Adverse Event|4
114944|NCT00421889|377719|P5|Overall Study|Adverse Event|1
114945|NCT00421889|377720|P4|Overall Study|Adverse Event|1
114946|NCT00421889|377721|P3|Overall Study|Adverse Event|1
114947|NCT00421889|377722|P2|Overall Study|Adverse Event|0
114948|NCT00421889|377723|P1|Overall Study|Adverse Event|1
114949|NCT00421928|377768|P3|Overall Study|Death|0
114950|NCT00421928|377769|P2|Overall Study|Death|1
114951|NCT00421928|377770|P1|Overall Study|Death|0
114952|NCT00421928|377768|P3|Overall Study|All other|27
114953|NCT00421928|377769|P2|Overall Study|All other|21
114954|NCT00421928|377770|P1|Overall Study|All other|26
114955|NCT00421928|377768|P3|Overall Study|Study drug non-compliant|4
114956|NCT00421928|377769|P2|Overall Study|Study drug non-compliant|7
114957|NCT00421928|377770|P1|Overall Study|Study drug non-compliant|6
114958|NCT00421928|377768|P3|Overall Study|Lack of Efficacy|35
114959|NCT00421928|377769|P2|Overall Study|Lack of Efficacy|7
114960|NCT00421928|377770|P1|Overall Study|Lack of Efficacy|15
114961|NCT00421928|377768|P3|Overall Study|Withdrawal by Subject|43
114962|NCT00421928|377769|P2|Overall Study|Withdrawal by Subject|48
114963|NCT00421928|377770|P1|Overall Study|Withdrawal by Subject|50
114964|NCT00421928|377768|P3|Overall Study|Lost to Follow-up|3
114965|NCT00421928|377769|P2|Overall Study|Lost to Follow-up|0
114966|NCT00421928|377770|P1|Overall Study|Lost to Follow-up|5
114967|NCT00421928|377768|P3|Overall Study|Adverse Event|22
114968|NCT00421928|377769|P2|Overall Study|Adverse Event|140
114969|NCT00421928|377770|P1|Overall Study|Adverse Event|61
114970|NCT00421993|377804|P4|Overall Study|Subject transportation issues|1
114971|NCT00421993|377805|P3|Overall Study|Subject transportation issues|0
114972|NCT00421993|377806|P2|Overall Study|Subject transportation issues|0
114973|NCT00421993|377807|P1|Overall Study|Subject transportation issues|0
114974|NCT00421993|377804|P4|Overall Study|Pregnancy|2
114975|NCT00421993|377805|P3|Overall Study|Pregnancy|1
114976|NCT00421993|377806|P2|Overall Study|Pregnancy|1
114977|NCT00421993|377807|P1|Overall Study|Pregnancy|0
114978|NCT00421993|377804|P4|Overall Study|Lack of Efficacy|5
114979|NCT00421993|377805|P3|Overall Study|Lack of Efficacy|0
114980|NCT00421993|377806|P2|Overall Study|Lack of Efficacy|3
114981|NCT00421993|377807|P1|Overall Study|Lack of Efficacy|0
114982|NCT00421993|377804|P4|Overall Study|Protocol Violation|1
114983|NCT00421993|377805|P3|Overall Study|Protocol Violation|0
114984|NCT00421993|377806|P2|Overall Study|Protocol Violation|2
114985|NCT00421993|377807|P1|Overall Study|Protocol Violation|2
114986|NCT00421993|377804|P4|Overall Study|Adverse Event|4
114987|NCT00421993|377805|P3|Overall Study|Adverse Event|6
114988|NCT00421993|377806|P2|Overall Study|Adverse Event|1
114989|NCT00421993|377807|P1|Overall Study|Adverse Event|11
114990|NCT00421993|377804|P4|Overall Study|Lost to Follow-up|20
114991|NCT00421993|377805|P3|Overall Study|Lost to Follow-up|22
114992|NCT00421993|377806|P2|Overall Study|Lost to Follow-up|19
114993|NCT00421993|377807|P1|Overall Study|Lost to Follow-up|18
114994|NCT00421993|377804|P4|Overall Study|Withdrawal by Subject|24
114995|NCT00421993|377805|P3|Overall Study|Withdrawal by Subject|23
114996|NCT00421993|377806|P2|Overall Study|Withdrawal by Subject|23
114997|NCT00421993|377807|P1|Overall Study|Withdrawal by Subject|22
114998|NCT00422058|377852|P6|Open-Label Extension, Week 20-104|Other|18
114999|NCT00422058|377853|P5|Open-Label Extension, Week 20-104|Other|16
115000|NCT00422058|377854|P4|Open-Label Extension, Week 20-104|Other|13
115001|NCT00422058|377855|P3|Open-Label Extension, Week 20-104|Other|6
115002|NCT00422058|377856|P2|Open-Label Extension, Week 20-104|Other|14
115003|NCT00422058|377857|P1|Open-Label Extension, Week 20-104|Other|13
115004|NCT00422058|377852|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
115005|NCT00422058|377853|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
115006|NCT00422058|377854|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
115007|NCT00422058|377855|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
115008|NCT00422058|377856|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
115009|NCT00422058|377857|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
115010|NCT00422058|377852|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
115011|NCT00422058|377853|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
115012|NCT00422058|377854|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
115013|NCT00422058|377855|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
115014|NCT00422058|377856|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
115015|NCT00422058|377857|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
115016|NCT00422058|377852|P6|Open-Label Extension, Week 20-104|Adverse Event|0
115017|NCT00422058|377853|P5|Open-Label Extension, Week 20-104|Adverse Event|4
115018|NCT00422058|377854|P4|Open-Label Extension, Week 20-104|Adverse Event|4
115019|NCT00422058|377855|P3|Open-Label Extension, Week 20-104|Adverse Event|7
115020|NCT00422058|377856|P2|Open-Label Extension, Week 20-104|Adverse Event|4
115021|NCT00422058|377857|P1|Open-Label Extension, Week 20-104|Adverse Event|3
115022|NCT00422058|377852|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
115023|NCT00422058|377853|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
115024|NCT00422058|377854|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
115025|NCT00422058|377855|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
115026|NCT00422058|377856|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
115027|NCT00422058|377857|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
115028|NCT00422058|377852|P6|Double-Blind, Week 0-20|Other|10
115029|NCT00422058|377853|P5|Double-Blind, Week 0-20|Other|4
115030|NCT00422058|377854|P4|Double-Blind, Week 0-20|Other|8
115031|NCT00422058|377855|P3|Double-Blind, Week 0-20|Other|8
115032|NCT00422058|377856|P2|Double-Blind, Week 0-20|Other|3
115033|NCT00422058|377857|P1|Double-Blind, Week 0-20|Other|11
115034|NCT00422058|377852|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
115035|NCT00422058|377853|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
115036|NCT00422058|377854|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
115037|NCT00422058|377855|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
115038|NCT00422058|377856|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
115039|NCT00422058|377857|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
115040|NCT00422058|377852|P6|Double-Blind, Week 0-20|Protocol Violation|2
115041|NCT00422058|377853|P5|Double-Blind, Week 0-20|Protocol Violation|2
115042|NCT00422058|377854|P4|Double-Blind, Week 0-20|Protocol Violation|3
115043|NCT00422058|377855|P3|Double-Blind, Week 0-20|Protocol Violation|2
115044|NCT00422058|377856|P2|Double-Blind, Week 0-20|Protocol Violation|2
115045|NCT00422058|377857|P1|Double-Blind, Week 0-20|Protocol Violation|3
115046|NCT00422058|377852|P6|Double-Blind, Week 0-20|Adverse Event|3
115047|NCT00422058|377853|P5|Double-Blind, Week 0-20|Adverse Event|5
115048|NCT00422058|377854|P4|Double-Blind, Week 0-20|Adverse Event|9
115049|NCT00422058|377855|P3|Double-Blind, Week 0-20|Adverse Event|5
115050|NCT00422058|377856|P2|Double-Blind, Week 0-20|Adverse Event|4
115051|NCT00422058|377857|P1|Double-Blind, Week 0-20|Adverse Event|3
115052|NCT00422097|377991|P8|Dose Level 2|Still on treatment|0
115053|NCT00422097|377992|P7|Dose Level 2|Still on treatment|0
115054|NCT00422097|377993|P6|Dose Level 2|Still on treatment|0
115055|NCT00422097|377994|P5|Dose Level 2|Still on treatment|0
115056|NCT00422097|377995|P4|Dose Level 2|Still on treatment|0
115057|NCT00422097|377996|P3|Dose Level 2|Still on treatment|0
115058|NCT00422097|377997|P2|Dose Level 2|Still on treatment|1
115059|NCT00422097|377998|P1|Dose Level 2|Still on treatment|0
115060|NCT00422162|378059|P2|Overall Study|Didn't Receive Treatment|1
115061|NCT00422162|378060|P1|Overall Study|Didn't Receive Treatment|0
115062|NCT00422162|378059|P2|Overall Study|Not Specified|1
115063|NCT00422162|378060|P1|Overall Study|Not Specified|0
115064|NCT00422162|378059|P2|Overall Study|Non-Compliant with Protocol|1
115065|NCT00422162|378060|P1|Overall Study|Non-Compliant with Protocol|1
115066|NCT00422162|378059|P2|Overall Study|Lost to Follow-up|2
115067|NCT00422162|378060|P1|Overall Study|Lost to Follow-up|1
115068|NCT00422162|378059|P2|Overall Study|Withdrawal by Subject|6
115069|NCT00422162|378060|P1|Overall Study|Withdrawal by Subject|7
115070|NCT00422162|378059|P2|Overall Study|Lack of Efficacy|10
115071|NCT00422162|378060|P1|Overall Study|Lack of Efficacy|4
115072|NCT00422162|378059|P2|Overall Study|Adverse Event|9
115073|NCT00422162|378060|P1|Overall Study|Adverse Event|11
115074|NCT00422227|378120|P2|Overall Study|Withdrawal by Subject|4
115075|NCT00422227|378121|P1|Overall Study|Withdrawal by Subject|0
115076|NCT00422227|378120|P2|Overall Study|Lost to Follow-up|3
115077|NCT00422227|378121|P1|Overall Study|Lost to Follow-up|1
115078|NCT00422227|378120|P2|Overall Study|Adverse Event|8
115079|NCT00422227|378121|P1|Overall Study|Adverse Event|3
115080|NCT00422292|378160|P4|Overall Study|Withdrawal by Subject|13
115081|NCT00422292|378161|P3|Overall Study|Withdrawal by Subject|7
115082|NCT00422292|378162|P2|Overall Study|Withdrawal by Subject|25
115083|NCT00422292|378163|P1|Overall Study|Withdrawal by Subject|6
115084|NCT00422292|378160|P4|Overall Study|Lost to Follow-up|6
115085|NCT00422292|378161|P3|Overall Study|Lost to Follow-up|6
115086|NCT00422292|378162|P2|Overall Study|Lost to Follow-up|12
115087|NCT00422292|378163|P1|Overall Study|Lost to Follow-up|6
115088|NCT00422292|378160|P4|Overall Study|Protocol Violation|5
115089|NCT00422292|378161|P3|Overall Study|Protocol Violation|8
115090|NCT00422292|378162|P2|Overall Study|Protocol Violation|25
115091|NCT00422292|378163|P1|Overall Study|Protocol Violation|4
115092|NCT00422292|378160|P4|Overall Study|Adverse Event|0
115093|NCT00422292|378161|P3|Overall Study|Adverse Event|1
115094|NCT00422292|378162|P2|Overall Study|Adverse Event|0
115095|NCT00422292|378163|P1|Overall Study|Adverse Event|1
115096|NCT00422292|378160|P4|Overall Study|Serious adverse events|0
115097|NCT00422292|378161|P3|Overall Study|Serious adverse events|0
115098|NCT00422292|378162|P2|Overall Study|Serious adverse events|4
115099|NCT00422292|378163|P1|Overall Study|Serious adverse events|1
115100|NCT00422383|378194|P5|Overall Study|Withdrawal by Subject|1
115101|NCT00422383|378195|P4|Overall Study|Withdrawal by Subject|0
115102|NCT00422383|378196|P3|Overall Study|Withdrawal by Subject|0
115103|NCT00422383|378197|P2|Overall Study|Withdrawal by Subject|5
115104|NCT00422383|378198|P1|Overall Study|Withdrawal by Subject|5
115105|NCT00422383|378194|P5|Overall Study|Protocol Violation|0
115106|NCT00422383|378195|P4|Overall Study|Protocol Violation|0
115107|NCT00422383|378196|P3|Overall Study|Protocol Violation|1
115108|NCT00422383|378197|P2|Overall Study|Protocol Violation|1
115109|NCT00422383|378198|P1|Overall Study|Protocol Violation|1
115110|NCT00422383|378194|P5|Overall Study|Lost to Follow-up|1
115111|NCT00422383|378195|P4|Overall Study|Lost to Follow-up|0
115112|NCT00422383|378196|P3|Overall Study|Lost to Follow-up|0
115113|NCT00422383|378197|P2|Overall Study|Lost to Follow-up|1
115114|NCT00422383|378198|P1|Overall Study|Lost to Follow-up|0
115115|NCT00422383|378194|P5|Overall Study|Lack of Efficacy|1
115116|NCT00422383|378195|P4|Overall Study|Lack of Efficacy|1
115117|NCT00422383|378196|P3|Overall Study|Lack of Efficacy|2
115118|NCT00422383|378197|P2|Overall Study|Lack of Efficacy|4
115119|NCT00422383|378198|P1|Overall Study|Lack of Efficacy|4
115120|NCT00422383|378194|P5|Overall Study|Adverse Event|0
115121|NCT00422383|378195|P4|Overall Study|Adverse Event|1
115122|NCT00422383|378196|P3|Overall Study|Adverse Event|1
115123|NCT00422383|378197|P2|Overall Study|Adverse Event|3
115124|NCT00422383|378198|P1|Overall Study|Adverse Event|5
115125|NCT00422422|378337|P1|Overall Study|AE, non-serious non-fatal|5
115126|NCT00422422|378337|P1|Overall Study|SAE, non-fatal|1
115127|NCT00422422|378337|P1|Overall Study|Withdrawal by Subject|2
115128|NCT00422422|378337|P1|Overall Study|Protocol Violation|1
115129|NCT00422422|378337|P1|Overall Study|Lack of Efficacy|1
115130|NCT00422513|378356|P2|Overall Study|Death|7
115131|NCT00422513|378357|P1|Overall Study|Death|3
115132|NCT00422513|378356|P2|Overall Study|Adverse Event|4
115133|NCT00422513|378357|P1|Overall Study|Adverse Event|4
115134|NCT00422513|378356|P2|Overall Study|early termination of the study|80
115135|NCT00422513|378357|P1|Overall Study|early termination of the study|67
115136|NCT00422513|378356|P2|Overall Study|Withdrawal by Subject|1
115137|NCT00422513|378357|P1|Overall Study|Withdrawal by Subject|2
115138|NCT00422513|378356|P2|Overall Study|Refused Treatment|2
115139|NCT00422513|378357|P1|Overall Study|Refused Treatment|4
115140|NCT00422513|378356|P2|Overall Study|Protocol Violation|7
115141|NCT00422513|378357|P1|Overall Study|Protocol Violation|23
115142|NCT00422513|378356|P2|Overall Study|Lack of Efficacy|5
115143|NCT00422513|378357|P1|Overall Study|Lack of Efficacy|4
115144|NCT00422669|378376|P3|Overall Study|The study was terminated early.|7
115145|NCT00422669|378377|P2|Overall Study|The study was terminated early.|100
115146|NCT00422669|378378|P1|Overall Study|The study was terminated early.|98
115147|NCT00422734|378412|P2|Overall Study|Partner Decision|3
115148|NCT00422734|378413|P1|Overall Study|Partner Decision|0
115149|NCT00422734|378412|P2|Overall Study|Adverse Event|3
115150|NCT00422734|378413|P1|Overall Study|Adverse Event|0
115151|NCT00422734|378412|P2|Overall Study|Withdrawal by Subject|8
115152|NCT00422734|378413|P1|Overall Study|Withdrawal by Subject|12
115153|NCT00422734|378412|P2|Overall Study|Protocol Violation|6
115154|NCT00422734|378413|P1|Overall Study|Protocol Violation|1
115155|NCT00422734|378412|P2|Overall Study|Physician Decision|1
115156|NCT00422734|378413|P1|Overall Study|Physician Decision|1
115157|NCT00422903|378447|P2|Overall Study|Informed Consent Withdrawn|2
115158|NCT00422903|378448|P1|Overall Study|Informed Consent Withdrawn|1
115159|NCT00422903|378447|P2|Overall Study|Adverse Event|2
115160|NCT00422903|378448|P1|Overall Study|Adverse Event|0
115161|NCT00422903|378447|P2|Overall Study|Disease Progression|1
115162|NCT00422903|378448|P1|Overall Study|Disease Progression|3
115163|NCT00422942|378472|P1|Overall Study|Study terminated by Sponsor|3
115164|NCT00423046|378491|P2|Overall Study|Unspecified|345
115165|NCT00423046|378492|P1|Overall Study|Unspecified|340
115166|NCT00423085|378561|P4|52-Week Open-Label Extension Phase|Death|2
115167|NCT00423085|378562|P3|52-Week Open-Label Extension Phase|Death|0
115168|NCT00423085|378563|P2|52-Week Open-Label Extension Phase|Death|0
115169|NCT00423085|378564|P1|52-Week Open-Label Extension Phase|Death|0
115170|NCT00423085|378561|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
115171|NCT00423085|378562|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
115172|NCT00423085|378563|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
115173|NCT00423085|378564|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
115174|NCT00423085|378561|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
115175|NCT00423085|378562|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
115176|NCT00423085|378563|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
115177|NCT00423085|378564|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
115178|NCT00423085|378561|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
115179|NCT00423085|378562|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
115180|NCT00423085|378563|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
115181|NCT00423085|378564|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
115182|NCT00423085|378561|P4|52-Week Open-Label Extension Phase|Adverse Event|97
115183|NCT00423085|378562|P3|52-Week Open-Label Extension Phase|Adverse Event|0
115184|NCT00423085|378563|P2|52-Week Open-Label Extension Phase|Adverse Event|0
115185|NCT00423085|378564|P1|52-Week Open-Label Extension Phase|Adverse Event|0
115186|NCT00423085|378561|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
115187|NCT00423085|378562|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
115188|NCT00423085|378563|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
115189|NCT00423085|378564|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
115190|NCT00423085|378561|P4|24-Week Double-Blind Treatment Phase|Death|0
115191|NCT00423085|378562|P3|24-Week Double-Blind Treatment Phase|Death|0
115192|NCT00423085|378563|P2|24-Week Double-Blind Treatment Phase|Death|1
115193|NCT00423085|378564|P1|24-Week Double-Blind Treatment Phase|Death|1
115194|NCT00423085|378561|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
115195|NCT00423085|378562|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
115196|NCT00423085|378563|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
115197|NCT00423085|378564|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
115198|NCT00423085|378561|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
115199|NCT00423085|378562|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
115200|NCT00423085|378563|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
115201|NCT00423085|378564|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
115202|NCT00423085|378561|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
115203|NCT00423085|378562|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
115204|NCT00423085|378563|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
115205|NCT00423085|378564|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
115206|NCT00423085|378561|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
115207|NCT00423085|378562|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
115208|NCT00423085|378563|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
115209|NCT00423085|378564|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
115210|NCT00423098|378593|P2|Overall Study|Death|0
115211|NCT00423098|378594|P1|Overall Study|Death|2
115212|NCT00423098|378593|P2|Overall Study|Administrative problems|1
115213|NCT00423098|378594|P1|Overall Study|Administrative problems|0
115214|NCT00423098|378593|P2|Overall Study|Unsatisfactory therapeutic effect|1
115215|NCT00423098|378594|P1|Overall Study|Unsatisfactory therapeutic effect|0
115216|NCT00423098|378593|P2|Overall Study|Adverse Event|2
115217|NCT00423098|378594|P1|Overall Study|Adverse Event|1
115218|NCT00423150|378618|P1|Overall Study|Administrative|4
115219|NCT00423150|378618|P1|Overall Study|Non-compliance with protocol|1
115220|NCT00423150|378618|P1|Overall Study|Withdrawal by Subject|1
115221|NCT00423150|378618|P1|Overall Study|Progression of disease being studied|69
115222|NCT00423150|378618|P1|Overall Study|Adverse Event|11
115223|NCT00423176|378624|P2|Overall Study|Did not meet protocol eligibility|4
115224|NCT00423176|378625|P1|Overall Study|Did not meet protocol eligibility|2
115225|NCT00423176|378624|P2|Overall Study|Protocol Violation|3
115226|NCT00423176|378625|P1|Overall Study|Protocol Violation|1
115227|NCT00423176|378624|P2|Overall Study|Withdrawal by Subject|3
115228|NCT00423176|378625|P1|Overall Study|Withdrawal by Subject|4
115229|NCT00423176|378624|P2|Overall Study|Lost to Follow-up|7
115230|NCT00423176|378625|P1|Overall Study|Lost to Follow-up|4
115231|NCT00423176|378624|P2|Overall Study|Treatment Failure|6
115232|NCT00423176|378625|P1|Overall Study|Treatment Failure|1
115233|NCT00423176|378624|P2|Overall Study|Adverse Event|6
115234|NCT00423176|378625|P1|Overall Study|Adverse Event|4
115235|NCT00423189|378636|P3|Overall Study|Death|0
115236|NCT00423189|378637|P2|Overall Study|Death|1
115237|NCT00423189|378638|P1|Overall Study|Death|0
115238|NCT00423267|378660|P2|Period A|Administrative|0
115239|NCT00423267|378661|P1|Period A|Administrative|1
115240|NCT00423267|378660|P2|Period A|Non-compliance with protocol|0
115241|NCT00423267|378661|P1|Period A|Non-compliance with protocol|1
115242|NCT00423267|378660|P2|Period A|Withdrawal by Subject|1
115243|NCT00423267|378661|P1|Period A|Withdrawal by Subject|0
115244|NCT00423293|378678|P1|Overall Study|Ineligible / No protocol treatment|11
115245|NCT00423319|378684|P2|Overall Study|Not specified|22
115246|NCT00423319|378685|P1|Overall Study|Not specified|23
115247|NCT00423319|378684|P2|Overall Study|No longer meets study criteria|15
115248|NCT00423319|378685|P1|Overall Study|No longer meets study criteria|15
115249|NCT00423319|378684|P2|Overall Study|Poor compliance or noncompliance|1
115250|NCT00423319|378685|P1|Overall Study|Poor compliance or noncompliance|1
115251|NCT00423319|378684|P2|Overall Study|Lost to Follow-up|3
115252|NCT00423319|378685|P1|Overall Study|Lost to Follow-up|4
115253|NCT00423319|378684|P2|Overall Study|Withdrawal by Subject|99
115254|NCT00423319|378685|P1|Overall Study|Withdrawal by Subject|86
115255|NCT00423319|378684|P2|Overall Study|Adverse Event|112
115256|NCT00423319|378685|P1|Overall Study|Adverse Event|93
115257|NCT00423319|378684|P2|Overall Study|Death|0
115258|NCT00423319|378685|P1|Overall Study|Death|2
115259|NCT00423332|378719|P2|Overall Study|Unblinded before 12 weeks|3
115260|NCT00423332|378720|P1|Overall Study|Unblinded before 12 weeks|1
115261|NCT00423332|378719|P2|Overall Study|Progressive at Week 6|1
115262|NCT00423332|378720|P1|Overall Study|Progressive at Week 6|0
115263|NCT00423332|378719|P2|Overall Study|Condition under investigation worsened|1
115264|NCT00423332|378720|P1|Overall Study|Condition under investigation worsened|1
115265|NCT00423332|378719|P2|Overall Study|Withdrawal by Subject|0
115266|NCT00423332|378720|P1|Overall Study|Withdrawal by Subject|1
115267|NCT00423332|378719|P2|Overall Study|Adverse Event|2
115268|NCT00423332|378720|P1|Overall Study|Adverse Event|6
115269|NCT00423449|378759|P5|Overall Study|Protocol Violation|0
115270|NCT00423449|378760|P4|Overall Study|Protocol Violation|1
115271|NCT00423449|378761|P3|Overall Study|Protocol Violation|2
115272|NCT00423449|378762|P2|Overall Study|Protocol Violation|0
115273|NCT00423449|378763|P1|Overall Study|Protocol Violation|0
115274|NCT00423449|378759|P5|Overall Study|Not Specified|0
115275|NCT00423449|378760|P4|Overall Study|Not Specified|1
115276|NCT00423449|378761|P3|Overall Study|Not Specified|0
115277|NCT00423449|378762|P2|Overall Study|Not Specified|0
115278|NCT00423449|378763|P1|Overall Study|Not Specified|0
115279|NCT00423449|378759|P5|Overall Study|Laboratory Adverse Event|0
115280|NCT00423449|378760|P4|Overall Study|Laboratory Adverse Event|0
115281|NCT00423449|378761|P3|Overall Study|Laboratory Adverse Event|2
115282|NCT00423449|378762|P2|Overall Study|Laboratory Adverse Event|1
115283|NCT00423449|378763|P1|Overall Study|Laboratory Adverse Event|0
115284|NCT00423449|378759|P5|Overall Study|Progressive Disease|4
115285|NCT00423449|378760|P4|Overall Study|Progressive Disease|11
115286|NCT00423449|378761|P3|Overall Study|Progressive Disease|8
115287|NCT00423449|378762|P2|Overall Study|Progressive Disease|3
115288|NCT00423449|378763|P1|Overall Study|Progressive Disease|1
115289|NCT00423449|378759|P5|Overall Study|Death|1
115290|NCT00423449|378760|P4|Overall Study|Death|1
115291|NCT00423449|378761|P3|Overall Study|Death|2
115292|NCT00423449|378762|P2|Overall Study|Death|0
115293|NCT00423449|378763|P1|Overall Study|Death|1
115294|NCT00423449|378759|P5|Overall Study|Clinical Adverse Event|2
115295|NCT00423449|378760|P4|Overall Study|Clinical Adverse Event|8
115296|NCT00423449|378761|P3|Overall Study|Clinical Adverse Event|1
115297|NCT00423449|378762|P2|Overall Study|Clinical Adverse Event|0
115298|NCT00423449|378763|P1|Overall Study|Clinical Adverse Event|1
115299|NCT00423488|378788|P2|Overall Study|No post baseline data|0
115300|NCT00423488|378789|P1|Overall Study|No post baseline data|3
115301|NCT00423488|378788|P2|Overall Study|No evidence of study drug intake|1
115302|NCT00423488|378789|P1|Overall Study|No evidence of study drug intake|2
115303|NCT00423579|378797|P2|Overall Study|Diagnosis of diabetes|1
115304|NCT00423579|378798|P1|Overall Study|Diagnosis of diabetes|0
115305|NCT00423579|378797|P2|Overall Study|Protocol Violation|3
115306|NCT00423579|378798|P1|Overall Study|Protocol Violation|1
115307|NCT00423579|378797|P2|Overall Study|Lost to Follow-up|0
115308|NCT00423579|378798|P1|Overall Study|Lost to Follow-up|3
115309|NCT00423592|378804|P1|Overall Study|Adverse Event (post Week 12)|5
115310|NCT00423592|378804|P1|Overall Study|Adverse Event (through Week 12)|2
115311|NCT00423605|378823|P1|Overall Study|Not one of the pre-specified options|5
115312|NCT00423605|378823|P1|Overall Study|Protocol Violation|7
115313|NCT00423605|378823|P1|Overall Study|Physician Decision|8
115314|NCT00423605|378823|P1|Overall Study|Sponsor Decision|3
115315|NCT00423605|378823|P1|Overall Study|Lack of Efficacy|38
115316|NCT00423605|378823|P1|Overall Study|Lost to Follow-up|15
115317|NCT00423605|378823|P1|Overall Study|Withdrawal by Subject|36
115318|NCT00423605|378823|P1|Overall Study|Adverse Event|129
115319|NCT00423657|378829|P2|Overall Study|Request of sponsor/investigator|0
115320|NCT00423657|378830|P1|Overall Study|Request of sponsor/investigator|1
115321|NCT00423657|378829|P2|Overall Study|Other|16
115322|NCT00423657|378830|P1|Overall Study|Other|15
115323|NCT00423657|378829|P2|Overall Study|Non-compliance|1
115324|NCT00423657|378830|P1|Overall Study|Non-compliance|0
115325|NCT00423657|378829|P2|Overall Study|Withdrew consent|8
115326|NCT00423657|378830|P1|Overall Study|Withdrew consent|10
115327|NCT00423670|378843|P8|Follow-up Period|Non-compliance with protocol|2
115328|NCT00423670|378844|P7|Follow-up Period|Non-compliance with protocol|3
115329|NCT00423670|378845|P6|Follow-up Period|Non-compliance with protocol|0
115330|NCT00423670|378846|P5|Follow-up Period|Non-compliance with protocol|0
115331|NCT00423670|378847|P4|Follow-up Period|Non-compliance with protocol|1
115332|NCT00423670|378848|P3|Follow-up Period|Non-compliance with protocol|1
115333|NCT00423670|378849|P2|Follow-up Period|Non-compliance with protocol|0
115334|NCT00423670|378850|P1|Follow-up Period|Non-compliance with protocol|2
115335|NCT00423670|378843|P8|Follow-up Period|Subject withdrew (not treatment related)|1
115336|NCT00423670|378844|P7|Follow-up Period|Subject withdrew (not treatment related)|1
115337|NCT00423670|378845|P6|Follow-up Period|Subject withdrew (not treatment related)|0
115338|NCT00423670|378846|P5|Follow-up Period|Subject withdrew (not treatment related)|1
115339|NCT00423670|378847|P4|Follow-up Period|Subject withdrew (not treatment related)|1
115340|NCT00423670|378848|P3|Follow-up Period|Subject withdrew (not treatment related)|2
115341|NCT00423670|378849|P2|Follow-up Period|Subject withdrew (not treatment related)|4
115342|NCT00423670|378850|P1|Follow-up Period|Subject withdrew (not treatment related)|1
115343|NCT00423670|378843|P8|Follow-up Period|Lost to Follow-up|0
115344|NCT00423670|378844|P7|Follow-up Period|Lost to Follow-up|5
115345|NCT00423670|378845|P6|Follow-up Period|Lost to Follow-up|0
115346|NCT00423670|378846|P5|Follow-up Period|Lost to Follow-up|1
115347|NCT00423670|378847|P4|Follow-up Period|Lost to Follow-up|3
115348|NCT00423670|378848|P3|Follow-up Period|Lost to Follow-up|8
115349|NCT00423670|378849|P2|Follow-up Period|Lost to Follow-up|12
115350|NCT00423670|378850|P1|Follow-up Period|Lost to Follow-up|0
115351|NCT00423670|378843|P8|Treatment Period|Non-compliance with protocol|2
115352|NCT00423670|378844|P7|Treatment Period|Non-compliance with protocol|2
115353|NCT00423670|378845|P6|Treatment Period|Non-compliance with protocol|0
115354|NCT00423670|378846|P5|Treatment Period|Non-compliance with protocol|2
115355|NCT00423670|378847|P4|Treatment Period|Non-compliance with protocol|3
115356|NCT00423670|378848|P3|Treatment Period|Non-compliance with protocol|1
115357|NCT00423670|378849|P2|Treatment Period|Non-compliance with protocol|1
115358|NCT00423670|378850|P1|Treatment Period|Non-compliance with protocol|3
115359|NCT00423670|378843|P8|Treatment Period|Investigator decision|1
115360|NCT00423670|378844|P7|Treatment Period|Investigator decision|0
115361|NCT00423670|378845|P6|Treatment Period|Investigator decision|0
115362|NCT00423670|378846|P5|Treatment Period|Investigator decision|0
115363|NCT00423670|378847|P4|Treatment Period|Investigator decision|0
115364|NCT00423670|378848|P3|Treatment Period|Investigator decision|0
115365|NCT00423670|378849|P2|Treatment Period|Investigator decision|0
115366|NCT00423670|378850|P1|Treatment Period|Investigator decision|0
115367|NCT00423670|378843|P8|Treatment Period|Subject withdrew (not treatment related)|0
115368|NCT00423670|378844|P7|Treatment Period|Subject withdrew (not treatment related)|3
115369|NCT00423670|378845|P6|Treatment Period|Subject withdrew (not treatment related)|0
115370|NCT00423670|378846|P5|Treatment Period|Subject withdrew (not treatment related)|5
115371|NCT00423670|378847|P4|Treatment Period|Subject withdrew (not treatment related)|4
115372|NCT00423670|378848|P3|Treatment Period|Subject withdrew (not treatment related)|4
115373|NCT00423670|378849|P2|Treatment Period|Subject withdrew (not treatment related)|9
115374|NCT00423670|378850|P1|Treatment Period|Subject withdrew (not treatment related)|3
115375|NCT00423670|378843|P8|Treatment Period|Lost to Follow-up|1
115376|NCT00423670|378844|P7|Treatment Period|Lost to Follow-up|3
115377|NCT00423670|378845|P6|Treatment Period|Lost to Follow-up|0
115378|NCT00423670|378846|P5|Treatment Period|Lost to Follow-up|6
115379|NCT00423670|378847|P4|Treatment Period|Lost to Follow-up|1
115380|NCT00423670|378848|P3|Treatment Period|Lost to Follow-up|3
115381|NCT00423670|378849|P2|Treatment Period|Lost to Follow-up|1
115382|NCT00423670|378850|P1|Treatment Period|Lost to Follow-up|2
115383|NCT00423670|378843|P8|Treatment Period|Protocol-defined clinical event|15
115384|NCT00423670|378844|P7|Treatment Period|Protocol-defined clinical event|16
115385|NCT00423670|378845|P6|Treatment Period|Protocol-defined clinical event|4
115386|NCT00423670|378846|P5|Treatment Period|Protocol-defined clinical event|5
115387|NCT00423670|378847|P4|Treatment Period|Protocol-defined clinical event|12
115388|NCT00423670|378848|P3|Treatment Period|Protocol-defined clinical event|4
115389|NCT00423670|378849|P2|Treatment Period|Protocol-defined clinical event|7
115390|NCT00423670|378850|P1|Treatment Period|Protocol-defined clinical event|0
115391|NCT00423670|378843|P8|Treatment Period|Adverse Event|2
115392|NCT00423670|378844|P7|Treatment Period|Adverse Event|7
115393|NCT00423670|378845|P6|Treatment Period|Adverse Event|4
115394|NCT00423670|378846|P5|Treatment Period|Adverse Event|9
115395|NCT00423670|378847|P4|Treatment Period|Adverse Event|20
115396|NCT00423670|378848|P3|Treatment Period|Adverse Event|15
115397|NCT00423670|378849|P2|Treatment Period|Adverse Event|12
115398|NCT00423670|378850|P1|Treatment Period|Adverse Event|8
115399|NCT00423670|378843|P8|Treatment Period|Switched to Arm 8 at TW 24|0
115400|NCT00423670|378844|P7|Treatment Period|Switched to Arm 8 at TW 24|0
115401|NCT00423670|378845|P6|Treatment Period|Switched to Arm 8 at TW 24|0
115402|NCT00423670|378846|P5|Treatment Period|Switched to Arm 8 at TW 24|0
115403|NCT00423670|378847|P4|Treatment Period|Switched to Arm 8 at TW 24|0
115404|NCT00423670|378848|P3|Treatment Period|Switched to Arm 8 at TW 24|0
115405|NCT00423670|378849|P2|Treatment Period|Switched to Arm 8 at TW 24|0
115406|NCT00423670|378850|P1|Treatment Period|Switched to Arm 8 at TW 24|36
115407|NCT00423722|378923|P2|Overall Study|Withdrawal by Subject|2
115408|NCT00423722|378924|P1|Overall Study|Withdrawal by Subject|4
115409|NCT00423722|378923|P2|Overall Study|Unable to complete questionnaires|4
115410|NCT00423722|378924|P1|Overall Study|Unable to complete questionnaires|4
115411|NCT00423722|378923|P2|Overall Study|Declined to participate|3
115412|NCT00423722|378924|P1|Overall Study|Declined to participate|2
115413|NCT00423722|378923|P2|Overall Study|Death|4
115414|NCT00423722|378924|P1|Overall Study|Death|4
115415|NCT00423735|378947|P3|Overall Study|Ineligible / No protocol treatment|0
115416|NCT00423735|378948|P2|Overall Study|Ineligible / No protocol treatment|6
115417|NCT00423735|378949|P1|Overall Study|Ineligible / No protocol treatment|8
115418|NCT00423800|378972|P2|Overall Study|Protocol Violation|1
115419|NCT00423800|378973|P1|Overall Study|Protocol Violation|0
115420|NCT00423813|378985|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
115421|NCT00423813|378986|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
115422|NCT00423813|378987|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
115423|NCT00423813|378985|P3|Overall Study|Will start exclusionary medications|0
115511|NCT00424021|379119|P3|AMB-220-E Study Period|Adverse Event|3
115424|NCT00423813|378986|P2|Overall Study|Will start exclusionary medications|1
115425|NCT00423813|378987|P1|Overall Study|Will start exclusionary medications|0
115426|NCT00423813|378985|P3|Overall Study|Subject started night shift work|0
115427|NCT00423813|378986|P2|Overall Study|Subject started night shift work|0
115428|NCT00423813|378987|P1|Overall Study|Subject started night shift work|1
115429|NCT00423813|378985|P3|Overall Study|Pregnancy|1
115430|NCT00423813|378986|P2|Overall Study|Pregnancy|0
115431|NCT00423813|378987|P1|Overall Study|Pregnancy|0
115432|NCT00423813|378985|P3|Overall Study|Protocol Violation|4
115433|NCT00423813|378986|P2|Overall Study|Protocol Violation|4
115434|NCT00423813|378987|P1|Overall Study|Protocol Violation|9
115435|NCT00423813|378985|P3|Overall Study|Sponsor Decision|0
115436|NCT00423813|378986|P2|Overall Study|Sponsor Decision|1
115437|NCT00423813|378987|P1|Overall Study|Sponsor Decision|0
115438|NCT00423813|378985|P3|Overall Study|Physician Decision|0
115439|NCT00423813|378986|P2|Overall Study|Physician Decision|0
115440|NCT00423813|378987|P1|Overall Study|Physician Decision|2
115441|NCT00423813|378985|P3|Overall Study|Lack of Efficacy|19
115442|NCT00423813|378986|P2|Overall Study|Lack of Efficacy|18
115443|NCT00423813|378987|P1|Overall Study|Lack of Efficacy|23
115444|NCT00423813|378985|P3|Overall Study|Lost to Follow-up|4
115445|NCT00423813|378986|P2|Overall Study|Lost to Follow-up|4
115446|NCT00423813|378987|P1|Overall Study|Lost to Follow-up|5
115447|NCT00423813|378985|P3|Overall Study|Withdrawal by Subject|5
115448|NCT00423813|378986|P2|Overall Study|Withdrawal by Subject|8
115449|NCT00423813|378987|P1|Overall Study|Withdrawal by Subject|6
115450|NCT00423813|378985|P3|Overall Study|Adverse Event|40
115451|NCT00423813|378986|P2|Overall Study|Adverse Event|30
115452|NCT00423813|378987|P1|Overall Study|Adverse Event|11
115453|NCT00423852|378995|P1|Overall Study|Removed pior to the high-dose portion|3
115454|NCT00423891|379014|P3|Post-Dosing Follow Up|Continuing Post Dosing Follow up|1
115455|NCT00423891|379015|P2|Post-Dosing Follow Up|Continuing Post Dosing Follow up|15
115456|NCT00423891|379016|P1|Post-Dosing Follow Up|Continuing Post Dosing Follow up|0
115457|NCT00423891|379014|P3|Post-Dosing Follow Up|Lost to Follow-up|0
115458|NCT00423891|379015|P2|Post-Dosing Follow Up|Lost to Follow-up|0
115459|NCT00423891|379016|P1|Post-Dosing Follow Up|Lost to Follow-up|2
115460|NCT00423891|379014|P3|Post-Dosing Follow Up|Withdrawal by Subject|0
115461|NCT00423891|379015|P2|Post-Dosing Follow Up|Withdrawal by Subject|2
115462|NCT00423891|379016|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
115463|NCT00423891|379014|P3|Treatment|continuing treatment|4
115464|NCT00423891|379015|P2|Treatment|continuing treatment|0
115465|NCT00423891|379016|P1|Treatment|continuing treatment|0
115466|NCT00423891|379014|P3|Treatment|Lost to Follow-up|0
115467|NCT00423891|379015|P2|Treatment|Lost to Follow-up|0
115468|NCT00423891|379016|P1|Treatment|Lost to Follow-up|1
115469|NCT00423891|379014|P3|Treatment|Withdrawal by Subject|0
115470|NCT00423891|379015|P2|Treatment|Withdrawal by Subject|0
115471|NCT00423891|379016|P1|Treatment|Withdrawal by Subject|1
115472|NCT00423891|379014|P3|Enrolled|No longer met criteria|1
115473|NCT00423891|379015|P2|Enrolled|No longer met criteria|2
115474|NCT00423891|379016|P1|Enrolled|No longer met criteria|11
115475|NCT00423891|379014|P3|Enrolled|Lost to Follow-up|1
115476|NCT00423891|379015|P2|Enrolled|Lost to Follow-up|0
115477|NCT00423891|379016|P1|Enrolled|Lost to Follow-up|0
115478|NCT00423891|379014|P3|Enrolled|Withdrawal by Subject|1
115479|NCT00423891|379015|P2|Enrolled|Withdrawal by Subject|0
115480|NCT00423891|379016|P1|Enrolled|Withdrawal by Subject|0
115481|NCT00423917|379083|P1|Overall Study|Ineligible|1
115482|NCT00423917|379083|P1|Overall Study|Cancel|2
115483|NCT00423930|379093|P1|Overall Study|Withdrawal by Subject|2
115484|NCT00424008|379100|P2|Overall Study|Administrative|257
115485|NCT00424008|379101|P1|Overall Study|Administrative|266
115486|NCT00424008|379100|P2|Overall Study|Did not meet protocol eligibility|21
115487|NCT00424008|379101|P1|Overall Study|Did not meet protocol eligibility|16
115488|NCT00424008|379100|P2|Overall Study|Noncompliance with protocol|7
115489|NCT00424008|379101|P1|Overall Study|Noncompliance with protocol|13
115490|NCT00424008|379100|P2|Overall Study|Withdrawal by Subject|8
115491|NCT00424008|379101|P1|Overall Study|Withdrawal by Subject|5
115492|NCT00424008|379100|P2|Overall Study|Lost to Follow-up|2
115493|NCT00424008|379101|P1|Overall Study|Lost to Follow-up|1
115494|NCT00424008|379100|P2|Overall Study|Lack of Efficacy|34
115495|NCT00424008|379101|P1|Overall Study|Lack of Efficacy|40
115496|NCT00424008|379100|P2|Overall Study|Adverse Event|6
115497|NCT00424008|379101|P1|Overall Study|Adverse Event|8
115498|NCT00424021|379118|P4|AMB-220-E Study Period|Physician Decision|1
115499|NCT00424021|379119|P3|AMB-220-E Study Period|Physician Decision|0
115500|NCT00424021|379120|P2|AMB-220-E Study Period|Physician Decision|0
115501|NCT00424021|379121|P1|AMB-220-E Study Period|Physician Decision|0
115502|NCT00424021|379118|P4|AMB-220-E Study Period|Lost to Follow-up|1
115503|NCT00424021|379119|P3|AMB-220-E Study Period|Lost to Follow-up|1
115504|NCT00424021|379120|P2|AMB-220-E Study Period|Lost to Follow-up|1
115505|NCT00424021|379121|P1|AMB-220-E Study Period|Lost to Follow-up|0
115506|NCT00424021|379118|P4|AMB-220-E Study Period|Death|1
115507|NCT00424021|379119|P3|AMB-220-E Study Period|Death|1
115508|NCT00424021|379120|P2|AMB-220-E Study Period|Death|0
115509|NCT00424021|379121|P1|AMB-220-E Study Period|Death|0
115510|NCT00424021|379118|P4|AMB-220-E Study Period|Adverse Event|7
115512|NCT00424021|379120|P2|AMB-220-E Study Period|Adverse Event|1
115513|NCT00424021|379121|P1|AMB-220-E Study Period|Adverse Event|1
115514|NCT00424021|379118|P4|NCT00046319 Study Period|Lost to Follow-up|0
115515|NCT00424021|379119|P3|NCT00046319 Study Period|Lost to Follow-up|0
115516|NCT00424021|379120|P2|NCT00046319 Study Period|Lost to Follow-up|1
115517|NCT00424021|379121|P1|NCT00046319 Study Period|Lost to Follow-up|0
115518|NCT00424021|379118|P4|NCT00046319 Study Period|Sponsor discretion|0
115519|NCT00424021|379119|P3|NCT00046319 Study Period|Sponsor discretion|0
115520|NCT00424021|379120|P2|NCT00046319 Study Period|Sponsor discretion|1
115521|NCT00424021|379121|P1|NCT00046319 Study Period|Sponsor discretion|0
115522|NCT00424021|379118|P4|NCT00046319 Study Period|Withdrawal by Subject|0
115523|NCT00424021|379119|P3|NCT00046319 Study Period|Withdrawal by Subject|0
115524|NCT00424021|379120|P2|NCT00046319 Study Period|Withdrawal by Subject|1
115525|NCT00424021|379121|P1|NCT00046319 Study Period|Withdrawal by Subject|0
115526|NCT00424021|379118|P4|NCT00046319 Study Period|Adverse Event|1
115527|NCT00424021|379119|P3|NCT00046319 Study Period|Adverse Event|1
115528|NCT00424021|379120|P2|NCT00046319 Study Period|Adverse Event|0
115529|NCT00424021|379121|P1|NCT00046319 Study Period|Adverse Event|1
115530|NCT00424047|379164|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
115531|NCT00424047|379165|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
115532|NCT00424047|379164|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
115533|NCT00424047|379165|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
115534|NCT00424047|379164|P2|Long Term Extension (Up to 25 Jun 2013)|Unspecified|4
115535|NCT00424047|379165|P1|Long Term Extension (Up to 25 Jun 2013)|Unspecified|12
115536|NCT00424047|379164|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
115537|NCT00424047|379165|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
115538|NCT00424047|379164|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
115539|NCT00424047|379165|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
115540|NCT00424047|379164|P2|On Study at Time of Unblinding|Unspecified|4
115541|NCT00424047|379165|P1|On Study at Time of Unblinding|Unspecified|5
115542|NCT00424047|379164|P2|On Study at Time of Unblinding|Death|11
115543|NCT00424047|379165|P1|On Study at Time of Unblinding|Death|11
115544|NCT00424047|379164|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
115545|NCT00424047|379165|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
115546|NCT00424047|379164|P2|On Study at Time of Unblinding|Lack of Efficacy|3
115547|NCT00424047|379165|P1|On Study at Time of Unblinding|Lack of Efficacy|1
115548|NCT00424047|379164|P2|On Study at Time of Unblinding|Progression of disease|128
115549|NCT00424047|379165|P1|On Study at Time of Unblinding|Progression of disease|92
115550|NCT00424047|379164|P2|On Study at Time of Unblinding|Adverse Event|12
115551|NCT00424047|379165|P1|On Study at Time of Unblinding|Adverse Event|22
115552|NCT00424047|379164|P2|Blinded Treatment (Up to 03 Aug 2005)|Unspecified|1
115553|NCT00424047|379165|P1|Blinded Treatment (Up to 03 Aug 2005)|Unspecified|2
115554|NCT00424047|379164|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
115555|NCT00424047|379165|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
115556|NCT00424047|379164|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
115557|NCT00424047|379165|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
115558|NCT00424047|379164|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
115559|NCT00424047|379165|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
115560|NCT00424047|379164|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
115561|NCT00424047|379165|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
115562|NCT00424047|379164|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
115563|NCT00424047|379165|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
115564|NCT00424177|379193|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
115565|NCT00424177|379193|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
115566|NCT00424177|379193|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
115567|NCT00424177|379193|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
115568|NCT00424177|379193|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
115569|NCT00424177|379193|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
115570|NCT00424177|379193|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
115571|NCT00424177|379193|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
115572|NCT00424177|379193|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
115573|NCT00424177|379193|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
115574|NCT00424190|379222|P2|Overall Study|Other|21
115575|NCT00424190|379223|P1|Overall Study|Other|15
115576|NCT00424190|379222|P2|Overall Study|Diagnosis of osteomyelitis|1
115577|NCT00424190|379223|P1|Overall Study|Diagnosis of osteomyelitis|0
115578|NCT00424190|379222|P2|Overall Study|Request of sponsor or investigator|2
115579|NCT00424190|379223|P1|Overall Study|Request of sponsor or investigator|0
115580|NCT00424190|379222|P2|Overall Study|Noncompliance|2
115581|NCT00424190|379223|P1|Overall Study|Noncompliance|1
115582|NCT00424190|379222|P2|Overall Study|Death|0
115583|NCT00424190|379223|P1|Overall Study|Death|3
115584|NCT00424190|379222|P2|Overall Study|Withdrew consent|4
115585|NCT00424190|379223|P1|Overall Study|Withdrew consent|3
115586|NCT00429923|379232|P3|Overall Study|Early Termination|0
115587|NCT00429923|379233|P2|Overall Study|Early Termination|1
115588|NCT00429923|379234|P1|Overall Study|Early Termination|0
115589|NCT00429923|379232|P3|Overall Study|Withdrew Consent|1
115590|NCT00429923|379233|P2|Overall Study|Withdrew Consent|0
115591|NCT00429923|379234|P1|Overall Study|Withdrew Consent|1
115592|NCT00429923|379232|P3|Overall Study|Lost to Follow-up|2
115593|NCT00429923|379233|P2|Overall Study|Lost to Follow-up|0
115594|NCT00429923|379234|P1|Overall Study|Lost to Follow-up|0
115595|NCT00429923|379232|P3|Overall Study|Lack of Efficacy|33
115596|NCT00429923|379233|P2|Overall Study|Lack of Efficacy|1
115597|NCT00429923|379234|P1|Overall Study|Lack of Efficacy|4
115598|NCT00429923|379232|P3|Overall Study|Adverse Event|3
115599|NCT00429923|379233|P2|Overall Study|Adverse Event|2
115600|NCT00429923|379234|P1|Overall Study|Adverse Event|0
115601|NCT00430027|379249|P1|Overall Study|Study terminated|8
115602|NCT00430092|379256|P3|Overall Study|Withdrawal by Subject|1
115603|NCT00430092|379257|P2|Overall Study|Withdrawal by Subject|1
115604|NCT00430092|379258|P1|Overall Study|Withdrawal by Subject|0
115605|NCT00430092|379256|P3|Overall Study|Protocol Violation|1
115606|NCT00430092|379257|P2|Overall Study|Protocol Violation|1
115607|NCT00430092|379258|P1|Overall Study|Protocol Violation|0
115608|NCT00430092|379256|P3|Overall Study|Lost to Follow-up|0
115609|NCT00430092|379257|P2|Overall Study|Lost to Follow-up|0
115610|NCT00430092|379258|P1|Overall Study|Lost to Follow-up|1
115611|NCT00430092|379256|P3|Overall Study|Lack of Efficacy|54
115612|NCT00430092|379257|P2|Overall Study|Lack of Efficacy|2
115613|NCT00430092|379258|P1|Overall Study|Lack of Efficacy|5
115614|NCT00430092|379256|P3|Overall Study|Adverse Event|1
115615|NCT00430092|379257|P2|Overall Study|Adverse Event|0
115616|NCT00430092|379258|P1|Overall Study|Adverse Event|0
115617|NCT00431496|379263|P1|Overall Study|Protocol-specified criteria|5
115618|NCT00431496|379263|P1|Overall Study|Withdrawal by Subject|2
115619|NCT00431496|379263|P1|Overall Study|Lost to Follow-up|1
115620|NCT00431496|379263|P1|Overall Study|Adverse Event|3
115621|NCT00431834|379281|P1|Overall Study|Lost to Follow-up|1
115622|NCT00431834|379281|P1|Overall Study|Missed Endpoint Visit|2
115623|NCT00431834|379281|P1|Overall Study|Death|3
115624|NCT00431834|379281|P1|Overall Study|Withdrawal by Subject|7
115625|NCT00431847|379292|P5|Overall Study|Protocol Violation|1
115626|NCT00431847|379293|P4|Overall Study|Protocol Violation|0
115627|NCT00431847|379294|P3|Overall Study|Protocol Violation|0
115628|NCT00431847|379295|P2|Overall Study|Protocol Violation|0
115629|NCT00431847|379296|P1|Overall Study|Protocol Violation|0
115630|NCT00431847|379292|P5|Overall Study|completion of less than two study visits|0
115631|NCT00431847|379293|P4|Overall Study|completion of less than two study visits|14
115632|NCT00431847|379294|P3|Overall Study|completion of less than two study visits|4
115633|NCT00431847|379295|P2|Overall Study|completion of less than two study visits|3
115634|NCT00431847|379296|P1|Overall Study|completion of less than two study visits|6
115635|NCT00431951|379374|P4|Overall Study|Adverse Event|0
115636|NCT00431951|379375|P3|Overall Study|Adverse Event|1
115637|NCT00431951|379376|P2|Overall Study|Adverse Event|0
115638|NCT00431951|379377|P1|Overall Study|Adverse Event|0
115639|NCT00431951|379374|P4|Overall Study|Withdrawal by Subject|0
115640|NCT00431951|379375|P3|Overall Study|Withdrawal by Subject|0
115641|NCT00431951|379376|P2|Overall Study|Withdrawal by Subject|1
115642|NCT00431951|379377|P1|Overall Study|Withdrawal by Subject|0
115643|NCT00431951|379374|P4|Overall Study|Lost to Follow-up|0
115644|NCT00431951|379375|P3|Overall Study|Lost to Follow-up|0
115645|NCT00431951|379376|P2|Overall Study|Lost to Follow-up|1
115646|NCT00431951|379377|P1|Overall Study|Lost to Follow-up|0
115647|NCT00431951|379374|P4|Overall Study|Inability to follow study procedures|2
115648|NCT00431951|379375|P3|Overall Study|Inability to follow study procedures|1
115649|NCT00431951|379376|P2|Overall Study|Inability to follow study procedures|0
115650|NCT00431951|379377|P1|Overall Study|Inability to follow study procedures|1
115651|NCT00431964|379437|P2|Overall Study|Due to Unstable Health|1
115652|NCT00431964|379438|P1|Overall Study|Due to Unstable Health|0
115653|NCT00431964|379437|P2|Overall Study|Parental Consent Withdrawn|2
115654|NCT00431964|379438|P1|Overall Study|Parental Consent Withdrawn|0
115655|NCT00431964|379437|P2|Overall Study|Withdrawal by Subject|1
115656|NCT00431964|379438|P1|Overall Study|Withdrawal by Subject|2
115657|NCT00431964|379437|P2|Overall Study|Physician Decision|2
115658|NCT00431964|379438|P1|Overall Study|Physician Decision|2
115659|NCT00431964|379437|P2|Overall Study|Lost to Follow-up|2
115660|NCT00431964|379438|P1|Overall Study|Lost to Follow-up|1
115661|NCT00431964|379437|P2|Overall Study|Adverse Event|0
115662|NCT00431964|379438|P1|Overall Study|Adverse Event|1
115663|NCT00432159|379449|P5|Overall Study|Missing NDI and/or neuro. assessment|7
115664|NCT00432159|379450|P4|Overall Study|Missing NDI and/or neuro. assessment|3
115665|NCT00432159|379451|P3|Overall Study|Missing NDI and/or neuro. assessment|1
115666|NCT00432159|379452|P2|Overall Study|Missing NDI and/or neuro. assessment|24
115667|NCT00432159|379453|P1|Overall Study|Missing NDI and/or neuro. assessment|13
115668|NCT00432159|379449|P5|Overall Study|Failure|3
115669|NCT00432159|379450|P4|Overall Study|Failure|2
115670|NCT00432159|379451|P3|Overall Study|Failure|3
115671|NCT00432159|379452|P2|Overall Study|Failure|5
115672|NCT00432159|379453|P1|Overall Study|Failure|9
115673|NCT00432159|379449|P5|Overall Study|Death|0
115674|NCT00432159|379450|P4|Overall Study|Death|0
115675|NCT00432159|379451|P3|Overall Study|Death|0
115676|NCT00432159|379452|P2|Overall Study|Death|1
115677|NCT00432159|379453|P1|Overall Study|Death|0
115678|NCT00432237|379561|P4|Overall Study|Lack of Qualifying Event|84
115679|NCT00432237|379562|P3|Overall Study|Lack of Qualifying Event|69
115680|NCT00432237|379563|P2|Overall Study|Lack of Qualifying Event|71
115681|NCT00432237|379564|P1|Overall Study|Lack of Qualifying Event|38
115682|NCT00432237|379561|P4|Overall Study|Withdrawal by Subject|11
115683|NCT00432237|379562|P3|Overall Study|Withdrawal by Subject|9
115684|NCT00432237|379563|P2|Overall Study|Withdrawal by Subject|6
115685|NCT00432237|379564|P1|Overall Study|Withdrawal by Subject|5
115686|NCT00432237|379561|P4|Overall Study|Protocol Violation|8
115687|NCT00432237|379562|P3|Overall Study|Protocol Violation|11
115688|NCT00432237|379563|P2|Overall Study|Protocol Violation|10
115689|NCT00432237|379564|P1|Overall Study|Protocol Violation|13
115690|NCT00432237|379561|P4|Overall Study|Pregnancy|0
115691|NCT00432237|379562|P3|Overall Study|Pregnancy|0
115692|NCT00432237|379563|P2|Overall Study|Pregnancy|1
115693|NCT00432237|379564|P1|Overall Study|Pregnancy|0
115694|NCT00432237|379561|P4|Overall Study|Physician Decision|1
115695|NCT00432237|379562|P3|Overall Study|Physician Decision|2
115696|NCT00432237|379563|P2|Overall Study|Physician Decision|3
115697|NCT00432237|379564|P1|Overall Study|Physician Decision|1
115698|NCT00432237|379561|P4|Overall Study|Lost to Follow-up|18
115699|NCT00432237|379562|P3|Overall Study|Lost to Follow-up|18
115700|NCT00432237|379563|P2|Overall Study|Lost to Follow-up|10
115701|NCT00432237|379564|P1|Overall Study|Lost to Follow-up|10
115702|NCT00432237|379561|P4|Overall Study|Lack of Efficacy|1
115703|NCT00432237|379562|P3|Overall Study|Lack of Efficacy|0
115704|NCT00432237|379563|P2|Overall Study|Lack of Efficacy|0
115705|NCT00432237|379564|P1|Overall Study|Lack of Efficacy|0
115706|NCT00432237|379561|P4|Overall Study|Adverse Event|1
115707|NCT00432237|379562|P3|Overall Study|Adverse Event|0
115708|NCT00432237|379563|P2|Overall Study|Adverse Event|0
115709|NCT00432237|379564|P1|Overall Study|Adverse Event|0
115710|NCT00432276|379604|P2|Overall Study|Other|3
115711|NCT00432276|379605|P1|Overall Study|Other|2
115712|NCT00432276|379604|P2|Overall Study|Physician Decision|8
115713|NCT00432276|379605|P1|Overall Study|Physician Decision|6
115714|NCT00432276|379604|P2|Overall Study|Withdrawal by Subject|20
115715|NCT00432276|379605|P1|Overall Study|Withdrawal by Subject|25
115716|NCT00432276|379604|P2|Overall Study|Lost to Follow-up|2
115717|NCT00432276|379605|P1|Overall Study|Lost to Follow-up|6
115718|NCT00432276|379604|P2|Overall Study|Protocol Violation|20
115719|NCT00432276|379605|P1|Overall Study|Protocol Violation|25
115720|NCT00432276|379604|P2|Overall Study|Adverse Event|16
115721|NCT00432276|379605|P1|Overall Study|Adverse Event|13
115722|NCT00432276|379604|P2|Overall Study|Hyperglycemic Rescue|87
115723|NCT00432276|379605|P1|Overall Study|Hyperglycemic Rescue|44
115724|NCT00432562|379745|P2|Overall Study|Death|0
115725|NCT00432562|379746|P1|Overall Study|Death|3
115726|NCT00432666|379781|P2|Open-Label Extension Period|Physician Decision|0
115727|NCT00432666|379782|P1|Open-Label Extension Period|Physician Decision|3
115728|NCT00432666|379781|P2|Open-Label Extension Period|Consent withdrawn|0
115729|NCT00432666|379782|P1|Open-Label Extension Period|Consent withdrawn|10
115730|NCT00432666|379781|P2|Open-Label Extension Period|Adverse Event|0
115731|NCT00432666|379782|P1|Open-Label Extension Period|Adverse Event|5
115732|NCT00432666|379781|P2|Open-Label Extension Period|Lack of Efficacy|0
115733|NCT00432666|379782|P1|Open-Label Extension Period|Lack of Efficacy|6
115734|NCT00432666|379781|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
115735|NCT00432666|379782|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
115736|NCT00432666|379781|P2|Main Period|Consent Withdrawn|0
115737|NCT00432666|379782|P1|Main Period|Consent Withdrawn|1
115738|NCT00432666|379781|P2|Main Period|Adverse Event|1
115739|NCT00432666|379782|P1|Main Period|Adverse Event|1
115740|NCT00432744|379946|P2|Months 7 - 12|Too disabled to score|1
115741|NCT00432744|379947|P1|Months 7 - 12|Too disabled to score|0
115742|NCT00432744|379946|P2|Months 7 - 12|Withdrawal by Subject|0
115743|NCT00432744|379947|P1|Months 7 - 12|Withdrawal by Subject|1
115744|NCT00432744|379946|P2|Months 0-6|Too disabled to score|0
115745|NCT00432744|379947|P1|Months 0-6|Too disabled to score|1
115746|NCT00432744|379946|P2|Months 0-6|Withdrawal by Subject|4
115747|NCT00432744|379947|P1|Months 0-6|Withdrawal by Subject|4
115748|NCT00432809|379960|P3|1 Year Follow-up|Withdrawal by Subject|1
115749|NCT00432809|379961|P2|1 Year Follow-up|Withdrawal by Subject|0
115750|NCT00432809|379962|P1|1 Year Follow-up|Withdrawal by Subject|7
115751|NCT00432809|379960|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
115752|NCT00432809|379961|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
115753|NCT00432809|379962|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
115754|NCT00432835|380035|P2|Overall Study|Adverse event: lead dislodgement.|7
115755|NCT00432835|380036|P1|Overall Study|Adverse event: lead dislodgement.|6
115756|NCT00432991|380048|P2|Overall Study|Protocol Violation|12
115757|NCT00432991|380049|P1|Overall Study|Protocol Violation|7
115758|NCT00433017|380061|P2|Overall Study|Subject no longer requires study drug|1
115759|NCT00433017|380062|P1|Overall Study|Subject no longer requires study drug|1
115760|NCT00433017|380061|P2|Overall Study|Death|2
115761|NCT00433017|380062|P1|Overall Study|Death|2
115762|NCT00433017|380061|P2|Overall Study|Protocol Violation|0
115763|NCT00433017|380062|P1|Overall Study|Protocol Violation|1
115764|NCT00433017|380061|P2|Overall Study|Administrative problems|86
115765|NCT00433017|380062|P1|Overall Study|Administrative problems|80
115766|NCT00433017|380061|P2|Overall Study|Lost to Follow-up|4
115767|NCT00433017|380062|P1|Overall Study|Lost to Follow-up|3
115768|NCT00433017|380061|P2|Overall Study|Withdrawal by Subject|5
115769|NCT00433017|380062|P1|Overall Study|Withdrawal by Subject|4
115770|NCT00433017|380061|P2|Overall Study|Adverse Event|3
115771|NCT00433017|380062|P1|Overall Study|Adverse Event|5
115772|NCT00433160|380078|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
115773|NCT00433160|380079|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
115774|NCT00433160|380078|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
115775|NCT00433160|380079|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
115776|NCT00433160|380078|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
115777|NCT00433160|380079|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
115778|NCT00433160|380078|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
115779|NCT00433160|380079|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
115780|NCT00433160|380078|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
115781|NCT00433160|380079|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
115782|NCT00433160|380078|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
115783|NCT00433160|380079|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
115784|NCT00433160|380078|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
115785|NCT00433160|380079|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
115786|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
115787|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
115788|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
115789|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
115790|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
115791|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
115792|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
115793|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
115794|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
115795|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
115796|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
115797|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
115798|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
115799|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
115800|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Death|0
115801|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Death|0
115802|NCT00433160|380078|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
115803|NCT00433160|380079|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
115804|NCT00433199|380129|P2|Open-Label Period|Administrative|1
115805|NCT00433199|380130|P1|Open-Label Period|Administrative|0
115806|NCT00433199|380129|P2|Open-Label Period|Protocol Violation|2
115807|NCT00433199|380130|P1|Open-Label Period|Protocol Violation|0
115808|NCT00433199|380129|P2|Open-Label Period|Withdrawal by Subject|7
115809|NCT00433199|380130|P1|Open-Label Period|Withdrawal by Subject|0
115810|NCT00433199|380129|P2|Open-Label Period|Lost to Follow-up|3
115811|NCT00433199|380130|P1|Open-Label Period|Lost to Follow-up|0
115812|NCT00433199|380129|P2|Open-Label Period|Lack of Efficacy|2
115813|NCT00433199|380130|P1|Open-Label Period|Lack of Efficacy|0
115814|NCT00433199|380129|P2|Open-Label Period|Adverse Event|19
115815|NCT00433199|380130|P1|Open-Label Period|Adverse Event|0
115816|NCT00433199|380129|P2|Double-Blind Period|Administrative|5
115817|NCT00433199|380130|P1|Double-Blind Period|Administrative|1
115818|NCT00433199|380129|P2|Double-Blind Period|Protocol Violation|10
115819|NCT00433199|380130|P1|Double-Blind Period|Protocol Violation|1
115820|NCT00433199|380129|P2|Double-Blind Period|Withdrawal by Subject|19
115821|NCT00433199|380130|P1|Double-Blind Period|Withdrawal by Subject|8
115822|NCT00433199|380129|P2|Double-Blind Period|Lost to Follow-up|5
115823|NCT00433199|380130|P1|Double-Blind Period|Lost to Follow-up|2
115824|NCT00433199|380129|P2|Double-Blind Period|Lack of Efficacy|2
115825|NCT00433199|380130|P1|Double-Blind Period|Lack of Efficacy|0
115826|NCT00433199|380129|P2|Double-Blind Period|Adverse Event|25
115827|NCT00433199|380130|P1|Double-Blind Period|Adverse Event|0
115828|NCT00433290|380150|P2|Overall Study|Lost to Follow-up|0
115829|NCT00433290|380151|P1|Overall Study|Lost to Follow-up|1
115830|NCT00433290|380150|P2|Overall Study|Entry Criteria Not Met|1
115831|NCT00433290|380151|P1|Overall Study|Entry Criteria Not Met|0
115832|NCT00433290|380150|P2|Overall Study|Physician Decision|0
115833|NCT00433290|380151|P1|Overall Study|Physician Decision|2
115834|NCT00433290|380150|P2|Overall Study|Protocol Violation|2
115835|NCT00433290|380151|P1|Overall Study|Protocol Violation|3
115836|NCT00433290|380150|P2|Overall Study|Withdrawal by Subject|2
115837|NCT00433290|380151|P1|Overall Study|Withdrawal by Subject|4
115838|NCT00433290|380150|P2|Overall Study|Lack of Efficacy|5
115839|NCT00433290|380151|P1|Overall Study|Lack of Efficacy|1
115840|NCT00433290|380150|P2|Overall Study|Adverse Event|7
115841|NCT00433290|380151|P1|Overall Study|Adverse Event|24
115842|NCT00433329|380218|P1|Overall Study|Physician Decision|1
115843|NCT00433329|380218|P1|Overall Study|Lost to Follow-up|1
115844|NCT00433329|380218|P1|Overall Study|Moved out of state|1
115845|NCT00433329|380218|P1|Overall Study|Discontinued sildenafil|2
115846|NCT00433329|380218|P1|Overall Study|Withdrew consent|3
115847|NCT00433329|380218|P1|Overall Study|Death|4
115848|NCT00433329|380218|P1|Overall Study|Adverse Event|9
115849|NCT00433381|380224|P2|Overall Study|Lost to follow-up before 6 months|0
115850|NCT00433381|380225|P1|Overall Study|Lost to follow-up before 6 months|2
115851|NCT00433381|380224|P2|Overall Study|Ineligible / no protocol treatment|3
115852|NCT00433381|380225|P1|Overall Study|Ineligible / no protocol treatment|3
115853|NCT00433446|380231|P1|Overall Study|Ineligible|9
115854|NCT00433446|380231|P1|Overall Study|Other - Not Protocol specified|3
115855|NCT00433446|380231|P1|Overall Study|Progression|44
115856|NCT00433446|380231|P1|Overall Study|Refusal Unrelated to Adverse Event|1
115857|NCT00433446|380231|P1|Overall Study|Adverse Event|4
115858|NCT00433537|380239|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
115859|NCT00433537|380240|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
115860|NCT00433537|380241|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
115861|NCT00433537|380239|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
115862|NCT00433537|380240|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
115863|NCT00433537|380241|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
115864|NCT00433537|380239|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
115865|NCT00433537|380240|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
115866|NCT00433537|380241|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
115867|NCT00433537|380239|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
115868|NCT00433537|380240|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
115869|NCT00433537|380241|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
115870|NCT00433537|380239|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
115871|NCT00433537|380240|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
115872|NCT00433537|380241|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
115873|NCT00433537|380239|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
115874|NCT00433537|380240|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
115875|NCT00433537|380241|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
115876|NCT00433537|380239|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
115877|NCT00433537|380240|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
115878|NCT00433537|380241|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
115879|NCT00433537|380239|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
115880|NCT00433537|380240|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
115881|NCT00433537|380241|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
115882|NCT00433537|380239|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
115883|NCT00433537|380240|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
115884|NCT00433537|380241|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
115885|NCT00433654|380267|P2|Overall Study|Withdrawal by Subject|2
115886|NCT00433654|380268|P1|Overall Study|Withdrawal by Subject|1
115887|NCT00433654|380267|P2|Overall Study|Subject not yet due for visit|0
115888|NCT00433654|380268|P1|Overall Study|Subject not yet due for visit|4
115889|NCT00433654|380267|P2|Overall Study|Missed visit|3
115890|NCT00433654|380268|P1|Overall Study|Missed visit|6
115891|NCT00433654|380267|P2|Overall Study|Death|0
115892|NCT00433654|380268|P1|Overall Study|Death|4
115893|NCT00433771|380304|P1|Overall Study|Failure to deploy stent|1
115894|NCT00433771|380304|P1|Overall Study|Death|2
115895|NCT00433771|380304|P1|Overall Study|Treated and later found to be ineligible|2
115896|NCT00433771|380304|P1|Overall Study|screen fail|14
115897|NCT00433836|380322|P2|Overall Study|Abnormal laboratory values|1
115898|NCT00433836|380323|P1|Overall Study|Abnormal laboratory values|0
115899|NCT00433836|380322|P2|Overall Study|Condition no longer requires study drug|1
115900|NCT00433836|380323|P1|Overall Study|Condition no longer requires study drug|0
115901|NCT00433836|380322|P2|Overall Study|Protocol Violation|2
115902|NCT00433836|380323|P1|Overall Study|Protocol Violation|0
115903|NCT00433836|380322|P2|Overall Study|Unsatisfactory therapeutic effect|1
115904|NCT00433836|380323|P1|Overall Study|Unsatisfactory therapeutic effect|1
115905|NCT00433836|380322|P2|Overall Study|Withdrawal by Subject|1
115906|NCT00433836|380323|P1|Overall Study|Withdrawal by Subject|2
115907|NCT00433836|380322|P2|Overall Study|Lost to Follow-up|0
115908|NCT00433836|380323|P1|Overall Study|Lost to Follow-up|3
115909|NCT00433836|380322|P2|Overall Study|Adverse Event|0
115910|NCT00433836|380323|P1|Overall Study|Adverse Event|7
115911|NCT00433914|380337|P2|Overall Study|Lost to Follow-up|1
115912|NCT00433914|380338|P1|Overall Study|Lost to Follow-up|0
115913|NCT00433914|380337|P2|Overall Study|Withdrawal by Subject|2
115914|NCT00433914|380338|P1|Overall Study|Withdrawal by Subject|0
115915|NCT00415597|380367|P1|Treatment|Multiple Reasons|1
115916|NCT00415597|380367|P1|Treatment|Sponsor Decision|1
115917|NCT00415597|380367|P1|Treatment|Administrative|3
115918|NCT00415597|380367|P1|Treatment|Drug Screen|2
115919|NCT00415597|380367|P1|Treatment|Lost to Follow-up|28
115920|NCT00415597|380367|P1|Treatment|Withdrawal by Subject|51
115921|NCT00415597|380367|P1|Treatment|Physician Decision|3
115922|NCT00415597|380367|P1|Treatment|Protocol Violation|67
115923|NCT00415597|380367|P1|Treatment|Lack of Efficacy|39
115924|NCT00415597|380367|P1|Treatment|Adverse Event|110
115925|NCT00415597|380367|P1|Enrollment|Protocol Violation|1
115926|NCT00415597|380367|P1|Enrollment|Withdrawal by Subject|1
115927|NCT00415610|380376|P3|Overall Study|Death|5
115928|NCT00415610|380377|P2|Overall Study|Death|2
115929|NCT00415610|380378|P1|Overall Study|Death|3
115930|NCT00415623|380394|P2|Overall Study|Withdrawal by Subject|1
115931|NCT00415623|380395|P1|Overall Study|Withdrawal by Subject|1
115932|NCT00415623|380394|P2|Overall Study|Death|0
115933|NCT00415623|380395|P1|Overall Study|Death|1
115934|NCT00415623|380394|P2|Overall Study|Adverse Event|4
115935|NCT00415623|380395|P1|Overall Study|Adverse Event|3
115936|NCT00415909|380439|P1|Overall Study|Death|1
115937|NCT00415909|380439|P1|Overall Study|Withdrawal by Subject|2
115938|NCT00416078|380445|P2|Overall Study|Lost to Follow-up|2
115939|NCT00416078|380446|P1|Overall Study|Lost to Follow-up|4
115940|NCT00416078|380445|P2|Overall Study|Physician Decision|0
115941|NCT00416078|380446|P1|Overall Study|Physician Decision|1
115942|NCT00416078|380445|P2|Overall Study|Withdrawal by Subject|2
115943|NCT00416078|380446|P1|Overall Study|Withdrawal by Subject|3
115944|NCT00416078|380445|P2|Overall Study|Death|4
115945|NCT00416078|380446|P1|Overall Study|Death|3
115946|NCT00416195|380479|P2|Overall Study|Not Specified|1
115947|NCT00416195|380480|P1|Overall Study|Not Specified|0
115948|NCT00416195|380479|P2|Overall Study|Protocol Violation|1
115949|NCT00416195|380480|P1|Overall Study|Protocol Violation|1
115950|NCT00416195|380479|P2|Overall Study|Adverse Event|2
115951|NCT00416195|380480|P1|Overall Study|Adverse Event|1
115952|NCT00434057|380507|P1|Overall Study|Withdrawal by Subject|1
115953|NCT00434109|380511|P1|Overall Study|had embolism, did not receive sunitinib|3
115954|NCT00434109|380511|P1|Overall Study|Protocol Violation|1
115955|NCT00434109|380511|P1|Overall Study|Adverse Event|5
115956|NCT00434109|380511|P1|Overall Study|Physician Decision|9
115957|NCT00434122|380522|P2|Overall Study|Travelling of subject.|0
115958|NCT00434122|380523|P1|Overall Study|Travelling of subject.|1
115959|NCT00434122|380522|P2|Overall Study|Low follicular response.|2
115960|NCT00434122|380523|P1|Overall Study|Low follicular response.|1
115961|NCT00434122|380522|P2|Overall Study|Large follicle size|2
115962|NCT00434122|380523|P1|Overall Study|Large follicle size|2
115963|NCT00434122|380522|P2|Overall Study|Personal reasons|1
115964|NCT00434122|380523|P1|Overall Study|Personal reasons|1
115965|NCT00434122|380522|P2|Overall Study|loss of subject contact|1
115966|NCT00434122|380523|P1|Overall Study|loss of subject contact|1
115967|NCT00434122|380522|P2|Overall Study|Non-compliance with protocol|1
115968|NCT00434122|380523|P1|Overall Study|Non-compliance with protocol|0
115969|NCT00434148|380534|P2|Overall Study|Abnormal test procedure result|1
115970|NCT00434148|380535|P1|Overall Study|Abnormal test procedure result|0
115971|NCT00434148|380534|P2|Overall Study|Condition no longer requires study drug|0
115972|NCT00434148|380535|P1|Overall Study|Condition no longer requires study drug|1
115973|NCT00434148|380534|P2|Overall Study|Lost to Follow-up|1
115974|NCT00434148|380535|P1|Overall Study|Lost to Follow-up|0
115975|NCT00434148|380534|P2|Overall Study|Administrative problems|10
115976|NCT00434148|380535|P1|Overall Study|Administrative problems|6
115977|NCT00434148|380534|P2|Overall Study|Protocol Violation|0
115978|NCT00434148|380535|P1|Overall Study|Protocol Violation|4
115979|NCT00434148|380534|P2|Overall Study|Withdrawal by Subject|15
115980|NCT00434148|380535|P1|Overall Study|Withdrawal by Subject|15
115981|NCT00434148|380534|P2|Overall Study|Lack of Efficacy|28
115982|NCT00434148|380535|P1|Overall Study|Lack of Efficacy|25
115983|NCT00434148|380534|P2|Overall Study|Adverse Event|18
115984|NCT00434148|380535|P1|Overall Study|Adverse Event|18
115985|NCT00434161|380572|P3|Overall Study|Logistical error study assessments|3
115986|NCT00434161|380573|P2|Overall Study|Logistical error study assessments|0
115987|NCT00434161|380574|P1|Overall Study|Logistical error study assessments|1
115988|NCT00434161|380572|P3|Overall Study|Withdrawal by Subject|3
115989|NCT00434161|380573|P2|Overall Study|Withdrawal by Subject|0
115990|NCT00434161|380574|P1|Overall Study|Withdrawal by Subject|2
115991|NCT00434161|380572|P3|Overall Study|Non-Compliance|0
115992|NCT00434161|380573|P2|Overall Study|Non-Compliance|1
115993|NCT00434161|380574|P1|Overall Study|Non-Compliance|1
115994|NCT00434161|380572|P3|Overall Study|Death|1
115995|NCT00434161|380573|P2|Overall Study|Death|0
115996|NCT00434161|380574|P1|Overall Study|Death|1
115997|NCT00434161|380572|P3|Overall Study|Lost to Follow-up|0
115998|NCT00434161|380573|P2|Overall Study|Lost to Follow-up|1
115999|NCT00434161|380574|P1|Overall Study|Lost to Follow-up|0
116000|NCT00434161|380572|P3|Overall Study|Adverse Event|4
116001|NCT00434161|380573|P2|Overall Study|Adverse Event|1
116002|NCT00434161|380574|P1|Overall Study|Adverse Event|5
116003|NCT00434213|380616|P1|Overall Study|Non-compliant to study schedule|1
116004|NCT00434213|380616|P1|Overall Study|Application site reaction|1
116005|NCT00434213|380616|P1|Overall Study|Unable to comply with study visit window|2
116006|NCT00434213|380616|P1|Overall Study|Protocol Violation|3
116007|NCT00434213|380616|P1|Overall Study|Withdrawal by Subject|7
116008|NCT00434213|380616|P1|Overall Study|Lost to Follow-up|14
116009|NCT00434213|380616|P1|Overall Study|Lack of Efficacy|9
116010|NCT00434213|380616|P1|Overall Study|Adverse Event|12
116011|NCT00434252|380637|P2|Overall Study|Withdrawal by Subject|7
116012|NCT00434252|380638|P1|Overall Study|Withdrawal by Subject|3
116013|NCT00434252|380637|P2|Overall Study|Physician Decision|8
116014|NCT00434252|380638|P1|Overall Study|Physician Decision|4
116015|NCT00434252|380637|P2|Overall Study|Lost to Follow-up|1
116016|NCT00434252|380638|P1|Overall Study|Lost to Follow-up|0
116017|NCT00434252|380637|P2|Overall Study|Death|2
116018|NCT00434252|380638|P1|Overall Study|Death|1
116019|NCT00434252|380637|P2|Overall Study|Adverse Event|13
116020|NCT00434252|380638|P1|Overall Study|Adverse Event|6
116021|NCT00434252|380637|P2|Overall Study|Lack of Efficacy|100
116022|NCT00434252|380638|P1|Overall Study|Lack of Efficacy|50
116023|NCT00434304|380669|P1|Overall Study|Withdrawal by Subject|4
116024|NCT00434304|380669|P1|Overall Study|Lack of Efficacy|2
116025|NCT00434304|380669|P1|Overall Study|Adverse Event|14
116026|NCT00434330|380711|P6|Overall Study|Subject Not Compliant With Study|0
116027|NCT00434330|380712|P5|Overall Study|Subject Not Compliant With Study|0
116028|NCT00434330|380713|P4|Overall Study|Subject Not Compliant With Study|0
116029|NCT00434330|380714|P3|Overall Study|Subject Not Compliant With Study|1
116030|NCT00434330|380715|P2|Overall Study|Subject Not Compliant With Study|0
116031|NCT00434330|380716|P1|Overall Study|Subject Not Compliant With Study|0
116032|NCT00434330|380711|P6|Overall Study|Renal transplant|0
116033|NCT00434330|380712|P5|Overall Study|Renal transplant|0
116034|NCT00434330|380713|P4|Overall Study|Renal transplant|1
116035|NCT00434330|380714|P3|Overall Study|Renal transplant|0
116036|NCT00434330|380715|P2|Overall Study|Renal transplant|0
116037|NCT00434330|380716|P1|Overall Study|Renal transplant|0
116038|NCT00434330|380711|P6|Overall Study|Withdrawal by Subject|0
116039|NCT00434330|380712|P5|Overall Study|Withdrawal by Subject|0
116040|NCT00434330|380713|P4|Overall Study|Withdrawal by Subject|1
116041|NCT00434330|380714|P3|Overall Study|Withdrawal by Subject|1
116042|NCT00434330|380715|P2|Overall Study|Withdrawal by Subject|0
116043|NCT00434330|380716|P1|Overall Study|Withdrawal by Subject|0
116044|NCT00434330|380711|P6|Overall Study|Death|1
116045|NCT00434330|380712|P5|Overall Study|Death|1
116046|NCT00434330|380713|P4|Overall Study|Death|0
116047|NCT00434330|380714|P3|Overall Study|Death|0
116048|NCT00434330|380715|P2|Overall Study|Death|0
116049|NCT00434330|380716|P1|Overall Study|Death|1
116050|NCT00434330|380711|P6|Overall Study|Adverse Event|0
116051|NCT00434330|380712|P5|Overall Study|Adverse Event|0
116052|NCT00434330|380713|P4|Overall Study|Adverse Event|0
116053|NCT00434330|380714|P3|Overall Study|Adverse Event|1
116054|NCT00434330|380715|P2|Overall Study|Adverse Event|0
116055|NCT00434330|380716|P1|Overall Study|Adverse Event|0
116056|NCT00435019|380777|P2|Overall Study|Personal reasons for withdrawal|7
116057|NCT00435019|380778|P1|Overall Study|Personal reasons for withdrawal|8
116058|NCT00435019|380777|P2|Overall Study|Protocol Violation|1
116059|NCT00435019|380778|P1|Overall Study|Protocol Violation|3
116060|NCT00435019|380777|P2|Overall Study|Lack of Efficacy|2
116061|NCT00435019|380778|P1|Overall Study|Lack of Efficacy|1
116062|NCT00435019|380777|P2|Overall Study|Adverse Event|0
116063|NCT00435019|380778|P1|Overall Study|Adverse Event|1
116064|NCT00435045|380790|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
116065|NCT00435045|380791|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
116066|NCT00435045|380790|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
116067|NCT00435045|380791|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
116068|NCT00435045|380790|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
116069|NCT00435045|380791|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
116070|NCT00435045|380790|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
116071|NCT00435045|380791|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
116072|NCT00435045|380790|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
116073|NCT00435045|380791|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
116074|NCT00435045|380790|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
116075|NCT00435045|380791|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
116076|NCT00435045|380790|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
116077|NCT00435045|380791|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
116078|NCT00435045|380790|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
116079|NCT00435045|380791|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
116080|NCT00435045|380790|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
116081|NCT00435045|380791|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
116082|NCT00435045|380790|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
116083|NCT00435045|380791|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
116084|NCT00435045|380790|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
116085|NCT00435045|380791|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
116086|NCT00435162|380848|P6|Period 2 (2 Weeks)|Adverse Event|0
116087|NCT00435162|380849|P5|Period 2 (2 Weeks)|Adverse Event|0
116088|NCT00435162|380850|P4|Period 2 (2 Weeks)|Adverse Event|0
116089|NCT00435162|380851|P3|Period 2 (2 Weeks)|Adverse Event|0
116090|NCT00435162|380852|P2|Period 2 (2 Weeks)|Adverse Event|1
116091|NCT00435162|380853|P1|Period 2 (2 Weeks)|Adverse Event|0
116092|NCT00435188|380873|P2|Overall Study|Lost to Follow-up|6
116093|NCT00435188|380874|P1|Overall Study|Lost to Follow-up|5
116094|NCT00435188|380873|P2|Overall Study|Withdrawal by Subject|11
116095|NCT00435188|380874|P1|Overall Study|Withdrawal by Subject|16
116096|NCT00435188|380873|P2|Overall Study|Death|6
116097|NCT00435188|380874|P1|Overall Study|Death|1
116098|NCT00435370|380916|P2|Overall Study|Antipsychotic medication changed|2
116099|NCT00435370|380917|P1|Overall Study|Antipsychotic medication changed|4
116100|NCT00435370|380916|P2|Overall Study|Withdrawal by Subject|10
116101|NCT00435370|380917|P1|Overall Study|Withdrawal by Subject|10
116102|NCT00435370|380916|P2|Overall Study|Adverse Event|8
116103|NCT00435370|380917|P1|Overall Study|Adverse Event|8
116104|NCT00435409|380925|P3|Overall Study|Sponsor decision|0
116105|NCT00435409|380926|P2|Overall Study|Sponsor decision|3
116106|NCT00435409|380927|P1|Overall Study|Sponsor decision|0
116107|NCT00435409|380925|P3|Overall Study|Adverse Event|8
116108|NCT00435409|380926|P2|Overall Study|Adverse Event|0
116109|NCT00435409|380927|P1|Overall Study|Adverse Event|0
116110|NCT00435409|380925|P3|Overall Study|Not specified|1
116111|NCT00435409|380926|P2|Overall Study|Not specified|30
116112|NCT00435409|380927|P1|Overall Study|Not specified|45
116113|NCT00435409|380925|P3|Overall Study|Withdrawal by Subject|1
116114|NCT00435409|380926|P2|Overall Study|Withdrawal by Subject|7
116115|NCT00435409|380927|P1|Overall Study|Withdrawal by Subject|8
116116|NCT00435409|380925|P3|Overall Study|Global deterioration of health status|4
116117|NCT00435409|380926|P2|Overall Study|Global deterioration of health status|0
116118|NCT00435409|380927|P1|Overall Study|Global deterioration of health status|0
116119|NCT00435409|380925|P3|Overall Study|Objective progression or relapse|58
116120|NCT00435409|380926|P2|Overall Study|Objective progression or relapse|93
116121|NCT00435409|380927|P1|Overall Study|Objective progression or relapse|158
116122|NCT00435409|380925|P3|Overall Study|Death|6
116123|NCT00435409|380926|P2|Overall Study|Death|6
116124|NCT00435409|380927|P1|Overall Study|Death|8
116125|NCT00435409|380925|P3|Overall Study|Lost to Follow-up|0
116126|NCT00435409|380926|P2|Overall Study|Lost to Follow-up|2
116127|NCT00435409|380927|P1|Overall Study|Lost to Follow-up|1
116128|NCT00435409|380925|P3|Overall Study|Protocol Violation|0
116129|NCT00435409|380926|P2|Overall Study|Protocol Violation|2
116130|NCT00435409|380927|P1|Overall Study|Protocol Violation|1
116131|NCT00435487|380949|P2|Overall Study|Received Drug in Other Treatment Group|1
116132|NCT00435487|380950|P1|Overall Study|Received Drug in Other Treatment Group|0
116133|NCT00435487|380949|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
116134|NCT00435487|380950|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
116135|NCT00435487|380949|P2|Overall Study|Withdrawal by Subject|1
116136|NCT00435487|380950|P1|Overall Study|Withdrawal by Subject|2
116137|NCT00435487|380949|P2|Overall Study|Other|2
116138|NCT00435487|380950|P1|Overall Study|Other|5
116139|NCT00435487|380949|P2|Overall Study|Lost to Follow-up|2
116140|NCT00435487|380950|P1|Overall Study|Lost to Follow-up|2
116141|NCT00435487|380949|P2|Overall Study|Adverse Event|3
116142|NCT00435487|380950|P1|Overall Study|Adverse Event|0
116143|NCT00435487|380949|P2|Overall Study|Death|4
116144|NCT00435487|380950|P1|Overall Study|Death|3
116145|NCT00435825|381026|P4|Overall Study|Did not complete full follow-up period|5
116146|NCT00435825|381027|P3|Overall Study|Did not complete full follow-up period|4
116147|NCT00435825|381028|P2|Overall Study|Did not complete full follow-up period|6
116148|NCT00435825|381029|P1|Overall Study|Did not complete full follow-up period|6
116149|NCT00435825|381026|P4|Overall Study|Did not enter follow-up|3
116150|NCT00435825|381027|P3|Overall Study|Did not enter follow-up|1
116151|NCT00435825|381028|P2|Overall Study|Did not enter follow-up|4
116152|NCT00435825|381029|P1|Overall Study|Did not enter follow-up|0
116153|NCT00435825|381026|P4|Overall Study|Did not receive study drug|0
116154|NCT00435825|381027|P3|Overall Study|Did not receive study drug|2
116155|NCT00435825|381028|P2|Overall Study|Did not receive study drug|0
116156|NCT00435825|381029|P1|Overall Study|Did not receive study drug|1
116157|NCT00435825|381026|P4|Overall Study|Failure to return|0
116158|NCT00435825|381027|P3|Overall Study|Failure to return|4
116159|NCT00435825|381028|P2|Overall Study|Failure to return|0
116160|NCT00435825|381029|P1|Overall Study|Failure to return|5
116161|NCT00435825|381026|P4|Overall Study|Refused treatment|5
116162|NCT00435825|381027|P3|Overall Study|Refused treatment|0
116163|NCT00435825|381028|P2|Overall Study|Refused treatment|0
116164|NCT00435825|381029|P1|Overall Study|Refused treatment|2
116165|NCT00435825|381026|P4|Overall Study|Other Protocol Violation|0
116166|NCT00435825|381027|P3|Overall Study|Other Protocol Violation|0
116167|NCT00435825|381028|P2|Overall Study|Other Protocol Violation|0
116168|NCT00435825|381029|P1|Overall Study|Other Protocol Violation|1
116169|NCT00435825|381026|P4|Overall Study|Insufficient Therapeutic Response|3
116170|NCT00435825|381027|P3|Overall Study|Insufficient Therapeutic Response|0
116171|NCT00435825|381028|P2|Overall Study|Insufficient Therapeutic Response|1
116172|NCT00435825|381029|P1|Overall Study|Insufficient Therapeutic Response|3
116173|NCT00435825|381026|P4|Overall Study|Abnormality of Laboratory Test|0
116174|NCT00435825|381027|P3|Overall Study|Abnormality of Laboratory Test|0
116175|NCT00435825|381028|P2|Overall Study|Abnormality of Laboratory Test|1
116176|NCT00435825|381029|P1|Overall Study|Abnormality of Laboratory Test|0
116177|NCT00435994|381115|P3|Overall Study|Lost to Follow-up|0
116178|NCT00435994|381116|P2|Overall Study|Lost to Follow-up|0
116179|NCT00435994|381117|P1|Overall Study|Lost to Follow-up|7
116180|NCT00436007|381129|P3|Overall Study|Unspecified|1
116181|NCT00436007|381130|P2|Overall Study|Unspecified|0
116182|NCT00436007|381131|P1|Overall Study|Unspecified|0
116183|NCT00436007|381129|P3|Overall Study|Death|3
116184|NCT00436007|381130|P2|Overall Study|Death|1
116185|NCT00436007|381131|P1|Overall Study|Death|0
116186|NCT00436007|381129|P3|Overall Study|Physician Decision|2
116187|NCT00436007|381130|P2|Overall Study|Physician Decision|0
116188|NCT00436007|381131|P1|Overall Study|Physician Decision|0
116189|NCT00436007|381129|P3|Overall Study|Lost to Follow-up|13
116190|NCT00436007|381130|P2|Overall Study|Lost to Follow-up|10
116191|NCT00436007|381131|P1|Overall Study|Lost to Follow-up|14
116192|NCT00436007|381129|P3|Overall Study|Withdrawal by Subject|4
116193|NCT00436007|381130|P2|Overall Study|Withdrawal by Subject|3
116194|NCT00436007|381131|P1|Overall Study|Withdrawal by Subject|5
116195|NCT00436163|381210|P1|Overall Study|Adverse Event|1
116196|NCT00436163|381210|P1|Overall Study|Lost to Follow-up|2
116197|NCT00436215|381221|P1|Overall Study|Small bowel obstruction|1
116198|NCT00436215|381221|P1|Overall Study|Refused further treatment|3
116199|NCT00436332|381227|P1|Overall Study|Never Received Treatment|3
116200|NCT00436332|381227|P1|Overall Study|Ineligible|2
116201|NCT00436332|381227|P1|Overall Study|Not Protocol Specified|6
116202|NCT00436332|381227|P1|Overall Study|Death|2
116203|NCT00436332|381227|P1|Overall Study|Progression|59
116204|NCT00436332|381227|P1|Overall Study|Withdrawal by Subject|2
116205|NCT00436332|381227|P1|Overall Study|Adverse Event|9
116206|NCT00436345|381236|P2|Overall Study|ICU resident beyond follow-up period|0
116207|NCT00436345|381237|P1|Overall Study|ICU resident beyond follow-up period|3
116208|NCT00436436|381290|P1|Overall Study|Death|6
116209|NCT00436436|381290|P1|Overall Study|Adverse Event|2
116210|NCT00436436|381290|P1|Overall Study|Progression|4
116211|NCT00436501|381301|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
116212|NCT00436501|381302|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
116213|NCT00436501|381301|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
116214|NCT00436501|381302|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
116215|NCT00436553|381316|P3|Overall Study|Withdrawal by Subject|3
116216|NCT00436553|381317|P2|Overall Study|Withdrawal by Subject|6
116217|NCT00436553|381318|P1|Overall Study|Withdrawal by Subject|5
116218|NCT00436553|381316|P3|Overall Study|Protocol Violation|0
116219|NCT00436553|381317|P2|Overall Study|Protocol Violation|0
116220|NCT00436553|381318|P1|Overall Study|Protocol Violation|1
116221|NCT00436553|381316|P3|Overall Study|Lost to Follow-up|0
116222|NCT00436553|381317|P2|Overall Study|Lost to Follow-up|2
116223|NCT00436553|381318|P1|Overall Study|Lost to Follow-up|0
116224|NCT00436553|381316|P3|Overall Study|Death|3
116225|NCT00436553|381317|P2|Overall Study|Death|1
116226|NCT00436553|381318|P1|Overall Study|Death|3
116227|NCT00436553|381316|P3|Overall Study|Adverse Event|4
116228|NCT00436553|381317|P2|Overall Study|Adverse Event|3
116229|NCT00436553|381318|P1|Overall Study|Adverse Event|4
116230|NCT00436566|381337|P1|Overall Study|Protocol Violation|1
116231|NCT00436566|381337|P1|Overall Study|Withdrawal by Subject|2
116232|NCT00436605|381341|P1|Overall Study|Protocol Violation|3
116233|NCT00436618|381349|P3|Overall Study|Still on treatment|7
116234|NCT00436618|381350|P2|Overall Study|Still on treatment|2
116235|NCT00436618|381351|P1|Overall Study|Still on treatment|1
116236|NCT00436618|381349|P3|Overall Study|New Primary or Other Reasons|12
116237|NCT00436618|381350|P2|Overall Study|New Primary or Other Reasons|2
116238|NCT00436618|381351|P1|Overall Study|New Primary or Other Reasons|6
116239|NCT00436618|381349|P3|Overall Study|Death|3
116240|NCT00436618|381350|P2|Overall Study|Death|2
116241|NCT00436618|381351|P1|Overall Study|Death|4
116242|NCT00436618|381349|P3|Overall Study|Other Medical Problems|7
116243|NCT00436618|381350|P2|Overall Study|Other Medical Problems|1
116244|NCT00436618|381351|P1|Overall Study|Other Medical Problems|3
116245|NCT00436618|381349|P3|Overall Study|Alternate Treatment|12
116246|NCT00436618|381350|P2|Overall Study|Alternate Treatment|4
116247|NCT00436618|381351|P1|Overall Study|Alternate Treatment|3
116248|NCT00436618|381349|P3|Overall Study|Adverse Event|9
116249|NCT00436618|381350|P2|Overall Study|Adverse Event|8
116250|NCT00436618|381351|P1|Overall Study|Adverse Event|8
116251|NCT00436618|381349|P3|Overall Study|Withdrawal by Subject|11
116252|NCT00436618|381350|P2|Overall Study|Withdrawal by Subject|8
116253|NCT00436618|381351|P1|Overall Study|Withdrawal by Subject|5
116254|NCT00436644|381368|P1|Overall Study|Death|1
116255|NCT00436644|381368|P1|Overall Study|Adverse Event|2
116256|NCT00436748|381377|P2|Overall Study|Other|0
116257|NCT00436748|381378|P1|Overall Study|Other|3
116258|NCT00436748|381377|P2|Overall Study|Protocol-specified Criteria|4
116259|NCT00436748|381378|P1|Overall Study|Protocol-specified Criteria|5
116260|NCT00436748|381377|P2|Overall Study|Lost to Follow-up|1
116261|NCT00436748|381378|P1|Overall Study|Lost to Follow-up|0
116262|NCT00436748|381377|P2|Overall Study|Administrative Decision|0
116263|NCT00436748|381378|P1|Overall Study|Administrative Decision|1
116264|NCT00436748|381377|P2|Overall Study|Consent Withdrawn|4
116265|NCT00436748|381378|P1|Overall Study|Consent Withdrawn|1
116266|NCT00436748|381377|P2|Overall Study|Adverse Event|2
116267|NCT00436748|381378|P1|Overall Study|Adverse Event|0
116268|NCT00436748|381377|P2|Overall Study|Ineligibility Determined|1
116269|NCT00436748|381378|P1|Overall Study|Ineligibility Determined|1
116270|NCT00436826|381414|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
116271|NCT00436826|381415|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
116272|NCT00436826|381416|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
116273|NCT00436826|381417|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
116274|NCT00436826|381418|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
116358|NCT00437203|381602|P5|Overall Study|Study terminated by sponsor|0
116275|NCT00436826|381419|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
116276|NCT00436826|381414|P6|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
116277|NCT00436826|381415|P5|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
116278|NCT00436826|381416|P4|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|24
116279|NCT00436826|381417|P3|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|44
116280|NCT00436826|381418|P2|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
116281|NCT00436826|381419|P1|Ext. Period (With Cladribine Treatment)|Sponsor's decision to terminate study|0
116282|NCT00436826|381414|P6|Double Blind Period|Unspecified|0
116283|NCT00436826|381415|P5|Double Blind Period|Unspecified|0
116284|NCT00436826|381416|P4|Double Blind Period|Unspecified|0
116285|NCT00436826|381417|P3|Double Blind Period|Unspecified|0
116286|NCT00436826|381418|P2|Double Blind Period|Unspecified|11
116287|NCT00436826|381419|P1|Double Blind Period|Unspecified|10
116288|NCT00436826|381414|P6|Double Blind Period|Protocol Violation|0
116289|NCT00436826|381415|P5|Double Blind Period|Protocol Violation|0
116290|NCT00436826|381416|P4|Double Blind Period|Protocol Violation|0
116291|NCT00436826|381417|P3|Double Blind Period|Protocol Violation|0
116292|NCT00436826|381418|P2|Double Blind Period|Protocol Violation|0
116293|NCT00436826|381419|P1|Double Blind Period|Protocol Violation|1
116294|NCT00436826|381414|P6|Double Blind Period|Adverse Event|0
116295|NCT00436826|381415|P5|Double Blind Period|Adverse Event|0
116296|NCT00436826|381416|P4|Double Blind Period|Adverse Event|0
116297|NCT00436826|381417|P3|Double Blind Period|Adverse Event|0
116298|NCT00436826|381418|P2|Double Blind Period|Adverse Event|0
116299|NCT00436826|381419|P1|Double Blind Period|Adverse Event|2
116300|NCT00436852|381441|P2|Overall Study|Ineligible|0
116301|NCT00436852|381442|P1|Overall Study|Ineligible|1
116302|NCT00436852|381441|P2|Overall Study|Withdrawal by Subject|4
116303|NCT00436852|381442|P1|Overall Study|Withdrawal by Subject|2
116304|NCT00436852|381441|P2|Overall Study|Lack of Efficacy|7
116305|NCT00436852|381442|P1|Overall Study|Lack of Efficacy|9
116306|NCT00436852|381441|P2|Overall Study|Death|34
116307|NCT00436852|381442|P1|Overall Study|Death|23
116308|NCT00436917|381459|P1|Overall Study|Still on treatment|47
116309|NCT00436917|381459|P1|Overall Study|Adverse Event|1
116310|NCT00436917|381459|P1|Overall Study|Withdrawal by Subject|6
116311|NCT00436956|381463|P2|Overall Study|Not evaluable|0
116312|NCT00436956|381464|P1|Overall Study|Not evaluable|1
116313|NCT00436982|381526|P2|Overall Study|Did not receive allocated intervention|1
116314|NCT00436982|381527|P1|Overall Study|Did not receive allocated intervention|0
116315|NCT00436982|381526|P2|Overall Study|Withdrawal by Subject|1
116316|NCT00436982|381527|P1|Overall Study|Withdrawal by Subject|2
116317|NCT00436982|381526|P2|Overall Study|Adverse Event|3
116318|NCT00436982|381527|P1|Overall Study|Adverse Event|3
116319|NCT00437034|381533|P1|Overall Study|Disease progression during treatment|5
116320|NCT00437034|381533|P1|Overall Study|Adverse Event|1
116321|NCT00437073|381539|P2|Overall Study|Physician Decision|1
116322|NCT00437073|381540|P1|Overall Study|Physician Decision|0
116323|NCT00437073|381539|P2|Overall Study|Sponsor Terminated Study|0
116324|NCT00437073|381540|P1|Overall Study|Sponsor Terminated Study|1
116325|NCT00437125|381568|P1|Overall Study|Physician Decision|1
116326|NCT00437125|381568|P1|Overall Study|Withdrawal by Caregiver|2
116327|NCT00437125|381568|P1|Overall Study|Withdrawal by Subject|13
116328|NCT00437125|381568|P1|Overall Study|Lost to Follow-up|1
116329|NCT00437125|381568|P1|Overall Study|Lack of Efficacy|1
116330|NCT00437125|381568|P1|Overall Study|Clinical Relapse|1
116331|NCT00437125|381568|P1|Overall Study|Death|1
116332|NCT00437125|381568|P1|Overall Study|Adverse Event|12
116333|NCT00437203|381597|P10|Overall Study|Unspecified|0
116334|NCT00437203|381598|P9|Overall Study|Unspecified|0
116335|NCT00437203|381599|P8|Overall Study|Unspecified|0
116336|NCT00437203|381600|P7|Overall Study|Unspecified|1
116337|NCT00437203|381601|P6|Overall Study|Unspecified|0
116338|NCT00437203|381602|P5|Overall Study|Unspecified|0
116339|NCT00437203|381603|P4|Overall Study|Unspecified|0
116340|NCT00437203|381604|P3|Overall Study|Unspecified|0
116341|NCT00437203|381605|P2|Overall Study|Unspecified|1
116342|NCT00437203|381606|P1|Overall Study|Unspecified|0
116343|NCT00437203|381597|P10|Overall Study|Objective progression or relapse|2
116344|NCT00437203|381598|P9|Overall Study|Objective progression or relapse|2
116345|NCT00437203|381599|P8|Overall Study|Objective progression or relapse|1
116346|NCT00437203|381600|P7|Overall Study|Objective progression or relapse|6
116347|NCT00437203|381601|P6|Overall Study|Objective progression or relapse|3
116348|NCT00437203|381602|P5|Overall Study|Objective progression or relapse|3
116349|NCT00437203|381603|P4|Overall Study|Objective progression or relapse|3
116350|NCT00437203|381604|P3|Overall Study|Objective progression or relapse|2
116351|NCT00437203|381605|P2|Overall Study|Objective progression or relapse|6
116352|NCT00437203|381606|P1|Overall Study|Objective progression or relapse|5
116353|NCT00437203|381597|P10|Overall Study|Study terminated by sponsor|0
116354|NCT00437203|381598|P9|Overall Study|Study terminated by sponsor|1
116355|NCT00437203|381599|P8|Overall Study|Study terminated by sponsor|0
116356|NCT00437203|381600|P7|Overall Study|Study terminated by sponsor|0
116357|NCT00437203|381601|P6|Overall Study|Study terminated by sponsor|0
116359|NCT00437203|381603|P4|Overall Study|Study terminated by sponsor|0
116360|NCT00437203|381604|P3|Overall Study|Study terminated by sponsor|0
116361|NCT00437203|381605|P2|Overall Study|Study terminated by sponsor|0
116362|NCT00437203|381606|P1|Overall Study|Study terminated by sponsor|0
116363|NCT00437203|381597|P10|Overall Study|Adverse Event|1
116364|NCT00437203|381598|P9|Overall Study|Adverse Event|0
116365|NCT00437203|381599|P8|Overall Study|Adverse Event|1
116366|NCT00437203|381600|P7|Overall Study|Adverse Event|0
116367|NCT00437203|381601|P6|Overall Study|Adverse Event|0
116368|NCT00437203|381602|P5|Overall Study|Adverse Event|0
116369|NCT00437203|381603|P4|Overall Study|Adverse Event|0
116370|NCT00437203|381604|P3|Overall Study|Adverse Event|0
116371|NCT00437203|381605|P2|Overall Study|Adverse Event|1
116372|NCT00437203|381606|P1|Overall Study|Adverse Event|1
116373|NCT00437203|381597|P10|Overall Study|Death|1
116374|NCT00437203|381598|P9|Overall Study|Death|0
116375|NCT00437203|381599|P8|Overall Study|Death|1
116376|NCT00437203|381600|P7|Overall Study|Death|0
116377|NCT00437203|381601|P6|Overall Study|Death|0
116378|NCT00437203|381602|P5|Overall Study|Death|0
116379|NCT00437203|381603|P4|Overall Study|Death|0
116380|NCT00437203|381604|P3|Overall Study|Death|1
116381|NCT00437203|381605|P2|Overall Study|Death|0
116382|NCT00437203|381606|P1|Overall Study|Death|0
116383|NCT00437281|381730|P20|Overall Study|Lost to Follow-up|1
116384|NCT00437281|381731|P19|Overall Study|Lost to Follow-up|0
116385|NCT00437281|381732|P18|Overall Study|Lost to Follow-up|0
116386|NCT00437281|381733|P17|Overall Study|Lost to Follow-up|0
116387|NCT00437281|381734|P16|Overall Study|Lost to Follow-up|0
116388|NCT00437281|381735|P15|Overall Study|Lost to Follow-up|0
116389|NCT00437281|381736|P14|Overall Study|Lost to Follow-up|0
116390|NCT00437281|381737|P13|Overall Study|Lost to Follow-up|0
116391|NCT00437281|381738|P12|Overall Study|Lost to Follow-up|0
116392|NCT00437281|381739|P11|Overall Study|Lost to Follow-up|0
116393|NCT00437281|381740|P10|Overall Study|Lost to Follow-up|0
116394|NCT00437281|381741|P9|Overall Study|Lost to Follow-up|0
116395|NCT00437281|381742|P8|Overall Study|Lost to Follow-up|0
116396|NCT00437281|381743|P7|Overall Study|Lost to Follow-up|0
116397|NCT00437281|381744|P6|Overall Study|Lost to Follow-up|0
116398|NCT00437281|381745|P5|Overall Study|Lost to Follow-up|0
116399|NCT00437281|381746|P4|Overall Study|Lost to Follow-up|0
116400|NCT00437281|381747|P3|Overall Study|Lost to Follow-up|0
116401|NCT00437281|381748|P2|Overall Study|Lost to Follow-up|0
116402|NCT00437281|381749|P1|Overall Study|Lost to Follow-up|0
116403|NCT00437281|381730|P20|Overall Study|Adverse Event|0
116404|NCT00437281|381731|P19|Overall Study|Adverse Event|1
116405|NCT00437281|381732|P18|Overall Study|Adverse Event|0
116406|NCT00437281|381733|P17|Overall Study|Adverse Event|0
116407|NCT00437281|381734|P16|Overall Study|Adverse Event|0
116408|NCT00437281|381735|P15|Overall Study|Adverse Event|1
116409|NCT00437281|381736|P14|Overall Study|Adverse Event|1
116410|NCT00437281|381737|P13|Overall Study|Adverse Event|0
116411|NCT00437281|381738|P12|Overall Study|Adverse Event|0
116412|NCT00437281|381739|P11|Overall Study|Adverse Event|0
116413|NCT00437281|381740|P10|Overall Study|Adverse Event|1
116414|NCT00437281|381741|P9|Overall Study|Adverse Event|0
116415|NCT00437281|381742|P8|Overall Study|Adverse Event|0
116416|NCT00437281|381743|P7|Overall Study|Adverse Event|0
116417|NCT00437281|381744|P6|Overall Study|Adverse Event|1
116418|NCT00437281|381745|P5|Overall Study|Adverse Event|0
116419|NCT00437281|381746|P4|Overall Study|Adverse Event|1
116420|NCT00437281|381747|P3|Overall Study|Adverse Event|0
116421|NCT00437281|381748|P2|Overall Study|Adverse Event|0
116422|NCT00437281|381749|P1|Overall Study|Adverse Event|0
116423|NCT00437489|382050|P2|Overall Study|Lost to Follow-up|1
116424|NCT00437489|382051|P1|Overall Study|Lost to Follow-up|0
116425|NCT00437489|382050|P2|Overall Study|Study terminated by sponsor|21
116426|NCT00437489|382051|P1|Overall Study|Study terminated by sponsor|23
116427|NCT00430248|382066|P3|Overall Study|Reason Not Specified|11
116428|NCT00430248|382067|P2|Overall Study|Reason Not Specified|8
116429|NCT00430248|382068|P1|Overall Study|Reason Not Specified|8
116430|NCT00430248|382066|P3|Overall Study|Gout Flare|2
116431|NCT00430248|382067|P2|Overall Study|Gout Flare|7
116432|NCT00430248|382068|P1|Overall Study|Gout Flare|3
116433|NCT00430248|382066|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
116434|NCT00430248|382067|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
116435|NCT00430248|382068|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
116436|NCT00430248|382066|P3|Overall Study|Withdrawal by Subject|16
116437|NCT00430248|382067|P2|Overall Study|Withdrawal by Subject|20
116438|NCT00430248|382068|P1|Overall Study|Withdrawal by Subject|14
116439|NCT00430248|382066|P3|Overall Study|Therapeutic Failure|1
116440|NCT00430248|382067|P2|Overall Study|Therapeutic Failure|1
116441|NCT00430248|382068|P1|Overall Study|Therapeutic Failure|1
116442|NCT00430248|382066|P3|Overall Study|Lost to Follow-up|28
116443|NCT00430248|382067|P2|Overall Study|Lost to Follow-up|33
116444|NCT00430248|382068|P1|Overall Study|Lost to Follow-up|28
116445|NCT00430248|382066|P3|Overall Study|Personal Reasons|9
116446|NCT00430248|382067|P2|Overall Study|Personal Reasons|24
116447|NCT00430248|382068|P1|Overall Study|Personal Reasons|12
116448|NCT00430248|382066|P3|Overall Study|Protocol Violation|4
116449|NCT00430248|382067|P2|Overall Study|Protocol Violation|2
116450|NCT00430248|382068|P1|Overall Study|Protocol Violation|10
116451|NCT00430248|382066|P3|Overall Study|Adverse Event|64
116452|NCT00430248|382067|P2|Overall Study|Adverse Event|61
116453|NCT00430248|382068|P1|Overall Study|Adverse Event|49
116454|NCT00430300|382128|P4|Overall Study|Unspecified|1
116455|NCT00430300|382129|P3|Overall Study|Unspecified|0
116456|NCT00430300|382130|P2|Overall Study|Unspecified|0
116457|NCT00430300|382131|P1|Overall Study|Unspecified|0
116458|NCT00430300|382128|P4|Overall Study|Laboratory abnormality|0
116459|NCT00430300|382129|P3|Overall Study|Laboratory abnormality|0
116460|NCT00430300|382130|P2|Overall Study|Laboratory abnormality|0
116461|NCT00430300|382131|P1|Overall Study|Laboratory abnormality|1
116462|NCT00430300|382128|P4|Overall Study|Withdrawal by Subject|0
116463|NCT00430300|382129|P3|Overall Study|Withdrawal by Subject|5
116464|NCT00430300|382130|P2|Overall Study|Withdrawal by Subject|0
116465|NCT00430300|382131|P1|Overall Study|Withdrawal by Subject|1
116466|NCT00430300|382128|P4|Overall Study|Adverse Event|1
116467|NCT00430300|382129|P3|Overall Study|Adverse Event|1
116468|NCT00430300|382130|P2|Overall Study|Adverse Event|2
116469|NCT00430300|382131|P1|Overall Study|Adverse Event|0
116470|NCT00430352|382233|P1|Overall Study|Not specified|48
116471|NCT00430352|382233|P1|Overall Study|Death|5
116472|NCT00430352|382233|P1|Overall Study|Adverse Event|16
116473|NCT00430352|382233|P1|Overall Study|Withdrawal by Subject|11
116474|NCT00430352|382233|P1|Overall Study|Disease progression|58
116475|NCT00430495|382251|P4|Overall Study|Randomized but not Treated|0
116476|NCT00430495|382252|P3|Overall Study|Randomized but not Treated|0
116477|NCT00430495|382253|P2|Overall Study|Randomized but not Treated|0
116478|NCT00430495|382254|P1|Overall Study|Randomized but not Treated|2
116479|NCT00430495|382251|P4|Overall Study|Unspecified|4
116480|NCT00430495|382252|P3|Overall Study|Unspecified|5
116481|NCT00430495|382253|P2|Overall Study|Unspecified|2
116482|NCT00430495|382254|P1|Overall Study|Unspecified|8
116483|NCT00430495|382251|P4|Overall Study|Disease Progression|0
116484|NCT00430495|382252|P3|Overall Study|Disease Progression|0
116485|NCT00430495|382253|P2|Overall Study|Disease Progression|1
116486|NCT00430495|382254|P1|Overall Study|Disease Progression|1
116487|NCT00430495|382251|P4|Overall Study|Protocol Violation|0
116488|NCT00430495|382252|P3|Overall Study|Protocol Violation|1
116489|NCT00430495|382253|P2|Overall Study|Protocol Violation|0
116490|NCT00430495|382254|P1|Overall Study|Protocol Violation|1
116491|NCT00430495|382251|P4|Overall Study|Lost to Follow-up|0
116492|NCT00430495|382252|P3|Overall Study|Lost to Follow-up|4
116493|NCT00430495|382253|P2|Overall Study|Lost to Follow-up|1
116494|NCT00430495|382254|P1|Overall Study|Lost to Follow-up|0
116495|NCT00430495|382251|P4|Overall Study|Death|0
116496|NCT00430495|382252|P3|Overall Study|Death|1
116497|NCT00430495|382253|P2|Overall Study|Death|0
116498|NCT00430495|382254|P1|Overall Study|Death|0
116499|NCT00430495|382251|P4|Overall Study|Adverse Event|0
116500|NCT00430495|382252|P3|Overall Study|Adverse Event|2
116501|NCT00430495|382253|P2|Overall Study|Adverse Event|3
116502|NCT00430495|382254|P1|Overall Study|Adverse Event|2
116503|NCT00430508|382296|P4|Overall Study|not specified|0
116504|NCT00430508|382297|P3|Overall Study|not specified|3
116505|NCT00430508|382298|P2|Overall Study|not specified|1
116506|NCT00430508|382299|P1|Overall Study|not specified|1
116507|NCT00430508|382296|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
116508|NCT00430508|382297|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
116509|NCT00430508|382298|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
116510|NCT00430508|382299|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
116511|NCT00430508|382296|P4|Overall Study|responder at visit 4|0
116512|NCT00430508|382297|P3|Overall Study|responder at visit 4|2
116513|NCT00430508|382298|P2|Overall Study|responder at visit 4|0
116514|NCT00430508|382299|P1|Overall Study|responder at visit 4|0
116515|NCT00430508|382296|P4|Overall Study|Withdrawal by Subject|1
116516|NCT00430508|382297|P3|Overall Study|Withdrawal by Subject|1
116517|NCT00430508|382298|P2|Overall Study|Withdrawal by Subject|1
116518|NCT00430508|382299|P1|Overall Study|Withdrawal by Subject|0
116519|NCT00430508|382296|P4|Overall Study|Adverse Event|3
116520|NCT00430508|382297|P3|Overall Study|Adverse Event|5
116521|NCT00430508|382298|P2|Overall Study|Adverse Event|3
116522|NCT00430508|382299|P1|Overall Study|Adverse Event|2
116523|NCT00430638|382354|P2|Overall Study|Not specified|2
116524|NCT00430638|382355|P1|Overall Study|Not specified|2
116525|NCT00430638|382354|P2|Overall Study|Non-compliant|1
116526|NCT00430638|382355|P1|Overall Study|Non-compliant|2
116527|NCT00430638|382354|P2|Overall Study|Withdrawal by Subject|6
116528|NCT00430638|382355|P1|Overall Study|Withdrawal by Subject|4
116529|NCT00430638|382354|P2|Overall Study|Protocol Violation|4
116530|NCT00430638|382355|P1|Overall Study|Protocol Violation|6
116531|NCT00430638|382354|P2|Overall Study|Lost to Follow-up|7
116532|NCT00430638|382355|P1|Overall Study|Lost to Follow-up|1
116533|NCT00430638|382354|P2|Overall Study|Uncontrolled blood pressure|13
116534|NCT00430638|382355|P1|Overall Study|Uncontrolled blood pressure|48
116535|NCT00430638|382354|P2|Overall Study|Adverse Event|15
116536|NCT00430638|382355|P1|Overall Study|Adverse Event|15
116537|NCT00430677|382374|P3|Long-term Extension Period|Poor compliance/noncompliance|0
116538|NCT00430677|382375|P2|Long-term Extension Period|Poor compliance/noncompliance|0
116539|NCT00430677|382376|P1|Long-term Extension Period|Poor compliance/noncompliance|1
116540|NCT00430677|382374|P3|Long-term Extension Period|Not specified|1
116541|NCT00430677|382375|P2|Long-term Extension Period|Not specified|1
116542|NCT00430677|382376|P1|Long-term Extension Period|Not specified|2
116543|NCT00430677|382374|P3|Long-term Extension Period|Administrative reason by sponsor|46
116544|NCT00430677|382375|P2|Long-term Extension Period|Administrative reason by sponsor|49
116545|NCT00430677|382376|P1|Long-term Extension Period|Administrative reason by sponsor|41
116546|NCT00430677|382374|P3|Long-term Extension Period|Pregnancy|0
116547|NCT00430677|382375|P2|Long-term Extension Period|Pregnancy|1
116548|NCT00430677|382376|P1|Long-term Extension Period|Pregnancy|1
116549|NCT00430677|382374|P3|Long-term Extension Period|Withdrawal by Subject|2
116550|NCT00430677|382375|P2|Long-term Extension Period|Withdrawal by Subject|1
116551|NCT00430677|382376|P1|Long-term Extension Period|Withdrawal by Subject|5
116552|NCT00430677|382374|P3|Long-term Extension Period|Lost to Follow-up|1
116553|NCT00430677|382375|P2|Long-term Extension Period|Lost to Follow-up|1
116554|NCT00430677|382376|P1|Long-term Extension Period|Lost to Follow-up|1
116555|NCT00430677|382374|P3|Long-term Extension Period|Lack of Efficacy|8
116556|NCT00430677|382375|P2|Long-term Extension Period|Lack of Efficacy|3
116557|NCT00430677|382376|P1|Long-term Extension Period|Lack of Efficacy|5
116558|NCT00430677|382374|P3|Long-term Extension Period|Adverse Event|5
116559|NCT00430677|382375|P2|Long-term Extension Period|Adverse Event|2
116560|NCT00430677|382376|P1|Long-term Extension Period|Adverse Event|3
116561|NCT00430677|382374|P3|Long-term Extension Period|Death|0
116562|NCT00430677|382375|P2|Long-term Extension Period|Death|0
116563|NCT00430677|382376|P1|Long-term Extension Period|Death|1
116564|NCT00430677|382374|P3|Short-term Period|Pregnancy|0
116565|NCT00430677|382375|P2|Short-term Period|Pregnancy|2
116566|NCT00430677|382376|P1|Short-term Period|Pregnancy|0
116567|NCT00430677|382374|P3|Short-term Period|Poor compliance/ noncompliance|0
116568|NCT00430677|382375|P2|Short-term Period|Poor compliance/ noncompliance|1
116569|NCT00430677|382376|P1|Short-term Period|Poor compliance/ noncompliance|0
116570|NCT00430677|382374|P3|Short-term Period|Participant no longer met study criteria|2
116571|NCT00430677|382375|P2|Short-term Period|Participant no longer met study criteria|1
116572|NCT00430677|382376|P1|Short-term Period|Participant no longer met study criteria|1
116573|NCT00430677|382374|P3|Short-term Period|Withdrawal by Subject|2
116574|NCT00430677|382375|P2|Short-term Period|Withdrawal by Subject|1
116575|NCT00430677|382376|P1|Short-term Period|Withdrawal by Subject|1
116576|NCT00430677|382374|P3|Short-term Period|Lack of Efficacy|4
116577|NCT00430677|382375|P2|Short-term Period|Lack of Efficacy|6
116578|NCT00430677|382376|P1|Short-term Period|Lack of Efficacy|5
116579|NCT00430677|382374|P3|Short-term Period|Adverse Event|9
116580|NCT00430677|382375|P2|Short-term Period|Adverse Event|13
116581|NCT00430677|382376|P1|Short-term Period|Adverse Event|15
116582|NCT00430677|382374|P3|Short-term Period|Death|5
116583|NCT00430677|382375|P2|Short-term Period|Death|1
116584|NCT00430677|382376|P1|Short-term Period|Death|1
116585|NCT00430716|382500|P3|Open Label Phase|Study terminated by sponsor|4
116586|NCT00430716|382501|P2|Open Label Phase|Study terminated by sponsor|5
116587|NCT00430716|382502|P1|Open Label Phase|Study terminated by sponsor|4
116588|NCT00430716|382500|P3|Open Label Phase|Protocol Violation|0
116589|NCT00430716|382501|P2|Open Label Phase|Protocol Violation|0
116590|NCT00430716|382502|P1|Open Label Phase|Protocol Violation|1
116591|NCT00430716|382500|P3|Open Label Phase|Unspecified|1
116592|NCT00430716|382501|P2|Open Label Phase|Unspecified|1
116593|NCT00430716|382502|P1|Open Label Phase|Unspecified|3
116594|NCT00430716|382500|P3|Open Label Phase|No longer willing to participate|1
116595|NCT00430716|382501|P2|Open Label Phase|No longer willing to participate|1
116596|NCT00430716|382502|P1|Open Label Phase|No longer willing to participate|0
116597|NCT00430716|382500|P3|Open Label Phase|Lost to Follow-up|1
116598|NCT00430716|382501|P2|Open Label Phase|Lost to Follow-up|0
116599|NCT00430716|382502|P1|Open Label Phase|Lost to Follow-up|1
116600|NCT00430716|382500|P3|Double Blind Phase|Not met eligibility criteria|0
116601|NCT00430716|382501|P2|Double Blind Phase|Not met eligibility criteria|0
116602|NCT00430716|382502|P1|Double Blind Phase|Not met eligibility criteria|1
116603|NCT00430716|382500|P3|Double Blind Phase|Adverse Event|3
116604|NCT00430716|382501|P2|Double Blind Phase|Adverse Event|1
116605|NCT00430716|382502|P1|Double Blind Phase|Adverse Event|1
116606|NCT00430716|382500|P3|Double Blind Phase|Study terminated by sponsor|2
116607|NCT00430716|382501|P2|Double Blind Phase|Study terminated by sponsor|1
116608|NCT00430716|382502|P1|Double Blind Phase|Study terminated by sponsor|1
116609|NCT00430716|382500|P3|Double Blind Phase|Unspecified|0
116610|NCT00430716|382501|P2|Double Blind Phase|Unspecified|2
116611|NCT00430716|382502|P1|Double Blind Phase|Unspecified|0
116612|NCT00430716|382500|P3|Double Blind Phase|No longer willing to participate|1
116613|NCT00430716|382501|P2|Double Blind Phase|No longer willing to participate|1
116614|NCT00430716|382502|P1|Double Blind Phase|No longer willing to participate|2
116615|NCT00430716|382500|P3|Double Blind Phase|Death|0
116616|NCT00430716|382501|P2|Double Blind Phase|Death|0
116617|NCT00430716|382502|P1|Double Blind Phase|Death|1
116618|NCT00430755|382531|P1|Overall Study|Withdrawal by Subject|53
116619|NCT00430781|382557|P3|End-of-Study Analysis; 28 July 2011|Other|0
116620|NCT00430781|382558|P2|End-of-Study Analysis; 28 July 2011|Other|1
116621|NCT00430781|382559|P1|End-of-Study Analysis; 28 July 2011|Other|4
116622|NCT00430781|382557|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
116698|NCT00430937|382585|P1|Overall Study|Withdrawal by Subject|5
116623|NCT00430781|382558|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
116624|NCT00430781|382559|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
116625|NCT00430781|382557|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
116626|NCT00430781|382558|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
116627|NCT00430781|382559|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
116628|NCT00430781|382557|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
116629|NCT00430781|382558|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
116630|NCT00430781|382559|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
116631|NCT00430781|382557|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
116632|NCT00430781|382558|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
116633|NCT00430781|382559|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
116634|NCT00430781|382557|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
116635|NCT00430781|382558|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
116636|NCT00430781|382559|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
116637|NCT00430781|382557|P3|Final Analysis; 31 July 2008|Ongoing|32
116638|NCT00430781|382558|P2|Final Analysis; 31 July 2008|Ongoing|29
116639|NCT00430781|382559|P1|Final Analysis; 31 July 2008|Ongoing|0
116640|NCT00430781|382557|P3|Final Analysis; 31 July 2008|Other|0
116641|NCT00430781|382558|P2|Final Analysis; 31 July 2008|Other|1
116642|NCT00430781|382559|P1|Final Analysis; 31 July 2008|Other|0
116643|NCT00430781|382557|P3|Final Analysis; 31 July 2008|Physician Decision|6
116644|NCT00430781|382558|P2|Final Analysis; 31 July 2008|Physician Decision|6
116645|NCT00430781|382559|P1|Final Analysis; 31 July 2008|Physician Decision|0
116646|NCT00430781|382557|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
116647|NCT00430781|382558|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
116648|NCT00430781|382559|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
116649|NCT00430781|382557|P3|Final Analysis; 31 July 2008|Protocol Violation|0
116650|NCT00430781|382558|P2|Final Analysis; 31 July 2008|Protocol Violation|1
116651|NCT00430781|382559|P1|Final Analysis; 31 July 2008|Protocol Violation|0
116652|NCT00430781|382557|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
116653|NCT00430781|382558|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
116654|NCT00430781|382559|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
116655|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Ongoing|25
116656|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Ongoing|20
116657|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Ongoing|23
116658|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Physician Decision|3
116659|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Physician Decision|3
116660|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Physician Decision|2
116661|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
116662|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
116663|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
116664|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Death|0
116665|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Death|1
116666|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Death|0
116667|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Disease Progression|22
116668|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Disease Progression|30
116669|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Disease Progression|16
116670|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
116671|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
116672|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
116673|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
116674|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
116675|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
116676|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
116677|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
116678|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
116679|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
116680|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
116681|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
116682|NCT00430781|382557|P3|Interim Analysis; 11 February 2008|Adverse Event|7
116683|NCT00430781|382558|P2|Interim Analysis; 11 February 2008|Adverse Event|3
116684|NCT00430781|382559|P1|Interim Analysis; 11 February 2008|Adverse Event|10
116685|NCT00430937|382584|P2|Overall Study|Unable to classify|1
116686|NCT00430937|382585|P1|Overall Study|Unable to classify|0
116687|NCT00430937|382584|P2|Overall Study|Protocol discontinuation criteria met|2
116688|NCT00430937|382585|P1|Overall Study|Protocol discontinuation criteria met|1
116689|NCT00430937|382584|P2|Overall Study|Administrative reasons|0
116690|NCT00430937|382585|P1|Overall Study|Administrative reasons|1
116691|NCT00430937|382584|P2|Overall Study|Inappropriate enrollment|1
116692|NCT00430937|382585|P1|Overall Study|Inappropriate enrollment|2
116693|NCT00430937|382584|P2|Overall Study|Lack of Efficacy|5
116694|NCT00430937|382585|P1|Overall Study|Lack of Efficacy|6
116695|NCT00430937|382584|P2|Overall Study|Protocol Violation|2
116696|NCT00430937|382585|P1|Overall Study|Protocol Violation|3
116697|NCT00430937|382584|P2|Overall Study|Withdrawal by Subject|2
116699|NCT00430937|382584|P2|Overall Study|Lost to Follow-up|6
116700|NCT00430937|382585|P1|Overall Study|Lost to Follow-up|6
116701|NCT00430937|382584|P2|Overall Study|Death|1
116702|NCT00430937|382585|P1|Overall Study|Death|0
116703|NCT00430937|382584|P2|Overall Study|Adverse Event|8
116704|NCT00430937|382585|P1|Overall Study|Adverse Event|3
116705|NCT00430950|382595|P2|Overall Study|concomitant medication,etc.|7
116706|NCT00430950|382596|P1|Overall Study|concomitant medication,etc.|5
116707|NCT00430950|382595|P2|Overall Study|Withdrawal by Subject|0
116708|NCT00430950|382596|P1|Overall Study|Withdrawal by Subject|1
116709|NCT00430950|382595|P2|Overall Study|Adverse Event|6
116710|NCT00430950|382596|P1|Overall Study|Adverse Event|7
116711|NCT00431067|382625|P1|Overall Study|Non-compliance,lost to follow-up|2
116712|NCT00431067|382625|P1|Overall Study|Progressive disease|30
116713|NCT00431067|382625|P1|Overall Study|Other Adverse Event|9
116714|NCT00431444|382651|P2|Overall Study|Administrative Problems|1
116715|NCT00431444|382652|P1|Overall Study|Administrative Problems|0
116716|NCT00431444|382651|P2|Overall Study|Lost to Follow-up|0
116717|NCT00431444|382652|P1|Overall Study|Lost to Follow-up|1
116718|NCT00431444|382651|P2|Overall Study|Withdrawal by Subject|1
116719|NCT00431444|382652|P1|Overall Study|Withdrawal by Subject|1
116720|NCT00431444|382651|P2|Overall Study|Adverse Event|1
116721|NCT00431444|382652|P1|Overall Study|Adverse Event|2
116722|NCT00431444|382651|P2|Overall Study|Protocol Violation|4
116723|NCT00431444|382652|P1|Overall Study|Protocol Violation|1
116724|NCT00437645|382678|P2|Overall Study|Condition no longer requires study drug|1
116725|NCT00437645|382679|P1|Overall Study|Condition no longer requires study drug|1
116726|NCT00437645|382678|P2|Overall Study|Lack of Efficacy|1
116727|NCT00437645|382679|P1|Overall Study|Lack of Efficacy|2
116728|NCT00437645|382678|P2|Overall Study|Administrative problems|1
116729|NCT00437645|382679|P1|Overall Study|Administrative problems|2
116730|NCT00437645|382678|P2|Overall Study|Lost to Follow-up|3
116731|NCT00437645|382679|P1|Overall Study|Lost to Follow-up|2
116732|NCT00437645|382678|P2|Overall Study|Protocol Violation|3
116733|NCT00437645|382679|P1|Overall Study|Protocol Violation|3
116734|NCT00437645|382678|P2|Overall Study|Withdrawal by Subject|22
116735|NCT00437645|382679|P1|Overall Study|Withdrawal by Subject|10
116736|NCT00437645|382678|P2|Overall Study|Adverse Event|84
116737|NCT00437645|382679|P1|Overall Study|Adverse Event|15
116738|NCT00439140|382728|P3|Treatment Cycle 2|Lost to Follow-up|0
116739|NCT00439140|382729|P2|Treatment Cycle 2|Lost to Follow-up|1
116740|NCT00439140|382730|P1|Treatment Cycle 2|Lost to Follow-up|1
116741|NCT00439140|382728|P3|Treatment Cycle 2|Withdrawal by Subject|0
116742|NCT00439140|382729|P2|Treatment Cycle 2|Withdrawal by Subject|0
116743|NCT00439140|382730|P1|Treatment Cycle 2|Withdrawal by Subject|1
116744|NCT00439140|382728|P3|Treatment Cycle 1|Withdrawal by Subject|0
116745|NCT00439140|382729|P2|Treatment Cycle 1|Withdrawal by Subject|1
116746|NCT00439140|382730|P1|Treatment Cycle 1|Withdrawal by Subject|0
116747|NCT00439140|382728|P3|Treatment Cycle 1|Personal reasons|0
116748|NCT00439140|382729|P2|Treatment Cycle 1|Personal reasons|2
116749|NCT00439140|382730|P1|Treatment Cycle 1|Personal reasons|0
116750|NCT00439140|382728|P3|Treatment Cycle 1|Lost to Follow-up|1
116751|NCT00439140|382729|P2|Treatment Cycle 1|Lost to Follow-up|1
116752|NCT00439140|382730|P1|Treatment Cycle 1|Lost to Follow-up|1
116753|NCT00439179|382763|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
116754|NCT00439179|382764|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
116755|NCT00439179|382765|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
116756|NCT00439179|382766|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
116757|NCT00439218|382780|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
116758|NCT00439231|382791|P1|Overall Study|Lack of Efficacy|28
116759|NCT00439244|382798|P3|Overall Study|Administrative problems|0
116760|NCT00439244|382799|P2|Overall Study|Administrative problems|0
116761|NCT00439244|382800|P1|Overall Study|Administrative problems|1
116762|NCT00439244|382798|P3|Overall Study|Protocol Violation|0
116763|NCT00439244|382799|P2|Overall Study|Protocol Violation|1
116764|NCT00439244|382800|P1|Overall Study|Protocol Violation|0
116765|NCT00439244|382798|P3|Overall Study|Death|0
116766|NCT00439244|382799|P2|Overall Study|Death|1
116767|NCT00439244|382800|P1|Overall Study|Death|0
116768|NCT00439244|382798|P3|Overall Study|Lost to Follow-up|2
116769|NCT00439244|382799|P2|Overall Study|Lost to Follow-up|1
116770|NCT00439244|382800|P1|Overall Study|Lost to Follow-up|2
116771|NCT00439244|382798|P3|Overall Study|Withdrawal by Subject|2
116772|NCT00439244|382799|P2|Overall Study|Withdrawal by Subject|1
116773|NCT00439244|382800|P1|Overall Study|Withdrawal by Subject|3
116774|NCT00439244|382798|P3|Overall Study|Adverse Event|3
116775|NCT00439244|382799|P2|Overall Study|Adverse Event|2
116776|NCT00439244|382800|P1|Overall Study|Adverse Event|5
116777|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
116778|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
116779|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
116780|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
116781|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
116782|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
116783|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
116784|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
116785|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
116786|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
116787|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
116788|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
116789|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
116790|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
116791|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
116792|NCT00439270|382825|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
116793|NCT00439270|382826|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
116794|NCT00439270|382827|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
116795|NCT00439270|382828|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
116796|NCT00439270|382829|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
116797|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
116798|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
116799|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
116800|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
116801|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
116802|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
116803|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
116804|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
116805|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
116806|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
116807|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
116808|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
116809|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
116810|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
116811|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
116812|NCT00439270|382825|P5|Phase 2 (51.6 Months)|Disease progression|0
116813|NCT00439270|382826|P4|Phase 2 (51.6 Months)|Disease progression|18
116814|NCT00439270|382827|P3|Phase 2 (51.6 Months)|Disease progression|0
116815|NCT00439270|382828|P2|Phase 2 (51.6 Months)|Disease progression|0
116816|NCT00439270|382829|P1|Phase 2 (51.6 Months)|Disease progression|0
116817|NCT00439270|382825|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
116818|NCT00439270|382826|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
116819|NCT00439270|382827|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
116820|NCT00439270|382828|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
116821|NCT00439270|382829|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
116822|NCT00439270|382825|P5|Phase 1 (18.1 Months)|Disease progression|3
116823|NCT00439270|382826|P4|Phase 1 (18.1 Months)|Disease progression|0
116824|NCT00439270|382827|P3|Phase 1 (18.1 Months)|Disease progression|3
116825|NCT00439270|382828|P2|Phase 1 (18.1 Months)|Disease progression|2
116826|NCT00439270|382829|P1|Phase 1 (18.1 Months)|Disease progression|3
116827|NCT00439309|382870|P2|Follow-Up|Late response by subject|1
116828|NCT00439309|382871|P1|Follow-Up|Late response by subject|0
116829|NCT00439309|382870|P2|Follow-Up|Withdrawal by Subject|1
116830|NCT00439309|382871|P1|Follow-Up|Withdrawal by Subject|0
116831|NCT00439309|382870|P2|Follow-Up|Lost to Follow-up|0
116832|NCT00439309|382871|P1|Follow-Up|Lost to Follow-up|2
116833|NCT00439309|382870|P2|Follow-Up|Death|0
116834|NCT00439309|382871|P1|Follow-Up|Death|1
116835|NCT00439517|382931|P2|Overall Study|Subject in survival follow-up|0
116836|NCT00439517|382932|P1|Overall Study|Subject in survival follow-up|1
116837|NCT00439517|382931|P2|Overall Study|Subject on treatment|0
116838|NCT00439517|382932|P1|Overall Study|Subject on treatment|1
116839|NCT00439569|382954|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
116840|NCT00439569|382954|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
116841|NCT00439569|382954|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
116842|NCT00439647|382971|P2|Overall Study|Lack of Efficacy|4
116843|NCT00439647|382972|P1|Overall Study|Lack of Efficacy|0
116844|NCT00439647|382971|P2|Overall Study|Protocol Violation|4
116845|NCT00439647|382972|P1|Overall Study|Protocol Violation|3
116846|NCT00439647|382971|P2|Overall Study|Lost to Follow-up|12
116847|NCT00439647|382972|P1|Overall Study|Lost to Follow-up|4
116848|NCT00439647|382971|P2|Overall Study|Adverse Event|11
116849|NCT00439647|382972|P1|Overall Study|Adverse Event|11
116850|NCT00439647|382971|P2|Overall Study|Death|18
116851|NCT00439647|382972|P1|Overall Study|Death|15
116852|NCT00439647|382971|P2|Overall Study|Withdrawal by Subject|22
116853|NCT00439647|382972|P1|Overall Study|Withdrawal by Subject|25
116854|NCT00439725|383006|P2|Observational Period|Participant convenience|0
116855|NCT00439725|383007|P1|Observational Period|Participant convenience|1
116856|NCT00439725|383006|P2|Observational Period|Technical problems|0
116857|NCT00439725|383007|P1|Observational Period|Technical problems|1
116858|NCT00439725|383006|P2|Observational Period|Clinical endpoint reached|1
116859|NCT00439725|383007|P1|Observational Period|Clinical endpoint reached|3
116860|NCT00439725|383006|P2|Observational Period|Study termination by sponsor|1
116861|NCT00439725|383007|P1|Observational Period|Study termination by sponsor|1
116862|NCT00439725|383006|P2|Observational Period|Death|2
116863|NCT00439725|383007|P1|Observational Period|Death|0
116864|NCT00439725|383006|P2|Observational Period|Lost to Follow-up|1
116865|NCT00439725|383007|P1|Observational Period|Lost to Follow-up|0
116866|NCT00439725|383006|P2|Observational Period|Withdrawal by Subject|2
116867|NCT00439725|383007|P1|Observational Period|Withdrawal by Subject|2
116868|NCT00439725|383006|P2|Treatment Period|Participant did not receive treatment|4
116869|NCT00439725|383007|P1|Treatment Period|Participant did not receive treatment|4
116870|NCT00439725|383006|P2|Treatment Period|Death|1
116871|NCT00439725|383007|P1|Treatment Period|Death|1
116872|NCT00439725|383006|P2|Treatment Period|Protocol driven decision point|1
116873|NCT00439725|383007|P1|Treatment Period|Protocol driven decision point|1
116874|NCT00439725|383006|P2|Treatment Period|Participant convenience|0
116875|NCT00439725|383007|P1|Treatment Period|Participant convenience|1
116876|NCT00439725|383006|P2|Treatment Period|Lost to Follow-up|1
116877|NCT00439725|383007|P1|Treatment Period|Lost to Follow-up|1
116878|NCT00439725|383006|P2|Treatment Period|Technical problems|0
116879|NCT00439725|383007|P1|Treatment Period|Technical problems|1
116880|NCT00439725|383006|P2|Treatment Period|Clinical endpoint reached|50
116881|NCT00439725|383007|P1|Treatment Period|Clinical endpoint reached|6
116882|NCT00439725|383006|P2|Treatment Period|Protocol Violation|1
116883|NCT00439725|383007|P1|Treatment Period|Protocol Violation|2
116884|NCT00439725|383006|P2|Treatment Period|Physician Decision|1
116885|NCT00439725|383007|P1|Treatment Period|Physician Decision|1
116886|NCT00439725|383006|P2|Treatment Period|Adverse Event|18
116887|NCT00439725|383007|P1|Treatment Period|Adverse Event|39
116888|NCT00439725|383006|P2|Treatment Period|Site closed by investigator|2
116889|NCT00439725|383007|P1|Treatment Period|Site closed by investigator|1
116890|NCT00439725|383006|P2|Treatment Period|Study terminated by sponsor|148
116891|NCT00439725|383007|P1|Treatment Period|Study terminated by sponsor|156
116892|NCT00439725|383006|P2|Treatment Period|Withdrawal by Subject|19
116893|NCT00439725|383007|P1|Treatment Period|Withdrawal by Subject|22
116894|NCT00439738|383053|P2|Overall Study|Abnormal Lab Values|0
116895|NCT00439738|383054|P1|Overall Study|Abnormal Lab Values|1
116896|NCT00439738|383053|P2|Overall Study|Lack of Efficacy|2
116897|NCT00439738|383054|P1|Overall Study|Lack of Efficacy|2
116898|NCT00439738|383053|P2|Overall Study|Protocol Violation|3
116899|NCT00439738|383054|P1|Overall Study|Protocol Violation|6
116900|NCT00439738|383053|P2|Overall Study|Lost to Follow-up|6
116901|NCT00439738|383054|P1|Overall Study|Lost to Follow-up|5
116902|NCT00439738|383053|P2|Overall Study|Adverse Event|4
116903|NCT00439738|383054|P1|Overall Study|Adverse Event|6
116904|NCT00439738|383053|P2|Overall Study|Withdrawal by Subject|13
116905|NCT00439738|383054|P1|Overall Study|Withdrawal by Subject|16
116906|NCT00439777|383072|P2|Observational Period|Technical problems|1
116907|NCT00439777|383073|P1|Observational Period|Technical problems|0
116908|NCT00439777|383072|P2|Observational Period|Lack of Efficacy|0
116909|NCT00439777|383073|P1|Observational Period|Lack of Efficacy|1
116910|NCT00439777|383072|P2|Observational Period|Protocol driven decision point|1
116911|NCT00439777|383073|P1|Observational Period|Protocol driven decision point|0
116912|NCT00439777|383072|P2|Observational Period|Study terminated by sponsor|1
116913|NCT00439777|383073|P1|Observational Period|Study terminated by sponsor|3
116914|NCT00439777|383072|P2|Observational Period|Death|20
116915|NCT00439777|383073|P1|Observational Period|Death|27
116916|NCT00439777|383072|P2|Observational Period|Lost to Follow-up|11
116917|NCT00439777|383073|P1|Observational Period|Lost to Follow-up|1
116918|NCT00439777|383072|P2|Observational Period|Withdrawal by Subject|5
116919|NCT00439777|383073|P1|Observational Period|Withdrawal by Subject|9
116920|NCT00439777|383072|P2|Observational Period|Protocol Violation|2
116921|NCT00439777|383073|P1|Observational Period|Protocol Violation|0
116922|NCT00439777|383072|P2|Treatment Period|Participant convenience|8
116923|NCT00439777|383073|P1|Treatment Period|Participant convenience|12
116924|NCT00439777|383072|P2|Treatment Period|Technical problems|1
116925|NCT00439777|383073|P1|Treatment Period|Technical problems|3
116926|NCT00439777|383072|P2|Treatment Period|Clinical endpoint reached|13
116927|NCT00439777|383073|P1|Treatment Period|Clinical endpoint reached|26
116928|NCT00439777|383072|P2|Treatment Period|Physician Decision|18
116929|NCT00439777|383073|P1|Treatment Period|Physician Decision|7
116930|NCT00439777|383072|P2|Treatment Period|Protocol driven decision point|3
116931|NCT00439777|383073|P1|Treatment Period|Protocol driven decision point|1
116932|NCT00439777|383072|P2|Treatment Period|Lost to Follow-up|10
116933|NCT00439777|383073|P1|Treatment Period|Lost to Follow-up|8
116934|NCT00439777|383072|P2|Treatment Period|Lack of Efficacy|4
116935|NCT00439777|383073|P1|Treatment Period|Lack of Efficacy|1
116936|NCT00439777|383072|P2|Treatment Period|Withdrawal by Subject|118
116937|NCT00439777|383073|P1|Treatment Period|Withdrawal by Subject|66
116938|NCT00439777|383072|P2|Treatment Period|Protocol Violation|30
116939|NCT00439777|383073|P1|Treatment Period|Protocol Violation|23
116940|NCT00439777|383072|P2|Treatment Period|Adverse Event|92
116941|NCT00439777|383073|P1|Treatment Period|Adverse Event|111
116942|NCT00439777|383072|P2|Treatment Period|Did not take study treatment|8
116943|NCT00439777|383073|P1|Treatment Period|Did not take study treatment|7
116944|NCT00439777|383072|P2|Treatment Period|Site closed by investigator|1
116945|NCT00439777|383073|P1|Treatment Period|Site closed by investigator|0
116946|NCT00439777|383072|P2|Treatment Period|Study terminated by sponsor|132
116947|NCT00439777|383073|P1|Treatment Period|Study terminated by sponsor|125
116948|NCT00439777|383072|P2|Treatment Period|Death|21
116949|NCT00439777|383073|P1|Treatment Period|Death|29
116950|NCT00440011|383128|P2|Overall Study|Withdrawal by Subject|0
116951|NCT00440011|383129|P1|Overall Study|Withdrawal by Subject|1
116952|NCT00440011|383128|P2|Overall Study|Protocol Violation|1
116953|NCT00440011|383129|P1|Overall Study|Protocol Violation|1
116954|NCT00440011|383128|P2|Overall Study|Lost to Follow-up|2
116955|NCT00440011|383129|P1|Overall Study|Lost to Follow-up|0
116956|NCT00440011|383128|P2|Overall Study|Adverse Event|0
116957|NCT00440011|383129|P1|Overall Study|Adverse Event|2
116958|NCT00440115|383155|P3|Overall Study|Incarceration|1
116959|NCT00440115|383156|P2|Overall Study|Incarceration|2
116960|NCT00440115|383157|P1|Overall Study|Incarceration|0
116961|NCT00440115|383155|P3|Overall Study|Death|5
116962|NCT00440115|383156|P2|Overall Study|Death|9
116963|NCT00440115|383157|P1|Overall Study|Death|7
116964|NCT00440193|383182|P2|Observational Period|Participant convenience|0
116965|NCT00440193|383183|P1|Observational Period|Participant convenience|2
116966|NCT00440193|383182|P2|Observational Period|Clinical endpoint reached|0
116967|NCT00440193|383183|P1|Observational Period|Clinical endpoint reached|1
116968|NCT00440193|383182|P2|Observational Period|Physician Decision|0
116969|NCT00440193|383183|P1|Observational Period|Physician Decision|1
116970|NCT00440193|383182|P2|Observational Period|Withdrawal by Subject|8
116971|NCT00440193|383183|P1|Observational Period|Withdrawal by Subject|11
116972|NCT00440193|383182|P2|Observational Period|Protocol Violation|0
116973|NCT00440193|383183|P1|Observational Period|Protocol Violation|1
116974|NCT00440193|383182|P2|Observational Period|Lost to Follow-up|8
116975|NCT00440193|383183|P1|Observational Period|Lost to Follow-up|12
116976|NCT00440193|383182|P2|Observational Period|Death|20
116977|NCT00440193|383183|P1|Observational Period|Death|15
116978|NCT00440193|383182|P2|Observational Period|Adverse Event|2
116979|NCT00440193|383183|P1|Observational Period|Adverse Event|2
116980|NCT00440193|383182|P2|Treatment Period|Site closed by investigator|2
116981|NCT00440193|383183|P1|Treatment Period|Site closed by investigator|0
116982|NCT00440193|383182|P2|Treatment Period|Participant did not receive treatment|13
116983|NCT00440193|383183|P1|Treatment Period|Participant did not receive treatment|7
116984|NCT00440193|383182|P2|Treatment Period|Participant convenience|2
116985|NCT00440193|383183|P1|Treatment Period|Participant convenience|5
116986|NCT00440193|383182|P2|Treatment Period|Technical problems|1
116987|NCT00440193|383183|P1|Treatment Period|Technical problems|1
116988|NCT00440193|383182|P2|Treatment Period|Switch to commercial drug|2
116989|NCT00440193|383183|P1|Treatment Period|Switch to commercial drug|0
116990|NCT00440193|383182|P2|Treatment Period|Protocol driven decision point|2
116991|NCT00440193|383183|P1|Treatment Period|Protocol driven decision point|2
116992|NCT00440193|383182|P2|Treatment Period|Study terminated by sponsor|94
116993|NCT00440193|383183|P1|Treatment Period|Study terminated by sponsor|102
116994|NCT00440193|383182|P2|Treatment Period|Clinical endpoint reached|25
116995|NCT00440193|383183|P1|Treatment Period|Clinical endpoint reached|28
116996|NCT00440193|383182|P2|Treatment Period|Withdrawal by Subject|77
116997|NCT00440193|383183|P1|Treatment Period|Withdrawal by Subject|36
116998|NCT00440193|383182|P2|Treatment Period|Protocol Violation|19
116999|NCT00440193|383183|P1|Treatment Period|Protocol Violation|16
117000|NCT00440193|383182|P2|Treatment Period|Physician Decision|6
117001|NCT00440193|383183|P1|Treatment Period|Physician Decision|3
117002|NCT00440193|383182|P2|Treatment Period|Lost to Follow-up|18
117003|NCT00440193|383183|P1|Treatment Period|Lost to Follow-up|12
117004|NCT00440193|383182|P2|Treatment Period|Lack of Efficacy|1
117005|NCT00440193|383183|P1|Treatment Period|Lack of Efficacy|0
117006|NCT00440193|383182|P2|Treatment Period|Death|22
117007|NCT00440193|383183|P1|Treatment Period|Death|19
117008|NCT00440193|383182|P2|Treatment Period|Adverse Event|67
117009|NCT00440193|383183|P1|Treatment Period|Adverse Event|74
117010|NCT00440232|383219|P2|Overall Study|Onset of headache within 4 hours of fast|2
117011|NCT00440232|383220|P1|Overall Study|Onset of headache within 4 hours of fast|2
117012|NCT00440232|383219|P2|Overall Study|Unable to treat within allowed time|1
117013|NCT00440232|383220|P1|Overall Study|Unable to treat within allowed time|0
117014|NCT00440232|383219|P2|Overall Study|Lost to Follow-up|1
117015|NCT00440232|383220|P1|Overall Study|Lost to Follow-up|1
117016|NCT00440271|383230|P2|Overall Study|Other|0
117017|NCT00440271|383231|P1|Overall Study|Other|2
117018|NCT00440271|383230|P2|Overall Study|Due to closure of trial|10
117019|NCT00440271|383231|P1|Overall Study|Due to closure of trial|8
117020|NCT00440271|383230|P2|Overall Study|Lack of Efficacy|1
117021|NCT00440271|383231|P1|Overall Study|Lack of Efficacy|0
117022|NCT00440271|383230|P2|Overall Study|Withdrawal by Subject|2
117023|NCT00440271|383231|P1|Overall Study|Withdrawal by Subject|0
117024|NCT00440271|383230|P2|Overall Study|Lost to Follow-up|0
117025|NCT00440271|383231|P1|Overall Study|Lost to Follow-up|1
117026|NCT00440271|383230|P2|Overall Study|Adverse Event|1
117027|NCT00440271|383231|P1|Overall Study|Adverse Event|0
117028|NCT00440271|383230|P2|Overall Study|Protocol Violation|1
117029|NCT00440271|383231|P1|Overall Study|Protocol Violation|1
117030|NCT00440297|383265|P2|Overall Study|Randomized by mistake|0
117031|NCT00440297|383266|P1|Overall Study|Randomized by mistake|1
117032|NCT00440297|383265|P2|Overall Study|Withdrawal by Subject|6
117033|NCT00440297|383266|P1|Overall Study|Withdrawal by Subject|1
117034|NCT00440297|383265|P2|Overall Study|Protocol Violation|7
117035|NCT00440297|383266|P1|Overall Study|Protocol Violation|11
117036|NCT00440297|383265|P2|Overall Study|Physician Decision|0
117037|NCT00440297|383266|P1|Overall Study|Physician Decision|1
117038|NCT00440297|383265|P2|Overall Study|Lost to Follow-up|0
117039|NCT00440297|383266|P1|Overall Study|Lost to Follow-up|1
117040|NCT00440297|383265|P2|Overall Study|Adverse Event|5
117041|NCT00440297|383266|P1|Overall Study|Adverse Event|8
117042|NCT00440310|383282|P2|Overall Study|Status Unknown|3
117043|NCT00440310|383283|P1|Overall Study|Status Unknown|1
117044|NCT00440310|383282|P2|Overall Study|Other|0
117045|NCT00440310|383283|P1|Overall Study|Other|1
117046|NCT00440310|383282|P2|Overall Study|No Reply at EOS|7
117047|NCT00440310|383283|P1|Overall Study|No Reply at EOS|7
117048|NCT00440310|383282|P2|Overall Study|Withdrawal by Subject|14
117049|NCT00440310|383283|P1|Overall Study|Withdrawal by Subject|15
117050|NCT00440310|383282|P2|Overall Study|Protocol Violation|1
117051|NCT00440310|383283|P1|Overall Study|Protocol Violation|0
117052|NCT00440310|383282|P2|Overall Study|Lost to Follow-up|5
117053|NCT00440310|383283|P1|Overall Study|Lost to Follow-up|4
117054|NCT00440401|383291|P2|Overall Study|Not specified|5
117055|NCT00440401|383292|P1|Overall Study|Not specified|2
117056|NCT00440401|383291|P2|Overall Study|Adverse Event|1
117057|NCT00440401|383292|P1|Overall Study|Adverse Event|2
117058|NCT00440466|383303|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
117059|NCT00440466|383304|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
117060|NCT00440466|383305|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
117061|NCT00440466|383303|P3|Overall Study|Began Dialysis|1
117062|NCT00440466|383304|P2|Overall Study|Began Dialysis|0
117063|NCT00440466|383305|P1|Overall Study|Began Dialysis|0
117064|NCT00440466|383303|P3|Overall Study|Withdrawal by Subject|9
117065|NCT00440466|383304|P2|Overall Study|Withdrawal by Subject|5
117066|NCT00440466|383305|P1|Overall Study|Withdrawal by Subject|2
117067|NCT00440466|383303|P3|Overall Study|Protocol Violation|4
117068|NCT00440466|383304|P2|Overall Study|Protocol Violation|0
117069|NCT00440466|383305|P1|Overall Study|Protocol Violation|2
117070|NCT00440466|383303|P3|Overall Study|Physician Decision|1
117071|NCT00440466|383304|P2|Overall Study|Physician Decision|0
117072|NCT00440466|383305|P1|Overall Study|Physician Decision|2
117073|NCT00440466|383303|P3|Overall Study|Lost to Follow-up|2
117074|NCT00440466|383304|P2|Overall Study|Lost to Follow-up|0
117075|NCT00440466|383305|P1|Overall Study|Lost to Follow-up|1
117076|NCT00440466|383303|P3|Overall Study|Adverse Event|11
117077|NCT00440466|383304|P2|Overall Study|Adverse Event|4
117078|NCT00440466|383305|P1|Overall Study|Adverse Event|3
117079|NCT00440466|383303|P3|Overall Study|Death|9
117080|NCT00440466|383304|P2|Overall Study|Death|2
117081|NCT00440466|383305|P1|Overall Study|Death|3
117082|NCT00440518|383362|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
117083|NCT00440518|383363|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
117084|NCT00440518|383364|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
117085|NCT00440518|383362|P3|Maintenance and Safety Follow-up Periods|Other|2
117086|NCT00440518|383363|P2|Maintenance and Safety Follow-up Periods|Other|0
117087|NCT00440518|383364|P1|Maintenance and Safety Follow-up Periods|Other|0
117088|NCT00440518|383362|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
117089|NCT00440518|383363|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
117090|NCT00440518|383364|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
117091|NCT00440518|383362|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
117092|NCT00440518|383363|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
117093|NCT00440518|383364|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
117094|NCT00440518|383362|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
117095|NCT00440518|383363|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
117096|NCT00440518|383364|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
117097|NCT00440518|383362|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
117098|NCT00440518|383363|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
117099|NCT00440518|383364|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
117100|NCT00440518|383362|P3|Randomized /Titration Period|Adverse Event|0
117101|NCT00440518|383363|P2|Randomized /Titration Period|Adverse Event|3
117102|NCT00440518|383364|P1|Randomized /Titration Period|Adverse Event|2
117103|NCT00440518|383362|P3|Randomized /Titration Period|Lost to Follow-up|1
117104|NCT00440518|383363|P2|Randomized /Titration Period|Lost to Follow-up|2
117105|NCT00440518|383364|P1|Randomized /Titration Period|Lost to Follow-up|2
117106|NCT00440518|383362|P3|Randomized /Titration Period|Other|0
117107|NCT00440518|383363|P2|Randomized /Titration Period|Other|0
117108|NCT00440518|383364|P1|Randomized /Titration Period|Other|1
117109|NCT00440518|383362|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
117110|NCT00440518|383363|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
117111|NCT00440518|383364|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
117112|NCT00440518|383362|P3|Randomized /Titration Period|Protocol Deviation|0
117113|NCT00440518|383363|P2|Randomized /Titration Period|Protocol Deviation|0
117114|NCT00440518|383364|P1|Randomized /Titration Period|Protocol Deviation|1
117115|NCT00440518|383362|P3|Randomized /Titration Period|Subject Withdrew Consent|0
117116|NCT00440518|383363|P2|Randomized /Titration Period|Subject Withdrew Consent|1
117117|NCT00440518|383364|P1|Randomized /Titration Period|Subject Withdrew Consent|4
117118|NCT00440518|383362|P3|Randomized /Titration Period|Lack of Efficacy|1
117119|NCT00440518|383363|P2|Randomized /Titration Period|Lack of Efficacy|0
117120|NCT00440518|383364|P1|Randomized /Titration Period|Lack of Efficacy|1
117121|NCT00440531|383387|P3|Overall Study|see pre-assignment details|0
117122|NCT00440531|383388|P2|Overall Study|see pre-assignment details|0
117123|NCT00440531|383389|P1|Overall Study|see pre-assignment details|2
117124|NCT00440531|383387|P3|Overall Study|Lost to Follow-up|5
117125|NCT00440531|383388|P2|Overall Study|Lost to Follow-up|3
117126|NCT00440531|383389|P1|Overall Study|Lost to Follow-up|4
117127|NCT00440531|383387|P3|Overall Study|Protocol Violation|0
117128|NCT00440531|383388|P2|Overall Study|Protocol Violation|2
117129|NCT00440531|383389|P1|Overall Study|Protocol Violation|1
117130|NCT00440531|383387|P3|Overall Study|Withdrawal by Subject|0
117131|NCT00440531|383388|P2|Overall Study|Withdrawal by Subject|0
117132|NCT00440531|383389|P1|Overall Study|Withdrawal by Subject|2
117133|NCT00440531|383387|P3|Overall Study|Adverse Event|2
117134|NCT00440531|383388|P2|Overall Study|Adverse Event|0
117135|NCT00440531|383389|P1|Overall Study|Adverse Event|1
117136|NCT00440557|383406|P3|Overall Study|Patient had surgery|0
117137|NCT00440557|383407|P2|Overall Study|Patient had surgery|0
117138|NCT00440557|383408|P1|Overall Study|Patient had surgery|1
117139|NCT00440557|383406|P3|Overall Study|Patient transferred to nursing home|0
117140|NCT00440557|383407|P2|Overall Study|Patient transferred to nursing home|1
117141|NCT00440557|383408|P1|Overall Study|Patient transferred to nursing home|0
117142|NCT00440557|383406|P3|Overall Study|Principal Investigator's office closed|4
117143|NCT00440557|383407|P2|Overall Study|Principal Investigator's office closed|6
117144|NCT00440557|383408|P1|Overall Study|Principal Investigator's office closed|3
117145|NCT00440557|383406|P3|Overall Study|Patient moved|1
117146|NCT00440557|383407|P2|Overall Study|Patient moved|2
117147|NCT00440557|383408|P1|Overall Study|Patient moved|1
117148|NCT00440557|383406|P3|Overall Study|Principal Investigator decision|1
117149|NCT00440557|383407|P2|Overall Study|Principal Investigator decision|3
117150|NCT00440557|383408|P1|Overall Study|Principal Investigator decision|0
117151|NCT00440557|383406|P3|Overall Study|Began Dialysis|4
117152|NCT00440557|383407|P2|Overall Study|Began Dialysis|1
117153|NCT00440557|383408|P1|Overall Study|Began Dialysis|4
117154|NCT00440557|383406|P3|Overall Study|Death|3
117155|NCT00440557|383407|P2|Overall Study|Death|6
117156|NCT00440557|383408|P1|Overall Study|Death|2
117157|NCT00440557|383406|P3|Overall Study|Adverse Event|5
117158|NCT00440557|383407|P2|Overall Study|Adverse Event|3
117159|NCT00440557|383408|P1|Overall Study|Adverse Event|3
117160|NCT00440557|383406|P3|Overall Study|Lost to Follow-up|6
117161|NCT00440557|383407|P2|Overall Study|Lost to Follow-up|2
117162|NCT00440557|383408|P1|Overall Study|Lost to Follow-up|1
117163|NCT00440557|383406|P3|Overall Study|Withdrawal by Subject|11
117164|NCT00440557|383407|P2|Overall Study|Withdrawal by Subject|5
117165|NCT00440557|383408|P1|Overall Study|Withdrawal by Subject|10
117166|NCT00440700|383440|P3|Overall Study|Withdrawal by Subject|4
117167|NCT00440700|383441|P2|Overall Study|Withdrawal by Subject|8
117168|NCT00440700|383442|P1|Overall Study|Withdrawal by Subject|8
117169|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
117170|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
117171|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
117172|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
117173|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
117174|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Physician Decision|1
117175|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Physician Decision|0
117176|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Physician Decision|0
117177|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Physician Decision|0
117178|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Physician Decision|0
117179|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Other|0
117180|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Other|1
117181|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Other|0
117182|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Other|0
117183|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Other|0
117184|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
117185|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
117186|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
117187|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
117188|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
117189|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Sponsor Request|1
117190|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Sponsor Request|1
117191|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Sponsor Request|0
117192|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Sponsor Request|0
117193|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Sponsor Request|0
117194|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Participant Moved|1
117195|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Participant Moved|1
117196|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Participant Moved|0
117197|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Participant Moved|0
117198|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Participant Moved|0
117199|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Pregnancy|0
117200|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Pregnancy|3
117201|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Pregnancy|0
117202|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Pregnancy|0
117203|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Pregnancy|0
117204|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
117205|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
117206|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
117207|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
117208|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
117209|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Protocol Violation|0
117210|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Protocol Violation|1
117211|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Protocol Violation|0
117212|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Protocol Violation|0
117213|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Protocol Violation|0
117214|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
117215|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
117216|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
117217|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
117218|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
117219|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Non-compliance|1
117220|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Non-compliance|1
117221|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Non-compliance|0
117222|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Non-compliance|0
117223|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Non-compliance|0
117224|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
117225|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
117226|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
117227|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
117228|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
117229|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
117230|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
117231|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
117232|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
117233|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
117234|NCT00440947|383483|P5|Optional 60-Week Extension Phase|Adverse Event|3
117235|NCT00440947|383484|P4|Optional 60-Week Extension Phase|Adverse Event|1
117236|NCT00440947|383485|P3|Optional 60-Week Extension Phase|Adverse Event|0
117237|NCT00440947|383486|P2|Optional 60-Week Extension Phase|Adverse Event|0
117238|NCT00440947|383487|P1|Optional 60-Week Extension Phase|Adverse Event|0
117239|NCT00440947|383483|P5|48-Week Randomization Phase|Physician Decision|0
117240|NCT00440947|383484|P4|48-Week Randomization Phase|Physician Decision|0
117241|NCT00440947|383485|P3|48-Week Randomization Phase|Physician Decision|0
117242|NCT00440947|383486|P2|48-Week Randomization Phase|Physician Decision|2
117243|NCT00440947|383487|P1|48-Week Randomization Phase|Physician Decision|0
117244|NCT00440947|383483|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
117245|NCT00440947|383484|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
117246|NCT00440947|383485|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
117247|NCT00440947|383486|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
117248|NCT00440947|383487|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
117249|NCT00440947|383483|P5|48-Week Randomization Phase|Incarceration|0
117250|NCT00440947|383484|P4|48-Week Randomization Phase|Incarceration|0
117251|NCT00440947|383485|P3|48-Week Randomization Phase|Incarceration|0
117252|NCT00440947|383486|P2|48-Week Randomization Phase|Incarceration|3
117253|NCT00440947|383487|P1|48-Week Randomization Phase|Incarceration|0
117254|NCT00440947|383483|P5|48-Week Randomization Phase|Pregnancy|0
117255|NCT00440947|383484|P4|48-Week Randomization Phase|Pregnancy|0
117256|NCT00440947|383485|P3|48-Week Randomization Phase|Pregnancy|1
117257|NCT00440947|383486|P2|48-Week Randomization Phase|Pregnancy|0
117258|NCT00440947|383487|P1|48-Week Randomization Phase|Pregnancy|0
117259|NCT00440947|383483|P5|48-Week Randomization Phase|Withdrawal by Subject|0
117260|NCT00440947|383484|P4|48-Week Randomization Phase|Withdrawal by Subject|0
117261|NCT00440947|383485|P3|48-Week Randomization Phase|Withdrawal by Subject|4
117262|NCT00440947|383486|P2|48-Week Randomization Phase|Withdrawal by Subject|2
117263|NCT00440947|383487|P1|48-Week Randomization Phase|Withdrawal by Subject|0
117264|NCT00440947|383483|P5|48-Week Randomization Phase|Protocol Violation|0
117265|NCT00440947|383484|P4|48-Week Randomization Phase|Protocol Violation|0
117266|NCT00440947|383485|P3|48-Week Randomization Phase|Protocol Violation|1
117267|NCT00440947|383486|P2|48-Week Randomization Phase|Protocol Violation|0
117268|NCT00440947|383487|P1|48-Week Randomization Phase|Protocol Violation|0
117269|NCT00440947|383483|P5|48-Week Randomization Phase|Lost to Follow-up|0
117270|NCT00440947|383484|P4|48-Week Randomization Phase|Lost to Follow-up|0
117271|NCT00440947|383485|P3|48-Week Randomization Phase|Lost to Follow-up|8
117272|NCT00440947|383486|P2|48-Week Randomization Phase|Lost to Follow-up|2
117273|NCT00440947|383487|P1|48-Week Randomization Phase|Lost to Follow-up|0
117274|NCT00440947|383483|P5|48-Week Randomization Phase|Non-compliance|0
117275|NCT00440947|383484|P4|48-Week Randomization Phase|Non-compliance|0
117276|NCT00440947|383485|P3|48-Week Randomization Phase|Non-compliance|4
117277|NCT00440947|383486|P2|48-Week Randomization Phase|Non-compliance|3
117278|NCT00440947|383487|P1|48-Week Randomization Phase|Non-compliance|0
117279|NCT00440947|383483|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
117280|NCT00440947|383484|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
117281|NCT00440947|383485|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
117282|NCT00440947|383486|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
117283|NCT00440947|383487|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
117284|NCT00440947|383483|P5|48-Week Randomization Phase|Adverse Event|0
117285|NCT00440947|383484|P4|48-Week Randomization Phase|Adverse Event|0
117286|NCT00440947|383485|P3|48-Week Randomization Phase|Adverse Event|5
117287|NCT00440947|383486|P2|48-Week Randomization Phase|Adverse Event|2
117288|NCT00440947|383487|P1|48-Week Randomization Phase|Adverse Event|0
117289|NCT00440947|383483|P5|36-Week Induction Phase|Pregnancy|0
117290|NCT00440947|383484|P4|36-Week Induction Phase|Pregnancy|0
117291|NCT00440947|383485|P3|36-Week Induction Phase|Pregnancy|0
117292|NCT00440947|383486|P2|36-Week Induction Phase|Pregnancy|0
117293|NCT00440947|383487|P1|36-Week Induction Phase|Pregnancy|1
117294|NCT00440947|383483|P5|36-Week Induction Phase|Incarceration|0
117295|NCT00440947|383484|P4|36-Week Induction Phase|Incarceration|0
117296|NCT00440947|383485|P3|36-Week Induction Phase|Incarceration|0
117297|NCT00440947|383486|P2|36-Week Induction Phase|Incarceration|0
117298|NCT00440947|383487|P1|36-Week Induction Phase|Incarceration|3
117299|NCT00440947|383483|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
117300|NCT00440947|383484|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
117301|NCT00440947|383485|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
117302|NCT00440947|383486|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
117303|NCT00440947|383487|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
117304|NCT00440947|383483|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
117305|NCT00440947|383484|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
117306|NCT00440947|383485|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
117307|NCT00440947|383486|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
117308|NCT00440947|383487|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
117309|NCT00440947|383483|P5|36-Week Induction Phase|Took Exclusionary Medications|0
117310|NCT00440947|383484|P4|36-Week Induction Phase|Took Exclusionary Medications|0
117311|NCT00440947|383485|P3|36-Week Induction Phase|Took Exclusionary Medications|0
117312|NCT00440947|383486|P2|36-Week Induction Phase|Took Exclusionary Medications|0
117313|NCT00440947|383487|P1|36-Week Induction Phase|Took Exclusionary Medications|1
117314|NCT00440947|383483|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
117315|NCT00440947|383484|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
117316|NCT00440947|383485|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
117317|NCT00440947|383486|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
117318|NCT00440947|383487|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
117319|NCT00440947|383483|P5|36-Week Induction Phase|Withdrawal by Subject|0
117320|NCT00440947|383484|P4|36-Week Induction Phase|Withdrawal by Subject|0
117321|NCT00440947|383485|P3|36-Week Induction Phase|Withdrawal by Subject|0
117322|NCT00440947|383486|P2|36-Week Induction Phase|Withdrawal by Subject|0
117323|NCT00440947|383487|P1|36-Week Induction Phase|Withdrawal by Subject|7
117324|NCT00440947|383483|P5|36-Week Induction Phase|Lost to Follow-up|0
117325|NCT00440947|383484|P4|36-Week Induction Phase|Lost to Follow-up|0
117326|NCT00440947|383485|P3|36-Week Induction Phase|Lost to Follow-up|0
117327|NCT00440947|383486|P2|36-Week Induction Phase|Lost to Follow-up|0
117328|NCT00440947|383487|P1|36-Week Induction Phase|Lost to Follow-up|16
117329|NCT00440947|383483|P5|36-Week Induction Phase|Non-compliance|0
117330|NCT00440947|383484|P4|36-Week Induction Phase|Non-compliance|0
117331|NCT00440947|383485|P3|36-Week Induction Phase|Non-compliance|0
117332|NCT00440947|383486|P2|36-Week Induction Phase|Non-compliance|0
117333|NCT00440947|383487|P1|36-Week Induction Phase|Non-compliance|10
117334|NCT00440947|383483|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
117335|NCT00440947|383484|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
117336|NCT00440947|383485|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
117337|NCT00440947|383486|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
117338|NCT00440947|383487|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
117339|NCT00440947|383483|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
117340|NCT00440947|383484|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
117341|NCT00440947|383485|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
117342|NCT00440947|383486|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
117343|NCT00440947|383487|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
117344|NCT00440947|383483|P5|36-Week Induction Phase|Adverse Event|0
117345|NCT00440947|383484|P4|36-Week Induction Phase|Adverse Event|0
117346|NCT00440947|383485|P3|36-Week Induction Phase|Adverse Event|0
117347|NCT00440947|383486|P2|36-Week Induction Phase|Adverse Event|0
117348|NCT00440947|383487|P1|36-Week Induction Phase|Adverse Event|16
117349|NCT00441012|383540|P2|Overall Study|Subject Randomized but Not Vaccinated|0
117350|NCT00441012|383541|P1|Overall Study|Subject Randomized but Not Vaccinated|1
117351|NCT00441012|383540|P2|Overall Study|Withdrawal by Subject|0
117352|NCT00441012|383541|P1|Overall Study|Withdrawal by Subject|4
117353|NCT00441012|383540|P2|Overall Study|Protocol Violation|9
117354|NCT00441012|383541|P1|Overall Study|Protocol Violation|10
117355|NCT00441012|383540|P2|Overall Study|Lost to Follow-up|3
117356|NCT00441012|383541|P1|Overall Study|Lost to Follow-up|3
117357|NCT00441012|383540|P2|Overall Study|Adverse Event|1
117358|NCT00441012|383541|P1|Overall Study|Adverse Event|0
117359|NCT00441064|383557|P2|Overall Study|Patient withdrew consent|2
117360|NCT00441064|383558|P1|Overall Study|Patient withdrew consent|5
117361|NCT00441064|383557|P2|Overall Study|Protocol Deviation|2
117362|NCT00441064|383558|P1|Overall Study|Protocol Deviation|3
117363|NCT00441064|383557|P2|Overall Study|Unsatisfactory therapeutic effect|0
117364|NCT00441064|383558|P1|Overall Study|Unsatisfactory therapeutic effect|1
117365|NCT00441064|383557|P2|Overall Study|Abnormal test procedure results|1
117366|NCT00441064|383558|P1|Overall Study|Abnormal test procedure results|0
117367|NCT00441064|383557|P2|Overall Study|Abnormal laboratory values|2
117368|NCT00441064|383558|P1|Overall Study|Abnormal laboratory values|0
117369|NCT00441064|383557|P2|Overall Study|Adverse Event|0
117370|NCT00441064|383558|P1|Overall Study|Adverse Event|1
117371|NCT00441103|383570|P2|Overall Study|Participant decided to stop|1
117372|NCT00441103|383571|P1|Overall Study|Participant decided to stop|0
117373|NCT00441103|383570|P2|Overall Study|Participant's reason|1
117374|NCT00441103|383571|P1|Overall Study|Participant's reason|0
117375|NCT00441103|383570|P2|Overall Study|Participant decided to withdraw|0
117376|NCT00441103|383571|P1|Overall Study|Participant decided to withdraw|1
117377|NCT00441103|383570|P2|Overall Study|Non-compliant|1
117378|NCT00441103|383571|P1|Overall Study|Non-compliant|0
117379|NCT00441103|383570|P2|Overall Study|Inclusion criteria absent|0
117380|NCT00441103|383571|P1|Overall Study|Inclusion criteria absent|1
117381|NCT00441103|383570|P2|Overall Study|Participant refused MRI|0
117382|NCT00441103|383571|P1|Overall Study|Participant refused MRI|1
117383|NCT00441103|383570|P2|Overall Study|Participant unable to use Rebiject II|0
117384|NCT00441103|383571|P1|Overall Study|Participant unable to use Rebiject II|1
117385|NCT00441103|383570|P2|Overall Study|Protocol Violation|0
117386|NCT00441103|383571|P1|Overall Study|Protocol Violation|1
117387|NCT00441103|383570|P2|Overall Study|Lost to Follow-up|0
117388|NCT00441103|383571|P1|Overall Study|Lost to Follow-up|1
117389|NCT00441103|383570|P2|Overall Study|Disease Progression|0
117390|NCT00441103|383571|P1|Overall Study|Disease Progression|2
117391|NCT00441103|383570|P2|Overall Study|Death|0
117392|NCT00441103|383571|P1|Overall Study|Death|1
117393|NCT00441103|383570|P2|Overall Study|Adverse Event|1
117394|NCT00441103|383571|P1|Overall Study|Adverse Event|2
117395|NCT00441116|383584|P2|Overall Study|Did not meet Eligibility Criteria|1
117396|NCT00441116|383585|P1|Overall Study|Did not meet Eligibility Criteria|1
117397|NCT00441116|383584|P2|Overall Study|Withdrawal by Subject|0
117398|NCT00441116|383585|P1|Overall Study|Withdrawal by Subject|1
117399|NCT00441116|383584|P2|Overall Study|Adverse Event|1
117400|NCT00441116|383585|P1|Overall Study|Adverse Event|1
117401|NCT00441142|383655|P4|Overall Study|Death|1
117402|NCT00441142|383656|P3|Overall Study|Death|0
117403|NCT00441142|383657|P2|Overall Study|Death|0
117404|NCT00441142|383658|P1|Overall Study|Death|0
117405|NCT00441142|383655|P4|Overall Study|Physician Decision|1
117406|NCT00441142|383656|P3|Overall Study|Physician Decision|0
117407|NCT00441142|383657|P2|Overall Study|Physician Decision|1
117408|NCT00441142|383658|P1|Overall Study|Physician Decision|0
117409|NCT00441142|383655|P4|Overall Study|Patient still receiving active study tx|2
117410|NCT00441142|383656|P3|Overall Study|Patient still receiving active study tx|0
117411|NCT00441142|383657|P2|Overall Study|Patient still receiving active study tx|0
117412|NCT00441142|383658|P1|Overall Study|Patient still receiving active study tx|1
117413|NCT00441142|383655|P4|Overall Study|Withdrawal by Subject|10
117414|NCT00441142|383656|P3|Overall Study|Withdrawal by Subject|2
117415|NCT00441142|383657|P2|Overall Study|Withdrawal by Subject|0
117416|NCT00441142|383658|P1|Overall Study|Withdrawal by Subject|0
117417|NCT00441142|383655|P4|Overall Study|Lack of Efficacy|32
117418|NCT00441142|383656|P3|Overall Study|Lack of Efficacy|17
117419|NCT00441142|383657|P2|Overall Study|Lack of Efficacy|3
117420|NCT00441142|383658|P1|Overall Study|Lack of Efficacy|3
117421|NCT00441142|383655|P4|Overall Study|Adverse Event|22
117422|NCT00441142|383656|P3|Overall Study|Adverse Event|3
117423|NCT00441142|383657|P2|Overall Study|Adverse Event|3
117424|NCT00441142|383658|P1|Overall Study|Adverse Event|2
117425|NCT00441168|383676|P2|Follow-up Period|Other|3
117426|NCT00441168|383677|P1|Follow-up Period|Other|1
117427|NCT00441168|383676|P2|Follow-up Period|Withdrawal by Subject|0
117428|NCT00441168|383677|P1|Follow-up Period|Withdrawal by Subject|3
117429|NCT00441168|383676|P2|Follow-up Period|Lost to Follow-up|6
117430|NCT00441168|383677|P1|Follow-up Period|Lost to Follow-up|5
117431|NCT00441168|383676|P2|Follow-up Period|Death|0
117432|NCT00441168|383677|P1|Follow-up Period|Death|3
117433|NCT00441168|383676|P2|Treatment Period|refractory disease|0
117434|NCT00441168|383677|P1|Treatment Period|refractory disease|1
117435|NCT00441168|383676|P2|Treatment Period|qualified for stem-cell transplantation|0
117436|NCT00441168|383677|P1|Treatment Period|qualified for stem-cell transplantation|3
117437|NCT00441168|383676|P2|Treatment Period|Withdrawal by Subject|0
117438|NCT00441168|383677|P1|Treatment Period|Withdrawal by Subject|3
117439|NCT00441168|383676|P2|Treatment Period|Lost to Follow-up|1
117440|NCT00441168|383677|P1|Treatment Period|Lost to Follow-up|0
117441|NCT00441168|383676|P2|Treatment Period|Protocol Violation|1
117442|NCT00441168|383677|P1|Treatment Period|Protocol Violation|0
117443|NCT00441168|383676|P2|Treatment Period|Progressive Disease|2
117444|NCT00441168|383677|P1|Treatment Period|Progressive Disease|0
117445|NCT00441168|383676|P2|Treatment Period|Adverse Event|2
117446|NCT00441168|383677|P1|Treatment Period|Adverse Event|1
117447|NCT00441168|383676|P2|Treatment Period|Death|0
117448|NCT00441168|383677|P1|Treatment Period|Death|3
117449|NCT00441272|383708|P2|Overall Study|Study terminated prior to enrollment|25
117450|NCT00441272|383709|P1|Overall Study|Study terminated prior to enrollment|25
117451|NCT00441337|383752|P4|Overall Study|Did not meet inclusion criteria|0
117452|NCT00441337|383753|P3|Overall Study|Did not meet inclusion criteria|1
117453|NCT00441337|383754|P2|Overall Study|Did not meet inclusion criteria|0
117454|NCT00441337|383755|P1|Overall Study|Did not meet inclusion criteria|0
117455|NCT00441337|383752|P4|Overall Study|Sponsor Decision|2
117456|NCT00441337|383753|P3|Overall Study|Sponsor Decision|1
117457|NCT00441337|383754|P2|Overall Study|Sponsor Decision|0
117458|NCT00441337|383755|P1|Overall Study|Sponsor Decision|0
117459|NCT00441337|383752|P4|Overall Study|Lost to Follow-up|1
117460|NCT00441337|383753|P3|Overall Study|Lost to Follow-up|0
117461|NCT00441337|383754|P2|Overall Study|Lost to Follow-up|0
117462|NCT00441337|383755|P1|Overall Study|Lost to Follow-up|0
117463|NCT00441337|383752|P4|Overall Study|Disease Progression|18
117464|NCT00441337|383753|P3|Overall Study|Disease Progression|4
117465|NCT00441337|383754|P2|Overall Study|Disease Progression|6
117466|NCT00441337|383755|P1|Overall Study|Disease Progression|6
117467|NCT00441363|383835|P2|Overall Study|not specified|0
117468|NCT00441363|383836|P1|Overall Study|not specified|2
117469|NCT00441363|383835|P2|Overall Study|Lost to Follow-up|2
117470|NCT00441363|383836|P1|Overall Study|Lost to Follow-up|2
117471|NCT00441363|383835|P2|Overall Study|Physician Decision|7
117472|NCT00441363|383836|P1|Overall Study|Physician Decision|6
117473|NCT00441363|383835|P2|Overall Study|Withdrawal by Subject|4
117474|NCT00441363|383836|P1|Overall Study|Withdrawal by Subject|3
117475|NCT00441363|383835|P2|Overall Study|Adverse Event|2
117476|NCT00441363|383836|P1|Overall Study|Adverse Event|4
117477|NCT00434421|383862|P1|Overall Study|Non-compliance with study treatment|1
117478|NCT00434421|383862|P1|Overall Study|Withdrawal by Subject|1
117479|NCT00434590|383884|P2|Overall Study|Administrative problems|5
117480|NCT00434590|383885|P1|Overall Study|Administrative problems|5
117481|NCT00434642|383893|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
117482|NCT00434642|383894|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
117483|NCT00434642|383893|P2|Open-label Treatment Phase|Adverse Event|5
117484|NCT00434642|383894|P1|Open-label Treatment Phase|Adverse Event|0
117485|NCT00434642|383893|P2|Blinded Treatment Phase|Did not Receive Treatment|1
117486|NCT00434642|383894|P1|Blinded Treatment Phase|Did not Receive Treatment|4
117487|NCT00434642|383893|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
117488|NCT00434642|383894|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
117489|NCT00434642|383893|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
117490|NCT00434642|383894|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
117491|NCT00434642|383893|P2|Blinded Treatment Phase|Physician Decision|27
117492|NCT00434642|383894|P1|Blinded Treatment Phase|Physician Decision|19
117493|NCT00434642|383893|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
117494|NCT00434642|383894|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
117495|NCT00434642|383893|P2|Blinded Treatment Phase|Clinical Disease Progression|5
117496|NCT00434642|383894|P1|Blinded Treatment Phase|Clinical Disease Progression|4
117497|NCT00434642|383893|P2|Blinded Treatment Phase|Adverse Event|58
117498|NCT00434642|383894|P1|Blinded Treatment Phase|Adverse Event|12
117499|NCT00434759|383912|P2|Overall Study|family affairs|0
117500|NCT00434759|383913|P1|Overall Study|family affairs|2
117501|NCT00434759|383912|P2|Overall Study|Withdrawal by Subject|1
117502|NCT00434759|383913|P1|Overall Study|Withdrawal by Subject|17
117503|NCT00434759|383912|P2|Overall Study|Lack of Efficacy|4
117504|NCT00434759|383913|P1|Overall Study|Lack of Efficacy|5
117505|NCT00434876|383929|P2|Overall Study|Lost to Follow-up|1
117506|NCT00434876|383930|P1|Overall Study|Lost to Follow-up|1
117507|NCT00434954|383944|P2|Overall Study|Subject decision|22
117508|NCT00434954|383945|P1|Overall Study|Subject decision|8
117509|NCT00434954|383944|P2|Overall Study|Sponsor decision|0
117510|NCT00434954|383945|P1|Overall Study|Sponsor decision|1
117511|NCT00434954|383944|P2|Overall Study|Protocol Violation|27
117512|NCT00434954|383945|P1|Overall Study|Protocol Violation|36
117513|NCT00434954|383944|P2|Overall Study|Physician Decision|3
117514|NCT00434954|383945|P1|Overall Study|Physician Decision|6
117515|NCT00434954|383944|P2|Overall Study|Lost to Follow-up|1
117516|NCT00434954|383945|P1|Overall Study|Lost to Follow-up|0
117517|NCT00434954|383944|P2|Overall Study|Entry criteria not met|16
117518|NCT00434954|383945|P1|Overall Study|Entry criteria not met|14
117519|NCT00434954|383944|P2|Overall Study|Adverse Event|2
117520|NCT00434954|383945|P1|Overall Study|Adverse Event|17
117521|NCT00434967|383977|P4|Overall Study|Patient Disposition Challenges|3
117522|NCT00434967|383978|P3|Overall Study|Patient Disposition Challenges|0
117523|NCT00434967|383979|P2|Overall Study|Patient Disposition Challenges|0
117524|NCT00434967|383980|P1|Overall Study|Patient Disposition Challenges|2
117525|NCT00434967|383977|P4|Overall Study|Physician Decision|0
117526|NCT00434967|383978|P3|Overall Study|Physician Decision|1
117527|NCT00434967|383979|P2|Overall Study|Physician Decision|1
117528|NCT00434967|383980|P1|Overall Study|Physician Decision|1
117529|NCT00434967|383977|P4|Overall Study|Protocol Violation|1
117530|NCT00434967|383978|P3|Overall Study|Protocol Violation|0
117531|NCT00434967|383979|P2|Overall Study|Protocol Violation|1
117532|NCT00434967|383980|P1|Overall Study|Protocol Violation|0
117533|NCT00434967|383977|P4|Overall Study|Randomized in error|1
117534|NCT00434967|383978|P3|Overall Study|Randomized in error|0
117535|NCT00434967|383979|P2|Overall Study|Randomized in error|0
117536|NCT00434967|383980|P1|Overall Study|Randomized in error|0
117537|NCT00434967|383977|P4|Overall Study|Withdrawal by Subject|6
117538|NCT00434967|383978|P3|Overall Study|Withdrawal by Subject|4
117539|NCT00434967|383979|P2|Overall Study|Withdrawal by Subject|2
117540|NCT00434967|383980|P1|Overall Study|Withdrawal by Subject|2
117541|NCT00434967|383977|P4|Overall Study|Lost to Follow-up|0
117542|NCT00434967|383978|P3|Overall Study|Lost to Follow-up|1
117543|NCT00434967|383979|P2|Overall Study|Lost to Follow-up|0
117544|NCT00434967|383980|P1|Overall Study|Lost to Follow-up|0
117545|NCT00434967|383977|P4|Overall Study|Adverse Event|3
117546|NCT00434967|383978|P3|Overall Study|Adverse Event|3
117547|NCT00434967|383979|P2|Overall Study|Adverse Event|4
117548|NCT00434967|383980|P1|Overall Study|Adverse Event|2
117549|NCT00441441|384000|P2|Overall Study|Not specified|3
117550|NCT00441441|384001|P1|Overall Study|Not specified|3
117551|NCT00441441|384000|P2|Overall Study|Withdrawal by Subject|2
117552|NCT00441441|384001|P1|Overall Study|Withdrawal by Subject|1
117553|NCT00441441|384000|P2|Overall Study|Exacerbation of asthma|2
117554|NCT00441441|384001|P1|Overall Study|Exacerbation of asthma|1
117555|NCT00441441|384000|P2|Overall Study|Protocol Violation|6
117556|NCT00441441|384001|P1|Overall Study|Protocol Violation|4
117557|NCT00441441|384000|P2|Overall Study|Adverse Event|1
117558|NCT00441441|384001|P1|Overall Study|Adverse Event|2
117559|NCT00441467|384059|P1|Overall Study|Progressive disease|9
117560|NCT00441467|384059|P1|Overall Study|Withdrawal by Subject|3
117561|NCT00441467|384059|P1|Overall Study|Adverse Event|6
117562|NCT00441480|384067|P2|Overall Study|Withdrawal by Subject|3
117563|NCT00441480|384068|P1|Overall Study|Withdrawal by Subject|2
117564|NCT00441480|384067|P2|Overall Study|Protocol Violation|1
117565|NCT00441480|384068|P1|Overall Study|Protocol Violation|1
117566|NCT00441545|384100|P2|Second Intervention|Subject moved|1
117567|NCT00441545|384101|P1|Second Intervention|Subject moved|0
117568|NCT00441545|384100|P2|Second Intervention|Subject exceeded safety criteria|0
117569|NCT00441545|384101|P1|Second Intervention|Subject exceeded safety criteria|1
117570|NCT00441545|384100|P2|Second Intervention|Lack of Efficacy|1
117571|NCT00441545|384101|P1|Second Intervention|Lack of Efficacy|0
117572|NCT00441545|384100|P2|Second Intervention|Kidney Transplant|1
117573|NCT00441545|384101|P1|Second Intervention|Kidney Transplant|1
117574|NCT00441545|384100|P2|Second Intervention|Withdrawal by Subject|1
117575|NCT00441545|384101|P1|Second Intervention|Withdrawal by Subject|1
117576|NCT00441545|384100|P2|Second Intervention|Protocol Violation|1
117577|NCT00441545|384101|P1|Second Intervention|Protocol Violation|4
117578|NCT00441545|384100|P2|Second Intervention|Adverse Event|2
117579|NCT00441545|384101|P1|Second Intervention|Adverse Event|5
117580|NCT00441545|384100|P2|First Intervention|Sponsor's request|0
117581|NCT00441545|384101|P1|First Intervention|Sponsor's request|1
117582|NCT00441545|384100|P2|First Intervention|Site error|0
117583|NCT00441545|384101|P1|First Intervention|Site error|1
117584|NCT00441545|384100|P2|First Intervention|Extended hospitalization|0
117585|NCT00441545|384101|P1|First Intervention|Extended hospitalization|1
117586|NCT00441545|384100|P2|First Intervention|Subject met an exclusionary criteria|0
117587|NCT00441545|384101|P1|First Intervention|Subject met an exclusionary criteria|1
117588|NCT00441545|384100|P2|First Intervention|Subject exceeded safety criteria|1
117589|NCT00441545|384101|P1|First Intervention|Subject exceeded safety criteria|0
117590|NCT00441545|384100|P2|First Intervention|Lack of Efficacy|0
117591|NCT00441545|384101|P1|First Intervention|Lack of Efficacy|2
117592|NCT00441545|384100|P2|First Intervention|Kidney transplant|1
117593|NCT00441545|384101|P1|First Intervention|Kidney transplant|1
117594|NCT00441545|384100|P2|First Intervention|Withdrawal by Subject|3
117595|NCT00441545|384101|P1|First Intervention|Withdrawal by Subject|3
117596|NCT00441545|384100|P2|First Intervention|Protocol Violation|2
117597|NCT00441545|384101|P1|First Intervention|Protocol Violation|2
117598|NCT00441545|384100|P2|First Intervention|Adverse Event|5
117599|NCT00441545|384101|P1|First Intervention|Adverse Event|6
117600|NCT00441584|384117|P1|Overall Study|Failure to meet eligibility criteria|3
117601|NCT00441584|384117|P1|Overall Study|Lost to Follow-up|4
117602|NCT00441584|384117|P1|Overall Study|Protocol Violation|5
117603|NCT00441584|384117|P1|Overall Study|Adverse Event|6
117604|NCT00441584|384117|P1|Overall Study|Withdrawal by Subject|8
117605|NCT00441584|384117|P1|Overall Study|Lack of Efficacy|79
117606|NCT00441701|384131|P10|Overall Study|Withdrawal by Subject|0
117607|NCT00441701|384132|P9|Overall Study|Withdrawal by Subject|0
117608|NCT00441701|384133|P8|Overall Study|Withdrawal by Subject|0
117609|NCT00441701|384134|P7|Overall Study|Withdrawal by Subject|0
117610|NCT00441701|384135|P6|Overall Study|Withdrawal by Subject|0
117611|NCT00441701|384136|P5|Overall Study|Withdrawal by Subject|0
117612|NCT00441701|384137|P4|Overall Study|Withdrawal by Subject|1
117613|NCT00441701|384138|P3|Overall Study|Withdrawal by Subject|1
117614|NCT00441701|384139|P2|Overall Study|Withdrawal by Subject|2
117615|NCT00441701|384140|P1|Overall Study|Withdrawal by Subject|0
117616|NCT00441701|384131|P10|Overall Study|Lack of Efficacy|0
117617|NCT00441701|384132|P9|Overall Study|Lack of Efficacy|0
117618|NCT00441701|384133|P8|Overall Study|Lack of Efficacy|0
117619|NCT00441701|384134|P7|Overall Study|Lack of Efficacy|0
117620|NCT00441701|384135|P6|Overall Study|Lack of Efficacy|1
117621|NCT00441701|384136|P5|Overall Study|Lack of Efficacy|0
117622|NCT00441701|384137|P4|Overall Study|Lack of Efficacy|2
117623|NCT00441701|384138|P3|Overall Study|Lack of Efficacy|2
117624|NCT00441701|384139|P2|Overall Study|Lack of Efficacy|0
117625|NCT00441701|384140|P1|Overall Study|Lack of Efficacy|2
117626|NCT00441701|384131|P10|Overall Study|Adverse Event|0
117627|NCT00441701|384132|P9|Overall Study|Adverse Event|0
117628|NCT00441701|384133|P8|Overall Study|Adverse Event|0
117629|NCT00441701|384134|P7|Overall Study|Adverse Event|0
117630|NCT00441701|384135|P6|Overall Study|Adverse Event|2
117631|NCT00441701|384136|P5|Overall Study|Adverse Event|2
117632|NCT00441701|384137|P4|Overall Study|Adverse Event|0
117633|NCT00441701|384138|P3|Overall Study|Adverse Event|1
117634|NCT00441701|384139|P2|Overall Study|Adverse Event|2
117635|NCT00441701|384140|P1|Overall Study|Adverse Event|3
117636|NCT00444457|384226|P4|Toddler Dose|Protocol Violation|1
117637|NCT00444457|384227|P3|Toddler Dose|Protocol Violation|0
117638|NCT00444457|384228|P2|Toddler Dose|Protocol Violation|0
117639|NCT00444457|384229|P1|Toddler Dose|Protocol Violation|1
117640|NCT00444457|384226|P4|Toddler Dose|Parent or legal guardian request|1
117641|NCT00444457|384227|P3|Toddler Dose|Parent or legal guardian request|2
117642|NCT00444457|384228|P2|Toddler Dose|Parent or legal guardian request|3
117643|NCT00444457|384229|P1|Toddler Dose|Parent or legal guardian request|0
117644|NCT00444457|384226|P4|Toddler Dose|Failed to return|3
117645|NCT00444457|384227|P3|Toddler Dose|Failed to return|1
117646|NCT00444457|384228|P2|Toddler Dose|Failed to return|2
117647|NCT00444457|384229|P1|Toddler Dose|Failed to return|2
117648|NCT00444457|384226|P4|Toddler Dose|Lost to Follow-up|3
117649|NCT00444457|384227|P3|Toddler Dose|Lost to Follow-up|1
117650|NCT00444457|384228|P2|Toddler Dose|Lost to Follow-up|1
117651|NCT00444457|384229|P1|Toddler Dose|Lost to Follow-up|4
117652|NCT00444457|384226|P4|After Infant Series|Unspecified|0
117653|NCT00444457|384227|P3|After Infant Series|Unspecified|0
117654|NCT00444457|384228|P2|After Infant Series|Unspecified|1
117655|NCT00444457|384229|P1|After Infant Series|Unspecified|0
117656|NCT00444457|384226|P4|After Infant Series|Investigator request|1
117657|NCT00444457|384227|P3|After Infant Series|Investigator request|0
117658|NCT00444457|384228|P2|After Infant Series|Investigator request|0
117659|NCT00444457|384229|P1|After Infant Series|Investigator request|0
117660|NCT00444457|384226|P4|After Infant Series|Adverse Event|0
117661|NCT00444457|384227|P3|After Infant Series|Adverse Event|0
117662|NCT00444457|384228|P2|After Infant Series|Adverse Event|2
117663|NCT00444457|384229|P1|After Infant Series|Adverse Event|2
117664|NCT00444457|384226|P4|After Infant Series|Protocol Violation|2
117665|NCT00444457|384227|P3|After Infant Series|Protocol Violation|2
117666|NCT00444457|384228|P2|After Infant Series|Protocol Violation|4
117667|NCT00444457|384229|P1|After Infant Series|Protocol Violation|2
117668|NCT00444457|384226|P4|After Infant Series|Lost to Follow-up|2
117669|NCT00444457|384227|P3|After Infant Series|Lost to Follow-up|5
117670|NCT00444457|384228|P2|After Infant Series|Lost to Follow-up|5
117671|NCT00444457|384229|P1|After Infant Series|Lost to Follow-up|5
117672|NCT00444457|384226|P4|After Infant Series|Failed to return|1
117673|NCT00444457|384227|P3|After Infant Series|Failed to return|5
117674|NCT00444457|384228|P2|After Infant Series|Failed to return|6
117675|NCT00444457|384229|P1|After Infant Series|Failed to return|7
117676|NCT00444457|384226|P4|After Infant Series|Parent or legal guardian request|3
117677|NCT00444457|384227|P3|After Infant Series|Parent or legal guardian request|6
117678|NCT00444457|384228|P2|After Infant Series|Parent or legal guardian request|11
117679|NCT00444457|384229|P1|After Infant Series|Parent or legal guardian request|4
117680|NCT00444457|384226|P4|After Infant Series|Other|1
117681|NCT00444457|384227|P3|After Infant Series|Other|1
117682|NCT00444457|384228|P2|After Infant Series|Other|1
117683|NCT00444457|384229|P1|After Infant Series|Other|0
117684|NCT00444457|384226|P4|Infant Series|Death|1
117685|NCT00444457|384227|P3|Infant Series|Death|1
117686|NCT00444457|384228|P2|Infant Series|Death|1
117687|NCT00444457|384229|P1|Infant Series|Death|0
117688|NCT00444457|384226|P4|Infant Series|Adverse Event|0
117689|NCT00444457|384227|P3|Infant Series|Adverse Event|2
117690|NCT00444457|384228|P2|Infant Series|Adverse Event|2
117691|NCT00444457|384229|P1|Infant Series|Adverse Event|1
117692|NCT00444457|384226|P4|Infant Series|Unspecified|0
117693|NCT00444457|384227|P3|Infant Series|Unspecified|4
117694|NCT00444457|384228|P2|Infant Series|Unspecified|2
117695|NCT00444457|384229|P1|Infant Series|Unspecified|0
117696|NCT00444457|384226|P4|Infant Series|Investigator request|2
117697|NCT00444457|384227|P3|Infant Series|Investigator request|3
117698|NCT00444457|384228|P2|Infant Series|Investigator request|3
117699|NCT00444457|384229|P1|Infant Series|Investigator request|4
117700|NCT00444457|384226|P4|Infant Series|Failed to return|2
117701|NCT00444457|384227|P3|Infant Series|Failed to return|4
117702|NCT00444457|384228|P2|Infant Series|Failed to return|4
117703|NCT00444457|384229|P1|Infant Series|Failed to return|5
117704|NCT00444457|384226|P4|Infant Series|Protocol Violation|3
117705|NCT00444457|384227|P3|Infant Series|Protocol Violation|6
117706|NCT00444457|384228|P2|Infant Series|Protocol Violation|8
117707|NCT00444457|384229|P1|Infant Series|Protocol Violation|16
117708|NCT00444457|384226|P4|Infant Series|Lost to Follow-up|6
117709|NCT00444457|384227|P3|Infant Series|Lost to Follow-up|7
117710|NCT00444457|384228|P2|Infant Series|Lost to Follow-up|11
117711|NCT00444457|384229|P1|Infant Series|Lost to Follow-up|10
117712|NCT00444457|384226|P4|Infant Series|Parent or legal guardian request|14
117713|NCT00444457|384227|P3|Infant Series|Parent or legal guardian request|34
117714|NCT00444457|384228|P2|Infant Series|Parent or legal guardian request|29
117715|NCT00444457|384229|P1|Infant Series|Parent or legal guardian request|18
117716|NCT00444457|384226|P4|Infant Series|Other|0
117717|NCT00444457|384227|P3|Infant Series|Other|0
117718|NCT00444457|384228|P2|Infant Series|Other|1
117719|NCT00444457|384229|P1|Infant Series|Other|0
117720|NCT00444535|384291|P1|Overall Study|Adverse Event|3
117721|NCT00444535|384291|P1|Overall Study|Investigator decision|2
117722|NCT00444535|384291|P1|Overall Study|Withdrawal by Subject|3
117723|NCT00444535|384291|P1|Overall Study|Treatment is ongoing|16
117724|NCT00444587|384300|P2|Overall Study|Missing|5
117725|NCT00444587|384301|P1|Overall Study|Missing|0
117726|NCT00444587|384300|P2|Overall Study|Protocol Violation|0
117727|NCT00444587|384301|P1|Overall Study|Protocol Violation|1
117728|NCT00444587|384300|P2|Overall Study|Investigator decision|0
117729|NCT00444587|384301|P1|Overall Study|Investigator decision|3
117730|NCT00444587|384300|P2|Overall Study|Refused treatment/did not cooperate|1
117731|NCT00444587|384301|P1|Overall Study|Refused treatment/did not cooperate|4
117732|NCT00444587|384300|P2|Overall Study|Progression of the disease|8
117733|NCT00444587|384301|P1|Overall Study|Progression of the disease|73
117734|NCT00444587|384300|P2|Overall Study|Death|1
117735|NCT00444587|384301|P1|Overall Study|Death|2
117736|NCT00444600|384326|P4|Overall Study|Missed visit|1
117737|NCT00444600|384327|P3|Overall Study|Missed visit|0
117738|NCT00444600|384328|P2|Overall Study|Missed visit|0
117739|NCT00444600|384329|P1|Overall Study|Missed visit|1
117740|NCT00444600|384326|P4|Overall Study|Dropped|7
117741|NCT00444600|384327|P3|Overall Study|Dropped|7
117742|NCT00444600|384328|P2|Overall Study|Dropped|11
117743|NCT00444600|384329|P1|Overall Study|Dropped|11
117744|NCT00444600|384326|P4|Overall Study|Death|2
117745|NCT00444600|384327|P3|Overall Study|Death|3
117746|NCT00444600|384328|P2|Overall Study|Death|5
117747|NCT00444600|384329|P1|Overall Study|Death|7
117748|NCT00444626|384419|P1|Initial Treatment Period|Lost to Follow-up|9
117749|NCT00444626|384419|P1|Initial Treatment Period|Adverse Event|1
117750|NCT00444626|384419|P1|Initial Treatment Period|Withdrawal by Subject|2
117751|NCT00444795|384445|P1|Overall Study|Treated Prior to the Contract Date|2
117752|NCT00444795|384445|P1|Overall Study|Not Treated|1
117753|NCT00444912|384452|P2|Overall Study|Participant Failed Mobilization|0
117754|NCT00444912|384453|P1|Overall Study|Participant Failed Mobilization|1
117755|NCT00444912|384452|P2|Overall Study|Lost to Follow-up|0
117756|NCT00444912|384453|P1|Overall Study|Lost to Follow-up|1
117757|NCT00444912|384452|P2|Overall Study|Death|2
117758|NCT00444912|384453|P1|Overall Study|Death|1
117759|NCT00444925|384484|P3|Double-blind Treatment Period|Other|12
117760|NCT00444925|384485|P2|Double-blind Treatment Period|Other|7
117761|NCT00444925|384486|P1|Double-blind Treatment Period|Other|7
117762|NCT00444925|384484|P3|Double-blind Treatment Period|Withdrawal by Subject|7
117763|NCT00444925|384485|P2|Double-blind Treatment Period|Withdrawal by Subject|8
117764|NCT00444925|384486|P1|Double-blind Treatment Period|Withdrawal by Subject|6
117765|NCT00444925|384484|P3|Double-blind Treatment Period|Lost to Follow-up|5
117766|NCT00444925|384485|P2|Double-blind Treatment Period|Lost to Follow-up|8
117767|NCT00444925|384486|P1|Double-blind Treatment Period|Lost to Follow-up|4
117768|NCT00444925|384484|P3|Double-blind Treatment Period|Lack of Efficacy|13
117769|NCT00444925|384485|P2|Double-blind Treatment Period|Lack of Efficacy|5
117770|NCT00444925|384486|P1|Double-blind Treatment Period|Lack of Efficacy|5
117771|NCT00444925|384484|P3|Double-blind Treatment Period|Adverse Event|44
117772|NCT00444925|384485|P2|Double-blind Treatment Period|Adverse Event|28
117773|NCT00444925|384486|P1|Double-blind Treatment Period|Adverse Event|6
117774|NCT00444925|384484|P3|Double-blind Treatment Period|Death|0
117775|NCT00444925|384485|P2|Double-blind Treatment Period|Death|0
117776|NCT00444925|384486|P1|Double-blind Treatment Period|Death|2
117777|NCT00444925|384484|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
117778|NCT00444925|384485|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
117861|NCT00445679|384886|P3|Overall Study|Withdrawal of Informed Consent|1
117779|NCT00444925|384486|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
117780|NCT00444951|384551|P3|Overall Study|Withdrawal by Subject|3
117781|NCT00444951|384552|P2|Overall Study|Withdrawal by Subject|5
117782|NCT00444951|384553|P1|Overall Study|Withdrawal by Subject|4
117783|NCT00444951|384551|P3|Overall Study|Lost to Follow-up|0
117784|NCT00444951|384552|P2|Overall Study|Lost to Follow-up|1
117785|NCT00444951|384553|P1|Overall Study|Lost to Follow-up|1
117786|NCT00445003|384570|P3|Overall Study|Dropped|2
117787|NCT00445003|384571|P2|Overall Study|Dropped|3
117788|NCT00445003|384572|P1|Overall Study|Dropped|1
117789|NCT00445003|384570|P3|Overall Study|Missed Visit|1
117790|NCT00445003|384571|P2|Overall Study|Missed Visit|5
117791|NCT00445003|384572|P1|Overall Study|Missed Visit|3
117792|NCT00445003|384570|P3|Overall Study|Death|1
117793|NCT00445003|384571|P2|Overall Study|Death|2
117794|NCT00445003|384572|P1|Overall Study|Death|1
117795|NCT00445146|384601|P1|Overall Study|Pregnancy|1
117796|NCT00445146|384601|P1|Overall Study|Protocol Violation|4
117797|NCT00445146|384601|P1|Overall Study|Death|9
117798|NCT00445146|384601|P1|Overall Study|Lost to Follow-up|13
117799|NCT00445146|384601|P1|Overall Study|Adverse Event|13
117800|NCT00445146|384601|P1|Overall Study|Investigator’s Discretion|22
117801|NCT00445146|384601|P1|Overall Study|Lack of Efficacy|28
117802|NCT00445146|384601|P1|Overall Study|Withdrew Consent|29
117803|NCT00445224|384639|P2|Specific Exercises|Withdrawal by Subject|0
117804|NCT00445224|384640|P1|Specific Exercises|Withdrawal by Subject|1
117805|NCT00445224|384639|P2|Specific Exercises|Withdrawal by Subject|3
117806|NCT00445224|384640|P1|Specific Exercises|Withdrawal by Subject|3
117807|NCT00445328|384793|P2|Overall Study|Protocol Violation|0
117808|NCT00445328|384794|P1|Overall Study|Protocol Violation|1
117809|NCT00445328|384793|P2|Overall Study|Withdrawal by Subject|0
117810|NCT00445328|384794|P1|Overall Study|Withdrawal by Subject|2
117811|NCT00445328|384793|P2|Overall Study|Other|2
117812|NCT00445328|384794|P1|Overall Study|Other|0
117813|NCT00445328|384793|P2|Overall Study|Adverse Event|3
117814|NCT00445328|384794|P1|Overall Study|Adverse Event|0
117815|NCT00445328|384793|P2|Overall Study|Death|1
117816|NCT00445328|384794|P1|Overall Study|Death|0
117817|NCT00445341|384812|P1|Overall Study|taken off treatment too early|1
117818|NCT00445341|384812|P1|Overall Study|refused further treatment|1
117819|NCT00445432|384820|P4|148 Weeks of Adalimumab Treatment|Not specified|9
117820|NCT00445432|384821|P3|148 Weeks of Adalimumab Treatment|Not specified|0
117821|NCT00445432|384822|P2|148 Weeks of Adalimumab Treatment|Not specified|0
117822|NCT00445432|384823|P1|148 Weeks of Adalimumab Treatment|Not specified|0
117823|NCT00445432|384820|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
117824|NCT00445432|384821|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
117825|NCT00445432|384822|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
117826|NCT00445432|384823|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
117827|NCT00445432|384820|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
117828|NCT00445432|384821|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
117829|NCT00445432|384822|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
117830|NCT00445432|384823|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
117831|NCT00445432|384820|P4|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
117832|NCT00445432|384821|P3|Through Week 52 of NCT00445432 (M06-837)|Not specified|2
117833|NCT00445432|384822|P2|Through Week 52 of NCT00445432 (M06-837)|Not specified|1
117834|NCT00445432|384823|P1|Through Week 52 of NCT00445432 (M06-837)|Not specified|0
117835|NCT00445432|384820|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
117836|NCT00445432|384821|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
117837|NCT00445432|384822|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
117838|NCT00445432|384823|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
117839|NCT00445432|384820|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
117840|NCT00445432|384821|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
117841|NCT00445432|384822|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
117842|NCT00445432|384823|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
117843|NCT00445432|384820|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
117844|NCT00445432|384821|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
117845|NCT00445432|384822|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
117846|NCT00445432|384823|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
117847|NCT00445549|384871|P1|Overall Study|progressive disease|12
117848|NCT00445679|384885|P4|Overall Study|Lack of Efficacy|0
117849|NCT00445679|384886|P3|Overall Study|Lack of Efficacy|2
117850|NCT00445679|384887|P2|Overall Study|Lack of Efficacy|6
117851|NCT00445679|384888|P1|Overall Study|Lack of Efficacy|2
117852|NCT00445679|384885|P4|Overall Study|Withdrawal by Subject|18
117853|NCT00445679|384886|P3|Overall Study|Withdrawal by Subject|20
117854|NCT00445679|384887|P2|Overall Study|Withdrawal by Subject|14
117855|NCT00445679|384888|P1|Overall Study|Withdrawal by Subject|8
117856|NCT00445679|384885|P4|Overall Study|Protocol Violation|1
117857|NCT00445679|384886|P3|Overall Study|Protocol Violation|3
117858|NCT00445679|384887|P2|Overall Study|Protocol Violation|3
117859|NCT00445679|384888|P1|Overall Study|Protocol Violation|2
117860|NCT00445679|384885|P4|Overall Study|Withdrawal of Informed Consent|0
117862|NCT00445679|384887|P2|Overall Study|Withdrawal of Informed Consent|0
117863|NCT00445679|384888|P1|Overall Study|Withdrawal of Informed Consent|0
117864|NCT00445679|384885|P4|Overall Study|Compliance|2
117865|NCT00445679|384886|P3|Overall Study|Compliance|1
117866|NCT00445679|384887|P2|Overall Study|Compliance|2
117867|NCT00445679|384888|P1|Overall Study|Compliance|3
117868|NCT00445679|384885|P4|Overall Study|Lost to Follow-up|5
117869|NCT00445679|384886|P3|Overall Study|Lost to Follow-up|6
117870|NCT00445679|384887|P2|Overall Study|Lost to Follow-up|6
117871|NCT00445679|384888|P1|Overall Study|Lost to Follow-up|10
117872|NCT00445679|384885|P4|Overall Study|Physician Decision|0
117873|NCT00445679|384886|P3|Overall Study|Physician Decision|1
117874|NCT00445679|384887|P2|Overall Study|Physician Decision|0
117875|NCT00445679|384888|P1|Overall Study|Physician Decision|0
117876|NCT00445679|384885|P4|Overall Study|Failed to return|2
117877|NCT00445679|384886|P3|Overall Study|Failed to return|2
117878|NCT00445679|384887|P2|Overall Study|Failed to return|3
117879|NCT00445679|384888|P1|Overall Study|Failed to return|1
117880|NCT00445679|384885|P4|Overall Study|Adverse Event|19
117881|NCT00445679|384886|P3|Overall Study|Adverse Event|30
117882|NCT00445679|384887|P2|Overall Study|Adverse Event|12
117883|NCT00445679|384888|P1|Overall Study|Adverse Event|22
117884|NCT00445770|384954|P3|Overall Study|Not specified|6
117885|NCT00445770|384955|P2|Overall Study|Not specified|5
117886|NCT00445770|384956|P1|Overall Study|Not specified|6
117887|NCT00445770|384954|P3|Overall Study|Lost to Follow-up|0
117888|NCT00445770|384955|P2|Overall Study|Lost to Follow-up|2
117889|NCT00445770|384956|P1|Overall Study|Lost to Follow-up|0
117890|NCT00445770|384954|P3|Overall Study|Lack of Efficacy|6
117891|NCT00445770|384955|P2|Overall Study|Lack of Efficacy|13
117892|NCT00445770|384956|P1|Overall Study|Lack of Efficacy|38
117893|NCT00445770|384954|P3|Overall Study|Adverse Event|19
117894|NCT00445770|384955|P2|Overall Study|Adverse Event|15
117895|NCT00445770|384956|P1|Overall Study|Adverse Event|9
117896|NCT00445848|385023|P1|Overall Study|Other-Not protocol specified|5
117897|NCT00445848|385023|P1|Overall Study|Progression|62
117898|NCT00445848|385023|P1|Overall Study|Withdrawal by Subject|4
117899|NCT00445848|385023|P1|Overall Study|Adverse Event|14
117900|NCT00445939|385033|P4|Period B - Week 4 - Week 8|Adverse Event|1
117901|NCT00445939|385034|P3|Period B - Week 4 - Week 8|Adverse Event|0
117902|NCT00445939|385035|P2|Period B - Week 4 - Week 8|Adverse Event|0
117903|NCT00445939|385036|P1|Period B - Week 4 - Week 8|Adverse Event|2
117904|NCT00445939|385033|P4|Period A - Week 0 - Week 4|Adverse Event|0
117905|NCT00445939|385034|P3|Period A - Week 0 - Week 4|Adverse Event|0
117906|NCT00445939|385035|P2|Period A - Week 0 - Week 4|Adverse Event|2
117907|NCT00445939|385036|P1|Period A - Week 0 - Week 4|Adverse Event|1
117908|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
117909|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
117910|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
117911|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
117912|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
117913|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
117914|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
117915|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
117916|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
117917|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
117918|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
117919|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
117920|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
117921|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
117922|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Death|2
117923|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Death|2
117924|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
117925|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
117926|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
117927|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
117928|NCT00446030|385061|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
117929|NCT00446030|385062|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
117930|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
117931|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
117932|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
117933|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
117934|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
117935|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
117936|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
117937|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
117938|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
117939|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
117940|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
117941|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
117942|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
117943|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
117944|NCT00446030|385061|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
117945|NCT00446030|385062|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
117946|NCT00446095|385075|P5|Phase I (28 Days)|Lack of Efficacy|3
117947|NCT00446095|385076|P4|Phase I (28 Days)|Lack of Efficacy|0
117948|NCT00446095|385077|P3|Phase I (28 Days)|Lack of Efficacy|0
117949|NCT00446095|385078|P2|Phase I (28 Days)|Lack of Efficacy|0
117950|NCT00446095|385079|P1|Phase I (28 Days)|Lack of Efficacy|0
117951|NCT00446095|385075|P5|Phase I (28 Days)|Adverse Event|0
117952|NCT00446095|385076|P4|Phase I (28 Days)|Adverse Event|1
117953|NCT00446095|385077|P3|Phase I (28 Days)|Adverse Event|0
117954|NCT00446095|385078|P2|Phase I (28 Days)|Adverse Event|0
117955|NCT00446095|385079|P1|Phase I (28 Days)|Adverse Event|0
117956|NCT00446095|385075|P5|Phase II (8 Weeks)|Ongoing|0
117957|NCT00446095|385076|P4|Phase II (8 Weeks)|Ongoing|0
117958|NCT00446095|385077|P3|Phase II (8 Weeks)|Ongoing|1
117959|NCT00446095|385078|P2|Phase II (8 Weeks)|Ongoing|0
117960|NCT00446095|385079|P1|Phase II (8 Weeks)|Ongoing|0
117961|NCT00446095|385075|P5|Phase II (8 Weeks)|Lack of Efficacy|0
117962|NCT00446095|385076|P4|Phase II (8 Weeks)|Lack of Efficacy|0
117963|NCT00446095|385077|P3|Phase II (8 Weeks)|Lack of Efficacy|1
117964|NCT00446095|385078|P2|Phase II (8 Weeks)|Lack of Efficacy|2
117965|NCT00446095|385079|P1|Phase II (8 Weeks)|Lack of Efficacy|9
117966|NCT00446095|385075|P5|Phase II (8 Weeks)|Physician Decision|0
117967|NCT00446095|385076|P4|Phase II (8 Weeks)|Physician Decision|0
117968|NCT00446095|385077|P3|Phase II (8 Weeks)|Physician Decision|0
117969|NCT00446095|385078|P2|Phase II (8 Weeks)|Physician Decision|0
117970|NCT00446095|385079|P1|Phase II (8 Weeks)|Physician Decision|1
117971|NCT00446095|385075|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
117972|NCT00446095|385076|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
117973|NCT00446095|385077|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
117974|NCT00446095|385078|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
117975|NCT00446095|385079|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
117976|NCT00446095|385075|P5|Phase II (8 Weeks)|Adverse Event|0
117977|NCT00446095|385076|P4|Phase II (8 Weeks)|Adverse Event|0
117978|NCT00446095|385077|P3|Phase II (8 Weeks)|Adverse Event|1
117979|NCT00446095|385078|P2|Phase II (8 Weeks)|Adverse Event|1
117980|NCT00446095|385079|P1|Phase II (8 Weeks)|Adverse Event|0
117981|NCT00446095|385075|P5|Phase II (8 Weeks)|Lost to Follow-up|0
117982|NCT00446095|385076|P4|Phase II (8 Weeks)|Lost to Follow-up|0
117983|NCT00446095|385077|P3|Phase II (8 Weeks)|Lost to Follow-up|0
117984|NCT00446095|385078|P2|Phase II (8 Weeks)|Lost to Follow-up|0
117985|NCT00446095|385079|P1|Phase II (8 Weeks)|Lost to Follow-up|1
117986|NCT00446134|385104|P4|Overall Study|Reason Not Completed|2
117987|NCT00446134|385105|P3|Overall Study|Reason Not Completed|1
117988|NCT00446134|385106|P2|Overall Study|Reason Not Completed|0
117989|NCT00446134|385107|P1|Overall Study|Reason Not Completed|3
117990|NCT00446134|385104|P4|Overall Study|Adverse Event-Diarrhea|0
117991|NCT00446134|385105|P3|Overall Study|Adverse Event-Diarrhea|2
117992|NCT00446134|385106|P2|Overall Study|Adverse Event-Diarrhea|1
117993|NCT00446134|385107|P1|Overall Study|Adverse Event-Diarrhea|1
117994|NCT00446134|385104|P4|Overall Study|Physician Decision|2
117995|NCT00446134|385105|P3|Overall Study|Physician Decision|0
117996|NCT00446134|385106|P2|Overall Study|Physician Decision|0
117997|NCT00446134|385107|P1|Overall Study|Physician Decision|0
117998|NCT00446134|385104|P4|Overall Study|Withdrawal by Subject|3
117999|NCT00446134|385105|P3|Overall Study|Withdrawal by Subject|1
118000|NCT00446134|385106|P2|Overall Study|Withdrawal by Subject|3
118001|NCT00446134|385107|P1|Overall Study|Withdrawal by Subject|3
118002|NCT00446134|385104|P4|Overall Study|Lost to Follow-up|1
118003|NCT00446134|385105|P3|Overall Study|Lost to Follow-up|1
118004|NCT00446134|385106|P2|Overall Study|Lost to Follow-up|3
118005|NCT00446134|385107|P1|Overall Study|Lost to Follow-up|1
118006|NCT00446134|385104|P4|Overall Study|Protocol Violation|0
118007|NCT00446134|385105|P3|Overall Study|Protocol Violation|1
118008|NCT00446134|385106|P2|Overall Study|Protocol Violation|2
118009|NCT00446134|385107|P1|Overall Study|Protocol Violation|0
118010|NCT00446134|385104|P4|Overall Study|Lack of Efficacy|19
118011|NCT00446134|385105|P3|Overall Study|Lack of Efficacy|24
118012|NCT00446134|385106|P2|Overall Study|Lack of Efficacy|19
118013|NCT00446134|385107|P1|Overall Study|Lack of Efficacy|19
118014|NCT00446134|385104|P4|Overall Study|Adverse Event|18
118015|NCT00446134|385105|P3|Overall Study|Adverse Event|13
118016|NCT00446134|385106|P2|Overall Study|Adverse Event|17
118017|NCT00446134|385107|P1|Overall Study|Adverse Event|7
118018|NCT00446199|385144|P4|Overall Study|Move|0
118019|NCT00446199|385145|P3|Overall Study|Move|0
118020|NCT00446199|385146|P2|Overall Study|Move|1
118021|NCT00446199|385147|P1|Overall Study|Move|0
118022|NCT00446199|385144|P4|Overall Study|In-/Exclusion criterion violated|1
118023|NCT00446199|385145|P3|Overall Study|In-/Exclusion criterion violated|2
118024|NCT00446199|385146|P2|Overall Study|In-/Exclusion criterion violated|1
118025|NCT00446199|385147|P1|Overall Study|In-/Exclusion criterion violated|2
118026|NCT00446199|385144|P4|Overall Study|Lost interest in study participation|0
118027|NCT00446199|385145|P3|Overall Study|Lost interest in study participation|0
118028|NCT00446199|385146|P2|Overall Study|Lost interest in study participation|1
118029|NCT00446199|385147|P1|Overall Study|Lost interest in study participation|0
118030|NCT00446199|385144|P4|Overall Study|Hormone fear|1
118031|NCT00446199|385145|P3|Overall Study|Hormone fear|0
118032|NCT00446199|385146|P2|Overall Study|Hormone fear|0
118033|NCT00446199|385147|P1|Overall Study|Hormone fear|0
118034|NCT00446199|385144|P4|Overall Study|Non-compliant with visit schedule|2
118035|NCT00446199|385145|P3|Overall Study|Non-compliant with visit schedule|1
118036|NCT00446199|385146|P2|Overall Study|Non-compliant with visit schedule|1
118037|NCT00446199|385147|P1|Overall Study|Non-compliant with visit schedule|1
118038|NCT00446199|385144|P4|Overall Study|Non-compliant with study drug|0
118039|NCT00446199|385145|P3|Overall Study|Non-compliant with study drug|5
118040|NCT00446199|385146|P2|Overall Study|Non-compliant with study drug|0
118041|NCT00446199|385147|P1|Overall Study|Non-compliant with study drug|1
118042|NCT00446199|385144|P4|Overall Study|Lack of Efficacy|1
118043|NCT00446199|385145|P3|Overall Study|Lack of Efficacy|0
118044|NCT00446199|385146|P2|Overall Study|Lack of Efficacy|0
118045|NCT00446199|385147|P1|Overall Study|Lack of Efficacy|1
118046|NCT00446199|385144|P4|Overall Study|Randomization in Error|1
118047|NCT00446199|385145|P3|Overall Study|Randomization in Error|1
118048|NCT00446199|385146|P2|Overall Study|Randomization in Error|0
118049|NCT00446199|385147|P1|Overall Study|Randomization in Error|2
118050|NCT00446199|385144|P4|Overall Study|Site termination|1
118051|NCT00446199|385145|P3|Overall Study|Site termination|0
118052|NCT00446199|385146|P2|Overall Study|Site termination|0
118053|NCT00446199|385147|P1|Overall Study|Site termination|2
118054|NCT00446199|385144|P4|Overall Study|Withdrawal by Subject|10
118055|NCT00446199|385145|P3|Overall Study|Withdrawal by Subject|9
118056|NCT00446199|385146|P2|Overall Study|Withdrawal by Subject|5
118057|NCT00446199|385147|P1|Overall Study|Withdrawal by Subject|2
118058|NCT00446199|385144|P4|Overall Study|Protocol Violation|3
118059|NCT00446199|385145|P3|Overall Study|Protocol Violation|1
118060|NCT00446199|385146|P2|Overall Study|Protocol Violation|2
118061|NCT00446199|385147|P1|Overall Study|Protocol Violation|1
118062|NCT00446199|385144|P4|Overall Study|Lost to Follow-up|6
118063|NCT00446199|385145|P3|Overall Study|Lost to Follow-up|2
118064|NCT00446199|385146|P2|Overall Study|Lost to Follow-up|5
118065|NCT00446199|385147|P1|Overall Study|Lost to Follow-up|4
118066|NCT00446199|385144|P4|Overall Study|Adverse Event|4
118067|NCT00446199|385145|P3|Overall Study|Adverse Event|6
118068|NCT00446199|385146|P2|Overall Study|Adverse Event|4
118069|NCT00446199|385147|P1|Overall Study|Adverse Event|7
118070|NCT00446251|385225|P1|Overall Study|Lost to Follow-up|1
118071|NCT00446251|385225|P1|Overall Study|Rituximab Infusion Reaction|2
118072|NCT00446251|385225|P1|Overall Study|On-study Transplants|2
118073|NCT00446446|385244|P1|Overall Study|On Treatment at Time of Data Cut-off|1
118074|NCT00446446|385244|P1|Overall Study|Adverse Event|1
118075|NCT00446446|385244|P1|Overall Study|Disease Progession|2
118076|NCT00446446|385244|P1|Overall Study|Other|4
118077|NCT00446446|385244|P1|Overall Study|Withdrawal by Subject|6
118078|NCT00446446|385244|P1|Overall Study|Death|10
118079|NCT00446459|385255|P1|12 Months|14 subjects to MMF + Rituximab Study|14
118080|NCT00446459|385255|P1|12 Months|Protocol Violation|4
118081|NCT00446459|385255|P1|8 Months|Protocol Violation|12
118082|NCT00446511|385267|P4|Overall Study|Administrative Problems|1
118083|NCT00446511|385268|P3|Overall Study|Administrative Problems|4
118084|NCT00446511|385269|P2|Overall Study|Administrative Problems|0
118085|NCT00446511|385270|P1|Overall Study|Administrative Problems|3
118086|NCT00446511|385267|P4|Overall Study|Withdrawal by Subject|3
118087|NCT00446511|385268|P3|Overall Study|Withdrawal by Subject|0
118088|NCT00446511|385269|P2|Overall Study|Withdrawal by Subject|0
118089|NCT00446511|385270|P1|Overall Study|Withdrawal by Subject|0
118090|NCT00446511|385267|P4|Overall Study|Protocol Violation|1
118091|NCT00446511|385268|P3|Overall Study|Protocol Violation|0
118092|NCT00446511|385269|P2|Overall Study|Protocol Violation|0
118093|NCT00446511|385270|P1|Overall Study|Protocol Violation|0
118094|NCT00446511|385267|P4|Overall Study|Adverse Event|1
118095|NCT00446511|385268|P3|Overall Study|Adverse Event|3
118096|NCT00446511|385269|P2|Overall Study|Adverse Event|2
118097|NCT00446511|385270|P1|Overall Study|Adverse Event|7
118098|NCT00446563|385296|P2|Overall Study|Administrative problems|1
118099|NCT00446563|385297|P1|Overall Study|Administrative problems|0
118100|NCT00446563|385296|P2|Overall Study|Withdrawal by Subject|1
118101|NCT00446563|385297|P1|Overall Study|Withdrawal by Subject|2
118102|NCT00446563|385296|P2|Overall Study|Unsatisfactory therapeutic effect|3
118103|NCT00446563|385297|P1|Overall Study|Unsatisfactory therapeutic effect|0
118104|NCT00446563|385296|P2|Overall Study|Abnormal test procedure result(s)|0
118105|NCT00446563|385297|P1|Overall Study|Abnormal test procedure result(s)|1
118106|NCT00446563|385296|P2|Overall Study|Abnormal laboratory value(s)|1
118107|NCT00446563|385297|P1|Overall Study|Abnormal laboratory value(s)|0
118108|NCT00446563|385296|P2|Overall Study|Adverse Event|3
118109|NCT00446563|385297|P1|Overall Study|Adverse Event|4
118110|NCT00446641|385333|P2|Overall Study|Lost to Follow-up|1
118111|NCT00446641|385334|P1|Overall Study|Lost to Follow-up|1
118112|NCT00446641|385333|P2|Overall Study|poor compliance|6
118113|NCT00446641|385334|P1|Overall Study|poor compliance|8
118114|NCT00446641|385333|P2|Overall Study|Withdrawal by Subject|3
118115|NCT00446641|385334|P1|Overall Study|Withdrawal by Subject|8
118116|NCT00446654|385354|P2|Overall Study|Adverse Event|0
118117|NCT00446654|385355|P1|Overall Study|Adverse Event|1
118118|NCT00446654|385354|P2|Overall Study|Withdrawal by Subject|0
118119|NCT00446654|385355|P1|Overall Study|Withdrawal by Subject|1
118120|NCT00446797|385363|P2|Overall Study|did not meet entrance criteria|1
118121|NCT00446797|385364|P1|Overall Study|did not meet entrance criteria|0
118122|NCT00446797|385363|P2|Overall Study|subject entered at another site|1
118123|NCT00446797|385364|P1|Overall Study|subject entered at another site|0
118124|NCT00446797|385363|P2|Overall Study|Protocol Violation|3
118125|NCT00446797|385364|P1|Overall Study|Protocol Violation|1
118126|NCT00446797|385363|P2|Overall Study|Withdrawal by Subject|2
118127|NCT00446797|385364|P1|Overall Study|Withdrawal by Subject|2
118128|NCT00446797|385363|P2|Overall Study|Lost to Follow-up|3
118129|NCT00446797|385364|P1|Overall Study|Lost to Follow-up|5
118130|NCT00446797|385363|P2|Overall Study|Lack of Efficacy|2
118131|NCT00446797|385364|P1|Overall Study|Lack of Efficacy|0
118132|NCT00437983|385410|P2|Overall Study|Withdrawal by Subject|6
118133|NCT00437983|385411|P1|Overall Study|Withdrawal by Subject|5
118134|NCT00437983|385410|P2|Overall Study|Protocol Violation|1
118135|NCT00437983|385411|P1|Overall Study|Protocol Violation|2
118136|NCT00437983|385410|P2|Overall Study|Adverse Event|6
118137|NCT00437983|385411|P1|Overall Study|Adverse Event|6
118138|NCT00438360|385451|P2|Overall Study|not specified|15
118139|NCT00438360|385452|P1|Overall Study|not specified|24
118140|NCT00438360|385451|P2|Overall Study|Lack of Efficacy|27
118141|NCT00438360|385452|P1|Overall Study|Lack of Efficacy|42
118142|NCT00438360|385451|P2|Overall Study|Adverse Event|1
118143|NCT00438360|385452|P1|Overall Study|Adverse Event|6
118144|NCT00438399|385469|P6|Overall Study|Patien stopped study at visit 4 by error|0
118145|NCT00438399|385470|P5|Overall Study|Patien stopped study at visit 4 by error|0
118146|NCT00438399|385471|P4|Overall Study|Patien stopped study at visit 4 by error|0
118147|NCT00438399|385472|P3|Overall Study|Patien stopped study at visit 4 by error|0
118148|NCT00438399|385473|P2|Overall Study|Patien stopped study at visit 4 by error|0
118149|NCT00438399|385474|P1|Overall Study|Patien stopped study at visit 4 by error|1
118150|NCT00438399|385469|P6|Overall Study|Pregnancy|1
118151|NCT00438399|385470|P5|Overall Study|Pregnancy|0
118152|NCT00438399|385471|P4|Overall Study|Pregnancy|0
118153|NCT00438399|385472|P3|Overall Study|Pregnancy|0
118154|NCT00438399|385473|P2|Overall Study|Pregnancy|0
118155|NCT00438399|385474|P1|Overall Study|Pregnancy|0
118156|NCT00438399|385469|P6|Overall Study|Subje stopped study|0
118157|NCT00438399|385470|P5|Overall Study|Subje stopped study|0
118158|NCT00438399|385471|P4|Overall Study|Subje stopped study|0
118159|NCT00438399|385472|P3|Overall Study|Subje stopped study|1
118160|NCT00438399|385473|P2|Overall Study|Subje stopped study|0
118161|NCT00438399|385474|P1|Overall Study|Subje stopped study|0
118162|NCT00438399|385469|P6|Overall Study|Protocol Violation|1
118163|NCT00438399|385470|P5|Overall Study|Protocol Violation|0
118164|NCT00438399|385471|P4|Overall Study|Protocol Violation|0
118165|NCT00438399|385472|P3|Overall Study|Protocol Violation|1
118166|NCT00438399|385473|P2|Overall Study|Protocol Violation|0
118167|NCT00438399|385474|P1|Overall Study|Protocol Violation|0
118168|NCT00438399|385469|P6|Overall Study|Withdrawal by Subject|2
118169|NCT00438399|385470|P5|Overall Study|Withdrawal by Subject|2
118170|NCT00438399|385471|P4|Overall Study|Withdrawal by Subject|2
118171|NCT00438399|385472|P3|Overall Study|Withdrawal by Subject|3
118172|NCT00438399|385473|P2|Overall Study|Withdrawal by Subject|6
118173|NCT00438399|385474|P1|Overall Study|Withdrawal by Subject|5
118174|NCT00438399|385469|P6|Overall Study|Adverse Event|1
118175|NCT00438399|385470|P5|Overall Study|Adverse Event|0
118176|NCT00438399|385471|P4|Overall Study|Adverse Event|1
118177|NCT00438399|385472|P3|Overall Study|Adverse Event|1
118178|NCT00438399|385473|P2|Overall Study|Adverse Event|0
118179|NCT00438399|385474|P1|Overall Study|Adverse Event|0
118180|NCT00438399|385469|P6|Overall Study|Lost to Follow-up|1
118181|NCT00438399|385470|P5|Overall Study|Lost to Follow-up|1
118182|NCT00438399|385471|P4|Overall Study|Lost to Follow-up|1
118183|NCT00438399|385472|P3|Overall Study|Lost to Follow-up|1
118184|NCT00438399|385473|P2|Overall Study|Lost to Follow-up|2
118185|NCT00438399|385474|P1|Overall Study|Lost to Follow-up|2
118186|NCT00438464|385531|P2|Overall Study|Incomplete data submission|2
118187|NCT00438464|385532|P1|Overall Study|Incomplete data submission|0
118188|NCT00438464|385531|P2|Overall Study|Terminated Early|5
118189|NCT00438464|385532|P1|Overall Study|Terminated Early|14
118190|NCT00438659|385595|P2|Overall Study|Cancel|2
118191|NCT00438659|385596|P1|Overall Study|Cancel|5
118192|NCT00438659|385595|P2|Overall Study|Discontinued Mometasone/Placebo|2
118193|NCT00438659|385596|P1|Overall Study|Discontinued Mometasone/Placebo|1
118194|NCT00438672|385620|P2|Overall Study|Lost to Follow-up|9
118195|NCT00438672|385621|P1|Overall Study|Lost to Follow-up|7
118196|NCT00438815|385650|P1|Overall Study|Death|1
118197|NCT00438815|385650|P1|Overall Study|Withdrawal by Subject|6
118198|NCT00438815|385650|P1|Overall Study|Lost to Follow-up|6
118199|NCT00438815|385650|P1|Overall Study|Transitioned to commercial C1INH-nf|6
118200|NCT00438815|385650|P1|Overall Study|Noncompliance with protocol requirements|9
118201|NCT00438815|385650|P1|Overall Study|3-month follow-up no longer required|12
118202|NCT00438815|385650|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
118203|NCT00446849|385679|P1|Maintenance Phase|concomitant medication use|1
118204|NCT00446849|385679|P1|Maintenance Phase|hydrocodone use|1
118205|NCT00446849|385679|P1|Maintenance Phase|study closure|1
118206|NCT00446849|385679|P1|Maintenance Phase|antibiotic use|1
118207|NCT00446849|385679|P1|Maintenance Phase|prohibited medication use|2
118208|NCT00446849|385679|P1|Maintenance Phase|noncompliance|2
118209|NCT00446849|385679|P1|Maintenance Phase|Pregnancy|1
118210|NCT00446849|385679|P1|Maintenance Phase|Lost to Follow-up|3
118211|NCT00446849|385679|P1|Maintenance Phase|Consent withdrawn|5
118212|NCT00446849|385679|P1|Maintenance Phase|Adverse Event|6
118213|NCT00446849|385679|P1|Maintenance Phase|Protocol Violation|7
118214|NCT00446849|385679|P1|Maintenance Phase|Lack of Efficacy|40
118215|NCT00446849|385679|P1|Acute Phase|noncompliance|1
118216|NCT00446849|385679|P1|Acute Phase|Physician Decision|1
118217|NCT00446849|385679|P1|Acute Phase|Lost to Follow-up|2
118218|NCT00446849|385679|P1|Acute Phase|Consent withdrawn|4
118219|NCT00446849|385679|P1|Acute Phase|Protocol Violation|10
118220|NCT00446849|385679|P1|Acute Phase|Lack of Efficacy|64
118221|NCT00446992|385689|P1|Overall Study|Lost to Follow-up|5
118222|NCT00446992|385689|P1|Overall Study|Adverse Event|11
118223|NCT00447005|385701|P1|Overall Study|Lack of Efficacy|11
118224|NCT00447005|385701|P1|Overall Study|Adverse Event|1
118225|NCT00447057|385719|P4|Overall Study|Death, study drug related|0
118226|NCT00447057|385720|P3|Overall Study|Death, study drug related|0
118227|NCT00447057|385721|P2|Overall Study|Death, study drug related|1
118228|NCT00447057|385722|P1|Overall Study|Death, study drug related|0
118229|NCT00447057|385719|P4|Overall Study|Death due to adverse event|2
118230|NCT00447057|385720|P3|Overall Study|Death due to adverse event|1
118231|NCT00447057|385721|P2|Overall Study|Death due to adverse event|0
118232|NCT00447057|385722|P1|Overall Study|Death due to adverse event|0
118233|NCT00447057|385719|P4|Overall Study|Progressive disease|18
118234|NCT00447057|385720|P3|Overall Study|Progressive disease|13
118235|NCT00447057|385721|P2|Overall Study|Progressive disease|43
118236|NCT00447057|385722|P1|Overall Study|Progressive disease|58
118237|NCT00447057|385719|P4|Overall Study|Sponsor decision|0
118238|NCT00447057|385720|P3|Overall Study|Sponsor decision|0
118239|NCT00447057|385721|P2|Overall Study|Sponsor decision|1
118240|NCT00447057|385722|P1|Overall Study|Sponsor decision|1
118241|NCT00447057|385719|P4|Overall Study|Physician Decision|1
118242|NCT00447057|385720|P3|Overall Study|Physician Decision|3
118243|NCT00447057|385721|P2|Overall Study|Physician Decision|6
118244|NCT00447057|385722|P1|Overall Study|Physician Decision|9
118245|NCT00447057|385719|P4|Overall Study|Withdrawal by Subject|1
118246|NCT00447057|385720|P3|Overall Study|Withdrawal by Subject|1
118247|NCT00447057|385721|P2|Overall Study|Withdrawal by Subject|5
118248|NCT00447057|385722|P1|Overall Study|Withdrawal by Subject|4
118249|NCT00447057|385719|P4|Overall Study|Protocol Violation|0
118250|NCT00447057|385720|P3|Overall Study|Protocol Violation|0
118251|NCT00447057|385721|P2|Overall Study|Protocol Violation|1
118252|NCT00447057|385722|P1|Overall Study|Protocol Violation|0
118253|NCT00447057|385719|P4|Overall Study|Entry criteria not met|0
118254|NCT00447057|385720|P3|Overall Study|Entry criteria not met|0
118255|NCT00447057|385721|P2|Overall Study|Entry criteria not met|1
118256|NCT00447057|385722|P1|Overall Study|Entry criteria not met|1
118257|NCT00447057|385719|P4|Overall Study|Lost to Follow-up|0
118258|NCT00447057|385720|P3|Overall Study|Lost to Follow-up|0
118259|NCT00447057|385721|P2|Overall Study|Lost to Follow-up|1
118260|NCT00447057|385722|P1|Overall Study|Lost to Follow-up|0
118261|NCT00447057|385719|P4|Overall Study|Death due to study disease|1
118262|NCT00447057|385720|P3|Overall Study|Death due to study disease|1
118263|NCT00447057|385721|P2|Overall Study|Death due to study disease|4
118264|NCT00447057|385722|P1|Overall Study|Death due to study disease|6
118265|NCT00447057|385719|P4|Overall Study|Adverse Event|3
118266|NCT00447057|385720|P3|Overall Study|Adverse Event|0
118267|NCT00447057|385721|P2|Overall Study|Adverse Event|10
118268|NCT00447057|385722|P1|Overall Study|Adverse Event|4
118269|NCT00447590|385744|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
118270|NCT00447590|385744|P1|Overall Study|Lost to Follow-up|24
118271|NCT00447590|385744|P1|Overall Study|Withdrawal by Subject|26
118272|NCT00447603|385753|P3|Filter Period|Study terminated by Sponsor|10
118273|NCT00447603|385754|P2|Filter Period|Study terminated by Sponsor|1
118274|NCT00447603|385755|P1|Filter Period|Study terminated by Sponsor|0
118275|NCT00447603|385753|P3|Filter Period|Screen Failure|4
118276|NCT00447603|385754|P2|Filter Period|Screen Failure|3
118277|NCT00447603|385755|P1|Filter Period|Screen Failure|0
118278|NCT00447603|385753|P3|Filter Period|Adverse Event|1
118279|NCT00447603|385754|P2|Filter Period|Adverse Event|0
118280|NCT00447603|385755|P1|Filter Period|Adverse Event|0
118281|NCT00447603|385753|P3|Screening|Study Terminated by Sponsor|0
118282|NCT00447603|385754|P2|Screening|Study Terminated by Sponsor|0
118283|NCT00447603|385755|P1|Screening|Study Terminated by Sponsor|15
118284|NCT00447603|385753|P3|Screening|Screen Failure|0
118285|NCT00447603|385754|P2|Screening|Screen Failure|0
118286|NCT00447603|385755|P1|Screening|Screen Failure|4
118287|NCT00447603|385753|P3|Screening|Protocol Violation|0
118288|NCT00447603|385754|P2|Screening|Protocol Violation|0
118289|NCT00447603|385755|P1|Screening|Protocol Violation|1
118290|NCT00447603|385753|P3|Screening|Withdrawal by Subject|0
118291|NCT00447603|385754|P2|Screening|Withdrawal by Subject|0
118292|NCT00447603|385755|P1|Screening|Withdrawal by Subject|1
118293|NCT00447876|385777|P2|Overall Study|Deterioration of symptomology|0
118294|NCT00447876|385778|P1|Overall Study|Deterioration of symptomology|1
118295|NCT00447876|385777|P2|Overall Study|Lost to Follow-up|0
118296|NCT00447876|385778|P1|Overall Study|Lost to Follow-up|1
118297|NCT00447876|385777|P2|Overall Study|Withdrawal by Subject|4
118298|NCT00447876|385778|P1|Overall Study|Withdrawal by Subject|1
118299|NCT00447902|385810|P2|Overall Study|Lack of Efficacy|1
118300|NCT00447902|385811|P1|Overall Study|Lack of Efficacy|2
118301|NCT00447902|385810|P2|Overall Study|included patients who discontinued|1
118302|NCT00447902|385811|P1|Overall Study|included patients who discontinued|1
118303|NCT00447902|385810|P2|Overall Study|Withdrawal by Subject|1
118304|NCT00447902|385811|P1|Overall Study|Withdrawal by Subject|0
118305|NCT00447902|385810|P2|Overall Study|Protocol Violation|0
118306|NCT00447902|385811|P1|Overall Study|Protocol Violation|1
118307|NCT00447902|385810|P2|Overall Study|Adverse Event|3
118308|NCT00447902|385811|P1|Overall Study|Adverse Event|0
118309|NCT00448019|385851|P1|Overall Study|Insurance Issues|1
118310|NCT00448019|385851|P1|Overall Study|Death|2
118311|NCT00448019|385851|P1|Overall Study|Disease progression|1
118312|NCT00448019|385851|P1|Overall Study|Withdrawal by Subject|3
118313|NCT00448123|385859|P2|Overall Study|Physician Decision|6
118314|NCT00448123|385860|P1|Overall Study|Physician Decision|6
118315|NCT00448123|385859|P2|Overall Study|Lost to Follow-up|6
118316|NCT00448123|385860|P1|Overall Study|Lost to Follow-up|9
118317|NCT00448136|385872|P2|Overall Study|Investigator's decision (progression)|0
118318|NCT00448136|385873|P1|Overall Study|Investigator's decision (progression)|1
118319|NCT00448136|385872|P2|Overall Study|Death|8
118320|NCT00448136|385873|P1|Overall Study|Death|3
118321|NCT00448279|385956|P2|Overall Study|Protocol Violation|1
118322|NCT00448279|385957|P1|Overall Study|Protocol Violation|0
118323|NCT00448279|385956|P2|Overall Study|Not specified|4
118324|NCT00448279|385957|P1|Overall Study|Not specified|6
118325|NCT00448279|385956|P2|Overall Study|Withdrawal by Subject|3
118326|NCT00448279|385957|P1|Overall Study|Withdrawal by Subject|4
118327|NCT00448279|385956|P2|Overall Study|Disease progression|18
118328|NCT00448279|385957|P1|Overall Study|Disease progression|16
118329|NCT00448279|385956|P2|Overall Study|Adverse Event|1
118330|NCT00448279|385957|P1|Overall Study|Adverse Event|1
118331|NCT00448279|385956|P2|Overall Study|Lost to Follow-up|2
118332|NCT00448279|385957|P1|Overall Study|Lost to Follow-up|2
118333|NCT00448344|385975|P2|Overall Study|Physician Decision|2
118334|NCT00448344|385976|P1|Overall Study|Physician Decision|1
118335|NCT00448344|385975|P2|Overall Study|Death|4
118336|NCT00448344|385976|P1|Overall Study|Death|3
118337|NCT00448344|385975|P2|Overall Study|Withdrawal by Subject|8
118338|NCT00448344|385976|P1|Overall Study|Withdrawal by Subject|6
118339|NCT00448344|385975|P2|Overall Study|Lost to Follow-up|22
118340|NCT00448344|385976|P1|Overall Study|Lost to Follow-up|20
118341|NCT00448435|386007|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
118342|NCT00448435|386008|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
118343|NCT00448448|386036|P2|Overall Study|Signed consent lost|1
118344|NCT00448448|386037|P1|Overall Study|Signed consent lost|0
118345|NCT00448448|386036|P2|Overall Study|Wrong diagnosis (n=3) or other|1
118346|NCT00448448|386037|P1|Overall Study|Wrong diagnosis (n=3) or other|2
118347|NCT00448448|386036|P2|Overall Study|Lost to Follow-up|1
118348|NCT00448448|386037|P1|Overall Study|Lost to Follow-up|2
118349|NCT00448448|386036|P2|Overall Study|On protocol when study ended|36
118350|NCT00448448|386037|P1|Overall Study|On protocol when study ended|83
118351|NCT00448448|386036|P2|Overall Study|Withdrawal by Subject|2
118352|NCT00448448|386037|P1|Overall Study|Withdrawal by Subject|13
118353|NCT00448539|386045|P2|Overall Study|Lost to Follow-up|3
118354|NCT00448539|386046|P1|Overall Study|Lost to Follow-up|1
118355|NCT00448539|386045|P2|Overall Study|Change of meds|3
118356|NCT00448539|386046|P1|Overall Study|Change of meds|2
118357|NCT00448539|386045|P2|Overall Study|Miscellaneous|1
118358|NCT00448539|386046|P1|Overall Study|Miscellaneous|2
118359|NCT00448539|386045|P2|Overall Study|Lack of Efficacy|40
118360|NCT00448539|386046|P1|Overall Study|Lack of Efficacy|27
118361|NCT00448539|386045|P2|Overall Study|Adverse Event|26
118362|NCT00448539|386046|P1|Overall Study|Adverse Event|9
118363|NCT00448539|386045|P2|Overall Study|Diary non-compliance|0
118364|NCT00448539|386046|P1|Overall Study|Diary non-compliance|1
118365|NCT00448539|386045|P2|Overall Study|Withdrawal by Subject|24
118366|NCT00448539|386046|P1|Overall Study|Withdrawal by Subject|20
118367|NCT00448539|386045|P2|Overall Study|Request of the investigator or sponsor|54
118368|NCT00448539|386046|P1|Overall Study|Request of the investigator or sponsor|67
118369|NCT00448539|386045|P2|Overall Study|Protocol Violation|0
118370|NCT00448539|386046|P1|Overall Study|Protocol Violation|1
118371|NCT00448539|386045|P2|Overall Study|Medication non-compliance|1
118372|NCT00448539|386046|P1|Overall Study|Medication non-compliance|4
118373|NCT00448591|386052|P1|Overall Study|Termination of Study|70
118374|NCT00448591|386052|P1|Overall Study|Not specified|154
118375|NCT00448591|386052|P1|Overall Study|Treatment Regimen Completed|70
118376|NCT00448591|386052|P1|Overall Study|Lost to Follow-up|19
118377|NCT00448591|386052|P1|Overall Study|Protocol Violation|41
118378|NCT00448591|386052|P1|Overall Study|Adverse Event|382
118379|NCT00448591|386052|P1|Overall Study|Progressive Disease|1382
118380|NCT00448591|386052|P1|Overall Study|Withdrawal by Subject|178
118381|NCT00448708|386114|P2|Overall Study|not listed|2
118382|NCT00448708|386115|P1|Overall Study|not listed|0
118383|NCT00448708|386114|P2|Overall Study|Lost to Follow-up|8
118384|NCT00448708|386115|P1|Overall Study|Lost to Follow-up|6
118385|NCT00448708|386114|P2|Overall Study|Withdrawal by Subject|4
118386|NCT00448708|386115|P1|Overall Study|Withdrawal by Subject|8
118387|NCT00448708|386114|P2|Overall Study|Death|17
118388|NCT00448708|386115|P1|Overall Study|Death|21
118389|NCT00448760|386123|P1|Overall Study|Death|3
118390|NCT00448864|386133|P3|Overall Study|Protocol Violation|0
118391|NCT00448864|386134|P2|Overall Study|Protocol Violation|2
118392|NCT00448864|386135|P1|Overall Study|Protocol Violation|0
118393|NCT00448864|386133|P3|Overall Study|Withdrawal by Subject|0
118394|NCT00448864|386134|P2|Overall Study|Withdrawal by Subject|2
118395|NCT00448864|386135|P1|Overall Study|Withdrawal by Subject|0
118396|NCT00448864|386133|P3|Overall Study|Physician Decision|1
118397|NCT00448864|386134|P2|Overall Study|Physician Decision|0
118398|NCT00448864|386135|P1|Overall Study|Physician Decision|1
118399|NCT00448864|386133|P3|Overall Study|Lost to Follow-up|0
118400|NCT00448864|386134|P2|Overall Study|Lost to Follow-up|1
118401|NCT00448864|386135|P1|Overall Study|Lost to Follow-up|3
118402|NCT00448864|386133|P3|Overall Study|Death|0
118403|NCT00448864|386134|P2|Overall Study|Death|0
118404|NCT00448864|386135|P1|Overall Study|Death|1
118405|NCT00448916|386155|P4|Overall Study|Protocol Violation|1
118406|NCT00448916|386156|P3|Overall Study|Protocol Violation|0
118407|NCT00448916|386157|P2|Overall Study|Protocol Violation|0
118408|NCT00448916|386158|P1|Overall Study|Protocol Violation|0
118409|NCT00448916|386155|P4|Overall Study|Lost to Follow-up|1
118410|NCT00448916|386156|P3|Overall Study|Lost to Follow-up|0
118411|NCT00448916|386157|P2|Overall Study|Lost to Follow-up|1
118412|NCT00448916|386158|P1|Overall Study|Lost to Follow-up|0
118413|NCT00448916|386155|P4|Overall Study|Not specified|0
118414|NCT00448916|386156|P3|Overall Study|Not specified|0
118415|NCT00448916|386157|P2|Overall Study|Not specified|0
118416|NCT00448916|386158|P1|Overall Study|Not specified|1
118417|NCT00448916|386155|P4|Overall Study|Withdrawal by Subject|1
118418|NCT00448916|386156|P3|Overall Study|Withdrawal by Subject|1
118419|NCT00448916|386157|P2|Overall Study|Withdrawal by Subject|3
118420|NCT00448916|386158|P1|Overall Study|Withdrawal by Subject|3
118421|NCT00448916|386155|P4|Overall Study|Lack of Efficacy|1
118422|NCT00448916|386156|P3|Overall Study|Lack of Efficacy|2
118423|NCT00448916|386157|P2|Overall Study|Lack of Efficacy|0
118424|NCT00448916|386158|P1|Overall Study|Lack of Efficacy|1
118425|NCT00448916|386155|P4|Overall Study|Adverse Event|2
118426|NCT00448916|386156|P3|Overall Study|Adverse Event|3
118427|NCT00448916|386157|P2|Overall Study|Adverse Event|2
118428|NCT00448916|386158|P1|Overall Study|Adverse Event|2
118429|NCT00449033|386231|P2|Follow-up Period|Reason Missing|113
118430|NCT00449033|386232|P1|Follow-up Period|Reason Missing|120
118431|NCT00449033|386231|P2|Follow-up Period|Lost to Follow-up|10
118432|NCT00449033|386232|P1|Follow-up Period|Lost to Follow-up|6
118433|NCT00449033|386231|P2|Follow-up Period|Death|311
118434|NCT00449033|386232|P1|Follow-up Period|Death|299
118435|NCT00449033|386231|P2|Treatment Period|Treatment Ongoing|4
118436|NCT00449033|386232|P1|Treatment Period|Treatment Ongoing|6
118437|NCT00449033|386231|P2|Treatment Period|Reason Missing|4
118438|NCT00449033|386232|P1|Treatment Period|Reason Missing|0
118439|NCT00449033|386231|P2|Treatment Period|Second Malignancy|1
118440|NCT00449033|386232|P1|Treatment Period|Second Malignancy|0
118441|NCT00449033|386231|P2|Treatment Period|Non-compliance|8
118442|NCT00449033|386232|P1|Treatment Period|Non-compliance|7
118443|NCT00449033|386231|P2|Treatment Period|Amended Protocol Criteria|18
118444|NCT00449033|386232|P1|Treatment Period|Amended Protocol Criteria|22
118445|NCT00449033|386231|P2|Treatment Period|Consent Withdrawn|20
118446|NCT00449033|386232|P1|Treatment Period|Consent Withdrawn|36
118447|NCT00449033|386231|P2|Treatment Period|Disease Progression|288
118448|NCT00449033|386232|P1|Treatment Period|Disease Progression|231
118449|NCT00449033|386231|P2|Treatment Period|Protocol Violation|7
118450|NCT00449033|386232|P1|Treatment Period|Protocol Violation|8
118451|NCT00449033|386231|P2|Treatment Period|Physician Decision|5
118452|NCT00449033|386232|P1|Treatment Period|Physician Decision|4
118453|NCT00449033|386231|P2|Treatment Period|Lost to Follow-up|2
118454|NCT00449033|386232|P1|Treatment Period|Lost to Follow-up|0
118455|NCT00449033|386231|P2|Treatment Period|Death|12
118456|NCT00449033|386232|P1|Treatment Period|Death|21
118457|NCT00449033|386231|P2|Treatment Period|Adverse Event|83
118458|NCT00449033|386232|P1|Treatment Period|Adverse Event|117
118459|NCT00449072|386279|P2|Overall Study|Relocation|2
118460|NCT00449072|386280|P1|Overall Study|Relocation|3
118461|NCT00449072|386279|P2|Overall Study|Sponsor decision|3
118462|NCT00449072|386280|P1|Overall Study|Sponsor decision|1
118463|NCT00449072|386279|P2|Overall Study|Non-compliance|5
118464|NCT00449072|386280|P1|Overall Study|Non-compliance|2
118465|NCT00449072|386279|P2|Overall Study|Excluded medication|2
118466|NCT00449072|386280|P1|Overall Study|Excluded medication|0
118467|NCT00449072|386279|P2|Overall Study|Not treated|1
118468|NCT00449072|386280|P1|Overall Study|Not treated|0
118469|NCT00449072|386279|P2|Overall Study|Physician Decision|0
118470|NCT00449072|386280|P1|Overall Study|Physician Decision|1
118471|NCT00449072|386279|P2|Overall Study|Lack of Efficacy|1
118472|NCT00449072|386280|P1|Overall Study|Lack of Efficacy|1
118473|NCT00449072|386279|P2|Overall Study|Withdrawal by Subject|8
118474|NCT00449072|386280|P1|Overall Study|Withdrawal by Subject|11
118475|NCT00449072|386279|P2|Overall Study|Lost to Follow-up|7
118476|NCT00449072|386280|P1|Overall Study|Lost to Follow-up|5
118477|NCT00449072|386279|P2|Overall Study|Protocol Violation|12
118478|NCT00449072|386280|P1|Overall Study|Protocol Violation|14
118479|NCT00449072|386279|P2|Overall Study|Adverse Event|1
118480|NCT00449072|386280|P1|Overall Study|Adverse Event|3
118481|NCT00449150|386307|P3|Overall Study|Protocol Violation|1
118482|NCT00449150|386308|P2|Overall Study|Protocol Violation|2
118483|NCT00449150|386309|P1|Overall Study|Protocol Violation|1
118484|NCT00449150|386307|P3|Overall Study|Withdrawal by Subject|21
118485|NCT00449150|386308|P2|Overall Study|Withdrawal by Subject|18
118486|NCT00449150|386309|P1|Overall Study|Withdrawal by Subject|17
118487|NCT00449150|386307|P3|Overall Study|Not specified|14
118488|NCT00449150|386308|P2|Overall Study|Not specified|13
118489|NCT00449150|386309|P1|Overall Study|Not specified|16
118490|NCT00449150|386307|P3|Overall Study|Lack of Efficacy|2
118491|NCT00449150|386308|P2|Overall Study|Lack of Efficacy|2
118492|NCT00449150|386309|P1|Overall Study|Lack of Efficacy|1
118493|NCT00449150|386307|P3|Overall Study|Adverse Event|9
118494|NCT00449150|386308|P2|Overall Study|Adverse Event|18
118495|NCT00449150|386309|P1|Overall Study|Adverse Event|11
118496|NCT00449163|386317|P1|Overall Study|Physician Decision|3
118497|NCT00449176|386327|P3|Overall Study|all other|20
118498|NCT00449176|386328|P2|Overall Study|all other|19
118499|NCT00449176|386329|P1|Overall Study|all other|22
118500|NCT00449176|386327|P3|Overall Study|Study drug non-compliant|11
118501|NCT00449176|386328|P2|Overall Study|Study drug non-compliant|11
118502|NCT00449176|386329|P1|Overall Study|Study drug non-compliant|14
118503|NCT00449176|386327|P3|Overall Study|Lack of Efficacy|50
118504|NCT00449176|386328|P2|Overall Study|Lack of Efficacy|7
118505|NCT00449176|386329|P1|Overall Study|Lack of Efficacy|13
118506|NCT00449176|386327|P3|Overall Study|Adverse Event|15
118507|NCT00449176|386328|P2|Overall Study|Adverse Event|107
118508|NCT00449176|386329|P1|Overall Study|Adverse Event|51
118509|NCT00449176|386327|P3|Overall Study|Lost to Follow-up|12
118510|NCT00449176|386328|P2|Overall Study|Lost to Follow-up|8
118511|NCT00449176|386329|P1|Overall Study|Lost to Follow-up|13
118512|NCT00449176|386327|P3|Overall Study|Withdrawal by Subject|59
118513|NCT00449176|386328|P2|Overall Study|Withdrawal by Subject|43
118514|NCT00449176|386329|P1|Overall Study|Withdrawal by Subject|39
118515|NCT00449540|386357|P3|Treatment Phase|did not experience or treat migraine|17
118516|NCT00449540|386358|P2|Treatment Phase|did not experience or treat migraine|20
118517|NCT00449540|386359|P1|Treatment Phase|did not experience or treat migraine|0
118518|NCT00449540|386357|P3|Pretreatment Phase|No migraine experienced|0
118519|NCT00449540|386358|P2|Pretreatment Phase|No migraine experienced|0
118520|NCT00449540|386359|P1|Pretreatment Phase|No migraine experienced|66
118521|NCT00449644|386377|P4|Overall Study|Rolled-over to treatment with TMC207|1
118522|NCT00449644|386378|P3|Overall Study|Rolled-over to treatment with TMC207|0
118523|NCT00449644|386379|P2|Overall Study|Rolled-over to treatment with TMC207|0
118524|NCT00449644|386380|P1|Overall Study|Rolled-over to treatment with TMC207|0
118525|NCT00449644|386377|P4|Overall Study|Not specified|0
118526|NCT00449644|386378|P3|Overall Study|Not specified|1
118527|NCT00449644|386379|P2|Overall Study|Not specified|4
118528|NCT00449644|386380|P1|Overall Study|Not specified|1
118529|NCT00449644|386377|P4|Overall Study|Inclusion/exclusion criteria not met|6
118530|NCT00449644|386378|P3|Overall Study|Inclusion/exclusion criteria not met|2
118531|NCT00449644|386379|P2|Overall Study|Inclusion/exclusion criteria not met|0
118532|NCT00449644|386380|P1|Overall Study|Inclusion/exclusion criteria not met|0
118533|NCT00449644|386377|P4|Overall Study|Withdrawal by Subject|7
118534|NCT00449644|386378|P3|Overall Study|Withdrawal by Subject|6
118535|NCT00449644|386379|P2|Overall Study|Withdrawal by Subject|4
118536|NCT00449644|386380|P1|Overall Study|Withdrawal by Subject|3
118537|NCT00449644|386377|P4|Overall Study|Protocol Violation|7
118538|NCT00449644|386378|P3|Overall Study|Protocol Violation|3
118539|NCT00449644|386379|P2|Overall Study|Protocol Violation|4
118540|NCT00449644|386380|P1|Overall Study|Protocol Violation|4
118541|NCT00449644|386377|P4|Overall Study|Pregnancy|2
118542|NCT00449644|386378|P3|Overall Study|Pregnancy|3
118543|NCT00449644|386379|P2|Overall Study|Pregnancy|0
118544|NCT00449644|386380|P1|Overall Study|Pregnancy|0
118545|NCT00449644|386377|P4|Overall Study|Lost to Follow-up|3
118546|NCT00449644|386378|P3|Overall Study|Lost to Follow-up|5
118547|NCT00449644|386379|P2|Overall Study|Lost to Follow-up|1
118548|NCT00449644|386380|P1|Overall Study|Lost to Follow-up|1
118549|NCT00449644|386377|P4|Overall Study|Death|1
118550|NCT00449644|386378|P3|Overall Study|Death|6
118551|NCT00449644|386379|P2|Overall Study|Death|0
118552|NCT00449644|386380|P1|Overall Study|Death|1
118553|NCT00449644|386377|P4|Overall Study|Adverse Event|5
118554|NCT00449644|386378|P3|Overall Study|Adverse Event|3
118555|NCT00449644|386379|P2|Overall Study|Adverse Event|0
118556|NCT00449644|386380|P1|Overall Study|Adverse Event|0
118557|NCT00449696|386400|P2|Overall Study|Others|0
118558|NCT00449696|386401|P1|Overall Study|Others|7
118559|NCT00449696|386400|P2|Overall Study|Lost to Follow-up|3
118560|NCT00449696|386401|P1|Overall Study|Lost to Follow-up|2
118561|NCT00449696|386400|P2|Overall Study|Withdrawal by Subject|5
118562|NCT00449696|386401|P1|Overall Study|Withdrawal by Subject|5
118563|NCT00449696|386400|P2|Overall Study|Other Treatment Required|1
118564|NCT00449696|386401|P1|Overall Study|Other Treatment Required|6
118565|NCT00449787|386429|P2|Overall Study|Did not require medication|92
118566|NCT00449787|386430|P1|Overall Study|Did not require medication|95
118567|NCT00449787|386429|P2|Overall Study|Lost to Follow-up|8
118568|NCT00449787|386430|P1|Overall Study|Lost to Follow-up|10
118569|NCT00449865|386442|P2|Overall Study|Study was stopped|328
118570|NCT00449865|386443|P1|Overall Study|Study was stopped|324
118571|NCT00449865|386442|P2|Overall Study|Protocol Violation|7
118572|NCT00449865|386443|P1|Overall Study|Protocol Violation|8
118573|NCT00449865|386442|P2|Overall Study|Death|40
118574|NCT00449865|386443|P1|Overall Study|Death|31
118575|NCT00449865|386442|P2|Overall Study|Physician Decision|12
118576|NCT00449865|386443|P1|Overall Study|Physician Decision|13
118577|NCT00449865|386442|P2|Overall Study|Lost to Follow-up|37
118578|NCT00449865|386443|P1|Overall Study|Lost to Follow-up|36
118579|NCT00449865|386442|P2|Overall Study|Withdrawal by Subject|110
118580|NCT00449865|386443|P1|Overall Study|Withdrawal by Subject|110
118581|NCT00449930|386451|P2|Overall Study|Glycemic discontinuation criteria|1
118582|NCT00449930|386452|P1|Overall Study|Glycemic discontinuation criteria|1
118583|NCT00449930|386451|P2|Overall Study|Withdrawal by Subject|23
118584|NCT00449930|386452|P1|Overall Study|Withdrawal by Subject|16
118585|NCT00449930|386451|P2|Overall Study|Protocol Violation|15
118586|NCT00449930|386452|P1|Overall Study|Protocol Violation|14
118587|NCT00449930|386451|P2|Overall Study|Physician Decision|2
118588|NCT00449930|386452|P1|Overall Study|Physician Decision|1
118589|NCT00449930|386451|P2|Overall Study|Lost to Follow-up|14
118590|NCT00449930|386452|P1|Overall Study|Lost to Follow-up|9
118591|NCT00449930|386451|P2|Overall Study|Lack of Efficacy|1
118592|NCT00449930|386452|P1|Overall Study|Lack of Efficacy|10
118593|NCT00449930|386451|P2|Overall Study|Trial Terminated ( Site Closed)|0
118594|NCT00449930|386452|P1|Overall Study|Trial Terminated ( Site Closed)|1
118595|NCT00449930|386451|P2|Overall Study|Adverse Event|19
118596|NCT00449930|386452|P1|Overall Study|Adverse Event|9
118597|NCT00449956|386469|P3|Overall Study|Physician Decision|1
118598|NCT00449956|386470|P2|Overall Study|Physician Decision|1
118599|NCT00449956|386471|P1|Overall Study|Physician Decision|2
118600|NCT00449956|386469|P3|Overall Study|Withdrawal by Subject|0
118601|NCT00449956|386470|P2|Overall Study|Withdrawal by Subject|1
118602|NCT00449956|386471|P1|Overall Study|Withdrawal by Subject|0
118603|NCT00449956|386469|P3|Overall Study|Protocol Violation|1
118604|NCT00449956|386470|P2|Overall Study|Protocol Violation|1
118605|NCT00449956|386471|P1|Overall Study|Protocol Violation|1
118606|NCT00449956|386469|P3|Overall Study|Lack of Efficacy|1
118607|NCT00449956|386470|P2|Overall Study|Lack of Efficacy|0
118608|NCT00449956|386471|P1|Overall Study|Lack of Efficacy|0
118609|NCT00449956|386469|P3|Overall Study|Adverse Event|6
118610|NCT00449956|386470|P2|Overall Study|Adverse Event|1
118611|NCT00449956|386471|P1|Overall Study|Adverse Event|7
118612|NCT00441974|386485|P1|Overall Study|Protocol Violation|7
118613|NCT00441974|386485|P1|Overall Study|Lost to Follow-up|80
118614|NCT00441974|386485|P1|Overall Study|Consent Withdrawn|35
118615|NCT00441974|386485|P1|Overall Study|Adverse Event|6
118616|NCT00442117|386520|P2|Overall Study|Met Withdrawal Criteria|1
118617|NCT00442117|386521|P1|Overall Study|Met Withdrawal Criteria|2
118618|NCT00442117|386520|P2|Overall Study|Non compliance with protocol|5
118619|NCT00442117|386521|P1|Overall Study|Non compliance with protocol|3
118620|NCT00442117|386520|P2|Overall Study|Major Deviation|20
118621|NCT00442117|386521|P1|Overall Study|Major Deviation|25
118622|NCT00442117|386520|P2|Overall Study|Withdrawal by Subject|2
118623|NCT00442117|386521|P1|Overall Study|Withdrawal by Subject|2
118624|NCT00442117|386520|P2|Overall Study|Lost to Follow-up|2
118625|NCT00442117|386521|P1|Overall Study|Lost to Follow-up|1
118626|NCT00442117|386520|P2|Overall Study|Lack of Efficacy|6
118627|NCT00442117|386521|P1|Overall Study|Lack of Efficacy|2
118628|NCT00442117|386520|P2|Overall Study|Adverse Event|2
118629|NCT00442117|386521|P1|Overall Study|Adverse Event|3
118630|NCT00442286|386585|P2|Overall Study|Patient Injury|0
118631|NCT00442286|386586|P1|Overall Study|Patient Injury|1
118632|NCT00442286|386585|P2|Overall Study|System explanted|0
118633|NCT00442286|386586|P1|Overall Study|System explanted|1
118634|NCT00442286|386585|P2|Overall Study|Withdrawal by Subject|0
118635|NCT00442286|386586|P1|Overall Study|Withdrawal by Subject|2
118636|NCT00442286|386585|P2|Overall Study|Lost to Follow-up|0
118637|NCT00442286|386586|P1|Overall Study|Lost to Follow-up|1
118638|NCT00442286|386585|P2|Overall Study|Death|2
118639|NCT00442286|386586|P1|Overall Study|Death|2
118640|NCT00442351|386612|P2|Overall Study|Not specified|1
118641|NCT00442351|386613|P1|Overall Study|Not specified|0
118642|NCT00442351|386612|P2|Overall Study|Did not meet protocol eligibility|0
118643|NCT00442351|386613|P1|Overall Study|Did not meet protocol eligibility|1
118644|NCT00442351|386612|P2|Overall Study|Administrative|5
118645|NCT00442351|386613|P1|Overall Study|Administrative|6
118646|NCT00442416|386625|P2|Overall Study|Administrative/Other|33
118647|NCT00442416|386626|P1|Overall Study|Administrative/Other|27
118648|NCT00442416|386625|P2|Overall Study|Withdrew consent|2
118649|NCT00442416|386626|P1|Overall Study|Withdrew consent|1
118650|NCT00442416|386625|P2|Overall Study|Protocol Violation|3
118651|NCT00442416|386626|P1|Overall Study|Protocol Violation|2
118652|NCT00442416|386625|P2|Overall Study|Lack of Efficacy|0
118653|NCT00442416|386626|P1|Overall Study|Lack of Efficacy|2
118654|NCT00442416|386625|P2|Overall Study|Death|0
118655|NCT00442416|386626|P1|Overall Study|Death|1
118656|NCT00442416|386625|P2|Overall Study|Adverse Event|1
118657|NCT00442416|386626|P1|Overall Study|Adverse Event|4
118658|NCT00442468|386659|P1|Overall Study|Did not complete all study procedures|88
118659|NCT00442468|386659|P1|Overall Study|Withdrawal by Subject|91
118660|NCT00442468|386659|P1|Overall Study|Adverse Event|4
118661|NCT00442546|386697|P3|Overall Study|Randomized But Not Treated|6
118662|NCT00442546|386698|P2|Overall Study|Randomized But Not Treated|4
118663|NCT00442546|386699|P1|Overall Study|Randomized But Not Treated|5
118664|NCT00442546|386697|P3|Overall Study|Withdrawal by Subject|7
118665|NCT00442546|386698|P2|Overall Study|Withdrawal by Subject|5
118666|NCT00442546|386699|P1|Overall Study|Withdrawal by Subject|5
118667|NCT00442546|386697|P3|Overall Study|Other|6
118668|NCT00442546|386698|P2|Overall Study|Other|9
118669|NCT00442546|386699|P1|Overall Study|Other|4
118670|NCT00442546|386697|P3|Overall Study|Lost to Follow-up|1
118671|NCT00442546|386698|P2|Overall Study|Lost to Follow-up|2
118672|NCT00442546|386699|P1|Overall Study|Lost to Follow-up|1
118673|NCT00442546|386697|P3|Overall Study|Adverse Event|13
118674|NCT00442546|386698|P2|Overall Study|Adverse Event|17
118675|NCT00442546|386699|P1|Overall Study|Adverse Event|11
118676|NCT00442559|386823|P2|Overall Study|Withdrawal by Subject|0
118677|NCT00442559|386824|P1|Overall Study|Withdrawal by Subject|1
118678|NCT00442559|386823|P2|Overall Study|Protocol Violation|1
118679|NCT00442559|386824|P1|Overall Study|Protocol Violation|1
118680|NCT00442559|386823|P2|Overall Study|Lost to Follow-up|34
118681|NCT00442559|386824|P1|Overall Study|Lost to Follow-up|32
118682|NCT00442572|386838|P2|Overall Study|Withdrawal by Subject|1
118683|NCT00442572|386839|P1|Overall Study|Withdrawal by Subject|0
118684|NCT00442572|386838|P2|Overall Study|Lost to Follow-up|1
118685|NCT00442572|386839|P1|Overall Study|Lost to Follow-up|0
118686|NCT00442572|386838|P2|Overall Study|Relapse|1
118687|NCT00442572|386839|P1|Overall Study|Relapse|8
118688|NCT00442598|386880|P3|Overall Study|Death|0
118689|NCT00442598|386881|P2|Overall Study|Death|1
118690|NCT00442598|386882|P1|Overall Study|Death|0
118691|NCT00442598|386880|P3|Overall Study|Reduced creatinine clearance|0
118692|NCT00442598|386881|P2|Overall Study|Reduced creatinine clearance|0
118693|NCT00442598|386882|P1|Overall Study|Reduced creatinine clearance|1
118694|NCT00442598|386880|P3|Overall Study|CA125 progression|0
118695|NCT00442598|386881|P2|Overall Study|CA125 progression|1
118696|NCT00442598|386882|P1|Overall Study|CA125 progression|0
118697|NCT00442598|386880|P3|Overall Study|Clinical deterioration|0
118698|NCT00442598|386881|P2|Overall Study|Clinical deterioration|2
118699|NCT00442598|386882|P1|Overall Study|Clinical deterioration|1
118700|NCT00442598|386880|P3|Overall Study|Tumor progression|0
118701|NCT00442598|386881|P2|Overall Study|Tumor progression|4
118702|NCT00442598|386882|P1|Overall Study|Tumor progression|3
118703|NCT00442598|386880|P3|Overall Study|Adverse Event|0
118704|NCT00442598|386881|P2|Overall Study|Adverse Event|0
118705|NCT00442598|386882|P1|Overall Study|Adverse Event|1
118706|NCT00442702|386944|P2|Evaluation Period|Site closure|1
118707|NCT00442702|386945|P1|Evaluation Period|Site closure|0
118708|NCT00442702|386944|P2|Evaluation Period|Failure to return|0
118709|NCT00442702|386945|P1|Evaluation Period|Failure to return|1
118710|NCT00442702|386944|P2|Evaluation Period|Renal transplant|1
118711|NCT00442702|386945|P1|Evaluation Period|Renal transplant|0
118712|NCT00442702|386944|P2|Evaluation Period|Refused treatment|1
118713|NCT00442702|386945|P1|Evaluation Period|Refused treatment|1
118714|NCT00442702|386944|P2|Evaluation Period|Insufficient Therapeutic Response|0
118715|NCT00442702|386945|P1|Evaluation Period|Insufficient Therapeutic Response|1
118716|NCT00442702|386944|P2|Evaluation Period|Death|1
118717|NCT00442702|386945|P1|Evaluation Period|Death|1
118718|NCT00442702|386944|P2|Evaluation Period|Adverse Event|0
118719|NCT00442702|386945|P1|Evaluation Period|Adverse Event|1
118720|NCT00442702|386944|P2|Titration Period|Hospitalized in another hospital|0
118721|NCT00442702|386945|P1|Titration Period|Hospitalized in another hospital|1
118722|NCT00442702|386944|P2|Titration Period|Failure to return|0
118723|NCT00442702|386945|P1|Titration Period|Failure to return|1
118724|NCT00442702|386944|P2|Titration Period|Refused Treatment|1
118725|NCT00442702|386945|P1|Titration Period|Refused Treatment|4
118726|NCT00442702|386944|P2|Titration Period|Insufficient Therapeutic Response|0
118727|NCT00442702|386945|P1|Titration Period|Insufficient Therapeutic Response|1
118728|NCT00442702|386944|P2|Titration Period|Death|2
118729|NCT00442702|386945|P1|Titration Period|Death|3
118730|NCT00442702|386944|P2|Titration Period|Adverse Event|0
118731|NCT00442702|386945|P1|Titration Period|Adverse Event|2
118732|NCT00442897|386959|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
118733|NCT00442897|386960|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
118734|NCT00442897|386959|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
118735|NCT00442897|386960|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
118736|NCT00442897|386959|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
118737|NCT00442897|386960|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
118738|NCT00442897|386959|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
118739|NCT00442897|386960|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
118740|NCT00442897|386959|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
118741|NCT00442897|386960|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
118742|NCT00442897|386959|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
118743|NCT00442897|386960|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
118744|NCT00442897|386959|P2|Base Study (12 Week Follow-up)|Death|1
118745|NCT00442897|386960|P1|Base Study (12 Week Follow-up)|Death|0
118746|NCT00442897|386959|P2|Base Study (12 Week Follow-up)|Adverse Event|0
118747|NCT00442897|386960|P1|Base Study (12 Week Follow-up)|Adverse Event|1
118748|NCT00442936|386972|P4|Overall Study|Protocol Violation|1
118749|NCT00442936|386973|P3|Overall Study|Protocol Violation|1
118750|NCT00442936|386974|P2|Overall Study|Protocol Violation|0
118751|NCT00442936|386975|P1|Overall Study|Protocol Violation|1
118752|NCT00442962|387021|P1|Overall Study|Lost to Follow-up|7
118753|NCT00442962|387021|P1|Overall Study|Pregnancy|1
118754|NCT00443040|387038|P3|Overall Study|Converted to an open laparotomy|1
118755|NCT00443040|387039|P2|Overall Study|Converted to an open laparotomy|0
118756|NCT00443040|387040|P1|Overall Study|Converted to an open laparotomy|3
118757|NCT00443040|387038|P3|Overall Study|Withdrawal by Subject|0
118758|NCT00443040|387039|P2|Overall Study|Withdrawal by Subject|0
118759|NCT00443040|387040|P1|Overall Study|Withdrawal by Subject|1
118760|NCT00443053|387050|P2|Overall Study|Physician Decision|4
118761|NCT00443053|387051|P1|Overall Study|Physician Decision|0
118762|NCT00443053|387050|P2|Overall Study|Other|4
118763|NCT00443053|387051|P1|Overall Study|Other|3
118764|NCT00443053|387050|P2|Overall Study|Noncompliance|1
118765|NCT00443053|387051|P1|Overall Study|Noncompliance|2
118766|NCT00443053|387050|P2|Overall Study|Did Not Meet Eligibility Criteria|0
118767|NCT00443053|387051|P1|Overall Study|Did Not Meet Eligibility Criteria|1
118768|NCT00443053|387050|P2|Overall Study|Lost to Follow-up|5
118769|NCT00443053|387051|P1|Overall Study|Lost to Follow-up|4
118770|NCT00443053|387050|P2|Overall Study|Withdrawal by Subject|18
118771|NCT00443053|387051|P1|Overall Study|Withdrawal by Subject|9
118772|NCT00443053|387050|P2|Overall Study|Adverse Event|1
118773|NCT00443053|387051|P1|Overall Study|Adverse Event|2
118774|NCT00443118|387072|P3|Overall Study|Withdrawal by Subject|0
118775|NCT00443118|387073|P2|Overall Study|Withdrawal by Subject|0
118776|NCT00443118|387074|P1|Overall Study|Withdrawal by Subject|1
118777|NCT00443118|387072|P3|Overall Study|unknown primary outcome|0
118778|NCT00443118|387073|P2|Overall Study|unknown primary outcome|1
118779|NCT00443118|387074|P1|Overall Study|unknown primary outcome|3
118780|NCT00443209|387120|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
118781|NCT00443209|387121|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
118782|NCT00443209|387120|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
118783|NCT00443209|387121|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
118784|NCT00443209|387120|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
118785|NCT00443209|387121|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
118786|NCT00443209|387120|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
118787|NCT00443209|387121|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
118788|NCT00443209|387120|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
118789|NCT00443209|387121|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
118790|NCT00443209|387120|P2|Months 13 to 18 Treatment Period|Adverse Event|0
118791|NCT00443209|387121|P1|Months 13 to 18 Treatment Period|Adverse Event|1
118792|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Not Treated|43
118793|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Not Treated|71
118794|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Missing|1
118795|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Missing|2
118796|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
118797|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
118798|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
118799|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
118800|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Pregnancy|4
118801|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Pregnancy|3
118802|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Physician Decision|4
118803|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Physician Decision|8
118804|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
118805|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
118806|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
118807|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
118808|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
118809|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
118810|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
118811|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
118812|NCT00443209|387120|P2|Months 1 to 12 Treatment Period|Adverse Event|11
118813|NCT00443209|387121|P1|Months 1 to 12 Treatment Period|Adverse Event|22
118814|NCT00443261|387135|P1|Overall Study|Death|1
118815|NCT00443430|387145|P2|Overall Study|Adverse Event|1
118816|NCT00443430|387146|P1|Overall Study|Adverse Event|1
118817|NCT00443430|387145|P2|Overall Study|Lack of Efficacy|3
118818|NCT00443430|387146|P1|Overall Study|Lack of Efficacy|3
118819|NCT00443456|387156|P1|Overall Study|Withdrawal by Subject|1
118820|NCT00443456|387156|P1|Overall Study|Move|1
118821|NCT00443456|387156|P1|Overall Study|Adverse Event|16
118822|NCT00443534|387189|P1|Overall Study|Enrolled, Not Treated|1
118823|NCT00443534|387189|P1|Overall Study|Unspecified|10
118824|NCT00443534|387189|P1|Overall Study|Study Terminated by Sponsor|12
118825|NCT00443534|387189|P1|Overall Study|Withdrawal by Subject|8
118826|NCT00443534|387189|P1|Overall Study|Death|9
118827|NCT00443534|387189|P1|Overall Study|Adverse Event|16
118828|NCT00443534|387189|P1|Overall Study|Lack of Efficacy|67
118829|NCT00443560|387198|P2|Overall Study|Multiple pregnancies or fetal demise|4
118830|NCT00443560|387199|P1|Overall Study|Multiple pregnancies or fetal demise|2
118831|NCT00443560|387198|P2|Overall Study|No intrathecal dose|26
118832|NCT00443560|387199|P1|Overall Study|No intrathecal dose|58
118833|NCT00443599|387211|P2|Overall Study|Cardiopulmonary bypass canceled|1
118834|NCT00443599|387212|P1|Overall Study|Cardiopulmonary bypass canceled|3
118835|NCT00443599|387211|P2|Overall Study|Death|1
118836|NCT00443599|387212|P1|Overall Study|Death|1
118837|NCT00443599|387211|P2|Overall Study|Physician Decision|1
118838|NCT00443599|387212|P1|Overall Study|Physician Decision|2
118839|NCT00443651|387246|P2|Overall Study|Pregnancy|1
118840|NCT00443651|387247|P1|Overall Study|Pregnancy|0
118841|NCT00443651|387246|P2|Overall Study|Physician Decision|4
118842|NCT00443651|387247|P1|Overall Study|Physician Decision|13
118843|NCT00443651|387246|P2|Overall Study|Patient's/Guardian's Decision|30
118844|NCT00443651|387247|P1|Overall Study|Patient's/Guardian's Decision|58
118845|NCT00443651|387246|P2|Overall Study|Lost to Follow-up|12
118846|NCT00443651|387247|P1|Overall Study|Lost to Follow-up|18
118847|NCT00443651|387246|P2|Overall Study|Adverse Event|6
118848|NCT00443651|387247|P1|Overall Study|Adverse Event|5
118849|NCT00443651|387246|P2|Overall Study|Death|5
118850|NCT00443651|387247|P1|Overall Study|Death|1
118851|NCT00443703|387267|P2|Overall Study|Progressive Disease|0
118852|NCT00443703|387268|P1|Overall Study|Progressive Disease|1
118853|NCT00443703|387267|P2|Overall Study|Withdrawal by Subject|6
118854|NCT00443703|387268|P1|Overall Study|Withdrawal by Subject|9
118855|NCT00443703|387267|P2|Overall Study|Protocol Violation|1
118856|NCT00443703|387268|P1|Overall Study|Protocol Violation|1
118857|NCT00443703|387267|P2|Overall Study|Physician Decision|2
118858|NCT00443703|387268|P1|Overall Study|Physician Decision|4
118859|NCT00443703|387267|P2|Overall Study|Lost to Follow-up|4
118860|NCT00443703|387268|P1|Overall Study|Lost to Follow-up|0
118861|NCT00443703|387267|P2|Overall Study|Lack of Efficacy|1
118862|NCT00443703|387268|P1|Overall Study|Lack of Efficacy|3
118863|NCT00443703|387267|P2|Overall Study|Adverse Event|3
118864|NCT00443703|387268|P1|Overall Study|Adverse Event|7
118865|NCT00443703|387267|P2|Overall Study|Never Treated|1
118866|NCT00443703|387268|P1|Overall Study|Never Treated|3
118867|NCT00443729|387320|P2|Overall Study|Withdrawal by Subject|1
118868|NCT00443729|387321|P1|Overall Study|Withdrawal by Subject|3
118869|NCT00443729|387320|P2|Overall Study|Protocol Violation|1
118870|NCT00443729|387321|P1|Overall Study|Protocol Violation|1
118871|NCT00443729|387320|P2|Overall Study|Physician Decision|1
118872|NCT00443729|387321|P1|Overall Study|Physician Decision|2
118873|NCT00443729|387320|P2|Overall Study|Lost to Follow-up|1
118874|NCT00443729|387321|P1|Overall Study|Lost to Follow-up|0
118875|NCT00443729|387320|P2|Overall Study|Lack of Efficacy|2
118876|NCT00443729|387321|P1|Overall Study|Lack of Efficacy|4
118877|NCT00443729|387320|P2|Overall Study|Never Treated|1
118878|NCT00443729|387321|P1|Overall Study|Never Treated|0
118879|NCT00443755|387369|P2|Overall Study|Withdrawal by Subject|1
118880|NCT00443755|387370|P1|Overall Study|Withdrawal by Subject|2
118881|NCT00443781|387402|P1|Overall Study|PD/FAD not done|1
118882|NCT00443781|387402|P1|Overall Study|Insurance not covered|2
118883|NCT00443781|387402|P1|Overall Study|Investigator terminated participation|1
118884|NCT00443781|387402|P1|Overall Study|Unable to comply with study follow up|2
118885|NCT00443781|387402|P1|Overall Study|Withdrawal by Subject|6
118886|NCT00443781|387402|P1|Overall Study|Protocol Violation|1
118887|NCT00443781|387402|P1|Overall Study|Physician Decision|2
118888|NCT00443781|387402|P1|Overall Study|Lost to Follow-up|10
118889|NCT00443820|387410|P4|Overall Study|Death|0
118890|NCT00443820|387411|P3|Overall Study|Death|1
118891|NCT00443820|387412|P2|Overall Study|Death|0
118892|NCT00443820|387413|P1|Overall Study|Death|0
118893|NCT00443820|387410|P4|Overall Study|Administrative problems|1
118894|NCT00443820|387411|P3|Overall Study|Administrative problems|0
118895|NCT00443820|387412|P2|Overall Study|Administrative problems|0
118896|NCT00443820|387413|P1|Overall Study|Administrative problems|0
118897|NCT00443820|387410|P4|Overall Study|Lost to Follow-up|5
118898|NCT00443820|387411|P3|Overall Study|Lost to Follow-up|6
118899|NCT00443820|387412|P2|Overall Study|Lost to Follow-up|8
118900|NCT00443820|387413|P1|Overall Study|Lost to Follow-up|9
118901|NCT00443820|387410|P4|Overall Study|Withdrawal by Subject|9
118902|NCT00443820|387411|P3|Overall Study|Withdrawal by Subject|8
118903|NCT00443820|387412|P2|Overall Study|Withdrawal by Subject|7
118904|NCT00443820|387413|P1|Overall Study|Withdrawal by Subject|6
118905|NCT00443820|387410|P4|Overall Study|Protocol Violation|1
118906|NCT00443820|387411|P3|Overall Study|Protocol Violation|2
118907|NCT00443820|387412|P2|Overall Study|Protocol Violation|1
118908|NCT00443820|387413|P1|Overall Study|Protocol Violation|2
118909|NCT00443820|387410|P4|Overall Study|Lack of Efficacy|1
118910|NCT00443820|387411|P3|Overall Study|Lack of Efficacy|1
118911|NCT00443820|387412|P2|Overall Study|Lack of Efficacy|2
118912|NCT00443820|387413|P1|Overall Study|Lack of Efficacy|3
118913|NCT00443820|387410|P4|Overall Study|Adverse Event|0
118914|NCT00443820|387411|P3|Overall Study|Adverse Event|0
118915|NCT00443820|387412|P2|Overall Study|Adverse Event|1
118916|NCT00443820|387413|P1|Overall Study|Adverse Event|1
118917|NCT00443872|387435|P1|Overall Study|Adverse Event|8
118918|NCT00443872|387435|P1|Overall Study|Lost to Follow-up|2
118919|NCT00443872|387435|P1|Overall Study|Protocol Violation|7
118920|NCT00443898|387452|P4|Overall Study|Death|0
118921|NCT00443898|387453|P3|Overall Study|Death|0
118922|NCT00443898|387454|P2|Overall Study|Death|1
118923|NCT00443898|387455|P1|Overall Study|Death|0
118924|NCT00443898|387452|P4|Overall Study|Lost to Follow-up|10
118925|NCT00443898|387453|P3|Overall Study|Lost to Follow-up|14
118926|NCT00443898|387454|P2|Overall Study|Lost to Follow-up|10
118927|NCT00443898|387455|P1|Overall Study|Lost to Follow-up|10
118928|NCT00443898|387452|P4|Overall Study|Withdrawal by Subject|6
118929|NCT00443898|387453|P3|Overall Study|Withdrawal by Subject|10
118930|NCT00443898|387454|P2|Overall Study|Withdrawal by Subject|10
118931|NCT00443898|387455|P1|Overall Study|Withdrawal by Subject|11
118932|NCT00443898|387452|P4|Overall Study|Protocol Violation|0
118933|NCT00443898|387453|P3|Overall Study|Protocol Violation|1
118934|NCT00443898|387454|P2|Overall Study|Protocol Violation|1
118935|NCT00443898|387455|P1|Overall Study|Protocol Violation|1
118936|NCT00443898|387452|P4|Overall Study|Lack of Efficacy|1
118937|NCT00443898|387453|P3|Overall Study|Lack of Efficacy|3
118938|NCT00443898|387454|P2|Overall Study|Lack of Efficacy|3
118939|NCT00443898|387455|P1|Overall Study|Lack of Efficacy|2
118940|NCT00443898|387452|P4|Overall Study|Adverse Event|1
118941|NCT00443898|387453|P3|Overall Study|Adverse Event|1
118942|NCT00443898|387454|P2|Overall Study|Adverse Event|0
118943|NCT00443898|387455|P1|Overall Study|Adverse Event|0
118944|NCT00444067|387479|P2|Overall Study|Lost to Follow-up|1
118945|NCT00444067|387480|P1|Overall Study|Lost to Follow-up|0
118946|NCT00444106|387493|P3|Overall Study|Abnormal Test Procedure Results|1
118947|NCT00444106|387494|P2|Overall Study|Abnormal Test Procedure Results|0
118948|NCT00444106|387495|P1|Overall Study|Abnormal Test Procedure Results|0
118949|NCT00444106|387493|P3|Overall Study|Lost to Follow-up|0
118950|NCT00444106|387494|P2|Overall Study|Lost to Follow-up|1
118951|NCT00444106|387495|P1|Overall Study|Lost to Follow-up|2
118952|NCT00444145|387510|P1|Overall Study|Screen Failures|5
118953|NCT00444145|387510|P1|Overall Study|non-compliant|11
118954|NCT00444145|387510|P1|Overall Study|Lost to Follow-up|1
118955|NCT00444145|387510|P1|Overall Study|Withdrawal by Subject|2
118956|NCT00444275|387517|P5|Maintenance Treatment Phase|Ineffectiveness|14
118957|NCT00444275|387518|P4|Maintenance Treatment Phase|Ineffectiveness|3
118958|NCT00444275|387519|P3|Maintenance Treatment Phase|Ineffectiveness|5
118959|NCT00444275|387520|P2|Maintenance Treatment Phase|Ineffectiveness|0
118960|NCT00444275|387521|P1|Maintenance Treatment Phase|Ineffectiveness|0
118961|NCT00444275|387517|P5|Maintenance Treatment Phase|Protocol Violation|87
118962|NCT00444275|387518|P4|Maintenance Treatment Phase|Protocol Violation|88
118963|NCT00444275|387519|P3|Maintenance Treatment Phase|Protocol Violation|103
118964|NCT00444275|387520|P2|Maintenance Treatment Phase|Protocol Violation|0
118965|NCT00444275|387521|P1|Maintenance Treatment Phase|Protocol Violation|0
118966|NCT00444275|387517|P5|Maintenance Treatment Phase|Patient's wish|20
118967|NCT00444275|387518|P4|Maintenance Treatment Phase|Patient's wish|9
118968|NCT00444275|387519|P3|Maintenance Treatment Phase|Patient's wish|19
118969|NCT00444275|387520|P2|Maintenance Treatment Phase|Patient's wish|0
118970|NCT00444275|387521|P1|Maintenance Treatment Phase|Patient's wish|0
118971|NCT00444275|387517|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
118972|NCT00444275|387518|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
118973|NCT00444275|387519|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
118974|NCT00444275|387520|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
118975|NCT00444275|387521|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
118976|NCT00444275|387517|P5|Maintenance Treatment Phase|Adverse Event|13
118977|NCT00444275|387518|P4|Maintenance Treatment Phase|Adverse Event|2
118978|NCT00444275|387519|P3|Maintenance Treatment Phase|Adverse Event|3
118979|NCT00444275|387520|P2|Maintenance Treatment Phase|Adverse Event|0
118980|NCT00444275|387521|P1|Maintenance Treatment Phase|Adverse Event|0
118981|NCT00444275|387517|P5|Maintenance Treatment Phase|Lost to Follow-up|10
118982|NCT00444275|387518|P4|Maintenance Treatment Phase|Lost to Follow-up|14
118983|NCT00444275|387519|P3|Maintenance Treatment Phase|Lost to Follow-up|8
118984|NCT00444275|387520|P2|Maintenance Treatment Phase|Lost to Follow-up|0
118985|NCT00444275|387521|P1|Maintenance Treatment Phase|Lost to Follow-up|0
118986|NCT00444275|387517|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
118987|NCT00444275|387518|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
118988|NCT00444275|387519|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
118989|NCT00444275|387520|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
118990|NCT00444275|387521|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
118991|NCT00450112|387586|P2|Overall Study|Others|3
118992|NCT00450112|387587|P1|Overall Study|Others|2
118993|NCT00450112|387586|P2|Overall Study|Lost to Follow-up|1
118994|NCT00450112|387587|P1|Overall Study|Lost to Follow-up|2
118995|NCT00450112|387586|P2|Overall Study|Withdrawal by Subject|1
118996|NCT00450112|387587|P1|Overall Study|Withdrawal by Subject|4
118997|NCT00450112|387586|P2|Overall Study|Other Treatment Required|1
118998|NCT00450112|387587|P1|Overall Study|Other Treatment Required|5
118999|NCT00450216|387611|P2|Overall Study|misc|20
119000|NCT00450216|387612|P1|Overall Study|misc|21
119001|NCT00450216|387611|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
119002|NCT00450216|387612|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
119003|NCT00450216|387611|P2|Overall Study|Lost to Follow-up|9
119004|NCT00450216|387612|P1|Overall Study|Lost to Follow-up|16
119005|NCT00450216|387611|P2|Overall Study|Withdrawal by Subject|26
119006|NCT00450216|387612|P1|Overall Study|Withdrawal by Subject|48
119007|NCT00450216|387611|P2|Overall Study|Adverse Event|23
119008|NCT00450216|387612|P1|Overall Study|Adverse Event|38
119009|NCT00450255|387639|P1|Overall Study|Prior RFA ablation of liver|1
119010|NCT00450333|387654|P4|Overall Study|Death|2
119011|NCT00450333|387655|P3|Overall Study|Death|2
119012|NCT00450333|387656|P2|Overall Study|Death|2
119013|NCT00450333|387657|P1|Overall Study|Death|3
119014|NCT00450333|387654|P4|Overall Study|Kidney transplant|3
119015|NCT00450333|387655|P3|Overall Study|Kidney transplant|1
119016|NCT00450333|387656|P2|Overall Study|Kidney transplant|0
119017|NCT00450333|387657|P1|Overall Study|Kidney transplant|1
119018|NCT00450333|387654|P4|Overall Study|Withdrawal by Subject|0
119019|NCT00450333|387655|P3|Overall Study|Withdrawal by Subject|3
119020|NCT00450333|387656|P2|Overall Study|Withdrawal by Subject|0
119021|NCT00450333|387657|P1|Overall Study|Withdrawal by Subject|1
119022|NCT00450333|387654|P4|Overall Study|Protocol Violation|0
119023|NCT00450333|387655|P3|Overall Study|Protocol Violation|1
119024|NCT00450333|387656|P2|Overall Study|Protocol Violation|0
119025|NCT00450333|387657|P1|Overall Study|Protocol Violation|1
119026|NCT00450333|387654|P4|Overall Study|Adverse Event|2
119027|NCT00450333|387655|P3|Overall Study|Adverse Event|2
119028|NCT00450333|387656|P2|Overall Study|Adverse Event|7
119029|NCT00450333|387657|P1|Overall Study|Adverse Event|1
119030|NCT00450333|387654|P4|Overall Study|Study terminated|21
119031|NCT00450333|387655|P3|Overall Study|Study terminated|16
119032|NCT00450333|387656|P2|Overall Study|Study terminated|54
119033|NCT00450333|387657|P1|Overall Study|Study terminated|47
119034|NCT00450372|387675|P1|Overall Study|Physician Decision|1
119035|NCT00450385|387684|P1|Overall Study|Other|3
119036|NCT00450385|387684|P1|Overall Study|Physician Decision|1
119037|NCT00450385|387684|P1|Overall Study|Adverse Event|1
119038|NCT00450385|387684|P1|Overall Study|Lack of Efficacy|2
119039|NCT00450385|387684|P1|Overall Study|Withdrawal by Subject|2
119040|NCT00450385|387684|P1|Overall Study|Protocol Violation|1
119041|NCT00450385|387684|P1|Overall Study|Death|3
119042|NCT00452114|387695|P2|Overall Study|Physician Decision|3
119043|NCT00452114|387696|P1|Overall Study|Physician Decision|3
119044|NCT00452348|387744|P2|Overall Study|Other|9
119045|NCT00452348|387745|P1|Overall Study|Other|9
119046|NCT00452348|387744|P2|Overall Study|Withdrawal by Subject|21
119047|NCT00452348|387745|P1|Overall Study|Withdrawal by Subject|18
119048|NCT00452348|387744|P2|Overall Study|Protocol Violation|28
119049|NCT00452348|387745|P1|Overall Study|Protocol Violation|22
119050|NCT00452348|387744|P2|Overall Study|Lost to Follow-up|8
119051|NCT00452348|387745|P1|Overall Study|Lost to Follow-up|14
119052|NCT00452348|387744|P2|Overall Study|Lack of Efficacy|9
119053|NCT00452348|387745|P1|Overall Study|Lack of Efficacy|10
119054|NCT00452348|387744|P2|Overall Study|Adverse Event|9
119055|NCT00452348|387745|P1|Overall Study|Adverse Event|6
119056|NCT00452361|387759|P2|Overall Study|Premature termination|9
119057|NCT00452361|387760|P1|Overall Study|Premature termination|13
119058|NCT00452361|387759|P2|Overall Study|Withdrawal by Subject|1
119059|NCT00452361|387760|P1|Overall Study|Withdrawal by Subject|0
119060|NCT00452361|387759|P2|Overall Study|Adverse Event|0
119061|NCT00452361|387760|P1|Overall Study|Adverse Event|8
119062|NCT00452400|387820|P5|Overall Study|Other reasons not listed above|1
119063|NCT00452400|387821|P4|Overall Study|Other reasons not listed above|1
119064|NCT00452400|387822|P3|Overall Study|Other reasons not listed above|0
119065|NCT00452400|387823|P2|Overall Study|Other reasons not listed above|0
119066|NCT00452400|387824|P1|Overall Study|Other reasons not listed above|0
119067|NCT00452400|387820|P5|Overall Study|Lack of Efficacy|0
119068|NCT00452400|387821|P4|Overall Study|Lack of Efficacy|0
119069|NCT00452400|387822|P3|Overall Study|Lack of Efficacy|0
119070|NCT00452400|387823|P2|Overall Study|Lack of Efficacy|0
119071|NCT00452400|387824|P1|Overall Study|Lack of Efficacy|2
119072|NCT00452400|387820|P5|Overall Study|Withdrawal by Subject|0
119073|NCT00452400|387821|P4|Overall Study|Withdrawal by Subject|0
119074|NCT00452400|387822|P3|Overall Study|Withdrawal by Subject|1
119075|NCT00452400|387823|P2|Overall Study|Withdrawal by Subject|0
119076|NCT00452400|387824|P1|Overall Study|Withdrawal by Subject|1
119077|NCT00452400|387820|P5|Overall Study|Lost to Follow-up|0
119078|NCT00452400|387821|P4|Overall Study|Lost to Follow-up|0
119079|NCT00452400|387822|P3|Overall Study|Lost to Follow-up|0
119080|NCT00452400|387823|P2|Overall Study|Lost to Follow-up|0
119081|NCT00452400|387824|P1|Overall Study|Lost to Follow-up|1
119082|NCT00452400|387820|P5|Overall Study|Protocol Violation|0
119083|NCT00452400|387821|P4|Overall Study|Protocol Violation|0
119084|NCT00452400|387822|P3|Overall Study|Protocol Violation|1
119085|NCT00452400|387823|P2|Overall Study|Protocol Violation|0
119086|NCT00452400|387824|P1|Overall Study|Protocol Violation|0
119087|NCT00452400|387820|P5|Overall Study|Adverse Event|2
119088|NCT00452400|387821|P4|Overall Study|Adverse Event|0
119089|NCT00452400|387822|P3|Overall Study|Adverse Event|5
119090|NCT00452400|387823|P2|Overall Study|Adverse Event|1
119091|NCT00452400|387824|P1|Overall Study|Adverse Event|1
119092|NCT00452452|388016|P3|Overall Study|Lost to Follow-up|0
119093|NCT00452452|388017|P2|Overall Study|Lost to Follow-up|0
119094|NCT00452452|388018|P1|Overall Study|Lost to Follow-up|1
119095|NCT00452452|388016|P3|Overall Study|Withdrawal by Subject|0
119096|NCT00452452|388017|P2|Overall Study|Withdrawal by Subject|0
119097|NCT00452452|388018|P1|Overall Study|Withdrawal by Subject|1
119098|NCT00452452|388016|P3|Overall Study|Protocol Violation|1
119099|NCT00452452|388017|P2|Overall Study|Protocol Violation|0
119100|NCT00452452|388018|P1|Overall Study|Protocol Violation|0
119101|NCT00452530|388043|P2|Overall Study|Not specified|11
119102|NCT00452530|388044|P1|Overall Study|Not specified|7
119103|NCT00452530|388043|P2|Overall Study|No longer met study criteria|22
119104|NCT00452530|388044|P1|Overall Study|No longer met study criteria|18
119105|NCT00452530|388043|P2|Overall Study|Poor compliance/noncompliance|2
119106|NCT00452530|388044|P1|Overall Study|Poor compliance/noncompliance|1
119107|NCT00452530|388043|P2|Overall Study|Lost to Follow-up|0
119108|NCT00452530|388044|P1|Overall Study|Lost to Follow-up|1
119109|NCT00452530|388043|P2|Overall Study|Withdrawal by Subject|57
119110|NCT00452530|388044|P1|Overall Study|Withdrawal by Subject|68
119111|NCT00452530|388043|P2|Overall Study|Adverse Event|44
119112|NCT00452530|388044|P1|Overall Study|Adverse Event|40
119113|NCT00452530|388043|P2|Overall Study|Death|0
119114|NCT00452530|388044|P1|Overall Study|Death|1
119115|NCT00452673|388081|P5|Dose Expansion Period|not specified|2
119116|NCT00452673|388082|P4|Dose Expansion Period|not specified|0
119117|NCT00452673|388083|P3|Dose Expansion Period|not specified|0
119118|NCT00452673|388084|P2|Dose Expansion Period|not specified|0
119119|NCT00452673|388085|P1|Dose Expansion Period|not specified|0
119120|NCT00452673|388081|P5|Dose Expansion Period|Disease Progression|19
119121|NCT00452673|388082|P4|Dose Expansion Period|Disease Progression|0
119122|NCT00452673|388083|P3|Dose Expansion Period|Disease Progression|0
119123|NCT00452673|388084|P2|Dose Expansion Period|Disease Progression|0
119124|NCT00452673|388085|P1|Dose Expansion Period|Disease Progression|0
119125|NCT00452673|388081|P5|Dose Escalation Period|Withdrawal by Subject|0
119126|NCT00452673|388082|P4|Dose Escalation Period|Withdrawal by Subject|1
119127|NCT00452673|388083|P3|Dose Escalation Period|Withdrawal by Subject|0
119128|NCT00452673|388084|P2|Dose Escalation Period|Withdrawal by Subject|0
119129|NCT00452673|388085|P1|Dose Escalation Period|Withdrawal by Subject|0
119130|NCT00452673|388081|P5|Dose Escalation Period|Adverse Event|0
119131|NCT00452673|388082|P4|Dose Escalation Period|Adverse Event|1
119132|NCT00452673|388083|P3|Dose Escalation Period|Adverse Event|0
119133|NCT00452673|388084|P2|Dose Escalation Period|Adverse Event|0
119134|NCT00452673|388085|P1|Dose Escalation Period|Adverse Event|0
119135|NCT00452673|388081|P5|Dose Escalation Period|not specified|0
119136|NCT00452673|388082|P4|Dose Escalation Period|not specified|0
119137|NCT00452673|388083|P3|Dose Escalation Period|not specified|1
119138|NCT00452673|388084|P2|Dose Escalation Period|not specified|0
119139|NCT00452673|388085|P1|Dose Escalation Period|not specified|0
119140|NCT00452673|388081|P5|Dose Escalation Period|study drug toxicity|0
119141|NCT00452673|388082|P4|Dose Escalation Period|study drug toxicity|1
119142|NCT00452673|388083|P3|Dose Escalation Period|study drug toxicity|3
119143|NCT00452673|388084|P2|Dose Escalation Period|study drug toxicity|3
119144|NCT00452673|388085|P1|Dose Escalation Period|study drug toxicity|1
119145|NCT00452673|388081|P5|Dose Escalation Period|Disease Progression|0
119146|NCT00452673|388082|P4|Dose Escalation Period|Disease Progression|6
119147|NCT00452673|388083|P3|Dose Escalation Period|Disease Progression|2
119148|NCT00452673|388084|P2|Dose Escalation Period|Disease Progression|6
119149|NCT00452673|388085|P1|Dose Escalation Period|Disease Progression|6
119150|NCT00452699|388117|P2|Overall Study|Other|7
119151|NCT00452699|388118|P1|Overall Study|Other|12
119152|NCT00452699|388117|P2|Overall Study|Withdrawal by Subject|25
119153|NCT00452699|388118|P1|Overall Study|Withdrawal by Subject|26
119154|NCT00452699|388117|P2|Overall Study|Protocol Violation|25
119155|NCT00452699|388118|P1|Overall Study|Protocol Violation|21
119156|NCT00452699|388117|P2|Overall Study|Lost to Follow-up|9
119157|NCT00452699|388118|P1|Overall Study|Lost to Follow-up|6
119158|NCT00452699|388117|P2|Overall Study|Lack of Efficacy|4
119159|NCT00452699|388118|P1|Overall Study|Lack of Efficacy|6
119160|NCT00452699|388117|P2|Overall Study|Adverse Event|3
119161|NCT00452699|388118|P1|Overall Study|Adverse Event|10
119162|NCT00452790|388132|P2|Toddler Dose|Parent/legal guardian request|1
119163|NCT00452790|388133|P1|Toddler Dose|Parent/legal guardian request|0
119164|NCT00452790|388132|P2|Toddler Dose|Failed to return|1
119165|NCT00452790|388133|P1|Toddler Dose|Failed to return|0
119166|NCT00452790|388132|P2|After Infant Series|Other reasons|0
119167|NCT00452790|388133|P1|After Infant Series|Other reasons|1
119168|NCT00452790|388132|P2|After Infant Series|Failed to return|0
119169|NCT00452790|388133|P1|After Infant Series|Failed to return|1
119170|NCT00452790|388132|P2|After Infant Series|Lost to Follow-up|0
119171|NCT00452790|388133|P1|After Infant Series|Lost to Follow-up|4
119172|NCT00452790|388132|P2|After Infant Series|Parent/legal guardian request|3
119173|NCT00452790|388133|P1|After Infant Series|Parent/legal guardian request|1
119174|NCT00452790|388132|P2|After Infant Series|Adverse Event|1
119175|NCT00452790|388133|P1|After Infant Series|Adverse Event|4
119176|NCT00452790|388132|P2|After Infant Series|Investigator request|10
119177|NCT00452790|388133|P1|After Infant Series|Investigator request|10
119178|NCT00452790|388132|P2|Infant Series|Death|1
119179|NCT00452790|388133|P1|Infant Series|Death|0
119180|NCT00452790|388132|P2|Infant Series|Investigator request|1
119181|NCT00452790|388133|P1|Infant Series|Investigator request|0
119182|NCT00452790|388132|P2|Infant Series|Other reasons|2
119183|NCT00452790|388133|P1|Infant Series|Other reasons|1
119184|NCT00452790|388132|P2|Infant Series|Adverse Event|2
119185|NCT00452790|388133|P1|Infant Series|Adverse Event|1
119186|NCT00452790|388132|P2|Infant Series|Lost to Follow-up|2
119187|NCT00452790|388133|P1|Infant Series|Lost to Follow-up|2
119188|NCT00452790|388132|P2|Infant Series|Protocol Violation|3
119189|NCT00452790|388133|P1|Infant Series|Protocol Violation|1
119190|NCT00452790|388132|P2|Infant Series|Failed to return|1
119191|NCT00452790|388133|P1|Infant Series|Failed to return|4
119192|NCT00452790|388132|P2|Infant Series|Parent/legal guardian request|6
119193|NCT00452790|388133|P1|Infant Series|Parent/legal guardian request|8
119194|NCT00452790|388132|P2|Infant Series|Clinical hold - consent withdrawn|123
119195|NCT00452790|388133|P1|Infant Series|Clinical hold - consent withdrawn|118
119196|NCT00453063|388173|P2|Overall Study|Protocol Violation|0
119197|NCT00453063|388174|P1|Overall Study|Protocol Violation|1
119198|NCT00453063|388173|P2|Overall Study|Withdrawal by Subject|1
119199|NCT00453063|388174|P1|Overall Study|Withdrawal by Subject|1
119200|NCT00453063|388173|P2|Overall Study|Adverse Event|2
119201|NCT00453063|388174|P1|Overall Study|Adverse Event|1
119202|NCT00453102|388188|P1|Overall Study|Withdrawal by Subject|2
119203|NCT00453154|388200|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
119204|NCT00453154|388201|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
119205|NCT00453154|388202|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
119206|NCT00453154|388203|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
119207|NCT00453154|388200|P4|Double BIind Maintenance|Medical Issues|1
119208|NCT00453154|388201|P3|Double BIind Maintenance|Medical Issues|3
119209|NCT00453154|388202|P2|Double BIind Maintenance|Medical Issues|0
119210|NCT00453154|388203|P1|Double BIind Maintenance|Medical Issues|0
119211|NCT00453154|388200|P4|Double BIind Maintenance|Progression|26
119212|NCT00453154|388201|P3|Double BIind Maintenance|Progression|29
119213|NCT00453154|388202|P2|Double BIind Maintenance|Progression|0
119214|NCT00453154|388203|P1|Double BIind Maintenance|Progression|0
119215|NCT00453154|388200|P4|Double BIind Maintenance|Withdrawal by Subject|4
119216|NCT00453154|388201|P3|Double BIind Maintenance|Withdrawal by Subject|4
119217|NCT00453154|388202|P2|Double BIind Maintenance|Withdrawal by Subject|0
119218|NCT00453154|388203|P1|Double BIind Maintenance|Withdrawal by Subject|0
119219|NCT00453154|388200|P4|Double BIind Maintenance|Death|1
119220|NCT00453154|388201|P3|Double BIind Maintenance|Death|2
119221|NCT00453154|388202|P2|Double BIind Maintenance|Death|0
119222|NCT00453154|388203|P1|Double BIind Maintenance|Death|0
119223|NCT00453154|388200|P4|Double BIind Maintenance|Adverse Event|12
119224|NCT00453154|388201|P3|Double BIind Maintenance|Adverse Event|3
119225|NCT00453154|388202|P2|Double BIind Maintenance|Adverse Event|0
119226|NCT00453154|388203|P1|Double BIind Maintenance|Adverse Event|0
119227|NCT00453180|388218|P2|Overall Study|Adverse Event|2
119228|NCT00453180|388219|P1|Overall Study|Adverse Event|1
119229|NCT00453180|388218|P2|Overall Study|Lost to Follow-up|1
119230|NCT00453180|388219|P1|Overall Study|Lost to Follow-up|2
119231|NCT00453206|388239|P1|Overall Study|Death|1
119232|NCT00453310|388243|P1|Overall Study|Progression of Disease|10
119233|NCT00453349|388254|P2|Completed Study|Lost to follow up after study treatment|11
119234|NCT00453349|388255|P1|Completed Study|Lost to follow up after study treatment|2
119235|NCT00453349|388254|P2|Completed Study|Withdrawal by Subject|5
119236|NCT00453349|388255|P1|Completed Study|Withdrawal by Subject|3
119237|NCT00453349|388254|P2|Completed Study|Protocol Violation|1
119238|NCT00453349|388255|P1|Completed Study|Protocol Violation|1
119239|NCT00453349|388254|P2|Completed Study|Lost to Follow-up|5
119240|NCT00453349|388255|P1|Completed Study|Lost to Follow-up|7
119241|NCT00453349|388254|P2|Completed Study|Lack of Efficacy|1
119242|NCT00453349|388255|P1|Completed Study|Lack of Efficacy|2
119243|NCT00453349|388254|P2|Completed Study|Adverse Event|11
119244|NCT00453349|388255|P1|Completed Study|Adverse Event|12
119245|NCT00453349|388254|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
119246|NCT00453349|388255|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
119247|NCT00453349|388254|P2|Randomized|Withdrawal by Subject|5
119248|NCT00453349|388255|P1|Randomized|Withdrawal by Subject|3
119249|NCT00453349|388254|P2|Randomized|Protocol Violation|1
119250|NCT00453349|388255|P1|Randomized|Protocol Violation|1
119251|NCT00453349|388254|P2|Randomized|Lost to Follow-up|5
119252|NCT00453349|388255|P1|Randomized|Lost to Follow-up|7
119253|NCT00453349|388254|P2|Randomized|Lack of Efficacy|1
119254|NCT00453349|388255|P1|Randomized|Lack of Efficacy|2
119255|NCT00453349|388254|P2|Randomized|Adverse Event|11
119256|NCT00453349|388255|P1|Randomized|Adverse Event|12
119257|NCT00453362|388281|P1|Overall Study|Screening Failure|14
119258|NCT00453362|388281|P1|Overall Study|Progression of disease|56
119259|NCT00453362|388281|P1|Overall Study|Withdrawal by Subject|3
119260|NCT00453362|388281|P1|Overall Study|Physician Decision|2
119261|NCT00453362|388281|P1|Overall Study|Death|7
119262|NCT00453362|388281|P1|Overall Study|Adverse Event|5
119263|NCT00453973|388336|P2|Overall Study|Sponsor Decision to Terminate Study|30
119264|NCT00453973|388337|P1|Overall Study|Sponsor Decision to Terminate Study|35
119265|NCT00453973|388336|P2|Overall Study|Site closed by sponsor|0
119266|NCT00453973|388337|P1|Overall Study|Site closed by sponsor|3
119267|NCT00453973|388336|P2|Overall Study|Renal transplant|1
119268|NCT00453973|388337|P1|Overall Study|Renal transplant|1
119269|NCT00453973|388336|P2|Overall Study|Relocation|0
119270|NCT00453973|388337|P1|Overall Study|Relocation|1
119271|NCT00453973|388336|P2|Overall Study|PI Decision|2
119272|NCT00453973|388337|P1|Overall Study|PI Decision|0
119273|NCT00453973|388336|P2|Overall Study|Withdrawal by Subject|6
119274|NCT00453973|388337|P1|Overall Study|Withdrawal by Subject|7
119275|NCT00453973|388336|P2|Overall Study|Adverse Event|9
119276|NCT00453973|388337|P1|Overall Study|Adverse Event|4
119277|NCT00453986|388348|P5|Overall Study|Lost to Follow-up|0
119278|NCT00453986|388349|P4|Overall Study|Lost to Follow-up|2
119279|NCT00453986|388350|P3|Overall Study|Lost to Follow-up|6
119280|NCT00453986|388351|P2|Overall Study|Lost to Follow-up|5
119281|NCT00453986|388352|P1|Overall Study|Lost to Follow-up|6
119282|NCT00453999|388448|P3|Overall Study|Subject Request|0
119283|NCT00453999|388449|P2|Overall Study|Subject Request|1
119284|NCT00453999|388450|P1|Overall Study|Subject Request|2
119285|NCT00453999|388448|P3|Overall Study|Withdrawal by Subject|1
119286|NCT00453999|388449|P2|Overall Study|Withdrawal by Subject|1
119287|NCT00453999|388450|P1|Overall Study|Withdrawal by Subject|2
119288|NCT00453999|388448|P3|Overall Study|Lost to Follow-up|1
119289|NCT00453999|388449|P2|Overall Study|Lost to Follow-up|1
119290|NCT00453999|388450|P1|Overall Study|Lost to Follow-up|0
119291|NCT00453999|388448|P3|Overall Study|Adverse Event|1
119292|NCT00453999|388449|P2|Overall Study|Adverse Event|2
119293|NCT00453999|388450|P1|Overall Study|Adverse Event|1
119294|NCT00454051|388475|P2|Overall Study|Protocol Violation|1
119295|NCT00454051|388476|P1|Overall Study|Protocol Violation|1
119296|NCT00454051|388475|P2|Overall Study|Withdrawal by Subject|0
119297|NCT00454051|388476|P1|Overall Study|Withdrawal by Subject|1
119298|NCT00454051|388475|P2|Overall Study|Adverse Event|2
119299|NCT00454051|388476|P1|Overall Study|Adverse Event|1
119300|NCT00454116|388509|P3|Overall Study|Other|0
119301|NCT00454116|388510|P2|Overall Study|Other|2
119302|NCT00454116|388511|P1|Overall Study|Other|2
119303|NCT00454116|388509|P3|Overall Study|Withdrawal by Subject|1
119304|NCT00454116|388510|P2|Overall Study|Withdrawal by Subject|3
119305|NCT00454116|388511|P1|Overall Study|Withdrawal by Subject|3
119306|NCT00454116|388509|P3|Overall Study|Condition under investigation worsened|18
119307|NCT00454116|388510|P2|Overall Study|Condition under investigation worsened|13
119308|NCT00454116|388511|P1|Overall Study|Condition under investigation worsened|17
119309|NCT00454116|388509|P3|Overall Study|Adverse Event|9
119310|NCT00454116|388510|P2|Overall Study|Adverse Event|11
119311|NCT00454116|388511|P1|Overall Study|Adverse Event|5
119312|NCT00454142|388519|P1|Overall Study|Withdrawal by Subject|1
119313|NCT00454181|388536|P2|Overall Study|Withdrawal by Subject|0
119314|NCT00454181|388537|P1|Overall Study|Withdrawal by Subject|2
119315|NCT00454181|388536|P2|Overall Study|Protocol Violation|1
119316|NCT00454181|388537|P1|Overall Study|Protocol Violation|1
119317|NCT00454181|388536|P2|Overall Study|Lost to Follow-up|1
119318|NCT00454181|388537|P1|Overall Study|Lost to Follow-up|11
119319|NCT00454181|388536|P2|Overall Study|Adverse Event|1
119320|NCT00454181|388537|P1|Overall Study|Adverse Event|1
119321|NCT00454194|388555|P2|Overall Study|Other Unspecified Reason|2
119322|NCT00454194|388556|P1|Overall Study|Other Unspecified Reason|2
119323|NCT00454194|388555|P2|Overall Study|Other Medical Problems|2
119324|NCT00454194|388556|P1|Overall Study|Other Medical Problems|1
119325|NCT00454194|388555|P2|Overall Study|Withdrawal by Subject|8
119326|NCT00454194|388556|P1|Overall Study|Withdrawal by Subject|12
119327|NCT00454194|388555|P2|Overall Study|Adverse Event|2
119328|NCT00454194|388556|P1|Overall Study|Adverse Event|7
119329|NCT00454207|388574|P2|Overall Study|Protocol Violation|1
119330|NCT00454207|388575|P1|Overall Study|Protocol Violation|0
119331|NCT00454207|388574|P2|Overall Study|Lack of Efficacy|0
119332|NCT00454207|388575|P1|Overall Study|Lack of Efficacy|1
119333|NCT00454207|388574|P2|Overall Study|Adverse Event|1
119334|NCT00454207|388575|P1|Overall Study|Adverse Event|3
119335|NCT00454246|388621|P3|Overall Study|Early termination of study|9
119336|NCT00454246|388622|P2|Overall Study|Early termination of study|26
119337|NCT00454246|388623|P1|Overall Study|Early termination of study|62
119338|NCT00454246|388621|P3|Overall Study|Failure to return|0
119339|NCT00454246|388622|P2|Overall Study|Failure to return|0
119340|NCT00454246|388623|P1|Overall Study|Failure to return|1
119341|NCT00454246|388621|P3|Overall Study|Refused Treatment|0
119342|NCT00454246|388622|P2|Overall Study|Refused Treatment|1
119343|NCT00454246|388623|P1|Overall Study|Refused Treatment|1
119344|NCT00454246|388621|P3|Overall Study|Protocol Violation|0
119345|NCT00454246|388622|P2|Overall Study|Protocol Violation|0
119346|NCT00454246|388623|P1|Overall Study|Protocol Violation|1
119347|NCT00454246|388621|P3|Overall Study|Violation of selection criteria at entry|0
119348|NCT00454246|388622|P2|Overall Study|Violation of selection criteria at entry|0
119349|NCT00454246|388623|P1|Overall Study|Violation of selection criteria at entry|6
119350|NCT00454246|388621|P3|Overall Study|Adverse Event|0
119351|NCT00454246|388622|P2|Overall Study|Adverse Event|2
119352|NCT00454246|388623|P1|Overall Study|Adverse Event|2
119353|NCT00454363|388654|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
119354|NCT00454363|388655|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
119355|NCT00454363|388654|P2|Overall Study|Adverse Event|2
119356|NCT00454363|388655|P1|Overall Study|Adverse Event|1
119357|NCT00454571|388689|P2|Overall Study|Withdrawal by Subject|5
119358|NCT00454571|388690|P1|Overall Study|Withdrawal by Subject|10
119359|NCT00454571|388689|P2|Overall Study|Protocol Violation|0
119360|NCT00454571|388690|P1|Overall Study|Protocol Violation|1
119361|NCT00454571|388689|P2|Overall Study|Physician Decision|1
119362|NCT00454571|388690|P1|Overall Study|Physician Decision|0
119363|NCT00454571|388689|P2|Overall Study|Adverse Event|0
119364|NCT00454571|388690|P1|Overall Study|Adverse Event|2
119365|NCT00441727|388701|P3|Overall Study|Various reason specified|5
119366|NCT00441727|388702|P2|Overall Study|Various reason specified|8
119367|NCT00441727|388703|P1|Overall Study|Various reason specified|6
119368|NCT00441727|388701|P3|Overall Study|Safety Reasons|3
119369|NCT00441727|388702|P2|Overall Study|Safety Reasons|1
119370|NCT00441727|388703|P1|Overall Study|Safety Reasons|3
119371|NCT00441727|388701|P3|Overall Study|Lost to Follow-up|5
119372|NCT00441727|388702|P2|Overall Study|Lost to Follow-up|6
119373|NCT00441727|388703|P1|Overall Study|Lost to Follow-up|5
119374|NCT00441727|388701|P3|Overall Study|Withdrawal by Subject|47
119375|NCT00441727|388702|P2|Overall Study|Withdrawal by Subject|34
119376|NCT00441727|388703|P1|Overall Study|Withdrawal by Subject|40
119377|NCT00441727|388701|P3|Overall Study|Lack of Efficacy|48
119378|NCT00441727|388702|P2|Overall Study|Lack of Efficacy|8
119379|NCT00441727|388703|P1|Overall Study|Lack of Efficacy|7
119380|NCT00441727|388701|P3|Overall Study|Adverse Event|28
119381|NCT00441727|388702|P2|Overall Study|Adverse Event|33
119382|NCT00441727|388703|P1|Overall Study|Adverse Event|26
119383|NCT00441727|388701|P3|Overall Study|Protocol Violation|32
119384|NCT00441727|388702|P2|Overall Study|Protocol Violation|28
119385|NCT00441727|388703|P1|Overall Study|Protocol Violation|19
119386|NCT00441792|388757|P2|Overall Study|Lost to Follow-up|2
119387|NCT00441792|388758|P1|Overall Study|Lost to Follow-up|0
119388|NCT00447226|388766|P2|Double-blind Phase|Disease Progression|3
119389|NCT00447226|388767|P1|Double-blind Phase|Disease Progression|4
119390|NCT00447226|388766|P2|12-Week Open-label Phase|Physician Decision|1
119391|NCT00447226|388767|P1|12-Week Open-label Phase|Physician Decision|0
119392|NCT00447226|388766|P2|12-Week Open-label Phase|Disease Progression|20
119393|NCT00447226|388767|P1|12-Week Open-label Phase|Disease Progression|0
119394|NCT00447226|388766|P2|12-Week Open-label Phase|Protocol Violation|1
119395|NCT00447226|388767|P1|12-Week Open-label Phase|Protocol Violation|0
119396|NCT00447226|388766|P2|12-Week Open-label Phase|Adverse Event|3
119397|NCT00447226|388767|P1|12-Week Open-label Phase|Adverse Event|0
119398|NCT00447265|388785|P2|Overall Study|Physician Decision|0
119399|NCT00447265|388786|P1|Overall Study|Physician Decision|1
119400|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
119401|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
119402|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
119403|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
119404|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
119405|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
119406|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
119407|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
119408|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
119409|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
119410|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
119411|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
119412|NCT00447278|388801|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
119413|NCT00447278|388802|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
119414|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
119415|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
119416|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
119417|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
119418|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Physician Decision|1
119419|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Physician Decision|4
119420|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
119421|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
119422|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Protocol Violation|7
119423|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Protocol Violation|10
119424|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
119425|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
119426|NCT00447278|388801|P2|Period II (6 Month Open-Label)|Adverse Event|3
119427|NCT00447278|388802|P1|Period II (6 Month Open-Label)|Adverse Event|7
119428|NCT00447382|388832|P2|Overall Study|Unclassified|5
119429|NCT00447382|388833|P1|Overall Study|Unclassified|2
119430|NCT00447382|388832|P2|Overall Study|Protocol Violation|0
119431|NCT00447382|388833|P1|Overall Study|Protocol Violation|2
119432|NCT00447382|388832|P2|Overall Study|Lack of Efficacy|0
119433|NCT00447382|388833|P1|Overall Study|Lack of Efficacy|1
119434|NCT00447382|388832|P2|Overall Study|Adverse Event|1
119435|NCT00447382|388833|P1|Overall Study|Adverse Event|1
119436|NCT00447421|388885|P1|Overall Study|Sponsor Decision|2
119437|NCT00447421|388885|P1|Overall Study|Adverse Event|3
119438|NCT00447421|388885|P1|Overall Study|Lack of Efficacy|1
119439|NCT00447499|388895|P1|Overall Study|Physician Decision|1
119440|NCT00447499|388895|P1|Overall Study|Sponsor Decision|1
119441|NCT00447499|388895|P1|Overall Study|Patient Decision|4
119442|NCT00447499|388895|P1|Overall Study|Adverse Event|1
119443|NCT00454584|388908|P6|After Controlled Period|Unspecified|17
119444|NCT00454584|388909|P5|After Controlled Period|Unspecified|5
119445|NCT00454584|388910|P4|After Controlled Period|Unspecified|13
119446|NCT00454584|388911|P3|After Controlled Period|Unspecified|0
119447|NCT00454584|388912|P2|After Controlled Period|Unspecified|0
119448|NCT00454584|388913|P1|After Controlled Period|Unspecified|0
119449|NCT00454584|388908|P6|After Controlled Period|Unspecified|0
119450|NCT00454584|388909|P5|After Controlled Period|Unspecified|0
119451|NCT00454584|388910|P4|After Controlled Period|Unspecified|1
119452|NCT00454584|388911|P3|After Controlled Period|Unspecified|0
119453|NCT00454584|388912|P2|After Controlled Period|Unspecified|0
119454|NCT00454584|388913|P1|After Controlled Period|Unspecified|0
119455|NCT00454584|388908|P6|After Controlled Period|Lost to Follow-up|6
119456|NCT00454584|388909|P5|After Controlled Period|Lost to Follow-up|4
119457|NCT00454584|388910|P4|After Controlled Period|Lost to Follow-up|2
119458|NCT00454584|388911|P3|After Controlled Period|Lost to Follow-up|0
119459|NCT00454584|388912|P2|After Controlled Period|Lost to Follow-up|0
119460|NCT00454584|388913|P1|After Controlled Period|Lost to Follow-up|0
119461|NCT00454584|388908|P6|After Controlled Period|Lack of Efficacy|0
119462|NCT00454584|388909|P5|After Controlled Period|Lack of Efficacy|0
119463|NCT00454584|388910|P4|After Controlled Period|Lack of Efficacy|1
119464|NCT00454584|388911|P3|After Controlled Period|Lack of Efficacy|0
119465|NCT00454584|388912|P2|After Controlled Period|Lack of Efficacy|0
119466|NCT00454584|388913|P1|After Controlled Period|Lack of Efficacy|0
119467|NCT00454584|388908|P6|After Controlled Period|Adverse Event|9
119468|NCT00454584|388909|P5|After Controlled Period|Adverse Event|3
119469|NCT00454584|388910|P4|After Controlled Period|Adverse Event|9
119470|NCT00454584|388911|P3|After Controlled Period|Adverse Event|0
119471|NCT00454584|388912|P2|After Controlled Period|Adverse Event|0
119472|NCT00454584|388913|P1|After Controlled Period|Adverse Event|0
119473|NCT00454584|388908|P6|Controlled Period|unspecified|0
119474|NCT00454584|388909|P5|Controlled Period|unspecified|0
119475|NCT00454584|388910|P4|Controlled Period|unspecified|0
119476|NCT00454584|388911|P3|Controlled Period|unspecified|2
119477|NCT00454584|388912|P2|Controlled Period|unspecified|4
119478|NCT00454584|388913|P1|Controlled Period|unspecified|5
119479|NCT00454584|388908|P6|Controlled Period|Lost to Follow-up|0
119480|NCT00454584|388909|P5|Controlled Period|Lost to Follow-up|0
119481|NCT00454584|388910|P4|Controlled Period|Lost to Follow-up|0
119482|NCT00454584|388911|P3|Controlled Period|Lost to Follow-up|2
119483|NCT00454584|388912|P2|Controlled Period|Lost to Follow-up|2
119484|NCT00454584|388913|P1|Controlled Period|Lost to Follow-up|1
119485|NCT00454584|388908|P6|Controlled Period|Adverse Event|0
119486|NCT00454584|388909|P5|Controlled Period|Adverse Event|0
119487|NCT00454584|388910|P4|Controlled Period|Adverse Event|0
119488|NCT00454584|388911|P3|Controlled Period|Adverse Event|1
119489|NCT00454584|388912|P2|Controlled Period|Adverse Event|2
119490|NCT00454584|388913|P1|Controlled Period|Adverse Event|5
119491|NCT00454636|388937|P4|Overall Study|Lost to Follow-up|0
119492|NCT00454636|388938|P3|Overall Study|Lost to Follow-up|0
119493|NCT00454636|388939|P2|Overall Study|Lost to Follow-up|1
119494|NCT00454636|388940|P1|Overall Study|Lost to Follow-up|0
119495|NCT00454636|388937|P4|Overall Study|Patient refusal|2
119496|NCT00454636|388938|P3|Overall Study|Patient refusal|3
119497|NCT00454636|388939|P2|Overall Study|Patient refusal|1
119498|NCT00454636|388940|P1|Overall Study|Patient refusal|1
119499|NCT00454636|388937|P4|Overall Study|Death|1
119500|NCT00454636|388938|P3|Overall Study|Death|1
119501|NCT00454636|388939|P2|Overall Study|Death|1
119502|NCT00454636|388940|P1|Overall Study|Death|6
119503|NCT00454636|388937|P4|Overall Study|Protocol Violation|3
119504|NCT00454636|388938|P3|Overall Study|Protocol Violation|3
119505|NCT00454636|388939|P2|Overall Study|Protocol Violation|2
119506|NCT00454636|388940|P1|Overall Study|Protocol Violation|3
119507|NCT00454636|388937|P4|Overall Study|Disease Progression|11
119508|NCT00454636|388938|P3|Overall Study|Disease Progression|4
119509|NCT00454636|388939|P2|Overall Study|Disease Progression|12
119510|NCT00454636|388940|P1|Overall Study|Disease Progression|11
119511|NCT00454636|388937|P4|Overall Study|Adverse Event|15
119512|NCT00454636|388938|P3|Overall Study|Adverse Event|9
119513|NCT00454636|388939|P2|Overall Study|Adverse Event|6
119514|NCT00454636|388940|P1|Overall Study|Adverse Event|10
119515|NCT00454649|388980|P10|Overall Study|Withdrawal by Subject|0
119516|NCT00454649|388981|P9|Overall Study|Withdrawal by Subject|1
119517|NCT00454649|388982|P8|Overall Study|Withdrawal by Subject|2
119518|NCT00454649|388983|P7|Overall Study|Withdrawal by Subject|0
119519|NCT00454649|388984|P6|Overall Study|Withdrawal by Subject|1
119520|NCT00454649|388985|P5|Overall Study|Withdrawal by Subject|0
119521|NCT00454649|388986|P4|Overall Study|Withdrawal by Subject|0
119522|NCT00454649|388987|P3|Overall Study|Withdrawal by Subject|0
119523|NCT00454649|388988|P2|Overall Study|Withdrawal by Subject|0
119524|NCT00454649|388989|P1|Overall Study|Withdrawal by Subject|0
119525|NCT00454649|388980|P10|Overall Study|Unspecified|1
119526|NCT00454649|388981|P9|Overall Study|Unspecified|3
119527|NCT00454649|388982|P8|Overall Study|Unspecified|0
119528|NCT00454649|388983|P7|Overall Study|Unspecified|0
119529|NCT00454649|388984|P6|Overall Study|Unspecified|0
119530|NCT00454649|388985|P5|Overall Study|Unspecified|0
119531|NCT00454649|388986|P4|Overall Study|Unspecified|3
119532|NCT00454649|388987|P3|Overall Study|Unspecified|5
119533|NCT00454649|388988|P2|Overall Study|Unspecified|1
119534|NCT00454649|388989|P1|Overall Study|Unspecified|1
119535|NCT00454649|388980|P10|Overall Study|Lost to Follow-up|0
119536|NCT00454649|388981|P9|Overall Study|Lost to Follow-up|0
119537|NCT00454649|388982|P8|Overall Study|Lost to Follow-up|0
119538|NCT00454649|388983|P7|Overall Study|Lost to Follow-up|1
119539|NCT00454649|388984|P6|Overall Study|Lost to Follow-up|0
119540|NCT00454649|388985|P5|Overall Study|Lost to Follow-up|0
119541|NCT00454649|388986|P4|Overall Study|Lost to Follow-up|0
119542|NCT00454649|388987|P3|Overall Study|Lost to Follow-up|1
119543|NCT00454649|388988|P2|Overall Study|Lost to Follow-up|0
119544|NCT00454649|388989|P1|Overall Study|Lost to Follow-up|0
119545|NCT00454649|388980|P10|Overall Study|Adverse Event|2
119546|NCT00454649|388981|P9|Overall Study|Adverse Event|6
119547|NCT00454649|388982|P8|Overall Study|Adverse Event|4
119548|NCT00454649|388983|P7|Overall Study|Adverse Event|3
119549|NCT00454649|388984|P6|Overall Study|Adverse Event|2
119550|NCT00454649|388985|P5|Overall Study|Adverse Event|1
119551|NCT00454649|388986|P4|Overall Study|Adverse Event|0
119552|NCT00454649|388987|P3|Overall Study|Adverse Event|3
119553|NCT00454649|388988|P2|Overall Study|Adverse Event|1
119554|NCT00454649|388989|P1|Overall Study|Adverse Event|0
119555|NCT00454649|388980|P10|Overall Study|Lack of Efficacy|2
119556|NCT00454649|388981|P9|Overall Study|Lack of Efficacy|10
119557|NCT00454649|388982|P8|Overall Study|Lack of Efficacy|13
119558|NCT00454649|388983|P7|Overall Study|Lack of Efficacy|5
119559|NCT00454649|388984|P6|Overall Study|Lack of Efficacy|4
119560|NCT00454649|388985|P5|Overall Study|Lack of Efficacy|0
119561|NCT00454649|388986|P4|Overall Study|Lack of Efficacy|3
119562|NCT00454649|388987|P3|Overall Study|Lack of Efficacy|10
119563|NCT00454649|388988|P2|Overall Study|Lack of Efficacy|2
119564|NCT00454649|388989|P1|Overall Study|Lack of Efficacy|2
119565|NCT00454779|389116|P2|Second-line Treatment Phase|Ongoing|1
119566|NCT00454779|389117|P1|Second-line Treatment Phase|Ongoing|0
119567|NCT00454779|389116|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
119568|NCT00454779|389117|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
119569|NCT00454779|389116|P2|Second-line Treatment Phase|Withdrawal by Subject|1
119570|NCT00454779|389117|P1|Second-line Treatment Phase|Withdrawal by Subject|0
119571|NCT00454779|389116|P2|First-line Treatment Phase|Ongoing|0
119572|NCT00454779|389117|P1|First-line Treatment Phase|Ongoing|1
119573|NCT00454779|389116|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
119574|NCT00454779|389117|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
119575|NCT00454779|389116|P2|First-line Treatment Phase|Protocol Violation|1
119576|NCT00454779|389117|P1|First-line Treatment Phase|Protocol Violation|0
119577|NCT00454779|389116|P2|First-line Treatment Phase|Lost to Follow-up|0
119578|NCT00454779|389117|P1|First-line Treatment Phase|Lost to Follow-up|1
119579|NCT00454779|389116|P2|First-line Treatment Phase|Withdrawal by Subject|4
119580|NCT00454779|389117|P1|First-line Treatment Phase|Withdrawal by Subject|2
119581|NCT00454779|389116|P2|First-line Treatment Phase|Lack of Efficacy|2
119582|NCT00454779|389117|P1|First-line Treatment Phase|Lack of Efficacy|0
119583|NCT00454805|389147|P2|Overall Study|In order to begin radiotherapy|0
119584|NCT00454805|389148|P1|Overall Study|In order to begin radiotherapy|1
119585|NCT00454805|389147|P2|Overall Study|Disease progression|19
119586|NCT00454805|389148|P1|Overall Study|Disease progression|16
119587|NCT00454805|389147|P2|Overall Study|Death|2
119588|NCT00454805|389148|P1|Overall Study|Death|0
119589|NCT00454805|389147|P2|Overall Study|Withdrawal by Subject|2
119590|NCT00454805|389148|P1|Overall Study|Withdrawal by Subject|9
119591|NCT00454818|389170|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
119592|NCT00454818|389171|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
119593|NCT00454818|389172|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
119594|NCT00454818|389173|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
119595|NCT00454818|389174|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
119596|NCT00454818|389170|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
119597|NCT00454818|389171|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
119598|NCT00454818|389172|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
119599|NCT00454818|389173|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
119600|NCT00454818|389174|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
119601|NCT00454818|389170|P5|Phase 2: Randomized Double-blind|Death|1
119602|NCT00454818|389171|P4|Phase 2: Randomized Double-blind|Death|0
119603|NCT00454818|389172|P3|Phase 2: Randomized Double-blind|Death|0
119604|NCT00454818|389173|P2|Phase 2: Randomized Double-blind|Death|1
119605|NCT00454818|389174|P1|Phase 2: Randomized Double-blind|Death|0
119606|NCT00454818|389170|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
119607|NCT00454818|389171|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
119608|NCT00454818|389172|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
119609|NCT00454818|389173|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
119610|NCT00454818|389174|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
119611|NCT00454818|389170|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
119612|NCT00454818|389171|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
119613|NCT00454818|389172|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
119614|NCT00454818|389173|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
119615|NCT00454818|389174|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
119616|NCT00454818|389170|P5|Phase I: Open-label Dose-escalation|Death|0
119617|NCT00454818|389171|P4|Phase I: Open-label Dose-escalation|Death|0
119618|NCT00454818|389172|P3|Phase I: Open-label Dose-escalation|Death|0
119619|NCT00454818|389173|P2|Phase I: Open-label Dose-escalation|Death|1
119620|NCT00454818|389174|P1|Phase I: Open-label Dose-escalation|Death|0
119621|NCT00454818|389170|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
119622|NCT00454818|389171|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
119623|NCT00454818|389172|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
119624|NCT00454818|389173|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
119625|NCT00454818|389174|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
119626|NCT00454857|389251|P1|Overall Study|Reason unknown|1
119627|NCT00454857|389251|P1|Overall Study|Other|11
119628|NCT00454857|389251|P1|Overall Study|Death|5
119629|NCT00454857|389251|P1|Overall Study|Noncompliance|6
119630|NCT00454857|389251|P1|Overall Study|Lost to Follow-up|16
119631|NCT00454857|389251|P1|Overall Study|Withdrawal by Subject|15
119632|NCT00454909|389271|P3|Overall Study|Others|0
119633|NCT00454909|389272|P2|Overall Study|Others|0
119634|NCT00454909|389273|P1|Overall Study|Others|1
119635|NCT00454909|389271|P3|Overall Study|Lost to follow-up (complete vaccination)|1
119636|NCT00454909|389272|P2|Overall Study|Lost to follow-up (complete vaccination)|3
119637|NCT00454909|389273|P1|Overall Study|Lost to follow-up (complete vaccination)|5
119638|NCT00454909|389271|P3|Overall Study|Migrated/moved from study area|1
119639|NCT00454909|389272|P2|Overall Study|Migrated/moved from study area|0
119640|NCT00454909|389273|P1|Overall Study|Migrated/moved from study area|0
119641|NCT00454909|389271|P3|Overall Study|Withdrawal by Subject|0
119642|NCT00454909|389272|P2|Overall Study|Withdrawal by Subject|0
119643|NCT00454909|389273|P1|Overall Study|Withdrawal by Subject|1
119644|NCT00455195|389313|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
119645|NCT00455195|389314|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
119646|NCT00455195|389313|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
119647|NCT00455195|389314|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
119648|NCT00455195|389313|P2|Double-blind Study AGLU02704|Death|0
119649|NCT00455195|389314|P1|Double-blind Study AGLU02704|Death|1
119650|NCT00455195|389313|P2|Double-blind Study AGLU02704|Adverse Event|1
119651|NCT00455195|389314|P1|Double-blind Study AGLU02704|Adverse Event|2
119652|NCT00455312|389330|P2|Overall Study|Death|1
119653|NCT00455312|389331|P1|Overall Study|Death|0
119654|NCT00455429|389359|P4|Overall Study|Unspecified|1
119655|NCT00455429|389360|P3|Overall Study|Unspecified|0
119656|NCT00455429|389361|P2|Overall Study|Unspecified|2
119657|NCT00455429|389362|P1|Overall Study|Unspecified|0
119658|NCT00455429|389359|P4|Overall Study|Non-compliance|1
119659|NCT00455429|389360|P3|Overall Study|Non-compliance|0
119660|NCT00455429|389361|P2|Overall Study|Non-compliance|0
119661|NCT00455429|389362|P1|Overall Study|Non-compliance|0
119662|NCT00455429|389359|P4|Overall Study|Personal Reason|0
119663|NCT00455429|389360|P3|Overall Study|Personal Reason|0
119664|NCT00455429|389361|P2|Overall Study|Personal Reason|0
119665|NCT00455429|389362|P1|Overall Study|Personal Reason|1
119666|NCT00455429|389359|P4|Overall Study|Randomly assigned but not treated|2
119667|NCT00455429|389360|P3|Overall Study|Randomly assigned but not treated|0
119668|NCT00455429|389361|P2|Overall Study|Randomly assigned but not treated|0
119669|NCT00455429|389362|P1|Overall Study|Randomly assigned but not treated|0
119670|NCT00455429|389359|P4|Overall Study|Adverse Event|3
119671|NCT00455429|389360|P3|Overall Study|Adverse Event|0
119672|NCT00455429|389361|P2|Overall Study|Adverse Event|1
119673|NCT00455429|389362|P1|Overall Study|Adverse Event|0
119674|NCT00455429|389359|P4|Overall Study|Lack of Efficacy|1
119675|NCT00455429|389360|P3|Overall Study|Lack of Efficacy|0
119676|NCT00455429|389361|P2|Overall Study|Lack of Efficacy|1
119677|NCT00455429|389362|P1|Overall Study|Lack of Efficacy|0
119678|NCT00455429|389359|P4|Overall Study|Withdrawal by Subject|0
119679|NCT00455429|389360|P3|Overall Study|Withdrawal by Subject|1
119680|NCT00455429|389361|P2|Overall Study|Withdrawal by Subject|1
119681|NCT00455429|389362|P1|Overall Study|Withdrawal by Subject|0
119682|NCT00455429|389359|P4|Overall Study|Lost to Follow-up|3
119683|NCT00455429|389360|P3|Overall Study|Lost to Follow-up|0
119684|NCT00455429|389361|P2|Overall Study|Lost to Follow-up|0
119685|NCT00455429|389362|P1|Overall Study|Lost to Follow-up|1
119686|NCT00455429|389359|P4|Overall Study|Study Terminated by Sponsor|3
119687|NCT00455429|389360|P3|Overall Study|Study Terminated by Sponsor|0
119688|NCT00455429|389361|P2|Overall Study|Study Terminated by Sponsor|0
119689|NCT00455429|389362|P1|Overall Study|Study Terminated by Sponsor|0
119690|NCT00455455|389419|P2|Washout|Withdrawal by Subject|0
119691|NCT00455455|389420|P1|Washout|Withdrawal by Subject|1
119692|NCT00455455|389419|P2|Washout|Withdrawal by Subject|1
119693|NCT00455455|389420|P1|Washout|Withdrawal by Subject|0
119694|NCT00455520|389438|P2|Double Blind Tapentadol ER vs Placebo|All other|6
119695|NCT00455520|389439|P1|Double Blind Tapentadol ER vs Placebo|All other|4
119696|NCT00455520|389438|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
119697|NCT00455520|389439|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
119698|NCT00455520|389438|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
119699|NCT00455520|389439|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
119700|NCT00455520|389438|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
119701|NCT00455520|389439|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
119702|NCT00455520|389438|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
119703|NCT00455520|389439|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
119704|NCT00455520|389438|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
119705|NCT00455520|389439|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
119706|NCT00455520|389438|P2|Open Label Tapentadol Extended Release|All other|0
119707|NCT00455520|389439|P1|Open Label Tapentadol Extended Release|All other|33
119708|NCT00455520|389438|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
119709|NCT00455520|389439|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
119710|NCT00455520|389438|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
119711|NCT00455520|389439|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
119712|NCT00455520|389438|P2|Open Label Tapentadol Extended Release|Adverse Event|0
119713|NCT00455520|389439|P1|Open Label Tapentadol Extended Release|Adverse Event|100
119714|NCT00455520|389438|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
119715|NCT00455520|389439|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
119716|NCT00455520|389438|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
119717|NCT00455520|389439|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
119718|NCT00455533|389457|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
119719|NCT00455533|389458|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
119720|NCT00455533|389459|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
119721|NCT00455533|389457|P3|Period Two: Randomized Period|Study Drug Toxicity|0
119722|NCT00455533|389458|P2|Period Two: Randomized Period|Study Drug Toxicity|2
119723|NCT00455533|389459|P1|Period Two: Randomized Period|Study Drug Toxicity|0
119724|NCT00455533|389457|P3|Period Two: Randomized Period|Other - need reasons|0
119725|NCT00455533|389458|P2|Period Two: Randomized Period|Other - need reasons|1
119726|NCT00455533|389459|P1|Period Two: Randomized Period|Other - need reasons|0
119727|NCT00455533|389457|P3|Period Two: Randomized Period|Lost to Follow-up|1
119728|NCT00455533|389458|P2|Period Two: Randomized Period|Lost to Follow-up|0
119729|NCT00455533|389459|P1|Period Two: Randomized Period|Lost to Follow-up|0
119730|NCT00455533|389457|P3|Period Two: Randomized Period|Disease Progression|1
119731|NCT00455533|389458|P2|Period Two: Randomized Period|Disease Progression|1
119732|NCT00455533|389459|P1|Period Two: Randomized Period|Disease Progression|0
119733|NCT00455533|389457|P3|Period Two: Randomized Period|Death|3
119734|NCT00455533|389458|P2|Period Two: Randomized Period|Death|0
119735|NCT00455533|389459|P1|Period Two: Randomized Period|Death|0
119736|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
119737|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
119738|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
119739|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
119740|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
119741|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
119742|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
119743|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
119744|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
119745|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
119746|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
119747|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
119748|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
119749|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
119750|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
119751|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Not Reported|0
119752|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Not Reported|0
119753|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Not Reported|1
119754|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
119755|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
119756|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
119757|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Disease Progression|0
119758|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Disease Progression|0
119759|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Disease Progression|5
119760|NCT00455533|389457|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
119761|NCT00455533|389458|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
119762|NCT00455533|389459|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
119763|NCT00455858|389574|P1|Overall Study|Withdrawal|1
119764|NCT00455858|389574|P1|Overall Study|Well controlled FPG without insulin|1
119765|NCT00455858|389574|P1|Overall Study|Lack of Efficacy|1
119766|NCT00455858|389574|P1|Overall Study|Protocol Violation|1
119767|NCT00455858|389574|P1|Overall Study|Lost to Follow-up|2
119768|NCT00456495|389625|P1|Overall Study|Physician Decision|2
119769|NCT00456521|389638|P2|Overall Study|Drug non-compliance, moved, other|11
119770|NCT00456521|389639|P1|Overall Study|Drug non-compliance, moved, other|26
119771|NCT00456521|389638|P2|Overall Study|Pregnancy|1
119772|NCT00456521|389639|P1|Overall Study|Pregnancy|1
119773|NCT00456521|389638|P2|Overall Study|Protocol Violation|0
119774|NCT00456521|389639|P1|Overall Study|Protocol Violation|4
119775|NCT00456521|389638|P2|Overall Study|Lack of Efficacy|6
119776|NCT00456521|389639|P1|Overall Study|Lack of Efficacy|3
119777|NCT00456521|389638|P2|Overall Study|Lost to Follow-up|17
119778|NCT00456521|389639|P1|Overall Study|Lost to Follow-up|22
119779|NCT00456521|389638|P2|Overall Study|Withdrawal by Subject|24
119780|NCT00456521|389639|P1|Overall Study|Withdrawal by Subject|43
119781|NCT00456521|389638|P2|Overall Study|Adverse Event|25
119782|NCT00456521|389639|P1|Overall Study|Adverse Event|150
119783|NCT00456599|389694|P1|Overall Study|Withdrawal by Subject|2
119784|NCT00456599|389694|P1|Overall Study|Non-compliance|1
119785|NCT00456612|389700|P1|Overall Study|Withdrawal by Subject|3
119786|NCT00456755|389713|P2|Overall Study|Lost to Follow-up|1
119787|NCT00456755|389714|P1|Overall Study|Lost to Follow-up|2
119788|NCT00456846|389743|P2|Overall Study|Unspecified|2
119789|NCT00456846|389744|P1|Overall Study|Unspecified|0
119790|NCT00456846|389743|P2|Overall Study|Participant Discretion|5
119791|NCT00456846|389744|P1|Overall Study|Participant Discretion|1
119792|NCT00456846|389743|P2|Overall Study|Protocol Deviation|0
119793|NCT00456846|389744|P1|Overall Study|Protocol Deviation|2
119794|NCT00456846|389743|P2|Overall Study|Physician Decision|6
119795|NCT00456846|389744|P1|Overall Study|Physician Decision|11
119796|NCT00456846|389743|P2|Overall Study|Adverse Event|15
119797|NCT00456846|389744|P1|Overall Study|Adverse Event|2
119798|NCT00457002|389770|P2|Overall Study|treated for 1 day; missing status/reason|0
119799|NCT00457002|389771|P1|Overall Study|treated for 1 day; missing status/reason|1
119800|NCT00457002|389770|P2|Overall Study|non-specified|38
119801|NCT00457002|389771|P1|Overall Study|non-specified|29
119802|NCT00457002|389770|P2|Overall Study|Administrative reason by Sponsor|0
119803|NCT00457002|389771|P1|Overall Study|Administrative reason by Sponsor|1
119804|NCT00457002|389770|P2|Overall Study|No longer met criteria|37
119805|NCT00457002|389771|P1|Overall Study|No longer met criteria|41
119806|NCT00457002|389770|P2|Overall Study|Poor/Non-compliance|33
119807|NCT00457002|389771|P1|Overall Study|Poor/Non-compliance|46
119808|NCT00457002|389770|P2|Overall Study|Lost to Follow-up|71
119809|NCT00457002|389771|P1|Overall Study|Lost to Follow-up|72
119810|NCT00457002|389770|P2|Overall Study|Withdrawal by Subject|271
119811|NCT00457002|389771|P1|Overall Study|Withdrawal by Subject|299
119812|NCT00457002|389770|P2|Overall Study|Adverse Event|260
119813|NCT00457002|389771|P1|Overall Study|Adverse Event|284
119814|NCT00457002|389770|P2|Overall Study|Death|47
119815|NCT00457002|389771|P1|Overall Study|Death|40
119816|NCT00457015|389841|P2|Overall Study|Left study site against medical advice|1
119817|NCT00457015|389842|P1|Overall Study|Left study site against medical advice|0
119818|NCT00457249|389883|P2|Overall Study|Serious Adverse Events|0
119819|NCT00457249|389884|P1|Overall Study|Serious Adverse Events|2
119820|NCT00457249|389883|P2|Overall Study|Withdrawal by Subject|1
119821|NCT00457249|389884|P1|Overall Study|Withdrawal by Subject|3
119822|NCT00457249|389883|P2|Overall Study|Protocol Violation|1
119823|NCT00457249|389884|P1|Overall Study|Protocol Violation|4
119824|NCT00457249|389883|P2|Overall Study|Lost to Follow-up|0
119825|NCT00457249|389884|P1|Overall Study|Lost to Follow-up|3
119826|NCT00457301|389898|P2|Overall Study|Death|7
119827|NCT00457301|389899|P1|Overall Study|Death|5
119828|NCT00457301|389898|P2|Overall Study|Censored out of the study|14
119829|NCT00457301|389899|P1|Overall Study|Censored out of the study|15
119830|NCT00457301|389898|P2|Overall Study|Withdrawal by Subject|3
119831|NCT00457301|389899|P1|Overall Study|Withdrawal by Subject|3
119832|NCT00457392|389913|P2|Overall Study|Randomized, Not Treated|3
119833|NCT00457392|389914|P1|Overall Study|Randomized, Not Treated|7
119834|NCT00457392|389913|P2|Overall Study|Study Terminated by Sponsor|4
119835|NCT00457392|389914|P1|Overall Study|Study Terminated by Sponsor|1
119836|NCT00457392|389913|P2|Overall Study|Unspecified|4
119837|NCT00457392|389914|P1|Overall Study|Unspecified|7
119838|NCT00457392|389913|P2|Overall Study|Protocol Violation|3
119839|NCT00457392|389914|P1|Overall Study|Protocol Violation|4
119840|NCT00457392|389913|P2|Overall Study|Lost to Follow-up|7
119841|NCT00457392|389914|P1|Overall Study|Lost to Follow-up|6
119842|NCT00457392|389913|P2|Overall Study|Withdrawal by Subject|8
119843|NCT00457392|389914|P1|Overall Study|Withdrawal by Subject|14
119844|NCT00457392|389913|P2|Overall Study|Global Deterioration of Health Status|8
119845|NCT00457392|389914|P1|Overall Study|Global Deterioration of Health Status|22
119846|NCT00457392|389913|P2|Overall Study|Adverse Event|41
119847|NCT00457392|389914|P1|Overall Study|Adverse Event|84
119848|NCT00457392|389913|P2|Overall Study|Death|106
119849|NCT00457392|389914|P1|Overall Study|Death|106
119850|NCT00457392|389913|P2|Overall Study|Objective Progression or Relapse|296
119851|NCT00457392|389914|P1|Overall Study|Objective Progression or Relapse|229
119852|NCT00457418|389930|P1|Post PK Maintenance|Lost to Follow-up|1
119853|NCT00457418|389930|P1|Post PK Maintenance|Withdrawal by Subject|11
119854|NCT00457418|389930|P1|Post PK Maintenance|Progression of Disease|6
119855|NCT00457418|389930|P1|Post PK Maintenance|Adverse Event|10
119856|NCT00457418|389930|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
119857|NCT00457418|389930|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
119858|NCT00457418|389930|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
119859|NCT00450437|389951|P4|Overall Study|Unable to Classify|0
119860|NCT00450437|389952|P3|Overall Study|Unable to Classify|1
119861|NCT00450437|389953|P2|Overall Study|Unable to Classify|0
119862|NCT00450437|389954|P1|Overall Study|Unable to Classify|1
119863|NCT00450437|389951|P4|Overall Study|Administrative reason|0
119864|NCT00450437|389952|P3|Overall Study|Administrative reason|1
119865|NCT00450437|389953|P2|Overall Study|Administrative reason|0
119866|NCT00450437|389954|P1|Overall Study|Administrative reason|0
119867|NCT00450437|389951|P4|Overall Study|Inappropriate enrollment|0
119868|NCT00450437|389952|P3|Overall Study|Inappropriate enrollment|3
119869|NCT00450437|389953|P2|Overall Study|Inappropriate enrollment|1
119870|NCT00450437|389954|P1|Overall Study|Inappropriate enrollment|4
119871|NCT00450437|389951|P4|Overall Study|Protocol Violation|1
119872|NCT00450437|389952|P3|Overall Study|Protocol Violation|0
119873|NCT00450437|389953|P2|Overall Study|Protocol Violation|1
119874|NCT00450437|389954|P1|Overall Study|Protocol Violation|0
119875|NCT00450437|389951|P4|Overall Study|Lost to Follow-up|9
119876|NCT00450437|389952|P3|Overall Study|Lost to Follow-up|19
119877|NCT00450437|389953|P2|Overall Study|Lost to Follow-up|12
119878|NCT00450437|389954|P1|Overall Study|Lost to Follow-up|31
119879|NCT00450437|389951|P4|Overall Study|Withdrawal by Subject|1
119880|NCT00450437|389952|P3|Overall Study|Withdrawal by Subject|0
119881|NCT00450437|389953|P2|Overall Study|Withdrawal by Subject|2
119882|NCT00450437|389954|P1|Overall Study|Withdrawal by Subject|10
119883|NCT00450450|389978|P2|Overall Study|Missing Data|0
119884|NCT00450450|389979|P1|Overall Study|Missing Data|2
119885|NCT00450450|389978|P2|Overall Study|Relapse|0
119886|NCT00450450|389979|P1|Overall Study|Relapse|2
119887|NCT00450450|389978|P2|Overall Study|Death|3
119888|NCT00450450|389979|P1|Overall Study|Death|1
119889|NCT00450580|390003|P2|Overall Study|Withdrawal due to pregnancy|1
119890|NCT00450580|390004|P1|Overall Study|Withdrawal due to pregnancy|0
119891|NCT00450580|390003|P2|Overall Study|Patient could not swallow Norvir|0
119892|NCT00450580|390004|P1|Overall Study|Patient could not swallow Norvir|1
119893|NCT00450580|390003|P2|Overall Study|Patient went to Brazil|0
119894|NCT00450580|390004|P1|Overall Study|Patient went to Brazil|1
119895|NCT00450580|390003|P2|Overall Study|Could not comply with scheduled visits|0
119896|NCT00450580|390004|P1|Overall Study|Could not comply with scheduled visits|1
119897|NCT00450580|390003|P2|Overall Study|Protocol-defined virologic failure|0
119898|NCT00450580|390004|P1|Overall Study|Protocol-defined virologic failure|1
119899|NCT00450580|390003|P2|Overall Study|Protocol Violation|1
119900|NCT00450580|390004|P1|Overall Study|Protocol Violation|1
119901|NCT00450580|390003|P2|Overall Study|Withdrawal by Subject|2
119902|NCT00450580|390004|P1|Overall Study|Withdrawal by Subject|2
119903|NCT00450580|390003|P2|Overall Study|Lost to Follow-up|5
119904|NCT00450580|390004|P1|Overall Study|Lost to Follow-up|4
119905|NCT00450580|390003|P2|Overall Study|Adverse Event|7
119906|NCT00450580|390004|P1|Overall Study|Adverse Event|5
119907|NCT00450619|390024|P2|Overall Study|Adverse Event|0
119908|NCT00450619|390025|P1|Overall Study|Adverse Event|1
119909|NCT00450619|390024|P2|Overall Study|did not progress; refused further trmt|1
119910|NCT00450619|390025|P1|Overall Study|did not progress; refused further trmt|1
119911|NCT00450619|390024|P2|Overall Study|refused treatment after randomization|0
119912|NCT00450619|390025|P1|Overall Study|refused treatment after randomization|2
119913|NCT00450658|390051|P2|Overall Study|misc|10
119914|NCT00450658|390052|P1|Overall Study|misc|21
119915|NCT00450658|390051|P2|Overall Study|UGI ulcer|34
119916|NCT00450658|390052|P1|Overall Study|UGI ulcer|33
119917|NCT00450658|390051|P2|Overall Study|Lost to Follow-up|5
119918|NCT00450658|390052|P1|Overall Study|Lost to Follow-up|22
119919|NCT00450658|390051|P2|Overall Study|Withdrawal by Subject|26
119920|NCT00450658|390052|P1|Overall Study|Withdrawal by Subject|43
119921|NCT00450658|390051|P2|Overall Study|Adverse Event|15
119922|NCT00450658|390052|P1|Overall Study|Adverse Event|24
119923|NCT00450723|390064|P1|Overall Study|Physician Decision|5
119924|NCT00450749|390073|P3|Overall Study|Noncompliant|0
119925|NCT00450749|390074|P2|Overall Study|Noncompliant|1
119926|NCT00450749|390075|P1|Overall Study|Noncompliant|0
119927|NCT00450749|390073|P3|Overall Study|Withdrawal by Subject|2
119928|NCT00450749|390074|P2|Overall Study|Withdrawal by Subject|0
119929|NCT00450749|390075|P1|Overall Study|Withdrawal by Subject|0
119930|NCT00450801|390083|P1|Overall Study|Death|1
119931|NCT00450866|390094|P2|Overall Study|Physician Decision|0
119932|NCT00450866|390095|P1|Overall Study|Physician Decision|1
119933|NCT00450866|390094|P2|Overall Study|Death|0
119934|NCT00450866|390095|P1|Overall Study|Death|1
119935|NCT00450866|390094|P2|Overall Study|Withdrawal by Subject|2
119936|NCT00450866|390095|P1|Overall Study|Withdrawal by Subject|5
119937|NCT00450866|390094|P2|Overall Study|Adverse Event|1
119938|NCT00450866|390095|P1|Overall Study|Adverse Event|0
119939|NCT00451191|390123|P2|Overall Study|withdrawal or received alternate tx|11
119940|NCT00451191|390124|P1|Overall Study|withdrawal or received alternate tx|15
119941|NCT00451204|390132|P2|Overall Study|Other|2
119942|NCT00451204|390133|P1|Overall Study|Other|1
119943|NCT00451204|390132|P2|Overall Study|Patient refusal|4
119944|NCT00451204|390133|P1|Overall Study|Patient refusal|8
119945|NCT00451204|390132|P2|Overall Study|Protocol Violation|0
119946|NCT00451204|390133|P1|Overall Study|Protocol Violation|1
119947|NCT00451204|390132|P2|Overall Study|Lost to Follow-up|4
119948|NCT00451204|390133|P1|Overall Study|Lost to Follow-up|4
119949|NCT00451204|390132|P2|Overall Study|Lack of Efficacy|4
119950|NCT00451204|390133|P1|Overall Study|Lack of Efficacy|4
119951|NCT00451204|390132|P2|Overall Study|Adverse Event|6
119952|NCT00451204|390133|P1|Overall Study|Adverse Event|4
119953|NCT00451282|390151|P2|Overall Study|Lost to Follow-up|5
119954|NCT00451282|390152|P1|Overall Study|Lost to Follow-up|6
119955|NCT00451451|390168|P4|Overall Study|Other Reasons for Not Completing Study|14
119956|NCT00451451|390169|P3|Overall Study|Other Reasons for Not Completing Study|17
119957|NCT00451451|390170|P2|Overall Study|Other Reasons for Not Completing Study|30
119958|NCT00451451|390171|P1|Overall Study|Other Reasons for Not Completing Study|34
119959|NCT00451451|390168|P4|Overall Study|Death|1
119960|NCT00451451|390169|P3|Overall Study|Death|0
119961|NCT00451451|390170|P2|Overall Study|Death|0
119962|NCT00451451|390171|P1|Overall Study|Death|1
119963|NCT00451451|390168|P4|Overall Study|Subject Non-Compliance|3
119964|NCT00451451|390169|P3|Overall Study|Subject Non-Compliance|3
119965|NCT00451451|390170|P2|Overall Study|Subject Non-Compliance|4
119966|NCT00451451|390171|P1|Overall Study|Subject Non-Compliance|8
119967|NCT00451451|390168|P4|Overall Study|Investigator Decision|2
119968|NCT00451451|390169|P3|Overall Study|Investigator Decision|1
119969|NCT00451451|390170|P2|Overall Study|Investigator Decision|2
119970|NCT00451451|390171|P1|Overall Study|Investigator Decision|6
119971|NCT00451451|390168|P4|Overall Study|Consent Withdrawn|17
119972|NCT00451451|390169|P3|Overall Study|Consent Withdrawn|17
119973|NCT00451451|390170|P2|Overall Study|Consent Withdrawn|9
119974|NCT00451451|390171|P1|Overall Study|Consent Withdrawn|14
119975|NCT00451451|390168|P4|Overall Study|Lost to Follow-up|11
119976|NCT00451451|390169|P3|Overall Study|Lost to Follow-up|8
119977|NCT00451451|390170|P2|Overall Study|Lost to Follow-up|9
119978|NCT00451451|390171|P1|Overall Study|Lost to Follow-up|11
119979|NCT00451451|390168|P4|Overall Study|Adverse Event|10
119980|NCT00451451|390169|P3|Overall Study|Adverse Event|26
119981|NCT00451451|390170|P2|Overall Study|Adverse Event|21
119982|NCT00451451|390171|P1|Overall Study|Adverse Event|11
119983|NCT00451906|390209|P1|Overall Study|Did not complete final visit|4
119984|NCT00451906|390209|P1|Overall Study|Other Reasons|121
119985|NCT00451906|390209|P1|Overall Study|Termination of the study|108
119986|NCT00451906|390209|P1|Overall Study|Progressive disease|1328
119987|NCT00451906|390209|P1|Overall Study|Protocol Violation|21
119988|NCT00451906|390209|P1|Overall Study|Withdrawal by Subject|111
119989|NCT00451906|390209|P1|Overall Study|Lost to Follow-up|31
119990|NCT00451906|390209|P1|Overall Study|Adverse Event|515
119991|NCT00451958|390221|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
119992|NCT00451958|390222|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
119993|NCT00451958|390223|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
119994|NCT00451958|390224|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
119995|NCT00451958|390225|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
119996|NCT00451958|390221|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
119997|NCT00451958|390222|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
119998|NCT00451958|390223|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
119999|NCT00451958|390224|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
120000|NCT00451958|390225|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
120001|NCT00451958|390221|P5|CS21A (NCT00451958)|Physician Decision|0
120002|NCT00451958|390222|P4|CS21A (NCT00451958)|Physician Decision|4
120003|NCT00451958|390223|P3|CS21A (NCT00451958)|Physician Decision|4
120004|NCT00451958|390224|P2|CS21A (NCT00451958)|Physician Decision|4
120005|NCT00451958|390225|P1|CS21A (NCT00451958)|Physician Decision|2
120006|NCT00451958|390221|P5|CS21A (NCT00451958)|Protocol Violation|0
120007|NCT00451958|390222|P4|CS21A (NCT00451958)|Protocol Violation|0
120008|NCT00451958|390223|P3|CS21A (NCT00451958)|Protocol Violation|2
120009|NCT00451958|390224|P2|CS21A (NCT00451958)|Protocol Violation|3
120010|NCT00451958|390225|P1|CS21A (NCT00451958)|Protocol Violation|1
120011|NCT00451958|390221|P5|CS21A (NCT00451958)|Lost to Follow-up|0
120012|NCT00451958|390222|P4|CS21A (NCT00451958)|Lost to Follow-up|1
120013|NCT00451958|390223|P3|CS21A (NCT00451958)|Lost to Follow-up|1
120014|NCT00451958|390224|P2|CS21A (NCT00451958)|Lost to Follow-up|5
120015|NCT00451958|390225|P1|CS21A (NCT00451958)|Lost to Follow-up|6
120016|NCT00451958|390221|P5|CS21A (NCT00451958)|Adverse Event|0
120017|NCT00451958|390222|P4|CS21A (NCT00451958)|Adverse Event|17
120018|NCT00451958|390223|P3|CS21A (NCT00451958)|Adverse Event|14
120019|NCT00451958|390224|P2|CS21A (NCT00451958)|Adverse Event|34
120020|NCT00451958|390225|P1|CS21A (NCT00451958)|Adverse Event|21
120021|NCT00457691|390257|P2|Overall Study|Disease progression, study terminated|196
120022|NCT00457691|390258|P1|Overall Study|Disease progression, study terminated|180
120023|NCT00457691|390257|P2|Overall Study|Subject refused (reason other than AE)|19
120024|NCT00457691|390258|P1|Overall Study|Subject refused (reason other than AE)|14
120025|NCT00457691|390257|P2|Overall Study|Study terminated by Sponsor|1
120026|NCT00457691|390258|P1|Overall Study|Study terminated by Sponsor|1
120027|NCT00457691|390257|P2|Overall Study|Lost to Follow-up|14
120028|NCT00457691|390258|P1|Overall Study|Lost to Follow-up|23
120029|NCT00457691|390257|P2|Overall Study|Protocol Violation|3
120030|NCT00457691|390258|P1|Overall Study|Protocol Violation|1
120031|NCT00457691|390257|P2|Overall Study|Death|148
120032|NCT00457691|390258|P1|Overall Study|Death|163
120033|NCT00457691|390257|P2|Overall Study|Adverse Event|1
120034|NCT00457691|390258|P1|Overall Study|Adverse Event|4
120035|NCT00457743|390294|P3|Overall Study|Lack of Efficacy|3
120036|NCT00457743|390295|P2|Overall Study|Lack of Efficacy|23
120037|NCT00457743|390296|P1|Overall Study|Lack of Efficacy|3
120038|NCT00457743|390294|P3|Overall Study|Adverse Event|0
120039|NCT00457743|390295|P2|Overall Study|Adverse Event|4
120040|NCT00457743|390296|P1|Overall Study|Adverse Event|0
120041|NCT00457821|390353|P8|Part 2|Withdrawal by Subject|1
120042|NCT00457821|390354|P7|Part 2|Withdrawal by Subject|0
120043|NCT00457821|390355|P6|Part 2|Withdrawal by Subject|0
120044|NCT00457821|390356|P5|Part 2|Withdrawal by Subject|0
120045|NCT00457821|390357|P4|Part 2|Withdrawal by Subject|0
120046|NCT00457821|390358|P3|Part 2|Withdrawal by Subject|0
120047|NCT00457821|390359|P2|Part 2|Withdrawal by Subject|0
120048|NCT00457821|390360|P1|Part 2|Withdrawal by Subject|0
120049|NCT00458705|390389|P1|Overall Study|Not Treated|1
120050|NCT00458705|390389|P1|Overall Study|Adverse Event|4
120051|NCT00459043|390406|P2|Overall Study|Withdrawal by Subject|0
120052|NCT00459043|390407|P1|Overall Study|Withdrawal by Subject|1
120053|NCT00459056|390419|P2|First Intervention (First Three Months)|Lost to Follow-up|1
120054|NCT00459056|390420|P1|First Intervention (First Three Months)|Lost to Follow-up|1
120055|NCT00459108|390426|P1|Overall Study|Progression|1
120056|NCT00459108|390426|P1|Overall Study|Death|2
120057|NCT00459108|390426|P1|Overall Study|Adverse Event|3
120058|NCT00459108|390426|P1|Overall Study|Withdrawal by Subject|5
120059|NCT00459134|390437|P2|Overall Study|Multiple Reasons|3
120060|NCT00459134|390438|P1|Overall Study|Multiple Reasons|2
120061|NCT00459134|390437|P2|Overall Study|Progression|0
120062|NCT00459134|390438|P1|Overall Study|Progression|1
120063|NCT00459134|390437|P2|Overall Study|Toxicity|5
120064|NCT00459134|390438|P1|Overall Study|Toxicity|4
120065|NCT00459134|390437|P2|Overall Study|Surgery|2
120066|NCT00459134|390438|P1|Overall Study|Surgery|1
120067|NCT00459134|390437|P2|Overall Study|Lost to Follow-up|7
120068|NCT00459134|390438|P1|Overall Study|Lost to Follow-up|6
120069|NCT00459134|390437|P2|Overall Study|Withdrawal by Subject|7
120070|NCT00459134|390438|P1|Overall Study|Withdrawal by Subject|8
120071|NCT00459134|390437|P2|Overall Study|Physician Decision|1
120072|NCT00459134|390438|P1|Overall Study|Physician Decision|1
120073|NCT00459186|390446|P1|PET Imaging and Assessment|Adverse Event|3
120074|NCT00459186|390446|P1|Single Agent RAD001|Withdrawal by Subject|1
120075|NCT00459290|390451|P1|Overall Study|Ineligible|2
120076|NCT00459290|390451|P1|Overall Study|Adverse Event|3
120077|NCT00459316|390480|P3|Step 3|Withdrawal by Subject|1
120078|NCT00459316|390481|P2|Step 3|Withdrawal by Subject|0
120079|NCT00459316|390482|P1|Step 3|Withdrawal by Subject|3
120080|NCT00459316|390480|P3|Steps 1 & 2|Lost to Follow-up|2
120081|NCT00459316|390481|P2|Steps 1 & 2|Lost to Follow-up|0
120082|NCT00459316|390482|P1|Steps 1 & 2|Lost to Follow-up|5
120083|NCT00459316|390480|P3|Steps 1 & 2|Not willing to adhere to regulations|0
120084|NCT00459316|390481|P2|Steps 1 & 2|Not willing to adhere to regulations|0
120085|NCT00459316|390482|P1|Steps 1 & 2|Not willing to adhere to regulations|1
120086|NCT00459316|390480|P3|Steps 1 & 2|Withdrawal by Subject|0
120087|NCT00459316|390481|P2|Steps 1 & 2|Withdrawal by Subject|1
120088|NCT00459316|390482|P1|Steps 1 & 2|Withdrawal by Subject|6
120089|NCT00459316|390480|P3|Steps 1 & 2|Not able to get to clinic|0
120090|NCT00459316|390481|P2|Steps 1 & 2|Not able to get to clinic|4
120091|NCT00459316|390482|P1|Steps 1 & 2|Not able to get to clinic|7
120092|NCT00459316|390480|P3|Steps 1 & 2|Death|0
120093|NCT00459316|390481|P2|Steps 1 & 2|Death|1
120094|NCT00459316|390482|P1|Steps 1 & 2|Death|1
120095|NCT00459316|390480|P3|Steps 1 & 2|Other eligibility failure|0
120096|NCT00459316|390481|P2|Steps 1 & 2|Other eligibility failure|1
120097|NCT00459316|390482|P1|Steps 1 & 2|Other eligibility failure|1
120098|NCT00459342|390536|P1|Overall Study|Not eligible|1
120099|NCT00459355|390543|P2|Overall Study|Subject no longer met inc criteria|18
120100|NCT00459355|390544|P1|Overall Study|Subject no longer met inc criteria|20
120101|NCT00459537|390577|P2|Overall Study|Missing|0
120102|NCT00459537|390578|P1|Overall Study|Missing|1
120103|NCT00459537|390577|P2|Overall Study|Protocol Violation|3
120104|NCT00459537|390578|P1|Overall Study|Protocol Violation|4
120105|NCT00459537|390577|P2|Overall Study|Administrative problems|0
120106|NCT00459537|390578|P1|Overall Study|Administrative problems|3
120107|NCT00459537|390577|P2|Overall Study|Lost to Follow-up|30
120108|NCT00459537|390578|P1|Overall Study|Lost to Follow-up|27
120109|NCT00459537|390577|P2|Overall Study|Withdrawal by Subject|26
120110|NCT00459537|390578|P1|Overall Study|Withdrawal by Subject|20
120111|NCT00459537|390577|P2|Overall Study|Lack of Efficacy|11
120112|NCT00459537|390578|P1|Overall Study|Lack of Efficacy|10
120113|NCT00459537|390577|P2|Overall Study|Adverse Event|6
120114|NCT00459537|390578|P1|Overall Study|Adverse Event|1
120115|NCT00459667|390595|P3|Overall Study|No treatment administered|1
120116|NCT00459667|390596|P2|Overall Study|No treatment administered|3
120117|NCT00459667|390597|P1|Overall Study|No treatment administered|6
120118|NCT00459667|390595|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
120119|NCT00459667|390596|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
120120|NCT00459667|390597|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
120121|NCT00459667|390595|P3|Overall Study|Other disease modifying treatment|1
120122|NCT00459667|390596|P2|Overall Study|Other disease modifying treatment|2
120123|NCT00459667|390597|P1|Overall Study|Other disease modifying treatment|1
120124|NCT00459667|390595|P3|Overall Study|Withdrawal by Subject|5
120125|NCT00459667|390596|P2|Overall Study|Withdrawal by Subject|5
120126|NCT00459667|390597|P1|Overall Study|Withdrawal by Subject|3
120127|NCT00459667|390595|P3|Overall Study|Protocol Violation|0
120128|NCT00459667|390596|P2|Overall Study|Protocol Violation|0
120129|NCT00459667|390597|P1|Overall Study|Protocol Violation|1
120130|NCT00459667|390595|P3|Overall Study|Pregnancy|1
120131|NCT00459667|390596|P2|Overall Study|Pregnancy|1
120132|NCT00459667|390597|P1|Overall Study|Pregnancy|1
120133|NCT00459667|390595|P3|Overall Study|Lost to Follow-up|3
120134|NCT00459667|390596|P2|Overall Study|Lost to Follow-up|9
120135|NCT00459667|390597|P1|Overall Study|Lost to Follow-up|5
120136|NCT00459667|390595|P3|Overall Study|Adverse Event|8
120137|NCT00459667|390596|P2|Overall Study|Adverse Event|12
120138|NCT00459667|390597|P1|Overall Study|Adverse Event|9
120139|NCT00459706|390619|P2|Overall Study|Unspecified|1
120140|NCT00459706|390620|P1|Overall Study|Unspecified|0
120141|NCT00459706|390619|P2|Overall Study|Failed to Return|0
120142|NCT00459706|390620|P1|Overall Study|Failed to Return|1
120143|NCT00459706|390619|P2|Overall Study|Protocol Violation|1
120144|NCT00459706|390620|P1|Overall Study|Protocol Violation|2
120145|NCT00459706|390619|P2|Overall Study|Discontinuation of Study by Sponsor|0
120146|NCT00459706|390620|P1|Overall Study|Discontinuation of Study by Sponsor|1
120147|NCT00459706|390619|P2|Overall Study|Physician Decision|0
120148|NCT00459706|390620|P1|Overall Study|Physician Decision|2
120149|NCT00459706|390619|P2|Overall Study|Withdrawal by Subject|6
120150|NCT00459706|390620|P1|Overall Study|Withdrawal by Subject|1
120151|NCT00459706|390619|P2|Overall Study|Adverse Event|13
120152|NCT00459706|390620|P1|Overall Study|Adverse Event|19
120153|NCT00459875|390790|P1|Overall Study|Adverse Event|2
120154|NCT00459875|390790|P1|Overall Study|Ineligible participant|1
120155|NCT00459953|390796|P2|Overall Study|not analyzed-household member in study|1
120156|NCT00459953|390797|P1|Overall Study|not analyzed-household member in study|1
120157|NCT00459979|390803|P1|Overall Study|Protocol Violation|1
120158|NCT00459979|390803|P1|Overall Study|Withdrawal by Subject|1
120159|NCT00460031|390813|P1|Overall Study|Death|1
120160|NCT00460031|390813|P1|Overall Study|Withdrawal by Subject|5
120161|NCT00460031|390813|P1|Overall Study|Adverse Event|5
120162|NCT00460109|390821|P1|Overall Study|Death|1
120163|NCT00460239|390829|P9|Overall Study|Withdrawal by Subject|0
120164|NCT00460239|390830|P8|Overall Study|Withdrawal by Subject|0
120165|NCT00460239|390831|P7|Overall Study|Withdrawal by Subject|0
120166|NCT00460239|390832|P6|Overall Study|Withdrawal by Subject|1
120167|NCT00460239|390833|P5|Overall Study|Withdrawal by Subject|0
120168|NCT00460239|390834|P4|Overall Study|Withdrawal by Subject|0
120169|NCT00460239|390835|P3|Overall Study|Withdrawal by Subject|0
120170|NCT00460239|390836|P2|Overall Study|Withdrawal by Subject|0
120171|NCT00460239|390837|P1|Overall Study|Withdrawal by Subject|0
120172|NCT00460239|390829|P9|Overall Study|Physician Decision|0
120173|NCT00460239|390830|P8|Overall Study|Physician Decision|0
120174|NCT00460239|390831|P7|Overall Study|Physician Decision|0
120175|NCT00460239|390832|P6|Overall Study|Physician Decision|2
120176|NCT00460239|390833|P5|Overall Study|Physician Decision|0
120177|NCT00460239|390834|P4|Overall Study|Physician Decision|0
120178|NCT00460239|390835|P3|Overall Study|Physician Decision|0
120179|NCT00460239|390836|P2|Overall Study|Physician Decision|1
120180|NCT00460239|390837|P1|Overall Study|Physician Decision|0
120181|NCT00460265|390908|P2|Overall Study|Ongoing|47
120182|NCT00460265|390909|P1|Overall Study|Ongoing|60
120183|NCT00460265|390908|P2|Overall Study|Withdrawal by Subject|25
120184|NCT00460265|390909|P1|Overall Study|Withdrawal by Subject|10
120185|NCT00460265|390908|P2|Overall Study|Physician Decision|2
120186|NCT00460265|390909|P1|Overall Study|Physician Decision|1
120187|NCT00460265|390908|P2|Overall Study|Lost to Follow-up|15
120188|NCT00460265|390909|P1|Overall Study|Lost to Follow-up|14
120189|NCT00460408|390929|P4|Overall Study|Unspecified|0
120190|NCT00460408|390930|P3|Overall Study|Unspecified|0
120191|NCT00460408|390931|P2|Overall Study|Unspecified|2
120192|NCT00460408|390932|P1|Overall Study|Unspecified|12
120193|NCT00460408|390929|P4|Overall Study|Insufficient clinical response|0
120194|NCT00460408|390930|P3|Overall Study|Insufficient clinical response|5
120195|NCT00460408|390931|P2|Overall Study|Insufficient clinical response|1
120196|NCT00460408|390932|P1|Overall Study|Insufficient clinical response|5
120197|NCT00460408|390929|P4|Overall Study|Withdrawal by Subject|0
120198|NCT00460408|390930|P3|Overall Study|Withdrawal by Subject|0
120199|NCT00460408|390931|P2|Overall Study|Withdrawal by Subject|0
120200|NCT00460408|390932|P1|Overall Study|Withdrawal by Subject|31
120201|NCT00460408|390929|P4|Overall Study|Lost to Follow-up|0
120202|NCT00460408|390930|P3|Overall Study|Lost to Follow-up|1
120203|NCT00460408|390931|P2|Overall Study|Lost to Follow-up|0
120204|NCT00460408|390932|P1|Overall Study|Lost to Follow-up|11
120205|NCT00460408|390929|P4|Overall Study|Death|0
120206|NCT00460408|390930|P3|Overall Study|Death|0
120207|NCT00460408|390931|P2|Overall Study|Death|0
120208|NCT00460408|390932|P1|Overall Study|Death|7
120209|NCT00460408|390929|P4|Overall Study|Adverse Event|0
120210|NCT00460408|390930|P3|Overall Study|Adverse Event|0
120211|NCT00460408|390931|P2|Overall Study|Adverse Event|0
120212|NCT00460408|390932|P1|Overall Study|Adverse Event|1
120213|NCT00460564|391068|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120214|NCT00460564|391069|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120215|NCT00460564|391070|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120216|NCT00460564|391071|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
120217|NCT00460564|391072|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120218|NCT00460564|391073|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120219|NCT00460564|391074|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120220|NCT00460564|391075|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
120221|NCT00460564|391068|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120222|NCT00460564|391069|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120223|NCT00460564|391070|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
120224|NCT00460564|391071|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
120225|NCT00460564|391072|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120226|NCT00460564|391073|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120227|NCT00460564|391074|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120228|NCT00460564|391075|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120229|NCT00460564|391068|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
120230|NCT00460564|391069|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
120231|NCT00460564|391070|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
120232|NCT00460564|391071|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
120233|NCT00460564|391072|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
120234|NCT00460564|391073|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
120235|NCT00460564|391074|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
120236|NCT00460564|391075|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
120237|NCT00460564|391068|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120238|NCT00460564|391069|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120239|NCT00460564|391070|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120240|NCT00460564|391071|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120241|NCT00460564|391072|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120242|NCT00460564|391073|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120243|NCT00460564|391074|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120244|NCT00460564|391075|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
120245|NCT00460564|391068|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
120246|NCT00460564|391069|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
120247|NCT00460564|391070|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
120248|NCT00460564|391071|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
120249|NCT00460564|391072|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
120250|NCT00460564|391073|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
120251|NCT00460564|391074|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
120252|NCT00460564|391075|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
120253|NCT00460577|391171|P2|Overall Study|Protocol Violation|6
120254|NCT00460577|391172|P1|Overall Study|Protocol Violation|2
120255|NCT00460603|391198|P12|Phase 2|Randomized, but not treated|0
120256|NCT00460603|391199|P11|Phase 2|Randomized, but not treated|0
120257|NCT00460603|391200|P10|Phase 2|Randomized, but not treated|3
120258|NCT00460603|391201|P9|Phase 2|Randomized, but not treated|0
120259|NCT00460603|391202|P8|Phase 2|Randomized, but not treated|0
120260|NCT00460603|391203|P7|Phase 2|Randomized, but not treated|0
120261|NCT00460603|391204|P6|Phase 2|Randomized, but not treated|0
120262|NCT00460603|391205|P5|Phase 2|Randomized, but not treated|0
120263|NCT00460603|391206|P4|Phase 2|Randomized, but not treated|0
120264|NCT00460603|391207|P3|Phase 2|Randomized, but not treated|0
120265|NCT00460603|391208|P2|Phase 2|Randomized, but not treated|0
120266|NCT00460603|391209|P1|Phase 2|Randomized, but not treated|0
120267|NCT00460603|391198|P12|Phase 2|Withdrawal by Subject|5
120268|NCT00460603|391199|P11|Phase 2|Withdrawal by Subject|4
120269|NCT00460603|391200|P10|Phase 2|Withdrawal by Subject|5
120270|NCT00460603|391201|P9|Phase 2|Withdrawal by Subject|0
120271|NCT00460603|391202|P8|Phase 2|Withdrawal by Subject|0
120272|NCT00460603|391203|P7|Phase 2|Withdrawal by Subject|0
120273|NCT00460603|391204|P6|Phase 2|Withdrawal by Subject|0
120274|NCT00460603|391205|P5|Phase 2|Withdrawal by Subject|0
120275|NCT00460603|391206|P4|Phase 2|Withdrawal by Subject|0
120276|NCT00460603|391207|P3|Phase 2|Withdrawal by Subject|0
120277|NCT00460603|391208|P2|Phase 2|Withdrawal by Subject|0
120278|NCT00460603|391209|P1|Phase 2|Withdrawal by Subject|0
120279|NCT00460603|391198|P12|Phase 2|Global Deterioration of Health Status|0
120280|NCT00460603|391199|P11|Phase 2|Global Deterioration of Health Status|1
120281|NCT00460603|391200|P10|Phase 2|Global Deterioration of Health Status|0
120282|NCT00460603|391201|P9|Phase 2|Global Deterioration of Health Status|0
120283|NCT00460603|391202|P8|Phase 2|Global Deterioration of Health Status|0
120284|NCT00460603|391203|P7|Phase 2|Global Deterioration of Health Status|0
120285|NCT00460603|391204|P6|Phase 2|Global Deterioration of Health Status|0
120286|NCT00460603|391205|P5|Phase 2|Global Deterioration of Health Status|0
120287|NCT00460603|391206|P4|Phase 2|Global Deterioration of Health Status|0
120288|NCT00460603|391207|P3|Phase 2|Global Deterioration of Health Status|0
120289|NCT00460603|391208|P2|Phase 2|Global Deterioration of Health Status|0
120290|NCT00460603|391209|P1|Phase 2|Global Deterioration of Health Status|0
120291|NCT00460603|391198|P12|Phase 2|Objective Progression or Relapse|17
120292|NCT00460603|391199|P11|Phase 2|Objective Progression or Relapse|10
120293|NCT00460603|391200|P10|Phase 2|Objective Progression or Relapse|9
120294|NCT00460603|391201|P9|Phase 2|Objective Progression or Relapse|0
120295|NCT00460603|391202|P8|Phase 2|Objective Progression or Relapse|0
120296|NCT00460603|391203|P7|Phase 2|Objective Progression or Relapse|0
120297|NCT00460603|391204|P6|Phase 2|Objective Progression or Relapse|0
120298|NCT00460603|391205|P5|Phase 2|Objective Progression or Relapse|0
120299|NCT00460603|391206|P4|Phase 2|Objective Progression or Relapse|0
120300|NCT00460603|391207|P3|Phase 2|Objective Progression or Relapse|0
120301|NCT00460603|391208|P2|Phase 2|Objective Progression or Relapse|0
120302|NCT00460603|391209|P1|Phase 2|Objective Progression or Relapse|0
120303|NCT00460603|391198|P12|Phase 2|Unspecified|7
120304|NCT00460603|391199|P11|Phase 2|Unspecified|16
120305|NCT00460603|391200|P10|Phase 2|Unspecified|6
120306|NCT00460603|391201|P9|Phase 2|Unspecified|0
120307|NCT00460603|391202|P8|Phase 2|Unspecified|0
120308|NCT00460603|391203|P7|Phase 2|Unspecified|0
120309|NCT00460603|391204|P6|Phase 2|Unspecified|0
120310|NCT00460603|391205|P5|Phase 2|Unspecified|0
120311|NCT00460603|391206|P4|Phase 2|Unspecified|0
120312|NCT00460603|391207|P3|Phase 2|Unspecified|0
120313|NCT00460603|391208|P2|Phase 2|Unspecified|0
120314|NCT00460603|391209|P1|Phase 2|Unspecified|0
120315|NCT00460603|391198|P12|Phase 2|Lost to Follow-up|0
120316|NCT00460603|391199|P11|Phase 2|Lost to Follow-up|0
120317|NCT00460603|391200|P10|Phase 2|Lost to Follow-up|1
120318|NCT00460603|391201|P9|Phase 2|Lost to Follow-up|0
120319|NCT00460603|391202|P8|Phase 2|Lost to Follow-up|0
120320|NCT00460603|391203|P7|Phase 2|Lost to Follow-up|0
120321|NCT00460603|391204|P6|Phase 2|Lost to Follow-up|0
120322|NCT00460603|391205|P5|Phase 2|Lost to Follow-up|0
120323|NCT00460603|391206|P4|Phase 2|Lost to Follow-up|0
120324|NCT00460603|391207|P3|Phase 2|Lost to Follow-up|0
120325|NCT00460603|391208|P2|Phase 2|Lost to Follow-up|0
120326|NCT00460603|391209|P1|Phase 2|Lost to Follow-up|0
120327|NCT00460603|391198|P12|Phase 2|Protocol Violation|0
120328|NCT00460603|391199|P11|Phase 2|Protocol Violation|1
120329|NCT00460603|391200|P10|Phase 2|Protocol Violation|1
120330|NCT00460603|391201|P9|Phase 2|Protocol Violation|0
120331|NCT00460603|391202|P8|Phase 2|Protocol Violation|0
120332|NCT00460603|391203|P7|Phase 2|Protocol Violation|0
120333|NCT00460603|391204|P6|Phase 2|Protocol Violation|0
120334|NCT00460603|391205|P5|Phase 2|Protocol Violation|0
120335|NCT00460603|391206|P4|Phase 2|Protocol Violation|0
120336|NCT00460603|391207|P3|Phase 2|Protocol Violation|0
120337|NCT00460603|391208|P2|Phase 2|Protocol Violation|0
120338|NCT00460603|391209|P1|Phase 2|Protocol Violation|0
120339|NCT00460603|391198|P12|Phase 2|Death|2
120340|NCT00460603|391199|P11|Phase 2|Death|2
120341|NCT00460603|391200|P10|Phase 2|Death|4
120342|NCT00460603|391201|P9|Phase 2|Death|0
120343|NCT00460603|391202|P8|Phase 2|Death|0
120344|NCT00460603|391203|P7|Phase 2|Death|0
120345|NCT00460603|391204|P6|Phase 2|Death|0
120346|NCT00460603|391205|P5|Phase 2|Death|0
120347|NCT00460603|391206|P4|Phase 2|Death|0
120348|NCT00460603|391207|P3|Phase 2|Death|0
120349|NCT00460603|391208|P2|Phase 2|Death|0
120350|NCT00460603|391209|P1|Phase 2|Death|0
120351|NCT00460603|391198|P12|Phase 2|Adverse Event|10
120352|NCT00460603|391199|P11|Phase 2|Adverse Event|9
120353|NCT00460603|391200|P10|Phase 2|Adverse Event|12
120354|NCT00460603|391201|P9|Phase 2|Adverse Event|0
120355|NCT00460603|391202|P8|Phase 2|Adverse Event|0
120356|NCT00460603|391203|P7|Phase 2|Adverse Event|0
120357|NCT00460603|391204|P6|Phase 2|Adverse Event|0
120358|NCT00460603|391205|P5|Phase 2|Adverse Event|0
120359|NCT00460603|391206|P4|Phase 2|Adverse Event|0
120360|NCT00460603|391207|P3|Phase 2|Adverse Event|0
120361|NCT00460603|391208|P2|Phase 2|Adverse Event|0
120362|NCT00460603|391209|P1|Phase 2|Adverse Event|0
120363|NCT00460603|391198|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120364|NCT00460603|391199|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120365|NCT00460603|391200|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
120366|NCT00460603|391201|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120367|NCT00460603|391202|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120368|NCT00460603|391203|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120369|NCT00460603|391204|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120370|NCT00460603|391205|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120371|NCT00460603|391206|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120372|NCT00460603|391207|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120373|NCT00460603|391208|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120374|NCT00460603|391209|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
120375|NCT00460603|391198|P12|Phase 1|Unspecified|0
120376|NCT00460603|391199|P11|Phase 1|Unspecified|0
120377|NCT00460603|391200|P10|Phase 1|Unspecified|0
120378|NCT00460603|391201|P9|Phase 1|Unspecified|0
120379|NCT00460603|391202|P8|Phase 1|Unspecified|1
120380|NCT00460603|391203|P7|Phase 1|Unspecified|0
120381|NCT00460603|391204|P6|Phase 1|Unspecified|2
120382|NCT00460603|391205|P5|Phase 1|Unspecified|1
120383|NCT00460603|391206|P4|Phase 1|Unspecified|1
120384|NCT00460603|391207|P3|Phase 1|Unspecified|1
120385|NCT00460603|391208|P2|Phase 1|Unspecified|3
120386|NCT00460603|391209|P1|Phase 1|Unspecified|0
120387|NCT00460603|391198|P12|Phase 1|Withdrawal by Subject|0
120388|NCT00460603|391199|P11|Phase 1|Withdrawal by Subject|0
120389|NCT00460603|391200|P10|Phase 1|Withdrawal by Subject|0
120390|NCT00460603|391201|P9|Phase 1|Withdrawal by Subject|2
120391|NCT00460603|391202|P8|Phase 1|Withdrawal by Subject|0
120392|NCT00460603|391203|P7|Phase 1|Withdrawal by Subject|1
120393|NCT00460603|391204|P6|Phase 1|Withdrawal by Subject|0
120394|NCT00460603|391205|P5|Phase 1|Withdrawal by Subject|3
120395|NCT00460603|391206|P4|Phase 1|Withdrawal by Subject|1
120396|NCT00460603|391207|P3|Phase 1|Withdrawal by Subject|1
120397|NCT00460603|391208|P2|Phase 1|Withdrawal by Subject|2
120398|NCT00460603|391209|P1|Phase 1|Withdrawal by Subject|1
120399|NCT00460603|391198|P12|Phase 1|Lack of Efficacy|0
120400|NCT00460603|391199|P11|Phase 1|Lack of Efficacy|0
120401|NCT00460603|391200|P10|Phase 1|Lack of Efficacy|0
120402|NCT00460603|391201|P9|Phase 1|Lack of Efficacy|11
120403|NCT00460603|391202|P8|Phase 1|Lack of Efficacy|2
120404|NCT00460603|391203|P7|Phase 1|Lack of Efficacy|2
120405|NCT00460603|391204|P6|Phase 1|Lack of Efficacy|2
120406|NCT00460603|391205|P5|Phase 1|Lack of Efficacy|2
120407|NCT00460603|391206|P4|Phase 1|Lack of Efficacy|2
120408|NCT00460603|391207|P3|Phase 1|Lack of Efficacy|1
120409|NCT00460603|391208|P2|Phase 1|Lack of Efficacy|0
120410|NCT00460603|391209|P1|Phase 1|Lack of Efficacy|1
120411|NCT00460603|391198|P12|Phase 1|Adverse Event|0
120412|NCT00460603|391199|P11|Phase 1|Adverse Event|0
120413|NCT00460603|391200|P10|Phase 1|Adverse Event|0
120414|NCT00460603|391201|P9|Phase 1|Adverse Event|4
120415|NCT00460603|391202|P8|Phase 1|Adverse Event|0
120416|NCT00460603|391203|P7|Phase 1|Adverse Event|3
120417|NCT00460603|391204|P6|Phase 1|Adverse Event|0
120418|NCT00460603|391205|P5|Phase 1|Adverse Event|0
120419|NCT00460603|391206|P4|Phase 1|Adverse Event|2
120420|NCT00460603|391207|P3|Phase 1|Adverse Event|1
120421|NCT00460603|391208|P2|Phase 1|Adverse Event|1
120422|NCT00460603|391209|P1|Phase 1|Adverse Event|3
120423|NCT00460603|391198|P12|Phase 1|Death|0
120424|NCT00460603|391199|P11|Phase 1|Death|0
120425|NCT00460603|391200|P10|Phase 1|Death|0
120426|NCT00460603|391201|P9|Phase 1|Death|1
120427|NCT00460603|391202|P8|Phase 1|Death|0
120428|NCT00460603|391203|P7|Phase 1|Death|0
120429|NCT00460603|391204|P6|Phase 1|Death|0
120430|NCT00460603|391205|P5|Phase 1|Death|0
120431|NCT00460603|391206|P4|Phase 1|Death|2
120432|NCT00460603|391207|P3|Phase 1|Death|0
120433|NCT00460603|391208|P2|Phase 1|Death|0
120434|NCT00460603|391209|P1|Phase 1|Death|1
120435|NCT00460655|391303|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
120436|NCT00460655|391304|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
120437|NCT00460655|391305|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
120438|NCT00460655|391306|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
120439|NCT00460655|391303|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
120440|NCT00460655|391304|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
120441|NCT00460655|391305|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120442|NCT00460655|391306|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
120443|NCT00460655|391303|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
120444|NCT00460655|391304|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
120445|NCT00460655|391305|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
120446|NCT00460655|391306|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
120447|NCT00460655|391303|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
120448|NCT00460655|391304|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
120449|NCT00460655|391305|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
120450|NCT00460655|391306|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
120451|NCT00460655|391303|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120452|NCT00460655|391304|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120453|NCT00460655|391305|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
120454|NCT00460655|391306|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
120455|NCT00460655|391303|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
120456|NCT00460655|391304|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
120457|NCT00460655|391305|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
120458|NCT00460655|391306|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
120459|NCT00460746|391338|P1|Overall Study|Lost to Follow-up|1
120460|NCT00460746|391338|P1|Overall Study|Adverse Event|1
120461|NCT00460798|391351|P1|Overall Study|Missing/Incomplete Dosing Information|27
120462|NCT00460798|391351|P1|Overall Study|Ongoing at Date of Cut-Off|82
120463|NCT00460798|391351|P1|Overall Study|Unspecified|27
120464|NCT00460798|391351|P1|Overall Study|Progressive Disease|99
120465|NCT00460798|391351|P1|Overall Study|Lost to Follow-up|19
120466|NCT00460798|391351|P1|Overall Study|Adverse Event|27
120467|NCT00460798|391351|P1|Overall Study|Death|59
120468|NCT00460811|391364|P5|Overall Study|Lost to Follow-up|6
120469|NCT00460811|391365|P4|Overall Study|Lost to Follow-up|3
120470|NCT00460811|391366|P3|Overall Study|Lost to Follow-up|5
120471|NCT00460811|391367|P2|Overall Study|Lost to Follow-up|2
120472|NCT00460811|391368|P1|Overall Study|Lost to Follow-up|3
120473|NCT00460811|391364|P5|Overall Study|Physician Decision|0
120474|NCT00460811|391365|P4|Overall Study|Physician Decision|0
120475|NCT00460811|391366|P3|Overall Study|Physician Decision|0
120476|NCT00460811|391367|P2|Overall Study|Physician Decision|0
120477|NCT00460811|391368|P1|Overall Study|Physician Decision|1
120478|NCT00460811|391364|P5|Overall Study|Withdrawal by Subject|11
120479|NCT00460811|391365|P4|Overall Study|Withdrawal by Subject|3
120480|NCT00460811|391366|P3|Overall Study|Withdrawal by Subject|6
120481|NCT00460811|391367|P2|Overall Study|Withdrawal by Subject|7
120482|NCT00460811|391368|P1|Overall Study|Withdrawal by Subject|7
120483|NCT00460811|391364|P5|Overall Study|Noncompliance|1
120484|NCT00460811|391365|P4|Overall Study|Noncompliance|2
120485|NCT00460811|391366|P3|Overall Study|Noncompliance|0
120486|NCT00460811|391367|P2|Overall Study|Noncompliance|0
120487|NCT00460811|391368|P1|Overall Study|Noncompliance|1
120488|NCT00460811|391364|P5|Overall Study|Adverse Event|2
120489|NCT00460811|391365|P4|Overall Study|Adverse Event|10
120490|NCT00460811|391366|P3|Overall Study|Adverse Event|3
120491|NCT00460811|391367|P2|Overall Study|Adverse Event|6
120492|NCT00460811|391368|P1|Overall Study|Adverse Event|4
120493|NCT00461032|391421|P2|Overall Study|Not Specified|5
120494|NCT00461032|391422|P1|Overall Study|Not Specified|7
120495|NCT00461032|391421|P2|Overall Study|Patient Moved or Relocated|1
120496|NCT00461032|391422|P1|Overall Study|Patient Moved or Relocated|2
120497|NCT00461032|391421|P2|Overall Study|Withdrawal by Subject|15
120498|NCT00461032|391422|P1|Overall Study|Withdrawal by Subject|7
120499|NCT00461032|391421|P2|Overall Study|Protocol Violation|4
120500|NCT00461032|391422|P1|Overall Study|Protocol Violation|4
120501|NCT00461032|391421|P2|Overall Study|Lost to Follow-up|12
120502|NCT00461032|391422|P1|Overall Study|Lost to Follow-up|7
120503|NCT00461032|391421|P2|Overall Study|Lack of Efficacy|1
120504|NCT00461032|391422|P1|Overall Study|Lack of Efficacy|5
120505|NCT00461032|391421|P2|Overall Study|Adverse Event|6
120506|NCT00461032|391422|P1|Overall Study|Adverse Event|5
120507|NCT00461123|391455|P2|Overall Study|Withdrawal by Subject|3
120508|NCT00461123|391456|P1|Overall Study|Withdrawal by Subject|1
120509|NCT00461123|391455|P2|Overall Study|Protocol Violation|2
120510|NCT00461123|391456|P1|Overall Study|Protocol Violation|3
120511|NCT00461123|391455|P2|Overall Study|Lost to Follow-up|1
120512|NCT00461123|391456|P1|Overall Study|Lost to Follow-up|1
120513|NCT00461123|391455|P2|Overall Study|Adverse Event|0
120514|NCT00461123|391456|P1|Overall Study|Adverse Event|1
120515|NCT00454987|391473|P3|Booster Period|Lost to Follow-up|0
120516|NCT00454987|391474|P2|Booster Period|Lost to Follow-up|0
120517|NCT00454987|391475|P1|Booster Period|Lost to Follow-up|1
120518|NCT00454987|391473|P3|Booster Period|Withdrawal by Subject|0
120519|NCT00454987|391474|P2|Booster Period|Withdrawal by Subject|1
120520|NCT00454987|391475|P1|Booster Period|Withdrawal by Subject|0
120521|NCT00454987|391473|P3|Booster Period|Adverse Event|0
120522|NCT00454987|391474|P2|Booster Period|Adverse Event|0
120523|NCT00454987|391475|P1|Booster Period|Adverse Event|1
120524|NCT00455013|391549|P3|Long Term Extension (LTE)|non-specified|1
120525|NCT00455013|391550|P2|Long Term Extension (LTE)|non-specified|0
120526|NCT00455013|391551|P1|Long Term Extension (LTE)|non-specified|0
120527|NCT00455013|391549|P3|Long Term Extension (LTE)|Poor non-compliance|0
120528|NCT00455013|391550|P2|Long Term Extension (LTE)|Poor non-compliance|1
120529|NCT00455013|391551|P1|Long Term Extension (LTE)|Poor non-compliance|0
120530|NCT00455013|391549|P3|Long Term Extension (LTE)|Subject Request or refused|3
120531|NCT00455013|391550|P2|Long Term Extension (LTE)|Subject Request or refused|0
120532|NCT00455013|391551|P1|Long Term Extension (LTE)|Subject Request or refused|0
120533|NCT00455013|391549|P3|Long Term Extension (LTE)|No longer met criteria|1
120534|NCT00455013|391550|P2|Long Term Extension (LTE)|No longer met criteria|0
120535|NCT00455013|391551|P1|Long Term Extension (LTE)|No longer met criteria|0
120536|NCT00455013|391549|P3|Long Term Extension (LTE)|Death|0
120537|NCT00455013|391550|P2|Long Term Extension (LTE)|Death|1
120538|NCT00455013|391551|P1|Long Term Extension (LTE)|Death|1
120539|NCT00455013|391549|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
120540|NCT00455013|391550|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
120541|NCT00455013|391551|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
120542|NCT00455013|391549|P3|Long Term Extension (LTE)|Adverse Event|1
120543|NCT00455013|391550|P2|Long Term Extension (LTE)|Adverse Event|1
120544|NCT00455013|391551|P1|Long Term Extension (LTE)|Adverse Event|0
120545|NCT00455013|391549|P3|Short Term Period|Unspecified|1
120546|NCT00455013|391550|P2|Short Term Period|Unspecified|0
120547|NCT00455013|391551|P1|Short Term Period|Unspecified|0
120548|NCT00455013|391549|P3|Short Term Period|Lack of Efficacy|0
120549|NCT00455013|391550|P2|Short Term Period|Lack of Efficacy|0
120550|NCT00455013|391551|P1|Short Term Period|Lack of Efficacy|4
120551|NCT00455013|391549|P3|Short Term Period|Withdrawal by Subject|1
120552|NCT00455013|391550|P2|Short Term Period|Withdrawal by Subject|0
120553|NCT00455013|391551|P1|Short Term Period|Withdrawal by Subject|0
120554|NCT00455013|391549|P3|Short Term Period|Adverse Event|0
120555|NCT00455013|391550|P2|Short Term Period|Adverse Event|5
120556|NCT00455013|391551|P1|Short Term Period|Adverse Event|2
120557|NCT00461175|391618|P2|Overall Study|Protocol Violation|365
120558|NCT00461175|391619|P1|Overall Study|Protocol Violation|522
120559|NCT00461253|391629|P2|Overall Study|administrative|7773
120560|NCT00461253|391630|P1|Overall Study|administrative|773
120561|NCT00461253|391629|P2|Overall Study|no response|11789
120562|NCT00461253|391630|P1|Overall Study|no response|2609
120563|NCT00461253|391629|P2|Overall Study|Protocol Violation|236
120564|NCT00461253|391630|P1|Overall Study|Protocol Violation|613
120565|NCT00461253|391629|P2|Overall Study|Death|0
120566|NCT00461253|391630|P1|Overall Study|Death|985
120567|NCT00461305|391660|P2|Continued Treatment|Other (missing drug etc)|0
120568|NCT00461305|391661|P1|Continued Treatment|Other (missing drug etc)|2
120569|NCT00461305|391660|P2|Continued Treatment|Partially missing diary|0
120570|NCT00461305|391661|P1|Continued Treatment|Partially missing diary|2
120571|NCT00461305|391660|P2|Continued Treatment|Withdrawal by Subject|0
120572|NCT00461305|391661|P1|Continued Treatment|Withdrawal by Subject|48
120573|NCT00461305|391660|P2|Continued Treatment|Protocol Violation|0
120574|NCT00461305|391661|P1|Continued Treatment|Protocol Violation|13
120575|NCT00461305|391660|P2|Continued Treatment|Lost to Follow-up|0
120576|NCT00461305|391661|P1|Continued Treatment|Lost to Follow-up|4
120577|NCT00461305|391660|P2|Continued Treatment|Adverse Event|0
120578|NCT00461305|391661|P1|Continued Treatment|Adverse Event|26
120579|NCT00461305|391660|P2|Treatment|Other (missing drug etc)|0
120580|NCT00461305|391661|P1|Treatment|Other (missing drug etc)|2
120581|NCT00461305|391660|P2|Treatment|Partially missing diary|0
120582|NCT00461305|391661|P1|Treatment|Partially missing diary|2
120583|NCT00461305|391660|P2|Treatment|Study drug not taken|0
120584|NCT00461305|391661|P1|Treatment|Study drug not taken|1
120585|NCT00461305|391660|P2|Treatment|Never dispensed|0
120586|NCT00461305|391661|P1|Treatment|Never dispensed|5
120587|NCT00461305|391660|P2|Treatment|Withdrawal by Subject|2
120588|NCT00461305|391661|P1|Treatment|Withdrawal by Subject|48
120589|NCT00461305|391660|P2|Treatment|Protocol Violation|2
120590|NCT00461305|391661|P1|Treatment|Protocol Violation|13
120591|NCT00461305|391660|P2|Treatment|Lost to Follow-up|2
120592|NCT00461305|391661|P1|Treatment|Lost to Follow-up|4
120593|NCT00461305|391660|P2|Treatment|Adverse Event|3
120594|NCT00461305|391661|P1|Treatment|Adverse Event|26
120595|NCT00461500|391734|P2|Overall Study|Lost to Follow-up|2
120596|NCT00461500|391735|P1|Overall Study|Lost to Follow-up|2
120597|NCT00461500|391734|P2|Overall Study|No Longer Willing to Take Part in Study|0
120598|NCT00461500|391735|P1|Overall Study|No Longer Willing to Take Part in Study|1
120599|NCT00461500|391734|P2|Overall Study|Drug Treatment Misuse|0
120600|NCT00461500|391735|P1|Overall Study|Drug Treatment Misuse|1
120601|NCT00461500|391734|P2|Overall Study|Study Stopped|2
120602|NCT00461500|391735|P1|Overall Study|Study Stopped|1
120603|NCT00461500|391734|P2|Overall Study|Expired Drug Treatment|1
120604|NCT00461500|391735|P1|Overall Study|Expired Drug Treatment|1
120605|NCT00461500|391734|P2|Overall Study|Lack of Efficacy|1
120606|NCT00461500|391735|P1|Overall Study|Lack of Efficacy|0
120607|NCT00461500|391734|P2|Overall Study|Adverse Event|0
120608|NCT00461500|391735|P1|Overall Study|Adverse Event|1
120609|NCT00461981|391780|P2|Overall Study|Withdrawal by Subject|3
120610|NCT00461981|391781|P1|Overall Study|Withdrawal by Subject|2
120611|NCT00461981|391780|P2|Overall Study|Lost to Follow-up|6
120612|NCT00461981|391781|P1|Overall Study|Lost to Follow-up|9
120613|NCT00462306|392009|P2|Overall Study|insufficient data|13
120614|NCT00462306|392010|P1|Overall Study|insufficient data|0
120615|NCT00462345|392029|P1|Overall Study|Did not complete second course|1
120616|NCT00462345|392029|P1|Overall Study|Withdrawal by Subject|2
120617|NCT00462384|392051|P1|Overall Study|Unspecified|4
120618|NCT00462384|392051|P1|Overall Study|Withdrawal by Subject|1
120619|NCT00462384|392051|P1|Overall Study|Death|2
120620|NCT00462384|392051|P1|Overall Study|Adverse Event|2
120621|NCT00462462|392081|P2|Overall Study|Physician Decision|1
120622|NCT00462462|392082|P1|Overall Study|Physician Decision|0
120623|NCT00462501|392090|P1|Overall Study|Adverse Event|2
120624|NCT00462501|392090|P1|Overall Study|Not treated|3
120625|NCT00462670|392125|P2|Overall Study|Resolution of signs and symptoms|2
120626|NCT00462670|392126|P1|Overall Study|Resolution of signs and symptoms|0
120627|NCT00462670|392125|P2|Overall Study|Protocol Violation|0
120628|NCT00462670|392126|P1|Overall Study|Protocol Violation|1
120629|NCT00462670|392125|P2|Overall Study|Lack of Efficacy|0
120630|NCT00462670|392126|P1|Overall Study|Lack of Efficacy|1
120631|NCT00462670|392125|P2|Overall Study|Adverse Event|5
120632|NCT00462670|392126|P1|Overall Study|Adverse Event|3
120633|NCT00462709|392134|P1|Overall Study|Withdrew to start treatment with Cetor|1
120634|NCT00462709|392134|P1|Overall Study|Physician Decision|1
120635|NCT00462709|392134|P1|Overall Study|Logistical reasons|2
120636|NCT00462709|392134|P1|Overall Study|Death|2
120637|NCT00462709|392134|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
120638|NCT00462709|392134|P1|Overall Study|Withdrawal by Subject|8
120639|NCT00462709|392134|P1|Overall Study|Lost to Follow-up|10
120640|NCT00462709|392134|P1|Overall Study|Transitioned to commercial C1INH-nf|40
120641|NCT00462748|392181|P3|Overall Study|Discontinued after 41 days Rx|0
120642|NCT00462748|392182|P2|Overall Study|Discontinued after 41 days Rx|0
120643|NCT00462748|392183|P1|Overall Study|Discontinued after 41 days Rx|1
120644|NCT00462748|392181|P3|Overall Study|Lost to Follow-up|1
120645|NCT00462748|392182|P2|Overall Study|Lost to Follow-up|1
120646|NCT00462748|392183|P1|Overall Study|Lost to Follow-up|1
120647|NCT00462748|392181|P3|Overall Study|Withdrew consent|0
120648|NCT00462748|392182|P2|Overall Study|Withdrew consent|3
120649|NCT00462748|392183|P1|Overall Study|Withdrew consent|3
120650|NCT00462748|392181|P3|Overall Study|Protocol Violation|1
120651|NCT00462748|392182|P2|Overall Study|Protocol Violation|2
120652|NCT00462748|392183|P1|Overall Study|Protocol Violation|0
120653|NCT00462748|392181|P3|Overall Study|Adverse Event|9
120654|NCT00462748|392182|P2|Overall Study|Adverse Event|5
120655|NCT00462748|392183|P1|Overall Study|Adverse Event|7
120656|NCT00462826|392191|P1|Overall Study|Never treated|1
120657|NCT00462826|392191|P1|Overall Study|Ineligible - wrong primary|2
120658|NCT00462826|392191|P1|Overall Study|Ineligible - wrong cell type|1
120659|NCT00462826|392191|P1|Overall Study|Ineligible - second primary|1
120660|NCT00462865|392210|P1|Overall Study|Adverse Event|1
120661|NCT00462943|392242|P3|Overall Study|Withdrawal by Subject|0
120662|NCT00462943|392243|P2|Overall Study|Withdrawal by Subject|1
120663|NCT00462943|392244|P1|Overall Study|Withdrawal by Subject|0
120664|NCT00462943|392242|P3|Overall Study|Physician Decision|0
120665|NCT00462943|392243|P2|Overall Study|Physician Decision|0
120666|NCT00462943|392244|P1|Overall Study|Physician Decision|1
120667|NCT00462943|392242|P3|Overall Study|Transplant - not specified|1
120668|NCT00462943|392243|P2|Overall Study|Transplant - not specified|0
120669|NCT00462943|392244|P1|Overall Study|Transplant - not specified|1
120670|NCT00462943|392242|P3|Overall Study|Required Lymphocyte Infusion|0
120671|NCT00462943|392243|P2|Overall Study|Required Lymphocyte Infusion|0
120672|NCT00462943|392244|P1|Overall Study|Required Lymphocyte Infusion|1
120673|NCT00462943|392242|P3|Overall Study|Bone Marrow Transplant|0
120674|NCT00462943|392243|P2|Overall Study|Bone Marrow Transplant|0
120675|NCT00462943|392244|P1|Overall Study|Bone Marrow Transplant|1
120676|NCT00462943|392242|P3|Overall Study|Stem Cell Transplant|0
120677|NCT00462943|392243|P2|Overall Study|Stem Cell Transplant|1
120678|NCT00462943|392244|P1|Overall Study|Stem Cell Transplant|1
120679|NCT00462943|392242|P3|Overall Study|Death|7
120680|NCT00462943|392243|P2|Overall Study|Death|2
120681|NCT00462943|392244|P1|Overall Study|Death|5
120682|NCT00462943|392242|P3|Overall Study|Disease Progression|9
120683|NCT00462943|392243|P2|Overall Study|Disease Progression|15
120684|NCT00462943|392244|P1|Overall Study|Disease Progression|15
120685|NCT00462943|392242|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
120686|NCT00462943|392243|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
120687|NCT00462943|392244|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
120688|NCT00462943|392242|P3|Overall Study|Protocol Violation|0
120689|NCT00462943|392243|P2|Overall Study|Protocol Violation|0
120690|NCT00462943|392244|P1|Overall Study|Protocol Violation|1
120691|NCT00462943|392242|P3|Overall Study|Adverse Event|1
120692|NCT00462943|392243|P2|Overall Study|Adverse Event|4
120693|NCT00462943|392244|P1|Overall Study|Adverse Event|6
120694|NCT00462943|392242|P3|Overall Study|Failure to achieve a response|1
120695|NCT00462943|392243|P2|Overall Study|Failure to achieve a response|5
120696|NCT00462943|392244|P1|Overall Study|Failure to achieve a response|5
120697|NCT00462982|392311|P1|Overall Study|Patient Not Treated|2
120698|NCT00462982|392311|P1|Overall Study|Adverse Event|1
120699|NCT00463047|392315|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
120700|NCT00463047|392316|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
120701|NCT00463047|392315|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
120702|NCT00463047|392316|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
120703|NCT00463047|392315|P2|Double-Blind Treatment Period 2|Adverse Event|1
120704|NCT00463047|392316|P1|Double-Blind Treatment Period 2|Adverse Event|0
120705|NCT00463047|392315|P2|Double-Blind Treatment Period 1|Not specified|0
120706|NCT00463047|392316|P1|Double-Blind Treatment Period 1|Not specified|1
120707|NCT00463047|392315|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
120708|NCT00463047|392316|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
120709|NCT00463047|392315|P2|Double-Blind Treatment Period 1|Protocol Violation|2
120710|NCT00463047|392316|P1|Double-Blind Treatment Period 1|Protocol Violation|1
120711|NCT00463047|392315|P2|Double-Blind Treatment Period 1|Adverse Event|2
120712|NCT00463047|392316|P1|Double-Blind Treatment Period 1|Adverse Event|0
120713|NCT00463047|392315|P2|Titration Period 2|Not specified|2
120714|NCT00463047|392316|P1|Titration Period 2|Not specified|3
120715|NCT00463047|392315|P2|Titration Period 2|Non-compliance procedures|1
120716|NCT00463047|392316|P1|Titration Period 2|Non-compliance procedures|4
120717|NCT00463047|392315|P2|Titration Period 2|Non-compliance study medication|2
120718|NCT00463047|392316|P1|Titration Period 2|Non-compliance study medication|4
120719|NCT00463047|392315|P2|Titration Period 2|Lost to Follow-up|2
120720|NCT00463047|392316|P1|Titration Period 2|Lost to Follow-up|1
120721|NCT00463047|392315|P2|Titration Period 2|Protocol Violation|3
120722|NCT00463047|392316|P1|Titration Period 2|Protocol Violation|2
120723|NCT00463047|392315|P2|Titration Period 2|Withdrawal by Subject|0
120724|NCT00463047|392316|P1|Titration Period 2|Withdrawal by Subject|1
120725|NCT00463047|392315|P2|Titration Period 2|Lack of Efficacy|4
120726|NCT00463047|392316|P1|Titration Period 2|Lack of Efficacy|6
120727|NCT00463047|392315|P2|Titration Period 2|Adverse Event|9
120728|NCT00463047|392316|P1|Titration Period 2|Adverse Event|9
120729|NCT00463047|392315|P2|Titration Period 1|Not specified|2
120730|NCT00463047|392316|P1|Titration Period 1|Not specified|0
120731|NCT00463047|392315|P2|Titration Period 1|Non-compliance procedures|10
120732|NCT00463047|392316|P1|Titration Period 1|Non-compliance procedures|4
120733|NCT00463047|392315|P2|Titration Period 1|Withdrawal by Subject|5
120734|NCT00463047|392316|P1|Titration Period 1|Withdrawal by Subject|3
120735|NCT00463047|392315|P2|Titration Period 1|Protocol Violation|5
120736|NCT00463047|392316|P1|Titration Period 1|Protocol Violation|5
120737|NCT00463047|392315|P2|Titration Period 1|Non-compliance with study medication|5
120738|NCT00463047|392316|P1|Titration Period 1|Non-compliance with study medication|3
120739|NCT00463047|392315|P2|Titration Period 1|Lost to Follow-up|0
120740|NCT00463047|392316|P1|Titration Period 1|Lost to Follow-up|2
120741|NCT00463047|392315|P2|Titration Period 1|Lack of Efficacy|4
120742|NCT00463047|392316|P1|Titration Period 1|Lack of Efficacy|10
120743|NCT00463047|392315|P2|Titration Period 1|Adverse Event|8
120744|NCT00463047|392316|P1|Titration Period 1|Adverse Event|10
120745|NCT00463229|392403|P2|Overall Study|Death|3
120746|NCT00463229|392404|P1|Overall Study|Death|4
120747|NCT00463229|392403|P2|Overall Study|Lost to Follow-up|7
120748|NCT00463229|392404|P1|Overall Study|Lost to Follow-up|5
120749|NCT00463346|392412|P2|Overall Study|Withdrawal by Subject|3
120750|NCT00463346|392413|P1|Overall Study|Withdrawal by Subject|3
120751|NCT00463385|392425|P4|Overall Study|1 participant received commercial drug|0
120752|NCT00463385|392426|P3|Overall Study|1 participant received commercial drug|0
120753|NCT00463385|392427|P2|Overall Study|1 participant received commercial drug|1
120754|NCT00463385|392428|P1|Overall Study|1 participant received commercial drug|0
120755|NCT00463385|392425|P4|Overall Study|Missing|2
120756|NCT00463385|392426|P3|Overall Study|Missing|0
120757|NCT00463385|392427|P2|Overall Study|Missing|0
120758|NCT00463385|392428|P1|Overall Study|Missing|2
120759|NCT00463385|392425|P4|Overall Study|Death|0
120760|NCT00463385|392426|P3|Overall Study|Death|2
120761|NCT00463385|392427|P2|Overall Study|Death|1
120762|NCT00463385|392428|P1|Overall Study|Death|2
120763|NCT00463385|392425|P4|Overall Study|Lost to Follow-up|1
120764|NCT00463385|392426|P3|Overall Study|Lost to Follow-up|0
120765|NCT00463385|392427|P2|Overall Study|Lost to Follow-up|0
120766|NCT00463385|392428|P1|Overall Study|Lost to Follow-up|0
120767|NCT00463385|392425|P4|Overall Study|Withdrawal by Subject|4
120768|NCT00463385|392426|P3|Overall Study|Withdrawal by Subject|3
120769|NCT00463385|392427|P2|Overall Study|Withdrawal by Subject|3
120770|NCT00463385|392428|P1|Overall Study|Withdrawal by Subject|3
120771|NCT00463385|392425|P4|Overall Study|Lack of Efficacy|9
120772|NCT00463385|392426|P3|Overall Study|Lack of Efficacy|7
120773|NCT00463385|392427|P2|Overall Study|Lack of Efficacy|6
120774|NCT00463385|392428|P1|Overall Study|Lack of Efficacy|6
120775|NCT00463385|392425|P4|Overall Study|Adverse Event|2
120776|NCT00463385|392426|P3|Overall Study|Adverse Event|4
120777|NCT00463385|392427|P2|Overall Study|Adverse Event|8
120778|NCT00463385|392428|P1|Overall Study|Adverse Event|5
120779|NCT00463385|392425|P4|Overall Study|Unspecified|4
120780|NCT00463385|392426|P3|Overall Study|Unspecified|6
120781|NCT00463385|392427|P2|Overall Study|Unspecified|3
120782|NCT00463385|392428|P1|Overall Study|Unspecified|4
120783|NCT00463437|392482|P4|Overall Study|Other|7
120784|NCT00463437|392483|P3|Overall Study|Other|6
120785|NCT00463437|392484|P2|Overall Study|Other|11
120786|NCT00463437|392485|P1|Overall Study|Other|4
120787|NCT00463567|392554|P7|Overall Study|Death|0
120788|NCT00463567|392555|P6|Overall Study|Death|0
120789|NCT00463567|392556|P5|Overall Study|Death|0
120790|NCT00463567|392557|P4|Overall Study|Death|0
120791|NCT00463567|392558|P3|Overall Study|Death|2
120792|NCT00463567|392559|P2|Overall Study|Death|0
120793|NCT00463567|392560|P1|Overall Study|Death|1
120794|NCT00463567|392554|P7|Overall Study|Abnormal test procedure result(s)|0
120795|NCT00463567|392555|P6|Overall Study|Abnormal test procedure result(s)|2
120796|NCT00463567|392556|P5|Overall Study|Abnormal test procedure result(s)|0
120797|NCT00463567|392557|P4|Overall Study|Abnormal test procedure result(s)|2
120798|NCT00463567|392558|P3|Overall Study|Abnormal test procedure result(s)|6
120799|NCT00463567|392559|P2|Overall Study|Abnormal test procedure result(s)|1
120800|NCT00463567|392560|P1|Overall Study|Abnormal test procedure result(s)|1
120801|NCT00463567|392554|P7|Overall Study|Abnormal lab value(s)|0
120802|NCT00463567|392555|P6|Overall Study|Abnormal lab value(s)|0
120803|NCT00463567|392556|P5|Overall Study|Abnormal lab value(s)|1
120804|NCT00463567|392557|P4|Overall Study|Abnormal lab value(s)|1
120805|NCT00463567|392558|P3|Overall Study|Abnormal lab value(s)|2
120806|NCT00463567|392559|P2|Overall Study|Abnormal lab value(s)|1
120807|NCT00463567|392560|P1|Overall Study|Abnormal lab value(s)|1
120808|NCT00463567|392554|P7|Overall Study|Lack of Efficacy|1
120809|NCT00463567|392555|P6|Overall Study|Lack of Efficacy|0
120810|NCT00463567|392556|P5|Overall Study|Lack of Efficacy|1
120811|NCT00463567|392557|P4|Overall Study|Lack of Efficacy|17
120812|NCT00463567|392558|P3|Overall Study|Lack of Efficacy|9
120813|NCT00463567|392559|P2|Overall Study|Lack of Efficacy|9
120814|NCT00463567|392560|P1|Overall Study|Lack of Efficacy|4
120815|NCT00463567|392554|P7|Overall Study|Administrative problems|2
120816|NCT00463567|392555|P6|Overall Study|Administrative problems|2
120817|NCT00463567|392556|P5|Overall Study|Administrative problems|3
120818|NCT00463567|392557|P4|Overall Study|Administrative problems|9
120819|NCT00463567|392558|P3|Overall Study|Administrative problems|6
120820|NCT00463567|392559|P2|Overall Study|Administrative problems|3
120821|NCT00463567|392560|P1|Overall Study|Administrative problems|5
120822|NCT00463567|392554|P7|Overall Study|Lost to Follow-up|1
120823|NCT00463567|392555|P6|Overall Study|Lost to Follow-up|1
120824|NCT00463567|392556|P5|Overall Study|Lost to Follow-up|1
120825|NCT00463567|392557|P4|Overall Study|Lost to Follow-up|8
120826|NCT00463567|392558|P3|Overall Study|Lost to Follow-up|13
120827|NCT00463567|392559|P2|Overall Study|Lost to Follow-up|6
120828|NCT00463567|392560|P1|Overall Study|Lost to Follow-up|12
120829|NCT00463567|392554|P7|Overall Study|Protocol Deviation|2
120830|NCT00463567|392555|P6|Overall Study|Protocol Deviation|1
120831|NCT00463567|392556|P5|Overall Study|Protocol Deviation|1
120832|NCT00463567|392557|P4|Overall Study|Protocol Deviation|11
120833|NCT00463567|392558|P3|Overall Study|Protocol Deviation|14
120834|NCT00463567|392559|P2|Overall Study|Protocol Deviation|9
120835|NCT00463567|392560|P1|Overall Study|Protocol Deviation|13
120836|NCT00463567|392554|P7|Overall Study|Withdrawal by Subject|1
120837|NCT00463567|392555|P6|Overall Study|Withdrawal by Subject|5
120838|NCT00463567|392556|P5|Overall Study|Withdrawal by Subject|6
120839|NCT00463567|392557|P4|Overall Study|Withdrawal by Subject|37
120840|NCT00463567|392558|P3|Overall Study|Withdrawal by Subject|20
120841|NCT00463567|392559|P2|Overall Study|Withdrawal by Subject|22
120842|NCT00463567|392560|P1|Overall Study|Withdrawal by Subject|29
120843|NCT00463567|392554|P7|Overall Study|Adverse Event|4
120844|NCT00463567|392555|P6|Overall Study|Adverse Event|10
120845|NCT00463567|392556|P5|Overall Study|Adverse Event|10
120846|NCT00463567|392557|P4|Overall Study|Adverse Event|46
120847|NCT00463567|392558|P3|Overall Study|Adverse Event|17
120848|NCT00463567|392559|P2|Overall Study|Adverse Event|26
120849|NCT00463567|392560|P1|Overall Study|Adverse Event|29
120850|NCT00463580|392593|P2|Overall Study|Medical/psychiatric complications|2
120851|NCT00463580|392594|P1|Overall Study|Medical/psychiatric complications|0
120852|NCT00463580|392593|P2|Overall Study|schedule conflict|0
120853|NCT00463580|392594|P1|Overall Study|schedule conflict|2
120854|NCT00463580|392593|P2|Overall Study|Lost to Follow-up|0
120855|NCT00463580|392594|P1|Overall Study|Lost to Follow-up|1
120856|NCT00463606|392605|P3|Overall Study|Protocol Violation|1
120857|NCT00463606|392606|P2|Overall Study|Protocol Violation|0
120858|NCT00463606|392607|P1|Overall Study|Protocol Violation|0
120859|NCT00463606|392605|P3|Overall Study|Participation in another ABT-335 trial|0
120860|NCT00463606|392606|P2|Overall Study|Participation in another ABT-335 trial|0
120861|NCT00463606|392607|P1|Overall Study|Participation in another ABT-335 trial|1
120862|NCT00463606|392605|P3|Overall Study|Patient randomized in error|0
120863|NCT00463606|392606|P2|Overall Study|Patient randomized in error|0
120864|NCT00463606|392607|P1|Overall Study|Patient randomized in error|1
120865|NCT00463606|392605|P3|Overall Study|Coordinator error|0
120866|NCT00463606|392606|P2|Overall Study|Coordinator error|0
120867|NCT00463606|392607|P1|Overall Study|Coordinator error|1
120868|NCT00463606|392605|P3|Overall Study|Exclusion criteria violation|0
120869|NCT00463606|392606|P2|Overall Study|Exclusion criteria violation|0
120870|NCT00463606|392607|P1|Overall Study|Exclusion criteria violation|2
120871|NCT00463606|392605|P3|Overall Study|Sponsor request|0
120872|NCT00463606|392606|P2|Overall Study|Sponsor request|1
120873|NCT00463606|392607|P1|Overall Study|Sponsor request|0
120874|NCT00463606|392605|P3|Overall Study|Physician Decision|0
120875|NCT00463606|392606|P2|Overall Study|Physician Decision|1
120876|NCT00463606|392607|P1|Overall Study|Physician Decision|0
120877|NCT00463606|392605|P3|Overall Study|Subject moved out of town|0
120878|NCT00463606|392606|P2|Overall Study|Subject moved out of town|0
120879|NCT00463606|392607|P1|Overall Study|Subject moved out of town|1
120880|NCT00463606|392605|P3|Overall Study|Subject noncompliance|0
120881|NCT00463606|392606|P2|Overall Study|Subject noncompliance|1
120882|NCT00463606|392607|P1|Overall Study|Subject noncompliance|1
120883|NCT00463606|392605|P3|Overall Study|Lost to Follow-up|3
120884|NCT00463606|392606|P2|Overall Study|Lost to Follow-up|2
120885|NCT00463606|392607|P1|Overall Study|Lost to Follow-up|2
120886|NCT00463606|392605|P3|Overall Study|Withdrawal by Subject|5
120887|NCT00463606|392606|P2|Overall Study|Withdrawal by Subject|11
120888|NCT00463606|392607|P1|Overall Study|Withdrawal by Subject|11
120889|NCT00463606|392605|P3|Overall Study|Adverse Event|11
120890|NCT00463606|392606|P2|Overall Study|Adverse Event|18
120891|NCT00463606|392607|P1|Overall Study|Adverse Event|21
120892|NCT00463788|392632|P2|Overall Study|Randomized but not treated|1
120893|NCT00463788|392633|P1|Overall Study|Randomized but not treated|1
120894|NCT00463788|392632|P2|Overall Study|Unspecified|0
120895|NCT00463788|392633|P1|Overall Study|Unspecified|3
120896|NCT00463788|392632|P2|Overall Study|Protocol Violation|1
120897|NCT00463788|392633|P1|Overall Study|Protocol Violation|0
120898|NCT00463788|392632|P2|Overall Study|Lost to Follow-up|0
120899|NCT00463788|392633|P1|Overall Study|Lost to Follow-up|1
120900|NCT00463788|392632|P2|Overall Study|Symptomatic Deterioration|3
120901|NCT00463788|392633|P1|Overall Study|Symptomatic Deterioration|2
120902|NCT00463788|392632|P2|Overall Study|Death|3
120903|NCT00463788|392633|P1|Overall Study|Death|4
120904|NCT00463788|392632|P2|Overall Study|Withdrawal by Subject|2
120905|NCT00463788|392633|P1|Overall Study|Withdrawal by Subject|6
120906|NCT00463788|392632|P2|Overall Study|Adverse Event|2
120907|NCT00463788|392633|P1|Overall Study|Adverse Event|6
120908|NCT00463788|392632|P2|Overall Study|Progressive Disease|42
120909|NCT00463788|392633|P1|Overall Study|Progressive Disease|86
120910|NCT00463801|392648|P1|Overall Study|No longer require therapy|1
120911|NCT00463801|392648|P1|Overall Study|Lost to Follow-up|5
120912|NCT00463801|392648|P1|Overall Study|Adverse Event|4
120913|NCT00463801|392648|P1|Overall Study|Lack of Efficacy|2
120914|NCT00463801|392648|P1|Overall Study|Protocol Violation|1
120915|NCT00463840|392652|P1|Overall Study|Adverse Event|3
120916|NCT00463840|392652|P1|Overall Study|Withdrawal by Subject|2
120917|NCT00463840|392652|P1|Overall Study|Disease progression|7
120918|NCT00463866|392658|P2|Overall Study|Unspecified|22
120919|NCT00463866|392659|P1|Overall Study|Unspecified|22
120920|NCT00463866|392658|P2|Overall Study|Mis-Randomization of subject|1
120921|NCT00463866|392659|P1|Overall Study|Mis-Randomization of subject|0
120922|NCT00463866|392658|P2|Overall Study|Safety Reason|3
120923|NCT00463866|392659|P1|Overall Study|Safety Reason|1
120924|NCT00463866|392658|P2|Overall Study|Severe Non-Compliance to Protocol|21
120925|NCT00463866|392659|P1|Overall Study|Severe Non-Compliance to Protocol|25
120926|NCT00463866|392658|P2|Overall Study|Incorrect Enrolment|66
120927|NCT00463866|392659|P1|Overall Study|Incorrect Enrolment|64
120928|NCT00463866|392658|P2|Overall Study|Lost to Follow-up|55
120929|NCT00463866|392659|P1|Overall Study|Lost to Follow-up|46
120930|NCT00463866|392658|P2|Overall Study|Withdrawal by Subject|79
120931|NCT00463866|392659|P1|Overall Study|Withdrawal by Subject|81
120932|NCT00463866|392658|P2|Overall Study|Adverse Event|93
120933|NCT00463866|392659|P1|Overall Study|Adverse Event|70
120934|NCT00464087|392682|P3|Overall Study|No PCI per inclusion criteria|29
120935|NCT00464087|392683|P2|Overall Study|No PCI per inclusion criteria|0
120936|NCT00464087|392684|P1|Overall Study|No PCI per inclusion criteria|0
120937|NCT00464269|392741|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
120938|NCT00464269|392742|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
120939|NCT00464269|392743|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
120940|NCT00464269|392744|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
120941|NCT00464269|392741|P4|Overall Study|AE, non-serious non-fatal|4
120942|NCT00464269|392742|P3|Overall Study|AE, non-serious non-fatal|3
120943|NCT00464269|392743|P2|Overall Study|AE, non-serious non-fatal|8
120944|NCT00464269|392744|P1|Overall Study|AE, non-serious non-fatal|2
120945|NCT00464269|392741|P4|Overall Study|SAE, non-fatal|1
120946|NCT00464269|392742|P3|Overall Study|SAE, non-fatal|0
120947|NCT00464269|392743|P2|Overall Study|SAE, non-fatal|0
120948|NCT00464269|392744|P1|Overall Study|SAE, non-fatal|0
120949|NCT00464269|392741|P4|Overall Study|AE, serious fatal|1
120950|NCT00464269|392742|P3|Overall Study|AE, serious fatal|1
120951|NCT00464269|392743|P2|Overall Study|AE, serious fatal|0
120952|NCT00464269|392744|P1|Overall Study|AE, serious fatal|0
120953|NCT00464269|392741|P4|Overall Study|Other reason|1
120954|NCT00464269|392742|P3|Overall Study|Other reason|1
120955|NCT00464269|392743|P2|Overall Study|Other reason|3
120956|NCT00464269|392744|P1|Overall Study|Other reason|3
120957|NCT00464269|392741|P4|Overall Study|Withdrawal by Subject|1
120958|NCT00464269|392742|P3|Overall Study|Withdrawal by Subject|1
120959|NCT00464269|392743|P2|Overall Study|Withdrawal by Subject|2
120960|NCT00464269|392744|P1|Overall Study|Withdrawal by Subject|0
120961|NCT00464269|392741|P4|Overall Study|Lost to Follow-up|1
120962|NCT00464269|392742|P3|Overall Study|Lost to Follow-up|0
120963|NCT00464269|392743|P2|Overall Study|Lost to Follow-up|4
120964|NCT00464269|392744|P1|Overall Study|Lost to Follow-up|0
120965|NCT00464269|392741|P4|Overall Study|Lack of Efficacy|0
120966|NCT00464269|392742|P3|Overall Study|Lack of Efficacy|0
120967|NCT00464269|392743|P2|Overall Study|Lack of Efficacy|0
120968|NCT00464269|392744|P1|Overall Study|Lack of Efficacy|1
120969|NCT00464308|392845|P3|Overall Study|Physician Decision|0
120970|NCT00464308|392846|P2|Overall Study|Physician Decision|0
120971|NCT00464308|392847|P1|Overall Study|Physician Decision|1
120972|NCT00464308|392845|P3|Overall Study|Patient discontinued and other reasons|23
120973|NCT00464308|392846|P2|Overall Study|Patient discontinued and other reasons|17
120974|NCT00464308|392847|P1|Overall Study|Patient discontinued and other reasons|17
120975|NCT00464308|392845|P3|Overall Study|Lost to Follow-up|20
120976|NCT00464308|392846|P2|Overall Study|Lost to Follow-up|19
120977|NCT00464308|392847|P1|Overall Study|Lost to Follow-up|29
120978|NCT00464308|392845|P3|Overall Study|Adverse Event|16
120979|NCT00464308|392846|P2|Overall Study|Adverse Event|27
120980|NCT00464308|392847|P1|Overall Study|Adverse Event|22
120981|NCT00464334|392884|P11|Overall Study|Withdrawal by Subject|0
120982|NCT00464334|392885|P10|Overall Study|Withdrawal by Subject|0
120983|NCT00464334|392886|P9|Overall Study|Withdrawal by Subject|3
120984|NCT00464334|392887|P8|Overall Study|Withdrawal by Subject|1
120985|NCT00464334|392888|P7|Overall Study|Withdrawal by Subject|2
120986|NCT00464334|392889|P6|Overall Study|Withdrawal by Subject|2
120987|NCT00464334|392890|P5|Overall Study|Withdrawal by Subject|2
120988|NCT00464334|392891|P4|Overall Study|Withdrawal by Subject|2
120989|NCT00464334|392892|P3|Overall Study|Withdrawal by Subject|4
120990|NCT00464334|392893|P2|Overall Study|Withdrawal by Subject|7
120991|NCT00464334|392894|P1|Overall Study|Withdrawal by Subject|1
120992|NCT00464334|392884|P11|Overall Study|Study Terminated by Sponsor|0
120993|NCT00464334|392885|P10|Overall Study|Study Terminated by Sponsor|0
120994|NCT00464334|392886|P9|Overall Study|Study Terminated by Sponsor|0
120995|NCT00464334|392887|P8|Overall Study|Study Terminated by Sponsor|0
120996|NCT00464334|392888|P7|Overall Study|Study Terminated by Sponsor|0
120997|NCT00464334|392889|P6|Overall Study|Study Terminated by Sponsor|0
120998|NCT00464334|392890|P5|Overall Study|Study Terminated by Sponsor|0
120999|NCT00464334|392891|P4|Overall Study|Study Terminated by Sponsor|1
121000|NCT00464334|392892|P3|Overall Study|Study Terminated by Sponsor|0
121001|NCT00464334|392893|P2|Overall Study|Study Terminated by Sponsor|0
121002|NCT00464334|392894|P1|Overall Study|Study Terminated by Sponsor|0
121003|NCT00464334|392884|P11|Overall Study|Progressive Disease|0
121004|NCT00464334|392885|P10|Overall Study|Progressive Disease|0
121005|NCT00464334|392886|P9|Overall Study|Progressive Disease|1
121006|NCT00464334|392887|P8|Overall Study|Progressive Disease|0
121007|NCT00464334|392888|P7|Overall Study|Progressive Disease|0
121008|NCT00464334|392889|P6|Overall Study|Progressive Disease|1
121009|NCT00464334|392890|P5|Overall Study|Progressive Disease|0
121010|NCT00464334|392891|P4|Overall Study|Progressive Disease|0
121011|NCT00464334|392892|P3|Overall Study|Progressive Disease|0
121012|NCT00464334|392893|P2|Overall Study|Progressive Disease|0
121013|NCT00464334|392894|P1|Overall Study|Progressive Disease|0
121014|NCT00464334|392884|P11|Overall Study|Lost to Follow-up|2
121015|NCT00464334|392885|P10|Overall Study|Lost to Follow-up|0
121016|NCT00464334|392886|P9|Overall Study|Lost to Follow-up|0
121017|NCT00464334|392887|P8|Overall Study|Lost to Follow-up|0
121018|NCT00464334|392888|P7|Overall Study|Lost to Follow-up|1
121019|NCT00464334|392889|P6|Overall Study|Lost to Follow-up|0
121020|NCT00464334|392890|P5|Overall Study|Lost to Follow-up|1
121021|NCT00464334|392891|P4|Overall Study|Lost to Follow-up|0
121022|NCT00464334|392892|P3|Overall Study|Lost to Follow-up|1
121023|NCT00464334|392893|P2|Overall Study|Lost to Follow-up|0
121024|NCT00464334|392894|P1|Overall Study|Lost to Follow-up|0
121025|NCT00464334|392884|P11|Overall Study|Lack of Efficacy|0
121026|NCT00464334|392885|P10|Overall Study|Lack of Efficacy|0
121027|NCT00464334|392886|P9|Overall Study|Lack of Efficacy|0
121028|NCT00464334|392887|P8|Overall Study|Lack of Efficacy|0
121029|NCT00464334|392888|P7|Overall Study|Lack of Efficacy|0
121030|NCT00464334|392889|P6|Overall Study|Lack of Efficacy|0
121031|NCT00464334|392890|P5|Overall Study|Lack of Efficacy|0
121032|NCT00464334|392891|P4|Overall Study|Lack of Efficacy|0
121033|NCT00464334|392892|P3|Overall Study|Lack of Efficacy|0
121034|NCT00464334|392893|P2|Overall Study|Lack of Efficacy|1
121035|NCT00464334|392894|P1|Overall Study|Lack of Efficacy|0
121036|NCT00464334|392884|P11|Overall Study|Adverse Event|2
121037|NCT00464334|392885|P10|Overall Study|Adverse Event|1
121038|NCT00464334|392886|P9|Overall Study|Adverse Event|2
121039|NCT00464334|392887|P8|Overall Study|Adverse Event|0
121040|NCT00464334|392888|P7|Overall Study|Adverse Event|0
121041|NCT00464334|392889|P6|Overall Study|Adverse Event|1
121042|NCT00464334|392890|P5|Overall Study|Adverse Event|1
121043|NCT00464334|392891|P4|Overall Study|Adverse Event|1
121044|NCT00464334|392892|P3|Overall Study|Adverse Event|0
121045|NCT00464334|392893|P2|Overall Study|Adverse Event|0
121046|NCT00464334|392894|P1|Overall Study|Adverse Event|0
121047|NCT00458211|392974|P1|Overall Study|Protocol Violation|2
121048|NCT00458211|392974|P1|Overall Study|Withdrawal by Subject|2
121049|NCT00458211|392974|P1|Overall Study|Lack of Efficacy|12
121050|NCT00458302|393001|P2|Overall Study|Other|2
121051|NCT00458302|393002|P1|Overall Study|Other|4
121052|NCT00458302|393001|P2|Overall Study|Lost to Follow-up|0
121053|NCT00458302|393002|P1|Overall Study|Lost to Follow-up|2
121054|NCT00458302|393001|P2|Overall Study|Study Termination By Sponsor|0
121055|NCT00458302|393002|P1|Overall Study|Study Termination By Sponsor|1
121056|NCT00458302|393001|P2|Overall Study|Inc/Exc Criteria Not Met|1
121057|NCT00458302|393002|P1|Overall Study|Inc/Exc Criteria Not Met|1
121058|NCT00458302|393001|P2|Overall Study|Withdrawal by Subject|4
121059|NCT00458302|393002|P1|Overall Study|Withdrawal by Subject|6
121060|NCT00458302|393001|P2|Overall Study|Protocol Violation|2
121061|NCT00458302|393002|P1|Overall Study|Protocol Violation|0
121062|NCT00458302|393001|P2|Overall Study|Pregnancy|1
121063|NCT00458302|393002|P1|Overall Study|Pregnancy|2
121064|NCT00458302|393001|P2|Overall Study|Adverse Event|14
121065|NCT00458302|393002|P1|Overall Study|Adverse Event|4
121066|NCT00458536|393054|P1|Overall Study|Progressive disease during treatment|2
121067|NCT00458536|393054|P1|Overall Study|Withdrawal by Subject|1
121068|NCT00458536|393054|P1|Overall Study|Ineligible due to toxicity|1
121069|NCT00458536|393054|P1|Overall Study|Patient did not have surgery|1
121070|NCT00458536|393054|P1|Overall Study|Did not have renal cell carcinoma|2
121071|NCT00458536|393054|P1|Overall Study|No measurable disease after surgery|2
121072|NCT00458536|393054|P1|Overall Study|Unable to make vaccine|3
121073|NCT00458536|393054|P1|Overall Study|Disease progression prior to treatment|7
121074|NCT00464490|393090|P2|Overall Study|Physician Decision|11
121075|NCT00464490|393091|P1|Overall Study|Physician Decision|11
121076|NCT00464542|393097|P1|Pre-treatment|Withdrawal by Subject|2
121077|NCT00464568|393102|P1|Overall Study|Adverse Event|2
121078|NCT00464672|393186|P6|Overall Study|Lost to Follow-up|0
121079|NCT00464672|393187|P5|Overall Study|Lost to Follow-up|1
121080|NCT00464672|393188|P4|Overall Study|Lost to Follow-up|0
121081|NCT00464672|393189|P3|Overall Study|Lost to Follow-up|0
121082|NCT00464672|393190|P2|Overall Study|Lost to Follow-up|10
121083|NCT00464672|393191|P1|Overall Study|Lost to Follow-up|25
121084|NCT00464672|393186|P6|Overall Study|withdrawal of consent|4
121085|NCT00464672|393187|P5|Overall Study|withdrawal of consent|9
121086|NCT00464672|393188|P4|Overall Study|withdrawal of consent|1
121087|NCT00464672|393189|P3|Overall Study|withdrawal of consent|0
121088|NCT00464672|393190|P2|Overall Study|withdrawal of consent|0
121089|NCT00464672|393191|P1|Overall Study|withdrawal of consent|0
121090|NCT00468845|393291|P3|Overall Study|Randomized, not treated|2
121091|NCT00468845|393292|P2|Overall Study|Randomized, not treated|4
121092|NCT00468845|393293|P1|Overall Study|Randomized, not treated|1
121093|NCT00468845|393291|P3|Overall Study|No longer willing to participate|10
121094|NCT00468845|393292|P2|Overall Study|No longer willing to participate|6
121095|NCT00468845|393293|P1|Overall Study|No longer willing to participate|5
121096|NCT00468845|393291|P3|Overall Study|Unspecified|5
121097|NCT00468845|393292|P2|Overall Study|Unspecified|9
121098|NCT00468845|393293|P1|Overall Study|Unspecified|4
121099|NCT00468845|393291|P3|Overall Study|Lost to Follow-up|2
121100|NCT00468845|393292|P2|Overall Study|Lost to Follow-up|1
121101|NCT00468845|393293|P1|Overall Study|Lost to Follow-up|2
121102|NCT00468845|393291|P3|Overall Study|Adverse Event|11
121103|NCT00468845|393292|P2|Overall Study|Adverse Event|14
121104|NCT00468845|393293|P1|Overall Study|Adverse Event|9
121105|NCT00468858|393430|P3|Overall Study|Other|1
121106|NCT00468858|393431|P2|Overall Study|Other|0
121107|NCT00468858|393432|P1|Overall Study|Other|0
121108|NCT00468858|393430|P3|Overall Study|Lost to Follow-up|5
121109|NCT00468858|393431|P2|Overall Study|Lost to Follow-up|2
121110|NCT00468858|393432|P1|Overall Study|Lost to Follow-up|1
121111|NCT00468858|393430|P3|Overall Study|Relocation|3
121112|NCT00468858|393431|P2|Overall Study|Relocation|3
121113|NCT00468858|393432|P1|Overall Study|Relocation|1
121114|NCT00468858|393430|P3|Overall Study|Withdrawal by Subject|5
121115|NCT00468858|393431|P2|Overall Study|Withdrawal by Subject|4
121116|NCT00468858|393432|P1|Overall Study|Withdrawal by Subject|7
121117|NCT00468858|393430|P3|Overall Study|Adverse Event|0
121118|NCT00468858|393431|P2|Overall Study|Adverse Event|1
121119|NCT00468858|393432|P1|Overall Study|Adverse Event|0
121120|NCT00468910|393552|P2|Overall Study|Medical Contraindication|1
121121|NCT00468910|393553|P1|Overall Study|Medical Contraindication|0
121122|NCT00468910|393552|P2|Overall Study|Withdrawal by Subject|1
121123|NCT00468910|393553|P1|Overall Study|Withdrawal by Subject|2
121124|NCT00468910|393552|P2|Overall Study|Lost to Follow-up|1
121125|NCT00468910|393553|P1|Overall Study|Lost to Follow-up|2
121126|NCT00469079|393572|P3|Overall Study|Ineligible|0
121127|NCT00469079|393573|P2|Overall Study|Ineligible|1
121128|NCT00469079|393574|P1|Overall Study|Ineligible|0
121129|NCT00469079|393572|P3|Overall Study|Withdrawal by Subject|2
121130|NCT00469079|393573|P2|Overall Study|Withdrawal by Subject|2
121131|NCT00469079|393574|P1|Overall Study|Withdrawal by Subject|1
121132|NCT00469079|393572|P3|Overall Study|Lost to Follow-up|10
121133|NCT00469079|393573|P2|Overall Study|Lost to Follow-up|8
121134|NCT00469079|393574|P1|Overall Study|Lost to Follow-up|4
121135|NCT00469079|393572|P3|Overall Study|Adverse Event|2
121136|NCT00469079|393573|P2|Overall Study|Adverse Event|3
121137|NCT00469079|393574|P1|Overall Study|Adverse Event|1
121138|NCT00469079|393572|P3|Overall Study|Lack of Efficacy|5
121139|NCT00469079|393573|P2|Overall Study|Lack of Efficacy|8
121140|NCT00469079|393574|P1|Overall Study|Lack of Efficacy|3
121141|NCT00469092|393593|P2|Overall Study|Use of Corticosteroid|0
121142|NCT00469092|393594|P1|Overall Study|Use of Corticosteroid|1
121143|NCT00469092|393593|P2|Overall Study|Abnormal lab value|0
121144|NCT00469092|393594|P1|Overall Study|Abnormal lab value|1
121145|NCT00469092|393593|P2|Overall Study|Hypoglycaemic Episodes|1
121146|NCT00469092|393594|P1|Overall Study|Hypoglycaemic Episodes|1
121147|NCT00469092|393593|P2|Overall Study|Use of lipid lowering drug|0
121148|NCT00469092|393594|P1|Overall Study|Use of lipid lowering drug|1
121149|NCT00469092|393593|P2|Overall Study|Contraindication metformin/glimepiride|0
121150|NCT00469092|393594|P1|Overall Study|Contraindication metformin/glimepiride|1
121151|NCT00469092|393593|P2|Overall Study|Incorrectly Randomised|3
121152|NCT00469092|393594|P1|Overall Study|Incorrectly Randomised|4
121153|NCT00469092|393593|P2|Overall Study|Withdrawal Criteria|4
121154|NCT00469092|393594|P1|Overall Study|Withdrawal Criteria|3
121155|NCT00469092|393593|P2|Overall Study|Withdrawal by Subject|4
121156|NCT00469092|393594|P1|Overall Study|Withdrawal by Subject|4
121157|NCT00469092|393593|P2|Overall Study|Protocol Violation|3
121158|NCT00469092|393594|P1|Overall Study|Protocol Violation|3
121159|NCT00469092|393593|P2|Overall Study|Lost to Follow-up|2
121160|NCT00469092|393594|P1|Overall Study|Lost to Follow-up|1
121161|NCT00469092|393593|P2|Overall Study|Lack of Efficacy|0
121162|NCT00469092|393594|P1|Overall Study|Lack of Efficacy|1
121163|NCT00469092|393593|P2|Overall Study|Adverse Event|4
121164|NCT00469092|393594|P1|Overall Study|Adverse Event|5
121165|NCT00469209|393613|P3|Overall Study|Adverse Event|1
121166|NCT00469209|393614|P2|Overall Study|Adverse Event|0
121167|NCT00469209|393615|P1|Overall Study|Adverse Event|1
121168|NCT00469456|393643|P2|Overall Study|Withdrawal by Subject|1
121169|NCT00469456|393644|P1|Overall Study|Withdrawal by Subject|4
121170|NCT00469456|393643|P2|Overall Study|Protocol Violation|0
121171|NCT00469456|393644|P1|Overall Study|Protocol Violation|1
121172|NCT00469456|393643|P2|Overall Study|Adverse Event|3
121173|NCT00469456|393644|P1|Overall Study|Adverse Event|4
121174|NCT00469833|393667|P1|Overall Study|No IV access|2
121175|NCT00469859|393679|P2|Overall Study|Inevaluable|2
121176|NCT00469859|393680|P1|Overall Study|Inevaluable|0
121177|NCT00469898|393688|P1|Overall Study|Decreased performance status|1
121178|NCT00469898|393688|P1|Overall Study|Disease progression|9
121179|NCT00469898|393688|P1|Overall Study|Death|4
121180|NCT00469898|393688|P1|Overall Study|Withdrawal by Subject|4
121181|NCT00469898|393688|P1|Overall Study|Adverse Event|7
121182|NCT00470054|393695|P1|Overall Study|Ineligible|1
121183|NCT00470067|393703|P1|Overall Study|Disease Progression|6
121184|NCT00470067|393703|P1|Overall Study|Death|1
121185|NCT00470158|393733|P5|Overall Study|Protocol Violation|0
121186|NCT00470158|393734|P4|Overall Study|Protocol Violation|0
121187|NCT00470158|393735|P3|Overall Study|Protocol Violation|0
121188|NCT00470158|393736|P2|Overall Study|Protocol Violation|0
121189|NCT00470158|393737|P1|Overall Study|Protocol Violation|1
121190|NCT00470158|393733|P5|Overall Study|Lost to Follow-up|4
121191|NCT00470158|393734|P4|Overall Study|Lost to Follow-up|5
121192|NCT00470158|393735|P3|Overall Study|Lost to Follow-up|8
121193|NCT00470158|393736|P2|Overall Study|Lost to Follow-up|8
121194|NCT00470158|393737|P1|Overall Study|Lost to Follow-up|7
121195|NCT00470158|393733|P5|Overall Study|Death|2
121196|NCT00470158|393734|P4|Overall Study|Death|0
121197|NCT00470158|393735|P3|Overall Study|Death|0
121198|NCT00470158|393736|P2|Overall Study|Death|0
121199|NCT00470158|393737|P1|Overall Study|Death|0
121200|NCT00470184|393749|P1|Overall Study|recurrence|1
121201|NCT00470184|393749|P1|Overall Study|other|5
121202|NCT00470184|393749|P1|Overall Study|Withdrawal by Subject|4
121203|NCT00470184|393749|P1|Overall Study|Adverse Event|3
121204|NCT00470184|393749|P1|Overall Study|disease Progression|4
121205|NCT00470184|393749|P1|Overall Study|Not treated (other)|1
121206|NCT00470184|393749|P1|Overall Study|Not Treated(became ineligible)|4
121207|NCT00470262|393758|P2|Overall Study|Withdrawal by Subject|0
121208|NCT00470262|393759|P1|Overall Study|Withdrawal by Subject|2
121209|NCT00470275|393767|P1|Overall Study|Withdrawal by Subject|2
121210|NCT00470275|393767|P1|Overall Study|Lack of Efficacy|7
121211|NCT00470275|393767|P1|Overall Study|Death|1
121212|NCT00470418|393790|P2|Overall Study|Withdrawal by Subject|0
121213|NCT00470418|393791|P1|Overall Study|Withdrawal by Subject|1
121214|NCT00470470|393799|P1|Overall Study|Not treated|1
121215|NCT00470470|393799|P1|Overall Study|Death|2
121216|NCT00470470|393799|P1|Overall Study|Adverse Event|2
121217|NCT00470535|393804|P1|Overall Study|Other|2
121218|NCT00470535|393804|P1|Overall Study|Death|1
121219|NCT00470535|393804|P1|Overall Study|Adverse Event|1
121220|NCT00470535|393804|P1|Overall Study|Withdrawal by Subject|1
121221|NCT00470535|393804|P1|Overall Study|Disease Progression|13
121222|NCT00470626|393849|P1|Overall Study|Withdrawal by Subject|7
121223|NCT00470626|393849|P1|Overall Study|Lost to Follow-up|10
121224|NCT00470834|393857|P2|Extension Period (24 Months)|Disease Progression|1
121225|NCT00470834|393858|P1|Extension Period (24 Months)|Disease Progression|0
121226|NCT00470834|393857|P2|Extension Period (24 Months)|Non-compliance|1
121227|NCT00470834|393858|P1|Extension Period (24 Months)|Non-compliance|0
121228|NCT00470834|393857|P2|Extension Period (24 Months)|Lost to Follow-up|1
121229|NCT00470834|393858|P1|Extension Period (24 Months)|Lost to Follow-up|0
121230|NCT00470834|393857|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
121231|NCT00470834|393858|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
121232|NCT00470834|393857|P2|Extension Period (24 Months)|Physician Decision|3
121233|NCT00470834|393858|P1|Extension Period (24 Months)|Physician Decision|4
121234|NCT00470834|393857|P2|Extension Period (24 Months)|Withdrawal by Subject|5
121235|NCT00470834|393858|P1|Extension Period (24 Months)|Withdrawal by Subject|2
121236|NCT00470834|393857|P2|Extension Period (24 Months)|Adverse Event|4
121237|NCT00470834|393858|P1|Extension Period (24 Months)|Adverse Event|3
121238|NCT00470834|393857|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
121239|NCT00470834|393858|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
121240|NCT00470834|393857|P2|Treatment Period (18 Months)|Lack of Efficacy|0
121241|NCT00470834|393858|P1|Treatment Period (18 Months)|Lack of Efficacy|1
121242|NCT00470834|393857|P2|Treatment Period (18 Months)|Non-compliance|0
121243|NCT00470834|393858|P1|Treatment Period (18 Months)|Non-compliance|1
121244|NCT00470834|393857|P2|Treatment Period (18 Months)|Lost to Follow-up|0
121245|NCT00470834|393858|P1|Treatment Period (18 Months)|Lost to Follow-up|1
121246|NCT00470834|393857|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
121247|NCT00470834|393858|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
121248|NCT00470834|393857|P2|Treatment Period (18 Months)|Protocol Violation|1
121249|NCT00470834|393858|P1|Treatment Period (18 Months)|Protocol Violation|3
121250|NCT00470834|393857|P2|Treatment Period (18 Months)|Physician Decision|4
121251|NCT00470834|393858|P1|Treatment Period (18 Months)|Physician Decision|4
121252|NCT00470834|393857|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
121253|NCT00470834|393858|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
121254|NCT00470834|393857|P2|Treatment Period (18 Months)|Adverse Event|6
121255|NCT00470834|393858|P1|Treatment Period (18 Months)|Adverse Event|7
121256|NCT00470834|393857|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
121257|NCT00470834|393858|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
121258|NCT00470847|393872|P1|Overall Study|Pt still receiving treatment|1
121259|NCT00471107|393895|P3|Overall Study|Technical problems/data loss|3
121260|NCT00471107|393896|P2|Overall Study|Technical problems/data loss|1
121261|NCT00471107|393897|P1|Overall Study|Technical problems/data loss|3
121262|NCT00471146|393907|P2|Overall Study|Unspecified|5
121263|NCT00471146|393908|P1|Overall Study|Unspecified|4
121264|NCT00471146|393907|P2|Overall Study|Randomized but not treated|8
121265|NCT00471146|393908|P1|Overall Study|Randomized but not treated|9
121266|NCT00471146|393907|P2|Overall Study|Global deterioration of health status|14
121267|NCT00471146|393908|P1|Overall Study|Global deterioration of health status|12
121268|NCT00471146|393907|P2|Overall Study|Objective progression or relapse|87
121269|NCT00471146|393908|P1|Overall Study|Objective progression or relapse|84
121270|NCT00471146|393907|P2|Overall Study|Protocol Violation|2
121271|NCT00471146|393908|P1|Overall Study|Protocol Violation|2
121272|NCT00471146|393907|P2|Overall Study|Lost to Follow-up|2
121273|NCT00471146|393908|P1|Overall Study|Lost to Follow-up|4
121274|NCT00471146|393907|P2|Overall Study|Death|12
121275|NCT00471146|393908|P1|Overall Study|Death|11
121276|NCT00471146|393907|P2|Overall Study|Withdrawal by Subject|11
121277|NCT00471146|393908|P1|Overall Study|Withdrawal by Subject|14
121278|NCT00471146|393907|P2|Overall Study|Adverse Event|33
121279|NCT00471146|393908|P1|Overall Study|Adverse Event|32
121280|NCT00471276|393930|P1|Overall Study|Refused treatment|6
121281|NCT00471276|393930|P1|Overall Study|Unspecified|3
121282|NCT00471276|393930|P1|Overall Study|Global deterioration of health status|1
121283|NCT00471276|393930|P1|Overall Study|Objective progression or relapse|54
121284|NCT00471276|393930|P1|Overall Study|Protocol Violation|1
121285|NCT00471276|393930|P1|Overall Study|Adverse Event|16
121286|NCT00471276|393930|P1|Overall Study|Death|2
121287|NCT00471315|393953|P1|Overall Study|Withdrawal by Subject|1
121288|NCT00471315|393953|P1|Overall Study|Adverse Event|7
121289|NCT00471328|393960|P2|Extension Phase|Administrative Problem|0
121290|NCT00471328|393961|P1|Extension Phase|Administrative Problem|1
121291|NCT00471328|393960|P2|Extension Phase|New cancer Therapy|0
121292|NCT00471328|393961|P1|Extension Phase|New cancer Therapy|1
121293|NCT00471328|393960|P2|Extension Phase|Disease Progression|44
121294|NCT00471328|393961|P1|Extension Phase|Disease Progression|32
121295|NCT00471328|393960|P2|Extension Phase|Treatment duration as per protocol|1
121296|NCT00471328|393961|P1|Extension Phase|Treatment duration as per protocol|0
121297|NCT00471328|393960|P2|Extension Phase|Protocol Deviation|1
121298|NCT00471328|393961|P1|Extension Phase|Protocol Deviation|3
121299|NCT00471328|393960|P2|Extension Phase|Death|7
121300|NCT00471328|393961|P1|Extension Phase|Death|1
121301|NCT00471328|393960|P2|Extension Phase|Withdrawal by Subject|2
121302|NCT00471328|393961|P1|Extension Phase|Withdrawal by Subject|0
121303|NCT00471328|393960|P2|Extension Phase|Adverse Event|12
121304|NCT00471328|393961|P1|Extension Phase|Adverse Event|3
121305|NCT00471328|393960|P2|Core Phase|Protocol Deviation|1
121306|NCT00471328|393961|P1|Core Phase|Protocol Deviation|0
121307|NCT00471328|393960|P2|Core Phase|Administrative Problem|1
121308|NCT00471328|393961|P1|Core Phase|Administrative Problem|0
121309|NCT00471328|393960|P2|Core Phase|Disease Progression|53
121310|NCT00471328|393961|P1|Core Phase|Disease Progression|78
121311|NCT00471328|393960|P2|Core Phase|Abnormal laboratory value|0
121312|NCT00471328|393961|P1|Core Phase|Abnormal laboratory value|1
121313|NCT00471328|393960|P2|Core Phase|Withdrawal by Subject|2
121314|NCT00471328|393961|P1|Core Phase|Withdrawal by Subject|2
121315|NCT00471328|393960|P2|Core Phase|Death|4
121316|NCT00471328|393961|P1|Core Phase|Death|8
121317|NCT00471328|393960|P2|Core Phase|Adverse Event|6
121318|NCT00471328|393961|P1|Core Phase|Adverse Event|18
121319|NCT00471354|393980|P1|Overall Study|Patient/Caregiver Decision|12
121320|NCT00471354|393980|P1|Overall Study|Lack of Efficacy|5
121321|NCT00471354|393980|P1|Overall Study|Lost to Follow-up|3
121322|NCT00471354|393980|P1|Overall Study|Sponsor Decision|1
121323|NCT00471354|393980|P1|Overall Study|Physician Decision|4
121324|NCT00471354|393980|P1|Overall Study|Withdrawal by Subject|1
121325|NCT00471354|393980|P1|Overall Study|Protocol Violation|12
121326|NCT00471354|393980|P1|Overall Study|Adverse Event|13
121327|NCT00471354|393980|P1|Overall Study|Protocol Entry Criteria Not Met|1
121328|NCT00461630|394003|P2|Overall Study|Lost to Follow-up|95
121329|NCT00461630|394004|P1|Overall Study|Lost to Follow-up|108
121330|NCT00461630|394003|P2|Overall Study|Death|732
121331|NCT00461630|394004|P1|Overall Study|Death|798
121332|NCT00461682|394018|P1|Overall Study|Protocol Violation|1
121333|NCT00461708|394046|P2|Overall Study|Death|1
121334|NCT00461708|394047|P1|Overall Study|Death|8
121335|NCT00461708|394046|P2|Overall Study|Not specified|4
121336|NCT00461708|394047|P1|Overall Study|Not specified|4
121337|NCT00461708|394046|P2|Overall Study|Withdrawal by Subject|2
121338|NCT00461708|394047|P1|Overall Study|Withdrawal by Subject|8
121339|NCT00461708|394046|P2|Overall Study|Physician Decision|4
121340|NCT00461708|394047|P1|Overall Study|Physician Decision|10
121341|NCT00461708|394046|P2|Overall Study|Lack of Efficacy|20
121342|NCT00461708|394047|P1|Overall Study|Lack of Efficacy|68
121343|NCT00461708|394046|P2|Overall Study|Adverse Event|7
121344|NCT00461708|394047|P1|Overall Study|Adverse Event|17
121345|NCT00461786|394108|P1|Overall Study|Inevaluable (Never Treated)|1
121346|NCT00461786|394108|P1|Overall Study|Entry Criteria Not Met|2
121347|NCT00471445|394125|P2|Overall Study|Protocol Violation|1
121348|NCT00471445|394126|P1|Overall Study|Protocol Violation|0
121349|NCT00471445|394125|P2|Overall Study|Ineligible|0
121350|NCT00471445|394126|P1|Overall Study|Ineligible|1
121351|NCT00471445|394125|P2|Overall Study|Withdrawal by Subject|1
121352|NCT00471445|394126|P1|Overall Study|Withdrawal by Subject|1
121353|NCT00471497|394135|P3|Overall Study|Sub optimal response or treat. failure|0
121354|NCT00471497|394136|P2|Overall Study|Sub optimal response or treat. failure|3
121355|NCT00471497|394137|P1|Overall Study|Sub optimal response or treat. failure|8
121356|NCT00471497|394135|P3|Overall Study|Protocol Violation|5
121357|NCT00471497|394136|P2|Overall Study|Protocol Violation|3
121358|NCT00471497|394137|P1|Overall Study|Protocol Violation|3
121359|NCT00471497|394135|P3|Overall Study|Disease Progression|2
121360|NCT00471497|394136|P2|Overall Study|Disease Progression|2
121361|NCT00471497|394137|P1|Overall Study|Disease Progression|8
121362|NCT00471497|394135|P3|Overall Study|Death|0
121363|NCT00471497|394136|P2|Overall Study|Death|2
121364|NCT00471497|394137|P1|Overall Study|Death|0
121365|NCT00471497|394135|P3|Overall Study|Lost to Follow-up|1
121366|NCT00471497|394136|P2|Overall Study|Lost to Follow-up|2
121367|NCT00471497|394137|P1|Overall Study|Lost to Follow-up|1
121368|NCT00471497|394135|P3|Overall Study|Withdrawal by Subject|5
121369|NCT00471497|394136|P2|Overall Study|Withdrawal by Subject|5
121370|NCT00471497|394137|P1|Overall Study|Withdrawal by Subject|3
121371|NCT00471497|394135|P3|Overall Study|Condition no longer requires study drug|0
121372|NCT00471497|394136|P2|Overall Study|Condition no longer requires study drug|1
121373|NCT00471497|394137|P1|Overall Study|Condition no longer requires study drug|0
121374|NCT00471497|394135|P3|Overall Study|Abnormal Test Procedure|1
121375|NCT00471497|394136|P2|Overall Study|Abnormal Test Procedure|0
121376|NCT00471497|394137|P1|Overall Study|Abnormal Test Procedure|1
121377|NCT00471497|394135|P3|Overall Study|Abnormal Laboratory Value|4
121378|NCT00471497|394136|P2|Overall Study|Abnormal Laboratory Value|6
121379|NCT00471497|394137|P1|Overall Study|Abnormal Laboratory Value|3
121380|NCT00471497|394135|P3|Overall Study|Adverse Event|22
121381|NCT00471497|394136|P2|Overall Study|Adverse Event|11
121382|NCT00471497|394137|P1|Overall Study|Adverse Event|19
121383|NCT00471536|394145|P1|Overall Study|Withdrawal by Subject|1
121384|NCT00473512|394159|P5|Period 2 (Phase 2)|Unspecified|0
121385|NCT00473512|394160|P4|Period 2 (Phase 2)|Unspecified|3
121386|NCT00473512|394161|P3|Period 2 (Phase 2)|Unspecified|0
121387|NCT00473512|394162|P2|Period 2 (Phase 2)|Unspecified|0
121388|NCT00473512|394163|P1|Period 2 (Phase 2)|Unspecified|1
121389|NCT00473512|394159|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
121390|NCT00473512|394160|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
121391|NCT00473512|394161|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
121392|NCT00473512|394162|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
121393|NCT00473512|394163|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
121394|NCT00473512|394159|P5|Period 2 (Phase 2)|Disease Progression|1
121395|NCT00473512|394160|P4|Period 2 (Phase 2)|Disease Progression|17
121396|NCT00473512|394161|P3|Period 2 (Phase 2)|Disease Progression|2
121397|NCT00473512|394162|P2|Period 2 (Phase 2)|Disease Progression|2
121398|NCT00473512|394163|P1|Period 2 (Phase 2)|Disease Progression|0
121399|NCT00473512|394159|P5|Period 2 (Phase 2)|Death|1
121400|NCT00473512|394160|P4|Period 2 (Phase 2)|Death|1
121401|NCT00473512|394161|P3|Period 2 (Phase 2)|Death|0
121402|NCT00473512|394162|P2|Period 2 (Phase 2)|Death|0
121403|NCT00473512|394163|P1|Period 2 (Phase 2)|Death|0
121404|NCT00473512|394159|P5|Period 2 (Phase 2)|Adverse Event|0
121405|NCT00473512|394160|P4|Period 2 (Phase 2)|Adverse Event|1
121406|NCT00473512|394161|P3|Period 2 (Phase 2)|Adverse Event|0
121407|NCT00473512|394162|P2|Period 2 (Phase 2)|Adverse Event|0
121408|NCT00473512|394163|P1|Period 2 (Phase 2)|Adverse Event|0
121409|NCT00473512|394159|P5|Period 1 (Phase 1)|Unspecified|0
121410|NCT00473512|394160|P4|Period 1 (Phase 1)|Unspecified|1
121411|NCT00473512|394161|P3|Period 1 (Phase 1)|Unspecified|0
121412|NCT00473512|394162|P2|Period 1 (Phase 1)|Unspecified|0
121413|NCT00473512|394163|P1|Period 1 (Phase 1)|Unspecified|0
121414|NCT00473512|394159|P5|Period 1 (Phase 1)|Disease Progression|1
121415|NCT00473512|394160|P4|Period 1 (Phase 1)|Disease Progression|10
121416|NCT00473512|394161|P3|Period 1 (Phase 1)|Disease Progression|0
121417|NCT00473512|394162|P2|Period 1 (Phase 1)|Disease Progression|1
121418|NCT00473512|394163|P1|Period 1 (Phase 1)|Disease Progression|1
121419|NCT00473512|394159|P5|Period 1 (Phase 1)|Death|0
121420|NCT00473512|394160|P4|Period 1 (Phase 1)|Death|1
121421|NCT00473512|394161|P3|Period 1 (Phase 1)|Death|0
121422|NCT00473512|394162|P2|Period 1 (Phase 1)|Death|0
121423|NCT00473512|394163|P1|Period 1 (Phase 1)|Death|0
121424|NCT00473512|394159|P5|Period 1 (Phase 1)|Adverse Event|0
121425|NCT00473512|394160|P4|Period 1 (Phase 1)|Adverse Event|5
121426|NCT00473512|394161|P3|Period 1 (Phase 1)|Adverse Event|0
121427|NCT00473512|394162|P2|Period 1 (Phase 1)|Adverse Event|0
121428|NCT00473512|394163|P1|Period 1 (Phase 1)|Adverse Event|0
121429|NCT00473564|394221|P1|Overall Study|robot surgery aborted in OR|23
121430|NCT00473590|394228|P2|Overall Study|Other|1
121431|NCT00473590|394229|P1|Overall Study|Other|0
121432|NCT00473590|394228|P2|Overall Study|Withdrawal by Subject|3
121433|NCT00473590|394229|P1|Overall Study|Withdrawal by Subject|5
121434|NCT00473590|394228|P2|Overall Study|Physician Decision|4
121435|NCT00473590|394229|P1|Overall Study|Physician Decision|2
121436|NCT00473590|394228|P2|Overall Study|Non–protocol-specified therapy|5
121437|NCT00473590|394229|P1|Overall Study|Non–protocol-specified therapy|7
121438|NCT00473590|394228|P2|Overall Study|Progression not resulting in death|20
121439|NCT00473590|394229|P1|Overall Study|Progression not resulting in death|24
121440|NCT00473590|394228|P2|Overall Study|Death|2
121441|NCT00473590|394229|P1|Overall Study|Death|4
121442|NCT00473590|394228|P2|Overall Study|Adverse Event|3
121443|NCT00473590|394229|P1|Overall Study|Adverse Event|3
121444|NCT00473655|394261|P3|Overall Study|Lost to Follow-up|8
121445|NCT00473655|394262|P2|Overall Study|Lost to Follow-up|5
121446|NCT00473655|394263|P1|Overall Study|Lost to Follow-up|9
121447|NCT00473668|394298|P3|Overall Study|Unspecified|4
121448|NCT00473668|394299|P2|Overall Study|Unspecified|3
121449|NCT00473668|394300|P1|Overall Study|Unspecified|2
121450|NCT00473668|394298|P3|Overall Study|Lost to Follow-up|6
121451|NCT00473668|394299|P2|Overall Study|Lost to Follow-up|4
121452|NCT00473668|394300|P1|Overall Study|Lost to Follow-up|0
121453|NCT00473668|394298|P3|Overall Study|Migrated/moved from study area|0
121454|NCT00473668|394299|P2|Overall Study|Migrated/moved from study area|2
121455|NCT00473668|394300|P1|Overall Study|Migrated/moved from study area|3
121456|NCT00473668|394298|P3|Overall Study|Withdrawal by Subject|0
121457|NCT00473668|394299|P2|Overall Study|Withdrawal by Subject|2
121458|NCT00473668|394300|P1|Overall Study|Withdrawal by Subject|0
121459|NCT00473746|394355|P5|Period 2 (Phase 2)|Reason not specified|3
121460|NCT00473746|394356|P4|Period 2 (Phase 2)|Reason not specified|0
121461|NCT00473746|394357|P3|Period 2 (Phase 2)|Reason not specified|0
121462|NCT00473746|394358|P2|Period 2 (Phase 2)|Reason not specified|0
121463|NCT00473746|394359|P1|Period 2 (Phase 2)|Reason not specified|0
121464|NCT00473746|394355|P5|Period 2 (Phase 2)|Progressive Disease|20
121465|NCT00473746|394356|P4|Period 2 (Phase 2)|Progressive Disease|0
121466|NCT00473746|394357|P3|Period 2 (Phase 2)|Progressive Disease|0
121467|NCT00473746|394358|P2|Period 2 (Phase 2)|Progressive Disease|0
121468|NCT00473746|394359|P1|Period 2 (Phase 2)|Progressive Disease|0
121469|NCT00473746|394355|P5|Period 2 (Phase 2)|Death|1
121470|NCT00473746|394356|P4|Period 2 (Phase 2)|Death|0
121471|NCT00473746|394357|P3|Period 2 (Phase 2)|Death|0
121472|NCT00473746|394358|P2|Period 2 (Phase 2)|Death|0
121473|NCT00473746|394359|P1|Period 2 (Phase 2)|Death|0
121474|NCT00473746|394355|P5|Period 2 (Phase 2)|Adverse Event|3
121475|NCT00473746|394356|P4|Period 2 (Phase 2)|Adverse Event|0
121476|NCT00473746|394357|P3|Period 2 (Phase 2)|Adverse Event|0
121477|NCT00473746|394358|P2|Period 2 (Phase 2)|Adverse Event|0
121478|NCT00473746|394359|P1|Period 2 (Phase 2)|Adverse Event|0
121479|NCT00473746|394355|P5|Period 1 (Phase 1)|Reason not specified|0
121480|NCT00473746|394356|P4|Period 1 (Phase 1)|Reason not specified|0
121481|NCT00473746|394357|P3|Period 1 (Phase 1)|Reason not specified|0
121482|NCT00473746|394358|P2|Period 1 (Phase 1)|Reason not specified|1
121483|NCT00473746|394359|P1|Period 1 (Phase 1)|Reason not specified|0
121484|NCT00473746|394355|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
121485|NCT00473746|394356|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
121486|NCT00473746|394357|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
121487|NCT00473746|394358|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
121488|NCT00473746|394359|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
121489|NCT00473746|394355|P5|Period 1 (Phase 1)|Progressive Disease|0
121490|NCT00473746|394356|P4|Period 1 (Phase 1)|Progressive Disease|10
121491|NCT00473746|394357|P3|Period 1 (Phase 1)|Progressive Disease|6
121492|NCT00473746|394358|P2|Period 1 (Phase 1)|Progressive Disease|6
121493|NCT00473746|394359|P1|Period 1 (Phase 1)|Progressive Disease|5
121494|NCT00473746|394355|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
121495|NCT00473746|394356|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
121496|NCT00473746|394357|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
121497|NCT00473746|394358|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
121498|NCT00473746|394359|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
121499|NCT00473746|394355|P5|Period 1 (Phase 1)|Adverse Event|0
121500|NCT00473746|394356|P4|Period 1 (Phase 1)|Adverse Event|0
121501|NCT00473746|394357|P3|Period 1 (Phase 1)|Adverse Event|0
121502|NCT00473746|394358|P2|Period 1 (Phase 1)|Adverse Event|0
121503|NCT00473746|394359|P1|Period 1 (Phase 1)|Adverse Event|1
121504|NCT00473824|394406|P2|Overall Study|Withdrawal by physician|0
121505|NCT00473824|394407|P1|Overall Study|Withdrawal by physician|1
121506|NCT00473824|394406|P2|Overall Study|Lost to Follow-up|0
121507|NCT00473824|394407|P1|Overall Study|Lost to Follow-up|1
121508|NCT00473824|394406|P2|Overall Study|Death|0
121509|NCT00473824|394407|P1|Overall Study|Death|1
121510|NCT00473824|394406|P2|Overall Study|Adverse Event|0
121511|NCT00473824|394407|P1|Overall Study|Adverse Event|1
121512|NCT00473824|394406|P2|Overall Study|Virologic Breakthrough|0
121513|NCT00473824|394407|P1|Overall Study|Virologic Breakthrough|1
121514|NCT00473876|394424|P2|Overall Study|Lost to Follow-up|1
121515|NCT00473876|394425|P1|Overall Study|Lost to Follow-up|3
121516|NCT00473889|394435|P2|Overall Study|Withdrawal by Subject|0
121517|NCT00473889|394436|P1|Overall Study|Withdrawal by Subject|5
121518|NCT00473889|394435|P2|Overall Study|Trial Terminated|6
121519|NCT00473889|394436|P1|Overall Study|Trial Terminated|3
121520|NCT00473889|394435|P2|Overall Study|Physician Decision|5
121521|NCT00473889|394436|P1|Overall Study|Physician Decision|10
121522|NCT00473889|394435|P2|Overall Study|Lost to Follow-up|1
121523|NCT00473889|394436|P1|Overall Study|Lost to Follow-up|2
121524|NCT00473889|394435|P2|Overall Study|Lack of Efficacy|29
121525|NCT00473889|394436|P1|Overall Study|Lack of Efficacy|28
121526|NCT00473889|394435|P2|Overall Study|Protocol Violation|2
121527|NCT00473889|394436|P1|Overall Study|Protocol Violation|4
121528|NCT00473889|394435|P2|Overall Study|Adverse Event|17
121529|NCT00473889|394436|P1|Overall Study|Adverse Event|30
121530|NCT00473889|394435|P2|Overall Study|Did not receive study medication|4
121531|NCT00473889|394436|P1|Overall Study|Did not receive study medication|1
121532|NCT00474045|394448|P2|Overall Study|Withdrawal criteria|50
121533|NCT00474045|394449|P1|Overall Study|Withdrawal criteria|60
121534|NCT00474045|394448|P2|Overall Study|Withdrawal by Subject|18
121535|NCT00474045|394449|P1|Overall Study|Withdrawal by Subject|16
121536|NCT00474045|394448|P2|Overall Study|Protocol Violation|12
121537|NCT00474045|394449|P1|Overall Study|Protocol Violation|10
121538|NCT00474045|394448|P2|Overall Study|Lost to Follow-up|1
121539|NCT00474045|394449|P1|Overall Study|Lost to Follow-up|1
121540|NCT00474045|394448|P2|Overall Study|Lack of Efficacy|9
121541|NCT00474045|394449|P1|Overall Study|Lack of Efficacy|0
121542|NCT00474045|394448|P2|Overall Study|Unclassified|3
121543|NCT00474045|394449|P1|Overall Study|Unclassified|1
121544|NCT00474045|394448|P2|Overall Study|Adverse Event|8
121545|NCT00474045|394449|P1|Overall Study|Adverse Event|18
121546|NCT00474058|394549|P2|Overall Study|Other|0
121547|NCT00474058|394550|P1|Overall Study|Other|2
121548|NCT00474058|394549|P2|Overall Study|Withdrawal by Subject|7
121549|NCT00474058|394550|P1|Overall Study|Withdrawal by Subject|11
121550|NCT00474058|394549|P2|Overall Study|Lack of Efficacy|4
121551|NCT00474058|394550|P1|Overall Study|Lack of Efficacy|0
121552|NCT00474058|394549|P2|Overall Study|Adverse Event|6
121553|NCT00474058|394550|P1|Overall Study|Adverse Event|11
121554|NCT00474175|394592|P3|Overall Study|Administrative|0
121555|NCT00474175|394593|P2|Overall Study|Administrative|1
121556|NCT00474175|394594|P1|Overall Study|Administrative|0
121557|NCT00474175|394592|P3|Overall Study|Protocol Violation|1
121558|NCT00474175|394593|P2|Overall Study|Protocol Violation|2
121559|NCT00474175|394594|P1|Overall Study|Protocol Violation|0
121560|NCT00474175|394592|P3|Overall Study|Ineligible|1
121561|NCT00474175|394593|P2|Overall Study|Ineligible|3
121562|NCT00474175|394594|P1|Overall Study|Ineligible|1
121563|NCT00474175|394592|P3|Overall Study|Withdrawal by Subject|1
121564|NCT00474175|394593|P2|Overall Study|Withdrawal by Subject|1
121565|NCT00474175|394594|P1|Overall Study|Withdrawal by Subject|0
121566|NCT00474175|394592|P3|Overall Study|Lack of Efficacy|1
121567|NCT00474175|394593|P2|Overall Study|Lack of Efficacy|0
121568|NCT00474175|394594|P1|Overall Study|Lack of Efficacy|0
121569|NCT00474188|394629|P1|Overall Study|Study discontinued by sponsor|5
121570|NCT00474188|394629|P1|Overall Study|Withdrawal by Subject|1
121571|NCT00474240|394647|P6|Overall Study|Removed due to lab value|1
121572|NCT00474240|394648|P5|Overall Study|Removed due to lab value|0
121573|NCT00474240|394649|P4|Overall Study|Removed due to lab value|0
121574|NCT00474240|394650|P3|Overall Study|Removed due to lab value|0
121575|NCT00474240|394651|P2|Overall Study|Removed due to lab value|0
121576|NCT00474240|394652|P1|Overall Study|Removed due to lab value|0
121577|NCT00474240|394647|P6|Overall Study|Adverse Event|16
121578|NCT00474240|394648|P5|Overall Study|Adverse Event|5
121579|NCT00474240|394649|P4|Overall Study|Adverse Event|14
121580|NCT00474240|394650|P3|Overall Study|Adverse Event|9
121581|NCT00474240|394651|P2|Overall Study|Adverse Event|0
121582|NCT00474240|394652|P1|Overall Study|Adverse Event|0
121583|NCT00474240|394647|P6|Overall Study|Withdrawal by Subject|1
121584|NCT00474240|394648|P5|Overall Study|Withdrawal by Subject|3
121585|NCT00474240|394649|P4|Overall Study|Withdrawal by Subject|2
121586|NCT00474240|394650|P3|Overall Study|Withdrawal by Subject|0
121587|NCT00474240|394651|P2|Overall Study|Withdrawal by Subject|1
121588|NCT00474240|394652|P1|Overall Study|Withdrawal by Subject|1
121589|NCT00474383|394672|P2|Extension|Progressive Disease|5
121590|NCT00474383|394673|P1|Extension|Progressive Disease|0
121591|NCT00474383|394672|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
121592|NCT00474383|394673|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
121593|NCT00474383|394672|P2|Main Study|Other|0
121594|NCT00474383|394673|P1|Main Study|Other|1
121595|NCT00474383|394672|P2|Main Study|Progressive Disease|0
121596|NCT00474383|394673|P1|Main Study|Progressive Disease|23
121597|NCT00474383|394672|P2|Main Study|Symptomatic Deterioration|0
121598|NCT00474383|394673|P1|Main Study|Symptomatic Deterioration|1
121599|NCT00474383|394672|P2|Main Study|Adverse Event|0
121600|NCT00474383|394673|P1|Main Study|Adverse Event|11
121601|NCT00474487|394688|P4|Overall Study|Death|0
121602|NCT00474487|394689|P3|Overall Study|Death|0
121603|NCT00474487|394690|P2|Overall Study|Death|1
121604|NCT00474487|394691|P1|Overall Study|Death|0
121605|NCT00474487|394688|P4|Overall Study|Inappropriate enrollment|0
121606|NCT00474487|394689|P3|Overall Study|Inappropriate enrollment|7
121607|NCT00474487|394690|P2|Overall Study|Inappropriate enrollment|0
121608|NCT00474487|394691|P1|Overall Study|Inappropriate enrollment|4
121609|NCT00474487|394688|P4|Overall Study|Lost to Follow-up|0
121610|NCT00474487|394689|P3|Overall Study|Lost to Follow-up|7
121611|NCT00474487|394690|P2|Overall Study|Lost to Follow-up|1
121612|NCT00474487|394691|P1|Overall Study|Lost to Follow-up|20
121613|NCT00474487|394688|P4|Overall Study|Withdrawal by Subject|0
121614|NCT00474487|394689|P3|Overall Study|Withdrawal by Subject|0
121615|NCT00474487|394690|P2|Overall Study|Withdrawal by Subject|0
121616|NCT00474487|394691|P1|Overall Study|Withdrawal by Subject|6
121617|NCT00474526|394728|P17|Overall Study|Withdrawal by Subject|1
121618|NCT00474526|394729|P16|Overall Study|Withdrawal by Subject|1
121619|NCT00474526|394730|P15|Overall Study|Withdrawal by Subject|22
121620|NCT00474526|394731|P14|Overall Study|Withdrawal by Subject|37
121621|NCT00474526|394732|P13|Overall Study|Withdrawal by Subject|4
121622|NCT00474526|394733|P12|Overall Study|Withdrawal by Subject|4
121623|NCT00474526|394734|P11|Overall Study|Withdrawal by Subject|5
121624|NCT00474526|394735|P10|Overall Study|Withdrawal by Subject|13
121625|NCT00474526|394736|P9|Overall Study|Withdrawal by Subject|4
121626|NCT00474526|394737|P8|Overall Study|Withdrawal by Subject|4
121627|NCT00474526|394738|P7|Overall Study|Withdrawal by Subject|12
121628|NCT00474526|394739|P6|Overall Study|Withdrawal by Subject|6
121629|NCT00474526|394740|P5|Overall Study|Withdrawal by Subject|38
121630|NCT00474526|394741|P4|Overall Study|Withdrawal by Subject|52
121631|NCT00474526|394742|P3|Overall Study|Withdrawal by Subject|21
121632|NCT00474526|394743|P2|Overall Study|Withdrawal by Subject|24
121633|NCT00474526|394744|P1|Overall Study|Withdrawal by Subject|9
121634|NCT00474526|394728|P17|Overall Study|UNABLE TO CLASSIFY|1
121635|NCT00474526|394729|P16|Overall Study|UNABLE TO CLASSIFY|6
121636|NCT00474526|394730|P15|Overall Study|UNABLE TO CLASSIFY|12
121637|NCT00474526|394731|P14|Overall Study|UNABLE TO CLASSIFY|20
121638|NCT00474526|394732|P13|Overall Study|UNABLE TO CLASSIFY|0
121639|NCT00474526|394733|P12|Overall Study|UNABLE TO CLASSIFY|0
121640|NCT00474526|394734|P11|Overall Study|UNABLE TO CLASSIFY|0
121641|NCT00474526|394735|P10|Overall Study|UNABLE TO CLASSIFY|3
121642|NCT00474526|394736|P9|Overall Study|UNABLE TO CLASSIFY|0
121643|NCT00474526|394737|P8|Overall Study|UNABLE TO CLASSIFY|1
121644|NCT00474526|394738|P7|Overall Study|UNABLE TO CLASSIFY|0
121645|NCT00474526|394739|P6|Overall Study|UNABLE TO CLASSIFY|2
121646|NCT00474526|394740|P5|Overall Study|UNABLE TO CLASSIFY|3
121647|NCT00474526|394741|P4|Overall Study|UNABLE TO CLASSIFY|1
121648|NCT00474526|394742|P3|Overall Study|UNABLE TO CLASSIFY|0
121649|NCT00474526|394743|P2|Overall Study|UNABLE TO CLASSIFY|0
121650|NCT00474526|394744|P1|Overall Study|UNABLE TO CLASSIFY|1
121651|NCT00474526|394728|P17|Overall Study|Protocol Violation|2
121652|NCT00474526|394729|P16|Overall Study|Protocol Violation|6
121653|NCT00474526|394730|P15|Overall Study|Protocol Violation|9
121654|NCT00474526|394731|P14|Overall Study|Protocol Violation|19
121655|NCT00474526|394732|P13|Overall Study|Protocol Violation|4
121656|NCT00474526|394733|P12|Overall Study|Protocol Violation|2
121657|NCT00474526|394734|P11|Overall Study|Protocol Violation|2
121658|NCT00474526|394735|P10|Overall Study|Protocol Violation|4
121659|NCT00474526|394736|P9|Overall Study|Protocol Violation|0
121660|NCT00474526|394737|P8|Overall Study|Protocol Violation|0
121661|NCT00474526|394738|P7|Overall Study|Protocol Violation|3
121662|NCT00474526|394739|P6|Overall Study|Protocol Violation|1
121663|NCT00474526|394740|P5|Overall Study|Protocol Violation|3
121664|NCT00474526|394741|P4|Overall Study|Protocol Violation|12
121665|NCT00474526|394742|P3|Overall Study|Protocol Violation|4
121666|NCT00474526|394743|P2|Overall Study|Protocol Violation|6
121667|NCT00474526|394744|P1|Overall Study|Protocol Violation|2
121668|NCT00474526|394728|P17|Overall Study|Lost to Follow-up|5
121669|NCT00474526|394729|P16|Overall Study|Lost to Follow-up|4
121670|NCT00474526|394730|P15|Overall Study|Lost to Follow-up|29
121671|NCT00474526|394731|P14|Overall Study|Lost to Follow-up|74
121672|NCT00474526|394732|P13|Overall Study|Lost to Follow-up|6
121673|NCT00474526|394733|P12|Overall Study|Lost to Follow-up|4
121674|NCT00474526|394734|P11|Overall Study|Lost to Follow-up|2
121675|NCT00474526|394735|P10|Overall Study|Lost to Follow-up|6
121676|NCT00474526|394736|P9|Overall Study|Lost to Follow-up|0
121677|NCT00474526|394737|P8|Overall Study|Lost to Follow-up|1
121678|NCT00474526|394738|P7|Overall Study|Lost to Follow-up|8
121679|NCT00474526|394739|P6|Overall Study|Lost to Follow-up|5
121680|NCT00474526|394740|P5|Overall Study|Lost to Follow-up|11
121681|NCT00474526|394741|P4|Overall Study|Lost to Follow-up|29
121682|NCT00474526|394742|P3|Overall Study|Lost to Follow-up|13
121683|NCT00474526|394743|P2|Overall Study|Lost to Follow-up|6
121684|NCT00474526|394744|P1|Overall Study|Lost to Follow-up|8
121685|NCT00474526|394728|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
121686|NCT00474526|394729|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
121687|NCT00474526|394730|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
121688|NCT00474526|394731|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
121689|NCT00474526|394732|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
121690|NCT00474526|394733|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
121691|NCT00474526|394734|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
121692|NCT00474526|394735|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
121693|NCT00474526|394736|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
121694|NCT00474526|394737|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
121695|NCT00474526|394738|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
121696|NCT00474526|394739|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
121697|NCT00474526|394740|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
121698|NCT00474526|394741|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
121699|NCT00474526|394742|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
121700|NCT00474526|394743|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
121701|NCT00474526|394744|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
121702|NCT00474526|394728|P17|Overall Study|Death|0
121703|NCT00474526|394729|P16|Overall Study|Death|0
121704|NCT00474526|394730|P15|Overall Study|Death|0
121705|NCT00474526|394731|P14|Overall Study|Death|3
121706|NCT00474526|394732|P13|Overall Study|Death|0
121707|NCT00474526|394733|P12|Overall Study|Death|0
121708|NCT00474526|394734|P11|Overall Study|Death|0
121709|NCT00474526|394735|P10|Overall Study|Death|0
121710|NCT00474526|394736|P9|Overall Study|Death|0
121711|NCT00474526|394737|P8|Overall Study|Death|0
121712|NCT00474526|394738|P7|Overall Study|Death|0
121713|NCT00474526|394739|P6|Overall Study|Death|0
121714|NCT00474526|394740|P5|Overall Study|Death|0
121715|NCT00474526|394741|P4|Overall Study|Death|0
121716|NCT00474526|394742|P3|Overall Study|Death|0
121717|NCT00474526|394743|P2|Overall Study|Death|0
121718|NCT00474526|394744|P1|Overall Study|Death|0
121719|NCT00474526|394728|P17|Overall Study|Adverse Event|0
121720|NCT00474526|394729|P16|Overall Study|Adverse Event|1
121721|NCT00474526|394730|P15|Overall Study|Adverse Event|1
121722|NCT00474526|394731|P14|Overall Study|Adverse Event|0
121723|NCT00474526|394732|P13|Overall Study|Adverse Event|0
121724|NCT00474526|394733|P12|Overall Study|Adverse Event|0
121725|NCT00474526|394734|P11|Overall Study|Adverse Event|0
121726|NCT00474526|394735|P10|Overall Study|Adverse Event|0
121727|NCT00474526|394736|P9|Overall Study|Adverse Event|0
121728|NCT00474526|394737|P8|Overall Study|Adverse Event|0
121729|NCT00474526|394738|P7|Overall Study|Adverse Event|1
121730|NCT00474526|394739|P6|Overall Study|Adverse Event|1
121731|NCT00474526|394740|P5|Overall Study|Adverse Event|2
121732|NCT00474526|394741|P4|Overall Study|Adverse Event|4
121733|NCT00474526|394742|P3|Overall Study|Adverse Event|2
121734|NCT00474526|394743|P2|Overall Study|Adverse Event|0
121735|NCT00474526|394744|P1|Overall Study|Adverse Event|2
121736|NCT00474526|394728|P17|Overall Study|ADMINISTRATIVE REASON|0
121737|NCT00474526|394729|P16|Overall Study|ADMINISTRATIVE REASON|0
121738|NCT00474526|394730|P15|Overall Study|ADMINISTRATIVE REASON|2
121739|NCT00474526|394731|P14|Overall Study|ADMINISTRATIVE REASON|1
121740|NCT00474526|394732|P13|Overall Study|ADMINISTRATIVE REASON|1
121741|NCT00474526|394733|P12|Overall Study|ADMINISTRATIVE REASON|1
121742|NCT00474526|394734|P11|Overall Study|ADMINISTRATIVE REASON|1
121743|NCT00474526|394735|P10|Overall Study|ADMINISTRATIVE REASON|1
121744|NCT00474526|394736|P9|Overall Study|ADMINISTRATIVE REASON|2
121745|NCT00474526|394737|P8|Overall Study|ADMINISTRATIVE REASON|0
121746|NCT00474526|394738|P7|Overall Study|ADMINISTRATIVE REASON|1
121747|NCT00474526|394739|P6|Overall Study|ADMINISTRATIVE REASON|1
121748|NCT00474526|394740|P5|Overall Study|ADMINISTRATIVE REASON|9
121749|NCT00474526|394741|P4|Overall Study|ADMINISTRATIVE REASON|20
121750|NCT00474526|394742|P3|Overall Study|ADMINISTRATIVE REASON|9
121751|NCT00474526|394743|P2|Overall Study|ADMINISTRATIVE REASON|9
121752|NCT00474526|394744|P1|Overall Study|ADMINISTRATIVE REASON|11
121753|NCT00474539|394907|P2|Toddler Dose|Protocol Violation|0
121754|NCT00474539|394908|P1|Toddler Dose|Protocol Violation|1
121755|NCT00474539|394907|P2|After Infant Series|Withdrawal by Subject|0
121756|NCT00474539|394908|P1|After Infant Series|Withdrawal by Subject|1
121757|NCT00474539|394907|P2|After Infant Series|Lost to Follow-up|0
121758|NCT00474539|394908|P1|After Infant Series|Lost to Follow-up|3
121759|NCT00474539|394907|P2|Infant Series|Protocol Violation|1
121760|NCT00474539|394908|P1|Infant Series|Protocol Violation|0
121761|NCT00474539|394907|P2|Infant Series|Lost to Follow-up|1
121762|NCT00474539|394908|P1|Infant Series|Lost to Follow-up|2
121763|NCT00474539|394907|P2|Infant Series|Randomization error|0
121764|NCT00474539|394908|P1|Infant Series|Randomization error|5
121765|NCT00474539|394907|P2|Infant Series|Withdrawal by Subject|4
121766|NCT00474539|394908|P1|Infant Series|Withdrawal by Subject|3
121767|NCT00474630|394958|P2|Overall Study|Drug noncompliance, other|4
121768|NCT00474630|394959|P1|Overall Study|Drug noncompliance, other|11
121769|NCT00474630|394958|P2|Overall Study|Lack of Efficacy|6
121770|NCT00474630|394959|P1|Overall Study|Lack of Efficacy|5
121771|NCT00474630|394958|P2|Overall Study|Protocol Violation|4
121772|NCT00474630|394959|P1|Overall Study|Protocol Violation|3
121773|NCT00474630|394958|P2|Overall Study|Withdrawal by Subject|15
121774|NCT00474630|394959|P1|Overall Study|Withdrawal by Subject|21
121775|NCT00474630|394958|P2|Overall Study|Lost to Follow-up|15
121776|NCT00474630|394959|P1|Overall Study|Lost to Follow-up|22
121777|NCT00474630|394958|P2|Overall Study|Adverse Event|26
121778|NCT00474630|394959|P1|Overall Study|Adverse Event|98
121779|NCT00474708|395015|P2|Overall Study|Physician Decision|6
121780|NCT00474708|395016|P1|Overall Study|Physician Decision|9
121781|NCT00474708|395015|P2|Overall Study|Lost to Follow-up|9
121782|NCT00474708|395016|P1|Overall Study|Lost to Follow-up|18
121783|NCT00474708|395015|P2|Overall Study|Lack of compliance|4
121784|NCT00474708|395016|P1|Overall Study|Lack of compliance|12
121785|NCT00474708|395015|P2|Overall Study|Withdrawal by Subject|0
121786|NCT00474708|395016|P1|Overall Study|Withdrawal by Subject|7
121787|NCT00474708|395015|P2|Overall Study|Suicide ideation/behavior|1
121788|NCT00474708|395016|P1|Overall Study|Suicide ideation/behavior|0
121789|NCT00474708|395015|P2|Overall Study|Lack of Efficacy|5
121790|NCT00474708|395016|P1|Overall Study|Lack of Efficacy|11
121791|NCT00474760|395031|P7|Overall Study|Terminated by sponsor|2
121792|NCT00474760|395032|P6|Overall Study|Terminated by sponsor|0
121793|NCT00474760|395033|P5|Overall Study|Terminated by sponsor|0
121794|NCT00474760|395034|P4|Overall Study|Terminated by sponsor|0
121795|NCT00474760|395035|P3|Overall Study|Terminated by sponsor|0
121796|NCT00474760|395036|P2|Overall Study|Terminated by sponsor|0
121797|NCT00474760|395037|P1|Overall Study|Terminated by sponsor|0
121798|NCT00474760|395031|P7|Overall Study|Progressive disease|7
121799|NCT00474760|395032|P6|Overall Study|Progressive disease|20
121800|NCT00474760|395033|P5|Overall Study|Progressive disease|8
121801|NCT00474760|395034|P4|Overall Study|Progressive disease|2
121802|NCT00474760|395035|P3|Overall Study|Progressive disease|3
121803|NCT00474760|395036|P2|Overall Study|Progressive disease|2
121804|NCT00474760|395037|P1|Overall Study|Progressive disease|3
121805|NCT00474760|395031|P7|Overall Study|Unspecified|0
121806|NCT00474760|395032|P6|Overall Study|Unspecified|0
121807|NCT00474760|395033|P5|Overall Study|Unspecified|1
121808|NCT00474760|395034|P4|Overall Study|Unspecified|0
121809|NCT00474760|395035|P3|Overall Study|Unspecified|0
121810|NCT00474760|395036|P2|Overall Study|Unspecified|1
121811|NCT00474760|395037|P1|Overall Study|Unspecified|0
121812|NCT00474760|395031|P7|Overall Study|Withdrawal by Subject|1
121813|NCT00474760|395032|P6|Overall Study|Withdrawal by Subject|1
121814|NCT00474760|395033|P5|Overall Study|Withdrawal by Subject|0
121815|NCT00474760|395034|P4|Overall Study|Withdrawal by Subject|1
121816|NCT00474760|395035|P3|Overall Study|Withdrawal by Subject|0
121817|NCT00474760|395036|P2|Overall Study|Withdrawal by Subject|0
121818|NCT00474760|395037|P1|Overall Study|Withdrawal by Subject|0
121819|NCT00474760|395031|P7|Overall Study|Laboratory abnormality|0
121820|NCT00474760|395032|P6|Overall Study|Laboratory abnormality|1
121821|NCT00474760|395033|P5|Overall Study|Laboratory abnormality|0
121822|NCT00474760|395034|P4|Overall Study|Laboratory abnormality|0
121823|NCT00474760|395035|P3|Overall Study|Laboratory abnormality|0
121824|NCT00474760|395036|P2|Overall Study|Laboratory abnormality|0
121825|NCT00474760|395037|P1|Overall Study|Laboratory abnormality|0
121826|NCT00474760|395031|P7|Overall Study|Adverse Event|0
121827|NCT00474760|395032|P6|Overall Study|Adverse Event|7
121828|NCT00474760|395033|P5|Overall Study|Adverse Event|1
121829|NCT00474760|395034|P4|Overall Study|Adverse Event|0
121830|NCT00474760|395035|P3|Overall Study|Adverse Event|0
121831|NCT00474760|395036|P2|Overall Study|Adverse Event|0
121832|NCT00474760|395037|P1|Overall Study|Adverse Event|0
121833|NCT00474760|395031|P7|Overall Study|Death|0
121834|NCT00474760|395032|P6|Overall Study|Death|0
121835|NCT00474760|395033|P5|Overall Study|Death|2
121836|NCT00474760|395034|P4|Overall Study|Death|0
121837|NCT00474760|395035|P3|Overall Study|Death|0
121838|NCT00474760|395036|P2|Overall Study|Death|0
121839|NCT00474760|395037|P1|Overall Study|Death|0
121840|NCT00474786|395144|P2|Overall Study|Not specified|0
121841|NCT00474786|395145|P1|Overall Study|Not specified|5
121842|NCT00474786|395144|P2|Overall Study|Withdrawal by Subject|15
121843|NCT00474786|395145|P1|Overall Study|Withdrawal by Subject|15
121844|NCT00474786|395144|P2|Overall Study|Protocol Violation|0
121845|NCT00474786|395145|P1|Overall Study|Protocol Violation|2
121846|NCT00474786|395144|P2|Overall Study|Lost to Follow-up|7
121847|NCT00474786|395145|P1|Overall Study|Lost to Follow-up|4
121848|NCT00474786|395144|P2|Overall Study|Discontinuation of Study by Sponsor|59
121849|NCT00474786|395145|P1|Overall Study|Discontinuation of Study by Sponsor|42
121850|NCT00474786|395144|P2|Overall Study|Death|170
121851|NCT00474786|395145|P1|Overall Study|Death|189
121852|NCT00474786|395144|P2|Overall Study|Investigator Request|1
121853|NCT00474786|395145|P1|Overall Study|Investigator Request|2
121854|NCT00474786|395144|P2|Overall Study|Not Meeting Study Criteria|1
121855|NCT00474786|395145|P1|Overall Study|Not Meeting Study Criteria|0
121856|NCT00474812|395163|P1|Overall Study|No Initiation of treatment|2
121857|NCT00474812|395163|P1|Overall Study|Withdrawal by Subject|5
121858|NCT00474903|395185|P3|Overall Study|Protocol Violation|2
121859|NCT00474903|395186|P2|Overall Study|Protocol Violation|5
121860|NCT00474903|395187|P1|Overall Study|Protocol Violation|1
121861|NCT00474929|395203|P5|Overall Study|Physician Decision|0
121862|NCT00474929|395204|P4|Overall Study|Physician Decision|2
121863|NCT00474929|395205|P3|Overall Study|Physician Decision|1
121864|NCT00474929|395206|P2|Overall Study|Physician Decision|0
121865|NCT00474929|395207|P1|Overall Study|Physician Decision|0
121866|NCT00474929|395203|P5|Overall Study|Unrelated medical condition|0
121867|NCT00474929|395204|P4|Overall Study|Unrelated medical condition|0
121868|NCT00474929|395205|P3|Overall Study|Unrelated medical condition|1
121869|NCT00474929|395206|P2|Overall Study|Unrelated medical condition|0
121870|NCT00474929|395207|P1|Overall Study|Unrelated medical condition|0
121871|NCT00474929|395203|P5|Overall Study|Withdrawal by Subject|0
121872|NCT00474929|395204|P4|Overall Study|Withdrawal by Subject|0
121873|NCT00474929|395205|P3|Overall Study|Withdrawal by Subject|0
121874|NCT00474929|395206|P2|Overall Study|Withdrawal by Subject|1
121875|NCT00474929|395207|P1|Overall Study|Withdrawal by Subject|0
121876|NCT00474955|395221|P1|Overall Study|Personal reasons|5
121877|NCT00474955|395221|P1|Overall Study|Drug unavailability|1
121878|NCT00474955|395221|P1|Overall Study|Adverse Event|2
121879|NCT00474968|395234|P2|Overall Study|Sample not collected|1
121880|NCT00474968|395235|P1|Overall Study|Sample not collected|1
121881|NCT00474968|395234|P2|Overall Study|Protocol Violation|8
121882|NCT00474968|395235|P1|Overall Study|Protocol Violation|9
121883|NCT00474968|395234|P2|Overall Study|Withdrawal by Subject|7
121884|NCT00474968|395235|P1|Overall Study|Withdrawal by Subject|8
121885|NCT00474994|395245|P1|Overall Study|Patient found to be ineligible|1
121886|NCT00474994|395245|P1|Overall Study|Patient evaluable for toxicity only|3
121887|NCT00474994|395245|P1|Overall Study|Patient Not treated|1
121888|NCT00475033|395251|P2|Toddler Dose|Lost to Follow-up|0
121889|NCT00475033|395252|P1|Toddler Dose|Lost to Follow-up|1
121890|NCT00475033|395251|P2|Toddler Dose|Failed to return|0
121891|NCT00475033|395252|P1|Toddler Dose|Failed to return|1
121892|NCT00475033|395251|P2|Toddler Dose|Parent or legal guardian request|0
121893|NCT00475033|395252|P1|Toddler Dose|Parent or legal guardian request|2
121894|NCT00475033|395251|P2|After the Infant Series|Unspecified|1
121895|NCT00475033|395252|P1|After the Infant Series|Unspecified|0
121896|NCT00475033|395251|P2|After the Infant Series|Lost to Follow-up|0
121897|NCT00475033|395252|P1|After the Infant Series|Lost to Follow-up|1
121898|NCT00475033|395251|P2|After the Infant Series|Protocol Violation|0
121899|NCT00475033|395252|P1|After the Infant Series|Protocol Violation|1
121900|NCT00475033|395251|P2|After the Infant Series|Failed to return|1
121901|NCT00475033|395252|P1|After the Infant Series|Failed to return|2
121902|NCT00475033|395251|P2|After the Infant Series|Parent or legal guardian request|2
121903|NCT00475033|395252|P1|After the Infant Series|Parent or legal guardian request|2
121904|NCT00475033|395251|P2|After the Infant Series|Adverse Event|4
121905|NCT00475033|395252|P1|After the Infant Series|Adverse Event|0
121906|NCT00475033|395251|P2|Infant Series|Adverse Event|2
121907|NCT00475033|395252|P1|Infant Series|Adverse Event|0
121908|NCT00475033|395251|P2|Infant Series|Lost to Follow-up|0
121909|NCT00475033|395252|P1|Infant Series|Lost to Follow-up|2
121910|NCT00475033|395251|P2|Infant Series|Protocol Violation|2
121911|NCT00475033|395252|P1|Infant Series|Protocol Violation|1
121912|NCT00475033|395251|P2|Infant Series|Parent or legal guardian request|5
121913|NCT00475033|395252|P1|Infant Series|Parent or legal guardian request|1
121914|NCT00475033|395251|P2|Infant Series|Failed to return|4
121915|NCT00475033|395252|P1|Infant Series|Failed to return|3
121916|NCT00475176|395333|P1|Overall Study|Protocol Violation|1
121917|NCT00475176|395333|P1|Overall Study|Withdrawal by Subject|1
121918|NCT00475176|395333|P1|Overall Study|Adverse Event|2
121919|NCT00475228|395340|P2|Overall Study|Lost to Follow-up|17
121920|NCT00475228|395341|P1|Overall Study|Lost to Follow-up|17
121921|NCT00475306|395364|P4|Overall Study|Protocol Violation|1
121922|NCT00475306|395365|P3|Overall Study|Protocol Violation|0
121923|NCT00475306|395366|P2|Overall Study|Protocol Violation|1
121924|NCT00475306|395367|P1|Overall Study|Protocol Violation|1
121925|NCT00475423|395402|P1|Overall Study|Lost to Follow-up|7
121926|NCT00475423|395402|P1|Overall Study|Reason not specified|1
121927|NCT00475423|395402|P1|Overall Study|Death|1
121928|NCT00475423|395402|P1|Overall Study|Lack of Efficacy|8
121929|NCT00475423|395402|P1|Overall Study|Withdrawal by Subject|6
121930|NCT00475423|395402|P1|Overall Study|Adverse Event|4
121931|NCT00475423|395402|P1|Overall Study|Protocol Violation|5
121932|NCT00475657|395480|P1|Overall Study|Sponsor's Decision|3
121933|NCT00475657|395480|P1|Overall Study|Death|1
121934|NCT00475670|395490|P2|Overall Study|Not Specified|3
121935|NCT00475670|395491|P1|Overall Study|Not Specified|0
121936|NCT00475670|395490|P2|Overall Study|Failure to Return|1
121937|NCT00475670|395491|P1|Overall Study|Failure to Return|0
121938|NCT00475670|395490|P2|Overall Study|Refused treatment|2
121939|NCT00475670|395491|P1|Overall Study|Refused treatment|0
121940|NCT00475670|395490|P2|Overall Study|Lack of Efficacy|34
121941|NCT00475670|395491|P1|Overall Study|Lack of Efficacy|3
121942|NCT00475670|395490|P2|Overall Study|Death|1
121943|NCT00475670|395491|P1|Overall Study|Death|0
121944|NCT00475709|395515|P1|Overall Study|Lost to Follow-up|21
121945|NCT00475709|395515|P1|Overall Study|Device Explant|6
121946|NCT00475709|395515|P1|Overall Study|Death|41
121947|NCT00475709|395515|P1|Overall Study|Did not meet eligibility criteria|8
121948|NCT00475722|395523|P2|Overall Study|Protocol Violation|0
121949|NCT00475722|395524|P1|Overall Study|Protocol Violation|3
121950|NCT00475722|395523|P2|Overall Study|Withdrawal by Subject|12
121951|NCT00475722|395524|P1|Overall Study|Withdrawal by Subject|12
121952|NCT00475735|395536|P6|Treatment Period 2|Withdrawal by Subject|0
121953|NCT00475735|395537|P5|Treatment Period 2|Withdrawal by Subject|1
121954|NCT00475735|395538|P4|Treatment Period 2|Withdrawal by Subject|0
121955|NCT00475735|395539|P3|Treatment Period 2|Withdrawal by Subject|0
121956|NCT00475735|395540|P2|Treatment Period 2|Withdrawal by Subject|0
121957|NCT00475735|395541|P1|Treatment Period 2|Withdrawal by Subject|0
121958|NCT00475735|395536|P6|Treatment Period 2|Lack of Efficacy|1
121959|NCT00475735|395537|P5|Treatment Period 2|Lack of Efficacy|0
121960|NCT00475735|395538|P4|Treatment Period 2|Lack of Efficacy|0
121961|NCT00475735|395539|P3|Treatment Period 2|Lack of Efficacy|0
121962|NCT00475735|395540|P2|Treatment Period 2|Lack of Efficacy|0
121963|NCT00475735|395541|P1|Treatment Period 2|Lack of Efficacy|0
121964|NCT00475735|395536|P6|Treatment Period 2|Adverse Event|0
121965|NCT00475735|395537|P5|Treatment Period 2|Adverse Event|0
121966|NCT00475735|395538|P4|Treatment Period 2|Adverse Event|2
121967|NCT00475735|395539|P3|Treatment Period 2|Adverse Event|0
121968|NCT00475735|395540|P2|Treatment Period 2|Adverse Event|1
121969|NCT00475735|395541|P1|Treatment Period 2|Adverse Event|0
121970|NCT00475735|395536|P6|Treatment Washout|Protocol Violation|0
121971|NCT00475735|395537|P5|Treatment Washout|Protocol Violation|0
121972|NCT00475735|395538|P4|Treatment Washout|Protocol Violation|0
121973|NCT00475735|395539|P3|Treatment Washout|Protocol Violation|0
121974|NCT00475735|395540|P2|Treatment Washout|Protocol Violation|1
121975|NCT00475735|395541|P1|Treatment Washout|Protocol Violation|0
121976|NCT00475735|395536|P6|Treatment Washout|Lost to Follow-up|0
121977|NCT00475735|395537|P5|Treatment Washout|Lost to Follow-up|0
121978|NCT00475735|395538|P4|Treatment Washout|Lost to Follow-up|0
121979|NCT00475735|395539|P3|Treatment Washout|Lost to Follow-up|0
121980|NCT00475735|395540|P2|Treatment Washout|Lost to Follow-up|1
121981|NCT00475735|395541|P1|Treatment Washout|Lost to Follow-up|0
121982|NCT00475735|395536|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
121983|NCT00475735|395537|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
121984|NCT00475735|395538|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
121985|NCT00475735|395539|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
121986|NCT00475735|395540|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
121987|NCT00475735|395541|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
121988|NCT00475735|395536|P6|Treatment Period 1|DC due to AE but continuing|2
121989|NCT00475735|395537|P5|Treatment Period 1|DC due to AE but continuing|2
121990|NCT00475735|395538|P4|Treatment Period 1|DC due to AE but continuing|1
121991|NCT00475735|395539|P3|Treatment Period 1|DC due to AE but continuing|0
121992|NCT00475735|395540|P2|Treatment Period 1|DC due to AE but continuing|0
121993|NCT00475735|395541|P1|Treatment Period 1|DC due to AE but continuing|0
121994|NCT00475735|395536|P6|Treatment Period 1|Withdrawal by Subject|0
121995|NCT00475735|395537|P5|Treatment Period 1|Withdrawal by Subject|0
121996|NCT00475735|395538|P4|Treatment Period 1|Withdrawal by Subject|0
121997|NCT00475735|395539|P3|Treatment Period 1|Withdrawal by Subject|0
121998|NCT00475735|395540|P2|Treatment Period 1|Withdrawal by Subject|1
121999|NCT00475735|395541|P1|Treatment Period 1|Withdrawal by Subject|1
122000|NCT00475735|395536|P6|Treatment Period 1|Protocol Violation|0
122001|NCT00475735|395537|P5|Treatment Period 1|Protocol Violation|0
122002|NCT00475735|395538|P4|Treatment Period 1|Protocol Violation|1
122003|NCT00475735|395539|P3|Treatment Period 1|Protocol Violation|0
122004|NCT00475735|395540|P2|Treatment Period 1|Protocol Violation|0
122005|NCT00475735|395541|P1|Treatment Period 1|Protocol Violation|0
122006|NCT00475735|395536|P6|Treatment Period 1|Lost to Follow-up|1
122007|NCT00475735|395537|P5|Treatment Period 1|Lost to Follow-up|0
122008|NCT00475735|395538|P4|Treatment Period 1|Lost to Follow-up|0
122009|NCT00475735|395539|P3|Treatment Period 1|Lost to Follow-up|0
122010|NCT00475735|395540|P2|Treatment Period 1|Lost to Follow-up|0
122011|NCT00475735|395541|P1|Treatment Period 1|Lost to Follow-up|0
122012|NCT00475735|395536|P6|Treatment Period 1|Lack of Efficacy|0
122013|NCT00475735|395537|P5|Treatment Period 1|Lack of Efficacy|0
122014|NCT00475735|395538|P4|Treatment Period 1|Lack of Efficacy|0
122015|NCT00475735|395539|P3|Treatment Period 1|Lack of Efficacy|0
122016|NCT00475735|395540|P2|Treatment Period 1|Lack of Efficacy|0
122017|NCT00475735|395541|P1|Treatment Period 1|Lack of Efficacy|1
122018|NCT00475735|395536|P6|Treatment Period 1|Adverse Event|0
122019|NCT00475735|395537|P5|Treatment Period 1|Adverse Event|0
122020|NCT00475735|395538|P4|Treatment Period 1|Adverse Event|0
122021|NCT00475735|395539|P3|Treatment Period 1|Adverse Event|0
122022|NCT00475735|395540|P2|Treatment Period 1|Adverse Event|0
122023|NCT00475735|395541|P1|Treatment Period 1|Adverse Event|2
122024|NCT00475852|395571|P2|Overall Study|Lost to Follow-up|68
122025|NCT00475852|395572|P1|Overall Study|Lost to Follow-up|54
122026|NCT00475852|395571|P2|Overall Study|Withdrawal by Subject|24
122027|NCT00475852|395572|P1|Overall Study|Withdrawal by Subject|19
122028|NCT00475852|395571|P2|Overall Study|Death|456
122029|NCT00475852|395572|P1|Overall Study|Death|444
122030|NCT00475865|395603|P3|Overall Study|Other than above|0
122031|NCT00475865|395604|P2|Overall Study|Other than above|1
122032|NCT00475865|395605|P1|Overall Study|Other than above|0
122033|NCT00475865|395603|P3|Overall Study|Participant did not wish to continue|0
122034|NCT00475865|395604|P2|Overall Study|Participant did not wish to continue|0
122035|NCT00475865|395605|P1|Overall Study|Participant did not wish to continue|1
122036|NCT00475865|395603|P3|Overall Study|Progressive disease|2
122037|NCT00475865|395604|P2|Overall Study|Progressive disease|1
122038|NCT00475865|395605|P1|Overall Study|Progressive disease|0
122039|NCT00475865|395603|P3|Overall Study|Lack of Efficacy|0
122040|NCT00475865|395604|P2|Overall Study|Lack of Efficacy|0
122041|NCT00475865|395605|P1|Overall Study|Lack of Efficacy|1
122042|NCT00475865|395603|P3|Overall Study|Adverse Event|4
122043|NCT00475865|395604|P2|Overall Study|Adverse Event|3
122044|NCT00475865|395605|P1|Overall Study|Adverse Event|0
122045|NCT00464737|395667|P3|Overall Study|Other: Subject's disability per sponsor|1
122046|NCT00464737|395668|P2|Overall Study|Other: Subject's disability per sponsor|0
122047|NCT00464737|395669|P1|Overall Study|Other: Subject's disability per sponsor|0
122048|NCT00464737|395667|P3|Overall Study|Other: Personal family reasons|1
122049|NCT00464737|395668|P2|Overall Study|Other: Personal family reasons|0
122050|NCT00464737|395669|P1|Overall Study|Other: Personal family reasons|0
122051|NCT00464737|395667|P3|Overall Study|Other: Study demands too great|0
122052|NCT00464737|395668|P2|Overall Study|Other: Study demands too great|1
122053|NCT00464737|395669|P1|Overall Study|Other: Study demands too great|0
122054|NCT00464737|395667|P3|Overall Study|Other: Subject left town; family illness|0
122055|NCT00464737|395668|P2|Overall Study|Other: Subject left town; family illness|0
122056|NCT00464737|395669|P1|Overall Study|Other: Subject left town; family illness|1
122057|NCT00464737|395667|P3|Overall Study|Other: Subject's schedule doesn't permit|0
122058|NCT00464737|395668|P2|Overall Study|Other: Subject's schedule doesn't permit|0
122059|NCT00464737|395669|P1|Overall Study|Other: Subject's schedule doesn't permit|1
122060|NCT00464737|395667|P3|Overall Study|Lost to Follow-up|5
122061|NCT00464737|395668|P2|Overall Study|Lost to Follow-up|2
122062|NCT00464737|395669|P1|Overall Study|Lost to Follow-up|5
122063|NCT00464737|395667|P3|Overall Study|Non-compliance|1
122064|NCT00464737|395668|P2|Overall Study|Non-compliance|1
122065|NCT00464737|395669|P1|Overall Study|Non-compliance|0
122066|NCT00464737|395667|P3|Overall Study|Protocol Violation|5
122067|NCT00464737|395668|P2|Overall Study|Protocol Violation|1
122068|NCT00464737|395669|P1|Overall Study|Protocol Violation|1
122069|NCT00464737|395667|P3|Overall Study|Withdrawal by Subject|5
122070|NCT00464737|395668|P2|Overall Study|Withdrawal by Subject|3
122071|NCT00464737|395669|P1|Overall Study|Withdrawal by Subject|5
122072|NCT00464737|395667|P3|Overall Study|Lack of Efficacy|4
122073|NCT00464737|395668|P2|Overall Study|Lack of Efficacy|7
122074|NCT00464737|395669|P1|Overall Study|Lack of Efficacy|7
122075|NCT00464737|395667|P3|Overall Study|Adverse Event|33
122076|NCT00464737|395668|P2|Overall Study|Adverse Event|17
122077|NCT00464737|395669|P1|Overall Study|Adverse Event|12
122078|NCT00464945|395718|P2|Toddler Dose|Lost to Follow-up|1
122079|NCT00464945|395719|P1|Toddler Dose|Lost to Follow-up|0
122080|NCT00464945|395718|P2|After Infant Series|Withdrawal by Subject|2
122081|NCT00464945|395719|P1|After Infant Series|Withdrawal by Subject|0
122082|NCT00464945|395718|P2|Infant Series|Lost to Follow-up|0
122083|NCT00464945|395719|P1|Infant Series|Lost to Follow-up|1
122084|NCT00464945|395718|P2|Infant Series|Protocol Violation|0
122085|NCT00464945|395719|P1|Infant Series|Protocol Violation|1
122086|NCT00464945|395718|P2|Infant Series|Withdrawal by parent/guardian request|1
122087|NCT00464945|395719|P1|Infant Series|Withdrawal by parent/guardian request|2
122088|NCT00465101|395782|P1|Overall Study|Withdrew consent prior to procedure|3
122089|NCT00465101|395782|P1|Overall Study|Physician Decision|1
122090|NCT00465101|395782|P1|Overall Study|Withdrawal by Subject|25
122091|NCT00465101|395782|P1|Overall Study|Death|3
122092|NCT00465101|395782|P1|Overall Study|Unable to obtain IRB approval|1
122093|NCT00465101|395782|P1|Overall Study|Site closed due to IRB expiration|1
122094|NCT00465101|395782|P1|Overall Study|Patient postponed procedure|1
122095|NCT00465101|395782|P1|Overall Study|Pt. Insurance not accepted at center|2
122096|NCT00465101|395782|P1|Overall Study|Other|6
122097|NCT00465101|395782|P1|Overall Study|Lost to Follow-up|5
122098|NCT00465101|395782|P1|Overall Study|Did not meet study criteria|4
122099|NCT00465101|395782|P1|Overall Study|Change in health precluded follow up|4
122100|NCT00465101|395782|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
122101|NCT00465179|395815|P1|Overall Study|Progression of Disease|47
122102|NCT00465179|395815|P1|Overall Study|Withdrawal by Subject|2
122103|NCT00465179|395815|P1|Overall Study|Adverse Event|4
122104|NCT00466505|395821|P1|Overall Study|Adverse Event|4
122105|NCT00466505|395821|P1|Overall Study|disease progression|13
122106|NCT00466687|395833|P1|Overall Study|Disease progression|29
122107|NCT00466687|395833|P1|Overall Study|Withdrawal by Subject|1
122108|NCT00466687|395833|P1|Overall Study|Other complicating illness|3
122109|NCT00466687|395833|P1|Overall Study|Adverse Event|1
122110|NCT00466947|395902|P2|Study End Analysis Period|Other – Unconformity in team’s treatment|1
122111|NCT00466947|395903|P1|Study End Analysis Period|Other – Unconformity in team’s treatment|0
122112|NCT00466947|395902|P2|Study End Analysis Period|Other – Subject without a legal guardian|0
122113|NCT00466947|395903|P1|Study End Analysis Period|Other – Subject without a legal guardian|1
122114|NCT00466947|395902|P2|Study End Analysis Period|Other – Forbidden vaccination|10
122115|NCT00466947|395903|P1|Study End Analysis Period|Other – Forbidden vaccination|21
122116|NCT00466947|395902|P2|Study End Analysis Period|Withdrawal by Subject|1267
122289|NCT00467779|396484|P1|Stage 3|Adverse Event|0
122117|NCT00466947|395903|P1|Study End Analysis Period|Withdrawal by Subject|1264
122118|NCT00466947|395902|P2|Study End Analysis Period|Protocol Violation|17
122119|NCT00466947|395903|P1|Study End Analysis Period|Protocol Violation|9
122120|NCT00466947|395902|P2|Study End Analysis Period|Physician Decision|29
122121|NCT00466947|395903|P1|Study End Analysis Period|Physician Decision|29
122122|NCT00466947|395902|P2|Study End Analysis Period|Lost to Follow-up|1167
122123|NCT00466947|395903|P1|Study End Analysis Period|Lost to Follow-up|1137
122124|NCT00466947|395902|P2|Study End Analysis Period|Adverse Event|43
122125|NCT00466947|395903|P1|Study End Analysis Period|Adverse Event|35
122126|NCT00466947|395902|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
122127|NCT00466947|395903|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
122128|NCT00467051|396045|P1|Overall Study|Adverse Event|2
122129|NCT00467259|396058|P2|Overall Study|Site Closed|1
122130|NCT00467259|396059|P1|Overall Study|Site Closed|2
122131|NCT00467259|396058|P2|Overall Study|Lost to Follow-up|34
122132|NCT00467259|396059|P1|Overall Study|Lost to Follow-up|14
122133|NCT00467259|396058|P2|Overall Study|Physician Decision|2
122134|NCT00467259|396059|P1|Overall Study|Physician Decision|0
122135|NCT00467259|396058|P2|Overall Study|Withdrawal by Subject|108
122136|NCT00467259|396059|P1|Overall Study|Withdrawal by Subject|34
122137|NCT00467259|396058|P2|Overall Study|Protocol Violation|7
122138|NCT00467259|396059|P1|Overall Study|Protocol Violation|1
122139|NCT00467259|396058|P2|Overall Study|Adverse Event|90
122140|NCT00467259|396059|P1|Overall Study|Adverse Event|24
122141|NCT00467285|396071|P2|Overall Study|Lost to Follow-up|4
122142|NCT00467285|396072|P1|Overall Study|Lost to Follow-up|4
122143|NCT00467363|396092|P2|Overall Study|Lost to Follow-up|70
122144|NCT00467363|396093|P1|Overall Study|Lost to Follow-up|80
122145|NCT00467519|396140|P2|Overall Study|Withdrawal by Subject|10
122146|NCT00467519|396141|P1|Overall Study|Withdrawal by Subject|4
122147|NCT00467519|396140|P2|Overall Study|Lost to Follow-up|9
122148|NCT00467519|396141|P1|Overall Study|Lost to Follow-up|2
122149|NCT00467519|396140|P2|Overall Study|Protocol Violation|4
122150|NCT00467519|396141|P1|Overall Study|Protocol Violation|8
122151|NCT00467558|396159|P2|Overall Study|Lost to Follow-up|0
122152|NCT00467558|396160|P1|Overall Study|Lost to Follow-up|2
122153|NCT00467584|396171|P3|Overall Study|Withdrawal by Subject|1
122154|NCT00467584|396172|P2|Overall Study|Withdrawal by Subject|5
122155|NCT00467584|396173|P1|Overall Study|Withdrawal by Subject|4
122156|NCT00467597|396185|P2|Overall Study|Withdrawal by Subject|0
122157|NCT00467597|396186|P1|Overall Study|Withdrawal by Subject|2
122158|NCT00467610|396196|P1|Overall Study|Withdrawal by Subject|1
122159|NCT00467649|396205|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
122160|NCT00467649|396206|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
122161|NCT00467649|396207|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
122162|NCT00467649|396208|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
122163|NCT00467649|396209|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
122164|NCT00467649|396210|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
122165|NCT00467649|396205|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
122166|NCT00467649|396206|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
122167|NCT00467649|396207|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
122168|NCT00467649|396208|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
122169|NCT00467649|396209|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
122170|NCT00467649|396210|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
122171|NCT00467649|396205|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
122172|NCT00467649|396206|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
122173|NCT00467649|396207|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
122174|NCT00467649|396208|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
122175|NCT00467649|396209|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
122176|NCT00467649|396210|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
122177|NCT00467649|396205|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
122178|NCT00467649|396206|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
122179|NCT00467649|396207|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
122180|NCT00467649|396208|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
122181|NCT00467649|396209|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
122182|NCT00467649|396210|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
122183|NCT00467649|396205|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
122184|NCT00467649|396206|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
122185|NCT00467649|396207|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
122186|NCT00467649|396208|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
122187|NCT00467649|396209|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
122188|NCT00467649|396210|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
122189|NCT00467649|396205|P6|Phase 1 (Randomized Population)|Investigator Decision|0
122190|NCT00467649|396206|P5|Phase 1 (Randomized Population)|Investigator Decision|0
122191|NCT00467649|396207|P4|Phase 1 (Randomized Population)|Investigator Decision|0
122192|NCT00467649|396208|P3|Phase 1 (Randomized Population)|Investigator Decision|0
122193|NCT00467649|396209|P2|Phase 1 (Randomized Population)|Investigator Decision|0
122194|NCT00467649|396210|P1|Phase 1 (Randomized Population)|Investigator Decision|1
122195|NCT00467649|396205|P6|Phase 1 (Randomized Population)|Adverse Event|0
122196|NCT00467649|396206|P5|Phase 1 (Randomized Population)|Adverse Event|0
122197|NCT00467649|396207|P4|Phase 1 (Randomized Population)|Adverse Event|0
122198|NCT00467649|396208|P3|Phase 1 (Randomized Population)|Adverse Event|0
122199|NCT00467649|396209|P2|Phase 1 (Randomized Population)|Adverse Event|0
122200|NCT00467649|396210|P1|Phase 1 (Randomized Population)|Adverse Event|2
122201|NCT00467740|396255|P5|Overall Study|Lack of Efficacy|0
122202|NCT00467740|396256|P4|Overall Study|Lack of Efficacy|0
122203|NCT00467740|396257|P3|Overall Study|Lack of Efficacy|0
122204|NCT00467740|396258|P2|Overall Study|Lack of Efficacy|1
122205|NCT00467740|396259|P1|Overall Study|Lack of Efficacy|0
122206|NCT00467740|396255|P5|Overall Study|Withdrawal by Subject|0
122207|NCT00467740|396256|P4|Overall Study|Withdrawal by Subject|1
122208|NCT00467740|396257|P3|Overall Study|Withdrawal by Subject|0
122209|NCT00467740|396258|P2|Overall Study|Withdrawal by Subject|1
122210|NCT00467740|396259|P1|Overall Study|Withdrawal by Subject|1
122211|NCT00467740|396255|P5|Overall Study|Lost to Follow-up|0
122212|NCT00467740|396256|P4|Overall Study|Lost to Follow-up|0
122213|NCT00467740|396257|P3|Overall Study|Lost to Follow-up|0
122214|NCT00467740|396258|P2|Overall Study|Lost to Follow-up|1
122215|NCT00467740|396259|P1|Overall Study|Lost to Follow-up|0
122216|NCT00467740|396255|P5|Overall Study|Protocol Violation|0
122217|NCT00467740|396256|P4|Overall Study|Protocol Violation|0
122218|NCT00467740|396257|P3|Overall Study|Protocol Violation|1
122219|NCT00467740|396258|P2|Overall Study|Protocol Violation|0
122220|NCT00467740|396259|P1|Overall Study|Protocol Violation|0
122221|NCT00467740|396255|P5|Overall Study|Adverse Event|0
122222|NCT00467740|396256|P4|Overall Study|Adverse Event|0
122223|NCT00467740|396257|P3|Overall Study|Adverse Event|1
122224|NCT00467740|396258|P2|Overall Study|Adverse Event|0
122225|NCT00467740|396259|P1|Overall Study|Adverse Event|0
122226|NCT00467753|396448|P2|Overall Study|Adverse Event|0
122227|NCT00467753|396449|P1|Overall Study|Adverse Event|2
122228|NCT00467753|396448|P2|Overall Study|Lost to Follow-up|2
122229|NCT00467753|396449|P1|Overall Study|Lost to Follow-up|1
122230|NCT00467779|396470|P15|Stage 3|Unspecified Reason|5
122231|NCT00467779|396471|P14|Stage 3|Unspecified Reason|0
122232|NCT00467779|396472|P13|Stage 3|Unspecified Reason|0
122233|NCT00467779|396473|P12|Stage 3|Unspecified Reason|0
122234|NCT00467779|396474|P11|Stage 3|Unspecified Reason|0
122235|NCT00467779|396475|P10|Stage 3|Unspecified Reason|0
122236|NCT00467779|396476|P9|Stage 3|Unspecified Reason|0
122237|NCT00467779|396477|P8|Stage 3|Unspecified Reason|0
122238|NCT00467779|396478|P7|Stage 3|Unspecified Reason|0
122239|NCT00467779|396479|P6|Stage 3|Unspecified Reason|0
122240|NCT00467779|396480|P5|Stage 3|Unspecified Reason|0
122241|NCT00467779|396481|P4|Stage 3|Unspecified Reason|0
122242|NCT00467779|396482|P3|Stage 3|Unspecified Reason|0
122243|NCT00467779|396483|P2|Stage 3|Unspecified Reason|0
122244|NCT00467779|396484|P1|Stage 3|Unspecified Reason|0
122245|NCT00467779|396470|P15|Stage 3|Disease Progression|9
122246|NCT00467779|396471|P14|Stage 3|Disease Progression|0
122247|NCT00467779|396472|P13|Stage 3|Disease Progression|0
122248|NCT00467779|396473|P12|Stage 3|Disease Progression|0
122249|NCT00467779|396474|P11|Stage 3|Disease Progression|0
122250|NCT00467779|396475|P10|Stage 3|Disease Progression|0
122251|NCT00467779|396476|P9|Stage 3|Disease Progression|0
122252|NCT00467779|396477|P8|Stage 3|Disease Progression|0
122253|NCT00467779|396478|P7|Stage 3|Disease Progression|0
122254|NCT00467779|396479|P6|Stage 3|Disease Progression|0
122255|NCT00467779|396480|P5|Stage 3|Disease Progression|0
122256|NCT00467779|396481|P4|Stage 3|Disease Progression|0
122257|NCT00467779|396482|P3|Stage 3|Disease Progression|0
122258|NCT00467779|396483|P2|Stage 3|Disease Progression|0
122259|NCT00467779|396484|P1|Stage 3|Disease Progression|0
122260|NCT00467779|396470|P15|Stage 3|Death|1
122261|NCT00467779|396471|P14|Stage 3|Death|0
122262|NCT00467779|396472|P13|Stage 3|Death|0
122263|NCT00467779|396473|P12|Stage 3|Death|0
122264|NCT00467779|396474|P11|Stage 3|Death|0
122265|NCT00467779|396475|P10|Stage 3|Death|0
122266|NCT00467779|396476|P9|Stage 3|Death|0
122267|NCT00467779|396477|P8|Stage 3|Death|0
122268|NCT00467779|396478|P7|Stage 3|Death|0
122269|NCT00467779|396479|P6|Stage 3|Death|0
122270|NCT00467779|396480|P5|Stage 3|Death|0
122271|NCT00467779|396481|P4|Stage 3|Death|0
122272|NCT00467779|396482|P3|Stage 3|Death|0
122273|NCT00467779|396483|P2|Stage 3|Death|0
122274|NCT00467779|396484|P1|Stage 3|Death|0
122275|NCT00467779|396470|P15|Stage 3|Adverse Event|2
122276|NCT00467779|396471|P14|Stage 3|Adverse Event|0
122277|NCT00467779|396472|P13|Stage 3|Adverse Event|0
122278|NCT00467779|396473|P12|Stage 3|Adverse Event|0
122279|NCT00467779|396474|P11|Stage 3|Adverse Event|0
122280|NCT00467779|396475|P10|Stage 3|Adverse Event|0
122281|NCT00467779|396476|P9|Stage 3|Adverse Event|0
122282|NCT00467779|396477|P8|Stage 3|Adverse Event|0
122283|NCT00467779|396478|P7|Stage 3|Adverse Event|0
122284|NCT00467779|396479|P6|Stage 3|Adverse Event|0
122285|NCT00467779|396480|P5|Stage 3|Adverse Event|0
122286|NCT00467779|396481|P4|Stage 3|Adverse Event|0
122287|NCT00467779|396482|P3|Stage 3|Adverse Event|0
122288|NCT00467779|396483|P2|Stage 3|Adverse Event|0
122290|NCT00467779|396470|P15|Stage 2A|Withdrawal by Subject|0
122291|NCT00467779|396471|P14|Stage 2A|Withdrawal by Subject|1
122292|NCT00467779|396472|P13|Stage 2A|Withdrawal by Subject|0
122293|NCT00467779|396473|P12|Stage 2A|Withdrawal by Subject|0
122294|NCT00467779|396474|P11|Stage 2A|Withdrawal by Subject|0
122295|NCT00467779|396475|P10|Stage 2A|Withdrawal by Subject|0
122296|NCT00467779|396476|P9|Stage 2A|Withdrawal by Subject|0
122297|NCT00467779|396477|P8|Stage 2A|Withdrawal by Subject|0
122298|NCT00467779|396478|P7|Stage 2A|Withdrawal by Subject|0
122299|NCT00467779|396479|P6|Stage 2A|Withdrawal by Subject|0
122300|NCT00467779|396480|P5|Stage 2A|Withdrawal by Subject|0
122301|NCT00467779|396481|P4|Stage 2A|Withdrawal by Subject|0
122302|NCT00467779|396482|P3|Stage 2A|Withdrawal by Subject|0
122303|NCT00467779|396483|P2|Stage 2A|Withdrawal by Subject|0
122304|NCT00467779|396484|P1|Stage 2A|Withdrawal by Subject|0
122305|NCT00467779|396470|P15|Stage 2A|Unspecified Reason|0
122306|NCT00467779|396471|P14|Stage 2A|Unspecified Reason|7
122307|NCT00467779|396472|P13|Stage 2A|Unspecified Reason|0
122308|NCT00467779|396473|P12|Stage 2A|Unspecified Reason|0
122309|NCT00467779|396474|P11|Stage 2A|Unspecified Reason|0
122310|NCT00467779|396475|P10|Stage 2A|Unspecified Reason|0
122311|NCT00467779|396476|P9|Stage 2A|Unspecified Reason|0
122312|NCT00467779|396477|P8|Stage 2A|Unspecified Reason|0
122313|NCT00467779|396478|P7|Stage 2A|Unspecified Reason|0
122314|NCT00467779|396479|P6|Stage 2A|Unspecified Reason|0
122315|NCT00467779|396480|P5|Stage 2A|Unspecified Reason|0
122316|NCT00467779|396481|P4|Stage 2A|Unspecified Reason|0
122317|NCT00467779|396482|P3|Stage 2A|Unspecified Reason|0
122318|NCT00467779|396483|P2|Stage 2A|Unspecified Reason|0
122319|NCT00467779|396484|P1|Stage 2A|Unspecified Reason|0
122320|NCT00467779|396470|P15|Stage 2A|Disease Progression|0
122321|NCT00467779|396471|P14|Stage 2A|Disease Progression|10
122322|NCT00467779|396472|P13|Stage 2A|Disease Progression|0
122323|NCT00467779|396473|P12|Stage 2A|Disease Progression|0
122324|NCT00467779|396474|P11|Stage 2A|Disease Progression|0
122325|NCT00467779|396475|P10|Stage 2A|Disease Progression|0
122326|NCT00467779|396476|P9|Stage 2A|Disease Progression|0
122327|NCT00467779|396477|P8|Stage 2A|Disease Progression|0
122328|NCT00467779|396478|P7|Stage 2A|Disease Progression|0
122329|NCT00467779|396479|P6|Stage 2A|Disease Progression|0
122330|NCT00467779|396480|P5|Stage 2A|Disease Progression|0
122331|NCT00467779|396481|P4|Stage 2A|Disease Progression|0
122332|NCT00467779|396482|P3|Stage 2A|Disease Progression|0
122333|NCT00467779|396483|P2|Stage 2A|Disease Progression|0
122334|NCT00467779|396484|P1|Stage 2A|Disease Progression|0
122335|NCT00467779|396470|P15|Stage 2A|Death|0
122336|NCT00467779|396471|P14|Stage 2A|Death|1
122337|NCT00467779|396472|P13|Stage 2A|Death|0
122338|NCT00467779|396473|P12|Stage 2A|Death|0
122339|NCT00467779|396474|P11|Stage 2A|Death|0
122340|NCT00467779|396475|P10|Stage 2A|Death|0
122341|NCT00467779|396476|P9|Stage 2A|Death|0
122342|NCT00467779|396477|P8|Stage 2A|Death|0
122343|NCT00467779|396478|P7|Stage 2A|Death|0
122344|NCT00467779|396479|P6|Stage 2A|Death|0
122345|NCT00467779|396480|P5|Stage 2A|Death|0
122346|NCT00467779|396481|P4|Stage 2A|Death|0
122347|NCT00467779|396482|P3|Stage 2A|Death|0
122348|NCT00467779|396483|P2|Stage 2A|Death|0
122349|NCT00467779|396484|P1|Stage 2A|Death|0
122350|NCT00467779|396470|P15|Stage 2A|Adverse Event|0
122351|NCT00467779|396471|P14|Stage 2A|Adverse Event|2
122352|NCT00467779|396472|P13|Stage 2A|Adverse Event|0
122353|NCT00467779|396473|P12|Stage 2A|Adverse Event|0
122354|NCT00467779|396474|P11|Stage 2A|Adverse Event|0
122355|NCT00467779|396475|P10|Stage 2A|Adverse Event|0
122356|NCT00467779|396476|P9|Stage 2A|Adverse Event|0
122357|NCT00467779|396477|P8|Stage 2A|Adverse Event|0
122358|NCT00467779|396478|P7|Stage 2A|Adverse Event|0
122359|NCT00467779|396479|P6|Stage 2A|Adverse Event|0
122360|NCT00467779|396480|P5|Stage 2A|Adverse Event|0
122361|NCT00467779|396481|P4|Stage 2A|Adverse Event|0
122362|NCT00467779|396482|P3|Stage 2A|Adverse Event|0
122363|NCT00467779|396483|P2|Stage 2A|Adverse Event|0
122364|NCT00467779|396484|P1|Stage 2A|Adverse Event|0
122365|NCT00467779|396470|P15|Stage 2|Unspecified Reason|0
122366|NCT00467779|396471|P14|Stage 2|Unspecified Reason|0
122367|NCT00467779|396472|P13|Stage 2|Unspecified Reason|0
122368|NCT00467779|396473|P12|Stage 2|Unspecified Reason|0
122369|NCT00467779|396474|P11|Stage 2|Unspecified Reason|0
122370|NCT00467779|396475|P10|Stage 2|Unspecified Reason|0
122371|NCT00467779|396476|P9|Stage 2|Unspecified Reason|3
122372|NCT00467779|396477|P8|Stage 2|Unspecified Reason|0
122373|NCT00467779|396478|P7|Stage 2|Unspecified Reason|0
122374|NCT00467779|396479|P6|Stage 2|Unspecified Reason|0
122375|NCT00467779|396480|P5|Stage 2|Unspecified Reason|0
122376|NCT00467779|396481|P4|Stage 2|Unspecified Reason|0
122377|NCT00467779|396482|P3|Stage 2|Unspecified Reason|0
122378|NCT00467779|396483|P2|Stage 2|Unspecified Reason|0
122379|NCT00467779|396484|P1|Stage 2|Unspecified Reason|0
122380|NCT00467779|396470|P15|Stage 2|Disease Progression|0
122381|NCT00467779|396471|P14|Stage 2|Disease Progression|0
122382|NCT00467779|396472|P13|Stage 2|Disease Progression|0
122383|NCT00467779|396473|P12|Stage 2|Disease Progression|0
122384|NCT00467779|396474|P11|Stage 2|Disease Progression|0
122385|NCT00467779|396475|P10|Stage 2|Disease Progression|0
122386|NCT00467779|396476|P9|Stage 2|Disease Progression|16
122387|NCT00467779|396477|P8|Stage 2|Disease Progression|0
122388|NCT00467779|396478|P7|Stage 2|Disease Progression|0
122389|NCT00467779|396479|P6|Stage 2|Disease Progression|0
122390|NCT00467779|396480|P5|Stage 2|Disease Progression|0
122391|NCT00467779|396481|P4|Stage 2|Disease Progression|0
122392|NCT00467779|396482|P3|Stage 2|Disease Progression|0
122393|NCT00467779|396483|P2|Stage 2|Disease Progression|0
122394|NCT00467779|396484|P1|Stage 2|Disease Progression|0
122395|NCT00467779|396470|P15|Stage 2|Death|0
122396|NCT00467779|396471|P14|Stage 2|Death|0
122397|NCT00467779|396472|P13|Stage 2|Death|0
122398|NCT00467779|396473|P12|Stage 2|Death|0
122399|NCT00467779|396474|P11|Stage 2|Death|0
122400|NCT00467779|396475|P10|Stage 2|Death|0
122401|NCT00467779|396476|P9|Stage 2|Death|1
122402|NCT00467779|396477|P8|Stage 2|Death|0
122403|NCT00467779|396478|P7|Stage 2|Death|0
122404|NCT00467779|396479|P6|Stage 2|Death|0
122405|NCT00467779|396480|P5|Stage 2|Death|0
122406|NCT00467779|396481|P4|Stage 2|Death|0
122407|NCT00467779|396482|P3|Stage 2|Death|0
122408|NCT00467779|396483|P2|Stage 2|Death|0
122409|NCT00467779|396484|P1|Stage 2|Death|0
122410|NCT00467779|396470|P15|Stage 2|Adverse Event|0
122411|NCT00467779|396471|P14|Stage 2|Adverse Event|0
122412|NCT00467779|396472|P13|Stage 2|Adverse Event|0
122413|NCT00467779|396473|P12|Stage 2|Adverse Event|0
122414|NCT00467779|396474|P11|Stage 2|Adverse Event|0
122415|NCT00467779|396475|P10|Stage 2|Adverse Event|0
122416|NCT00467779|396476|P9|Stage 2|Adverse Event|1
122417|NCT00467779|396477|P8|Stage 2|Adverse Event|0
122418|NCT00467779|396478|P7|Stage 2|Adverse Event|0
122419|NCT00467779|396479|P6|Stage 2|Adverse Event|0
122420|NCT00467779|396480|P5|Stage 2|Adverse Event|0
122421|NCT00467779|396481|P4|Stage 2|Adverse Event|0
122422|NCT00467779|396482|P3|Stage 2|Adverse Event|0
122423|NCT00467779|396483|P2|Stage 2|Adverse Event|0
122424|NCT00467779|396484|P1|Stage 2|Adverse Event|0
122425|NCT00467779|396470|P15|Stage 1A|Unspecified Reason|0
122426|NCT00467779|396471|P14|Stage 1A|Unspecified Reason|0
122427|NCT00467779|396472|P13|Stage 1A|Unspecified Reason|1
122428|NCT00467779|396473|P12|Stage 1A|Unspecified Reason|1
122429|NCT00467779|396474|P11|Stage 1A|Unspecified Reason|0
122430|NCT00467779|396475|P10|Stage 1A|Unspecified Reason|0
122431|NCT00467779|396476|P9|Stage 1A|Unspecified Reason|0
122432|NCT00467779|396477|P8|Stage 1A|Unspecified Reason|0
122433|NCT00467779|396478|P7|Stage 1A|Unspecified Reason|0
122434|NCT00467779|396479|P6|Stage 1A|Unspecified Reason|0
122435|NCT00467779|396480|P5|Stage 1A|Unspecified Reason|0
122436|NCT00467779|396481|P4|Stage 1A|Unspecified Reason|0
122437|NCT00467779|396482|P3|Stage 1A|Unspecified Reason|0
122438|NCT00467779|396483|P2|Stage 1A|Unspecified Reason|0
122439|NCT00467779|396484|P1|Stage 1A|Unspecified Reason|0
122440|NCT00467779|396470|P15|Stage 1A|Withdrawal by Subject|0
122441|NCT00467779|396471|P14|Stage 1A|Withdrawal by Subject|0
122442|NCT00467779|396472|P13|Stage 1A|Withdrawal by Subject|1
122443|NCT00467779|396473|P12|Stage 1A|Withdrawal by Subject|1
122444|NCT00467779|396474|P11|Stage 1A|Withdrawal by Subject|1
122445|NCT00467779|396475|P10|Stage 1A|Withdrawal by Subject|0
122446|NCT00467779|396476|P9|Stage 1A|Withdrawal by Subject|0
122447|NCT00467779|396477|P8|Stage 1A|Withdrawal by Subject|0
122448|NCT00467779|396478|P7|Stage 1A|Withdrawal by Subject|0
122449|NCT00467779|396479|P6|Stage 1A|Withdrawal by Subject|0
122450|NCT00467779|396480|P5|Stage 1A|Withdrawal by Subject|0
122451|NCT00467779|396481|P4|Stage 1A|Withdrawal by Subject|0
122452|NCT00467779|396482|P3|Stage 1A|Withdrawal by Subject|0
122453|NCT00467779|396483|P2|Stage 1A|Withdrawal by Subject|0
122454|NCT00467779|396484|P1|Stage 1A|Withdrawal by Subject|0
122455|NCT00467779|396470|P15|Stage 1A|Physician Decision|0
122456|NCT00467779|396471|P14|Stage 1A|Physician Decision|0
122457|NCT00467779|396472|P13|Stage 1A|Physician Decision|0
122458|NCT00467779|396473|P12|Stage 1A|Physician Decision|0
122459|NCT00467779|396474|P11|Stage 1A|Physician Decision|0
122460|NCT00467779|396475|P10|Stage 1A|Physician Decision|1
122461|NCT00467779|396476|P9|Stage 1A|Physician Decision|0
122462|NCT00467779|396477|P8|Stage 1A|Physician Decision|0
122463|NCT00467779|396478|P7|Stage 1A|Physician Decision|0
122464|NCT00467779|396479|P6|Stage 1A|Physician Decision|0
122465|NCT00467779|396480|P5|Stage 1A|Physician Decision|0
122466|NCT00467779|396481|P4|Stage 1A|Physician Decision|0
122467|NCT00467779|396482|P3|Stage 1A|Physician Decision|0
122468|NCT00467779|396483|P2|Stage 1A|Physician Decision|0
122469|NCT00467779|396484|P1|Stage 1A|Physician Decision|0
122470|NCT00467779|396470|P15|Stage 1A|Disease Progression|0
122471|NCT00467779|396471|P14|Stage 1A|Disease Progression|0
122472|NCT00467779|396472|P13|Stage 1A|Disease Progression|2
122473|NCT00467779|396473|P12|Stage 1A|Disease Progression|5
122474|NCT00467779|396474|P11|Stage 1A|Disease Progression|2
122475|NCT00467779|396475|P10|Stage 1A|Disease Progression|2
122476|NCT00467779|396476|P9|Stage 1A|Disease Progression|0
122477|NCT00467779|396477|P8|Stage 1A|Disease Progression|0
122478|NCT00467779|396478|P7|Stage 1A|Disease Progression|0
122479|NCT00467779|396479|P6|Stage 1A|Disease Progression|0
122480|NCT00467779|396480|P5|Stage 1A|Disease Progression|0
122481|NCT00467779|396481|P4|Stage 1A|Disease Progression|0
122482|NCT00467779|396482|P3|Stage 1A|Disease Progression|0
122483|NCT00467779|396483|P2|Stage 1A|Disease Progression|0
122484|NCT00467779|396484|P1|Stage 1A|Disease Progression|0
122485|NCT00467779|396470|P15|Stage 1A|Death|0
122486|NCT00467779|396471|P14|Stage 1A|Death|0
122487|NCT00467779|396472|P13|Stage 1A|Death|1
122488|NCT00467779|396473|P12|Stage 1A|Death|1
122489|NCT00467779|396474|P11|Stage 1A|Death|0
122490|NCT00467779|396475|P10|Stage 1A|Death|0
122491|NCT00467779|396476|P9|Stage 1A|Death|0
122492|NCT00467779|396477|P8|Stage 1A|Death|0
122493|NCT00467779|396478|P7|Stage 1A|Death|0
122494|NCT00467779|396479|P6|Stage 1A|Death|0
122495|NCT00467779|396480|P5|Stage 1A|Death|0
122496|NCT00467779|396481|P4|Stage 1A|Death|0
122497|NCT00467779|396482|P3|Stage 1A|Death|0
122498|NCT00467779|396483|P2|Stage 1A|Death|0
122499|NCT00467779|396484|P1|Stage 1A|Death|0
122500|NCT00467779|396470|P15|Stage 1A|Adverse Event|0
122501|NCT00467779|396471|P14|Stage 1A|Adverse Event|0
122502|NCT00467779|396472|P13|Stage 1A|Adverse Event|1
122503|NCT00467779|396473|P12|Stage 1A|Adverse Event|0
122504|NCT00467779|396474|P11|Stage 1A|Adverse Event|0
122505|NCT00467779|396475|P10|Stage 1A|Adverse Event|0
122506|NCT00467779|396476|P9|Stage 1A|Adverse Event|0
122507|NCT00467779|396477|P8|Stage 1A|Adverse Event|0
122508|NCT00467779|396478|P7|Stage 1A|Adverse Event|0
122509|NCT00467779|396479|P6|Stage 1A|Adverse Event|0
122510|NCT00467779|396480|P5|Stage 1A|Adverse Event|0
122511|NCT00467779|396481|P4|Stage 1A|Adverse Event|0
122512|NCT00467779|396482|P3|Stage 1A|Adverse Event|0
122513|NCT00467779|396483|P2|Stage 1A|Adverse Event|0
122514|NCT00467779|396484|P1|Stage 1A|Adverse Event|0
122515|NCT00467779|396470|P15|Stage 1|Withdrawal by Subject|0
122516|NCT00467779|396471|P14|Stage 1|Withdrawal by Subject|0
122517|NCT00467779|396472|P13|Stage 1|Withdrawal by Subject|0
122518|NCT00467779|396473|P12|Stage 1|Withdrawal by Subject|0
122519|NCT00467779|396474|P11|Stage 1|Withdrawal by Subject|0
122520|NCT00467779|396475|P10|Stage 1|Withdrawal by Subject|0
122521|NCT00467779|396476|P9|Stage 1|Withdrawal by Subject|0
122522|NCT00467779|396477|P8|Stage 1|Withdrawal by Subject|1
122523|NCT00467779|396478|P7|Stage 1|Withdrawal by Subject|1
122524|NCT00467779|396479|P6|Stage 1|Withdrawal by Subject|0
122525|NCT00467779|396480|P5|Stage 1|Withdrawal by Subject|0
122526|NCT00467779|396481|P4|Stage 1|Withdrawal by Subject|0
122527|NCT00467779|396482|P3|Stage 1|Withdrawal by Subject|0
122528|NCT00467779|396483|P2|Stage 1|Withdrawal by Subject|0
122529|NCT00467779|396484|P1|Stage 1|Withdrawal by Subject|0
122530|NCT00467779|396470|P15|Stage 1|Physician Decision|0
122531|NCT00467779|396471|P14|Stage 1|Physician Decision|0
122532|NCT00467779|396472|P13|Stage 1|Physician Decision|0
122533|NCT00467779|396473|P12|Stage 1|Physician Decision|0
122534|NCT00467779|396474|P11|Stage 1|Physician Decision|0
122535|NCT00467779|396475|P10|Stage 1|Physician Decision|0
122536|NCT00467779|396476|P9|Stage 1|Physician Decision|0
122537|NCT00467779|396477|P8|Stage 1|Physician Decision|0
122538|NCT00467779|396478|P7|Stage 1|Physician Decision|0
122539|NCT00467779|396479|P6|Stage 1|Physician Decision|0
122540|NCT00467779|396480|P5|Stage 1|Physician Decision|0
122541|NCT00467779|396481|P4|Stage 1|Physician Decision|0
122542|NCT00467779|396482|P3|Stage 1|Physician Decision|0
122543|NCT00467779|396483|P2|Stage 1|Physician Decision|1
122544|NCT00467779|396484|P1|Stage 1|Physician Decision|0
122545|NCT00467779|396470|P15|Stage 1|Unspecified Reason|0
122546|NCT00467779|396471|P14|Stage 1|Unspecified Reason|0
122547|NCT00467779|396472|P13|Stage 1|Unspecified Reason|0
122548|NCT00467779|396473|P12|Stage 1|Unspecified Reason|0
122549|NCT00467779|396474|P11|Stage 1|Unspecified Reason|0
122550|NCT00467779|396475|P10|Stage 1|Unspecified Reason|0
122551|NCT00467779|396476|P9|Stage 1|Unspecified Reason|0
122552|NCT00467779|396477|P8|Stage 1|Unspecified Reason|0
122553|NCT00467779|396478|P7|Stage 1|Unspecified Reason|0
122554|NCT00467779|396479|P6|Stage 1|Unspecified Reason|2
122555|NCT00467779|396480|P5|Stage 1|Unspecified Reason|1
122556|NCT00467779|396481|P4|Stage 1|Unspecified Reason|0
122557|NCT00467779|396482|P3|Stage 1|Unspecified Reason|1
122558|NCT00467779|396483|P2|Stage 1|Unspecified Reason|0
122559|NCT00467779|396484|P1|Stage 1|Unspecified Reason|1
122560|NCT00467779|396470|P15|Stage 1|Disease Progression|0
122561|NCT00467779|396471|P14|Stage 1|Disease Progression|0
122562|NCT00467779|396472|P13|Stage 1|Disease Progression|0
122563|NCT00467779|396473|P12|Stage 1|Disease Progression|0
122564|NCT00467779|396474|P11|Stage 1|Disease Progression|0
122565|NCT00467779|396475|P10|Stage 1|Disease Progression|0
122566|NCT00467779|396476|P9|Stage 1|Disease Progression|0
122567|NCT00467779|396477|P8|Stage 1|Disease Progression|5
122568|NCT00467779|396478|P7|Stage 1|Disease Progression|4
122569|NCT00467779|396479|P6|Stage 1|Disease Progression|2
122570|NCT00467779|396480|P5|Stage 1|Disease Progression|2
122571|NCT00467779|396481|P4|Stage 1|Disease Progression|3
122572|NCT00467779|396482|P3|Stage 1|Disease Progression|2
122573|NCT00467779|396483|P2|Stage 1|Disease Progression|2
122574|NCT00467779|396484|P1|Stage 1|Disease Progression|2
122575|NCT00467779|396470|P15|Stage 1|Adverse Event|0
122576|NCT00467779|396471|P14|Stage 1|Adverse Event|0
122577|NCT00467779|396472|P13|Stage 1|Adverse Event|0
122578|NCT00467779|396473|P12|Stage 1|Adverse Event|0
122579|NCT00467779|396474|P11|Stage 1|Adverse Event|0
122580|NCT00467779|396475|P10|Stage 1|Adverse Event|0
122581|NCT00467779|396476|P9|Stage 1|Adverse Event|0
122582|NCT00467779|396477|P8|Stage 1|Adverse Event|1
122583|NCT00467779|396478|P7|Stage 1|Adverse Event|2
122584|NCT00467779|396479|P6|Stage 1|Adverse Event|1
122585|NCT00467779|396480|P5|Stage 1|Adverse Event|0
122586|NCT00467779|396481|P4|Stage 1|Adverse Event|0
122587|NCT00467779|396482|P3|Stage 1|Adverse Event|0
122588|NCT00467779|396483|P2|Stage 1|Adverse Event|0
122589|NCT00467779|396484|P1|Stage 1|Adverse Event|1
122590|NCT00467831|396656|P1|Overall Study|Withdrawal by Subject|1
122591|NCT00467831|396656|P1|Overall Study|Death|2
122592|NCT00467857|396678|P2|Overall Study|Discontinuation reason missing|3
122593|NCT00467857|396679|P1|Overall Study|Discontinuation reason missing|0
122594|NCT00467857|396678|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
122595|NCT00467857|396679|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
122596|NCT00467857|396678|P2|Overall Study|Emergency care required|1
122597|NCT00467857|396679|P1|Overall Study|Emergency care required|0
122598|NCT00467857|396678|P2|Overall Study|Discharged from court service|1
122599|NCT00467857|396679|P1|Overall Study|Discharged from court service|0
122600|NCT00467857|396678|P2|Overall Study|Death|1
122601|NCT00467857|396679|P1|Overall Study|Death|0
122602|NCT00467857|396678|P2|Overall Study|Withdrew consent|0
122603|NCT00467857|396679|P1|Overall Study|Withdrew consent|2
122604|NCT00467857|396678|P2|Overall Study|Adverse Event|0
122605|NCT00467857|396679|P1|Overall Study|Adverse Event|1
122606|NCT00467870|396717|P6|Overall Study|Other/Unknown|0
122607|NCT00467870|396718|P5|Overall Study|Other/Unknown|4
122608|NCT00467870|396719|P4|Overall Study|Other/Unknown|5
122609|NCT00467870|396720|P3|Overall Study|Other/Unknown|1
122610|NCT00467870|396721|P2|Overall Study|Other/Unknown|5
122611|NCT00467870|396722|P1|Overall Study|Other/Unknown|8
122612|NCT00467870|396717|P6|Overall Study|Subject Non-compliance|0
122613|NCT00467870|396718|P5|Overall Study|Subject Non-compliance|5
122614|NCT00467870|396719|P4|Overall Study|Subject Non-compliance|1
122615|NCT00467870|396720|P3|Overall Study|Subject Non-compliance|0
122616|NCT00467870|396721|P2|Overall Study|Subject Non-compliance|4
122617|NCT00467870|396722|P1|Overall Study|Subject Non-compliance|3
122618|NCT00467870|396717|P6|Overall Study|Lost to Follow-up|0
122619|NCT00467870|396718|P5|Overall Study|Lost to Follow-up|3
122620|NCT00467870|396719|P4|Overall Study|Lost to Follow-up|1
122621|NCT00467870|396720|P3|Overall Study|Lost to Follow-up|1
122622|NCT00467870|396721|P2|Overall Study|Lost to Follow-up|3
122623|NCT00467870|396722|P1|Overall Study|Lost to Follow-up|5
122624|NCT00467870|396717|P6|Overall Study|Withdrawal by Subject|1
122625|NCT00467870|396718|P5|Overall Study|Withdrawal by Subject|10
122626|NCT00467870|396719|P4|Overall Study|Withdrawal by Subject|9
122627|NCT00467870|396720|P3|Overall Study|Withdrawal by Subject|0
122628|NCT00467870|396721|P2|Overall Study|Withdrawal by Subject|21
122629|NCT00467870|396722|P1|Overall Study|Withdrawal by Subject|14
122630|NCT00467870|396717|P6|Overall Study|Protocol Violation|0
122631|NCT00467870|396718|P5|Overall Study|Protocol Violation|0
122632|NCT00467870|396719|P4|Overall Study|Protocol Violation|2
122633|NCT00467870|396720|P3|Overall Study|Protocol Violation|1
122634|NCT00467870|396721|P2|Overall Study|Protocol Violation|1
122635|NCT00467870|396722|P1|Overall Study|Protocol Violation|2
122636|NCT00467870|396717|P6|Overall Study|Adverse Event|1
122637|NCT00467870|396718|P5|Overall Study|Adverse Event|15
122638|NCT00467870|396719|P4|Overall Study|Adverse Event|15
122639|NCT00467870|396720|P3|Overall Study|Adverse Event|1
122640|NCT00467870|396721|P2|Overall Study|Adverse Event|9
122641|NCT00467870|396722|P1|Overall Study|Adverse Event|13
122642|NCT00467896|396763|P1|Overall Study|Patient had no improvement|1
122643|NCT00467896|396763|P1|Overall Study|Started inhaled Remodulin|1
122644|NCT00467896|396763|P1|Overall Study|Started intravenous prostacyclin|1
122645|NCT00467896|396763|P1|Overall Study|Mainly used Prodose not I-neb® device|1
122646|NCT00467896|396763|P1|Overall Study|Patient weaned off iloprost|1
122647|NCT00467896|396763|P1|Overall Study|Patient had atrial septostomy|1
122648|NCT00467896|396763|P1|Overall Study|Patient received transplant|2
122649|NCT00467896|396763|P1|Overall Study|Changed therapy|2
122650|NCT00467896|396763|P1|Overall Study|Non-compliance|3
122651|NCT00467896|396763|P1|Overall Study|Serious Adverse Event|13
122652|NCT00467896|396763|P1|Overall Study|Adverse Event|7
122653|NCT00467896|396763|P1|Overall Study|Consent Withdrawal|18
122654|NCT00467961|396783|P1|Overall Study|Disease Progression|2
122655|NCT00467961|396783|P1|Overall Study|Technical Failures|5
122656|NCT00468052|396789|P2|Overall Study|Protocol Violation|8
122657|NCT00468052|396790|P1|Overall Study|Protocol Violation|7
122658|NCT00468104|396808|P2|Second Intervention|discarded for malposition of chest tube|2
122659|NCT00468104|396809|P1|Second Intervention|discarded for malposition of chest tube|0
122660|NCT00468104|396808|P2|Second Intervention|Withdrawal by Subject|2
122661|NCT00468104|396809|P1|Second Intervention|Withdrawal by Subject|5
122662|NCT00468104|396808|P2|First Intervention|trapped lung|0
122663|NCT00468104|396809|P1|First Intervention|trapped lung|1
122664|NCT00468104|396808|P2|First Intervention|associated prolonged pneumothorax|0
122665|NCT00468104|396809|P1|First Intervention|associated prolonged pneumothorax|1
122666|NCT00468104|396808|P2|First Intervention|large lung mass with minimal effusion|0
122667|NCT00468104|396809|P1|First Intervention|large lung mass with minimal effusion|1
122668|NCT00468104|396808|P2|First Intervention|malposition/blocked chest tube tube|0
122669|NCT00468104|396809|P1|First Intervention|malposition/blocked chest tube tube|2
122670|NCT00468104|396808|P2|First Intervention|died within 3 weeks|0
122671|NCT00468104|396809|P1|First Intervention|died within 3 weeks|1
122672|NCT00468104|396808|P2|First Intervention|bleeding at chest tube site--first dose|0
122673|NCT00468104|396809|P1|First Intervention|bleeding at chest tube site--first dose|1
122674|NCT00468104|396808|P2|First Intervention|Protocol Violation|1
122675|NCT00468104|396809|P1|First Intervention|Protocol Violation|2
122676|NCT00468143|396824|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
122677|NCT00468143|396825|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
122678|NCT00468143|396824|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
122679|NCT00468143|396825|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
122680|NCT00468286|396849|P2|Overall Study|Physician Decision|1
122681|NCT00468286|396850|P1|Overall Study|Physician Decision|0
122682|NCT00468286|396849|P2|Overall Study|Withdrawal by Subject|3
122683|NCT00468286|396850|P1|Overall Study|Withdrawal by Subject|4
122684|NCT00468286|396849|P2|Overall Study|Protocol Violation|2
122685|NCT00468286|396850|P1|Overall Study|Protocol Violation|2
122686|NCT00468286|396849|P2|Overall Study|Adverse Event|6
122687|NCT00468286|396850|P1|Overall Study|Adverse Event|1
122688|NCT00468299|396874|P2|Overall Study|Withdrawal by Subject|1
122689|NCT00468299|396875|P1|Overall Study|Withdrawal by Subject|0
122690|NCT00468312|396885|P2|Overall Study|Did not meet protocol eligibility|1
122691|NCT00468312|396886|P1|Overall Study|Did not meet protocol eligibility|0
122692|NCT00468312|396885|P2|Overall Study|Protocol Violation|1
122693|NCT00468312|396886|P1|Overall Study|Protocol Violation|2
122694|NCT00468312|396885|P2|Overall Study|Withdrawal by Subject|1
122695|NCT00468312|396886|P1|Overall Study|Withdrawal by Subject|0
122696|NCT00468312|396885|P2|Overall Study|Lack of Efficacy|1
122697|NCT00468312|396886|P1|Overall Study|Lack of Efficacy|0
122698|NCT00468312|396885|P2|Overall Study|Adverse Event|1
122699|NCT00468312|396886|P1|Overall Study|Adverse Event|2
122700|NCT00468481|396902|P2|Overall Study|Other|0
122701|NCT00468481|396903|P1|Overall Study|Other|6
122702|NCT00468481|396902|P2|Overall Study|Non-Compliance|0
122703|NCT00468481|396903|P1|Overall Study|Non-Compliance|5
122704|NCT00468481|396902|P2|Overall Study|Moved out of area|1
122705|NCT00468481|396903|P1|Overall Study|Moved out of area|4
122706|NCT00468481|396902|P2|Overall Study|Egg Donor|0
122707|NCT00468481|396903|P1|Overall Study|Egg Donor|1
122708|NCT00468481|396902|P2|Overall Study|Prohibited Medication|1
122709|NCT00468481|396903|P1|Overall Study|Prohibited Medication|1
122710|NCT00468481|396902|P2|Overall Study|susp/diag malignant/premalignant disease|0
122711|NCT00468481|396903|P1|Overall Study|susp/diag malignant/premalignant disease|1
122712|NCT00468481|396902|P2|Overall Study|Withdrawal by Subject|3
122713|NCT00468481|396903|P1|Overall Study|Withdrawal by Subject|12
122714|NCT00468481|396902|P2|Overall Study|Protocol Violation|8
122715|NCT00468481|396903|P1|Overall Study|Protocol Violation|18
122716|NCT00468481|396902|P2|Overall Study|Pregnancy|0
122717|NCT00468481|396903|P1|Overall Study|Pregnancy|2
122718|NCT00468481|396902|P2|Overall Study|Lost to Follow-up|8
122719|NCT00468481|396903|P1|Overall Study|Lost to Follow-up|25
122720|NCT00468481|396902|P2|Overall Study|Adverse Event|3
122721|NCT00468481|396903|P1|Overall Study|Adverse Event|13
122722|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Other|14
122723|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Other|17
122724|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
122725|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
122726|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Failure to return|2
122727|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Failure to return|1
122728|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Refused treatment|7
122729|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Refused treatment|4
122730|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
122731|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
122732|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
122733|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
122734|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Death|0
122735|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Death|1
122736|NCT00468546|397003|P2|Week 24 to Week 104 Analysis|Adverse Event|5
122737|NCT00468546|397004|P1|Week 24 to Week 104 Analysis|Adverse Event|2
122738|NCT00468546|397003|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
122739|NCT00468546|397004|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
122740|NCT00468546|397003|P2|Week 24 Analysis|Went onto rescue therapy|0
122741|NCT00468546|397004|P1|Week 24 Analysis|Went onto rescue therapy|1
122742|NCT00468546|397003|P2|Week 24 Analysis|Due to clinical hold|0
122743|NCT00468546|397004|P1|Week 24 Analysis|Due to clinical hold|1
122744|NCT00468546|397003|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
122745|NCT00468546|397004|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
122746|NCT00468546|397003|P2|Week 24 Analysis|Rescue therapy|0
122747|NCT00468546|397004|P1|Week 24 Analysis|Rescue therapy|2
122748|NCT00468546|397003|P2|Week 24 Analysis|Failure to return|4
122749|NCT00468546|397004|P1|Week 24 Analysis|Failure to return|3
122750|NCT00468546|397003|P2|Week 24 Analysis|Adverse Event|8
122751|NCT00468546|397004|P1|Week 24 Analysis|Adverse Event|1
122752|NCT00468546|397003|P2|Week 24 Analysis|Refused treatment|5
122753|NCT00468546|397004|P1|Week 24 Analysis|Refused treatment|5
122754|NCT00468546|397003|P2|Week 24 Analysis|Lack of Efficacy|37
122755|NCT00468546|397004|P1|Week 24 Analysis|Lack of Efficacy|83
122756|NCT00468559|397034|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
122757|NCT00468559|397035|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
122758|NCT00468559|397036|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
122759|NCT00468559|397034|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
122760|NCT00468559|397035|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
122761|NCT00468559|397036|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
122762|NCT00468559|397034|P3|Open-label Treatment Phase|Withdrawal by Subject|0
122763|NCT00468559|397035|P2|Open-label Treatment Phase|Withdrawal by Subject|0
122764|NCT00468559|397036|P1|Open-label Treatment Phase|Withdrawal by Subject|4
122765|NCT00468559|397034|P3|Open-label Treatment Phase|Lack of Efficacy|0
122766|NCT00468559|397035|P2|Open-label Treatment Phase|Lack of Efficacy|0
122767|NCT00468559|397036|P1|Open-label Treatment Phase|Lack of Efficacy|9
122768|NCT00468559|397034|P3|Open-label Treatment Phase|Adverse Event|0
122769|NCT00468559|397035|P2|Open-label Treatment Phase|Adverse Event|0
122770|NCT00468559|397036|P1|Open-label Treatment Phase|Adverse Event|5
122771|NCT00468585|397066|P4|Overall Study|Withdrawal by Subject|1
122772|NCT00468585|397067|P3|Overall Study|Withdrawal by Subject|2
122773|NCT00468585|397068|P2|Overall Study|Withdrawal by Subject|0
122774|NCT00468585|397069|P1|Overall Study|Withdrawal by Subject|0
122775|NCT00468585|397066|P4|Overall Study|Adverse Event|0
122776|NCT00468585|397067|P3|Overall Study|Adverse Event|1
122777|NCT00468585|397068|P2|Overall Study|Adverse Event|0
122778|NCT00468585|397069|P1|Overall Study|Adverse Event|0
122779|NCT00468585|397066|P4|Overall Study|Patient found to be ineligible|0
122780|NCT00468585|397067|P3|Overall Study|Patient found to be ineligible|1
122781|NCT00468585|397068|P2|Overall Study|Patient found to be ineligible|0
122782|NCT00468585|397069|P1|Overall Study|Patient found to be ineligible|0
122783|NCT00468585|397066|P4|Overall Study|Patient not treated|0
122784|NCT00468585|397067|P3|Overall Study|Patient not treated|1
122785|NCT00468585|397068|P2|Overall Study|Patient not treated|0
122786|NCT00468585|397069|P1|Overall Study|Patient not treated|1
122787|NCT00468650|397079|P1|Overall Study|Protocol Violation|1
122788|NCT00468650|397079|P1|Overall Study|Withdrawal by Subject|2
122789|NCT00468650|397079|P1|Overall Study|Lost to Follow-up|4
122790|NCT00468676|397125|P2|Overall Study|Death|1
122791|NCT00468676|397126|P1|Overall Study|Death|2
122792|NCT00468676|397125|P2|Overall Study|Lost to Follow-up|11
122793|NCT00468676|397126|P1|Overall Study|Lost to Follow-up|14
122794|NCT00468728|397145|P2|Follow-up|mITT failure|31
122795|NCT00468728|397146|P1|Follow-up|mITT failure|34
122796|NCT00468728|397145|P2|Treatment|criteria for mITT population|11
122797|NCT00468728|397146|P1|Treatment|criteria for mITT population|4
122798|NCT00468819|397159|P3|Overall Study|Drop-outs (Treatment never received)|0
122799|NCT00468819|397160|P2|Overall Study|Drop-outs (Treatment never received)|0
122800|NCT00468819|397161|P1|Overall Study|Drop-outs (Treatment never received)|2
122801|NCT00468819|397159|P3|Overall Study|Lost to Follow-up|1
122802|NCT00468819|397160|P2|Overall Study|Lost to Follow-up|0
122803|NCT00468819|397161|P1|Overall Study|Lost to Follow-up|0
122804|NCT00468819|397159|P3|Overall Study|Withdrawal by Subject|1
122805|NCT00468819|397160|P2|Overall Study|Withdrawal by Subject|0
122806|NCT00468819|397161|P1|Overall Study|Withdrawal by Subject|4
122807|NCT00476008|397241|P2|Overall Study|Death|0
122808|NCT00476008|397242|P1|Overall Study|Death|1
122809|NCT00476008|397241|P2|Overall Study|Withdrawal by Subject|1
122810|NCT00476008|397242|P1|Overall Study|Withdrawal by Subject|0
122811|NCT00476008|397241|P2|Overall Study|Physician Decision: Medication Noncompli|1
122812|NCT00476008|397242|P1|Overall Study|Physician Decision: Medication Noncompli|2
122813|NCT00476008|397241|P2|Overall Study|Placebo concerns|2
122814|NCT00476008|397242|P1|Overall Study|Placebo concerns|2
122815|NCT00476008|397241|P2|Overall Study|Adverse Event|4
122816|NCT00476008|397242|P1|Overall Study|Adverse Event|4
122817|NCT00476086|397283|P1|Overall Study|Progressive Disease|4
122818|NCT00476086|397283|P1|Overall Study|Alternative therapy|1
122819|NCT00476151|397291|P2|Overall Study|Physician Decision|2
122820|NCT00476151|397292|P1|Overall Study|Physician Decision|0
122821|NCT00476151|397291|P2|Overall Study|Withdrawal by Subject|0
122822|NCT00476151|397292|P1|Overall Study|Withdrawal by Subject|2
122823|NCT00476151|397291|P2|Overall Study|Protocol Violation|3
122824|NCT00476151|397292|P1|Overall Study|Protocol Violation|1
122825|NCT00476151|397291|P2|Overall Study|Adverse Event|2
122826|NCT00476151|397292|P1|Overall Study|Adverse Event|0
122827|NCT00476229|397298|P1|Overall Study|Progressive shortness of breath|1
122828|NCT00476957|397356|P2|Overall Study|Lost to Follow-up|193
122829|NCT00476957|397357|P1|Overall Study|Lost to Follow-up|176
122830|NCT00477152|397365|P1|Overall Study|Adverse Event|1
122831|NCT00477152|397365|P1|Overall Study|Parent withdrew consent|2
122832|NCT00477165|397374|P2|Overall Study|Adverse Event|2
122833|NCT00477165|397375|P1|Overall Study|Adverse Event|7
122834|NCT00477269|397414|P3|Open Label Extension|Death|4
122835|NCT00477269|397415|P2|Open Label Extension|Death|0
122836|NCT00477269|397416|P1|Open Label Extension|Death|0
122837|NCT00477269|397414|P3|Open Label Extension|Adminiatrative problems|2
122838|NCT00477269|397415|P2|Open Label Extension|Adminiatrative problems|0
122839|NCT00477269|397416|P1|Open Label Extension|Adminiatrative problems|0
122840|NCT00477269|397414|P3|Open Label Extension|unsatisfactory therapeutic effects|2
122841|NCT00477269|397415|P2|Open Label Extension|unsatisfactory therapeutic effects|0
122842|NCT00477269|397416|P1|Open Label Extension|unsatisfactory therapeutic effects|0
122843|NCT00477269|397414|P3|Open Label Extension|Abnormal laboratory values|1
122844|NCT00477269|397415|P2|Open Label Extension|Abnormal laboratory values|0
122845|NCT00477269|397416|P1|Open Label Extension|Abnormal laboratory values|0
122846|NCT00477269|397414|P3|Open Label Extension|Adverse Event|4
122847|NCT00477269|397415|P2|Open Label Extension|Adverse Event|0
122848|NCT00477269|397416|P1|Open Label Extension|Adverse Event|0
122849|NCT00477269|397414|P3|Core Study|Withdrawn Consent|0
122850|NCT00477269|397415|P2|Core Study|Withdrawn Consent|1
122851|NCT00477269|397416|P1|Core Study|Withdrawn Consent|0
122852|NCT00477269|397414|P3|Core Study|Death|0
122853|NCT00477269|397415|P2|Core Study|Death|3
122854|NCT00477269|397416|P1|Core Study|Death|3
122855|NCT00477269|397414|P3|Core Study|Adverse Event|0
122856|NCT00477269|397415|P2|Core Study|Adverse Event|4
122857|NCT00477269|397416|P1|Core Study|Adverse Event|6
122858|NCT00477295|397470|P2|Overall Study|Not specified|3
122859|NCT00477295|397471|P1|Overall Study|Not specified|4
122860|NCT00477295|397470|P2|Overall Study|Lost to Follow-up|11
122861|NCT00477295|397471|P1|Overall Study|Lost to Follow-up|21
122862|NCT00477295|397470|P2|Overall Study|Physician Decision|5
122863|NCT00477295|397471|P1|Overall Study|Physician Decision|4
122864|NCT00477295|397470|P2|Overall Study|Protocol Violation|8
122865|NCT00477295|397471|P1|Overall Study|Protocol Violation|3
122866|NCT00477295|397470|P2|Overall Study|Lack of Efficacy|23
122867|NCT00477295|397471|P1|Overall Study|Lack of Efficacy|23
122868|NCT00477295|397470|P2|Overall Study|Withdrawal by Subject|24
122869|NCT00477295|397471|P1|Overall Study|Withdrawal by Subject|35
122870|NCT00477295|397470|P2|Overall Study|Adverse Event|35
122871|NCT00477295|397471|P1|Overall Study|Adverse Event|31
122872|NCT00477334|397499|P2|Overall Study|Protocol Violation|1
122873|NCT00477334|397500|P1|Overall Study|Protocol Violation|7
122874|NCT00477334|397499|P2|Overall Study|Administrative Problems|15
122875|NCT00477334|397500|P1|Overall Study|Administrative Problems|39
122876|NCT00477334|397499|P2|Overall Study|Lost to Follow-up|4
122877|NCT00477334|397500|P1|Overall Study|Lost to Follow-up|15
122878|NCT00477334|397499|P2|Overall Study|Withdrawal by Subject|1
122879|NCT00477334|397500|P1|Overall Study|Withdrawal by Subject|2
122880|NCT00477334|397499|P2|Overall Study|Adverse Event|2
122881|NCT00477334|397500|P1|Overall Study|Adverse Event|1
122882|NCT00477334|397499|P2|Overall Study|Discontinued prior to taking study drug|53
122883|NCT00477334|397500|P1|Overall Study|Discontinued prior to taking study drug|106
122884|NCT00477386|397526|P2|Overall Study|Withdrawal by Subject|0
122885|NCT00477386|397527|P1|Overall Study|Withdrawal by Subject|1
122886|NCT00477386|397526|P2|Overall Study|Physician Decision|0
122887|NCT00477386|397527|P1|Overall Study|Physician Decision|1
122888|NCT00477386|397526|P2|Overall Study|Other|2
122889|NCT00477386|397527|P1|Overall Study|Other|1
122890|NCT00477386|397526|P2|Overall Study|Disease progression, refractory|3
122891|NCT00477386|397527|P1|Overall Study|Disease progression, refractory|1
122892|NCT00477386|397526|P2|Overall Study|Disease progression, relapse|4
122893|NCT00477386|397527|P1|Overall Study|Disease progression, relapse|3
122894|NCT00477386|397526|P2|Overall Study|Adverse Event|8
122895|NCT00477386|397527|P1|Overall Study|Adverse Event|4
122896|NCT00477464|397554|P1|Overall Study|Completion of protocol-defined follow-up|14
122897|NCT00477464|397554|P1|Overall Study|Death|36
122898|NCT00477464|397554|P1|Overall Study|Lost to Follow-up|1
122899|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
122900|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
122901|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
122902|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
122903|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
122904|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
122905|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
122906|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
122907|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
122908|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
122909|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
122910|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
122911|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
122912|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
122913|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
122914|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
122915|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
122916|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
122917|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122918|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122919|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122920|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122921|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122922|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122923|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122924|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
122925|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
122926|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
122927|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
122928|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
122929|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
122930|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
122931|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
122932|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
122933|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
122934|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
122935|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
122936|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
122937|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
122938|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
122939|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
122940|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
122941|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
122942|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
122943|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
122944|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
122945|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
122946|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
122947|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
122948|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
122949|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
122950|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
122951|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
122952|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
122953|NCT00477490|397582|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
122954|NCT00477490|397583|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
122955|NCT00477490|397584|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
122956|NCT00477490|397585|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
122957|NCT00477490|397586|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
122958|NCT00477490|397587|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
122959|NCT00477490|397588|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
122960|NCT00477490|397589|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
122961|NCT00477490|397590|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
122962|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Not Reported|0
122963|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Not Reported|0
122964|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Not Reported|0
122965|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Not Reported|0
122966|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Not Reported|1
122967|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Not Reported|0
122968|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Not Reported|3
122969|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Not Reported|2
122970|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Not Reported|1
122971|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Other, not specified|0
122972|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Other, not specified|0
122973|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Other, not specified|0
122974|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Other, not specified|0
122975|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Other, not specified|1
122976|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Other, not specified|1
122977|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Other, not specified|0
122978|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Other, not specified|4
122979|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Other, not specified|2
122980|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
122981|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
122982|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
122983|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
122984|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
122985|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
122986|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
122987|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
122988|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
122989|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
122990|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
122991|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
122992|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
122993|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
122994|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
122995|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
122996|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
122997|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
122998|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Protocol Violation|0
122999|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Protocol Violation|0
123000|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Protocol Violation|0
123001|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Protocol Violation|0
123002|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Protocol Violation|1
123003|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Protocol Violation|0
123004|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Protocol Violation|0
123005|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Protocol Violation|0
123006|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Protocol Violation|2
123007|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
123008|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
123009|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
123010|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
123011|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
123012|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
123013|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
123014|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
123015|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
123016|NCT00477490|397582|P9|Part I: 4 Week Efficacy|Adverse Event|0
123017|NCT00477490|397583|P8|Part I: 4 Week Efficacy|Adverse Event|0
123018|NCT00477490|397584|P7|Part I: 4 Week Efficacy|Adverse Event|0
123019|NCT00477490|397585|P6|Part I: 4 Week Efficacy|Adverse Event|0
123020|NCT00477490|397586|P5|Part I: 4 Week Efficacy|Adverse Event|6
123021|NCT00477490|397587|P4|Part I: 4 Week Efficacy|Adverse Event|5
123022|NCT00477490|397588|P3|Part I: 4 Week Efficacy|Adverse Event|0
123023|NCT00477490|397589|P2|Part I: 4 Week Efficacy|Adverse Event|4
123024|NCT00477490|397590|P1|Part I: 4 Week Efficacy|Adverse Event|1
123025|NCT00477594|397676|P2|Follow-up Period|Other|0
123026|NCT00477594|397677|P1|Follow-up Period|Other|1
123027|NCT00477594|397676|P2|Follow-up Period|Withdrawal by Subject|1
123028|NCT00477594|397677|P1|Follow-up Period|Withdrawal by Subject|2
123029|NCT00477594|397676|P2|Year 3|Withdrawal by Subject|0
123030|NCT00477594|397677|P1|Year 3|Withdrawal by Subject|1
123031|NCT00477594|397676|P2|Year 3|Adverse Event|0
123032|NCT00477594|397677|P1|Year 3|Adverse Event|1
123033|NCT00477594|397676|P2|Year 1 and Year 2|Other|0
123034|NCT00477594|397677|P1|Year 1 and Year 2|Other|1
123035|NCT00477594|397676|P2|Year 1 and Year 2|Withdrawal by Subject|1
123036|NCT00477594|397677|P1|Year 1 and Year 2|Withdrawal by Subject|2
123037|NCT00477594|397676|P2|Year 1 and Year 2|Physician Decision|1
123038|NCT00477594|397677|P1|Year 1 and Year 2|Physician Decision|2
123039|NCT00477594|397676|P2|Year 1 and Year 2|Adverse Event|2
123040|NCT00477594|397677|P1|Year 1 and Year 2|Adverse Event|4
123041|NCT00477607|397735|P2|Overall Study|Lost to Follow-up|7
123042|NCT00477607|397736|P1|Overall Study|Lost to Follow-up|7
123043|NCT00477633|397746|P1|Overall Study|Various (Moving, Enrollment closed)|75
123044|NCT00477633|397746|P1|Overall Study|Protocol Violation|25
123045|NCT00477633|397746|P1|Overall Study|Withdrawal by Subject|149
123046|NCT00477633|397746|P1|Overall Study|Lost to Follow-up|271
123047|NCT00477633|397746|P1|Overall Study|Pregnancy|23
123048|NCT00477633|397746|P1|Overall Study|Adverse Event|143
123049|NCT00477633|397746|P1|Overall Study|Did not receive treatment|23
123050|NCT00477672|397755|P3|Overall Study|Discretion of Sponsor|0
123051|NCT00477672|397756|P2|Overall Study|Discretion of Sponsor|2
123052|NCT00477672|397757|P1|Overall Study|Discretion of Sponsor|1
123053|NCT00477672|397755|P3|Overall Study|Consent withdrawn|10
123054|NCT00477672|397756|P2|Overall Study|Consent withdrawn|5
123055|NCT00477672|397757|P1|Overall Study|Consent withdrawn|2
123056|NCT00477672|397755|P3|Overall Study|Protocol noncompliance|0
123057|NCT00477672|397756|P2|Overall Study|Protocol noncompliance|2
123058|NCT00477672|397757|P1|Overall Study|Protocol noncompliance|0
123059|NCT00477672|397755|P3|Overall Study|Physician Decision|0
123060|NCT00477672|397756|P2|Overall Study|Physician Decision|0
123061|NCT00477672|397757|P1|Overall Study|Physician Decision|1
123062|NCT00477672|397755|P3|Overall Study|Disease progression|0
123063|NCT00477672|397756|P2|Overall Study|Disease progression|1
123064|NCT00477672|397757|P1|Overall Study|Disease progression|0
123065|NCT00477672|397755|P3|Overall Study|Death|0
123066|NCT00477672|397756|P2|Overall Study|Death|1
123067|NCT00477672|397757|P1|Overall Study|Death|0
123068|NCT00477672|397755|P3|Overall Study|Adverse Event|6
123069|NCT00477672|397756|P2|Overall Study|Adverse Event|5
123070|NCT00477672|397757|P1|Overall Study|Adverse Event|3
123071|NCT00477750|397773|P1|Overall Study|Currently Receiving Treatment|11
123072|NCT00477971|397779|P2|Overall Study|Alternative treatment|1
123073|NCT00477971|397780|P1|Overall Study|Alternative treatment|3
123074|NCT00477971|397779|P2|Overall Study|Death|4
123075|NCT00477971|397780|P1|Overall Study|Death|2
123076|NCT00477971|397779|P2|Overall Study|Adverse Event|0
123077|NCT00477971|397780|P1|Overall Study|Adverse Event|3
123078|NCT00477971|397779|P2|Overall Study|Withdrawal by Subject|1
123079|NCT00477971|397780|P1|Overall Study|Withdrawal by Subject|3
123080|NCT00477971|397779|P2|Overall Study|Disease progression|0
123081|NCT00477971|397780|P1|Overall Study|Disease progression|6
123082|NCT00478023|397797|P5|Overall Study|Lack of pain, Technical difficulties|3
123083|NCT00478023|397798|P4|Overall Study|Lack of pain, Technical difficulties|6
123084|NCT00478023|397799|P3|Overall Study|Lack of pain, Technical difficulties|5
123085|NCT00478023|397800|P2|Overall Study|Lack of pain, Technical difficulties|3
123086|NCT00478023|397801|P1|Overall Study|Lack of pain, Technical difficulties|7
123087|NCT00478023|397797|P5|Overall Study|Withdrawal by Subject|5
123088|NCT00478023|397798|P4|Overall Study|Withdrawal by Subject|4
123089|NCT00478023|397799|P3|Overall Study|Withdrawal by Subject|2
123090|NCT00478023|397800|P2|Overall Study|Withdrawal by Subject|3
123091|NCT00478023|397801|P1|Overall Study|Withdrawal by Subject|2
123092|NCT00478023|397797|P5|Overall Study|Lost to Follow-up|0
123093|NCT00478023|397798|P4|Overall Study|Lost to Follow-up|1
123094|NCT00478023|397799|P3|Overall Study|Lost to Follow-up|1
123095|NCT00478023|397800|P2|Overall Study|Lost to Follow-up|1
123096|NCT00478023|397801|P1|Overall Study|Lost to Follow-up|3
123097|NCT00478023|397797|P5|Overall Study|Lack of Efficacy|41
123098|NCT00478023|397798|P4|Overall Study|Lack of Efficacy|5
123099|NCT00478023|397799|P3|Overall Study|Lack of Efficacy|4
123100|NCT00478023|397800|P2|Overall Study|Lack of Efficacy|10
123101|NCT00478023|397801|P1|Overall Study|Lack of Efficacy|11
123102|NCT00478023|397797|P5|Overall Study|Death|0
123103|NCT00478023|397798|P4|Overall Study|Death|0
123104|NCT00478023|397799|P3|Overall Study|Death|0
123105|NCT00478023|397800|P2|Overall Study|Death|0
123106|NCT00478023|397801|P1|Overall Study|Death|1
123107|NCT00478023|397797|P5|Overall Study|Adverse Event|6
123108|NCT00478023|397798|P4|Overall Study|Adverse Event|14
123109|NCT00478023|397799|P3|Overall Study|Adverse Event|8
123110|NCT00478023|397800|P2|Overall Study|Adverse Event|7
123111|NCT00478023|397801|P1|Overall Study|Adverse Event|11
123112|NCT00478140|397831|P1|Overall Study|Disease Progression|3
123113|NCT00478205|397869|P2|Overall Study|Not specified|12
123114|NCT00478205|397870|P1|Overall Study|Not specified|24
123115|NCT00478205|397869|P2|Overall Study|Lack of Efficacy|0
123116|NCT00478205|397870|P1|Overall Study|Lack of Efficacy|1
123117|NCT00478205|397869|P2|Overall Study|Withdrawal by Subject|22
123118|NCT00478205|397870|P1|Overall Study|Withdrawal by Subject|61
123119|NCT00478205|397869|P2|Overall Study|Request of Investigator or Sponsor|5
123120|NCT00478205|397870|P1|Overall Study|Request of Investigator or Sponsor|4
123121|NCT00478205|397869|P2|Overall Study|Protocol Violation|5
123122|NCT00478205|397870|P1|Overall Study|Protocol Violation|15
123123|NCT00478205|397869|P2|Overall Study|Medication Non-compliance|4
123124|NCT00478205|397870|P1|Overall Study|Medication Non-compliance|9
123125|NCT00478205|397869|P2|Overall Study|Adverse Event|39
123126|NCT00478205|397870|P1|Overall Study|Adverse Event|182
123127|NCT00478231|397897|P1|Overall Study|Randomized, not treated|3
123128|NCT00478231|397897|P1|Overall Study|Adverse Event|5
123129|NCT00478231|397897|P1|Overall Study|Unspecified|9
123130|NCT00478231|397897|P1|Overall Study|Withdrawal by Subject|6
123131|NCT00478231|397897|P1|Overall Study|Lost to Follow-up|7
123132|NCT00478231|397897|P1|Overall Study|Lack of Efficacy|47
123133|NCT00478231|397897|P1|Overall Study|Death|7
123134|NCT00478244|397916|P1|Overall Study|Did not receive transplant|1
123135|NCT00478257|397931|P2|Overall Study|Withdrawal by Subject|3
123136|NCT00478257|397932|P1|Overall Study|Withdrawal by Subject|8
123137|NCT00478608|397963|P1|Overall Study|Protocol Violation|3
123138|NCT00478608|397963|P1|Overall Study|Withdrawal by Subject|2
123139|NCT00478608|397963|P1|Overall Study|Serious Adverse Event|14
123140|NCT00478608|397963|P1|Overall Study|Adverse Event|1
123141|NCT00478647|397971|P1|Overall Study|Withdrawal by Subject|1
123142|NCT00478647|397971|P1|Overall Study|Adverse Event|1
123143|NCT00478673|397979|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
123144|NCT00478673|397979|P1|12-Months Post-Procedure|Missed Visit|25
123145|NCT00478673|397979|P1|12-Months Post-Procedure|Withdrawal by Subject|6
123146|NCT00478673|397979|P1|12-Months Post-Procedure|Lost to Follow-up|4
123147|NCT00478673|397979|P1|12-Months Post-Procedure|Death|23
123148|NCT00478673|397979|P1|30-Days Post-Procedure|Missed Visit|7
123149|NCT00478673|397979|P1|30-Days Post-Procedure|Withdrawal by Subject|1
123150|NCT00478673|397979|P1|30-Days Post-Procedure|Death|2
123151|NCT00478777|397984|P1|Overall Study|Not treated with lenalidomide|6
123152|NCT00478777|397984|P1|Overall Study|End of therapy|2
123153|NCT00478777|397984|P1|Overall Study|Lymphocytes infusion|1
123154|NCT00478777|397984|P1|Overall Study|Lack of compliance|1
123155|NCT00478777|397984|P1|Overall Study|Intolerance of therapy|1
123156|NCT00478777|397984|P1|Overall Study|Physician Decision|1
123157|NCT00478777|397984|P1|Overall Study|Lost to Follow-up|3
123158|NCT00478777|397984|P1|Overall Study|Protocol Violation|3
123159|NCT00478777|397984|P1|Overall Study|Death|3
123160|NCT00478777|397984|P1|Overall Study|Withdrawal by Subject|4
123161|NCT00478777|397984|P1|Overall Study|Lack of Efficacy|23
123162|NCT00478777|397984|P1|Overall Study|Adverse Event|29
123163|NCT00478881|397993|P2|Overall Study|Non-Compliance with Study Medication|2
123164|NCT00478881|397994|P1|Overall Study|Non-Compliance with Study Medication|0
123165|NCT00478881|397993|P2|Overall Study|Withdrawal by Subject|2
123166|NCT00478881|397994|P1|Overall Study|Withdrawal by Subject|6
123167|NCT00478881|397993|P2|Overall Study|Protocol Violation|2
123168|NCT00478881|397994|P1|Overall Study|Protocol Violation|2
123169|NCT00478881|397993|P2|Overall Study|Lost to Follow-up|1
123170|NCT00478881|397994|P1|Overall Study|Lost to Follow-up|0
123171|NCT00478881|397993|P2|Overall Study|Lack of Efficacy|3
123172|NCT00478881|397994|P1|Overall Study|Lack of Efficacy|0
123173|NCT00478881|397993|P2|Overall Study|Adverse Event|12
123174|NCT00478881|397994|P1|Overall Study|Adverse Event|31
123175|NCT00479232|398055|P6|Overall Study|Withdrew Consent|3
123176|NCT00479232|398056|P5|Overall Study|Withdrew Consent|1
123177|NCT00479232|398057|P4|Overall Study|Withdrew Consent|0
123178|NCT00479232|398058|P3|Overall Study|Withdrew Consent|6
123179|NCT00479232|398059|P2|Overall Study|Withdrew Consent|2
123180|NCT00479232|398060|P1|Overall Study|Withdrew Consent|0
123181|NCT00479232|398055|P6|Overall Study|Progressive Disease|12
123182|NCT00479232|398056|P5|Overall Study|Progressive Disease|3
123183|NCT00479232|398057|P4|Overall Study|Progressive Disease|3
123184|NCT00479232|398058|P3|Overall Study|Progressive Disease|12
123185|NCT00479232|398059|P2|Overall Study|Progressive Disease|1
123186|NCT00479232|398060|P1|Overall Study|Progressive Disease|3
123187|NCT00479232|398055|P6|Overall Study|Physician Decision|1
123188|NCT00479232|398056|P5|Overall Study|Physician Decision|0
123189|NCT00479232|398057|P4|Overall Study|Physician Decision|0
123190|NCT00479232|398058|P3|Overall Study|Physician Decision|2
123191|NCT00479232|398059|P2|Overall Study|Physician Decision|0
123192|NCT00479232|398060|P1|Overall Study|Physician Decision|0
123193|NCT00479232|398055|P6|Overall Study|Lack of Efficacy|4
123194|NCT00479232|398056|P5|Overall Study|Lack of Efficacy|0
123195|NCT00479232|398057|P4|Overall Study|Lack of Efficacy|0
123196|NCT00479232|398058|P3|Overall Study|Lack of Efficacy|2
123197|NCT00479232|398059|P2|Overall Study|Lack of Efficacy|0
123198|NCT00479232|398060|P1|Overall Study|Lack of Efficacy|0
123199|NCT00479232|398055|P6|Overall Study|Deviation from Protocol|0
123200|NCT00479232|398056|P5|Overall Study|Deviation from Protocol|0
123201|NCT00479232|398057|P4|Overall Study|Deviation from Protocol|0
123202|NCT00479232|398058|P3|Overall Study|Deviation from Protocol|1
123203|NCT00479232|398059|P2|Overall Study|Deviation from Protocol|0
123204|NCT00479232|398060|P1|Overall Study|Deviation from Protocol|0
123205|NCT00479232|398055|P6|Overall Study|Adverse Event|10
123206|NCT00479232|398056|P5|Overall Study|Adverse Event|0
123207|NCT00479232|398057|P4|Overall Study|Adverse Event|0
123208|NCT00479232|398058|P3|Overall Study|Adverse Event|5
123209|NCT00479232|398059|P2|Overall Study|Adverse Event|0
123210|NCT00479232|398060|P1|Overall Study|Adverse Event|0
123211|NCT00479336|398089|P4|Overall Study|Resolution of all hepatic edema findings|0
123212|NCT00479336|398090|P3|Overall Study|Resolution of all hepatic edema findings|0
123213|NCT00479336|398091|P2|Overall Study|Resolution of all hepatic edema findings|1
123214|NCT00479336|398092|P1|Overall Study|Resolution of all hepatic edema findings|1
123215|NCT00479336|398089|P4|Overall Study|Physician Decision|2
123216|NCT00479336|398090|P3|Overall Study|Physician Decision|0
123217|NCT00479336|398091|P2|Overall Study|Physician Decision|1
123218|NCT00479336|398092|P1|Overall Study|Physician Decision|0
123219|NCT00479336|398089|P4|Overall Study|Withdrawal by Subject|0
123220|NCT00479336|398090|P3|Overall Study|Withdrawal by Subject|0
123221|NCT00479336|398091|P2|Overall Study|Withdrawal by Subject|2
123222|NCT00479336|398092|P1|Overall Study|Withdrawal by Subject|1
123223|NCT00479336|398089|P4|Overall Study|Protocol Violation|0
123224|NCT00479336|398090|P3|Overall Study|Protocol Violation|0
123225|NCT00479336|398091|P2|Overall Study|Protocol Violation|1
123226|NCT00479336|398092|P1|Overall Study|Protocol Violation|0
123227|NCT00479336|398089|P4|Overall Study|Lack of Efficacy|0
123228|NCT00479336|398090|P3|Overall Study|Lack of Efficacy|0
123229|NCT00479336|398091|P2|Overall Study|Lack of Efficacy|0
123230|NCT00479336|398092|P1|Overall Study|Lack of Efficacy|1
123231|NCT00479336|398089|P4|Overall Study|Adverse Event|3
123232|NCT00479336|398090|P3|Overall Study|Adverse Event|1
123233|NCT00479336|398091|P2|Overall Study|Adverse Event|1
123234|NCT00479336|398092|P1|Overall Study|Adverse Event|1
123235|NCT00465569|398108|P2|Overall Study|persistent eczema during dose escalation|0
123236|NCT00465569|398109|P1|Overall Study|persistent eczema during dose escalation|1
123237|NCT00465647|398123|P4|Overall Study|"The other reasons included loss of IV"|2
123238|NCT00465647|398124|P3|Overall Study|"The other reasons included loss of IV"|3
123239|NCT00465647|398125|P2|Overall Study|"The other reasons included loss of IV"|4
123240|NCT00465647|398126|P1|Overall Study|"The other reasons included loss of IV"|8
123241|NCT00465647|398123|P4|Overall Study|Withdrawal by Subject|7
123242|NCT00465647|398124|P3|Overall Study|Withdrawal by Subject|2
123243|NCT00465647|398125|P2|Overall Study|Withdrawal by Subject|2
123244|NCT00465647|398126|P1|Overall Study|Withdrawal by Subject|1
123245|NCT00465647|398123|P4|Overall Study|Adverse Event|2
123246|NCT00465647|398124|P3|Overall Study|Adverse Event|3
123247|NCT00465647|398125|P2|Overall Study|Adverse Event|0
123248|NCT00465647|398126|P1|Overall Study|Adverse Event|2
123249|NCT00465647|398123|P4|Overall Study|Administrative|2
123250|NCT00465647|398124|P3|Overall Study|Administrative|3
123251|NCT00465647|398125|P2|Overall Study|Administrative|2
123252|NCT00465647|398126|P1|Overall Study|Administrative|2
123253|NCT00465738|398151|P2|Overall Study|Other|5
123254|NCT00465738|398152|P1|Overall Study|Other|2
123255|NCT00465738|398151|P2|Overall Study|Withdrawal by Subject|0
123256|NCT00465738|398152|P1|Overall Study|Withdrawal by Subject|2
123257|NCT00465738|398151|P2|Overall Study|Adverse Event|1
123258|NCT00465738|398152|P1|Overall Study|Adverse Event|0
123259|NCT00465738|398151|P2|Overall Study|Lost to Follow-up|0
123260|NCT00465738|398152|P1|Overall Study|Lost to Follow-up|2
123261|NCT00465816|398245|P3|Overall Study|Lost to Follow-up|2
123262|NCT00465816|398246|P2|Overall Study|Lost to Follow-up|0
123263|NCT00465816|398247|P1|Overall Study|Lost to Follow-up|0
123264|NCT00465972|398338|P2|Overall Study|Withdrawal by Subject|1
123265|NCT00465972|398339|P1|Overall Study|Withdrawal by Subject|2
123266|NCT00465985|398347|P2|Part III - Open-label Treatment Period|Adverse Event|0
123267|NCT00465985|398348|P1|Part III - Open-label Treatment Period|Adverse Event|1
123268|NCT00465985|398347|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
123269|NCT00465985|398348|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
123270|NCT00465985|398347|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
123271|NCT00465985|398348|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
123272|NCT00465985|398347|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
123273|NCT00465985|398348|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
123274|NCT00466167|398377|P3|Overall Study|Not treated|0
123275|NCT00466167|398378|P2|Overall Study|Not treated|0
123276|NCT00466167|398379|P1|Overall Study|Not treated|1
123277|NCT00466167|398377|P3|Overall Study|patient did not meet inclusion criteria|1
123278|NCT00466167|398378|P2|Overall Study|patient did not meet inclusion criteria|0
123279|NCT00466167|398379|P1|Overall Study|patient did not meet inclusion criteria|1
123280|NCT00466167|398377|P3|Overall Study|Withdrawal by Subject|6
123281|NCT00466167|398378|P2|Overall Study|Withdrawal by Subject|1
123282|NCT00466167|398379|P1|Overall Study|Withdrawal by Subject|4
123283|NCT00466167|398377|P3|Overall Study|Lost to Follow-up|2
123284|NCT00466167|398378|P2|Overall Study|Lost to Follow-up|2
123285|NCT00466167|398379|P1|Overall Study|Lost to Follow-up|3
123286|NCT00466167|398377|P3|Overall Study|Protocol Violation|2
123287|NCT00466167|398378|P2|Overall Study|Protocol Violation|1
123288|NCT00466167|398379|P1|Overall Study|Protocol Violation|1
123289|NCT00466167|398377|P3|Overall Study|Lack of Efficacy|3
123290|NCT00466167|398378|P2|Overall Study|Lack of Efficacy|0
123291|NCT00466167|398379|P1|Overall Study|Lack of Efficacy|2
123292|NCT00466167|398377|P3|Overall Study|Adverse Event|7
123293|NCT00466167|398378|P2|Overall Study|Adverse Event|8
123294|NCT00466167|398379|P1|Overall Study|Adverse Event|8
123295|NCT00466193|398437|P2|Overall Study|Patient refused Visit 4 procedures|0
123296|NCT00466193|398438|P1|Overall Study|Patient refused Visit 4 procedures|1
123297|NCT00466193|398437|P2|Overall Study|Withdrawal by Subject|2
123298|NCT00466193|398438|P1|Overall Study|Withdrawal by Subject|7
123299|NCT00466193|398437|P2|Overall Study|Protocol Violation|1
123300|NCT00466193|398438|P1|Overall Study|Protocol Violation|1
123301|NCT00466193|398437|P2|Overall Study|Physician Decision|0
123302|NCT00466193|398438|P1|Overall Study|Physician Decision|1
123303|NCT00466193|398437|P2|Overall Study|Lost to Follow-up|4
123304|NCT00466193|398438|P1|Overall Study|Lost to Follow-up|2
123305|NCT00466193|398437|P2|Overall Study|Adverse Event|1
123306|NCT00466193|398438|P1|Overall Study|Adverse Event|0
123307|NCT00471718|398517|P1|Overall Study|Withdrawal by Subject|1
123308|NCT00471718|398517|P1|Overall Study|disease progression|22
123309|NCT00471718|398517|P1|Overall Study|other complicating disease|1
123310|NCT00471718|398517|P1|Overall Study|Adverse Event|3
123311|NCT00471822|398526|P1|Overall Study|Protocol Violation|2
123312|NCT00472030|398536|P2|Overall Study|Physician Decision|0
123313|NCT00472030|398537|P1|Overall Study|Physician Decision|1
123314|NCT00472082|398568|P1|Overall Study|Study prematurely terminated|5
123315|NCT00472199|398575|P2|Overall Study|patient was asymptomatic|0
123316|NCT00472199|398576|P1|Overall Study|patient was asymptomatic|1
123317|NCT00472199|398575|P2|Overall Study|personal reason|1
123318|NCT00472199|398576|P1|Overall Study|personal reason|0
123319|NCT00472199|398575|P2|Overall Study|Withdrawal by Subject|5
123320|NCT00472199|398576|P1|Overall Study|Withdrawal by Subject|6
123321|NCT00472199|398575|P2|Overall Study|Protocol Violation|2
123322|NCT00472199|398576|P1|Overall Study|Protocol Violation|3
123323|NCT00472199|398575|P2|Overall Study|Lost to Follow-up|4
123324|NCT00472199|398576|P1|Overall Study|Lost to Follow-up|2
123325|NCT00472199|398575|P2|Overall Study|Lack of Efficacy|25
123326|NCT00472199|398576|P1|Overall Study|Lack of Efficacy|4
123327|NCT00472199|398575|P2|Overall Study|Adverse Event|23
123328|NCT00472199|398576|P1|Overall Study|Adverse Event|19
123329|NCT00472290|398642|P1|Overall Study|Requirement for alternative therapy|7
123330|NCT00472290|398642|P1|Overall Study|Adverse Event|6
123331|NCT00472290|398642|P1|Overall Study|Withdrawal by Subject|5
123332|NCT00472290|398642|P1|Overall Study|Disease Progression|4
123333|NCT00472290|398642|P1|Overall Study|Lack of Efficacy|1
123334|NCT00472290|398642|P1|Overall Study|Lost to Follow-up|1
123335|NCT00472290|398642|P1|Overall Study|Death|3
123336|NCT00472290|398642|P1|Overall Study|Administrative Decision|37
123337|NCT00472290|398642|P1|Overall Study|Protocol Specified Criteria|7
123338|NCT00472290|398642|P1|Overall Study|Progression of Therapy-Related MDS|1
123339|NCT00472303|398654|P3|Maintenance Phase|not specified|0
123340|NCT00472303|398655|P2|Maintenance Phase|not specified|1
123341|NCT00472303|398656|P1|Maintenance Phase|not specified|1
123342|NCT00472303|398654|P3|Maintenance Phase|Resolution of pain|1
123343|NCT00472303|398655|P2|Maintenance Phase|Resolution of pain|0
123344|NCT00472303|398656|P1|Maintenance Phase|Resolution of pain|0
123345|NCT00472303|398654|P3|Maintenance Phase|Trial medication non-compliant|1
123346|NCT00472303|398655|P2|Maintenance Phase|Trial medication non-compliant|0
123347|NCT00472303|398656|P1|Maintenance Phase|Trial medication non-compliant|0
123348|NCT00472303|398654|P3|Maintenance Phase|Withdrawal by Subject|3
123349|NCT00472303|398655|P2|Maintenance Phase|Withdrawal by Subject|7
123350|NCT00472303|398656|P1|Maintenance Phase|Withdrawal by Subject|6
123351|NCT00472303|398654|P3|Maintenance Phase|Lack of Efficacy|4
123352|NCT00472303|398655|P2|Maintenance Phase|Lack of Efficacy|2
123353|NCT00472303|398656|P1|Maintenance Phase|Lack of Efficacy|2
123354|NCT00472303|398654|P3|Maintenance Phase|Death|2
123355|NCT00472303|398655|P2|Maintenance Phase|Death|0
123356|NCT00472303|398656|P1|Maintenance Phase|Death|3
123357|NCT00472303|398654|P3|Maintenance Phase|Adverse Event|6
123358|NCT00472303|398655|P2|Maintenance Phase|Adverse Event|6
123359|NCT00472303|398656|P1|Maintenance Phase|Adverse Event|5
123360|NCT00472303|398654|P3|Discontinuations After Titration Phase|not specified|0
123361|NCT00472303|398655|P2|Discontinuations After Titration Phase|not specified|0
123362|NCT00472303|398656|P1|Discontinuations After Titration Phase|not specified|5
123363|NCT00472303|398654|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
123364|NCT00472303|398655|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
123365|NCT00472303|398656|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
123366|NCT00472303|398654|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
123367|NCT00472303|398655|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
123368|NCT00472303|398656|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
123369|NCT00472303|398654|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
123370|NCT00472303|398655|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
123371|NCT00472303|398656|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
123372|NCT00472303|398654|P3|Discontinuations After Titration Phase|Adverse Event|0
123373|NCT00472303|398655|P2|Discontinuations After Titration Phase|Adverse Event|0
123374|NCT00472303|398656|P1|Discontinuations After Titration Phase|Adverse Event|6
123375|NCT00472303|398654|P3|Titration Phase|not specified|0
123376|NCT00472303|398655|P2|Titration Phase|not specified|1
123377|NCT00472303|398656|P1|Titration Phase|not specified|3
123378|NCT00472303|398654|P3|Titration Phase|Trial Medication non-compliant|0
123379|NCT00472303|398655|P2|Titration Phase|Trial Medication non-compliant|1
123380|NCT00472303|398656|P1|Titration Phase|Trial Medication non-compliant|4
123381|NCT00472303|398654|P3|Titration Phase|Withdrawal by Subject|0
123382|NCT00472303|398655|P2|Titration Phase|Withdrawal by Subject|13
123383|NCT00472303|398656|P1|Titration Phase|Withdrawal by Subject|16
123384|NCT00472303|398654|P3|Titration Phase|Lack of Efficacy|0
123385|NCT00472303|398655|P2|Titration Phase|Lack of Efficacy|0
123386|NCT00472303|398656|P1|Titration Phase|Lack of Efficacy|10
123387|NCT00472303|398654|P3|Titration Phase|Death|0
123388|NCT00472303|398655|P2|Titration Phase|Death|2
123389|NCT00472303|398656|P1|Titration Phase|Death|4
123390|NCT00472303|398654|P3|Titration Phase|Adverse Event|0
123391|NCT00472303|398655|P2|Titration Phase|Adverse Event|12
123392|NCT00472303|398656|P1|Titration Phase|Adverse Event|22
123393|NCT00472420|398719|P1|Follow-up Period|Protocol Violation|1
123394|NCT00472420|398719|P1|Follow-up Period|Lost to Follow-up|2
123395|NCT00472420|398719|P1|Follow-up Period|Physician Decision|9
123396|NCT00472420|398719|P1|Follow-up Period|Death|5
123397|NCT00472420|398719|P1|Induction Treatment Period|Death|3
123398|NCT00472420|398719|P1|Induction Treatment Period|Non-compliance|1
123399|NCT00472420|398719|P1|Induction Treatment Period|Adverse Event|3
123400|NCT00472420|398719|P1|Induction Treatment Period|Physician Decision|9
123401|NCT00472446|398729|P4|Overall Study|Questionnaires not returned|4
123402|NCT00472446|398730|P3|Overall Study|Questionnaires not returned|6
123403|NCT00472446|398731|P2|Overall Study|Questionnaires not returned|6
123404|NCT00472446|398732|P1|Overall Study|Questionnaires not returned|5
123405|NCT00472446|398729|P4|Overall Study|Reintervention|1
123406|NCT00472446|398730|P3|Overall Study|Reintervention|1
123407|NCT00472446|398731|P2|Overall Study|Reintervention|0
123408|NCT00472446|398732|P1|Overall Study|Reintervention|0
123409|NCT00472446|398729|P4|Overall Study|Protocol Violation|1
123410|NCT00472446|398730|P3|Overall Study|Protocol Violation|0
123411|NCT00472446|398731|P2|Overall Study|Protocol Violation|0
123412|NCT00472446|398732|P1|Overall Study|Protocol Violation|0
123413|NCT00472641|398773|P1|Overall Study|Lost to Follow-up|1
123414|NCT00472641|398773|P1|Overall Study|Adverse Event|3
123415|NCT00472641|398773|P1|Overall Study|Lack of Efficacy|3
123416|NCT00473083|398830|P3|Overall Study|Adverse Event|0
123417|NCT00473083|398831|P2|Overall Study|Adverse Event|0
123418|NCT00473083|398832|P1|Overall Study|Adverse Event|1
123419|NCT00473265|398858|P1|Overall Study|Off treatment early|15
123420|NCT00473265|398858|P1|Overall Study|Unrelated adverse event|5
123421|NCT00473330|398870|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
123422|NCT00473330|398871|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
123423|NCT00473330|398872|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
123424|NCT00473330|398870|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
123425|NCT00473330|398871|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
123426|NCT00473330|398872|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
123427|NCT00473330|398870|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|62
123428|NCT00473330|398871|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|71
123429|NCT00473330|398872|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|77
123430|NCT00473330|398870|P3|Open-label Extension Through Month 60|Subject's Decision|4
123431|NCT00473330|398871|P2|Open-label Extension Through Month 60|Subject's Decision|3
123432|NCT00473330|398872|P1|Open-label Extension Through Month 60|Subject's Decision|1
123433|NCT00473330|398870|P3|Open-label Extension Through Month 60|Physician's Decision|3
123434|NCT00473330|398871|P2|Open-label Extension Through Month 60|Physician's Decision|1
123435|NCT00473330|398872|P1|Open-label Extension Through Month 60|Physician's Decision|2
123436|NCT00473330|398870|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
123437|NCT00473330|398871|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
123438|NCT00473330|398872|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
123439|NCT00473330|398870|P3|Open-label Extension Through Month 60|Death|1
123440|NCT00473330|398871|P2|Open-label Extension Through Month 60|Death|2
123441|NCT00473330|398872|P1|Open-label Extension Through Month 60|Death|2
123442|NCT00473330|398870|P3|Open-label Extension Through Month 60|Adverse Event|2
123443|NCT00473330|398871|P2|Open-label Extension Through Month 60|Adverse Event|0
123444|NCT00473330|398872|P1|Open-label Extension Through Month 60|Adverse Event|0
123445|NCT00473330|398870|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
123446|NCT00473330|398871|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
123447|NCT00473330|398872|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
123448|NCT00473330|398870|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
123449|NCT00473330|398871|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
123450|NCT00473330|398872|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
123451|NCT00473330|398870|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|16
123526|NCT00473382|398930|P3|Core Study|Subject's decision|10
123452|NCT00473330|398871|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|15
123453|NCT00473330|398872|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|18
123454|NCT00473330|398870|P3|Open-label Extension Through Month 48|Subject's Decision|3
123455|NCT00473330|398871|P2|Open-label Extension Through Month 48|Subject's Decision|3
123456|NCT00473330|398872|P1|Open-label Extension Through Month 48|Subject's Decision|1
123457|NCT00473330|398870|P3|Open-label Extension Through Month 48|Physician's Decision|3
123458|NCT00473330|398871|P2|Open-label Extension Through Month 48|Physician's Decision|1
123459|NCT00473330|398872|P1|Open-label Extension Through Month 48|Physician's Decision|2
123460|NCT00473330|398870|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
123461|NCT00473330|398871|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
123462|NCT00473330|398872|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
123463|NCT00473330|398870|P3|Open-label Extension Through Month 48|Death|0
123464|NCT00473330|398871|P2|Open-label Extension Through Month 48|Death|0
123465|NCT00473330|398872|P1|Open-label Extension Through Month 48|Death|2
123466|NCT00473330|398870|P3|Open-label Extension Through Month 48|Adverse Event|2
123467|NCT00473330|398871|P2|Open-label Extension Through Month 48|Adverse Event|0
123468|NCT00473330|398872|P1|Open-label Extension Through Month 48|Adverse Event|0
123469|NCT00473330|398870|P3|Core Study|Subject's Decision|19
123470|NCT00473330|398871|P2|Core Study|Subject's Decision|8
123471|NCT00473330|398872|P1|Core Study|Subject's Decision|9
123472|NCT00473330|398870|P3|Core Study|Subject Required Other Therapy|3
123473|NCT00473330|398871|P2|Core Study|Subject Required Other Therapy|1
123474|NCT00473330|398872|P1|Core Study|Subject Required Other Therapy|0
123475|NCT00473330|398870|P3|Core Study|Subject Non-compliance|1
123476|NCT00473330|398871|P2|Core Study|Subject Non-compliance|2
123477|NCT00473330|398872|P1|Core Study|Subject Non-compliance|1
123478|NCT00473330|398870|P3|Core Study|Physician Decision|3
123479|NCT00473330|398871|P2|Core Study|Physician Decision|1
123480|NCT00473330|398872|P1|Core Study|Physician Decision|2
123481|NCT00473330|398870|P3|Core Study|Lost to Follow-up|10
123482|NCT00473330|398871|P2|Core Study|Lost to Follow-up|5
123483|NCT00473330|398872|P1|Core Study|Lost to Follow-up|5
123484|NCT00473330|398870|P3|Core Study|Death|4
123485|NCT00473330|398871|P2|Core Study|Death|4
123486|NCT00473330|398872|P1|Core Study|Death|6
123487|NCT00473330|398870|P3|Core Study|Adverse Event|1
123488|NCT00473330|398871|P2|Core Study|Adverse Event|4
123489|NCT00473330|398872|P1|Core Study|Adverse Event|4
123490|NCT00473382|398930|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
123491|NCT00473382|398931|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
123492|NCT00473382|398932|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
123493|NCT00473382|398930|P3|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|69
123494|NCT00473382|398931|P2|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|70
123495|NCT00473382|398932|P1|Open-label Extension Through Month 60|Sponsor’s Decision to Terminate Study|75
123496|NCT00473382|398930|P3|Open-label Extension Through Month 60|Subject's Decision|6
123497|NCT00473382|398931|P2|Open-label Extension Through Month 60|Subject's Decision|1
123498|NCT00473382|398932|P1|Open-label Extension Through Month 60|Subject's Decision|7
123499|NCT00473382|398930|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
123500|NCT00473382|398931|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
123501|NCT00473382|398932|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
123502|NCT00473382|398930|P3|Open-label Extension Through Month 60|Death|4
123503|NCT00473382|398931|P2|Open-label Extension Through Month 60|Death|7
123504|NCT00473382|398932|P1|Open-label Extension Through Month 60|Death|1
123505|NCT00473382|398930|P3|Open-label Extension Through Month 60|Adverse Event|2
123506|NCT00473382|398931|P2|Open-label Extension Through Month 60|Adverse Event|0
123507|NCT00473382|398932|P1|Open-label Extension Through Month 60|Adverse Event|0
123508|NCT00473382|398930|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
123509|NCT00473382|398931|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
123510|NCT00473382|398932|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
123511|NCT00473382|398930|P3|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|36
123512|NCT00473382|398931|P2|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|34
123513|NCT00473382|398932|P1|Open-label Extension Through Month 48|Sponsor’s Decision to Terminate Study|41
123514|NCT00473382|398930|P3|Open-label Extension Through Month 48|Subject's Decision|6
123515|NCT00473382|398931|P2|Open-label Extension Through Month 48|Subject's Decision|1
123516|NCT00473382|398932|P1|Open-label Extension Through Month 48|Subject's Decision|5
123517|NCT00473382|398930|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
123518|NCT00473382|398931|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
123519|NCT00473382|398932|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
123520|NCT00473382|398930|P3|Open-label Extension Through Month 48|Death|3
123521|NCT00473382|398931|P2|Open-label Extension Through Month 48|Death|3
123522|NCT00473382|398932|P1|Open-label Extension Through Month 48|Death|1
123523|NCT00473382|398930|P3|Open-label Extension Through Month 48|Adverse Event|1
123524|NCT00473382|398931|P2|Open-label Extension Through Month 48|Adverse Event|0
123525|NCT00473382|398932|P1|Open-label Extension Through Month 48|Adverse Event|0
123527|NCT00473382|398931|P2|Core Study|Subject's decision|11
123528|NCT00473382|398932|P1|Core Study|Subject's decision|12
123529|NCT00473382|398930|P3|Core Study|Subject needed other treatment|2
123530|NCT00473382|398931|P2|Core Study|Subject needed other treatment|3
123531|NCT00473382|398932|P1|Core Study|Subject needed other treatment|1
123532|NCT00473382|398930|P3|Core Study|Subject non-compliance|1
123533|NCT00473382|398931|P2|Core Study|Subject non-compliance|2
123534|NCT00473382|398932|P1|Core Study|Subject non-compliance|5
123535|NCT00473382|398930|P3|Core Study|Physician Decision|2
123536|NCT00473382|398931|P2|Core Study|Physician Decision|2
123537|NCT00473382|398932|P1|Core Study|Physician Decision|1
123538|NCT00473382|398930|P3|Core Study|Lost to Follow-up|3
123539|NCT00473382|398931|P2|Core Study|Lost to Follow-up|3
123540|NCT00473382|398932|P1|Core Study|Lost to Follow-up|3
123541|NCT00473382|398930|P3|Core Study|Death|10
123542|NCT00473382|398931|P2|Core Study|Death|5
123543|NCT00473382|398932|P1|Core Study|Death|3
123544|NCT00473382|398930|P3|Core Study|Adverse Event|1
123545|NCT00473382|398931|P2|Core Study|Adverse Event|1
123546|NCT00473382|398932|P1|Core Study|Adverse Event|3
123547|NCT00473434|398987|P1|Overall Study|No longer required|1
123548|NCT00473434|398987|P1|Overall Study|Switching to trial medication|1
123549|NCT00473434|398987|P1|Overall Study|Ceased in favor of Paliperidone|1
123550|NCT00473434|398987|P1|Overall Study|Reason not specified|6
123551|NCT00473434|398987|P1|Overall Study|Safety evaluation|1
123552|NCT00473434|398987|P1|Overall Study|Patient was selling medication to others|1
123553|NCT00473434|398987|P1|Overall Study|Adverse Event|3
123554|NCT00473434|398987|P1|Overall Study|Lack of Efficacy|3
123555|NCT00473434|398987|P1|Overall Study|Compliance|3
123556|NCT00473434|398987|P1|Overall Study|Withdrawal by Subject|9
123557|NCT00473434|398987|P1|Overall Study|Physician Decision|3
123558|NCT00479388|399051|P2|Overall Study|Withdrawal by Subject|17
123559|NCT00479388|399052|P1|Overall Study|Withdrawal by Subject|32
123560|NCT00479388|399051|P2|Overall Study|Protocol Violation|9
123561|NCT00479388|399052|P1|Overall Study|Protocol Violation|10
123562|NCT00479388|399051|P2|Overall Study|Lost to Follow-up|2
123563|NCT00479388|399052|P1|Overall Study|Lost to Follow-up|0
123564|NCT00479388|399051|P2|Overall Study|Adverse Event|45
123565|NCT00479388|399052|P1|Overall Study|Adverse Event|90
123566|NCT00479401|399065|P3|Overall Study|Exclusion criteria, relocation|0
123567|NCT00479401|399066|P2|Overall Study|Exclusion criteria, relocation|3
123568|NCT00479401|399067|P1|Overall Study|Exclusion criteria, relocation|4
123569|NCT00479401|399065|P3|Overall Study|Withdrawal by Subject|2
123570|NCT00479401|399066|P2|Overall Study|Withdrawal by Subject|10
123571|NCT00479401|399067|P1|Overall Study|Withdrawal by Subject|16
123572|NCT00479401|399065|P3|Overall Study|Lost to Follow-up|1
123573|NCT00479401|399066|P2|Overall Study|Lost to Follow-up|1
123574|NCT00479401|399067|P1|Overall Study|Lost to Follow-up|1
123575|NCT00479401|399065|P3|Overall Study|Protocol Violation|1
123576|NCT00479401|399066|P2|Overall Study|Protocol Violation|1
123577|NCT00479401|399067|P1|Overall Study|Protocol Violation|2
123578|NCT00479401|399065|P3|Overall Study|Lack of Efficacy|4
123579|NCT00479401|399066|P2|Overall Study|Lack of Efficacy|2
123580|NCT00479401|399067|P1|Overall Study|Lack of Efficacy|2
123581|NCT00479401|399065|P3|Overall Study|Adverse Event|4
123582|NCT00479401|399066|P2|Overall Study|Adverse Event|20
123583|NCT00479401|399067|P1|Overall Study|Adverse Event|24
123584|NCT00479466|399126|P6|Overall Study|Withdrawal by Subject|1
123585|NCT00479466|399127|P5|Overall Study|Withdrawal by Subject|3
123586|NCT00479466|399128|P4|Overall Study|Withdrawal by Subject|2
123587|NCT00479466|399129|P3|Overall Study|Withdrawal by Subject|0
123588|NCT00479466|399130|P2|Overall Study|Withdrawal by Subject|5
123589|NCT00479466|399131|P1|Overall Study|Withdrawal by Subject|3
123590|NCT00479466|399126|P6|Overall Study|Protocol Violation|0
123591|NCT00479466|399127|P5|Overall Study|Protocol Violation|0
123592|NCT00479466|399128|P4|Overall Study|Protocol Violation|0
123593|NCT00479466|399129|P3|Overall Study|Protocol Violation|0
123594|NCT00479466|399130|P2|Overall Study|Protocol Violation|0
123595|NCT00479466|399131|P1|Overall Study|Protocol Violation|1
123596|NCT00479466|399126|P6|Overall Study|Pregnancy|0
123597|NCT00479466|399127|P5|Overall Study|Pregnancy|1
123598|NCT00479466|399128|P4|Overall Study|Pregnancy|0
123599|NCT00479466|399129|P3|Overall Study|Pregnancy|0
123600|NCT00479466|399130|P2|Overall Study|Pregnancy|0
123601|NCT00479466|399131|P1|Overall Study|Pregnancy|0
123602|NCT00479466|399126|P6|Overall Study|Physician Decision|0
123603|NCT00479466|399127|P5|Overall Study|Physician Decision|0
123604|NCT00479466|399128|P4|Overall Study|Physician Decision|0
123605|NCT00479466|399129|P3|Overall Study|Physician Decision|1
123606|NCT00479466|399130|P2|Overall Study|Physician Decision|1
123607|NCT00479466|399131|P1|Overall Study|Physician Decision|2
123608|NCT00479466|399126|P6|Overall Study|Lost to Follow-up|2
123609|NCT00479466|399127|P5|Overall Study|Lost to Follow-up|2
123610|NCT00479466|399128|P4|Overall Study|Lost to Follow-up|0
123611|NCT00479466|399129|P3|Overall Study|Lost to Follow-up|1
123612|NCT00479466|399130|P2|Overall Study|Lost to Follow-up|1
123613|NCT00479466|399131|P1|Overall Study|Lost to Follow-up|0
123614|NCT00479466|399126|P6|Overall Study|Lack of Efficacy|0
123615|NCT00479466|399127|P5|Overall Study|Lack of Efficacy|0
123616|NCT00479466|399128|P4|Overall Study|Lack of Efficacy|0
123617|NCT00479466|399129|P3|Overall Study|Lack of Efficacy|1
123618|NCT00479466|399130|P2|Overall Study|Lack of Efficacy|0
123619|NCT00479466|399131|P1|Overall Study|Lack of Efficacy|2
123620|NCT00479466|399126|P6|Overall Study|Hyperglycemia|1
123621|NCT00479466|399127|P5|Overall Study|Hyperglycemia|0
123622|NCT00479466|399128|P4|Overall Study|Hyperglycemia|0
123623|NCT00479466|399129|P3|Overall Study|Hyperglycemia|0
123624|NCT00479466|399130|P2|Overall Study|Hyperglycemia|0
123625|NCT00479466|399131|P1|Overall Study|Hyperglycemia|0
123626|NCT00479466|399126|P6|Overall Study|Adverse Event|0
123627|NCT00479466|399127|P5|Overall Study|Adverse Event|2
123628|NCT00479466|399128|P4|Overall Study|Adverse Event|1
123629|NCT00479466|399129|P3|Overall Study|Adverse Event|0
123630|NCT00479466|399130|P2|Overall Study|Adverse Event|1
123631|NCT00479466|399131|P1|Overall Study|Adverse Event|5
123632|NCT00479557|399164|P7|Overall Study|Not specified|0
123633|NCT00479557|399165|P6|Overall Study|Not specified|3
123634|NCT00479557|399166|P5|Overall Study|Not specified|0
123635|NCT00479557|399167|P4|Overall Study|Not specified|0
123636|NCT00479557|399168|P3|Overall Study|Not specified|1
123637|NCT00479557|399169|P2|Overall Study|Not specified|3
123638|NCT00479557|399170|P1|Overall Study|Not specified|2
123639|NCT00479557|399164|P7|Overall Study|Subject Request|1
123640|NCT00479557|399165|P6|Overall Study|Subject Request|4
123641|NCT00479557|399166|P5|Overall Study|Subject Request|1
123642|NCT00479557|399167|P4|Overall Study|Subject Request|1
123643|NCT00479557|399168|P3|Overall Study|Subject Request|1
123644|NCT00479557|399169|P2|Overall Study|Subject Request|0
123645|NCT00479557|399170|P1|Overall Study|Subject Request|3
123646|NCT00479557|399164|P7|Overall Study|Investigator Request|0
123647|NCT00479557|399165|P6|Overall Study|Investigator Request|0
123648|NCT00479557|399166|P5|Overall Study|Investigator Request|0
123649|NCT00479557|399167|P4|Overall Study|Investigator Request|0
123650|NCT00479557|399168|P3|Overall Study|Investigator Request|1
123651|NCT00479557|399169|P2|Overall Study|Investigator Request|0
123652|NCT00479557|399170|P1|Overall Study|Investigator Request|0
123653|NCT00479557|399164|P7|Overall Study|Caregiver Request|0
123654|NCT00479557|399165|P6|Overall Study|Caregiver Request|2
123655|NCT00479557|399166|P5|Overall Study|Caregiver Request|1
123656|NCT00479557|399167|P4|Overall Study|Caregiver Request|0
123657|NCT00479557|399168|P3|Overall Study|Caregiver Request|2
123658|NCT00479557|399169|P2|Overall Study|Caregiver Request|2
123659|NCT00479557|399170|P1|Overall Study|Caregiver Request|2
123660|NCT00479557|399164|P7|Overall Study|AE not related to Study Drug|1
123661|NCT00479557|399165|P6|Overall Study|AE not related to Study Drug|2
123662|NCT00479557|399166|P5|Overall Study|AE not related to Study Drug|2
123663|NCT00479557|399167|P4|Overall Study|AE not related to Study Drug|0
123664|NCT00479557|399168|P3|Overall Study|AE not related to Study Drug|0
123665|NCT00479557|399169|P2|Overall Study|AE not related to Study Drug|3
123666|NCT00479557|399170|P1|Overall Study|AE not related to Study Drug|1
123667|NCT00479557|399164|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
123668|NCT00479557|399165|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
123669|NCT00479557|399166|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
123670|NCT00479557|399167|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
123671|NCT00479557|399168|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
123672|NCT00479557|399169|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
123673|NCT00479557|399170|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
123674|NCT00479557|399164|P7|Overall Study|Lost to Follow-up|0
123675|NCT00479557|399165|P6|Overall Study|Lost to Follow-up|0
123676|NCT00479557|399166|P5|Overall Study|Lost to Follow-up|0
123677|NCT00479557|399167|P4|Overall Study|Lost to Follow-up|2
123678|NCT00479557|399168|P3|Overall Study|Lost to Follow-up|0
123679|NCT00479557|399169|P2|Overall Study|Lost to Follow-up|2
123680|NCT00479557|399170|P1|Overall Study|Lost to Follow-up|0
123681|NCT00479557|399164|P7|Overall Study|Lack of Efficacy|0
123682|NCT00479557|399165|P6|Overall Study|Lack of Efficacy|0
123683|NCT00479557|399166|P5|Overall Study|Lack of Efficacy|0
123684|NCT00479557|399167|P4|Overall Study|Lack of Efficacy|0
123685|NCT00479557|399168|P3|Overall Study|Lack of Efficacy|0
123686|NCT00479557|399169|P2|Overall Study|Lack of Efficacy|0
123687|NCT00479557|399170|P1|Overall Study|Lack of Efficacy|1
123688|NCT00479557|399164|P7|Overall Study|Death|0
123689|NCT00479557|399165|P6|Overall Study|Death|1
123690|NCT00479557|399166|P5|Overall Study|Death|0
123691|NCT00479557|399167|P4|Overall Study|Death|0
123692|NCT00479557|399168|P3|Overall Study|Death|0
123693|NCT00479557|399169|P2|Overall Study|Death|0
123694|NCT00479557|399170|P1|Overall Study|Death|0
123695|NCT00479674|399207|P1|Overall Study|none provided|3
123696|NCT00479674|399207|P1|Overall Study|Physician Decision|14
123697|NCT00479674|399207|P1|Overall Study|Withdrawal by Subject|6
123698|NCT00479674|399207|P1|Overall Study|Adverse Event|18
123699|NCT00479713|399217|P2|Overall Study|Withdrawal by Subject|1
123700|NCT00479713|399218|P1|Overall Study|Withdrawal by Subject|4
123701|NCT00479713|399217|P2|Overall Study|Protocol Violation|1
123702|NCT00479713|399218|P1|Overall Study|Protocol Violation|0
123703|NCT00479713|399217|P2|Overall Study|Lost to Follow-up|1
123704|NCT00479713|399218|P1|Overall Study|Lost to Follow-up|0
123705|NCT00479713|399217|P2|Overall Study|Death|0
123706|NCT00479713|399218|P1|Overall Study|Death|1
123707|NCT00479713|399217|P2|Overall Study|Adverse Event|6
123708|NCT00479713|399218|P1|Overall Study|Adverse Event|8
123709|NCT00483652|399244|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
123710|NCT00483652|399245|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
123711|NCT00483652|399244|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
123712|NCT00483652|399245|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
123713|NCT00483652|399244|P2|Double-blind Treatment Period|Adverse Event|4
123714|NCT00483652|399245|P1|Double-blind Treatment Period|Adverse Event|3
123715|NCT00483652|399244|P2|Double-blind Treatment Period|Protocol Violation|1
123716|NCT00483652|399245|P1|Double-blind Treatment Period|Protocol Violation|2
123717|NCT00483704|399256|P3|Treatment|Physician Decision|4
123718|NCT00483704|399257|P2|Treatment|Physician Decision|1
123719|NCT00483704|399258|P1|Treatment|Physician Decision|0
123720|NCT00483704|399256|P3|Treatment|Pregnancy|0
123721|NCT00483704|399257|P2|Treatment|Pregnancy|1
123722|NCT00483704|399258|P1|Treatment|Pregnancy|0
123723|NCT00483704|399256|P3|Treatment|Lack of Efficacy|1
123724|NCT00483704|399257|P2|Treatment|Lack of Efficacy|1
123725|NCT00483704|399258|P1|Treatment|Lack of Efficacy|1
123726|NCT00483704|399256|P3|Treatment|Lost to Follow-up|5
123727|NCT00483704|399257|P2|Treatment|Lost to Follow-up|7
123728|NCT00483704|399258|P1|Treatment|Lost to Follow-up|2
123729|NCT00483704|399256|P3|Treatment|Protocol Violation|5
123730|NCT00483704|399257|P2|Treatment|Protocol Violation|3
123731|NCT00483704|399258|P1|Treatment|Protocol Violation|6
123732|NCT00483704|399256|P3|Treatment|Withdrawal by Subject|21
123733|NCT00483704|399257|P2|Treatment|Withdrawal by Subject|12
123734|NCT00483704|399258|P1|Treatment|Withdrawal by Subject|16
123735|NCT00483704|399256|P3|Treatment|Adverse Event|4
123736|NCT00483704|399257|P2|Treatment|Adverse Event|5
123737|NCT00483704|399258|P1|Treatment|Adverse Event|3
123738|NCT00483704|399256|P3|Treatment|Lack of qualifying migraines|116
123739|NCT00483704|399257|P2|Treatment|Lack of qualifying migraines|99
123740|NCT00483704|399258|P1|Treatment|Lack of qualifying migraines|101
123741|NCT00483704|399256|P3|Randomization|Lack of qualifying migraines|31
123742|NCT00483704|399257|P2|Randomization|Lack of qualifying migraines|25
123743|NCT00483704|399258|P1|Randomization|Lack of qualifying migraines|21
123744|NCT00483704|399256|P3|Randomization|Progressive disease|1
123745|NCT00483704|399257|P2|Randomization|Progressive disease|0
123746|NCT00483704|399258|P1|Randomization|Progressive disease|0
123747|NCT00483704|399256|P3|Randomization|Physician Decision|0
123748|NCT00483704|399257|P2|Randomization|Physician Decision|4
123749|NCT00483704|399258|P1|Randomization|Physician Decision|2
123750|NCT00483704|399256|P3|Randomization|Pregnancy|0
123751|NCT00483704|399257|P2|Randomization|Pregnancy|0
123752|NCT00483704|399258|P1|Randomization|Pregnancy|1
123753|NCT00483704|399256|P3|Randomization|Lost to Follow-up|19
123754|NCT00483704|399257|P2|Randomization|Lost to Follow-up|14
123755|NCT00483704|399258|P1|Randomization|Lost to Follow-up|14
123756|NCT00483704|399256|P3|Randomization|Protocol Violation|22
123757|NCT00483704|399257|P2|Randomization|Protocol Violation|25
123758|NCT00483704|399258|P1|Randomization|Protocol Violation|14
123759|NCT00483704|399256|P3|Randomization|Withdrawal by Subject|18
123760|NCT00483704|399257|P2|Randomization|Withdrawal by Subject|28
123761|NCT00483704|399258|P1|Randomization|Withdrawal by Subject|19
123762|NCT00483717|399304|P2|Overall Study|Withdrawal by Subject|0
123763|NCT00483717|399305|P1|Overall Study|Withdrawal by Subject|1
123764|NCT00483717|399304|P2|Overall Study|Lost to Follow-up|0
123765|NCT00483717|399305|P1|Overall Study|Lost to Follow-up|1
123766|NCT00483717|399304|P2|Overall Study|No treatment for migraine|13
123767|NCT00483717|399305|P1|Overall Study|No treatment for migraine|16
123768|NCT00483717|399304|P2|Overall Study|Time of dosing missing|1
123769|NCT00483717|399305|P1|Overall Study|Time of dosing missing|1
123770|NCT00483717|399304|P2|Overall Study|Protocol Violation|7
123771|NCT00483717|399305|P1|Overall Study|Protocol Violation|5
123772|NCT00483756|399328|P3|Overall Study|Randomized, Not Treated|4
123773|NCT00483756|399329|P2|Overall Study|Randomized, Not Treated|4
123774|NCT00483756|399330|P1|Overall Study|Randomized, Not Treated|1
123775|NCT00483756|399328|P3|Overall Study|Unspecified|3
123776|NCT00483756|399329|P2|Overall Study|Unspecified|4
123777|NCT00483756|399330|P1|Overall Study|Unspecified|2
123778|NCT00483756|399328|P3|Overall Study|Withdrawal by Subject|4
123779|NCT00483756|399329|P2|Overall Study|Withdrawal by Subject|3
123780|NCT00483756|399330|P1|Overall Study|Withdrawal by Subject|5
123781|NCT00483756|399328|P3|Overall Study|Lost to Follow-up|0
123782|NCT00483756|399329|P2|Overall Study|Lost to Follow-up|1
123783|NCT00483756|399330|P1|Overall Study|Lost to Follow-up|3
123784|NCT00483756|399328|P3|Overall Study|Lack of Efficacy|0
123785|NCT00483756|399329|P2|Overall Study|Lack of Efficacy|0
123786|NCT00483756|399330|P1|Overall Study|Lack of Efficacy|1
123787|NCT00483756|399328|P3|Overall Study|Adverse Event|40
123788|NCT00483756|399329|P2|Overall Study|Adverse Event|38
123789|NCT00483756|399330|P1|Overall Study|Adverse Event|19
123790|NCT00483756|399328|P3|Overall Study|Death|1
123791|NCT00483756|399329|P2|Overall Study|Death|0
123792|NCT00483756|399330|P1|Overall Study|Death|2
123793|NCT00483938|399399|P7|Overall Study|Unspecified|32
123794|NCT00483938|399400|P6|Overall Study|Unspecified|4
123795|NCT00483938|399401|P5|Overall Study|Unspecified|0
123796|NCT00483938|399402|P4|Overall Study|Unspecified|4
123797|NCT00483938|399403|P3|Overall Study|Unspecified|0
123798|NCT00483938|399404|P2|Overall Study|Unspecified|9
123799|NCT00483938|399405|P1|Overall Study|Unspecified|3
123800|NCT00483938|399399|P7|Overall Study|Death|0
123801|NCT00483938|399400|P6|Overall Study|Death|0
123802|NCT00483938|399401|P5|Overall Study|Death|0
123803|NCT00483938|399402|P4|Overall Study|Death|0
123804|NCT00483938|399403|P3|Overall Study|Death|0
123805|NCT00483938|399404|P2|Overall Study|Death|2
123806|NCT00483938|399405|P1|Overall Study|Death|0
123807|NCT00483938|399399|P7|Overall Study|Lost to Follow-up|3
123808|NCT00483938|399400|P6|Overall Study|Lost to Follow-up|1
123809|NCT00483938|399401|P5|Overall Study|Lost to Follow-up|1
123810|NCT00483938|399402|P4|Overall Study|Lost to Follow-up|2
123811|NCT00483938|399403|P3|Overall Study|Lost to Follow-up|0
123812|NCT00483938|399404|P2|Overall Study|Lost to Follow-up|2
123813|NCT00483938|399405|P1|Overall Study|Lost to Follow-up|1
123814|NCT00483938|399399|P7|Overall Study|Withdrawal by Subject|2
123815|NCT00483938|399400|P6|Overall Study|Withdrawal by Subject|3
123816|NCT00483938|399401|P5|Overall Study|Withdrawal by Subject|1
123817|NCT00483938|399402|P4|Overall Study|Withdrawal by Subject|0
123818|NCT00483938|399403|P3|Overall Study|Withdrawal by Subject|0
123819|NCT00483938|399404|P2|Overall Study|Withdrawal by Subject|6
123820|NCT00483938|399405|P1|Overall Study|Withdrawal by Subject|1
123821|NCT00483938|399399|P7|Overall Study|Protocol Violation|3
123822|NCT00483938|399400|P6|Overall Study|Protocol Violation|0
123823|NCT00483938|399401|P5|Overall Study|Protocol Violation|0
123824|NCT00483938|399402|P4|Overall Study|Protocol Violation|0
123825|NCT00483938|399403|P3|Overall Study|Protocol Violation|0
123826|NCT00483938|399404|P2|Overall Study|Protocol Violation|0
123827|NCT00483938|399405|P1|Overall Study|Protocol Violation|0
123828|NCT00484094|399426|P1|Overall Study|Other|3
123829|NCT00484094|399426|P1|Overall Study|Discontinued|39
123830|NCT00484159|399438|P3|Overall Study|Lost to Follow-up|0
123831|NCT00484159|399439|P2|Overall Study|Lost to Follow-up|1
123832|NCT00484159|399440|P1|Overall Study|Lost to Follow-up|1
123833|NCT00484185|399451|P1|Overall Study|Death|2
123834|NCT00484185|399451|P1|Overall Study|Randomized but not treated|5
123835|NCT00484185|399451|P1|Overall Study|Unspecified|20
123836|NCT00484185|399451|P1|Overall Study|Lost to Follow-up|44
123837|NCT00484289|399473|P3|Post Marketing Phase|Adverse Event|0
123838|NCT00484289|399474|P2|Post Marketing Phase|Adverse Event|1
123839|NCT00484289|399475|P1|Post Marketing Phase|Adverse Event|0
123840|NCT00484289|399473|P3|Long Term Phase|Other Reason|1
123841|NCT00484289|399474|P2|Long Term Phase|Other Reason|5
123842|NCT00484289|399475|P1|Long Term Phase|Other Reason|0
123843|NCT00484289|399473|P3|Long Term Phase|Inadequate response|4
123844|NCT00484289|399474|P2|Long Term Phase|Inadequate response|7
123845|NCT00484289|399475|P1|Long Term Phase|Inadequate response|2
123846|NCT00484289|399473|P3|Long Term Phase|Withdrawal by Subject|6
123847|NCT00484289|399474|P2|Long Term Phase|Withdrawal by Subject|7
123848|NCT00484289|399475|P1|Long Term Phase|Withdrawal by Subject|0
123849|NCT00484289|399473|P3|Long Term Phase|Adverse Event|5
123850|NCT00484289|399474|P2|Long Term Phase|Adverse Event|17
123851|NCT00484289|399475|P1|Long Term Phase|Adverse Event|1
123852|NCT00484315|399549|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
123853|NCT00484315|399550|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
123854|NCT00484315|399549|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
123855|NCT00484315|399550|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
123856|NCT00484315|399549|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
123857|NCT00484315|399550|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
123858|NCT00484315|399549|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
123859|NCT00484315|399550|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
123860|NCT00484315|399549|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
123861|NCT00484315|399550|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
123862|NCT00484315|399549|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
123863|NCT00484315|399550|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
123864|NCT00484315|399549|P2|12-Month Clinical Follow-up|Death|2
123865|NCT00484315|399550|P1|12-Month Clinical Follow-up|Death|6
123866|NCT00484419|399570|P3|Overall Study|sponsor decision, randomized in error|2
123867|NCT00484419|399571|P2|Overall Study|sponsor decision, randomized in error|0
123868|NCT00484419|399572|P1|Overall Study|sponsor decision, randomized in error|0
123869|NCT00484419|399570|P3|Overall Study|subject relocated|0
123870|NCT00484419|399571|P2|Overall Study|subject relocated|1
123871|NCT00484419|399572|P1|Overall Study|subject relocated|0
123872|NCT00484419|399570|P3|Overall Study|subject unable to receive medication|0
123873|NCT00484419|399571|P2|Overall Study|subject unable to receive medication|0
123874|NCT00484419|399572|P1|Overall Study|subject unable to receive medication|1
123875|NCT00484419|399570|P3|Overall Study|Physician Decision|1
123876|NCT00484419|399571|P2|Overall Study|Physician Decision|1
123877|NCT00484419|399572|P1|Overall Study|Physician Decision|1
123878|NCT00484419|399570|P3|Overall Study|required restricted medication|1
123879|NCT00484419|399571|P2|Overall Study|required restricted medication|0
123880|NCT00484419|399572|P1|Overall Study|required restricted medication|1
123881|NCT00484419|399570|P3|Overall Study|subject met discontinuation criteria|4
123882|NCT00484419|399571|P2|Overall Study|subject met discontinuation criteria|2
123883|NCT00484419|399572|P1|Overall Study|subject met discontinuation criteria|2
123884|NCT00484419|399570|P3|Overall Study|Withdrawal by Subject|1
123885|NCT00484419|399571|P2|Overall Study|Withdrawal by Subject|1
123886|NCT00484419|399572|P1|Overall Study|Withdrawal by Subject|3
123887|NCT00484419|399570|P3|Overall Study|Lost to Follow-up|2
123888|NCT00484419|399571|P2|Overall Study|Lost to Follow-up|0
123889|NCT00484419|399572|P1|Overall Study|Lost to Follow-up|1
123890|NCT00484419|399570|P3|Overall Study|Adverse Event|0
123891|NCT00484419|399571|P2|Overall Study|Adverse Event|0
123892|NCT00484419|399572|P1|Overall Study|Adverse Event|3
123893|NCT00484679|399628|P1|Overall Study|Withdrawal by Subject|3
123894|NCT00484939|399634|P2|Overall Study|Reason Not Specified|6
123895|NCT00484939|399635|P1|Overall Study|Reason Not Specified|11
123896|NCT00484939|399634|P2|Overall Study|Screen Failure|2
123897|NCT00484939|399635|P1|Overall Study|Screen Failure|2
123898|NCT00484939|399634|P2|Overall Study|Disease progression|88
123899|NCT00484939|399635|P1|Overall Study|Disease progression|67
123900|NCT00484939|399634|P2|Overall Study|Discretion of Investigator or Sponsor|3
123901|NCT00484939|399635|P1|Overall Study|Discretion of Investigator or Sponsor|7
123902|NCT00484939|399634|P2|Overall Study|Lost to Follow-up|3
123903|NCT00484939|399635|P1|Overall Study|Lost to Follow-up|0
123904|NCT00484939|399634|P2|Overall Study|Protocol Violation|3
123905|NCT00484939|399635|P1|Overall Study|Protocol Violation|3
123906|NCT00484939|399634|P2|Overall Study|Patient Withdrew Consent|10
123907|NCT00484939|399635|P1|Overall Study|Patient Withdrew Consent|19
123908|NCT00484939|399634|P2|Overall Study|Adverse Event|12
123909|NCT00484939|399635|P1|Overall Study|Adverse Event|22
123910|NCT00484939|399634|P2|Overall Study|Death|13
123911|NCT00484939|399635|P1|Overall Study|Death|9
123912|NCT00485069|399657|P2|Overall Study|Withdrawal by Subject|6
123913|NCT00485069|399658|P1|Overall Study|Withdrawal by Subject|6
123914|NCT00485069|399657|P2|Overall Study|Protocol Violation|1
123915|NCT00485069|399658|P1|Overall Study|Protocol Violation|0
123916|NCT00485069|399657|P2|Overall Study|Lack of Efficacy|1
123917|NCT00485069|399658|P1|Overall Study|Lack of Efficacy|2
123918|NCT00485069|399657|P2|Overall Study|Adverse Event|4
123919|NCT00485069|399658|P1|Overall Study|Adverse Event|10
123920|NCT00485173|399703|P2|Overall Study|Lost to Follow-up|61
123921|NCT00485173|399704|P1|Overall Study|Lost to Follow-up|32
123922|NCT00485173|399703|P2|Overall Study|Death|3
123923|NCT00485173|399704|P1|Overall Study|Death|4
123924|NCT00485264|399750|P6|Overall Study|Data frozen before reaching week 48|0
123925|NCT00485264|399751|P5|Overall Study|Data frozen before reaching week 48|0
123926|NCT00485264|399752|P4|Overall Study|Data frozen before reaching week 48|9
123927|NCT00485264|399753|P3|Overall Study|Data frozen before reaching week 48|0
123928|NCT00485264|399754|P2|Overall Study|Data frozen before reaching week 48|0
123929|NCT00485264|399755|P1|Overall Study|Data frozen before reaching week 48|0
123930|NCT00485264|399750|P6|Overall Study|Lack of Efficacy|0
123931|NCT00485264|399751|P5|Overall Study|Lack of Efficacy|0
123932|NCT00485264|399752|P4|Overall Study|Lack of Efficacy|1
123933|NCT00485264|399753|P3|Overall Study|Lack of Efficacy|0
123934|NCT00485264|399754|P2|Overall Study|Lack of Efficacy|0
123935|NCT00485264|399755|P1|Overall Study|Lack of Efficacy|0
123936|NCT00485264|399750|P6|Overall Study|Physician Decision|0
123937|NCT00485264|399751|P5|Overall Study|Physician Decision|0
123938|NCT00485264|399752|P4|Overall Study|Physician Decision|0
123939|NCT00485264|399753|P3|Overall Study|Physician Decision|0
123940|NCT00485264|399754|P2|Overall Study|Physician Decision|1
123941|NCT00485264|399755|P1|Overall Study|Physician Decision|0
123942|NCT00485264|399750|P6|Overall Study|Non-compliant|0
123943|NCT00485264|399751|P5|Overall Study|Non-compliant|0
123944|NCT00485264|399752|P4|Overall Study|Non-compliant|0
123945|NCT00485264|399753|P3|Overall Study|Non-compliant|0
123946|NCT00485264|399754|P2|Overall Study|Non-compliant|0
123947|NCT00485264|399755|P1|Overall Study|Non-compliant|6
123948|NCT00485303|399839|P1|Overall Study|Treatment ongoing at cutoff date|2
123949|NCT00485303|399839|P1|Overall Study|Initiation of new anti-cancer treatment|2
123950|NCT00485303|399839|P1|Overall Study|Unspecified|3
123951|NCT00485303|399839|P1|Overall Study|Progressive Disease|44
123952|NCT00485303|399839|P1|Overall Study|Adverse Event|5
123953|NCT00485472|399868|P2|Overall Study|Lost to Follow-up|1
123954|NCT00485472|399869|P1|Overall Study|Lost to Follow-up|0
123955|NCT00485472|399868|P2|Overall Study|Unspecified|1
123956|NCT00485472|399869|P1|Overall Study|Unspecified|2
123957|NCT00485472|399868|P2|Overall Study|Protocol Violation|1
123958|NCT00485472|399869|P1|Overall Study|Protocol Violation|0
123959|NCT00485472|399868|P2|Overall Study|Withdrawal by Subject|0
123960|NCT00485472|399869|P1|Overall Study|Withdrawal by Subject|1
123961|NCT00485472|399868|P2|Overall Study|Lack of Efficacy|4
123962|NCT00485472|399869|P1|Overall Study|Lack of Efficacy|5
123963|NCT00485472|399868|P2|Overall Study|Adverse Event|5
123964|NCT00485472|399869|P1|Overall Study|Adverse Event|8
123965|NCT00485732|399909|P2|Overall Study|Lost to Follow-up|2
123966|NCT00485732|399910|P1|Overall Study|Lost to Follow-up|2
123967|NCT00485732|399909|P2|Overall Study|Withdrawal by Subject|4
123968|NCT00485732|399910|P1|Overall Study|Withdrawal by Subject|5
123969|NCT00485732|399909|P2|Overall Study|Protocol Violation|3
123970|NCT00485732|399910|P1|Overall Study|Protocol Violation|1
123971|NCT00485758|399932|P2|Overall Study|Study Terminated by Sponsor|0
123972|NCT00485758|399933|P1|Overall Study|Study Terminated by Sponsor|3
123973|NCT00485758|399932|P2|Overall Study|Withdrawal by Subject|27
123974|NCT00485758|399933|P1|Overall Study|Withdrawal by Subject|32
123975|NCT00485758|399932|P2|Overall Study|Protocol Violation|2
123976|NCT00485758|399933|P1|Overall Study|Protocol Violation|11
123977|NCT00485758|399932|P2|Overall Study|Physician Decision|3
123978|NCT00485758|399933|P1|Overall Study|Physician Decision|3
123979|NCT00485758|399932|P2|Overall Study|Lost to Follow-up|1
123980|NCT00485758|399933|P1|Overall Study|Lost to Follow-up|5
123981|NCT00485758|399932|P2|Overall Study|Death|1
123982|NCT00485758|399933|P1|Overall Study|Death|0
123983|NCT00485758|399932|P2|Overall Study|Adverse Event|31
123984|NCT00485758|399933|P1|Overall Study|Adverse Event|102
123985|NCT00486044|400016|P2|Overall Study|Lost to Follow-up|1
123986|NCT00486044|400017|P1|Overall Study|Lost to Follow-up|0
123987|NCT00486044|400016|P2|Overall Study|Adverse Event|1
123988|NCT00486044|400017|P1|Overall Study|Adverse Event|0
123989|NCT00486044|400016|P2|Overall Study|Withdrawal by Subject|1
123990|NCT00486044|400017|P1|Overall Study|Withdrawal by Subject|2
123991|NCT00465361|400029|P1|Baseline Assessment|Personal Issues/Scheduling|4
123992|NCT00476476|400048|P2|Overall Study|Progressive Disease|17
123993|NCT00476476|400049|P1|Overall Study|Progressive Disease|0
123994|NCT00476476|400048|P2|Overall Study|Adverse Event|7
123995|NCT00476476|400049|P1|Overall Study|Adverse Event|2
123996|NCT00476593|400058|P4|Overall Study|Lost to Follow-up|22
123997|NCT00476593|400059|P3|Overall Study|Lost to Follow-up|8
123998|NCT00476593|400060|P2|Overall Study|Lost to Follow-up|2
123999|NCT00476593|400061|P1|Overall Study|Lost to Follow-up|10
124000|NCT00486226|400082|P1|Overall Study|Lost to Follow-up|8
124001|NCT00486226|400082|P1|Overall Study|Withdrawal by Subject|1
124002|NCT00486226|400082|P1|Overall Study|Adverse Event|1
124003|NCT00486226|400082|P1|Overall Study|Death|3
124004|NCT00486252|400090|P1|Overall Study|Other|18
124005|NCT00486252|400090|P1|Overall Study|Lost to Follow-up|24
124006|NCT00486252|400090|P1|Overall Study|Lack of Efficacy|9
124007|NCT00486252|400090|P1|Overall Study|Adverse Event|7
124008|NCT00486265|400105|P1|Overall Study|Lack of Efficacy|8
124009|NCT00486265|400105|P1|Overall Study|Adverse Event|1
124010|NCT00486278|400109|P1|Overall Study|Physician Decision|2
124011|NCT00486278|400109|P1|Overall Study|Withdrawal by Subject|2
124012|NCT00486278|400109|P1|Overall Study|Adverse Event|5
124013|NCT00486291|400245|P2|Overall Study|requirement for restricted medication|3
124014|NCT00486291|400246|P1|Overall Study|requirement for restricted medication|0
124015|NCT00486291|400245|P2|Overall Study|protocol non-compliance|15
124016|NCT00486291|400246|P1|Overall Study|protocol non-compliance|10
124017|NCT00486291|400245|P2|Overall Study|Lost to Follow-up|7
124018|NCT00486291|400246|P1|Overall Study|Lost to Follow-up|3
124019|NCT00486291|400245|P2|Overall Study|Adverse Event|4
124020|NCT00486291|400246|P1|Overall Study|Adverse Event|3
124021|NCT00486330|400254|P1|Overall Study|Adverse Event|2
124022|NCT00486434|400260|P2|Overall Study|Personal reasons|6
124023|NCT00486434|400261|P1|Overall Study|Personal reasons|5
124024|NCT00486434|400260|P2|Overall Study|Death|2
124025|NCT00486434|400261|P1|Overall Study|Death|1
124026|NCT00486434|400260|P2|Overall Study|Lost to Follow-up|3
124027|NCT00486434|400261|P1|Overall Study|Lost to Follow-up|2
124028|NCT00486434|400260|P2|Overall Study|Lack of Efficacy|19
124029|NCT00486434|400261|P1|Overall Study|Lack of Efficacy|12
124030|NCT00486434|400260|P2|Overall Study|Protocol Violation|21
124031|NCT00486434|400261|P1|Overall Study|Protocol Violation|22
124032|NCT00486434|400260|P2|Overall Study|Adverse Event|44
124033|NCT00486434|400261|P1|Overall Study|Adverse Event|118
124034|NCT00486434|400260|P2|Overall Study|Withdrawal by Subject|39
124035|NCT00486434|400261|P1|Overall Study|Withdrawal by Subject|34
124036|NCT00487084|400274|P3|Overall Study|Did not receive intervention|5
124037|NCT00487084|400275|P2|Overall Study|Did not receive intervention|3
124038|NCT00487084|400276|P1|Overall Study|Did not receive intervention|4
124039|NCT00487162|400295|P2|Overall Study|Withdrawal by Subject|3
124040|NCT00487162|400296|P1|Overall Study|Withdrawal by Subject|2
124041|NCT00487162|400295|P2|Overall Study|Physician Decision|1
124042|NCT00487162|400296|P1|Overall Study|Physician Decision|0
124043|NCT00487162|400295|P2|Overall Study|Adverse Event|1
124044|NCT00487162|400296|P1|Overall Study|Adverse Event|0
124045|NCT00487188|400306|P3|Maintenance Phase|Administrative|1
124046|NCT00487188|400307|P2|Maintenance Phase|Administrative|0
124047|NCT00487188|400308|P1|Maintenance Phase|Administrative|0
124048|NCT00487188|400306|P3|Maintenance Phase|Lost to Follow-up|0
124049|NCT00487188|400307|P2|Maintenance Phase|Lost to Follow-up|0
124050|NCT00487188|400308|P1|Maintenance Phase|Lost to Follow-up|1
124051|NCT00487188|400306|P3|Maintenance Phase|Death|0
124052|NCT00487188|400307|P2|Maintenance Phase|Death|0
124053|NCT00487188|400308|P1|Maintenance Phase|Death|1
124054|NCT00487188|400306|P3|Maintenance Phase|Adverse Event|0
124055|NCT00487188|400307|P2|Maintenance Phase|Adverse Event|0
124056|NCT00487188|400308|P1|Maintenance Phase|Adverse Event|1
124057|NCT00487188|400306|P3|Induction Phase|Administrative|0
124058|NCT00487188|400307|P2|Induction Phase|Administrative|1
124059|NCT00487188|400308|P1|Induction Phase|Administrative|0
124060|NCT00487188|400306|P3|Induction Phase|Lost to Follow-up|0
124061|NCT00487188|400307|P2|Induction Phase|Lost to Follow-up|2
124062|NCT00487188|400308|P1|Induction Phase|Lost to Follow-up|2
124063|NCT00487188|400306|P3|Induction Phase|Refused Treatment|0
124064|NCT00487188|400307|P2|Induction Phase|Refused Treatment|2
124065|NCT00487188|400308|P1|Induction Phase|Refused Treatment|1
124066|NCT00487188|400306|P3|Induction Phase|Protocol Violation|0
124067|NCT00487188|400307|P2|Induction Phase|Protocol Violation|0
124068|NCT00487188|400308|P1|Induction Phase|Protocol Violation|1
124069|NCT00487188|400306|P3|Induction Phase|Lack of Efficacy|0
124070|NCT00487188|400307|P2|Induction Phase|Lack of Efficacy|1
124071|NCT00487188|400308|P1|Induction Phase|Lack of Efficacy|0
124072|NCT00487188|400306|P3|Induction Phase|Adverse Event|0
124073|NCT00487188|400307|P2|Induction Phase|Adverse Event|0
124074|NCT00487188|400308|P1|Induction Phase|Adverse Event|5
124075|NCT00487188|400306|P3|Induction Phase|Abnormality of Laboratory Test|0
124076|NCT00487188|400307|P2|Induction Phase|Abnormality of Laboratory Test|1
124077|NCT00487188|400308|P1|Induction Phase|Abnormality of Laboratory Test|0
124078|NCT00487240|400347|P2|Overall Study|Physician Decision|0
124079|NCT00487240|400348|P1|Overall Study|Physician Decision|2
124080|NCT00487240|400347|P2|Overall Study|Sponsor Decision|1
124081|NCT00487240|400348|P1|Overall Study|Sponsor Decision|2
124082|NCT00487240|400347|P2|Overall Study|Entry Criteria Not Met|4
124083|NCT00487240|400348|P1|Overall Study|Entry Criteria Not Met|3
124084|NCT00487240|400347|P2|Overall Study|Protocol Violation|5
124085|NCT00487240|400348|P1|Overall Study|Protocol Violation|5
124086|NCT00487240|400347|P2|Overall Study|Adverse Event|4
124087|NCT00487240|400348|P1|Overall Study|Adverse Event|0
124088|NCT00487240|400347|P2|Overall Study|Lost to Follow-up|6
124089|NCT00487240|400348|P1|Overall Study|Lost to Follow-up|7
124090|NCT00487240|400347|P2|Overall Study|Withdrawal by Subject|6
124091|NCT00487240|400348|P1|Overall Study|Withdrawal by Subject|12
124092|NCT00487279|400376|P2|Overall Study|Withdrawal by Subject|2
124093|NCT00487279|400377|P1|Overall Study|Withdrawal by Subject|0
124094|NCT00487279|400376|P2|Overall Study|Death|0
124095|NCT00487279|400377|P1|Overall Study|Death|1
124096|NCT00487435|400391|P1|Overall Study|Other|83
124097|NCT00487435|400391|P1|Overall Study|Study Medication Non-Compliant|32
124098|NCT00487435|400391|P1|Overall Study|Resolution Of Pain|1
124099|NCT00487435|400391|P1|Overall Study|Withdrawal by Subject|132
124100|NCT00487435|400391|P1|Overall Study|Pregnancy|2
124101|NCT00487435|400391|P1|Overall Study|Lost to Follow-up|54
124102|NCT00487435|400391|P1|Overall Study|Lack of Efficacy|33
124103|NCT00487435|400391|P1|Overall Study|Death|2
124104|NCT00487435|400391|P1|Overall Study|Adverse Event|146
124105|NCT00487539|400416|P4|Overall Study|Unspecified|2
124106|NCT00487539|400417|P3|Overall Study|Unspecified|2
124107|NCT00487539|400418|P2|Overall Study|Unspecified|1
124108|NCT00487539|400419|P1|Overall Study|Unspecified|3
124109|NCT00487539|400416|P4|Overall Study|Unsatisfactory therapeutic effect|1
124110|NCT00487539|400417|P3|Overall Study|Unsatisfactory therapeutic effect|0
124111|NCT00487539|400418|P2|Overall Study|Unsatisfactory therapeutic effect|0
124112|NCT00487539|400419|P1|Overall Study|Unsatisfactory therapeutic effect|1
124113|NCT00487539|400416|P4|Overall Study|Adverse Event|1
124114|NCT00487539|400417|P3|Overall Study|Adverse Event|1
124115|NCT00487539|400418|P2|Overall Study|Adverse Event|2
124116|NCT00487539|400419|P1|Overall Study|Adverse Event|3
124117|NCT00487552|400437|P1|Overall Study|Stent not placed|1
124118|NCT00487552|400437|P1|Overall Study|Death due to progressive malignancy|2
124119|NCT00487552|400437|P1|Overall Study|Unsuccessful magnet placements|3
124120|NCT00487578|400448|P2|Overall Study|Lost to Follow-up|1
124121|NCT00487578|400449|P1|Overall Study|Lost to Follow-up|0
124122|NCT00487578|400448|P2|Overall Study|Lack of Efficacy|1
124123|NCT00487578|400449|P1|Overall Study|Lack of Efficacy|0
124124|NCT00487578|400448|P2|Overall Study|Adverse Event|2
124125|NCT00487578|400449|P1|Overall Study|Adverse Event|1
124126|NCT00487695|400475|P2|Second Procedure|Withdrawal by Subject|2
124127|NCT00487695|400476|P1|Second Procedure|Withdrawal by Subject|1
124128|NCT00487695|400475|P2|Second Procedure|active wheezing|1
124129|NCT00487695|400476|P1|Second Procedure|active wheezing|0
124130|NCT00487695|400475|P2|First Procedure|esophageal stricture found (excl crit)|0
124131|NCT00487695|400476|P1|First Procedure|esophageal stricture found (excl crit)|1
124132|NCT00487695|400475|P2|First Procedure|active wheezing (did not have procedure)|0
124133|NCT00487695|400476|P1|First Procedure|active wheezing (did not have procedure)|1
124134|NCT00487695|400475|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
124135|NCT00487695|400476|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
124136|NCT00487747|400500|P1|Overall Study|Lack of Efficacy|1
124137|NCT00487747|400500|P1|Overall Study|Lost to Follow-up|9
124138|NCT00487747|400500|P1|Overall Study|Adverse Event|1
124139|NCT00487825|400511|P2|Overall Study|not specified|2
124140|NCT00487825|400512|P1|Overall Study|not specified|3
124141|NCT00487825|400511|P2|Overall Study|Lack of Efficacy|1
124142|NCT00487825|400512|P1|Overall Study|Lack of Efficacy|1
124143|NCT00487825|400511|P2|Overall Study|Adverse Event|2
124144|NCT00487825|400512|P1|Overall Study|Adverse Event|2
124145|NCT00487942|400528|P4|Overall Study|Withdrawal by Subject|0
124146|NCT00487942|400529|P3|Overall Study|Withdrawal by Subject|2
124147|NCT00487942|400530|P2|Overall Study|Withdrawal by Subject|1
124148|NCT00487942|400531|P1|Overall Study|Withdrawal by Subject|0
124149|NCT00487942|400528|P4|Overall Study|Protocol Violation|0
124150|NCT00487942|400529|P3|Overall Study|Protocol Violation|0
124151|NCT00487942|400530|P2|Overall Study|Protocol Violation|1
124152|NCT00487942|400531|P1|Overall Study|Protocol Violation|1
124153|NCT00487942|400528|P4|Overall Study|Lost to Follow-up|1
124154|NCT00487942|400529|P3|Overall Study|Lost to Follow-up|0
124155|NCT00487942|400530|P2|Overall Study|Lost to Follow-up|0
124156|NCT00487942|400531|P1|Overall Study|Lost to Follow-up|1
124157|NCT00487942|400528|P4|Overall Study|Adverse Event|1
124158|NCT00487942|400529|P3|Overall Study|Adverse Event|1
124159|NCT00487942|400530|P2|Overall Study|Adverse Event|1
124160|NCT00487942|400531|P1|Overall Study|Adverse Event|1
124161|NCT00487981|400913|P1|Overall Study|Hypothyroidism diagnosis|1
124162|NCT00488033|400919|P2|Overall Study|Withdrawal by Subject|0
124163|NCT00488033|400920|P1|Overall Study|Withdrawal by Subject|1
124164|NCT00488293|400957|P2|Overall Study|Misrandomization/Other Unspecified|1
124165|NCT00488293|400958|P1|Overall Study|Misrandomization/Other Unspecified|1
124166|NCT00488293|400957|P2|Overall Study|Death|1
124167|NCT00488293|400958|P1|Overall Study|Death|2
124168|NCT00488293|400957|P2|Overall Study|Withdrawal by Subject|3
124169|NCT00488293|400958|P1|Overall Study|Withdrawal by Subject|5
124170|NCT00488293|400957|P2|Overall Study|Lost to Follow-up|25
124171|NCT00488293|400958|P1|Overall Study|Lost to Follow-up|28
124172|NCT00488319|400985|P3|Overall Study|Other reasons for withdrawal|12
124173|NCT00488319|400986|P2|Overall Study|Other reasons for withdrawal|4
124174|NCT00488319|400987|P1|Overall Study|Other reasons for withdrawal|0
124175|NCT00488319|400985|P3|Overall Study|Withdrawal by Subject|44
124176|NCT00488319|400986|P2|Overall Study|Withdrawal by Subject|20
124177|NCT00488319|400987|P1|Overall Study|Withdrawal by Subject|5
124178|NCT00488319|400985|P3|Overall Study|Lost to Follow-up|16
124179|NCT00488319|400986|P2|Overall Study|Lost to Follow-up|5
124180|NCT00488319|400987|P1|Overall Study|Lost to Follow-up|3
124181|NCT00488319|400985|P3|Overall Study|Lack of Efficacy|27
124182|NCT00488319|400986|P2|Overall Study|Lack of Efficacy|12
124183|NCT00488319|400987|P1|Overall Study|Lack of Efficacy|6
124184|NCT00488319|400985|P3|Overall Study|Adverse Event|23
124185|NCT00488319|400986|P2|Overall Study|Adverse Event|2
124186|NCT00488319|400987|P1|Overall Study|Adverse Event|1
124187|NCT00488345|401075|P3|Overall Study|Parent/legal guardian request|1
124188|NCT00488345|401076|P2|Overall Study|Parent/legal guardian request|1
124189|NCT00488345|401077|P1|Overall Study|Parent/legal guardian request|0
124190|NCT00488345|401075|P3|Overall Study|Surgical team recommendation|0
124191|NCT00488345|401076|P2|Overall Study|Surgical team recommendation|1
124192|NCT00488345|401077|P1|Overall Study|Surgical team recommendation|0
124193|NCT00488345|401075|P3|Overall Study|Institutional Review Board review|1
124194|NCT00488345|401076|P2|Overall Study|Institutional Review Board review|0
124195|NCT00488345|401077|P1|Overall Study|Institutional Review Board review|0
124196|NCT00488345|401075|P3|Overall Study|Unable to administer antibiotics at home|0
124197|NCT00488345|401076|P2|Overall Study|Unable to administer antibiotics at home|1
124198|NCT00488345|401077|P1|Overall Study|Unable to administer antibiotics at home|0
124199|NCT00488345|401075|P3|Overall Study|Adverse Event|1
124200|NCT00488345|401076|P2|Overall Study|Adverse Event|1
124201|NCT00488345|401077|P1|Overall Study|Adverse Event|0
124202|NCT00488475|401100|P1|Overall Study|Unspecified|1754
124203|NCT00488514|401141|P1|Overall Study|Increased use of concomitant medication|1
124204|NCT00488514|401141|P1|Overall Study|Increase in number of migraines|2
124205|NCT00488514|401141|P1|Overall Study|Participant had too few migraines|5
124206|NCT00488514|401141|P1|Overall Study|Investigator decision|1
124207|NCT00488514|401141|P1|Overall Study|Withdrawn per medical monitor decision|2
124208|NCT00488514|401141|P1|Overall Study|Postive drug screen|1
124209|NCT00488514|401141|P1|Overall Study|Did not meet criteria for treatment|30
124210|NCT00488514|401141|P1|Overall Study|Lack of Efficacy|28
124211|NCT00488514|401141|P1|Overall Study|Withdrawal by Subject|106
124212|NCT00488514|401141|P1|Overall Study|Protocol Violation|32
124213|NCT00488514|401141|P1|Overall Study|Lost to Follow-up|44
124214|NCT00488514|401141|P1|Overall Study|Adverse Event|41
124215|NCT00488592|401214|P1|Overall Study|Enrolled but not treated|1
124216|NCT00488592|401214|P1|Overall Study|Disease progression|1
124217|NCT00488592|401214|P1|Overall Study|Withdrawal by Subject|1
124218|NCT00488618|401220|P2|Overall Study|Lost to Follow-up|0
124219|NCT00488618|401221|P1|Overall Study|Lost to Follow-up|1
124220|NCT00488618|401220|P2|Overall Study|Withdrawal of Consent|13
124221|NCT00488618|401221|P1|Overall Study|Withdrawal of Consent|15
124222|NCT00488618|401220|P2|Overall Study|Protocol Violation|2
124223|NCT00488618|401221|P1|Overall Study|Protocol Violation|0
124224|NCT00488618|401220|P2|Overall Study|Insufficient Therapeutic Response|11
124225|NCT00488618|401221|P1|Overall Study|Insufficient Therapeutic Response|18
124226|NCT00488618|401220|P2|Overall Study|Adverse Event|17
124227|NCT00488618|401221|P1|Overall Study|Adverse Event|13
124228|NCT00488631|401235|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124229|NCT00488631|401236|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
124230|NCT00488631|401237|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
124231|NCT00488631|401238|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
124232|NCT00488631|401239|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124233|NCT00488631|401240|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124234|NCT00488631|401241|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124235|NCT00488631|401242|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124236|NCT00488631|401243|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124237|NCT00488631|401244|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
124238|NCT00488631|401235|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124239|NCT00488631|401236|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
124240|NCT00488631|401237|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124241|NCT00488631|401238|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
124242|NCT00488631|401239|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124243|NCT00488631|401240|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124244|NCT00488631|401241|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124245|NCT00488631|401242|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124246|NCT00488631|401243|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124247|NCT00488631|401244|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
124248|NCT00488631|401235|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
124249|NCT00488631|401236|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
124250|NCT00488631|401237|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
124251|NCT00488631|401238|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
124252|NCT00488631|401239|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
124253|NCT00488631|401240|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
124254|NCT00488631|401241|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
124255|NCT00488631|401242|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
124256|NCT00488631|401243|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
124257|NCT00488631|401244|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
124258|NCT00488631|401235|P10|Open Label Study Extension (Week 54-228)|Death|0
124259|NCT00488631|401236|P9|Open Label Study Extension (Week 54-228)|Death|1
124260|NCT00488631|401237|P8|Open Label Study Extension (Week 54-228)|Death|0
124261|NCT00488631|401238|P7|Open Label Study Extension (Week 54-228)|Death|0
124262|NCT00488631|401239|P6|Open Label Study Extension (Week 54-228)|Death|0
124263|NCT00488631|401240|P5|Open Label Study Extension (Week 54-228)|Death|0
124264|NCT00488631|401241|P4|Open Label Study Extension (Week 54-228)|Death|0
124265|NCT00488631|401242|P3|Open Label Study Extension (Week 54-228)|Death|0
124266|NCT00488631|401243|P2|Open Label Study Extension (Week 54-228)|Death|0
124267|NCT00488631|401244|P1|Open Label Study Extension (Week 54-228)|Death|0
124268|NCT00488631|401235|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
124269|NCT00488631|401236|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
124270|NCT00488631|401237|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
124271|NCT00488631|401238|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
124272|NCT00488631|401239|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
124273|NCT00488631|401240|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
124274|NCT00488631|401241|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
124275|NCT00488631|401242|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
124276|NCT00488631|401243|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
124277|NCT00488631|401244|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
124278|NCT00488631|401235|P10|Double Blind Period (Week 0-54)|Unspecified|0
124279|NCT00488631|401236|P9|Double Blind Period (Week 0-54)|Unspecified|0
124280|NCT00488631|401237|P8|Double Blind Period (Week 0-54)|Unspecified|0
124281|NCT00488631|401238|P7|Double Blind Period (Week 0-54)|Unspecified|0
124282|NCT00488631|401239|P6|Double Blind Period (Week 0-54)|Unspecified|34
124283|NCT00488631|401240|P5|Double Blind Period (Week 0-54)|Unspecified|14
124284|NCT00488631|401241|P4|Double Blind Period (Week 0-54)|Unspecified|11
124285|NCT00488631|401242|P3|Double Blind Period (Week 0-54)|Unspecified|10
124286|NCT00488631|401243|P2|Double Blind Period (Week 0-54)|Unspecified|12
124287|NCT00488631|401244|P1|Double Blind Period (Week 0-54)|Unspecified|6
124288|NCT00488631|401235|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
124289|NCT00488631|401236|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
124290|NCT00488631|401237|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
124291|NCT00488631|401238|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
124292|NCT00488631|401239|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
124293|NCT00488631|401240|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
124294|NCT00488631|401241|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
124295|NCT00488631|401242|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
124296|NCT00488631|401243|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
124297|NCT00488631|401244|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
124298|NCT00488631|401235|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
124299|NCT00488631|401236|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
124300|NCT00488631|401237|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
124301|NCT00488631|401238|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
124302|NCT00488631|401239|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
124303|NCT00488631|401240|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
124304|NCT00488631|401241|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
124305|NCT00488631|401242|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
124306|NCT00488631|401243|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
124307|NCT00488631|401244|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
124308|NCT00488631|401235|P10|Double Blind Period (Week 0-54)|Death|0
124309|NCT00488631|401236|P9|Double Blind Period (Week 0-54)|Death|0
124310|NCT00488631|401237|P8|Double Blind Period (Week 0-54)|Death|0
124311|NCT00488631|401238|P7|Double Blind Period (Week 0-54)|Death|0
124312|NCT00488631|401239|P6|Double Blind Period (Week 0-54)|Death|1
124313|NCT00488631|401240|P5|Double Blind Period (Week 0-54)|Death|0
124314|NCT00488631|401241|P4|Double Blind Period (Week 0-54)|Death|0
124315|NCT00488631|401242|P3|Double Blind Period (Week 0-54)|Death|0
124316|NCT00488631|401243|P2|Double Blind Period (Week 0-54)|Death|0
124317|NCT00488631|401244|P1|Double Blind Period (Week 0-54)|Death|0
124318|NCT00488631|401235|P10|Double Blind Period (Week 0-54)|Adverse Event|0
124319|NCT00488631|401236|P9|Double Blind Period (Week 0-54)|Adverse Event|0
124320|NCT00488631|401237|P8|Double Blind Period (Week 0-54)|Adverse Event|0
124321|NCT00488631|401238|P7|Double Blind Period (Week 0-54)|Adverse Event|0
124322|NCT00488631|401239|P6|Double Blind Period (Week 0-54)|Adverse Event|50
124323|NCT00488631|401240|P5|Double Blind Period (Week 0-54)|Adverse Event|30
124324|NCT00488631|401241|P4|Double Blind Period (Week 0-54)|Adverse Event|12
124325|NCT00488631|401242|P3|Double Blind Period (Week 0-54)|Adverse Event|12
124326|NCT00488631|401243|P2|Double Blind Period (Week 0-54)|Adverse Event|12
124327|NCT00488631|401244|P1|Double Blind Period (Week 0-54)|Adverse Event|17
124328|NCT00488644|401279|P1|Overall Study|Not Evaluable|1
124329|NCT00488644|401279|P1|Overall Study|Not Eligible|1
124330|NCT00488683|401286|P3|Overall Study|Unable to Classify|0
124331|NCT00488683|401287|P2|Overall Study|Unable to Classify|0
124332|NCT00488683|401288|P1|Overall Study|Unable to Classify|1
124333|NCT00488683|401286|P3|Overall Study|Protocol Violation|0
124334|NCT00488683|401287|P2|Overall Study|Protocol Violation|1
124335|NCT00488683|401288|P1|Overall Study|Protocol Violation|5
124336|NCT00488683|401286|P3|Overall Study|Lost to Follow-up|0
124337|NCT00488683|401287|P2|Overall Study|Lost to Follow-up|3
124338|NCT00488683|401288|P1|Overall Study|Lost to Follow-up|5
124339|NCT00488683|401286|P3|Overall Study|Withdrawal by Subject|2
124340|NCT00488683|401287|P2|Overall Study|Withdrawal by Subject|2
124341|NCT00488683|401288|P1|Overall Study|Withdrawal by Subject|1
124342|NCT00488774|401351|P4|Overall Study|Lost to Follow-up|1
124343|NCT00488774|401352|P3|Overall Study|Lost to Follow-up|1
124344|NCT00488774|401353|P2|Overall Study|Lost to Follow-up|0
124345|NCT00488774|401354|P1|Overall Study|Lost to Follow-up|0
124346|NCT00488774|401351|P4|Overall Study|unspecified|2
124347|NCT00488774|401352|P3|Overall Study|unspecified|2
124348|NCT00488774|401353|P2|Overall Study|unspecified|3
124349|NCT00488774|401354|P1|Overall Study|unspecified|6
124350|NCT00488774|401351|P4|Overall Study|Withdrawal of consent|0
124351|NCT00488774|401352|P3|Overall Study|Withdrawal of consent|2
124352|NCT00488774|401353|P2|Overall Study|Withdrawal of consent|2
124353|NCT00488774|401354|P1|Overall Study|Withdrawal of consent|2
124354|NCT00488826|401371|P3|Overall Study|Protocol Deviations|1
124355|NCT00488826|401372|P2|Overall Study|Protocol Deviations|1
124356|NCT00488826|401373|P1|Overall Study|Protocol Deviations|2
124357|NCT00488826|401371|P3|Overall Study|Lost to Follow-up|0
124358|NCT00488826|401372|P2|Overall Study|Lost to Follow-up|1
124359|NCT00488826|401373|P1|Overall Study|Lost to Follow-up|5
124360|NCT00488826|401371|P3|Overall Study|Adverse Event|4
124361|NCT00488826|401372|P2|Overall Study|Adverse Event|15
124362|NCT00488826|401373|P1|Overall Study|Adverse Event|9
124363|NCT00488826|401371|P3|Overall Study|Protocol Violation|2
124364|NCT00488826|401372|P2|Overall Study|Protocol Violation|0
124365|NCT00488826|401373|P1|Overall Study|Protocol Violation|0
124366|NCT00488826|401371|P3|Overall Study|Withdrawal by Subject|19
124367|NCT00488826|401372|P2|Overall Study|Withdrawal by Subject|35
124368|NCT00488826|401373|P1|Overall Study|Withdrawal by Subject|40
124369|NCT00489216|401394|P1|Overall Study|Adverse Event|1
124370|NCT00489255|401405|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
124371|NCT00489255|401406|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
124372|NCT00489255|401405|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
124373|NCT00489255|401406|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
124374|NCT00489255|401405|P2|Period 3: Days 57 to 84|Adverse Event|3
124375|NCT00489255|401406|P1|Period 3: Days 57 to 84|Adverse Event|3
124376|NCT00489255|401405|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
124377|NCT00489255|401406|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
124378|NCT00489255|401405|P2|Period 2: Days 29 to 56|Adverse Event|1
124379|NCT00489255|401406|P1|Period 2: Days 29 to 56|Adverse Event|3
124380|NCT00489255|401405|P2|Period 1: Days 1 to 28|Noncompliance|0
124381|NCT00489255|401406|P1|Period 1: Days 1 to 28|Noncompliance|2
124382|NCT00489255|401405|P2|Period 1: Days 1 to 28|Physician Decision|4
124383|NCT00489255|401406|P1|Period 1: Days 1 to 28|Physician Decision|1
124384|NCT00489255|401405|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
124385|NCT00489255|401406|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
124386|NCT00489255|401405|P2|Period 1: Days 1 to 28|Adverse Event|8
124387|NCT00489255|401406|P1|Period 1: Days 1 to 28|Adverse Event|21
124388|NCT00489255|401405|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
124389|NCT00489255|401406|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
124390|NCT00489359|401492|P2|Overall Study|Adverse Event|16
124391|NCT00489359|401493|P1|Overall Study|Adverse Event|0
124392|NCT00489359|401492|P2|Overall Study|Withdrawal by Subject|5
124393|NCT00489359|401493|P1|Overall Study|Withdrawal by Subject|1
124394|NCT00489359|401492|P2|Overall Study|Lost to Follow-up|0
124395|NCT00489359|401493|P1|Overall Study|Lost to Follow-up|1
124396|NCT00489359|401492|P2|Overall Study|Progressive Disease|6
124397|NCT00489359|401493|P1|Overall Study|Progressive Disease|5
124398|NCT00489359|401492|P2|Overall Study|Death|2
124399|NCT00489359|401493|P1|Overall Study|Death|0
124400|NCT00489411|401518|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
124401|NCT00489411|401519|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
124402|NCT00489411|401518|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
124403|NCT00489411|401519|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
124404|NCT00489411|401518|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
124405|NCT00489411|401519|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
124406|NCT00489411|401518|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
124407|NCT00489411|401519|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
124408|NCT00489411|401518|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
124409|NCT00489411|401519|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
124410|NCT00489424|401534|P3|Overall Study|Administrative problems|1
124411|NCT00489424|401535|P2|Overall Study|Administrative problems|2
124412|NCT00489424|401536|P1|Overall Study|Administrative problems|0
124413|NCT00489424|401534|P3|Overall Study|Lack of Efficacy|0
124414|NCT00489424|401535|P2|Overall Study|Lack of Efficacy|0
124415|NCT00489424|401536|P1|Overall Study|Lack of Efficacy|1
124416|NCT00489424|401534|P3|Overall Study|Adverse Event|4
124417|NCT00489424|401535|P2|Overall Study|Adverse Event|3
124418|NCT00489424|401536|P1|Overall Study|Adverse Event|3
124419|NCT00489476|401569|P4|Overall Study|Lost to Follow-up|0
124420|NCT00489476|401570|P3|Overall Study|Lost to Follow-up|0
124421|NCT00489476|401571|P2|Overall Study|Lost to Follow-up|1
124422|NCT00489476|401572|P1|Overall Study|Lost to Follow-up|0
124423|NCT00489489|401593|P3|Overall Study|Other than above|0
124424|NCT00489489|401594|P2|Overall Study|Other than above|1
124425|NCT00489489|401595|P1|Overall Study|Other than above|0
124426|NCT00489489|401593|P3|Overall Study|Participant did not wish to continue|0
124427|NCT00489489|401594|P2|Overall Study|Participant did not wish to continue|1
124428|NCT00489489|401595|P1|Overall Study|Participant did not wish to continue|1
124429|NCT00489489|401593|P3|Overall Study|Progressive disease|0
124430|NCT00489489|401594|P2|Overall Study|Progressive disease|1
124431|NCT00489489|401595|P1|Overall Study|Progressive disease|0
124432|NCT00489489|401593|P3|Overall Study|Protocol Violation|1
124433|NCT00489489|401594|P2|Overall Study|Protocol Violation|0
124434|NCT00489489|401595|P1|Overall Study|Protocol Violation|1
124435|NCT00489489|401593|P3|Overall Study|Adverse Event|1
124436|NCT00489489|401594|P2|Overall Study|Adverse Event|1
124437|NCT00489489|401595|P1|Overall Study|Adverse Event|1
124438|NCT00489489|401593|P3|Overall Study|Not treated due to protocol violation|1
124439|NCT00489489|401594|P2|Overall Study|Not treated due to protocol violation|1
124440|NCT00489489|401595|P1|Overall Study|Not treated due to protocol violation|0
124441|NCT00489541|401625|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
124442|NCT00489541|401626|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
124443|NCT00489541|401625|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
124444|NCT00489541|401626|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
124445|NCT00489541|401625|P2|12-Month Clinical Follow-up|Death|2
124446|NCT00489541|401626|P1|12-Month Clinical Follow-up|Death|3
124447|NCT00489541|401625|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
124448|NCT00489541|401626|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
124449|NCT00489541|401625|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
124450|NCT00489541|401626|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
124451|NCT00489541|401625|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
124452|NCT00489541|401626|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
124453|NCT00489554|401634|P1|Overall Study|Lost to Follow-up|1
124454|NCT00489554|401634|P1|Overall Study|Withdrawal by Subject|1
124455|NCT00489554|401634|P1|Overall Study|Adverse Event|2
124456|NCT00479765|401652|P1|Overall Study|study terminated|4
124457|NCT00479856|401656|P1|Overall Study|Physician Decision|1
124458|NCT00479856|401656|P1|Overall Study|Withdrawal by Subject|1
124459|NCT00479856|401656|P1|Overall Study|Adverse Event|1
124460|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
124461|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
124462|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
124463|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
124464|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
124465|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
124466|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
124467|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
124468|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
124469|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
124470|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
124471|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
124472|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Other|2
124473|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Other|2
124474|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Other|0
124475|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Other|5
124476|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
124477|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
124478|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
124479|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
124480|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
124481|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
124482|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
124483|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
124484|NCT00479882|401669|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
124485|NCT00479882|401670|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
124486|NCT00479882|401671|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
124487|NCT00479882|401672|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
124488|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
124489|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
124490|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
124491|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
124492|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
124493|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
124494|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
124495|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
124496|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
124497|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
124498|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
124499|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
124500|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
124501|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
124502|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
124503|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
124504|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
124505|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
124506|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
124507|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
124508|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
124509|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
124510|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
124511|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
124512|NCT00479882|401669|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
124513|NCT00479882|401670|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
124514|NCT00479882|401671|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
124515|NCT00479882|401672|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
124516|NCT00480324|401804|P2|Overall Study|Subject’s mother pregnant|1
124517|NCT00480324|401805|P1|Overall Study|Subject’s mother pregnant|0
124518|NCT00480324|401804|P2|Overall Study|Lost to Follow-up|8
124519|NCT00480324|401805|P1|Overall Study|Lost to Follow-up|17
124520|NCT00480324|401804|P2|Overall Study|Withdrawal by Subject|5
124521|NCT00480324|401805|P1|Overall Study|Withdrawal by Subject|14
124522|NCT00480324|401804|P2|Overall Study|Protocol Violation|1
124523|NCT00480324|401805|P1|Overall Study|Protocol Violation|0
124524|NCT00480324|401804|P2|Overall Study|Adverse Event|1
124525|NCT00480324|401805|P1|Overall Study|Adverse Event|1
124526|NCT00480493|401833|P2|Overall Study|moved|7
124527|NCT00480493|401834|P1|Overall Study|moved|2
124528|NCT00480532|401848|P4|Overall Study|Protocol Violation|0
124529|NCT00480532|401849|P3|Overall Study|Protocol Violation|1
124530|NCT00480532|401850|P2|Overall Study|Protocol Violation|0
124531|NCT00480532|401851|P1|Overall Study|Protocol Violation|0
124532|NCT00480532|401848|P4|Overall Study|Withdrawal by Subject|1
124533|NCT00480532|401849|P3|Overall Study|Withdrawal by Subject|3
124534|NCT00480532|401850|P2|Overall Study|Withdrawal by Subject|4
124535|NCT00480532|401851|P1|Overall Study|Withdrawal by Subject|2
124536|NCT00480636|401869|P1|Overall Study|Lost to follow-up; subsequently died|1
124537|NCT00480636|401869|P1|Overall Study|Unspecified|2
124538|NCT00480636|401869|P1|Overall Study|Lost to Follow-up|4
124539|NCT00480636|401869|P1|Overall Study|Death|12
124540|NCT00480779|401892|P2|Overall Study|Job and Health-related|3
124541|NCT00480779|401893|P1|Overall Study|Job and Health-related|0
124542|NCT00480779|401892|P2|Overall Study|Other|0
124543|NCT00480779|401893|P1|Overall Study|Other|2
124544|NCT00480857|401917|P1|Overall Study|Lack of Efficacy|2
124545|NCT00481195|401928|P2|Overall Study|Miscellaneous|2
124546|NCT00481195|401929|P1|Overall Study|Miscellaneous|2
124547|NCT00481195|401928|P2|Overall Study|Withdrawal by Subject|9
124548|NCT00481195|401929|P1|Overall Study|Withdrawal by Subject|3
124549|NCT00481195|401928|P2|Overall Study|Protocol Violation|7
124550|NCT00481195|401929|P1|Overall Study|Protocol Violation|10
124551|NCT00481195|401928|P2|Overall Study|Physician Decision|1
124552|NCT00481195|401929|P1|Overall Study|Physician Decision|3
124553|NCT00481195|401928|P2|Overall Study|Lost to Follow-up|6
124554|NCT00481195|401929|P1|Overall Study|Lost to Follow-up|4
124555|NCT00481195|401928|P2|Overall Study|Lack of Efficacy|3
124556|NCT00481195|401929|P1|Overall Study|Lack of Efficacy|1
124557|NCT00481195|401928|P2|Overall Study|Adverse Event|11
124558|NCT00481195|401929|P1|Overall Study|Adverse Event|16
124559|NCT00481247|402015|P2|Overall Study|Did not receive treatment|2
124560|NCT00481247|402016|P1|Overall Study|Did not receive treatment|1
124561|NCT00481247|402015|P2|Overall Study|Varied|15
124562|NCT00481247|402016|P1|Overall Study|Varied|6
124563|NCT00481247|402015|P2|Overall Study|Administrative reason by sponsor|162
124564|NCT00481247|402016|P1|Overall Study|Administrative reason by sponsor|157
124565|NCT00481247|402015|P2|Overall Study|Poor compliance/noncompliance|7
124566|NCT00481247|402016|P1|Overall Study|Poor compliance/noncompliance|1
124567|NCT00481247|402015|P2|Overall Study|Lost to Follow-up|2
124568|NCT00481247|402016|P1|Overall Study|Lost to Follow-up|1
124569|NCT00481247|402015|P2|Overall Study|Pregnancy|1
124570|NCT00481247|402016|P1|Overall Study|Pregnancy|2
124571|NCT00481247|402015|P2|Overall Study|Withdrawal by Subject|13
124572|NCT00481247|402016|P1|Overall Study|Withdrawal by Subject|8
124573|NCT00481247|402015|P2|Overall Study|AE unrelated to study drug|4
124574|NCT00481247|402016|P1|Overall Study|AE unrelated to study drug|13
124575|NCT00481247|402015|P2|Overall Study|Treatment failure|14
124576|NCT00481247|402016|P1|Overall Study|Treatment failure|10
124577|NCT00481247|402015|P2|Overall Study|Intolerance|17
124578|NCT00481247|402016|P1|Overall Study|Intolerance|42
124579|NCT00481247|402015|P2|Overall Study|Disease progression|22
124580|NCT00481247|402016|P1|Overall Study|Disease progression|18
124581|NCT00481247|402015|P2|Overall Study|Death|1
124582|NCT00481247|402016|P1|Overall Study|Death|0
124583|NCT00481676|402066|P2|Overall Study|Administrative problem|0
124584|NCT00481676|402067|P1|Overall Study|Administrative problem|1
124585|NCT00481676|402066|P2|Overall Study|Unsatisfactory therapeutic effect|4
124586|NCT00481676|402067|P1|Overall Study|Unsatisfactory therapeutic effect|1
124587|NCT00481676|402066|P2|Overall Study|Adverse Event|1
124588|NCT00481676|402067|P1|Overall Study|Adverse Event|0
124589|NCT00481767|402091|P2|Overall Study|Lost to Follow-up|10
124590|NCT00481767|402092|P1|Overall Study|Lost to Follow-up|16
124591|NCT00481767|402091|P2|Overall Study|Withdrawal by Subject|11
124592|NCT00481767|402092|P1|Overall Study|Withdrawal by Subject|16
124593|NCT00481871|402138|P5|Overall Study|Progressive Disease - pt withdrew|0
124594|NCT00481871|402139|P4|Overall Study|Progressive Disease - pt withdrew|0
124595|NCT00481871|402140|P3|Overall Study|Progressive Disease - pt withdrew|1
124596|NCT00481871|402141|P2|Overall Study|Progressive Disease - pt withdrew|0
124597|NCT00481871|402142|P1|Overall Study|Progressive Disease - pt withdrew|0
124598|NCT00481988|402158|P2|Overall Study|Withdrawal by Subject|1
124599|NCT00481988|402159|P1|Overall Study|Withdrawal by Subject|1
124600|NCT00482014|402171|P4|Overall Study|Sponsor Decision|1
124601|NCT00482014|402172|P3|Overall Study|Sponsor Decision|1
124602|NCT00482014|402173|P2|Overall Study|Sponsor Decision|2
124603|NCT00482014|402174|P1|Overall Study|Sponsor Decision|1
124604|NCT00482014|402171|P4|Overall Study|Lack of Efficacy|6
124605|NCT00482014|402172|P3|Overall Study|Lack of Efficacy|4
124606|NCT00482014|402173|P2|Overall Study|Lack of Efficacy|0
124607|NCT00482014|402174|P1|Overall Study|Lack of Efficacy|1
124608|NCT00482014|402171|P4|Overall Study|Death|4
124609|NCT00482014|402172|P3|Overall Study|Death|1
124610|NCT00482014|402173|P2|Overall Study|Death|2
124611|NCT00482014|402174|P1|Overall Study|Death|1
124612|NCT00482014|402171|P4|Overall Study|Adverse Event|8
124613|NCT00482014|402172|P3|Overall Study|Adverse Event|2
124614|NCT00482014|402173|P2|Overall Study|Adverse Event|0
124615|NCT00482014|402174|P1|Overall Study|Adverse Event|3
124616|NCT00482014|402171|P4|Overall Study|Withdrawal by Subject|4
124617|NCT00482014|402172|P3|Overall Study|Withdrawal by Subject|3
124618|NCT00482014|402173|P2|Overall Study|Withdrawal by Subject|2
124619|NCT00482014|402174|P1|Overall Study|Withdrawal by Subject|1
124620|NCT00482170|402198|P2|Overall Study|Unspecified reason|2
124621|NCT00482170|402199|P1|Overall Study|Unspecified reason|0
124622|NCT00482170|402198|P2|Overall Study|Lost to Follow-up|0
124623|NCT00482170|402199|P1|Overall Study|Lost to Follow-up|2
124624|NCT00482170|402198|P2|Overall Study|Protocol Violation|3
124625|NCT00482170|402199|P1|Overall Study|Protocol Violation|2
124626|NCT00482170|402198|P2|Overall Study|Withdrawal by Subject|1
124627|NCT00482170|402199|P1|Overall Study|Withdrawal by Subject|6
124628|NCT00482170|402198|P2|Overall Study|Adverse Event|14
124629|NCT00482170|402199|P1|Overall Study|Adverse Event|5
124630|NCT00482274|402317|P1|Overall Study|Adverse Event|1
124631|NCT00482391|402325|P1|Overall Study|Death|1
124632|NCT00482391|402325|P1|Overall Study|Adverse Event|1
124633|NCT00482391|402325|P1|Overall Study|Withdrawal by Subject|1
124634|NCT00482612|402357|P4|Follow-up Period|Reasons not related to trial|3
124635|NCT00482612|402358|P3|Follow-up Period|Reasons not related to trial|1
124636|NCT00482612|402359|P2|Follow-up Period|Reasons not related to trial|0
124637|NCT00482612|402360|P1|Follow-up Period|Reasons not related to trial|1
124638|NCT00482612|402357|P4|Follow-up Period|Withdrawal by Subject|2
124639|NCT00482612|402358|P3|Follow-up Period|Withdrawal by Subject|7
124640|NCT00482612|402359|P2|Follow-up Period|Withdrawal by Subject|5
124641|NCT00482612|402360|P1|Follow-up Period|Withdrawal by Subject|3
124642|NCT00482612|402357|P4|Follow-up Period|Lack of Efficacy|0
124643|NCT00482612|402358|P3|Follow-up Period|Lack of Efficacy|1
124644|NCT00482612|402359|P2|Follow-up Period|Lack of Efficacy|0
124645|NCT00482612|402360|P1|Follow-up Period|Lack of Efficacy|2
124646|NCT00482612|402357|P4|Follow-up Period|Adverse Event|0
124647|NCT00482612|402358|P3|Follow-up Period|Adverse Event|9
124648|NCT00482612|402359|P2|Follow-up Period|Adverse Event|7
124649|NCT00482612|402360|P1|Follow-up Period|Adverse Event|4
124650|NCT00482612|402357|P4|Follow-up Period|Lost to Follow-up|1
124651|NCT00482612|402358|P3|Follow-up Period|Lost to Follow-up|2
124652|NCT00482612|402359|P2|Follow-up Period|Lost to Follow-up|4
124653|NCT00482612|402360|P1|Follow-up Period|Lost to Follow-up|0
124654|NCT00482612|402357|P4|Follow-up Period|Lack of compliance|0
124655|NCT00482612|402358|P3|Follow-up Period|Lack of compliance|1
124656|NCT00482612|402359|P2|Follow-up Period|Lack of compliance|0
124657|NCT00482612|402360|P1|Follow-up Period|Lack of compliance|0
124658|NCT00482612|402357|P4|Follow-up Period|Unspecified|2
124659|NCT00482612|402358|P3|Follow-up Period|Unspecified|1
124660|NCT00482612|402359|P2|Follow-up Period|Unspecified|2
124661|NCT00482612|402360|P1|Follow-up Period|Unspecified|4
124662|NCT00482612|402357|P4|In-treatment Period|No study medication administered|0
124663|NCT00482612|402358|P3|In-treatment Period|No study medication administered|1
124664|NCT00482612|402359|P2|In-treatment Period|No study medication administered|0
124665|NCT00482612|402360|P1|In-treatment Period|No study medication administered|0
124666|NCT00482703|402397|P2|Overall Study|Poor compliance|0
124667|NCT00482703|402398|P1|Overall Study|Poor compliance|1
124668|NCT00482729|402445|P2|Overall Study|Withdrawal by Subject|69
124669|NCT00482729|402446|P1|Overall Study|Withdrawal by Subject|67
124670|NCT00482729|402445|P2|Overall Study|Protocol Violation|18
124671|NCT00482729|402446|P1|Overall Study|Protocol Violation|10
124672|NCT00482729|402445|P2|Overall Study|Pregnancy|2
124673|NCT00482729|402446|P1|Overall Study|Pregnancy|4
124674|NCT00482729|402445|P2|Overall Study|Physician Decision|7
124675|NCT00482729|402446|P1|Overall Study|Physician Decision|10
124676|NCT00482729|402445|P2|Overall Study|Lost to Follow-up|66
124677|NCT00482729|402446|P1|Overall Study|Lost to Follow-up|86
124678|NCT00482729|402445|P2|Overall Study|Lack of Efficacy|16
124679|NCT00482729|402446|P1|Overall Study|Lack of Efficacy|4
124680|NCT00482729|402445|P2|Overall Study|Hyperglycemia Criteria|5
124681|NCT00482729|402446|P1|Overall Study|Hyperglycemia Criteria|7
124682|NCT00482729|402445|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
124683|NCT00482729|402446|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
124684|NCT00482729|402445|P2|Overall Study|Adverse Event|33
124685|NCT00482729|402446|P1|Overall Study|Adverse Event|29
124686|NCT00483002|402477|P1|Overall Study|Unspecified|967
124687|NCT00483002|402477|P1|Overall Study|Other|2
124688|NCT00483002|402477|P1|Overall Study|Lost to Follow-up|962
124689|NCT00483002|402477|P1|Overall Study|Lack of Efficacy|555
124690|NCT00483002|402477|P1|Overall Study|Adverse Event|68
124691|NCT00483041|402485|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
124692|NCT00483041|402486|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
124693|NCT00483119|402518|P2|Overall Study|Physician Decision|0
124694|NCT00483119|402519|P1|Overall Study|Physician Decision|1
124695|NCT00483119|402518|P2|Overall Study|Adverse Event|1
124696|NCT00483119|402519|P1|Overall Study|Adverse Event|0
124697|NCT00483184|402534|P3|Overall Study|Protocol Violation|1
124698|NCT00483184|402535|P2|Overall Study|Protocol Violation|0
124699|NCT00483184|402536|P1|Overall Study|Protocol Violation|1
124700|NCT00483184|402534|P3|Overall Study|Adverse Event|2
124701|NCT00483184|402535|P2|Overall Study|Adverse Event|2
124702|NCT00483184|402536|P1|Overall Study|Adverse Event|1
124703|NCT00483184|402534|P3|Overall Study|Lost to Follow-up|0
124704|NCT00483184|402535|P2|Overall Study|Lost to Follow-up|0
124705|NCT00483184|402536|P1|Overall Study|Lost to Follow-up|1
124706|NCT00483184|402534|P3|Overall Study|Withdrawal by Subject|0
124707|NCT00483184|402535|P2|Overall Study|Withdrawal by Subject|2
124708|NCT00483184|402536|P1|Overall Study|Withdrawal by Subject|2
124709|NCT00483327|402564|P1|Overall Study|Patient Non Compliance|2
124710|NCT00483327|402564|P1|Overall Study|Lost to Follow-up|4
124711|NCT00483327|402564|P1|Overall Study|Withdrawal by Subject|3
124712|NCT00483327|402564|P1|Overall Study|Adverse Event|1
124713|NCT00483379|402573|P2|Treatment Period|Withdrawal by Subject|0
124714|NCT00483379|402574|P1|Treatment Period|Withdrawal by Subject|1
124715|NCT00483379|402573|P2|Treatment Period|Adverse Event|0
124716|NCT00483379|402574|P1|Treatment Period|Adverse Event|1
124717|NCT00483405|402610|P1|Overall Study|Other complicating disease|1
124718|NCT00483405|402610|P1|Overall Study|Withdrawal by Subject|2
124719|NCT00483405|402610|P1|Overall Study|Death|3
124720|NCT00483405|402610|P1|Overall Study|Lack of Efficacy|14
124721|NCT00483405|402610|P1|Overall Study|Adverse Event|8
124722|NCT00483548|402630|P2|Overall Study|Withdrawal by Subject|2
124723|NCT00483548|402631|P1|Overall Study|Withdrawal by Subject|5
124724|NCT00483548|402630|P2|Overall Study|Lost to Follow-up|4
124725|NCT00483548|402631|P1|Overall Study|Lost to Follow-up|3
124726|NCT00483548|402630|P2|Overall Study|Non-compliance with medication|0
124727|NCT00483548|402631|P1|Overall Study|Non-compliance with medication|2
124728|NCT00483548|402630|P2|Overall Study|Unable to comply with protocol schedule|0
124729|NCT00483548|402631|P1|Overall Study|Unable to comply with protocol schedule|1
124730|NCT00483548|402630|P2|Overall Study|Protocol required discontinuation|6
124731|NCT00483548|402631|P1|Overall Study|Protocol required discontinuation|6
124732|NCT00483548|402630|P2|Overall Study|Pregnancy|0
124733|NCT00483548|402631|P1|Overall Study|Pregnancy|1
124734|NCT00483548|402630|P2|Overall Study|Protocol Violation|7
124735|NCT00483548|402631|P1|Overall Study|Protocol Violation|11
124736|NCT00483548|402630|P2|Overall Study|Lack of Efficacy|8
124737|NCT00483548|402631|P1|Overall Study|Lack of Efficacy|4
124738|NCT00483548|402630|P2|Overall Study|Laboratory abnormality|2
124739|NCT00483548|402631|P1|Overall Study|Laboratory abnormality|1
124740|NCT00483548|402630|P2|Overall Study|Adverse Event|14
124741|NCT00483548|402631|P1|Overall Study|Adverse Event|25
124742|NCT00483548|402630|P2|Overall Study|Randomized; not treated with study drug|3
124743|NCT00483548|402631|P1|Overall Study|Randomized; not treated with study drug|1
124744|NCT00483574|402671|P2|Overall Study|Withdrawal by Subject|0
124745|NCT00483574|402672|P1|Overall Study|Withdrawal by Subject|52
124746|NCT00483574|402671|P2|Overall Study|Lost to Follow-up|4
124747|NCT00483574|402672|P1|Overall Study|Lost to Follow-up|16
124748|NCT00483574|402671|P2|Overall Study|Protocol Violation|9
124749|NCT00483574|402672|P1|Overall Study|Protocol Violation|28
124750|NCT00483574|402671|P2|Overall Study|Adverse Event|0
124751|NCT00483574|402672|P1|Overall Study|Adverse Event|6
124752|NCT00489736|402682|P2|Overall Study|Not coded/ Not pre-specified|8
124753|NCT00489736|402683|P1|Overall Study|Not coded/ Not pre-specified|5
124754|NCT00489736|402682|P2|Overall Study|Poor compliance|2
124755|NCT00489736|402683|P1|Overall Study|Poor compliance|6
124756|NCT00489736|402682|P2|Overall Study|Adverse Event|45
124757|NCT00489736|402683|P1|Overall Study|Adverse Event|32
124758|NCT00489736|402682|P2|Overall Study|Lack of Efficacy|14
124759|NCT00489736|402683|P1|Overall Study|Lack of Efficacy|53
124760|NCT00489853|402693|P3|Treatment Period 3|Study specific discontinuation criteria|0
124761|NCT00489853|402694|P2|Treatment Period 3|Study specific discontinuation criteria|1
124762|NCT00489853|402695|P1|Treatment Period 3|Study specific discontinuation criteria|0
124763|NCT00489853|402693|P3|Wash-out Period 2|Study specific discontinuation criteria|2
124764|NCT00489853|402694|P2|Wash-out Period 2|Study specific discontinuation criteria|2
124765|NCT00489853|402695|P1|Wash-out Period 2|Study specific discontinuation criteria|3
124766|NCT00489853|402693|P3|Wash-out Period 2|Adverse Event|0
124767|NCT00489853|402694|P2|Wash-out Period 2|Adverse Event|1
124768|NCT00489853|402695|P1|Wash-out Period 2|Adverse Event|1
124769|NCT00489853|402693|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
124770|NCT00489853|402694|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
124771|NCT00489853|402695|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
124772|NCT00489853|402693|P3|Wash-out Period 1|Protocol Violation|1
124773|NCT00489853|402694|P2|Wash-out Period 1|Protocol Violation|1
124774|NCT00489853|402695|P1|Wash-out Period 1|Protocol Violation|0
124775|NCT00489853|402693|P3|Wash-out Period 1|Adverse Event|1
124776|NCT00489853|402694|P2|Wash-out Period 1|Adverse Event|1
124777|NCT00489853|402695|P1|Wash-out Period 1|Adverse Event|0
124778|NCT00489853|402693|P3|Wash-out Period 1|Withdrawal by Subject|0
124779|NCT00489853|402694|P2|Wash-out Period 1|Withdrawal by Subject|0
124780|NCT00489853|402695|P1|Wash-out Period 1|Withdrawal by Subject|1
124781|NCT00490646|402809|P2|Overall Study|Never Treated (withdrew consent)|1
124782|NCT00490646|402810|P1|Overall Study|Never Treated (withdrew consent)|0
124783|NCT00490646|402809|P2|Overall Study|Never Treated (had an adverse event)|0
124784|NCT00490646|402810|P1|Overall Study|Never Treated (had an adverse event)|1
124785|NCT00490646|402809|P2|Overall Study|Still on trastuzumab monotherapy|1
124786|NCT00490646|402810|P1|Overall Study|Still on trastuzumab monotherapy|1
124787|NCT00490698|402830|P1|Overall Study|Physician Decision|2
124788|NCT00490698|402830|P1|Overall Study|Disease Progression|7
124789|NCT00490698|402830|P1|Overall Study|Withdrawal by Subject|1
124790|NCT00490724|402837|P3|Period II|Treatment Discontinuation|3
124791|NCT00490724|402838|P2|Period II|Treatment Discontinuation|1
124792|NCT00490724|402839|P1|Period II|Treatment Discontinuation|3
124793|NCT00490724|402837|P3|Period I|Physician Decision|1
124794|NCT00490724|402838|P2|Period I|Physician Decision|0
124795|NCT00490724|402839|P1|Period I|Physician Decision|0
124796|NCT00490815|402923|P2|Overall Study|Death|3
124797|NCT00490815|402924|P1|Overall Study|Death|1
124798|NCT00490815|402923|P2|Overall Study|Lost to Follow-up|3
124799|NCT00490815|402924|P1|Overall Study|Lost to Follow-up|1
124800|NCT00490815|402923|P2|Overall Study|Withdrawal by Subject|0
124801|NCT00490815|402924|P1|Overall Study|Withdrawal by Subject|4
124802|NCT00490815|402923|P2|Overall Study|Adverse Event|3
124803|NCT00490815|402924|P1|Overall Study|Adverse Event|2
124804|NCT00490841|402932|P1|Overall Study|30 day f/u, only non-study stent used|3
124805|NCT00490841|402932|P1|Overall Study|Lost to Follow-up|1
124806|NCT00490841|402932|P1|Overall Study|Withdrawal by Subject|4
124807|NCT00490841|402932|P1|Overall Study|Death|5
124808|NCT00490919|402954|P3|Double-blind Phase|Administrative|6
124809|NCT00490919|402955|P2|Double-blind Phase|Administrative|6
124810|NCT00490919|402956|P1|Double-blind Phase|Administrative|0
124811|NCT00490919|402954|P3|Double-blind Phase|Lack of Efficacy|36
124812|NCT00490919|402955|P2|Double-blind Phase|Lack of Efficacy|22
124813|NCT00490919|402956|P1|Double-blind Phase|Lack of Efficacy|0
124814|NCT00490919|402954|P3|Double-blind Phase|Lost to Follow-up|11
124815|NCT00490919|402955|P2|Double-blind Phase|Lost to Follow-up|8
124816|NCT00490919|402956|P1|Double-blind Phase|Lost to Follow-up|0
124817|NCT00490919|402954|P3|Double-blind Phase|Withdrawal by Subject|11
124818|NCT00490919|402955|P2|Double-blind Phase|Withdrawal by Subject|10
124819|NCT00490919|402956|P1|Double-blind Phase|Withdrawal by Subject|0
124820|NCT00490919|402954|P3|Double-blind Phase|Adverse Event|20
124821|NCT00490919|402955|P2|Double-blind Phase|Adverse Event|40
124822|NCT00490919|402956|P1|Double-blind Phase|Adverse Event|0
124823|NCT00490919|402954|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
124824|NCT00490919|402955|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
124825|NCT00490919|402956|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
124826|NCT00490919|402954|P3|Open-label Run-in Period|Administrative|0
124827|NCT00490919|402955|P2|Open-label Run-in Period|Administrative|0
124828|NCT00490919|402956|P1|Open-label Run-in Period|Administrative|40
124829|NCT00490919|402954|P3|Open-label Run-in Period|Lack of Efficacy|0
124830|NCT00490919|402955|P2|Open-label Run-in Period|Lack of Efficacy|0
124831|NCT00490919|402956|P1|Open-label Run-in Period|Lack of Efficacy|143
124832|NCT00490919|402954|P3|Open-label Run-in Period|Lost to Follow-up|0
124833|NCT00490919|402955|P2|Open-label Run-in Period|Lost to Follow-up|0
124834|NCT00490919|402956|P1|Open-label Run-in Period|Lost to Follow-up|21
124835|NCT00490919|402954|P3|Open-label Run-in Period|Withdrawal by Subject|0
124836|NCT00490919|402955|P2|Open-label Run-in Period|Withdrawal by Subject|0
124837|NCT00490919|402956|P1|Open-label Run-in Period|Withdrawal by Subject|37
124838|NCT00490919|402954|P3|Open-label Run-in Period|Adverse Event|0
124839|NCT00490919|402955|P2|Open-label Run-in Period|Adverse Event|0
124840|NCT00490919|402956|P1|Open-label Run-in Period|Adverse Event|239
124841|NCT00490945|402972|P5|Overall Study|Adverse Event|0
124842|NCT00490945|402973|P4|Overall Study|Adverse Event|0
124843|NCT00490945|402974|P3|Overall Study|Adverse Event|0
124844|NCT00490945|402975|P2|Overall Study|Adverse Event|1
124845|NCT00490945|402976|P1|Overall Study|Adverse Event|0
124846|NCT00490971|403012|P5|Maintenance|Not specified|3
124847|NCT00490971|403013|P4|Maintenance|Not specified|9
124848|NCT00490971|403014|P3|Maintenance|Not specified|11
124849|NCT00490971|403015|P2|Maintenance|Not specified|0
124850|NCT00490971|403016|P1|Maintenance|Not specified|0
124851|NCT00490971|403012|P5|Maintenance|Withdrawal by Subject|18
124852|NCT00490971|403013|P4|Maintenance|Withdrawal by Subject|28
124853|NCT00490971|403014|P3|Maintenance|Withdrawal by Subject|26
124854|NCT00490971|403015|P2|Maintenance|Withdrawal by Subject|0
124855|NCT00490971|403016|P1|Maintenance|Withdrawal by Subject|0
124856|NCT00490971|403012|P5|Maintenance|Protocol Violation|1
124857|NCT00490971|403013|P4|Maintenance|Protocol Violation|1
124858|NCT00490971|403014|P3|Maintenance|Protocol Violation|4
124859|NCT00490971|403015|P2|Maintenance|Protocol Violation|0
124860|NCT00490971|403016|P1|Maintenance|Protocol Violation|0
124861|NCT00490971|403012|P5|Maintenance|Pregnancy|0
124862|NCT00490971|403013|P4|Maintenance|Pregnancy|0
124863|NCT00490971|403014|P3|Maintenance|Pregnancy|1
124864|NCT00490971|403015|P2|Maintenance|Pregnancy|0
124865|NCT00490971|403016|P1|Maintenance|Pregnancy|0
124866|NCT00490971|403012|P5|Maintenance|Lost to Follow-up|10
124867|NCT00490971|403013|P4|Maintenance|Lost to Follow-up|8
124868|NCT00490971|403014|P3|Maintenance|Lost to Follow-up|5
124869|NCT00490971|403015|P2|Maintenance|Lost to Follow-up|0
124870|NCT00490971|403016|P1|Maintenance|Lost to Follow-up|0
124871|NCT00490971|403012|P5|Maintenance|Death|0
124872|NCT00490971|403013|P4|Maintenance|Death|2
124873|NCT00490971|403014|P3|Maintenance|Death|0
124874|NCT00490971|403015|P2|Maintenance|Death|0
124875|NCT00490971|403016|P1|Maintenance|Death|0
124876|NCT00490971|403012|P5|Maintenance|Adverse Event|7
124877|NCT00490971|403013|P4|Maintenance|Adverse Event|5
124878|NCT00490971|403014|P3|Maintenance|Adverse Event|4
124879|NCT00490971|403015|P2|Maintenance|Adverse Event|0
124880|NCT00490971|403016|P1|Maintenance|Adverse Event|0
124881|NCT00490971|403012|P5|Acute/Continuation|Not specified|0
124882|NCT00490971|403013|P4|Acute/Continuation|Not specified|0
124883|NCT00490971|403014|P3|Acute/Continuation|Not specified|0
124884|NCT00490971|403015|P2|Acute/Continuation|Not specified|4
124885|NCT00490971|403016|P1|Acute/Continuation|Not specified|11
124886|NCT00490971|403012|P5|Acute/Continuation|Withdrawal by Subject|0
124887|NCT00490971|403013|P4|Acute/Continuation|Withdrawal by Subject|0
124888|NCT00490971|403014|P3|Acute/Continuation|Withdrawal by Subject|0
124889|NCT00490971|403015|P2|Acute/Continuation|Withdrawal by Subject|24
124890|NCT00490971|403016|P1|Acute/Continuation|Withdrawal by Subject|92
124891|NCT00490971|403012|P5|Acute/Continuation|Protocol Violation|0
124892|NCT00490971|403013|P4|Acute/Continuation|Protocol Violation|0
124893|NCT00490971|403014|P3|Acute/Continuation|Protocol Violation|0
124894|NCT00490971|403015|P2|Acute/Continuation|Protocol Violation|2
124895|NCT00490971|403016|P1|Acute/Continuation|Protocol Violation|10
124896|NCT00490971|403012|P5|Acute/Continuation|Lost to Follow-up|0
124897|NCT00490971|403013|P4|Acute/Continuation|Lost to Follow-up|0
124898|NCT00490971|403014|P3|Acute/Continuation|Lost to Follow-up|0
124899|NCT00490971|403015|P2|Acute/Continuation|Lost to Follow-up|7
124900|NCT00490971|403016|P1|Acute/Continuation|Lost to Follow-up|23
124901|NCT00490971|403012|P5|Acute/Continuation|Lack of Efficacy|0
124902|NCT00490971|403013|P4|Acute/Continuation|Lack of Efficacy|0
124903|NCT00490971|403014|P3|Acute/Continuation|Lack of Efficacy|0
124904|NCT00490971|403015|P2|Acute/Continuation|Lack of Efficacy|12
124905|NCT00490971|403016|P1|Acute/Continuation|Lack of Efficacy|106
124906|NCT00490971|403012|P5|Acute/Continuation|Death|0
124907|NCT00490971|403013|P4|Acute/Continuation|Death|0
124908|NCT00490971|403014|P3|Acute/Continuation|Death|0
124909|NCT00490971|403015|P2|Acute/Continuation|Death|0
124910|NCT00490971|403016|P1|Acute/Continuation|Death|2
124911|NCT00490971|403012|P5|Acute/Continuation|Adverse Event|0
124912|NCT00490971|403013|P4|Acute/Continuation|Adverse Event|0
124913|NCT00490971|403014|P3|Acute/Continuation|Adverse Event|0
124914|NCT00490971|403015|P2|Acute/Continuation|Adverse Event|13
124915|NCT00490971|403016|P1|Acute/Continuation|Adverse Event|62
124916|NCT00491075|403058|P1|Overall Study|Physician Decision|1
124917|NCT00491075|403058|P1|Overall Study|Withdrawal by Subject|1
124918|NCT00491179|403064|P2|Overall Study|Withdrawal by Subject|1
124919|NCT00491179|403065|P1|Overall Study|Withdrawal by Subject|2
124920|NCT00491179|403064|P2|Overall Study|Adverse Event|1
124921|NCT00491179|403065|P1|Overall Study|Adverse Event|5
124922|NCT00491400|403099|P2|Overall Study|Withdrawal by Subject|4
124923|NCT00491400|403100|P1|Overall Study|Withdrawal by Subject|5
124924|NCT00491504|403112|P4|Overall Study|Protocol Violation|2
124925|NCT00491504|403113|P3|Overall Study|Protocol Violation|3
124926|NCT00491504|403114|P2|Overall Study|Protocol Violation|0
124927|NCT00491504|403115|P1|Overall Study|Protocol Violation|0
124928|NCT00491504|403112|P4|Overall Study|Withdrawal by Subject|2
124929|NCT00491504|403113|P3|Overall Study|Withdrawal by Subject|1
124930|NCT00491504|403114|P2|Overall Study|Withdrawal by Subject|0
124931|NCT00491504|403115|P1|Overall Study|Withdrawal by Subject|0
124932|NCT00491504|403112|P4|Overall Study|Adverse Event|0
124933|NCT00491504|403113|P3|Overall Study|Adverse Event|0
124934|NCT00491504|403114|P2|Overall Study|Adverse Event|1
124935|NCT00491504|403115|P1|Overall Study|Adverse Event|0
124936|NCT00491530|403126|P3|Overall Study|Use of Prohibited Medication|1
124937|NCT00491530|403127|P2|Overall Study|Use of Prohibited Medication|0
124938|NCT00491530|403128|P1|Overall Study|Use of Prohibited Medication|0
124939|NCT00491530|403126|P3|Overall Study|Patient Request|0
124940|NCT00491530|403127|P2|Overall Study|Patient Request|1
124941|NCT00491530|403128|P1|Overall Study|Patient Request|0
124942|NCT00491530|403126|P3|Overall Study|Investigator Discretion|0
124943|NCT00491530|403127|P2|Overall Study|Investigator Discretion|1
124944|NCT00491530|403128|P1|Overall Study|Investigator Discretion|0
124945|NCT00491530|403126|P3|Overall Study|Lack of Efficacy|0
124946|NCT00491530|403127|P2|Overall Study|Lack of Efficacy|1
124947|NCT00491530|403128|P1|Overall Study|Lack of Efficacy|0
124948|NCT00491530|403126|P3|Overall Study|Lost to Follow-up|2
124949|NCT00491530|403127|P2|Overall Study|Lost to Follow-up|2
124950|NCT00491530|403128|P1|Overall Study|Lost to Follow-up|3
124951|NCT00491530|403126|P3|Overall Study|Withdrawal by Subject|0
124952|NCT00491530|403127|P2|Overall Study|Withdrawal by Subject|0
124953|NCT00491530|403128|P1|Overall Study|Withdrawal by Subject|3
124954|NCT00491530|403126|P3|Overall Study|Adverse Event|2
124955|NCT00491530|403127|P2|Overall Study|Adverse Event|1
124956|NCT00491530|403128|P1|Overall Study|Adverse Event|6
124957|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
124958|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
124959|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
124960|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
124961|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|0
124962|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Not Specified|2
124963|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
124964|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
124965|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
124966|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
124967|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
124968|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
124969|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
124970|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
124971|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
124972|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
124973|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
124974|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
124975|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
124976|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
124977|NCT00491556|403156|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
124978|NCT00491556|403157|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
124979|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|0
124980|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Not Specified|3
124981|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
124982|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
124983|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
124984|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
124985|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
124986|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
124987|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
124988|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
124989|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
124990|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
124991|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
124992|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
124993|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
124994|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
124995|NCT00491556|403156|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
124996|NCT00491556|403157|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
124997|NCT00491608|403213|P1|Overall Study|Withdrawal by Subject|1
124998|NCT00491608|403213|P1|Overall Study|Death|2
124999|NCT00491764|403235|P6|Overall Study|Administrative|0
125000|NCT00491764|403236|P5|Overall Study|Administrative|0
125001|NCT00491764|403237|P4|Overall Study|Administrative|1
125002|NCT00491764|403238|P3|Overall Study|Administrative|2
125003|NCT00491764|403239|P2|Overall Study|Administrative|0
125004|NCT00491764|403240|P1|Overall Study|Administrative|1
125005|NCT00491764|403235|P6|Overall Study|Did not Meet Protocol Eligibility|1
125006|NCT00491764|403236|P5|Overall Study|Did not Meet Protocol Eligibility|1
125007|NCT00491764|403237|P4|Overall Study|Did not Meet Protocol Eligibility|0
125008|NCT00491764|403238|P3|Overall Study|Did not Meet Protocol Eligibility|1
125009|NCT00491764|403239|P2|Overall Study|Did not Meet Protocol Eligibility|1
125010|NCT00491764|403240|P1|Overall Study|Did not Meet Protocol Eligibility|0
125011|NCT00491764|403235|P6|Overall Study|Non Compliance with the Protocol|0
125012|NCT00491764|403236|P5|Overall Study|Non Compliance with the Protocol|0
125013|NCT00491764|403237|P4|Overall Study|Non Compliance with the Protocol|0
125014|NCT00491764|403238|P3|Overall Study|Non Compliance with the Protocol|0
125015|NCT00491764|403239|P2|Overall Study|Non Compliance with the Protocol|0
125016|NCT00491764|403240|P1|Overall Study|Non Compliance with the Protocol|1
125017|NCT00491764|403235|P6|Overall Study|Withdrawal by Subject|4
125018|NCT00491764|403236|P5|Overall Study|Withdrawal by Subject|2
125019|NCT00491764|403237|P4|Overall Study|Withdrawal by Subject|2
125020|NCT00491764|403238|P3|Overall Study|Withdrawal by Subject|1
125021|NCT00491764|403239|P2|Overall Study|Withdrawal by Subject|3
125022|NCT00491764|403240|P1|Overall Study|Withdrawal by Subject|2
125023|NCT00491764|403235|P6|Overall Study|Lost to Follow-up|3
125024|NCT00491764|403236|P5|Overall Study|Lost to Follow-up|0
125025|NCT00491764|403237|P4|Overall Study|Lost to Follow-up|1
125026|NCT00491764|403238|P3|Overall Study|Lost to Follow-up|0
125027|NCT00491764|403239|P2|Overall Study|Lost to Follow-up|1
125028|NCT00491764|403240|P1|Overall Study|Lost to Follow-up|0
125029|NCT00491764|403235|P6|Overall Study|Adverse Event|1
125030|NCT00491764|403236|P5|Overall Study|Adverse Event|0
125031|NCT00491764|403237|P4|Overall Study|Adverse Event|4
125032|NCT00491764|403238|P3|Overall Study|Adverse Event|4
125033|NCT00491764|403239|P2|Overall Study|Adverse Event|2
125034|NCT00491764|403240|P1|Overall Study|Adverse Event|1
125035|NCT00491894|403279|P1|Overall Study|Other-Intake of prohibited medication|1
125036|NCT00491894|403279|P1|Overall Study|Protocol Violation|2
125037|NCT00491894|403279|P1|Overall Study|Physician Decision|2
125038|NCT00491894|403279|P1|Overall Study|Other-Failed to meet any criteria|2
125039|NCT00491894|403279|P1|Overall Study|Lack of Efficacy|2
125040|NCT00491894|403279|P1|Overall Study|Lost to Follow-up|3
125041|NCT00491894|403279|P1|Overall Study|Death|3
125042|NCT00491894|403279|P1|Overall Study|Withdrawal by Subject|5
125043|NCT00491894|403279|P1|Overall Study|Adverse Event|14
125044|NCT00492024|403289|P2|Follow up|Lost to Follow-up|1
125045|NCT00492024|403290|P1|Follow up|Lost to Follow-up|1
125046|NCT00492024|403289|P2|Follow up|Lack of Efficacy|1
125047|NCT00492024|403290|P1|Follow up|Lack of Efficacy|0
125048|NCT00492024|403289|P2|Treatment|Withdrawal by Subject|0
125049|NCT00492024|403290|P1|Treatment|Withdrawal by Subject|2
125050|NCT00492024|403289|P2|Treatment|Lost to Follow-up|1
125051|NCT00492024|403290|P1|Treatment|Lost to Follow-up|3
125052|NCT00492024|403289|P2|Treatment|Lack of Efficacy|20
125053|NCT00492024|403290|P1|Treatment|Lack of Efficacy|21
125054|NCT00492024|403289|P2|Treatment|Adverse Event|1
125055|NCT00492024|403290|P1|Treatment|Adverse Event|3
125056|NCT00492063|403310|P4|Overall Study|Protocol Violation|1
125057|NCT00492063|403311|P3|Overall Study|Protocol Violation|0
125058|NCT00492063|403312|P2|Overall Study|Protocol Violation|0
125059|NCT00492063|403313|P1|Overall Study|Protocol Violation|0
125060|NCT00492063|403310|P4|Overall Study|Lost to Follow-up|3
125061|NCT00492063|403311|P3|Overall Study|Lost to Follow-up|5
125062|NCT00492063|403312|P2|Overall Study|Lost to Follow-up|11
125063|NCT00492063|403313|P1|Overall Study|Lost to Follow-up|6
125064|NCT00492063|403310|P4|Overall Study|Withdrawal by Subject|4
125065|NCT00492063|403311|P3|Overall Study|Withdrawal by Subject|5
125066|NCT00492063|403312|P2|Overall Study|Withdrawal by Subject|3
125067|NCT00492063|403313|P1|Overall Study|Withdrawal by Subject|4
125068|NCT00492063|403310|P4|Overall Study|Death|2
125069|NCT00492063|403311|P3|Overall Study|Death|1
125070|NCT00492063|403312|P2|Overall Study|Death|0
125071|NCT00492063|403313|P1|Overall Study|Death|0
125072|NCT00492232|403353|P2|Open-Label Treatment|Withdrawal by Subject|0
125073|NCT00492232|403354|P1|Open-Label Treatment|Withdrawal by Subject|1
125074|NCT00492232|403353|P2|Double-Blind Treatment|Randomized not treated|0
125075|NCT00492232|403354|P1|Double-Blind Treatment|Randomized not treated|1
125076|NCT00492232|403353|P2|Double-Blind Treatment|Other|5
125077|NCT00492232|403354|P1|Double-Blind Treatment|Other|6
125078|NCT00492232|403353|P2|Double-Blind Treatment|Lack of Efficacy|0
125079|NCT00492232|403354|P1|Double-Blind Treatment|Lack of Efficacy|1
125080|NCT00492232|403353|P2|Double-Blind Treatment|Withdrawal by Subject|8
125081|NCT00492232|403354|P1|Double-Blind Treatment|Withdrawal by Subject|4
125082|NCT00492232|403353|P2|Double-Blind Treatment|Lost to Follow-up|3
125083|NCT00492232|403354|P1|Double-Blind Treatment|Lost to Follow-up|2
125084|NCT00492232|403353|P2|Double-Blind Treatment|Protocol Violation|7
125085|NCT00492232|403354|P1|Double-Blind Treatment|Protocol Violation|3
125086|NCT00492232|403353|P2|Double-Blind Treatment|Adverse Event|2
125087|NCT00492232|403354|P1|Double-Blind Treatment|Adverse Event|1
125088|NCT00492232|403353|P2|Placebo Run-in|Missing|2
125089|NCT00492232|403354|P1|Placebo Run-in|Missing|0
125090|NCT00492232|403353|P2|Placebo Run-in|Other|6
125091|NCT00492232|403354|P1|Placebo Run-in|Other|0
125092|NCT00492232|403353|P2|Placebo Run-in|Entrance criteria not met|45
125093|NCT00492232|403354|P1|Placebo Run-in|Entrance criteria not met|0
125094|NCT00492232|403353|P2|Placebo Run-in|Pregnancy|1
125095|NCT00492232|403354|P1|Placebo Run-in|Pregnancy|0
125096|NCT00492232|403353|P2|Placebo Run-in|Withdrawal by Subject|8
125097|NCT00492232|403354|P1|Placebo Run-in|Withdrawal by Subject|0
125098|NCT00492232|403353|P2|Placebo Run-in|Lost to Follow-up|3
125099|NCT00492232|403354|P1|Placebo Run-in|Lost to Follow-up|0
125100|NCT00492232|403353|P2|Placebo Run-in|Protocol Violation|3
125101|NCT00492232|403354|P1|Placebo Run-in|Protocol Violation|0
125102|NCT00492232|403353|P2|Placebo Run-in|Adverse Event|2
125103|NCT00492232|403354|P1|Placebo Run-in|Adverse Event|0
125104|NCT00492284|403390|P4|Overall Study|Withdrawal by Subject|2
125105|NCT00492284|403391|P3|Overall Study|Withdrawal by Subject|0
125106|NCT00492284|403392|P2|Overall Study|Withdrawal by Subject|0
125107|NCT00492284|403393|P1|Overall Study|Withdrawal by Subject|1
125108|NCT00492284|403390|P4|Overall Study|Death|5
125109|NCT00492284|403391|P3|Overall Study|Death|2
125110|NCT00492284|403392|P2|Overall Study|Death|3
125111|NCT00492284|403393|P1|Overall Study|Death|0
125112|NCT00492284|403390|P4|Overall Study|Lost to Follow-up|1
125113|NCT00492284|403391|P3|Overall Study|Lost to Follow-up|3
125114|NCT00492284|403392|P2|Overall Study|Lost to Follow-up|0
125115|NCT00492284|403393|P1|Overall Study|Lost to Follow-up|0
125116|NCT00492284|403390|P4|Overall Study|Adverse Event|2
125117|NCT00492284|403391|P3|Overall Study|Adverse Event|1
125118|NCT00492284|403392|P2|Overall Study|Adverse Event|1
125119|NCT00492284|403393|P1|Overall Study|Adverse Event|0
125120|NCT00492297|403435|P1|Survival Only Follow-up|Study terminated by sponsor|12
125121|NCT00492297|403435|P1|Survival Only Follow-up|Lack of Efficacy|1
125122|NCT00492297|403435|P1|Survival Only Follow-up|Death|46
125123|NCT00492297|403435|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
125124|NCT00492297|403435|P1|Active Follow-up 30(+4) Days Duration|Death|17
125125|NCT00492297|403435|P1|Treatment|Study terminated by sponsor|3
125126|NCT00492297|403435|P1|Treatment|Death|2
125127|NCT00492531|403469|P2|Overall Study|Withdrawn(More than one reason selected)|23
125128|NCT00492531|403470|P1|Overall Study|Withdrawn(More than one reason selected)|22
125129|NCT00492557|403496|P2|Overall Study|Lost to Follow-up|1
125130|NCT00492557|403497|P1|Overall Study|Lost to Follow-up|0
125131|NCT00492557|403496|P2|Overall Study|Failed to return|0
125132|NCT00492557|403497|P1|Overall Study|Failed to return|1
125133|NCT00492557|403496|P2|Overall Study|Adverse Event|0
125134|NCT00492557|403497|P1|Overall Study|Adverse Event|1
125135|NCT00492557|403496|P2|Overall Study|Death|1
125136|NCT00492557|403497|P1|Overall Study|Death|1
125137|NCT00492557|403496|P2|Overall Study|Unspecified|2
125138|NCT00492557|403497|P1|Overall Study|Unspecified|2
125139|NCT00492557|403496|P2|Overall Study|Protocol Violation|8
125140|NCT00492557|403497|P1|Overall Study|Protocol Violation|7
125141|NCT00492557|403496|P2|Overall Study|Subject request|11
125142|NCT00492557|403497|P1|Overall Study|Subject request|12
125143|NCT00492726|403534|P2|Overall Study|Non compliant with study medication|3
125144|NCT00492726|403535|P1|Overall Study|Non compliant with study medication|0
125145|NCT00492726|403534|P2|Overall Study|Withdrawal by Subject|3
125146|NCT00492726|403535|P1|Overall Study|Withdrawal by Subject|6
125147|NCT00492726|403534|P2|Overall Study|Physician Decision|1
125148|NCT00492726|403535|P1|Overall Study|Physician Decision|0
125149|NCT00492726|403534|P2|Overall Study|Lost to Follow-up|19
125150|NCT00492726|403535|P1|Overall Study|Lost to Follow-up|27
125151|NCT00492726|403534|P2|Overall Study|Lack of Efficacy|2
125152|NCT00492726|403535|P1|Overall Study|Lack of Efficacy|0
125153|NCT00492726|403534|P2|Overall Study|Death|2
125154|NCT00492726|403535|P1|Overall Study|Death|7
125155|NCT00492726|403534|P2|Overall Study|Adverse Event|6
125156|NCT00492726|403535|P1|Overall Study|Adverse Event|10
125157|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
125158|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
125159|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
125160|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
125161|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
125162|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
125163|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
125164|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
125165|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
125166|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
125167|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
125168|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
125169|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
125170|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
125171|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
125172|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
125173|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
125174|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
125175|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
125176|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
125177|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
125178|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
125179|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
125180|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
125181|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Death|1
125182|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Death|45
125183|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Death|5
125184|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Death|75
125185|NCT00492752|403561|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
125186|NCT00492752|403562|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
125187|NCT00492752|403563|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
125188|NCT00492752|403564|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
125189|NCT00492752|403561|P4|Double Blind Treatment|Protocol Violation|0
125190|NCT00492752|403562|P3|Double Blind Treatment|Protocol Violation|1
125191|NCT00492752|403563|P2|Double Blind Treatment|Protocol Violation|0
125192|NCT00492752|403564|P1|Double Blind Treatment|Protocol Violation|0
125193|NCT00492752|403561|P4|Double Blind Treatment|Adverse Event|0
125194|NCT00492752|403562|P3|Double Blind Treatment|Adverse Event|0
125195|NCT00492752|403563|P2|Double Blind Treatment|Adverse Event|0
125196|NCT00492752|403564|P1|Double Blind Treatment|Adverse Event|1
125197|NCT00492752|403561|P4|Double Blind Treatment|Death|0
125198|NCT00492752|403562|P3|Double Blind Treatment|Death|2
125199|NCT00492752|403563|P2|Double Blind Treatment|Death|0
125200|NCT00492752|403564|P1|Double Blind Treatment|Death|13
125201|NCT00492856|403597|P4|Post-consolidation|Observation Arm|0
125202|NCT00492856|403598|P3|Post-consolidation|Observation Arm|27
125203|NCT00492856|403599|P2|Post-consolidation|Observation Arm|0
125204|NCT00492856|403600|P1|Post-consolidation|Observation Arm|0
125205|NCT00492856|403597|P4|Post-consolidation|Lost to Follow-up|0
125206|NCT00492856|403598|P3|Post-consolidation|Lost to Follow-up|0
125207|NCT00492856|403599|P2|Post-consolidation|Lost to Follow-up|2
125208|NCT00492856|403600|P1|Post-consolidation|Lost to Follow-up|0
125209|NCT00492856|403597|P4|Post-consolidation|Not protocol specified|0
125210|NCT00492856|403598|P3|Post-consolidation|Not protocol specified|0
125211|NCT00492856|403599|P2|Post-consolidation|Not protocol specified|1
125212|NCT00492856|403600|P1|Post-consolidation|Not protocol specified|0
125213|NCT00492856|403597|P4|Post-consolidation|Death|0
125214|NCT00492856|403598|P3|Post-consolidation|Death|0
125215|NCT00492856|403599|P2|Post-consolidation|Death|1
125216|NCT00492856|403600|P1|Post-consolidation|Death|0
125217|NCT00492856|403597|P4|Post-consolidation|Withdrawal by Subject|0
125218|NCT00492856|403598|P3|Post-consolidation|Withdrawal by Subject|0
125219|NCT00492856|403599|P2|Post-consolidation|Withdrawal by Subject|4
125220|NCT00492856|403600|P1|Post-consolidation|Withdrawal by Subject|0
125221|NCT00492856|403597|P4|Post-consolidation|Adverse Event|1
125222|NCT00492856|403598|P3|Post-consolidation|Adverse Event|0
125223|NCT00492856|403599|P2|Post-consolidation|Adverse Event|4
125224|NCT00492856|403600|P1|Post-consolidation|Adverse Event|0
125225|NCT00492856|403597|P4|Consolidation|Lost to Follow-up|0
125226|NCT00492856|403598|P3|Consolidation|Lost to Follow-up|0
125227|NCT00492856|403599|P2|Consolidation|Lost to Follow-up|0
125228|NCT00492856|403600|P1|Consolidation|Lost to Follow-up|1
125229|NCT00492856|403597|P4|Consolidation|Not protocol specified|0
125230|NCT00492856|403598|P3|Consolidation|Not protocol specified|0
125231|NCT00492856|403599|P2|Consolidation|Not protocol specified|0
125232|NCT00492856|403600|P1|Consolidation|Not protocol specified|2
125233|NCT00492856|403597|P4|Consolidation|Adverse Event|0
125234|NCT00492856|403598|P3|Consolidation|Adverse Event|0
125235|NCT00492856|403599|P2|Consolidation|Adverse Event|0
125236|NCT00492856|403600|P1|Consolidation|Adverse Event|6
125237|NCT00492856|403597|P4|Induction|Death|0
125238|NCT00492856|403598|P3|Induction|Death|0
125239|NCT00492856|403599|P2|Induction|Death|0
125240|NCT00492856|403600|P1|Induction|Death|3
125241|NCT00492856|403597|P4|Induction|Withdrawal by Subject|0
125242|NCT00492856|403598|P3|Induction|Withdrawal by Subject|0
125243|NCT00492856|403599|P2|Induction|Withdrawal by Subject|0
125244|NCT00492856|403600|P1|Induction|Withdrawal by Subject|1
125245|NCT00492856|403597|P4|Induction|Adverse Event|0
125246|NCT00492856|403598|P3|Induction|Adverse Event|0
125247|NCT00492856|403599|P2|Induction|Adverse Event|0
125248|NCT00492856|403600|P1|Induction|Adverse Event|2
125249|NCT00493012|403631|P2|Overall Study|Lost to Follow-up|17
125250|NCT00493012|403632|P1|Overall Study|Lost to Follow-up|18
125251|NCT00493038|403660|P2|Follow-up|Lost to Follow-up|0
125252|NCT00493038|403661|P1|Follow-up|Lost to Follow-up|1
125253|NCT00493038|403660|P2|Treatment|Other|1
125254|NCT00493038|403661|P1|Treatment|Other|0
125255|NCT00493038|403660|P2|Treatment|Withdrawal by Subject|12
125256|NCT00493038|403661|P1|Treatment|Withdrawal by Subject|11
125257|NCT00493038|403660|P2|Treatment|Lost to Follow-up|3
125258|NCT00493038|403661|P1|Treatment|Lost to Follow-up|5
125259|NCT00493038|403660|P2|Treatment|Adverse Event|4
125260|NCT00493038|403661|P1|Treatment|Adverse Event|8
125261|NCT00481065|403683|P8|Overall Study|Unable to classify|0
125262|NCT00481065|403684|P7|Overall Study|Unable to classify|0
125263|NCT00481065|403685|P6|Overall Study|Unable to classify|0
125264|NCT00481065|403686|P5|Overall Study|Unable to classify|1
125265|NCT00481065|403687|P4|Overall Study|Unable to classify|0
125266|NCT00481065|403688|P3|Overall Study|Unable to classify|2
125267|NCT00481065|403689|P2|Overall Study|Unable to classify|1
125268|NCT00481065|403690|P1|Overall Study|Unable to classify|0
125269|NCT00481065|403683|P8|Overall Study|Protocol Violation|2
125270|NCT00481065|403684|P7|Overall Study|Protocol Violation|3
125271|NCT00481065|403685|P6|Overall Study|Protocol Violation|6
125272|NCT00481065|403686|P5|Overall Study|Protocol Violation|2
125273|NCT00481065|403687|P4|Overall Study|Protocol Violation|1
125274|NCT00481065|403688|P3|Overall Study|Protocol Violation|1
125275|NCT00481065|403689|P2|Overall Study|Protocol Violation|1
125276|NCT00481065|403690|P1|Overall Study|Protocol Violation|2
125277|NCT00481065|403683|P8|Overall Study|Administrative reason|0
125278|NCT00481065|403684|P7|Overall Study|Administrative reason|1
125279|NCT00481065|403685|P6|Overall Study|Administrative reason|2
125280|NCT00481065|403686|P5|Overall Study|Administrative reason|0
125281|NCT00481065|403687|P4|Overall Study|Administrative reason|0
125282|NCT00481065|403688|P3|Overall Study|Administrative reason|0
125283|NCT00481065|403689|P2|Overall Study|Administrative reason|0
125284|NCT00481065|403690|P1|Overall Study|Administrative reason|0
125285|NCT00481065|403683|P8|Overall Study|Inappropriate enrollment|1
125286|NCT00481065|403684|P7|Overall Study|Inappropriate enrollment|0
125287|NCT00481065|403685|P6|Overall Study|Inappropriate enrollment|1
125288|NCT00481065|403686|P5|Overall Study|Inappropriate enrollment|2
125289|NCT00481065|403687|P4|Overall Study|Inappropriate enrollment|0
125290|NCT00481065|403688|P3|Overall Study|Inappropriate enrollment|2
125291|NCT00481065|403689|P2|Overall Study|Inappropriate enrollment|0
125292|NCT00481065|403690|P1|Overall Study|Inappropriate enrollment|4
125293|NCT00481065|403683|P8|Overall Study|Lost to Follow-up|5
125294|NCT00481065|403684|P7|Overall Study|Lost to Follow-up|2
125295|NCT00481065|403685|P6|Overall Study|Lost to Follow-up|3
125296|NCT00481065|403686|P5|Overall Study|Lost to Follow-up|3
125297|NCT00481065|403687|P4|Overall Study|Lost to Follow-up|3
125298|NCT00481065|403688|P3|Overall Study|Lost to Follow-up|4
125299|NCT00481065|403689|P2|Overall Study|Lost to Follow-up|2
125300|NCT00481065|403690|P1|Overall Study|Lost to Follow-up|4
125301|NCT00481065|403683|P8|Overall Study|Withdrawal by Subject|10
125302|NCT00481065|403684|P7|Overall Study|Withdrawal by Subject|9
125303|NCT00481065|403685|P6|Overall Study|Withdrawal by Subject|12
125304|NCT00481065|403686|P5|Overall Study|Withdrawal by Subject|13
125305|NCT00481065|403687|P4|Overall Study|Withdrawal by Subject|11
125306|NCT00481065|403688|P3|Overall Study|Withdrawal by Subject|7
125307|NCT00481065|403689|P2|Overall Study|Withdrawal by Subject|12
125308|NCT00481065|403690|P1|Overall Study|Withdrawal by Subject|11
125309|NCT00481065|403683|P8|Overall Study|Adverse event or death|1
125310|NCT00481065|403684|P7|Overall Study|Adverse event or death|1
125311|NCT00481065|403685|P6|Overall Study|Adverse event or death|0
125312|NCT00481065|403686|P5|Overall Study|Adverse event or death|2
125313|NCT00481065|403687|P4|Overall Study|Adverse event or death|0
125314|NCT00481065|403688|P3|Overall Study|Adverse event or death|3
125315|NCT00481065|403689|P2|Overall Study|Adverse event or death|1
125316|NCT00481065|403690|P1|Overall Study|Adverse event or death|1
125317|NCT00481078|403778|P2|Overall Study|Brain metastasis|1
125318|NCT00481078|403779|P1|Overall Study|Brain metastasis|0
125319|NCT00481078|403778|P2|Overall Study|Received other treatment|1
125320|NCT00481078|403779|P1|Overall Study|Received other treatment|2
125321|NCT00481078|403778|P2|Overall Study|Information not available|0
125322|NCT00481078|403779|P1|Overall Study|Information not available|1
125323|NCT00481078|403778|P2|Overall Study|Withdrawal by Subject|1
125324|NCT00481078|403779|P1|Overall Study|Withdrawal by Subject|7
125325|NCT00481078|403778|P2|Overall Study|Intercurrent illness|0
125326|NCT00481078|403779|P1|Overall Study|Intercurrent illness|1
125327|NCT00481078|403778|P2|Overall Study|Death|3
125328|NCT00481078|403779|P1|Overall Study|Death|5
125329|NCT00481078|403778|P2|Overall Study|Adverse Event|3
125330|NCT00481078|403779|P1|Overall Study|Adverse Event|15
125331|NCT00481078|403778|P2|Overall Study|Progression of disease|11
125332|NCT00481078|403779|P1|Overall Study|Progression of disease|11
125333|NCT00486720|403840|P2|Overall Study|Progressive Disease|1
125334|NCT00486720|403841|P1|Overall Study|Progressive Disease|0
125335|NCT00486720|403840|P2|Overall Study|Withdrawal by Subject|1
125336|NCT00486720|403841|P1|Overall Study|Withdrawal by Subject|3
125337|NCT00486720|403840|P2|Overall Study|Protocol Violation|0
125338|NCT00486720|403841|P1|Overall Study|Protocol Violation|1
125339|NCT00486720|403840|P2|Overall Study|Physician Decision|2
125340|NCT00486720|403841|P1|Overall Study|Physician Decision|1
125341|NCT00486720|403840|P2|Overall Study|Lack of Efficacy|6
125342|NCT00486720|403841|P1|Overall Study|Lack of Efficacy|4
125343|NCT00486720|403840|P2|Overall Study|Adverse Event|2
125344|NCT00486720|403841|P1|Overall Study|Adverse Event|1
125345|NCT00486759|403851|P2|Safety Follow-up|Adverse event/intercurrent illness|0
125346|NCT00486759|403852|P1|Safety Follow-up|Adverse event/intercurrent illness|4
125347|NCT00486759|403851|P2|Safety Follow-up|Refused treatment/did not cooperate|4
125348|NCT00486759|403852|P1|Safety Follow-up|Refused treatment/did not cooperate|6
125349|NCT00486759|403851|P2|Safety Follow-up|Administrative/not specified|6
125350|NCT00486759|403852|P1|Safety Follow-up|Administrative/not specified|8
125351|NCT00486759|403851|P2|Safety Follow-up|Failure to return|6
125352|NCT00486759|403852|P1|Safety Follow-up|Failure to return|9
125353|NCT00486759|403851|P2|Safety Follow-up|Withdrew consent|23
125354|NCT00486759|403852|P1|Safety Follow-up|Withdrew consent|32
125355|NCT00486759|403851|P2|Safety Follow-up|Death|29
125356|NCT00486759|403852|P1|Safety Follow-up|Death|40
125357|NCT00486759|403851|P2|Safety Follow-up|Insufficient therapeutic response|50
125358|NCT00486759|403852|P1|Safety Follow-up|Insufficient therapeutic response|40
125359|NCT00486759|403851|P2|Treatment|Failure to return|1
125360|NCT00486759|403852|P1|Treatment|Failure to return|1
125361|NCT00486759|403851|P2|Treatment|Other protocol violation|5
125362|NCT00486759|403852|P1|Treatment|Other protocol violation|1
125363|NCT00486759|403851|P2|Treatment|Violation of selection criteria at entry|3
125364|NCT00486759|403852|P1|Treatment|Violation of selection criteria at entry|3
125365|NCT00486759|403851|P2|Treatment|Refused treatment|7
125366|NCT00486759|403852|P1|Treatment|Refused treatment|10
125367|NCT00486759|403851|P2|Treatment|Administrative/reason not specified|21
125368|NCT00486759|403852|P1|Treatment|Administrative/reason not specified|17
125369|NCT00486759|403851|P2|Treatment|Withdrew consent|12
125370|NCT00486759|403852|P1|Treatment|Withdrew consent|15
125371|NCT00486759|403851|P2|Treatment|Death|10
125372|NCT00486759|403852|P1|Treatment|Death|17
125373|NCT00486759|403851|P2|Treatment|Insufficient therapeutic response|39
125374|NCT00486759|403852|P1|Treatment|Insufficient therapeutic response|37
125375|NCT00486759|403851|P2|Treatment|Adverse event/intercurrent illness|39
125376|NCT00486759|403852|P1|Treatment|Adverse event/intercurrent illness|86
125377|NCT00486811|403865|P3|Overall Study|All other|7
125378|NCT00486811|403866|P2|Overall Study|All other|11
125379|NCT00486811|403867|P1|Overall Study|All other|18
125380|NCT00486811|403865|P3|Overall Study|Study drug non-compliant|3
125381|NCT00486811|403866|P2|Overall Study|Study drug non-compliant|6
125382|NCT00486811|403867|P1|Overall Study|Study drug non-compliant|5
125383|NCT00486811|403865|P3|Overall Study|Withdrawal by Subject|58
125384|NCT00486811|403866|P2|Overall Study|Withdrawal by Subject|44
125385|NCT00486811|403867|P1|Overall Study|Withdrawal by Subject|33
125386|NCT00486811|403865|P3|Overall Study|Lost to Follow-up|4
125387|NCT00486811|403866|P2|Overall Study|Lost to Follow-up|6
125388|NCT00486811|403867|P1|Overall Study|Lost to Follow-up|4
125389|NCT00486811|403865|P3|Overall Study|Lack of Efficacy|7
125390|NCT00486811|403866|P2|Overall Study|Lack of Efficacy|14
125391|NCT00486811|403867|P1|Overall Study|Lack of Efficacy|34
125392|NCT00486811|403865|P3|Overall Study|Adverse Event|135
125393|NCT00486811|403866|P2|Overall Study|Adverse Event|60
125394|NCT00486811|403867|P1|Overall Study|Adverse Event|28
125395|NCT00486837|403910|P2|Overall Study|No sputum, devise issues, exacerbation|4
125396|NCT00486837|403911|P1|Overall Study|No sputum, devise issues, exacerbation|3
125397|NCT00486837|403910|P2|Overall Study|Protocol Violation|2
125398|NCT00486837|403911|P1|Overall Study|Protocol Violation|4
125399|NCT00486837|403910|P2|Overall Study|Adverse Event|1
125400|NCT00486837|403911|P1|Overall Study|Adverse Event|1
125401|NCT00486837|403910|P2|Overall Study|Withdrawal by Subject|0
125402|NCT00486837|403911|P1|Overall Study|Withdrawal by Subject|1
125403|NCT00486902|403974|P2|Overall Study|No toradol due to hemmorhage or allergy|1
125404|NCT00486902|403975|P1|Overall Study|No toradol due to hemmorhage or allergy|3
125405|NCT00486902|403974|P2|Overall Study|Did not meet inclusion criteria|0
125406|NCT00486902|403975|P1|Overall Study|Did not meet inclusion criteria|1
125407|NCT00486902|403974|P2|Overall Study|spinal anesthetic protocal violation|1
125408|NCT00486902|403975|P1|Overall Study|spinal anesthetic protocal violation|1
125409|NCT00486902|403974|P2|Overall Study|decision for postpartum tubal ligation|1
125410|NCT00486902|403975|P1|Overall Study|decision for postpartum tubal ligation|3
125411|NCT00486902|403974|P2|Overall Study|Withdrawal by Subject|2
125412|NCT00486902|403975|P1|Overall Study|Withdrawal by Subject|1
125413|NCT00486954|403999|P5|Randomized Part|Sponsor Terminated Study|13
125414|NCT00486954|404000|P4|Randomized Part|Sponsor Terminated Study|19
125415|NCT00486954|404001|P3|Randomized Part|Sponsor Terminated Study|0
125416|NCT00486954|404002|P2|Randomized Part|Sponsor Terminated Study|0
125417|NCT00486954|404003|P1|Randomized Part|Sponsor Terminated Study|0
125418|NCT00486954|403999|P5|Randomized Part|Withdrawal by Subject|0
125419|NCT00486954|404000|P4|Randomized Part|Withdrawal by Subject|1
125420|NCT00486954|404001|P3|Randomized Part|Withdrawal by Subject|0
125421|NCT00486954|404002|P2|Randomized Part|Withdrawal by Subject|0
125422|NCT00486954|404003|P1|Randomized Part|Withdrawal by Subject|0
125423|NCT00486954|403999|P5|Randomized Part|Lost to Follow-up|1
125424|NCT00486954|404000|P4|Randomized Part|Lost to Follow-up|0
125425|NCT00486954|404001|P3|Randomized Part|Lost to Follow-up|0
125426|NCT00486954|404002|P2|Randomized Part|Lost to Follow-up|0
125427|NCT00486954|404003|P1|Randomized Part|Lost to Follow-up|0
125428|NCT00486954|403999|P5|Pilot Part|Disease Progression|0
125429|NCT00486954|404000|P4|Pilot Part|Disease Progression|0
125430|NCT00486954|404001|P3|Pilot Part|Disease Progression|1
125431|NCT00486954|404002|P2|Pilot Part|Disease Progression|0
125432|NCT00486954|404003|P1|Pilot Part|Disease Progression|2
125433|NCT00486954|403999|P5|Pilot Part|Adverse Event|0
125434|NCT00486954|404000|P4|Pilot Part|Adverse Event|0
125435|NCT00486954|404001|P3|Pilot Part|Adverse Event|5
125436|NCT00486954|404002|P2|Pilot Part|Adverse Event|0
125437|NCT00486954|404003|P1|Pilot Part|Adverse Event|4
125438|NCT00493220|404109|P6|Third Intervention|Withdrawal by Subject|0
125439|NCT00493220|404110|P5|Third Intervention|Withdrawal by Subject|0
125440|NCT00493220|404111|P4|Third Intervention|Withdrawal by Subject|0
125441|NCT00493220|404112|P3|Third Intervention|Withdrawal by Subject|0
125442|NCT00493220|404113|P2|Third Intervention|Withdrawal by Subject|0
125443|NCT00493220|404114|P1|Third Intervention|Withdrawal by Subject|1
125444|NCT00493246|404139|P8|Overall Study|Lost to Follow-up|0
125445|NCT00493246|404140|P7|Overall Study|Lost to Follow-up|1
125446|NCT00493246|404141|P6|Overall Study|Lost to Follow-up|0
125447|NCT00493246|404142|P5|Overall Study|Lost to Follow-up|0
125448|NCT00493246|404143|P4|Overall Study|Lost to Follow-up|0
125449|NCT00493246|404144|P3|Overall Study|Lost to Follow-up|0
125450|NCT00493246|404145|P2|Overall Study|Lost to Follow-up|0
125451|NCT00493246|404146|P1|Overall Study|Lost to Follow-up|0
125452|NCT00493246|404139|P8|Overall Study|No access to draw blood|0
125453|NCT00493246|404140|P7|Overall Study|No access to draw blood|0
125454|NCT00493246|404141|P6|Overall Study|No access to draw blood|1
125455|NCT00493246|404142|P5|Overall Study|No access to draw blood|0
125456|NCT00493246|404143|P4|Overall Study|No access to draw blood|0
125457|NCT00493246|404144|P3|Overall Study|No access to draw blood|0
125458|NCT00493246|404145|P2|Overall Study|No access to draw blood|0
125459|NCT00493246|404146|P1|Overall Study|No access to draw blood|0
125460|NCT00493246|404139|P8|Overall Study|Withdrawal by Subject|0
125461|NCT00493246|404140|P7|Overall Study|Withdrawal by Subject|0
125462|NCT00493246|404141|P6|Overall Study|Withdrawal by Subject|0
125463|NCT00493246|404142|P5|Overall Study|Withdrawal by Subject|1
125464|NCT00493246|404143|P4|Overall Study|Withdrawal by Subject|0
125465|NCT00493246|404144|P3|Overall Study|Withdrawal by Subject|0
125466|NCT00493246|404145|P2|Overall Study|Withdrawal by Subject|0
125467|NCT00493246|404146|P1|Overall Study|Withdrawal by Subject|0
125468|NCT00493285|404210|P6|Overall Study|Lost to Follow-up|0
125469|NCT00493285|404211|P5|Overall Study|Lost to Follow-up|1
125470|NCT00493285|404212|P4|Overall Study|Lost to Follow-up|0
125471|NCT00493285|404213|P3|Overall Study|Lost to Follow-up|0
125472|NCT00493285|404214|P2|Overall Study|Lost to Follow-up|0
125473|NCT00493285|404215|P1|Overall Study|Lost to Follow-up|0
125474|NCT00493311|404441|P2|Overall Study|Need for rescue medication|2
125475|NCT00493311|404442|P1|Overall Study|Need for rescue medication|2
125476|NCT00494676|404460|P2|Second Intervention|Withdrawal by Subject|1
125477|NCT00494676|404461|P1|Second Intervention|Withdrawal by Subject|1
125478|NCT00494676|404460|P2|First Intervention|Withdrawal by Subject|3
125479|NCT00494676|404461|P1|First Intervention|Withdrawal by Subject|1
125480|NCT00494676|404460|P2|Allocation|Withdrawal by Subject|4
125481|NCT00494676|404461|P1|Allocation|Withdrawal by Subject|2
125482|NCT00494780|404470|P2|Overall Study|Insurance Issues|1
125483|NCT00494780|404471|P1|Overall Study|Insurance Issues|0
125484|NCT00494780|404470|P2|Overall Study|Residual Tumour Mass|1
125485|NCT00494780|404471|P1|Overall Study|Residual Tumour Mass|0
125486|NCT00494780|404470|P2|Overall Study|Non-compliance|0
125487|NCT00494780|404471|P1|Overall Study|Non-compliance|1
125488|NCT00494780|404470|P2|Overall Study|New Treatment|2
125489|NCT00494780|404471|P1|Overall Study|New Treatment|2
125490|NCT00494780|404470|P2|Overall Study|Progression of Study Disease|8
125491|NCT00494780|404471|P1|Overall Study|Progression of Study Disease|7
125492|NCT00494780|404470|P2|Overall Study|Withdrew before Dosed|1
125493|NCT00494780|404471|P1|Overall Study|Withdrew before Dosed|0
125494|NCT00494780|404470|P2|Overall Study|Adverse Event|0
125495|NCT00494780|404471|P1|Overall Study|Adverse Event|1
125496|NCT00494871|404520|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
125497|NCT00494871|404521|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
125498|NCT00494871|404520|P2|Follow-up (FU) Period|Withdrawal by Subject|5
125499|NCT00494871|404521|P1|Follow-up (FU) Period|Withdrawal by Subject|5
125500|NCT00494871|404520|P2|Follow-up (FU) Period|Protocol Violation|0
125501|NCT00494871|404521|P1|Follow-up (FU) Period|Protocol Violation|1
125502|NCT00494871|404520|P2|Follow-up (FU) Period|Physician Decision|1
125503|NCT00494871|404521|P1|Follow-up (FU) Period|Physician Decision|0
125504|NCT00494871|404520|P2|Follow-up (FU) Period|Lost to Follow-up|2
125505|NCT00494871|404521|P1|Follow-up (FU) Period|Lost to Follow-up|6
125506|NCT00494871|404520|P2|Follow-up (FU) Period|Death|12
125507|NCT00494871|404521|P1|Follow-up (FU) Period|Death|13
125508|NCT00494871|404520|P2|Follow-up (FU) Period|Adverse Event|1
125509|NCT00494871|404521|P1|Follow-up (FU) Period|Adverse Event|1
125510|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
125511|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
125512|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
125513|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
125514|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
125515|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
125516|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
125517|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
125518|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
125519|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
125520|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
125521|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
125522|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
125523|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
125524|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
125525|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
125526|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Physician Decision|13
125527|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Physician Decision|4
125528|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Death|3
125529|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Death|8
125530|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
125531|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
125532|NCT00494871|404520|P2|Double-blind (DB) Treatment Period|Adverse Event|70
125533|NCT00494871|404521|P1|Double-blind (DB) Treatment Period|Adverse Event|73
125534|NCT00495131|404569|P2|Overall Study|Withdrawal by Subject|0
125535|NCT00495131|404570|P1|Overall Study|Withdrawal by Subject|1
125536|NCT00495131|404569|P2|Overall Study|Lost to Follow-up|2
125537|NCT00495131|404570|P1|Overall Study|Lost to Follow-up|0
125538|NCT00495131|404569|P2|Overall Study|Lack of Efficacy|2
125539|NCT00495131|404570|P1|Overall Study|Lack of Efficacy|0
125540|NCT00495131|404569|P2|Overall Study|Adverse Event|2
125541|NCT00495131|404570|P1|Overall Study|Adverse Event|6
125542|NCT00495391|404598|P2|Overall Study|Withdrawal by Subject|3
125543|NCT00495391|404599|P1|Overall Study|Withdrawal by Subject|2
125544|NCT00495391|404598|P2|Overall Study|Lack of Efficacy|18
125545|NCT00495391|404599|P1|Overall Study|Lack of Efficacy|34
125546|NCT00495495|404619|P1|Overall Study|Protocol Violation|99
125547|NCT00495586|404634|P2|Overall Study|Withdrawal by Subject|4
125548|NCT00495586|404635|P1|Overall Study|Withdrawal by Subject|4
125549|NCT00495612|404645|P2|Overall Study|Subject's Decision to Withdraw|0
125550|NCT00495612|404646|P1|Overall Study|Subject's Decision to Withdraw|3
125551|NCT00495612|404645|P2|Overall Study|Lost to Follow-up|0
125552|NCT00495612|404646|P1|Overall Study|Lost to Follow-up|1
125553|NCT00495625|404662|P1|Overall Study|Did not complete at least 1 42 day cycle|10
125554|NCT00495677|404678|P7|Stage 1 (25 Days)|Adverse Event|0
125555|NCT00495677|404679|P6|Stage 1 (25 Days)|Adverse Event|0
125556|NCT00495677|404680|P5|Stage 1 (25 Days)|Adverse Event|0
125557|NCT00495677|404681|P4|Stage 1 (25 Days)|Adverse Event|0
125558|NCT00495677|404682|P3|Stage 1 (25 Days)|Adverse Event|1
125559|NCT00495677|404683|P2|Stage 1 (25 Days)|Adverse Event|0
125560|NCT00495677|404684|P1|Stage 1 (25 Days)|Adverse Event|0
125561|NCT00495755|404739|P1|Overall Study|Adverse Event|3
125562|NCT00495794|404746|P2|Overall Study|Pharmacist did not activate patient|0
125563|NCT00495794|404747|P1|Overall Study|Pharmacist did not activate patient|522
125564|NCT00495820|404759|P2|Overall Study|Adverse Event|1
125565|NCT00495820|404760|P1|Overall Study|Adverse Event|1
125566|NCT00496054|404770|P1|Overall Study|Lost to Follow-up|7
125567|NCT00496054|404770|P1|Overall Study|Adverse Event|1
125568|NCT00496080|404797|P1|Overall Study|Physician Decision|6
125569|NCT00496080|404797|P1|Overall Study|Withdrawal by Subject|5
125570|NCT00496080|404797|P1|Overall Study|Surgical re-intervention|7
125571|NCT00496080|404797|P1|Overall Study|Lost to Follow-up|9
125572|NCT00496197|404807|P1|Overall Study|Protocol Violation|8
125573|NCT00496197|404807|P1|Overall Study|Unspecified|14
125574|NCT00496197|404807|P1|Overall Study|Pathogen not isolated baseline specimen|4
125575|NCT00496197|404807|P1|Overall Study|Withdrawal by Subject|11
125576|NCT00496197|404807|P1|Overall Study|Lost to Follow-up|11
125577|NCT00496197|404807|P1|Overall Study|Insufficient bacteriological response|10
125578|NCT00496197|404807|P1|Overall Study|Insufficient clinical response|3
125579|NCT00496197|404807|P1|Overall Study|Does not meet entrance criteria|5
125580|NCT00496197|404807|P1|Overall Study|Adverse Event|13
125581|NCT00496197|404807|P1|Overall Study|Discontinued study due to death|43
125582|NCT00496366|404860|P1|Overall Study|Death|1
125583|NCT00496470|404875|P2|Overall Study|Other reason|2
125584|NCT00496470|404876|P1|Overall Study|Other reason|0
125585|NCT00496470|404875|P2|Overall Study|Incorrectly enrolled|5
125586|NCT00496470|404876|P1|Overall Study|Incorrectly enrolled|13
125587|NCT00496470|404875|P2|Overall Study|Withdrawal by Subject|12
125588|NCT00496470|404876|P1|Overall Study|Withdrawal by Subject|5
125589|NCT00496470|404875|P2|Overall Study|Adverse Event|10
125590|NCT00496470|404876|P1|Overall Study|Adverse Event|8
125591|NCT00496483|404954|P1|Overall Study|Lack of Efficacy|1
125592|NCT00496483|404954|P1|Overall Study|Adverse Event|2
125593|NCT00496483|404954|P1|Overall Study|Not dosed|9
125594|NCT00496587|404969|P1|Overall Study|Complications unrelated|2
125595|NCT00496587|404969|P1|Overall Study|Death|1
125596|NCT00496587|404969|P1|Overall Study|Withdrawal by Subject|2
125597|NCT00496587|404969|P1|Overall Study|Progressive Disease|24
125598|NCT00496587|404969|P1|Overall Study|Adverse Event|2
125599|NCT00496626|404977|P2|Overall Study|Relocated|1
125600|NCT00496626|404978|P1|Overall Study|Relocated|0
125601|NCT00496626|404977|P2|Overall Study|Withdrawal by Subject|4
125602|NCT00496626|404978|P1|Overall Study|Withdrawal by Subject|5
125603|NCT00496626|404977|P2|Overall Study|Protocol Violation|0
125604|NCT00496626|404978|P1|Overall Study|Protocol Violation|1
125605|NCT00496626|404977|P2|Overall Study|Lost to Follow-up|1
125606|NCT00496626|404978|P1|Overall Study|Lost to Follow-up|0
125607|NCT00496730|404992|P2|Overall Study|Withdrawal by Subject|2
125608|NCT00496730|404993|P1|Overall Study|Withdrawal by Subject|2
125609|NCT00496730|404992|P2|Overall Study|Lost to Follow-up|3
125610|NCT00496730|404993|P1|Overall Study|Lost to Follow-up|4
125611|NCT00496769|405005|P2|Overall Study|>=1 reason assigned per patient|649
125612|NCT00496769|405006|P1|Overall Study|>=1 reason assigned per patient|558
125613|NCT00496782|405030|P2|Overall Study|Protocol Violation|2
125614|NCT00496782|405031|P1|Overall Study|Protocol Violation|1
125615|NCT00496834|405070|P2|Overall Study|Blood Pressure control failure|1
125616|NCT00496834|405071|P1|Overall Study|Blood Pressure control failure|2
125617|NCT00496834|405070|P2|Overall Study|Lost to Follow-up|0
125618|NCT00496834|405071|P1|Overall Study|Lost to Follow-up|2
125619|NCT00496834|405070|P2|Overall Study|IP administration violation|0
125620|NCT00496834|405071|P1|Overall Study|IP administration violation|2
125621|NCT00496834|405070|P2|Overall Study|Adverse Event|3
125622|NCT00496834|405071|P1|Overall Study|Adverse Event|5
125623|NCT00496834|405070|P2|Overall Study|Inclusion/exclusion criteria not met|2
125624|NCT00496834|405071|P1|Overall Study|Inclusion/exclusion criteria not met|3
125625|NCT00496834|405070|P2|Overall Study|Contraindicated medication administered|1
125626|NCT00496834|405071|P1|Overall Study|Contraindicated medication administered|0
125627|NCT00496834|405070|P2|Overall Study|Withdrawal by Subject|6
125628|NCT00496834|405071|P1|Overall Study|Withdrawal by Subject|4
125629|NCT00496873|405108|P1|Overall Study|Withdrawal by Subject|3
125630|NCT00496873|405108|P1|Overall Study|Death|2
125631|NCT00496873|405108|P1|Overall Study|Ineligible|2
125632|NCT00496964|405116|P2|Overall Study|Withdrawal by Subject|1
125633|NCT00496964|405117|P1|Overall Study|Withdrawal by Subject|0
125634|NCT00490022|405186|P2|Overall Study|Subject failed to disclose concommitant|1
125635|NCT00490022|405187|P1|Overall Study|Subject failed to disclose concommitant|0
125636|NCT00490022|405186|P2|Overall Study|Withdrawal by Subject|0
125637|NCT00490022|405187|P1|Overall Study|Withdrawal by Subject|1
125638|NCT00490022|405186|P2|Overall Study|Adverse Event|2
125639|NCT00490022|405187|P1|Overall Study|Adverse Event|0
125640|NCT00490035|405199|P4|Overall Study|AE of unknown type|0
125641|NCT00490035|405200|P3|Overall Study|AE of unknown type|2
125642|NCT00490035|405201|P2|Overall Study|AE of unknown type|0
125643|NCT00490035|405202|P1|Overall Study|AE of unknown type|0
125644|NCT00490035|405199|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
125645|NCT00490035|405200|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
125646|NCT00490035|405201|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
125647|NCT00490035|405202|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
125648|NCT00490035|405199|P4|Overall Study|AE, serious fatal|0
125649|NCT00490035|405200|P3|Overall Study|AE, serious fatal|0
125650|NCT00490035|405201|P2|Overall Study|AE, serious fatal|0
125651|NCT00490035|405202|P1|Overall Study|AE, serious fatal|1
125652|NCT00490035|405199|P4|Overall Study|Other reason|1
125653|NCT00490035|405200|P3|Overall Study|Other reason|3
125654|NCT00490035|405201|P2|Overall Study|Other reason|1
125655|NCT00490035|405202|P1|Overall Study|Other reason|0
125656|NCT00490035|405199|P4|Overall Study|Withdrawal by Subject|0
125657|NCT00490035|405200|P3|Overall Study|Withdrawal by Subject|1
125658|NCT00490035|405201|P2|Overall Study|Withdrawal by Subject|1
125659|NCT00490035|405202|P1|Overall Study|Withdrawal by Subject|2
125660|NCT00490035|405199|P4|Overall Study|Lost to Follow-up|0
125661|NCT00490035|405200|P3|Overall Study|Lost to Follow-up|1
125662|NCT00490035|405201|P2|Overall Study|Lost to Follow-up|0
125663|NCT00490035|405202|P1|Overall Study|Lost to Follow-up|2
125664|NCT00490035|405199|P4|Overall Study|AE, non-serious non-fatal|5
125665|NCT00490035|405200|P3|Overall Study|AE, non-serious non-fatal|4
125666|NCT00490035|405201|P2|Overall Study|AE, non-serious non-fatal|4
125667|NCT00490035|405202|P1|Overall Study|AE, non-serious non-fatal|3
125668|NCT00490061|405300|P1|Overall Study|Physician Decision|1
125669|NCT00490139|405314|P4|Overall Study|Participant Withdrew Consent|116
125670|NCT00490139|405315|P3|Overall Study|Participant Withdrew Consent|208
125671|NCT00490139|405316|P2|Overall Study|Participant Withdrew Consent|110
125672|NCT00490139|405317|P1|Overall Study|Participant Withdrew Consent|146
125673|NCT00490139|405314|P4|Overall Study|Lost to Follow-up|56
125674|NCT00490139|405315|P3|Overall Study|Lost to Follow-up|58
125675|NCT00490139|405316|P2|Overall Study|Lost to Follow-up|46
125676|NCT00490139|405317|P1|Overall Study|Lost to Follow-up|56
125677|NCT00490139|405314|P4|Overall Study|Death|135
125678|NCT00490139|405315|P3|Overall Study|Death|168
125679|NCT00490139|405316|P2|Overall Study|Death|119
125680|NCT00490139|405317|P1|Overall Study|Death|106
125681|NCT00490490|405374|P1|Completed Assessment for TTP|Lost to Follow-up|2
125682|NCT00490490|405374|P1|Completed Assessment for TTP|Withdrawal by Subject|1
125683|NCT00490542|405382|P2|Overall Study|Lack of Efficacy|1
125684|NCT00490542|405383|P1|Overall Study|Lack of Efficacy|1
125685|NCT00490542|405382|P2|Overall Study|Adverse Event|3
125686|NCT00490542|405383|P1|Overall Study|Adverse Event|3
125687|NCT00490542|405382|P2|Overall Study|Lost to Follow-up|0
125688|NCT00490542|405383|P1|Overall Study|Lost to Follow-up|3
125689|NCT00490555|405393|P4|Overall Study|noncompliant with drug administration|0
125690|NCT00490555|405394|P3|Overall Study|noncompliant with drug administration|2
125691|NCT00490555|405395|P2|Overall Study|noncompliant with drug administration|0
125692|NCT00490555|405396|P1|Overall Study|noncompliant with drug administration|0
125693|NCT00497146|405424|P2|Long-term Follow-up Period|Other|1
125694|NCT00497146|405425|P1|Long-term Follow-up Period|Other|0
125695|NCT00497146|405424|P2|Long-term Follow-up Period|Lost to Follow-up|1
125696|NCT00497146|405425|P1|Long-term Follow-up Period|Lost to Follow-up|5
125697|NCT00497146|405424|P2|Long-term Follow-up Period|Withdrawal by Subject|2
125698|NCT00497146|405425|P1|Long-term Follow-up Period|Withdrawal by Subject|8
125699|NCT00497146|405424|P2|Long-term Follow-up Period|Adverse Event|2
125700|NCT00497146|405425|P1|Long-term Follow-up Period|Adverse Event|2
125701|NCT00497146|405424|P2|Treatment Period|Other Reason|3
125702|NCT00497146|405425|P1|Treatment Period|Other Reason|2
125703|NCT00497146|405424|P2|Treatment Period|Unable to dose reduce per protocol|1
125704|NCT00497146|405425|P1|Treatment Period|Unable to dose reduce per protocol|4
125705|NCT00497146|405424|P2|Treatment Period|Change in RAAS inhibitor therapy|2
125706|NCT00497146|405425|P1|Treatment Period|Change in RAAS inhibitor therapy|5
125707|NCT00497146|405424|P2|Treatment Period|Required dialysis|1
125708|NCT00497146|405425|P1|Treatment Period|Required dialysis|4
125709|NCT00497146|405424|P2|Treatment Period|Lost to Follow-up|3
125710|NCT00497146|405425|P1|Treatment Period|Lost to Follow-up|1
125711|NCT00497146|405424|P2|Treatment Period|Withdrawal by Subject|9
125712|NCT00497146|405425|P1|Treatment Period|Withdrawal by Subject|5
125713|NCT00497146|405424|P2|Treatment Period|Adverse Event|2
125714|NCT00497146|405425|P1|Treatment Period|Adverse Event|6
125715|NCT00497198|405467|P2|Overall Study|Withdrawal by Subject|1
125716|NCT00497198|405468|P1|Overall Study|Withdrawal by Subject|0
125717|NCT00497198|405467|P2|Overall Study|Physician Decision|2
125718|NCT00497198|405468|P1|Overall Study|Physician Decision|1
125719|NCT00497198|405467|P2|Overall Study|Adverse Event|2
125720|NCT00497198|405468|P1|Overall Study|Adverse Event|4
125721|NCT00499863|405484|P2|Overall Study|Lost to Follow-up|1
125722|NCT00499863|405485|P1|Overall Study|Lost to Follow-up|1
125723|NCT00499863|405484|P2|Overall Study|Sponsor decision|2
125724|NCT00499863|405485|P1|Overall Study|Sponsor decision|2
125725|NCT00499863|405484|P2|Overall Study|Adverse Event|2
125726|NCT00499863|405485|P1|Overall Study|Adverse Event|8
125727|NCT00499863|405484|P2|Overall Study|Withdrawal by Subject|4
125728|NCT00499863|405485|P1|Overall Study|Withdrawal by Subject|6
125729|NCT00499863|405484|P2|Overall Study|Protocol Violation|7
125730|NCT00499863|405485|P1|Overall Study|Protocol Violation|12
125731|NCT00499863|405484|P2|Overall Study|Lack of Efficacy|27
125732|NCT00499863|405485|P1|Overall Study|Lack of Efficacy|21
125733|NCT00499889|405513|P1|Overall Study|Infection prior to treatment|1
125734|NCT00500071|405528|P1|30-day Safety Follow-up|Lost to Follow-up|17
125735|NCT00500071|405528|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
125736|NCT00500071|405528|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
125821|NCT00500682|405713|P1|Overall Study|Adverse Event|37
125737|NCT00500071|405528|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
125738|NCT00500071|405528|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
125739|NCT00500071|405528|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
125740|NCT00500071|405528|P1|Screening and Washout Phase|Protocol Violation|1
125741|NCT00500110|405537|P1|Overall Study|Withdrawal by Subject|3
125742|NCT00500149|405541|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
125743|NCT00500149|405542|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
125744|NCT00500149|405541|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
125745|NCT00500149|405542|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
125746|NCT00500149|405541|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
125747|NCT00500149|405542|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
125748|NCT00500149|405541|P2|First Intervention (Cross-over Phase)|Adverse Event|1
125749|NCT00500149|405542|P1|First Intervention (Cross-over Phase)|Adverse Event|0
125750|NCT00500149|405541|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
125751|NCT00500149|405542|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
125752|NCT00500149|405541|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
125753|NCT00500149|405542|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
125754|NCT00500149|405541|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
125755|NCT00500149|405542|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
125756|NCT00500266|405563|P1|Overall Study|Assigned, not treated|4
125757|NCT00500266|405563|P1|Overall Study|Withdrawal by Subject|3
125758|NCT00500266|405563|P1|Overall Study|Lost to Follow-up|3
125759|NCT00500266|405563|P1|Overall Study|Death|3
125760|NCT00500292|405573|P3|Overall Study|Other|4
125761|NCT00500292|405574|P2|Overall Study|Other|1
125762|NCT00500292|405575|P1|Overall Study|Other|1
125763|NCT00500292|405573|P3|Overall Study|Withdrawal by Subject|0
125764|NCT00500292|405574|P2|Overall Study|Withdrawal by Subject|1
125765|NCT00500292|405575|P1|Overall Study|Withdrawal by Subject|0
125766|NCT00500292|405573|P3|Overall Study|Condition under investigation worsened|19
125767|NCT00500292|405574|P2|Overall Study|Condition under investigation worsened|23
125768|NCT00500292|405575|P1|Overall Study|Condition under investigation worsened|21
125769|NCT00500292|405573|P3|Overall Study|Adverse Event|4
125770|NCT00500292|405574|P2|Overall Study|Adverse Event|6
125771|NCT00500292|405575|P1|Overall Study|Adverse Event|3
125772|NCT00500318|405585|P2|Overall Study|Other Reason|1
125773|NCT00500318|405586|P1|Overall Study|Other Reason|0
125774|NCT00500318|405585|P2|Overall Study|Lack of Efficacy|3
125775|NCT00500318|405586|P1|Overall Study|Lack of Efficacy|0
125776|NCT00500318|405585|P2|Overall Study|Withdrawal by Subject|2
125777|NCT00500318|405586|P1|Overall Study|Withdrawal by Subject|1
125778|NCT00500318|405585|P2|Overall Study|Protocol Violation|3
125779|NCT00500318|405586|P1|Overall Study|Protocol Violation|1
125780|NCT00500318|405585|P2|Overall Study|Adverse Event|8
125781|NCT00500318|405586|P1|Overall Study|Adverse Event|3
125782|NCT00500357|405600|P1|Overall Study|Death|1
125783|NCT00500370|405621|P2|Overall Study|Subject Decision|17
125784|NCT00500370|405622|P1|Overall Study|Subject Decision|10
125785|NCT00500370|405621|P2|Overall Study|Sponsor Decision|0
125786|NCT00500370|405622|P1|Overall Study|Sponsor Decision|2
125787|NCT00500370|405621|P2|Overall Study|Protocol Violation|4
125788|NCT00500370|405622|P1|Overall Study|Protocol Violation|2
125789|NCT00500370|405621|P2|Overall Study|Lost to Follow-up|10
125790|NCT00500370|405622|P1|Overall Study|Lost to Follow-up|10
125791|NCT00500370|405621|P2|Overall Study|Adverse Event|3
125792|NCT00500370|405622|P1|Overall Study|Adverse Event|9
125793|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Missing|3
125794|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
125795|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Death|1
125796|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Administrative problems|1
125797|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
125798|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
125799|NCT00500539|405675|P1|Follow-up Period (16 Weeks)|Adverse Event|1
125800|NCT00500539|405675|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
125801|NCT00500539|405675|P1|Treatment Period (24 Weeks)|Administrative problems|2
125802|NCT00500539|405675|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
125803|NCT00500539|405675|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
125804|NCT00500539|405675|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
125805|NCT00500539|405675|P1|Treatment Period (24 Weeks)|Adverse Event|4
125806|NCT00500682|405712|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
125807|NCT00500682|405713|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
125808|NCT00500682|405712|P2|Overall Study|Withdrawal by Subject|74
125809|NCT00500682|405713|P1|Overall Study|Withdrawal by Subject|80
125810|NCT00500682|405712|P2|Overall Study|Protocol Violation|3
125811|NCT00500682|405713|P1|Overall Study|Protocol Violation|1
125812|NCT00500682|405712|P2|Overall Study|Pregnancy|0
125813|NCT00500682|405713|P1|Overall Study|Pregnancy|2
125814|NCT00500682|405712|P2|Overall Study|Physician Decision|10
125815|NCT00500682|405713|P1|Overall Study|Physician Decision|6
125816|NCT00500682|405712|P2|Overall Study|Lost to Follow-up|11
125817|NCT00500682|405713|P1|Overall Study|Lost to Follow-up|11
125818|NCT00500682|405712|P2|Overall Study|Death|16
125819|NCT00500682|405713|P1|Overall Study|Death|25
125820|NCT00500682|405712|P2|Overall Study|Adverse Event|29
125822|NCT00500760|405721|P2|Overall Study|Other|2
125823|NCT00500760|405722|P1|Overall Study|Other|1
125824|NCT00500760|405721|P2|Overall Study|Lost to Follow-up|0
125825|NCT00500760|405722|P1|Overall Study|Lost to Follow-up|3
125826|NCT00500760|405721|P2|Overall Study|Administrative decision|0
125827|NCT00500760|405722|P1|Overall Study|Administrative decision|2
125828|NCT00500760|405721|P2|Overall Study|Withdrawal by Subject|7
125829|NCT00500760|405722|P1|Overall Study|Withdrawal by Subject|5
125830|NCT00500760|405721|P2|Overall Study|Death|15
125831|NCT00500760|405722|P1|Overall Study|Death|32
125832|NCT00501007|405740|P2|Overall Study|Inclusion criteria not met.|25
125833|NCT00501007|405741|P1|Overall Study|Inclusion criteria not met.|29
125834|NCT00501046|405749|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
125835|NCT00501046|405750|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
125836|NCT00501046|405749|P2|Overall Study|Withdrawal by Subject|83
125837|NCT00501046|405750|P1|Overall Study|Withdrawal by Subject|84
125838|NCT00501046|405749|P2|Overall Study|Protocol Violation|1
125839|NCT00501046|405750|P1|Overall Study|Protocol Violation|2
125840|NCT00501046|405749|P2|Overall Study|Pregnancy|3
125841|NCT00501046|405750|P1|Overall Study|Pregnancy|0
125842|NCT00501046|405749|P2|Overall Study|Physician Decision|2
125843|NCT00501046|405750|P1|Overall Study|Physician Decision|7
125844|NCT00501046|405749|P2|Overall Study|Lost to Follow-up|13
125845|NCT00501046|405750|P1|Overall Study|Lost to Follow-up|14
125846|NCT00501046|405749|P2|Overall Study|Death|30
125847|NCT00501046|405750|P1|Overall Study|Death|23
125848|NCT00501046|405749|P2|Overall Study|Adverse Event|25
125849|NCT00501046|405750|P1|Overall Study|Adverse Event|21
125850|NCT00501085|405756|P1|Overall Study|Other loss to follow-up|32
125851|NCT00501085|405756|P1|Overall Study|Study closed by sponsor|109
125852|NCT00501085|405756|P1|Overall Study|Non-Compliance|24
125853|NCT00501085|405756|P1|Overall Study|Adverse Event|4
125854|NCT00501085|405756|P1|Overall Study|Explantation Surgery|26
125855|NCT00501085|405756|P1|Overall Study|Revision Surgery|7
125856|NCT00501085|405756|P1|Overall Study|Subject Decision|1
125857|NCT00501085|405756|P1|Overall Study|Withdrawal by Subject|34
125858|NCT00501085|405756|P1|Overall Study|Lost to Follow-up|195
125859|NCT00501228|405764|P1|Overall Study|Withdrawal by Subject|1
125860|NCT00501293|405770|P2|Maintenance Period|Application site reaction|0
125861|NCT00501293|405771|P1|Maintenance Period|Application site reaction|1
125862|NCT00501293|405770|P2|Maintenance Period|Would not wear patch|0
125863|NCT00501293|405771|P1|Maintenance Period|Would not wear patch|1
125864|NCT00501293|405770|P2|Maintenance Period|Went into rehabilitation|0
125865|NCT00501293|405771|P1|Maintenance Period|Went into rehabilitation|1
125866|NCT00501293|405770|P2|Maintenance Period|Noncompliant with study medication|0
125867|NCT00501293|405771|P1|Maintenance Period|Noncompliant with study medication|5
125868|NCT00501293|405770|P2|Maintenance Period|Lack of Efficacy|1
125869|NCT00501293|405771|P1|Maintenance Period|Lack of Efficacy|4
125870|NCT00501293|405770|P2|Maintenance Period|Protocol Violation|1
125871|NCT00501293|405771|P1|Maintenance Period|Protocol Violation|2
125872|NCT00501293|405770|P2|Maintenance Period|Adverse Event|6
125873|NCT00501293|405771|P1|Maintenance Period|Adverse Event|6
125874|NCT00501293|405770|P2|Maintenance Period|Lost to Follow-up|7
125875|NCT00501293|405771|P1|Maintenance Period|Lost to Follow-up|12
125876|NCT00501293|405770|P2|Maintenance Period|Withdrawal by Subject|13
125877|NCT00501293|405771|P1|Maintenance Period|Withdrawal by Subject|14
125878|NCT00501293|405770|P2|Optimization Period|Enrolled in error|0
125879|NCT00501293|405771|P1|Optimization Period|Enrolled in error|1
125880|NCT00501540|405802|P1|Overall Study|Death|5
125881|NCT00501644|405833|P1|Overall Study|Withdrawal by Subject|1
125882|NCT00501644|405833|P1|Overall Study|Adverse Event|4
125883|NCT00501852|405837|P1|Overall Study|Withdrawal by Subject|2
125884|NCT00501852|405837|P1|Overall Study|Adverse Event|3
125885|NCT00501969|405883|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
125886|NCT00501969|405883|P1|Overall Study|Other: Admin Request from the Sponsor|3
125887|NCT00501969|405883|P1|Overall Study|Other: As Required by Local EC|2
125888|NCT00501969|405883|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
125889|NCT00501969|405883|P1|Overall Study|Other: Pat Pending Surgery for PD|1
125890|NCT00501969|405883|P1|Overall Study|Other: Patient is Going to Have DBS|1
125891|NCT00501969|405883|P1|Overall Study|Other: Patients + Investigator Agreement|1
125892|NCT00501969|405883|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
125893|NCT00501969|405883|P1|Overall Study|Other: Sponsor Stopped Study|12
125894|NCT00501969|405883|P1|Overall Study|Other: Sponsor Termination at Site|1
125895|NCT00501969|405883|P1|Overall Study|Other: Sponsors Request|10
125896|NCT00501969|405883|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
125897|NCT00501969|405883|P1|Overall Study|Lost to Follow-up|4
125898|NCT00501969|405883|P1|Overall Study|Subject withdrew consent|51
125899|NCT00501969|405883|P1|Overall Study|Unsatisfactory compliance of subject|7
125900|NCT00501969|405883|P1|Overall Study|Adverse Event|76
125901|NCT00501969|405883|P1|Overall Study|Lack of Efficacy|29
125902|NCT00501969|405883|P1|Overall Study|Major Protocol Violation|4
125903|NCT00502203|405894|P1|Overall Study|Inevaluable|1
125904|NCT00502242|405909|P2|Overall Study|Withdrawal by Subject|7
125905|NCT00502242|405910|P1|Overall Study|Withdrawal by Subject|6
125906|NCT00502242|405909|P2|Overall Study|Protocol Violation|1
125907|NCT00502242|405910|P1|Overall Study|Protocol Violation|3
125908|NCT00502242|405909|P2|Overall Study|Other - Unspecified|14
125909|NCT00502242|405910|P1|Overall Study|Other - Unspecified|8
125910|NCT00502242|405909|P2|Overall Study|Physician Decision|3
125911|NCT00502242|405910|P1|Overall Study|Physician Decision|2
125912|NCT00502242|405909|P2|Overall Study|Adverse Event|20
125913|NCT00502242|405910|P1|Overall Study|Adverse Event|31
125914|NCT00502242|405909|P2|Overall Study|Lack of Efficacy|11
125915|NCT00502242|405910|P1|Overall Study|Lack of Efficacy|1
125916|NCT00493454|405961|P1|Overall Study|Withdrawal by Subject|1
125917|NCT00493636|405967|P2|Overall Study|Mis-randomization|1
125918|NCT00493636|405968|P1|Overall Study|Mis-randomization|1
125919|NCT00493636|405967|P2|Overall Study|Disease progression/recurrence/relapse|1
125920|NCT00493636|405968|P1|Overall Study|Disease progression/recurrence/relapse|0
125921|NCT00493636|405967|P2|Overall Study|Withdrawal by Subject|0
125922|NCT00493636|405968|P1|Overall Study|Withdrawal by Subject|1
125923|NCT00493649|405982|P1|Overall Study|Other|13
125924|NCT00493649|405982|P1|Overall Study|Lost to Follow-up|1
125925|NCT00493649|405982|P1|Overall Study|Disease Progression|1
125926|NCT00493649|405982|P1|Overall Study|Investigator Request|2
125927|NCT00493649|405982|P1|Overall Study|Patient Request|21
125928|NCT00493649|405982|P1|Overall Study|Adverse Event|44
125929|NCT00493779|405993|P1|Overall Study|Logistical issue at site|1
125930|NCT00493974|406011|P2|Overall Study|Lost to Follow-up|6
125931|NCT00493974|406012|P1|Overall Study|Lost to Follow-up|4
125932|NCT00493974|406011|P2|Overall Study|Withdrawal by Subject|6
125933|NCT00493974|406012|P1|Overall Study|Withdrawal by Subject|8
125934|NCT00493974|406011|P2|Overall Study|Death|2
125935|NCT00493974|406012|P1|Overall Study|Death|1
125936|NCT00494013|406032|P2|Overall Study|Sponsor Decision|1
125937|NCT00494013|406033|P1|Overall Study|Sponsor Decision|0
125938|NCT00494013|406032|P2|Overall Study|Withdrawal by Subject|14
125939|NCT00494013|406033|P1|Overall Study|Withdrawal by Subject|13
125940|NCT00494013|406032|P2|Overall Study|Protocol Violation|5
125941|NCT00494013|406033|P1|Overall Study|Protocol Violation|8
125942|NCT00494013|406032|P2|Overall Study|Physician Decision|5
125943|NCT00494013|406033|P1|Overall Study|Physician Decision|3
125944|NCT00494013|406032|P2|Overall Study|Lost to Follow-up|6
125945|NCT00494013|406033|P1|Overall Study|Lost to Follow-up|5
125946|NCT00494013|406032|P2|Overall Study|Entry Criteria Not Met|4
125947|NCT00494013|406033|P1|Overall Study|Entry Criteria Not Met|1
125948|NCT00494013|406032|P2|Overall Study|Adverse Event|1
125949|NCT00494013|406033|P1|Overall Study|Adverse Event|0
125950|NCT00494026|406061|P1|Overall Study|Sponsor Decision|4
125951|NCT00494091|406071|P2|Overall Study|Withdrawal by Subject|7
125952|NCT00494091|406072|P1|Overall Study|Withdrawal by Subject|0
125953|NCT00494091|406071|P2|Overall Study|Not Specified|11
125954|NCT00494091|406072|P1|Overall Study|Not Specified|1
125955|NCT00494091|406071|P2|Overall Study|Lost to Follow-up|4
125956|NCT00494091|406072|P1|Overall Study|Lost to Follow-up|0
125957|NCT00494091|406071|P2|Overall Study|Death|54
125958|NCT00494091|406072|P1|Overall Study|Death|5
125959|NCT00494221|406116|P3|Overall Study|Withdrawal by Subject|0
125960|NCT00494221|406117|P2|Overall Study|Withdrawal by Subject|2
125961|NCT00494221|406118|P1|Overall Study|Withdrawal by Subject|1
125962|NCT00494221|406116|P3|Overall Study|Death|14
125963|NCT00494221|406117|P2|Overall Study|Death|9
125964|NCT00494221|406118|P1|Overall Study|Death|15
125965|NCT00494234|406140|P2|Overall Study|Death|1
125966|NCT00494234|406141|P1|Overall Study|Death|2
125967|NCT00494234|406140|P2|Overall Study|Withdrawal by Subject|0
125968|NCT00494234|406141|P1|Overall Study|Withdrawal by Subject|1
125969|NCT00494234|406140|P2|Overall Study|Lack of Efficacy|9
125970|NCT00494234|406141|P1|Overall Study|Lack of Efficacy|12
125971|NCT00494299|406159|P2|Overall Study|Protocol Driven Decision Point|22
125972|NCT00494299|406160|P1|Overall Study|Protocol Driven Decision Point|11
125973|NCT00494299|406159|P2|Overall Study|Site Closed by Sponsor|0
125974|NCT00494299|406160|P1|Overall Study|Site Closed by Sponsor|6
125975|NCT00494299|406159|P2|Overall Study|Participant Did Not Take Study Drug|2
125976|NCT00494299|406160|P1|Overall Study|Participant Did Not Take Study Drug|0
125977|NCT00494299|406159|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
125978|NCT00494299|406160|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
125979|NCT00494299|406159|P2|Overall Study|Withdrawal by Subject|3
125980|NCT00494299|406160|P1|Overall Study|Withdrawal by Subject|8
125981|NCT00494299|406159|P2|Overall Study|Protocol Violation|2
125982|NCT00494299|406160|P1|Overall Study|Protocol Violation|1
125983|NCT00494299|406159|P2|Overall Study|Physician Decision|2
125984|NCT00494299|406160|P1|Overall Study|Physician Decision|0
125985|NCT00494299|406159|P2|Overall Study|Lost to Follow-up|0
125986|NCT00494299|406160|P1|Overall Study|Lost to Follow-up|1
125987|NCT00494299|406159|P2|Overall Study|Adverse Event|13
125988|NCT00494299|406160|P1|Overall Study|Adverse Event|93
125989|NCT00494442|406172|P2|Overall Study|Intercurrent illness|1
125990|NCT00494442|406173|P1|Overall Study|Intercurrent illness|0
125991|NCT00494442|406172|P2|Overall Study|Non-compliance|1
125992|NCT00494442|406173|P1|Overall Study|Non-compliance|0
125993|NCT00494442|406172|P2|Overall Study|Physician Decision|1
125994|NCT00494442|406173|P1|Overall Study|Physician Decision|0
125995|NCT00494442|406172|P2|Overall Study|Adverse Event|2
125996|NCT00494442|406173|P1|Overall Study|Adverse Event|0
125997|NCT00494442|406172|P2|Overall Study|Lack of Efficacy|10
125998|NCT00494442|406173|P1|Overall Study|Lack of Efficacy|16
125999|NCT00494442|406172|P2|Overall Study|Death|1
126000|NCT00494442|406173|P1|Overall Study|Death|1
126001|NCT00494481|406189|P2|Overall Study|Never received IP|0
126002|NCT00494481|406190|P1|Overall Study|Never received IP|2
126003|NCT00494481|406189|P2|Overall Study|Other|0
126004|NCT00494481|406190|P1|Overall Study|Other|1
126005|NCT00494481|406189|P2|Overall Study|Adverse Event|11
126006|NCT00494481|406190|P1|Overall Study|Adverse Event|15
126007|NCT00494481|406189|P2|Overall Study|Condition under investigation worsened|13
126008|NCT00494481|406190|P1|Overall Study|Condition under investigation worsened|11
126009|NCT00494507|406217|P4|Open-Label Phase|Worsening Disease|2
126010|NCT00494507|406218|P3|Open-Label Phase|Worsening Disease|0
126011|NCT00494507|406219|P2|Open-Label Phase|Worsening Disease|0
126012|NCT00494507|406220|P1|Open-Label Phase|Worsening Disease|0
126013|NCT00494507|406217|P4|Open-Label Phase|Adverse Event|3
126014|NCT00494507|406218|P3|Open-Label Phase|Adverse Event|5
126015|NCT00494507|406219|P2|Open-Label Phase|Adverse Event|1
126016|NCT00494507|406220|P1|Open-Label Phase|Adverse Event|0
126017|NCT00494507|406217|P4|Double-Blind Phase|Negative DNA test|1
126018|NCT00494507|406218|P3|Double-Blind Phase|Negative DNA test|0
126019|NCT00494507|406219|P2|Double-Blind Phase|Negative DNA test|0
126020|NCT00494507|406220|P1|Double-Blind Phase|Negative DNA test|0
126021|NCT00494507|406217|P4|Double-Blind Phase|Subject Non-compliance|0
126022|NCT00494507|406218|P3|Double-Blind Phase|Subject Non-compliance|1
126023|NCT00494507|406219|P2|Double-Blind Phase|Subject Non-compliance|0
126024|NCT00494507|406220|P1|Double-Blind Phase|Subject Non-compliance|0
126025|NCT00494507|406217|P4|Double-Blind Phase|Withdrawal by Subject|0
126026|NCT00494507|406218|P3|Double-Blind Phase|Withdrawal by Subject|0
126027|NCT00494507|406219|P2|Double-Blind Phase|Withdrawal by Subject|0
126028|NCT00494507|406220|P1|Double-Blind Phase|Withdrawal by Subject|1
126029|NCT00494507|406217|P4|Double-Blind Phase|Adverse Event|0
126030|NCT00494507|406218|P3|Double-Blind Phase|Adverse Event|1
126031|NCT00494507|406219|P2|Double-Blind Phase|Adverse Event|0
126032|NCT00494507|406220|P1|Double-Blind Phase|Adverse Event|2
126033|NCT00502320|406270|P2|Overall Study|Adverse Event|5
126034|NCT00502320|406271|P1|Overall Study|Adverse Event|3
126035|NCT00502320|406270|P2|Overall Study|Screen Failure|1
126036|NCT00502320|406271|P1|Overall Study|Screen Failure|0
126037|NCT00502320|406270|P2|Overall Study|No longer met criteria|0
126038|NCT00502320|406271|P1|Overall Study|No longer met criteria|1
126039|NCT00502320|406270|P2|Overall Study|Withdrew Consent|0
126040|NCT00502320|406271|P1|Overall Study|Withdrew Consent|1
126041|NCT00502320|406270|P2|Overall Study|Lost to Follow-up|1
126042|NCT00502320|406271|P1|Overall Study|Lost to Follow-up|1
126043|NCT00502593|406293|P12|Overall Study|Lost to Follow-up|0
126044|NCT00502593|406294|P11|Overall Study|Lost to Follow-up|1
126045|NCT00502593|406295|P10|Overall Study|Lost to Follow-up|0
126046|NCT00502593|406296|P9|Overall Study|Lost to Follow-up|3
126047|NCT00502593|406297|P8|Overall Study|Lost to Follow-up|0
126048|NCT00502593|406298|P7|Overall Study|Lost to Follow-up|0
126049|NCT00502593|406299|P6|Overall Study|Lost to Follow-up|0
126050|NCT00502593|406300|P5|Overall Study|Lost to Follow-up|0
126051|NCT00502593|406301|P4|Overall Study|Lost to Follow-up|1
126052|NCT00502593|406302|P3|Overall Study|Lost to Follow-up|1
126053|NCT00502593|406303|P2|Overall Study|Lost to Follow-up|1
126054|NCT00502593|406304|P1|Overall Study|Lost to Follow-up|2
126055|NCT00502593|406293|P12|Overall Study|Withdrawal by Subject|0
126056|NCT00502593|406294|P11|Overall Study|Withdrawal by Subject|1
126057|NCT00502593|406295|P10|Overall Study|Withdrawal by Subject|0
126058|NCT00502593|406296|P9|Overall Study|Withdrawal by Subject|3
126059|NCT00502593|406297|P8|Overall Study|Withdrawal by Subject|0
126060|NCT00502593|406298|P7|Overall Study|Withdrawal by Subject|3
126061|NCT00502593|406299|P6|Overall Study|Withdrawal by Subject|0
126062|NCT00502593|406300|P5|Overall Study|Withdrawal by Subject|2
126063|NCT00502593|406301|P4|Overall Study|Withdrawal by Subject|2
126064|NCT00502593|406302|P3|Overall Study|Withdrawal by Subject|6
126065|NCT00502593|406303|P2|Overall Study|Withdrawal by Subject|0
126066|NCT00502593|406304|P1|Overall Study|Withdrawal by Subject|0
126067|NCT00502593|406293|P12|Overall Study|Withdrawn unspecified reason|0
126068|NCT00502593|406294|P11|Overall Study|Withdrawn unspecified reason|0
126069|NCT00502593|406295|P10|Overall Study|Withdrawn unspecified reason|0
126070|NCT00502593|406296|P9|Overall Study|Withdrawn unspecified reason|0
126071|NCT00502593|406297|P8|Overall Study|Withdrawn unspecified reason|0
126072|NCT00502593|406298|P7|Overall Study|Withdrawn unspecified reason|2
126073|NCT00502593|406299|P6|Overall Study|Withdrawn unspecified reason|0
126074|NCT00502593|406300|P5|Overall Study|Withdrawn unspecified reason|2
126075|NCT00502593|406301|P4|Overall Study|Withdrawn unspecified reason|1
126076|NCT00502593|406302|P3|Overall Study|Withdrawn unspecified reason|3
126077|NCT00502593|406303|P2|Overall Study|Withdrawn unspecified reason|1
126078|NCT00502593|406304|P1|Overall Study|Withdrawn unspecified reason|1
126079|NCT00503399|406820|P2|Overall Study|Lost to Follow-up|2
126080|NCT00503399|406821|P1|Overall Study|Lost to Follow-up|0
126081|NCT00503399|406820|P2|Overall Study|Adverse Event|3
126082|NCT00503399|406821|P1|Overall Study|Adverse Event|0
126083|NCT00503399|406820|P2|Overall Study|Withdrawal by Subject|2
126084|NCT00503399|406821|P1|Overall Study|Withdrawal by Subject|4
126085|NCT00503399|406820|P2|Overall Study|Protocol Violation|0
126086|NCT00503399|406821|P1|Overall Study|Protocol Violation|1
126087|NCT00503399|406820|P2|Overall Study|Death|1
126088|NCT00503399|406821|P1|Overall Study|Death|2
126089|NCT00503425|406843|P1|Overall Study|Missing Data/Unknown|4
126090|NCT00503425|406843|P1|Overall Study|Death|3
126091|NCT00503425|406843|P1|Overall Study|Lost to Follow-up|3
126092|NCT00503425|406843|P1|Overall Study|Withdrawal by Subject|8
126093|NCT00503425|406843|P1|Overall Study|Lack of Efficacy|25
126094|NCT00503425|406843|P1|Overall Study|Adverse Event|5
126095|NCT00503425|406843|P1|Overall Study|Participant files lost|6
126096|NCT00503698|406853|P2|Overall Study|Not exposed to trial drug|6
126097|NCT00503698|406854|P1|Overall Study|Not exposed to trial drug|11
126098|NCT00503698|406853|P2|Overall Study|Unclassified|32
126099|NCT00503698|406854|P1|Overall Study|Unclassified|48
126100|NCT00503698|406853|P2|Overall Study|Critically ill|0
126101|NCT00503698|406854|P1|Overall Study|Critically ill|2
126102|NCT00503698|406853|P2|Overall Study|Move to nonparticipating dialysis center|1
126103|NCT00503698|406854|P1|Overall Study|Move to nonparticipating dialysis center|2
126104|NCT00503698|406853|P2|Overall Study|Switch to peritoneal or home dialysis|2
126105|NCT00503698|406854|P1|Overall Study|Switch to peritoneal or home dialysis|2
126106|NCT00503698|406853|P2|Overall Study|Any condition in exclusion criteria|6
126107|NCT00503698|406854|P1|Overall Study|Any condition in exclusion criteria|4
126108|NCT00503698|406853|P2|Overall Study|Pregnancy/intention to become pregnant|0
126109|NCT00503698|406854|P1|Overall Study|Pregnancy/intention to become pregnant|1
126110|NCT00503698|406853|P2|Overall Study|End hemodialysis due to renal transplant|4
126111|NCT00503698|406854|P1|Overall Study|End hemodialysis due to renal transplant|10
126112|NCT00503698|406853|P2|Overall Study|Trial terminated|253
126113|NCT00503698|406854|P1|Overall Study|Trial terminated|216
126114|NCT00503698|406853|P2|Overall Study|Lack of Efficacy|4
126115|NCT00503698|406854|P1|Overall Study|Lack of Efficacy|3
126116|NCT00503698|406853|P2|Overall Study|Death|0
126117|NCT00503698|406854|P1|Overall Study|Death|1
126118|NCT00503698|406853|P2|Overall Study|Adverse Event|41
126119|NCT00503698|406854|P1|Overall Study|Adverse Event|52
126120|NCT00503698|406853|P2|Overall Study|Protocol Violation|6
126121|NCT00503698|406854|P1|Overall Study|Protocol Violation|5
126122|NCT00503776|406877|P4|Overall Study|Physician Decision|1
126123|NCT00503776|406878|P3|Overall Study|Physician Decision|1
126124|NCT00503776|406879|P2|Overall Study|Physician Decision|0
126125|NCT00503776|406880|P1|Overall Study|Physician Decision|0
126126|NCT00503776|406877|P4|Overall Study|Withdrawal by Subject|1
126127|NCT00503776|406878|P3|Overall Study|Withdrawal by Subject|1
126128|NCT00503776|406879|P2|Overall Study|Withdrawal by Subject|0
126129|NCT00503776|406880|P1|Overall Study|Withdrawal by Subject|1
126130|NCT00503841|406906|P1|Overall Study|All screen failures|44
126131|NCT00503906|406910|P1|Overall Study|Withdrawal by Subject|1
126132|NCT00503984|406921|P6|Overall Study|Death|0
126133|NCT00503984|406922|P5|Overall Study|Death|1
126134|NCT00503984|406923|P4|Overall Study|Death|0
126135|NCT00503984|406924|P3|Overall Study|Death|0
126136|NCT00503984|406925|P2|Overall Study|Death|0
126137|NCT00503984|406926|P1|Overall Study|Death|0
126138|NCT00503984|406921|P6|Overall Study|Adverse Event|0
126139|NCT00503984|406922|P5|Overall Study|Adverse Event|0
126140|NCT00503984|406923|P4|Overall Study|Adverse Event|0
126141|NCT00503984|406924|P3|Overall Study|Adverse Event|0
126142|NCT00503984|406925|P2|Overall Study|Adverse Event|1
126143|NCT00503984|406926|P1|Overall Study|Adverse Event|0
126144|NCT00503984|406921|P6|Overall Study|Protocol Violation|0
126145|NCT00503984|406922|P5|Overall Study|Protocol Violation|0
126146|NCT00503984|406923|P4|Overall Study|Protocol Violation|0
126147|NCT00503984|406924|P3|Overall Study|Protocol Violation|0
126148|NCT00503984|406925|P2|Overall Study|Protocol Violation|1
126149|NCT00503984|406926|P1|Overall Study|Protocol Violation|0
126150|NCT00503997|406952|P1|Overall Study|Withdrawal by Subject|1
126151|NCT00503997|406952|P1|Overall Study|Death|1
126152|NCT00503997|406952|P1|Overall Study|Adverse Event|5
126153|NCT00503997|406952|P1|Overall Study|disease progression|1
126154|NCT00504075|406956|P1|Overall Study|Required other therapeutic intervention|1
126155|NCT00504075|406956|P1|Overall Study|Withdrawal by Subject|1
126156|NCT00504075|406956|P1|Overall Study|Lost to Follow-up|5
126157|NCT00504075|406956|P1|Overall Study|Adverse Event|1
126158|NCT00504153|406962|P1|Overall Study|Death|1
126159|NCT00504153|406962|P1|Overall Study|Adverse Event|4
126160|NCT00504153|406962|P1|Overall Study|Withdrawal by Subject|1
126161|NCT00504166|406972|P2|Overall Study|Lost to Follow-up|3
126162|NCT00504166|406973|P1|Overall Study|Lost to Follow-up|1
126163|NCT00504166|406972|P2|Overall Study|Physician Decision|1
126164|NCT00504166|406973|P1|Overall Study|Physician Decision|1
126165|NCT00504166|406972|P2|Overall Study|Withdrawal by Subject|6
126166|NCT00504166|406973|P1|Overall Study|Withdrawal by Subject|3
126167|NCT00504166|406972|P2|Overall Study|Adverse Event|4
126168|NCT00504166|406973|P1|Overall Study|Adverse Event|1
126169|NCT00504231|406983|P4|Overall Study|Discrepant chart documentation re route|0
126170|NCT00504231|406984|P3|Overall Study|Discrepant chart documentation re route|1
126171|NCT00504231|406985|P2|Overall Study|Discrepant chart documentation re route|0
126172|NCT00504231|406986|P1|Overall Study|Discrepant chart documentation re route|0
126173|NCT00504257|407004|P1|Overall Study|ineligible histology|2
126174|NCT00504257|407004|P1|Overall Study|Withdrawal by Subject|2
126175|NCT00504426|407016|P4|Overall Study|Withdrawal by Subject|0
126176|NCT00504426|407017|P3|Overall Study|Withdrawal by Subject|0
126177|NCT00504426|407018|P2|Overall Study|Withdrawal by Subject|0
126178|NCT00504426|407019|P1|Overall Study|Withdrawal by Subject|2
126179|NCT00504426|407016|P4|Overall Study|Protocol Violation|0
126180|NCT00504426|407017|P3|Overall Study|Protocol Violation|2
126181|NCT00504426|407018|P2|Overall Study|Protocol Violation|1
126182|NCT00504426|407019|P1|Overall Study|Protocol Violation|1
126183|NCT00504426|407016|P4|Overall Study|Adverse Event|0
126184|NCT00504426|407017|P3|Overall Study|Adverse Event|2
126185|NCT00504426|407018|P2|Overall Study|Adverse Event|0
126186|NCT00504426|407019|P1|Overall Study|Adverse Event|0
126187|NCT00504556|407042|P5|Overall Study|not in safety analysis set|1
126188|NCT00504556|407043|P4|Overall Study|not in safety analysis set|0
126189|NCT00504556|407044|P3|Overall Study|not in safety analysis set|1
126190|NCT00504556|407045|P2|Overall Study|not in safety analysis set|1
126191|NCT00504556|407046|P1|Overall Study|not in safety analysis set|0
126192|NCT00504556|407042|P5|Overall Study|not specified|0
126193|NCT00504556|407043|P4|Overall Study|not specified|3
126194|NCT00504556|407044|P3|Overall Study|not specified|2
126195|NCT00504556|407045|P2|Overall Study|not specified|2
126196|NCT00504556|407046|P1|Overall Study|not specified|2
126197|NCT00504556|407042|P5|Overall Study|data monitor committee decision|0
126198|NCT00504556|407043|P4|Overall Study|data monitor committee decision|100
126199|NCT00504556|407044|P3|Overall Study|data monitor committee decision|0
126200|NCT00504556|407045|P2|Overall Study|data monitor committee decision|0
126201|NCT00504556|407046|P1|Overall Study|data monitor committee decision|0
126202|NCT00504556|407042|P5|Overall Study|did not meet entry criteria|0
126203|NCT00504556|407043|P4|Overall Study|did not meet entry criteria|1
126204|NCT00504556|407044|P3|Overall Study|did not meet entry criteria|1
126205|NCT00504556|407045|P2|Overall Study|did not meet entry criteria|0
126206|NCT00504556|407046|P1|Overall Study|did not meet entry criteria|2
126207|NCT00504556|407042|P5|Overall Study|administrative reasons|2
126208|NCT00504556|407043|P4|Overall Study|administrative reasons|1
126209|NCT00504556|407044|P3|Overall Study|administrative reasons|2
126210|NCT00504556|407045|P2|Overall Study|administrative reasons|2
126211|NCT00504556|407046|P1|Overall Study|administrative reasons|0
126212|NCT00504556|407042|P5|Overall Study|Withdrawal by Subject|12
126213|NCT00504556|407043|P4|Overall Study|Withdrawal by Subject|8
126214|NCT00504556|407044|P3|Overall Study|Withdrawal by Subject|7
126215|NCT00504556|407045|P2|Overall Study|Withdrawal by Subject|16
126216|NCT00504556|407046|P1|Overall Study|Withdrawal by Subject|16
126217|NCT00504556|407042|P5|Overall Study|Lost to Follow-up|1
126218|NCT00504556|407043|P4|Overall Study|Lost to Follow-up|1
126219|NCT00504556|407044|P3|Overall Study|Lost to Follow-up|1
126220|NCT00504556|407045|P2|Overall Study|Lost to Follow-up|0
126221|NCT00504556|407046|P1|Overall Study|Lost to Follow-up|0
126222|NCT00504556|407042|P5|Overall Study|Protocol Violation|2
126223|NCT00504556|407043|P4|Overall Study|Protocol Violation|1
126224|NCT00504556|407044|P3|Overall Study|Protocol Violation|2
126225|NCT00504556|407045|P2|Overall Study|Protocol Violation|3
126226|NCT00504556|407046|P1|Overall Study|Protocol Violation|1
126227|NCT00504556|407042|P5|Overall Study|Death|2
126228|NCT00504556|407043|P4|Overall Study|Death|0
126229|NCT00504556|407044|P3|Overall Study|Death|1
126230|NCT00504556|407045|P2|Overall Study|Death|3
126231|NCT00504556|407046|P1|Overall Study|Death|3
126232|NCT00504556|407042|P5|Overall Study|Adverse Event|5
126233|NCT00504556|407043|P4|Overall Study|Adverse Event|13
126234|NCT00504556|407044|P3|Overall Study|Adverse Event|14
126235|NCT00504556|407045|P2|Overall Study|Adverse Event|11
126236|NCT00504556|407046|P1|Overall Study|Adverse Event|11
126237|NCT00504595|407110|P4|Overall Study|Not specified|0
126238|NCT00504595|407111|P3|Overall Study|Not specified|2
126239|NCT00504595|407112|P2|Overall Study|Not specified|0
126240|NCT00504595|407113|P1|Overall Study|Not specified|0
126241|NCT00504595|407110|P4|Overall Study|Lack of Efficacy|0
126242|NCT00504595|407111|P3|Overall Study|Lack of Efficacy|0
126243|NCT00504595|407112|P2|Overall Study|Lack of Efficacy|0
126244|NCT00504595|407113|P1|Overall Study|Lack of Efficacy|1
126245|NCT00504725|407136|P2|Overall Study|Protocol Violation|0
126246|NCT00504725|407137|P1|Overall Study|Protocol Violation|1
126247|NCT00504777|407151|P1|Overall Study|Adverse Event|1
126248|NCT00504881|407160|P2|Overall Study|AE of unknown type|0
126249|NCT00504881|407161|P1|Overall Study|AE of unknown type|1
126250|NCT00504881|407160|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
126251|NCT00504881|407161|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
126252|NCT00504881|407160|P2|Overall Study|AE, non-serious non-fatal|14
126253|NCT00504881|407161|P1|Overall Study|AE, non-serious non-fatal|4
126254|NCT00504881|407160|P2|Overall Study|SAE, non-fatal|6
126255|NCT00504881|407161|P1|Overall Study|SAE, non-fatal|2
126256|NCT00504881|407160|P2|Overall Study|AE, serious fatal|1
126257|NCT00504881|407161|P1|Overall Study|AE, serious fatal|0
126258|NCT00504881|407160|P2|Overall Study|Safety Visit not performed|1
126259|NCT00504881|407161|P1|Overall Study|Safety Visit not performed|0
126260|NCT00504881|407160|P2|Overall Study|No Birth Control|1
126261|NCT00504881|407161|P1|Overall Study|No Birth Control|0
126262|NCT00504881|407160|P2|Overall Study|Non-Compliance|0
126263|NCT00504881|407161|P1|Overall Study|Non-Compliance|1
126264|NCT00504881|407160|P2|Overall Study|Withdrawal by Subject|4
126265|NCT00504881|407161|P1|Overall Study|Withdrawal by Subject|1
126266|NCT00504881|407160|P2|Overall Study|Lost to Follow-up|2
126267|NCT00504881|407161|P1|Overall Study|Lost to Follow-up|0
126268|NCT00504881|407160|P2|Overall Study|Lack of Efficacy|5
126269|NCT00504881|407161|P1|Overall Study|Lack of Efficacy|1
126270|NCT00505076|407227|P3|Overall Study|Withdrawal by Subject|2
126271|NCT00505076|407228|P2|Overall Study|Withdrawal by Subject|1
126272|NCT00505076|407229|P1|Overall Study|Withdrawal by Subject|0
126273|NCT00505076|407227|P3|Overall Study|Protocol Violation|2
126274|NCT00505076|407228|P2|Overall Study|Protocol Violation|1
126275|NCT00505076|407229|P1|Overall Study|Protocol Violation|2
126276|NCT00505076|407227|P3|Overall Study|Adverse Event|1
126277|NCT00505076|407228|P2|Overall Study|Adverse Event|0
126278|NCT00505076|407229|P1|Overall Study|Adverse Event|1
126279|NCT00505284|407248|P5|Overall Study|Not specified|4
126280|NCT00505284|407249|P4|Overall Study|Not specified|4
126281|NCT00505284|407250|P3|Overall Study|Not specified|0
126282|NCT00505284|407251|P2|Overall Study|Not specified|0
126283|NCT00505284|407252|P1|Overall Study|Not specified|5
126284|NCT00505284|407248|P5|Overall Study|Physician Decision|0
126285|NCT00505284|407249|P4|Overall Study|Physician Decision|0
126286|NCT00505284|407250|P3|Overall Study|Physician Decision|0
126287|NCT00505284|407251|P2|Overall Study|Physician Decision|1
126288|NCT00505284|407252|P1|Overall Study|Physician Decision|0
126289|NCT00505284|407248|P5|Overall Study|Lack of Efficacy|1
126290|NCT00505284|407249|P4|Overall Study|Lack of Efficacy|1
126291|NCT00505284|407250|P3|Overall Study|Lack of Efficacy|1
126292|NCT00505284|407251|P2|Overall Study|Lack of Efficacy|1
126293|NCT00505284|407252|P1|Overall Study|Lack of Efficacy|0
126294|NCT00505284|407248|P5|Overall Study|Withdrawal by Subject|6
126295|NCT00505284|407249|P4|Overall Study|Withdrawal by Subject|0
126296|NCT00505284|407250|P3|Overall Study|Withdrawal by Subject|1
126297|NCT00505284|407251|P2|Overall Study|Withdrawal by Subject|6
126298|NCT00505284|407252|P1|Overall Study|Withdrawal by Subject|2
126299|NCT00505284|407248|P5|Overall Study|Protocol Violation|0
126300|NCT00505284|407249|P4|Overall Study|Protocol Violation|0
126301|NCT00505284|407250|P3|Overall Study|Protocol Violation|1
126302|NCT00505284|407251|P2|Overall Study|Protocol Violation|1
126303|NCT00505284|407252|P1|Overall Study|Protocol Violation|0
126304|NCT00505284|407248|P5|Overall Study|Adverse Event|22
126305|NCT00505284|407249|P4|Overall Study|Adverse Event|14
126306|NCT00505284|407250|P3|Overall Study|Adverse Event|9
126307|NCT00505284|407251|P2|Overall Study|Adverse Event|7
126308|NCT00505284|407252|P1|Overall Study|Adverse Event|3
126309|NCT00505375|407332|P2|Overall Study|Travel issues|1
126310|NCT00505375|407333|P1|Overall Study|Travel issues|0
126311|NCT00505375|407332|P2|Overall Study|Pregnancy|0
126312|NCT00505375|407333|P1|Overall Study|Pregnancy|1
126313|NCT00505375|407332|P2|Overall Study|Lost to Follow-up|2
126314|NCT00505375|407333|P1|Overall Study|Lost to Follow-up|0
126315|NCT00505375|407332|P2|Overall Study|Withdrawal by Subject|2
126316|NCT00505375|407333|P1|Overall Study|Withdrawal by Subject|2
126317|NCT00505375|407332|P2|Overall Study|Death|0
126318|NCT00505375|407333|P1|Overall Study|Death|1
126319|NCT00505414|407341|P5|Maintenance Phase|underlying disease and therapy required|0
126320|NCT00505414|407342|P4|Maintenance Phase|underlying disease and therapy required|0
126321|NCT00505414|407343|P3|Maintenance Phase|underlying disease and therapy required|2
126322|NCT00505414|407344|P2|Maintenance Phase|underlying disease and therapy required|2
126323|NCT00505414|407345|P1|Maintenance Phase|underlying disease and therapy required|0
126324|NCT00505414|407341|P5|Maintenance Phase|Withdrawal by Subject|0
126325|NCT00505414|407342|P4|Maintenance Phase|Withdrawal by Subject|0
126326|NCT00505414|407343|P3|Maintenance Phase|Withdrawal by Subject|1
126327|NCT00505414|407344|P2|Maintenance Phase|Withdrawal by Subject|0
126328|NCT00505414|407345|P1|Maintenance Phase|Withdrawal by Subject|0
126329|NCT00505414|407341|P5|Maintenance Phase|Lack of Efficacy|0
126330|NCT00505414|407342|P4|Maintenance Phase|Lack of Efficacy|0
126331|NCT00505414|407343|P3|Maintenance Phase|Lack of Efficacy|1
126332|NCT00505414|407344|P2|Maintenance Phase|Lack of Efficacy|1
126333|NCT00505414|407345|P1|Maintenance Phase|Lack of Efficacy|2
126334|NCT00505414|407341|P5|Maintenance Phase|Death|0
126335|NCT00505414|407342|P4|Maintenance Phase|Death|0
126336|NCT00505414|407343|P3|Maintenance Phase|Death|1
126337|NCT00505414|407344|P2|Maintenance Phase|Death|0
126338|NCT00505414|407345|P1|Maintenance Phase|Death|2
126339|NCT00505414|407341|P5|Maintenance Phase|Adverse Event|0
126340|NCT00505414|407342|P4|Maintenance Phase|Adverse Event|0
126341|NCT00505414|407343|P3|Maintenance Phase|Adverse Event|3
126342|NCT00505414|407344|P2|Maintenance Phase|Adverse Event|2
126343|NCT00505414|407345|P1|Maintenance Phase|Adverse Event|2
126344|NCT00505414|407341|P5|Titration Phase|Underlying disease and therapy required|3
126345|NCT00505414|407342|P4|Titration Phase|Underlying disease and therapy required|7
126346|NCT00505414|407343|P3|Titration Phase|Underlying disease and therapy required|0
126347|NCT00505414|407344|P2|Titration Phase|Underlying disease and therapy required|0
126348|NCT00505414|407345|P1|Titration Phase|Underlying disease and therapy required|0
126349|NCT00505414|407341|P5|Titration Phase|Withdrawal by Subject|4
126350|NCT00505414|407342|P4|Titration Phase|Withdrawal by Subject|3
126351|NCT00505414|407343|P3|Titration Phase|Withdrawal by Subject|0
126352|NCT00505414|407344|P2|Titration Phase|Withdrawal by Subject|0
126353|NCT00505414|407345|P1|Titration Phase|Withdrawal by Subject|0
126354|NCT00505414|407341|P5|Titration Phase|Protocol Violation|1
126355|NCT00505414|407342|P4|Titration Phase|Protocol Violation|0
126356|NCT00505414|407343|P3|Titration Phase|Protocol Violation|0
126357|NCT00505414|407344|P2|Titration Phase|Protocol Violation|0
126358|NCT00505414|407345|P1|Titration Phase|Protocol Violation|0
126359|NCT00505414|407341|P5|Titration Phase|Lack of Efficacy|1
126360|NCT00505414|407342|P4|Titration Phase|Lack of Efficacy|10
126361|NCT00505414|407343|P3|Titration Phase|Lack of Efficacy|0
126362|NCT00505414|407344|P2|Titration Phase|Lack of Efficacy|0
126363|NCT00505414|407345|P1|Titration Phase|Lack of Efficacy|0
126364|NCT00505414|407341|P5|Titration Phase|Death|0
126365|NCT00505414|407342|P4|Titration Phase|Death|2
126366|NCT00505414|407343|P3|Titration Phase|Death|0
126367|NCT00505414|407344|P2|Titration Phase|Death|0
126368|NCT00505414|407345|P1|Titration Phase|Death|0
126369|NCT00505414|407341|P5|Titration Phase|Adverse Event|3
126370|NCT00505414|407342|P4|Titration Phase|Adverse Event|8
126371|NCT00505414|407343|P3|Titration Phase|Adverse Event|0
126372|NCT00505414|407344|P2|Titration Phase|Adverse Event|0
126373|NCT00505414|407345|P1|Titration Phase|Adverse Event|0
126374|NCT00505622|407369|P3|Overall Study|Study termination by sponsor|90
126375|NCT00505622|407370|P2|Overall Study|Study termination by sponsor|98
126376|NCT00505622|407371|P1|Overall Study|Study termination by sponsor|115
126377|NCT00505622|407369|P3|Overall Study|Withdrawal by Subject|2
126378|NCT00505622|407370|P2|Overall Study|Withdrawal by Subject|3
126379|NCT00505622|407371|P1|Overall Study|Withdrawal by Subject|0
126380|NCT00505622|407369|P3|Overall Study|Protocol Violation|0
126381|NCT00505622|407370|P2|Overall Study|Protocol Violation|1
126382|NCT00505622|407371|P1|Overall Study|Protocol Violation|1
126383|NCT00505622|407369|P3|Overall Study|Adverse Event|4
126384|NCT00505622|407370|P2|Overall Study|Adverse Event|6
126385|NCT00505622|407371|P1|Overall Study|Adverse Event|5
126386|NCT00505661|407392|P1|Overall Study|Not Eligible|4
126387|NCT00505687|407396|P1|Overall Study|Other: As Per Sponsor|8
126388|NCT00505687|407396|P1|Overall Study|Other: Disease Progression|1
126389|NCT00505687|407396|P1|Overall Study|Other: Neupro Given In Hospital|1
126390|NCT00505687|407396|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
126391|NCT00505687|407396|P1|Overall Study|Other: Prolonged Hospitalization|1
126392|NCT00505687|407396|P1|Overall Study|Other: Scheduled DBS Surgery|1
126393|NCT00505687|407396|P1|Overall Study|Other: Underwent Implantation Of DBS|1
126394|NCT00505687|407396|P1|Overall Study|Lost to Follow-up|1
126395|NCT00505687|407396|P1|Overall Study|Subject withdrew consent|15
126396|NCT00505687|407396|P1|Overall Study|Adverse Event|48
126397|NCT00505687|407396|P1|Overall Study|Lack of Efficacy|15
126398|NCT00505687|407396|P1|Overall Study|Important protocol violation|2
126399|NCT00505752|407406|P4|Overall Study|Unspecified|2
126400|NCT00505752|407407|P3|Overall Study|Unspecified|1
126401|NCT00505752|407408|P2|Overall Study|Unspecified|2
126402|NCT00505752|407409|P1|Overall Study|Unspecified|1
126403|NCT00505752|407406|P4|Overall Study|All embryos/blastocysts discarded|1
126404|NCT00505752|407407|P3|Overall Study|All embryos/blastocysts discarded|1
126405|NCT00505752|407408|P2|Overall Study|All embryos/blastocysts discarded|0
126406|NCT00505752|407409|P1|Overall Study|All embryos/blastocysts discarded|0
126407|NCT00505752|407406|P4|Overall Study|No Fertilization|1
126408|NCT00505752|407407|P3|Overall Study|No Fertilization|2
126409|NCT00505752|407408|P2|Overall Study|No Fertilization|1
126410|NCT00505752|407409|P1|Overall Study|No Fertilization|1
126411|NCT00505752|407406|P4|Overall Study|No oocytes retrieved|1
126412|NCT00505752|407407|P3|Overall Study|No oocytes retrieved|0
126413|NCT00505752|407408|P2|Overall Study|No oocytes retrieved|2
126414|NCT00505752|407409|P1|Overall Study|No oocytes retrieved|0
126415|NCT00505752|407406|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
126416|NCT00505752|407407|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
126417|NCT00505752|407408|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
126418|NCT00505752|407409|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
126419|NCT00505752|407406|P4|Overall Study|Lack of ovarian response|0
126420|NCT00505752|407407|P3|Overall Study|Lack of ovarian response|0
126421|NCT00505752|407408|P2|Overall Study|Lack of ovarian response|3
126422|NCT00505752|407409|P1|Overall Study|Lack of ovarian response|1
126423|NCT00505752|407406|P4|Overall Study|Lost to Follow-up|0
126424|NCT00505752|407407|P3|Overall Study|Lost to Follow-up|0
126425|NCT00505752|407408|P2|Overall Study|Lost to Follow-up|0
126426|NCT00505752|407409|P1|Overall Study|Lost to Follow-up|1
126427|NCT00505752|407406|P4|Overall Study|Adverse Event|0
126428|NCT00505752|407407|P3|Overall Study|Adverse Event|1
126429|NCT00505752|407408|P2|Overall Study|Adverse Event|0
126430|NCT00505752|407409|P1|Overall Study|Adverse Event|1
126431|NCT00505765|407426|P3|Overall Study|Noncompliance|3
126432|NCT00505765|407427|P2|Overall Study|Noncompliance|1
126433|NCT00505765|407428|P1|Overall Study|Noncompliance|0
126434|NCT00505765|407426|P3|Overall Study|Adverse Event|0
126435|NCT00505765|407427|P2|Overall Study|Adverse Event|2
126436|NCT00505765|407428|P1|Overall Study|Adverse Event|1
126437|NCT00505765|407426|P3|Overall Study|Withdrawal by Subject|0
126438|NCT00505765|407427|P2|Overall Study|Withdrawal by Subject|0
126439|NCT00505765|407428|P1|Overall Study|Withdrawal by Subject|1
126440|NCT00505778|407453|P2|Overall Study|Took No Study Drug|2
126441|NCT00505778|407454|P1|Overall Study|Took No Study Drug|2
126442|NCT00505778|407453|P2|Overall Study|Relapse|65
126443|NCT00505778|407454|P1|Overall Study|Relapse|65
126444|NCT00505778|407453|P2|Overall Study|Withdrawal by Subject|14
126445|NCT00505778|407454|P1|Overall Study|Withdrawal by Subject|29
126446|NCT00505778|407453|P2|Overall Study|Protocol Violation|9
126447|NCT00505778|407454|P1|Overall Study|Protocol Violation|7
126448|NCT00505778|407453|P2|Overall Study|Unable to Meet Protocol Criteria|1
126449|NCT00505778|407454|P1|Overall Study|Unable to Meet Protocol Criteria|4
126450|NCT00505778|407453|P2|Overall Study|Lost to Follow-up|23
126451|NCT00505778|407454|P1|Overall Study|Lost to Follow-up|17
126452|NCT00505778|407453|P2|Overall Study|Physician Decision|14
126453|NCT00505778|407454|P1|Overall Study|Physician Decision|8
126454|NCT00505778|407453|P2|Overall Study|Adverse Event|7
126455|NCT00505778|407454|P1|Overall Study|Adverse Event|2
126456|NCT00505921|407481|P1|Overall Study|Failed to Mobilize|8
126457|NCT00505921|407481|P1|Overall Study|Ineligible|1
126458|NCT00497796|407544|P2|Overall Study|Not applicable (randomized not treated)|4
126459|NCT00497796|407545|P1|Overall Study|Not applicable (randomized not treated)|0
126460|NCT00497796|407544|P2|Overall Study|Lost to Follow-up|1
126461|NCT00497796|407545|P1|Overall Study|Lost to Follow-up|0
126462|NCT00497796|407544|P2|Overall Study|Investigator/sponsor discretion|34
126463|NCT00497796|407545|P1|Overall Study|Investigator/sponsor discretion|31
126464|NCT00497796|407544|P2|Overall Study|Consent withdrawn|3
126465|NCT00497796|407545|P1|Overall Study|Consent withdrawn|10
126466|NCT00497796|407544|P2|Overall Study|CMV infection or disease treatment|4
126467|NCT00497796|407545|P1|Overall Study|CMV infection or disease treatment|30
126468|NCT00497796|407544|P2|Overall Study|Adverse event (related)|4
126469|NCT00497796|407545|P1|Overall Study|Adverse event (related)|5
126470|NCT00497796|407544|P2|Overall Study|Adverse event (not related)|9
126471|NCT00497796|407545|P1|Overall Study|Adverse event (not related)|9
126472|NCT00497874|407575|P2|Overall Study|Unable to schedule|24
126473|NCT00497874|407576|P1|Overall Study|Unable to schedule|37
126474|NCT00497874|407575|P2|Overall Study|Unable to contact|67
126475|NCT00497874|407576|P1|Overall Study|Unable to contact|52
126476|NCT00497874|407575|P2|Overall Study|Death|4
126477|NCT00497874|407576|P1|Overall Study|Death|2
126478|NCT00497874|407575|P2|Overall Study|Illness|4
126479|NCT00497874|407576|P1|Overall Study|Illness|8
126480|NCT00497874|407575|P2|Overall Study|Withdrawal by Subject|17
126481|NCT00497874|407576|P1|Overall Study|Withdrawal by Subject|48
126482|NCT00498173|407594|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
126483|NCT00498173|407595|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
126484|NCT00498173|407596|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
126485|NCT00498186|407624|P1|Overall Study|Other|10
126486|NCT00498186|407624|P1|Overall Study|Lost to Follow-up|3
126487|NCT00498186|407624|P1|Overall Study|Withdrawal by Subject|18
126488|NCT00498186|407624|P1|Overall Study|Unsatisfactory compliance of subject|12
126489|NCT00498186|407624|P1|Overall Study|Adverse Event|89
126490|NCT00498186|407624|P1|Overall Study|Lack of Efficacy|31
126491|NCT00498186|407624|P1|Overall Study|Protocol Violation|10
126492|NCT00498355|407629|P1|Overall Study|Lost to Follow-up|1
126493|NCT00498368|407635|P2|Overall Study|Withdrawal by Subject|2
126494|NCT00498368|407636|P1|Overall Study|Withdrawal by Subject|3
126495|NCT00498433|407651|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
126496|NCT00498433|407652|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
126497|NCT00498433|407653|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
126498|NCT00498433|407651|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
126499|NCT00498433|407652|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
126500|NCT00498433|407653|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
126501|NCT00498433|407651|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
126502|NCT00498433|407652|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
126503|NCT00498433|407653|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
126504|NCT00498433|407651|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
126505|NCT00498433|407652|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
126506|NCT00498433|407653|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
126507|NCT00498485|407698|P2|Overall Study|Adverse Event|5
126508|NCT00498485|407699|P1|Overall Study|Adverse Event|1
126509|NCT00498602|407723|P7|Overall Study|Not specified|0
126510|NCT00498602|407724|P6|Overall Study|Not specified|3
126511|NCT00498602|407725|P5|Overall Study|Not specified|0
126512|NCT00498602|407726|P4|Overall Study|Not specified|0
126513|NCT00498602|407727|P3|Overall Study|Not specified|1
126514|NCT00498602|407728|P2|Overall Study|Not specified|3
126515|NCT00498602|407729|P1|Overall Study|Not specified|2
126516|NCT00498602|407723|P7|Overall Study|Subject Request|1
126517|NCT00498602|407724|P6|Overall Study|Subject Request|4
126518|NCT00498602|407725|P5|Overall Study|Subject Request|1
126519|NCT00498602|407726|P4|Overall Study|Subject Request|1
126520|NCT00498602|407727|P3|Overall Study|Subject Request|1
126521|NCT00498602|407728|P2|Overall Study|Subject Request|0
126522|NCT00498602|407729|P1|Overall Study|Subject Request|3
126523|NCT00498602|407723|P7|Overall Study|Investigator Request|0
126524|NCT00498602|407724|P6|Overall Study|Investigator Request|0
126525|NCT00498602|407725|P5|Overall Study|Investigator Request|0
126526|NCT00498602|407726|P4|Overall Study|Investigator Request|0
126527|NCT00498602|407727|P3|Overall Study|Investigator Request|1
126528|NCT00498602|407728|P2|Overall Study|Investigator Request|0
126529|NCT00498602|407729|P1|Overall Study|Investigator Request|0
126530|NCT00498602|407723|P7|Overall Study|Caregiver Request|0
126531|NCT00498602|407724|P6|Overall Study|Caregiver Request|2
126532|NCT00498602|407725|P5|Overall Study|Caregiver Request|1
126533|NCT00498602|407726|P4|Overall Study|Caregiver Request|0
126534|NCT00498602|407727|P3|Overall Study|Caregiver Request|2
126535|NCT00498602|407728|P2|Overall Study|Caregiver Request|2
126536|NCT00498602|407729|P1|Overall Study|Caregiver Request|2
126537|NCT00498602|407723|P7|Overall Study|AE not related to Study Drug|1
126538|NCT00498602|407724|P6|Overall Study|AE not related to Study Drug|2
126539|NCT00498602|407725|P5|Overall Study|AE not related to Study Drug|2
126540|NCT00498602|407726|P4|Overall Study|AE not related to Study Drug|0
126541|NCT00498602|407727|P3|Overall Study|AE not related to Study Drug|0
126542|NCT00498602|407728|P2|Overall Study|AE not related to Study Drug|3
126543|NCT00498602|407729|P1|Overall Study|AE not related to Study Drug|1
126544|NCT00498602|407723|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
126545|NCT00498602|407724|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
126546|NCT00498602|407725|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
126547|NCT00498602|407726|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
126548|NCT00498602|407727|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
126549|NCT00498602|407728|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
126550|NCT00498602|407729|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
126551|NCT00498602|407723|P7|Overall Study|Lost to Follow-up|0
126552|NCT00498602|407724|P6|Overall Study|Lost to Follow-up|0
126553|NCT00498602|407725|P5|Overall Study|Lost to Follow-up|0
126554|NCT00498602|407726|P4|Overall Study|Lost to Follow-up|2
126555|NCT00498602|407727|P3|Overall Study|Lost to Follow-up|0
126556|NCT00498602|407728|P2|Overall Study|Lost to Follow-up|2
126557|NCT00498602|407729|P1|Overall Study|Lost to Follow-up|0
126558|NCT00498602|407723|P7|Overall Study|Lack of Efficacy|0
126559|NCT00498602|407724|P6|Overall Study|Lack of Efficacy|0
126560|NCT00498602|407725|P5|Overall Study|Lack of Efficacy|0
126561|NCT00498602|407726|P4|Overall Study|Lack of Efficacy|0
126562|NCT00498602|407727|P3|Overall Study|Lack of Efficacy|0
126563|NCT00498602|407728|P2|Overall Study|Lack of Efficacy|0
126564|NCT00498602|407729|P1|Overall Study|Lack of Efficacy|1
126565|NCT00498602|407723|P7|Overall Study|Death|0
126566|NCT00498602|407724|P6|Overall Study|Death|1
126567|NCT00498602|407725|P5|Overall Study|Death|0
126568|NCT00498602|407726|P4|Overall Study|Death|0
126569|NCT00498602|407727|P3|Overall Study|Death|0
126570|NCT00498602|407728|P2|Overall Study|Death|0
126571|NCT00498602|407729|P1|Overall Study|Death|0
126572|NCT00498797|407811|P2|Overall Study|Other|1
126573|NCT00498797|407812|P1|Overall Study|Other|3
126574|NCT00498797|407811|P2|Overall Study|Condition under investigation worsened|21
126575|NCT00498797|407812|P1|Overall Study|Condition under investigation worsened|19
126576|NCT00498797|407811|P2|Overall Study|Adverse Event|5
126577|NCT00498797|407812|P1|Overall Study|Adverse Event|12
126578|NCT00498797|407811|P2|Overall Study|Withdrawal by Subject|2
126579|NCT00498797|407812|P1|Overall Study|Withdrawal by Subject|4
126580|NCT00499031|407834|P1|Overall Study|Never treated|1
126581|NCT00499031|407834|P1|Overall Study|Required test not done|1
126582|NCT00499031|407834|P1|Overall Study|Improper pre-protocol treatment|1
126583|NCT00499122|407876|P1|Overall Study|Withdrawal by Subject|2
126584|NCT00499252|407881|P1|Overall Study|<no further label>|3
126585|NCT00499252|407881|P1|Overall Study|Ineligible|4
126586|NCT00499252|407881|P1|Overall Study|Refused further treatment|2
126587|NCT00499252|407881|P1|Overall Study|Adverse Event|3
126588|NCT00499369|407901|P5|Overall Study|Ineligible|0
126589|NCT00499369|407902|P4|Overall Study|Ineligible|1
126590|NCT00499369|407903|P3|Overall Study|Ineligible|1
126591|NCT00499369|407904|P2|Overall Study|Ineligible|2
126592|NCT00499369|407905|P1|Overall Study|Ineligible|2
126593|NCT00499369|407901|P5|Overall Study|Not protocol specified|0
126594|NCT00499369|407902|P4|Overall Study|Not protocol specified|1
126595|NCT00499369|407903|P3|Overall Study|Not protocol specified|3
126596|NCT00499369|407904|P2|Overall Study|Not protocol specified|0
126597|NCT00499369|407905|P1|Overall Study|Not protocol specified|2
126598|NCT00499369|407901|P5|Overall Study|Death|0
126599|NCT00499369|407902|P4|Overall Study|Death|0
126600|NCT00499369|407903|P3|Overall Study|Death|0
126601|NCT00499369|407904|P2|Overall Study|Death|1
126602|NCT00499369|407905|P1|Overall Study|Death|0
126603|NCT00499369|407901|P5|Overall Study|Progression|10
126604|NCT00499369|407902|P4|Overall Study|Progression|6
126605|NCT00499369|407903|P3|Overall Study|Progression|9
126606|NCT00499369|407904|P2|Overall Study|Progression|12
126607|NCT00499369|407905|P1|Overall Study|Progression|10
126608|NCT00499369|407901|P5|Overall Study|Withdrawal by Subject|0
126609|NCT00499369|407902|P4|Overall Study|Withdrawal by Subject|0
126610|NCT00499369|407903|P3|Overall Study|Withdrawal by Subject|1
126611|NCT00499369|407904|P2|Overall Study|Withdrawal by Subject|1
126612|NCT00499369|407905|P1|Overall Study|Withdrawal by Subject|0
126613|NCT00499369|407901|P5|Overall Study|Adverse Event|2
126614|NCT00499369|407902|P4|Overall Study|Adverse Event|1
126615|NCT00499369|407903|P3|Overall Study|Adverse Event|3
126616|NCT00499369|407904|P2|Overall Study|Adverse Event|2
126617|NCT00499369|407905|P1|Overall Study|Adverse Event|2
126618|NCT00499460|407942|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
126619|NCT00499460|407943|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
126620|NCT00499460|407942|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
126621|NCT00499460|407943|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
126622|NCT00499460|407942|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
126623|NCT00499460|407943|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
126624|NCT00499486|407978|P1|Overall Study|Withdrawal by Subject|16
126625|NCT00499590|407987|P3|Overall Study|Not treated|1
126626|NCT00499590|407988|P2|Overall Study|Not treated|0
126627|NCT00499590|407989|P1|Overall Study|Not treated|1
126628|NCT00499590|407987|P3|Overall Study|Study Terminated|112
126629|NCT00499590|407988|P2|Overall Study|Study Terminated|112
126630|NCT00499590|407989|P1|Overall Study|Study Terminated|112
126631|NCT00499603|408002|P2|Overall Study|Adverse Event|1
126632|NCT00499603|408003|P1|Overall Study|Adverse Event|0
126633|NCT00499616|408017|P4|Overall Study|Patient/Parent Refusal|0
126634|NCT00499616|408018|P3|Overall Study|Patient/Parent Refusal|3
126635|NCT00499616|408019|P2|Overall Study|Patient/Parent Refusal|5
126636|NCT00499616|408020|P1|Overall Study|Patient/Parent Refusal|1
126637|NCT00499616|408017|P4|Overall Study|Not evaluable|41
126638|NCT00499616|408018|P3|Overall Study|Not evaluable|0
126639|NCT00499616|408019|P2|Overall Study|Not evaluable|0
126640|NCT00499616|408020|P1|Overall Study|Not evaluable|0
126641|NCT00499616|408017|P4|Overall Study|Ineligible|15
126642|NCT00499616|408018|P3|Overall Study|Ineligible|0
126643|NCT00499616|408019|P2|Overall Study|Ineligible|2
126644|NCT00499616|408020|P1|Overall Study|Ineligible|1
126645|NCT00499616|408017|P4|Overall Study|Withdrawal by Subject|0
126646|NCT00499616|408018|P3|Overall Study|Withdrawal by Subject|1
126647|NCT00499616|408019|P2|Overall Study|Withdrawal by Subject|0
126648|NCT00499616|408020|P1|Overall Study|Withdrawal by Subject|1
126649|NCT00499616|408017|P4|Overall Study|Physician Decision|0
126650|NCT00499616|408018|P3|Overall Study|Physician Decision|9
126651|NCT00499616|408019|P2|Overall Study|Physician Decision|16
126652|NCT00499616|408020|P1|Overall Study|Physician Decision|6
126653|NCT00499616|408017|P4|Overall Study|Lost to Follow-up|0
126654|NCT00499616|408018|P3|Overall Study|Lost to Follow-up|1
126655|NCT00499616|408019|P2|Overall Study|Lost to Follow-up|0
126656|NCT00499616|408020|P1|Overall Study|Lost to Follow-up|0
126657|NCT00499616|408017|P4|Overall Study|Lack of Efficacy|0
126658|NCT00499616|408018|P3|Overall Study|Lack of Efficacy|19
126659|NCT00499616|408019|P2|Overall Study|Lack of Efficacy|0
126660|NCT00499616|408020|P1|Overall Study|Lack of Efficacy|5
126661|NCT00499616|408017|P4|Overall Study|Death|1
126662|NCT00499616|408018|P3|Overall Study|Death|3
126663|NCT00499616|408019|P2|Overall Study|Death|5
126664|NCT00499616|408020|P1|Overall Study|Death|1
126665|NCT00499681|408074|P2|Overall Study|disease progression|1
126666|NCT00499681|408075|P1|Overall Study|disease progression|0
126667|NCT00499681|408074|P2|Overall Study|toxicity|1
126668|NCT00499681|408075|P1|Overall Study|toxicity|0
126669|NCT00499694|408081|P1|Overall Study|Patient never received treatment.|1
126670|NCT00505934|408085|P1|Overall Study|Other: IV dose needed to be changed|1
126671|NCT00505934|408085|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
126672|NCT00505934|408085|P1|Overall Study|Adverse Event|1
126673|NCT00506077|408115|P2|Treatment Period 2|Withdrawal by Subject|0
126674|NCT00506077|408116|P1|Treatment Period 2|Withdrawal by Subject|1
126675|NCT00506077|408115|P2|Treatment Period 2|Adverse Event|1
126676|NCT00506077|408116|P1|Treatment Period 2|Adverse Event|0
126677|NCT00506077|408115|P2|Treatment Period 1|Withdrawal by Subject|0
126678|NCT00506077|408116|P1|Treatment Period 1|Withdrawal by Subject|2
126679|NCT00506077|408115|P2|Treatment Period 1|Lost to Follow-up|2
126680|NCT00506077|408116|P1|Treatment Period 1|Lost to Follow-up|0
126681|NCT00506077|408115|P2|Treatment Period 1|Adverse Event|1
126682|NCT00506077|408116|P1|Treatment Period 1|Adverse Event|2
126683|NCT00506662|408143|P2|Overall Study|Not recorded|6
126684|NCT00506662|408144|P1|Overall Study|Not recorded|4
126685|NCT00506662|408143|P2|Overall Study|Trial terminated|16
126686|NCT00506662|408144|P1|Overall Study|Trial terminated|10
126687|NCT00506662|408143|P2|Overall Study|Protocol Violation|4
126688|NCT00506662|408144|P1|Overall Study|Protocol Violation|2
126689|NCT00506662|408143|P2|Overall Study|Lack of Efficacy|0
126690|NCT00506662|408144|P1|Overall Study|Lack of Efficacy|1
126691|NCT00506662|408143|P2|Overall Study|Adverse Event|2
126692|NCT00506662|408144|P1|Overall Study|Adverse Event|0
126693|NCT00506831|408200|P1|Overall Study|Withdrawal by Subject|1
126694|NCT00506831|408200|P1|Overall Study|Death|1
126695|NCT00506883|408212|P3|Overall Study|Other|1
126696|NCT00506883|408213|P2|Overall Study|Other|1
126697|NCT00506883|408214|P1|Overall Study|Other|5
126698|NCT00506883|408212|P3|Overall Study|Lack of Efficacy|1
126699|NCT00506883|408213|P2|Overall Study|Lack of Efficacy|1
126700|NCT00506883|408214|P1|Overall Study|Lack of Efficacy|0
126701|NCT00506883|408212|P3|Overall Study|Withdrawal by Subject|1
126702|NCT00506883|408213|P2|Overall Study|Withdrawal by Subject|0
126703|NCT00506883|408214|P1|Overall Study|Withdrawal by Subject|1
126704|NCT00506883|408212|P3|Overall Study|Lost to Follow-up|1
126705|NCT00506883|408213|P2|Overall Study|Lost to Follow-up|1
126706|NCT00506883|408214|P1|Overall Study|Lost to Follow-up|1
126707|NCT00506922|408227|P5|Overall Study|Withdrawal by Subject|1
126708|NCT00506922|408228|P4|Overall Study|Withdrawal by Subject|0
126709|NCT00506922|408229|P3|Overall Study|Withdrawal by Subject|0
126710|NCT00506922|408230|P2|Overall Study|Withdrawal by Subject|0
126711|NCT00506922|408231|P1|Overall Study|Withdrawal by Subject|0
126712|NCT00506922|408227|P5|Overall Study|Physician Decision|0
126713|NCT00506922|408228|P4|Overall Study|Physician Decision|2
126714|NCT00506922|408229|P3|Overall Study|Physician Decision|0
126715|NCT00506922|408230|P2|Overall Study|Physician Decision|0
126716|NCT00506922|408231|P1|Overall Study|Physician Decision|0
126717|NCT00506948|408239|P1|Overall Study|Physician Decision|1
126718|NCT00506948|408239|P1|Overall Study|Adverse Event|5
126719|NCT00506948|408239|P1|Overall Study|Death|4
126720|NCT00507130|408247|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
126721|NCT00507130|408248|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
126722|NCT00507130|408249|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
126723|NCT00507130|408250|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
126724|NCT00507130|408247|P4|Overall Study|Lost to Follow-up|1
126725|NCT00507130|408248|P3|Overall Study|Lost to Follow-up|1
126726|NCT00507130|408249|P2|Overall Study|Lost to Follow-up|0
126727|NCT00507130|408250|P1|Overall Study|Lost to Follow-up|0
126728|NCT00507416|408304|P3|Overall Study|Did not Receive Study Treatment|4
126729|NCT00507416|408305|P2|Overall Study|Did not Receive Study Treatment|9
126730|NCT00507416|408306|P1|Overall Study|Did not Receive Study Treatment|3
126731|NCT00507416|408304|P3|Overall Study|Other|13
126732|NCT00507416|408305|P2|Overall Study|Other|16
126733|NCT00507416|408306|P1|Overall Study|Other|11
126734|NCT00507416|408304|P3|Overall Study|Patient declined further treatment|11
126735|NCT00507416|408305|P2|Overall Study|Patient declined further treatment|14
126736|NCT00507416|408306|P1|Overall Study|Patient declined further treatment|18
126737|NCT00507416|408304|P3|Overall Study|Progressive Disease|13
126738|NCT00507416|408305|P2|Overall Study|Progressive Disease|10
126739|NCT00507416|408306|P1|Overall Study|Progressive Disease|20
126740|NCT00507416|408304|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
126741|NCT00507416|408305|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
126742|NCT00507416|408306|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
126743|NCT00507416|408304|P3|Overall Study|Protocol Violation|0
126744|NCT00507416|408305|P2|Overall Study|Protocol Violation|2
126745|NCT00507416|408306|P1|Overall Study|Protocol Violation|1
126746|NCT00507416|408304|P3|Overall Study|Adverse Event|65
126747|NCT00507416|408305|P2|Overall Study|Adverse Event|67
126748|NCT00507416|408306|P1|Overall Study|Adverse Event|58
126749|NCT00507429|408337|P2|Maintenance Phase|Progressive Disease|0
126750|NCT00507429|408338|P1|Maintenance Phase|Progressive Disease|14
126751|NCT00507429|408337|P2|Treatment Phase|Other|3
126752|NCT00507429|408338|P1|Treatment Phase|Other|6
126753|NCT00507429|408337|P2|Treatment Phase|Physician Decision|2
126754|NCT00507429|408338|P1|Treatment Phase|Physician Decision|4
126755|NCT00507429|408337|P2|Treatment Phase|Withdrawal by Subject|3
126756|NCT00507429|408338|P1|Treatment Phase|Withdrawal by Subject|3
126757|NCT00507429|408337|P2|Treatment Phase|Adverse Event|5
126758|NCT00507429|408338|P1|Treatment Phase|Adverse Event|12
126759|NCT00507429|408337|P2|Treatment Phase|Disease Progression|5
126760|NCT00507429|408338|P1|Treatment Phase|Disease Progression|12
126761|NCT00507442|408350|P4|Overall Study|Not Specified|2
126762|NCT00507442|408351|P3|Overall Study|Not Specified|2
126763|NCT00507442|408352|P2|Overall Study|Not Specified|5
126764|NCT00507442|408353|P1|Overall Study|Not Specified|2
126765|NCT00507442|408350|P4|Overall Study|Withdrawal by Subject|1
126766|NCT00507442|408351|P3|Overall Study|Withdrawal by Subject|2
126767|NCT00507442|408352|P2|Overall Study|Withdrawal by Subject|4
126768|NCT00507442|408353|P1|Overall Study|Withdrawal by Subject|4
126769|NCT00507442|408350|P4|Overall Study|Progressive Disease|0
126770|NCT00507442|408351|P3|Overall Study|Progressive Disease|2
126771|NCT00507442|408352|P2|Overall Study|Progressive Disease|4
126772|NCT00507442|408353|P1|Overall Study|Progressive Disease|2
126773|NCT00507442|408350|P4|Overall Study|Physician Decision|1
126774|NCT00507442|408351|P3|Overall Study|Physician Decision|4
126775|NCT00507442|408352|P2|Overall Study|Physician Decision|2
126776|NCT00507442|408353|P1|Overall Study|Physician Decision|0
126777|NCT00507442|408350|P4|Overall Study|Lost to Follow-up|0
126778|NCT00507442|408351|P3|Overall Study|Lost to Follow-up|1
126779|NCT00507442|408352|P2|Overall Study|Lost to Follow-up|0
126780|NCT00507442|408353|P1|Overall Study|Lost to Follow-up|0
126781|NCT00507442|408350|P4|Overall Study|Protocol Violation|0
126782|NCT00507442|408351|P3|Overall Study|Protocol Violation|0
126783|NCT00507442|408352|P2|Overall Study|Protocol Violation|1
126784|NCT00507442|408353|P1|Overall Study|Protocol Violation|0
126785|NCT00507442|408350|P4|Overall Study|Adverse Event|1
126786|NCT00507442|408351|P3|Overall Study|Adverse Event|4
126787|NCT00507442|408352|P2|Overall Study|Adverse Event|11
126788|NCT00507442|408353|P1|Overall Study|Adverse Event|8
126789|NCT00507455|408406|P3|Overall Study|Other - miscellaneous reason|1
126790|NCT00507455|408407|P2|Overall Study|Other - miscellaneous reason|0
126791|NCT00507455|408408|P1|Overall Study|Other - miscellaneous reason|1
126792|NCT00507455|408406|P3|Overall Study|Lack of Efficacy|0
126793|NCT00507455|408407|P2|Overall Study|Lack of Efficacy|1
126794|NCT00507455|408408|P1|Overall Study|Lack of Efficacy|0
126795|NCT00507455|408406|P3|Overall Study|Lost to Follow-up|2
126796|NCT00507455|408407|P2|Overall Study|Lost to Follow-up|0
126797|NCT00507455|408408|P1|Overall Study|Lost to Follow-up|2
126798|NCT00507455|408406|P3|Overall Study|Protocol Violation|1
126799|NCT00507455|408407|P2|Overall Study|Protocol Violation|1
126800|NCT00507455|408408|P1|Overall Study|Protocol Violation|4
126801|NCT00507455|408406|P3|Overall Study|Withdrawal by Subject|2
126802|NCT00507455|408407|P2|Overall Study|Withdrawal by Subject|1
126803|NCT00507455|408408|P1|Overall Study|Withdrawal by Subject|2
126804|NCT00507455|408406|P3|Overall Study|Adverse Event|6
126805|NCT00507455|408407|P2|Overall Study|Adverse Event|3
126806|NCT00507455|408408|P1|Overall Study|Adverse Event|3
126807|NCT00507507|408469|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
126808|NCT00507507|408470|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
126809|NCT00507507|408469|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
126810|NCT00507507|408470|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
126811|NCT00507507|408469|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
126812|NCT00507507|408470|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
126813|NCT00507507|408469|P2|Treatment Period|Withdrawal by Subject|47
126814|NCT00507507|408470|P1|Treatment Period|Withdrawal by Subject|46
126815|NCT00507507|408469|P2|Treatment Period|Adverse Event|1
126816|NCT00507507|408470|P1|Treatment Period|Adverse Event|1
126817|NCT00507507|408469|P2|Treatment Period|Protocol Violation|2
126818|NCT00507507|408470|P1|Treatment Period|Protocol Violation|1
126819|NCT00507507|408469|P2|Treatment Period|Physician Decision|1
126820|NCT00507507|408470|P1|Treatment Period|Physician Decision|4
126821|NCT00507507|408469|P2|Treatment Period|Lost to Follow-up|2
126822|NCT00507507|408470|P1|Treatment Period|Lost to Follow-up|0
126823|NCT00507546|408504|P2|Overall Study|Physician Decision|1
126824|NCT00507546|408505|P1|Overall Study|Physician Decision|0
126825|NCT00507546|408504|P2|Overall Study|Protocol Violation|0
126826|NCT00507546|408505|P1|Overall Study|Protocol Violation|1
126827|NCT00507546|408504|P2|Overall Study|Withdrawal by Subject|0
126828|NCT00507546|408505|P1|Overall Study|Withdrawal by Subject|1
126829|NCT00507689|408529|P2|Randomized Period|Withdrawal by Subject|1
126830|NCT00507689|408530|P1|Randomized Period|Withdrawal by Subject|0
126831|NCT00507689|408529|P2|Randomized Period|Adverse Event|1
126832|NCT00507689|408530|P1|Randomized Period|Adverse Event|1
126833|NCT00507689|408529|P2|Pre-Randomization Period|Withdrawal by Subject|0
126834|NCT00507689|408530|P1|Pre-Randomization Period|Withdrawal by Subject|1
126835|NCT00507689|408529|P2|Pre-Randomization Period|Physician Decision|0
126836|NCT00507689|408530|P1|Pre-Randomization Period|Physician Decision|1
126837|NCT00507689|408529|P2|Pre-Randomization Period|Adverse Event|0
126838|NCT00507689|408530|P1|Pre-Randomization Period|Adverse Event|1
126839|NCT00507819|408551|P2|Washout (6 Weeks)|Withdrawal by Subject|0
126840|NCT00507819|408552|P1|Washout (6 Weeks)|Withdrawal by Subject|1
126841|NCT00508001|408567|P3|Overall Study|Withdrawal by Subject|1
126842|NCT00508001|408568|P2|Overall Study|Withdrawal by Subject|4
126843|NCT00508001|408569|P1|Overall Study|Withdrawal by Subject|4
126844|NCT00508001|408567|P3|Overall Study|Death|1
126845|NCT00508001|408568|P2|Overall Study|Death|1
126846|NCT00508001|408569|P1|Overall Study|Death|0
126847|NCT00508001|408567|P3|Overall Study|condition under investigation worsened|1
126848|NCT00508001|408568|P2|Overall Study|condition under investigation worsened|7
126849|NCT00508001|408569|P1|Overall Study|condition under investigation worsened|13
126850|NCT00508001|408567|P3|Overall Study|Adverse Event|4
126851|NCT00508001|408568|P2|Overall Study|Adverse Event|0
126852|NCT00508001|408569|P1|Overall Study|Adverse Event|2
126853|NCT00508027|408586|P1|Dose Level 2|Withdrawal by Subject|2
126854|NCT00508027|408586|P1|Dose Level 2|Lost to Follow-up|2
126855|NCT00508027|408586|P1|Dose Level 1|Physician Decision|2
126856|NCT00508027|408586|P1|Dose Level 1|Withdrawal by Subject|2
126857|NCT00508027|408586|P1|Dose Level 1|Lost to Follow-up|4
126858|NCT00508144|408646|P1|Overall Study|Death|5
126859|NCT00508144|408646|P1|Overall Study|Not eligible|6
126860|NCT00508157|408652|P2|Overall Study|Other known cause|1
126861|NCT00508157|408653|P1|Overall Study|Other known cause|0
126862|NCT00508157|408652|P2|Overall Study|Subject no longer met study criteria|1
126863|NCT00508157|408653|P1|Overall Study|Subject no longer met study criteria|0
126864|NCT00508157|408652|P2|Overall Study|Lost to Follow-up|0
126865|NCT00508157|408653|P1|Overall Study|Lost to Follow-up|1
126866|NCT00508157|408652|P2|Overall Study|Subject Withdrew Consent|0
126867|NCT00508157|408653|P1|Overall Study|Subject Withdrew Consent|1
126868|NCT00508157|408652|P2|Overall Study|Adverse Event|1
126869|NCT00508157|408653|P1|Overall Study|Adverse Event|0
126870|NCT00508274|408675|P1|Overall Study|Withdrawal by Subject|1
126871|NCT00508274|408675|P1|Overall Study|Adverse Event|1
126872|NCT00508391|408686|P2|Second Treatment|Withdrawal by Subject|0
126873|NCT00508391|408687|P1|Second Treatment|Withdrawal by Subject|2
126874|NCT00508391|408686|P2|First Treatment|Withdrawal by Subject|3
126875|NCT00508391|408687|P1|First Treatment|Withdrawal by Subject|6
126876|NCT00508404|408698|P1|Overall Study|Other - Not Specified|3
126877|NCT00508404|408698|P1|Overall Study|Lost to Follow-up|2
126878|NCT00508404|408698|P1|Overall Study|Protocol-specified Criteria|2
126879|NCT00508404|408698|P1|Overall Study|Withdrawal by Subject|3
126880|NCT00508404|408698|P1|Overall Study|Physician Decision|2
126881|NCT00508404|408698|P1|Overall Study|Death|16
126882|NCT00508404|408698|P1|Overall Study|Adverse Event|2
126883|NCT00508404|408698|P1|Overall Study|Ongoing at Data Cut-off|12
126884|NCT00508482|408735|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
126885|NCT00508482|408736|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
126886|NCT00508482|408737|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
126887|NCT00508482|408735|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
126888|NCT00508482|408736|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
126889|NCT00508482|408737|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
126890|NCT00508482|408735|P3|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|4
126891|NCT00508482|408736|P2|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|7
126892|NCT00508482|408737|P1|Over 4 Weeks of Treatment|Changed mind, didn’t want to participate|9
126893|NCT00508651|408778|P2|Overall Study|Withdrawal by Subject|1
126894|NCT00508651|408779|P1|Overall Study|Withdrawal by Subject|1
126895|NCT00508651|408778|P2|Overall Study|Lost to Follow-up|1
126896|NCT00508651|408779|P1|Overall Study|Lost to Follow-up|3
126897|NCT00508742|408864|P2|Period 3: Toddler Dose|Unspecified|4
126898|NCT00508742|408865|P1|Period 3: Toddler Dose|Unspecified|5
126899|NCT00508742|408864|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
126900|NCT00508742|408865|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
126901|NCT00508742|408864|P2|Period 3: Toddler Dose|Lost to Follow-up|3
126902|NCT00508742|408865|P1|Period 3: Toddler Dose|Lost to Follow-up|2
126903|NCT00508742|408864|P2|Period 3: Toddler Dose|Adverse Event|0
126904|NCT00508742|408865|P1|Period 3: Toddler Dose|Adverse Event|1
126905|NCT00508742|408864|P2|Period 2: After Infant Series|Unspecified|1
126906|NCT00508742|408865|P1|Period 2: After Infant Series|Unspecified|2
126907|NCT00508742|408864|P2|Period 2: After Infant Series|Failed to Return|0
126908|NCT00508742|408865|P1|Period 2: After Infant Series|Failed to Return|1
126909|NCT00508742|408864|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
126910|NCT00508742|408865|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
126911|NCT00508742|408864|P2|Period 2: After Infant Series|Protocol Violation|0
126912|NCT00508742|408865|P1|Period 2: After Infant Series|Protocol Violation|1
126913|NCT00508742|408864|P2|Period 2: After Infant Series|Lost to Follow-up|1
126914|NCT00508742|408865|P1|Period 2: After Infant Series|Lost to Follow-up|1
126915|NCT00508742|408864|P2|Period 2: After Infant Series|Adverse Event|6
126916|NCT00508742|408865|P1|Period 2: After Infant Series|Adverse Event|2
126917|NCT00508742|408864|P2|Period 1: Infant Series|Unspecified|1
126918|NCT00508742|408865|P1|Period 1: Infant Series|Unspecified|4
126919|NCT00508742|408864|P2|Period 1: Infant Series|Physician Decision|0
126920|NCT00508742|408865|P1|Period 1: Infant Series|Physician Decision|1
126921|NCT00508742|408864|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
126922|NCT00508742|408865|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
126923|NCT00508742|408864|P2|Period 1: Infant Series|Protocol Violation|0
126924|NCT00508742|408865|P1|Period 1: Infant Series|Protocol Violation|1
126925|NCT00508742|408864|P2|Period 1: Infant Series|Adverse Event|4
126926|NCT00508742|408865|P1|Period 1: Infant Series|Adverse Event|5
126927|NCT00508755|408879|P1|Overall Study|Withdrawal by Subject|1
126928|NCT00508820|408887|P2|Overall Study|Protocol-specified Criteria|12
126929|NCT00508820|408888|P1|Overall Study|Protocol-specified Criteria|3
126930|NCT00508820|408887|P2|Overall Study|Requirement for alternative therapy|15
126931|NCT00508820|408888|P1|Overall Study|Requirement for alternative therapy|7
126932|NCT00508820|408887|P2|Overall Study|Noncompliance|0
126933|NCT00508820|408888|P1|Overall Study|Noncompliance|1
126934|NCT00508820|408887|P2|Overall Study|Other|2
126935|NCT00508820|408888|P1|Overall Study|Other|11
126936|NCT00508820|408887|P2|Overall Study|Withdrawal by Subject|12
126937|NCT00508820|408888|P1|Overall Study|Withdrawal by Subject|10
126938|NCT00508820|408887|P2|Overall Study|Protocol Violation|0
126939|NCT00508820|408888|P1|Overall Study|Protocol Violation|2
126940|NCT00508820|408887|P2|Overall Study|Pregnancy|2
126941|NCT00508820|408888|P1|Overall Study|Pregnancy|0
126942|NCT00508820|408887|P2|Overall Study|Physician Decision|2
126943|NCT00508820|408888|P1|Overall Study|Physician Decision|8
126944|NCT00508820|408887|P2|Overall Study|Lost to Follow-up|1
126945|NCT00508820|408888|P1|Overall Study|Lost to Follow-up|1
126946|NCT00508820|408887|P2|Overall Study|Death|8
126947|NCT00508820|408888|P1|Overall Study|Death|6
126948|NCT00508820|408887|P2|Overall Study|Adverse Event|10
126949|NCT00508820|408888|P1|Overall Study|Adverse Event|6
126950|NCT00508872|408898|P1|Overall Study|Physician Decision|1
126951|NCT00508872|408898|P1|Overall Study|Lost to Follow-up|1
126952|NCT00508924|408906|P4|Overall Study|Protocol Violation|1
126953|NCT00508924|408907|P3|Overall Study|Protocol Violation|1
126954|NCT00508924|408908|P2|Overall Study|Protocol Violation|0
126955|NCT00508924|408909|P1|Overall Study|Protocol Violation|0
126956|NCT00509028|408925|P2|Overall Study|Non-compliance|1
126957|NCT00509028|408926|P1|Overall Study|Non-compliance|2
126958|NCT00509028|408925|P2|Overall Study|Protocol Violation|2
126959|NCT00509028|408926|P1|Overall Study|Protocol Violation|4
126960|NCT00509028|408925|P2|Overall Study|Lost to Follow-up|1
126961|NCT00509028|408926|P1|Overall Study|Lost to Follow-up|0
126962|NCT00509028|408925|P2|Overall Study|Withdrawal by Subject|3
126963|NCT00509028|408926|P1|Overall Study|Withdrawal by Subject|4
126964|NCT00509028|408925|P2|Overall Study|Adverse Event|0
126965|NCT00509028|408926|P1|Overall Study|Adverse Event|2
126966|NCT00509067|408967|P2|Overall Study|Protocol Violation|3
126967|NCT00509067|408968|P1|Overall Study|Protocol Violation|0
126968|NCT00509067|408967|P2|Overall Study|Adverse Event|1
126969|NCT00509067|408968|P1|Overall Study|Adverse Event|3
126970|NCT00509067|408967|P2|Overall Study|Lost to Follow-up|1
126971|NCT00509067|408968|P1|Overall Study|Lost to Follow-up|1
126972|NCT00502671|408974|P1|Overall Study|Adverse Event|19
126973|NCT00502671|408974|P1|Overall Study|Protocol Violation|16
126974|NCT00502671|408974|P1|Overall Study|Lost to Follow-up|7
126975|NCT00502671|408974|P1|Overall Study|Personal Reasons|22
126976|NCT00502671|408974|P1|Overall Study|Disease Progression|13
126977|NCT00502697|408981|P2|Overall Study|did not meet assignment criteria|2
126978|NCT00502697|408982|P1|Overall Study|did not meet assignment criteria|4
126979|NCT00502697|408981|P2|Overall Study|found not to meet eligibility criteria|4
126980|NCT00502697|408982|P1|Overall Study|found not to meet eligibility criteria|3
126981|NCT00502697|408981|P2|Overall Study|disenrolled due to pregnancy loss|5
126982|NCT00502697|408982|P1|Overall Study|disenrolled due to pregnancy loss|3
126983|NCT00502697|408981|P2|Overall Study|Withdrawal by Subject|1
126984|NCT00502697|408982|P1|Overall Study|Withdrawal by Subject|3
126985|NCT00502775|408993|P3|Overall Study|Subject took disallowed drug|1
126986|NCT00502775|408994|P2|Overall Study|Subject took disallowed drug|0
126987|NCT00502775|408995|P1|Overall Study|Subject took disallowed drug|0
126988|NCT00502775|408993|P3|Overall Study|Subject in jail|0
126989|NCT00502775|408994|P2|Overall Study|Subject in jail|1
126990|NCT00502775|408995|P1|Overall Study|Subject in jail|0
126991|NCT00502775|408993|P3|Overall Study|Declining pollen counts|1
126992|NCT00502775|408994|P2|Overall Study|Declining pollen counts|1
126993|NCT00502775|408995|P1|Overall Study|Declining pollen counts|0
126994|NCT00502775|408993|P3|Overall Study|Outside pollen area more than 48 hours|0
126995|NCT00502775|408994|P2|Overall Study|Outside pollen area more than 48 hours|1
126996|NCT00502775|408995|P1|Overall Study|Outside pollen area more than 48 hours|0
126997|NCT00502775|408993|P3|Overall Study|Non-compliance|2
126998|NCT00502775|408994|P2|Overall Study|Non-compliance|2
126999|NCT00502775|408995|P1|Overall Study|Non-compliance|0
127000|NCT00502775|408993|P3|Overall Study|Randomized in error|1
127001|NCT00502775|408994|P2|Overall Study|Randomized in error|1
127002|NCT00502775|408995|P1|Overall Study|Randomized in error|0
127003|NCT00502775|408993|P3|Overall Study|Logpad compliance <80%|0
127004|NCT00502775|408994|P2|Overall Study|Logpad compliance <80%|0
127005|NCT00502775|408995|P1|Overall Study|Logpad compliance <80%|1
127006|NCT00502775|408993|P3|Overall Study|Subject unable to swallow capsule|1
127007|NCT00502775|408994|P2|Overall Study|Subject unable to swallow capsule|0
127008|NCT00502775|408995|P1|Overall Study|Subject unable to swallow capsule|1
127009|NCT00502775|408993|P3|Overall Study|Non-compliance with eDiary|1
127010|NCT00502775|408994|P2|Overall Study|Non-compliance with eDiary|1
127011|NCT00502775|408995|P1|Overall Study|Non-compliance with eDiary|4
127012|NCT00502775|408993|P3|Overall Study|Sponsor Terminated Study|1
127013|NCT00502775|408994|P2|Overall Study|Sponsor Terminated Study|0
127014|NCT00502775|408995|P1|Overall Study|Sponsor Terminated Study|1
127015|NCT00502775|408993|P3|Overall Study|Withdrawal by Subject|2
127016|NCT00502775|408994|P2|Overall Study|Withdrawal by Subject|1
127017|NCT00502775|408995|P1|Overall Study|Withdrawal by Subject|1
127018|NCT00502775|408993|P3|Overall Study|Protocol Violation|2
127019|NCT00502775|408994|P2|Overall Study|Protocol Violation|5
127020|NCT00502775|408995|P1|Overall Study|Protocol Violation|1
127021|NCT00502775|408993|P3|Overall Study|Adverse Event|1
127022|NCT00502775|408994|P2|Overall Study|Adverse Event|2
127023|NCT00502775|408995|P1|Overall Study|Adverse Event|1
127024|NCT00502801|409036|P1|End of Therapy to Test of Cure|OTHER|2
127025|NCT00502801|409036|P1|End of Therapy to Test of Cure|Death|3
127026|NCT00502801|409036|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
127027|NCT00502801|409036|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
127028|NCT00502801|409036|P1|Treatment Period|OTHER|30
127029|NCT00502801|409036|P1|Treatment Period|Death|14
127030|NCT00502801|409036|P1|Treatment Period|Adverse Event|7
127031|NCT00502801|409036|P1|Treatment Period|Withdrawal by Subject|3
127032|NCT00502840|409041|P1|Overall Study|Not specified|20
127033|NCT00502840|409041|P1|Overall Study|Administrative problems|1
127034|NCT00502840|409041|P1|Overall Study|Lost to Follow-up|6
127035|NCT00502840|409041|P1|Overall Study|Withdrawal by Subject|5
127036|NCT00502840|409041|P1|Overall Study|Protocol Violation|4
127037|NCT00502840|409041|P1|Overall Study|Lack of Efficacy|11
127038|NCT00502840|409041|P1|Overall Study|Additional or changed therapy|48
127039|NCT00502840|409041|P1|Overall Study|Adverse Event|5
127040|NCT00502996|409113|P1|Overall Study|Adverse Event|2
127041|NCT00502996|409113|P1|Overall Study|Withdrawal Informed Consent|6
127042|NCT00502996|409113|P1|Overall Study|Treatment failure|25
127043|NCT00502996|409113|P1|Overall Study|Protocol Violation|2
127044|NCT00502996|409113|P1|Overall Study|Lost to Follow-up|9
127045|NCT00503009|409140|P3|Overall Study|Physician Decision|1
127046|NCT00503009|409141|P2|Overall Study|Physician Decision|1
127047|NCT00503009|409142|P1|Overall Study|Physician Decision|0
127048|NCT00503009|409140|P3|Overall Study|Withdrawal by Subject|1
127049|NCT00503009|409141|P2|Overall Study|Withdrawal by Subject|1
127050|NCT00503009|409142|P1|Overall Study|Withdrawal by Subject|0
127051|NCT00503009|409140|P3|Overall Study|Protocol Violation|1
127052|NCT00503009|409141|P2|Overall Study|Protocol Violation|0
127053|NCT00503009|409142|P1|Overall Study|Protocol Violation|1
127054|NCT00503139|409193|P1|Overall Study|Protocol Violation|4
127055|NCT00503139|409193|P1|Overall Study|Case Report Forms were not collected|4
127056|NCT00503308|409206|P2|Overall Study|Protocol Violation|1
127057|NCT00503308|409207|P1|Overall Study|Protocol Violation|2
127058|NCT00509106|409215|P2|Overall Study|Death|6
127059|NCT00509106|409216|P1|Overall Study|Death|6
127060|NCT00509106|409215|P2|Overall Study|Other|0
127061|NCT00509106|409216|P1|Overall Study|Other|1
127062|NCT00509106|409215|P2|Overall Study|Lost to Follow-up|10
127063|NCT00509106|409216|P1|Overall Study|Lost to Follow-up|16
127064|NCT00509106|409215|P2|Overall Study|Withdrew consent|8
127065|NCT00509106|409216|P1|Overall Study|Withdrew consent|4
127066|NCT00509106|409215|P2|Overall Study|At the request of sponsor/investigator|2
127067|NCT00509106|409216|P1|Overall Study|At the request of sponsor/investigator|1
127068|NCT00509106|409215|P2|Overall Study|Noncompliance|1
127069|NCT00509106|409216|P1|Overall Study|Noncompliance|0
127070|NCT00509106|409215|P2|Overall Study|Adverse Event|2
127071|NCT00509106|409216|P1|Overall Study|Adverse Event|3
127072|NCT00509223|409239|P2|Overall Study|Did not meet revised inclusion criteria|62
127073|NCT00509223|409240|P1|Overall Study|Did not meet revised inclusion criteria|56
127074|NCT00509223|409239|P2|Overall Study|Including: subject change of address|2
127075|NCT00509223|409240|P1|Overall Study|Including: subject change of address|5
127076|NCT00509223|409239|P2|Overall Study|Withdrawal by Subject|6
127077|NCT00509223|409240|P1|Overall Study|Withdrawal by Subject|25
127078|NCT00509223|409239|P2|Overall Study|Adverse Event|1
127079|NCT00509223|409240|P1|Overall Study|Adverse Event|1
127080|NCT00509223|409239|P2|Overall Study|Lost to Follow-up|1
127081|NCT00509223|409240|P1|Overall Study|Lost to Follow-up|1
127082|NCT00509236|409248|P2|Overall Study|Scheduled Kidney Transplant|0
127083|NCT00509236|409249|P1|Overall Study|Scheduled Kidney Transplant|1
127084|NCT00509236|409248|P2|Overall Study|Excluded Medication|1
127085|NCT00509236|409249|P1|Overall Study|Excluded Medication|1
127086|NCT00509236|409248|P2|Overall Study|Protocol Violation|0
127087|NCT00509236|409249|P1|Overall Study|Protocol Violation|3
127088|NCT00509236|409248|P2|Overall Study|Withdrawal by Subject|10
127089|NCT00509236|409249|P1|Overall Study|Withdrawal by Subject|5
127090|NCT00509236|409248|P2|Overall Study|Adverse Event|9
127091|NCT00509236|409249|P1|Overall Study|Adverse Event|7
127092|NCT00509262|409268|P2|Overall Study|Withdrawal by Subject|11
127093|NCT00509262|409269|P1|Overall Study|Withdrawal by Subject|24
127094|NCT00509262|409268|P2|Overall Study|Protocol Violation|2
127095|NCT00509262|409269|P1|Overall Study|Protocol Violation|2
127096|NCT00509262|409268|P2|Overall Study|Physician Decision|3
127097|NCT00509262|409269|P1|Overall Study|Physician Decision|1
127098|NCT00509262|409268|P2|Overall Study|Lost to Follow-up|6
127099|NCT00509262|409269|P1|Overall Study|Lost to Follow-up|1
127100|NCT00509262|409268|P2|Overall Study|Lack of Efficacy|0
127101|NCT00509262|409269|P1|Overall Study|Lack of Efficacy|1
127102|NCT00509262|409268|P2|Overall Study|Not specified|2
127103|NCT00509262|409269|P1|Overall Study|Not specified|2
127104|NCT00509262|409268|P2|Overall Study|Adverse Event|18
127105|NCT00509262|409269|P1|Overall Study|Adverse Event|16
127106|NCT00509366|409297|P5|Overall Study|Not Treated (Screen Failure)|0
127107|NCT00509366|409298|P4|Overall Study|Not Treated (Screen Failure)|0
127108|NCT00509366|409299|P3|Overall Study|Not Treated (Screen Failure)|1
127109|NCT00509366|409300|P2|Overall Study|Not Treated (Screen Failure)|1
127110|NCT00509366|409301|P1|Overall Study|Not Treated (Screen Failure)|1
127111|NCT00510146|409364|P2|Open-Label Treatment|Sponsor Decision|0
127112|NCT00510146|409365|P1|Open-Label Treatment|Sponsor Decision|2
127113|NCT00510146|409364|P2|Open-Label Treatment|Clinical Relapse|1
127114|NCT00510146|409365|P1|Open-Label Treatment|Clinical Relapse|1
127115|NCT00510146|409364|P2|Open-Label Treatment|Withdrawal by Subject|12
127116|NCT00510146|409365|P1|Open-Label Treatment|Withdrawal by Subject|24
127117|NCT00510146|409364|P2|Open-Label Treatment|Protocol Violation|2
127118|NCT00510146|409365|P1|Open-Label Treatment|Protocol Violation|4
127119|NCT00510146|409364|P2|Open-Label Treatment|Physician Decision|1
127120|NCT00510146|409365|P1|Open-Label Treatment|Physician Decision|3
127121|NCT00510146|409364|P2|Open-Label Treatment|Lost to Follow-up|1
127122|NCT00510146|409365|P1|Open-Label Treatment|Lost to Follow-up|10
127123|NCT00510146|409364|P2|Open-Label Treatment|Lack of Efficacy|0
127124|NCT00510146|409365|P1|Open-Label Treatment|Lack of Efficacy|4
127125|NCT00510146|409364|P2|Open-Label Treatment|Death|1
127126|NCT00510146|409365|P1|Open-Label Treatment|Death|1
127127|NCT00510146|409364|P2|Open-Label Treatment|Adverse Event|8
127128|NCT00510146|409365|P1|Open-Label Treatment|Adverse Event|22
127129|NCT00510146|409364|P2|Double-Blind Treatment|Entry Criteria Not Met|0
127130|NCT00510146|409365|P1|Double-Blind Treatment|Entry Criteria Not Met|3
127131|NCT00510146|409364|P2|Double-Blind Treatment|Clinical Relapse|1
127132|NCT00510146|409365|P1|Double-Blind Treatment|Clinical Relapse|0
127133|NCT00510146|409364|P2|Double-Blind Treatment|Withdrawal by Subject|13
127134|NCT00510146|409365|P1|Double-Blind Treatment|Withdrawal by Subject|27
127135|NCT00510146|409364|P2|Double-Blind Treatment|Protocol Violation|2
127136|NCT00510146|409365|P1|Double-Blind Treatment|Protocol Violation|1
127137|NCT00510146|409364|P2|Double-Blind Treatment|Physician Decision|0
127138|NCT00510146|409365|P1|Double-Blind Treatment|Physician Decision|6
127139|NCT00510146|409364|P2|Double-Blind Treatment|Lost to Follow-up|7
127140|NCT00510146|409365|P1|Double-Blind Treatment|Lost to Follow-up|3
127141|NCT00510146|409364|P2|Double-Blind Treatment|Lack of Efficacy|13
127142|NCT00510146|409365|P1|Double-Blind Treatment|Lack of Efficacy|6
127143|NCT00510146|409364|P2|Double-Blind Treatment|Adverse Event|13
127144|NCT00510146|409365|P1|Double-Blind Treatment|Adverse Event|30
127145|NCT00510276|409461|P2|Extension Open-Label Phase|Subject Decision|9
127146|NCT00510276|409462|P1|Extension Open-Label Phase|Subject Decision|7
127147|NCT00510276|409461|P2|Extension Open-Label Phase|Sponsor Decision|0
127148|NCT00510276|409462|P1|Extension Open-Label Phase|Sponsor Decision|1
127149|NCT00510276|409461|P2|Extension Open-Label Phase|Protocol Violation|1
127150|NCT00510276|409462|P1|Extension Open-Label Phase|Protocol Violation|0
127151|NCT00510276|409461|P2|Extension Open-Label Phase|Physician Decision|3
127152|NCT00510276|409462|P1|Extension Open-Label Phase|Physician Decision|2
127153|NCT00510276|409461|P2|Extension Open-Label Phase|Lost to Follow-up|10
127154|NCT00510276|409462|P1|Extension Open-Label Phase|Lost to Follow-up|12
127155|NCT00510276|409461|P2|Extension Open-Label Phase|Lack of Efficacy|7
127156|NCT00510276|409462|P1|Extension Open-Label Phase|Lack of Efficacy|2
127157|NCT00510276|409461|P2|Extension Open-Label Phase|Adverse Event|18
127158|NCT00510276|409462|P1|Extension Open-Label Phase|Adverse Event|9
127159|NCT00510276|409461|P2|Acute Double-Blind Phase|Subject Decision|28
127160|NCT00510276|409462|P1|Acute Double-Blind Phase|Subject Decision|26
127161|NCT00510276|409461|P2|Acute Double-Blind Phase|Sponsor Decision|1
127162|NCT00510276|409462|P1|Acute Double-Blind Phase|Sponsor Decision|2
127163|NCT00510276|409461|P2|Acute Double-Blind Phase|Protocol Violation|3
127164|NCT00510276|409462|P1|Acute Double-Blind Phase|Protocol Violation|4
127165|NCT00510276|409461|P2|Acute Double-Blind Phase|Physician Decision|3
127166|NCT00510276|409462|P1|Acute Double-Blind Phase|Physician Decision|0
127167|NCT00510276|409461|P2|Acute Double-Blind Phase|Lost to Follow-up|49
127168|NCT00510276|409462|P1|Acute Double-Blind Phase|Lost to Follow-up|48
127169|NCT00510276|409461|P2|Acute Double-Blind Phase|Lack of Efficacy|4
127170|NCT00510276|409462|P1|Acute Double-Blind Phase|Lack of Efficacy|3
127171|NCT00510276|409461|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
127172|NCT00510276|409462|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
127173|NCT00510276|409461|P2|Acute Double-Blind Phase|Adverse Event|6
127174|NCT00510276|409462|P1|Acute Double-Blind Phase|Adverse Event|21
127175|NCT00510289|409547|P1|Overall Study|Progressed prior to starting drug|2
127176|NCT00510289|409547|P1|Overall Study|Lost to Follow-up|1
127177|NCT00510289|409547|P1|Overall Study|Refused bone marrow biopsy|2
127178|NCT00510289|409547|P1|Overall Study|Withdrawal by Subject|7
127179|NCT00510484|409557|P2|Wash-out Period|Adverse Event|1
127180|NCT00510484|409558|P1|Wash-out Period|Adverse Event|0
127181|NCT00510510|409586|P3|Overall Study|Protocol Violation|4
127182|NCT00510510|409587|P2|Overall Study|Protocol Violation|3
127183|NCT00510510|409588|P1|Overall Study|Protocol Violation|0
127184|NCT00510510|409586|P3|Overall Study|Lost to Follow-up|1
127185|NCT00510510|409587|P2|Overall Study|Lost to Follow-up|0
127186|NCT00510510|409588|P1|Overall Study|Lost to Follow-up|0
127187|NCT00510510|409586|P3|Overall Study|Withdrawal by Subject|3
127188|NCT00510510|409587|P2|Overall Study|Withdrawal by Subject|2
127189|NCT00510510|409588|P1|Overall Study|Withdrawal by Subject|1
127190|NCT00510510|409586|P3|Overall Study|Subjects no longer requires study drug|2
127191|NCT00510510|409587|P2|Overall Study|Subjects no longer requires study drug|0
127192|NCT00510510|409588|P1|Overall Study|Subjects no longer requires study drug|0
127193|NCT00510510|409586|P3|Overall Study|Lack of Efficacy|1
127194|NCT00510510|409587|P2|Overall Study|Lack of Efficacy|1
127195|NCT00510510|409588|P1|Overall Study|Lack of Efficacy|0
127196|NCT00510510|409586|P3|Overall Study|Adverse Event|6
127197|NCT00510510|409587|P2|Overall Study|Adverse Event|3
127198|NCT00510510|409588|P1|Overall Study|Adverse Event|4
127199|NCT00510653|409599|P1|Overall Study|Monetary|3
127200|NCT00510653|409599|P1|Overall Study|Withdrawal by Subject|8
127201|NCT00510692|409605|P2|Overall Study|Withdrawal by Subject|0
127202|NCT00510692|409606|P1|Overall Study|Withdrawal by Subject|1
127203|NCT00510692|409605|P2|Overall Study|Adverse Event|3
127204|NCT00510692|409606|P1|Overall Study|Adverse Event|1
127205|NCT00510783|409626|P2|Overall Study|Protocol Violation|1
127206|NCT00510783|409627|P1|Overall Study|Protocol Violation|0
127207|NCT00510783|409626|P2|Overall Study|Withdrawal by Subject|3
127208|NCT00510783|409627|P1|Overall Study|Withdrawal by Subject|2
127209|NCT00510783|409626|P2|Overall Study|Lost to Follow-up|25
127210|NCT00510783|409627|P1|Overall Study|Lost to Follow-up|29
127211|NCT00510835|409652|P3|Overall Study|Withdrawal by Subject|2
127212|NCT00510835|409653|P2|Overall Study|Withdrawal by Subject|2
127213|NCT00510835|409654|P1|Overall Study|Withdrawal by Subject|6
127214|NCT00510874|409669|P7|Overall Study|Lost to Follow-up|1
127215|NCT00510874|409670|P6|Overall Study|Lost to Follow-up|0
127216|NCT00510874|409671|P5|Overall Study|Lost to Follow-up|4
127217|NCT00510874|409672|P4|Overall Study|Lost to Follow-up|3
127218|NCT00510874|409673|P3|Overall Study|Lost to Follow-up|1
127219|NCT00510874|409674|P2|Overall Study|Lost to Follow-up|3
127220|NCT00510874|409675|P1|Overall Study|Lost to Follow-up|2
127221|NCT00510874|409669|P7|Overall Study|Withdrawal by Subject|0
127222|NCT00510874|409670|P6|Overall Study|Withdrawal by Subject|0
127223|NCT00510874|409671|P5|Overall Study|Withdrawal by Subject|3
127224|NCT00510874|409672|P4|Overall Study|Withdrawal by Subject|0
127225|NCT00510874|409673|P3|Overall Study|Withdrawal by Subject|0
127226|NCT00510874|409674|P2|Overall Study|Withdrawal by Subject|1
127227|NCT00510874|409675|P1|Overall Study|Withdrawal by Subject|1
127228|NCT00510887|409775|P1|Overall Study|Lost to Follow-up|1
127229|NCT00510952|409786|P2|Overall Study|Did Not Receive Study Drug|0
127230|NCT00510952|409787|P1|Overall Study|Did Not Receive Study Drug|2
127231|NCT00510952|409786|P2|Overall Study|Withdrawal by Subject|7
127232|NCT00510952|409787|P1|Overall Study|Withdrawal by Subject|6
127233|NCT00510952|409786|P2|Overall Study|Sponsor Decision|0
127234|NCT00510952|409787|P1|Overall Study|Sponsor Decision|1
127235|NCT00510952|409786|P2|Overall Study|Protocol Violation|4
127236|NCT00510952|409787|P1|Overall Study|Protocol Violation|7
127237|NCT00510952|409786|P2|Overall Study|Physician Decision|1
127238|NCT00510952|409787|P1|Overall Study|Physician Decision|1
127239|NCT00510952|409786|P2|Overall Study|Lost to Follow-up|3
127240|NCT00510952|409787|P1|Overall Study|Lost to Follow-up|5
127241|NCT00510952|409786|P2|Overall Study|Entry Criteria Not Met|1
127242|NCT00510952|409787|P1|Overall Study|Entry Criteria Not Met|3
127243|NCT00510952|409786|P2|Overall Study|Adverse Event|0
127244|NCT00510952|409787|P1|Overall Study|Adverse Event|1
127245|NCT00511004|409816|P3|Overall Study|Lost to Follow-up|4
127246|NCT00511004|409817|P2|Overall Study|Lost to Follow-up|0
127247|NCT00511004|409818|P1|Overall Study|Lost to Follow-up|0
127248|NCT00511108|409845|P4|Overall Study|Withdrawal by Subject|2
127249|NCT00511108|409846|P3|Overall Study|Withdrawal by Subject|3
127250|NCT00511108|409847|P2|Overall Study|Withdrawal by Subject|0
127251|NCT00511108|409848|P1|Overall Study|Withdrawal by Subject|4
127252|NCT00511108|409845|P4|Overall Study|Physician Decision|1
127253|NCT00511108|409846|P3|Overall Study|Physician Decision|0
127254|NCT00511108|409847|P2|Overall Study|Physician Decision|0
127255|NCT00511108|409848|P1|Overall Study|Physician Decision|0
127256|NCT00511108|409845|P4|Overall Study|Lost to Follow-up|0
127257|NCT00511108|409846|P3|Overall Study|Lost to Follow-up|1
127258|NCT00511108|409847|P2|Overall Study|Lost to Follow-up|2
127259|NCT00511108|409848|P1|Overall Study|Lost to Follow-up|0
127260|NCT00511108|409845|P4|Overall Study|Adverse Event|2
127261|NCT00511108|409846|P3|Overall Study|Adverse Event|1
127262|NCT00511108|409847|P2|Overall Study|Adverse Event|0
127263|NCT00511108|409848|P1|Overall Study|Adverse Event|2
127264|NCT00511134|409868|P2|Overall Study|Withdrawal by Subject|2
127265|NCT00511134|409869|P1|Overall Study|Withdrawal by Subject|0
127266|NCT00511147|409877|P1|Overall Study|Required platelet transfusion|1
127267|NCT00511147|409877|P1|Overall Study|Disease progression|5
127268|NCT00511147|409877|P1|Overall Study|Withdrawal by Subject|1
127269|NCT00511199|409891|P2|Overall Study|Other Reason|37
127270|NCT00511199|409892|P1|Overall Study|Other Reason|78
127271|NCT00511199|409891|P2|Overall Study|Lost to Follow-up|17
127272|NCT00511199|409892|P1|Overall Study|Lost to Follow-up|40
127273|NCT00511199|409891|P2|Overall Study|Pregnancy Wish|8
127274|NCT00511199|409892|P1|Overall Study|Pregnancy Wish|16
127275|NCT00511199|409891|P2|Overall Study|Pregnancy|3
127276|NCT00511199|409892|P1|Overall Study|Pregnancy|6
127277|NCT00511199|409891|P2|Overall Study|Withdrawal of Informed Consent|4
127278|NCT00511199|409892|P1|Overall Study|Withdrawal of Informed Consent|19
127279|NCT00511199|409891|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
127280|NCT00511199|409892|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
127281|NCT00511199|409891|P2|Overall Study|Unacceptable Vaginal Bleeding|4
127282|NCT00511199|409892|P1|Overall Study|Unacceptable Vaginal Bleeding|63
127283|NCT00511238|409918|P2|Overall Study|various reasons|14
127284|NCT00511238|409919|P1|Overall Study|various reasons|4
127285|NCT00511238|409918|P2|Overall Study|Progressive Disease|157
127286|NCT00511238|409919|P1|Overall Study|Progressive Disease|23
127287|NCT00511238|409918|P2|Overall Study|Withdrawal by Subject|22
127288|NCT00511238|409919|P1|Overall Study|Withdrawal by Subject|2
127289|NCT00511238|409918|P2|Overall Study|Adverse Event|33
127290|NCT00511238|409919|P1|Overall Study|Adverse Event|13
127291|NCT00511342|409938|P2|Overall Study|Other Reason|2
127292|NCT00511342|409939|P1|Overall Study|Other Reason|2
127293|NCT00511342|409938|P2|Overall Study|Lost to Follow-up|5
127294|NCT00511342|409939|P1|Overall Study|Lost to Follow-up|1
127295|NCT00511342|409938|P2|Overall Study|Pregnancy wish|1
127296|NCT00511342|409939|P1|Overall Study|Pregnancy wish|0
127297|NCT00511342|409938|P2|Overall Study|Pregnancy|1
127298|NCT00511342|409939|P1|Overall Study|Pregnancy|0
127299|NCT00511342|409938|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
127300|NCT00511342|409939|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
127301|NCT00511342|409938|P2|Overall Study|Unacceptable vaginal bleeding|1
127302|NCT00511342|409939|P1|Overall Study|Unacceptable vaginal bleeding|2
127303|NCT00511355|409965|P2|Overall Study|Other reason pre-treatment|1
127304|NCT00511355|409966|P1|Overall Study|Other reason pre-treatment|0
127305|NCT00511355|409965|P2|Overall Study|Withdrawal of informed consent|1
127306|NCT00511355|409966|P1|Overall Study|Withdrawal of informed consent|0
127307|NCT00511355|409965|P2|Overall Study|Pre-treatment (serious) adverse event|1
127308|NCT00511355|409966|P1|Overall Study|Pre-treatment (serious) adverse event|0
127309|NCT00511355|409965|P2|Overall Study|Other Reason|1
127310|NCT00511355|409966|P1|Overall Study|Other Reason|0
127311|NCT00511355|409965|P2|Overall Study|Lost to Follow-up|1
127312|NCT00511355|409966|P1|Overall Study|Lost to Follow-up|2
127313|NCT00511355|409965|P2|Overall Study|Pregnancy Wish|0
127314|NCT00511355|409966|P1|Overall Study|Pregnancy Wish|1
127315|NCT00511355|409965|P2|Overall Study|Adverse Event|4
127316|NCT00511355|409966|P1|Overall Study|Adverse Event|4
127317|NCT00511433|410066|P2|Overall Study|Other Reason|1
127318|NCT00511433|410067|P1|Overall Study|Other Reason|1
127319|NCT00511433|410066|P2|Overall Study|Adverse Event|0
127320|NCT00511433|410067|P1|Overall Study|Adverse Event|5
127321|NCT00511472|410107|P2|Overall Study|Not reported|2
127322|NCT00511472|410108|P1|Overall Study|Not reported|2
127323|NCT00511472|410107|P2|Overall Study|Laboratory Adverse Event|2
127324|NCT00511472|410108|P1|Overall Study|Laboratory Adverse Event|0
127325|NCT00511472|410107|P2|Overall Study|Clinical Adverse Event|2
127326|NCT00511472|410108|P1|Overall Study|Clinical Adverse Event|1
127327|NCT00511667|410127|P2|Overall Study|Other|1
127328|NCT00511667|410128|P1|Overall Study|Other|2
127329|NCT00511667|410127|P2|Overall Study|Site terminated|1
127330|NCT00511667|410128|P1|Overall Study|Site terminated|6
127331|NCT00511667|410127|P2|Overall Study|Withdrawal by Subject|0
127332|NCT00511667|410128|P1|Overall Study|Withdrawal by Subject|2
127333|NCT00511667|410127|P2|Overall Study|Protocol Violation|1
127334|NCT00511667|410128|P1|Overall Study|Protocol Violation|1
127335|NCT00511667|410127|P2|Overall Study|Adverse Event|0
127336|NCT00511667|410128|P1|Overall Study|Adverse Event|1
127337|NCT00511797|410180|P4|Overall Study|Other (moving etc)|2
127338|NCT00511797|410181|P3|Overall Study|Other (moving etc)|1
127339|NCT00511797|410182|P2|Overall Study|Other (moving etc)|0
127340|NCT00511797|410183|P1|Overall Study|Other (moving etc)|1
127341|NCT00511797|410180|P4|Overall Study|Partially missing diary|0
127342|NCT00511797|410181|P3|Overall Study|Partially missing diary|1
127343|NCT00511797|410182|P2|Overall Study|Partially missing diary|0
127344|NCT00511797|410183|P1|Overall Study|Partially missing diary|0
127345|NCT00511797|410180|P4|Overall Study|Study drug not taken|1
127346|NCT00511797|410181|P3|Overall Study|Study drug not taken|0
127347|NCT00511797|410182|P2|Overall Study|Study drug not taken|1
127348|NCT00511797|410183|P1|Overall Study|Study drug not taken|0
127349|NCT00511797|410180|P4|Overall Study|Never dispensed|3
127350|NCT00511797|410181|P3|Overall Study|Never dispensed|1
127351|NCT00511797|410182|P2|Overall Study|Never dispensed|0
127352|NCT00511797|410183|P1|Overall Study|Never dispensed|1
127353|NCT00511797|410180|P4|Overall Study|Withdrawal by Subject|2
127354|NCT00511797|410181|P3|Overall Study|Withdrawal by Subject|4
127355|NCT00511797|410182|P2|Overall Study|Withdrawal by Subject|3
127356|NCT00511797|410183|P1|Overall Study|Withdrawal by Subject|3
127357|NCT00511797|410180|P4|Overall Study|Protocol Violation|3
127358|NCT00511797|410181|P3|Overall Study|Protocol Violation|2
127359|NCT00511797|410182|P2|Overall Study|Protocol Violation|2
127360|NCT00511797|410183|P1|Overall Study|Protocol Violation|0
127361|NCT00511797|410180|P4|Overall Study|Pregnancy|1
127362|NCT00511797|410181|P3|Overall Study|Pregnancy|0
127363|NCT00511797|410182|P2|Overall Study|Pregnancy|0
127364|NCT00511797|410183|P1|Overall Study|Pregnancy|0
127365|NCT00511797|410180|P4|Overall Study|Lost to Follow-up|1
127366|NCT00511797|410181|P3|Overall Study|Lost to Follow-up|0
127367|NCT00511797|410182|P2|Overall Study|Lost to Follow-up|0
127368|NCT00511797|410183|P1|Overall Study|Lost to Follow-up|1
127369|NCT00511797|410180|P4|Overall Study|Adverse Event|2
127370|NCT00511797|410181|P3|Overall Study|Adverse Event|2
127371|NCT00511797|410182|P2|Overall Study|Adverse Event|2
127372|NCT00511797|410183|P1|Overall Study|Adverse Event|1
127373|NCT00511810|410287|P2|Overall Study|Refused second scn|1
127374|NCT00511810|410288|P1|Overall Study|Refused second scn|0
127375|NCT00511810|410287|P2|Overall Study|Lack of Efficacy|2
127376|NCT00511810|410288|P1|Overall Study|Lack of Efficacy|0
127377|NCT00511810|410287|P2|Overall Study|Lost to Follow-up|2
127378|NCT00511810|410288|P1|Overall Study|Lost to Follow-up|1
127379|NCT00511836|410296|P2|Double-blind Period|Lost to Follow-up|0
127380|NCT00511836|410297|P1|Double-blind Period|Lost to Follow-up|1
127381|NCT00511901|410330|P2|Overall Study|Withdrawal by Subject|3
127382|NCT00511901|410331|P1|Overall Study|Withdrawal by Subject|1
127383|NCT00512096|410373|P1|Overall Study|Lack of Efficacy|3
127384|NCT00512096|410373|P1|Overall Study|Withdrawal by Subject|2
127385|NCT00512096|410373|P1|Overall Study|Adverse Event|2
127386|NCT00512148|410377|P1|Primay Study Period|Withdrawal by Subject|1
127387|NCT00512252|410385|P3|Overall Study|Death|1
127388|NCT00512252|410386|P2|Overall Study|Death|0
127389|NCT00512252|410387|P1|Overall Study|Death|0
127390|NCT00512252|410385|P3|Overall Study|Protocol Violation|1
127391|NCT00512252|410386|P2|Overall Study|Protocol Violation|0
127392|NCT00512252|410387|P1|Overall Study|Protocol Violation|0
127393|NCT00512252|410385|P3|Overall Study|Lost to Follow-up|1
127394|NCT00512252|410386|P2|Overall Study|Lost to Follow-up|0
127395|NCT00512252|410387|P1|Overall Study|Lost to Follow-up|0
127396|NCT00506285|410417|P2|6-month Open Label Phase|Withdrawal by Subject|5
127397|NCT00506285|410418|P1|6-month Open Label Phase|Withdrawal by Subject|9
127398|NCT00506285|410417|P2|6-month Open Label Phase|Lost to Follow-up|7
127399|NCT00506285|410418|P1|6-month Open Label Phase|Lost to Follow-up|1
127400|NCT00506285|410417|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
127401|NCT00506285|410418|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
127402|NCT00506285|410417|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
127403|NCT00506285|410418|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
127404|NCT00506285|410417|P2|3 Week Screening Phase|Withdrawal by Subject|10
127405|NCT00506285|410418|P1|3 Week Screening Phase|Withdrawal by Subject|17
127406|NCT00506389|410429|P3|In-treatment Period|Randomized but not treated|1
127407|NCT00506389|410430|P2|In-treatment Period|Randomized but not treated|1
127408|NCT00506389|410431|P1|In-treatment Period|Randomized but not treated|4
127409|NCT00506389|410429|P3|In-treatment Period|Adverse Event|2
127410|NCT00506389|410430|P2|In-treatment Period|Adverse Event|5
127411|NCT00506389|410431|P1|In-treatment Period|Adverse Event|11
127412|NCT00506389|410429|P3|In-treatment Period|Lack of Efficacy|0
127413|NCT00506389|410430|P2|In-treatment Period|Lack of Efficacy|2
127414|NCT00506389|410431|P1|In-treatment Period|Lack of Efficacy|0
127415|NCT00506389|410429|P3|In-treatment Period|Withdrawal by Subject|4
127416|NCT00506389|410430|P2|In-treatment Period|Withdrawal by Subject|3
127417|NCT00506389|410431|P1|In-treatment Period|Withdrawal by Subject|3
127418|NCT00506389|410429|P3|In-treatment Period|Reasons not related to trial|0
127419|NCT00506389|410430|P2|In-treatment Period|Reasons not related to trial|1
127420|NCT00506389|410431|P1|In-treatment Period|Reasons not related to trial|4
127421|NCT00506389|410429|P3|In-treatment Period|Lack of compliance|0
127422|NCT00506389|410430|P2|In-treatment Period|Lack of compliance|0
127423|NCT00506389|410431|P1|In-treatment Period|Lack of compliance|1
127424|NCT00506389|410429|P3|In-treatment Period|Lost to Follow-up|1
127425|NCT00506389|410430|P2|In-treatment Period|Lost to Follow-up|0
127426|NCT00506389|410431|P1|In-treatment Period|Lost to Follow-up|0
127427|NCT00506389|410429|P3|In-treatment Period|Not specified|4
127428|NCT00506389|410430|P2|In-treatment Period|Not specified|3
127429|NCT00506389|410431|P1|In-treatment Period|Not specified|3
127430|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
127431|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
127432|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
127433|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
127434|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
127435|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
127436|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
127437|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
127438|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
127439|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
127440|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
127441|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
127442|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
127443|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
127444|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
127445|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
127446|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
127447|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
127448|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
127449|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
127450|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
127451|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
127452|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
127453|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
127454|NCT00506415|410448|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
127455|NCT00506415|410449|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
127456|NCT00506415|410450|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
127457|NCT00506415|410451|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
127458|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
127459|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
127460|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
127461|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
127462|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
127463|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
127464|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
127465|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
127466|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
127624|NCT00514514|410609|P3|Pre-phase|abnormal lab values|0
127467|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
127468|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
127469|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
127470|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
127471|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
127472|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
127473|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
127474|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
127475|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
127476|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
127477|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
127478|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
127479|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
127480|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
127481|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
127482|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Death|0
127483|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Death|3
127484|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Death|5
127485|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Death|0
127486|NCT00506415|410448|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
127487|NCT00506415|410449|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
127488|NCT00506415|410450|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
127489|NCT00506415|410451|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
127490|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
127491|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
127492|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
127493|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
127494|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
127495|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
127496|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
127497|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
127498|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
127499|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
127500|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
127501|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
127502|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
127503|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
127504|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
127505|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
127506|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
127507|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
127508|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
127509|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
127510|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
127511|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
127512|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
127513|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
127514|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
127515|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
127516|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
127517|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
127518|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
127519|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
127520|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
127521|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
127522|NCT00506415|410448|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
127523|NCT00506415|410449|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
127524|NCT00506415|410450|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
127525|NCT00506415|410451|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
127526|NCT00506441|410473|P2|Period 2; Double-blind Period|Other Reason|1
127527|NCT00506441|410474|P1|Period 2; Double-blind Period|Other Reason|1
127528|NCT00506441|410473|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
127529|NCT00506441|410474|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
127530|NCT00506441|410473|P2|Period 2; Double-blind Period|Physician Decision|1
127531|NCT00506441|410474|P1|Period 2; Double-blind Period|Physician Decision|1
127532|NCT00506441|410473|P2|Period 2; Double-blind Period|Lack of Efficacy|2
127533|NCT00506441|410474|P1|Period 2; Double-blind Period|Lack of Efficacy|0
127534|NCT00506441|410473|P2|Period 2; Double-blind Period|Adverse Event|1
127535|NCT00506441|410474|P1|Period 2; Double-blind Period|Adverse Event|0
127536|NCT00506441|410473|P2|Period 1; Open-label Period|Other Reasons|0
127537|NCT00506441|410474|P1|Period 1; Open-label Period|Other Reasons|13
127538|NCT00506441|410473|P2|Period 1; Open-label Period|Withdrawal by Subject|0
127539|NCT00506441|410474|P1|Period 1; Open-label Period|Withdrawal by Subject|13
127540|NCT00506441|410473|P2|Period 1; Open-label Period|Protocol Violation|0
127541|NCT00506441|410474|P1|Period 1; Open-label Period|Protocol Violation|9
127542|NCT00506441|410473|P2|Period 1; Open-label Period|Physician Decision|0
127543|NCT00506441|410474|P1|Period 1; Open-label Period|Physician Decision|5
127544|NCT00506441|410473|P2|Period 1; Open-label Period|Lost to Follow-up|0
127545|NCT00506441|410474|P1|Period 1; Open-label Period|Lost to Follow-up|2
127546|NCT00506441|410473|P2|Period 1; Open-label Period|Lack of Efficacy|0
127547|NCT00506441|410474|P1|Period 1; Open-label Period|Lack of Efficacy|13
127548|NCT00506441|410473|P2|Period 1; Open-label Period|Adverse Event|0
127549|NCT00506441|410474|P1|Period 1; Open-label Period|Adverse Event|21
127550|NCT00506454|410484|P2|Overall Study|Withdrawal by Subject|1
127551|NCT00506454|410485|P1|Overall Study|Withdrawal by Subject|1
127552|NCT00506493|410491|P1|Overall Study|Withdrawal by Subject|5
127553|NCT00506493|410491|P1|Overall Study|Death|6
127554|NCT00512707|410504|P2|Overall Study|Unable to tolerate the smell of the gel|0
127555|NCT00512707|410505|P1|Overall Study|Unable to tolerate the smell of the gel|1
127556|NCT00512707|410504|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
127557|NCT00512707|410505|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
127558|NCT00512707|410504|P2|Overall Study|Developed skin irritation|1
127559|NCT00512707|410505|P1|Overall Study|Developed skin irritation|2
127560|NCT00512707|410504|P2|Overall Study|Lost to Follow-up|11
127561|NCT00512707|410505|P1|Overall Study|Lost to Follow-up|5
127562|NCT00512798|410537|P2|Overall Study|Withdrawal by Subject|0
127563|NCT00512798|410538|P1|Overall Study|Withdrawal by Subject|3
127564|NCT00512798|410537|P2|Overall Study|Progression of disease|20
127565|NCT00512798|410538|P1|Overall Study|Progression of disease|14
127566|NCT00512798|410537|P2|Overall Study|Adverse Event|4
127567|NCT00512798|410538|P1|Overall Study|Adverse Event|2
127568|NCT00512798|410537|P2|Overall Study|Death|3
127569|NCT00512798|410538|P1|Overall Study|Death|0
127570|NCT00512902|410552|P1|Overall Study|Lost to Follow-up|1
127571|NCT00512902|410552|P1|Overall Study|Adverse Event|7
127572|NCT00514020|410585|P1|Overall Study|"patients moved to the no tx group"|6
127573|NCT00514020|410585|P1|Overall Study|patient went to radiation treatment|1
127574|NCT00514020|410585|P1|Overall Study|other complicating disease|2
127575|NCT00514020|410585|P1|Overall Study|disease progression|9
127576|NCT00514020|410585|P1|Overall Study|Physician Decision|1
127577|NCT00514020|410585|P1|Overall Study|Withdrawal by Subject|3
127578|NCT00514020|410585|P1|Overall Study|Adverse Event|6
127579|NCT00514514|410609|P3|Extension - 4 Years|Adverse Event|3
127580|NCT00514514|410610|P2|Extension - 4 Years|Adverse Event|6
127581|NCT00514514|410611|P1|Extension - 4 Years|Adverse Event|9
127582|NCT00514514|410609|P3|Extension - 4 Years|Death|6
127583|NCT00514514|410610|P2|Extension - 4 Years|Death|3
127584|NCT00514514|410611|P1|Extension - 4 Years|Death|8
127585|NCT00514514|410609|P3|Extension - 4 Years|Administrative problems|1
127586|NCT00514514|410610|P2|Extension - 4 Years|Administrative problems|1
127587|NCT00514514|410611|P1|Extension - 4 Years|Administrative problems|3
127588|NCT00514514|410609|P3|Extension - 4 Years|Lost to Follow-up|9
127589|NCT00514514|410610|P2|Extension - 4 Years|Lost to Follow-up|10
127590|NCT00514514|410611|P1|Extension - 4 Years|Lost to Follow-up|12
127591|NCT00514514|410609|P3|Extension - 4 Years|Withdrawal by Subject|2
127592|NCT00514514|410610|P2|Extension - 4 Years|Withdrawal by Subject|2
127593|NCT00514514|410611|P1|Extension - 4 Years|Withdrawal by Subject|5
127594|NCT00514514|410609|P3|Randomized - 9 Month|Adverse Event|27
127595|NCT00514514|410610|P2|Randomized - 9 Month|Adverse Event|44
127596|NCT00514514|410611|P1|Randomized - 9 Month|Adverse Event|25
127597|NCT00514514|410609|P3|Randomized - 9 Month|Abnormal laboratory values|1
127598|NCT00514514|410610|P2|Randomized - 9 Month|Abnormal laboratory values|3
127599|NCT00514514|410611|P1|Randomized - 9 Month|Abnormal laboratory values|0
127600|NCT00514514|410609|P3|Randomized - 9 Month|Lack of Efficacy|1
127601|NCT00514514|410610|P2|Randomized - 9 Month|Lack of Efficacy|3
127602|NCT00514514|410611|P1|Randomized - 9 Month|Lack of Efficacy|2
127603|NCT00514514|410609|P3|Randomized - 9 Month|Protocol Violation|0
127604|NCT00514514|410610|P2|Randomized - 9 Month|Protocol Violation|1
127605|NCT00514514|410611|P1|Randomized - 9 Month|Protocol Violation|1
127606|NCT00514514|410609|P3|Randomized - 9 Month|Withdrawal by Subject|5
127607|NCT00514514|410610|P2|Randomized - 9 Month|Withdrawal by Subject|7
127608|NCT00514514|410611|P1|Randomized - 9 Month|Withdrawal by Subject|7
127609|NCT00514514|410609|P3|Randomized - 9 Month|Administrative problems|2
127610|NCT00514514|410610|P2|Randomized - 9 Month|Administrative problems|1
127611|NCT00514514|410611|P1|Randomized - 9 Month|Administrative problems|1
127612|NCT00514514|410609|P3|Randomized - 9 Month|Death|2
127613|NCT00514514|410610|P2|Randomized - 9 Month|Death|2
127614|NCT00514514|410611|P1|Randomized - 9 Month|Death|3
127615|NCT00514514|410609|P3|Pre-phase|Withdrawal by Subject|0
127616|NCT00514514|410610|P2|Pre-phase|Withdrawal by Subject|0
127617|NCT00514514|410611|P1|Pre-phase|Withdrawal by Subject|66
127618|NCT00514514|410609|P3|Pre-phase|Adverse Event|0
127619|NCT00514514|410610|P2|Pre-phase|Adverse Event|0
127620|NCT00514514|410611|P1|Pre-phase|Adverse Event|137
127621|NCT00514514|410609|P3|Pre-phase|Lack of Efficacy|0
127622|NCT00514514|410610|P2|Pre-phase|Lack of Efficacy|0
127623|NCT00514514|410611|P1|Pre-phase|Lack of Efficacy|35
127625|NCT00514514|410610|P2|Pre-phase|abnormal lab values|0
127626|NCT00514514|410611|P1|Pre-phase|abnormal lab values|23
127627|NCT00514514|410609|P3|Pre-phase|Lost to Follow-up|0
127628|NCT00514514|410610|P2|Pre-phase|Lost to Follow-up|0
127629|NCT00514514|410611|P1|Pre-phase|Lost to Follow-up|2
127630|NCT00514514|410609|P3|Pre-phase|abnormal test procedure results|0
127631|NCT00514514|410610|P2|Pre-phase|abnormal test procedure results|0
127632|NCT00514514|410611|P1|Pre-phase|abnormal test procedure results|15
127633|NCT00514514|410609|P3|Pre-phase|condition no longer requires study drug|0
127634|NCT00514514|410610|P2|Pre-phase|condition no longer requires study drug|0
127635|NCT00514514|410611|P1|Pre-phase|condition no longer requires study drug|7
127636|NCT00514514|410609|P3|Pre-phase|Protocol Violation|0
127637|NCT00514514|410610|P2|Pre-phase|Protocol Violation|0
127638|NCT00514514|410611|P1|Pre-phase|Protocol Violation|6
127639|NCT00514514|410609|P3|Pre-phase|administrative problems|0
127640|NCT00514514|410610|P2|Pre-phase|administrative problems|0
127641|NCT00514514|410611|P1|Pre-phase|administrative problems|2
127642|NCT00514514|410609|P3|Pre-phase|Death|0
127643|NCT00514514|410610|P2|Pre-phase|Death|0
127644|NCT00514514|410611|P1|Pre-phase|Death|10
127645|NCT00514683|410665|P5|Overall Study|Reason other than listed above|1
127646|NCT00514683|410666|P4|Overall Study|Reason other than listed above|0
127647|NCT00514683|410667|P3|Overall Study|Reason other than listed above|2
127648|NCT00514683|410668|P2|Overall Study|Reason other than listed above|1
127649|NCT00514683|410669|P1|Overall Study|Reason other than listed above|0
127650|NCT00514683|410665|P5|Overall Study|Withdrawal by Subject|4
127651|NCT00514683|410666|P4|Overall Study|Withdrawal by Subject|0
127652|NCT00514683|410667|P3|Overall Study|Withdrawal by Subject|1
127653|NCT00514683|410668|P2|Overall Study|Withdrawal by Subject|2
127654|NCT00514683|410669|P1|Overall Study|Withdrawal by Subject|2
127655|NCT00514683|410665|P5|Overall Study|Protocol Violation|0
127656|NCT00514683|410666|P4|Overall Study|Protocol Violation|1
127657|NCT00514683|410667|P3|Overall Study|Protocol Violation|0
127658|NCT00514683|410668|P2|Overall Study|Protocol Violation|1
127659|NCT00514683|410669|P1|Overall Study|Protocol Violation|1
127660|NCT00514683|410665|P5|Overall Study|Adverse Event|27
127661|NCT00514683|410666|P4|Overall Study|Adverse Event|13
127662|NCT00514683|410667|P3|Overall Study|Adverse Event|15
127663|NCT00514683|410668|P2|Overall Study|Adverse Event|20
127664|NCT00514683|410669|P1|Overall Study|Adverse Event|21
127665|NCT00514683|410665|P5|Overall Study|Not treated|1
127666|NCT00514683|410666|P4|Overall Study|Not treated|0
127667|NCT00514683|410667|P3|Overall Study|Not treated|0
127668|NCT00514683|410668|P2|Overall Study|Not treated|1
127669|NCT00514683|410669|P1|Overall Study|Not treated|2
127670|NCT00514735|410875|P2|Overall Study|Lost to Follow-up|1
127671|NCT00514735|410876|P1|Overall Study|Lost to Follow-up|0
127672|NCT00514735|410875|P2|Overall Study|Death|0
127673|NCT00514735|410876|P1|Overall Study|Death|1
127674|NCT00514735|410875|P2|Overall Study|Withdrawal by Subject|5
127675|NCT00514735|410876|P1|Overall Study|Withdrawal by Subject|13
127676|NCT00514813|410898|P4|Overall Study|Death|2
127677|NCT00514813|410899|P3|Overall Study|Death|3
127678|NCT00514813|410900|P2|Overall Study|Death|2
127679|NCT00514813|410901|P1|Overall Study|Death|0
127680|NCT00514813|410898|P4|Overall Study|Kidney transplant|0
127681|NCT00514813|410899|P3|Overall Study|Kidney transplant|2
127682|NCT00514813|410900|P2|Overall Study|Kidney transplant|6
127683|NCT00514813|410901|P1|Overall Study|Kidney transplant|0
127684|NCT00514813|410898|P4|Overall Study|Lack of Efficacy|0
127685|NCT00514813|410899|P3|Overall Study|Lack of Efficacy|0
127686|NCT00514813|410900|P2|Overall Study|Lack of Efficacy|1
127687|NCT00514813|410901|P1|Overall Study|Lack of Efficacy|0
127688|NCT00514813|410898|P4|Overall Study|Withdrawal by Subject|0
127689|NCT00514813|410899|P3|Overall Study|Withdrawal by Subject|0
127690|NCT00514813|410900|P2|Overall Study|Withdrawal by Subject|1
127691|NCT00514813|410901|P1|Overall Study|Withdrawal by Subject|0
127692|NCT00514813|410898|P4|Overall Study|Protocol Violation|0
127693|NCT00514813|410899|P3|Overall Study|Protocol Violation|0
127694|NCT00514813|410900|P2|Overall Study|Protocol Violation|0
127695|NCT00514813|410901|P1|Overall Study|Protocol Violation|1
127696|NCT00514813|410898|P4|Overall Study|Adverse Event|0
127697|NCT00514813|410899|P3|Overall Study|Adverse Event|2
127698|NCT00514813|410900|P2|Overall Study|Adverse Event|2
127699|NCT00514813|410901|P1|Overall Study|Adverse Event|0
127700|NCT00514813|410898|P4|Overall Study|Study terminated|2
127701|NCT00514813|410899|P3|Overall Study|Study terminated|40
127702|NCT00514813|410900|P2|Overall Study|Study terminated|74
127703|NCT00514813|410901|P1|Overall Study|Study terminated|14
127704|NCT00514917|410948|P2|Overall Study|Undefined|5
127705|NCT00514917|410949|P1|Overall Study|Undefined|11
127706|NCT00514917|410948|P2|Overall Study|Discontinued due to study closure|81
127707|NCT00514917|410949|P1|Overall Study|Discontinued due to study closure|88
127708|NCT00514917|410948|P2|Overall Study|Withdrawal by Subject|16
127709|NCT00514917|410949|P1|Overall Study|Withdrawal by Subject|18
127710|NCT00514917|410948|P2|Overall Study|Lost to Follow-up|3
127711|NCT00514917|410949|P1|Overall Study|Lost to Follow-up|4
127712|NCT00514917|410948|P2|Overall Study|Protocol Violation|0
127713|NCT00514917|410949|P1|Overall Study|Protocol Violation|1
127714|NCT00514917|410948|P2|Overall Study|Death|10
127715|NCT00514917|410949|P1|Overall Study|Death|4
127716|NCT00514943|410977|P2|Stage 2|Other than stated above|2
127717|NCT00514943|410978|P1|Stage 2|Other than stated above|0
127718|NCT00514943|410977|P2|Stage 2|Patient refused to continue study meds|0
127719|NCT00514943|410978|P1|Stage 2|Patient refused to continue study meds|2
127720|NCT00514943|410977|P2|Stage 2|Other Adverse Event|10
127721|NCT00514943|410978|P1|Stage 2|Other Adverse Event|3
127722|NCT00514943|410977|P2|Stage 2|Progressive disease|24
127723|NCT00514943|410978|P1|Stage 2|Progressive disease|27
127724|NCT00514943|410977|P2|Stage 1|Other than stated above|7
127725|NCT00514943|410978|P1|Stage 1|Other than stated above|1
127726|NCT00514943|410977|P2|Stage 1|Patient refused to continue study meds|3
127727|NCT00514943|410978|P1|Stage 1|Patient refused to continue study meds|8
127728|NCT00514943|410977|P2|Stage 1|Not treated|2
127729|NCT00514943|410978|P1|Stage 1|Not treated|1
127730|NCT00514943|410977|P2|Stage 1|Other Adverse Event|6
127731|NCT00514943|410978|P1|Stage 1|Other Adverse Event|16
127732|NCT00514943|410977|P2|Stage 1|Progressive disease|8
127733|NCT00514943|410978|P1|Stage 1|Progressive disease|4
127734|NCT00515008|411036|P2|Overall Study|Scheduling conflict|0
127735|NCT00515008|411037|P1|Overall Study|Scheduling conflict|1
127736|NCT00515008|411036|P2|Overall Study|Left the Boston Area|1
127737|NCT00515008|411037|P1|Overall Study|Left the Boston Area|1
127738|NCT00515008|411036|P2|Overall Study|Declined|3
127739|NCT00515008|411037|P1|Overall Study|Declined|0
127740|NCT00515008|411036|P2|Overall Study|Lost to Follow-up|0
127741|NCT00515008|411037|P1|Overall Study|Lost to Follow-up|1
127742|NCT00515034|411063|P4|Overall Study|Other|1
127743|NCT00515034|411064|P3|Overall Study|Other|2
127744|NCT00515034|411065|P2|Overall Study|Other|0
127745|NCT00515034|411066|P1|Overall Study|Other|1
127746|NCT00515034|411063|P4|Overall Study|Physician Decision|1
127747|NCT00515034|411064|P3|Overall Study|Physician Decision|1
127748|NCT00515034|411065|P2|Overall Study|Physician Decision|0
127749|NCT00515034|411066|P1|Overall Study|Physician Decision|0
127750|NCT00515034|411063|P4|Overall Study|Withdrawal by Subject|0
127751|NCT00515034|411064|P3|Overall Study|Withdrawal by Subject|3
127752|NCT00515034|411065|P2|Overall Study|Withdrawal by Subject|0
127753|NCT00515034|411066|P1|Overall Study|Withdrawal by Subject|1
127754|NCT00515034|411063|P4|Overall Study|Death|3
127755|NCT00515034|411064|P3|Overall Study|Death|1
127756|NCT00515034|411065|P2|Overall Study|Death|2
127757|NCT00515034|411066|P1|Overall Study|Death|4
127758|NCT00515034|411063|P4|Overall Study|Adverse Event|0
127759|NCT00515034|411064|P3|Overall Study|Adverse Event|1
127760|NCT00515034|411065|P2|Overall Study|Adverse Event|0
127761|NCT00515034|411066|P1|Overall Study|Adverse Event|2
127762|NCT00515073|411084|P1|Overall Study|Physician Decision|1
127763|NCT00515073|411084|P1|Overall Study|Withdrawal by Subject|1
127764|NCT00515086|411092|P4|Overall Study|Death|0
127765|NCT00515086|411093|P3|Overall Study|Death|0
127766|NCT00515086|411094|P2|Overall Study|Death|0
127767|NCT00515086|411095|P1|Overall Study|Death|2
127768|NCT00515086|411092|P4|Overall Study|Study drug no longer required|0
127769|NCT00515086|411093|P3|Overall Study|Study drug no longer required|0
127770|NCT00515086|411094|P2|Overall Study|Study drug no longer required|1
127771|NCT00515086|411095|P1|Overall Study|Study drug no longer required|0
127772|NCT00515086|411092|P4|Overall Study|Lost to Follow-up|0
127773|NCT00515086|411093|P3|Overall Study|Lost to Follow-up|0
127774|NCT00515086|411094|P2|Overall Study|Lost to Follow-up|0
127775|NCT00515086|411095|P1|Overall Study|Lost to Follow-up|1
127776|NCT00515086|411092|P4|Overall Study|Unsatisfactory therapeutic effect|2
127777|NCT00515086|411093|P3|Overall Study|Unsatisfactory therapeutic effect|3
127778|NCT00515086|411094|P2|Overall Study|Unsatisfactory therapeutic effect|3
127779|NCT00515086|411095|P1|Overall Study|Unsatisfactory therapeutic effect|18
127780|NCT00515086|411092|P4|Overall Study|Withdrawal by Subject|1
127781|NCT00515086|411093|P3|Overall Study|Withdrawal by Subject|0
127782|NCT00515086|411094|P2|Overall Study|Withdrawal by Subject|0
127783|NCT00515086|411095|P1|Overall Study|Withdrawal by Subject|1
127784|NCT00515086|411092|P4|Overall Study|Administrative|0
127785|NCT00515086|411093|P3|Overall Study|Administrative|0
127786|NCT00515086|411094|P2|Overall Study|Administrative|1
127787|NCT00515086|411095|P1|Overall Study|Administrative|1
127788|NCT00515086|411092|P4|Overall Study|Adverse Event|3
127789|NCT00515086|411093|P3|Overall Study|Adverse Event|2
127790|NCT00515086|411094|P2|Overall Study|Adverse Event|1
127791|NCT00515086|411095|P1|Overall Study|Adverse Event|1
127792|NCT00515099|411124|P2|Overall Study|IRB Recommendation|0
127793|NCT00515099|411125|P1|Overall Study|IRB Recommendation|1
127794|NCT00515099|411124|P2|Overall Study|Withdrawal by Subject|0
127795|NCT00515099|411125|P1|Overall Study|Withdrawal by Subject|2
127796|NCT00515099|411124|P2|Overall Study|Lost to Follow-up|4
127797|NCT00515099|411125|P1|Overall Study|Lost to Follow-up|0
127798|NCT00515112|411145|P2|Overall Study|The study was terminated|2
127799|NCT00515112|411146|P1|Overall Study|The study was terminated|3
127800|NCT00515112|411145|P2|Overall Study|Death|1
127801|NCT00515112|411146|P1|Overall Study|Death|0
127802|NCT00515216|411192|P1|Overall Study|Withdrawal by Subject|1
127803|NCT00515294|411218|P4|Overall Study|Caffeine amount inaccurate|0
127804|NCT00515294|411219|P3|Overall Study|Caffeine amount inaccurate|7
127805|NCT00515294|411220|P2|Overall Study|Caffeine amount inaccurate|0
127806|NCT00515294|411221|P1|Overall Study|Caffeine amount inaccurate|5
127807|NCT00515294|411218|P4|Overall Study|Driver simulator problems|3
127808|NCT00515294|411219|P3|Overall Study|Driver simulator problems|1
127809|NCT00515294|411220|P2|Overall Study|Driver simulator problems|1
127810|NCT00515294|411221|P1|Overall Study|Driver simulator problems|1
127811|NCT00515294|411218|P4|Overall Study|Lost to Follow-up|1
127812|NCT00515294|411219|P3|Overall Study|Lost to Follow-up|3
127813|NCT00515294|411220|P2|Overall Study|Lost to Follow-up|2
127814|NCT00515294|411221|P1|Overall Study|Lost to Follow-up|3
127815|NCT00515463|411266|P2|Overall Study|Other|1
127816|NCT00515463|411267|P1|Overall Study|Other|0
127817|NCT00515463|411266|P2|Overall Study|Lost to Follow-up|5
127818|NCT00515463|411267|P1|Overall Study|Lost to Follow-up|6
127819|NCT00515463|411266|P2|Overall Study|Withdrawal by Subject|4
127820|NCT00515463|411267|P1|Overall Study|Withdrawal by Subject|3
127821|NCT00515463|411266|P2|Overall Study|Adverse Event|2
127822|NCT00515463|411267|P1|Overall Study|Adverse Event|1
127823|NCT00515463|411266|P2|Overall Study|Physician Decision|2
127824|NCT00515463|411267|P1|Overall Study|Physician Decision|4
127825|NCT00515502|411417|P12|Treatment Period 2|Adverse Event|0
127826|NCT00515502|411418|P11|Treatment Period 2|Adverse Event|0
127827|NCT00515502|411419|P10|Treatment Period 2|Adverse Event|0
127828|NCT00515502|411420|P9|Treatment Period 2|Adverse Event|0
127829|NCT00515502|411421|P8|Treatment Period 2|Adverse Event|0
127830|NCT00515502|411422|P7|Treatment Period 2|Adverse Event|0
127831|NCT00515502|411423|P6|Treatment Period 2|Adverse Event|0
127832|NCT00515502|411424|P5|Treatment Period 2|Adverse Event|0
127833|NCT00515502|411425|P4|Treatment Period 2|Adverse Event|0
127834|NCT00515502|411426|P3|Treatment Period 2|Adverse Event|0
127835|NCT00515502|411427|P2|Treatment Period 2|Adverse Event|1
127836|NCT00515502|411428|P1|Treatment Period 2|Adverse Event|0
127837|NCT00515502|411417|P12|Treatment Period 1|Adverse Event|1
127838|NCT00515502|411418|P11|Treatment Period 1|Adverse Event|0
127839|NCT00515502|411419|P10|Treatment Period 1|Adverse Event|0
127840|NCT00515502|411420|P9|Treatment Period 1|Adverse Event|1
127841|NCT00515502|411421|P8|Treatment Period 1|Adverse Event|0
127842|NCT00515502|411422|P7|Treatment Period 1|Adverse Event|1
127843|NCT00515502|411423|P6|Treatment Period 1|Adverse Event|0
127844|NCT00515502|411424|P5|Treatment Period 1|Adverse Event|0
127845|NCT00515502|411425|P4|Treatment Period 1|Adverse Event|0
127846|NCT00515502|411426|P3|Treatment Period 1|Adverse Event|0
127847|NCT00515502|411427|P2|Treatment Period 1|Adverse Event|0
127848|NCT00515502|411428|P1|Treatment Period 1|Adverse Event|0
127849|NCT00515541|411590|P4|Overall Study|Withdrawal by Subject|2
127850|NCT00515541|411591|P3|Overall Study|Withdrawal by Subject|0
127851|NCT00515541|411592|P2|Overall Study|Withdrawal by Subject|2
127852|NCT00515541|411593|P1|Overall Study|Withdrawal by Subject|0
127853|NCT00515541|411590|P4|Overall Study|No show for appointments|2
127854|NCT00515541|411591|P3|Overall Study|No show for appointments|0
127855|NCT00515541|411592|P2|Overall Study|No show for appointments|1
127856|NCT00515541|411593|P1|Overall Study|No show for appointments|0
127857|NCT00515541|411590|P4|Overall Study|Physician Decision|1
127858|NCT00515541|411591|P3|Overall Study|Physician Decision|0
127859|NCT00515541|411592|P2|Overall Study|Physician Decision|2
127860|NCT00515541|411593|P1|Overall Study|Physician Decision|0
127861|NCT00515619|411615|P1|Overall Study|Other: Subject interested in other AED|1
127862|NCT00515619|411615|P1|Overall Study|Other: Drug available on license|1
127863|NCT00515619|411615|P1|Overall Study|Other: Request from sponsor|1
127864|NCT00515619|411615|P1|Overall Study|Other: Subject became pregnant|1
127865|NCT00515619|411615|P1|Overall Study|Other: Investigator decision|1
127866|NCT00515619|411615|P1|Overall Study|Other: Subject moved to another country|1
127867|NCT00515619|411615|P1|Overall Study|Other: Subject required surgery|1
127868|NCT00515619|411615|P1|Overall Study|Other: Subject cannot attend visits|2
127869|NCT00515619|411615|P1|Overall Study|Other: Site discontinuing trials|2
127870|NCT00515619|411615|P1|Overall Study|Unsatisfactory compliance|6
127871|NCT00515619|411615|P1|Overall Study|Lost to Follow-up|4
127872|NCT00515619|411615|P1|Overall Study|Protocol Violation|3
127873|NCT00515619|411615|P1|Overall Study|Withdrawal by Subject|66
127874|NCT00515619|411615|P1|Overall Study|Lack of Efficacy|92
127875|NCT00515619|411615|P1|Overall Study|Adverse Event|34
127876|NCT00515671|411625|P2|Overall Study|incarcerated|2
127877|NCT00515671|411626|P1|Overall Study|incarcerated|1
127878|NCT00515671|411625|P2|Overall Study|Withdrawal by Subject|5
127879|NCT00515671|411626|P1|Overall Study|Withdrawal by Subject|3
127880|NCT00515671|411625|P2|Overall Study|Lost to Follow-up|10
127881|NCT00515671|411626|P1|Overall Study|Lost to Follow-up|13
127882|NCT00515827|411647|P2|Second Intervention (12 Weeks)|Consent withdraw|0
127883|NCT00515827|411648|P1|Second Intervention (12 Weeks)|Consent withdraw|1
127884|NCT00515827|411647|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
127885|NCT00515827|411648|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
127886|NCT00516048|411683|P3|Overall Study|Subject Decision|0
127887|NCT00516048|411684|P2|Overall Study|Subject Decision|2
127888|NCT00516048|411685|P1|Overall Study|Subject Decision|0
127889|NCT00516048|411683|P3|Overall Study|Death|1
127890|NCT00516048|411684|P2|Overall Study|Death|0
127891|NCT00516048|411685|P1|Overall Study|Death|0
127892|NCT00516074|411701|P2|Overall Study|Loss of Glucose Control|0
127893|NCT00516074|411702|P1|Overall Study|Loss of Glucose Control|2
127894|NCT00516074|411701|P2|Overall Study|Subject Decision|2
127895|NCT00516074|411702|P1|Overall Study|Subject Decision|4
127896|NCT00516074|411701|P2|Overall Study|Adverse Event|1
127897|NCT00516074|411702|P1|Overall Study|Adverse Event|0
127898|NCT00516139|411718|P1|Overall Study|Lack of Efficacy|1
127899|NCT00516139|411718|P1|Overall Study|Withdrawal by Subject|8
127900|NCT00516139|411718|P1|Overall Study|Protocol Violation|1
127901|NCT00516139|411718|P1|Overall Study|Lost to Follow-up|1
127902|NCT00516139|411718|P1|Overall Study|Adverse Event|27
127903|NCT00516269|411764|P2|Overall Study|Protocol Violation|1
127904|NCT00516269|411765|P1|Overall Study|Protocol Violation|0
127905|NCT00516269|411764|P2|Overall Study|Lost to Follow-up|1
127906|NCT00516269|411765|P1|Overall Study|Lost to Follow-up|0
127907|NCT00516269|411764|P2|Overall Study|Adverse Event|1
127908|NCT00516269|411765|P1|Overall Study|Adverse Event|2
127909|NCT00509600|411790|P1|Overall Study|Adverse Event|1
127910|NCT00509769|411794|P1|Overall Study|Use of prohibited therapies during study|1
127911|NCT00509769|411794|P1|Overall Study|Physician Decision|8
127912|NCT00509769|411794|P1|Overall Study|Patient’s decision|1
127913|NCT00509769|411794|P1|Overall Study|Adverse Event|4
127914|NCT00509769|411794|P1|Overall Study|Progressive disease|77
127915|NCT00509795|411807|P4|Overall Study|Withdrawal by Subject|8
127916|NCT00509795|411808|P3|Overall Study|Withdrawal by Subject|7
127917|NCT00509795|411809|P2|Overall Study|Withdrawal by Subject|5
127918|NCT00509795|411810|P1|Overall Study|Withdrawal by Subject|10
127919|NCT00509795|411807|P4|Overall Study|Protocol Violation|1
127920|NCT00509795|411808|P3|Overall Study|Protocol Violation|3
127921|NCT00509795|411809|P2|Overall Study|Protocol Violation|0
127922|NCT00509795|411810|P1|Overall Study|Protocol Violation|3
127923|NCT00509795|411807|P4|Overall Study|OTHER|1
127924|NCT00509795|411808|P3|Overall Study|OTHER|4
127925|NCT00509795|411809|P2|Overall Study|OTHER|0
127926|NCT00509795|411810|P1|Overall Study|OTHER|1
127927|NCT00509795|411807|P4|Overall Study|Lost to Follow-up|4
127928|NCT00509795|411808|P3|Overall Study|Lost to Follow-up|4
127929|NCT00509795|411809|P2|Overall Study|Lost to Follow-up|2
127930|NCT00509795|411810|P1|Overall Study|Lost to Follow-up|1
127931|NCT00509795|411807|P4|Overall Study|Lack of Efficacy|2
127932|NCT00509795|411808|P3|Overall Study|Lack of Efficacy|2
127933|NCT00509795|411809|P2|Overall Study|Lack of Efficacy|0
127934|NCT00509795|411810|P1|Overall Study|Lack of Efficacy|0
127935|NCT00509795|411807|P4|Overall Study|Death|7
127936|NCT00509795|411808|P3|Overall Study|Death|2
127937|NCT00509795|411809|P2|Overall Study|Death|1
127938|NCT00509795|411810|P1|Overall Study|Death|3
127939|NCT00509795|411807|P4|Overall Study|Adverse Event|4
127940|NCT00509795|411808|P3|Overall Study|Adverse Event|5
127941|NCT00509795|411809|P2|Overall Study|Adverse Event|3
127942|NCT00509795|411810|P1|Overall Study|Adverse Event|4
127943|NCT00509899|411866|P8|Overall Study|Lack of Efficacy|0
127944|NCT00509899|411867|P7|Overall Study|Lack of Efficacy|0
127945|NCT00509899|411868|P6|Overall Study|Lack of Efficacy|1
127946|NCT00509899|411869|P5|Overall Study|Lack of Efficacy|0
127947|NCT00509899|411870|P4|Overall Study|Lack of Efficacy|0
127948|NCT00509899|411871|P3|Overall Study|Lack of Efficacy|2
127949|NCT00509899|411872|P2|Overall Study|Lack of Efficacy|0
127950|NCT00509899|411873|P1|Overall Study|Lack of Efficacy|1
127951|NCT00509899|411866|P8|Overall Study|Death|1
127952|NCT00509899|411867|P7|Overall Study|Death|1
127953|NCT00509899|411868|P6|Overall Study|Death|1
127954|NCT00509899|411869|P5|Overall Study|Death|1
127955|NCT00509899|411870|P4|Overall Study|Death|0
127956|NCT00509899|411871|P3|Overall Study|Death|3
127957|NCT00509899|411872|P2|Overall Study|Death|2
127958|NCT00509899|411873|P1|Overall Study|Death|2
127959|NCT00509899|411866|P8|Overall Study|Intercurrent Illness|0
127960|NCT00509899|411867|P7|Overall Study|Intercurrent Illness|0
127961|NCT00509899|411868|P6|Overall Study|Intercurrent Illness|1
127962|NCT00509899|411869|P5|Overall Study|Intercurrent Illness|0
127963|NCT00509899|411870|P4|Overall Study|Intercurrent Illness|1
127964|NCT00509899|411871|P3|Overall Study|Intercurrent Illness|0
127965|NCT00509899|411872|P2|Overall Study|Intercurrent Illness|0
127966|NCT00509899|411873|P1|Overall Study|Intercurrent Illness|1
127967|NCT00509899|411866|P8|Overall Study|Physician Decision|0
127968|NCT00509899|411867|P7|Overall Study|Physician Decision|0
127969|NCT00509899|411868|P6|Overall Study|Physician Decision|4
127970|NCT00509899|411869|P5|Overall Study|Physician Decision|1
127971|NCT00509899|411870|P4|Overall Study|Physician Decision|0
127972|NCT00509899|411871|P3|Overall Study|Physician Decision|7
127973|NCT00509899|411872|P2|Overall Study|Physician Decision|2
127974|NCT00509899|411873|P1|Overall Study|Physician Decision|4
127975|NCT00509899|411866|P8|Overall Study|Withdrawal by Subject|0
127976|NCT00509899|411867|P7|Overall Study|Withdrawal by Subject|0
127977|NCT00509899|411868|P6|Overall Study|Withdrawal by Subject|2
127978|NCT00509899|411869|P5|Overall Study|Withdrawal by Subject|3
127979|NCT00509899|411870|P4|Overall Study|Withdrawal by Subject|0
127980|NCT00509899|411871|P3|Overall Study|Withdrawal by Subject|3
127981|NCT00509899|411872|P2|Overall Study|Withdrawal by Subject|2
127982|NCT00509899|411873|P1|Overall Study|Withdrawal by Subject|6
127983|NCT00509899|411866|P8|Overall Study|Unacceptable Toxicity|0
127984|NCT00509899|411867|P7|Overall Study|Unacceptable Toxicity|0
127985|NCT00509899|411868|P6|Overall Study|Unacceptable Toxicity|0
127986|NCT00509899|411869|P5|Overall Study|Unacceptable Toxicity|0
127987|NCT00509899|411870|P4|Overall Study|Unacceptable Toxicity|2
127988|NCT00509899|411871|P3|Overall Study|Unacceptable Toxicity|0
127989|NCT00509899|411872|P2|Overall Study|Unacceptable Toxicity|0
127990|NCT00509899|411873|P1|Overall Study|Unacceptable Toxicity|1
127991|NCT00509899|411866|P8|Overall Study|Progressive disease|0
127992|NCT00509899|411867|P7|Overall Study|Progressive disease|0
127993|NCT00509899|411868|P6|Overall Study|Progressive disease|1
127994|NCT00509899|411869|P5|Overall Study|Progressive disease|0
127995|NCT00509899|411870|P4|Overall Study|Progressive disease|1
127996|NCT00509899|411871|P3|Overall Study|Progressive disease|5
127997|NCT00509899|411872|P2|Overall Study|Progressive disease|3
127998|NCT00509899|411873|P1|Overall Study|Progressive disease|1
127999|NCT00509925|411911|P2|Overall Study|Personal reasons|1
128000|NCT00509925|411912|P1|Overall Study|Personal reasons|0
128001|NCT00510068|411954|P2|Open-label Period|Abnormal laboratory value (s)|0
128002|NCT00510068|411955|P1|Open-label Period|Abnormal laboratory value (s)|1
128003|NCT00510068|411954|P2|Open-label Period|Protocol Violation|0
128004|NCT00510068|411955|P1|Open-label Period|Protocol Violation|2
128005|NCT00510068|411954|P2|Open-label Period|New cancer therapy|0
128006|NCT00510068|411955|P1|Open-label Period|New cancer therapy|7
128007|NCT00510068|411954|P2|Open-label Period|Death|0
128008|NCT00510068|411955|P1|Open-label Period|Death|7
128009|NCT00510068|411954|P2|Open-label Period|Administrative problems|0
128010|NCT00510068|411955|P1|Open-label Period|Administrative problems|17
128011|NCT00510068|411954|P2|Open-label Period|Withdrawal by Subject|0
128012|NCT00510068|411955|P1|Open-label Period|Withdrawal by Subject|21
128013|NCT00510068|411954|P2|Open-label Period|Adverse Event|0
128014|NCT00510068|411955|P1|Open-label Period|Adverse Event|46
128015|NCT00510068|411954|P2|Open-label Period|Disease Progression|0
128016|NCT00510068|411955|P1|Open-label Period|Disease Progression|124
128017|NCT00510068|411954|P2|Double-blind Period|Protocol Violation|0
128018|NCT00510068|411955|P1|Double-blind Period|Protocol Violation|6
128019|NCT00510068|411954|P2|Double-blind Period|Lost to Follow-up|0
128020|NCT00510068|411955|P1|Double-blind Period|Lost to Follow-up|1
128021|NCT00510068|411954|P2|Double-blind Period|Abnormal test result (s)|0
128022|NCT00510068|411955|P1|Double-blind Period|Abnormal test result (s)|1
128023|NCT00510068|411954|P2|Double-blind Period|Death|3
128024|NCT00510068|411955|P1|Double-blind Period|Death|4
128025|NCT00510068|411954|P2|Double-blind Period|Withdrawal by Subject|6
128026|NCT00510068|411955|P1|Double-blind Period|Withdrawal by Subject|8
128027|NCT00510068|411954|P2|Double-blind Period|Adverse Event|7
128028|NCT00510068|411955|P1|Double-blind Period|Adverse Event|37
128029|NCT00510068|411954|P2|Double-blind Period|Final primary analysis|18
128030|NCT00510068|411955|P1|Double-blind Period|Final primary analysis|52
128031|NCT00510068|411954|P2|Double-blind Period|Disease progression|169
128032|NCT00510068|411955|P1|Double-blind Period|Disease progression|98
128033|NCT00516295|411999|P3|Overall Study|Ineligible|0
128034|NCT00516295|412000|P2|Overall Study|Ineligible|0
128035|NCT00516295|412001|P1|Overall Study|Ineligible|1
128036|NCT00516295|411999|P3|Overall Study|Lack of Efficacy|0
128037|NCT00516295|412000|P2|Overall Study|Lack of Efficacy|0
128038|NCT00516295|412001|P1|Overall Study|Lack of Efficacy|2
128039|NCT00516321|412014|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
128040|NCT00516321|412015|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
128041|NCT00516321|412016|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
128042|NCT00516321|412014|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
128043|NCT00516321|412015|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
128044|NCT00516321|412016|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
128045|NCT00516321|412014|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
128046|NCT00516321|412015|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
128047|NCT00516321|412016|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
128048|NCT00516321|412014|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
128049|NCT00516321|412015|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
128050|NCT00516321|412016|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
128051|NCT00516321|412014|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
128052|NCT00516321|412015|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
128053|NCT00516321|412016|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
128054|NCT00516321|412014|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
128055|NCT00516321|412015|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
128056|NCT00516321|412016|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
128057|NCT00516321|412014|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
128058|NCT00516321|412015|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
128059|NCT00516321|412016|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
128060|NCT00516321|412014|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
128061|NCT00516321|412015|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
128062|NCT00516321|412016|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
128063|NCT00516321|412014|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
128064|NCT00516321|412015|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
128065|NCT00516321|412016|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
128066|NCT00516321|412014|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
128067|NCT00516321|412015|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
128068|NCT00516321|412016|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
128069|NCT00516321|412014|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
128070|NCT00516321|412015|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
128071|NCT00516321|412016|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
128072|NCT00516386|412064|P1|Overall Study|Lost to Follow-up|2
128073|NCT00516386|412064|P1|Overall Study|not interested in the study|4
128074|NCT00517699|412090|P1|Overall Study|Study terminated by Sponsor|2
128075|NCT00517699|412090|P1|Overall Study|Administrative error|1
128076|NCT00517699|412090|P1|Overall Study|Lack of Efficacy|1
128077|NCT00517699|412090|P1|Overall Study|Withdrawal by Subject|1
128078|NCT00517751|412098|P1|Overall Study|Missing|3
128079|NCT00517751|412098|P1|Overall Study|Patient not due for visit|76
128080|NCT00517751|412098|P1|Overall Study|patient not over due|6
128081|NCT00517751|412098|P1|Overall Study|Lost to Follow-up|4
128082|NCT00517751|412098|P1|Overall Study|Withdrawal by Subject|37
128083|NCT00517751|412098|P1|Overall Study|Death|3
128084|NCT00517829|412123|P2|Overall Study|Other|1
128085|NCT00517829|412124|P1|Overall Study|Other|3
128086|NCT00517829|412123|P2|Overall Study|Investigator Request|3
128087|NCT00517829|412124|P1|Overall Study|Investigator Request|5
128088|NCT00517829|412123|P2|Overall Study|Patient Request|5
128089|NCT00517829|412124|P1|Overall Study|Patient Request|6
128090|NCT00517829|412123|P2|Overall Study|Disease Progression|32
128091|NCT00517829|412124|P1|Overall Study|Disease Progression|39
128092|NCT00517829|412123|P2|Overall Study|Adverse Event|34
128093|NCT00517829|412124|P1|Overall Study|Adverse Event|22
128094|NCT00517881|412138|P1|Overall Study|Renal transplantation|2
128095|NCT00517881|412138|P1|Overall Study|Adverse Event|1
128096|NCT00517881|412138|P1|Overall Study|Protocol Violation|2
128097|NCT00517933|412150|P2|Period 2|Underwent lung transplant|2
128098|NCT00517933|412151|P1|Period 2|Underwent lung transplant|0
128099|NCT00517933|412150|P2|Period 2|Withdrawal by Subject|3
128100|NCT00517933|412151|P1|Period 2|Withdrawal by Subject|1
128101|NCT00517933|412150|P2|Period 2|Physician Decision|0
128102|NCT00517933|412151|P1|Period 2|Physician Decision|1
128103|NCT00517933|412150|P2|Period 2|Adverse Event|4
128104|NCT00517933|412151|P1|Period 2|Adverse Event|2
128105|NCT00517933|412150|P2|Period 2|Death|4
128106|NCT00517933|412151|P1|Period 2|Death|2
128107|NCT00517933|412150|P2|Period 1|Underwent lung transplant|1
128108|NCT00517933|412151|P1|Period 1|Underwent lung transplant|0
128109|NCT00517933|412150|P2|Period 1|Lost to Follow-up|0
128110|NCT00517933|412151|P1|Period 1|Lost to Follow-up|2
128111|NCT00517933|412150|P2|Period 1|Adverse Event|4
128112|NCT00517933|412151|P1|Period 1|Adverse Event|4
128113|NCT00517933|412150|P2|Period 1|Death|1
128114|NCT00517933|412151|P1|Period 1|Death|2
128115|NCT00518011|412217|P2|Overall Study|Withdrawal by Subject|0
128116|NCT00518011|412218|P1|Overall Study|Withdrawal by Subject|1
128117|NCT00518011|412217|P2|Overall Study|Other Reasons|2
128118|NCT00518011|412218|P1|Overall Study|Other Reasons|3
128119|NCT00518011|412217|P2|Overall Study|Disease Progression|2
128120|NCT00518011|412218|P1|Overall Study|Disease Progression|2
128121|NCT00518011|412217|P2|Overall Study|Adverse Event|3
128122|NCT00518011|412218|P1|Overall Study|Adverse Event|2
128123|NCT00518011|412217|P2|Overall Study|Death|1
128124|NCT00518011|412218|P1|Overall Study|Death|1
128125|NCT00518115|412265|P10|Overall Study|Moved Out of State|1
128126|NCT00518115|412266|P9|Overall Study|Moved Out of State|0
128127|NCT00518115|412267|P8|Overall Study|Moved Out of State|0
128128|NCT00518115|412268|P7|Overall Study|Moved Out of State|0
128129|NCT00518115|412269|P6|Overall Study|Moved Out of State|0
128130|NCT00518115|412270|P5|Overall Study|Moved Out of State|0
128131|NCT00518115|412271|P4|Overall Study|Moved Out of State|0
128132|NCT00518115|412272|P3|Overall Study|Moved Out of State|0
128133|NCT00518115|412273|P2|Overall Study|Moved Out of State|0
128134|NCT00518115|412274|P1|Overall Study|Moved Out of State|0
128135|NCT00518115|412265|P10|Overall Study|Withdrew Consent|0
128136|NCT00518115|412266|P9|Overall Study|Withdrew Consent|0
128137|NCT00518115|412267|P8|Overall Study|Withdrew Consent|0
128138|NCT00518115|412268|P7|Overall Study|Withdrew Consent|0
128139|NCT00518115|412269|P6|Overall Study|Withdrew Consent|1
128140|NCT00518115|412270|P5|Overall Study|Withdrew Consent|0
128141|NCT00518115|412271|P4|Overall Study|Withdrew Consent|0
128142|NCT00518115|412272|P3|Overall Study|Withdrew Consent|0
128143|NCT00518115|412273|P2|Overall Study|Withdrew Consent|0
128144|NCT00518115|412274|P1|Overall Study|Withdrew Consent|0
128145|NCT00518115|412265|P10|Overall Study|Family Emergency; Had to Go to England|0
128146|NCT00518115|412266|P9|Overall Study|Family Emergency; Had to Go to England|0
128147|NCT00518115|412267|P8|Overall Study|Family Emergency; Had to Go to England|0
128148|NCT00518115|412268|P7|Overall Study|Family Emergency; Had to Go to England|0
128149|NCT00518115|412269|P6|Overall Study|Family Emergency; Had to Go to England|0
128150|NCT00518115|412270|P5|Overall Study|Family Emergency; Had to Go to England|1
128151|NCT00518115|412271|P4|Overall Study|Family Emergency; Had to Go to England|0
128152|NCT00518115|412272|P3|Overall Study|Family Emergency; Had to Go to England|0
128153|NCT00518115|412273|P2|Overall Study|Family Emergency; Had to Go to England|0
128154|NCT00518115|412274|P1|Overall Study|Family Emergency; Had to Go to England|0
128155|NCT00518115|412265|P10|Overall Study|Violation of Exclusion Criteria|0
128156|NCT00518115|412266|P9|Overall Study|Violation of Exclusion Criteria|0
128157|NCT00518115|412267|P8|Overall Study|Violation of Exclusion Criteria|0
128158|NCT00518115|412268|P7|Overall Study|Violation of Exclusion Criteria|1
128159|NCT00518115|412269|P6|Overall Study|Violation of Exclusion Criteria|0
128160|NCT00518115|412270|P5|Overall Study|Violation of Exclusion Criteria|0
128161|NCT00518115|412271|P4|Overall Study|Violation of Exclusion Criteria|1
128162|NCT00518115|412272|P3|Overall Study|Violation of Exclusion Criteria|0
128163|NCT00518115|412273|P2|Overall Study|Violation of Exclusion Criteria|0
128164|NCT00518115|412274|P1|Overall Study|Violation of Exclusion Criteria|0
128165|NCT00518115|412265|P10|Overall Study|Wrong Monotherapy Administered|0
128166|NCT00518115|412266|P9|Overall Study|Wrong Monotherapy Administered|0
128167|NCT00518115|412267|P8|Overall Study|Wrong Monotherapy Administered|0
128168|NCT00518115|412268|P7|Overall Study|Wrong Monotherapy Administered|1
128169|NCT00518115|412269|P6|Overall Study|Wrong Monotherapy Administered|0
128170|NCT00518115|412270|P5|Overall Study|Wrong Monotherapy Administered|0
128171|NCT00518115|412271|P4|Overall Study|Wrong Monotherapy Administered|0
128172|NCT00518115|412272|P3|Overall Study|Wrong Monotherapy Administered|1
128173|NCT00518115|412273|P2|Overall Study|Wrong Monotherapy Administered|0
128174|NCT00518115|412274|P1|Overall Study|Wrong Monotherapy Administered|0
128175|NCT00518115|412265|P10|Overall Study|Different Monotherapy Diabetic Drug|0
128176|NCT00518115|412266|P9|Overall Study|Different Monotherapy Diabetic Drug|1
128177|NCT00518115|412267|P8|Overall Study|Different Monotherapy Diabetic Drug|0
128178|NCT00518115|412268|P7|Overall Study|Different Monotherapy Diabetic Drug|0
128179|NCT00518115|412269|P6|Overall Study|Different Monotherapy Diabetic Drug|0
128180|NCT00518115|412270|P5|Overall Study|Different Monotherapy Diabetic Drug|0
128181|NCT00518115|412271|P4|Overall Study|Different Monotherapy Diabetic Drug|0
128182|NCT00518115|412272|P3|Overall Study|Different Monotherapy Diabetic Drug|1
128183|NCT00518115|412273|P2|Overall Study|Different Monotherapy Diabetic Drug|0
128184|NCT00518115|412274|P1|Overall Study|Different Monotherapy Diabetic Drug|0
128185|NCT00518115|412265|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
128186|NCT00518115|412266|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
128187|NCT00518115|412267|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
128188|NCT00518115|412268|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
128189|NCT00518115|412269|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
128190|NCT00518115|412270|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
128191|NCT00518115|412271|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
128192|NCT00518115|412272|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
128193|NCT00518115|412273|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
128194|NCT00518115|412274|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
128195|NCT00518115|412265|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
128196|NCT00518115|412266|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
128197|NCT00518115|412267|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
128198|NCT00518115|412268|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
128199|NCT00518115|412269|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
128200|NCT00518115|412270|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
128201|NCT00518115|412271|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
128202|NCT00518115|412272|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
128203|NCT00518115|412273|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
128204|NCT00518115|412274|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
128205|NCT00518115|412265|P10|Overall Study|Non-Compliance|1
128206|NCT00518115|412266|P9|Overall Study|Non-Compliance|0
128207|NCT00518115|412267|P8|Overall Study|Non-Compliance|1
128208|NCT00518115|412268|P7|Overall Study|Non-Compliance|1
128209|NCT00518115|412269|P6|Overall Study|Non-Compliance|1
128210|NCT00518115|412270|P5|Overall Study|Non-Compliance|1
128211|NCT00518115|412271|P4|Overall Study|Non-Compliance|0
128212|NCT00518115|412272|P3|Overall Study|Non-Compliance|1
128213|NCT00518115|412273|P2|Overall Study|Non-Compliance|0
128214|NCT00518115|412274|P1|Overall Study|Non-Compliance|1
128215|NCT00518115|412265|P10|Overall Study|Lack of Efficacy|0
128216|NCT00518115|412266|P9|Overall Study|Lack of Efficacy|0
128217|NCT00518115|412267|P8|Overall Study|Lack of Efficacy|1
128218|NCT00518115|412268|P7|Overall Study|Lack of Efficacy|0
128219|NCT00518115|412269|P6|Overall Study|Lack of Efficacy|0
128220|NCT00518115|412270|P5|Overall Study|Lack of Efficacy|0
128221|NCT00518115|412271|P4|Overall Study|Lack of Efficacy|1
128222|NCT00518115|412272|P3|Overall Study|Lack of Efficacy|1
128223|NCT00518115|412273|P2|Overall Study|Lack of Efficacy|0
128224|NCT00518115|412274|P1|Overall Study|Lack of Efficacy|1
128225|NCT00518115|412265|P10|Overall Study|Withdrawal by Subject|3
128226|NCT00518115|412266|P9|Overall Study|Withdrawal by Subject|1
128227|NCT00518115|412267|P8|Overall Study|Withdrawal by Subject|2
128228|NCT00518115|412268|P7|Overall Study|Withdrawal by Subject|0
128229|NCT00518115|412269|P6|Overall Study|Withdrawal by Subject|1
128230|NCT00518115|412270|P5|Overall Study|Withdrawal by Subject|2
128231|NCT00518115|412271|P4|Overall Study|Withdrawal by Subject|0
128232|NCT00518115|412272|P3|Overall Study|Withdrawal by Subject|5
128233|NCT00518115|412273|P2|Overall Study|Withdrawal by Subject|1
128234|NCT00518115|412274|P1|Overall Study|Withdrawal by Subject|1
128235|NCT00518115|412265|P10|Overall Study|Protocol Violation|0
128236|NCT00518115|412266|P9|Overall Study|Protocol Violation|0
128237|NCT00518115|412267|P8|Overall Study|Protocol Violation|0
128238|NCT00518115|412268|P7|Overall Study|Protocol Violation|0
128239|NCT00518115|412269|P6|Overall Study|Protocol Violation|0
128240|NCT00518115|412270|P5|Overall Study|Protocol Violation|0
128241|NCT00518115|412271|P4|Overall Study|Protocol Violation|0
128242|NCT00518115|412272|P3|Overall Study|Protocol Violation|1
128243|NCT00518115|412273|P2|Overall Study|Protocol Violation|3
128244|NCT00518115|412274|P1|Overall Study|Protocol Violation|1
128245|NCT00518115|412265|P10|Overall Study|Lost to Follow-up|1
128246|NCT00518115|412266|P9|Overall Study|Lost to Follow-up|1
128247|NCT00518115|412267|P8|Overall Study|Lost to Follow-up|1
128248|NCT00518115|412268|P7|Overall Study|Lost to Follow-up|0
128249|NCT00518115|412269|P6|Overall Study|Lost to Follow-up|3
128250|NCT00518115|412270|P5|Overall Study|Lost to Follow-up|1
128251|NCT00518115|412271|P4|Overall Study|Lost to Follow-up|3
128252|NCT00518115|412272|P3|Overall Study|Lost to Follow-up|2
128253|NCT00518115|412273|P2|Overall Study|Lost to Follow-up|0
128254|NCT00518115|412274|P1|Overall Study|Lost to Follow-up|0
128255|NCT00518115|412265|P10|Overall Study|Adverse Event|9
128256|NCT00518115|412266|P9|Overall Study|Adverse Event|2
128257|NCT00518115|412267|P8|Overall Study|Adverse Event|10
128258|NCT00518115|412268|P7|Overall Study|Adverse Event|5
128259|NCT00518115|412269|P6|Overall Study|Adverse Event|5
128260|NCT00518115|412270|P5|Overall Study|Adverse Event|5
128261|NCT00518115|412271|P4|Overall Study|Adverse Event|6
128262|NCT00518115|412272|P3|Overall Study|Adverse Event|5
128263|NCT00518115|412273|P2|Overall Study|Adverse Event|1
128264|NCT00518115|412274|P1|Overall Study|Adverse Event|6
128265|NCT00518180|412433|P3|Overall Study|Adverse Event|0
128266|NCT00518180|412434|P2|Overall Study|Adverse Event|0
128267|NCT00518180|412435|P1|Overall Study|Adverse Event|1
128268|NCT00518180|412433|P3|Overall Study|Unable to classify|0
128269|NCT00518180|412434|P2|Overall Study|Unable to classify|2
128270|NCT00518180|412435|P1|Overall Study|Unable to classify|0
128271|NCT00518180|412433|P3|Overall Study|Protocol Violation|4
128272|NCT00518180|412434|P2|Overall Study|Protocol Violation|7
128273|NCT00518180|412435|P1|Overall Study|Protocol Violation|5
128274|NCT00518180|412433|P3|Overall Study|Administrative reason|2
128275|NCT00518180|412434|P2|Overall Study|Administrative reason|2
128276|NCT00518180|412435|P1|Overall Study|Administrative reason|0
128277|NCT00518180|412433|P3|Overall Study|Lost to Follow-up|34
128278|NCT00518180|412434|P2|Overall Study|Lost to Follow-up|28
128279|NCT00518180|412435|P1|Overall Study|Lost to Follow-up|30
128280|NCT00518180|412433|P3|Overall Study|Withdrawal by Subject|42
128281|NCT00518180|412434|P2|Overall Study|Withdrawal by Subject|30
128282|NCT00518180|412435|P1|Overall Study|Withdrawal by Subject|29
128283|NCT00518206|412479|P2|Overall Study|Completion Status Unknown|0
128284|NCT00518206|412480|P1|Overall Study|Completion Status Unknown|1
128285|NCT00518206|412479|P2|Overall Study|Reason Unknown|0
128286|NCT00518206|412480|P1|Overall Study|Reason Unknown|1
128287|NCT00518206|412479|P2|Overall Study|Drug Supply Issue|0
128288|NCT00518206|412480|P1|Overall Study|Drug Supply Issue|1
128289|NCT00518206|412479|P2|Overall Study|Withdrawal by Subject|0
128290|NCT00518206|412480|P1|Overall Study|Withdrawal by Subject|2
128291|NCT00518206|412479|P2|Overall Study|Disease Progression Requiring Therapy|6
128292|NCT00518206|412480|P1|Overall Study|Disease Progression Requiring Therapy|6
128293|NCT00518284|412498|P4|Overall Study|Study Termination|2
128294|NCT00518284|412499|P3|Overall Study|Study Termination|1
128295|NCT00518284|412500|P2|Overall Study|Study Termination|2
128296|NCT00518284|412501|P1|Overall Study|Study Termination|0
128297|NCT00518284|412498|P4|Overall Study|Adverse Event|0
128298|NCT00518284|412499|P3|Overall Study|Adverse Event|0
128299|NCT00518284|412500|P2|Overall Study|Adverse Event|1
128300|NCT00518284|412501|P1|Overall Study|Adverse Event|0
128301|NCT00518323|412559|P4|Overall Study|Prohibited medication and others|0
128302|NCT00518323|412560|P3|Overall Study|Prohibited medication and others|1
128303|NCT00518323|412561|P2|Overall Study|Prohibited medication and others|1
128304|NCT00518323|412562|P1|Overall Study|Prohibited medication and others|3
128305|NCT00518323|412559|P4|Overall Study|Adverse Event|0
128306|NCT00518323|412560|P3|Overall Study|Adverse Event|1
128307|NCT00518323|412561|P2|Overall Study|Adverse Event|1
128308|NCT00518323|412562|P1|Overall Study|Adverse Event|1
128309|NCT00518323|412559|P4|Overall Study|Lost to Follow-up|3
128310|NCT00518323|412560|P3|Overall Study|Lost to Follow-up|1
128311|NCT00518323|412561|P2|Overall Study|Lost to Follow-up|2
128312|NCT00518323|412562|P1|Overall Study|Lost to Follow-up|0
128313|NCT00518323|412559|P4|Overall Study|Withdrawal by Subject|2
128314|NCT00518323|412560|P3|Overall Study|Withdrawal by Subject|4
128315|NCT00518323|412561|P2|Overall Study|Withdrawal by Subject|2
128316|NCT00518323|412562|P1|Overall Study|Withdrawal by Subject|1
128317|NCT00518323|412559|P4|Overall Study|Lack of Efficacy|20
128318|NCT00518323|412560|P3|Overall Study|Lack of Efficacy|4
128319|NCT00518323|412561|P2|Overall Study|Lack of Efficacy|2
128320|NCT00518323|412562|P1|Overall Study|Lack of Efficacy|14
128321|NCT00518336|412590|P2|Year 9|Personal reasons|0
128322|NCT00518336|412591|P1|Year 9|Personal reasons|1
128323|NCT00518336|412590|P2|Year 9|Lost to Follow-up|0
128324|NCT00518336|412591|P1|Year 9|Lost to Follow-up|3
128325|NCT00518336|412590|P2|Year 9|Migrated/moved from study area|1
128326|NCT00518336|412591|P1|Year 9|Migrated/moved from study area|1
128327|NCT00518336|412590|P2|Year 8|Could not attend in time|1
128328|NCT00518336|412591|P1|Year 8|Could not attend in time|0
128329|NCT00518336|412590|P2|Year 8|Lost to Follow-up|1
128330|NCT00518336|412591|P1|Year 8|Lost to Follow-up|1
128331|NCT00518336|412590|P2|Year 7|Could not attend in time|3
128332|NCT00518336|412591|P1|Year 7|Could not attend in time|0
128333|NCT00518336|412590|P2|Year 7|Lost to Follow-up|0
128334|NCT00518336|412591|P1|Year 7|Lost to Follow-up|2
128335|NCT00518531|412755|P2|Treatment Period 2|Non-compliance|2
128336|NCT00518531|412756|P1|Treatment Period 2|Non-compliance|1
128337|NCT00518531|412755|P2|Treatment Period 2|Protocol-specified criteria|1
128338|NCT00518531|412756|P1|Treatment Period 2|Protocol-specified criteria|0
128339|NCT00518531|412755|P2|Treatment Period 2|Adverse Event|7
128340|NCT00518531|412756|P1|Treatment Period 2|Adverse Event|1
128341|NCT00518531|412755|P2|Treatment Period 2|Complete out of scheduled visit window|2
128342|NCT00518531|412756|P1|Treatment Period 2|Complete out of scheduled visit window|1
128343|NCT00518531|412755|P2|Treatment Period 2|Withdrawal by Subject|8
128344|NCT00518531|412756|P1|Treatment Period 2|Withdrawal by Subject|0
128345|NCT00518531|412755|P2|Treatment Period 1|Early crossover|3
128346|NCT00518531|412756|P1|Treatment Period 1|Early crossover|1
128347|NCT00518531|412755|P2|Treatment Period 1|Withdrawal by Subject|6
128348|NCT00518531|412756|P1|Treatment Period 1|Withdrawal by Subject|4
128349|NCT00518531|412755|P2|Treatment Period 1|Protocol Violation|0
128350|NCT00518531|412756|P1|Treatment Period 1|Protocol Violation|2
128351|NCT00518531|412755|P2|Treatment Period 1|Physician Decision|0
128352|NCT00518531|412756|P1|Treatment Period 1|Physician Decision|1
128353|NCT00518531|412755|P2|Treatment Period 1|Lost to Follow-up|3
128354|NCT00518531|412756|P1|Treatment Period 1|Lost to Follow-up|5
128355|NCT00518531|412755|P2|Treatment Period 1|Adverse Event|0
128356|NCT00518531|412756|P1|Treatment Period 1|Adverse Event|5
128357|NCT00518622|412798|P8|Overall Study|Study medication taken incorrectly|0
128358|NCT00518622|412799|P7|Overall Study|Study medication taken incorrectly|0
128359|NCT00518622|412800|P6|Overall Study|Study medication taken incorrectly|0
128360|NCT00518622|412801|P5|Overall Study|Study medication taken incorrectly|0
128361|NCT00518622|412802|P4|Overall Study|Study medication taken incorrectly|0
128362|NCT00518622|412803|P3|Overall Study|Study medication taken incorrectly|0
128363|NCT00518622|412804|P2|Overall Study|Study medication taken incorrectly|1
128364|NCT00518622|412805|P1|Overall Study|Study medication taken incorrectly|0
128365|NCT00518622|412798|P8|Overall Study|Lost to Follow-up|0
128366|NCT00518622|412799|P7|Overall Study|Lost to Follow-up|0
128367|NCT00518622|412800|P6|Overall Study|Lost to Follow-up|0
128368|NCT00518622|412801|P5|Overall Study|Lost to Follow-up|0
128369|NCT00518622|412802|P4|Overall Study|Lost to Follow-up|0
128370|NCT00518622|412803|P3|Overall Study|Lost to Follow-up|1
128371|NCT00518622|412804|P2|Overall Study|Lost to Follow-up|0
128372|NCT00518622|412805|P1|Overall Study|Lost to Follow-up|0
128373|NCT00518687|412833|P2|Overall Study|Withdrawal by Subject|110
128374|NCT00518687|412834|P1|Overall Study|Withdrawal by Subject|110
128375|NCT00518687|412833|P2|Overall Study|Study terminated by sponsor|918
128376|NCT00518687|412834|P1|Overall Study|Study terminated by sponsor|930
128377|NCT00518687|412833|P2|Overall Study|Protocol Violation|10
128378|NCT00518687|412834|P1|Overall Study|Protocol Violation|8
128379|NCT00518687|412833|P2|Overall Study|Progressive disease|2
128380|NCT00518687|412834|P1|Overall Study|Progressive disease|2
128381|NCT00518687|412833|P2|Overall Study|Physician Decision|48
128382|NCT00518687|412834|P1|Overall Study|Physician Decision|42
128383|NCT00518687|412833|P2|Overall Study|Lost to Follow-up|155
128384|NCT00518687|412834|P1|Overall Study|Lost to Follow-up|144
128385|NCT00518687|412833|P2|Overall Study|Adverse Event|177
128386|NCT00518687|412834|P1|Overall Study|Adverse Event|201
128387|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
128388|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
128389|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Subject decision|0
128390|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Subject decision|2
128391|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
128392|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
128393|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
128394|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
128395|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Creatine increased|0
128396|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Creatine increased|1
128397|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Change in treatment|1
128398|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Change in treatment|1
128399|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
128400|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
128401|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
128402|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
128403|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
128404|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
128405|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
128406|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
128407|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
128408|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
128409|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
128410|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
128411|NCT00518882|412913|P2|Open-Label Extension, Week 26-78|Adverse Event|9
128412|NCT00518882|412914|P1|Open-Label Extension, Week 26-78|Adverse Event|3
128413|NCT00518882|412913|P2|Double-Blind, Week 0-26|Mutual consent|1
128414|NCT00518882|412914|P1|Double-Blind, Week 0-26|Mutual consent|0
128415|NCT00518882|412913|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
128416|NCT00518882|412914|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
128417|NCT00518882|412913|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
128418|NCT00518882|412914|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
128419|NCT00518882|412913|P2|Double-Blind, Week 0-26|Loss of trust|1
128420|NCT00518882|412914|P1|Double-Blind, Week 0-26|Loss of trust|0
128421|NCT00518882|412913|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
128422|NCT00518882|412914|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
128423|NCT00518882|412913|P2|Double-Blind, Week 0-26|Subject decision|1
128424|NCT00518882|412914|P1|Double-Blind, Week 0-26|Subject decision|1
128425|NCT00518882|412913|P2|Double-Blind, Week 0-26|Lost to follow up|1
128426|NCT00518882|412914|P1|Double-Blind, Week 0-26|Lost to follow up|2
128427|NCT00518882|412913|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
128428|NCT00518882|412914|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
128429|NCT00518882|412913|P2|Double-Blind, Week 0-26|Protocol Violation|3
128430|NCT00518882|412914|P1|Double-Blind, Week 0-26|Protocol Violation|4
128431|NCT00518882|412913|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
128432|NCT00518882|412914|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
128433|NCT00518882|412913|P2|Double-Blind, Week 0-26|Adverse Event|31
128434|NCT00518882|412914|P1|Double-Blind, Week 0-26|Adverse Event|23
128435|NCT00518986|413030|P2|Overall Study|Non-Specific|1
128436|NCT00518986|413031|P1|Overall Study|Non-Specific|2
128437|NCT00518986|413030|P2|Overall Study|Withdrawal by Subject|4
128438|NCT00518986|413031|P1|Overall Study|Withdrawal by Subject|4
128439|NCT00518986|413030|P2|Overall Study|Protocol Violation|7
128440|NCT00518986|413031|P1|Overall Study|Protocol Violation|5
128441|NCT00518986|413030|P2|Overall Study|Physician Decision|3
128442|NCT00518986|413031|P1|Overall Study|Physician Decision|0
128443|NCT00518986|413030|P2|Overall Study|Lost to Follow-up|2
128444|NCT00518986|413031|P1|Overall Study|Lost to Follow-up|3
128445|NCT00518986|413030|P2|Overall Study|Lack of Efficacy|2
128446|NCT00518986|413031|P1|Overall Study|Lack of Efficacy|0
128447|NCT00518986|413030|P2|Overall Study|Adverse Event|7
128448|NCT00518986|413031|P1|Overall Study|Adverse Event|12
128449|NCT00519077|413155|P1|Overall Study|Other|2
128450|NCT00519077|413155|P1|Overall Study|Death|6
128451|NCT00519194|413171|P1|Overall Study|Lost to Follow-up|3
128452|NCT00519194|413171|P1|Overall Study|Death|9
128453|NCT00519194|413171|P1|Overall Study|Withdrawal by Subject|9
128454|NCT00519285|413177|P2|Overall Study|Treatment ongoing|2
128455|NCT00519285|413178|P1|Overall Study|Treatment ongoing|1
128456|NCT00519285|413177|P2|Overall Study|Not treated|7
128457|NCT00519285|413178|P1|Overall Study|Not treated|8
128458|NCT00519285|413177|P2|Overall Study|Reason unspecified|8
128459|NCT00519285|413178|P1|Overall Study|Reason unspecified|5
128460|NCT00519285|413177|P2|Overall Study|Poor compliance to protocol|7
128461|NCT00519285|413178|P1|Overall Study|Poor compliance to protocol|5
128462|NCT00519285|413177|P2|Overall Study|Consent withdrawn|5
128463|NCT00519285|413178|P1|Overall Study|Consent withdrawn|4
128464|NCT00519285|413177|P2|Overall Study|Participant's request|84
128465|NCT00519285|413178|P1|Overall Study|Participant's request|53
128466|NCT00519285|413177|P2|Overall Study|Physician Decision|47
128467|NCT00519285|413178|P1|Overall Study|Physician Decision|75
128468|NCT00519285|413177|P2|Overall Study|Disease progression|186
128469|NCT00519285|413178|P1|Overall Study|Disease progression|334
128470|NCT00519285|413177|P2|Overall Study|Adverse Event|266
128471|NCT00519285|413178|P1|Overall Study|Adverse Event|127
128472|NCT00519376|413204|P16|Treatment Period 4|Lost to Follow-up|0
128473|NCT00519376|413205|P15|Treatment Period 4|Lost to Follow-up|0
128474|NCT00519376|413206|P14|Treatment Period 4|Lost to Follow-up|0
128475|NCT00519376|413207|P13|Treatment Period 4|Lost to Follow-up|0
128476|NCT00519376|413208|P12|Treatment Period 4|Lost to Follow-up|0
128477|NCT00519376|413209|P11|Treatment Period 4|Lost to Follow-up|0
128478|NCT00519376|413210|P10|Treatment Period 4|Lost to Follow-up|0
128479|NCT00519376|413211|P9|Treatment Period 4|Lost to Follow-up|0
128480|NCT00519376|413212|P8|Treatment Period 4|Lost to Follow-up|0
128481|NCT00519376|413213|P7|Treatment Period 4|Lost to Follow-up|0
128482|NCT00519376|413214|P6|Treatment Period 4|Lost to Follow-up|0
128483|NCT00519376|413215|P5|Treatment Period 4|Lost to Follow-up|0
128484|NCT00519376|413216|P4|Treatment Period 4|Lost to Follow-up|0
128485|NCT00519376|413217|P3|Treatment Period 4|Lost to Follow-up|1
128486|NCT00519376|413218|P2|Treatment Period 4|Lost to Follow-up|0
128487|NCT00519376|413219|P1|Treatment Period 4|Lost to Follow-up|0
128488|NCT00519376|413204|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128489|NCT00519376|413205|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128490|NCT00519376|413206|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128491|NCT00519376|413207|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
128492|NCT00519376|413208|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128493|NCT00519376|413209|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128494|NCT00519376|413210|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128495|NCT00519376|413211|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128496|NCT00519376|413212|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128497|NCT00519376|413213|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128498|NCT00519376|413214|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128499|NCT00519376|413215|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128500|NCT00519376|413216|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128501|NCT00519376|413217|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128502|NCT00519376|413218|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128503|NCT00519376|413219|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
128504|NCT00519532|413341|P1|Overall Study|Lost to Follow-up|2
128505|NCT00519532|413341|P1|Overall Study|Withdrawal by Subject|5
128506|NCT00519532|413341|P1|Overall Study|Adverse Event|11
128507|NCT00519623|413377|P1|Overall Study|Adverse Event|1
128508|NCT00519636|413386|P4|Post Study Period|Subject randomized in error|1
128509|NCT00519636|413387|P3|Post Study Period|Subject randomized in error|0
128510|NCT00519636|413388|P2|Post Study Period|Subject randomized in error|0
128511|NCT00519636|413389|P1|Post Study Period|Subject randomized in error|0
128512|NCT00519636|413386|P4|Treatment Period 2|Subject misrandomized|1
128513|NCT00519636|413387|P3|Treatment Period 2|Subject misrandomized|0
128514|NCT00519636|413388|P2|Treatment Period 2|Subject misrandomized|0
128515|NCT00519636|413389|P1|Treatment Period 2|Subject misrandomized|0
128516|NCT00519636|413386|P4|Treatment Period 2|Per doctors request|0
128517|NCT00519636|413387|P3|Treatment Period 2|Per doctors request|1
128518|NCT00519636|413388|P2|Treatment Period 2|Per doctors request|0
128519|NCT00519636|413389|P1|Treatment Period 2|Per doctors request|0
128520|NCT00519636|413386|P4|Treatment Period 2|Subject randomized in error|0
128521|NCT00519636|413387|P3|Treatment Period 2|Subject randomized in error|0
128522|NCT00519636|413388|P2|Treatment Period 2|Subject randomized in error|1
128523|NCT00519636|413389|P1|Treatment Period 2|Subject randomized in error|0
128524|NCT00519636|413386|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
128525|NCT00519636|413387|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
128526|NCT00519636|413388|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
128527|NCT00519636|413389|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
128528|NCT00519636|413386|P4|Washout Period|Prohibited medications|0
128529|NCT00519636|413387|P3|Washout Period|Prohibited medications|1
128530|NCT00519636|413388|P2|Washout Period|Prohibited medications|0
128531|NCT00519636|413389|P1|Washout Period|Prohibited medications|0
128532|NCT00519636|413386|P4|Washout Period|Subject randomized in error|0
128533|NCT00519636|413387|P3|Washout Period|Subject randomized in error|1
128534|NCT00519636|413388|P2|Washout Period|Subject randomized in error|0
128535|NCT00519636|413389|P1|Washout Period|Subject randomized in error|0
128536|NCT00519636|413386|P4|Washout Period|Per doctors request|0
128537|NCT00519636|413387|P3|Washout Period|Per doctors request|0
128538|NCT00519636|413388|P2|Washout Period|Per doctors request|1
128539|NCT00519636|413389|P1|Washout Period|Per doctors request|0
128540|NCT00519636|413386|P4|Washout Period|Non-compliant|0
128541|NCT00519636|413387|P3|Washout Period|Non-compliant|0
128542|NCT00519636|413388|P2|Washout Period|Non-compliant|1
128543|NCT00519636|413389|P1|Washout Period|Non-compliant|0
128544|NCT00519636|413386|P4|Washout Period|Participating in study at another site|0
128545|NCT00519636|413387|P3|Washout Period|Participating in study at another site|0
128546|NCT00519636|413388|P2|Washout Period|Participating in study at another site|0
128547|NCT00519636|413389|P1|Washout Period|Participating in study at another site|1
128548|NCT00519636|413386|P4|Washout Period|Out of pollen area > 48 hours|0
128549|NCT00519636|413387|P3|Washout Period|Out of pollen area > 48 hours|0
128550|NCT00519636|413388|P2|Washout Period|Out of pollen area > 48 hours|0
128551|NCT00519636|413389|P1|Washout Period|Out of pollen area > 48 hours|1
128552|NCT00519636|413386|P4|Washout Period|Failed to meet continuation criteria|3
128553|NCT00519636|413387|P3|Washout Period|Failed to meet continuation criteria|9
128554|NCT00519636|413388|P2|Washout Period|Failed to meet continuation criteria|11
128555|NCT00519636|413389|P1|Washout Period|Failed to meet continuation criteria|14
128556|NCT00519636|413386|P4|Washout Period|Withdrawal by Subject|0
128557|NCT00519636|413387|P3|Washout Period|Withdrawal by Subject|1
128558|NCT00519636|413388|P2|Washout Period|Withdrawal by Subject|0
128559|NCT00519636|413389|P1|Washout Period|Withdrawal by Subject|1
128560|NCT00519636|413386|P4|Washout Period|Protocol Violation|2
128561|NCT00519636|413387|P3|Washout Period|Protocol Violation|1
128562|NCT00519636|413388|P2|Washout Period|Protocol Violation|0
128563|NCT00519636|413389|P1|Washout Period|Protocol Violation|0
128564|NCT00519636|413386|P4|Washout Period|Lost to Follow-up|0
128565|NCT00519636|413387|P3|Washout Period|Lost to Follow-up|0
128566|NCT00519636|413388|P2|Washout Period|Lost to Follow-up|0
128567|NCT00519636|413389|P1|Washout Period|Lost to Follow-up|1
128568|NCT00519636|413386|P4|Washout Period|Adverse Event|0
128569|NCT00519636|413387|P3|Washout Period|Adverse Event|1
128570|NCT00519636|413388|P2|Washout Period|Adverse Event|1
128571|NCT00519636|413389|P1|Washout Period|Adverse Event|2
128572|NCT00519636|413386|P4|Treatment Period 1|Sponsor request due to missed visit|0
128573|NCT00519636|413387|P3|Treatment Period 1|Sponsor request due to missed visit|0
128574|NCT00519636|413388|P2|Treatment Period 1|Sponsor request due to missed visit|0
128575|NCT00519636|413389|P1|Treatment Period 1|Sponsor request due to missed visit|1
128576|NCT00519636|413386|P4|Treatment Period 1|Adverse Event|0
128577|NCT00519636|413387|P3|Treatment Period 1|Adverse Event|1
128578|NCT00519636|413388|P2|Treatment Period 1|Adverse Event|0
128579|NCT00519636|413389|P1|Treatment Period 1|Adverse Event|1
128580|NCT00519649|413419|P1|Overall Study|Withdrawal by Subject|1
128581|NCT00519779|413430|P2|Overall Study|Withdrawal by Subject|1
128582|NCT00519779|413431|P1|Overall Study|Withdrawal by Subject|0
128583|NCT00519831|413455|P1|Overall Study|Adverse Event|3
128584|NCT00519896|413462|P1|Overall Study|Adverse Event|1
128585|NCT00519896|413462|P1|Overall Study|Protocol Violation|1
128586|NCT00520013|413471|P3|Overall Study|Physician Decision|3
128587|NCT00520013|413472|P2|Overall Study|Physician Decision|0
128588|NCT00520013|413473|P1|Overall Study|Physician Decision|0
128589|NCT00520013|413471|P3|Overall Study|Death|0
128590|NCT00520013|413472|P2|Overall Study|Death|1
128591|NCT00520013|413473|P1|Overall Study|Death|0
128592|NCT00520013|413471|P3|Overall Study|Clinical Progression|0
128593|NCT00520013|413472|P2|Overall Study|Clinical Progression|1
128594|NCT00520013|413473|P1|Overall Study|Clinical Progression|3
128595|NCT00520013|413471|P3|Overall Study|Progressive Disease|0
128596|NCT00520013|413472|P2|Overall Study|Progressive Disease|3
128597|NCT00520013|413473|P1|Overall Study|Progressive Disease|7
128598|NCT00520013|413471|P3|Overall Study|Adverse Event|7
128599|NCT00520013|413472|P2|Overall Study|Adverse Event|10
128600|NCT00520013|413473|P1|Overall Study|Adverse Event|2
128601|NCT00520013|413471|P3|Overall Study|Withdrawal by Subject|1
128602|NCT00520013|413472|P2|Overall Study|Withdrawal by Subject|0
128603|NCT00520013|413473|P1|Overall Study|Withdrawal by Subject|0
128604|NCT00520130|413485|P2|Overall Study|Physician Decision|1
128605|NCT00520130|413486|P1|Overall Study|Physician Decision|1
128606|NCT00520130|413485|P2|Overall Study|Disease progression on study|0
128607|NCT00520130|413486|P1|Overall Study|Disease progression on study|4
128608|NCT00513019|413528|P2|Overall Study|Withdrawal by Subject|5
128609|NCT00513019|413529|P1|Overall Study|Withdrawal by Subject|4
128610|NCT00513019|413528|P2|Overall Study|Adverse Event|0
128611|NCT00513019|413529|P1|Overall Study|Adverse Event|1
128612|NCT00513071|413535|P1|Overall Study|Physician Decision|3
128613|NCT00513071|413535|P1|Overall Study|Withdrawal by Subject|1
128614|NCT00513071|413535|P1|Overall Study|Adverse Event|1
128615|NCT00513240|413542|P2|Overall Study|Withdrawal by Subject|4
128616|NCT00513240|413543|P1|Overall Study|Withdrawal by Subject|7
128617|NCT00513240|413542|P2|Overall Study|Death|3
128618|NCT00513240|413543|P1|Overall Study|Death|3
128619|NCT00513240|413542|P2|Overall Study|Did not have intended surgery|0
128620|NCT00513240|413543|P1|Overall Study|Did not have intended surgery|3
128621|NCT00513305|413571|P2|Overall Study|Sponsor Decision|2
128622|NCT00513305|413572|P1|Overall Study|Sponsor Decision|0
128623|NCT00513305|413571|P2|Overall Study|Persistent hypocellularity|1
128624|NCT00513305|413572|P1|Overall Study|Persistent hypocellularity|0
128625|NCT00513305|413571|P2|Overall Study|Physician Decision|0
128626|NCT00513305|413572|P1|Overall Study|Physician Decision|1
128627|NCT00513305|413571|P2|Overall Study|Hematologic counts did not recover|0
128628|NCT00513305|413572|P1|Overall Study|Hematologic counts did not recover|1
128629|NCT00513305|413571|P2|Overall Study|Eligible for stem cell transplant|0
128630|NCT00513305|413572|P1|Overall Study|Eligible for stem cell transplant|1
128631|NCT00513305|413571|P2|Overall Study|Disease progression|5
128632|NCT00513305|413572|P1|Overall Study|Disease progression|8
128633|NCT00513305|413571|P2|Overall Study|Withdrawal by Subject|2
128634|NCT00513305|413572|P1|Overall Study|Withdrawal by Subject|1
128635|NCT00513305|413571|P2|Overall Study|Lack of Efficacy|13
128636|NCT00513305|413572|P1|Overall Study|Lack of Efficacy|8
128637|NCT00513305|413571|P2|Overall Study|Death (through Consolidation Treatment)|2
128638|NCT00513305|413572|P1|Overall Study|Death (through Consolidation Treatment)|2
128639|NCT00513305|413571|P2|Overall Study|Adverse Event|2
128640|NCT00513305|413572|P1|Overall Study|Adverse Event|6
128641|NCT00513357|413601|P2|Overall Study|Disease Progression|1
128642|NCT00513357|413602|P1|Overall Study|Disease Progression|2
128643|NCT00513357|413601|P2|Overall Study|Withdrawal by Subject|4
128644|NCT00513357|413602|P1|Overall Study|Withdrawal by Subject|5
128645|NCT00513357|413601|P2|Overall Study|Death|0
128646|NCT00513357|413602|P1|Overall Study|Death|2
128647|NCT00513357|413601|P2|Overall Study|Adverse Event|2
128648|NCT00513357|413602|P1|Overall Study|Adverse Event|4
128649|NCT00513357|413601|P2|Overall Study|did not receive allocated placebo|3
128650|NCT00513357|413602|P1|Overall Study|did not receive allocated placebo|2
128651|NCT00513409|413638|P2|Overall Study|Visit 3 not done|2
128652|NCT00513409|413639|P1|Overall Study|Visit 3 not done|1
128653|NCT00513409|413638|P2|Overall Study|Physician Decision|0
128654|NCT00513409|413639|P1|Overall Study|Physician Decision|1
128655|NCT00513409|413638|P2|Overall Study|Lost to Follow-up|1
128656|NCT00513409|413639|P1|Overall Study|Lost to Follow-up|0
128657|NCT00513409|413638|P2|Overall Study|Withdrawal by Subject|2
128658|NCT00513409|413639|P1|Overall Study|Withdrawal by Subject|0
128659|NCT00513409|413638|P2|Overall Study|Adverse Event|1
128660|NCT00513409|413639|P1|Overall Study|Adverse Event|0
128661|NCT00513474|413672|P2|Overall Study|Participant Withdrew Consent|0
128662|NCT00513474|413673|P1|Overall Study|Participant Withdrew Consent|1
128663|NCT00513474|413672|P2|Overall Study|Death|9
128664|NCT00513474|413673|P1|Overall Study|Death|6
128665|NCT00513500|413687|P2|Overall Study|Hospitalized|14
128666|NCT00513500|413688|P1|Overall Study|Hospitalized|4
128667|NCT00513500|413687|P2|Overall Study|Death|1
128668|NCT00513500|413688|P1|Overall Study|Death|2
128669|NCT00513500|413687|P2|Overall Study|Lost to Follow-up|39
128670|NCT00513500|413688|P1|Overall Study|Lost to Follow-up|35
128671|NCT00513604|413718|P5|Overall Study|Death during treatment|0
128672|NCT00513604|413719|P4|Overall Study|Death during treatment|0
128673|NCT00513604|413720|P3|Overall Study|Death during treatment|2
128674|NCT00513604|413721|P2|Overall Study|Death during treatment|3
128675|NCT00513604|413722|P1|Overall Study|Death during treatment|0
128676|NCT00513604|413718|P5|Overall Study|Not treated|0
128677|NCT00513604|413719|P4|Overall Study|Not treated|0
128678|NCT00513604|413720|P3|Overall Study|Not treated|1
128679|NCT00513604|413721|P2|Overall Study|Not treated|0
128680|NCT00513604|413722|P1|Overall Study|Not treated|2
128681|NCT00513682|413755|P1|Washout Phase|Adverse Event|2
128682|NCT00513695|413764|P1|Overall Study|Progression prior to surgery|3
128683|NCT00513695|413764|P1|Overall Study|Discontinued therapy|2
128684|NCT00513708|413776|P3|Overall Study|Lost to Follow-up|4
128685|NCT00513708|413777|P2|Overall Study|Lost to Follow-up|4
128686|NCT00513708|413778|P1|Overall Study|Lost to Follow-up|4
128687|NCT00520299|413819|P3|Overall Study|Progressive disease|4
128688|NCT00520299|413820|P2|Overall Study|Progressive disease|3
128689|NCT00520299|413821|P1|Overall Study|Progressive disease|0
128690|NCT00520299|413819|P3|Overall Study|Withdrawal by Subject|2
128691|NCT00520299|413820|P2|Overall Study|Withdrawal by Subject|0
128692|NCT00520299|413821|P1|Overall Study|Withdrawal by Subject|0
128693|NCT00520351|413852|P2|First Intervention|Withdrawal by Subject|1
128694|NCT00520351|413853|P1|First Intervention|Withdrawal by Subject|1
128695|NCT00520403|413865|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
128696|NCT00520403|413865|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
128697|NCT00520403|413865|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
128698|NCT00520403|413865|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
128699|NCT00520403|413865|P1|Bevacizumab + IFN/Vinblastine|Death|2
128700|NCT00520403|413865|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
128701|NCT00520403|413865|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
128702|NCT00520403|413865|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
128703|NCT00520494|413876|P1|Overall Study|Withdrawal by Subject|1
128704|NCT00522457|413899|P1|Overall Study|Adverse Event|2
128705|NCT00522457|413899|P1|Overall Study|Due to disease progression|16
128706|NCT00522626|413905|P1|Overall Study|Lost to Follow-up|7
128707|NCT00522873|413915|P2|Overall Study|Never Received Medication|0
128708|NCT00522873|413916|P1|Overall Study|Never Received Medication|1
128709|NCT00522873|413915|P2|Overall Study|Medication Errors|1
128710|NCT00522873|413916|P1|Overall Study|Medication Errors|1
128711|NCT00522873|413915|P2|Overall Study|Personal Reasons|1
128712|NCT00522873|413916|P1|Overall Study|Personal Reasons|8
128713|NCT00522873|413915|P2|Overall Study|Lost to Follow-up|3
128714|NCT00522873|413916|P1|Overall Study|Lost to Follow-up|11
128715|NCT00522873|413915|P2|Overall Study|Protocol Violation|4
128716|NCT00522873|413916|P1|Overall Study|Protocol Violation|14
128717|NCT00522873|413915|P2|Overall Study|Withdrawal by Subject|9
128718|NCT00522873|413916|P1|Overall Study|Withdrawal by Subject|20
128719|NCT00522873|413915|P2|Overall Study|Adverse Event|26
128720|NCT00522873|413916|P1|Overall Study|Adverse Event|41
128721|NCT00522951|413938|P2|Period 2|residual contrast medium|1
128722|NCT00522951|413939|P1|Period 2|residual contrast medium|1
128723|NCT00522951|413938|P2|Period 2|Withdrawal by Subject|0
128724|NCT00522951|413939|P1|Period 2|Withdrawal by Subject|1
128725|NCT00522951|413938|P2|Washout Period|Death|1
128726|NCT00522951|413939|P1|Washout Period|Death|0
128727|NCT00522951|413938|P2|Washout Period|Adverse Event|1
128728|NCT00522951|413939|P1|Washout Period|Adverse Event|0
128729|NCT00522951|413938|P2|Period 1|body motion|1
128730|NCT00522951|413939|P1|Period 1|body motion|0
128731|NCT00523341|413985|P2|Overall Study|Disease Progression|0
128732|NCT00523341|413986|P1|Overall Study|Disease Progression|1
128733|NCT00523341|413985|P2|Overall Study|Ineligibility Determined|4
128734|NCT00523341|413986|P1|Overall Study|Ineligibility Determined|3
128735|NCT00523341|413985|P2|Overall Study|Protocol Deviation|5
128736|NCT00523341|413986|P1|Overall Study|Protocol Deviation|6
128737|NCT00523341|413985|P2|Overall Study|Requirement for Alternative Therapy|14
128738|NCT00523341|413986|P1|Overall Study|Requirement for Alternative Therapy|4
128739|NCT00523341|413985|P2|Overall Study|Physician Decision|13
128740|NCT00523341|413986|P1|Overall Study|Physician Decision|14
128741|NCT00523341|413985|P2|Overall Study|Non-compliance|13
128742|NCT00523341|413986|P1|Overall Study|Non-compliance|20
128743|NCT00523341|413985|P2|Overall Study|Lost to Follow-up|61
128744|NCT00523341|413986|P1|Overall Study|Lost to Follow-up|73
128745|NCT00523341|413985|P2|Overall Study|Death|110
128746|NCT00523341|413986|P1|Overall Study|Death|101
128747|NCT00523341|413985|P2|Overall Study|Adverse Event|155
128748|NCT00523341|413986|P1|Overall Study|Adverse Event|122
128749|NCT00523341|413985|P2|Overall Study|Other|198
128750|NCT00523341|413986|P1|Overall Study|Other|181
128751|NCT00523341|413985|P2|Overall Study|Withdrawal by Subject|427
128752|NCT00523341|413986|P1|Overall Study|Withdrawal by Subject|399
128753|NCT00523367|414086|P1|Overall Study|4 Withdrawn by PI|4
128754|NCT00523367|414086|P1|Overall Study|19 screen failures|19
128755|NCT00523419|414090|P1|Overall Study|Death due to Adverse Event|2
128756|NCT00523419|414090|P1|Overall Study|Death due to Study Disease|4
128757|NCT00523419|414090|P1|Overall Study|Progressive Disease|22
128758|NCT00523419|414090|P1|Overall Study|Physician Decision|2
128759|NCT00523419|414090|P1|Overall Study|Withdrawal by Subject|1
128760|NCT00523419|414090|P1|Overall Study|Adverse Event|1
128761|NCT00523549|414102|P2|Overall Study|Lost to Follow-up|5
128762|NCT00523549|414103|P1|Overall Study|Lost to Follow-up|3
128763|NCT00523549|414102|P2|Overall Study|Patient withdrew consent|6
128764|NCT00523549|414103|P1|Overall Study|Patient withdrew consent|7
128765|NCT00523549|414102|P2|Overall Study|Protocol Deviation|1
128766|NCT00523549|414103|P1|Overall Study|Protocol Deviation|3
128767|NCT00523549|414102|P2|Overall Study|Unsatisfactory therapeutic effect|1
128768|NCT00523549|414103|P1|Overall Study|Unsatisfactory therapeutic effect|0
128769|NCT00523549|414102|P2|Overall Study|Adverse Event|3
128770|NCT00523549|414103|P1|Overall Study|Adverse Event|6
128771|NCT00523640|414130|P1|Overall Study|Death|1
128772|NCT00523705|414138|P2|Overall Study|No time for study.|1
128773|NCT00523705|414139|P1|Overall Study|No time for study.|0
128774|NCT00523718|414153|P2|Overall Study|Protocol Violation|0
128775|NCT00523718|414154|P1|Overall Study|Protocol Violation|2
128776|NCT00523718|414153|P2|Overall Study|Withdrawal by Subject|0
128777|NCT00523718|414154|P1|Overall Study|Withdrawal by Subject|1
128778|NCT00523744|414166|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
128779|NCT00523744|414166|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
128780|NCT00523744|414166|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
128781|NCT00523744|414166|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
128782|NCT00523744|414166|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
128783|NCT00523744|414166|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
128784|NCT00523848|414187|P1|Overall Study|Other, unspecified|4
128785|NCT00523848|414187|P1|Overall Study|Disease Progression|5
128786|NCT00523848|414187|P1|Overall Study|NOT TREATED (Became ineligible)|2
128787|NCT00523848|414187|P1|Overall Study|Withdrawal by Subject|2
128788|NCT00523848|414187|P1|Overall Study|Adverse Event|11
128789|NCT00523978|414205|P2|Overall Study|Death|0
128790|NCT00523978|414206|P1|Overall Study|Death|1
128791|NCT00523978|414205|P2|Overall Study|Screen Failures|1
128792|NCT00523978|414206|P1|Overall Study|Screen Failures|5
128793|NCT00523978|414205|P2|Overall Study|Withdrawal by Subject|7
128794|NCT00523978|414206|P1|Overall Study|Withdrawal by Subject|3
128795|NCT00523991|414220|P2|Overall Study|Other reason (not specified)|0
128796|NCT00523991|414221|P1|Overall Study|Other reason (not specified)|3
128797|NCT00523991|414220|P2|Overall Study|Withdrawal by Subject|17
128798|NCT00523991|414221|P1|Overall Study|Withdrawal by Subject|7
128799|NCT00523991|414220|P2|Overall Study|Lost to Follow-up|1
128800|NCT00523991|414221|P1|Overall Study|Lost to Follow-up|4
128801|NCT00523991|414220|P2|Overall Study|Protocol Violation|4
128802|NCT00523991|414221|P1|Overall Study|Protocol Violation|1
128803|NCT00523991|414220|P2|Overall Study|Adverse Event|5
128804|NCT00523991|414221|P1|Overall Study|Adverse Event|6
128805|NCT00524030|414501|P2|Overall Study|Death|1
128806|NCT00524030|414502|P1|Overall Study|Death|0
128807|NCT00524030|414501|P2|Overall Study|Adverse Event|21
128808|NCT00524030|414502|P1|Overall Study|Adverse Event|3
128809|NCT00524030|414501|P2|Overall Study|Pregnancy|0
128810|NCT00524030|414502|P1|Overall Study|Pregnancy|1
128811|NCT00524030|414501|P2|Overall Study|Protocol Violation|1
128812|NCT00524030|414502|P1|Overall Study|Protocol Violation|0
128813|NCT00524030|414501|P2|Overall Study|Noncompliance/Investigator discretion|2
128814|NCT00524030|414502|P1|Overall Study|Noncompliance/Investigator discretion|0
128815|NCT00524030|414501|P2|Overall Study|Withdrawal by Subject|8
128816|NCT00524030|414502|P1|Overall Study|Withdrawal by Subject|3
128817|NCT00524030|414501|P2|Overall Study|Lost to Follow-up|2
128818|NCT00524030|414502|P1|Overall Study|Lost to Follow-up|0
128819|NCT00524030|414501|P2|Overall Study|Lack of Efficacy|24
128820|NCT00524030|414502|P1|Overall Study|Lack of Efficacy|10
128821|NCT00524043|414521|P3|Overall Study|Various (eg, incarceration)|0
128822|NCT00524043|414522|P2|Overall Study|Various (eg, incarceration)|1
128823|NCT00524043|414523|P1|Overall Study|Various (eg, incarceration)|2
128824|NCT00524043|414521|P3|Overall Study|Lost to Follow-up|3
128825|NCT00524043|414522|P2|Overall Study|Lost to Follow-up|5
128826|NCT00524043|414523|P1|Overall Study|Lost to Follow-up|3
128827|NCT00524043|414521|P3|Overall Study|Adverse Event|7
128828|NCT00524043|414522|P2|Overall Study|Adverse Event|2
128829|NCT00524043|414523|P1|Overall Study|Adverse Event|5
128830|NCT00524043|414521|P3|Overall Study|Withdrawal by Subject|7
128831|NCT00524043|414522|P2|Overall Study|Withdrawal by Subject|7
128832|NCT00524043|414523|P1|Overall Study|Withdrawal by Subject|5
128833|NCT00524043|414521|P3|Overall Study|Lack of Efficacy|14
128834|NCT00524043|414522|P2|Overall Study|Lack of Efficacy|13
128835|NCT00524043|414523|P1|Overall Study|Lack of Efficacy|15
128836|NCT00524121|414543|P1|Overall Study|Not treated (changed mind)|1
128837|NCT00524121|414543|P1|Overall Study|Not treated (became ineligible)|4
128838|NCT00524121|414543|P1|Overall Study|Death|1
128839|NCT00524121|414543|P1|Overall Study|unspecified|1
128840|NCT00524121|414543|P1|Overall Study|Patient refused|2
128841|NCT00524121|414543|P1|Overall Study|Adverse Event|4
128842|NCT00524121|414543|P1|Overall Study|Disease progression|6
128843|NCT00524134|414560|P1|Overall Study|Physician Decision|1
128844|NCT00524134|414560|P1|Overall Study|Withdrawal by Subject|1
128845|NCT00524303|414590|P3|Overall Study|Completed 5 years|1
128846|NCT00524303|414591|P2|Overall Study|Completed 5 years|0
128847|NCT00524303|414592|P1|Overall Study|Completed 5 years|0
128848|NCT00524303|414590|P3|Overall Study|Physician Decision|1
128849|NCT00524303|414591|P2|Overall Study|Physician Decision|0
128850|NCT00524303|414592|P1|Overall Study|Physician Decision|0
128851|NCT00524303|414590|P3|Overall Study|Sponsor Request|1
128852|NCT00524303|414591|P2|Overall Study|Sponsor Request|0
128853|NCT00524303|414592|P1|Overall Study|Sponsor Request|0
128854|NCT00524303|414590|P3|Overall Study|Disease Recurrence|0
128855|NCT00524303|414591|P2|Overall Study|Disease Recurrence|1
128856|NCT00524303|414592|P1|Overall Study|Disease Recurrence|0
128857|NCT00524303|414590|P3|Overall Study|Disease Progression|1
128858|NCT00524303|414591|P2|Overall Study|Disease Progression|4
128859|NCT00524303|414592|P1|Overall Study|Disease Progression|0
128860|NCT00524303|414590|P3|Overall Study|Worsening Peripheral Neuropathy|0
128861|NCT00524303|414591|P2|Overall Study|Worsening Peripheral Neuropathy|0
128862|NCT00524303|414592|P1|Overall Study|Worsening Peripheral Neuropathy|1
128863|NCT00524303|414590|P3|Overall Study|Did not Complete Study Dosing|0
128864|NCT00524303|414591|P2|Overall Study|Did not Complete Study Dosing|0
128865|NCT00524303|414592|P1|Overall Study|Did not Complete Study Dosing|1
128866|NCT00524303|414590|P3|Overall Study|Adverse Event|3
128867|NCT00524303|414591|P2|Overall Study|Adverse Event|2
128868|NCT00524303|414592|P1|Overall Study|Adverse Event|1
128869|NCT00524303|414590|P3|Overall Study|Death|3
128870|NCT00524303|414591|P2|Overall Study|Death|2
128871|NCT00524303|414592|P1|Overall Study|Death|0
128872|NCT00524303|414590|P3|Overall Study|Withdrawal by Subject|4
128873|NCT00524303|414591|P2|Overall Study|Withdrawal by Subject|0
128874|NCT00524303|414592|P1|Overall Study|Withdrawal by Subject|3
128875|NCT00524303|414590|P3|Overall Study|Protocol Violation|1
128876|NCT00524303|414591|P2|Overall Study|Protocol Violation|1
128877|NCT00524303|414592|P1|Overall Study|Protocol Violation|0
128878|NCT00524303|414590|P3|Overall Study|Lost to Follow-up|3
128879|NCT00524303|414591|P2|Overall Study|Lost to Follow-up|0
128880|NCT00524303|414592|P1|Overall Study|Lost to Follow-up|6
128881|NCT00524316|414620|P1|Overall Study|Disease Progression|7
128882|NCT00524316|414620|P1|Overall Study|Adverse Event|7
128883|NCT00524316|414620|P1|Overall Study|Withdrawal by Subject|2
128884|NCT00524368|414636|P2|Overall Study|Unspecified|2
128885|NCT00524368|414637|P1|Overall Study|Unspecified|3
128886|NCT00524368|414636|P2|Overall Study|Ineligible to Continue the study|5
128887|NCT00524368|414637|P1|Overall Study|Ineligible to Continue the study|2
128888|NCT00524368|414636|P2|Overall Study|Sponsor's Decision|0
128889|NCT00524368|414637|P1|Overall Study|Sponsor's Decision|2
128890|NCT00524368|414636|P2|Overall Study|Reached a Virologic Endpoint|2
128891|NCT00524368|414637|P1|Overall Study|Reached a Virologic Endpoint|3
128892|NCT00524368|414636|P2|Overall Study|Non-compliant|9
128893|NCT00524368|414637|P1|Overall Study|Non-compliant|8
128894|NCT00524368|414636|P2|Overall Study|Withdrawal by Subject|5
128895|NCT00524368|414637|P1|Overall Study|Withdrawal by Subject|4
128896|NCT00524368|414636|P2|Overall Study|Lost to Follow-up|13
128897|NCT00524368|414637|P1|Overall Study|Lost to Follow-up|9
128898|NCT00524368|414636|P2|Overall Study|Adverse Event|12
128899|NCT00524368|414637|P1|Overall Study|Adverse Event|10
128900|NCT00524420|414671|P2|Overall Study|Lack of Efficacy|0
128901|NCT00524420|414672|P1|Overall Study|Lack of Efficacy|1
128902|NCT00524459|414684|P1|Overall Study|Other|1
128903|NCT00524459|414684|P1|Overall Study|Withdrawal by Subject|1
128904|NCT00524485|414692|P1|Overall Study|Withdrawal by Subject|5
128905|NCT00524589|414748|P1|Overall Study|Disease Progression|16
128906|NCT00524589|414748|P1|Overall Study|Withdrawal by Subject|2
128907|NCT00524680|414756|P4|Overall Study|Withdrawal by Subject|1
128908|NCT00524680|414757|P3|Overall Study|Withdrawal by Subject|1
128909|NCT00524680|414758|P2|Overall Study|Withdrawal by Subject|0
128910|NCT00524680|414759|P1|Overall Study|Withdrawal by Subject|1
128911|NCT00524680|414756|P4|Overall Study|not specified|3
128912|NCT00524680|414757|P3|Overall Study|not specified|2
128913|NCT00524680|414758|P2|Overall Study|not specified|1
128914|NCT00524680|414759|P1|Overall Study|not specified|0
128915|NCT00524680|414756|P4|Overall Study|Adverse Event|1
128916|NCT00524680|414757|P3|Overall Study|Adverse Event|0
128917|NCT00524680|414758|P2|Overall Study|Adverse Event|0
128918|NCT00524680|414759|P1|Overall Study|Adverse Event|2
128919|NCT00524680|414756|P4|Overall Study|progression|1
128920|NCT00524680|414757|P3|Overall Study|progression|0
128921|NCT00524680|414758|P2|Overall Study|progression|0
128922|NCT00524680|414759|P1|Overall Study|progression|0
128923|NCT00524745|414785|P4|Overall Study|subject withdrawal or lost to follow up|22
128924|NCT00524745|414786|P3|Overall Study|subject withdrawal or lost to follow up|29
128925|NCT00524745|414787|P2|Overall Study|subject withdrawal or lost to follow up|13
128926|NCT00524745|414788|P1|Overall Study|subject withdrawal or lost to follow up|34
128927|NCT00524771|414812|P2|Overall Study|Protocol Violation|585
128928|NCT00524771|414813|P1|Overall Study|Protocol Violation|220
128929|NCT00516737|414830|P2|Overall Study|Lack of Qualifying Event|6
128930|NCT00516737|414831|P1|Overall Study|Lack of Qualifying Event|9
128931|NCT00516737|414830|P2|Overall Study|Withdrawal by Subject|1
128932|NCT00516737|414831|P1|Overall Study|Withdrawal by Subject|0
128933|NCT00516737|414830|P2|Overall Study|Physician Decision|1
128934|NCT00516737|414831|P1|Overall Study|Physician Decision|0
128935|NCT00516737|414830|P2|Overall Study|Lost to Follow-up|0
128936|NCT00516737|414831|P1|Overall Study|Lost to Follow-up|2
128937|NCT00516893|414849|P1|Overall Study|Received Medication From Another Study|1
128938|NCT00516893|414849|P1|Overall Study|Pregnancy|1
128939|NCT00516893|414849|P1|Overall Study|Relocated|1
128940|NCT00516893|414849|P1|Overall Study|Persistent Antibodies per Protocol|6
128941|NCT00516893|414849|P1|Overall Study|Death|1
128942|NCT00516893|414849|P1|Overall Study|Noncompliance|2
128943|NCT00516893|414849|P1|Overall Study|Withdrawal by Subject|2
128944|NCT00516893|414849|P1|Overall Study|Adverse Event|3
128945|NCT00516893|414849|P1|Overall Study|Lost to Follow-up|4
128946|NCT00516906|414858|P2|Overall Study|Final Dressing Removal Data not captured|2
128947|NCT00516906|414859|P1|Overall Study|Final Dressing Removal Data not captured|6
128948|NCT00517192|414928|P2|Overall Study|Early termination of the trial|18
128949|NCT00517192|414929|P1|Overall Study|Early termination of the trial|16
128950|NCT00517192|414928|P2|Overall Study|Withdrawal by Subject|0
128951|NCT00517192|414929|P1|Overall Study|Withdrawal by Subject|1
128952|NCT00517192|414928|P2|Overall Study|Lost to Follow-up|1
128953|NCT00517192|414929|P1|Overall Study|Lost to Follow-up|1
128954|NCT00517192|414928|P2|Overall Study|Adverse Event|1
128955|NCT00517192|414929|P1|Overall Study|Adverse Event|1
128956|NCT00517296|414979|P2|Overall Study|Withdrawal by Subject|0
128957|NCT00517296|414980|P1|Overall Study|Withdrawal by Subject|1
128958|NCT00517361|414990|P1|Overall Study|The study was terminated|5
128959|NCT00517361|414990|P1|Overall Study|Death|6
128960|NCT00517413|414997|P1|Overall Study|Other-Reasons|23
128961|NCT00517413|414997|P1|Overall Study|Failure to return|1
128962|NCT00517413|414997|P1|Overall Study|Withdrawal by Subject|2
128963|NCT00517413|414997|P1|Overall Study|Protocol Violation|15
128964|NCT00517413|414997|P1|Overall Study|Death|13
128965|NCT00517413|414997|P1|Overall Study|Adverse Event|7
128966|NCT00517634|415109|P6|Second Treatment Period|Withdrawal by Subject|0
128967|NCT00517634|415110|P5|Second Treatment Period|Withdrawal by Subject|1
128968|NCT00517634|415111|P4|Second Treatment Period|Withdrawal by Subject|0
128969|NCT00517634|415112|P3|Second Treatment Period|Withdrawal by Subject|0
128970|NCT00517634|415113|P2|Second Treatment Period|Withdrawal by Subject|0
128971|NCT00517634|415114|P1|Second Treatment Period|Withdrawal by Subject|0
128972|NCT00525031|415127|P2|Overall Study|Disease Progression|1
128973|NCT00525031|415128|P1|Overall Study|Disease Progression|1
128974|NCT00525148|415147|P4|Overall Study|Other than stated|3
128975|NCT00525148|415148|P3|Overall Study|Other than stated|0
128976|NCT00525148|415149|P2|Overall Study|Other than stated|1
128977|NCT00525148|415150|P1|Overall Study|Other than stated|2
128978|NCT00525148|415147|P4|Overall Study|Refused continuation of study medication|1
128979|NCT00525148|415148|P3|Overall Study|Refused continuation of study medication|0
128980|NCT00525148|415149|P2|Overall Study|Refused continuation of study medication|2
128981|NCT00525148|415150|P1|Overall Study|Refused continuation of study medication|0
128982|NCT00525148|415147|P4|Overall Study|Progressive disease|49
128983|NCT00525148|415148|P3|Overall Study|Progressive disease|6
128984|NCT00525148|415149|P2|Overall Study|Progressive disease|30
128985|NCT00525148|415150|P1|Overall Study|Progressive disease|18
128986|NCT00525148|415147|P4|Overall Study|Other Adverse Event|8
128987|NCT00525148|415148|P3|Overall Study|Other Adverse Event|1
128988|NCT00525148|415149|P2|Overall Study|Other Adverse Event|5
128989|NCT00525148|415150|P1|Overall Study|Other Adverse Event|3
128990|NCT00525161|415168|P1|Overall Study|Adverse Event|1
128991|NCT00525265|415227|P2|Overall Study|Protocol Violation|0
128992|NCT00525265|415228|P1|Overall Study|Protocol Violation|1
128993|NCT00530023|415236|P2|Overall Study|Withdrawal by Subject|1
128994|NCT00530023|415237|P1|Overall Study|Withdrawal by Subject|0
128995|NCT00530075|415251|P1|Overall Study|Withdrawal by Subject|1
128996|NCT00530075|415251|P1|Overall Study|Protocol Violation|1
128997|NCT00530075|415251|P1|Overall Study|Lack of Efficacy|3
128998|NCT00530075|415251|P1|Overall Study|Death|1
128999|NCT00530075|415251|P1|Overall Study|Adverse Event|1
129000|NCT00530088|415262|P1|Overall Study|Other Not Specified|2
129001|NCT00530088|415262|P1|Overall Study|Physician Decision|4
129002|NCT00530088|415262|P1|Overall Study|Disease Progression|4
129003|NCT00530257|415267|P1|Overall Study|Lost to Follow-up|1
129004|NCT00530270|415297|P2|Overall Study|Protocol Violation|0
129005|NCT00530270|415298|P1|Overall Study|Protocol Violation|1
129006|NCT00530335|415312|P1|Overall Study|Physician Decision|1
129007|NCT00530335|415312|P1|Overall Study|Withdrawal by Subject|1
129008|NCT00530335|415312|P1|Overall Study|Protocol Violation|1
129009|NCT00530335|415312|P1|Overall Study|Adverse Event|3
129010|NCT00530348|415329|P2|Overall Study|Noncompliance with inclusion criterion 3|1
129011|NCT00530348|415330|P1|Overall Study|Noncompliance with inclusion criterion 3|0
129012|NCT00530348|415329|P2|Overall Study|Randomised in error|0
129013|NCT00530348|415330|P1|Overall Study|Randomised in error|1
129014|NCT00530348|415329|P2|Overall Study|Withdrawal by Subject|12
129015|NCT00530348|415330|P1|Overall Study|Withdrawal by Subject|12
129016|NCT00530348|415329|P2|Overall Study|Pregnancy|0
129017|NCT00530348|415330|P1|Overall Study|Pregnancy|1
129018|NCT00530348|415329|P2|Overall Study|Physician Decision|2
129019|NCT00530348|415330|P1|Overall Study|Physician Decision|1
129020|NCT00530348|415329|P2|Overall Study|Lost to Follow-up|2
129021|NCT00530348|415330|P1|Overall Study|Lost to Follow-up|0
129022|NCT00530348|415329|P2|Overall Study|Lack of Efficacy|0
129023|NCT00530348|415330|P1|Overall Study|Lack of Efficacy|2
129024|NCT00530348|415329|P2|Overall Study|Death|1
129025|NCT00530348|415330|P1|Overall Study|Death|0
129026|NCT00530348|415329|P2|Overall Study|Adverse Event|1
129027|NCT00530348|415330|P1|Overall Study|Adverse Event|5
129028|NCT00530439|415348|P2|Overall Study|Severe malformation/abortion|3
129029|NCT00530439|415349|P1|Overall Study|Severe malformation/abortion|0
129030|NCT00530439|415348|P2|Overall Study|Twin pregnancy|2
129031|NCT00530439|415349|P1|Overall Study|Twin pregnancy|0
129032|NCT00530439|415348|P2|Overall Study|Misclassification|0
129033|NCT00530439|415349|P1|Overall Study|Misclassification|2
129034|NCT00530439|415348|P2|Overall Study|Missed abortion|4
129035|NCT00530439|415349|P1|Overall Study|Missed abortion|1
129036|NCT00530439|415348|P2|Overall Study|Withdraw|14
129037|NCT00530439|415349|P1|Overall Study|Withdraw|18
129038|NCT00530439|415348|P2|Overall Study|GDM|3
129039|NCT00530439|415349|P1|Overall Study|GDM|9
129040|NCT00530504|415355|P1|Overall Study|Exited study due to other reasons|33
129041|NCT00530504|415355|P1|Overall Study|Withdrawal by Subject|39
129042|NCT00530504|415355|P1|Overall Study|Lost to Follow-up|26
129043|NCT00530504|415355|P1|Overall Study|Death|54
129044|NCT00530712|415363|P1|12 Month Follow-up Visit|Death|9
129045|NCT00530712|415363|P1|12 Month Follow-up Visit|Lost to Follow-up|7
129046|NCT00530712|415363|P1|12 Month Follow-up Visit|Missed Visit|3
129047|NCT00530712|415363|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
129048|NCT00530712|415363|P1|6 Month Follow-up Visit|Death|2
129049|NCT00530712|415363|P1|6 Month Follow-up Visit|Lost to Follow-up|3
129050|NCT00530712|415363|P1|6 Month Follow-up Visit|Missed Visit|3
129051|NCT00530712|415363|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
129052|NCT00530712|415363|P1|30 Day Follow-up Visit|Missed Visit|5
129053|NCT00530712|415363|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
129054|NCT00530777|415429|P2|Overall Study|Unable to adhere to visit schedule|1
129055|NCT00530777|415430|P1|Overall Study|Unable to adhere to visit schedule|5
129056|NCT00530777|415429|P2|Overall Study|Withdrawal by Subject|1
129057|NCT00530777|415430|P1|Overall Study|Withdrawal by Subject|0
129058|NCT00530777|415429|P2|Overall Study|Physician Decision|0
129059|NCT00530777|415430|P1|Overall Study|Physician Decision|1
129060|NCT00530777|415429|P2|Overall Study|Death|2
129061|NCT00530777|415430|P1|Overall Study|Death|1
129062|NCT00530777|415429|P2|Overall Study|Lost to Follow-up|1
129063|NCT00530777|415430|P1|Overall Study|Lost to Follow-up|0
129064|NCT00530790|415438|P1|Overall Study|Physician Decision|1
129065|NCT00530790|415438|P1|Overall Study|Withdrawal by Subject|2
129066|NCT00530790|415438|P1|Overall Study|Adverse Event|2
129067|NCT00530816|415461|P3|Overall Study|Withdrawal by Subject|6
129068|NCT00530816|415462|P2|Overall Study|Withdrawal by Subject|2
129069|NCT00530816|415463|P1|Overall Study|Withdrawal by Subject|1
129070|NCT00530816|415461|P3|Overall Study|Other|4
129071|NCT00530816|415462|P2|Overall Study|Other|3
129072|NCT00530816|415463|P1|Overall Study|Other|3
129073|NCT00530816|415461|P3|Overall Study|Adverse Event|7
129074|NCT00530816|415462|P2|Overall Study|Adverse Event|13
129075|NCT00530816|415463|P1|Overall Study|Adverse Event|6
129076|NCT00530816|415461|P3|Overall Study|Progressive Disease|24
129077|NCT00530816|415462|P2|Overall Study|Progressive Disease|24
129078|NCT00530816|415463|P1|Overall Study|Progressive Disease|16
129079|NCT00530842|415491|P2|Period 2|Individual different reasons|0
129080|NCT00530842|415492|P1|Period 2|Individual different reasons|2
129081|NCT00530842|415491|P2|Period 2|Withdrawal by Subject|2
129082|NCT00530842|415492|P1|Period 2|Withdrawal by Subject|1
129083|NCT00530842|415491|P2|Period 2|Protocol Violation|0
129084|NCT00530842|415492|P1|Period 2|Protocol Violation|1
129085|NCT00530842|415491|P2|Period 2|Lost to Follow-up|4
129086|NCT00530842|415492|P1|Period 2|Lost to Follow-up|0
129087|NCT00530842|415491|P2|Period 2|Lack of Efficacy|0
129088|NCT00530842|415492|P1|Period 2|Lack of Efficacy|1
129089|NCT00530842|415491|P2|Period 2|Adverse Event|3
129090|NCT00530842|415492|P1|Period 2|Adverse Event|3
129091|NCT00530842|415491|P2|Period 1|Individual different reasons|3
129092|NCT00530842|415492|P1|Period 1|Individual different reasons|2
129093|NCT00530842|415491|P2|Period 1|Withdrawal by Subject|3
129094|NCT00530842|415492|P1|Period 1|Withdrawal by Subject|2
129095|NCT00530842|415491|P2|Period 1|Protocol Violation|1
129096|NCT00530842|415492|P1|Period 1|Protocol Violation|2
129097|NCT00530842|415491|P2|Period 1|Lack of Efficacy|1
129098|NCT00530842|415492|P1|Period 1|Lack of Efficacy|1
129099|NCT00530842|415491|P2|Period 1|Adverse Event|3
129100|NCT00530842|415492|P1|Period 1|Adverse Event|7
129101|NCT00530842|415491|P2|Overall Study|Individual different reasons|3
129102|NCT00530842|415492|P1|Overall Study|Individual different reasons|4
129103|NCT00530842|415491|P2|Overall Study|Withdrawal by Subject|5
129104|NCT00530842|415492|P1|Overall Study|Withdrawal by Subject|4
129105|NCT00530842|415491|P2|Overall Study|Protocol Violation|2
129106|NCT00530842|415492|P1|Overall Study|Protocol Violation|3
129107|NCT00530842|415491|P2|Overall Study|Lost to Follow-up|4
129108|NCT00530842|415492|P1|Overall Study|Lost to Follow-up|0
129109|NCT00530842|415491|P2|Overall Study|Lack of Efficacy|1
129110|NCT00530842|415492|P1|Overall Study|Lack of Efficacy|2
129111|NCT00530842|415491|P2|Overall Study|Adverse Event|6
129112|NCT00530842|415492|P1|Overall Study|Adverse Event|10
129113|NCT00530855|415616|P1|Overall Study|Other reason for premature termination|17
129114|NCT00530855|415616|P1|Overall Study|Lost to Follow-up|9
129115|NCT00530855|415616|P1|Overall Study|Unsatisfactory compliance of subject|11
129116|NCT00530855|415616|P1|Overall Study|Protocol Violation|3
129117|NCT00530855|415616|P1|Overall Study|Non Fatal Non Serious AE|12
129118|NCT00530855|415616|P1|Overall Study|Non Fatal Serious AE|7
129119|NCT00530855|415616|P1|Overall Study|Fatal Serious AE|3
129120|NCT00530855|415616|P1|Overall Study|Withdrawal by Subject|30
129121|NCT00530855|415616|P1|Overall Study|Lack of Efficacy|20
129122|NCT00530894|415627|P4|Overall Study|Alive and censored prior to 1 year|0
129123|NCT00530894|415628|P3|Overall Study|Alive and censored prior to 1 year|0
129124|NCT00530894|415629|P2|Overall Study|Alive and censored prior to 1 year|0
129125|NCT00530894|415630|P1|Overall Study|Alive and censored prior to 1 year|2
129126|NCT00530894|415627|P4|Overall Study|Withdrawal by Subject|5
129127|NCT00530894|415628|P3|Overall Study|Withdrawal by Subject|0
129128|NCT00530894|415629|P2|Overall Study|Withdrawal by Subject|23
129129|NCT00530894|415630|P1|Overall Study|Withdrawal by Subject|1
129130|NCT00530894|415627|P4|Overall Study|Lost to Follow-up|0
129131|NCT00530894|415628|P3|Overall Study|Lost to Follow-up|0
129132|NCT00530894|415629|P2|Overall Study|Lost to Follow-up|3
129133|NCT00530894|415630|P1|Overall Study|Lost to Follow-up|1
129134|NCT00530894|415627|P4|Overall Study|Death|89
129135|NCT00530894|415628|P3|Overall Study|Death|55
129136|NCT00530894|415629|P2|Overall Study|Death|89
129137|NCT00530894|415630|P1|Overall Study|Death|84
129138|NCT00530920|415661|P3|Overall Study|Withdrawal by Subject|1
129139|NCT00530920|415662|P2|Overall Study|Withdrawal by Subject|0
129140|NCT00530920|415663|P1|Overall Study|Withdrawal by Subject|0
129141|NCT00530920|415661|P3|Overall Study|Adverse Event|3
129142|NCT00530920|415662|P2|Overall Study|Adverse Event|0
129143|NCT00530920|415663|P1|Overall Study|Adverse Event|0
129144|NCT00530920|415661|P3|Overall Study|Randomized but not treated|0
129145|NCT00530920|415662|P2|Overall Study|Randomized but not treated|2
129146|NCT00530920|415663|P1|Overall Study|Randomized but not treated|0
129147|NCT00530946|415723|P4|Overall Study|Noncompliance|0
129148|NCT00530946|415724|P3|Overall Study|Noncompliance|0
129149|NCT00530946|415725|P2|Overall Study|Noncompliance|0
129150|NCT00530946|415726|P1|Overall Study|Noncompliance|1
129151|NCT00530946|415723|P4|Overall Study|Protocol Violation|1
129152|NCT00530946|415724|P3|Overall Study|Protocol Violation|0
129153|NCT00530946|415725|P2|Overall Study|Protocol Violation|0
129154|NCT00530946|415726|P1|Overall Study|Protocol Violation|0
129155|NCT00530946|415723|P4|Overall Study|Adverse Event|1
129156|NCT00530946|415724|P3|Overall Study|Adverse Event|1
129157|NCT00530946|415725|P2|Overall Study|Adverse Event|2
129158|NCT00530946|415726|P1|Overall Study|Adverse Event|1
129159|NCT00531011|415778|P2|Overall Study|Physician Decision|3
129160|NCT00531011|415779|P1|Overall Study|Physician Decision|0
129161|NCT00531011|415778|P2|Overall Study|Lost to Follow-up|0
129162|NCT00531011|415779|P1|Overall Study|Lost to Follow-up|1
129163|NCT00531011|415778|P2|Overall Study|Death|0
129164|NCT00531011|415779|P1|Overall Study|Death|1
129165|NCT00531011|415778|P2|Overall Study|Withdrawal by Subject|4
129166|NCT00531011|415779|P1|Overall Study|Withdrawal by Subject|2
129167|NCT00531050|415827|P6|Part 2: Period 3|Abnormal test procedure|1
129168|NCT00531050|415828|P5|Part 2: Period 3|Abnormal test procedure|0
129169|NCT00531050|415829|P4|Part 2: Period 3|Abnormal test procedure|0
129170|NCT00531050|415830|P3|Part 2: Period 3|Abnormal test procedure|0
129171|NCT00531050|415831|P2|Part 2: Period 3|Abnormal test procedure|0
129172|NCT00531050|415832|P1|Part 2: Period 3|Abnormal test procedure|1
129173|NCT00531050|415827|P6|Part 2: Period 1|Adverse Event|1
129174|NCT00531050|415828|P5|Part 2: Period 1|Adverse Event|0
129175|NCT00531050|415829|P4|Part 2: Period 1|Adverse Event|0
129176|NCT00531050|415830|P3|Part 2: Period 1|Adverse Event|0
129177|NCT00531050|415831|P2|Part 2: Period 1|Adverse Event|0
129178|NCT00531050|415832|P1|Part 2: Period 1|Adverse Event|0
129179|NCT00531050|415827|P6|Part 1: Period 3|Adverse Event|0
129180|NCT00531050|415828|P5|Part 1: Period 3|Adverse Event|0
129181|NCT00531050|415829|P4|Part 1: Period 3|Adverse Event|0
129182|NCT00531050|415830|P3|Part 1: Period 3|Adverse Event|0
129183|NCT00531050|415831|P2|Part 1: Period 3|Adverse Event|0
129184|NCT00531050|415832|P1|Part 1: Period 3|Adverse Event|1
129185|NCT00531050|415827|P6|Part 1: Period 1|Protocol Deviation|0
129186|NCT00531050|415828|P5|Part 1: Period 1|Protocol Deviation|0
129187|NCT00531050|415829|P4|Part 1: Period 1|Protocol Deviation|1
129188|NCT00531050|415830|P3|Part 1: Period 1|Protocol Deviation|0
129189|NCT00531050|415831|P2|Part 1: Period 1|Protocol Deviation|0
129190|NCT00531050|415832|P1|Part 1: Period 1|Protocol Deviation|0
129191|NCT00531050|415827|P6|Part 1: Period 1|Adverse Event|0
129192|NCT00531050|415828|P5|Part 1: Period 1|Adverse Event|0
129193|NCT00531050|415829|P4|Part 1: Period 1|Adverse Event|0
129194|NCT00531050|415830|P3|Part 1: Period 1|Adverse Event|0
129195|NCT00531050|415831|P2|Part 1: Period 1|Adverse Event|1
129196|NCT00531050|415832|P1|Part 1: Period 1|Adverse Event|0
129197|NCT00531206|415859|P1|Overall Study|including non-related adverse events|8
129198|NCT00531206|415859|P1|Overall Study|Lost to Follow-up|5
129199|NCT00531206|415859|P1|Overall Study|Lack of Efficacy|2
129200|NCT00531206|415859|P1|Overall Study|Adverse Event related|5
129201|NCT00531284|415900|P17|Overall Study|Other|0
129202|NCT00531284|415901|P16|Overall Study|Other|0
129203|NCT00531284|415902|P15|Overall Study|Other|1
129204|NCT00531284|415903|P14|Overall Study|Other|0
129205|NCT00531284|415904|P13|Overall Study|Other|0
129206|NCT00531284|415905|P12|Overall Study|Other|2
129207|NCT00531284|415906|P11|Overall Study|Other|0
129208|NCT00531284|415907|P10|Overall Study|Other|1
129209|NCT00531284|415908|P9|Overall Study|Other|2
129210|NCT00531284|415909|P8|Overall Study|Other|0
129211|NCT00531284|415910|P7|Overall Study|Other|0
129212|NCT00531284|415911|P6|Overall Study|Other|1
129213|NCT00531284|415912|P5|Overall Study|Other|2
129214|NCT00531284|415913|P4|Overall Study|Other|10
129215|NCT00531284|415914|P3|Overall Study|Other|0
129216|NCT00531284|415915|P2|Overall Study|Other|0
129217|NCT00531284|415916|P1|Overall Study|Other|1
129218|NCT00531284|415900|P17|Overall Study|Withdrawal by Subject|1
129219|NCT00531284|415901|P16|Overall Study|Withdrawal by Subject|1
129220|NCT00531284|415902|P15|Overall Study|Withdrawal by Subject|0
129221|NCT00531284|415903|P14|Overall Study|Withdrawal by Subject|1
129222|NCT00531284|415904|P13|Overall Study|Withdrawal by Subject|0
129223|NCT00531284|415905|P12|Overall Study|Withdrawal by Subject|3
129224|NCT00531284|415906|P11|Overall Study|Withdrawal by Subject|0
129225|NCT00531284|415907|P10|Overall Study|Withdrawal by Subject|0
129226|NCT00531284|415908|P9|Overall Study|Withdrawal by Subject|0
129227|NCT00531284|415909|P8|Overall Study|Withdrawal by Subject|0
129228|NCT00531284|415910|P7|Overall Study|Withdrawal by Subject|0
129229|NCT00531284|415911|P6|Overall Study|Withdrawal by Subject|0
129230|NCT00531284|415912|P5|Overall Study|Withdrawal by Subject|0
129231|NCT00531284|415913|P4|Overall Study|Withdrawal by Subject|4
129232|NCT00531284|415914|P3|Overall Study|Withdrawal by Subject|0
129233|NCT00531284|415915|P2|Overall Study|Withdrawal by Subject|0
129234|NCT00531284|415916|P1|Overall Study|Withdrawal by Subject|1
129235|NCT00531284|415900|P17|Overall Study|Adverse Event|2
129236|NCT00531284|415901|P16|Overall Study|Adverse Event|0
129237|NCT00531284|415902|P15|Overall Study|Adverse Event|1
129238|NCT00531284|415903|P14|Overall Study|Adverse Event|1
129239|NCT00531284|415904|P13|Overall Study|Adverse Event|0
129240|NCT00531284|415905|P12|Overall Study|Adverse Event|5
129241|NCT00531284|415906|P11|Overall Study|Adverse Event|0
129242|NCT00531284|415907|P10|Overall Study|Adverse Event|0
129243|NCT00531284|415908|P9|Overall Study|Adverse Event|3
129244|NCT00531284|415909|P8|Overall Study|Adverse Event|2
129245|NCT00531284|415910|P7|Overall Study|Adverse Event|3
129246|NCT00531284|415911|P6|Overall Study|Adverse Event|2
129247|NCT00531284|415912|P5|Overall Study|Adverse Event|0
129248|NCT00531284|415913|P4|Overall Study|Adverse Event|7
129249|NCT00531284|415914|P3|Overall Study|Adverse Event|1
129250|NCT00531284|415915|P2|Overall Study|Adverse Event|1
129251|NCT00531284|415916|P1|Overall Study|Adverse Event|0
129252|NCT00531284|415900|P17|Overall Study|Progressive Disease|5
129253|NCT00531284|415901|P16|Overall Study|Progressive Disease|11
129254|NCT00531284|415902|P15|Overall Study|Progressive Disease|2
129255|NCT00531284|415903|P14|Overall Study|Progressive Disease|1
129256|NCT00531284|415904|P13|Overall Study|Progressive Disease|2
129257|NCT00531284|415905|P12|Overall Study|Progressive Disease|14
129258|NCT00531284|415906|P11|Overall Study|Progressive Disease|3
129259|NCT00531284|415907|P10|Overall Study|Progressive Disease|3
129260|NCT00531284|415908|P9|Overall Study|Progressive Disease|6
129261|NCT00531284|415909|P8|Overall Study|Progressive Disease|8
129262|NCT00531284|415910|P7|Overall Study|Progressive Disease|3
129263|NCT00531284|415911|P6|Overall Study|Progressive Disease|4
129264|NCT00531284|415912|P5|Overall Study|Progressive Disease|4
129265|NCT00531284|415913|P4|Overall Study|Progressive Disease|42
129266|NCT00531284|415914|P3|Overall Study|Progressive Disease|5
129267|NCT00531284|415915|P2|Overall Study|Progressive Disease|3
129268|NCT00531284|415916|P1|Overall Study|Progressive Disease|1
129269|NCT00531427|416068|P2|Overall Study|Administrative|9
129270|NCT00531427|416069|P1|Overall Study|Administrative|4
129271|NCT00531427|416068|P2|Overall Study|Lack of Efficacy|39
129272|NCT00531427|416069|P1|Overall Study|Lack of Efficacy|14
129273|NCT00531427|416068|P2|Overall Study|Lost to Follow-up|3
129274|NCT00531427|416069|P1|Overall Study|Lost to Follow-up|4
129275|NCT00531427|416068|P2|Overall Study|Adverse Event|30
129276|NCT00531427|416069|P1|Overall Study|Adverse Event|44
129277|NCT00531427|416068|P2|Overall Study|Withdrawal by Subject|13
129278|NCT00531427|416069|P1|Overall Study|Withdrawal by Subject|7
129279|NCT00531479|416093|P2|Overall Study|Did not receive treatment|3
129280|NCT00531479|416094|P1|Overall Study|Did not receive treatment|2
129281|NCT00531479|416093|P2|Overall Study|Withdrawal by Subject|6
129282|NCT00531479|416094|P1|Overall Study|Withdrawal by Subject|6
129283|NCT00531479|416093|P2|Overall Study|Unspecified|1
129284|NCT00531479|416094|P1|Overall Study|Unspecified|0
129285|NCT00531479|416093|P2|Overall Study|Lost to Follow-up|2
129286|NCT00531479|416094|P1|Overall Study|Lost to Follow-up|0
129287|NCT00531479|416093|P2|Overall Study|Death|71
129288|NCT00531479|416094|P1|Overall Study|Death|68
129289|NCT00531752|416148|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
129290|NCT00531752|416149|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
129291|NCT00531752|416150|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
129292|NCT00531752|416151|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
129293|NCT00531752|416148|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
129294|NCT00531752|416149|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
129295|NCT00531752|416150|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
129296|NCT00531752|416151|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
129297|NCT00531752|416148|P4|Second Double-blind Intervention Period|unspecified|0
129298|NCT00531752|416149|P3|Second Double-blind Intervention Period|unspecified|0
129299|NCT00531752|416150|P2|Second Double-blind Intervention Period|unspecified|1
129300|NCT00531752|416151|P1|Second Double-blind Intervention Period|unspecified|1
129301|NCT00531752|416148|P4|Second Double-blind Intervention Period|Adverse Event|0
129302|NCT00531752|416149|P3|Second Double-blind Intervention Period|Adverse Event|0
129303|NCT00531752|416150|P2|Second Double-blind Intervention Period|Adverse Event|1
129304|NCT00531752|416151|P1|Second Double-blind Intervention Period|Adverse Event|1
129305|NCT00531752|416148|P4|First Double-blind Intervention Period|Randomized but not treated|0
129306|NCT00531752|416149|P3|First Double-blind Intervention Period|Randomized but not treated|0
129307|NCT00531752|416150|P2|First Double-blind Intervention Period|Randomized but not treated|0
129308|NCT00531752|416151|P1|First Double-blind Intervention Period|Randomized but not treated|1
129309|NCT00531752|416148|P4|First Double-blind Intervention Period|Lost to Follow-up|1
129310|NCT00531752|416149|P3|First Double-blind Intervention Period|Lost to Follow-up|1
129311|NCT00531752|416150|P2|First Double-blind Intervention Period|Lost to Follow-up|0
129312|NCT00531752|416151|P1|First Double-blind Intervention Period|Lost to Follow-up|0
129313|NCT00531752|416148|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
129314|NCT00531752|416149|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
129315|NCT00531752|416150|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
129316|NCT00531752|416151|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
129317|NCT00531752|416148|P4|First Double-blind Intervention Period|unspecified|0
129318|NCT00531752|416149|P3|First Double-blind Intervention Period|unspecified|4
129319|NCT00531752|416150|P2|First Double-blind Intervention Period|unspecified|4
129320|NCT00531752|416151|P1|First Double-blind Intervention Period|unspecified|1
129321|NCT00531752|416148|P4|First Double-blind Intervention Period|Adverse Event|1
129322|NCT00531752|416149|P3|First Double-blind Intervention Period|Adverse Event|1
129323|NCT00531752|416150|P2|First Double-blind Intervention Period|Adverse Event|0
129324|NCT00531752|416151|P1|First Double-blind Intervention Period|Adverse Event|2
129325|NCT00531934|416286|P2|Overall Study|Not specified|2
129326|NCT00531934|416287|P1|Overall Study|Not specified|2
129327|NCT00531934|416286|P2|Overall Study|Withdrawal by Subject|1
129328|NCT00531934|416287|P1|Overall Study|Withdrawal by Subject|1
129329|NCT00531934|416286|P2|Overall Study|Death|10
129330|NCT00531934|416287|P1|Overall Study|Death|7
129331|NCT00531934|416286|P2|Overall Study|Progression|42
129332|NCT00531934|416287|P1|Overall Study|Progression|52
129333|NCT00531934|416286|P2|Overall Study|Adverse Event|8
129334|NCT00531934|416287|P1|Overall Study|Adverse Event|4
129335|NCT00531947|416357|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
129336|NCT00531947|416358|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
129337|NCT00531947|416357|P2|Overall Study|Non-Compliance|7
129338|NCT00531947|416358|P1|Overall Study|Non-Compliance|4
129339|NCT00531947|416357|P2|Overall Study|Protocol Violation|1
129340|NCT00531947|416358|P1|Overall Study|Protocol Violation|2
129341|NCT00531947|416357|P2|Overall Study|Withdrawal by Subject|19
129342|NCT00531947|416358|P1|Overall Study|Withdrawal by Subject|14
129343|NCT00531947|416357|P2|Overall Study|Lost to Follow-up|9
129344|NCT00531947|416358|P1|Overall Study|Lost to Follow-up|12
129345|NCT00531947|416357|P2|Overall Study|Adverse Event|10
129346|NCT00531947|416358|P1|Overall Study|Adverse Event|5
129347|NCT00531960|416402|P2|Overall Study|Not Specified|10
129348|NCT00531960|416403|P1|Overall Study|Not Specified|4
129349|NCT00531960|416402|P2|Overall Study|Refused Treatment|6
129350|NCT00531960|416403|P1|Overall Study|Refused Treatment|5
129351|NCT00531960|416402|P2|Overall Study|Violation of Selection Criteria|0
129352|NCT00531960|416403|P1|Overall Study|Violation of Selection Criteria|2
129353|NCT00531960|416402|P2|Overall Study|Lack of Efficacy|41
129354|NCT00531960|416403|P1|Overall Study|Lack of Efficacy|42
129355|NCT00531960|416402|P2|Overall Study|Death|2
129356|NCT00531960|416403|P1|Overall Study|Death|3
129357|NCT00531960|416402|P2|Overall Study|Adverse Event|4
129358|NCT00531960|416403|P1|Overall Study|Adverse Event|5
129359|NCT00532129|416419|P1|Follow-up Period|Unspecified|6
129360|NCT00532129|416419|P1|Follow-up Period|Lost to Follow-up|1
129361|NCT00532129|416419|P1|Follow-up Period|Disease progression|57
129362|NCT00532129|416419|P1|Follow-up Period|Adverse event/Serious adverse event|1
129363|NCT00532129|416419|P1|Treatment Period|Unspecified|5
129364|NCT00532129|416419|P1|Treatment Period|Protocol Violation|1
129365|NCT00532129|416419|P1|Treatment Period|Disease progression|3
129366|NCT00532129|416419|P1|Treatment Period|Physician Decision|15
129367|NCT00532129|416419|P1|Treatment Period|Adverse event/Serious adverse event|25
129368|NCT00532155|416439|P2|Overall Study|Did not receive study medication|6
129369|NCT00532155|416440|P1|Overall Study|Did not receive study medication|2
129370|NCT00532155|416439|P2|Overall Study|Study termination stop further treatment|0
129371|NCT00532155|416440|P1|Overall Study|Study termination stop further treatment|4
129372|NCT00532155|416439|P2|Overall Study|Study terminated by sponsor|0
129373|NCT00532155|416440|P1|Overall Study|Study terminated by sponsor|1
129374|NCT00532155|416439|P2|Overall Study|Study stopped|0
129375|NCT00532155|416440|P1|Overall Study|Study stopped|1
129376|NCT00532155|416439|P2|Overall Study|Had brain metastasis, was mis-randomized|0
129377|NCT00532155|416440|P1|Overall Study|Had brain metastasis, was mis-randomized|1
129378|NCT00532155|416439|P2|Overall Study|Progressive disease (by incorrect scan)|1
129379|NCT00532155|416440|P1|Overall Study|Progressive disease (by incorrect scan)|0
129380|NCT00532155|416439|P2|Overall Study|Promotor ended study|0
129381|NCT00532155|416440|P1|Overall Study|Promotor ended study|1
129382|NCT00532155|416439|P2|Overall Study|Occurence of a secondary cancer|1
129383|NCT00532155|416440|P1|Overall Study|Occurence of a secondary cancer|0
129384|NCT00532155|416439|P2|Overall Study|Occurence of a second cancer|1
129385|NCT00532155|416440|P1|Overall Study|Occurence of a second cancer|0
129386|NCT00532155|416439|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
129387|NCT00532155|416440|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
129388|NCT00532155|416439|P2|Overall Study|Moved|0
129389|NCT00532155|416440|P1|Overall Study|Moved|1
129390|NCT00532155|416439|P2|Overall Study|Consent withdrawn|7
129391|NCT00532155|416440|P1|Overall Study|Consent withdrawn|5
129392|NCT00532155|416439|P2|Overall Study|Withdrawal by Subject|44
129393|NCT00532155|416440|P1|Overall Study|Withdrawal by Subject|23
129394|NCT00532155|416439|P2|Overall Study|Physician Decision|15
129395|NCT00532155|416440|P1|Overall Study|Physician Decision|16
129396|NCT00532155|416439|P2|Overall Study|Lost to Follow-up|0
129397|NCT00532155|416440|P1|Overall Study|Lost to Follow-up|2
129398|NCT00532155|416439|P2|Overall Study|Protocol Violation|3
129399|NCT00532155|416440|P1|Overall Study|Protocol Violation|1
129400|NCT00532155|416439|P2|Overall Study|Lack of Efficacy|255
129401|NCT00532155|416440|P1|Overall Study|Lack of Efficacy|332
129402|NCT00532155|416439|P2|Overall Study|Adverse Event|123
129403|NCT00532155|416440|P1|Overall Study|Adverse Event|66
129404|NCT00532259|416454|P1|Overall Study|Protocol Violation|1
129405|NCT00532259|416454|P1|Overall Study|Physician Decision|3
129406|NCT00532259|416454|P1|Overall Study|Lost to Follow-up|3
129407|NCT00532259|416454|P1|Overall Study|Lack of Efficacy|21
129408|NCT00532259|416454|P1|Overall Study|Death|1
129409|NCT00532259|416454|P1|Overall Study|Adverse Event|1
129410|NCT00532259|416454|P1|Overall Study|Withdrawal by Subject|2
129411|NCT00532298|416465|P6|Overall Study|Lost to Follow-up|1
129412|NCT00532298|416466|P5|Overall Study|Lost to Follow-up|0
129413|NCT00532298|416467|P4|Overall Study|Lost to Follow-up|0
129414|NCT00532298|416468|P3|Overall Study|Lost to Follow-up|1
129415|NCT00532298|416469|P2|Overall Study|Lost to Follow-up|1
129416|NCT00532298|416470|P1|Overall Study|Lost to Follow-up|1
129417|NCT00532298|416465|P6|Overall Study|Adverse Event|1
129418|NCT00532298|416466|P5|Overall Study|Adverse Event|1
129419|NCT00532298|416467|P4|Overall Study|Adverse Event|0
129420|NCT00532298|416468|P3|Overall Study|Adverse Event|0
129421|NCT00532298|416469|P2|Overall Study|Adverse Event|0
129422|NCT00532298|416470|P1|Overall Study|Adverse Event|1
129423|NCT00532441|416550|P2|Overall Study|Death|0
129424|NCT00532441|416551|P1|Overall Study|Death|1
129425|NCT00532493|416566|P2|Overall Study|Contraindicative Medication|0
129426|NCT00532493|416567|P1|Overall Study|Contraindicative Medication|1
129427|NCT00532493|416566|P2|Overall Study|Subject Moved Away|1
129428|NCT00532493|416567|P1|Overall Study|Subject Moved Away|3
129429|NCT00532493|416566|P2|Overall Study|Protocol Deviation|0
129430|NCT00532493|416567|P1|Overall Study|Protocol Deviation|1
129431|NCT00532493|416566|P2|Overall Study|Adverse Event|5
129432|NCT00532493|416567|P1|Overall Study|Adverse Event|6
129433|NCT00532493|416566|P2|Overall Study|Physician Decision|6
129434|NCT00532493|416567|P1|Overall Study|Physician Decision|1
129435|NCT00532493|416566|P2|Overall Study|Withdrawal by Subject|9
129436|NCT00532493|416567|P1|Overall Study|Withdrawal by Subject|7
129437|NCT00532493|416566|P2|Overall Study|Lost to Follow-up|7
129438|NCT00532493|416567|P1|Overall Study|Lost to Follow-up|10
129439|NCT00532493|416566|P2|Overall Study|Death|1
129440|NCT00532493|416567|P1|Overall Study|Death|1
129441|NCT00520546|416597|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
129442|NCT00520546|416597|P1|Overall Study|Withdrawal by Subject|1
129443|NCT00520572|416618|P6|Overall Study|Did not receive Treatment|0
129444|NCT00520572|416619|P5|Overall Study|Did not receive Treatment|0
129445|NCT00520572|416620|P4|Overall Study|Did not receive Treatment|0
129446|NCT00520572|416621|P3|Overall Study|Did not receive Treatment|1
129447|NCT00520572|416622|P2|Overall Study|Did not receive Treatment|0
129448|NCT00520572|416623|P1|Overall Study|Did not receive Treatment|1
129449|NCT00520572|416618|P6|Overall Study|Long break in taking Medication|0
129450|NCT00520572|416619|P5|Overall Study|Long break in taking Medication|0
129451|NCT00520572|416620|P4|Overall Study|Long break in taking Medication|1
129452|NCT00520572|416621|P3|Overall Study|Long break in taking Medication|0
129453|NCT00520572|416622|P2|Overall Study|Long break in taking Medication|0
129454|NCT00520572|416623|P1|Overall Study|Long break in taking Medication|0
129455|NCT00520572|416618|P6|Overall Study|Oral corticotherapy for acute urticaria|0
129456|NCT00520572|416619|P5|Overall Study|Oral corticotherapy for acute urticaria|0
129457|NCT00520572|416620|P4|Overall Study|Oral corticotherapy for acute urticaria|0
129458|NCT00520572|416621|P3|Overall Study|Oral corticotherapy for acute urticaria|0
129459|NCT00520572|416622|P2|Overall Study|Oral corticotherapy for acute urticaria|1
129460|NCT00520572|416623|P1|Overall Study|Oral corticotherapy for acute urticaria|0
129461|NCT00520572|416618|P6|Overall Study|Incorrect enrollment|0
129462|NCT00520572|416619|P5|Overall Study|Incorrect enrollment|1
129463|NCT00520572|416620|P4|Overall Study|Incorrect enrollment|0
129464|NCT00520572|416621|P3|Overall Study|Incorrect enrollment|1
129465|NCT00520572|416622|P2|Overall Study|Incorrect enrollment|0
129466|NCT00520572|416623|P1|Overall Study|Incorrect enrollment|1
129467|NCT00520572|416618|P6|Overall Study|Lost to Follow-up|0
129468|NCT00520572|416619|P5|Overall Study|Lost to Follow-up|1
129469|NCT00520572|416620|P4|Overall Study|Lost to Follow-up|0
129470|NCT00520572|416621|P3|Overall Study|Lost to Follow-up|0
129471|NCT00520572|416622|P2|Overall Study|Lost to Follow-up|0
129472|NCT00520572|416623|P1|Overall Study|Lost to Follow-up|0
129473|NCT00520572|416618|P6|Overall Study|Lack of Efficacy|0
129474|NCT00520572|416619|P5|Overall Study|Lack of Efficacy|1
129475|NCT00520572|416620|P4|Overall Study|Lack of Efficacy|2
129476|NCT00520572|416621|P3|Overall Study|Lack of Efficacy|1
129477|NCT00520572|416622|P2|Overall Study|Lack of Efficacy|1
129478|NCT00520572|416623|P1|Overall Study|Lack of Efficacy|1
129479|NCT00520572|416618|P6|Overall Study|Protocol Violation|0
129480|NCT00520572|416619|P5|Overall Study|Protocol Violation|0
129481|NCT00520572|416620|P4|Overall Study|Protocol Violation|0
129482|NCT00520572|416621|P3|Overall Study|Protocol Violation|1
129483|NCT00520572|416622|P2|Overall Study|Protocol Violation|0
129484|NCT00520572|416623|P1|Overall Study|Protocol Violation|0
129485|NCT00520572|416618|P6|Overall Study|Withdrawal by Subject|0
129486|NCT00520572|416619|P5|Overall Study|Withdrawal by Subject|2
129487|NCT00520572|416620|P4|Overall Study|Withdrawal by Subject|2
129488|NCT00520572|416621|P3|Overall Study|Withdrawal by Subject|5
129489|NCT00520572|416622|P2|Overall Study|Withdrawal by Subject|9
129490|NCT00520572|416623|P1|Overall Study|Withdrawal by Subject|0
129491|NCT00520572|416618|P6|Overall Study|Adverse Event|2
129492|NCT00520572|416619|P5|Overall Study|Adverse Event|7
129493|NCT00520572|416620|P4|Overall Study|Adverse Event|9
129494|NCT00520572|416621|P3|Overall Study|Adverse Event|6
129495|NCT00520572|416622|P2|Overall Study|Adverse Event|3
129496|NCT00520572|416623|P1|Overall Study|Adverse Event|9
129497|NCT00520676|416663|P2|Overall Study|Withdrawal by Subject|11
129498|NCT00520676|416664|P1|Overall Study|Withdrawal by Subject|7
129499|NCT00520676|416663|P2|Overall Study|Physician Decision|1
129500|NCT00520676|416664|P1|Overall Study|Physician Decision|4
129501|NCT00520676|416663|P2|Overall Study|Lost to Follow-up|10
129502|NCT00520676|416664|P1|Overall Study|Lost to Follow-up|6
129503|NCT00520676|416663|P2|Overall Study|Death|81
129504|NCT00520676|416664|P1|Overall Study|Death|84
129505|NCT00520741|416686|P2|Overall Study|Other reasons for premature termination|6
129506|NCT00520741|416687|P1|Overall Study|Other reasons for premature termination|0
129507|NCT00520741|416686|P2|Overall Study|Lost to Follow-up|4
129508|NCT00520741|416687|P1|Overall Study|Lost to Follow-up|4
129509|NCT00520741|416686|P2|Overall Study|Unsatisfactory compliance of subject|3
129510|NCT00520741|416687|P1|Overall Study|Unsatisfactory compliance of subject|4
129511|NCT00520741|416686|P2|Overall Study|Protocol Violation|15
129512|NCT00520741|416687|P1|Overall Study|Protocol Violation|2
129513|NCT00520741|416686|P2|Overall Study|Withdrawal by Subject|11
129514|NCT00520741|416687|P1|Overall Study|Withdrawal by Subject|0
129515|NCT00520741|416686|P2|Overall Study|Lack of Efficacy|30
129516|NCT00520741|416687|P1|Overall Study|Lack of Efficacy|11
129517|NCT00520741|416686|P2|Overall Study|Adverse Event|56
129518|NCT00520741|416687|P1|Overall Study|Adverse Event|16
129519|NCT00520767|416703|P1|Overall Study|Death|2
129520|NCT00520845|416707|P1|Overall Study|Alternative Therapy|1
129521|NCT00520845|416707|P1|Overall Study|Withdrawal by Subject|1
129522|NCT00520845|416707|P1|Overall Study|Disease Progression, relapse|13
129523|NCT00520845|416707|P1|Overall Study|Adverse Event|4
129524|NCT00520845|416707|P1|Overall Study|Death|3
129525|NCT00520936|416723|P8|Overall Study|Protocol Violation|0
129526|NCT00520936|416724|P7|Overall Study|Protocol Violation|1
129527|NCT00520936|416725|P6|Overall Study|Protocol Violation|0
129528|NCT00520936|416726|P5|Overall Study|Protocol Violation|1
129529|NCT00520936|416727|P4|Overall Study|Protocol Violation|0
129530|NCT00520936|416728|P3|Overall Study|Protocol Violation|1
129531|NCT00520936|416729|P2|Overall Study|Protocol Violation|1
129532|NCT00520936|416730|P1|Overall Study|Protocol Violation|0
129533|NCT00520936|416723|P8|Overall Study|Death|0
129534|NCT00520936|416724|P7|Overall Study|Death|1
129535|NCT00520936|416725|P6|Overall Study|Death|0
129536|NCT00520936|416726|P5|Overall Study|Death|0
129537|NCT00520936|416727|P4|Overall Study|Death|0
129538|NCT00520936|416728|P3|Overall Study|Death|0
129539|NCT00520936|416729|P2|Overall Study|Death|0
129540|NCT00520936|416730|P1|Overall Study|Death|0
129541|NCT00520936|416723|P8|Overall Study|Toxicity Requiring Removal from Study|0
129542|NCT00520936|416724|P7|Overall Study|Toxicity Requiring Removal from Study|2
129543|NCT00520936|416725|P6|Overall Study|Toxicity Requiring Removal from Study|0
129544|NCT00520936|416726|P5|Overall Study|Toxicity Requiring Removal from Study|0
129545|NCT00520936|416727|P4|Overall Study|Toxicity Requiring Removal from Study|0
129546|NCT00520936|416728|P3|Overall Study|Toxicity Requiring Removal from Study|0
129547|NCT00520936|416729|P2|Overall Study|Toxicity Requiring Removal from Study|1
129548|NCT00520936|416730|P1|Overall Study|Toxicity Requiring Removal from Study|0
129549|NCT00520936|416723|P8|Overall Study|Withdrawal by Subject|1
129550|NCT00520936|416724|P7|Overall Study|Withdrawal by Subject|0
129551|NCT00520936|416725|P6|Overall Study|Withdrawal by Subject|0
129552|NCT00520936|416726|P5|Overall Study|Withdrawal by Subject|0
129553|NCT00520936|416727|P4|Overall Study|Withdrawal by Subject|0
129554|NCT00520936|416728|P3|Overall Study|Withdrawal by Subject|0
129555|NCT00520936|416729|P2|Overall Study|Withdrawal by Subject|0
129556|NCT00520936|416730|P1|Overall Study|Withdrawal by Subject|0
129557|NCT00520936|416723|P8|Overall Study|Physician Decision|0
129558|NCT00520936|416724|P7|Overall Study|Physician Decision|0
129559|NCT00520936|416725|P6|Overall Study|Physician Decision|0
129560|NCT00520936|416726|P5|Overall Study|Physician Decision|0
129561|NCT00520936|416727|P4|Overall Study|Physician Decision|0
129562|NCT00520936|416728|P3|Overall Study|Physician Decision|1
129563|NCT00520936|416729|P2|Overall Study|Physician Decision|2
129564|NCT00520936|416730|P1|Overall Study|Physician Decision|0
129565|NCT00520975|416759|P2|Overall Study|Not start protocol therapy|2
129566|NCT00520975|416760|P1|Overall Study|Not start protocol therapy|1
129567|NCT00520975|416759|P2|Overall Study|Other reasons|2
129568|NCT00520975|416760|P1|Overall Study|Other reasons|4
129569|NCT00520975|416759|P2|Overall Study|Other therapy|4
129570|NCT00520975|416760|P1|Overall Study|Other therapy|2
129571|NCT00520975|416759|P2|Overall Study|Withdrawal by Subject|5
129572|NCT00520975|416760|P1|Overall Study|Withdrawal by Subject|3
129573|NCT00520975|416759|P2|Overall Study|Death|2
129574|NCT00520975|416760|P1|Overall Study|Death|0
129575|NCT00520975|416759|P2|Overall Study|Adverse Event|10
129576|NCT00520975|416760|P1|Overall Study|Adverse Event|7
129577|NCT00520975|416759|P2|Overall Study|Disease progression|23
129578|NCT00520975|416760|P1|Overall Study|Disease progression|31
129579|NCT00521001|416784|P1|Overall Study|Ineligible|1
129580|NCT00521014|416791|P1|Overall Study|Inevaluable, not treated|1
129581|NCT00521053|416795|P1|Observation Phase|Physician Decision|1
129582|NCT00521053|416795|P1|Observation Phase|Other non-study melanoma treatment|1
129583|NCT00521053|416795|P1|Observation Phase|Adverse Event|1
129584|NCT00521053|416795|P1|Observation Phase|Death|2
129585|NCT00521053|416795|P1|Observation Phase|Additional PV-10 via alternate protocol|8
129586|NCT00521053|416795|P1|Observation Phase|Disease Progression|55
129587|NCT00521079|416807|P2|Overall Study|Withdrawal by Subject|3
129588|NCT00521079|416808|P1|Overall Study|Withdrawal by Subject|5
129589|NCT00521079|416807|P2|Overall Study|Lost to Follow-up|1
129590|NCT00521079|416808|P1|Overall Study|Lost to Follow-up|2
129591|NCT00521079|416807|P2|Overall Study|Adverse Event|1
129592|NCT00521079|416808|P1|Overall Study|Adverse Event|7
129593|NCT00521144|416823|P5|Overall Study|Progressive Disease|6
129594|NCT00521144|416824|P4|Overall Study|Progressive Disease|0
129595|NCT00521144|416825|P3|Overall Study|Progressive Disease|2
129596|NCT00521144|416826|P2|Overall Study|Progressive Disease|2
129597|NCT00521144|416827|P1|Overall Study|Progressive Disease|4
129598|NCT00521144|416823|P5|Overall Study|Adverse Event|1
129599|NCT00521144|416824|P4|Overall Study|Adverse Event|0
129600|NCT00521144|416825|P3|Overall Study|Adverse Event|0
129601|NCT00521144|416826|P2|Overall Study|Adverse Event|1
129602|NCT00521144|416827|P1|Overall Study|Adverse Event|0
129603|NCT00521144|416823|P5|Overall Study|Not Treated|0
129604|NCT00521144|416824|P4|Overall Study|Not Treated|1
129605|NCT00521144|416825|P3|Overall Study|Not Treated|0
129606|NCT00521144|416826|P2|Overall Study|Not Treated|0
129607|NCT00521144|416827|P1|Overall Study|Not Treated|0
129608|NCT00521339|416839|P3|Treatment Extension Phase|Death|1
129609|NCT00521339|416840|P2|Treatment Extension Phase|Death|0
129610|NCT00521339|416841|P1|Treatment Extension Phase|Death|0
129611|NCT00521339|416839|P3|Treatment Extension Phase|Withdrawal by Subject|2
129612|NCT00521339|416840|P2|Treatment Extension Phase|Withdrawal by Subject|0
129613|NCT00521339|416841|P1|Treatment Extension Phase|Withdrawal by Subject|0
129614|NCT00521339|416839|P3|Treatment Phase|Protocol Violation|0
129615|NCT00521339|416840|P2|Treatment Phase|Protocol Violation|0
129616|NCT00521339|416841|P1|Treatment Phase|Protocol Violation|1
129617|NCT00521339|416839|P3|Treatment Phase|Lost to Follow-up|0
129618|NCT00521339|416840|P2|Treatment Phase|Lost to Follow-up|0
129619|NCT00521339|416841|P1|Treatment Phase|Lost to Follow-up|1
129620|NCT00521339|416839|P3|Treatment Phase|Withdrawal by Subject|0
129621|NCT00521339|416840|P2|Treatment Phase|Withdrawal by Subject|0
129622|NCT00521339|416841|P1|Treatment Phase|Withdrawal by Subject|3
129623|NCT00521339|416839|P3|Treatment Phase|Lack of Efficacy|0
129624|NCT00521339|416840|P2|Treatment Phase|Lack of Efficacy|0
129625|NCT00521339|416841|P1|Treatment Phase|Lack of Efficacy|3
129626|NCT00521339|416839|P3|Treatment Phase|Intolerability to study drug|0
129627|NCT00521339|416840|P2|Treatment Phase|Intolerability to study drug|0
129628|NCT00521339|416841|P1|Treatment Phase|Intolerability to study drug|2
129629|NCT00521339|416839|P3|Treatment Phase|Adverse Event|0
129630|NCT00521339|416840|P2|Treatment Phase|Adverse Event|0
129631|NCT00521339|416841|P1|Treatment Phase|Adverse Event|2
129632|NCT00521365|416917|P1|Overall Study|Usage of not allowed drugs|6
129633|NCT00521365|416917|P1|Overall Study|Drug compliance|3
129634|NCT00521365|416917|P1|Overall Study|Protocol deviation|2
129635|NCT00521365|416917|P1|Overall Study|Lost to Follow-up|6
129636|NCT00521365|416917|P1|Overall Study|Adverse Event|3
129637|NCT00521586|416951|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
129638|NCT00521586|416952|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
129639|NCT00521586|416951|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
129640|NCT00521586|416952|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
129641|NCT00521586|416951|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
129642|NCT00521586|416952|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
129643|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
129644|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
129645|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
129646|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
129647|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|26
129648|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|unspecified|22
129649|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
129650|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
129651|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
129652|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
129653|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
129654|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
129655|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
129656|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
129657|NCT00521586|416951|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
129658|NCT00521586|416952|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
129659|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Failed to return|1
129660|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Failed to return|0
129661|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Death|0
129662|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Death|1
129663|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Adverse Event|1
129664|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Adverse Event|0
129665|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Investigator request|0
129666|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Investigator request|2
129667|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Other, unspecified|1
129668|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Other, unspecified|3
129669|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Protocol Violation|5
129670|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Protocol Violation|2
129671|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
129672|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
129673|NCT00521586|416951|P2|Initial Vaccination (Year 0)|Subject request|11
129674|NCT00521586|416952|P1|Initial Vaccination (Year 0)|Subject request|8
129675|NCT00521599|417013|P3|Overall Study|Did not meet protocol eligibility|1
129676|NCT00521599|417014|P2|Overall Study|Did not meet protocol eligibility|2
129677|NCT00521599|417015|P1|Overall Study|Did not meet protocol eligibility|2
129678|NCT00521599|417013|P3|Overall Study|Protocol Violation|2
129679|NCT00521599|417014|P2|Overall Study|Protocol Violation|4
129680|NCT00521599|417015|P1|Overall Study|Protocol Violation|2
129681|NCT00521599|417013|P3|Overall Study|Withdrawal by subject treatment related|2
129682|NCT00521599|417014|P2|Overall Study|Withdrawal by subject treatment related|1
129683|NCT00521599|417015|P1|Overall Study|Withdrawal by subject treatment related|3
129684|NCT00521599|417013|P3|Overall Study|Withdrawal by Subject|1
129685|NCT00521599|417014|P2|Overall Study|Withdrawal by Subject|5
129686|NCT00521599|417015|P1|Overall Study|Withdrawal by Subject|3
129687|NCT00521599|417013|P3|Overall Study|Lost to Follow-up|2
129688|NCT00521599|417014|P2|Overall Study|Lost to Follow-up|1
129689|NCT00521599|417015|P1|Overall Study|Lost to Follow-up|2
129690|NCT00521599|417013|P3|Overall Study|Treatment Failure|22
129691|NCT00521599|417014|P2|Overall Study|Treatment Failure|9
129692|NCT00521599|417015|P1|Overall Study|Treatment Failure|8
129693|NCT00521599|417013|P3|Overall Study|Adverse Event|6
129694|NCT00521599|417014|P2|Overall Study|Adverse Event|7
129695|NCT00521599|417015|P1|Overall Study|Adverse Event|5
129696|NCT00522041|417061|P2|Overall Study|Did not receive treatment|1
129697|NCT00522041|417062|P1|Overall Study|Did not receive treatment|0
129698|NCT00522041|417061|P2|Overall Study|Voluntary withdrawal|4
129699|NCT00522041|417062|P1|Overall Study|Voluntary withdrawal|5
129700|NCT00522041|417061|P2|Overall Study|Lost to Follow-up|4
129701|NCT00522041|417062|P1|Overall Study|Lost to Follow-up|1
129702|NCT00522041|417061|P2|Overall Study|Protocol Violation|0
129703|NCT00522041|417062|P1|Overall Study|Protocol Violation|2
129704|NCT00522041|417061|P2|Overall Study|Adverse Event|3
129705|NCT00522041|417062|P1|Overall Study|Adverse Event|9
129706|NCT00522275|417083|P1|Overall Study|Other: Subject had surgery for epilepsy|2
129707|NCT00522275|417083|P1|Overall Study|Other: Subject ran out of medication|1
129708|NCT00522275|417083|P1|Overall Study|Other: Sponsor request|2
129709|NCT00522275|417083|P1|Overall Study|Other: Travel to / from site difficulty|3
129710|NCT00522275|417083|P1|Overall Study|Other: Site / clinic closed|4
129711|NCT00522275|417083|P1|Overall Study|Other: Subject arrested|1
129712|NCT00522275|417083|P1|Overall Study|Other: Subject relocated|2
129713|NCT00522275|417083|P1|Overall Study|Other: Subject is pregnant|2
129714|NCT00522275|417083|P1|Overall Study|Other: Subject wants to become pregnant|2
129715|NCT00522275|417083|P1|Overall Study|Lost to Follow-up|8
129716|NCT00522275|417083|P1|Overall Study|Unsatisfactory compliance|11
129717|NCT00522275|417083|P1|Overall Study|Protocol deviation|1
129718|NCT00522275|417083|P1|Overall Study|Subject withdrew consent|16
129719|NCT00522275|417083|P1|Overall Study|Lack of Efficacy|80
129720|NCT00522275|417083|P1|Overall Study|Adverse Event|35
129721|NCT00522301|417091|P1|Overall Study|Adverse Event|5
129722|NCT00522301|417091|P1|Overall Study|Withdrawal by Subject|1
129723|NCT00522379|417100|P5|Overall Study|Subject Withdrawal|0
129724|NCT00522379|417101|P4|Overall Study|Subject Withdrawal|1
129725|NCT00522379|417102|P3|Overall Study|Subject Withdrawal|0
129726|NCT00522379|417103|P2|Overall Study|Subject Withdrawal|0
129727|NCT00522379|417104|P1|Overall Study|Subject Withdrawal|0
129728|NCT00522379|417100|P5|Overall Study|Site Closed|0
129729|NCT00522379|417101|P4|Overall Study|Site Closed|1
129730|NCT00522379|417102|P3|Overall Study|Site Closed|0
129731|NCT00522379|417103|P2|Overall Study|Site Closed|0
129732|NCT00522379|417104|P1|Overall Study|Site Closed|0
129733|NCT00522379|417100|P5|Overall Study|Family Problem|0
129734|NCT00522379|417101|P4|Overall Study|Family Problem|0
129735|NCT00522379|417102|P3|Overall Study|Family Problem|1
129736|NCT00522379|417103|P2|Overall Study|Family Problem|0
129737|NCT00522379|417104|P1|Overall Study|Family Problem|0
129738|NCT00522379|417100|P5|Overall Study|Sponsor Request|0
129739|NCT00522379|417101|P4|Overall Study|Sponsor Request|0
129740|NCT00522379|417102|P3|Overall Study|Sponsor Request|0
129741|NCT00522379|417103|P2|Overall Study|Sponsor Request|1
129742|NCT00522379|417104|P1|Overall Study|Sponsor Request|0
129743|NCT00522379|417100|P5|Overall Study|Subject Moved|0
129744|NCT00522379|417101|P4|Overall Study|Subject Moved|0
129745|NCT00522379|417102|P3|Overall Study|Subject Moved|0
129746|NCT00522379|417103|P2|Overall Study|Subject Moved|1
129747|NCT00522379|417104|P1|Overall Study|Subject Moved|1
129748|NCT00522379|417100|P5|Overall Study|Dispensing error|0
129749|NCT00522379|417101|P4|Overall Study|Dispensing error|1
129750|NCT00522379|417102|P3|Overall Study|Dispensing error|0
129751|NCT00522379|417103|P2|Overall Study|Dispensing error|0
129752|NCT00522379|417104|P1|Overall Study|Dispensing error|1
129753|NCT00522379|417100|P5|Overall Study|Randomization error|1
129754|NCT00522379|417101|P4|Overall Study|Randomization error|0
129755|NCT00522379|417102|P3|Overall Study|Randomization error|0
129756|NCT00522379|417103|P2|Overall Study|Randomization error|0
129757|NCT00522379|417104|P1|Overall Study|Randomization error|0
129758|NCT00522379|417100|P5|Overall Study|Lost to Follow-up|2
129759|NCT00522379|417101|P4|Overall Study|Lost to Follow-up|2
129760|NCT00522379|417102|P3|Overall Study|Lost to Follow-up|4
129761|NCT00522379|417103|P2|Overall Study|Lost to Follow-up|0
129762|NCT00522379|417104|P1|Overall Study|Lost to Follow-up|1
129763|NCT00522379|417100|P5|Overall Study|Unsatisfactory Subject Compliance|0
129764|NCT00522379|417101|P4|Overall Study|Unsatisfactory Subject Compliance|0
129765|NCT00522379|417102|P3|Overall Study|Unsatisfactory Subject Compliance|0
129766|NCT00522379|417103|P2|Overall Study|Unsatisfactory Subject Compliance|2
129767|NCT00522379|417104|P1|Overall Study|Unsatisfactory Subject Compliance|1
129768|NCT00522379|417100|P5|Overall Study|Protocol Violation|0
129769|NCT00522379|417101|P4|Overall Study|Protocol Violation|0
129770|NCT00522379|417102|P3|Overall Study|Protocol Violation|2
129771|NCT00522379|417103|P2|Overall Study|Protocol Violation|1
129772|NCT00522379|417104|P1|Overall Study|Protocol Violation|1
129773|NCT00522379|417100|P5|Overall Study|Withdrawal by Subject|0
129774|NCT00522379|417101|P4|Overall Study|Withdrawal by Subject|2
129775|NCT00522379|417102|P3|Overall Study|Withdrawal by Subject|1
129776|NCT00522379|417103|P2|Overall Study|Withdrawal by Subject|3
129777|NCT00522379|417104|P1|Overall Study|Withdrawal by Subject|2
129778|NCT00522379|417100|P5|Overall Study|Lack of Efficacy|7
129779|NCT00522379|417101|P4|Overall Study|Lack of Efficacy|2
129780|NCT00522379|417102|P3|Overall Study|Lack of Efficacy|2
129781|NCT00522379|417103|P2|Overall Study|Lack of Efficacy|0
129782|NCT00522379|417104|P1|Overall Study|Lack of Efficacy|3
129783|NCT00522379|417100|P5|Overall Study|Adverse Event|17
129784|NCT00522379|417101|P4|Overall Study|Adverse Event|5
129785|NCT00522379|417102|P3|Overall Study|Adverse Event|12
129786|NCT00522379|417103|P2|Overall Study|Adverse Event|15
129787|NCT00522379|417104|P1|Overall Study|Adverse Event|12
129788|NCT00522392|417208|P2|Overall Study|Non-compliance|1
129789|NCT00522392|417209|P1|Overall Study|Non-compliance|0
129790|NCT00522392|417208|P2|Overall Study|Physician Decision|1
129791|NCT00522392|417209|P1|Overall Study|Physician Decision|0
129792|NCT00522392|417208|P2|Overall Study|Withdrawal by Subject|1
129793|NCT00522392|417209|P1|Overall Study|Withdrawal by Subject|1
129794|NCT00522392|417208|P2|Overall Study|Adverse Event|7
129795|NCT00522392|417209|P1|Overall Study|Adverse Event|7
129796|NCT00522392|417208|P2|Overall Study|Disease progression|3
129797|NCT00522392|417209|P1|Overall Study|Disease progression|0
129798|NCT00522418|417223|P2|Overall Study|Lack of Efficacy|1
129799|NCT00522418|417224|P1|Overall Study|Lack of Efficacy|0
129800|NCT00522418|417223|P2|Overall Study|Consent Withdraw|2
129801|NCT00522418|417224|P1|Overall Study|Consent Withdraw|1
129802|NCT00522418|417223|P2|Overall Study|Reason Not Specified|1
129803|NCT00522418|417224|P1|Overall Study|Reason Not Specified|3
129804|NCT00522418|417223|P2|Overall Study|Noncompliance|2
129805|NCT00522418|417224|P1|Overall Study|Noncompliance|2
129806|NCT00522418|417223|P2|Overall Study|Early Study Termination|47
129807|NCT00522418|417224|P1|Overall Study|Early Study Termination|46
129808|NCT00522418|417223|P2|Overall Study|Local IRB Consent Violation|5
129809|NCT00522418|417224|P1|Overall Study|Local IRB Consent Violation|5
129810|NCT00522431|417270|P1|Overall Study|Other/unknown|1
129811|NCT00522431|417270|P1|Overall Study|Subject non-compliance|1
129812|NCT00522431|417270|P1|Overall Study|Withdrawal by Subject|2
129813|NCT00522431|417270|P1|Overall Study|Protocol Violation|2
129814|NCT00522431|417270|P1|Overall Study|Adverse Event|5
129815|NCT00532779|417278|P3|Overall Study|Drug noncompliance, moved, other|29
129816|NCT00532779|417279|P2|Overall Study|Drug noncompliance, moved, other|23
129817|NCT00532779|417280|P1|Overall Study|Drug noncompliance, moved, other|14
129818|NCT00532779|417278|P3|Overall Study|Death|0
129819|NCT00532779|417279|P2|Overall Study|Death|1
129820|NCT00532779|417280|P1|Overall Study|Death|0
129821|NCT00532779|417278|P3|Overall Study|Pregnancy|3
129822|NCT00532779|417279|P2|Overall Study|Pregnancy|5
129823|NCT00532779|417280|P1|Overall Study|Pregnancy|2
129824|NCT00532779|417278|P3|Overall Study|Protocol Violation|7
129825|NCT00532779|417279|P2|Overall Study|Protocol Violation|9
129826|NCT00532779|417280|P1|Overall Study|Protocol Violation|5
129827|NCT00532779|417278|P3|Overall Study|Lack of Efficacy|40
129828|NCT00532779|417279|P2|Overall Study|Lack of Efficacy|12
129829|NCT00532779|417280|P1|Overall Study|Lack of Efficacy|12
129830|NCT00532779|417278|P3|Overall Study|Withdrawal by Subject|90
129831|NCT00532779|417279|P2|Overall Study|Withdrawal by Subject|60
129832|NCT00532779|417280|P1|Overall Study|Withdrawal by Subject|63
129833|NCT00532779|417278|P3|Overall Study|Lost to Follow-up|66
129834|NCT00532779|417279|P2|Overall Study|Lost to Follow-up|65
129835|NCT00532779|417280|P1|Overall Study|Lost to Follow-up|76
129836|NCT00532779|417278|P3|Overall Study|Adverse Event|56
129837|NCT00532779|417279|P2|Overall Study|Adverse Event|112
129838|NCT00532779|417280|P1|Overall Study|Adverse Event|122
129839|NCT00536198|417341|P2|Overall Study|Protocol Violation|1
129840|NCT00536198|417342|P1|Overall Study|Protocol Violation|0
129841|NCT00536198|417341|P2|Overall Study|Pregnancy|1
129842|NCT00536198|417342|P1|Overall Study|Pregnancy|1
129843|NCT00536198|417341|P2|Overall Study|Rescue|9
129844|NCT00536198|417342|P1|Overall Study|Rescue|3
129845|NCT00536198|417341|P2|Overall Study|Adverse Event|2
129846|NCT00536198|417342|P1|Overall Study|Adverse Event|2
129847|NCT00536198|417341|P2|Overall Study|Withdrawal by Subject|12
129848|NCT00536198|417342|P1|Overall Study|Withdrawal by Subject|16
129849|NCT00536198|417341|P2|Overall Study|Lost to Follow-up|14
129850|NCT00536198|417342|P1|Overall Study|Lost to Follow-up|15
129851|NCT00536263|417373|P3|Overall Study|Did not meet protocol eligibility|2
129852|NCT00536263|417374|P2|Overall Study|Did not meet protocol eligibility|2
129853|NCT00536263|417375|P1|Overall Study|Did not meet protocol eligibility|1
129854|NCT00536263|417373|P3|Overall Study|Noncompliance with protocol|1
129855|NCT00536263|417374|P2|Overall Study|Noncompliance with protocol|0
129856|NCT00536263|417375|P1|Overall Study|Noncompliance with protocol|0
129857|NCT00536263|417373|P3|Overall Study|Subject withdrew - treatment related|2
129858|NCT00536263|417374|P2|Overall Study|Subject withdrew - treatment related|3
129859|NCT00536263|417375|P1|Overall Study|Subject withdrew - treatment related|0
129860|NCT00536263|417373|P3|Overall Study|Subject withdrew - not treatment related|5
129861|NCT00536263|417374|P2|Overall Study|Subject withdrew - not treatment related|0
129862|NCT00536263|417375|P1|Overall Study|Subject withdrew - not treatment related|2
129863|NCT00536263|417373|P3|Overall Study|Lost to Follow-up|4
129864|NCT00536263|417374|P2|Overall Study|Lost to Follow-up|4
129865|NCT00536263|417375|P1|Overall Study|Lost to Follow-up|3
129866|NCT00536263|417373|P3|Overall Study|Adverse Event|7
129867|NCT00536263|417374|P2|Overall Study|Adverse Event|5
129868|NCT00536263|417375|P1|Overall Study|Adverse Event|5
129869|NCT00536380|417429|P3|Overall Study|Administrative|1
129870|NCT00536380|417430|P2|Overall Study|Administrative|0
129871|NCT00536380|417431|P1|Overall Study|Administrative|0
129872|NCT00536380|417429|P3|Overall Study|Did not meet protocol eligibility|1
129873|NCT00536380|417430|P2|Overall Study|Did not meet protocol eligibility|0
129874|NCT00536380|417431|P1|Overall Study|Did not meet protocol eligibility|0
129875|NCT00536380|417429|P3|Overall Study|Noncompliance with protocol|2
129876|NCT00536380|417430|P2|Overall Study|Noncompliance with protocol|2
129877|NCT00536380|417431|P1|Overall Study|Noncompliance with protocol|3
129878|NCT00536380|417429|P3|Overall Study|Withdrawal related to study drug|2
129879|NCT00536380|417430|P2|Overall Study|Withdrawal related to study drug|5
129880|NCT00536380|417431|P1|Overall Study|Withdrawal related to study drug|7
129881|NCT00536380|417429|P3|Overall Study|Withdrawal unrelated to study drug|1
129882|NCT00536380|417430|P2|Overall Study|Withdrawal unrelated to study drug|0
129883|NCT00536380|417431|P1|Overall Study|Withdrawal unrelated to study drug|2
129884|NCT00536380|417429|P3|Overall Study|Lost to Follow-up|1
129885|NCT00536380|417430|P2|Overall Study|Lost to Follow-up|0
129886|NCT00536380|417431|P1|Overall Study|Lost to Follow-up|0
129887|NCT00536380|417429|P3|Overall Study|Adverse Event|2
129888|NCT00536380|417430|P2|Overall Study|Adverse Event|2
129889|NCT00536380|417431|P1|Overall Study|Adverse Event|0
129890|NCT00536471|417443|P4|Overall Study|Sponsor Decision|2
129891|NCT00536471|417444|P3|Overall Study|Sponsor Decision|3
129892|NCT00536471|417445|P2|Overall Study|Sponsor Decision|1
129893|NCT00536471|417446|P1|Overall Study|Sponsor Decision|0
129894|NCT00536471|417443|P4|Overall Study|Death|2
129895|NCT00536471|417444|P3|Overall Study|Death|1
129896|NCT00536471|417445|P2|Overall Study|Death|0
129897|NCT00536471|417446|P1|Overall Study|Death|0
129898|NCT00536471|417443|P4|Overall Study|Physician Decision|2
129899|NCT00536471|417444|P3|Overall Study|Physician Decision|3
129900|NCT00536471|417445|P2|Overall Study|Physician Decision|1
129901|NCT00536471|417446|P1|Overall Study|Physician Decision|11
129902|NCT00536471|417443|P4|Overall Study|Protocol Violation|3
129903|NCT00536471|417444|P3|Overall Study|Protocol Violation|2
129904|NCT00536471|417445|P2|Overall Study|Protocol Violation|1
129905|NCT00536471|417446|P1|Overall Study|Protocol Violation|8
129906|NCT00536471|417443|P4|Overall Study|Lack of Efficacy|9
129907|NCT00536471|417444|P3|Overall Study|Lack of Efficacy|11
129908|NCT00536471|417445|P2|Overall Study|Lack of Efficacy|18
129909|NCT00536471|417446|P1|Overall Study|Lack of Efficacy|17
129910|NCT00536471|417443|P4|Overall Study|Withdrawal by Subject|21
129911|NCT00536471|417444|P3|Overall Study|Withdrawal by Subject|43
129912|NCT00536471|417445|P2|Overall Study|Withdrawal by Subject|24
129913|NCT00536471|417446|P1|Overall Study|Withdrawal by Subject|40
129914|NCT00536471|417443|P4|Overall Study|Adverse Event|13
129915|NCT00536471|417444|P3|Overall Study|Adverse Event|28
129916|NCT00536471|417445|P2|Overall Study|Adverse Event|16
129917|NCT00536471|417446|P1|Overall Study|Adverse Event|32
129918|NCT00536471|417443|P4|Overall Study|Lost to Follow-up|22
129919|NCT00536471|417444|P3|Overall Study|Lost to Follow-up|48
129920|NCT00536471|417445|P2|Overall Study|Lost to Follow-up|23
129921|NCT00536471|417446|P1|Overall Study|Lost to Follow-up|48
129922|NCT00536484|417690|P2|Overall Study|Other|0
129923|NCT00536484|417691|P1|Overall Study|Other|4
129924|NCT00536484|417690|P2|Overall Study|Lack of Efficacy|5
129925|NCT00536484|417691|P1|Overall Study|Lack of Efficacy|16
129926|NCT00536484|417690|P2|Overall Study|Lost to Follow-up|6
129927|NCT00536484|417691|P1|Overall Study|Lost to Follow-up|8
129928|NCT00536484|417690|P2|Overall Study|Withdrawal by Subject|11
129929|NCT00536484|417691|P1|Overall Study|Withdrawal by Subject|11
129930|NCT00536484|417690|P2|Overall Study|Adverse Event|34
129931|NCT00536484|417691|P1|Overall Study|Adverse Event|21
129932|NCT00536510|417723|P2|Overall Study|Patient Discontinued for Other Reasons|2
129933|NCT00536510|417724|P1|Overall Study|Patient Discontinued for Other Reasons|2
129934|NCT00536510|417723|P2|Overall Study|Laboratory Adverse Event|1
129935|NCT00536510|417724|P1|Overall Study|Laboratory Adverse Event|2
129936|NCT00536510|417723|P2|Overall Study|Flushing with Product|0
129937|NCT00536510|417724|P1|Overall Study|Flushing with Product|20
129938|NCT00536510|417723|P2|Overall Study|Withdrawal by Subject|9
129939|NCT00536510|417724|P1|Overall Study|Withdrawal by Subject|16
129940|NCT00536510|417723|P2|Overall Study|Protocol Violation|5
129941|NCT00536510|417724|P1|Overall Study|Protocol Violation|4
129942|NCT00536510|417723|P2|Overall Study|Lost to Follow-up|8
129943|NCT00536510|417724|P1|Overall Study|Lost to Follow-up|11
129944|NCT00536510|417723|P2|Overall Study|Adverse Event|4
129945|NCT00536510|417724|P1|Overall Study|Adverse Event|27
129946|NCT00536575|417732|P1|Overall Study|Death|1
129947|NCT00536575|417732|P1|Overall Study|Withdrawal by Subject|1
129948|NCT00536731|417739|P3|Overall Study|Other|0
129949|NCT00536731|417740|P2|Overall Study|Other|1
129950|NCT00536731|417741|P1|Overall Study|Other|1
129951|NCT00536731|417739|P3|Overall Study|Safety reasons|1
129952|NCT00536731|417740|P2|Overall Study|Safety reasons|0
129953|NCT00536731|417741|P1|Overall Study|Safety reasons|0
129954|NCT00536731|417739|P3|Overall Study|Intake of prohibited conc. medication|1
129955|NCT00536731|417740|P2|Overall Study|Intake of prohibited conc. medication|0
129956|NCT00536731|417741|P1|Overall Study|Intake of prohibited conc. medication|0
129957|NCT00536731|417739|P3|Overall Study|Withdrawal by Subject|0
129958|NCT00536731|417740|P2|Overall Study|Withdrawal by Subject|2
129959|NCT00536731|417741|P1|Overall Study|Withdrawal by Subject|0
129960|NCT00536731|417739|P3|Overall Study|Adverse Event|3
129961|NCT00536731|417740|P2|Overall Study|Adverse Event|2
129962|NCT00536731|417741|P1|Overall Study|Adverse Event|3
129963|NCT00536744|417787|P2|Overall Study|PI tried alternative treatment|3
129964|NCT00536744|417788|P1|Overall Study|PI tried alternative treatment|1
129965|NCT00536744|417787|P2|Overall Study|Withdrawal by Subject|8
129966|NCT00536744|417788|P1|Overall Study|Withdrawal by Subject|7
129967|NCT00536744|417787|P2|Overall Study|Lost to Follow-up|5
129968|NCT00536744|417788|P1|Overall Study|Lost to Follow-up|3
129969|NCT00536744|417787|P2|Overall Study|Physician Decision|1
129970|NCT00536744|417788|P1|Overall Study|Physician Decision|3
129971|NCT00536744|417787|P2|Overall Study|Death|1
129972|NCT00536744|417788|P1|Overall Study|Death|2
129973|NCT00536744|417787|P2|Overall Study|Adverse Event|10
129974|NCT00536744|417788|P1|Overall Study|Adverse Event|13
129975|NCT00536809|417794|P1|Phase II|Referred for surgical resection|1
129976|NCT00536809|417794|P1|Phase II|Adverse Event|1
129977|NCT00536874|417815|P1|Overall Study|Withdrawal by Subject|1
129978|NCT00536874|417815|P1|Overall Study|Death|2
129979|NCT00536874|417815|P1|Overall Study|Adverse Event|1
129980|NCT00536978|417850|P1|Overall Study|Not eligible for Adback Infusion|22
129981|NCT00536991|417854|P1|Overall Study|patient ineligible|2
129982|NCT00536991|417854|P1|Overall Study|Physician Decision|1
129983|NCT00536991|417854|P1|Overall Study|Withdrawal by Subject|10
129984|NCT00537017|417861|P1|Follow-up Phase|Withdrawal by Subject|9
129985|NCT00537017|417861|P1|Treatment Phase|Protocol Violation|2
129986|NCT00537017|417861|P1|Treatment Phase|Withdrawal by Subject|13
129987|NCT00537017|417861|P1|Treatment Phase|Adverse Event|19
129988|NCT00537030|417872|P1|Overall Study|Inevaluable|3
129989|NCT00537030|417872|P1|Overall Study|Confirm patient ineligibility|1
129990|NCT00537030|417872|P1|Overall Study|Disease progression or relapse during ac|1
129991|NCT00537030|417872|P1|Overall Study|Greater then or equal to a Grade 2 aller|7
129992|NCT00537030|417872|P1|Overall Study|Withdrawal by Subject|2
129993|NCT00537030|417872|P1|Overall Study|Physician Decision|2
129994|NCT00537056|417876|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
129995|NCT00537082|417891|P3|Overall Study|Discontinued before initiating treatment|0
129996|NCT00537082|417892|P2|Overall Study|Discontinued before initiating treatment|0
129997|NCT00537082|417893|P1|Overall Study|Discontinued before initiating treatment|3
129998|NCT00537082|417891|P3|Overall Study|Withdrawal by Subject|0
129999|NCT00537082|417892|P2|Overall Study|Withdrawal by Subject|1
130000|NCT00537082|417893|P1|Overall Study|Withdrawal by Subject|0
130001|NCT00537082|417891|P3|Overall Study|Lack of Efficacy|2
130002|NCT00537082|417892|P2|Overall Study|Lack of Efficacy|0
130003|NCT00537082|417893|P1|Overall Study|Lack of Efficacy|0
130004|NCT00537082|417891|P3|Overall Study|Protocol Violation|1
130005|NCT00537082|417892|P2|Overall Study|Protocol Violation|2
130006|NCT00537082|417893|P1|Overall Study|Protocol Violation|0
130007|NCT00537082|417891|P3|Overall Study|Adverse Event|3
130008|NCT00537082|417892|P2|Overall Study|Adverse Event|6
130009|NCT00537082|417893|P1|Overall Study|Adverse Event|6
130010|NCT00537095|417912|P2|Overall Study|Incorrect enrolment|1
130011|NCT00537095|417913|P1|Overall Study|Incorrect enrolment|0
130012|NCT00537095|417912|P2|Overall Study|subjective disease progression|1
130013|NCT00537095|417913|P1|Overall Study|subjective disease progression|0
130014|NCT00537095|417912|P2|Overall Study|Withdrawal by Subject|2
130015|NCT00537095|417913|P1|Overall Study|Withdrawal by Subject|2
130016|NCT00537095|417912|P2|Overall Study|Death|1
130017|NCT00537095|417913|P1|Overall Study|Death|3
130018|NCT00537095|417912|P2|Overall Study|disease progression|48
130019|NCT00537095|417913|P1|Overall Study|disease progression|21
130020|NCT00537095|417912|P2|Overall Study|Adverse Event|4
130021|NCT00537095|417913|P1|Overall Study|Adverse Event|24
130022|NCT00537095|417912|P2|Overall Study|surgery|0
130023|NCT00537095|417913|P1|Overall Study|surgery|1
130024|NCT00537199|417925|P1|Overall Study|Study Terminated|1
130025|NCT00537238|417931|P2|Overall Study|Unspecified|52
130026|NCT00537238|417932|P1|Overall Study|Unspecified|44
130027|NCT00537238|417931|P2|Overall Study|Does not meet entrance criteria|2
130028|NCT00537238|417932|P1|Overall Study|Does not meet entrance criteria|0
130029|NCT00537238|417931|P2|Overall Study|Protocol Violation|19
130030|NCT00537238|417932|P1|Overall Study|Protocol Violation|15
130031|NCT00537238|417931|P2|Overall Study|Withdrawal by Subject|47
130032|NCT00537238|417932|P1|Overall Study|Withdrawal by Subject|51
130033|NCT00537238|417931|P2|Overall Study|Lost to Follow-up|8
130034|NCT00537238|417932|P1|Overall Study|Lost to Follow-up|12
130035|NCT00537238|417931|P2|Overall Study|Lack of Efficacy|21
130036|NCT00537238|417932|P1|Overall Study|Lack of Efficacy|20
130037|NCT00537238|417931|P2|Overall Study|Adverse Event|22
130038|NCT00537238|417932|P1|Overall Study|Adverse Event|31
130039|NCT00537238|417931|P2|Overall Study|Death|2
130040|NCT00537238|417932|P1|Overall Study|Death|1
130041|NCT00537277|417952|P1|Overall Study|Non-compliance with trial procedures|15
130042|NCT00537277|417952|P1|Overall Study|Inability to tolerate trial medication|4
130043|NCT00537277|417952|P1|Overall Study|Unclassified|4
130044|NCT00537277|417952|P1|Overall Study|Protocol Violation|11
130045|NCT00537277|417952|P1|Overall Study|Lost to Follow-up|12
130046|NCT00537277|417952|P1|Overall Study|Lack of Efficacy|2
130047|NCT00537277|417952|P1|Overall Study|Adverse Event|1
130048|NCT00537303|417963|P2|Overall Study|Unclassified|7
130049|NCT00537303|417964|P1|Overall Study|Unclassified|8
130050|NCT00537303|417963|P2|Overall Study|Withdrawal criteria|3
130051|NCT00537303|417964|P1|Overall Study|Withdrawal criteria|3
130052|NCT00537303|417963|P2|Overall Study|Protocol Violation|4
130053|NCT00537303|417964|P1|Overall Study|Protocol Violation|8
130054|NCT00537303|417963|P2|Overall Study|Lack of Efficacy|7
130055|NCT00537303|417964|P1|Overall Study|Lack of Efficacy|6
130056|NCT00537303|417963|P2|Overall Study|Adverse Event|4
130057|NCT00537303|417964|P1|Overall Study|Adverse Event|1
130058|NCT00537316|417986|P7|Part 2|Administrative|1
130059|NCT00537316|417987|P6|Part 2|Administrative|4
130060|NCT00537316|417988|P5|Part 2|Administrative|1
130061|NCT00537316|417989|P4|Part 2|Administrative|3
130062|NCT00537316|417990|P3|Part 2|Administrative|24
130063|NCT00537316|417991|P2|Part 2|Administrative|8
130064|NCT00537316|417992|P1|Part 2|Administrative|16
130065|NCT00537316|417986|P7|Part 2|Withdrawal by Subject|0
130066|NCT00537316|417987|P6|Part 2|Withdrawal by Subject|0
130067|NCT00537316|417988|P5|Part 2|Withdrawal by Subject|0
130068|NCT00537316|417989|P4|Part 2|Withdrawal by Subject|0
130069|NCT00537316|417990|P3|Part 2|Withdrawal by Subject|4
130070|NCT00537316|417991|P2|Part 2|Withdrawal by Subject|1
130071|NCT00537316|417992|P1|Part 2|Withdrawal by Subject|5
130072|NCT00537316|417986|P7|Part 2|Lost to Follow-up|0
130073|NCT00537316|417987|P6|Part 2|Lost to Follow-up|0
130074|NCT00537316|417988|P5|Part 2|Lost to Follow-up|0
130075|NCT00537316|417989|P4|Part 2|Lost to Follow-up|0
130076|NCT00537316|417990|P3|Part 2|Lost to Follow-up|2
130077|NCT00537316|417991|P2|Part 2|Lost to Follow-up|0
130078|NCT00537316|417992|P1|Part 2|Lost to Follow-up|1
130079|NCT00537316|417986|P7|Part 2|Adverse Event|0
130080|NCT00537316|417987|P6|Part 2|Adverse Event|0
130081|NCT00537316|417988|P5|Part 2|Adverse Event|0
130082|NCT00537316|417989|P4|Part 2|Adverse Event|0
130083|NCT00537316|417990|P3|Part 2|Adverse Event|2
130084|NCT00537316|417991|P2|Part 2|Adverse Event|0
130085|NCT00537316|417992|P1|Part 2|Adverse Event|4
130086|NCT00537316|417986|P7|Part 2|Never entered follow-up|1
130087|NCT00537316|417987|P6|Part 2|Never entered follow-up|0
130088|NCT00537316|417988|P5|Part 2|Never entered follow-up|0
130089|NCT00537316|417989|P4|Part 2|Never entered follow-up|0
130090|NCT00537316|417990|P3|Part 2|Never entered follow-up|0
130091|NCT00537316|417991|P2|Part 2|Never entered follow-up|0
130092|NCT00537316|417992|P1|Part 2|Never entered follow-up|0
130093|NCT00537316|417986|P7|Part 1|Administrative|0
130094|NCT00537316|417987|P6|Part 1|Administrative|0
130095|NCT00537316|417988|P5|Part 1|Administrative|0
130096|NCT00537316|417989|P4|Part 1|Administrative|0
130097|NCT00537316|417990|P3|Part 1|Administrative|2
130098|NCT00537316|417991|P2|Part 1|Administrative|0
130099|NCT00537316|417992|P1|Part 1|Administrative|0
130100|NCT00537316|417986|P7|Part 1|Did not meet protocol eligibility|0
130101|NCT00537316|417987|P6|Part 1|Did not meet protocol eligibility|0
130102|NCT00537316|417988|P5|Part 1|Did not meet protocol eligibility|0
130103|NCT00537316|417989|P4|Part 1|Did not meet protocol eligibility|0
130104|NCT00537316|417990|P3|Part 1|Did not meet protocol eligibility|2
130105|NCT00537316|417991|P2|Part 1|Did not meet protocol eligibility|3
130106|NCT00537316|417992|P1|Part 1|Did not meet protocol eligibility|1
130107|NCT00537316|417986|P7|Part 1|Protocol Violation|0
130108|NCT00537316|417987|P6|Part 1|Protocol Violation|0
130109|NCT00537316|417988|P5|Part 1|Protocol Violation|0
130110|NCT00537316|417989|P4|Part 1|Protocol Violation|0
130111|NCT00537316|417990|P3|Part 1|Protocol Violation|1
130112|NCT00537316|417991|P2|Part 1|Protocol Violation|5
130113|NCT00537316|417992|P1|Part 1|Protocol Violation|1
130114|NCT00537316|417986|P7|Part 1|Withdrawal by Subject|0
130115|NCT00537316|417987|P6|Part 1|Withdrawal by Subject|0
130116|NCT00537316|417988|P5|Part 1|Withdrawal by Subject|0
130117|NCT00537316|417989|P4|Part 1|Withdrawal by Subject|0
130118|NCT00537316|417990|P3|Part 1|Withdrawal by Subject|4
130119|NCT00537316|417991|P2|Part 1|Withdrawal by Subject|8
130120|NCT00537316|417992|P1|Part 1|Withdrawal by Subject|3
130121|NCT00537316|417986|P7|Part 1|Lost to Follow-up|0
130122|NCT00537316|417987|P6|Part 1|Lost to Follow-up|0
130123|NCT00537316|417988|P5|Part 1|Lost to Follow-up|0
130124|NCT00537316|417989|P4|Part 1|Lost to Follow-up|0
130125|NCT00537316|417990|P3|Part 1|Lost to Follow-up|0
130126|NCT00537316|417991|P2|Part 1|Lost to Follow-up|0
130127|NCT00537316|417992|P1|Part 1|Lost to Follow-up|1
130128|NCT00537316|417986|P7|Part 1|Protocol defined clinical event|0
130129|NCT00537316|417987|P6|Part 1|Protocol defined clinical event|0
130130|NCT00537316|417988|P5|Part 1|Protocol defined clinical event|0
130131|NCT00537316|417989|P4|Part 1|Protocol defined clinical event|0
130132|NCT00537316|417990|P3|Part 1|Protocol defined clinical event|0
130133|NCT00537316|417991|P2|Part 1|Protocol defined clinical event|0
130134|NCT00537316|417992|P1|Part 1|Protocol defined clinical event|1
130135|NCT00537316|417986|P7|Part 1|Adverse Event|0
130136|NCT00537316|417987|P6|Part 1|Adverse Event|0
130137|NCT00537316|417988|P5|Part 1|Adverse Event|0
130138|NCT00537316|417989|P4|Part 1|Adverse Event|0
130139|NCT00537316|417990|P3|Part 1|Adverse Event|8
130140|NCT00537316|417991|P2|Part 1|Adverse Event|11
130141|NCT00537316|417992|P1|Part 1|Adverse Event|7
130142|NCT00537329|418017|P1|Overall Study|Unspecified|1
130143|NCT00537329|418017|P1|Overall Study|Withdrawal by Subject|4
130144|NCT00537329|418017|P1|Overall Study|Lost to Follow-up|6
130145|NCT00537329|418017|P1|Overall Study|Lack of Efficacy|2
130146|NCT00537329|418017|P1|Overall Study|Adverse Event|3
130147|NCT00537329|418017|P1|Overall Study|Death|10
130148|NCT00537381|418033|P2|Overall Study|Unspecified|3
130149|NCT00537381|418034|P1|Overall Study|Unspecified|5
130150|NCT00537381|418033|P2|Overall Study|Sponsor decision|9
130151|NCT00537381|418034|P1|Overall Study|Sponsor decision|14
130152|NCT00537381|418033|P2|Overall Study|Disease Progression|18
130153|NCT00537381|418034|P1|Overall Study|Disease Progression|9
130154|NCT00537381|418033|P2|Overall Study|Physician Decision|6
130155|NCT00537381|418034|P1|Overall Study|Physician Decision|7
130156|NCT00537381|418033|P2|Overall Study|Withdrawal by Subject|14
130157|NCT00537381|418034|P1|Overall Study|Withdrawal by Subject|5
130158|NCT00537381|418033|P2|Overall Study|Death|3
130159|NCT00537381|418034|P1|Overall Study|Death|3
130160|NCT00537381|418033|P2|Overall Study|Adverse Event|9
130161|NCT00537381|418034|P1|Overall Study|Adverse Event|13
130162|NCT00537394|418057|P3|2nd Year of Follow-up|Clinic site closure|0
130163|NCT00537394|418058|P2|2nd Year of Follow-up|Clinic site closure|0
130164|NCT00537394|418059|P1|2nd Year of Follow-up|Clinic site closure|1
130165|NCT00537394|418057|P3|2nd Year of Follow-up|Lost to Follow-up|2
130166|NCT00537394|418058|P2|2nd Year of Follow-up|Lost to Follow-up|7
130167|NCT00537394|418059|P1|2nd Year of Follow-up|Lost to Follow-up|6
130168|NCT00537394|418057|P3|2nd Year of Follow-up|Withdrawal by Subject|2
130169|NCT00537394|418058|P2|2nd Year of Follow-up|Withdrawal by Subject|1
130170|NCT00537394|418059|P1|2nd Year of Follow-up|Withdrawal by Subject|0
130171|NCT00537394|418057|P3|2nd Year of Follow-up|Death|2
130172|NCT00537394|418058|P2|2nd Year of Follow-up|Death|1
130173|NCT00537394|418059|P1|2nd Year of Follow-up|Death|4
130174|NCT00537394|418057|P3|First Year of Follow-up|Lost to Follow-up|1
130175|NCT00537394|418058|P2|First Year of Follow-up|Lost to Follow-up|5
130176|NCT00537394|418059|P1|First Year of Follow-up|Lost to Follow-up|1
130177|NCT00537394|418057|P3|First Year of Follow-up|Withdrawal by Subject|1
130178|NCT00537394|418058|P2|First Year of Follow-up|Withdrawal by Subject|6
130179|NCT00537394|418059|P1|First Year of Follow-up|Withdrawal by Subject|3
130180|NCT00537394|418057|P3|First Year of Follow-up|Severe debilitation|1
130181|NCT00537394|418058|P2|First Year of Follow-up|Severe debilitation|0
130182|NCT00537394|418059|P1|First Year of Follow-up|Severe debilitation|1
130183|NCT00537394|418057|P3|First Year of Follow-up|Death|0
130184|NCT00537394|418058|P2|First Year of Follow-up|Death|0
130185|NCT00537394|418059|P1|First Year of Follow-up|Death|7
130186|NCT00537485|418141|P2|Overall Study|Physician Decision|0
130187|NCT00537485|418142|P1|Overall Study|Physician Decision|1
130188|NCT00537485|418141|P2|Overall Study|Withdrawal by Subject|3
130189|NCT00537485|418142|P1|Overall Study|Withdrawal by Subject|1
130190|NCT00537485|418141|P2|Overall Study|Withdrawal by Subject|2
130191|NCT00537485|418142|P1|Overall Study|Withdrawal by Subject|3
130192|NCT00537485|418141|P2|Overall Study|Adverse Event|5
130193|NCT00537485|418142|P1|Overall Study|Adverse Event|10
130194|NCT00537745|418204|P1|Overall Study|Subject unable to provide Interlock info|1
130195|NCT00537745|418204|P1|Overall Study|Withdrawal by Subject|2
130196|NCT00537745|418204|P1|Overall Study|Did not meet eligibility criteria|2
130197|NCT00537771|418211|P2|Overall Study|Severe Non-Compliance to Protocol|2
130287|NCT00525512|418613|P1|Open-Label Phase|Adverse Event|0
130198|NCT00537771|418212|P1|Overall Study|Severe Non-Compliance to Protocol|4
130199|NCT00537771|418211|P2|Overall Study|Protocol Violation|6
130200|NCT00537771|418212|P1|Overall Study|Protocol Violation|2
130201|NCT00537771|418211|P2|Overall Study|Lost to Follow-up|15
130202|NCT00537771|418212|P1|Overall Study|Lost to Follow-up|9
130203|NCT00537771|418211|P2|Overall Study|Adverse Event|15
130204|NCT00537771|418212|P1|Overall Study|Adverse Event|8
130205|NCT00537771|418211|P2|Overall Study|Withdrawal by Subject|23
130206|NCT00537771|418212|P1|Overall Study|Withdrawal by Subject|6
130207|NCT00537810|418226|P4|Overall Study|Medically withdrawn|1
130208|NCT00537810|418227|P3|Overall Study|Medically withdrawn|0
130209|NCT00537810|418228|P2|Overall Study|Medically withdrawn|2
130210|NCT00537810|418229|P1|Overall Study|Medically withdrawn|2
130211|NCT00537810|418226|P4|Overall Study|Withdrawal by Subject|3
130212|NCT00537810|418227|P3|Overall Study|Withdrawal by Subject|4
130213|NCT00537810|418228|P2|Overall Study|Withdrawal by Subject|11
130214|NCT00537810|418229|P1|Overall Study|Withdrawal by Subject|4
130215|NCT00537823|418245|P2|Overall Study|Adverse Event|0
130216|NCT00537823|418246|P1|Overall Study|Adverse Event|2
130217|NCT00537940|418270|P2|Overall Study|Unspecified|12
130218|NCT00537940|418271|P1|Overall Study|Unspecified|10
130219|NCT00537940|418270|P2|Overall Study|Study terminated by sponsor|3
130220|NCT00537940|418271|P1|Overall Study|Study terminated by sponsor|2
130221|NCT00537940|418270|P2|Overall Study|Pregnancy|1
130222|NCT00537940|418271|P1|Overall Study|Pregnancy|1
130223|NCT00537940|418270|P2|Overall Study|Protocol Violation|4
130224|NCT00537940|418271|P1|Overall Study|Protocol Violation|6
130225|NCT00537940|418270|P2|Overall Study|Withdrawal by Subject|95
130226|NCT00537940|418271|P1|Overall Study|Withdrawal by Subject|113
130227|NCT00537940|418270|P2|Overall Study|Lost to Follow-up|29
130228|NCT00537940|418271|P1|Overall Study|Lost to Follow-up|23
130229|NCT00537940|418270|P2|Overall Study|Lack of Efficacy|16
130230|NCT00537940|418271|P1|Overall Study|Lack of Efficacy|8
130231|NCT00537940|418270|P2|Overall Study|Adverse Event|19
130232|NCT00537940|418271|P1|Overall Study|Adverse Event|20
130233|NCT00537979|418295|P2|Overall Study|Heart failure|1
130234|NCT00537979|418296|P1|Overall Study|Heart failure|0
130235|NCT00537979|418295|P2|Overall Study|Kidney transplant|3
130236|NCT00537979|418296|P1|Overall Study|Kidney transplant|0
130237|NCT00537979|418295|P2|Overall Study|Death|3
130238|NCT00537979|418296|P1|Overall Study|Death|0
130239|NCT00537979|418295|P2|Overall Study|Non-compliance with treatment/procedure|2
130240|NCT00537979|418296|P1|Overall Study|Non-compliance with treatment/procedure|2
130241|NCT00537979|418295|P2|Overall Study|Lack of Efficacy|1
130242|NCT00537979|418296|P1|Overall Study|Lack of Efficacy|0
130243|NCT00537979|418295|P2|Overall Study|Lost to Follow-up|4
130244|NCT00537979|418296|P1|Overall Study|Lost to Follow-up|1
130245|NCT00537979|418295|P2|Overall Study|Withdrawal by Subject|4
130246|NCT00537979|418296|P1|Overall Study|Withdrawal by Subject|1
130247|NCT00537979|418295|P2|Overall Study|Adverse Event|2
130248|NCT00537979|418296|P1|Overall Study|Adverse Event|2
130249|NCT00538291|418362|P1|Overall Study|Withdrawal by Subject|1
130250|NCT00538291|418362|P1|Overall Study|Adverse Event|2
130251|NCT00538473|418416|P2|Overall Study|Adverse Event|0
130252|NCT00538473|418417|P1|Overall Study|Adverse Event|1
130253|NCT00538590|418464|P2|Overall Study|Death|0
130254|NCT00538590|418465|P1|Overall Study|Death|1
130255|NCT00538629|418488|P1|Overall Study|Subject's untimely distrust of medicine|1
130256|NCT00538629|418488|P1|Overall Study|Lost to Follow-up|6
130257|NCT00538629|418488|P1|Overall Study|Lack of Efficacy|12
130258|NCT00538629|418488|P1|Overall Study|Adverse Event|2
130259|NCT00538629|418488|P1|Overall Study|At subject's request|1
130260|NCT00525499|418591|P4|Overall Study|Protocol Violation|0
130261|NCT00525499|418592|P3|Overall Study|Protocol Violation|1
130262|NCT00525499|418593|P2|Overall Study|Protocol Violation|1
130263|NCT00525499|418594|P1|Overall Study|Protocol Violation|0
130264|NCT00525499|418591|P4|Overall Study|Withdrawal by Subject|2
130265|NCT00525499|418592|P3|Overall Study|Withdrawal by Subject|5
130266|NCT00525499|418593|P2|Overall Study|Withdrawal by Subject|1
130267|NCT00525499|418594|P1|Overall Study|Withdrawal by Subject|5
130268|NCT00525499|418591|P4|Overall Study|Adverse Event|1
130269|NCT00525499|418592|P3|Overall Study|Adverse Event|0
130270|NCT00525499|418593|P2|Overall Study|Adverse Event|1
130271|NCT00525499|418594|P1|Overall Study|Adverse Event|0
130272|NCT00525499|418591|P4|Overall Study|Lost to Follow-up|4
130273|NCT00525499|418592|P3|Overall Study|Lost to Follow-up|1
130274|NCT00525499|418593|P2|Overall Study|Lost to Follow-up|4
130275|NCT00525499|418594|P1|Overall Study|Lost to Follow-up|2
130276|NCT00525512|418610|P4|Open-Label Phase|Other reason (not specified)|5
130277|NCT00525512|418611|P3|Open-Label Phase|Other reason (not specified)|4
130278|NCT00525512|418612|P2|Open-Label Phase|Other reason (not specified)|0
130279|NCT00525512|418613|P1|Open-Label Phase|Other reason (not specified)|0
130280|NCT00525512|418610|P4|Open-Label Phase|Lost to Follow-up|0
130281|NCT00525512|418611|P3|Open-Label Phase|Lost to Follow-up|1
130282|NCT00525512|418612|P2|Open-Label Phase|Lost to Follow-up|0
130283|NCT00525512|418613|P1|Open-Label Phase|Lost to Follow-up|0
130284|NCT00525512|418610|P4|Open-Label Phase|Adverse Event|0
130285|NCT00525512|418611|P3|Open-Label Phase|Adverse Event|1
130286|NCT00525512|418612|P2|Open-Label Phase|Adverse Event|0
130288|NCT00525512|418610|P4|Double-Blind Phase|Other reason (not specified)|0
130289|NCT00525512|418611|P3|Double-Blind Phase|Other reason (not specified)|0
130290|NCT00525512|418612|P2|Double-Blind Phase|Other reason (not specified)|13
130291|NCT00525512|418613|P1|Double-Blind Phase|Other reason (not specified)|12
130292|NCT00525512|418610|P4|Double-Blind Phase|Lack of Efficacy|0
130293|NCT00525512|418611|P3|Double-Blind Phase|Lack of Efficacy|0
130294|NCT00525512|418612|P2|Double-Blind Phase|Lack of Efficacy|5
130295|NCT00525512|418613|P1|Double-Blind Phase|Lack of Efficacy|13
130296|NCT00525512|418610|P4|Double-Blind Phase|Withdrawal by Subject|0
130297|NCT00525512|418611|P3|Double-Blind Phase|Withdrawal by Subject|0
130298|NCT00525512|418612|P2|Double-Blind Phase|Withdrawal by Subject|12
130299|NCT00525512|418613|P1|Double-Blind Phase|Withdrawal by Subject|17
130300|NCT00525512|418610|P4|Double-Blind Phase|Lost to Follow-up|0
130301|NCT00525512|418611|P3|Double-Blind Phase|Lost to Follow-up|0
130302|NCT00525512|418612|P2|Double-Blind Phase|Lost to Follow-up|7
130303|NCT00525512|418613|P1|Double-Blind Phase|Lost to Follow-up|3
130304|NCT00525512|418610|P4|Double-Blind Phase|Protocol Violation|0
130305|NCT00525512|418611|P3|Double-Blind Phase|Protocol Violation|0
130306|NCT00525512|418612|P2|Double-Blind Phase|Protocol Violation|1
130307|NCT00525512|418613|P1|Double-Blind Phase|Protocol Violation|3
130308|NCT00525512|418610|P4|Double-Blind Phase|Adverse Event|0
130309|NCT00525512|418611|P3|Double-Blind Phase|Adverse Event|0
130310|NCT00525512|418612|P2|Double-Blind Phase|Adverse Event|28
130311|NCT00525512|418613|P1|Double-Blind Phase|Adverse Event|48
130312|NCT00525824|418798|P4|Overall Study|Other|1
130313|NCT00525824|418799|P3|Overall Study|Other|3
130314|NCT00525824|418800|P2|Overall Study|Other|3
130315|NCT00525824|418801|P1|Overall Study|Other|1
130316|NCT00525824|418798|P4|Overall Study|Safety reasons|0
130317|NCT00525824|418799|P3|Overall Study|Safety reasons|1
130318|NCT00525824|418800|P2|Overall Study|Safety reasons|0
130319|NCT00525824|418801|P1|Overall Study|Safety reasons|1
130320|NCT00525824|418798|P4|Overall Study|Severe non-compliance|1
130321|NCT00525824|418799|P3|Overall Study|Severe non-compliance|1
130322|NCT00525824|418800|P2|Overall Study|Severe non-compliance|1
130323|NCT00525824|418801|P1|Overall Study|Severe non-compliance|0
130324|NCT00525824|418798|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
130325|NCT00525824|418799|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
130326|NCT00525824|418800|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
130327|NCT00525824|418801|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
130328|NCT00525824|418798|P4|Overall Study|Lost to Follow-up|0
130329|NCT00525824|418799|P3|Overall Study|Lost to Follow-up|4
130330|NCT00525824|418800|P2|Overall Study|Lost to Follow-up|2
130331|NCT00525824|418801|P1|Overall Study|Lost to Follow-up|4
130332|NCT00525824|418798|P4|Overall Study|Withdrawal by Subject|4
130333|NCT00525824|418799|P3|Overall Study|Withdrawal by Subject|3
130334|NCT00525824|418800|P2|Overall Study|Withdrawal by Subject|9
130335|NCT00525824|418801|P1|Overall Study|Withdrawal by Subject|5
130336|NCT00525824|418798|P4|Overall Study|Adverse Event|7
130337|NCT00525824|418799|P3|Overall Study|Adverse Event|6
130338|NCT00525824|418800|P2|Overall Study|Adverse Event|11
130339|NCT00525824|418801|P1|Overall Study|Adverse Event|7
130340|NCT00525902|418876|P1|Overall Study|Lack of Efficacy|1
130341|NCT00525915|418883|P2|Overall Study|Unrelated illness|0
130342|NCT00525915|418884|P1|Overall Study|Unrelated illness|1
130343|NCT00525915|418883|P2|Overall Study|Refused Surgery|2
130344|NCT00525915|418884|P1|Overall Study|Refused Surgery|1
130345|NCT00525915|418883|P2|Overall Study|Withdrawal by Subject|0
130346|NCT00525915|418884|P1|Overall Study|Withdrawal by Subject|1
130347|NCT00525915|418883|P2|Overall Study|Disease Progression|6
130348|NCT00525915|418884|P1|Overall Study|Disease Progression|5
130349|NCT00525915|418883|P2|Overall Study|Non-Compliance|1
130350|NCT00525915|418884|P1|Overall Study|Non-Compliance|0
130351|NCT00526097|418901|P2|Overall Study|Other|1
130352|NCT00526097|418902|P1|Overall Study|Other|2
130353|NCT00526097|418901|P2|Overall Study|Withdrawal by Subject|1
130354|NCT00526097|418902|P1|Overall Study|Withdrawal by Subject|3
130355|NCT00526097|418901|P2|Overall Study|Protocol Violation|10
130356|NCT00526097|418902|P1|Overall Study|Protocol Violation|4
130357|NCT00526097|418901|P2|Overall Study|Adverse Event|44
130358|NCT00526097|418902|P1|Overall Study|Adverse Event|6
130359|NCT00526110|419080|P2|Overall Study|Poor Tolerance|5
130360|NCT00526110|419081|P1|Overall Study|Poor Tolerance|0
130361|NCT00526110|419080|P2|Overall Study|Withdrawal by Subject|2
130362|NCT00526110|419081|P1|Overall Study|Withdrawal by Subject|0
130363|NCT00526110|419080|P2|Overall Study|Maximal Response|6
130364|NCT00526110|419081|P1|Overall Study|Maximal Response|0
130365|NCT00526110|419080|P2|Overall Study|Disease Progression|19
130366|NCT00526110|419081|P1|Overall Study|Disease Progression|0
130367|NCT00526110|419080|P2|Overall Study|Adverse Event|9
130368|NCT00526110|419081|P1|Overall Study|Adverse Event|2
130369|NCT00526162|419111|P1|Overall Study|Device not implanted|3
130370|NCT00526227|419122|P1|Overall Study|Death|1
130371|NCT00526227|419122|P1|Overall Study|Device not implanted|1
130372|NCT00526331|419131|P1|Overall Study|Sponsor Termination|55
130373|NCT00526630|419206|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
130374|NCT00526630|419207|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
130375|NCT00526630|419206|P2|First Intervention Period - 12 Weeks|Withdrawn|3
130376|NCT00526630|419207|P1|First Intervention Period - 12 Weeks|Withdrawn|0
130377|NCT00526669|419235|P2|Combined Treatment Phase|Death|2
130378|NCT00526669|419236|P1|Combined Treatment Phase|Death|0
130379|NCT00526669|419235|P2|Combined Treatment Phase|Sponsor Terminated Study|2
130380|NCT00526669|419236|P1|Combined Treatment Phase|Sponsor Terminated Study|0
130381|NCT00526669|419235|P2|Combined Treatment Phase|Withdrawal by Subject|2
130382|NCT00526669|419236|P1|Combined Treatment Phase|Withdrawal by Subject|0
130383|NCT00526669|419235|P2|Combined Treatment Phase|Lost to Follow-up|2
130384|NCT00526669|419236|P1|Combined Treatment Phase|Lost to Follow-up|0
130385|NCT00527514|419265|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
130386|NCT00527514|419265|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
130387|NCT00527514|419265|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
130388|NCT00527514|419265|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
130389|NCT00527514|419265|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
130390|NCT00527514|419265|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
130391|NCT00527514|419265|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
130392|NCT00527605|419294|P2|Overall Study|Protocol Violation|2
130393|NCT00527605|419295|P1|Overall Study|Protocol Violation|1
130394|NCT00527605|419294|P2|Overall Study|Lost to Follow-up|2
130395|NCT00527605|419295|P1|Overall Study|Lost to Follow-up|6
130396|NCT00527605|419294|P2|Overall Study|Withdrawal by Subject|7
130397|NCT00527605|419295|P1|Overall Study|Withdrawal by Subject|3
130398|NCT00527605|419294|P2|Overall Study|Adverse Event|0
130399|NCT00527605|419295|P1|Overall Study|Adverse Event|3
130400|NCT00527618|419331|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
130401|NCT00527618|419332|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
130402|NCT00527618|419331|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
130403|NCT00527618|419332|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
130404|NCT00527618|419331|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
130405|NCT00527618|419332|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
130406|NCT00527618|419331|P2|Week 13-14 (Washout)|Lost to Follow-up|0
130407|NCT00527618|419332|P1|Week 13-14 (Washout)|Lost to Follow-up|1
130408|NCT00527618|419331|P2|Week 1-12 (First Intervention)|Adverse Event|1
130409|NCT00527618|419332|P1|Week 1-12 (First Intervention)|Adverse Event|0
130410|NCT00527618|419331|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
130411|NCT00527618|419332|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
130412|NCT00527735|419357|P3|Overall Study|Completed treatment during maintenance|1
130413|NCT00527735|419358|P2|Overall Study|Completed treatment during maintenance|2
130414|NCT00527735|419359|P1|Overall Study|Completed treatment during maintenance|2
130415|NCT00527735|419357|P3|Overall Study|Poor compliance or noncompliance|1
130416|NCT00527735|419358|P2|Overall Study|Poor compliance or noncompliance|1
130417|NCT00527735|419359|P1|Overall Study|Poor compliance or noncompliance|0
130418|NCT00527735|419357|P3|Overall Study|Lost to Follow-up|3
130419|NCT00527735|419358|P2|Overall Study|Lost to Follow-up|0
130420|NCT00527735|419359|P1|Overall Study|Lost to Follow-up|0
130421|NCT00527735|419357|P3|Overall Study|No longer met study criteria|1
130422|NCT00527735|419358|P2|Overall Study|No longer met study criteria|2
130423|NCT00527735|419359|P1|Overall Study|No longer met study criteria|2
130424|NCT00527735|419357|P3|Overall Study|Withdrawal by Subject|3
130425|NCT00527735|419358|P2|Overall Study|Withdrawal by Subject|4
130426|NCT00527735|419359|P1|Overall Study|Withdrawal by Subject|5
130427|NCT00527735|419357|P3|Overall Study|Not identified|5
130428|NCT00527735|419358|P2|Overall Study|Not identified|5
130429|NCT00527735|419359|P1|Overall Study|Not identified|5
130430|NCT00527735|419357|P3|Overall Study|Adverse Event|7
130431|NCT00527735|419358|P2|Overall Study|Adverse Event|6
130432|NCT00527735|419359|P1|Overall Study|Adverse Event|10
130433|NCT00527735|419357|P3|Overall Study|Completed treatment in treatment phase|18
130434|NCT00527735|419358|P2|Overall Study|Completed treatment in treatment phase|13
130435|NCT00527735|419359|P1|Overall Study|Completed treatment in treatment phase|14
130436|NCT00527735|419357|P3|Overall Study|Death|15
130437|NCT00527735|419358|P2|Overall Study|Death|13
130438|NCT00527735|419359|P1|Overall Study|Death|23
130439|NCT00527735|419357|P3|Overall Study|Disease progression|53
130440|NCT00527735|419358|P2|Overall Study|Disease progression|61
130441|NCT00527735|419359|P1|Overall Study|Disease progression|47
130442|NCT00527748|419431|P1|Overall Study|Other|3
130443|NCT00527787|419437|P2|Overall Study|misc|2
130444|NCT00527787|419438|P1|Overall Study|misc|5
130445|NCT00527787|419437|P2|Overall Study|Duodenal Ulcer|10
130446|NCT00527787|419438|P1|Overall Study|Duodenal Ulcer|1
130447|NCT00527787|419437|P2|Overall Study|Lost to Follow-up|2
130448|NCT00527787|419438|P1|Overall Study|Lost to Follow-up|5
130449|NCT00527787|419437|P2|Overall Study|Withdrawal by Subject|25
130450|NCT00527787|419438|P1|Overall Study|Withdrawal by Subject|13
130451|NCT00527787|419437|P2|Overall Study|Adverse Event|24
130452|NCT00527787|419438|P1|Overall Study|Adverse Event|14
130453|NCT00527826|419462|P2|Overall Study|Participant moved away|1
130454|NCT00527826|419463|P1|Overall Study|Participant moved away|0
130455|NCT00527826|419462|P2|Overall Study|Additional Intake of Viani forte|1
130456|NCT00527826|419463|P1|Overall Study|Additional Intake of Viani forte|0
130457|NCT00527826|419462|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
130458|NCT00527826|419463|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
130459|NCT00527826|419462|P2|Overall Study|Inclusion Criteria Not Met|3
130460|NCT00527826|419463|P1|Overall Study|Inclusion Criteria Not Met|3
130461|NCT00527826|419462|P2|Overall Study|Withdrawal by Subject|8
130462|NCT00527826|419463|P1|Overall Study|Withdrawal by Subject|5
130463|NCT00527826|419462|P2|Overall Study|Lost to Follow-up|2
130464|NCT00527826|419463|P1|Overall Study|Lost to Follow-up|3
130465|NCT00527826|419462|P2|Overall Study|Adverse Event|10
130466|NCT00527826|419463|P1|Overall Study|Adverse Event|10
130467|NCT00527904|419523|P1|Overall Study|misc|22
130468|NCT00527904|419523|P1|Overall Study|Lost to Follow-up|8
130469|NCT00527904|419523|P1|Overall Study|Withdrawal by Subject|21
130470|NCT00527904|419523|P1|Overall Study|Adverse Event|45
130471|NCT00527982|419564|P2|Overall Study|Physician Decision|0
130472|NCT00527982|419565|P1|Overall Study|Physician Decision|1
130473|NCT00528021|419575|P4|Overall Study|Lack of Efficacy|9
130474|NCT00528021|419576|P3|Overall Study|Lack of Efficacy|7
130475|NCT00528021|419577|P2|Overall Study|Lack of Efficacy|13
130476|NCT00528021|419578|P1|Overall Study|Lack of Efficacy|17
130477|NCT00528112|419590|P2|Extension Phase|Protocol Violation|2
130478|NCT00528112|419591|P1|Extension Phase|Protocol Violation|0
130479|NCT00528112|419590|P2|Extension Phase|Adverse Event|36
130480|NCT00528112|419591|P1|Extension Phase|Adverse Event|0
130481|NCT00528112|419590|P2|Extension Phase|Death|1
130482|NCT00528112|419591|P1|Extension Phase|Death|0
130483|NCT00528112|419590|P2|Extension Phase|Lost to Follow-up|12
130484|NCT00528112|419591|P1|Extension Phase|Lost to Follow-up|0
130485|NCT00528112|419590|P2|Extension Phase|Pregnancy|3
130486|NCT00528112|419591|P1|Extension Phase|Pregnancy|0
130487|NCT00528112|419590|P2|Extension Phase|Other reasons|100
130488|NCT00528112|419591|P1|Extension Phase|Other reasons|0
130489|NCT00528112|419590|P2|Extension Phase|Withdrawal by Subject|3
130490|NCT00528112|419591|P1|Extension Phase|Withdrawal by Subject|0
130491|NCT00528112|419590|P2|Treatment up to 3 Years|Other reasons|186
130492|NCT00528112|419591|P1|Treatment up to 3 Years|Other reasons|186
130493|NCT00528112|419590|P2|Treatment up to 3 Years|Pregnancy|10
130494|NCT00528112|419591|P1|Treatment up to 3 Years|Pregnancy|9
130495|NCT00528112|419590|P2|Treatment up to 3 Years|Lost to Follow-up|61
130496|NCT00528112|419591|P1|Treatment up to 3 Years|Lost to Follow-up|63
130497|NCT00528112|419590|P2|Treatment up to 3 Years|Death|1
130498|NCT00528112|419591|P1|Treatment up to 3 Years|Death|0
130499|NCT00528112|419590|P2|Treatment up to 3 Years|Protocol Violation|16
130500|NCT00528112|419591|P1|Treatment up to 3 Years|Protocol Violation|16
130501|NCT00528112|419590|P2|Treatment up to 3 Years|Withdrawal by Subject|31
130502|NCT00528112|419591|P1|Treatment up to 3 Years|Withdrawal by Subject|26
130503|NCT00528112|419590|P2|Treatment up to 3 Years|Adverse Event|278
130504|NCT00528112|419591|P1|Treatment up to 3 Years|Adverse Event|313
130505|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Not specified|0
130506|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Not specified|1
130507|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Not specified|3
130508|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Not specified|0
130509|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Not specified|3
130510|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Not specified|2
130511|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Not specified|1
130512|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Not specified|2
130513|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Not specified|2
130514|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
130515|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
130516|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
130517|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
130518|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
130519|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
130520|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
130521|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
130522|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
130523|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130524|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130525|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130526|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
130527|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
130528|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130529|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130530|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130531|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
130532|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
130533|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
130534|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130535|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
130536|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
130537|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130538|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130539|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
130540|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
130541|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
130542|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
130543|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
130544|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
130545|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
130546|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
130547|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
130548|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
130549|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
130550|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
130551|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
130552|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
130553|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
130554|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
130555|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
130556|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
130557|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
130558|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
130559|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
130560|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
130561|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
130562|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
130563|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
130564|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
130565|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
130566|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
130567|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
130568|NCT00528372|419672|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
130569|NCT00528372|419673|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
130570|NCT00528372|419674|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
130571|NCT00528372|419675|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
130572|NCT00528372|419676|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
130573|NCT00528372|419677|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
130574|NCT00528372|419678|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
130575|NCT00528372|419679|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
130576|NCT00528372|419680|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
130577|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130578|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
130579|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130580|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130581|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130582|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Not specified|1
130583|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130584|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Not specified|0
130585|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Not specified|3
130586|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130587|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130588|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130589|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
130590|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130591|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130592|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
130593|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
130594|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
130595|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130596|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130597|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130598|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
130599|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130600|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
130601|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130602|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130603|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
130604|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
130605|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
130606|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
130607|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
130608|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
130609|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
130610|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
130611|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
130612|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
130613|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
130614|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
130615|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
130616|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
130617|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
130618|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
130619|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
130620|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
130621|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
130622|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130623|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130624|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
130625|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
130626|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130627|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
130628|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
130629|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
130630|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
130631|NCT00528372|419672|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130632|NCT00528372|419673|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130633|NCT00528372|419674|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130634|NCT00528372|419675|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130635|NCT00528372|419676|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130636|NCT00528372|419677|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130637|NCT00528372|419678|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130638|NCT00528372|419679|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
130639|NCT00528372|419680|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
130640|NCT00528411|419800|P3|Overall Study|Prior commitment medication|0
130641|NCT00528411|419801|P2|Overall Study|Prior commitment medication|1
130642|NCT00528411|419802|P1|Overall Study|Prior commitment medication|0
130643|NCT00528411|419800|P3|Overall Study|Severe non-compliance to protocol|0
130644|NCT00528411|419801|P2|Overall Study|Severe non-compliance to protocol|1
130645|NCT00528411|419802|P1|Overall Study|Severe non-compliance to protocol|0
130646|NCT00528411|419800|P3|Overall Study|Incorrect Enrolment|0
130647|NCT00528411|419801|P2|Overall Study|Incorrect Enrolment|1
130648|NCT00528411|419802|P1|Overall Study|Incorrect Enrolment|1
130649|NCT00528411|419800|P3|Overall Study|Adverse Event|1
130650|NCT00528411|419801|P2|Overall Study|Adverse Event|0
130651|NCT00528411|419802|P1|Overall Study|Adverse Event|4
130652|NCT00528424|419925|P1|Overall Study|Not specified|12
130653|NCT00528424|419925|P1|Overall Study|Administrative reason|2
130654|NCT00528424|419925|P1|Overall Study|Withdrew consent|2
130655|NCT00528424|419925|P1|Overall Study|Lost to Follow-up|13
130656|NCT00528528|419937|P4|Overall Study|Ongoing participant|0
130657|NCT00528528|419938|P3|Overall Study|Ongoing participant|1
130658|NCT00528528|419939|P2|Overall Study|Ongoing participant|0
130659|NCT00528528|419940|P1|Overall Study|Ongoing participant|0
130660|NCT00528528|419937|P4|Overall Study|Withdrawal by Subject|1
130661|NCT00528528|419938|P3|Overall Study|Withdrawal by Subject|1
130662|NCT00528528|419939|P2|Overall Study|Withdrawal by Subject|2
130663|NCT00528528|419940|P1|Overall Study|Withdrawal by Subject|3
130664|NCT00528528|419937|P4|Overall Study|Unspecified|0
130665|NCT00528528|419938|P3|Overall Study|Unspecified|0
130666|NCT00528528|419939|P2|Overall Study|Unspecified|1
130667|NCT00528528|419940|P1|Overall Study|Unspecified|0
130668|NCT00528528|419937|P4|Overall Study|Ineligible to continue the trial|1
130669|NCT00528528|419938|P3|Overall Study|Ineligible to continue the trial|0
130670|NCT00528528|419939|P2|Overall Study|Ineligible to continue the trial|0
130671|NCT00528528|419940|P1|Overall Study|Ineligible to continue the trial|0
130672|NCT00528528|419937|P4|Overall Study|Lost to Follow-up|1
130673|NCT00528528|419938|P3|Overall Study|Lost to Follow-up|1
130674|NCT00528528|419939|P2|Overall Study|Lost to Follow-up|0
130675|NCT00528528|419940|P1|Overall Study|Lost to Follow-up|0
130676|NCT00528567|420001|P2|Overall Study|Administrative/Other|75
130677|NCT00528567|420002|P1|Overall Study|Administrative/Other|22
130678|NCT00528567|420001|P2|Overall Study|Other Protocol Violation|21
130679|NCT00528567|420002|P1|Overall Study|Other Protocol Violation|5
130680|NCT00528567|420001|P2|Overall Study|Failure to Return|4
130681|NCT00528567|420002|P1|Overall Study|Failure to Return|1
130682|NCT00528567|420001|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
130683|NCT00528567|420002|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
130684|NCT00528567|420001|P2|Overall Study|Withdrew Consent|55
130685|NCT00528567|420002|P1|Overall Study|Withdrew Consent|59
130686|NCT00528567|420001|P2|Overall Study|Violation Criteria at Entry|17
130687|NCT00528567|420002|P1|Overall Study|Violation Criteria at Entry|3
130688|NCT00528567|420001|P2|Overall Study|Adverse Event/Intermittent Illness|29
130689|NCT00528567|420002|P1|Overall Study|Adverse Event/Intermittent Illness|255
130690|NCT00528567|420001|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
130691|NCT00528567|420002|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
130692|NCT00528567|420001|P2|Overall Study|Death|5
130693|NCT00528567|420002|P1|Overall Study|Death|4
130694|NCT00528606|420042|P2|Overall Study|Not specified|0
130695|NCT00528606|420043|P1|Overall Study|Not specified|2
130696|NCT00528606|420042|P2|Overall Study|Adverse Event|0
130697|NCT00528606|420043|P1|Overall Study|Adverse Event|3
130698|NCT00528606|420042|P2|Overall Study|Lost to Follow-up|1
130699|NCT00528606|420043|P1|Overall Study|Lost to Follow-up|4
130700|NCT00528606|420042|P2|Overall Study|Withdrew consent|3
130701|NCT00528606|420043|P1|Overall Study|Withdrew consent|4
130702|NCT00528645|420049|P1|Overall Study|Adverse Event|3
130703|NCT00528775|420053|P1|Overall Study|Other not specified|1
130704|NCT00528801|420067|P2|Overall Study|Administrative Reasons|1
130705|NCT00528801|420068|P1|Overall Study|Administrative Reasons|0
130706|NCT00528801|420067|P2|Overall Study|Lost to Follow-up|4
130707|NCT00528801|420068|P1|Overall Study|Lost to Follow-up|15
130708|NCT00528801|420067|P2|Overall Study|Protocol Violation|5
130709|NCT00528801|420068|P1|Overall Study|Protocol Violation|11
130710|NCT00528801|420067|P2|Overall Study|Withdrawal by Subject|1
130711|NCT00528801|420068|P1|Overall Study|Withdrawal by Subject|1
130712|NCT00528840|420078|P1|Overall Study|Not Specified|2
130713|NCT00528840|420078|P1|Overall Study|Administrative Reasons|1
130714|NCT00528840|420078|P1|Overall Study|Death|2
130715|NCT00528840|420078|P1|Overall Study|Withdrawal by Subject|17
130716|NCT00528840|420078|P1|Overall Study|Adverse Event|1
130717|NCT00528840|420078|P1|Overall Study|Lost to Follow-up|10
130718|NCT00528866|420082|P1|Overall Study|Protocol Violation|6
130719|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
130720|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
130721|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
130722|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
130723|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
130724|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
130725|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
130726|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
130727|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
130728|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
130729|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
130730|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
130731|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
130732|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
130733|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
130734|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
130735|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Death|0
130736|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Death|0
130737|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Death|1
130738|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Death|0
130739|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
130740|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
130741|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
130742|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
130743|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
130744|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
130745|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
130746|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
130747|NCT00528879|420098|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
130748|NCT00528879|420099|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
130749|NCT00528879|420100|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
130750|NCT00528879|420101|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
130751|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Not specified|1
130752|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Not specified|1
130753|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Not specified|0
130754|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Not specified|0
130755|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
130756|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
130757|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
130758|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
130759|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
130760|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
130761|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
130838|NCT00529243|420376|P1|Overall Study|Death|1
130762|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
130763|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
130764|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
130765|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
130766|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
130767|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
130768|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
130769|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
130770|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
130771|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
130772|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
130773|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
130774|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
130775|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
130776|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
130777|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
130778|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
130779|NCT00528879|420098|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
130780|NCT00528879|420099|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
130781|NCT00528879|420100|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
130782|NCT00528879|420101|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
130783|NCT00528931|420167|P1|Overall Study|Lost to Follow-up|1
130784|NCT00528957|420177|P2|Second Extension (Week 144 to Week 240)|Poor adherence|0
130785|NCT00528957|420178|P1|Second Extension (Week 144 to Week 240)|Poor adherence|1
130786|NCT00528957|420177|P2|Second Extension (Week 144 to Week 240)|Lack of Efficacy|0
130787|NCT00528957|420178|P1|Second Extension (Week 144 to Week 240)|Lack of Efficacy|1
130788|NCT00528957|420177|P2|Second Extension (Week 144 to Week 240)|Adverse Event|2
130789|NCT00528957|420178|P1|Second Extension (Week 144 to Week 240)|Adverse Event|2
130790|NCT00528957|420177|P2|Second Extension (Week 144 to Week 240)|Physician Decision|0
130791|NCT00528957|420178|P1|Second Extension (Week 144 to Week 240)|Physician Decision|2
130876|NCT00529516|420474|P2|Overall Study|Lost to Follow-up|0
130792|NCT00528957|420177|P2|Second Extension (Week 144 to Week 240)|Study Ongoing|38
130793|NCT00528957|420178|P1|Second Extension (Week 144 to Week 240)|Study Ongoing|28
130794|NCT00528957|420177|P2|First Extension (Week 48 to Week 144)|Adverse Event|0
130795|NCT00528957|420178|P1|First Extension (Week 48 to Week 144)|Adverse Event|1
130796|NCT00528957|420177|P2|First Extension (Week 48 to Week 144)|Withdrawal by Subject|1
130797|NCT00528957|420178|P1|First Extension (Week 48 to Week 144)|Withdrawal by Subject|0
130798|NCT00528957|420177|P2|First Extension (Week 48 to Week 144)|Physician Decision|0
130799|NCT00528957|420178|P1|First Extension (Week 48 to Week 144)|Physician Decision|2
130800|NCT00528957|420177|P2|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|0
130801|NCT00528957|420178|P1|Randomized Phase (Baseline to Week 48)|Intolerability to oral powder|1
130802|NCT00528957|420177|P2|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|0
130803|NCT00528957|420178|P1|Randomized Phase (Baseline to Week 48)|Lack of Efficacy|1
130804|NCT00528957|420177|P2|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|1
130805|NCT00528957|420178|P1|Randomized Phase (Baseline to Week 48)|Withdrawal by Subject|2
130806|NCT00529035|420221|P1|Overall Study|Withdrawal by Subject|1
130807|NCT00529087|420235|P3|Overall Study|Protocol deviation|2
130808|NCT00529087|420236|P2|Overall Study|Protocol deviation|1
130809|NCT00529087|420237|P1|Overall Study|Protocol deviation|1
130810|NCT00529087|420235|P3|Overall Study|Withdrawal by Subject|3
130811|NCT00529087|420236|P2|Overall Study|Withdrawal by Subject|3
130812|NCT00529087|420237|P1|Overall Study|Withdrawal by Subject|3
130813|NCT00529087|420235|P3|Overall Study|Protocol Violation|6
130814|NCT00529087|420236|P2|Overall Study|Protocol Violation|7
130815|NCT00529087|420237|P1|Overall Study|Protocol Violation|8
130816|NCT00529087|420235|P3|Overall Study|Lost to Follow-up|1
130817|NCT00529087|420236|P2|Overall Study|Lost to Follow-up|4
130818|NCT00529087|420237|P1|Overall Study|Lost to Follow-up|6
130819|NCT00529087|420235|P3|Overall Study|Adverse Event|4
130820|NCT00529087|420236|P2|Overall Study|Adverse Event|13
130821|NCT00529087|420237|P1|Overall Study|Adverse Event|10
130822|NCT00529100|420304|P2|Overall Study|Participant Ineligibility|1
130823|NCT00529100|420305|P1|Overall Study|Participant Ineligibility|0
130824|NCT00529100|420304|P2|Overall Study|Withdrawal by Subject|1
130825|NCT00529100|420305|P1|Overall Study|Withdrawal by Subject|0
130826|NCT00529100|420304|P2|Overall Study|Progressive Disease|1
130827|NCT00529100|420305|P1|Overall Study|Progressive Disease|0
130828|NCT00529100|420304|P2|Overall Study|Protocol Violation|1
130829|NCT00529100|420305|P1|Overall Study|Protocol Violation|0
130830|NCT00529100|420304|P2|Overall Study|Adverse Event|5
130831|NCT00529100|420305|P1|Overall Study|Adverse Event|0
130832|NCT00529152|420336|P1|Overall Study|Lost to Follow-up|1
130833|NCT00529152|420336|P1|Overall Study|Withdrawal by Subject|2
130834|NCT00529152|420336|P1|Overall Study|Adverse Event|2
130835|NCT00529217|420371|P1|Overall Study|Unable to adhere to study schedule|2
130836|NCT00529217|420371|P1|Overall Study|Lack of Efficacy|2
130837|NCT00529243|420376|P1|Overall Study|Relocated|1
130839|NCT00529243|420376|P1|Overall Study|Adverse Event|1
130840|NCT00529308|420398|P2|Overall Study|Withdrawal by Subject|1
130841|NCT00529308|420399|P1|Overall Study|Withdrawal by Subject|1
130842|NCT00529399|420416|P3|Overall Study|Non-compliant|0
130843|NCT00529399|420417|P2|Overall Study|Non-compliant|1
130844|NCT00529399|420418|P1|Overall Study|Non-compliant|0
130845|NCT00529399|420416|P3|Overall Study|Withdrawal by Subject|1
130846|NCT00529399|420417|P2|Overall Study|Withdrawal by Subject|0
130847|NCT00529399|420418|P1|Overall Study|Withdrawal by Subject|1
130848|NCT00529399|420416|P3|Overall Study|Lost to Follow-up|1
130849|NCT00529399|420417|P2|Overall Study|Lost to Follow-up|0
130850|NCT00529399|420418|P1|Overall Study|Lost to Follow-up|1
130851|NCT00529451|420430|P4|Overall Study|Administrative problems|2
130852|NCT00529451|420431|P3|Overall Study|Administrative problems|0
130853|NCT00529451|420432|P2|Overall Study|Administrative problems|1
130854|NCT00529451|420433|P1|Overall Study|Administrative problems|1
130855|NCT00529451|420430|P4|Overall Study|Protocol deviation|1
130856|NCT00529451|420431|P3|Overall Study|Protocol deviation|4
130857|NCT00529451|420432|P2|Overall Study|Protocol deviation|1
130858|NCT00529451|420433|P1|Overall Study|Protocol deviation|1
130859|NCT00529451|420430|P4|Overall Study|Lost to Follow-up|4
130860|NCT00529451|420431|P3|Overall Study|Lost to Follow-up|4
130861|NCT00529451|420432|P2|Overall Study|Lost to Follow-up|7
130862|NCT00529451|420433|P1|Overall Study|Lost to Follow-up|4
130863|NCT00529451|420430|P4|Overall Study|Unsatisfactory therapeutic response|4
130864|NCT00529451|420431|P3|Overall Study|Unsatisfactory therapeutic response|5
130865|NCT00529451|420432|P2|Overall Study|Unsatisfactory therapeutic response|2
130866|NCT00529451|420433|P1|Overall Study|Unsatisfactory therapeutic response|6
130867|NCT00529451|420430|P4|Overall Study|Adverse Event|8
130868|NCT00529451|420431|P3|Overall Study|Adverse Event|14
130869|NCT00529451|420432|P2|Overall Study|Adverse Event|16
130870|NCT00529451|420433|P1|Overall Study|Adverse Event|9
130871|NCT00529451|420430|P4|Overall Study|Subject withdrew consent|12
130872|NCT00529451|420431|P3|Overall Study|Subject withdrew consent|13
130873|NCT00529451|420432|P2|Overall Study|Subject withdrew consent|21
130874|NCT00529451|420433|P1|Overall Study|Subject withdrew consent|16
130875|NCT00529516|420473|P3|Overall Study|Lost to Follow-up|1
130877|NCT00529516|420475|P1|Overall Study|Lost to Follow-up|0
130878|NCT00529516|420473|P3|Overall Study|Withdrawal by Subject|0
130879|NCT00529516|420474|P2|Overall Study|Withdrawal by Subject|1
130880|NCT00529516|420475|P1|Overall Study|Withdrawal by Subject|1
130881|NCT00529516|420473|P3|Overall Study|Adverse Event|0
130882|NCT00529516|420474|P2|Overall Study|Adverse Event|1
130883|NCT00529516|420475|P1|Overall Study|Adverse Event|2
130884|NCT00529529|420546|P3|Overall Study|Administrative problems|3
130885|NCT00529529|420547|P2|Overall Study|Administrative problems|0
130886|NCT00529529|420548|P1|Overall Study|Administrative problems|1
130887|NCT00529529|420546|P3|Overall Study|Abnormal test procedure result(s)|0
130888|NCT00529529|420547|P2|Overall Study|Abnormal test procedure result(s)|0
130889|NCT00529529|420548|P1|Overall Study|Abnormal test procedure result(s)|1
130890|NCT00529529|420546|P3|Overall Study|Death|0
130891|NCT00529529|420547|P2|Overall Study|Death|0
130892|NCT00529529|420548|P1|Overall Study|Death|2
130893|NCT00529529|420546|P3|Overall Study|Unsatisfactory therapeutic effect|2
130894|NCT00529529|420547|P2|Overall Study|Unsatisfactory therapeutic effect|2
130895|NCT00529529|420548|P1|Overall Study|Unsatisfactory therapeutic effect|2
130896|NCT00529529|420546|P3|Overall Study|Lost to Follow-up|1
130897|NCT00529529|420547|P2|Overall Study|Lost to Follow-up|3
130898|NCT00529529|420548|P1|Overall Study|Lost to Follow-up|5
130899|NCT00529529|420546|P3|Overall Study|Protocol deviation|5
130900|NCT00529529|420547|P2|Overall Study|Protocol deviation|12
130901|NCT00529529|420548|P1|Overall Study|Protocol deviation|8
130902|NCT00529529|420546|P3|Overall Study|Subject withdrew consent|12
130903|NCT00529529|420547|P2|Overall Study|Subject withdrew consent|9
130904|NCT00529529|420548|P1|Overall Study|Subject withdrew consent|12
130905|NCT00529529|420546|P3|Overall Study|Adverse Event|8
130906|NCT00529529|420547|P2|Overall Study|Adverse Event|17
130907|NCT00529529|420548|P1|Overall Study|Adverse Event|12
130908|NCT00529542|420606|P2|Overall Study|Lost to Follow-up|1
130909|NCT00529542|420607|P1|Overall Study|Lost to Follow-up|0
130910|NCT00529542|420606|P2|Overall Study|Withdrawal by Subject|0
130911|NCT00529542|420607|P1|Overall Study|Withdrawal by Subject|1
130912|NCT00529568|420662|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
130913|NCT00529568|420663|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
130914|NCT00529568|420664|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
130915|NCT00529568|420662|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
130916|NCT00529568|420663|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
130917|NCT00529568|420664|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
130918|NCT00529568|420662|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
130919|NCT00529568|420663|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
130920|NCT00529568|420664|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
130921|NCT00529568|420662|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
130922|NCT00529568|420663|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
130923|NCT00529568|420664|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
130924|NCT00529568|420662|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
130925|NCT00529568|420663|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
130926|NCT00529568|420664|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
130927|NCT00529568|420662|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
130928|NCT00529568|420663|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
130929|NCT00529568|420664|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
130930|NCT00529568|420662|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
130931|NCT00529568|420663|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
130932|NCT00529568|420664|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
130933|NCT00529568|420662|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
130934|NCT00529568|420663|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
130935|NCT00529568|420664|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
130936|NCT00529568|420662|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
130937|NCT00529568|420663|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
130938|NCT00529568|420664|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
130939|NCT00529568|420662|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
130940|NCT00529568|420663|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
130941|NCT00529568|420664|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
130942|NCT00529568|420662|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
130943|NCT00529568|420663|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
130944|NCT00529568|420664|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
130945|NCT00529633|420714|P2|Overall Study|Withdrawal by Subject|1
130946|NCT00529633|420715|P1|Overall Study|Withdrawal by Subject|1
130947|NCT00529659|420727|P2|Overall Study|Withdrawal by Subject|6
130948|NCT00529659|420728|P1|Overall Study|Withdrawal by Subject|1
130949|NCT00529659|420727|P2|Overall Study|Protocol Violation|6
130950|NCT00529659|420728|P1|Overall Study|Protocol Violation|2
130951|NCT00529659|420727|P2|Overall Study|Physician Decision|2
130952|NCT00529659|420728|P1|Overall Study|Physician Decision|0
130953|NCT00529659|420727|P2|Overall Study|Lost to Follow-up|2
130954|NCT00529659|420728|P1|Overall Study|Lost to Follow-up|0
130955|NCT00529659|420727|P2|Overall Study|Adverse Event|7
130956|NCT00529659|420728|P1|Overall Study|Adverse Event|8
130957|NCT00529763|420747|P3|Overall Study|Patient Withdrew Consent|2
130958|NCT00529763|420748|P2|Overall Study|Patient Withdrew Consent|3
130959|NCT00529763|420749|P1|Overall Study|Patient Withdrew Consent|2
130960|NCT00529763|420747|P3|Overall Study|Study Drug Toxicity|1
130961|NCT00529763|420748|P2|Overall Study|Study Drug Toxicity|6
130962|NCT00529763|420749|P1|Overall Study|Study Drug Toxicity|1
130963|NCT00529763|420747|P3|Overall Study|Stem Cell Transplant|0
130964|NCT00529763|420748|P2|Overall Study|Stem Cell Transplant|3
130965|NCT00529763|420749|P1|Overall Study|Stem Cell Transplant|0
130966|NCT00529763|420747|P3|Overall Study|Lost to Follow-up|1
130967|NCT00529763|420748|P2|Overall Study|Lost to Follow-up|1
130968|NCT00529763|420749|P1|Overall Study|Lost to Follow-up|0
130969|NCT00529763|420747|P3|Overall Study|Disease Progression|1
130970|NCT00529763|420748|P2|Overall Study|Disease Progression|16
130971|NCT00529763|420749|P1|Overall Study|Disease Progression|6
130972|NCT00529763|420747|P3|Overall Study|Death|1
130973|NCT00529763|420748|P2|Overall Study|Death|1
130974|NCT00529763|420749|P1|Overall Study|Death|0
130975|NCT00529763|420747|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
130976|NCT00529763|420748|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
130977|NCT00529763|420749|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
130978|NCT00529789|420785|P1|Study Period IV|Lost to Follow-up|3
130979|NCT00529789|420785|P1|Study Period IV|Lack of Efficacy|1
130980|NCT00529789|420785|P1|Study Period IV|Adverse Event|1
130981|NCT00529789|420785|P1|Study Period IV|Parent/Caregiver Decision|1
130982|NCT00529789|420785|P1|Study Period II/III|Lost to Follow-up|3
130983|NCT00529789|420785|P1|Study Period II/III|Physician Decision|3
130984|NCT00529789|420785|P1|Study Period II/III|Protocol Violation|3
130985|NCT00529789|420785|P1|Study Period II/III|Withdrawal by Subject|1
130986|NCT00529789|420785|P1|Study Period II/III|Lack of Efficacy|2
130987|NCT00529789|420785|P1|Study Period II/III|Adverse Event|3
130988|NCT00529789|420785|P1|Study Period II/III|Parent/Caregiver Decision|9
130989|NCT00538733|420807|P1|Overall Study|still on therapy|1
130990|NCT00538733|420807|P1|Overall Study|declined to participate|2
130991|NCT00538733|420807|P1|Overall Study|Death|1
130992|NCT00538733|420807|P1|Overall Study|Adverse Event|8
130993|NCT00538785|420816|P2|Overall Study|Lost to Follow-up|0
130994|NCT00538785|420817|P1|Overall Study|Lost to Follow-up|1
130995|NCT00538785|420816|P2|Overall Study|Withdrawal of consent|7
130996|NCT00538785|420817|P1|Overall Study|Withdrawal of consent|9
130997|NCT00538785|420816|P2|Overall Study|Death|10
130998|NCT00538785|420817|P1|Overall Study|Death|9
130999|NCT00538902|420865|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
131000|NCT00538902|420866|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
131001|NCT00538902|420867|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
131002|NCT00538902|420865|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
131003|NCT00538902|420866|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
131004|NCT00538902|420867|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
131005|NCT00538902|420865|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
131006|NCT00538902|420866|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
131007|NCT00538902|420867|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
131008|NCT00538902|420865|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
131009|NCT00538902|420866|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
131010|NCT00538902|420867|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
131011|NCT00538902|420865|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
131012|NCT00538902|420866|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
131013|NCT00538902|420867|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
131014|NCT00538902|420865|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
131015|NCT00538902|420866|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
131016|NCT00538902|420867|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
131017|NCT00538902|420865|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
131018|NCT00538902|420866|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
131019|NCT00538902|420867|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
131020|NCT00538902|420865|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
131021|NCT00538902|420866|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
131022|NCT00538902|420867|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
131023|NCT00539006|420918|P4|Treatment Period 2|Other|0
131024|NCT00539006|420919|P3|Treatment Period 2|Other|0
131025|NCT00539006|420920|P2|Treatment Period 2|Other|1
131026|NCT00539006|420921|P1|Treatment Period 2|Other|0
131027|NCT00539006|420918|P4|Treatment Period 2|Protocol Violation|0
131028|NCT00539006|420919|P3|Treatment Period 2|Protocol Violation|0
131029|NCT00539006|420920|P2|Treatment Period 2|Protocol Violation|0
131030|NCT00539006|420921|P1|Treatment Period 2|Protocol Violation|1
131031|NCT00539006|420918|P4|Washout|Other|3
131032|NCT00539006|420919|P3|Washout|Other|2
131033|NCT00539006|420920|P2|Washout|Other|1
131034|NCT00539006|420921|P1|Washout|Other|1
131035|NCT00539006|420918|P4|Washout|Failed to meet continuation criteria|6
131036|NCT00539006|420919|P3|Washout|Failed to meet continuation criteria|14
131037|NCT00539006|420920|P2|Washout|Failed to meet continuation criteria|5
131038|NCT00539006|420921|P1|Washout|Failed to meet continuation criteria|16
131039|NCT00539006|420918|P4|Washout|Withdrawal by Subject|0
131040|NCT00539006|420919|P3|Washout|Withdrawal by Subject|0
131041|NCT00539006|420920|P2|Washout|Withdrawal by Subject|2
131042|NCT00539006|420921|P1|Washout|Withdrawal by Subject|0
131043|NCT00539006|420918|P4|Washout|Protocol Violation|0
131044|NCT00539006|420919|P3|Washout|Protocol Violation|0
131045|NCT00539006|420920|P2|Washout|Protocol Violation|1
131046|NCT00539006|420921|P1|Washout|Protocol Violation|1
131047|NCT00539006|420918|P4|Washout|Adverse Event|0
131048|NCT00539006|420919|P3|Washout|Adverse Event|0
131049|NCT00539006|420920|P2|Washout|Adverse Event|1
131050|NCT00539006|420921|P1|Washout|Adverse Event|2
131051|NCT00539006|420918|P4|Treatment Period 1|Lack of Efficacy|1
131052|NCT00539006|420919|P3|Treatment Period 1|Lack of Efficacy|0
131053|NCT00539006|420920|P2|Treatment Period 1|Lack of Efficacy|0
131054|NCT00539006|420921|P1|Treatment Period 1|Lack of Efficacy|0
131055|NCT00539006|420918|P4|Treatment Period 1|Protocol Violation|0
131056|NCT00539006|420919|P3|Treatment Period 1|Protocol Violation|1
131057|NCT00539006|420920|P2|Treatment Period 1|Protocol Violation|0
131058|NCT00539006|420921|P1|Treatment Period 1|Protocol Violation|0
131059|NCT00539006|420918|P4|Treatment Period 1|Lost to Follow-up|0
131060|NCT00539006|420919|P3|Treatment Period 1|Lost to Follow-up|1
131061|NCT00539006|420920|P2|Treatment Period 1|Lost to Follow-up|0
131062|NCT00539006|420921|P1|Treatment Period 1|Lost to Follow-up|0
131063|NCT00539006|420918|P4|Pre-treatment|Other|0
131064|NCT00539006|420919|P3|Pre-treatment|Other|0
131065|NCT00539006|420920|P2|Pre-treatment|Other|1
131066|NCT00539006|420921|P1|Pre-treatment|Other|0
131067|NCT00539513|420953|P2|Overall Study|Lost to Follow-up|1
131068|NCT00539513|420954|P1|Overall Study|Lost to Follow-up|0
131069|NCT00539513|420953|P2|Overall Study|Withdrawal by Subject|1
131070|NCT00539513|420954|P1|Overall Study|Withdrawal by Subject|2
131071|NCT00539591|421011|P3|Overall Study|Disease progression|3
131072|NCT00539591|421012|P2|Overall Study|Disease progression|2
131073|NCT00539591|421013|P1|Overall Study|Disease progression|2
131074|NCT00539591|421011|P3|Overall Study|Toxicity|0
131075|NCT00539591|421012|P2|Overall Study|Toxicity|0
131076|NCT00539591|421013|P1|Overall Study|Toxicity|3
131077|NCT00539734|421130|P1|Overall Study|Protocol Violation|1
131078|NCT00539864|421137|P2|Overall Study|Withdrawal by Subject|1
131079|NCT00539864|421138|P1|Overall Study|Withdrawal by Subject|1
131080|NCT00539864|421137|P2|Overall Study|Lost to Follow-up|1
131081|NCT00539864|421138|P1|Overall Study|Lost to Follow-up|0
131082|NCT00539994|421164|P3|Overall Study|Physician Decision|1
131083|NCT00539994|421165|P2|Overall Study|Physician Decision|0
131084|NCT00539994|421166|P1|Overall Study|Physician Decision|0
131085|NCT00539994|421164|P3|Overall Study|Withdrawal by Subject|1
131086|NCT00539994|421165|P2|Overall Study|Withdrawal by Subject|0
131087|NCT00539994|421166|P1|Overall Study|Withdrawal by Subject|1
131088|NCT00539994|421164|P3|Overall Study|Lost to Follow-up|0
131089|NCT00539994|421165|P2|Overall Study|Lost to Follow-up|1
131090|NCT00539994|421166|P1|Overall Study|Lost to Follow-up|2
131091|NCT00540046|421205|P2|Overall Study|Lost to Follow-up|23
131092|NCT00540046|421206|P1|Overall Study|Lost to Follow-up|33
131093|NCT00540124|421217|P3|Overall Study|Withdrawal by Subject|0
131094|NCT00540124|421218|P2|Overall Study|Withdrawal by Subject|1
131095|NCT00540124|421219|P1|Overall Study|Withdrawal by Subject|1
131096|NCT00540124|421217|P3|Overall Study|Lack of Efficacy|0
131097|NCT00540124|421218|P2|Overall Study|Lack of Efficacy|0
131098|NCT00540124|421219|P1|Overall Study|Lack of Efficacy|1
131099|NCT00540124|421217|P3|Overall Study|Entry Criteria Not Met|0
131100|NCT00540124|421218|P2|Overall Study|Entry Criteria Not Met|0
131101|NCT00540124|421219|P1|Overall Study|Entry Criteria Not Met|2
131102|NCT00540124|421217|P3|Overall Study|Adverse Event|1
131103|NCT00540124|421218|P2|Overall Study|Adverse Event|2
131104|NCT00540124|421219|P1|Overall Study|Adverse Event|0
131105|NCT00540228|421268|P5|Overall Study|Lost to Follow-up|0
131106|NCT00540228|421269|P4|Overall Study|Lost to Follow-up|0
131107|NCT00540228|421270|P3|Overall Study|Lost to Follow-up|0
131108|NCT00540228|421271|P2|Overall Study|Lost to Follow-up|1
131109|NCT00540228|421272|P1|Overall Study|Lost to Follow-up|1
131110|NCT00540228|421268|P5|Overall Study|Adverse Event|0
131111|NCT00540228|421269|P4|Overall Study|Adverse Event|0
131112|NCT00540228|421270|P3|Overall Study|Adverse Event|0
131113|NCT00540228|421271|P2|Overall Study|Adverse Event|0
131114|NCT00540228|421272|P1|Overall Study|Adverse Event|2
131115|NCT00540293|421339|P1|Overall Study|Protocol violation, & subject schedule|12
131116|NCT00540293|421339|P1|Overall Study|Withdrawal by Subject|6
131117|NCT00540293|421339|P1|Overall Study|Adverse event not related to study drug|7
131118|NCT00540293|421339|P1|Overall Study|Adverse event related to study drug|10
131119|NCT00540423|421384|P3|Open-Label Treatment Period|Lack of Efficacy|2
131120|NCT00540423|421385|P2|Open-Label Treatment Period|Lack of Efficacy|0
131121|NCT00540423|421386|P1|Open-Label Treatment Period|Lack of Efficacy|0
131122|NCT00540423|421384|P3|Double-Blind Treatment Period|Adverse Event|0
131123|NCT00540423|421385|P2|Double-Blind Treatment Period|Adverse Event|1
131124|NCT00540423|421386|P1|Double-Blind Treatment Period|Adverse Event|0
131125|NCT00540436|421436|P1|Second 12-Week Treatment Period|Adverse Event|1
131126|NCT00540436|421436|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
131463|NCT00532935|422329|P2|Overall Study|Pregnancy|0
131127|NCT00540436|421436|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
131128|NCT00540436|421436|P1|First 12-Week Treatment Period|Adverse Event|1
131129|NCT00540449|421451|P2|Overall Study|Not specified|4
131130|NCT00540449|421452|P1|Overall Study|Not specified|1
131131|NCT00540449|421451|P2|Overall Study|Withdrawal by Subject|10
131132|NCT00540449|421452|P1|Overall Study|Withdrawal by Subject|10
131133|NCT00540449|421451|P2|Overall Study|Subject Reached A Virologic Endpoint|8
131134|NCT00540449|421452|P1|Overall Study|Subject Reached A Virologic Endpoint|32
131135|NCT00540449|421451|P2|Overall Study|Subject Non-Compliant|5
131136|NCT00540449|421452|P1|Overall Study|Subject Non-Compliant|7
131137|NCT00540449|421451|P2|Overall Study|Lost to Follow-up|17
131138|NCT00540449|421452|P1|Overall Study|Lost to Follow-up|19
131139|NCT00540449|421451|P2|Overall Study|Subject Ineligible To Continue The Trial|1
131140|NCT00540449|421452|P1|Overall Study|Subject Ineligible To Continue The Trial|2
131141|NCT00540449|421451|P2|Overall Study|Sponsor's Decision|1
131142|NCT00540449|421452|P1|Overall Study|Sponsor's Decision|1
131143|NCT00540449|421451|P2|Overall Study|Adverse Event|32
131144|NCT00540449|421452|P1|Overall Study|Adverse Event|12
131145|NCT00540514|421476|P2|Overall Study|Paclitaxel not available|2
131146|NCT00540514|421477|P1|Overall Study|Paclitaxel not available|0
131147|NCT00540514|421476|P2|Overall Study|Excluded prior to treatment|7
131148|NCT00540514|421477|P1|Overall Study|Excluded prior to treatment|7
131149|NCT00540514|421476|P2|Overall Study|Withdrawal by Subject|67
131150|NCT00540514|421477|P1|Overall Study|Withdrawal by Subject|65
131151|NCT00540514|421476|P2|Overall Study|Lost to Follow-up|1
131152|NCT00540514|421477|P1|Overall Study|Lost to Follow-up|1
131153|NCT00540514|421476|P2|Overall Study|Protocol Deviation|4
131154|NCT00540514|421477|P1|Overall Study|Protocol Deviation|3
131155|NCT00540514|421476|P2|Overall Study|Physician Decision|99
131156|NCT00540514|421477|P1|Overall Study|Physician Decision|86
131157|NCT00540514|421476|P2|Overall Study|Adverse Event|24
131158|NCT00540514|421477|P1|Overall Study|Adverse Event|20
131159|NCT00540514|421476|P2|Overall Study|Unacceptable Toxicity|62
131160|NCT00540514|421477|P1|Overall Study|Unacceptable Toxicity|61
131161|NCT00540514|421476|P2|Overall Study|Still on treatment|0
131162|NCT00540514|421477|P1|Overall Study|Still on treatment|3
131163|NCT00540592|421522|P10|Overall Study|Withdrawal by Subject|0
131164|NCT00540592|421523|P9|Overall Study|Withdrawal by Subject|0
131165|NCT00540592|421524|P8|Overall Study|Withdrawal by Subject|0
131166|NCT00540592|421525|P7|Overall Study|Withdrawal by Subject|0
131167|NCT00540592|421526|P6|Overall Study|Withdrawal by Subject|0
131168|NCT00540592|421527|P5|Overall Study|Withdrawal by Subject|0
131169|NCT00540592|421528|P4|Overall Study|Withdrawal by Subject|1
131170|NCT00540592|421529|P3|Overall Study|Withdrawal by Subject|1
131171|NCT00540592|421530|P2|Overall Study|Withdrawal by Subject|0
131172|NCT00540592|421531|P1|Overall Study|Withdrawal by Subject|0
131173|NCT00540592|421522|P10|Overall Study|Lost to Follow-up|0
131174|NCT00540592|421523|P9|Overall Study|Lost to Follow-up|0
131175|NCT00540592|421524|P8|Overall Study|Lost to Follow-up|0
131176|NCT00540592|421525|P7|Overall Study|Lost to Follow-up|0
131177|NCT00540592|421526|P6|Overall Study|Lost to Follow-up|0
131178|NCT00540592|421527|P5|Overall Study|Lost to Follow-up|0
131179|NCT00540592|421528|P4|Overall Study|Lost to Follow-up|0
131180|NCT00540592|421529|P3|Overall Study|Lost to Follow-up|0
131181|NCT00540592|421530|P2|Overall Study|Lost to Follow-up|0
131182|NCT00540592|421531|P1|Overall Study|Lost to Follow-up|2
131183|NCT00540592|421522|P10|Overall Study|Adverse Event|2
131184|NCT00540592|421523|P9|Overall Study|Adverse Event|1
131185|NCT00540592|421524|P8|Overall Study|Adverse Event|1
131186|NCT00540592|421525|P7|Overall Study|Adverse Event|0
131187|NCT00540592|421526|P6|Overall Study|Adverse Event|0
131188|NCT00540592|421527|P5|Overall Study|Adverse Event|1
131189|NCT00540592|421528|P4|Overall Study|Adverse Event|0
131190|NCT00540592|421529|P3|Overall Study|Adverse Event|0
131191|NCT00540592|421530|P2|Overall Study|Adverse Event|1
131192|NCT00540592|421531|P1|Overall Study|Adverse Event|0
131193|NCT00540644|421765|P2|Overall Study|Noncomplilance|0
131194|NCT00540644|421766|P1|Overall Study|Noncomplilance|1
131195|NCT00540644|421765|P2|Overall Study|Withdrawal by Subject|2
131196|NCT00540644|421766|P1|Overall Study|Withdrawal by Subject|2
131197|NCT00540644|421765|P2|Overall Study|Physician Decision|5
131198|NCT00540644|421766|P1|Overall Study|Physician Decision|0
131199|NCT00540644|421765|P2|Overall Study|Disease Progression|1
131200|NCT00540644|421766|P1|Overall Study|Disease Progression|3
131201|NCT00540644|421765|P2|Overall Study|Adverse Event|1
131202|NCT00540644|421766|P1|Overall Study|Adverse Event|3
131203|NCT00541034|421797|P1|Overall Study|Non-Compliance|3
131204|NCT00541099|421801|P1|Overall Study|Ineligible|3
131205|NCT00541229|421822|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
131206|NCT00541229|421823|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
131207|NCT00541229|421824|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
131208|NCT00541229|421825|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
131209|NCT00541229|421826|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
131210|NCT00541229|421827|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
131211|NCT00541229|421822|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
131212|NCT00541229|421823|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
131464|NCT00532935|422330|P1|Overall Study|Pregnancy|1
131213|NCT00541229|421824|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
131214|NCT00541229|421825|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
131215|NCT00541229|421826|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
131216|NCT00541229|421827|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
131217|NCT00541229|421822|P6|Treatment Period III (Week 11)|Adverse Event|0
131218|NCT00541229|421823|P5|Treatment Period III (Week 11)|Adverse Event|1
131219|NCT00541229|421824|P4|Treatment Period III (Week 11)|Adverse Event|0
131220|NCT00541229|421825|P3|Treatment Period III (Week 11)|Adverse Event|0
131221|NCT00541229|421826|P2|Treatment Period III (Week 11)|Adverse Event|0
131222|NCT00541229|421827|P1|Treatment Period III (Week 11)|Adverse Event|0
131223|NCT00541229|421822|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
131224|NCT00541229|421823|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
131225|NCT00541229|421824|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
131226|NCT00541229|421825|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
131227|NCT00541229|421826|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
131228|NCT00541229|421827|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
131229|NCT00541229|421822|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
131230|NCT00541229|421823|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
131231|NCT00541229|421824|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
131232|NCT00541229|421825|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
131233|NCT00541229|421826|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
131234|NCT00541229|421827|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
131235|NCT00541229|421822|P6|Washout Period II (Week 7-10)|Protocol Violation|0
131236|NCT00541229|421823|P5|Washout Period II (Week 7-10)|Protocol Violation|0
131237|NCT00541229|421824|P4|Washout Period II (Week 7-10)|Protocol Violation|0
131238|NCT00541229|421825|P3|Washout Period II (Week 7-10)|Protocol Violation|0
131239|NCT00541229|421826|P2|Washout Period II (Week 7-10)|Protocol Violation|0
131240|NCT00541229|421827|P1|Washout Period II (Week 7-10)|Protocol Violation|1
131241|NCT00541229|421822|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
131242|NCT00541229|421823|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
131243|NCT00541229|421824|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
131244|NCT00541229|421825|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
131245|NCT00541229|421826|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
131246|NCT00541229|421827|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
131247|NCT00541229|421822|P6|Treatment Period II (Week 6)|Protocol Violation|1
131248|NCT00541229|421823|P5|Treatment Period II (Week 6)|Protocol Violation|1
131249|NCT00541229|421824|P4|Treatment Period II (Week 6)|Protocol Violation|0
131250|NCT00541229|421825|P3|Treatment Period II (Week 6)|Protocol Violation|0
131251|NCT00541229|421826|P2|Treatment Period II (Week 6)|Protocol Violation|0
131252|NCT00541229|421827|P1|Treatment Period II (Week 6)|Protocol Violation|0
131253|NCT00541229|421822|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
131335|NCT00541450|421871|P1|Phase A|Adverse Event|3
131254|NCT00541229|421823|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
131255|NCT00541229|421824|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
131256|NCT00541229|421825|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
131257|NCT00541229|421826|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
131258|NCT00541229|421827|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
131259|NCT00541229|421822|P6|Washout Period I (Week 2-5)|Protocol Violation|1
131260|NCT00541229|421823|P5|Washout Period I (Week 2-5)|Protocol Violation|0
131261|NCT00541229|421824|P4|Washout Period I (Week 2-5)|Protocol Violation|0
131262|NCT00541229|421825|P3|Washout Period I (Week 2-5)|Protocol Violation|0
131263|NCT00541229|421826|P2|Washout Period I (Week 2-5)|Protocol Violation|0
131264|NCT00541229|421827|P1|Washout Period I (Week 2-5)|Protocol Violation|0
131265|NCT00541229|421822|P6|Washout Period I (Week 2-5)|Physician Decision|0
131266|NCT00541229|421823|P5|Washout Period I (Week 2-5)|Physician Decision|0
131267|NCT00541229|421824|P4|Washout Period I (Week 2-5)|Physician Decision|1
131268|NCT00541229|421825|P3|Washout Period I (Week 2-5)|Physician Decision|0
131269|NCT00541229|421826|P2|Washout Period I (Week 2-5)|Physician Decision|0
131270|NCT00541229|421827|P1|Washout Period I (Week 2-5)|Physician Decision|0
131271|NCT00541229|421822|P6|Washout Period I (Week 2-5)|Adverse Event|0
131272|NCT00541229|421823|P5|Washout Period I (Week 2-5)|Adverse Event|0
131273|NCT00541229|421824|P4|Washout Period I (Week 2-5)|Adverse Event|0
131274|NCT00541229|421825|P3|Washout Period I (Week 2-5)|Adverse Event|1
131275|NCT00541229|421826|P2|Washout Period I (Week 2-5)|Adverse Event|0
131276|NCT00541229|421827|P1|Washout Period I (Week 2-5)|Adverse Event|1
131277|NCT00541229|421822|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
131278|NCT00541229|421823|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
131279|NCT00541229|421824|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
131280|NCT00541229|421825|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
131281|NCT00541229|421826|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
131282|NCT00541229|421827|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
131283|NCT00541229|421822|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
131284|NCT00541229|421823|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
131285|NCT00541229|421824|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
131286|NCT00541229|421825|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
131287|NCT00541229|421826|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
131288|NCT00541229|421827|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
131289|NCT00541229|421822|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
131290|NCT00541229|421823|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
131291|NCT00541229|421824|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
131292|NCT00541229|421825|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
131293|NCT00541229|421826|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
131294|NCT00541229|421827|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
131295|NCT00541229|421822|P6|Treatment Period I (Week 1)|Physician Decision|0
131296|NCT00541229|421823|P5|Treatment Period I (Week 1)|Physician Decision|0
131297|NCT00541229|421824|P4|Treatment Period I (Week 1)|Physician Decision|0
131298|NCT00541229|421825|P3|Treatment Period I (Week 1)|Physician Decision|1
131299|NCT00541229|421826|P2|Treatment Period I (Week 1)|Physician Decision|0
131300|NCT00541229|421827|P1|Treatment Period I (Week 1)|Physician Decision|0
131301|NCT00541307|421846|P1|Overall Study|Surgical Bypass|5
131302|NCT00541307|421846|P1|Overall Study|Subject returned early (outside window)|1
131303|NCT00541307|421846|P1|Overall Study|Lost to Follow-up|4
131304|NCT00541307|421846|P1|Overall Study|Withdrawal by Subject|6
131305|NCT00541307|421846|P1|Overall Study|Physician Decision|3
131306|NCT00541307|421846|P1|Overall Study|Death|5
131307|NCT00541346|421854|P1|Follow-up|Adverse Event|1
131308|NCT00541450|421870|P2|Phase B|Withdrawal by Subject|6
131309|NCT00541450|421871|P1|Phase B|Withdrawal by Subject|8
131310|NCT00541450|421870|P2|Phase B|Protocol Violation|3
131311|NCT00541450|421871|P1|Phase B|Protocol Violation|3
131312|NCT00541450|421870|P2|Phase B|Pregnancy|1
131313|NCT00541450|421871|P1|Phase B|Pregnancy|0
131314|NCT00541450|421870|P2|Phase B|Physician Decision|2
131315|NCT00541450|421871|P1|Phase B|Physician Decision|4
131316|NCT00541450|421870|P2|Phase B|Lost to Follow-up|4
131317|NCT00541450|421871|P1|Phase B|Lost to Follow-up|6
131318|NCT00541450|421870|P2|Phase B|Hyperglycemia|9
131319|NCT00541450|421871|P1|Phase B|Hyperglycemia|10
131320|NCT00541450|421870|P2|Phase B|Adverse Event|6
131321|NCT00541450|421871|P1|Phase B|Adverse Event|6
131322|NCT00541450|421870|P2|Phase A|Withdrawal by Subject|7
131323|NCT00541450|421871|P1|Phase A|Withdrawal by Subject|7
131324|NCT00541450|421870|P2|Phase A|Protocol Violation|3
131325|NCT00541450|421871|P1|Phase A|Protocol Violation|2
131326|NCT00541450|421870|P2|Phase A|Physician Decision|0
131327|NCT00541450|421871|P1|Phase A|Physician Decision|2
131328|NCT00541450|421870|P2|Phase A|Lost to Follow-up|4
131329|NCT00541450|421871|P1|Phase A|Lost to Follow-up|6
131330|NCT00541450|421870|P2|Phase A|Hyperglycemia|1
131331|NCT00541450|421871|P1|Phase A|Hyperglycemia|0
131332|NCT00541450|421870|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
131333|NCT00541450|421871|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
131334|NCT00541450|421870|P2|Phase A|Adverse Event|0
131336|NCT00541658|421896|P3|Overall Study|Took No Study Drug|0
131337|NCT00541658|421897|P2|Overall Study|Took No Study Drug|0
131338|NCT00541658|421898|P1|Overall Study|Took No Study Drug|1
131339|NCT00541658|421896|P3|Overall Study|Withdrawal by Subject|32
131340|NCT00541658|421897|P2|Overall Study|Withdrawal by Subject|32
131341|NCT00541658|421898|P1|Overall Study|Withdrawal by Subject|28
131342|NCT00541658|421896|P3|Overall Study|Protocol Violation|1
131343|NCT00541658|421897|P2|Overall Study|Protocol Violation|1
131344|NCT00541658|421898|P1|Overall Study|Protocol Violation|0
131345|NCT00541658|421896|P3|Overall Study|Lost to Follow-up|6
131346|NCT00541658|421897|P2|Overall Study|Lost to Follow-up|3
131347|NCT00541658|421898|P1|Overall Study|Lost to Follow-up|3
131348|NCT00541658|421896|P3|Overall Study|Physician Decision|4
131349|NCT00541658|421897|P2|Overall Study|Physician Decision|0
131350|NCT00541658|421898|P1|Overall Study|Physician Decision|0
131351|NCT00541658|421896|P3|Overall Study|Adverse Event|25
131352|NCT00541658|421897|P2|Overall Study|Adverse Event|37
131353|NCT00541658|421898|P1|Overall Study|Adverse Event|28
131354|NCT00541775|422067|P3|Overall Study|Withdrawal by Subject and Other|2
131355|NCT00541775|422068|P2|Overall Study|Withdrawal by Subject and Other|0
131356|NCT00541775|422069|P1|Overall Study|Withdrawal by Subject and Other|5
131357|NCT00541775|422067|P3|Overall Study|Protocol Violation|0
131358|NCT00541775|422068|P2|Overall Study|Protocol Violation|0
131359|NCT00541775|422069|P1|Overall Study|Protocol Violation|1
131360|NCT00541775|422067|P3|Overall Study|Lost to Follow-up|2
131361|NCT00541775|422068|P2|Overall Study|Lost to Follow-up|0
131362|NCT00541775|422069|P1|Overall Study|Lost to Follow-up|0
131363|NCT00541775|422067|P3|Overall Study|Lack of Efficacy|3
131364|NCT00541775|422068|P2|Overall Study|Lack of Efficacy|0
131365|NCT00541775|422069|P1|Overall Study|Lack of Efficacy|0
131366|NCT00541775|422067|P3|Overall Study|Adverse Event|1
131367|NCT00541775|422068|P2|Overall Study|Adverse Event|2
131368|NCT00541775|422069|P1|Overall Study|Adverse Event|3
131369|NCT00526799|422085|P2|Overall Study|Intercurrent Complicating Disease|1
131370|NCT00526799|422086|P1|Overall Study|Intercurrent Complicating Disease|0
131371|NCT00526799|422085|P2|Overall Study|Withdrawal by Subject|0
131372|NCT00526799|422086|P1|Overall Study|Withdrawal by Subject|1
131373|NCT00526890|422094|P1|Overall Study|Adverse Event|2
131374|NCT00526890|422094|P1|Overall Study|Not treated (became ineligible)|5
131375|NCT00526994|422106|P3|Overall Study|incarcerated, impaired, incomplete|3
131376|NCT00526994|422107|P2|Overall Study|incarcerated, impaired, incomplete|3
131377|NCT00526994|422108|P1|Overall Study|incarcerated, impaired, incomplete|4
131378|NCT00526994|422106|P3|Overall Study|Withdrawal by Subject|5
131379|NCT00526994|422107|P2|Overall Study|Withdrawal by Subject|7
131380|NCT00526994|422108|P1|Overall Study|Withdrawal by Subject|2
131381|NCT00526994|422106|P3|Overall Study|Death|3
131382|NCT00526994|422107|P2|Overall Study|Death|3
131383|NCT00526994|422108|P1|Overall Study|Death|4
131384|NCT00526994|422106|P3|Overall Study|Lost to Follow-up|96
131385|NCT00526994|422107|P2|Overall Study|Lost to Follow-up|108
131386|NCT00526994|422108|P1|Overall Study|Lost to Follow-up|98
131387|NCT00527072|422125|P1|Overall Study|Withdrawal by Subject|7
131388|NCT00527072|422125|P1|Overall Study|Protocol Violation|2
131389|NCT00527072|422125|P1|Overall Study|Lost to Follow-up|3
131390|NCT00527072|422125|P1|Overall Study|Lack of Efficacy|11
131391|NCT00527072|422125|P1|Overall Study|Adverse Event|13
131392|NCT00527111|422141|P2|Overall Study|Other|2
131393|NCT00527111|422142|P1|Overall Study|Other|2
131394|NCT00527111|422141|P2|Overall Study|Patient Request|5
131395|NCT00527111|422142|P1|Overall Study|Patient Request|2
131396|NCT00527111|422141|P2|Overall Study|Investigator Request|1
131397|NCT00527111|422142|P1|Overall Study|Investigator Request|2
131398|NCT00527111|422141|P2|Overall Study|Death|1
131399|NCT00527111|422142|P1|Overall Study|Death|0
131400|NCT00527111|422141|P2|Overall Study|Adverse Event|13
131401|NCT00527111|422142|P1|Overall Study|Adverse Event|14
131402|NCT00527319|422168|P3|Overall Study|Adverse Event|1
131403|NCT00527319|422169|P2|Overall Study|Adverse Event|0
131404|NCT00527319|422170|P1|Overall Study|Adverse Event|0
131405|NCT00527319|422168|P3|Overall Study|Intercurrent Medical Illness|3
131406|NCT00527319|422169|P2|Overall Study|Intercurrent Medical Illness|1
131407|NCT00527319|422170|P1|Overall Study|Intercurrent Medical Illness|0
131408|NCT00527319|422168|P3|Overall Study|Death|1
131409|NCT00527319|422169|P2|Overall Study|Death|3
131410|NCT00527319|422170|P1|Overall Study|Death|0
131411|NCT00527319|422168|P3|Overall Study|Lost to Follow-up|0
131412|NCT00527319|422169|P2|Overall Study|Lost to Follow-up|0
131413|NCT00527319|422170|P1|Overall Study|Lost to Follow-up|1
131414|NCT00527319|422168|P3|Overall Study|Withdrawal by Subject|1
131415|NCT00527319|422169|P2|Overall Study|Withdrawal by Subject|0
131416|NCT00527319|422170|P1|Overall Study|Withdrawal by Subject|5
131417|NCT00527332|422183|P2|Overall Study|Withdrew consent|1
131418|NCT00527332|422184|P1|Overall Study|Withdrew consent|5
131419|NCT00527332|422183|P2|Overall Study|Protocol Violation|8
131420|NCT00527332|422184|P1|Overall Study|Protocol Violation|4
131421|NCT00527397|422190|P1|Overall Study|Study terminated by sponsor|13
131422|NCT00527397|422190|P1|Overall Study|Withdrawal by Subject|6
131423|NCT00527397|422190|P1|Overall Study|Protocol Violation|1
131424|NCT00527397|422190|P1|Overall Study|Lack of Efficacy|1
131425|NCT00527397|422190|P1|Overall Study|Adverse Event|3
131426|NCT00527423|422214|P1|Overall Study|Death|9
131427|NCT00527423|422214|P1|Overall Study|OTHER|4
131428|NCT00527423|422214|P1|Overall Study|Lost to Follow-up|4
131429|NCT00527423|422214|P1|Overall Study|Withdrawal by Subject|10
131430|NCT00527423|422214|P1|Overall Study|Physician Decision|4
131431|NCT00527423|422214|P1|Overall Study|Adverse Event|5
131432|NCT00527423|422214|P1|Overall Study|Protocol Violation|1
131433|NCT00527488|422233|P4|Overall Study|Withdrawn prior to dosing|0
131434|NCT00527488|422234|P3|Overall Study|Withdrawn prior to dosing|1
131435|NCT00527488|422235|P2|Overall Study|Withdrawn prior to dosing|1
131436|NCT00527488|422236|P1|Overall Study|Withdrawn prior to dosing|0
131437|NCT00532883|422314|P4|Overall Study|Early Study Termination|4
131438|NCT00532883|422315|P3|Overall Study|Early Study Termination|1
131439|NCT00532883|422316|P2|Overall Study|Early Study Termination|4
131440|NCT00532883|422317|P1|Overall Study|Early Study Termination|4
131441|NCT00532883|422314|P4|Overall Study|Subject was Nonadherent|0
131442|NCT00532883|422315|P3|Overall Study|Subject was Nonadherent|1
131443|NCT00532883|422316|P2|Overall Study|Subject was Nonadherent|1
131444|NCT00532883|422317|P1|Overall Study|Subject was Nonadherent|0
131445|NCT00532883|422314|P4|Overall Study|Withdrawal by Subject|0
131446|NCT00532883|422315|P3|Overall Study|Withdrawal by Subject|1
131447|NCT00532883|422316|P2|Overall Study|Withdrawal by Subject|1
131448|NCT00532883|422317|P1|Overall Study|Withdrawal by Subject|0
131449|NCT00532883|422314|P4|Overall Study|Lost to Follow-up|0
131450|NCT00532883|422315|P3|Overall Study|Lost to Follow-up|1
131451|NCT00532883|422316|P2|Overall Study|Lost to Follow-up|1
131452|NCT00532883|422317|P1|Overall Study|Lost to Follow-up|1
131453|NCT00532883|422314|P4|Overall Study|Adverse Event|1
131454|NCT00532883|422315|P3|Overall Study|Adverse Event|0
131455|NCT00532883|422316|P2|Overall Study|Adverse Event|0
131456|NCT00532883|422317|P1|Overall Study|Adverse Event|1
131457|NCT00532935|422329|P2|Overall Study|Protocol Specific Criteria|15
131458|NCT00532935|422330|P1|Overall Study|Protocol Specific Criteria|11
131459|NCT00532935|422329|P2|Overall Study|Withdrawal by Subject|9
131460|NCT00532935|422330|P1|Overall Study|Withdrawal by Subject|10
131461|NCT00532935|422329|P2|Overall Study|Protocol Violation|2
131462|NCT00532935|422330|P1|Overall Study|Protocol Violation|4
131465|NCT00532935|422329|P2|Overall Study|Physician Decision|5
131466|NCT00532935|422330|P1|Overall Study|Physician Decision|4
131467|NCT00532935|422329|P2|Overall Study|Lost to Follow-up|6
131468|NCT00532935|422330|P1|Overall Study|Lost to Follow-up|10
131469|NCT00532935|422329|P2|Overall Study|Lack of Efficacy|3
131470|NCT00532935|422330|P1|Overall Study|Lack of Efficacy|0
131471|NCT00532935|422329|P2|Overall Study|Adverse Event|12
131472|NCT00532935|422330|P1|Overall Study|Adverse Event|11
131473|NCT00532948|422347|P3|Overall Study|Failure to return|0
131474|NCT00532948|422348|P2|Overall Study|Failure to return|1
131475|NCT00532948|422349|P1|Overall Study|Failure to return|0
131476|NCT00532948|422347|P3|Overall Study|Violation of selection criteria at entry|0
131477|NCT00532948|422348|P2|Overall Study|Violation of selection criteria at entry|1
131478|NCT00532948|422349|P1|Overall Study|Violation of selection criteria at entry|0
131479|NCT00532948|422347|P3|Overall Study|Death|4
131480|NCT00532948|422348|P2|Overall Study|Death|3
131481|NCT00532948|422349|P1|Overall Study|Death|3
131482|NCT00532948|422347|P3|Overall Study|Protocol Violation|0
131483|NCT00532948|422348|P2|Overall Study|Protocol Violation|0
131484|NCT00532948|422349|P1|Overall Study|Protocol Violation|1
131485|NCT00533702|422381|P2|Overall Study|Found ineligible after randomization|1
131486|NCT00533702|422382|P1|Overall Study|Found ineligible after randomization|2
131487|NCT00533702|422381|P2|Overall Study|Withdrawal by Subject|1
131488|NCT00533702|422382|P1|Overall Study|Withdrawal by Subject|3
131489|NCT00533897|422409|P8|Long Term Extension (LTE)|not specified|6
131490|NCT00533897|422410|P7|Long Term Extension (LTE)|not specified|1
131491|NCT00533897|422411|P6|Long Term Extension (LTE)|not specified|0
131492|NCT00533897|422412|P5|Long Term Extension (LTE)|not specified|0
131493|NCT00533897|422413|P4|Long Term Extension (LTE)|not specified|0
131494|NCT00533897|422414|P3|Long Term Extension (LTE)|not specified|0
131495|NCT00533897|422415|P2|Long Term Extension (LTE)|not specified|0
131496|NCT00533897|422416|P1|Long Term Extension (LTE)|not specified|0
131497|NCT00533897|422409|P8|Long Term Extension (LTE)|Lost to Follow-up|1
131498|NCT00533897|422410|P7|Long Term Extension (LTE)|Lost to Follow-up|1
131499|NCT00533897|422411|P6|Long Term Extension (LTE)|Lost to Follow-up|0
131500|NCT00533897|422412|P5|Long Term Extension (LTE)|Lost to Follow-up|0
131501|NCT00533897|422413|P4|Long Term Extension (LTE)|Lost to Follow-up|0
131502|NCT00533897|422414|P3|Long Term Extension (LTE)|Lost to Follow-up|0
131503|NCT00533897|422415|P2|Long Term Extension (LTE)|Lost to Follow-up|0
131504|NCT00533897|422416|P1|Long Term Extension (LTE)|Lost to Follow-up|0
131505|NCT00533897|422409|P8|Long Term Extension (LTE)|Pregnancy|2
131506|NCT00533897|422410|P7|Long Term Extension (LTE)|Pregnancy|0
131507|NCT00533897|422411|P6|Long Term Extension (LTE)|Pregnancy|0
131508|NCT00533897|422412|P5|Long Term Extension (LTE)|Pregnancy|0
131509|NCT00533897|422413|P4|Long Term Extension (LTE)|Pregnancy|0
131510|NCT00533897|422414|P3|Long Term Extension (LTE)|Pregnancy|0
131511|NCT00533897|422415|P2|Long Term Extension (LTE)|Pregnancy|0
131512|NCT00533897|422416|P1|Long Term Extension (LTE)|Pregnancy|0
131513|NCT00533897|422409|P8|Long Term Extension (LTE)|Adverse Event|5
131514|NCT00533897|422410|P7|Long Term Extension (LTE)|Adverse Event|2
131515|NCT00533897|422411|P6|Long Term Extension (LTE)|Adverse Event|0
131516|NCT00533897|422412|P5|Long Term Extension (LTE)|Adverse Event|0
131517|NCT00533897|422413|P4|Long Term Extension (LTE)|Adverse Event|0
131518|NCT00533897|422414|P3|Long Term Extension (LTE)|Adverse Event|0
131519|NCT00533897|422415|P2|Long Term Extension (LTE)|Adverse Event|0
131520|NCT00533897|422416|P1|Long Term Extension (LTE)|Adverse Event|0
131521|NCT00533897|422409|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
131522|NCT00533897|422410|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
131523|NCT00533897|422411|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
131524|NCT00533897|422412|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
131525|NCT00533897|422413|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
131526|NCT00533897|422414|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
131527|NCT00533897|422415|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
131528|NCT00533897|422416|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
131529|NCT00533897|422409|P8|Long Term Extension (LTE)|Lack of Efficacy|3
131530|NCT00533897|422410|P7|Long Term Extension (LTE)|Lack of Efficacy|5
131531|NCT00533897|422411|P6|Long Term Extension (LTE)|Lack of Efficacy|0
131532|NCT00533897|422412|P5|Long Term Extension (LTE)|Lack of Efficacy|0
131533|NCT00533897|422413|P4|Long Term Extension (LTE)|Lack of Efficacy|0
131534|NCT00533897|422414|P3|Long Term Extension (LTE)|Lack of Efficacy|0
131535|NCT00533897|422415|P2|Long Term Extension (LTE)|Lack of Efficacy|0
131536|NCT00533897|422416|P1|Long Term Extension (LTE)|Lack of Efficacy|0
131537|NCT00533897|422409|P8|Long Term Extension (LTE)|Death|3
131538|NCT00533897|422410|P7|Long Term Extension (LTE)|Death|1
131539|NCT00533897|422411|P6|Long Term Extension (LTE)|Death|0
131540|NCT00533897|422412|P5|Long Term Extension (LTE)|Death|0
131541|NCT00533897|422413|P4|Long Term Extension (LTE)|Death|0
131542|NCT00533897|422414|P3|Long Term Extension (LTE)|Death|0
131543|NCT00533897|422415|P2|Long Term Extension (LTE)|Death|0
131544|NCT00533897|422416|P1|Long Term Extension (LTE)|Death|0
131545|NCT00533897|422409|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
131546|NCT00533897|422410|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
131547|NCT00533897|422411|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
131548|NCT00533897|422412|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
131549|NCT00533897|422413|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
131550|NCT00533897|422414|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
131551|NCT00533897|422415|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
131552|NCT00533897|422416|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
131553|NCT00533897|422409|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131554|NCT00533897|422410|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131555|NCT00533897|422411|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
131556|NCT00533897|422412|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131557|NCT00533897|422413|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131558|NCT00533897|422414|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131559|NCT00533897|422415|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131560|NCT00533897|422416|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
131561|NCT00533897|422409|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131562|NCT00533897|422410|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131563|NCT00533897|422411|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
131564|NCT00533897|422412|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131565|NCT00533897|422413|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131566|NCT00533897|422414|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131567|NCT00533897|422415|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131568|NCT00533897|422416|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
131569|NCT00533897|422409|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131570|NCT00533897|422410|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131571|NCT00533897|422411|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131572|NCT00533897|422412|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131573|NCT00533897|422413|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131574|NCT00533897|422414|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
131575|NCT00533897|422415|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131576|NCT00533897|422416|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
131577|NCT00533897|422409|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
131578|NCT00533897|422410|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
131579|NCT00533897|422411|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
131580|NCT00533897|422412|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
131581|NCT00533897|422413|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
131582|NCT00533897|422414|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
131583|NCT00533897|422415|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
131584|NCT00533897|422416|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
131585|NCT00533897|422409|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131586|NCT00533897|422410|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131587|NCT00533897|422411|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131588|NCT00533897|422412|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131589|NCT00533897|422413|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131590|NCT00533897|422414|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131591|NCT00533897|422415|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
131592|NCT00533897|422416|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
131593|NCT00533897|422409|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
131594|NCT00533897|422410|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
131595|NCT00533897|422411|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
131596|NCT00533897|422412|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
131597|NCT00533897|422413|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
131598|NCT00533897|422414|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
131599|NCT00533897|422415|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
131600|NCT00533897|422416|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
131601|NCT00533897|422409|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131602|NCT00533897|422410|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131603|NCT00533897|422411|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131604|NCT00533897|422412|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131605|NCT00533897|422413|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131606|NCT00533897|422414|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131607|NCT00533897|422415|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
131608|NCT00533897|422416|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
131609|NCT00533897|422409|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
131610|NCT00533897|422410|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
131611|NCT00533897|422411|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
131612|NCT00533897|422412|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
131613|NCT00533897|422413|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
131614|NCT00533897|422414|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
131615|NCT00533897|422415|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
131616|NCT00533897|422416|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
131617|NCT00533897|422409|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131618|NCT00533897|422410|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131619|NCT00533897|422411|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131620|NCT00533897|422412|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131621|NCT00533897|422413|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131622|NCT00533897|422414|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131623|NCT00533897|422415|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
131624|NCT00533897|422416|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
131625|NCT00533897|422409|P8|Lead-in (LI) Period 1|Adverse Event|0
131626|NCT00533897|422410|P7|Lead-in (LI) Period 1|Adverse Event|0
131627|NCT00533897|422411|P6|Lead-in (LI) Period 1|Adverse Event|0
131628|NCT00533897|422412|P5|Lead-in (LI) Period 1|Adverse Event|0
131629|NCT00533897|422413|P4|Lead-in (LI) Period 1|Adverse Event|0
131630|NCT00533897|422414|P3|Lead-in (LI) Period 1|Adverse Event|0
131631|NCT00533897|422415|P2|Lead-in (LI) Period 1|Adverse Event|0
131632|NCT00533897|422416|P1|Lead-in (LI) Period 1|Adverse Event|1
131633|NCT00533949|422558|P4|Overall Study|Withdrawal by Subject|1
131634|NCT00533949|422559|P3|Overall Study|Withdrawal by Subject|1
131635|NCT00533949|422560|P2|Overall Study|Withdrawal by Subject|2
131636|NCT00533949|422561|P1|Overall Study|Withdrawal by Subject|3
131637|NCT00533949|422558|P4|Overall Study|Protocol Violation|9
131638|NCT00533949|422559|P3|Overall Study|Protocol Violation|9
131639|NCT00533949|422560|P2|Overall Study|Protocol Violation|12
131640|NCT00533949|422561|P1|Overall Study|Protocol Violation|12
131641|NCT00534092|422602|P2|Overall Study|personal reasons/family concerns|0
131642|NCT00534092|422603|P1|Overall Study|personal reasons/family concerns|1
131643|NCT00534092|422602|P2|Overall Study|Lost to Follow-up|0
131644|NCT00534092|422603|P1|Overall Study|Lost to Follow-up|1
131645|NCT00534105|422628|P2|Overall Study|Lost to Follow-up|39
131646|NCT00534105|422629|P1|Overall Study|Lost to Follow-up|23
131647|NCT00534248|422647|P2|Overall Study|Withdrawal by Subject|255
131648|NCT00534248|422648|P1|Overall Study|Withdrawal by Subject|263
131649|NCT00534248|422647|P2|Overall Study|Protocol Violation|4
131650|NCT00534248|422648|P1|Overall Study|Protocol Violation|3
131651|NCT00534248|422647|P2|Overall Study|Physician Decision|7
131652|NCT00534248|422648|P1|Overall Study|Physician Decision|10
131653|NCT00534248|422647|P2|Overall Study|Other protocol specified criteria|3
131654|NCT00534248|422648|P1|Overall Study|Other protocol specified criteria|13
131655|NCT00534248|422647|P2|Overall Study|Lost to Follow-up|375
131656|NCT00534248|422648|P1|Overall Study|Lost to Follow-up|353
131657|NCT00534248|422647|P2|Overall Study|Adverse Event|29
131658|NCT00534248|422648|P1|Overall Study|Adverse Event|19
131659|NCT00534313|422662|P4|Long-term Period|Not specified|2
131660|NCT00534313|422663|P3|Long-term Period|Not specified|2
131661|NCT00534313|422664|P2|Long-term Period|Not specified|2
131662|NCT00534313|422665|P1|Long-term Period|Not specified|1
131663|NCT00534313|422662|P4|Long-term Period|Administrative reason by sponsor|18
131664|NCT00534313|422663|P3|Long-term Period|Administrative reason by sponsor|26
131665|NCT00534313|422664|P2|Long-term Period|Administrative reason by sponsor|15
131666|NCT00534313|422665|P1|Long-term Period|Administrative reason by sponsor|17
131667|NCT00534313|422662|P4|Long-term Period|Poor compliance/noncompliance|0
131668|NCT00534313|422663|P3|Long-term Period|Poor compliance/noncompliance|1
131669|NCT00534313|422664|P2|Long-term Period|Poor compliance/noncompliance|1
131670|NCT00534313|422665|P1|Long-term Period|Poor compliance/noncompliance|0
131671|NCT00534313|422662|P4|Long-term Period|No longer meets study criteria|0
131672|NCT00534313|422663|P3|Long-term Period|No longer meets study criteria|0
131673|NCT00534313|422664|P2|Long-term Period|No longer meets study criteria|1
131674|NCT00534313|422665|P1|Long-term Period|No longer meets study criteria|0
131675|NCT00534313|422662|P4|Long-term Period|Withdrawal by Subject|0
131676|NCT00534313|422663|P3|Long-term Period|Withdrawal by Subject|0
131677|NCT00534313|422664|P2|Long-term Period|Withdrawal by Subject|2
131678|NCT00534313|422665|P1|Long-term Period|Withdrawal by Subject|2
131679|NCT00534313|422662|P4|Long-term Period|Lost to Follow-up|0
131680|NCT00534313|422663|P3|Long-term Period|Lost to Follow-up|0
131681|NCT00534313|422664|P2|Long-term Period|Lost to Follow-up|2
131682|NCT00534313|422665|P1|Long-term Period|Lost to Follow-up|1
131683|NCT00534313|422662|P4|Long-term Period|Lack of Efficacy|12
131684|NCT00534313|422663|P3|Long-term Period|Lack of Efficacy|14
131685|NCT00534313|422664|P2|Long-term Period|Lack of Efficacy|10
131686|NCT00534313|422665|P1|Long-term Period|Lack of Efficacy|14
131687|NCT00534313|422662|P4|Long-term Period|Adverse Event|1
131688|NCT00534313|422663|P3|Long-term Period|Adverse Event|0
131689|NCT00534313|422664|P2|Long-term Period|Adverse Event|1
131690|NCT00534313|422665|P1|Long-term Period|Adverse Event|2
131691|NCT00534313|422662|P4|Short-term Period|Pregnancy|0
131692|NCT00534313|422663|P3|Short-term Period|Pregnancy|1
131693|NCT00534313|422664|P2|Short-term Period|Pregnancy|0
131694|NCT00534313|422665|P1|Short-term Period|Pregnancy|0
131695|NCT00534313|422662|P4|Short-term Period|Participant withdrew consent|2
131696|NCT00534313|422663|P3|Short-term Period|Participant withdrew consent|0
131697|NCT00534313|422664|P2|Short-term Period|Participant withdrew consent|0
131698|NCT00534313|422665|P1|Short-term Period|Participant withdrew consent|2
131699|NCT00534313|422662|P4|Short-term Period|Participant not meeting study criteria|1
131700|NCT00534313|422663|P3|Short-term Period|Participant not meeting study criteria|0
131701|NCT00534313|422664|P2|Short-term Period|Participant not meeting study criteria|0
131702|NCT00534313|422665|P1|Short-term Period|Participant not meeting study criteria|0
131703|NCT00534313|422662|P4|Short-term Period|Lack of Efficacy|3
131704|NCT00534313|422663|P3|Short-term Period|Lack of Efficacy|0
131705|NCT00534313|422664|P2|Short-term Period|Lack of Efficacy|4
131706|NCT00534313|422665|P1|Short-term Period|Lack of Efficacy|3
131707|NCT00534313|422662|P4|Short-term Period|Adverse Event|3
131708|NCT00534313|422663|P3|Short-term Period|Adverse Event|1
131709|NCT00534313|422664|P2|Short-term Period|Adverse Event|2
131710|NCT00534313|422665|P1|Short-term Period|Adverse Event|1
131711|NCT00534352|422758|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
131712|NCT00534352|422758|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
131713|NCT00534352|422758|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
131714|NCT00534352|422758|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
131715|NCT00534352|422758|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
131716|NCT00534352|422758|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
131717|NCT00534404|422818|P3|Overall Study|Lost to Follow-up|201
131718|NCT00534404|422819|P2|Overall Study|Lost to Follow-up|138
131719|NCT00534404|422820|P1|Overall Study|Lost to Follow-up|170
131720|NCT00534404|422818|P3|Overall Study|Removed by study staff|1
131721|NCT00534404|422819|P2|Overall Study|Removed by study staff|3
131722|NCT00534404|422820|P1|Overall Study|Removed by study staff|2
131723|NCT00534404|422818|P3|Overall Study|Withdrawal by Subject|38
131724|NCT00534404|422819|P2|Overall Study|Withdrawal by Subject|2
131725|NCT00534404|422820|P1|Overall Study|Withdrawal by Subject|8
131726|NCT00534404|422818|P3|Overall Study|Death|2
131727|NCT00534404|422819|P2|Overall Study|Death|0
131728|NCT00534404|422820|P1|Overall Study|Death|0
131729|NCT00534495|422848|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
131730|NCT00534495|422849|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
131731|NCT00534495|422850|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
131732|NCT00534495|422848|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
131733|NCT00534495|422849|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
131734|NCT00534495|422850|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
131735|NCT00534495|422848|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
131736|NCT00534495|422849|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
131737|NCT00534495|422850|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
131738|NCT00534495|422848|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
131739|NCT00534495|422849|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
131740|NCT00534495|422850|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
131741|NCT00534495|422848|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
131742|NCT00534495|422849|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
131743|NCT00534495|422850|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
131744|NCT00534495|422848|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
131745|NCT00534495|422849|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
131746|NCT00534495|422850|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
131747|NCT00534495|422848|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
131748|NCT00534495|422849|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
131749|NCT00534495|422850|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
131750|NCT00534495|422848|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
131751|NCT00534495|422849|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
131752|NCT00534495|422850|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
131753|NCT00534495|422848|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
131754|NCT00534495|422849|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
131755|NCT00534495|422850|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
131756|NCT00534599|422875|P2|Overall Study|Unspecified|0
131757|NCT00534599|422876|P1|Overall Study|Unspecified|7
131758|NCT00534599|422875|P2|Overall Study|Withdrawal by Subject|6
131759|NCT00534599|422876|P1|Overall Study|Withdrawal by Subject|4
131760|NCT00534599|422875|P2|Overall Study|Lost to Follow-up|14
131761|NCT00534599|422876|P1|Overall Study|Lost to Follow-up|11
131762|NCT00534599|422875|P2|Overall Study|Protocol Violation|3
131763|NCT00534599|422876|P1|Overall Study|Protocol Violation|1
131764|NCT00534599|422875|P2|Overall Study|Generalized anxiety disorder worsened|1
131765|NCT00534599|422876|P1|Overall Study|Generalized anxiety disorder worsened|0
131766|NCT00534599|422875|P2|Overall Study|Lack of Efficacy|1
131767|NCT00534599|422876|P1|Overall Study|Lack of Efficacy|0
131768|NCT00534599|422875|P2|Overall Study|Developed study-specific d/c criteria|0
131769|NCT00534599|422876|P1|Overall Study|Developed study-specific d/c criteria|5
131770|NCT00534599|422875|P2|Overall Study|Mis-randomization|2
131771|NCT00534599|422876|P1|Overall Study|Mis-randomization|2
131772|NCT00534599|422875|P2|Overall Study|Incorrect enrollment|1
131773|NCT00534599|422876|P1|Overall Study|Incorrect enrollment|2
131774|NCT00534599|422875|P2|Overall Study|Adverse Event|4
131775|NCT00534599|422876|P1|Overall Study|Adverse Event|25
131776|NCT00534638|422912|P2|Overall Study|Refused participation to study|883
131777|NCT00534638|422913|P1|Overall Study|Refused participation to study|1665
131778|NCT00534638|422912|P2|Overall Study|Rejected origin of signature|2
131779|NCT00534638|422913|P1|Overall Study|Rejected origin of signature|0
131780|NCT00534638|422912|P2|Overall Study|Received without ICF|1
131781|NCT00534638|422913|P1|Overall Study|Received without ICF|0
131782|NCT00534638|422912|P2|Overall Study|Subject unable to read|1
131783|NCT00534638|422913|P1|Overall Study|Subject unable to read|0
131784|NCT00534638|422912|P2|Overall Study|ICF not returned|1
131785|NCT00534638|422913|P1|Overall Study|ICF not returned|0
131786|NCT00534638|422912|P2|Overall Study|Mentally disabled|0
131787|NCT00534638|422913|P1|Overall Study|Mentally disabled|1
131788|NCT00534638|422912|P2|Overall Study|Death|5
131789|NCT00534638|422913|P1|Overall Study|Death|5
131790|NCT00534638|422912|P2|Overall Study|Pregnancy|4
131791|NCT00534638|422913|P1|Overall Study|Pregnancy|6
131792|NCT00534638|422912|P2|Overall Study|Blinded treatment broken|0
131793|NCT00534638|422913|P1|Overall Study|Blinded treatment broken|2
131794|NCT00534638|422912|P2|Overall Study|Urticaria|0
131795|NCT00534638|422913|P1|Overall Study|Urticaria|1
131796|NCT00534638|422912|P2|Overall Study|Already received HPV vaccine|1
131797|NCT00534638|422913|P1|Overall Study|Already received HPV vaccine|0
131798|NCT00534638|422912|P2|Overall Study|Lost to Follow-up|10875
131799|NCT00534638|422913|P1|Overall Study|Lost to Follow-up|4793
131800|NCT00534638|422912|P2|Overall Study|Migrated/moved from study area|13
131801|NCT00534638|422913|P1|Overall Study|Migrated/moved from study area|14
131802|NCT00534638|422912|P2|Overall Study|Withdrawal by Subject|5
131803|NCT00534638|422913|P1|Overall Study|Withdrawal by Subject|4
131804|NCT00534976|422987|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
131805|NCT00534976|422988|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
131806|NCT00534976|422987|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
131807|NCT00534976|422988|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
131808|NCT00534976|422987|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
131809|NCT00534976|422988|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
131810|NCT00535132|423039|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
131811|NCT00535132|423040|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
131812|NCT00535132|423039|P2|Safety Analysis Set|Did Not Receive Study Medication|2
131813|NCT00535132|423040|P1|Safety Analysis Set|Did Not Receive Study Medication|2
131814|NCT00535145|423090|P1|Phase II|Subject non-compliance|2
131815|NCT00535145|423090|P1|Phase II|Withdrawal by Subject|5
131816|NCT00535145|423090|P1|Phase II|Lost to Follow-up|5
131817|NCT00535145|423090|P1|Phase II|Lack of Efficacy|1
131818|NCT00535145|423090|P1|Phase II|Adverse Event|2
131819|NCT00535145|423090|P1|Phase I|(diagnosis)|3
131820|NCT00535145|423090|P1|Phase I|(PI decision)|1
131821|NCT00535145|423090|P1|Phase I|(protocol violation)|1
131822|NCT00535145|423090|P1|Phase I|(eligibility)|8
131823|NCT00535145|423090|P1|Phase I|Withdrawal by Subject|6
131824|NCT00535145|423090|P1|Phase I|Lost to Follow-up|7
131825|NCT00535145|423090|P1|Phase I|Adverse Event|3
131826|NCT00535223|423102|P2|Overall Study|Withdrawal by Subject|1
131827|NCT00535223|423103|P1|Overall Study|Withdrawal by Subject|4
131828|NCT00535262|423111|P1|Overall Study|No funding|3
131829|NCT00535288|423120|P5|Overall Study|Not specified|1
131830|NCT00535288|423121|P4|Overall Study|Not specified|2
131831|NCT00535288|423122|P3|Overall Study|Not specified|1
131832|NCT00535288|423123|P2|Overall Study|Not specified|1
131833|NCT00535288|423124|P1|Overall Study|Not specified|2
131834|NCT00535288|423120|P5|Overall Study|Unwilling to cooperate|4
131835|NCT00535288|423121|P4|Overall Study|Unwilling to cooperate|3
131836|NCT00535288|423122|P3|Overall Study|Unwilling to cooperate|3
131837|NCT00535288|423123|P2|Overall Study|Unwilling to cooperate|6
131838|NCT00535288|423124|P1|Overall Study|Unwilling to cooperate|6
131839|NCT00535288|423120|P5|Overall Study|Lack of Efficacy|7
131840|NCT00535288|423121|P4|Overall Study|Lack of Efficacy|4
131841|NCT00535288|423122|P3|Overall Study|Lack of Efficacy|4
131842|NCT00535288|423123|P2|Overall Study|Lack of Efficacy|3
131843|NCT00535288|423124|P1|Overall Study|Lack of Efficacy|26
131844|NCT00535288|423120|P5|Overall Study|Lost to Follow-up|0
131845|NCT00535288|423121|P4|Overall Study|Lost to Follow-up|0
131846|NCT00535288|423122|P3|Overall Study|Lost to Follow-up|0
131847|NCT00535288|423123|P2|Overall Study|Lost to Follow-up|3
131848|NCT00535288|423124|P1|Overall Study|Lost to Follow-up|0
131849|NCT00535288|423120|P5|Overall Study|Adverse Event|30
131850|NCT00535288|423121|P4|Overall Study|Adverse Event|20
131851|NCT00535288|423122|P3|Overall Study|Adverse Event|25
131852|NCT00535288|423123|P2|Overall Study|Adverse Event|19
131853|NCT00535288|423124|P1|Overall Study|Adverse Event|20
131854|NCT00535405|423225|P5|Overall Study|Withdrawal by Subject|8
131855|NCT00535405|423226|P4|Overall Study|Withdrawal by Subject|10
131856|NCT00535405|423227|P3|Overall Study|Withdrawal by Subject|10
131857|NCT00535405|423228|P2|Overall Study|Withdrawal by Subject|11
131858|NCT00535405|423229|P1|Overall Study|Withdrawal by Subject|5
131859|NCT00535405|423225|P5|Overall Study|Protocol Violation|0
131860|NCT00535405|423226|P4|Overall Study|Protocol Violation|1
131861|NCT00535405|423227|P3|Overall Study|Protocol Violation|2
131862|NCT00535405|423228|P2|Overall Study|Protocol Violation|2
131863|NCT00535405|423229|P1|Overall Study|Protocol Violation|2
131864|NCT00535405|423225|P5|Overall Study|Physician Decision|1
131865|NCT00535405|423226|P4|Overall Study|Physician Decision|1
131866|NCT00535405|423227|P3|Overall Study|Physician Decision|0
131867|NCT00535405|423228|P2|Overall Study|Physician Decision|2
131868|NCT00535405|423229|P1|Overall Study|Physician Decision|3
131869|NCT00535405|423225|P5|Overall Study|Lost to Follow-up|1
131870|NCT00535405|423226|P4|Overall Study|Lost to Follow-up|2
131871|NCT00535405|423227|P3|Overall Study|Lost to Follow-up|3
131872|NCT00535405|423228|P2|Overall Study|Lost to Follow-up|3
131873|NCT00535405|423229|P1|Overall Study|Lost to Follow-up|1
131874|NCT00535405|423225|P5|Overall Study|Adverse Event|6
131875|NCT00535405|423226|P4|Overall Study|Adverse Event|8
131876|NCT00535405|423227|P3|Overall Study|Adverse Event|3
131877|NCT00535405|423228|P2|Overall Study|Adverse Event|8
131878|NCT00535405|423229|P1|Overall Study|Adverse Event|6
131879|NCT00535496|423268|P4|Overall Study|Not treated with sugammadex|0
131880|NCT00535496|423269|P3|Overall Study|Not treated with sugammadex|0
131881|NCT00535496|423270|P2|Overall Study|Not treated with sugammadex|1
131882|NCT00535496|423271|P1|Overall Study|Not treated with sugammadex|0
131883|NCT00535496|423268|P4|Overall Study|Lost to Follow-up|0
131884|NCT00535496|423269|P3|Overall Study|Lost to Follow-up|0
131885|NCT00535496|423270|P2|Overall Study|Lost to Follow-up|1
131886|NCT00535496|423271|P1|Overall Study|Lost to Follow-up|0
131887|NCT00535730|423307|P2|Overall Study|Withdrawal by Subject|4
131888|NCT00535730|423308|P1|Overall Study|Withdrawal by Subject|0
131889|NCT00535730|423307|P2|Overall Study|Protocol Violation|0
131890|NCT00535730|423308|P1|Overall Study|Protocol Violation|1
131891|NCT00535730|423307|P2|Overall Study|Physician Decision|1
131892|NCT00535730|423308|P1|Overall Study|Physician Decision|0
131893|NCT00535730|423307|P2|Overall Study|Lost to Follow-up|1
131894|NCT00535730|423308|P1|Overall Study|Lost to Follow-up|0
131895|NCT00535730|423307|P2|Overall Study|Adverse Event|1
131896|NCT00535730|423308|P1|Overall Study|Adverse Event|1
131897|NCT00535847|423368|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
131898|NCT00535847|423369|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
131899|NCT00535847|423370|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
131900|NCT00535847|423368|P3|Overall Study|Non compliance|0
131901|NCT00535847|423369|P2|Overall Study|Non compliance|1
131902|NCT00535847|423370|P1|Overall Study|Non compliance|1
131903|NCT00535847|423368|P3|Overall Study|Adverse Event|2
131904|NCT00535847|423369|P2|Overall Study|Adverse Event|3
131905|NCT00535847|423370|P1|Overall Study|Adverse Event|5
131906|NCT00536107|423439|P2|Overall Study|Study Termination|4
131907|NCT00536107|423440|P1|Overall Study|Study Termination|2
131908|NCT00536107|423439|P2|Overall Study|Withdrawal by Subject|1
131909|NCT00536107|423440|P1|Overall Study|Withdrawal by Subject|0
131910|NCT00536107|423439|P2|Overall Study|Incorrect enrolment|0
131911|NCT00536107|423440|P1|Overall Study|Incorrect enrolment|1
131912|NCT00536107|423439|P2|Overall Study|Death|1
131913|NCT00536107|423440|P1|Overall Study|Death|5
131914|NCT00536120|423450|P2|Overall Study|Missed Study Visit|1
131915|NCT00536120|423451|P1|Overall Study|Missed Study Visit|0
131916|NCT00536120|423450|P2|Overall Study|Steroid Use|2
131917|NCT00536120|423451|P1|Overall Study|Steroid Use|0
131918|NCT00536120|423450|P2|Overall Study|Sponsor Decision Due to Lab Values|0
131919|NCT00536120|423451|P1|Overall Study|Sponsor Decision Due to Lab Values|1
131920|NCT00536120|423450|P2|Overall Study|Non-compliance|0
131921|NCT00536120|423451|P1|Overall Study|Non-compliance|1
131922|NCT00536120|423450|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
131923|NCT00536120|423451|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
131924|NCT00536120|423450|P2|Overall Study|Lost to Follow-up|0
131925|NCT00536120|423451|P1|Overall Study|Lost to Follow-up|1
131926|NCT00541970|423476|P4|Month 60|Protocol Violation|72
131927|NCT00541970|423477|P3|Month 60|Protocol Violation|82
131928|NCT00541970|423478|P2|Month 60|Protocol Violation|77
131929|NCT00541970|423479|P1|Month 60|Protocol Violation|78
131930|NCT00541970|423476|P4|Month 48|Lost to Follow-up|73
131931|NCT00541970|423477|P3|Month 48|Lost to Follow-up|68
131932|NCT00541970|423478|P2|Month 48|Lost to Follow-up|68
131933|NCT00541970|423479|P1|Month 48|Lost to Follow-up|66
131934|NCT00541970|423476|P4|Month 48|Unspecified|0
131935|NCT00541970|423477|P3|Month 48|Unspecified|1
131936|NCT00541970|423478|P2|Month 48|Unspecified|1
131937|NCT00541970|423479|P1|Month 48|Unspecified|3
131938|NCT00541970|423476|P4|Month 48|Withdrawal by Subject|2
131939|NCT00541970|423477|P3|Month 48|Withdrawal by Subject|4
131940|NCT00541970|423478|P2|Month 48|Withdrawal by Subject|4
131941|NCT00541970|423479|P1|Month 48|Withdrawal by Subject|2
131942|NCT00541970|423476|P4|Month 36|Protocol Violation|60
131943|NCT00541970|423477|P3|Month 36|Protocol Violation|66
131944|NCT00541970|423478|P2|Month 36|Protocol Violation|66
131945|NCT00541970|423479|P1|Month 36|Protocol Violation|61
131946|NCT00541970|423476|P4|Month 24|Protocol Violation|21
131947|NCT00541970|423477|P3|Month 24|Protocol Violation|31
131948|NCT00541970|423478|P2|Month 24|Protocol Violation|31
131949|NCT00541970|423479|P1|Month 24|Protocol Violation|29
131950|NCT00541970|423476|P4|Month 24|Adverse Event|1
131951|NCT00541970|423477|P3|Month 24|Adverse Event|1
131952|NCT00541970|423478|P2|Month 24|Adverse Event|1
131953|NCT00541970|423479|P1|Month 24|Adverse Event|0
131954|NCT00541970|423476|P4|Month 18|Protocol Violation|16
131955|NCT00541970|423477|P3|Month 18|Protocol Violation|24
131956|NCT00541970|423478|P2|Month 18|Protocol Violation|23
131957|NCT00541970|423479|P1|Month 18|Protocol Violation|14
131958|NCT00541970|423476|P4|Month 18|Adverse Event|1
131959|NCT00541970|423477|P3|Month 18|Adverse Event|1
131960|NCT00541970|423478|P2|Month 18|Adverse Event|1
131961|NCT00541970|423479|P1|Month 18|Adverse Event|0
131962|NCT00541970|423476|P4|Month 12|Protocol Violation|15
131963|NCT00541970|423477|P3|Month 12|Protocol Violation|20
131964|NCT00541970|423478|P2|Month 12|Protocol Violation|21
131965|NCT00541970|423479|P1|Month 12|Protocol Violation|12
131966|NCT00541970|423476|P4|Month 12|Adverse Event|1
131967|NCT00541970|423477|P3|Month 12|Adverse Event|1
131968|NCT00541970|423478|P2|Month 12|Adverse Event|1
131969|NCT00541970|423479|P1|Month 12|Adverse Event|0
131970|NCT00541970|423476|P4|Month 7|Protocol Violation|5
131971|NCT00541970|423477|P3|Month 7|Protocol Violation|11
131972|NCT00541970|423478|P2|Month 7|Protocol Violation|13
131973|NCT00541970|423479|P1|Month 7|Protocol Violation|9
131974|NCT00542178|423634|P8|Overall Study|did not complete year 4 follow-up|85
131975|NCT00542178|423635|P7|Overall Study|did not complete year 4 follow-up|87
131976|NCT00542178|423636|P6|Overall Study|did not complete year 4 follow-up|89
131977|NCT00542178|423637|P5|Overall Study|did not complete year 4 follow-up|64
131978|NCT00542178|423638|P4|Overall Study|did not complete year 4 follow-up|62
131979|NCT00542178|423639|P3|Overall Study|did not complete year 4 follow-up|74
131980|NCT00542178|423640|P2|Overall Study|did not complete year 4 follow-up|80
131981|NCT00542178|423641|P1|Overall Study|did not complete year 4 follow-up|75
131982|NCT00543140|423655|P1|Overall Study|Conversion to different procedure|1
131983|NCT00543140|423655|P1|Overall Study|Subject moved|1
131984|NCT00543140|423655|P1|Overall Study|Death|1
131985|NCT00543140|423655|P1|Overall Study|SAE leading to explant of SAGB|3
131986|NCT00543140|423655|P1|Overall Study|Insufficient weight loss|10
131987|NCT00543140|423655|P1|Overall Study|Protocol Violation|10
131988|NCT00543140|423655|P1|Overall Study|Withdrawal by Subject|13
131989|NCT00543140|423655|P1|Overall Study|Lost to Follow-up|33
131990|NCT00543296|423663|P1|Overall Study|Physician Decision|7
131991|NCT00543543|423674|P4|Extension Study|Withdrawal by Subject|120
131992|NCT00543543|423675|P3|Extension Study|Withdrawal by Subject|0
131993|NCT00543543|423676|P2|Extension Study|Withdrawal by Subject|0
131994|NCT00543543|423677|P1|Extension Study|Withdrawal by Subject|0
131995|NCT00543543|423674|P4|Extension Study|Protocol Violation|11
131996|NCT00543543|423675|P3|Extension Study|Protocol Violation|0
131997|NCT00543543|423676|P2|Extension Study|Protocol Violation|0
131998|NCT00543543|423677|P1|Extension Study|Protocol Violation|0
131999|NCT00543543|423674|P4|Extension Study|Pregnancy|6
132000|NCT00543543|423675|P3|Extension Study|Pregnancy|0
132001|NCT00543543|423676|P2|Extension Study|Pregnancy|0
132002|NCT00543543|423677|P1|Extension Study|Pregnancy|0
132003|NCT00543543|423674|P4|Extension Study|Physician Decision|7
132004|NCT00543543|423675|P3|Extension Study|Physician Decision|0
132005|NCT00543543|423676|P2|Extension Study|Physician Decision|0
132006|NCT00543543|423677|P1|Extension Study|Physician Decision|0
132007|NCT00543543|423674|P4|Extension Study|Lost to Follow-up|77
132008|NCT00543543|423675|P3|Extension Study|Lost to Follow-up|0
132009|NCT00543543|423676|P2|Extension Study|Lost to Follow-up|0
132010|NCT00543543|423677|P1|Extension Study|Lost to Follow-up|0
132011|NCT00543543|423674|P4|Extension Study|Adverse Event|5
132012|NCT00543543|423675|P3|Extension Study|Adverse Event|0
132013|NCT00543543|423676|P2|Extension Study|Adverse Event|0
132014|NCT00543543|423677|P1|Extension Study|Adverse Event|0
132015|NCT00543543|423674|P4|Base Study|Withdrawal by Subject|503
132016|NCT00543543|423675|P3|Base Study|Withdrawal by Subject|5
132017|NCT00543543|423676|P2|Base Study|Withdrawal by Subject|482
132018|NCT00543543|423677|P1|Base Study|Withdrawal by Subject|7
132019|NCT00543543|423674|P4|Base Study|Protocol Violation|6
132020|NCT00543543|423675|P3|Base Study|Protocol Violation|0
132021|NCT00543543|423676|P2|Base Study|Protocol Violation|6
132022|NCT00543543|423677|P1|Base Study|Protocol Violation|0
132023|NCT00543543|423674|P4|Base Study|Physician Decision|7
132024|NCT00543543|423675|P3|Base Study|Physician Decision|0
132025|NCT00543543|423676|P2|Base Study|Physician Decision|4
132026|NCT00543543|423677|P1|Base Study|Physician Decision|0
132027|NCT00543543|423674|P4|Base Study|Lost to Follow-up|701
132028|NCT00543543|423675|P3|Base Study|Lost to Follow-up|9
132029|NCT00543543|423676|P2|Base Study|Lost to Follow-up|749
132030|NCT00543543|423677|P1|Base Study|Lost to Follow-up|12
132031|NCT00543543|423674|P4|Base Study|Adverse Event|5
132032|NCT00543543|423675|P3|Base Study|Adverse Event|0
132033|NCT00543543|423676|P2|Base Study|Adverse Event|11
132034|NCT00543543|423677|P1|Base Study|Adverse Event|1
132035|NCT00543569|423722|P4|Overall Study|Randomized but never received study drug|3
132036|NCT00543569|423723|P3|Overall Study|Randomized but never received study drug|5
132037|NCT00543569|423724|P2|Overall Study|Randomized but never received study drug|3
132038|NCT00543569|423725|P1|Overall Study|Randomized but never received study drug|3
132039|NCT00543569|423722|P4|Overall Study|Miscellaneous Reasons|4
132040|NCT00543569|423723|P3|Overall Study|Miscellaneous Reasons|11
132041|NCT00543569|423724|P2|Overall Study|Miscellaneous Reasons|3
132042|NCT00543569|423725|P1|Overall Study|Miscellaneous Reasons|7
132043|NCT00543569|423722|P4|Overall Study|Lost to Follow-up|1
132044|NCT00543569|423723|P3|Overall Study|Lost to Follow-up|1
132045|NCT00543569|423724|P2|Overall Study|Lost to Follow-up|0
132046|NCT00543569|423725|P1|Overall Study|Lost to Follow-up|0
132047|NCT00543569|423722|P4|Overall Study|Death|1
132048|NCT00543569|423723|P3|Overall Study|Death|3
132049|NCT00543569|423724|P2|Overall Study|Death|2
132050|NCT00543569|423725|P1|Overall Study|Death|2
132051|NCT00543725|423829|P2|Overall Study|Not specified|3
132052|NCT00543725|423830|P1|Overall Study|Not specified|3
132053|NCT00543725|423829|P2|Overall Study|Lost to Follow-up|11
132054|NCT00543725|423830|P1|Overall Study|Lost to Follow-up|15
132055|NCT00543725|423829|P2|Overall Study|Withdrawal by Subject|13
132056|NCT00543725|423830|P1|Overall Study|Withdrawal by Subject|4
132057|NCT00543725|423829|P2|Overall Study|Protocol Violation|1
132058|NCT00543725|423830|P1|Overall Study|Protocol Violation|0
132059|NCT00543725|423829|P2|Overall Study|Subject Reached A Virologic Endpoint|14
132060|NCT00543725|423830|P1|Overall Study|Subject Reached A Virologic Endpoint|22
132061|NCT00543725|423829|P2|Overall Study|Subject Ineligible To Continue The Trial|0
132062|NCT00543725|423830|P1|Overall Study|Subject Ineligible To Continue The Trial|2
132063|NCT00543725|423829|P2|Overall Study|Subject Non-Compliant|4
132064|NCT00543725|423830|P1|Overall Study|Subject Non-Compliant|4
132065|NCT00543725|423829|P2|Overall Study|Sponsor's Decision|1
132066|NCT00543725|423830|P1|Overall Study|Sponsor's Decision|0
132067|NCT00543725|423829|P2|Overall Study|Adverse Event|27
132068|NCT00543725|423830|P1|Overall Study|Adverse Event|18
132069|NCT00543803|423861|P1|Overall Study|not specified|86
132070|NCT00543803|423861|P1|Overall Study|Lost to Follow-up|20
132071|NCT00543803|423861|P1|Overall Study|Lack of Efficacy|22
132072|NCT00543803|423861|P1|Overall Study|Adverse Event|14
132073|NCT00543855|423882|P4|Overall Study|Protocol Violation|0
132074|NCT00543855|423883|P3|Overall Study|Protocol Violation|0
132075|NCT00543855|423884|P2|Overall Study|Protocol Violation|0
132076|NCT00543855|423885|P1|Overall Study|Protocol Violation|1
132077|NCT00543855|423882|P4|Overall Study|Withdrawal by Subject|0
132078|NCT00543855|423883|P3|Overall Study|Withdrawal by Subject|2
132079|NCT00543855|423884|P2|Overall Study|Withdrawal by Subject|1
132080|NCT00543855|423885|P1|Overall Study|Withdrawal by Subject|0
132081|NCT00543855|423882|P4|Overall Study|Lost to Follow-up|0
132082|NCT00543855|423883|P3|Overall Study|Lost to Follow-up|1
132083|NCT00543855|423884|P2|Overall Study|Lost to Follow-up|0
132084|NCT00543855|423885|P1|Overall Study|Lost to Follow-up|0
132085|NCT00543855|423882|P4|Overall Study|Adverse Event|4
132086|NCT00543855|423883|P3|Overall Study|Adverse Event|3
132087|NCT00543855|423884|P2|Overall Study|Adverse Event|1
132088|NCT00543855|423885|P1|Overall Study|Adverse Event|3
132089|NCT00543985|423907|P1|Overall Study|Withdrawal by Subject|4
132090|NCT00544167|423914|P1|Overall Study|Physician Decision|8
132091|NCT00544167|423914|P1|Overall Study|Adverse Event|21
132092|NCT00544440|423918|P1|Overall Study|Unspecified|5
132093|NCT00544440|423918|P1|Overall Study|Progressive Disease|47
132094|NCT00544440|423918|P1|Overall Study|Subject Non-compliance|1
132095|NCT00544440|423918|P1|Overall Study|Withdrawal by Subject|2
132096|NCT00544440|423918|P1|Overall Study|Adverse Event|1
132097|NCT00544440|423918|P1|Overall Study|Other|1
132098|NCT00544544|423925|P1|Overall Study|Lost to Follow-up|1
132099|NCT00544544|423925|P1|Overall Study|Adverse Event|1
132100|NCT00544544|423925|P1|Overall Study|Withdrawal by Subject|1
132101|NCT00544557|423929|P1|Overall Study|Unspecified|98
132102|NCT00544557|423929|P1|Overall Study|Lack of Efficacy|196
132103|NCT00544557|423929|P1|Overall Study|Adverse Event|140
132104|NCT00544648|423962|P2|Overall Study|progression of disease|0
132105|NCT00544648|423963|P1|Overall Study|progression of disease|1
132106|NCT00544648|423962|P2|Overall Study|Adverse Event|1
132107|NCT00544648|423963|P1|Overall Study|Adverse Event|1
132108|NCT00544648|423962|P2|Overall Study|Withdrawal by Subject|0
132109|NCT00544648|423963|P1|Overall Study|Withdrawal by Subject|1
132110|NCT00544817|424018|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
132111|NCT00544817|424018|P1|Follow-up Systemic Therapy|Physician Decision|3
132112|NCT00544817|424018|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
132113|NCT00544817|424018|P1|No Treatment Interval|Adverse Event|1
132114|NCT00544817|424018|P1|No Treatment Interval|Physician Decision|3
132115|NCT00544817|424018|P1|No Treatment Interval|Lack of Efficacy|8
132116|NCT00544817|424018|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
132117|NCT00544817|424018|P1|Combined Modality|Adverse Event|2
132118|NCT00544817|424018|P1|Combined Modality|Worsening Neurologic Symptoms|2
132119|NCT00544817|424018|P1|Combined Modality|Lack of Efficacy|2
132120|NCT00544869|424027|P3|Overall Study|Physician Decision|0
132121|NCT00544869|424028|P2|Overall Study|Physician Decision|0
132122|NCT00544869|424029|P1|Overall Study|Physician Decision|2
132123|NCT00544869|424027|P3|Overall Study|Lack of Efficacy|0
132124|NCT00544869|424028|P2|Overall Study|Lack of Efficacy|1
132125|NCT00544869|424029|P1|Overall Study|Lack of Efficacy|1
132126|NCT00544869|424027|P3|Overall Study|Adverse Event|0
132127|NCT00544869|424028|P2|Overall Study|Adverse Event|1
132128|NCT00544869|424029|P1|Overall Study|Adverse Event|6
132129|NCT00544869|424027|P3|Overall Study|Rsolution of congenitive symptoms|0
132130|NCT00544869|424028|P2|Overall Study|Rsolution of congenitive symptoms|0
132131|NCT00544869|424029|P1|Overall Study|Rsolution of congenitive symptoms|3
132132|NCT00544882|424039|P3|Cycle 3: Follow-up|Pregnancy|0
132133|NCT00544882|424040|P2|Cycle 3: Follow-up|Pregnancy|1
132134|NCT00544882|424041|P1|Cycle 3: Follow-up|Pregnancy|0
132135|NCT00544882|424039|P3|Cycle 3: Follow-up|Noncompliance|0
132136|NCT00544882|424040|P2|Cycle 3: Follow-up|Noncompliance|1
132137|NCT00544882|424041|P1|Cycle 3: Follow-up|Noncompliance|0
132138|NCT00544882|424039|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
132139|NCT00544882|424040|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
132140|NCT00544882|424041|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
132141|NCT00544882|424039|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
132142|NCT00544882|424040|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
132143|NCT00544882|424041|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
132144|NCT00544882|424039|P3|Cycle 1: Run-in Cycle|Adverse Event|0
132145|NCT00544882|424040|P2|Cycle 1: Run-in Cycle|Adverse Event|0
132146|NCT00544882|424041|P1|Cycle 1: Run-in Cycle|Adverse Event|1
132147|NCT00544882|424039|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
132148|NCT00544882|424040|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
132149|NCT00544882|424041|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
132150|NCT00545051|424093|P2|Overall Study|Administrative reasons|1
132151|NCT00545051|424094|P1|Overall Study|Administrative reasons|0
132152|NCT00545051|424093|P2|Overall Study|Withdrawal by Subject|1
132153|NCT00545051|424094|P1|Overall Study|Withdrawal by Subject|0
132154|NCT00545051|424093|P2|Overall Study|Protocol Violation|0
132155|NCT00545051|424094|P1|Overall Study|Protocol Violation|1
132156|NCT00545051|424093|P2|Overall Study|Violation of inclusion/exclusion|2
132157|NCT00545051|424094|P1|Overall Study|Violation of inclusion/exclusion|0
132158|NCT00545051|424093|P2|Overall Study|Death|0
132159|NCT00545051|424094|P1|Overall Study|Death|1
132160|NCT00545051|424093|P2|Overall Study|Adverse Event|3
132161|NCT00545051|424094|P1|Overall Study|Adverse Event|7
132162|NCT00545064|424108|P1|Overall Study|inclement weather|1
132163|NCT00545064|424108|P1|Overall Study|cancel all appointments, no rebooking|1
132164|NCT00545064|424108|P1|Overall Study|did not complete course of treatment|1
132165|NCT00545064|424108|P1|Overall Study|Withdrawal by Subject|2
132166|NCT00545064|424108|P1|Overall Study|Lost to Follow-up|3
132167|NCT00545103|424121|P4|Overall Study|Death|0
132168|NCT00545103|424122|P3|Overall Study|Death|0
132169|NCT00545103|424123|P2|Overall Study|Death|1
132170|NCT00545103|424124|P1|Overall Study|Death|0
132171|NCT00545103|424121|P4|Overall Study|Subject met endpoint under protocol v. 1|0
132172|NCT00545103|424122|P3|Overall Study|Subject met endpoint under protocol v. 1|1
132173|NCT00545103|424123|P2|Overall Study|Subject met endpoint under protocol v. 1|0
132174|NCT00545103|424124|P1|Overall Study|Subject met endpoint under protocol v. 1|0
132175|NCT00545103|424121|P4|Overall Study|Does not want to take study drug anymore|0
132176|NCT00545103|424122|P3|Overall Study|Does not want to take study drug anymore|1
132177|NCT00545103|424123|P2|Overall Study|Does not want to take study drug anymore|0
132178|NCT00545103|424124|P1|Overall Study|Does not want to take study drug anymore|1
132179|NCT00545103|424121|P4|Overall Study|Use of prohibited medication|0
132180|NCT00545103|424122|P3|Overall Study|Use of prohibited medication|1
132181|NCT00545103|424123|P2|Overall Study|Use of prohibited medication|0
132182|NCT00545103|424124|P1|Overall Study|Use of prohibited medication|0
132183|NCT00545103|424121|P4|Overall Study|Subject moved|0
132184|NCT00545103|424122|P3|Overall Study|Subject moved|0
132185|NCT00545103|424123|P2|Overall Study|Subject moved|1
132186|NCT00545103|424124|P1|Overall Study|Subject moved|0
132187|NCT00545103|424121|P4|Overall Study|Investigator decision|0
132188|NCT00545103|424122|P3|Overall Study|Investigator decision|1
132189|NCT00545103|424123|P2|Overall Study|Investigator decision|0
132190|NCT00545103|424124|P1|Overall Study|Investigator decision|0
132191|NCT00545103|424121|P4|Overall Study|Noncompliance|0
132192|NCT00545103|424122|P3|Overall Study|Noncompliance|0
132193|NCT00545103|424123|P2|Overall Study|Noncompliance|1
132194|NCT00545103|424124|P1|Overall Study|Noncompliance|0
132195|NCT00545103|424121|P4|Overall Study|Subject's decision|0
132196|NCT00545103|424122|P3|Overall Study|Subject's decision|0
132197|NCT00545103|424123|P2|Overall Study|Subject's decision|0
132198|NCT00545103|424124|P1|Overall Study|Subject's decision|1
132199|NCT00545103|424121|P4|Overall Study|Personal reasons|0
132200|NCT00545103|424122|P3|Overall Study|Personal reasons|0
132201|NCT00545103|424123|P2|Overall Study|Personal reasons|0
132202|NCT00545103|424124|P1|Overall Study|Personal reasons|1
132203|NCT00545103|424121|P4|Overall Study|Diverticulitis crisis|1
132204|NCT00545103|424122|P3|Overall Study|Diverticulitis crisis|0
132205|NCT00545103|424123|P2|Overall Study|Diverticulitis crisis|0
132206|NCT00545103|424124|P1|Overall Study|Diverticulitis crisis|0
132207|NCT00545103|424121|P4|Overall Study|Wish to start a family|1
132208|NCT00545103|424122|P3|Overall Study|Wish to start a family|0
132209|NCT00545103|424123|P2|Overall Study|Wish to start a family|0
132210|NCT00545103|424124|P1|Overall Study|Wish to start a family|0
132211|NCT00545103|424121|P4|Overall Study|Investigational product not taken|1
132212|NCT00545103|424122|P3|Overall Study|Investigational product not taken|0
132213|NCT00545103|424123|P2|Overall Study|Investigational product not taken|0
132214|NCT00545103|424124|P1|Overall Study|Investigational product not taken|1
132215|NCT00545103|424121|P4|Overall Study|Difficult to open package|1
132216|NCT00545103|424122|P3|Overall Study|Difficult to open package|0
132217|NCT00545103|424123|P2|Overall Study|Difficult to open package|0
132218|NCT00545103|424124|P1|Overall Study|Difficult to open package|0
132219|NCT00545103|424121|P4|Overall Study|Suspected recurrence of diverticulitis|3
132220|NCT00545103|424122|P3|Overall Study|Suspected recurrence of diverticulitis|0
132221|NCT00545103|424123|P2|Overall Study|Suspected recurrence of diverticulitis|0
132222|NCT00545103|424124|P1|Overall Study|Suspected recurrence of diverticulitis|1
132223|NCT00545103|424121|P4|Overall Study|Protocol Violation|0
132224|NCT00545103|424122|P3|Overall Study|Protocol Violation|3
132225|NCT00545103|424123|P2|Overall Study|Protocol Violation|2
132226|NCT00545103|424124|P1|Overall Study|Protocol Violation|1
132227|NCT00545103|424121|P4|Overall Study|Lost to Follow-up|4
132228|NCT00545103|424122|P3|Overall Study|Lost to Follow-up|3
132229|NCT00545103|424123|P2|Overall Study|Lost to Follow-up|6
132230|NCT00545103|424124|P1|Overall Study|Lost to Follow-up|4
132231|NCT00545103|424121|P4|Overall Study|Adverse Event|10
132232|NCT00545103|424122|P3|Overall Study|Adverse Event|17
132233|NCT00545103|424123|P2|Overall Study|Adverse Event|12
132234|NCT00545103|424124|P1|Overall Study|Adverse Event|11
132235|NCT00545103|424121|P4|Overall Study|Withdrawal by Subject|22
132236|NCT00545103|424122|P3|Overall Study|Withdrawal by Subject|18
132237|NCT00545103|424123|P2|Overall Study|Withdrawal by Subject|10
132238|NCT00545103|424124|P1|Overall Study|Withdrawal by Subject|6
132239|NCT00545103|424121|P4|Overall Study|Lack of Efficacy|27
132240|NCT00545103|424122|P3|Overall Study|Lack of Efficacy|31
132241|NCT00545103|424123|P2|Overall Study|Lack of Efficacy|45
132242|NCT00545103|424124|P1|Overall Study|Lack of Efficacy|48
132243|NCT00545168|424174|P3|Overall Study|Visit for Day 21 was not done in error|2
132244|NCT00545168|424175|P2|Overall Study|Visit for Day 21 was not done in error|0
132245|NCT00545168|424176|P1|Overall Study|Visit for Day 21 was not done in error|1
132246|NCT00545168|424174|P3|Overall Study|Protocol Violation|1
132247|NCT00545168|424175|P2|Overall Study|Protocol Violation|0
132248|NCT00545168|424176|P1|Overall Study|Protocol Violation|1
132249|NCT00545168|424174|P3|Overall Study|Withdrawal by Subject|13
132250|NCT00545168|424175|P2|Overall Study|Withdrawal by Subject|0
132251|NCT00545168|424176|P1|Overall Study|Withdrawal by Subject|9
132252|NCT00545168|424174|P3|Overall Study|Lost to Follow-up|5
132253|NCT00545168|424175|P2|Overall Study|Lost to Follow-up|5
132254|NCT00545168|424176|P1|Overall Study|Lost to Follow-up|5
132255|NCT00545233|424196|P2|Overall Study|Physician Decision|1
132256|NCT00545233|424197|P1|Overall Study|Physician Decision|2
132257|NCT00545233|424196|P2|Overall Study|Insufficient response|15
132258|NCT00545233|424197|P1|Overall Study|Insufficient response|14
132259|NCT00545233|424196|P2|Overall Study|Failure to Return|6
132260|NCT00545233|424197|P1|Overall Study|Failure to Return|4
132261|NCT00545233|424196|P2|Overall Study|Refused Treatment|7
132262|NCT00545233|424197|P1|Overall Study|Refused Treatment|9
132263|NCT00545233|424196|P2|Overall Study|Protocol Violation|0
132264|NCT00545233|424197|P1|Overall Study|Protocol Violation|2
132265|NCT00545233|424196|P2|Overall Study|Violation of Selection Criteria at Entry|1
132266|NCT00545233|424197|P1|Overall Study|Violation of Selection Criteria at Entry|5
132267|NCT00545233|424196|P2|Overall Study|Adverse Event|5
132268|NCT00545233|424197|P1|Overall Study|Adverse Event|10
132269|NCT00545272|424250|P6|Overall Study|Lost to Follow-up|0
132270|NCT00545272|424251|P5|Overall Study|Lost to Follow-up|1
132271|NCT00545272|424252|P4|Overall Study|Lost to Follow-up|0
132272|NCT00545272|424253|P3|Overall Study|Lost to Follow-up|0
132273|NCT00545272|424254|P2|Overall Study|Lost to Follow-up|0
132274|NCT00545272|424255|P1|Overall Study|Lost to Follow-up|0
132275|NCT00545272|424250|P6|Overall Study|Abnormal test procedure result(s)|0
132276|NCT00545272|424251|P5|Overall Study|Abnormal test procedure result(s)|1
132277|NCT00545272|424252|P4|Overall Study|Abnormal test procedure result(s)|0
132278|NCT00545272|424253|P3|Overall Study|Abnormal test procedure result(s)|0
132279|NCT00545272|424254|P2|Overall Study|Abnormal test procedure result(s)|0
132280|NCT00545272|424255|P1|Overall Study|Abnormal test procedure result(s)|0
132281|NCT00545272|424250|P6|Overall Study|Abnormal laboratory value(s)|1
132282|NCT00545272|424251|P5|Overall Study|Abnormal laboratory value(s)|0
132283|NCT00545272|424252|P4|Overall Study|Abnormal laboratory value(s)|0
132284|NCT00545272|424253|P3|Overall Study|Abnormal laboratory value(s)|0
132285|NCT00545272|424254|P2|Overall Study|Abnormal laboratory value(s)|0
132286|NCT00545272|424255|P1|Overall Study|Abnormal laboratory value(s)|0
132287|NCT00545272|424250|P6|Overall Study|Adverse Event|1
132288|NCT00545272|424251|P5|Overall Study|Adverse Event|0
132289|NCT00545272|424252|P4|Overall Study|Adverse Event|0
132290|NCT00545272|424253|P3|Overall Study|Adverse Event|1
132291|NCT00545272|424254|P2|Overall Study|Adverse Event|0
132292|NCT00545272|424255|P1|Overall Study|Adverse Event|0
132293|NCT00545272|424250|P6|Overall Study|Protocol deviation|1
132294|NCT00545272|424251|P5|Overall Study|Protocol deviation|0
132295|NCT00545272|424252|P4|Overall Study|Protocol deviation|1
132296|NCT00545272|424253|P3|Overall Study|Protocol deviation|0
132297|NCT00545272|424254|P2|Overall Study|Protocol deviation|1
132298|NCT00545272|424255|P1|Overall Study|Protocol deviation|0
132299|NCT00545298|424308|P3|Overall Study|Issues with Standard of Care|1
132300|NCT00545298|424309|P2|Overall Study|Issues with Standard of Care|0
132301|NCT00545298|424310|P1|Overall Study|Issues with Standard of Care|2
132302|NCT00545363|424323|P2|Overall Study|Unspecified|1
132303|NCT00545363|424324|P1|Overall Study|Unspecified|1
132304|NCT00545363|424323|P2|Overall Study|Lost to Follow-up|0
132305|NCT00545363|424324|P1|Overall Study|Lost to Follow-up|2
132306|NCT00545363|424323|P2|Overall Study|Did not meet entry criteria|1
132307|NCT00545363|424324|P1|Overall Study|Did not meet entry criteria|1
132308|NCT00545363|424323|P2|Overall Study|Non-compliance|1
132309|NCT00545363|424324|P1|Overall Study|Non-compliance|3
132310|NCT00545363|424323|P2|Overall Study|Withdrawal by Subject|5
132311|NCT00545363|424324|P1|Overall Study|Withdrawal by Subject|6
132312|NCT00545363|424323|P2|Overall Study|Adverse Event|7
132313|NCT00545363|424324|P1|Overall Study|Adverse Event|6
132314|NCT00545402|424338|P2|Overall Study|Reason not specified|1
132315|NCT00545402|424339|P1|Overall Study|Reason not specified|1
132316|NCT00545402|424338|P2|Overall Study|Protocol Violation|0
132317|NCT00545402|424339|P1|Overall Study|Protocol Violation|1
132318|NCT00545402|424338|P2|Overall Study|Withdrawal by Subject|1
132319|NCT00545402|424339|P1|Overall Study|Withdrawal by Subject|0
132320|NCT00545402|424338|P2|Overall Study|Graft loss|4
132321|NCT00545402|424339|P1|Overall Study|Graft loss|2
132322|NCT00545402|424338|P2|Overall Study|Death|7
132323|NCT00545402|424339|P1|Overall Study|Death|5
132324|NCT00545402|424338|P2|Overall Study|Use of unauthorized immunosuppressant|7
132325|NCT00545402|424339|P1|Overall Study|Use of unauthorized immunosuppressant|8
132326|NCT00545402|424338|P2|Overall Study|Discontinuation of treatment|9
132327|NCT00545402|424339|P1|Overall Study|Discontinuation of treatment|17
132328|NCT00545441|424357|P2|Overall Study|Patients were not treated|3
132329|NCT00545441|424358|P1|Overall Study|Patients were not treated|1
132330|NCT00545441|424357|P2|Overall Study|Persistence or recurrence of fistula|2
132331|NCT00545441|424358|P1|Overall Study|Persistence or recurrence of fistula|5
132332|NCT00545441|424357|P2|Overall Study|Withdrawal by Subject|1
132333|NCT00545441|424358|P1|Overall Study|Withdrawal by Subject|1
132334|NCT00545441|424357|P2|Overall Study|Technical failure|1
132335|NCT00545441|424358|P1|Overall Study|Technical failure|0
132336|NCT00545441|424357|P2|Overall Study|Lost to Follow-up|5
132337|NCT00545441|424358|P1|Overall Study|Lost to Follow-up|9
132338|NCT00545441|424357|P2|Overall Study|Fistula draining at 6 months|4
132339|NCT00545441|424358|P1|Overall Study|Fistula draining at 6 months|2
132340|NCT00545571|424373|P1|Overall Study|Kidney Transplantation|3
132341|NCT00545571|424373|P1|Overall Study|Early Termination of Study|24
132342|NCT00545571|424373|P1|Overall Study|Transfusion|12
132343|NCT00545571|424373|P1|Overall Study|Screen Failure|16
132344|NCT00545571|424373|P1|Overall Study|Refused Treatment|1
132345|NCT00545571|424373|P1|Overall Study|Protocol Violation|2
132346|NCT00545571|424373|P1|Overall Study|Lack of Efficacy|1
132347|NCT00545571|424373|P1|Overall Study|Death|5
132348|NCT00545571|424373|P1|Overall Study|Adverse Event|2
132349|NCT00545571|424373|P1|Overall Study|Administrative Reasons|1
132350|NCT00545584|424389|P3|Overall Study|Two or more reasons for discontinuation|8
132351|NCT00545584|424390|P2|Overall Study|Two or more reasons for discontinuation|19
132352|NCT00545584|424391|P1|Overall Study|Two or more reasons for discontinuation|17
132353|NCT00545584|424389|P3|Overall Study|Only one reason for discontinuation|48
132354|NCT00545584|424390|P2|Overall Study|Only one reason for discontinuation|61
132355|NCT00545584|424391|P1|Overall Study|Only one reason for discontinuation|62
132356|NCT00533273|424445|P2|Open-label|Withdrawal by Subject|0
132357|NCT00533273|424446|P1|Open-label|Withdrawal by Subject|6
132358|NCT00533273|424445|P2|Double-blind|Withdrew consent|2
132359|NCT00533273|424446|P1|Double-blind|Withdrew consent|0
132360|NCT00533507|424476|P1|Overall Study|Withdrawal by Subject|1
132361|NCT00539032|424504|P2|Overall Study|Withdrawal by Subject|1
132362|NCT00539032|424505|P1|Overall Study|Withdrawal by Subject|2
132363|NCT00539188|424526|P2|Overall Study|Lost to Follow-up|1
132364|NCT00539188|424527|P1|Overall Study|Lost to Follow-up|2
132365|NCT00539188|424526|P2|Overall Study|Withdrawal by Subject|0
132366|NCT00539188|424527|P1|Overall Study|Withdrawal by Subject|1
132367|NCT00539240|424542|P3|Overall Study|Adverse Event|10
132368|NCT00539240|424543|P2|Overall Study|Adverse Event|1
132369|NCT00539240|424544|P1|Overall Study|Adverse Event|3
132370|NCT00539240|424542|P3|Overall Study|Lost to Follow-up|1
132371|NCT00539240|424543|P2|Overall Study|Lost to Follow-up|3
132372|NCT00539240|424544|P1|Overall Study|Lost to Follow-up|2
132373|NCT00539240|424542|P3|Overall Study|Protocol Violation|4
132374|NCT00539240|424543|P2|Overall Study|Protocol Violation|1
132375|NCT00539240|424544|P1|Overall Study|Protocol Violation|1
132376|NCT00539240|424542|P3|Overall Study|Withdrawal by Subject|0
132377|NCT00539240|424543|P2|Overall Study|Withdrawal by Subject|2
132378|NCT00539240|424544|P1|Overall Study|Withdrawal by Subject|0
132379|NCT00539279|424563|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
132380|NCT00539279|424564|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
132381|NCT00539279|424563|P2|Post-Treatment Assessment|Lost to Follow-up|9
132382|NCT00539279|424564|P1|Post-Treatment Assessment|Lost to Follow-up|12
132383|NCT00539279|424563|P2|Treatment|Death|0
132384|NCT00539279|424564|P1|Treatment|Death|1
132385|NCT00539279|424563|P2|Treatment|Withdrawal by Subject|8
132386|NCT00539279|424564|P1|Treatment|Withdrawal by Subject|10
132387|NCT00539305|424584|P2|Overall Study|Withdrawal by Subject|1
132388|NCT00539305|424585|P1|Overall Study|Withdrawal by Subject|0
132389|NCT00539305|424584|P2|Overall Study|Substance Use|1
132390|NCT00539305|424585|P1|Overall Study|Substance Use|0
132391|NCT00539305|424584|P2|Overall Study|Adverse Event|0
132392|NCT00539305|424585|P1|Overall Study|Adverse Event|1
132393|NCT00545688|424601|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
132394|NCT00545688|424602|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
132395|NCT00545688|424603|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
132396|NCT00545688|424604|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
132397|NCT00545688|424601|P4|Follow-Up Period|Unspecified Reason|8
132398|NCT00545688|424602|P3|Follow-Up Period|Unspecified Reason|6
132399|NCT00545688|424603|P2|Follow-Up Period|Unspecified Reason|5
132400|NCT00545688|424604|P1|Follow-Up Period|Unspecified Reason|2
132401|NCT00545688|424601|P4|Follow-Up Period|Lost to Follow-up|1
132402|NCT00545688|424602|P3|Follow-Up Period|Lost to Follow-up|3
132403|NCT00545688|424603|P2|Follow-Up Period|Lost to Follow-up|3
132404|NCT00545688|424604|P1|Follow-Up Period|Lost to Follow-up|3
132405|NCT00545688|424601|P4|Follow-Up Period|Refused Treatment|2
132406|NCT00545688|424602|P3|Follow-Up Period|Refused Treatment|0
132407|NCT00545688|424603|P2|Follow-Up Period|Refused Treatment|2
132408|NCT00545688|424604|P1|Follow-Up Period|Refused Treatment|6
132409|NCT00545688|424601|P4|Follow-Up Period|Disease Progression|9
132410|NCT00545688|424602|P3|Follow-Up Period|Disease Progression|9
132411|NCT00545688|424603|P2|Follow-Up Period|Disease Progression|5
132412|NCT00545688|424604|P1|Follow-Up Period|Disease Progression|6
132413|NCT00545688|424601|P4|Follow-Up Period|Death|6
132414|NCT00545688|424602|P3|Follow-Up Period|Death|2
132415|NCT00545688|424603|P2|Follow-Up Period|Death|2
132416|NCT00545688|424604|P1|Follow-Up Period|Death|4
132417|NCT00545688|424601|P4|Adjuvant Treatment Period|Unknown Reason|0
132418|NCT00545688|424602|P3|Adjuvant Treatment Period|Unknown Reason|0
132419|NCT00545688|424603|P2|Adjuvant Treatment Period|Unknown Reason|1
132420|NCT00545688|424604|P1|Adjuvant Treatment Period|Unknown Reason|0
132421|NCT00545688|424601|P4|Adjuvant Treatment Period|Adverse Event|2
132422|NCT00545688|424602|P3|Adjuvant Treatment Period|Adverse Event|2
132423|NCT00545688|424603|P2|Adjuvant Treatment Period|Adverse Event|3
132424|NCT00545688|424604|P1|Adjuvant Treatment Period|Adverse Event|0
132425|NCT00545688|424601|P4|Adjuvant Treatment Period|Lost to Follow-up|0
132426|NCT00545688|424602|P3|Adjuvant Treatment Period|Lost to Follow-up|1
132427|NCT00545688|424603|P2|Adjuvant Treatment Period|Lost to Follow-up|0
132428|NCT00545688|424604|P1|Adjuvant Treatment Period|Lost to Follow-up|1
132429|NCT00545688|424601|P4|Adjuvant Treatment Period|Refused Treatment|5
132430|NCT00545688|424602|P3|Adjuvant Treatment Period|Refused Treatment|1
132431|NCT00545688|424603|P2|Adjuvant Treatment Period|Refused Treatment|1
132432|NCT00545688|424604|P1|Adjuvant Treatment Period|Refused Treatment|1
132433|NCT00545688|424601|P4|Adjuvant Treatment Period|Disease Progression|7
132434|NCT00545688|424602|P3|Adjuvant Treatment Period|Disease Progression|0
132435|NCT00545688|424603|P2|Adjuvant Treatment Period|Disease Progression|3
132436|NCT00545688|424604|P1|Adjuvant Treatment Period|Disease Progression|3
132437|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
132438|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
132439|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
132440|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
132441|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
132442|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
132443|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
132444|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
132445|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
132446|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
132447|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
132448|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
132449|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Death|0
132450|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Death|0
132451|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Death|1
132452|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Death|0
132453|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
132454|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
132455|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
132456|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
132457|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
132458|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
132459|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
132460|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
132461|NCT00545688|424601|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
132462|NCT00545688|424602|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
132463|NCT00545688|424603|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
132464|NCT00545688|424604|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
132465|NCT00545740|424678|P4|Overall Study|Husband against study|0
132466|NCT00545740|424679|P3|Overall Study|Husband against study|1
132467|NCT00545740|424680|P2|Overall Study|Husband against study|0
132468|NCT00545740|424681|P1|Overall Study|Husband against study|0
132469|NCT00545740|424678|P4|Overall Study|Patient difficulties|0
132470|NCT00545740|424679|P3|Overall Study|Patient difficulties|0
132471|NCT00545740|424680|P2|Overall Study|Patient difficulties|1
132472|NCT00545740|424681|P1|Overall Study|Patient difficulties|0
132473|NCT00545740|424678|P4|Overall Study|Non-adherence to visits|0
132474|NCT00545740|424679|P3|Overall Study|Non-adherence to visits|0
132475|NCT00545740|424680|P2|Overall Study|Non-adherence to visits|1
132476|NCT00545740|424681|P1|Overall Study|Non-adherence to visits|0
132477|NCT00545740|424678|P4|Overall Study|Lack of time|0
132478|NCT00545740|424679|P3|Overall Study|Lack of time|0
132479|NCT00545740|424680|P2|Overall Study|Lack of time|1
132480|NCT00545740|424681|P1|Overall Study|Lack of time|0
132481|NCT00545740|424678|P4|Overall Study|Sponsor decision|0
132482|NCT00545740|424679|P3|Overall Study|Sponsor decision|0
132483|NCT00545740|424680|P2|Overall Study|Sponsor decision|1
132484|NCT00545740|424681|P1|Overall Study|Sponsor decision|0
132485|NCT00545740|424678|P4|Overall Study|Accepted only monthly telephone calls|0
132486|NCT00545740|424679|P3|Overall Study|Accepted only monthly telephone calls|0
132487|NCT00545740|424680|P2|Overall Study|Accepted only monthly telephone calls|0
132488|NCT00545740|424681|P1|Overall Study|Accepted only monthly telephone calls|1
132489|NCT00545740|424678|P4|Overall Study|Physician Decision|0
132490|NCT00545740|424679|P3|Overall Study|Physician Decision|3
132491|NCT00545740|424680|P2|Overall Study|Physician Decision|0
132492|NCT00545740|424681|P1|Overall Study|Physician Decision|0
132493|NCT00545740|424678|P4|Overall Study|Missed visit|0
132494|NCT00545740|424679|P3|Overall Study|Missed visit|0
132495|NCT00545740|424680|P2|Overall Study|Missed visit|0
132496|NCT00545740|424681|P1|Overall Study|Missed visit|1
132497|NCT00545740|424678|P4|Overall Study|Site closure|0
132498|NCT00545740|424679|P3|Overall Study|Site closure|0
132499|NCT00545740|424680|P2|Overall Study|Site closure|0
132500|NCT00545740|424681|P1|Overall Study|Site closure|1
132501|NCT00545740|424678|P4|Overall Study|Suspected Diverticulitis Recurrence|1
132502|NCT00545740|424679|P3|Overall Study|Suspected Diverticulitis Recurrence|1
132503|NCT00545740|424680|P2|Overall Study|Suspected Diverticulitis Recurrence|1
132504|NCT00545740|424681|P1|Overall Study|Suspected Diverticulitis Recurrence|1
132505|NCT00545740|424678|P4|Overall Study|Diverticulitis attack|1
132506|NCT00545740|424679|P3|Overall Study|Diverticulitis attack|1
132507|NCT00545740|424680|P2|Overall Study|Diverticulitis attack|0
132508|NCT00545740|424681|P1|Overall Study|Diverticulitis attack|0
132509|NCT00545740|424678|P4|Overall Study|Moved|0
132510|NCT00545740|424679|P3|Overall Study|Moved|1
132511|NCT00545740|424680|P2|Overall Study|Moved|0
132512|NCT00545740|424681|P1|Overall Study|Moved|2
132513|NCT00545740|424678|P4|Overall Study|Non-compliance|0
132514|NCT00545740|424679|P3|Overall Study|Non-compliance|1
132515|NCT00545740|424680|P2|Overall Study|Non-compliance|2
132516|NCT00545740|424681|P1|Overall Study|Non-compliance|0
132517|NCT00545740|424678|P4|Overall Study|Protocol Violation|0
132518|NCT00545740|424679|P3|Overall Study|Protocol Violation|1
132519|NCT00545740|424680|P2|Overall Study|Protocol Violation|3
132520|NCT00545740|424681|P1|Overall Study|Protocol Violation|1
132521|NCT00545740|424678|P4|Overall Study|Lost to Follow-up|6
132522|NCT00545740|424679|P3|Overall Study|Lost to Follow-up|5
132523|NCT00545740|424680|P2|Overall Study|Lost to Follow-up|5
132524|NCT00545740|424681|P1|Overall Study|Lost to Follow-up|7
132525|NCT00545740|424678|P4|Overall Study|Adverse Event|9
132526|NCT00545740|424679|P3|Overall Study|Adverse Event|19
132527|NCT00545740|424680|P2|Overall Study|Adverse Event|18
132528|NCT00545740|424681|P1|Overall Study|Adverse Event|10
132529|NCT00545740|424678|P4|Overall Study|Withdrawal by Subject|18
132530|NCT00545740|424679|P3|Overall Study|Withdrawal by Subject|16
132531|NCT00545740|424680|P2|Overall Study|Withdrawal by Subject|15
132532|NCT00545740|424681|P1|Overall Study|Withdrawal by Subject|17
132533|NCT00545740|424678|P4|Overall Study|Lack of Efficacy|36
132534|NCT00545740|424679|P3|Overall Study|Lack of Efficacy|47
132535|NCT00545740|424680|P2|Overall Study|Lack of Efficacy|35
132536|NCT00545740|424681|P1|Overall Study|Lack of Efficacy|34
132537|NCT00545753|424718|P3|Overall Study|Protocol Violation|4
132538|NCT00545753|424719|P2|Overall Study|Protocol Violation|1
132539|NCT00545753|424720|P1|Overall Study|Protocol Violation|3
132540|NCT00545753|424718|P3|Overall Study|Lost to Follow-up|12
132541|NCT00545753|424719|P2|Overall Study|Lost to Follow-up|3
132542|NCT00545753|424720|P1|Overall Study|Lost to Follow-up|13
132543|NCT00545753|424718|P3|Overall Study|Withdrawal by Subject|10
132544|NCT00545753|424719|P2|Overall Study|Withdrawal by Subject|1
132545|NCT00545753|424720|P1|Overall Study|Withdrawal by Subject|0
132546|NCT00545779|424733|P1|Overall Study|Failure to return|3
132547|NCT00545779|424733|P1|Overall Study|Adverse Event/intercurrent illness|5
132548|NCT00545779|424733|P1|Overall Study|Withdrawal by Subject|20
132549|NCT00545779|424733|P1|Overall Study|Did not cooperate|7
132550|NCT00545779|424733|P1|Overall Study|Other protocol violation|1
132551|NCT00545779|424733|P1|Overall Study|Violation of selection criteria at entry|8
132552|NCT00545792|424746|P1|Overall Study|Withdrawal by Subject|1
132553|NCT00545844|424751|P1|Overall Study|Withdrawal by Subject|2
132554|NCT00545844|424751|P1|Overall Study|Protocol Violation|1
132555|NCT00545844|424751|P1|Overall Study|Lost to Follow-up|9
132556|NCT00545948|424768|P3|Overall Study|Not Treated|7
132557|NCT00545948|424769|P2|Overall Study|Not Treated|1
132558|NCT00545948|424770|P1|Overall Study|Not Treated|1
132559|NCT00546000|424791|P1|Overall Study|Baseline HPA Axis Supression|2
132560|NCT00546000|424791|P1|Overall Study|Lost to Follow-up|1
132561|NCT00546000|424791|P1|Overall Study|Adverse Event|1
132562|NCT00546078|424798|P2|Overall Study|Other reason|1
132563|NCT00546078|424799|P1|Overall Study|Other reason|1
132564|NCT00546078|424798|P2|Overall Study|Withdrawal by Subject|3
132565|NCT00546078|424799|P1|Overall Study|Withdrawal by Subject|2
132566|NCT00546078|424798|P2|Overall Study|Lost to Follow-up|3
132567|NCT00546078|424799|P1|Overall Study|Lost to Follow-up|1
132568|NCT00546117|424848|P2|Overall Study|Inability to schedule follow-up visit|0
132569|NCT00546117|424849|P1|Overall Study|Inability to schedule follow-up visit|1
132570|NCT00546117|424848|P2|Overall Study|Withdrawal by Subject|0
132571|NCT00546117|424849|P1|Overall Study|Withdrawal by Subject|3
132572|NCT00546260|424869|P2|Overall Study|Drug not given pre diagnostic angiogr|2
132573|NCT00546260|424870|P1|Overall Study|Drug not given pre diagnostic angiogr|8
132574|NCT00546351|424896|P1|Overall Study|Other reasons for premature termination|17
132575|NCT00546351|424896|P1|Overall Study|Unsatisfactory compliance|9
132576|NCT00546351|424896|P1|Overall Study|Protocol Deviation|1
132577|NCT00546351|424896|P1|Overall Study|Lost to Follow-up|9
132578|NCT00546351|424896|P1|Overall Study|Withdrawal by Subject|109
132579|NCT00546351|424896|P1|Overall Study|Lack of Efficacy|15
132580|NCT00546351|424896|P1|Overall Study|Adverse Event|76
132581|NCT00546364|424927|P3|Overall Study|Sponsor decision|1
132582|NCT00546364|424928|P2|Overall Study|Sponsor decision|0
132583|NCT00546364|424929|P1|Overall Study|Sponsor decision|0
132584|NCT00546364|424927|P3|Overall Study|Physician Decision|1
132585|NCT00546364|424928|P2|Overall Study|Physician Decision|0
132586|NCT00546364|424929|P1|Overall Study|Physician Decision|0
132587|NCT00546364|424927|P3|Overall Study|Target lesions resected|0
132588|NCT00546364|424928|P2|Overall Study|Target lesions resected|0
132589|NCT00546364|424929|P1|Overall Study|Target lesions resected|1
132590|NCT00546364|424927|P3|Overall Study|Palliative treatment|1
132591|NCT00546364|424928|P2|Overall Study|Palliative treatment|0
132592|NCT00546364|424929|P1|Overall Study|Palliative treatment|1
132593|NCT00546364|424927|P3|Overall Study|Mixed response|0
132594|NCT00546364|424928|P2|Overall Study|Mixed response|0
132595|NCT00546364|424929|P1|Overall Study|Mixed response|1
132596|NCT00546364|424927|P3|Overall Study|Prior taxotere|0
132597|NCT00546364|424928|P2|Overall Study|Prior taxotere|0
132598|NCT00546364|424929|P1|Overall Study|Prior taxotere|1
132599|NCT00546364|424927|P3|Overall Study|Withdrawal by Subject|3
132600|NCT00546364|424928|P2|Overall Study|Withdrawal by Subject|6
132601|NCT00546364|424929|P1|Overall Study|Withdrawal by Subject|5
132602|NCT00546364|424927|P3|Overall Study|No longer meets study criteria|0
132603|NCT00546364|424928|P2|Overall Study|No longer meets study criteria|1
132604|NCT00546364|424929|P1|Overall Study|No longer meets study criteria|1
132605|NCT00546364|424927|P3|Overall Study|Poor compliance/noncompliance|1
132606|NCT00546364|424928|P2|Overall Study|Poor compliance/noncompliance|0
132607|NCT00546364|424929|P1|Overall Study|Poor compliance/noncompliance|0
132608|NCT00546364|424927|P3|Overall Study|Administrative reason by sponsor|0
132609|NCT00546364|424928|P2|Overall Study|Administrative reason by sponsor|0
132610|NCT00546364|424929|P1|Overall Study|Administrative reason by sponsor|1
132611|NCT00546364|424927|P3|Overall Study|Completed and off treatment|2
132612|NCT00546364|424928|P2|Overall Study|Completed and off treatment|0
132613|NCT00546364|424929|P1|Overall Study|Completed and off treatment|1
132614|NCT00546364|424927|P3|Overall Study|Disease progression|8
132615|NCT00546364|424928|P2|Overall Study|Disease progression|11
132616|NCT00546364|424929|P1|Overall Study|Disease progression|5
132617|NCT00546377|424964|P1|Overall Study|Adverse Event|6
132618|NCT00546377|424964|P1|Overall Study|Deemed ineligible|1
132619|NCT00546481|424975|P3|Maintenance Phase (CERA)|Other Reason|1
132620|NCT00546481|424976|P2|Maintenance Phase (CERA)|Other Reason|0
132621|NCT00546481|424977|P1|Maintenance Phase (CERA)|Other Reason|0
132622|NCT00546481|424975|P3|Maintenance Phase (CERA)|Kidney transplantation|1
132623|NCT00546481|424976|P2|Maintenance Phase (CERA)|Kidney transplantation|0
132624|NCT00546481|424977|P1|Maintenance Phase (CERA)|Kidney transplantation|0
132625|NCT00546481|424975|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
132626|NCT00546481|424976|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
132627|NCT00546481|424977|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
132628|NCT00546481|424975|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
132629|NCT00546481|424976|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
132630|NCT00546481|424977|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
132631|NCT00546481|424975|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
132632|NCT00546481|424976|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
132633|NCT00546481|424977|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
132634|NCT00546481|424975|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
132635|NCT00546481|424976|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
132636|NCT00546481|424977|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
132637|NCT00546481|424975|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
132638|NCT00546481|424976|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
132639|NCT00546481|424977|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
132640|NCT00546481|424975|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
132641|NCT00546481|424976|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
132642|NCT00546481|424977|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
132643|NCT00546481|424975|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
132644|NCT00546481|424976|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
132645|NCT00546481|424977|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
132646|NCT00546572|425002|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
132905|NCT00548405|425737|P1|Overall Study|Lack of Efficacy|6
132647|NCT00546572|425003|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
132648|NCT00546572|425002|P2|Vax 2 / Year 1|Adverse Event|0
132649|NCT00546572|425003|P1|Vax 2 / Year 1|Adverse Event|1
132650|NCT00546572|425002|P2|Vax 2 / Year 1|Unspecified|1
132651|NCT00546572|425003|P1|Vax 2 / Year 1|Unspecified|1
132652|NCT00546572|425002|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
132653|NCT00546572|425003|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
132654|NCT00546572|425002|P2|Vax 1 / Year 0|Lost to Follow-up|1
132655|NCT00546572|425003|P1|Vax 1 / Year 0|Lost to Follow-up|0
132656|NCT00546572|425002|P2|Vax 1 / Year 0|Adverse Event|1
132657|NCT00546572|425003|P1|Vax 1 / Year 0|Adverse Event|0
132658|NCT00546572|425002|P2|Vax 1 / Year 0|Death|2
132659|NCT00546572|425003|P1|Vax 1 / Year 0|Death|2
132660|NCT00546572|425002|P2|Vax 1 / Year 0|Protocol Violation|4
132661|NCT00546572|425003|P1|Vax 1 / Year 0|Protocol Violation|3
132662|NCT00546572|425002|P2|Vax 1 / Year 0|Withdrawal by Subject|2
132663|NCT00546572|425003|P1|Vax 1 / Year 0|Withdrawal by Subject|3
132664|NCT00546572|425002|P2|Vax 1 / Year 0|Randomized, not treated|1
132665|NCT00546572|425003|P1|Vax 1 / Year 0|Randomized, not treated|1
132666|NCT00546637|425047|P2|Overall Study|Randomized, but not treated|1
132667|NCT00546637|425048|P1|Overall Study|Randomized, but not treated|3
132668|NCT00546637|425047|P2|Overall Study|Withdrawal by Subject|9
132669|NCT00546637|425048|P1|Overall Study|Withdrawal by Subject|7
132670|NCT00546637|425047|P2|Overall Study|Unspecified|12
132671|NCT00546637|425048|P1|Overall Study|Unspecified|10
132672|NCT00546637|425047|P2|Overall Study|Lost to Follow-up|2
132673|NCT00546637|425048|P1|Overall Study|Lost to Follow-up|2
132674|NCT00546637|425047|P2|Overall Study|Lack of Efficacy|5
132675|NCT00546637|425048|P1|Overall Study|Lack of Efficacy|5
132676|NCT00546637|425047|P2|Overall Study|Adverse Event|20
132677|NCT00546637|425048|P1|Overall Study|Adverse Event|46
132678|NCT00546715|425124|P4|Overall Study|Withdrawal by Subject|0
132679|NCT00546715|425125|P3|Overall Study|Withdrawal by Subject|0
132680|NCT00546715|425126|P2|Overall Study|Withdrawal by Subject|1
132681|NCT00546715|425127|P1|Overall Study|Withdrawal by Subject|0
132682|NCT00546754|425191|P2|Overall Study|Missing|7
132683|NCT00546754|425192|P1|Overall Study|Missing|14
132684|NCT00546754|425191|P2|Overall Study|Patient's Decision|1
132685|NCT00546754|425192|P1|Overall Study|Patient's Decision|0
132686|NCT00546754|425191|P2|Overall Study|Elevated Creatinine and Potassium levels|1
132687|NCT00546754|425192|P1|Overall Study|Elevated Creatinine and Potassium levels|0
132688|NCT00546754|425191|P2|Overall Study|Missing Cooperation|0
132689|NCT00546754|425192|P1|Overall Study|Missing Cooperation|1
132690|NCT00546754|425191|P2|Overall Study|Suicide|0
132691|NCT00546754|425192|P1|Overall Study|Suicide|1
132692|NCT00546754|425191|P2|Overall Study|Hip Replacement|0
132693|NCT00546754|425192|P1|Overall Study|Hip Replacement|1
132694|NCT00546754|425191|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
132695|NCT00546754|425192|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
132696|NCT00546754|425191|P2|Overall Study|Dyspnea|0
132697|NCT00546754|425192|P1|Overall Study|Dyspnea|1
132698|NCT00546754|425191|P2|Overall Study|Withdrawal by Subject|7
132699|NCT00546754|425192|P1|Overall Study|Withdrawal by Subject|6
132700|NCT00546754|425191|P2|Overall Study|Protocol Violation|0
132701|NCT00546754|425192|P1|Overall Study|Protocol Violation|3
132702|NCT00546754|425191|P2|Overall Study|Lost to Follow-up|15
132703|NCT00546754|425192|P1|Overall Study|Lost to Follow-up|9
132704|NCT00546754|425191|P2|Overall Study|Lack of Efficacy|1
132705|NCT00546754|425192|P1|Overall Study|Lack of Efficacy|1
132706|NCT00546754|425191|P2|Overall Study|Adverse Event|16
132707|NCT00546754|425192|P1|Overall Study|Adverse Event|11
132708|NCT00546754|425191|P2|Overall Study|Serious Adverse Event|1
132709|NCT00546754|425192|P1|Overall Study|Serious Adverse Event|1
132710|NCT00546819|425224|P2|Overall Study|Withdrawal by Subject|2
132711|NCT00546819|425225|P1|Overall Study|Withdrawal by Subject|4
132712|NCT00546819|425224|P2|Overall Study|Lost to Follow-up|1
132713|NCT00546819|425225|P1|Overall Study|Lost to Follow-up|2
132714|NCT00546819|425224|P2|Overall Study|Adverse Event|3
132715|NCT00546819|425225|P1|Overall Study|Adverse Event|2
132716|NCT00546871|425235|P2|Study Extension Period|Withdrawal by Subject|1
132717|NCT00546871|425236|P1|Study Extension Period|Withdrawal by Subject|0
132718|NCT00546871|425235|P2|Study Extension Period|Protocol Violation|0
132719|NCT00546871|425236|P1|Study Extension Period|Protocol Violation|1
132720|NCT00546871|425235|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
132721|NCT00546871|425236|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
132722|NCT00546871|425235|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
132723|NCT00546871|425236|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
132724|NCT00546871|425235|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
132725|NCT00546871|425236|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
132726|NCT00546910|425389|P2|Overall Study|Withdrawal by Subject|0
132727|NCT00546910|425390|P1|Overall Study|Withdrawal by Subject|2
132728|NCT00546910|425389|P2|Overall Study|Physician Decision|1
132729|NCT00546910|425390|P1|Overall Study|Physician Decision|0
132730|NCT00546910|425389|P2|Overall Study|Lack of Efficacy|7
132731|NCT00546910|425390|P1|Overall Study|Lack of Efficacy|5
132732|NCT00546910|425389|P2|Overall Study|Adverse Event|3
132733|NCT00546910|425390|P1|Overall Study|Adverse Event|2
132734|NCT00547118|425410|P2|Overall Study|Did not qualify prior to starting drug|2
132735|NCT00547118|425411|P1|Overall Study|Did not qualify prior to starting drug|0
132736|NCT00547118|425410|P2|Overall Study|Withdrawal by Subject|0
132737|NCT00547118|425411|P1|Overall Study|Withdrawal by Subject|1
132738|NCT00547157|425419|P2|Overall Study|Lost to Follow-up|2
132739|NCT00547157|425420|P1|Overall Study|Lost to Follow-up|4
132740|NCT00547157|425419|P2|Overall Study|Administrative decision|2
132741|NCT00547157|425420|P1|Overall Study|Administrative decision|3
132742|NCT00547157|425419|P2|Overall Study|Withdrawal by Subject|1
132743|NCT00547157|425420|P1|Overall Study|Withdrawal by Subject|3
132744|NCT00547157|425419|P2|Overall Study|Death|18
132745|NCT00547157|425420|P1|Overall Study|Death|38
132746|NCT00547157|425419|P2|Overall Study|Other|0
132747|NCT00547157|425420|P1|Overall Study|Other|1
132748|NCT00547365|425436|P1|Overall Study|death (not related to study)|4
132749|NCT00547365|425436|P1|Overall Study|Protocol Violation|2
132750|NCT00547365|425436|P1|Overall Study|Lost to Follow-up|1
132751|NCT00547365|425436|P1|Overall Study|Physician Decision|1
132752|NCT00547521|425447|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
132753|NCT00547521|425448|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
132754|NCT00547521|425447|P2|Long Term Extension (LTE) Study|Not Specified|2
132755|NCT00547521|425448|P1|Long Term Extension (LTE) Study|Not Specified|0
132756|NCT00547521|425447|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
132757|NCT00547521|425448|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
132758|NCT00547521|425447|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
132759|NCT00547521|425448|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
132760|NCT00547521|425447|P2|Long Term Extension (LTE) Study|Adverse Event|9
132761|NCT00547521|425448|P1|Long Term Extension (LTE) Study|Adverse Event|0
132762|NCT00547521|425447|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
132763|NCT00547521|425448|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
132764|NCT00547521|425447|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
132765|NCT00547521|425448|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
132766|NCT00547521|425447|P2|Short Term Study (4 Months)|Withdrawal of consent|1
132767|NCT00547521|425448|P1|Short Term Study (4 Months)|Withdrawal of consent|0
132768|NCT00547521|425447|P2|Short Term Study (4 Months)|Lack of Efficacy|2
132769|NCT00547521|425448|P1|Short Term Study (4 Months)|Lack of Efficacy|0
132770|NCT00547521|425447|P2|Short Term Study (4 Months)|Adverse Event|0
132771|NCT00547521|425448|P1|Short Term Study (4 Months)|Adverse Event|1
132772|NCT00547534|425518|P1|Overall Study|Disease Progression|4
132773|NCT00547534|425518|P1|Overall Study|Adverse Event|7
132774|NCT00547703|425545|P2|Overall Study|Lost to Follow-up|0
132775|NCT00547703|425546|P1|Overall Study|Lost to Follow-up|1
132776|NCT00547911|425556|P6|Overall Study|Adverse Event|0
132777|NCT00547911|425557|P5|Overall Study|Adverse Event|0
132778|NCT00547911|425558|P4|Overall Study|Adverse Event|1
132779|NCT00547911|425559|P3|Overall Study|Adverse Event|0
132780|NCT00547911|425560|P2|Overall Study|Adverse Event|0
132781|NCT00547911|425561|P1|Overall Study|Adverse Event|0
132782|NCT00548145|425607|P2|Overall Study|Physician Decision|1
132783|NCT00548145|425608|P1|Overall Study|Physician Decision|1
132784|NCT00548145|425607|P2|Overall Study|Withdrawal by Subject|2
132785|NCT00548145|425608|P1|Overall Study|Withdrawal by Subject|0
132786|NCT00548145|425607|P2|Overall Study|Death|1
132787|NCT00548145|425608|P1|Overall Study|Death|0
132788|NCT00548184|425614|P1|Overall Study|Found Her2 negative|1
132789|NCT00548184|425614|P1|Overall Study|took other drug|1
132790|NCT00548184|425614|P1|Overall Study|Adverse Event|3
132791|NCT00548249|425623|P5|Overall Study|Sponsor's request|0
132792|NCT00548249|425624|P4|Overall Study|Sponsor's request|1
132793|NCT00548249|425625|P3|Overall Study|Sponsor's request|0
132794|NCT00548249|425626|P2|Overall Study|Sponsor's request|0
132795|NCT00548249|425627|P1|Overall Study|Sponsor's request|0
132796|NCT00548249|425623|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
132797|NCT00548249|425624|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
132798|NCT00548249|425625|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
132799|NCT00548249|425626|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
132800|NCT00548249|425627|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
132801|NCT00548249|425623|P5|Overall Study|Withdrawal by Subject|0
132802|NCT00548249|425624|P4|Overall Study|Withdrawal by Subject|0
132803|NCT00548249|425625|P3|Overall Study|Withdrawal by Subject|0
132804|NCT00548249|425626|P2|Overall Study|Withdrawal by Subject|0
132805|NCT00548249|425627|P1|Overall Study|Withdrawal by Subject|2
132806|NCT00548249|425623|P5|Overall Study|Prolonged hospitalization|0
132807|NCT00548249|425624|P4|Overall Study|Prolonged hospitalization|1
132808|NCT00548249|425625|P3|Overall Study|Prolonged hospitalization|2
132809|NCT00548249|425626|P2|Overall Study|Prolonged hospitalization|0
132810|NCT00548249|425627|P1|Overall Study|Prolonged hospitalization|0
132811|NCT00548249|425623|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
132812|NCT00548249|425624|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
132813|NCT00548249|425625|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
132814|NCT00548249|425626|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
132815|NCT00548249|425627|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
132816|NCT00548249|425623|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
132817|NCT00548249|425624|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
132818|NCT00548249|425625|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
132819|NCT00548249|425626|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
132820|NCT00548249|425627|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
132821|NCT00548249|425623|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
132822|NCT00548249|425624|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
132823|NCT00548249|425625|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
132824|NCT00548249|425626|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
132825|NCT00548249|425627|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
132826|NCT00548249|425623|P5|Overall Study|Adverse Event|1
132827|NCT00548249|425624|P4|Overall Study|Adverse Event|1
132828|NCT00548249|425625|P3|Overall Study|Adverse Event|0
132829|NCT00548249|425626|P2|Overall Study|Adverse Event|2
132830|NCT00548249|425627|P1|Overall Study|Adverse Event|2
132831|NCT00548249|425623|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
132832|NCT00548249|425624|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
132833|NCT00548249|425625|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
132834|NCT00548249|425626|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
132835|NCT00548249|425627|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
132836|NCT00548249|425623|P5|Overall Study|Miscellaneous|2
132837|NCT00548249|425624|P4|Overall Study|Miscellaneous|0
132838|NCT00548249|425625|P3|Overall Study|Miscellaneous|2
132839|NCT00548249|425626|P2|Overall Study|Miscellaneous|3
132840|NCT00548249|425627|P1|Overall Study|Miscellaneous|2
132841|NCT00548249|425623|P5|Overall Study|Protocol Violation|3
132842|NCT00548249|425624|P4|Overall Study|Protocol Violation|0
132843|NCT00548249|425625|P3|Overall Study|Protocol Violation|4
132844|NCT00548249|425626|P2|Overall Study|Protocol Violation|1
132845|NCT00548249|425627|P1|Overall Study|Protocol Violation|1
132846|NCT00548249|425623|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
132847|NCT00548249|425624|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
132848|NCT00548249|425625|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
132849|NCT00548249|425626|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
132850|NCT00548249|425627|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
132851|NCT00548249|425623|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
132852|NCT00548249|425624|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
132853|NCT00548249|425625|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
132854|NCT00548249|425626|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
132855|NCT00548249|425627|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
132856|NCT00548262|425664|P1|Overall Study|Withdrawal by Subject|1
132857|NCT00548262|425664|P1|Overall Study|Unspecified|3
132858|NCT00548262|425664|P1|Overall Study|Lost to Follow-up|1
132859|NCT00548262|425664|P1|Overall Study|Lack of Efficacy|4
132860|NCT00548262|425664|P1|Overall Study|Adverse Event|2
132861|NCT00548262|425664|P1|Overall Study|Death|21
132862|NCT00548327|425691|P2|Overall Study|Adverse Event|1
132863|NCT00548327|425692|P1|Overall Study|Adverse Event|0
132864|NCT00548340|425713|P3|Overall Study|Other|1
132865|NCT00548340|425714|P2|Overall Study|Other|1
132866|NCT00548340|425715|P1|Overall Study|Other|1
132867|NCT00548340|425713|P3|Overall Study|Withdrawal by Subject|3
132868|NCT00548340|425714|P2|Overall Study|Withdrawal by Subject|4
132869|NCT00548340|425715|P1|Overall Study|Withdrawal by Subject|2
132870|NCT00548340|425713|P3|Overall Study|Lost to Follow-up|0
132871|NCT00548340|425714|P2|Overall Study|Lost to Follow-up|1
132872|NCT00548340|425715|P1|Overall Study|Lost to Follow-up|1
132873|NCT00548340|425713|P3|Overall Study|Adverse Event|2
132874|NCT00548340|425714|P2|Overall Study|Adverse Event|2
132875|NCT00548340|425715|P1|Overall Study|Adverse Event|2
132876|NCT00548340|425713|P3|Overall Study|Protocol Violation|3
132877|NCT00548340|425714|P2|Overall Study|Protocol Violation|3
132878|NCT00548340|425715|P1|Overall Study|Protocol Violation|2
132879|NCT00548405|425735|P3|Overall Study|Randomized but not treated|0
132880|NCT00548405|425736|P2|Overall Study|Randomized but not treated|0
132881|NCT00548405|425737|P1|Overall Study|Randomized but not treated|1
132882|NCT00548405|425735|P3|Overall Study|Sponsor decision|0
132883|NCT00548405|425736|P2|Overall Study|Sponsor decision|0
132884|NCT00548405|425737|P1|Overall Study|Sponsor decision|1
132885|NCT00548405|425735|P3|Overall Study|Death|1
132886|NCT00548405|425736|P2|Overall Study|Death|1
132887|NCT00548405|425737|P1|Overall Study|Death|0
132888|NCT00548405|425735|P3|Overall Study|Lost to Follow-up|2
132889|NCT00548405|425736|P2|Overall Study|Lost to Follow-up|1
132890|NCT00548405|425737|P1|Overall Study|Lost to Follow-up|1
132891|NCT00548405|425735|P3|Overall Study|Withdrawal by Subject|5
132892|NCT00548405|425736|P2|Overall Study|Withdrawal by Subject|12
132893|NCT00548405|425737|P1|Overall Study|Withdrawal by Subject|36
132894|NCT00548405|425735|P3|Overall Study|Protocol Violation|0
132895|NCT00548405|425736|P2|Overall Study|Protocol Violation|0
132896|NCT00548405|425737|P1|Overall Study|Protocol Violation|1
132897|NCT00548405|425735|P3|Overall Study|Pregnancy|0
132898|NCT00548405|425736|P2|Overall Study|Pregnancy|0
132899|NCT00548405|425737|P1|Overall Study|Pregnancy|1
132900|NCT00548405|425735|P3|Overall Study|Physician Decision|1
132901|NCT00548405|425736|P2|Overall Study|Physician Decision|4
132902|NCT00548405|425737|P1|Overall Study|Physician Decision|3
132903|NCT00548405|425735|P3|Overall Study|Lack of Efficacy|0
132904|NCT00548405|425736|P2|Overall Study|Lack of Efficacy|0
132906|NCT00548405|425735|P3|Overall Study|Adverse Event|0
132907|NCT00548405|425736|P2|Overall Study|Adverse Event|2
132908|NCT00548405|425737|P1|Overall Study|Adverse Event|6
132909|NCT00548548|425769|P2|Overall Study|Lost to Follow-up|18
132910|NCT00548548|425770|P1|Overall Study|Lost to Follow-up|17
132911|NCT00548548|425769|P2|Overall Study|Death|348
132912|NCT00548548|425770|P1|Overall Study|Death|345
132913|NCT00542269|425793|P3|Overall Study|Administrative problems|1
132914|NCT00542269|425794|P2|Overall Study|Administrative problems|1
132915|NCT00542269|425795|P1|Overall Study|Administrative problems|1
132916|NCT00542269|425793|P3|Overall Study|Withdrawal by Subject|0
132917|NCT00542269|425794|P2|Overall Study|Withdrawal by Subject|0
132918|NCT00542269|425795|P1|Overall Study|Withdrawal by Subject|1
132919|NCT00542269|425793|P3|Overall Study|Protocol Violation|0
132920|NCT00542269|425794|P2|Overall Study|Protocol Violation|1
132921|NCT00542269|425795|P1|Overall Study|Protocol Violation|1
132922|NCT00542269|425793|P3|Overall Study|Adverse Event|5
132923|NCT00542269|425794|P2|Overall Study|Adverse Event|4
132924|NCT00542269|425795|P1|Overall Study|Adverse Event|10
132925|NCT00542321|425831|P2|Overall Study|Death|1
132926|NCT00542321|425832|P1|Overall Study|Death|0
132927|NCT00542386|425852|P6|Overall Study|Other Reasons|2
132928|NCT00542386|425853|P5|Overall Study|Other Reasons|4
132929|NCT00542386|425854|P4|Overall Study|Other Reasons|3
132930|NCT00542386|425855|P3|Overall Study|Other Reasons|4
132931|NCT00542386|425856|P2|Overall Study|Other Reasons|1
132932|NCT00542386|425857|P1|Overall Study|Other Reasons|4
132933|NCT00542386|425852|P6|Overall Study|Withdrawal by Subject|7
132934|NCT00542386|425853|P5|Overall Study|Withdrawal by Subject|15
132935|NCT00542386|425854|P4|Overall Study|Withdrawal by Subject|11
132936|NCT00542386|425855|P3|Overall Study|Withdrawal by Subject|10
132937|NCT00542386|425856|P2|Overall Study|Withdrawal by Subject|8
132938|NCT00542386|425857|P1|Overall Study|Withdrawal by Subject|5
132939|NCT00542386|425852|P6|Overall Study|Protocol Violation|4
132940|NCT00542386|425853|P5|Overall Study|Protocol Violation|0
132941|NCT00542386|425854|P4|Overall Study|Protocol Violation|0
132942|NCT00542386|425855|P3|Overall Study|Protocol Violation|1
132943|NCT00542386|425856|P2|Overall Study|Protocol Violation|0
132944|NCT00542386|425857|P1|Overall Study|Protocol Violation|0
132945|NCT00542386|425852|P6|Overall Study|Physician Decision|0
132946|NCT00542386|425853|P5|Overall Study|Physician Decision|0
132947|NCT00542386|425854|P4|Overall Study|Physician Decision|1
132948|NCT00542386|425855|P3|Overall Study|Physician Decision|0
132949|NCT00542386|425856|P2|Overall Study|Physician Decision|0
132950|NCT00542386|425857|P1|Overall Study|Physician Decision|1
132951|NCT00542386|425852|P6|Overall Study|Lack of Efficacy|31
132952|NCT00542386|425853|P5|Overall Study|Lack of Efficacy|7
132953|NCT00542386|425854|P4|Overall Study|Lack of Efficacy|13
132954|NCT00542386|425855|P3|Overall Study|Lack of Efficacy|10
132955|NCT00542386|425856|P2|Overall Study|Lack of Efficacy|12
132956|NCT00542386|425857|P1|Overall Study|Lack of Efficacy|32
132957|NCT00542386|425852|P6|Overall Study|Death|2
132958|NCT00542386|425853|P5|Overall Study|Death|1
132959|NCT00542386|425854|P4|Overall Study|Death|2
132960|NCT00542386|425855|P3|Overall Study|Death|1
132961|NCT00542386|425856|P2|Overall Study|Death|0
132962|NCT00542386|425857|P1|Overall Study|Death|0
132963|NCT00542386|425852|P6|Overall Study|Adverse Event|4
132964|NCT00542386|425853|P5|Overall Study|Adverse Event|13
132965|NCT00542386|425854|P4|Overall Study|Adverse Event|8
132966|NCT00542386|425855|P3|Overall Study|Adverse Event|7
132967|NCT00542386|425856|P2|Overall Study|Adverse Event|7
132968|NCT00542386|425857|P1|Overall Study|Adverse Event|1
132969|NCT00542425|425882|P5|Extended 24 Weeks of Treatment|Other|1
132970|NCT00542425|425883|P4|Extended 24 Weeks of Treatment|Other|0
132971|NCT00542425|425884|P3|Extended 24 Weeks of Treatment|Other|0
132972|NCT00542425|425885|P2|Extended 24 Weeks of Treatment|Other|1
132973|NCT00542425|425886|P1|Extended 24 Weeks of Treatment|Other|1
132974|NCT00542425|425882|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
132975|NCT00542425|425883|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
132976|NCT00542425|425884|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
132977|NCT00542425|425885|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
132978|NCT00542425|425886|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
132979|NCT00542425|425882|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
132980|NCT00542425|425883|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
132981|NCT00542425|425884|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
132982|NCT00542425|425885|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
132983|NCT00542425|425886|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
132984|NCT00542425|425882|P5|Extended 24 Weeks of Treatment|Adverse Event|0
132985|NCT00542425|425883|P4|Extended 24 Weeks of Treatment|Adverse Event|1
132986|NCT00542425|425884|P3|Extended 24 Weeks of Treatment|Adverse Event|1
132987|NCT00542425|425885|P2|Extended 24 Weeks of Treatment|Adverse Event|0
132988|NCT00542425|425886|P1|Extended 24 Weeks of Treatment|Adverse Event|0
132989|NCT00542425|425882|P5|Initial 24 Weeks|Other|0
132990|NCT00542425|425883|P4|Initial 24 Weeks|Other|0
132991|NCT00542425|425884|P3|Initial 24 Weeks|Other|1
132992|NCT00542425|425885|P2|Initial 24 Weeks|Other|2
132993|NCT00542425|425886|P1|Initial 24 Weeks|Other|0
132994|NCT00542425|425882|P5|Initial 24 Weeks|Refusal of treatment|1
132995|NCT00542425|425883|P4|Initial 24 Weeks|Refusal of treatment|4
132996|NCT00542425|425884|P3|Initial 24 Weeks|Refusal of treatment|1
132997|NCT00542425|425885|P2|Initial 24 Weeks|Refusal of treatment|2
132998|NCT00542425|425886|P1|Initial 24 Weeks|Refusal of treatment|2
132999|NCT00542425|425882|P5|Initial 24 Weeks|Protocol Violation|0
133000|NCT00542425|425883|P4|Initial 24 Weeks|Protocol Violation|1
133001|NCT00542425|425884|P3|Initial 24 Weeks|Protocol Violation|0
133002|NCT00542425|425885|P2|Initial 24 Weeks|Protocol Violation|0
133003|NCT00542425|425886|P1|Initial 24 Weeks|Protocol Violation|0
133004|NCT00542425|425882|P5|Initial 24 Weeks|Non-compliance|1
133005|NCT00542425|425883|P4|Initial 24 Weeks|Non-compliance|1
133006|NCT00542425|425884|P3|Initial 24 Weeks|Non-compliance|0
133007|NCT00542425|425885|P2|Initial 24 Weeks|Non-compliance|0
133008|NCT00542425|425886|P1|Initial 24 Weeks|Non-compliance|0
133009|NCT00542425|425882|P5|Initial 24 Weeks|Lost to Follow-up|0
133010|NCT00542425|425883|P4|Initial 24 Weeks|Lost to Follow-up|0
133011|NCT00542425|425884|P3|Initial 24 Weeks|Lost to Follow-up|1
133012|NCT00542425|425885|P2|Initial 24 Weeks|Lost to Follow-up|2
133013|NCT00542425|425886|P1|Initial 24 Weeks|Lost to Follow-up|2
133014|NCT00542425|425882|P5|Initial 24 Weeks|Inability to complete procedures|2
133015|NCT00542425|425883|P4|Initial 24 Weeks|Inability to complete procedures|1
133016|NCT00542425|425884|P3|Initial 24 Weeks|Inability to complete procedures|2
133017|NCT00542425|425885|P2|Initial 24 Weeks|Inability to complete procedures|3
133018|NCT00542425|425886|P1|Initial 24 Weeks|Inability to complete procedures|0
133019|NCT00542425|425882|P5|Initial 24 Weeks|Adverse Event|2
133020|NCT00542425|425883|P4|Initial 24 Weeks|Adverse Event|3
133021|NCT00542425|425884|P3|Initial 24 Weeks|Adverse Event|1
133022|NCT00542425|425885|P2|Initial 24 Weeks|Adverse Event|1
133023|NCT00542425|425886|P1|Initial 24 Weeks|Adverse Event|0
133024|NCT00542425|425882|P5|Initial 24 Weeks|Administrative reasons|0
133025|NCT00542425|425883|P4|Initial 24 Weeks|Administrative reasons|1
133026|NCT00542425|425884|P3|Initial 24 Weeks|Administrative reasons|1
133027|NCT00542425|425885|P2|Initial 24 Weeks|Administrative reasons|0
133028|NCT00542425|425886|P1|Initial 24 Weeks|Administrative reasons|0
133029|NCT00542789|425996|P2|Overall Study|Recurrence of Gastric Ulcer|57
133030|NCT00542789|425997|P1|Overall Study|Recurrence of Gastric Ulcer|8
133031|NCT00542789|425996|P2|Overall Study|Protocol Violation|1
133032|NCT00542789|425997|P1|Overall Study|Protocol Violation|8
133033|NCT00542789|425996|P2|Overall Study|Withdrawal by Subject|3
133034|NCT00542789|425997|P1|Overall Study|Withdrawal by Subject|7
133035|NCT00542789|425996|P2|Overall Study|Adverse Event|17
133036|NCT00542789|425997|P1|Overall Study|Adverse Event|18
133037|NCT00542815|426010|P3|Overall Study|Other reasons|10
133038|NCT00542815|426011|P2|Overall Study|Other reasons|10
133039|NCT00542815|426012|P1|Overall Study|Other reasons|24
133040|NCT00542815|426010|P3|Overall Study|Withdrawal by Subject|8
133041|NCT00542815|426011|P2|Overall Study|Withdrawal by Subject|5
133042|NCT00542815|426012|P1|Overall Study|Withdrawal by Subject|41
133043|NCT00542815|426010|P3|Overall Study|Protocol Violation|2
133044|NCT00542815|426011|P2|Overall Study|Protocol Violation|1
133045|NCT00542815|426012|P1|Overall Study|Protocol Violation|1
133046|NCT00542815|426010|P3|Overall Study|Physician Decision|0
133047|NCT00542815|426011|P2|Overall Study|Physician Decision|1
133048|NCT00542815|426012|P1|Overall Study|Physician Decision|2
133049|NCT00542815|426010|P3|Overall Study|Lack of Efficacy|0
133050|NCT00542815|426011|P2|Overall Study|Lack of Efficacy|2
133051|NCT00542815|426012|P1|Overall Study|Lack of Efficacy|9
133052|NCT00542815|426010|P3|Overall Study|Death|3
133053|NCT00542815|426011|P2|Overall Study|Death|7
133054|NCT00542815|426012|P1|Overall Study|Death|10
133055|NCT00542815|426010|P3|Overall Study|Adverse Event|9
133056|NCT00542815|426011|P2|Overall Study|Adverse Event|6
133057|NCT00542815|426012|P1|Overall Study|Adverse Event|19
133058|NCT00542828|426023|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
133059|NCT00542828|426023|P1|Overall Study|Study Prematurely Discontinued|7
133060|NCT00542828|426023|P1|Overall Study|Need for Prohibited Treatment|3
133061|NCT00542828|426023|P1|Overall Study|Physician Decision|1
133062|NCT00542880|426040|P2|Period 3|Adverse Event|2
133063|NCT00542880|426041|P1|Period 3|Adverse Event|0
133064|NCT00542880|426040|P2|Period 2|Not specified|1
133065|NCT00542880|426041|P1|Period 2|Not specified|0
133066|NCT00542880|426040|P2|Period 2|Severe non-compliance|1
133067|NCT00542880|426041|P1|Period 2|Severe non-compliance|0
133068|NCT00542880|426040|P2|Period 2|Discontinuation criteria|0
133069|NCT00542880|426041|P1|Period 2|Discontinuation criteria|2
133070|NCT00542880|426040|P2|Period 2|Eligibility not fulfilled|1
133071|NCT00542880|426041|P1|Period 2|Eligibility not fulfilled|0
133072|NCT00542880|426040|P2|Period 2|Adverse Event|7
133073|NCT00542880|426041|P1|Period 2|Adverse Event|5
133074|NCT00542880|426040|P2|Period 1|Protocol Violation|1
133075|NCT00542880|426041|P1|Period 1|Protocol Violation|0
133076|NCT00542880|426040|P2|Period 1|Withdrawal by Subject|1
133077|NCT00542880|426041|P1|Period 1|Withdrawal by Subject|1
133078|NCT00542880|426040|P2|Period 1|Development of study-specific criteria|2
133079|NCT00542880|426041|P1|Period 1|Development of study-specific criteria|1
133080|NCT00542880|426040|P2|Period 1|Adverse Event|2
133081|NCT00542880|426041|P1|Period 1|Adverse Event|2
133082|NCT00542880|426040|P2|Period 1|Eligibility criteria not fulfilled|6
133083|NCT00542880|426041|P1|Period 1|Eligibility criteria not fulfilled|2
133084|NCT00542997|426082|P1|Efficacy Period|Adverse Event|3
133085|NCT00542997|426082|P1|Wash in / Wash Out Period|Adverse Event|3
133086|NCT00542997|426082|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
133087|NCT00548717|426123|P2|Overall Study|Alternative treatment for GVHD|0
133088|NCT00548717|426124|P1|Overall Study|Alternative treatment for GVHD|1
133089|NCT00548717|426123|P2|Overall Study|Relapse|0
133090|NCT00548717|426124|P1|Overall Study|Relapse|3
133091|NCT00548717|426123|P2|Overall Study|Death|2
133092|NCT00548717|426124|P1|Overall Study|Death|5
133093|NCT00548808|426143|P2|Overall Study|Sponsor Decision|1
133094|NCT00548808|426144|P1|Overall Study|Sponsor Decision|1
133095|NCT00548808|426143|P2|Overall Study|Lack of Efficacy|0
133096|NCT00548808|426144|P1|Overall Study|Lack of Efficacy|2
133097|NCT00548808|426143|P2|Overall Study|Entry Criteria Not Met|2
133098|NCT00548808|426144|P1|Overall Study|Entry Criteria Not Met|2
133099|NCT00548808|426143|P2|Overall Study|Death|0
133100|NCT00548808|426144|P1|Overall Study|Death|2
133101|NCT00548808|426143|P2|Overall Study|Adverse Event|5
133102|NCT00548808|426144|P1|Overall Study|Adverse Event|4
133103|NCT00548808|426143|P2|Overall Study|Physician Decision|3
133104|NCT00548808|426144|P1|Overall Study|Physician Decision|6
133105|NCT00548808|426143|P2|Overall Study|Withdrawal by Subject|4
133106|NCT00548808|426144|P1|Overall Study|Withdrawal by Subject|8
133107|NCT00548808|426143|P2|Overall Study|Protocol Violation|8
133108|NCT00548808|426144|P1|Overall Study|Protocol Violation|8
133109|NCT00548808|426143|P2|Overall Study|Lost to Follow-up|3
133110|NCT00548808|426144|P1|Overall Study|Lost to Follow-up|9
133111|NCT00548847|426166|P1|Overall Study|Disease progression|7
133112|NCT00549198|426203|P2|Overall Study|Not Exposed to Study Drug|4
133113|NCT00549198|426204|P1|Overall Study|Not Exposed to Study Drug|3
133114|NCT00549198|426203|P2|Overall Study|Pregnancy|3
133115|NCT00549198|426204|P1|Overall Study|Pregnancy|0
133116|NCT00549198|426203|P2|Overall Study|No scan facilities|2
133117|NCT00549198|426204|P1|Overall Study|No scan facilities|0
133118|NCT00549198|426203|P2|Overall Study|Participant overweight, no scan possible|0
133119|NCT00549198|426204|P1|Overall Study|Participant overweight, no scan possible|1
133120|NCT00549198|426203|P2|Overall Study|Participant planning pregnancy|0
133121|NCT00549198|426204|P1|Overall Study|Participant planning pregnancy|1
133122|NCT00549198|426203|P2|Overall Study|Prohibited Medication|2
133123|NCT00549198|426204|P1|Overall Study|Prohibited Medication|1
133124|NCT00549198|426203|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
133125|NCT00549198|426204|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
133126|NCT00549198|426203|P2|Overall Study|Participant not able to perform Week 96|0
133127|NCT00549198|426204|P1|Overall Study|Participant not able to perform Week 96|1
133128|NCT00549198|426203|P2|Overall Study|Participant Moved|0
133129|NCT00549198|426204|P1|Overall Study|Participant Moved|2
133130|NCT00549198|426203|P2|Overall Study|Disease Progression|0
133131|NCT00549198|426204|P1|Overall Study|Disease Progression|1
133132|NCT00549198|426203|P2|Overall Study|Withdrawal by Subject|7
133133|NCT00549198|426204|P1|Overall Study|Withdrawal by Subject|7
133134|NCT00549198|426203|P2|Overall Study|Investigator Decision|3
133135|NCT00549198|426204|P1|Overall Study|Investigator Decision|4
133136|NCT00549198|426203|P2|Overall Study|Protocol Violation|2
133137|NCT00549198|426204|P1|Overall Study|Protocol Violation|7
133138|NCT00549198|426203|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
133139|NCT00549198|426204|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
133140|NCT00549198|426203|P2|Overall Study|Lost to Follow-up|8
133141|NCT00549198|426204|P1|Overall Study|Lost to Follow-up|7
133142|NCT00549198|426203|P2|Overall Study|Non-compliance|4
133143|NCT00549198|426204|P1|Overall Study|Non-compliance|2
133144|NCT00549198|426203|P2|Overall Study|Protocol-defined Virological Failure|0
133145|NCT00549198|426204|P1|Overall Study|Protocol-defined Virological Failure|7
133146|NCT00549198|426203|P2|Overall Study|Insufficient Viral Load Response|2
133147|NCT00549198|426204|P1|Overall Study|Insufficient Viral Load Response|4
133148|NCT00549198|426203|P2|Overall Study|Adverse Event|26
133149|NCT00549198|426204|P1|Overall Study|Adverse Event|28
133150|NCT00549302|426326|P3|Open-Label|Withdrawal by Subject|6
133151|NCT00549302|426327|P2|Open-Label|Withdrawal by Subject|0
133152|NCT00549302|426328|P1|Open-Label|Withdrawal by Subject|0
133153|NCT00549302|426326|P3|Open-Label|New drug pulmonary atrial hypertension|2
133154|NCT00549302|426327|P2|Open-Label|New drug pulmonary atrial hypertension|0
133155|NCT00549302|426328|P1|Open-Label|New drug pulmonary atrial hypertension|0
133156|NCT00549302|426326|P3|Open-Label|Unspecified|3
133157|NCT00549302|426327|P2|Open-Label|Unspecified|0
133158|NCT00549302|426328|P1|Open-Label|Unspecified|0
133159|NCT00549302|426326|P3|Open-Label|Lost to Follow-up|2
133160|NCT00549302|426327|P2|Open-Label|Lost to Follow-up|0
133161|NCT00549302|426328|P1|Open-Label|Lost to Follow-up|0
133162|NCT00549302|426326|P3|Open-Label|Investigator Decision|5
133163|NCT00549302|426327|P2|Open-Label|Investigator Decision|0
133164|NCT00549302|426328|P1|Open-Label|Investigator Decision|0
133165|NCT00549302|426326|P3|Open-Label|Death|40
133166|NCT00549302|426327|P2|Open-Label|Death|0
133167|NCT00549302|426328|P1|Open-Label|Death|0
133168|NCT00549302|426326|P3|Open-Label|Adverse Event|11
133169|NCT00549302|426327|P2|Open-Label|Adverse Event|0
133170|NCT00549302|426328|P1|Open-Label|Adverse Event|0
133171|NCT00549302|426326|P3|Double-Blind|New condition or starts new therapy|0
133172|NCT00549302|426327|P2|Double-Blind|New condition or starts new therapy|2
133173|NCT00549302|426328|P1|Double-Blind|New condition or starts new therapy|0
133174|NCT00549302|426326|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
133175|NCT00549302|426327|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
133176|NCT00549302|426328|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
133177|NCT00549302|426326|P3|Double-Blind|Lost to Follow-up|0
133178|NCT00549302|426327|P2|Double-Blind|Lost to Follow-up|2
133179|NCT00549302|426328|P1|Double-Blind|Lost to Follow-up|1
133180|NCT00549302|426326|P3|Double-Blind|Sponsor Decision|0
133181|NCT00549302|426327|P2|Double-Blind|Sponsor Decision|1
133182|NCT00549302|426328|P1|Double-Blind|Sponsor Decision|0
133183|NCT00549302|426326|P3|Double-Blind|Investigator Decision|0
133184|NCT00549302|426327|P2|Double-Blind|Investigator Decision|5
133185|NCT00549302|426328|P1|Double-Blind|Investigator Decision|1
133186|NCT00549302|426326|P3|Double-Blind|Withdrawal by Subject|0
133187|NCT00549302|426327|P2|Double-Blind|Withdrawal by Subject|8
133188|NCT00549302|426328|P1|Double-Blind|Withdrawal by Subject|3
133189|NCT00549302|426326|P3|Double-Blind|Adverse Event|0
133190|NCT00549302|426327|P2|Double-Blind|Adverse Event|16
133191|NCT00549302|426328|P1|Double-Blind|Adverse Event|3
133192|NCT00549302|426326|P3|Double-Blind|Death|0
133193|NCT00549302|426327|P2|Double-Blind|Death|9
133194|NCT00549302|426328|P1|Double-Blind|Death|2
133195|NCT00549328|426338|P1|Overall Study|Use of Prohibited Medication|1
133196|NCT00549328|426338|P1|Overall Study|Death|1
133197|NCT00549328|426338|P1|Overall Study|Disease Progression|10
133198|NCT00549328|426338|P1|Overall Study|Adverse Event|2
133199|NCT00549445|426362|P2|Overall Study|Sputum & Blood Samples Not Available|17
133200|NCT00549445|426363|P1|Overall Study|Sputum & Blood Samples Not Available|15
133201|NCT00549549|426373|P4|Overall Study|Randomized but not treated|1
133202|NCT00549549|426374|P3|Overall Study|Randomized but not treated|1
133203|NCT00549549|426375|P2|Overall Study|Randomized but not treated|0
133204|NCT00549549|426376|P1|Overall Study|Randomized but not treated|0
133205|NCT00549549|426373|P4|Overall Study|Unspecified|11
133206|NCT00549549|426374|P3|Overall Study|Unspecified|9
133207|NCT00549549|426375|P2|Overall Study|Unspecified|9
133208|NCT00549549|426376|P1|Overall Study|Unspecified|9
133209|NCT00549549|426373|P4|Overall Study|Withdrawal by Subject|0
133210|NCT00549549|426374|P3|Overall Study|Withdrawal by Subject|1
133211|NCT00549549|426375|P2|Overall Study|Withdrawal by Subject|4
133212|NCT00549549|426376|P1|Overall Study|Withdrawal by Subject|0
133213|NCT00549549|426373|P4|Overall Study|Lost to Follow-up|2
133214|NCT00549549|426374|P3|Overall Study|Lost to Follow-up|1
133215|NCT00549549|426375|P2|Overall Study|Lost to Follow-up|0
133216|NCT00549549|426376|P1|Overall Study|Lost to Follow-up|1
133217|NCT00549549|426373|P4|Overall Study|Lack of Efficacy|2
133218|NCT00549549|426374|P3|Overall Study|Lack of Efficacy|4
133219|NCT00549549|426375|P2|Overall Study|Lack of Efficacy|6
133220|NCT00549549|426376|P1|Overall Study|Lack of Efficacy|9
133221|NCT00549549|426373|P4|Overall Study|Adverse Event|9
133222|NCT00549549|426374|P3|Overall Study|Adverse Event|1
133223|NCT00549549|426375|P2|Overall Study|Adverse Event|3
133224|NCT00549549|426376|P1|Overall Study|Adverse Event|5
133225|NCT00549562|426442|P1|Overall Study|Lack of Efficacy|1
133226|NCT00549562|426442|P1|Overall Study|Adverse Event|1
133227|NCT00549601|426453|P3|Received Study Drug|Withdrawal by Subject|1
133228|NCT00549601|426454|P2|Received Study Drug|Withdrawal by Subject|0
133229|NCT00549601|426455|P1|Received Study Drug|Withdrawal by Subject|2
133230|NCT00549601|426453|P3|Received Study Drug|Protocol Violation|1
133231|NCT00549601|426454|P2|Received Study Drug|Protocol Violation|4
133232|NCT00549601|426455|P1|Received Study Drug|Protocol Violation|3
133233|NCT00549601|426453|P3|Received Study Drug|Lost to Follow-up|1
133234|NCT00549601|426454|P2|Received Study Drug|Lost to Follow-up|1
133235|NCT00549601|426455|P1|Received Study Drug|Lost to Follow-up|0
133236|NCT00549601|426453|P3|Received Study Drug|Death|0
133237|NCT00549601|426454|P2|Received Study Drug|Death|1
133238|NCT00549601|426455|P1|Received Study Drug|Death|0
133239|NCT00549601|426453|P3|Received Study Drug|Adverse Event|1
133240|NCT00549601|426454|P2|Received Study Drug|Adverse Event|5
133241|NCT00549601|426455|P1|Received Study Drug|Adverse Event|2
133242|NCT00549601|426453|P3|Randomized|Withdrawal by Subject|1
133243|NCT00549601|426454|P2|Randomized|Withdrawal by Subject|1
133244|NCT00549601|426455|P1|Randomized|Withdrawal by Subject|0
133245|NCT00549601|426453|P3|Randomized|Protocol Violation|1
133246|NCT00549601|426454|P2|Randomized|Protocol Violation|0
133247|NCT00549601|426455|P1|Randomized|Protocol Violation|0
133248|NCT00549640|426479|P2|Overall Study|Lost to Follow-up|4
133249|NCT00549640|426480|P1|Overall Study|Lost to Follow-up|7
133250|NCT00549640|426479|P2|Overall Study|Adverse Event|0
133251|NCT00549640|426480|P1|Overall Study|Adverse Event|5
133252|NCT00549640|426479|P2|Overall Study|Withdrawal by Subject|12
133253|NCT00549640|426480|P1|Overall Study|Withdrawal by Subject|6
133254|NCT00549718|426494|P4|Overall Study|Administrative|1
133255|NCT00549718|426495|P3|Overall Study|Administrative|2
133256|NCT00549718|426496|P2|Overall Study|Administrative|2
133257|NCT00549718|426497|P1|Overall Study|Administrative|2
133258|NCT00549718|426494|P4|Overall Study|Withdrawal by Subject|13
133259|NCT00549718|426495|P3|Overall Study|Withdrawal by Subject|12
133260|NCT00549718|426496|P2|Overall Study|Withdrawal by Subject|18
133261|NCT00549718|426497|P1|Overall Study|Withdrawal by Subject|9
133262|NCT00549718|426494|P4|Overall Study|Lost to Follow-up|6
133263|NCT00549718|426495|P3|Overall Study|Lost to Follow-up|0
133264|NCT00549718|426496|P2|Overall Study|Lost to Follow-up|2
133265|NCT00549718|426497|P1|Overall Study|Lost to Follow-up|4
133266|NCT00549718|426494|P4|Overall Study|Adverse Event|3
133267|NCT00549718|426495|P3|Overall Study|Adverse Event|7
133268|NCT00549718|426496|P2|Overall Study|Adverse Event|8
133269|NCT00549718|426497|P1|Overall Study|Adverse Event|6
133270|NCT00549718|426494|P4|Overall Study|Insufficient clinical response|32
133271|NCT00549718|426495|P3|Overall Study|Insufficient clinical response|18
133272|NCT00549718|426496|P2|Overall Study|Insufficient clinical response|7
133273|NCT00549718|426497|P1|Overall Study|Insufficient clinical response|20
133274|NCT00549757|426513|P2|Extension Period (in Average 9 Months)|Patient's request|436
133275|NCT00549757|426514|P1|Extension Period (in Average 9 Months)|Patient's request|421
133276|NCT00549757|426513|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
133277|NCT00549757|426514|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
133278|NCT00549757|426513|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
133279|NCT00549757|426514|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
133280|NCT00549757|426513|P2|Extension Period (in Average 9 Months)|Death|136
133281|NCT00549757|426514|P1|Extension Period (in Average 9 Months)|Death|143
133282|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
133283|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
133284|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
133285|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
133286|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
133287|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
133288|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Death|200
133289|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Death|188
133290|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
133291|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
133292|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
133293|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
133294|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
133295|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
133296|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
133297|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
133548|NCT00550446|426938|P9|Up To Week 12|Lost to Follow-up|0
133298|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
133299|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
133300|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
133301|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
133302|NCT00549757|426513|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
133303|NCT00549757|426514|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
133304|NCT00549770|426580|P8|Overall Study|Adverse Event|4
133305|NCT00549770|426581|P7|Overall Study|Adverse Event|5
133306|NCT00549770|426582|P6|Overall Study|Adverse Event|0
133307|NCT00549770|426583|P5|Overall Study|Adverse Event|1
133308|NCT00549770|426584|P4|Overall Study|Adverse Event|2
133309|NCT00549770|426585|P3|Overall Study|Adverse Event|1
133310|NCT00549770|426586|P2|Overall Study|Adverse Event|3
133311|NCT00549770|426587|P1|Overall Study|Adverse Event|1
133312|NCT00549770|426580|P8|Overall Study|Abnormal laboratory values|0
133313|NCT00549770|426581|P7|Overall Study|Abnormal laboratory values|0
133314|NCT00549770|426582|P6|Overall Study|Abnormal laboratory values|1
133315|NCT00549770|426583|P5|Overall Study|Abnormal laboratory values|0
133316|NCT00549770|426584|P4|Overall Study|Abnormal laboratory values|0
133317|NCT00549770|426585|P3|Overall Study|Abnormal laboratory values|0
133318|NCT00549770|426586|P2|Overall Study|Abnormal laboratory values|0
133319|NCT00549770|426587|P1|Overall Study|Abnormal laboratory values|0
133320|NCT00549770|426580|P8|Overall Study|Abnormal test procedure results|1
133321|NCT00549770|426581|P7|Overall Study|Abnormal test procedure results|1
133322|NCT00549770|426582|P6|Overall Study|Abnormal test procedure results|1
133323|NCT00549770|426583|P5|Overall Study|Abnormal test procedure results|0
133324|NCT00549770|426584|P4|Overall Study|Abnormal test procedure results|2
133325|NCT00549770|426585|P3|Overall Study|Abnormal test procedure results|0
133326|NCT00549770|426586|P2|Overall Study|Abnormal test procedure results|0
133327|NCT00549770|426587|P1|Overall Study|Abnormal test procedure results|0
133328|NCT00549770|426580|P8|Overall Study|Lack of Efficacy|8
133329|NCT00549770|426581|P7|Overall Study|Lack of Efficacy|3
133330|NCT00549770|426582|P6|Overall Study|Lack of Efficacy|1
133331|NCT00549770|426583|P5|Overall Study|Lack of Efficacy|5
133332|NCT00549770|426584|P4|Overall Study|Lack of Efficacy|3
133333|NCT00549770|426585|P3|Overall Study|Lack of Efficacy|2
133334|NCT00549770|426586|P2|Overall Study|Lack of Efficacy|0
133335|NCT00549770|426587|P1|Overall Study|Lack of Efficacy|1
133336|NCT00549770|426580|P8|Overall Study|Withdrawal by Subject|9
133337|NCT00549770|426581|P7|Overall Study|Withdrawal by Subject|4
133338|NCT00549770|426582|P6|Overall Study|Withdrawal by Subject|6
133339|NCT00549770|426583|P5|Overall Study|Withdrawal by Subject|6
133340|NCT00549770|426584|P4|Overall Study|Withdrawal by Subject|5
133341|NCT00549770|426585|P3|Overall Study|Withdrawal by Subject|4
133342|NCT00549770|426586|P2|Overall Study|Withdrawal by Subject|6
133343|NCT00549770|426587|P1|Overall Study|Withdrawal by Subject|4
133344|NCT00549770|426580|P8|Overall Study|Lost to Follow-up|0
133345|NCT00549770|426581|P7|Overall Study|Lost to Follow-up|0
133346|NCT00549770|426582|P6|Overall Study|Lost to Follow-up|2
133347|NCT00549770|426583|P5|Overall Study|Lost to Follow-up|3
133348|NCT00549770|426584|P4|Overall Study|Lost to Follow-up|2
133349|NCT00549770|426585|P3|Overall Study|Lost to Follow-up|2
133350|NCT00549770|426586|P2|Overall Study|Lost to Follow-up|0
133351|NCT00549770|426587|P1|Overall Study|Lost to Follow-up|0
133352|NCT00549770|426580|P8|Overall Study|Administrative problems|1
133353|NCT00549770|426581|P7|Overall Study|Administrative problems|0
133354|NCT00549770|426582|P6|Overall Study|Administrative problems|0
133355|NCT00549770|426583|P5|Overall Study|Administrative problems|0
133356|NCT00549770|426584|P4|Overall Study|Administrative problems|0
133357|NCT00549770|426585|P3|Overall Study|Administrative problems|0
133358|NCT00549770|426586|P2|Overall Study|Administrative problems|1
133359|NCT00549770|426587|P1|Overall Study|Administrative problems|0
133360|NCT00549770|426580|P8|Overall Study|Protocol deviation|2
133361|NCT00549770|426581|P7|Overall Study|Protocol deviation|1
133362|NCT00549770|426582|P6|Overall Study|Protocol deviation|2
133363|NCT00549770|426583|P5|Overall Study|Protocol deviation|2
133364|NCT00549770|426584|P4|Overall Study|Protocol deviation|2
133365|NCT00549770|426585|P3|Overall Study|Protocol deviation|1
133366|NCT00549770|426586|P2|Overall Study|Protocol deviation|1
133367|NCT00549770|426587|P1|Overall Study|Protocol deviation|1
133368|NCT00549900|426708|P1|Overall Study|Adverse Event|1
133369|NCT00549939|426720|P3|40-week Open Label Treatment Period|Other|4
133370|NCT00549939|426721|P2|40-week Open Label Treatment Period|Other|1
133371|NCT00549939|426722|P1|40-week Open Label Treatment Period|Other|0
133372|NCT00549939|426720|P3|40-week Open Label Treatment Period|Protocol Violation|0
133373|NCT00549939|426721|P2|40-week Open Label Treatment Period|Protocol Violation|1
133374|NCT00549939|426722|P1|40-week Open Label Treatment Period|Protocol Violation|0
133375|NCT00549939|426720|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
133376|NCT00549939|426721|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
133377|NCT00549939|426722|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
133378|NCT00549939|426720|P3|40-week Open Label Treatment Period|Adverse Event|1
133379|NCT00549939|426721|P2|40-week Open Label Treatment Period|Adverse Event|2
133380|NCT00549939|426722|P1|40-week Open Label Treatment Period|Adverse Event|0
133381|NCT00549939|426720|P3|12-week Double Blind Treatment Period|Too many blood draws|0
133382|NCT00549939|426721|P2|12-week Double Blind Treatment Period|Too many blood draws|1
133383|NCT00549939|426722|P1|12-week Double Blind Treatment Period|Too many blood draws|0
133384|NCT00549939|426720|P3|12-week Double Blind Treatment Period|Adverse Event|2
133385|NCT00549939|426721|P2|12-week Double Blind Treatment Period|Adverse Event|1
133386|NCT00549939|426722|P1|12-week Double Blind Treatment Period|Adverse Event|1
133387|NCT00550043|426754|P5|Overall Study|Other Reasons- Unspecified|0
133388|NCT00550043|426755|P4|Overall Study|Other Reasons- Unspecified|1
133389|NCT00550043|426756|P3|Overall Study|Other Reasons- Unspecified|0
133390|NCT00550043|426757|P2|Overall Study|Other Reasons- Unspecified|1
133391|NCT00550043|426758|P1|Overall Study|Other Reasons- Unspecified|0
133392|NCT00550043|426754|P5|Overall Study|Subject Withdrew Consent|0
133393|NCT00550043|426755|P4|Overall Study|Subject Withdrew Consent|0
133394|NCT00550043|426756|P3|Overall Study|Subject Withdrew Consent|1
133395|NCT00550043|426757|P2|Overall Study|Subject Withdrew Consent|2
133396|NCT00550043|426758|P1|Overall Study|Subject Withdrew Consent|0
133397|NCT00550043|426754|P5|Overall Study|Adverse Event|1
133398|NCT00550043|426755|P4|Overall Study|Adverse Event|1
133399|NCT00550043|426756|P3|Overall Study|Adverse Event|0
133400|NCT00550043|426757|P2|Overall Study|Adverse Event|0
133401|NCT00550043|426758|P1|Overall Study|Adverse Event|0
133402|NCT00550147|426810|P1|Quetiapine Addition Treatment Period|Moved out of state|1
133403|NCT00550147|426810|P1|Quetiapine Addition Treatment Period|Noncompliance|2
133404|NCT00550147|426810|P1|Quetiapine Addition Treatment Period|Adverse Event|3
133405|NCT00550147|426810|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
133406|NCT00550147|426810|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
133407|NCT00550173|426831|P3|Overall Study|Lost to Follow-up|3
133408|NCT00550173|426832|P2|Overall Study|Lost to Follow-up|4
133409|NCT00550173|426833|P1|Overall Study|Lost to Follow-up|4
133410|NCT00550173|426831|P3|Overall Study|Sponsor Decision|1
133411|NCT00550173|426832|P2|Overall Study|Sponsor Decision|7
133412|NCT00550173|426833|P1|Overall Study|Sponsor Decision|13
133413|NCT00550173|426831|P3|Overall Study|Withdrawal by Subject|17
133414|NCT00550173|426832|P2|Overall Study|Withdrawal by Subject|12
133415|NCT00550173|426833|P1|Overall Study|Withdrawal by Subject|9
133416|NCT00550173|426831|P3|Overall Study|Physician Decision|2
133417|NCT00550173|426832|P2|Overall Study|Physician Decision|2
133418|NCT00550173|426833|P1|Overall Study|Physician Decision|1
133419|NCT00550173|426831|P3|Overall Study|Death|50
133420|NCT00550173|426832|P2|Overall Study|Death|38
133421|NCT00550173|426833|P1|Overall Study|Death|45
133422|NCT00550407|426894|P3|26-Week Randomized Phase|Withdrawal by Subject|3
133423|NCT00550407|426895|P2|26-Week Randomized Phase|Withdrawal by Subject|1
133424|NCT00550407|426896|P1|26-Week Randomized Phase|Withdrawal by Subject|0
133425|NCT00550407|426894|P3|26-Week Randomized Phase|Investigator Discretion|0
133426|NCT00550407|426895|P2|26-Week Randomized Phase|Investigator Discretion|1
133427|NCT00550407|426896|P1|26-Week Randomized Phase|Investigator Discretion|0
133428|NCT00550407|426894|P3|26-Week Randomized Phase|Lack of Efficacy|19
133429|NCT00550407|426895|P2|26-Week Randomized Phase|Lack of Efficacy|36
133430|NCT00550407|426896|P1|26-Week Randomized Phase|Lack of Efficacy|0
133431|NCT00550407|426894|P3|26-Week Randomized Phase|Adverse Event|2
133432|NCT00550407|426895|P2|26-Week Randomized Phase|Adverse Event|5
133433|NCT00550407|426896|P1|26-Week Randomized Phase|Adverse Event|0
133434|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
133435|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
133436|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
133437|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
133438|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
133439|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
133440|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
133441|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
133442|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
133443|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
133444|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
133445|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
133446|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
133447|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
133448|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
133449|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
133450|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
133451|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
133452|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
133453|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
133454|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
133455|NCT00550407|426894|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
133456|NCT00550407|426895|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
133457|NCT00550407|426896|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
133458|NCT00550446|426936|P11|Post Week 12|Unspecified|0
133459|NCT00550446|426937|P10|Post Week 12|Unspecified|1
133460|NCT00550446|426938|P9|Post Week 12|Unspecified|1
133461|NCT00550446|426939|P8|Post Week 12|Unspecified|0
133462|NCT00550446|426940|P7|Post Week 12|Unspecified|1
133463|NCT00550446|426941|P6|Post Week 12|Unspecified|0
133464|NCT00550446|426942|P5|Post Week 12|Unspecified|0
133465|NCT00550446|426943|P4|Post Week 12|Unspecified|1
133466|NCT00550446|426944|P3|Post Week 12|Unspecified|0
133467|NCT00550446|426945|P2|Post Week 12|Unspecified|1
133468|NCT00550446|426946|P1|Post Week 12|Unspecified|1
133469|NCT00550446|426936|P11|Post Week 12|Withdrawal by Subject|0
133470|NCT00550446|426937|P10|Post Week 12|Withdrawal by Subject|0
133471|NCT00550446|426938|P9|Post Week 12|Withdrawal by Subject|0
133472|NCT00550446|426939|P8|Post Week 12|Withdrawal by Subject|0
133473|NCT00550446|426940|P7|Post Week 12|Withdrawal by Subject|0
133474|NCT00550446|426941|P6|Post Week 12|Withdrawal by Subject|0
133475|NCT00550446|426942|P5|Post Week 12|Withdrawal by Subject|1
133476|NCT00550446|426943|P4|Post Week 12|Withdrawal by Subject|0
133477|NCT00550446|426944|P3|Post Week 12|Withdrawal by Subject|0
133478|NCT00550446|426945|P2|Post Week 12|Withdrawal by Subject|0
133479|NCT00550446|426946|P1|Post Week 12|Withdrawal by Subject|0
133480|NCT00550446|426936|P11|Post Week 12|Lost to Follow-up|0
133481|NCT00550446|426937|P10|Post Week 12|Lost to Follow-up|0
133482|NCT00550446|426938|P9|Post Week 12|Lost to Follow-up|0
133483|NCT00550446|426939|P8|Post Week 12|Lost to Follow-up|0
133484|NCT00550446|426940|P7|Post Week 12|Lost to Follow-up|1
133485|NCT00550446|426941|P6|Post Week 12|Lost to Follow-up|0
133486|NCT00550446|426942|P5|Post Week 12|Lost to Follow-up|0
133487|NCT00550446|426943|P4|Post Week 12|Lost to Follow-up|1
133488|NCT00550446|426944|P3|Post Week 12|Lost to Follow-up|1
133489|NCT00550446|426945|P2|Post Week 12|Lost to Follow-up|0
133490|NCT00550446|426946|P1|Post Week 12|Lost to Follow-up|0
133491|NCT00550446|426936|P11|Post Week 12|Lack of Efficacy|1
133492|NCT00550446|426937|P10|Post Week 12|Lack of Efficacy|2
133493|NCT00550446|426938|P9|Post Week 12|Lack of Efficacy|1
133494|NCT00550446|426939|P8|Post Week 12|Lack of Efficacy|1
133495|NCT00550446|426940|P7|Post Week 12|Lack of Efficacy|0
133496|NCT00550446|426941|P6|Post Week 12|Lack of Efficacy|0
133497|NCT00550446|426942|P5|Post Week 12|Lack of Efficacy|0
133498|NCT00550446|426943|P4|Post Week 12|Lack of Efficacy|0
133499|NCT00550446|426944|P3|Post Week 12|Lack of Efficacy|1
133500|NCT00550446|426945|P2|Post Week 12|Lack of Efficacy|0
133501|NCT00550446|426946|P1|Post Week 12|Lack of Efficacy|0
133502|NCT00550446|426936|P11|Post Week 12|Adverse Event|0
133503|NCT00550446|426937|P10|Post Week 12|Adverse Event|4
133504|NCT00550446|426938|P9|Post Week 12|Adverse Event|0
133505|NCT00550446|426939|P8|Post Week 12|Adverse Event|0
133506|NCT00550446|426940|P7|Post Week 12|Adverse Event|0
133507|NCT00550446|426941|P6|Post Week 12|Adverse Event|1
133508|NCT00550446|426942|P5|Post Week 12|Adverse Event|1
133509|NCT00550446|426943|P4|Post Week 12|Adverse Event|1
133510|NCT00550446|426944|P3|Post Week 12|Adverse Event|1
133511|NCT00550446|426945|P2|Post Week 12|Adverse Event|1
133512|NCT00550446|426946|P1|Post Week 12|Adverse Event|2
133513|NCT00550446|426936|P11|Up To Week 12|Randomized not treated|0
133514|NCT00550446|426937|P10|Up To Week 12|Randomized not treated|0
133515|NCT00550446|426938|P9|Up To Week 12|Randomized not treated|0
133516|NCT00550446|426939|P8|Up To Week 12|Randomized not treated|0
133517|NCT00550446|426940|P7|Up To Week 12|Randomized not treated|0
133518|NCT00550446|426941|P6|Up To Week 12|Randomized not treated|0
133519|NCT00550446|426942|P5|Up To Week 12|Randomized not treated|0
133520|NCT00550446|426943|P4|Up To Week 12|Randomized not treated|0
133521|NCT00550446|426944|P3|Up To Week 12|Randomized not treated|1
133522|NCT00550446|426945|P2|Up To Week 12|Randomized not treated|1
133523|NCT00550446|426946|P1|Up To Week 12|Randomized not treated|0
133524|NCT00550446|426936|P11|Up To Week 12|Unspecified|0
133525|NCT00550446|426937|P10|Up To Week 12|Unspecified|0
133526|NCT00550446|426938|P9|Up To Week 12|Unspecified|0
133527|NCT00550446|426939|P8|Up To Week 12|Unspecified|0
133528|NCT00550446|426940|P7|Up To Week 12|Unspecified|4
133529|NCT00550446|426941|P6|Up To Week 12|Unspecified|1
133530|NCT00550446|426942|P5|Up To Week 12|Unspecified|0
133531|NCT00550446|426943|P4|Up To Week 12|Unspecified|0
133532|NCT00550446|426944|P3|Up To Week 12|Unspecified|0
133533|NCT00550446|426945|P2|Up To Week 12|Unspecified|0
133534|NCT00550446|426946|P1|Up To Week 12|Unspecified|3
133535|NCT00550446|426936|P11|Up To Week 12|Withdrawal by Subject|0
133536|NCT00550446|426937|P10|Up To Week 12|Withdrawal by Subject|0
133537|NCT00550446|426938|P9|Up To Week 12|Withdrawal by Subject|0
133538|NCT00550446|426939|P8|Up To Week 12|Withdrawal by Subject|0
133539|NCT00550446|426940|P7|Up To Week 12|Withdrawal by Subject|3
133540|NCT00550446|426941|P6|Up To Week 12|Withdrawal by Subject|1
133541|NCT00550446|426942|P5|Up To Week 12|Withdrawal by Subject|0
133542|NCT00550446|426943|P4|Up To Week 12|Withdrawal by Subject|2
133543|NCT00550446|426944|P3|Up To Week 12|Withdrawal by Subject|3
133544|NCT00550446|426945|P2|Up To Week 12|Withdrawal by Subject|0
133545|NCT00550446|426946|P1|Up To Week 12|Withdrawal by Subject|2
133546|NCT00550446|426936|P11|Up To Week 12|Lost to Follow-up|0
133547|NCT00550446|426937|P10|Up To Week 12|Lost to Follow-up|0
133549|NCT00550446|426939|P8|Up To Week 12|Lost to Follow-up|0
133550|NCT00550446|426940|P7|Up To Week 12|Lost to Follow-up|2
133551|NCT00550446|426941|P6|Up To Week 12|Lost to Follow-up|1
133552|NCT00550446|426942|P5|Up To Week 12|Lost to Follow-up|1
133553|NCT00550446|426943|P4|Up To Week 12|Lost to Follow-up|0
133554|NCT00550446|426944|P3|Up To Week 12|Lost to Follow-up|0
133555|NCT00550446|426945|P2|Up To Week 12|Lost to Follow-up|1
133556|NCT00550446|426946|P1|Up To Week 12|Lost to Follow-up|0
133557|NCT00550446|426936|P11|Up To Week 12|Lack of Efficacy|0
133558|NCT00550446|426937|P10|Up To Week 12|Lack of Efficacy|0
133559|NCT00550446|426938|P9|Up To Week 12|Lack of Efficacy|0
133560|NCT00550446|426939|P8|Up To Week 12|Lack of Efficacy|0
133561|NCT00550446|426940|P7|Up To Week 12|Lack of Efficacy|3
133562|NCT00550446|426941|P6|Up To Week 12|Lack of Efficacy|3
133563|NCT00550446|426942|P5|Up To Week 12|Lack of Efficacy|0
133564|NCT00550446|426943|P4|Up To Week 12|Lack of Efficacy|1
133565|NCT00550446|426944|P3|Up To Week 12|Lack of Efficacy|0
133566|NCT00550446|426945|P2|Up To Week 12|Lack of Efficacy|1
133567|NCT00550446|426946|P1|Up To Week 12|Lack of Efficacy|3
133568|NCT00550446|426936|P11|Up To Week 12|Adverse Event|0
133569|NCT00550446|426937|P10|Up To Week 12|Adverse Event|0
133570|NCT00550446|426938|P9|Up To Week 12|Adverse Event|0
133571|NCT00550446|426939|P8|Up To Week 12|Adverse Event|0
133572|NCT00550446|426940|P7|Up To Week 12|Adverse Event|1
133573|NCT00550446|426941|P6|Up To Week 12|Adverse Event|2
133574|NCT00550446|426942|P5|Up To Week 12|Adverse Event|2
133575|NCT00550446|426943|P4|Up To Week 12|Adverse Event|0
133576|NCT00550446|426944|P3|Up To Week 12|Adverse Event|0
133577|NCT00550446|426945|P2|Up To Week 12|Adverse Event|2
133578|NCT00550446|426946|P1|Up To Week 12|Adverse Event|2
133579|NCT00550459|427380|P2|Overall Study|Withdrawal by Subject|1
133580|NCT00550459|427381|P1|Overall Study|Withdrawal by Subject|1
133581|NCT00550459|427380|P2|Overall Study|Adverse Event|2
133582|NCT00550459|427381|P1|Overall Study|Adverse Event|0
133583|NCT00550537|427443|P1|Overall Study|Treated closer to home|4
133584|NCT00550537|427443|P1|Overall Study|Declining performance status|2
133585|NCT00550537|427443|P1|Overall Study|Other complicating ilness|3
133586|NCT00550537|427443|P1|Overall Study|Change in treatment plan|4
133587|NCT00550537|427443|P1|Overall Study|Withdrawal by Subject|7
133588|NCT00550537|427443|P1|Overall Study|Disease progression before|46
133589|NCT00550537|427443|P1|Overall Study|Adverse Event|20
133590|NCT00550537|427443|P1|Overall Study|Death|18
133591|NCT00550550|427460|P2|Overall Study|Randomized But Not Treated|0
133592|NCT00550550|427461|P1|Overall Study|Randomized But Not Treated|1
133593|NCT00550550|427460|P2|Overall Study|Did Not Meet Protocol Eligibility|1
133594|NCT00550550|427461|P1|Overall Study|Did Not Meet Protocol Eligibility|1
133595|NCT00550550|427460|P2|Overall Study|Protocol Violation|14
133596|NCT00550550|427461|P1|Overall Study|Protocol Violation|5
133597|NCT00550550|427460|P2|Overall Study|Withdrawal by Subject|8
133598|NCT00550550|427461|P1|Overall Study|Withdrawal by Subject|10
133599|NCT00550550|427460|P2|Overall Study|Lost to Follow-up|0
133600|NCT00550550|427461|P1|Overall Study|Lost to Follow-up|4
133601|NCT00550550|427460|P2|Overall Study|Treatment Failure|1
133602|NCT00550550|427461|P1|Overall Study|Treatment Failure|0
133603|NCT00550550|427460|P2|Overall Study|Adverse Event|5
133604|NCT00550550|427461|P1|Overall Study|Adverse Event|13
133605|NCT00550680|427494|P1|Overall Study|Screen Failure|6
133606|NCT00550680|427494|P1|Overall Study|Refused Treatment|19
133607|NCT00550680|427494|P1|Overall Study|Protocol Violation|7
133608|NCT00550680|427494|P1|Overall Study|Not Specified|10
133609|NCT00550680|427494|P1|Overall Study|Lack of Efficacy|1
133610|NCT00550680|427494|P1|Overall Study|Lost to Follow-up|3
133611|NCT00550680|427494|P1|Overall Study|Early Improvement|1
133612|NCT00550680|427494|P1|Overall Study|Death|3
133613|NCT00550680|427494|P1|Overall Study|Adverse Event|5
133614|NCT00550680|427494|P1|Overall Study|Administrative Reasons|1
133615|NCT00550732|427503|P1|Overall Study|Adverse Event|1
133616|NCT00550732|427503|P1|Overall Study|Palliative care|1
133617|NCT00550732|427503|P1|Overall Study|Lost to Follow-up|1
133618|NCT00550732|427503|P1|Overall Study|Physician Decision|2
133619|NCT00550732|427503|P1|Overall Study|Withdrawal by Subject|2
133620|NCT00550732|427503|P1|Overall Study|Death|4
133621|NCT00550745|427516|P2|Overall Study|Screen failure|0
133622|NCT00550745|427517|P1|Overall Study|Screen failure|1
133623|NCT00550745|427516|P2|Overall Study|Withdrawal by Subject|10
133624|NCT00550745|427517|P1|Overall Study|Withdrawal by Subject|17
133625|NCT00550745|427516|P2|Overall Study|Protocol Violation|2
133626|NCT00550745|427517|P1|Overall Study|Protocol Violation|4
133627|NCT00550745|427516|P2|Overall Study|Physician Decision|2
133628|NCT00550745|427517|P1|Overall Study|Physician Decision|0
133629|NCT00550745|427516|P2|Overall Study|Lost to Follow-up|30
133630|NCT00550745|427517|P1|Overall Study|Lost to Follow-up|45
133631|NCT00550745|427516|P2|Overall Study|Death|16
133632|NCT00550745|427517|P1|Overall Study|Death|20
133633|NCT00550771|427527|P2|Overall Study|Protocol Violation|5
133634|NCT00550771|427528|P1|Overall Study|Protocol Violation|4
133635|NCT00550771|427527|P2|Overall Study|Withdrawal by Subject|1
133636|NCT00550771|427528|P1|Overall Study|Withdrawal by Subject|0
133637|NCT00550771|427527|P2|Overall Study|Physician Decision|0
133638|NCT00550771|427528|P1|Overall Study|Physician Decision|2
133639|NCT00550771|427527|P2|Overall Study|Discontinued for study-related reasons|1
133640|NCT00550771|427528|P1|Overall Study|Discontinued for study-related reasons|0
133641|NCT00550771|427527|P2|Overall Study|Adverse Event|3
133642|NCT00550771|427528|P1|Overall Study|Adverse Event|11
133643|NCT00550836|427542|P2|Overall Study|Withdrawal by Subject|9
133644|NCT00550836|427543|P1|Overall Study|Withdrawal by Subject|3
133645|NCT00550953|427584|P2|Overall Study|Not able to visit the site|3
133646|NCT00550953|427585|P1|Overall Study|Not able to visit the site|2
133647|NCT00550953|427584|P2|Overall Study|Adverse Event|3
133648|NCT00550953|427585|P1|Overall Study|Adverse Event|4
133649|NCT00551031|427610|P5|Overall Study|Did not receive vaccine|0
133650|NCT00551031|427611|P4|Overall Study|Did not receive vaccine|0
133651|NCT00551031|427612|P3|Overall Study|Did not receive vaccine|0
133652|NCT00551031|427613|P2|Overall Study|Did not receive vaccine|2
133653|NCT00551031|427614|P1|Overall Study|Did not receive vaccine|1
133654|NCT00551031|427610|P5|Overall Study|Serious Adverse Event|0
133655|NCT00551031|427611|P4|Overall Study|Serious Adverse Event|0
133656|NCT00551031|427612|P3|Overall Study|Serious Adverse Event|1
133657|NCT00551031|427613|P2|Overall Study|Serious Adverse Event|2
133658|NCT00551031|427614|P1|Overall Study|Serious Adverse Event|0
133659|NCT00551031|427610|P5|Overall Study|Withdrawal by Subject|0
133660|NCT00551031|427611|P4|Overall Study|Withdrawal by Subject|2
133661|NCT00551031|427612|P3|Overall Study|Withdrawal by Subject|1
133662|NCT00551031|427613|P2|Overall Study|Withdrawal by Subject|4
133663|NCT00551031|427614|P1|Overall Study|Withdrawal by Subject|0
133664|NCT00551031|427610|P5|Overall Study|Lost to Follow-up|1
133665|NCT00551031|427611|P4|Overall Study|Lost to Follow-up|1
133666|NCT00551031|427612|P3|Overall Study|Lost to Follow-up|0
133667|NCT00551031|427613|P2|Overall Study|Lost to Follow-up|1
133668|NCT00551031|427614|P1|Overall Study|Lost to Follow-up|0
133669|NCT00551031|427610|P5|Overall Study|Protocol Violation|0
133670|NCT00551031|427611|P4|Overall Study|Protocol Violation|0
133671|NCT00551031|427612|P3|Overall Study|Protocol Violation|0
133672|NCT00551031|427613|P2|Overall Study|Protocol Violation|1
133673|NCT00551031|427614|P1|Overall Study|Protocol Violation|1
133674|NCT00551031|427610|P5|Overall Study|Adverse Event|0
133675|NCT00551031|427611|P4|Overall Study|Adverse Event|0
133676|NCT00551031|427612|P3|Overall Study|Adverse Event|0
133677|NCT00551031|427613|P2|Overall Study|Adverse Event|1
133678|NCT00551031|427614|P1|Overall Study|Adverse Event|0
133679|NCT00551135|427655|P4|Overall Study|Withdrawal by Subject|1
133680|NCT00551135|427656|P3|Overall Study|Withdrawal by Subject|3
133681|NCT00551135|427657|P2|Overall Study|Withdrawal by Subject|0
133682|NCT00551135|427658|P1|Overall Study|Withdrawal by Subject|1
133683|NCT00551135|427655|P4|Overall Study|Unspecified|2
133684|NCT00551135|427656|P3|Overall Study|Unspecified|1
133685|NCT00551135|427657|P2|Overall Study|Unspecified|2
133686|NCT00551135|427658|P1|Overall Study|Unspecified|3
133687|NCT00551135|427655|P4|Overall Study|Lost to Follow-up|1
133688|NCT00551135|427656|P3|Overall Study|Lost to Follow-up|0
133689|NCT00551135|427657|P2|Overall Study|Lost to Follow-up|0
133690|NCT00551135|427658|P1|Overall Study|Lost to Follow-up|0
133691|NCT00551135|427655|P4|Overall Study|Adverse Event|1
133692|NCT00551135|427656|P3|Overall Study|Adverse Event|1
133693|NCT00551135|427657|P2|Overall Study|Adverse Event|0
133694|NCT00551135|427658|P1|Overall Study|Adverse Event|1
133695|NCT00551161|427772|P1|Overall Study|Withdrawal by Subject|1
133696|NCT00551213|427806|P2|Overall Study|Not Treated|2
133697|NCT00551213|427807|P1|Overall Study|Not Treated|1
133698|NCT00551213|427806|P2|Overall Study|Withdrawal by Subject|0
133699|NCT00551213|427807|P1|Overall Study|Withdrawal by Subject|2
133700|NCT00551213|427806|P2|Overall Study|Progressive Disease|12
133701|NCT00551213|427807|P1|Overall Study|Progressive Disease|41
133702|NCT00551213|427806|P2|Overall Study|Adverse Event|3
133703|NCT00551213|427807|P1|Overall Study|Adverse Event|6
133704|NCT00551291|427823|P1|Overall Study|Physician Decision|1
133705|NCT00551369|427829|P1|Overall Study|Not treated per protocol and re|1
133706|NCT00551369|427829|P1|Overall Study|Withdrawal by Subject|1
133707|NCT00551369|427829|P1|Overall Study|Protocol Violation|5
133708|NCT00551421|427836|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
133709|NCT00551525|427843|P1|Overall Study|Protocol Violation|5
133710|NCT00546052|427852|P1|Overall Study|Non Compliance|7
133711|NCT00546052|427852|P1|Overall Study|Withdrawal by Subject|20
133712|NCT00546052|427852|P1|Overall Study|Protocol Violation|9
133713|NCT00546052|427852|P1|Overall Study|Lost to Follow-up|144
133714|NCT00546052|427852|P1|Overall Study|Adverse Event|47
133715|NCT00551642|427872|P2|Overall Study|Inclusion/Exclusion criteria|4
133716|NCT00551642|427873|P1|Overall Study|Inclusion/Exclusion criteria|4
133717|NCT00551642|427872|P2|Overall Study|Delivery device failure|3
133718|NCT00551642|427873|P1|Overall Study|Delivery device failure|1
133719|NCT00551642|427872|P2|Overall Study|Physician Decision|1
133720|NCT00551642|427873|P1|Overall Study|Physician Decision|0
133721|NCT00551642|427872|P2|Overall Study|Protocol Violation|11
133722|NCT00551642|427873|P1|Overall Study|Protocol Violation|6
133723|NCT00551642|427872|P2|Overall Study|Death|31
133724|NCT00551642|427873|P1|Overall Study|Death|33
133725|NCT00551642|427872|P2|Overall Study|Adverse Event|12
133726|NCT00551642|427873|P1|Overall Study|Adverse Event|15
133727|NCT00551642|427872|P2|Overall Study|Withdrawal by Subject|1
133728|NCT00551642|427873|P1|Overall Study|Withdrawal by Subject|2
133729|NCT00551759|427914|P1|Overall Study|Ineligible|1
133730|NCT00551759|427914|P1|Overall Study|Death|5
133731|NCT00551759|427914|P1|Overall Study|Adverse Event|7
133732|NCT00553631|427920|P2|Overall Study|Lost to Follow-up|0
133733|NCT00553631|427921|P1|Overall Study|Lost to Follow-up|1
133734|NCT00553631|427920|P2|Overall Study|Withdrawal by Subject|1
133735|NCT00553631|427921|P1|Overall Study|Withdrawal by Subject|0
133736|NCT00553644|427941|P1|Overall Study|Alternative therapy|6
133737|NCT00553644|427941|P1|Overall Study|Physician Decision|1
133738|NCT00553644|427941|P1|Overall Study|Withdrawal by Subject|4
133739|NCT00553644|427941|P1|Overall Study|Adverse Event|17
133740|NCT00553696|427952|P4|Overall Study|Withdrawal by Subject|0
133741|NCT00553696|427953|P3|Overall Study|Withdrawal by Subject|0
133742|NCT00553696|427954|P2|Overall Study|Withdrawal by Subject|1
133743|NCT00553696|427955|P1|Overall Study|Withdrawal by Subject|0
133744|NCT00553696|427952|P4|Overall Study|Objective progression or relapse|0
133745|NCT00553696|427953|P3|Overall Study|Objective progression or relapse|6
133746|NCT00553696|427954|P2|Overall Study|Objective progression or relapse|9
133747|NCT00553696|427955|P1|Overall Study|Objective progression or relapse|2
133748|NCT00553696|427952|P4|Overall Study|Global deterioration of health status|0
133749|NCT00553696|427953|P3|Overall Study|Global deterioration of health status|0
133750|NCT00553696|427954|P2|Overall Study|Global deterioration of health status|2
133751|NCT00553696|427955|P1|Overall Study|Global deterioration of health status|0
133752|NCT00553696|427952|P4|Overall Study|Adverse Event|1
133753|NCT00553696|427953|P3|Overall Study|Adverse Event|0
133754|NCT00553696|427954|P2|Overall Study|Adverse Event|4
133755|NCT00553696|427955|P1|Overall Study|Adverse Event|2
133756|NCT00553787|428013|P3|Overall Study|not specified|13
133757|NCT00553787|428014|P2|Overall Study|not specified|10
133758|NCT00553787|428015|P1|Overall Study|not specified|18
133759|NCT00553787|428013|P3|Overall Study|Requirement for restricted medication|5
133760|NCT00553787|428014|P2|Overall Study|Requirement for restricted medication|7
133761|NCT00553787|428015|P1|Overall Study|Requirement for restricted medication|8
133762|NCT00553787|428013|P3|Overall Study|non compliance|11
133763|NCT00553787|428014|P2|Overall Study|non compliance|0
133764|NCT00553787|428015|P1|Overall Study|non compliance|4
133765|NCT00553787|428013|P3|Overall Study|Pregnancy|2
133766|NCT00553787|428014|P2|Overall Study|Pregnancy|1
133767|NCT00553787|428015|P1|Overall Study|Pregnancy|0
133768|NCT00553787|428013|P3|Overall Study|Lack of Efficacy|3
133769|NCT00553787|428014|P2|Overall Study|Lack of Efficacy|1
133770|NCT00553787|428015|P1|Overall Study|Lack of Efficacy|31
133771|NCT00553787|428013|P3|Overall Study|Withdrawal by Subject|83
133772|NCT00553787|428014|P2|Overall Study|Withdrawal by Subject|40
133773|NCT00553787|428015|P1|Overall Study|Withdrawal by Subject|151
133774|NCT00553787|428013|P3|Overall Study|Lost to Follow-up|78
133775|NCT00553787|428014|P2|Overall Study|Lost to Follow-up|44
133776|NCT00553787|428015|P1|Overall Study|Lost to Follow-up|132
133777|NCT00553787|428013|P3|Overall Study|Adverse Event|67
133778|NCT00553787|428014|P2|Overall Study|Adverse Event|21
133779|NCT00553787|428015|P1|Overall Study|Adverse Event|34
133780|NCT00554099|428052|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
133781|NCT00554099|428053|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
133782|NCT00554099|428054|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
133783|NCT00554099|428052|P3|Non-Treatment Phase (9 Months)|Relapse|1
133784|NCT00554099|428053|P2|Non-Treatment Phase (9 Months)|Relapse|1
133785|NCT00554099|428054|P1|Non-Treatment Phase (9 Months)|Relapse|2
133786|NCT00554099|428052|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
133787|NCT00554099|428053|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
133788|NCT00554099|428054|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
133789|NCT00554099|428052|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
133790|NCT00554099|428053|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
133791|NCT00554099|428054|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
133792|NCT00554099|428052|P3|Treatment Period (12 Weeks)|Protocol Violation|2
133793|NCT00554099|428053|P2|Treatment Period (12 Weeks)|Protocol Violation|0
133794|NCT00554099|428054|P1|Treatment Period (12 Weeks)|Protocol Violation|0
133795|NCT00554099|428052|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
133796|NCT00554099|428053|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
133797|NCT00554099|428054|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
133798|NCT00554099|428052|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
133799|NCT00554099|428053|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
133800|NCT00554099|428054|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
133801|NCT00554099|428052|P3|Treatment Period (12 Weeks)|Physician Decision|0
133802|NCT00554099|428053|P2|Treatment Period (12 Weeks)|Physician Decision|0
133803|NCT00554099|428054|P1|Treatment Period (12 Weeks)|Physician Decision|3
133804|NCT00554099|428052|P3|Treatment Period (12 Weeks)|Adverse Event|1
133805|NCT00554099|428053|P2|Treatment Period (12 Weeks)|Adverse Event|5
133806|NCT00554099|428054|P1|Treatment Period (12 Weeks)|Adverse Event|3
133807|NCT00554190|428083|P1|Overall Study|Termination forms not completed|10
133808|NCT00554216|428092|P3|Overall Study|Lack of Efficacy|0
133809|NCT00554216|428093|P2|Overall Study|Lack of Efficacy|3
133810|NCT00554216|428094|P1|Overall Study|Lack of Efficacy|15
133811|NCT00554216|428092|P3|Overall Study|not specified|10
133812|NCT00554216|428093|P2|Overall Study|not specified|7
133813|NCT00554216|428094|P1|Overall Study|not specified|12
133814|NCT00554216|428092|P3|Overall Study|Restricted med|1
133815|NCT00554216|428093|P2|Overall Study|Restricted med|1
133816|NCT00554216|428094|P1|Overall Study|Restricted med|3
133817|NCT00554216|428092|P3|Overall Study|Pregnancy|14
133818|NCT00554216|428093|P2|Overall Study|Pregnancy|1
133819|NCT00554216|428094|P1|Overall Study|Pregnancy|2
133820|NCT00554216|428092|P3|Overall Study|Non compliance|5
133821|NCT00554216|428093|P2|Overall Study|Non compliance|4
133822|NCT00554216|428094|P1|Overall Study|Non compliance|10
133823|NCT00554216|428092|P3|Overall Study|Withdrawal by Subject|43
133824|NCT00554216|428093|P2|Overall Study|Withdrawal by Subject|31
133825|NCT00554216|428094|P1|Overall Study|Withdrawal by Subject|92
133826|NCT00554216|428092|P3|Overall Study|Adverse Event|36
133827|NCT00554216|428093|P2|Overall Study|Adverse Event|16
133828|NCT00554216|428094|P1|Overall Study|Adverse Event|16
133829|NCT00554216|428092|P3|Overall Study|Lost to Follow-up|63
133830|NCT00554216|428093|P2|Overall Study|Lost to Follow-up|31
133831|NCT00554216|428094|P1|Overall Study|Lost to Follow-up|92
133832|NCT00554229|428107|P2|Overall Study|Randomised but no treatment received|0
133833|NCT00554229|428108|P1|Overall Study|Randomised but no treatment received|1
133834|NCT00554229|428107|P2|Overall Study|Reason not otherwise captured, eg; death|140
133835|NCT00554229|428108|P1|Overall Study|Reason not otherwise captured, eg; death|119
133836|NCT00554229|428107|P2|Overall Study|Protocol Violation|3
133837|NCT00554229|428108|P1|Overall Study|Protocol Violation|3
133838|NCT00554229|428107|P2|Overall Study|Adverse Event|39
133839|NCT00554229|428108|P1|Overall Study|Adverse Event|71
133840|NCT00554229|428107|P2|Overall Study|Withdrawal by Subject|37
133841|NCT00554229|428108|P1|Overall Study|Withdrawal by Subject|29
133842|NCT00554229|428107|P2|Overall Study|Lost to Follow-up|6
133843|NCT00554229|428108|P1|Overall Study|Lost to Follow-up|3
133844|NCT00554515|428156|P1|Overall Study|Misc|15
133845|NCT00554515|428156|P1|Overall Study|Other|1
133846|NCT00554515|428156|P1|Overall Study|Achieved Stable Disease|7
133847|NCT00554515|428156|P1|Overall Study|Death|2
133848|NCT00554515|428156|P1|Overall Study|Adverse Event|9
133849|NCT00554515|428156|P1|Overall Study|Withdrawal by Subject|11
133850|NCT00554515|428156|P1|Overall Study|Physician Decision|18
133851|NCT00554515|428156|P1|Overall Study|Disease progression|52
133852|NCT00554515|428156|P1|Overall Study|Withdrawal by Subject|3
133853|NCT00554619|428185|P1|Overall Study|Liver Function Test Abnormality|1
133854|NCT00554619|428185|P1|Overall Study|Physician Decision|1
133855|NCT00554619|428185|P1|Overall Study|Adverse Event|1
133856|NCT00554801|428215|P2|Overall Study|Withdrawal by Subject|0
133857|NCT00554801|428216|P1|Overall Study|Withdrawal by Subject|14
133858|NCT00554801|428215|P2|Overall Study|left area before completion|0
133859|NCT00554801|428216|P1|Overall Study|left area before completion|5
133860|NCT00554840|428224|P2|Overall Study|Physician Decision|1
133861|NCT00554840|428225|P1|Overall Study|Physician Decision|0
133862|NCT00555009|428299|P2|Overall Study|Terminated by Sponsor|5
133863|NCT00555009|428300|P1|Overall Study|Terminated by Sponsor|2
133864|NCT00555009|428299|P2|Overall Study|Withdrawal by Subject|1
133865|NCT00555009|428300|P1|Overall Study|Withdrawal by Subject|0
133866|NCT00555061|428332|P1|Overall Study|Participant enrolled, but never treated|1
133867|NCT00555061|428332|P1|Overall Study|Withdrawal by Subject|2
133868|NCT00555061|428332|P1|Overall Study|Lost to Follow-up|2
133869|NCT00555061|428332|P1|Overall Study|Protocol Violation|1
133870|NCT00555061|428332|P1|Overall Study|Adverse Event|3
133871|NCT00555217|428370|P2|Overall Study|close out sites|17
133872|NCT00555217|428371|P1|Overall Study|close out sites|21
133873|NCT00555217|428370|P2|Overall Study|Lost to Follow-up|20
133874|NCT00555217|428371|P1|Overall Study|Lost to Follow-up|19
133875|NCT00555217|428370|P2|Overall Study|Withdrawal by Subject|31
133876|NCT00555217|428371|P1|Overall Study|Withdrawal by Subject|35
133877|NCT00555321|428384|P5|Long-term Extension Phase|Other Reason|0
133878|NCT00555321|428385|P4|Long-term Extension Phase|Other Reason|0
133879|NCT00555321|428386|P3|Long-term Extension Phase|Other Reason|2
133880|NCT00555321|428387|P2|Long-term Extension Phase|Other Reason|0
133881|NCT00555321|428388|P1|Long-term Extension Phase|Other Reason|1
133882|NCT00555321|428384|P5|Long-term Extension Phase|Participant did not meet study criteria|1
133883|NCT00555321|428385|P4|Long-term Extension Phase|Participant did not meet study criteria|0
133884|NCT00555321|428386|P3|Long-term Extension Phase|Participant did not meet study criteria|0
133885|NCT00555321|428387|P2|Long-term Extension Phase|Participant did not meet study criteria|0
133886|NCT00555321|428388|P1|Long-term Extension Phase|Participant did not meet study criteria|0
133887|NCT00555321|428384|P5|Long-term Extension Phase|Death|0
133888|NCT00555321|428385|P4|Long-term Extension Phase|Death|3
133889|NCT00555321|428386|P3|Long-term Extension Phase|Death|0
133890|NCT00555321|428387|P2|Long-term Extension Phase|Death|0
133891|NCT00555321|428388|P1|Long-term Extension Phase|Death|2
133892|NCT00555321|428384|P5|Long-term Extension Phase|Administrative reason by sponsor|23
133893|NCT00555321|428385|P4|Long-term Extension Phase|Administrative reason by sponsor|31
133894|NCT00555321|428386|P3|Long-term Extension Phase|Administrative reason by sponsor|18
133895|NCT00555321|428387|P2|Long-term Extension Phase|Administrative reason by sponsor|21
133896|NCT00555321|428388|P1|Long-term Extension Phase|Administrative reason by sponsor|23
133897|NCT00555321|428384|P5|Long-term Extension Phase|Withdrawal by Subject|2
133898|NCT00555321|428385|P4|Long-term Extension Phase|Withdrawal by Subject|3
133899|NCT00555321|428386|P3|Long-term Extension Phase|Withdrawal by Subject|2
133900|NCT00555321|428387|P2|Long-term Extension Phase|Withdrawal by Subject|1
133901|NCT00555321|428388|P1|Long-term Extension Phase|Withdrawal by Subject|2
133902|NCT00555321|428384|P5|Long-term Extension Phase|Adverse Event|0
133903|NCT00555321|428385|P4|Long-term Extension Phase|Adverse Event|1
133904|NCT00555321|428386|P3|Long-term Extension Phase|Adverse Event|2
133905|NCT00555321|428387|P2|Long-term Extension Phase|Adverse Event|5
133906|NCT00555321|428388|P1|Long-term Extension Phase|Adverse Event|2
133907|NCT00555321|428384|P5|Treatment Phase up to 12-months|Never treated|4
133908|NCT00555321|428385|P4|Treatment Phase up to 12-months|Never treated|0
133909|NCT00555321|428386|P3|Treatment Phase up to 12-months|Never treated|1
133910|NCT00555321|428387|P2|Treatment Phase up to 12-months|Never treated|3
133911|NCT00555321|428388|P1|Treatment Phase up to 12-months|Never treated|2
133912|NCT00555321|428384|P5|Treatment Phase up to 12-months|Other Reason|0
133913|NCT00555321|428385|P4|Treatment Phase up to 12-months|Other Reason|0
133914|NCT00555321|428386|P3|Treatment Phase up to 12-months|Other Reason|2
133915|NCT00555321|428387|P2|Treatment Phase up to 12-months|Other Reason|3
133916|NCT00555321|428388|P1|Treatment Phase up to 12-months|Other Reason|1
133917|NCT00555321|428384|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
133918|NCT00555321|428385|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
133919|NCT00555321|428386|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
133920|NCT00555321|428387|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
133921|NCT00555321|428388|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
133922|NCT00555321|428384|P5|Treatment Phase up to 12-months|Death|0
133923|NCT00555321|428385|P4|Treatment Phase up to 12-months|Death|0
133924|NCT00555321|428386|P3|Treatment Phase up to 12-months|Death|4
133925|NCT00555321|428387|P2|Treatment Phase up to 12-months|Death|1
133926|NCT00555321|428388|P1|Treatment Phase up to 12-months|Death|2
133927|NCT00555321|428384|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
133928|NCT00555321|428385|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
133929|NCT00555321|428386|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
133930|NCT00555321|428387|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
133931|NCT00555321|428388|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
133932|NCT00555321|428384|P5|Treatment Phase up to 12-months|Adverse Event|18
133933|NCT00555321|428385|P4|Treatment Phase up to 12-months|Adverse Event|7
133934|NCT00555321|428386|P3|Treatment Phase up to 12-months|Adverse Event|11
133935|NCT00555321|428387|P2|Treatment Phase up to 12-months|Adverse Event|7
133936|NCT00555321|428388|P1|Treatment Phase up to 12-months|Adverse Event|6
133937|NCT00555425|428705|P2|Overall Study|Became pregnant and transferred care|1
133938|NCT00555425|428706|P1|Overall Study|Became pregnant and transferred care|0
133939|NCT00555425|428705|P2|Overall Study|Met criteria for protective transfer|3
133940|NCT00555425|428706|P1|Overall Study|Met criteria for protective transfer|16
133941|NCT00555425|428705|P2|Overall Study|Missed 3 physician management visits|0
133942|NCT00555425|428706|P1|Overall Study|Missed 3 physician management visits|1
133943|NCT00555425|428705|P2|Overall Study|Missed Medication > 1 wk|15
133944|NCT00555425|428706|P1|Overall Study|Missed Medication > 1 wk|34
133945|NCT00555438|428724|P1|Between 10 Days and 30 Days Postoperativ|Death|5
133946|NCT00555438|428724|P1|10 Days Post-operative|Death|4
133947|NCT00555477|428745|P2|Overall Study|Physician Decision|2
133948|NCT00555477|428746|P1|Overall Study|Physician Decision|1
133949|NCT00555477|428745|P2|Overall Study|Withdrawal by Subject|2
133950|NCT00555477|428746|P1|Overall Study|Withdrawal by Subject|1
133951|NCT00555477|428745|P2|Overall Study|Adverse Event|9
133952|NCT00555477|428746|P1|Overall Study|Adverse Event|0
133953|NCT00555568|428754|P3|Overall Study|Lost to Follow-up|16
133954|NCT00555568|428755|P2|Overall Study|Lost to Follow-up|16
133955|NCT00555568|428756|P1|Overall Study|Lost to Follow-up|26
133956|NCT00555620|428782|P6|Overall Study|Not specified|3
133957|NCT00555620|428783|P5|Overall Study|Not specified|0
133958|NCT00555620|428784|P4|Overall Study|Not specified|1
133959|NCT00555620|428785|P3|Overall Study|Not specified|0
133960|NCT00555620|428786|P2|Overall Study|Not specified|0
133961|NCT00555620|428787|P1|Overall Study|Not specified|0
133962|NCT00555620|428782|P6|Overall Study|Participant refused treatment|1
133963|NCT00555620|428783|P5|Overall Study|Participant refused treatment|0
133964|NCT00555620|428784|P4|Overall Study|Participant refused treatment|0
133965|NCT00555620|428785|P3|Overall Study|Participant refused treatment|1
133966|NCT00555620|428786|P2|Overall Study|Participant refused treatment|1
133967|NCT00555620|428787|P1|Overall Study|Participant refused treatment|0
133968|NCT00555620|428782|P6|Overall Study|Objective progression or relapse|16
133969|NCT00555620|428783|P5|Overall Study|Objective progression or relapse|3
133970|NCT00555620|428784|P4|Overall Study|Objective progression or relapse|17
133971|NCT00555620|428785|P3|Overall Study|Objective progression or relapse|12
133972|NCT00555620|428786|P2|Overall Study|Objective progression or relapse|5
133973|NCT00555620|428787|P1|Overall Study|Objective progression or relapse|6
133974|NCT00555620|428782|P6|Overall Study|Adverse Event|1
133975|NCT00555620|428783|P5|Overall Study|Adverse Event|0
133976|NCT00555620|428784|P4|Overall Study|Adverse Event|5
133977|NCT00555620|428785|P3|Overall Study|Adverse Event|1
133978|NCT00555620|428786|P2|Overall Study|Adverse Event|0
133979|NCT00555620|428787|P1|Overall Study|Adverse Event|0
133980|NCT00555620|428782|P6|Overall Study|Study terminated by sponsor|0
133981|NCT00555620|428783|P5|Overall Study|Study terminated by sponsor|0
133982|NCT00555620|428784|P4|Overall Study|Study terminated by sponsor|0
133983|NCT00555620|428785|P3|Overall Study|Study terminated by sponsor|1
133984|NCT00555620|428786|P2|Overall Study|Study terminated by sponsor|0
133985|NCT00555620|428787|P1|Overall Study|Study terminated by sponsor|0
133986|NCT00555620|428782|P6|Overall Study|Death|1
133987|NCT00555620|428783|P5|Overall Study|Death|0
133988|NCT00555620|428784|P4|Overall Study|Death|0
133989|NCT00555620|428785|P3|Overall Study|Death|0
133990|NCT00555620|428786|P2|Overall Study|Death|1
133991|NCT00555620|428787|P1|Overall Study|Death|0
133992|NCT00555672|428901|P2|Overall Study|Participant refused|0
133993|NCT00555672|428902|P1|Overall Study|Participant refused|2
133994|NCT00555672|428901|P2|Overall Study|Unspecified|1
133995|NCT00555672|428902|P1|Overall Study|Unspecified|3
133996|NCT00555672|428901|P2|Overall Study|Objective progression or relapse|5
133997|NCT00555672|428902|P1|Overall Study|Objective progression or relapse|11
133998|NCT00555672|428901|P2|Overall Study|Adverse Event|2
133999|NCT00555672|428902|P1|Overall Study|Adverse Event|8
134000|NCT00555672|428901|P2|Overall Study|Death|2
134001|NCT00555672|428902|P1|Overall Study|Death|0
134002|NCT00555906|429008|P5|Phase 2|Randomized but not Treated|2
134003|NCT00555906|429009|P4|Phase 2|Randomized but not Treated|0
134004|NCT00555906|429010|P3|Phase 2|Randomized but not Treated|0
134005|NCT00555906|429011|P2|Phase 2|Randomized but not Treated|0
134006|NCT00555906|429012|P1|Phase 2|Randomized but not Treated|0
134007|NCT00555906|429008|P5|Phase 2|Unspecified|6
134008|NCT00555906|429009|P4|Phase 2|Unspecified|0
134009|NCT00555906|429010|P3|Phase 2|Unspecified|0
134010|NCT00555906|429011|P2|Phase 2|Unspecified|0
134011|NCT00555906|429012|P1|Phase 2|Unspecified|0
134012|NCT00555906|429008|P5|Phase 2|Withdrawal by Subject|2
134013|NCT00555906|429009|P4|Phase 2|Withdrawal by Subject|0
134014|NCT00555906|429010|P3|Phase 2|Withdrawal by Subject|0
134015|NCT00555906|429011|P2|Phase 2|Withdrawal by Subject|0
134016|NCT00555906|429012|P1|Phase 2|Withdrawal by Subject|0
134017|NCT00555906|429008|P5|Phase 2|Objective Progression or Relapse|16
134018|NCT00555906|429009|P4|Phase 2|Objective Progression or Relapse|0
134019|NCT00555906|429010|P3|Phase 2|Objective Progression or Relapse|0
134020|NCT00555906|429011|P2|Phase 2|Objective Progression or Relapse|0
134021|NCT00555906|429012|P1|Phase 2|Objective Progression or Relapse|0
134022|NCT00555906|429008|P5|Phase 2|Global Deterioration of Health Status|2
134023|NCT00555906|429009|P4|Phase 2|Global Deterioration of Health Status|0
134024|NCT00555906|429010|P3|Phase 2|Global Deterioration of Health Status|0
134025|NCT00555906|429011|P2|Phase 2|Global Deterioration of Health Status|0
134026|NCT00555906|429012|P1|Phase 2|Global Deterioration of Health Status|0
134027|NCT00555906|429008|P5|Phase 2|Adverse Event|4
134028|NCT00555906|429009|P4|Phase 2|Adverse Event|0
134029|NCT00555906|429010|P3|Phase 2|Adverse Event|0
134030|NCT00555906|429011|P2|Phase 2|Adverse Event|0
134031|NCT00555906|429012|P1|Phase 2|Adverse Event|0
134032|NCT00555906|429008|P5|Phase 1|Withdrawal by Subject|0
134033|NCT00555906|429009|P4|Phase 1|Withdrawal by Subject|1
134034|NCT00555906|429010|P3|Phase 1|Withdrawal by Subject|0
134035|NCT00555906|429011|P2|Phase 1|Withdrawal by Subject|0
134036|NCT00555906|429012|P1|Phase 1|Withdrawal by Subject|0
134037|NCT00555906|429008|P5|Phase 1|Adverse Event|0
134038|NCT00555906|429009|P4|Phase 1|Adverse Event|2
134039|NCT00555906|429010|P3|Phase 1|Adverse Event|3
134040|NCT00555906|429011|P2|Phase 1|Adverse Event|0
134041|NCT00555906|429012|P1|Phase 1|Adverse Event|0
134042|NCT00555906|429008|P5|Phase 1|Global Deterioration of Health Status|0
134043|NCT00555906|429009|P4|Phase 1|Global Deterioration of Health Status|1
134044|NCT00555906|429010|P3|Phase 1|Global Deterioration of Health Status|1
134045|NCT00555906|429011|P2|Phase 1|Global Deterioration of Health Status|1
134046|NCT00555906|429012|P1|Phase 1|Global Deterioration of Health Status|0
134047|NCT00555906|429008|P5|Phase 1|Objective Progression or Relapse|0
134048|NCT00555906|429009|P4|Phase 1|Objective Progression or Relapse|1
134049|NCT00555906|429010|P3|Phase 1|Objective Progression or Relapse|3
134050|NCT00555906|429011|P2|Phase 1|Objective Progression or Relapse|5
134051|NCT00555906|429012|P1|Phase 1|Objective Progression or Relapse|3
134052|NCT00556075|429071|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
134053|NCT00556075|429072|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
134054|NCT00556075|429073|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
134055|NCT00556075|429071|P3|Overall Study|Personal issues|0
134056|NCT00556075|429072|P2|Overall Study|Personal issues|1
134057|NCT00556075|429073|P1|Overall Study|Personal issues|4
134058|NCT00556075|429071|P3|Overall Study|Adverse Event|0
134059|NCT00556075|429072|P2|Overall Study|Adverse Event|2
134060|NCT00556075|429073|P1|Overall Study|Adverse Event|1
134061|NCT00556075|429071|P3|Overall Study|Not eligible|2
134062|NCT00556075|429072|P2|Overall Study|Not eligible|1
134063|NCT00556075|429073|P1|Overall Study|Not eligible|1
134064|NCT00556075|429071|P3|Overall Study|Protocol Violation|3
134065|NCT00556075|429072|P2|Overall Study|Protocol Violation|1
134066|NCT00556075|429073|P1|Overall Study|Protocol Violation|1
134067|NCT00556075|429071|P3|Overall Study|Withdrawal by Subject|0
134068|NCT00556075|429072|P2|Overall Study|Withdrawal by Subject|3
134069|NCT00556075|429073|P1|Overall Study|Withdrawal by Subject|3
134070|NCT00556075|429071|P3|Overall Study|Lost to Follow-up|3
134071|NCT00556075|429072|P2|Overall Study|Lost to Follow-up|0
134072|NCT00556075|429073|P1|Overall Study|Lost to Follow-up|3
134073|NCT00549055|429101|P1|Overall Study|Very low visual acuity (VA)|1
134074|NCT00549055|429101|P1|Overall Study|Choroidal neovascularization|1
134075|NCT00549055|429101|P1|Overall Study|Growth choroidal neovascularisation|1
134076|NCT00549055|429101|P1|Overall Study|Vitreous hemorrhage|1
134077|NCT00549055|429101|P1|Overall Study|Active choroidal neovascula increased|1
134078|NCT00549055|429101|P1|Overall Study|Decrease of size|1
134079|NCT00549055|429101|P1|Overall Study|Progression to fibrosis|2
134080|NCT00549055|429101|P1|Overall Study|Stabilization|5
134081|NCT00549055|429101|P1|Overall Study|Lack of efficacy|18
134082|NCT00549055|429101|P1|Overall Study|Adverse Event|4
134083|NCT00556166|429111|P1|Overall Study|Withdrawal by Subject|1
134084|NCT00556322|429118|P2|Overall Study|Death|14
134085|NCT00556322|429119|P1|Overall Study|Death|20
134086|NCT00556322|429118|P2|Overall Study|Ongoing at data cutoff|5
134087|NCT00556322|429119|P1|Overall Study|Ongoing at data cutoff|3
134088|NCT00556322|429118|P2|Overall Study|Protocol Violation|1
134089|NCT00556322|429119|P1|Overall Study|Protocol Violation|5
134090|NCT00556322|429118|P2|Overall Study|Withdrawal by Subject|7
134091|NCT00556322|429119|P1|Overall Study|Withdrawal by Subject|19
134092|NCT00556322|429118|P2|Overall Study|Lost to Follow-up|3
134093|NCT00556322|429119|P1|Overall Study|Lost to Follow-up|5
134094|NCT00556322|429118|P2|Overall Study|Unspecified|1
134095|NCT00556322|429119|P1|Overall Study|Unspecified|4
134096|NCT00556322|429118|P2|Overall Study|Adverse Event|4
134097|NCT00556322|429119|P1|Overall Study|Adverse Event|7
134098|NCT00556322|429118|P2|Overall Study|Insufficient therapeutic response|168
134099|NCT00556322|429119|P1|Overall Study|Insufficient therapeutic response|158
134100|NCT00556374|429169|P2|Overall Study|Lost to Follow-up|5
134101|NCT00556374|429170|P1|Overall Study|Lost to Follow-up|7
134102|NCT00556374|429169|P2|Overall Study|Death|43
134103|NCT00556374|429170|P1|Overall Study|Death|50
134104|NCT00556374|429169|P2|Overall Study|Withdrawal by Subject|172
134105|NCT00556374|429170|P1|Overall Study|Withdrawal by Subject|190
134106|NCT00556426|429198|P1|Overall Study|Death|6
134107|NCT00556426|429198|P1|Overall Study|Withdrawal by Subject|3
134108|NCT00559507|429245|P1|Overall Study|Not treated, patient ineligible|3
134109|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
134110|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
134111|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|non-specified|0
134112|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|non-specified|71
134113|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
134114|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
134115|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
134116|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
134117|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
134118|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
134119|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Death|0
134120|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Death|20
134121|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
134122|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
134123|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
134124|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
134125|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
134126|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
134127|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
134128|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
134129|NCT00559585|429253|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
134130|NCT00559585|429254|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
134131|NCT00559585|429253|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
134132|NCT00559585|429254|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
134133|NCT00559585|429253|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
134134|NCT00559585|429254|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
134135|NCT00559585|429253|P2|Double Blind ST Period Main Study|Investigator Decision|1
134136|NCT00559585|429254|P1|Double Blind ST Period Main Study|Investigator Decision|0
134137|NCT00559585|429253|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
134138|NCT00559585|429254|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
134139|NCT00559585|429253|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
134140|NCT00559585|429254|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
134141|NCT00559585|429253|P2|Double Blind ST Period Main Study|Early Discontinuation|1
134142|NCT00559585|429254|P1|Double Blind ST Period Main Study|Early Discontinuation|0
134143|NCT00559585|429253|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
134144|NCT00559585|429254|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
134145|NCT00559585|429253|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
134146|NCT00559585|429254|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
134147|NCT00559585|429253|P2|Double Blind ST Period Main Study|Missed Doses|1
134148|NCT00559585|429254|P1|Double Blind ST Period Main Study|Missed Doses|0
134149|NCT00559585|429253|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
134150|NCT00559585|429254|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
134151|NCT00559585|429253|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
134152|NCT00559585|429254|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
134153|NCT00559585|429253|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
134154|NCT00559585|429254|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
134155|NCT00559585|429253|P2|Double Blind ST Period Main Study|Death|1
134156|NCT00559585|429254|P1|Double Blind ST Period Main Study|Death|1
134157|NCT00559585|429253|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
134158|NCT00559585|429254|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
134159|NCT00559585|429253|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
134160|NCT00559585|429254|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
134161|NCT00559585|429253|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
134162|NCT00559585|429254|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
134163|NCT00559585|429253|P2|Double Blind ST Period Main Study|Adverse Event|25
134164|NCT00559585|429254|P1|Double Blind ST Period Main Study|Adverse Event|17
134165|NCT00559637|429314|P1|Overall Study|Inclusion or exclusion criteria violated|2
134166|NCT00559637|429314|P1|Overall Study|Change of home|1
134167|NCT00559637|429314|P1|Overall Study|Change of center|1
134168|NCT00559637|429314|P1|Overall Study|Delayed administration of C.E.R.A|1
134169|NCT00559637|429314|P1|Overall Study|Participation in another study|1
134170|NCT00559637|429314|P1|Overall Study|Suspected lung cancer|1
134171|NCT00559637|429314|P1|Overall Study|Started requiring dialysis after month 7|2
134172|NCT00559637|429314|P1|Overall Study|Insufficient response|3
134173|NCT00559637|429314|P1|Overall Study|Failure to return|6
134174|NCT00559637|429314|P1|Overall Study|Withdrawal criteria fulfilled|4
134175|NCT00559637|429314|P1|Overall Study|Protocol Violation|6
134176|NCT00559637|429314|P1|Overall Study|Withdrawal by Subject|4
134177|NCT00559637|429314|P1|Overall Study|Adverse Event|22
134178|NCT00559754|429325|P1|Overall Study|Withdrawal by Subject|2
134179|NCT00559754|429325|P1|Overall Study|Investigator criteria|2
134180|NCT00559754|429325|P1|Overall Study|Protocol Violation|1
134181|NCT00559754|429325|P1|Overall Study|Adverse Event|5
134182|NCT00559754|429325|P1|Overall Study|Disease progression|1
134183|NCT00559949|429358|P1|Overall Study|No disease evaluation per protocol|1
134184|NCT00559949|429358|P1|Overall Study|Withdrawal by Subject|4
134185|NCT00559949|429358|P1|Overall Study|Adverse Event|1
134186|NCT00559949|429358|P1|Overall Study|Progressive Disease during cycle 1|1
134187|NCT00559962|429373|P8|Overall Study|Inclusion/exclusion criteria not met|0
134188|NCT00559962|429374|P7|Overall Study|Inclusion/exclusion criteria not met|1
134189|NCT00559962|429375|P6|Overall Study|Inclusion/exclusion criteria not met|0
134190|NCT00559962|429376|P5|Overall Study|Inclusion/exclusion criteria not met|0
134191|NCT00559962|429377|P4|Overall Study|Inclusion/exclusion criteria not met|0
134192|NCT00559962|429378|P3|Overall Study|Inclusion/exclusion criteria not met|0
134193|NCT00559962|429379|P2|Overall Study|Inclusion/exclusion criteria not met|0
134194|NCT00559962|429380|P1|Overall Study|Inclusion/exclusion criteria not met|0
134195|NCT00559962|429373|P8|Overall Study|Withdrawal by Subject|2
134196|NCT00559962|429374|P7|Overall Study|Withdrawal by Subject|0
134197|NCT00559962|429375|P6|Overall Study|Withdrawal by Subject|1
134198|NCT00559962|429376|P5|Overall Study|Withdrawal by Subject|3
134199|NCT00559962|429377|P4|Overall Study|Withdrawal by Subject|0
134200|NCT00559962|429378|P3|Overall Study|Withdrawal by Subject|2
134201|NCT00559962|429379|P2|Overall Study|Withdrawal by Subject|1
134202|NCT00559962|429380|P1|Overall Study|Withdrawal by Subject|1
134203|NCT00559962|429373|P8|Overall Study|Lost to Follow-up|0
134204|NCT00559962|429374|P7|Overall Study|Lost to Follow-up|0
134205|NCT00559962|429375|P6|Overall Study|Lost to Follow-up|0
134206|NCT00559962|429376|P5|Overall Study|Lost to Follow-up|0
134207|NCT00559962|429377|P4|Overall Study|Lost to Follow-up|0
134208|NCT00559962|429378|P3|Overall Study|Lost to Follow-up|0
134209|NCT00559962|429379|P2|Overall Study|Lost to Follow-up|1
134210|NCT00559962|429380|P1|Overall Study|Lost to Follow-up|0
134211|NCT00559962|429373|P8|Overall Study|Adverse Event|2
134212|NCT00559962|429374|P7|Overall Study|Adverse Event|4
134213|NCT00559962|429375|P6|Overall Study|Adverse Event|4
134214|NCT00559962|429376|P5|Overall Study|Adverse Event|11
134215|NCT00559962|429377|P4|Overall Study|Adverse Event|5
134216|NCT00559962|429378|P3|Overall Study|Adverse Event|8
134217|NCT00559962|429379|P2|Overall Study|Adverse Event|7
134218|NCT00559962|429380|P1|Overall Study|Adverse Event|1
134219|NCT00559988|429402|P2|Overall Study|ICD device explanted|17
134220|NCT00559988|429403|P1|Overall Study|ICD device explanted|10
134221|NCT00559988|429402|P2|Overall Study|Lost to Follow-up|56
134222|NCT00559988|429403|P1|Overall Study|Lost to Follow-up|42
134223|NCT00559988|429402|P2|Overall Study|Withdrawal by Subject|139
134224|NCT00559988|429403|P1|Overall Study|Withdrawal by Subject|152
134225|NCT00559988|429402|P2|Overall Study|Death|140
134226|NCT00559988|429403|P1|Overall Study|Death|147
134227|NCT00560066|429411|P2|Overall Study|Missing primary reason|2
134228|NCT00560066|429412|P1|Overall Study|Missing primary reason|0
134229|NCT00560066|429411|P2|Overall Study|Administrative reason|5
134230|NCT00560066|429412|P1|Overall Study|Administrative reason|0
134231|NCT00560066|429411|P2|Overall Study|Protocol Violation|1
134232|NCT00560066|429412|P1|Overall Study|Protocol Violation|0
134233|NCT00560066|429411|P2|Overall Study|Lost to Follow-up|10
134234|NCT00560066|429412|P1|Overall Study|Lost to Follow-up|4
134235|NCT00560066|429411|P2|Overall Study|Withdrawal by Subject|3
134236|NCT00560066|429412|P1|Overall Study|Withdrawal by Subject|0
134237|NCT00560066|429411|P2|Overall Study|Death|1
134238|NCT00560066|429412|P1|Overall Study|Death|2
134239|NCT00560105|429444|P2|Overall Study|musculoskeletal chest discomfort with us|2
134240|NCT00560105|429445|P1|Overall Study|musculoskeletal chest discomfort with us|1
134241|NCT00560235|429460|P3|Phase 2|Ongoing at Date of Cut-Off|1
134242|NCT00560235|429461|P2|Phase 2|Ongoing at Date of Cut-Off|0
134243|NCT00560235|429462|P1|Phase 2|Ongoing at Date of Cut-Off|0
134244|NCT00560235|429460|P3|Phase 2|Discontinued|96
134245|NCT00560235|429461|P2|Phase 2|Discontinued|0
134246|NCT00560235|429462|P1|Phase 2|Discontinued|0
134247|NCT00560235|429460|P3|Phase 1B|Discontinued|0
134248|NCT00560235|429461|P2|Phase 1B|Discontinued|19
134249|NCT00560235|429462|P1|Phase 1B|Discontinued|0
134250|NCT00560235|429460|P3|Phase 1|Discontinued|0
134251|NCT00560235|429461|P2|Phase 1|Discontinued|0
134252|NCT00560235|429462|P1|Phase 1|Discontinued|8
134253|NCT00560313|429491|P1|Overall Study|Protocol Violation|1
134254|NCT00560313|429491|P1|Overall Study|Lost to Follow-up|1
134255|NCT00560313|429491|P1|Overall Study|Withdrawal by Subject|2
134256|NCT00560313|429491|P1|Overall Study|Adverse Events or Death|2
134257|NCT00560352|429518|P3|Overall Study|Maximum clinical benefit|0
134258|NCT00560352|429519|P2|Overall Study|Maximum clinical benefit|0
134259|NCT00560352|429520|P1|Overall Study|Maximum clinical benefit|1
134260|NCT00560352|429518|P3|Overall Study|Withdrawal by Subject|1
134261|NCT00560352|429519|P2|Overall Study|Withdrawal by Subject|1
134262|NCT00560352|429520|P1|Overall Study|Withdrawal by Subject|1
134263|NCT00560352|429518|P3|Overall Study|Disease progression|1
134264|NCT00560352|429519|P2|Overall Study|Disease progression|1
134265|NCT00560352|429520|P1|Overall Study|Disease progression|0
134266|NCT00560352|429518|P3|Overall Study|Study drug toxicity|1
134267|NCT00560352|429519|P2|Overall Study|Study drug toxicity|0
134268|NCT00560352|429520|P1|Overall Study|Study drug toxicity|3
134269|NCT00560352|429518|P3|Overall Study|Adverse event unrelated to study drug|1
134270|NCT00560352|429519|P2|Overall Study|Adverse event unrelated to study drug|1
134271|NCT00560352|429520|P1|Overall Study|Adverse event unrelated to study drug|2
134272|NCT00560391|429542|P5|Overall Study|Still on treatment|2
134273|NCT00560391|429543|P4|Overall Study|Still on treatment|1
134274|NCT00560391|429544|P3|Overall Study|Still on treatment|0
134275|NCT00560391|429545|P2|Overall Study|Still on treatment|0
134276|NCT00560391|429546|P1|Overall Study|Still on treatment|0
134277|NCT00560404|429601|P2|Overall Study|Other withdrawal reason|5
134278|NCT00560404|429602|P1|Overall Study|Other withdrawal reason|13
134279|NCT00560404|429601|P2|Overall Study|Failure to return|2
134280|NCT00560404|429602|P1|Overall Study|Failure to return|1
134281|NCT00560404|429601|P2|Overall Study|Withdrew Consent|0
134282|NCT00560404|429602|P1|Overall Study|Withdrew Consent|4
134283|NCT00560404|429601|P2|Overall Study|Administrative Reasons|1
134284|NCT00560404|429602|P1|Overall Study|Administrative Reasons|1
134285|NCT00560404|429601|P2|Overall Study|Protocol Violation|7
134286|NCT00560404|429602|P1|Overall Study|Protocol Violation|12
134287|NCT00560404|429601|P2|Overall Study|Death|3
134288|NCT00560404|429602|P1|Overall Study|Death|3
134289|NCT00560404|429601|P2|Overall Study|Adverse Event|3
134290|NCT00560404|429602|P1|Overall Study|Adverse Event|2
134291|NCT00560417|429646|P2|Overall Study|Withdrawal by Subject|3
134292|NCT00560417|429647|P1|Overall Study|Withdrawal by Subject|3
134293|NCT00560417|429646|P2|Overall Study|Sponsor Decision|0
134294|NCT00560417|429647|P1|Overall Study|Sponsor Decision|2
134295|NCT00560417|429646|P2|Overall Study|Protocol Violation|5
134296|NCT00560417|429647|P1|Overall Study|Protocol Violation|6
134297|NCT00560417|429646|P2|Overall Study|Physician Decision|6
134298|NCT00560417|429647|P1|Overall Study|Physician Decision|2
134299|NCT00560417|429646|P2|Overall Study|Lost to Follow-up|1
134300|NCT00560417|429647|P1|Overall Study|Lost to Follow-up|0
134301|NCT00560417|429646|P2|Overall Study|Entry Criteria Not Met|0
134302|NCT00560417|429647|P1|Overall Study|Entry Criteria Not Met|1
134303|NCT00560417|429646|P2|Overall Study|Adverse Event|2
134304|NCT00560417|429647|P1|Overall Study|Adverse Event|3
134305|NCT00560508|429675|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
134306|NCT00560508|429676|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
134307|NCT00560508|429675|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
134308|NCT00560508|429676|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
134309|NCT00560508|429675|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
134310|NCT00560508|429676|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
134311|NCT00560508|429675|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
134312|NCT00560508|429676|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
134313|NCT00560508|429675|P2|12 Week Double-blind Period|Withdrawal by Subject|1
134314|NCT00560508|429676|P1|12 Week Double-blind Period|Withdrawal by Subject|1
134315|NCT00560508|429675|P2|12 Week Double-blind Period|Protocol Violation|0
134316|NCT00560508|429676|P1|12 Week Double-blind Period|Protocol Violation|1
134317|NCT00560508|429675|P2|12 Week Double-blind Period|Adverse Event|2
134318|NCT00560508|429676|P1|12 Week Double-blind Period|Adverse Event|3
134319|NCT00560573|429756|P6|Overall Study|Enrolled, not treated|0
134320|NCT00560573|429757|P5|Overall Study|Enrolled, not treated|1
134321|NCT00560573|429758|P4|Overall Study|Enrolled, not treated|0
134322|NCT00560573|429759|P3|Overall Study|Enrolled, not treated|0
134323|NCT00560573|429760|P2|Overall Study|Enrolled, not treated|0
134324|NCT00560573|429761|P1|Overall Study|Enrolled, not treated|0
134325|NCT00560573|429756|P6|Overall Study|Unspecified|3
134326|NCT00560573|429757|P5|Overall Study|Unspecified|3
134327|NCT00560573|429758|P4|Overall Study|Unspecified|3
134328|NCT00560573|429759|P3|Overall Study|Unspecified|2
134329|NCT00560573|429760|P2|Overall Study|Unspecified|2
134330|NCT00560573|429761|P1|Overall Study|Unspecified|2
134331|NCT00560573|429756|P6|Overall Study|Withdrawal by Subject|0
134332|NCT00560573|429757|P5|Overall Study|Withdrawal by Subject|1
134333|NCT00560573|429758|P4|Overall Study|Withdrawal by Subject|1
134334|NCT00560573|429759|P3|Overall Study|Withdrawal by Subject|0
134335|NCT00560573|429760|P2|Overall Study|Withdrawal by Subject|0
134336|NCT00560573|429761|P1|Overall Study|Withdrawal by Subject|0
134337|NCT00560573|429756|P6|Overall Study|Lost to Follow-up|0
134338|NCT00560573|429757|P5|Overall Study|Lost to Follow-up|1
134339|NCT00560573|429758|P4|Overall Study|Lost to Follow-up|1
134340|NCT00560573|429759|P3|Overall Study|Lost to Follow-up|0
134341|NCT00560573|429760|P2|Overall Study|Lost to Follow-up|0
134342|NCT00560573|429761|P1|Overall Study|Lost to Follow-up|0
134343|NCT00560573|429756|P6|Overall Study|Death|10
134344|NCT00560573|429757|P5|Overall Study|Death|1
134345|NCT00560573|429758|P4|Overall Study|Death|5
134346|NCT00560573|429759|P3|Overall Study|Death|4
134347|NCT00560573|429760|P2|Overall Study|Death|1
134348|NCT00560573|429761|P1|Overall Study|Death|4
134349|NCT00560703|429824|P2|Overall Study|non-compliance|1
134350|NCT00560703|429825|P1|Overall Study|non-compliance|0
134351|NCT00560703|429824|P2|Overall Study|Withdrawal by Subject|1
134352|NCT00560703|429825|P1|Overall Study|Withdrawal by Subject|0
134353|NCT00560703|429824|P2|Overall Study|Protocol Violation|2
134354|NCT00560703|429825|P1|Overall Study|Protocol Violation|0
134355|NCT00560703|429824|P2|Overall Study|Adverse Event|2
134356|NCT00560703|429825|P1|Overall Study|Adverse Event|0
134357|NCT00560794|429833|P1|Overall Study|Received Bone Marrow Transplant|6
134358|NCT00560794|429833|P1|Overall Study|Hematological Relapse|1
134359|NCT00560794|429833|P1|Overall Study|Minimal Residual Disease Relapse|1
134360|NCT00560794|429833|P1|Overall Study|Patient was not Compliant|1
134361|NCT00560794|429833|P1|Overall Study|Adverse Event|2
134362|NCT00560833|429855|P5|Overall Study|Never received drug|1
134363|NCT00560833|429856|P4|Overall Study|Never received drug|0
134364|NCT00560833|429857|P3|Overall Study|Never received drug|0
134365|NCT00560833|429858|P2|Overall Study|Never received drug|1
134366|NCT00560833|429859|P1|Overall Study|Never received drug|0
134367|NCT00560833|429855|P5|Overall Study|Unspecified|0
134368|NCT00560833|429856|P4|Overall Study|Unspecified|0
134369|NCT00560833|429857|P3|Overall Study|Unspecified|3
134370|NCT00560833|429858|P2|Overall Study|Unspecified|1
134371|NCT00560833|429859|P1|Overall Study|Unspecified|1
134372|NCT00560833|429855|P5|Overall Study|Participant uncooperative|2
134373|NCT00560833|429856|P4|Overall Study|Participant uncooperative|4
134374|NCT00560833|429857|P3|Overall Study|Participant uncooperative|4
134375|NCT00560833|429858|P2|Overall Study|Participant uncooperative|5
134376|NCT00560833|429859|P1|Overall Study|Participant uncooperative|5
134377|NCT00560833|429855|P5|Overall Study|Lack of Efficacy|4
134378|NCT00560833|429856|P4|Overall Study|Lack of Efficacy|4
134379|NCT00560833|429857|P3|Overall Study|Lack of Efficacy|6
134380|NCT00560833|429858|P2|Overall Study|Lack of Efficacy|9
134381|NCT00560833|429859|P1|Overall Study|Lack of Efficacy|22
134382|NCT00560833|429855|P5|Overall Study|Lost to Follow-up|0
134383|NCT00560833|429856|P4|Overall Study|Lost to Follow-up|0
134384|NCT00560833|429857|P3|Overall Study|Lost to Follow-up|1
134385|NCT00560833|429858|P2|Overall Study|Lost to Follow-up|0
134386|NCT00560833|429859|P1|Overall Study|Lost to Follow-up|0
134387|NCT00560833|429855|P5|Overall Study|Adverse Event|35
134388|NCT00560833|429856|P4|Overall Study|Adverse Event|23
134389|NCT00560833|429857|P3|Overall Study|Adverse Event|25
134390|NCT00560833|429858|P2|Overall Study|Adverse Event|10
134391|NCT00560833|429859|P1|Overall Study|Adverse Event|16
134392|NCT00560885|429904|P1|Overall Study|Withdrawal by Subject|1
134393|NCT00560885|429904|P1|Overall Study|Death|7
134394|NCT00560937|429913|P2|Overall Study|Physician Decision|1
134395|NCT00560937|429914|P1|Overall Study|Physician Decision|1
134396|NCT00560937|429913|P2|Overall Study|Withdrawal by Subject|1
134397|NCT00560937|429914|P1|Overall Study|Withdrawal by Subject|0
134398|NCT00560950|429932|P2|Overall Study|Lost to Follow-up|0
134399|NCT00560950|429933|P1|Overall Study|Lost to Follow-up|1
134400|NCT00561015|429990|P6|Overall Study|Participant non-compliance|0
134401|NCT00561015|429991|P5|Overall Study|Participant non-compliance|0
134402|NCT00561015|429992|P4|Overall Study|Participant non-compliance|0
134403|NCT00561015|429993|P3|Overall Study|Participant non-compliance|0
134404|NCT00561015|429994|P2|Overall Study|Participant non-compliance|0
134405|NCT00561015|429995|P1|Overall Study|Participant non-compliance|2
134406|NCT00561015|429990|P6|Overall Study|Lost to Follow-up|3
134407|NCT00561015|429991|P5|Overall Study|Lost to Follow-up|0
134408|NCT00561015|429992|P4|Overall Study|Lost to Follow-up|1
134409|NCT00561015|429993|P3|Overall Study|Lost to Follow-up|0
134410|NCT00561015|429994|P2|Overall Study|Lost to Follow-up|0
134411|NCT00561015|429995|P1|Overall Study|Lost to Follow-up|2
134412|NCT00561015|429990|P6|Overall Study|Adverse Event|0
134413|NCT00561015|429991|P5|Overall Study|Adverse Event|1
134414|NCT00561015|429992|P4|Overall Study|Adverse Event|0
134415|NCT00561015|429993|P3|Overall Study|Adverse Event|0
134416|NCT00561015|429994|P2|Overall Study|Adverse Event|0
134417|NCT00561015|429995|P1|Overall Study|Adverse Event|0
134418|NCT00561340|430080|P2|Overall Study|refused to drink pediasure|0
134419|NCT00561340|430081|P1|Overall Study|refused to drink pediasure|6
134420|NCT00561353|430099|P10|Overall Study|Withdrawal by Subject|0
134421|NCT00561353|430100|P9|Overall Study|Withdrawal by Subject|0
134422|NCT00561353|430101|P8|Overall Study|Withdrawal by Subject|0
134423|NCT00561353|430102|P7|Overall Study|Withdrawal by Subject|0
134424|NCT00561353|430103|P6|Overall Study|Withdrawal by Subject|0
134425|NCT00561353|430104|P5|Overall Study|Withdrawal by Subject|0
134426|NCT00561353|430105|P4|Overall Study|Withdrawal by Subject|0
134427|NCT00561353|430106|P3|Overall Study|Withdrawal by Subject|0
134428|NCT00561353|430107|P2|Overall Study|Withdrawal by Subject|2
134429|NCT00561353|430108|P1|Overall Study|Withdrawal by Subject|0
134430|NCT00561353|430099|P10|Overall Study|Lost to Follow-up|0
134431|NCT00561353|430100|P9|Overall Study|Lost to Follow-up|0
134432|NCT00561353|430101|P8|Overall Study|Lost to Follow-up|0
134433|NCT00561353|430102|P7|Overall Study|Lost to Follow-up|0
134434|NCT00561353|430103|P6|Overall Study|Lost to Follow-up|0
134435|NCT00561353|430104|P5|Overall Study|Lost to Follow-up|0
134436|NCT00561353|430105|P4|Overall Study|Lost to Follow-up|0
134437|NCT00561353|430106|P3|Overall Study|Lost to Follow-up|1
134438|NCT00561353|430107|P2|Overall Study|Lost to Follow-up|0
134439|NCT00561353|430108|P1|Overall Study|Lost to Follow-up|2
134440|NCT00561353|430099|P10|Overall Study|Adverse Event|1
134441|NCT00561353|430100|P9|Overall Study|Adverse Event|0
134442|NCT00561353|430101|P8|Overall Study|Adverse Event|0
134443|NCT00561353|430102|P7|Overall Study|Adverse Event|1
134444|NCT00561353|430103|P6|Overall Study|Adverse Event|0
134445|NCT00561353|430104|P5|Overall Study|Adverse Event|0
134446|NCT00561353|430105|P4|Overall Study|Adverse Event|2
134447|NCT00561353|430106|P3|Overall Study|Adverse Event|0
134448|NCT00561353|430107|P2|Overall Study|Adverse Event|0
134449|NCT00561353|430108|P1|Overall Study|Adverse Event|0
134450|NCT00561353|430099|P10|Overall Study|Not specified|0
134451|NCT00561353|430100|P9|Overall Study|Not specified|0
134452|NCT00561353|430101|P8|Overall Study|Not specified|0
134453|NCT00561353|430102|P7|Overall Study|Not specified|0
134454|NCT00561353|430103|P6|Overall Study|Not specified|2
134455|NCT00561353|430104|P5|Overall Study|Not specified|0
134456|NCT00561353|430105|P4|Overall Study|Not specified|0
134457|NCT00561353|430106|P3|Overall Study|Not specified|1
134458|NCT00561353|430107|P2|Overall Study|Not specified|0
134459|NCT00561353|430108|P1|Overall Study|Not specified|1
134460|NCT00561353|430099|P10|Overall Study|Subject ineligible to continue the trial|1
134461|NCT00561353|430100|P9|Overall Study|Subject ineligible to continue the trial|2
134462|NCT00561353|430101|P8|Overall Study|Subject ineligible to continue the trial|0
134463|NCT00561353|430102|P7|Overall Study|Subject ineligible to continue the trial|1
134464|NCT00561353|430103|P6|Overall Study|Subject ineligible to continue the trial|1
134465|NCT00561353|430104|P5|Overall Study|Subject ineligible to continue the trial|0
134466|NCT00561353|430105|P4|Overall Study|Subject ineligible to continue the trial|0
134467|NCT00561353|430106|P3|Overall Study|Subject ineligible to continue the trial|0
134468|NCT00561353|430107|P2|Overall Study|Subject ineligible to continue the trial|0
134469|NCT00561353|430108|P1|Overall Study|Subject ineligible to continue the trial|0
134470|NCT00561353|430099|P10|Overall Study|Subject reached a virologic endpoint|0
134471|NCT00561353|430100|P9|Overall Study|Subject reached a virologic endpoint|5
134472|NCT00561353|430101|P8|Overall Study|Subject reached a virologic endpoint|4
134473|NCT00561353|430102|P7|Overall Study|Subject reached a virologic endpoint|4
134474|NCT00561353|430103|P6|Overall Study|Subject reached a virologic endpoint|3
134475|NCT00561353|430104|P5|Overall Study|Subject reached a virologic endpoint|1
134476|NCT00561353|430105|P4|Overall Study|Subject reached a virologic endpoint|4
134477|NCT00561353|430106|P3|Overall Study|Subject reached a virologic endpoint|1
134478|NCT00561353|430107|P2|Overall Study|Subject reached a virologic endpoint|1
134479|NCT00561353|430108|P1|Overall Study|Subject reached a virologic endpoint|2
134480|NCT00561392|430261|P1|Overall Study|Administrative problems|4
134481|NCT00561392|430261|P1|Overall Study|Withdrawal by Subject|8
134482|NCT00561392|430261|P1|Overall Study|Protocol Violation|1
134483|NCT00561392|430261|P1|Overall Study|Lack of Efficacy|2
134484|NCT00561392|430261|P1|Overall Study|Adverse Event|38
134485|NCT00561470|430297|P2|Overall Study|Ongoing Treatment|14
134486|NCT00561470|430298|P1|Overall Study|Ongoing Treatment|11
134487|NCT00561470|430297|P2|Overall Study|Planning surgery|1
134488|NCT00561470|430298|P1|Overall Study|Planning surgery|1
134489|NCT00561470|430297|P2|Overall Study|Missed visit window|4
134490|NCT00561470|430298|P1|Overall Study|Missed visit window|1
134491|NCT00561470|430297|P2|Overall Study|Randomized but not treated|5
134492|NCT00561470|430298|P1|Overall Study|Randomized but not treated|5
134493|NCT00561470|430297|P2|Overall Study|Unauthorized procedure|1
134494|NCT00561470|430298|P1|Overall Study|Unauthorized procedure|3
134495|NCT00561470|430297|P2|Overall Study|Metastatic surgery|12
134496|NCT00561470|430298|P1|Overall Study|Metastatic surgery|10
134497|NCT00561470|430297|P2|Overall Study|Subject request|77
134498|NCT00561470|430298|P1|Overall Study|Subject request|43
134499|NCT00561470|430297|P2|Overall Study|Consent Withdrawn|6
134500|NCT00561470|430298|P1|Overall Study|Consent Withdrawn|2
134501|NCT00561470|430297|P2|Overall Study|Physician Decision|20
134502|NCT00561470|430298|P1|Overall Study|Physician Decision|21
134503|NCT00561470|430297|P2|Overall Study|Lost to Follow-up|0
134504|NCT00561470|430298|P1|Overall Study|Lost to Follow-up|2
134505|NCT00561470|430297|P2|Overall Study|poor compliance to protocol|4
134506|NCT00561470|430298|P1|Overall Study|poor compliance to protocol|4
134507|NCT00561470|430297|P2|Overall Study|Disease progression|305
134508|NCT00561470|430298|P1|Overall Study|Disease progression|437
134509|NCT00561470|430297|P2|Overall Study|Adverse Event|163
134510|NCT00561470|430298|P1|Overall Study|Adverse Event|74
134511|NCT00561574|430314|P2|Overall Study|Unspecified|7
134512|NCT00561574|430315|P1|Overall Study|Unspecified|5
134513|NCT00561574|430314|P2|Overall Study|Lost to Follow-up|0
134514|NCT00561574|430315|P1|Overall Study|Lost to Follow-up|1
134515|NCT00561574|430314|P2|Overall Study|Reason Unrelated to Trial|2
134516|NCT00561574|430315|P1|Overall Study|Reason Unrelated to Trial|6
134517|NCT00561574|430314|P2|Overall Study|Withdrawal by Subject|4
134518|NCT00561574|430315|P1|Overall Study|Withdrawal by Subject|4
134519|NCT00561574|430314|P2|Overall Study|Lack of Efficacy|21
134520|NCT00561574|430315|P1|Overall Study|Lack of Efficacy|11
134521|NCT00561574|430314|P2|Overall Study|Adverse Event|24
134522|NCT00561574|430315|P1|Overall Study|Adverse Event|21
134523|NCT00561652|430404|P2|Overall Study|Withdrawal by Subject|1
134524|NCT00561652|430405|P1|Overall Study|Withdrawal by Subject|0
134525|NCT00561678|430425|P2|Overall Study|anesthesia provider refusal|0
134526|NCT00561678|430426|P1|Overall Study|anesthesia provider refusal|1
134527|NCT00561678|430425|P2|Overall Study|surgery rescheduled to different site|2
134528|NCT00561678|430426|P1|Overall Study|surgery rescheduled to different site|2
134529|NCT00561678|430425|P2|Overall Study|surgery cancelled|1
134530|NCT00561678|430426|P1|Overall Study|surgery cancelled|1
134531|NCT00561678|430425|P2|Overall Study|Withdrawal by Subject|3
134532|NCT00561678|430426|P1|Overall Study|Withdrawal by Subject|4
134533|NCT00561730|430442|P1|Overall Study|Not specified reasons|1
134534|NCT00561730|430442|P1|Overall Study|Lost to Follow-up|5
134535|NCT00561730|430442|P1|Overall Study|Handling of the drug|1
134536|NCT00561730|430442|P1|Overall Study|Adverse Event|2
134537|NCT00561795|430458|P4|Overall Study|Physician Decision|0
134538|NCT00561795|430459|P3|Overall Study|Physician Decision|0
134539|NCT00561795|430460|P2|Overall Study|Physician Decision|0
134540|NCT00561795|430461|P1|Overall Study|Physician Decision|1
134541|NCT00561795|430458|P4|Overall Study|Study Closed/Terminated|0
134542|NCT00561795|430459|P3|Overall Study|Study Closed/Terminated|0
134543|NCT00561795|430460|P2|Overall Study|Study Closed/Terminated|3
134544|NCT00561795|430461|P1|Overall Study|Study Closed/Terminated|0
134545|NCT00561795|430458|P4|Overall Study|Adverse Event|0
134546|NCT00561795|430459|P3|Overall Study|Adverse Event|0
134547|NCT00561795|430460|P2|Overall Study|Adverse Event|3
134548|NCT00561795|430461|P1|Overall Study|Adverse Event|3
134549|NCT00561821|430485|P4|Overall Study|Adverse Event|1
134550|NCT00561821|430486|P3|Overall Study|Adverse Event|1
134551|NCT00561821|430487|P2|Overall Study|Adverse Event|3
134552|NCT00561821|430488|P1|Overall Study|Adverse Event|2
134553|NCT00561821|430485|P4|Overall Study|Other (reason not specified)|0
134554|NCT00561821|430486|P3|Overall Study|Other (reason not specified)|0
134555|NCT00561821|430487|P2|Overall Study|Other (reason not specified)|1
134556|NCT00561821|430488|P1|Overall Study|Other (reason not specified)|1
134557|NCT00561821|430485|P4|Overall Study|Reasons not related to trial|0
134558|NCT00561821|430486|P3|Overall Study|Reasons not related to trial|0
134559|NCT00561821|430487|P2|Overall Study|Reasons not related to trial|1
134560|NCT00561821|430488|P1|Overall Study|Reasons not related to trial|2
134561|NCT00561821|430485|P4|Overall Study|Withdrawal by Subject|2
134562|NCT00561821|430486|P3|Overall Study|Withdrawal by Subject|0
134563|NCT00561821|430487|P2|Overall Study|Withdrawal by Subject|1
134564|NCT00561821|430488|P1|Overall Study|Withdrawal by Subject|0
134565|NCT00561821|430485|P4|Overall Study|Not treated|0
134566|NCT00561821|430486|P3|Overall Study|Not treated|1
134567|NCT00561821|430487|P2|Overall Study|Not treated|0
134568|NCT00561821|430488|P1|Overall Study|Not treated|0
134569|NCT00561912|430566|P1|Overall Study|ineligible|1
134570|NCT00561925|430573|P5|Open-Label Extension Period|Declined entry into extension period|50
134571|NCT00561925|430574|P4|Open-Label Extension Period|Declined entry into extension period|43
134572|NCT00561925|430575|P3|Open-Label Extension Period|Declined entry into extension period|0
134573|NCT00561925|430576|P2|Open-Label Extension Period|Declined entry into extension period|0
134574|NCT00561925|430577|P1|Open-Label Extension Period|Declined entry into extension period|0
134575|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Other|0
134576|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Other|0
134577|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Other|11
134578|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Other|8
134579|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Other|0
134580|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
134581|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
134582|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
134583|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
134584|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
134585|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Death|0
134586|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Death|0
134587|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Death|3
134588|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Death|6
134589|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Death|0
134590|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Pregnancy|0
134591|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Pregnancy|0
134592|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Pregnancy|9
134593|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Pregnancy|1
134594|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Pregnancy|0
134595|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
134596|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
134597|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
134598|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
134599|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
134600|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
134601|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
134602|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
134603|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
134604|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
134605|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
134606|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
134607|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
134608|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
134609|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
134610|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
134611|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
134612|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
134613|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
134614|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
134615|NCT00561925|430573|P5|144-week Double-blind, Double-dummy|Adverse Event|0
134616|NCT00561925|430574|P4|144-week Double-blind, Double-dummy|Adverse Event|0
134617|NCT00561925|430575|P3|144-week Double-blind, Double-dummy|Adverse Event|43
134618|NCT00561925|430576|P2|144-week Double-blind, Double-dummy|Adverse Event|48
134619|NCT00561925|430577|P1|144-week Double-blind, Double-dummy|Adverse Event|0
134620|NCT00561925|430573|P5|14 Day Lead-In Period|Other|0
134621|NCT00561925|430574|P4|14 Day Lead-In Period|Other|0
134622|NCT00561925|430575|P3|14 Day Lead-In Period|Other|0
134623|NCT00561925|430576|P2|14 Day Lead-In Period|Other|0
134624|NCT00561925|430577|P1|14 Day Lead-In Period|Other|5
134625|NCT00561925|430573|P5|14 Day Lead-In Period|Withdrawal by Subject|0
134626|NCT00561925|430574|P4|14 Day Lead-In Period|Withdrawal by Subject|0
134627|NCT00561925|430575|P3|14 Day Lead-In Period|Withdrawal by Subject|0
134628|NCT00561925|430576|P2|14 Day Lead-In Period|Withdrawal by Subject|0
134629|NCT00561925|430577|P1|14 Day Lead-In Period|Withdrawal by Subject|4
134630|NCT00561925|430573|P5|14 Day Lead-In Period|Lost to Follow-up|0
134631|NCT00561925|430574|P4|14 Day Lead-In Period|Lost to Follow-up|0
134632|NCT00561925|430575|P3|14 Day Lead-In Period|Lost to Follow-up|0
134633|NCT00561925|430576|P2|14 Day Lead-In Period|Lost to Follow-up|0
134634|NCT00561925|430577|P1|14 Day Lead-In Period|Lost to Follow-up|4
134635|NCT00561925|430573|P5|14 Day Lead-In Period|In/Exclusion criteria|0
134636|NCT00561925|430574|P4|14 Day Lead-In Period|In/Exclusion criteria|0
134637|NCT00561925|430575|P3|14 Day Lead-In Period|In/Exclusion criteria|0
134638|NCT00561925|430576|P2|14 Day Lead-In Period|In/Exclusion criteria|0
134639|NCT00561925|430577|P1|14 Day Lead-In Period|In/Exclusion criteria|4
134640|NCT00561925|430573|P5|14 Day Lead-In Period|Adverse Event|0
134641|NCT00561925|430574|P4|14 Day Lead-In Period|Adverse Event|0
134642|NCT00561925|430575|P3|14 Day Lead-In Period|Adverse Event|0
134643|NCT00561925|430576|P2|14 Day Lead-In Period|Adverse Event|0
134644|NCT00561925|430577|P1|14 Day Lead-In Period|Adverse Event|38
134645|NCT00561951|430629|P3|Overall Study|Adverse Event Occured Before Treatment|1
134646|NCT00561951|430630|P2|Overall Study|Adverse Event Occured Before Treatment|2
134647|NCT00561951|430631|P1|Overall Study|Adverse Event Occured Before Treatment|1
134648|NCT00561951|430629|P3|Overall Study|Meet Withdrawal Criterion|1
134649|NCT00561951|430630|P2|Overall Study|Meet Withdrawal Criterion|1
134650|NCT00561951|430631|P1|Overall Study|Meet Withdrawal Criterion|0
134651|NCT00561951|430629|P3|Overall Study|Pregnancy|0
134652|NCT00561951|430630|P2|Overall Study|Pregnancy|1
134653|NCT00561951|430631|P1|Overall Study|Pregnancy|0
134654|NCT00561951|430629|P3|Overall Study|Physician Decision|0
134655|NCT00561951|430630|P2|Overall Study|Physician Decision|0
134656|NCT00561951|430631|P1|Overall Study|Physician Decision|1
134657|NCT00561951|430629|P3|Overall Study|Protocol Violation|4
134658|NCT00561951|430630|P2|Overall Study|Protocol Violation|3
134659|NCT00561951|430631|P1|Overall Study|Protocol Violation|4
134660|NCT00561951|430629|P3|Overall Study|Withdrawal by Subject|10
134661|NCT00561951|430630|P2|Overall Study|Withdrawal by Subject|9
134662|NCT00561951|430631|P1|Overall Study|Withdrawal by Subject|10
134663|NCT00561951|430629|P3|Overall Study|Lost to Follow-up|0
134664|NCT00561951|430630|P2|Overall Study|Lost to Follow-up|1
134665|NCT00561951|430631|P1|Overall Study|Lost to Follow-up|1
134666|NCT00561951|430629|P3|Overall Study|Lack of Efficacy|2
134667|NCT00561951|430630|P2|Overall Study|Lack of Efficacy|3
134668|NCT00561951|430631|P1|Overall Study|Lack of Efficacy|5
134669|NCT00561951|430629|P3|Overall Study|Adverse Event|14
134670|NCT00561951|430630|P2|Overall Study|Adverse Event|14
134671|NCT00561951|430631|P1|Overall Study|Adverse Event|11
134672|NCT00552032|430686|P2|Overall Study|Lost to Follow-up|5
134673|NCT00552032|430687|P1|Overall Study|Lost to Follow-up|8
134674|NCT00552032|430686|P2|Overall Study|Protocol Violation|12
134675|NCT00552032|430687|P1|Overall Study|Protocol Violation|7
134676|NCT00552032|430686|P2|Overall Study|Withdrawal by Subject|2
134677|NCT00552032|430687|P1|Overall Study|Withdrawal by Subject|2
134678|NCT00552058|430733|P2|Overall Study|Other: Early Roll Over|0
134679|NCT00552058|430734|P1|Overall Study|Other: Early Roll Over|1
134680|NCT00552058|430733|P2|Overall Study|Other: Sponsors Decision|1
134681|NCT00552058|430734|P1|Overall Study|Other: Sponsors Decision|0
134682|NCT00552058|430733|P2|Overall Study|Other: Randomized in error|1
134683|NCT00552058|430734|P1|Overall Study|Other: Randomized in error|0
134684|NCT00552058|430733|P2|Overall Study|Other: Positive Stool Result|1
134685|NCT00552058|430734|P1|Overall Study|Other: Positive Stool Result|0
134686|NCT00552058|430733|P2|Overall Study|Other: Low CDAI score, entry violation|1
134687|NCT00552058|430734|P1|Overall Study|Other: Low CDAI score, entry violation|0
134688|NCT00552058|430733|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
134689|NCT00552058|430734|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
134690|NCT00552058|430733|P2|Overall Study|Other: Non Compliance|2
134691|NCT00552058|430734|P1|Overall Study|Other: Non Compliance|1
134692|NCT00552058|430733|P2|Overall Study|Other: Protocol Violation|1
134693|NCT00552058|430734|P1|Overall Study|Other: Protocol Violation|0
134694|NCT00552058|430733|P2|Overall Study|Withdrawal by Subject|4
134695|NCT00552058|430734|P1|Overall Study|Withdrawal by Subject|4
134696|NCT00552058|430733|P2|Overall Study|Lost to Follow-up|0
134697|NCT00552058|430734|P1|Overall Study|Lost to Follow-up|1
134698|NCT00552058|430733|P2|Overall Study|Lack of Efficacy|5
134699|NCT00552058|430734|P1|Overall Study|Lack of Efficacy|1
134700|NCT00552058|430733|P2|Overall Study|Adverse Event|7
134701|NCT00552058|430734|P1|Overall Study|Adverse Event|8
134702|NCT00552084|430774|P2|Overall Study|change in anti-arrythmic drug|1
134703|NCT00552084|430775|P1|Overall Study|change in anti-arrythmic drug|1
134704|NCT00552084|430774|P2|Overall Study|Protocol Violation|0
134705|NCT00552084|430775|P1|Overall Study|Protocol Violation|1
134706|NCT00552084|430774|P2|Overall Study|Withdrawal by Subject|5
134707|NCT00552084|430775|P1|Overall Study|Withdrawal by Subject|4
134708|NCT00552084|430774|P2|Overall Study|Adverse Event|3
134709|NCT00552084|430775|P1|Overall Study|Adverse Event|2
134710|NCT00552110|430786|P5|Overall Study|Nonserious Adverse Event (AE)|0
134711|NCT00552110|430787|P4|Overall Study|Nonserious Adverse Event (AE)|1
134712|NCT00552110|430788|P3|Overall Study|Nonserious Adverse Event (AE)|0
134713|NCT00552110|430789|P2|Overall Study|Nonserious Adverse Event (AE)|0
134714|NCT00552110|430790|P1|Overall Study|Nonserious Adverse Event (AE)|1
134715|NCT00552110|430786|P5|Overall Study|Increased Blood Pressure at Visit 2|0
134716|NCT00552110|430787|P4|Overall Study|Increased Blood Pressure at Visit 2|1
134717|NCT00552110|430788|P3|Overall Study|Increased Blood Pressure at Visit 2|0
134718|NCT00552110|430789|P2|Overall Study|Increased Blood Pressure at Visit 2|0
134719|NCT00552110|430790|P1|Overall Study|Increased Blood Pressure at Visit 2|0
134720|NCT00552110|430786|P5|Overall Study|Delay of Study due to Relabeling|0
134721|NCT00552110|430787|P4|Overall Study|Delay of Study due to Relabeling|1
134722|NCT00552110|430788|P3|Overall Study|Delay of Study due to Relabeling|0
134723|NCT00552110|430789|P2|Overall Study|Delay of Study due to Relabeling|0
134724|NCT00552110|430790|P1|Overall Study|Delay of Study due to Relabeling|0
134725|NCT00552110|430786|P5|Overall Study|Use of Prohibited Medication|0
134726|NCT00552110|430787|P4|Overall Study|Use of Prohibited Medication|0
134727|NCT00552110|430788|P3|Overall Study|Use of Prohibited Medication|0
134728|NCT00552110|430789|P2|Overall Study|Use of Prohibited Medication|1
134729|NCT00552110|430790|P1|Overall Study|Use of Prohibited Medication|1
134730|NCT00552110|430786|P5|Overall Study|Withdrawn per Sponsor|1
134731|NCT00552110|430787|P4|Overall Study|Withdrawn per Sponsor|0
134732|NCT00552110|430788|P3|Overall Study|Withdrawn per Sponsor|0
134733|NCT00552110|430789|P2|Overall Study|Withdrawn per Sponsor|1
134734|NCT00552110|430790|P1|Overall Study|Withdrawn per Sponsor|0
134735|NCT00552110|430786|P5|Overall Study|Failed to Comply With Study Requirements|1
134736|NCT00552110|430787|P4|Overall Study|Failed to Comply With Study Requirements|0
134737|NCT00552110|430788|P3|Overall Study|Failed to Comply With Study Requirements|1
134738|NCT00552110|430789|P2|Overall Study|Failed to Comply With Study Requirements|1
134739|NCT00552110|430790|P1|Overall Study|Failed to Comply With Study Requirements|1
134740|NCT00552110|430786|P5|Overall Study|Lost to Follow-up|1
134741|NCT00552110|430787|P4|Overall Study|Lost to Follow-up|1
134742|NCT00552110|430788|P3|Overall Study|Lost to Follow-up|0
134743|NCT00552110|430789|P2|Overall Study|Lost to Follow-up|0
134744|NCT00552110|430790|P1|Overall Study|Lost to Follow-up|0
134745|NCT00552110|430786|P5|Overall Study|Withdrawal by Subject|2
134746|NCT00552110|430787|P4|Overall Study|Withdrawal by Subject|3
134747|NCT00552110|430788|P3|Overall Study|Withdrawal by Subject|0
134748|NCT00552110|430789|P2|Overall Study|Withdrawal by Subject|2
134749|NCT00552110|430790|P1|Overall Study|Withdrawal by Subject|0
134750|NCT00552110|430786|P5|Overall Study|Lack of Efficacy|4
134751|NCT00552110|430787|P4|Overall Study|Lack of Efficacy|1
134752|NCT00552110|430788|P3|Overall Study|Lack of Efficacy|0
134753|NCT00552110|430789|P2|Overall Study|Lack of Efficacy|0
134754|NCT00552110|430790|P1|Overall Study|Lack of Efficacy|1
134755|NCT00552110|430786|P5|Overall Study|Serious or Life-Threatening AE|0
134756|NCT00552110|430787|P4|Overall Study|Serious or Life-Threatening AE|0
134757|NCT00552110|430788|P3|Overall Study|Serious or Life-Threatening AE|1
134758|NCT00552110|430789|P2|Overall Study|Serious or Life-Threatening AE|0
134759|NCT00552110|430790|P1|Overall Study|Serious or Life-Threatening AE|0
134760|NCT00552175|430810|P3|Overall Study|Reason Not Specified|1
134761|NCT00552175|430811|P2|Overall Study|Reason Not Specified|1
134762|NCT00552175|430812|P1|Overall Study|Reason Not Specified|3
134763|NCT00552175|430810|P3|Overall Study|Entry Criteria Not Met|0
134764|NCT00552175|430811|P2|Overall Study|Entry Criteria Not Met|1
134765|NCT00552175|430812|P1|Overall Study|Entry Criteria Not Met|1
134766|NCT00552175|430810|P3|Overall Study|Lost to Follow-up|1
134767|NCT00552175|430811|P2|Overall Study|Lost to Follow-up|0
134768|NCT00552175|430812|P1|Overall Study|Lost to Follow-up|0
134769|NCT00552175|430810|P3|Overall Study|Withdrawal by Subject|1
134770|NCT00552175|430811|P2|Overall Study|Withdrawal by Subject|2
134771|NCT00552175|430812|P1|Overall Study|Withdrawal by Subject|2
134772|NCT00552175|430810|P3|Overall Study|Adverse Event|10
134773|NCT00552175|430811|P2|Overall Study|Adverse Event|9
134774|NCT00552175|430812|P1|Overall Study|Adverse Event|9
134775|NCT00552175|430810|P3|Overall Study|Lack of Efficacy|1
134776|NCT00552175|430811|P2|Overall Study|Lack of Efficacy|0
134777|NCT00552175|430812|P1|Overall Study|Lack of Efficacy|2
134778|NCT00552188|430849|P2|Overall Study|Subject returned to home country|1
134779|NCT00552188|430850|P1|Overall Study|Subject returned to home country|0
134780|NCT00552188|430849|P2|Overall Study|Withdrawal of consent|1
134781|NCT00552188|430850|P1|Overall Study|Withdrawal of consent|0
134782|NCT00552188|430849|P2|Overall Study|Lost to Follow-up|1
134783|NCT00552188|430850|P1|Overall Study|Lost to Follow-up|2
134784|NCT00552188|430849|P2|Overall Study|Adverse Event|2
134785|NCT00552188|430850|P1|Overall Study|Adverse Event|0
134786|NCT00552240|430860|P2|Overall Study|not specified|0
134787|NCT00552240|430861|P1|Overall Study|not specified|1
134788|NCT00552240|430860|P2|Overall Study|Lack of Efficacy|0
134789|NCT00552240|430861|P1|Overall Study|Lack of Efficacy|6
134790|NCT00552240|430860|P2|Overall Study|Withdrawal by Subject|2
134791|NCT00552240|430861|P1|Overall Study|Withdrawal by Subject|2
134792|NCT00552240|430860|P2|Overall Study|Lost to Follow-up|6
134793|NCT00552240|430861|P1|Overall Study|Lost to Follow-up|5
134794|NCT00552240|430860|P2|Overall Study|Protocol Violation|1
134795|NCT00552240|430861|P1|Overall Study|Protocol Violation|1
134796|NCT00552240|430860|P2|Overall Study|Adverse Event|9
134797|NCT00552240|430861|P1|Overall Study|Adverse Event|9
134798|NCT00552279|430963|P2|Overall Study|Other|1
134799|NCT00552279|430964|P1|Overall Study|Other|1
134800|NCT00552279|430963|P2|Overall Study|Lost to Follow-up|0
134801|NCT00552279|430964|P1|Overall Study|Lost to Follow-up|1
134802|NCT00552279|430963|P2|Overall Study|Withdrawal by Subject|1
134803|NCT00552279|430964|P1|Overall Study|Withdrawal by Subject|12
134804|NCT00552279|430963|P2|Overall Study|Adverse Event|1
134805|NCT00552279|430964|P1|Overall Study|Adverse Event|0
134806|NCT00552305|430988|P1|Overall Study|Other: Subject went to rehab|1
134807|NCT00552305|430988|P1|Overall Study|Other: Subject incarcerated|1
134808|NCT00552305|430988|P1|Overall Study|Other: Subject moved from area|2
134809|NCT00552305|430988|P1|Overall Study|Other: Health problems, not drug related|1
134810|NCT00552305|430988|P1|Overall Study|Other: Subject became pregnant|1
134811|NCT00552305|430988|P1|Overall Study|Other: Subject underwent surgery|4
134812|NCT00552305|430988|P1|Overall Study|Other: Unable to attend visits|1
134813|NCT00552305|430988|P1|Overall Study|Other: Personal problems|1
134814|NCT00552305|430988|P1|Overall Study|Other: Site closed|4
134815|NCT00552305|430988|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
134816|NCT00552305|430988|P1|Overall Study|AE/Other: prohibited drug required|1
134817|NCT00552305|430988|P1|Overall Study|Poor compliance/lost to follow-up|1
134818|NCT00552305|430988|P1|Overall Study|Unsatisfactory compliance|11
134819|NCT00552305|430988|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
134820|NCT00552305|430988|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
134821|NCT00552305|430988|P1|Overall Study|Lack of efficacy/withdrew consent|1
134822|NCT00552305|430988|P1|Overall Study|Withdrawal by Subject|44
134823|NCT00552305|430988|P1|Overall Study|Protocol Violation|3
134824|NCT00552305|430988|P1|Overall Study|Lost to Follow-up|4
134825|NCT00552305|430988|P1|Overall Study|Lack of Efficacy|120
134826|NCT00552305|430988|P1|Overall Study|Adverse Event|43
134827|NCT00552344|430996|P1|Overall Study|Other Reason|22
134828|NCT00552344|430996|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
134829|NCT00552344|430996|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
134830|NCT00552344|430996|P1|Overall Study|AE, non-serious non-fatal|38
134831|NCT00552344|430996|P1|Overall Study|SAE, non-fatal|6
134832|NCT00552344|430996|P1|Overall Study|Withdrawal by Subject|48
134833|NCT00552344|430996|P1|Overall Study|Lost to Follow-up|8
134834|NCT00552344|430996|P1|Overall Study|Loss of efficacy|75
134835|NCT00552344|430996|P1|Overall Study|Lack of Efficacy|55
134836|NCT00552396|431012|P7|Overall Study|protocol withdrawal criteria|9
134837|NCT00552396|431013|P6|Overall Study|protocol withdrawal criteria|3
134838|NCT00552396|431014|P5|Overall Study|protocol withdrawal criteria|3
134839|NCT00552396|431015|P4|Overall Study|protocol withdrawal criteria|6
134840|NCT00552396|431016|P3|Overall Study|protocol withdrawal criteria|3
134841|NCT00552396|431017|P2|Overall Study|protocol withdrawal criteria|3
134842|NCT00552396|431018|P1|Overall Study|protocol withdrawal criteria|3
134843|NCT00552513|431085|P2|Overall Study|Lost to Follow-up|1
134844|NCT00552513|431086|P1|Overall Study|Lost to Follow-up|5
134845|NCT00552578|431098|P2|Overall Study|Lost to Follow-up|1
134846|NCT00552578|431099|P1|Overall Study|Lost to Follow-up|1
134847|NCT00552669|431111|P2|Overall Study|Death|7
134848|NCT00552669|431112|P1|Overall Study|Death|3
134849|NCT00552760|431135|P2|Overall Study|Medication Change|0
134850|NCT00552760|431136|P1|Overall Study|Medication Change|1
134851|NCT00552760|431135|P2|Overall Study|Withdrawal by Subject|0
134852|NCT00552760|431136|P1|Overall Study|Withdrawal by Subject|3
134853|NCT00552760|431135|P2|Overall Study|Medical Condition|1
134854|NCT00552760|431136|P1|Overall Study|Medical Condition|1
134855|NCT00552760|431135|P2|Overall Study|Non-compliance|1
134856|NCT00552760|431136|P1|Overall Study|Non-compliance|1
134857|NCT00552760|431135|P2|Overall Study|Lost to Follow-up|1
134858|NCT00552760|431136|P1|Overall Study|Lost to Follow-up|1
134859|NCT00552760|431135|P2|Overall Study|Protocol Violation|1
134860|NCT00552760|431136|P1|Overall Study|Protocol Violation|0
134861|NCT00552760|431135|P2|Overall Study|Relapsed- Mixed Event|5
134862|NCT00552760|431136|P1|Overall Study|Relapsed- Mixed Event|3
134863|NCT00552760|431135|P2|Overall Study|Relapse- Manic Event|3
134864|NCT00552760|431136|P1|Overall Study|Relapse- Manic Event|3
134865|NCT00552760|431135|P2|Overall Study|Relapsed- Depressed Event|16
134866|NCT00552760|431136|P1|Overall Study|Relapsed- Depressed Event|10
134867|NCT00552760|431135|P2|Overall Study|Adverse Event|5
134868|NCT00552760|431136|P1|Overall Study|Adverse Event|3
134869|NCT00553150|431183|P4|Overall Study|Ineligible|1
134870|NCT00553150|431184|P3|Overall Study|Ineligible|0
134871|NCT00553150|431185|P2|Overall Study|Ineligible|0
134872|NCT00553150|431186|P1|Overall Study|Ineligible|0
134873|NCT00553150|431183|P4|Overall Study|Protocol Violation|1
134874|NCT00553150|431184|P3|Overall Study|Protocol Violation|0
134875|NCT00553150|431185|P2|Overall Study|Protocol Violation|0
134876|NCT00553150|431186|P1|Overall Study|Protocol Violation|0
134877|NCT00553150|431183|P4|Overall Study|Withdrawal by Subject|2
134878|NCT00553150|431184|P3|Overall Study|Withdrawal by Subject|0
134879|NCT00553150|431185|P2|Overall Study|Withdrawal by Subject|0
134880|NCT00553150|431186|P1|Overall Study|Withdrawal by Subject|0
134881|NCT00553202|431198|P1|Overall Study|Fails to meet organ function|6
134882|NCT00553202|431198|P1|Overall Study|No donor identified|16
134883|NCT00553202|431198|P1|Overall Study|Withdrawal by Subject|1
134884|NCT00553202|431198|P1|Overall Study|Physician Decision|28
134885|NCT00553202|431198|P1|Overall Study|Lost to Follow-up|1
134886|NCT00553202|431198|P1|Overall Study|Death|16
134887|NCT00553267|431209|P3|Overall Study|Specified category|1
134888|NCT00553267|431210|P2|Overall Study|Specified category|2
134889|NCT00553267|431211|P1|Overall Study|Specified category|1
134890|NCT00553267|431209|P3|Overall Study|Consent withdrawn|1
134891|NCT00553267|431210|P2|Overall Study|Consent withdrawn|3
134892|NCT00553267|431211|P1|Overall Study|Consent withdrawn|2
134893|NCT00553267|431209|P3|Overall Study|Lost to Follow-up|1
134894|NCT00553267|431210|P2|Overall Study|Lost to Follow-up|0
134895|NCT00553267|431211|P1|Overall Study|Lost to Follow-up|0
134896|NCT00553267|431209|P3|Overall Study|Non compliant with protocol|2
134897|NCT00553267|431210|P2|Overall Study|Non compliant with protocol|3
134898|NCT00553267|431211|P1|Overall Study|Non compliant with protocol|3
134899|NCT00553267|431209|P3|Overall Study|Adverse Event|5
134900|NCT00553267|431210|P2|Overall Study|Adverse Event|10
134901|NCT00553267|431211|P1|Overall Study|Adverse Event|8
134902|NCT00553280|431246|P1|Overall Study|Physician Decision|1
134903|NCT00553280|431246|P1|Overall Study|Withdrawal by Subject|3
134904|NCT00553280|431246|P1|Overall Study|Lack of Efficacy|3
134905|NCT00553280|431246|P1|Overall Study|Adverse Event|19
134906|NCT00553319|431258|P3|Overall Study|moved|1
134907|NCT00553319|431259|P2|Overall Study|moved|0
134908|NCT00553319|431260|P1|Overall Study|moved|1
134909|NCT00553319|431258|P3|Overall Study|incarceration|0
134910|NCT00553319|431259|P2|Overall Study|incarceration|0
134911|NCT00553319|431260|P1|Overall Study|incarceration|1
134912|NCT00553319|431258|P3|Overall Study|non-compliance|2
134913|NCT00553319|431259|P2|Overall Study|non-compliance|0
134914|NCT00553319|431260|P1|Overall Study|non-compliance|0
134915|NCT00553319|431258|P3|Overall Study|wanted treatment elsewhere|1
134916|NCT00553319|431259|P2|Overall Study|wanted treatment elsewhere|1
134917|NCT00553319|431260|P1|Overall Study|wanted treatment elsewhere|2
134918|NCT00553319|431258|P3|Overall Study|Lost to Follow-up|5
134919|NCT00553319|431259|P2|Overall Study|Lost to Follow-up|9
134920|NCT00553319|431260|P1|Overall Study|Lost to Follow-up|10
134921|NCT00553332|431271|P1|Overall Study|ineligible, incorrect diagnosis|1
134922|NCT00553358|431283|P3|Overall Study|Other: Reason Not Specified|20
134923|NCT00553358|431284|P2|Overall Study|Other: Reason Not Specified|4
134924|NCT00553358|431285|P1|Overall Study|Other: Reason Not Specified|15
134925|NCT00553358|431283|P3|Overall Study|Missing|1
134926|NCT00553358|431284|P2|Overall Study|Missing|1
134927|NCT00553358|431285|P1|Overall Study|Missing|1
134928|NCT00553358|431283|P3|Overall Study|Participant Withdrawal from Drug|3
134929|NCT00553358|431284|P2|Overall Study|Participant Withdrawal from Drug|0
134930|NCT00553358|431285|P1|Overall Study|Participant Withdrawal from Drug|0
134931|NCT00553358|431283|P3|Overall Study|Recurrence of Disease|1
134932|NCT00553358|431284|P2|Overall Study|Recurrence of Disease|4
134933|NCT00553358|431285|P1|Overall Study|Recurrence of Disease|3
134934|NCT00553358|431283|P3|Overall Study|Withdrawal by Subject|1
134935|NCT00553358|431284|P2|Overall Study|Withdrawal by Subject|0
134936|NCT00553358|431285|P1|Overall Study|Withdrawal by Subject|5
134937|NCT00553358|431283|P3|Overall Study|Protocol Violation|1
134938|NCT00553358|431284|P2|Overall Study|Protocol Violation|1
134939|NCT00553358|431285|P1|Overall Study|Protocol Violation|0
134940|NCT00553358|431283|P3|Overall Study|Lost to Follow-up|1
134941|NCT00553358|431284|P2|Overall Study|Lost to Follow-up|0
134942|NCT00553358|431285|P1|Overall Study|Lost to Follow-up|0
134943|NCT00553358|431283|P3|Overall Study|Adverse Event|32
134944|NCT00553358|431284|P2|Overall Study|Adverse Event|2
134945|NCT00553358|431285|P1|Overall Study|Adverse Event|29
134946|NCT00553436|431311|P1|Overall Study|Conversion to another procedure|1
134947|NCT00553462|431317|P1|Overall Study|Physician Decision|1
134948|NCT00553462|431317|P1|Overall Study|Withdrawal by Subject|5
134949|NCT00553462|431317|P1|Overall Study|Progression|4
134950|NCT00553462|431317|P1|Overall Study|Adverse Event|4
134951|NCT00553475|431326|P3|Overall Study|Due to moving|0
134952|NCT00553475|431327|P2|Overall Study|Due to moving|1
134953|NCT00553475|431328|P1|Overall Study|Due to moving|0
134954|NCT00553475|431326|P3|Overall Study|Physician Decision|0
134955|NCT00553475|431327|P2|Overall Study|Physician Decision|0
134956|NCT00553475|431328|P1|Overall Study|Physician Decision|1
134957|NCT00553475|431326|P3|Overall Study|Withdrawal by Subject|0
134958|NCT00553475|431327|P2|Overall Study|Withdrawal by Subject|1
134959|NCT00553475|431328|P1|Overall Study|Withdrawal by Subject|1
134960|NCT00553475|431326|P3|Overall Study|Lack of Efficacy|0
134961|NCT00553475|431327|P2|Overall Study|Lack of Efficacy|1
134962|NCT00553475|431328|P1|Overall Study|Lack of Efficacy|7
134963|NCT00553475|431326|P3|Overall Study|Adverse Event|13
134964|NCT00553475|431327|P2|Overall Study|Adverse Event|17
134965|NCT00553475|431328|P1|Overall Study|Adverse Event|7
134966|NCT00553501|431450|P1|Overall Study|Progression|1
134967|NCT00553501|431450|P1|Overall Study|Death|1
134968|NCT00553501|431450|P1|Overall Study|Adverse Event|2
134969|NCT00553514|431461|P5|Overall Study|Unspecified|1
134970|NCT00553514|431462|P4|Overall Study|Unspecified|0
134971|NCT00553514|431463|P3|Overall Study|Unspecified|0
134972|NCT00553514|431464|P2|Overall Study|Unspecified|1
134973|NCT00553514|431465|P1|Overall Study|Unspecified|1
134974|NCT00553514|431461|P5|Overall Study|Risk of multiple pregnancy|0
134975|NCT00553514|431462|P4|Overall Study|Risk of multiple pregnancy|1
134976|NCT00553514|431463|P3|Overall Study|Risk of multiple pregnancy|0
134977|NCT00553514|431464|P2|Overall Study|Risk of multiple pregnancy|2
134978|NCT00553514|431465|P1|Overall Study|Risk of multiple pregnancy|0
134979|NCT00553514|431461|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
134980|NCT00553514|431462|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
134981|NCT00553514|431463|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
134982|NCT00553514|431464|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
134983|NCT00553514|431465|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
134984|NCT00553514|431461|P5|Overall Study|Lack of ovarian response|6
134985|NCT00553514|431462|P4|Overall Study|Lack of ovarian response|5
134986|NCT00553514|431463|P3|Overall Study|Lack of ovarian response|5
134987|NCT00553514|431464|P2|Overall Study|Lack of ovarian response|5
134988|NCT00553514|431465|P1|Overall Study|Lack of ovarian response|4
134989|NCT00553514|431461|P5|Overall Study|Protocol deviation|0
134990|NCT00553514|431462|P4|Overall Study|Protocol deviation|1
134991|NCT00553514|431463|P3|Overall Study|Protocol deviation|0
134992|NCT00553514|431464|P2|Overall Study|Protocol deviation|0
134993|NCT00553514|431465|P1|Overall Study|Protocol deviation|0
134994|NCT00553605|431504|P2|Overall Study|Randomized but not treated|0
134995|NCT00553605|431505|P1|Overall Study|Randomized but not treated|2
134996|NCT00553605|431504|P2|Overall Study|Did not receive full dose|0
134997|NCT00553605|431505|P1|Overall Study|Did not receive full dose|1
134998|NCT00553605|431504|P2|Overall Study|Did not meet entrance criteria|3
134999|NCT00553605|431505|P1|Overall Study|Did not meet entrance criteria|1
135000|NCT00561977|431532|P3|Overall Study|Pregnancy|1
135001|NCT00561977|431533|P2|Overall Study|Pregnancy|1
135002|NCT00561977|431534|P1|Overall Study|Pregnancy|0
135003|NCT00561977|431532|P3|Overall Study|Withdrawal by Subject|1
135004|NCT00561977|431533|P2|Overall Study|Withdrawal by Subject|2
135005|NCT00561977|431534|P1|Overall Study|Withdrawal by Subject|0
135006|NCT00562094|431557|P1|Overall Study|Lost to Follow-up|62
135007|NCT00562120|431569|P4|First Intervention Period|Randomized but not Treated|0
135008|NCT00562120|431570|P3|First Intervention Period|Randomized but not Treated|0
135009|NCT00562120|431571|P2|First Intervention Period|Randomized but not Treated|0
135010|NCT00562120|431572|P1|First Intervention Period|Randomized but not Treated|1
135011|NCT00562120|431569|P4|First Intervention Period|Adverse Event|0
135012|NCT00562120|431570|P3|First Intervention Period|Adverse Event|0
135013|NCT00562120|431571|P2|First Intervention Period|Adverse Event|0
135014|NCT00562120|431572|P1|First Intervention Period|Adverse Event|1
135015|NCT00562159|431606|P2|Overall Study|Did not meet protocol eligibility|1
135016|NCT00562159|431607|P1|Overall Study|Did not meet protocol eligibility|1
135017|NCT00562159|431606|P2|Overall Study|Protocol Violation|12
135018|NCT00562159|431607|P1|Overall Study|Protocol Violation|12
135019|NCT00562159|431606|P2|Overall Study|Withdrawal by Subject|8
135020|NCT00562159|431607|P1|Overall Study|Withdrawal by Subject|9
135021|NCT00562159|431606|P2|Overall Study|Lost to Follow-up|4
135022|NCT00562159|431607|P1|Overall Study|Lost to Follow-up|5
135023|NCT00562159|431606|P2|Overall Study|Adverse Event|8
135024|NCT00562159|431607|P1|Overall Study|Adverse Event|11
135025|NCT00562302|431621|P2|Overall Study|Not stated|4
135026|NCT00562302|431622|P1|Overall Study|Not stated|1
135027|NCT00562302|431621|P2|Overall Study|Lung resection prior to study completion|7
135028|NCT00562302|431622|P1|Overall Study|Lung resection prior to study completion|7
135029|NCT00562302|431621|P2|Overall Study|Death|2
135030|NCT00562302|431622|P1|Overall Study|Death|1
135031|NCT00562302|431621|P2|Overall Study|Withdrawal by Subject|8
135032|NCT00562302|431622|P1|Overall Study|Withdrawal by Subject|7
135033|NCT00562302|431621|P2|Overall Study|Non-compliance|2
135034|NCT00562302|431622|P1|Overall Study|Non-compliance|1
135035|NCT00562302|431621|P2|Overall Study|Adverse Event|6
135036|NCT00562302|431622|P1|Overall Study|Adverse Event|0
135037|NCT00562302|431621|P2|Overall Study|Lost to Follow-up|3
135038|NCT00562302|431622|P1|Overall Study|Lost to Follow-up|3
135039|NCT00562861|431644|P2|Overall Study|Lost to Follow-up|3
135040|NCT00562861|431645|P1|Overall Study|Lost to Follow-up|7
135041|NCT00562861|431644|P2|Overall Study|noncompliance, moved|2
135042|NCT00562861|431645|P1|Overall Study|noncompliance, moved|7
135043|NCT00562861|431644|P2|Overall Study|Lack of Efficacy|5
135044|NCT00562861|431645|P1|Overall Study|Lack of Efficacy|5
135045|NCT00562861|431644|P2|Overall Study|Adverse Event|1
135046|NCT00562861|431645|P1|Overall Study|Adverse Event|1
135047|NCT00563316|431663|P1|Overall Study|Other|1
135048|NCT00563316|431663|P1|Overall Study|On-going in study as of 16 July 2009.|5
135049|NCT00563316|431663|P1|Overall Study|Death|1
135050|NCT00563316|431663|P1|Overall Study|Lost to Follow-up|2
135051|NCT00563316|431663|P1|Overall Study|Physician Decision|1
135052|NCT00563316|431663|P1|Overall Study|Adverse Event|2
135053|NCT00563368|431681|P7|Overall Study|not specified|0
135054|NCT00563368|431682|P6|Overall Study|not specified|4
135055|NCT00563368|431683|P5|Overall Study|not specified|4
135056|NCT00563368|431684|P4|Overall Study|not specified|4
135057|NCT00563368|431685|P3|Overall Study|not specified|3
135058|NCT00563368|431686|P2|Overall Study|not specified|5
135059|NCT00563368|431687|P1|Overall Study|not specified|5
135060|NCT00563368|431681|P7|Overall Study|requirement for restricted medication|0
135061|NCT00563368|431682|P6|Overall Study|requirement for restricted medication|0
135062|NCT00563368|431683|P5|Overall Study|requirement for restricted medication|0
135063|NCT00563368|431684|P4|Overall Study|requirement for restricted medication|0
135064|NCT00563368|431685|P3|Overall Study|requirement for restricted medication|2
135065|NCT00563368|431686|P2|Overall Study|requirement for restricted medication|0
135066|NCT00563368|431687|P1|Overall Study|requirement for restricted medication|0
135067|NCT00563368|431681|P7|Overall Study|Pregnancy|0
135068|NCT00563368|431682|P6|Overall Study|Pregnancy|2
135069|NCT00563368|431683|P5|Overall Study|Pregnancy|1
135070|NCT00563368|431684|P4|Overall Study|Pregnancy|2
135071|NCT00563368|431685|P3|Overall Study|Pregnancy|1
135072|NCT00563368|431686|P2|Overall Study|Pregnancy|0
135073|NCT00563368|431687|P1|Overall Study|Pregnancy|1
135074|NCT00563368|431681|P7|Overall Study|protocol non-compliance|3
135075|NCT00563368|431682|P6|Overall Study|protocol non-compliance|1
135076|NCT00563368|431683|P5|Overall Study|protocol non-compliance|0
135077|NCT00563368|431684|P4|Overall Study|protocol non-compliance|1
135078|NCT00563368|431685|P3|Overall Study|protocol non-compliance|2
135079|NCT00563368|431686|P2|Overall Study|protocol non-compliance|1
135080|NCT00563368|431687|P1|Overall Study|protocol non-compliance|1
135081|NCT00563368|431681|P7|Overall Study|Withdrawal by Subject|4
135082|NCT00563368|431682|P6|Overall Study|Withdrawal by Subject|5
135083|NCT00563368|431683|P5|Overall Study|Withdrawal by Subject|8
135084|NCT00563368|431684|P4|Overall Study|Withdrawal by Subject|7
135085|NCT00563368|431685|P3|Overall Study|Withdrawal by Subject|5
135086|NCT00563368|431686|P2|Overall Study|Withdrawal by Subject|6
135087|NCT00563368|431687|P1|Overall Study|Withdrawal by Subject|11
135088|NCT00563368|431681|P7|Overall Study|Adverse Event|17
135089|NCT00563368|431682|P6|Overall Study|Adverse Event|10
135090|NCT00563368|431683|P5|Overall Study|Adverse Event|6
135091|NCT00563368|431684|P4|Overall Study|Adverse Event|9
135092|NCT00563368|431685|P3|Overall Study|Adverse Event|5
135093|NCT00563368|431686|P2|Overall Study|Adverse Event|4
135094|NCT00563368|431687|P1|Overall Study|Adverse Event|3
135095|NCT00563368|431681|P7|Overall Study|Lost to Follow-up|9
135096|NCT00563368|431682|P6|Overall Study|Lost to Follow-up|8
135097|NCT00563368|431683|P5|Overall Study|Lost to Follow-up|9
135098|NCT00563368|431684|P4|Overall Study|Lost to Follow-up|6
135099|NCT00563368|431685|P3|Overall Study|Lost to Follow-up|12
135100|NCT00563368|431686|P2|Overall Study|Lost to Follow-up|14
135101|NCT00563368|431687|P1|Overall Study|Lost to Follow-up|14
135102|NCT00563381|431712|P2|Overall Study|Individual different reasons|34
135103|NCT00563381|431713|P1|Overall Study|Individual different reasons|24
135104|NCT00563381|431712|P2|Overall Study|Lack of Efficacy|24
135105|NCT00563381|431713|P1|Overall Study|Lack of Efficacy|32
135106|NCT00563381|431712|P2|Overall Study|Withdrawal by Subject|209
135107|NCT00563381|431713|P1|Overall Study|Withdrawal by Subject|192
135108|NCT00563381|431712|P2|Overall Study|Lost to Follow-up|15
135109|NCT00563381|431713|P1|Overall Study|Lost to Follow-up|7
135110|NCT00563381|431712|P2|Overall Study|Protocol Violation|74
135111|NCT00563381|431713|P1|Overall Study|Protocol Violation|66
135112|NCT00563381|431712|P2|Overall Study|Adverse Event|292
135113|NCT00563381|431713|P1|Overall Study|Adverse Event|264
135114|NCT00563706|431801|P9|DB Treatment Period (Day 1 up to Day 28)|Unspecified|2
135115|NCT00563706|431802|P8|DB Treatment Period (Day 1 up to Day 28)|Unspecified|1
135116|NCT00563706|431803|P7|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135117|NCT00563706|431804|P6|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135118|NCT00563706|431805|P5|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135119|NCT00563706|431806|P4|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135120|NCT00563706|431807|P3|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135121|NCT00563706|431808|P2|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135122|NCT00563706|431809|P1|DB Treatment Period (Day 1 up to Day 28)|Unspecified|0
135123|NCT00563706|431801|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135201|NCT00565136|432198|P1|Overall Study|Protocol Violation|1
135124|NCT00563706|431802|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
135125|NCT00563706|431803|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135126|NCT00563706|431804|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135127|NCT00563706|431805|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135128|NCT00563706|431806|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135129|NCT00563706|431807|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135130|NCT00563706|431808|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
135131|NCT00563706|431809|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
135132|NCT00563706|431801|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
135133|NCT00563706|431802|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
135134|NCT00563706|431803|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
135135|NCT00563706|431804|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
135136|NCT00563706|431805|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
135137|NCT00563706|431806|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
135138|NCT00563706|431807|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
135139|NCT00563706|431808|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
135140|NCT00563706|431809|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
135141|NCT00563706|431801|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
135142|NCT00563706|431802|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
135143|NCT00563706|431803|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
135144|NCT00563706|431804|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
135145|NCT00563706|431805|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
135146|NCT00563706|431806|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
135147|NCT00563706|431807|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
135148|NCT00563706|431808|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
135149|NCT00563706|431809|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
135150|NCT00563706|431801|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
135151|NCT00563706|431802|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
135152|NCT00563706|431803|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
135153|NCT00563706|431804|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
135154|NCT00563706|431805|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
135155|NCT00563706|431806|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
135156|NCT00563706|431807|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
135157|NCT00563706|431808|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
135158|NCT00563706|431809|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
135159|NCT00563797|431912|P2|Overall Study|Lost to Follow-up|2
135160|NCT00563797|431913|P1|Overall Study|Lost to Follow-up|7
135161|NCT00564278|431931|P2|Overall Study|Withdrawal by Subject|7
135162|NCT00564278|431932|P1|Overall Study|Withdrawal by Subject|11
135163|NCT00564278|431931|P2|Overall Study|Physician Decision|2
135164|NCT00564278|431932|P1|Overall Study|Physician Decision|1
135165|NCT00564278|431931|P2|Overall Study|Lost to Follow-up|33
135166|NCT00564278|431932|P1|Overall Study|Lost to Follow-up|35
135167|NCT00564486|431984|P4|Overall Study|Lost to Follow-up|2
135168|NCT00564486|431985|P3|Overall Study|Lost to Follow-up|2
135169|NCT00564486|431986|P2|Overall Study|Lost to Follow-up|0
135170|NCT00564486|431987|P1|Overall Study|Lost to Follow-up|3
135171|NCT00564486|431984|P4|Overall Study|Subject refused to have blood drawn|0
135172|NCT00564486|431985|P3|Overall Study|Subject refused to have blood drawn|1
135173|NCT00564486|431986|P2|Overall Study|Subject refused to have blood drawn|0
135174|NCT00564486|431987|P1|Overall Study|Subject refused to have blood drawn|0
135175|NCT00564486|431984|P4|Overall Study|Withdrawal by Subject|5
135176|NCT00564486|431985|P3|Overall Study|Withdrawal by Subject|0
135177|NCT00564486|431986|P2|Overall Study|Withdrawal by Subject|0
135178|NCT00564486|431987|P1|Overall Study|Withdrawal by Subject|4
135179|NCT00564486|431984|P4|Overall Study|Adverse Event|0
135180|NCT00564486|431985|P3|Overall Study|Adverse Event|0
135181|NCT00564486|431986|P2|Overall Study|Adverse Event|1
135182|NCT00564486|431987|P1|Overall Study|Adverse Event|0
135183|NCT00564629|432005|P2|Overall Study|Vomited within 2 hours of receiving drug|9
135184|NCT00564629|432006|P1|Overall Study|Vomited within 2 hours of receiving drug|15
135185|NCT00564733|432056|P1|Overall Study|Ineligible|5
135186|NCT00564733|432056|P1|Overall Study|Withdrawal by Subject|4
135187|NCT00564850|432060|P1|Overall Study|Protocol Violation|2
135188|NCT00564889|432085|P1|Overall Study|Other, not specified|4
135189|NCT00564889|432085|P1|Overall Study|Disease progression|3
135190|NCT00564889|432085|P1|Overall Study|Alternative treatment|3
135191|NCT00564889|432085|P1|Overall Study|Adverse Event|12
135192|NCT00564889|432085|P1|Overall Study|Death|7
135193|NCT00564902|432096|P3|Overall Study|Death|0
135194|NCT00564902|432097|P2|Overall Study|Death|1
135195|NCT00564902|432098|P1|Overall Study|Death|1
135196|NCT00564902|432096|P3|Overall Study|Withdrawal by Subject|4
135197|NCT00564902|432097|P2|Overall Study|Withdrawal by Subject|3
135198|NCT00564902|432098|P1|Overall Study|Withdrawal by Subject|0
135199|NCT00565058|432168|P2|Overall Study|Adverse Event|0
135200|NCT00565058|432169|P1|Overall Study|Adverse Event|1
135202|NCT00565136|432198|P1|Overall Study|Withdrawal by Subject|1
135203|NCT00565136|432198|P1|Overall Study|Lost to Follow-up|1
135204|NCT00556894|432227|P3|Overall Study|Withdrawal by Subject|1
135205|NCT00556894|432228|P2|Overall Study|Withdrawal by Subject|1
135206|NCT00556894|432229|P1|Overall Study|Withdrawal by Subject|1
135207|NCT00556894|432227|P3|Overall Study|Change in therapy|2
135208|NCT00556894|432228|P2|Overall Study|Change in therapy|1
135209|NCT00556894|432229|P1|Overall Study|Change in therapy|2
135210|NCT00556894|432227|P3|Overall Study|regulatory decision in Bulgaria|13
135211|NCT00556894|432228|P2|Overall Study|regulatory decision in Bulgaria|14
135212|NCT00556894|432229|P1|Overall Study|regulatory decision in Bulgaria|10
135213|NCT00556894|432227|P3|Overall Study|Death|0
135214|NCT00556894|432228|P2|Overall Study|Death|0
135215|NCT00556894|432229|P1|Overall Study|Death|1
135216|NCT00556894|432227|P3|Overall Study|Adverse Event|3
135217|NCT00556894|432228|P2|Overall Study|Adverse Event|3
135218|NCT00556894|432229|P1|Overall Study|Adverse Event|2
135219|NCT00556933|432241|P4|CNI Withdrawal vs. Minimization|Death|1
135220|NCT00556933|432242|P3|CNI Withdrawal vs. Minimization|Death|0
135221|NCT00556933|432243|P2|CNI Withdrawal vs. Minimization|Death|0
135222|NCT00556933|432244|P1|CNI Withdrawal vs. Minimization|Death|0
135223|NCT00556933|432241|P4|CNI Withdrawal vs. Minimization|Graft loss|0
135224|NCT00556933|432242|P3|CNI Withdrawal vs. Minimization|Graft loss|2
135225|NCT00556933|432243|P2|CNI Withdrawal vs. Minimization|Graft loss|1
135226|NCT00556933|432244|P1|CNI Withdrawal vs. Minimization|Graft loss|0
135227|NCT00556933|432241|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
135228|NCT00556933|432242|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
135229|NCT00556933|432243|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
135230|NCT00556933|432244|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
135231|NCT00556933|432241|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
135232|NCT00556933|432242|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
135233|NCT00556933|432243|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
135234|NCT00556933|432244|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
135235|NCT00556933|432241|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
135236|NCT00556933|432242|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
135237|NCT00556933|432243|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
135238|NCT00556933|432244|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
135239|NCT00556933|432241|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
135240|NCT00556933|432242|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
135241|NCT00556933|432243|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
135242|NCT00556933|432244|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
135243|NCT00556933|432241|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
135244|NCT00556933|432242|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
135245|NCT00556933|432243|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
135246|NCT00556933|432244|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
135247|NCT00556933|432241|P4|Single vs. Divided-dose rATG Induction|Death|0
135248|NCT00556933|432242|P3|Single vs. Divided-dose rATG Induction|Death|0
135249|NCT00556933|432243|P2|Single vs. Divided-dose rATG Induction|Death|1
135250|NCT00556933|432244|P1|Single vs. Divided-dose rATG Induction|Death|0
135251|NCT00556933|432241|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
135252|NCT00556933|432242|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
135253|NCT00556933|432243|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
135254|NCT00556933|432244|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
135255|NCT00556933|432241|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
135256|NCT00556933|432242|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
135257|NCT00556933|432243|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
135258|NCT00556933|432244|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
135259|NCT00556933|432241|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
135260|NCT00556933|432242|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
135261|NCT00556933|432243|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
135262|NCT00556933|432244|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
135263|NCT00556998|432309|P1|Voriconazole Oral|Intolerant of oral treatment|1
135264|NCT00556998|432309|P1|Voriconazole Oral|Adverse Event|1
135265|NCT00556998|432309|P1|Voriconazole Intravenous (IV)|unspecified|4
135266|NCT00556998|432309|P1|Voriconazole Intravenous (IV)|Adverse Event|1
135267|NCT00557076|432331|P2|Overall Study|Unblinding|1
135268|NCT00557076|432332|P1|Overall Study|Unblinding|0
135269|NCT00557245|432343|P3|Overall Study|Ineligible|2
135270|NCT00557245|432344|P2|Overall Study|Ineligible|4
135271|NCT00557245|432345|P1|Overall Study|Ineligible|5
135272|NCT00557245|432343|P3|Overall Study|Lost to Follow-up|10
135273|NCT00557245|432344|P2|Overall Study|Lost to Follow-up|8
135274|NCT00557245|432345|P1|Overall Study|Lost to Follow-up|7
135275|NCT00557310|432406|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
135276|NCT00557310|432406|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
135277|NCT00557310|432406|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
135278|NCT00557310|432406|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
135279|NCT00557310|432406|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
135280|NCT00557310|432406|P1|Main Study (0 - 18 Months)|Adverse Event|4
135281|NCT00557323|432426|P1|Overall Study|Administrative change|2
135282|NCT00557323|432426|P1|Overall Study|Withdrawal by Subject|2
135283|NCT00557323|432426|P1|Overall Study|Death|3
135284|NCT00557440|432468|P3|Treatment Period 1|Adverse Event|1
135285|NCT00557440|432469|P2|Treatment Period 1|Adverse Event|0
135286|NCT00557440|432470|P1|Treatment Period 1|Adverse Event|0
135287|NCT00557466|432496|P6|Overall Study|Lost to Follow-up|0
135288|NCT00557466|432497|P5|Overall Study|Lost to Follow-up|0
135289|NCT00557466|432498|P4|Overall Study|Lost to Follow-up|1
135290|NCT00557466|432499|P3|Overall Study|Lost to Follow-up|0
135291|NCT00557466|432500|P2|Overall Study|Lost to Follow-up|0
135292|NCT00557466|432501|P1|Overall Study|Lost to Follow-up|0
135293|NCT00557466|432496|P6|Overall Study|Abnormal test procedure results|0
135294|NCT00557466|432497|P5|Overall Study|Abnormal test procedure results|0
135295|NCT00557466|432498|P4|Overall Study|Abnormal test procedure results|0
135296|NCT00557466|432499|P3|Overall Study|Abnormal test procedure results|1
135297|NCT00557466|432500|P2|Overall Study|Abnormal test procedure results|0
135298|NCT00557466|432501|P1|Overall Study|Abnormal test procedure results|0
135299|NCT00557466|432496|P6|Overall Study|Administrative problems|0
135300|NCT00557466|432497|P5|Overall Study|Administrative problems|0
135301|NCT00557466|432498|P4|Overall Study|Administrative problems|0
135302|NCT00557466|432499|P3|Overall Study|Administrative problems|1
135303|NCT00557466|432500|P2|Overall Study|Administrative problems|1
135304|NCT00557466|432501|P1|Overall Study|Administrative problems|0
135305|NCT00557466|432496|P6|Overall Study|Subject withdrew consent|2
135306|NCT00557466|432497|P5|Overall Study|Subject withdrew consent|1
135307|NCT00557466|432498|P4|Overall Study|Subject withdrew consent|0
135308|NCT00557466|432499|P3|Overall Study|Subject withdrew consent|0
135309|NCT00557466|432500|P2|Overall Study|Subject withdrew consent|0
135310|NCT00557466|432501|P1|Overall Study|Subject withdrew consent|0
135311|NCT00557466|432496|P6|Overall Study|Protocol deviation|0
135312|NCT00557466|432497|P5|Overall Study|Protocol deviation|0
135313|NCT00557466|432498|P4|Overall Study|Protocol deviation|2
135314|NCT00557466|432499|P3|Overall Study|Protocol deviation|0
135315|NCT00557466|432500|P2|Overall Study|Protocol deviation|1
135316|NCT00557466|432501|P1|Overall Study|Protocol deviation|0
135317|NCT00557466|432496|P6|Overall Study|Abnormal laboratory value(s)|0
135318|NCT00557466|432497|P5|Overall Study|Abnormal laboratory value(s)|0
135319|NCT00557466|432498|P4|Overall Study|Abnormal laboratory value(s)|0
135320|NCT00557466|432499|P3|Overall Study|Abnormal laboratory value(s)|0
135321|NCT00557466|432500|P2|Overall Study|Abnormal laboratory value(s)|2
135322|NCT00557466|432501|P1|Overall Study|Abnormal laboratory value(s)|1
135323|NCT00557466|432496|P6|Overall Study|Adverse Event|4
135324|NCT00557466|432497|P5|Overall Study|Adverse Event|2
135325|NCT00557466|432498|P4|Overall Study|Adverse Event|1
135326|NCT00557466|432499|P3|Overall Study|Adverse Event|4
135327|NCT00557466|432500|P2|Overall Study|Adverse Event|1
135328|NCT00557466|432501|P1|Overall Study|Adverse Event|3
135329|NCT00557492|432551|P1|Overall Study|Change in health insurance|1
135330|NCT00557505|432572|P9|Overall Study|Withdrawal by Subject|1
135331|NCT00557505|432573|P8|Overall Study|Withdrawal by Subject|0
135332|NCT00557505|432574|P7|Overall Study|Withdrawal by Subject|0
135333|NCT00557505|432575|P6|Overall Study|Withdrawal by Subject|0
135334|NCT00557505|432576|P5|Overall Study|Withdrawal by Subject|0
135335|NCT00557505|432577|P4|Overall Study|Withdrawal by Subject|1
135336|NCT00557505|432578|P3|Overall Study|Withdrawal by Subject|0
135337|NCT00557505|432579|P2|Overall Study|Withdrawal by Subject|0
135338|NCT00557505|432580|P1|Overall Study|Withdrawal by Subject|0
135339|NCT00557505|432572|P9|Overall Study|Objective progression or relapse|15
135340|NCT00557505|432573|P8|Overall Study|Objective progression or relapse|5
135341|NCT00557505|432574|P7|Overall Study|Objective progression or relapse|2
135342|NCT00557505|432575|P6|Overall Study|Objective progression or relapse|3
135343|NCT00557505|432576|P5|Overall Study|Objective progression or relapse|2
135344|NCT00557505|432577|P4|Overall Study|Objective progression or relapse|2
135345|NCT00557505|432578|P3|Overall Study|Objective progression or relapse|3
135346|NCT00557505|432579|P2|Overall Study|Objective progression or relapse|3
135347|NCT00557505|432580|P1|Overall Study|Objective progression or relapse|2
135348|NCT00557505|432572|P9|Overall Study|Global deterioration of health|0
135349|NCT00557505|432573|P8|Overall Study|Global deterioration of health|0
135350|NCT00557505|432574|P7|Overall Study|Global deterioration of health|0
135351|NCT00557505|432575|P6|Overall Study|Global deterioration of health|0
135352|NCT00557505|432576|P5|Overall Study|Global deterioration of health|0
135353|NCT00557505|432577|P4|Overall Study|Global deterioration of health|0
135354|NCT00557505|432578|P3|Overall Study|Global deterioration of health|0
135355|NCT00557505|432579|P2|Overall Study|Global deterioration of health|0
135356|NCT00557505|432580|P1|Overall Study|Global deterioration of health|1
135357|NCT00557505|432572|P9|Overall Study|Adverse Event|0
135358|NCT00557505|432573|P8|Overall Study|Adverse Event|0
135359|NCT00557505|432574|P7|Overall Study|Adverse Event|1
135360|NCT00557505|432575|P6|Overall Study|Adverse Event|0
135361|NCT00557505|432576|P5|Overall Study|Adverse Event|0
135362|NCT00557505|432577|P4|Overall Study|Adverse Event|0
135363|NCT00557505|432578|P3|Overall Study|Adverse Event|1
135364|NCT00557505|432579|P2|Overall Study|Adverse Event|0
135365|NCT00557505|432580|P1|Overall Study|Adverse Event|0
135366|NCT00557505|432572|P9|Overall Study|Death|1
135367|NCT00557505|432573|P8|Overall Study|Death|0
135368|NCT00557505|432574|P7|Overall Study|Death|0
135369|NCT00557505|432575|P6|Overall Study|Death|0
135370|NCT00557505|432576|P5|Overall Study|Death|0
135371|NCT00557505|432577|P4|Overall Study|Death|0
135372|NCT00557505|432578|P3|Overall Study|Death|0
135373|NCT00557505|432579|P2|Overall Study|Death|0
135374|NCT00557505|432580|P1|Overall Study|Death|0
135375|NCT00557622|432746|P2|12-Week Treatment Phase|Lost to Follow-up|1
135376|NCT00557622|432747|P1|12-Week Treatment Phase|Lost to Follow-up|0
135377|NCT00557622|432746|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
135378|NCT00557622|432747|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
135379|NCT00557622|432746|P2|4-Week Run-in Phase|Withdrawal by Subject|0
135380|NCT00557622|432747|P1|4-Week Run-in Phase|Withdrawal by Subject|1
135381|NCT00557830|432770|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
135382|NCT00557830|432771|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
135383|NCT00557830|432772|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
135384|NCT00557830|432770|P3|Screening Treatment Phase|Adverse Event|0
135385|NCT00557830|432771|P2|Screening Treatment Phase|Adverse Event|0
135386|NCT00557830|432772|P1|Screening Treatment Phase|Adverse Event|2
135387|NCT00557830|432770|P3|Screening Treatment Phase|Withdrawal by Subject|0
135388|NCT00557830|432771|P2|Screening Treatment Phase|Withdrawal by Subject|0
135389|NCT00557830|432772|P1|Screening Treatment Phase|Withdrawal by Subject|1
135390|NCT00557856|432792|P9|Part 2: Exploratory Phase|global deterioration of health status|1
135391|NCT00557856|432793|P8|Part 2: Exploratory Phase|global deterioration of health status|0
135392|NCT00557856|432794|P7|Part 2: Exploratory Phase|global deterioration of health status|0
135393|NCT00557856|432795|P6|Part 2: Exploratory Phase|global deterioration of health status|0
135394|NCT00557856|432796|P5|Part 2: Exploratory Phase|global deterioration of health status|0
135395|NCT00557856|432797|P4|Part 2: Exploratory Phase|global deterioration of health status|0
135396|NCT00557856|432798|P3|Part 2: Exploratory Phase|global deterioration of health status|0
135397|NCT00557856|432799|P2|Part 2: Exploratory Phase|global deterioration of health status|0
135398|NCT00557856|432800|P1|Part 2: Exploratory Phase|global deterioration of health status|0
135399|NCT00557856|432792|P9|Part 2: Exploratory Phase|Death|2
135400|NCT00557856|432793|P8|Part 2: Exploratory Phase|Death|0
135401|NCT00557856|432794|P7|Part 2: Exploratory Phase|Death|0
135402|NCT00557856|432795|P6|Part 2: Exploratory Phase|Death|0
135403|NCT00557856|432796|P5|Part 2: Exploratory Phase|Death|0
135404|NCT00557856|432797|P4|Part 2: Exploratory Phase|Death|0
135405|NCT00557856|432798|P3|Part 2: Exploratory Phase|Death|0
135406|NCT00557856|432799|P2|Part 2: Exploratory Phase|Death|0
135407|NCT00557856|432800|P1|Part 2: Exploratory Phase|Death|0
135408|NCT00557856|432792|P9|Part 2: Exploratory Phase|unspecified|1
135409|NCT00557856|432793|P8|Part 2: Exploratory Phase|unspecified|0
135410|NCT00557856|432794|P7|Part 2: Exploratory Phase|unspecified|0
135411|NCT00557856|432795|P6|Part 2: Exploratory Phase|unspecified|0
135412|NCT00557856|432796|P5|Part 2: Exploratory Phase|unspecified|0
135413|NCT00557856|432797|P4|Part 2: Exploratory Phase|unspecified|0
135414|NCT00557856|432798|P3|Part 2: Exploratory Phase|unspecified|0
135415|NCT00557856|432799|P2|Part 2: Exploratory Phase|unspecified|0
135416|NCT00557856|432800|P1|Part 2: Exploratory Phase|unspecified|0
135417|NCT00557856|432792|P9|Part 2: Exploratory Phase|Adverse Event|4
135418|NCT00557856|432793|P8|Part 2: Exploratory Phase|Adverse Event|0
135419|NCT00557856|432794|P7|Part 2: Exploratory Phase|Adverse Event|0
135420|NCT00557856|432795|P6|Part 2: Exploratory Phase|Adverse Event|0
135421|NCT00557856|432796|P5|Part 2: Exploratory Phase|Adverse Event|0
135422|NCT00557856|432797|P4|Part 2: Exploratory Phase|Adverse Event|0
135423|NCT00557856|432798|P3|Part 2: Exploratory Phase|Adverse Event|0
135424|NCT00557856|432799|P2|Part 2: Exploratory Phase|Adverse Event|0
135425|NCT00557856|432800|P1|Part 2: Exploratory Phase|Adverse Event|0
135426|NCT00557856|432792|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
135427|NCT00557856|432793|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
135428|NCT00557856|432794|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
135429|NCT00557856|432795|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
135430|NCT00557856|432796|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
135431|NCT00557856|432797|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
135432|NCT00557856|432798|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
135433|NCT00557856|432799|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
135434|NCT00557856|432800|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
135435|NCT00557856|432792|P9|Part 2: Exploratory Phase|objective progression or relapse|15
135436|NCT00557856|432793|P8|Part 2: Exploratory Phase|objective progression or relapse|0
135437|NCT00557856|432794|P7|Part 2: Exploratory Phase|objective progression or relapse|0
135438|NCT00557856|432795|P6|Part 2: Exploratory Phase|objective progression or relapse|0
135439|NCT00557856|432796|P5|Part 2: Exploratory Phase|objective progression or relapse|0
135440|NCT00557856|432797|P4|Part 2: Exploratory Phase|objective progression or relapse|0
135441|NCT00557856|432798|P3|Part 2: Exploratory Phase|objective progression or relapse|0
135442|NCT00557856|432799|P2|Part 2: Exploratory Phase|objective progression or relapse|0
135443|NCT00557856|432800|P1|Part 2: Exploratory Phase|objective progression or relapse|0
135444|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
135445|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
135446|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
135447|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
135448|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
135449|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
135450|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
135451|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
135452|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
135453|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
135454|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
135455|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
135456|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
135457|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
135458|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
135459|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
135460|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
135461|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
135462|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|Death|0
135463|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|Death|0
135464|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|Death|0
135465|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|Death|1
135466|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|Death|0
135467|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|Death|0
135468|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|Death|0
135469|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|Death|0
135470|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|Death|0
135471|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|unspecified|0
135472|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|unspecified|1
135473|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|unspecified|0
135474|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|unspecified|0
135475|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|unspecified|0
135476|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|unspecified|1
135477|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|unspecified|1
135478|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|unspecified|0
135479|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|unspecified|0
135480|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|Adverse Event|0
135481|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|Adverse Event|2
135482|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|Adverse Event|1
135483|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|Adverse Event|3
135484|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|Adverse Event|1
135485|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|Adverse Event|1
135486|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|Adverse Event|1
135487|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|Adverse Event|0
135488|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|Adverse Event|1
135489|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135490|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135491|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135492|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135493|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135494|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135495|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
135496|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
135497|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
135498|NCT00557856|432792|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
135499|NCT00557856|432793|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
135500|NCT00557856|432794|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
135501|NCT00557856|432795|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
135502|NCT00557856|432796|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
135503|NCT00557856|432797|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
135504|NCT00557856|432798|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
135505|NCT00557856|432799|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
135506|NCT00557856|432800|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
135507|NCT00558025|433023|P2|Overall Study|Protocol Violation|0
135508|NCT00558025|433024|P1|Overall Study|Protocol Violation|1
135509|NCT00558025|433023|P2|Overall Study|Withdrawal by Subject|2
135510|NCT00558025|433024|P1|Overall Study|Withdrawal by Subject|2
135511|NCT00558025|433023|P2|Overall Study|Adverse Event|1
135512|NCT00558025|433024|P1|Overall Study|Adverse Event|1
135513|NCT00558064|433048|P2|Overall Study|No visit within allowance period|0
135514|NCT00558064|433049|P1|Overall Study|No visit within allowance period|1
135515|NCT00558064|433048|P2|Overall Study|Withdrawal by Subject|1
135516|NCT00558064|433049|P1|Overall Study|Withdrawal by Subject|0
135517|NCT00558064|433048|P2|Overall Study|Lost to Follow-up|1
135518|NCT00558064|433049|P1|Overall Study|Lost to Follow-up|0
135519|NCT00558064|433048|P2|Overall Study|Protocol Violation|0
135520|NCT00558064|433049|P1|Overall Study|Protocol Violation|1
135521|NCT00558064|433048|P2|Overall Study|Lack of Efficacy|1
135522|NCT00558064|433049|P1|Overall Study|Lack of Efficacy|0
135523|NCT00558064|433048|P2|Overall Study|Adverse Event|2
135524|NCT00558064|433049|P1|Overall Study|Adverse Event|3
135525|NCT00558103|433074|P6|Monotherapy Extension Phase|Disease Progression|8
135526|NCT00558103|433075|P5|Monotherapy Extension Phase|Disease Progression|0
135527|NCT00558103|433076|P4|Monotherapy Extension Phase|Disease Progression|0
135528|NCT00558103|433077|P3|Monotherapy Extension Phase|Disease Progression|0
135529|NCT00558103|433078|P2|Monotherapy Extension Phase|Disease Progression|0
135530|NCT00558103|433079|P1|Monotherapy Extension Phase|Disease Progression|0
135531|NCT00558103|433074|P6|Monotherapy Extension Phase|Protocol Violation|1
135532|NCT00558103|433075|P5|Monotherapy Extension Phase|Protocol Violation|0
135533|NCT00558103|433076|P4|Monotherapy Extension Phase|Protocol Violation|0
135534|NCT00558103|433077|P3|Monotherapy Extension Phase|Protocol Violation|0
135535|NCT00558103|433078|P2|Monotherapy Extension Phase|Protocol Violation|0
135536|NCT00558103|433079|P1|Monotherapy Extension Phase|Protocol Violation|0
135537|NCT00558103|433074|P6|Randomized Treatment Phase|Adverse Event|0
135538|NCT00558103|433075|P5|Randomized Treatment Phase|Adverse Event|1
135539|NCT00558103|433076|P4|Randomized Treatment Phase|Adverse Event|1
135540|NCT00558103|433077|P3|Randomized Treatment Phase|Adverse Event|0
135541|NCT00558103|433078|P2|Randomized Treatment Phase|Adverse Event|0
135542|NCT00558103|433079|P1|Randomized Treatment Phase|Adverse Event|0
135543|NCT00558103|433074|P6|Randomized Treatment Phase|Disease Progression|0
135544|NCT00558103|433075|P5|Randomized Treatment Phase|Disease Progression|0
135545|NCT00558103|433076|P4|Randomized Treatment Phase|Disease Progression|0
135546|NCT00558103|433077|P3|Randomized Treatment Phase|Disease Progression|1
135547|NCT00558103|433078|P2|Randomized Treatment Phase|Disease Progression|0
135548|NCT00558103|433079|P1|Randomized Treatment Phase|Disease Progression|1
135549|NCT00558103|433074|P6|Randomized Treatment Phase|Withdrawal by Subject|0
135550|NCT00558103|433075|P5|Randomized Treatment Phase|Withdrawal by Subject|1
135551|NCT00558103|433076|P4|Randomized Treatment Phase|Withdrawal by Subject|0
135552|NCT00558103|433077|P3|Randomized Treatment Phase|Withdrawal by Subject|0
135553|NCT00558103|433078|P2|Randomized Treatment Phase|Withdrawal by Subject|2
135554|NCT00558103|433079|P1|Randomized Treatment Phase|Withdrawal by Subject|2
135555|NCT00558103|433074|P6|Randomized Treatment Phase|Lost to Follow-up|0
135556|NCT00558103|433075|P5|Randomized Treatment Phase|Lost to Follow-up|3
135557|NCT00558103|433076|P4|Randomized Treatment Phase|Lost to Follow-up|1
135558|NCT00558103|433077|P3|Randomized Treatment Phase|Lost to Follow-up|2
135559|NCT00558103|433078|P2|Randomized Treatment Phase|Lost to Follow-up|2
135560|NCT00558103|433079|P1|Randomized Treatment Phase|Lost to Follow-up|2
135561|NCT00558259|433124|P2|Overall Study|Withdrawal by Subject|13
135562|NCT00558259|433125|P1|Overall Study|Withdrawal by Subject|12
135563|NCT00558259|433124|P2|Overall Study|Protocol Violation|5
135564|NCT00558259|433125|P1|Overall Study|Protocol Violation|9
135565|NCT00558259|433124|P2|Overall Study|Adverse Event|81
135566|NCT00558259|433125|P1|Overall Study|Adverse Event|50
135567|NCT00558272|433147|P2|Overall Study|Withdrawal by Subject|1
135568|NCT00558272|433148|P1|Overall Study|Withdrawal by Subject|0
135569|NCT00558272|433147|P2|Overall Study|Incorrectly enrolled|0
135570|NCT00558272|433148|P1|Overall Study|Incorrectly enrolled|1
135571|NCT00558272|433147|P2|Overall Study|AZ study team decision|1
135572|NCT00558272|433148|P1|Overall Study|AZ study team decision|0
135573|NCT00558272|433147|P2|Overall Study|Dev. of study specific discon. criteria|0
135574|NCT00558272|433148|P1|Overall Study|Dev. of study specific discon. criteria|1
135575|NCT00558272|433147|P2|Overall Study|Death|0
135576|NCT00558272|433148|P1|Overall Study|Death|1
135577|NCT00558272|433147|P2|Overall Study|Adverse Event|0
135578|NCT00558272|433148|P1|Overall Study|Adverse Event|10
135579|NCT00558285|433191|P5|Overall Study|Protocol deviation|0
135580|NCT00558285|433192|P4|Overall Study|Protocol deviation|1
135581|NCT00558285|433193|P3|Overall Study|Protocol deviation|0
135582|NCT00558285|433194|P2|Overall Study|Protocol deviation|1
135583|NCT00558285|433195|P1|Overall Study|Protocol deviation|1
135584|NCT00558285|433191|P5|Overall Study|Administrative problems|1
135585|NCT00558285|433192|P4|Overall Study|Administrative problems|1
135586|NCT00558285|433193|P3|Overall Study|Administrative problems|0
135587|NCT00558285|433194|P2|Overall Study|Administrative problems|0
135588|NCT00558285|433195|P1|Overall Study|Administrative problems|0
135589|NCT00558285|433191|P5|Overall Study|Lost to Follow-up|0
135590|NCT00558285|433192|P4|Overall Study|Lost to Follow-up|0
135591|NCT00558285|433193|P3|Overall Study|Lost to Follow-up|0
135592|NCT00558285|433194|P2|Overall Study|Lost to Follow-up|1
135593|NCT00558285|433195|P1|Overall Study|Lost to Follow-up|1
135594|NCT00558285|433191|P5|Overall Study|Subject withdrew consent|1
135595|NCT00558285|433192|P4|Overall Study|Subject withdrew consent|1
135596|NCT00558285|433193|P3|Overall Study|Subject withdrew consent|1
135597|NCT00558285|433194|P2|Overall Study|Subject withdrew consent|0
135598|NCT00558285|433195|P1|Overall Study|Subject withdrew consent|2
135599|NCT00558285|433191|P5|Overall Study|Abnormal test procedure result(s)|0
135600|NCT00558285|433192|P4|Overall Study|Abnormal test procedure result(s)|0
135601|NCT00558285|433193|P3|Overall Study|Abnormal test procedure result(s)|0
135602|NCT00558285|433194|P2|Overall Study|Abnormal test procedure result(s)|0
135603|NCT00558285|433195|P1|Overall Study|Abnormal test procedure result(s)|1
135604|NCT00558285|433191|P5|Overall Study|Adverse Event|2
135605|NCT00558285|433192|P4|Overall Study|Adverse Event|1
135606|NCT00558285|433193|P3|Overall Study|Adverse Event|4
135607|NCT00558285|433194|P2|Overall Study|Adverse Event|1
135608|NCT00558285|433195|P1|Overall Study|Adverse Event|1
135609|NCT00558363|433239|P2|Overall Study|Hospitalized; Unable to Continue|1
135610|NCT00558363|433240|P1|Overall Study|Hospitalized; Unable to Continue|0
135611|NCT00558363|433239|P2|Overall Study|Randomized in Error|2
135612|NCT00558363|433240|P1|Overall Study|Randomized in Error|1
135613|NCT00558363|433239|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
135614|NCT00558363|433240|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
135615|NCT00558363|433239|P2|Overall Study|Lost to Follow-up|1
135616|NCT00558363|433240|P1|Overall Study|Lost to Follow-up|0
135617|NCT00558363|433239|P2|Overall Study|Protocol Violation|1
135618|NCT00558363|433240|P1|Overall Study|Protocol Violation|2
135619|NCT00558363|433239|P2|Overall Study|Lack of Efficacy|2
135620|NCT00558363|433240|P1|Overall Study|Lack of Efficacy|2
135621|NCT00558363|433239|P2|Overall Study|Adverse Event|5
135622|NCT00558363|433240|P1|Overall Study|Adverse Event|5
135623|NCT00558363|433239|P2|Overall Study|Withdrawal by Subject|4
135624|NCT00558363|433240|P1|Overall Study|Withdrawal by Subject|11
135625|NCT00558363|433239|P2|Overall Study|Physician Decision|4
135626|NCT00558363|433240|P1|Overall Study|Physician Decision|18
135627|NCT00558428|433294|P4|Overall Study|Other|1
135628|NCT00558428|433295|P3|Overall Study|Other|0
135629|NCT00558428|433296|P2|Overall Study|Other|0
135630|NCT00558428|433297|P1|Overall Study|Other|3
135631|NCT00558428|433294|P4|Overall Study|Consent withdrawn|1
135632|NCT00558428|433295|P3|Overall Study|Consent withdrawn|0
135633|NCT00558428|433296|P2|Overall Study|Consent withdrawn|1
135634|NCT00558428|433297|P1|Overall Study|Consent withdrawn|2
135635|NCT00558428|433294|P4|Overall Study|Non compliant with protocol|3
135636|NCT00558428|433295|P3|Overall Study|Non compliant with protocol|0
135637|NCT00558428|433296|P2|Overall Study|Non compliant with protocol|0
135638|NCT00558428|433297|P1|Overall Study|Non compliant with protocol|1
135639|NCT00558428|433294|P4|Overall Study|Lack of Efficacy|2
135640|NCT00558428|433295|P3|Overall Study|Lack of Efficacy|1
135641|NCT00558428|433296|P2|Overall Study|Lack of Efficacy|0
135642|NCT00558428|433297|P1|Overall Study|Lack of Efficacy|0
135643|NCT00558428|433294|P4|Overall Study|Lost to Follow-up|0
135644|NCT00558428|433295|P3|Overall Study|Lost to Follow-up|0
135645|NCT00558428|433296|P2|Overall Study|Lost to Follow-up|1
135646|NCT00558428|433297|P1|Overall Study|Lost to Follow-up|0
135647|NCT00558428|433294|P4|Overall Study|Adverse Event|4
135648|NCT00558428|433295|P3|Overall Study|Adverse Event|3
135649|NCT00558428|433296|P2|Overall Study|Adverse Event|22
135650|NCT00558428|433297|P1|Overall Study|Adverse Event|6
135651|NCT00558467|433337|P2|Overall Study|Patient moving out of state|1
135652|NCT00558467|433338|P1|Overall Study|Patient moving out of state|0
135653|NCT00558467|433337|P2|Overall Study|Lack of Efficacy|1
135654|NCT00558467|433338|P1|Overall Study|Lack of Efficacy|0
135655|NCT00558467|433337|P2|Overall Study|Adverse Event|2
135656|NCT00558467|433338|P1|Overall Study|Adverse Event|1
135657|NCT00558558|433394|P1|Overall Study|Lack of Efficacy|4
135658|NCT00558558|433394|P1|Overall Study|Withdrawal by Subject|1
135659|NCT00558558|433394|P1|Overall Study|Unable to swallow|1
135660|NCT00558636|433482|P2|Follow-up|Premature termination of the study|7
135661|NCT00558636|433483|P1|Follow-up|Premature termination of the study|12
135662|NCT00558636|433482|P2|Treatment|Disease progression|5
135663|NCT00558636|433483|P1|Treatment|Disease progression|1
135664|NCT00558636|433482|P2|Treatment|Premature termination of the study|37
135665|NCT00558636|433483|P1|Treatment|Premature termination of the study|35
135666|NCT00558636|433482|P2|Treatment|Withdrawal by Subject|0
135667|NCT00558636|433483|P1|Treatment|Withdrawal by Subject|2
135668|NCT00558636|433482|P2|Treatment|Adverse Event|2
135669|NCT00558636|433483|P1|Treatment|Adverse Event|9
135670|NCT00558701|433503|P2|Overall Study|Protocol Deviations|4
135671|NCT00558701|433504|P1|Overall Study|Protocol Deviations|1
135672|NCT00558753|433512|P2|Overall Study|Lost to Follow-up|7
135673|NCT00558753|433513|P1|Overall Study|Lost to Follow-up|5
135674|NCT00558831|433572|P1|Overall Study|Lost to Follow-up|1
135675|NCT00558896|433596|P7|Overall Study|Continues on treatment|6
135676|NCT00558896|433597|P6|Overall Study|Continues on treatment|25
135677|NCT00558896|433598|P5|Overall Study|Continues on treatment|9
135678|NCT00558896|433599|P4|Overall Study|Continues on treatment|1
135679|NCT00558896|433600|P3|Overall Study|Continues on treatment|0
135680|NCT00558896|433601|P2|Overall Study|Continues on treatment|1
135681|NCT00558896|433602|P1|Overall Study|Continues on treatment|10
135682|NCT00558896|433596|P7|Overall Study|Physician discretion|3
135683|NCT00558896|433597|P6|Overall Study|Physician discretion|3
135684|NCT00558896|433598|P5|Overall Study|Physician discretion|1
135685|NCT00558896|433599|P4|Overall Study|Physician discretion|2
135686|NCT00558896|433600|P3|Overall Study|Physician discretion|1
135687|NCT00558896|433601|P2|Overall Study|Physician discretion|2
135688|NCT00558896|433602|P1|Overall Study|Physician discretion|3
135689|NCT00558896|433596|P7|Overall Study|Alternative Treatment|1
135690|NCT00558896|433597|P6|Overall Study|Alternative Treatment|7
135691|NCT00558896|433598|P5|Overall Study|Alternative Treatment|6
135692|NCT00558896|433599|P4|Overall Study|Alternative Treatment|2
135693|NCT00558896|433600|P3|Overall Study|Alternative Treatment|0
135694|NCT00558896|433601|P2|Overall Study|Alternative Treatment|2
135695|NCT00558896|433602|P1|Overall Study|Alternative Treatment|2
135696|NCT00558896|433596|P7|Overall Study|Withdrawal by Subject|5
135697|NCT00558896|433597|P6|Overall Study|Withdrawal by Subject|5
135698|NCT00558896|433598|P5|Overall Study|Withdrawal by Subject|1
135699|NCT00558896|433599|P4|Overall Study|Withdrawal by Subject|1
135700|NCT00558896|433600|P3|Overall Study|Withdrawal by Subject|1
135701|NCT00558896|433601|P2|Overall Study|Withdrawal by Subject|1
135702|NCT00558896|433602|P1|Overall Study|Withdrawal by Subject|2
135703|NCT00558896|433596|P7|Overall Study|Death|6
135704|NCT00558896|433597|P6|Overall Study|Death|2
135705|NCT00558896|433598|P5|Overall Study|Death|2
135706|NCT00558896|433599|P4|Overall Study|Death|3
135707|NCT00558896|433600|P3|Overall Study|Death|2
135708|NCT00558896|433601|P2|Overall Study|Death|0
135709|NCT00558896|433602|P1|Overall Study|Death|3
135710|NCT00558896|433596|P7|Overall Study|Adverse Event|3
135711|NCT00558896|433597|P6|Overall Study|Adverse Event|10
135712|NCT00558896|433598|P5|Overall Study|Adverse Event|4
135713|NCT00558896|433599|P4|Overall Study|Adverse Event|3
135714|NCT00558896|433600|P3|Overall Study|Adverse Event|1
135715|NCT00558896|433601|P2|Overall Study|Adverse Event|1
135716|NCT00558896|433602|P1|Overall Study|Adverse Event|1
135717|NCT00559104|433638|P2|Overall Study|Lack of Efficacy|0
135718|NCT00559104|433639|P1|Overall Study|Lack of Efficacy|9
135719|NCT00559273|433651|P2|Evaluation Period (8 Weeks)|Physician Decision|1
135720|NCT00559273|433652|P1|Evaluation Period (8 Weeks)|Physician Decision|0
135721|NCT00559273|433651|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
135722|NCT00559273|433652|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
135723|NCT00559273|433651|P2|Evaluation Period (8 Weeks)|Adverse Event|1
135724|NCT00559273|433652|P1|Evaluation Period (8 Weeks)|Adverse Event|0
135725|NCT00559273|433651|P2|Evaluation Period (8 Weeks)|Death|3
135726|NCT00559273|433652|P1|Evaluation Period (8 Weeks)|Death|1
135727|NCT00559273|433651|P2|Correction Period (20 Weeks)|Did not received study treatment|0
135728|NCT00559273|433652|P1|Correction Period (20 Weeks)|Did not received study treatment|2
135729|NCT00559273|433651|P2|Correction Period (20 Weeks)|Participant treated by another center|1
135730|NCT00559273|433652|P1|Correction Period (20 Weeks)|Participant treated by another center|0
135731|NCT00559273|433651|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
135732|NCT00559273|433652|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
135733|NCT00559273|433651|P2|Correction Period (20 Weeks)|Adverse Event|1
135734|NCT00559273|433652|P1|Correction Period (20 Weeks)|Adverse Event|2
135735|NCT00559273|433651|P2|Correction Period (20 Weeks)|Death|4
135736|NCT00559273|433652|P1|Correction Period (20 Weeks)|Death|3
135737|NCT00559364|433674|P2|Overall Study|Inclusion/exclusion criteria failure|0
135738|NCT00559364|433675|P1|Overall Study|Inclusion/exclusion criteria failure|1
135739|NCT00559377|433685|P1|Overall Study|Withdrawal by Subject|9
135740|NCT00565409|433701|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
135741|NCT00565409|433702|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
135742|NCT00565409|433703|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
135743|NCT00565409|433704|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
135744|NCT00565409|433701|P4|Period 2 Double-Blind|unspecified|9
135745|NCT00565409|433702|P3|Period 2 Double-Blind|unspecified|5
135746|NCT00565409|433703|P2|Period 2 Double-Blind|unspecified|4
135747|NCT00565409|433704|P1|Period 2 Double-Blind|unspecified|0
135748|NCT00565409|433701|P4|Period 2 Double-Blind|Lost to Follow-up|0
135749|NCT00565409|433702|P3|Period 2 Double-Blind|Lost to Follow-up|1
135750|NCT00565409|433703|P2|Period 2 Double-Blind|Lost to Follow-up|0
135751|NCT00565409|433704|P1|Period 2 Double-Blind|Lost to Follow-up|0
135752|NCT00565409|433701|P4|Period 2 Double-Blind|Protocol Violation|2
135753|NCT00565409|433702|P3|Period 2 Double-Blind|Protocol Violation|6
135754|NCT00565409|433703|P2|Period 2 Double-Blind|Protocol Violation|4
135755|NCT00565409|433704|P1|Period 2 Double-Blind|Protocol Violation|0
135756|NCT00565409|433701|P4|Period 2 Double-Blind|Death|0
135757|NCT00565409|433702|P3|Period 2 Double-Blind|Death|0
135758|NCT00565409|433703|P2|Period 2 Double-Blind|Death|2
135759|NCT00565409|433704|P1|Period 2 Double-Blind|Death|0
135760|NCT00565409|433701|P4|Period 2 Double-Blind|Adverse Event|5
135761|NCT00565409|433702|P3|Period 2 Double-Blind|Adverse Event|4
135762|NCT00565409|433703|P2|Period 2 Double-Blind|Adverse Event|7
135763|NCT00565409|433704|P1|Period 2 Double-Blind|Adverse Event|0
135764|NCT00565409|433701|P4|After Period 1, Prior to Period 2|did not meet criteria|0
135765|NCT00565409|433702|P3|After Period 1, Prior to Period 2|did not meet criteria|0
135766|NCT00565409|433703|P2|After Period 1, Prior to Period 2|did not meet criteria|0
135767|NCT00565409|433704|P1|After Period 1, Prior to Period 2|did not meet criteria|152
135768|NCT00565409|433701|P4|Period 1 Open Label|no conclusion of participation record|0
135769|NCT00565409|433702|P3|Period 1 Open Label|no conclusion of participation record|0
135770|NCT00565409|433703|P2|Period 1 Open Label|no conclusion of participation record|0
135771|NCT00565409|433704|P1|Period 1 Open Label|no conclusion of participation record|1
135772|NCT00565409|433701|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
135773|NCT00565409|433702|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
135774|NCT00565409|433703|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
135775|NCT00565409|433704|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
135776|NCT00565409|433701|P4|Period 1 Open Label|Protocol Violation|0
135777|NCT00565409|433702|P3|Period 1 Open Label|Protocol Violation|0
135778|NCT00565409|433703|P2|Period 1 Open Label|Protocol Violation|0
135779|NCT00565409|433704|P1|Period 1 Open Label|Protocol Violation|14
135780|NCT00565409|433701|P4|Period 1 Open Label|unspecified|0
135781|NCT00565409|433702|P3|Period 1 Open Label|unspecified|0
135782|NCT00565409|433703|P2|Period 1 Open Label|unspecified|0
135783|NCT00565409|433704|P1|Period 1 Open Label|unspecified|21
135784|NCT00565409|433701|P4|Period 1 Open Label|Lost to Follow-up|0
135785|NCT00565409|433702|P3|Period 1 Open Label|Lost to Follow-up|0
135786|NCT00565409|433703|P2|Period 1 Open Label|Lost to Follow-up|0
135787|NCT00565409|433704|P1|Period 1 Open Label|Lost to Follow-up|1
135788|NCT00565409|433701|P4|Period 1 Open Label|Death|0
135789|NCT00565409|433702|P3|Period 1 Open Label|Death|0
135790|NCT00565409|433703|P2|Period 1 Open Label|Death|0
135791|NCT00565409|433704|P1|Period 1 Open Label|Death|2
135792|NCT00565409|433701|P4|Period 1 Open Label|Adverse Event|0
135793|NCT00565409|433702|P3|Period 1 Open Label|Adverse Event|0
135794|NCT00565409|433703|P2|Period 1 Open Label|Adverse Event|0
135795|NCT00565409|433704|P1|Period 1 Open Label|Adverse Event|17
135796|NCT00565448|433808|P2|Overall Study|Withdrawal by Subject|0
135797|NCT00565448|433809|P1|Overall Study|Withdrawal by Subject|1
135798|NCT00565448|433808|P2|Overall Study|Disease progression|0
135799|NCT00565448|433809|P1|Overall Study|Disease progression|1
135800|NCT00565448|433808|P2|Overall Study|Adverse Event|2
135801|NCT00565448|433809|P1|Overall Study|Adverse Event|1
135802|NCT00565604|433839|P1|Overall Study|Lost to Follow-up|2
135803|NCT00565604|433839|P1|Overall Study|Failure to treat|2
135804|NCT00566020|433867|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
135805|NCT00566020|433868|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
135806|NCT00566020|433867|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
135807|NCT00566020|433868|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
135808|NCT00566020|433867|P2|46-week Long-term Administration Phase|Physician Decision|7
135809|NCT00566020|433868|P1|46-week Long-term Administration Phase|Physician Decision|0
135810|NCT00566020|433867|P2|46-week Long-term Administration Phase|Adverse Event|7
135811|NCT00566020|433868|P1|46-week Long-term Administration Phase|Adverse Event|0
135812|NCT00566020|433867|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
135813|NCT00566020|433868|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
135814|NCT00566020|433867|P2|6-week Dosage Adjustment Phase|Adverse Event|0
135815|NCT00566020|433868|P1|6-week Dosage Adjustment Phase|Adverse Event|5
135816|NCT00566111|433895|P2|Overall Study|Adverse Event|2
135817|NCT00566111|433896|P1|Overall Study|Adverse Event|0
135818|NCT00566254|433927|P2|Overall Study|Not Specified|2
135819|NCT00566254|433928|P1|Overall Study|Not Specified|0
135820|NCT00566254|433927|P2|Overall Study|Lack of Efficacy|6
135821|NCT00566254|433928|P1|Overall Study|Lack of Efficacy|5
135822|NCT00566254|433927|P2|Overall Study|Withdrawal by Subject|2
135823|NCT00566254|433928|P1|Overall Study|Withdrawal by Subject|1
135824|NCT00566254|433927|P2|Overall Study|Protocol Violation|3
135825|NCT00566254|433928|P1|Overall Study|Protocol Violation|1
135826|NCT00566254|433927|P2|Overall Study|Adverse Event|1
135827|NCT00566254|433928|P1|Overall Study|Adverse Event|3
135828|NCT00566631|433969|P1|Part 2: Extension Phase|Unspecified|5
135829|NCT00566631|433969|P1|Part 2: Extension Phase|Death|1
135830|NCT00566631|433969|P1|Part 2: Extension Phase|Lost to Follow-up|6
135831|NCT00566631|433969|P1|Part 2: Extension Phase|Adverse Event|11
135832|NCT00566631|433969|P1|Part 2: Extension Phase|Withdrawal by Subject|34
135833|NCT00566631|433969|P1|Part 2: Extension Phase|Lack of Efficacy|25
135834|NCT00566631|433969|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
135835|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
135836|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
135837|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
135838|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
135839|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Adverse Event|9
135840|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Physician Decision|1
135841|NCT00566631|433969|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
135842|NCT00566696|433984|P1|Overall Study|Non-Patient Donors|37
135843|NCT00566696|433984|P1|Overall Study|Physician Decision|1
135844|NCT00566696|433984|P1|Overall Study|Health Status Change|1
135845|NCT00566696|433984|P1|Overall Study|Muromonab not available|1
135846|NCT00566696|433984|P1|Overall Study|Met Exclusion Criteria|2
135847|NCT00566709|433994|P2|Overall Study|Protocol Violation|0
135848|NCT00566709|433995|P1|Overall Study|Protocol Violation|5
135849|NCT00566722|434014|P3|Overall Study|Noncompliant with drug administration|1
135850|NCT00566722|434015|P2|Overall Study|Noncompliant with drug administration|0
135851|NCT00566722|434016|P1|Overall Study|Noncompliant with drug administration|0
135852|NCT00566722|434014|P3|Overall Study|Serious adverse event|0
135853|NCT00566722|434015|P2|Overall Study|Serious adverse event|1
135854|NCT00566722|434016|P1|Overall Study|Serious adverse event|0
135855|NCT00566722|434014|P3|Overall Study|Did not meet exclusion criteria|2
135856|NCT00566722|434015|P2|Overall Study|Did not meet exclusion criteria|0
135857|NCT00566722|434016|P1|Overall Study|Did not meet exclusion criteria|0
135858|NCT00566722|434014|P3|Overall Study|Lack of Efficacy|4
135859|NCT00566722|434015|P2|Overall Study|Lack of Efficacy|2
135860|NCT00566722|434016|P1|Overall Study|Lack of Efficacy|1
135861|NCT00566722|434014|P3|Overall Study|Lost to Follow-up|1
135862|NCT00566722|434015|P2|Overall Study|Lost to Follow-up|1
135863|NCT00566722|434016|P1|Overall Study|Lost to Follow-up|1
135864|NCT00566722|434014|P3|Overall Study|Withdrawal by Subject|1
135865|NCT00566722|434015|P2|Overall Study|Withdrawal by Subject|0
135866|NCT00566722|434016|P1|Overall Study|Withdrawal by Subject|0
135867|NCT00566722|434014|P3|Overall Study|Adverse Event|0
135868|NCT00566722|434015|P2|Overall Study|Adverse Event|1
135869|NCT00566722|434016|P1|Overall Study|Adverse Event|0
135870|NCT00566735|434062|P2|Overall Study|Switched into a manic episode|1
135871|NCT00566735|434063|P1|Overall Study|Switched into a manic episode|0
135872|NCT00566735|434062|P2|Overall Study|Refused neuropsychological testing|5
135873|NCT00566735|434063|P1|Overall Study|Refused neuropsychological testing|2
135874|NCT00566735|434062|P2|Overall Study|Withdrawal by Subject|1
135875|NCT00566735|434063|P1|Overall Study|Withdrawal by Subject|0
135876|NCT00566852|434075|P2|Overall Study|Missing reason not reported|20
135877|NCT00566852|434076|P1|Overall Study|Missing reason not reported|16
135878|NCT00566852|434075|P2|Overall Study|Missing reason not specified|2
135879|NCT00566852|434076|P1|Overall Study|Missing reason not specified|1
135880|NCT00566852|434075|P2|Overall Study|Not tested due to disability|12
135881|NCT00566852|434076|P1|Overall Study|Not tested due to disability|6
135882|NCT00566852|434075|P2|Overall Study|Patient refusal|37
135883|NCT00566852|434076|P1|Overall Study|Patient refusal|37
135884|NCT00566852|434075|P2|Overall Study|Withdrawal by Subject|25
135885|NCT00566852|434076|P1|Overall Study|Withdrawal by Subject|30
135886|NCT00566852|434075|P2|Overall Study|Death|78
135887|NCT00566852|434076|P1|Overall Study|Death|95
135888|NCT00566852|434075|P2|Overall Study|Protocol Violation|24
135889|NCT00566852|434076|P1|Overall Study|Protocol Violation|22
135890|NCT00566982|434135|P2|Overall Study|Other-family problems & doctor's request|2
135891|NCT00566982|434136|P1|Overall Study|Other-family problems & doctor's request|0
135892|NCT00566982|434135|P2|Overall Study|Lost to Follow-up|1
135893|NCT00566982|434136|P1|Overall Study|Lost to Follow-up|0
135894|NCT00566982|434135|P2|Overall Study|Protocol Violation|4
135895|NCT00566982|434136|P1|Overall Study|Protocol Violation|1
135896|NCT00566982|434135|P2|Overall Study|Withdrawal by Subject|14
135897|NCT00566982|434136|P1|Overall Study|Withdrawal by Subject|1
135898|NCT00566982|434135|P2|Overall Study|Adverse Event|48
135899|NCT00566982|434136|P1|Overall Study|Adverse Event|6
135900|NCT00566995|434158|P1|Overall Study|Withdrew consent|4
135901|NCT00566995|434158|P1|Overall Study|Physician Decision|1
135902|NCT00566995|434158|P1|Overall Study|Toxicity|3
135903|NCT00567112|434172|P3|Washout Period 3 (3 Days)|Protocol Violation|0
135904|NCT00567112|434173|P2|Washout Period 3 (3 Days)|Protocol Violation|0
135905|NCT00567112|434174|P1|Washout Period 3 (3 Days)|Protocol Violation|1
135906|NCT00567112|434172|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
135907|NCT00567112|434173|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
135908|NCT00567112|434174|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
135909|NCT00567112|434172|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
135910|NCT00567112|434173|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
135911|NCT00567112|434174|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
135912|NCT00567164|434199|P3|Overall Study|Missing|0
135913|NCT00567164|434200|P2|Overall Study|Missing|0
135914|NCT00567164|434201|P1|Overall Study|Missing|1
135915|NCT00567164|434199|P3|Overall Study|Primary Reason coded as 'Other'|16
135916|NCT00567164|434200|P2|Overall Study|Primary Reason coded as 'Other'|8
135917|NCT00567164|434201|P1|Overall Study|Primary Reason coded as 'Other'|37
135918|NCT00567164|434199|P3|Overall Study|Pregnancy|6
135919|NCT00567164|434200|P2|Overall Study|Pregnancy|4
135920|NCT00567164|434201|P1|Overall Study|Pregnancy|20
135921|NCT00567164|434199|P3|Overall Study|Lost to Follow-up|21
135922|NCT00567164|434200|P2|Overall Study|Lost to Follow-up|23
135923|NCT00567164|434201|P1|Overall Study|Lost to Follow-up|202
135924|NCT00567164|434199|P3|Overall Study|Death|1
135925|NCT00567164|434200|P2|Overall Study|Death|0
135926|NCT00567164|434201|P1|Overall Study|Death|0
135927|NCT00567164|434199|P3|Overall Study|Adverse Event|9
135928|NCT00567164|434200|P2|Overall Study|Adverse Event|13
135929|NCT00567164|434201|P1|Overall Study|Adverse Event|92
135930|NCT00567164|434199|P3|Overall Study|Protocol Violation|2
135931|NCT00567164|434200|P2|Overall Study|Protocol Violation|4
135932|NCT00567164|434201|P1|Overall Study|Protocol Violation|23
135933|NCT00567164|434199|P3|Overall Study|Withdrawal by Subject|17
135934|NCT00567164|434200|P2|Overall Study|Withdrawal by Subject|21
135935|NCT00567164|434201|P1|Overall Study|Withdrawal by Subject|171
135936|NCT00567190|434275|P2|Overall Study|Withdrew Consent or Lost to Follow-up|43
135937|NCT00567190|434276|P1|Overall Study|Withdrew Consent or Lost to Follow-up|42
135938|NCT00567190|434275|P2|Overall Study|Death|221
135939|NCT00567190|434276|P1|Overall Study|Death|168
135940|NCT00567255|434312|P2|Overall Study|Drug noncompliance,moved,other|15
135941|NCT00567255|434313|P1|Overall Study|Drug noncompliance,moved,other|25
135942|NCT00567255|434312|P2|Overall Study|Pregnancy|0
135943|NCT00567255|434313|P1|Overall Study|Pregnancy|6
135944|NCT00567255|434312|P2|Overall Study|Protocol Violation|8
135945|NCT00567255|434313|P1|Overall Study|Protocol Violation|20
135946|NCT00567255|434312|P2|Overall Study|Lack of Efficacy|33
135947|NCT00567255|434313|P1|Overall Study|Lack of Efficacy|19
135948|NCT00567255|434312|P2|Overall Study|Withdrawal by Subject|56
135949|NCT00567255|434313|P1|Overall Study|Withdrawal by Subject|75
135950|NCT00567255|434312|P2|Overall Study|Lost to Follow-up|48
135951|NCT00567255|434313|P1|Overall Study|Lost to Follow-up|77
135952|NCT00567255|434312|P2|Overall Study|Adverse Event|68
135953|NCT00567255|434313|P1|Overall Study|Adverse Event|241
135954|NCT00567268|434357|P1|Overall Study|"Safety Evaluation Not Assessable"|1
135955|NCT00567268|434357|P1|Overall Study|No Drug Administration|4
135956|NCT00567268|434357|P1|Overall Study|No Visit After First Day of Treatment|2
135957|NCT00567268|434357|P1|Overall Study|Lost to Follow-up|36
135958|NCT00567268|434357|P1|Overall Study|Protocol Violation|7
135959|NCT00567476|434426|P2|Overall Study|Non-adherence to protocol|1
135960|NCT00567476|434427|P1|Overall Study|Non-adherence to protocol|0
135961|NCT00567476|434426|P2|Overall Study|Medical Decision|1
135962|NCT00567476|434427|P1|Overall Study|Medical Decision|0
135963|NCT00567476|434426|P2|Overall Study|Administrative issues|0
135964|NCT00567476|434427|P1|Overall Study|Administrative issues|1
135965|NCT00567476|434426|P2|Overall Study|Lost to Follow-up|1
135966|NCT00567476|434427|P1|Overall Study|Lost to Follow-up|0
135967|NCT00567476|434426|P2|Overall Study|Protocol Violation|1
135968|NCT00567476|434427|P1|Overall Study|Protocol Violation|4
135969|NCT00567476|434426|P2|Overall Study|Pregnancy|0
135970|NCT00567476|434427|P1|Overall Study|Pregnancy|1
135971|NCT00567476|434426|P2|Overall Study|Adverse Event|0
135972|NCT00567476|434427|P1|Overall Study|Adverse Event|2
135973|NCT00567502|434455|P4|Overall Study|Never Initiated Treatment|72
135974|NCT00567502|434456|P3|Overall Study|Never Initiated Treatment|0
135975|NCT00567502|434457|P2|Overall Study|Never Initiated Treatment|0
135976|NCT00567502|434458|P1|Overall Study|Never Initiated Treatment|0
135977|NCT00567502|434455|P4|Overall Study|Sponsor request|1
135978|NCT00567502|434456|P3|Overall Study|Sponsor request|30
135979|NCT00567502|434457|P2|Overall Study|Sponsor request|0
135980|NCT00567502|434458|P1|Overall Study|Sponsor request|9
135981|NCT00567502|434455|P4|Overall Study|Participant request|1
135982|NCT00567502|434456|P3|Overall Study|Participant request|33
135983|NCT00567502|434457|P2|Overall Study|Participant request|1
135984|NCT00567502|434458|P1|Overall Study|Participant request|12
135985|NCT00567502|434455|P4|Overall Study|Unspecified|6
135986|NCT00567502|434456|P3|Overall Study|Unspecified|134
135987|NCT00567502|434457|P2|Overall Study|Unspecified|2
135988|NCT00567502|434458|P1|Overall Study|Unspecified|64
135989|NCT00567502|434455|P4|Overall Study|Death|5
135990|NCT00567502|434456|P3|Overall Study|Death|360
135991|NCT00567502|434457|P2|Overall Study|Death|16
135992|NCT00567502|434458|P1|Overall Study|Death|65
135993|NCT00567502|434455|P4|Overall Study|Lost to Follow-up|2
135994|NCT00567502|434456|P3|Overall Study|Lost to Follow-up|351
135995|NCT00567502|434457|P2|Overall Study|Lost to Follow-up|14
135996|NCT00567502|434458|P1|Overall Study|Lost to Follow-up|91
135997|NCT00567541|434495|P2|Overall Study|Adverse Event|1
135998|NCT00567541|434496|P1|Overall Study|Adverse Event|0
135999|NCT00567567|434505|P3|Overall Study|Unable adequate stem cell for transplant|2
136000|NCT00567567|434506|P2|Overall Study|Unable adequate stem cell for transplant|0
136001|NCT00567567|434507|P1|Overall Study|Unable adequate stem cell for transplant|0
136002|NCT00567567|434505|P3|Overall Study|Enrolled another COG therapeutic study|0
136003|NCT00567567|434506|P2|Overall Study|Enrolled another COG therapeutic study|80
136004|NCT00567567|434507|P1|Overall Study|Enrolled another COG therapeutic study|99
136005|NCT00567567|434505|P3|Overall Study|Refusal by patient/parent/guardian|122
136006|NCT00567567|434506|P2|Overall Study|Refusal by patient/parent/guardian|16
136007|NCT00567567|434507|P1|Overall Study|Refusal by patient/parent/guardian|9
136008|NCT00567567|434505|P3|Overall Study|Ineligible|9
136009|NCT00567567|434506|P2|Overall Study|Ineligible|0
136010|NCT00567567|434507|P1|Overall Study|Ineligible|4
136011|NCT00567567|434505|P3|Overall Study|Withdrawal by Subject|2
136012|NCT00567567|434506|P2|Overall Study|Withdrawal by Subject|0
136013|NCT00567567|434507|P1|Overall Study|Withdrawal by Subject|0
136014|NCT00567567|434505|P3|Overall Study|Physician Decision|84
136015|NCT00567567|434506|P2|Overall Study|Physician Decision|18
136016|NCT00567567|434507|P1|Overall Study|Physician Decision|16
136017|NCT00567567|434505|P3|Overall Study|Lost to Follow-up|1
136018|NCT00567567|434506|P2|Overall Study|Lost to Follow-up|0
136019|NCT00567567|434507|P1|Overall Study|Lost to Follow-up|0
136020|NCT00567567|434505|P3|Overall Study|Lack of Efficacy|48
136021|NCT00567567|434506|P2|Overall Study|Lack of Efficacy|17
136022|NCT00567567|434507|P1|Overall Study|Lack of Efficacy|16
136023|NCT00567567|434505|P3|Overall Study|Death|5
136024|NCT00567567|434506|P2|Overall Study|Death|1
136025|NCT00567567|434507|P1|Overall Study|Death|8
136026|NCT00567567|434505|P3|Overall Study|Adverse Event|5
136027|NCT00567567|434506|P2|Overall Study|Adverse Event|2
136028|NCT00567567|434507|P1|Overall Study|Adverse Event|0
136029|NCT00567593|434531|P1|Overall Study|Physician Decision|1
136030|NCT00567593|434531|P1|Overall Study|Adverse Event|1
136031|NCT00567879|434587|P6|Overall Study|Disease progression|3
136032|NCT00567879|434588|P5|Overall Study|Disease progression|11
136033|NCT00567879|434589|P4|Overall Study|Disease progression|5
136034|NCT00567879|434590|P3|Overall Study|Disease progression|15
136035|NCT00567879|434591|P2|Overall Study|Disease progression|7
136036|NCT00567879|434592|P1|Overall Study|Disease progression|5
136037|NCT00567879|434587|P6|Overall Study|New cancer therapy|0
136038|NCT00567879|434588|P5|Overall Study|New cancer therapy|0
136039|NCT00567879|434589|P4|Overall Study|New cancer therapy|0
136040|NCT00567879|434590|P3|Overall Study|New cancer therapy|1
136041|NCT00567879|434591|P2|Overall Study|New cancer therapy|0
136042|NCT00567879|434592|P1|Overall Study|New cancer therapy|0
136043|NCT00567879|434587|P6|Overall Study|Withdrawal by Subject|0
136044|NCT00567879|434588|P5|Overall Study|Withdrawal by Subject|0
136045|NCT00567879|434589|P4|Overall Study|Withdrawal by Subject|1
136046|NCT00567879|434590|P3|Overall Study|Withdrawal by Subject|3
136047|NCT00567879|434591|P2|Overall Study|Withdrawal by Subject|0
136048|NCT00567879|434592|P1|Overall Study|Withdrawal by Subject|0
136049|NCT00567879|434587|P6|Overall Study|Abnormal test procedure(s)|0
136050|NCT00567879|434588|P5|Overall Study|Abnormal test procedure(s)|0
136051|NCT00567879|434589|P4|Overall Study|Abnormal test procedure(s)|0
136052|NCT00567879|434590|P3|Overall Study|Abnormal test procedure(s)|1
136053|NCT00567879|434591|P2|Overall Study|Abnormal test procedure(s)|0
136054|NCT00567879|434592|P1|Overall Study|Abnormal test procedure(s)|0
136055|NCT00567879|434587|P6|Overall Study|Adverse Event|0
136056|NCT00567879|434588|P5|Overall Study|Adverse Event|1
136057|NCT00567879|434589|P4|Overall Study|Adverse Event|0
136058|NCT00567879|434590|P3|Overall Study|Adverse Event|1
136059|NCT00567879|434591|P2|Overall Study|Adverse Event|0
136060|NCT00567879|434592|P1|Overall Study|Adverse Event|2
136061|NCT00567892|434615|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
136062|NCT00567892|434616|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
136063|NCT00567892|434617|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
136064|NCT00567892|434618|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
136065|NCT00567892|434615|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
136066|NCT00567892|434616|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
136067|NCT00567892|434617|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
136068|NCT00567892|434618|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
136069|NCT00567996|434633|P3|Overall Study|Patient's inability to use the device|0
136070|NCT00567996|434634|P2|Overall Study|Patient's inability to use the device|1
136071|NCT00567996|434635|P1|Overall Study|Patient's inability to use the device|0
136072|NCT00567996|434633|P3|Overall Study|Death|2
136073|NCT00567996|434634|P2|Overall Study|Death|0
136074|NCT00567996|434635|P1|Overall Study|Death|1
136075|NCT00567996|434633|P3|Overall Study|Administrative problems|0
136076|NCT00567996|434634|P2|Overall Study|Administrative problems|1
136077|NCT00567996|434635|P1|Overall Study|Administrative problems|1
136078|NCT00567996|434633|P3|Overall Study|Unsatisfactory therapeutic effect|15
136079|NCT00567996|434634|P2|Overall Study|Unsatisfactory therapeutic effect|2
136080|NCT00567996|434635|P1|Overall Study|Unsatisfactory therapeutic effect|1
136081|NCT00567996|434633|P3|Overall Study|Lost to Follow-up|2
136082|NCT00567996|434634|P2|Overall Study|Lost to Follow-up|5
136083|NCT00567996|434635|P1|Overall Study|Lost to Follow-up|2
136084|NCT00567996|434633|P3|Overall Study|Abnormal test procedure result(s)|1
136085|NCT00567996|434634|P2|Overall Study|Abnormal test procedure result(s)|1
136086|NCT00567996|434635|P1|Overall Study|Abnormal test procedure result(s)|2
136087|NCT00567996|434633|P3|Overall Study|Abnormal Lab value(s)|2
136088|NCT00567996|434634|P2|Overall Study|Abnormal Lab value(s)|1
136089|NCT00567996|434635|P1|Overall Study|Abnormal Lab value(s)|2
136090|NCT00567996|434633|P3|Overall Study|Withdrawal by Subject|22
136091|NCT00567996|434634|P2|Overall Study|Withdrawal by Subject|12
136092|NCT00567996|434635|P1|Overall Study|Withdrawal by Subject|8
136093|NCT00567996|434633|P3|Overall Study|Protocol Deviation|13
136094|NCT00567996|434634|P2|Overall Study|Protocol Deviation|11
136095|NCT00567996|434635|P1|Overall Study|Protocol Deviation|9
136096|NCT00567996|434633|P3|Overall Study|Adverse Event|13
136097|NCT00567996|434634|P2|Overall Study|Adverse Event|16
136098|NCT00567996|434635|P1|Overall Study|Adverse Event|18
136099|NCT00568061|434686|P2|Overall Study|Adverse Event|1
136100|NCT00568061|434687|P1|Overall Study|Adverse Event|0
136101|NCT00568061|434686|P2|Overall Study|Inclusion / exclusion criteria|1
136102|NCT00568061|434687|P1|Overall Study|Inclusion / exclusion criteria|5
136103|NCT00568178|434708|P6|Open Label Extension|Withdrawal by Subject|4
136104|NCT00568178|434709|P5|Open Label Extension|Withdrawal by Subject|4
136105|NCT00568178|434710|P4|Open Label Extension|Withdrawal by Subject|0
136106|NCT00568178|434711|P3|Open Label Extension|Withdrawal by Subject|0
136107|NCT00568178|434712|P2|Open Label Extension|Withdrawal by Subject|0
136108|NCT00568178|434713|P1|Open Label Extension|Withdrawal by Subject|0
136109|NCT00568178|434708|P6|Open Label Extension|Termination of Trial|47
136110|NCT00568178|434709|P5|Open Label Extension|Termination of Trial|45
136111|NCT00568178|434710|P4|Open Label Extension|Termination of Trial|0
136112|NCT00568178|434711|P3|Open Label Extension|Termination of Trial|0
136113|NCT00568178|434712|P2|Open Label Extension|Termination of Trial|0
136114|NCT00568178|434713|P1|Open Label Extension|Termination of Trial|0
136115|NCT00568178|434708|P6|Open Label Extension|Progressive Disease|1
136116|NCT00568178|434709|P5|Open Label Extension|Progressive Disease|3
136117|NCT00568178|434710|P4|Open Label Extension|Progressive Disease|0
136118|NCT00568178|434711|P3|Open Label Extension|Progressive Disease|0
136119|NCT00568178|434712|P2|Open Label Extension|Progressive Disease|0
136120|NCT00568178|434713|P1|Open Label Extension|Progressive Disease|0
136121|NCT00568178|434708|P6|Open Label Extension|Pregnancy|1
136122|NCT00568178|434709|P5|Open Label Extension|Pregnancy|0
136123|NCT00568178|434710|P4|Open Label Extension|Pregnancy|0
136124|NCT00568178|434711|P3|Open Label Extension|Pregnancy|0
136125|NCT00568178|434712|P2|Open Label Extension|Pregnancy|0
136126|NCT00568178|434713|P1|Open Label Extension|Pregnancy|0
136127|NCT00568178|434708|P6|Open Label Extension|Physician Decision|8
136128|NCT00568178|434709|P5|Open Label Extension|Physician Decision|9
136129|NCT00568178|434710|P4|Open Label Extension|Physician Decision|0
136130|NCT00568178|434711|P3|Open Label Extension|Physician Decision|0
136131|NCT00568178|434712|P2|Open Label Extension|Physician Decision|0
136132|NCT00568178|434713|P1|Open Label Extension|Physician Decision|0
136133|NCT00568178|434708|P6|Open Label Extension|Lost to Follow-up|11
136134|NCT00568178|434709|P5|Open Label Extension|Lost to Follow-up|6
136135|NCT00568178|434710|P4|Open Label Extension|Lost to Follow-up|0
136136|NCT00568178|434711|P3|Open Label Extension|Lost to Follow-up|0
136137|NCT00568178|434712|P2|Open Label Extension|Lost to Follow-up|0
136138|NCT00568178|434713|P1|Open Label Extension|Lost to Follow-up|0
136139|NCT00568178|434708|P6|Open Label Extension|Protocol Violation|0
136140|NCT00568178|434709|P5|Open Label Extension|Protocol Violation|1
136141|NCT00568178|434710|P4|Open Label Extension|Protocol Violation|0
136142|NCT00568178|434711|P3|Open Label Extension|Protocol Violation|0
136143|NCT00568178|434712|P2|Open Label Extension|Protocol Violation|0
136144|NCT00568178|434713|P1|Open Label Extension|Protocol Violation|0
136145|NCT00568178|434708|P6|Open Label Extension|Adverse Event|8
136146|NCT00568178|434709|P5|Open Label Extension|Adverse Event|11
136147|NCT00568178|434710|P4|Open Label Extension|Adverse Event|0
136148|NCT00568178|434711|P3|Open Label Extension|Adverse Event|0
136149|NCT00568178|434712|P2|Open Label Extension|Adverse Event|0
136150|NCT00568178|434713|P1|Open Label Extension|Adverse Event|0
136151|NCT00568178|434708|P6|Double Blind Base Study|Progressive Disease|0
136152|NCT00568178|434709|P5|Double Blind Base Study|Progressive Disease|0
136153|NCT00568178|434710|P4|Double Blind Base Study|Progressive Disease|1
136154|NCT00568178|434711|P3|Double Blind Base Study|Progressive Disease|0
136155|NCT00568178|434712|P2|Double Blind Base Study|Progressive Disease|0
136156|NCT00568178|434713|P1|Double Blind Base Study|Progressive Disease|0
136157|NCT00568178|434708|P6|Double Blind Base Study|Withdrawal by Subject|0
136158|NCT00568178|434709|P5|Double Blind Base Study|Withdrawal by Subject|0
136159|NCT00568178|434710|P4|Double Blind Base Study|Withdrawal by Subject|0
136160|NCT00568178|434711|P3|Double Blind Base Study|Withdrawal by Subject|0
136161|NCT00568178|434712|P2|Double Blind Base Study|Withdrawal by Subject|1
136162|NCT00568178|434713|P1|Double Blind Base Study|Withdrawal by Subject|1
136163|NCT00568178|434708|P6|Double Blind Base Study|Protocol Violation|0
136164|NCT00568178|434709|P5|Double Blind Base Study|Protocol Violation|0
136165|NCT00568178|434710|P4|Double Blind Base Study|Protocol Violation|0
136166|NCT00568178|434711|P3|Double Blind Base Study|Protocol Violation|0
136167|NCT00568178|434712|P2|Double Blind Base Study|Protocol Violation|2
136168|NCT00568178|434713|P1|Double Blind Base Study|Protocol Violation|3
136169|NCT00568178|434708|P6|Double Blind Base Study|Physician Decision|0
136170|NCT00568178|434709|P5|Double Blind Base Study|Physician Decision|0
136171|NCT00568178|434710|P4|Double Blind Base Study|Physician Decision|1
136172|NCT00568178|434711|P3|Double Blind Base Study|Physician Decision|0
136173|NCT00568178|434712|P2|Double Blind Base Study|Physician Decision|1
136174|NCT00568178|434713|P1|Double Blind Base Study|Physician Decision|1
136175|NCT00568178|434708|P6|Double Blind Base Study|Lost to Follow-up|0
136176|NCT00568178|434709|P5|Double Blind Base Study|Lost to Follow-up|0
136177|NCT00568178|434710|P4|Double Blind Base Study|Lost to Follow-up|1
136178|NCT00568178|434711|P3|Double Blind Base Study|Lost to Follow-up|0
136179|NCT00568178|434712|P2|Double Blind Base Study|Lost to Follow-up|0
136180|NCT00568178|434713|P1|Double Blind Base Study|Lost to Follow-up|1
136181|NCT00568178|434708|P6|Double Blind Base Study|Adverse Event|0
136182|NCT00568178|434709|P5|Double Blind Base Study|Adverse Event|0
136183|NCT00568178|434710|P4|Double Blind Base Study|Adverse Event|2
136184|NCT00568178|434711|P3|Double Blind Base Study|Adverse Event|1
136185|NCT00568178|434712|P2|Double Blind Base Study|Adverse Event|2
136186|NCT00568178|434713|P1|Double Blind Base Study|Adverse Event|0
136187|NCT00568334|434731|P2|Overall Study|Lost to Follow-up|0
136188|NCT00568334|434732|P1|Overall Study|Lost to Follow-up|1
136189|NCT00568334|434731|P2|Overall Study|Withdrawal by Subject|1
136190|NCT00568334|434732|P1|Overall Study|Withdrawal by Subject|0
136191|NCT00568399|434765|P1|Overall Study|Withdrawal by Subject|8
136192|NCT00568399|434765|P1|Overall Study|Adverse Event|5
136193|NCT00568399|434765|P1|Overall Study|Death|2
136194|NCT00568451|434773|P4|Overall Study|Disease Progression|7
136195|NCT00568451|434774|P3|Overall Study|Disease Progression|2
136196|NCT00568451|434775|P2|Overall Study|Disease Progression|0
136197|NCT00568451|434776|P1|Overall Study|Disease Progression|0
136198|NCT00556673|434840|P2|Overall Study|Protocol deviation|2
136199|NCT00556673|434841|P1|Overall Study|Protocol deviation|3
136200|NCT00556712|434879|P2|Overall Study|Ongoing at Data Cutoff|66
136201|NCT00556712|434880|P1|Overall Study|Ongoing at Data Cutoff|32
136202|NCT00556712|434879|P2|Overall Study|Not Specified|2
136203|NCT00556712|434880|P1|Overall Study|Not Specified|2
136204|NCT00556712|434879|P2|Overall Study|Failure to Return|3
136205|NCT00556712|434880|P1|Overall Study|Failure to Return|2
136206|NCT00556712|434879|P2|Overall Study|Refused Treatment|16
136207|NCT00556712|434880|P1|Overall Study|Refused Treatment|17
136208|NCT00556712|434879|P2|Overall Study|Protocol Violation|2
136209|NCT00556712|434880|P1|Overall Study|Protocol Violation|3
136210|NCT00556712|434879|P2|Overall Study|Progressive Disease|320
136211|NCT00556712|434880|P1|Overall Study|Progressive Disease|383
136212|NCT00556712|434879|P2|Overall Study|Death|10
136213|NCT00556712|434880|P1|Overall Study|Death|5
136214|NCT00556712|434879|P2|Overall Study|Adverse Event|19
136215|NCT00556712|434880|P1|Overall Study|Adverse Event|7
136216|NCT00562354|434977|P2|Overall Study|Lost to Follow-up|1
136217|NCT00562354|434978|P1|Overall Study|Lost to Follow-up|0
136218|NCT00562354|434977|P2|Overall Study|Physician Decision|1
136219|NCT00562354|434978|P1|Overall Study|Physician Decision|0
136220|NCT00562484|435021|P2|Overall Study|Reason not provided or not specified|12
136221|NCT00562484|435022|P1|Overall Study|Reason not provided or not specified|25
136222|NCT00562484|435021|P2|Overall Study|Lost to Follow-up|71
136223|NCT00562484|435022|P1|Overall Study|Lost to Follow-up|132
136224|NCT00562484|435021|P2|Overall Study|Moved away from the study area|9
136225|NCT00562484|435022|P1|Overall Study|Moved away from the study area|20
136226|NCT00562484|435021|P2|Overall Study|Withdrawal by Subject|9
136227|NCT00562484|435022|P1|Overall Study|Withdrawal by Subject|12
136228|NCT00562484|435021|P2|Overall Study|Protocol Violation|2
136229|NCT00562484|435022|P1|Overall Study|Protocol Violation|11
136230|NCT00562484|435021|P2|Overall Study|Adverse Event|1
136231|NCT00562484|435022|P1|Overall Study|Adverse Event|6
136232|NCT00562588|435054|P2|Overall Study|Other|2
136233|NCT00562588|435055|P1|Overall Study|Other|0
136234|NCT00562588|435054|P2|Overall Study|Withdrawal by Subject|9
136235|NCT00562588|435055|P1|Overall Study|Withdrawal by Subject|10
136236|NCT00562588|435054|P2|Overall Study|Lost to Follow-up|4
136237|NCT00562588|435055|P1|Overall Study|Lost to Follow-up|12
136238|NCT00562588|435054|P2|Overall Study|Protocol Violation|26
136239|NCT00562588|435055|P1|Overall Study|Protocol Violation|30
136240|NCT00562588|435054|P2|Overall Study|Adverse Event|58
136241|NCT00562588|435055|P1|Overall Study|Adverse Event|40
136242|NCT00562627|435086|P3|Overall Study|Protocol Violation|1
136243|NCT00562627|435087|P2|Overall Study|Protocol Violation|1
136244|NCT00562627|435088|P1|Overall Study|Protocol Violation|1
136245|NCT00568555|435104|P2|Overall Study|Withdrawal by Subject|1
136246|NCT00568555|435105|P1|Overall Study|Withdrawal by Subject|1
136247|NCT00568685|435122|P3|Overall Study|Protocol Violation|0
136248|NCT00568685|435123|P2|Overall Study|Protocol Violation|0
136249|NCT00568685|435124|P1|Overall Study|Protocol Violation|1
136250|NCT00568685|435122|P3|Overall Study|Withdrawal by Subject|2
136251|NCT00568685|435123|P2|Overall Study|Withdrawal by Subject|2
136252|NCT00568685|435124|P1|Overall Study|Withdrawal by Subject|7
136253|NCT00568685|435122|P3|Overall Study|Adverse Event|3
136254|NCT00568685|435123|P2|Overall Study|Adverse Event|3
136255|NCT00568685|435124|P1|Overall Study|Adverse Event|2
136256|NCT00568776|435160|P4|Overall Study|Miscellaeneous|4
136257|NCT00568776|435161|P3|Overall Study|Miscellaeneous|1
136258|NCT00568776|435162|P2|Overall Study|Miscellaeneous|3
136259|NCT00568776|435163|P1|Overall Study|Miscellaeneous|3
136260|NCT00568776|435160|P4|Overall Study|Sponsor Decision|42
136261|NCT00568776|435161|P3|Overall Study|Sponsor Decision|41
136262|NCT00568776|435162|P2|Overall Study|Sponsor Decision|2
136263|NCT00568776|435163|P1|Overall Study|Sponsor Decision|2
136264|NCT00568776|435160|P4|Overall Study|Loss of Caregiver|2
136265|NCT00568776|435161|P3|Overall Study|Loss of Caregiver|1
136266|NCT00568776|435162|P2|Overall Study|Loss of Caregiver|2
136267|NCT00568776|435163|P1|Overall Study|Loss of Caregiver|0
136268|NCT00568776|435160|P4|Overall Study|Withdrawal by Subject|7
136269|NCT00568776|435161|P3|Overall Study|Withdrawal by Subject|13
136270|NCT00568776|435162|P2|Overall Study|Withdrawal by Subject|15
136271|NCT00568776|435163|P1|Overall Study|Withdrawal by Subject|13
136272|NCT00568776|435160|P4|Overall Study|Protocol Violation|1
136273|NCT00568776|435161|P3|Overall Study|Protocol Violation|1
136274|NCT00568776|435162|P2|Overall Study|Protocol Violation|0
136275|NCT00568776|435163|P1|Overall Study|Protocol Violation|1
136276|NCT00568776|435160|P4|Overall Study|Lost to Follow-up|1
136277|NCT00568776|435161|P3|Overall Study|Lost to Follow-up|1
136278|NCT00568776|435162|P2|Overall Study|Lost to Follow-up|1
136279|NCT00568776|435163|P1|Overall Study|Lost to Follow-up|1
136280|NCT00568776|435160|P4|Overall Study|Lack of Efficacy|4
136281|NCT00568776|435161|P3|Overall Study|Lack of Efficacy|2
136282|NCT00568776|435162|P2|Overall Study|Lack of Efficacy|2
136283|NCT00568776|435163|P1|Overall Study|Lack of Efficacy|2
136284|NCT00568776|435160|P4|Overall Study|Physician Decision|0
136285|NCT00568776|435161|P3|Overall Study|Physician Decision|0
136286|NCT00568776|435162|P2|Overall Study|Physician Decision|2
136287|NCT00568776|435163|P1|Overall Study|Physician Decision|0
136288|NCT00568776|435160|P4|Overall Study|Death|3
136289|NCT00568776|435161|P3|Overall Study|Death|4
136290|NCT00568776|435162|P2|Overall Study|Death|1
136291|NCT00568776|435163|P1|Overall Study|Death|0
136292|NCT00568776|435160|P4|Overall Study|Adverse Event|8
136293|NCT00568776|435161|P3|Overall Study|Adverse Event|10
136294|NCT00568776|435162|P2|Overall Study|Adverse Event|8
136295|NCT00568776|435163|P1|Overall Study|Adverse Event|8
136296|NCT00568958|435210|P2|Follow-Up|Family Emergency|0
136297|NCT00568958|435211|P1|Follow-Up|Family Emergency|1
136298|NCT00568958|435210|P2|Follow-Up|Physician Decision|1
136299|NCT00568958|435211|P1|Follow-Up|Physician Decision|1
136300|NCT00568958|435210|P2|Follow-Up|Withdrawal by Subject|3
136301|NCT00568958|435211|P1|Follow-Up|Withdrawal by Subject|6
136302|NCT00568958|435210|P2|Allocation|Physician Decision|0
136303|NCT00568958|435211|P1|Allocation|Physician Decision|2
136304|NCT00568958|435210|P2|Allocation|Withdrawal by Subject|3
136305|NCT00568958|435211|P1|Allocation|Withdrawal by Subject|7
136306|NCT00569127|435248|P2|Overall Study|Still on Treatment|3
136307|NCT00569127|435249|P1|Overall Study|Still on Treatment|7
136308|NCT00569127|435248|P2|Overall Study|Not Eligible|11
136309|NCT00569127|435249|P1|Overall Study|Not Eligible|14
136310|NCT00569127|435248|P2|Overall Study|Lost to Follow-up|3
136311|NCT00569127|435249|P1|Overall Study|Lost to Follow-up|0
136312|NCT00569127|435248|P2|Overall Study|Not Specified|19
136313|NCT00569127|435249|P1|Overall Study|Not Specified|20
136314|NCT00569127|435248|P2|Overall Study|Death|3
136315|NCT00569127|435249|P1|Overall Study|Death|4
136316|NCT00569127|435248|P2|Overall Study|Progression|100
136317|NCT00569127|435249|P1|Overall Study|Progression|99
136318|NCT00569127|435248|P2|Overall Study|Withdrawal by Subject|27
136319|NCT00569127|435249|P1|Overall Study|Withdrawal by Subject|13
136320|NCT00569127|435248|P2|Overall Study|Adverse Event|47
136321|NCT00569127|435249|P1|Overall Study|Adverse Event|57
136322|NCT00569166|435268|P3|Overall Study|Lost to Follow-up|1
136323|NCT00569166|435269|P2|Overall Study|Lost to Follow-up|1
136324|NCT00569166|435270|P1|Overall Study|Lost to Follow-up|2
136325|NCT00569166|435268|P3|Overall Study|Withdrawal by Subject|3
136326|NCT00569166|435269|P2|Overall Study|Withdrawal by Subject|5
136327|NCT00569166|435270|P1|Overall Study|Withdrawal by Subject|7
136328|NCT00569231|435330|P1|Overall Study|Non-compliance|2
136329|NCT00569231|435330|P1|Overall Study|Car accident injury|1
136330|NCT00569231|435330|P1|Overall Study|Withdrawal by Subject|1
136331|NCT00569231|435330|P1|Overall Study|Airfare expense|2
136332|NCT00569231|435330|P1|Overall Study|Study unrelated surgery|1
136333|NCT00569270|435337|P2|Period: First Intervention|Protocol Violation|1
136334|NCT00569270|435338|P1|Period: First Intervention|Protocol Violation|0
136335|NCT00569374|435373|P1|Overall Study|Withdrawal by Subject|4
136336|NCT00569582|435394|P1|Overall Study|Subject was non-compliant.|1
136337|NCT00569582|435394|P1|Overall Study|Subject was too ill to travel.|1
136338|NCT00569582|435394|P1|Overall Study|Adverse Event|7
136339|NCT00569582|435394|P1|Overall Study|Death|2
136340|NCT00569582|435394|P1|Overall Study|Withdrawal by Subject|5
136341|NCT00569777|435409|P2|Overall Study|pregnant|0
136342|NCT00569777|435410|P1|Overall Study|pregnant|1
136343|NCT00569777|435409|P2|Overall Study|did not meet exclusion criteria|2
136344|NCT00569777|435410|P1|Overall Study|did not meet exclusion criteria|1
136345|NCT00569777|435409|P2|Overall Study|scheduled eye surgery|1
136346|NCT00569777|435410|P1|Overall Study|scheduled eye surgery|0
136347|NCT00569777|435409|P2|Overall Study|Lost to Follow-up|0
136348|NCT00569777|435410|P1|Overall Study|Lost to Follow-up|1
136349|NCT00569777|435409|P2|Overall Study|Adverse Event|0
136350|NCT00569777|435410|P1|Overall Study|Adverse Event|3
136351|NCT00569777|435409|P2|Overall Study|Withdrawal by Subject|0
136352|NCT00569777|435410|P1|Overall Study|Withdrawal by Subject|4
136353|NCT00569803|435460|P8|Overall Study|Withdrawal by Subject|1
136354|NCT00569803|435461|P7|Overall Study|Withdrawal by Subject|0
136355|NCT00569803|435462|P6|Overall Study|Withdrawal by Subject|0
136356|NCT00569803|435463|P5|Overall Study|Withdrawal by Subject|0
136357|NCT00569803|435464|P4|Overall Study|Withdrawal by Subject|0
136358|NCT00569803|435465|P3|Overall Study|Withdrawal by Subject|0
136359|NCT00569803|435466|P2|Overall Study|Withdrawal by Subject|0
136360|NCT00569803|435467|P1|Overall Study|Withdrawal by Subject|0
136361|NCT00569803|435460|P8|Overall Study|injection syringe leaked during dosing|0
136362|NCT00569803|435461|P7|Overall Study|injection syringe leaked during dosing|0
136363|NCT00569803|435462|P6|Overall Study|injection syringe leaked during dosing|0
136364|NCT00569803|435463|P5|Overall Study|injection syringe leaked during dosing|0
136365|NCT00569803|435464|P4|Overall Study|injection syringe leaked during dosing|1
136366|NCT00569803|435465|P3|Overall Study|injection syringe leaked during dosing|0
136367|NCT00569803|435466|P2|Overall Study|injection syringe leaked during dosing|0
136368|NCT00569803|435467|P1|Overall Study|injection syringe leaked during dosing|0
136369|NCT00569803|435460|P8|Overall Study|Lost to Follow-up|0
136370|NCT00569803|435461|P7|Overall Study|Lost to Follow-up|0
136371|NCT00569803|435462|P6|Overall Study|Lost to Follow-up|0
136372|NCT00569803|435463|P5|Overall Study|Lost to Follow-up|0
136373|NCT00569803|435464|P4|Overall Study|Lost to Follow-up|0
136374|NCT00569803|435465|P3|Overall Study|Lost to Follow-up|0
136375|NCT00569803|435466|P2|Overall Study|Lost to Follow-up|0
136376|NCT00569803|435467|P1|Overall Study|Lost to Follow-up|1
136377|NCT00569946|435600|P1|Overall Study|Global Deterioration of Health Status|1
136378|NCT00569946|435600|P1|Overall Study|Objective Progression or Relapse|42
136379|NCT00569946|435600|P1|Overall Study|Adverse Event|16
136380|NCT00570037|435618|P2|Overall Study|Could not reach for 6-8 week contact|69
136381|NCT00570037|435619|P1|Overall Study|Could not reach for 6-8 week contact|44
136382|NCT00570141|435638|P1|Overall Study|Lost to Follow-up|1
136383|NCT00570141|435638|P1|Overall Study|Missed visits|1
136384|NCT00570141|435638|P1|Overall Study|Adverse Event|1
136385|NCT00570232|435643|P1|Overall Study|discontinued due to noncompliance|2
136386|NCT00570232|435643|P1|Overall Study|discontinued due to recurrence|8
136387|NCT00570232|435643|P1|Overall Study|discontinued due to medical condition|3
136388|NCT00570232|435643|P1|Overall Study|Adverse Event|10
136389|NCT00570310|435651|P2|Overall Study|Lack of Efficacy|4
136390|NCT00570310|435652|P1|Overall Study|Lack of Efficacy|1
136391|NCT00570310|435651|P2|Overall Study|Adverse Event|2
136392|NCT00570310|435652|P1|Overall Study|Adverse Event|1
136393|NCT00570401|435688|P1|Overall Study|Adverse Event|2
136394|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
136395|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
136396|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
136397|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
136398|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
136399|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
136400|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Physician Decision|4
136401|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Physician Decision|2
136402|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Physician Decision|0
136403|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Adverse Event|5
136404|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Adverse Event|5
136405|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Adverse Event|0
136406|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
136407|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
136408|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
136409|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Protocol Violation|15
136410|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Protocol Violation|12
136411|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Protocol Violation|0
136412|NCT00570492|435694|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
136413|NCT00570492|435695|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
136414|NCT00570492|435696|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
136415|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
136416|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
136417|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
136418|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Adverse Event|0
136419|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Adverse Event|0
136420|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Adverse Event|1
136421|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
136422|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
136423|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
136424|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Protocol Violation|0
136425|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Protocol Violation|0
136426|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Protocol Violation|15
136427|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
136428|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
136429|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
136430|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
136431|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
136432|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
136433|NCT00570492|435694|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
136434|NCT00570492|435695|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
136435|NCT00570492|435696|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
136436|NCT00570505|435734|P1|Overall Study|Other loss to follow-up|4
136437|NCT00570505|435734|P1|Overall Study|Lost to Follow-up|23
136438|NCT00570505|435734|P1|Overall Study|Withdrawal by Subject|7
136439|NCT00570505|435734|P1|Overall Study|Adverse Event|7
136440|NCT00570674|435751|P7|Overall Study|Withdrawal by Subject|0
136441|NCT00570674|435752|P6|Overall Study|Withdrawal by Subject|0
136442|NCT00570674|435753|P5|Overall Study|Withdrawal by Subject|0
136443|NCT00570674|435754|P4|Overall Study|Withdrawal by Subject|0
136444|NCT00570674|435755|P3|Overall Study|Withdrawal by Subject|1
136445|NCT00570674|435756|P2|Overall Study|Withdrawal by Subject|0
136446|NCT00570674|435757|P1|Overall Study|Withdrawal by Subject|0
136447|NCT00570687|435772|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136448|NCT00570687|435773|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136449|NCT00570687|435774|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136450|NCT00570687|435775|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
136451|NCT00570687|435776|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136452|NCT00570687|435777|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136453|NCT00570687|435778|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136454|NCT00570687|435779|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136455|NCT00570687|435780|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136456|NCT00570687|435781|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136457|NCT00570687|435772|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136458|NCT00570687|435773|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
136459|NCT00570687|435774|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136460|NCT00570687|435775|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136461|NCT00570687|435776|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136462|NCT00570687|435777|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136463|NCT00570687|435778|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136464|NCT00570687|435779|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136465|NCT00570687|435780|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136466|NCT00570687|435781|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136467|NCT00570687|435772|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
136468|NCT00570687|435773|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
136469|NCT00570687|435774|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
136470|NCT00570687|435775|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
136471|NCT00570687|435776|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
136472|NCT00570687|435777|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
136473|NCT00570687|435778|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136474|NCT00570687|435779|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136475|NCT00570687|435780|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136476|NCT00570687|435781|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
136477|NCT00570713|435809|P2|Overall Study|Discontinuation of Study by the Sponsor|7
136478|NCT00570713|435810|P1|Overall Study|Discontinuation of Study by the Sponsor|10
136479|NCT00570713|435809|P2|Overall Study|Withdrawal by Subject|3
136480|NCT00570713|435810|P1|Overall Study|Withdrawal by Subject|3
136481|NCT00570713|435809|P2|Overall Study|Physician Decision|2
136482|NCT00570713|435810|P1|Overall Study|Physician Decision|2
136483|NCT00570713|435809|P2|Overall Study|Lack of Efficacy|49
136484|NCT00570713|435810|P1|Overall Study|Lack of Efficacy|40
136485|NCT00570713|435809|P2|Overall Study|Death|7
136486|NCT00570713|435810|P1|Overall Study|Death|7
136487|NCT00570713|435809|P2|Overall Study|Adverse Event|9
136488|NCT00570713|435810|P1|Overall Study|Adverse Event|16
136489|NCT00570739|435824|P4|Overall Study|Not specified|3
136490|NCT00570739|435825|P3|Overall Study|Not specified|5
136491|NCT00570739|435826|P2|Overall Study|Not specified|2
136492|NCT00570739|435827|P1|Overall Study|Not specified|0
136493|NCT00570739|435824|P4|Overall Study|Met discontinuation criteria|1
136494|NCT00570739|435825|P3|Overall Study|Met discontinuation criteria|1
136495|NCT00570739|435826|P2|Overall Study|Met discontinuation criteria|0
136496|NCT00570739|435827|P1|Overall Study|Met discontinuation criteria|1
136497|NCT00570739|435824|P4|Overall Study|Required restricted medication|0
136498|NCT00570739|435825|P3|Overall Study|Required restricted medication|1
136499|NCT00570739|435826|P2|Overall Study|Required restricted medication|0
136500|NCT00570739|435827|P1|Overall Study|Required restricted medication|0
136501|NCT00570739|435824|P4|Overall Study|Withdrawal by Subject|5
136502|NCT00570739|435825|P3|Overall Study|Withdrawal by Subject|3
136503|NCT00570739|435826|P2|Overall Study|Withdrawal by Subject|7
136504|NCT00570739|435827|P1|Overall Study|Withdrawal by Subject|7
136505|NCT00570739|435824|P4|Overall Study|Physician Decision|0
136506|NCT00570739|435825|P3|Overall Study|Physician Decision|0
136507|NCT00570739|435826|P2|Overall Study|Physician Decision|1
136508|NCT00570739|435827|P1|Overall Study|Physician Decision|1
136509|NCT00570739|435824|P4|Overall Study|Lost to Follow-up|1
136510|NCT00570739|435825|P3|Overall Study|Lost to Follow-up|4
136511|NCT00570739|435826|P2|Overall Study|Lost to Follow-up|5
136512|NCT00570739|435827|P1|Overall Study|Lost to Follow-up|4
136513|NCT00570739|435824|P4|Overall Study|Adverse Event|2
136514|NCT00570739|435825|P3|Overall Study|Adverse Event|2
136515|NCT00570739|435826|P2|Overall Study|Adverse Event|6
136516|NCT00570739|435827|P1|Overall Study|Adverse Event|8
136517|NCT00570778|435996|P4|Overall Study|Subject no longer requires study drug|0
136518|NCT00570778|435997|P3|Overall Study|Subject no longer requires study drug|0
136519|NCT00570778|435998|P2|Overall Study|Subject no longer requires study drug|1
136520|NCT00570778|435999|P1|Overall Study|Subject no longer requires study drug|0
136521|NCT00570778|435996|P4|Overall Study|Lost to Follow-up|0
136522|NCT00570778|435997|P3|Overall Study|Lost to Follow-up|1
136523|NCT00570778|435998|P2|Overall Study|Lost to Follow-up|0
136524|NCT00570778|435999|P1|Overall Study|Lost to Follow-up|0
136525|NCT00570778|435996|P4|Overall Study|Unsatisfactory therapeutic effect|0
136526|NCT00570778|435997|P3|Overall Study|Unsatisfactory therapeutic effect|0
136527|NCT00570778|435998|P2|Overall Study|Unsatisfactory therapeutic effect|0
136528|NCT00570778|435999|P1|Overall Study|Unsatisfactory therapeutic effect|1
136529|NCT00570778|435996|P4|Overall Study|Abnormal test procedure|0
136530|NCT00570778|435997|P3|Overall Study|Abnormal test procedure|0
136531|NCT00570778|435998|P2|Overall Study|Abnormal test procedure|0
136532|NCT00570778|435999|P1|Overall Study|Abnormal test procedure|1
136533|NCT00570778|435996|P4|Overall Study|Subject withdrew consent|1
136534|NCT00570778|435997|P3|Overall Study|Subject withdrew consent|0
136535|NCT00570778|435998|P2|Overall Study|Subject withdrew consent|1
136536|NCT00570778|435999|P1|Overall Study|Subject withdrew consent|0
136537|NCT00570778|435996|P4|Overall Study|Adverse Event|1
136538|NCT00570778|435997|P3|Overall Study|Adverse Event|4
136539|NCT00570778|435998|P2|Overall Study|Adverse Event|1
136540|NCT00570778|435999|P1|Overall Study|Adverse Event|0
136541|NCT00570778|435996|P4|Overall Study|Protocol deviation|2
136542|NCT00570778|435997|P3|Overall Study|Protocol deviation|2
136543|NCT00570778|435998|P2|Overall Study|Protocol deviation|1
136544|NCT00570778|435999|P1|Overall Study|Protocol deviation|2
136545|NCT00570908|436017|P1|Overall Study|Withdrawal by Subject|2
136546|NCT00570908|436017|P1|Overall Study|Adverse Event|5
136547|NCT00570921|436021|P1|Overall Study|Physician Decision|1
136548|NCT00570921|436021|P1|Overall Study|Protocol Violation|1
136549|NCT00571038|436038|P2|Overall Study|Moved out of state|2
136550|NCT00571038|436039|P1|Overall Study|Moved out of state|2
136551|NCT00571038|436038|P2|Overall Study|Withdrawal by Subject|3
136552|NCT00571038|436039|P1|Overall Study|Withdrawal by Subject|1
136553|NCT00571038|436038|P2|Overall Study|Death|5
136554|NCT00571038|436039|P1|Overall Study|Death|7
136555|NCT00571038|436038|P2|Overall Study|Lost to Follow-up|4
136556|NCT00571038|436039|P1|Overall Study|Lost to Follow-up|1
136557|NCT00571103|436085|P1|Overall Study|Lost to Follow-up|1
136558|NCT00571103|436085|P1|Overall Study|Withdrawal by Subject|1
136559|NCT00565721|436142|P1|Overall Study|Other reasons|6
136560|NCT00565721|436142|P1|Overall Study|Physician Decision|2
136561|NCT00565721|436142|P1|Overall Study|Technical Problems|1
136562|NCT00565721|436142|P1|Overall Study|Lost to Follow-up|6
136563|NCT00565721|436142|P1|Overall Study|Screen Failure|2
136564|NCT00565747|436163|P2|Overall Study|No embryo transfer|73
136565|NCT00565747|436164|P1|Overall Study|No embryo transfer|67
136566|NCT00565812|436177|P3|Overall Study|Physician Decision|0
136567|NCT00565812|436178|P2|Overall Study|Physician Decision|0
136568|NCT00565812|436179|P1|Overall Study|Physician Decision|2
136569|NCT00565812|436177|P3|Overall Study|Follow-up Visit Not Completed|1
136570|NCT00565812|436178|P2|Overall Study|Follow-up Visit Not Completed|0
136571|NCT00565812|436179|P1|Overall Study|Follow-up Visit Not Completed|2
136572|NCT00565812|436177|P3|Overall Study|Low Compliance|1
136573|NCT00565812|436178|P2|Overall Study|Low Compliance|0
136574|NCT00565812|436179|P1|Overall Study|Low Compliance|1
136575|NCT00565812|436177|P3|Overall Study|Surgical Intervention|2
136576|NCT00565812|436178|P2|Overall Study|Surgical Intervention|1
136577|NCT00565812|436179|P1|Overall Study|Surgical Intervention|0
136578|NCT00565812|436177|P3|Overall Study|Research Site Closure|8
136579|NCT00565812|436178|P2|Overall Study|Research Site Closure|1
136580|NCT00565812|436179|P1|Overall Study|Research Site Closure|6
136581|NCT00565812|436177|P3|Overall Study|Domestic Reasons|3
136582|NCT00565812|436178|P2|Overall Study|Domestic Reasons|1
136583|NCT00565812|436179|P1|Overall Study|Domestic Reasons|7
136584|NCT00565812|436177|P3|Overall Study|Sponsor Decision|1
136585|NCT00565812|436178|P2|Overall Study|Sponsor Decision|5
136586|NCT00565812|436179|P1|Overall Study|Sponsor Decision|1
136587|NCT00565812|436177|P3|Overall Study|Relocated Out of Area|9
136588|NCT00565812|436178|P2|Overall Study|Relocated Out of Area|8
136589|NCT00565812|436179|P1|Overall Study|Relocated Out of Area|5
136590|NCT00565812|436177|P3|Overall Study|Jury Duty|0
136591|NCT00565812|436178|P2|Overall Study|Jury Duty|0
136592|NCT00565812|436179|P1|Overall Study|Jury Duty|1
136593|NCT00565812|436177|P3|Overall Study|Adverse Event|40
136594|NCT00565812|436178|P2|Overall Study|Adverse Event|54
136595|NCT00565812|436179|P1|Overall Study|Adverse Event|41
136596|NCT00565812|436177|P3|Overall Study|Protocol Violation|4
136597|NCT00565812|436178|P2|Overall Study|Protocol Violation|6
136598|NCT00565812|436179|P1|Overall Study|Protocol Violation|2
136599|NCT00565812|436177|P3|Overall Study|Work Schedule|1
136600|NCT00565812|436178|P2|Overall Study|Work Schedule|3
136601|NCT00565812|436179|P1|Overall Study|Work Schedule|5
136602|NCT00565812|436177|P3|Overall Study|Withdrawal by Subject|48
136603|NCT00565812|436178|P2|Overall Study|Withdrawal by Subject|47
136604|NCT00565812|436179|P1|Overall Study|Withdrawal by Subject|58
136605|NCT00565812|436177|P3|Overall Study|Lost to Follow-up|8
136606|NCT00565812|436178|P2|Overall Study|Lost to Follow-up|8
136607|NCT00565812|436179|P1|Overall Study|Lost to Follow-up|10
136608|NCT00565812|436177|P3|Overall Study|Did not Meet Entrance Criteria|1
136609|NCT00565812|436178|P2|Overall Study|Did not Meet Entrance Criteria|0
136610|NCT00565812|436179|P1|Overall Study|Did not Meet Entrance Criteria|1
136611|NCT00565812|436177|P3|Overall Study|Death|3
136612|NCT00565812|436178|P2|Overall Study|Death|1
136613|NCT00565812|436179|P1|Overall Study|Death|2
136614|NCT00571649|436318|P2|Follow-up Period|Protocol Violation|12
136615|NCT00571649|436319|P1|Follow-up Period|Protocol Violation|5
136616|NCT00571649|436318|P2|Follow-up Period|Patient convenience|121
136617|NCT00571649|436319|P1|Follow-up Period|Patient convenience|136
136618|NCT00571649|436318|P2|Follow-up Period|Lost to Follow-up|92
136619|NCT00571649|436319|P1|Follow-up Period|Lost to Follow-up|95
136620|NCT00571649|436318|P2|Follow-up Period|Physician Decision|13
136621|NCT00571649|436319|P1|Follow-up Period|Physician Decision|7
136622|NCT00571649|436318|P2|Follow-up Period|Death|133
136623|NCT00571649|436319|P1|Follow-up Period|Death|132
136624|NCT00571649|436318|P2|Follow-up Period|Withdrawal by Subject|115
136625|NCT00571649|436319|P1|Follow-up Period|Withdrawal by Subject|119
136626|NCT00571649|436318|P2|Follow-up Period|Clinical endpoint reached|2
136627|NCT00571649|436319|P1|Follow-up Period|Clinical endpoint reached|5
136628|NCT00571649|436318|P2|Follow-up Period|Adverse Event|40
136629|NCT00571649|436319|P1|Follow-up Period|Adverse Event|46
136630|NCT00571649|436318|P2|Treatment Period|Technical problems|5
136631|NCT00571649|436319|P1|Treatment Period|Technical problems|3
136632|NCT00571649|436318|P2|Treatment Period|Protocol Violation|92
136633|NCT00571649|436319|P1|Treatment Period|Protocol Violation|90
136634|NCT00571649|436318|P2|Treatment Period|Patient convenience|13
136635|NCT00571649|436319|P1|Treatment Period|Patient convenience|11
136636|NCT00571649|436318|P2|Treatment Period|Non-compliant with study medication|89
136637|NCT00571649|436319|P1|Treatment Period|Non-compliant with study medication|88
136638|NCT00571649|436318|P2|Treatment Period|Lost to Follow-up|41
136639|NCT00571649|436319|P1|Treatment Period|Lost to Follow-up|43
136640|NCT00571649|436318|P2|Treatment Period|Physician Decision|9
136641|NCT00571649|436319|P1|Treatment Period|Physician Decision|8
136642|NCT00571649|436318|P2|Treatment Period|Death|59
136643|NCT00571649|436319|P1|Treatment Period|Death|76
136644|NCT00571649|436318|P2|Treatment Period|Withdrawal by Subject|255
136645|NCT00571649|436319|P1|Treatment Period|Withdrawal by Subject|285
136646|NCT00571649|436318|P2|Treatment Period|Clinical endpoint reached|56
136647|NCT00571649|436319|P1|Treatment Period|Clinical endpoint reached|50
136648|NCT00571649|436318|P2|Treatment Period|Adverse Event|385
136649|NCT00571649|436319|P1|Treatment Period|Adverse Event|438
136650|NCT00571662|436351|P1|Overall Study|Adverse Event|5
136651|NCT00571662|436351|P1|Overall Study|psychiatric instability|1
136652|NCT00571662|436351|P1|Overall Study|Withdrawal by Subject|2
136653|NCT00571688|436359|P2|Overall Study|subject moved out of the area|0
136654|NCT00571688|436360|P1|Overall Study|subject moved out of the area|1
136655|NCT00571688|436359|P2|Overall Study|subject did not tolerate Consta|0
136656|NCT00571688|436360|P1|Overall Study|subject did not tolerate Consta|1
136657|NCT00571688|436359|P2|Overall Study|Lost to Follow-up|6
136658|NCT00571688|436360|P1|Overall Study|Lost to Follow-up|3
136659|NCT00571701|436368|P2|Second Intervention 12 Months|Withdrawal by Subject|0
136660|NCT00571701|436369|P1|Second Intervention 12 Months|Withdrawal by Subject|3
136661|NCT00571701|436368|P2|Second Intervention 12 Months|Adverse Event|1
136662|NCT00571701|436369|P1|Second Intervention 12 Months|Adverse Event|0
136663|NCT00571701|436368|P2|First Intervention 12 Months|Death|0
136664|NCT00571701|436369|P1|First Intervention 12 Months|Death|1
136665|NCT00571701|436368|P2|First Intervention 12 Months|Withdrawal by Subject|1
136666|NCT00571701|436369|P1|First Intervention 12 Months|Withdrawal by Subject|2
136667|NCT00573131|436395|P2|Overall Study|Withdrawal by Subject|8
136668|NCT00573131|436396|P1|Overall Study|Withdrawal by Subject|10
136669|NCT00573144|436404|P2|Overall Study|Withdrawal by Subject|3
136670|NCT00573144|436405|P1|Overall Study|Withdrawal by Subject|2
136671|NCT00573157|436417|P2|Overall Study|Unspecified|1
136672|NCT00573157|436418|P1|Overall Study|Unspecified|1
136673|NCT00573157|436417|P2|Overall Study|Adverse Event|1
136674|NCT00573157|436418|P1|Overall Study|Adverse Event|3
136675|NCT00573170|436428|P6|Third Treatment Period|Lost to Follow-up|2
136676|NCT00573170|436429|P5|Third Treatment Period|Lost to Follow-up|0
136677|NCT00573170|436430|P4|Third Treatment Period|Lost to Follow-up|0
136678|NCT00573170|436431|P3|Third Treatment Period|Lost to Follow-up|0
136679|NCT00573170|436432|P2|Third Treatment Period|Lost to Follow-up|0
136680|NCT00573170|436433|P1|Third Treatment Period|Lost to Follow-up|0
136681|NCT00573170|436428|P6|Third Treatment Period|Withdrawal by Subject|0
136682|NCT00573170|436429|P5|Third Treatment Period|Withdrawal by Subject|0
136683|NCT00573170|436430|P4|Third Treatment Period|Withdrawal by Subject|0
136684|NCT00573170|436431|P3|Third Treatment Period|Withdrawal by Subject|0
136685|NCT00573170|436432|P2|Third Treatment Period|Withdrawal by Subject|0
136686|NCT00573170|436433|P1|Third Treatment Period|Withdrawal by Subject|1
136687|NCT00573170|436428|P6|Second Washout Period|Other|2
136688|NCT00573170|436429|P5|Second Washout Period|Other|6
136689|NCT00573170|436430|P4|Second Washout Period|Other|4
136690|NCT00573170|436431|P3|Second Washout Period|Other|1
136691|NCT00573170|436432|P2|Second Washout Period|Other|2
136692|NCT00573170|436433|P1|Second Washout Period|Other|1
136693|NCT00573170|436428|P6|Second Washout Period|Lost to Follow-up|0
136694|NCT00573170|436429|P5|Second Washout Period|Lost to Follow-up|0
136695|NCT00573170|436430|P4|Second Washout Period|Lost to Follow-up|1
136696|NCT00573170|436431|P3|Second Washout Period|Lost to Follow-up|0
136697|NCT00573170|436432|P2|Second Washout Period|Lost to Follow-up|0
136698|NCT00573170|436433|P1|Second Washout Period|Lost to Follow-up|0
136699|NCT00573170|436428|P6|Second Washout Period|Withdrawal by Subject|0
136700|NCT00573170|436429|P5|Second Washout Period|Withdrawal by Subject|1
136701|NCT00573170|436430|P4|Second Washout Period|Withdrawal by Subject|0
136702|NCT00573170|436431|P3|Second Washout Period|Withdrawal by Subject|2
136703|NCT00573170|436432|P2|Second Washout Period|Withdrawal by Subject|1
136704|NCT00573170|436433|P1|Second Washout Period|Withdrawal by Subject|1
136705|NCT00573170|436428|P6|Second Washout Period|Protocol Violation|0
136706|NCT00573170|436429|P5|Second Washout Period|Protocol Violation|0
136707|NCT00573170|436430|P4|Second Washout Period|Protocol Violation|0
136708|NCT00573170|436431|P3|Second Washout Period|Protocol Violation|1
136709|NCT00573170|436432|P2|Second Washout Period|Protocol Violation|1
136710|NCT00573170|436433|P1|Second Washout Period|Protocol Violation|2
136711|NCT00573170|436428|P6|Second Washout Period|Adverse Event|0
136712|NCT00573170|436429|P5|Second Washout Period|Adverse Event|1
136713|NCT00573170|436430|P4|Second Washout Period|Adverse Event|0
136714|NCT00573170|436431|P3|Second Washout Period|Adverse Event|0
136715|NCT00573170|436432|P2|Second Washout Period|Adverse Event|0
136716|NCT00573170|436433|P1|Second Washout Period|Adverse Event|1
136717|NCT00573170|436428|P6|First Washout Period|Other|0
136718|NCT00573170|436429|P5|First Washout Period|Other|0
136719|NCT00573170|436430|P4|First Washout Period|Other|1
136720|NCT00573170|436431|P3|First Washout Period|Other|1
136721|NCT00573170|436432|P2|First Washout Period|Other|0
136722|NCT00573170|436433|P1|First Washout Period|Other|4
136723|NCT00573170|436428|P6|First Washout Period|Withdrawal by Subject|3
136724|NCT00573170|436429|P5|First Washout Period|Withdrawal by Subject|3
136725|NCT00573170|436430|P4|First Washout Period|Withdrawal by Subject|2
136726|NCT00573170|436431|P3|First Washout Period|Withdrawal by Subject|0
136727|NCT00573170|436432|P2|First Washout Period|Withdrawal by Subject|0
136728|NCT00573170|436433|P1|First Washout Period|Withdrawal by Subject|2
136729|NCT00573170|436428|P6|First Washout Period|Lost to Follow-up|2
136730|NCT00573170|436429|P5|First Washout Period|Lost to Follow-up|0
136731|NCT00573170|436430|P4|First Washout Period|Lost to Follow-up|2
136732|NCT00573170|436431|P3|First Washout Period|Lost to Follow-up|0
136733|NCT00573170|436432|P2|First Washout Period|Lost to Follow-up|1
136734|NCT00573170|436433|P1|First Washout Period|Lost to Follow-up|1
136735|NCT00573170|436428|P6|First Washout Period|Lack of Efficacy|1
136736|NCT00573170|436429|P5|First Washout Period|Lack of Efficacy|0
136737|NCT00573170|436430|P4|First Washout Period|Lack of Efficacy|0
136738|NCT00573170|436431|P3|First Washout Period|Lack of Efficacy|0
136739|NCT00573170|436432|P2|First Washout Period|Lack of Efficacy|0
136740|NCT00573170|436433|P1|First Washout Period|Lack of Efficacy|0
136741|NCT00573170|436428|P6|First Washout Period|Adverse Event|1
136742|NCT00573170|436429|P5|First Washout Period|Adverse Event|0
136743|NCT00573170|436430|P4|First Washout Period|Adverse Event|0
136744|NCT00573170|436431|P3|First Washout Period|Adverse Event|0
136745|NCT00573170|436432|P2|First Washout Period|Adverse Event|1
136746|NCT00573170|436433|P1|First Washout Period|Adverse Event|1
136747|NCT00573170|436428|P6|First Treatment Period|Did Not Treat Attack 1|0
136748|NCT00573170|436429|P5|First Treatment Period|Did Not Treat Attack 1|1
136749|NCT00573170|436430|P4|First Treatment Period|Did Not Treat Attack 1|0
136750|NCT00573170|436431|P3|First Treatment Period|Did Not Treat Attack 1|0
136751|NCT00573170|436432|P2|First Treatment Period|Did Not Treat Attack 1|0
136752|NCT00573170|436433|P1|First Treatment Period|Did Not Treat Attack 1|0
136753|NCT00573183|436509|P2|Overall Study|Unspecified|2
136754|NCT00573183|436510|P1|Overall Study|Unspecified|5
136755|NCT00573183|436509|P2|Overall Study|Incarceration|8
136756|NCT00573183|436510|P1|Overall Study|Incarceration|5
136757|NCT00573183|436509|P2|Overall Study|Adverse Event|0
136758|NCT00573183|436510|P1|Overall Study|Adverse Event|2
136759|NCT00573183|436509|P2|Overall Study|Death|1
136760|NCT00573183|436510|P1|Overall Study|Death|0
136761|NCT00573183|436509|P2|Overall Study|Withdrawal by Subject|2
136762|NCT00573183|436510|P1|Overall Study|Withdrawal by Subject|8
136763|NCT00573183|436509|P2|Overall Study|Lost to Follow-up|50
136764|NCT00573183|436510|P1|Overall Study|Lost to Follow-up|52
136765|NCT00573248|436520|P2|Overall Study|scheduling conflicts|11
136766|NCT00573248|436521|P1|Overall Study|scheduling conflicts|15
136767|NCT00573313|436575|P4|Overall Study|Protocol Violation|0
136768|NCT00573313|436576|P3|Overall Study|Protocol Violation|6
136769|NCT00573313|436577|P2|Overall Study|Protocol Violation|0
136770|NCT00573313|436578|P1|Overall Study|Protocol Violation|5
136771|NCT00573391|436588|P2|Overall Study|Death|0
136772|NCT00573391|436589|P1|Overall Study|Death|1
136773|NCT00573391|436588|P2|Overall Study|study stopped|2
136774|NCT00573391|436589|P1|Overall Study|study stopped|2
136775|NCT00573430|436598|P3|Overall Study|Eligibility criteria not fulfilled|3
136776|NCT00573430|436599|P2|Overall Study|Eligibility criteria not fulfilled|0
136777|NCT00573430|436600|P1|Overall Study|Eligibility criteria not fulfilled|0
136778|NCT00573430|436598|P3|Overall Study|Protocol Violation|1
136779|NCT00573430|436599|P2|Overall Study|Protocol Violation|1
136780|NCT00573430|436600|P1|Overall Study|Protocol Violation|0
136781|NCT00573430|436598|P3|Overall Study|Withdrawal by Subject|1
136782|NCT00573430|436599|P2|Overall Study|Withdrawal by Subject|0
136783|NCT00573430|436600|P1|Overall Study|Withdrawal by Subject|1
136784|NCT00573430|436598|P3|Overall Study|Adverse Event|2
136785|NCT00573430|436599|P2|Overall Study|Adverse Event|0
136786|NCT00573430|436600|P1|Overall Study|Adverse Event|0
136787|NCT00573430|436598|P3|Overall Study|Incorrect enrollment of randomization|3
136788|NCT00573430|436599|P2|Overall Study|Incorrect enrollment of randomization|4
136789|NCT00573430|436600|P1|Overall Study|Incorrect enrollment of randomization|0
136790|NCT00573443|436623|P3|Open-Label Extension Phase|Not Specified|0
136791|NCT00573443|436624|P2|Open-Label Extension Phase|Not Specified|0
136792|NCT00573443|436625|P1|Open-Label Extension Phase|Not Specified|2
136793|NCT00573443|436623|P3|Open-Label Extension Phase|Protocol Violation|0
136794|NCT00573443|436624|P2|Open-Label Extension Phase|Protocol Violation|0
136795|NCT00573443|436625|P1|Open-Label Extension Phase|Protocol Violation|2
136796|NCT00573443|436623|P3|Open-Label Extension Phase|Withdrawal by Subject|0
136797|NCT00573443|436624|P2|Open-Label Extension Phase|Withdrawal by Subject|0
136798|NCT00573443|436625|P1|Open-Label Extension Phase|Withdrawal by Subject|3
136799|NCT00573443|436623|P3|Open-Label Extension Phase|Serious Adverse Event|0
136800|NCT00573443|436624|P2|Open-Label Extension Phase|Serious Adverse Event|0
136801|NCT00573443|436625|P1|Open-Label Extension Phase|Serious Adverse Event|5
136802|NCT00573443|436623|P3|Open-Label Extension Phase|Adverse Event|0
136803|NCT00573443|436624|P2|Open-Label Extension Phase|Adverse Event|0
136804|NCT00573443|436625|P1|Open-Label Extension Phase|Adverse Event|3
136805|NCT00573443|436623|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
136806|NCT00573443|436624|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
136807|NCT00573443|436625|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
136808|NCT00573443|436623|P3|Open-Label Extension Phase|Lost to Follow-up|0
136809|NCT00573443|436624|P2|Open-Label Extension Phase|Lost to Follow-up|0
136810|NCT00573443|436625|P1|Open-Label Extension Phase|Lost to Follow-up|1
136811|NCT00573443|436623|P3|Double-Blind Phase|Not specified|3
136812|NCT00573443|436624|P2|Double-Blind Phase|Not specified|2
136813|NCT00573443|436625|P1|Double-Blind Phase|Not specified|0
136814|NCT00573443|436623|P3|Double-Blind Phase|Protocol Violation|1
136815|NCT00573443|436624|P2|Double-Blind Phase|Protocol Violation|2
136816|NCT00573443|436625|P1|Double-Blind Phase|Protocol Violation|0
136817|NCT00573443|436623|P3|Double-Blind Phase|Withdrawal by Subject|7
136818|NCT00573443|436624|P2|Double-Blind Phase|Withdrawal by Subject|2
136819|NCT00573443|436625|P1|Double-Blind Phase|Withdrawal by Subject|2
136820|NCT00573443|436623|P3|Double-Blind Phase|Medication refusal due to AE|0
136821|NCT00573443|436624|P2|Double-Blind Phase|Medication refusal due to AE|2
136822|NCT00573443|436625|P1|Double-Blind Phase|Medication refusal due to AE|2
136823|NCT00573443|436623|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
136824|NCT00573443|436624|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
136825|NCT00573443|436625|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
136826|NCT00573443|436623|P3|Double-Blind Phase|Adverse Event|0
136827|NCT00573443|436624|P2|Double-Blind Phase|Adverse Event|5
136828|NCT00573443|436625|P1|Double-Blind Phase|Adverse Event|1
136829|NCT00573443|436623|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
136830|NCT00573443|436624|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
136831|NCT00573443|436625|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
136832|NCT00573443|436623|P3|Double-Blind Phase|Lost to Follow-up|2
136833|NCT00573443|436624|P2|Double-Blind Phase|Lost to Follow-up|3
136834|NCT00573443|436625|P1|Double-Blind Phase|Lost to Follow-up|1
136835|NCT00573469|436655|P3|Overall Study|Not Specified|3
136836|NCT00573469|436656|P2|Overall Study|Not Specified|1
136837|NCT00573469|436657|P1|Overall Study|Not Specified|5
136838|NCT00573469|436655|P3|Overall Study|Withdrawal by Subject|0
136839|NCT00573469|436656|P2|Overall Study|Withdrawal by Subject|2
136840|NCT00573469|436657|P1|Overall Study|Withdrawal by Subject|0
136841|NCT00573469|436655|P3|Overall Study|Adverse Event|1
136842|NCT00573469|436656|P2|Overall Study|Adverse Event|1
136843|NCT00573469|436657|P1|Overall Study|Adverse Event|1
136844|NCT00573534|436710|P1|Overall Study|oppositional behavior|3
136845|NCT00573755|436717|P2|Overall Study|Still receiving treatment|0
136846|NCT00573755|436718|P1|Overall Study|Still receiving treatment|1
136847|NCT00573768|436737|P3|Overall Study|Lost to Follow-up|1
136848|NCT00573768|436738|P2|Overall Study|Lost to Follow-up|0
136849|NCT00573768|436739|P1|Overall Study|Lost to Follow-up|0
136850|NCT00573768|436737|P3|Overall Study|Withdrawal by Subject|0
136851|NCT00573768|436738|P2|Overall Study|Withdrawal by Subject|1
136852|NCT00573768|436739|P1|Overall Study|Withdrawal by Subject|0
136853|NCT00573768|436737|P3|Overall Study|Protocol Violation|1
136854|NCT00573768|436738|P2|Overall Study|Protocol Violation|0
136855|NCT00573768|436739|P1|Overall Study|Protocol Violation|1
136856|NCT00573768|436737|P3|Overall Study|Adverse Event|2
136857|NCT00573768|436738|P2|Overall Study|Adverse Event|1
136858|NCT00573768|436739|P1|Overall Study|Adverse Event|1
136859|NCT00573859|436747|P1|Smoking Versus Abstinence|Scheduling conflicts|12
136860|NCT00573859|436747|P1|Medication Versus Placebo|Scheduling conflicts|12
136861|NCT00573937|436755|P2|Overall Study|Study Terminated|1
136862|NCT00573937|436756|P1|Overall Study|Study Terminated|0
136863|NCT00574080|436807|P2|Overall Study|Death|10
136864|NCT00574080|436808|P1|Overall Study|Death|10
136865|NCT00574145|436815|P2|Overall Study|Withdrawal by Subject|1
136866|NCT00574145|436816|P1|Overall Study|Withdrawal by Subject|2
136867|NCT00574249|436832|P2|Overall Study|PPD test taken twice|1
136868|NCT00574249|436833|P1|Overall Study|PPD test taken twice|0
136869|NCT00574249|436832|P2|Overall Study|Excluded by company|1
136870|NCT00574249|436833|P1|Overall Study|Excluded by company|0
136871|NCT00574249|436832|P2|Overall Study|Pregnancy|0
136872|NCT00574249|436833|P1|Overall Study|Pregnancy|1
136873|NCT00574249|436832|P2|Overall Study|Physician Decision|0
136874|NCT00574249|436833|P1|Overall Study|Physician Decision|1
136875|NCT00574249|436832|P2|Overall Study|Withdrawal by Subject|0
136876|NCT00574249|436833|P1|Overall Study|Withdrawal by Subject|3
136877|NCT00574249|436832|P2|Overall Study|History of carcinoma|0
136878|NCT00574249|436833|P1|Overall Study|History of carcinoma|1
136879|NCT00574249|436832|P2|Overall Study|Protocol Violation|2
136880|NCT00574249|436833|P1|Overall Study|Protocol Violation|5
136881|NCT00574249|436832|P2|Overall Study|Lost to Follow-up|3
136882|NCT00574249|436833|P1|Overall Study|Lost to Follow-up|4
136883|NCT00574249|436832|P2|Overall Study|Lack of Efficacy|3
136884|NCT00574249|436833|P1|Overall Study|Lack of Efficacy|5
136885|NCT00574249|436832|P2|Overall Study|Adverse Event|18
136886|NCT00574249|436833|P1|Overall Study|Adverse Event|6
136887|NCT00574275|436875|P2|Overall Study|Operation for curative intent|1
136888|NCT00574275|436876|P1|Overall Study|Operation for curative intent|0
136889|NCT00574275|436875|P2|Overall Study|Insurance change|1
136890|NCT00574275|436876|P1|Overall Study|Insurance change|0
136891|NCT00574275|436875|P2|Overall Study|Patient and Investigator decision|1
136892|NCT00574275|436876|P1|Overall Study|Patient and Investigator decision|0
136893|NCT00574275|436875|P2|Overall Study|Protocol Violation|1
136894|NCT00574275|436876|P1|Overall Study|Protocol Violation|0
136895|NCT00574275|436875|P2|Overall Study|Physician Decision|1
136896|NCT00574275|436876|P1|Overall Study|Physician Decision|1
136897|NCT00574275|436875|P2|Overall Study|Error calculating tumor measurement|0
136898|NCT00574275|436876|P1|Overall Study|Error calculating tumor measurement|1
136899|NCT00574275|436875|P2|Overall Study|Withdrawal by Subject|17
136900|NCT00574275|436876|P1|Overall Study|Withdrawal by Subject|15
136901|NCT00574275|436875|P2|Overall Study|Study stopped based on DMC decision|23
136902|NCT00574275|436876|P1|Overall Study|Study stopped based on DMC decision|62
136903|NCT00574275|436875|P2|Overall Study|Lost to Follow-up|1
136904|NCT00574275|436876|P1|Overall Study|Lost to Follow-up|2
136905|NCT00574275|436875|P2|Overall Study|Disease progression|146
136906|NCT00574275|436876|P1|Overall Study|Disease progression|160
136907|NCT00574275|436875|P2|Overall Study|Adverse Event|76
136908|NCT00574275|436876|P1|Overall Study|Adverse Event|32
136909|NCT00574275|436875|P2|Overall Study|Randomized but not treated|3
136910|NCT00574275|436876|P1|Overall Study|Randomized but not treated|2
136911|NCT00574288|436899|P7|Overall Study|Ongoing|14
136912|NCT00574288|436900|P6|Overall Study|Ongoing|0
136913|NCT00574288|436901|P5|Overall Study|Ongoing|0
136914|NCT00574288|436902|P4|Overall Study|Ongoing|0
136915|NCT00574288|436903|P3|Overall Study|Ongoing|0
136916|NCT00574288|436904|P2|Overall Study|Ongoing|0
136917|NCT00574288|436905|P1|Overall Study|Ongoing|0
136918|NCT00574288|436899|P7|Overall Study|Progressive disease|23
136919|NCT00574288|436900|P6|Overall Study|Progressive disease|30
136920|NCT00574288|436901|P5|Overall Study|Progressive disease|0
136921|NCT00574288|436902|P4|Overall Study|Progressive disease|2
136922|NCT00574288|436903|P3|Overall Study|Progressive disease|0
136923|NCT00574288|436904|P2|Overall Study|Progressive disease|0
136924|NCT00574288|436905|P1|Overall Study|Progressive disease|10
136925|NCT00574288|436899|P7|Overall Study|Physician Decision|4
136926|NCT00574288|436900|P6|Overall Study|Physician Decision|0
136927|NCT00574288|436901|P5|Overall Study|Physician Decision|0
136928|NCT00574288|436902|P4|Overall Study|Physician Decision|0
136929|NCT00574288|436903|P3|Overall Study|Physician Decision|0
136930|NCT00574288|436904|P2|Overall Study|Physician Decision|0
136931|NCT00574288|436905|P1|Overall Study|Physician Decision|0
136932|NCT00574288|436899|P7|Overall Study|Adverse Event|1
136933|NCT00574288|436900|P6|Overall Study|Adverse Event|0
136934|NCT00574288|436901|P5|Overall Study|Adverse Event|1
136935|NCT00574288|436902|P4|Overall Study|Adverse Event|0
136936|NCT00574288|436903|P3|Overall Study|Adverse Event|0
136937|NCT00574288|436904|P2|Overall Study|Adverse Event|1
136938|NCT00574288|436905|P1|Overall Study|Adverse Event|3
136939|NCT00574405|436950|P2|Overall Study|Withdrawal by Subject|2
136940|NCT00574405|436951|P1|Overall Study|Withdrawal by Subject|3
136941|NCT00574795|437021|P1|Toddler Dose|Withdrawal by Subject|1
136942|NCT00574795|437021|P1|After Infant Series|Adverse Event|2
136943|NCT00574795|437021|P1|After Infant Series|Withdrawal by Subject|1
136944|NCT00574795|437021|P1|Infant Series|Adverse Event|1
136945|NCT00574795|437021|P1|Infant Series|Protocol Violation|2
136946|NCT00574795|437021|P1|Infant Series|Withdrawal by Subject|2
136947|NCT00574847|437053|P2|Overall Study|Did not receive medication (declined)|5
136948|NCT00574847|437054|P1|Overall Study|Did not receive medication (declined)|2
136949|NCT00574847|437053|P2|Overall Study|Physician Decision|0
136950|NCT00574847|437054|P1|Overall Study|Physician Decision|1
136951|NCT00574847|437053|P2|Overall Study|Withdrawal by Subject|2
136952|NCT00574847|437054|P1|Overall Study|Withdrawal by Subject|2
136953|NCT00574847|437053|P2|Overall Study|Death|0
136954|NCT00574847|437054|P1|Overall Study|Death|1
136955|NCT00574847|437053|P2|Overall Study|Adverse Event|0
136956|NCT00574847|437054|P1|Overall Study|Adverse Event|2
136957|NCT00574873|437088|P2|Overall Study|Extension Study|0
136958|NCT00574873|437089|P1|Overall Study|Extension Study|126
136959|NCT00574873|437088|P2|Overall Study|Blank, site closed per local regulations|2
136960|NCT00574873|437089|P1|Overall Study|Blank, site closed per local regulations|2
136961|NCT00574873|437088|P2|Overall Study|Discontinuation of study by sponsor|199
136962|NCT00574873|437089|P1|Overall Study|Discontinuation of study by sponsor|5
136963|NCT00574873|437088|P2|Overall Study|Unspecified|4
136964|NCT00574873|437089|P1|Overall Study|Unspecified|40
136965|NCT00574873|437088|P2|Overall Study|Lost to Follow-up|5
136966|NCT00574873|437089|P1|Overall Study|Lost to Follow-up|14
136967|NCT00574873|437088|P2|Overall Study|Death|14
136968|NCT00574873|437089|P1|Overall Study|Death|15
136969|NCT00574873|437088|P2|Overall Study|Investigator request|8
136970|NCT00574873|437089|P1|Overall Study|Investigator request|18
136971|NCT00574873|437088|P2|Overall Study|Withdrawal by Subject|19
136972|NCT00574873|437089|P1|Overall Study|Withdrawal by Subject|18
136973|NCT00574912|437105|P1|Overall Study|Physician Decision|2
136974|NCT00574912|437105|P1|Overall Study|scheduling conflicts|3
136975|NCT00574912|437105|P1|Overall Study|Could not place IV lines.|3
136976|NCT00575042|437163|P1|Overall Study|Lost to Follow-up|1
136977|NCT00575042|437163|P1|Overall Study|Adverse Event|2
136978|NCT00575094|437168|P1|Overall Study|Withdrawal by Subject|1
136979|NCT00575094|437168|P1|Overall Study|Adverse Event|2
136980|NCT00575380|437200|P2|Overall Study|Various|2
136981|NCT00575380|437201|P1|Overall Study|Various|0
136982|NCT00575380|437200|P2|Overall Study|Adverse Event|1
136983|NCT00575380|437201|P1|Overall Study|Adverse Event|0
136984|NCT00575380|437200|P2|Overall Study|Withdrawal by Subject|0
136985|NCT00575380|437201|P1|Overall Study|Withdrawal by Subject|1
136986|NCT00575510|437212|P3|Overall Study|Pregnancy|1
136987|NCT00575510|437213|P2|Overall Study|Pregnancy|0
136988|NCT00575510|437214|P1|Overall Study|Pregnancy|0
136989|NCT00575510|437212|P3|Overall Study|Clinic Called Patient|7
136990|NCT00575510|437213|P2|Overall Study|Clinic Called Patient|7
136991|NCT00575510|437214|P1|Overall Study|Clinic Called Patient|7
136992|NCT00575510|437212|P3|Overall Study|Withdrawal by Subject|0
136993|NCT00575510|437213|P2|Overall Study|Withdrawal by Subject|0
136994|NCT00575510|437214|P1|Overall Study|Withdrawal by Subject|1
136995|NCT00575510|437212|P3|Overall Study|Lost to Follow-up|9
136996|NCT00575510|437213|P2|Overall Study|Lost to Follow-up|6
136997|NCT00575510|437214|P1|Overall Study|Lost to Follow-up|4
136998|NCT00575588|437227|P2|Overall Study|Impossible to determine HbA1c|1
136999|NCT00575588|437228|P1|Overall Study|Impossible to determine HbA1c|0
137000|NCT00575588|437227|P2|Overall Study|Patient moved|3
137001|NCT00575588|437228|P1|Overall Study|Patient moved|1
137002|NCT00575588|437227|P2|Overall Study|Elevated triglyceride|0
137003|NCT00575588|437228|P1|Overall Study|Elevated triglyceride|1
137004|NCT00575588|437227|P2|Overall Study|Safety reasons|1
137005|NCT00575588|437228|P1|Overall Study|Safety reasons|2
137006|NCT00575588|437227|P2|Overall Study|Severe non-compliance to protocol|7
137007|NCT00575588|437228|P1|Overall Study|Severe non-compliance to protocol|5
137008|NCT00575588|437227|P2|Overall Study|Study specific discontinuation criteria|218
137009|NCT00575588|437228|P1|Overall Study|Study specific discontinuation criteria|203
137010|NCT00575588|437227|P2|Overall Study|Incorrect enrollment|4
137011|NCT00575588|437228|P1|Overall Study|Incorrect enrollment|8
137012|NCT00575588|437227|P2|Overall Study|Death|2
137013|NCT00575588|437228|P1|Overall Study|Death|4
137014|NCT00575588|437227|P2|Overall Study|Lost to Follow-up|3
137015|NCT00575588|437228|P1|Overall Study|Lost to Follow-up|1
137016|NCT00575588|437227|P2|Overall Study|Withdrawal by Subject|31
137017|NCT00575588|437228|P1|Overall Study|Withdrawal by Subject|27
137018|NCT00575588|437227|P2|Overall Study|Adverse Event|13
137019|NCT00575588|437228|P1|Overall Study|Adverse Event|11
137020|NCT00575666|437250|P2|Overall Study|Physician Decision|1
137021|NCT00575666|437251|P1|Overall Study|Physician Decision|1
137022|NCT00575666|437250|P2|Overall Study|Withdrawal by Subject|2
137023|NCT00575666|437251|P1|Overall Study|Withdrawal by Subject|3
137024|NCT00579059|437300|P2|Overall Study|Study Canceled at 1 Year|10
137025|NCT00579059|437301|P1|Overall Study|Study Canceled at 1 Year|21
137026|NCT00579098|437311|P2|Overall Study|AF returned after ablation|2
137027|NCT00579098|437312|P1|Overall Study|AF returned after ablation|3
137028|NCT00579098|437311|P2|Overall Study|Withdrawal by Subject|3
137029|NCT00579098|437312|P1|Overall Study|Withdrawal by Subject|2
137030|NCT00579098|437311|P2|Overall Study|Adverse Event|3
137031|NCT00579098|437312|P1|Overall Study|Adverse Event|2
137032|NCT00579098|437311|P2|Overall Study|Lost to Follow-up|0
137033|NCT00579098|437312|P1|Overall Study|Lost to Follow-up|2
137034|NCT00579254|437344|P1|Overall Study|Discontinued when study terminated|73
137035|NCT00579254|437344|P1|Overall Study|Lost to Follow-up|39
137036|NCT00579345|437356|P8|Overall Study|Death|0
137037|NCT00579345|437357|P7|Overall Study|Death|0
137038|NCT00579345|437358|P6|Overall Study|Death|0
137039|NCT00579345|437359|P5|Overall Study|Death|0
137040|NCT00579345|437360|P4|Overall Study|Death|1
137041|NCT00579345|437361|P3|Overall Study|Death|1
137042|NCT00579345|437362|P2|Overall Study|Death|1
137043|NCT00579345|437363|P1|Overall Study|Death|1
137044|NCT00579345|437356|P8|Overall Study|Protocol Violation|1
137045|NCT00579345|437357|P7|Overall Study|Protocol Violation|0
137046|NCT00579345|437358|P6|Overall Study|Protocol Violation|0
137047|NCT00579345|437359|P5|Overall Study|Protocol Violation|0
137048|NCT00579345|437360|P4|Overall Study|Protocol Violation|0
137049|NCT00579345|437361|P3|Overall Study|Protocol Violation|0
137050|NCT00579345|437362|P2|Overall Study|Protocol Violation|0
137051|NCT00579345|437363|P1|Overall Study|Protocol Violation|1
137052|NCT00579345|437356|P8|Overall Study|Adverse Event|0
137053|NCT00579345|437357|P7|Overall Study|Adverse Event|0
137054|NCT00579345|437358|P6|Overall Study|Adverse Event|0
137055|NCT00579345|437359|P5|Overall Study|Adverse Event|0
137056|NCT00579345|437360|P4|Overall Study|Adverse Event|0
137057|NCT00579345|437361|P3|Overall Study|Adverse Event|1
137058|NCT00579345|437362|P2|Overall Study|Adverse Event|0
137059|NCT00579345|437363|P1|Overall Study|Adverse Event|0
137060|NCT00579345|437356|P8|Overall Study|Lost to Follow-up|0
137061|NCT00579345|437357|P7|Overall Study|Lost to Follow-up|0
137062|NCT00579345|437358|P6|Overall Study|Lost to Follow-up|0
137063|NCT00579345|437359|P5|Overall Study|Lost to Follow-up|0
137064|NCT00579345|437360|P4|Overall Study|Lost to Follow-up|0
137065|NCT00579345|437361|P3|Overall Study|Lost to Follow-up|0
137066|NCT00579345|437362|P2|Overall Study|Lost to Follow-up|0
137067|NCT00579345|437363|P1|Overall Study|Lost to Follow-up|1
137068|NCT00579345|437356|P8|Overall Study|Withdrawal by Subject|1
137069|NCT00579345|437357|P7|Overall Study|Withdrawal by Subject|0
137070|NCT00579345|437358|P6|Overall Study|Withdrawal by Subject|0
137071|NCT00579345|437359|P5|Overall Study|Withdrawal by Subject|0
137072|NCT00579345|437360|P4|Overall Study|Withdrawal by Subject|0
137073|NCT00579345|437361|P3|Overall Study|Withdrawal by Subject|0
137074|NCT00579345|437362|P2|Overall Study|Withdrawal by Subject|0
137075|NCT00579345|437363|P1|Overall Study|Withdrawal by Subject|2
137076|NCT00579501|437395|P1|Overall Study|Radiation therapy before surgery|1
137077|NCT00579501|437395|P1|Overall Study|Secondary lesion|1
137078|NCT00579501|437395|P1|Overall Study|toxicity|1
137079|NCT00579501|437395|P1|Overall Study|End of neoadjuvant therapy|25
137080|NCT00579501|437395|P1|Overall Study|Death|1
137081|NCT00579670|437405|P5|Overall Study|Withdrawal by Subject|0
137082|NCT00579670|437406|P4|Overall Study|Withdrawal by Subject|0
137083|NCT00579670|437407|P3|Overall Study|Withdrawal by Subject|1
137084|NCT00579670|437408|P2|Overall Study|Withdrawal by Subject|0
137085|NCT00579670|437409|P1|Overall Study|Withdrawal by Subject|0
137086|NCT00579670|437405|P5|Overall Study|Other|0
137087|NCT00579670|437406|P4|Overall Study|Other|2
137088|NCT00579670|437407|P3|Overall Study|Other|1
137089|NCT00579670|437408|P2|Overall Study|Other|0
137090|NCT00579670|437409|P1|Overall Study|Other|0
137091|NCT00579670|437405|P5|Overall Study|Lost to Follow-up|0
137092|NCT00579670|437406|P4|Overall Study|Lost to Follow-up|4
137093|NCT00579670|437407|P3|Overall Study|Lost to Follow-up|0
137094|NCT00579670|437408|P2|Overall Study|Lost to Follow-up|1
137095|NCT00579670|437409|P1|Overall Study|Lost to Follow-up|0
137096|NCT00579670|437405|P5|Overall Study|Lack of Efficacy|0
137097|NCT00579670|437406|P4|Overall Study|Lack of Efficacy|14
137098|NCT00579670|437407|P3|Overall Study|Lack of Efficacy|1
137099|NCT00579670|437408|P2|Overall Study|Lack of Efficacy|0
137100|NCT00579670|437409|P1|Overall Study|Lack of Efficacy|0
137101|NCT00579670|437405|P5|Overall Study|Adverse Event|0
137102|NCT00579670|437406|P4|Overall Study|Adverse Event|2
137103|NCT00579670|437407|P3|Overall Study|Adverse Event|1
137104|NCT00579670|437408|P2|Overall Study|Adverse Event|0
137105|NCT00579670|437409|P1|Overall Study|Adverse Event|1
137106|NCT00579670|437405|P5|Overall Study|Death|0
137107|NCT00579670|437406|P4|Overall Study|Death|0
137108|NCT00579670|437407|P3|Overall Study|Death|0
137109|NCT00579670|437408|P2|Overall Study|Death|0
137110|NCT00579670|437409|P1|Overall Study|Death|1
137111|NCT00579826|437642|P2|Overall Study|Withdrawal by Subject|3
137112|NCT00579826|437643|P1|Overall Study|Withdrawal by Subject|5
137113|NCT00579982|437653|P1|Overall Study|Protocol Violation|4
137114|NCT00579982|437653|P1|Overall Study|Adverse Event|4
137115|NCT00580034|437672|P2|Overall Study|Toxicity|0
137116|NCT00580034|437673|P1|Overall Study|Toxicity|10
137117|NCT00580606|437739|P2|Open Label (OL)|Needed Prohibited Medication|1
137118|NCT00580606|437740|P1|Open Label (OL)|Needed Prohibited Medication|0
137119|NCT00580606|437739|P2|Open Label (OL)|Physician Decision|1
137120|NCT00580606|437740|P1|Open Label (OL)|Physician Decision|1
137121|NCT00580606|437739|P2|Open Label (OL)|Non-compliance|0
137122|NCT00580606|437740|P1|Open Label (OL)|Non-compliance|2
137123|NCT00580606|437739|P2|Open Label (OL)|Pregnancy|1
137124|NCT00580606|437740|P1|Open Label (OL)|Pregnancy|0
137125|NCT00580606|437739|P2|Open Label (OL)|Lost to Follow-up|1
137126|NCT00580606|437740|P1|Open Label (OL)|Lost to Follow-up|0
137127|NCT00580606|437739|P2|Open Label (OL)|Dosing Symptoms|1
137128|NCT00580606|437740|P1|Open Label (OL)|Dosing Symptoms|0
137129|NCT00580606|437739|P2|Open Label (OL)|Withdrawal by Subject|6
137130|NCT00580606|437740|P1|Open Label (OL)|Withdrawal by Subject|4
137131|NCT00580606|437739|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
137132|NCT00580606|437740|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
137133|NCT00580723|437777|P1|Overall Study|Lost to Follow-up|5
137134|NCT00580723|437777|P1|Overall Study|Did not want to participate in extension|3
137135|NCT00580788|437787|P4|Overall Study|Adverse Event|1
137136|NCT00580788|437788|P3|Overall Study|Adverse Event|0
137137|NCT00580788|437789|P2|Overall Study|Adverse Event|0
137138|NCT00580788|437790|P1|Overall Study|Adverse Event|0
137139|NCT00580801|437851|P3|Overall Study|Travel|0
137140|NCT00580801|437852|P2|Overall Study|Travel|0
137141|NCT00580801|437853|P1|Overall Study|Travel|1
137142|NCT00580801|437851|P3|Overall Study|Participant non-compliant|1
137143|NCT00580801|437852|P2|Overall Study|Participant non-compliant|0
137144|NCT00580801|437853|P1|Overall Study|Participant non-compliant|0
137145|NCT00580801|437851|P3|Overall Study|Reached a virologic endpoint|2
137146|NCT00580801|437852|P2|Overall Study|Reached a virologic endpoint|1
137147|NCT00580801|437853|P1|Overall Study|Reached a virologic endpoint|0
137148|NCT00580801|437851|P3|Overall Study|Lost to Follow-up|0
137149|NCT00580801|437852|P2|Overall Study|Lost to Follow-up|0
137150|NCT00580801|437853|P1|Overall Study|Lost to Follow-up|2
137151|NCT00580801|437851|P3|Overall Study|Adverse Event|0
137152|NCT00580801|437852|P2|Overall Study|Adverse Event|0
137153|NCT00580801|437853|P1|Overall Study|Adverse Event|2
137154|NCT00580801|437851|P3|Overall Study|Physician Decision|0
137155|NCT00580801|437852|P2|Overall Study|Physician Decision|0
137156|NCT00580801|437853|P1|Overall Study|Physician Decision|1
137157|NCT00580840|437888|P4|Double-Blind|Other: Forbidden Medication|0
137158|NCT00580840|437889|P3|Double-Blind|Other: Forbidden Medication|1
137159|NCT00580840|437890|P2|Double-Blind|Other: Forbidden Medication|0
137160|NCT00580840|437891|P1|Double-Blind|Other: Forbidden Medication|0
137161|NCT00580840|437888|P4|Double-Blind|Other: Discontinued Methotrexate|0
137162|NCT00580840|437889|P3|Double-Blind|Other: Discontinued Methotrexate|0
137163|NCT00580840|437890|P2|Double-Blind|Other: Discontinued Methotrexate|1
137164|NCT00580840|437891|P1|Double-Blind|Other: Discontinued Methotrexate|0
137165|NCT00580840|437888|P4|Double-Blind|Withdrawal by Subject|2
137166|NCT00580840|437889|P3|Double-Blind|Withdrawal by Subject|2
137167|NCT00580840|437890|P2|Double-Blind|Withdrawal by Subject|1
137168|NCT00580840|437891|P1|Double-Blind|Withdrawal by Subject|0
137169|NCT00580840|437888|P4|Double-Blind|Lost to Follow-up|2
137170|NCT00580840|437889|P3|Double-Blind|Lost to Follow-up|0
137171|NCT00580840|437890|P2|Double-Blind|Lost to Follow-up|1
137172|NCT00580840|437891|P1|Double-Blind|Lost to Follow-up|0
137173|NCT00580840|437888|P4|Double-Blind|Loss of Efficacy|10
137174|NCT00580840|437889|P3|Double-Blind|Loss of Efficacy|2
137175|NCT00580840|437890|P2|Double-Blind|Loss of Efficacy|1
137176|NCT00580840|437891|P1|Double-Blind|Loss of Efficacy|0
137177|NCT00580840|437888|P4|Double-Blind|Adverse Event|1
137178|NCT00580840|437889|P3|Double-Blind|Adverse Event|4
137179|NCT00580840|437890|P2|Double-Blind|Adverse Event|3
137180|NCT00580840|437891|P1|Double-Blind|Adverse Event|0
137181|NCT00580840|437888|P4|Run-in|Other: Exclusionary Lab Value|0
137182|NCT00580840|437889|P3|Run-in|Other: Exclusionary Lab Value|0
137183|NCT00580840|437890|P2|Run-in|Other: Exclusionary Lab Value|0
137184|NCT00580840|437891|P1|Run-in|Other: Exclusionary Lab Value|1
137185|NCT00580840|437888|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
137186|NCT00580840|437889|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
137187|NCT00580840|437890|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
137188|NCT00580840|437891|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
137189|NCT00580840|437888|P4|Run-in|Other: Per Sponsor Request|0
137190|NCT00580840|437889|P3|Run-in|Other: Per Sponsor Request|0
137191|NCT00580840|437890|P2|Run-in|Other: Per Sponsor Request|0
137192|NCT00580840|437891|P1|Run-in|Other: Per Sponsor Request|2
137193|NCT00580840|437888|P4|Run-in|Withdrawal by Subject|0
137194|NCT00580840|437889|P3|Run-in|Withdrawal by Subject|0
137195|NCT00580840|437890|P2|Run-in|Withdrawal by Subject|0
137196|NCT00580840|437891|P1|Run-in|Withdrawal by Subject|5
137197|NCT00580840|437888|P4|Run-in|Lost to Follow-up|0
137198|NCT00580840|437889|P3|Run-in|Lost to Follow-up|0
137199|NCT00580840|437890|P2|Run-in|Lost to Follow-up|0
137200|NCT00580840|437891|P1|Run-in|Lost to Follow-up|4
137201|NCT00580840|437888|P4|Run-in|Loss of Efficacy|0
137202|NCT00580840|437889|P3|Run-in|Loss of Efficacy|0
137203|NCT00580840|437890|P2|Run-in|Loss of Efficacy|0
137204|NCT00580840|437891|P1|Run-in|Loss of Efficacy|1
137205|NCT00580840|437888|P4|Run-in|Lack of Efficacy|0
137206|NCT00580840|437889|P3|Run-in|Lack of Efficacy|0
137207|NCT00580840|437890|P2|Run-in|Lack of Efficacy|0
137208|NCT00580840|437891|P1|Run-in|Lack of Efficacy|93
137209|NCT00580840|437888|P4|Run-in|Adverse Event|0
137210|NCT00580840|437889|P3|Run-in|Adverse Event|0
137211|NCT00580840|437890|P2|Run-in|Adverse Event|0
137212|NCT00580840|437891|P1|Run-in|Adverse Event|17
137213|NCT00580866|438014|P2|Overall Study|Lost to Follow-up|2
137214|NCT00580866|438015|P1|Overall Study|Lost to Follow-up|2
137215|NCT00580970|438034|P1|Treatment (Lovastatin)|Death|1
137216|NCT00580970|438034|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
137217|NCT00580970|438034|P1|Treatment (Lovastatin)|Physician Decision|4
137218|NCT00580970|438034|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
137219|NCT00580970|438034|P1|Treatment (Lovastatin)|Non-compliance|6
137220|NCT00580970|438034|P1|Pre-treatment|Non-compliance|1
137221|NCT00580983|438038|P1|Overall Study|Did not complete 12 mon post RT studies|7
137222|NCT00581100|438051|P2|Overall Study|Unspecified|0
137223|NCT00581100|438052|P1|Overall Study|Unspecified|3
137224|NCT00581100|438051|P2|Overall Study|Withdrawal by Subject|4
137225|NCT00581100|438052|P1|Overall Study|Withdrawal by Subject|1
137226|NCT00581100|438051|P2|Overall Study|Adverse Event|1
137227|NCT00581100|438052|P1|Overall Study|Adverse Event|2
137228|NCT00581100|438051|P2|Overall Study|Death|0
137229|NCT00581100|438052|P1|Overall Study|Death|1
137230|NCT00581113|438090|P2|Overall Study|Withdrawal by Subject|1
137231|NCT00581113|438091|P1|Overall Study|Withdrawal by Subject|0
137232|NCT00581308|438121|P1|Month 12|Other|3
137233|NCT00581308|438121|P1|Month 12|Device Removed|1
137234|NCT00581308|438121|P1|Month 12|Withdrawal by Subject|2
137235|NCT00581308|438121|P1|Month 12|Lost to Follow-up|14
137236|NCT00581308|438121|P1|Month 12|Death|1
137237|NCT00581308|438121|P1|Month 6|Withdrawal by Subject|4
137238|NCT00581308|438121|P1|Month 6|Lost to Follow-up|1
137239|NCT00581308|438121|P1|Month 1|Device Removed|2
137240|NCT00581308|438121|P1|Month 1|Withdrawal by Subject|3
137241|NCT00581308|438121|P1|Month 1|Lost to Follow-up|4
137242|NCT00581308|438121|P1|Pre Discharge|Device Removed|1
137243|NCT00581308|438121|P1|Pre Discharge|Lost to Follow-up|2
137244|NCT00581360|438140|P1|Overall Study|Withdrawal by Subject|1
137245|NCT00571922|438189|P2|Overall Study|Completion unknown|36
137246|NCT00571922|438190|P1|Overall Study|Completion unknown|36
137247|NCT00571948|438200|P2|Overall Study|Parent were afraid of blood colection|5
137248|NCT00571948|438201|P1|Overall Study|Parent were afraid of blood colection|2
137249|NCT00571948|438200|P2|Overall Study|infant refused study meal|4
137250|NCT00571948|438201|P1|Overall Study|infant refused study meal|3
137251|NCT00571948|438200|P2|Overall Study|Protocol Violation|3
137252|NCT00571948|438201|P1|Overall Study|Protocol Violation|3
137253|NCT00571948|438200|P2|Overall Study|Withdrawal by Subject|2
137254|NCT00571948|438201|P1|Overall Study|Withdrawal by Subject|1
137255|NCT00571948|438200|P2|Overall Study|Lost to Follow-up|0
137256|NCT00571948|438201|P1|Overall Study|Lost to Follow-up|2
137257|NCT00572039|438227|P2|Overall Study|Ill|1
137258|NCT00572039|438228|P1|Overall Study|Ill|5
137259|NCT00572039|438227|P2|Overall Study|Death|3
137260|NCT00572039|438228|P1|Overall Study|Death|2
137261|NCT00572039|438227|P2|Overall Study|Withdrawal by Subject|6
137262|NCT00572039|438228|P1|Overall Study|Withdrawal by Subject|9
137263|NCT00572156|438255|P4|Overall Study|Sponsor Decision|19
137264|NCT00572156|438256|P3|Overall Study|Sponsor Decision|17
137265|NCT00572156|438257|P2|Overall Study|Sponsor Decision|16
137266|NCT00572156|438258|P1|Overall Study|Sponsor Decision|20
137267|NCT00572156|438255|P4|Overall Study|Patient/Parent Decision|3
137268|NCT00572156|438256|P3|Overall Study|Patient/Parent Decision|4
137269|NCT00572156|438257|P2|Overall Study|Patient/Parent Decision|6
137270|NCT00572156|438258|P1|Overall Study|Patient/Parent Decision|1
137271|NCT00572156|438255|P4|Overall Study|Protocol Violation|2
137272|NCT00572156|438256|P3|Overall Study|Protocol Violation|0
137273|NCT00572156|438257|P2|Overall Study|Protocol Violation|2
137274|NCT00572156|438258|P1|Overall Study|Protocol Violation|1
137275|NCT00572156|438255|P4|Overall Study|Lost to Follow-up|0
137276|NCT00572156|438256|P3|Overall Study|Lost to Follow-up|1
137277|NCT00572156|438257|P2|Overall Study|Lost to Follow-up|1
137278|NCT00572156|438258|P1|Overall Study|Lost to Follow-up|1
137279|NCT00572156|438255|P4|Overall Study|Adverse Event|1
137280|NCT00572156|438256|P3|Overall Study|Adverse Event|5
137281|NCT00572156|438257|P2|Overall Study|Adverse Event|1
137282|NCT00572156|438258|P1|Overall Study|Adverse Event|3
137283|NCT00572533|438333|P2|Overall Study|Transfer out of Facility|1
137284|NCT00572533|438334|P1|Overall Study|Transfer out of Facility|0
137285|NCT00572533|438333|P2|Overall Study|Social Issues|0
137286|NCT00572533|438334|P1|Overall Study|Social Issues|1
137287|NCT00572533|438333|P2|Overall Study|Received Kidney Transplant|1
137288|NCT00572533|438334|P1|Overall Study|Received Kidney Transplant|2
137289|NCT00572533|438333|P2|Overall Study|Death|1
137290|NCT00572533|438334|P1|Overall Study|Death|4
137291|NCT00572572|438356|P2|Overall Study|Withdrawal by Subject|6
137292|NCT00572572|438357|P1|Overall Study|Withdrawal by Subject|3
137293|NCT00572624|438375|P2|Overall Study|Health issues unrelated to the study|0
137294|NCT00572624|438376|P1|Overall Study|Health issues unrelated to the study|1
137295|NCT00572624|438375|P2|Overall Study|Problem with vascular access|0
137296|NCT00572624|438376|P1|Overall Study|Problem with vascular access|1
137297|NCT00572624|438375|P2|Overall Study|Refused to do the stress test|0
137298|NCT00572624|438376|P1|Overall Study|Refused to do the stress test|1
137299|NCT00572624|438375|P2|Overall Study|Admitted to being a smoker|0
137300|NCT00572624|438376|P1|Overall Study|Admitted to being a smoker|1
137301|NCT00572624|438375|P2|Overall Study|Started a new job-- no time for study|0
137302|NCT00572624|438376|P1|Overall Study|Started a new job-- no time for study|1
137303|NCT00572624|438375|P2|Overall Study|Medication change|0
137304|NCT00572624|438376|P1|Overall Study|Medication change|1
137305|NCT00572624|438375|P2|Overall Study|Wanted to do a different diet program|0
137306|NCT00572624|438376|P1|Overall Study|Wanted to do a different diet program|1
137307|NCT00572624|438375|P2|Overall Study|Lost to Follow-up|4
137308|NCT00572624|438376|P1|Overall Study|Lost to Follow-up|10
137309|NCT00572728|438402|P1|Overall Study|Pathology missing|1
137310|NCT00572728|438402|P1|Overall Study|FLT2 after second chemotherapy initiated|7
137311|NCT00572728|438402|P1|Overall Study|Second chemotherapy not initiated|1
137312|NCT00572728|438402|P1|Overall Study|FLT2 not completed|5
137313|NCT00572728|438402|P1|Overall Study|First Chemotherapy not initiated|2
137314|NCT00572728|438402|P1|Overall Study|FLT1 not completed|4
137315|NCT00572728|438402|P1|Overall Study|Offstudy due to complicating disease|1
137316|NCT00572728|438402|P1|Overall Study|Enrolled under Amendment 4|5
137317|NCT00572728|438402|P1|Overall Study|Ineligible|3
137318|NCT00572728|438402|P1|Overall Study|Withdrawal by Subject|10
137319|NCT00572832|438416|P2|Overall Study|Pregnancy|1
137320|NCT00572832|438417|P1|Overall Study|Pregnancy|0
137321|NCT00572832|438416|P2|Overall Study|Lost to Follow-up|11
137322|NCT00572832|438417|P1|Overall Study|Lost to Follow-up|0
137323|NCT00572910|438448|P11|Overall Study|Withdrawal by Subject|1
137324|NCT00572910|438449|P10|Overall Study|Withdrawal by Subject|2
137325|NCT00572910|438450|P9|Overall Study|Withdrawal by Subject|2
137326|NCT00572910|438451|P8|Overall Study|Withdrawal by Subject|2
137327|NCT00572910|438452|P7|Overall Study|Withdrawal by Subject|0
137328|NCT00572910|438453|P6|Overall Study|Withdrawal by Subject|3
137329|NCT00572910|438454|P5|Overall Study|Withdrawal by Subject|1
137330|NCT00572910|438455|P4|Overall Study|Withdrawal by Subject|0
137331|NCT00572910|438456|P3|Overall Study|Withdrawal by Subject|1
137332|NCT00572910|438457|P2|Overall Study|Withdrawal by Subject|0
137333|NCT00572910|438458|P1|Overall Study|Withdrawal by Subject|3
137334|NCT00572910|438448|P11|Overall Study|Lost to Follow-up|0
137335|NCT00572910|438449|P10|Overall Study|Lost to Follow-up|1
137336|NCT00572910|438450|P9|Overall Study|Lost to Follow-up|0
137337|NCT00572910|438451|P8|Overall Study|Lost to Follow-up|0
137338|NCT00572910|438452|P7|Overall Study|Lost to Follow-up|0
137339|NCT00572910|438453|P6|Overall Study|Lost to Follow-up|0
137340|NCT00572910|438454|P5|Overall Study|Lost to Follow-up|1
137341|NCT00572910|438455|P4|Overall Study|Lost to Follow-up|2
137342|NCT00572910|438456|P3|Overall Study|Lost to Follow-up|1
137343|NCT00572910|438457|P2|Overall Study|Lost to Follow-up|1
137344|NCT00572910|438458|P1|Overall Study|Lost to Follow-up|0
137345|NCT00572910|438448|P11|Overall Study|Adverse Event|2
137346|NCT00572910|438449|P10|Overall Study|Adverse Event|3
137347|NCT00572910|438450|P9|Overall Study|Adverse Event|1
137348|NCT00572910|438451|P8|Overall Study|Adverse Event|2
137349|NCT00572910|438452|P7|Overall Study|Adverse Event|4
137350|NCT00572910|438453|P6|Overall Study|Adverse Event|0
137351|NCT00572910|438454|P5|Overall Study|Adverse Event|0
137352|NCT00572910|438455|P4|Overall Study|Adverse Event|2
137353|NCT00572910|438456|P3|Overall Study|Adverse Event|0
137354|NCT00572910|438457|P2|Overall Study|Adverse Event|2
137355|NCT00572910|438458|P1|Overall Study|Adverse Event|1
137356|NCT00573066|438504|P1|Overall Study|Postoperative bleeding|1
137357|NCT00573066|438504|P1|Overall Study|IV malfunction|1
137358|NCT00573066|438504|P1|Overall Study|Exclusion criteria|18
137359|NCT00581542|438515|P2|Overall Study|Lost to Follow-up|21
137360|NCT00581542|438516|P1|Overall Study|Lost to Follow-up|9
137361|NCT00581542|438515|P2|Overall Study|they met an exclusion criteria|2
137362|NCT00581542|438516|P1|Overall Study|they met an exclusion criteria|2
137363|NCT00581555|438526|P2|Overall Study|Other reasons|4
137364|NCT00581555|438527|P1|Overall Study|Other reasons|16
137365|NCT00581555|438526|P2|Overall Study|Lost to Follow-up|2
137366|NCT00581555|438527|P1|Overall Study|Lost to Follow-up|2
137367|NCT00581555|438526|P2|Overall Study|Withdrawal by Subject|9
137368|NCT00581555|438527|P1|Overall Study|Withdrawal by Subject|18
137369|NCT00581555|438526|P2|Overall Study|Physician Decision|2
137370|NCT00581555|438527|P1|Overall Study|Physician Decision|3
137371|NCT00581555|438526|P2|Overall Study|Adverse Event|3
137372|NCT00581555|438527|P1|Overall Study|Adverse Event|4
137373|NCT00581776|438558|P1|Overall Study|Disease progression or no response|3
137374|NCT00581828|438565|P1|Overall Study|Protocol Violation|1
137375|NCT00582491|438575|P2|Overall Study|Withdrawal by Subject|0
137376|NCT00582491|438576|P1|Overall Study|Withdrawal by Subject|1
137377|NCT00582556|438610|P3|Overall Study|Physician Decision|1
137378|NCT00582556|438611|P2|Overall Study|Physician Decision|0
137379|NCT00582556|438612|P1|Overall Study|Physician Decision|0
137380|NCT00582556|438610|P3|Overall Study|Withdrawal by Subject|1
137381|NCT00582556|438611|P2|Overall Study|Withdrawal by Subject|1
137382|NCT00582556|438612|P1|Overall Study|Withdrawal by Subject|0
137383|NCT00582608|438629|P1|Overall Study|Lack of accrual|4
137384|NCT00582608|438629|P1|Overall Study|Patient Ineligible|1
137385|NCT00582608|438629|P1|Overall Study|Not Treated|7
137386|NCT00582712|438644|P1|Overall Study|Complicating disease requiring treatment|1
137387|NCT00582712|438644|P1|Overall Study|Withdrawal by Subject|1
137388|NCT00582712|438644|P1|Overall Study|Lack of Efficacy|1
137389|NCT00582712|438644|P1|Overall Study|Adverse Event|1
137390|NCT00582738|438650|P2|Overall Study|Withdrawal by Subject|3
137391|NCT00582738|438651|P1|Overall Study|Withdrawal by Subject|0
137392|NCT00582738|438650|P2|Overall Study|Protocol Violation|1
137393|NCT00582738|438651|P1|Overall Study|Protocol Violation|1
137394|NCT00582738|438650|P2|Overall Study|Other|0
137395|NCT00582738|438651|P1|Overall Study|Other|1
137396|NCT00582738|438650|P2|Overall Study|Graft Lost|1
137397|NCT00582738|438651|P1|Overall Study|Graft Lost|0
137398|NCT00582738|438650|P2|Overall Study|Adverse Event|5
137399|NCT00582738|438651|P1|Overall Study|Adverse Event|0
137400|NCT00582738|438650|P2|Overall Study|Administrative Problems|8
137401|NCT00582738|438651|P1|Overall Study|Administrative Problems|7
137402|NCT00582790|438675|P1|Overall Study|Rapid progression of disease|1
137403|NCT00582816|438682|P1|Overall Study|Engraftment Failure|3
137404|NCT00582907|438699|P4|2nd Course|Lack of Efficacy|0
137405|NCT00582907|438700|P3|2nd Course|Lack of Efficacy|0
137406|NCT00582907|438701|P2|2nd Course|Lack of Efficacy|0
137407|NCT00582907|438702|P1|2nd Course|Lack of Efficacy|1
137408|NCT00582907|438699|P4|1st Course|Lost to Follow-up|1
137409|NCT00582907|438700|P3|1st Course|Lost to Follow-up|0
137410|NCT00582907|438701|P2|1st Course|Lost to Follow-up|0
137411|NCT00582907|438702|P1|1st Course|Lost to Follow-up|0
137412|NCT00582907|438699|P4|1st Course|Withdrawal by Subject|0
137413|NCT00582907|438700|P3|1st Course|Withdrawal by Subject|0
137414|NCT00582907|438701|P2|1st Course|Withdrawal by Subject|0
137415|NCT00582907|438702|P1|1st Course|Withdrawal by Subject|1
137416|NCT00582933|438734|P1|Overall Study|Physician Decision|3
137417|NCT00582972|438742|P1|Overall Study|Protocol Violation|2
137418|NCT00583115|438747|P1|Overall Study|Death|1
137419|NCT00583219|438752|P1|Phase 2|Withdrawal by Subject|1
137420|NCT00583362|438769|P1|Overall Study|Withdrawal by Subject|57
137421|NCT00583362|438769|P1|Overall Study|Protocol Violation|2
137422|NCT00583362|438769|P1|Overall Study|Physician Decision|19
137423|NCT00583362|438769|P1|Overall Study|Sponsor request due to missed doses|1
137424|NCT00583362|438769|P1|Overall Study|Behavioral problems and non-compliance|1
137425|NCT00583362|438769|P1|Overall Study|Misunderstanding of protocol|1
137426|NCT00583362|438769|P1|Overall Study|Missed visits due to staff changes|1
137427|NCT00583362|438769|P1|Overall Study|Subject moved out of the country/state|2
137428|NCT00583362|438769|P1|Overall Study|Subject not dosed in LBSL99|1
137429|NCT00583362|438769|P1|Overall Study|Current site closed|7
137430|NCT00583362|438769|P1|Overall Study|Miscommunication of visit window|5
137431|NCT00583362|438769|P1|Overall Study|Pregnancy|7
137432|NCT00583362|438769|P1|Overall Study|Non-compliance with study drug|28
137433|NCT00583362|438769|P1|Overall Study|Lost to Follow-up|4
137434|NCT00583362|438769|P1|Overall Study|Lack of Efficacy|22
137435|NCT00583362|438769|P1|Overall Study|Adverse Event|44
137436|NCT00583453|438795|P2|Overall Study|discontinued intervention|2
137437|NCT00583453|438796|P1|Overall Study|discontinued intervention|0
137438|NCT00583557|438829|P1|Overall Study|Did not receive belimumab in LBRA99|2
137439|NCT00583557|438829|P1|Overall Study|Other|5
137440|NCT00583557|438829|P1|Overall Study|Lack of Compliance|5
137441|NCT00583557|438829|P1|Overall Study|Lack of Efficacy|31
137442|NCT00583557|438829|P1|Overall Study|Adverse Event|9
137443|NCT00583557|438829|P1|Overall Study|Withdrawal by Subject|18
137444|NCT00583596|438833|P1|Overall Study|Outside f-up window|26
137445|NCT00583596|438833|P1|Overall Study|Not consented|15
137446|NCT00583596|438833|P1|Overall Study|Data not complete|1
137447|NCT00583596|438833|P1|Overall Study|Lost to Follow-up|94
137448|NCT00583596|438833|P1|Overall Study|Withdrawal by Subject|6
137449|NCT00583596|438833|P1|Overall Study|Death|2
137450|NCT00583596|438833|P1|Overall Study|Excluded due to Hurricane Katrina|30
137451|NCT00583596|438833|P1|Overall Study|Lost to Follow-up|110
137452|NCT00583947|438956|P2|Cross-over Period|not specified|1
137453|NCT00583947|438957|P1|Cross-over Period|not specified|1
137454|NCT00583947|438956|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
137455|NCT00583947|438957|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
137456|NCT00583947|438956|P2|Cross-over Period|Withdrawal by Subject|0
137457|NCT00583947|438957|P1|Cross-over Period|Withdrawal by Subject|2
137458|NCT00583947|438956|P2|Cross-over Period|Adverse Event|0
137459|NCT00583947|438957|P1|Cross-over Period|Adverse Event|2
137460|NCT00584194|439011|P1|Overall Study|Not specified|135
137461|NCT00584415|439033|P1|Overall Study|Adverse Event|7
137462|NCT00584454|439038|P1|Overall Study|Clinical Hold|2
137463|NCT00584454|439038|P1|Overall Study|Relocation|1
137464|NCT00584454|439038|P1|Overall Study|Adverse Event|1
137465|NCT00584727|439051|P6|Third Intervention|Protocol Violation|2
137466|NCT00584727|439052|P5|Third Intervention|Protocol Violation|4
137467|NCT00584727|439053|P4|Third Intervention|Protocol Violation|0
137468|NCT00584727|439054|P3|Third Intervention|Protocol Violation|1
137469|NCT00584727|439055|P2|Third Intervention|Protocol Violation|0
137470|NCT00584727|439056|P1|Third Intervention|Protocol Violation|0
137471|NCT00584727|439051|P6|First Intervention|Discontinuation|0
137472|NCT00584727|439052|P5|First Intervention|Discontinuation|0
137473|NCT00584727|439053|P4|First Intervention|Discontinuation|0
137474|NCT00584727|439054|P3|First Intervention|Discontinuation|1
137475|NCT00584727|439055|P2|First Intervention|Discontinuation|0
137476|NCT00584727|439056|P1|First Intervention|Discontinuation|0
137477|NCT00584740|439082|P2|Overall Study|Lost to Follow-up|1
137478|NCT00584740|439083|P1|Overall Study|Lost to Follow-up|0
137479|NCT00584740|439082|P2|Overall Study|Withdrawal by Subject|2
137480|NCT00584740|439083|P1|Overall Study|Withdrawal by Subject|3
137481|NCT00584740|439082|P2|Overall Study|Lack of Efficacy|2
137482|NCT00584740|439083|P1|Overall Study|Lack of Efficacy|8
137483|NCT00584740|439082|P2|Overall Study|Adverse Event|1
137484|NCT00584740|439083|P1|Overall Study|Adverse Event|1
137485|NCT00584844|439141|P1|Overall Study|Screen Failure|20
137486|NCT00584844|439141|P1|Overall Study|Withdrawal by Subject|59
137487|NCT00584909|439156|P1|Overall Study|Adverse Event|4
137488|NCT00576472|439191|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
137489|NCT00576472|439192|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
137490|NCT00576472|439193|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
137491|NCT00576472|439194|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
137492|NCT00576472|439195|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
137493|NCT00576472|439196|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
137494|NCT00576472|439197|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
137495|NCT00576472|439198|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
137496|NCT00576472|439199|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
137497|NCT00576472|439200|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
137498|NCT00576472|439201|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
137499|NCT00576472|439202|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
137500|NCT00576472|439203|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
137501|NCT00576472|439204|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
137502|NCT00576472|439205|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
137503|NCT00576472|439191|P15|MPH Home Maintenance Phase|Medical reasons|6
137504|NCT00576472|439192|P14|MPH Home Maintenance Phase|Medical reasons|0
137505|NCT00576472|439193|P13|MPH Home Maintenance Phase|Medical reasons|0
137506|NCT00576472|439194|P12|MPH Home Maintenance Phase|Medical reasons|0
137507|NCT00576472|439195|P11|MPH Home Maintenance Phase|Medical reasons|0
137508|NCT00576472|439196|P10|MPH Home Maintenance Phase|Medical reasons|0
137509|NCT00576472|439197|P9|MPH Home Maintenance Phase|Medical reasons|0
137510|NCT00576472|439198|P8|MPH Home Maintenance Phase|Medical reasons|0
137511|NCT00576472|439199|P7|MPH Home Maintenance Phase|Medical reasons|0
137512|NCT00576472|439200|P6|MPH Home Maintenance Phase|Medical reasons|0
137513|NCT00576472|439201|P5|MPH Home Maintenance Phase|Medical reasons|0
137514|NCT00576472|439202|P4|MPH Home Maintenance Phase|Medical reasons|0
137515|NCT00576472|439203|P3|MPH Home Maintenance Phase|Medical reasons|0
137516|NCT00576472|439204|P2|MPH Home Maintenance Phase|Medical reasons|0
137517|NCT00576472|439205|P1|MPH Home Maintenance Phase|Medical reasons|0
137518|NCT00576472|439191|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
137519|NCT00576472|439192|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
137520|NCT00576472|439193|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
137521|NCT00576472|439194|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
137522|NCT00576472|439195|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
137523|NCT00576472|439196|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
137524|NCT00576472|439197|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
137525|NCT00576472|439198|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
137526|NCT00576472|439199|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
137527|NCT00576472|439200|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
137528|NCT00576472|439201|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
137529|NCT00576472|439202|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
137530|NCT00576472|439203|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
137531|NCT00576472|439204|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
137532|NCT00576472|439205|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
137533|NCT00576472|439191|P15|MPH Home Maintenance Phase|Side effects|8
137534|NCT00576472|439192|P14|MPH Home Maintenance Phase|Side effects|0
137535|NCT00576472|439193|P13|MPH Home Maintenance Phase|Side effects|0
137536|NCT00576472|439194|P12|MPH Home Maintenance Phase|Side effects|0
137537|NCT00576472|439195|P11|MPH Home Maintenance Phase|Side effects|0
137538|NCT00576472|439196|P10|MPH Home Maintenance Phase|Side effects|0
137539|NCT00576472|439197|P9|MPH Home Maintenance Phase|Side effects|0
137540|NCT00576472|439198|P8|MPH Home Maintenance Phase|Side effects|0
137541|NCT00576472|439199|P7|MPH Home Maintenance Phase|Side effects|0
137542|NCT00576472|439200|P6|MPH Home Maintenance Phase|Side effects|0
137543|NCT00576472|439201|P5|MPH Home Maintenance Phase|Side effects|0
137544|NCT00576472|439202|P4|MPH Home Maintenance Phase|Side effects|0
137545|NCT00576472|439203|P3|MPH Home Maintenance Phase|Side effects|0
137546|NCT00576472|439204|P2|MPH Home Maintenance Phase|Side effects|0
137547|NCT00576472|439205|P1|MPH Home Maintenance Phase|Side effects|0
137548|NCT00576472|439191|P15|MPH Home Maintenance Phase|Insufficient data|0
137549|NCT00576472|439192|P14|MPH Home Maintenance Phase|Insufficient data|4
137550|NCT00576472|439193|P13|MPH Home Maintenance Phase|Insufficient data|0
137551|NCT00576472|439194|P12|MPH Home Maintenance Phase|Insufficient data|0
137552|NCT00576472|439195|P11|MPH Home Maintenance Phase|Insufficient data|0
137553|NCT00576472|439196|P10|MPH Home Maintenance Phase|Insufficient data|0
137554|NCT00576472|439197|P9|MPH Home Maintenance Phase|Insufficient data|0
137555|NCT00576472|439198|P8|MPH Home Maintenance Phase|Insufficient data|0
137556|NCT00576472|439199|P7|MPH Home Maintenance Phase|Insufficient data|0
137557|NCT00576472|439200|P6|MPH Home Maintenance Phase|Insufficient data|0
137558|NCT00576472|439201|P5|MPH Home Maintenance Phase|Insufficient data|0
137559|NCT00576472|439202|P4|MPH Home Maintenance Phase|Insufficient data|0
137560|NCT00576472|439203|P3|MPH Home Maintenance Phase|Insufficient data|0
137561|NCT00576472|439204|P2|MPH Home Maintenance Phase|Insufficient data|0
137562|NCT00576472|439205|P1|MPH Home Maintenance Phase|Insufficient data|0
137563|NCT00576472|439191|P15|MPH Home Maintenance Phase|Declined to participate|0
137564|NCT00576472|439192|P14|MPH Home Maintenance Phase|Declined to participate|7
137565|NCT00576472|439193|P13|MPH Home Maintenance Phase|Declined to participate|0
137566|NCT00576472|439194|P12|MPH Home Maintenance Phase|Declined to participate|0
137567|NCT00576472|439195|P11|MPH Home Maintenance Phase|Declined to participate|0
137568|NCT00576472|439196|P10|MPH Home Maintenance Phase|Declined to participate|0
137569|NCT00576472|439197|P9|MPH Home Maintenance Phase|Declined to participate|0
137570|NCT00576472|439198|P8|MPH Home Maintenance Phase|Declined to participate|0
137571|NCT00576472|439199|P7|MPH Home Maintenance Phase|Declined to participate|0
137572|NCT00576472|439200|P6|MPH Home Maintenance Phase|Declined to participate|0
137573|NCT00576472|439201|P5|MPH Home Maintenance Phase|Declined to participate|0
137574|NCT00576472|439202|P4|MPH Home Maintenance Phase|Declined to participate|0
137575|NCT00576472|439203|P3|MPH Home Maintenance Phase|Declined to participate|0
137576|NCT00576472|439204|P2|MPH Home Maintenance Phase|Declined to participate|0
137577|NCT00576472|439205|P1|MPH Home Maintenance Phase|Declined to participate|0
137578|NCT00576472|439191|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
137579|NCT00576472|439192|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
137580|NCT00576472|439193|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
137581|NCT00576472|439194|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
137582|NCT00576472|439195|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
137583|NCT00576472|439196|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
137584|NCT00576472|439197|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
137585|NCT00576472|439198|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
137586|NCT00576472|439199|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
137587|NCT00576472|439200|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
137588|NCT00576472|439201|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
137589|NCT00576472|439202|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
137590|NCT00576472|439203|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
137591|NCT00576472|439204|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
137592|NCT00576472|439205|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
137593|NCT00576472|439191|P15|MPH Cross Over Phase|Did not complete cross over phase|0
137594|NCT00576472|439192|P14|MPH Cross Over Phase|Did not complete cross over phase|0
137595|NCT00576472|439193|P13|MPH Cross Over Phase|Did not complete cross over phase|0
137596|NCT00576472|439194|P12|MPH Cross Over Phase|Did not complete cross over phase|1
137597|NCT00576472|439195|P11|MPH Cross Over Phase|Did not complete cross over phase|1
137598|NCT00576472|439196|P10|MPH Cross Over Phase|Did not complete cross over phase|0
137599|NCT00576472|439197|P9|MPH Cross Over Phase|Did not complete cross over phase|2
137600|NCT00576472|439198|P8|MPH Cross Over Phase|Did not complete cross over phase|0
137601|NCT00576472|439199|P7|MPH Cross Over Phase|Did not complete cross over phase|0
137602|NCT00576472|439200|P6|MPH Cross Over Phase|Did not complete cross over phase|0
137603|NCT00576472|439201|P5|MPH Cross Over Phase|Did not complete cross over phase|0
137604|NCT00576472|439202|P4|MPH Cross Over Phase|Did not complete cross over phase|0
137605|NCT00576472|439203|P3|MPH Cross Over Phase|Did not complete cross over phase|0
137606|NCT00576472|439204|P2|MPH Cross Over Phase|Did not complete cross over phase|0
137607|NCT00576472|439205|P1|MPH Cross Over Phase|Did not complete cross over phase|0
137608|NCT00576472|439191|P15|MPH Cross Over Phase|Physician Decision|0
137609|NCT00576472|439192|P14|MPH Cross Over Phase|Physician Decision|0
137610|NCT00576472|439193|P13|MPH Cross Over Phase|Physician Decision|0
137611|NCT00576472|439194|P12|MPH Cross Over Phase|Physician Decision|0
137612|NCT00576472|439195|P11|MPH Cross Over Phase|Physician Decision|0
137613|NCT00576472|439196|P10|MPH Cross Over Phase|Physician Decision|0
137614|NCT00576472|439197|P9|MPH Cross Over Phase|Physician Decision|0
137615|NCT00576472|439198|P8|MPH Cross Over Phase|Physician Decision|0
137616|NCT00576472|439199|P7|MPH Cross Over Phase|Physician Decision|4
137617|NCT00576472|439200|P6|MPH Cross Over Phase|Physician Decision|0
137618|NCT00576472|439201|P5|MPH Cross Over Phase|Physician Decision|0
137619|NCT00576472|439202|P4|MPH Cross Over Phase|Physician Decision|0
137620|NCT00576472|439203|P3|MPH Cross Over Phase|Physician Decision|0
137621|NCT00576472|439204|P2|MPH Cross Over Phase|Physician Decision|0
137622|NCT00576472|439205|P1|MPH Cross Over Phase|Physician Decision|0
137623|NCT00576472|439191|P15|MPH Cross Over Phase|Ineligible due to disease|0
137624|NCT00576472|439192|P14|MPH Cross Over Phase|Ineligible due to disease|0
137625|NCT00576472|439193|P13|MPH Cross Over Phase|Ineligible due to disease|0
137626|NCT00576472|439194|P12|MPH Cross Over Phase|Ineligible due to disease|0
137627|NCT00576472|439195|P11|MPH Cross Over Phase|Ineligible due to disease|0
137628|NCT00576472|439196|P10|MPH Cross Over Phase|Ineligible due to disease|0
137629|NCT00576472|439197|P9|MPH Cross Over Phase|Ineligible due to disease|0
137630|NCT00576472|439198|P8|MPH Cross Over Phase|Ineligible due to disease|0
137631|NCT00576472|439199|P7|MPH Cross Over Phase|Ineligible due to disease|2
137632|NCT00576472|439200|P6|MPH Cross Over Phase|Ineligible due to disease|0
137633|NCT00576472|439201|P5|MPH Cross Over Phase|Ineligible due to disease|0
137634|NCT00576472|439202|P4|MPH Cross Over Phase|Ineligible due to disease|0
137635|NCT00576472|439203|P3|MPH Cross Over Phase|Ineligible due to disease|0
137636|NCT00576472|439204|P2|MPH Cross Over Phase|Ineligible due to disease|0
137637|NCT00576472|439205|P1|MPH Cross Over Phase|Ineligible due to disease|0
137638|NCT00576472|439191|P15|MPH Cross Over Phase|Withdrawal by Subject|0
137639|NCT00576472|439192|P14|MPH Cross Over Phase|Withdrawal by Subject|0
137640|NCT00576472|439193|P13|MPH Cross Over Phase|Withdrawal by Subject|0
137641|NCT00576472|439194|P12|MPH Cross Over Phase|Withdrawal by Subject|0
137642|NCT00576472|439195|P11|MPH Cross Over Phase|Withdrawal by Subject|0
137643|NCT00576472|439196|P10|MPH Cross Over Phase|Withdrawal by Subject|0
137644|NCT00576472|439197|P9|MPH Cross Over Phase|Withdrawal by Subject|0
137645|NCT00576472|439198|P8|MPH Cross Over Phase|Withdrawal by Subject|0
137646|NCT00576472|439199|P7|MPH Cross Over Phase|Withdrawal by Subject|6
137647|NCT00576472|439200|P6|MPH Cross Over Phase|Withdrawal by Subject|0
137648|NCT00576472|439201|P5|MPH Cross Over Phase|Withdrawal by Subject|0
137649|NCT00576472|439202|P4|MPH Cross Over Phase|Withdrawal by Subject|0
137650|NCT00576472|439203|P3|MPH Cross Over Phase|Withdrawal by Subject|0
137651|NCT00576472|439204|P2|MPH Cross Over Phase|Withdrawal by Subject|0
137652|NCT00576472|439205|P1|MPH Cross Over Phase|Withdrawal by Subject|0
137653|NCT00576472|439191|P15|MPH In-Lab Phase|Psychiatric exclusion|0
137654|NCT00576472|439192|P14|MPH In-Lab Phase|Psychiatric exclusion|0
137655|NCT00576472|439193|P13|MPH In-Lab Phase|Psychiatric exclusion|0
137656|NCT00576472|439194|P12|MPH In-Lab Phase|Psychiatric exclusion|0
137657|NCT00576472|439195|P11|MPH In-Lab Phase|Psychiatric exclusion|0
137658|NCT00576472|439196|P10|MPH In-Lab Phase|Psychiatric exclusion|0
137659|NCT00576472|439197|P9|MPH In-Lab Phase|Psychiatric exclusion|0
137660|NCT00576472|439198|P8|MPH In-Lab Phase|Psychiatric exclusion|0
137661|NCT00576472|439199|P7|MPH In-Lab Phase|Psychiatric exclusion|0
137662|NCT00576472|439200|P6|MPH In-Lab Phase|Psychiatric exclusion|0
137663|NCT00576472|439201|P5|MPH In-Lab Phase|Psychiatric exclusion|0
137664|NCT00576472|439202|P4|MPH In-Lab Phase|Psychiatric exclusion|10
137665|NCT00576472|439203|P3|MPH In-Lab Phase|Psychiatric exclusion|0
137666|NCT00576472|439204|P2|MPH In-Lab Phase|Psychiatric exclusion|0
137667|NCT00576472|439205|P1|MPH In-Lab Phase|Psychiatric exclusion|0
137668|NCT00576472|439191|P15|MPH In-Lab Phase|No attention/academic problems|0
137669|NCT00576472|439192|P14|MPH In-Lab Phase|No attention/academic problems|0
137670|NCT00576472|439193|P13|MPH In-Lab Phase|No attention/academic problems|0
137671|NCT00576472|439194|P12|MPH In-Lab Phase|No attention/academic problems|0
137672|NCT00576472|439195|P11|MPH In-Lab Phase|No attention/academic problems|0
137673|NCT00576472|439196|P10|MPH In-Lab Phase|No attention/academic problems|0
137674|NCT00576472|439197|P9|MPH In-Lab Phase|No attention/academic problems|0
137675|NCT00576472|439198|P8|MPH In-Lab Phase|No attention/academic problems|0
137676|NCT00576472|439199|P7|MPH In-Lab Phase|No attention/academic problems|0
137677|NCT00576472|439200|P6|MPH In-Lab Phase|No attention/academic problems|0
137678|NCT00576472|439201|P5|MPH In-Lab Phase|No attention/academic problems|0
137679|NCT00576472|439202|P4|MPH In-Lab Phase|No attention/academic problems|245
137680|NCT00576472|439203|P3|MPH In-Lab Phase|No attention/academic problems|0
137681|NCT00576472|439204|P2|MPH In-Lab Phase|No attention/academic problems|0
137682|NCT00576472|439205|P1|MPH In-Lab Phase|No attention/academic problems|0
137683|NCT00576472|439191|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137684|NCT00576472|439192|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137685|NCT00576472|439193|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137686|NCT00576472|439194|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137687|NCT00576472|439195|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137688|NCT00576472|439196|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137689|NCT00576472|439197|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137690|NCT00576472|439198|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137691|NCT00576472|439199|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137692|NCT00576472|439200|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137693|NCT00576472|439201|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137694|NCT00576472|439202|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
137695|NCT00576472|439203|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137696|NCT00576472|439204|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137697|NCT00576472|439205|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
137698|NCT00576472|439191|P15|MPH In-Lab Phase|Lost to Follow-up|0
137699|NCT00576472|439192|P14|MPH In-Lab Phase|Lost to Follow-up|0
137700|NCT00576472|439193|P13|MPH In-Lab Phase|Lost to Follow-up|0
137701|NCT00576472|439194|P12|MPH In-Lab Phase|Lost to Follow-up|0
137702|NCT00576472|439195|P11|MPH In-Lab Phase|Lost to Follow-up|0
137703|NCT00576472|439196|P10|MPH In-Lab Phase|Lost to Follow-up|0
137704|NCT00576472|439197|P9|MPH In-Lab Phase|Lost to Follow-up|0
137705|NCT00576472|439198|P8|MPH In-Lab Phase|Lost to Follow-up|0
137706|NCT00576472|439199|P7|MPH In-Lab Phase|Lost to Follow-up|0
137707|NCT00576472|439200|P6|MPH In-Lab Phase|Lost to Follow-up|0
137708|NCT00576472|439201|P5|MPH In-Lab Phase|Lost to Follow-up|0
137709|NCT00576472|439202|P4|MPH In-Lab Phase|Lost to Follow-up|1
137710|NCT00576472|439203|P3|MPH In-Lab Phase|Lost to Follow-up|0
137711|NCT00576472|439204|P2|MPH In-Lab Phase|Lost to Follow-up|0
137712|NCT00576472|439205|P1|MPH In-Lab Phase|Lost to Follow-up|0
137713|NCT00576472|439191|P15|MPH In-Lab Phase|Declined participation in medication pha|0
137714|NCT00576472|439192|P14|MPH In-Lab Phase|Declined participation in medication pha|0
137715|NCT00576472|439193|P13|MPH In-Lab Phase|Declined participation in medication pha|0
137716|NCT00576472|439194|P12|MPH In-Lab Phase|Declined participation in medication pha|0
137717|NCT00576472|439195|P11|MPH In-Lab Phase|Declined participation in medication pha|0
137718|NCT00576472|439196|P10|MPH In-Lab Phase|Declined participation in medication pha|0
137719|NCT00576472|439197|P9|MPH In-Lab Phase|Declined participation in medication pha|0
137720|NCT00576472|439198|P8|MPH In-Lab Phase|Declined participation in medication pha|0
137721|NCT00576472|439199|P7|MPH In-Lab Phase|Declined participation in medication pha|0
137722|NCT00576472|439200|P6|MPH In-Lab Phase|Declined participation in medication pha|0
137723|NCT00576472|439201|P5|MPH In-Lab Phase|Declined participation in medication pha|0
137724|NCT00576472|439202|P4|MPH In-Lab Phase|Declined participation in medication pha|75
137725|NCT00576472|439203|P3|MPH In-Lab Phase|Declined participation in medication pha|0
137726|NCT00576472|439204|P2|MPH In-Lab Phase|Declined participation in medication pha|0
137727|NCT00576472|439205|P1|MPH In-Lab Phase|Declined participation in medication pha|0
137728|NCT00576576|439308|P1|Overall Study|Protocol Violation|1
137729|NCT00576576|439308|P1|Overall Study|Lost to Follow-up|6
137730|NCT00576628|439314|P1|Overall Study|Dialysis|15
137731|NCT00576628|439314|P1|Overall Study|Transplantation|1
137732|NCT00576628|439314|P1|Overall Study|The patient move into other town|1
137733|NCT00576628|439314|P1|Overall Study|Progression of Renal Failure|1
137734|NCT00576628|439314|P1|Overall Study|Progression of Kidney Disease|1
137735|NCT00576628|439314|P1|Overall Study|RBC transfusion|1
137736|NCT00576628|439314|P1|Overall Study|Pregnancy|1
137737|NCT00576628|439314|P1|Overall Study|Refused Treatment|8
137738|NCT00576628|439314|P1|Overall Study|Failure to return|1
137739|NCT00576628|439314|P1|Overall Study|Death|2
137740|NCT00576628|439314|P1|Overall Study|Adverse Event|11
137741|NCT00576693|439336|P2|Overall Study|Withdrawal by Subject|13
137742|NCT00576693|439337|P1|Overall Study|Withdrawal by Subject|3
137743|NCT00576693|439336|P2|Overall Study|Lost to Follow-up|11
137744|NCT00576693|439337|P1|Overall Study|Lost to Follow-up|7
137745|NCT00576732|439346|P6|OPEN LABEL|Protocol Violation|0
137746|NCT00576732|439347|P5|OPEN LABEL|Protocol Violation|1
137747|NCT00576732|439348|P4|OPEN LABEL|Protocol Violation|2
137748|NCT00576732|439349|P3|OPEN LABEL|Protocol Violation|0
137749|NCT00576732|439350|P2|OPEN LABEL|Protocol Violation|0
137750|NCT00576732|439351|P1|OPEN LABEL|Protocol Violation|0
137751|NCT00576732|439346|P6|OPEN LABEL|Lack of Efficacy|3
137752|NCT00576732|439347|P5|OPEN LABEL|Lack of Efficacy|2
137753|NCT00576732|439348|P4|OPEN LABEL|Lack of Efficacy|2
137754|NCT00576732|439349|P3|OPEN LABEL|Lack of Efficacy|0
137755|NCT00576732|439350|P2|OPEN LABEL|Lack of Efficacy|0
137756|NCT00576732|439351|P1|OPEN LABEL|Lack of Efficacy|0
137757|NCT00576732|439346|P6|OPEN LABEL|OTHER|2
137758|NCT00576732|439347|P5|OPEN LABEL|OTHER|0
137759|NCT00576732|439348|P4|OPEN LABEL|OTHER|0
137760|NCT00576732|439349|P3|OPEN LABEL|OTHER|0
137761|NCT00576732|439350|P2|OPEN LABEL|OTHER|0
137762|NCT00576732|439351|P1|OPEN LABEL|OTHER|0
137763|NCT00576732|439346|P6|OPEN LABEL|Withdrawal by Subject|1
137764|NCT00576732|439347|P5|OPEN LABEL|Withdrawal by Subject|0
137765|NCT00576732|439348|P4|OPEN LABEL|Withdrawal by Subject|1
137766|NCT00576732|439349|P3|OPEN LABEL|Withdrawal by Subject|0
137767|NCT00576732|439350|P2|OPEN LABEL|Withdrawal by Subject|0
137768|NCT00576732|439351|P1|OPEN LABEL|Withdrawal by Subject|0
137769|NCT00576732|439346|P6|OPEN LABEL|Lost to Follow-up|1
137770|NCT00576732|439347|P5|OPEN LABEL|Lost to Follow-up|1
137771|NCT00576732|439348|P4|OPEN LABEL|Lost to Follow-up|2
137772|NCT00576732|439349|P3|OPEN LABEL|Lost to Follow-up|0
137773|NCT00576732|439350|P2|OPEN LABEL|Lost to Follow-up|0
137774|NCT00576732|439351|P1|OPEN LABEL|Lost to Follow-up|0
137775|NCT00576732|439346|P6|OPEN LABEL|Adverse Event|1
137776|NCT00576732|439347|P5|OPEN LABEL|Adverse Event|0
137777|NCT00576732|439348|P4|OPEN LABEL|Adverse Event|4
137778|NCT00576732|439349|P3|OPEN LABEL|Adverse Event|0
137779|NCT00576732|439350|P2|OPEN LABEL|Adverse Event|0
137780|NCT00576732|439351|P1|OPEN LABEL|Adverse Event|0
137781|NCT00576732|439346|P6|DOUBLE BLIND|Protocol Violation|0
137782|NCT00576732|439347|P5|DOUBLE BLIND|Protocol Violation|0
137783|NCT00576732|439348|P4|DOUBLE BLIND|Protocol Violation|0
137784|NCT00576732|439349|P3|DOUBLE BLIND|Protocol Violation|0
137785|NCT00576732|439350|P2|DOUBLE BLIND|Protocol Violation|0
137786|NCT00576732|439351|P1|DOUBLE BLIND|Protocol Violation|1
137787|NCT00576732|439346|P6|DOUBLE BLIND|Lack of Efficacy|0
137788|NCT00576732|439347|P5|DOUBLE BLIND|Lack of Efficacy|0
137789|NCT00576732|439348|P4|DOUBLE BLIND|Lack of Efficacy|0
137790|NCT00576732|439349|P3|DOUBLE BLIND|Lack of Efficacy|0
137791|NCT00576732|439350|P2|DOUBLE BLIND|Lack of Efficacy|1
137792|NCT00576732|439351|P1|DOUBLE BLIND|Lack of Efficacy|6
137793|NCT00576732|439346|P6|DOUBLE BLIND|OTHER|0
137794|NCT00576732|439347|P5|DOUBLE BLIND|OTHER|0
137795|NCT00576732|439348|P4|DOUBLE BLIND|OTHER|0
137796|NCT00576732|439349|P3|DOUBLE BLIND|OTHER|1
137797|NCT00576732|439350|P2|DOUBLE BLIND|OTHER|2
137798|NCT00576732|439351|P1|DOUBLE BLIND|OTHER|0
137799|NCT00576732|439346|P6|DOUBLE BLIND|Withdrawal by Subject|0
137800|NCT00576732|439347|P5|DOUBLE BLIND|Withdrawal by Subject|0
137801|NCT00576732|439348|P4|DOUBLE BLIND|Withdrawal by Subject|0
137802|NCT00576732|439349|P3|DOUBLE BLIND|Withdrawal by Subject|3
137803|NCT00576732|439350|P2|DOUBLE BLIND|Withdrawal by Subject|1
137804|NCT00576732|439351|P1|DOUBLE BLIND|Withdrawal by Subject|1
137805|NCT00576732|439346|P6|DOUBLE BLIND|Lost to Follow-up|0
137806|NCT00576732|439347|P5|DOUBLE BLIND|Lost to Follow-up|0
137807|NCT00576732|439348|P4|DOUBLE BLIND|Lost to Follow-up|0
137808|NCT00576732|439349|P3|DOUBLE BLIND|Lost to Follow-up|1
137809|NCT00576732|439350|P2|DOUBLE BLIND|Lost to Follow-up|1
137810|NCT00576732|439351|P1|DOUBLE BLIND|Lost to Follow-up|0
137811|NCT00576732|439346|P6|DOUBLE BLIND|Adverse Event|0
137812|NCT00576732|439347|P5|DOUBLE BLIND|Adverse Event|0
137813|NCT00576732|439348|P4|DOUBLE BLIND|Adverse Event|0
137814|NCT00576732|439349|P3|DOUBLE BLIND|Adverse Event|1
137815|NCT00576732|439350|P2|DOUBLE BLIND|Adverse Event|0
137816|NCT00576732|439351|P1|DOUBLE BLIND|Adverse Event|0
137817|NCT00576758|439383|P2|Follow-up Period|Withdrew consent|1
137818|NCT00576758|439384|P1|Follow-up Period|Withdrew consent|2
137819|NCT00576758|439383|P2|Follow-up Period|Insufficient therapeutic response|5
137820|NCT00576758|439384|P1|Follow-up Period|Insufficient therapeutic response|16
137821|NCT00576758|439383|P2|Follow-up Period|Death|3
137822|NCT00576758|439384|P1|Follow-up Period|Death|3
137823|NCT00576758|439383|P2|Follow-up Period|Administrative/Other|8
137824|NCT00576758|439384|P1|Follow-up Period|Administrative/Other|6
137825|NCT00576758|439383|P2|Extension Treatment Period|Administrative/Other|1
137826|NCT00576758|439384|P1|Extension Treatment Period|Administrative/Other|3
137827|NCT00576758|439383|P2|Extension Treatment Period|Insufficient therapeutic response|33
137828|NCT00576758|439384|P1|Extension Treatment Period|Insufficient therapeutic response|30
137829|NCT00576758|439383|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
137830|NCT00576758|439384|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
137831|NCT00576758|439383|P2|Extension Treatment Period|Death|1
137832|NCT00576758|439384|P1|Extension Treatment Period|Death|1
137833|NCT00576758|439383|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
137834|NCT00576758|439384|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
137835|NCT00576758|439383|P2|Induction Treatment Period|Withdrew consent|0
137836|NCT00576758|439384|P1|Induction Treatment Period|Withdrew consent|1
137837|NCT00576758|439383|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
137838|NCT00576758|439384|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
137839|NCT00576758|439383|P2|Induction Treatment Period|Death|0
137840|NCT00576758|439384|P1|Induction Treatment Period|Death|1
137841|NCT00576758|439383|P2|Induction Treatment Period|Violation of selection criteria at entry|1
137842|NCT00576758|439384|P1|Induction Treatment Period|Violation of selection criteria at entry|1
137843|NCT00576758|439383|P2|Induction Treatment Period|Insufficient therapeutic response|0
137844|NCT00576758|439384|P1|Induction Treatment Period|Insufficient therapeutic response|2
137845|NCT00576758|439383|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
137846|NCT00576758|439384|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
137847|NCT00576823|439430|P3|40-week Safety Extension Phase|Lack of Efficacy|0
137848|NCT00576823|439431|P2|40-week Safety Extension Phase|Lack of Efficacy|0
137849|NCT00576823|439432|P1|40-week Safety Extension Phase|Lack of Efficacy|1
137850|NCT00576823|439430|P3|12-week Efficacy Phase|Parentʼs schedule issue|0
137851|NCT00576823|439431|P2|12-week Efficacy Phase|Parentʼs schedule issue|0
137852|NCT00576823|439432|P1|12-week Efficacy Phase|Parentʼs schedule issue|1
137853|NCT00576901|439446|P1|Overall Study|Protocol Violation|1
137854|NCT00576901|439446|P1|Overall Study|Disease course|1
137855|NCT00576901|439446|P1|Overall Study|Withdrawal by Subject|1
137856|NCT00576927|439456|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
137857|NCT00576927|439456|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
137858|NCT00576927|439456|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
137859|NCT00576927|439456|P1|Sleep Hygiene Behavioral Intervention|Death|1
137860|NCT00576927|439456|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
137861|NCT00576927|439456|P1|Baseline|Withdrawal by Subject|3
137862|NCT00576927|439456|P1|Baseline|Medication Change by PCP of subject|1
137863|NCT00576927|439456|P1|Baseline|Physician Decision|9
137864|NCT00576927|439456|P1|Clinical Assessment|Physician Decision|1
137865|NCT00576927|439456|P1|Clinical Assessment|Withdrawal by Subject|10
137866|NCT00576927|439456|P1|Clinical Assessment|Death|1
137867|NCT00576927|439456|P1|Clinical Assessment|Lack of Efficacy|24
137868|NCT00577005|439470|P2|Overall Study|Withdrawal by Subject|1
137869|NCT00577005|439471|P1|Overall Study|Withdrawal by Subject|2
137870|NCT00577005|439470|P2|Overall Study|Lost to Follow-up|2
137871|NCT00577005|439471|P1|Overall Study|Lost to Follow-up|3
137872|NCT00577031|439483|P1|Overall Study|Death|6
137873|NCT00577031|439483|P1|Overall Study|Medical decision|14
137874|NCT00577031|439483|P1|Overall Study|Need for surgery|17
137875|NCT00577031|439483|P1|Overall Study|Participant non-compliance|5
137876|NCT00577031|439483|P1|Overall Study|Participant withdrew consent|13
137877|NCT00577031|439483|P1|Overall Study|Protocol Violation|5
137878|NCT00577031|439483|P1|Overall Study|Progression of disease|93
137879|NCT00577031|439483|P1|Overall Study|Adverse Event|52
137880|NCT00577096|439513|P2|Short Term Participation|Death|1
137881|NCT00577096|439514|P1|Short Term Participation|Death|1
137882|NCT00577096|439513|P2|Short Term Participation|Withdrawal by Subject|5
137883|NCT00577096|439514|P1|Short Term Participation|Withdrawal by Subject|3
137884|NCT00577096|439513|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
137885|NCT00577096|439514|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
137886|NCT00577122|439540|P2|Overall Study|Alternative Therapy|1
137887|NCT00577122|439541|P1|Overall Study|Alternative Therapy|0
137888|NCT00577122|439540|P2|Overall Study|Prog, refract disease during active trt|5
137889|NCT00577122|439541|P1|Overall Study|Prog, refract disease during active trt|8
137890|NCT00577122|439540|P2|Overall Study|Progression, relapse during active trt|8
137891|NCT00577122|439541|P1|Overall Study|Progression, relapse during active trt|6
137892|NCT00577122|439540|P2|Overall Study|Adverse Event|2
137893|NCT00577122|439541|P1|Overall Study|Adverse Event|0
137894|NCT00577382|439684|P2|Overall Study|Lost to Follow-up|2
137895|NCT00577382|439685|P1|Overall Study|Lost to Follow-up|2
137896|NCT00577382|439684|P2|Overall Study|Death|1
137897|NCT00577382|439685|P1|Overall Study|Death|1
137898|NCT00577382|439684|P2|Overall Study|Intercurrent Illness|2
137899|NCT00577382|439685|P1|Overall Study|Intercurrent Illness|1
137900|NCT00577382|439684|P2|Overall Study|Progressive Disease|19
137901|NCT00577382|439685|P1|Overall Study|Progressive Disease|17
137902|NCT00577382|439684|P2|Overall Study|Withdrawal by Subject|1
137903|NCT00577382|439685|P1|Overall Study|Withdrawal by Subject|0
137904|NCT00577382|439684|P2|Overall Study|Adverse Event|6
137905|NCT00577382|439685|P1|Overall Study|Adverse Event|0
137906|NCT00577395|439699|P2|Overall Study|Study was terminated early by Sponsor|6
137907|NCT00577395|439700|P1|Overall Study|Study was terminated early by Sponsor|7
137908|NCT00577408|439710|P2|Overall Study|Psychiatric hospitalization|1
137909|NCT00577408|439711|P1|Overall Study|Psychiatric hospitalization|0
137910|NCT00577408|439710|P2|Overall Study|Death|1
137911|NCT00577408|439711|P1|Overall Study|Death|0
137912|NCT00577408|439710|P2|Overall Study|Scheduling Issues|3
137913|NCT00577408|439711|P1|Overall Study|Scheduling Issues|0
137914|NCT00577408|439710|P2|Overall Study|Moved out of state|1
137915|NCT00577408|439711|P1|Overall Study|Moved out of state|0
137916|NCT00577408|439710|P2|Overall Study|Refused Oral Naltrexone|1
137917|NCT00577408|439711|P1|Overall Study|Refused Oral Naltrexone|0
137918|NCT00577408|439710|P2|Overall Study|Non-compliance with study meds|3
137919|NCT00577408|439711|P1|Overall Study|Non-compliance with study meds|0
137920|NCT00577408|439710|P2|Overall Study|Continued opioid use|2
137921|NCT00577408|439711|P1|Overall Study|Continued opioid use|3
137922|NCT00577408|439710|P2|Overall Study|Stopped attending study visits|11
137923|NCT00577408|439711|P1|Overall Study|Stopped attending study visits|9
137924|NCT00577460|439720|P3|Overall Study|not specified|2
137925|NCT00577460|439721|P2|Overall Study|not specified|3
137926|NCT00577460|439722|P1|Overall Study|not specified|0
137927|NCT00577460|439720|P3|Overall Study|Withdrawal by Subject|6
137928|NCT00577460|439721|P2|Overall Study|Withdrawal by Subject|5
137929|NCT00577460|439722|P1|Overall Study|Withdrawal by Subject|5
137930|NCT00577460|439720|P3|Overall Study|Lost to Follow-up|4
137931|NCT00577460|439721|P2|Overall Study|Lost to Follow-up|3
137932|NCT00577460|439722|P1|Overall Study|Lost to Follow-up|0
137933|NCT00577460|439720|P3|Overall Study|Protocol Violation|1
137934|NCT00577460|439721|P2|Overall Study|Protocol Violation|1
137935|NCT00577460|439722|P1|Overall Study|Protocol Violation|0
137936|NCT00577460|439720|P3|Overall Study|Adverse Event|14
137937|NCT00577460|439721|P2|Overall Study|Adverse Event|7
137938|NCT00577460|439722|P1|Overall Study|Adverse Event|11
137939|NCT00577473|439831|P2|Overall Study|Lack of Efficacy|7
137940|NCT00577473|439832|P1|Overall Study|Lack of Efficacy|8
137941|NCT00577473|439831|P2|Overall Study|Physician Decision|2
137942|NCT00577473|439832|P1|Overall Study|Physician Decision|2
137943|NCT00577473|439831|P2|Overall Study|Withdrawal by Subject|6
137944|NCT00577473|439832|P1|Overall Study|Withdrawal by Subject|2
137945|NCT00577473|439831|P2|Overall Study|Adverse Event|5
137946|NCT00577473|439832|P1|Overall Study|Adverse Event|8
137947|NCT00577473|439831|P2|Overall Study|Protocol Violation|4
137948|NCT00577473|439832|P1|Overall Study|Protocol Violation|1
137949|NCT00577629|439864|P1|Long Term Follow-Up|Physician Decision|1
137950|NCT00577629|439864|P1|Long Term Follow-Up|Withdrawal by Subject|4
137951|NCT00577629|439864|P1|Long Term Follow-Up|Lost to Follow-up|5
137952|NCT00577629|439864|P1|Long Term Follow-Up|Death|15
137953|NCT00577629|439864|P1|Treatment Period|Death|1
137954|NCT00577642|439872|P1|Overall Study|Clinical Disease Progression|1
137955|NCT00577655|439878|P2|Overall Study|Lost to Follow-up|1
137956|NCT00577655|439879|P1|Overall Study|Lost to Follow-up|1
137957|NCT00577655|439878|P2|Overall Study|Protocol Violation|1
137958|NCT00577655|439879|P1|Overall Study|Protocol Violation|0
137959|NCT00577655|439878|P2|Overall Study|Patient Request|2
137960|NCT00577655|439879|P1|Overall Study|Patient Request|0
137961|NCT00577707|439917|P1|Overall Study|Withdrawal by Subject|3
137962|NCT00577720|439925|P4|Overall Study|Withdrawal by Subject|2
137963|NCT00577720|439926|P3|Overall Study|Withdrawal by Subject|0
137964|NCT00577720|439927|P2|Overall Study|Withdrawal by Subject|0
137965|NCT00577720|439928|P1|Overall Study|Withdrawal by Subject|2
137966|NCT00577720|439925|P4|Overall Study|Protocol Violation|1
137967|NCT00577720|439926|P3|Overall Study|Protocol Violation|0
137968|NCT00577720|439927|P2|Overall Study|Protocol Violation|0
137969|NCT00577720|439928|P1|Overall Study|Protocol Violation|0
137970|NCT00577720|439925|P4|Overall Study|Lost to Follow-up|0
137971|NCT00577720|439926|P3|Overall Study|Lost to Follow-up|1
137972|NCT00577720|439927|P2|Overall Study|Lost to Follow-up|0
137973|NCT00577720|439928|P1|Overall Study|Lost to Follow-up|0
137974|NCT00577720|439925|P4|Overall Study|Adverse Event|4
137975|NCT00577720|439926|P3|Overall Study|Adverse Event|0
137976|NCT00577720|439927|P2|Overall Study|Adverse Event|1
137977|NCT00577720|439928|P1|Overall Study|Adverse Event|2
137978|NCT00577772|439948|P2|Overall Study|Lost to Follow-up|1
137979|NCT00577772|439949|P1|Overall Study|Lost to Follow-up|0
137980|NCT00577824|439958|P3|Overall Study|Protocol Violation|0
137981|NCT00577824|439959|P2|Overall Study|Protocol Violation|1
137982|NCT00577824|439960|P1|Overall Study|Protocol Violation|1
137983|NCT00577824|439958|P3|Overall Study|Patient decision|1
137984|NCT00577824|439959|P2|Overall Study|Patient decision|1
137985|NCT00577824|439960|P1|Overall Study|Patient decision|0
137986|NCT00577824|439958|P3|Overall Study|Adverse Event|1
137987|NCT00577824|439959|P2|Overall Study|Adverse Event|18
137988|NCT00577824|439960|P1|Overall Study|Adverse Event|6
137989|NCT00577863|440018|P2|Overall Study|Did Not Receive at Least One Injection|1
137990|NCT00577863|440019|P1|Overall Study|Did Not Receive at Least One Injection|0
137991|NCT00577863|440018|P2|Overall Study|Sponsor Decision|7
137992|NCT00577863|440019|P1|Overall Study|Sponsor Decision|2
137993|NCT00577863|440018|P2|Overall Study|Withdrawal by Subject|2
137994|NCT00577863|440019|P1|Overall Study|Withdrawal by Subject|0
137995|NCT00577863|440018|P2|Overall Study|Entry Criteria Exclusion|0
137996|NCT00577863|440019|P1|Overall Study|Entry Criteria Exclusion|1
137997|NCT00577863|440018|P2|Overall Study|Lost to Follow-up|2
137998|NCT00577863|440019|P1|Overall Study|Lost to Follow-up|2
137999|NCT00577863|440018|P2|Overall Study|Death|0
138000|NCT00577863|440019|P1|Overall Study|Death|1
138001|NCT00577863|440018|P2|Overall Study|Adverse Event|2
138002|NCT00577863|440019|P1|Overall Study|Adverse Event|4
138003|NCT00577889|440061|P3|Overall Study|Withdrawal by Subject|0
138004|NCT00577889|440062|P2|Overall Study|Withdrawal by Subject|0
138005|NCT00577889|440063|P1|Overall Study|Withdrawal by Subject|1
138006|NCT00578136|440089|P2|Overall Study|Not given intervention|1
138007|NCT00578136|440090|P1|Overall Study|Not given intervention|1
138008|NCT00578227|440235|P3|Overall Study|Withdrawal by Subject|3
138009|NCT00578227|440236|P2|Overall Study|Withdrawal by Subject|1
138010|NCT00578227|440237|P1|Overall Study|Withdrawal by Subject|5
138011|NCT00578227|440235|P3|Overall Study|Lost to Follow-up|1
138012|NCT00578227|440236|P2|Overall Study|Lost to Follow-up|1
138013|NCT00578227|440237|P1|Overall Study|Lost to Follow-up|0
138014|NCT00578318|440382|P2|Overall Study|Physician Decision|0
138015|NCT00578318|440383|P1|Overall Study|Physician Decision|1
138016|NCT00578318|440382|P2|Overall Study|Lost to Follow-up|0
138017|NCT00578318|440383|P1|Overall Study|Lost to Follow-up|2
138018|NCT00578448|440437|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
138019|NCT00578448|440437|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
138020|NCT00578448|440437|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
138021|NCT00578448|440437|P1|Day 1 up to 3 Years of Planned Study|Death|1
138022|NCT00578565|440472|P1|Overall Study|Adverse Event|3
138023|NCT00578786|440504|P3|Overall Study|Qualified but Not Enrolled in Extension|0
138024|NCT00578786|440505|P2|Overall Study|Qualified but Not Enrolled in Extension|3
138025|NCT00578786|440506|P1|Overall Study|Qualified but Not Enrolled in Extension|0
138026|NCT00578786|440504|P3|Overall Study|Not Otherwise Specified|1
138027|NCT00578786|440505|P2|Overall Study|Not Otherwise Specified|4
138028|NCT00578786|440506|P1|Overall Study|Not Otherwise Specified|0
138029|NCT00578786|440504|P3|Overall Study|Pregnancy|0
138030|NCT00578786|440505|P2|Overall Study|Pregnancy|1
138031|NCT00578786|440506|P1|Overall Study|Pregnancy|0
138032|NCT00578786|440504|P3|Overall Study|Lost to Follow-up|0
138033|NCT00578786|440505|P2|Overall Study|Lost to Follow-up|4
138034|NCT00578786|440506|P1|Overall Study|Lost to Follow-up|0
138035|NCT00578786|440504|P3|Overall Study|Sponsor Decision|1
138036|NCT00578786|440505|P2|Overall Study|Sponsor Decision|0
138037|NCT00578786|440506|P1|Overall Study|Sponsor Decision|0
138038|NCT00578786|440504|P3|Overall Study|Physician Decision|1
138039|NCT00578786|440505|P2|Overall Study|Physician Decision|0
138040|NCT00578786|440506|P1|Overall Study|Physician Decision|1
138041|NCT00578786|440504|P3|Overall Study|Protocol Violation|1
138042|NCT00578786|440505|P2|Overall Study|Protocol Violation|3
138043|NCT00578786|440506|P1|Overall Study|Protocol Violation|0
138044|NCT00578786|440504|P3|Overall Study|Withdrawal by Subject|5
138045|NCT00578786|440505|P2|Overall Study|Withdrawal by Subject|8
138046|NCT00578786|440506|P1|Overall Study|Withdrawal by Subject|7
138047|NCT00578786|440504|P3|Overall Study|Early Escape from Prior Study|2
138048|NCT00578786|440505|P2|Overall Study|Early Escape from Prior Study|1
138049|NCT00578786|440506|P1|Overall Study|Early Escape from Prior Study|2
138050|NCT00578786|440504|P3|Overall Study|Lack of Efficacy|2
138051|NCT00578786|440505|P2|Overall Study|Lack of Efficacy|5
138052|NCT00578786|440506|P1|Overall Study|Lack of Efficacy|2
138053|NCT00578786|440504|P3|Overall Study|Adverse Event|17
138054|NCT00578786|440505|P2|Overall Study|Adverse Event|37
138055|NCT00578786|440506|P1|Overall Study|Adverse Event|27
138056|NCT00578812|440587|P2|Overall Study|Not treated|7
138057|NCT00578812|440588|P1|Overall Study|Not treated|6
138058|NCT00578864|440626|P2|Overall Study|Death|0
138059|NCT00578864|440627|P1|Overall Study|Death|1
138060|NCT00578877|440643|P2|Overall Study|did not provide follow-up data|17
138061|NCT00578877|440644|P1|Overall Study|did not provide follow-up data|12
138062|NCT00578877|440643|P2|Overall Study|early discontinue|101
138063|NCT00578877|440644|P1|Overall Study|early discontinue|61
138064|NCT00578877|440643|P2|Overall Study|Lost to Follow-up|10
138065|NCT00578877|440644|P1|Overall Study|Lost to Follow-up|8
138066|NCT00578942|440681|P1|Overall Study|Lost to Follow-up|1
138067|NCT00584987|440757|P4|Overall Study|Adverse Event|1
138068|NCT00584987|440758|P3|Overall Study|Adverse Event|0
138069|NCT00584987|440759|P2|Overall Study|Adverse Event|0
138070|NCT00584987|440760|P1|Overall Study|Adverse Event|0
138071|NCT00584987|440757|P4|Overall Study|Protocol Violation|0
138072|NCT00584987|440758|P3|Overall Study|Protocol Violation|1
138073|NCT00584987|440759|P2|Overall Study|Protocol Violation|1
138074|NCT00584987|440760|P1|Overall Study|Protocol Violation|1
138075|NCT00585039|440809|P2|Overall Study|medication spilled|0
138076|NCT00585039|440810|P1|Overall Study|medication spilled|2
138077|NCT00585078|440818|P1|Overall Study|Death|1
138078|NCT00585078|440818|P1|Overall Study|Adverse Event|10
138079|NCT00585078|440818|P1|Overall Study|Disease Progression|24
138080|NCT00585078|440818|P1|Overall Study|Poor performance status|1
138081|NCT00585078|440818|P1|Overall Study|Withdrawal by Subject|4
138082|NCT00585169|440829|P1|Overall Study|Withdrawal by Subject|1
138083|NCT00585221|440840|P1|Overall Study|Protocol Violation|8
138084|NCT00585286|440845|P1|Overall Study|Lost to Follow-up|1
138085|NCT00585312|440854|P2|Overall Study|Study terminated by the sponsor|31
138086|NCT00585312|440855|P1|Overall Study|Study terminated by the sponsor|34
138087|NCT00585312|440854|P2|Overall Study|Withdrawal by Subject|1
138088|NCT00585312|440855|P1|Overall Study|Withdrawal by Subject|5
138089|NCT00585312|440854|P2|Overall Study|Reason not specified|0
138090|NCT00585312|440855|P1|Overall Study|Reason not specified|2
138091|NCT00585312|440854|P2|Overall Study|Lost to Follow-up|1
138092|NCT00585312|440855|P1|Overall Study|Lost to Follow-up|1
138093|NCT00585312|440854|P2|Overall Study|Lack of Efficacy|11
138094|NCT00585312|440855|P1|Overall Study|Lack of Efficacy|6
138095|NCT00585312|440854|P2|Overall Study|Adverse Event|0
138096|NCT00585312|440855|P1|Overall Study|Adverse Event|3
138097|NCT00586898|440867|P1|Overall Study|Evaluable for Toxicity Only|5
138098|NCT00586898|440867|P1|Overall Study|Patiemt Non-compliance|1
138099|NCT00586898|440867|P1|Overall Study|Adverse Event|1
138100|NCT00587054|440887|P1|Overall Study|Patient not treated|9
138101|NCT00587158|440916|P2|Overall Study|Subject did not want to take study med|1
138102|NCT00587158|440917|P1|Overall Study|Subject did not want to take study med|0
138103|NCT00587158|440916|P2|Overall Study|Death|1
138104|NCT00587158|440917|P1|Overall Study|Death|0
138105|NCT00587158|440916|P2|Overall Study|Lost to Follow-up|2
138106|NCT00587158|440917|P1|Overall Study|Lost to Follow-up|1
138107|NCT00587158|440916|P2|Overall Study|Physician Decision|1
138108|NCT00587158|440917|P1|Overall Study|Physician Decision|0
138109|NCT00587158|440916|P2|Overall Study|Did not want to do 24 hr urine collect.|3
138110|NCT00587158|440917|P1|Overall Study|Did not want to do 24 hr urine collect.|4
138111|NCT00587171|440949|P2|Overall Study|Lost to Follow-up|1
138112|NCT00587171|440950|P1|Overall Study|Lost to Follow-up|1
138113|NCT00587223|440978|P1|Overall Study|Adverse Event|1
138114|NCT00587288|440995|P2|Overall Study|Protocol Violation|0
138115|NCT00587288|440996|P1|Overall Study|Protocol Violation|1
138116|NCT00587288|440995|P2|Overall Study|Lack of Efficacy|8
138117|NCT00587288|440996|P1|Overall Study|Lack of Efficacy|2
138118|NCT00587288|440995|P2|Overall Study|Adverse Event|1
138119|NCT00587288|440996|P1|Overall Study|Adverse Event|0
138120|NCT00587431|441016|P2|Overall Study|Withdrawal by Subject|1
138121|NCT00587431|441017|P1|Overall Study|Withdrawal by Subject|0
138122|NCT00587431|441016|P2|Overall Study|Adverse Event|0
138123|NCT00587431|441017|P1|Overall Study|Adverse Event|1
138124|NCT00587457|441029|P3|Overall Study|Development of neutralizing Abs|1
138125|NCT00587457|441030|P2|Overall Study|Development of neutralizing Abs|0
138126|NCT00587457|441031|P1|Overall Study|Development of neutralizing Abs|0
138127|NCT00587457|441029|P3|Overall Study|Undefined|1
138128|NCT00587457|441030|P2|Overall Study|Undefined|0
138129|NCT00587457|441031|P1|Overall Study|Undefined|0
138130|NCT00587457|441029|P3|Overall Study|Initiation of alternative therapy|0
138131|NCT00587457|441030|P2|Overall Study|Initiation of alternative therapy|1
138132|NCT00587457|441031|P1|Overall Study|Initiation of alternative therapy|0
138133|NCT00587457|441029|P3|Overall Study|Disease progression|2
138134|NCT00587457|441030|P2|Overall Study|Disease progression|0
138135|NCT00587457|441031|P1|Overall Study|Disease progression|2
138136|NCT00587457|441029|P3|Overall Study|Adverse Event|1
138137|NCT00587457|441030|P2|Overall Study|Adverse Event|2
138138|NCT00587457|441031|P1|Overall Study|Adverse Event|1
138139|NCT00587587|441099|P2|Overall Study|Lost to Follow-up|1
138140|NCT00587587|441100|P1|Overall Study|Lost to Follow-up|6
138141|NCT00587639|441120|P1|Overall Study|Withdrawal by Subject|1
138142|NCT00587795|441175|P2|Overall Study|Withdrawal by Subject|0
138143|NCT00587795|441176|P1|Overall Study|Withdrawal by Subject|1
138144|NCT00587847|441198|P1|Overall Study|Adverse Event|2
138145|NCT00587847|441198|P1|Overall Study|Lack of Efficacy|5
138146|NCT00587860|441205|P2|Overall Study|Withdrawal by Subject|3
138147|NCT00587860|441206|P1|Overall Study|Withdrawal by Subject|3
138148|NCT00587860|441205|P2|Overall Study|Lost to Follow-up|2
138149|NCT00587860|441206|P1|Overall Study|Lost to Follow-up|2
138150|NCT00587964|441226|P1|Overall Study|Progression of Disease|4
138151|NCT00587964|441226|P1|Overall Study|Patient did not receive intervention|5
138152|NCT00587964|441226|P1|Overall Study|Patient found to be ineligible|1
138153|NCT00587964|441226|P1|Overall Study|Lost to Follow-up|1
138154|NCT00587964|441226|P1|Overall Study|Withdrawal by Subject|1
138155|NCT00588094|441243|P1|Overall Study|Progression of Disease|2
138156|NCT00588094|441243|P1|Overall Study|Adverse Event|3
138157|NCT00588146|441247|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
138158|NCT00588146|441248|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
138159|NCT00588237|441273|P1|Overall Study|Patien not treated|1
138160|NCT00588237|441273|P1|Overall Study|Evaluable for toxicity only|3
138161|NCT00588341|441277|P1|Overall Study|Patient ineligible|1
138162|NCT00588341|441277|P1|Overall Study|Not treated due to metastatic disease|1
138163|NCT00588341|441277|P1|Overall Study|Withdrawal by Subject|3
138164|NCT00588354|441283|P2|Baseline to 4 Weeks|Lost to Follow-up|1
138165|NCT00588354|441284|P1|Baseline to 4 Weeks|Lost to Follow-up|0
138166|NCT00588354|441283|P2|Baseline to 2 Weeks|Lack of Efficacy|0
138167|NCT00588354|441284|P1|Baseline to 2 Weeks|Lack of Efficacy|1
138168|NCT00588354|441283|P2|Baseline to 2 Weeks|Adverse Event|0
138169|NCT00588354|441284|P1|Baseline to 2 Weeks|Adverse Event|1
138170|NCT00588445|441320|P1|Overall Study|Not Treated|10
138171|NCT00588445|441320|P1|Overall Study|Disease Progression|1
138172|NCT00588445|441320|P1|Overall Study|Withdrawal by Subject|3
138173|NCT00588445|441320|P1|Overall Study|Protocol Violation|1
138174|NCT00588640|441341|P1|Overall Study|Ineligible Patient|1
138175|NCT00588640|441341|P1|Overall Study|Physician Decision|1
138176|NCT00588666|441345|P1|Overall Study|Adverse Event|4
138177|NCT00588692|441352|P2|Overall Study|Death|0
138178|NCT00588692|441353|P1|Overall Study|Death|1
138179|NCT00588692|441352|P2|Overall Study|Cancer|0
138180|NCT00588692|441353|P1|Overall Study|Cancer|1
138181|NCT00588692|441352|P2|Overall Study|Severe Peptic Ulcer Disease|0
138182|NCT00588692|441353|P1|Overall Study|Severe Peptic Ulcer Disease|1
138183|NCT00588692|441352|P2|Overall Study|Hip Surgery|1
138184|NCT00588692|441353|P1|Overall Study|Hip Surgery|0
138185|NCT00588692|441352|P2|Overall Study|Withdrawal by Subject|2
138186|NCT00588692|441353|P1|Overall Study|Withdrawal by Subject|4
138187|NCT00588731|441391|P2|Overall Study|Withdrawal by Subject|2
138188|NCT00588731|441392|P1|Overall Study|Withdrawal by Subject|3
138189|NCT00588822|441409|P1|Overall Study|progression of disease|8
138190|NCT00588861|441431|P2|10 Years|Incomplete due to study termination|114
138191|NCT00588861|441432|P1|10 Years|Incomplete due to study termination|107
138192|NCT00588861|441431|P2|8 Years|Patients did not return for follow-up|114
138193|NCT00588861|441432|P1|8 Years|Patients did not return for follow-up|105
138194|NCT00588861|441431|P2|6 Years|Patients did not return for follow-up|109
138195|NCT00588861|441432|P1|6 Years|Patients did not return for follow-up|104
138196|NCT00588861|441431|P2|4 Years|Patients did not return for follow-up|103
138197|NCT00588861|441432|P1|4 Years|Patients did not return for follow-up|91
138198|NCT00588861|441431|P2|2 Years|Patients did not return for follow-up|87
138199|NCT00588861|441432|P1|2 Years|Patients did not return for follow-up|92
138200|NCT00588861|441431|P2|1 Year|Patients did not return for follow-up|82
138201|NCT00588861|441432|P1|1 Year|Patients did not return for follow-up|89
138202|NCT00588861|441431|P2|6 Months|Patients did not return for follow-up|73
138203|NCT00588861|441432|P1|6 Months|Patients did not return for follow-up|98
138204|NCT00588861|441431|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
138205|NCT00588861|441432|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
138206|NCT00588952|441448|P2|Overall Study|Withdrawal by Subject|5
138207|NCT00588952|441449|P1|Overall Study|Withdrawal by Subject|3
138208|NCT00588952|441448|P2|Overall Study|Adverse Event|2
138209|NCT00588952|441449|P1|Overall Study|Adverse Event|0
138210|NCT00589108|441480|P3|Overall Study|Death|4
138211|NCT00589108|441481|P2|Overall Study|Death|3
138212|NCT00589108|441482|P1|Overall Study|Death|3
138213|NCT00589108|441480|P3|Overall Study|Lost to Follow-up|1
138214|NCT00589108|441481|P2|Overall Study|Lost to Follow-up|1
138215|NCT00589108|441482|P1|Overall Study|Lost to Follow-up|1
138216|NCT00589121|441504|P2|Overall Study|No protocol treatment received|1
138217|NCT00589121|441505|P1|Overall Study|No protocol treatment received|0
138218|NCT00589121|441504|P2|Overall Study|Protocol Violation|6
138219|NCT00589121|441505|P1|Overall Study|Protocol Violation|2
138220|NCT00589290|441535|P1|Overall Study|Withdrawal by Subject|1
138221|NCT00589303|441545|P2|Overall Study|Withdrawal by Subject|1
138222|NCT00589303|441546|P1|Overall Study|Withdrawal by Subject|2
138223|NCT00576056|441552|P1|Overall Study|Physician Decision|1
138224|NCT00576056|441552|P1|Overall Study|did not meet eligibility criteria|8
138225|NCT00576056|441552|P1|Overall Study|Withdrawal by Subject|2
138226|NCT00576056|441552|P1|Overall Study|Lack of Efficacy|1
138227|NCT00576056|441552|P1|Overall Study|Death|1
138228|NCT00576056|441552|P1|Overall Study|Adverse Event|1
138229|NCT00576199|441561|P1|Overall Study|Reason Unspecified|2
138230|NCT00576199|441561|P1|Overall Study|Refused Treatment|2
138231|NCT00576199|441561|P1|Overall Study|Insufficient Therapeutic Response|14
138232|NCT00576199|441561|P1|Overall Study|Adverse Event|12
138233|NCT00576303|441579|P1|Long Term Safety Period|Early withdrawal|16
138234|NCT00576303|441579|P1|Efficacy Evaluation Period|Early withdrawal|5
138235|NCT00576303|441579|P1|Dose Titration Period|Early withdrawal|17
138236|NCT00576316|441588|P1|Overall Study|Protocol Violation|9
138237|NCT00576316|441588|P1|Overall Study|Withdrawal by Subject|2
138238|NCT00576316|441588|P1|Overall Study|Adverse Event|9
138239|NCT00576381|441593|P1|Overall Study|Adverse Event|4
138240|NCT00576381|441593|P1|Overall Study|Reoperation|3
138241|NCT00576420|441600|P3|Overall Study|Death|1
138242|NCT00576420|441601|P2|Overall Study|Death|0
138243|NCT00576420|441602|P1|Overall Study|Death|0
138244|NCT00581919|441776|P1|Overall Study|Withdrawal by Subject|1
138245|NCT00581919|441776|P1|Overall Study|Started Non-Protocol Therapy|2
138246|NCT00581919|441776|P1|Overall Study|Other Complicating Disease|1
138247|NCT00581919|441776|P1|Overall Study|Physician Decision|1
138248|NCT00581919|441776|P1|Overall Study|Disease Progression|10
138249|NCT00581919|441776|P1|Overall Study|Death|1
138250|NCT00581919|441776|P1|Overall Study|Adverse Event|8
138251|NCT00581945|441784|P2|Overall Study|Death|0
138252|NCT00581945|441785|P1|Overall Study|Death|1
138253|NCT00581945|441784|P2|Overall Study|Withdrawal by Subject|6
138254|NCT00581945|441785|P1|Overall Study|Withdrawal by Subject|2
138255|NCT00581945|441784|P2|Overall Study|Unsatisfactory therapeutic effect|0
138256|NCT00581945|441785|P1|Overall Study|Unsatisfactory therapeutic effect|2
138257|NCT00581945|441784|P2|Overall Study|Adverse Event|4
138258|NCT00581945|441785|P1|Overall Study|Adverse Event|4
138259|NCT00582010|441808|P2|Overall Study|Death|1
138260|NCT00582010|441809|P1|Overall Study|Death|0
138261|NCT00582036|441833|P2|Overall Study|Withdrawal by Subject|1
138262|NCT00582036|441834|P1|Overall Study|Withdrawal by Subject|0
138263|NCT00582114|441847|P2|Overall Study|Stopped by data safety monitoring board|20
138264|NCT00582114|441848|P1|Overall Study|Stopped by data safety monitoring board|19
138265|NCT00582114|441847|P2|Overall Study|Physician Decision|6
138266|NCT00582114|441848|P1|Overall Study|Physician Decision|0
138267|NCT00582114|441847|P2|Overall Study|Adverse Event|1
138268|NCT00582114|441848|P1|Overall Study|Adverse Event|1
138269|NCT00582114|441847|P2|Overall Study|Withdrawal by Subject|16
138270|NCT00582114|441848|P1|Overall Study|Withdrawal by Subject|8
138271|NCT00582114|441847|P2|Overall Study|Lost to Follow-up|6
138272|NCT00582114|441848|P1|Overall Study|Lost to Follow-up|7
138273|NCT00582114|441847|P2|Overall Study|Kidney Transplant|1
138274|NCT00582114|441848|P1|Overall Study|Kidney Transplant|3
138275|NCT00582114|441847|P2|Overall Study|Death|4
138276|NCT00582114|441848|P1|Overall Study|Death|4
138277|NCT00582309|441864|P3|Overall Study|Protocol Violation|2
138278|NCT00582309|441865|P2|Overall Study|Protocol Violation|0
138279|NCT00582309|441866|P1|Overall Study|Protocol Violation|0
138280|NCT00582426|441894|P2|Overall Study|Use of illicit drugs|0
138281|NCT00582426|441895|P1|Overall Study|Use of illicit drugs|1
138282|NCT00582426|441894|P2|Overall Study|Disease Progression|2
138283|NCT00582426|441895|P1|Overall Study|Disease Progression|2
138284|NCT00582426|441894|P2|Overall Study|Withdrawal by Subject|2
138285|NCT00582426|441895|P1|Overall Study|Withdrawal by Subject|3
138286|NCT00582426|441894|P2|Overall Study|Death|3
138287|NCT00582426|441895|P1|Overall Study|Death|4
138288|NCT00582426|441894|P2|Overall Study|Protocol Violation|2
138289|NCT00582426|441895|P1|Overall Study|Protocol Violation|6
138290|NCT00582426|441894|P2|Overall Study|Adverse Event|2
138291|NCT00582426|441895|P1|Overall Study|Adverse Event|4
138292|NCT00582426|441894|P2|Overall Study|Lost to Follow-up|2
138293|NCT00582426|441895|P1|Overall Study|Lost to Follow-up|0
138294|NCT00589602|441948|P1|Overall Study|Did not collect enough CD34+ cells|1
138295|NCT00589628|441958|P2|Overall Study|Lost to Follow-up|1
138296|NCT00589628|441959|P1|Overall Study|Lost to Follow-up|0
138297|NCT00589667|441965|P1|Overall Study|Withdrawal by Subject|1
138298|NCT00589667|441965|P1|Overall Study|Adverse Event|2
138299|NCT00589693|441972|P2|Overall Study|Protocol Violation|1
138300|NCT00589693|441973|P1|Overall Study|Protocol Violation|1
138301|NCT00589693|441972|P2|Overall Study|Physician Decision|1
138302|NCT00589693|441973|P1|Overall Study|Physician Decision|0
138303|NCT00589693|441972|P2|Overall Study|Lost to Follow-up|0
138304|NCT00589693|441973|P1|Overall Study|Lost to Follow-up|1
138305|NCT00589693|441972|P2|Overall Study|Lack of Efficacy|1
138306|NCT00589693|441973|P1|Overall Study|Lack of Efficacy|0
138307|NCT00589693|441972|P2|Overall Study|Death|16
138308|NCT00589693|441973|P1|Overall Study|Death|26
138309|NCT00589693|441972|P2|Overall Study|Adverse Event|4
138310|NCT00589693|441973|P1|Overall Study|Adverse Event|4
138311|NCT00589693|441972|P2|Overall Study|randomized in error|6
138312|NCT00589693|441973|P1|Overall Study|randomized in error|12
138313|NCT00589784|441989|P2|Overall Study|Adverse Event|4
138314|NCT00589784|441990|P1|Overall Study|Adverse Event|0
138315|NCT00589784|441989|P2|Overall Study|Patient inevaluable|0
138316|NCT00589784|441990|P1|Overall Study|Patient inevaluable|1
138317|NCT00589784|441989|P2|Overall Study|Withdrawal by Subject|6
138318|NCT00589784|441990|P1|Overall Study|Withdrawal by Subject|0
138319|NCT00593333|442012|P2|Overall Study|Lost to Follow-up|11
138320|NCT00593333|442013|P1|Overall Study|Lost to Follow-up|10
138321|NCT00593606|442120|P1|Overall Study|Screen Failure|3
138322|NCT00593606|442120|P1|Overall Study|Run-In Failure|5
138323|NCT00593606|442120|P1|Overall Study|Lost to Follow-up|2
138324|NCT00593606|442120|P1|Overall Study|Protocol Violation|3
138325|NCT00593606|442120|P1|Overall Study|Withdrawal by Subject|1
138326|NCT00593606|442120|P1|Overall Study|Adverse Event|13
138327|NCT00593684|442232|P2|Overall Study|Death|1
138328|NCT00593684|442233|P1|Overall Study|Death|2
138329|NCT00593736|442249|P4|Treatment Period and Placebo Run-out|Various|0
138330|NCT00593736|442250|P3|Treatment Period and Placebo Run-out|Various|1
138331|NCT00593736|442251|P2|Treatment Period and Placebo Run-out|Various|1
138332|NCT00593736|442252|P1|Treatment Period and Placebo Run-out|Various|1
138333|NCT00593736|442249|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
138334|NCT00593736|442250|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
138335|NCT00593736|442251|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
138336|NCT00593736|442252|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
138337|NCT00593736|442249|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
138338|NCT00593736|442250|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
138339|NCT00593736|442251|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
138340|NCT00593736|442252|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
138341|NCT00593736|442249|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
138342|NCT00593736|442250|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
138343|NCT00593736|442251|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
138344|NCT00593736|442252|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
138345|NCT00593736|442249|P4|Screening Period and Placebo Run-in|Various|25
138346|NCT00593736|442250|P3|Screening Period and Placebo Run-in|Various|0
138347|NCT00593736|442251|P2|Screening Period and Placebo Run-in|Various|0
138348|NCT00593736|442252|P1|Screening Period and Placebo Run-in|Various|0
138349|NCT00593736|442249|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
138350|NCT00593736|442250|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
138351|NCT00593736|442251|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
138352|NCT00593736|442252|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
138353|NCT00593736|442249|P4|Screening Period and Placebo Run-in|Study Termination|15
138354|NCT00593736|442250|P3|Screening Period and Placebo Run-in|Study Termination|0
138355|NCT00593736|442251|P2|Screening Period and Placebo Run-in|Study Termination|0
138356|NCT00593736|442252|P1|Screening Period and Placebo Run-in|Study Termination|0
138357|NCT00593736|442249|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
138358|NCT00593736|442250|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
138359|NCT00593736|442251|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
138360|NCT00593736|442252|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
138361|NCT00593736|442249|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
138362|NCT00593736|442250|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
138363|NCT00593736|442251|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
138364|NCT00593736|442252|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
138365|NCT00593736|442249|P4|Screening Period and Placebo Run-in|Adverse Event|3
138366|NCT00593736|442250|P3|Screening Period and Placebo Run-in|Adverse Event|0
138367|NCT00593736|442251|P2|Screening Period and Placebo Run-in|Adverse Event|0
138368|NCT00593736|442252|P1|Screening Period and Placebo Run-in|Adverse Event|0
138369|NCT00593814|442500|P2|Overall Study|Physician Decision|0
138370|NCT00593814|442501|P1|Overall Study|Physician Decision|3
138371|NCT00593814|442500|P2|Overall Study|Lost to Follow-up|0
138372|NCT00593814|442501|P1|Overall Study|Lost to Follow-up|7
138373|NCT00593814|442500|P2|Overall Study|Withdrawal by Subject|0
138374|NCT00593814|442501|P1|Overall Study|Withdrawal by Subject|7
138375|NCT00593814|442500|P2|Overall Study|Death|0
138376|NCT00593814|442501|P1|Overall Study|Death|7
138377|NCT00593827|442509|P2|Overall Study|On Active Treatment/Pending|2
138378|NCT00593827|442510|P1|Overall Study|On Active Treatment/Pending|0
138379|NCT00593840|442532|P1|Overall Study|Withdrawal by Subject|1
138380|NCT00593918|442549|P2|Overall Study|Withdrawal by Subject|24
138381|NCT00593918|442550|P1|Overall Study|Withdrawal by Subject|5
138382|NCT00593957|442561|P3|Overall Study|Physician Decision|2
138383|NCT00593957|442562|P2|Overall Study|Physician Decision|1
138384|NCT00593957|442563|P1|Overall Study|Physician Decision|0
138385|NCT00594035|442604|P2|Overall Study|Subject couldn't return due to job|1
138386|NCT00594035|442605|P1|Overall Study|Subject couldn't return due to job|0
138387|NCT00594035|442604|P2|Overall Study|Subject transferred to nursing home|1
138388|NCT00594035|442605|P1|Overall Study|Subject transferred to nursing home|0
138389|NCT00594035|442604|P2|Overall Study|Withdrawal by Subject|0
138390|NCT00594035|442605|P1|Overall Study|Withdrawal by Subject|1
138391|NCT00594035|442604|P2|Overall Study|Lost to Follow-up|1
138392|NCT00594035|442605|P1|Overall Study|Lost to Follow-up|1
138393|NCT00594100|442611|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
138394|NCT00594100|442611|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
138395|NCT00594100|442611|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
138396|NCT00594100|442611|P1|Procedure|Technical Failure|9
138397|NCT00594165|442620|P1|Overall Study|Other: Site terminated participation|2
138398|NCT00594165|442620|P1|Overall Study|Other: Subject enrolled in other trial|1
138399|NCT00594165|442620|P1|Overall Study|Other: House bound; can't get to clinic|1
138400|NCT00594165|442620|P1|Overall Study|Other: Brain surgery controlled symptoms|1
138401|NCT00594165|442620|P1|Overall Study|Other: Subject moving|3
138402|NCT00594165|442620|P1|Overall Study|Other: PI discretion|5
138403|NCT00594165|442620|P1|Overall Study|Lost to Follow-up|4
138404|NCT00594165|442620|P1|Overall Study|Study ended per sponsor|102
138405|NCT00594165|442620|P1|Overall Study|Subject withdrew consent|27
138406|NCT00594165|442620|P1|Overall Study|Unsatisfactory compliance of subject|6
138407|NCT00594165|442620|P1|Overall Study|Adverse Event|52
138408|NCT00594165|442620|P1|Overall Study|Lack of Efficacy|12
138409|NCT00594165|442620|P1|Overall Study|Major protocol violation|1
138410|NCT00594178|442626|P1|Overall Study|Physician Decision|5
138411|NCT00594204|442633|P2|Overall Study|Randomized but not treated|1
138412|NCT00594204|442634|P1|Overall Study|Randomized but not treated|4
138413|NCT00594204|442633|P2|Overall Study|Lack of Efficacy|4
138414|NCT00594204|442634|P1|Overall Study|Lack of Efficacy|3
138415|NCT00594204|442633|P2|Overall Study|Unspecified|3
138416|NCT00594204|442634|P1|Overall Study|Unspecified|4
138417|NCT00594204|442633|P2|Overall Study|Withdrawal by Subject|29
138418|NCT00594204|442634|P1|Overall Study|Withdrawal by Subject|23
138419|NCT00594204|442633|P2|Overall Study|Lost to Follow-up|5
138420|NCT00594204|442634|P1|Overall Study|Lost to Follow-up|9
138421|NCT00594204|442633|P2|Overall Study|Adverse Event|3
138422|NCT00594204|442634|P1|Overall Study|Adverse Event|15
138423|NCT00594386|442669|P1|Overall Study|Other: Loss of drivers license|1
138424|NCT00594386|442669|P1|Overall Study|Other: Patient wants prescription Neupro|1
138425|NCT00594386|442669|P1|Overall Study|Other: Site terminated participation|1
138426|NCT00594386|442669|P1|Overall Study|Other: Sponsor closure of study|1
138427|NCT00594386|442669|P1|Overall Study|Other: Study terminated per investigator|2
138428|NCT00594386|442669|P1|Overall Study|Other: Subject admitted to nursing home|1
138429|NCT00594386|442669|P1|Overall Study|Other: Subject moved to Seattle|1
138430|NCT00594386|442669|P1|Overall Study|Other: Patient went off patch (hospital)|1
138431|NCT00594386|442669|P1|Overall Study|Lost to Follow-up|6
138432|NCT00594386|442669|P1|Overall Study|Study ended per sponsor|115
138433|NCT00594386|442669|P1|Overall Study|Subject withdrew consent|35
138434|NCT00594386|442669|P1|Overall Study|Unsatisfactory compliance of subject|11
138435|NCT00594386|442669|P1|Overall Study|Adverse Event|68
138436|NCT00594386|442669|P1|Overall Study|Lack of Efficacy|12
138437|NCT00594386|442669|P1|Overall Study|Major protocol violation|2
138438|NCT00594399|442677|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
138439|NCT00594399|442678|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
138440|NCT00594399|442679|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
138441|NCT00594399|442677|P3|Rerandomization Arm 1 Only|Death|0
138442|NCT00594399|442678|P2|Rerandomization Arm 1 Only|Death|1
138443|NCT00594399|442679|P1|Rerandomization Arm 1 Only|Death|2
138444|NCT00594399|442677|P3|Initial 3 Month Counseling|Family illness|0
138445|NCT00594399|442678|P2|Initial 3 Month Counseling|Family illness|0
138446|NCT00594399|442679|P1|Initial 3 Month Counseling|Family illness|1
138447|NCT00594399|442677|P3|Initial 3 Month Counseling|Moved|0
138448|NCT00594399|442678|P2|Initial 3 Month Counseling|Moved|0
138449|NCT00594399|442679|P1|Initial 3 Month Counseling|Moved|1
138450|NCT00594399|442677|P3|Initial 3 Month Counseling|Pain|0
138451|NCT00594399|442678|P2|Initial 3 Month Counseling|Pain|0
138452|NCT00594399|442679|P1|Initial 3 Month Counseling|Pain|2
138453|NCT00594399|442677|P3|Initial 3 Month Counseling|Too busy|0
138454|NCT00594399|442678|P2|Initial 3 Month Counseling|Too busy|1
138455|NCT00594399|442679|P1|Initial 3 Month Counseling|Too busy|7
138456|NCT00594399|442677|P3|Initial 3 Month Counseling|Personal issues|0
138457|NCT00594399|442678|P2|Initial 3 Month Counseling|Personal issues|0
138458|NCT00594399|442679|P1|Initial 3 Month Counseling|Personal issues|2
138459|NCT00594399|442677|P3|Initial 3 Month Counseling|Lack of Interest|0
138460|NCT00594399|442678|P2|Initial 3 Month Counseling|Lack of Interest|3
138461|NCT00594399|442679|P1|Initial 3 Month Counseling|Lack of Interest|3
138462|NCT00594399|442677|P3|Initial 3 Month Counseling|Not ready to exercise|0
138463|NCT00594399|442678|P2|Initial 3 Month Counseling|Not ready to exercise|0
138464|NCT00594399|442679|P1|Initial 3 Month Counseling|Not ready to exercise|1
138465|NCT00594464|442816|P1|Overall Study|Delay in operation|2
138466|NCT00594464|442816|P1|Overall Study|Withdrawal by Subject|1
138467|NCT00594516|442828|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
138468|NCT00594516|442829|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
138469|NCT00594516|442830|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
138470|NCT00594516|442828|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
138471|NCT00594516|442829|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
138472|NCT00594516|442830|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
138473|NCT00594516|442828|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
138474|NCT00594516|442829|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
138475|NCT00594516|442830|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
138476|NCT00594516|442828|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
138477|NCT00594516|442829|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
138478|NCT00594516|442830|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
138479|NCT00594516|442828|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
138480|NCT00594516|442829|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
138481|NCT00594516|442830|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
138482|NCT00594516|442828|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
138483|NCT00594516|442829|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
138484|NCT00594516|442830|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
138485|NCT00594516|442828|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
138486|NCT00594516|442829|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
138487|NCT00594516|442830|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
138488|NCT00594516|442828|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
138489|NCT00594516|442829|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
138490|NCT00594516|442830|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
138491|NCT00594516|442828|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
138492|NCT00594516|442829|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
138493|NCT00594516|442830|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
138494|NCT00594568|442841|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
138495|NCT00594568|442842|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
138496|NCT00594568|442843|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
138497|NCT00594568|442841|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
138498|NCT00594568|442842|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
138499|NCT00594568|442843|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
138500|NCT00594568|442841|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
138501|NCT00594568|442842|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
138502|NCT00594568|442843|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
138503|NCT00594568|442841|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
138504|NCT00594568|442842|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
138505|NCT00594568|442843|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
138506|NCT00594568|442841|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
138507|NCT00594568|442842|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
138508|NCT00594568|442843|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
138509|NCT00594568|442841|P3|Safety Follow Up (SFU)-Optional|Death|0
138510|NCT00594568|442842|P2|Safety Follow Up (SFU)-Optional|Death|1
138511|NCT00594568|442843|P1|Safety Follow Up (SFU)-Optional|Death|0
138512|NCT00594568|442841|P3|Delayed Start|Sponsor Decision|59
138513|NCT00594568|442842|P2|Delayed Start|Sponsor Decision|66
138514|NCT00594568|442843|P1|Delayed Start|Sponsor Decision|77
138515|NCT00594568|442841|P3|Delayed Start|Caregiver Decision|2
138516|NCT00594568|442842|P2|Delayed Start|Caregiver Decision|6
138517|NCT00594568|442843|P1|Delayed Start|Caregiver Decision|5
138518|NCT00594568|442841|P3|Delayed Start|Lost to Follow-up|1
138519|NCT00594568|442842|P2|Delayed Start|Lost to Follow-up|0
138520|NCT00594568|442843|P1|Delayed Start|Lost to Follow-up|0
138521|NCT00594568|442841|P3|Delayed Start|Physician Decision|1
138522|NCT00594568|442842|P2|Delayed Start|Physician Decision|0
138523|NCT00594568|442843|P1|Delayed Start|Physician Decision|0
138524|NCT00594568|442841|P3|Delayed Start|Withdrawal by Subject|0
138525|NCT00594568|442842|P2|Delayed Start|Withdrawal by Subject|3
138526|NCT00594568|442843|P1|Delayed Start|Withdrawal by Subject|4
138527|NCT00594568|442841|P3|Delayed Start|Adverse Event|2
138528|NCT00594568|442842|P2|Delayed Start|Adverse Event|2
138529|NCT00594568|442843|P1|Delayed Start|Adverse Event|12
138530|NCT00594568|442841|P3|Delayed Start|Death|1
138531|NCT00594568|442842|P2|Delayed Start|Death|0
138532|NCT00594568|442843|P1|Delayed Start|Death|0
138533|NCT00594568|442841|P3|Initial Treatment|Entry criteria exclusion|1
138534|NCT00594568|442842|P2|Initial Treatment|Entry criteria exclusion|1
138535|NCT00594568|442843|P1|Initial Treatment|Entry criteria exclusion|0
138536|NCT00594568|442841|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
138537|NCT00594568|442842|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
138538|NCT00594568|442843|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
138539|NCT00594568|442841|P3|Initial Treatment|Caregiver decision|36
138540|NCT00594568|442842|P2|Initial Treatment|Caregiver decision|36
138541|NCT00594568|442843|P1|Initial Treatment|Caregiver decision|21
138542|NCT00594568|442841|P3|Initial Treatment|Sponsor decision|147
138543|NCT00594568|442842|P2|Initial Treatment|Sponsor decision|142
138544|NCT00594568|442843|P1|Initial Treatment|Sponsor decision|193
138545|NCT00594568|442841|P3|Initial Treatment|Withdrawal by Subject|46
138546|NCT00594568|442842|P2|Initial Treatment|Withdrawal by Subject|31
138547|NCT00594568|442843|P1|Initial Treatment|Withdrawal by Subject|25
138548|NCT00594568|442841|P3|Initial Treatment|Protocol Violation|5
138549|NCT00594568|442842|P2|Initial Treatment|Protocol Violation|2
138550|NCT00594568|442843|P1|Initial Treatment|Protocol Violation|2
138551|NCT00594568|442841|P3|Initial Treatment|Physician Decision|4
138552|NCT00594568|442842|P2|Initial Treatment|Physician Decision|2
138553|NCT00594568|442843|P1|Initial Treatment|Physician Decision|3
138554|NCT00594568|442841|P3|Initial Treatment|Lost to Follow-up|4
138555|NCT00594568|442842|P2|Initial Treatment|Lost to Follow-up|1
138556|NCT00594568|442843|P1|Initial Treatment|Lost to Follow-up|4
138557|NCT00594568|442841|P3|Initial Treatment|Death|15
138558|NCT00594568|442842|P2|Initial Treatment|Death|11
138559|NCT00594568|442843|P1|Initial Treatment|Death|6
138560|NCT00594568|442841|P3|Initial Treatment|Adverse Event|144
138561|NCT00594568|442842|P2|Initial Treatment|Adverse Event|121
138562|NCT00594568|442843|P1|Initial Treatment|Adverse Event|51
138563|NCT00594646|442931|P1|Overall Study|Lost to Follow-up|15
138564|NCT00594646|442931|P1|Overall Study|Withdrawal by Subject|1
138565|NCT00594659|442939|P3|Overall Study|Lost to Follow-up|7
138566|NCT00594659|442940|P2|Overall Study|Lost to Follow-up|9
138567|NCT00594659|442941|P1|Overall Study|Lost to Follow-up|13
138568|NCT00594815|442969|P1|Overall Study|Toxicity|4
138569|NCT00594815|442969|P1|Overall Study|Withdrawal by Subject|2
138570|NCT00594815|442969|P1|Overall Study|Never Treated|3
138571|NCT00594854|442976|P2|Overall Study|Study terminated|10
138572|NCT00594854|442977|P1|Overall Study|Study terminated|7
138573|NCT00594880|442989|P2|Overall Study|Lost to Follow-up|0
138574|NCT00594880|442990|P1|Overall Study|Lost to Follow-up|1
138575|NCT00594880|442989|P2|Overall Study|Withdrawal by Subject|1
138576|NCT00594880|442990|P1|Overall Study|Withdrawal by Subject|1
138577|NCT00594906|443002|P2|Overall Study|Death|1
138578|NCT00594906|443003|P1|Overall Study|Death|0
138579|NCT00594906|443002|P2|Overall Study|Physician Decision|1
138580|NCT00594906|443003|P1|Overall Study|Physician Decision|0
138581|NCT00594906|443002|P2|Overall Study|Physician Decision|0
138582|NCT00594906|443003|P1|Overall Study|Physician Decision|1
138583|NCT00594958|443023|P3|Overall Study|administrative|2
138584|NCT00594958|443024|P2|Overall Study|administrative|0
138585|NCT00594958|443025|P1|Overall Study|administrative|3
138586|NCT00594958|443023|P3|Overall Study|Lost to Follow-up|3
138587|NCT00594958|443024|P2|Overall Study|Lost to Follow-up|0
138588|NCT00594958|443025|P1|Overall Study|Lost to Follow-up|5
138589|NCT00594958|443023|P3|Overall Study|Protocol Violation|2
138590|NCT00594958|443024|P2|Overall Study|Protocol Violation|0
138591|NCT00594958|443025|P1|Overall Study|Protocol Violation|1
138592|NCT00594958|443023|P3|Overall Study|Pregnancy|0
138593|NCT00594958|443024|P2|Overall Study|Pregnancy|2
138594|NCT00594958|443025|P1|Overall Study|Pregnancy|0
138595|NCT00594958|443023|P3|Overall Study|Adverse Event|2
138596|NCT00594958|443024|P2|Overall Study|Adverse Event|1
138597|NCT00594958|443025|P1|Overall Study|Adverse Event|4
138598|NCT00594958|443023|P3|Overall Study|Withdrawal by Subject|1
138599|NCT00594958|443024|P2|Overall Study|Withdrawal by Subject|0
138600|NCT00594958|443025|P1|Overall Study|Withdrawal by Subject|1
138601|NCT00595075|443035|P2|Overall Study|Withdrawal by Subject|0
138602|NCT00595075|443036|P1|Overall Study|Withdrawal by Subject|1
138603|NCT00595127|443070|P1|Overall Study|joined another trial|1
138604|NCT00595127|443070|P1|Overall Study|Relapsed|3
138605|NCT00595127|443070|P1|Overall Study|Death|6
138606|NCT00595309|443100|P1|Overall Study|personal reason|1
138607|NCT00595309|443100|P1|Overall Study|acute infection after V0|1
138608|NCT00595309|443100|P1|Overall Study|planned vaccination against yellow fever|1
138609|NCT00595309|443100|P1|Overall Study|Lost to Follow-up|1
138610|NCT00595335|443106|P2|Six Months to Twelve Months|Disease Progression|0
138611|NCT00595335|443107|P1|Six Months to Twelve Months|Disease Progression|1
138612|NCT00595335|443106|P2|Six Months to Twelve Months|Withdrawal by Subject|1
138613|NCT00595335|443107|P1|Six Months to Twelve Months|Withdrawal by Subject|0
138614|NCT00595335|443106|P2|Baseline to Six Months|Adverse Event|0
138615|NCT00595335|443107|P1|Baseline to Six Months|Adverse Event|1
138616|NCT00595335|443106|P2|Baseline to Six Months|Disease Progression|1
138617|NCT00595335|443107|P1|Baseline to Six Months|Disease Progression|1
138618|NCT00595335|443106|P2|Baseline to Six Months|Withdrawal by Subject|1
138619|NCT00595335|443107|P1|Baseline to Six Months|Withdrawal by Subject|0
138620|NCT00595413|443144|P4|Overall Study|Unspecified|0
138621|NCT00595413|443145|P3|Overall Study|Unspecified|5
138622|NCT00595413|443146|P2|Overall Study|Unspecified|1
138623|NCT00595413|443147|P1|Overall Study|Unspecified|5
138624|NCT00595413|443144|P4|Overall Study|Death|0
138625|NCT00595413|443145|P3|Overall Study|Death|1
138626|NCT00595413|443146|P2|Overall Study|Death|0
138627|NCT00595413|443147|P1|Overall Study|Death|0
138628|NCT00595413|443144|P4|Overall Study|Lost to Follow-up|3
138629|NCT00595413|443145|P3|Overall Study|Lost to Follow-up|1
138630|NCT00595413|443146|P2|Overall Study|Lost to Follow-up|2
138631|NCT00595413|443147|P1|Overall Study|Lost to Follow-up|2
138632|NCT00595413|443144|P4|Overall Study|Adverse Event|1
138633|NCT00595413|443145|P3|Overall Study|Adverse Event|1
138634|NCT00595413|443146|P2|Overall Study|Adverse Event|2
138635|NCT00595413|443147|P1|Overall Study|Adverse Event|0
138636|NCT00595465|443176|P3|Overall Study|administrative reason|1
138637|NCT00595465|443177|P2|Overall Study|administrative reason|0
138638|NCT00595465|443178|P1|Overall Study|administrative reason|0
138639|NCT00595465|443176|P3|Overall Study|Lost to Follow-up|2
138640|NCT00595465|443177|P2|Overall Study|Lost to Follow-up|0
138641|NCT00595465|443178|P1|Overall Study|Lost to Follow-up|0
138642|NCT00595465|443176|P3|Overall Study|Protocol Violation|0
138643|NCT00595465|443177|P2|Overall Study|Protocol Violation|1
138644|NCT00595465|443178|P1|Overall Study|Protocol Violation|2
138645|NCT00595465|443176|P3|Overall Study|Pregnancy|1
138646|NCT00595465|443177|P2|Overall Study|Pregnancy|0
138647|NCT00595465|443178|P1|Overall Study|Pregnancy|0
138648|NCT00595465|443176|P3|Overall Study|Adverse Event|3
138649|NCT00595465|443177|P2|Overall Study|Adverse Event|3
138650|NCT00595465|443178|P1|Overall Study|Adverse Event|4
138651|NCT00595504|443188|P2|Overall Study|Physician Decision|0
138652|NCT00595504|443189|P1|Overall Study|Physician Decision|1
138653|NCT00595504|443188|P2|Overall Study|Withdrawal by Subject|3
138654|NCT00595504|443189|P1|Overall Study|Withdrawal by Subject|1
138655|NCT00595517|443199|P1|Overall Study|No intention to attend regularly|1
138656|NCT00595517|443199|P1|Overall Study|usage of prohibited treatment|1
138657|NCT00595517|443199|P1|Overall Study|Recurrence of ulcer|5
138658|NCT00595517|443199|P1|Overall Study|Protocol Violation|2
138659|NCT00595517|443199|P1|Overall Study|Withdrawal by Subject|4
138660|NCT00595517|443199|P1|Overall Study|Adverse Event|6
138661|NCT00595582|443227|P1|Overall Study|Physician Decision|5
138662|NCT00595582|443227|P1|Overall Study|Adverse Event|2
138663|NCT00595582|443227|P1|Overall Study|Lost to Follow-up|1
138664|NCT00595582|443227|P1|Overall Study|Pilot study that PI terminated|2
138665|NCT00585351|443237|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
138666|NCT00585351|443238|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
138667|NCT00585351|443239|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
138668|NCT00585351|443240|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
138669|NCT00585351|443241|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
138670|NCT00585351|443242|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
138671|NCT00585351|443243|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
138672|NCT00585351|443244|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
138673|NCT00585351|443237|P8|Enrollment Period (Intervention)|Death|0
138674|NCT00585351|443238|P7|Enrollment Period (Intervention)|Death|1
138675|NCT00585351|443239|P6|Enrollment Period (Intervention)|Death|0
138676|NCT00585351|443240|P5|Enrollment Period (Intervention)|Death|1
138677|NCT00585351|443241|P4|Enrollment Period (Intervention)|Death|0
138678|NCT00585351|443242|P3|Enrollment Period (Intervention)|Death|0
138679|NCT00585351|443243|P2|Enrollment Period (Intervention)|Death|0
138680|NCT00585351|443244|P1|Enrollment Period (Intervention)|Death|0
138681|NCT00585351|443237|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
138682|NCT00585351|443238|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
138683|NCT00585351|443239|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
138684|NCT00585351|443240|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
138685|NCT00585351|443241|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
138686|NCT00585351|443242|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
138687|NCT00585351|443243|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
138688|NCT00585351|443244|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
138689|NCT00585351|443237|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
138690|NCT00585351|443238|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
138691|NCT00585351|443239|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
138692|NCT00585351|443240|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
138693|NCT00585351|443241|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
138694|NCT00585351|443242|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
138695|NCT00585351|443243|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
138696|NCT00585351|443244|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
138697|NCT00585351|443237|P8|Notification Period (Informed Consent)|No study medication on flight|0
138698|NCT00585351|443238|P7|Notification Period (Informed Consent)|No study medication on flight|0
138699|NCT00585351|443239|P6|Notification Period (Informed Consent)|No study medication on flight|0
138700|NCT00585351|443240|P5|Notification Period (Informed Consent)|No study medication on flight|0
138701|NCT00585351|443241|P4|Notification Period (Informed Consent)|No study medication on flight|0
138702|NCT00585351|443242|P3|Notification Period (Informed Consent)|No study medication on flight|0
138703|NCT00585351|443243|P2|Notification Period (Informed Consent)|No study medication on flight|1
138704|NCT00585351|443244|P1|Notification Period (Informed Consent)|No study medication on flight|0
138705|NCT00585351|443237|P8|Notification Period (Informed Consent)|Flight aborted|0
138706|NCT00585351|443238|P7|Notification Period (Informed Consent)|Flight aborted|0
138707|NCT00585351|443239|P6|Notification Period (Informed Consent)|Flight aborted|0
138708|NCT00585351|443240|P5|Notification Period (Informed Consent)|Flight aborted|0
138709|NCT00585351|443241|P4|Notification Period (Informed Consent)|Flight aborted|0
138710|NCT00585351|443242|P3|Notification Period (Informed Consent)|Flight aborted|0
138711|NCT00585351|443243|P2|Notification Period (Informed Consent)|Flight aborted|1
138712|NCT00585351|443244|P1|Notification Period (Informed Consent)|Flight aborted|2
138713|NCT00585351|443237|P8|Notification Period (Informed Consent)|Physician Decision|0
138714|NCT00585351|443238|P7|Notification Period (Informed Consent)|Physician Decision|0
138715|NCT00585351|443239|P6|Notification Period (Informed Consent)|Physician Decision|0
138716|NCT00585351|443240|P5|Notification Period (Informed Consent)|Physician Decision|0
138717|NCT00585351|443241|P4|Notification Period (Informed Consent)|Physician Decision|0
138718|NCT00585351|443242|P3|Notification Period (Informed Consent)|Physician Decision|0
138719|NCT00585351|443243|P2|Notification Period (Informed Consent)|Physician Decision|2
138720|NCT00585351|443244|P1|Notification Period (Informed Consent)|Physician Decision|0
138721|NCT00585468|443264|P2|First Intervention|Withdrawal by Subject|1
138722|NCT00585468|443265|P1|First Intervention|Withdrawal by Subject|1
138723|NCT00585533|443289|P1|Overall Study|objective or symptomatic progression|9
138724|NCT00585585|443294|P1|Overall Study|Adverse Event|1
138725|NCT00585689|443340|P1|Overall Study|Death|1
138726|NCT00585689|443340|P1|Overall Study|Patient had unresectable disease|1
138727|NCT00585689|443340|P1|Overall Study|Patient Declined Surgery|1
138728|NCT00585689|443340|P1|Overall Study|Adverse Event|1
138729|NCT00585689|443340|P1|Overall Study|Received different ABI-007 schedule|3
138730|NCT00585923|443363|P2|Overall Study|Physician decided not to continue|33
138731|NCT00585923|443364|P1|Overall Study|Physician decided not to continue|31
138732|NCT00585975|443380|P2|Overall Study|Enrollment met/over-enrolled|9
138733|NCT00585975|443381|P1|Overall Study|Enrollment met/over-enrolled|10
138734|NCT00585975|443380|P2|Overall Study|Lost to Follow-up|1
138735|NCT00585975|443381|P1|Overall Study|Lost to Follow-up|2
138736|NCT00585975|443380|P2|Overall Study|Withdrawal by Subject|3
138737|NCT00585975|443381|P1|Overall Study|Withdrawal by Subject|3
138738|NCT00586066|443391|P2|Overall Study|Withdrawal of consent|2
138739|NCT00586066|443392|P1|Overall Study|Withdrawal of consent|4
138740|NCT00586066|443391|P2|Overall Study|Physician Decision|0
138741|NCT00586066|443392|P1|Overall Study|Physician Decision|1
138742|NCT00586066|443391|P2|Overall Study|Adverse Event|2
138743|NCT00586066|443392|P1|Overall Study|Adverse Event|2
138744|NCT00586066|443391|P2|Overall Study|Lack of Efficacy|3
138745|NCT00586066|443392|P1|Overall Study|Lack of Efficacy|5
138746|NCT00586066|443391|P2|Overall Study|Lost to Follow-up|3
138747|NCT00586066|443392|P1|Overall Study|Lost to Follow-up|6
138748|NCT00586105|443402|P1|Overall Study|Reason not reported|1
138749|NCT00586105|443402|P1|Overall Study|Switched to commercial drug|9
138750|NCT00586105|443402|P1|Overall Study|Disease progression|19
138751|NCT00586105|443402|P1|Overall Study|Withdrawal by Subject|3
138752|NCT00586105|443402|P1|Overall Study|Protocol Violation|1
138753|NCT00586105|443402|P1|Overall Study|Death|2
138754|NCT00586105|443402|P1|Overall Study|Adverse Event|4
138755|NCT00586157|443415|P2|Second Intervention|Adverse Event|1
138756|NCT00586157|443416|P1|Second Intervention|Adverse Event|0
138757|NCT00586157|443415|P2|Second Intervention|Worsening behavior|0
138758|NCT00586157|443416|P1|Second Intervention|Worsening behavior|1
138759|NCT00586157|443415|P2|Second Intervention|Withdrawal by Subject|0
138760|NCT00586157|443416|P1|Second Intervention|Withdrawal by Subject|1
138761|NCT00586157|443415|P2|First Intervention|Worsening behavior|0
138762|NCT00586157|443416|P1|First Intervention|Worsening behavior|1
138763|NCT00586313|443457|P1|Overall Study|Lack of Efficacy|2
138764|NCT00586326|443462|P1|Treated Through 5-yr Follow Up-Treated|Other|2
138765|NCT00586326|443462|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
138766|NCT00586326|443462|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
138767|NCT00586326|443462|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
138768|NCT00586326|443462|P1|Treated Through 5-yr Follow Up-Treated|Death|2
138769|NCT00586326|443462|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
138770|NCT00586326|443462|P1|Device Placed toTreatment-ITT|Physician Decision|1
138771|NCT00586326|443462|P1|Device Placed toTreatment-ITT|Positive Margins|3
138772|NCT00586326|443462|P1|Device Placed toTreatment-ITT|Microinvasion|1
138773|NCT00586326|443462|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
138774|NCT00586326|443462|P1|Device Placed toTreatment-ITT|Skin Distance|7
138775|NCT00586326|443462|P1|Enrollment to Device Placement-Enrolled|Other|1
138776|NCT00586326|443462|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
138777|NCT00586326|443462|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
138778|NCT00586326|443462|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
138779|NCT00586326|443462|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
138780|NCT00586326|443462|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
138781|NCT00586339|443476|P3|Overall Study|Withdrawal by Subject|1
138782|NCT00586339|443477|P2|Overall Study|Withdrawal by Subject|3
138783|NCT00586339|443478|P1|Overall Study|Withdrawal by Subject|1
138784|NCT00586339|443476|P3|Overall Study|Lost to Follow-up|5
138785|NCT00586339|443477|P2|Overall Study|Lost to Follow-up|4
138786|NCT00586339|443478|P1|Overall Study|Lost to Follow-up|6
138787|NCT00586469|443572|P2|Overall Study|Adverse Event|1
138788|NCT00586469|443573|P1|Overall Study|Adverse Event|0
138789|NCT00586495|443614|P1|Follow-up|Switch to commercial drug|10
138790|NCT00586495|443614|P1|Follow-up|Protocol driven decision point|37
138791|NCT00586495|443614|P1|Follow-up|Withdrawal by Subject|4
138792|NCT00586495|443614|P1|Follow-up|Lost to Follow-up|1
138793|NCT00586495|443614|P1|Follow-up|Death|40
138794|NCT00586495|443614|P1|Treatment Period|Switch to commercial drug|10
138795|NCT00586495|443614|P1|Treatment Period|Disease progression, recurrence/relapse|71
138796|NCT00586495|443614|P1|Treatment Period|Withdrawal by Subject|1
138797|NCT00586495|443614|P1|Treatment Period|Protocol Violation|1
138798|NCT00586495|443614|P1|Treatment Period|Death|1
138799|NCT00586495|443614|P1|Treatment Period|Adverse Event|11
138800|NCT00586521|443624|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
138801|NCT00586612|443637|P2|Booster Phase|Lost to Follow-up|1
138802|NCT00586612|443638|P1|Booster Phase|Lost to Follow-up|3
138803|NCT00586612|443637|P2|Primary Phase|Withdrawal by Subject|2
138804|NCT00586612|443638|P1|Primary Phase|Withdrawal by Subject|0
138805|NCT00586612|443637|P2|Primary Phase|Lost to Follow-up|1
138806|NCT00586612|443638|P1|Primary Phase|Lost to Follow-up|0
138807|NCT00586612|443637|P2|Primary Phase|Protocol Violation|0
138808|NCT00586612|443638|P1|Primary Phase|Protocol Violation|1
138809|NCT00586625|443706|P2|Overall Study|Subject unable to return for visit|0
138810|NCT00586625|443707|P1|Overall Study|Subject unable to return for visit|2
138811|NCT00586625|443706|P2|Overall Study|Subject non-compliance|1
138812|NCT00586625|443707|P1|Overall Study|Subject non-compliance|0
138813|NCT00586625|443706|P2|Overall Study|Withdrawal by Subject|10
138814|NCT00586625|443707|P1|Overall Study|Withdrawal by Subject|32
138815|NCT00586625|443706|P2|Overall Study|Protocol Violation|0
138816|NCT00586625|443707|P1|Overall Study|Protocol Violation|3
138817|NCT00586625|443706|P2|Overall Study|Adverse Event|6
138818|NCT00586625|443707|P1|Overall Study|Adverse Event|6
138819|NCT00586664|443716|P3|Overall Study|Exclusion criteria met|0
138820|NCT00586664|443717|P2|Overall Study|Exclusion criteria met|0
138821|NCT00586664|443718|P1|Overall Study|Exclusion criteria met|2
138822|NCT00586664|443716|P3|Overall Study|Withdrawal by Subject|1
138823|NCT00586664|443717|P2|Overall Study|Withdrawal by Subject|7
138824|NCT00586664|443718|P1|Overall Study|Withdrawal by Subject|3
138825|NCT00586690|443764|P2|Overall Study|Lab can't accommodate|0
138826|NCT00586690|443765|P1|Overall Study|Lab can't accommodate|1
138827|NCT00586690|443764|P2|Overall Study|Lack of Efficacy|0
138828|NCT00586690|443765|P1|Overall Study|Lack of Efficacy|2
138829|NCT00586690|443764|P2|Overall Study|Adverse Event|0
138830|NCT00586690|443765|P1|Overall Study|Adverse Event|1
138831|NCT00586690|443764|P2|Overall Study|Disease Progression|0
138832|NCT00586690|443765|P1|Overall Study|Disease Progression|10
138833|NCT00586690|443764|P2|Overall Study|Death|0
138834|NCT00586690|443765|P1|Overall Study|Death|2
138835|NCT00586703|443772|P1|Overall Study|Death|12
138836|NCT00586820|443802|P2|Overall Study|Unsuccessful PCI|0
138837|NCT00586820|443803|P1|Overall Study|Unsuccessful PCI|1
138838|NCT00586846|443811|P1|Overall Study|Evaluable for Toxicity Only|4
138839|NCT00586846|443811|P1|Overall Study|Death|1
138840|NCT00586846|443811|P1|Overall Study|Physician Decision|1
138841|NCT00595764|443817|P2|Overall Study|Withdrawal by Subject|0
138842|NCT00595764|443818|P1|Overall Study|Withdrawal by Subject|4
138843|NCT00595764|443817|P2|Overall Study|Missed 3 PM visits|7
138844|NCT00595764|443818|P1|Overall Study|Missed 3 PM visits|1
138845|NCT00595764|443817|P2|Overall Study|Missed Medication >1 week|17
138846|NCT00595764|443818|P1|Overall Study|Missed Medication >1 week|10
138847|NCT00595764|443817|P2|Overall Study|Protocol Violation|19
138848|NCT00595764|443818|P1|Overall Study|Protocol Violation|24
138849|NCT00595868|443847|P2|Overall Study|Lost to Follow-up|50
138850|NCT00595868|443848|P1|Overall Study|Lost to Follow-up|45
138851|NCT00595920|443861|P1|Overall Study|The OLTERMS study was discontinued by th|116
138852|NCT00595959|443884|P1|Overall Study|Lost to Follow-up|1
138853|NCT00595959|443884|P1|Overall Study|Withdrawal by Subject|1
138854|NCT00596011|443901|P2|Overall Study|Adverse Event|7
138855|NCT00596011|443902|P1|Overall Study|Adverse Event|11
138856|NCT00596011|443901|P2|Overall Study|Withdrawal by Subject|3
138857|NCT00596011|443902|P1|Overall Study|Withdrawal by Subject|2
138858|NCT00597116|443932|P2|Overall Study|Progressive disease|6
138859|NCT00597116|443933|P1|Overall Study|Progressive disease|11
138860|NCT00597116|443932|P2|Overall Study|Lost to Follow-up|0
138861|NCT00597116|443933|P1|Overall Study|Lost to Follow-up|1
138862|NCT00597116|443932|P2|Overall Study|Death|1
138863|NCT00597116|443933|P1|Overall Study|Death|0
138864|NCT00597116|443932|P2|Overall Study|Physician Decision|1
138865|NCT00597116|443933|P1|Overall Study|Physician Decision|0
138866|NCT00597116|443932|P2|Overall Study|Withdrawal by Subject|2
138867|NCT00597116|443933|P1|Overall Study|Withdrawal by Subject|0
138868|NCT00597116|443932|P2|Overall Study|Adverse Event|1
138869|NCT00597116|443933|P1|Overall Study|Adverse Event|2
138870|NCT00597207|443947|P2|Overall Study|Lost to Follow-up|7
138871|NCT00597207|443948|P1|Overall Study|Lost to Follow-up|5
138872|NCT00597376|443985|P2|Overall Study|Adverse Event|1
138873|NCT00597376|443986|P1|Overall Study|Adverse Event|4
138874|NCT00597376|443985|P2|Overall Study|Withdrawal by Subject|3
138875|NCT00597376|443986|P1|Overall Study|Withdrawal by Subject|4
138876|NCT00597506|444039|P1|Overall Study|Subject is being followed for survival|1
138877|NCT00597519|444044|P1|Overall Study|Death|1
138878|NCT00597584|444065|P2|Overall Study|Renal transplant|7
138879|NCT00597584|444066|P1|Overall Study|Renal transplant|9
138880|NCT00597584|444065|P2|Overall Study|Relocation|6
138881|NCT00597584|444066|P1|Overall Study|Relocation|8
138882|NCT00597584|444065|P2|Overall Study|Never dosed|0
138883|NCT00597584|444066|P1|Overall Study|Never dosed|1
138884|NCT00597584|444065|P2|Overall Study|Lost ability to consent|1
138885|NCT00597584|444066|P1|Overall Study|Lost ability to consent|1
138886|NCT00597584|444065|P2|Overall Study|Discontinued Dialysis|1
138887|NCT00597584|444066|P1|Overall Study|Discontinued Dialysis|0
138888|NCT00597584|444065|P2|Overall Study|Withdrawal by Subject|12
138889|NCT00597584|444066|P1|Overall Study|Withdrawal by Subject|44
138890|NCT00597584|444065|P2|Overall Study|Pregnancy|0
138891|NCT00597584|444066|P1|Overall Study|Pregnancy|2
138892|NCT00597584|444065|P2|Overall Study|Physician Decision|0
138893|NCT00597584|444066|P1|Overall Study|Physician Decision|3
138894|NCT00597584|444065|P2|Overall Study|Lost to Follow-up|4
138895|NCT00597584|444066|P1|Overall Study|Lost to Follow-up|2
138896|NCT00597584|444065|P2|Overall Study|Lack of Efficacy|0
138897|NCT00597584|444066|P1|Overall Study|Lack of Efficacy|1
138898|NCT00597584|444065|P2|Overall Study|Death|30
138899|NCT00597584|444066|P1|Overall Study|Death|53
138900|NCT00597584|444065|P2|Overall Study|Adverse Event|2
138901|NCT00597584|444066|P1|Overall Study|Adverse Event|4
138902|NCT00597701|444092|P2|Overall Study|Did not start intervention (pharmacy er)|2
138903|NCT00597701|444093|P1|Overall Study|Did not start intervention (pharmacy er)|0
138904|NCT00597701|444092|P2|Overall Study|Physician Decision|0
138905|NCT00597701|444093|P1|Overall Study|Physician Decision|2
138906|NCT00597701|444092|P2|Overall Study|Death|1
138907|NCT00597701|444093|P1|Overall Study|Death|0
138908|NCT00597701|444092|P2|Overall Study|Withdrawal by Subject|5
138909|NCT00597701|444093|P1|Overall Study|Withdrawal by Subject|5
138910|NCT00597714|444101|P3|Overall Study|Recipient death|10
138911|NCT00597714|444102|P2|Overall Study|Recipient death|0
138912|NCT00597714|444103|P1|Overall Study|Recipient death|0
138913|NCT00597714|444101|P3|Overall Study|Death|0
138914|NCT00597714|444102|P2|Overall Study|Death|46
138915|NCT00597714|444103|P1|Overall Study|Death|56
138916|NCT00597753|444137|P2|Overall Study|Site elected to close|4
138917|NCT00597753|444138|P1|Overall Study|Site elected to close|2
138918|NCT00597753|444137|P2|Overall Study|Site closed by sponsor|7
138919|NCT00597753|444138|P1|Overall Study|Site closed by sponsor|19
138920|NCT00597753|444137|P2|Overall Study|Renal transplant|3
138921|NCT00597753|444138|P1|Overall Study|Renal transplant|10
138922|NCT00597753|444137|P2|Overall Study|Relocation|6
138923|NCT00597753|444138|P1|Overall Study|Relocation|17
138924|NCT00597753|444137|P2|Overall Study|Noncompliance|1
138925|NCT00597753|444138|P1|Overall Study|Noncompliance|2
138926|NCT00597753|444137|P2|Overall Study|Never dosed|0
138927|NCT00597753|444138|P1|Overall Study|Never dosed|2
138928|NCT00597753|444137|P2|Overall Study|Discontinued Dialysis|1
138929|NCT00597753|444138|P1|Overall Study|Discontinued Dialysis|0
138930|NCT00597753|444137|P2|Overall Study|Withdrawal by Subject|12
138931|NCT00597753|444138|P1|Overall Study|Withdrawal by Subject|35
138932|NCT00597753|444137|P2|Overall Study|Pregnancy|0
138933|NCT00597753|444138|P1|Overall Study|Pregnancy|1
138934|NCT00597753|444137|P2|Overall Study|Physician Decision|1
138935|NCT00597753|444138|P1|Overall Study|Physician Decision|5
138936|NCT00597753|444137|P2|Overall Study|Lost to Follow-up|3
138937|NCT00597753|444138|P1|Overall Study|Lost to Follow-up|10
138938|NCT00597753|444137|P2|Overall Study|Lack of Efficacy|0
138939|NCT00597753|444138|P1|Overall Study|Lack of Efficacy|2
138940|NCT00597753|444137|P2|Overall Study|Death|29
138941|NCT00597753|444138|P1|Overall Study|Death|55
138942|NCT00597753|444137|P2|Overall Study|Adverse Event|2
138943|NCT00597753|444138|P1|Overall Study|Adverse Event|6
138944|NCT00598078|444190|P2|Period 2 (Day 2)|Adverse Event|0
138945|NCT00598078|444191|P1|Period 2 (Day 2)|Adverse Event|1
138946|NCT00598273|444202|P3|Overall Study|Started dialysis|5
138947|NCT00598273|444203|P2|Overall Study|Started dialysis|4
138948|NCT00598273|444204|P1|Overall Study|Started dialysis|6
138949|NCT00598273|444202|P3|Overall Study|Site elected to close|0
138950|NCT00598273|444203|P2|Overall Study|Site elected to close|0
138951|NCT00598273|444204|P1|Overall Study|Site elected to close|1
138952|NCT00598273|444202|P3|Overall Study|Renal transplant|1
138953|NCT00598273|444203|P2|Overall Study|Renal transplant|0
138954|NCT00598273|444204|P1|Overall Study|Renal transplant|1
138955|NCT00598273|444202|P3|Overall Study|Relocation|4
138956|NCT00598273|444203|P2|Overall Study|Relocation|2
138957|NCT00598273|444204|P1|Overall Study|Relocation|0
138958|NCT00598273|444202|P3|Overall Study|Noncompliance|3
138959|NCT00598273|444203|P2|Overall Study|Noncompliance|2
138960|NCT00598273|444204|P1|Overall Study|Noncompliance|3
138961|NCT00598273|444202|P3|Overall Study|Withdrawal by Subject|10
138962|NCT00598273|444203|P2|Overall Study|Withdrawal by Subject|10
138963|NCT00598273|444204|P1|Overall Study|Withdrawal by Subject|12
138964|NCT00598273|444202|P3|Overall Study|Physician Decision|1
138965|NCT00598273|444203|P2|Overall Study|Physician Decision|0
138966|NCT00598273|444204|P1|Overall Study|Physician Decision|0
138967|NCT00598273|444202|P3|Overall Study|Lost to Follow-up|5
138968|NCT00598273|444203|P2|Overall Study|Lost to Follow-up|3
138969|NCT00598273|444204|P1|Overall Study|Lost to Follow-up|8
138970|NCT00598273|444202|P3|Overall Study|Death|8
138971|NCT00598273|444203|P2|Overall Study|Death|12
138972|NCT00598273|444204|P1|Overall Study|Death|6
138973|NCT00598273|444202|P3|Overall Study|Adverse Event|2
138974|NCT00598273|444203|P2|Overall Study|Adverse Event|5
138975|NCT00598273|444204|P1|Overall Study|Adverse Event|4
138976|NCT00598442|444221|P3|Overall Study|Started dialysis|0
138977|NCT00598442|444222|P2|Overall Study|Started dialysis|0
138978|NCT00598442|444223|P1|Overall Study|Started dialysis|1
138979|NCT00598442|444221|P3|Overall Study|Site closed by sponsor|1
138980|NCT00598442|444222|P2|Overall Study|Site closed by sponsor|2
138981|NCT00598442|444223|P1|Overall Study|Site closed by sponsor|5
138982|NCT00598442|444221|P3|Overall Study|Renal transplant|1
138983|NCT00598442|444222|P2|Overall Study|Renal transplant|0
138984|NCT00598442|444223|P1|Overall Study|Renal transplant|0
138985|NCT00598442|444221|P3|Overall Study|Relocation|0
138986|NCT00598442|444222|P2|Overall Study|Relocation|4
138987|NCT00598442|444223|P1|Overall Study|Relocation|1
138988|NCT00598442|444221|P3|Overall Study|Noncompliance|1
138989|NCT00598442|444222|P2|Overall Study|Noncompliance|2
138990|NCT00598442|444223|P1|Overall Study|Noncompliance|0
138991|NCT00598442|444221|P3|Overall Study|Withdrawal by Subject|6
138992|NCT00598442|444222|P2|Overall Study|Withdrawal by Subject|16
138993|NCT00598442|444223|P1|Overall Study|Withdrawal by Subject|8
138994|NCT00598442|444221|P3|Overall Study|Physician Decision|1
138995|NCT00598442|444222|P2|Overall Study|Physician Decision|1
138996|NCT00598442|444223|P1|Overall Study|Physician Decision|2
138997|NCT00598442|444221|P3|Overall Study|Lost to Follow-up|3
138998|NCT00598442|444222|P2|Overall Study|Lost to Follow-up|3
138999|NCT00598442|444223|P1|Overall Study|Lost to Follow-up|4
139000|NCT00598442|444221|P3|Overall Study|Death|11
139001|NCT00598442|444222|P2|Overall Study|Death|11
139002|NCT00598442|444223|P1|Overall Study|Death|19
139003|NCT00598442|444221|P3|Overall Study|Adverse Event|0
139004|NCT00598442|444222|P2|Overall Study|Adverse Event|0
139005|NCT00598442|444223|P1|Overall Study|Adverse Event|3
139006|NCT00598559|444247|P3|Overall Study|Subject unable/unwilling to attend visit|0
139007|NCT00598559|444248|P2|Overall Study|Subject unable/unwilling to attend visit|7
139008|NCT00598559|444249|P1|Overall Study|Subject unable/unwilling to attend visit|4
139009|NCT00598559|444247|P3|Overall Study|Early discharge from hospital|3
139010|NCT00598559|444248|P2|Overall Study|Early discharge from hospital|12
139011|NCT00598559|444249|P1|Overall Study|Early discharge from hospital|9
139012|NCT00598559|444247|P3|Overall Study|Protocol Non-compliance|0
139013|NCT00598559|444248|P2|Overall Study|Protocol Non-compliance|0
139014|NCT00598559|444249|P1|Overall Study|Protocol Non-compliance|1
139015|NCT00598559|444247|P3|Overall Study|Withdrawal by Subject|0
139016|NCT00598559|444248|P2|Overall Study|Withdrawal by Subject|2
139017|NCT00598559|444249|P1|Overall Study|Withdrawal by Subject|2
139018|NCT00598559|444247|P3|Overall Study|Adverse Event|0
139019|NCT00598559|444248|P2|Overall Study|Adverse Event|7
139020|NCT00598559|444249|P1|Overall Study|Adverse Event|11
139021|NCT00598585|444268|P2|Overall Study|Lost to Follow-up|0
139022|NCT00598585|444269|P1|Overall Study|Lost to Follow-up|1
139023|NCT00598650|444275|P1|Overall Study|Physician Decision|2
139024|NCT00598650|444275|P1|Overall Study|Prohibited Concomitant Medication|2
139025|NCT00598650|444275|P1|Overall Study|Not eligible|1
139026|NCT00598650|444275|P1|Overall Study|No treatment for 3 weeks|1
139027|NCT00598650|444275|P1|Overall Study|Adverse Event|18
139028|NCT00598650|444275|P1|Overall Study|Withdrawal by Subject|3
139029|NCT00598702|444303|P8|Overall Study|Dose limiting toxicity|0
139030|NCT00598702|444304|P7|Overall Study|Dose limiting toxicity|0
139031|NCT00598702|444305|P6|Overall Study|Dose limiting toxicity|1
139032|NCT00598702|444306|P5|Overall Study|Dose limiting toxicity|1
139033|NCT00598702|444307|P4|Overall Study|Dose limiting toxicity|1
139034|NCT00598702|444308|P3|Overall Study|Dose limiting toxicity|0
139035|NCT00598702|444309|P2|Overall Study|Dose limiting toxicity|0
139036|NCT00598702|444310|P1|Overall Study|Dose limiting toxicity|0
139037|NCT00598702|444303|P8|Overall Study|Physician Decision|0
139038|NCT00598702|444304|P7|Overall Study|Physician Decision|0
139039|NCT00598702|444305|P6|Overall Study|Physician Decision|0
139040|NCT00598702|444306|P5|Overall Study|Physician Decision|1
139041|NCT00598702|444307|P4|Overall Study|Physician Decision|0
139042|NCT00598702|444308|P3|Overall Study|Physician Decision|0
139043|NCT00598702|444309|P2|Overall Study|Physician Decision|0
139044|NCT00598702|444310|P1|Overall Study|Physician Decision|0
139045|NCT00598702|444303|P8|Overall Study|Withdrawal by Subject|0
139046|NCT00598702|444304|P7|Overall Study|Withdrawal by Subject|0
139047|NCT00598702|444305|P6|Overall Study|Withdrawal by Subject|0
139048|NCT00598702|444306|P5|Overall Study|Withdrawal by Subject|1
139049|NCT00598702|444307|P4|Overall Study|Withdrawal by Subject|1
139050|NCT00598702|444308|P3|Overall Study|Withdrawal by Subject|0
139051|NCT00598702|444309|P2|Overall Study|Withdrawal by Subject|0
139052|NCT00598702|444310|P1|Overall Study|Withdrawal by Subject|0
139053|NCT00598702|444303|P8|Overall Study|Adverse Event|0
139054|NCT00598702|444304|P7|Overall Study|Adverse Event|0
139055|NCT00598702|444305|P6|Overall Study|Adverse Event|0
139056|NCT00598702|444306|P5|Overall Study|Adverse Event|0
139057|NCT00598702|444307|P4|Overall Study|Adverse Event|1
139058|NCT00598702|444308|P3|Overall Study|Adverse Event|0
139059|NCT00598702|444309|P2|Overall Study|Adverse Event|0
139060|NCT00598702|444310|P1|Overall Study|Adverse Event|0
139061|NCT00598702|444303|P8|Overall Study|Early discharge from hospital|0
139062|NCT00598702|444304|P7|Overall Study|Early discharge from hospital|1
139063|NCT00598702|444305|P6|Overall Study|Early discharge from hospital|10
139064|NCT00598702|444306|P5|Overall Study|Early discharge from hospital|0
139065|NCT00598702|444307|P4|Overall Study|Early discharge from hospital|5
139066|NCT00598702|444308|P3|Overall Study|Early discharge from hospital|2
139067|NCT00598702|444309|P2|Overall Study|Early discharge from hospital|0
139068|NCT00598702|444310|P1|Overall Study|Early discharge from hospital|0
139069|NCT00598702|444303|P8|Overall Study|Not specified|0
139070|NCT00598702|444304|P7|Overall Study|Not specified|0
139071|NCT00598702|444305|P6|Overall Study|Not specified|1
139072|NCT00598702|444306|P5|Overall Study|Not specified|0
139073|NCT00598702|444307|P4|Overall Study|Not specified|0
139074|NCT00598702|444308|P3|Overall Study|Not specified|0
139075|NCT00598702|444309|P2|Overall Study|Not specified|2
139076|NCT00598702|444310|P1|Overall Study|Not specified|0
139077|NCT00598832|444373|P2|Overall Study|Non compliance|0
139078|NCT00598832|444374|P1|Overall Study|Non compliance|1
139079|NCT00598832|444373|P2|Overall Study|Physician Decision|4
139080|NCT00598832|444374|P1|Overall Study|Physician Decision|1
139081|NCT00598832|444373|P2|Overall Study|Pregnancy|2
139082|NCT00598832|444374|P1|Overall Study|Pregnancy|2
139083|NCT00598832|444373|P2|Overall Study|Lost to Follow-up|29
139084|NCT00598832|444374|P1|Overall Study|Lost to Follow-up|24
139085|NCT00598832|444373|P2|Overall Study|Protocol Violation|2
139086|NCT00598832|444374|P1|Overall Study|Protocol Violation|0
139087|NCT00598832|444373|P2|Overall Study|Withdrawal by Subject|36
139088|NCT00598832|444374|P1|Overall Study|Withdrawal by Subject|25
139089|NCT00598832|444373|P2|Overall Study|Adverse Event|2
139090|NCT00598832|444374|P1|Overall Study|Adverse Event|6
139091|NCT00598832|444373|P2|Overall Study|Lack of Efficacy|7
139092|NCT00598832|444374|P1|Overall Study|Lack of Efficacy|3
139093|NCT00598871|444390|P2|Overall Study|Adverse Event|1
139094|NCT00598871|444391|P1|Overall Study|Adverse Event|0
139095|NCT00599027|444406|P2|Overall Study|Treatment Failure|1
139096|NCT00599027|444407|P1|Overall Study|Treatment Failure|0
139097|NCT00599027|444406|P2|Overall Study|Adverse Event|1
139098|NCT00599027|444407|P1|Overall Study|Adverse Event|0
139099|NCT00599027|444406|P2|Overall Study|Withdrawal by Subject|1
139100|NCT00599027|444407|P1|Overall Study|Withdrawal by Subject|1
139101|NCT00599196|444436|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
139102|NCT00599196|444436|P1|Overall Study|Other: Patient Stopped Due To Moving|1
139103|NCT00599196|444436|P1|Overall Study|Other: Pt Moved To Australia|1
139104|NCT00599196|444436|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
139105|NCT00599196|444436|P1|Overall Study|Other: Spouse Withdrew Consent|1
139106|NCT00599196|444436|P1|Overall Study|Other: Patient Leaving For Israel|1
139107|NCT00599196|444436|P1|Overall Study|Lost to Follow-up|17
139108|NCT00599196|444436|P1|Overall Study|Study ended per sponsor|197
139109|NCT00599196|444436|P1|Overall Study|Subject withdrew consent|43
139110|NCT00599196|444436|P1|Overall Study|Unsatisfactory compliance of subject|3
139111|NCT00599196|444436|P1|Overall Study|Adverse Event|93
139112|NCT00599196|444436|P1|Overall Study|Lack of Efficacy|22
139113|NCT00599313|444475|P1|Overall Study|Ineligible|1
139114|NCT00599313|444475|P1|Overall Study|Patient Request|4
139115|NCT00599313|444475|P1|Overall Study|Disease Progression|12
139116|NCT00599313|444475|P1|Overall Study|Adverse Event|19
139117|NCT00599326|444484|P1|Overall Study|Noncompliant|1
139118|NCT00599326|444484|P1|Overall Study|Lost to Follow-up|1
139119|NCT00599339|444489|P1|Overall Study|Study Termination Status Unknown|12
139120|NCT00599339|444489|P1|Overall Study|No valid data consent|36
139121|NCT00599339|444489|P1|Overall Study|Lost to Follow-up|221
139122|NCT00599339|444489|P1|Overall Study|Other Reason|179
139123|NCT00599339|444489|P1|Overall Study|Withdrawal by Subject|137
139124|NCT00599339|444489|P1|Overall Study|Adverse Event|79
139125|NCT00599521|444593|P2|Overall Study|Pregnancy|2
139126|NCT00599521|444594|P1|Overall Study|Pregnancy|0
139127|NCT00599521|444593|P2|Overall Study|Lost to Follow-up|23
139128|NCT00599521|444594|P1|Overall Study|Lost to Follow-up|23
139129|NCT00599521|444593|P2|Overall Study|Protocol Violation|1
139130|NCT00599521|444594|P1|Overall Study|Protocol Violation|1
139131|NCT00599521|444593|P2|Overall Study|Withdrawal by Subject|34
139132|NCT00599521|444594|P1|Overall Study|Withdrawal by Subject|28
139133|NCT00599521|444593|P2|Overall Study|Adverse Event|1
139134|NCT00599521|444594|P1|Overall Study|Adverse Event|4
139135|NCT00599521|444593|P2|Overall Study|Lack of Efficacy|8
139136|NCT00599521|444594|P1|Overall Study|Lack of Efficacy|4
139137|NCT00590720|444610|P2|Overall Study|Withdrawal by Subject|1
139138|NCT00590720|444611|P1|Overall Study|Withdrawal by Subject|0
139139|NCT00590720|444610|P2|Overall Study|Lost to Follow-up|0
139140|NCT00590720|444611|P1|Overall Study|Lost to Follow-up|1
139141|NCT00590759|444653|P1|Overall Study|Lost to Follow-up|28
139142|NCT00590759|444653|P1|Overall Study|Death|52
139143|NCT00590902|444689|P1|Overall Study|Death|1
139144|NCT00590967|444695|P2|Overall Study|Did not receive chemo per protocol|0
139145|NCT00590967|444696|P1|Overall Study|Did not receive chemo per protocol|1
139146|NCT00590967|444695|P2|Overall Study|Did not sign consent form|1
139147|NCT00590967|444696|P1|Overall Study|Did not sign consent form|0
139148|NCT00590967|444695|P2|Overall Study|Non-compliant|2
139149|NCT00590967|444696|P1|Overall Study|Non-compliant|0
139150|NCT00590967|444695|P2|Overall Study|Poor performance status|1
139151|NCT00590967|444696|P1|Overall Study|Poor performance status|0
139152|NCT00590967|444695|P2|Overall Study|Ineligible|0
139153|NCT00590967|444696|P1|Overall Study|Ineligible|1
139154|NCT00590967|444695|P2|Overall Study|Withdrawal by Subject|1
139155|NCT00590967|444696|P1|Overall Study|Withdrawal by Subject|1
139156|NCT00591006|444708|P24|Overall Study|Adverse Event|0
139157|NCT00591006|444709|P23|Overall Study|Adverse Event|1
139158|NCT00591006|444710|P22|Overall Study|Adverse Event|0
139159|NCT00591006|444711|P21|Overall Study|Adverse Event|0
139160|NCT00591006|444712|P20|Overall Study|Adverse Event|0
139161|NCT00591006|444713|P19|Overall Study|Adverse Event|0
139162|NCT00591006|444714|P18|Overall Study|Adverse Event|0
139163|NCT00591006|444715|P17|Overall Study|Adverse Event|0
139164|NCT00591006|444716|P16|Overall Study|Adverse Event|0
139165|NCT00591006|444717|P15|Overall Study|Adverse Event|0
139166|NCT00591006|444718|P14|Overall Study|Adverse Event|0
139167|NCT00591006|444719|P13|Overall Study|Adverse Event|0
139168|NCT00591006|444720|P12|Overall Study|Adverse Event|0
139169|NCT00591006|444721|P11|Overall Study|Adverse Event|0
139170|NCT00591006|444722|P10|Overall Study|Adverse Event|0
139171|NCT00591006|444723|P9|Overall Study|Adverse Event|0
139172|NCT00591006|444724|P8|Overall Study|Adverse Event|0
139173|NCT00591006|444725|P7|Overall Study|Adverse Event|0
139174|NCT00591006|444726|P6|Overall Study|Adverse Event|0
139175|NCT00591006|444727|P5|Overall Study|Adverse Event|0
139176|NCT00591006|444728|P4|Overall Study|Adverse Event|0
139177|NCT00591006|444729|P3|Overall Study|Adverse Event|0
139178|NCT00591006|444730|P2|Overall Study|Adverse Event|0
139179|NCT00591006|444731|P1|Overall Study|Adverse Event|0
139180|NCT00591006|444708|P24|Overall Study|Withdrawal by Subject|1
139181|NCT00591006|444709|P23|Overall Study|Withdrawal by Subject|0
139182|NCT00591006|444710|P22|Overall Study|Withdrawal by Subject|0
139183|NCT00591006|444711|P21|Overall Study|Withdrawal by Subject|0
139184|NCT00591006|444712|P20|Overall Study|Withdrawal by Subject|0
139185|NCT00591006|444713|P19|Overall Study|Withdrawal by Subject|0
139186|NCT00591006|444714|P18|Overall Study|Withdrawal by Subject|0
139187|NCT00591006|444715|P17|Overall Study|Withdrawal by Subject|0
139188|NCT00591006|444716|P16|Overall Study|Withdrawal by Subject|1
139189|NCT00591006|444717|P15|Overall Study|Withdrawal by Subject|0
139190|NCT00591006|444718|P14|Overall Study|Withdrawal by Subject|0
139191|NCT00591006|444719|P13|Overall Study|Withdrawal by Subject|0
139192|NCT00591006|444720|P12|Overall Study|Withdrawal by Subject|0
139193|NCT00591006|444721|P11|Overall Study|Withdrawal by Subject|0
139194|NCT00591006|444722|P10|Overall Study|Withdrawal by Subject|0
139195|NCT00591006|444723|P9|Overall Study|Withdrawal by Subject|0
139196|NCT00591006|444724|P8|Overall Study|Withdrawal by Subject|0
139197|NCT00591006|444725|P7|Overall Study|Withdrawal by Subject|0
139198|NCT00591006|444726|P6|Overall Study|Withdrawal by Subject|0
139199|NCT00591006|444727|P5|Overall Study|Withdrawal by Subject|0
139200|NCT00591006|444728|P4|Overall Study|Withdrawal by Subject|0
139201|NCT00591006|444729|P3|Overall Study|Withdrawal by Subject|0
139202|NCT00591006|444730|P2|Overall Study|Withdrawal by Subject|0
139203|NCT00591006|444731|P1|Overall Study|Withdrawal by Subject|0
139204|NCT00591149|444761|P1|Overall Study|Withdrawal by Subject|1
139205|NCT00591149|444761|P1|Overall Study|Adverse Event|4
139206|NCT00591214|444765|P1|Overall Study|Withdrawal by Subject|1
139207|NCT00591214|444765|P1|Overall Study|Physician Decision|7
139208|NCT00591253|444795|P3|Overall Study|Other|3
139209|NCT00591253|444796|P2|Overall Study|Other|5
139210|NCT00591253|444797|P1|Overall Study|Other|5
139211|NCT00591253|444795|P3|Overall Study|Lack of Efficacy|3
139212|NCT00591253|444796|P2|Overall Study|Lack of Efficacy|0
139213|NCT00591253|444797|P1|Overall Study|Lack of Efficacy|1
139214|NCT00591253|444795|P3|Overall Study|Withdrawal by Subject|6
139215|NCT00591253|444796|P2|Overall Study|Withdrawal by Subject|7
139216|NCT00591253|444797|P1|Overall Study|Withdrawal by Subject|1
139217|NCT00591253|444795|P3|Overall Study|Lost to Follow-up|0
139218|NCT00591253|444796|P2|Overall Study|Lost to Follow-up|4
139219|NCT00591253|444797|P1|Overall Study|Lost to Follow-up|2
139220|NCT00591253|444795|P3|Overall Study|Protocol Violation|2
139221|NCT00591253|444796|P2|Overall Study|Protocol Violation|2
139222|NCT00591253|444797|P1|Overall Study|Protocol Violation|2
139223|NCT00591253|444795|P3|Overall Study|Adverse Event|1
139224|NCT00591253|444796|P2|Overall Study|Adverse Event|3
139225|NCT00591253|444797|P1|Overall Study|Adverse Event|3
139226|NCT00591266|444850|P3|Overall Study|Other|5
139227|NCT00591266|444851|P2|Overall Study|Other|4
139228|NCT00591266|444852|P1|Overall Study|Other|1
139229|NCT00591266|444850|P3|Overall Study|Lack of Efficacy|0
139230|NCT00591266|444851|P2|Overall Study|Lack of Efficacy|2
139231|NCT00591266|444852|P1|Overall Study|Lack of Efficacy|0
139232|NCT00591266|444850|P3|Overall Study|Withdrawal by Subject|5
139233|NCT00591266|444851|P2|Overall Study|Withdrawal by Subject|2
139234|NCT00591266|444852|P1|Overall Study|Withdrawal by Subject|6
139235|NCT00591266|444850|P3|Overall Study|Protocol Violation|1
139236|NCT00591266|444851|P2|Overall Study|Protocol Violation|0
139237|NCT00591266|444852|P1|Overall Study|Protocol Violation|0
139238|NCT00591266|444850|P3|Overall Study|Lost to Follow-up|0
139239|NCT00591266|444851|P2|Overall Study|Lost to Follow-up|1
139240|NCT00591266|444852|P1|Overall Study|Lost to Follow-up|0
139241|NCT00591266|444850|P3|Overall Study|Adverse Event|3
139242|NCT00591266|444851|P2|Overall Study|Adverse Event|2
139243|NCT00591266|444852|P1|Overall Study|Adverse Event|2
139244|NCT00591344|444917|P2|Overall Study|Did not want to come off medication|1
139245|NCT00591344|444918|P1|Overall Study|Did not want to come off medication|0
139246|NCT00591344|444917|P2|Overall Study|Lost to Follow-up|1
139247|NCT00591344|444918|P1|Overall Study|Lost to Follow-up|0
139248|NCT00591344|444917|P2|Overall Study|Death|1
139249|NCT00591344|444918|P1|Overall Study|Death|0
139250|NCT00591344|444917|P2|Overall Study|Underwent DBS|2
139251|NCT00591344|444918|P1|Overall Study|Underwent DBS|2
139252|NCT00591344|444917|P2|Overall Study|Medical complications|3
139253|NCT00591344|444918|P1|Overall Study|Medical complications|1
139254|NCT00591344|444917|P2|Overall Study|Moved out of state|0
139255|NCT00591344|444918|P1|Overall Study|Moved out of state|1
139256|NCT00591344|444917|P2|Overall Study|Transportation issues|0
139257|NCT00591344|444918|P1|Overall Study|Transportation issues|1
139258|NCT00591370|444928|P1|Overall Study|Not Treated|2
139259|NCT00591565|444934|P1|Overall Study|lost follow up, withdrawn|5
139260|NCT00591578|444941|P3|Open-Label Extension Phase|Other|0
139261|NCT00591578|444942|P2|Open-Label Extension Phase|Other|0
139262|NCT00591578|444943|P1|Open-Label Extension Phase|Other|1
139263|NCT00591578|444941|P3|Open-Label Extension Phase|Withdrawal by Subject|0
139264|NCT00591578|444942|P2|Open-Label Extension Phase|Withdrawal by Subject|1
139265|NCT00591578|444943|P1|Open-Label Extension Phase|Withdrawal by Subject|1
139266|NCT00591578|444941|P3|Open-Label Extension Phase|Lost to Follow-up|0
139267|NCT00591578|444942|P2|Open-Label Extension Phase|Lost to Follow-up|4
139268|NCT00591578|444943|P1|Open-Label Extension Phase|Lost to Follow-up|1
139269|NCT00591578|444941|P3|Open-Label Extension Phase|Adverse Event|0
139270|NCT00591578|444942|P2|Open-Label Extension Phase|Adverse Event|5
139271|NCT00591578|444943|P1|Open-Label Extension Phase|Adverse Event|3
139272|NCT00591578|444941|P3|Double-Blind Treatment Phase|Other|4
139273|NCT00591578|444942|P2|Double-Blind Treatment Phase|Other|9
139274|NCT00591578|444943|P1|Double-Blind Treatment Phase|Other|4
139275|NCT00591578|444941|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
139276|NCT00591578|444942|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
139277|NCT00591578|444943|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
139278|NCT00591578|444941|P3|Double-Blind Treatment Phase|Pregnancy|0
139279|NCT00591578|444942|P2|Double-Blind Treatment Phase|Pregnancy|0
139280|NCT00591578|444943|P1|Double-Blind Treatment Phase|Pregnancy|1
139281|NCT00591578|444941|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
139282|NCT00591578|444942|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
139283|NCT00591578|444943|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
139284|NCT00591578|444941|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
139285|NCT00591578|444942|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
139286|NCT00591578|444943|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
139287|NCT00591578|444941|P3|Double-Blind Treatment Phase|Protocol Violation|3
139288|NCT00591578|444942|P2|Double-Blind Treatment Phase|Protocol Violation|2
139289|NCT00591578|444943|P1|Double-Blind Treatment Phase|Protocol Violation|3
139290|NCT00591578|444941|P3|Double-Blind Treatment Phase|Adverse Event|19
139291|NCT00591578|444942|P2|Double-Blind Treatment Phase|Adverse Event|26
139292|NCT00591578|444943|P1|Double-Blind Treatment Phase|Adverse Event|20
139293|NCT00591591|444996|P2|Overall Study|Lack of Efficacy|2
139294|NCT00591591|444997|P1|Overall Study|Lack of Efficacy|10
139295|NCT00591591|444996|P2|Overall Study|Withdrawal by Subject|37
139296|NCT00591591|444997|P1|Overall Study|Withdrawal by Subject|1
139297|NCT00591721|445013|P2|Overall Study|Intervention not received|8
139298|NCT00591721|445014|P1|Overall Study|Intervention not received|10
139299|NCT00591721|445013|P2|Overall Study|Lost to Follow-up|4
139300|NCT00591721|445014|P1|Overall Study|Lost to Follow-up|1
139301|NCT00591721|445013|P2|Overall Study|Withdrawal by Subject|10
139302|NCT00591721|445014|P1|Overall Study|Withdrawal by Subject|10
139303|NCT00591734|445020|P1|Overall Study|Intercurrent Illness|8
139304|NCT00591734|445020|P1|Overall Study|Physician Decision|5
139305|NCT00591734|445020|P1|Overall Study|Adverse Event|5
139306|NCT00591734|445020|P1|Overall Study|Lack of Efficacy|35
139307|NCT00591773|445036|P3|Overall Study|Other|4
139308|NCT00591773|445037|P2|Overall Study|Other|1
139309|NCT00591773|445038|P1|Overall Study|Other|1
139310|NCT00591773|445036|P3|Overall Study|Lack of Efficacy|2
139311|NCT00591773|445037|P2|Overall Study|Lack of Efficacy|2
139312|NCT00591773|445038|P1|Overall Study|Lack of Efficacy|1
139313|NCT00591773|445036|P3|Overall Study|Withdrawal by Subject|3
139314|NCT00591773|445037|P2|Overall Study|Withdrawal by Subject|5
139315|NCT00591773|445038|P1|Overall Study|Withdrawal by Subject|2
139316|NCT00591773|445036|P3|Overall Study|Lost to Follow-up|1
139317|NCT00591773|445037|P2|Overall Study|Lost to Follow-up|4
139318|NCT00591773|445038|P1|Overall Study|Lost to Follow-up|1
139319|NCT00591773|445036|P3|Overall Study|Protocol Violation|0
139320|NCT00591773|445037|P2|Overall Study|Protocol Violation|3
139321|NCT00591773|445038|P1|Overall Study|Protocol Violation|2
139322|NCT00591773|445036|P3|Overall Study|Adverse Event|6
139323|NCT00591773|445037|P2|Overall Study|Adverse Event|9
139324|NCT00591773|445038|P1|Overall Study|Adverse Event|9
139325|NCT00591851|445121|P1|Overall Study|Progressive Disease|1
139326|NCT00591851|445121|P1|Overall Study|Adverse Event|2
139327|NCT00591851|445121|P1|Overall Study|Withdrawal by Subject|3
139328|NCT00591864|445125|P1|Overall Study|Incomplete Imaging|5
139329|NCT00592007|445131|P1|Overall Study|patient ineligible (out of lab range)|1
139330|NCT00592007|445131|P1|Overall Study|Withdrawal by Subject|1
139331|NCT00592072|445136|P2|Wash Out Period|Lost to Follow-up|1
139332|NCT00592072|445137|P1|Wash Out Period|Lost to Follow-up|1
139333|NCT00592319|445228|P2|Overall Study|Lost to Follow-up|3
139334|NCT00592319|445229|P1|Overall Study|Lost to Follow-up|0
139335|NCT00592358|445237|P1|Overall Study|Inability to swallow pills|1
139336|NCT00592358|445237|P1|Overall Study|Lack of Efficacy|2
139337|NCT00592358|445237|P1|Overall Study|Adverse Event|1
139338|NCT00592358|445237|P1|Overall Study|Withdrawal by Subject|2
139339|NCT00592384|445244|P2|Overall Study|Withdrawal by Subject|6
139340|NCT00592384|445245|P1|Overall Study|Withdrawal by Subject|5
139341|NCT00592631|445292|P2|Overall Study|Lost to Follow-up|2
139342|NCT00592631|445293|P1|Overall Study|Lost to Follow-up|0
139343|NCT00592683|445301|P2|Overall Study|Lost to Follow-up|1
139344|NCT00592683|445302|P1|Overall Study|Lost to Follow-up|0
139345|NCT00592683|445301|P2|Overall Study|Other|0
139346|NCT00592683|445302|P1|Overall Study|Other|1
139347|NCT00592683|445301|P2|Overall Study|Study drug expired|0
139348|NCT00592683|445302|P1|Overall Study|Study drug expired|1
139349|NCT00592683|445301|P2|Overall Study|Protocol Violation|0
139350|NCT00592683|445302|P1|Overall Study|Protocol Violation|1
139351|NCT00592683|445301|P2|Overall Study|Adverse Event|2
139352|NCT00592683|445302|P1|Overall Study|Adverse Event|0
139353|NCT00592683|445301|P2|Overall Study|Withdrawal by Subject|0
139354|NCT00592683|445302|P1|Overall Study|Withdrawal by Subject|1
139355|NCT00592683|445301|P2|Overall Study|Found ineligible|1
139356|NCT00592683|445302|P1|Overall Study|Found ineligible|0
139357|NCT00592774|445328|P5|Overall Study|Not specified|2
139358|NCT00592774|445329|P4|Overall Study|Not specified|0
139359|NCT00592774|445330|P3|Overall Study|Not specified|1
139360|NCT00592774|445331|P2|Overall Study|Not specified|1
139361|NCT00592774|445332|P1|Overall Study|Not specified|0
139362|NCT00592774|445328|P5|Overall Study|Physician Decision|1
139363|NCT00592774|445329|P4|Overall Study|Physician Decision|0
139364|NCT00592774|445330|P3|Overall Study|Physician Decision|1
139365|NCT00592774|445331|P2|Overall Study|Physician Decision|1
139366|NCT00592774|445332|P1|Overall Study|Physician Decision|0
139367|NCT00592774|445328|P5|Overall Study|Lack of Efficacy|2
139368|NCT00592774|445329|P4|Overall Study|Lack of Efficacy|0
139369|NCT00592774|445330|P3|Overall Study|Lack of Efficacy|0
139370|NCT00592774|445331|P2|Overall Study|Lack of Efficacy|3
139371|NCT00592774|445332|P1|Overall Study|Lack of Efficacy|3
139372|NCT00592774|445328|P5|Overall Study|Withdrawal by Subject|0
139373|NCT00592774|445329|P4|Overall Study|Withdrawal by Subject|0
139374|NCT00592774|445330|P3|Overall Study|Withdrawal by Subject|0
139375|NCT00592774|445331|P2|Overall Study|Withdrawal by Subject|7
139376|NCT00592774|445332|P1|Overall Study|Withdrawal by Subject|3
139377|NCT00592774|445328|P5|Overall Study|Protocol Violation|1
139378|NCT00592774|445329|P4|Overall Study|Protocol Violation|0
139379|NCT00592774|445330|P3|Overall Study|Protocol Violation|0
139380|NCT00592774|445331|P2|Overall Study|Protocol Violation|1
139381|NCT00592774|445332|P1|Overall Study|Protocol Violation|0
139382|NCT00592774|445328|P5|Overall Study|Adverse Event|8
139383|NCT00592774|445329|P4|Overall Study|Adverse Event|14
139384|NCT00592774|445330|P3|Overall Study|Adverse Event|2
139385|NCT00592774|445331|P2|Overall Study|Adverse Event|19
139386|NCT00592774|445332|P1|Overall Study|Adverse Event|5
139387|NCT00592839|445392|P3|Overall Study|Lost to Follow-up|1
139388|NCT00592839|445393|P2|Overall Study|Lost to Follow-up|1
139389|NCT00592839|445394|P1|Overall Study|Lost to Follow-up|0
139390|NCT00592839|445392|P3|Overall Study|Adverse Event|0
139391|NCT00592839|445393|P2|Overall Study|Adverse Event|1
139392|NCT00592839|445394|P1|Overall Study|Adverse Event|0
139393|NCT00592839|445392|P3|Overall Study|Protocol Violation|2
139394|NCT00592839|445393|P2|Overall Study|Protocol Violation|1
139395|NCT00592839|445394|P1|Overall Study|Protocol Violation|1
139396|NCT00592839|445392|P3|Overall Study|Withdrawal by Subject|3
139397|NCT00592839|445393|P2|Overall Study|Withdrawal by Subject|1
139398|NCT00592839|445394|P1|Overall Study|Withdrawal by Subject|1
139399|NCT00592852|445417|P1|Overall Study|Withdrawal by Subject|1
139400|NCT00592852|445417|P1|Overall Study|Found ineligible|1
139401|NCT00592852|445417|P1|Overall Study|Adverse Event|3
139402|NCT00592852|445417|P1|Overall Study|Non-compliance|1
139403|NCT00592904|445426|P4|Overall Study|Not specified|0
139404|NCT00592904|445427|P3|Overall Study|Not specified|0
139405|NCT00592904|445428|P2|Overall Study|Not specified|3
139406|NCT00592904|445429|P1|Overall Study|Not specified|3
139407|NCT00592904|445426|P4|Overall Study|Physician Decision|0
139408|NCT00592904|445427|P3|Overall Study|Physician Decision|1
139409|NCT00592904|445428|P2|Overall Study|Physician Decision|3
139410|NCT00592904|445429|P1|Overall Study|Physician Decision|0
139411|NCT00592904|445426|P4|Overall Study|Lack of Efficacy|3
139412|NCT00592904|445427|P3|Overall Study|Lack of Efficacy|2
139413|NCT00592904|445428|P2|Overall Study|Lack of Efficacy|7
139414|NCT00592904|445429|P1|Overall Study|Lack of Efficacy|2
139415|NCT00592904|445426|P4|Overall Study|Withdrawal by Subject|2
139416|NCT00592904|445427|P3|Overall Study|Withdrawal by Subject|1
139417|NCT00592904|445428|P2|Overall Study|Withdrawal by Subject|16
139418|NCT00592904|445429|P1|Overall Study|Withdrawal by Subject|4
139419|NCT00592904|445426|P4|Overall Study|Protocol Violation|1
139420|NCT00592904|445427|P3|Overall Study|Protocol Violation|0
139421|NCT00592904|445428|P2|Overall Study|Protocol Violation|1
139422|NCT00592904|445429|P1|Overall Study|Protocol Violation|1
139423|NCT00592904|445426|P4|Overall Study|Adverse Event|5
139424|NCT00592904|445427|P3|Overall Study|Adverse Event|13
139425|NCT00592904|445428|P2|Overall Study|Adverse Event|25
139426|NCT00592904|445429|P1|Overall Study|Adverse Event|15
139427|NCT00593112|445470|P2|Overall Study|Withdrawal by Subject|0
139428|NCT00593112|445471|P1|Overall Study|Withdrawal by Subject|5
139429|NCT00593112|445470|P2|Overall Study|Unreadable Scan|0
139430|NCT00593112|445471|P1|Overall Study|Unreadable Scan|1
139431|NCT00593112|445470|P2|Overall Study|Abnormal Scan|0
139432|NCT00593112|445471|P1|Overall Study|Abnormal Scan|1
139433|NCT00593112|445470|P2|Overall Study|Scan Anxiety|0
139434|NCT00593112|445471|P1|Overall Study|Scan Anxiety|3
139435|NCT00599755|445481|P1|Overall Study|No data available|1
139436|NCT00599755|445481|P1|Overall Study|Other Reason|2
139437|NCT00599755|445481|P1|Overall Study|Progression of Disease|3
139438|NCT00599755|445481|P1|Overall Study|Withdrawal by Subject|2
139439|NCT00599755|445481|P1|Overall Study|Adverse Event|11
139440|NCT00599924|445516|P7|Overall Study|Other|2
139441|NCT00599924|445517|P6|Overall Study|Other|0
139442|NCT00599924|445518|P5|Overall Study|Other|2
139443|NCT00599924|445519|P4|Overall Study|Other|1
139444|NCT00599924|445520|P3|Overall Study|Other|0
139445|NCT00599924|445521|P2|Overall Study|Other|0
139446|NCT00599924|445522|P1|Overall Study|Other|0
139447|NCT00599924|445516|P7|Overall Study|Withdrawal by Subject|0
139448|NCT00599924|445517|P6|Overall Study|Withdrawal by Subject|0
139449|NCT00599924|445518|P5|Overall Study|Withdrawal by Subject|1
139450|NCT00599924|445519|P4|Overall Study|Withdrawal by Subject|0
139451|NCT00599924|445520|P3|Overall Study|Withdrawal by Subject|1
139452|NCT00599924|445521|P2|Overall Study|Withdrawal by Subject|0
139453|NCT00599924|445522|P1|Overall Study|Withdrawal by Subject|0
139454|NCT00599924|445516|P7|Overall Study|Protocol Violation|0
139455|NCT00599924|445517|P6|Overall Study|Protocol Violation|0
139456|NCT00599924|445518|P5|Overall Study|Protocol Violation|0
139457|NCT00599924|445519|P4|Overall Study|Protocol Violation|1
139458|NCT00599924|445520|P3|Overall Study|Protocol Violation|0
139459|NCT00599924|445521|P2|Overall Study|Protocol Violation|0
139460|NCT00599924|445522|P1|Overall Study|Protocol Violation|0
139461|NCT00599924|445516|P7|Overall Study|Death|1
139462|NCT00599924|445517|P6|Overall Study|Death|2
139463|NCT00599924|445518|P5|Overall Study|Death|0
139464|NCT00599924|445519|P4|Overall Study|Death|2
139465|NCT00599924|445520|P3|Overall Study|Death|0
139466|NCT00599924|445521|P2|Overall Study|Death|0
139467|NCT00599924|445522|P1|Overall Study|Death|0
139468|NCT00599924|445516|P7|Overall Study|Adverse Event|2
139469|NCT00599924|445517|P6|Overall Study|Adverse Event|0
139470|NCT00599924|445518|P5|Overall Study|Adverse Event|0
139471|NCT00599924|445519|P4|Overall Study|Adverse Event|2
139472|NCT00599924|445520|P3|Overall Study|Adverse Event|0
139473|NCT00599924|445521|P2|Overall Study|Adverse Event|0
139474|NCT00599924|445522|P1|Overall Study|Adverse Event|0
139475|NCT00599924|445516|P7|Overall Study|Lack of Efficacy|0
139476|NCT00599924|445517|P6|Overall Study|Lack of Efficacy|2
139477|NCT00599924|445518|P5|Overall Study|Lack of Efficacy|3
139478|NCT00599924|445519|P4|Overall Study|Lack of Efficacy|2
139479|NCT00599924|445520|P3|Overall Study|Lack of Efficacy|1
139480|NCT00599924|445521|P2|Overall Study|Lack of Efficacy|5
139481|NCT00599924|445522|P1|Overall Study|Lack of Efficacy|3
139482|NCT00601250|445609|P2|Overall Study|Other incl. lack of efficacy|9
139483|NCT00601250|445610|P1|Overall Study|Other incl. lack of efficacy|2
139484|NCT00601250|445609|P2|Overall Study|Withdrawal by Subject|13
139485|NCT00601250|445610|P1|Overall Study|Withdrawal by Subject|4
139486|NCT00601250|445609|P2|Overall Study|Lost to Follow-up|6
139487|NCT00601250|445610|P1|Overall Study|Lost to Follow-up|2
139488|NCT00601250|445609|P2|Overall Study|Protocol Violation|2
139489|NCT00601250|445610|P1|Overall Study|Protocol Violation|3
139490|NCT00601250|445609|P2|Overall Study|Adverse Event|9
139491|NCT00601250|445610|P1|Overall Study|Adverse Event|3
139492|NCT00601354|445646|P2|Overall Study|Lost to Follow-up|5
139493|NCT00601354|445647|P1|Overall Study|Lost to Follow-up|4
139494|NCT00601419|445661|P1|Overall Study|Missed Visits|1
139495|NCT00601419|445661|P1|Overall Study|Lost to Follow-up|3
139496|NCT00601458|445688|P3|Overall Study|Early Termination|1
139497|NCT00601458|445689|P2|Overall Study|Early Termination|1
139498|NCT00601458|445690|P1|Overall Study|Early Termination|0
139499|NCT00601458|445688|P3|Overall Study|Protocol Violation|1
139500|NCT00601458|445689|P2|Overall Study|Protocol Violation|2
139501|NCT00601458|445690|P1|Overall Study|Protocol Violation|3
139502|NCT00601458|445688|P3|Overall Study|Incomplete Data|0
139503|NCT00601458|445689|P2|Overall Study|Incomplete Data|2
139504|NCT00601458|445690|P1|Overall Study|Incomplete Data|0
139505|NCT00601458|445688|P3|Overall Study|Dosing Error|0
139506|NCT00601458|445689|P2|Overall Study|Dosing Error|0
139507|NCT00601458|445690|P1|Overall Study|Dosing Error|1
139508|NCT00601523|445703|P2|Overall Study|not specified|1
139509|NCT00601523|445704|P1|Overall Study|not specified|9
139510|NCT00601523|445703|P2|Overall Study|Withdrawal by Subject|9
139511|NCT00601523|445704|P1|Overall Study|Withdrawal by Subject|18
139512|NCT00601523|445703|P2|Overall Study|Lost to Follow-up|1
139513|NCT00601523|445704|P1|Overall Study|Lost to Follow-up|0
139514|NCT00601523|445703|P2|Overall Study|Protocol Violation|1
139515|NCT00601523|445704|P1|Overall Study|Protocol Violation|5
139516|NCT00601523|445703|P2|Overall Study|Lack of Efficacy|0
139517|NCT00601523|445704|P1|Overall Study|Lack of Efficacy|3
139518|NCT00601523|445703|P2|Overall Study|Adverse Event|14
139519|NCT00601523|445704|P1|Overall Study|Adverse Event|42
139520|NCT00601640|445748|P3|Overall Study|change in eligibility status|1
139521|NCT00601640|445749|P2|Overall Study|change in eligibility status|1
139522|NCT00601640|445750|P1|Overall Study|change in eligibility status|0
139523|NCT00601640|445748|P3|Overall Study|intercurrent illness|0
139524|NCT00601640|445749|P2|Overall Study|intercurrent illness|0
139525|NCT00601640|445750|P1|Overall Study|intercurrent illness|1
139526|NCT00601640|445748|P3|Overall Study|Adverse Event|2
139527|NCT00601640|445749|P2|Overall Study|Adverse Event|4
139528|NCT00601640|445750|P1|Overall Study|Adverse Event|0
139529|NCT00601640|445748|P3|Overall Study|Death|0
139530|NCT00601640|445749|P2|Overall Study|Death|0
139531|NCT00601640|445750|P1|Overall Study|Death|1
139532|NCT00601640|445748|P3|Overall Study|Withdrawal by Subject|7
139533|NCT00601640|445749|P2|Overall Study|Withdrawal by Subject|0
139534|NCT00601640|445750|P1|Overall Study|Withdrawal by Subject|3
139535|NCT00601835|445845|P2|Overall Study|Relocate|2
139536|NCT00601835|445846|P1|Overall Study|Relocate|12
139537|NCT00601835|445845|P2|Overall Study|Adverse Event|1
139538|NCT00601835|445846|P1|Overall Study|Adverse Event|1
139539|NCT00601835|445845|P2|Overall Study|Lost to Follow-up|5
139540|NCT00601835|445846|P1|Overall Study|Lost to Follow-up|37
139541|NCT00601835|445845|P2|Overall Study|Physician Decision|0
139542|NCT00601835|445846|P1|Overall Study|Physician Decision|1
139543|NCT00601835|445845|P2|Overall Study|Withdrawal by Subject|6
139544|NCT00601835|445846|P1|Overall Study|Withdrawal by Subject|9
139545|NCT00601900|445858|P2|Overall Study|Withdrawal by Subject|3
139546|NCT00601900|445859|P1|Overall Study|Withdrawal by Subject|0
139547|NCT00602420|445954|P2|Overall Study|Adverse Event|0
139548|NCT00602420|445955|P1|Overall Study|Adverse Event|1
139549|NCT00602420|445954|P2|Overall Study|Withdrawal by Subject|17
139550|NCT00602420|445955|P1|Overall Study|Withdrawal by Subject|18
139551|NCT00602420|445954|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
139552|NCT00602420|445955|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
139553|NCT00602420|445954|P2|Overall Study|Death|4
139554|NCT00602420|445955|P1|Overall Study|Death|1
139555|NCT00602472|445991|P2|Overall Study|Other incl. lack of efficacy|2
139556|NCT00602472|445992|P1|Overall Study|Other incl. lack of efficacy|4
139557|NCT00602472|445991|P2|Overall Study|Withdrawal by Subject|14
139558|NCT00602472|445992|P1|Overall Study|Withdrawal by Subject|8
139559|NCT00602472|445991|P2|Overall Study|Protocol Violation|19
139560|NCT00602472|445992|P1|Overall Study|Protocol Violation|4
139561|NCT00602472|445991|P2|Overall Study|Adverse Event|23
139562|NCT00602472|445992|P1|Overall Study|Adverse Event|5
139563|NCT00602537|446024|P2|Follow Up Study Comparison|Withdrawal by Subject|2
139564|NCT00602537|446025|P1|Follow Up Study Comparison|Withdrawal by Subject|2
139565|NCT00602537|446024|P2|Follow Up Study Comparison|Lost to Follow-up|1
139566|NCT00602537|446025|P1|Follow Up Study Comparison|Lost to Follow-up|8
139567|NCT00602537|446024|P2|Follow Up Study Comparison|Adverse Event|0
139568|NCT00602537|446025|P1|Follow Up Study Comparison|Adverse Event|1
139569|NCT00602537|446024|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
139570|NCT00602537|446025|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
139571|NCT00602537|446024|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
139572|NCT00602537|446025|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
139573|NCT00602537|446024|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
139574|NCT00602537|446025|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
139575|NCT00602537|446024|P2|12 Week Double Blind Comparison|Adverse Event|5
139576|NCT00602537|446025|P1|12 Week Double Blind Comparison|Adverse Event|2
139577|NCT00602641|446035|P2|Overall Study|Other|1
139578|NCT00602641|446036|P1|Overall Study|Other|3
139579|NCT00602641|446035|P2|Overall Study|Administrative Closure|1
139580|NCT00602641|446036|P1|Overall Study|Administrative Closure|1
139581|NCT00602641|446035|P2|Overall Study|Physician Decision|4
139582|NCT00602641|446036|P1|Overall Study|Physician Decision|5
139583|NCT00602641|446035|P2|Overall Study|Other Complicating Disease|2
139584|NCT00602641|446036|P1|Overall Study|Other Complicating Disease|5
139585|NCT00602641|446035|P2|Overall Study|Alternative therapy|2
139586|NCT00602641|446036|P1|Overall Study|Alternative therapy|5
139587|NCT00602641|446035|P2|Overall Study|Withdrawal by Subject|12
139588|NCT00602641|446036|P1|Overall Study|Withdrawal by Subject|15
139589|NCT00602641|446035|P2|Overall Study|Death|5
139590|NCT00602641|446036|P1|Overall Study|Death|6
139591|NCT00602641|446035|P2|Overall Study|Disease progression|55
139592|NCT00602641|446036|P1|Overall Study|Disease progression|38
139593|NCT00602641|446035|P2|Overall Study|Adverse Event|53
139594|NCT00602641|446036|P1|Overall Study|Adverse Event|62
139595|NCT00602641|446035|P2|Overall Study|Still on treatment at time of analysis|15
139596|NCT00602641|446036|P1|Overall Study|Still on treatment at time of analysis|8
139597|NCT00602641|446035|P2|Overall Study|Never started protocol therapy|2
139598|NCT00602641|446036|P1|Overall Study|Never started protocol therapy|6
139599|NCT00602927|446063|P2|Period 3: 13 Days|MRI data quality|2
139600|NCT00602927|446064|P1|Period 3: 13 Days|MRI data quality|2
139601|NCT00602927|446063|P2|Period 3: 13 Days|Protocol Violation|1
139602|NCT00602927|446064|P1|Period 3: 13 Days|Protocol Violation|0
139603|NCT00602927|446063|P2|Period 2: 14 Days|Protocol Violation|2
139604|NCT00602927|446064|P1|Period 2: 14 Days|Protocol Violation|0
139605|NCT00602927|446063|P2|Period 1: 13 Days|Claustrophobia|1
139606|NCT00602927|446064|P1|Period 1: 13 Days|Claustrophobia|0
139607|NCT00602927|446063|P2|Period 1: 13 Days|Time|0
139608|NCT00602927|446064|P1|Period 1: 13 Days|Time|1
139609|NCT00602927|446063|P2|Period 1: 13 Days|MRI scanner technical issue|0
139610|NCT00602927|446064|P1|Period 1: 13 Days|MRI scanner technical issue|1
139611|NCT00602927|446063|P2|Period 1: 13 Days|Protocol Violation|4
139612|NCT00602927|446064|P1|Period 1: 13 Days|Protocol Violation|2
139613|NCT00602979|446077|P5|Overall Study|Failed Intubation|0
139614|NCT00602979|446078|P4|Overall Study|Failed Intubation|1
139615|NCT00602979|446079|P3|Overall Study|Failed Intubation|0
139616|NCT00602979|446080|P2|Overall Study|Failed Intubation|1
139617|NCT00602979|446081|P1|Overall Study|Failed Intubation|0
139618|NCT00602979|446077|P5|Overall Study|Lost to Follow-up|3
139619|NCT00602979|446078|P4|Overall Study|Lost to Follow-up|2
139620|NCT00602979|446079|P3|Overall Study|Lost to Follow-up|3
139621|NCT00602979|446080|P2|Overall Study|Lost to Follow-up|2
139622|NCT00602979|446081|P1|Overall Study|Lost to Follow-up|3
139623|NCT00603239|446125|P2|Overall Study|Subject decision|1
139624|NCT00603239|446126|P1|Overall Study|Subject decision|2
139625|NCT00603239|446125|P2|Overall Study|Protocol Violation|0
139626|NCT00603239|446126|P1|Overall Study|Protocol Violation|2
139627|NCT00603239|446125|P2|Overall Study|Physician Decision|0
139628|NCT00603239|446126|P1|Overall Study|Physician Decision|2
139629|NCT00603239|446125|P2|Overall Study|Lost to Follow-up|1
139630|NCT00603239|446126|P1|Overall Study|Lost to Follow-up|2
139631|NCT00603239|446125|P2|Overall Study|Loss of glucose control|0
139632|NCT00603239|446126|P1|Overall Study|Loss of glucose control|3
139633|NCT00603239|446125|P2|Overall Study|Entry criteria not met|1
139634|NCT00603239|446126|P1|Overall Study|Entry criteria not met|0
139635|NCT00603239|446125|P2|Overall Study|Adverse Event|1
139636|NCT00603239|446126|P1|Overall Study|Adverse Event|4
139637|NCT00603265|446155|P3|Overall Study|Protocol Violation|0
139638|NCT00603265|446156|P2|Overall Study|Protocol Violation|0
139639|NCT00603265|446157|P1|Overall Study|Protocol Violation|1
139640|NCT00603265|446155|P3|Overall Study|Participant Left Country, No Responses|0
139641|NCT00603265|446156|P2|Overall Study|Participant Left Country, No Responses|1
139642|NCT00603265|446157|P1|Overall Study|Participant Left Country, No Responses|0
139643|NCT00603265|446155|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
139644|NCT00603265|446156|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
139645|NCT00603265|446157|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
139646|NCT00603265|446155|P3|Overall Study|Lost to Follow-up|0
139647|NCT00603265|446156|P2|Overall Study|Lost to Follow-up|1
139648|NCT00603265|446157|P1|Overall Study|Lost to Follow-up|0
139649|NCT00603265|446155|P3|Overall Study|Lack of Efficacy|3
139650|NCT00603265|446156|P2|Overall Study|Lack of Efficacy|0
139651|NCT00603265|446157|P1|Overall Study|Lack of Efficacy|3
139652|NCT00603265|446155|P3|Overall Study|Withdrawal by Subject|1
139653|NCT00603265|446156|P2|Overall Study|Withdrawal by Subject|2
139654|NCT00603265|446157|P1|Overall Study|Withdrawal by Subject|1
139655|NCT00603265|446155|P3|Overall Study|Adverse Event|1
139656|NCT00603265|446156|P2|Overall Study|Adverse Event|11
139657|NCT00603265|446157|P1|Overall Study|Adverse Event|2
139658|NCT00603278|446189|P6|Overall Study|Lost to Follow-up|0
139659|NCT00603278|446190|P5|Overall Study|Lost to Follow-up|1
139660|NCT00603278|446191|P4|Overall Study|Lost to Follow-up|0
139661|NCT00603278|446192|P3|Overall Study|Lost to Follow-up|0
139662|NCT00603278|446193|P2|Overall Study|Lost to Follow-up|0
139663|NCT00603278|446194|P1|Overall Study|Lost to Follow-up|1
139664|NCT00603278|446189|P6|Overall Study|Physician Decision|1
139665|NCT00603278|446190|P5|Overall Study|Physician Decision|2
139666|NCT00603278|446191|P4|Overall Study|Physician Decision|0
139667|NCT00603278|446192|P3|Overall Study|Physician Decision|0
139668|NCT00603278|446193|P2|Overall Study|Physician Decision|1
139669|NCT00603278|446194|P1|Overall Study|Physician Decision|0
139670|NCT00603278|446189|P6|Overall Study|Protocol Violation|1
139671|NCT00603278|446190|P5|Overall Study|Protocol Violation|0
139672|NCT00603278|446191|P4|Overall Study|Protocol Violation|1
139673|NCT00603278|446192|P3|Overall Study|Protocol Violation|1
139674|NCT00603278|446193|P2|Overall Study|Protocol Violation|0
139675|NCT00603278|446194|P1|Overall Study|Protocol Violation|3
139676|NCT00603278|446189|P6|Overall Study|Withdrawal by Subject|2
139677|NCT00603278|446190|P5|Overall Study|Withdrawal by Subject|1
139678|NCT00603278|446191|P4|Overall Study|Withdrawal by Subject|2
139679|NCT00603278|446192|P3|Overall Study|Withdrawal by Subject|1
139680|NCT00603278|446193|P2|Overall Study|Withdrawal by Subject|3
139681|NCT00603278|446194|P1|Overall Study|Withdrawal by Subject|2
139682|NCT00603278|446189|P6|Overall Study|Adverse Event|1
139683|NCT00603278|446190|P5|Overall Study|Adverse Event|2
139684|NCT00603278|446191|P4|Overall Study|Adverse Event|0
139685|NCT00603278|446192|P3|Overall Study|Adverse Event|1
139686|NCT00603278|446193|P2|Overall Study|Adverse Event|3
139687|NCT00603278|446194|P1|Overall Study|Adverse Event|0
139688|NCT00603278|446189|P6|Overall Study|Lack of Efficacy|14
139689|NCT00603278|446190|P5|Overall Study|Lack of Efficacy|7
139690|NCT00603278|446191|P4|Overall Study|Lack of Efficacy|8
139691|NCT00603278|446192|P3|Overall Study|Lack of Efficacy|11
139692|NCT00603278|446193|P2|Overall Study|Lack of Efficacy|10
139693|NCT00603278|446194|P1|Overall Study|Lack of Efficacy|35
139694|NCT00603304|446358|P2|Overall Study|Patient Decision|0
139695|NCT00603304|446359|P1|Overall Study|Patient Decision|2
139696|NCT00603304|446358|P2|Overall Study|Not Specified|0
139697|NCT00603304|446359|P1|Overall Study|Not Specified|2
139698|NCT00603304|446358|P2|Overall Study|Moved Away|2
139699|NCT00603304|446359|P1|Overall Study|Moved Away|0
139700|NCT00603304|446358|P2|Overall Study|Non-Compliant|1
139701|NCT00603304|446359|P1|Overall Study|Non-Compliant|0
139702|NCT00603304|446358|P2|Overall Study|Exclusionary Medication|3
139703|NCT00603304|446359|P1|Overall Study|Exclusionary Medication|2
139704|NCT00603304|446358|P2|Overall Study|Crossed Over to Open Label Therapy|3
139705|NCT00603304|446359|P1|Overall Study|Crossed Over to Open Label Therapy|3
139706|NCT00603304|446358|P2|Overall Study|Unacceptable Treatment Toxicity|8
139707|NCT00603304|446359|P1|Overall Study|Unacceptable Treatment Toxicity|5
139708|NCT00603304|446358|P2|Overall Study|Adverse Event|2
139709|NCT00603304|446359|P1|Overall Study|Adverse Event|4
139710|NCT00603304|446358|P2|Overall Study|Protocol Violation|0
139711|NCT00603304|446359|P1|Overall Study|Protocol Violation|1
139712|NCT00603304|446358|P2|Overall Study|Withdrawal by Subject|5
139713|NCT00603304|446359|P1|Overall Study|Withdrawal by Subject|8
139714|NCT00603304|446358|P2|Overall Study|Lost to Follow-up|7
139715|NCT00603304|446359|P1|Overall Study|Lost to Follow-up|5
139716|NCT00603382|446399|P6|Overall Study|Withdrawal by Subject|1
139717|NCT00603382|446400|P5|Overall Study|Withdrawal by Subject|0
139718|NCT00603382|446401|P4|Overall Study|Withdrawal by Subject|1
139719|NCT00603382|446402|P3|Overall Study|Withdrawal by Subject|1
139720|NCT00603382|446403|P2|Overall Study|Withdrawal by Subject|3
139721|NCT00603382|446404|P1|Overall Study|Withdrawal by Subject|3
139722|NCT00603382|446399|P6|Overall Study|Physician Decision|3
139723|NCT00603382|446400|P5|Overall Study|Physician Decision|1
139724|NCT00603382|446401|P4|Overall Study|Physician Decision|0
139725|NCT00603382|446402|P3|Overall Study|Physician Decision|2
139726|NCT00603382|446403|P2|Overall Study|Physician Decision|0
139727|NCT00603382|446404|P1|Overall Study|Physician Decision|0
139728|NCT00603382|446399|P6|Overall Study|Lost to Follow-up|1
139729|NCT00603382|446400|P5|Overall Study|Lost to Follow-up|0
139730|NCT00603382|446401|P4|Overall Study|Lost to Follow-up|1
139731|NCT00603382|446402|P3|Overall Study|Lost to Follow-up|1
139732|NCT00603382|446403|P2|Overall Study|Lost to Follow-up|1
139733|NCT00603382|446404|P1|Overall Study|Lost to Follow-up|0
139734|NCT00603382|446399|P6|Overall Study|Protocol Violation|0
139735|NCT00603382|446400|P5|Overall Study|Protocol Violation|1
139736|NCT00603382|446401|P4|Overall Study|Protocol Violation|2
139737|NCT00603382|446402|P3|Overall Study|Protocol Violation|1
139738|NCT00603382|446403|P2|Overall Study|Protocol Violation|0
139739|NCT00603382|446404|P1|Overall Study|Protocol Violation|1
139740|NCT00603382|446399|P6|Overall Study|Lack of Efficacy|11
139741|NCT00603382|446400|P5|Overall Study|Lack of Efficacy|6
139742|NCT00603382|446401|P4|Overall Study|Lack of Efficacy|6
139743|NCT00603382|446402|P3|Overall Study|Lack of Efficacy|3
139744|NCT00603382|446403|P2|Overall Study|Lack of Efficacy|9
139745|NCT00603382|446404|P1|Overall Study|Lack of Efficacy|14
139746|NCT00603382|446399|P6|Overall Study|Adverse Event|2
139747|NCT00603382|446400|P5|Overall Study|Adverse Event|1
139748|NCT00603382|446401|P4|Overall Study|Adverse Event|2
139749|NCT00603382|446402|P3|Overall Study|Adverse Event|1
139750|NCT00603382|446403|P2|Overall Study|Adverse Event|1
139751|NCT00603382|446404|P1|Overall Study|Adverse Event|0
139752|NCT00603447|446568|P7|Overall Study|Withdrew Consent|1
139753|NCT00603447|446569|P6|Overall Study|Withdrew Consent|0
139754|NCT00603447|446570|P5|Overall Study|Withdrew Consent|1
139755|NCT00603447|446571|P4|Overall Study|Withdrew Consent|0
139756|NCT00603447|446572|P3|Overall Study|Withdrew Consent|0
139757|NCT00603447|446573|P2|Overall Study|Withdrew Consent|2
139758|NCT00603447|446574|P1|Overall Study|Withdrew Consent|0
139759|NCT00603447|446568|P7|Overall Study|Other|13
139760|NCT00603447|446569|P6|Overall Study|Other|0
139761|NCT00603447|446570|P5|Overall Study|Other|3
139762|NCT00603447|446571|P4|Overall Study|Other|0
139763|NCT00603447|446572|P3|Overall Study|Other|1
139764|NCT00603447|446573|P2|Overall Study|Other|0
139765|NCT00603447|446574|P1|Overall Study|Other|0
139766|NCT00603447|446568|P7|Overall Study|Adverse Event|10
139767|NCT00603447|446569|P6|Overall Study|Adverse Event|2
139768|NCT00603447|446570|P5|Overall Study|Adverse Event|1
139769|NCT00603447|446571|P4|Overall Study|Adverse Event|2
139770|NCT00603447|446572|P3|Overall Study|Adverse Event|1
139771|NCT00603447|446573|P2|Overall Study|Adverse Event|1
139772|NCT00603447|446574|P1|Overall Study|Adverse Event|0
139773|NCT00603473|446596|P1|Overall Study|Protocol Violation|1
139774|NCT00603473|446596|P1|Overall Study|Lack of Efficacy|4
139775|NCT00603473|446596|P1|Overall Study|Adverse Event|4
139776|NCT00603512|446607|P5|Overall Study|Randomized but not treated|0
139777|NCT00603512|446608|P4|Overall Study|Randomized but not treated|2
139778|NCT00603512|446609|P3|Overall Study|Randomized but not treated|1
139779|NCT00603512|446610|P2|Overall Study|Randomized but not treated|1
139780|NCT00603512|446611|P1|Overall Study|Randomized but not treated|0
139781|NCT00603512|446607|P5|Overall Study|Withdrawal by Subject|1
139782|NCT00603512|446608|P4|Overall Study|Withdrawal by Subject|0
139783|NCT00603512|446609|P3|Overall Study|Withdrawal by Subject|0
139784|NCT00603512|446610|P2|Overall Study|Withdrawal by Subject|0
139785|NCT00603512|446611|P1|Overall Study|Withdrawal by Subject|0
139786|NCT00603512|446607|P5|Overall Study|Unspecified|1
139787|NCT00603512|446608|P4|Overall Study|Unspecified|1
139788|NCT00603512|446609|P3|Overall Study|Unspecified|0
139789|NCT00603512|446610|P2|Overall Study|Unspecified|1
139790|NCT00603512|446611|P1|Overall Study|Unspecified|2
139791|NCT00603512|446607|P5|Overall Study|Lack of Efficacy|1
139792|NCT00603512|446608|P4|Overall Study|Lack of Efficacy|0
139793|NCT00603512|446609|P3|Overall Study|Lack of Efficacy|0
139794|NCT00603512|446610|P2|Overall Study|Lack of Efficacy|1
139795|NCT00603512|446611|P1|Overall Study|Lack of Efficacy|0
139796|NCT00603512|446607|P5|Overall Study|Adverse Event|2
139797|NCT00603512|446608|P4|Overall Study|Adverse Event|4
139798|NCT00603512|446609|P3|Overall Study|Adverse Event|4
139799|NCT00603512|446610|P2|Overall Study|Adverse Event|2
139800|NCT00603512|446611|P1|Overall Study|Adverse Event|0
139801|NCT00603525|446755|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
139802|NCT00603525|446756|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
139803|NCT00603525|446757|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
139804|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
139805|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
139806|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
139807|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
139808|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
139809|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
139810|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
139811|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
139812|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
139813|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
139814|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
139815|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
139816|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
139817|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
139818|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
139819|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
139820|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
139821|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
139822|NCT00603525|446755|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
139823|NCT00603525|446756|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
139824|NCT00603525|446757|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
139825|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
139826|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
139827|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
139828|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
139829|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
139830|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
139831|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
139832|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
139833|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
139834|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
139835|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
139836|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
139837|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
139838|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
139839|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
139840|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
139841|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
139842|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
139843|NCT00603525|446755|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
139844|NCT00603525|446756|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
139845|NCT00603525|446757|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
139846|NCT00603538|446887|P3|Overall Study|Objective progression or relapse|0
139847|NCT00603538|446888|P2|Overall Study|Objective progression or relapse|0
139848|NCT00603538|446889|P1|Overall Study|Objective progression or relapse|3
139849|NCT00603538|446887|P3|Overall Study|Adverse Event|2
139850|NCT00603538|446888|P2|Overall Study|Adverse Event|4
139851|NCT00603538|446889|P1|Overall Study|Adverse Event|0
139852|NCT00603590|446940|P2|Overall Study|Cardiovascular event|1
139853|NCT00603590|446941|P1|Overall Study|Cardiovascular event|0
139854|NCT00603590|446940|P2|Overall Study|Lost to Follow-up|4
139855|NCT00603590|446941|P1|Overall Study|Lost to Follow-up|8
139856|NCT00603590|446940|P2|Overall Study|Adverse Event|0
139857|NCT00603590|446941|P1|Overall Study|Adverse Event|2
139858|NCT00603590|446940|P2|Overall Study|Patient discontinued study drug|15
139859|NCT00603590|446941|P1|Overall Study|Patient discontinued study drug|22
139860|NCT00603590|446940|P2|Overall Study|Refused blood test|1
139861|NCT00603590|446941|P1|Overall Study|Refused blood test|5
139862|NCT00603590|446940|P2|Overall Study|Did not attend study clinic|30
139863|NCT00603590|446941|P1|Overall Study|Did not attend study clinic|39
139864|NCT00603733|446970|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
139865|NCT00603733|446971|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
139866|NCT00603733|446970|P2|Maintenance Phase ITT|Physician Decision|1
139867|NCT00603733|446971|P1|Maintenance Phase ITT|Physician Decision|0
139868|NCT00603733|446970|P2|Maintenance Phase ITT|Lack of Efficacy|2
139869|NCT00603733|446971|P1|Maintenance Phase ITT|Lack of Efficacy|2
139870|NCT00603733|446970|P2|Maintenance Phase ITT|Lost to Follow-up|1
139871|NCT00603733|446971|P1|Maintenance Phase ITT|Lost to Follow-up|0
139872|NCT00603733|446970|P2|Maintenance Phase ITT|Protocol Violation|1
139873|NCT00603733|446971|P1|Maintenance Phase ITT|Protocol Violation|1
139874|NCT00603733|446970|P2|Maintenance Phase ITT|Withdrawal by Subject|0
139875|NCT00603733|446971|P1|Maintenance Phase ITT|Withdrawal by Subject|1
139876|NCT00603733|446970|P2|Maintenance Phase ITT|Adverse Event|6
139877|NCT00603733|446971|P1|Maintenance Phase ITT|Adverse Event|3
139878|NCT00603733|446970|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
139879|NCT00603733|446971|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
139880|NCT00603733|446970|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
139881|NCT00603733|446971|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
139882|NCT00603733|446970|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
139883|NCT00603733|446971|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
139884|NCT00603733|446970|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
139885|NCT00603733|446971|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
139886|NCT00603733|446970|P2|Run-In Phase - 4 Weeks|Adverse Event|1
139887|NCT00603733|446971|P1|Run-In Phase - 4 Weeks|Adverse Event|2
139888|NCT00603733|446970|P2|Active Phase ITT|Subject moved, site closed|1
139889|NCT00603733|446971|P1|Active Phase ITT|Subject moved, site closed|1
139890|NCT00603733|446970|P2|Active Phase ITT|Lack of Efficacy|2
139891|NCT00603733|446971|P1|Active Phase ITT|Lack of Efficacy|1
139892|NCT00603733|446970|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
139893|NCT00603733|446971|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
139894|NCT00603733|446970|P2|Active Phase ITT|Lost to Follow-up|1
139895|NCT00603733|446971|P1|Active Phase ITT|Lost to Follow-up|0
139896|NCT00603733|446970|P2|Active Phase ITT|Withdrawal by Subject|3
139897|NCT00603733|446971|P1|Active Phase ITT|Withdrawal by Subject|0
139898|NCT00603733|446970|P2|Active Phase ITT|Adverse Event|7
139899|NCT00603733|446971|P1|Active Phase ITT|Adverse Event|8
139900|NCT00603746|446987|P6|Overall Study|Withdrawal by Subject|1
139901|NCT00603746|446988|P5|Overall Study|Withdrawal by Subject|3
139902|NCT00603746|446989|P4|Overall Study|Withdrawal by Subject|1
139903|NCT00603746|446990|P3|Overall Study|Withdrawal by Subject|0
139904|NCT00603746|446991|P2|Overall Study|Withdrawal by Subject|0
139905|NCT00603746|446992|P1|Overall Study|Withdrawal by Subject|1
139906|NCT00603746|446987|P6|Overall Study|Physician Decision|0
139907|NCT00603746|446988|P5|Overall Study|Physician Decision|1
139908|NCT00603746|446989|P4|Overall Study|Physician Decision|0
139909|NCT00603746|446990|P3|Overall Study|Physician Decision|0
139910|NCT00603746|446991|P2|Overall Study|Physician Decision|0
139911|NCT00603746|446992|P1|Overall Study|Physician Decision|1
139912|NCT00603746|446987|P6|Overall Study|Lost to Follow-up|0
139913|NCT00603746|446988|P5|Overall Study|Lost to Follow-up|0
139914|NCT00603746|446989|P4|Overall Study|Lost to Follow-up|0
139915|NCT00603746|446990|P3|Overall Study|Lost to Follow-up|1
139916|NCT00603746|446991|P2|Overall Study|Lost to Follow-up|1
139917|NCT00603746|446992|P1|Overall Study|Lost to Follow-up|0
139918|NCT00603746|446987|P6|Overall Study|Protocol Violation|0
139919|NCT00603746|446988|P5|Overall Study|Protocol Violation|1
139920|NCT00603746|446989|P4|Overall Study|Protocol Violation|0
139921|NCT00603746|446990|P3|Overall Study|Protocol Violation|1
139922|NCT00603746|446991|P2|Overall Study|Protocol Violation|3
139923|NCT00603746|446992|P1|Overall Study|Protocol Violation|0
139924|NCT00603746|446987|P6|Overall Study|Lack of Efficacy|8
139925|NCT00603746|446988|P5|Overall Study|Lack of Efficacy|12
139926|NCT00603746|446989|P4|Overall Study|Lack of Efficacy|11
139927|NCT00603746|446990|P3|Overall Study|Lack of Efficacy|6
139928|NCT00603746|446991|P2|Overall Study|Lack of Efficacy|11
139929|NCT00603746|446992|P1|Overall Study|Lack of Efficacy|34
139930|NCT00603746|446987|P6|Overall Study|Adverse Event|4
139931|NCT00603746|446988|P5|Overall Study|Adverse Event|0
139932|NCT00603746|446989|P4|Overall Study|Adverse Event|1
139933|NCT00603746|446990|P3|Overall Study|Adverse Event|0
139934|NCT00603746|446991|P2|Overall Study|Adverse Event|3
139935|NCT00603746|446992|P1|Overall Study|Adverse Event|2
139936|NCT00589914|447160|P2|Overall Study|Other|17
139937|NCT00589914|447161|P1|Overall Study|Other|22
139938|NCT00589914|447160|P2|Overall Study|Withdrawal by Subject|49
139939|NCT00589914|447161|P1|Overall Study|Withdrawal by Subject|55
139940|NCT00589914|447160|P2|Overall Study|Pregnancy|0
139941|NCT00589914|447161|P1|Overall Study|Pregnancy|1
139942|NCT00589914|447160|P2|Overall Study|Lost to Follow-up|18
139943|NCT00589914|447161|P1|Overall Study|Lost to Follow-up|11
139944|NCT00589914|447160|P2|Overall Study|Lack of Efficacy|43
139945|NCT00589914|447161|P1|Overall Study|Lack of Efficacy|40
139946|NCT00589914|447160|P2|Overall Study|Death|0
139947|NCT00589914|447161|P1|Overall Study|Death|2
139948|NCT00589914|447160|P2|Overall Study|Adverse Event|10
139949|NCT00589914|447161|P1|Overall Study|Adverse Event|19
139950|NCT00589979|447173|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
139951|NCT00589979|447174|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
139952|NCT00589979|447175|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
139953|NCT00589979|447173|P3|Double-Blind Treatment Period 3|Protocol Violation|0
139954|NCT00589979|447174|P2|Double-Blind Treatment Period 3|Protocol Violation|1
139955|NCT00589979|447175|P1|Double-Blind Treatment Period 3|Protocol Violation|0
139956|NCT00589979|447173|P3|Double-Blind Treatment Period 2|Other|1
139957|NCT00589979|447174|P2|Double-Blind Treatment Period 2|Other|0
139958|NCT00589979|447175|P1|Double-Blind Treatment Period 2|Other|0
139959|NCT00589979|447173|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
139960|NCT00589979|447174|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
139961|NCT00589979|447175|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
139962|NCT00589979|447173|P3|Double-Blind Treatment Period 2|Adverse Event|0
139963|NCT00589979|447174|P2|Double-Blind Treatment Period 2|Adverse Event|1
139964|NCT00589979|447175|P1|Double-Blind Treatment Period 2|Adverse Event|0
139965|NCT00589979|447173|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
139966|NCT00589979|447174|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
139967|NCT00589979|447175|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
139968|NCT00589979|447173|P3|Double-Blind Treatment Period 1|Protocol Violation|1
139969|NCT00589979|447174|P2|Double-Blind Treatment Period 1|Protocol Violation|1
139970|NCT00589979|447175|P1|Double-Blind Treatment Period 1|Protocol Violation|0
139971|NCT00589979|447173|P3|Double-Blind Treatment Period 1|Adverse Event|0
139972|NCT00589979|447174|P2|Double-Blind Treatment Period 1|Adverse Event|1
139973|NCT00589979|447175|P1|Double-Blind Treatment Period 1|Adverse Event|0
139974|NCT00589979|447173|P3|Run-In Period|Informed Consent Withdrawn|0
139975|NCT00589979|447174|P2|Run-In Period|Informed Consent Withdrawn|0
139976|NCT00589979|447175|P1|Run-In Period|Informed Consent Withdrawn|4
139977|NCT00589979|447173|P3|Run-In Period|Withdrawal by Subject|0
139978|NCT00589979|447174|P2|Run-In Period|Withdrawal by Subject|0
139979|NCT00589979|447175|P1|Run-In Period|Withdrawal by Subject|10
139980|NCT00589979|447173|P3|Run-In Period|Did not qualify for randomization|0
139981|NCT00589979|447174|P2|Run-In Period|Did not qualify for randomization|0
139982|NCT00589979|447175|P1|Run-In Period|Did not qualify for randomization|54
139983|NCT00589979|447173|P3|Run-In Period|Protocol Violation|0
139984|NCT00589979|447174|P2|Run-In Period|Protocol Violation|0
139985|NCT00589979|447175|P1|Run-In Period|Protocol Violation|3
139986|NCT00589979|447173|P3|Run-In Period|Adverse Event|0
139987|NCT00589979|447174|P2|Run-In Period|Adverse Event|0
139988|NCT00589979|447175|P1|Run-In Period|Adverse Event|5
139989|NCT00590031|447232|P1|Overall Study|Admin Hold|1
139990|NCT00590031|447232|P1|Overall Study|Metastatic Disease|1
139991|NCT00590031|447232|P1|Overall Study|Withdrawal by Subject|1
139992|NCT00590031|447232|P1|Overall Study|Adverse Event|3
139993|NCT00590044|447239|P2|Overall Study|Protocol Violation|0
139994|NCT00590044|447240|P1|Overall Study|Protocol Violation|1
139995|NCT00590044|447239|P2|Overall Study|wrong insulin arm assigned|0
139996|NCT00590044|447240|P1|Overall Study|wrong insulin arm assigned|1
139997|NCT00590044|447239|P2|Overall Study|Withdrawal by Subject|2
139998|NCT00590044|447240|P1|Overall Study|Withdrawal by Subject|2
139999|NCT00590135|447246|P1|Overall Study|Primary endpoint measure not obtainable|59
140000|NCT00590317|447276|P2|Overall Study|Lack of Efficacy|5
140001|NCT00590317|447277|P1|Overall Study|Lack of Efficacy|1
140002|NCT00590538|447318|P1|Overall Study|Study terminated before completed|2
140003|NCT00590564|447326|P1|Overall Study|Patient Non-compliance|6
140004|NCT00590564|447326|P1|Overall Study|Patient Found to be Ineligible|1
140005|NCT00590564|447326|P1|Overall Study|Protocol Violation|1
140006|NCT00590564|447326|P1|Overall Study|Lost to Follow-up|6
140007|NCT00590564|447326|P1|Overall Study|Withdrawal by Subject|4
140008|NCT00590577|447334|P4|Overall Study|Various reasons|2
140009|NCT00590577|447335|P3|Overall Study|Various reasons|1
140010|NCT00590577|447336|P2|Overall Study|Various reasons|3
140011|NCT00590577|447337|P1|Overall Study|Various reasons|1
140012|NCT00590577|447334|P4|Overall Study|Pregnancy|0
140013|NCT00590577|447335|P3|Overall Study|Pregnancy|0
140014|NCT00590577|447336|P2|Overall Study|Pregnancy|1
140015|NCT00590577|447337|P1|Overall Study|Pregnancy|0
140016|NCT00590577|447334|P4|Overall Study|Lost to Follow-up|9
140017|NCT00590577|447335|P3|Overall Study|Lost to Follow-up|6
140018|NCT00590577|447336|P2|Overall Study|Lost to Follow-up|6
140019|NCT00590577|447337|P1|Overall Study|Lost to Follow-up|12
140020|NCT00590577|447334|P4|Overall Study|Adverse Event|11
140021|NCT00590577|447335|P3|Overall Study|Adverse Event|13
140022|NCT00590577|447336|P2|Overall Study|Adverse Event|10
140023|NCT00590577|447337|P1|Overall Study|Adverse Event|10
140024|NCT00590577|447334|P4|Overall Study|Withdrawal by Subject|26
140025|NCT00590577|447335|P3|Overall Study|Withdrawal by Subject|30
140026|NCT00590577|447336|P2|Overall Study|Withdrawal by Subject|28
140027|NCT00590577|447337|P1|Overall Study|Withdrawal by Subject|23
140028|NCT00590577|447334|P4|Overall Study|Lack of Efficacy|45
140029|NCT00590577|447335|P3|Overall Study|Lack of Efficacy|23
140030|NCT00590577|447336|P2|Overall Study|Lack of Efficacy|28
140031|NCT00590577|447337|P1|Overall Study|Lack of Efficacy|31
140032|NCT00590590|447358|P3|Overall Study|Did not complete study|0
140033|NCT00590590|447359|P2|Overall Study|Did not complete study|1
140034|NCT00590590|447360|P1|Overall Study|Did not complete study|0
140035|NCT00590590|447358|P3|Overall Study|Did not complete due to study closure|1
140036|NCT00590590|447359|P2|Overall Study|Did not complete due to study closure|1
140037|NCT00590590|447360|P1|Overall Study|Did not complete due to study closure|1
140038|NCT00590590|447358|P3|Overall Study|Withdrawal by Subject|1
140039|NCT00590590|447359|P2|Overall Study|Withdrawal by Subject|1
140040|NCT00590590|447360|P1|Overall Study|Withdrawal by Subject|0
140041|NCT00590590|447358|P3|Overall Study|Lost to Follow-up|2
140042|NCT00590590|447359|P2|Overall Study|Lost to Follow-up|1
140043|NCT00590590|447360|P1|Overall Study|Lost to Follow-up|4
140044|NCT00590590|447358|P3|Overall Study|Protocol Violation|2
140045|NCT00590590|447359|P2|Overall Study|Protocol Violation|0
140046|NCT00590590|447360|P1|Overall Study|Protocol Violation|0
140047|NCT00590590|447358|P3|Overall Study|Adverse Event|0
140048|NCT00590590|447359|P2|Overall Study|Adverse Event|0
140049|NCT00590590|447360|P1|Overall Study|Adverse Event|1
140050|NCT00590590|447358|P3|Overall Study|Lack of Efficacy|0
140051|NCT00590590|447359|P2|Overall Study|Lack of Efficacy|2
140052|NCT00590590|447360|P1|Overall Study|Lack of Efficacy|1
140053|NCT00596362|447401|P1|Overall Study|Progressive Disease|1
140054|NCT00596427|447407|P2|Overall Study|Protocol Violation|0
140055|NCT00596427|447408|P1|Overall Study|Protocol Violation|1
140056|NCT00596427|447407|P2|Overall Study|Increased Fasting Triacylglycerol level|0
140057|NCT00596427|447408|P1|Overall Study|Increased Fasting Triacylglycerol level|1
140058|NCT00596427|447407|P2|Overall Study|Withdrawal by Subject|2
140059|NCT00596427|447408|P1|Overall Study|Withdrawal by Subject|2
140060|NCT00596466|447458|P1|Overall Study|Enrolled, not treated|2
140061|NCT00596466|447458|P1|Overall Study|Unpecified|2
140062|NCT00596466|447458|P1|Overall Study|Protocol Violation|2
140063|NCT00596466|447458|P1|Overall Study|Withdrawal by Subject|2
140064|NCT00596466|447458|P1|Overall Study|Adverse Event|4
140065|NCT00596466|447458|P1|Overall Study|Lack of Efficacy|5
140066|NCT00596635|447479|P3|Overall Study|Could not provide urine specimen|2
140067|NCT00596635|447480|P2|Overall Study|Could not provide urine specimen|2
140068|NCT00596635|447481|P1|Overall Study|Could not provide urine specimen|1
140069|NCT00596635|447479|P3|Overall Study|Hip fracture|3
140070|NCT00596635|447480|P2|Overall Study|Hip fracture|3
140071|NCT00596635|447481|P1|Overall Study|Hip fracture|2
140072|NCT00596635|447479|P3|Overall Study|Treatment for symptomatic UTI|3
140073|NCT00596635|447480|P2|Overall Study|Treatment for symptomatic UTI|6
140074|NCT00596635|447481|P1|Overall Study|Treatment for symptomatic UTI|4
140075|NCT00596635|447479|P3|Overall Study|Lost to Follow-up|0
140076|NCT00596635|447480|P2|Overall Study|Lost to Follow-up|2
140077|NCT00596635|447481|P1|Overall Study|Lost to Follow-up|0
140078|NCT00596687|447497|P2|Overall Study|cancelled surgery|1
140079|NCT00596687|447498|P1|Overall Study|cancelled surgery|1
140080|NCT00596687|447497|P2|Overall Study|Withdrawal by Subject|1
140081|NCT00596687|447498|P1|Overall Study|Withdrawal by Subject|3
140082|NCT00596687|447497|P2|Overall Study|continuous insulin infusion during TPN|1
140083|NCT00596687|447498|P1|Overall Study|continuous insulin infusion during TPN|2
140084|NCT00596687|447497|P2|Overall Study|< 24 hours of insulin treatment|6
140085|NCT00596687|447498|P1|Overall Study|< 24 hours of insulin treatment|8
140086|NCT00596752|447508|P2|Overall Study|Protocol Violation|0
140087|NCT00596752|447509|P1|Overall Study|Protocol Violation|1
140088|NCT00596752|447508|P2|Overall Study|Lack of Efficacy|7
140089|NCT00596752|447509|P1|Overall Study|Lack of Efficacy|4
140090|NCT00596752|447508|P2|Overall Study|Unsatisfactory Compliance|6
140091|NCT00596752|447509|P1|Overall Study|Unsatisfactory Compliance|9
140092|NCT00596752|447508|P2|Overall Study|Withdrawal by Subject|9
140093|NCT00596752|447509|P1|Overall Study|Withdrawal by Subject|12
140094|NCT00596752|447508|P2|Overall Study|Lost to Follow-up|38
140095|NCT00596752|447509|P1|Overall Study|Lost to Follow-up|22
140096|NCT00596752|447508|P2|Overall Study|Adverse Event|34
140097|NCT00596752|447509|P1|Overall Study|Adverse Event|34
140098|NCT00596752|447508|P2|Overall Study|Other Reason|49
140099|NCT00596752|447509|P1|Overall Study|Other Reason|44
140100|NCT00596817|447540|P2|Double-blind Period|Other Reasons|18
140101|NCT00596817|447541|P1|Double-blind Period|Other Reasons|10
140102|NCT00596817|447540|P2|Double-blind Period|Lost to Follow-up|2
140103|NCT00596817|447541|P1|Double-blind Period|Lost to Follow-up|0
140104|NCT00596817|447540|P2|Double-blind Period|Withdrawal of Consent|3
140105|NCT00596817|447541|P1|Double-blind Period|Withdrawal of Consent|7
140106|NCT00596817|447540|P2|Double-blind Period|Protocol Violation|8
140107|NCT00596817|447541|P1|Double-blind Period|Protocol Violation|11
140108|NCT00596817|447540|P2|Double-blind Period|Non-compliance With Study Product|4
140109|NCT00596817|447541|P1|Double-blind Period|Non-compliance With Study Product|3
140110|NCT00596817|447540|P2|Double-blind Period|Lack of Efficacy|28
140111|NCT00596817|447541|P1|Double-blind Period|Lack of Efficacy|52
140112|NCT00596817|447540|P2|Double-blind Period|Adverse Event|16
140113|NCT00596817|447541|P1|Double-blind Period|Adverse Event|5
140114|NCT00596817|447540|P2|Open-label Period to Double-blind Period|Other Reasons|14
140115|NCT00596817|447541|P1|Open-label Period to Double-blind Period|Other Reasons|0
140116|NCT00596817|447540|P2|Open-label Period to Double-blind Period|Not Eligible|49
140117|NCT00596817|447541|P1|Open-label Period to Double-blind Period|Not Eligible|0
140118|NCT00596817|447540|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
140119|NCT00596817|447541|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
140120|NCT00596817|447540|P2|Open-label Period to Double-blind Period|Adverse Event|5
140121|NCT00596817|447541|P1|Open-label Period to Double-blind Period|Adverse Event|0
140122|NCT00596817|447540|P2|Open-label Period|Other Reasons|65
140123|NCT00596817|447541|P1|Open-label Period|Other Reasons|0
140124|NCT00596817|447540|P2|Open-label Period|Lack of Efficacy|33
140125|NCT00596817|447541|P1|Open-label Period|Lack of Efficacy|0
140126|NCT00596817|447540|P2|Open-label Period|Adverse Event|49
140127|NCT00596817|447541|P1|Open-label Period|Adverse Event|0
140128|NCT00596830|447566|P2|Overall Study|Randomized but not treated|7
140129|NCT00596830|447567|P1|Overall Study|Randomized but not treated|3
140130|NCT00596830|447566|P2|Overall Study|Follow-up was discontinued|0
140131|NCT00596830|447567|P1|Overall Study|Follow-up was discontinued|1
140132|NCT00596830|447566|P2|Overall Study|Study terminated by sponsor|62
140133|NCT00596830|447567|P1|Overall Study|Study terminated by sponsor|51
140134|NCT00596830|447566|P2|Overall Study|Withdrawal by Subject|12
140135|NCT00596830|447567|P1|Overall Study|Withdrawal by Subject|22
140136|NCT00596830|447566|P2|Overall Study|Lost to Follow-up|11
140137|NCT00596830|447567|P1|Overall Study|Lost to Follow-up|7
140138|NCT00596830|447566|P2|Overall Study|Death|247
140139|NCT00596830|447567|P1|Overall Study|Death|258
140140|NCT00596934|447590|P1|Overall Study|Withdrawal by Subject|1
140141|NCT00596934|447590|P1|Overall Study|Protocol Violation|1
140142|NCT00596947|447603|P2|Overall Study|Lost to Follow-up|0
140143|NCT00596947|447604|P1|Overall Study|Lost to Follow-up|1
140144|NCT00596947|447603|P2|Overall Study|study halted due to low enrollment|3
140145|NCT00596947|447604|P1|Overall Study|study halted due to low enrollment|5
140146|NCT00596960|447646|P2|Overall Study|No alcohol use data|1
140147|NCT00596960|447647|P1|Overall Study|No alcohol use data|0
140148|NCT00596960|447646|P2|Overall Study|Protocol Violation|1
140149|NCT00596960|447647|P1|Overall Study|Protocol Violation|0
140150|NCT00596960|447646|P2|Overall Study|Physician Decision|0
140151|NCT00596960|447647|P1|Overall Study|Physician Decision|1
140152|NCT00596960|447646|P2|Overall Study|Incarcerated|0
140153|NCT00596960|447647|P1|Overall Study|Incarcerated|2
140154|NCT00596960|447646|P2|Overall Study|Withdrawal by Subject|0
140155|NCT00596960|447647|P1|Overall Study|Withdrawal by Subject|1
140156|NCT00596960|447646|P2|Overall Study|Lost to Follow-up|5
140157|NCT00596960|447647|P1|Overall Study|Lost to Follow-up|6
140158|NCT00596960|447646|P2|Overall Study|Death|2
140159|NCT00596960|447647|P1|Overall Study|Death|1
140160|NCT00597012|447659|P2|Overall Study|Lost to Follow-up|2
140161|NCT00597012|447660|P1|Overall Study|Lost to Follow-up|0
140162|NCT00597012|447659|P2|Overall Study|Ineligible|0
140163|NCT00597012|447660|P1|Overall Study|Ineligible|2
140164|NCT00597012|447659|P2|Overall Study|Withdrawal by Subject|4
140165|NCT00597012|447660|P1|Overall Study|Withdrawal by Subject|7
140166|NCT00597012|447659|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
140167|NCT00597012|447660|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
140168|NCT00597012|447659|P2|Overall Study|Death|1
140169|NCT00597012|447660|P1|Overall Study|Death|1
140170|NCT00603798|447685|P3|Overall Study|Not due to AE|4
140171|NCT00603798|447686|P2|Overall Study|Not due to AE|1
140172|NCT00603798|447687|P1|Overall Study|Not due to AE|1
140173|NCT00603798|447685|P3|Overall Study|Non-compliance with study procedures|0
140174|NCT00603798|447686|P2|Overall Study|Non-compliance with study procedures|1
140175|NCT00603798|447687|P1|Overall Study|Non-compliance with study procedures|0
140176|NCT00603798|447685|P3|Overall Study|Lost to Follow-up|1
140177|NCT00603798|447686|P2|Overall Study|Lost to Follow-up|0
140178|NCT00603798|447687|P1|Overall Study|Lost to Follow-up|1
140179|NCT00603798|447685|P3|Overall Study|Withdrawal by Subject|4
140180|NCT00603798|447686|P2|Overall Study|Withdrawal by Subject|3
140181|NCT00603798|447687|P1|Overall Study|Withdrawal by Subject|4
140182|NCT00603798|447685|P3|Overall Study|Adverse Event|1
140183|NCT00603798|447686|P2|Overall Study|Adverse Event|2
140184|NCT00603798|447687|P1|Overall Study|Adverse Event|4
140185|NCT00603837|447706|P2|Overall Study|Physician Decision|0
140186|NCT00603837|447707|P1|Overall Study|Physician Decision|3
140187|NCT00603915|447736|P1|Overall Study|Physician Decision|1
140188|NCT00604383|447774|P2|Overall Study|Physician Decision|3
140189|NCT00604383|447775|P1|Overall Study|Physician Decision|0
140190|NCT00604383|447774|P2|Overall Study|Adverse Event|9
140191|NCT00604383|447775|P1|Overall Study|Adverse Event|16
140192|NCT00604383|447774|P2|Overall Study|Death|22
140193|NCT00604383|447775|P1|Overall Study|Death|14
140194|NCT00604383|447774|P2|Overall Study|Lost to Follow-up|19
140195|NCT00604383|447775|P1|Overall Study|Lost to Follow-up|24
140196|NCT00604383|447774|P2|Overall Study|Withdrawal by Subject|31
140197|NCT00604383|447775|P1|Overall Study|Withdrawal by Subject|33
140198|NCT00604500|447794|P1|Overall Study|Did not meet protocol eligibility|1
140199|NCT00604500|447794|P1|Overall Study|Administrative|1
140200|NCT00604500|447794|P1|Overall Study|Withdrawal by Subject|4
140201|NCT00604500|447794|P1|Overall Study|Treatment Failure|1
140202|NCT00604500|447794|P1|Overall Study|Protocol Violation|2
140203|NCT00604500|447794|P1|Overall Study|Adverse Event|2
140204|NCT00604565|447812|P2|Overall Study|Study terminated|3
140205|NCT00604565|447813|P1|Overall Study|Study terminated|0
140206|NCT00604669|447821|P1|Overall Study|lack of information in chart|7
140207|NCT00604695|447827|P2|Overall Study|Did not receive first bolus.|4
140208|NCT00604695|447828|P1|Overall Study|Did not receive first bolus.|0
140209|NCT00604708|447852|P2|Overall Study|Adverse Event|6
140210|NCT00604708|447853|P1|Overall Study|Adverse Event|6
140211|NCT00604708|447852|P2|Overall Study|administrative reasons|11
140212|NCT00604708|447853|P1|Overall Study|administrative reasons|9
140213|NCT00604708|447852|P2|Overall Study|Lost to Follow-up|5
140214|NCT00604708|447853|P1|Overall Study|Lost to Follow-up|5
140215|NCT00604708|447852|P2|Overall Study|Protocol Violation|8
140216|NCT00604708|447853|P1|Overall Study|Protocol Violation|2
140217|NCT00604708|447852|P2|Overall Study|Withdrawal by Subject|10
140218|NCT00604708|447853|P1|Overall Study|Withdrawal by Subject|9
140219|NCT00604721|447861|P1|Overall Study|Withdrawal by Subject|1
140220|NCT00604721|447861|P1|Overall Study|Physician Decision|1
140221|NCT00604786|447869|P2|Overall Study|Lost to Follow-up|0
140222|NCT00604786|447870|P1|Overall Study|Lost to Follow-up|2
140223|NCT00605033|447928|P2|Overall Study|Protocol Violation|1
140224|NCT00605033|447929|P1|Overall Study|Protocol Violation|1
140225|NCT00605033|447928|P2|Overall Study|Withdrawal by Subject|4
140226|NCT00605033|447929|P1|Overall Study|Withdrawal by Subject|3
140227|NCT00605033|447928|P2|Overall Study|Lost to Follow-up|1
140228|NCT00605033|447929|P1|Overall Study|Lost to Follow-up|1
140229|NCT00605033|447928|P2|Overall Study|Adverse Event|2
140230|NCT00605033|447929|P1|Overall Study|Adverse Event|2
140231|NCT00605085|447962|P2|Overall Study|administrative reasons|8
140232|NCT00605085|447963|P1|Overall Study|administrative reasons|18
140233|NCT00605085|447962|P2|Overall Study|Lost to Follow-up|5
140234|NCT00605085|447963|P1|Overall Study|Lost to Follow-up|10
140235|NCT00605085|447962|P2|Overall Study|Protocol Violation|2
140236|NCT00605085|447963|P1|Overall Study|Protocol Violation|3
140237|NCT00605085|447962|P2|Overall Study|Pregnancy|0
140238|NCT00605085|447963|P1|Overall Study|Pregnancy|2
140239|NCT00605085|447962|P2|Overall Study|Adverse Event|5
140240|NCT00605085|447963|P1|Overall Study|Adverse Event|9
140241|NCT00605085|447962|P2|Overall Study|Withdrawal by Subject|5
140242|NCT00605085|447963|P1|Overall Study|Withdrawal by Subject|8
140243|NCT00605176|447976|P3|Overall Study|Other (not due to AE)|0
140244|NCT00605176|447977|P2|Overall Study|Other (not due to AE)|1
140245|NCT00605176|447978|P1|Overall Study|Other (not due to AE)|1
140246|NCT00605176|447976|P3|Overall Study|Use of concomitant therapy|1
140247|NCT00605176|447977|P2|Overall Study|Use of concomitant therapy|0
140248|NCT00605176|447978|P1|Overall Study|Use of concomitant therapy|1
140249|NCT00605176|447976|P3|Overall Study|Non-complicance with study procedures|0
140250|NCT00605176|447977|P2|Overall Study|Non-complicance with study procedures|0
140251|NCT00605176|447978|P1|Overall Study|Non-complicance with study procedures|1
140252|NCT00605176|447976|P3|Overall Study|Lost to Follow-up|1
140253|NCT00605176|447977|P2|Overall Study|Lost to Follow-up|2
140254|NCT00605176|447978|P1|Overall Study|Lost to Follow-up|2
140255|NCT00605176|447976|P3|Overall Study|Withdrawal by Subject|4
140256|NCT00605176|447977|P2|Overall Study|Withdrawal by Subject|2
140257|NCT00605176|447978|P1|Overall Study|Withdrawal by Subject|4
140258|NCT00605176|447976|P3|Overall Study|Adverse Event|3
140259|NCT00605176|447977|P2|Overall Study|Adverse Event|1
140260|NCT00605176|447978|P1|Overall Study|Adverse Event|2
140261|NCT00605267|448004|P2|Overall Study|Withdrawal by Subject|3
140262|NCT00605267|448005|P1|Overall Study|Withdrawal by Subject|2
140263|NCT00605267|448004|P2|Overall Study|Lack of Efficacy|5
140264|NCT00605267|448005|P1|Overall Study|Lack of Efficacy|1
140265|NCT00605267|448004|P2|Overall Study|Adverse Event|1
140266|NCT00605267|448005|P1|Overall Study|Adverse Event|0
140267|NCT00605280|448047|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
140268|NCT00605280|448048|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
140269|NCT00605280|448049|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
140270|NCT00605280|448050|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
140271|NCT00605280|448047|P4|Year 3 Extension|Unspecified|0
140272|NCT00605280|448048|P3|Year 3 Extension|Unspecified|0
140273|NCT00605280|448049|P2|Year 3 Extension|Unspecified|0
140274|NCT00605280|448050|P1|Year 3 Extension|Unspecified|2
140275|NCT00605280|448047|P4|Year 3 Extension|Withdrawal by Subject|5
140276|NCT00605280|448048|P3|Year 3 Extension|Withdrawal by Subject|0
140277|NCT00605280|448049|P2|Year 3 Extension|Withdrawal by Subject|0
140278|NCT00605280|448050|P1|Year 3 Extension|Withdrawal by Subject|2
140279|NCT00605280|448047|P4|Year 3 Extension|Physician Decision|2
140280|NCT00605280|448048|P3|Year 3 Extension|Physician Decision|0
140281|NCT00605280|448049|P2|Year 3 Extension|Physician Decision|0
140282|NCT00605280|448050|P1|Year 3 Extension|Physician Decision|0
140283|NCT00605280|448047|P4|Year 3 Extension|Adverse Event|2
140284|NCT00605280|448048|P3|Year 3 Extension|Adverse Event|0
140285|NCT00605280|448049|P2|Year 3 Extension|Adverse Event|0
140286|NCT00605280|448050|P1|Year 3 Extension|Adverse Event|2
140287|NCT00605280|448047|P4|Year 2|Lost to Follow-up or Patient non-comply|2
140288|NCT00605280|448048|P3|Year 2|Lost to Follow-up or Patient non-comply|0
140289|NCT00605280|448049|P2|Year 2|Lost to Follow-up or Patient non-comply|0
140290|NCT00605280|448050|P1|Year 2|Lost to Follow-up or Patient non-comply|4
140291|NCT00605280|448047|P4|Year 2|Unspecified|1
140292|NCT00605280|448048|P3|Year 2|Unspecified|0
140293|NCT00605280|448049|P2|Year 2|Unspecified|0
140294|NCT00605280|448050|P1|Year 2|Unspecified|1
140295|NCT00605280|448047|P4|Year 2|Withdrawal by Subject|4
140296|NCT00605280|448048|P3|Year 2|Withdrawal by Subject|0
140297|NCT00605280|448049|P2|Year 2|Withdrawal by Subject|0
140298|NCT00605280|448050|P1|Year 2|Withdrawal by Subject|4
140299|NCT00605280|448047|P4|Year 2|Physician Decision|11
140300|NCT00605280|448048|P3|Year 2|Physician Decision|4
140301|NCT00605280|448049|P2|Year 2|Physician Decision|6
140302|NCT00605280|448050|P1|Year 2|Physician Decision|11
140303|NCT00605280|448047|P4|Year 2|Adverse Event|4
140304|NCT00605280|448048|P3|Year 2|Adverse Event|2
140305|NCT00605280|448049|P2|Year 2|Adverse Event|0
140306|NCT00605280|448050|P1|Year 2|Adverse Event|4
140307|NCT00605280|448047|P4|Year 1|Lost to Follow-up or Patient non-comply|2
140308|NCT00605280|448048|P3|Year 1|Lost to Follow-up or Patient non-comply|0
140309|NCT00605280|448049|P2|Year 1|Lost to Follow-up or Patient non-comply|1
140310|NCT00605280|448050|P1|Year 1|Lost to Follow-up or Patient non-comply|5
140311|NCT00605280|448047|P4|Year 1|Unspecified|1
140312|NCT00605280|448048|P3|Year 1|Unspecified|0
140313|NCT00605280|448049|P2|Year 1|Unspecified|1
140314|NCT00605280|448050|P1|Year 1|Unspecified|2
140315|NCT00605280|448047|P4|Year 1|Withdrawal by Subject|4
140316|NCT00605280|448048|P3|Year 1|Withdrawal by Subject|0
140317|NCT00605280|448049|P2|Year 1|Withdrawal by Subject|4
140318|NCT00605280|448050|P1|Year 1|Withdrawal by Subject|2
140319|NCT00605280|448047|P4|Year 1|Physician Decision|6
140320|NCT00605280|448048|P3|Year 1|Physician Decision|0
140321|NCT00605280|448049|P2|Year 1|Physician Decision|4
140322|NCT00605280|448050|P1|Year 1|Physician Decision|7
140323|NCT00605280|448047|P4|Year 1|Adverse Event|5
140324|NCT00605280|448048|P3|Year 1|Adverse Event|1
140325|NCT00605280|448049|P2|Year 1|Adverse Event|1
140326|NCT00605280|448050|P1|Year 1|Adverse Event|3
140327|NCT00605280|448047|P4|Year 1|Protocol Violation|1
140328|NCT00605280|448048|P3|Year 1|Protocol Violation|0
140329|NCT00605280|448049|P2|Year 1|Protocol Violation|0
140330|NCT00605280|448050|P1|Year 1|Protocol Violation|0
140331|NCT00605293|448084|P2|Overall Study|Principal Investigator Decision|1
140332|NCT00605293|448085|P1|Overall Study|Principal Investigator Decision|0
140333|NCT00605293|448084|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
140334|NCT00605293|448085|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
140335|NCT00605293|448084|P2|Overall Study|Incorrect Epoetin Beta Administration|0
140336|NCT00605293|448085|P1|Overall Study|Incorrect Epoetin Beta Administration|1
140337|NCT00605293|448084|P2|Overall Study|Renal Transplantation|1
140338|NCT00605293|448085|P1|Overall Study|Renal Transplantation|3
140339|NCT00605293|448084|P2|Overall Study|Blood Transfusion|1
140340|NCT00605293|448085|P1|Overall Study|Blood Transfusion|7
140341|NCT00605293|448084|P2|Overall Study|Holidays Dialysis Out|0
140342|NCT00605293|448085|P1|Overall Study|Holidays Dialysis Out|1
140343|NCT00605293|448084|P2|Overall Study|Adverse Event|0
140344|NCT00605293|448085|P1|Overall Study|Adverse Event|1
140345|NCT00605293|448084|P2|Overall Study|Insufficient Therapeutic Response|0
140346|NCT00605293|448085|P1|Overall Study|Insufficient Therapeutic Response|2
140347|NCT00605293|448084|P2|Overall Study|Death|1
140348|NCT00605293|448085|P1|Overall Study|Death|2
140349|NCT00605306|448103|P2|Overall Study|Adverse Event|1
140350|NCT00605306|448104|P1|Overall Study|Adverse Event|0
140351|NCT00605345|448118|P2|Overall Study|Protocol Violation|2
140352|NCT00605345|448119|P1|Overall Study|Protocol Violation|0
140353|NCT00605345|448118|P2|Overall Study|Adverse Event|1
140354|NCT00605345|448119|P1|Overall Study|Adverse Event|0
140355|NCT00605345|448118|P2|Overall Study|Withdrawal by Subject|0
140356|NCT00605345|448119|P1|Overall Study|Withdrawal by Subject|1
140357|NCT00605475|448198|P10|Overall Study|Withdrawal by Subject|1
140358|NCT00605475|448199|P9|Overall Study|Withdrawal by Subject|0
140359|NCT00605475|448200|P8|Overall Study|Withdrawal by Subject|0
140360|NCT00605475|448201|P7|Overall Study|Withdrawal by Subject|0
140361|NCT00605475|448202|P6|Overall Study|Withdrawal by Subject|2
140362|NCT00605475|448203|P5|Overall Study|Withdrawal by Subject|0
140363|NCT00605475|448204|P4|Overall Study|Withdrawal by Subject|0
140364|NCT00605475|448205|P3|Overall Study|Withdrawal by Subject|0
140365|NCT00605475|448206|P2|Overall Study|Withdrawal by Subject|0
140366|NCT00605475|448207|P1|Overall Study|Withdrawal by Subject|0
140367|NCT00605475|448198|P10|Overall Study|Protocol Violation|0
140368|NCT00605475|448199|P9|Overall Study|Protocol Violation|0
140369|NCT00605475|448200|P8|Overall Study|Protocol Violation|0
140370|NCT00605475|448201|P7|Overall Study|Protocol Violation|0
140371|NCT00605475|448202|P6|Overall Study|Protocol Violation|0
140372|NCT00605475|448203|P5|Overall Study|Protocol Violation|1
140373|NCT00605475|448204|P4|Overall Study|Protocol Violation|0
140374|NCT00605475|448205|P3|Overall Study|Protocol Violation|0
140375|NCT00605475|448206|P2|Overall Study|Protocol Violation|0
140376|NCT00605475|448207|P1|Overall Study|Protocol Violation|0
140377|NCT00605475|448198|P10|Overall Study|Lost to Follow-up|1
140378|NCT00605475|448199|P9|Overall Study|Lost to Follow-up|1
140379|NCT00605475|448200|P8|Overall Study|Lost to Follow-up|0
140380|NCT00605475|448201|P7|Overall Study|Lost to Follow-up|0
140381|NCT00605475|448202|P6|Overall Study|Lost to Follow-up|0
140382|NCT00605475|448203|P5|Overall Study|Lost to Follow-up|0
140383|NCT00605475|448204|P4|Overall Study|Lost to Follow-up|0
140384|NCT00605475|448205|P3|Overall Study|Lost to Follow-up|0
140385|NCT00605475|448206|P2|Overall Study|Lost to Follow-up|0
140386|NCT00605475|448207|P1|Overall Study|Lost to Follow-up|0
140387|NCT00605475|448198|P10|Overall Study|Administrative problems|0
140388|NCT00605475|448199|P9|Overall Study|Administrative problems|0
140389|NCT00605475|448200|P8|Overall Study|Administrative problems|0
140390|NCT00605475|448201|P7|Overall Study|Administrative problems|1
140391|NCT00605475|448202|P6|Overall Study|Administrative problems|0
140392|NCT00605475|448203|P5|Overall Study|Administrative problems|0
140393|NCT00605475|448204|P4|Overall Study|Administrative problems|0
140394|NCT00605475|448205|P3|Overall Study|Administrative problems|0
140395|NCT00605475|448206|P2|Overall Study|Administrative problems|0
140396|NCT00605475|448207|P1|Overall Study|Administrative problems|0
140397|NCT00605475|448198|P10|Overall Study|Abnormal Laboratory Values|0
140398|NCT00605475|448199|P9|Overall Study|Abnormal Laboratory Values|1
140399|NCT00605475|448200|P8|Overall Study|Abnormal Laboratory Values|0
140400|NCT00605475|448201|P7|Overall Study|Abnormal Laboratory Values|0
140401|NCT00605475|448202|P6|Overall Study|Abnormal Laboratory Values|0
140402|NCT00605475|448203|P5|Overall Study|Abnormal Laboratory Values|0
140403|NCT00605475|448204|P4|Overall Study|Abnormal Laboratory Values|0
140404|NCT00605475|448205|P3|Overall Study|Abnormal Laboratory Values|0
140405|NCT00605475|448206|P2|Overall Study|Abnormal Laboratory Values|0
140406|NCT00605475|448207|P1|Overall Study|Abnormal Laboratory Values|0
140407|NCT00605540|448329|P1|Overall Study|Lost to Follow-up|23
140408|NCT00605540|448329|P1|Overall Study|Death|15
140409|NCT00605657|448337|P1|Overall Study|Protocol Violation|1
140410|NCT00605657|448337|P1|Overall Study|Adverse Event|1
140411|NCT00605722|448353|P1|Overall Study|Failure to return|1
140412|NCT00605722|448353|P1|Overall Study|Insufficient therapeutic response|44
140413|NCT00605722|448353|P1|Overall Study|Adverse Event|6
140414|NCT00605813|448363|P1|Overall Study|Protocol Violation|25
140415|NCT00605839|448379|P3|Overall Study|Protocol Violation|0
140416|NCT00605839|448380|P2|Overall Study|Protocol Violation|0
140417|NCT00605839|448381|P1|Overall Study|Protocol Violation|1
140418|NCT00605865|448389|P1|Overall Study|Protocol Violation|115
140419|NCT00605917|448441|P1|Overall Study|Protocol Violation|79
140420|NCT00606008|448480|P1|Overall Study|Withdrawal by Subject|4
140421|NCT00606008|448480|P1|Overall Study|Adverse Event|1
140422|NCT00606021|448496|P3|Maintenance Phase|Lost to Follow-up|2
140423|NCT00606021|448497|P2|Maintenance Phase|Lost to Follow-up|5
140424|NCT00606021|448498|P1|Maintenance Phase|Lost to Follow-up|0
140425|NCT00606021|448496|P3|Maintenance Phase|Physician Decision|0
140426|NCT00606021|448497|P2|Maintenance Phase|Physician Decision|1
140427|NCT00606021|448498|P1|Maintenance Phase|Physician Decision|0
140428|NCT00606021|448496|P3|Maintenance Phase|Death|15
140429|NCT00606021|448497|P2|Maintenance Phase|Death|17
140430|NCT00606021|448498|P1|Maintenance Phase|Death|0
140431|NCT00606021|448496|P3|Induction Phase|Lost to Follow-up|0
140432|NCT00606021|448497|P2|Induction Phase|Lost to Follow-up|0
140433|NCT00606021|448498|P1|Induction Phase|Lost to Follow-up|10
140434|NCT00606021|448496|P3|Induction Phase|Withdrawal by Subject|0
140435|NCT00606021|448497|P2|Induction Phase|Withdrawal by Subject|0
140436|NCT00606021|448498|P1|Induction Phase|Withdrawal by Subject|2
140437|NCT00606021|448496|P3|Induction Phase|Physician Decision|0
140438|NCT00606021|448497|P2|Induction Phase|Physician Decision|0
140439|NCT00606021|448498|P1|Induction Phase|Physician Decision|2
140440|NCT00606021|448496|P3|Induction Phase|Death|0
140441|NCT00606021|448497|P2|Induction Phase|Death|0
140442|NCT00606021|448498|P1|Induction Phase|Death|73
140443|NCT00606034|448516|P1|Overall Study|incarceration|1
140444|NCT00606086|448524|P2|Overall Study|Randomized, not treated|2
140445|NCT00606086|448525|P1|Overall Study|Randomized, not treated|1
140446|NCT00606086|448524|P2|Overall Study|Non-compliance|1
140447|NCT00606086|448525|P1|Overall Study|Non-compliance|0
140448|NCT00606086|448524|P2|Overall Study|Withdrawal by Subject|3
140449|NCT00606086|448525|P1|Overall Study|Withdrawal by Subject|5
140450|NCT00606086|448524|P2|Overall Study|Protocol Violation|0
140451|NCT00606086|448525|P1|Overall Study|Protocol Violation|1
140452|NCT00606086|448524|P2|Overall Study|Lost to Follow-up|8
140453|NCT00606086|448525|P1|Overall Study|Lost to Follow-up|4
140454|NCT00606086|448524|P2|Overall Study|Adverse Event|1
140455|NCT00606086|448525|P1|Overall Study|Adverse Event|1
140456|NCT00606177|448550|P2|Overall Study|Change of residence or other commitments|1
140457|NCT00606177|448551|P1|Overall Study|Change of residence or other commitments|1
140458|NCT00606177|448550|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
140459|NCT00606177|448551|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
140460|NCT00606177|448550|P2|Overall Study|Progression to depressive phase|1
140461|NCT00606177|448551|P1|Overall Study|Progression to depressive phase|6
140462|NCT00606177|448550|P2|Overall Study|Withdrawal by Subject|6
140463|NCT00606177|448551|P1|Overall Study|Withdrawal by Subject|5
140464|NCT00606177|448550|P2|Overall Study|Protocol Violation|4
140465|NCT00606177|448551|P1|Overall Study|Protocol Violation|1
140466|NCT00606177|448550|P2|Overall Study|Physician Decision|0
140467|NCT00606177|448551|P1|Overall Study|Physician Decision|1
140468|NCT00606177|448550|P2|Overall Study|Lack of Efficacy|7
140469|NCT00606177|448551|P1|Overall Study|Lack of Efficacy|3
140470|NCT00606177|448550|P2|Overall Study|Adverse Event|5
140471|NCT00606177|448551|P1|Overall Study|Adverse Event|9
140472|NCT00606229|448559|P1|Overall Study|change of residence or other commitments|2
140473|NCT00606229|448559|P1|Overall Study|does not meet inclusion criterion 1-3|4
140474|NCT00606229|448559|P1|Overall Study|Withdrawal by Subject|4
140475|NCT00606229|448559|P1|Overall Study|Lack of Efficacy|1
140476|NCT00606229|448559|P1|Overall Study|Adverse Event|11
140477|NCT00606281|448566|P2|Overall Study|Change of residence or other commitments|1
140478|NCT00606281|448567|P1|Overall Study|Change of residence or other commitments|1
140479|NCT00606281|448566|P2|Overall Study|Progression to depressive phase|1
140480|NCT00606281|448567|P1|Overall Study|Progression to depressive phase|1
140481|NCT00606281|448566|P2|Overall Study|Withdrawal by Subject|13
140482|NCT00606281|448567|P1|Overall Study|Withdrawal by Subject|11
140483|NCT00606281|448566|P2|Overall Study|Protocol Violation|3
140484|NCT00606281|448567|P1|Overall Study|Protocol Violation|3
140485|NCT00606281|448566|P2|Overall Study|Physician Decision|1
140486|NCT00606281|448567|P1|Overall Study|Physician Decision|0
140487|NCT00606281|448566|P2|Overall Study|Lack of Efficacy|35
140488|NCT00606281|448567|P1|Overall Study|Lack of Efficacy|28
140489|NCT00606281|448566|P2|Overall Study|Death|0
140490|NCT00606281|448567|P1|Overall Study|Death|1
140491|NCT00606281|448566|P2|Overall Study|Adverse Event|12
140492|NCT00606281|448567|P1|Overall Study|Adverse Event|11
140493|NCT00606320|448575|P1|Overall Study|Progression to depressive phase|4
140494|NCT00606320|448575|P1|Overall Study|Withdrawal by Subject|10
140495|NCT00606320|448575|P1|Overall Study|Protocol Violation|8
140496|NCT00606320|448575|P1|Overall Study|Physician Decision|7
140497|NCT00606320|448575|P1|Overall Study|Lack of Efficacy|5
140498|NCT00606320|448575|P1|Overall Study|Adverse Event|3
140499|NCT00606502|448591|P2|Treatment|Treatment ongoing at time of data cutoff|3
140500|NCT00606502|448592|P1|Treatment|Treatment ongoing at time of data cutoff|0
140501|NCT00606502|448591|P2|Randomization|Randomized but not treated|0
140502|NCT00606502|448592|P1|Randomization|Randomized but not treated|3
140503|NCT00606580|448620|P3|Overall Study|Withdrawal by Subject|0
140504|NCT00606580|448621|P2|Overall Study|Withdrawal by Subject|1
140505|NCT00606580|448622|P1|Overall Study|Withdrawal by Subject|0
140506|NCT00606580|448620|P3|Overall Study|Withdrawal by investigator|6
140507|NCT00606580|448621|P2|Overall Study|Withdrawal by investigator|1
140508|NCT00606580|448622|P1|Overall Study|Withdrawal by investigator|0
140509|NCT00606580|448620|P3|Overall Study|Clinical failures|12
140510|NCT00606580|448621|P2|Overall Study|Clinical failures|0
140511|NCT00606580|448622|P1|Overall Study|Clinical failures|1
140512|NCT00606580|448620|P3|Overall Study|Lost to Follow-up|4
140513|NCT00606580|448621|P2|Overall Study|Lost to Follow-up|1
140514|NCT00606580|448622|P1|Overall Study|Lost to Follow-up|1
140515|NCT00606593|448663|P10|Overall Study|Administrative/Other|0
140516|NCT00606593|448664|P9|Overall Study|Administrative/Other|0
140517|NCT00606593|448665|P8|Overall Study|Administrative/Other|0
140518|NCT00606593|448666|P7|Overall Study|Administrative/Other|0
140519|NCT00606593|448667|P6|Overall Study|Administrative/Other|0
140520|NCT00606593|448668|P5|Overall Study|Administrative/Other|0
140521|NCT00606593|448669|P4|Overall Study|Administrative/Other|0
140522|NCT00606593|448670|P3|Overall Study|Administrative/Other|1
140523|NCT00606593|448671|P2|Overall Study|Administrative/Other|0
140524|NCT00606593|448672|P1|Overall Study|Administrative/Other|0
140525|NCT00606593|448663|P10|Overall Study|Withdrawal of consent|0
140526|NCT00606593|448664|P9|Overall Study|Withdrawal of consent|0
140527|NCT00606593|448665|P8|Overall Study|Withdrawal of consent|0
140528|NCT00606593|448666|P7|Overall Study|Withdrawal of consent|0
140529|NCT00606593|448667|P6|Overall Study|Withdrawal of consent|0
140530|NCT00606593|448668|P5|Overall Study|Withdrawal of consent|0
140531|NCT00606593|448669|P4|Overall Study|Withdrawal of consent|0
140532|NCT00606593|448670|P3|Overall Study|Withdrawal of consent|1
140533|NCT00606593|448671|P2|Overall Study|Withdrawal of consent|0
140534|NCT00606593|448672|P1|Overall Study|Withdrawal of consent|1
140535|NCT00606593|448663|P10|Overall Study|Adverse Event|0
140536|NCT00606593|448664|P9|Overall Study|Adverse Event|1
140537|NCT00606593|448665|P8|Overall Study|Adverse Event|2
140538|NCT00606593|448666|P7|Overall Study|Adverse Event|1
140539|NCT00606593|448667|P6|Overall Study|Adverse Event|0
140540|NCT00606593|448668|P5|Overall Study|Adverse Event|1
140541|NCT00606593|448669|P4|Overall Study|Adverse Event|1
140542|NCT00606593|448670|P3|Overall Study|Adverse Event|0
140543|NCT00606593|448671|P2|Overall Study|Adverse Event|0
140544|NCT00606593|448672|P1|Overall Study|Adverse Event|0
140545|NCT00606632|448690|P1|Overall Study|Miscellaneous reasons|9
140546|NCT00606632|448690|P1|Overall Study|Withdrawal by Subject|13
140547|NCT00606684|448703|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
140548|NCT00606684|448704|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
140549|NCT00606684|448705|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
140550|NCT00606684|448706|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
140551|NCT00606684|448707|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
140552|NCT00606684|448708|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
140553|NCT00606684|448709|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
140554|NCT00606684|448703|P7|Double-Blind Treatment Period|Physician Decision|2
140555|NCT00606684|448704|P6|Double-Blind Treatment Period|Physician Decision|1
140556|NCT00606684|448705|P5|Double-Blind Treatment Period|Physician Decision|3
140557|NCT00606684|448706|P4|Double-Blind Treatment Period|Physician Decision|0
140558|NCT00606684|448707|P3|Double-Blind Treatment Period|Physician Decision|1
140559|NCT00606684|448708|P2|Double-Blind Treatment Period|Physician Decision|5
140560|NCT00606684|448709|P1|Double-Blind Treatment Period|Physician Decision|0
140561|NCT00606684|448703|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
140562|NCT00606684|448704|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
140563|NCT00606684|448705|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
140564|NCT00606684|448706|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
140565|NCT00606684|448707|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
140566|NCT00606684|448708|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
140567|NCT00606684|448709|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
140568|NCT00606684|448703|P7|Double-Blind Treatment Period|Protocol Violation|4
140569|NCT00606684|448704|P6|Double-Blind Treatment Period|Protocol Violation|3
140570|NCT00606684|448705|P5|Double-Blind Treatment Period|Protocol Violation|0
140571|NCT00606684|448706|P4|Double-Blind Treatment Period|Protocol Violation|3
140572|NCT00606684|448707|P3|Double-Blind Treatment Period|Protocol Violation|5
140573|NCT00606684|448708|P2|Double-Blind Treatment Period|Protocol Violation|5
140574|NCT00606684|448709|P1|Double-Blind Treatment Period|Protocol Violation|0
140575|NCT00606684|448703|P7|Double-Blind Treatment Period|Lack of Efficacy|0
140576|NCT00606684|448704|P6|Double-Blind Treatment Period|Lack of Efficacy|0
140577|NCT00606684|448705|P5|Double-Blind Treatment Period|Lack of Efficacy|1
140578|NCT00606684|448706|P4|Double-Blind Treatment Period|Lack of Efficacy|0
140579|NCT00606684|448707|P3|Double-Blind Treatment Period|Lack of Efficacy|0
140580|NCT00606684|448708|P2|Double-Blind Treatment Period|Lack of Efficacy|1
140581|NCT00606684|448709|P1|Double-Blind Treatment Period|Lack of Efficacy|0
140582|NCT00606684|448703|P7|Double-Blind Treatment Period|Adverse Event|1
140583|NCT00606684|448704|P6|Double-Blind Treatment Period|Adverse Event|0
140584|NCT00606684|448705|P5|Double-Blind Treatment Period|Adverse Event|2
140585|NCT00606684|448706|P4|Double-Blind Treatment Period|Adverse Event|4
140586|NCT00606684|448707|P3|Double-Blind Treatment Period|Adverse Event|2
140587|NCT00606684|448708|P2|Double-Blind Treatment Period|Adverse Event|3
140588|NCT00606684|448709|P1|Double-Blind Treatment Period|Adverse Event|0
140589|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
140590|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
140591|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
140592|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
140593|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
140594|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
140595|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
140596|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Adverse Event|0
140597|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Adverse Event|0
140598|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Adverse Event|0
140599|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Adverse Event|0
140600|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Adverse Event|0
140601|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Adverse Event|0
140602|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Adverse Event|2
140603|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
140604|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
140605|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
140606|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
140607|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
140608|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
140609|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
140610|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
140611|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
140612|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
140613|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
140614|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
140615|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
140616|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
140617|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Physician Decision|0
140618|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Physician Decision|0
140619|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Physician Decision|0
140620|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Physician Decision|0
140621|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Physician Decision|0
140622|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Physician Decision|0
140623|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Physician Decision|18
140624|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
140625|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
140626|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
140627|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
140628|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
140629|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
140630|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
140631|NCT00606684|448703|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
140632|NCT00606684|448704|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
140633|NCT00606684|448705|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
140634|NCT00606684|448706|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
140635|NCT00606684|448707|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
140636|NCT00606684|448708|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
140637|NCT00606684|448709|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
140638|NCT00606801|448743|P2|Intervention|Protocol Violation|3
140639|NCT00606801|448744|P1|Intervention|Protocol Violation|3
140640|NCT00600028|448779|P2|Second Intervention (12 Weeks)|Adverse Event|2
140641|NCT00600028|448780|P1|Second Intervention (12 Weeks)|Adverse Event|0
140642|NCT00600028|448779|P2|First Intervention (12 Weeks)|Adverse Event|1
140643|NCT00600028|448780|P1|First Intervention (12 Weeks)|Adverse Event|0
140644|NCT00600028|448779|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
140645|NCT00600028|448780|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
140646|NCT00600067|448794|P2|Overall Study|Lack of Efficacy|0
140647|NCT00600067|448795|P1|Overall Study|Lack of Efficacy|1
140648|NCT00600067|448794|P2|Overall Study|protocol non-compliance|3
140649|NCT00600067|448795|P1|Overall Study|protocol non-compliance|0
140650|NCT00600067|448794|P2|Overall Study|Lost to Follow-up|3
140651|NCT00600067|448795|P1|Overall Study|Lost to Follow-up|2
140652|NCT00600067|448794|P2|Overall Study|Adverse Event|1
140653|NCT00600067|448795|P1|Overall Study|Adverse Event|0
140654|NCT00600119|448822|P6|Follow-up Period|Other|0
140655|NCT00600119|448823|P5|Follow-up Period|Other|0
140656|NCT00600119|448824|P4|Follow-up Period|Other|0
140657|NCT00600119|448825|P3|Follow-up Period|Other|0
140658|NCT00600119|448826|P2|Follow-up Period|Other|0
140659|NCT00600119|448827|P1|Follow-up Period|Other|1
140660|NCT00600119|448822|P6|Follow-up Period|Adverse Event|1
140661|NCT00600119|448823|P5|Follow-up Period|Adverse Event|0
140662|NCT00600119|448824|P4|Follow-up Period|Adverse Event|0
140663|NCT00600119|448825|P3|Follow-up Period|Adverse Event|0
140664|NCT00600119|448826|P2|Follow-up Period|Adverse Event|0
140665|NCT00600119|448827|P1|Follow-up Period|Adverse Event|0
140666|NCT00600119|448822|P6|Double-blind Treatment Period|Adverse Event|10
140667|NCT00600119|448823|P5|Double-blind Treatment Period|Adverse Event|2
140668|NCT00600119|448824|P4|Double-blind Treatment Period|Adverse Event|1
140669|NCT00600119|448825|P3|Double-blind Treatment Period|Adverse Event|0
140670|NCT00600119|448826|P2|Double-blind Treatment Period|Adverse Event|1
140671|NCT00600119|448827|P1|Double-blind Treatment Period|Adverse Event|1
140672|NCT00600119|448822|P6|Double-blind Treatment Period|Lost to Follow-up|0
140673|NCT00600119|448823|P5|Double-blind Treatment Period|Lost to Follow-up|0
140674|NCT00600119|448824|P4|Double-blind Treatment Period|Lost to Follow-up|0
140675|NCT00600119|448825|P3|Double-blind Treatment Period|Lost to Follow-up|0
140676|NCT00600119|448826|P2|Double-blind Treatment Period|Lost to Follow-up|1
140677|NCT00600119|448827|P1|Double-blind Treatment Period|Lost to Follow-up|0
140678|NCT00600119|448822|P6|Double-blind Treatment Period|Physician Decision|0
140679|NCT00600119|448823|P5|Double-blind Treatment Period|Physician Decision|0
140680|NCT00600119|448824|P4|Double-blind Treatment Period|Physician Decision|0
140681|NCT00600119|448825|P3|Double-blind Treatment Period|Physician Decision|0
140682|NCT00600119|448826|P2|Double-blind Treatment Period|Physician Decision|0
140683|NCT00600119|448827|P1|Double-blind Treatment Period|Physician Decision|2
140684|NCT00600119|448822|P6|Double-blind Treatment Period|Sponsor Decision|0
140685|NCT00600119|448823|P5|Double-blind Treatment Period|Sponsor Decision|1
140686|NCT00600119|448824|P4|Double-blind Treatment Period|Sponsor Decision|0
140687|NCT00600119|448825|P3|Double-blind Treatment Period|Sponsor Decision|0
140688|NCT00600119|448826|P2|Double-blind Treatment Period|Sponsor Decision|1
140689|NCT00600119|448827|P1|Double-blind Treatment Period|Sponsor Decision|0
140690|NCT00600119|448822|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
140691|NCT00600119|448823|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
140692|NCT00600119|448824|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
140693|NCT00600119|448825|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
140694|NCT00600119|448826|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
140695|NCT00600119|448827|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
140696|NCT00600119|448822|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
140697|NCT00600119|448823|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
140698|NCT00600119|448824|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
140699|NCT00600119|448825|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
140700|NCT00600119|448826|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
140701|NCT00600119|448827|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
140702|NCT00600119|448822|P6|Double-blind Treatment Period|Other|1
140703|NCT00600119|448823|P5|Double-blind Treatment Period|Other|2
140704|NCT00600119|448824|P4|Double-blind Treatment Period|Other|0
140705|NCT00600119|448825|P3|Double-blind Treatment Period|Other|0
140706|NCT00600119|448826|P2|Double-blind Treatment Period|Other|0
140707|NCT00600119|448827|P1|Double-blind Treatment Period|Other|0
140708|NCT00600119|448822|P6|Double-blind Treatment Period|Withdrawal by Subject|3
140709|NCT00600119|448823|P5|Double-blind Treatment Period|Withdrawal by Subject|0
140710|NCT00600119|448824|P4|Double-blind Treatment Period|Withdrawal by Subject|1
140711|NCT00600119|448825|P3|Double-blind Treatment Period|Withdrawal by Subject|0
140712|NCT00600119|448826|P2|Double-blind Treatment Period|Withdrawal by Subject|0
140713|NCT00600119|448827|P1|Double-blind Treatment Period|Withdrawal by Subject|2
140714|NCT00600119|448822|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
140715|NCT00600119|448823|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
140716|NCT00600119|448824|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
140717|NCT00600119|448825|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
140718|NCT00600119|448826|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
140719|NCT00600119|448827|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
140720|NCT00600119|448822|P6|Single-blind Placebo run-in Period|Adverse Event|1
140721|NCT00600119|448823|P5|Single-blind Placebo run-in Period|Adverse Event|0
140722|NCT00600119|448824|P4|Single-blind Placebo run-in Period|Adverse Event|1
140723|NCT00600119|448825|P3|Single-blind Placebo run-in Period|Adverse Event|0
140724|NCT00600119|448826|P2|Single-blind Placebo run-in Period|Adverse Event|0
140725|NCT00600119|448827|P1|Single-blind Placebo run-in Period|Adverse Event|0
140726|NCT00600119|448822|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
140727|NCT00600119|448823|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
140728|NCT00600119|448824|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
140729|NCT00600119|448825|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
140730|NCT00600119|448826|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
140731|NCT00600119|448827|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
140732|NCT00600119|448822|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
140733|NCT00600119|448823|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
140734|NCT00600119|448824|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
140735|NCT00600119|448825|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
140736|NCT00600119|448826|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
140737|NCT00600119|448827|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
140738|NCT00600119|448822|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
140739|NCT00600119|448823|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
140740|NCT00600119|448824|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
140741|NCT00600119|448825|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
140742|NCT00600119|448826|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
140743|NCT00600119|448827|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
140744|NCT00600119|448822|P6|Single-blind Placebo run-in Period|Other - Not specified|1
140745|NCT00600119|448823|P5|Single-blind Placebo run-in Period|Other - Not specified|1
140746|NCT00600119|448824|P4|Single-blind Placebo run-in Period|Other - Not specified|0
140747|NCT00600119|448825|P3|Single-blind Placebo run-in Period|Other - Not specified|0
140748|NCT00600119|448826|P2|Single-blind Placebo run-in Period|Other - Not specified|0
140749|NCT00600119|448827|P1|Single-blind Placebo run-in Period|Other - Not specified|1
140750|NCT00600171|448865|P6|Overall Study|Lost to Follow-up|0
140751|NCT00600171|448866|P5|Overall Study|Lost to Follow-up|0
140752|NCT00600171|448867|P4|Overall Study|Lost to Follow-up|1
140753|NCT00600171|448868|P3|Overall Study|Lost to Follow-up|0
140754|NCT00600171|448869|P2|Overall Study|Lost to Follow-up|0
140755|NCT00600171|448870|P1|Overall Study|Lost to Follow-up|0
140756|NCT00600171|448865|P6|Overall Study|Physician Decision|2
140757|NCT00600171|448866|P5|Overall Study|Physician Decision|0
140758|NCT00600171|448867|P4|Overall Study|Physician Decision|1
140759|NCT00600171|448868|P3|Overall Study|Physician Decision|0
140760|NCT00600171|448869|P2|Overall Study|Physician Decision|1
140761|NCT00600171|448870|P1|Overall Study|Physician Decision|0
140762|NCT00600171|448865|P6|Overall Study|Withdrawal by Subject|1
140763|NCT00600171|448866|P5|Overall Study|Withdrawal by Subject|1
140764|NCT00600171|448867|P4|Overall Study|Withdrawal by Subject|1
140765|NCT00600171|448868|P3|Overall Study|Withdrawal by Subject|0
140766|NCT00600171|448869|P2|Overall Study|Withdrawal by Subject|0
140767|NCT00600171|448870|P1|Overall Study|Withdrawal by Subject|3
140768|NCT00600171|448865|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
140769|NCT00600171|448866|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
140770|NCT00600171|448867|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
140771|NCT00600171|448868|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
140772|NCT00600171|448869|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
140773|NCT00600171|448870|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
140774|NCT00600171|448865|P6|Overall Study|Protocol Violation|0
140775|NCT00600171|448866|P5|Overall Study|Protocol Violation|0
140776|NCT00600171|448867|P4|Overall Study|Protocol Violation|1
140777|NCT00600171|448868|P3|Overall Study|Protocol Violation|0
140778|NCT00600171|448869|P2|Overall Study|Protocol Violation|2
140779|NCT00600171|448870|P1|Overall Study|Protocol Violation|1
140780|NCT00600171|448865|P6|Overall Study|Lack of Efficacy|0
140781|NCT00600171|448866|P5|Overall Study|Lack of Efficacy|4
140782|NCT00600171|448867|P4|Overall Study|Lack of Efficacy|5
140783|NCT00600171|448868|P3|Overall Study|Lack of Efficacy|3
140784|NCT00600171|448869|P2|Overall Study|Lack of Efficacy|12
140785|NCT00600171|448870|P1|Overall Study|Lack of Efficacy|9
140786|NCT00600171|448865|P6|Overall Study|Adverse Event|0
140787|NCT00600171|448866|P5|Overall Study|Adverse Event|1
140788|NCT00600171|448867|P4|Overall Study|Adverse Event|0
140789|NCT00600171|448868|P3|Overall Study|Adverse Event|0
140790|NCT00600171|448869|P2|Overall Study|Adverse Event|1
140791|NCT00600171|448870|P1|Overall Study|Adverse Event|0
140792|NCT00600353|448940|P2|Overall Study|History of prepartive regimen|1
140793|NCT00600353|448941|P1|Overall Study|History of prepartive regimen|0
140794|NCT00600353|448940|P2|Overall Study|history of malignancy within 5 years|0
140795|NCT00600353|448941|P1|Overall Study|history of malignancy within 5 years|1
140796|NCT00600613|448953|P1|Overall Study|Protocol Deviation|1
140797|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
140798|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
140799|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
140800|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
140801|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
140802|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
140803|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
140804|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
140805|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
140806|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
140807|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
140808|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
140809|NCT00600756|449002|P2|Overall Study Analysis After 12 Months|Adverse Event|44
140810|NCT00600756|449003|P1|Overall Study Analysis After 12 Months|Adverse Event|53
140811|NCT00600756|449002|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
140812|NCT00600756|449003|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
140813|NCT00600756|449002|P2|Analysis After 6 Months|Lost to Follow-up|8
140814|NCT00600756|449003|P1|Analysis After 6 Months|Lost to Follow-up|10
140815|NCT00600756|449002|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
140816|NCT00600756|449003|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
140817|NCT00600756|449002|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
140818|NCT00600756|449003|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
140819|NCT00600756|449002|P2|Analysis After 6 Months|Incorrect Enrollment|21
140820|NCT00600756|449003|P1|Analysis After 6 Months|Incorrect Enrollment|12
140821|NCT00600756|449002|P2|Analysis After 6 Months|Withdrawal by Subject|30
140822|NCT00600756|449003|P1|Analysis After 6 Months|Withdrawal by Subject|38
140823|NCT00600756|449002|P2|Analysis After 6 Months|Adverse Event|33
140824|NCT00600756|449003|P1|Analysis After 6 Months|Adverse Event|43
140825|NCT00600821|449071|P2|Overall Study|Unspecified|3
140826|NCT00600821|449072|P1|Overall Study|Unspecified|2
140827|NCT00600821|449071|P2|Overall Study|Randomized but not treated|1
140828|NCT00600821|449072|P1|Overall Study|Randomized but not treated|0
140829|NCT00600821|449071|P2|Overall Study|Objective progression or relapse|1
140830|NCT00600821|449072|P1|Overall Study|Objective progression or relapse|0
140831|NCT00600821|449071|P2|Overall Study|Terminated by sponsor|6
140832|NCT00600821|449072|P1|Overall Study|Terminated by sponsor|8
140833|NCT00600821|449071|P2|Overall Study|Withdrawal by Subject|1
140834|NCT00600821|449072|P1|Overall Study|Withdrawal by Subject|1
140835|NCT00600821|449071|P2|Overall Study|Lost to Follow-up|2
140836|NCT00600821|449072|P1|Overall Study|Lost to Follow-up|2
140837|NCT00600821|449071|P2|Overall Study|Death|46
140838|NCT00600821|449072|P1|Overall Study|Death|45
140839|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Death|0
140840|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Death|1
140841|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
140842|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
140843|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
140844|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
140845|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Administrative Problems|4
140846|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Administrative Problems|4
140847|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
140848|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
140849|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
140850|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
140851|NCT00600886|449100|P2|Extension - After Crossover (CAS)|Adverse Event|1
140852|NCT00600886|449101|P1|Extension - After Crossover (CAS)|Adverse Event|19
140853|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
140854|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
140855|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Death|1
140856|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Death|1
140857|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
140858|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
140859|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Adverse Event|1
140860|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Adverse Event|4
140861|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
140862|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
140863|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
140864|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
140865|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
140866|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
140867|NCT00600886|449100|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
140868|NCT00600886|449101|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
140869|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Death|1
140870|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Death|0
140871|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
140872|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
140873|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
140874|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
140875|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
140876|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
140877|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
140878|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
140879|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
140880|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
140881|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
140882|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
140883|NCT00600886|449100|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
140884|NCT00600886|449101|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
140885|NCT00600938|449165|P4|Extension Study|Death|0
140886|NCT00600938|449166|P3|Extension Study|Death|0
140887|NCT00600938|449167|P2|Extension Study|Death|0
140888|NCT00600938|449168|P1|Extension Study|Death|1
140889|NCT00600938|449165|P4|Extension Study|Lost to Follow-up|0
140890|NCT00600938|449166|P3|Extension Study|Lost to Follow-up|2
140891|NCT00600938|449167|P2|Extension Study|Lost to Follow-up|1
140892|NCT00600938|449168|P1|Extension Study|Lost to Follow-up|1
140893|NCT00600938|449165|P4|Extension Study|Withdrawal by Subject|0
140894|NCT00600938|449166|P3|Extension Study|Withdrawal by Subject|3
140895|NCT00600938|449167|P2|Extension Study|Withdrawal by Subject|2
140896|NCT00600938|449168|P1|Extension Study|Withdrawal by Subject|2
140897|NCT00600938|449165|P4|Extension Study|Unsatisfactory therapeutic effect|0
140898|NCT00600938|449166|P3|Extension Study|Unsatisfactory therapeutic effect|1
140899|NCT00600938|449167|P2|Extension Study|Unsatisfactory therapeutic effect|1
140900|NCT00600938|449168|P1|Extension Study|Unsatisfactory therapeutic effect|4
140901|NCT00600938|449165|P4|Extension Study|Abnormal test procedure results|1
140902|NCT00600938|449166|P3|Extension Study|Abnormal test procedure results|1
140903|NCT00600938|449167|P2|Extension Study|Abnormal test procedure results|1
140904|NCT00600938|449168|P1|Extension Study|Abnormal test procedure results|0
140905|NCT00600938|449165|P4|Extension Study|Adverse Event|0
140906|NCT00600938|449166|P3|Extension Study|Adverse Event|2
140907|NCT00600938|449167|P2|Extension Study|Adverse Event|0
140908|NCT00600938|449168|P1|Extension Study|Adverse Event|1
140909|NCT00600938|449165|P4|Core Study|Protocol Violation|0
140910|NCT00600938|449166|P3|Core Study|Protocol Violation|0
140911|NCT00600938|449167|P2|Core Study|Protocol Violation|2
140912|NCT00600938|449168|P1|Core Study|Protocol Violation|1
140913|NCT00600938|449165|P4|Core Study|Death|0
140914|NCT00600938|449166|P3|Core Study|Death|0
140915|NCT00600938|449167|P2|Core Study|Death|1
140916|NCT00600938|449168|P1|Core Study|Death|1
140917|NCT00600938|449165|P4|Core Study|Lost to Follow-up|0
140918|NCT00600938|449166|P3|Core Study|Lost to Follow-up|0
140919|NCT00600938|449167|P2|Core Study|Lost to Follow-up|2
140920|NCT00600938|449168|P1|Core Study|Lost to Follow-up|3
140921|NCT00600938|449165|P4|Core Study|Patient withdrew consent|0
140922|NCT00600938|449166|P3|Core Study|Patient withdrew consent|0
140923|NCT00600938|449167|P2|Core Study|Patient withdrew consent|12
140924|NCT00600938|449168|P1|Core Study|Patient withdrew consent|7
140925|NCT00600938|449165|P4|Core Study|Unsatisfactory therapeutic effect|0
140926|NCT00600938|449166|P3|Core Study|Unsatisfactory therapeutic effect|0
140927|NCT00600938|449167|P2|Core Study|Unsatisfactory therapeutic effect|2
140928|NCT00600938|449168|P1|Core Study|Unsatisfactory therapeutic effect|1
140929|NCT00600938|449165|P4|Core Study|Abnormal test procedure result(s)|0
140930|NCT00600938|449166|P3|Core Study|Abnormal test procedure result(s)|0
140931|NCT00600938|449167|P2|Core Study|Abnormal test procedure result(s)|2
140932|NCT00600938|449168|P1|Core Study|Abnormal test procedure result(s)|3
140933|NCT00601107|449234|P4|Overall Study|Undefined|0
140934|NCT00601107|449235|P3|Overall Study|Undefined|1
140935|NCT00601107|449236|P2|Overall Study|Undefined|0
140936|NCT00601107|449237|P1|Overall Study|Undefined|1
140937|NCT00601107|449234|P4|Overall Study|Worsening of Psoriasis|4
140938|NCT00601107|449235|P3|Overall Study|Worsening of Psoriasis|1
140939|NCT00601107|449236|P2|Overall Study|Worsening of Psoriasis|1
140940|NCT00601107|449237|P1|Overall Study|Worsening of Psoriasis|4
140941|NCT00601107|449234|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
140942|NCT00601107|449235|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
140943|NCT00601107|449236|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
140944|NCT00601107|449237|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
140945|NCT00601107|449234|P4|Overall Study|Lost to Follow-up|3
140946|NCT00601107|449235|P3|Overall Study|Lost to Follow-up|0
140947|NCT00601107|449236|P2|Overall Study|Lost to Follow-up|3
140948|NCT00601107|449237|P1|Overall Study|Lost to Follow-up|3
140949|NCT00601107|449234|P4|Overall Study|Withdrawal by Subject|4
140950|NCT00601107|449235|P3|Overall Study|Withdrawal by Subject|7
140951|NCT00601107|449236|P2|Overall Study|Withdrawal by Subject|4
140952|NCT00601107|449237|P1|Overall Study|Withdrawal by Subject|5
140953|NCT00601107|449234|P4|Overall Study|Adverse Event|0
140954|NCT00601107|449235|P3|Overall Study|Adverse Event|3
140955|NCT00601107|449236|P2|Overall Study|Adverse Event|1
140956|NCT00601107|449237|P1|Overall Study|Adverse Event|0
140957|NCT00606892|449259|P2|First Intervention|Protocol Violation|4
140958|NCT00606892|449260|P1|First Intervention|Protocol Violation|1
140959|NCT00606905|449294|P2|Overall Study|Withdrew|5
140960|NCT00606905|449295|P1|Overall Study|Withdrew|5
140961|NCT00606905|449294|P2|Overall Study|Non-Index Pregnancy|4
140962|NCT00606905|449295|P1|Overall Study|Non-Index Pregnancy|1
140963|NCT00606905|449294|P2|Overall Study|No Pregnancy|6
140964|NCT00606905|449295|P1|Overall Study|No Pregnancy|9
140965|NCT00606931|449301|P1|Overall Study|Withdrawal by Subject|3
140966|NCT00607048|449318|P6|Overall Study|Unspecified|1
140967|NCT00607048|449319|P5|Overall Study|Unspecified|0
140968|NCT00607048|449320|P4|Overall Study|Unspecified|0
140969|NCT00607048|449321|P3|Overall Study|Unspecified|0
140970|NCT00607048|449322|P2|Overall Study|Unspecified|1
140971|NCT00607048|449323|P1|Overall Study|Unspecified|1
140972|NCT00607048|449318|P6|Overall Study|Withdrawal by Subject|2
140973|NCT00607048|449319|P5|Overall Study|Withdrawal by Subject|0
140974|NCT00607048|449320|P4|Overall Study|Withdrawal by Subject|1
140975|NCT00607048|449321|P3|Overall Study|Withdrawal by Subject|0
140976|NCT00607048|449322|P2|Overall Study|Withdrawal by Subject|0
140977|NCT00607048|449323|P1|Overall Study|Withdrawal by Subject|0
140978|NCT00607048|449318|P6|Overall Study|Objective disease progression - relapse|2
140979|NCT00607048|449319|P5|Overall Study|Objective disease progression - relapse|2
140980|NCT00607048|449320|P4|Overall Study|Objective disease progression - relapse|2
140981|NCT00607048|449321|P3|Overall Study|Objective disease progression - relapse|4
140982|NCT00607048|449322|P2|Overall Study|Objective disease progression - relapse|2
140983|NCT00607048|449323|P1|Overall Study|Objective disease progression - relapse|1
140984|NCT00607048|449318|P6|Overall Study|Global deterioration of health|0
140985|NCT00607048|449319|P5|Overall Study|Global deterioration of health|0
140986|NCT00607048|449320|P4|Overall Study|Global deterioration of health|0
140987|NCT00607048|449321|P3|Overall Study|Global deterioration of health|0
140988|NCT00607048|449322|P2|Overall Study|Global deterioration of health|0
140989|NCT00607048|449323|P1|Overall Study|Global deterioration of health|1
140990|NCT00607048|449318|P6|Overall Study|Adverse Event|0
140991|NCT00607048|449319|P5|Overall Study|Adverse Event|4
140992|NCT00607048|449320|P4|Overall Study|Adverse Event|0
140993|NCT00607048|449321|P3|Overall Study|Adverse Event|0
140994|NCT00607048|449322|P2|Overall Study|Adverse Event|1
140995|NCT00607048|449323|P1|Overall Study|Adverse Event|0
140996|NCT00607087|449408|P3|Period 3|Adverse Event|0
140997|NCT00607087|449409|P2|Period 3|Adverse Event|1
140998|NCT00607087|449410|P1|Period 3|Adverse Event|0
140999|NCT00607087|449408|P3|Period 3|Withdrawal by Subject|0
141000|NCT00607087|449409|P2|Period 3|Withdrawal by Subject|1
141001|NCT00607087|449410|P1|Period 3|Withdrawal by Subject|2
141002|NCT00607087|449408|P3|Period 2|Poor compliance to protocol|1
141003|NCT00607087|449409|P2|Period 2|Poor compliance to protocol|0
141004|NCT00607087|449410|P1|Period 2|Poor compliance to protocol|0
141005|NCT00607087|449408|P3|Period 2|Adverse Event|3
141006|NCT00607087|449409|P2|Period 2|Adverse Event|1
141007|NCT00607087|449410|P1|Period 2|Adverse Event|0
141008|NCT00607087|449408|P3|Period 2|Other reason|0
141009|NCT00607087|449409|P2|Period 2|Other reason|1
141010|NCT00607087|449410|P1|Period 2|Other reason|1
141011|NCT00607087|449408|P3|Period 2|Withdrawal by Subject|1
141012|NCT00607087|449409|P2|Period 2|Withdrawal by Subject|1
141013|NCT00607087|449410|P1|Period 2|Withdrawal by Subject|0
141014|NCT00607087|449408|P3|Period 1|Other reason|2
141015|NCT00607087|449409|P2|Period 1|Other reason|4
141016|NCT00607087|449410|P1|Period 1|Other reason|0
141017|NCT00607087|449408|P3|Period 1|Lost to Follow-up|0
141018|NCT00607087|449409|P2|Period 1|Lost to Follow-up|0
141019|NCT00607087|449410|P1|Period 1|Lost to Follow-up|1
141020|NCT00607087|449408|P3|Period 1|Poor compliance to protocol|0
141021|NCT00607087|449409|P2|Period 1|Poor compliance to protocol|0
141022|NCT00607087|449410|P1|Period 1|Poor compliance to protocol|1
141023|NCT00607087|449408|P3|Period 1|Adverse Event|0
141024|NCT00607087|449409|P2|Period 1|Adverse Event|0
141025|NCT00607087|449410|P1|Period 1|Adverse Event|3
141026|NCT00607087|449408|P3|Period 1|Withdrawal by Subject|3
141027|NCT00607087|449409|P2|Period 1|Withdrawal by Subject|2
141028|NCT00607087|449410|P1|Period 1|Withdrawal by Subject|7
141029|NCT00607087|449408|P3|Overall Study|Lost to Follow-up|0
141030|NCT00607087|449409|P2|Overall Study|Lost to Follow-up|0
141031|NCT00607087|449410|P1|Overall Study|Lost to Follow-up|1
141032|NCT00607087|449408|P3|Overall Study|Poor compliance to protocol|1
141033|NCT00607087|449409|P2|Overall Study|Poor compliance to protocol|0
141034|NCT00607087|449410|P1|Overall Study|Poor compliance to protocol|1
141035|NCT00607087|449408|P3|Overall Study|Other reason|2
141036|NCT00607087|449409|P2|Overall Study|Other reason|5
141037|NCT00607087|449410|P1|Overall Study|Other reason|1
141038|NCT00607087|449408|P3|Overall Study|Adverse Event|3
141039|NCT00607087|449409|P2|Overall Study|Adverse Event|2
141040|NCT00607087|449410|P1|Overall Study|Adverse Event|3
141041|NCT00607087|449408|P3|Overall Study|Withdrawal by Subject|4
141042|NCT00607087|449409|P2|Overall Study|Withdrawal by Subject|4
141043|NCT00607087|449410|P1|Overall Study|Withdrawal by Subject|9
141044|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
141045|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
141046|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
141047|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
141048|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
141049|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
141050|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
141051|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
141052|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
141053|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
141054|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
141055|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
141056|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
141057|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
141058|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
141059|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
141060|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
141061|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
141062|NCT00611455|449536|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
141063|NCT00611455|449537|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
141064|NCT00611455|449538|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
141065|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
141066|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
141067|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
141068|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
141069|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
141070|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
141071|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
141072|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
141073|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
141074|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
141075|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
141076|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
141077|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
141078|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
141079|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
141080|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
141081|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
141082|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
141083|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
141084|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
141085|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
141086|NCT00611455|449536|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
141087|NCT00611455|449537|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
141088|NCT00611455|449538|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
141089|NCT00611455|449536|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
141090|NCT00611455|449537|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
141091|NCT00611455|449538|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
141092|NCT00611455|449536|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
141093|NCT00611455|449537|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
141094|NCT00611455|449538|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
141095|NCT00611455|449536|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
141096|NCT00611455|449537|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
141097|NCT00611455|449538|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
141098|NCT00611455|449536|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
141099|NCT00611455|449537|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
141100|NCT00611455|449538|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
141101|NCT00611455|449536|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
141102|NCT00611455|449537|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
141103|NCT00611455|449538|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
141104|NCT00611455|449536|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
141105|NCT00611455|449537|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
141106|NCT00611455|449538|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
141107|NCT00611533|449677|P2|Second Intervention (6 Weeks)|Adverse Event|2
141108|NCT00611533|449678|P1|Second Intervention (6 Weeks)|Adverse Event|0
141109|NCT00611533|449677|P2|First Intervention (6 Weeks)|Adverse Event|1
141110|NCT00611533|449678|P1|First Intervention (6 Weeks)|Adverse Event|0
141111|NCT00611533|449677|P2|First Intervention (6 Weeks)|Never started study|1
141112|NCT00611533|449678|P1|First Intervention (6 Weeks)|Never started study|0
141113|NCT00611559|449700|P3|Overall Study|Protocol Violation|1
141114|NCT00611559|449701|P2|Overall Study|Protocol Violation|0
141115|NCT00611559|449702|P1|Overall Study|Protocol Violation|1
141116|NCT00611559|449700|P3|Overall Study|Lost to Follow-up|0
141117|NCT00611559|449701|P2|Overall Study|Lost to Follow-up|1
141118|NCT00611559|449702|P1|Overall Study|Lost to Follow-up|0
141119|NCT00611715|449768|P2|Overall Study|two patients are still on treatment|0
141120|NCT00611715|449769|P1|Overall Study|two patients are still on treatment|2
141121|NCT00611715|449768|P2|Overall Study|Death|0
141122|NCT00611715|449769|P1|Overall Study|Death|1
141123|NCT00611715|449768|P2|Overall Study|Adverse Event|1
141124|NCT00611715|449769|P1|Overall Study|Adverse Event|9
141125|NCT00611715|449768|P2|Overall Study|Withdrawal by Subject|1
141126|NCT00611715|449769|P1|Overall Study|Withdrawal by Subject|5
141127|NCT00611715|449768|P2|Overall Study|Disease Progression|4
141128|NCT00611715|449769|P1|Overall Study|Disease Progression|24
141129|NCT00611767|449783|P2|Overall Study|Physician Decision|0
141130|NCT00611767|449784|P1|Overall Study|Physician Decision|1
141131|NCT00611767|449783|P2|Overall Study|didn't like the medication|1
141132|NCT00611767|449784|P1|Overall Study|didn't like the medication|1
141133|NCT00611767|449783|P2|Overall Study|Thiopental not available|0
141134|NCT00611767|449784|P1|Overall Study|Thiopental not available|3
141135|NCT00611767|449783|P2|Overall Study|Withdrawal by Subject|1
141136|NCT00611767|449784|P1|Overall Study|Withdrawal by Subject|4
141137|NCT00611806|449946|P2|Overall Study|Lost to Follow-up|0
141138|NCT00611806|449947|P1|Overall Study|Lost to Follow-up|6
141139|NCT00611806|449946|P2|Overall Study|Adverse Event|1
141140|NCT00611806|449947|P1|Overall Study|Adverse Event|2
141141|NCT00611806|449946|P2|Overall Study|Withdrawal by Subject|2
141142|NCT00611806|449947|P1|Overall Study|Withdrawal by Subject|8
141143|NCT00611884|449963|P4|Overall Study|Unclassified|3
141144|NCT00611884|449964|P3|Overall Study|Unclassified|2
141145|NCT00611884|449965|P2|Overall Study|Unclassified|4
141146|NCT00611884|449966|P1|Overall Study|Unclassified|7
141147|NCT00611884|449963|P4|Overall Study|Lack of Efficacy|0
141148|NCT00611884|449964|P3|Overall Study|Lack of Efficacy|0
141149|NCT00611884|449965|P2|Overall Study|Lack of Efficacy|1
141150|NCT00611884|449966|P1|Overall Study|Lack of Efficacy|0
141151|NCT00611884|449963|P4|Overall Study|Non-Compliance|2
141152|NCT00611884|449964|P3|Overall Study|Non-Compliance|2
141153|NCT00611884|449965|P2|Overall Study|Non-Compliance|4
141154|NCT00611884|449966|P1|Overall Study|Non-Compliance|1
141155|NCT00611884|449963|P4|Overall Study|Adverse Event|1
141156|NCT00611884|449964|P3|Overall Study|Adverse Event|0
141157|NCT00611884|449965|P2|Overall Study|Adverse Event|0
141158|NCT00611884|449966|P1|Overall Study|Adverse Event|1
141159|NCT00612040|450048|P3|Overall Study|Unclassified|5
141160|NCT00612040|450049|P2|Overall Study|Unclassified|2
141161|NCT00612040|450050|P1|Overall Study|Unclassified|2
141162|NCT00612040|450048|P3|Overall Study|Lack of Efficacy|0
141163|NCT00612040|450049|P2|Overall Study|Lack of Efficacy|1
141164|NCT00612040|450050|P1|Overall Study|Lack of Efficacy|2
141165|NCT00612040|450048|P3|Overall Study|Protocol Violation|1
141166|NCT00612040|450049|P2|Overall Study|Protocol Violation|2
141167|NCT00612040|450050|P1|Overall Study|Protocol Violation|1
141168|NCT00612040|450048|P3|Overall Study|Adverse Event|1
141169|NCT00612040|450049|P2|Overall Study|Adverse Event|2
141170|NCT00612040|450050|P1|Overall Study|Adverse Event|0
141171|NCT00612066|450094|P1|Overall Study|Adverse Event|1
141172|NCT00612105|450100|P2|Period Title 3: 3-Week Taper Phase|Other|0
141173|NCT00612105|450101|P1|Period Title 3: 3-Week Taper Phase|Other|1
141174|NCT00612105|450100|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
141175|NCT00612105|450101|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
141176|NCT00612105|450100|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
141177|NCT00612105|450101|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
141178|NCT00612105|450100|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
141179|NCT00612105|450101|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
141180|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Other|1
141181|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Other|0
141182|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
141183|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
141184|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
141185|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
141186|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
141187|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
141188|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
141189|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
141190|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
141191|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
141192|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
141193|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
141194|NCT00612105|450100|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
141195|NCT00612105|450101|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
141196|NCT00612313|450159|P2|Overall Study|Lost to Follow-up|4
141197|NCT00612313|450160|P1|Overall Study|Lost to Follow-up|11
141198|NCT00612313|450159|P2|Overall Study|Withdrawal by Subject|9
141199|NCT00612313|450160|P1|Overall Study|Withdrawal by Subject|6
141200|NCT00612352|450182|P2|Overall Study|didn't return calls/show up on test date|1
141201|NCT00612352|450183|P1|Overall Study|didn't return calls/show up on test date|4
141202|NCT00612352|450182|P2|Overall Study|moved out of state|0
141203|NCT00612352|450183|P1|Overall Study|moved out of state|1
141204|NCT00612352|450182|P2|Overall Study|Withdrawal by Subject|5
141205|NCT00612352|450183|P1|Overall Study|Withdrawal by Subject|3
141206|NCT00612352|450182|P2|Overall Study|Adverse Event|0
141207|NCT00612352|450183|P1|Overall Study|Adverse Event|1
141208|NCT00612508|450316|P2|Overall Study|Withdrawal by Subject|4
141209|NCT00612508|450317|P1|Overall Study|Withdrawal by Subject|3
141210|NCT00612534|450329|P4|Overall Study|Other Reason|0
141211|NCT00612534|450330|P3|Overall Study|Other Reason|0
141212|NCT00612534|450331|P2|Overall Study|Other Reason|1
141213|NCT00612534|450332|P1|Overall Study|Other Reason|0
141214|NCT00612534|450329|P4|Overall Study|Lack of Efficacy|16
141215|NCT00612534|450330|P3|Overall Study|Lack of Efficacy|5
141216|NCT00612534|450331|P2|Overall Study|Lack of Efficacy|12
141217|NCT00612534|450332|P1|Overall Study|Lack of Efficacy|13
141218|NCT00612534|450329|P4|Overall Study|Adverse Event|1
141219|NCT00612534|450330|P3|Overall Study|Adverse Event|2
141220|NCT00612534|450331|P2|Overall Study|Adverse Event|4
141221|NCT00612534|450332|P1|Overall Study|Adverse Event|0
141222|NCT00612677|450400|P1|Overall Study|study closed before treatment started|1
141223|NCT00612690|450408|P2|Overall Study|Withdrawal by Site|0
141224|NCT00612690|450409|P1|Overall Study|Withdrawal by Site|11
141225|NCT00612690|450408|P2|Overall Study|Withdrawal by Subject|20
141226|NCT00612690|450409|P1|Overall Study|Withdrawal by Subject|32
141227|NCT00612690|450408|P2|Overall Study|Lost to Follow-up|98
141228|NCT00612690|450409|P1|Overall Study|Lost to Follow-up|72
141229|NCT00612807|450419|P2|Overall Study|Withdrawal by Subject|0
141230|NCT00612807|450420|P1|Overall Study|Withdrawal by Subject|2
141231|NCT00613015|450448|P6|Overall Study|Lost to Follow-up|3
141232|NCT00613015|450449|P5|Overall Study|Lost to Follow-up|2
141233|NCT00613015|450450|P4|Overall Study|Lost to Follow-up|3
141234|NCT00613015|450451|P3|Overall Study|Lost to Follow-up|3
141235|NCT00613015|450452|P2|Overall Study|Lost to Follow-up|1
141236|NCT00613015|450453|P1|Overall Study|Lost to Follow-up|0
141237|NCT00613080|450490|P1|Overall Study|Ineligible / no protocol treatment|11
141238|NCT00613106|450496|P2|Overall Study|misc|3
141239|NCT00613106|450497|P1|Overall Study|misc|4
141240|NCT00613106|450496|P2|Overall Study|Lost to Follow-up|2
141241|NCT00613106|450497|P1|Overall Study|Lost to Follow-up|7
141242|NCT00613106|450496|P2|Overall Study|Withdrawal by Subject|3
141243|NCT00613106|450497|P1|Overall Study|Withdrawal by Subject|6
141244|NCT00613106|450496|P2|Overall Study|Adverse Event|1
141245|NCT00613106|450497|P1|Overall Study|Adverse Event|3
141246|NCT00613301|450503|P1|Overall Study|Irregularly enrolled patients|12
141247|NCT00613301|450503|P1|Overall Study|No data was collected|53
141248|NCT00613301|450503|P1|Overall Study|Physician Decision|2
141249|NCT00613301|450503|P1|Overall Study|Lack of Efficacy|13
141250|NCT00613301|450503|P1|Overall Study|Death|6
141251|NCT00613301|450503|P1|Overall Study|Withdrawal by Subject|5
141252|NCT00613301|450503|P1|Overall Study|Lost to Follow-up|88
141253|NCT00613301|450503|P1|Overall Study|Adverse Event|49
141254|NCT00613314|450510|P1|Overall Study|Other reason not defined above|90
141255|NCT00613314|450510|P1|Overall Study|Lost to Follow-up|46
141256|NCT00613314|450510|P1|Overall Study|Protocol Violation|14
141257|NCT00613314|450510|P1|Overall Study|Adverse Event|5
141258|NCT00613327|450518|P1|Overall Study|Unspecified|47
141259|NCT00613327|450518|P1|Overall Study|Protocol Violation|2
141260|NCT00613327|450518|P1|Overall Study|Withdrawal by Subject|6
141261|NCT00613327|450518|P1|Overall Study|Lost to Follow-up|8
141262|NCT00613327|450518|P1|Overall Study|Adverse Event|38
141263|NCT00613366|450539|P2|Overall Study|Withdrawal by Subject|2
141264|NCT00613366|450540|P1|Overall Study|Withdrawal by Subject|3
141265|NCT00613509|450572|P2|Cycle 1|Other administrative reason|1
141266|NCT00613509|450573|P1|Cycle 1|Other administrative reason|0
141267|NCT00613509|450572|P2|Cycle 1|Unacceptable Toxicity|0
141268|NCT00613509|450573|P1|Cycle 1|Unacceptable Toxicity|1
141269|NCT00613509|450572|P2|Cycle 1|Disease Progression|6
141270|NCT00613509|450573|P1|Cycle 1|Disease Progression|2
141271|NCT00613509|450572|P2|Cycle 1|Adverse Event|1
141272|NCT00613509|450573|P1|Cycle 1|Adverse Event|2
141273|NCT00613574|450595|P1|Overall Study|Other|1
141274|NCT00613574|450595|P1|Overall Study|Lost to Follow-up|2
141275|NCT00613574|450595|P1|Overall Study|Adverse Event|3
141276|NCT00613626|450608|P3|Overall Study|Ineligible|0
141277|NCT00613626|450609|P2|Overall Study|Ineligible|1
141278|NCT00613626|450610|P1|Overall Study|Ineligible|0
141279|NCT00613730|450626|P1|Overall Study|Administrative decision|1
141280|NCT00613730|450626|P1|Overall Study|Disease progression|2
141281|NCT00604162|450632|P1|Overall Study|Withdrawal by Subject|1
141282|NCT00604162|450632|P1|Overall Study|Physician Decision|3
141283|NCT00604175|450646|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
141284|NCT00604175|450647|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
141285|NCT00604175|450648|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
141286|NCT00604175|450646|P3|Week 29 Through Week 72|Site closure|0
141287|NCT00604175|450647|P2|Week 29 Through Week 72|Site closure|1
141288|NCT00604175|450648|P1|Week 29 Through Week 72|Site closure|0
141289|NCT00604175|450646|P3|Week 29 Through Week 72|Lost to Follow-up|2
141290|NCT00604175|450647|P2|Week 29 Through Week 72|Lost to Follow-up|6
141291|NCT00604175|450648|P1|Week 29 Through Week 72|Lost to Follow-up|12
141292|NCT00604175|450646|P3|Week 29 Through Week 72|Death|1
141293|NCT00604175|450647|P2|Week 29 Through Week 72|Death|0
141294|NCT00604175|450648|P1|Week 29 Through Week 72|Death|0
141295|NCT00604175|450646|P3|Entry Through Week 28|Did not start intervention|1
141296|NCT00604175|450647|P2|Entry Through Week 28|Did not start intervention|0
141297|NCT00604175|450648|P1|Entry Through Week 28|Did not start intervention|2
141298|NCT00604175|450646|P3|Entry Through Week 28|Ineligible|0
141299|NCT00604175|450647|P2|Entry Through Week 28|Ineligible|0
141300|NCT00604175|450648|P1|Entry Through Week 28|Ineligible|1
141301|NCT00604175|450646|P3|Entry Through Week 28|Lost to Follow-up|0
141302|NCT00604175|450647|P2|Entry Through Week 28|Lost to Follow-up|3
141303|NCT00604175|450648|P1|Entry Through Week 28|Lost to Follow-up|4
141304|NCT00604175|450646|P3|Entry Through Week 28|Withdrawal by Subject|0
141305|NCT00604175|450647|P2|Entry Through Week 28|Withdrawal by Subject|0
141306|NCT00604175|450648|P1|Entry Through Week 28|Withdrawal by Subject|1
141307|NCT00604175|450646|P3|Entry Through Week 28|Death|0
141308|NCT00604175|450647|P2|Entry Through Week 28|Death|0
141309|NCT00604175|450648|P1|Entry Through Week 28|Death|2
141310|NCT00604188|450703|P2|Overall Study|Did not receive study drug|1
141311|NCT00604188|450704|P1|Overall Study|Did not receive study drug|0
141312|NCT00604188|450703|P2|Overall Study|Non-compliance with protocol|4
141313|NCT00604188|450704|P1|Overall Study|Non-compliance with protocol|4
141314|NCT00604188|450703|P2|Overall Study|Withdrawal by Subject|1
141315|NCT00604188|450704|P1|Overall Study|Withdrawal by Subject|5
141316|NCT00604188|450703|P2|Overall Study|Lost to Follow-up|15
141317|NCT00604188|450704|P1|Overall Study|Lost to Follow-up|17
141318|NCT00604188|450703|P2|Overall Study|Adverse Event|4
141319|NCT00604188|450704|P1|Overall Study|Adverse Event|1
141320|NCT00604214|450726|P2|Day 91 to Day 180|Withdrawal by Subject|1
141321|NCT00604214|450727|P1|Day 91 to Day 180|Withdrawal by Subject|1
141322|NCT00604214|450726|P2|Day 91 to Day 180|Lost to Follow-up|8
141323|NCT00604214|450727|P1|Day 91 to Day 180|Lost to Follow-up|6
141324|NCT00604214|450726|P2|Day 91 to Day 180|Death|23
141325|NCT00604214|450727|P1|Day 91 to Day 180|Death|19
141326|NCT00604214|450726|P2|Day 29 to Day 90|Withdrawal by Subject|6
141327|NCT00604214|450727|P1|Day 29 to Day 90|Withdrawal by Subject|0
141328|NCT00604214|450726|P2|Day 29 to Day 90|Lost to Follow-up|6
141329|NCT00604214|450727|P1|Day 29 to Day 90|Lost to Follow-up|4
141330|NCT00604214|450726|P2|Day 29 to Day 90|Death|67
141331|NCT00604214|450727|P1|Day 29 to Day 90|Death|64
141332|NCT00604214|450726|P2|Baseline to Day 28|Withdrawal by Subject|7
141333|NCT00604214|450727|P1|Baseline to Day 28|Withdrawal by Subject|3
141334|NCT00604214|450726|P2|Baseline to Day 28|Lost to Follow-up|4
141335|NCT00604214|450727|P1|Baseline to Day 28|Lost to Follow-up|2
141336|NCT00604214|450726|P2|Baseline to Day 28|Death|202
141337|NCT00604214|450727|P1|Baseline to Day 28|Death|223
141338|NCT00604279|450759|P2|Overall Study|unspecified|4
141339|NCT00604279|450760|P1|Overall Study|unspecified|8
141340|NCT00604279|450759|P2|Overall Study|Adverse Event|5
141341|NCT00604279|450760|P1|Overall Study|Adverse Event|4
141342|NCT00604279|450759|P2|Overall Study|Withdrawal by Subject|5
141343|NCT00604279|450760|P1|Overall Study|Withdrawal by Subject|16
141344|NCT00604279|450759|P2|Overall Study|Protocol Violation|1
141345|NCT00604279|450760|P1|Overall Study|Protocol Violation|3
141346|NCT00604279|450759|P2|Overall Study|Pregnancy|0
141347|NCT00604279|450760|P1|Overall Study|Pregnancy|2
141348|NCT00604279|450759|P2|Overall Study|Lost to Follow-up|14
141349|NCT00604279|450760|P1|Overall Study|Lost to Follow-up|9
141350|NCT00604279|450759|P2|Overall Study|Lack of Efficacy|9
141351|NCT00604279|450760|P1|Overall Study|Lack of Efficacy|22
141352|NCT00613821|450776|P2|Overall Study|Physician Decision|1
141353|NCT00613821|450777|P1|Overall Study|Physician Decision|1
141354|NCT00613821|450776|P2|Overall Study|Withdrawal by Subject|0
141355|NCT00613821|450777|P1|Overall Study|Withdrawal by Subject|1
141356|NCT00613925|450785|P2|Overall Study|1 did not tolerate outpatient biopsy|1
141357|NCT00613925|450786|P1|Overall Study|1 did not tolerate outpatient biopsy|0
141358|NCT00613938|450798|P4|Overall Study|Other|3
141359|NCT00613938|450799|P3|Overall Study|Other|1
141360|NCT00613938|450800|P2|Overall Study|Other|2
141361|NCT00613938|450801|P1|Overall Study|Other|1
141362|NCT00613938|450798|P4|Overall Study|Lack of Efficacy|9
141363|NCT00613938|450799|P3|Overall Study|Lack of Efficacy|5
141364|NCT00613938|450800|P2|Overall Study|Lack of Efficacy|18
141365|NCT00613938|450801|P1|Overall Study|Lack of Efficacy|16
141366|NCT00613938|450798|P4|Overall Study|Adverse Event|5
141367|NCT00613938|450799|P3|Overall Study|Adverse Event|8
141368|NCT00613938|450800|P2|Overall Study|Adverse Event|4
141369|NCT00613938|450801|P1|Overall Study|Adverse Event|1
141370|NCT00613938|450798|P4|Overall Study|Withdrawal by Subject|9
141371|NCT00613938|450799|P3|Overall Study|Withdrawal by Subject|9
141372|NCT00613938|450800|P2|Overall Study|Withdrawal by Subject|4
141373|NCT00613938|450801|P1|Overall Study|Withdrawal by Subject|2
141374|NCT00613951|450834|P3|Overall Study|Unclassified|2
141375|NCT00613951|450835|P2|Overall Study|Unclassified|3
141376|NCT00613951|450836|P1|Overall Study|Unclassified|5
141377|NCT00613951|450834|P3|Overall Study|Protocol Violation|1
141378|NCT00613951|450835|P2|Overall Study|Protocol Violation|1
141379|NCT00613951|450836|P1|Overall Study|Protocol Violation|1
141380|NCT00613951|450834|P3|Overall Study|Lack of Efficacy|1
141381|NCT00613951|450835|P2|Overall Study|Lack of Efficacy|1
141382|NCT00613951|450836|P1|Overall Study|Lack of Efficacy|0
141383|NCT00613951|450834|P3|Overall Study|Adverse Event|1
141384|NCT00613951|450835|P2|Overall Study|Adverse Event|0
141385|NCT00613951|450836|P1|Overall Study|Adverse Event|1
141386|NCT00614055|450880|P3|Overall Study|Unclassified|2
141387|NCT00614055|450881|P2|Overall Study|Unclassified|4
141388|NCT00614055|450882|P1|Overall Study|Unclassified|1
141389|NCT00614055|450880|P3|Overall Study|Lack of Efficacy|2
141390|NCT00614055|450881|P2|Overall Study|Lack of Efficacy|0
141391|NCT00614055|450882|P1|Overall Study|Lack of Efficacy|0
141392|NCT00614055|450880|P3|Overall Study|Protocol Violation|1
141393|NCT00614055|450881|P2|Overall Study|Protocol Violation|2
141394|NCT00614055|450882|P1|Overall Study|Protocol Violation|2
141395|NCT00614055|450880|P3|Overall Study|Adverse Event|0
141396|NCT00614055|450881|P2|Overall Study|Adverse Event|0
141397|NCT00614055|450882|P1|Overall Study|Adverse Event|1
141398|NCT00614120|450930|P4|Overall Study|Lost to Follow-up|4
141399|NCT00614120|450931|P3|Overall Study|Lost to Follow-up|3
141400|NCT00614120|450932|P2|Overall Study|Lost to Follow-up|2
141401|NCT00614120|450933|P1|Overall Study|Lost to Follow-up|1
141402|NCT00614120|450930|P4|Overall Study|Taken inhibition medication eg Prandin|1
141403|NCT00614120|450931|P3|Overall Study|Taken inhibition medication eg Prandin|1
141404|NCT00614120|450932|P2|Overall Study|Taken inhibition medication eg Prandin|0
141405|NCT00614120|450933|P1|Overall Study|Taken inhibition medication eg Prandin|0
141406|NCT00614120|450930|P4|Overall Study|Late syphilis, latent|0
141407|NCT00614120|450931|P3|Overall Study|Late syphilis, latent|0
141408|NCT00614120|450932|P2|Overall Study|Late syphilis, latent|0
141409|NCT00614120|450933|P1|Overall Study|Late syphilis, latent|1
141410|NCT00614120|450930|P4|Overall Study|Lack of trial product|0
141411|NCT00614120|450931|P3|Overall Study|Lack of trial product|2
141412|NCT00614120|450932|P2|Overall Study|Lack of trial product|3
141413|NCT00614120|450933|P1|Overall Study|Lack of trial product|3
141414|NCT00614120|450930|P4|Overall Study|Hypoglycaemia|1
141415|NCT00614120|450931|P3|Overall Study|Hypoglycaemia|0
141416|NCT00614120|450932|P2|Overall Study|Hypoglycaemia|0
141417|NCT00614120|450933|P1|Overall Study|Hypoglycaemia|0
141418|NCT00614120|450930|P4|Overall Study|hCG positive (not pregnant)|0
141419|NCT00614120|450931|P3|Overall Study|hCG positive (not pregnant)|1
141420|NCT00614120|450932|P2|Overall Study|hCG positive (not pregnant)|0
141421|NCT00614120|450933|P1|Overall Study|hCG positive (not pregnant)|0
141422|NCT00614120|450930|P4|Overall Study|Did not meet trial criteria|1
141423|NCT00614120|450931|P3|Overall Study|Did not meet trial criteria|1
141424|NCT00614120|450932|P2|Overall Study|Did not meet trial criteria|1
141425|NCT00614120|450933|P1|Overall Study|Did not meet trial criteria|0
141426|NCT00614120|450930|P4|Overall Study|Withdrawal by Subject|3
141427|NCT00614120|450931|P3|Overall Study|Withdrawal by Subject|16
141428|NCT00614120|450932|P2|Overall Study|Withdrawal by Subject|10
141429|NCT00614120|450933|P1|Overall Study|Withdrawal by Subject|9
141430|NCT00614120|450930|P4|Overall Study|Withdrawal criteria|0
141431|NCT00614120|450931|P3|Overall Study|Withdrawal criteria|0
141432|NCT00614120|450932|P2|Overall Study|Withdrawal criteria|0
141433|NCT00614120|450933|P1|Overall Study|Withdrawal criteria|1
141434|NCT00614120|450930|P4|Overall Study|Protocol Violation|1
141435|NCT00614120|450931|P3|Overall Study|Protocol Violation|3
141436|NCT00614120|450932|P2|Overall Study|Protocol Violation|5
141437|NCT00614120|450933|P1|Overall Study|Protocol Violation|2
141438|NCT00614120|450930|P4|Overall Study|Lack of Efficacy|2
141439|NCT00614120|450931|P3|Overall Study|Lack of Efficacy|2
141440|NCT00614120|450932|P2|Overall Study|Lack of Efficacy|3
141441|NCT00614120|450933|P1|Overall Study|Lack of Efficacy|3
141442|NCT00614120|450930|P4|Overall Study|Adverse Event|3
141443|NCT00614120|450931|P3|Overall Study|Adverse Event|30
141444|NCT00614120|450932|P2|Overall Study|Adverse Event|22
141445|NCT00614120|450933|P1|Overall Study|Adverse Event|9
141446|NCT00616421|450974|P3|Overall Study|Unable to classify|0
141447|NCT00616421|450975|P2|Overall Study|Unable to classify|0
141448|NCT00616421|450976|P1|Overall Study|Unable to classify|1
141449|NCT00616421|450974|P3|Overall Study|Protocol Violation|2
141450|NCT00616421|450975|P2|Overall Study|Protocol Violation|1
141451|NCT00616421|450976|P1|Overall Study|Protocol Violation|0
141452|NCT00616421|450974|P3|Overall Study|Administrative reason|0
141453|NCT00616421|450975|P2|Overall Study|Administrative reason|0
141454|NCT00616421|450976|P1|Overall Study|Administrative reason|1
141455|NCT00616421|450974|P3|Overall Study|Inappropriate enrollment|1
141456|NCT00616421|450975|P2|Overall Study|Inappropriate enrollment|0
141457|NCT00616421|450976|P1|Overall Study|Inappropriate enrollment|3
141458|NCT00616421|450974|P3|Overall Study|Lost to Follow-up|30
141459|NCT00616421|450975|P2|Overall Study|Lost to Follow-up|26
141460|NCT00616421|450976|P1|Overall Study|Lost to Follow-up|12
141461|NCT00616421|450974|P3|Overall Study|Withdrawal by Subject|8
141462|NCT00616421|450975|P2|Overall Study|Withdrawal by Subject|11
141463|NCT00616421|450976|P1|Overall Study|Withdrawal by Subject|9
141464|NCT00616434|451015|P2|Overall Study|Protocol deviation|1
141465|NCT00616434|451016|P1|Overall Study|Protocol deviation|0
141466|NCT00616434|451015|P2|Overall Study|Withdrawal by Subject|1
141467|NCT00616434|451016|P1|Overall Study|Withdrawal by Subject|1
141468|NCT00616434|451015|P2|Overall Study|Physician Decision|4
141469|NCT00616434|451016|P1|Overall Study|Physician Decision|0
141470|NCT00616434|451015|P2|Overall Study|Adverse Event|2
141471|NCT00616434|451016|P1|Overall Study|Adverse Event|5
141472|NCT00616603|451042|P3|Overall Study|Physician Decision|2
141473|NCT00616603|451043|P2|Overall Study|Physician Decision|0
141474|NCT00616603|451044|P1|Overall Study|Physician Decision|2
141475|NCT00616629|451057|P5|Overall Study|AV-block|0
141476|NCT00616629|451058|P4|Overall Study|AV-block|0
141477|NCT00616629|451059|P3|Overall Study|AV-block|0
141478|NCT00616629|451060|P2|Overall Study|AV-block|0
141479|NCT00616629|451061|P1|Overall Study|AV-block|1
141480|NCT00616629|451057|P5|Overall Study|Protocol Violation|0
141481|NCT00616629|451058|P4|Overall Study|Protocol Violation|0
141482|NCT00616629|451059|P3|Overall Study|Protocol Violation|1
141483|NCT00616629|451060|P2|Overall Study|Protocol Violation|2
141484|NCT00616629|451061|P1|Overall Study|Protocol Violation|1
141485|NCT00616642|451105|P2|Overall Study|Withdrawal by Subject|1
141486|NCT00616642|451106|P1|Overall Study|Withdrawal by Subject|0
141487|NCT00616655|451115|P3|Overall Study|unspecified|5
141488|NCT00616655|451116|P2|Overall Study|unspecified|6
141489|NCT00616655|451117|P1|Overall Study|unspecified|6
141490|NCT00616655|451115|P3|Overall Study|Does not meet in/ex criteria|2
141491|NCT00616655|451116|P2|Overall Study|Does not meet in/ex criteria|0
141492|NCT00616655|451117|P1|Overall Study|Does not meet in/ex criteria|0
141493|NCT00616655|451115|P3|Overall Study|Withdrawal by Subject|11
141494|NCT00616655|451116|P2|Overall Study|Withdrawal by Subject|7
141495|NCT00616655|451117|P1|Overall Study|Withdrawal by Subject|9
141496|NCT00616655|451115|P3|Overall Study|Protocol Violation|3
141497|NCT00616655|451116|P2|Overall Study|Protocol Violation|4
141498|NCT00616655|451117|P1|Overall Study|Protocol Violation|2
141499|NCT00616655|451115|P3|Overall Study|Lost to Follow-up|10
141500|NCT00616655|451116|P2|Overall Study|Lost to Follow-up|12
141501|NCT00616655|451117|P1|Overall Study|Lost to Follow-up|3
141502|NCT00616655|451115|P3|Overall Study|Lack of Efficacy|5
141503|NCT00616655|451116|P2|Overall Study|Lack of Efficacy|5
141504|NCT00616655|451117|P1|Overall Study|Lack of Efficacy|5
141505|NCT00616655|451115|P3|Overall Study|Adverse Event|12
141506|NCT00616655|451116|P2|Overall Study|Adverse Event|7
141507|NCT00616655|451117|P1|Overall Study|Adverse Event|10
141508|NCT00616759|451157|P2|Overall Study|Withdrawal by Subject|2
141509|NCT00616759|451158|P1|Overall Study|Withdrawal by Subject|1
141510|NCT00616759|451157|P2|Overall Study|Physician Decision|0
141511|NCT00616759|451158|P1|Overall Study|Physician Decision|2
141512|NCT00616902|451183|P2|Overall Study|Termination of study|6
141513|NCT00616902|451184|P1|Overall Study|Termination of study|6
141514|NCT00616928|451212|P4|Overall Study|Lost to Follow-up|0
141515|NCT00616928|451213|P3|Overall Study|Lost to Follow-up|0
141516|NCT00616928|451214|P2|Overall Study|Lost to Follow-up|7
141517|NCT00616928|451215|P1|Overall Study|Lost to Follow-up|5
141518|NCT00616928|451212|P4|Overall Study|Unspecified|5
141519|NCT00616928|451213|P3|Overall Study|Unspecified|15
141520|NCT00616928|451214|P2|Overall Study|Unspecified|8
141521|NCT00616928|451215|P1|Overall Study|Unspecified|51
141522|NCT00616928|451212|P4|Overall Study|Adverse Event|2
141523|NCT00616928|451213|P3|Overall Study|Adverse Event|2
141524|NCT00616928|451214|P2|Overall Study|Adverse Event|3
141525|NCT00616928|451215|P1|Overall Study|Adverse Event|6
141526|NCT00616967|451279|P3|Overall Study|Withdrawal by Subject|1
141527|NCT00616967|451280|P2|Overall Study|Withdrawal by Subject|0
141528|NCT00616967|451281|P1|Overall Study|Withdrawal by Subject|0
141529|NCT00617084|451335|P2|Overall Study|Missed 12 Months visit|19
141530|NCT00617084|451336|P1|Overall Study|Missed 12 Months visit|16
141531|NCT00617084|451335|P2|Overall Study|Withdrawal by Subject|7
141532|NCT00617084|451336|P1|Overall Study|Withdrawal by Subject|5
141533|NCT00617123|451361|P2|Study Treatment Period|Noncompliance with Protocol|1
141534|NCT00617123|451362|P1|Study Treatment Period|Noncompliance with Protocol|0
141535|NCT00617123|451361|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
141536|NCT00617123|451362|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
141537|NCT00617123|451361|P2|Study Treatment Period|Adverse Event|3
141538|NCT00617123|451362|P1|Study Treatment Period|Adverse Event|7
141539|NCT00617123|451361|P2|Study Treatment Period|Withdrawal by Subject|12
141540|NCT00617123|451362|P1|Study Treatment Period|Withdrawal by Subject|8
141541|NCT00617123|451361|P2|Referral Screening Period|Adverse Event|1
141542|NCT00617123|451362|P1|Referral Screening Period|Adverse Event|0
141543|NCT00617123|451361|P2|Referral Screening Period|Did Not Wish To Continue|1
141544|NCT00617123|451362|P1|Referral Screening Period|Did Not Wish To Continue|3
141545|NCT00617123|451361|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
141546|NCT00617123|451362|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
141547|NCT00617201|451396|P2|Overall Study|Lost to Follow-up|13
141548|NCT00617201|451397|P1|Overall Study|Lost to Follow-up|9
141549|NCT00617240|451407|P2|Overall Study|Lack of Efficacy|0
141550|NCT00617240|451408|P1|Overall Study|Lack of Efficacy|1
141551|NCT00617279|451428|P2|Overall Study|Death|2
141552|NCT00617279|451429|P1|Overall Study|Death|1
141553|NCT00617279|451428|P2|Overall Study|Lost to Follow-up|0
141554|NCT00617279|451429|P1|Overall Study|Lost to Follow-up|1
141555|NCT00617279|451428|P2|Overall Study|Graft abandonment|0
141556|NCT00617279|451429|P1|Overall Study|Graft abandonment|2
141557|NCT00617279|451428|P2|Overall Study|Study terminated by Sponsor|15
141558|NCT00617279|451429|P1|Overall Study|Study terminated by Sponsor|10
141559|NCT00617305|451486|P3|Overall Study|Withdrawal by Subject|0
141560|NCT00617305|451487|P2|Overall Study|Withdrawal by Subject|0
141561|NCT00617305|451488|P1|Overall Study|Withdrawal by Subject|1
141562|NCT00617305|451486|P3|Overall Study|Protocol Violation|1
141563|NCT00617305|451487|P2|Overall Study|Protocol Violation|0
141564|NCT00617305|451488|P1|Overall Study|Protocol Violation|1
141565|NCT00617305|451486|P3|Overall Study|Physician Decision|0
141566|NCT00617305|451487|P2|Overall Study|Physician Decision|0
141567|NCT00617305|451488|P1|Overall Study|Physician Decision|1
141568|NCT00617305|451486|P3|Overall Study|Death|0
141569|NCT00617305|451487|P2|Overall Study|Death|0
141570|NCT00617305|451488|P1|Overall Study|Death|1
141571|NCT00617305|451486|P3|Overall Study|Adverse Event|0
141572|NCT00617305|451487|P2|Overall Study|Adverse Event|0
141573|NCT00617305|451488|P1|Overall Study|Adverse Event|4
141574|NCT00617357|451542|P1|Overall Study|Physician Decision|1
141575|NCT00617357|451542|P1|Overall Study|Withdrawal by Subject|1
141576|NCT00617357|451542|P1|Overall Study|insurance concerns|2
141577|NCT00617357|451542|P1|Overall Study|Death|5
141578|NCT00617357|451542|P1|Overall Study|Lost to Follow-up|7
141579|NCT00617409|451559|P3|Overall Study|Alternative Therapy|0
141580|NCT00617409|451560|P2|Overall Study|Alternative Therapy|2
141581|NCT00617409|451561|P1|Overall Study|Alternative Therapy|1
141582|NCT00617409|451559|P3|Overall Study|Death|4
141583|NCT00617409|451560|P2|Overall Study|Death|5
141584|NCT00617409|451561|P1|Overall Study|Death|3
141585|NCT00617409|451559|P3|Overall Study|Disease Progression|18
141586|NCT00617409|451560|P2|Overall Study|Disease Progression|8
141587|NCT00617409|451561|P1|Overall Study|Disease Progression|8
141588|NCT00617409|451559|P3|Overall Study|Adverse Event|3
141589|NCT00617409|451560|P2|Overall Study|Adverse Event|2
141590|NCT00617409|451561|P1|Overall Study|Adverse Event|0
141591|NCT00617409|451559|P3|Overall Study|Withdrawal by Subject|2
141592|NCT00617409|451560|P2|Overall Study|Withdrawal by Subject|1
141593|NCT00617409|451561|P1|Overall Study|Withdrawal by Subject|4
141594|NCT00617461|451572|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
141595|NCT00617461|451573|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
141596|NCT00617461|451572|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
141597|NCT00617461|451573|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
141598|NCT00617461|451572|P2|Second Treatment Intervention Period|Lack of Efficacy|3
141599|NCT00617461|451573|P1|Second Treatment Intervention Period|Lack of Efficacy|0
141600|NCT00617461|451572|P2|Second Treatment Intervention Period|Adverse Event|1
141601|NCT00617461|451573|P1|Second Treatment Intervention Period|Adverse Event|0
141602|NCT00617461|451572|P2|4-Day Crossover Period|Withdrawal by Subject|0
141603|NCT00617461|451573|P1|4-Day Crossover Period|Withdrawal by Subject|1
141604|NCT00617461|451572|P2|First Treatment Intervention Period|Withdrawal by Subject|0
141605|NCT00617461|451573|P1|First Treatment Intervention Period|Withdrawal by Subject|4
141606|NCT00617461|451572|P2|First Treatment Intervention Period|Investigator Discretion|1
141607|NCT00617461|451573|P1|First Treatment Intervention Period|Investigator Discretion|1
141608|NCT00617461|451572|P2|First Treatment Intervention Period|Lost to Follow-up|1
141609|NCT00617461|451573|P1|First Treatment Intervention Period|Lost to Follow-up|0
141610|NCT00617461|451572|P2|First Treatment Intervention Period|Protocol Violation|1
141611|NCT00617461|451573|P1|First Treatment Intervention Period|Protocol Violation|2
141612|NCT00617461|451572|P2|First Treatment Intervention Period|Lack of Efficacy|0
141613|NCT00617461|451573|P1|First Treatment Intervention Period|Lack of Efficacy|1
141614|NCT00617461|451572|P2|First Treatment Intervention Period|Adverse Event|0
141615|NCT00617461|451573|P1|First Treatment Intervention Period|Adverse Event|2
141616|NCT00617591|451626|P1|Overall Study|Withdrew consent during Maintenance|6
141617|NCT00617591|451626|P1|Overall Study|Withdrew consent during Induction|4
141618|NCT00617604|451636|P2|Overall Study|Randomized but Never Received Study Drug|3
141619|NCT00617604|451637|P1|Overall Study|Randomized but Never Received Study Drug|3
141620|NCT00617604|451636|P2|Overall Study|Withdrawal by Subject|6
141621|NCT00617604|451637|P1|Overall Study|Withdrawal by Subject|4
141622|NCT00617604|451636|P2|Overall Study|Miscellaneous Reasons|10
141623|NCT00617604|451637|P1|Overall Study|Miscellaneous Reasons|8
141624|NCT00617604|451636|P2|Overall Study|Lost to Follow-up|0
141625|NCT00617604|451637|P1|Overall Study|Lost to Follow-up|1
141626|NCT00617604|451636|P2|Overall Study|Death|1
141627|NCT00617604|451637|P1|Overall Study|Death|2
141628|NCT00617669|451683|P2|Overall Study|Patients randomized but not treated|3
141629|NCT00617669|451684|P1|Overall Study|Patients randomized but not treated|2
141630|NCT00617669|451683|P2|Overall Study|Reason not otherwise captured, eg; death|290
141631|NCT00617669|451684|P1|Overall Study|Reason not otherwise captured, eg; death|265
141632|NCT00617669|451683|P2|Overall Study|Protocol Violation|3
141633|NCT00617669|451684|P1|Overall Study|Protocol Violation|2
141634|NCT00617669|451683|P2|Overall Study|Adverse Event|76
141635|NCT00617669|451684|P1|Overall Study|Adverse Event|87
141636|NCT00617669|451683|P2|Overall Study|Lost to Follow-up|2
141637|NCT00617669|451684|P1|Overall Study|Lost to Follow-up|3
141638|NCT00617669|451683|P2|Overall Study|Withdrawal by Subject|77
141639|NCT00617669|451684|P1|Overall Study|Withdrawal by Subject|71
141640|NCT00617708|451707|P3|Overall Study|Not eligible|5
141641|NCT00617708|451708|P2|Overall Study|Not eligible|3
141642|NCT00617708|451709|P1|Overall Study|Not eligible|1
141643|NCT00617708|451707|P3|Overall Study|Not protocol specified|2
141644|NCT00617708|451708|P2|Overall Study|Not protocol specified|4
141645|NCT00617708|451709|P1|Overall Study|Not protocol specified|1
141646|NCT00617708|451707|P3|Overall Study|Progression/Relapse|36
141647|NCT00617708|451708|P2|Overall Study|Progression/Relapse|40
141648|NCT00617708|451709|P1|Overall Study|Progression/Relapse|7
141649|NCT00617708|451707|P3|Overall Study|Death|5
141650|NCT00617708|451708|P2|Overall Study|Death|6
141651|NCT00617708|451709|P1|Overall Study|Death|0
141652|NCT00617708|451707|P3|Overall Study|Withdrawal by Subject|7
141653|NCT00617708|451708|P2|Overall Study|Withdrawal by Subject|1
141654|NCT00617708|451709|P1|Overall Study|Withdrawal by Subject|1
141655|NCT00617708|451707|P3|Overall Study|Adverse Event|9
141656|NCT00617708|451708|P2|Overall Study|Adverse Event|6
141657|NCT00617708|451709|P1|Overall Study|Adverse Event|0
141658|NCT00617773|451724|P1|Overall Study|Protocol Violation|1
141659|NCT00617773|451724|P1|Overall Study|Progressive disease|19
141660|NCT00617773|451724|P1|Overall Study|Death|1
141661|NCT00617773|451724|P1|Overall Study|Withdrawal by Subject|1
141662|NCT00617773|451724|P1|Overall Study|Lack of compliance with the protocol|1
141663|NCT00617773|451724|P1|Overall Study|Physician Decision|1
141664|NCT00617851|451743|P4|Overall Study|Unable to classify|0
141665|NCT00617851|451744|P3|Overall Study|Unable to classify|1
141666|NCT00617851|451745|P2|Overall Study|Unable to classify|0
141667|NCT00617851|451746|P1|Overall Study|Unable to classify|1
141668|NCT00617851|451743|P4|Overall Study|Inappropriate Enrollment|1
141669|NCT00617851|451744|P3|Overall Study|Inappropriate Enrollment|1
141670|NCT00617851|451745|P2|Overall Study|Inappropriate Enrollment|4
141671|NCT00617851|451746|P1|Overall Study|Inappropriate Enrollment|5
141672|NCT00617851|451743|P4|Overall Study|Lost to Follow-up|19
141673|NCT00617851|451744|P3|Overall Study|Lost to Follow-up|31
141674|NCT00617851|451745|P2|Overall Study|Lost to Follow-up|29
141675|NCT00617851|451746|P1|Overall Study|Lost to Follow-up|27
141676|NCT00617851|451743|P4|Overall Study|Withdrawal by Subject|4
141677|NCT00617851|451744|P3|Overall Study|Withdrawal by Subject|12
141678|NCT00617851|451745|P2|Overall Study|Withdrawal by Subject|7
141679|NCT00617851|451746|P1|Overall Study|Withdrawal by Subject|14
141680|NCT00617851|451743|P4|Overall Study|Death|1
141681|NCT00617851|451744|P3|Overall Study|Death|0
141682|NCT00617851|451745|P2|Overall Study|Death|0
141683|NCT00617851|451746|P1|Overall Study|Death|0
141684|NCT00617890|451788|P4|Overall Study|Not treated|1
141685|NCT00617890|451789|P3|Overall Study|Not treated|1
141686|NCT00617890|451790|P2|Overall Study|Not treated|0
141687|NCT00617890|451791|P1|Overall Study|Not treated|1
141688|NCT00617890|451788|P4|Overall Study|Adverse Event|8
141689|NCT00617890|451789|P3|Overall Study|Adverse Event|3
141690|NCT00617890|451790|P2|Overall Study|Adverse Event|0
141691|NCT00617890|451791|P1|Overall Study|Adverse Event|1
141692|NCT00617890|451788|P4|Overall Study|Protocol Violation|0
141693|NCT00617890|451789|P3|Overall Study|Protocol Violation|0
141694|NCT00617890|451790|P2|Overall Study|Protocol Violation|1
141695|NCT00617890|451791|P1|Overall Study|Protocol Violation|2
141696|NCT00617890|451788|P4|Overall Study|Withdrawal by Subject|2
141697|NCT00617890|451789|P3|Overall Study|Withdrawal by Subject|0
141698|NCT00617890|451790|P2|Overall Study|Withdrawal by Subject|1
141699|NCT00617890|451791|P1|Overall Study|Withdrawal by Subject|4
141700|NCT00617890|451788|P4|Overall Study|Lost to Follow-up|2
141701|NCT00617890|451789|P3|Overall Study|Lost to Follow-up|1
141702|NCT00617890|451790|P2|Overall Study|Lost to Follow-up|0
141703|NCT00617890|451791|P1|Overall Study|Lost to Follow-up|0
141704|NCT00617890|451788|P4|Overall Study|Lack of Efficacy|97
141705|NCT00617890|451789|P3|Overall Study|Lack of Efficacy|30
141706|NCT00617890|451790|P2|Overall Study|Lack of Efficacy|26
141707|NCT00617890|451791|P1|Overall Study|Lack of Efficacy|23
141708|NCT00617890|451788|P4|Overall Study|Treatment ongoing at data cut-off|5
141709|NCT00617890|451789|P3|Overall Study|Treatment ongoing at data cut-off|0
141710|NCT00617890|451790|P2|Overall Study|Treatment ongoing at data cut-off|0
141711|NCT00617890|451791|P1|Overall Study|Treatment ongoing at data cut-off|0
141712|NCT00617903|451825|P2|Overall Study|noncompliance|1
141713|NCT00617903|451826|P1|Overall Study|noncompliance|0
141714|NCT00617903|451825|P2|Overall Study|Adverse Event|1
141715|NCT00617903|451826|P1|Overall Study|Adverse Event|0
141716|NCT00617903|451825|P2|Overall Study|Lack of Efficacy|1
141717|NCT00617903|451826|P1|Overall Study|Lack of Efficacy|0
141718|NCT00617903|451825|P2|Overall Study|Lost to Follow-up|1
141719|NCT00617903|451826|P1|Overall Study|Lost to Follow-up|1
141720|NCT00617903|451825|P2|Overall Study|Withdrawal by Subject|3
141721|NCT00617903|451826|P1|Overall Study|Withdrawal by Subject|2
141722|NCT00617929|451868|P1|Overall Study|Physician Decision|1
141723|NCT00618072|451905|P3|Overall Study|Physician Decision|1
141724|NCT00618072|451906|P2|Overall Study|Physician Decision|1
141725|NCT00618072|451907|P1|Overall Study|Physician Decision|0
141726|NCT00618072|451905|P3|Overall Study|Lost to Follow-up|3
141727|NCT00618072|451906|P2|Overall Study|Lost to Follow-up|0
141728|NCT00618072|451907|P1|Overall Study|Lost to Follow-up|2
141729|NCT00618371|451964|P1|Overall Study|Withdrawal by Subject|2
141730|NCT00618410|451969|P2|Washout Period (2 Weeks)|Physician Decision|1
141731|NCT00618410|451970|P1|Washout Period (2 Weeks)|Physician Decision|0
141732|NCT00618449|452001|P2|Overall Study|Lost to Follow-up|110
141733|NCT00618449|452002|P1|Overall Study|Lost to Follow-up|98
141734|NCT00618514|452010|P3|Overall Study|Lost to Follow-up|4
141735|NCT00618514|452011|P2|Overall Study|Lost to Follow-up|12
141736|NCT00618514|452012|P1|Overall Study|Lost to Follow-up|11
141737|NCT00618618|452045|P4|Overall Study|Death|0
141738|NCT00618618|452046|P3|Overall Study|Death|0
141739|NCT00618618|452047|P2|Overall Study|Death|1
141740|NCT00618618|452048|P1|Overall Study|Death|0
141741|NCT00618618|452045|P4|Overall Study|Did Not Meet Entry Criteria|0
141742|NCT00618618|452046|P3|Overall Study|Did Not Meet Entry Criteria|1
141743|NCT00618618|452047|P2|Overall Study|Did Not Meet Entry Criteria|0
141744|NCT00618618|452048|P1|Overall Study|Did Not Meet Entry Criteria|0
141745|NCT00618618|452045|P4|Overall Study|Non-compliance|0
141746|NCT00618618|452046|P3|Overall Study|Non-compliance|0
141747|NCT00618618|452047|P2|Overall Study|Non-compliance|1
141748|NCT00618618|452048|P1|Overall Study|Non-compliance|1
141749|NCT00618618|452045|P4|Overall Study|Lost to Follow-up|1
141750|NCT00618618|452046|P3|Overall Study|Lost to Follow-up|0
141751|NCT00618618|452047|P2|Overall Study|Lost to Follow-up|0
141752|NCT00618618|452048|P1|Overall Study|Lost to Follow-up|3
141753|NCT00618618|452045|P4|Overall Study|Inability to Complete Study Procedures|0
141754|NCT00618618|452046|P3|Overall Study|Inability to Complete Study Procedures|0
141755|NCT00618618|452047|P2|Overall Study|Inability to Complete Study Procedures|1
141756|NCT00618618|452048|P1|Overall Study|Inability to Complete Study Procedures|0
141757|NCT00618618|452045|P4|Overall Study|Patient Request|0
141758|NCT00618618|452046|P3|Overall Study|Patient Request|2
141759|NCT00618618|452047|P2|Overall Study|Patient Request|0
141760|NCT00618618|452048|P1|Overall Study|Patient Request|0
141761|NCT00618722|452098|P4|Overall Study|Miscellaneous Reasons|1
141762|NCT00618722|452099|P3|Overall Study|Miscellaneous Reasons|1
141763|NCT00618722|452100|P2|Overall Study|Miscellaneous Reasons|0
141764|NCT00618722|452101|P1|Overall Study|Miscellaneous Reasons|0
141765|NCT00618722|452098|P4|Overall Study|Lost to Follow-up|2
141766|NCT00618722|452099|P3|Overall Study|Lost to Follow-up|0
141767|NCT00618722|452100|P2|Overall Study|Lost to Follow-up|0
141768|NCT00618722|452101|P1|Overall Study|Lost to Follow-up|2
141769|NCT00618722|452098|P4|Overall Study|Inability to Complete Study Procedure|0
141770|NCT00618722|452099|P3|Overall Study|Inability to Complete Study Procedure|0
141771|NCT00618722|452100|P2|Overall Study|Inability to Complete Study Procedure|1
141772|NCT00618722|452101|P1|Overall Study|Inability to Complete Study Procedure|0
141773|NCT00618722|452098|P4|Overall Study|Patient Request|1
141774|NCT00618722|452099|P3|Overall Study|Patient Request|1
141775|NCT00618722|452100|P2|Overall Study|Patient Request|1
141776|NCT00618722|452101|P1|Overall Study|Patient Request|1
141777|NCT00618722|452098|P4|Overall Study|Refusal of Treatment|0
141778|NCT00618722|452099|P3|Overall Study|Refusal of Treatment|1
141779|NCT00618722|452100|P2|Overall Study|Refusal of Treatment|0
141780|NCT00618722|452101|P1|Overall Study|Refusal of Treatment|0
141781|NCT00618748|452138|P3|Overall Study|Withdrawal by Subject|5
141782|NCT00618748|452139|P2|Overall Study|Withdrawal by Subject|1
141783|NCT00618748|452140|P1|Overall Study|Withdrawal by Subject|4
141784|NCT00618748|452138|P3|Overall Study|Physician Decision|1
141785|NCT00618748|452139|P2|Overall Study|Physician Decision|1
141786|NCT00618748|452140|P1|Overall Study|Physician Decision|3
141787|NCT00618748|452138|P3|Overall Study|Adverse Event|8
141788|NCT00618748|452139|P2|Overall Study|Adverse Event|3
141789|NCT00618748|452140|P1|Overall Study|Adverse Event|4
141790|NCT00618774|452183|P2|Overall Study|Withdrawal by Subject|0
141791|NCT00618774|452184|P1|Overall Study|Withdrawal by Subject|1
141792|NCT00618774|452183|P2|Overall Study|Adverse Event|3
141793|NCT00618774|452184|P1|Overall Study|Adverse Event|5
141794|NCT00618787|452216|P2|Overall Study|Lost to Follow-up|0
141795|NCT00618787|452217|P1|Overall Study|Lost to Follow-up|1
141796|NCT00618787|452216|P2|Overall Study|Withdrawal by Subject|1
141797|NCT00618787|452217|P1|Overall Study|Withdrawal by Subject|2
141798|NCT00618787|452216|P2|Overall Study|Adverse Event|1
141799|NCT00618787|452217|P1|Overall Study|Adverse Event|0
141800|NCT00618813|452223|P1|Overall Study|Withdrawal by Subject|1
141801|NCT00618813|452223|P1|Overall Study|Physician Decision|2
141802|NCT00618813|452223|P1|Overall Study|Lack of Efficacy|1
141803|NCT00618826|452231|P1|Overall Study|Adverse Event|1
141804|NCT00607373|452279|P2|Follow-up Period|Withdrawal by Subject|3
141805|NCT00607373|452280|P1|Follow-up Period|Withdrawal by Subject|1
141806|NCT00607373|452279|P2|Follow-up Period|Protocol Violation|1
141807|NCT00607373|452280|P1|Follow-up Period|Protocol Violation|0
141808|NCT00607373|452279|P2|Follow-up Period|Not specified|1
141809|NCT00607373|452280|P1|Follow-up Period|Not specified|0
141810|NCT00607373|452279|P2|Treatment Period|Withdrawal by Subject|1
141811|NCT00607373|452280|P1|Treatment Period|Withdrawal by Subject|0
141812|NCT00607373|452279|P2|Treatment Period|Physician Decision|1
141813|NCT00607373|452280|P1|Treatment Period|Physician Decision|0
141814|NCT00607373|452279|P2|Treatment Period|Adverse Event|4
141815|NCT00607373|452280|P1|Treatment Period|Adverse Event|0
141816|NCT00607386|452324|P1|Overall Study|Physician Decision|1
141817|NCT00607724|452409|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
141818|NCT00607724|452410|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
141819|NCT00607724|452411|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
141820|NCT00607724|452412|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
141821|NCT00607724|452413|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
141822|NCT00607724|452414|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
141823|NCT00607724|452415|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
141824|NCT00607724|452409|P7|Stage 2: Expanded Cohort|Physician Decision|0
141825|NCT00607724|452410|P6|Stage 2: Expanded Cohort|Physician Decision|1
141826|NCT00607724|452411|P5|Stage 2: Expanded Cohort|Physician Decision|1
141827|NCT00607724|452412|P4|Stage 2: Expanded Cohort|Physician Decision|0
141828|NCT00607724|452413|P3|Stage 2: Expanded Cohort|Physician Decision|0
141829|NCT00607724|452414|P2|Stage 2: Expanded Cohort|Physician Decision|0
141830|NCT00607724|452415|P1|Stage 2: Expanded Cohort|Physician Decision|0
141831|NCT00607724|452409|P7|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|10
141832|NCT00607724|452410|P6|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|11
141833|NCT00607724|452411|P5|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|8
141834|NCT00607724|452412|P4|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|4
141835|NCT00607724|452413|P3|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
141836|NCT00607724|452414|P2|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
141837|NCT00607724|452415|P1|Stage 2: Expanded Cohort|Tumour Progression−Clinical/Radiographic|0
141838|NCT00607724|452409|P7|Stage 2: Expanded Cohort|Adverse Event|1
141839|NCT00607724|452410|P6|Stage 2: Expanded Cohort|Adverse Event|0
141840|NCT00607724|452411|P5|Stage 2: Expanded Cohort|Adverse Event|0
141841|NCT00607724|452412|P4|Stage 2: Expanded Cohort|Adverse Event|0
141842|NCT00607724|452413|P3|Stage 2: Expanded Cohort|Adverse Event|0
141843|NCT00607724|452414|P2|Stage 2: Expanded Cohort|Adverse Event|0
141844|NCT00607724|452415|P1|Stage 2: Expanded Cohort|Adverse Event|0
141845|NCT00607724|452409|P7|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
141846|NCT00607724|452410|P6|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
141847|NCT00607724|452411|P5|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
141848|NCT00607724|452412|P4|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|0
141849|NCT00607724|452413|P3|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|4
141850|NCT00607724|452414|P2|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|8
141851|NCT00607724|452415|P1|Stage 1: Dose Escalation|Tumour Progression−Clinical/Radiographic|7
141852|NCT00608829|452495|P1|Overall Study|Subject refuses to follow up or return.|5
141853|NCT00608829|452495|P1|Overall Study|Withdrawal by Subject|4
141854|NCT00608829|452495|P1|Overall Study|Death|6
141855|NCT00608842|452503|P4|Overall Study|Lost to Follow-up|0
141856|NCT00608842|452504|P3|Overall Study|Lost to Follow-up|0
141857|NCT00608842|452505|P2|Overall Study|Lost to Follow-up|0
141858|NCT00608842|452506|P1|Overall Study|Lost to Follow-up|1
141859|NCT00608842|452503|P4|Overall Study|Participant's Request|1
141860|NCT00608842|452504|P3|Overall Study|Participant's Request|2
141861|NCT00608842|452505|P2|Overall Study|Participant's Request|1
141862|NCT00608842|452506|P1|Overall Study|Participant's Request|0
141863|NCT00608868|452540|P1|Overall Study|Physician Decision|2
141864|NCT00608868|452540|P1|Overall Study|Adverse Event|1
141865|NCT00608868|452540|P1|Overall Study|Lost to Follow-up|2
141866|NCT00608868|452540|P1|Overall Study|Protocol Violation|3
141867|NCT00608868|452540|P1|Overall Study|Withdrawal by Subject|7
141868|NCT00608881|452549|P2|Overall Study|Institutionalized|2
141869|NCT00608881|452550|P1|Overall Study|Institutionalized|1
141870|NCT00608881|452549|P2|Overall Study|Physician Decision|5
141871|NCT00608881|452550|P1|Overall Study|Physician Decision|5
141872|NCT00608881|452549|P2|Overall Study|Withdrawal by Subject|29
141873|NCT00608881|452550|P1|Overall Study|Withdrawal by Subject|18
141874|NCT00608881|452549|P2|Overall Study|Lost to Follow-up|14
141875|NCT00608881|452550|P1|Overall Study|Lost to Follow-up|28
141876|NCT00608881|452549|P2|Overall Study|Adverse Event|3
141877|NCT00608881|452550|P1|Overall Study|Adverse Event|5
141878|NCT00608881|452549|P2|Overall Study|Death|13
141879|NCT00608881|452550|P1|Overall Study|Death|22
141880|NCT00608907|452587|P3|Overall Study|Progressive Disease|0
141881|NCT00608907|452588|P2|Overall Study|Progressive Disease|0
141882|NCT00608907|452589|P1|Overall Study|Progressive Disease|1
141883|NCT00608907|452587|P3|Overall Study|Withdrawal by Subject|0
141884|NCT00608907|452588|P2|Overall Study|Withdrawal by Subject|0
141885|NCT00608907|452589|P1|Overall Study|Withdrawal by Subject|4
141886|NCT00608907|452587|P3|Overall Study|Death|0
141887|NCT00608907|452588|P2|Overall Study|Death|0
141888|NCT00608907|452589|P1|Overall Study|Death|1
141889|NCT00608907|452587|P3|Overall Study|Adverse Event|1
141890|NCT00608907|452588|P2|Overall Study|Adverse Event|0
141891|NCT00608907|452589|P1|Overall Study|Adverse Event|6
141892|NCT00608959|452599|P1|Part 1|Did not meet eligibility criteria|1
141893|NCT00608985|452613|P4|Overall Study|Lost to Follow-up|0
141894|NCT00608985|452614|P3|Overall Study|Lost to Follow-up|0
141895|NCT00608985|452615|P2|Overall Study|Lost to Follow-up|1
141896|NCT00608985|452616|P1|Overall Study|Lost to Follow-up|2
141897|NCT00608985|452613|P4|Overall Study|Withdrawal of Consent|1
141898|NCT00608985|452614|P3|Overall Study|Withdrawal of Consent|1
141899|NCT00608985|452615|P2|Overall Study|Withdrawal of Consent|1
141900|NCT00608985|452616|P1|Overall Study|Withdrawal of Consent|5
141901|NCT00608985|452613|P4|Overall Study|Administrative/Other|2
141902|NCT00608985|452614|P3|Overall Study|Administrative/Other|1
141903|NCT00608985|452615|P2|Overall Study|Administrative/Other|4
141904|NCT00608985|452616|P1|Overall Study|Administrative/Other|7
141905|NCT00608985|452613|P4|Overall Study|Adverse Event|6
141906|NCT00608985|452614|P3|Overall Study|Adverse Event|4
141907|NCT00608985|452615|P2|Overall Study|Adverse Event|7
141908|NCT00608985|452616|P1|Overall Study|Adverse Event|2
141909|NCT00609167|452648|P2|Overall Study|Stem Cell Transplant|6
141910|NCT00609167|452649|P1|Overall Study|Stem Cell Transplant|0
141911|NCT00609167|452648|P2|Overall Study|Disease Progression|0
141912|NCT00609167|452649|P1|Overall Study|Disease Progression|1
141913|NCT00609167|452648|P2|Overall Study|Adverse Event|1
141914|NCT00609167|452649|P1|Overall Study|Adverse Event|5
141915|NCT00609167|452648|P2|Overall Study|Lack of Efficacy|0
141916|NCT00609167|452649|P1|Overall Study|Lack of Efficacy|1
141917|NCT00609167|452648|P2|Overall Study|Withdrawal by Subject|0
141918|NCT00609167|452649|P1|Overall Study|Withdrawal by Subject|1
141919|NCT00609245|452671|P1|Overall Study|Adverse Event|1
141920|NCT00609336|452677|P1|Overall Study|LA or Met at Surgery|9
141921|NCT00609336|452677|P1|Overall Study|Death|1
141922|NCT00609336|452677|P1|Overall Study|Protocol Violation|3
141923|NCT00609362|452691|P2|Overall Study|Adverse Event|0
141924|NCT00609362|452692|P1|Overall Study|Adverse Event|1
141925|NCT00609362|452691|P2|Overall Study|Withdrawal by Subject|1
141926|NCT00609362|452692|P1|Overall Study|Withdrawal by Subject|2
141927|NCT00609466|452705|P3|Overall Study|Lack of Efficacy|2
141928|NCT00609466|452706|P2|Overall Study|Lack of Efficacy|2
141929|NCT00609466|452707|P1|Overall Study|Lack of Efficacy|0
141930|NCT00609466|452705|P3|Overall Study|Adverse Event|1
141931|NCT00609466|452706|P2|Overall Study|Adverse Event|3
141932|NCT00609466|452707|P1|Overall Study|Adverse Event|2
141933|NCT00609466|452705|P3|Overall Study|Withdrawal by Subject|1
141934|NCT00609466|452706|P2|Overall Study|Withdrawal by Subject|1
141935|NCT00609466|452707|P1|Overall Study|Withdrawal by Subject|0
141936|NCT00609492|452736|P3|Overall Study|Lost to Follow-up|4
141937|NCT00609492|452737|P2|Overall Study|Lost to Follow-up|1
141938|NCT00609492|452738|P1|Overall Study|Lost to Follow-up|1
141939|NCT00609492|452736|P3|Overall Study|Withdrawal by Subject|3
141940|NCT00609492|452737|P2|Overall Study|Withdrawal by Subject|2
141941|NCT00609492|452738|P1|Overall Study|Withdrawal by Subject|0
141942|NCT00609518|452822|P2|Overall Study|Death from Adverse Event|2
141943|NCT00609518|452823|P1|Overall Study|Death from Adverse Event|2
141944|NCT00609518|452822|P2|Overall Study|Physician Decision|3
141945|NCT00609518|452823|P1|Overall Study|Physician Decision|1
141946|NCT00609518|452822|P2|Overall Study|Lost to Follow-up|0
141947|NCT00609518|452823|P1|Overall Study|Lost to Follow-up|3
141948|NCT00609518|452822|P2|Overall Study|Withdrawal by Subject|3
141949|NCT00609518|452823|P1|Overall Study|Withdrawal by Subject|5
141950|NCT00609518|452822|P2|Overall Study|Death from Study Disease|32
141951|NCT00609518|452823|P1|Overall Study|Death from Study Disease|32
141952|NCT00609622|452837|P2|Overall Study|Global deterioration of health status|2
141953|NCT00609622|452838|P1|Overall Study|Global deterioration of health status|6
141954|NCT00609622|452837|P2|Overall Study|Unspecified|14
141955|NCT00609622|452838|P1|Overall Study|Unspecified|7
141956|NCT00609622|452837|P2|Overall Study|Study terminated by sponsor|3
141957|NCT00609622|452838|P1|Overall Study|Study terminated by sponsor|16
141958|NCT00609622|452837|P2|Overall Study|Objective progression or relapse|41
141959|NCT00609622|452838|P1|Overall Study|Objective progression or relapse|47
141960|NCT00609622|452837|P2|Overall Study|Protocol Violation|1
141961|NCT00609622|452838|P1|Overall Study|Protocol Violation|1
141962|NCT00609622|452837|P2|Overall Study|Death|4
141963|NCT00609622|452838|P1|Overall Study|Death|1
141964|NCT00609622|452837|P2|Overall Study|Withdrawal by Subject|20
141965|NCT00609622|452838|P1|Overall Study|Withdrawal by Subject|4
141966|NCT00609622|452837|P2|Overall Study|Adverse Event|10
141967|NCT00609622|452838|P1|Overall Study|Adverse Event|14
141968|NCT00609674|452860|P2|Overall Study|Withdrew consent|1
141969|NCT00609674|452861|P1|Overall Study|Withdrew consent|2
141970|NCT00609674|452860|P2|Overall Study|Lost to Follow-up|0
141971|NCT00609674|452861|P1|Overall Study|Lost to Follow-up|1
141972|NCT00609674|452860|P2|Overall Study|Protocol Violation|5
141973|NCT00609674|452861|P1|Overall Study|Protocol Violation|3
141974|NCT00609674|452860|P2|Overall Study|Adverse Event|1
141975|NCT00609674|452861|P1|Overall Study|Adverse Event|1
141976|NCT00609765|452902|P1|Overall Study|Study ended prior to 12 months|1
141977|NCT00609869|452920|P1|Overall Study|Mantle cell: not evaluable|4
141978|NCT00609869|452920|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
141979|NCT00609869|452920|P1|Overall Study|Hepatitis B infection|1
141980|NCT00609869|452920|P1|Overall Study|Severe tumor flare reaction|1
141981|NCT00609869|452920|P1|Overall Study|Seizures|1
141982|NCT00609869|452920|P1|Overall Study|Withdrawal by Subject|1
141983|NCT00609869|452920|P1|Overall Study|Severe hematologic toxicity|1
141984|NCT00609869|452920|P1|Overall Study|Withdrawn, ischemic stroke|1
141985|NCT00609947|452926|P1|Overall Study|Death|1
141986|NCT00609973|452933|P2|Overall Study|Withdrawal by Subject|1
141987|NCT00609973|452934|P1|Overall Study|Withdrawal by Subject|0
141988|NCT00609973|452933|P2|Overall Study|Lost to Follow-up|1
141989|NCT00609973|452934|P1|Overall Study|Lost to Follow-up|2
141990|NCT00609973|452933|P2|Overall Study|Protocol Violation|3
141991|NCT00609973|452934|P1|Overall Study|Protocol Violation|4
141992|NCT00609973|452933|P2|Overall Study|Adverse Event|1
141993|NCT00609973|452934|P1|Overall Study|Adverse Event|2
141994|NCT00609986|452944|P2|Overall Study|Did not receive transplant or treatment|3
141995|NCT00609986|452945|P1|Overall Study|Did not receive transplant or treatment|8
141996|NCT00610129|452957|P1|Overall Study|Not treated since patients ineligible|3
141997|NCT00610155|452961|P6|Period 3|Adverse Event|0
141998|NCT00610155|452962|P5|Period 3|Adverse Event|0
141999|NCT00610155|452963|P4|Period 3|Adverse Event|0
142000|NCT00610155|452964|P3|Period 3|Adverse Event|0
142001|NCT00610155|452965|P2|Period 3|Adverse Event|0
142002|NCT00610155|452966|P1|Period 3|Adverse Event|1
142003|NCT00610155|452961|P6|Period 1|Withdrawal by Subject|0
142004|NCT00610155|452962|P5|Period 1|Withdrawal by Subject|0
142005|NCT00610155|452963|P4|Period 1|Withdrawal by Subject|0
142006|NCT00610155|452964|P3|Period 1|Withdrawal by Subject|1
142007|NCT00610155|452965|P2|Period 1|Withdrawal by Subject|0
142008|NCT00610155|452966|P1|Period 1|Withdrawal by Subject|0
142009|NCT00610168|453015|P2|Overall Study|Withdrawal by Subject|0
142010|NCT00610168|453016|P1|Overall Study|Withdrawal by Subject|2
142011|NCT00610207|453035|P1|Overall Study|Lost to Follow-up|3
142012|NCT00610363|453049|P2|Overall Study|Other than specified above|1
142013|NCT00610363|453050|P1|Overall Study|Other than specified above|1
142014|NCT00610363|453049|P2|Overall Study|Withdrawal by Subject|0
142015|NCT00610363|453050|P1|Overall Study|Withdrawal by Subject|1
142016|NCT00610363|453049|P2|Overall Study|Lost to Follow-up|0
142017|NCT00610363|453050|P1|Overall Study|Lost to Follow-up|4
142018|NCT00610363|453049|P2|Overall Study|Lack of Efficacy|0
142019|NCT00610363|453050|P1|Overall Study|Lack of Efficacy|2
142020|NCT00610363|453049|P2|Overall Study|Adverse Event|1
142021|NCT00610363|453050|P1|Overall Study|Adverse Event|3
142022|NCT00610363|453049|P2|Overall Study|Non-compliance with protocol|1
142023|NCT00610363|453050|P1|Overall Study|Non-compliance with protocol|0
142024|NCT00610441|453072|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
142025|NCT00610441|453073|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
142026|NCT00610441|453074|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
142027|NCT00610441|453075|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
142028|NCT00610441|453072|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
142029|NCT00610441|453073|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
142030|NCT00610441|453074|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
142031|NCT00610441|453075|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
142032|NCT00610441|453072|P4|Treatment Period 2 - 3 Weeks|Unspecified|1
142033|NCT00610441|453073|P3|Treatment Period 2 - 3 Weeks|Unspecified|0
142034|NCT00610441|453074|P2|Treatment Period 2 - 3 Weeks|Unspecified|1
142035|NCT00610441|453075|P1|Treatment Period 2 - 3 Weeks|Unspecified|1
142036|NCT00610441|453072|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
142037|NCT00610441|453073|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
142038|NCT00610441|453074|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
142039|NCT00610441|453075|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
142040|NCT00610441|453072|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
142041|NCT00610441|453073|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
142042|NCT00610441|453074|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
142043|NCT00610441|453075|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
142044|NCT00610441|453072|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
142045|NCT00610441|453073|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
142046|NCT00610441|453074|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
142047|NCT00610441|453075|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
142048|NCT00610441|453072|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
142049|NCT00610441|453073|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
142050|NCT00610441|453074|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
142051|NCT00610441|453075|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
142052|NCT00610441|453072|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
142053|NCT00610441|453073|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
142054|NCT00610441|453074|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
142055|NCT00610441|453075|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
142056|NCT00610441|453072|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
142057|NCT00610441|453073|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
142058|NCT00610441|453074|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
142059|NCT00610441|453075|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
142060|NCT00610649|453183|P11|Overall Study|Withdrawal by Subject|0
142061|NCT00610649|453184|P10|Overall Study|Withdrawal by Subject|1
142062|NCT00610649|453185|P9|Overall Study|Withdrawal by Subject|0
142063|NCT00610649|453186|P8|Overall Study|Withdrawal by Subject|0
142064|NCT00610649|453187|P7|Overall Study|Withdrawal by Subject|0
142065|NCT00610649|453188|P6|Overall Study|Withdrawal by Subject|0
142066|NCT00610649|453189|P5|Overall Study|Withdrawal by Subject|0
142067|NCT00610649|453190|P4|Overall Study|Withdrawal by Subject|0
142068|NCT00610649|453191|P3|Overall Study|Withdrawal by Subject|0
142069|NCT00610649|453192|P2|Overall Study|Withdrawal by Subject|0
142070|NCT00610649|453193|P1|Overall Study|Withdrawal by Subject|0
142071|NCT00610649|453183|P11|Overall Study|Family Emergency|0
142072|NCT00610649|453184|P10|Overall Study|Family Emergency|0
142073|NCT00610649|453185|P9|Overall Study|Family Emergency|0
142074|NCT00610649|453186|P8|Overall Study|Family Emergency|0
142075|NCT00610649|453187|P7|Overall Study|Family Emergency|0
142076|NCT00610649|453188|P6|Overall Study|Family Emergency|0
142077|NCT00610649|453189|P5|Overall Study|Family Emergency|0
142078|NCT00610649|453190|P4|Overall Study|Family Emergency|0
142079|NCT00610649|453191|P3|Overall Study|Family Emergency|0
142080|NCT00610649|453192|P2|Overall Study|Family Emergency|1
142081|NCT00610649|453193|P1|Overall Study|Family Emergency|0
142082|NCT00610649|453183|P11|Overall Study|Adverse Event|1
142083|NCT00610649|453184|P10|Overall Study|Adverse Event|0
142084|NCT00610649|453185|P9|Overall Study|Adverse Event|0
142085|NCT00610649|453186|P8|Overall Study|Adverse Event|0
142086|NCT00610649|453187|P7|Overall Study|Adverse Event|0
142087|NCT00610649|453188|P6|Overall Study|Adverse Event|0
142088|NCT00610649|453189|P5|Overall Study|Adverse Event|0
142089|NCT00610649|453190|P4|Overall Study|Adverse Event|0
142090|NCT00610649|453191|P3|Overall Study|Adverse Event|0
142091|NCT00610649|453192|P2|Overall Study|Adverse Event|0
142092|NCT00610649|453193|P1|Overall Study|Adverse Event|1
142093|NCT00610675|453247|P1|Overall Study|Other reason (not specified)|25
142094|NCT00610675|453247|P1|Overall Study|Lost to Follow-up|31
142095|NCT00610675|453247|P1|Overall Study|Lack of Compliance|7
142096|NCT00610675|453247|P1|Overall Study|Reasons unrelated to trial|27
142097|NCT00610675|453247|P1|Overall Study|Withdrawal by Subject|28
142098|NCT00610675|453247|P1|Overall Study|Insufficient Effect|31
142099|NCT00610675|453247|P1|Overall Study|Adverse Event|67
142100|NCT00610675|453247|P1|Overall Study|Untreated|4
142101|NCT00610714|453288|P2|Overall Study|Study completion at 120 PFS events|2
142102|NCT00610714|453289|P1|Overall Study|Study completion at 120 PFS events|2
142103|NCT00610714|453288|P2|Overall Study|Withdrawal by Subject|3
142104|NCT00610714|453289|P1|Overall Study|Withdrawal by Subject|9
142105|NCT00610714|453288|P2|Overall Study|Death|18
142106|NCT00610714|453289|P1|Overall Study|Death|12
142107|NCT00610714|453288|P2|Overall Study|Adverse Event|1
142108|NCT00610714|453289|P1|Overall Study|Adverse Event|3
142109|NCT00610857|453305|P1|Overall Study|Not evaluable for response|2
142110|NCT00611026|453328|P3|Double-blind Treatment Period|Unspecified|18
142111|NCT00611026|453329|P2|Double-blind Treatment Period|Unspecified|20
142112|NCT00611026|453330|P1|Double-blind Treatment Period|Unspecified|13
142113|NCT00611026|453328|P3|Double-blind Treatment Period|Withdrawal by Subject|16
142114|NCT00611026|453329|P2|Double-blind Treatment Period|Withdrawal by Subject|19
142115|NCT00611026|453330|P1|Double-blind Treatment Period|Withdrawal by Subject|7
142116|NCT00611026|453328|P3|Double-blind Treatment Period|Lost to Follow-up|14
142117|NCT00611026|453329|P2|Double-blind Treatment Period|Lost to Follow-up|11
142118|NCT00611026|453330|P1|Double-blind Treatment Period|Lost to Follow-up|6
142119|NCT00611026|453328|P3|Double-blind Treatment Period|Lack of Efficacy|4
142120|NCT00611026|453329|P2|Double-blind Treatment Period|Lack of Efficacy|10
142121|NCT00611026|453330|P1|Double-blind Treatment Period|Lack of Efficacy|11
142122|NCT00611026|453328|P3|Double-blind Treatment Period|Adverse Event|46
142123|NCT00611026|453329|P2|Double-blind Treatment Period|Adverse Event|28
142124|NCT00611026|453330|P1|Double-blind Treatment Period|Adverse Event|9
142125|NCT00611026|453328|P3|Double-blind Treatment Period|Death|0
142126|NCT00611026|453329|P2|Double-blind Treatment Period|Death|0
142127|NCT00611026|453330|P1|Double-blind Treatment Period|Death|1
142128|NCT00611026|453328|P3|Randomized to Double-blind Treatment|Not treated|3
142129|NCT00611026|453329|P2|Randomized to Double-blind Treatment|Not treated|1
142130|NCT00611026|453330|P1|Randomized to Double-blind Treatment|Not treated|2
142131|NCT00611130|453396|P2|Overall Study|Death|0
142132|NCT00611130|453397|P1|Overall Study|Death|1
142133|NCT00611130|453396|P2|Overall Study|Adverse Event|0
142134|NCT00611130|453397|P1|Overall Study|Adverse Event|1
142135|NCT00611130|453396|P2|Overall Study|Administrative|1
142136|NCT00611130|453397|P1|Overall Study|Administrative|1
142137|NCT00611130|453396|P2|Overall Study|Incarceration|2
142138|NCT00611130|453397|P1|Overall Study|Incarceration|3
142139|NCT00611130|453396|P2|Overall Study|Unspecified|4
142140|NCT00611130|453397|P1|Overall Study|Unspecified|5
142141|NCT00611130|453396|P2|Overall Study|Withdrawal by Subject|5
142142|NCT00611130|453397|P1|Overall Study|Withdrawal by Subject|6
142143|NCT00611130|453396|P2|Overall Study|Protocol noncompliance|6
142144|NCT00611130|453397|P1|Overall Study|Protocol noncompliance|7
142145|NCT00611130|453396|P2|Overall Study|Lost to Follow-up|29
142146|NCT00611130|453397|P1|Overall Study|Lost to Follow-up|25
142147|NCT00611247|453406|P2|Overall Study|Lack of Efficacy|16
142148|NCT00611247|453407|P1|Overall Study|Lack of Efficacy|1
142149|NCT00611247|453406|P2|Overall Study|Death|5
142150|NCT00611247|453407|P1|Overall Study|Death|1
142151|NCT00618956|453419|P2|Overall Study|did not meet criteria, non-compliance|1
142152|NCT00618956|453420|P1|Overall Study|did not meet criteria, non-compliance|2
142153|NCT00618956|453419|P2|Overall Study|Protocol Violation|2
142154|NCT00618956|453420|P1|Overall Study|Protocol Violation|2
142155|NCT00618956|453419|P2|Overall Study|Lost to Follow-up|5
142156|NCT00618956|453420|P1|Overall Study|Lost to Follow-up|4
142157|NCT00618956|453419|P2|Overall Study|Withdrawal by Subject|7
142158|NCT00618956|453420|P1|Overall Study|Withdrawal by Subject|5
142159|NCT00618956|453419|P2|Overall Study|Lack of Efficacy|1
142160|NCT00618956|453420|P1|Overall Study|Lack of Efficacy|2
142161|NCT00618956|453419|P2|Overall Study|Adverse Event|34
142162|NCT00618956|453420|P1|Overall Study|Adverse Event|10
142163|NCT00618982|453436|P1|Overall Study|ongoing, still treated with study med.|25
142164|NCT00618982|453436|P1|Overall Study|Protocol Violation|1
142165|NCT00618982|453436|P1|Overall Study|Withdrawal by Subject|1
142166|NCT00618982|453436|P1|Overall Study|Adverse Event|23
142167|NCT00618995|453457|P4|Period 4|Adverse Event|0
142168|NCT00618995|453458|P3|Period 4|Adverse Event|0
142169|NCT00618995|453459|P2|Period 4|Adverse Event|0
142170|NCT00618995|453460|P1|Period 4|Adverse Event|1
142171|NCT00618995|453457|P4|Period 2|Protocol Violation|0
142172|NCT00618995|453458|P3|Period 2|Protocol Violation|1
142173|NCT00618995|453459|P2|Period 2|Protocol Violation|0
142174|NCT00618995|453460|P1|Period 2|Protocol Violation|0
142175|NCT00618995|453457|P4|Period 1|Protocol Violation|0
142176|NCT00618995|453458|P3|Period 1|Protocol Violation|1
142177|NCT00618995|453459|P2|Period 1|Protocol Violation|1
142178|NCT00618995|453460|P1|Period 1|Protocol Violation|0
142179|NCT00618995|453457|P4|Period 1|Adverse Event|0
142180|NCT00618995|453458|P3|Period 1|Adverse Event|1
142181|NCT00618995|453459|P2|Period 1|Adverse Event|0
142182|NCT00618995|453460|P1|Period 1|Adverse Event|0
142183|NCT00619099|453492|P2|Overall Study|Physician Decision|6
142184|NCT00619099|453493|P1|Overall Study|Physician Decision|9
142185|NCT00619099|453492|P2|Overall Study|Withdrawal by Subject|2
142186|NCT00619099|453493|P1|Overall Study|Withdrawal by Subject|10
142187|NCT00619099|453492|P2|Overall Study|Emergence of Clinically Significant Lab|2
142188|NCT00619099|453493|P1|Overall Study|Emergence of Clinically Significant Lab|1
142189|NCT00619099|453492|P2|Overall Study|Adverse Event|3
142190|NCT00619099|453493|P1|Overall Study|Adverse Event|4
142191|NCT00619099|453492|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
142192|NCT00619099|453493|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
142193|NCT00619099|453492|P2|Overall Study|Progressive Disease|5
142194|NCT00619099|453493|P1|Overall Study|Progressive Disease|7
142195|NCT00619151|453505|P2|Overall Study|Study terminated prior to followup|0
142196|NCT00619151|453506|P1|Overall Study|Study terminated prior to followup|1
142197|NCT00619177|453514|P1|Overall Study|Not specified reasons|6
142198|NCT00619177|453514|P1|Overall Study|Missing termination information|481
142199|NCT00619177|453514|P1|Overall Study|Lack of Efficacy|1
142200|NCT00619177|453514|P1|Overall Study|Lost to Follow-up|2
142201|NCT00619177|453514|P1|Overall Study|Adverse Event|18
142202|NCT00619229|453537|P2|Overall Study|Investigator planned Cataract Operation|0
142203|NCT00619229|453538|P1|Overall Study|Investigator planned Cataract Operation|1
142204|NCT00619229|453537|P2|Overall Study|Termination of the Study by the Sponsor|1
142205|NCT00619229|453538|P1|Overall Study|Termination of the Study by the Sponsor|1
142206|NCT00619229|453537|P2|Overall Study|Lost to Follow-up|0
142207|NCT00619229|453538|P1|Overall Study|Lost to Follow-up|1
142208|NCT00619229|453537|P2|Overall Study|Withdrawal by Subject|1
142209|NCT00619229|453538|P1|Overall Study|Withdrawal by Subject|1
142210|NCT00619801|453575|P2|Overall Study|Loss of efficacy|1
142211|NCT00619801|453576|P1|Overall Study|Loss of efficacy|0
142212|NCT00619801|453575|P2|Overall Study|Withdrawal by Subject|1
142213|NCT00619801|453576|P1|Overall Study|Withdrawal by Subject|1
142214|NCT00619801|453575|P2|Overall Study|Lack of Efficacy|1
142215|NCT00619801|453576|P1|Overall Study|Lack of Efficacy|0
142216|NCT00619827|453608|P2|Overall Study|Withdrawal by Subject|2
142217|NCT00619827|453609|P1|Overall Study|Withdrawal by Subject|2
142218|NCT00619827|453608|P2|Overall Study|Adverse Event|2
142219|NCT00619827|453609|P1|Overall Study|Adverse Event|1
142220|NCT00619892|453617|P2|Overall Study|Intercurrent illness|1
142221|NCT00619892|453618|P1|Overall Study|Intercurrent illness|0
142222|NCT00619892|453617|P2|Overall Study|Lost to Follow-up|1
142223|NCT00619892|453618|P1|Overall Study|Lost to Follow-up|0
142224|NCT00619892|453617|P2|Overall Study|Adverse Event|0
142225|NCT00619892|453618|P1|Overall Study|Adverse Event|3
142226|NCT00619918|453628|P2|Overall Study|Left before receiving first dose|8
142227|NCT00619918|453629|P1|Overall Study|Left before receiving first dose|5
142228|NCT00619918|453628|P2|Overall Study|Transfer to outside facility|3
142229|NCT00619918|453629|P1|Overall Study|Transfer to outside facility|3
142230|NCT00619918|453628|P2|Overall Study|Physician Decision|8
142231|NCT00619918|453629|P1|Overall Study|Physician Decision|8
142232|NCT00619918|453628|P2|Overall Study|Withdrawal by Subject|3
142233|NCT00619918|453629|P1|Overall Study|Withdrawal by Subject|4
142234|NCT00619957|453639|P2|Month 48 Open-Label|Withdrawal by Subject|9
142235|NCT00619957|453640|P1|Month 48 Open-Label|Withdrawal by Subject|6
142236|NCT00619957|453639|P2|Month 48 Open-Label|Lost to Follow-up|4
142237|NCT00619957|453640|P1|Month 48 Open-Label|Lost to Follow-up|2
142238|NCT00619957|453639|P2|Month 48 Open-Label|Adverse Event|4
142239|NCT00619957|453640|P1|Month 48 Open-Label|Adverse Event|4
142240|NCT00619957|453639|P2|Month 24 Double-Blind|Did not take any study medication|1
142241|NCT00619957|453640|P1|Month 24 Double-Blind|Did not take any study medication|0
142242|NCT00619957|453639|P2|Month 24 Double-Blind|Lost to Follow-up|0
142243|NCT00619957|453640|P1|Month 24 Double-Blind|Lost to Follow-up|1
142244|NCT00619957|453639|P2|Month 24 Double-Blind|Withdrawal by Subject|9
142245|NCT00619957|453640|P1|Month 24 Double-Blind|Withdrawal by Subject|7
142246|NCT00619957|453639|P2|Month 24 Double-Blind|Protocol Violation|0
142247|NCT00619957|453640|P1|Month 24 Double-Blind|Protocol Violation|1
142248|NCT00619957|453639|P2|Month 24 Double-Blind|Adverse Event|7
142249|NCT00619957|453640|P1|Month 24 Double-Blind|Adverse Event|9
142250|NCT00619983|453739|P4|Test Drug Alone|Failure of daily diary device|2
142251|NCT00619983|453740|P3|Test Drug Alone|Failure of daily diary device|2
142252|NCT00619983|453741|P2|Test Drug Alone|Failure of daily diary device|1
142253|NCT00619983|453742|P1|Test Drug Alone|Failure of daily diary device|1
142254|NCT00619983|453739|P4|Test Drug Alone|Withdrawal by Subject|1
142255|NCT00619983|453740|P3|Test Drug Alone|Withdrawal by Subject|0
142256|NCT00619983|453741|P2|Test Drug Alone|Withdrawal by Subject|0
142257|NCT00619983|453742|P1|Test Drug Alone|Withdrawal by Subject|1
142258|NCT00620022|453752|P2|Treatment Period 2|Adverse Event|2
142259|NCT00620022|453753|P1|Treatment Period 2|Adverse Event|2
142260|NCT00620022|453752|P2|Treatment Period 1|Subject withdrew consent|0
142261|NCT00620022|453753|P1|Treatment Period 1|Subject withdrew consent|1
142262|NCT00620022|453752|P2|Treatment Period 1|Adverse Event|6
142263|NCT00620022|453753|P1|Treatment Period 1|Adverse Event|4
142264|NCT00620035|453761|P1|Overall Study|Other Reason|38
142265|NCT00620035|453761|P1|Overall Study|Withdrawal of Informed Consent|1
142266|NCT00620035|453761|P1|Overall Study|Adverse Event|106
142267|NCT00620074|453771|P1|Overall Study|Adverse Event|1
142268|NCT00620113|453783|P4|Overall Study|Withdrawal by Subject|5
142269|NCT00620113|453784|P3|Overall Study|Withdrawal by Subject|3
142270|NCT00620113|453785|P2|Overall Study|Withdrawal by Subject|1
142271|NCT00620113|453786|P1|Overall Study|Withdrawal by Subject|5
142272|NCT00620113|453783|P4|Overall Study|Protocol Violation|0
142273|NCT00620113|453784|P3|Overall Study|Protocol Violation|0
142274|NCT00620113|453785|P2|Overall Study|Protocol Violation|1
142275|NCT00620113|453786|P1|Overall Study|Protocol Violation|2
142276|NCT00620113|453783|P4|Overall Study|Physician Decision|2
142277|NCT00620113|453784|P3|Overall Study|Physician Decision|0
142278|NCT00620113|453785|P2|Overall Study|Physician Decision|0
142279|NCT00620113|453786|P1|Overall Study|Physician Decision|1
142280|NCT00620113|453783|P4|Overall Study|Lack of Efficacy|2
142281|NCT00620113|453784|P3|Overall Study|Lack of Efficacy|0
142282|NCT00620113|453785|P2|Overall Study|Lack of Efficacy|3
142283|NCT00620113|453786|P1|Overall Study|Lack of Efficacy|2
142284|NCT00620113|453783|P4|Overall Study|Adverse Event|1
142285|NCT00620113|453784|P3|Overall Study|Adverse Event|2
142286|NCT00620113|453785|P2|Overall Study|Adverse Event|2
142287|NCT00620113|453786|P1|Overall Study|Adverse Event|3
142288|NCT00620282|453852|P3|Overall Study|Withdrawal by Subject|0
142289|NCT00620282|453853|P2|Overall Study|Withdrawal by Subject|1
142290|NCT00620282|453854|P1|Overall Study|Withdrawal by Subject|0
142291|NCT00620282|453852|P3|Overall Study|Arterial line unable to be placed|1
142292|NCT00620282|453853|P2|Overall Study|Arterial line unable to be placed|0
142293|NCT00620282|453854|P1|Overall Study|Arterial line unable to be placed|0
142294|NCT00620282|453852|P3|Overall Study|Adverse Event|0
142295|NCT00620282|453853|P2|Overall Study|Adverse Event|1
142296|NCT00620282|453854|P1|Overall Study|Adverse Event|0
142297|NCT00620373|453901|P1|Overall Study|Unverified cancer status|33
142298|NCT00620464|453930|P2|Overall Study|Used prohibited medication|0
142299|NCT00620464|453931|P1|Overall Study|Used prohibited medication|1
142300|NCT00620464|453930|P2|Overall Study|Personal|2
142301|NCT00620464|453931|P1|Overall Study|Personal|2
142302|NCT00620464|453930|P2|Overall Study|Planning Pregnancy|4
142303|NCT00620464|453931|P1|Overall Study|Planning Pregnancy|1
142304|NCT00620464|453930|P2|Overall Study|Lost to Follow-up|1
142305|NCT00620464|453931|P1|Overall Study|Lost to Follow-up|1
142306|NCT00620464|453930|P2|Overall Study|Adverse Event|17
142307|NCT00620464|453931|P1|Overall Study|Adverse Event|15
142308|NCT00620542|453941|P4|Part B (2 Year Core Study)|IVUS not available|2
142309|NCT00620542|453942|P3|Part B (2 Year Core Study)|IVUS not available|3
142310|NCT00620542|453943|P2|Part B (2 Year Core Study)|IVUS not available|0
142311|NCT00620542|453944|P1|Part B (2 Year Core Study)|IVUS not available|0
142312|NCT00620542|453941|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
142313|NCT00620542|453942|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
142314|NCT00620542|453943|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
142315|NCT00620542|453944|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
142316|NCT00620542|453941|P4|Part B (2 Year Core Study)|Safety reasons|3
142317|NCT00620542|453942|P3|Part B (2 Year Core Study)|Safety reasons|2
142318|NCT00620542|453943|P2|Part B (2 Year Core Study)|Safety reasons|0
142319|NCT00620542|453944|P1|Part B (2 Year Core Study)|Safety reasons|0
142320|NCT00620542|453941|P4|Part B (2 Year Core Study)|Protocol Violation|16
142321|NCT00620542|453942|P3|Part B (2 Year Core Study)|Protocol Violation|13
142322|NCT00620542|453943|P2|Part B (2 Year Core Study)|Protocol Violation|0
142323|NCT00620542|453944|P1|Part B (2 Year Core Study)|Protocol Violation|0
142324|NCT00620542|453941|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
142325|NCT00620542|453942|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
142326|NCT00620542|453943|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
142327|NCT00620542|453944|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
142328|NCT00620542|453941|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
142329|NCT00620542|453942|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
142330|NCT00620542|453943|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
142331|NCT00620542|453944|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
142332|NCT00620542|453941|P4|Part B (2 Year Core Study)|Protocol Violation|5
142333|NCT00620542|453942|P3|Part B (2 Year Core Study)|Protocol Violation|3
142334|NCT00620542|453943|P2|Part B (2 Year Core Study)|Protocol Violation|0
142335|NCT00620542|453944|P1|Part B (2 Year Core Study)|Protocol Violation|0
142336|NCT00620542|453941|P4|Part B (2 Year Core Study)|Adverse Event|49
142337|NCT00620542|453942|P3|Part B (2 Year Core Study)|Adverse Event|46
142338|NCT00620542|453943|P2|Part B (2 Year Core Study)|Adverse Event|0
142339|NCT00620542|453944|P1|Part B (2 Year Core Study)|Adverse Event|0
142340|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
142341|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
142342|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
142343|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
142344|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
142345|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
142346|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
142347|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
142348|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
142349|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
142350|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
142351|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
142352|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
142353|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
142354|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
142355|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
142356|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
142357|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
142358|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
142359|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
142360|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
142361|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
142362|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
142363|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
142364|NCT00620542|453941|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
142365|NCT00620542|453942|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
142366|NCT00620542|453943|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
142367|NCT00620542|453944|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
142368|NCT00620555|453982|P1|Overall Study|Visit failure against planned|1
142369|NCT00620555|453982|P1|Overall Study|Choice of other treatment|1
142370|NCT00620555|453982|P1|Overall Study|Withdrawal by Subject|1
142371|NCT00620555|453982|P1|Overall Study|Lack of Efficacy|12
142372|NCT00620555|453982|P1|Overall Study|Protocol Violation|2
142373|NCT00620555|453982|P1|Overall Study|Adverse Event|4
142374|NCT00620659|453989|P6|Treatment Period 3|Withdrawal by Subject|0
142375|NCT00620659|453990|P5|Treatment Period 3|Withdrawal by Subject|0
142376|NCT00620659|453991|P4|Treatment Period 3|Withdrawal by Subject|1
142377|NCT00620659|453992|P3|Treatment Period 3|Withdrawal by Subject|0
142378|NCT00620659|453993|P2|Treatment Period 3|Withdrawal by Subject|0
142379|NCT00620659|453994|P1|Treatment Period 3|Withdrawal by Subject|0
142380|NCT00620659|453989|P6|Treatment Period 3|Adverse Event|0
142381|NCT00620659|453990|P5|Treatment Period 3|Adverse Event|0
142382|NCT00620659|453991|P4|Treatment Period 3|Adverse Event|0
142383|NCT00620659|453992|P3|Treatment Period 3|Adverse Event|0
142384|NCT00620659|453993|P2|Treatment Period 3|Adverse Event|2
142385|NCT00620659|453994|P1|Treatment Period 3|Adverse Event|0
142386|NCT00620659|453989|P6|Placebo Washout Period 2|Adverse Event|0
142387|NCT00620659|453990|P5|Placebo Washout Period 2|Adverse Event|0
142388|NCT00620659|453991|P4|Placebo Washout Period 2|Adverse Event|0
142389|NCT00620659|453992|P3|Placebo Washout Period 2|Adverse Event|0
142390|NCT00620659|453993|P2|Placebo Washout Period 2|Adverse Event|0
142391|NCT00620659|453994|P1|Placebo Washout Period 2|Adverse Event|2
142392|NCT00620659|453989|P6|Treatment Period 2|Withdrawal by Subject|0
142393|NCT00620659|453990|P5|Treatment Period 2|Withdrawal by Subject|3
142394|NCT00620659|453991|P4|Treatment Period 2|Withdrawal by Subject|0
142395|NCT00620659|453992|P3|Treatment Period 2|Withdrawal by Subject|1
142396|NCT00620659|453993|P2|Treatment Period 2|Withdrawal by Subject|0
142397|NCT00620659|453994|P1|Treatment Period 2|Withdrawal by Subject|0
142398|NCT00620659|453989|P6|Treatment Period 2|Adverse Event|0
142399|NCT00620659|453990|P5|Treatment Period 2|Adverse Event|2
142400|NCT00620659|453991|P4|Treatment Period 2|Adverse Event|0
142401|NCT00620659|453992|P3|Treatment Period 2|Adverse Event|0
142402|NCT00620659|453993|P2|Treatment Period 2|Adverse Event|3
142403|NCT00620659|453994|P1|Treatment Period 2|Adverse Event|0
142404|NCT00620659|453989|P6|Placebo Washout Period 1|Withdrawal by Subject|0
142405|NCT00620659|453990|P5|Placebo Washout Period 1|Withdrawal by Subject|0
142406|NCT00620659|453991|P4|Placebo Washout Period 1|Withdrawal by Subject|1
142407|NCT00620659|453992|P3|Placebo Washout Period 1|Withdrawal by Subject|0
142408|NCT00620659|453993|P2|Placebo Washout Period 1|Withdrawal by Subject|0
142409|NCT00620659|453994|P1|Placebo Washout Period 1|Withdrawal by Subject|0
142410|NCT00620659|453989|P6|Treatment Period 1|Withdrawal by Subject|0
142411|NCT00620659|453990|P5|Treatment Period 1|Withdrawal by Subject|1
142412|NCT00620659|453991|P4|Treatment Period 1|Withdrawal by Subject|0
142413|NCT00620659|453992|P3|Treatment Period 1|Withdrawal by Subject|1
142414|NCT00620659|453993|P2|Treatment Period 1|Withdrawal by Subject|0
142415|NCT00620659|453994|P1|Treatment Period 1|Withdrawal by Subject|1
142416|NCT00620659|453989|P6|Treatment Period 1|Protocol Violation|0
142417|NCT00620659|453990|P5|Treatment Period 1|Protocol Violation|0
142418|NCT00620659|453991|P4|Treatment Period 1|Protocol Violation|0
142419|NCT00620659|453992|P3|Treatment Period 1|Protocol Violation|0
142420|NCT00620659|453993|P2|Treatment Period 1|Protocol Violation|0
142421|NCT00620659|453994|P1|Treatment Period 1|Protocol Violation|1
142422|NCT00620659|453989|P6|Treatment Period 1|Adverse Event|0
142423|NCT00620659|453990|P5|Treatment Period 1|Adverse Event|0
142424|NCT00620659|453991|P4|Treatment Period 1|Adverse Event|3
142425|NCT00620659|453992|P3|Treatment Period 1|Adverse Event|0
142426|NCT00620659|453993|P2|Treatment Period 1|Adverse Event|0
142427|NCT00620659|453994|P1|Treatment Period 1|Adverse Event|1
142428|NCT00620750|454023|P1|Overall Study|Lost to Follow-up|25
142429|NCT00620763|454027|P2|Period: Second Intervention|Withdrawal by Subject|0
142430|NCT00620763|454028|P1|Period: Second Intervention|Withdrawal by Subject|1
142431|NCT00620763|454027|P2|Period: First Intervention|Protocol Violation|3
142432|NCT00620763|454028|P1|Period: First Intervention|Protocol Violation|0
142433|NCT00620763|454027|P2|Period: First Intervention|Withdrawal by Subject|2
142434|NCT00620763|454028|P1|Period: First Intervention|Withdrawal by Subject|0
142435|NCT00620776|454036|P2|Overall Study|Withdrawal by Subject|2
142436|NCT00620776|454037|P1|Overall Study|Withdrawal by Subject|3
142437|NCT00620776|454036|P2|Overall Study|Lost to Follow-up|5
142438|NCT00620776|454037|P1|Overall Study|Lost to Follow-up|2
142439|NCT00620776|454036|P2|Overall Study|Lack of Efficacy|1
142440|NCT00620776|454037|P1|Overall Study|Lack of Efficacy|2
142441|NCT00620776|454036|P2|Overall Study|Adverse Event|3
142442|NCT00620776|454037|P1|Overall Study|Adverse Event|2
142443|NCT00620776|454036|P2|Overall Study|Did not receive treatment|5
142444|NCT00620776|454037|P1|Overall Study|Did not receive treatment|3
142445|NCT00620815|454068|P3|Overall Study|Protocol Violation|1
142446|NCT00620815|454069|P2|Overall Study|Protocol Violation|2
142447|NCT00620815|454070|P1|Overall Study|Protocol Violation|1
142448|NCT00620815|454068|P3|Overall Study|Inappropriate enrolment|1
142449|NCT00620815|454069|P2|Overall Study|Inappropriate enrolment|0
142450|NCT00620815|454070|P1|Overall Study|Inappropriate enrolment|0
142451|NCT00620815|454068|P3|Overall Study|Lost to Follow-up|3
142452|NCT00620815|454069|P2|Overall Study|Lost to Follow-up|6
142453|NCT00620815|454070|P1|Overall Study|Lost to Follow-up|1
142454|NCT00620815|454068|P3|Overall Study|Withdrawal by Subject|0
142455|NCT00620815|454069|P2|Overall Study|Withdrawal by Subject|2
142456|NCT00620815|454070|P1|Overall Study|Withdrawal by Subject|1
142457|NCT00620815|454068|P3|Overall Study|Adverse Event|2
142458|NCT00620815|454069|P2|Overall Study|Adverse Event|1
142459|NCT00620815|454070|P1|Overall Study|Adverse Event|1
142460|NCT00620854|454131|P6|Washout 1|Withdrawal by Subject|0
142461|NCT00620854|454132|P5|Washout 1|Withdrawal by Subject|0
142462|NCT00620854|454133|P4|Washout 1|Withdrawal by Subject|1
142463|NCT00620854|454134|P3|Washout 1|Withdrawal by Subject|1
142464|NCT00620854|454135|P2|Washout 1|Withdrawal by Subject|0
142465|NCT00620854|454136|P1|Washout 1|Withdrawal by Subject|0
142466|NCT00621023|454147|P1|Overall Study|Follow up discontinued|1
142467|NCT00621023|454147|P1|Overall Study|Death|5
142468|NCT00621140|454170|P2|Overall Study|Other incl. lack of efficacy|5
142469|NCT00621140|454171|P1|Overall Study|Other incl. lack of efficacy|6
142470|NCT00621140|454170|P2|Overall Study|Withdrawal by Subject|6
142471|NCT00621140|454171|P1|Overall Study|Withdrawal by Subject|4
142472|NCT00621140|454170|P2|Overall Study|Lost to Follow-up|2
142473|NCT00621140|454171|P1|Overall Study|Lost to Follow-up|1
142474|NCT00621140|454170|P2|Overall Study|Adverse Event|5
142475|NCT00621140|454171|P1|Overall Study|Adverse Event|4
142476|NCT00621153|454205|P2|Overall Study|Withdrawal by Subject|5
142477|NCT00621153|454206|P1|Overall Study|Withdrawal by Subject|4
142478|NCT00621153|454205|P2|Overall Study|Lost to Follow-up|1
142479|NCT00621153|454206|P1|Overall Study|Lost to Follow-up|5
142480|NCT00621153|454205|P2|Overall Study|Adverse Event|2
142481|NCT00621153|454206|P1|Overall Study|Adverse Event|3
142482|NCT00621153|454205|P2|Overall Study|Safety Reason|7
142483|NCT00621153|454206|P1|Overall Study|Safety Reason|8
142484|NCT00621192|454216|P4|Overall Study|Final Assessments not Completed|1
142485|NCT00621192|454217|P3|Overall Study|Final Assessments not Completed|3
142486|NCT00621192|454218|P2|Overall Study|Final Assessments not Completed|0
142487|NCT00621192|454219|P1|Overall Study|Final Assessments not Completed|0
142488|NCT00621192|454216|P4|Overall Study|Death|0
142489|NCT00621192|454217|P3|Overall Study|Death|0
142490|NCT00621192|454218|P2|Overall Study|Death|5
142491|NCT00621192|454219|P1|Overall Study|Death|2
142492|NCT00621192|454216|P4|Overall Study|Adverse Event|1
142493|NCT00621192|454217|P3|Overall Study|Adverse Event|0
142494|NCT00621192|454218|P2|Overall Study|Adverse Event|1
142495|NCT00621192|454219|P1|Overall Study|Adverse Event|0
142496|NCT00621192|454216|P4|Overall Study|Protocol Violation|1
142497|NCT00621192|454217|P3|Overall Study|Protocol Violation|0
142498|NCT00621192|454218|P2|Overall Study|Protocol Violation|0
142499|NCT00621192|454219|P1|Overall Study|Protocol Violation|1
142500|NCT00621192|454216|P4|Overall Study|Physician Decision|0
142501|NCT00621192|454217|P3|Overall Study|Physician Decision|0
142502|NCT00621192|454218|P2|Overall Study|Physician Decision|3
142503|NCT00621192|454219|P1|Overall Study|Physician Decision|1
142504|NCT00621192|454216|P4|Overall Study|Withdrawal by Subject|0
142505|NCT00621192|454217|P3|Overall Study|Withdrawal by Subject|2
142506|NCT00621192|454218|P2|Overall Study|Withdrawal by Subject|0
142507|NCT00621192|454219|P1|Overall Study|Withdrawal by Subject|0
142508|NCT00621244|454245|P4|Overall Study|Administrative problems|2
142509|NCT00621244|454246|P3|Overall Study|Administrative problems|0
142510|NCT00621244|454247|P2|Overall Study|Administrative problems|1
142511|NCT00621244|454248|P1|Overall Study|Administrative problems|5
142512|NCT00621244|454245|P4|Overall Study|Adverse Event|2
142513|NCT00621244|454246|P3|Overall Study|Adverse Event|9
142514|NCT00621244|454247|P2|Overall Study|Adverse Event|7
142515|NCT00621244|454248|P1|Overall Study|Adverse Event|27
142516|NCT00621244|454245|P4|Overall Study|Death|1
142517|NCT00621244|454246|P3|Overall Study|Death|1
142518|NCT00621244|454247|P2|Overall Study|Death|3
142519|NCT00621244|454248|P1|Overall Study|Death|3
142520|NCT00621244|454245|P4|Overall Study|Disease progression|15
142521|NCT00621244|454246|P3|Overall Study|Disease progression|20
142522|NCT00621244|454247|P2|Overall Study|Disease progression|20
142523|NCT00621244|454248|P1|Overall Study|Disease progression|44
142524|NCT00621244|454245|P4|Overall Study|Withdrawal by Subject|3
142525|NCT00621244|454246|P3|Overall Study|Withdrawal by Subject|3
142526|NCT00621244|454247|P2|Overall Study|Withdrawal by Subject|3
142527|NCT00621244|454248|P1|Overall Study|Withdrawal by Subject|7
142528|NCT00621257|454353|P5|Overall Study|Withdrawal by Subject|1
142529|NCT00621257|454354|P4|Overall Study|Withdrawal by Subject|1
142530|NCT00621257|454355|P3|Overall Study|Withdrawal by Subject|0
142531|NCT00621257|454356|P2|Overall Study|Withdrawal by Subject|0
142532|NCT00621257|454357|P1|Overall Study|Withdrawal by Subject|0
142533|NCT00621257|454353|P5|Overall Study|Physician Decision|1
142534|NCT00621257|454354|P4|Overall Study|Physician Decision|1
142535|NCT00621257|454355|P3|Overall Study|Physician Decision|0
142536|NCT00621257|454356|P2|Overall Study|Physician Decision|2
142537|NCT00621257|454357|P1|Overall Study|Physician Decision|0
142538|NCT00621257|454353|P5|Overall Study|Adverse Event|0
142539|NCT00621257|454354|P4|Overall Study|Adverse Event|0
142540|NCT00621257|454355|P3|Overall Study|Adverse Event|1
142541|NCT00621257|454356|P2|Overall Study|Adverse Event|1
142542|NCT00621257|454357|P1|Overall Study|Adverse Event|0
142543|NCT00621257|454353|P5|Overall Study|Lost to Follow-up|7
142544|NCT00621257|454354|P4|Overall Study|Lost to Follow-up|4
142545|NCT00621257|454355|P3|Overall Study|Lost to Follow-up|2
142546|NCT00621257|454356|P2|Overall Study|Lost to Follow-up|0
142547|NCT00621257|454357|P1|Overall Study|Lost to Follow-up|4
142548|NCT00621296|454369|P1|Overall Study|Stopping Criteria|3
142549|NCT00621296|454369|P1|Overall Study|Unmatch Criteria|1
142550|NCT00621296|454369|P1|Overall Study|Physician Decision|7
142551|NCT00621296|454369|P1|Overall Study|Lack of Efficacy|1
142552|NCT00621296|454369|P1|Overall Study|Adverse Event|2
142553|NCT00621322|454379|P6|Overall Study|Migrated/moved from study area|2
142554|NCT00621322|454380|P5|Overall Study|Migrated/moved from study area|0
142555|NCT00621322|454381|P4|Overall Study|Migrated/moved from study area|1
142556|NCT00621322|454382|P3|Overall Study|Migrated/moved from study area|1
142557|NCT00621322|454383|P2|Overall Study|Migrated/moved from study area|0
142558|NCT00621322|454384|P1|Overall Study|Migrated/moved from study area|1
142559|NCT00621322|454379|P6|Overall Study|Withdrawal by Subject|2
142560|NCT00621322|454380|P5|Overall Study|Withdrawal by Subject|0
142561|NCT00621322|454381|P4|Overall Study|Withdrawal by Subject|1
142562|NCT00621322|454382|P3|Overall Study|Withdrawal by Subject|0
142563|NCT00621322|454383|P2|Overall Study|Withdrawal by Subject|0
142564|NCT00621322|454384|P1|Overall Study|Withdrawal by Subject|0
142565|NCT00621322|454379|P6|Overall Study|Physician Decision|0
142566|NCT00621322|454380|P5|Overall Study|Physician Decision|0
142567|NCT00621322|454381|P4|Overall Study|Physician Decision|1
142568|NCT00621322|454382|P3|Overall Study|Physician Decision|1
142569|NCT00621322|454383|P2|Overall Study|Physician Decision|0
142570|NCT00621322|454384|P1|Overall Study|Physician Decision|0
142571|NCT00621322|454379|P6|Overall Study|Lost to Follow-up|0
142572|NCT00621322|454380|P5|Overall Study|Lost to Follow-up|1
142573|NCT00621322|454381|P4|Overall Study|Lost to Follow-up|0
142574|NCT00621322|454382|P3|Overall Study|Lost to Follow-up|0
142575|NCT00621322|454383|P2|Overall Study|Lost to Follow-up|0
142576|NCT00621322|454384|P1|Overall Study|Lost to Follow-up|0
142577|NCT00621504|454488|P2|Overall Study|Death|6
142578|NCT00621504|454489|P1|Overall Study|Death|6
142579|NCT00621504|454488|P2|Overall Study|Other|0
142580|NCT00621504|454489|P1|Overall Study|Other|1
142581|NCT00621504|454488|P2|Overall Study|Lost to Follow-up|10
142582|NCT00621504|454489|P1|Overall Study|Lost to Follow-up|8
142583|NCT00621504|454488|P2|Overall Study|Withdrew consent|6
142584|NCT00621504|454489|P1|Overall Study|Withdrew consent|9
142585|NCT00621504|454488|P2|Overall Study|At the request of sponsor/investigator|0
142586|NCT00621504|454489|P1|Overall Study|At the request of sponsor/investigator|1
142587|NCT00621504|454488|P2|Overall Study|Adverse Event|3
142588|NCT00621504|454489|P1|Overall Study|Adverse Event|1
142589|NCT00621517|454497|P2|Overall Study|Adverse Event|0
142590|NCT00621517|454498|P1|Overall Study|Adverse Event|1
142591|NCT00621517|454497|P2|Overall Study|Withdrawal by Subject|4
142592|NCT00621517|454498|P1|Overall Study|Withdrawal by Subject|3
142593|NCT00621517|454497|P2|Overall Study|Lost to Follow-up|3
142594|NCT00621517|454498|P1|Overall Study|Lost to Follow-up|3
142595|NCT00621543|454521|P1|Overall Study|Lost to Follow-up|23
142596|NCT00621582|454526|P1|Overall Study|issues not identified by investigators|18
142597|NCT00621582|454526|P1|Overall Study|Lost to Follow-up|24
142598|NCT00621582|454526|P1|Overall Study|Protocol Violation|57
142599|NCT00621582|454526|P1|Overall Study|Adverse Event|7
142600|NCT00621621|454536|P2|Overall Study|Subjects were exited at EP study|0
142601|NCT00621621|454537|P1|Overall Study|Subjects were exited at EP study|30
142602|NCT00621764|454562|P4|Overall Study|Protocol Violation|1
142603|NCT00621764|454563|P3|Overall Study|Protocol Violation|0
142604|NCT00621764|454564|P2|Overall Study|Protocol Violation|0
142605|NCT00621764|454565|P1|Overall Study|Protocol Violation|0
142606|NCT00621777|454597|P2|Randomized Phase|Death|1
142607|NCT00621777|454598|P1|Randomized Phase|Death|0
142608|NCT00621777|454597|P2|Randomized Phase|administrative|3
142609|NCT00621777|454598|P1|Randomized Phase|administrative|0
142610|NCT00621777|454597|P2|Randomized Phase|Withdrawal by Subject|9
142611|NCT00621777|454598|P1|Randomized Phase|Withdrawal by Subject|1
142612|NCT00621777|454597|P2|Randomized Phase|Lost to Follow-up|3
142613|NCT00621777|454598|P1|Randomized Phase|Lost to Follow-up|3
142614|NCT00621777|454597|P2|Randomized Phase|Adverse Event|3
142615|NCT00621777|454598|P1|Randomized Phase|Adverse Event|3
142616|NCT00621777|454597|P2|Open Phase|Lost to Follow-up|0
142617|NCT00621777|454598|P1|Open Phase|Lost to Follow-up|10
142618|NCT00621777|454597|P2|Open Phase|administrative|0
142619|NCT00621777|454598|P1|Open Phase|administrative|13
142620|NCT00621777|454597|P2|Open Phase|Withdrawal by Subject|0
142621|NCT00621777|454598|P1|Open Phase|Withdrawal by Subject|17
142622|NCT00621777|454597|P2|Open Phase|Did not abstain during open phase|0
142623|NCT00621777|454598|P1|Open Phase|Did not abstain during open phase|56
142624|NCT00621777|454597|P2|Open Phase|Adverse Event|0
142625|NCT00621777|454598|P1|Open Phase|Adverse Event|20
142626|NCT00621842|454605|P1|Overall Study|Lack of Efficacy|2
142627|NCT00621842|454605|P1|Overall Study|Protocol Violation|4
142628|NCT00621842|454605|P1|Overall Study|Withdrawal by Subject|7
142629|NCT00621842|454605|P1|Overall Study|Adverse Event|6
142630|NCT00621855|454625|P5|Overall Study|Patients did not receive study drug|2
142631|NCT00621855|454626|P4|Overall Study|Patients did not receive study drug|4
142632|NCT00621855|454627|P3|Overall Study|Patients did not receive study drug|5
142633|NCT00621855|454628|P2|Overall Study|Patients did not receive study drug|3
142634|NCT00621855|454629|P1|Overall Study|Patients did not receive study drug|3
142635|NCT00621855|454625|P5|Overall Study|Other|4
142636|NCT00621855|454626|P4|Overall Study|Other|5
142637|NCT00621855|454627|P3|Overall Study|Other|6
142638|NCT00621855|454628|P2|Overall Study|Other|7
142639|NCT00621855|454629|P1|Overall Study|Other|9
142640|NCT00621855|454625|P5|Overall Study|Withdrawal by Subject|9
142641|NCT00621855|454626|P4|Overall Study|Withdrawal by Subject|13
142642|NCT00621855|454627|P3|Overall Study|Withdrawal by Subject|13
142643|NCT00621855|454628|P2|Overall Study|Withdrawal by Subject|11
142644|NCT00621855|454629|P1|Overall Study|Withdrawal by Subject|16
142645|NCT00621855|454625|P5|Overall Study|Protocol Violation|8
142646|NCT00621855|454626|P4|Overall Study|Protocol Violation|7
142647|NCT00621855|454627|P3|Overall Study|Protocol Violation|6
142648|NCT00621855|454628|P2|Overall Study|Protocol Violation|8
142649|NCT00621855|454629|P1|Overall Study|Protocol Violation|16
142650|NCT00621855|454625|P5|Overall Study|Lost to Follow-up|1
142651|NCT00621855|454626|P4|Overall Study|Lost to Follow-up|4
142652|NCT00621855|454627|P3|Overall Study|Lost to Follow-up|3
142653|NCT00621855|454628|P2|Overall Study|Lost to Follow-up|1
142654|NCT00621855|454629|P1|Overall Study|Lost to Follow-up|0
142655|NCT00621855|454625|P5|Overall Study|Adverse Event|31
142656|NCT00621855|454626|P4|Overall Study|Adverse Event|34
142657|NCT00621855|454627|P3|Overall Study|Adverse Event|48
142658|NCT00621855|454628|P2|Overall Study|Adverse Event|31
142659|NCT00621855|454629|P1|Overall Study|Adverse Event|32
142660|NCT00621959|454699|P2|Overall Study|Other|3
142661|NCT00621959|454700|P1|Overall Study|Other|1
142662|NCT00621959|454699|P2|Overall Study|Withdrawal by Subject|1
142663|NCT00621959|454700|P1|Overall Study|Withdrawal by Subject|1
142664|NCT00621959|454699|P2|Overall Study|Lost to Follow-up|2
142665|NCT00621959|454700|P1|Overall Study|Lost to Follow-up|0
142666|NCT00621959|454699|P2|Overall Study|Lack of Efficacy|1
142667|NCT00621959|454700|P1|Overall Study|Lack of Efficacy|1
142668|NCT00621959|454699|P2|Overall Study|Adverse Event|2
142669|NCT00621959|454700|P1|Overall Study|Adverse Event|4
142670|NCT00621985|454708|P1|Dexamethasone Admission|Adverse Event|1
142671|NCT00622167|454714|P1|Overall Study|Did not meet angiographic criteria|20
142672|NCT00607789|454720|P2|Overall Study|Withdrawal by Subject|0
142673|NCT00607789|454721|P1|Overall Study|Withdrawal by Subject|1
142674|NCT00607789|454720|P2|Overall Study|Lost to Follow-up|5
142675|NCT00607789|454721|P1|Overall Study|Lost to Follow-up|0
142676|NCT00607789|454720|P2|Overall Study|Inadequate adherence|0
142677|NCT00607789|454721|P1|Overall Study|Inadequate adherence|3
142678|NCT00607789|454720|P2|Overall Study|Lack of Efficacy|1
142679|NCT00607789|454721|P1|Overall Study|Lack of Efficacy|0
142680|NCT00607789|454720|P2|Overall Study|Adverse Event|0
142681|NCT00607789|454721|P1|Overall Study|Adverse Event|3
142682|NCT00607880|454767|P2|Overall Study|Unable to place port due to occlusion|0
142683|NCT00607880|454768|P1|Overall Study|Unable to place port due to occlusion|1
142684|NCT00608426|454782|P2|Overall Study|refused, health issues, wrong address|348
142685|NCT00608426|454783|P1|Overall Study|refused, health issues, wrong address|319
142686|NCT00608426|454782|P2|Overall Study|Lost to Follow-up|521
142687|NCT00608426|454783|P1|Overall Study|Lost to Follow-up|485
142688|NCT00608426|454782|P2|Overall Study|Death|36
142689|NCT00608426|454783|P1|Overall Study|Death|32
142690|NCT00608517|454948|P3|Overall Study|Death|0
142691|NCT00608517|454949|P2|Overall Study|Death|0
142692|NCT00608517|454950|P1|Overall Study|Death|1
142693|NCT00608530|454978|P2|Overall Study|Withdrawal by Subject|5
142694|NCT00608530|454979|P1|Overall Study|Withdrawal by Subject|11
142695|NCT00608543|454989|P1|Overall Study|Adverse Event|4
142696|NCT00608569|455000|P2|Overall Study|Unable to adhere with study requirements|1
142697|NCT00608569|455001|P1|Overall Study|Unable to adhere with study requirements|0
142698|NCT00608569|455000|P2|Overall Study|Adverse Event|0
142699|NCT00608569|455001|P1|Overall Study|Adverse Event|1
142700|NCT00608569|455000|P2|Overall Study|Withdrawal by Subject|0
142701|NCT00608569|455001|P1|Overall Study|Withdrawal by Subject|1
142702|NCT00608569|455000|P2|Overall Study|Lost to Follow-up|5
142703|NCT00608569|455001|P1|Overall Study|Lost to Follow-up|4
142704|NCT00608569|455000|P2|Overall Study|Death|3
142705|NCT00608569|455001|P1|Overall Study|Death|4
142706|NCT00608582|455023|P2|Overall Study|Early stage Design Change|3
142707|NCT00608582|455024|P1|Overall Study|Early stage Design Change|0
142708|NCT00608582|455023|P2|Overall Study|Illicit Drug Use|0
142709|NCT00608582|455024|P1|Overall Study|Illicit Drug Use|1
142710|NCT00608582|455023|P2|Overall Study|No Best Response in Phase 1 located|1
142711|NCT00608582|455024|P1|Overall Study|No Best Response in Phase 1 located|1
142712|NCT00608582|455023|P2|Overall Study|Lost to Follow-up|0
142713|NCT00608582|455024|P1|Overall Study|Lost to Follow-up|2
142714|NCT00614380|455066|P4|Overall Study|Consent withdrawn|0
142715|NCT00614380|455067|P3|Overall Study|Consent withdrawn|0
142716|NCT00614380|455068|P2|Overall Study|Consent withdrawn|1
142717|NCT00614380|455069|P1|Overall Study|Consent withdrawn|3
142718|NCT00614380|455066|P4|Overall Study|Non compliant with the protocol|2
142719|NCT00614380|455067|P3|Overall Study|Non compliant with the protocol|1
142720|NCT00614380|455068|P2|Overall Study|Non compliant with the protocol|2
142721|NCT00614380|455069|P1|Overall Study|Non compliant with the protocol|12
142722|NCT00614380|455066|P4|Overall Study|Lost to Follow-up|0
142723|NCT00614380|455067|P3|Overall Study|Lost to Follow-up|0
142724|NCT00614380|455068|P2|Overall Study|Lost to Follow-up|1
142725|NCT00614380|455069|P1|Overall Study|Lost to Follow-up|6
142726|NCT00614380|455066|P4|Overall Study|Adverse Event|0
142727|NCT00614380|455067|P3|Overall Study|Adverse Event|0
142728|NCT00614380|455068|P2|Overall Study|Adverse Event|4
142729|NCT00614380|455069|P1|Overall Study|Adverse Event|14
142730|NCT00614393|455123|P5|Overall Study|Not Treated|2
142731|NCT00614393|455124|P4|Overall Study|Not Treated|0
142732|NCT00614393|455125|P3|Overall Study|Not Treated|0
142733|NCT00614393|455126|P2|Overall Study|Not Treated|0
142734|NCT00614393|455127|P1|Overall Study|Not Treated|0
142735|NCT00614393|455123|P5|Overall Study|Other|2
142736|NCT00614393|455124|P4|Overall Study|Other|4
142737|NCT00614393|455125|P3|Overall Study|Other|0
142738|NCT00614393|455126|P2|Overall Study|Other|0
142739|NCT00614393|455127|P1|Overall Study|Other|4
142740|NCT00614393|455123|P5|Overall Study|Withdrawal by Subject|13
142741|NCT00614393|455124|P4|Overall Study|Withdrawal by Subject|16
142742|NCT00614393|455125|P3|Overall Study|Withdrawal by Subject|1
142743|NCT00614393|455126|P2|Overall Study|Withdrawal by Subject|1
142744|NCT00614393|455127|P1|Overall Study|Withdrawal by Subject|20
142745|NCT00614393|455123|P5|Overall Study|Terminated by Sponsor|1
142746|NCT00614393|455124|P4|Overall Study|Terminated by Sponsor|0
142747|NCT00614393|455125|P3|Overall Study|Terminated by Sponsor|0
142748|NCT00614393|455126|P2|Overall Study|Terminated by Sponsor|0
142749|NCT00614393|455127|P1|Overall Study|Terminated by Sponsor|0
142750|NCT00614393|455123|P5|Overall Study|Protocol Violation|0
142751|NCT00614393|455124|P4|Overall Study|Protocol Violation|0
142752|NCT00614393|455125|P3|Overall Study|Protocol Violation|0
142753|NCT00614393|455126|P2|Overall Study|Protocol Violation|0
142754|NCT00614393|455127|P1|Overall Study|Protocol Violation|1
142755|NCT00614393|455123|P5|Overall Study|Progressive Disease|130
142756|NCT00614393|455124|P4|Overall Study|Progressive Disease|138
142757|NCT00614393|455125|P3|Overall Study|Progressive Disease|5
142758|NCT00614393|455126|P2|Overall Study|Progressive Disease|5
142759|NCT00614393|455127|P1|Overall Study|Progressive Disease|118
142760|NCT00614393|455123|P5|Overall Study|Physician Decision|9
142761|NCT00614393|455124|P4|Overall Study|Physician Decision|8
142762|NCT00614393|455125|P3|Overall Study|Physician Decision|1
142763|NCT00614393|455126|P2|Overall Study|Physician Decision|0
142764|NCT00614393|455127|P1|Overall Study|Physician Decision|17
142765|NCT00614393|455123|P5|Overall Study|Lost to Follow-up|2
142766|NCT00614393|455124|P4|Overall Study|Lost to Follow-up|1
142767|NCT00614393|455125|P3|Overall Study|Lost to Follow-up|0
142768|NCT00614393|455126|P2|Overall Study|Lost to Follow-up|0
142769|NCT00614393|455127|P1|Overall Study|Lost to Follow-up|0
142770|NCT00614393|455123|P5|Overall Study|Adverse Event|21
142771|NCT00614393|455124|P4|Overall Study|Adverse Event|13
142772|NCT00614393|455125|P3|Overall Study|Adverse Event|3
142773|NCT00614393|455126|P2|Overall Study|Adverse Event|2
142774|NCT00614393|455127|P1|Overall Study|Adverse Event|20
142775|NCT00614523|455198|P2|Overall Study|Administrative Decision|46
142776|NCT00614523|455199|P1|Overall Study|Administrative Decision|23
142777|NCT00614523|455198|P2|Overall Study|Disease Progression|8
142778|NCT00614523|455199|P1|Overall Study|Disease Progression|0
142779|NCT00614523|455198|P2|Overall Study|Ineligibility Determined|2
142780|NCT00614523|455199|P1|Overall Study|Ineligibility Determined|1
142781|NCT00614523|455198|P2|Overall Study|Other|11
142782|NCT00614523|455199|P1|Overall Study|Other|6
142783|NCT00614523|455198|P2|Overall Study|Withdrawal by Subject|22
142784|NCT00614523|455199|P1|Overall Study|Withdrawal by Subject|12
142785|NCT00614523|455198|P2|Overall Study|Protocol Violation|2
142786|NCT00614523|455199|P1|Overall Study|Protocol Violation|3
142787|NCT00614523|455198|P2|Overall Study|Lost to Follow-up|1
142788|NCT00614523|455199|P1|Overall Study|Lost to Follow-up|0
142789|NCT00614523|455198|P2|Overall Study|Lack of Efficacy|11
142790|NCT00614523|455199|P1|Overall Study|Lack of Efficacy|9
142791|NCT00614523|455198|P2|Overall Study|Death|8
142792|NCT00614523|455199|P1|Overall Study|Death|5
142793|NCT00614523|455198|P2|Overall Study|Adverse Event|20
142794|NCT00614523|455199|P1|Overall Study|Adverse Event|4
142795|NCT00614575|455223|P1|Overall Study|No treatment|1
142796|NCT00614575|455223|P1|Overall Study|Irregularly enrolled patients|23
142797|NCT00614575|455223|P1|Overall Study|No data were collected.|18
142798|NCT00614575|455223|P1|Overall Study|Physician Decision|2
142799|NCT00614575|455223|P1|Overall Study|Death|3
142800|NCT00614575|455223|P1|Overall Study|Withdrawal by Subject|6
142801|NCT00614575|455223|P1|Overall Study|Lack of Efficacy|14
142802|NCT00614575|455223|P1|Overall Study|Lost to Follow-up|55
142803|NCT00614575|455223|P1|Overall Study|Adverse Event|106
142804|NCT00614614|455234|P5|Booster Vaccination Phase|Unspecified|1
142805|NCT00614614|455235|P4|Booster Vaccination Phase|Unspecified|2
142806|NCT00614614|455236|P3|Booster Vaccination Phase|Unspecified|3
142807|NCT00614614|455237|P2|Booster Vaccination Phase|Unspecified|1
142808|NCT00614614|455238|P1|Booster Vaccination Phase|Unspecified|0
142809|NCT00614614|455234|P5|Booster Vaccination Phase|Protocol Violation|0
142810|NCT00614614|455235|P4|Booster Vaccination Phase|Protocol Violation|3
142811|NCT00614614|455236|P3|Booster Vaccination Phase|Protocol Violation|2
142812|NCT00614614|455237|P2|Booster Vaccination Phase|Protocol Violation|0
142813|NCT00614614|455238|P1|Booster Vaccination Phase|Protocol Violation|0
142814|NCT00614614|455234|P5|Booster Vaccination Phase|Lost to Follow-up|8
142815|NCT00614614|455235|P4|Booster Vaccination Phase|Lost to Follow-up|10
142816|NCT00614614|455236|P3|Booster Vaccination Phase|Lost to Follow-up|17
142817|NCT00614614|455237|P2|Booster Vaccination Phase|Lost to Follow-up|5
142818|NCT00614614|455238|P1|Booster Vaccination Phase|Lost to Follow-up|0
142819|NCT00614614|455234|P5|Booster Vaccination Phase|Withdrawal by Subject|4
142820|NCT00614614|455235|P4|Booster Vaccination Phase|Withdrawal by Subject|3
142821|NCT00614614|455236|P3|Booster Vaccination Phase|Withdrawal by Subject|4
142822|NCT00614614|455237|P2|Booster Vaccination Phase|Withdrawal by Subject|0
142823|NCT00614614|455238|P1|Booster Vaccination Phase|Withdrawal by Subject|0
142824|NCT00614614|455234|P5|Booster Vaccination Phase|Adverse Event|0
142825|NCT00614614|455235|P4|Booster Vaccination Phase|Adverse Event|1
142826|NCT00614614|455236|P3|Booster Vaccination Phase|Adverse Event|1
142827|NCT00614614|455237|P2|Booster Vaccination Phase|Adverse Event|0
142828|NCT00614614|455238|P1|Booster Vaccination Phase|Adverse Event|0
142829|NCT00614614|455234|P5|Primary Vaccination Phase|Unspecified|0
142830|NCT00614614|455235|P4|Primary Vaccination Phase|Unspecified|0
142831|NCT00614614|455236|P3|Primary Vaccination Phase|Unspecified|0
142832|NCT00614614|455237|P2|Primary Vaccination Phase|Unspecified|0
142833|NCT00614614|455238|P1|Primary Vaccination Phase|Unspecified|4
142834|NCT00614614|455234|P5|Primary Vaccination Phase|Protocol Violation|0
142835|NCT00614614|455235|P4|Primary Vaccination Phase|Protocol Violation|0
142836|NCT00614614|455236|P3|Primary Vaccination Phase|Protocol Violation|0
142837|NCT00614614|455237|P2|Primary Vaccination Phase|Protocol Violation|3
142838|NCT00614614|455238|P1|Primary Vaccination Phase|Protocol Violation|9
142839|NCT00614614|455234|P5|Primary Vaccination Phase|Lost to Follow-up|0
142840|NCT00614614|455235|P4|Primary Vaccination Phase|Lost to Follow-up|0
142841|NCT00614614|455236|P3|Primary Vaccination Phase|Lost to Follow-up|0
142842|NCT00614614|455237|P2|Primary Vaccination Phase|Lost to Follow-up|8
142843|NCT00614614|455238|P1|Primary Vaccination Phase|Lost to Follow-up|26
142844|NCT00614614|455234|P5|Primary Vaccination Phase|Withdrawal by Subject|0
142845|NCT00614614|455235|P4|Primary Vaccination Phase|Withdrawal by Subject|0
142846|NCT00614614|455236|P3|Primary Vaccination Phase|Withdrawal by Subject|0
142847|NCT00614614|455237|P2|Primary Vaccination Phase|Withdrawal by Subject|6
142848|NCT00614614|455238|P1|Primary Vaccination Phase|Withdrawal by Subject|45
142849|NCT00614614|455234|P5|Primary Vaccination Phase|Adverse Event|0
142850|NCT00614614|455235|P4|Primary Vaccination Phase|Adverse Event|0
142851|NCT00614614|455236|P3|Primary Vaccination Phase|Adverse Event|0
142852|NCT00614614|455237|P2|Primary Vaccination Phase|Adverse Event|0
142853|NCT00614614|455238|P1|Primary Vaccination Phase|Adverse Event|6
142854|NCT00614744|455363|P2|Overall Study|Incomplete for Behavior Issues|2
142855|NCT00614744|455364|P1|Overall Study|Incomplete for Behavior Issues|0
142856|NCT00614744|455363|P2|Overall Study|Lost to Follow-up|4
142857|NCT00614744|455364|P1|Overall Study|Lost to Follow-up|5
142858|NCT00614874|455388|P1|Overall Study|Withdrawal by Subject|1
142859|NCT00614874|455388|P1|Overall Study|Protocol Violation|1
142860|NCT00614926|455402|P2|Overall Study|Adverse Event|0
142861|NCT00614926|455403|P1|Overall Study|Adverse Event|3
142862|NCT00614926|455402|P2|Overall Study|Burden of travel|0
142863|NCT00614926|455403|P1|Overall Study|Burden of travel|1
142864|NCT00614939|455413|P2|Overall Study|Hospitalized due to kidney transplant|0
142865|NCT00614939|455414|P1|Overall Study|Hospitalized due to kidney transplant|1
142866|NCT00614939|455413|P2|Overall Study|Poor/non-compliance|0
142867|NCT00614939|455414|P1|Overall Study|Poor/non-compliance|4
142868|NCT00614939|455413|P2|Overall Study|Death|3
142869|NCT00614939|455414|P1|Overall Study|Death|4
142870|NCT00614939|455413|P2|Overall Study|Incorrect enrollment|2
142871|NCT00614939|455414|P1|Overall Study|Incorrect enrollment|1
142872|NCT00614939|455413|P2|Overall Study|Adverse Event|5
142873|NCT00614939|455414|P1|Overall Study|Adverse Event|2
142874|NCT00614939|455413|P2|Overall Study|Study specific discontinuation criteris|16
142875|NCT00614939|455414|P1|Overall Study|Study specific discontinuation criteris|13
142876|NCT00614939|455413|P2|Overall Study|Withdrawal by Subject|17
142877|NCT00614939|455414|P1|Overall Study|Withdrawal by Subject|10
142878|NCT00614991|455452|P6|Overall Study|Adverse Event|0
142879|NCT00614991|455453|P5|Overall Study|Adverse Event|1
142880|NCT00614991|455454|P4|Overall Study|Adverse Event|0
142881|NCT00614991|455455|P3|Overall Study|Adverse Event|0
142882|NCT00614991|455456|P2|Overall Study|Adverse Event|3
142883|NCT00614991|455457|P1|Overall Study|Adverse Event|3
142884|NCT00615017|455495|P6|Overall Study|Physician discontinued drug|1
142885|NCT00615017|455496|P5|Overall Study|Physician discontinued drug|0
142886|NCT00615017|455497|P4|Overall Study|Physician discontinued drug|0
142887|NCT00615017|455498|P3|Overall Study|Physician discontinued drug|0
142888|NCT00615017|455499|P2|Overall Study|Physician discontinued drug|0
142889|NCT00615017|455500|P1|Overall Study|Physician discontinued drug|0
142890|NCT00615017|455495|P6|Overall Study|Transferred out of Intensive Care Unit|0
142891|NCT00615017|455496|P5|Overall Study|Transferred out of Intensive Care Unit|0
142892|NCT00615017|455497|P4|Overall Study|Transferred out of Intensive Care Unit|1
142893|NCT00615017|455498|P3|Overall Study|Transferred out of Intensive Care Unit|0
142894|NCT00615017|455499|P2|Overall Study|Transferred out of Intensive Care Unit|0
142895|NCT00615017|455500|P1|Overall Study|Transferred out of Intensive Care Unit|0
142896|NCT00615017|455495|P6|Overall Study|Sepsis resolved|0
142897|NCT00615017|455496|P5|Overall Study|Sepsis resolved|0
142898|NCT00615017|455497|P4|Overall Study|Sepsis resolved|0
142899|NCT00615017|455498|P3|Overall Study|Sepsis resolved|1
142900|NCT00615017|455499|P2|Overall Study|Sepsis resolved|0
142901|NCT00615017|455500|P1|Overall Study|Sepsis resolved|0
142902|NCT00615017|455495|P6|Overall Study|Death|1
142903|NCT00615017|455496|P5|Overall Study|Death|1
142904|NCT00615017|455497|P4|Overall Study|Death|0
142905|NCT00615017|455498|P3|Overall Study|Death|2
142906|NCT00615017|455499|P2|Overall Study|Death|0
142907|NCT00615017|455500|P1|Overall Study|Death|0
142908|NCT00615017|455495|P6|Overall Study|Adverse Event|1
142909|NCT00615017|455496|P5|Overall Study|Adverse Event|0
142910|NCT00615017|455497|P4|Overall Study|Adverse Event|0
142911|NCT00615017|455498|P3|Overall Study|Adverse Event|2
142912|NCT00615017|455499|P2|Overall Study|Adverse Event|1
142913|NCT00615017|455500|P1|Overall Study|Adverse Event|0
142914|NCT00615030|455652|P12|Period III|Administrative problems|0
142915|NCT00615030|455653|P11|Period III|Administrative problems|0
142916|NCT00615030|455654|P10|Period III|Administrative problems|0
142917|NCT00615030|455655|P9|Period III|Administrative problems|0
142918|NCT00615030|455656|P8|Period III|Administrative problems|0
142919|NCT00615030|455657|P7|Period III|Administrative problems|0
142920|NCT00615030|455658|P6|Period III|Administrative problems|0
142921|NCT00615030|455659|P5|Period III|Administrative problems|0
142922|NCT00615030|455660|P4|Period III|Administrative problems|1
142923|NCT00615030|455661|P3|Period III|Administrative problems|0
142924|NCT00615030|455662|P2|Period III|Administrative problems|0
142925|NCT00615030|455663|P1|Period III|Administrative problems|1
142926|NCT00615030|455652|P12|Period II|Subject withdrew consent|0
142927|NCT00615030|455653|P11|Period II|Subject withdrew consent|0
142928|NCT00615030|455654|P10|Period II|Subject withdrew consent|0
142929|NCT00615030|455655|P9|Period II|Subject withdrew consent|0
142930|NCT00615030|455656|P8|Period II|Subject withdrew consent|0
142931|NCT00615030|455657|P7|Period II|Subject withdrew consent|1
142932|NCT00615030|455658|P6|Period II|Subject withdrew consent|0
142933|NCT00615030|455659|P5|Period II|Subject withdrew consent|0
142934|NCT00615030|455660|P4|Period II|Subject withdrew consent|1
142935|NCT00615030|455661|P3|Period II|Subject withdrew consent|0
142936|NCT00615030|455662|P2|Period II|Subject withdrew consent|0
142937|NCT00615030|455663|P1|Period II|Subject withdrew consent|0
142938|NCT00615030|455652|P12|Period II|Adverse Event|0
142939|NCT00615030|455653|P11|Period II|Adverse Event|0
142940|NCT00615030|455654|P10|Period II|Adverse Event|0
142941|NCT00615030|455655|P9|Period II|Adverse Event|1
142942|NCT00615030|455656|P8|Period II|Adverse Event|0
142943|NCT00615030|455657|P7|Period II|Adverse Event|0
142944|NCT00615030|455658|P6|Period II|Adverse Event|0
142945|NCT00615030|455659|P5|Period II|Adverse Event|0
142946|NCT00615030|455660|P4|Period II|Adverse Event|0
142947|NCT00615030|455661|P3|Period II|Adverse Event|1
142948|NCT00615030|455662|P2|Period II|Adverse Event|0
142949|NCT00615030|455663|P1|Period II|Adverse Event|0
142950|NCT00615030|455652|P12|Period I|Abnormal laboratory value(s)|0
142951|NCT00615030|455653|P11|Period I|Abnormal laboratory value(s)|0
142952|NCT00615030|455654|P10|Period I|Abnormal laboratory value(s)|0
142953|NCT00615030|455655|P9|Period I|Abnormal laboratory value(s)|0
142954|NCT00615030|455656|P8|Period I|Abnormal laboratory value(s)|0
142955|NCT00615030|455657|P7|Period I|Abnormal laboratory value(s)|0
142956|NCT00615030|455658|P6|Period I|Abnormal laboratory value(s)|1
142957|NCT00615030|455659|P5|Period I|Abnormal laboratory value(s)|0
142958|NCT00615030|455660|P4|Period I|Abnormal laboratory value(s)|0
142959|NCT00615030|455661|P3|Period I|Abnormal laboratory value(s)|0
142960|NCT00615030|455662|P2|Period I|Abnormal laboratory value(s)|0
142961|NCT00615030|455663|P1|Period I|Abnormal laboratory value(s)|0
142962|NCT00615030|455652|P12|Period I|Subject withdrew consent|1
142963|NCT00615030|455653|P11|Period I|Subject withdrew consent|1
142964|NCT00615030|455654|P10|Period I|Subject withdrew consent|0
142965|NCT00615030|455655|P9|Period I|Subject withdrew consent|1
142966|NCT00615030|455656|P8|Period I|Subject withdrew consent|0
142967|NCT00615030|455657|P7|Period I|Subject withdrew consent|0
142968|NCT00615030|455658|P6|Period I|Subject withdrew consent|0
142969|NCT00615030|455659|P5|Period I|Subject withdrew consent|0
142970|NCT00615030|455660|P4|Period I|Subject withdrew consent|0
142971|NCT00615030|455661|P3|Period I|Subject withdrew consent|0
142972|NCT00615030|455662|P2|Period I|Subject withdrew consent|0
142973|NCT00615030|455663|P1|Period I|Subject withdrew consent|0
142974|NCT00615030|455652|P12|Period I|Protocol deviation|0
142975|NCT00615030|455653|P11|Period I|Protocol deviation|0
142976|NCT00615030|455654|P10|Period I|Protocol deviation|0
142977|NCT00615030|455655|P9|Period I|Protocol deviation|0
142978|NCT00615030|455656|P8|Period I|Protocol deviation|0
142979|NCT00615030|455657|P7|Period I|Protocol deviation|0
142980|NCT00615030|455658|P6|Period I|Protocol deviation|0
142981|NCT00615030|455659|P5|Period I|Protocol deviation|0
142982|NCT00615030|455660|P4|Period I|Protocol deviation|0
142983|NCT00615030|455661|P3|Period I|Protocol deviation|0
142984|NCT00615030|455662|P2|Period I|Protocol deviation|0
142985|NCT00615030|455663|P1|Period I|Protocol deviation|1
142986|NCT00615030|455652|P12|Period I|Administrative problem|0
142987|NCT00615030|455653|P11|Period I|Administrative problem|0
142988|NCT00615030|455654|P10|Period I|Administrative problem|0
142989|NCT00615030|455655|P9|Period I|Administrative problem|0
142990|NCT00615030|455656|P8|Period I|Administrative problem|0
142991|NCT00615030|455657|P7|Period I|Administrative problem|0
142992|NCT00615030|455658|P6|Period I|Administrative problem|0
142993|NCT00615030|455659|P5|Period I|Administrative problem|1
142994|NCT00615030|455660|P4|Period I|Administrative problem|0
142995|NCT00615030|455661|P3|Period I|Administrative problem|0
142996|NCT00615030|455662|P2|Period I|Administrative problem|0
142997|NCT00615030|455663|P1|Period I|Administrative problem|0
142998|NCT00615056|455681|P4|Overall Study|Randomized but not treated|0
142999|NCT00615056|455682|P3|Overall Study|Randomized but not treated|0
143000|NCT00615056|455683|P2|Overall Study|Randomized but not treated|0
143001|NCT00615056|455684|P1|Overall Study|Randomized but not treated|3
143002|NCT00615056|455681|P4|Overall Study|Discontinued by Sponsor|0
143003|NCT00615056|455682|P3|Overall Study|Discontinued by Sponsor|0
143004|NCT00615056|455683|P2|Overall Study|Discontinued by Sponsor|0
143005|NCT00615056|455684|P1|Overall Study|Discontinued by Sponsor|1
143006|NCT00615056|455681|P4|Overall Study|Withdrawal by Subject|0
143007|NCT00615056|455682|P3|Overall Study|Withdrawal by Subject|1
143008|NCT00615056|455683|P2|Overall Study|Withdrawal by Subject|1
143009|NCT00615056|455684|P1|Overall Study|Withdrawal by Subject|0
143010|NCT00615056|455681|P4|Overall Study|Objective progression or relapse|0
143011|NCT00615056|455682|P3|Overall Study|Objective progression or relapse|0
143012|NCT00615056|455683|P2|Overall Study|Objective progression or relapse|2
143013|NCT00615056|455684|P1|Overall Study|Objective progression or relapse|0
143014|NCT00615056|455681|P4|Overall Study|Unspecified|7
143015|NCT00615056|455682|P3|Overall Study|Unspecified|10
143016|NCT00615056|455683|P2|Overall Study|Unspecified|15
143017|NCT00615056|455684|P1|Overall Study|Unspecified|13
143018|NCT00615056|455681|P4|Overall Study|Lost to Follow-up|5
143019|NCT00615056|455682|P3|Overall Study|Lost to Follow-up|4
143020|NCT00615056|455683|P2|Overall Study|Lost to Follow-up|2
143021|NCT00615056|455684|P1|Overall Study|Lost to Follow-up|1
143022|NCT00615056|455681|P4|Overall Study|Death|23
143023|NCT00615056|455682|P3|Overall Study|Death|21
143024|NCT00615056|455683|P2|Overall Study|Death|31
143025|NCT00615056|455684|P1|Overall Study|Death|31
143026|NCT00615069|455714|P1|Overall Study|Withdrawal by Subject|4
143027|NCT00615069|455714|P1|Overall Study|Physician Decision|2
143028|NCT00615069|455714|P1|Overall Study|Death|10
143029|NCT00615108|455719|P1|Overall Study|Lost to Follow-up|15
143030|NCT00615108|455719|P1|Overall Study|Other|370
143031|NCT00615108|455719|P1|Overall Study|Adverse Event|122
143032|NCT00615199|455738|P4|Overall Study|Withdrawal by Subject|0
143033|NCT00615199|455739|P3|Overall Study|Withdrawal by Subject|0
143034|NCT00615199|455740|P2|Overall Study|Withdrawal by Subject|1
143035|NCT00615199|455741|P1|Overall Study|Withdrawal by Subject|2
143036|NCT00615199|455738|P4|Overall Study|Unspecified|1
143037|NCT00615199|455739|P3|Overall Study|Unspecified|0
143038|NCT00615199|455740|P2|Overall Study|Unspecified|0
143039|NCT00615199|455741|P1|Overall Study|Unspecified|0
143040|NCT00615199|455738|P4|Overall Study|Lost to Follow-up|0
143041|NCT00615199|455739|P3|Overall Study|Lost to Follow-up|0
143042|NCT00615199|455740|P2|Overall Study|Lost to Follow-up|0
143043|NCT00615199|455741|P1|Overall Study|Lost to Follow-up|1
143044|NCT00615199|455738|P4|Overall Study|Lack of Efficacy|1
143045|NCT00615199|455739|P3|Overall Study|Lack of Efficacy|0
143046|NCT00615199|455740|P2|Overall Study|Lack of Efficacy|0
143047|NCT00615199|455741|P1|Overall Study|Lack of Efficacy|2
143048|NCT00615199|455738|P4|Overall Study|Adverse Event|0
143049|NCT00615199|455739|P3|Overall Study|Adverse Event|1
143050|NCT00615199|455740|P2|Overall Study|Adverse Event|1
143051|NCT00615199|455741|P1|Overall Study|Adverse Event|3
143052|NCT00615264|455777|P2|Overall Study|Dermal Hypersensitivity|3
143053|NCT00615264|455778|P1|Overall Study|Dermal Hypersensitivity|0
143054|NCT00615264|455777|P2|Overall Study|Not defined|4
143055|NCT00615264|455778|P1|Overall Study|Not defined|7
143056|NCT00615264|455777|P2|Overall Study|Protocol Violation|7
143057|NCT00615264|455778|P1|Overall Study|Protocol Violation|11
143058|NCT00615264|455777|P2|Overall Study|Death|1
143059|NCT00615264|455778|P1|Overall Study|Death|1
143060|NCT00615264|455777|P2|Overall Study|Adverse Event|5
143061|NCT00615264|455778|P1|Overall Study|Adverse Event|8
143062|NCT00615264|455777|P2|Overall Study|Lost to Follow-up|13
143063|NCT00615264|455778|P1|Overall Study|Lost to Follow-up|6
143064|NCT00615264|455777|P2|Overall Study|Withdrawal by Subject|19
143065|NCT00615264|455778|P1|Overall Study|Withdrawal by Subject|17
143066|NCT00615290|455786|P1|Overall Study|Other|2
143067|NCT00615290|455786|P1|Overall Study|Withdrawal by Subject|1
143068|NCT00615290|455786|P1|Overall Study|Lost to Follow-up|3
143069|NCT00615290|455786|P1|Overall Study|Adverse Event|2
143070|NCT00615459|455819|P4|Period III|Unsatisfactory therapeutic effect|0
143071|NCT00615459|455820|P3|Period III|Unsatisfactory therapeutic effect|0
143072|NCT00615459|455821|P2|Period III|Unsatisfactory therapeutic effect|1
143073|NCT00615459|455822|P1|Period III|Unsatisfactory therapeutic effect|0
143074|NCT00615459|455819|P4|Period III|Administrative problems|0
143075|NCT00615459|455820|P3|Period III|Administrative problems|1
143076|NCT00615459|455821|P2|Period III|Administrative problems|1
143077|NCT00615459|455822|P1|Period III|Administrative problems|0
143078|NCT00615459|455819|P4|Period III|Adverse Event|0
143079|NCT00615459|455820|P3|Period III|Adverse Event|0
143080|NCT00615459|455821|P2|Period III|Adverse Event|1
143081|NCT00615459|455822|P1|Period III|Adverse Event|0
143082|NCT00615459|455819|P4|Period II|Lost to Follow-up|1
143083|NCT00615459|455820|P3|Period II|Lost to Follow-up|0
143084|NCT00615459|455821|P2|Period II|Lost to Follow-up|0
143085|NCT00615459|455822|P1|Period II|Lost to Follow-up|0
143086|NCT00615459|455819|P4|Period II|Adverse Event|0
143087|NCT00615459|455820|P3|Period II|Adverse Event|0
143088|NCT00615459|455821|P2|Period II|Adverse Event|0
143089|NCT00615459|455822|P1|Period II|Adverse Event|1
143090|NCT00615459|455819|P4|Period I|Abnormal test procedure results|0
143091|NCT00615459|455820|P3|Period I|Abnormal test procedure results|1
143092|NCT00615459|455821|P2|Period I|Abnormal test procedure results|1
143093|NCT00615459|455822|P1|Period I|Abnormal test procedure results|1
143094|NCT00615459|455819|P4|Period I|Subject withdrew consent|1
143095|NCT00615459|455820|P3|Period I|Subject withdrew consent|0
143096|NCT00615459|455821|P2|Period I|Subject withdrew consent|0
143097|NCT00615459|455822|P1|Period I|Subject withdrew consent|1
143098|NCT00615459|455819|P4|Period I|Adverse Event|0
143099|NCT00615459|455820|P3|Period I|Adverse Event|1
143100|NCT00615459|455821|P2|Period I|Adverse Event|0
143101|NCT00615459|455822|P1|Period I|Adverse Event|2
143102|NCT00615550|455847|P2|Overall Study|Lost to Follow-up|1
143103|NCT00615550|455848|P1|Overall Study|Lost to Follow-up|6
143104|NCT00615719|455870|P1|Overall Study|Physician Decision|5
143105|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
143106|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
143107|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
143108|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
143109|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
143110|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Not reported|0
143111|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Not reported|4
143112|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Not reported|1
143113|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Not reported|4
143114|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Not reported|6
143115|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Not specified|0
143116|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Not specified|8
143117|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Not specified|8
143118|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Not specified|7
143119|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Not specified|10
143120|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
143121|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
143122|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
143123|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
143124|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
143125|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
143126|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
143127|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
143128|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
143129|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
143130|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
143131|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
143132|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
143133|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
143134|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
143135|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
143136|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
143137|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
143138|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
143139|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
143140|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
143141|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
143142|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
143143|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
143144|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
143145|NCT00615836|455878|P5|Extension Study (FE992026 CS31)|Adverse Event|0
143146|NCT00615836|455879|P4|Extension Study (FE992026 CS31)|Adverse Event|13
143147|NCT00615836|455880|P3|Extension Study (FE992026 CS31)|Adverse Event|15
143148|NCT00615836|455881|P2|Extension Study (FE992026 CS31)|Adverse Event|12
143149|NCT00615836|455882|P1|Extension Study (FE992026 CS31)|Adverse Event|7
143150|NCT00615901|455942|P1|Overall Study|Adverse Event|7
143151|NCT00615901|455942|P1|Overall Study|Withdrawal by Subject|2
143152|NCT00615914|455946|P1|Overall Study|Irregularly enrolled patients|10
143153|NCT00615914|455946|P1|Overall Study|No treatment|2
143154|NCT00615914|455946|P1|Overall Study|No data was collected.|65
143155|NCT00615914|455946|P1|Overall Study|Physician Decision|4
143156|NCT00615914|455946|P1|Overall Study|Withdrawal by Subject|16
143157|NCT00615914|455946|P1|Overall Study|Lost to Follow-up|187
143158|NCT00615914|455946|P1|Overall Study|Lack of Efficacy|59
143159|NCT00615914|455946|P1|Overall Study|Death|20
143160|NCT00615914|455946|P1|Overall Study|Adverse Event|274
143161|NCT00615992|455970|P1|Overall Study|Protocol Violation|67
143162|NCT00616018|455979|P1|Overall Study|Protocol Violation|3
143163|NCT00616239|456004|P1|Overall Study|Withdrawal by Subject|2
143164|NCT00622284|456014|P2|Overall Study|Other reason (not specified)|24
143165|NCT00622284|456015|P1|Overall Study|Other reason (not specified)|33
143166|NCT00622284|456014|P2|Overall Study|Withdrawal by Subject|24
143167|NCT00622284|456015|P1|Overall Study|Withdrawal by Subject|27
143168|NCT00622284|456014|P2|Overall Study|Lost to Follow-up|13
143169|NCT00622284|456015|P1|Overall Study|Lost to Follow-up|11
143170|NCT00622284|456014|P2|Overall Study|Protocol Violation|5
143171|NCT00622284|456015|P1|Overall Study|Protocol Violation|12
143172|NCT00622284|456014|P2|Overall Study|Adverse Event|90
143173|NCT00622284|456015|P1|Overall Study|Adverse Event|61
143174|NCT00622284|456014|P2|Overall Study|Lack of Efficacy|15
143175|NCT00622284|456015|P1|Overall Study|Lack of Efficacy|45
143176|NCT00622336|456077|P1|Extension Phase|Unspecified|9
143177|NCT00622336|456077|P1|Extension Phase|Lost to Follow-up|1
143178|NCT00622336|456077|P1|Extension Phase|Withdrawal by Subject|1
143179|NCT00622336|456077|P1|Extension Phase|Lack of therapeutic effect|2
143180|NCT00622336|456077|P1|Extension Phase|Progressive Disease|6
143181|NCT00622336|456077|P1|Extension Phase|Adverse Event|2
143182|NCT00622336|456077|P1|Treatment Phase|Lost to Follow-up|2
143183|NCT00622336|456077|P1|Treatment Phase|Withdrawal by Subject|13
143184|NCT00622336|456077|P1|Treatment Phase|Lack of therapeutic effect|13
143185|NCT00622336|456077|P1|Treatment Phase|Death|14
143186|NCT00622336|456077|P1|Treatment Phase|Unspecified|40
143187|NCT00622336|456077|P1|Treatment Phase|Adverse Event|46
143188|NCT00622336|456077|P1|Treatment Phase|Progression of Disease|181
143189|NCT00622388|456086|P1|Overall Study|Insurance Expired|1
143190|NCT00622388|456086|P1|Overall Study|Withdrew Consent|1
143191|NCT00622388|456086|P1|Overall Study|Took Prohibited Medication|2
143192|NCT00622388|456086|P1|Overall Study|Received Alternate Anticancer Therapy|8
143193|NCT00622388|456086|P1|Overall Study|Death|3
143194|NCT00622388|456086|P1|Overall Study|Participant Refusal|1
143195|NCT00622388|456086|P1|Overall Study|Protocol Violation|3
143196|NCT00622388|456086|P1|Overall Study|Adverse Event|6
143197|NCT00622388|456086|P1|Overall Study|Disease Progression|47
143198|NCT00622401|456107|P3|Overall Study|Disease progression prior to treatment|0
143199|NCT00622401|456108|P2|Overall Study|Disease progression prior to treatment|2
143200|NCT00622401|456109|P1|Overall Study|Disease progression prior to treatment|3
143201|NCT00622440|456126|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
143202|NCT00622440|456127|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
143203|NCT00622440|456126|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
143204|NCT00622440|456127|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
143205|NCT00622440|456126|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
143206|NCT00622440|456127|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
143288|NCT00623779|456423|P2|Overall Study|Adverse Event|3
143207|NCT00622440|456126|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
143208|NCT00622440|456127|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
143209|NCT00623428|456152|P2|Follow-up Period|Death|1
143210|NCT00623428|456153|P1|Follow-up Period|Death|0
143211|NCT00623428|456152|P2|Follow-up Period|Reason not specified|1
143212|NCT00623428|456153|P1|Follow-up Period|Reason not specified|1
143213|NCT00623428|456152|P2|Follow-up Period|Did not cooperate|3
143214|NCT00623428|456153|P1|Follow-up Period|Did not cooperate|0
143215|NCT00623428|456152|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
143216|NCT00623428|456153|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
143217|NCT00623428|456152|P2|Follow-up Period|Patient withdrew consent|4
143218|NCT00623428|456153|P1|Follow-up Period|Patient withdrew consent|5
143219|NCT00623428|456152|P2|Follow-up Period|Failure to return|2
143220|NCT00623428|456153|P1|Follow-up Period|Failure to return|10
143221|NCT00623428|456152|P2|Follow-up Period|Relapse post-treatment|3
143222|NCT00623428|456153|P1|Follow-up Period|Relapse post-treatment|11
143223|NCT00623428|456152|P2|Treatment Period|Withdrawal by Subject|1
143224|NCT00623428|456153|P1|Treatment Period|Withdrawal by Subject|0
143225|NCT00623428|456152|P2|Treatment Period|Other|1
143226|NCT00623428|456153|P1|Treatment Period|Other|0
143227|NCT00623428|456152|P2|Treatment Period|Insufficient therapeutic response|2
143228|NCT00623428|456153|P1|Treatment Period|Insufficient therapeutic response|0
143229|NCT00623428|456152|P2|Treatment Period|Did not cooperate / refused treatment|13
143230|NCT00623428|456153|P1|Treatment Period|Did not cooperate / refused treatment|0
143231|NCT00623428|456152|P2|Treatment Period|Death|1
143232|NCT00623428|456153|P1|Treatment Period|Death|0
143233|NCT00623428|456152|P2|Treatment Period|Adverse event/intercurrent illness|9
143234|NCT00623428|456153|P1|Treatment Period|Adverse event/intercurrent illness|0
143235|NCT00623467|456175|P1|Overall Study|Withdrawal by Subject|2
143236|NCT00623467|456175|P1|Overall Study|Protocol Violation|4
143237|NCT00623467|456175|P1|Overall Study|Lost to Follow-up|1
143238|NCT00623480|456241|P2|Overall Study|Site closed by sponsor|1
143239|NCT00623480|456242|P1|Overall Study|Site closed by sponsor|0
143240|NCT00623480|456241|P2|Overall Study|Protocol Violation|1
143241|NCT00623480|456242|P1|Overall Study|Protocol Violation|0
143242|NCT00623480|456241|P2|Overall Study|Non-compliant with study medication|0
143243|NCT00623480|456242|P1|Overall Study|Non-compliant with study medication|4
143244|NCT00623480|456241|P2|Overall Study|Lack of Efficacy|0
143245|NCT00623480|456242|P1|Overall Study|Lack of Efficacy|1
143246|NCT00623480|456241|P2|Overall Study|Withdrawal by Subject|4
143247|NCT00623480|456242|P1|Overall Study|Withdrawal by Subject|2
143248|NCT00623480|456241|P2|Overall Study|Lost to Follow-up|1
143249|NCT00623480|456242|P1|Overall Study|Lost to Follow-up|0
143250|NCT00623545|456267|P1|Overall Study|Withdrawal by Subject|4
143251|NCT00623545|456267|P1|Overall Study|Adverse Event|6
143252|NCT00623597|456274|P2|Overall Study|Failed to return|0
143253|NCT00623597|456275|P1|Overall Study|Failed to return|1
143254|NCT00623727|456373|P2|Open Label Follow-up|Participant convenience|1
143255|NCT00623727|456374|P1|Open Label Follow-up|Participant convenience|0
143256|NCT00623727|456373|P2|Open Label Follow-up|Study termination|6
143257|NCT00623727|456374|P1|Open Label Follow-up|Study termination|0
143258|NCT00623727|456373|P2|Open Label Follow-up|Withdrawal by Subject|1
143259|NCT00623727|456374|P1|Open Label Follow-up|Withdrawal by Subject|0
143260|NCT00623727|456373|P2|Double Blind (DB)|Protocol Violation|2
143261|NCT00623727|456374|P1|Double Blind (DB)|Protocol Violation|2
143262|NCT00623727|456373|P2|Double Blind (DB)|Lost to Follow-up|1
143263|NCT00623727|456374|P1|Double Blind (DB)|Lost to Follow-up|1
143264|NCT00623727|456373|P2|Double Blind (DB)|Termination of the double-blind period|21
143265|NCT00623727|456374|P1|Double Blind (DB)|Termination of the double-blind period|22
143266|NCT00623727|456373|P2|Double Blind (DB)|Lack of Efficacy|2
143267|NCT00623727|456374|P1|Double Blind (DB)|Lack of Efficacy|2
143268|NCT00623727|456373|P2|Double Blind (DB)|Withdrawal by Subject|2
143269|NCT00623727|456374|P1|Double Blind (DB)|Withdrawal by Subject|8
143270|NCT00623727|456373|P2|Double Blind (DB)|Physician Decision|1
143271|NCT00623727|456374|P1|Double Blind (DB)|Physician Decision|0
143272|NCT00623727|456373|P2|Double Blind (DB)|Adverse Event|3
143273|NCT00623727|456374|P1|Double Blind (DB)|Adverse Event|1
143274|NCT00623766|456396|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
143275|NCT00623766|456397|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
143276|NCT00623766|456396|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
143277|NCT00623766|456397|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
143278|NCT00623766|456396|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
143279|NCT00623766|456397|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
143280|NCT00623766|456396|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
143281|NCT00623766|456397|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
143282|NCT00623766|456396|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
143283|NCT00623766|456397|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
143284|NCT00623779|456422|P3|Overall Study|Criteria from CSR|1
143285|NCT00623779|456423|P2|Overall Study|Criteria from CSR|0
143286|NCT00623779|456424|P1|Overall Study|Criteria from CSR|2
143287|NCT00623779|456422|P3|Overall Study|Adverse Event|0
143289|NCT00623779|456424|P1|Overall Study|Adverse Event|1
143290|NCT00623805|456473|P2|Overall Study|Reason not Specified|6
143291|NCT00623805|456474|P1|Overall Study|Reason not Specified|3
143292|NCT00623805|456473|P2|Overall Study|Protocol Violation|1
143293|NCT00623805|456474|P1|Overall Study|Protocol Violation|1
143294|NCT00623805|456473|P2|Overall Study|Lost to Follow-up|2
143295|NCT00623805|456474|P1|Overall Study|Lost to Follow-up|2
143296|NCT00623805|456473|P2|Overall Study|Lack of Efficacy|7
143297|NCT00623805|456474|P1|Overall Study|Lack of Efficacy|3
143298|NCT00623805|456473|P2|Overall Study|Death|0
143299|NCT00623805|456474|P1|Overall Study|Death|2
143300|NCT00623805|456473|P2|Overall Study|Adverse Event|6
143301|NCT00623805|456474|P1|Overall Study|Adverse Event|9
143302|NCT00623831|456490|P2|Overall Study|Progressive Disease|1
143303|NCT00623831|456491|P1|Overall Study|Progressive Disease|0
143304|NCT00623831|456490|P2|Overall Study|Withdrawal by Subject|0
143305|NCT00623831|456491|P1|Overall Study|Withdrawal by Subject|1
143306|NCT00623935|456501|P1|Overall Study|Patient Declined Transplant|1
143307|NCT00623935|456501|P1|Overall Study|Death|1
143308|NCT00624052|456527|P4|Overall Study|Changed job/ran out if meds|0
143309|NCT00624052|456528|P3|Overall Study|Changed job/ran out if meds|0
143310|NCT00624052|456529|P2|Overall Study|Changed job/ran out if meds|2
143311|NCT00624052|456530|P1|Overall Study|Changed job/ran out if meds|0
143312|NCT00624052|456527|P4|Overall Study|Consent withdrawn|0
143313|NCT00624052|456528|P3|Overall Study|Consent withdrawn|1
143314|NCT00624052|456529|P2|Overall Study|Consent withdrawn|1
143315|NCT00624052|456530|P1|Overall Study|Consent withdrawn|3
143316|NCT00624052|456527|P4|Overall Study|Non compliant with the protocol|1
143317|NCT00624052|456528|P3|Overall Study|Non compliant with the protocol|1
143318|NCT00624052|456529|P2|Overall Study|Non compliant with the protocol|1
143319|NCT00624052|456530|P1|Overall Study|Non compliant with the protocol|2
143320|NCT00624052|456527|P4|Overall Study|Lost to Follow-up|0
143321|NCT00624052|456528|P3|Overall Study|Lost to Follow-up|1
143322|NCT00624052|456529|P2|Overall Study|Lost to Follow-up|3
143323|NCT00624052|456530|P1|Overall Study|Lost to Follow-up|2
143324|NCT00624052|456527|P4|Overall Study|Lack of Efficacy|0
143325|NCT00624052|456528|P3|Overall Study|Lack of Efficacy|0
143326|NCT00624052|456529|P2|Overall Study|Lack of Efficacy|1
143327|NCT00624052|456530|P1|Overall Study|Lack of Efficacy|1
143328|NCT00624052|456527|P4|Overall Study|Adverse Event|3
143329|NCT00624052|456528|P3|Overall Study|Adverse Event|0
143330|NCT00624052|456529|P2|Overall Study|Adverse Event|6
143331|NCT00624052|456530|P1|Overall Study|Adverse Event|7
143332|NCT00624065|456581|P2|Overall Study|Met protocol-defined stopping criteria|9
143333|NCT00624065|456582|P1|Overall Study|Met protocol-defined stopping criteria|4
143334|NCT00624065|456581|P2|Overall Study|Lack of Efficacy|3
143335|NCT00624065|456582|P1|Overall Study|Lack of Efficacy|0
143336|NCT00624065|456581|P2|Overall Study|Consent withdrawn|5
143337|NCT00624065|456582|P1|Overall Study|Consent withdrawn|6
143338|NCT00624065|456581|P2|Overall Study|Lost to Follow-up|1
143339|NCT00624065|456582|P1|Overall Study|Lost to Follow-up|4
143340|NCT00624065|456581|P2|Overall Study|Adverse Event|6
143341|NCT00624065|456582|P1|Overall Study|Adverse Event|5
143342|NCT00624286|456635|P2|Overall Study|Death|1
143343|NCT00624286|456636|P1|Overall Study|Death|0
143344|NCT00624286|456635|P2|Overall Study|Abnormal test procedure result(s)|1
143345|NCT00624286|456636|P1|Overall Study|Abnormal test procedure result(s)|0
143346|NCT00624286|456635|P2|Overall Study|Not stated|1
143347|NCT00624286|456636|P1|Overall Study|Not stated|0
143348|NCT00624286|456635|P2|Overall Study|Lack of Efficacy|6
143349|NCT00624286|456636|P1|Overall Study|Lack of Efficacy|1
143350|NCT00624286|456635|P2|Overall Study|Administrative problems|0
143351|NCT00624286|456636|P1|Overall Study|Administrative problems|3
143352|NCT00624286|456635|P2|Overall Study|Lost to Follow-up|2
143353|NCT00624286|456636|P1|Overall Study|Lost to Follow-up|3
143354|NCT00624286|456635|P2|Overall Study|Withdrawal by Subject|4
143355|NCT00624286|456636|P1|Overall Study|Withdrawal by Subject|5
143356|NCT00624286|456635|P2|Overall Study|Adverse Event|3
143357|NCT00624286|456636|P1|Overall Study|Adverse Event|6
143358|NCT00624286|456635|P2|Overall Study|Protocol Deviation|9
143359|NCT00624286|456636|P1|Overall Study|Protocol Deviation|7
143360|NCT00624338|456647|P3|Overall Study|Randomized but not treated|3
143361|NCT00624338|456648|P2|Overall Study|Randomized but not treated|1
143362|NCT00624338|456649|P1|Overall Study|Randomized but not treated|2
143363|NCT00624338|456647|P3|Overall Study|Unspecified|9
143364|NCT00624338|456648|P2|Overall Study|Unspecified|5
143365|NCT00624338|456649|P1|Overall Study|Unspecified|15
143366|NCT00624338|456647|P3|Overall Study|Termination of 150 mg group by Sponsor|0
143367|NCT00624338|456648|P2|Overall Study|Termination of 150 mg group by Sponsor|55
143368|NCT00624338|456649|P1|Overall Study|Termination of 150 mg group by Sponsor|0
143369|NCT00624338|456647|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
143370|NCT00624338|456648|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
143371|NCT00624338|456649|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
143372|NCT00624338|456647|P3|Overall Study|Death|0
143373|NCT00624338|456648|P2|Overall Study|Death|2
143374|NCT00624338|456649|P1|Overall Study|Death|0
143375|NCT00624338|456647|P3|Overall Study|Protocol Violation|2
143376|NCT00624338|456648|P2|Overall Study|Protocol Violation|3
143377|NCT00624338|456649|P1|Overall Study|Protocol Violation|3
143378|NCT00624338|456647|P3|Overall Study|Lack of Efficacy|14
143379|NCT00624338|456648|P2|Overall Study|Lack of Efficacy|3
143380|NCT00624338|456649|P1|Overall Study|Lack of Efficacy|11
143381|NCT00624338|456647|P3|Overall Study|Lost to Follow-up|0
143382|NCT00624338|456648|P2|Overall Study|Lost to Follow-up|0
143383|NCT00624338|456649|P1|Overall Study|Lost to Follow-up|1
143384|NCT00624338|456647|P3|Overall Study|Adverse Event|18
143385|NCT00624338|456648|P2|Overall Study|Adverse Event|14
143386|NCT00624338|456649|P1|Overall Study|Adverse Event|14
143387|NCT00624377|456669|P1|Overall Study|Non-evaluable population|84
143388|NCT00624377|456669|P1|Overall Study|Other|91
143389|NCT00624377|456669|P1|Overall Study|Adverse Event|14
143390|NCT00624377|456669|P1|Overall Study|Withdrawal by Subject|100
143391|NCT00624377|456669|P1|Overall Study|Lost to Follow-up|355
143392|NCT00624468|456723|P4|Safety Follow-up (SFU) Period|Unspecified|1
143393|NCT00624468|456724|P3|Safety Follow-up (SFU) Period|Unspecified|1
143394|NCT00624468|456725|P2|Safety Follow-up (SFU) Period|Unspecified|0
143395|NCT00624468|456726|P1|Safety Follow-up (SFU) Period|Unspecified|0
143396|NCT00624468|456723|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
143397|NCT00624468|456724|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
143398|NCT00624468|456725|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
143399|NCT00624468|456726|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
143400|NCT00624468|456723|P4|Double-blind Period|Withdrew Prematurely|0
143401|NCT00624468|456724|P3|Double-blind Period|Withdrew Prematurely|0
143402|NCT00624468|456725|P2|Double-blind Period|Withdrew Prematurely|1
143403|NCT00624468|456726|P1|Double-blind Period|Withdrew Prematurely|1
143404|NCT00624468|456723|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
143405|NCT00624468|456724|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
143406|NCT00624468|456725|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
143407|NCT00624468|456726|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
143408|NCT00624520|456754|P2|Overall Study|Death|1
143409|NCT00624520|456755|P1|Overall Study|Death|0
143410|NCT00624520|456754|P2|Overall Study|Withdrawal by Subject|7
143411|NCT00624520|456755|P1|Overall Study|Withdrawal by Subject|12
143412|NCT00624585|456801|P1|Overall Study|Adverse Event|3
143413|NCT00624585|456801|P1|Overall Study|Disease Progression|6
143414|NCT00624585|456801|P1|Overall Study|Death|3
143415|NCT00624780|456814|P6|Follow-up (Week 26)|Unspecified|0
143416|NCT00624780|456815|P5|Follow-up (Week 26)|Unspecified|0
143417|NCT00624780|456816|P4|Follow-up (Week 26)|Unspecified|0
143418|NCT00624780|456817|P3|Follow-up (Week 26)|Unspecified|0
143419|NCT00624780|456818|P2|Follow-up (Week 26)|Unspecified|1
143420|NCT00624780|456819|P1|Follow-up (Week 26)|Unspecified|1
143421|NCT00624780|456814|P6|Follow-up (Week 26)|Withdrawal by Subject|0
143422|NCT00624780|456815|P5|Follow-up (Week 26)|Withdrawal by Subject|0
143423|NCT00624780|456816|P4|Follow-up (Week 26)|Withdrawal by Subject|0
143424|NCT00624780|456817|P3|Follow-up (Week 26)|Withdrawal by Subject|0
143425|NCT00624780|456818|P2|Follow-up (Week 26)|Withdrawal by Subject|0
143426|NCT00624780|456819|P1|Follow-up (Week 26)|Withdrawal by Subject|1
143427|NCT00624780|456814|P6|Follow-up (Week 26)|Lost to Follow-up|0
143428|NCT00624780|456815|P5|Follow-up (Week 26)|Lost to Follow-up|1
143429|NCT00624780|456816|P4|Follow-up (Week 26)|Lost to Follow-up|0
143430|NCT00624780|456817|P3|Follow-up (Week 26)|Lost to Follow-up|1
143431|NCT00624780|456818|P2|Follow-up (Week 26)|Lost to Follow-up|0
143432|NCT00624780|456819|P1|Follow-up (Week 26)|Lost to Follow-up|0
143433|NCT00624780|456814|P6|Follow-up (Week 26)|Adverse Event|0
143434|NCT00624780|456815|P5|Follow-up (Week 26)|Adverse Event|1
143435|NCT00624780|456816|P4|Follow-up (Week 26)|Adverse Event|0
143436|NCT00624780|456817|P3|Follow-up (Week 26)|Adverse Event|0
143437|NCT00624780|456818|P2|Follow-up (Week 26)|Adverse Event|0
143438|NCT00624780|456819|P1|Follow-up (Week 26)|Adverse Event|0
143439|NCT00624780|456814|P6|Follow-up (Week 26)|Death|0
143440|NCT00624780|456815|P5|Follow-up (Week 26)|Death|0
143441|NCT00624780|456816|P4|Follow-up (Week 26)|Death|0
143442|NCT00624780|456817|P3|Follow-up (Week 26)|Death|1
143443|NCT00624780|456818|P2|Follow-up (Week 26)|Death|0
143444|NCT00624780|456819|P1|Follow-up (Week 26)|Death|0
143445|NCT00624780|456814|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
143446|NCT00624780|456815|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
143447|NCT00624780|456816|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
143448|NCT00624780|456817|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
143449|NCT00624780|456818|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
143450|NCT00624780|456819|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
143451|NCT00624780|456814|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
143452|NCT00624780|456815|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
143453|NCT00624780|456816|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
143454|NCT00624780|456817|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
143455|NCT00624780|456818|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
143456|NCT00624780|456819|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
143457|NCT00624780|456814|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
143458|NCT00624780|456815|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
143459|NCT00624780|456816|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
143460|NCT00624780|456817|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
143461|NCT00624780|456818|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
143462|NCT00624780|456819|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
143463|NCT00624780|456814|P6|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
143464|NCT00624780|456815|P5|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
143465|NCT00624780|456816|P4|Fixed Dosing (Week 13 to Week 24)|Unspecified|1
143466|NCT00624780|456817|P3|Fixed Dosing (Week 13 to Week 24)|Unspecified|4
143467|NCT00624780|456818|P2|Fixed Dosing (Week 13 to Week 24)|Unspecified|3
143468|NCT00624780|456819|P1|Fixed Dosing (Week 13 to Week 24)|Unspecified|5
143469|NCT00624780|456814|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
143470|NCT00624780|456815|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
143471|NCT00624780|456816|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
143472|NCT00624780|456817|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
143473|NCT00624780|456818|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
143474|NCT00624780|456819|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
143475|NCT00624780|456814|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
143476|NCT00624780|456815|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
143477|NCT00624780|456816|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
143478|NCT00624780|456817|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
143479|NCT00624780|456818|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
143480|NCT00624780|456819|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
143481|NCT00624780|456814|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
143482|NCT00624780|456815|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
143483|NCT00624780|456816|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
143484|NCT00624780|456817|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
143485|NCT00624780|456818|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
143486|NCT00624780|456819|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
143487|NCT00624780|456814|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
143488|NCT00624780|456815|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
143489|NCT00624780|456816|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
143490|NCT00624780|456817|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
143491|NCT00624780|456818|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
143492|NCT00624780|456819|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
143493|NCT00624780|456814|P6|Treatment Optimization (Up to Week 12)|Unspecified|0
143494|NCT00624780|456815|P5|Treatment Optimization (Up to Week 12)|Unspecified|9
143495|NCT00624780|456816|P4|Treatment Optimization (Up to Week 12)|Unspecified|2
143496|NCT00624780|456817|P3|Treatment Optimization (Up to Week 12)|Unspecified|8
143497|NCT00624780|456818|P2|Treatment Optimization (Up to Week 12)|Unspecified|4
143498|NCT00624780|456819|P1|Treatment Optimization (Up to Week 12)|Unspecified|10
143499|NCT00624780|456814|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
143500|NCT00624780|456815|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
143501|NCT00624780|456816|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
143502|NCT00624780|456817|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
143503|NCT00624780|456818|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
143504|NCT00624780|456819|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
143505|NCT00624780|456814|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
143506|NCT00624780|456815|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
143507|NCT00624780|456816|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
143508|NCT00624780|456817|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
143509|NCT00624780|456818|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
143510|NCT00624780|456819|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
143511|NCT00624780|456814|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
143512|NCT00624780|456815|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
143513|NCT00624780|456816|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
143514|NCT00624780|456817|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
143515|NCT00624780|456818|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
143516|NCT00624780|456819|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
143517|NCT00624780|456814|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
143518|NCT00624780|456815|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
143519|NCT00624780|456816|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
143520|NCT00624780|456817|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
143521|NCT00624780|456818|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
143522|NCT00624780|456819|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
143523|NCT00624832|457018|P4|Overall Study|Abnormal Laboratory Value|0
143524|NCT00624832|457019|P3|Overall Study|Abnormal Laboratory Value|0
143525|NCT00624832|457020|P2|Overall Study|Abnormal Laboratory Value|0
143526|NCT00624832|457021|P1|Overall Study|Abnormal Laboratory Value|2
143527|NCT00624832|457018|P4|Overall Study|Adverse Event|1
143528|NCT00624832|457019|P3|Overall Study|Adverse Event|0
143529|NCT00624832|457020|P2|Overall Study|Adverse Event|1
143530|NCT00624832|457021|P1|Overall Study|Adverse Event|0
143531|NCT00625131|457035|P3|Overall Study|Withdrawal by Subject|5
143532|NCT00625131|457036|P2|Overall Study|Withdrawal by Subject|0
143533|NCT00625131|457037|P1|Overall Study|Withdrawal by Subject|1
143534|NCT00625131|457035|P3|Overall Study|Lost to Follow-up|0
143535|NCT00625131|457036|P2|Overall Study|Lost to Follow-up|2
143536|NCT00625131|457037|P1|Overall Study|Lost to Follow-up|3
143537|NCT00625183|457047|P1|Overall Study|Disease Progression|1
143538|NCT00625365|457054|P1|Overall Study|VSD|1
143539|NCT00625365|457054|P1|Overall Study|No IV access|5
143540|NCT00625365|457054|P1|Overall Study|Withdrawal by Subject|1
143541|NCT00625586|457110|P1|Overall Study|Adverse Event|1
143542|NCT00625742|457129|P1|Overall Study|Ineligible|1
143543|NCT00625742|457129|P1|Overall Study|Lost to Follow-up|4
143544|NCT00625742|457129|P1|Overall Study|Adverse Event|4
143545|NCT00625742|457129|P1|Overall Study|Withdrawal by Subject|1
143546|NCT00625742|457129|P1|Overall Study|Disease Progression|2
143547|NCT00625820|457134|P1|Overall Study|Withdrawal by Subject|1
143548|NCT00607919|457142|P2|Open-Label Phase|Parent/Caregiver Decision|2
143549|NCT00607919|457143|P1|Open-Label Phase|Parent/Caregiver Decision|1
143550|NCT00607919|457142|P2|Open-Label Phase|Withdrawal by Subject|2
143551|NCT00607919|457143|P1|Open-Label Phase|Withdrawal by Subject|2
143552|NCT00607919|457142|P2|Open-Label Phase|Protocol Violation|2
143553|NCT00607919|457143|P1|Open-Label Phase|Protocol Violation|2
143554|NCT00607919|457142|P2|Open-Label Phase|Lost to Follow-up|1
143555|NCT00607919|457143|P1|Open-Label Phase|Lost to Follow-up|4
143556|NCT00607919|457142|P2|Open-Label Phase|Adverse Event|5
143557|NCT00607919|457143|P1|Open-Label Phase|Adverse Event|1
143558|NCT00607919|457142|P2|Acute Phase|Withdrawal by Subject|3
143559|NCT00607919|457143|P1|Acute Phase|Withdrawal by Subject|3
143560|NCT00607919|457142|P2|Acute Phase|Protocol Violation|1
143561|NCT00607919|457143|P1|Acute Phase|Protocol Violation|5
143562|NCT00607919|457142|P2|Acute Phase|Parent/Caregiver Decision|4
143563|NCT00607919|457143|P1|Acute Phase|Parent/Caregiver Decision|6
143564|NCT00607919|457142|P2|Acute Phase|Lost to Follow-up|3
143565|NCT00607919|457143|P1|Acute Phase|Lost to Follow-up|9
143566|NCT00607919|457142|P2|Acute Phase|Lack of Efficacy|2
143567|NCT00607919|457143|P1|Acute Phase|Lack of Efficacy|1
143568|NCT00607919|457142|P2|Acute Phase|Entry Criteria Not Met|1
143569|NCT00607919|457143|P1|Acute Phase|Entry Criteria Not Met|1
143570|NCT00607919|457142|P2|Acute Phase|Adverse Event|2
143571|NCT00607919|457143|P1|Acute Phase|Adverse Event|9
143572|NCT00607997|457203|P4|Overall Study|Other without explanation|1
143573|NCT00607997|457204|P3|Overall Study|Other without explanation|4
143574|NCT00607997|457205|P2|Overall Study|Other without explanation|0
143575|NCT00607997|457206|P1|Overall Study|Other without explanation|2
143576|NCT00607997|457203|P4|Overall Study|Relapse, recurrent illness|0
143577|NCT00607997|457204|P3|Overall Study|Relapse, recurrent illness|2
143578|NCT00607997|457205|P2|Overall Study|Relapse, recurrent illness|0
143579|NCT00607997|457206|P1|Overall Study|Relapse, recurrent illness|4
143580|NCT00607997|457203|P4|Overall Study|Physician Decision|0
143581|NCT00607997|457204|P3|Overall Study|Physician Decision|0
143582|NCT00607997|457205|P2|Overall Study|Physician Decision|1
143583|NCT00607997|457206|P1|Overall Study|Physician Decision|4
143584|NCT00607997|457203|P4|Overall Study|Adverse Event|0
143585|NCT00607997|457204|P3|Overall Study|Adverse Event|2
143586|NCT00607997|457205|P2|Overall Study|Adverse Event|1
143587|NCT00607997|457206|P1|Overall Study|Adverse Event|3
143588|NCT00607997|457203|P4|Overall Study|Death|5
143589|NCT00607997|457204|P3|Overall Study|Death|2
143590|NCT00607997|457205|P2|Overall Study|Death|5
143591|NCT00607997|457206|P1|Overall Study|Death|8
143592|NCT00607997|457203|P4|Overall Study|Lack of Efficacy|10
143593|NCT00607997|457204|P3|Overall Study|Lack of Efficacy|14
143594|NCT00607997|457205|P2|Overall Study|Lack of Efficacy|20
143595|NCT00607997|457206|P1|Overall Study|Lack of Efficacy|6
143596|NCT00608023|457265|P3|Overall Study|Unknown reason|0
143597|NCT00608023|457266|P2|Overall Study|Unknown reason|3
143598|NCT00608023|457267|P1|Overall Study|Unknown reason|0
143599|NCT00608023|457265|P3|Overall Study|Protocol Violation|1
143600|NCT00608023|457266|P2|Overall Study|Protocol Violation|3
143601|NCT00608023|457267|P1|Overall Study|Protocol Violation|1
143602|NCT00608023|457265|P3|Overall Study|Lost to Follow-up|1
143603|NCT00608023|457266|P2|Overall Study|Lost to Follow-up|2
143604|NCT00608023|457267|P1|Overall Study|Lost to Follow-up|2
143605|NCT00608023|457265|P3|Overall Study|Adverse Event|5
143606|NCT00608023|457266|P2|Overall Study|Adverse Event|4
143607|NCT00608023|457267|P1|Overall Study|Adverse Event|1
143608|NCT00608023|457265|P3|Overall Study|Withdrawal by Subject|7
143609|NCT00608023|457266|P2|Overall Study|Withdrawal by Subject|10
143610|NCT00608023|457267|P1|Overall Study|Withdrawal by Subject|8
143611|NCT00608205|457300|P2|Overall Study|Patient non-compliant|1
143612|NCT00608205|457301|P1|Overall Study|Patient non-compliant|0
143613|NCT00608205|457300|P2|Overall Study|Adverse Event|2
143614|NCT00608205|457301|P1|Overall Study|Adverse Event|3
143615|NCT00608244|457389|P1|Overall Study|Low trough levels|1
143616|NCT00608244|457389|P1|Overall Study|Adverse Event|1
143617|NCT00608322|457400|P2|Overall Study|Death|1
143618|NCT00608322|457401|P1|Overall Study|Death|2
143619|NCT00619307|457409|P2|Overall Study|MS attack plus steroids|1
143620|NCT00619307|457410|P1|Overall Study|MS attack plus steroids|0
143621|NCT00619307|457409|P2|Overall Study|Severe migraine|1
143622|NCT00619307|457410|P1|Overall Study|Severe migraine|0
143623|NCT00619307|457409|P2|Overall Study|Withdrew consent|0
143624|NCT00619307|457410|P1|Overall Study|Withdrew consent|1
143625|NCT00619307|457409|P2|Overall Study|Protocol Violation|0
143626|NCT00619307|457410|P1|Overall Study|Protocol Violation|3
143627|NCT00619307|457409|P2|Overall Study|Lost to Follow-up|1
143628|NCT00619307|457410|P1|Overall Study|Lost to Follow-up|0
143629|NCT00619307|457409|P2|Overall Study|Adverse Event|1
143630|NCT00619307|457410|P1|Overall Study|Adverse Event|0
143631|NCT00619359|457426|P2|Overall Study|Progressive Disease|1
143632|NCT00619359|457427|P1|Overall Study|Progressive Disease|3
143633|NCT00619359|457426|P2|Overall Study|Withdrawal by Subject|20
143634|NCT00619359|457427|P1|Overall Study|Withdrawal by Subject|19
143635|NCT00619359|457426|P2|Overall Study|Protocol Violation|1
143636|NCT00619359|457427|P1|Overall Study|Protocol Violation|1
143637|NCT00619359|457426|P2|Overall Study|Physician Decision|7
143638|NCT00619359|457427|P1|Overall Study|Physician Decision|0
143639|NCT00619359|457426|P2|Overall Study|Lost to Follow-up|16
143640|NCT00619359|457427|P1|Overall Study|Lost to Follow-up|12
143641|NCT00619359|457426|P2|Overall Study|Adverse Event|36
143642|NCT00619359|457427|P1|Overall Study|Adverse Event|32
143643|NCT00619385|457440|P3|Overall Study|Other|1
143644|NCT00619385|457441|P2|Overall Study|Other|2
143645|NCT00619385|457442|P1|Overall Study|Other|1
143646|NCT00619385|457440|P3|Overall Study|Adverse Event|3
143647|NCT00619385|457441|P2|Overall Study|Adverse Event|0
143648|NCT00619385|457442|P1|Overall Study|Adverse Event|0
143649|NCT00619476|457459|P4|Overall Study|Withdrawal by Subject|4
143650|NCT00619476|457460|P3|Overall Study|Withdrawal by Subject|5
143651|NCT00619476|457461|P2|Overall Study|Withdrawal by Subject|7
143652|NCT00619476|457462|P1|Overall Study|Withdrawal by Subject|5
143653|NCT00619476|457459|P4|Overall Study|Investigator Discretion|0
143654|NCT00619476|457460|P3|Overall Study|Investigator Discretion|2
143655|NCT00619476|457461|P2|Overall Study|Investigator Discretion|2
143656|NCT00619476|457462|P1|Overall Study|Investigator Discretion|2
143657|NCT00619476|457459|P4|Overall Study|Lost to Follow-up|1
143658|NCT00619476|457460|P3|Overall Study|Lost to Follow-up|0
143659|NCT00619476|457461|P2|Overall Study|Lost to Follow-up|2
143660|NCT00619476|457462|P1|Overall Study|Lost to Follow-up|1
143661|NCT00619476|457459|P4|Overall Study|Protocol Violation|9
143662|NCT00619476|457460|P3|Overall Study|Protocol Violation|4
143663|NCT00619476|457461|P2|Overall Study|Protocol Violation|4
143664|NCT00619476|457462|P1|Overall Study|Protocol Violation|5
143665|NCT00619476|457459|P4|Overall Study|Lack of Efficacy|4
143666|NCT00619476|457460|P3|Overall Study|Lack of Efficacy|1
143667|NCT00619476|457461|P2|Overall Study|Lack of Efficacy|1
143668|NCT00619476|457462|P1|Overall Study|Lack of Efficacy|6
143669|NCT00619476|457459|P4|Overall Study|Adverse Event|16
143670|NCT00619476|457460|P3|Overall Study|Adverse Event|12
143671|NCT00619476|457461|P2|Overall Study|Adverse Event|6
143672|NCT00619476|457462|P1|Overall Study|Adverse Event|12
143673|NCT00619489|457546|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
143674|NCT00619489|457547|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
143675|NCT00619489|457546|P2|Overall Study|Lack of Efficacy|11
143676|NCT00619489|457547|P1|Overall Study|Lack of Efficacy|0
143677|NCT00619489|457546|P2|Overall Study|Withdrawal by Subject|1
143678|NCT00619489|457547|P1|Overall Study|Withdrawal by Subject|1
143679|NCT00619489|457546|P2|Overall Study|Adverse Event|7
143680|NCT00619489|457547|P1|Overall Study|Adverse Event|0
143681|NCT00619502|457567|P2|Overall Study|Lost to Follow-up|10
143682|NCT00619502|457568|P1|Overall Study|Lost to Follow-up|8
143683|NCT00619619|457586|P8|Overall Study|Adverse Event|2
143684|NCT00619619|457587|P7|Overall Study|Adverse Event|0
143685|NCT00619619|457588|P6|Overall Study|Adverse Event|0
143686|NCT00619619|457589|P5|Overall Study|Adverse Event|2
143687|NCT00619619|457590|P4|Overall Study|Adverse Event|0
143688|NCT00619619|457591|P3|Overall Study|Adverse Event|0
143689|NCT00619619|457592|P2|Overall Study|Adverse Event|0
143690|NCT00619619|457593|P1|Overall Study|Adverse Event|0
143691|NCT00619619|457586|P8|Overall Study|Protocol Violation|1
143692|NCT00619619|457587|P7|Overall Study|Protocol Violation|1
143693|NCT00619619|457588|P6|Overall Study|Protocol Violation|0
143694|NCT00619619|457589|P5|Overall Study|Protocol Violation|0
143695|NCT00619619|457590|P4|Overall Study|Protocol Violation|1
143696|NCT00619619|457591|P3|Overall Study|Protocol Violation|0
143697|NCT00619619|457592|P2|Overall Study|Protocol Violation|0
143698|NCT00619619|457593|P1|Overall Study|Protocol Violation|0
143699|NCT00619619|457586|P8|Overall Study|Physician Decision|0
143700|NCT00619619|457587|P7|Overall Study|Physician Decision|0
143701|NCT00619619|457588|P6|Overall Study|Physician Decision|0
143702|NCT00619619|457589|P5|Overall Study|Physician Decision|0
143703|NCT00619619|457590|P4|Overall Study|Physician Decision|0
143704|NCT00619619|457591|P3|Overall Study|Physician Decision|1
143705|NCT00619619|457592|P2|Overall Study|Physician Decision|0
143706|NCT00619619|457593|P1|Overall Study|Physician Decision|0
143707|NCT00619645|457678|P1|Overall Study|Adverse Event|1
143708|NCT00625872|457695|P2|Overall Study|Randomized but not treated|1
143709|NCT00625872|457696|P1|Overall Study|Randomized but not treated|0
143710|NCT00625872|457695|P2|Overall Study|Terminated by sponsor|5
143711|NCT00625872|457696|P1|Overall Study|Terminated by sponsor|2
143712|NCT00625872|457695|P2|Overall Study|Does not meet inclusion criteria|0
143713|NCT00625872|457696|P1|Overall Study|Does not meet inclusion criteria|1
143714|NCT00625872|457695|P2|Overall Study|Withdrawal by Subject|0
143715|NCT00625872|457696|P1|Overall Study|Withdrawal by Subject|1
143716|NCT00626028|457816|P2|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|6
143717|NCT00626028|457817|P1|Treatment 1 NO First, O2 Last|Inclusion/Exclusion Criteria|3
143718|NCT00626028|457816|P2|Treatment 1 NO First, O2 Last|Physician Decision|1
143719|NCT00626028|457817|P1|Treatment 1 NO First, O2 Last|Physician Decision|2
143720|NCT00626028|457816|P2|Treatment 1 NO First, O2 Last|Device Failure|1
143721|NCT00626028|457817|P1|Treatment 1 NO First, O2 Last|Device Failure|0
143722|NCT00626028|457816|P2|Treatment 1 NO First, O2 Last|Adverse Event|1
143723|NCT00626028|457817|P1|Treatment 1 NO First, O2 Last|Adverse Event|1
143724|NCT00626093|457827|P1|Overall Study|One of the required devices not implante|6
143725|NCT00626093|457827|P1|Overall Study|Protocol Violation|1
143726|NCT00626093|457827|P1|Overall Study|Withdrawal by Subject|6
143727|NCT00626093|457827|P1|Overall Study|Physician Decision|4
143728|NCT00626093|457827|P1|Overall Study|Death|1
143729|NCT00626093|457827|P1|Overall Study|Lost to Follow-up|5
143730|NCT00629707|457842|P2|Overall Study|Physician Decision|1
143731|NCT00629707|457843|P1|Overall Study|Physician Decision|0
143732|NCT00629707|457842|P2|Overall Study|Withdrawal by Subject|1
143733|NCT00629707|457843|P1|Overall Study|Withdrawal by Subject|0
143734|NCT00629772|457851|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
143735|NCT00629772|457852|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
143736|NCT00629772|457851|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
143737|NCT00629772|457852|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
143738|NCT00630058|457885|P2|Overall Study|stopping criteria|2
143739|NCT00630058|457886|P1|Overall Study|stopping criteria|3
143740|NCT00630058|457885|P2|Overall Study|Withdrawal by Subject|1
143741|NCT00630058|457886|P1|Overall Study|Withdrawal by Subject|0
143742|NCT00630058|457885|P2|Overall Study|Adverse Event|1
143743|NCT00630058|457886|P1|Overall Study|Adverse Event|1
143744|NCT00630292|457902|P1|Overall Study|Withdrawal by Subject|1
143745|NCT00630305|457906|P1|Overall Study|Inability to insert contact lens|1
143746|NCT00630305|457906|P1|Overall Study|Withdrawal by Subject|1
143747|NCT00630331|457931|P3|Overall Study|Protocol Violation|6
143748|NCT00630331|457932|P2|Overall Study|Protocol Violation|5
143749|NCT00630331|457933|P1|Overall Study|Protocol Violation|4
143750|NCT00630331|457931|P3|Overall Study|Unable to classify|3
143751|NCT00630331|457932|P2|Overall Study|Unable to classify|4
143752|NCT00630331|457933|P1|Overall Study|Unable to classify|9
143753|NCT00630331|457931|P3|Overall Study|Inappropriate enrollment|3
143754|NCT00630331|457932|P2|Overall Study|Inappropriate enrollment|6
143755|NCT00630331|457933|P1|Overall Study|Inappropriate enrollment|3
143756|NCT00630331|457931|P3|Overall Study|Lost to Follow-up|170
143757|NCT00630331|457932|P2|Overall Study|Lost to Follow-up|143
143758|NCT00630331|457933|P1|Overall Study|Lost to Follow-up|175
143759|NCT00630331|457931|P3|Overall Study|Withdrawal by Subject|5
143760|NCT00630331|457932|P2|Overall Study|Withdrawal by Subject|7
143761|NCT00630331|457933|P1|Overall Study|Withdrawal by Subject|12
143762|NCT00630331|457931|P3|Overall Study|Adverse Event|0
143763|NCT00630331|457932|P2|Overall Study|Adverse Event|0
143764|NCT00630331|457933|P1|Overall Study|Adverse Event|1
143765|NCT00630331|457931|P3|Overall Study|Death|1
143766|NCT00630331|457932|P2|Overall Study|Death|1
143767|NCT00630331|457933|P1|Overall Study|Death|2
143768|NCT00630396|457978|P1|Overall Study|Lost to Follow-up|3
143769|NCT00630396|457978|P1|Overall Study|Death|4
143770|NCT00630539|458030|P4|Overall Study|Withdrawal by Subject|1
143771|NCT00630539|458031|P3|Overall Study|Withdrawal by Subject|0
143772|NCT00630539|458032|P2|Overall Study|Withdrawal by Subject|1
143773|NCT00630539|458033|P1|Overall Study|Withdrawal by Subject|0
143774|NCT00630539|458030|P4|Overall Study|Adverse Event|2
143775|NCT00630539|458031|P3|Overall Study|Adverse Event|1
143776|NCT00630539|458032|P2|Overall Study|Adverse Event|3
143777|NCT00630539|458033|P1|Overall Study|Adverse Event|1
143778|NCT00630747|458127|P1|Overall Study|Returned to country of origin|1
143779|NCT00630747|458127|P1|Overall Study|Transferred to Study TKT031NPU|7
143780|NCT00630747|458127|P1|Overall Study|Death|1
143781|NCT00630786|458139|P3|Overall Study|Not specified|0
143782|NCT00630786|458140|P2|Overall Study|Not specified|0
143783|NCT00630786|458141|P1|Overall Study|Not specified|1
143784|NCT00630786|458139|P3|Overall Study|Lost to Follow-up|0
143785|NCT00630786|458140|P2|Overall Study|Lost to Follow-up|1
143786|NCT00630786|458141|P1|Overall Study|Lost to Follow-up|0
143787|NCT00630786|458139|P3|Overall Study|Withdrawal by Subject|1
143788|NCT00630786|458140|P2|Overall Study|Withdrawal by Subject|1
143789|NCT00630786|458141|P1|Overall Study|Withdrawal by Subject|0
143790|NCT00630786|458139|P3|Overall Study|Physician Decision|1
143791|NCT00630786|458140|P2|Overall Study|Physician Decision|0
143792|NCT00630786|458141|P1|Overall Study|Physician Decision|0
143793|NCT00630825|458164|P4|Overall Study|Withdrawal by Subject|3
143794|NCT00630825|458165|P3|Overall Study|Withdrawal by Subject|2
143795|NCT00630825|458166|P2|Overall Study|Withdrawal by Subject|2
143796|NCT00630825|458167|P1|Overall Study|Withdrawal by Subject|2
143797|NCT00630825|458164|P4|Overall Study|Physician Decision|0
143798|NCT00630825|458165|P3|Overall Study|Physician Decision|0
143799|NCT00630825|458166|P2|Overall Study|Physician Decision|0
143800|NCT00630825|458167|P1|Overall Study|Physician Decision|1
143801|NCT00630825|458164|P4|Overall Study|Lost to Follow-up|1
143802|NCT00630825|458165|P3|Overall Study|Lost to Follow-up|1
143803|NCT00630825|458166|P2|Overall Study|Lost to Follow-up|1
143804|NCT00630825|458167|P1|Overall Study|Lost to Follow-up|1
143805|NCT00630825|458164|P4|Overall Study|Entry Criteria Not Met|1
143806|NCT00630825|458165|P3|Overall Study|Entry Criteria Not Met|2
143807|NCT00630825|458166|P2|Overall Study|Entry Criteria Not Met|0
143808|NCT00630825|458167|P1|Overall Study|Entry Criteria Not Met|1
143809|NCT00630825|458164|P4|Overall Study|Adverse Event|1
143810|NCT00630825|458165|P3|Overall Study|Adverse Event|3
143811|NCT00630825|458166|P2|Overall Study|Adverse Event|4
143812|NCT00630825|458167|P1|Overall Study|Adverse Event|4
143813|NCT00630838|458238|P2|Overall Study|Lost to Follow-up|1
143814|NCT00630838|458239|P1|Overall Study|Lost to Follow-up|0
143815|NCT00630838|458238|P2|Overall Study|Death|1
143816|NCT00630838|458239|P1|Overall Study|Death|0
143817|NCT00630864|458247|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
143818|NCT00630864|458247|P1|Part 1 (up to Week 6)|Adverse Event|1
143819|NCT00630877|458287|P3|Overall Study|Personal reasons|1
143820|NCT00630877|458288|P2|Overall Study|Personal reasons|0
143821|NCT00630877|458289|P1|Overall Study|Personal reasons|0
143822|NCT00630877|458287|P3|Overall Study|Protocol violation|1
143823|NCT00630877|458288|P2|Overall Study|Protocol violation|0
143824|NCT00630877|458289|P1|Overall Study|Protocol violation|1
143825|NCT00630877|458287|P3|Overall Study|Noncompliance|1
143826|NCT00630877|458288|P2|Overall Study|Noncompliance|3
143827|NCT00630877|458289|P1|Overall Study|Noncompliance|2
143828|NCT00630877|458287|P3|Overall Study|Lost to Follow-up|0
143829|NCT00630877|458288|P2|Overall Study|Lost to Follow-up|0
143830|NCT00630877|458289|P1|Overall Study|Lost to Follow-up|2
143831|NCT00630877|458287|P3|Overall Study|Withdrawal by Subject|0
143832|NCT00630877|458288|P2|Overall Study|Withdrawal by Subject|4
143833|NCT00630877|458289|P1|Overall Study|Withdrawal by Subject|3
143834|NCT00630877|458287|P3|Overall Study|Adverse Event|7
143835|NCT00630877|458288|P2|Overall Study|Adverse Event|8
143836|NCT00630877|458289|P1|Overall Study|Adverse Event|11
143837|NCT00630916|458307|P1|Overall Study|Lack of Efficacy|3
143838|NCT00630916|458307|P1|Overall Study|Physician Decision|47
143839|NCT00630916|458307|P1|Overall Study|Protocol Violation|7
143840|NCT00630916|458307|P1|Overall Study|Withdrawal by Subject|30
143841|NCT00630916|458307|P1|Overall Study|Lost to Follow-up|5
143842|NCT00630916|458307|P1|Overall Study|Explant|8
143843|NCT00630916|458307|P1|Overall Study|Death|110
143844|NCT00630994|458330|P1|Overall Study|Other|1
143845|NCT00630994|458330|P1|Overall Study|Lack of Efficacy|1
143846|NCT00630994|458330|P1|Overall Study|Disease Progression|1
143847|NCT00630994|458330|P1|Overall Study|Adverse Event|1
143848|NCT00631007|458344|P6|Overall Study|Other|0
143849|NCT00631007|458345|P5|Overall Study|Other|1
143850|NCT00631007|458346|P4|Overall Study|Other|0
143851|NCT00631007|458347|P3|Overall Study|Other|0
143852|NCT00631007|458348|P2|Overall Study|Other|1
143853|NCT00631007|458349|P1|Overall Study|Other|2
143854|NCT00631007|458344|P6|Overall Study|Withdrawal by Subject|3
143855|NCT00631007|458345|P5|Overall Study|Withdrawal by Subject|1
143856|NCT00631007|458346|P4|Overall Study|Withdrawal by Subject|2
143857|NCT00631007|458347|P3|Overall Study|Withdrawal by Subject|2
143858|NCT00631007|458348|P2|Overall Study|Withdrawal by Subject|5
143859|NCT00631007|458349|P1|Overall Study|Withdrawal by Subject|4
143860|NCT00631007|458344|P6|Overall Study|Persistent Hyperglycemia|5
143861|NCT00631007|458345|P5|Overall Study|Persistent Hyperglycemia|2
143862|NCT00631007|458346|P4|Overall Study|Persistent Hyperglycemia|1
143863|NCT00631007|458347|P3|Overall Study|Persistent Hyperglycemia|5
143864|NCT00631007|458348|P2|Overall Study|Persistent Hyperglycemia|2
143865|NCT00631007|458349|P1|Overall Study|Persistent Hyperglycemia|2
143866|NCT00631007|458344|P6|Overall Study|Physician Decision|2
143867|NCT00631007|458345|P5|Overall Study|Physician Decision|0
143868|NCT00631007|458346|P4|Overall Study|Physician Decision|0
143869|NCT00631007|458347|P3|Overall Study|Physician Decision|1
143870|NCT00631007|458348|P2|Overall Study|Physician Decision|0
143871|NCT00631007|458349|P1|Overall Study|Physician Decision|1
143872|NCT00631007|458344|P6|Overall Study|Lost to Follow-up|3
143873|NCT00631007|458345|P5|Overall Study|Lost to Follow-up|5
143874|NCT00631007|458346|P4|Overall Study|Lost to Follow-up|4
143875|NCT00631007|458347|P3|Overall Study|Lost to Follow-up|2
143876|NCT00631007|458348|P2|Overall Study|Lost to Follow-up|1
143877|NCT00631007|458349|P1|Overall Study|Lost to Follow-up|2
143878|NCT00631007|458344|P6|Overall Study|Adverse Event|2
143879|NCT00631007|458345|P5|Overall Study|Adverse Event|3
143880|NCT00631007|458346|P4|Overall Study|Adverse Event|2
143881|NCT00631007|458347|P3|Overall Study|Adverse Event|0
143882|NCT00631007|458348|P2|Overall Study|Adverse Event|2
143883|NCT00631007|458349|P1|Overall Study|Adverse Event|0
143884|NCT00631020|458369|P1|Overall Study|Incarcerated|1
143885|NCT00631020|458369|P1|Overall Study|Lost to Follow-up|7
143886|NCT00631189|458382|P4|Treatment Phase|patient did not take pravastatin|0
143887|NCT00631189|458383|P3|Treatment Phase|patient did not take pravastatin|1
143888|NCT00631189|458384|P2|Treatment Phase|patient did not take pravastatin|0
143889|NCT00631189|458385|P1|Treatment Phase|patient did not take pravastatin|0
143890|NCT00631189|458382|P4|Treatment Phase|Pregnancy|0
143891|NCT00631189|458383|P3|Treatment Phase|Pregnancy|1
143892|NCT00631189|458384|P2|Treatment Phase|Pregnancy|0
143893|NCT00631189|458385|P1|Treatment Phase|Pregnancy|0
143894|NCT00631189|458382|P4|Treatment Phase|Lost to Follow-up|0
143895|NCT00631189|458383|P3|Treatment Phase|Lost to Follow-up|0
143896|NCT00631189|458384|P2|Treatment Phase|Lost to Follow-up|1
143897|NCT00631189|458385|P1|Treatment Phase|Lost to Follow-up|0
143898|NCT00631189|458382|P4|Treatment Phase|Adverse Event|4
143899|NCT00631189|458383|P3|Treatment Phase|Adverse Event|2
143900|NCT00631189|458384|P2|Treatment Phase|Adverse Event|3
143901|NCT00631189|458385|P1|Treatment Phase|Adverse Event|0
143902|NCT00631189|458382|P4|Treatment Phase|Protocol Violation|2
143903|NCT00631189|458383|P3|Treatment Phase|Protocol Violation|6
143904|NCT00631189|458384|P2|Treatment Phase|Protocol Violation|1
143905|NCT00631189|458385|P1|Treatment Phase|Protocol Violation|0
143906|NCT00631189|458382|P4|Treatment Phase|Withdrawal by Subject|1
143907|NCT00631189|458383|P3|Treatment Phase|Withdrawal by Subject|1
143908|NCT00631189|458384|P2|Treatment Phase|Withdrawal by Subject|2
143909|NCT00631189|458385|P1|Treatment Phase|Withdrawal by Subject|0
143910|NCT00631189|458382|P4|Initial Phase|Withdrawal by Subject|0
143911|NCT00631189|458383|P3|Initial Phase|Withdrawal by Subject|0
143912|NCT00631189|458384|P2|Initial Phase|Withdrawal by Subject|0
143913|NCT00631189|458385|P1|Initial Phase|Withdrawal by Subject|4
143914|NCT00631189|458382|P4|Initial Phase|Protocol Violation|0
143915|NCT00631189|458383|P3|Initial Phase|Protocol Violation|0
143916|NCT00631189|458384|P2|Initial Phase|Protocol Violation|0
143917|NCT00631189|458385|P1|Initial Phase|Protocol Violation|347
143918|NCT00631371|458446|P2|Overall Study|Death|239
143919|NCT00631371|458447|P1|Overall Study|Death|263
143920|NCT00631371|458446|P2|Overall Study|Discontinuation of study by Sponsor|76
143921|NCT00631371|458447|P1|Overall Study|Discontinuation of study by Sponsor|70
143922|NCT00631371|458446|P2|Overall Study|subject request|45
143923|NCT00631371|458447|P1|Overall Study|subject request|38
143924|NCT00631371|458446|P2|Overall Study|Other reason|12
143925|NCT00631371|458447|P1|Overall Study|Other reason|5
143926|NCT00631371|458446|P2|Overall Study|Lost to Follow-up|19
143927|NCT00631371|458447|P1|Overall Study|Lost to Follow-up|24
143928|NCT00631410|458461|P2|Overall Study|Surgery|0
143929|NCT00631410|458462|P1|Overall Study|Surgery|1
143930|NCT00631410|458461|P2|Overall Study|Objective Progression or Relapse|3
143931|NCT00631410|458462|P1|Overall Study|Objective Progression or Relapse|4
143932|NCT00631410|458461|P2|Overall Study|Adverse Event|3
143933|NCT00631410|458462|P1|Overall Study|Adverse Event|1
143934|NCT00631475|458488|P1|Overall Study|Preparation for lung transplant|8
143935|NCT00631475|458488|P1|Overall Study|Withdrew consent|5
143936|NCT00631475|458488|P1|Overall Study|Adverse Event|14
143937|NCT00631475|458488|P1|Overall Study|Death|18
143938|NCT00631488|458499|P3|Overall Study|Protocol Violation|1
143939|NCT00631488|458500|P2|Overall Study|Protocol Violation|0
143940|NCT00631488|458501|P1|Overall Study|Protocol Violation|0
143941|NCT00631488|458499|P3|Overall Study|Physician Decision|1
143942|NCT00631488|458500|P2|Overall Study|Physician Decision|0
143943|NCT00631488|458501|P1|Overall Study|Physician Decision|1
143944|NCT00631488|458499|P3|Overall Study|Lost to Follow-up|0
143945|NCT00631488|458500|P2|Overall Study|Lost to Follow-up|2
143946|NCT00631488|458501|P1|Overall Study|Lost to Follow-up|2
143947|NCT00631488|458499|P3|Overall Study|Adverse Event|0
143948|NCT00631488|458500|P2|Overall Study|Adverse Event|0
143949|NCT00631488|458501|P1|Overall Study|Adverse Event|1
143950|NCT00631540|458521|P1|Overall Study|Core Lab Data Unavailable|3
143951|NCT00631540|458521|P1|Overall Study|Lost to Follow-up|2
143952|NCT00631540|458521|P1|Overall Study|Death|4
143953|NCT00631540|458521|P1|Overall Study|Withdrawal by Subject|5
143954|NCT00631657|458532|P3|7-Day Discontinuation Period|Unspecified|0
143955|NCT00631657|458533|P2|7-Day Discontinuation Period|Unspecified|0
143956|NCT00631657|458534|P1|7-Day Discontinuation Period|Unspecified|1
143957|NCT00631657|458532|P3|7-Day Discontinuation Period|Not Treated|1
143958|NCT00631657|458533|P2|7-Day Discontinuation Period|Not Treated|1
143959|NCT00631657|458534|P1|7-Day Discontinuation Period|Not Treated|1
143960|NCT00631657|458532|P3|6-Month Treatment Period|Not Treated|1
143961|NCT00631657|458533|P2|6-Month Treatment Period|Not Treated|0
143962|NCT00631657|458534|P1|6-Month Treatment Period|Not Treated|2
143963|NCT00631657|458532|P3|6-Month Treatment Period|Unspecified|4
143964|NCT00631657|458533|P2|6-Month Treatment Period|Unspecified|0
143965|NCT00631657|458534|P1|6-Month Treatment Period|Unspecified|16
143966|NCT00631657|458532|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
143967|NCT00631657|458533|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
143968|NCT00631657|458534|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
143969|NCT00631657|458532|P3|6-Month Treatment Period|Lost to Follow-up|2
143970|NCT00631657|458533|P2|6-Month Treatment Period|Lost to Follow-up|0
143971|NCT00631657|458534|P1|6-Month Treatment Period|Lost to Follow-up|7
143972|NCT00631657|458532|P3|6-Month Treatment Period|Lack of Efficacy|25
143973|NCT00631657|458533|P2|6-Month Treatment Period|Lack of Efficacy|0
143974|NCT00631657|458534|P1|6-Month Treatment Period|Lack of Efficacy|34
143975|NCT00631657|458532|P3|6-Month Treatment Period|Withdrawal by Subject|5
143976|NCT00631657|458533|P2|6-Month Treatment Period|Withdrawal by Subject|0
143977|NCT00631657|458534|P1|6-Month Treatment Period|Withdrawal by Subject|14
143978|NCT00631657|458532|P3|6-Month Treatment Period|Adverse Event|7
143979|NCT00631657|458533|P2|6-Month Treatment Period|Adverse Event|0
143980|NCT00631657|458534|P1|6-Month Treatment Period|Adverse Event|47
143981|NCT00631696|458580|P2|Overall Study|Adverse Event|0
143982|NCT00631696|458581|P1|Overall Study|Adverse Event|5
143983|NCT00631696|458580|P2|Overall Study|Study terminated by sponsor|3
143984|NCT00631696|458581|P1|Overall Study|Study terminated by sponsor|3
143985|NCT00631696|458580|P2|Overall Study|Protocol Violation|9
143986|NCT00631696|458581|P1|Overall Study|Protocol Violation|9
143987|NCT00631696|458580|P2|Overall Study|Unspecified|8
143988|NCT00631696|458581|P1|Overall Study|Unspecified|8
143989|NCT00631696|458580|P2|Overall Study|Withdrawal by Subject|9
143990|NCT00631696|458581|P1|Overall Study|Withdrawal by Subject|2
143991|NCT00631696|458580|P2|Overall Study|Lost to Follow-up|10
143992|NCT00631696|458581|P1|Overall Study|Lost to Follow-up|7
143993|NCT00631696|458580|P2|Overall Study|Follow up after database release date|0
143994|NCT00631696|458581|P1|Overall Study|Follow up after database release date|1
143995|NCT00631696|458580|P2|Overall Study|Discontinued after database release date|0
143996|NCT00631696|458581|P1|Overall Study|Discontinued after database release date|1
143997|NCT00631696|458580|P2|Overall Study|Entered, not randomized to treatment|1
143998|NCT00631696|458581|P1|Overall Study|Entered, not randomized to treatment|1
143999|NCT00631917|458618|P2|Overall Study|Death|0
144000|NCT00631917|458619|P1|Overall Study|Death|1
144001|NCT00631917|458618|P2|Overall Study|Administrative problems|0
144002|NCT00631917|458619|P1|Overall Study|Administrative problems|2
144003|NCT00631917|458618|P2|Overall Study|Lost to Follow-up|7
144004|NCT00631917|458619|P1|Overall Study|Lost to Follow-up|7
144005|NCT00631917|458618|P2|Overall Study|Subject withdrew consent|33
144006|NCT00631917|458619|P1|Overall Study|Subject withdrew consent|25
144007|NCT00631917|458618|P2|Overall Study|Protocol deviation|5
144008|NCT00631917|458619|P1|Overall Study|Protocol deviation|6
144009|NCT00631917|458618|P2|Overall Study|No longer required study drug|1
144010|NCT00631917|458619|P1|Overall Study|No longer required study drug|0
144011|NCT00631917|458618|P2|Overall Study|Unsatisfactory therapeutic effect|14
144012|NCT00631917|458619|P1|Overall Study|Unsatisfactory therapeutic effect|8
144013|NCT00631917|458618|P2|Overall Study|Abnormal test procedure result(s)|2
144014|NCT00631917|458619|P1|Overall Study|Abnormal test procedure result(s)|3
144015|NCT00631917|458618|P2|Overall Study|Abnormal laboratory value(s)|1
144016|NCT00631917|458619|P1|Overall Study|Abnormal laboratory value(s)|2
144017|NCT00631917|458618|P2|Overall Study|Adverse Event|45
144018|NCT00631917|458619|P1|Overall Study|Adverse Event|34
144019|NCT00631969|458635|P2|Overall Study|No Drug Exposure|2
144020|NCT00631969|458636|P1|Overall Study|No Drug Exposure|2
144021|NCT00631969|458635|P2|Overall Study|Noncompliant With Study Medication|1
144022|NCT00631969|458636|P1|Overall Study|Noncompliant With Study Medication|0
144023|NCT00631969|458635|P2|Overall Study|Consent Withdrawn|7
144024|NCT00631969|458636|P1|Overall Study|Consent Withdrawn|5
144025|NCT00631969|458635|P2|Overall Study|Protocol Violation|1
144026|NCT00631969|458636|P1|Overall Study|Protocol Violation|1
144027|NCT00631969|458635|P2|Overall Study|Lost to Follow-up|1
144028|NCT00631969|458636|P1|Overall Study|Lost to Follow-up|2
144029|NCT00631969|458635|P2|Overall Study|Lack of Efficacy|8
144030|NCT00631969|458636|P1|Overall Study|Lack of Efficacy|2
144031|NCT00631969|458635|P2|Overall Study|Adverse Event|1
144032|NCT00631969|458636|P1|Overall Study|Adverse Event|3
144033|NCT00622635|458680|P6|Treatment Period 3|Withdrawal by Subject|0
144034|NCT00622635|458681|P5|Treatment Period 3|Withdrawal by Subject|0
144035|NCT00622635|458682|P4|Treatment Period 3|Withdrawal by Subject|1
144036|NCT00622635|458683|P3|Treatment Period 3|Withdrawal by Subject|0
144037|NCT00622635|458684|P2|Treatment Period 3|Withdrawal by Subject|0
144038|NCT00622635|458685|P1|Treatment Period 3|Withdrawal by Subject|0
144039|NCT00622635|458680|P6|Treatment Period 3|Adverse Event|0
144040|NCT00622635|458681|P5|Treatment Period 3|Adverse Event|0
144041|NCT00622635|458682|P4|Treatment Period 3|Adverse Event|2
144042|NCT00622635|458683|P3|Treatment Period 3|Adverse Event|0
144043|NCT00622635|458684|P2|Treatment Period 3|Adverse Event|0
144044|NCT00622635|458685|P1|Treatment Period 3|Adverse Event|0
144045|NCT00622635|458680|P6|Treatment Period 2|Adverse Event|0
144046|NCT00622635|458681|P5|Treatment Period 2|Adverse Event|0
144047|NCT00622635|458682|P4|Treatment Period 2|Adverse Event|0
144048|NCT00622635|458683|P3|Treatment Period 2|Adverse Event|0
144049|NCT00622635|458684|P2|Treatment Period 2|Adverse Event|0
144050|NCT00622635|458685|P1|Treatment Period 2|Adverse Event|1
144051|NCT00622635|458680|P6|Treatment Period 1|Abnormal test procedure result(s)|0
144052|NCT00622635|458681|P5|Treatment Period 1|Abnormal test procedure result(s)|1
144053|NCT00622635|458682|P4|Treatment Period 1|Abnormal test procedure result(s)|0
144054|NCT00622635|458683|P3|Treatment Period 1|Abnormal test procedure result(s)|0
144055|NCT00622635|458684|P2|Treatment Period 1|Abnormal test procedure result(s)|0
144056|NCT00622635|458685|P1|Treatment Period 1|Abnormal test procedure result(s)|0
144057|NCT00622635|458680|P6|Treatment Period 1|Withdrawal by Subject|0
144058|NCT00622635|458681|P5|Treatment Period 1|Withdrawal by Subject|0
144059|NCT00622635|458682|P4|Treatment Period 1|Withdrawal by Subject|0
144060|NCT00622635|458683|P3|Treatment Period 1|Withdrawal by Subject|0
144061|NCT00622635|458684|P2|Treatment Period 1|Withdrawal by Subject|1
144062|NCT00622635|458685|P1|Treatment Period 1|Withdrawal by Subject|0
144063|NCT00622635|458680|P6|Treatment Period 1|Adverse Event|0
144064|NCT00622635|458681|P5|Treatment Period 1|Adverse Event|0
144065|NCT00622635|458682|P4|Treatment Period 1|Adverse Event|0
144066|NCT00622635|458683|P3|Treatment Period 1|Adverse Event|1
144067|NCT00622635|458684|P2|Treatment Period 1|Adverse Event|0
144068|NCT00622635|458685|P1|Treatment Period 1|Adverse Event|0
144069|NCT00622700|458753|P7|Extension Treatment Period|Other than specified above|1
144070|NCT00622700|458754|P6|Extension Treatment Period|Other than specified above|1
144071|NCT00622700|458755|P5|Extension Treatment Period|Other than specified above|0
144072|NCT00622700|458756|P4|Extension Treatment Period|Other than specified above|0
144073|NCT00622700|458757|P3|Extension Treatment Period|Other than specified above|0
144074|NCT00622700|458758|P2|Extension Treatment Period|Other than specified above|0
144075|NCT00622700|458759|P1|Extension Treatment Period|Other than specified above|0
144076|NCT00622700|458753|P7|Extension Treatment Period|Missing|0
144077|NCT00622700|458754|P6|Extension Treatment Period|Missing|1
144078|NCT00622700|458755|P5|Extension Treatment Period|Missing|3
144079|NCT00622700|458756|P4|Extension Treatment Period|Missing|2
144080|NCT00622700|458757|P3|Extension Treatment Period|Missing|0
144081|NCT00622700|458758|P2|Extension Treatment Period|Missing|0
144082|NCT00622700|458759|P1|Extension Treatment Period|Missing|0
144083|NCT00622700|458753|P7|Extension Treatment Period|Withdrawal by Subject|10
144084|NCT00622700|458754|P6|Extension Treatment Period|Withdrawal by Subject|6
144085|NCT00622700|458755|P5|Extension Treatment Period|Withdrawal by Subject|16
144086|NCT00622700|458756|P4|Extension Treatment Period|Withdrawal by Subject|11
144087|NCT00622700|458757|P3|Extension Treatment Period|Withdrawal by Subject|0
144088|NCT00622700|458758|P2|Extension Treatment Period|Withdrawal by Subject|0
144089|NCT00622700|458759|P1|Extension Treatment Period|Withdrawal by Subject|0
144090|NCT00622700|458753|P7|Extension Treatment Period|Progressive Disease|2
144091|NCT00622700|458754|P6|Extension Treatment Period|Progressive Disease|0
144092|NCT00622700|458755|P5|Extension Treatment Period|Progressive Disease|2
144093|NCT00622700|458756|P4|Extension Treatment Period|Progressive Disease|1
144094|NCT00622700|458757|P3|Extension Treatment Period|Progressive Disease|0
144095|NCT00622700|458758|P2|Extension Treatment Period|Progressive Disease|0
144096|NCT00622700|458759|P1|Extension Treatment Period|Progressive Disease|0
144097|NCT00622700|458753|P7|Extension Treatment Period|Lost to Follow-up|0
144098|NCT00622700|458754|P6|Extension Treatment Period|Lost to Follow-up|0
144099|NCT00622700|458755|P5|Extension Treatment Period|Lost to Follow-up|1
144100|NCT00622700|458756|P4|Extension Treatment Period|Lost to Follow-up|0
144101|NCT00622700|458757|P3|Extension Treatment Period|Lost to Follow-up|0
144102|NCT00622700|458758|P2|Extension Treatment Period|Lost to Follow-up|0
144103|NCT00622700|458759|P1|Extension Treatment Period|Lost to Follow-up|0
144104|NCT00622700|458753|P7|Extension Treatment Period|Protocol Violation|0
144105|NCT00622700|458754|P6|Extension Treatment Period|Protocol Violation|2
144106|NCT00622700|458755|P5|Extension Treatment Period|Protocol Violation|0
144107|NCT00622700|458756|P4|Extension Treatment Period|Protocol Violation|0
144108|NCT00622700|458757|P3|Extension Treatment Period|Protocol Violation|0
144109|NCT00622700|458758|P2|Extension Treatment Period|Protocol Violation|0
144110|NCT00622700|458759|P1|Extension Treatment Period|Protocol Violation|0
144111|NCT00622700|458753|P7|Extension Treatment Period|Lack of Efficacy|9
144112|NCT00622700|458754|P6|Extension Treatment Period|Lack of Efficacy|1
144113|NCT00622700|458755|P5|Extension Treatment Period|Lack of Efficacy|8
144114|NCT00622700|458756|P4|Extension Treatment Period|Lack of Efficacy|2
144115|NCT00622700|458757|P3|Extension Treatment Period|Lack of Efficacy|0
144116|NCT00622700|458758|P2|Extension Treatment Period|Lack of Efficacy|0
144117|NCT00622700|458759|P1|Extension Treatment Period|Lack of Efficacy|0
144118|NCT00622700|458753|P7|Extension Treatment Period|Adverse Event|8
144119|NCT00622700|458754|P6|Extension Treatment Period|Adverse Event|6
144120|NCT00622700|458755|P5|Extension Treatment Period|Adverse Event|9
144121|NCT00622700|458756|P4|Extension Treatment Period|Adverse Event|5
144122|NCT00622700|458757|P3|Extension Treatment Period|Adverse Event|0
144123|NCT00622700|458758|P2|Extension Treatment Period|Adverse Event|0
144124|NCT00622700|458759|P1|Extension Treatment Period|Adverse Event|0
144125|NCT00622700|458753|P7|Core Treatment Period|Other than specified above|0
144126|NCT00622700|458754|P6|Core Treatment Period|Other than specified above|0
144127|NCT00622700|458755|P5|Core Treatment Period|Other than specified above|0
144128|NCT00622700|458756|P4|Core Treatment Period|Other than specified above|0
144129|NCT00622700|458757|P3|Core Treatment Period|Other than specified above|5
144130|NCT00622700|458758|P2|Core Treatment Period|Other than specified above|2
144131|NCT00622700|458759|P1|Core Treatment Period|Other than specified above|2
144132|NCT00622700|458753|P7|Core Treatment Period|Withdrawal by Subject|0
144133|NCT00622700|458754|P6|Core Treatment Period|Withdrawal by Subject|0
144134|NCT00622700|458755|P5|Core Treatment Period|Withdrawal by Subject|0
144135|NCT00622700|458756|P4|Core Treatment Period|Withdrawal by Subject|0
144136|NCT00622700|458757|P3|Core Treatment Period|Withdrawal by Subject|15
144137|NCT00622700|458758|P2|Core Treatment Period|Withdrawal by Subject|18
144138|NCT00622700|458759|P1|Core Treatment Period|Withdrawal by Subject|12
144139|NCT00622700|458753|P7|Core Treatment Period|Progressive Disease|0
144140|NCT00622700|458754|P6|Core Treatment Period|Progressive Disease|0
144141|NCT00622700|458755|P5|Core Treatment Period|Progressive Disease|0
144142|NCT00622700|458756|P4|Core Treatment Period|Progressive Disease|0
144143|NCT00622700|458757|P3|Core Treatment Period|Progressive Disease|0
144144|NCT00622700|458758|P2|Core Treatment Period|Progressive Disease|1
144145|NCT00622700|458759|P1|Core Treatment Period|Progressive Disease|3
144146|NCT00622700|458753|P7|Core Treatment Period|Death|0
144147|NCT00622700|458754|P6|Core Treatment Period|Death|0
144148|NCT00622700|458755|P5|Core Treatment Period|Death|0
144149|NCT00622700|458756|P4|Core Treatment Period|Death|0
144150|NCT00622700|458757|P3|Core Treatment Period|Death|0
144151|NCT00622700|458758|P2|Core Treatment Period|Death|0
144152|NCT00622700|458759|P1|Core Treatment Period|Death|1
144153|NCT00622700|458753|P7|Core Treatment Period|Lost to Follow-up|0
144154|NCT00622700|458754|P6|Core Treatment Period|Lost to Follow-up|0
144155|NCT00622700|458755|P5|Core Treatment Period|Lost to Follow-up|0
144156|NCT00622700|458756|P4|Core Treatment Period|Lost to Follow-up|0
144157|NCT00622700|458757|P3|Core Treatment Period|Lost to Follow-up|1
144158|NCT00622700|458758|P2|Core Treatment Period|Lost to Follow-up|1
144159|NCT00622700|458759|P1|Core Treatment Period|Lost to Follow-up|1
144160|NCT00622700|458753|P7|Core Treatment Period|Lack of Efficacy|0
144161|NCT00622700|458754|P6|Core Treatment Period|Lack of Efficacy|0
144162|NCT00622700|458755|P5|Core Treatment Period|Lack of Efficacy|0
144163|NCT00622700|458756|P4|Core Treatment Period|Lack of Efficacy|0
144164|NCT00622700|458757|P3|Core Treatment Period|Lack of Efficacy|12
144165|NCT00622700|458758|P2|Core Treatment Period|Lack of Efficacy|6
144166|NCT00622700|458759|P1|Core Treatment Period|Lack of Efficacy|19
144167|NCT00622700|458753|P7|Core Treatment Period|Adverse Event|0
144168|NCT00622700|458754|P6|Core Treatment Period|Adverse Event|0
144169|NCT00622700|458755|P5|Core Treatment Period|Adverse Event|0
144170|NCT00622700|458756|P4|Core Treatment Period|Adverse Event|0
144171|NCT00622700|458757|P3|Core Treatment Period|Adverse Event|18
144172|NCT00622700|458758|P2|Core Treatment Period|Adverse Event|25
144173|NCT00622700|458759|P1|Core Treatment Period|Adverse Event|18
144174|NCT00622700|458753|P7|Core Treatment Period|Randomized but Not Treated|0
144175|NCT00622700|458754|P6|Core Treatment Period|Randomized but Not Treated|0
144176|NCT00622700|458755|P5|Core Treatment Period|Randomized but Not Treated|0
144177|NCT00622700|458756|P4|Core Treatment Period|Randomized but Not Treated|0
144178|NCT00622700|458757|P3|Core Treatment Period|Randomized but Not Treated|2
144179|NCT00622700|458758|P2|Core Treatment Period|Randomized but Not Treated|2
144180|NCT00622700|458759|P1|Core Treatment Period|Randomized but Not Treated|0
144181|NCT00622713|458818|P1|Overall Study|Did not meet eligibility criteria|1
144182|NCT00622713|458818|P1|Overall Study|Subject no longer required study drug|1
144183|NCT00622713|458818|P1|Overall Study|Death|2
144184|NCT00622713|458818|P1|Overall Study|Lost to Follow-up|5
144185|NCT00622713|458818|P1|Overall Study|Withdrawal by Subject|11
144186|NCT00622713|458818|P1|Overall Study|Administrative problems|4
144187|NCT00622713|458818|P1|Overall Study|Adverse Event|35
144188|NCT00622726|458828|P2|August, 2010 to April, 2013|Death|5
144189|NCT00622726|458829|P1|August, 2010 to April, 2013|Death|1
144190|NCT00622726|458828|P2|March, 2008 to August, 2010|Death|2
144191|NCT00622726|458829|P1|March, 2008 to August, 2010|Death|5
144192|NCT00622739|458841|P2|Overall Study|Lost to Follow-up|1
144193|NCT00622739|458842|P1|Overall Study|Lost to Follow-up|0
144194|NCT00622739|458841|P2|Overall Study|Withdrawal by Subject|1
144195|NCT00622739|458842|P1|Overall Study|Withdrawal by Subject|0
144196|NCT00622739|458841|P2|Overall Study|Lack of Efficacy|2
144197|NCT00622739|458842|P1|Overall Study|Lack of Efficacy|0
144198|NCT00622739|458841|P2|Overall Study|Adverse Event|2
144199|NCT00622739|458842|P1|Overall Study|Adverse Event|1
144200|NCT00622739|458841|P2|Overall Study|Physician Decision|0
144201|NCT00622739|458842|P1|Overall Study|Physician Decision|1
144202|NCT00622869|458851|P3|Overall Study|Missing|1
144203|NCT00622869|458852|P2|Overall Study|Missing|1
144204|NCT00622869|458853|P1|Overall Study|Missing|0
144205|NCT00622869|458851|P3|Overall Study|Graft Loss|2
144206|NCT00622869|458852|P2|Overall Study|Graft Loss|3
144207|NCT00622869|458853|P1|Overall Study|Graft Loss|5
144208|NCT00622869|458851|P3|Overall Study|Lost to Follow-up|2
144209|NCT00622869|458852|P2|Overall Study|Lost to Follow-up|4
144210|NCT00622869|458853|P1|Overall Study|Lost to Follow-up|2
144211|NCT00622869|458851|P3|Overall Study|Death|10
144212|NCT00622869|458852|P2|Overall Study|Death|15
144213|NCT00622869|458853|P1|Overall Study|Death|12
144214|NCT00622869|458851|P3|Overall Study|Administrative Problems|13
144215|NCT00622869|458852|P2|Overall Study|Administrative Problems|17
144216|NCT00622869|458853|P1|Overall Study|Administrative Problems|11
144217|NCT00622869|458851|P3|Overall Study|Subject Withdrew Consent|11
144218|NCT00622869|458852|P2|Overall Study|Subject Withdrew Consent|17
144219|NCT00622869|458853|P1|Overall Study|Subject Withdrew Consent|13
144220|NCT00622908|458872|P2|Overall Study|Termination by study sponser|1
144221|NCT00622908|458873|P1|Overall Study|Termination by study sponser|0
144222|NCT00622908|458872|P2|Overall Study|Refusal|1
144223|NCT00622908|458873|P1|Overall Study|Refusal|0
144224|NCT00622908|458872|P2|Overall Study|Lost to Follow-up|0
144225|NCT00622908|458873|P1|Overall Study|Lost to Follow-up|1
144226|NCT00622908|458872|P2|Overall Study|Lack of Efficacy|7
144227|NCT00622908|458873|P1|Overall Study|Lack of Efficacy|1
144228|NCT00622908|458872|P2|Overall Study|Adverse Event|1
144229|NCT00622908|458873|P1|Overall Study|Adverse Event|0
144230|NCT00622908|458872|P2|Overall Study|Protocol Violation|0
144231|NCT00622908|458873|P1|Overall Study|Protocol Violation|1
144232|NCT00623103|458893|P2|Overall Study|Protocol deviation|1
144233|NCT00623103|458894|P1|Overall Study|Protocol deviation|2
144234|NCT00623103|458893|P2|Overall Study|Death|11
144235|NCT00623103|458894|P1|Overall Study|Death|11
144236|NCT00623103|458893|P2|Overall Study|Administrative problems|4
144237|NCT00623103|458894|P1|Overall Study|Administrative problems|2
144238|NCT00623103|458893|P2|Overall Study|Lost to Follow-up|1
144239|NCT00623103|458894|P1|Overall Study|Lost to Follow-up|4
144240|NCT00623103|458893|P2|Overall Study|Withdrawal by Subject|24
144241|NCT00623103|458894|P1|Overall Study|Withdrawal by Subject|18
144242|NCT00623103|458893|P2|Overall Study|Unsatisfactory therapeutic effect|12
144243|NCT00623103|458894|P1|Overall Study|Unsatisfactory therapeutic effect|4
144244|NCT00623103|458893|P2|Overall Study|Adverse Event|60
144245|NCT00623103|458894|P1|Overall Study|Adverse Event|70
144246|NCT00623194|458929|P1|Overall Study|Unclassified|1
144247|NCT00623194|458929|P1|Overall Study|Protocol Violation|3
144248|NCT00623194|458929|P1|Overall Study|Lack of Efficacy|1
144249|NCT00623233|458949|P1|Overall Study|Withdrawal by Subject|3
144250|NCT00623233|458949|P1|Overall Study|Lost to Follow-up|1
144251|NCT00623233|458949|P1|Overall Study|Physician Decision|10
144252|NCT00623233|458949|P1|Overall Study|Adverse Event|10
144253|NCT00632021|458958|P2|Overall Study|Withdrawal/death|4
144254|NCT00632021|458959|P1|Overall Study|Withdrawal/death|7
144255|NCT00632099|458969|P2|Overall Study|Lost to Follow-up|3
144256|NCT00632099|458970|P1|Overall Study|Lost to Follow-up|3
144257|NCT00632125|458976|P1|Overall Study|Moved to other dialysis unit, etc.|102
144258|NCT00632125|458976|P1|Overall Study|Development of uncontrolled hypertension|5
144259|NCT00632125|458976|P1|Overall Study|Non-compliance|8
144260|NCT00632125|458976|P1|Overall Study|Need for systemic immunosuppressive medi|8
144261|NCT00632125|458976|P1|Overall Study|Renal transplantation|17
144262|NCT00632125|458976|P1|Overall Study|Adverse Event|36
144263|NCT00632125|458976|P1|Overall Study|Withdrawal by Subject|44
144264|NCT00632125|458976|P1|Overall Study|Death|82
144265|NCT00632203|458982|P2|Overall Study|Did not start study treatment|0
144266|NCT00632203|458983|P1|Overall Study|Did not start study treatment|1
144267|NCT00632229|459003|P2|Overall Study|Undisclosed reasons within the first wee|1
144268|NCT00632229|459004|P1|Overall Study|Undisclosed reasons within the first wee|0
144269|NCT00632229|459003|P2|Overall Study|Lack of Efficacy|2
144270|NCT00632229|459004|P1|Overall Study|Lack of Efficacy|0
144271|NCT00632229|459003|P2|Overall Study|Lost to Follow-up|3
144272|NCT00632229|459004|P1|Overall Study|Lost to Follow-up|0
144273|NCT00632229|459003|P2|Overall Study|Adverse Event|0
144274|NCT00632229|459004|P1|Overall Study|Adverse Event|6
144275|NCT00632463|459020|P3|Overall Study|Adverse Event|0
144276|NCT00632463|459021|P2|Overall Study|Adverse Event|1
144277|NCT00632463|459022|P1|Overall Study|Adverse Event|0
144278|NCT00632502|459054|P2|Overall Study|Randomized not treated|0
144279|NCT00632502|459055|P1|Overall Study|Randomized not treated|3
144280|NCT00632502|459054|P2|Overall Study|Adverse Event|1
144281|NCT00632502|459055|P1|Overall Study|Adverse Event|0
144282|NCT00632541|459080|P1|Overall Study|Adverse Event|7
144283|NCT00632736|459114|P1|Overall Study|Other|16
144284|NCT00632736|459114|P1|Overall Study|Non-compliance|10
144285|NCT00632736|459114|P1|Overall Study|Sponsor terminated study|5
144286|NCT00632736|459114|P1|Overall Study|Lack of Efficacy|5
144287|NCT00632736|459114|P1|Overall Study|Withdrawal by Subject|99
144288|NCT00632736|459114|P1|Overall Study|Protocol Violation|14
144289|NCT00632736|459114|P1|Overall Study|Lost to Follow-up|15
144290|NCT00632736|459114|P1|Overall Study|Adverse Event|104
144291|NCT00632749|459133|P14|Overall Study|Reason other than those specified above|2
144292|NCT00632749|459134|P13|Overall Study|Reason other than those specified above|0
144293|NCT00632749|459135|P12|Overall Study|Reason other than those specified above|1
144294|NCT00632749|459136|P11|Overall Study|Reason other than those specified above|2
144295|NCT00632749|459137|P10|Overall Study|Reason other than those specified above|0
144296|NCT00632749|459138|P9|Overall Study|Reason other than those specified above|0
144297|NCT00632749|459139|P8|Overall Study|Reason other than those specified above|0
144298|NCT00632749|459140|P7|Overall Study|Reason other than those specified above|1
144299|NCT00632749|459141|P6|Overall Study|Reason other than those specified above|0
144300|NCT00632749|459142|P5|Overall Study|Reason other than those specified above|1
144301|NCT00632749|459143|P4|Overall Study|Reason other than those specified above|0
144302|NCT00632749|459144|P3|Overall Study|Reason other than those specified above|0
144303|NCT00632749|459145|P2|Overall Study|Reason other than those specified above|2
144304|NCT00632749|459146|P1|Overall Study|Reason other than those specified above|0
144305|NCT00632749|459133|P14|Overall Study|Refuse to continue medication|0
144306|NCT00632749|459134|P13|Overall Study|Refuse to continue medication|0
144307|NCT00632749|459135|P12|Overall Study|Refuse to continue medication|0
144308|NCT00632749|459136|P11|Overall Study|Refuse to continue medication|0
144309|NCT00632749|459137|P10|Overall Study|Refuse to continue medication|1
144310|NCT00632749|459138|P9|Overall Study|Refuse to continue medication|0
144311|NCT00632749|459139|P8|Overall Study|Refuse to continue medication|0
144312|NCT00632749|459140|P7|Overall Study|Refuse to continue medication|0
144313|NCT00632749|459141|P6|Overall Study|Refuse to continue medication|0
144314|NCT00632749|459142|P5|Overall Study|Refuse to continue medication|0
144315|NCT00632749|459143|P4|Overall Study|Refuse to continue medication|1
144316|NCT00632749|459144|P3|Overall Study|Refuse to continue medication|0
144317|NCT00632749|459145|P2|Overall Study|Refuse to continue medication|0
144318|NCT00632749|459146|P1|Overall Study|Refuse to continue medication|0
144319|NCT00632749|459133|P14|Overall Study|Other Adverse event|0
144320|NCT00632749|459134|P13|Overall Study|Other Adverse event|1
144321|NCT00632749|459135|P12|Overall Study|Other Adverse event|0
144322|NCT00632749|459136|P11|Overall Study|Other Adverse event|1
144323|NCT00632749|459137|P10|Overall Study|Other Adverse event|0
144324|NCT00632749|459138|P9|Overall Study|Other Adverse event|2
144325|NCT00632749|459139|P8|Overall Study|Other Adverse event|2
144326|NCT00632749|459140|P7|Overall Study|Other Adverse event|1
144327|NCT00632749|459141|P6|Overall Study|Other Adverse event|4
144328|NCT00632749|459142|P5|Overall Study|Other Adverse event|2
144329|NCT00632749|459143|P4|Overall Study|Other Adverse event|1
144330|NCT00632749|459144|P3|Overall Study|Other Adverse event|1
144331|NCT00632749|459145|P2|Overall Study|Other Adverse event|1
144332|NCT00632749|459146|P1|Overall Study|Other Adverse event|1
144333|NCT00632749|459133|P14|Overall Study|Progressive disease|4
144334|NCT00632749|459134|P13|Overall Study|Progressive disease|2
144335|NCT00632749|459135|P12|Overall Study|Progressive disease|3
144336|NCT00632749|459136|P11|Overall Study|Progressive disease|4
144337|NCT00632749|459137|P10|Overall Study|Progressive disease|2
144338|NCT00632749|459138|P9|Overall Study|Progressive disease|3
144339|NCT00632749|459139|P8|Overall Study|Progressive disease|2
144340|NCT00632749|459140|P7|Overall Study|Progressive disease|3
144341|NCT00632749|459141|P6|Overall Study|Progressive disease|4
144342|NCT00632749|459142|P5|Overall Study|Progressive disease|4
144343|NCT00632749|459143|P4|Overall Study|Progressive disease|2
144344|NCT00632749|459144|P3|Overall Study|Progressive disease|2
144345|NCT00632749|459145|P2|Overall Study|Progressive disease|2
144346|NCT00632749|459146|P1|Overall Study|Progressive disease|3
144347|NCT00632931|459477|P3|Part 2|Withdrawal by Subject|3
144348|NCT00632931|459478|P2|Part 2|Withdrawal by Subject|0
144349|NCT00632931|459479|P1|Part 2|Withdrawal by Subject|0
144350|NCT00632931|459477|P3|Part 2|Lack of Efficacy|17
144351|NCT00632931|459478|P2|Part 2|Lack of Efficacy|0
144352|NCT00632931|459479|P1|Part 2|Lack of Efficacy|0
144353|NCT00632931|459477|P3|Part 2|Death|1
144354|NCT00632931|459478|P2|Part 2|Death|0
144355|NCT00632931|459479|P1|Part 2|Death|0
144356|NCT00632931|459477|P3|Part 2|Adverse Event|3
144357|NCT00632931|459478|P2|Part 2|Adverse Event|0
144358|NCT00632931|459479|P1|Part 2|Adverse Event|0
144359|NCT00632931|459477|P3|Part 1, Period 1|Withdrawal by Subject|0
144360|NCT00632931|459478|P2|Part 1, Period 1|Withdrawal by Subject|0
144361|NCT00632931|459479|P1|Part 1, Period 1|Withdrawal by Subject|1
144362|NCT00632931|459477|P3|Part 1, Period 1|Protocol Violation|0
144363|NCT00632931|459478|P2|Part 1, Period 1|Protocol Violation|0
144364|NCT00632931|459479|P1|Part 1, Period 1|Protocol Violation|1
144365|NCT00633074|459525|P2|Overall Study|Adverse Event|0
144366|NCT00633074|459526|P1|Overall Study|Adverse Event|1
144367|NCT00633126|459561|P1|Overall Study|Did not receive full dose|1
144368|NCT00633139|459569|P3|Overall Study|Withdrawal by Subject|0
144369|NCT00633139|459570|P2|Overall Study|Withdrawal by Subject|1
144370|NCT00633139|459571|P1|Overall Study|Withdrawal by Subject|0
144371|NCT00633139|459569|P3|Overall Study|Non compliance|1
144372|NCT00633139|459570|P2|Overall Study|Non compliance|0
144373|NCT00633139|459571|P1|Overall Study|Non compliance|0
144374|NCT00633152|459587|P2|Overall Study|Miscellaneous Other|2
144375|NCT00633152|459588|P1|Overall Study|Miscellaneous Other|3
144376|NCT00633152|459587|P2|Overall Study|Lost to Follow-up|1
144377|NCT00633152|459588|P1|Overall Study|Lost to Follow-up|4
144378|NCT00633152|459587|P2|Overall Study|Withdrawal by Subject|1
144379|NCT00633152|459588|P1|Overall Study|Withdrawal by Subject|1
144380|NCT00633152|459587|P2|Overall Study|Randomized, did not receive study drug|2
144381|NCT00633152|459588|P1|Overall Study|Randomized, did not receive study drug|5
144382|NCT00633152|459587|P2|Overall Study|Adverse Event|0
144383|NCT00633152|459588|P1|Overall Study|Adverse Event|1
144384|NCT00633217|459598|P2|Overall Study|Withdrew Consent|3
144385|NCT00633217|459599|P1|Overall Study|Withdrew Consent|3
144386|NCT00633217|459598|P2|Overall Study|Investigator Discretion|0
144387|NCT00633217|459599|P1|Overall Study|Investigator Discretion|2
144388|NCT00633217|459598|P2|Overall Study|Lost to Follow-up|2
144389|NCT00633217|459599|P1|Overall Study|Lost to Follow-up|2
144390|NCT00633217|459598|P2|Overall Study|Protocol Violation|7
144391|NCT00633217|459599|P1|Overall Study|Protocol Violation|3
144392|NCT00633217|459598|P2|Overall Study|Lack of Efficacy|2
144393|NCT00633217|459599|P1|Overall Study|Lack of Efficacy|0
144394|NCT00633217|459598|P2|Overall Study|Adverse Event|9
144395|NCT00633217|459599|P1|Overall Study|Adverse Event|5
144396|NCT00633243|459611|P2|Overall Study|Couldn't tolerate side-effects|1
144397|NCT00633243|459612|P1|Overall Study|Couldn't tolerate side-effects|1
144398|NCT00633243|459611|P2|Overall Study|Mental Health--Depression|1
144399|NCT00633243|459612|P1|Overall Study|Mental Health--Depression|0
144400|NCT00633243|459611|P2|Overall Study|Not comfortable with self-injecting|1
144401|NCT00633243|459612|P1|Overall Study|Not comfortable with self-injecting|0
144402|NCT00633243|459611|P2|Overall Study|Homeless--no refrigeration for meds|1
144403|NCT00633243|459612|P1|Overall Study|Homeless--no refrigeration for meds|0
144404|NCT00633243|459611|P2|Overall Study|incarceration|2
144405|NCT00633243|459612|P1|Overall Study|incarceration|0
144406|NCT00633243|459611|P2|Overall Study|Withdrawal by Subject|1
144407|NCT00633243|459612|P1|Overall Study|Withdrawal by Subject|0
144408|NCT00633360|459633|P2|Overall Study|Protocol Violation|1
144409|NCT00633360|459634|P1|Overall Study|Protocol Violation|0
144410|NCT00633360|459633|P2|Overall Study|Adverse Event|1
144411|NCT00633360|459634|P1|Overall Study|Adverse Event|3
144412|NCT00633360|459633|P2|Overall Study|Lost to Follow-up|1
144413|NCT00633360|459634|P1|Overall Study|Lost to Follow-up|1
144414|NCT00633464|459657|P2|Overall Study|Never Treated (Randomized in error)|1
144415|NCT00633464|459658|P1|Overall Study|Never Treated (Randomized in error)|0
144416|NCT00633464|459657|P2|Overall Study|Never Treated (Not met study criteria)|1
144417|NCT00633464|459658|P1|Overall Study|Never Treated (Not met study criteria)|0
144418|NCT00633477|459680|P2|Overall Study|Randomized but not treated|0
144419|NCT00633477|459681|P1|Overall Study|Randomized but not treated|1
144420|NCT00633477|459680|P2|Overall Study|Death|0
144421|NCT00633477|459681|P1|Overall Study|Death|1
144422|NCT00633594|459698|P3|Overall Study|Disease Progression|1
144423|NCT00633594|459699|P2|Overall Study|Disease Progression|0
144424|NCT00633594|459700|P1|Overall Study|Disease Progression|0
144425|NCT00633594|459698|P3|Overall Study|Death|2
144426|NCT00633594|459699|P2|Overall Study|Death|1
144427|NCT00633594|459700|P1|Overall Study|Death|0
144428|NCT00633594|459698|P3|Overall Study|Adverse Event|7
144429|NCT00633594|459699|P2|Overall Study|Adverse Event|4
144430|NCT00633594|459700|P1|Overall Study|Adverse Event|0
144431|NCT00633750|459727|P1|Overall Study|Withdrawal by Subject|3
144432|NCT00633750|459727|P1|Overall Study|Adverse Event|2
144433|NCT00633880|459745|P3|Open Label Titration|Withdrawal by Subject|0
144434|NCT00633880|459746|P2|Open Label Titration|Withdrawal by Subject|0
144435|NCT00633880|459747|P1|Open Label Titration|Withdrawal by Subject|4
144436|NCT00633880|459745|P3|Open Label Titration|Physician Decision|0
144437|NCT00633880|459746|P2|Open Label Titration|Physician Decision|0
144438|NCT00633880|459747|P1|Open Label Titration|Physician Decision|1
144439|NCT00633880|459745|P3|Open Label Titration|Protocol Violation|0
144440|NCT00633880|459746|P2|Open Label Titration|Protocol Violation|0
144441|NCT00633880|459747|P1|Open Label Titration|Protocol Violation|6
144442|NCT00633880|459745|P3|Open Label Titration|Treatment Failure|0
144443|NCT00633880|459746|P2|Open Label Titration|Treatment Failure|0
144444|NCT00633880|459747|P1|Open Label Titration|Treatment Failure|55
144445|NCT00633880|459745|P3|Open Label Titration|Adverse Event|0
144446|NCT00633880|459746|P2|Open Label Titration|Adverse Event|0
144447|NCT00633880|459747|P1|Open Label Titration|Adverse Event|13
144448|NCT00633880|459745|P3|Open Label Titration|Lack of Efficacy|0
144449|NCT00633880|459746|P2|Open Label Titration|Lack of Efficacy|0
144450|NCT00633880|459747|P1|Open Label Titration|Lack of Efficacy|1
144451|NCT00633893|459777|P3|Overall Study|not specified|31
144452|NCT00633893|459778|P2|Overall Study|not specified|33
144453|NCT00633893|459779|P1|Overall Study|not specified|28
144454|NCT00633893|459777|P3|Overall Study|Not meet/no longer meets criteria|4
144455|NCT00633893|459778|P2|Overall Study|Not meet/no longer meets criteria|6
144456|NCT00633893|459779|P1|Overall Study|Not meet/no longer meets criteria|4
144457|NCT00633893|459777|P3|Overall Study|Pregnancy|1
144458|NCT00633893|459778|P2|Overall Study|Pregnancy|1
144459|NCT00633893|459779|P1|Overall Study|Pregnancy|2
144460|NCT00633893|459777|P3|Overall Study|Poor/non-compliance|3
144461|NCT00633893|459778|P2|Overall Study|Poor/non-compliance|12
144462|NCT00633893|459779|P1|Overall Study|Poor/non-compliance|5
144463|NCT00633893|459777|P3|Overall Study|Lost to Follow-up|8
144464|NCT00633893|459778|P2|Overall Study|Lost to Follow-up|4
144465|NCT00633893|459779|P1|Overall Study|Lost to Follow-up|2
144466|NCT00633893|459777|P3|Overall Study|Withdrawal by Subject|6
144467|NCT00633893|459778|P2|Overall Study|Withdrawal by Subject|12
144468|NCT00633893|459779|P1|Overall Study|Withdrawal by Subject|7
144469|NCT00633893|459777|P3|Overall Study|Adverse Event|126
144470|NCT00633893|459778|P2|Overall Study|Adverse Event|58
144471|NCT00633893|459779|P1|Overall Study|Adverse Event|65
144472|NCT00633893|459777|P3|Overall Study|Death|9
144473|NCT00633893|459778|P2|Overall Study|Death|3
144474|NCT00633893|459779|P1|Overall Study|Death|1
144475|NCT00633932|459870|P3|Overall Study|Moved Away|0
144476|NCT00633932|459871|P2|Overall Study|Moved Away|0
144477|NCT00633932|459872|P1|Overall Study|Moved Away|1
144478|NCT00633932|459870|P3|Overall Study|Doctor's judgement|0
144479|NCT00633932|459871|P2|Overall Study|Doctor's judgement|0
144480|NCT00633932|459872|P1|Overall Study|Doctor's judgement|1
144481|NCT00633932|459870|P3|Overall Study|Physician Decision|1
144482|NCT00633932|459871|P2|Overall Study|Physician Decision|0
144483|NCT00633932|459872|P1|Overall Study|Physician Decision|0
144484|NCT00633932|459870|P3|Overall Study|Protocol Violation|3
144485|NCT00633932|459871|P2|Overall Study|Protocol Violation|2
144486|NCT00633932|459872|P1|Overall Study|Protocol Violation|5
144487|NCT00633932|459870|P3|Overall Study|Lost to Follow-up|2
144488|NCT00633932|459871|P2|Overall Study|Lost to Follow-up|0
144489|NCT00633932|459872|P1|Overall Study|Lost to Follow-up|1
144490|NCT00633932|459870|P3|Overall Study|Withdrawal by Subject|1
144491|NCT00633932|459871|P2|Overall Study|Withdrawal by Subject|9
144492|NCT00633932|459872|P1|Overall Study|Withdrawal by Subject|3
144493|NCT00633932|459870|P3|Overall Study|Adverse Event|4
144494|NCT00633932|459871|P2|Overall Study|Adverse Event|3
144495|NCT00633932|459872|P1|Overall Study|Adverse Event|1
144496|NCT00633984|459885|P2|Overall Study|Hospitalized|0
144497|NCT00633984|459886|P1|Overall Study|Hospitalized|1
144498|NCT00633984|459885|P2|Overall Study|Withdrawal by Subject|7
144499|NCT00633984|459886|P1|Overall Study|Withdrawal by Subject|8
144500|NCT00633984|459885|P2|Overall Study|Lost to Follow-up|6
144501|NCT00633984|459886|P1|Overall Study|Lost to Follow-up|0
144502|NCT00634010|459896|P2|Overall Study|Non-Compliant|1
144503|NCT00634010|459897|P1|Overall Study|Non-Compliant|1
144504|NCT00634010|459896|P2|Overall Study|Disease Progression|1
144505|NCT00634010|459897|P1|Overall Study|Disease Progression|1
144506|NCT00634010|459896|P2|Overall Study|Physician Decision|1
144507|NCT00634010|459897|P1|Overall Study|Physician Decision|1
144508|NCT00634010|459896|P2|Overall Study|Withdrawal by Subject|6
144509|NCT00634010|459897|P1|Overall Study|Withdrawal by Subject|5
144510|NCT00634010|459896|P2|Overall Study|Adverse Event|5
144511|NCT00634010|459897|P1|Overall Study|Adverse Event|2
144512|NCT00634036|459905|P2|Overall Study|Withdrawal by Subject|1
144513|NCT00634036|459906|P1|Overall Study|Withdrawal by Subject|1
144514|NCT00634036|459905|P2|Overall Study|Lost to Follow-up|1
144515|NCT00634036|459906|P1|Overall Study|Lost to Follow-up|1
144516|NCT00634049|459918|P1|Overall Study|Screening failure|1
144517|NCT00634049|459918|P1|Overall Study|Died prior to receiving study drug|1
144518|NCT00634049|459918|P1|Overall Study|Never received study drug|1
144519|NCT00634088|459999|P4|Time Period 3: Dose Level 3|Progressive disease|0
144520|NCT00634088|460000|P3|Time Period 3: Dose Level 3|Progressive disease|1
144521|NCT00634088|460001|P2|Time Period 3: Dose Level 3|Progressive disease|0
144522|NCT00634088|460002|P1|Time Period 3: Dose Level 3|Progressive disease|0
144523|NCT00634088|459999|P4|Time Period 2: Dose Level 2|Progressive disease|0
144524|NCT00634088|460000|P3|Time Period 2: Dose Level 2|Progressive disease|0
144525|NCT00634088|460001|P2|Time Period 2: Dose Level 2|Progressive disease|1
144526|NCT00634088|460002|P1|Time Period 2: Dose Level 2|Progressive disease|0
144527|NCT00634088|459999|P4|Time Period 2: Dose Level 2|Adverse Event|0
144528|NCT00634088|460000|P3|Time Period 2: Dose Level 2|Adverse Event|0
144529|NCT00634088|460001|P2|Time Period 2: Dose Level 2|Adverse Event|2
144530|NCT00634088|460002|P1|Time Period 2: Dose Level 2|Adverse Event|0
144531|NCT00634088|459999|P4|Time Period 1: Dose Level 1|Adverse Event|0
144532|NCT00634088|460000|P3|Time Period 1: Dose Level 1|Adverse Event|0
144533|NCT00634088|460001|P2|Time Period 1: Dose Level 1|Adverse Event|0
144534|NCT00634088|460002|P1|Time Period 1: Dose Level 1|Adverse Event|3
144535|NCT00634088|459999|P4|Time Period 1: Dose Level 1|Physician Decision|0
144536|NCT00634088|460000|P3|Time Period 1: Dose Level 1|Physician Decision|0
144537|NCT00634088|460001|P2|Time Period 1: Dose Level 1|Physician Decision|0
144538|NCT00634088|460002|P1|Time Period 1: Dose Level 1|Physician Decision|1
144539|NCT00634088|459999|P4|Time Period 1: Dose Level 1|Disease progression|0
144540|NCT00634088|460000|P3|Time Period 1: Dose Level 1|Disease progression|0
144541|NCT00634088|460001|P2|Time Period 1: Dose Level 1|Disease progression|0
144542|NCT00634088|460002|P1|Time Period 1: Dose Level 1|Disease progression|2
144543|NCT00634114|460056|P3|Overall Study|Other reason|1
144544|NCT00634114|460057|P2|Overall Study|Other reason|1
144545|NCT00634114|460058|P1|Overall Study|Other reason|1
144546|NCT00634114|460056|P3|Overall Study|Difficult to continue|1
144547|NCT00634114|460057|P2|Overall Study|Difficult to continue|1
144548|NCT00634114|460058|P1|Overall Study|Difficult to continue|3
144549|NCT00634114|460056|P3|Overall Study|Recurrence of reflux esophagitis|21
144550|NCT00634114|460057|P2|Overall Study|Recurrence of reflux esophagitis|15
144551|NCT00634114|460058|P1|Overall Study|Recurrence of reflux esophagitis|5
144552|NCT00634114|460056|P3|Overall Study|Incorrect enrolment|0
144553|NCT00634114|460057|P2|Overall Study|Incorrect enrolment|1
144554|NCT00634114|460058|P1|Overall Study|Incorrect enrolment|0
144555|NCT00634114|460056|P3|Overall Study|Pregnancy|0
144556|NCT00634114|460057|P2|Overall Study|Pregnancy|0
144557|NCT00634114|460058|P1|Overall Study|Pregnancy|1
144558|NCT00634114|460056|P3|Overall Study|Protocol Violation|1
144559|NCT00634114|460057|P2|Overall Study|Protocol Violation|3
144560|NCT00634114|460058|P1|Overall Study|Protocol Violation|3
144561|NCT00634114|460056|P3|Overall Study|Lost to Follow-up|1
144562|NCT00634114|460057|P2|Overall Study|Lost to Follow-up|0
144563|NCT00634114|460058|P1|Overall Study|Lost to Follow-up|0
144564|NCT00634114|460056|P3|Overall Study|Withdrawal by Subject|11
144565|NCT00634114|460057|P2|Overall Study|Withdrawal by Subject|6
144566|NCT00634114|460058|P1|Overall Study|Withdrawal by Subject|9
144567|NCT00634114|460056|P3|Overall Study|Adverse Event|3
144568|NCT00634114|460057|P2|Overall Study|Adverse Event|8
144569|NCT00634114|460058|P1|Overall Study|Adverse Event|6
144570|NCT00634179|460081|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
144571|NCT00634244|460091|P3|Overall Study|Other complicating disease|0
144572|NCT00634244|460092|P2|Overall Study|Other complicating disease|1
144573|NCT00634244|460093|P1|Overall Study|Other complicating disease|0
144574|NCT00634244|460091|P3|Overall Study|Disease progression/relapse|0
144575|NCT00634244|460092|P2|Overall Study|Disease progression/relapse|1
144576|NCT00634244|460093|P1|Overall Study|Disease progression/relapse|0
144577|NCT00634244|460091|P3|Overall Study|Physician Decision|0
144578|NCT00634244|460092|P2|Overall Study|Physician Decision|1
144579|NCT00634244|460093|P1|Overall Study|Physician Decision|0
144580|NCT00634244|460091|P3|Overall Study|Withdrawal by Subject|0
144581|NCT00634244|460092|P2|Overall Study|Withdrawal by Subject|1
144582|NCT00634244|460093|P1|Overall Study|Withdrawal by Subject|0
144583|NCT00634244|460091|P3|Overall Study|Adverse Event|0
144584|NCT00634244|460092|P2|Overall Study|Adverse Event|2
144585|NCT00634244|460093|P1|Overall Study|Adverse Event|0
144586|NCT00634244|460091|P3|Overall Study|Death|0
144587|NCT00634244|460092|P2|Overall Study|Death|6
144588|NCT00634244|460093|P1|Overall Study|Death|1
144589|NCT00634244|460091|P3|Overall Study|Never started treatment|0
144590|NCT00634244|460092|P2|Overall Study|Never started treatment|1
144591|NCT00634244|460093|P1|Overall Study|Never started treatment|0
144592|NCT00634504|460146|P2|Overall Study|Protocol Violation|0
144593|NCT00634504|460147|P1|Overall Study|Protocol Violation|1
144594|NCT00634543|460155|P2|Overall Study|Lost to Follow-up|1
144595|NCT00634543|460156|P1|Overall Study|Lost to Follow-up|0
144596|NCT00634543|460155|P2|Overall Study|Withdrawal by Subject|4
144597|NCT00634543|460156|P1|Overall Study|Withdrawal by Subject|4
144598|NCT00634543|460155|P2|Overall Study|Adverse Event|11
144599|NCT00634543|460156|P1|Overall Study|Adverse Event|11
144600|NCT00634543|460155|P2|Overall Study|Protocol Violation|3
144601|NCT00634543|460156|P1|Overall Study|Protocol Violation|3
144602|NCT00634543|460155|P2|Overall Study|Unspecified|2
144603|NCT00634543|460156|P1|Overall Study|Unspecified|1
144604|NCT00634569|460174|P2|Overall Study|Physician Decision|1
144605|NCT00634569|460175|P1|Overall Study|Physician Decision|0
144606|NCT00634569|460174|P2|Overall Study|Withdrawal by Subject|4
144607|NCT00634569|460175|P1|Overall Study|Withdrawal by Subject|0
144608|NCT00634647|460199|P1|Overall Study|declined to participate before treatment|1
144609|NCT00634647|460199|P1|Overall Study|refused further treatment|3
144610|NCT00634647|460199|P1|Overall Study|death on study|5
144611|NCT00634751|460208|P4|Pancreatic and Bilial Tract Cancer|Death|1
144612|NCT00634751|460209|P3|Pancreatic and Bilial Tract Cancer|Death|1
144613|NCT00634751|460210|P2|Pancreatic and Bilial Tract Cancer|Death|0
144614|NCT00634751|460211|P1|Pancreatic and Bilial Tract Cancer|Death|0
144615|NCT00634751|460208|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
144616|NCT00634751|460209|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
144617|NCT00634751|460210|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
144618|NCT00634751|460211|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
144619|NCT00634751|460208|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
144620|NCT00634751|460209|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
144621|NCT00634751|460210|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
144622|NCT00634751|460211|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
144623|NCT00634842|460231|P2|Overall Study|Subject off study drug for too long|1
144869|NCT00626522|460532|P1|Overall Study|Inconsistent reason reported|1
144624|NCT00634842|460232|P1|Overall Study|Subject off study drug for too long|0
144625|NCT00634842|460231|P2|Overall Study|No wish to keep taking Avandia|1
144626|NCT00634842|460232|P1|Overall Study|No wish to keep taking Avandia|0
144627|NCT00634842|460231|P2|Overall Study|No need of study drug to treat diabetes|1
144628|NCT00634842|460232|P1|Overall Study|No need of study drug to treat diabetes|0
144629|NCT00634842|460231|P2|Overall Study|Discontinued due to injection|2
144630|NCT00634842|460232|P1|Overall Study|Discontinued due to injection|0
144631|NCT00634842|460231|P2|Overall Study|Lack of time and intolerance to drug|1
144632|NCT00634842|460232|P1|Overall Study|Lack of time and intolerance to drug|0
144633|NCT00634842|460231|P2|Overall Study|Withdrawal by Subject|3
144634|NCT00634842|460232|P1|Overall Study|Withdrawal by Subject|1
144635|NCT00634842|460231|P2|Overall Study|Physician Decision|0
144636|NCT00634842|460232|P1|Overall Study|Physician Decision|1
144637|NCT00634842|460231|P2|Overall Study|Lost to Follow-up|2
144638|NCT00634842|460232|P1|Overall Study|Lost to Follow-up|1
144639|NCT00634842|460231|P2|Overall Study|Inclusion criteria were not met|0
144640|NCT00634842|460232|P1|Overall Study|Inclusion criteria were not met|1
144641|NCT00634842|460231|P2|Overall Study|Move to another state|0
144642|NCT00634842|460232|P1|Overall Study|Move to another state|1
144643|NCT00634842|460231|P2|Overall Study|Protocol Violation|4
144644|NCT00634842|460232|P1|Overall Study|Protocol Violation|8
144645|NCT00634842|460231|P2|Overall Study|Adverse Event|3
144646|NCT00634842|460232|P1|Overall Study|Adverse Event|2
144647|NCT00634907|460246|P2|Overall Study|Withdrawal by Subject|8
144648|NCT00634907|460247|P1|Overall Study|Withdrawal by Subject|11
144649|NCT00634907|460246|P2|Overall Study|Physician Decision|9
144650|NCT00634907|460247|P1|Overall Study|Physician Decision|3
144651|NCT00634907|460246|P2|Overall Study|Withdrawal by Subject|0
144652|NCT00634907|460247|P1|Overall Study|Withdrawal by Subject|3
144653|NCT00634920|460272|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
144654|NCT00634920|460273|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
144655|NCT00634920|460274|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
144656|NCT00634920|460272|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
144657|NCT00634920|460273|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
144658|NCT00634920|460274|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
144659|NCT00634920|460272|P3|Period 2 - Post-Randomization|Death|0
144660|NCT00634920|460273|P2|Period 2 - Post-Randomization|Death|5
144661|NCT00634920|460274|P1|Period 2 - Post-Randomization|Death|2
144662|NCT00634920|460272|P3|Period 2 - Post-Randomization|Rejection|0
144663|NCT00634920|460273|P2|Period 2 - Post-Randomization|Rejection|5
144664|NCT00634920|460274|P1|Period 2 - Post-Randomization|Rejection|11
144665|NCT00634920|460272|P3|Period 2 - Post-Randomization|Adverse Event|0
144666|NCT00634920|460273|P2|Period 2 - Post-Randomization|Adverse Event|9
144667|NCT00634920|460274|P1|Period 2 - Post-Randomization|Adverse Event|37
144668|NCT00634920|460272|P3|Period 1 - Pre-Randomization|Other issues|6
144669|NCT00634920|460273|P2|Period 1 - Pre-Randomization|Other issues|0
144670|NCT00634920|460274|P1|Period 1 - Pre-Randomization|Other issues|0
144671|NCT00634920|460272|P3|Period 1 - Pre-Randomization|Non-Compliance|3
144672|NCT00634920|460273|P2|Period 1 - Pre-Randomization|Non-Compliance|0
144673|NCT00634920|460274|P1|Period 1 - Pre-Randomization|Non-Compliance|0
144674|NCT00634920|460272|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
144675|NCT00634920|460273|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
144676|NCT00634920|460274|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
144677|NCT00634920|460272|P3|Period 1 - Pre-Randomization|Rejections|55
144678|NCT00634920|460273|P2|Period 1 - Pre-Randomization|Rejections|0
144679|NCT00634920|460274|P1|Period 1 - Pre-Randomization|Rejections|0
144680|NCT00634920|460272|P3|Period 1 - Pre-Randomization|Wound healing problems|16
144681|NCT00634920|460273|P2|Period 1 - Pre-Randomization|Wound healing problems|0
144682|NCT00634920|460274|P1|Period 1 - Pre-Randomization|Wound healing problems|0
144683|NCT00634920|460272|P3|Period 1 - Pre-Randomization|Adverse Event|36
144684|NCT00634920|460273|P2|Period 1 - Pre-Randomization|Adverse Event|0
144685|NCT00634920|460274|P1|Period 1 - Pre-Randomization|Adverse Event|0
144686|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Unspecified|1
144687|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Unspecified|0
144688|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Unspecified|5
144689|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Unspecified|0
144690|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Unspecified|0
144691|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
144692|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
144693|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
144694|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
144695|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
144696|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
144697|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
144698|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
144699|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
144700|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
144701|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Protocol Violation|1
144702|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Protocol Violation|0
144703|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Protocol Violation|0
144704|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Protocol Violation|0
144705|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Protocol Violation|0
144706|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Physician Decision|0
144707|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Physician Decision|0
144708|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Physician Decision|1
144709|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Physician Decision|1
144710|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Physician Decision|0
144711|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
144712|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
144713|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
144714|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
144715|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
144716|NCT00634933|460319|P5|Part B: Week 24 to Week 52|Adverse Event|0
144717|NCT00634933|460320|P4|Part B: Week 24 to Week 52|Adverse Event|1
144718|NCT00634933|460321|P3|Part B: Week 24 to Week 52|Adverse Event|1
144719|NCT00634933|460322|P2|Part B: Week 24 to Week 52|Adverse Event|1
144720|NCT00634933|460323|P1|Part B: Week 24 to Week 52|Adverse Event|0
144721|NCT00634933|460319|P5|Between Part A and Part B|Physician Decision|0
144722|NCT00634933|460320|P4|Between Part A and Part B|Physician Decision|0
144723|NCT00634933|460321|P3|Between Part A and Part B|Physician Decision|0
144724|NCT00634933|460322|P2|Between Part A and Part B|Physician Decision|1
144725|NCT00634933|460323|P1|Between Part A and Part B|Physician Decision|0
144726|NCT00634933|460319|P5|Part A: Baseline to Week 24|Unspecified|0
144727|NCT00634933|460320|P4|Part A: Baseline to Week 24|Unspecified|0
144728|NCT00634933|460321|P3|Part A: Baseline to Week 24|Unspecified|5
144729|NCT00634933|460322|P2|Part A: Baseline to Week 24|Unspecified|8
144730|NCT00634933|460323|P1|Part A: Baseline to Week 24|Unspecified|1
144731|NCT00634933|460319|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
144732|NCT00634933|460320|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
144733|NCT00634933|460321|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
144734|NCT00634933|460322|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
144735|NCT00634933|460323|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
144736|NCT00634933|460319|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
144737|NCT00634933|460320|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
144738|NCT00634933|460321|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
144739|NCT00634933|460322|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
144740|NCT00634933|460323|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
144741|NCT00634933|460319|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
144742|NCT00634933|460320|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
144743|NCT00634933|460321|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
144744|NCT00634933|460322|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
144745|NCT00634933|460323|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
144746|NCT00634933|460319|P5|Part A: Baseline to Week 24|Investigator Request|0
144747|NCT00634933|460320|P4|Part A: Baseline to Week 24|Investigator Request|0
144748|NCT00634933|460321|P3|Part A: Baseline to Week 24|Investigator Request|1
144749|NCT00634933|460322|P2|Part A: Baseline to Week 24|Investigator Request|1
144750|NCT00634933|460323|P1|Part A: Baseline to Week 24|Investigator Request|1
144751|NCT00634933|460319|P5|Part A: Baseline to Week 24|Failed to Return|0
144752|NCT00634933|460320|P4|Part A: Baseline to Week 24|Failed to Return|0
144753|NCT00634933|460321|P3|Part A: Baseline to Week 24|Failed to Return|0
144754|NCT00634933|460322|P2|Part A: Baseline to Week 24|Failed to Return|0
144755|NCT00634933|460323|P1|Part A: Baseline to Week 24|Failed to Return|1
144756|NCT00634933|460319|P5|Part A: Baseline to Week 24|Death|0
144757|NCT00634933|460320|P4|Part A: Baseline to Week 24|Death|0
144758|NCT00634933|460321|P3|Part A: Baseline to Week 24|Death|0
144759|NCT00634933|460322|P2|Part A: Baseline to Week 24|Death|0
144760|NCT00634933|460323|P1|Part A: Baseline to Week 24|Death|1
144761|NCT00634933|460319|P5|Part A: Baseline to Week 24|Adverse Event|0
144762|NCT00634933|460320|P4|Part A: Baseline to Week 24|Adverse Event|0
144763|NCT00634933|460321|P3|Part A: Baseline to Week 24|Adverse Event|8
144764|NCT00634933|460322|P2|Part A: Baseline to Week 24|Adverse Event|4
144765|NCT00634933|460323|P1|Part A: Baseline to Week 24|Adverse Event|4
144766|NCT00626275|460393|P8|Part B|Withdrawal by Subject|1
144767|NCT00626275|460394|P7|Part B|Withdrawal by Subject|0
144768|NCT00626275|460395|P6|Part B|Withdrawal by Subject|0
144769|NCT00626275|460396|P5|Part B|Withdrawal by Subject|0
144770|NCT00626275|460397|P4|Part B|Withdrawal by Subject|0
144771|NCT00626275|460398|P3|Part B|Withdrawal by Subject|0
144772|NCT00626275|460399|P2|Part B|Withdrawal by Subject|0
144773|NCT00626275|460400|P1|Part B|Withdrawal by Subject|0
144774|NCT00626275|460393|P8|Part B|Lost to Follow-up|0
144775|NCT00626275|460394|P7|Part B|Lost to Follow-up|1
144776|NCT00626275|460395|P6|Part B|Lost to Follow-up|0
144777|NCT00626275|460396|P5|Part B|Lost to Follow-up|0
144778|NCT00626275|460397|P4|Part B|Lost to Follow-up|0
144779|NCT00626275|460398|P3|Part B|Lost to Follow-up|0
144780|NCT00626275|460399|P2|Part B|Lost to Follow-up|0
144781|NCT00626275|460400|P1|Part B|Lost to Follow-up|0
144782|NCT00626275|460393|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
144783|NCT00626275|460394|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
144784|NCT00626275|460395|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
144785|NCT00626275|460396|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
144786|NCT00626275|460397|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
144787|NCT00626275|460398|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
144788|NCT00626275|460399|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
144789|NCT00626275|460400|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
144790|NCT00626275|460393|P8|Part A - Treatment Period 1|Adverse Event|0
144791|NCT00626275|460394|P7|Part A - Treatment Period 1|Adverse Event|0
144792|NCT00626275|460395|P6|Part A - Treatment Period 1|Adverse Event|0
144793|NCT00626275|460396|P5|Part A - Treatment Period 1|Adverse Event|0
144794|NCT00626275|460397|P4|Part A - Treatment Period 1|Adverse Event|0
144795|NCT00626275|460398|P3|Part A - Treatment Period 1|Adverse Event|0
144796|NCT00626275|460399|P2|Part A - Treatment Period 1|Adverse Event|0
144797|NCT00626275|460400|P1|Part A - Treatment Period 1|Adverse Event|1
144798|NCT00626327|460443|P3|Overall Study|Protocol Violation|26
144799|NCT00626327|460444|P2|Overall Study|Protocol Violation|4
144800|NCT00626327|460445|P1|Overall Study|Protocol Violation|26
144801|NCT00626327|460443|P3|Overall Study|Administrative Reason|6
144802|NCT00626327|460444|P2|Overall Study|Administrative Reason|0
144803|NCT00626327|460445|P1|Overall Study|Administrative Reason|2
144804|NCT00626327|460443|P3|Overall Study|Inappropriate enrollment|3
144805|NCT00626327|460444|P2|Overall Study|Inappropriate enrollment|5
144806|NCT00626327|460445|P1|Overall Study|Inappropriate enrollment|4
144807|NCT00626327|460443|P3|Overall Study|Lost to Follow-up|23
144808|NCT00626327|460444|P2|Overall Study|Lost to Follow-up|21
144809|NCT00626327|460445|P1|Overall Study|Lost to Follow-up|24
144810|NCT00626327|460443|P3|Overall Study|Adverse Event|0
144811|NCT00626327|460444|P2|Overall Study|Adverse Event|0
144812|NCT00626327|460445|P1|Overall Study|Adverse Event|1
144813|NCT00626327|460443|P3|Overall Study|Withdrawal by Subject|30
144814|NCT00626327|460444|P2|Overall Study|Withdrawal by Subject|29
144815|NCT00626327|460445|P1|Overall Study|Withdrawal by Subject|21
144816|NCT00626392|460481|P6|Coadministration Period|Other|1
144817|NCT00626392|460482|P5|Coadministration Period|Other|1
144818|NCT00626392|460483|P4|Coadministration Period|Other|1
144819|NCT00626392|460484|P3|Coadministration Period|Other|3
144820|NCT00626392|460485|P2|Coadministration Period|Other|2
144821|NCT00626392|460486|P1|Coadministration Period|Other|0
144822|NCT00626392|460481|P6|Coadministration Period|Protocol Violation|0
144823|NCT00626392|460482|P5|Coadministration Period|Protocol Violation|1
144824|NCT00626392|460483|P4|Coadministration Period|Protocol Violation|1
144825|NCT00626392|460484|P3|Coadministration Period|Protocol Violation|0
144826|NCT00626392|460485|P2|Coadministration Period|Protocol Violation|1
144827|NCT00626392|460486|P1|Coadministration Period|Protocol Violation|0
144828|NCT00626392|460481|P6|Coadministration Period|Withdrawal by Subject|1
144829|NCT00626392|460482|P5|Coadministration Period|Withdrawal by Subject|0
144830|NCT00626392|460483|P4|Coadministration Period|Withdrawal by Subject|1
144831|NCT00626392|460484|P3|Coadministration Period|Withdrawal by Subject|0
144832|NCT00626392|460485|P2|Coadministration Period|Withdrawal by Subject|1
144833|NCT00626392|460486|P1|Coadministration Period|Withdrawal by Subject|1
144834|NCT00626392|460481|P6|Coadministration Period|Adverse Event|4
144835|NCT00626392|460482|P5|Coadministration Period|Adverse Event|3
144836|NCT00626392|460483|P4|Coadministration Period|Adverse Event|4
144837|NCT00626392|460484|P3|Coadministration Period|Adverse Event|7
144838|NCT00626392|460485|P2|Coadministration Period|Adverse Event|1
144839|NCT00626392|460486|P1|Coadministration Period|Adverse Event|3
144840|NCT00626392|460481|P6|Run-in Period|Noncompliance|0
144841|NCT00626392|460482|P5|Run-in Period|Noncompliance|0
144842|NCT00626392|460483|P4|Run-in Period|Noncompliance|0
144843|NCT00626392|460484|P3|Run-in Period|Noncompliance|1
144844|NCT00626392|460485|P2|Run-in Period|Noncompliance|0
144845|NCT00626392|460486|P1|Run-in Period|Noncompliance|1
144846|NCT00626392|460481|P6|Run-in Period|Withdrawal by Subject|1
144847|NCT00626392|460482|P5|Run-in Period|Withdrawal by Subject|3
144848|NCT00626392|460483|P4|Run-in Period|Withdrawal by Subject|1
144849|NCT00626392|460484|P3|Run-in Period|Withdrawal by Subject|1
144850|NCT00626392|460485|P2|Run-in Period|Withdrawal by Subject|1
144851|NCT00626392|460486|P1|Run-in Period|Withdrawal by Subject|0
144852|NCT00626392|460481|P6|Run-in Period|Adverse Event|0
144853|NCT00626392|460482|P5|Run-in Period|Adverse Event|1
144854|NCT00626392|460483|P4|Run-in Period|Adverse Event|0
144855|NCT00626392|460484|P3|Run-in Period|Adverse Event|1
144856|NCT00626392|460485|P2|Run-in Period|Adverse Event|0
144857|NCT00626392|460486|P1|Run-in Period|Adverse Event|0
144858|NCT00626522|460527|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
144859|NCT00626522|460528|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
144860|NCT00626522|460529|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
144861|NCT00626522|460530|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
144862|NCT00626522|460531|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
144863|NCT00626522|460532|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
144864|NCT00626522|460527|P6|Overall Study|Inconsistent reason reported|0
144865|NCT00626522|460528|P5|Overall Study|Inconsistent reason reported|0
144866|NCT00626522|460529|P4|Overall Study|Inconsistent reason reported|0
144867|NCT00626522|460530|P3|Overall Study|Inconsistent reason reported|0
144868|NCT00626522|460531|P2|Overall Study|Inconsistent reason reported|0
144870|NCT00626522|460527|P6|Overall Study|Lost to Follow-up|0
144871|NCT00626522|460528|P5|Overall Study|Lost to Follow-up|0
144872|NCT00626522|460529|P4|Overall Study|Lost to Follow-up|0
144873|NCT00626522|460530|P3|Overall Study|Lost to Follow-up|0
144874|NCT00626522|460531|P2|Overall Study|Lost to Follow-up|1
144875|NCT00626522|460532|P1|Overall Study|Lost to Follow-up|0
144876|NCT00626522|460527|P6|Overall Study|COPD exacerbation|0
144877|NCT00626522|460528|P5|Overall Study|COPD exacerbation|1
144878|NCT00626522|460529|P4|Overall Study|COPD exacerbation|1
144879|NCT00626522|460530|P3|Overall Study|COPD exacerbation|0
144880|NCT00626522|460531|P2|Overall Study|COPD exacerbation|0
144881|NCT00626522|460532|P1|Overall Study|COPD exacerbation|0
144882|NCT00626522|460527|P6|Overall Study|Withdrawal by Subject|1
144883|NCT00626522|460528|P5|Overall Study|Withdrawal by Subject|4
144884|NCT00626522|460529|P4|Overall Study|Withdrawal by Subject|0
144885|NCT00626522|460530|P3|Overall Study|Withdrawal by Subject|5
144886|NCT00626522|460531|P2|Overall Study|Withdrawal by Subject|5
144887|NCT00626522|460532|P1|Overall Study|Withdrawal by Subject|2
144888|NCT00626522|460527|P6|Overall Study|Adverse Event|1
144889|NCT00626522|460528|P5|Overall Study|Adverse Event|1
144890|NCT00626522|460529|P4|Overall Study|Adverse Event|0
144891|NCT00626522|460530|P3|Overall Study|Adverse Event|2
144892|NCT00626522|460531|P2|Overall Study|Adverse Event|1
144893|NCT00626522|460532|P1|Overall Study|Adverse Event|2
144894|NCT00626522|460527|P6|Overall Study|Protocol Violation|0
144895|NCT00626522|460528|P5|Overall Study|Protocol Violation|1
144896|NCT00626522|460529|P4|Overall Study|Protocol Violation|0
144897|NCT00626522|460530|P3|Overall Study|Protocol Violation|0
144898|NCT00626522|460531|P2|Overall Study|Protocol Violation|0
144899|NCT00626522|460532|P1|Overall Study|Protocol Violation|0
144900|NCT00626548|460572|P2|Overall Study|Other termination reason|613
144901|NCT00626548|460573|P1|Overall Study|Other termination reason|493
144902|NCT00626548|460572|P2|Overall Study|Lost to Follow-up|2
144903|NCT00626548|460573|P1|Overall Study|Lost to Follow-up|2
144904|NCT00626548|460572|P2|Overall Study|Protocol Violation|11
144905|NCT00626548|460573|P1|Overall Study|Protocol Violation|4
144906|NCT00626548|460572|P2|Overall Study|Withdrawal by Subject|46
144907|NCT00626548|460573|P1|Overall Study|Withdrawal by Subject|42
144908|NCT00626548|460572|P2|Overall Study|Adverse Event|44
144909|NCT00626548|460573|P1|Overall Study|Adverse Event|164
144910|NCT00626561|460581|P1|Overall Study|Disease Progression|2
144911|NCT00626561|460581|P1|Overall Study|Withdrawal by Subject|2
144912|NCT00626639|460596|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
144913|NCT00626639|460597|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
144914|NCT00627016|460617|P2|Overall Study|Pregnancy|0
144915|NCT00627016|460618|P1|Overall Study|Pregnancy|1
144916|NCT00627016|460617|P2|Overall Study|Placed on Excluded Drugs|0
144917|NCT00627016|460618|P1|Overall Study|Placed on Excluded Drugs|1
144918|NCT00627016|460617|P2|Overall Study|Lack of Efficacy|0
144919|NCT00627016|460618|P1|Overall Study|Lack of Efficacy|1
144920|NCT00627016|460617|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
144921|NCT00627016|460618|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
144922|NCT00627016|460617|P2|Overall Study|Withdrawal by Subject|1
144923|NCT00627016|460618|P1|Overall Study|Withdrawal by Subject|2
144924|NCT00627016|460617|P2|Overall Study|Lost to Follow-up|1
144925|NCT00627016|460618|P1|Overall Study|Lost to Follow-up|0
144926|NCT00627016|460617|P2|Overall Study|Protocol Violation|2
144927|NCT00627016|460618|P1|Overall Study|Protocol Violation|0
144928|NCT00627016|460617|P2|Overall Study|Adverse Event|1
144929|NCT00627016|460618|P1|Overall Study|Adverse Event|1
144930|NCT00627042|460628|P1|Overall Study|Withdrawal by Subject|2
144931|NCT00627094|460640|P2|Overall Study|Other reason|0
144932|NCT00627094|460641|P1|Overall Study|Other reason|1
144933|NCT00627094|460640|P2|Overall Study|ulcer healed|7
144934|NCT00627094|460641|P1|Overall Study|ulcer healed|1
144935|NCT00627094|460640|P2|Overall Study|Withdrawal by Subject|1
144936|NCT00627094|460641|P1|Overall Study|Withdrawal by Subject|1
144937|NCT00627094|460640|P2|Overall Study|Lost to Follow-up|0
144938|NCT00627094|460641|P1|Overall Study|Lost to Follow-up|1
144939|NCT00627094|460640|P2|Overall Study|Adverse Event|7
144940|NCT00627094|460641|P1|Overall Study|Adverse Event|8
144941|NCT00627393|460655|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
144942|NCT00627393|460656|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
144943|NCT00627393|460655|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
144944|NCT00627393|460656|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
144945|NCT00627393|460655|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
144946|NCT00627393|460656|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
144947|NCT00627393|460655|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
144948|NCT00627393|460656|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
144949|NCT00627445|460698|P2|Overall Study|Other|8
144950|NCT00627445|460699|P1|Overall Study|Other|6
144951|NCT00627445|460698|P2|Overall Study|Lack of Efficacy|1
144952|NCT00627445|460699|P1|Overall Study|Lack of Efficacy|0
144953|NCT00627445|460698|P2|Overall Study|Adverse Event|3
144954|NCT00627445|460699|P1|Overall Study|Adverse Event|3
144955|NCT00627458|460722|P3|Overall Study|Lost to Follow-up|0
144956|NCT00627458|460723|P2|Overall Study|Lost to Follow-up|1
144957|NCT00627458|460724|P1|Overall Study|Lost to Follow-up|1
144958|NCT00627458|460722|P3|Overall Study|Withdrawal by Subject|5
144959|NCT00627458|460723|P2|Overall Study|Withdrawal by Subject|6
144960|NCT00627458|460724|P1|Overall Study|Withdrawal by Subject|2
144961|NCT00627458|460722|P3|Overall Study|Migrated from study area|1
144962|NCT00627458|460723|P2|Overall Study|Migrated from study area|0
144963|NCT00627458|460724|P1|Overall Study|Migrated from study area|1
144964|NCT00627497|460801|P4|Overall Study|Lost to Follow-up|0
144965|NCT00627497|460802|P3|Overall Study|Lost to Follow-up|0
144966|NCT00627497|460803|P2|Overall Study|Lost to Follow-up|1
144967|NCT00627497|460804|P1|Overall Study|Lost to Follow-up|1
144968|NCT00627523|460864|P2|Overall Study|Not specified|0
144969|NCT00627523|460865|P1|Overall Study|Not specified|1
144970|NCT00627523|460864|P2|Overall Study|Withdrawal by Subject|2
144971|NCT00627523|460865|P1|Overall Study|Withdrawal by Subject|0
144972|NCT00627523|460864|P2|Overall Study|Lack of Efficacy|0
144973|NCT00627523|460865|P1|Overall Study|Lack of Efficacy|1
144974|NCT00627705|460920|P2|Overall Study|Lost to Follow-up|1
144975|NCT00627705|460921|P1|Overall Study|Lost to Follow-up|0
144976|NCT00627705|460920|P2|Overall Study|Withdrawal by Subject|2
144977|NCT00627705|460921|P1|Overall Study|Withdrawal by Subject|0
144978|NCT00627705|460920|P2|Overall Study|Adverse Event|0
144979|NCT00627705|460921|P1|Overall Study|Adverse Event|1
144980|NCT00627705|460920|P2|Overall Study|Unwilling to take the compound (taste)|3
144981|NCT00627705|460921|P1|Overall Study|Unwilling to take the compound (taste)|1
144982|NCT00627926|460950|P3|Overall Study|Noncompliance/unspecified|17
144983|NCT00627926|460951|P2|Overall Study|Noncompliance/unspecified|23
144984|NCT00627926|460952|P1|Overall Study|Noncompliance/unspecified|8
144985|NCT00627926|460950|P3|Overall Study|Lack of Efficacy|38
144986|NCT00627926|460951|P2|Overall Study|Lack of Efficacy|40
144987|NCT00627926|460952|P1|Overall Study|Lack of Efficacy|118
144988|NCT00627926|460950|P3|Overall Study|Withdrawal by Subject|0
144989|NCT00627926|460951|P2|Overall Study|Withdrawal by Subject|1
144990|NCT00627926|460952|P1|Overall Study|Withdrawal by Subject|2
144991|NCT00627926|460950|P3|Overall Study|Lost to Follow-up|4
144992|NCT00627926|460951|P2|Overall Study|Lost to Follow-up|3
144993|NCT00627926|460952|P1|Overall Study|Lost to Follow-up|4
144994|NCT00627926|460950|P3|Overall Study|Death|0
144995|NCT00627926|460951|P2|Overall Study|Death|0
144996|NCT00627926|460952|P1|Overall Study|Death|1
144997|NCT00627926|460950|P3|Overall Study|Adverse Event|36
144998|NCT00627926|460951|P2|Overall Study|Adverse Event|37
144999|NCT00627926|460952|P1|Overall Study|Adverse Event|26
145000|NCT00628030|461007|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
145001|NCT00628030|461008|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
145002|NCT00628030|461007|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
145003|NCT00628030|461008|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
145004|NCT00628030|461007|P2|Baseline to Post-Assessment|Lost to Follow-up|29
145005|NCT00628030|461008|P1|Baseline to Post-Assessment|Lost to Follow-up|28
145006|NCT00628108|461024|P2|Overall Study|Withdrawal by Subject|0
145007|NCT00628108|461025|P1|Overall Study|Withdrawal by Subject|1
145008|NCT00628108|461024|P2|Overall Study|Adverse Event|3
145009|NCT00628108|461025|P1|Overall Study|Adverse Event|0
145010|NCT00628212|461083|P4|Overall Study|Physician Decision|3
145011|NCT00628212|461084|P3|Overall Study|Physician Decision|2
145012|NCT00628212|461085|P2|Overall Study|Physician Decision|1
145013|NCT00628212|461086|P1|Overall Study|Physician Decision|1
145014|NCT00628212|461083|P4|Overall Study|Adverse Event|2
145015|NCT00628212|461084|P3|Overall Study|Adverse Event|1
145016|NCT00628212|461085|P2|Overall Study|Adverse Event|0
145017|NCT00628212|461086|P1|Overall Study|Adverse Event|2
145018|NCT00628251|461111|P3|Cross-over/ Continuation of Olaparib|Other|0
145019|NCT00628251|461112|P2|Cross-over/ Continuation of Olaparib|Other|1
145020|NCT00628251|461113|P1|Cross-over/ Continuation of Olaparib|Other|1
145021|NCT00628251|461111|P3|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|4
145022|NCT00628251|461112|P2|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|2
145023|NCT00628251|461113|P1|Cross-over/ Continuation of Olaparib|Withdrawal by Subject|1
145024|NCT00628251|461111|P3|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|13
145025|NCT00628251|461112|P2|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|21
145026|NCT00628251|461113|P1|Cross-over/ Continuation of Olaparib|Condition under investigation worsened|24
145027|NCT00628251|461111|P3|Cross-over/ Continuation of Olaparib|Adverse Event|0
145028|NCT00628251|461112|P2|Cross-over/ Continuation of Olaparib|Adverse Event|2
145029|NCT00628251|461113|P1|Cross-over/ Continuation of Olaparib|Adverse Event|1
145030|NCT00628251|461111|P3|Randomised Part|Did not receive cross over treatment|8
145031|NCT00628251|461112|P2|Randomised Part|Did not receive cross over treatment|0
145032|NCT00628251|461113|P1|Randomised Part|Did not receive cross over treatment|0
145033|NCT00628355|461154|P2|Overall Study|Withdrawal by Subject|1
145034|NCT00628355|461155|P1|Overall Study|Withdrawal by Subject|1
145035|NCT00628446|461167|P1|Overall Study|Protocol Violation|3
145036|NCT00628446|461167|P1|Overall Study|Withdrawal by Subject|1
145037|NCT00628446|461167|P1|Overall Study|Lost to Follow-up|3
145038|NCT00628758|461202|P2|Overall Study|Treatment Failure|2
145039|NCT00628758|461203|P1|Overall Study|Treatment Failure|0
145040|NCT00628758|461202|P2|Overall Study|Investigator Moved|0
145041|NCT00628758|461203|P1|Overall Study|Investigator Moved|3
145042|NCT00628758|461202|P2|Overall Study|Pregnancy|2
145043|NCT00628758|461203|P1|Overall Study|Pregnancy|2
145044|NCT00628758|461202|P2|Overall Study|Lost to Follow-up|31
145045|NCT00628758|461203|P1|Overall Study|Lost to Follow-up|25
145046|NCT00628758|461202|P2|Overall Study|Protocol Violation|1
145047|NCT00628758|461203|P1|Overall Study|Protocol Violation|5
145048|NCT00628758|461202|P2|Overall Study|Death|0
145049|NCT00628758|461203|P1|Overall Study|Death|1
145050|NCT00628758|461202|P2|Overall Study|Withdrawal by Subject|3
145051|NCT00628758|461203|P1|Overall Study|Withdrawal by Subject|6
145052|NCT00628758|461202|P2|Overall Study|Adverse Event|3
145053|NCT00628758|461203|P1|Overall Study|Adverse Event|2
145054|NCT00628862|461218|P3|Overall Study|COPD Exacerbation|0
145055|NCT00628862|461219|P2|Overall Study|COPD Exacerbation|1
145056|NCT00628862|461220|P1|Overall Study|COPD Exacerbation|0
145057|NCT00628862|461218|P3|Overall Study|Protocol Violation|0
145058|NCT00628862|461219|P2|Overall Study|Protocol Violation|0
145059|NCT00628862|461220|P1|Overall Study|Protocol Violation|1
145060|NCT00628862|461218|P3|Overall Study|Lost to Follow-up|1
145061|NCT00628862|461219|P2|Overall Study|Lost to Follow-up|2
145062|NCT00628862|461220|P1|Overall Study|Lost to Follow-up|0
145063|NCT00628862|461218|P3|Overall Study|Withdrawal by Subject|11
145064|NCT00628862|461219|P2|Overall Study|Withdrawal by Subject|6
145065|NCT00628862|461220|P1|Overall Study|Withdrawal by Subject|4
145066|NCT00628862|461218|P3|Overall Study|Adverse Event|10
145067|NCT00628862|461219|P2|Overall Study|Adverse Event|8
145068|NCT00628862|461220|P1|Overall Study|Adverse Event|6
145069|NCT00628927|461297|P2|Overall Study|Equipment failure|0
145070|NCT00628927|461298|P1|Overall Study|Equipment failure|1
145071|NCT00628927|461297|P2|Overall Study|Lost to Follow-up|0
145072|NCT00628927|461298|P1|Overall Study|Lost to Follow-up|1
145073|NCT00628927|461297|P2|Overall Study|Problems performing blood draw|0
145074|NCT00628927|461298|P1|Overall Study|Problems performing blood draw|6
145075|NCT00629239|461322|P2|Overall Study|Physician Decision|0
145076|NCT00629239|461323|P1|Overall Study|Physician Decision|1
145077|NCT00629239|461322|P2|Overall Study|Adverse Event|4
145078|NCT00629239|461323|P1|Overall Study|Adverse Event|7
145079|NCT00629265|461357|P2|Overall Study|Unknown Reason|2
145080|NCT00629265|461358|P1|Overall Study|Unknown Reason|2
145081|NCT00629265|461357|P2|Overall Study|Unrelated Medical Complications|1
145082|NCT00629265|461358|P1|Overall Study|Unrelated Medical Complications|3
145083|NCT00629265|461357|P2|Overall Study|Needed Esophageal Dilation|1
145084|NCT00629265|461358|P1|Overall Study|Needed Esophageal Dilation|4
145085|NCT00629265|461357|P2|Overall Study|Other CA Requiring Treatment|3
145086|NCT00629265|461358|P1|Overall Study|Other CA Requiring Treatment|1
145087|NCT00629265|461357|P2|Overall Study|HNC Recurrence|0
145088|NCT00629265|461358|P1|Overall Study|HNC Recurrence|4
145089|NCT00629265|461357|P2|Overall Study|Adverse Event|0
145090|NCT00629265|461358|P1|Overall Study|Adverse Event|2
145091|NCT00629265|461357|P2|Overall Study|Death|0
145092|NCT00629265|461358|P1|Overall Study|Death|1
145093|NCT00629265|461357|P2|Overall Study|Withdrawal by Subject|8
145094|NCT00629265|461358|P1|Overall Study|Withdrawal by Subject|11
145095|NCT00629265|461357|P2|Overall Study|Lost to Follow-up|5
145096|NCT00629265|461358|P1|Overall Study|Lost to Follow-up|4
145097|NCT00635024|461370|P1|Overall Study|Adverse Event|1
145098|NCT00635050|461378|P1|Overall Study|Withdrawal by Subject|1
145099|NCT00635089|461385|P1|Overall Study|Not Specified|31
145100|NCT00635089|461385|P1|Overall Study|Lost to Follow-up|8
145101|NCT00635089|461385|P1|Overall Study|Protocol Deviation|4
145102|NCT00635089|461385|P1|Overall Study|Lack of Efficacy|28
145103|NCT00635089|461385|P1|Overall Study|Adverse Event|7
145104|NCT00635102|461414|P2|Overall Study|Withdrawal by Subject|8
145105|NCT00635102|461415|P1|Overall Study|Withdrawal by Subject|7
145106|NCT00635154|461540|P1|Overall Study|Still on treatment|21
145107|NCT00635154|461540|P1|Overall Study|Other|4
145108|NCT00635154|461540|P1|Overall Study|Alternative Treatment|8
145109|NCT00635219|461555|P5|Overall Study|Administrative or Other Reasons|1
145110|NCT00635219|461556|P4|Overall Study|Administrative or Other Reasons|0
145111|NCT00635219|461557|P3|Overall Study|Administrative or Other Reasons|1
145112|NCT00635219|461558|P2|Overall Study|Administrative or Other Reasons|1
145113|NCT00635219|461559|P1|Overall Study|Administrative or Other Reasons|0
145114|NCT00635219|461555|P5|Overall Study|Lost to Follow-up|3
145115|NCT00635219|461556|P4|Overall Study|Lost to Follow-up|0
145116|NCT00635219|461557|P3|Overall Study|Lost to Follow-up|2
145117|NCT00635219|461558|P2|Overall Study|Lost to Follow-up|0
145118|NCT00635219|461559|P1|Overall Study|Lost to Follow-up|0
145119|NCT00635219|461555|P5|Overall Study|Withdrawal of Consent|8
145120|NCT00635219|461556|P4|Overall Study|Withdrawal of Consent|11
145121|NCT00635219|461557|P3|Overall Study|Withdrawal of Consent|8
145122|NCT00635219|461558|P2|Overall Study|Withdrawal of Consent|6
145123|NCT00635219|461559|P1|Overall Study|Withdrawal of Consent|8
145124|NCT00635219|461555|P5|Overall Study|Protocol Violation|4
145125|NCT00635219|461556|P4|Overall Study|Protocol Violation|2
145126|NCT00635219|461557|P3|Overall Study|Protocol Violation|3
145127|NCT00635219|461558|P2|Overall Study|Protocol Violation|2
145128|NCT00635219|461559|P1|Overall Study|Protocol Violation|0
145129|NCT00635219|461555|P5|Overall Study|Non-compliance With Study Product|1
145130|NCT00635219|461556|P4|Overall Study|Non-compliance With Study Product|2
145131|NCT00635219|461557|P3|Overall Study|Non-compliance With Study Product|0
145132|NCT00635219|461558|P2|Overall Study|Non-compliance With Study Product|0
145133|NCT00635219|461559|P1|Overall Study|Non-compliance With Study Product|0
145134|NCT00635219|461555|P5|Overall Study|Lack of Efficacy|6
145135|NCT00635219|461556|P4|Overall Study|Lack of Efficacy|4
145136|NCT00635219|461557|P3|Overall Study|Lack of Efficacy|3
145137|NCT00635219|461558|P2|Overall Study|Lack of Efficacy|6
145138|NCT00635219|461559|P1|Overall Study|Lack of Efficacy|5
145139|NCT00635219|461555|P5|Overall Study|Adverse Event|19
145140|NCT00635219|461556|P4|Overall Study|Adverse Event|15
145141|NCT00635219|461557|P3|Overall Study|Adverse Event|18
145142|NCT00635219|461558|P2|Overall Study|Adverse Event|10
145143|NCT00635219|461559|P1|Overall Study|Adverse Event|12
145144|NCT00635661|461647|P1|Overall Study|Withdrawal by Subject|4
145145|NCT00635804|461668|P8|Overall Study|Withdrawal by Subject|0
145146|NCT00635804|461669|P7|Overall Study|Withdrawal by Subject|0
145147|NCT00635804|461670|P6|Overall Study|Withdrawal by Subject|0
145148|NCT00635804|461671|P5|Overall Study|Withdrawal by Subject|0
145149|NCT00635804|461672|P4|Overall Study|Withdrawal by Subject|0
145150|NCT00635804|461673|P3|Overall Study|Withdrawal by Subject|0
145151|NCT00635804|461674|P2|Overall Study|Withdrawal by Subject|0
145152|NCT00635804|461675|P1|Overall Study|Withdrawal by Subject|1
145153|NCT00635804|461668|P8|Overall Study|Adverse Event|0
145154|NCT00635804|461669|P7|Overall Study|Adverse Event|0
145155|NCT00635804|461670|P6|Overall Study|Adverse Event|1
145156|NCT00635804|461671|P5|Overall Study|Adverse Event|0
145157|NCT00635804|461672|P4|Overall Study|Adverse Event|0
145158|NCT00635804|461673|P3|Overall Study|Adverse Event|0
145159|NCT00635804|461674|P2|Overall Study|Adverse Event|0
145160|NCT00635804|461675|P1|Overall Study|Adverse Event|0
145161|NCT00635882|461838|P6|Overall Study|Protocol Violation|0
145162|NCT00635882|461839|P5|Overall Study|Protocol Violation|0
145163|NCT00635882|461840|P4|Overall Study|Protocol Violation|0
145164|NCT00635882|461841|P3|Overall Study|Protocol Violation|0
145165|NCT00635882|461842|P2|Overall Study|Protocol Violation|0
145166|NCT00635882|461843|P1|Overall Study|Protocol Violation|1
145167|NCT00636155|461938|P1|Overall Study|Physician Decision|5
145168|NCT00636155|461938|P1|Overall Study|Stem cell transplant|1
145169|NCT00636155|461938|P1|Overall Study|Withdrawal by Subject|3
145170|NCT00636155|461938|P1|Overall Study|Lack of Efficacy|1
145171|NCT00636155|461938|P1|Overall Study|Adverse Event|8
145172|NCT00636168|461946|P2|Treated With Study Drug|Still remains on treatment|94
145173|NCT00636168|461947|P1|Treated With Study Drug|Still remains on treatment|48
145174|NCT00636168|461946|P2|Treated With Study Drug|non-specified|1
145175|NCT00636168|461947|P1|Treated With Study Drug|non-specified|1
145176|NCT00636168|461946|P2|Treated With Study Drug|No longer meets criteria|0
145177|NCT00636168|461947|P1|Treated With Study Drug|No longer meets criteria|1
145178|NCT00636168|461946|P2|Treated With Study Drug|Pregnancy|0
145179|NCT00636168|461947|P1|Treated With Study Drug|Pregnancy|1
145180|NCT00636168|461946|P2|Treated With Study Drug|Death|0
145181|NCT00636168|461947|P1|Treated With Study Drug|Death|3
145182|NCT00636168|461946|P2|Treated With Study Drug|Poor or non-compliance|3
145183|NCT00636168|461947|P1|Treated With Study Drug|Poor or non-compliance|1
145184|NCT00636168|461946|P2|Treated With Study Drug|Withdrawal by Subject|20
145185|NCT00636168|461947|P1|Treated With Study Drug|Withdrawal by Subject|16
145186|NCT00636168|461946|P2|Treated With Study Drug|Adverse Event|20
145187|NCT00636168|461947|P1|Treated With Study Drug|Adverse Event|244
145188|NCT00636168|461946|P2|Treated With Study Drug|Recurrence of disease|273
145189|NCT00636168|461947|P1|Treated With Study Drug|Recurrence of disease|132
145190|NCT00636168|461946|P2|Randomized to Study Drug|No longer met study criteria|0
145191|NCT00636168|461947|P1|Randomized to Study Drug|No longer met study criteria|1
145192|NCT00636168|461946|P2|Randomized to Study Drug|Adverse Event|0
145193|NCT00636168|461947|P1|Randomized to Study Drug|Adverse Event|1
145194|NCT00636168|461946|P2|Randomized to Study Drug|Withdrawal by Subject|2
145195|NCT00636168|461947|P1|Randomized to Study Drug|Withdrawal by Subject|2
145196|NCT00636194|461969|P2|Overall Study|Protocol Violation|0
145197|NCT00636194|461970|P1|Overall Study|Protocol Violation|2
145198|NCT00636194|461969|P2|Overall Study|Study related symptoms and complaints|0
145199|NCT00636194|461970|P1|Overall Study|Study related symptoms and complaints|1
145200|NCT00636207|461983|P7|Overall Study|Withdrawal by Subject|0
145201|NCT00636207|461984|P6|Overall Study|Withdrawal by Subject|0
145202|NCT00636207|461985|P5|Overall Study|Withdrawal by Subject|1
145203|NCT00636207|461986|P4|Overall Study|Withdrawal by Subject|0
145204|NCT00636207|461987|P3|Overall Study|Withdrawal by Subject|0
145205|NCT00636207|461988|P2|Overall Study|Withdrawal by Subject|1
145206|NCT00636207|461989|P1|Overall Study|Withdrawal by Subject|0
145207|NCT00636207|461983|P7|Overall Study|Adverse Event|0
145208|NCT00636207|461984|P6|Overall Study|Adverse Event|0
145209|NCT00636207|461985|P5|Overall Study|Adverse Event|0
145210|NCT00636207|461986|P4|Overall Study|Adverse Event|0
145211|NCT00636207|461987|P3|Overall Study|Adverse Event|0
145212|NCT00636207|461988|P2|Overall Study|Adverse Event|0
145213|NCT00636207|461989|P1|Overall Study|Adverse Event|1
145214|NCT00636363|462058|P3|Overall Study|Withdrawal by Subject|2
145215|NCT00636363|462059|P2|Overall Study|Withdrawal by Subject|3
145216|NCT00636363|462060|P1|Overall Study|Withdrawal by Subject|1
145217|NCT00636363|462058|P3|Overall Study|Lost to Follow-up|2
145218|NCT00636363|462059|P2|Overall Study|Lost to Follow-up|4
145219|NCT00636363|462060|P1|Overall Study|Lost to Follow-up|3
145220|NCT00636363|462058|P3|Overall Study|Protocol Violation|0
145221|NCT00636363|462059|P2|Overall Study|Protocol Violation|3
145222|NCT00636363|462060|P1|Overall Study|Protocol Violation|0
145223|NCT00636363|462058|P3|Overall Study|Lack of motivation|1
145224|NCT00636363|462059|P2|Overall Study|Lack of motivation|0
145225|NCT00636363|462060|P1|Overall Study|Lack of motivation|1
145226|NCT00636363|462058|P3|Overall Study|Missed > 1 visit|3
145227|NCT00636363|462059|P2|Overall Study|Missed > 1 visit|1
145228|NCT00636363|462060|P1|Overall Study|Missed > 1 visit|0
145229|NCT00636363|462058|P3|Overall Study|Met ineligibility criteria|3
145230|NCT00636363|462059|P2|Overall Study|Met ineligibility criteria|0
145231|NCT00636363|462060|P1|Overall Study|Met ineligibility criteria|0
145232|NCT00636363|462058|P3|Overall Study|Study related symptoms/complaints|4
145233|NCT00636363|462059|P2|Overall Study|Study related symptoms/complaints|7
145234|NCT00636363|462060|P1|Overall Study|Study related symptoms/complaints|8
145235|NCT00636363|462058|P3|Overall Study|Positive slit lamp finding|1
145236|NCT00636363|462059|P2|Overall Study|Positive slit lamp finding|2
145237|NCT00636363|462060|P1|Overall Study|Positive slit lamp finding|0
145238|NCT00636363|462058|P3|Overall Study|Adverse Event|1
145239|NCT00636363|462059|P2|Overall Study|Adverse Event|0
145240|NCT00636363|462060|P1|Overall Study|Adverse Event|0
145241|NCT00636363|462058|P3|Overall Study|Conjunctivitis|1
145242|NCT00636363|462059|P2|Overall Study|Conjunctivitis|0
145243|NCT00636363|462060|P1|Overall Study|Conjunctivitis|0
145244|NCT00636441|462092|P7|Overall Study|Screen Failure|17
145245|NCT00636441|462093|P6|Overall Study|Screen Failure|0
145246|NCT00636441|462094|P5|Overall Study|Screen Failure|0
145247|NCT00636441|462095|P4|Overall Study|Screen Failure|0
145248|NCT00636441|462096|P3|Overall Study|Screen Failure|0
145249|NCT00636441|462097|P2|Overall Study|Screen Failure|0
145250|NCT00636441|462098|P1|Overall Study|Screen Failure|0
145251|NCT00636441|462092|P7|Overall Study|Late, ineligible|1
145252|NCT00636441|462093|P6|Overall Study|Late, ineligible|0
145253|NCT00636441|462094|P5|Overall Study|Late, ineligible|0
145254|NCT00636441|462095|P4|Overall Study|Late, ineligible|0
145255|NCT00636441|462096|P3|Overall Study|Late, ineligible|0
145256|NCT00636441|462097|P2|Overall Study|Late, ineligible|0
145257|NCT00636441|462098|P1|Overall Study|Late, ineligible|0
145258|NCT00636441|462092|P7|Overall Study|Adverse Event|0
145259|NCT00636441|462093|P6|Overall Study|Adverse Event|1
145260|NCT00636441|462094|P5|Overall Study|Adverse Event|0
145261|NCT00636441|462095|P4|Overall Study|Adverse Event|0
145262|NCT00636441|462096|P3|Overall Study|Adverse Event|1
145263|NCT00636441|462097|P2|Overall Study|Adverse Event|1
145264|NCT00636441|462098|P1|Overall Study|Adverse Event|0
145265|NCT00636610|462129|P2|Overall Study|Reason for discontinuation not available|2
145266|NCT00636610|462130|P1|Overall Study|Reason for discontinuation not available|3
145267|NCT00636610|462129|P2|Overall Study|Disease progression - clinical|3
145268|NCT00636610|462130|P1|Overall Study|Disease progression - clinical|8
145269|NCT00636610|462129|P2|Overall Study|Disease progression - radiographic|51
145270|NCT00636610|462130|P1|Overall Study|Disease progression - radiographic|41
145271|NCT00636610|462129|P2|Overall Study|Subject decision to withdraw|11
145272|NCT00636610|462130|P1|Overall Study|Subject decision to withdraw|15
145273|NCT00636610|462129|P2|Overall Study|Physician decision to withdraw patient|9
145274|NCT00636610|462130|P1|Overall Study|Physician decision to withdraw patient|15
145275|NCT00636610|462129|P2|Overall Study|Death|3
145276|NCT00636610|462130|P1|Overall Study|Death|6
145277|NCT00636610|462129|P2|Overall Study|Adverse Event|4
145278|NCT00636610|462130|P1|Overall Study|Adverse Event|4
145279|NCT00636636|462142|P2|Overall Study|Withdrawal by Subject|9
145280|NCT00636636|462143|P1|Overall Study|Withdrawal by Subject|4
145281|NCT00636636|462142|P2|Overall Study|Death|1
145282|NCT00636636|462143|P1|Overall Study|Death|0
145283|NCT00636636|462142|P2|Overall Study|Lost to Follow-up|1
145284|NCT00636636|462143|P1|Overall Study|Lost to Follow-up|0
145285|NCT00636636|462142|P2|Overall Study|Protocol Violation|2
145286|NCT00636636|462143|P1|Overall Study|Protocol Violation|2
145287|NCT00636636|462142|P2|Overall Study|Lack of Efficacy|12
145288|NCT00636636|462143|P1|Overall Study|Lack of Efficacy|7
145289|NCT00636636|462142|P2|Overall Study|Adverse Event|8
145290|NCT00636636|462143|P1|Overall Study|Adverse Event|19
145291|NCT00636636|462142|P2|Overall Study|Other reason|6
145292|NCT00636636|462143|P1|Overall Study|Other reason|4
145293|NCT00636792|462197|P1|Overall Study|Other|3
145294|NCT00636792|462197|P1|Overall Study|Withdrawal by Subject|3
145295|NCT00636792|462197|P1|Overall Study|Progressive Disease|4
145296|NCT00636792|462197|P1|Overall Study|Physician Decision|7
145297|NCT00636792|462197|P1|Overall Study|Adverse Event|16
145298|NCT00636818|462212|P1|Overall Study|Withdrawal by Subject|4
145299|NCT00636818|462212|P1|Overall Study|Protocol Violation|1
145300|NCT00636818|462212|P1|Overall Study|Entry Criteria Exclusion|3
145301|NCT00636818|462212|P1|Overall Study|Lost to Follow-up|2
145302|NCT00636818|462212|P1|Overall Study|Adverse Event|1
145303|NCT00636961|462229|P2|Period 2|Adverse Event|0
145304|NCT00636961|462230|P1|Period 2|Adverse Event|1
145305|NCT00636961|462229|P2|Period 1|Administrative problems|1
145306|NCT00636961|462230|P1|Period 1|Administrative problems|1
145307|NCT00636987|462244|P1|Overall Study|5 year visit window not complete|69
145308|NCT00636987|462244|P1|Overall Study|Lost to Follow-up|63
145309|NCT00636987|462244|P1|Overall Study|Explanted|13
145310|NCT00636987|462244|P1|Overall Study|Death|44
145311|NCT00637000|462254|P2|Overall Study|Withdrawal by Subject|3
145312|NCT00637000|462255|P1|Overall Study|Withdrawal by Subject|4
145313|NCT00637156|462297|P2|Overall Study|Lost to Follow-up|16
145314|NCT00637156|462298|P1|Overall Study|Lost to Follow-up|10
145315|NCT00637156|462297|P2|Overall Study|Death|1
145316|NCT00637156|462298|P1|Overall Study|Death|0
145317|NCT00637156|462297|P2|Overall Study|Withdrawal by Subject|7
145318|NCT00637156|462298|P1|Overall Study|Withdrawal by Subject|0
145319|NCT00637195|462340|P2|Overall Study|Withdrawal by Subject|1
145320|NCT00637195|462341|P1|Overall Study|Withdrawal by Subject|0
145321|NCT00637195|462340|P2|Overall Study|Other|0
145322|NCT00637195|462341|P1|Overall Study|Other|2
145323|NCT00637195|462340|P2|Overall Study|Lost to Follow-up|0
145324|NCT00637195|462341|P1|Overall Study|Lost to Follow-up|1
145325|NCT00637273|462391|P3|Overall Study|Loss of Glucose Control|1
145326|NCT00637273|462392|P2|Overall Study|Loss of Glucose Control|1
145327|NCT00637273|462393|P1|Overall Study|Loss of Glucose Control|1
145328|NCT00637273|462391|P3|Overall Study|Administrative|0
145329|NCT00637273|462392|P2|Overall Study|Administrative|0
145330|NCT00637273|462393|P1|Overall Study|Administrative|2
145331|NCT00637273|462391|P3|Overall Study|Investigator Decision|1
145332|NCT00637273|462392|P2|Overall Study|Investigator Decision|3
145333|NCT00637273|462393|P1|Overall Study|Investigator Decision|1
145334|NCT00637273|462391|P3|Overall Study|Withdrawal of Consent|18
145335|NCT00637273|462392|P2|Overall Study|Withdrawal of Consent|6
145336|NCT00637273|462393|P1|Overall Study|Withdrawal of Consent|18
145337|NCT00637273|462391|P3|Overall Study|Protocol Violation|1
145338|NCT00637273|462392|P2|Overall Study|Protocol Violation|4
145339|NCT00637273|462393|P1|Overall Study|Protocol Violation|2
145340|NCT00637273|462391|P3|Overall Study|Lost to Follow-up|13
145341|NCT00637273|462392|P2|Overall Study|Lost to Follow-up|9
145342|NCT00637273|462393|P1|Overall Study|Lost to Follow-up|8
145343|NCT00637273|462391|P3|Overall Study|Adverse Event|7
145344|NCT00637273|462392|P2|Overall Study|Adverse Event|5
145345|NCT00637273|462393|P1|Overall Study|Adverse Event|11
145346|NCT00637377|462458|P4|Overall Study|Other (no further information available)|5
145347|NCT00637377|462459|P3|Overall Study|Other (no further information available)|10
145348|NCT00637377|462460|P2|Overall Study|Other (no further information available)|6
145349|NCT00637377|462461|P1|Overall Study|Other (no further information available)|7
145350|NCT00637377|462458|P4|Overall Study|Withdrawal by Subject|11
145351|NCT00637377|462459|P3|Overall Study|Withdrawal by Subject|13
145352|NCT00637377|462460|P2|Overall Study|Withdrawal by Subject|15
145353|NCT00637377|462461|P1|Overall Study|Withdrawal by Subject|11
145354|NCT00637377|462458|P4|Overall Study|Protocol Violation|0
145355|NCT00637377|462459|P3|Overall Study|Protocol Violation|1
145356|NCT00637377|462460|P2|Overall Study|Protocol Violation|1
145357|NCT00637377|462461|P1|Overall Study|Protocol Violation|2
145358|NCT00637377|462458|P4|Overall Study|Lost to Follow-up|2
145359|NCT00637377|462459|P3|Overall Study|Lost to Follow-up|2
145360|NCT00637377|462460|P2|Overall Study|Lost to Follow-up|1
145361|NCT00637377|462461|P1|Overall Study|Lost to Follow-up|4
145362|NCT00637377|462458|P4|Overall Study|Lack of Efficacy|1
145363|NCT00637377|462459|P3|Overall Study|Lack of Efficacy|1
145364|NCT00637377|462460|P2|Overall Study|Lack of Efficacy|0
145365|NCT00637377|462461|P1|Overall Study|Lack of Efficacy|0
145366|NCT00637377|462458|P4|Overall Study|Death|1
145367|NCT00637377|462459|P3|Overall Study|Death|2
145368|NCT00637377|462460|P2|Overall Study|Death|3
145369|NCT00637377|462461|P1|Overall Study|Death|1
145370|NCT00637377|462458|P4|Overall Study|Adverse Event|9
145371|NCT00637377|462459|P3|Overall Study|Adverse Event|8
145372|NCT00637377|462460|P2|Overall Study|Adverse Event|6
145373|NCT00637377|462461|P1|Overall Study|Adverse Event|2
145374|NCT00637416|462489|P2|Overall Study|Unable to take study drug|1
145375|NCT00637416|462490|P1|Overall Study|Unable to take study drug|0
145376|NCT00637416|462489|P2|Overall Study|Lost to Follow-up|1
145377|NCT00637416|462490|P1|Overall Study|Lost to Follow-up|1
145378|NCT00637572|462509|P2|Overall Study|Illicit Drug Use|0
145379|NCT00637572|462510|P1|Overall Study|Illicit Drug Use|1
145380|NCT00637572|462509|P2|Overall Study|Withdrawal by Subject|2
145381|NCT00637572|462510|P1|Overall Study|Withdrawal by Subject|0
145382|NCT00637572|462509|P2|Overall Study|Physician Decision|1
145383|NCT00637572|462510|P1|Overall Study|Physician Decision|1
145384|NCT00637572|462509|P2|Overall Study|Lost to Follow-up|1
145385|NCT00637572|462510|P1|Overall Study|Lost to Follow-up|0
145386|NCT00637572|462509|P2|Overall Study|Death|1
145387|NCT00637572|462510|P1|Overall Study|Death|0
145388|NCT00637572|462509|P2|Overall Study|Adverse Event|2
145389|NCT00637572|462510|P1|Overall Study|Adverse Event|1
145390|NCT00637728|462538|P3|Double-blind Phase|Study Discontinued|0
145391|NCT00637728|462539|P2|Double-blind Phase|Study Discontinued|1
145392|NCT00637728|462540|P1|Double-blind Phase|Study Discontinued|1
145393|NCT00637728|462538|P3|Double-blind Phase|Non-compliance|0
145394|NCT00637728|462539|P2|Double-blind Phase|Non-compliance|0
145395|NCT00637728|462540|P1|Double-blind Phase|Non-compliance|2
145396|NCT00637728|462538|P3|Double-blind Phase|Adverse Event|0
145397|NCT00637728|462539|P2|Double-blind Phase|Adverse Event|0
145398|NCT00637728|462540|P1|Double-blind Phase|Adverse Event|1
145399|NCT00637806|462571|P4|Extension Phase|Study Discontinued|1
145400|NCT00637806|462572|P3|Extension Phase|Study Discontinued|0
145401|NCT00637806|462573|P2|Extension Phase|Study Discontinued|0
145402|NCT00637806|462574|P1|Extension Phase|Study Discontinued|0
145403|NCT00637806|462571|P4|Double-blind Phase|Study Discontinued|0
145404|NCT00637806|462572|P3|Double-blind Phase|Study Discontinued|1
145405|NCT00637806|462573|P2|Double-blind Phase|Study Discontinued|0
145406|NCT00637806|462574|P1|Double-blind Phase|Study Discontinued|2
145407|NCT00638027|462628|P2|Overall Study|Adverse Event|2
145408|NCT00638027|462629|P1|Overall Study|Adverse Event|0
145409|NCT00638157|462641|P2|Overall Study|Randomized, not treated|0
145410|NCT00638157|462642|P1|Overall Study|Randomized, not treated|2
145411|NCT00638157|462641|P2|Overall Study|Not Specified|2
145412|NCT00638157|462642|P1|Overall Study|Not Specified|1
145413|NCT00638157|462641|P2|Overall Study|Physician Decision|0
145414|NCT00638157|462642|P1|Overall Study|Physician Decision|1
145415|NCT00638157|462641|P2|Overall Study|Lost to Follow-up|0
145416|NCT00638157|462642|P1|Overall Study|Lost to Follow-up|1
145417|NCT00638157|462641|P2|Overall Study|Microbiological failure|0
145418|NCT00638157|462642|P1|Overall Study|Microbiological failure|1
145419|NCT00638157|462641|P2|Overall Study|Clinical (symptomatic) failure|1
145420|NCT00638157|462642|P1|Overall Study|Clinical (symptomatic) failure|1
145421|NCT00638157|462641|P2|Overall Study|Adverse Event|1
145422|NCT00638157|462642|P1|Overall Study|Adverse Event|0
145423|NCT00626821|462743|P1|Overall Study|other/unknown reason|104
145424|NCT00626821|462743|P1|Overall Study|Product dysfunction|21
145425|NCT00626821|462743|P1|Overall Study|Physician Decision|9
145426|NCT00626821|462743|P1|Overall Study|Withdrawal by Subject|10
145427|NCT00626821|462743|P1|Overall Study|Protocol Violation|33
145428|NCT00626821|462743|P1|Overall Study|Adverse Event|44
145429|NCT00626925|462749|P2|Overall Study|Time constraints|1
145430|NCT00626925|462750|P1|Overall Study|Time constraints|3
145431|NCT00626925|462749|P2|Overall Study|Lack of Efficacy|4
145432|NCT00626925|462750|P1|Overall Study|Lack of Efficacy|1
145433|NCT00626925|462749|P2|Overall Study|Adverse effect|2
145434|NCT00626925|462750|P1|Overall Study|Adverse effect|6
145435|NCT00626925|462749|P2|Overall Study|relapse|0
145436|NCT00626925|462750|P1|Overall Study|relapse|1
145437|NCT00626925|462749|P2|Overall Study|Lost to Follow-up|2
145438|NCT00626925|462750|P1|Overall Study|Lost to Follow-up|1
145439|NCT00632424|462788|P1|Overall Study|Study Drug Toxicity|1
145440|NCT00632424|462788|P1|Overall Study|Disease Progression|17
145441|NCT00638183|462810|P1|Overall Study|Other reason not defined above|27
145442|NCT00638183|462810|P1|Overall Study|Lost to Follow-up|46
145443|NCT00638183|462810|P1|Overall Study|Physician Decision|9
145444|NCT00638183|462810|P1|Overall Study|Lack of Efficacy|14
145445|NCT00638183|462810|P1|Overall Study|Adverse Event|23
145446|NCT00638235|462838|P9|Overall Study|Lost to Follow-up|18
145447|NCT00638235|462839|P8|Overall Study|Lost to Follow-up|1
145448|NCT00638235|462840|P7|Overall Study|Lost to Follow-up|0
145449|NCT00638235|462841|P6|Overall Study|Lost to Follow-up|26
145450|NCT00638235|462842|P5|Overall Study|Lost to Follow-up|13
145451|NCT00638235|462843|P4|Overall Study|Lost to Follow-up|10
145452|NCT00638235|462844|P3|Overall Study|Lost to Follow-up|18
145453|NCT00638235|462845|P2|Overall Study|Lost to Follow-up|3
145454|NCT00638235|462846|P1|Overall Study|Lost to Follow-up|31
145455|NCT00638378|463257|P1|Overall Study|Physician Decision|4
145456|NCT00638378|463257|P1|Overall Study|Disease progression|15
145457|NCT00638378|463257|P1|Overall Study|Adverse Event|1
145458|NCT00638378|463257|P1|Overall Study|Death|2
145459|NCT00638443|463264|P2|First Intervention|Adverse Event|1
145460|NCT00638443|463265|P1|First Intervention|Adverse Event|2
145461|NCT00640393|463293|P3|Part 2|Adverse Event|0
145462|NCT00640393|463294|P2|Part 2|Adverse Event|1
145463|NCT00640393|463295|P1|Part 2|Adverse Event|0
145464|NCT00640393|463293|P3|Part 2|Non-adherence|0
145465|NCT00640393|463294|P2|Part 2|Non-adherence|1
145466|NCT00640393|463295|P1|Part 2|Non-adherence|0
145467|NCT00640393|463293|P3|Part 2|Withdrawal by Subject|1
145468|NCT00640393|463294|P2|Part 2|Withdrawal by Subject|6
145469|NCT00640393|463295|P1|Part 2|Withdrawal by Subject|0
145470|NCT00640393|463293|P3|Part 2|Lost to Follow-up|2
145471|NCT00640393|463294|P2|Part 2|Lost to Follow-up|2
145472|NCT00640393|463295|P1|Part 2|Lost to Follow-up|0
145473|NCT00640393|463293|P3|Randomization|Never randomized by site|0
145474|NCT00640393|463294|P2|Randomization|Never randomized by site|0
145475|NCT00640393|463295|P1|Randomization|Never randomized by site|2
145476|NCT00640393|463293|P3|Randomization|Withdrawn per protocol|0
145477|NCT00640393|463294|P2|Randomization|Withdrawn per protocol|0
145478|NCT00640393|463295|P1|Randomization|Withdrawn per protocol|17
145479|NCT00640393|463293|P3|Part 1|Withdrawal by Subject|0
145480|NCT00640393|463294|P2|Part 1|Withdrawal by Subject|0
145481|NCT00640393|463295|P1|Part 1|Withdrawal by Subject|3
145482|NCT00640393|463293|P3|Part 1|Lost to Follow-up|0
145483|NCT00640393|463294|P2|Part 1|Lost to Follow-up|0
145484|NCT00640393|463295|P1|Part 1|Lost to Follow-up|2
145485|NCT00640510|463359|P2|Overall Study|Physician Decision|1
145486|NCT00640510|463360|P1|Overall Study|Physician Decision|0
145487|NCT00640510|463359|P2|Overall Study|Protocol Violation|0
145488|NCT00640510|463360|P1|Overall Study|Protocol Violation|1
145489|NCT00640510|463359|P2|Overall Study|Lack of Efficacy|1
145490|NCT00640510|463360|P1|Overall Study|Lack of Efficacy|0
145491|NCT00640562|463374|P2|Overall Study|Glycosylated Hemoglobin >8|0
145492|NCT00640562|463375|P1|Overall Study|Glycosylated Hemoglobin >8|1
145493|NCT00640562|463374|P2|Overall Study|Low study drug dose|1
145494|NCT00640562|463375|P1|Overall Study|Low study drug dose|0
145495|NCT00640562|463374|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
145496|NCT00640562|463375|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
145497|NCT00640562|463374|P2|Overall Study|Known risperidone intolerance|1
145498|NCT00640562|463375|P1|Overall Study|Known risperidone intolerance|0
145499|NCT00640562|463374|P2|Overall Study|Withdrawal by Subject|10
145500|NCT00640562|463375|P1|Overall Study|Withdrawal by Subject|6
145501|NCT00640562|463374|P2|Overall Study|Protocol Violation|4
145502|NCT00640562|463375|P1|Overall Study|Protocol Violation|2
145503|NCT00640562|463374|P2|Overall Study|Lack of Efficacy|4
145504|NCT00640562|463375|P1|Overall Study|Lack of Efficacy|1
145505|NCT00640562|463374|P2|Overall Study|Adverse Event|5
145506|NCT00640562|463375|P1|Overall Study|Adverse Event|8
145507|NCT00640601|463401|P1|Overall Study|treatment naive, combination therapy|10
145508|NCT00640601|463401|P1|Overall Study|Physician Decision|8
145509|NCT00640601|463401|P1|Overall Study|Lost to Follow-up|9
145510|NCT00640601|463401|P1|Overall Study|Lack of Efficacy|16
145511|NCT00640601|463401|P1|Overall Study|Protocol Violation|6
145512|NCT00640601|463401|P1|Overall Study|Withdrawal by Subject|20
145513|NCT00640601|463401|P1|Overall Study|Adverse Event|43
145514|NCT00640614|463417|P2|Overall Study|Lost to Follow-up|0
145515|NCT00640614|463418|P1|Overall Study|Lost to Follow-up|1
145516|NCT00640835|463475|P2|Overall Study|Other Reason|4
145517|NCT00640835|463476|P1|Overall Study|Other Reason|19
145518|NCT00640835|463475|P2|Overall Study|Lost to Follow-up|13
145519|NCT00640835|463476|P1|Overall Study|Lost to Follow-up|17
145520|NCT00640835|463475|P2|Overall Study|Protocol Violation|2
145521|NCT00640835|463476|P1|Overall Study|Protocol Violation|2
145522|NCT00640835|463475|P2|Overall Study|Sponsor's Decision|7
145523|NCT00640835|463476|P1|Overall Study|Sponsor's Decision|11
145524|NCT00640835|463475|P2|Overall Study|Physician Decision|14
145525|NCT00640835|463476|P1|Overall Study|Physician Decision|10
145526|NCT00640835|463475|P2|Overall Study|Withdrawal by Subject|14
145527|NCT00640835|463476|P1|Overall Study|Withdrawal by Subject|12
145528|NCT00640835|463475|P2|Overall Study|Adverse Event|3
145529|NCT00640835|463476|P1|Overall Study|Adverse Event|5
145530|NCT00640926|463487|P3|Overall Study|Withdrawal by Subject|1
145531|NCT00640926|463488|P2|Overall Study|Withdrawal by Subject|0
145532|NCT00640926|463489|P1|Overall Study|Withdrawal by Subject|1
145533|NCT00640926|463487|P3|Overall Study|Lost to Follow-up|2
145534|NCT00640926|463488|P2|Overall Study|Lost to Follow-up|1
145535|NCT00640926|463489|P1|Overall Study|Lost to Follow-up|3
145536|NCT00640926|463487|P3|Overall Study|Protocol Violation|2
145537|NCT00640926|463488|P2|Overall Study|Protocol Violation|0
145538|NCT00640926|463489|P1|Overall Study|Protocol Violation|2
145539|NCT00640926|463487|P3|Overall Study|Lack of Efficacy|1
145540|NCT00640926|463488|P2|Overall Study|Lack of Efficacy|2
145541|NCT00640926|463489|P1|Overall Study|Lack of Efficacy|0
145542|NCT00640926|463487|P3|Overall Study|Adverse Event|2
145543|NCT00640926|463488|P2|Overall Study|Adverse Event|3
145544|NCT00640926|463489|P1|Overall Study|Adverse Event|2
145545|NCT00641043|463506|P2|Overall Study|Other incl. lack of efficacy|2
145546|NCT00641043|463507|P1|Overall Study|Other incl. lack of efficacy|4
145547|NCT00641043|463506|P2|Overall Study|Withdrawal by Subject|4
145548|NCT00641043|463507|P1|Overall Study|Withdrawal by Subject|4
145549|NCT00641043|463506|P2|Overall Study|Lost to Follow-up|2
145550|NCT00641043|463507|P1|Overall Study|Lost to Follow-up|3
145551|NCT00641043|463506|P2|Overall Study|Protocol Violation|3
145552|NCT00641043|463507|P1|Overall Study|Protocol Violation|2
145553|NCT00641043|463506|P2|Overall Study|Adverse Event|4
145554|NCT00641043|463507|P1|Overall Study|Adverse Event|6
145555|NCT00641056|463539|P2|Overall Study|Sponsor Decision|2
145556|NCT00641056|463540|P1|Overall Study|Sponsor Decision|1
145557|NCT00641056|463539|P2|Overall Study|Subject Decision|19
145558|NCT00641056|463540|P1|Overall Study|Subject Decision|6
145559|NCT00641056|463539|P2|Overall Study|Entry Criteria Not Met|0
145560|NCT00641056|463540|P1|Overall Study|Entry Criteria Not Met|3
145561|NCT00641056|463539|P2|Overall Study|Protocol Violation|0
145562|NCT00641056|463540|P1|Overall Study|Protocol Violation|2
145563|NCT00641056|463539|P2|Overall Study|Physician Decision|1
145564|NCT00641056|463540|P1|Overall Study|Physician Decision|3
145565|NCT00641056|463539|P2|Overall Study|Lost to Follow-up|1
145566|NCT00641056|463540|P1|Overall Study|Lost to Follow-up|2
145567|NCT00641056|463539|P2|Overall Study|Adverse Event|2
145568|NCT00641056|463540|P1|Overall Study|Adverse Event|12
145569|NCT00641537|463571|P8|24-Week Supplemental Follow-up Period|Unspecified|1
145570|NCT00641537|463572|P7|24-Week Supplemental Follow-up Period|Unspecified|1
145571|NCT00641537|463573|P6|24-Week Supplemental Follow-up Period|Unspecified|0
145572|NCT00641537|463574|P5|24-Week Supplemental Follow-up Period|Unspecified|3
145573|NCT00641537|463575|P4|24-Week Supplemental Follow-up Period|Unspecified|1
145574|NCT00641537|463576|P3|24-Week Supplemental Follow-up Period|Unspecified|2
145575|NCT00641537|463577|P2|24-Week Supplemental Follow-up Period|Unspecified|2
145576|NCT00641537|463578|P1|24-Week Supplemental Follow-up Period|Unspecified|0
145577|NCT00641537|463571|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
145578|NCT00641537|463572|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
145579|NCT00641537|463573|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
145580|NCT00641537|463574|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
145581|NCT00641537|463575|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
145582|NCT00641537|463576|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
145583|NCT00641537|463577|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
145584|NCT00641537|463578|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
145585|NCT00641537|463571|P8|96-week Period|Unspecified|6
145586|NCT00641537|463572|P7|96-week Period|Unspecified|4
145587|NCT00641537|463573|P6|96-week Period|Unspecified|6
145588|NCT00641537|463574|P5|96-week Period|Unspecified|12
145589|NCT00641537|463575|P4|96-week Period|Unspecified|9
145590|NCT00641537|463576|P3|96-week Period|Unspecified|14
145591|NCT00641537|463577|P2|96-week Period|Unspecified|7
145592|NCT00641537|463578|P1|96-week Period|Unspecified|4
145593|NCT00641537|463571|P8|96-week Period|Death|0
145594|NCT00641537|463572|P7|96-week Period|Death|0
145595|NCT00641537|463573|P6|96-week Period|Death|0
145596|NCT00641537|463574|P5|96-week Period|Death|0
145597|NCT00641537|463575|P4|96-week Period|Death|0
145598|NCT00641537|463576|P3|96-week Period|Death|1
145599|NCT00641537|463577|P2|96-week Period|Death|0
145600|NCT00641537|463578|P1|96-week Period|Death|2
145601|NCT00641537|463571|P8|96-week Period|Protocol Violation|0
145602|NCT00641537|463572|P7|96-week Period|Protocol Violation|0
145603|NCT00641537|463573|P6|96-week Period|Protocol Violation|1
145604|NCT00641537|463574|P5|96-week Period|Protocol Violation|0
145605|NCT00641537|463575|P4|96-week Period|Protocol Violation|1
145606|NCT00641537|463576|P3|96-week Period|Protocol Violation|0
145607|NCT00641537|463577|P2|96-week Period|Protocol Violation|1
145608|NCT00641537|463578|P1|96-week Period|Protocol Violation|0
145609|NCT00641537|463571|P8|96-week Period|Lost to Follow-up|0
145610|NCT00641537|463572|P7|96-week Period|Lost to Follow-up|1
145611|NCT00641537|463573|P6|96-week Period|Lost to Follow-up|0
145612|NCT00641537|463574|P5|96-week Period|Lost to Follow-up|4
145613|NCT00641537|463575|P4|96-week Period|Lost to Follow-up|2
145614|NCT00641537|463576|P3|96-week Period|Lost to Follow-up|2
145615|NCT00641537|463577|P2|96-week Period|Lost to Follow-up|1
145616|NCT00641537|463578|P1|96-week Period|Lost to Follow-up|3
145617|NCT00641537|463571|P8|96-week Period|Adverse Event|0
145618|NCT00641537|463572|P7|96-week Period|Adverse Event|0
145619|NCT00641537|463573|P6|96-week Period|Adverse Event|0
145620|NCT00641537|463574|P5|96-week Period|Adverse Event|2
145621|NCT00641537|463575|P4|96-week Period|Adverse Event|0
145622|NCT00641537|463576|P3|96-week Period|Adverse Event|3
145623|NCT00641537|463577|P2|96-week Period|Adverse Event|1
145624|NCT00641537|463578|P1|96-week Period|Adverse Event|0
145625|NCT00641667|463644|P1|Overall Study|Worsening of underlying disease|3
145626|NCT00641667|463644|P1|Overall Study|Physician Decision|1
145627|NCT00641667|463644|P1|Overall Study|Adverse Event|1
145628|NCT00641667|463644|P1|Overall Study|Withdrawal by Subject|1
145629|NCT00641706|463656|P2|Overall Study|Lead Investigator Decision|1
145630|NCT00641706|463657|P1|Overall Study|Lead Investigator Decision|0
145631|NCT00641706|463656|P2|Overall Study|Clinical Decline|0
145632|NCT00641706|463657|P1|Overall Study|Clinical Decline|1
145633|NCT00641706|463656|P2|Overall Study|Withdrawal by Subject|1
145634|NCT00641706|463657|P1|Overall Study|Withdrawal by Subject|6
145635|NCT00641706|463656|P2|Overall Study|Adverse Event|1
145636|NCT00641706|463657|P1|Overall Study|Adverse Event|2
145637|NCT00641719|463671|P2|Overall Study|Reason Not Specified|2
145638|NCT00641719|463672|P1|Overall Study|Reason Not Specified|1
145639|NCT00641719|463671|P2|Overall Study|Withdrawal by Subject|4
145640|NCT00641719|463672|P1|Overall Study|Withdrawal by Subject|4
145641|NCT00641719|463671|P2|Overall Study|Adverse Event|29
145642|NCT00641719|463672|P1|Overall Study|Adverse Event|24
145643|NCT00641719|463671|P2|Overall Study|Lack of Efficacy|2
145644|NCT00641719|463672|P1|Overall Study|Lack of Efficacy|1
145645|NCT00642174|463714|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
145646|NCT00642174|463715|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
145647|NCT00642278|463736|P7|Overall Study|Not specified|0
145648|NCT00642278|463737|P6|Overall Study|Not specified|1
145649|NCT00642278|463738|P5|Overall Study|Not specified|0
145650|NCT00642278|463739|P4|Overall Study|Not specified|1
145651|NCT00642278|463740|P3|Overall Study|Not specified|0
145652|NCT00642278|463741|P2|Overall Study|Not specified|1
145653|NCT00642278|463742|P1|Overall Study|Not specified|2
145654|NCT00642278|463736|P7|Overall Study|Noncompliance with study drug regimen|0
145655|NCT00642278|463737|P6|Overall Study|Noncompliance with study drug regimen|0
145656|NCT00642278|463738|P5|Overall Study|Noncompliance with study drug regimen|0
145657|NCT00642278|463739|P4|Overall Study|Noncompliance with study drug regimen|1
145658|NCT00642278|463740|P3|Overall Study|Noncompliance with study drug regimen|0
145659|NCT00642278|463741|P2|Overall Study|Noncompliance with study drug regimen|0
145817|NCT00642460|463840|P1|Part I: 12 Week Double-Blind|Adverse Event|0
145660|NCT00642278|463742|P1|Overall Study|Noncompliance with study drug regimen|0
145661|NCT00642278|463736|P7|Overall Study|Withdrawal by Subject|2
145662|NCT00642278|463737|P6|Overall Study|Withdrawal by Subject|2
145663|NCT00642278|463738|P5|Overall Study|Withdrawal by Subject|6
145664|NCT00642278|463739|P4|Overall Study|Withdrawal by Subject|3
145665|NCT00642278|463740|P3|Overall Study|Withdrawal by Subject|1
145666|NCT00642278|463741|P2|Overall Study|Withdrawal by Subject|1
145667|NCT00642278|463742|P1|Overall Study|Withdrawal by Subject|1
145668|NCT00642278|463736|P7|Overall Study|Protocol Violation|2
145669|NCT00642278|463737|P6|Overall Study|Protocol Violation|1
145670|NCT00642278|463738|P5|Overall Study|Protocol Violation|0
145671|NCT00642278|463739|P4|Overall Study|Protocol Violation|1
145672|NCT00642278|463740|P3|Overall Study|Protocol Violation|1
145673|NCT00642278|463741|P2|Overall Study|Protocol Violation|0
145674|NCT00642278|463742|P1|Overall Study|Protocol Violation|0
145675|NCT00642278|463736|P7|Overall Study|Physician Decision|0
145676|NCT00642278|463737|P6|Overall Study|Physician Decision|0
145677|NCT00642278|463738|P5|Overall Study|Physician Decision|0
145678|NCT00642278|463739|P4|Overall Study|Physician Decision|1
145679|NCT00642278|463740|P3|Overall Study|Physician Decision|0
145680|NCT00642278|463741|P2|Overall Study|Physician Decision|0
145681|NCT00642278|463742|P1|Overall Study|Physician Decision|0
145682|NCT00642278|463736|P7|Overall Study|Lost to Follow-up|1
145683|NCT00642278|463737|P6|Overall Study|Lost to Follow-up|1
145684|NCT00642278|463738|P5|Overall Study|Lost to Follow-up|0
145685|NCT00642278|463739|P4|Overall Study|Lost to Follow-up|1
145686|NCT00642278|463740|P3|Overall Study|Lost to Follow-up|0
145687|NCT00642278|463741|P2|Overall Study|Lost to Follow-up|1
145688|NCT00642278|463742|P1|Overall Study|Lost to Follow-up|5
145689|NCT00642278|463736|P7|Overall Study|Lack of Efficacy|0
145690|NCT00642278|463737|P6|Overall Study|Lack of Efficacy|0
145691|NCT00642278|463738|P5|Overall Study|Lack of Efficacy|0
145692|NCT00642278|463739|P4|Overall Study|Lack of Efficacy|0
145693|NCT00642278|463740|P3|Overall Study|Lack of Efficacy|0
145694|NCT00642278|463741|P2|Overall Study|Lack of Efficacy|1
145695|NCT00642278|463742|P1|Overall Study|Lack of Efficacy|0
145696|NCT00642278|463736|P7|Overall Study|Adverse Event|0
145697|NCT00642278|463737|P6|Overall Study|Adverse Event|2
145698|NCT00642278|463738|P5|Overall Study|Adverse Event|2
145699|NCT00642278|463739|P4|Overall Study|Adverse Event|1
145700|NCT00642278|463740|P3|Overall Study|Adverse Event|3
145701|NCT00642278|463741|P2|Overall Study|Adverse Event|1
145702|NCT00642278|463742|P1|Overall Study|Adverse Event|2
145703|NCT00642304|463793|P1|Overall Study|Transplantation|1
145704|NCT00642304|463793|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
145705|NCT00642304|463793|P1|Overall Study|Blood transfusion|2
145706|NCT00642304|463793|P1|Overall Study|Death|1
145707|NCT00642304|463793|P1|Overall Study|Adverse Event|1
145708|NCT00642356|463804|P2|Overall Study|Lack of Efficacy|0
145709|NCT00642356|463805|P1|Overall Study|Lack of Efficacy|1
145710|NCT00642356|463804|P2|Overall Study|Protocol Violation|3
145711|NCT00642356|463805|P1|Overall Study|Protocol Violation|0
145712|NCT00642356|463804|P2|Overall Study|Adverse Event|0
145713|NCT00642356|463805|P1|Overall Study|Adverse Event|1
145714|NCT00642369|463815|P2|Overall Study|Lack of Efficacy|2
145715|NCT00642369|463816|P1|Overall Study|Lack of Efficacy|2
145716|NCT00642369|463815|P2|Overall Study|misdiagnosis|1
145717|NCT00642369|463816|P1|Overall Study|misdiagnosis|0
145718|NCT00642369|463815|P2|Overall Study|Withdrawal by Subject|0
145719|NCT00642369|463816|P1|Overall Study|Withdrawal by Subject|1
145720|NCT00642369|463815|P2|Overall Study|Adverse Event|3
145721|NCT00642369|463816|P1|Overall Study|Adverse Event|2
145722|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
145723|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
145724|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
145725|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
145726|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
145727|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
145728|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
145729|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
145730|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
145731|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
145732|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
145733|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
145734|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Death|3
145735|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Death|0
145736|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Death|0
145737|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Death|0
145738|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Death|0
145739|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Death|0
145740|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Unspecified|2
145741|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Unspecified|2
145742|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Unspecified|0
145743|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Unspecified|0
145744|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Unspecified|0
145745|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Unspecified|0
145746|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
145747|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
145748|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
145749|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
145750|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
145751|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
145752|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
145753|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
145754|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
145755|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
145756|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
145757|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
145758|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
145759|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
145760|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
145761|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
145762|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
145763|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
145764|NCT00642460|463835|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
145765|NCT00642460|463836|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
145766|NCT00642460|463837|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
145767|NCT00642460|463838|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
145768|NCT00642460|463839|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
145769|NCT00642460|463840|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
145770|NCT00642460|463835|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
145771|NCT00642460|463836|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
145772|NCT00642460|463837|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
145773|NCT00642460|463838|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
145774|NCT00642460|463839|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
145775|NCT00642460|463840|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
145776|NCT00642460|463835|P6|Part II: Open-Label Up to Week 92|Failure to return|0
145777|NCT00642460|463836|P5|Part II: Open-Label Up to Week 92|Failure to return|0
145778|NCT00642460|463837|P4|Part II: Open-Label Up to Week 92|Failure to return|0
145779|NCT00642460|463838|P3|Part II: Open-Label Up to Week 92|Failure to return|0
145780|NCT00642460|463839|P2|Part II: Open-Label Up to Week 92|Failure to return|1
145781|NCT00642460|463840|P1|Part II: Open-Label Up to Week 92|Failure to return|0
145782|NCT00642460|463835|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
145783|NCT00642460|463836|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
145784|NCT00642460|463837|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
145785|NCT00642460|463838|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
145786|NCT00642460|463839|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
145787|NCT00642460|463840|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
145788|NCT00642460|463835|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
145789|NCT00642460|463836|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
145790|NCT00642460|463837|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
145791|NCT00642460|463838|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
145792|NCT00642460|463839|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
145793|NCT00642460|463840|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
145794|NCT00642460|463835|P6|Part II: Open-Label Up to Week 92|Death|0
145795|NCT00642460|463836|P5|Part II: Open-Label Up to Week 92|Death|0
145796|NCT00642460|463837|P4|Part II: Open-Label Up to Week 92|Death|2
145797|NCT00642460|463838|P3|Part II: Open-Label Up to Week 92|Death|0
145798|NCT00642460|463839|P2|Part II: Open-Label Up to Week 92|Death|1
145799|NCT00642460|463840|P1|Part II: Open-Label Up to Week 92|Death|0
145800|NCT00642460|463835|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
145801|NCT00642460|463836|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
145802|NCT00642460|463837|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
145803|NCT00642460|463838|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
145804|NCT00642460|463839|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
145805|NCT00642460|463840|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
145806|NCT00642460|463835|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
145807|NCT00642460|463836|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
145808|NCT00642460|463837|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
145809|NCT00642460|463838|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
145810|NCT00642460|463839|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
145811|NCT00642460|463840|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
145812|NCT00642460|463835|P6|Part I: 12 Week Double-Blind|Adverse Event|0
145813|NCT00642460|463836|P5|Part I: 12 Week Double-Blind|Adverse Event|0
145814|NCT00642460|463837|P4|Part I: 12 Week Double-Blind|Adverse Event|0
145815|NCT00642460|463838|P3|Part I: 12 Week Double-Blind|Adverse Event|1
145816|NCT00642460|463839|P2|Part I: 12 Week Double-Blind|Adverse Event|1
145818|NCT00642473|463906|P2|Overall Study|Unspecified|2
145819|NCT00642473|463907|P1|Overall Study|Unspecified|2
145820|NCT00642473|463906|P2|Overall Study|Progression or death|4
145821|NCT00642473|463907|P1|Overall Study|Progression or death|2
145822|NCT00642473|463906|P2|Overall Study|Withdrawal by Subject|5
145823|NCT00642473|463907|P1|Overall Study|Withdrawal by Subject|0
145824|NCT00642616|463932|P4|Overall Study|Physician Decision|1
145825|NCT00642616|463933|P3|Overall Study|Physician Decision|1
145826|NCT00642616|463934|P2|Overall Study|Physician Decision|0
145827|NCT00642616|463935|P1|Overall Study|Physician Decision|0
145828|NCT00642616|463932|P4|Overall Study|Protocol Violation|0
145829|NCT00642616|463933|P3|Overall Study|Protocol Violation|2
145830|NCT00642616|463934|P2|Overall Study|Protocol Violation|0
145831|NCT00642616|463935|P1|Overall Study|Protocol Violation|0
145832|NCT00642616|463932|P4|Overall Study|Withdrawal by Subject|1
145833|NCT00642616|463933|P3|Overall Study|Withdrawal by Subject|1
145834|NCT00642616|463934|P2|Overall Study|Withdrawal by Subject|1
145835|NCT00642616|463935|P1|Overall Study|Withdrawal by Subject|0
145836|NCT00642616|463932|P4|Overall Study|Study Terminated by Sponsor|5
145837|NCT00642616|463933|P3|Overall Study|Study Terminated by Sponsor|4
145838|NCT00642616|463934|P2|Overall Study|Study Terminated by Sponsor|6
145839|NCT00642616|463935|P1|Overall Study|Study Terminated by Sponsor|7
145840|NCT00642616|463932|P4|Overall Study|Adverse Event|0
145841|NCT00642616|463933|P3|Overall Study|Adverse Event|1
145842|NCT00642616|463934|P2|Overall Study|Adverse Event|0
145843|NCT00642616|463935|P1|Overall Study|Adverse Event|2
145844|NCT00642642|463957|P1|Treatment & Follow Up|Lost to Follow-up|10
145845|NCT00642642|463957|P1|Treatment & Follow Up|Withdrawal by Subject|5
145846|NCT00642642|463957|P1|Treatment & Follow Up|Adverse Event|2
145847|NCT00642668|463970|P1|Overall Study|Blood Transfusion|2
145848|NCT00642668|463970|P1|Overall Study|Dialysis Initiation|5
145849|NCT00642668|463970|P1|Overall Study|Failure to Return|1
145850|NCT00642668|463970|P1|Overall Study|Insufficient Therapeutic Response|1
145851|NCT00642668|463970|P1|Overall Study|Death|2
145852|NCT00642668|463970|P1|Overall Study|Adverse Event|2
145853|NCT00642668|463970|P1|Overall Study|Lost to Follow-up|1
145854|NCT00642707|463993|P4|Overall Study|Withdrawal by Subject|0
145855|NCT00642707|463994|P3|Overall Study|Withdrawal by Subject|0
145856|NCT00642707|463995|P2|Overall Study|Withdrawal by Subject|0
145857|NCT00642707|463996|P1|Overall Study|Withdrawal by Subject|1
145858|NCT00642707|463993|P4|Overall Study|Adverse Event|2
145859|NCT00642707|463994|P3|Overall Study|Adverse Event|0
145860|NCT00642707|463995|P2|Overall Study|Adverse Event|0
145861|NCT00642707|463996|P1|Overall Study|Adverse Event|0
145862|NCT00642746|464008|P2|Overall Study|Patient unevaluable|0
145863|NCT00642746|464009|P1|Overall Study|Patient unevaluable|1
145864|NCT00642759|464019|P1|Overall Study|Protocol Violation|1
145865|NCT00642772|464026|P1|Overall Study|Withdrawal by Subject|7
145866|NCT00642772|464026|P1|Overall Study|Lost to Follow-up|3
145867|NCT00642811|464036|P6|Overall Study|Other|0
145868|NCT00642811|464037|P5|Overall Study|Other|0
145869|NCT00642811|464038|P4|Overall Study|Other|1
145870|NCT00642811|464039|P3|Overall Study|Other|0
145871|NCT00642811|464040|P2|Overall Study|Other|1
145872|NCT00642811|464041|P1|Overall Study|Other|0
145873|NCT00642811|464036|P6|Overall Study|Severe Non-compliance to protocol|0
145874|NCT00642811|464037|P5|Overall Study|Severe Non-compliance to protocol|0
145875|NCT00642811|464038|P4|Overall Study|Severe Non-compliance to protocol|0
145876|NCT00642811|464039|P3|Overall Study|Severe Non-compliance to protocol|0
145877|NCT00642811|464040|P2|Overall Study|Severe Non-compliance to protocol|0
145878|NCT00642811|464041|P1|Overall Study|Severe Non-compliance to protocol|1
145879|NCT00642811|464036|P6|Overall Study|Developement of discontinuation criteria|0
145880|NCT00642811|464037|P5|Overall Study|Developement of discontinuation criteria|1
145881|NCT00642811|464038|P4|Overall Study|Developement of discontinuation criteria|0
145882|NCT00642811|464039|P3|Overall Study|Developement of discontinuation criteria|0
145883|NCT00642811|464040|P2|Overall Study|Developement of discontinuation criteria|0
145884|NCT00642811|464041|P1|Overall Study|Developement of discontinuation criteria|0
145885|NCT00642811|464036|P6|Overall Study|Adverse Event|1
145886|NCT00642811|464037|P5|Overall Study|Adverse Event|0
145887|NCT00642811|464038|P4|Overall Study|Adverse Event|0
145888|NCT00642811|464039|P3|Overall Study|Adverse Event|0
145889|NCT00642811|464040|P2|Overall Study|Adverse Event|3
145890|NCT00642811|464041|P1|Overall Study|Adverse Event|2
145891|NCT00635349|464065|P2|Overall Study|Adverse Event|9
145892|NCT00635349|464066|P1|Overall Study|Adverse Event|11
145893|NCT00635349|464065|P2|Overall Study|Lost to Follow-up|3
145894|NCT00635349|464066|P1|Overall Study|Lost to Follow-up|4
145895|NCT00635349|464065|P2|Overall Study|Withdrawal by Subject|8
145896|NCT00635349|464066|P1|Overall Study|Withdrawal by Subject|3
145897|NCT00635349|464065|P2|Overall Study|Protocol Violation|22
145898|NCT00635349|464066|P1|Overall Study|Protocol Violation|18
145899|NCT00635349|464065|P2|Overall Study|Unspecified|6
145900|NCT00635349|464066|P1|Overall Study|Unspecified|8
145901|NCT00635427|464106|P5|Overall Study|Withdrawal Of Consent|2
145902|NCT00635427|464107|P4|Overall Study|Withdrawal Of Consent|2
145903|NCT00635427|464108|P3|Overall Study|Withdrawal Of Consent|0
145904|NCT00635427|464109|P2|Overall Study|Withdrawal Of Consent|0
145905|NCT00635427|464110|P1|Overall Study|Withdrawal Of Consent|0
145906|NCT00635427|464106|P5|Overall Study|Termination Of Study By Sponsor|6
145907|NCT00635427|464107|P4|Overall Study|Termination Of Study By Sponsor|6
145908|NCT00635427|464108|P3|Overall Study|Termination Of Study By Sponsor|10
145909|NCT00635427|464109|P2|Overall Study|Termination Of Study By Sponsor|6
145910|NCT00635427|464110|P1|Overall Study|Termination Of Study By Sponsor|12
145911|NCT00635427|464106|P5|Overall Study|Death|0
145912|NCT00635427|464107|P4|Overall Study|Death|1
145913|NCT00635427|464108|P3|Overall Study|Death|0
145914|NCT00635427|464109|P2|Overall Study|Death|0
145915|NCT00635427|464110|P1|Overall Study|Death|0
145916|NCT00635427|464106|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
145917|NCT00635427|464107|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
145918|NCT00635427|464108|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
145919|NCT00635427|464109|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
145920|NCT00635427|464110|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
145921|NCT00635492|464141|P2|Overall Study|Withdrawal by Subject|45
145922|NCT00635492|464142|P1|Overall Study|Withdrawal by Subject|82
145923|NCT00635492|464141|P2|Overall Study|Sponsor decision|3
145924|NCT00635492|464142|P1|Overall Study|Sponsor decision|2
145925|NCT00635492|464141|P2|Overall Study|Physician Decision|22
145926|NCT00635492|464142|P1|Overall Study|Physician Decision|32
145927|NCT00635492|464141|P2|Overall Study|Lost to Follow-up|172
145928|NCT00635492|464142|P1|Overall Study|Lost to Follow-up|151
145929|NCT00635492|464141|P2|Overall Study|Death|40
145930|NCT00635492|464142|P1|Overall Study|Death|12
145931|NCT00635570|464188|P2|Overall Study|Early termination(No sexual activity)|1
145932|NCT00635570|464189|P1|Overall Study|Early termination(No sexual activity)|1
145933|NCT00635570|464188|P2|Overall Study|Did not complete survey|1
145934|NCT00635570|464189|P1|Overall Study|Did not complete survey|2
145935|NCT00635570|464188|P2|Overall Study|Physician Decision|0
145936|NCT00635570|464189|P1|Overall Study|Physician Decision|1
145937|NCT00635570|464188|P2|Overall Study|Adverse Event|0
145938|NCT00635570|464189|P1|Overall Study|Adverse Event|2
145939|NCT00635570|464188|P2|Overall Study|Withdrawal by Subject|1
145940|NCT00635570|464189|P1|Overall Study|Withdrawal by Subject|1
145941|NCT00635570|464188|P2|Overall Study|Lost to Follow-up|8
145942|NCT00635570|464189|P1|Overall Study|Lost to Follow-up|8
145943|NCT00635648|464214|P1|Overall Study|Other reason|2
145944|NCT00635648|464214|P1|Overall Study|Noncompliance with protocol|1
145945|NCT00635648|464214|P1|Overall Study|No improvement after 7-10 days treatment|4
145946|NCT00635648|464214|P1|Overall Study|Use of other antifungal agent needed|1
145947|NCT00635648|464214|P1|Overall Study|Rapid progression of baseline disease|4
145948|NCT00635648|464214|P1|Overall Study|Physician Decision|4
145949|NCT00635648|464214|P1|Overall Study|Withdrawal by Subject|9
145950|NCT00635648|464214|P1|Overall Study|Adverse Event|12
145951|NCT00642850|464221|P1|Overall Study|Other reasons|7
145952|NCT00642850|464221|P1|Overall Study|Blood transfusion|6
145953|NCT00642850|464221|P1|Overall Study|Kidney transplantation|8
145954|NCT00642850|464221|P1|Overall Study|Protocol Violation|2
145955|NCT00642850|464221|P1|Overall Study|Lack of Efficacy|1
145956|NCT00642850|464221|P1|Overall Study|Adverse Event|2
145957|NCT00642850|464221|P1|Overall Study|Death|7
145958|NCT00642902|464235|P4|Overall Study|Unspecified|4
145959|NCT00642902|464236|P3|Overall Study|Unspecified|1
145960|NCT00642902|464237|P2|Overall Study|Unspecified|5
145961|NCT00642902|464238|P1|Overall Study|Unspecified|1
145962|NCT00642902|464235|P4|Overall Study|Randomized, but not treated|0
145963|NCT00642902|464236|P3|Overall Study|Randomized, but not treated|1
145964|NCT00642902|464237|P2|Overall Study|Randomized, but not treated|0
145965|NCT00642902|464238|P1|Overall Study|Randomized, but not treated|0
145966|NCT00642902|464235|P4|Overall Study|Premature termination of clinical trial|35
145967|NCT00642902|464236|P3|Overall Study|Premature termination of clinical trial|35
145968|NCT00642902|464237|P2|Overall Study|Premature termination of clinical trial|32
145969|NCT00642902|464238|P1|Overall Study|Premature termination of clinical trial|37
145970|NCT00642902|464235|P4|Overall Study|Death|0
145971|NCT00642902|464236|P3|Overall Study|Death|0
145972|NCT00642902|464237|P2|Overall Study|Death|0
145973|NCT00642902|464238|P1|Overall Study|Death|1
145974|NCT00642902|464235|P4|Overall Study|Lack of Efficacy|0
145975|NCT00642902|464236|P3|Overall Study|Lack of Efficacy|3
145976|NCT00642902|464237|P2|Overall Study|Lack of Efficacy|3
145977|NCT00642902|464238|P1|Overall Study|Lack of Efficacy|0
145978|NCT00642902|464235|P4|Overall Study|Lost to Follow-up|0
145979|NCT00642902|464236|P3|Overall Study|Lost to Follow-up|0
145980|NCT00642902|464237|P2|Overall Study|Lost to Follow-up|1
145981|NCT00642902|464238|P1|Overall Study|Lost to Follow-up|1
145982|NCT00642902|464235|P4|Overall Study|Adverse Event|1
145983|NCT00642902|464236|P3|Overall Study|Adverse Event|3
145984|NCT00642902|464237|P2|Overall Study|Adverse Event|1
145985|NCT00642902|464238|P1|Overall Study|Adverse Event|0
145986|NCT00642993|464262|P2|Overall Study|Administrative|0
145987|NCT00642993|464263|P1|Overall Study|Administrative|1
145988|NCT00642993|464262|P2|Overall Study|Did not meet protocol eligibility|1
145989|NCT00642993|464263|P1|Overall Study|Did not meet protocol eligibility|0
145990|NCT00642993|464262|P2|Overall Study|Protocol Violation|4
145991|NCT00642993|464263|P1|Overall Study|Protocol Violation|1
146079|NCT00646958|464594|P3|Overall Study|Protocol Violation|0
145992|NCT00642993|464262|P2|Overall Study|Withdrew - reason unrelated to treatment|3
145993|NCT00642993|464263|P1|Overall Study|Withdrew - reason unrelated to treatment|11
145994|NCT00642993|464262|P2|Overall Study|Lost to Follow-up|4
145995|NCT00642993|464263|P1|Overall Study|Lost to Follow-up|8
145996|NCT00642993|464262|P2|Overall Study|Adverse Event|4
145997|NCT00642993|464263|P1|Overall Study|Adverse Event|85
145998|NCT00643006|464279|P2|Overall Study|Lost to Follow-up|4
145999|NCT00643006|464280|P1|Overall Study|Lost to Follow-up|5
146000|NCT00645528|464310|P1|Overall Study|Did not show up for Visit 2|7
146001|NCT00645567|464319|P1|Overall Study|Adverse Event|1
146002|NCT00645593|464329|P2|Overall Study|Later found to be ineligible|0
146003|NCT00645593|464330|P1|Overall Study|Later found to be ineligible|1
146004|NCT00645671|464344|P2|Overall Study|Physician Decision|1
146005|NCT00645671|464345|P1|Overall Study|Physician Decision|0
146006|NCT00645671|464344|P2|Overall Study|Adverse Event|1
146007|NCT00645671|464345|P1|Overall Study|Adverse Event|0
146008|NCT00645671|464344|P2|Overall Study|Withdrawal by Subject|4
146009|NCT00645671|464345|P1|Overall Study|Withdrawal by Subject|0
146010|NCT00645671|464344|P2|Overall Study|Protocol Violation|0
146011|NCT00645671|464345|P1|Overall Study|Protocol Violation|1
146012|NCT00645788|464367|P4|Overall Study|Pulmonary exacerbation|9
146013|NCT00645788|464368|P3|Overall Study|Pulmonary exacerbation|11
146014|NCT00645788|464369|P2|Overall Study|Pulmonary exacerbation|16
146015|NCT00645788|464370|P1|Overall Study|Pulmonary exacerbation|13
146016|NCT00645788|464367|P4|Overall Study|Withdrawal by Subject|2
146017|NCT00645788|464368|P3|Overall Study|Withdrawal by Subject|0
146018|NCT00645788|464369|P2|Overall Study|Withdrawal by Subject|1
146019|NCT00645788|464370|P1|Overall Study|Withdrawal by Subject|0
146020|NCT00645788|464367|P4|Overall Study|Protocol Violation|0
146021|NCT00645788|464368|P3|Overall Study|Protocol Violation|2
146022|NCT00645788|464369|P2|Overall Study|Protocol Violation|0
146023|NCT00645788|464370|P1|Overall Study|Protocol Violation|1
146024|NCT00645788|464367|P4|Overall Study|Lost to Follow-up|0
146025|NCT00645788|464368|P3|Overall Study|Lost to Follow-up|0
146026|NCT00645788|464369|P2|Overall Study|Lost to Follow-up|0
146027|NCT00645788|464370|P1|Overall Study|Lost to Follow-up|1
146028|NCT00645788|464367|P4|Overall Study|Adverse Event|3
146029|NCT00645788|464368|P3|Overall Study|Adverse Event|5
146030|NCT00645788|464369|P2|Overall Study|Adverse Event|9
146031|NCT00645788|464370|P1|Overall Study|Adverse Event|4
146032|NCT00645788|464367|P4|Overall Study|Did not receive study drug|0
146033|NCT00645788|464368|P3|Overall Study|Did not receive study drug|0
146034|NCT00645788|464369|P2|Overall Study|Did not receive study drug|1
146035|NCT00645788|464370|P1|Overall Study|Did not receive study drug|1
146036|NCT00645853|464431|P2|Overall Study|recall of ICF, planned operation, death|4
146037|NCT00645853|464432|P1|Overall Study|recall of ICF, planned operation, death|7
146038|NCT00645853|464431|P2|Overall Study|Discontinuation criteria|2
146039|NCT00645853|464432|P1|Overall Study|Discontinuation criteria|2
146040|NCT00645853|464431|P2|Overall Study|Protocol Violation|2
146041|NCT00645853|464432|P1|Overall Study|Protocol Violation|0
146042|NCT00645853|464431|P2|Overall Study|Withdrawal by Subject|2
146043|NCT00645853|464432|P1|Overall Study|Withdrawal by Subject|5
146044|NCT00645853|464431|P2|Overall Study|AZ study closure in Hungary|40
146045|NCT00645853|464432|P1|Overall Study|AZ study closure in Hungary|60
146046|NCT00645853|464431|P2|Overall Study|Adverse Event|7
146047|NCT00645853|464432|P1|Overall Study|Adverse Event|18
146048|NCT00645944|464452|P2|Received Medication|Protocol Violation|1
146049|NCT00645944|464453|P1|Received Medication|Protocol Violation|2
146050|NCT00645944|464452|P2|Received Medication|Lost to Follow-up|0
146051|NCT00645944|464453|P1|Received Medication|Lost to Follow-up|1
146052|NCT00645944|464452|P2|Received Medication|Withdrawal by Subject|1
146053|NCT00645944|464453|P1|Received Medication|Withdrawal by Subject|1
146054|NCT00645944|464452|P2|Received Medication|Adverse Event|1
146055|NCT00645944|464453|P1|Received Medication|Adverse Event|2
146056|NCT00645944|464452|P2|Randomized|Withdrawal by Subject|2
146057|NCT00645944|464453|P1|Randomized|Withdrawal by Subject|1
146058|NCT00646282|464476|P2|Overall Study|Protocol terminated|4
146059|NCT00646282|464477|P1|Overall Study|Protocol terminated|4
146060|NCT00646399|464485|P2|Overall Study|Other Reason|11
146061|NCT00646399|464486|P1|Overall Study|Other Reason|11
146062|NCT00646399|464485|P2|Overall Study|Withdrawal by Subject|10
146063|NCT00646399|464486|P1|Overall Study|Withdrawal by Subject|9
146064|NCT00646399|464485|P2|Overall Study|Death|53
146065|NCT00646399|464486|P1|Overall Study|Death|63
146066|NCT00646776|464543|P2|Overall Study|Investigator discretion|4
146067|NCT00646776|464544|P1|Overall Study|Investigator discretion|0
146068|NCT00646776|464543|P2|Overall Study|Adverse Event|9
146069|NCT00646776|464544|P1|Overall Study|Adverse Event|1
146070|NCT00646958|464594|P3|Overall Study|Did not receive study drug|2
146071|NCT00646958|464595|P2|Overall Study|Did not receive study drug|0
146072|NCT00646958|464596|P1|Overall Study|Did not receive study drug|2
146073|NCT00646958|464594|P3|Overall Study|Withdrawal by Subject|0
146074|NCT00646958|464595|P2|Overall Study|Withdrawal by Subject|2
146075|NCT00646958|464596|P1|Overall Study|Withdrawal by Subject|1
146076|NCT00646958|464594|P3|Overall Study|Abnormal screening lab tests|0
146077|NCT00646958|464595|P2|Overall Study|Abnormal screening lab tests|1
146078|NCT00646958|464596|P1|Overall Study|Abnormal screening lab tests|1
146080|NCT00646958|464595|P2|Overall Study|Protocol Violation|1
146081|NCT00646958|464596|P1|Overall Study|Protocol Violation|1
146082|NCT00646958|464594|P3|Overall Study|Lost to Follow-up|7
146083|NCT00646958|464595|P2|Overall Study|Lost to Follow-up|5
146084|NCT00646958|464596|P1|Overall Study|Lost to Follow-up|1
146085|NCT00646958|464594|P3|Overall Study|Adverse Event|0
146086|NCT00646958|464595|P2|Overall Study|Adverse Event|0
146087|NCT00646958|464596|P1|Overall Study|Adverse Event|4
146088|NCT00646958|464594|P3|Overall Study|Lack of Efficacy|0
146089|NCT00646958|464595|P2|Overall Study|Lack of Efficacy|0
146090|NCT00646958|464596|P1|Overall Study|Lack of Efficacy|1
146091|NCT00647270|464610|P3|Period 2, Placebo Switched to Adalimumab|Other|0
146092|NCT00647270|464611|P2|Period 2, Placebo Switched to Adalimumab|Other|6
146093|NCT00647270|464612|P1|Period 2, Placebo Switched to Adalimumab|Other|2
146094|NCT00647270|464610|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
146095|NCT00647270|464611|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
146096|NCT00647270|464612|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
146097|NCT00647270|464610|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
146098|NCT00647270|464611|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
146099|NCT00647270|464612|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
146100|NCT00647270|464610|P3|Period 1, Placebo-control (12 Weeks)|Other|8
146101|NCT00647270|464611|P2|Period 1, Placebo-control (12 Weeks)|Other|4
146102|NCT00647270|464612|P1|Period 1, Placebo-control (12 Weeks)|Other|4
146103|NCT00647270|464610|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
146104|NCT00647270|464611|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
146105|NCT00647270|464612|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
146106|NCT00647270|464610|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
146107|NCT00647270|464611|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
146108|NCT00647270|464612|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
146109|NCT00647270|464610|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
146110|NCT00647270|464611|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
146111|NCT00647270|464612|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
146112|NCT00647556|464650|P2|Overall Study|Surgery for pre-existing neck pain|0
146113|NCT00647556|464651|P1|Overall Study|Surgery for pre-existing neck pain|1
146114|NCT00647556|464650|P2|Overall Study|Withdrawal by Subject|0
146115|NCT00647556|464651|P1|Overall Study|Withdrawal by Subject|1
146116|NCT00647556|464650|P2|Overall Study|Protocol Violation|1
146117|NCT00647556|464651|P1|Overall Study|Protocol Violation|0
146118|NCT00647556|464650|P2|Overall Study|Lost to Follow-up|0
146119|NCT00647556|464651|P1|Overall Study|Lost to Follow-up|1
146120|NCT00647556|464650|P2|Overall Study|Adverse Event|1
146121|NCT00647556|464651|P1|Overall Study|Adverse Event|0
146122|NCT00647699|464667|P2|Overall Study|Withdrawal by Subject|8
146123|NCT00647699|464668|P1|Overall Study|Withdrawal by Subject|3
146124|NCT00647699|464667|P2|Overall Study|Lost to Follow-up|4
146125|NCT00647699|464668|P1|Overall Study|Lost to Follow-up|5
146126|NCT00638690|464681|P2|Overall Study|Lost to Follow-up|2
146127|NCT00638690|464682|P1|Overall Study|Lost to Follow-up|4
146128|NCT00638690|464681|P2|Overall Study|Withdrawal by Subject|5
146129|NCT00638690|464682|P1|Overall Study|Withdrawal by Subject|22
146130|NCT00638690|464681|P2|Overall Study|Death|335
146131|NCT00638690|464682|P1|Overall Study|Death|655
146132|NCT00638846|464723|P2|Overall Study|lens issue|3
146133|NCT00638846|464724|P1|Overall Study|lens issue|1
146134|NCT00638846|464723|P2|Overall Study|Lost to Follow-up|2
146135|NCT00638846|464724|P1|Overall Study|Lost to Follow-up|3
146136|NCT00638846|464723|P2|Overall Study|Adverse Event|1
146137|NCT00638846|464724|P1|Overall Study|Adverse Event|0
146138|NCT00638963|464761|P2|Overall Study|Withdrawal by Subject|0
146139|NCT00638963|464762|P1|Overall Study|Withdrawal by Subject|1
146140|NCT00638989|464784|P3|Overall Study|Lost to Follow-up|1
146141|NCT00638989|464785|P2|Overall Study|Lost to Follow-up|0
146142|NCT00638989|464786|P1|Overall Study|Lost to Follow-up|0
146143|NCT00639002|464824|P1|Overall Study|Lack of Efficacy|1
146144|NCT00639002|464824|P1|Overall Study|Physician Decision|6
146145|NCT00639002|464824|P1|Overall Study|Disease progression|3
146146|NCT00639002|464824|P1|Overall Study|Protocol Violation|1
146147|NCT00639002|464824|P1|Overall Study|Adverse Event|1
146148|NCT00639002|464824|P1|Overall Study|Death|1
146149|NCT00639223|464864|P2|Overall Study|Lost to Follow-up|2
146150|NCT00639223|464865|P1|Overall Study|Lost to Follow-up|0
146151|NCT00639379|464873|P2|Period 1 - 2 Weeks|lens issue|0
146152|NCT00639379|464874|P1|Period 1 - 2 Weeks|lens issue|3
146153|NCT00639379|464873|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
146154|NCT00639379|464874|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
146155|NCT00639457|464915|P2|Overall Study|Withdrawal by Subject|3
146156|NCT00639457|464916|P1|Overall Study|Withdrawal by Subject|2
146157|NCT00639509|464950|P1|Overall Study|Death|1
146158|NCT00639678|464960|P4|Overall Study|Lack of Compliance|0
146159|NCT00639678|464961|P3|Overall Study|Lack of Compliance|1
146160|NCT00639678|464962|P2|Overall Study|Lack of Compliance|0
146161|NCT00639678|464963|P1|Overall Study|Lack of Compliance|0
146162|NCT00639678|464960|P4|Overall Study|Adverse Event|0
146163|NCT00639678|464961|P3|Overall Study|Adverse Event|0
146164|NCT00639678|464962|P2|Overall Study|Adverse Event|1
146165|NCT00639678|464963|P1|Overall Study|Adverse Event|0
146166|NCT00639678|464960|P4|Overall Study|Lost to Follow-up|0
146167|NCT00639678|464961|P3|Overall Study|Lost to Follow-up|6
146168|NCT00639678|464962|P2|Overall Study|Lost to Follow-up|0
146169|NCT00639678|464963|P1|Overall Study|Lost to Follow-up|1
146170|NCT00639678|464960|P4|Overall Study|Withdrawal by Subject|0
146171|NCT00639678|464961|P3|Overall Study|Withdrawal by Subject|4
146172|NCT00639678|464962|P2|Overall Study|Withdrawal by Subject|0
146173|NCT00639678|464963|P1|Overall Study|Withdrawal by Subject|3
146174|NCT00639769|465031|P1|Overall Study|Withdrawal by Subject|4
146175|NCT00639769|465031|P1|Overall Study|Disease progression|26
146176|NCT00639769|465031|P1|Overall Study|Lack of Efficacy|1
146177|NCT00639769|465031|P1|Overall Study|Adverse Event|7
146178|NCT00639769|465031|P1|Overall Study|Death|2
146179|NCT00640016|465048|P4|Overall Study|Adverse Event|1
146180|NCT00640016|465049|P3|Overall Study|Adverse Event|0
146181|NCT00640016|465050|P2|Overall Study|Adverse Event|0
146182|NCT00640016|465051|P1|Overall Study|Adverse Event|0
146183|NCT00640016|465048|P4|Overall Study|Study termination|2
146184|NCT00640016|465049|P3|Overall Study|Study termination|3
146185|NCT00640016|465050|P2|Overall Study|Study termination|1
146186|NCT00640016|465051|P1|Overall Study|Study termination|2
146187|NCT00640016|465048|P4|Overall Study|Withdrawal by Subject|0
146188|NCT00640016|465049|P3|Overall Study|Withdrawal by Subject|0
146189|NCT00640016|465050|P2|Overall Study|Withdrawal by Subject|1
146190|NCT00640016|465051|P1|Overall Study|Withdrawal by Subject|0
146191|NCT00640042|465095|P1|Enrollment|Did not receive study drug|83
146192|NCT00640315|465109|P2|Overall Study|Withdrawal by Subject|1
146193|NCT00640315|465110|P1|Overall Study|Withdrawal by Subject|0
146194|NCT00640328|465242|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
146195|NCT00640328|465243|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
146196|NCT00640328|465244|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
146197|NCT00640328|465245|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
146198|NCT00640328|465246|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
146199|NCT00640328|465247|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
146200|NCT00640328|465242|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
146201|NCT00640328|465243|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
146202|NCT00640328|465244|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
146203|NCT00640328|465245|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
146204|NCT00640328|465246|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
146205|NCT00640328|465247|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
146206|NCT00640328|465242|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
146207|NCT00640328|465243|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
146208|NCT00640328|465244|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
146209|NCT00640328|465245|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
146210|NCT00640328|465246|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
146211|NCT00640328|465247|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
146212|NCT00640328|465242|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
146213|NCT00640328|465243|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
146214|NCT00640328|465244|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
146215|NCT00640328|465245|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
146216|NCT00640328|465246|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
146217|NCT00640328|465247|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
146218|NCT00640341|465414|P3|Overall Study|Adverse event and positive slit lamp|0
146219|NCT00640341|465415|P2|Overall Study|Adverse event and positive slit lamp|0
146220|NCT00640341|465416|P1|Overall Study|Adverse event and positive slit lamp|1
146221|NCT00640341|465414|P3|Overall Study|Ineligable at Baseline|2
146222|NCT00640341|465415|P2|Overall Study|Ineligable at Baseline|3
146223|NCT00640341|465416|P1|Overall Study|Ineligable at Baseline|5
146224|NCT00640341|465414|P3|Overall Study|Poor fit/Uncomfortable|0
146225|NCT00640341|465415|P2|Overall Study|Poor fit/Uncomfortable|0
146226|NCT00640341|465416|P1|Overall Study|Poor fit/Uncomfortable|4
146227|NCT00640341|465414|P3|Overall Study|Unacceptable Lens Movement|0
146228|NCT00640341|465415|P2|Overall Study|Unacceptable Lens Movement|0
146229|NCT00640341|465416|P1|Overall Study|Unacceptable Lens Movement|1
146230|NCT00640341|465414|P3|Overall Study|Withdrawal by Subject|1
146231|NCT00640341|465415|P2|Overall Study|Withdrawal by Subject|0
146232|NCT00640341|465416|P1|Overall Study|Withdrawal by Subject|4
146233|NCT00640341|465414|P3|Overall Study|Lost to Follow-up|0
146234|NCT00640341|465415|P2|Overall Study|Lost to Follow-up|0
146235|NCT00640341|465416|P1|Overall Study|Lost to Follow-up|2
146236|NCT00640341|465414|P3|Overall Study|Failure to Follow Subject Instructions|0
146237|NCT00640341|465415|P2|Overall Study|Failure to Follow Subject Instructions|0
146238|NCT00640341|465416|P1|Overall Study|Failure to Follow Subject Instructions|1
146239|NCT00640341|465414|P3|Overall Study|Inability to Maintain Wearing Schedule|0
146240|NCT00640341|465415|P2|Overall Study|Inability to Maintain Wearing Schedule|1
146241|NCT00640341|465416|P1|Overall Study|Inability to Maintain Wearing Schedule|1
146242|NCT00640341|465414|P3|Overall Study|Study Related Symptoms/Complaints|2
146243|NCT00640341|465415|P2|Overall Study|Study Related Symptoms/Complaints|1
146244|NCT00640341|465416|P1|Overall Study|Study Related Symptoms/Complaints|2
146245|NCT00640341|465414|P3|Overall Study|Positive Slit Lamp Findings|1
146246|NCT00640341|465415|P2|Overall Study|Positive Slit Lamp Findings|0
146247|NCT00640341|465416|P1|Overall Study|Positive Slit Lamp Findings|0
146248|NCT00640341|465414|P3|Overall Study|Adverse Event|1
146249|NCT00640341|465415|P2|Overall Study|Adverse Event|0
146250|NCT00640341|465416|P1|Overall Study|Adverse Event|0
146251|NCT00648037|465443|P1|Overall Study|Other|1
146252|NCT00648037|465443|P1|Overall Study|Relapse|2
146253|NCT00648037|465443|P1|Overall Study|Adverse Event|11
146254|NCT00648037|465443|P1|Overall Study|Withdrawal by Subject|1
146255|NCT00648037|465443|P1|Overall Study|Not Treated|1
146256|NCT00648167|465463|P1|Overall Study|unable to swallow tablets|1
146257|NCT00648167|465463|P1|Overall Study|Adverse Event|6
146258|NCT00650585|465474|P2|Overall Study|Excluded/ruled ineligible|129
146259|NCT00650585|465475|P1|Overall Study|Excluded/ruled ineligible|357
146260|NCT00650585|465474|P2|Overall Study|No parental consent|866
146261|NCT00650585|465475|P1|Overall Study|No parental consent|935
146262|NCT00650585|465474|P2|Overall Study|Lost to Follow-up|482
146263|NCT00650585|465475|P1|Overall Study|Lost to Follow-up|505
146264|NCT00650767|465499|P4|Overall Study|Other|0
146265|NCT00650767|465500|P3|Overall Study|Other|0
146266|NCT00650767|465501|P2|Overall Study|Other|1
146267|NCT00650767|465502|P1|Overall Study|Other|1
146268|NCT00650767|465499|P4|Overall Study|Lost to Follow-up|0
146269|NCT00650767|465500|P3|Overall Study|Lost to Follow-up|1
146270|NCT00650767|465501|P2|Overall Study|Lost to Follow-up|1
146271|NCT00650767|465502|P1|Overall Study|Lost to Follow-up|1
146272|NCT00650767|465499|P4|Overall Study|Withdrawal by Subject|3
146273|NCT00650767|465500|P3|Overall Study|Withdrawal by Subject|3
146274|NCT00650767|465501|P2|Overall Study|Withdrawal by Subject|4
146275|NCT00650767|465502|P1|Overall Study|Withdrawal by Subject|2
146276|NCT00650767|465499|P4|Overall Study|Death|0
146277|NCT00650767|465500|P3|Overall Study|Death|0
146278|NCT00650767|465501|P2|Overall Study|Death|0
146279|NCT00650767|465502|P1|Overall Study|Death|1
146280|NCT00650767|465499|P4|Overall Study|Adverse Event|8
146281|NCT00650767|465500|P3|Overall Study|Adverse Event|10
146282|NCT00650767|465501|P2|Overall Study|Adverse Event|3
146283|NCT00650767|465502|P1|Overall Study|Adverse Event|0
146284|NCT00650806|466008|P4|Overall Study|Not specified|0
146285|NCT00650806|466009|P3|Overall Study|Not specified|2
146286|NCT00650806|466010|P2|Overall Study|Not specified|1
146287|NCT00650806|466011|P1|Overall Study|Not specified|1
146288|NCT00650806|466008|P4|Overall Study|Study terminated by sponsor|4
146289|NCT00650806|466009|P3|Overall Study|Study terminated by sponsor|5
146290|NCT00650806|466010|P2|Overall Study|Study terminated by sponsor|3
146291|NCT00650806|466011|P1|Overall Study|Study terminated by sponsor|2
146292|NCT00650806|466008|P4|Overall Study|Noncompliance with study drug regimen|0
146293|NCT00650806|466009|P3|Overall Study|Noncompliance with study drug regimen|0
146294|NCT00650806|466010|P2|Overall Study|Noncompliance with study drug regimen|1
146295|NCT00650806|466011|P1|Overall Study|Noncompliance with study drug regimen|1
146296|NCT00650806|466008|P4|Overall Study|Withdrawal by Subject|6
146297|NCT00650806|466009|P3|Overall Study|Withdrawal by Subject|8
146298|NCT00650806|466010|P2|Overall Study|Withdrawal by Subject|5
146299|NCT00650806|466011|P1|Overall Study|Withdrawal by Subject|7
146300|NCT00650806|466008|P4|Overall Study|Pregnancy|1
146301|NCT00650806|466009|P3|Overall Study|Pregnancy|0
146302|NCT00650806|466010|P2|Overall Study|Pregnancy|0
146303|NCT00650806|466011|P1|Overall Study|Pregnancy|0
146304|NCT00650806|466008|P4|Overall Study|Protocol Violation|1
146305|NCT00650806|466009|P3|Overall Study|Protocol Violation|0
146306|NCT00650806|466010|P2|Overall Study|Protocol Violation|0
146307|NCT00650806|466011|P1|Overall Study|Protocol Violation|0
146308|NCT00650806|466008|P4|Overall Study|Lost to Follow-up|10
146309|NCT00650806|466009|P3|Overall Study|Lost to Follow-up|11
146310|NCT00650806|466010|P2|Overall Study|Lost to Follow-up|6
146311|NCT00650806|466011|P1|Overall Study|Lost to Follow-up|7
146312|NCT00650806|466008|P4|Overall Study|Adverse Event|4
146313|NCT00650806|466009|P3|Overall Study|Adverse Event|3
146314|NCT00650806|466010|P2|Overall Study|Adverse Event|5
146315|NCT00650806|466011|P1|Overall Study|Adverse Event|0
146316|NCT00650845|466051|P2|Overall Study|Protocol Violation|13
146317|NCT00650845|466052|P1|Overall Study|Protocol Violation|0
146318|NCT00650845|466051|P2|Overall Study|Withdrawal by Subject|0
146319|NCT00650845|466052|P1|Overall Study|Withdrawal by Subject|5
146320|NCT00651118|466100|P4|Overall Study|Withdrawal by Subject|1
146321|NCT00651118|466101|P3|Overall Study|Withdrawal by Subject|1
146322|NCT00651118|466102|P2|Overall Study|Withdrawal by Subject|1
146323|NCT00651118|466103|P1|Overall Study|Withdrawal by Subject|0
146324|NCT00651118|466100|P4|Overall Study|administrative|1
146325|NCT00651118|466101|P3|Overall Study|administrative|2
146326|NCT00651118|466102|P2|Overall Study|administrative|4
146327|NCT00651118|466103|P1|Overall Study|administrative|1
146328|NCT00651118|466100|P4|Overall Study|Lost to Follow-up|2
146329|NCT00651118|466101|P3|Overall Study|Lost to Follow-up|1
146330|NCT00651118|466102|P2|Overall Study|Lost to Follow-up|0
146331|NCT00651118|466103|P1|Overall Study|Lost to Follow-up|2
146332|NCT00651118|466100|P4|Overall Study|Protocol Violation|2
146333|NCT00651118|466101|P3|Overall Study|Protocol Violation|6
146334|NCT00651118|466102|P2|Overall Study|Protocol Violation|2
146335|NCT00651118|466103|P1|Overall Study|Protocol Violation|2
146336|NCT00651118|466100|P4|Overall Study|Adverse Event|1
146337|NCT00651118|466101|P3|Overall Study|Adverse Event|1
146338|NCT00651118|466102|P2|Overall Study|Adverse Event|0
146339|NCT00651118|466103|P1|Overall Study|Adverse Event|4
146340|NCT00651157|466121|P1|Overall Study|Protocol Violation|1
146341|NCT00651157|466121|P1|Overall Study|Death|1
146342|NCT00651183|466129|P2|Overall Study|missing|0
146343|NCT00651183|466130|P1|Overall Study|missing|1
146344|NCT00651183|466129|P2|Overall Study|Other reasons|2
146345|NCT00651183|466130|P1|Overall Study|Other reasons|4
146346|NCT00651183|466129|P2|Overall Study|Lost to Follow-up|1
146347|NCT00651183|466130|P1|Overall Study|Lost to Follow-up|3
146348|NCT00651183|466129|P2|Overall Study|Withdrawal by Subject|3
146349|NCT00651183|466130|P1|Overall Study|Withdrawal by Subject|6
146350|NCT00651183|466129|P2|Overall Study|Tolerability insufficient +Patients wish|1
146351|NCT00651183|466130|P1|Overall Study|Tolerability insufficient +Patients wish|0
146352|NCT00651183|466129|P2|Overall Study|Tolerability insufficient|2
146353|NCT00651183|466130|P1|Overall Study|Tolerability insufficient|5
146354|NCT00651183|466129|P2|Overall Study|Efficacy insufficient + patients wish|1
146355|NCT00651183|466130|P1|Overall Study|Efficacy insufficient + patients wish|0
146356|NCT00651183|466129|P2|Overall Study|Lack of Efficacy|0
146357|NCT00651183|466130|P1|Overall Study|Lack of Efficacy|1
146358|NCT00651261|466144|P2|Overall Study|Never treated|3
146359|NCT00651261|466145|P1|Overall Study|Never treated|5
146360|NCT00651261|466144|P2|Overall Study|Other disease or participant decisions|23
146361|NCT00651261|466145|P1|Overall Study|Other disease or participant decisions|23
146362|NCT00651261|466144|P2|Overall Study|Alternative therapy|107
146363|NCT00651261|466145|P1|Overall Study|Alternative therapy|109
146364|NCT00651261|466144|P2|Overall Study|Disease progression|58
146365|NCT00651261|466145|P1|Overall Study|Disease progression|58
146366|NCT00651261|466144|P2|Overall Study|Induction failure|35
146367|NCT00651261|466145|P1|Overall Study|Induction failure|24
146368|NCT00651261|466144|P2|Overall Study|Withdrawal by Subject|40
146369|NCT00651261|466145|P1|Overall Study|Withdrawal by Subject|22
146370|NCT00651261|466144|P2|Overall Study|Death|18
146371|NCT00651261|466145|P1|Overall Study|Death|18
146372|NCT00651261|466144|P2|Overall Study|Adverse Event|22
146373|NCT00651261|466145|P1|Overall Study|Adverse Event|32
146374|NCT00651313|466161|P2|Overall Study|Adminstrative Discontinuation|3
146375|NCT00651313|466162|P1|Overall Study|Adminstrative Discontinuation|2
146376|NCT00651313|466161|P2|Overall Study|Lost to Follow-up|1
146377|NCT00651313|466162|P1|Overall Study|Lost to Follow-up|1
146378|NCT00651313|466161|P2|Overall Study|Withdrawal by Subject|1
146379|NCT00651313|466162|P1|Overall Study|Withdrawal by Subject|3
146380|NCT00651313|466161|P2|Overall Study|Adverse Event|1
146381|NCT00651313|466162|P1|Overall Study|Adverse Event|0
146382|NCT00651755|466195|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
146383|NCT00651755|466196|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
146384|NCT00651755|466195|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
146385|NCT00651755|466196|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
146386|NCT00651820|466212|P1|Overall Study|Lost to Follow-up|2
146387|NCT00651924|466221|P2|Overall Study|Withdrawal by Subject|5
146388|NCT00651924|466222|P1|Overall Study|Withdrawal by Subject|0
146389|NCT00651924|466221|P2|Overall Study|Withdrawal by PI|2
146390|NCT00651924|466222|P1|Overall Study|Withdrawal by PI|0
146391|NCT00652028|466232|P4|Overall Study|Physician Decision|0
146392|NCT00652028|466233|P3|Overall Study|Physician Decision|1
146393|NCT00652028|466234|P2|Overall Study|Physician Decision|0
146394|NCT00652028|466235|P1|Overall Study|Physician Decision|0
146395|NCT00652028|466232|P4|Overall Study|No Longer Meets Entry Criteria|0
146396|NCT00652028|466233|P3|Overall Study|No Longer Meets Entry Criteria|0
146397|NCT00652028|466234|P2|Overall Study|No Longer Meets Entry Criteria|1
146398|NCT00652028|466235|P1|Overall Study|No Longer Meets Entry Criteria|0
146399|NCT00652028|466232|P4|Overall Study|Adverse Event|0
146400|NCT00652028|466233|P3|Overall Study|Adverse Event|0
146401|NCT00652028|466234|P2|Overall Study|Adverse Event|0
146402|NCT00652028|466235|P1|Overall Study|Adverse Event|1
146403|NCT00652093|466283|P6|Overall Study|Physician Decision|0
146404|NCT00652093|466284|P5|Overall Study|Physician Decision|1
146405|NCT00652093|466285|P4|Overall Study|Physician Decision|0
146406|NCT00652093|466286|P3|Overall Study|Physician Decision|0
146407|NCT00652093|466287|P2|Overall Study|Physician Decision|0
146408|NCT00652093|466288|P1|Overall Study|Physician Decision|0
146409|NCT00652093|466283|P6|Overall Study|Withdrawal by Subject|0
146410|NCT00652093|466284|P5|Overall Study|Withdrawal by Subject|1
146411|NCT00652093|466285|P4|Overall Study|Withdrawal by Subject|0
146412|NCT00652093|466286|P3|Overall Study|Withdrawal by Subject|1
146413|NCT00652093|466287|P2|Overall Study|Withdrawal by Subject|0
146414|NCT00652093|466288|P1|Overall Study|Withdrawal by Subject|0
146415|NCT00652327|466400|P2|Overall Study|Lost to Follow-up|3
146416|NCT00652327|466401|P1|Overall Study|Lost to Follow-up|0
146417|NCT00652327|466400|P2|Overall Study|Adverse Event|2
146418|NCT00652327|466401|P1|Overall Study|Adverse Event|0
146419|NCT00652340|466409|P2|Overall Study|Had not progressed.|3
146420|NCT00652340|466410|P1|Overall Study|Had not progressed.|4
146421|NCT00652366|466423|P5|Overall Study|Not specified|0
146422|NCT00652366|466424|P4|Overall Study|Not specified|4
146423|NCT00652366|466425|P3|Overall Study|Not specified|3
146424|NCT00652366|466426|P2|Overall Study|Not specified|2
146425|NCT00652366|466427|P1|Overall Study|Not specified|5
146426|NCT00652366|466423|P5|Overall Study|Refused treatment|5
146427|NCT00652366|466424|P4|Overall Study|Refused treatment|17
146428|NCT00652366|466425|P3|Overall Study|Refused treatment|6
146429|NCT00652366|466426|P2|Overall Study|Refused treatment|7
146430|NCT00652366|466427|P1|Overall Study|Refused treatment|3
146431|NCT00652366|466423|P5|Overall Study|Protocol Violation|0
146432|NCT00652366|466424|P4|Overall Study|Protocol Violation|0
146433|NCT00652366|466425|P3|Overall Study|Protocol Violation|0
146434|NCT00652366|466426|P2|Overall Study|Protocol Violation|0
146435|NCT00652366|466427|P1|Overall Study|Protocol Violation|1
146436|NCT00652366|466423|P5|Overall Study|Violation of Selection Criteria|0
146437|NCT00652366|466424|P4|Overall Study|Violation of Selection Criteria|0
146438|NCT00652366|466425|P3|Overall Study|Violation of Selection Criteria|1
146439|NCT00652366|466426|P2|Overall Study|Violation of Selection Criteria|0
146440|NCT00652366|466427|P1|Overall Study|Violation of Selection Criteria|0
146441|NCT00652366|466423|P5|Overall Study|Lack of Efficacy|13
146442|NCT00652366|466424|P4|Overall Study|Lack of Efficacy|133
146443|NCT00652366|466425|P3|Overall Study|Lack of Efficacy|53
146444|NCT00652366|466426|P2|Overall Study|Lack of Efficacy|58
146445|NCT00652366|466427|P1|Overall Study|Lack of Efficacy|84
146446|NCT00652366|466423|P5|Overall Study|Death|5
146447|NCT00652366|466424|P4|Overall Study|Death|8
146448|NCT00652366|466425|P3|Overall Study|Death|1
146449|NCT00652366|466426|P2|Overall Study|Death|4
146450|NCT00652366|466427|P1|Overall Study|Death|5
146451|NCT00652366|466423|P5|Overall Study|Adverse Event|13
146452|NCT00652366|466424|P4|Overall Study|Adverse Event|17
146453|NCT00652366|466425|P3|Overall Study|Adverse Event|7
146454|NCT00652366|466426|P2|Overall Study|Adverse Event|4
146455|NCT00652366|466427|P1|Overall Study|Adverse Event|8
146456|NCT00652626|466467|P7|Extension Phase|Death|1
146457|NCT00652626|466468|P6|Extension Phase|Death|1
146458|NCT00652626|466469|P5|Extension Phase|Death|0
146459|NCT00652626|466470|P4|Extension Phase|Death|0
146460|NCT00652626|466471|P3|Extension Phase|Death|0
146461|NCT00652626|466472|P2|Extension Phase|Death|0
146462|NCT00652626|466473|P1|Extension Phase|Death|0
146463|NCT00652626|466467|P7|Extension Phase|Physician Decision|1
146464|NCT00652626|466468|P6|Extension Phase|Physician Decision|1
146465|NCT00652626|466469|P5|Extension Phase|Physician Decision|0
146466|NCT00652626|466470|P4|Extension Phase|Physician Decision|0
146467|NCT00652626|466471|P3|Extension Phase|Physician Decision|0
146468|NCT00652626|466472|P2|Extension Phase|Physician Decision|0
146469|NCT00652626|466473|P1|Extension Phase|Physician Decision|0
146470|NCT00652626|466467|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
146471|NCT00652626|466468|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
146472|NCT00652626|466469|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
146473|NCT00652626|466470|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
146474|NCT00652626|466471|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
146475|NCT00652626|466472|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
146476|NCT00652626|466473|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
146477|NCT00652626|466467|P7|Extension Phase|Adverse Event|1
146478|NCT00652626|466468|P6|Extension Phase|Adverse Event|2
146479|NCT00652626|466469|P5|Extension Phase|Adverse Event|0
146480|NCT00652626|466470|P4|Extension Phase|Adverse Event|0
146481|NCT00652626|466471|P3|Extension Phase|Adverse Event|0
146482|NCT00652626|466472|P2|Extension Phase|Adverse Event|0
146483|NCT00652626|466473|P1|Extension Phase|Adverse Event|0
146484|NCT00652626|466467|P7|Extension Phase|Withdrawal by Subject|0
146485|NCT00652626|466468|P6|Extension Phase|Withdrawal by Subject|2
146486|NCT00652626|466469|P5|Extension Phase|Withdrawal by Subject|0
146487|NCT00652626|466470|P4|Extension Phase|Withdrawal by Subject|0
146488|NCT00652626|466471|P3|Extension Phase|Withdrawal by Subject|0
146489|NCT00652626|466472|P2|Extension Phase|Withdrawal by Subject|0
146490|NCT00652626|466473|P1|Extension Phase|Withdrawal by Subject|0
146491|NCT00652626|466467|P7|Initial Treatment Phase|Lost to Follow-up|0
146492|NCT00652626|466468|P6|Initial Treatment Phase|Lost to Follow-up|0
146493|NCT00652626|466469|P5|Initial Treatment Phase|Lost to Follow-up|1
146494|NCT00652626|466470|P4|Initial Treatment Phase|Lost to Follow-up|0
146495|NCT00652626|466471|P3|Initial Treatment Phase|Lost to Follow-up|0
146496|NCT00652626|466472|P2|Initial Treatment Phase|Lost to Follow-up|0
146497|NCT00652626|466473|P1|Initial Treatment Phase|Lost to Follow-up|0
146498|NCT00652626|466467|P7|Initial Treatment Phase|Sponsor Request|0
146499|NCT00652626|466468|P6|Initial Treatment Phase|Sponsor Request|0
146500|NCT00652626|466469|P5|Initial Treatment Phase|Sponsor Request|0
146501|NCT00652626|466470|P4|Initial Treatment Phase|Sponsor Request|0
146502|NCT00652626|466471|P3|Initial Treatment Phase|Sponsor Request|1
146503|NCT00652626|466472|P2|Initial Treatment Phase|Sponsor Request|0
146504|NCT00652626|466473|P1|Initial Treatment Phase|Sponsor Request|0
146505|NCT00652626|466467|P7|Initial Treatment Phase|Physician Decision|0
146506|NCT00652626|466468|P6|Initial Treatment Phase|Physician Decision|0
146507|NCT00652626|466469|P5|Initial Treatment Phase|Physician Decision|1
146508|NCT00652626|466470|P4|Initial Treatment Phase|Physician Decision|0
146509|NCT00652626|466471|P3|Initial Treatment Phase|Physician Decision|0
146510|NCT00652626|466472|P2|Initial Treatment Phase|Physician Decision|0
146511|NCT00652626|466473|P1|Initial Treatment Phase|Physician Decision|0
146512|NCT00652626|466467|P7|Initial Treatment Phase|Protocol Violation|0
146513|NCT00652626|466468|P6|Initial Treatment Phase|Protocol Violation|0
146514|NCT00652626|466469|P5|Initial Treatment Phase|Protocol Violation|0
146515|NCT00652626|466470|P4|Initial Treatment Phase|Protocol Violation|1
146516|NCT00652626|466471|P3|Initial Treatment Phase|Protocol Violation|0
146517|NCT00652626|466472|P2|Initial Treatment Phase|Protocol Violation|0
146518|NCT00652626|466473|P1|Initial Treatment Phase|Protocol Violation|0
146519|NCT00652626|466467|P7|Initial Treatment Phase|Adverse Event|0
146520|NCT00652626|466468|P6|Initial Treatment Phase|Adverse Event|0
146521|NCT00652626|466469|P5|Initial Treatment Phase|Adverse Event|1
146522|NCT00652626|466470|P4|Initial Treatment Phase|Adverse Event|0
146523|NCT00652626|466471|P3|Initial Treatment Phase|Adverse Event|0
146524|NCT00652626|466472|P2|Initial Treatment Phase|Adverse Event|0
146525|NCT00652626|466473|P1|Initial Treatment Phase|Adverse Event|0
146526|NCT00643201|466539|P2|Completed Study Follow Up|non-specified|0
146527|NCT00643201|466540|P1|Completed Study Follow Up|non-specified|1
146528|NCT00643201|466539|P2|Completed Study Follow Up|Lost to Follow-up|16
146529|NCT00643201|466540|P1|Completed Study Follow Up|Lost to Follow-up|18
146530|NCT00643201|466539|P2|Completed Study Follow Up|Withdrawal by Subject|29
146531|NCT00643201|466540|P1|Completed Study Follow Up|Withdrawal by Subject|23
146532|NCT00643201|466539|P2|Completed Study Follow Up|Death|34
146533|NCT00643201|466540|P1|Completed Study Follow Up|Death|28
146534|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|not specified|107
146535|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|not specified|107
146536|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
146537|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
146538|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
146539|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
146540|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
146541|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
146542|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
146543|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
146544|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
146545|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
146546|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
146547|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
146548|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
146549|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
146550|NCT00643201|466539|P2|Randomized, Completed 6 Months of Study|Death|26
146551|NCT00643201|466540|P1|Randomized, Completed 6 Months of Study|Death|20
146552|NCT00643448|466589|P3|Overall Study|QTcF>550 ms|0
146553|NCT00643448|466590|P2|Overall Study|QTcF>550 ms|3
146554|NCT00643448|466591|P1|Overall Study|QTcF>550 ms|0
146555|NCT00643448|466589|P3|Overall Study|Adverse Event|2
146556|NCT00643448|466590|P2|Overall Study|Adverse Event|2
146557|NCT00643448|466591|P1|Overall Study|Adverse Event|2
146558|NCT00643448|466589|P3|Overall Study|Lack of Efficacy|4
146559|NCT00643448|466590|P2|Overall Study|Lack of Efficacy|0
146560|NCT00643448|466591|P1|Overall Study|Lack of Efficacy|2
146561|NCT00643487|466606|P1|Overall Study|Technical difficulty|3
146562|NCT00643565|466612|P2|Overall Study|Lost to Follow-up|0
146563|NCT00643565|466613|P1|Overall Study|Lost to Follow-up|2
146564|NCT00643565|466612|P2|Overall Study|Withdrawal by Subject|1
146565|NCT00643565|466613|P1|Overall Study|Withdrawal by Subject|2
146566|NCT00643565|466612|P2|Overall Study|Ongoing in Follow-up|39
146567|NCT00643565|466613|P1|Overall Study|Ongoing in Follow-up|39
146568|NCT00643565|466612|P2|Overall Study|Death|34
146569|NCT00643565|466613|P1|Overall Study|Death|37
146570|NCT00643604|466644|P1|Overall Study|Death|1
146571|NCT00643682|466663|P2|Overall Study|did not keep appointment|509
146572|NCT00643682|466664|P1|Overall Study|did not keep appointment|522
146573|NCT00643760|466681|P5|Overall Study|Withdrawal by Subject|1
146574|NCT00643760|466682|P4|Overall Study|Withdrawal by Subject|4
146575|NCT00643760|466683|P3|Overall Study|Withdrawal by Subject|2
146576|NCT00643760|466684|P2|Overall Study|Withdrawal by Subject|1
146577|NCT00643760|466685|P1|Overall Study|Withdrawal by Subject|3
146578|NCT00643760|466681|P5|Overall Study|Investigator Discretion|0
146579|NCT00643760|466682|P4|Overall Study|Investigator Discretion|2
146580|NCT00643760|466683|P3|Overall Study|Investigator Discretion|0
146581|NCT00643760|466684|P2|Overall Study|Investigator Discretion|0
146582|NCT00643760|466685|P1|Overall Study|Investigator Discretion|0
146583|NCT00643760|466681|P5|Overall Study|Lost to Follow-up|3
146584|NCT00643760|466682|P4|Overall Study|Lost to Follow-up|3
146585|NCT00643760|466683|P3|Overall Study|Lost to Follow-up|1
146586|NCT00643760|466684|P2|Overall Study|Lost to Follow-up|2
146587|NCT00643760|466685|P1|Overall Study|Lost to Follow-up|6
146588|NCT00643760|466681|P5|Overall Study|Protocol Violation|6
146589|NCT00643760|466682|P4|Overall Study|Protocol Violation|4
146590|NCT00643760|466683|P3|Overall Study|Protocol Violation|4
146591|NCT00643760|466684|P2|Overall Study|Protocol Violation|6
146592|NCT00643760|466685|P1|Overall Study|Protocol Violation|7
146593|NCT00643760|466681|P5|Overall Study|Lack of Efficacy|3
146594|NCT00643760|466682|P4|Overall Study|Lack of Efficacy|4
146595|NCT00643760|466683|P3|Overall Study|Lack of Efficacy|0
146596|NCT00643760|466684|P2|Overall Study|Lack of Efficacy|1
146597|NCT00643760|466685|P1|Overall Study|Lack of Efficacy|3
146598|NCT00643760|466681|P5|Overall Study|Adverse Event|6
146599|NCT00643760|466682|P4|Overall Study|Adverse Event|21
146600|NCT00643760|466683|P3|Overall Study|Adverse Event|12
146601|NCT00643760|466684|P2|Overall Study|Adverse Event|5
146602|NCT00643760|466685|P1|Overall Study|Adverse Event|11
146603|NCT00643851|466790|P3|Overall Study|Non-compl., not met criteria, etc.|6
146604|NCT00643851|466791|P2|Overall Study|Non-compl., not met criteria, etc.|4
146605|NCT00643851|466792|P1|Overall Study|Non-compl., not met criteria, etc.|3
146606|NCT00643851|466790|P3|Overall Study|Withdrawal by Subject|9
146607|NCT00643851|466791|P2|Overall Study|Withdrawal by Subject|15
146608|NCT00643851|466792|P1|Overall Study|Withdrawal by Subject|8
146609|NCT00643851|466790|P3|Overall Study|Lost to Follow-up|9
146610|NCT00643851|466791|P2|Overall Study|Lost to Follow-up|6
146611|NCT00643851|466792|P1|Overall Study|Lost to Follow-up|4
146612|NCT00643851|466790|P3|Overall Study|Adverse Event|6
146613|NCT00643851|466791|P2|Overall Study|Adverse Event|6
146614|NCT00643851|466792|P1|Overall Study|Adverse Event|2
146615|NCT00643851|466790|P3|Overall Study|Lack of Efficacy|0
146616|NCT00643851|466791|P2|Overall Study|Lack of Efficacy|1
146617|NCT00643851|466792|P1|Overall Study|Lack of Efficacy|0
146618|NCT00643851|466790|P3|Overall Study|Death|0
146619|NCT00643851|466791|P2|Overall Study|Death|1
146620|NCT00643851|466792|P1|Overall Study|Death|0
146621|NCT00643916|466821|P6|Overall Study|Not Vaccinated|0
146622|NCT00643916|466822|P5|Overall Study|Not Vaccinated|2
146623|NCT00643916|466823|P4|Overall Study|Not Vaccinated|0
146624|NCT00643916|466824|P3|Overall Study|Not Vaccinated|3
146625|NCT00643916|466825|P2|Overall Study|Not Vaccinated|2
146626|NCT00643916|466826|P1|Overall Study|Not Vaccinated|2
146627|NCT00643916|466821|P6|Overall Study|Withdrawal by Subject|1
146628|NCT00643916|466822|P5|Overall Study|Withdrawal by Subject|0
146629|NCT00643916|466823|P4|Overall Study|Withdrawal by Subject|1
146630|NCT00643916|466824|P3|Overall Study|Withdrawal by Subject|2
146631|NCT00643916|466825|P2|Overall Study|Withdrawal by Subject|2
146632|NCT00643916|466826|P1|Overall Study|Withdrawal by Subject|2
146633|NCT00643916|466821|P6|Overall Study|Lost to Follow-up|0
146634|NCT00643916|466822|P5|Overall Study|Lost to Follow-up|0
146635|NCT00643916|466823|P4|Overall Study|Lost to Follow-up|0
146636|NCT00643916|466824|P3|Overall Study|Lost to Follow-up|0
146637|NCT00643916|466825|P2|Overall Study|Lost to Follow-up|1
146638|NCT00643916|466826|P1|Overall Study|Lost to Follow-up|0
146639|NCT00643916|466821|P6|Overall Study|Protocol Violation|0
146640|NCT00643916|466822|P5|Overall Study|Protocol Violation|0
146641|NCT00643916|466823|P4|Overall Study|Protocol Violation|1
146642|NCT00643916|466824|P3|Overall Study|Protocol Violation|1
146643|NCT00643916|466825|P2|Overall Study|Protocol Violation|1
146644|NCT00643916|466826|P1|Overall Study|Protocol Violation|0
146645|NCT00644059|466849|P3|Overall Study|Unable to classify|3
146646|NCT00644059|466850|P2|Overall Study|Unable to classify|2
146647|NCT00644059|466851|P1|Overall Study|Unable to classify|6
146648|NCT00644059|466849|P3|Overall Study|Protocol Deviation/violation|15
146649|NCT00644059|466850|P2|Overall Study|Protocol Deviation/violation|19
146650|NCT00644059|466851|P1|Overall Study|Protocol Deviation/violation|20
146651|NCT00644059|466849|P3|Overall Study|Inappropriate Enrollment|0
146652|NCT00644059|466850|P2|Overall Study|Inappropriate Enrollment|3
146653|NCT00644059|466851|P1|Overall Study|Inappropriate Enrollment|1
146654|NCT00644059|466849|P3|Overall Study|Adverse Event|1
146655|NCT00644059|466850|P2|Overall Study|Adverse Event|5
146656|NCT00644059|466851|P1|Overall Study|Adverse Event|8
146657|NCT00644059|466849|P3|Overall Study|Withdrawal by Subject|30
146658|NCT00644059|466850|P2|Overall Study|Withdrawal by Subject|60
146659|NCT00644059|466851|P1|Overall Study|Withdrawal by Subject|52
146660|NCT00644059|466849|P3|Overall Study|Lost to Follow-up|16
146661|NCT00644059|466850|P2|Overall Study|Lost to Follow-up|34
146662|NCT00644059|466851|P1|Overall Study|Lost to Follow-up|37
146663|NCT00644228|466953|P2|Maintenance|On Treatment|40
146664|NCT00644228|466954|P1|Maintenance|On Treatment|26
146665|NCT00644228|466953|P2|Maintenance|Not Protocol-Specified|15
146666|NCT00644228|466954|P1|Maintenance|Not Protocol-Specified|14
146667|NCT00644228|466953|P2|Maintenance|Death|3
146668|NCT00644228|466954|P1|Maintenance|Death|3
146669|NCT00644228|466953|P2|Maintenance|Progression/Relapse|42
146670|NCT00644228|466954|P1|Maintenance|Progression/Relapse|67
146671|NCT00644228|466953|P2|Maintenance|Withdrawal by Subject|4
146672|NCT00644228|466954|P1|Maintenance|Withdrawal by Subject|6
146673|NCT00644228|466953|P2|Maintenance|Adverse Event|31
146674|NCT00644228|466954|P1|Maintenance|Adverse Event|27
146675|NCT00644228|466953|P2|Induction Therapy|Not Protocol-Specified|28
146676|NCT00644228|466954|P1|Induction Therapy|Not Protocol-Specified|24
146677|NCT00644228|466953|P2|Induction Therapy|Death|7
146678|NCT00644228|466954|P1|Induction Therapy|Death|3
146679|NCT00644228|466953|P2|Induction Therapy|Progression/Relapse|12
146680|NCT00644228|466954|P1|Induction Therapy|Progression/Relapse|24
146681|NCT00644228|466953|P2|Induction Therapy|Withdrawal by Subject|3
146682|NCT00644228|466954|P1|Induction Therapy|Withdrawal by Subject|10
146683|NCT00644228|466953|P2|Induction Therapy|Adverse Event|55
146684|NCT00644228|466954|P1|Induction Therapy|Adverse Event|22
146685|NCT00644228|466953|P2|Randomization & Eligibility|Invalid Consent|1
146686|NCT00644228|466954|P1|Randomization & Eligibility|Invalid Consent|0
146687|NCT00644228|466953|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
146688|NCT00644228|466954|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
146689|NCT00644228|466953|P2|Randomization & Eligibility|Ineligible|21
146690|NCT00644228|466954|P1|Randomization & Eligibility|Ineligible|31
146691|NCT00644332|466975|P1|Overall Study|Could Not Attend Scheduled Visits|1
146692|NCT00644332|466975|P1|Overall Study|Did Not Meet Eligibility Requirements|1
146693|NCT00644332|466975|P1|Overall Study|Completion Status Unknown|2
146694|NCT00644332|466975|P1|Overall Study|Withdrawal by Subject|6
146695|NCT00644332|466975|P1|Overall Study|Adverse Event|11
146696|NCT00644787|467002|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
146697|NCT00644787|467003|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
146698|NCT00644787|467004|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
146699|NCT00644787|467002|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
146700|NCT00644787|467003|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
146701|NCT00644787|467004|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
146702|NCT00644787|467002|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
146703|NCT00644787|467003|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
146704|NCT00644787|467004|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
146705|NCT00644787|467002|P3|Period 2: Double Blind Phase|Adverse Event|4
146706|NCT00644787|467003|P2|Period 2: Double Blind Phase|Adverse Event|2
146707|NCT00644787|467004|P1|Period 2: Double Blind Phase|Adverse Event|0
146708|NCT00644787|467002|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
146709|NCT00644787|467003|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
146710|NCT00644787|467004|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
146711|NCT00644787|467002|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
146712|NCT00644787|467003|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
146713|NCT00644787|467004|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
146714|NCT00644787|467002|P3|Period 1: Titration Phase|Worsening of symptoms|0
146715|NCT00644787|467003|P2|Period 1: Titration Phase|Worsening of symptoms|0
146716|NCT00644787|467004|P1|Period 1: Titration Phase|Worsening of symptoms|1
146717|NCT00644787|467002|P3|Period 1: Titration Phase|Worsening of complications|0
146718|NCT00644787|467003|P2|Period 1: Titration Phase|Worsening of complications|0
146719|NCT00644787|467004|P1|Period 1: Titration Phase|Worsening of complications|1
146720|NCT00644787|467002|P3|Period 1: Titration Phase|Worsening of underlying disease|0
146721|NCT00644787|467003|P2|Period 1: Titration Phase|Worsening of underlying disease|0
146722|NCT00644787|467004|P1|Period 1: Titration Phase|Worsening of underlying disease|5
146723|NCT00644787|467002|P3|Period 1: Titration Phase|Physician Decision|0
146724|NCT00644787|467003|P2|Period 1: Titration Phase|Physician Decision|0
146725|NCT00644787|467004|P1|Period 1: Titration Phase|Physician Decision|1
146726|NCT00644787|467002|P3|Period 1: Titration Phase|Withdrawal by Subject|0
146727|NCT00644787|467003|P2|Period 1: Titration Phase|Withdrawal by Subject|0
146728|NCT00644787|467004|P1|Period 1: Titration Phase|Withdrawal by Subject|2
146729|NCT00644787|467002|P3|Period 1: Titration Phase|Adverse Event|0
146730|NCT00644787|467003|P2|Period 1: Titration Phase|Adverse Event|0
146731|NCT00644787|467004|P1|Period 1: Titration Phase|Adverse Event|11
146732|NCT00644917|467032|P1|Overall Study|Withdrawal by Subject|2
146733|NCT00644969|467042|P2|Post Treatment Phase|Unspecified|0
146734|NCT00644969|467043|P1|Post Treatment Phase|Unspecified|1
146735|NCT00644969|467042|P2|Post Treatment Phase|Lost to Follow-up|1
146736|NCT00644969|467043|P1|Post Treatment Phase|Lost to Follow-up|4
146737|NCT00644969|467042|P2|Post Treatment Phase|Withdrawal by Subject|2
146738|NCT00644969|467043|P1|Post Treatment Phase|Withdrawal by Subject|4
146739|NCT00644969|467042|P2|Post Treatment Phase|Death|0
146740|NCT00644969|467043|P1|Post Treatment Phase|Death|1
146741|NCT00644969|467042|P2|Treatment Phase|Unspecified|1
146742|NCT00644969|467043|P1|Treatment Phase|Unspecified|4
146743|NCT00644969|467042|P2|Treatment Phase|Lost to Follow-up|2
146744|NCT00644969|467043|P1|Treatment Phase|Lost to Follow-up|2
146745|NCT00644969|467042|P2|Treatment Phase|Withdrawal by Subject|0
146746|NCT00644969|467043|P1|Treatment Phase|Withdrawal by Subject|4
146747|NCT00644969|467042|P2|Treatment Phase|Adverse Event|0
146748|NCT00644969|467043|P1|Treatment Phase|Adverse Event|3
146749|NCT00644969|467042|P2|Treatment Phase|Randomized, not treated|0
146750|NCT00644969|467043|P1|Treatment Phase|Randomized, not treated|1
146751|NCT00644995|467091|P2|Overall Study|Refused|0
146752|NCT00644995|467092|P1|Overall Study|Refused|1
146753|NCT00644995|467091|P2|Overall Study|Lost to Follow-up|4
146754|NCT00644995|467092|P1|Overall Study|Lost to Follow-up|1
146755|NCT00645099|467137|P2|Overall Study|Other|5
146756|NCT00645099|467138|P1|Overall Study|Other|9
146757|NCT00645099|467137|P2|Overall Study|Adverse Event|5
146758|NCT00645099|467138|P1|Overall Study|Adverse Event|11
146759|NCT00645099|467137|P2|Overall Study|Lost to Follow-up|4
146760|NCT00645099|467138|P1|Overall Study|Lost to Follow-up|6
146761|NCT00645099|467137|P2|Overall Study|Withdrawal by Subject|22
146762|NCT00645099|467138|P1|Overall Study|Withdrawal by Subject|30
146763|NCT00645099|467137|P2|Overall Study|Lack of Efficacy|6
146764|NCT00645099|467138|P1|Overall Study|Lack of Efficacy|15
146765|NCT00645164|467180|P1|Overall Study|Protocol Violation|1
146766|NCT00645164|467180|P1|Overall Study|Withdrawal by Subject|4
146767|NCT00645164|467180|P1|Overall Study|Lost to Follow-up|2
146768|NCT00645411|467198|P4|Overall Study|Unable to classify|4
146769|NCT00645411|467199|P3|Overall Study|Unable to classify|3
146770|NCT00645411|467200|P2|Overall Study|Unable to classify|0
146771|NCT00645411|467201|P1|Overall Study|Unable to classify|0
146772|NCT00645411|467198|P4|Overall Study|Inappropriate enrollment|1
146773|NCT00645411|467199|P3|Overall Study|Inappropriate enrollment|4
146774|NCT00645411|467200|P2|Overall Study|Inappropriate enrollment|0
146775|NCT00645411|467201|P1|Overall Study|Inappropriate enrollment|0
146776|NCT00645411|467198|P4|Overall Study|Protocol Violation|0
146777|NCT00645411|467199|P3|Overall Study|Protocol Violation|1
146778|NCT00645411|467200|P2|Overall Study|Protocol Violation|0
146779|NCT00645411|467201|P1|Overall Study|Protocol Violation|1
146780|NCT00645411|467198|P4|Overall Study|Lost to Follow-up|75
146781|NCT00645411|467199|P3|Overall Study|Lost to Follow-up|124
146782|NCT00645411|467200|P2|Overall Study|Lost to Follow-up|5
146783|NCT00645411|467201|P1|Overall Study|Lost to Follow-up|10
146784|NCT00645411|467198|P4|Overall Study|Withdrawal by Subject|21
146785|NCT00645411|467199|P3|Overall Study|Withdrawal by Subject|19
146786|NCT00645411|467200|P2|Overall Study|Withdrawal by Subject|1
146787|NCT00645411|467201|P1|Overall Study|Withdrawal by Subject|2
146788|NCT00645411|467198|P4|Overall Study|Adverse Event|2
146789|NCT00645411|467199|P3|Overall Study|Adverse Event|0
146790|NCT00645411|467200|P2|Overall Study|Adverse Event|0
146791|NCT00645411|467201|P1|Overall Study|Adverse Event|0
146792|NCT00652834|467233|P1|Overall Study|Lost to Follow-up|2
146793|NCT00652834|467233|P1|Overall Study|Withdrawal by Subject|3
146794|NCT00652899|467237|P1|Overall Study|Treating physician decision|1
146795|NCT00652899|467237|P1|Overall Study|Death|1
146796|NCT00652938|467250|P3|Overall Study|fear of blood sampling|0
146797|NCT00652938|467251|P2|Overall Study|fear of blood sampling|1
146798|NCT00652938|467252|P1|Overall Study|fear of blood sampling|0
146799|NCT00652938|467250|P3|Overall Study|Lost to Follow-up|2
146800|NCT00652938|467251|P2|Overall Study|Lost to Follow-up|0
146801|NCT00652938|467252|P1|Overall Study|Lost to Follow-up|0
146802|NCT00652938|467250|P3|Overall Study|Withdrawal by Subject|1
146803|NCT00652938|467251|P2|Overall Study|Withdrawal by Subject|6
146804|NCT00652938|467252|P1|Overall Study|Withdrawal by Subject|0
146805|NCT00652938|467250|P3|Overall Study|Adverse Event|2
146806|NCT00652938|467251|P2|Overall Study|Adverse Event|0
146807|NCT00652938|467252|P1|Overall Study|Adverse Event|1
146808|NCT00653068|467321|P1|Overall Study|Ineligible|2
146809|NCT00653068|467321|P1|Overall Study|Withdrawal by Subject|1
146810|NCT00653068|467321|P1|Overall Study|Physician Decision|4
146811|NCT00653068|467321|P1|Overall Study|Lack of Efficacy|34
146812|NCT00653068|467321|P1|Overall Study|Death|9
146813|NCT00653159|467343|P2|Overall Study|Lost to Follow-up|2
146814|NCT00653159|467344|P1|Overall Study|Lost to Follow-up|1
146815|NCT00653159|467343|P2|Overall Study|Adverse Event|1
146816|NCT00653159|467344|P1|Overall Study|Adverse Event|4
146817|NCT00654420|467362|P4|Phase II|Missing Disposition Record|0
146818|NCT00654420|467363|P3|Phase II|Missing Disposition Record|1
146819|NCT00654420|467364|P2|Phase II|Missing Disposition Record|0
146820|NCT00654420|467365|P1|Phase II|Missing Disposition Record|0
146821|NCT00654420|467362|P4|Phase II|Withdrawal by Subject|1
146822|NCT00654420|467363|P3|Phase II|Withdrawal by Subject|4
146823|NCT00654420|467364|P2|Phase II|Withdrawal by Subject|0
146824|NCT00654420|467365|P1|Phase II|Withdrawal by Subject|0
146825|NCT00654420|467362|P4|Phase II|Progressive Disease|29
146826|NCT00654420|467363|P3|Phase II|Progressive Disease|29
146827|NCT00654420|467364|P2|Phase II|Progressive Disease|0
146828|NCT00654420|467365|P1|Phase II|Progressive Disease|0
146829|NCT00654420|467362|P4|Phase II|Physician Decision|4
146830|NCT00654420|467363|P3|Phase II|Physician Decision|0
146831|NCT00654420|467364|P2|Phase II|Physician Decision|0
146832|NCT00654420|467365|P1|Phase II|Physician Decision|0
146833|NCT00654420|467362|P4|Phase II|Lost to Follow-up|1
146834|NCT00654420|467363|P3|Phase II|Lost to Follow-up|0
146835|NCT00654420|467364|P2|Phase II|Lost to Follow-up|0
146836|NCT00654420|467365|P1|Phase II|Lost to Follow-up|0
146837|NCT00654420|467362|P4|Phase II|Adverse Event|3
146838|NCT00654420|467363|P3|Phase II|Adverse Event|3
146839|NCT00654420|467364|P2|Phase II|Adverse Event|0
146840|NCT00654420|467365|P1|Phase II|Adverse Event|0
146841|NCT00654420|467362|P4|Phase I (Dose Escalation)|Progressive Disease|0
146842|NCT00654420|467363|P3|Phase I (Dose Escalation)|Progressive Disease|0
146843|NCT00654420|467364|P2|Phase I (Dose Escalation)|Progressive Disease|15
146844|NCT00654420|467365|P1|Phase I (Dose Escalation)|Progressive Disease|4
146845|NCT00654420|467362|P4|Phase I (Dose Escalation)|Adverse Event|0
146846|NCT00654420|467363|P3|Phase I (Dose Escalation)|Adverse Event|0
146847|NCT00654420|467364|P2|Phase I (Dose Escalation)|Adverse Event|1
146848|NCT00654420|467365|P1|Phase I (Dose Escalation)|Adverse Event|0
146849|NCT00654498|467389|P2|Overall Study|Other reason not defined above|5
146850|NCT00654498|467390|P1|Overall Study|Other reason not defined above|4
146851|NCT00654498|467389|P2|Overall Study|Withdrawal by Subject|0
146852|NCT00654498|467390|P1|Overall Study|Withdrawal by Subject|1
146853|NCT00654498|467389|P2|Overall Study|Lost to Follow-up|5
146854|NCT00654498|467390|P1|Overall Study|Lost to Follow-up|1
146855|NCT00654498|467389|P2|Overall Study|Protocol Violation|1
146856|NCT00654498|467390|P1|Overall Study|Protocol Violation|1
146857|NCT00654498|467389|P2|Overall Study|Adverse Event|1
146858|NCT00654498|467390|P1|Overall Study|Adverse Event|6
146859|NCT00654498|467389|P2|Overall Study|Not Treated|0
146860|NCT00654498|467390|P1|Overall Study|Not Treated|1
146861|NCT00654628|467439|P1|6 –Week Extension Period (Single Site)|Lost to Follow-up|1
146862|NCT00654628|467439|P1|6 –Week Extension Period (Single Site)|Adverse Event|4
146863|NCT00654628|467439|P1|6-week Active Treatment Period|Out of window period|1
146864|NCT00654628|467439|P1|6-week Active Treatment Period|Transferred to branch hospital|1
146865|NCT00654628|467439|P1|6-week Active Treatment Period|Lost to Follow-up|10
146866|NCT00654628|467439|P1|6-week Active Treatment Period|Adverse Event|9
146867|NCT00654641|467456|P2|Overall Study|Lost to Follow-up|3
146868|NCT00654641|467457|P1|Overall Study|Lost to Follow-up|2
146869|NCT00654745|467468|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
146870|NCT00654745|467468|P1|Overall Study|Withdrawal by Subject|10
146871|NCT00654745|467468|P1|Overall Study|Protocol Violation|11
146872|NCT00654745|467468|P1|Overall Study|Lost to Follow-up|7
146873|NCT00654745|467468|P1|Overall Study|Adverse Event|12
146874|NCT00654875|467517|P2|Overall Study|Administrative Problems|0
146875|NCT00654875|467518|P1|Overall Study|Administrative Problems|1
146876|NCT00654875|467517|P2|Overall Study|Abnormal Test Procedure Result(s)|0
146877|NCT00654875|467518|P1|Overall Study|Abnormal Test Procedure Result(s)|1
146878|NCT00654875|467517|P2|Overall Study|Lost to Follow-up|3
146879|NCT00654875|467518|P1|Overall Study|Lost to Follow-up|1
146880|NCT00654875|467517|P2|Overall Study|Lack of Efficacy|2
146881|NCT00654875|467518|P1|Overall Study|Lack of Efficacy|2
146882|NCT00654875|467517|P2|Overall Study|Protocol Violation|3
146883|NCT00654875|467518|P1|Overall Study|Protocol Violation|3
146884|NCT00654875|467517|P2|Overall Study|Withdrawal by Subject|4
146885|NCT00654875|467518|P1|Overall Study|Withdrawal by Subject|4
146886|NCT00654875|467517|P2|Overall Study|Adverse Event|5
146887|NCT00654875|467518|P1|Overall Study|Adverse Event|5
146888|NCT00654901|467540|P4|Overall Study|Withdrawal by Subject|0
146889|NCT00654901|467541|P3|Overall Study|Withdrawal by Subject|1
146890|NCT00654901|467542|P2|Overall Study|Withdrawal by Subject|0
146891|NCT00654901|467543|P1|Overall Study|Withdrawal by Subject|3
146892|NCT00654901|467540|P4|Overall Study|Lost to Follow-up|0
146893|NCT00654901|467541|P3|Overall Study|Lost to Follow-up|1
146894|NCT00654901|467542|P2|Overall Study|Lost to Follow-up|0
146895|NCT00654901|467543|P1|Overall Study|Lost to Follow-up|1
146896|NCT00654940|467571|P2|Period 1|Intolerable Pain Level|0
146897|NCT00654940|467572|P1|Period 1|Intolerable Pain Level|1
146898|NCT00654940|467571|P2|Period 1|Adverse Event|1
146899|NCT00654940|467572|P1|Period 1|Adverse Event|0
146900|NCT00655356|467623|P2|Overall Study|Other Reason|0
146901|NCT00655356|467624|P1|Overall Study|Other Reason|1
146902|NCT00655356|467623|P2|Overall Study|Protocol Violation|1
146903|NCT00655356|467624|P1|Overall Study|Protocol Violation|2
146904|NCT00655356|467623|P2|Overall Study|Adverse Event|1
146905|NCT00655356|467624|P1|Overall Study|Adverse Event|1
146906|NCT00655356|467623|P2|Overall Study|Sponsor Request|4
146907|NCT00655356|467624|P1|Overall Study|Sponsor Request|10
146908|NCT00655356|467623|P2|Overall Study|Withdrawal by Subject|4
146909|NCT00655356|467624|P1|Overall Study|Withdrawal by Subject|3
146910|NCT00655486|467636|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
146911|NCT00655486|467636|P1|Overall Study|Other: Could not tolerate BID dosing|1
146912|NCT00655486|467636|P1|Overall Study|Other: Pregnancy|1
146913|NCT00655486|467636|P1|Overall Study|Unsatisfactory compliance|2
146914|NCT00655486|467636|P1|Overall Study|Protocol Violation|1
146915|NCT00655486|467636|P1|Overall Study|Withdrawal by Subject|4
146916|NCT00655486|467636|P1|Overall Study|Lack of Efficacy|8
146917|NCT00655486|467636|P1|Overall Study|Adverse Event|10
146918|NCT00655551|467644|P3|Period 4 (up to 7 Days)|Adverse Event|0
146919|NCT00655551|467645|P2|Period 4 (up to 7 Days)|Adverse Event|2
146920|NCT00655551|467646|P1|Period 4 (up to 7 Days)|Adverse Event|0
146921|NCT00655551|467644|P3|Period 3 (up to 7 Days)|Adverse Event|4
146922|NCT00655551|467645|P2|Period 3 (up to 7 Days)|Adverse Event|0
146923|NCT00655551|467646|P1|Period 3 (up to 7 Days)|Adverse Event|0
146924|NCT00655551|467644|P3|Period 2 (up to 7 Days)|Adverse Event|0
146925|NCT00655551|467645|P2|Period 2 (up to 7 Days)|Adverse Event|1
146926|NCT00655551|467646|P1|Period 2 (up to 7 Days)|Adverse Event|0
146927|NCT00655551|467644|P3|All Periods Combined|Adverse Event|4
146928|NCT00655551|467645|P2|All Periods Combined|Adverse Event|3
146929|NCT00655551|467646|P1|All Periods Combined|Adverse Event|0
146930|NCT00655564|467660|P1|Overall Study|Desired Alternate Therapy|1
146931|NCT00655564|467660|P1|Overall Study|Lost to Follow-up|1
146932|NCT00655564|467660|P1|Overall Study|Adverse Event|1
146933|NCT00655629|467667|P2|Overall Study|consent withdrawn|4
146934|NCT00655629|467668|P1|Overall Study|consent withdrawn|6
146935|NCT00655629|467667|P2|Overall Study|Protocol Violation|3
146936|NCT00655629|467668|P1|Overall Study|Protocol Violation|5
146937|NCT00655629|467667|P2|Overall Study|Lost to Follow-up|3
146938|NCT00655629|467668|P1|Overall Study|Lost to Follow-up|4
146939|NCT00655629|467667|P2|Overall Study|Lack of Efficacy|12
146940|NCT00655629|467668|P1|Overall Study|Lack of Efficacy|2
146941|NCT00655629|467667|P2|Overall Study|Adverse Event|1
146942|NCT00655629|467668|P1|Overall Study|Adverse Event|4
146943|NCT00655668|467721|P1|Overall Study|Withdrawal by Subject|2
146944|NCT00655668|467721|P1|Overall Study|New Lymphoma Treatment Started|4
146945|NCT00655668|467721|P1|Overall Study|Unspecified|1
146946|NCT00655668|467721|P1|Overall Study|Study Terminated|9
146947|NCT00655668|467721|P1|Overall Study|Disease Progression|27
146948|NCT00655668|467721|P1|Overall Study|Death|5
146949|NCT00655668|467721|P1|Overall Study|Adverse Event|6
146950|NCT00655733|467731|P2|Overall Study|Physician Decision|1
146951|NCT00655733|467732|P1|Overall Study|Physician Decision|0
146952|NCT00655733|467731|P2|Overall Study|Withdrawal by Subject|3
146953|NCT00655733|467732|P1|Overall Study|Withdrawal by Subject|3
146954|NCT00655733|467731|P2|Overall Study|Adverse Event|2
146955|NCT00655733|467732|P1|Overall Study|Adverse Event|2
146956|NCT00655733|467731|P2|Overall Study|Lost to Follow-up|2
146957|NCT00655733|467732|P1|Overall Study|Lost to Follow-up|2
146958|NCT00655746|467738|P1|Overall Study|Withdrawal by Subject|1
146959|NCT00655824|467769|P1|Follow-up (FU) Period|Did Not Show for Scheduled FU Visit|1
146960|NCT00655824|467769|P1|Follow-up (FU) Period|Physician Decision; Low B-cells|1
146961|NCT00655824|467769|P1|Follow-up (FU) Period|Started Adalimumab Therapy|1
146962|NCT00655824|467769|P1|Follow-up (FU) Period|Withdrawal by Subject|4
146963|NCT00655824|467769|P1|Follow-up (FU) Period|Protocol Violation|59
146964|NCT00655824|467769|P1|Treatment Period|Deterioration of Trial Disease|2
146965|NCT00655824|467769|P1|Treatment Period|Withdrawal by Subject|4
146966|NCT00655824|467769|P1|Treatment Period|Protocol Violation|1
146967|NCT00655824|467769|P1|Treatment Period|Early Termination of Study by Sponsor|74
146968|NCT00655824|467769|P1|Treatment Period|Adverse Event|3
146969|NCT00655850|467813|P1|Overall Study|Withdrawal by Subject|1
146970|NCT00655850|467813|P1|Overall Study|Death|2
146971|NCT00655863|467823|P3|Overall Study|Lost to Follow-up|1
146972|NCT00655863|467824|P2|Overall Study|Lost to Follow-up|0
146973|NCT00655863|467825|P1|Overall Study|Lost to Follow-up|0
146974|NCT00655889|467884|P1|Overall Study|Protocol Violation|1
146975|NCT00655889|467884|P1|Overall Study|Inadequate cell growth|1
146976|NCT00656058|467889|P1|Overall Study|Withdrawal by Subject|4
146977|NCT00656058|467889|P1|Overall Study|Withdrawal by Subject|2
146978|NCT00656084|467898|P1|Overall Study|Investigator Request|1
146979|NCT00656084|467898|P1|Overall Study|Patient Request|1
146980|NCT00656084|467898|P1|Overall Study|Withdrawal by Subject|1
146981|NCT00656084|467898|P1|Overall Study|Adverse Event|4
146982|NCT00656136|467907|P2|Overall Study|Unknown and others|4
146983|NCT00656136|467908|P1|Overall Study|Unknown and others|4
146984|NCT00656136|467907|P2|Overall Study|Patient refused to take study medication|10
146985|NCT00656136|467908|P1|Overall Study|Patient refused to take study medication|7
146986|NCT00656136|467907|P2|Overall Study|Protocol Violation|3
146987|NCT00656136|467908|P1|Overall Study|Protocol Violation|2
146988|NCT00656136|467907|P2|Overall Study|Other Adverse Event|51
146989|NCT00656136|467908|P1|Overall Study|Other Adverse Event|5
146990|NCT00656136|467907|P2|Overall Study|Progressive disease|322
146991|NCT00656136|467908|P1|Overall Study|Progressive disease|177
146992|NCT00656175|467920|P2|Overall Study|Transportation issues|1
146993|NCT00656175|467921|P1|Overall Study|Transportation issues|0
146994|NCT00656175|467920|P2|Overall Study|Adverse Event|0
146995|NCT00656175|467921|P1|Overall Study|Adverse Event|1
146996|NCT00656292|467938|P2|Overall Study|Screen failure|2
146997|NCT00656292|467939|P1|Overall Study|Screen failure|1
146998|NCT00656292|467938|P2|Overall Study|Withdrawal by Subject|3
146999|NCT00656292|467939|P1|Overall Study|Withdrawal by Subject|2
147000|NCT00656370|467955|P1|Overall Study|Alternates|3
147001|NCT00656370|467955|P1|Overall Study|Screen Failures|7
147002|NCT00656474|467972|P1|Overall Study|Other Reason|1
147003|NCT00656513|468010|P3|Overall Study|Missing baseline form|5
147004|NCT00656513|468011|P2|Overall Study|Missing baseline form|5
147005|NCT00656513|468012|P1|Overall Study|Missing baseline form|0
147006|NCT00656513|468010|P3|Overall Study|Treatment completed outside of timeframe|1
147007|NCT00656513|468011|P2|Overall Study|Treatment completed outside of timeframe|3
147008|NCT00656513|468012|P1|Overall Study|Treatment completed outside of timeframe|0
147009|NCT00656513|468010|P3|Overall Study|Incomplete treatment|0
147010|NCT00656513|468011|P2|Overall Study|Incomplete treatment|0
147011|NCT00656513|468012|P1|Overall Study|Incomplete treatment|3
147012|NCT00656513|468010|P3|Overall Study|Missing data|9
147013|NCT00656513|468011|P2|Overall Study|Missing data|11
147014|NCT00656513|468012|P1|Overall Study|Missing data|0
147015|NCT00656513|468010|P3|Overall Study|Death|1
147016|NCT00656513|468011|P2|Overall Study|Death|0
147017|NCT00656513|468012|P1|Overall Study|Death|0
147018|NCT00656513|468010|P3|Overall Study|Withdrawal by Subject|4
147019|NCT00656513|468011|P2|Overall Study|Withdrawal by Subject|11
147020|NCT00656513|468012|P1|Overall Study|Withdrawal by Subject|0
147021|NCT00656513|468010|P3|Overall Study|Protocol Violation|2
147022|NCT00656513|468011|P2|Overall Study|Protocol Violation|0
147023|NCT00656513|468012|P1|Overall Study|Protocol Violation|1
147024|NCT00656617|468031|P1|Overall Study|Move to different clinical trial|2
147025|NCT00656617|468031|P1|Overall Study|Insurance Issues|2
147026|NCT00656617|468031|P1|Overall Study|Death|2
147027|NCT00656617|468031|P1|Overall Study|Adverse Event|1
147028|NCT00656669|468067|P1|AC (Cycles 6-9)|Did not start segment 3|1
147029|NCT00656669|468067|P1|AC (Cycles 6-9)|Adverse Event|1
147030|NCT00656669|468067|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
147031|NCT00656669|468067|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
147032|NCT00656799|468076|P1|Overall Study|Death|2
147033|NCT00656851|468100|P2|Overall Study|Withdrawal by Subject|4
147034|NCT00656851|468101|P1|Overall Study|Withdrawal by Subject|0
147035|NCT00648895|468125|P2|Overall Study|Lack of Efficacy|1
147036|NCT00648895|468126|P1|Overall Study|Lack of Efficacy|0
147037|NCT00649220|468140|P1|Overall Study|Withdrawal by Subject|1
147038|NCT00649220|468140|P1|Overall Study|Adverse Event|2
147039|NCT00649389|468155|P4|Overall Study|Other|6
147040|NCT00649389|468156|P3|Overall Study|Other|1
147041|NCT00649389|468157|P2|Overall Study|Other|9
147042|NCT00649389|468158|P1|Overall Study|Other|3
147043|NCT00649389|468155|P4|Overall Study|Withdrawal by Subject|23
147044|NCT00649389|468156|P3|Overall Study|Withdrawal by Subject|19
147045|NCT00649389|468157|P2|Overall Study|Withdrawal by Subject|21
147046|NCT00649389|468158|P1|Overall Study|Withdrawal by Subject|20
147047|NCT00649389|468155|P4|Overall Study|Protocol Violation|8
147048|NCT00649389|468156|P3|Overall Study|Protocol Violation|9
147049|NCT00649389|468157|P2|Overall Study|Protocol Violation|13
147050|NCT00649389|468158|P1|Overall Study|Protocol Violation|11
147051|NCT00649389|468155|P4|Overall Study|Lost to Follow-up|26
147052|NCT00649389|468156|P3|Overall Study|Lost to Follow-up|21
147053|NCT00649389|468157|P2|Overall Study|Lost to Follow-up|17
147054|NCT00649389|468158|P1|Overall Study|Lost to Follow-up|15
147055|NCT00649389|468155|P4|Overall Study|Adverse Event|48
147056|NCT00649389|468156|P3|Overall Study|Adverse Event|38
147057|NCT00649389|468157|P2|Overall Study|Adverse Event|46
147058|NCT00649389|468158|P1|Overall Study|Adverse Event|22
147059|NCT00649428|468182|P2|Overall Study|Physician Decision|1
147060|NCT00649428|468183|P1|Overall Study|Physician Decision|0
147061|NCT00649428|468182|P2|Overall Study|Protocol Violation|2
147062|NCT00649428|468183|P1|Overall Study|Protocol Violation|6
147063|NCT00649428|468182|P2|Overall Study|Insufficient manufacturing yield|1
147064|NCT00649428|468183|P1|Overall Study|Insufficient manufacturing yield|5
147065|NCT00649428|468182|P2|Overall Study|Lost to Follow-up|3
147066|NCT00649428|468183|P1|Overall Study|Lost to Follow-up|1
147067|NCT00649428|468182|P2|Overall Study|Withdrawal by Subject|6
147068|NCT00649428|468183|P1|Overall Study|Withdrawal by Subject|6
147069|NCT00649428|468182|P2|Overall Study|Adverse Event|2
147070|NCT00649428|468183|P1|Overall Study|Adverse Event|2
147071|NCT00650091|468220|P3|Amended Study Design|Not specified|0
147072|NCT00650091|468221|P2|Amended Study Design|Not specified|3
147073|NCT00650091|468222|P1|Amended Study Design|Not specified|1
147074|NCT00650091|468220|P3|Amended Study Design|Lung transplantation|0
147075|NCT00650091|468221|P2|Amended Study Design|Lung transplantation|2
147076|NCT00650091|468222|P1|Amended Study Design|Lung transplantation|4
147077|NCT00650091|468220|P3|Amended Study Design|Adverse Event|0
147078|NCT00650091|468221|P2|Amended Study Design|Adverse Event|4
147079|NCT00650091|468222|P1|Amended Study Design|Adverse Event|1
147080|NCT00650091|468220|P3|Amended Study Design|Physician Decision|0
147081|NCT00650091|468221|P2|Amended Study Design|Physician Decision|0
147082|NCT00650091|468222|P1|Amended Study Design|Physician Decision|5
147083|NCT00650091|468220|P3|Amended Study Design|Withdrawal by Subject|0
147084|NCT00650091|468221|P2|Amended Study Design|Withdrawal by Subject|11
147085|NCT00650091|468222|P1|Amended Study Design|Withdrawal by Subject|12
147086|NCT00650104|468240|P1|Overall Study|Sponsor Terminated Dosing|1
147087|NCT00650104|468240|P1|Overall Study|Non-compliance|2
147088|NCT00650104|468240|P1|Overall Study|Lost to Follow-up|1
147089|NCT00650104|468240|P1|Overall Study|Physician Decision|7
147090|NCT00650104|468240|P1|Overall Study|Withdrawal by Subject|11
147091|NCT00650104|468240|P1|Overall Study|Death|2
147092|NCT00650104|468240|P1|Overall Study|Adverse Event|17
147093|NCT00657020|468292|P2|PERIOD 1|Adverse Event|1
147094|NCT00657020|468293|P1|PERIOD 1|Adverse Event|0
147095|NCT00657046|468324|P3|Overall Study|Surgery|1
147096|NCT00657046|468325|P2|Overall Study|Surgery|0
147097|NCT00657046|468326|P1|Overall Study|Surgery|0
147098|NCT00657046|468324|P3|Overall Study|Death|1
147099|NCT00657046|468325|P2|Overall Study|Death|0
147100|NCT00657046|468326|P1|Overall Study|Death|0
147101|NCT00657046|468324|P3|Overall Study|Withdrawal by Subject|0
147102|NCT00657046|468325|P2|Overall Study|Withdrawal by Subject|0
147103|NCT00657046|468326|P1|Overall Study|Withdrawal by Subject|1
147104|NCT00657046|468324|P3|Overall Study|Protocol Violation|0
147105|NCT00657046|468325|P2|Overall Study|Protocol Violation|2
147106|NCT00657046|468326|P1|Overall Study|Protocol Violation|2
147107|NCT00657046|468324|P3|Overall Study|Adverse Event|0
147108|NCT00657046|468325|P2|Overall Study|Adverse Event|1
147109|NCT00657046|468326|P1|Overall Study|Adverse Event|1
147110|NCT00657150|468360|P2|Treatment|Not Specified|15
147111|NCT00657150|468361|P1|Treatment|Not Specified|13
147112|NCT00657150|468360|P2|Treatment|Withdrawal by Subject|20
147113|NCT00657150|468361|P1|Treatment|Withdrawal by Subject|23
147114|NCT00657150|468360|P2|Treatment|Lost to Follow-up|0
147115|NCT00657150|468361|P1|Treatment|Lost to Follow-up|1
147116|NCT00657150|468360|P2|Treatment|Non-compliant with protocol|9
147117|NCT00657150|468361|P1|Treatment|Non-compliant with protocol|10
147118|NCT00657150|468360|P2|Treatment|Adverse Event|53
147119|NCT00657150|468361|P1|Treatment|Adverse Event|60
147120|NCT00657150|468360|P2|Overall Study|Not Specified|38
147121|NCT00657150|468361|P1|Overall Study|Not Specified|38
147122|NCT00657150|468360|P2|Overall Study|Withdrawal by Subject|36
147123|NCT00657150|468361|P1|Overall Study|Withdrawal by Subject|51
147124|NCT00657150|468360|P2|Overall Study|Lost to Follow-up|0
147125|NCT00657150|468361|P1|Overall Study|Lost to Follow-up|2
147126|NCT00657150|468360|P2|Overall Study|Non-compliant with protocol|9
147127|NCT00657150|468361|P1|Overall Study|Non-compliant with protocol|5
147128|NCT00657150|468360|P2|Overall Study|Adverse Event|10
147129|NCT00657150|468361|P1|Overall Study|Adverse Event|19
147130|NCT00658320|468400|P2|Extension Study: After Month 24|Subject withdrew consent|0
147131|NCT00658320|468401|P1|Extension Study: After Month 24|Subject withdrew consent|2
147132|NCT00658320|468400|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
147133|NCT00658320|468401|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
147134|NCT00658320|468400|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
147135|NCT00658320|468401|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
147136|NCT00658320|468400|P2|Core Study: 12 Months|Subject withdrew consent|3
147137|NCT00658320|468401|P1|Core Study: 12 Months|Subject withdrew consent|5
147138|NCT00658333|468426|P2|Overall Study|Adverse Event|1
147139|NCT00658333|468427|P1|Overall Study|Adverse Event|2
147140|NCT00658528|468449|P2|Overall Study|Not specified|4
147141|NCT00658528|468450|P1|Overall Study|Not specified|8
147142|NCT00658528|468449|P2|Overall Study|Withdrawal of consent|6
147143|NCT00658528|468450|P1|Overall Study|Withdrawal of consent|5
147144|NCT00658528|468449|P2|Overall Study|Withdrawal by Subject|6
147145|NCT00658528|468450|P1|Overall Study|Withdrawal by Subject|8
147146|NCT00658528|468449|P2|Overall Study|Lost to Follow-up|22
147147|NCT00658528|468450|P1|Overall Study|Lost to Follow-up|14
147148|NCT00658528|468449|P2|Overall Study|Adverse Event|7
147149|NCT00658528|468450|P1|Overall Study|Adverse Event|5
147150|NCT00658541|468460|P2|Washout Period of 7 Days|Withdrawal by Subject|1
147151|NCT00658541|468461|P1|Washout Period of 7 Days|Withdrawal by Subject|0
147152|NCT00658541|468460|P2|Washout Period of 7 Days|Withdrawal by Subject|1
147153|NCT00658541|468461|P1|Washout Period of 7 Days|Withdrawal by Subject|1
147154|NCT00658567|468474|P3|Overall Study|At Discretion of Sponsor|1
147155|NCT00658567|468475|P2|Overall Study|At Discretion of Sponsor|1
147156|NCT00658567|468476|P1|Overall Study|At Discretion of Sponsor|1
147157|NCT00658567|468474|P3|Overall Study|Physician Decision|0
147158|NCT00658567|468475|P2|Overall Study|Physician Decision|1
147159|NCT00658567|468476|P1|Overall Study|Physician Decision|0
147160|NCT00658567|468474|P3|Overall Study|Voluntary Withdrawal of Consent|2
147161|NCT00658567|468475|P2|Overall Study|Voluntary Withdrawal of Consent|0
147162|NCT00658567|468476|P1|Overall Study|Voluntary Withdrawal of Consent|2
147163|NCT00658567|468474|P3|Overall Study|Adverse Event|3
147164|NCT00658567|468475|P2|Overall Study|Adverse Event|2
147165|NCT00658567|468476|P1|Overall Study|Adverse Event|5
147166|NCT00658606|468489|P2|Overall Study|Lack of Compliance|3
147167|NCT00658606|468490|P1|Overall Study|Lack of Compliance|0
147168|NCT00658606|468489|P2|Overall Study|Withdrawal by Subject|16
147169|NCT00658606|468490|P1|Overall Study|Withdrawal by Subject|7
147170|NCT00658606|468489|P2|Overall Study|Lost to Follow-up|0
147171|NCT00658606|468490|P1|Overall Study|Lost to Follow-up|1
147172|NCT00658606|468489|P2|Overall Study|Lack of Efficacy|3
147173|NCT00658606|468490|P1|Overall Study|Lack of Efficacy|6
147174|NCT00658606|468489|P2|Overall Study|Adverse Event|1
147175|NCT00658606|468490|P1|Overall Study|Adverse Event|2
147176|NCT00658632|468547|P2|Overall Study|Not specified|8
147177|NCT00658632|468548|P1|Overall Study|Not specified|7
147178|NCT00658632|468547|P2|Overall Study|Pregnancy|1
147179|NCT00658632|468548|P1|Overall Study|Pregnancy|1
147180|NCT00658632|468547|P2|Overall Study|Withdrawal of consent|14
147181|NCT00658632|468548|P1|Overall Study|Withdrawal of consent|8
147182|NCT00658632|468547|P2|Overall Study|Lack of Efficacy|1
147183|NCT00658632|468548|P1|Overall Study|Lack of Efficacy|0
147184|NCT00658632|468547|P2|Overall Study|Withdrawal by Subject|7
147185|NCT00658632|468548|P1|Overall Study|Withdrawal by Subject|10
147186|NCT00658632|468547|P2|Overall Study|Lost to Follow-up|23
147187|NCT00658632|468548|P1|Overall Study|Lost to Follow-up|25
147188|NCT00658632|468547|P2|Overall Study|Adverse Event|11
147189|NCT00658632|468548|P1|Overall Study|Adverse Event|13
147190|NCT00658658|468563|P5|Overall Study|Other|1
147191|NCT00658658|468564|P4|Overall Study|Other|0
147192|NCT00658658|468565|P3|Overall Study|Other|0
147193|NCT00658658|468566|P2|Overall Study|Other|0
147194|NCT00658658|468567|P1|Overall Study|Other|0
147195|NCT00658658|468563|P5|Overall Study|Protocol-specified Criteria|0
147196|NCT00658658|468564|P4|Overall Study|Protocol-specified Criteria|0
147197|NCT00658658|468565|P3|Overall Study|Protocol-specified Criteria|0
147198|NCT00658658|468566|P2|Overall Study|Protocol-specified Criteria|0
147199|NCT00658658|468567|P1|Overall Study|Protocol-specified Criteria|1
147200|NCT00658658|468563|P5|Overall Study|Disease Progression|3
147201|NCT00658658|468564|P4|Overall Study|Disease Progression|1
147202|NCT00658658|468565|P3|Overall Study|Disease Progression|0
147203|NCT00658658|468566|P2|Overall Study|Disease Progression|1
147204|NCT00658658|468567|P1|Overall Study|Disease Progression|0
147205|NCT00658658|468563|P5|Overall Study|Death|1
147206|NCT00658658|468564|P4|Overall Study|Death|1
147207|NCT00658658|468565|P3|Overall Study|Death|0
147208|NCT00658658|468566|P2|Overall Study|Death|0
147209|NCT00658658|468567|P1|Overall Study|Death|4
147210|NCT00658658|468563|P5|Overall Study|Withdrawal by Subject|0
147211|NCT00658658|468564|P4|Overall Study|Withdrawal by Subject|0
147212|NCT00658658|468565|P3|Overall Study|Withdrawal by Subject|0
147213|NCT00658658|468566|P2|Overall Study|Withdrawal by Subject|1
147214|NCT00658658|468567|P1|Overall Study|Withdrawal by Subject|0
147215|NCT00658684|468627|P4|Overall Study|Pregnancy|0
147216|NCT00658684|468628|P3|Overall Study|Pregnancy|0
147217|NCT00658684|468629|P2|Overall Study|Pregnancy|1
147218|NCT00658684|468630|P1|Overall Study|Pregnancy|1
147219|NCT00658684|468627|P4|Overall Study|Protocol Violation|0
147220|NCT00658684|468628|P3|Overall Study|Protocol Violation|0
147221|NCT00658684|468629|P2|Overall Study|Protocol Violation|1
147222|NCT00658684|468630|P1|Overall Study|Protocol Violation|1
147223|NCT00658684|468627|P4|Overall Study|Lack of Efficacy|0
147224|NCT00658684|468628|P3|Overall Study|Lack of Efficacy|0
147225|NCT00658684|468629|P2|Overall Study|Lack of Efficacy|1
147226|NCT00658684|468630|P1|Overall Study|Lack of Efficacy|1
147227|NCT00658684|468627|P4|Overall Study|Withdrawal by Subject|1
147228|NCT00658684|468628|P3|Overall Study|Withdrawal by Subject|1
147229|NCT00658684|468629|P2|Overall Study|Withdrawal by Subject|4
147230|NCT00658684|468630|P1|Overall Study|Withdrawal by Subject|6
147231|NCT00658684|468627|P4|Overall Study|Adverse Event|0
147232|NCT00658684|468628|P3|Overall Study|Adverse Event|2
147233|NCT00658684|468629|P2|Overall Study|Adverse Event|8
147234|NCT00658684|468630|P1|Overall Study|Adverse Event|10
147235|NCT00658723|468690|P3|Overall Study|Withdrawal by Subject|1
147236|NCT00658723|468691|P2|Overall Study|Withdrawal by Subject|0
147237|NCT00658723|468692|P1|Overall Study|Withdrawal by Subject|1
147238|NCT00658723|468690|P3|Overall Study|Scheduling Issue|0
147239|NCT00658723|468691|P2|Overall Study|Scheduling Issue|1
147240|NCT00658723|468692|P1|Overall Study|Scheduling Issue|1
147241|NCT00658723|468690|P3|Overall Study|Death|4
147242|NCT00658723|468691|P2|Overall Study|Death|1
147243|NCT00658723|468692|P1|Overall Study|Death|2
147244|NCT00658723|468690|P3|Overall Study|Lost to Follow-up|2
147245|NCT00658723|468691|P2|Overall Study|Lost to Follow-up|2
147246|NCT00658723|468692|P1|Overall Study|Lost to Follow-up|0
147247|NCT00658775|468732|P2|Overall Study|Not specified|8
147248|NCT00658775|468733|P1|Overall Study|Not specified|7
147249|NCT00658775|468732|P2|Overall Study|Withdrawal of consent|7
147250|NCT00658775|468733|P1|Overall Study|Withdrawal of consent|8
147251|NCT00658775|468732|P2|Overall Study|Withdrawal by Subject|4
147252|NCT00658775|468733|P1|Overall Study|Withdrawal by Subject|6
147253|NCT00658775|468732|P2|Overall Study|Lost to Follow-up|18
147254|NCT00658775|468733|P1|Overall Study|Lost to Follow-up|17
147255|NCT00658775|468732|P2|Overall Study|Adverse Event|6
147256|NCT00658775|468733|P1|Overall Study|Adverse Event|4
147257|NCT00658788|468743|P1|Overall Study|Treatment Discontinuation|32
147258|NCT00658788|468743|P1|Overall Study|Lost to Follow-up|18
147259|NCT00658788|468743|P1|Overall Study|Withdrawal by Subject|13
147260|NCT00658788|468743|P1|Overall Study|Adverse Event|11
147261|NCT00658814|468798|P2|Maintenance Therapy|Not eligible|0
147262|NCT00658814|468799|P1|Maintenance Therapy|Not eligible|1
147263|NCT00658814|468798|P2|Maintenance Therapy|Not protocol specified|0
147264|NCT00658814|468799|P1|Maintenance Therapy|Not protocol specified|1
147265|NCT00658814|468798|P2|Maintenance Therapy|Adverse Event|1
147266|NCT00658814|468799|P1|Maintenance Therapy|Adverse Event|1
147267|NCT00658814|468798|P2|Consolidation Therapy|Not eligible|2
147268|NCT00658814|468799|P1|Consolidation Therapy|Not eligible|2
147269|NCT00658814|468798|P2|Consolidation Therapy|Not protocol specified|1
147270|NCT00658814|468799|P1|Consolidation Therapy|Not protocol specified|0
147271|NCT00658814|468798|P2|Remission Induction Chemotherapy|Not eligible|2
147272|NCT00658814|468799|P1|Remission Induction Chemotherapy|Not eligible|1
147273|NCT00658814|468798|P2|Remission Induction Chemotherapy|Not protocol specified|4
147274|NCT00658814|468799|P1|Remission Induction Chemotherapy|Not protocol specified|2
147275|NCT00658814|468798|P2|Remission Induction Chemotherapy|Death|4
147276|NCT00658814|468799|P1|Remission Induction Chemotherapy|Death|1
147277|NCT00658814|468798|P2|Remission Induction Chemotherapy|Progression/Relapse|1
147278|NCT00658814|468799|P1|Remission Induction Chemotherapy|Progression/Relapse|0
147279|NCT00658814|468798|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
147280|NCT00658814|468799|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
147281|NCT00658814|468798|P2|Remission Induction Chemotherapy|Adverse Event|3
147282|NCT00658814|468799|P1|Remission Induction Chemotherapy|Adverse Event|1
147283|NCT00658996|468813|P2|Second Intervention|Positive slit lamp finding|1
147284|NCT00658996|468814|P1|Second Intervention|Positive slit lamp finding|0
147285|NCT00658996|468813|P2|Second Intervention|Developed a stye on upper lid|0
147286|NCT00658996|468814|P1|Second Intervention|Developed a stye on upper lid|1
147287|NCT00658996|468813|P2|Crossover Period|Ineligible|1
147288|NCT00658996|468814|P1|Crossover Period|Ineligible|1
147289|NCT00658996|468813|P2|Crossover Period|Physician Decision|0
147290|NCT00658996|468814|P1|Crossover Period|Physician Decision|1
147291|NCT00658996|468813|P2|First Intervention|Lack of lenses|1
147292|NCT00658996|468814|P1|First Intervention|Lack of lenses|0
147293|NCT00658996|468813|P2|First Intervention|Positive slit lamp finding|0
147294|NCT00658996|468814|P1|First Intervention|Positive slit lamp finding|1
147295|NCT00659061|468826|P2|Overall Study|Migration due to political unrest|15
147296|NCT00659061|468827|P1|Overall Study|Migration due to political unrest|21
147297|NCT00659230|468856|P2|Overall Study|Did not return post-randomization|3
147298|NCT00659230|468857|P1|Overall Study|Did not return post-randomization|2
147299|NCT00659230|468856|P2|Overall Study|Lost source documentation|4
147300|NCT00659230|468857|P1|Overall Study|Lost source documentation|5
147301|NCT00659230|468856|P2|Overall Study|Lost to Follow-up|5
147302|NCT00659230|468857|P1|Overall Study|Lost to Follow-up|2
147303|NCT00659269|468871|P2|Overall Study|Physician Decision|1
147304|NCT00659269|468872|P1|Overall Study|Physician Decision|1
147305|NCT00659334|468916|P7|Overall Study|Screen Failure|1
147306|NCT00659334|468917|P6|Overall Study|Screen Failure|0
147307|NCT00659334|468918|P5|Overall Study|Screen Failure|0
147308|NCT00659334|468919|P4|Overall Study|Screen Failure|0
147309|NCT00659334|468920|P3|Overall Study|Screen Failure|0
147310|NCT00659334|468921|P2|Overall Study|Screen Failure|5
147311|NCT00659334|468922|P1|Overall Study|Screen Failure|8
147312|NCT00659373|468948|P2|Overall Study|Assessment Missed|2
147313|NCT00659373|468949|P1|Overall Study|Assessment Missed|2
147314|NCT00659373|468948|P2|Overall Study|Withdrawal by Subject|5
147315|NCT00659373|468949|P1|Overall Study|Withdrawal by Subject|3
147316|NCT00659438|468957|P2|Overall Study|Lost to Follow-up|0
147317|NCT00659438|468958|P1|Overall Study|Lost to Follow-up|1
147318|NCT00659438|468957|P2|Overall Study|Death|6
147319|NCT00659438|468958|P1|Overall Study|Death|11
147320|NCT00659438|468957|P2|Overall Study|Withdrawal by Subject|2
147321|NCT00659438|468958|P1|Overall Study|Withdrawal by Subject|2
147322|NCT00659490|468983|P3|Overall Study|Lost to Follow-up|1
147323|NCT00659490|468984|P2|Overall Study|Lost to Follow-up|0
147324|NCT00659490|468985|P1|Overall Study|Lost to Follow-up|2
147325|NCT00659529|469056|P1|Overall Study|Screen failure|9
147326|NCT00659529|469056|P1|Overall Study|Protocol Violation|3
147327|NCT00659529|469056|P1|Overall Study|Withdrawal by Subject|4
147328|NCT00659581|469060|P1|Overall Study|Other|6393
147329|NCT00659581|469060|P1|Overall Study|Lack of Efficacy|1183
147330|NCT00659581|469060|P1|Overall Study|Adverse Event|1006
147331|NCT00659607|469072|P1|Overall Study|Inconsistent BP measuring date|2
147332|NCT00659607|469072|P1|Overall Study|No recorded efficacy data|15
147333|NCT00659607|469072|P1|Overall Study|‘Unable to evaluate’ for the final asses|67
147334|NCT00659607|469072|P1|Overall Study|Unknown measuring date of blood pressure|85
147335|NCT00659607|469072|P1|Overall Study|No blood pressure recorded|147
147336|NCT00659815|469142|P2|Overall Study|Withdrawal by Subject|1
147337|NCT00659815|469143|P1|Overall Study|Withdrawal by Subject|1
147338|NCT00659815|469142|P2|Overall Study|Inability to maintain wearing schedule|2
147339|NCT00659815|469143|P1|Overall Study|Inability to maintain wearing schedule|1
147340|NCT00659815|469142|P2|Overall Study|Study related symptoms and complaints|1
147341|NCT00659815|469143|P1|Overall Study|Study related symptoms and complaints|2
147342|NCT00659880|469153|P1|Overall Study|Lost to Follow-up|5
147343|NCT00659984|469167|P1|Overall Study|Adverse Event|1
147344|NCT00660010|469178|P1|Overall Study|Noncompliance with visit schedule|3
147345|NCT00660010|469178|P1|Overall Study|Adverse Event|1
147346|NCT00660010|469178|P1|Overall Study|Lost to Follow-up|3
147347|NCT00660010|469178|P1|Overall Study|Withdrawal by Subject|2
147348|NCT00660023|469192|P1|Overall Study|Other Screening Failure|9
147349|NCT00660023|469192|P1|Overall Study|Missed Pregnancy Test|1
147350|NCT00660023|469192|P1|Overall Study|Withdrawal by Subject|1
147351|NCT00660023|469192|P1|Overall Study|Renal Transplantation|3
147352|NCT00660023|469192|P1|Overall Study|Blood Transfusion|5
147353|NCT00660023|469192|P1|Overall Study|Death|8
147354|NCT00660023|469192|P1|Overall Study|Adverse Event|2
147355|NCT00660179|469219|P3|Overall Study|Incorrect randomization|0
147356|NCT00660179|469220|P2|Overall Study|Incorrect randomization|0
147357|NCT00660179|469221|P1|Overall Study|Incorrect randomization|1
147358|NCT00660179|469219|P3|Overall Study|Administrative reason|1
147359|NCT00660179|469220|P2|Overall Study|Administrative reason|0
147360|NCT00660179|469221|P1|Overall Study|Administrative reason|0
147361|NCT00660179|469219|P3|Overall Study|Lost to Follow-up|2
147362|NCT00660179|469220|P2|Overall Study|Lost to Follow-up|5
147363|NCT00660179|469221|P1|Overall Study|Lost to Follow-up|7
147364|NCT00660179|469219|P3|Overall Study|Withdrawal of consent|4
147365|NCT00660179|469220|P2|Overall Study|Withdrawal of consent|6
147366|NCT00660179|469221|P1|Overall Study|Withdrawal of consent|4
147367|NCT00660179|469219|P3|Overall Study|Death|34
147368|NCT00660179|469220|P2|Overall Study|Death|47
147369|NCT00660179|469221|P1|Overall Study|Death|44
147370|NCT00660192|469255|P2|Overall Study|Lost to Follow-up|3
147371|NCT00660192|469256|P1|Overall Study|Lost to Follow-up|2
147372|NCT00653224|469266|P2|Overall Study|Other|4
147373|NCT00653224|469267|P1|Overall Study|Other|2
147374|NCT00653224|469266|P2|Overall Study|Lost to Follow-up|0
147375|NCT00653224|469267|P1|Overall Study|Lost to Follow-up|1
147376|NCT00653224|469266|P2|Overall Study|Loss of efficacy|0
147377|NCT00653224|469267|P1|Overall Study|Loss of efficacy|1
147378|NCT00653224|469266|P2|Overall Study|Lack of Efficacy|2
147379|NCT00653224|469267|P1|Overall Study|Lack of Efficacy|1
147380|NCT00653224|469266|P2|Overall Study|Adverse Event|1
147381|NCT00653224|469267|P1|Overall Study|Adverse Event|2
147382|NCT00653263|469451|P1|Overall Study|Physician Decision|1
147383|NCT00653263|469451|P1|Overall Study|Withdrawal by Subject|1
147384|NCT00653328|469457|P1|Overall Study|Drug manufacturer no longing making drug|2
147385|NCT00653328|469457|P1|Overall Study|Disease progression|10
147386|NCT00653328|469457|P1|Overall Study|Adverse Event|2
147387|NCT00653328|469457|P1|Overall Study|Withdrawal by Subject|1
147388|NCT00653523|469464|P1|Overall Study|Adverse reaction did not improve (4)|1
147389|NCT00653523|469464|P1|Overall Study|Elevated alanine aminotransferase (3)|2
147390|NCT00653523|469464|P1|Overall Study|Withdrawal by Subject|6
147391|NCT00653523|469464|P1|Overall Study|Adverse Event|7
147392|NCT00653523|469464|P1|Overall Study|Elevated creatine phosphokinase (2)|1
147393|NCT00653523|469464|P1|Overall Study|Drop in low density lipoprotein (1)|2
147394|NCT00653939|469479|P2|Overall Study|Not Specified|6
147395|NCT00653939|469480|P1|Overall Study|Not Specified|2
147396|NCT00653939|469479|P2|Overall Study|Disease Progression|3
147397|NCT00653939|469480|P1|Overall Study|Disease Progression|2
147398|NCT00653939|469479|P2|Overall Study|Physician Decision|0
147399|NCT00653939|469480|P1|Overall Study|Physician Decision|4
147400|NCT00653939|469479|P2|Overall Study|Withdrawal by Subject|3
147401|NCT00653939|469480|P1|Overall Study|Withdrawal by Subject|3
147402|NCT00653939|469479|P2|Overall Study|Adverse Event|3
147403|NCT00653939|469480|P1|Overall Study|Adverse Event|1
147404|NCT00654004|469498|P2|Overall Study|Lost to Follow-up|0
147405|NCT00654004|469499|P1|Overall Study|Lost to Follow-up|1
147406|NCT00654095|469517|P1|Overall Study|Did not meet inclusion criteria|1
147407|NCT00654095|469517|P1|Overall Study|Adverse reaction did not improve (5)|4
147408|NCT00654095|469517|P1|Overall Study|Elevated alanine aminotransferase (4)|7
147409|NCT00654095|469517|P1|Overall Study|Withdrawal by Subject|5
147410|NCT00654095|469517|P1|Overall Study|Adverse Event|11
147411|NCT00654095|469517|P1|Overall Study|Elevated alanine aminotransferase (3)|1
147412|NCT00654095|469517|P1|Overall Study|Elevated triglyceride level (2)|1
147413|NCT00654095|469517|P1|Overall Study|Drop in low density lipoprotein (1)|2
147414|NCT00654186|469540|P1|Overall Study|Withdrawal by Subject|5
147415|NCT00654355|469569|P2|Overall Study|Lost to Follow-up|2
147416|NCT00654355|469570|P1|Overall Study|Lost to Follow-up|2
147417|NCT00654368|469583|P3|Overall Study|Adverse Event|6
147418|NCT00654368|469584|P2|Overall Study|Adverse Event|9
147419|NCT00654368|469585|P1|Overall Study|Adverse Event|14
147420|NCT00654368|469583|P3|Overall Study|Other|3
147421|NCT00654368|469584|P2|Overall Study|Other|2
147422|NCT00654368|469585|P1|Overall Study|Other|0
147423|NCT00654368|469583|P3|Overall Study|Pregnancy|2
147424|NCT00654368|469584|P2|Overall Study|Pregnancy|0
147425|NCT00654368|469585|P1|Overall Study|Pregnancy|0
147426|NCT00654368|469583|P3|Overall Study|Death|0
147427|NCT00654368|469584|P2|Overall Study|Death|0
147428|NCT00654368|469585|P1|Overall Study|Death|1
147429|NCT00654368|469583|P3|Overall Study|Physician Decision|2
147430|NCT00654368|469584|P2|Overall Study|Physician Decision|0
147431|NCT00654368|469585|P1|Overall Study|Physician Decision|0
147432|NCT00654368|469583|P3|Overall Study|Requirement for alternative therapy|1
147433|NCT00654368|469584|P2|Overall Study|Requirement for alternative therapy|1
147434|NCT00654368|469585|P1|Overall Study|Requirement for alternative therapy|1
147435|NCT00654368|469583|P3|Overall Study|Disease progression|13
147436|NCT00654368|469584|P2|Overall Study|Disease progression|31
147437|NCT00654368|469585|P1|Overall Study|Disease progression|21
147438|NCT00654368|469583|P3|Overall Study|Withdrawal by Subject|2
147439|NCT00654368|469584|P2|Overall Study|Withdrawal by Subject|2
147440|NCT00654368|469585|P1|Overall Study|Withdrawal by Subject|5
147441|NCT00654368|469583|P3|Overall Study|Non-compliance|2
147442|NCT00654368|469584|P2|Overall Study|Non-compliance|1
147443|NCT00654368|469585|P1|Overall Study|Non-compliance|2
147444|NCT00654368|469583|P3|Overall Study|Protocol deviation|1
147445|NCT00654368|469584|P2|Overall Study|Protocol deviation|2
147446|NCT00654368|469585|P1|Overall Study|Protocol deviation|3
147447|NCT00654368|469583|P3|Overall Study|Ineligibility determined|0
147448|NCT00654368|469584|P2|Overall Study|Ineligibility determined|0
147449|NCT00654368|469585|P1|Overall Study|Ineligibility determined|6
147450|NCT00654381|469620|P6|Extension Stage|Closure of the trial site|1
147451|NCT00654381|469621|P5|Extension Stage|Closure of the trial site|1
147452|NCT00654381|469622|P4|Extension Stage|Closure of the trial site|0
147453|NCT00654381|469623|P3|Extension Stage|Closure of the trial site|0
147454|NCT00654381|469624|P2|Extension Stage|Closure of the trial site|0
147455|NCT00654381|469625|P1|Extension Stage|Closure of the trial site|0
147456|NCT00654381|469620|P6|Extension Stage|Withdrawal by Subject|1
147457|NCT00654381|469621|P5|Extension Stage|Withdrawal by Subject|1
147458|NCT00654381|469622|P4|Extension Stage|Withdrawal by Subject|1
147459|NCT00654381|469623|P3|Extension Stage|Withdrawal by Subject|1
147460|NCT00654381|469624|P2|Extension Stage|Withdrawal by Subject|0
147461|NCT00654381|469625|P1|Extension Stage|Withdrawal by Subject|0
147462|NCT00654381|469620|P6|Extension Stage|Lack of Efficacy|0
147463|NCT00654381|469621|P5|Extension Stage|Lack of Efficacy|0
147464|NCT00654381|469622|P4|Extension Stage|Lack of Efficacy|0
147465|NCT00654381|469623|P3|Extension Stage|Lack of Efficacy|1
147466|NCT00654381|469624|P2|Extension Stage|Lack of Efficacy|0
147467|NCT00654381|469625|P1|Extension Stage|Lack of Efficacy|0
147468|NCT00654381|469620|P6|Extension Stage|Protocol Violation|0
147469|NCT00654381|469621|P5|Extension Stage|Protocol Violation|0
147470|NCT00654381|469622|P4|Extension Stage|Protocol Violation|1
147471|NCT00654381|469623|P3|Extension Stage|Protocol Violation|0
147472|NCT00654381|469624|P2|Extension Stage|Protocol Violation|0
147473|NCT00654381|469625|P1|Extension Stage|Protocol Violation|0
147474|NCT00654381|469620|P6|Extension Stage|Adverse Event|1
147475|NCT00654381|469621|P5|Extension Stage|Adverse Event|1
147476|NCT00654381|469622|P4|Extension Stage|Adverse Event|7
147477|NCT00654381|469623|P3|Extension Stage|Adverse Event|9
147478|NCT00654381|469624|P2|Extension Stage|Adverse Event|2
147479|NCT00654381|469625|P1|Extension Stage|Adverse Event|1
147480|NCT00654381|469620|P6|2nd Stage|Investigator's decision|0
147481|NCT00654381|469621|P5|2nd Stage|Investigator's decision|0
147482|NCT00654381|469622|P4|2nd Stage|Investigator's decision|1
147483|NCT00654381|469623|P3|2nd Stage|Investigator's decision|1
147484|NCT00654381|469624|P2|2nd Stage|Investigator's decision|0
147485|NCT00654381|469625|P1|2nd Stage|Investigator's decision|0
147486|NCT00654381|469620|P6|2nd Stage|Withdrawal by Subject|1
147487|NCT00654381|469621|P5|2nd Stage|Withdrawal by Subject|1
147488|NCT00654381|469622|P4|2nd Stage|Withdrawal by Subject|0
147489|NCT00654381|469623|P3|2nd Stage|Withdrawal by Subject|0
147490|NCT00654381|469624|P2|2nd Stage|Withdrawal by Subject|0
147491|NCT00654381|469625|P1|2nd Stage|Withdrawal by Subject|0
147492|NCT00654381|469620|P6|2nd Stage|Adverse Event|2
147493|NCT00654381|469621|P5|2nd Stage|Adverse Event|7
147494|NCT00654381|469622|P4|2nd Stage|Adverse Event|3
147495|NCT00654381|469623|P3|2nd Stage|Adverse Event|2
147496|NCT00654381|469624|P2|2nd Stage|Adverse Event|0
147497|NCT00654381|469625|P1|2nd Stage|Adverse Event|2
147498|NCT00654381|469620|P6|1st Stage|Investigator's decision|0
147499|NCT00654381|469621|P5|1st Stage|Investigator's decision|0
147500|NCT00654381|469622|P4|1st Stage|Investigator's decision|1
147501|NCT00654381|469623|P3|1st Stage|Investigator's decision|0
147502|NCT00654381|469624|P2|1st Stage|Investigator's decision|0
147503|NCT00654381|469625|P1|1st Stage|Investigator's decision|0
147504|NCT00654381|469620|P6|1st Stage|Withdrawal by Subject|1
147505|NCT00654381|469621|P5|1st Stage|Withdrawal by Subject|0
147506|NCT00654381|469622|P4|1st Stage|Withdrawal by Subject|1
147507|NCT00654381|469623|P3|1st Stage|Withdrawal by Subject|0
147508|NCT00654381|469624|P2|1st Stage|Withdrawal by Subject|0
147509|NCT00654381|469625|P1|1st Stage|Withdrawal by Subject|0
147510|NCT00654381|469620|P6|1st Stage|Adverse Event|1
147511|NCT00654381|469621|P5|1st Stage|Adverse Event|2
147512|NCT00654381|469622|P4|1st Stage|Adverse Event|3
147513|NCT00654381|469623|P3|1st Stage|Adverse Event|3
147514|NCT00654381|469624|P2|1st Stage|Adverse Event|3
147515|NCT00654381|469625|P1|1st Stage|Adverse Event|3
147516|NCT00660309|469661|P2|Overall Study|Withdrawal by Subject|3
147517|NCT00660309|469662|P1|Overall Study|Withdrawal by Subject|0
147518|NCT00660309|469661|P2|Overall Study|Adverse Event|0
147519|NCT00660309|469662|P1|Overall Study|Adverse Event|2
147520|NCT00660348|469703|P2|Overall Study|Withdrawal by Subject|0
147521|NCT00660348|469704|P1|Overall Study|Withdrawal by Subject|1
147522|NCT00660387|469712|P2|Overall Study|Protocol Violation|0
147523|NCT00660387|469713|P1|Overall Study|Protocol Violation|1
147524|NCT00660387|469712|P2|Overall Study|Lack of Efficacy|1
147525|NCT00660387|469713|P1|Overall Study|Lack of Efficacy|0
147526|NCT00660387|469712|P2|Overall Study|Adverse Event|2
147527|NCT00660387|469713|P1|Overall Study|Adverse Event|1
147528|NCT00660400|469765|P1|Overall Study|Withdrawal by Subject|1
147529|NCT00660400|469765|P1|Overall Study|Intracranial hemorrhage|1
147530|NCT00660400|469765|P1|Overall Study|Suboptimal organ function|1
147531|NCT00660400|469765|P1|Overall Study|Lack of insurance approval|1
147532|NCT00660595|469823|P2|Overall Study|Non Specified reasons|0
147533|NCT00660595|469824|P1|Overall Study|Non Specified reasons|5
147534|NCT00660595|469823|P2|Overall Study|Participant left hospital|0
147535|NCT00660595|469824|P1|Overall Study|Participant left hospital|1
147536|NCT00660595|469823|P2|Overall Study|Did not consent to participate in study|8
147537|NCT00660595|469824|P1|Overall Study|Did not consent to participate in study|12
147538|NCT00660595|469823|P2|Overall Study|Lost to Follow-up|1
147539|NCT00660595|469824|P1|Overall Study|Lost to Follow-up|0
147540|NCT00660816|469838|P2|Overall Study|Complicating Disease|1
147541|NCT00660816|469839|P1|Overall Study|Complicating Disease|0
147542|NCT00660816|469838|P2|Overall Study|Disease Progression|12
147543|NCT00660816|469839|P1|Overall Study|Disease Progression|16
147544|NCT00660816|469838|P2|Overall Study|Protocol Violation|0
147545|NCT00660816|469839|P1|Overall Study|Protocol Violation|1
147546|NCT00660816|469838|P2|Overall Study|Physician Decision|2
147547|NCT00660816|469839|P1|Overall Study|Physician Decision|0
147548|NCT00660816|469838|P2|Overall Study|Lack of Efficacy|0
147549|NCT00660816|469839|P1|Overall Study|Lack of Efficacy|1
147550|NCT00660816|469838|P2|Overall Study|Death|2
147551|NCT00660816|469839|P1|Overall Study|Death|0
147552|NCT00660816|469838|P2|Overall Study|Withdrawal by Subject|0
147553|NCT00660816|469839|P1|Overall Study|Withdrawal by Subject|1
147554|NCT00660816|469838|P2|Overall Study|Adverse Event|2
147555|NCT00660816|469839|P1|Overall Study|Adverse Event|1
147556|NCT00660829|469853|P2|Overall Study|Other|4
147557|NCT00660829|469854|P1|Overall Study|Other|9
147558|NCT00660829|469853|P2|Overall Study|Lost to Follow-up|2
147559|NCT00660829|469854|P1|Overall Study|Lost to Follow-up|3
147560|NCT00660829|469853|P2|Overall Study|Withdrawal by Subject|2
147561|NCT00660829|469854|P1|Overall Study|Withdrawal by Subject|1
147562|NCT00660829|469853|P2|Overall Study|Non-Compliance|4
147563|NCT00660829|469854|P1|Overall Study|Non-Compliance|0
147564|NCT00660829|469853|P2|Overall Study|Lack of Efficacy|3
147565|NCT00660829|469854|P1|Overall Study|Lack of Efficacy|2
147566|NCT00660829|469853|P2|Overall Study|Adverse Event|4
147567|NCT00660829|469854|P1|Overall Study|Adverse Event|3
147568|NCT00660907|469872|P2|Overall Study|Various|8
147569|NCT00660907|469873|P1|Overall Study|Various|11
147570|NCT00660907|469872|P2|Overall Study|Death|3
147571|NCT00660907|469873|P1|Overall Study|Death|1
147572|NCT00660907|469872|P2|Overall Study|Safety|0
147573|NCT00660907|469873|P1|Overall Study|Safety|1
147574|NCT00660907|469872|P2|Overall Study|Poor/Non-Compliance|1
147575|NCT00660907|469873|P1|Overall Study|Poor/Non-Compliance|5
147576|NCT00660907|469872|P2|Overall Study|Lost to Follow-up|3
147577|NCT00660907|469873|P1|Overall Study|Lost to Follow-up|3
147578|NCT00660907|469872|P2|Overall Study|Withdrawal by Subject|32
147579|NCT00660907|469873|P1|Overall Study|Withdrawal by Subject|23
147580|NCT00660907|469872|P2|Overall Study|Subject No Longer Meets Study Criteria|27
147581|NCT00660907|469873|P1|Overall Study|Subject No Longer Meets Study Criteria|6
147582|NCT00660907|469872|P2|Overall Study|Adverse Event|19
147583|NCT00660907|469873|P1|Overall Study|Adverse Event|33
147584|NCT00660907|469872|P2|Overall Study|Incorrect Enrollment|1
147585|NCT00660907|469873|P1|Overall Study|Incorrect Enrollment|1
147586|NCT00661089|469925|P2|Overall Study|death at 8 weeks due to new stroke|1
147587|NCT00661089|469926|P1|Overall Study|death at 8 weeks due to new stroke|0
147588|NCT00661089|469925|P2|Overall Study|1 subject withdrawal|1
147589|NCT00661089|469926|P1|Overall Study|1 subject withdrawal|0
147590|NCT00661193|469936|P2|Overall Study|Not protocol specified|0
147591|NCT00661193|469937|P1|Overall Study|Not protocol specified|1
147592|NCT00661193|469936|P2|Overall Study|Progression|24
147593|NCT00661193|469937|P1|Overall Study|Progression|27
147594|NCT00661193|469936|P2|Overall Study|Withdrawal by Subject|1
147595|NCT00661193|469937|P1|Overall Study|Withdrawal by Subject|3
147596|NCT00661193|469936|P2|Overall Study|Adverse Event|1
147597|NCT00661193|469937|P1|Overall Study|Adverse Event|2
147598|NCT00661258|469947|P2|Overall Study|caught by police and in detox center|1
147599|NCT00661258|469948|P1|Overall Study|caught by police and in detox center|2
147600|NCT00661258|469947|P2|Overall Study|Death|0
147601|NCT00661258|469948|P1|Overall Study|Death|1
147602|NCT00661362|469958|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
147603|NCT00661362|469959|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
147604|NCT00661362|469958|P2|Overall Study|Safety reasons|0
147605|NCT00661362|469959|P1|Overall Study|Safety reasons|1
147606|NCT00661362|469958|P2|Overall Study|Severe non-compliance to protocol|1
147607|NCT00661362|469959|P1|Overall Study|Severe non-compliance to protocol|0
147608|NCT00661362|469958|P2|Overall Study|Lost to Follow-up|1
147609|NCT00661362|469959|P1|Overall Study|Lost to Follow-up|3
147610|NCT00661362|469958|P2|Overall Study|Withdrawal by Subject|23
147611|NCT00661362|469959|P1|Overall Study|Withdrawal by Subject|13
147612|NCT00661362|469958|P2|Overall Study|Study specific discontinuation criteria|11
147613|NCT00661362|469959|P1|Overall Study|Study specific discontinuation criteria|4
147614|NCT00661362|469958|P2|Overall Study|Incorrect enrollment|0
147615|NCT00661362|469959|P1|Overall Study|Incorrect enrollment|2
147616|NCT00661362|469958|P2|Overall Study|Adverse Event|4
147617|NCT00661362|469959|P1|Overall Study|Adverse Event|5
147618|NCT00661388|469975|P1|Overall Study|Administrative reasons|1
147619|NCT00661388|469975|P1|Overall Study|Dialysis initiation|1
147620|NCT00661388|469975|P1|Overall Study|Renal transplantation|1
147621|NCT00661388|469975|P1|Overall Study|Protocol Violation|7
147622|NCT00661388|469975|P1|Overall Study|Adverse Event|14
147623|NCT00661427|469998|P2|Overall Study|Patient not treated|2
147624|NCT00661427|469999|P1|Overall Study|Patient not treated|0
147625|NCT00661427|469998|P2|Overall Study|Adverse Event|5
147626|NCT00661427|469999|P1|Overall Study|Adverse Event|5
147627|NCT00661492|470031|P2|Overall Study|Other|0
147628|NCT00661492|470032|P1|Overall Study|Other|1
147629|NCT00661492|470031|P2|Overall Study|Lost to Follow-up|1
147630|NCT00661492|470032|P1|Overall Study|Lost to Follow-up|0
147631|NCT00661492|470031|P2|Overall Study|Investigator Request|0
147632|NCT00661492|470032|P1|Overall Study|Investigator Request|1
147633|NCT00661492|470031|P2|Overall Study|Patient Request|1
147634|NCT00661492|470032|P1|Overall Study|Patient Request|6
147635|NCT00661492|470031|P2|Overall Study|Disease Progression|14
147636|NCT00661492|470032|P1|Overall Study|Disease Progression|44
147637|NCT00661492|470031|P2|Overall Study|Adverse Event|13
147638|NCT00661492|470032|P1|Overall Study|Adverse Event|16
147639|NCT00661505|470052|P1|Overall Study|Not Specified|2
147640|NCT00661505|470052|P1|Overall Study|Lost to Follow-up|3
147641|NCT00661505|470052|P1|Overall Study|Withdrawal by Subject|8
147642|NCT00661505|470052|P1|Overall Study|Protocol Violation|14
147643|NCT00661505|470052|P1|Overall Study|Adverse Event|3
147644|NCT00661531|470078|P1|Overall Study|Withdrawal by Subject|3
147645|NCT00661609|470116|P1|Overall Study|Disease progression|3
147646|NCT00661609|470116|P1|Overall Study|Survival follow up stage discontinued|11
147647|NCT00661609|470116|P1|Overall Study|PI Decision|1
147648|NCT00661609|470116|P1|Overall Study|Withdrawal by Subject|2
147649|NCT00661609|470116|P1|Overall Study|Death|20
147650|NCT00661609|470116|P1|Overall Study|Adverse Event|4
147651|NCT00661622|470125|P2|Overall Study|Protocol Violation|0
147652|NCT00661622|470126|P1|Overall Study|Protocol Violation|1
147653|NCT00661661|470142|P2|Overall Study|Not assigned treatment|0
147654|NCT00661661|470143|P1|Overall Study|Not assigned treatment|1
147655|NCT00661661|470142|P2|Overall Study|Unspecified|7
147656|NCT00661661|470143|P1|Overall Study|Unspecified|22
147657|NCT00661661|470142|P2|Overall Study|Withdrawal by Subject|5
147658|NCT00661661|470143|P1|Overall Study|Withdrawal by Subject|15
147659|NCT00661661|470142|P2|Overall Study|Lost to Follow-up|1
147660|NCT00661661|470143|P1|Overall Study|Lost to Follow-up|0
147661|NCT00661661|470142|P2|Overall Study|Lack of Efficacy|2
147662|NCT00661661|470143|P1|Overall Study|Lack of Efficacy|3
147663|NCT00661661|470142|P2|Overall Study|Adverse Event|24
147664|NCT00661661|470143|P1|Overall Study|Adverse Event|99
147665|NCT00661687|470233|P1|Overall Study|Adverse Event|2
147666|NCT00661687|470233|P1|Overall Study|Physician Decision|1
147667|NCT00661687|470233|P1|Overall Study|Inability to maintain wearing schedule|3
147668|NCT00661687|470233|P1|Overall Study|Positive slit lamp findings|4
147669|NCT00661687|470233|P1|Overall Study|Study related symptoms and complaints|5
147670|NCT00661713|470251|P8|Overall Study|Inappropriate Enrollment|0
147671|NCT00661713|470252|P7|Overall Study|Inappropriate Enrollment|1
147672|NCT00661713|470253|P6|Overall Study|Inappropriate Enrollment|0
147673|NCT00661713|470254|P5|Overall Study|Inappropriate Enrollment|0
147674|NCT00661713|470255|P4|Overall Study|Inappropriate Enrollment|0
147675|NCT00661713|470256|P3|Overall Study|Inappropriate Enrollment|0
147676|NCT00661713|470257|P2|Overall Study|Inappropriate Enrollment|0
147677|NCT00661713|470258|P1|Overall Study|Inappropriate Enrollment|0
147678|NCT00661713|470251|P8|Overall Study|Adverse Event|0
147679|NCT00661713|470252|P7|Overall Study|Adverse Event|1
147680|NCT00661713|470253|P6|Overall Study|Adverse Event|0
147681|NCT00661713|470254|P5|Overall Study|Adverse Event|0
147682|NCT00661713|470255|P4|Overall Study|Adverse Event|0
147683|NCT00661713|470256|P3|Overall Study|Adverse Event|0
147684|NCT00661713|470257|P2|Overall Study|Adverse Event|0
147685|NCT00661713|470258|P1|Overall Study|Adverse Event|0
147686|NCT00661713|470251|P8|Overall Study|Administrative Reason|0
147687|NCT00661713|470252|P7|Overall Study|Administrative Reason|1
147688|NCT00661713|470253|P6|Overall Study|Administrative Reason|2
147689|NCT00661713|470254|P5|Overall Study|Administrative Reason|2
147690|NCT00661713|470255|P4|Overall Study|Administrative Reason|2
147691|NCT00661713|470256|P3|Overall Study|Administrative Reason|0
147692|NCT00661713|470257|P2|Overall Study|Administrative Reason|1
147693|NCT00661713|470258|P1|Overall Study|Administrative Reason|0
147694|NCT00661713|470251|P8|Overall Study|Lost to Follow-up|1
147695|NCT00661713|470252|P7|Overall Study|Lost to Follow-up|14
147696|NCT00661713|470253|P6|Overall Study|Lost to Follow-up|7
147697|NCT00661713|470254|P5|Overall Study|Lost to Follow-up|5
147698|NCT00661713|470255|P4|Overall Study|Lost to Follow-up|2
147699|NCT00661713|470256|P3|Overall Study|Lost to Follow-up|2
147700|NCT00661713|470257|P2|Overall Study|Lost to Follow-up|7
147701|NCT00661713|470258|P1|Overall Study|Lost to Follow-up|2
147702|NCT00661713|470251|P8|Overall Study|Withdrawal by Subject|9
147703|NCT00661713|470252|P7|Overall Study|Withdrawal by Subject|45
147704|NCT00661713|470253|P6|Overall Study|Withdrawal by Subject|26
147705|NCT00661713|470254|P5|Overall Study|Withdrawal by Subject|12
147706|NCT00661713|470255|P4|Overall Study|Withdrawal by Subject|21
147707|NCT00661713|470256|P3|Overall Study|Withdrawal by Subject|12
147708|NCT00661713|470257|P2|Overall Study|Withdrawal by Subject|25
147709|NCT00661713|470258|P1|Overall Study|Withdrawal by Subject|11
147710|NCT00661713|470251|P8|Overall Study|Protocol Violation|1
147711|NCT00661713|470252|P7|Overall Study|Protocol Violation|2
147712|NCT00661713|470253|P6|Overall Study|Protocol Violation|2
147713|NCT00661713|470254|P5|Overall Study|Protocol Violation|0
147714|NCT00661713|470255|P4|Overall Study|Protocol Violation|3
147715|NCT00661713|470256|P3|Overall Study|Protocol Violation|3
147716|NCT00661713|470257|P2|Overall Study|Protocol Violation|6
147717|NCT00661713|470258|P1|Overall Study|Protocol Violation|1
147718|NCT00661713|470251|P8|Overall Study|Unable to Classify|0
147719|NCT00661713|470252|P7|Overall Study|Unable to Classify|0
147720|NCT00661713|470253|P6|Overall Study|Unable to Classify|0
147721|NCT00661713|470254|P5|Overall Study|Unable to Classify|0
147722|NCT00661713|470255|P4|Overall Study|Unable to Classify|0
147723|NCT00661713|470256|P3|Overall Study|Unable to Classify|0
147724|NCT00661713|470257|P2|Overall Study|Unable to Classify|0
147725|NCT00661713|470258|P1|Overall Study|Unable to Classify|1
147726|NCT00661713|470251|P8|Overall Study|Death|0
147727|NCT00661713|470252|P7|Overall Study|Death|0
147728|NCT00661713|470253|P6|Overall Study|Death|0
147729|NCT00661713|470254|P5|Overall Study|Death|1
147730|NCT00661713|470255|P4|Overall Study|Death|0
147731|NCT00661713|470256|P3|Overall Study|Death|0
147732|NCT00661713|470257|P2|Overall Study|Death|0
147733|NCT00661713|470258|P1|Overall Study|Death|1
147734|NCT00661726|470348|P1|Overall Study|Adverse Event|1
147735|NCT00661778|470363|P1|Overall Study|Withdrawal of Consent|1
147736|NCT00661778|470363|P1|Overall Study|Protocol Violation|2
147737|NCT00661778|470363|P1|Overall Study|Reason not Specified|6
147738|NCT00661778|470363|P1|Overall Study|Adverse Event|18
147739|NCT00661778|470363|P1|Overall Study|Disease Progression|23
147740|NCT00661830|470372|P2|Overall Study|Other reason|5
147741|NCT00661830|470373|P1|Overall Study|Other reason|1
147742|NCT00661830|470372|P2|Overall Study|Withdrawal by Subject|1
147743|NCT00661830|470373|P1|Overall Study|Withdrawal by Subject|1
147744|NCT00661830|470372|P2|Overall Study|Lost to Follow-up|3
147745|NCT00661830|470373|P1|Overall Study|Lost to Follow-up|1
147746|NCT00661830|470372|P2|Overall Study|Death|33
147747|NCT00661830|470373|P1|Overall Study|Death|37
147748|NCT00661999|470410|P3|Overall Study|Other Medical Problems|9
147749|NCT00661999|470411|P2|Overall Study|Other Medical Problems|4
147750|NCT00661999|470412|P1|Overall Study|Other Medical Problems|4
147751|NCT00661999|470410|P3|Overall Study|Alternative Treatment|0
147752|NCT00661999|470411|P2|Overall Study|Alternative Treatment|0
147753|NCT00661999|470412|P1|Overall Study|Alternative Treatment|1
147754|NCT00661999|470410|P3|Overall Study|Withdrawal by Subject|14
147755|NCT00661999|470411|P2|Overall Study|Withdrawal by Subject|23
147756|NCT00661999|470412|P1|Overall Study|Withdrawal by Subject|30
147757|NCT00661999|470410|P3|Overall Study|Other Reasons|23
147758|NCT00661999|470411|P2|Overall Study|Other Reasons|12
147759|NCT00661999|470412|P1|Overall Study|Other Reasons|5
147760|NCT00661999|470410|P3|Overall Study|Death|3
147761|NCT00661999|470411|P2|Overall Study|Death|6
147762|NCT00661999|470412|P1|Overall Study|Death|8
147763|NCT00661999|470410|P3|Overall Study|Adverse Event|8
147764|NCT00661999|470411|P2|Overall Study|Adverse Event|5
147765|NCT00661999|470412|P1|Overall Study|Adverse Event|11
147766|NCT00662012|470465|P1|Overall Study|Withdrawal by Subject|1
147767|NCT00662012|470465|P1|Overall Study|Death|1
147768|NCT00662012|470465|P1|Overall Study|Lost to Follow-up|85
147769|NCT00662025|470470|P1|Overall Study|Domestic circumstances|1
147770|NCT00662025|470470|P1|Overall Study|Target lesion cannot be evaluated|1
147771|NCT00662025|470470|P1|Overall Study|Results of other clinical study|2
147772|NCT00662025|470470|P1|Overall Study|Withdrawal by Subject|1
147773|NCT00662025|470470|P1|Overall Study|Adverse Event|7
147774|NCT00662025|470470|P1|Overall Study|Objective progression or relapse|51
147775|NCT00662038|470490|P1|Overall Study|Continued treatment|5
147776|NCT00662038|470490|P1|Overall Study|Adverse Event|358
147777|NCT00662038|470490|P1|Overall Study|Death|95
147778|NCT00662038|470490|P1|Overall Study|Lost to Follow-up|1
147779|NCT00662038|470490|P1|Overall Study|Lung transplantation|44
147780|NCT00662038|470490|P1|Overall Study|Physician Decision|19
147781|NCT00662038|470490|P1|Overall Study|Sponsor decision|1
147782|NCT00662038|470490|P1|Overall Study|Withdrawal by Subject|83
147783|NCT00662038|470490|P1|Overall Study|Withdrawn consent|22
147784|NCT00662038|470490|P1|Overall Study|Reason not specified|3
147785|NCT00662129|470494|P1|Overall Study|Ineligible|1
147786|NCT00662129|470494|P1|Overall Study|Cancel prior to beginning treatment|1
147787|NCT00662129|470494|P1|Overall Study|Protocol Violation|1
147788|NCT00662311|470535|P3|Overall Study|Respiratory Infection|0
147789|NCT00662311|470536|P2|Overall Study|Respiratory Infection|0
147790|NCT00662311|470537|P1|Overall Study|Respiratory Infection|1
147791|NCT00662363|470562|P2|Overall Study|Protocol Violation|1
147792|NCT00662363|470563|P1|Overall Study|Protocol Violation|1
147793|NCT00662363|470562|P2|Overall Study|Discharged early from rehab|1
147794|NCT00662363|470563|P1|Overall Study|Discharged early from rehab|4
147795|NCT00662363|470562|P2|Overall Study|Adverse Event|3
147796|NCT00662363|470563|P1|Overall Study|Adverse Event|0
147797|NCT00662363|470562|P2|Overall Study|Withdrawal by Subject|5
147798|NCT00662363|470563|P1|Overall Study|Withdrawal by Subject|6
147799|NCT00662532|470576|P2|Overall Study|Lost to Follow-up|1
147800|NCT00662532|470577|P1|Overall Study|Lost to Follow-up|0
147801|NCT00662532|470576|P2|Overall Study|Adverse Event|1
147802|NCT00662532|470577|P1|Overall Study|Adverse Event|0
147803|NCT00662558|470606|P2|Overall Study|Randomized But Did Not Receive Treatment|8
147804|NCT00662558|470607|P1|Overall Study|Randomized But Did Not Receive Treatment|2
147805|NCT00662558|470606|P2|Overall Study|Withdrawal by Subject|12
147806|NCT00662558|470607|P1|Overall Study|Withdrawal by Subject|7
147807|NCT00662558|470606|P2|Overall Study|Other|14
147808|NCT00662558|470607|P1|Overall Study|Other|9
147809|NCT00662558|470606|P2|Overall Study|Lost to Follow-up|10
147810|NCT00662558|470607|P1|Overall Study|Lost to Follow-up|13
147811|NCT00662558|470606|P2|Overall Study|Lack of Efficacy|7
147812|NCT00662558|470607|P1|Overall Study|Lack of Efficacy|4
147813|NCT00662558|470606|P2|Overall Study|Adverse Event|59
147814|NCT00662558|470607|P1|Overall Study|Adverse Event|21
147815|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
147816|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
147817|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
147818|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
147819|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
147820|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
147821|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
147822|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
147823|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
147824|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
147825|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
147826|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
147827|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
147828|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
147829|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
147830|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
147831|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
147832|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
147833|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
147834|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
147835|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
147836|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
147837|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
147838|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
147839|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
147840|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Adverse Event|10
147841|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Adverse Event|6
147842|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Adverse Event|0
147843|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Adverse Event|9
147844|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Adverse Event|6
147845|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Administrative problems|0
147846|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Administrative problems|1
147847|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Administrative problems|0
147848|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Administrative problems|0
147849|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Administrative problems|0
147850|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
147851|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
147852|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
147853|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
147854|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
147855|NCT00662649|470643|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
147856|NCT00662649|470644|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
147857|NCT00662649|470645|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
147858|NCT00662649|470646|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
147859|NCT00662649|470647|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
147860|NCT00662649|470643|P5|Core Study (24 Months)|Death|0
147861|NCT00662649|470644|P4|Core Study (24 Months)|Death|0
147862|NCT00662649|470645|P3|Core Study (24 Months)|Death|2
147863|NCT00662649|470646|P2|Core Study (24 Months)|Death|0
147864|NCT00662649|470647|P1|Core Study (24 Months)|Death|1
147865|NCT00662649|470643|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
147866|NCT00662649|470644|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
147867|NCT00662649|470645|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
147868|NCT00662649|470646|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
147869|NCT00662649|470647|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
147870|NCT00662649|470643|P5|Core Study (24 Months)|Protocol Violation|0
147871|NCT00662649|470644|P4|Core Study (24 Months)|Protocol Violation|0
147872|NCT00662649|470645|P3|Core Study (24 Months)|Protocol Violation|4
147873|NCT00662649|470646|P2|Core Study (24 Months)|Protocol Violation|5
147874|NCT00662649|470647|P1|Core Study (24 Months)|Protocol Violation|5
147875|NCT00662649|470643|P5|Core Study (24 Months)|Lost to Follow-up|0
147876|NCT00662649|470644|P4|Core Study (24 Months)|Lost to Follow-up|0
147877|NCT00662649|470645|P3|Core Study (24 Months)|Lost to Follow-up|7
147878|NCT00662649|470646|P2|Core Study (24 Months)|Lost to Follow-up|5
147879|NCT00662649|470647|P1|Core Study (24 Months)|Lost to Follow-up|3
147880|NCT00662649|470643|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
147881|NCT00662649|470644|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
147882|NCT00662649|470645|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
147883|NCT00662649|470646|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
147884|NCT00662649|470647|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
147885|NCT00662649|470643|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
147886|NCT00662649|470644|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
147887|NCT00662649|470645|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
147888|NCT00662649|470646|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
147889|NCT00662649|470647|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
147890|NCT00662649|470643|P5|Core Study (24 Months)|Adverse Event|0
147891|NCT00662649|470644|P4|Core Study (24 Months)|Adverse Event|0
147892|NCT00662649|470645|P3|Core Study (24 Months)|Adverse Event|18
147893|NCT00662649|470646|P2|Core Study (24 Months)|Adverse Event|13
147894|NCT00662649|470647|P1|Core Study (24 Months)|Adverse Event|22
147895|NCT00662649|470643|P5|Core Study (24 Months)|Withdrawal by Subject|0
147896|NCT00662649|470644|P4|Core Study (24 Months)|Withdrawal by Subject|0
147897|NCT00662649|470645|P3|Core Study (24 Months)|Withdrawal by Subject|28
147898|NCT00662649|470646|P2|Core Study (24 Months)|Withdrawal by Subject|17
147899|NCT00662649|470647|P1|Core Study (24 Months)|Withdrawal by Subject|31
147900|NCT00662831|470725|P2|Overall Study|Adverse Event|16
147901|NCT00662831|470726|P1|Overall Study|Adverse Event|23
147902|NCT00662831|470725|P2|Overall Study|Protocol Violation|4
147903|NCT00662831|470726|P1|Overall Study|Protocol Violation|8
147904|NCT00662831|470725|P2|Overall Study|Unspecified|31
147905|NCT00662831|470726|P1|Overall Study|Unspecified|62
147906|NCT00662831|470725|P2|Overall Study|Withdrawal by Subject|1
147907|NCT00662831|470726|P1|Overall Study|Withdrawal by Subject|2
147908|NCT00662831|470725|P2|Overall Study|Lost to Follow-up|0
147909|NCT00662831|470726|P1|Overall Study|Lost to Follow-up|1
147910|NCT00662831|470725|P2|Overall Study|Lack of Efficacy|6
147911|NCT00662831|470726|P1|Overall Study|Lack of Efficacy|6
147912|NCT00662831|470725|P2|Overall Study|Death|1
147913|NCT00662831|470726|P1|Overall Study|Death|4
147914|NCT00662857|470764|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
147915|NCT00662857|470765|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
147916|NCT00662857|470764|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
147917|NCT00662857|470765|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
147918|NCT00662857|470764|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
147919|NCT00662857|470765|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
147920|NCT00662909|470781|P3|Overall Study|Eligibility criterion not met|1
147921|NCT00662909|470782|P2|Overall Study|Eligibility criterion not met|1
147922|NCT00662909|470783|P1|Overall Study|Eligibility criterion not met|0
147923|NCT00662909|470781|P3|Overall Study|Physician Decision|2
147924|NCT00662909|470782|P2|Overall Study|Physician Decision|1
147925|NCT00662909|470783|P1|Overall Study|Physician Decision|1
147926|NCT00662909|470781|P3|Overall Study|Non-compliance with study procedures|2
147927|NCT00662909|470782|P2|Overall Study|Non-compliance with study procedures|3
147928|NCT00662909|470783|P1|Overall Study|Non-compliance with study procedures|3
147929|NCT00662909|470781|P3|Overall Study|Randomized- never received study drug|0
147930|NCT00662909|470782|P2|Overall Study|Randomized- never received study drug|0
147931|NCT00662909|470783|P1|Overall Study|Randomized- never received study drug|1
147932|NCT00662909|470781|P3|Overall Study|Protocol Violation|5
147933|NCT00662909|470782|P2|Overall Study|Protocol Violation|4
147934|NCT00662909|470783|P1|Overall Study|Protocol Violation|7
147935|NCT00662909|470781|P3|Overall Study|Lost to Follow-up|3
147936|NCT00662909|470782|P2|Overall Study|Lost to Follow-up|9
147937|NCT00662909|470783|P1|Overall Study|Lost to Follow-up|2
147938|NCT00662909|470781|P3|Overall Study|Withdrawal by Subject|16
147939|NCT00662909|470782|P2|Overall Study|Withdrawal by Subject|22
147940|NCT00662909|470783|P1|Overall Study|Withdrawal by Subject|29
147941|NCT00662909|470781|P3|Overall Study|Lack of Efficacy|5
147942|NCT00662909|470782|P2|Overall Study|Lack of Efficacy|1
147943|NCT00662909|470783|P1|Overall Study|Lack of Efficacy|9
147944|NCT00662909|470781|P3|Overall Study|Adverse Event|19
147945|NCT00662909|470782|P2|Overall Study|Adverse Event|18
147946|NCT00662909|470783|P1|Overall Study|Adverse Event|17
147947|NCT00663026|470884|P3|Overall Study|Withdrawal by Subject|1
147948|NCT00663026|470885|P2|Overall Study|Withdrawal by Subject|0
147949|NCT00663026|470886|P1|Overall Study|Withdrawal by Subject|0
147950|NCT00663026|470884|P3|Overall Study|Caregiver Request|0
147951|NCT00663026|470885|P2|Overall Study|Caregiver Request|2
147952|NCT00663026|470886|P1|Overall Study|Caregiver Request|0
147953|NCT00663026|470884|P3|Overall Study|Adverse Event|3
147954|NCT00663026|470885|P2|Overall Study|Adverse Event|2
147955|NCT00663026|470886|P1|Overall Study|Adverse Event|0
147956|NCT00663026|470884|P3|Overall Study|Unspecified|0
147957|NCT00663026|470885|P2|Overall Study|Unspecified|2
147958|NCT00663026|470886|P1|Overall Study|Unspecified|1
147959|NCT00663026|470884|P3|Overall Study|Lost to Follow-up|0
147960|NCT00663026|470885|P2|Overall Study|Lost to Follow-up|0
147961|NCT00663026|470886|P1|Overall Study|Lost to Follow-up|1
147962|NCT00663052|470908|P2|Overall Study|Unspecified|1
147963|NCT00663052|470909|P1|Overall Study|Unspecified|0
147964|NCT00663052|470908|P2|Overall Study|Unsatisfactory Response - Efficacy|1
147965|NCT00663052|470909|P1|Overall Study|Unsatisfactory Response - Efficacy|1
147966|NCT00663052|470908|P2|Overall Study|Withdrawal by Subject|5
147967|NCT00663052|470909|P1|Overall Study|Withdrawal by Subject|2
147968|NCT00663052|470908|P2|Overall Study|Protocol Violation|0
147969|NCT00663052|470909|P1|Overall Study|Protocol Violation|1
147970|NCT00663052|470908|P2|Overall Study|Discontinuation of Study by Sponsor|0
147971|NCT00663052|470909|P1|Overall Study|Discontinuation of Study by Sponsor|2
147972|NCT00663052|470908|P2|Overall Study|Adverse Event|3
147973|NCT00663052|470909|P1|Overall Study|Adverse Event|6
147974|NCT00663117|470991|P2|Overall Study|Lack of Efficacy|0
147975|NCT00663117|470992|P1|Overall Study|Lack of Efficacy|1
147976|NCT00663208|471037|P7|Follow-up Period|Other reason|1
147977|NCT00663208|471038|P6|Follow-up Period|Other reason|0
147978|NCT00663208|471039|P5|Follow-up Period|Other reason|0
147979|NCT00663208|471040|P4|Follow-up Period|Other reason|0
147980|NCT00663208|471041|P3|Follow-up Period|Other reason|0
147981|NCT00663208|471042|P2|Follow-up Period|Other reason|0
147982|NCT00663208|471043|P1|Follow-up Period|Other reason|1
147983|NCT00663208|471037|P7|Follow-up Period|Lost to Follow-up|0
147984|NCT00663208|471038|P6|Follow-up Period|Lost to Follow-up|0
147985|NCT00663208|471039|P5|Follow-up Period|Lost to Follow-up|0
147986|NCT00663208|471040|P4|Follow-up Period|Lost to Follow-up|2
147987|NCT00663208|471041|P3|Follow-up Period|Lost to Follow-up|3
147988|NCT00663208|471042|P2|Follow-up Period|Lost to Follow-up|0
147989|NCT00663208|471043|P1|Follow-up Period|Lost to Follow-up|2
147990|NCT00663208|471037|P7|Treatment Period|Lost to Follow-up|0
147991|NCT00663208|471038|P6|Treatment Period|Lost to Follow-up|0
147992|NCT00663208|471039|P5|Treatment Period|Lost to Follow-up|0
147993|NCT00663208|471040|P4|Treatment Period|Lost to Follow-up|0
147994|NCT00663208|471041|P3|Treatment Period|Lost to Follow-up|0
147995|NCT00663208|471042|P2|Treatment Period|Lost to Follow-up|1
147996|NCT00663208|471043|P1|Treatment Period|Lost to Follow-up|0
147997|NCT00663234|471193|P1|Overall Study|Not willing to adhere to requirements|1
147998|NCT00663260|471222|P3|Overall Study|non-compliance, not met criteria, etc.|3
147999|NCT00663260|471223|P2|Overall Study|non-compliance, not met criteria, etc.|2
148000|NCT00663260|471224|P1|Overall Study|non-compliance, not met criteria, etc.|3
148001|NCT00663260|471222|P3|Overall Study|Lost to Follow-up|0
148002|NCT00663260|471223|P2|Overall Study|Lost to Follow-up|1
148003|NCT00663260|471224|P1|Overall Study|Lost to Follow-up|0
148004|NCT00663260|471222|P3|Overall Study|Death|1
148005|NCT00663260|471223|P2|Overall Study|Death|0
148006|NCT00663260|471224|P1|Overall Study|Death|1
148007|NCT00663260|471222|P3|Overall Study|Withdrawal by Subject|6
148008|NCT00663260|471223|P2|Overall Study|Withdrawal by Subject|1
148009|NCT00663260|471224|P1|Overall Study|Withdrawal by Subject|3
148010|NCT00663260|471222|P3|Overall Study|Adverse Event|6
148011|NCT00663260|471223|P2|Overall Study|Adverse Event|7
148012|NCT00663260|471224|P1|Overall Study|Adverse Event|12
148013|NCT00663260|471222|P3|Overall Study|Lack of Efficacy|0
148014|NCT00663260|471223|P2|Overall Study|Lack of Efficacy|0
148015|NCT00663260|471224|P1|Overall Study|Lack of Efficacy|2
148016|NCT00657267|471238|P1|Overall Study|Adverse Event|9
148017|NCT00657267|471238|P1|Overall Study|Progressive disease|45
148018|NCT00657358|471250|P1|Overall Study|Lack of Efficacy|6
148019|NCT00657371|471258|P1|Overall Study|Pre-existing medical condition|4
148020|NCT00657371|471258|P1|Overall Study|Device- related reasons|13
148021|NCT00657371|471258|P1|Overall Study|Protocol Violation|2
148022|NCT00657371|471258|P1|Overall Study|Unable to intubate the cecum|5
148023|NCT00657371|471258|P1|Overall Study|Poor bowel preparation|15
148024|NCT00657553|471265|P2|Overall Study|low accrual, no analysis run|5
148025|NCT00657553|471266|P1|Overall Study|low accrual, no analysis run|5
148026|NCT00657709|471285|P5|Overall Study|Protocol Violation|2
148027|NCT00657709|471286|P4|Overall Study|Protocol Violation|1
148028|NCT00657709|471287|P3|Overall Study|Protocol Violation|0
148029|NCT00657709|471288|P2|Overall Study|Protocol Violation|2
148030|NCT00657709|471289|P1|Overall Study|Protocol Violation|0
148031|NCT00657709|471285|P5|Overall Study|Lost to Follow-up|21
148032|NCT00657709|471286|P4|Overall Study|Lost to Follow-up|1
148033|NCT00657709|471287|P3|Overall Study|Lost to Follow-up|7
148034|NCT00657709|471288|P2|Overall Study|Lost to Follow-up|9
148035|NCT00657709|471289|P1|Overall Study|Lost to Follow-up|9
148036|NCT00657709|471285|P5|Overall Study|Withdrawal by Subject|9
148037|NCT00657709|471286|P4|Overall Study|Withdrawal by Subject|5
148038|NCT00657709|471287|P3|Overall Study|Withdrawal by Subject|15
148039|NCT00657709|471288|P2|Overall Study|Withdrawal by Subject|15
148040|NCT00657709|471289|P1|Overall Study|Withdrawal by Subject|7
148041|NCT00657709|471285|P5|Overall Study|AE or Death|1
148042|NCT00657709|471286|P4|Overall Study|AE or Death|7
148043|NCT00657709|471287|P3|Overall Study|AE or Death|6
148044|NCT00657709|471288|P2|Overall Study|AE or Death|7
148045|NCT00657709|471289|P1|Overall Study|AE or Death|7
148046|NCT00664742|471340|P1|Overall Study|Lost to Follow-up|92
148047|NCT00664742|471340|P1|Overall Study|Withdrawal by Subject|31
148048|NCT00664742|471340|P1|Overall Study|Withdrawn due to adverse events|3
148049|NCT00665002|471345|P1|Overall Study|Cytogenetic resistance|1
148050|NCT00665002|471345|P1|Overall Study|Progression/relapse during treatment|11
148051|NCT00665353|471357|P1|Study Step 2|Lack of Efficacy|12
148052|NCT00665353|471357|P1|Study Step 2|Lost to Follow-up|2
148053|NCT00665353|471357|P1|Study Step 1|Withdrawal by Subject|2
148054|NCT00665353|471357|P1|Study Step 1|Adverse Event|1
148055|NCT00665366|471369|P2|Overall Study|Other reasons|1
148056|NCT00665366|471370|P1|Overall Study|Other reasons|4
148057|NCT00665366|471369|P2|Overall Study|No longer meets study criteria|1
148058|NCT00665366|471370|P1|Overall Study|No longer meets study criteria|0
148059|NCT00665366|471369|P2|Overall Study|Pregnancy|0
148060|NCT00665366|471370|P1|Overall Study|Pregnancy|1
148061|NCT00665366|471369|P2|Overall Study|Poor compliance/noncompliance|5
148062|NCT00665366|471370|P1|Overall Study|Poor compliance/noncompliance|3
148063|NCT00665366|471369|P2|Overall Study|Lost to Follow-up|5
148064|NCT00665366|471370|P1|Overall Study|Lost to Follow-up|3
148065|NCT00665366|471369|P2|Overall Study|Withdrawal by Subject|14
148066|NCT00665366|471370|P1|Overall Study|Withdrawal by Subject|11
148067|NCT00665366|471369|P2|Overall Study|Adverse Event|23
148068|NCT00665366|471370|P1|Overall Study|Adverse Event|25
148069|NCT00665366|471369|P2|Overall Study|Lack of Efficacy|10
148070|NCT00665366|471370|P1|Overall Study|Lack of Efficacy|11
148071|NCT00665431|471401|P3|Overall Study|Other|2
148072|NCT00665431|471402|P2|Overall Study|Other|7
148073|NCT00665431|471403|P1|Overall Study|Other|4
148074|NCT00665431|471401|P3|Overall Study|Lost to Follow-up|1
148075|NCT00665431|471402|P2|Overall Study|Lost to Follow-up|3
148076|NCT00665431|471403|P1|Overall Study|Lost to Follow-up|3
148077|NCT00665431|471401|P3|Overall Study|Withdrawal by Subject|15
148078|NCT00665431|471402|P2|Overall Study|Withdrawal by Subject|25
148079|NCT00665431|471403|P1|Overall Study|Withdrawal by Subject|17
148080|NCT00665431|471401|P3|Overall Study|Adverse Event|6
148081|NCT00665431|471402|P2|Overall Study|Adverse Event|22
148082|NCT00665431|471403|P1|Overall Study|Adverse Event|16
148083|NCT00665444|471444|P1|Overall Study|Study Terminated by Study Sponsor|1
148084|NCT00665444|471444|P1|Overall Study|Physician Decision|1
148085|NCT00665626|471462|P2|Overall Study|Death|0
148086|NCT00665626|471463|P1|Overall Study|Death|1
148087|NCT00665626|471462|P2|Overall Study|Unably to comply with dosing regimen|1
148088|NCT00665626|471463|P1|Overall Study|Unably to comply with dosing regimen|0
148089|NCT00665626|471462|P2|Overall Study|Did not fulfil inclusion criteria|1
148090|NCT00665626|471463|P1|Overall Study|Did not fulfil inclusion criteria|0
148091|NCT00665626|471462|P2|Overall Study|Due to exclusion criteria|1
148092|NCT00665626|471463|P1|Overall Study|Due to exclusion criteria|0
148093|NCT00665626|471462|P2|Overall Study|Adverse Event|9
148094|NCT00665626|471463|P1|Overall Study|Adverse Event|1
148095|NCT00665626|471462|P2|Overall Study|Protocol Violation|2
148096|NCT00665626|471463|P1|Overall Study|Protocol Violation|0
148097|NCT00665626|471462|P2|Overall Study|Withdrawal by Subject|1
148098|NCT00665626|471463|P1|Overall Study|Withdrawal by Subject|0
148099|NCT00665626|471462|P2|Overall Study|Lost to Follow-up|2
148100|NCT00665626|471463|P1|Overall Study|Lost to Follow-up|0
148101|NCT00665626|471462|P2|Overall Study|Lack of Efficacy|5
148102|NCT00665626|471463|P1|Overall Study|Lack of Efficacy|8
148103|NCT00665847|471534|P1|Overall Study|Switch to Commercial Medication|1
148104|NCT00665847|471534|P1|Overall Study|Subject ineligible to continue the trial|1
148105|NCT00665847|471534|P1|Overall Study|Resistance to TMC125|1
148106|NCT00665847|471534|P1|Overall Study|Subject reached a virologic endpoint|4
148107|NCT00665847|471534|P1|Overall Study|Subject non-compliant|8
148108|NCT00665847|471534|P1|Overall Study|Withdrawal by Subject|2
148109|NCT00665847|471534|P1|Overall Study|Adverse Event|8
148110|NCT00665925|471550|P4|Overall Study|Due to exclusion criteria|0
148111|NCT00665925|471551|P3|Overall Study|Due to exclusion criteria|0
148112|NCT00665925|471552|P2|Overall Study|Due to exclusion criteria|0
148113|NCT00665925|471553|P1|Overall Study|Due to exclusion criteria|1
148114|NCT00665925|471550|P4|Overall Study|Enrolled by mistake|1
148115|NCT00665925|471551|P3|Overall Study|Enrolled by mistake|0
148116|NCT00665925|471552|P2|Overall Study|Enrolled by mistake|0
148117|NCT00665925|471553|P1|Overall Study|Enrolled by mistake|0
148118|NCT00665925|471550|P4|Overall Study|Adverse Event|5
148119|NCT00665925|471551|P3|Overall Study|Adverse Event|10
148120|NCT00665925|471552|P2|Overall Study|Adverse Event|5
148121|NCT00665925|471553|P1|Overall Study|Adverse Event|1
148122|NCT00665925|471550|P4|Overall Study|Severe Non-Compliance to Protocol|1
148123|NCT00665925|471551|P3|Overall Study|Severe Non-Compliance to Protocol|1
148124|NCT00665925|471552|P2|Overall Study|Severe Non-Compliance to Protocol|0
148125|NCT00665925|471553|P1|Overall Study|Severe Non-Compliance to Protocol|0
148126|NCT00665925|471550|P4|Overall Study|Physician Decision|2
148127|NCT00665925|471551|P3|Overall Study|Physician Decision|1
148128|NCT00665925|471552|P2|Overall Study|Physician Decision|0
148129|NCT00665925|471553|P1|Overall Study|Physician Decision|0
148130|NCT00665925|471550|P4|Overall Study|Withdrawal by Subject|2
148131|NCT00665925|471551|P3|Overall Study|Withdrawal by Subject|3
148132|NCT00665925|471552|P2|Overall Study|Withdrawal by Subject|2
148133|NCT00665925|471553|P1|Overall Study|Withdrawal by Subject|2
148134|NCT00665925|471550|P4|Overall Study|Lost to Follow-up|2
148135|NCT00665925|471551|P3|Overall Study|Lost to Follow-up|2
148136|NCT00665925|471552|P2|Overall Study|Lost to Follow-up|2
148137|NCT00665925|471553|P1|Overall Study|Lost to Follow-up|1
148138|NCT00665925|471550|P4|Overall Study|Lack of Efficacy|8
148139|NCT00665925|471551|P3|Overall Study|Lack of Efficacy|9
148140|NCT00665925|471552|P2|Overall Study|Lack of Efficacy|8
148141|NCT00665925|471553|P1|Overall Study|Lack of Efficacy|10
148142|NCT00666198|471975|P1|Overall Study|No Drug Administration|4
148143|NCT00666198|471975|P1|Overall Study|Safety Not Assessable|6
148144|NCT00666198|471975|P1|Overall Study|No Visit After First Day of Treatment|13
148145|NCT00666198|471975|P1|Overall Study|Protocol Violation|10
148146|NCT00666211|471990|P2|Overall Study|Physician Decision|1
148147|NCT00666211|471991|P1|Overall Study|Physician Decision|0
148148|NCT00666211|471990|P2|Overall Study|off tx for other complicating disease|1
148149|NCT00666211|471991|P1|Overall Study|off tx for other complicating disease|0
148150|NCT00666211|471990|P2|Overall Study|Death|2
148151|NCT00666211|471991|P1|Overall Study|Death|0
148152|NCT00666211|471990|P2|Overall Study|hospital admission|5
148153|NCT00666211|471991|P1|Overall Study|hospital admission|0
148154|NCT00666211|471990|P2|Overall Study|toxicity|2
148155|NCT00666211|471991|P1|Overall Study|toxicity|0
148156|NCT00666211|471990|P2|Overall Study|Lost to Follow-up|0
148157|NCT00666211|471991|P1|Overall Study|Lost to Follow-up|2
148158|NCT00666211|471990|P2|Overall Study|disease progression|8
148159|NCT00666211|471991|P1|Overall Study|disease progression|1
148160|NCT00666211|471990|P2|Overall Study|patient non-compliant|6
148161|NCT00666211|471991|P1|Overall Study|patient non-compliant|6
148162|NCT00666211|471990|P2|Overall Study|went off medication, no more pain|0
148163|NCT00666211|471991|P1|Overall Study|went off medication, no more pain|1
148164|NCT00666211|471990|P2|Overall Study|Withdrawal by Subject|13
148165|NCT00666211|471991|P1|Overall Study|Withdrawal by Subject|10
148166|NCT00666224|472011|P2|Open-Label|Undefined/Unknown|1
148167|NCT00666224|472012|P1|Open-Label|Undefined/Unknown|1
148168|NCT00666224|472011|P2|Open-Label|Noncompliance|1
148169|NCT00666224|472012|P1|Open-Label|Noncompliance|2
148170|NCT00666224|472011|P2|Open-Label|Pregnancy|5
148171|NCT00666224|472012|P1|Open-Label|Pregnancy|1
148172|NCT00666224|472011|P2|Open-Label|Physician Decision|5
148173|NCT00666224|472012|P1|Open-Label|Physician Decision|7
148174|NCT00666224|472011|P2|Open-Label|Withdrawal by Subject|25
148175|NCT00666224|472012|P1|Open-Label|Withdrawal by Subject|12
148176|NCT00666224|472011|P2|Open-Label|Lost to Follow-up|5
148177|NCT00666224|472012|P1|Open-Label|Lost to Follow-up|4
148178|NCT00666224|472011|P2|Open-Label|Adverse Event|43
148179|NCT00666224|472012|P1|Open-Label|Adverse Event|8
148180|NCT00666224|472011|P2|Double-Blind|Undefined/Unknown|1
148181|NCT00666224|472012|P1|Double-Blind|Undefined/Unknown|4
148182|NCT00666224|472011|P2|Double-Blind|Death|0
148183|NCT00666224|472012|P1|Double-Blind|Death|1
148184|NCT00666224|472011|P2|Double-Blind|Noncompliance|0
148185|NCT00666224|472012|P1|Double-Blind|Noncompliance|1
148186|NCT00666224|472011|P2|Double-Blind|Pregnancy|2
148187|NCT00666224|472012|P1|Double-Blind|Pregnancy|3
148188|NCT00666224|472011|P2|Double-Blind|Sponsor decision|0
148189|NCT00666224|472012|P1|Double-Blind|Sponsor decision|1
148190|NCT00666224|472011|P2|Double-Blind|Physician Decision|3
148191|NCT00666224|472012|P1|Double-Blind|Physician Decision|0
148192|NCT00666224|472011|P2|Double-Blind|Withdrawal by Subject|14
148193|NCT00666224|472012|P1|Double-Blind|Withdrawal by Subject|18
148194|NCT00666224|472011|P2|Double-Blind|Lost to Follow-up|2
148195|NCT00666224|472012|P1|Double-Blind|Lost to Follow-up|2
148196|NCT00666224|472011|P2|Double-Blind|Adverse Event|5
148197|NCT00666224|472012|P1|Double-Blind|Adverse Event|15
148198|NCT00666263|472029|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
148199|NCT00666263|472030|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
148200|NCT00666263|472029|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
148201|NCT00666263|472030|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
148202|NCT00666263|472029|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
148203|NCT00666263|472030|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
148204|NCT00666276|472172|P1|Overall Study|Protocol Violation|34
148205|NCT00666328|472196|P1|Overall Study|No longer met eligibility criteria|1
148206|NCT00666328|472196|P1|Overall Study|Lost to Follow-up|2
148207|NCT00666328|472196|P1|Overall Study|Death|2
148208|NCT00666458|472287|P2|Overall Study|Medical history of anemia|0
148209|NCT00666458|472288|P1|Overall Study|Medical history of anemia|1
148210|NCT00666458|472287|P2|Overall Study|Safety reasons|0
148211|NCT00666458|472288|P1|Overall Study|Safety reasons|1
148212|NCT00666458|472287|P2|Overall Study|Severe non-compliance to the protocol|1
148213|NCT00666458|472288|P1|Overall Study|Severe non-compliance to the protocol|1
148214|NCT00666458|472287|P2|Overall Study|Study specific discontinuation criteria|7
148215|NCT00666458|472288|P1|Overall Study|Study specific discontinuation criteria|14
148216|NCT00666458|472287|P2|Overall Study|Incorrect enrollment|1
148217|NCT00666458|472288|P1|Overall Study|Incorrect enrollment|7
148218|NCT00666458|472287|P2|Overall Study|Administrative reason by sponsor|1
148219|NCT00666458|472288|P1|Overall Study|Administrative reason by sponsor|1
148220|NCT00666458|472287|P2|Overall Study|Lost to Follow-up|3
148221|NCT00666458|472288|P1|Overall Study|Lost to Follow-up|0
148222|NCT00666458|472287|P2|Overall Study|Withdrawal by Subject|4
148223|NCT00666458|472288|P1|Overall Study|Withdrawal by Subject|5
148224|NCT00666458|472287|P2|Overall Study|Adverse Event|7
148225|NCT00666458|472288|P1|Overall Study|Adverse Event|8
148226|NCT00666536|472302|P2|Overall Study|Lost to Follow-up|3
148227|NCT00666536|472303|P1|Overall Study|Lost to Follow-up|4
148228|NCT00666536|472302|P2|Overall Study|Withdrawal by Subject|9
148229|NCT00666536|472303|P1|Overall Study|Withdrawal by Subject|10
148230|NCT00666536|472302|P2|Overall Study|Protocol deviation(s)|6
148231|NCT00666536|472303|P1|Overall Study|Protocol deviation(s)|8
148232|NCT00666536|472302|P2|Overall Study|Unsatisfactory therapeutic effect|0
148233|NCT00666536|472303|P1|Overall Study|Unsatisfactory therapeutic effect|2
148234|NCT00666536|472302|P2|Overall Study|Adverse Event|19
148235|NCT00666536|472303|P1|Overall Study|Adverse Event|9
148236|NCT00666562|472322|P3|Overall Study|Concomitant Medication|0
148237|NCT00666562|472323|P2|Overall Study|Concomitant Medication|1
148238|NCT00666562|472324|P1|Overall Study|Concomitant Medication|0
148239|NCT00666562|472322|P3|Overall Study|Withdrawal by Subject|0
148240|NCT00666562|472323|P2|Overall Study|Withdrawal by Subject|1
148241|NCT00666562|472324|P1|Overall Study|Withdrawal by Subject|0
148242|NCT00666588|472373|P4|Overall Study|inevaluable|0
148243|NCT00666588|472374|P3|Overall Study|inevaluable|0
148244|NCT00666588|472375|P2|Overall Study|inevaluable|0
148245|NCT00666588|472376|P1|Overall Study|inevaluable|2
148246|NCT00666588|472373|P4|Overall Study|ineligible|2
148247|NCT00666588|472374|P3|Overall Study|ineligible|0
148248|NCT00666588|472375|P2|Overall Study|ineligible|0
148249|NCT00666588|472376|P1|Overall Study|ineligible|2
148250|NCT00666679|472398|P2|Second Intervention|Death|1
148251|NCT00666679|472399|P1|Second Intervention|Death|0
148252|NCT00666679|472398|P2|Second Intervention|Adverse Event|0
148253|NCT00666679|472399|P1|Second Intervention|Adverse Event|1
148254|NCT00666679|472398|P2|Washout Period of 1 Week|Protocol Violation|1
148255|NCT00666679|472399|P1|Washout Period of 1 Week|Protocol Violation|0
148256|NCT00666679|472398|P2|Washout Period of 1 Week|Lost to Follow-up|1
148257|NCT00666679|472399|P1|Washout Period of 1 Week|Lost to Follow-up|0
148258|NCT00666679|472398|P2|First Intervention|Randomized did not start treatment|1
148259|NCT00666679|472399|P1|First Intervention|Randomized did not start treatment|1
148260|NCT00666679|472398|P2|First Intervention|Withdrawal by Subject|0
148261|NCT00666679|472399|P1|First Intervention|Withdrawal by Subject|1
148262|NCT00666679|472398|P2|First Intervention|Protocol Violation|0
148263|NCT00666679|472399|P1|First Intervention|Protocol Violation|1
148264|NCT00666679|472398|P2|First Intervention|Lost to Follow-up|0
148265|NCT00666679|472399|P1|First Intervention|Lost to Follow-up|1
148266|NCT00666705|472419|P1|Overall Study|Withdrawal by Subject|1
148267|NCT00666718|472438|P2|Overall Study|Physician Decision|2
148268|NCT00666718|472439|P1|Overall Study|Physician Decision|0
148269|NCT00666718|472438|P2|Overall Study|Withdrawal by Subject|12
148270|NCT00666718|472439|P1|Overall Study|Withdrawal by Subject|7
148271|NCT00666718|472438|P2|Overall Study|Protocol Violation|3
148272|NCT00666718|472439|P1|Overall Study|Protocol Violation|1
148273|NCT00666718|472438|P2|Overall Study|Entry Criteria Not Met|0
148274|NCT00666718|472439|P1|Overall Study|Entry Criteria Not Met|2
148275|NCT00666718|472438|P2|Overall Study|Lost to Follow-up|0
148276|NCT00666718|472439|P1|Overall Study|Lost to Follow-up|1
148277|NCT00666718|472438|P2|Overall Study|Death|0
148278|NCT00666718|472439|P1|Overall Study|Death|1
148279|NCT00666718|472438|P2|Overall Study|Adverse Event|1
148280|NCT00666718|472439|P1|Overall Study|Adverse Event|0
148281|NCT00666757|472467|P2|Overall Study|Sponsor decision|1
148282|NCT00666757|472468|P1|Overall Study|Sponsor decision|0
148283|NCT00666757|472467|P2|Overall Study|Physician Decision|2
148284|NCT00666757|472468|P1|Overall Study|Physician Decision|0
148285|NCT00666757|472467|P2|Overall Study|Lack of Efficacy|6
148286|NCT00666757|472468|P1|Overall Study|Lack of Efficacy|3
148287|NCT00666757|472467|P2|Overall Study|Withdrawal by Subject|17
148288|NCT00666757|472468|P1|Overall Study|Withdrawal by Subject|13
148289|NCT00666757|472467|P2|Overall Study|Adverse Event|12
148290|NCT00666757|472468|P1|Overall Study|Adverse Event|22
148291|NCT00666757|472467|P2|Overall Study|Protocol Violation|24
148292|NCT00666757|472468|P1|Overall Study|Protocol Violation|23
148293|NCT00666757|472467|P2|Overall Study|Lost to Follow-up|35
148294|NCT00666757|472468|P1|Overall Study|Lost to Follow-up|39
148295|NCT00666835|472527|P2|Overall Study|Physician Decision|2
148296|NCT00666835|472528|P1|Overall Study|Physician Decision|1
148297|NCT00666835|472527|P2|Overall Study|Planned operation|0
148298|NCT00666835|472528|P1|Overall Study|Planned operation|2
148299|NCT00666835|472527|P2|Overall Study|Hemoglobulin concentration|3
148300|NCT00666835|472528|P1|Overall Study|Hemoglobulin concentration|4
148301|NCT00666835|472527|P2|Overall Study|Kidney Transplantation (NTX)|2
148302|NCT00666835|472528|P1|Overall Study|Kidney Transplantation (NTX)|10
148303|NCT00666835|472527|P2|Overall Study|Death|4
148304|NCT00666835|472528|P1|Overall Study|Death|15
148305|NCT00666835|472527|P2|Overall Study|Protocol Violation|0
148306|NCT00666835|472528|P1|Overall Study|Protocol Violation|2
148307|NCT00666835|472527|P2|Overall Study|Adverse Event|6
148308|NCT00666835|472528|P1|Overall Study|Adverse Event|7
148309|NCT00666835|472527|P2|Overall Study|Incl./excl. not fulfilled|2
148310|NCT00666835|472528|P1|Overall Study|Incl./excl. not fulfilled|7
148311|NCT00666835|472527|P2|Overall Study|Lack of Efficacy|1
148312|NCT00666835|472528|P1|Overall Study|Lack of Efficacy|0
148313|NCT00666835|472527|P2|Overall Study|Withdrawal by Subject|2
148314|NCT00666835|472528|P1|Overall Study|Withdrawal by Subject|5
148315|NCT00666926|472552|P16|Overall Study|Death|0
148316|NCT00666926|472553|P15|Overall Study|Death|0
148317|NCT00666926|472554|P14|Overall Study|Death|0
148318|NCT00666926|472555|P13|Overall Study|Death|0
148319|NCT00666926|472556|P12|Overall Study|Death|1
148320|NCT00666926|472557|P11|Overall Study|Death|0
148321|NCT00666926|472558|P10|Overall Study|Death|0
148322|NCT00666926|472559|P9|Overall Study|Death|0
148323|NCT00666926|472560|P8|Overall Study|Death|0
148324|NCT00666926|472561|P7|Overall Study|Death|0
148325|NCT00666926|472562|P6|Overall Study|Death|0
148326|NCT00666926|472563|P5|Overall Study|Death|0
148327|NCT00666926|472564|P4|Overall Study|Death|0
148328|NCT00666926|472565|P3|Overall Study|Death|0
148329|NCT00666926|472566|P2|Overall Study|Death|0
148330|NCT00666926|472567|P1|Overall Study|Death|0
148331|NCT00666926|472552|P16|Overall Study|Withdrawal by Subject|3
148332|NCT00666926|472553|P15|Overall Study|Withdrawal by Subject|3
148333|NCT00666926|472554|P14|Overall Study|Withdrawal by Subject|1
148334|NCT00666926|472555|P13|Overall Study|Withdrawal by Subject|0
148335|NCT00666926|472556|P12|Overall Study|Withdrawal by Subject|3
148336|NCT00666926|472557|P11|Overall Study|Withdrawal by Subject|0
148337|NCT00666926|472558|P10|Overall Study|Withdrawal by Subject|3
148338|NCT00666926|472559|P9|Overall Study|Withdrawal by Subject|0
148339|NCT00666926|472560|P8|Overall Study|Withdrawal by Subject|1
148340|NCT00666926|472561|P7|Overall Study|Withdrawal by Subject|0
148341|NCT00666926|472562|P6|Overall Study|Withdrawal by Subject|0
148342|NCT00666926|472563|P5|Overall Study|Withdrawal by Subject|0
148343|NCT00666926|472564|P4|Overall Study|Withdrawal by Subject|0
148344|NCT00666926|472565|P3|Overall Study|Withdrawal by Subject|0
148345|NCT00666926|472566|P2|Overall Study|Withdrawal by Subject|0
148346|NCT00666926|472567|P1|Overall Study|Withdrawal by Subject|0
148347|NCT00666926|472552|P16|Overall Study|Unspecified|4
148348|NCT00666926|472553|P15|Overall Study|Unspecified|4
148349|NCT00666926|472554|P14|Overall Study|Unspecified|2
148350|NCT00666926|472555|P13|Overall Study|Unspecified|3
148351|NCT00666926|472556|P12|Overall Study|Unspecified|26
148352|NCT00666926|472557|P11|Overall Study|Unspecified|3
148353|NCT00666926|472558|P10|Overall Study|Unspecified|5
148354|NCT00666926|472559|P9|Overall Study|Unspecified|3
148355|NCT00666926|472560|P8|Overall Study|Unspecified|0
148356|NCT00666926|472561|P7|Overall Study|Unspecified|4
148357|NCT00666926|472562|P6|Overall Study|Unspecified|3
148358|NCT00666926|472563|P5|Overall Study|Unspecified|3
148359|NCT00666926|472564|P4|Overall Study|Unspecified|3
148360|NCT00666926|472565|P3|Overall Study|Unspecified|3
148361|NCT00666926|472566|P2|Overall Study|Unspecified|4
148362|NCT00666926|472567|P1|Overall Study|Unspecified|2
148363|NCT00666926|472552|P16|Overall Study|Lost to Follow-up|0
148364|NCT00666926|472553|P15|Overall Study|Lost to Follow-up|0
148365|NCT00666926|472554|P14|Overall Study|Lost to Follow-up|0
148366|NCT00666926|472555|P13|Overall Study|Lost to Follow-up|0
148367|NCT00666926|472556|P12|Overall Study|Lost to Follow-up|0
148368|NCT00666926|472557|P11|Overall Study|Lost to Follow-up|0
148369|NCT00666926|472558|P10|Overall Study|Lost to Follow-up|0
148370|NCT00666926|472559|P9|Overall Study|Lost to Follow-up|0
148371|NCT00666926|472560|P8|Overall Study|Lost to Follow-up|0
148372|NCT00666926|472561|P7|Overall Study|Lost to Follow-up|0
148373|NCT00666926|472562|P6|Overall Study|Lost to Follow-up|0
148374|NCT00666926|472563|P5|Overall Study|Lost to Follow-up|0
148375|NCT00666926|472564|P4|Overall Study|Lost to Follow-up|1
148376|NCT00666926|472565|P3|Overall Study|Lost to Follow-up|0
148377|NCT00666926|472566|P2|Overall Study|Lost to Follow-up|0
148378|NCT00666926|472567|P1|Overall Study|Lost to Follow-up|0
148379|NCT00666926|472552|P16|Overall Study|Lack of Efficacy|0
148380|NCT00666926|472553|P15|Overall Study|Lack of Efficacy|0
148381|NCT00666926|472554|P14|Overall Study|Lack of Efficacy|0
148382|NCT00666926|472555|P13|Overall Study|Lack of Efficacy|0
148383|NCT00666926|472556|P12|Overall Study|Lack of Efficacy|1
148384|NCT00666926|472557|P11|Overall Study|Lack of Efficacy|0
148385|NCT00666926|472558|P10|Overall Study|Lack of Efficacy|0
148386|NCT00666926|472559|P9|Overall Study|Lack of Efficacy|0
148387|NCT00666926|472560|P8|Overall Study|Lack of Efficacy|0
148388|NCT00666926|472561|P7|Overall Study|Lack of Efficacy|0
148389|NCT00666926|472562|P6|Overall Study|Lack of Efficacy|1
148390|NCT00666926|472563|P5|Overall Study|Lack of Efficacy|0
148391|NCT00666926|472564|P4|Overall Study|Lack of Efficacy|0
148392|NCT00666926|472565|P3|Overall Study|Lack of Efficacy|0
148393|NCT00666926|472566|P2|Overall Study|Lack of Efficacy|0
148394|NCT00666926|472567|P1|Overall Study|Lack of Efficacy|0
148395|NCT00666926|472552|P16|Overall Study|Laboratory abnormality|1
148396|NCT00666926|472553|P15|Overall Study|Laboratory abnormality|0
148397|NCT00666926|472554|P14|Overall Study|Laboratory abnormality|0
148398|NCT00666926|472555|P13|Overall Study|Laboratory abnormality|0
148399|NCT00666926|472556|P12|Overall Study|Laboratory abnormality|0
148400|NCT00666926|472557|P11|Overall Study|Laboratory abnormality|1
148401|NCT00666926|472558|P10|Overall Study|Laboratory abnormality|0
148402|NCT00666926|472559|P9|Overall Study|Laboratory abnormality|0
148403|NCT00666926|472560|P8|Overall Study|Laboratory abnormality|0
148404|NCT00666926|472561|P7|Overall Study|Laboratory abnormality|0
148405|NCT00666926|472562|P6|Overall Study|Laboratory abnormality|0
148406|NCT00666926|472563|P5|Overall Study|Laboratory abnormality|0
148407|NCT00666926|472564|P4|Overall Study|Laboratory abnormality|0
148408|NCT00666926|472565|P3|Overall Study|Laboratory abnormality|0
148409|NCT00666926|472566|P2|Overall Study|Laboratory abnormality|0
148410|NCT00666926|472567|P1|Overall Study|Laboratory abnormality|0
148411|NCT00666926|472552|P16|Overall Study|Adverse Event|0
148412|NCT00666926|472553|P15|Overall Study|Adverse Event|0
148413|NCT00666926|472554|P14|Overall Study|Adverse Event|1
148414|NCT00666926|472555|P13|Overall Study|Adverse Event|0
148415|NCT00666926|472556|P12|Overall Study|Adverse Event|2
148416|NCT00666926|472557|P11|Overall Study|Adverse Event|2
148417|NCT00666926|472558|P10|Overall Study|Adverse Event|2
148418|NCT00666926|472559|P9|Overall Study|Adverse Event|0
148419|NCT00666926|472560|P8|Overall Study|Adverse Event|0
148420|NCT00666926|472561|P7|Overall Study|Adverse Event|0
148421|NCT00666926|472562|P6|Overall Study|Adverse Event|0
148422|NCT00666926|472563|P5|Overall Study|Adverse Event|0
148423|NCT00666926|472564|P4|Overall Study|Adverse Event|0
148424|NCT00666926|472565|P3|Overall Study|Adverse Event|0
148425|NCT00666926|472566|P2|Overall Study|Adverse Event|0
148426|NCT00666926|472567|P1|Overall Study|Adverse Event|0
148427|NCT00666965|472862|P4|Overall Study|Withdrawal by Subject|2
148428|NCT00666965|472863|P3|Overall Study|Withdrawal by Subject|0
148429|NCT00666965|472864|P2|Overall Study|Withdrawal by Subject|0
148430|NCT00666965|472865|P1|Overall Study|Withdrawal by Subject|0
148431|NCT00666965|472862|P4|Overall Study|Discontinuation criteria|2
148432|NCT00666965|472863|P3|Overall Study|Discontinuation criteria|1
148433|NCT00666965|472864|P2|Overall Study|Discontinuation criteria|1
148434|NCT00666965|472865|P1|Overall Study|Discontinuation criteria|2
148435|NCT00666965|472862|P4|Overall Study|Protocol Violation|2
148436|NCT00666965|472863|P3|Overall Study|Protocol Violation|0
148437|NCT00666965|472864|P2|Overall Study|Protocol Violation|0
148438|NCT00666965|472865|P1|Overall Study|Protocol Violation|0
148439|NCT00666965|472862|P4|Overall Study|Lack of Efficacy|0
148440|NCT00666965|472863|P3|Overall Study|Lack of Efficacy|0
148441|NCT00666965|472864|P2|Overall Study|Lack of Efficacy|1
148442|NCT00666965|472865|P1|Overall Study|Lack of Efficacy|1
148443|NCT00666965|472862|P4|Overall Study|Adverse Event|9
148444|NCT00666965|472863|P3|Overall Study|Adverse Event|1
148445|NCT00666965|472864|P2|Overall Study|Adverse Event|2
148446|NCT00666965|472865|P1|Overall Study|Adverse Event|0
148447|NCT00667095|472909|P2|Overall Study|Withdrawal by Subject|1
148448|NCT00667095|472910|P1|Overall Study|Withdrawal by Subject|0
148449|NCT00660660|472928|P2|Overall Study|New medication after randomization|0
148450|NCT00660660|472929|P1|Overall Study|New medication after randomization|1
148451|NCT00660660|472928|P2|Overall Study|Incorrect enrollment and other|1
148452|NCT00660660|472929|P1|Overall Study|Incorrect enrollment and other|0
148453|NCT00660660|472928|P2|Overall Study|Withdrawal by Subject|0
148454|NCT00660660|472929|P1|Overall Study|Withdrawal by Subject|3
148455|NCT00660660|472928|P2|Overall Study|Lack of Efficacy|2
148456|NCT00660660|472929|P1|Overall Study|Lack of Efficacy|0
148457|NCT00660660|472928|P2|Overall Study|Lost to Follow-up|6
148458|NCT00660660|472929|P1|Overall Study|Lost to Follow-up|0
148459|NCT00660660|472928|P2|Overall Study|Adverse Event|0
148460|NCT00660660|472929|P1|Overall Study|Adverse Event|1
148461|NCT00660699|473027|P1|Overall Study|Withdrawal by Subject|2
148462|NCT00667225|473054|P2|Overall Study|Lost to Follow-up|1
148463|NCT00667225|473055|P1|Overall Study|Lost to Follow-up|0
148464|NCT00667225|473054|P2|Overall Study|Subject had no more lesions to treat.|0
148465|NCT00667225|473055|P1|Overall Study|Subject had no more lesions to treat.|1
148466|NCT00667251|473065|P2|Overall Study|Symptomatic progression|2
148467|NCT00667251|473066|P1|Overall Study|Symptomatic progression|1
148468|NCT00667251|473065|P2|Overall Study|Intercurrent Illness|3
148469|NCT00667251|473066|P1|Overall Study|Intercurrent Illness|4
148470|NCT00667251|473065|P2|Overall Study|Other/missing|84
148471|NCT00667251|473066|P1|Overall Study|Other/missing|46
148472|NCT00667251|473065|P2|Overall Study|Withdrawal by Subject|2
148473|NCT00667251|473066|P1|Overall Study|Withdrawal by Subject|6
148474|NCT00667251|473065|P2|Overall Study|Adverse Event|4
148475|NCT00667251|473066|P1|Overall Study|Adverse Event|13
148476|NCT00667277|473090|P1|Overall Study|Withdrawal by Subject|2
148477|NCT00667342|473098|P3|Overall Study|Ineligible|1
148478|NCT00667342|473099|P2|Overall Study|Ineligible|0
148479|NCT00667342|473100|P1|Overall Study|Ineligible|0
148480|NCT00667342|473098|P3|Overall Study|Adverse Event|1
148481|NCT00667342|473099|P2|Overall Study|Adverse Event|0
148482|NCT00667342|473100|P1|Overall Study|Adverse Event|0
148483|NCT00667342|473098|P3|Overall Study|Relapse or tumor progression|7
148484|NCT00667342|473099|P2|Overall Study|Relapse or tumor progression|0
148485|NCT00667342|473100|P1|Overall Study|Relapse or tumor progression|9
148486|NCT00667342|473098|P3|Overall Study|Physician Decision|0
148487|NCT00667342|473099|P2|Overall Study|Physician Decision|0
148488|NCT00667342|473100|P1|Overall Study|Physician Decision|3
148489|NCT00667342|473098|P3|Overall Study|Withdrawal by Subject|0
148490|NCT00667342|473099|P2|Overall Study|Withdrawal by Subject|0
148491|NCT00667342|473100|P1|Overall Study|Withdrawal by Subject|1
148492|NCT00667342|473098|P3|Overall Study|Protocol Violation|0
148493|NCT00667342|473099|P2|Overall Study|Protocol Violation|0
148494|NCT00667342|473100|P1|Overall Study|Protocol Violation|1
148495|NCT00667355|473138|P1|Overall Study|Other reason was not specified|5
148496|NCT00667355|473138|P1|Overall Study|Lost to Follow-up|1
148497|NCT00667355|473138|P1|Overall Study|Adverse Event|5
148498|NCT00667368|473162|P2|Overall Study|Discontinued early|17
148499|NCT00667368|473163|P1|Overall Study|Discontinued early|24
148500|NCT00667368|473162|P2|Overall Study|Lost to Follow-up|155
148501|NCT00667368|473163|P1|Overall Study|Lost to Follow-up|176
148502|NCT00667394|473190|P2|Overall Study|Progressive disease|0
148503|NCT00667394|473191|P1|Overall Study|Progressive disease|1
148504|NCT00667394|473190|P2|Overall Study|Adverse Event|0
148505|NCT00667394|473191|P1|Overall Study|Adverse Event|3
148506|NCT00667420|473199|P1|Overall Study|Withdrawal by Subject|2
148507|NCT00667420|473199|P1|Overall Study|Physician Decision|1
148508|NCT00667420|473199|P1|Overall Study|Lack of Efficacy|5
148509|NCT00667420|473199|P1|Overall Study|Adverse Event|2
148510|NCT00667446|473209|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
148511|NCT00667446|473210|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
148512|NCT00667446|473209|P2|Treatment Period (36 Months)|Therapeutic Failure|1
148513|NCT00667446|473210|P1|Treatment Period (36 Months)|Therapeutic Failure|1
148514|NCT00667446|473209|P2|Treatment Period (36 Months)|Protocol Violation|1
148515|NCT00667446|473210|P1|Treatment Period (36 Months)|Protocol Violation|1
148516|NCT00667446|473209|P2|Treatment Period (36 Months)|Lost to Follow-up|0
148517|NCT00667446|473210|P1|Treatment Period (36 Months)|Lost to Follow-up|1
148518|NCT00667446|473209|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
148519|NCT00667446|473210|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
148520|NCT00667446|473209|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
148521|NCT00667446|473210|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
148522|NCT00667446|473209|P2|Treatment Period (36 Months)|Personal reasons|2
148523|NCT00667446|473210|P1|Treatment Period (36 Months)|Personal reasons|2
148524|NCT00667446|473209|P2|Treatment Period (36 Months)|Other|2
148525|NCT00667446|473210|P1|Treatment Period (36 Months)|Other|2
148526|NCT00667446|473209|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
148527|NCT00667446|473210|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
148528|NCT00667459|473234|P2|Overall Study|Lost to Follow-up|43
148529|NCT00667459|473235|P1|Overall Study|Lost to Follow-up|8
148530|NCT00667459|473234|P2|Overall Study|Death|2
148531|NCT00667459|473235|P1|Overall Study|Death|0
148532|NCT00667563|473275|P1|Overall Study|Protocol Violation|24
148533|NCT00667576|473290|P5|Overall Study|Missed Visit|0
148534|NCT00667576|473291|P4|Overall Study|Missed Visit|1
148535|NCT00667576|473292|P3|Overall Study|Missed Visit|0
148536|NCT00667576|473293|P2|Overall Study|Missed Visit|0
148537|NCT00667576|473294|P1|Overall Study|Missed Visit|0
148538|NCT00667576|473290|P5|Overall Study|Physician Decision|0
148539|NCT00667576|473291|P4|Overall Study|Physician Decision|1
148540|NCT00667576|473292|P3|Overall Study|Physician Decision|0
148541|NCT00667576|473293|P2|Overall Study|Physician Decision|0
148542|NCT00667576|473294|P1|Overall Study|Physician Decision|0
148543|NCT00667576|473290|P5|Overall Study|Protocol Violation|0
148544|NCT00667576|473291|P4|Overall Study|Protocol Violation|1
148545|NCT00667576|473292|P3|Overall Study|Protocol Violation|0
148546|NCT00667576|473293|P2|Overall Study|Protocol Violation|0
148547|NCT00667576|473294|P1|Overall Study|Protocol Violation|0
148548|NCT00667576|473290|P5|Overall Study|Lost to Follow-up|0
148549|NCT00667576|473291|P4|Overall Study|Lost to Follow-up|0
148550|NCT00667576|473292|P3|Overall Study|Lost to Follow-up|1
148551|NCT00667576|473293|P2|Overall Study|Lost to Follow-up|0
148552|NCT00667576|473294|P1|Overall Study|Lost to Follow-up|0
148553|NCT00667576|473290|P5|Overall Study|Adverse Event|0
148554|NCT00667576|473291|P4|Overall Study|Adverse Event|0
148555|NCT00667576|473292|P3|Overall Study|Adverse Event|0
148556|NCT00667576|473293|P2|Overall Study|Adverse Event|1
148557|NCT00667576|473294|P1|Overall Study|Adverse Event|1
148558|NCT00667576|473290|P5|Overall Study|Withdrawal by Subject|1
148559|NCT00667576|473291|P4|Overall Study|Withdrawal by Subject|1
148560|NCT00667576|473292|P3|Overall Study|Withdrawal by Subject|1
148561|NCT00667576|473293|P2|Overall Study|Withdrawal by Subject|0
148562|NCT00667576|473294|P1|Overall Study|Withdrawal by Subject|1
148563|NCT00667602|473361|P3|Overall Study|Protocol Violation|0
148564|NCT00667602|473362|P2|Overall Study|Protocol Violation|1
148565|NCT00667602|473363|P1|Overall Study|Protocol Violation|0
148566|NCT00667602|473361|P3|Overall Study|Administrative reason|2
148567|NCT00667602|473362|P2|Overall Study|Administrative reason|0
148568|NCT00667602|473363|P1|Overall Study|Administrative reason|0
148569|NCT00667602|473361|P3|Overall Study|Lost to Follow-up|6
148570|NCT00667602|473362|P2|Overall Study|Lost to Follow-up|5
148571|NCT00667602|473363|P1|Overall Study|Lost to Follow-up|4
148572|NCT00667602|473361|P3|Overall Study|Withdrawal by Subject|10
148573|NCT00667602|473362|P2|Overall Study|Withdrawal by Subject|9
148574|NCT00667602|473363|P1|Overall Study|Withdrawal by Subject|4
148575|NCT00667732|473420|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
148576|NCT00667732|473421|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
148577|NCT00667732|473422|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
148578|NCT00667732|473420|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
148579|NCT00667732|473421|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
148580|NCT00667732|473422|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
148581|NCT00667732|473420|P3|Run -In (8 Weeks)|Adverse Event|0
148582|NCT00667732|473421|P2|Run -In (8 Weeks)|Adverse Event|0
148583|NCT00667732|473422|P1|Run -In (8 Weeks)|Adverse Event|4
148584|NCT00667810|473448|P4|Overall Study|Not specified|0
148585|NCT00667810|473449|P3|Overall Study|Not specified|5
148586|NCT00667810|473450|P2|Overall Study|Not specified|6
148587|NCT00667810|473451|P1|Overall Study|Not specified|6
148588|NCT00667810|473448|P4|Overall Study|Vasogenic Edema Recurrence|0
148589|NCT00667810|473449|P3|Overall Study|Vasogenic Edema Recurrence|0
148590|NCT00667810|473450|P2|Overall Study|Vasogenic Edema Recurrence|3
148591|NCT00667810|473451|P1|Overall Study|Vasogenic Edema Recurrence|0
148592|NCT00667810|473448|P4|Overall Study|Loss of Caregiver|0
148593|NCT00667810|473449|P3|Overall Study|Loss of Caregiver|3
148594|NCT00667810|473450|P2|Overall Study|Loss of Caregiver|1
148595|NCT00667810|473451|P1|Overall Study|Loss of Caregiver|0
148596|NCT00667810|473448|P4|Overall Study|Failed to Return|0
148597|NCT00667810|473449|P3|Overall Study|Failed to Return|2
148598|NCT00667810|473450|P2|Overall Study|Failed to Return|0
148599|NCT00667810|473451|P1|Overall Study|Failed to Return|0
148600|NCT00667810|473448|P4|Overall Study|Discontinuation of Study by Sponsor|0
148601|NCT00667810|473449|P3|Overall Study|Discontinuation of Study by Sponsor|155
148602|NCT00667810|473450|P2|Overall Study|Discontinuation of Study by Sponsor|118
148603|NCT00667810|473451|P1|Overall Study|Discontinuation of Study by Sponsor|130
148604|NCT00667810|473448|P4|Overall Study|Withdrawal by Subject|1
148605|NCT00667810|473449|P3|Overall Study|Withdrawal by Subject|29
148606|NCT00667810|473450|P2|Overall Study|Withdrawal by Subject|20
148607|NCT00667810|473451|P1|Overall Study|Withdrawal by Subject|14
148608|NCT00667810|473448|P4|Overall Study|Protocol Violation|0
148609|NCT00667810|473449|P3|Overall Study|Protocol Violation|0
148610|NCT00667810|473450|P2|Overall Study|Protocol Violation|2
148611|NCT00667810|473451|P1|Overall Study|Protocol Violation|0
148612|NCT00667810|473448|P4|Overall Study|Physician Decision|0
148613|NCT00667810|473449|P3|Overall Study|Physician Decision|2
148614|NCT00667810|473450|P2|Overall Study|Physician Decision|1
148615|NCT00667810|473451|P1|Overall Study|Physician Decision|1
148616|NCT00667810|473448|P4|Overall Study|Lost to Follow-up|0
148617|NCT00667810|473449|P3|Overall Study|Lost to Follow-up|2
148618|NCT00667810|473450|P2|Overall Study|Lost to Follow-up|4
148619|NCT00667810|473451|P1|Overall Study|Lost to Follow-up|1
148620|NCT00667810|473448|P4|Overall Study|Lack of Efficacy|0
148621|NCT00667810|473449|P3|Overall Study|Lack of Efficacy|2
148622|NCT00667810|473450|P2|Overall Study|Lack of Efficacy|0
148623|NCT00667810|473451|P1|Overall Study|Lack of Efficacy|1
148624|NCT00667810|473448|P4|Overall Study|Death|0
148625|NCT00667810|473449|P3|Overall Study|Death|3
148626|NCT00667810|473450|P2|Overall Study|Death|1
148627|NCT00667810|473451|P1|Overall Study|Death|1
148628|NCT00667810|473448|P4|Overall Study|Adverse Event|1
148629|NCT00667810|473449|P3|Overall Study|Adverse Event|19
148630|NCT00667810|473450|P2|Overall Study|Adverse Event|14
148631|NCT00667810|473451|P1|Overall Study|Adverse Event|13
148632|NCT00667875|473524|P3|Overall Study|Withdrawal by Subject|7
148633|NCT00667875|473525|P2|Overall Study|Withdrawal by Subject|9
148634|NCT00667875|473526|P1|Overall Study|Withdrawal by Subject|10
148635|NCT00667875|473524|P3|Overall Study|Adverse Event|6
148636|NCT00667875|473525|P2|Overall Study|Adverse Event|2
148637|NCT00667875|473526|P1|Overall Study|Adverse Event|0
148638|NCT00667992|473536|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
148639|NCT00667992|473537|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
148640|NCT00667992|473536|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
148641|NCT00667992|473537|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
148642|NCT00667992|473536|P2|Wash-out|Withdrawal by Subject|0
148643|NCT00667992|473537|P1|Wash-out|Withdrawal by Subject|1
148644|NCT00667992|473536|P2|Wash-out|Failure to wash-out|2
148645|NCT00667992|473537|P1|Wash-out|Failure to wash-out|2
148646|NCT00667992|473536|P2|Wash-out|Not within one doubling dilution|3
148647|NCT00667992|473537|P1|Wash-out|Not within one doubling dilution|4
148648|NCT00667992|473536|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
148649|NCT00667992|473537|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
148650|NCT00667992|473536|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
148651|NCT00667992|473537|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
148652|NCT00667992|473536|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
148653|NCT00667992|473537|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
148654|NCT00667992|473536|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
148655|NCT00667992|473537|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
148656|NCT00667992|473536|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
148657|NCT00667992|473537|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
148658|NCT00667992|473536|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
148659|NCT00667992|473537|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
148660|NCT00667992|473536|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
148661|NCT00667992|473537|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
148662|NCT00667992|473536|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
148663|NCT00667992|473537|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
148664|NCT00668200|473591|P1|Overall Study|Lost to Follow-up|1
148665|NCT00668200|473591|P1|Overall Study|Withdrawal by Subject|2
148666|NCT00668317|473608|P1|Overall Study|Adverse Event|2
148667|NCT00668395|473619|P3|Overall Study|Physician Decision|0
148668|NCT00668395|473620|P2|Overall Study|Physician Decision|1
148669|NCT00668395|473621|P1|Overall Study|Physician Decision|1
148670|NCT00668395|473619|P3|Overall Study|Adverse Event|0
148671|NCT00668395|473620|P2|Overall Study|Adverse Event|1
148672|NCT00668395|473621|P1|Overall Study|Adverse Event|1
148673|NCT00668395|473619|P3|Overall Study|Withdrawal by Subject|1
148674|NCT00668395|473620|P2|Overall Study|Withdrawal by Subject|4
148675|NCT00668395|473621|P1|Overall Study|Withdrawal by Subject|4
148676|NCT00668733|473667|P2|Overall Study|Withdrawal by Subject|4
148677|NCT00668733|473668|P1|Overall Study|Withdrawal by Subject|0
148678|NCT00668733|473667|P2|Overall Study|Lost to Follow-up|3
148679|NCT00668733|473668|P1|Overall Study|Lost to Follow-up|2
148680|NCT00668746|473676|P2|Overall Study|Lost to Follow-up|1
148681|NCT00668746|473677|P1|Overall Study|Lost to Follow-up|2
148682|NCT00668863|473699|P1|Overall Study|Physician Decision|1
148683|NCT00668863|473699|P1|Overall Study|Subject’s work scheduling problem|1
148684|NCT00668863|473699|P1|Overall Study|Surgery|1
148685|NCT00668863|473699|P1|Overall Study|Withdrawal by Subject|1
148686|NCT00668863|473699|P1|Overall Study|Global Deterioration of Health Status|4
148687|NCT00668863|473699|P1|Overall Study|Study Terminated by Sponsor|8
148688|NCT00668863|473699|P1|Overall Study|Adverse Event|13
148689|NCT00668863|473699|P1|Overall Study|Objective Progression or Relapse|42
148690|NCT00669032|473738|P2|Overall Study|No fulfilment of the selection criteria|5
148691|NCT00669032|473739|P1|Overall Study|No fulfilment of the selection criteria|5
148692|NCT00669032|473738|P2|Overall Study|Physician Decision|1
148693|NCT00669032|473739|P1|Overall Study|Physician Decision|1
148694|NCT00669032|473738|P2|Overall Study|Adverse Event|16
148695|NCT00669032|473739|P1|Overall Study|Adverse Event|12
148696|NCT00669032|473738|P2|Overall Study|Withdrawal by Subject|13
148697|NCT00669032|473739|P1|Overall Study|Withdrawal by Subject|12
148698|NCT00669032|473738|P2|Overall Study|Lack of Efficacy|19
148699|NCT00669032|473739|P1|Overall Study|Lack of Efficacy|8
148700|NCT00669032|473738|P2|Overall Study|Lost to Follow-up|5
148701|NCT00669032|473739|P1|Overall Study|Lost to Follow-up|6
148702|NCT00669071|473767|P1|Overall Study|Final visit 40 days out of window|1
148703|NCT00669071|473767|P1|Overall Study|Lost to Follow-up|3
148704|NCT00669110|473788|P2|Overall Study|Withdrawal by Subject|2
148705|NCT00669110|473789|P1|Overall Study|Withdrawal by Subject|0
148706|NCT00669110|473788|P2|Overall Study|Protocol Violation|5
148707|NCT00669110|473789|P1|Overall Study|Protocol Violation|0
148708|NCT00669110|473788|P2|Overall Study|Lost to Follow-up|0
148709|NCT00669110|473789|P1|Overall Study|Lost to Follow-up|1
148710|NCT00669110|473788|P2|Overall Study|Physician Decision|1
148711|NCT00669110|473789|P1|Overall Study|Physician Decision|0
148712|NCT00669110|473788|P2|Overall Study|Caregiver request|2
148713|NCT00669110|473789|P1|Overall Study|Caregiver request|3
148714|NCT00669110|473788|P2|Overall Study|Adverse Event|3
148715|NCT00669110|473789|P1|Overall Study|Adverse Event|4
148716|NCT00669240|473860|P1|Overall Study|Enrolled but no dosing record|1
148717|NCT00669240|473860|P1|Overall Study|Enrolled but not treated|15
148718|NCT00669240|473860|P1|Overall Study|Unspecified|19
148719|NCT00669240|473860|P1|Overall Study|Adverse Event|21
148720|NCT00669240|473860|P1|Overall Study|Lost to Follow-up|34
148721|NCT00669240|473860|P1|Overall Study|Withdrawal by Subject|42
148722|NCT00669240|473860|P1|Overall Study|Lack of Efficacy|33
148723|NCT00669318|473883|P1|Overall Study|Withdrawal by Subject|2
148724|NCT00669331|473893|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
148725|NCT00669331|473894|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
148726|NCT00669331|473893|P2|Blinded Treatment Period|Physician Decision|3
148727|NCT00669331|473894|P1|Blinded Treatment Period|Physician Decision|3
148728|NCT00669331|473893|P2|Blinded Treatment Period|Death|2
148729|NCT00669331|473894|P1|Blinded Treatment Period|Death|0
148730|NCT00669331|473893|P2|Blinded Treatment Period|Lost to Follow-up|2
148731|NCT00669331|473894|P1|Blinded Treatment Period|Lost to Follow-up|3
148732|NCT00669331|473893|P2|Blinded Treatment Period|Withdrawal by Subject|19
148733|NCT00669331|473894|P1|Blinded Treatment Period|Withdrawal by Subject|17
148734|NCT00669331|473893|P2|Blinded Treatment Period|Protocol Violation|1
148735|NCT00669331|473894|P1|Blinded Treatment Period|Protocol Violation|1
148736|NCT00669331|473893|P2|Blinded Treatment Period|Adverse Event|10
148737|NCT00669331|473894|P1|Blinded Treatment Period|Adverse Event|16
148738|NCT00669331|473893|P2|Randomisation to First Dose|Randomised in error|10
148739|NCT00669331|473894|P1|Randomisation to First Dose|Randomised in error|3
148740|NCT00669331|473893|P2|Randomisation to First Dose|Sponsor decision|1
148741|NCT00669331|473894|P1|Randomisation to First Dose|Sponsor decision|0
148742|NCT00669331|473893|P2|Randomisation to First Dose|Death|0
148743|NCT00669331|473894|P1|Randomisation to First Dose|Death|1
148744|NCT00669331|473893|P2|Randomisation to First Dose|Lost to Follow-up|0
148745|NCT00669331|473894|P1|Randomisation to First Dose|Lost to Follow-up|2
148746|NCT00669331|473893|P2|Randomisation to First Dose|Withdrawal by Subject|2
148747|NCT00669331|473894|P1|Randomisation to First Dose|Withdrawal by Subject|3
148748|NCT00669331|473893|P2|Randomisation to First Dose|Protocol Violation|0
148749|NCT00669331|473894|P1|Randomisation to First Dose|Protocol Violation|1
148750|NCT00669331|473893|P2|Randomisation to First Dose|Adverse Event|0
148751|NCT00669331|473894|P1|Randomisation to First Dose|Adverse Event|1
148752|NCT00669396|473938|P2|Overall Study|Lost to Follow-up|12
148753|NCT00669396|473939|P1|Overall Study|Lost to Follow-up|10
148754|NCT00669617|473985|P5|Period 3|Lost to Follow-up|0
148755|NCT00669617|473986|P4|Period 3|Lost to Follow-up|0
148756|NCT00669617|473987|P3|Period 3|Lost to Follow-up|0
148757|NCT00669617|473988|P2|Period 3|Lost to Follow-up|0
148758|NCT00669617|473989|P1|Period 3|Lost to Follow-up|1
148759|NCT00669617|473985|P5|Period 1|Protocol Deviation|1
148760|NCT00669617|473986|P4|Period 1|Protocol Deviation|0
148761|NCT00669617|473987|P3|Period 1|Protocol Deviation|0
148762|NCT00669617|473988|P2|Period 1|Protocol Deviation|0
148763|NCT00669617|473989|P1|Period 1|Protocol Deviation|0
148764|NCT00669617|473985|P5|Period 1|Withdrawal by Subject|0
148765|NCT00669617|473986|P4|Period 1|Withdrawal by Subject|0
148766|NCT00669617|473987|P3|Period 1|Withdrawal by Subject|1
148767|NCT00669617|473988|P2|Period 1|Withdrawal by Subject|0
148768|NCT00669617|473989|P1|Period 1|Withdrawal by Subject|0
148769|NCT00669864|474006|P1|Overall Study|Other|2
148770|NCT00669864|474006|P1|Overall Study|Withdrawal by Subject|3
148771|NCT00669864|474006|P1|Overall Study|Protocol Violation|2
148772|NCT00669864|474006|P1|Overall Study|Lost to Follow-up|2
148773|NCT00669903|474019|P4|Overall Study|Protocol Violation|0
148774|NCT00669903|474020|P3|Overall Study|Protocol Violation|0
148775|NCT00669903|474021|P2|Overall Study|Protocol Violation|1
148776|NCT00669903|474022|P1|Overall Study|Protocol Violation|0
148777|NCT00669903|474019|P4|Overall Study|Lost to Follow-up|1
148778|NCT00669903|474020|P3|Overall Study|Lost to Follow-up|0
148779|NCT00669903|474021|P2|Overall Study|Lost to Follow-up|1
148780|NCT00669903|474022|P1|Overall Study|Lost to Follow-up|1
148781|NCT00669903|474019|P4|Overall Study|Withdrawal by Subject|2
148782|NCT00669903|474020|P3|Overall Study|Withdrawal by Subject|2
148783|NCT00669903|474021|P2|Overall Study|Withdrawal by Subject|2
148784|NCT00669903|474022|P1|Overall Study|Withdrawal by Subject|0
148785|NCT00669903|474019|P4|Overall Study|Adverse Event|1
148786|NCT00669903|474020|P3|Overall Study|Adverse Event|3
148787|NCT00669903|474021|P2|Overall Study|Adverse Event|1
148788|NCT00669903|474022|P1|Overall Study|Adverse Event|0
148789|NCT00669942|474081|P12|Parts 2 and 3|Protocol Violation|0
148790|NCT00669942|474082|P11|Parts 2 and 3|Protocol Violation|0
148791|NCT00669942|474083|P10|Parts 2 and 3|Protocol Violation|0
148792|NCT00669942|474084|P9|Parts 2 and 3|Protocol Violation|0
148793|NCT00669942|474085|P8|Parts 2 and 3|Protocol Violation|0
148794|NCT00669942|474086|P7|Parts 2 and 3|Protocol Violation|0
148795|NCT00669942|474087|P6|Parts 2 and 3|Protocol Violation|1
148796|NCT00669942|474088|P5|Parts 2 and 3|Protocol Violation|0
148797|NCT00669942|474089|P4|Parts 2 and 3|Protocol Violation|0
148798|NCT00669942|474090|P3|Parts 2 and 3|Protocol Violation|0
148799|NCT00669942|474091|P2|Parts 2 and 3|Protocol Violation|0
148800|NCT00669942|474092|P1|Parts 2 and 3|Protocol Violation|0
148801|NCT00669942|474081|P12|Parts 2 and 3|Withdrawal by Subject|0
148802|NCT00669942|474082|P11|Parts 2 and 3|Withdrawal by Subject|0
148803|NCT00669942|474083|P10|Parts 2 and 3|Withdrawal by Subject|0
148804|NCT00669942|474084|P9|Parts 2 and 3|Withdrawal by Subject|2
148805|NCT00669942|474085|P8|Parts 2 and 3|Withdrawal by Subject|0
148806|NCT00669942|474086|P7|Parts 2 and 3|Withdrawal by Subject|0
148807|NCT00669942|474087|P6|Parts 2 and 3|Withdrawal by Subject|1
148808|NCT00669942|474088|P5|Parts 2 and 3|Withdrawal by Subject|0
148809|NCT00669942|474089|P4|Parts 2 and 3|Withdrawal by Subject|0
148810|NCT00669942|474090|P3|Parts 2 and 3|Withdrawal by Subject|0
148811|NCT00669942|474091|P2|Parts 2 and 3|Withdrawal by Subject|0
148812|NCT00669942|474092|P1|Parts 2 and 3|Withdrawal by Subject|0
148813|NCT00669942|474081|P12|Parts 2 and 3|Adverse Event|0
148814|NCT00669942|474082|P11|Parts 2 and 3|Adverse Event|0
148815|NCT00669942|474083|P10|Parts 2 and 3|Adverse Event|0
148816|NCT00669942|474084|P9|Parts 2 and 3|Adverse Event|1
148817|NCT00669942|474085|P8|Parts 2 and 3|Adverse Event|2
148818|NCT00669942|474086|P7|Parts 2 and 3|Adverse Event|0
148819|NCT00669942|474087|P6|Parts 2 and 3|Adverse Event|0
148820|NCT00669942|474088|P5|Parts 2 and 3|Adverse Event|0
148821|NCT00669942|474089|P4|Parts 2 and 3|Adverse Event|0
148822|NCT00669942|474090|P3|Parts 2 and 3|Adverse Event|0
148823|NCT00669942|474091|P2|Parts 2 and 3|Adverse Event|0
148824|NCT00669942|474092|P1|Parts 2 and 3|Adverse Event|0
148825|NCT00669955|474156|P2|Overall Study|not compliant with study drug/visit|3
148826|NCT00669955|474157|P1|Overall Study|not compliant with study drug/visit|2
148827|NCT00669955|474156|P2|Overall Study|Investigator Sponsor Judgement|1
148828|NCT00669955|474157|P1|Overall Study|Investigator Sponsor Judgement|0
148829|NCT00669955|474156|P2|Overall Study|Protocol Violation|7
148830|NCT00669955|474157|P1|Overall Study|Protocol Violation|2
148831|NCT00669955|474156|P2|Overall Study|Lost to Follow-up|7
148832|NCT00669955|474157|P1|Overall Study|Lost to Follow-up|5
148833|NCT00669955|474156|P2|Overall Study|Withdrawal by Subject|3
148834|NCT00669955|474157|P1|Overall Study|Withdrawal by Subject|2
148835|NCT00669955|474156|P2|Overall Study|Death|1
148836|NCT00669955|474157|P1|Overall Study|Death|0
148837|NCT00669955|474156|P2|Overall Study|Adverse Event|5
148838|NCT00669955|474157|P1|Overall Study|Adverse Event|3
148839|NCT00663702|474177|P2|Overall Study|Lack of Efficacy|3
148840|NCT00663702|474178|P1|Overall Study|Lack of Efficacy|3
148841|NCT00663702|474177|P2|Overall Study|Death|1
148842|NCT00663702|474178|P1|Overall Study|Death|1
148843|NCT00663702|474177|P2|Overall Study|Lost to Follow-up|0
148844|NCT00663702|474178|P1|Overall Study|Lost to Follow-up|3
148845|NCT00663702|474177|P2|Overall Study|Pregnancy|1
148846|NCT00663702|474178|P1|Overall Study|Pregnancy|0
148847|NCT00663702|474177|P2|Overall Study|Withdrawal by Subject|1
148848|NCT00663702|474178|P1|Overall Study|Withdrawal by Subject|3
148849|NCT00663702|474177|P2|Overall Study|Adverse Event|4
148850|NCT00663702|474178|P1|Overall Study|Adverse Event|8
148851|NCT00663858|474226|P3|Overall Study|Other|4
148852|NCT00663858|474227|P2|Overall Study|Other|2
148853|NCT00663858|474228|P1|Overall Study|Other|8
148854|NCT00663858|474226|P3|Overall Study|Protocol Violation|4
148855|NCT00663858|474227|P2|Overall Study|Protocol Violation|3
148856|NCT00663858|474228|P1|Overall Study|Protocol Violation|5
148857|NCT00663858|474226|P3|Overall Study|Withdrawal by Subject|3
148858|NCT00663858|474227|P2|Overall Study|Withdrawal by Subject|3
148859|NCT00663858|474228|P1|Overall Study|Withdrawal by Subject|7
148860|NCT00663858|474226|P3|Overall Study|Lack of Efficacy|3
148861|NCT00663858|474227|P2|Overall Study|Lack of Efficacy|1
148862|NCT00663858|474228|P1|Overall Study|Lack of Efficacy|5
148863|NCT00663858|474226|P3|Overall Study|Adverse Event|6
148864|NCT00663858|474227|P2|Overall Study|Adverse Event|1
148865|NCT00663858|474228|P1|Overall Study|Adverse Event|9
148866|NCT00663923|474236|P1|Overall Study|Lost to Follow-up|2
148867|NCT00663962|474252|P2|Overall Study|somnolence|0
148868|NCT00663962|474253|P1|Overall Study|somnolence|1
148869|NCT00664066|474259|P1|Overall Study|Study terminated|3
148870|NCT00664105|474263|P1|Overall Study|Disease progression|7
148871|NCT00664105|474263|P1|Overall Study|Adverse Event|9
148872|NCT00664105|474263|P1|Overall Study|Withdrawal by Subject|5
148873|NCT00664105|474263|P1|Overall Study|Death|3
148874|NCT00664326|474270|P1|Overall Study|ongoing with treatment|6
148875|NCT00664326|474270|P1|Overall Study|Physician Decision|1
148876|NCT00664326|474270|P1|Overall Study|Withdrawal by Subject|1
148877|NCT00664326|474270|P1|Overall Study|Noncompliance with study medication|3
148878|NCT00664326|474270|P1|Overall Study|Adverse Event|13
148879|NCT00664521|474297|P2|Overall Study|Unspecified|0
148880|NCT00664521|474298|P1|Overall Study|Unspecified|1
148881|NCT00664521|474297|P2|Overall Study|Lost to Follow-up|0
148882|NCT00664521|474298|P1|Overall Study|Lost to Follow-up|1
148883|NCT00664521|474297|P2|Overall Study|Adverse Event|1
148884|NCT00664521|474298|P1|Overall Study|Adverse Event|4
148885|NCT00664534|474320|P2|Overall Study|Sponsor decision|6
148886|NCT00664534|474321|P1|Overall Study|Sponsor decision|8
148887|NCT00664534|474320|P2|Overall Study|Physician Decision|0
148888|NCT00664534|474321|P1|Overall Study|Physician Decision|8
148889|NCT00664534|474320|P2|Overall Study|Withdrawal by Subject|6
148890|NCT00664534|474321|P1|Overall Study|Withdrawal by Subject|7
148891|NCT00664534|474320|P2|Overall Study|Protocol Violation|8
148892|NCT00664534|474321|P1|Overall Study|Protocol Violation|10
148893|NCT00664534|474320|P2|Overall Study|Lost to Follow-up|10
148894|NCT00664534|474321|P1|Overall Study|Lost to Follow-up|6
148895|NCT00664534|474320|P2|Overall Study|Adverse Event|3
148896|NCT00664534|474321|P1|Overall Study|Adverse Event|2
148897|NCT00664560|474350|P3|Overall Study|Other|5
148898|NCT00664560|474351|P2|Overall Study|Other|4
148899|NCT00664560|474352|P1|Overall Study|Other|11
148900|NCT00664560|474350|P3|Overall Study|Lost to Follow-up|0
148901|NCT00664560|474351|P2|Overall Study|Lost to Follow-up|2
148902|NCT00664560|474352|P1|Overall Study|Lost to Follow-up|0
148903|NCT00664560|474350|P3|Overall Study|Withdrawal by Subject|7
148904|NCT00664560|474351|P2|Overall Study|Withdrawal by Subject|13
148905|NCT00664560|474352|P1|Overall Study|Withdrawal by Subject|9
148906|NCT00664560|474350|P3|Overall Study|Adverse Event|7
148907|NCT00664560|474351|P2|Overall Study|Adverse Event|16
148908|NCT00664560|474352|P1|Overall Study|Adverse Event|19
148909|NCT00670007|474393|P1|Overall Study|Withdrawal by Subject|4
148910|NCT00670007|474393|P1|Overall Study|Adverse Event|1
148911|NCT00670007|474393|P1|Overall Study|Adverse event, serious fatal|1
148912|NCT00670007|474393|P1|Overall Study|Travel/Vacation|1
148913|NCT00670007|474393|P1|Overall Study|Lung transplant|1
148914|NCT00670007|474393|P1|Overall Study|Drug abuse|1
148915|NCT00670111|474421|P3|Enrollment to One Month|Physician Decision|0
148916|NCT00670111|474422|P2|Enrollment to One Month|Physician Decision|0
148917|NCT00670111|474423|P1|Enrollment to One Month|Physician Decision|1
148918|NCT00670111|474421|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
148919|NCT00670111|474422|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
148920|NCT00670111|474423|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
148921|NCT00670111|474421|P3|Enrollment to One Month|Testing Failure|13
148922|NCT00670111|474422|P2|Enrollment to One Month|Testing Failure|0
148923|NCT00670111|474423|P1|Enrollment to One Month|Testing Failure|0
148924|NCT00670228|474442|P2|Overall Study|Not meeting the selection criteria|0
148925|NCT00670228|474443|P1|Overall Study|Not meeting the selection criteria|2
148926|NCT00670228|474442|P2|Overall Study|Not treated|2
148927|NCT00670228|474443|P1|Overall Study|Not treated|2
148928|NCT00670228|474442|P2|Overall Study|Death or MACE|1
148929|NCT00670228|474443|P1|Overall Study|Death or MACE|0
148930|NCT00670228|474442|P2|Overall Study|Adverse Event|0
148931|NCT00670228|474443|P1|Overall Study|Adverse Event|1
148932|NCT00670306|474488|P1|Overall Study|incl/excl criterias did not meet|19
148933|NCT00670306|474488|P1|Overall Study|Lost to Follow-up|8
148934|NCT00670306|474488|P1|Overall Study|Physician Decision|1
148935|NCT00670306|474488|P1|Overall Study|Withdrawal by Subject|9
148936|NCT00670306|474488|P1|Overall Study|Lack of Efficacy|10
148937|NCT00670306|474488|P1|Overall Study|Adverse Event|8
148938|NCT00670930|474494|P2|Overall Study|Lost to Follow-up|0
148939|NCT00670930|474495|P1|Overall Study|Lost to Follow-up|1
148940|NCT00670930|474494|P2|Overall Study|Adminstrative Problem|1
148941|NCT00670930|474495|P1|Overall Study|Adminstrative Problem|0
148942|NCT00671060|474529|P2|Overall Study|Physician Decision|1
148943|NCT00671060|474530|P1|Overall Study|Physician Decision|0
148944|NCT00671060|474529|P2|Overall Study|Protocol Violation|0
148945|NCT00671060|474530|P1|Overall Study|Protocol Violation|1
148946|NCT00671437|474549|P1|Overall Study|Ineligible post-hoc|1
148947|NCT00671437|474549|P1|Overall Study|Adverse Event|3
148948|NCT00671437|474549|P1|Overall Study|Cutaneous SCC of head and neck|3
148949|NCT00671437|474549|P1|Overall Study|Progressive disease before C1 week 8|8
148950|NCT00671554|474602|P1|Overall Study|Disease progression|3
148951|NCT00671749|474656|P1|Overall Study|Lost to Follow-up|1
148952|NCT00671749|474656|P1|Overall Study|Protocol Violation|1
148953|NCT00671749|474656|P1|Overall Study|Withdrawal by Subject|4
148954|NCT00671749|474656|P1|Overall Study|Adverse Event|2
148955|NCT00671788|474666|P1|Overall Study|Other|1
148956|NCT00671788|474666|P1|Overall Study|MD Decision|1
148957|NCT00671788|474666|P1|Overall Study|Ineligible|1
148958|NCT00671788|474666|P1|Overall Study|Refused further treatment|3
148959|NCT00671788|474666|P1|Overall Study|Adverse Event|8
148960|NCT00671853|474675|P2|Overall Study|Non-adherence with study procedures|4
148961|NCT00671853|474676|P1|Overall Study|Non-adherence with study procedures|1
148962|NCT00671853|474675|P2|Overall Study|Physician Decision|2
148963|NCT00671853|474676|P1|Overall Study|Physician Decision|0
148964|NCT00671853|474675|P2|Overall Study|Lost to Follow-up|8
148965|NCT00671853|474676|P1|Overall Study|Lost to Follow-up|8
148966|NCT00671853|474675|P2|Overall Study|Withdrawal by Subject|5
148967|NCT00671853|474676|P1|Overall Study|Withdrawal by Subject|1
148968|NCT00671853|474675|P2|Overall Study|Adverse Event|1
148969|NCT00671853|474676|P1|Overall Study|Adverse Event|7
148970|NCT00671853|474675|P2|Overall Study|Lack of Efficacy|7
148971|NCT00671853|474676|P1|Overall Study|Lack of Efficacy|3
148972|NCT00671879|474695|P3|Overall Study|Withdrawal by Subject|6
148973|NCT00671879|474696|P2|Overall Study|Withdrawal by Subject|4
148974|NCT00671879|474697|P1|Overall Study|Withdrawal by Subject|0
148975|NCT00671931|474718|P5|Overall Study|Physician Decision|1
148976|NCT00671931|474719|P4|Overall Study|Physician Decision|2
148977|NCT00671931|474720|P3|Overall Study|Physician Decision|0
148978|NCT00671931|474721|P2|Overall Study|Physician Decision|0
148979|NCT00671931|474722|P1|Overall Study|Physician Decision|1
148980|NCT00672256|474796|P1|Overall Study|PI dropped, bad data|44
148981|NCT00672490|474839|P2|Overall Study|No reason was provided|2
148982|NCT00672490|474840|P1|Overall Study|No reason was provided|6
148983|NCT00672490|474839|P2|Overall Study|Lost to Follow-up|5
148984|NCT00672490|474840|P1|Overall Study|Lost to Follow-up|1
148985|NCT00672490|474839|P2|Overall Study|Intolerance|2
148986|NCT00672490|474840|P1|Overall Study|Intolerance|0
148987|NCT00672490|474839|P2|Overall Study|Violation of Concomitant Medicine|0
148988|NCT00672490|474840|P1|Overall Study|Violation of Concomitant Medicine|1
148989|NCT00672490|474839|P2|Overall Study|Adverse Event|8
148990|NCT00672490|474840|P1|Overall Study|Adverse Event|5
148991|NCT00672490|474839|P2|Overall Study|Mismatch Include/Exclude Criteria|0
148992|NCT00672490|474840|P1|Overall Study|Mismatch Include/Exclude Criteria|1
148993|NCT00672490|474839|P2|Overall Study|Lack of Compliance|7
148994|NCT00672490|474840|P1|Overall Study|Lack of Compliance|2
148995|NCT00672490|474839|P2|Overall Study|Withdrawal by Subject|8
148996|NCT00672490|474840|P1|Overall Study|Withdrawal by Subject|8
148997|NCT00672555|474862|P1|Overall Study|Did not want to answer questionnaire|2
148998|NCT00672555|474862|P1|Overall Study|Lost to Follow-up|4
148999|NCT00672620|474886|P4|Overall Study|Reason not Specified|1
149000|NCT00672620|474887|P3|Overall Study|Reason not Specified|2
149001|NCT00672620|474888|P2|Overall Study|Reason not Specified|3
149002|NCT00672620|474889|P1|Overall Study|Reason not Specified|3
149003|NCT00672620|474886|P4|Overall Study|Lost to Follow-up|11
149004|NCT00672620|474887|P3|Overall Study|Lost to Follow-up|8
149005|NCT00672620|474888|P2|Overall Study|Lost to Follow-up|19
149006|NCT00672620|474889|P1|Overall Study|Lost to Follow-up|8
149007|NCT00672620|474886|P4|Overall Study|Withdrawal of Consent|6
149008|NCT00672620|474887|P3|Overall Study|Withdrawal of Consent|5
149009|NCT00672620|474888|P2|Overall Study|Withdrawal of Consent|12
149010|NCT00672620|474889|P1|Overall Study|Withdrawal of Consent|6
149011|NCT00672620|474886|P4|Overall Study|Protocol Deviations|5
149012|NCT00672620|474887|P3|Overall Study|Protocol Deviations|2
149013|NCT00672620|474888|P2|Overall Study|Protocol Deviations|7
149014|NCT00672620|474889|P1|Overall Study|Protocol Deviations|5
149015|NCT00672620|474886|P4|Overall Study|Noncompliance with Study Drug|2
149016|NCT00672620|474887|P3|Overall Study|Noncompliance with Study Drug|0
149017|NCT00672620|474888|P2|Overall Study|Noncompliance with Study Drug|4
149018|NCT00672620|474889|P1|Overall Study|Noncompliance with Study Drug|3
149019|NCT00672620|474886|P4|Overall Study|Lack of Efficacy|0
149020|NCT00672620|474887|P3|Overall Study|Lack of Efficacy|2
149021|NCT00672620|474888|P2|Overall Study|Lack of Efficacy|2
149022|NCT00672620|474889|P1|Overall Study|Lack of Efficacy|1
149023|NCT00672620|474886|P4|Overall Study|Adverse Event|17
149024|NCT00672620|474887|P3|Overall Study|Adverse Event|12
149025|NCT00672620|474888|P2|Overall Study|Adverse Event|7
149026|NCT00672620|474889|P1|Overall Study|Adverse Event|7
149027|NCT00672633|474945|P2|Overall Study|Withdrawal by Subject|1
149028|NCT00672633|474946|P1|Overall Study|Withdrawal by Subject|0
149029|NCT00672646|474959|P3|Overall Study|Withdrawal by Subject|1
149030|NCT00672646|474960|P2|Overall Study|Withdrawal by Subject|0
149031|NCT00672646|474961|P1|Overall Study|Withdrawal by Subject|0
149032|NCT00672646|474959|P3|Overall Study|Lost to Follow-up|2
149033|NCT00672646|474960|P2|Overall Study|Lost to Follow-up|1
149034|NCT00672646|474961|P1|Overall Study|Lost to Follow-up|0
149035|NCT00672841|474993|P2|Overall Study|Pregnancy|1
149036|NCT00672841|474994|P1|Overall Study|Pregnancy|0
149037|NCT00672841|474993|P2|Overall Study|Adverse Event|3
149038|NCT00672841|474994|P1|Overall Study|Adverse Event|0
149039|NCT00672841|474993|P2|Overall Study|Antifungal therapy, negative glucan|4
149040|NCT00672841|474994|P1|Overall Study|Antifungal therapy, negative glucan|0
149041|NCT00672841|474993|P2|Overall Study|icteric specimens|3
149042|NCT00672841|474994|P1|Overall Study|icteric specimens|0
149043|NCT00672841|474993|P2|Overall Study|Comfort care|4
149044|NCT00672841|474994|P1|Overall Study|Comfort care|1
149045|NCT00672958|475028|P2|Overall Study|Reason not specified|3
149046|NCT00672958|475029|P1|Overall Study|Reason not specified|0
149047|NCT00672958|475028|P2|Overall Study|Lost to Follow-up|17
149048|NCT00672958|475029|P1|Overall Study|Lost to Follow-up|22
149049|NCT00672958|475028|P2|Overall Study|Voluntary withdrawal|8
149050|NCT00672958|475029|P1|Overall Study|Voluntary withdrawal|12
149051|NCT00672958|475028|P2|Overall Study|Protocol deviations|5
149052|NCT00672958|475029|P1|Overall Study|Protocol deviations|11
149053|NCT00672958|475028|P2|Overall Study|Non-compliance with study drug|3
149054|NCT00672958|475029|P1|Overall Study|Non-compliance with study drug|2
149055|NCT00672958|475028|P2|Overall Study|Lack of Efficacy|11
149056|NCT00672958|475029|P1|Overall Study|Lack of Efficacy|6
149057|NCT00672958|475028|P2|Overall Study|Adverse Event|9
149058|NCT00672958|475029|P1|Overall Study|Adverse Event|11
149059|NCT00672984|475062|P3|Third Intervention|Adverse Event|1
149060|NCT00672984|475063|P2|Third Intervention|Adverse Event|0
149061|NCT00672984|475064|P1|Third Intervention|Adverse Event|1
149062|NCT00672984|475062|P3|Second Intervention|Protocol Violation|1
149063|NCT00672984|475063|P2|Second Intervention|Protocol Violation|1
149064|NCT00672984|475064|P1|Second Intervention|Protocol Violation|0
149065|NCT00672984|475062|P3|Second Intervention|Withdrawal by Subject|0
149066|NCT00672984|475063|P2|Second Intervention|Withdrawal by Subject|3
149067|NCT00672984|475064|P1|Second Intervention|Withdrawal by Subject|0
149068|NCT00672984|475062|P3|Second Intervention|Non-compliance with facility policies|0
149069|NCT00672984|475063|P2|Second Intervention|Non-compliance with facility policies|2
149070|NCT00672984|475064|P1|Second Intervention|Non-compliance with facility policies|0
149071|NCT00672984|475062|P3|First Intervention|Sponsor decision|0
149072|NCT00672984|475063|P2|First Intervention|Sponsor decision|0
149073|NCT00672984|475064|P1|First Intervention|Sponsor decision|3
149074|NCT00672984|475062|P3|First Intervention|Withdrawal by Subject|2
149075|NCT00672984|475063|P2|First Intervention|Withdrawal by Subject|2
149076|NCT00672984|475064|P1|First Intervention|Withdrawal by Subject|1
149077|NCT00672984|475062|P3|First Intervention|Adverse Event|0
149078|NCT00672984|475063|P2|First Intervention|Adverse Event|0
149079|NCT00672984|475064|P1|First Intervention|Adverse Event|5
149080|NCT00673049|475115|P4|After Progression on Erlotinib|study terminated by sponsor|4
149081|NCT00673049|475116|P3|After Progression on Erlotinib|study terminated by sponsor|0
149082|NCT00673049|475117|P2|After Progression on Erlotinib|study terminated by sponsor|0
149083|NCT00673049|475118|P1|After Progression on Erlotinib|study terminated by sponsor|0
149084|NCT00673049|475115|P4|After Progression on Erlotinib|Withdrawal by Subject|5
149085|NCT00673049|475116|P3|After Progression on Erlotinib|Withdrawal by Subject|0
149086|NCT00673049|475117|P2|After Progression on Erlotinib|Withdrawal by Subject|0
149087|NCT00673049|475118|P1|After Progression on Erlotinib|Withdrawal by Subject|0
149088|NCT00673049|475115|P4|After Progression on Erlotinib|Lost to Follow-up|3
149089|NCT00673049|475116|P3|After Progression on Erlotinib|Lost to Follow-up|0
149090|NCT00673049|475117|P2|After Progression on Erlotinib|Lost to Follow-up|0
149091|NCT00673049|475118|P1|After Progression on Erlotinib|Lost to Follow-up|0
149092|NCT00673049|475115|P4|After Progression on Erlotinib|Death|71
149093|NCT00673049|475116|P3|After Progression on Erlotinib|Death|0
149094|NCT00673049|475117|P2|After Progression on Erlotinib|Death|0
149095|NCT00673049|475118|P1|After Progression on Erlotinib|Death|0
149096|NCT00673049|475115|P4|Before Progression on Erlotinib|Switched to figitumumab|0
149097|NCT00673049|475116|P3|Before Progression on Erlotinib|Switched to figitumumab|0
149098|NCT00673049|475117|P2|Before Progression on Erlotinib|Switched to figitumumab|83
149099|NCT00673049|475118|P1|Before Progression on Erlotinib|Switched to figitumumab|0
149100|NCT00673049|475115|P4|Before Progression on Erlotinib|study terminated by sponsor|0
149101|NCT00673049|475116|P3|Before Progression on Erlotinib|study terminated by sponsor|0
149102|NCT00673049|475117|P2|Before Progression on Erlotinib|study terminated by sponsor|14
149103|NCT00673049|475118|P1|Before Progression on Erlotinib|study terminated by sponsor|18
149104|NCT00673049|475115|P4|Before Progression on Erlotinib|Unspecified|0
149105|NCT00673049|475116|P3|Before Progression on Erlotinib|Unspecified|0
149106|NCT00673049|475117|P2|Before Progression on Erlotinib|Unspecified|2
149107|NCT00673049|475118|P1|Before Progression on Erlotinib|Unspecified|1
149108|NCT00673049|475115|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
149109|NCT00673049|475116|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
149110|NCT00673049|475117|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
149111|NCT00673049|475118|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
149112|NCT00673049|475115|P4|Before Progression on Erlotinib|Lost to Follow-up|0
149113|NCT00673049|475116|P3|Before Progression on Erlotinib|Lost to Follow-up|0
149114|NCT00673049|475117|P2|Before Progression on Erlotinib|Lost to Follow-up|5
149115|NCT00673049|475118|P1|Before Progression on Erlotinib|Lost to Follow-up|9
149116|NCT00673049|475115|P4|Before Progression on Erlotinib|Death|0
149117|NCT00673049|475116|P3|Before Progression on Erlotinib|Death|1
149118|NCT00673049|475117|P2|Before Progression on Erlotinib|Death|167
149119|NCT00673049|475118|P1|Before Progression on Erlotinib|Death|235
149120|NCT00673049|475115|P4|Before Progression on Erlotinib|Randomized but not treated|0
149121|NCT00673049|475116|P3|Before Progression on Erlotinib|Randomized but not treated|0
149122|NCT00673049|475117|P2|Before Progression on Erlotinib|Randomized but not treated|1
149123|NCT00673049|475118|P1|Before Progression on Erlotinib|Randomized but not treated|3
149124|NCT00673179|475182|P2|Overall Study|Toxicity/Complications|0
149125|NCT00673179|475183|P1|Overall Study|Toxicity/Complications|3
149126|NCT00673231|475193|P4|Overall Study|Study criteria,compliance,safety, other|4
149127|NCT00673231|475194|P3|Overall Study|Study criteria,compliance,safety, other|7
149128|NCT00673231|475195|P2|Overall Study|Study criteria,compliance,safety, other|5
149129|NCT00673231|475196|P1|Overall Study|Study criteria,compliance,safety, other|8
149130|NCT00673231|475193|P4|Overall Study|Death|0
149131|NCT00673231|475194|P3|Overall Study|Death|1
149132|NCT00673231|475195|P2|Overall Study|Death|0
149133|NCT00673231|475196|P1|Overall Study|Death|0
149134|NCT00673231|475193|P4|Overall Study|Lost to Follow-up|2
149135|NCT00673231|475194|P3|Overall Study|Lost to Follow-up|1
149136|NCT00673231|475195|P2|Overall Study|Lost to Follow-up|2
149137|NCT00673231|475196|P1|Overall Study|Lost to Follow-up|1
149138|NCT00673231|475193|P4|Overall Study|Adverse Event|6
149139|NCT00673231|475194|P3|Overall Study|Adverse Event|9
149140|NCT00673231|475195|P2|Overall Study|Adverse Event|5
149141|NCT00673231|475196|P1|Overall Study|Adverse Event|6
149142|NCT00673231|475193|P4|Overall Study|Withdrawal by Subject|6
149143|NCT00673231|475194|P3|Overall Study|Withdrawal by Subject|8
149144|NCT00673231|475195|P2|Overall Study|Withdrawal by Subject|10
149145|NCT00673231|475196|P1|Overall Study|Withdrawal by Subject|14
149146|NCT00673257|475226|P1|Overall Study|Unable to obtain specimen|1
149147|NCT00673257|475226|P1|Overall Study|Withdrawal by Subject|4
149148|NCT00673361|475231|P1|Overall Study|Screen Failure|2
149149|NCT00673387|475251|P8|Overall Study|Lost to Follow-up|5
149150|NCT00673387|475252|P7|Overall Study|Lost to Follow-up|8
149151|NCT00673387|475253|P6|Overall Study|Lost to Follow-up|5
149152|NCT00673387|475254|P5|Overall Study|Lost to Follow-up|6
149153|NCT00673387|475255|P4|Overall Study|Lost to Follow-up|6
149154|NCT00673387|475256|P3|Overall Study|Lost to Follow-up|5
149155|NCT00673387|475257|P2|Overall Study|Lost to Follow-up|6
149156|NCT00673387|475258|P1|Overall Study|Lost to Follow-up|8
149157|NCT00673387|475251|P8|Overall Study|Protocol Violation|3
149158|NCT00673387|475252|P7|Overall Study|Protocol Violation|1
149159|NCT00673387|475253|P6|Overall Study|Protocol Violation|1
149160|NCT00673387|475254|P5|Overall Study|Protocol Violation|0
149161|NCT00673387|475255|P4|Overall Study|Protocol Violation|2
149162|NCT00673387|475256|P3|Overall Study|Protocol Violation|1
149163|NCT00673387|475257|P2|Overall Study|Protocol Violation|0
149164|NCT00673387|475258|P1|Overall Study|Protocol Violation|3
149165|NCT00673387|475251|P8|Overall Study|Physician Decision|1
149166|NCT00673387|475252|P7|Overall Study|Physician Decision|1
149167|NCT00673387|475253|P6|Overall Study|Physician Decision|5
149168|NCT00673387|475254|P5|Overall Study|Physician Decision|0
149169|NCT00673387|475255|P4|Overall Study|Physician Decision|0
149170|NCT00673387|475256|P3|Overall Study|Physician Decision|0
149171|NCT00673387|475257|P2|Overall Study|Physician Decision|0
149172|NCT00673387|475258|P1|Overall Study|Physician Decision|0
149173|NCT00673387|475251|P8|Overall Study|Adverse Event|5
149174|NCT00673387|475252|P7|Overall Study|Adverse Event|5
149175|NCT00673387|475253|P6|Overall Study|Adverse Event|2
149176|NCT00673387|475254|P5|Overall Study|Adverse Event|6
149177|NCT00673387|475255|P4|Overall Study|Adverse Event|2
149178|NCT00673387|475256|P3|Overall Study|Adverse Event|5
149179|NCT00673387|475257|P2|Overall Study|Adverse Event|1
149180|NCT00673387|475258|P1|Overall Study|Adverse Event|3
149181|NCT00673387|475251|P8|Overall Study|Withdrawal by Subject|21
149182|NCT00673387|475252|P7|Overall Study|Withdrawal by Subject|15
149183|NCT00673387|475253|P6|Overall Study|Withdrawal by Subject|21
149184|NCT00673387|475254|P5|Overall Study|Withdrawal by Subject|18
149185|NCT00673387|475255|P4|Overall Study|Withdrawal by Subject|16
149186|NCT00673387|475256|P3|Overall Study|Withdrawal by Subject|20
149187|NCT00673387|475257|P2|Overall Study|Withdrawal by Subject|16
149188|NCT00673387|475258|P1|Overall Study|Withdrawal by Subject|15
149189|NCT00673452|475497|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
149190|NCT00673452|475498|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
149191|NCT00673452|475497|P2|Continuation Double-Blind Phase|Physician Decision|0
149192|NCT00673452|475498|P1|Continuation Double-Blind Phase|Physician Decision|2
149193|NCT00673452|475497|P2|Continuation Double-Blind Phase|Sponsor Decision|3
149194|NCT00673452|475498|P1|Continuation Double-Blind Phase|Sponsor Decision|0
149195|NCT00673452|475497|P2|Continuation Double-Blind Phase|Protocol Violation|3
149196|NCT00673452|475498|P1|Continuation Double-Blind Phase|Protocol Violation|2
149197|NCT00673452|475497|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
149198|NCT00673452|475498|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
149199|NCT00673452|475497|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
149200|NCT00673452|475498|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
149201|NCT00673452|475497|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
149202|NCT00673452|475498|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
149203|NCT00673452|475497|P2|Continuation Double-Blind Phase|Adverse Event|13
149204|NCT00673452|475498|P1|Continuation Double-Blind Phase|Adverse Event|5
149205|NCT00673452|475497|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
149206|NCT00673452|475498|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
149207|NCT00673452|475497|P2|Acute Double-Blind Phase|Sponsor Decision|1
149208|NCT00673452|475498|P1|Acute Double-Blind Phase|Sponsor Decision|0
149209|NCT00673452|475497|P2|Acute Double-Blind Phase|Protocol Violation|3
149210|NCT00673452|475498|P1|Acute Double-Blind Phase|Protocol Violation|5
149211|NCT00673452|475497|P2|Acute Double-Blind Phase|Physician Decision|6
149212|NCT00673452|475498|P1|Acute Double-Blind Phase|Physician Decision|0
149213|NCT00673452|475497|P2|Acute Double-Blind Phase|Lost to Follow-up|19
149214|NCT00673452|475498|P1|Acute Double-Blind Phase|Lost to Follow-up|16
149215|NCT00673452|475497|P2|Acute Double-Blind Phase|Lack of Efficacy|14
149216|NCT00673452|475498|P1|Acute Double-Blind Phase|Lack of Efficacy|9
149217|NCT00673452|475497|P2|Acute Double-Blind Phase|Adverse Event|24
149218|NCT00673452|475498|P1|Acute Double-Blind Phase|Adverse Event|41
149219|NCT00673465|475532|P12|Part 1/Period 2 (United States)|Protocol Violation|0
149220|NCT00673465|475533|P11|Part 1/Period 2 (United States)|Protocol Violation|0
149221|NCT00673465|475534|P10|Part 1/Period 2 (United States)|Protocol Violation|0
149222|NCT00673465|475535|P9|Part 1/Period 2 (United States)|Protocol Violation|0
149223|NCT00673465|475536|P8|Part 1/Period 2 (United States)|Protocol Violation|0
149224|NCT00673465|475537|P7|Part 1/Period 2 (United States)|Protocol Violation|0
149225|NCT00673465|475538|P6|Part 1/Period 2 (United States)|Protocol Violation|0
149226|NCT00673465|475539|P5|Part 1/Period 2 (United States)|Protocol Violation|1
149227|NCT00673465|475540|P4|Part 1/Period 2 (United States)|Protocol Violation|0
149228|NCT00673465|475541|P3|Part 1/Period 2 (United States)|Protocol Violation|0
149313|NCT00676091|475811|P2|Infant Series|Failed to return|3
149229|NCT00673465|475542|P2|Part 1/Period 2 (United States)|Protocol Violation|0
149230|NCT00673465|475543|P1|Part 1/Period 2 (United States)|Protocol Violation|0
149231|NCT00673465|475532|P12|Part 1/Period 1 (United States)|Protocol Violation|0
149232|NCT00673465|475533|P11|Part 1/Period 1 (United States)|Protocol Violation|0
149233|NCT00673465|475534|P10|Part 1/Period 1 (United States)|Protocol Violation|0
149234|NCT00673465|475535|P9|Part 1/Period 1 (United States)|Protocol Violation|0
149235|NCT00673465|475536|P8|Part 1/Period 1 (United States)|Protocol Violation|0
149236|NCT00673465|475537|P7|Part 1/Period 1 (United States)|Protocol Violation|0
149237|NCT00673465|475538|P6|Part 1/Period 1 (United States)|Protocol Violation|1
149238|NCT00673465|475539|P5|Part 1/Period 1 (United States)|Protocol Violation|1
149239|NCT00673465|475540|P4|Part 1/Period 1 (United States)|Protocol Violation|0
149240|NCT00673465|475541|P3|Part 1/Period 1 (United States)|Protocol Violation|0
149241|NCT00673465|475542|P2|Part 1/Period 1 (United States)|Protocol Violation|0
149242|NCT00673465|475543|P1|Part 1/Period 1 (United States)|Protocol Violation|0
149243|NCT00673660|475601|P1|Overall Study|Lost to Follow-up|107
149244|NCT00673673|475612|P1|Overall Study|Investigators' discretion|2
149245|NCT00673673|475612|P1|Overall Study|Withdrawal by Subject|3
149246|NCT00673673|475612|P1|Overall Study|Adverse Event|4
149247|NCT00673673|475612|P1|Overall Study|Progressive disease|27
149248|NCT00675428|475638|P2|Overall Study|Physician Decision|0
149249|NCT00675428|475639|P1|Overall Study|Physician Decision|1
149250|NCT00675428|475638|P2|Overall Study|No Disease Response After Cycle 6|1
149251|NCT00675428|475639|P1|Overall Study|No Disease Response After Cycle 6|0
149252|NCT00675428|475638|P2|Overall Study|Disease Progression|2
149253|NCT00675428|475639|P1|Overall Study|Disease Progression|2
149254|NCT00675441|475657|P1|Overall Study|Death|1
149255|NCT00675441|475657|P1|Overall Study|Withdrawal by Subject|2
149256|NCT00675506|475663|P2|Overall Study|Schedule conflict|1
149257|NCT00675506|475664|P1|Overall Study|Schedule conflict|0
149258|NCT00675506|475663|P2|Overall Study|Declined participation|0
149259|NCT00675506|475664|P1|Overall Study|Declined participation|1
149260|NCT00675506|475663|P2|Overall Study|Disclosed history of cancer|0
149261|NCT00675506|475664|P1|Overall Study|Disclosed history of cancer|1
149262|NCT00675506|475663|P2|Overall Study|Hypersensitivity Reaction|0
149263|NCT00675506|475664|P1|Overall Study|Hypersensitivity Reaction|1
149264|NCT00675506|475663|P2|Overall Study|Elevated IGF-1|0
149265|NCT00675506|475664|P1|Overall Study|Elevated IGF-1|2
149266|NCT00675506|475663|P2|Overall Study|Elevated IGF-1 prior to treatment|0
149267|NCT00675506|475664|P1|Overall Study|Elevated IGF-1 prior to treatment|1
149268|NCT00675506|475663|P2|Overall Study|Elevated fasting glucose|1
149269|NCT00675506|475664|P1|Overall Study|Elevated fasting glucose|2
149270|NCT00675506|475663|P2|Overall Study|Lost interest|5
149271|NCT00675506|475664|P1|Overall Study|Lost interest|3
149272|NCT00675506|475663|P2|Overall Study|Lost to Follow-up|5
149273|NCT00675506|475664|P1|Overall Study|Lost to Follow-up|1
149274|NCT00675597|475704|P1|Overall Study|Withdrawal by Subject|3
149275|NCT00675766|475712|P4|Overall Study|Lost to Follow-up|26
149276|NCT00675766|475713|P3|Overall Study|Lost to Follow-up|21
149277|NCT00675766|475714|P2|Overall Study|Lost to Follow-up|5
149278|NCT00675766|475715|P1|Overall Study|Lost to Follow-up|6
149279|NCT00675948|475764|P2|Overall Study|Patient feels unable to take medication|1
149280|NCT00675948|475765|P1|Overall Study|Patient feels unable to take medication|0
149281|NCT00675948|475764|P2|Overall Study|Patient unable to comply with diaries|0
149282|NCT00675948|475765|P1|Overall Study|Patient unable to comply with diaries|1
149283|NCT00675948|475764|P2|Overall Study|Patient died|0
149284|NCT00675948|475765|P1|Overall Study|Patient died|1
149285|NCT00675948|475764|P2|Overall Study|Sponsor decision|1
149286|NCT00675948|475765|P1|Overall Study|Sponsor decision|0
149287|NCT00675948|475764|P2|Overall Study|Pain under control|0
149288|NCT00675948|475765|P1|Overall Study|Pain under control|1
149289|NCT00675948|475764|P2|Overall Study|Protocol Violation|0
149290|NCT00675948|475765|P1|Overall Study|Protocol Violation|1
149291|NCT00675948|475764|P2|Overall Study|Lost to Follow-up|0
149292|NCT00675948|475765|P1|Overall Study|Lost to Follow-up|2
149293|NCT00675948|475764|P2|Overall Study|Withdrawal by Subject|0
149294|NCT00675948|475765|P1|Overall Study|Withdrawal by Subject|7
149295|NCT00675948|475764|P2|Overall Study|Lack of Efficacy|0
149296|NCT00675948|475765|P1|Overall Study|Lack of Efficacy|3
149297|NCT00675948|475764|P2|Overall Study|Adverse Event|1
149298|NCT00675948|475765|P1|Overall Study|Adverse Event|23
149299|NCT00676091|475811|P2|Toddler Dose|Parent or legal guardian request|0
149300|NCT00676091|475812|P1|Toddler Dose|Parent or legal guardian request|1
149301|NCT00676091|475811|P2|Toddler Dose|Failed to return|0
149302|NCT00676091|475812|P1|Toddler Dose|Failed to return|2
149303|NCT00676091|475811|P2|After Infant Series|Failed to return|1
149304|NCT00676091|475812|P1|After Infant Series|Failed to return|1
149305|NCT00676091|475811|P2|After Infant Series|Protocol Violation|1
149306|NCT00676091|475812|P1|After Infant Series|Protocol Violation|0
149307|NCT00676091|475811|P2|After Infant Series|Adverse Event|1
149308|NCT00676091|475812|P1|After Infant Series|Adverse Event|0
149309|NCT00676091|475811|P2|Infant Series|Died prior to receiving 7vPnC|1
149310|NCT00676091|475812|P1|Infant Series|Died prior to receiving 7vPnC|0
149311|NCT00676091|475811|P2|Infant Series|Lost to Follow-up|0
149312|NCT00676091|475812|P1|Infant Series|Lost to Follow-up|1
149314|NCT00676091|475812|P1|Infant Series|Failed to return|1
149315|NCT00676091|475811|P2|Infant Series|Adverse Event|3
149316|NCT00676091|475812|P1|Infant Series|Adverse Event|2
149317|NCT00676091|475811|P2|Infant Series|Protocol Violation|3
149318|NCT00676091|475812|P1|Infant Series|Protocol Violation|6
149319|NCT00676091|475811|P2|Infant Series|Parent or legal guardian request|8
149320|NCT00676091|475812|P1|Infant Series|Parent or legal guardian request|10
149321|NCT00676130|475846|P2|Overall Study|Withdrawal by Subject|1
149322|NCT00676130|475847|P1|Overall Study|Withdrawal by Subject|0
149323|NCT00676130|475846|P2|Overall Study|Found ineligible|2
149324|NCT00676130|475847|P1|Overall Study|Found ineligible|3
149325|NCT00676130|475846|P2|Overall Study|Lost to Follow-up|1
149326|NCT00676130|475847|P1|Overall Study|Lost to Follow-up|0
149327|NCT00676143|475857|P2|Overall Study|Vasogenic edema recurrence|3
149328|NCT00676143|475858|P1|Overall Study|Vasogenic edema recurrence|1
149329|NCT00676143|475857|P2|Overall Study|Participant participation unknown|4
149330|NCT00676143|475858|P1|Overall Study|Participant participation unknown|1
149331|NCT00676143|475857|P2|Overall Study|Not specified|20
149332|NCT00676143|475858|P1|Overall Study|Not specified|11
149333|NCT00676143|475857|P2|Overall Study|Loss of caregiver|3
149334|NCT00676143|475858|P1|Overall Study|Loss of caregiver|5
149335|NCT00676143|475857|P2|Overall Study|Failed to return|1
149336|NCT00676143|475858|P1|Overall Study|Failed to return|2
149337|NCT00676143|475857|P2|Overall Study|Discontinuation of study by sponsor|88
149338|NCT00676143|475858|P1|Overall Study|Discontinuation of study by sponsor|65
149339|NCT00676143|475857|P2|Overall Study|Withdrawal by Subject|42
149340|NCT00676143|475858|P1|Overall Study|Withdrawal by Subject|24
149341|NCT00676143|475857|P2|Overall Study|Protocol Violation|8
149342|NCT00676143|475858|P1|Overall Study|Protocol Violation|4
149343|NCT00676143|475857|P2|Overall Study|Physician Decision|8
149344|NCT00676143|475858|P1|Overall Study|Physician Decision|5
149345|NCT00676143|475857|P2|Overall Study|Lost to Follow-up|13
149346|NCT00676143|475858|P1|Overall Study|Lost to Follow-up|0
149347|NCT00676143|475857|P2|Overall Study|Lack of Efficacy|6
149348|NCT00676143|475858|P1|Overall Study|Lack of Efficacy|0
149349|NCT00676143|475857|P2|Overall Study|Death|4
149350|NCT00676143|475858|P1|Overall Study|Death|4
149351|NCT00676143|475857|P2|Overall Study|Adverse Event|60
149352|NCT00676143|475858|P1|Overall Study|Adverse Event|34
149353|NCT00676195|475911|P1|Overall Study|Physician Decision|1
149354|NCT00676195|475911|P1|Overall Study|Adverse Event|1
149355|NCT00676195|475911|P1|Overall Study|Lost to Follow-up|1
149356|NCT00676208|475921|P2|Overall Study|Incomplete data|4
149357|NCT00676208|475922|P1|Overall Study|Incomplete data|2
149358|NCT00676208|475921|P2|Overall Study|Lost to Follow-up|2
149359|NCT00676208|475922|P1|Overall Study|Lost to Follow-up|0
149360|NCT00676338|475934|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
149361|NCT00676338|475935|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
149362|NCT00676338|475936|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
149363|NCT00676338|475937|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
149364|NCT00676338|475934|P4|Overall Study|Entry Criteria Not Met|1
149365|NCT00676338|475935|P3|Overall Study|Entry Criteria Not Met|1
149366|NCT00676338|475936|P2|Overall Study|Entry Criteria Not Met|2
149367|NCT00676338|475937|P1|Overall Study|Entry Criteria Not Met|0
149368|NCT00676338|475934|P4|Overall Study|Withdrawal by Subject|6
149369|NCT00676338|475935|P3|Overall Study|Withdrawal by Subject|12
149370|NCT00676338|475936|P2|Overall Study|Withdrawal by Subject|9
149371|NCT00676338|475937|P1|Overall Study|Withdrawal by Subject|17
149372|NCT00676338|475934|P4|Overall Study|Protocol Violation|5
149373|NCT00676338|475935|P3|Overall Study|Protocol Violation|2
149374|NCT00676338|475936|P2|Overall Study|Protocol Violation|9
149375|NCT00676338|475937|P1|Overall Study|Protocol Violation|5
149376|NCT00676338|475934|P4|Overall Study|Physician Decision|3
149377|NCT00676338|475935|P3|Overall Study|Physician Decision|2
149378|NCT00676338|475936|P2|Overall Study|Physician Decision|3
149379|NCT00676338|475937|P1|Overall Study|Physician Decision|3
149380|NCT00676338|475934|P4|Overall Study|Lost to Follow-up|4
149381|NCT00676338|475935|P3|Overall Study|Lost to Follow-up|3
149382|NCT00676338|475936|P2|Overall Study|Lost to Follow-up|1
149383|NCT00676338|475937|P1|Overall Study|Lost to Follow-up|4
149384|NCT00676338|475934|P4|Overall Study|Adverse Event|1
149385|NCT00676338|475935|P3|Overall Study|Adverse Event|5
149386|NCT00676338|475936|P2|Overall Study|Adverse Event|6
149387|NCT00676338|475937|P1|Overall Study|Adverse Event|6
149388|NCT00676403|476004|P6|Overall Study|Withdrawal by Subject|1
149389|NCT00676403|476005|P5|Overall Study|Withdrawal by Subject|0
149390|NCT00676403|476006|P4|Overall Study|Withdrawal by Subject|0
149391|NCT00676403|476007|P3|Overall Study|Withdrawal by Subject|0
149392|NCT00676403|476008|P2|Overall Study|Withdrawal by Subject|0
149393|NCT00676403|476009|P1|Overall Study|Withdrawal by Subject|0
149394|NCT00676403|476004|P6|Overall Study|Reason Unspecified|1
149395|NCT00676403|476005|P5|Overall Study|Reason Unspecified|0
149396|NCT00676403|476006|P4|Overall Study|Reason Unspecified|0
149397|NCT00676403|476007|P3|Overall Study|Reason Unspecified|1
149398|NCT00676403|476008|P2|Overall Study|Reason Unspecified|0
149399|NCT00676403|476009|P1|Overall Study|Reason Unspecified|1
149400|NCT00676403|476004|P6|Overall Study|Lost to Follow-up|1
149401|NCT00676403|476005|P5|Overall Study|Lost to Follow-up|0
149402|NCT00676403|476006|P4|Overall Study|Lost to Follow-up|0
149403|NCT00676403|476007|P3|Overall Study|Lost to Follow-up|0
149404|NCT00676403|476008|P2|Overall Study|Lost to Follow-up|0
149405|NCT00676403|476009|P1|Overall Study|Lost to Follow-up|0
149406|NCT00676403|476004|P6|Overall Study|Adverse Event|2
149407|NCT00676403|476005|P5|Overall Study|Adverse Event|1
149408|NCT00676403|476006|P4|Overall Study|Adverse Event|5
149409|NCT00676403|476007|P3|Overall Study|Adverse Event|0
149410|NCT00676403|476008|P2|Overall Study|Adverse Event|2
149411|NCT00676403|476009|P1|Overall Study|Adverse Event|1
149412|NCT00676494|476142|P1|Overall Study|Withdrawal by Subject|6
149413|NCT00676494|476142|P1|Overall Study|Missed Visit|8
149414|NCT00676520|476148|P1|Overall Study|Other Reason|18
149415|NCT00676520|476148|P1|Overall Study|Ineligible for Randomization to DAPT|209
149416|NCT00676520|476148|P1|Overall Study|Physician Decision|20
149417|NCT00676520|476148|P1|Overall Study|Death|159
149418|NCT00676520|476148|P1|Overall Study|Lost to Follow-up|162
149419|NCT00676520|476148|P1|Overall Study|Withdrawal by Subject|163
149420|NCT00676650|476220|P2|Overall Study|Randomized but not treated|4
149421|NCT00676650|476221|P1|Overall Study|Randomized but not treated|3
149422|NCT00676650|476220|P2|Overall Study|Withdrawal by Subject|24
149423|NCT00676650|476221|P1|Overall Study|Withdrawal by Subject|48
149424|NCT00676650|476220|P2|Overall Study|Study terminated by sponsor|43
149425|NCT00676650|476221|P1|Overall Study|Study terminated by sponsor|57
149426|NCT00676650|476220|P2|Overall Study|Protocol Violation|1
149427|NCT00676650|476221|P1|Overall Study|Protocol Violation|3
149428|NCT00676650|476220|P2|Overall Study|Unspecified|10
149429|NCT00676650|476221|P1|Overall Study|Unspecified|14
149430|NCT00676650|476220|P2|Overall Study|Objective progression or relapse|140
149431|NCT00676650|476221|P1|Overall Study|Objective progression or relapse|189
149432|NCT00676650|476220|P2|Overall Study|Lost to Follow-up|1
149433|NCT00676650|476221|P1|Overall Study|Lost to Follow-up|0
149434|NCT00676650|476220|P2|Overall Study|Global deterioration of health status|31
149435|NCT00676650|476221|P1|Overall Study|Global deterioration of health status|66
149436|NCT00676650|476220|P2|Overall Study|Adverse Event|21
149437|NCT00676650|476221|P1|Overall Study|Adverse Event|159
149438|NCT00676650|476220|P2|Overall Study|Death|14
149439|NCT00676650|476221|P1|Overall Study|Death|45
149440|NCT00676689|476243|P1|Overall Study|Continuing FU|49
149441|NCT00676689|476243|P1|Overall Study|Withdrawal by Subject|3
149442|NCT00676689|476243|P1|Overall Study|Physician Decision|1
149443|NCT00676689|476243|P1|Overall Study|Lost to Follow-up|4
149444|NCT00676689|476243|P1|Overall Study|Death|2
149445|NCT00676689|476243|P1|Overall Study|Screen Failure|2
149446|NCT00676715|476253|P4|Overall Study|Participants Ongoing|24
149447|NCT00676715|476254|P3|Overall Study|Participants Ongoing|17
149448|NCT00676715|476255|P2|Overall Study|Participants Ongoing|29
149449|NCT00676715|476256|P1|Overall Study|Participants Ongoing|29
149450|NCT00676715|476253|P4|Overall Study|Adverse Event|0
149451|NCT00676715|476254|P3|Overall Study|Adverse Event|2
149452|NCT00676715|476255|P2|Overall Study|Adverse Event|1
149453|NCT00676715|476256|P1|Overall Study|Adverse Event|0
149454|NCT00676715|476253|P4|Overall Study|Death|0
149455|NCT00676715|476254|P3|Overall Study|Death|1
149456|NCT00676715|476255|P2|Overall Study|Death|1
149457|NCT00676715|476256|P1|Overall Study|Death|1
149458|NCT00676715|476253|P4|Overall Study|Lost to Follow-up|3
149459|NCT00676715|476254|P3|Overall Study|Lost to Follow-up|7
149460|NCT00676715|476255|P2|Overall Study|Lost to Follow-up|1
149461|NCT00676715|476256|P1|Overall Study|Lost to Follow-up|1
149462|NCT00676715|476253|P4|Overall Study|Unspecified|3
149463|NCT00676715|476254|P3|Overall Study|Unspecified|4
149464|NCT00676715|476255|P2|Overall Study|Unspecified|6
149465|NCT00676715|476256|P1|Overall Study|Unspecified|2
149466|NCT00676715|476253|P4|Overall Study|Withdrawal by Subject|10
149467|NCT00676715|476254|P3|Overall Study|Withdrawal by Subject|10
149468|NCT00676715|476255|P2|Overall Study|Withdrawal by Subject|9
149469|NCT00676715|476256|P1|Overall Study|Withdrawal by Subject|7
149470|NCT00677014|476330|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
149471|NCT00677014|476331|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
149472|NCT00677014|476332|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
149473|NCT00677014|476330|P3|Overall Study|Death|7
149474|NCT00677014|476331|P2|Overall Study|Death|15
149475|NCT00677014|476332|P1|Overall Study|Death|6
149476|NCT00677014|476330|P3|Overall Study|Lost to Follow-up|24
149477|NCT00677014|476331|P2|Overall Study|Lost to Follow-up|12
149478|NCT00677014|476332|P1|Overall Study|Lost to Follow-up|20
149479|NCT00677092|476340|P1|Overall Study|Death Prior to Receiving Treatment|1
149480|NCT00677092|476340|P1|Overall Study|Withdrawal by Subject|3
149481|NCT00677092|476340|P1|Overall Study|Lost to Follow-up|1
149482|NCT00677092|476340|P1|Overall Study|Adverse Event|1
149483|NCT00677235|476351|P2|Overall Study|Adverse Experience|0
149484|NCT00677235|476352|P1|Overall Study|Adverse Experience|1
149485|NCT00677235|476351|P2|Overall Study|Death|36
149486|NCT00677235|476352|P1|Overall Study|Death|37
149487|NCT00677235|476351|P2|Overall Study|Lost to Follow-up|1
149488|NCT00677235|476352|P1|Overall Study|Lost to Follow-up|2
149489|NCT00677235|476351|P2|Overall Study|Withdrawal by Subject|1
149490|NCT00677235|476352|P1|Overall Study|Withdrawal by Subject|1
149491|NCT00677352|476394|P2|Tapering Phase|Job transfer|1
149492|NCT00677352|476395|P1|Tapering Phase|Job transfer|0
149493|NCT00677352|476394|P2|Tapering Phase|Pregnancy|1
149494|NCT00677352|476395|P1|Tapering Phase|Pregnancy|0
149495|NCT00677352|476394|P2|Tapering Phase|Withdrawal by Subject|3
149496|NCT00677352|476395|P1|Tapering Phase|Withdrawal by Subject|5
149497|NCT00677352|476394|P2|Tapering Phase|Adverse Event|5
149498|NCT00677352|476395|P1|Tapering Phase|Adverse Event|1
149499|NCT00677352|476394|P2|Treatment Phase|Not treated|2
149500|NCT00677352|476395|P1|Treatment Phase|Not treated|0
149501|NCT00677352|476394|P2|Treatment Phase|Transference or work related matter|5
149502|NCT00677352|476395|P1|Treatment Phase|Transference or work related matter|0
149503|NCT00677352|476394|P2|Treatment Phase|Protocol Violation|1
149504|NCT00677352|476395|P1|Treatment Phase|Protocol Violation|1
149505|NCT00677352|476394|P2|Treatment Phase|Pregnancy|1
149506|NCT00677352|476395|P1|Treatment Phase|Pregnancy|0
149507|NCT00677352|476394|P2|Treatment Phase|Physician Decision|0
149508|NCT00677352|476395|P1|Treatment Phase|Physician Decision|1
149509|NCT00677352|476394|P2|Treatment Phase|Withdrawal by Subject|7
149510|NCT00677352|476395|P1|Treatment Phase|Withdrawal by Subject|7
149511|NCT00677352|476394|P2|Treatment Phase|Lost to Follow-up|1
149512|NCT00677352|476395|P1|Treatment Phase|Lost to Follow-up|0
149513|NCT00677352|476394|P2|Treatment Phase|Lack of Efficacy|3
149514|NCT00677352|476395|P1|Treatment Phase|Lack of Efficacy|2
149515|NCT00677352|476394|P2|Treatment Phase|Adverse Event|22
149516|NCT00677352|476395|P1|Treatment Phase|Adverse Event|14
149517|NCT00677365|476417|P4|Overall Study|Other reason|1
149518|NCT00677365|476418|P3|Overall Study|Other reason|0
149519|NCT00677365|476419|P2|Overall Study|Other reason|0
149520|NCT00677365|476420|P1|Overall Study|Other reason|0
149521|NCT00677365|476417|P4|Overall Study|Withdrawal by Subject|0
149522|NCT00677365|476418|P3|Overall Study|Withdrawal by Subject|1
149523|NCT00677365|476419|P2|Overall Study|Withdrawal by Subject|0
149524|NCT00677365|476420|P1|Overall Study|Withdrawal by Subject|0
149525|NCT00677365|476417|P4|Overall Study|Adverse Event|2
149526|NCT00677365|476418|P3|Overall Study|Adverse Event|1
149527|NCT00677365|476419|P2|Overall Study|Adverse Event|1
149528|NCT00677365|476420|P1|Overall Study|Adverse Event|2
149529|NCT00677534|476450|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
149530|NCT00677534|476450|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
149531|NCT00677534|476450|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
149532|NCT00670449|476475|P4|Overall Study|Abnormal Laboratory Value(s)|0
149533|NCT00670449|476476|P3|Overall Study|Abnormal Laboratory Value(s)|0
149534|NCT00670449|476477|P2|Overall Study|Abnormal Laboratory Value(s)|2
149535|NCT00670449|476478|P1|Overall Study|Abnormal Laboratory Value(s)|0
149536|NCT00670449|476475|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
149537|NCT00670449|476476|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
149538|NCT00670449|476477|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
149539|NCT00670449|476478|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
149540|NCT00670449|476475|P4|Overall Study|Subject Withdrew Consent|1
149541|NCT00670449|476476|P3|Overall Study|Subject Withdrew Consent|0
149542|NCT00670449|476477|P2|Overall Study|Subject Withdrew Consent|2
149543|NCT00670449|476478|P1|Overall Study|Subject Withdrew Consent|0
149544|NCT00670449|476475|P4|Overall Study|Administrative Problems|1
149545|NCT00670449|476476|P3|Overall Study|Administrative Problems|0
149546|NCT00670449|476477|P2|Overall Study|Administrative Problems|2
149547|NCT00670449|476478|P1|Overall Study|Administrative Problems|0
149548|NCT00670449|476475|P4|Overall Study|Protocol Deviation|1
149549|NCT00670449|476476|P3|Overall Study|Protocol Deviation|0
149550|NCT00670449|476477|P2|Overall Study|Protocol Deviation|2
149551|NCT00670449|476478|P1|Overall Study|Protocol Deviation|1
149552|NCT00670449|476475|P4|Overall Study|Adverse Event|5
149553|NCT00670449|476476|P3|Overall Study|Adverse Event|8
149554|NCT00670449|476477|P2|Overall Study|Adverse Event|2
149555|NCT00670449|476478|P1|Overall Study|Adverse Event|6
149556|NCT00670540|476533|P1|Overall Study|missing information inclusion criteria|1
149557|NCT00670540|476533|P1|Overall Study|controls randomised for no follow up|2770
149558|NCT00670540|476533|P1|Overall Study|refused to participate|189
149559|NCT00670540|476533|P1|Overall Study|not living in France|348
149560|NCT00670540|476533|P1|Overall Study|ineligible|17
149561|NCT00670748|476564|P4|Overall Study|Not off study|1
149562|NCT00670748|476565|P3|Overall Study|Not off study|1
149563|NCT00670748|476566|P2|Overall Study|Not off study|1
149564|NCT00670748|476567|P1|Overall Study|Not off study|2
149565|NCT00670748|476564|P4|Overall Study|Death during treatment|0
149566|NCT00670748|476565|P3|Overall Study|Death during treatment|1
149567|NCT00670748|476566|P2|Overall Study|Death during treatment|1
149568|NCT00670748|476567|P1|Overall Study|Death during treatment|1
149569|NCT00670800|476587|P2|Overall Study|2 controls were insulin resistant|2
149570|NCT00670800|476588|P1|Overall Study|2 controls were insulin resistant|0
149571|NCT00677807|476607|P3|Overall Study|Protocol Deviation|0
149572|NCT00677807|476608|P2|Overall Study|Protocol Deviation|3
149573|NCT00677807|476609|P1|Overall Study|Protocol Deviation|1
149574|NCT00677807|476607|P3|Overall Study|Death|1
149575|NCT00677807|476608|P2|Overall Study|Death|1
149576|NCT00677807|476609|P1|Overall Study|Death|0
149577|NCT00677807|476607|P3|Overall Study|Administrative problems|2
149578|NCT00677807|476608|P2|Overall Study|Administrative problems|1
149579|NCT00677807|476609|P1|Overall Study|Administrative problems|1
149580|NCT00677807|476607|P3|Overall Study|Lost to Follow-up|2
149581|NCT00677807|476608|P2|Overall Study|Lost to Follow-up|2
149582|NCT00677807|476609|P1|Overall Study|Lost to Follow-up|2
149583|NCT00677807|476607|P3|Overall Study|Withdrawal by Subject|6
149584|NCT00677807|476608|P2|Overall Study|Withdrawal by Subject|3
149585|NCT00677807|476609|P1|Overall Study|Withdrawal by Subject|10
149586|NCT00677807|476607|P3|Overall Study|Participant no longer needs study drug|1
149587|NCT00677807|476608|P2|Overall Study|Participant no longer needs study drug|0
149588|NCT00677807|476609|P1|Overall Study|Participant no longer needs study drug|0
149589|NCT00677807|476607|P3|Overall Study|Lack of Efficacy|2
149590|NCT00677807|476608|P2|Overall Study|Lack of Efficacy|0
149591|NCT00677807|476609|P1|Overall Study|Lack of Efficacy|0
149592|NCT00677807|476607|P3|Overall Study|Adverse Event|6
149593|NCT00677807|476608|P2|Overall Study|Adverse Event|1
149594|NCT00677807|476609|P1|Overall Study|Adverse Event|4
149595|NCT00677820|476640|P2|Overall Study|Lost to Follow-up|0
149596|NCT00677820|476641|P1|Overall Study|Lost to Follow-up|1
149597|NCT00677833|476663|P4|Overall Study|Lost to Follow-up|0
149598|NCT00677833|476664|P3|Overall Study|Lost to Follow-up|1
149599|NCT00677833|476665|P2|Overall Study|Lost to Follow-up|0
149600|NCT00677833|476666|P1|Overall Study|Lost to Follow-up|0
149601|NCT00677833|476663|P4|Overall Study|Withdrawal by Subject|3
149602|NCT00677833|476664|P3|Overall Study|Withdrawal by Subject|1
149603|NCT00677833|476665|P2|Overall Study|Withdrawal by Subject|0
149604|NCT00677833|476666|P1|Overall Study|Withdrawal by Subject|4
149605|NCT00678041|476753|P2|Overall Study|Physician Decision|5
149606|NCT00678041|476754|P1|Overall Study|Physician Decision|5
149607|NCT00679055|476768|P2|Overall Study|Study Terminated|1
149608|NCT00679055|476769|P1|Overall Study|Study Terminated|2
149609|NCT00679055|476768|P2|Overall Study|Other|3
149610|NCT00679055|476769|P1|Overall Study|Other|0
149611|NCT00679055|476768|P2|Overall Study|Adverse Event|1
149612|NCT00679055|476769|P1|Overall Study|Adverse Event|0
149613|NCT00679081|476779|P1|Overall Study|Lost to Follow-up|1
149614|NCT00679172|476792|P5|Overall Study|Other not specified|0
149615|NCT00679172|476793|P4|Overall Study|Other not specified|0
149616|NCT00679172|476794|P3|Overall Study|Other not specified|1
149617|NCT00679172|476795|P2|Overall Study|Other not specified|0
149618|NCT00679172|476796|P1|Overall Study|Other not specified|0
149619|NCT00679172|476792|P5|Overall Study|Non-compliance|0
149620|NCT00679172|476793|P4|Overall Study|Non-compliance|1
149621|NCT00679172|476794|P3|Overall Study|Non-compliance|0
149622|NCT00679172|476795|P2|Overall Study|Non-compliance|1
149623|NCT00679172|476796|P1|Overall Study|Non-compliance|1
149624|NCT00679211|476859|P1|Overall Study|Other|1
149625|NCT00679211|476859|P1|Overall Study|Transferred to extension study TDM4529g|12
149626|NCT00679211|476859|P1|Overall Study|Refused to undergo protocol procedures|1
149627|NCT00679211|476859|P1|Overall Study|Physician Decision|5
149628|NCT00679211|476859|P1|Overall Study|Withdrawal by Subject|2
149629|NCT00679211|476859|P1|Overall Study|Adverse Event|7
149630|NCT00679211|476859|P1|Overall Study|Progressive disease|82
149631|NCT00679263|476874|P3|Visit 2/Dose 1|subject not compliance|0
149632|NCT00679263|476875|P2|Visit 2/Dose 1|subject not compliance|1
149633|NCT00679263|476876|P1|Visit 2/Dose 1|subject not compliance|1
149634|NCT00679263|476874|P3|Visit 2/Dose 1|Adverse Event|0
149635|NCT00679263|476875|P2|Visit 2/Dose 1|Adverse Event|0
149636|NCT00679263|476876|P1|Visit 2/Dose 1|Adverse Event|1
149637|NCT00679302|476889|P2|Overall Study|Lost to Follow-up|4
149638|NCT00679302|476890|P1|Overall Study|Lost to Follow-up|8
149639|NCT00679341|476900|P2|Overall Study|Physician/patient decision to withdraw|6
149640|NCT00679341|476901|P1|Overall Study|Physician/patient decision to withdraw|0
149641|NCT00679341|476900|P2|Overall Study|Not treated|2
149642|NCT00679341|476901|P1|Overall Study|Not treated|0
149643|NCT00679341|476900|P2|Overall Study|Physician Decision|0
149644|NCT00679341|476901|P1|Overall Study|Physician Decision|1
149645|NCT00679341|476900|P2|Overall Study|Not specified|0
149646|NCT00679341|476901|P1|Overall Study|Not specified|1
149647|NCT00679341|476900|P2|Overall Study|Death|1
149648|NCT00679341|476901|P1|Overall Study|Death|1
149649|NCT00679341|476900|P2|Overall Study|Subject/guardian decision to discontinue|0
149650|NCT00679341|476901|P1|Overall Study|Subject/guardian decision to discontinue|3
149651|NCT00679341|476900|P2|Overall Study|Adverse Event|6
149652|NCT00679341|476901|P1|Overall Study|Adverse Event|5
149653|NCT00679341|476900|P2|Overall Study|Disease progression|36
149654|NCT00679341|476901|P1|Overall Study|Disease progression|42
149655|NCT00679354|476919|P1|Overall Study|Ineligible|1
149656|NCT00679354|476919|P1|Overall Study|Physician Decision|4
149657|NCT00679354|476919|P1|Overall Study|Lack of Efficacy|22
149658|NCT00679354|476919|P1|Overall Study|Death|3
149659|NCT00679367|476923|P1|Overall Study|Withdrawal by Subject|1
149660|NCT00679367|476923|P1|Overall Study|Lack of Efficacy|3
149661|NCT00679367|476923|P1|Overall Study|inability to swallow oral drugs|1
149662|NCT00679367|476923|P1|Overall Study|Adverse Event|7
149663|NCT00679432|476958|P4|Overall Study|Randomization error, return to prior Rx|0
149664|NCT00679432|476959|P3|Overall Study|Randomization error, return to prior Rx|3
149665|NCT00679432|476960|P2|Overall Study|Randomization error, return to prior Rx|0
149666|NCT00679432|476961|P1|Overall Study|Randomization error, return to prior Rx|0
149667|NCT00679432|476958|P4|Overall Study|Infectious colitis, normal histology|3
149668|NCT00679432|476959|P3|Overall Study|Infectious colitis, normal histology|8
149669|NCT00679432|476960|P2|Overall Study|Infectious colitis, normal histology|4
149670|NCT00679432|476961|P1|Overall Study|Infectious colitis, normal histology|5
149671|NCT00679432|476958|P4|Overall Study|Lack of Efficacy|8
149672|NCT00679432|476959|P3|Overall Study|Lack of Efficacy|14
149673|NCT00679432|476960|P2|Overall Study|Lack of Efficacy|9
149674|NCT00679432|476961|P1|Overall Study|Lack of Efficacy|13
149675|NCT00679432|476958|P4|Overall Study|Sponsor decision|0
149676|NCT00679432|476959|P3|Overall Study|Sponsor decision|0
149677|NCT00679432|476960|P2|Overall Study|Sponsor decision|0
149678|NCT00679432|476961|P1|Overall Study|Sponsor decision|1
149679|NCT00679432|476958|P4|Overall Study|Physician Decision|2
149680|NCT00679432|476959|P3|Overall Study|Physician Decision|2
149681|NCT00679432|476960|P2|Overall Study|Physician Decision|2
149682|NCT00679432|476961|P1|Overall Study|Physician Decision|3
149683|NCT00679432|476958|P4|Overall Study|Lost to Follow-up|2
149684|NCT00679432|476959|P3|Overall Study|Lost to Follow-up|4
149685|NCT00679432|476960|P2|Overall Study|Lost to Follow-up|5
149686|NCT00679432|476961|P1|Overall Study|Lost to Follow-up|1
149687|NCT00679432|476958|P4|Overall Study|Withdrawal by Subject|9
149688|NCT00679432|476959|P3|Overall Study|Withdrawal by Subject|10
149689|NCT00679432|476960|P2|Overall Study|Withdrawal by Subject|11
149690|NCT00679432|476961|P1|Overall Study|Withdrawal by Subject|8
149691|NCT00679432|476958|P4|Overall Study|Protocol Violation|1
149692|NCT00679432|476959|P3|Overall Study|Protocol Violation|2
149693|NCT00679432|476960|P2|Overall Study|Protocol Violation|1
149694|NCT00679432|476961|P1|Overall Study|Protocol Violation|1
149695|NCT00679432|476958|P4|Overall Study|Adverse Event|7
149696|NCT00679432|476959|P3|Overall Study|Adverse Event|10
149697|NCT00679432|476960|P2|Overall Study|Adverse Event|6
149698|NCT00679432|476961|P1|Overall Study|Adverse Event|5
149699|NCT00679627|476981|P2|Overall Study|Early Study Closure|405
149700|NCT00679627|476982|P1|Overall Study|Early Study Closure|425
149701|NCT00679627|476981|P2|Overall Study|Lost to Follow-up|26
149702|NCT00679627|476982|P1|Overall Study|Lost to Follow-up|22
149703|NCT00679627|476981|P2|Overall Study|Withdrawal by Subject|172
149704|NCT00679627|476982|P1|Overall Study|Withdrawal by Subject|168
149705|NCT00679627|476981|P2|Overall Study|Adverse Event|53
149706|NCT00679627|476982|P1|Overall Study|Adverse Event|43
149707|NCT00679627|476981|P2|Overall Study|Death|29
149708|NCT00679627|476982|P1|Overall Study|Death|41
149709|NCT00679783|477011|P7|Overall Study|Ongoing at data cut-off|0
149710|NCT00679783|477012|P6|Overall Study|Ongoing at data cut-off|0
149711|NCT00679783|477013|P5|Overall Study|Ongoing at data cut-off|1
149712|NCT00679783|477014|P4|Overall Study|Ongoing at data cut-off|9
149713|NCT00679783|477015|P3|Overall Study|Ongoing at data cut-off|0
149714|NCT00679783|477016|P2|Overall Study|Ongoing at data cut-off|2
149715|NCT00679783|477017|P1|Overall Study|Ongoing at data cut-off|2
149716|NCT00679783|477011|P7|Overall Study|Not Captured|0
149717|NCT00679783|477012|P6|Overall Study|Not Captured|0
149718|NCT00679783|477013|P5|Overall Study|Not Captured|0
149719|NCT00679783|477014|P4|Overall Study|Not Captured|5
149720|NCT00679783|477015|P3|Overall Study|Not Captured|0
149721|NCT00679783|477016|P2|Overall Study|Not Captured|0
149722|NCT00679783|477017|P1|Overall Study|Not Captured|0
149723|NCT00679783|477011|P7|Overall Study|Withdrawal by Subject|0
149724|NCT00679783|477012|P6|Overall Study|Withdrawal by Subject|0
149725|NCT00679783|477013|P5|Overall Study|Withdrawal by Subject|0
149726|NCT00679783|477014|P4|Overall Study|Withdrawal by Subject|1
149727|NCT00679783|477015|P3|Overall Study|Withdrawal by Subject|1
149728|NCT00679783|477016|P2|Overall Study|Withdrawal by Subject|0
149729|NCT00679783|477017|P1|Overall Study|Withdrawal by Subject|0
149730|NCT00679783|477011|P7|Overall Study|Lack of Efficacy|0
149731|NCT00679783|477012|P6|Overall Study|Lack of Efficacy|0
149732|NCT00679783|477013|P5|Overall Study|Lack of Efficacy|0
149733|NCT00679783|477014|P4|Overall Study|Lack of Efficacy|2
149734|NCT00679783|477015|P3|Overall Study|Lack of Efficacy|0
149735|NCT00679783|477016|P2|Overall Study|Lack of Efficacy|1
149736|NCT00679783|477017|P1|Overall Study|Lack of Efficacy|0
149737|NCT00679783|477011|P7|Overall Study|Adverse Event|1
149738|NCT00679783|477012|P6|Overall Study|Adverse Event|0
149739|NCT00679783|477013|P5|Overall Study|Adverse Event|0
149740|NCT00679783|477014|P4|Overall Study|Adverse Event|3
149741|NCT00679783|477015|P3|Overall Study|Adverse Event|0
149742|NCT00679783|477016|P2|Overall Study|Adverse Event|0
149743|NCT00679783|477017|P1|Overall Study|Adverse Event|0
149744|NCT00679913|477070|P2|Overall Study|Protocol Violation|13
149745|NCT00679913|477071|P1|Overall Study|Protocol Violation|18
149746|NCT00679939|477081|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
149747|NCT00679939|477082|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
149748|NCT00679939|477081|P2|24-Week Open-Label (OL) Period|Physician Decision|0
149749|NCT00679939|477082|P1|24-Week Open-Label (OL) Period|Physician Decision|1
149750|NCT00679939|477081|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
149751|NCT00679939|477082|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
149752|NCT00679939|477081|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
149753|NCT00679939|477082|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
149754|NCT00679939|477081|P2|24-Week Open-Label (OL) Period|Adverse Event|1
149755|NCT00679939|477082|P1|24-Week Open-Label (OL) Period|Adverse Event|0
149756|NCT00679939|477081|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
149757|NCT00679939|477082|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
149758|NCT00679939|477081|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
149759|NCT00679939|477082|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
149760|NCT00679939|477081|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
149761|NCT00679939|477082|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
149762|NCT00679939|477081|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
149763|NCT00679939|477082|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
149764|NCT00679939|477081|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
149765|NCT00679939|477082|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
149766|NCT00680017|477242|P2|Overall Study|Lost to Follow-up|0
149767|NCT00680017|477243|P1|Overall Study|Lost to Follow-up|2
149768|NCT00680017|477242|P2|Overall Study|Withdrawal by Subject|5
149769|NCT00680017|477243|P1|Overall Study|Withdrawal by Subject|2
149770|NCT00680017|477242|P2|Overall Study|Adverse Event|7
149771|NCT00680017|477243|P1|Overall Study|Adverse Event|13
149772|NCT00680043|477254|P3|Overall Study|Renal Transplant|4
149773|NCT00680043|477255|P2|Overall Study|Renal Transplant|0
149774|NCT00680043|477256|P1|Overall Study|Renal Transplant|1
149775|NCT00680043|477254|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
149776|NCT00680043|477255|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
149777|NCT00680043|477256|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
149778|NCT00680043|477254|P3|Overall Study|Withdrawal by Subject|0
149779|NCT00680043|477255|P2|Overall Study|Withdrawal by Subject|0
149780|NCT00680043|477256|P1|Overall Study|Withdrawal by Subject|1
149781|NCT00680056|477272|P2|Second Intervention|Protocol Violation|1
149782|NCT00680056|477273|P1|Second Intervention|Protocol Violation|3
149783|NCT00680056|477272|P2|First Intervention|Mainly Exacerbation of COPD|2
149784|NCT00680056|477273|P1|First Intervention|Mainly Exacerbation of COPD|1
149785|NCT00680121|477283|P2|Overall Study|Lost to Follow-up|23
149786|NCT00680121|477284|P1|Overall Study|Lost to Follow-up|27
149787|NCT00680186|477298|P2|Overall Study|Other|1
149788|NCT00680186|477299|P1|Overall Study|Other|4
149789|NCT00680186|477298|P2|Overall Study|Withdrawal by Subject|39
149790|NCT00680186|477299|P1|Overall Study|Withdrawal by Subject|32
149791|NCT00680186|477298|P2|Overall Study|Lost to Follow-up|6
149792|NCT00680186|477299|P1|Overall Study|Lost to Follow-up|11
149793|NCT00680186|477298|P2|Overall Study|Protocol Violation|26
149794|NCT00680186|477299|P1|Overall Study|Protocol Violation|31
149795|NCT00680186|477298|P2|Overall Study|Adverse Event|44
149796|NCT00680186|477299|P1|Overall Study|Adverse Event|47
149797|NCT00680368|477343|P1|Overall Study|not supervised, not eligible|15
149798|NCT00680407|477352|P3|Overall Study|Withdrawal by Subject|2
149799|NCT00680407|477353|P2|Overall Study|Withdrawal by Subject|2
149800|NCT00680407|477354|P1|Overall Study|Withdrawal by Subject|5
149801|NCT00680407|477352|P3|Overall Study|Lost to Follow-up|1
149802|NCT00680407|477353|P2|Overall Study|Lost to Follow-up|3
149803|NCT00680407|477354|P1|Overall Study|Lost to Follow-up|3
149804|NCT00680745|477413|P4|Overall Study|False Treatment|0
149805|NCT00680745|477414|P3|Overall Study|False Treatment|3
149806|NCT00680745|477415|P2|Overall Study|False Treatment|1
149807|NCT00680745|477416|P1|Overall Study|False Treatment|0
149808|NCT00680745|477413|P4|Overall Study|Subject No Longer Meets Study Criteria|2
149809|NCT00680745|477414|P3|Overall Study|Subject No Longer Meets Study Criteria|0
149810|NCT00680745|477415|P2|Overall Study|Subject No Longer Meets Study Criteria|2
149811|NCT00680745|477416|P1|Overall Study|Subject No Longer Meets Study Criteria|0
149812|NCT00680745|477413|P4|Overall Study|Poor/Non-compliance|0
149813|NCT00680745|477414|P3|Overall Study|Poor/Non-compliance|0
149814|NCT00680745|477415|P2|Overall Study|Poor/Non-compliance|3
149815|NCT00680745|477416|P1|Overall Study|Poor/Non-compliance|0
149816|NCT00680745|477413|P4|Overall Study|Adverse Event|3
149817|NCT00680745|477414|P3|Overall Study|Adverse Event|3
149818|NCT00680745|477415|P2|Overall Study|Adverse Event|3
149819|NCT00680745|477416|P1|Overall Study|Adverse Event|5
149820|NCT00680745|477413|P4|Overall Study|Death|0
149821|NCT00680745|477414|P3|Overall Study|Death|1
149822|NCT00680745|477415|P2|Overall Study|Death|0
149823|NCT00680745|477416|P1|Overall Study|Death|1
149824|NCT00680745|477413|P4|Overall Study|Lost to Follow-up|0
149825|NCT00680745|477414|P3|Overall Study|Lost to Follow-up|1
149826|NCT00680745|477415|P2|Overall Study|Lost to Follow-up|1
149827|NCT00680745|477416|P1|Overall Study|Lost to Follow-up|0
149828|NCT00680745|477413|P4|Overall Study|Withdrawal by Subject|8
149829|NCT00680745|477414|P3|Overall Study|Withdrawal by Subject|2
149830|NCT00680745|477415|P2|Overall Study|Withdrawal by Subject|3
149831|NCT00680745|477416|P1|Overall Study|Withdrawal by Subject|8
149832|NCT00680771|477448|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
149833|NCT00680771|477449|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
149834|NCT00680771|477448|P2|Overall Study|Sleep Apnea suspected after PSG|0
149835|NCT00680771|477449|P1|Overall Study|Sleep Apnea suspected after PSG|1
149836|NCT00680771|477448|P2|Overall Study|Withdrawal by Subject|0
149837|NCT00680771|477449|P1|Overall Study|Withdrawal by Subject|1
149838|NCT00680836|477474|P2|Overall Study|Physician Decision|1
149839|NCT00680836|477475|P1|Overall Study|Physician Decision|2
149840|NCT00680836|477474|P2|Overall Study|Lost to Follow-up|1
149841|NCT00680836|477475|P1|Overall Study|Lost to Follow-up|3
149842|NCT00680836|477474|P2|Overall Study|Withdrawal by Subject|0
149843|NCT00680836|477475|P1|Overall Study|Withdrawal by Subject|3
149844|NCT00680901|477497|P2|Overall Study|Ongoing: In Follow Up|41
149845|NCT00680901|477498|P1|Overall Study|Ongoing: In Follow Up|45
149846|NCT00680901|477497|P2|Overall Study|Ongoing: On Study Treatment|13
149847|NCT00680901|477498|P1|Overall Study|Ongoing: On Study Treatment|16
149848|NCT00680901|477497|P2|Overall Study|Physician Decision|1
149849|NCT00680901|477498|P1|Overall Study|Physician Decision|0
149850|NCT00680901|477497|P2|Overall Study|Withdrawal by Subject|13
149851|NCT00680901|477498|P1|Overall Study|Withdrawal by Subject|4
149852|NCT00680901|477497|P2|Overall Study|Lost to Follow-up|8
149853|NCT00680901|477498|P1|Overall Study|Lost to Follow-up|8
149854|NCT00680914|477532|P2|Overall Study|serious adverse event (SAE)|1
149855|NCT00680914|477533|P1|Overall Study|serious adverse event (SAE)|0
149856|NCT00680914|477532|P2|Overall Study|Lost to Follow-up|0
149857|NCT00680914|477533|P1|Overall Study|Lost to Follow-up|4
149858|NCT00680914|477532|P2|Overall Study|Consent withdrawal|3
149859|NCT00680914|477533|P1|Overall Study|Consent withdrawal|6
149860|NCT00681109|477595|P3|Overall Study|Lost to Follow-up|0
149861|NCT00681109|477596|P2|Overall Study|Lost to Follow-up|6
149862|NCT00681109|477597|P1|Overall Study|Lost to Follow-up|2
149863|NCT00681187|477607|P2|Overall Study|Adverse Event|1
149864|NCT00681187|477608|P1|Overall Study|Adverse Event|0
149865|NCT00681187|477607|P2|Overall Study|Death|1
149866|NCT00681187|477608|P1|Overall Study|Death|0
149867|NCT00681187|477607|P2|Overall Study|Withdrawal by Subject|0
149868|NCT00681187|477608|P1|Overall Study|Withdrawal by Subject|1
149869|NCT00673816|477691|P1|Overall Study|Withdrawal by Subject|1
149870|NCT00673816|477691|P1|Overall Study|Adverse Event|1
149871|NCT00673881|477705|P1|Overall Study|Withdrawal by Subject|1
149872|NCT00673933|477712|P1|Overall Study|Lost to Follow-up|1
149873|NCT00673933|477712|P1|Overall Study|Withdrawal by Subject|2
149874|NCT00674128|477749|P2|Overall Study|Withdrawal by Subject|23
149875|NCT00674128|477750|P1|Overall Study|Withdrawal by Subject|25
149876|NCT00674154|477758|P2|Overall Study|Did not want parathyroidectomy|2
149877|NCT00674154|477759|P1|Overall Study|Did not want parathyroidectomy|0
149878|NCT00674154|477758|P2|Overall Study|Withdrawal by Subject|1
149879|NCT00674154|477759|P1|Overall Study|Withdrawal by Subject|3
149880|NCT00674323|477773|P3|Overall Study|Protocol Violation|0
149881|NCT00674323|477774|P2|Overall Study|Protocol Violation|0
149882|NCT00674323|477775|P1|Overall Study|Protocol Violation|1
149883|NCT00674323|477773|P3|Overall Study|Adverse Event|0
149884|NCT00674323|477774|P2|Overall Study|Adverse Event|1
149885|NCT00674323|477775|P1|Overall Study|Adverse Event|0
149886|NCT00674362|477794|P2|Open Label|Other: Subject moved to extension study|0
149887|NCT00674362|477795|P1|Open Label|Other: Subject moved to extension study|1
149888|NCT00674362|477794|P2|Open Label|Adverse Event|0
149889|NCT00674362|477795|P1|Open Label|Adverse Event|1
149890|NCT00674362|477794|P2|Double Blind|Other: Surgery|1
149891|NCT00674362|477795|P1|Double Blind|Other: Surgery|0
149892|NCT00674362|477794|P2|Double Blind|Other: Loss of Patient Compliance|1
149893|NCT00674362|477795|P1|Double Blind|Other: Loss of Patient Compliance|0
149894|NCT00674362|477794|P2|Double Blind|Withdrawal by Subject|3
149895|NCT00674362|477795|P1|Double Blind|Withdrawal by Subject|4
149896|NCT00674362|477794|P2|Double Blind|Loss of efficacy|1
149897|NCT00674362|477795|P1|Double Blind|Loss of efficacy|0
149898|NCT00674362|477794|P2|Double Blind|Lack of Efficacy|6
149899|NCT00674362|477795|P1|Double Blind|Lack of Efficacy|2
149900|NCT00674362|477794|P2|Double Blind|Adverse Event|6
149901|NCT00674362|477795|P1|Double Blind|Adverse Event|6
149902|NCT00674661|477947|P2|Overall Study|Withdrawal by Subject|5
149903|NCT00674661|477948|P1|Overall Study|Withdrawal by Subject|0
149904|NCT00674661|477947|P2|Overall Study|Lost to Follow-up|3
149905|NCT00674661|477948|P1|Overall Study|Lost to Follow-up|6
149906|NCT00674661|477947|P2|Overall Study|not specified|7
149907|NCT00674661|477948|P1|Overall Study|not specified|5
149908|NCT00674700|477957|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
149909|NCT00674700|477958|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
149910|NCT00674700|477959|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
149911|NCT00674700|477957|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
149912|NCT00674700|477958|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
149913|NCT00674700|477959|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
149914|NCT00674700|477957|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
149915|NCT00674700|477958|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
149916|NCT00674700|477959|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
149917|NCT00674700|477957|P3|Year 1|Any other reason not above-mentioned|6
149918|NCT00674700|477958|P2|Year 1|Any other reason not above-mentioned|7
149919|NCT00674700|477959|P1|Year 1|Any other reason not above-mentioned|7
149920|NCT00674700|477957|P3|Year 1|Withdrawal by Subject|6
149921|NCT00674700|477958|P2|Year 1|Withdrawal by Subject|7
149922|NCT00674700|477959|P1|Year 1|Withdrawal by Subject|7
149923|NCT00674700|477957|P3|Year 1|Adverse Event|5
149924|NCT00674700|477958|P2|Year 1|Adverse Event|20
149925|NCT00674700|477959|P1|Year 1|Adverse Event|17
149926|NCT00674817|477998|P1|Period 4|Adverse Event|1
149927|NCT00674817|477998|P1|Period 3|Protocol Violation|1
149928|NCT00674817|477998|P1|Period 3|Adverse Event|1
149929|NCT00674817|477998|P1|Period 1|Protocol Violation|1
149930|NCT00674817|477998|P1|Period 1|Withdrawal by Subject|2
149931|NCT00674973|478146|P2|Overall Study|Protocol Violation|1
149932|NCT00674973|478147|P1|Overall Study|Protocol Violation|0
149933|NCT00674973|478146|P2|Overall Study|Death|15
149934|NCT00674973|478147|P1|Overall Study|Death|19
149935|NCT00674973|478146|P2|Overall Study|Adverse Event|9
149936|NCT00674973|478147|P1|Overall Study|Adverse Event|2
149937|NCT00674973|478146|P2|Overall Study|Failure to Return|0
149938|NCT00674973|478147|P1|Overall Study|Failure to Return|1
149939|NCT00674973|478146|P2|Overall Study|Refused Treatment|5
149940|NCT00674973|478147|P1|Overall Study|Refused Treatment|1
149941|NCT00674973|478146|P2|Overall Study|Insufficient Therapeutic Response|72
149942|NCT00674973|478147|P1|Overall Study|Insufficient Therapeutic Response|77
149943|NCT00674986|478163|P2|Overall Study|Other reasons|8
149944|NCT00674986|478164|P1|Overall Study|Other reasons|4
149945|NCT00674986|478163|P2|Overall Study|Lost to Follow-up|53
149946|NCT00674986|478164|P1|Overall Study|Lost to Follow-up|25
149947|NCT00674986|478163|P2|Overall Study|Subject withdrew consent|19
149948|NCT00674986|478164|P1|Overall Study|Subject withdrew consent|12
149949|NCT00674986|478163|P2|Overall Study|Adverse Event|1
149950|NCT00674986|478164|P1|Overall Study|Adverse Event|2
149951|NCT00675103|478183|P1|Overall Study|Adverse Event|1
149952|NCT00675103|478183|P1|Overall Study|Lack of Efficacy|2
149953|NCT00681564|478229|P2|Overall Study|Death|1
149954|NCT00681564|478230|P1|Overall Study|Death|0
149955|NCT00681564|478229|P2|Overall Study|Withdrawal by Subject|1
149956|NCT00681564|478230|P1|Overall Study|Withdrawal by Subject|0
149957|NCT00681564|478229|P2|Overall Study|Lost to Follow-up|6
149958|NCT00681564|478230|P1|Overall Study|Lost to Follow-up|6
149959|NCT00681590|478260|P2|Overall Study|Withdrawal by Subject|12
149960|NCT00681590|478261|P1|Overall Study|Withdrawal by Subject|2
149961|NCT00681629|478271|P2|Overall Study|Adverse Event|0
149962|NCT00681629|478272|P1|Overall Study|Adverse Event|1
149963|NCT00681629|478271|P2|Overall Study|Study termination|2
149964|NCT00681629|478272|P1|Overall Study|Study termination|4
149965|NCT00681668|478316|P1|Overall Study|Withdrawal by Subject|1
149966|NCT00681668|478316|P1|Overall Study|Protocol Violation|1
149967|NCT00682461|478347|P2|Overall Study|Withdrawal by Subject|19
149968|NCT00682461|478348|P1|Overall Study|Withdrawal by Subject|12
149969|NCT00682461|478347|P2|Overall Study|Lost to Follow-up|5
149970|NCT00682461|478348|P1|Overall Study|Lost to Follow-up|8
149971|NCT00682461|478347|P2|Overall Study|Adverse Event|7
149972|NCT00682461|478348|P1|Overall Study|Adverse Event|5
149973|NCT00682539|478365|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
149974|NCT00682539|478366|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
149975|NCT00682539|478367|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
149976|NCT00682539|478365|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
149977|NCT00682539|478366|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
149978|NCT00682539|478367|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
149979|NCT00682643|478406|P2|Overall Study|Did Not Receive Study Drug|1
149980|NCT00682643|478407|P1|Overall Study|Did Not Receive Study Drug|1
149981|NCT00682643|478406|P2|Overall Study|Withdrawal by Subject|53
149982|NCT00682643|478407|P1|Overall Study|Withdrawal by Subject|19
149983|NCT00682643|478406|P2|Overall Study|Physician Decision|6
149984|NCT00682643|478407|P1|Overall Study|Physician Decision|2
149985|NCT00682643|478406|P2|Overall Study|Lost to Follow-up|6
149986|NCT00682643|478407|P1|Overall Study|Lost to Follow-up|1
149987|NCT00682643|478406|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
149988|NCT00682643|478407|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
149989|NCT00682643|478406|P2|Overall Study|Protocol Violation|76
149990|NCT00682643|478407|P1|Overall Study|Protocol Violation|38
149991|NCT00682643|478406|P2|Overall Study|Lack of Efficacy|0
149992|NCT00682643|478407|P1|Overall Study|Lack of Efficacy|2
149993|NCT00682643|478406|P2|Overall Study|Adverse Event|23
149994|NCT00682643|478407|P1|Overall Study|Adverse Event|12
149995|NCT00682786|478454|P2|Overall Study|Did not receive irinotecan|1
149996|NCT00682786|478455|P1|Overall Study|Did not receive irinotecan|0
149997|NCT00682786|478454|P2|Overall Study|Withdrawal by Subject|2
149998|NCT00682786|478455|P1|Overall Study|Withdrawal by Subject|2
149999|NCT00682890|478519|P2|Overall Study|heavy menstrual bleeding|0
150000|NCT00682890|478520|P1|Overall Study|heavy menstrual bleeding|1
150001|NCT00682890|478519|P2|Overall Study|subject moved away|1
150002|NCT00682890|478520|P1|Overall Study|subject moved away|0
150003|NCT00682890|478519|P2|Overall Study|Lost to Follow-up|1
150004|NCT00682890|478520|P1|Overall Study|Lost to Follow-up|1
150005|NCT00683293|478582|P2|Overall Study|Withdrawal by Subject|3
150006|NCT00683293|478583|P1|Overall Study|Withdrawal by Subject|2
150007|NCT00683384|478595|P1|Overall Study|Adverse Event|1
150008|NCT00683384|478595|P1|Overall Study|Death|1
150009|NCT00683449|478608|P5|Overall Study|Lost to Follow-up|0
150010|NCT00683449|478609|P4|Overall Study|Lost to Follow-up|0
150011|NCT00683449|478610|P3|Overall Study|Lost to Follow-up|0
150012|NCT00683449|478611|P2|Overall Study|Lost to Follow-up|1
150013|NCT00683449|478612|P1|Overall Study|Lost to Follow-up|0
150014|NCT00683475|478636|P2|Overall Study|Never Treated: Progressive Disease|0
150015|NCT00683475|478637|P1|Overall Study|Never Treated: Progressive Disease|1
150016|NCT00683475|478636|P2|Overall Study|Never Treated: Adverse Event|3
150017|NCT00683475|478637|P1|Overall Study|Never Treated: Adverse Event|2
150018|NCT00683475|478636|P2|Overall Study|Withdrawal by Subject|0
150019|NCT00683475|478637|P1|Overall Study|Withdrawal by Subject|1
150020|NCT00683592|478669|P2|Overall Study|Other|1
150021|NCT00683592|478670|P1|Overall Study|Other|1
150022|NCT00683592|478669|P2|Overall Study|Non-compliance|5
150023|NCT00683592|478670|P1|Overall Study|Non-compliance|3
150024|NCT00683592|478669|P2|Overall Study|Physician Decision|1
150025|NCT00683592|478670|P1|Overall Study|Physician Decision|0
150026|NCT00683592|478669|P2|Overall Study|Lack of Efficacy|7
150027|NCT00683592|478670|P1|Overall Study|Lack of Efficacy|3
150028|NCT00683592|478669|P2|Overall Study|Lost to Follow-up|17
150029|NCT00683592|478670|P1|Overall Study|Lost to Follow-up|17
150030|NCT00683592|478669|P2|Overall Study|Withdrawal by Subject|11
150031|NCT00683592|478670|P1|Overall Study|Withdrawal by Subject|11
150032|NCT00683592|478669|P2|Overall Study|Adverse Event|4
150033|NCT00683592|478670|P1|Overall Study|Adverse Event|12
150034|NCT00683618|478689|P3|Extension Treatment Period|Protocol Violation|0
150035|NCT00683618|478690|P2|Extension Treatment Period|Protocol Violation|0
150036|NCT00683618|478691|P1|Extension Treatment Period|Protocol Violation|1
150037|NCT00683618|478689|P3|Extension Treatment Period|Adverse Event|0
150038|NCT00683618|478690|P2|Extension Treatment Period|Adverse Event|0
150039|NCT00683618|478691|P1|Extension Treatment Period|Adverse Event|1
150040|NCT00683618|478689|P3|Extension Treatment Period|Withdrawal by Subject|0
150041|NCT00683618|478690|P2|Extension Treatment Period|Withdrawal by Subject|0
150042|NCT00683618|478691|P1|Extension Treatment Period|Withdrawal by Subject|1
150043|NCT00683618|478689|P3|Randomised Treatment Period|Reason not provided|2
150044|NCT00683618|478690|P2|Randomised Treatment Period|Reason not provided|0
150045|NCT00683618|478691|P1|Randomised Treatment Period|Reason not provided|0
150046|NCT00683618|478689|P3|Randomised Treatment Period|Adverse Event|2
150047|NCT00683618|478690|P2|Randomised Treatment Period|Adverse Event|0
150048|NCT00683618|478691|P1|Randomised Treatment Period|Adverse Event|2
150049|NCT00683618|478689|P3|Randomised Treatment Period|Protocol Violation|0
150050|NCT00683618|478690|P2|Randomised Treatment Period|Protocol Violation|1
150051|NCT00683618|478691|P1|Randomised Treatment Period|Protocol Violation|0
150052|NCT00683618|478689|P3|Randomised Treatment Period|Withdrawal by Subject|2
150053|NCT00683618|478690|P2|Randomised Treatment Period|Withdrawal by Subject|1
150054|NCT00683618|478691|P1|Randomised Treatment Period|Withdrawal by Subject|4
150055|NCT00683657|478741|P2|Overall Study|Subject Withdrew Consent|0
150056|NCT00683657|478742|P1|Overall Study|Subject Withdrew Consent|1
150057|NCT00683657|478741|P2|Overall Study|Adverse Event|1
150058|NCT00683657|478742|P1|Overall Study|Adverse Event|0
150059|NCT00683696|478758|P2|Overall Study|Death|30
150060|NCT00683696|478759|P1|Overall Study|Death|46
150061|NCT00683696|478758|P2|Overall Study|Vital status follow-up only|3
150062|NCT00683696|478759|P1|Overall Study|Vital status follow-up only|3
150063|NCT00683696|478758|P2|Overall Study|Lost to Follow-up|6
150064|NCT00683696|478759|P1|Overall Study|Lost to Follow-up|5
150065|NCT00683696|478758|P2|Overall Study|Withdrawn prior to study closure|28
150066|NCT00683696|478759|P1|Overall Study|Withdrawn prior to study closure|13
150067|NCT00683696|478758|P2|Overall Study|Withdrawn due to study closure|338
150068|NCT00683696|478759|P1|Overall Study|Withdrawn due to study closure|337
150069|NCT00683774|478768|P2|Overall Study|Physician Decision|0
150070|NCT00683774|478769|P1|Overall Study|Physician Decision|3
150071|NCT00683774|478768|P2|Overall Study|Withdrawal by Subject|1
150072|NCT00683774|478769|P1|Overall Study|Withdrawal by Subject|0
150073|NCT00683787|478780|P3|Overall Study|Adverse Event|2
150074|NCT00683787|478781|P2|Overall Study|Adverse Event|0
150075|NCT00683787|478782|P1|Overall Study|Adverse Event|0
150076|NCT00683787|478780|P3|Overall Study|Progression|0
150077|NCT00683787|478781|P2|Overall Study|Progression|3
150078|NCT00683787|478782|P1|Overall Study|Progression|3
150079|NCT00683800|478801|P2|Overall Study|Randomized, not treated|33
150080|NCT00683800|478802|P1|Overall Study|Randomized, not treated|35
150081|NCT00683800|478801|P2|Overall Study|Lack of Efficacy|104
150082|NCT00683800|478802|P1|Overall Study|Lack of Efficacy|61
150083|NCT00683800|478801|P2|Overall Study|Withdrawal by Subject|64
150084|NCT00683800|478802|P1|Overall Study|Withdrawal by Subject|66
150085|NCT00683800|478801|P2|Overall Study|Protocol Violation|16
150086|NCT00683800|478802|P1|Overall Study|Protocol Violation|13
150087|NCT00683800|478801|P2|Overall Study|Unspecified|2
150088|NCT00683800|478802|P1|Overall Study|Unspecified|5
150089|NCT00683800|478801|P2|Overall Study|Lost to Follow-up|44
150090|NCT00683800|478802|P1|Overall Study|Lost to Follow-up|57
150091|NCT00683800|478801|P2|Overall Study|Death|1
150092|NCT00683800|478802|P1|Overall Study|Death|0
150093|NCT00683800|478801|P2|Overall Study|Adverse Event|102
150094|NCT00683800|478802|P1|Overall Study|Adverse Event|195
150095|NCT00683878|478915|P3|Overall Study|Non-compliance, not met criteria etc.|0
150096|NCT00683878|478916|P2|Overall Study|Non-compliance, not met criteria etc.|2
150097|NCT00683878|478917|P1|Overall Study|Non-compliance, not met criteria etc.|3
150098|NCT00683878|478915|P3|Overall Study|Lost to Follow-up|4
150099|NCT00683878|478916|P2|Overall Study|Lost to Follow-up|2
150100|NCT00683878|478917|P1|Overall Study|Lost to Follow-up|4
150101|NCT00683878|478915|P3|Overall Study|Death|0
150102|NCT00683878|478916|P2|Overall Study|Death|1
150103|NCT00683878|478917|P1|Overall Study|Death|0
150104|NCT00683878|478915|P3|Overall Study|Withdrawal by Subject|6
150105|NCT00683878|478916|P2|Overall Study|Withdrawal by Subject|8
150106|NCT00683878|478917|P1|Overall Study|Withdrawal by Subject|9
150107|NCT00683878|478915|P3|Overall Study|Adverse Event|3
150108|NCT00683878|478916|P2|Overall Study|Adverse Event|3
150109|NCT00683878|478917|P1|Overall Study|Adverse Event|4
150110|NCT00683878|478915|P3|Overall Study|Lack of Efficacy|1
150111|NCT00683878|478916|P2|Overall Study|Lack of Efficacy|0
150112|NCT00683878|478917|P1|Overall Study|Lack of Efficacy|3
150113|NCT00683904|478945|P2|Dose Level 2|Adverse Event|2
150114|NCT00683904|478946|P1|Dose Level 2|Adverse Event|0
150115|NCT00683904|478945|P2|Dose Level 1|Adverse Event|0
150116|NCT00683904|478946|P1|Dose Level 1|Adverse Event|1
150117|NCT00683904|478945|P2|Dose Level 1|Disease progression|0
150118|NCT00683904|478946|P1|Dose Level 1|Disease progression|2
150119|NCT00683917|478982|P1|Overall Study|Study prematurely terminated|10
150120|NCT00684021|479014|P4|Overall Study|Death|0
150121|NCT00684021|479015|P3|Overall Study|Death|0
150122|NCT00684021|479016|P2|Overall Study|Death|0
150123|NCT00684021|479017|P1|Overall Study|Death|1
150124|NCT00684021|479014|P4|Overall Study|MRI not performed|2
150125|NCT00684021|479015|P3|Overall Study|MRI not performed|1
150126|NCT00684021|479016|P2|Overall Study|MRI not performed|1
150127|NCT00684021|479017|P1|Overall Study|MRI not performed|0
150128|NCT00684021|479014|P4|Overall Study|MRI Contraindicated|0
150129|NCT00684021|479015|P3|Overall Study|MRI Contraindicated|1
150130|NCT00684021|479016|P2|Overall Study|MRI Contraindicated|1
150131|NCT00684021|479017|P1|Overall Study|MRI Contraindicated|1
150132|NCT00684060|479072|P2|Overall Study|Death|1
150133|NCT00684060|479073|P1|Overall Study|Death|0
150134|NCT00684060|479072|P2|Overall Study|Unable to collect MRI|2
150135|NCT00684060|479073|P1|Overall Study|Unable to collect MRI|1
150136|NCT00684060|479072|P2|Overall Study|New stenosis identified|0
150137|NCT00684060|479073|P1|Overall Study|New stenosis identified|1
150138|NCT00684060|479072|P2|Overall Study|Lost to Follow-up|0
150139|NCT00684060|479073|P1|Overall Study|Lost to Follow-up|1
150140|NCT00684073|479093|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
150141|NCT00684073|479093|P1|Selection|request of the sponsor|1
150142|NCT00684073|479093|P1|Selection|Lost to Follow-up|1
150143|NCT00684073|479093|P1|Selection|noncompliance|1
150144|NCT00684073|479093|P1|Selection|Death|1
150145|NCT00684073|479093|P1|Selection|Selection/non-selection criteria|3
150146|NCT00684177|479122|P2|Overall Study|Other|2
150147|NCT00684177|479123|P1|Overall Study|Other|1
150148|NCT00684177|479122|P2|Overall Study|Withdrawal by Subject|2
150149|NCT00684177|479123|P1|Overall Study|Withdrawal by Subject|1
150150|NCT00684177|479122|P2|Overall Study|Physician Decision|0
150151|NCT00684177|479123|P1|Overall Study|Physician Decision|2
150152|NCT00684177|479122|P2|Overall Study|Lost to Follow-up|1
150153|NCT00684177|479123|P1|Overall Study|Lost to Follow-up|2
150154|NCT00684177|479122|P2|Overall Study|Protocol Violation|0
150155|NCT00684177|479123|P1|Overall Study|Protocol Violation|1
150156|NCT00684177|479122|P2|Overall Study|Lack of Efficacy|15
150157|NCT00684177|479123|P1|Overall Study|Lack of Efficacy|10
150158|NCT00684177|479122|P2|Overall Study|Adverse Event|3
150159|NCT00684177|479123|P1|Overall Study|Adverse Event|4
150160|NCT00684203|479145|P6|Overall Study|Did not meet protocol eligibility|0
150161|NCT00684203|479146|P5|Overall Study|Did not meet protocol eligibility|0
150162|NCT00684203|479147|P4|Overall Study|Did not meet protocol eligibility|0
150163|NCT00684203|479148|P3|Overall Study|Did not meet protocol eligibility|0
150164|NCT00684203|479149|P2|Overall Study|Did not meet protocol eligibility|1
150165|NCT00684203|479150|P1|Overall Study|Did not meet protocol eligibility|0
150166|NCT00684203|479145|P6|Overall Study|Withdrawal by Subject|0
150167|NCT00684203|479146|P5|Overall Study|Withdrawal by Subject|0
150168|NCT00684203|479147|P4|Overall Study|Withdrawal by Subject|0
150169|NCT00684203|479148|P3|Overall Study|Withdrawal by Subject|1
150170|NCT00684203|479149|P2|Overall Study|Withdrawal by Subject|2
150171|NCT00684203|479150|P1|Overall Study|Withdrawal by Subject|0
150172|NCT00684203|479145|P6|Overall Study|Protocol-defined clinical event|0
150173|NCT00684203|479146|P5|Overall Study|Protocol-defined clinical event|0
150174|NCT00684203|479147|P4|Overall Study|Protocol-defined clinical event|0
150175|NCT00684203|479148|P3|Overall Study|Protocol-defined clinical event|0
150176|NCT00684203|479149|P2|Overall Study|Protocol-defined clinical event|1
150177|NCT00684203|479150|P1|Overall Study|Protocol-defined clinical event|3
150178|NCT00684203|479145|P6|Overall Study|Adverse Event|0
150179|NCT00684203|479146|P5|Overall Study|Adverse Event|0
150180|NCT00684203|479147|P4|Overall Study|Adverse Event|0
150181|NCT00684203|479148|P3|Overall Study|Adverse Event|8
150182|NCT00684203|479149|P2|Overall Study|Adverse Event|4
150183|NCT00684203|479150|P1|Overall Study|Adverse Event|6
150184|NCT00684307|479223|P5|Overall Study|Criteria from the CSR|3
150185|NCT00684307|479224|P4|Overall Study|Criteria from the CSR|3
150186|NCT00684307|479225|P3|Overall Study|Criteria from the CSR|1
150187|NCT00684307|479226|P2|Overall Study|Criteria from the CSR|0
150188|NCT00684307|479227|P1|Overall Study|Criteria from the CSR|0
150189|NCT00684307|479223|P5|Overall Study|Participant not willing to continue|8
150190|NCT00684307|479224|P4|Overall Study|Participant not willing to continue|5
150191|NCT00684307|479225|P3|Overall Study|Participant not willing to continue|11
150192|NCT00684307|479226|P2|Overall Study|Participant not willing to continue|10
150193|NCT00684307|479227|P1|Overall Study|Participant not willing to continue|7
150194|NCT00684307|479223|P5|Overall Study|Severe non compliance to protocol|2
150195|NCT00684307|479224|P4|Overall Study|Severe non compliance to protocol|1
150196|NCT00684307|479225|P3|Overall Study|Severe non compliance to protocol|0
150197|NCT00684307|479226|P2|Overall Study|Severe non compliance to protocol|0
150198|NCT00684307|479227|P1|Overall Study|Severe non compliance to protocol|1
150199|NCT00684307|479223|P5|Overall Study|Interupted IP for more than 7 days|3
150200|NCT00684307|479224|P4|Overall Study|Interupted IP for more than 7 days|3
150201|NCT00684307|479225|P3|Overall Study|Interupted IP for more than 7 days|1
150202|NCT00684307|479226|P2|Overall Study|Interupted IP for more than 7 days|4
150203|NCT00684307|479227|P1|Overall Study|Interupted IP for more than 7 days|0
150204|NCT00684307|479223|P5|Overall Study|Incorrect enrolment or randomization|0
150205|NCT00684307|479224|P4|Overall Study|Incorrect enrolment or randomization|0
150206|NCT00684307|479225|P3|Overall Study|Incorrect enrolment or randomization|0
150207|NCT00684307|479226|P2|Overall Study|Incorrect enrolment or randomization|0
150208|NCT00684307|479227|P1|Overall Study|Incorrect enrolment or randomization|4
150209|NCT00684307|479223|P5|Overall Study|Fullfillment of exclusion criteria|1
150210|NCT00684307|479224|P4|Overall Study|Fullfillment of exclusion criteria|3
150211|NCT00684307|479225|P3|Overall Study|Fullfillment of exclusion criteria|0
150212|NCT00684307|479226|P2|Overall Study|Fullfillment of exclusion criteria|0
150213|NCT00684307|479227|P1|Overall Study|Fullfillment of exclusion criteria|1
150214|NCT00684307|479223|P5|Overall Study|Development of increasing Liver Function|0
150215|NCT00684307|479224|P4|Overall Study|Development of increasing Liver Function|1
150216|NCT00684307|479225|P3|Overall Study|Development of increasing Liver Function|0
150217|NCT00684307|479226|P2|Overall Study|Development of increasing Liver Function|2
150218|NCT00684307|479227|P1|Overall Study|Development of increasing Liver Function|0
150219|NCT00684307|479223|P5|Overall Study|Adverse Event|8
150220|NCT00684307|479224|P4|Overall Study|Adverse Event|16
150221|NCT00684307|479225|P3|Overall Study|Adverse Event|15
150222|NCT00684307|479226|P2|Overall Study|Adverse Event|6
150223|NCT00684307|479227|P1|Overall Study|Adverse Event|11
150224|NCT00684411|479305|P1|Overall Study|Adverse Event|1
150225|NCT00684411|479305|P1|Overall Study|Disease Progression|10
150226|NCT00684411|479305|P1|Overall Study|New Primary Cancer|1
150227|NCT00684424|479311|P1|Overall Study|Not Specified|2
150228|NCT00684424|479311|P1|Overall Study|Lost to Follow-up|2
150229|NCT00684424|479311|P1|Overall Study|Adverse Event|1
150230|NCT00684515|479329|P3|Overall Study|Protocol-Defined Clinical Event|0
150231|NCT00684515|479330|P2|Overall Study|Protocol-Defined Clinical Event|0
150232|NCT00684515|479331|P1|Overall Study|Protocol-Defined Clinical Event|1
150233|NCT00684515|479329|P3|Overall Study|Adverse Event|1
150234|NCT00684515|479330|P2|Overall Study|Adverse Event|3
150235|NCT00684515|479331|P1|Overall Study|Adverse Event|3
150236|NCT00684567|479376|P1|Monotherapy Period|Progression of primary disease|11
150237|NCT00684567|479376|P1|Monotherapy Period|Death|1
150238|NCT00684567|479376|P1|Monotherapy Period|Adverse Event|2
150239|NCT00684567|479376|P1|Concomitant Radiotherapy Period|Adverse Event|2
150240|NCT00684593|479386|P2|Overall Study|Adverse Event|2
150241|NCT00684593|479387|P1|Overall Study|Adverse Event|0
150242|NCT00678210|479403|P4|Overall Study|Unspecified|0
150243|NCT00678210|479404|P3|Overall Study|Unspecified|1
150244|NCT00678210|479405|P2|Overall Study|Unspecified|0
150245|NCT00678210|479406|P1|Overall Study|Unspecified|1
150246|NCT00678210|479403|P4|Overall Study|Withdrawal by Subject|7
150247|NCT00678210|479404|P3|Overall Study|Withdrawal by Subject|1
150248|NCT00678210|479405|P2|Overall Study|Withdrawal by Subject|4
150249|NCT00678210|479406|P1|Overall Study|Withdrawal by Subject|3
150250|NCT00678210|479403|P4|Overall Study|Lost to Follow-up|1
150251|NCT00678210|479404|P3|Overall Study|Lost to Follow-up|0
150252|NCT00678210|479405|P2|Overall Study|Lost to Follow-up|2
150253|NCT00678210|479406|P1|Overall Study|Lost to Follow-up|4
150254|NCT00678210|479403|P4|Overall Study|Lack of Efficacy|9
150255|NCT00678210|479404|P3|Overall Study|Lack of Efficacy|1
150256|NCT00678210|479405|P2|Overall Study|Lack of Efficacy|3
150257|NCT00678210|479406|P1|Overall Study|Lack of Efficacy|2
150258|NCT00678210|479403|P4|Overall Study|Adverse Event|3
150259|NCT00678210|479404|P3|Overall Study|Adverse Event|3
150260|NCT00678210|479405|P2|Overall Study|Adverse Event|2
150261|NCT00678210|479406|P1|Overall Study|Adverse Event|1
150262|NCT00678288|479479|P2|Overall Study|Disease progression/recurrence/relapse|1
150263|NCT00678288|479480|P1|Overall Study|Disease progression/recurrence/relapse|6
150264|NCT00678288|479479|P2|Overall Study|Reason not reported|0
150265|NCT00678288|479480|P1|Overall Study|Reason not reported|1
150266|NCT00678288|479479|P2|Overall Study|Switch to commercial drug|1
150267|NCT00678288|479480|P1|Overall Study|Switch to commercial drug|0
150268|NCT00678288|479479|P2|Overall Study|Not compliant with study medication|1
150269|NCT00678288|479480|P1|Overall Study|Not compliant with study medication|0
150270|NCT00678288|479479|P2|Overall Study|Study terminated by the sponsor|0
150271|NCT00678288|479480|P1|Overall Study|Study terminated by the sponsor|2
150272|NCT00678288|479479|P2|Overall Study|Withdrawal by Subject|1
150273|NCT00678288|479480|P1|Overall Study|Withdrawal by Subject|1
150274|NCT00678288|479479|P2|Overall Study|Adverse Event|2
150275|NCT00678288|479480|P1|Overall Study|Adverse Event|0
150276|NCT00678379|479497|P3|Overall Study|Incomplete Data|3
150277|NCT00678379|479498|P2|Overall Study|Incomplete Data|3
150278|NCT00678379|479499|P1|Overall Study|Incomplete Data|4
150279|NCT00678379|479497|P3|Overall Study|Injection performed after tonsillectomy|1
150280|NCT00678379|479498|P2|Overall Study|Injection performed after tonsillectomy|0
150281|NCT00678379|479499|P1|Overall Study|Injection performed after tonsillectomy|2
150282|NCT00678392|479527|P2|Overall Study|Unspecified|53
150283|NCT00678392|479528|P1|Overall Study|Unspecified|56
150284|NCT00678392|479527|P2|Overall Study|Randomized But Not Treated|7
150285|NCT00678392|479528|P1|Overall Study|Randomized But Not Treated|2
150286|NCT00678392|479527|P2|Overall Study|Withdrawal by Subject|4
150287|NCT00678392|479528|P1|Overall Study|Withdrawal by Subject|4
150288|NCT00678392|479527|P2|Overall Study|Sponsor's Decision|2
150289|NCT00678392|479528|P1|Overall Study|Sponsor's Decision|1
150290|NCT00678392|479527|P2|Overall Study|Objective Progression or Relapse|8
150291|NCT00678392|479528|P1|Overall Study|Objective Progression or Relapse|3
150292|NCT00678392|479527|P2|Overall Study|Lost to Follow-up|13
150293|NCT00678392|479528|P1|Overall Study|Lost to Follow-up|15
150294|NCT00678392|479527|P2|Overall Study|Death|269
150295|NCT00678392|479528|P1|Overall Study|Death|280
150296|NCT00678392|479527|P2|Overall Study|Adverse Event|6
150297|NCT00678392|479528|P1|Overall Study|Adverse Event|0
150298|NCT00678587|479611|P2|Overall Study|Withdrew Consent|3
150299|NCT00678587|479612|P1|Overall Study|Withdrew Consent|8
150300|NCT00678587|479611|P2|Overall Study|Investigator Discretion|6
150301|NCT00678587|479612|P1|Overall Study|Investigator Discretion|2
150302|NCT00678587|479611|P2|Overall Study|Lost to Follow-up|5
150303|NCT00678587|479612|P1|Overall Study|Lost to Follow-up|3
150304|NCT00678587|479611|P2|Overall Study|Study Closed/Terminated|0
150305|NCT00678587|479612|P1|Overall Study|Study Closed/Terminated|1
150306|NCT00678587|479611|P2|Overall Study|Protocol Violation|1
150307|NCT00678587|479612|P1|Overall Study|Protocol Violation|2
150308|NCT00678587|479611|P2|Overall Study|Lack of Efficacy|0
150309|NCT00678587|479612|P1|Overall Study|Lack of Efficacy|1
150310|NCT00678587|479611|P2|Overall Study|Adverse Event|3
150311|NCT00678587|479612|P1|Overall Study|Adverse Event|3
150312|NCT00678639|479646|P2|Overall Study|Lost to Follow-up at 30 days|0
150313|NCT00678639|479647|P1|Overall Study|Lost to Follow-up at 30 days|2
150314|NCT00678691|479662|P2|Overall Study|Adverse Event|4
150315|NCT00678691|479663|P1|Overall Study|Adverse Event|6
150316|NCT00678795|479671|P2|Overall Study|Lack of Efficacy|1
150317|NCT00678795|479672|P1|Overall Study|Lack of Efficacy|1
150318|NCT00678795|479671|P2|Overall Study|Lost to Follow-up|1
150319|NCT00678795|479672|P1|Overall Study|Lost to Follow-up|0
150320|NCT00678795|479671|P2|Overall Study|Protocol Violation|1
150321|NCT00678795|479672|P1|Overall Study|Protocol Violation|0
150322|NCT00678795|479671|P2|Overall Study|Withdrawal by Subject|0
150323|NCT00678795|479672|P1|Overall Study|Withdrawal by Subject|3
150324|NCT00678795|479671|P2|Overall Study|Adverse Event|3
150325|NCT00678795|479672|P1|Overall Study|Adverse Event|7
150326|NCT00678899|479715|P1|Overall Study|Adverse Event|1
150327|NCT00684645|479722|P1|Overall Study|Not specified|15
150328|NCT00684645|479722|P1|Overall Study|Lost to Follow-up|3
150329|NCT00684645|479722|P1|Overall Study|Adverse Event|27
150330|NCT00684645|479722|P1|Overall Study|Progressive disease|67
150331|NCT00684645|479722|P1|Overall Study|Death|2
150332|NCT00684671|479743|P3|Overall Study|Alcoholic dependance|0
150333|NCT00684671|479744|P2|Overall Study|Alcoholic dependance|0
150334|NCT00684671|479745|P1|Overall Study|Alcoholic dependance|1
150335|NCT00684671|479743|P3|Overall Study|Lost to Follow-up|0
150336|NCT00684671|479744|P2|Overall Study|Lost to Follow-up|0
150337|NCT00684671|479745|P1|Overall Study|Lost to Follow-up|1
150338|NCT00684671|479743|P3|Overall Study|Adverse Event|0
150339|NCT00684671|479744|P2|Overall Study|Adverse Event|0
150340|NCT00684671|479745|P1|Overall Study|Adverse Event|1
150341|NCT00684762|479789|P2|Washout Period of 7 Days|Withdrawal by Subject|2
150342|NCT00684762|479790|P1|Washout Period of 7 Days|Withdrawal by Subject|2
150343|NCT00684814|479800|P2|Second Intervention|Adverse Event|0
150344|NCT00684814|479801|P1|Second Intervention|Adverse Event|1
150345|NCT00684814|479800|P2|Washout Period of 7 Days|Withdrawal by Subject|2
150346|NCT00684814|479801|P1|Washout Period of 7 Days|Withdrawal by Subject|1
150347|NCT00684814|479800|P2|Washout Period of 7 Days|Adverse Event|2
150348|NCT00684814|479801|P1|Washout Period of 7 Days|Adverse Event|1
150349|NCT00686036|479813|P2|Overall Study|Other reasons not identified|4
150350|NCT00686036|479814|P1|Overall Study|Other reasons not identified|0
150351|NCT00686036|479813|P2|Overall Study|PSA ≥ 10ng/mL|0
150352|NCT00686036|479814|P1|Overall Study|PSA ≥ 10ng/mL|1
150353|NCT00686036|479813|P2|Overall Study|Study terminated by AstraZeneca|1
150354|NCT00686036|479814|P1|Overall Study|Study terminated by AstraZeneca|2
150355|NCT00686036|479813|P2|Overall Study|Withdrawal by Subject|1
150356|NCT00686036|479814|P1|Overall Study|Withdrawal by Subject|3
150357|NCT00686036|479813|P2|Overall Study|Adverse Event|0
150358|NCT00686036|479814|P1|Overall Study|Adverse Event|3
150359|NCT00686075|479836|P10|Overall Study|unspecified|1
150360|NCT00686075|479837|P9|Overall Study|unspecified|0
150361|NCT00686075|479838|P8|Overall Study|unspecified|0
150362|NCT00686075|479839|P7|Overall Study|unspecified|0
150363|NCT00686075|479840|P6|Overall Study|unspecified|0
150364|NCT00686075|479841|P5|Overall Study|unspecified|0
150365|NCT00686075|479842|P4|Overall Study|unspecified|0
150366|NCT00686075|479843|P3|Overall Study|unspecified|0
150367|NCT00686075|479844|P2|Overall Study|unspecified|1
150368|NCT00686075|479845|P1|Overall Study|unspecified|1
150369|NCT00686075|479836|P10|Overall Study|Lost to Follow-up|3
150370|NCT00686075|479837|P9|Overall Study|Lost to Follow-up|2
150371|NCT00686075|479838|P8|Overall Study|Lost to Follow-up|0
150372|NCT00686075|479839|P7|Overall Study|Lost to Follow-up|0
150373|NCT00686075|479840|P6|Overall Study|Lost to Follow-up|3
150374|NCT00686075|479841|P5|Overall Study|Lost to Follow-up|3
150375|NCT00686075|479842|P4|Overall Study|Lost to Follow-up|2
150376|NCT00686075|479843|P3|Overall Study|Lost to Follow-up|3
150377|NCT00686075|479844|P2|Overall Study|Lost to Follow-up|6
150378|NCT00686075|479845|P1|Overall Study|Lost to Follow-up|3
150379|NCT00686075|479836|P10|Overall Study|Withdrawal by Subject|6
150380|NCT00686075|479837|P9|Overall Study|Withdrawal by Subject|4
150381|NCT00686075|479838|P8|Overall Study|Withdrawal by Subject|2
150382|NCT00686075|479839|P7|Overall Study|Withdrawal by Subject|0
150383|NCT00686075|479840|P6|Overall Study|Withdrawal by Subject|0
150384|NCT00686075|479841|P5|Overall Study|Withdrawal by Subject|1
150385|NCT00686075|479842|P4|Overall Study|Withdrawal by Subject|7
150386|NCT00686075|479843|P3|Overall Study|Withdrawal by Subject|3
150387|NCT00686075|479844|P2|Overall Study|Withdrawal by Subject|3
150388|NCT00686075|479845|P1|Overall Study|Withdrawal by Subject|4
150389|NCT00686127|480039|P2|Overall Study|Withdrawal by Subject|6
150390|NCT00686127|480040|P1|Overall Study|Withdrawal by Subject|14
150391|NCT00686166|480046|P1|Overall Study|Did not begin protocol therapy|4
150392|NCT00686166|480046|P1|Overall Study|Ineligible|5
150393|NCT00686166|480046|P1|Overall Study|Not Protocol Specified|1
150394|NCT00686166|480046|P1|Overall Study|Death|1
150395|NCT00686166|480046|P1|Overall Study|Progression/Relapse|1
150396|NCT00686166|480046|P1|Overall Study|Withdrawal by Subject|1
150397|NCT00686166|480046|P1|Overall Study|Adverse Event|7
150398|NCT00686205|480058|P2|Overall Study|Specimens not confirmed HIV positive|981
150399|NCT00686205|480059|P1|Overall Study|Specimens not confirmed HIV positive|0
150400|NCT00686205|480058|P2|Overall Study|Specimen handling procedure altered|0
150401|NCT00686205|480059|P1|Overall Study|Specimen handling procedure altered|5878
150402|NCT00686205|480058|P2|Overall Study|Withdrawal by Subject|0
150403|NCT00686205|480059|P1|Overall Study|Withdrawal by Subject|2
150404|NCT00686205|480058|P2|Overall Study|Protocol Violation|0
150405|NCT00686205|480059|P1|Overall Study|Protocol Violation|127
150406|NCT00686335|480087|P1|Run-in Period|violation of inclusion/exclusion criteri|3
150407|NCT00686335|480087|P1|Run-in Period|asthma exacerbation|1
150408|NCT00686335|480087|P1|Run-in Period|Adverse Event|1
150409|NCT00686517|480096|P3|Treatment|Protocol Violation|0
150410|NCT00686517|480097|P2|Treatment|Protocol Violation|1
150411|NCT00686517|480098|P1|Treatment|Protocol Violation|2
150412|NCT00686517|480096|P3|Treatment|Poor Protocol Compliance|0
150413|NCT00686517|480097|P2|Treatment|Poor Protocol Compliance|0
150414|NCT00686517|480098|P1|Treatment|Poor Protocol Compliance|1
150415|NCT00686517|480096|P3|Treatment|Adverse Event|0
150416|NCT00686517|480097|P2|Treatment|Adverse Event|0
150417|NCT00686517|480098|P1|Treatment|Adverse Event|2
150418|NCT00686517|480096|P3|Treatment|Serious Adverse Event|1
150419|NCT00686517|480097|P2|Treatment|Serious Adverse Event|2
150420|NCT00686517|480098|P1|Treatment|Serious Adverse Event|1
150421|NCT00686543|480125|P4|Overall Study|Protocol Violation|1
150422|NCT00686543|480126|P3|Overall Study|Protocol Violation|2
150423|NCT00686543|480127|P2|Overall Study|Protocol Violation|0
150424|NCT00686543|480128|P1|Overall Study|Protocol Violation|3
150425|NCT00686543|480125|P4|Overall Study|Withdrawal by Subject|0
150426|NCT00686543|480126|P3|Overall Study|Withdrawal by Subject|0
150427|NCT00686543|480127|P2|Overall Study|Withdrawal by Subject|0
150428|NCT00686543|480128|P1|Overall Study|Withdrawal by Subject|2
150429|NCT00686543|480125|P4|Overall Study|Adverse Event|2
150430|NCT00686543|480126|P3|Overall Study|Adverse Event|3
150431|NCT00686543|480127|P2|Overall Study|Adverse Event|1
150432|NCT00686543|480128|P1|Overall Study|Adverse Event|9
150433|NCT00686595|480146|P1|Overall Study|Poor Compliance|1
150434|NCT00686595|480146|P1|Overall Study|Lack of Efficacy|1
150435|NCT00686595|480146|P1|Overall Study|Lost to Follow-up|1
150436|NCT00686595|480146|P1|Overall Study|Protocol Violation|1
150437|NCT00686595|480146|P1|Overall Study|Adverse Event|3
150438|NCT00686634|480171|P1|Overall Study|Protocol Violation|6
150439|NCT00686647|480178|P1|Overall Study|Death|1
150440|NCT00686647|480178|P1|Overall Study|Lost to Follow-up|1
150441|NCT00686686|480184|P1|Overall Study|Lost to Follow-up|3
150442|NCT00686686|480184|P1|Overall Study|Adverse Event|2
150443|NCT00686686|480184|P1|Overall Study|Non-compliance|1
150444|NCT00686699|480194|P2|Treatment Period 1|Adverse Event|2
150445|NCT00686699|480195|P1|Treatment Period 1|Adverse Event|0
150446|NCT00686712|480222|P3|Overall Study|Adverse Event|0
150447|NCT00686712|480223|P2|Overall Study|Adverse Event|1
150448|NCT00686712|480224|P1|Overall Study|Adverse Event|1
150449|NCT00686712|480222|P3|Overall Study|Lost to Follow-up|3
150450|NCT00686712|480223|P2|Overall Study|Lost to Follow-up|2
150451|NCT00686712|480224|P1|Overall Study|Lost to Follow-up|1
150452|NCT00686712|480222|P3|Overall Study|Protocol Violation|10
150453|NCT00686712|480223|P2|Overall Study|Protocol Violation|8
150454|NCT00686712|480224|P1|Overall Study|Protocol Violation|8
150455|NCT00686725|480252|P2|Overall Study|Not Specified|3
150456|NCT00686725|480253|P1|Overall Study|Not Specified|1
150457|NCT00686725|480252|P2|Overall Study|Protocol Violation|3
150458|NCT00686725|480253|P1|Overall Study|Protocol Violation|1
150459|NCT00686725|480252|P2|Overall Study|Withdrawal by Subject|4
150460|NCT00686725|480253|P1|Overall Study|Withdrawal by Subject|13
150461|NCT00686725|480252|P2|Overall Study|Death|3
150462|NCT00686725|480253|P1|Overall Study|Death|6
150463|NCT00686725|480252|P2|Overall Study|Lost to Follow-up|5
150464|NCT00686725|480253|P1|Overall Study|Lost to Follow-up|7
150465|NCT00686725|480252|P2|Overall Study|Progressive Disease|23
150466|NCT00686725|480253|P1|Overall Study|Progressive Disease|17
150467|NCT00686725|480252|P2|Overall Study|Adverse Event|1
150468|NCT00686725|480253|P1|Overall Study|Adverse Event|1
150469|NCT00686777|480275|P1|Overall Study|No Visit|1
150470|NCT00686777|480275|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
150471|NCT00686777|480275|P1|Overall Study|Withdrawal by Subject|2
150472|NCT00686777|480275|P1|Overall Study|Pregnancy|1
150473|NCT00686777|480275|P1|Overall Study|Adverse Event|2
150474|NCT00686790|480281|P1|Overall Study|Lost to Follow-up|12
150475|NCT00686790|480281|P1|Overall Study|Death|1
150476|NCT00686790|480281|P1|Overall Study|Withdrawal by Subject|1
150477|NCT00686790|480281|P1|Overall Study|Adverse Event|2
150478|NCT00686855|480311|P2|Overall Study|Progressive GVHD|1
150479|NCT00686855|480312|P1|Overall Study|Progressive GVHD|0
150480|NCT00686855|480311|P2|Overall Study|Lost to Follow-up|0
150481|NCT00686855|480312|P1|Overall Study|Lost to Follow-up|1
150482|NCT00686881|480320|P2|Overall Study|Never received study drug|6
150483|NCT00686881|480321|P1|Overall Study|Never received study drug|2
150484|NCT00686881|480320|P2|Overall Study|Study discontinuation|32
150485|NCT00686881|480321|P1|Overall Study|Study discontinuation|35
150486|NCT00686881|480320|P2|Overall Study|Irregular visits|0
150487|NCT00686881|480321|P1|Overall Study|Irregular visits|1
150488|NCT00686881|480320|P2|Overall Study|Did not meet protocol eligibility|0
150489|NCT00686881|480321|P1|Overall Study|Did not meet protocol eligibility|1
150490|NCT00686881|480320|P2|Overall Study|Circumstances of site|1
150491|NCT00686881|480321|P1|Overall Study|Circumstances of site|1
150492|NCT00686881|480320|P2|Overall Study|Physician Decision|0
150493|NCT00686881|480321|P1|Overall Study|Physician Decision|1
150494|NCT00686881|480320|P2|Overall Study|Lack of Efficacy|3
150495|NCT00686881|480321|P1|Overall Study|Lack of Efficacy|4
150496|NCT00686881|480320|P2|Overall Study|Onset of malignant tumor|11
150497|NCT00686881|480321|P1|Overall Study|Onset of malignant tumor|11
150498|NCT00686881|480320|P2|Overall Study|Met discontinuation criteria|0
150499|NCT00686881|480321|P1|Overall Study|Met discontinuation criteria|5
150500|NCT00686881|480320|P2|Overall Study|Treatment-related adverse event|9
150501|NCT00686881|480321|P1|Overall Study|Treatment-related adverse event|10
150502|NCT00686881|480320|P2|Overall Study|Lost to Follow-up|1
150503|NCT00686881|480321|P1|Overall Study|Lost to Follow-up|0
150504|NCT00686881|480320|P2|Overall Study|Withdrawal by Subject|18
150505|NCT00686881|480321|P1|Overall Study|Withdrawal by Subject|11
150506|NCT00686894|480331|P1|Overall Study|Protocol Violation|4
150507|NCT00686894|480331|P1|Overall Study|Relapse|2
150508|NCT00686959|480337|P2|Overall Study|Participants censored (no death events)|117
150509|NCT00686959|480338|P1|Overall Study|Participants censored (no death events)|124
150510|NCT00686972|480356|P1|Overall Study|P.I, Left institution. Study terminated|51
150511|NCT00686998|480363|P3|Overall Study|Safety Reasons|0
150512|NCT00686998|480364|P2|Overall Study|Safety Reasons|0
150513|NCT00686998|480365|P1|Overall Study|Safety Reasons|1
150514|NCT00686998|480363|P3|Overall Study|Not specified|1
150515|NCT00686998|480364|P2|Overall Study|Not specified|0
150516|NCT00686998|480365|P1|Overall Study|Not specified|0
150517|NCT00686998|480363|P3|Overall Study|Lack of Efficacy|0
150518|NCT00686998|480364|P2|Overall Study|Lack of Efficacy|5
150519|NCT00686998|480365|P1|Overall Study|Lack of Efficacy|7
150520|NCT00686998|480363|P3|Overall Study|Withdrawal by Subject|2
150521|NCT00686998|480364|P2|Overall Study|Withdrawal by Subject|1
150522|NCT00686998|480365|P1|Overall Study|Withdrawal by Subject|2
150523|NCT00686998|480363|P3|Overall Study|Adverse Event|1
150524|NCT00686998|480364|P2|Overall Study|Adverse Event|2
150525|NCT00686998|480365|P1|Overall Study|Adverse Event|3
150526|NCT00687193|480399|P6|Overall Study|Protocol Violation|0
150527|NCT00687193|480400|P5|Overall Study|Protocol Violation|2
150528|NCT00687193|480401|P4|Overall Study|Protocol Violation|1
150529|NCT00687193|480402|P3|Overall Study|Protocol Violation|0
150530|NCT00687193|480403|P2|Overall Study|Protocol Violation|2
150531|NCT00687193|480404|P1|Overall Study|Protocol Violation|1
150532|NCT00687193|480399|P6|Overall Study|Lack of Efficacy|2
150533|NCT00687193|480400|P5|Overall Study|Lack of Efficacy|0
150534|NCT00687193|480401|P4|Overall Study|Lack of Efficacy|0
150535|NCT00687193|480402|P3|Overall Study|Lack of Efficacy|0
150536|NCT00687193|480403|P2|Overall Study|Lack of Efficacy|1
150537|NCT00687193|480404|P1|Overall Study|Lack of Efficacy|1
150538|NCT00687193|480399|P6|Overall Study|Adverse Event|2
150539|NCT00687193|480400|P5|Overall Study|Adverse Event|0
150540|NCT00687193|480401|P4|Overall Study|Adverse Event|3
150541|NCT00687193|480402|P3|Overall Study|Adverse Event|2
150542|NCT00687193|480403|P2|Overall Study|Adverse Event|1
150543|NCT00687193|480404|P1|Overall Study|Adverse Event|0
150544|NCT00687219|480568|P1|Overall Study|Lack of Efficacy|1
150545|NCT00687219|480568|P1|Overall Study|Withdrawal by Subject|1
150546|NCT00687219|480568|P1|Overall Study|HCV-RNA positive conversion|34
150547|NCT00687219|480568|P1|Overall Study|Discontinuance criteria met|7
150548|NCT00687219|480568|P1|Overall Study|Adverse Event|8
150549|NCT00687297|480576|P2|Induction|Other|1
150550|NCT00687297|480577|P1|Induction|Other|0
150551|NCT00687297|480576|P2|Induction|Physician Decision|2
150552|NCT00687297|480577|P1|Induction|Physician Decision|0
150553|NCT00687297|480576|P2|Induction|Patient Noncompliance|0
150554|NCT00687297|480577|P1|Induction|Patient Noncompliance|1
150555|NCT00687297|480576|P2|Induction|Ineligible|1
150556|NCT00687297|480577|P1|Induction|Ineligible|0
150557|NCT00687297|480576|P2|Induction|Lack of Efficacy|21
150558|NCT00687297|480577|P1|Induction|Lack of Efficacy|17
150559|NCT00687297|480576|P2|Induction|Death|11
150560|NCT00687297|480577|P1|Induction|Death|7
150561|NCT00687297|480576|P2|Induction|Adverse Event|15
150562|NCT00687297|480577|P1|Induction|Adverse Event|16
150563|NCT00687297|480576|P2|Induction|Withdrawal by Subject|4
150564|NCT00687297|480577|P1|Induction|Withdrawal by Subject|4
150565|NCT00687297|480576|P2|Randomization|Withdrew before treatment, ineligible|1
150566|NCT00687297|480577|P1|Randomization|Withdrew before treatment, ineligible|1
150567|NCT00687297|480576|P2|Randomization|Withdrawal by Subject|0
150568|NCT00687297|480577|P1|Randomization|Withdrawal by Subject|2
150569|NCT00687323|480587|P1|Overall Study|Screen failure|148
150570|NCT00687323|480587|P1|Overall Study|Excluded from efficacy evaluations|6
150571|NCT00687323|480587|P1|Overall Study|Withdrawal by Subject|1
150572|NCT00687323|480587|P1|Overall Study|Death|25
150573|NCT00687362|480601|P1|Overall Study|Withdrawal by Subject|1
150574|NCT00687362|480601|P1|Overall Study|Protocol Violation|2
150575|NCT00687401|480605|P1|Overall Study|For reasons different from those above|4
150576|NCT00687401|480605|P1|Overall Study|Did not return for visit|3
150577|NCT00687401|480605|P1|Overall Study|Withdrawal by Subject|4
150578|NCT00687401|480605|P1|Overall Study|Lack of Efficacy|6
150579|NCT00687401|480605|P1|Overall Study|Adverse Event|6
150580|NCT00687401|480605|P1|Overall Study|Protocol Violation|7
150581|NCT00687440|480610|P1|Overall Study|Missing|1
150582|NCT00687440|480610|P1|Overall Study|Not specified|1
150583|NCT00687440|480610|P1|Overall Study|Death|2
150584|NCT00687440|480610|P1|Overall Study|Lack of Efficacy|2
150585|NCT00687440|480610|P1|Overall Study|Lost to Follow-up|3
150586|NCT00687440|480610|P1|Overall Study|Adverse Event|3
150587|NCT00687531|480623|P1|Overall Study|Lost to Follow-up|26
150588|NCT00687531|480623|P1|Overall Study|Adverse Event|5
150589|NCT00687531|480623|P1|Overall Study|Did not meet protocol eligibility|104
150590|NCT00687609|480646|P1|Overall Study|Withdrawal by Subject|2
150591|NCT00687609|480646|P1|Overall Study|Physician Decision|1
150592|NCT00687804|480681|P3|Open-Label Extension Study|Death|3
150593|NCT00687804|480682|P2|Open-Label Extension Study|Death|3
150594|NCT00687804|480683|P1|Open-Label Extension Study|Death|2
150595|NCT00687804|480681|P3|Open-Label Extension Study|Administrative problems|0
150596|NCT00687804|480682|P2|Open-Label Extension Study|Administrative problems|1
150597|NCT00687804|480683|P1|Open-Label Extension Study|Administrative problems|1
150598|NCT00687804|480681|P3|Open-Label Extension Study|Lost to Follow-up|2
150599|NCT00687804|480682|P2|Open-Label Extension Study|Lost to Follow-up|1
150600|NCT00687804|480683|P1|Open-Label Extension Study|Lost to Follow-up|2
150601|NCT00687804|480681|P3|Open-Label Extension Study|Subject withdrew consent|4
150602|NCT00687804|480682|P2|Open-Label Extension Study|Subject withdrew consent|4
150603|NCT00687804|480683|P1|Open-Label Extension Study|Subject withdrew consent|3
150604|NCT00687804|480681|P3|Open-Label Extension Study|Adverse Event|2
150605|NCT00687804|480682|P2|Open-Label Extension Study|Adverse Event|2
150606|NCT00687804|480683|P1|Open-Label Extension Study|Adverse Event|2
150607|NCT00687804|480681|P3|Core Study|Protocol Violation|0
150608|NCT00687804|480682|P2|Core Study|Protocol Violation|1
150609|NCT00687804|480683|P1|Core Study|Protocol Violation|1
150610|NCT00687804|480681|P3|Core Study|Death|2
150611|NCT00687804|480682|P2|Core Study|Death|2
150612|NCT00687804|480683|P1|Core Study|Death|2
150613|NCT00687804|480681|P3|Core Study|Lost to Follow-up|0
150614|NCT00687804|480682|P2|Core Study|Lost to Follow-up|1
150615|NCT00687804|480683|P1|Core Study|Lost to Follow-up|0
150616|NCT00687804|480681|P3|Core Study|Withdrawal by Subject|7
150617|NCT00687804|480682|P2|Core Study|Withdrawal by Subject|7
150618|NCT00687804|480683|P1|Core Study|Withdrawal by Subject|4
150619|NCT00687804|480681|P3|Core Study|Lack of Efficacy|1
150620|NCT00687804|480682|P2|Core Study|Lack of Efficacy|1
150621|NCT00687804|480683|P1|Core Study|Lack of Efficacy|1
150622|NCT00687804|480681|P3|Core Study|Abnormal laboratory value(s)|0
150623|NCT00687804|480682|P2|Core Study|Abnormal laboratory value(s)|0
150624|NCT00687804|480683|P1|Core Study|Abnormal laboratory value(s)|1
150625|NCT00687804|480681|P3|Core Study|Adverse Event|3
150626|NCT00687804|480682|P2|Core Study|Adverse Event|3
150627|NCT00687804|480683|P1|Core Study|Adverse Event|5
150628|NCT00687973|480760|P2|Overall Study|Withdrawal by Subject|3
150629|NCT00687973|480761|P1|Overall Study|Withdrawal by Subject|3
150630|NCT00687973|480760|P2|Overall Study|Administrative Reasons|2
150631|NCT00687973|480761|P1|Overall Study|Administrative Reasons|0
150632|NCT00687973|480760|P2|Overall Study|Protocol Violation|2
150633|NCT00687973|480761|P1|Overall Study|Protocol Violation|1
150634|NCT00687973|480760|P2|Overall Study|Lack of Efficacy|3
150635|NCT00687973|480761|P1|Overall Study|Lack of Efficacy|2
150636|NCT00687973|480760|P2|Overall Study|Adverse Event|28
150637|NCT00687973|480761|P1|Overall Study|Adverse Event|18
150638|NCT00688064|480790|P2|Overall Study|Any other reasons|3
150639|NCT00688064|480791|P1|Overall Study|Any other reasons|1
150640|NCT00688064|480790|P2|Overall Study|Pregnancy|0
150641|NCT00688064|480791|P1|Overall Study|Pregnancy|1
150642|NCT00688064|480790|P2|Overall Study|Lack of Efficacy|1
150643|NCT00688064|480791|P1|Overall Study|Lack of Efficacy|0
150644|NCT00688064|480790|P2|Overall Study|Lost to Follow-up|10
150645|NCT00688064|480791|P1|Overall Study|Lost to Follow-up|10
150646|NCT00688064|480790|P2|Overall Study|Withdrawal by Subject|7
150647|NCT00688064|480791|P1|Overall Study|Withdrawal by Subject|7
150648|NCT00688064|480790|P2|Overall Study|Adverse Event|4
150649|NCT00688064|480791|P1|Overall Study|Adverse Event|2
150650|NCT00688064|480790|P2|Overall Study|Protocol Violation|1
150651|NCT00688064|480791|P1|Overall Study|Protocol Violation|0
150652|NCT00688103|480807|P2|Overall Study|complex reasons|9
150653|NCT00688103|480808|P1|Overall Study|complex reasons|11
150654|NCT00688103|480807|P2|Overall Study|Withdrawal by Subject|2
150655|NCT00688103|480808|P1|Overall Study|Withdrawal by Subject|4
150656|NCT00688103|480807|P2|Overall Study|Lack of Efficacy|1
150657|NCT00688103|480808|P1|Overall Study|Lack of Efficacy|11
150658|NCT00688103|480807|P2|Overall Study|Adverse Event|1
150659|NCT00688103|480808|P1|Overall Study|Adverse Event|4
150660|NCT00688467|480820|P2|Treatment Period 2|Adverse Event|1
150661|NCT00688467|480821|P1|Treatment Period 2|Adverse Event|0
150662|NCT00688467|480820|P2|Treatment Period 2|Protocol Violation|1
150663|NCT00688467|480821|P1|Treatment Period 2|Protocol Violation|0
150664|NCT00688467|480820|P2|Treatment Period 1|Did not meet protocol eligibility|1
150665|NCT00688467|480821|P1|Treatment Period 1|Did not meet protocol eligibility|0
150666|NCT00688467|480820|P2|Treatment Period 1|Adverse Event|1
150667|NCT00688467|480821|P1|Treatment Period 1|Adverse Event|2
150668|NCT00681811|480853|P2|Overall Study|Non-compliance|1
150669|NCT00681811|480854|P1|Overall Study|Non-compliance|0
150670|NCT00681811|480853|P2|Overall Study|Withdrawal by Subject|2
150671|NCT00681811|480854|P1|Overall Study|Withdrawal by Subject|2
150672|NCT00681811|480853|P2|Overall Study|Adverse Event|1
150673|NCT00681811|480854|P1|Overall Study|Adverse Event|1
150674|NCT00681824|480885|P3|Overall Study|Death|0
150675|NCT00681824|480886|P2|Overall Study|Death|1
150676|NCT00681824|480887|P1|Overall Study|Death|0
150677|NCT00681824|480885|P3|Overall Study|scheduling conflict|0
150678|NCT00681824|480886|P2|Overall Study|scheduling conflict|0
150679|NCT00681824|480887|P1|Overall Study|scheduling conflict|1
150680|NCT00681824|480885|P3|Overall Study|withdrawn by investigator|1
150681|NCT00681824|480886|P2|Overall Study|withdrawn by investigator|0
150682|NCT00681824|480887|P1|Overall Study|withdrawn by investigator|0
150683|NCT00681863|480903|P1|Overall Study|not specified|18
150684|NCT00681863|480903|P1|Overall Study|Lack of Efficacy|2
150685|NCT00681863|480903|P1|Overall Study|Lost to Follow-up|2
150686|NCT00681863|480903|P1|Overall Study|Adverse Event|1
150687|NCT00688519|480954|P2|Overall Study|Pregnancy|1
150688|NCT00688519|480955|P1|Overall Study|Pregnancy|0
150689|NCT00688519|480954|P2|Overall Study|Subject moved out of area|0
150690|NCT00688519|480955|P1|Overall Study|Subject moved out of area|1
150691|NCT00688519|480954|P2|Overall Study|Investigator decision|0
150692|NCT00688519|480955|P1|Overall Study|Investigator decision|1
150693|NCT00688519|480954|P2|Overall Study|Subject moved out of state|0
150694|NCT00688519|480955|P1|Overall Study|Subject moved out of state|1
150695|NCT00688519|480954|P2|Overall Study|Non-compliance|1
150696|NCT00688519|480955|P1|Overall Study|Non-compliance|0
150697|NCT00688519|480954|P2|Overall Study|Prohibited medication|0
150698|NCT00688519|480955|P1|Overall Study|Prohibited medication|1
150699|NCT00688519|480954|P2|Overall Study|Withdrawal by Subject|6
150700|NCT00688519|480955|P1|Overall Study|Withdrawal by Subject|7
150701|NCT00688519|480954|P2|Overall Study|Lack of Efficacy|1
150702|NCT00688519|480955|P1|Overall Study|Lack of Efficacy|3
150703|NCT00688519|480954|P2|Overall Study|Lost to Follow-up|3
150704|NCT00688519|480955|P1|Overall Study|Lost to Follow-up|3
150705|NCT00688519|480954|P2|Overall Study|Adverse Event|3
150706|NCT00688519|480955|P1|Overall Study|Adverse Event|2
150707|NCT00688545|480973|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
150708|NCT00688545|480974|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
150709|NCT00688545|480973|P2|Overall Study|Withdrawal by Subject|3
150710|NCT00688545|480974|P1|Overall Study|Withdrawal by Subject|2
150711|NCT00688545|480973|P2|Overall Study|Insurance/cost of drug|1
150712|NCT00688545|480974|P1|Overall Study|Insurance/cost of drug|0
150713|NCT00688545|480973|P2|Overall Study|Lost to Follow-up|4
150714|NCT00688545|480974|P1|Overall Study|Lost to Follow-up|1
150715|NCT00688636|480984|P2|Overall Study|Adverse Event|1
150716|NCT00688636|480985|P1|Overall Study|Adverse Event|2
150717|NCT00688688|481013|P3|Overall Study|Violation of exclusion criterion|0
150718|NCT00688688|481014|P2|Overall Study|Violation of exclusion criterion|1
150719|NCT00688688|481015|P1|Overall Study|Violation of exclusion criterion|0
150720|NCT00688688|481013|P3|Overall Study|Site closure|0
150721|NCT00688688|481014|P2|Overall Study|Site closure|1
150722|NCT00688688|481015|P1|Overall Study|Site closure|0
150723|NCT00688688|481013|P3|Overall Study|Taking exclusionary medications|0
150724|NCT00688688|481014|P2|Overall Study|Taking exclusionary medications|0
150725|NCT00688688|481015|P1|Overall Study|Taking exclusionary medications|1
150726|NCT00688688|481013|P3|Overall Study|Non-compliance with study procedures|4
150727|NCT00688688|481014|P2|Overall Study|Non-compliance with study procedures|3
150728|NCT00688688|481015|P1|Overall Study|Non-compliance with study procedures|5
150729|NCT00688688|481013|P3|Overall Study|Randomized but never received study drug|0
150730|NCT00688688|481014|P2|Overall Study|Randomized but never received study drug|0
150731|NCT00688688|481015|P1|Overall Study|Randomized but never received study drug|1
150732|NCT00688688|481013|P3|Overall Study|Protocol Violation|11
150733|NCT00688688|481014|P2|Overall Study|Protocol Violation|9
150734|NCT00688688|481015|P1|Overall Study|Protocol Violation|6
150735|NCT00688688|481013|P3|Overall Study|Lost to Follow-up|7
150736|NCT00688688|481014|P2|Overall Study|Lost to Follow-up|7
150737|NCT00688688|481015|P1|Overall Study|Lost to Follow-up|14
150738|NCT00688688|481013|P3|Overall Study|Withdrawal by Subject|65
150739|NCT00688688|481014|P2|Overall Study|Withdrawal by Subject|75
150740|NCT00688688|481015|P1|Overall Study|Withdrawal by Subject|66
150741|NCT00688688|481013|P3|Overall Study|Lack of Efficacy|45
150742|NCT00688688|481014|P2|Overall Study|Lack of Efficacy|25
150743|NCT00688688|481015|P1|Overall Study|Lack of Efficacy|34
150744|NCT00688688|481013|P3|Overall Study|Adverse Event|50
150745|NCT00688688|481014|P2|Overall Study|Adverse Event|51
150746|NCT00688688|481015|P1|Overall Study|Adverse Event|52
150747|NCT00688688|481013|P3|Overall Study|Eligibility criterion not met|10
150748|NCT00688688|481014|P2|Overall Study|Eligibility criterion not met|7
150749|NCT00688688|481015|P1|Overall Study|Eligibility criterion not met|7
150750|NCT00688701|481107|P4|Overall Study|Poor compliance to protocol|0
150751|NCT00688701|481108|P3|Overall Study|Poor compliance to protocol|1
150752|NCT00688701|481109|P2|Overall Study|Poor compliance to protocol|1
150753|NCT00688701|481110|P1|Overall Study|Poor compliance to protocol|0
150754|NCT00688701|481107|P4|Overall Study|Withdrawal by Subject|8
150755|NCT00688701|481108|P3|Overall Study|Withdrawal by Subject|4
150756|NCT00688701|481109|P2|Overall Study|Withdrawal by Subject|3
150757|NCT00688701|481110|P1|Overall Study|Withdrawal by Subject|3
150758|NCT00688701|481107|P4|Overall Study|Lack of Efficacy|0
150759|NCT00688701|481108|P3|Overall Study|Lack of Efficacy|0
150760|NCT00688701|481109|P2|Overall Study|Lack of Efficacy|1
150761|NCT00688701|481110|P1|Overall Study|Lack of Efficacy|0
150762|NCT00688701|481107|P4|Overall Study|Adverse Event|3
150763|NCT00688701|481108|P3|Overall Study|Adverse Event|5
150764|NCT00688701|481109|P2|Overall Study|Adverse Event|0
150765|NCT00688701|481110|P1|Overall Study|Adverse Event|1
150766|NCT00688740|481150|P2|Overall Study|Violation of Inclusion Criteria|3
150767|NCT00688740|481151|P1|Overall Study|Violation of Inclusion Criteria|1
150768|NCT00688740|481150|P2|Overall Study|Breast Cancer Relapse|4
150769|NCT00688740|481151|P1|Overall Study|Breast Cancer Relapse|1
150770|NCT00688740|481150|P2|Overall Study|Consent Withdrawn|17
150771|NCT00688740|481151|P1|Overall Study|Consent Withdrawn|17
150772|NCT00688740|481150|P2|Overall Study|Lost to Follow-up|1
150773|NCT00688740|481151|P1|Overall Study|Lost to Follow-up|0
150774|NCT00688740|481150|P2|Overall Study|Death|2
150775|NCT00688740|481151|P1|Overall Study|Death|2
150776|NCT00688740|481150|P2|Overall Study|Adverse Event|8
150777|NCT00688740|481151|P1|Overall Study|Adverse Event|45
150778|NCT00688753|481161|P1|Overall Study|Lost to Follow-up|3
150779|NCT00688753|481161|P1|Overall Study|Protocol Violation|1
150780|NCT00688753|481161|P1|Overall Study|Adverse Event|20
150781|NCT00688753|481161|P1|Overall Study|Withdrawal by Subject|3
150782|NCT00688753|481161|P1|Overall Study|Death|9
150783|NCT00688753|481161|P1|Overall Study|Missing|1
150784|NCT00688753|481161|P1|Overall Study|Disease progression|55
150785|NCT00689611|481172|P2|Overall Study|Lost to Follow-up|28
150786|NCT00689611|481173|P1|Overall Study|Lost to Follow-up|27
150787|NCT00689611|481172|P2|Overall Study|Withdrawal by Subject|9
150788|NCT00689611|481173|P1|Overall Study|Withdrawal by Subject|8
150789|NCT00689611|481172|P2|Overall Study|Death|9
150790|NCT00689611|481173|P1|Overall Study|Death|6
150791|NCT00689793|481183|P2|Overall Study|Lost to Follow-up|5
150792|NCT00689793|481184|P1|Overall Study|Lost to Follow-up|4
150793|NCT00689871|481215|P4|Overall Study|Physician Decision|0
150794|NCT00689871|481216|P3|Overall Study|Physician Decision|1
150795|NCT00689871|481217|P2|Overall Study|Physician Decision|1
150796|NCT00689871|481218|P1|Overall Study|Physician Decision|2
150797|NCT00689871|481215|P4|Overall Study|Death|2
150798|NCT00689871|481216|P3|Overall Study|Death|2
150799|NCT00689871|481217|P2|Overall Study|Death|10
150800|NCT00689871|481218|P1|Overall Study|Death|1
150801|NCT00689871|481215|P4|Overall Study|Withdrawal by Subject|1
150802|NCT00689871|481216|P3|Overall Study|Withdrawal by Subject|4
150803|NCT00689871|481217|P2|Overall Study|Withdrawal by Subject|3
150804|NCT00689871|481218|P1|Overall Study|Withdrawal by Subject|13
150805|NCT00689871|481215|P4|Overall Study|Explanted of All Study Devices|3
150806|NCT00689871|481216|P3|Overall Study|Explanted of All Study Devices|29
150807|NCT00689871|481217|P2|Overall Study|Explanted of All Study Devices|25
150808|NCT00689871|481218|P1|Overall Study|Explanted of All Study Devices|36
150809|NCT00689871|481215|P4|Overall Study|Lost to Follow-up|1
150810|NCT00689871|481216|P3|Overall Study|Lost to Follow-up|37
150811|NCT00689871|481217|P2|Overall Study|Lost to Follow-up|13
150812|NCT00689871|481218|P1|Overall Study|Lost to Follow-up|123
150813|NCT00689936|481240|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
150814|NCT00689936|481241|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
150815|NCT00689936|481242|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
150816|NCT00689936|481240|P3|Active Treatment Phase|Miscellaneous|47
150817|NCT00689936|481241|P2|Active Treatment Phase|Miscellaneous|34
150818|NCT00689936|481242|P1|Active Treatment Phase|Miscellaneous|52
150819|NCT00689936|481240|P3|Active Treatment Phase|Study Close Out|21
150820|NCT00689936|481241|P2|Active Treatment Phase|Study Close Out|26
150821|NCT00689936|481242|P1|Active Treatment Phase|Study Close Out|64
150822|NCT00689936|481240|P3|Active Treatment Phase|Protocol Violation|4
150823|NCT00689936|481241|P2|Active Treatment Phase|Protocol Violation|2
150824|NCT00689936|481242|P1|Active Treatment Phase|Protocol Violation|2
150825|NCT00689936|481240|P3|Active Treatment Phase|Lost to Follow-up|2
150826|NCT00689936|481241|P2|Active Treatment Phase|Lost to Follow-up|2
150827|NCT00689936|481242|P1|Active Treatment Phase|Lost to Follow-up|0
150828|NCT00689936|481240|P3|Active Treatment Phase|Death|37
150829|NCT00689936|481241|P2|Active Treatment Phase|Death|28
150830|NCT00689936|481242|P1|Active Treatment Phase|Death|60
150831|NCT00689936|481240|P3|Active Treatment Phase|Withdrawal by Subject|21
150832|NCT00689936|481241|P2|Active Treatment Phase|Withdrawal by Subject|16
150833|NCT00689936|481242|P1|Active Treatment Phase|Withdrawal by Subject|16
150834|NCT00689936|481240|P3|Active Treatment Phase|Disease Progression|339
150835|NCT00689936|481241|P2|Active Treatment Phase|Disease Progression|362
150836|NCT00689936|481242|P1|Active Treatment Phase|Disease Progression|273
150837|NCT00689936|481240|P3|Active Treatment Phase|Adverse Event|76
150838|NCT00689936|481241|P2|Active Treatment Phase|Adverse Event|71
150839|NCT00689936|481242|P1|Active Treatment Phase|Adverse Event|68
150840|NCT00690430|481414|P3|Extension Phase|Early Termination|3
150841|NCT00690430|481415|P2|Extension Phase|Early Termination|1
150842|NCT00690430|481416|P1|Extension Phase|Early Termination|10
150843|NCT00690430|481414|P3|Extension Phase|Withdrawal by Subject|2
150844|NCT00690430|481415|P2|Extension Phase|Withdrawal by Subject|0
150845|NCT00690430|481416|P1|Extension Phase|Withdrawal by Subject|0
150846|NCT00690430|481414|P3|Extension Phase|Death|1
150847|NCT00690430|481415|P2|Extension Phase|Death|1
150848|NCT00690430|481416|P1|Extension Phase|Death|1
150849|NCT00690430|481414|P3|Extension Phase|Adverse Event|2
150850|NCT00690430|481415|P2|Extension Phase|Adverse Event|1
150851|NCT00690430|481416|P1|Extension Phase|Adverse Event|2
150852|NCT00690430|481414|P3|Extension Phase|Administrative Problems|1
150853|NCT00690430|481415|P2|Extension Phase|Administrative Problems|1
150854|NCT00690430|481416|P1|Extension Phase|Administrative Problems|0
150855|NCT00690430|481414|P3|Extension Phase|Abnormal test procedure results|0
150856|NCT00690430|481415|P2|Extension Phase|Abnormal test procedure results|0
150857|NCT00690430|481416|P1|Extension Phase|Abnormal test procedure results|1
150858|NCT00690430|481414|P3|Extension Phase|Abnormal Lab Values|0
150859|NCT00690430|481415|P2|Extension Phase|Abnormal Lab Values|0
150860|NCT00690430|481416|P1|Extension Phase|Abnormal Lab Values|1
150861|NCT00690430|481414|P3|Extension Phase|Lack of Efficacy|4
150862|NCT00690430|481415|P2|Extension Phase|Lack of Efficacy|1
150863|NCT00690430|481416|P1|Extension Phase|Lack of Efficacy|3
150864|NCT00690430|481414|P3|Core Phase|Early Termination|0
150865|NCT00690430|481415|P2|Core Phase|Early Termination|5
150866|NCT00690430|481416|P1|Core Phase|Early Termination|0
150867|NCT00690430|481414|P3|Core Phase|Administrative Problems|0
150868|NCT00690430|481415|P2|Core Phase|Administrative Problems|1
150869|NCT00690430|481416|P1|Core Phase|Administrative Problems|0
150870|NCT00690430|481414|P3|Core Phase|Lack of Efficacy|0
150871|NCT00690430|481415|P2|Core Phase|Lack of Efficacy|10
150872|NCT00690430|481416|P1|Core Phase|Lack of Efficacy|8
150873|NCT00690430|481414|P3|Core Phase|Subject no longer requires study drug|0
150874|NCT00690430|481415|P2|Core Phase|Subject no longer requires study drug|0
150875|NCT00690430|481416|P1|Core Phase|Subject no longer requires study drug|1
150876|NCT00690430|481414|P3|Core Phase|Withdrawal by Subject|0
150877|NCT00690430|481415|P2|Core Phase|Withdrawal by Subject|3
150878|NCT00690430|481416|P1|Core Phase|Withdrawal by Subject|3
150879|NCT00690430|481414|P3|Core Phase|Protocol Violation|0
150880|NCT00690430|481415|P2|Core Phase|Protocol Violation|0
150881|NCT00690430|481416|P1|Core Phase|Protocol Violation|1
150882|NCT00690430|481414|P3|Core Phase|Death|0
150883|NCT00690430|481415|P2|Core Phase|Death|2
150884|NCT00690430|481416|P1|Core Phase|Death|0
150885|NCT00690430|481414|P3|Core Phase|Adverse Event|0
150886|NCT00690430|481415|P2|Core Phase|Adverse Event|1
150887|NCT00690430|481416|P1|Core Phase|Adverse Event|5
150888|NCT00690430|481414|P3|Core Phase|Abnormal Laboratory value|0
150889|NCT00690430|481415|P2|Core Phase|Abnormal Laboratory value|1
150890|NCT00690430|481416|P1|Core Phase|Abnormal Laboratory value|0
150891|NCT00690443|481445|P2|Overall Study|Adverse Event|2
150892|NCT00690443|481446|P1|Overall Study|Adverse Event|1
150893|NCT00690482|481456|P2|Overall Study|withdrew consent at rand.day|1
150894|NCT00690482|481457|P1|Overall Study|withdrew consent at rand.day|0
150895|NCT00690482|481456|P2|Overall Study|Intake of prohibited medicine|0
150896|NCT00690482|481457|P1|Overall Study|Intake of prohibited medicine|1
150897|NCT00690482|481456|P2|Overall Study|Study-specific discontinuation criteria|0
150898|NCT00690482|481457|P1|Overall Study|Study-specific discontinuation criteria|1
150899|NCT00690482|481456|P2|Overall Study|Incorrect enrolment|1
150900|NCT00690482|481457|P1|Overall Study|Incorrect enrolment|0
150901|NCT00690482|481456|P2|Overall Study|Adverse Event|1
150902|NCT00690482|481457|P1|Overall Study|Adverse Event|2
150903|NCT00690573|481498|P1|Overall Study|Withdrawal by Subject|1
150904|NCT00690573|481498|P1|Overall Study|Lack of Efficacy|8
150905|NCT00690612|481506|P1|Overall Study|Withdrawal by Subject|2
150906|NCT00690612|481506|P1|Overall Study|Adverse Event|1
150907|NCT00690755|481518|P7|Overall Study|Physician Decision|0
150908|NCT00690755|481519|P6|Overall Study|Physician Decision|4
150909|NCT00690755|481520|P5|Overall Study|Physician Decision|0
150910|NCT00690755|481521|P4|Overall Study|Physician Decision|5
150911|NCT00690755|481522|P3|Overall Study|Physician Decision|46
150912|NCT00690755|481523|P2|Overall Study|Physician Decision|0
150913|NCT00690755|481524|P1|Overall Study|Physician Decision|2
150914|NCT00690794|481542|P2|Overall Study|Other not specified|3
150915|NCT00690794|481543|P1|Overall Study|Other not specified|1
150916|NCT00690794|481542|P2|Overall Study|Noncompliance|2
150917|NCT00690794|481543|P1|Overall Study|Noncompliance|1
150918|NCT00690794|481542|P2|Overall Study|Protocol Violation|7
150919|NCT00690794|481543|P1|Overall Study|Protocol Violation|6
150920|NCT00690794|481542|P2|Overall Study|Withdrawal by Subject|9
150921|NCT00690794|481543|P1|Overall Study|Withdrawal by Subject|0
150922|NCT00690794|481542|P2|Overall Study|Lost to Follow-up|4
150923|NCT00690794|481543|P1|Overall Study|Lost to Follow-up|1
150924|NCT00690794|481542|P2|Overall Study|Adverse Event|10
150925|NCT00690794|481543|P1|Overall Study|Adverse Event|12
150926|NCT00690820|481553|P2|Period 1|Withdrawal by Subject|1
150927|NCT00690820|481554|P1|Period 1|Withdrawal by Subject|0
150928|NCT00690898|481578|P1|TREATMENT|Other (not otherwise specified)|1
150929|NCT00690898|481578|P1|TREATMENT|Withdrawal by Subject|4
150930|NCT00690898|481578|P1|TREATMENT|Lack of Efficacy|18
150931|NCT00690898|481578|P1|TREATMENT|Adverse Event|3
150932|NCT00690898|481578|P1|SCREENING|Screen failure|18
150933|NCT00691015|481592|P1|Overall Study|Refused further treatment|1
150934|NCT00691028|481606|P4|Double-blind Period|not come to a hospital.|0
150935|NCT00691028|481607|P3|Double-blind Period|not come to a hospital.|0
150936|NCT00691028|481608|P2|Double-blind Period|not come to a hospital.|1
150937|NCT00691028|481609|P1|Double-blind Period|not come to a hospital.|0
150938|NCT00691028|481606|P4|Double-blind Period|Withdrawal by Subject|0
150939|NCT00691028|481607|P3|Double-blind Period|Withdrawal by Subject|1
150940|NCT00691028|481608|P2|Double-blind Period|Withdrawal by Subject|0
150941|NCT00691028|481609|P1|Double-blind Period|Withdrawal by Subject|1
150942|NCT00691028|481606|P4|Double-blind Period|Lack of Efficacy|0
150943|NCT00691028|481607|P3|Double-blind Period|Lack of Efficacy|2
150944|NCT00691028|481608|P2|Double-blind Period|Lack of Efficacy|3
150945|NCT00691028|481609|P1|Double-blind Period|Lack of Efficacy|4
150946|NCT00691028|481606|P4|Double-blind Period|Adverse Event|0
150947|NCT00691028|481607|P3|Double-blind Period|Adverse Event|6
150948|NCT00691028|481608|P2|Double-blind Period|Adverse Event|9
150949|NCT00691028|481609|P1|Double-blind Period|Adverse Event|8
150950|NCT00691028|481606|P4|Open-label Period|not come to a hospital|1
150951|NCT00691028|481607|P3|Open-label Period|not come to a hospital|0
150952|NCT00691028|481608|P2|Open-label Period|not come to a hospital|0
150953|NCT00691028|481609|P1|Open-label Period|not come to a hospital|0
150954|NCT00691028|481606|P4|Open-label Period|Withdrawal by Subject|3
150955|NCT00691028|481607|P3|Open-label Period|Withdrawal by Subject|0
150956|NCT00691028|481608|P2|Open-label Period|Withdrawal by Subject|0
150957|NCT00691028|481609|P1|Open-label Period|Withdrawal by Subject|0
150958|NCT00691028|481606|P4|Open-label Period|Adverse Event|16
150959|NCT00691028|481607|P3|Open-label Period|Adverse Event|0
150960|NCT00691028|481608|P2|Open-label Period|Adverse Event|0
150961|NCT00691028|481609|P1|Open-label Period|Adverse Event|0
150962|NCT00691054|481642|P1|Overall Study|Withdrawal by Subject|1
150963|NCT00691093|481651|P1|Overall Study|Ongoing at Date of Cut-Off|4
150964|NCT00691093|481651|P1|Overall Study|Lack of Efficacy|1
150965|NCT00691093|481651|P1|Overall Study|Lost to Follow-up|1
150966|NCT00691093|481651|P1|Overall Study|Adverse Event|1
150967|NCT00691132|481687|P2|Overall Study|Withdrawal by Subject|10
150968|NCT00691132|481688|P1|Overall Study|Withdrawal by Subject|10
150969|NCT00691132|481687|P2|Overall Study|Adverse Event|3
150970|NCT00691132|481688|P1|Overall Study|Adverse Event|2
150971|NCT00691210|481730|P8|Overall Study|Lack of Efficacy|0
150972|NCT00691210|481731|P7|Overall Study|Lack of Efficacy|0
150973|NCT00691210|481732|P6|Overall Study|Lack of Efficacy|1
150974|NCT00691210|481733|P5|Overall Study|Lack of Efficacy|0
150975|NCT00691210|481734|P4|Overall Study|Lack of Efficacy|1
150976|NCT00691210|481735|P3|Overall Study|Lack of Efficacy|0
150977|NCT00691210|481736|P2|Overall Study|Lack of Efficacy|0
150978|NCT00691210|481737|P1|Overall Study|Lack of Efficacy|0
150979|NCT00691210|481730|P8|Overall Study|Progression of Disease|0
150980|NCT00691210|481731|P7|Overall Study|Progression of Disease|0
150981|NCT00691210|481732|P6|Overall Study|Progression of Disease|0
150982|NCT00691210|481733|P5|Overall Study|Progression of Disease|0
150983|NCT00691210|481734|P4|Overall Study|Progression of Disease|2
150984|NCT00691210|481735|P3|Overall Study|Progression of Disease|0
150985|NCT00691210|481736|P2|Overall Study|Progression of Disease|0
150986|NCT00691210|481737|P1|Overall Study|Progression of Disease|0
150987|NCT00691483|481768|P2|Overall Study|Randomized by not treated|1
150988|NCT00691483|481769|P1|Overall Study|Randomized by not treated|7
150989|NCT00691483|481768|P2|Overall Study|Other known cause|1
150990|NCT00691483|481769|P1|Overall Study|Other known cause|6
150991|NCT00691483|481768|P2|Overall Study|Withdrawal by Subject|7
150992|NCT00691483|481769|P1|Overall Study|Withdrawal by Subject|24
150993|NCT00691483|481768|P2|Overall Study|Lost to Follow-up|10
150994|NCT00691483|481769|P1|Overall Study|Lost to Follow-up|17
150995|NCT00691483|481768|P2|Overall Study|Adverse Event|6
150996|NCT00691483|481769|P1|Overall Study|Adverse Event|14
150997|NCT00691704|481804|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
150998|NCT00691704|481804|P1|Two Years of Maintenance Therapy|Physician Decision|4
150999|NCT00691704|481804|P1|Two Years of Maintenance Therapy|Disease Progression|8
151000|NCT00691704|481804|P1|Induction Therapy|Active Hepatitis|1
151001|NCT00691704|481804|P1|Induction Therapy|Disease Progression|1
151002|NCT00691938|481865|P7|Overall Study|QTc prolongation|0
151003|NCT00691938|481866|P6|Overall Study|QTc prolongation|0
151004|NCT00691938|481867|P5|Overall Study|QTc prolongation|0
151005|NCT00691938|481868|P4|Overall Study|QTc prolongation|0
151006|NCT00691938|481869|P3|Overall Study|QTc prolongation|0
151007|NCT00691938|481870|P2|Overall Study|QTc prolongation|0
151008|NCT00691938|481871|P1|Overall Study|QTc prolongation|1
151009|NCT00692003|481894|P2|Overall Study|Sponsor Decision|1
151010|NCT00692003|481895|P1|Overall Study|Sponsor Decision|5
151011|NCT00684996|481912|P1|Overall Study|Other reasons not protocol specified|1
151012|NCT00684996|481912|P1|Overall Study|Progression/relapse|2
151013|NCT00684996|481912|P1|Overall Study|Refusal unrelated to adverse event|1
151014|NCT00684996|481912|P1|Overall Study|Adverse Event|1
151015|NCT00685035|481925|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
151016|NCT00685035|481926|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
151017|NCT00685165|481959|P2|Washout Period of 14 Days|Adverse Event|0
151018|NCT00685165|481960|P1|Washout Period of 14 Days|Adverse Event|1
151019|NCT00685178|481974|P4|Overall Study|Pregnancy|1
151020|NCT00685178|481975|P3|Overall Study|Pregnancy|0
151021|NCT00685178|481976|P2|Overall Study|Pregnancy|0
151022|NCT00685178|481977|P1|Overall Study|Pregnancy|0
151023|NCT00685178|481974|P4|Overall Study|administrative (disciplinary) discharge|2
151024|NCT00685178|481975|P3|Overall Study|administrative (disciplinary) discharge|0
151025|NCT00685178|481976|P2|Overall Study|administrative (disciplinary) discharge|1
151026|NCT00685178|481977|P1|Overall Study|administrative (disciplinary) discharge|0
151027|NCT00685178|481974|P4|Overall Study|incarcerated|0
151028|NCT00685178|481975|P3|Overall Study|incarcerated|7
151029|NCT00685178|481976|P2|Overall Study|incarcerated|3
151030|NCT00685178|481977|P1|Overall Study|incarcerated|1
151031|NCT00685178|481974|P4|Overall Study|voluntary study discharge|1
151032|NCT00685178|481975|P3|Overall Study|voluntary study discharge|1
151033|NCT00685178|481976|P2|Overall Study|voluntary study discharge|5
151034|NCT00685178|481977|P1|Overall Study|voluntary study discharge|4
151035|NCT00685178|481974|P4|Overall Study|missed 3 consecutive methadone clin days|6
151036|NCT00685178|481975|P3|Overall Study|missed 3 consecutive methadone clin days|2
151037|NCT00685178|481976|P2|Overall Study|missed 3 consecutive methadone clin days|5
151038|NCT00685178|481977|P1|Overall Study|missed 3 consecutive methadone clin days|7
151039|NCT00685178|481974|P4|Overall Study|Adverse Event|4
151040|NCT00685178|481975|P3|Overall Study|Adverse Event|2
151041|NCT00685178|481976|P2|Overall Study|Adverse Event|5
151042|NCT00685178|481977|P1|Overall Study|Adverse Event|1
151043|NCT00685334|482006|P2|Overall Study|Chose to enter hospital|1
151044|NCT00685334|482007|P1|Overall Study|Chose to enter hospital|1
151045|NCT00685334|482006|P2|Overall Study|Lost to Follow-up|0
151046|NCT00685334|482007|P1|Overall Study|Lost to Follow-up|4
151047|NCT00685334|482006|P2|Overall Study|Withdrawal by Subject|6
151048|NCT00685334|482007|P1|Overall Study|Withdrawal by Subject|5
151049|NCT00685373|482015|P1|Overall Study|Protocol Violation|1
151050|NCT00685373|482015|P1|Overall Study|Lost to Follow-up|2
151051|NCT00685373|482015|P1|Overall Study|Condition no longer requires study drug|1
151052|NCT00685373|482015|P1|Overall Study|Lack of Efficacy|3
151053|NCT00685373|482015|P1|Overall Study|Withdrawal by Subject|5
151054|NCT00685373|482015|P1|Overall Study|Adverse Event|3
151055|NCT00685399|482029|P8|Extension|Adverse Event|0
151056|NCT00685399|482030|P7|Extension|Adverse Event|0
151057|NCT00685399|482031|P6|Extension|Adverse Event|0
151058|NCT00685399|482032|P5|Extension|Adverse Event|0
151059|NCT00685399|482033|P4|Extension|Adverse Event|2
151060|NCT00685399|482034|P3|Extension|Adverse Event|0
151061|NCT00685399|482035|P2|Extension|Adverse Event|0
151062|NCT00685399|482036|P1|Extension|Adverse Event|0
151063|NCT00685399|482029|P8|Extension|Lack of Efficacy|0
151064|NCT00685399|482030|P7|Extension|Lack of Efficacy|0
151065|NCT00685399|482031|P6|Extension|Lack of Efficacy|0
151066|NCT00685399|482032|P5|Extension|Lack of Efficacy|0
151067|NCT00685399|482033|P4|Extension|Lack of Efficacy|2
151068|NCT00685399|482034|P3|Extension|Lack of Efficacy|0
151069|NCT00685399|482035|P2|Extension|Lack of Efficacy|0
151070|NCT00685399|482036|P1|Extension|Lack of Efficacy|0
151071|NCT00685399|482029|P8|Extension|Protocol Violation|0
151072|NCT00685399|482030|P7|Extension|Protocol Violation|0
151073|NCT00685399|482031|P6|Extension|Protocol Violation|0
151074|NCT00685399|482032|P5|Extension|Protocol Violation|0
151075|NCT00685399|482033|P4|Extension|Protocol Violation|1
151076|NCT00685399|482034|P3|Extension|Protocol Violation|0
151077|NCT00685399|482035|P2|Extension|Protocol Violation|0
151078|NCT00685399|482036|P1|Extension|Protocol Violation|0
151079|NCT00685399|482029|P8|Extension|Withdrawal by Subject|0
151080|NCT00685399|482030|P7|Extension|Withdrawal by Subject|0
151081|NCT00685399|482031|P6|Extension|Withdrawal by Subject|0
151082|NCT00685399|482032|P5|Extension|Withdrawal by Subject|0
151083|NCT00685399|482033|P4|Extension|Withdrawal by Subject|1
151084|NCT00685399|482034|P3|Extension|Withdrawal by Subject|0
151085|NCT00685399|482035|P2|Extension|Withdrawal by Subject|0
151086|NCT00685399|482036|P1|Extension|Withdrawal by Subject|0
151087|NCT00685399|482029|P8|Extension|Administrative Issues|0
151088|NCT00685399|482030|P7|Extension|Administrative Issues|0
151089|NCT00685399|482031|P6|Extension|Administrative Issues|0
151090|NCT00685399|482032|P5|Extension|Administrative Issues|0
151091|NCT00685399|482033|P4|Extension|Administrative Issues|1
151092|NCT00685399|482034|P3|Extension|Administrative Issues|0
151093|NCT00685399|482035|P2|Extension|Administrative Issues|0
151094|NCT00685399|482036|P1|Extension|Administrative Issues|0
151095|NCT00685399|482029|P8|Treatment Period 2|Lack of Efficacy|0
151096|NCT00685399|482030|P7|Treatment Period 2|Lack of Efficacy|0
151097|NCT00685399|482031|P6|Treatment Period 2|Lack of Efficacy|1
151098|NCT00685399|482032|P5|Treatment Period 2|Lack of Efficacy|0
151099|NCT00685399|482033|P4|Treatment Period 2|Lack of Efficacy|0
151100|NCT00685399|482034|P3|Treatment Period 2|Lack of Efficacy|2
151101|NCT00685399|482035|P2|Treatment Period 2|Lack of Efficacy|10
151102|NCT00685399|482036|P1|Treatment Period 2|Lack of Efficacy|0
151103|NCT00685399|482029|P8|Treatment Period 2|Adverse Event|0
151104|NCT00685399|482030|P7|Treatment Period 2|Adverse Event|0
151105|NCT00685399|482031|P6|Treatment Period 2|Adverse Event|1
151106|NCT00685399|482032|P5|Treatment Period 2|Adverse Event|0
151107|NCT00685399|482033|P4|Treatment Period 2|Adverse Event|0
151108|NCT00685399|482034|P3|Treatment Period 2|Adverse Event|0
151109|NCT00685399|482035|P2|Treatment Period 2|Adverse Event|0
151110|NCT00685399|482036|P1|Treatment Period 2|Adverse Event|0
151111|NCT00685399|482029|P8|Treatment Period 2|Withdrawal by Subject|2
151112|NCT00685399|482030|P7|Treatment Period 2|Withdrawal by Subject|0
151113|NCT00685399|482031|P6|Treatment Period 2|Withdrawal by Subject|0
151114|NCT00685399|482032|P5|Treatment Period 2|Withdrawal by Subject|0
151115|NCT00685399|482033|P4|Treatment Period 2|Withdrawal by Subject|0
151116|NCT00685399|482034|P3|Treatment Period 2|Withdrawal by Subject|0
151117|NCT00685399|482035|P2|Treatment Period 2|Withdrawal by Subject|0
151118|NCT00685399|482036|P1|Treatment Period 2|Withdrawal by Subject|0
151119|NCT00685399|482029|P8|Treatment Period 2|Administrative Problems|0
151120|NCT00685399|482030|P7|Treatment Period 2|Administrative Problems|0
151121|NCT00685399|482031|P6|Treatment Period 2|Administrative Problems|0
151122|NCT00685399|482032|P5|Treatment Period 2|Administrative Problems|0
151123|NCT00685399|482033|P4|Treatment Period 2|Administrative Problems|0
151124|NCT00685399|482034|P3|Treatment Period 2|Administrative Problems|1
151125|NCT00685399|482035|P2|Treatment Period 2|Administrative Problems|2
151126|NCT00685399|482036|P1|Treatment Period 2|Administrative Problems|0
151127|NCT00685399|482029|P8|Treatment Period 1|Lack of Efficacy|0
151128|NCT00685399|482030|P7|Treatment Period 1|Lack of Efficacy|0
151129|NCT00685399|482031|P6|Treatment Period 1|Lack of Efficacy|0
151130|NCT00685399|482032|P5|Treatment Period 1|Lack of Efficacy|0
151131|NCT00685399|482033|P4|Treatment Period 1|Lack of Efficacy|0
151132|NCT00685399|482034|P3|Treatment Period 1|Lack of Efficacy|0
151133|NCT00685399|482035|P2|Treatment Period 1|Lack of Efficacy|0
151134|NCT00685399|482036|P1|Treatment Period 1|Lack of Efficacy|1
151135|NCT00685399|482029|P8|Treatment Period 1|Administrative|0
151136|NCT00685399|482030|P7|Treatment Period 1|Administrative|0
151137|NCT00685399|482031|P6|Treatment Period 1|Administrative|0
151138|NCT00685399|482032|P5|Treatment Period 1|Administrative|0
151139|NCT00685399|482033|P4|Treatment Period 1|Administrative|0
151140|NCT00685399|482034|P3|Treatment Period 1|Administrative|0
151141|NCT00685399|482035|P2|Treatment Period 1|Administrative|0
151142|NCT00685399|482036|P1|Treatment Period 1|Administrative|2
151143|NCT00685399|482029|P8|Treatment Period 1|Protocol Violation|0
151144|NCT00685399|482030|P7|Treatment Period 1|Protocol Violation|0
151145|NCT00685399|482031|P6|Treatment Period 1|Protocol Violation|0
151146|NCT00685399|482032|P5|Treatment Period 1|Protocol Violation|0
151147|NCT00685399|482033|P4|Treatment Period 1|Protocol Violation|0
151148|NCT00685399|482034|P3|Treatment Period 1|Protocol Violation|0
151149|NCT00685399|482035|P2|Treatment Period 1|Protocol Violation|0
151150|NCT00685399|482036|P1|Treatment Period 1|Protocol Violation|1
151151|NCT00685399|482029|P8|Treatment Period 1|Withdrawal by Subject|0
151152|NCT00685399|482030|P7|Treatment Period 1|Withdrawal by Subject|0
151153|NCT00685399|482031|P6|Treatment Period 1|Withdrawal by Subject|0
151154|NCT00685399|482032|P5|Treatment Period 1|Withdrawal by Subject|0
151155|NCT00685399|482033|P4|Treatment Period 1|Withdrawal by Subject|0
151156|NCT00685399|482034|P3|Treatment Period 1|Withdrawal by Subject|0
151157|NCT00685399|482035|P2|Treatment Period 1|Withdrawal by Subject|0
151158|NCT00685399|482036|P1|Treatment Period 1|Withdrawal by Subject|2
151159|NCT00685685|482205|P2|Washout Period of 7 Days|Withdrawal by Subject|1
151160|NCT00685685|482206|P1|Washout Period of 7 Days|Withdrawal by Subject|0
151161|NCT00685685|482205|P2|Washout Period of 7 Days|Adverse Event|0
151162|NCT00685685|482206|P1|Washout Period of 7 Days|Adverse Event|2
151163|NCT00685698|482216|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
151164|NCT00685698|482216|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
151165|NCT00685698|482216|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
151166|NCT00685698|482216|P1|Overall Study|Adverse Event|3
151167|NCT00685698|482216|P1|Overall Study|Protocol Violation|6
151168|NCT00685698|482216|P1|Overall Study|Withdrawal by Subject|1
151169|NCT00685763|482251|P1|Overall Study|Protocol Violation|1
151170|NCT00685763|482251|P1|Overall Study|Intercurrent death-incomplete treatment|1
151171|NCT00685802|482255|P2|Washout Period of 7 Days|Withdrawal by Subject|1
151172|NCT00685802|482256|P1|Washout Period of 7 Days|Withdrawal by Subject|0
151173|NCT00685802|482255|P2|Washout Period of 7 Days|Protocol Violation|0
151174|NCT00685802|482256|P1|Washout Period of 7 Days|Protocol Violation|2
151175|NCT00685945|482275|P1|L-NMMA + Bradykinin|Physician Decision|1
151176|NCT00692237|482346|P2|Overall Study|Adverse Event|1
151177|NCT00692237|482347|P1|Overall Study|Adverse Event|0
151178|NCT00692237|482346|P2|Overall Study|Withdrawal by Subject|3
151179|NCT00692237|482347|P1|Overall Study|Withdrawal by Subject|1
151180|NCT00696696|482423|P1|Overall Study|Death|3
151181|NCT00696696|482423|P1|Overall Study|Physician Decision|2
151182|NCT00696696|482423|P1|Overall Study|Withdrawal by Subject|8
151183|NCT00696696|482423|P1|Overall Study|Adverse Event|5
151184|NCT00696774|482453|P3|Period III|Lack of Efficacy|0
151185|NCT00696774|482454|P2|Period III|Lack of Efficacy|2
151186|NCT00696774|482455|P1|Period III|Lack of Efficacy|0
151187|NCT00696774|482453|P3|Period III|Sponsor Decision|0
151188|NCT00696774|482454|P2|Period III|Sponsor Decision|0
151189|NCT00696774|482455|P1|Period III|Sponsor Decision|2
151190|NCT00696774|482453|P3|Period III|Withdrawal by Subject|0
151191|NCT00696774|482454|P2|Period III|Withdrawal by Subject|2
151192|NCT00696774|482455|P1|Period III|Withdrawal by Subject|1
151193|NCT00696774|482453|P3|Period III|Protocol Violation|0
151194|NCT00696774|482454|P2|Period III|Protocol Violation|1
151195|NCT00696774|482455|P1|Period III|Protocol Violation|1
151196|NCT00696774|482453|P3|Period III|Lost to Follow-up|0
151197|NCT00696774|482454|P2|Period III|Lost to Follow-up|1
151198|NCT00696774|482455|P1|Period III|Lost to Follow-up|2
151199|NCT00696774|482453|P3|Period III|Adverse Event|0
151200|NCT00696774|482454|P2|Period III|Adverse Event|1
151201|NCT00696774|482455|P1|Period III|Adverse Event|1
151202|NCT00696774|482453|P3|Period II|Lack of Efficacy|2
151203|NCT00696774|482454|P2|Period II|Lack of Efficacy|0
151204|NCT00696774|482455|P1|Period II|Lack of Efficacy|0
151205|NCT00696774|482453|P3|Period II|Sponsor Decision|0
151206|NCT00696774|482454|P2|Period II|Sponsor Decision|0
151207|NCT00696774|482455|P1|Period II|Sponsor Decision|0
151208|NCT00696774|482453|P3|Period II|Withdrawal by Subject|4
151209|NCT00696774|482454|P2|Period II|Withdrawal by Subject|0
151210|NCT00696774|482455|P1|Period II|Withdrawal by Subject|0
151211|NCT00696774|482453|P3|Period II|Protocol Violation|11
151212|NCT00696774|482454|P2|Period II|Protocol Violation|0
151213|NCT00696774|482455|P1|Period II|Protocol Violation|0
151214|NCT00696774|482453|P3|Period II|Lost to Follow-up|4
151215|NCT00696774|482454|P2|Period II|Lost to Follow-up|0
151216|NCT00696774|482455|P1|Period II|Lost to Follow-up|0
151217|NCT00696774|482453|P3|Period II|Adverse Event|15
151218|NCT00696774|482454|P2|Period II|Adverse Event|0
151219|NCT00696774|482455|P1|Period II|Adverse Event|0
151220|NCT00696787|482492|P3|Overall Study|Failed to return|1
151221|NCT00696787|482493|P2|Overall Study|Failed to return|3
151222|NCT00696787|482494|P1|Overall Study|Failed to return|1
151223|NCT00696787|482492|P3|Overall Study|Withdrawal by Subject|2
151224|NCT00696787|482493|P2|Overall Study|Withdrawal by Subject|3
151225|NCT00696787|482494|P1|Overall Study|Withdrawal by Subject|0
151226|NCT00696787|482492|P3|Overall Study|Lost to Follow-up|3
151227|NCT00696787|482493|P2|Overall Study|Lost to Follow-up|0
151228|NCT00696787|482494|P1|Overall Study|Lost to Follow-up|4
151229|NCT00696787|482492|P3|Overall Study|Lack of Efficacy|0
151230|NCT00696787|482493|P2|Overall Study|Lack of Efficacy|1
151231|NCT00696787|482494|P1|Overall Study|Lack of Efficacy|0
151232|NCT00696787|482492|P3|Overall Study|Discontinuation by Sponsor|14
151233|NCT00696787|482493|P2|Overall Study|Discontinuation by Sponsor|13
151234|NCT00696787|482494|P1|Overall Study|Discontinuation by Sponsor|9
151235|NCT00696787|482492|P3|Overall Study|Adverse Event|6
151236|NCT00696787|482493|P2|Overall Study|Adverse Event|0
151237|NCT00696787|482494|P1|Overall Study|Adverse Event|1
151238|NCT00696800|482507|P2|Overall Study|Not treated|2
151239|NCT00696800|482508|P1|Overall Study|Not treated|1
151240|NCT00696800|482507|P2|Overall Study|Other Reasons|3
151241|NCT00696800|482508|P1|Overall Study|Other Reasons|5
151242|NCT00696800|482507|P2|Overall Study|No/too few/bad quality embryos|18
151243|NCT00696800|482508|P1|Overall Study|No/too few/bad quality embryos|24
151244|NCT00696800|482507|P2|Overall Study|No/abnormal fertilization|13
151245|NCT00696800|482508|P1|Overall Study|No/abnormal fertilization|11
151246|NCT00696800|482507|P2|Overall Study|No/too few/bad quality oocytes|3
151247|NCT00696800|482508|P1|Overall Study|No/too few/bad quality oocytes|4
151248|NCT00696800|482507|P2|Overall Study|Too high ovarian response|1
151249|NCT00696800|482508|P1|Overall Study|Too high ovarian response|6
151250|NCT00696800|482507|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
151251|NCT00696800|482508|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
151252|NCT00696800|482507|P2|Overall Study|Insufficient ovarian response|1
151253|NCT00696800|482508|P1|Overall Study|Insufficient ovarian response|4
151254|NCT00696800|482507|P2|Overall Study|Insufficient ovarian response on Day 8|1
151255|NCT00696800|482508|P1|Overall Study|Insufficient ovarian response on Day 8|4
151256|NCT00696800|482507|P2|Overall Study|Insufficient compliance with medication|1
151257|NCT00696800|482508|P1|Overall Study|Insufficient compliance with medication|2
151258|NCT00696800|482507|P2|Overall Study|Adverse Event|3
151259|NCT00696800|482508|P1|Overall Study|Adverse Event|16
151260|NCT00696878|482558|P1|Overall Study|Other reason (not specified)|55
151261|NCT00696878|482558|P1|Overall Study|Trial stopped|32
151262|NCT00696878|482558|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
151263|NCT00696878|482558|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
151264|NCT00696878|482558|P1|Overall Study|Withdrawal by Subject|87
151265|NCT00696878|482558|P1|Overall Study|Adverse Event|8
151266|NCT00697073|482630|P1|Overall Study|non compliance and other|6
151267|NCT00697073|482630|P1|Overall Study|Pregnancy|1
151268|NCT00697073|482630|P1|Overall Study|Withdrawal by Subject|2
151269|NCT00697112|482634|P1|Overall Study|Did not meet inclusion criteria|1
151270|NCT00697112|482634|P1|Overall Study|Lost to Follow-up|1
151271|NCT00697112|482634|P1|Overall Study|Adverse Event|8
151272|NCT00697255|482695|P2|Stage 1b|Insufficient ovarian response|1
151273|NCT00697255|482696|P1|Stage 1b|Insufficient ovarian response|0
151274|NCT00697255|482695|P2|Stage 1b|Not growing of dominant follicle|1
151275|NCT00697255|482696|P1|Stage 1b|Not growing of dominant follicle|0
151276|NCT00697255|482695|P2|Stage 1a|Not growing of dominant follicle|0
151277|NCT00697255|482696|P1|Stage 1a|Not growing of dominant follicle|1
151278|NCT00697255|482695|P2|Stage 1a|Multifollicular growth|0
151279|NCT00697255|482696|P1|Stage 1a|Multifollicular growth|1
151280|NCT00697255|482695|P2|Stage 1a|Insufficient ovarian response|0
151281|NCT00697255|482696|P1|Stage 1a|Insufficient ovarian response|1
151282|NCT00697515|482712|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
151283|NCT00697515|482713|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
151284|NCT00697515|482712|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
151285|NCT00697515|482713|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
151286|NCT00697515|482712|P2|First Intervention (Crossover Period)|Adverse Event|2
151287|NCT00697515|482713|P1|First Intervention (Crossover Period)|Adverse Event|0
151288|NCT00697515|482712|P2|First Intervention (Crossover Period)|Natural disaster|9
151289|NCT00697515|482713|P1|First Intervention (Crossover Period)|Natural disaster|8
151290|NCT00697515|482712|P2|Dose Optimization Period|elevated QTc|0
151291|NCT00697515|482713|P1|Dose Optimization Period|elevated QTc|1
151292|NCT00697515|482712|P2|Dose Optimization Period|called to active duty|0
151293|NCT00697515|482713|P1|Dose Optimization Period|called to active duty|1
151294|NCT00697515|482712|P2|Dose Optimization Period|sponsor request|0
151295|NCT00697515|482713|P1|Dose Optimization Period|sponsor request|2
151296|NCT00697515|482712|P2|Dose Optimization Period|Lost to Follow-up|0
151297|NCT00697515|482713|P1|Dose Optimization Period|Lost to Follow-up|2
151298|NCT00697515|482712|P2|Dose Optimization Period|Withdrawal by Subject|0
151299|NCT00697515|482713|P1|Dose Optimization Period|Withdrawal by Subject|5
151300|NCT00697515|482712|P2|Dose Optimization Period|Adverse Event|0
151301|NCT00697515|482713|P1|Dose Optimization Period|Adverse Event|4
151302|NCT00697593|482754|P1|Overall Study|Suspension of the study by sponsor|12
151303|NCT00697593|482754|P1|Overall Study|Lack of Efficacy|3
151304|NCT00697593|482754|P1|Overall Study|Protocol Violation|1
151305|NCT00697593|482754|P1|Overall Study|Adverse Event|3
151306|NCT00697619|482787|P2|Overall Study|Adverse Event|6
151307|NCT00697619|482788|P1|Overall Study|Adverse Event|4
151308|NCT00697619|482787|P2|Overall Study|Lack of Efficacy|2
151309|NCT00697619|482788|P1|Overall Study|Lack of Efficacy|2
151310|NCT00697788|482805|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151311|NCT00697788|482806|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151312|NCT00697788|482807|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151313|NCT00697788|482808|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
151314|NCT00697788|482809|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151315|NCT00697788|482810|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151316|NCT00697788|482811|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151317|NCT00697788|482812|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
151318|NCT00697788|482805|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151319|NCT00697788|482806|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151320|NCT00697788|482807|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151321|NCT00697788|482808|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151322|NCT00697788|482809|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151323|NCT00697788|482810|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151324|NCT00697788|482811|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
151325|NCT00697788|482812|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
151326|NCT00697827|482875|P2|Overall Study|enrolled but not treated|1
151327|NCT00697827|482876|P1|Overall Study|enrolled but not treated|2
151328|NCT00698009|482884|P1|Overall Study|Withdrawal by Subject|1
151329|NCT00698204|482942|P2|Overall Study|Withdrawal by Subject|0
151330|NCT00698204|482943|P1|Overall Study|Withdrawal by Subject|1
151331|NCT00698451|482951|P1|Overall Study|Disease progression|3
151332|NCT00698451|482951|P1|Overall Study|Withdrawal by Subject|6
151333|NCT00698451|482951|P1|Overall Study|Protocol Violation|6
151334|NCT00698451|482951|P1|Overall Study|Physician Decision|2
151335|NCT00698451|482951|P1|Overall Study|Adverse Event|22
151336|NCT00698516|482956|P1|Overall Study|Withdrawal by Subject|3
151337|NCT00698516|482956|P1|Overall Study|Study Termination|2
151338|NCT00698581|482976|P2|Overall Study|AE of unknown type|0
151339|NCT00698581|482977|P1|Overall Study|AE of unknown type|1
151340|NCT00698581|482976|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
151341|NCT00698581|482977|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
151342|NCT00698581|482976|P2|Overall Study|AE, non-serious non-fatal|0
151343|NCT00698581|482977|P1|Overall Study|AE, non-serious non-fatal|4
151344|NCT00698581|482976|P2|Overall Study|SAE, non-fatal|0
151345|NCT00698581|482977|P1|Overall Study|SAE, non-fatal|1
151346|NCT00698581|482976|P2|Overall Study|Other reason|1
151347|NCT00698581|482977|P1|Overall Study|Other reason|9
151348|NCT00698581|482976|P2|Overall Study|Withdrawal by Subject|0
151349|NCT00698581|482977|P1|Overall Study|Withdrawal by Subject|6
151350|NCT00698581|482976|P2|Overall Study|Lack of Efficacy|11
151351|NCT00698581|482977|P1|Overall Study|Lack of Efficacy|23
151352|NCT00698646|482991|P3|Overall Study|Administrative problems|1
151353|NCT00698646|482992|P2|Overall Study|Administrative problems|0
151354|NCT00698646|482993|P1|Overall Study|Administrative problems|1
151355|NCT00698646|482991|P3|Overall Study|Lost to Follow-up|2
151356|NCT00698646|482992|P2|Overall Study|Lost to Follow-up|0
151357|NCT00698646|482993|P1|Overall Study|Lost to Follow-up|0
151358|NCT00698646|482991|P3|Overall Study|Withdrawal by Subject|8
151359|NCT00698646|482992|P2|Overall Study|Withdrawal by Subject|11
151360|NCT00698646|482993|P1|Overall Study|Withdrawal by Subject|10
151361|NCT00698646|482991|P3|Overall Study|Protocol Deviation|3
151362|NCT00698646|482992|P2|Overall Study|Protocol Deviation|2
151363|NCT00698646|482993|P1|Overall Study|Protocol Deviation|6
151364|NCT00698646|482991|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
151365|NCT00698646|482992|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
151366|NCT00698646|482993|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
151367|NCT00698646|482991|P3|Overall Study|Adverse Event|8
151368|NCT00698646|482992|P2|Overall Study|Adverse Event|7
151369|NCT00698646|482993|P1|Overall Study|Adverse Event|8
151370|NCT00698685|483016|P1|Overall Study|Off study pre transplant by clinic MD|1
151371|NCT00698685|483016|P1|Overall Study|Sister withdrew as donor|1
151372|NCT00698815|483024|P3|Overall Study|Did not receive protocol treatment|2
151373|NCT00698815|483025|P2|Overall Study|Did not receive protocol treatment|2
151374|NCT00698815|483026|P1|Overall Study|Did not receive protocol treatment|1
151375|NCT00698815|483024|P3|Overall Study|MD discretion|2
151376|NCT00698815|483025|P2|Overall Study|MD discretion|7
151377|NCT00698815|483026|P1|Overall Study|MD discretion|2
151378|NCT00698815|483024|P3|Overall Study|Withdrawal by Subject|2
151379|NCT00698815|483025|P2|Overall Study|Withdrawal by Subject|3
151380|NCT00698815|483026|P1|Overall Study|Withdrawal by Subject|6
151381|NCT00698815|483024|P3|Overall Study|Death|4
151382|NCT00698815|483025|P2|Overall Study|Death|2
151383|NCT00698815|483026|P1|Overall Study|Death|1
151384|NCT00698841|483043|P1|Overall Study|Other|2
151385|NCT00698841|483043|P1|Overall Study|Study drug toxicity|2
151386|NCT00698841|483043|P1|Overall Study|Failure to meet eligibility criteria|2
151387|NCT00698841|483043|P1|Overall Study|Disease progression|7
151388|NCT00698841|483043|P1|Overall Study|Adverse Event|3
151389|NCT00698841|483043|P1|Overall Study|Withdrawal by Subject|2
151390|NCT00698932|483066|P2|Overall Study|Death|0
151391|NCT00698932|483067|P1|Overall Study|Death|1
151392|NCT00698932|483066|P2|Overall Study|Safety reasons|2
151393|NCT00698932|483067|P1|Overall Study|Safety reasons|0
151394|NCT00698932|483066|P2|Overall Study|Severe non-compliance to protocol|2
151395|NCT00698932|483067|P1|Overall Study|Severe non-compliance to protocol|1
151396|NCT00698932|483066|P2|Overall Study|Lost to Follow-up|1
151397|NCT00698932|483067|P1|Overall Study|Lost to Follow-up|6
151398|NCT00698932|483066|P2|Overall Study|Withdrawal by Subject|23
151399|NCT00698932|483067|P1|Overall Study|Withdrawal by Subject|11
151400|NCT00698932|483066|P2|Overall Study|Study specific discontinuation criteria|4
151401|NCT00698932|483067|P1|Overall Study|Study specific discontinuation criteria|3
151402|NCT00698932|483066|P2|Overall Study|Incorrect enrollment|2
151403|NCT00698932|483067|P1|Overall Study|Incorrect enrollment|0
151404|NCT00698932|483066|P2|Overall Study|Adverse Event|2
151405|NCT00698932|483067|P1|Overall Study|Adverse Event|0
151406|NCT00688844|483083|P1|Overall Study|Lost to Follow-up|10
151407|NCT00688870|483095|P2|Infant Series|Parent or legal guardian request|0
151408|NCT00688870|483096|P1|Infant Series|Parent or legal guardian request|4
151409|NCT00689026|483130|P2|Overall Study|Withdrawal by Subject|6
151410|NCT00689026|483131|P1|Overall Study|Withdrawal by Subject|13
151411|NCT00689052|483139|P2|Overall Study|Early termination of the trial|24
151412|NCT00689052|483140|P1|Overall Study|Early termination of the trial|22
151413|NCT00689052|483139|P2|Overall Study|Withdrawal by Subject|0
151414|NCT00689052|483140|P1|Overall Study|Withdrawal by Subject|2
151415|NCT00689052|483139|P2|Overall Study|Lost to Follow-up|0
151416|NCT00689052|483140|P1|Overall Study|Lost to Follow-up|2
151417|NCT00689052|483139|P2|Overall Study|Protocol Violation|0
151418|NCT00689052|483140|P1|Overall Study|Protocol Violation|1
151419|NCT00689052|483139|P2|Overall Study|Adverse Event|6
151420|NCT00689052|483140|P1|Overall Study|Adverse Event|4
151421|NCT00689104|483183|P4|Overall Study|Non-compliance with study procedures|0
151422|NCT00689104|483184|P3|Overall Study|Non-compliance with study procedures|1
151423|NCT00689104|483185|P2|Overall Study|Non-compliance with study procedures|0
151424|NCT00689104|483186|P1|Overall Study|Non-compliance with study procedures|0
151425|NCT00689104|483183|P4|Overall Study|Physician Decision|0
151426|NCT00689104|483184|P3|Overall Study|Physician Decision|0
151427|NCT00689104|483185|P2|Overall Study|Physician Decision|0
151428|NCT00689104|483186|P1|Overall Study|Physician Decision|1
151429|NCT00689104|483183|P4|Overall Study|Randomized but never received study drug|0
151430|NCT00689104|483184|P3|Overall Study|Randomized but never received study drug|1
151431|NCT00689104|483185|P2|Overall Study|Randomized but never received study drug|1
151432|NCT00689104|483186|P1|Overall Study|Randomized but never received study drug|2
151433|NCT00689104|483183|P4|Overall Study|Protocol Violation|3
151434|NCT00689104|483184|P3|Overall Study|Protocol Violation|5
151435|NCT00689104|483185|P2|Overall Study|Protocol Violation|3
151436|NCT00689104|483186|P1|Overall Study|Protocol Violation|2
151437|NCT00689104|483183|P4|Overall Study|Lost to Follow-up|5
151438|NCT00689104|483184|P3|Overall Study|Lost to Follow-up|2
151439|NCT00689104|483185|P2|Overall Study|Lost to Follow-up|3
151440|NCT00689104|483186|P1|Overall Study|Lost to Follow-up|4
151441|NCT00689104|483183|P4|Overall Study|Withdrawal by Subject|11
151442|NCT00689104|483184|P3|Overall Study|Withdrawal by Subject|18
151443|NCT00689104|483185|P2|Overall Study|Withdrawal by Subject|11
151444|NCT00689104|483186|P1|Overall Study|Withdrawal by Subject|12
151445|NCT00689104|483183|P4|Overall Study|Lack of Efficacy|3
151446|NCT00689104|483184|P3|Overall Study|Lack of Efficacy|2
151447|NCT00689104|483185|P2|Overall Study|Lack of Efficacy|6
151448|NCT00689104|483186|P1|Overall Study|Lack of Efficacy|5
151449|NCT00689104|483183|P4|Overall Study|Adverse Event|24
151450|NCT00689104|483184|P3|Overall Study|Adverse Event|16
151451|NCT00689104|483185|P2|Overall Study|Adverse Event|25
151452|NCT00689104|483186|P1|Overall Study|Adverse Event|13
151453|NCT00689104|483183|P4|Overall Study|Eligibility criterion not met|4
151454|NCT00689104|483184|P3|Overall Study|Eligibility criterion not met|0
151455|NCT00689104|483185|P2|Overall Study|Eligibility criterion not met|8
151456|NCT00689104|483186|P1|Overall Study|Eligibility criterion not met|5
151457|NCT00689117|483320|P4|Overall Study|Dispensing Error|0
151458|NCT00689117|483321|P3|Overall Study|Dispensing Error|0
151459|NCT00689117|483322|P2|Overall Study|Dispensing Error|1
151460|NCT00689117|483323|P1|Overall Study|Dispensing Error|0
151461|NCT00689117|483320|P4|Overall Study|Personal Reason|0
151462|NCT00689117|483321|P3|Overall Study|Personal Reason|0
151463|NCT00689117|483322|P2|Overall Study|Personal Reason|1
151464|NCT00689117|483323|P1|Overall Study|Personal Reason|0
151465|NCT00689117|483320|P4|Overall Study|Patient Withdrew from Study|1
151466|NCT00689117|483321|P3|Overall Study|Patient Withdrew from Study|0
151467|NCT00689117|483322|P2|Overall Study|Patient Withdrew from Study|0
151468|NCT00689117|483323|P1|Overall Study|Patient Withdrew from Study|0
151469|NCT00689117|483320|P4|Overall Study|Transportation|0
151470|NCT00689117|483321|P3|Overall Study|Transportation|0
151471|NCT00689117|483322|P2|Overall Study|Transportation|0
151472|NCT00689117|483323|P1|Overall Study|Transportation|1
151473|NCT00689117|483320|P4|Overall Study|Fear of Birth Defects|0
151474|NCT00689117|483321|P3|Overall Study|Fear of Birth Defects|1
151475|NCT00689117|483322|P2|Overall Study|Fear of Birth Defects|0
151476|NCT00689117|483323|P1|Overall Study|Fear of Birth Defects|0
151477|NCT00689117|483320|P4|Overall Study|Incarceration|0
151478|NCT00689117|483321|P3|Overall Study|Incarceration|0
151479|NCT00689117|483322|P2|Overall Study|Incarceration|0
151480|NCT00689117|483323|P1|Overall Study|Incarceration|2
151481|NCT00689117|483320|P4|Overall Study|Pregnancy|2
151482|NCT00689117|483321|P3|Overall Study|Pregnancy|0
151483|NCT00689117|483322|P2|Overall Study|Pregnancy|2
151484|NCT00689117|483323|P1|Overall Study|Pregnancy|0
151485|NCT00689117|483320|P4|Overall Study|Use of Prohibitive Medication|0
151486|NCT00689117|483321|P3|Overall Study|Use of Prohibitive Medication|3
151487|NCT00689117|483322|P2|Overall Study|Use of Prohibitive Medication|1
151488|NCT00689117|483323|P1|Overall Study|Use of Prohibitive Medication|2
151489|NCT00689117|483320|P4|Overall Study|Change/Discontinuation of Birth Control|0
151490|NCT00689117|483321|P3|Overall Study|Change/Discontinuation of Birth Control|1
151491|NCT00689117|483322|P2|Overall Study|Change/Discontinuation of Birth Control|1
151492|NCT00689117|483323|P1|Overall Study|Change/Discontinuation of Birth Control|1
151493|NCT00689117|483320|P4|Overall Study|Non-compliance with Treatment Regimen|0
151494|NCT00689117|483321|P3|Overall Study|Non-compliance with Treatment Regimen|0
151495|NCT00689117|483322|P2|Overall Study|Non-compliance with Treatment Regimen|1
151496|NCT00689117|483323|P1|Overall Study|Non-compliance with Treatment Regimen|0
151497|NCT00689117|483320|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
151498|NCT00689117|483321|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
151499|NCT00689117|483322|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
151500|NCT00689117|483323|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
151501|NCT00689117|483320|P4|Overall Study|Unable to Comply with Visit Schedule|1
151502|NCT00689117|483321|P3|Overall Study|Unable to Comply with Visit Schedule|1
151503|NCT00689117|483322|P2|Overall Study|Unable to Comply with Visit Schedule|0
151504|NCT00689117|483323|P1|Overall Study|Unable to Comply with Visit Schedule|0
151505|NCT00689117|483320|P4|Overall Study|Withdrawal by Subject|13
151506|NCT00689117|483321|P3|Overall Study|Withdrawal by Subject|26
151507|NCT00689117|483322|P2|Overall Study|Withdrawal by Subject|18
151508|NCT00689117|483323|P1|Overall Study|Withdrawal by Subject|19
151509|NCT00689117|483320|P4|Overall Study|Non-Compliance with Study Treatment|1
151510|NCT00689117|483321|P3|Overall Study|Non-Compliance with Study Treatment|3
151511|NCT00689117|483322|P2|Overall Study|Non-Compliance with Study Treatment|3
151512|NCT00689117|483323|P1|Overall Study|Non-Compliance with Study Treatment|3
151513|NCT00689117|483320|P4|Overall Study|Lack of Efficacy|2
151514|NCT00689117|483321|P3|Overall Study|Lack of Efficacy|2
151515|NCT00689117|483322|P2|Overall Study|Lack of Efficacy|2
151516|NCT00689117|483323|P1|Overall Study|Lack of Efficacy|1
151517|NCT00689117|483320|P4|Overall Study|Lost to Follow-up|11
151518|NCT00689117|483321|P3|Overall Study|Lost to Follow-up|17
151519|NCT00689117|483322|P2|Overall Study|Lost to Follow-up|19
151520|NCT00689117|483323|P1|Overall Study|Lost to Follow-up|26
151521|NCT00689117|483320|P4|Overall Study|Adverse Event|0
151522|NCT00689117|483321|P3|Overall Study|Adverse Event|5
151523|NCT00689117|483322|P2|Overall Study|Adverse Event|0
151524|NCT00689117|483323|P1|Overall Study|Adverse Event|6
151525|NCT00689221|483351|P2|Overall Study|Ongoing at cut-off date|36
151526|NCT00689221|483352|P1|Overall Study|Ongoing at cut-off date|39
151527|NCT00689299|483399|P3|Overall Study|Protocol Violation|0
151528|NCT00689299|483400|P2|Overall Study|Protocol Violation|0
151529|NCT00689299|483401|P1|Overall Study|Protocol Violation|1
151530|NCT00689299|483399|P3|Overall Study|Withdrawal by Subject|3
151531|NCT00689299|483400|P2|Overall Study|Withdrawal by Subject|1
151532|NCT00689299|483401|P1|Overall Study|Withdrawal by Subject|4
151533|NCT00689299|483399|P3|Overall Study|Lost to Follow-up|1
151534|NCT00689299|483400|P2|Overall Study|Lost to Follow-up|1
151535|NCT00689299|483401|P1|Overall Study|Lost to Follow-up|0
151536|NCT00689299|483399|P3|Overall Study|Adverse Event|1
151537|NCT00689299|483400|P2|Overall Study|Adverse Event|1
151538|NCT00689299|483401|P1|Overall Study|Adverse Event|2
151539|NCT00689338|483409|P1|Overall Study|Protocol Violation|15
151540|NCT00689338|483409|P1|Overall Study|Withdrawal by Subject|3
151541|NCT00689338|483409|P1|Overall Study|Lost to Follow-up|5
151542|NCT00689338|483409|P1|Overall Study|Did not Meet Entrance Criteria|27
151543|NCT00689338|483409|P1|Overall Study|Unspecified|8
151544|NCT00689338|483409|P1|Overall Study|Lack of Efficacy|6
151545|NCT00689338|483409|P1|Overall Study|Insufficient Clinical Response|1
151546|NCT00689338|483409|P1|Overall Study|Adverse Event|13
151547|NCT00689338|483409|P1|Overall Study|Death|65
151548|NCT00689351|483421|P2|After Infant Series|Parent/legal guardian request|0
151549|NCT00689351|483422|P1|After Infant Series|Parent/legal guardian request|1
151550|NCT00689351|483421|P2|Infant Series of Dosing|Lost to Follow-up|1
151551|NCT00689351|483422|P1|Infant Series of Dosing|Lost to Follow-up|0
151552|NCT00689351|483421|P2|Infant Series of Dosing|Adverse Event|0
151553|NCT00689351|483422|P1|Infant Series of Dosing|Adverse Event|1
151554|NCT00689351|483421|P2|Infant Series of Dosing|Parent/legal guardian request|0
151555|NCT00689351|483422|P1|Infant Series of Dosing|Parent/legal guardian request|5
151556|NCT00689390|483456|P2|Overall Study|Administrative|0
151557|NCT00689390|483457|P1|Overall Study|Administrative|37
151558|NCT00689390|483456|P2|Overall Study|Did Not Meet Protocol Eligibility|0
151559|NCT00689390|483457|P1|Overall Study|Did Not Meet Protocol Eligibility|1
151560|NCT00689390|483456|P2|Overall Study|Non-Compliance With Protocol|0
151561|NCT00689390|483457|P1|Overall Study|Non-Compliance With Protocol|21
151562|NCT00689390|483456|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
151563|NCT00689390|483457|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
151564|NCT00689390|483456|P2|Overall Study|Withdrawal by Subject|3
151565|NCT00689390|483457|P1|Overall Study|Withdrawal by Subject|117
151566|NCT00689390|483456|P2|Overall Study|Lost to Follow-up|7
151567|NCT00689390|483457|P1|Overall Study|Lost to Follow-up|179
151568|NCT00689390|483456|P2|Overall Study|Adverse Event|0
151569|NCT00689390|483457|P1|Overall Study|Adverse Event|19
151570|NCT00689481|483475|P2|Overall Study|Subject early term, left on vacation|1
151571|NCT00689481|483476|P1|Overall Study|Subject early term, left on vacation|0
151572|NCT00689481|483475|P2|Overall Study|Excluded medication started during study|1
151573|NCT00689481|483476|P1|Overall Study|Excluded medication started during study|0
151574|NCT00689481|483475|P2|Overall Study|Withdrawal by Subject|4
151575|NCT00689481|483476|P1|Overall Study|Withdrawal by Subject|8
151576|NCT00689481|483475|P2|Overall Study|Non-compliance with study treatment|1
151577|NCT00689481|483476|P1|Overall Study|Non-compliance with study treatment|1
151578|NCT00689481|483475|P2|Overall Study|Lack of Efficacy|3
151579|NCT00689481|483476|P1|Overall Study|Lack of Efficacy|4
151580|NCT00689481|483475|P2|Overall Study|Lost to Follow-up|3
151581|NCT00689481|483476|P1|Overall Study|Lost to Follow-up|4
151582|NCT00689481|483475|P2|Overall Study|Adverse Event|1
151583|NCT00689481|483476|P1|Overall Study|Adverse Event|7
151584|NCT00699153|483506|P2|Overall Study|Travel Problem|0
151585|NCT00699153|483507|P1|Overall Study|Travel Problem|1
151586|NCT00699153|483506|P2|Overall Study|Protocol Violation|0
151587|NCT00699153|483507|P1|Overall Study|Protocol Violation|1
151588|NCT00699153|483506|P2|Overall Study|Adverse Event|2
151589|NCT00699153|483507|P1|Overall Study|Adverse Event|0
151590|NCT00699153|483506|P2|Overall Study|Lost to Follow-up|0
151591|NCT00699153|483507|P1|Overall Study|Lost to Follow-up|1
151592|NCT00699192|483522|P3|Overall Study|Protocol Violation|0
151593|NCT00699192|483523|P2|Overall Study|Protocol Violation|2
151594|NCT00699192|483524|P1|Overall Study|Protocol Violation|2
151595|NCT00699192|483522|P3|Overall Study|Administrative problems|1
151596|NCT00699192|483523|P2|Overall Study|Administrative problems|3
151597|NCT00699192|483524|P1|Overall Study|Administrative problems|1
151598|NCT00699192|483522|P3|Overall Study|Withdrawal by Subject|4
151599|NCT00699192|483523|P2|Overall Study|Withdrawal by Subject|2
151600|NCT00699192|483524|P1|Overall Study|Withdrawal by Subject|3
151601|NCT00699192|483522|P3|Overall Study|Lack of Efficacy|1
151602|NCT00699192|483523|P2|Overall Study|Lack of Efficacy|0
151603|NCT00699192|483524|P1|Overall Study|Lack of Efficacy|0
151604|NCT00699192|483522|P3|Overall Study|Abnormal test procedure result(s)|1
151605|NCT00699192|483523|P2|Overall Study|Abnormal test procedure result(s)|0
151606|NCT00699192|483524|P1|Overall Study|Abnormal test procedure result(s)|0
151607|NCT00699192|483522|P3|Overall Study|Adverse Event|3
151608|NCT00699192|483523|P2|Overall Study|Adverse Event|4
151609|NCT00699192|483524|P1|Overall Study|Adverse Event|9
151610|NCT00699192|483522|P3|Overall Study|Missing|1
151611|NCT00699192|483523|P2|Overall Study|Missing|1
151612|NCT00699192|483524|P1|Overall Study|Missing|1
151613|NCT00699283|483546|P2|Overall Study|AE of unknown type|0
151614|NCT00699283|483547|P1|Overall Study|AE of unknown type|1
151615|NCT00699283|483546|P2|Overall Study|AE, non-serious non-fatal|1
151616|NCT00699283|483547|P1|Overall Study|AE, non-serious non-fatal|8
151617|NCT00699283|483546|P2|Overall Study|SAE, non-fatal|1
151618|NCT00699283|483547|P1|Overall Study|SAE, non-fatal|1
151619|NCT00699283|483546|P2|Overall Study|Other Reason|1
151620|NCT00699283|483547|P1|Overall Study|Other Reason|5
151621|NCT00699283|483546|P2|Overall Study|Withdrawal by Subject|0
151622|NCT00699283|483547|P1|Overall Study|Withdrawal by Subject|1
151623|NCT00699283|483546|P2|Overall Study|Lost to Follow-up|0
151624|NCT00699283|483547|P1|Overall Study|Lost to Follow-up|2
151625|NCT00699283|483546|P2|Overall Study|Lack of Efficacy|5
151626|NCT00699283|483547|P1|Overall Study|Lack of Efficacy|15
151627|NCT00699335|483552|P1|Overall Study|Missing data|52
151628|NCT00699335|483552|P1|Overall Study|Combination of multiple reasons|176
151629|NCT00699348|483583|P1|Overall Study|Unspecified|5
151630|NCT00699348|483583|P1|Overall Study|Renal transplantation|10
151631|NCT00699348|483583|P1|Overall Study|Blood transfusion|24
151632|NCT00699348|483583|P1|Overall Study|Failure to return|1
151633|NCT00699348|483583|P1|Overall Study|Lack of Efficacy|8
151634|NCT00699348|483583|P1|Overall Study|Protocol Violation|10
151635|NCT00699348|483583|P1|Overall Study|Withdrawal by Subject|11
151636|NCT00699348|483583|P1|Overall Study|Adverse Event|15
151637|NCT00699348|483583|P1|Overall Study|Death|6
151638|NCT00699374|483594|P2|Overall Study|Died 28 days after last dose|9
151639|NCT00699374|483595|P1|Overall Study|Died 28 days after last dose|5
151640|NCT00699374|483594|P2|Overall Study|Randomized but not treated|2
151641|NCT00699374|483595|P1|Overall Study|Randomized but not treated|4
151642|NCT00699374|483594|P2|Overall Study|Study terminated by sponsor|28
151643|NCT00699374|483595|P1|Overall Study|Study terminated by sponsor|13
151644|NCT00699374|483594|P2|Overall Study|Protocol Violation|6
151645|NCT00699374|483595|P1|Overall Study|Protocol Violation|2
151646|NCT00699374|483594|P2|Overall Study|Unspecified|15
151647|NCT00699374|483595|P1|Overall Study|Unspecified|18
151648|NCT00699374|483594|P2|Overall Study|Objective progression or relapse|277
151649|NCT00699374|483595|P1|Overall Study|Objective progression or relapse|281
151650|NCT00699374|483594|P2|Overall Study|Withdrawal by Subject|44
151651|NCT00699374|483595|P1|Overall Study|Withdrawal by Subject|34
151652|NCT00699374|483594|P2|Overall Study|Lost to Follow-up|5
151653|NCT00699374|483595|P1|Overall Study|Lost to Follow-up|3
151654|NCT00699374|483594|P2|Overall Study|Global deterioration of health status|8
151655|NCT00699374|483595|P1|Overall Study|Global deterioration of health status|7
151656|NCT00699374|483594|P2|Overall Study|Adverse Event|67
151657|NCT00699374|483595|P1|Overall Study|Adverse Event|70
151658|NCT00699374|483594|P2|Overall Study|Death|83
151659|NCT00699374|483595|P1|Overall Study|Death|93
151660|NCT00699608|483656|P6|Second Intervention|Withdrawal by Subject|0
151661|NCT00699608|483657|P5|Second Intervention|Withdrawal by Subject|0
151662|NCT00699608|483658|P4|Second Intervention|Withdrawal by Subject|1
151663|NCT00699608|483659|P3|Second Intervention|Withdrawal by Subject|0
151664|NCT00699608|483660|P2|Second Intervention|Withdrawal by Subject|0
151665|NCT00699608|483661|P1|Second Intervention|Withdrawal by Subject|0
151666|NCT00699608|483656|P6|Second Intervention|Adverse Event|0
151667|NCT00699608|483657|P5|Second Intervention|Adverse Event|0
151668|NCT00699608|483658|P4|Second Intervention|Adverse Event|0
151669|NCT00699608|483659|P3|Second Intervention|Adverse Event|1
151670|NCT00699608|483660|P2|Second Intervention|Adverse Event|0
151671|NCT00699608|483661|P1|Second Intervention|Adverse Event|0
151672|NCT00699608|483656|P6|First Intervention|Protocol Violation|0
151673|NCT00699608|483657|P5|First Intervention|Protocol Violation|1
151674|NCT00699608|483658|P4|First Intervention|Protocol Violation|0
151675|NCT00699608|483659|P3|First Intervention|Protocol Violation|0
151676|NCT00699608|483660|P2|First Intervention|Protocol Violation|0
151677|NCT00699608|483661|P1|First Intervention|Protocol Violation|0
151678|NCT00699608|483656|P6|First Intervention|Withdrawal by Subject|0
151679|NCT00699608|483657|P5|First Intervention|Withdrawal by Subject|0
151680|NCT00699608|483658|P4|First Intervention|Withdrawal by Subject|0
151681|NCT00699608|483659|P3|First Intervention|Withdrawal by Subject|1
151682|NCT00699608|483660|P2|First Intervention|Withdrawal by Subject|0
151683|NCT00699608|483661|P1|First Intervention|Withdrawal by Subject|0
151684|NCT00699660|483713|P2|Overall Study|missing reports and recording failures|6
151685|NCT00699660|483714|P1|Overall Study|missing reports and recording failures|10
151686|NCT00699660|483713|P2|Overall Study|Lost to Follow-up|2
151687|NCT00699660|483714|P1|Overall Study|Lost to Follow-up|4
151688|NCT00699699|483726|P1|Overall Study|Individual different reasons|21
151689|NCT00699699|483726|P1|Overall Study|Adverse Event|36
151690|NCT00699751|483735|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
151691|NCT00699751|483736|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
151692|NCT00699751|483735|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
151693|NCT00699751|483736|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
151694|NCT00699751|483735|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
151695|NCT00699751|483736|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
151696|NCT00699751|483735|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
151697|NCT00699751|483736|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
151698|NCT00699751|483735|P2|Period 1: Without/Before Drug Switch|Unspecified|20
151699|NCT00699751|483736|P1|Period 1: Without/Before Drug Switch|Unspecified|30
151700|NCT00699751|483735|P2|Period 1: Without/Before Drug Switch|Subject Request|23
151701|NCT00699751|483736|P1|Period 1: Without/Before Drug Switch|Subject Request|43
151702|NCT00699751|483735|P2|Period 1: Without/Before Drug Switch|Death|29
151703|NCT00699751|483736|P1|Period 1: Without/Before Drug Switch|Death|28
151704|NCT00699751|483735|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
151705|NCT00699751|483736|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
151706|NCT00699816|483823|P2|Overall Study|Protocol Violation|3
151707|NCT00699816|483824|P1|Overall Study|Protocol Violation|1
151708|NCT00699842|483843|P3|Overall Study|Death|0
151709|NCT00699842|483844|P2|Overall Study|Death|1
151710|NCT00699842|483845|P1|Overall Study|Death|0
151711|NCT00699972|483859|P3|Overall Study|Randomized, Not Treated|1
151712|NCT00699972|483860|P2|Overall Study|Randomized, Not Treated|0
151713|NCT00699972|483861|P1|Overall Study|Randomized, Not Treated|1
151714|NCT00699972|483859|P3|Overall Study|Administrative/Other|4
151715|NCT00699972|483860|P2|Overall Study|Administrative/Other|1
151716|NCT00699972|483861|P1|Overall Study|Administrative/Other|3
151717|NCT00699972|483859|P3|Overall Study|Lack of Efficacy|2
151718|NCT00699972|483860|P2|Overall Study|Lack of Efficacy|0
151719|NCT00699972|483861|P1|Overall Study|Lack of Efficacy|2
151720|NCT00699972|483859|P3|Overall Study|Withdrawal by Subject|4
151721|NCT00699972|483860|P2|Overall Study|Withdrawal by Subject|7
151722|NCT00699972|483861|P1|Overall Study|Withdrawal by Subject|3
151723|NCT00699972|483859|P3|Overall Study|Lost to Follow-up|0
151724|NCT00699972|483860|P2|Overall Study|Lost to Follow-up|2
151725|NCT00699972|483861|P1|Overall Study|Lost to Follow-up|0
151726|NCT00699972|483859|P3|Overall Study|Adverse Event|24
151727|NCT00699972|483860|P2|Overall Study|Adverse Event|9
151728|NCT00699972|483861|P1|Overall Study|Adverse Event|7
151729|NCT00699998|483879|P4|Overall Study|Lost to Follow-up|1
151730|NCT00699998|483880|P3|Overall Study|Lost to Follow-up|3
151731|NCT00699998|483881|P2|Overall Study|Lost to Follow-up|1
151732|NCT00699998|483882|P1|Overall Study|Lost to Follow-up|2
151733|NCT00699998|483879|P4|Overall Study|Physician Decision|1
151734|NCT00699998|483880|P3|Overall Study|Physician Decision|1
151735|NCT00699998|483881|P2|Overall Study|Physician Decision|2
151736|NCT00699998|483882|P1|Overall Study|Physician Decision|3
151737|NCT00699998|483879|P4|Overall Study|Withdrawal by Subject|80
151738|NCT00699998|483880|P3|Overall Study|Withdrawal by Subject|202
151739|NCT00699998|483881|P2|Overall Study|Withdrawal by Subject|83
151740|NCT00699998|483882|P1|Overall Study|Withdrawal by Subject|194
151741|NCT00700011|483926|P2|Overall Study|Death|1
151742|NCT00700011|483927|P1|Overall Study|Death|0
151743|NCT00700102|484062|P2|Overall Study|Lost to Follow-up|10
151744|NCT00700102|484063|P1|Overall Study|Lost to Follow-up|8
151745|NCT00700102|484062|P2|Overall Study|Died|385
151746|NCT00700102|484063|P1|Overall Study|Died|394
151747|NCT00700115|484081|P2|Overall Study|Lost to Follow-up|1
151748|NCT00700115|484082|P1|Overall Study|Lost to Follow-up|0
151749|NCT00700115|484081|P2|Overall Study|Withdrawal by Subject|0
151750|NCT00700115|484082|P1|Overall Study|Withdrawal by Subject|1
151751|NCT00700180|484097|P2|Overall Study|Lost to Follow-up|5
151752|NCT00700180|484098|P1|Overall Study|Lost to Follow-up|4
151753|NCT00700180|484097|P2|Overall Study|Alive in follow-up|27
151754|NCT00700180|484098|P1|Overall Study|Alive in follow-up|46
151755|NCT00700180|484097|P2|Overall Study|Alive on treatment|3
151756|NCT00700180|484098|P1|Overall Study|Alive on treatment|5
151757|NCT00700180|484097|P2|Overall Study|Death|114
151758|NCT00700180|484098|P1|Overall Study|Death|99
151759|NCT00700271|484122|P2|Overall Study|Lost to Follow-up|2
151760|NCT00700271|484123|P1|Overall Study|Lost to Follow-up|2
151761|NCT00700271|484122|P2|Overall Study|Withdrawal by Subject|4
151762|NCT00700271|484123|P1|Overall Study|Withdrawal by Subject|6
151763|NCT00700271|484122|P2|Overall Study|Administrative Reasons|0
151764|NCT00700271|484123|P1|Overall Study|Administrative Reasons|1
151765|NCT00700271|484122|P2|Overall Study|Protocol Violation|0
151766|NCT00700271|484123|P1|Overall Study|Protocol Violation|1
151767|NCT00700271|484122|P2|Overall Study|Adverse Event|6
151768|NCT00700271|484123|P1|Overall Study|Adverse Event|4
151769|NCT00700310|484153|P4|Overall Study|Randomized, Not Treated|2
151770|NCT00700310|484154|P3|Overall Study|Randomized, Not Treated|2
151771|NCT00700310|484155|P2|Overall Study|Randomized, Not Treated|0
151772|NCT00700310|484156|P1|Overall Study|Randomized, Not Treated|2
151773|NCT00700310|484153|P4|Overall Study|Administrative/Other|3
151774|NCT00700310|484154|P3|Overall Study|Administrative/Other|1
151775|NCT00700310|484155|P2|Overall Study|Administrative/Other|3
151776|NCT00700310|484156|P1|Overall Study|Administrative/Other|1
151777|NCT00700310|484153|P4|Overall Study|Lack of Efficacy|1
151778|NCT00700310|484154|P3|Overall Study|Lack of Efficacy|0
151779|NCT00700310|484155|P2|Overall Study|Lack of Efficacy|3
151780|NCT00700310|484156|P1|Overall Study|Lack of Efficacy|0
151781|NCT00700310|484153|P4|Overall Study|Withdrawal by Subject|8
151782|NCT00700310|484154|P3|Overall Study|Withdrawal by Subject|8
151783|NCT00700310|484155|P2|Overall Study|Withdrawal by Subject|9
151784|NCT00700310|484156|P1|Overall Study|Withdrawal by Subject|8
151785|NCT00700310|484153|P4|Overall Study|Lost to Follow-up|1
151786|NCT00700310|484154|P3|Overall Study|Lost to Follow-up|0
151787|NCT00700310|484155|P2|Overall Study|Lost to Follow-up|1
151788|NCT00700310|484156|P1|Overall Study|Lost to Follow-up|4
151789|NCT00700310|484153|P4|Overall Study|Adverse Event|11
151790|NCT00700310|484154|P3|Overall Study|Adverse Event|5
151791|NCT00700310|484155|P2|Overall Study|Adverse Event|10
151792|NCT00700310|484156|P1|Overall Study|Adverse Event|6
151793|NCT00700401|484183|P1|Overall Study|Withdrawal by Subject|2
151794|NCT00700401|484183|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
151795|NCT00700401|484183|P1|Overall Study|Treatment never started|1
151796|NCT00700401|484183|P1|Overall Study|Lost to Follow-up|1
151797|NCT00700401|484183|P1|Overall Study|Refused Treatment|2
151798|NCT00700401|484183|P1|Overall Study|Adverse Event|5
151799|NCT00700401|484183|P1|Overall Study|Detectable HCV RNA after Week 4|82
151800|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
151801|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
151802|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
151803|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
151804|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
151805|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
151806|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
151807|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
151808|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
151809|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
151810|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
151811|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
151812|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
151813|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
151814|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
151815|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
151816|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
151817|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
151818|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
151819|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
151820|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
151821|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
151822|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
151823|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
151824|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
151825|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
151826|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
151827|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
151828|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
151829|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
151830|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
151831|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
151832|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
151833|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
151834|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
151835|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Death|1
151836|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Death|0
151837|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Death|0
151838|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Death|0
151839|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Death|0
151840|NCT00700427|484194|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
151841|NCT00700427|484195|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
151842|NCT00700427|484196|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
151843|NCT00700427|484197|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
151844|NCT00700427|484198|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
151845|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Death|0
151846|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Death|0
151847|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Death|1
151848|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Death|0
151849|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Death|0
151850|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
151851|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
151852|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
151853|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
151854|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
151855|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
151856|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
151857|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
151858|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
151859|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
151860|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
151861|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
151862|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
151863|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
151864|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
151865|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
151866|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
151867|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
151868|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
152011|NCT00700635|484252|P2|Overall Study|Withdrawal by Subject|3
151869|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
151870|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
151871|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
151872|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
151873|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
151874|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
151875|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
151876|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
151877|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
151878|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
151879|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
151880|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
151881|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
151882|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
151883|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
151884|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
151885|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
151886|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
151887|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
151888|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
151889|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
151890|NCT00700427|484194|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
151891|NCT00700427|484195|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
151892|NCT00700427|484196|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
151893|NCT00700427|484197|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
151894|NCT00700427|484198|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
151895|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
151896|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
151897|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
151898|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
151899|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
151900|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
151901|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
151902|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
151903|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
151904|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
151905|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
151906|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
151907|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
151908|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
151909|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
151910|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
151911|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
151912|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
151913|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
151914|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
151915|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
151916|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
151917|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
151918|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
151919|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
151920|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
151921|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
151922|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
151923|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
151924|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
151925|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
151926|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
151927|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
151928|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
151929|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
151930|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
151931|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
151932|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
151933|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
151934|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
151935|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
151936|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
152012|NCT00700635|484253|P1|Overall Study|Withdrawal by Subject|7
151937|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
151938|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
151939|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
151940|NCT00700427|484194|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
151941|NCT00700427|484195|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
151942|NCT00700427|484196|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
151943|NCT00700427|484197|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
151944|NCT00700427|484198|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
151945|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
151946|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
151947|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
151948|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
151949|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
151950|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
151951|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
151952|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
151953|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
151954|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
151955|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
151956|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
151957|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
151958|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
151959|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
151960|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
151961|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
151962|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
151963|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
151964|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
151965|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
151966|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
151967|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
151968|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
151969|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
151970|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
151971|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
151972|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
151973|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
151974|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
151975|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
151976|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
151977|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
151978|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
151979|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
151980|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
151981|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
151982|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
151983|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
151984|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
151985|NCT00700427|484194|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
151986|NCT00700427|484195|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
151987|NCT00700427|484196|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
151988|NCT00700427|484197|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
151989|NCT00700427|484198|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
151990|NCT00700570|484226|P2|Overall Study|Withdrawal by Subject|6
151991|NCT00700570|484227|P1|Overall Study|Withdrawal by Subject|1
151992|NCT00700570|484226|P2|Overall Study|Disease Progression|11
151993|NCT00700570|484227|P1|Overall Study|Disease Progression|8
151994|NCT00700570|484226|P2|Overall Study|Discretion of Investigator or Sponsor|3
151995|NCT00700570|484227|P1|Overall Study|Discretion of Investigator or Sponsor|0
151996|NCT00700570|484226|P2|Overall Study|Adverse Event|6
151997|NCT00700570|484227|P1|Overall Study|Adverse Event|2
151998|NCT00700622|484241|P2|Overall Study|Other|1
151999|NCT00700622|484242|P1|Overall Study|Other|3
152000|NCT00700622|484241|P2|Overall Study|Withdrawal by Subject|1
152001|NCT00700622|484242|P1|Overall Study|Withdrawal by Subject|4
152002|NCT00700622|484241|P2|Overall Study|Protocol Violation|1
152003|NCT00700622|484242|P1|Overall Study|Protocol Violation|0
152004|NCT00700622|484241|P2|Overall Study|Physician Decision|1
152005|NCT00700622|484242|P1|Overall Study|Physician Decision|2
152006|NCT00700622|484241|P2|Overall Study|Lost to Follow-up|1
152007|NCT00700622|484242|P1|Overall Study|Lost to Follow-up|0
152008|NCT00700622|484241|P2|Overall Study|Adverse Event|0
152009|NCT00700622|484242|P1|Overall Study|Adverse Event|4
152010|NCT00700635|484251|P3|Overall Study|Withdrawal by Subject|1
152013|NCT00700635|484251|P3|Overall Study|Protocol Violation|0
152014|NCT00700635|484252|P2|Overall Study|Protocol Violation|2
152015|NCT00700635|484253|P1|Overall Study|Protocol Violation|2
152016|NCT00700635|484251|P3|Overall Study|Lost to Follow-up|0
152017|NCT00700635|484252|P2|Overall Study|Lost to Follow-up|3
152018|NCT00700635|484253|P1|Overall Study|Lost to Follow-up|1
152019|NCT00700635|484251|P3|Overall Study|Adverse Event|0
152020|NCT00700635|484252|P2|Overall Study|Adverse Event|0
152021|NCT00700635|484253|P1|Overall Study|Adverse Event|1
152022|NCT00700713|484276|P3|Overall Study|Withdrawal by Subject|1
152023|NCT00700713|484277|P2|Overall Study|Withdrawal by Subject|0
152024|NCT00700713|484278|P1|Overall Study|Withdrawal by Subject|0
152025|NCT00700713|484276|P3|Overall Study|Protocol Violation|1
152026|NCT00700713|484277|P2|Overall Study|Protocol Violation|0
152027|NCT00700713|484278|P1|Overall Study|Protocol Violation|1
152028|NCT00700739|484294|P2|Overall Study|Lost to Follow-up|4
152029|NCT00700739|484295|P1|Overall Study|Lost to Follow-up|4
152030|NCT00700752|484331|P2|First Intervention|Withdrawal by Subject|2
152031|NCT00700752|484332|P1|First Intervention|Withdrawal by Subject|0
152032|NCT00700804|484340|P2|Overall Study|Loose Stools|1
152033|NCT00700804|484341|P1|Overall Study|Loose Stools|1
152034|NCT00700804|484340|P2|Overall Study|Protocol Violation|1
152035|NCT00700804|484341|P1|Overall Study|Protocol Violation|1
152036|NCT00700804|484340|P2|Overall Study|Withdrawal by Subject|2
152037|NCT00700804|484341|P1|Overall Study|Withdrawal by Subject|1
152038|NCT00700817|484354|P5|Week 52-78 (Extension Period 2)|Unclassified|1
152039|NCT00700817|484355|P4|Week 52-78 (Extension Period 2)|Unclassified|0
152040|NCT00700817|484356|P3|Week 52-78 (Extension Period 2)|Unclassified|0
152041|NCT00700817|484357|P2|Week 52-78 (Extension Period 2)|Unclassified|4
152042|NCT00700817|484358|P1|Week 52-78 (Extension Period 2)|Unclassified|2
152043|NCT00700817|484354|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
152044|NCT00700817|484355|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
152045|NCT00700817|484356|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
152046|NCT00700817|484357|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
152047|NCT00700817|484358|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
152048|NCT00700817|484354|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
152049|NCT00700817|484355|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
152050|NCT00700817|484356|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
152051|NCT00700817|484357|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
152052|NCT00700817|484358|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
152053|NCT00700817|484354|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
152054|NCT00700817|484355|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
152055|NCT00700817|484356|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
152056|NCT00700817|484357|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
152057|NCT00700817|484358|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
152058|NCT00700817|484354|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
152059|NCT00700817|484355|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
152060|NCT00700817|484356|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
152061|NCT00700817|484357|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
152062|NCT00700817|484358|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
152063|NCT00700817|484354|P5|Week 26-52 (Extension Period 1)|Unclassified|0
152064|NCT00700817|484355|P4|Week 26-52 (Extension Period 1)|Unclassified|0
152065|NCT00700817|484356|P3|Week 26-52 (Extension Period 1)|Unclassified|1
152066|NCT00700817|484357|P2|Week 26-52 (Extension Period 1)|Unclassified|3
152067|NCT00700817|484358|P1|Week 26-52 (Extension Period 1)|Unclassified|4
152068|NCT00700817|484354|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
152069|NCT00700817|484355|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
152070|NCT00700817|484356|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
152071|NCT00700817|484357|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
152072|NCT00700817|484358|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
152073|NCT00700817|484354|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
152074|NCT00700817|484355|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
152075|NCT00700817|484356|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
152076|NCT00700817|484357|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
152077|NCT00700817|484358|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
152078|NCT00700817|484354|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
152079|NCT00700817|484355|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
152080|NCT00700817|484356|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
152081|NCT00700817|484357|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
152082|NCT00700817|484358|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
152083|NCT00700817|484354|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
152084|NCT00700817|484355|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
152085|NCT00700817|484356|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
152086|NCT00700817|484357|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
152087|NCT00700817|484358|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
152088|NCT00700817|484354|P5|Week 0-26 (Main Period)|Unclassified|0
152089|NCT00700817|484355|P4|Week 0-26 (Main Period)|Unclassified|0
152090|NCT00700817|484356|P3|Week 0-26 (Main Period)|Unclassified|8
152091|NCT00700817|484357|P2|Week 0-26 (Main Period)|Unclassified|4
152092|NCT00700817|484358|P1|Week 0-26 (Main Period)|Unclassified|14
152093|NCT00700817|484354|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
152094|NCT00700817|484355|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
152095|NCT00700817|484356|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
152096|NCT00700817|484357|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
152097|NCT00700817|484358|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
152098|NCT00700817|484354|P5|Week 0-26 (Main Period)|Protocol Violation|0
152099|NCT00700817|484355|P4|Week 0-26 (Main Period)|Protocol Violation|0
152100|NCT00700817|484356|P3|Week 0-26 (Main Period)|Protocol Violation|4
152101|NCT00700817|484357|P2|Week 0-26 (Main Period)|Protocol Violation|4
152102|NCT00700817|484358|P1|Week 0-26 (Main Period)|Protocol Violation|14
152103|NCT00700817|484354|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
152104|NCT00700817|484355|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
152105|NCT00700817|484356|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
152106|NCT00700817|484357|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
152107|NCT00700817|484358|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
152108|NCT00700817|484354|P5|Week 0-26 (Main Period)|Adverse Event|0
152109|NCT00700817|484355|P4|Week 0-26 (Main Period)|Adverse Event|0
152110|NCT00700817|484356|P3|Week 0-26 (Main Period)|Adverse Event|4
152111|NCT00700817|484357|P2|Week 0-26 (Main Period)|Adverse Event|15
152112|NCT00700817|484358|P1|Week 0-26 (Main Period)|Adverse Event|14
152113|NCT00700999|484749|P2|Overall Study|Withdrawal by Subject|1
152114|NCT00700999|484750|P1|Overall Study|Withdrawal by Subject|8
152115|NCT00700999|484749|P2|Overall Study|Excluded - did not meet study criteria|1
152116|NCT00700999|484750|P1|Overall Study|Excluded - did not meet study criteria|0
152117|NCT00700999|484749|P2|Overall Study|Lost to Follow-up|7
152118|NCT00700999|484750|P1|Overall Study|Lost to Follow-up|7
152119|NCT00701038|484758|P2|Overall Study|study amended pilot group of patients|4
152120|NCT00701038|484759|P1|Overall Study|study amended pilot group of patients|4
152121|NCT00701051|484767|P3|Exercise Intervention|time conflict; non-study related illness|3
152122|NCT00701051|484768|P2|Exercise Intervention|time conflict; non-study related illness|5
152123|NCT00701051|484769|P1|Exercise Intervention|time conflict; non-study related illness|0
152124|NCT00701051|484767|P3|Screening|Time conflicts|0
152125|NCT00701051|484768|P2|Screening|Time conflicts|0
152126|NCT00701051|484769|P1|Screening|Time conflicts|19
152127|NCT00701051|484767|P3|Screening|Failed Screening|0
152128|NCT00701051|484768|P2|Screening|Failed Screening|0
152129|NCT00701051|484769|P1|Screening|Failed Screening|40
152130|NCT00701064|484787|P2|Overall Study|initiated other PTSD treatment|2
152131|NCT00701064|484788|P1|Overall Study|initiated other PTSD treatment|2
152132|NCT00701064|484787|P2|Overall Study|Withdrawal by Subject|1
152133|NCT00701064|484788|P1|Overall Study|Withdrawal by Subject|1
152134|NCT00701064|484787|P2|Overall Study|Protocol Violation|1
152135|NCT00701064|484788|P1|Overall Study|Protocol Violation|1
152136|NCT00701090|484796|P2|Overall Study|Other|12
152137|NCT00701090|484797|P1|Overall Study|Other|7
152138|NCT00701090|484796|P2|Overall Study|Withdrawal by Subject|16
152139|NCT00701090|484797|P1|Overall Study|Withdrawal by Subject|11
152140|NCT00701090|484796|P2|Overall Study|Protocol Violation|3
152141|NCT00701090|484797|P1|Overall Study|Protocol Violation|2
152142|NCT00701090|484796|P2|Overall Study|Physician Decision|4
152143|NCT00701090|484797|P1|Overall Study|Physician Decision|3
152144|NCT00701090|484796|P2|Overall Study|Lost to Follow-up|9
152145|NCT00701090|484797|P1|Overall Study|Lost to Follow-up|9
152146|NCT00701090|484796|P2|Overall Study|Lack of Efficacy|4
152147|NCT00701090|484797|P1|Overall Study|Lack of Efficacy|5
152148|NCT00701090|484796|P2|Overall Study|Death|1
152149|NCT00701090|484797|P1|Overall Study|Death|0
152150|NCT00701090|484796|P2|Overall Study|Adverse Event|2
152151|NCT00701090|484797|P1|Overall Study|Adverse Event|11
152152|NCT00701103|484824|P11|Overall Study|Unspecified|0
152153|NCT00701103|484825|P10|Overall Study|Unspecified|1
152154|NCT00701103|484826|P9|Overall Study|Unspecified|1
152155|NCT00701103|484827|P8|Overall Study|Unspecified|0
152156|NCT00701103|484828|P7|Overall Study|Unspecified|0
152157|NCT00701103|484829|P6|Overall Study|Unspecified|0
152158|NCT00701103|484830|P5|Overall Study|Unspecified|0
152159|NCT00701103|484831|P4|Overall Study|Unspecified|0
152160|NCT00701103|484832|P3|Overall Study|Unspecified|0
152161|NCT00701103|484833|P2|Overall Study|Unspecified|0
152162|NCT00701103|484834|P1|Overall Study|Unspecified|0
152163|NCT00701103|484824|P11|Overall Study|Withdrawal by Subject|0
152164|NCT00701103|484825|P10|Overall Study|Withdrawal by Subject|0
152165|NCT00701103|484826|P9|Overall Study|Withdrawal by Subject|0
152166|NCT00701103|484827|P8|Overall Study|Withdrawal by Subject|0
152167|NCT00701103|484828|P7|Overall Study|Withdrawal by Subject|0
152168|NCT00701103|484829|P6|Overall Study|Withdrawal by Subject|0
152169|NCT00701103|484830|P5|Overall Study|Withdrawal by Subject|0
152170|NCT00701103|484831|P4|Overall Study|Withdrawal by Subject|0
152171|NCT00701103|484832|P3|Overall Study|Withdrawal by Subject|1
152172|NCT00701103|484833|P2|Overall Study|Withdrawal by Subject|1
152173|NCT00701103|484834|P1|Overall Study|Withdrawal by Subject|0
152174|NCT00701103|484824|P11|Overall Study|Progressive Disease|11
152175|NCT00701103|484825|P10|Overall Study|Progressive Disease|8
152176|NCT00701103|484826|P9|Overall Study|Progressive Disease|8
152177|NCT00701103|484827|P8|Overall Study|Progressive Disease|7
152178|NCT00701103|484828|P7|Overall Study|Progressive Disease|7
152179|NCT00701103|484829|P6|Overall Study|Progressive Disease|5
152180|NCT00701103|484830|P5|Overall Study|Progressive Disease|6
152181|NCT00701103|484831|P4|Overall Study|Progressive Disease|5
152182|NCT00701103|484832|P3|Overall Study|Progressive Disease|6
152183|NCT00701103|484833|P2|Overall Study|Progressive Disease|2
152184|NCT00701103|484834|P1|Overall Study|Progressive Disease|5
152185|NCT00701103|484824|P11|Overall Study|Adverse Event|0
152186|NCT00701103|484825|P10|Overall Study|Adverse Event|2
152187|NCT00701103|484826|P9|Overall Study|Adverse Event|0
152188|NCT00701103|484827|P8|Overall Study|Adverse Event|0
152189|NCT00701103|484828|P7|Overall Study|Adverse Event|1
152190|NCT00701103|484829|P6|Overall Study|Adverse Event|1
152191|NCT00701103|484830|P5|Overall Study|Adverse Event|0
152192|NCT00701103|484831|P4|Overall Study|Adverse Event|1
152193|NCT00701103|484832|P3|Overall Study|Adverse Event|1
152194|NCT00701103|484833|P2|Overall Study|Adverse Event|0
152195|NCT00701103|484834|P1|Overall Study|Adverse Event|0
152196|NCT00701129|484938|P1|Overall Study|Death|2
152197|NCT00701311|484949|P1|Overall Study|Withdrawal by Subject|2
152198|NCT00701311|484949|P1|Overall Study|Adverse Event|3
152199|NCT00701311|484949|P1|Overall Study|Lack of Efficacy|3
152200|NCT00701363|484957|P4|Treatment Phase 2|Withdrawal by Subject|0
152201|NCT00701363|484958|P3|Treatment Phase 2|Withdrawal by Subject|1
152202|NCT00701363|484959|P2|Treatment Phase 2|Withdrawal by Subject|0
152203|NCT00701363|484960|P1|Treatment Phase 2|Withdrawal by Subject|0
152204|NCT00701363|484957|P4|Treatment Phase 2|Adverse Event|0
152205|NCT00701363|484958|P3|Treatment Phase 2|Adverse Event|1
152206|NCT00701363|484959|P2|Treatment Phase 2|Adverse Event|0
152207|NCT00701363|484960|P1|Treatment Phase 2|Adverse Event|0
152208|NCT00701363|484957|P4|Treatment Phase 1|Lack of Efficacy|0
152209|NCT00701363|484958|P3|Treatment Phase 1|Lack of Efficacy|0
152210|NCT00701363|484959|P2|Treatment Phase 1|Lack of Efficacy|0
152211|NCT00701363|484960|P1|Treatment Phase 1|Lack of Efficacy|1
152212|NCT00701363|484957|P4|Treatment Phase 1|Withdrawal by Subject|0
152213|NCT00701363|484958|P3|Treatment Phase 1|Withdrawal by Subject|0
152214|NCT00701363|484959|P2|Treatment Phase 1|Withdrawal by Subject|0
152215|NCT00701363|484960|P1|Treatment Phase 1|Withdrawal by Subject|5
152216|NCT00701363|484957|P4|Treatment Phase 1|Protocol Violation|0
152217|NCT00701363|484958|P3|Treatment Phase 1|Protocol Violation|0
152218|NCT00701363|484959|P2|Treatment Phase 1|Protocol Violation|0
152219|NCT00701363|484960|P1|Treatment Phase 1|Protocol Violation|1
152220|NCT00701363|484957|P4|Treatment Phase 1|Adverse Event|0
152221|NCT00701363|484958|P3|Treatment Phase 1|Adverse Event|0
152222|NCT00701363|484959|P2|Treatment Phase 1|Adverse Event|0
152223|NCT00701363|484960|P1|Treatment Phase 1|Adverse Event|7
152224|NCT00701363|484957|P4|Treatment Phase 1|Does not meet entry Criteria|0
152225|NCT00701363|484958|P3|Treatment Phase 1|Does not meet entry Criteria|0
152226|NCT00701363|484959|P2|Treatment Phase 1|Does not meet entry Criteria|0
152227|NCT00701363|484960|P1|Treatment Phase 1|Does not meet entry Criteria|1
152228|NCT00701363|484957|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
152229|NCT00701363|484958|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
152230|NCT00701363|484959|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
152231|NCT00701363|484960|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
152232|NCT00701415|485023|P2|Overall Study|Social/family issues and needle phobia|0
152233|NCT00701415|485024|P1|Overall Study|Social/family issues and needle phobia|1
152234|NCT00701415|485023|P2|Overall Study|Adverse Event|1
152235|NCT00701415|485024|P1|Overall Study|Adverse Event|0
152236|NCT00701441|485036|P2|Overall Study|failure in cpap compliance|4
152237|NCT00701441|485037|P1|Overall Study|failure in cpap compliance|0
152238|NCT00701558|485047|P1|Overall Study|Lost to Follow-up|8
152239|NCT00701558|485047|P1|Overall Study|Death|7
152240|NCT00701662|485061|P1|Overall Study|Lack of Efficacy|1
152241|NCT00701727|485091|P2|Second Treatment Period|Withdrawal by Subject|0
152242|NCT00701727|485092|P1|Second Treatment Period|Withdrawal by Subject|2
152243|NCT00701727|485091|P2|First Treatment Period|Lost to Follow-up|1
152244|NCT00701727|485092|P1|First Treatment Period|Lost to Follow-up|0
152245|NCT00701727|485091|P2|First Treatment Period|sponsor decision|1
152246|NCT00701727|485092|P1|First Treatment Period|sponsor decision|0
152247|NCT00701727|485091|P2|First Treatment Period|Withdrawal by Subject|0
152248|NCT00701727|485092|P1|First Treatment Period|Withdrawal by Subject|1
152249|NCT00701727|485091|P2|First Treatment Period|Adverse Event|0
152250|NCT00701727|485092|P1|First Treatment Period|Adverse Event|0
152251|NCT00701779|485110|P1|Overall Study|Withdrawal by Subject|2
152252|NCT00701779|485110|P1|Overall Study|Lost to Follow-up|1
152253|NCT00701779|485110|P1|Overall Study|Adverse Event|6
152254|NCT00701805|485123|P4|Overall Study|Resumption criteria were not met|0
152255|NCT00701805|485124|P3|Overall Study|Resumption criteria were not met|0
152256|NCT00701805|485125|P2|Overall Study|Resumption criteria were not met|1
152257|NCT00701805|485126|P1|Overall Study|Resumption criteria were not met|0
152258|NCT00701805|485123|P4|Overall Study|Difficult to travel to dialysis site|0
152259|NCT00701805|485124|P3|Overall Study|Difficult to travel to dialysis site|1
152260|NCT00701805|485125|P2|Overall Study|Difficult to travel to dialysis site|0
152261|NCT00701805|485126|P1|Overall Study|Difficult to travel to dialysis site|0
152262|NCT00701805|485123|P4|Overall Study|Physician decision, change of therapy|1
152263|NCT00701805|485124|P3|Overall Study|Physician decision, change of therapy|0
152264|NCT00701805|485125|P2|Overall Study|Physician decision, change of therapy|0
152265|NCT00701805|485126|P1|Overall Study|Physician decision, change of therapy|0
152266|NCT00701805|485123|P4|Overall Study|Admitted to hospital for 2 weeks|0
152267|NCT00701805|485124|P3|Overall Study|Admitted to hospital for 2 weeks|1
152268|NCT00701805|485125|P2|Overall Study|Admitted to hospital for 2 weeks|0
152269|NCT00701805|485126|P1|Overall Study|Admitted to hospital for 2 weeks|0
152270|NCT00701805|485123|P4|Overall Study|Missed 7 consecutive doses|0
152271|NCT00701805|485124|P3|Overall Study|Missed 7 consecutive doses|0
152272|NCT00701805|485125|P2|Overall Study|Missed 7 consecutive doses|1
152273|NCT00701805|485126|P1|Overall Study|Missed 7 consecutive doses|0
152274|NCT00701805|485123|P4|Overall Study|Adverse Event|0
152275|NCT00701805|485124|P3|Overall Study|Adverse Event|1
152276|NCT00701805|485125|P2|Overall Study|Adverse Event|1
152277|NCT00701805|485126|P1|Overall Study|Adverse Event|0
152278|NCT00701805|485123|P4|Overall Study|Withdrawal by Subject|3
152279|NCT00701805|485124|P3|Overall Study|Withdrawal by Subject|4
152280|NCT00701805|485125|P2|Overall Study|Withdrawal by Subject|1
152281|NCT00701805|485126|P1|Overall Study|Withdrawal by Subject|3
152282|NCT00694096|485224|P1|Overall Study|Withdrawal by Subject|5
152283|NCT00694109|485230|P1|Overall Study|Consented but no additional treatment|3
152284|NCT00694109|485230|P1|Overall Study|Unspecified|2
152285|NCT00694109|485230|P1|Overall Study|Enrolled but not treated|1
152286|NCT00694109|485230|P1|Overall Study|Pregnancy|1
152287|NCT00694109|485230|P1|Overall Study|Withdrawal by Subject|13
152288|NCT00694109|485230|P1|Overall Study|Lack of Efficacy|2
152289|NCT00694109|485230|P1|Overall Study|Not consent of more 2 years of treatment|18
152290|NCT00694109|485230|P1|Overall Study|Adverse Event|74
152291|NCT00694109|485230|P1|Overall Study|Physician Decision|3
152292|NCT00694122|485254|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
152293|NCT00694122|485255|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
152294|NCT00694122|485254|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
152295|NCT00694122|485255|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
152296|NCT00694122|485254|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
152297|NCT00694122|485255|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
152298|NCT00694161|485271|P1|Part 2 (After Week 6 up to Month 12)|Death|1
152299|NCT00694161|485271|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
152300|NCT00694161|485271|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
152301|NCT00694304|485310|P1|Overall Study|Administrative or Other Reasons|32
152302|NCT00694304|485310|P1|Overall Study|Lost to Follow-up|15
152303|NCT00694304|485310|P1|Overall Study|Withdrawal of Consent|61
152304|NCT00694304|485310|P1|Overall Study|Protocol Violation|6
152305|NCT00694304|485310|P1|Overall Study|Non-compliance With Study Product|16
152306|NCT00694304|485310|P1|Overall Study|Lack of Efficacy|35
152307|NCT00694304|485310|P1|Overall Study|Adverse Event|42
152308|NCT00694356|485326|P3|Overall Study|Progressive Disease|6
152309|NCT00694356|485327|P2|Overall Study|Progressive Disease|6
152310|NCT00694356|485328|P1|Overall Study|Progressive Disease|2
152311|NCT00694356|485326|P3|Overall Study|Adverse Event|0
152312|NCT00694356|485327|P2|Overall Study|Adverse Event|0
152313|NCT00694356|485328|P1|Overall Study|Adverse Event|1
152314|NCT00694369|485368|P5|Overall Study|Withdrawal by Subject|2
152315|NCT00694369|485369|P4|Overall Study|Withdrawal by Subject|1
152316|NCT00694369|485370|P3|Overall Study|Withdrawal by Subject|1
152317|NCT00694369|485371|P2|Overall Study|Withdrawal by Subject|1
152318|NCT00694369|485372|P1|Overall Study|Withdrawal by Subject|1
152319|NCT00694369|485368|P5|Overall Study|Protocol Violation|0
152320|NCT00694369|485369|P4|Overall Study|Protocol Violation|0
152321|NCT00694369|485370|P3|Overall Study|Protocol Violation|0
152322|NCT00694369|485371|P2|Overall Study|Protocol Violation|1
152323|NCT00694369|485372|P1|Overall Study|Protocol Violation|0
152324|NCT00694369|485368|P5|Overall Study|Physician Decision|1
152325|NCT00694369|485369|P4|Overall Study|Physician Decision|0
152326|NCT00694369|485370|P3|Overall Study|Physician Decision|0
152327|NCT00694369|485371|P2|Overall Study|Physician Decision|0
152328|NCT00694369|485372|P1|Overall Study|Physician Decision|0
152329|NCT00694369|485368|P5|Overall Study|Lost to Follow-up|0
152330|NCT00694369|485369|P4|Overall Study|Lost to Follow-up|1
152331|NCT00694369|485370|P3|Overall Study|Lost to Follow-up|1
152332|NCT00694369|485371|P2|Overall Study|Lost to Follow-up|0
152333|NCT00694369|485372|P1|Overall Study|Lost to Follow-up|0
152334|NCT00694369|485368|P5|Overall Study|Adverse Event|3
152335|NCT00694369|485369|P4|Overall Study|Adverse Event|1
152336|NCT00694369|485370|P3|Overall Study|Adverse Event|0
152337|NCT00694369|485371|P2|Overall Study|Adverse Event|1
152338|NCT00694369|485372|P1|Overall Study|Adverse Event|0
152339|NCT00694551|485392|P3|Overall Study|Disease Progression|1
152340|NCT00694551|485393|P2|Overall Study|Disease Progression|0
152341|NCT00694551|485394|P1|Overall Study|Disease Progression|1
152342|NCT00695019|485420|P3|Overall Study|Various|4
152343|NCT00695019|485421|P2|Overall Study|Various|5
152344|NCT00695019|485422|P1|Overall Study|Various|4
152345|NCT00695019|485420|P3|Overall Study|Lack of Efficacy|1
152346|NCT00695019|485421|P2|Overall Study|Lack of Efficacy|0
152347|NCT00695019|485422|P1|Overall Study|Lack of Efficacy|0
152348|NCT00695019|485420|P3|Overall Study|Protocol Violation|1
152349|NCT00695019|485421|P2|Overall Study|Protocol Violation|3
152350|NCT00695019|485422|P1|Overall Study|Protocol Violation|1
152351|NCT00695019|485420|P3|Overall Study|Withdrawal by Subject|4
152352|NCT00695019|485421|P2|Overall Study|Withdrawal by Subject|6
152353|NCT00695019|485422|P1|Overall Study|Withdrawal by Subject|8
152354|NCT00695136|485460|P1|Overall Study|unrelated adverse event|1
152355|NCT00695136|485460|P1|Overall Study|Withdrawal by Subject|1
152356|NCT00695318|485480|P2|Overall Study|Study Terminated|0
152357|NCT00695318|485481|P1|Overall Study|Study Terminated|1
152358|NCT00695318|485480|P2|Overall Study|Death|1
152359|NCT00695318|485481|P1|Overall Study|Death|1
152360|NCT00695318|485480|P2|Overall Study|Withdrawal by Subject|0
152361|NCT00695318|485481|P1|Overall Study|Withdrawal by Subject|2
152362|NCT00695318|485480|P2|Overall Study|Lost to Follow-up|0
152363|NCT00695318|485481|P1|Overall Study|Lost to Follow-up|1
152364|NCT00695396|485495|P3|Overall Study|Withdrawal by Subject|0
152365|NCT00695396|485496|P2|Overall Study|Withdrawal by Subject|2
152366|NCT00695396|485497|P1|Overall Study|Withdrawal by Subject|2
152367|NCT00695396|485495|P3|Overall Study|Study Closed Prematurely|8
152368|NCT00695396|485496|P2|Overall Study|Study Closed Prematurely|6
152369|NCT00695396|485497|P1|Overall Study|Study Closed Prematurely|5
152370|NCT00695565|485539|P2|Overall Study|Subject did not follow instructions|1
152371|NCT00695565|485540|P1|Overall Study|Subject did not follow instructions|1
152372|NCT00695565|485539|P2|Overall Study|Lack of Efficacy|1
152373|NCT00695565|485540|P1|Overall Study|Lack of Efficacy|1
152374|NCT00695565|485539|P2|Overall Study|Withdrawal by Subject|1
152375|NCT00695565|485540|P1|Overall Study|Withdrawal by Subject|1
152376|NCT00695565|485539|P2|Overall Study|Protocol Violation|1
152377|NCT00695565|485540|P1|Overall Study|Protocol Violation|3
152378|NCT00695565|485539|P2|Overall Study|Adverse Event|1
152379|NCT00695565|485540|P1|Overall Study|Adverse Event|3
152380|NCT00695565|485539|P2|Overall Study|Lost to Follow-up|4
152381|NCT00695565|485540|P1|Overall Study|Lost to Follow-up|4
152382|NCT00695669|485576|P4|Overall Study|Lost to Follow-up|4
152383|NCT00695669|485577|P3|Overall Study|Lost to Follow-up|1
152384|NCT00695669|485578|P2|Overall Study|Lost to Follow-up|4
152385|NCT00695669|485579|P1|Overall Study|Lost to Follow-up|4
152386|NCT00695669|485576|P4|Overall Study|Adverse Event|0
152387|NCT00695669|485577|P3|Overall Study|Adverse Event|2
152388|NCT00695669|485578|P2|Overall Study|Adverse Event|0
152389|NCT00695669|485579|P1|Overall Study|Adverse Event|0
152390|NCT00695864|485653|P1|Placebo|Physician Decision|4
152391|NCT00695864|485653|P1|Placebo|Withdrawal by Subject|1
152392|NCT00695903|485661|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
152393|NCT00695903|485662|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
152394|NCT00695903|485661|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
152395|NCT00695903|485662|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
152396|NCT00695903|485661|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
152397|NCT00695903|485662|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
152398|NCT00695903|485661|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
152399|NCT00695903|485662|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
152400|NCT00695903|485661|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
152401|NCT00695903|485662|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
152402|NCT00695903|485661|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
152403|NCT00695903|485662|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
152404|NCT00695903|485661|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
152405|NCT00695903|485662|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
152406|NCT00695903|485661|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
152407|NCT00695903|485662|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
152408|NCT00695903|485661|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
152409|NCT00695903|485662|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
152410|NCT00695955|485674|P1|Cohort 2|Other|5
152411|NCT00695955|485674|P1|Cohort 2|Lack of Efficacy|4
152412|NCT00695955|485674|P1|Cohort 2|Withdrawal by Subject|28
152413|NCT00695955|485674|P1|Cohort 2|Lost to Follow-up|38
152414|NCT00695955|485674|P1|Cohort 2|Protocol Violation|5
152415|NCT00695955|485674|P1|Cohort 2|Adverse Event|24
152416|NCT00695955|485674|P1|Cohort 1|Other|16
152417|NCT00695955|485674|P1|Cohort 1|Lack of Efficacy|3
152418|NCT00695955|485674|P1|Cohort 1|Withdrawal by Subject|25
152419|NCT00695955|485674|P1|Cohort 1|Lost to Follow-up|30
152420|NCT00695955|485674|P1|Cohort 1|Protocol Violation|2
152421|NCT00695955|485674|P1|Cohort 1|Adverse Event|26
152422|NCT00696020|485688|P4|Overall Study|Other not stated above|1
152423|NCT00696020|485689|P3|Overall Study|Other not stated above|1
152424|NCT00696020|485690|P2|Overall Study|Other not stated above|0
152425|NCT00696020|485691|P1|Overall Study|Other not stated above|0
152426|NCT00696020|485688|P4|Overall Study|Withdrawal by Subject|1
152427|NCT00696020|485689|P3|Overall Study|Withdrawal by Subject|0
152428|NCT00696020|485690|P2|Overall Study|Withdrawal by Subject|1
152429|NCT00696020|485691|P1|Overall Study|Withdrawal by Subject|0
152430|NCT00696020|485688|P4|Overall Study|Protocol Violation|1
152431|NCT00696020|485689|P3|Overall Study|Protocol Violation|0
152432|NCT00696020|485690|P2|Overall Study|Protocol Violation|0
152433|NCT00696020|485691|P1|Overall Study|Protocol Violation|0
152434|NCT00696020|485688|P4|Overall Study|Lack of Efficacy|0
152435|NCT00696020|485689|P3|Overall Study|Lack of Efficacy|0
152436|NCT00696020|485690|P2|Overall Study|Lack of Efficacy|0
152437|NCT00696020|485691|P1|Overall Study|Lack of Efficacy|1
152438|NCT00696020|485688|P4|Overall Study|Adverse Event|1
152439|NCT00696020|485689|P3|Overall Study|Adverse Event|2
152440|NCT00696020|485690|P2|Overall Study|Adverse Event|1
152441|NCT00696020|485691|P1|Overall Study|Adverse Event|3
152442|NCT00696072|485801|P2|Overall Study|Non-specified|2
152443|NCT00696072|485802|P1|Overall Study|Non-specified|1
152444|NCT00696072|485801|P2|Overall Study|Disease Progression|30
152445|NCT00696072|485802|P1|Overall Study|Disease Progression|32
152446|NCT00696072|485801|P2|Overall Study|Sponsor Request|1
152447|NCT00696072|485802|P1|Overall Study|Sponsor Request|0
152448|NCT00696072|485801|P2|Overall Study|Investigator Request|4
152449|NCT00696072|485802|P1|Overall Study|Investigator Request|1
152450|NCT00696072|485801|P2|Overall Study|Patient Request|7
152451|NCT00696072|485802|P1|Overall Study|Patient Request|3
152452|NCT00696072|485801|P2|Overall Study|Adverse Event|6
152453|NCT00696072|485802|P1|Overall Study|Adverse Event|10
152454|NCT00696072|485801|P2|Overall Study|continuing active treatment|13
152455|NCT00696072|485802|P1|Overall Study|continuing active treatment|10
152456|NCT00696241|485824|P5|Overall Study|Other|1
152457|NCT00696241|485825|P4|Overall Study|Other|2
152458|NCT00696241|485826|P3|Overall Study|Other|5
152459|NCT00696241|485827|P2|Overall Study|Other|1
152460|NCT00696241|485828|P1|Overall Study|Other|6
152461|NCT00696241|485824|P5|Overall Study|Lack of Efficacy|3
152462|NCT00696241|485825|P4|Overall Study|Lack of Efficacy|5
152463|NCT00696241|485826|P3|Overall Study|Lack of Efficacy|4
152464|NCT00696241|485827|P2|Overall Study|Lack of Efficacy|5
152465|NCT00696241|485828|P1|Overall Study|Lack of Efficacy|1
152466|NCT00696241|485824|P5|Overall Study|Withdrawal by Subject|0
152467|NCT00696241|485825|P4|Overall Study|Withdrawal by Subject|1
152468|NCT00696241|485826|P3|Overall Study|Withdrawal by Subject|6
152469|NCT00696241|485827|P2|Overall Study|Withdrawal by Subject|8
152470|NCT00696241|485828|P1|Overall Study|Withdrawal by Subject|4
152471|NCT00696241|485824|P5|Overall Study|Lost to Follow-up|0
152472|NCT00696241|485825|P4|Overall Study|Lost to Follow-up|2
152473|NCT00696241|485826|P3|Overall Study|Lost to Follow-up|1
152474|NCT00696241|485827|P2|Overall Study|Lost to Follow-up|4
152475|NCT00696241|485828|P1|Overall Study|Lost to Follow-up|1
152476|NCT00696241|485824|P5|Overall Study|Protocol Violation|3
152477|NCT00696241|485825|P4|Overall Study|Protocol Violation|0
152478|NCT00696241|485826|P3|Overall Study|Protocol Violation|2
152479|NCT00696241|485827|P2|Overall Study|Protocol Violation|1
152480|NCT00696241|485828|P1|Overall Study|Protocol Violation|1
152481|NCT00696241|485824|P5|Overall Study|Adverse Event|5
152482|NCT00696241|485825|P4|Overall Study|Adverse Event|4
152483|NCT00696241|485826|P3|Overall Study|Adverse Event|6
152484|NCT00696241|485827|P2|Overall Study|Adverse Event|3
152485|NCT00696241|485828|P1|Overall Study|Adverse Event|11
152486|NCT00696384|485915|P3|Double Blind Phase|Physician Decision|0
152487|NCT00696384|485916|P2|Double Blind Phase|Physician Decision|2
152488|NCT00696384|485917|P1|Double Blind Phase|Physician Decision|0
152489|NCT00696384|485915|P3|Double Blind Phase|Lack of Efficacy|0
152490|NCT00696384|485916|P2|Double Blind Phase|Lack of Efficacy|1
152491|NCT00696384|485917|P1|Double Blind Phase|Lack of Efficacy|0
152492|NCT00696384|485915|P3|Double Blind Phase|Withdrawal by Subject|3
152493|NCT00696384|485916|P2|Double Blind Phase|Withdrawal by Subject|4
152494|NCT00696384|485917|P1|Double Blind Phase|Withdrawal by Subject|0
152495|NCT00696384|485915|P3|Double Blind Phase|Lost to Follow-up|1
152496|NCT00696384|485916|P2|Double Blind Phase|Lost to Follow-up|2
152497|NCT00696384|485917|P1|Double Blind Phase|Lost to Follow-up|0
152498|NCT00696384|485915|P3|Double Blind Phase|Adverse Event|2
152499|NCT00696384|485916|P2|Double Blind Phase|Adverse Event|2
152500|NCT00696384|485917|P1|Double Blind Phase|Adverse Event|0
152501|NCT00696384|485915|P3|Open Label Phase|Physician Decision|0
152502|NCT00696384|485916|P2|Open Label Phase|Physician Decision|0
152503|NCT00696384|485917|P1|Open Label Phase|Physician Decision|4
152504|NCT00696384|485915|P3|Open Label Phase|Lack of Efficacy|0
152505|NCT00696384|485916|P2|Open Label Phase|Lack of Efficacy|0
152506|NCT00696384|485917|P1|Open Label Phase|Lack of Efficacy|3
152507|NCT00696384|485915|P3|Open Label Phase|Other|0
152508|NCT00696384|485916|P2|Open Label Phase|Other|0
152509|NCT00696384|485917|P1|Open Label Phase|Other|6
152510|NCT00696384|485915|P3|Open Label Phase|Withdrawal by Subject|0
152511|NCT00696384|485916|P2|Open Label Phase|Withdrawal by Subject|0
152512|NCT00696384|485917|P1|Open Label Phase|Withdrawal by Subject|37
152513|NCT00696384|485915|P3|Open Label Phase|Lost to Follow-up|0
152514|NCT00696384|485916|P2|Open Label Phase|Lost to Follow-up|0
152515|NCT00696384|485917|P1|Open Label Phase|Lost to Follow-up|24
152516|NCT00696384|485915|P3|Open Label Phase|Protocol Violation|0
152517|NCT00696384|485916|P2|Open Label Phase|Protocol Violation|0
152518|NCT00696384|485917|P1|Open Label Phase|Protocol Violation|18
152519|NCT00696384|485915|P3|Open Label Phase|Adverse Event|0
152520|NCT00696384|485916|P2|Open Label Phase|Adverse Event|0
152521|NCT00696384|485917|P1|Open Label Phase|Adverse Event|27
152522|NCT00696423|485933|P2|Overall Study|Lost to Follow-up|5
152523|NCT00696423|485934|P1|Overall Study|Lost to Follow-up|0
152524|NCT00696436|485969|P5|Overall Study|Missing|0
152525|NCT00696436|485970|P4|Overall Study|Missing|0
152526|NCT00696436|485971|P3|Overall Study|Missing|1
152527|NCT00696436|485972|P2|Overall Study|Missing|1
152528|NCT00696436|485973|P1|Overall Study|Missing|0
152529|NCT00696436|485969|P5|Overall Study|Administrative Decision|0
152530|NCT00696436|485970|P4|Overall Study|Administrative Decision|0
152531|NCT00696436|485971|P3|Overall Study|Administrative Decision|0
152532|NCT00696436|485972|P2|Overall Study|Administrative Decision|0
152533|NCT00696436|485973|P1|Overall Study|Administrative Decision|1
152534|NCT00696436|485969|P5|Overall Study|Participant Non-compliance|0
152535|NCT00696436|485970|P4|Overall Study|Participant Non-compliance|2
152536|NCT00696436|485971|P3|Overall Study|Participant Non-compliance|1
152537|NCT00696436|485972|P2|Overall Study|Participant Non-compliance|0
152538|NCT00696436|485973|P1|Overall Study|Participant Non-compliance|0
152539|NCT00696436|485969|P5|Overall Study|Administrative Error|0
152540|NCT00696436|485970|P4|Overall Study|Administrative Error|0
152541|NCT00696436|485971|P3|Overall Study|Administrative Error|2
152542|NCT00696436|485972|P2|Overall Study|Administrative Error|0
152543|NCT00696436|485973|P1|Overall Study|Administrative Error|2
152544|NCT00696436|485969|P5|Overall Study|Participant Unavailability|0
152545|NCT00696436|485970|P4|Overall Study|Participant Unavailability|1
152546|NCT00696436|485971|P3|Overall Study|Participant Unavailability|2
152547|NCT00696436|485972|P2|Overall Study|Participant Unavailability|0
152548|NCT00696436|485973|P1|Overall Study|Participant Unavailability|2
152549|NCT00696436|485969|P5|Overall Study|Lack of Efficacy|4
152550|NCT00696436|485970|P4|Overall Study|Lack of Efficacy|2
152551|NCT00696436|485971|P3|Overall Study|Lack of Efficacy|5
152552|NCT00696436|485972|P2|Overall Study|Lack of Efficacy|1
152553|NCT00696436|485973|P1|Overall Study|Lack of Efficacy|3
152554|NCT00696436|485969|P5|Overall Study|Withdrawal by Subject|1
152555|NCT00696436|485970|P4|Overall Study|Withdrawal by Subject|7
152556|NCT00696436|485971|P3|Overall Study|Withdrawal by Subject|5
152557|NCT00696436|485972|P2|Overall Study|Withdrawal by Subject|11
152558|NCT00696436|485973|P1|Overall Study|Withdrawal by Subject|4
152559|NCT00696436|485969|P5|Overall Study|Lost to Follow-up|3
152560|NCT00696436|485970|P4|Overall Study|Lost to Follow-up|4
152561|NCT00696436|485971|P3|Overall Study|Lost to Follow-up|2
152562|NCT00696436|485972|P2|Overall Study|Lost to Follow-up|6
152563|NCT00696436|485973|P1|Overall Study|Lost to Follow-up|1
152564|NCT00696436|485969|P5|Overall Study|Protocol Violation|1
152565|NCT00696436|485970|P4|Overall Study|Protocol Violation|0
152566|NCT00696436|485971|P3|Overall Study|Protocol Violation|2
152567|NCT00696436|485972|P2|Overall Study|Protocol Violation|2
152568|NCT00696436|485973|P1|Overall Study|Protocol Violation|3
152569|NCT00696436|485969|P5|Overall Study|Adverse Event|4
152570|NCT00696436|485970|P4|Overall Study|Adverse Event|6
152571|NCT00696436|485971|P3|Overall Study|Adverse Event|8
152572|NCT00696436|485972|P2|Overall Study|Adverse Event|9
152573|NCT00696436|485973|P1|Overall Study|Adverse Event|7
152574|NCT00702143|486079|P3|Overall Study|Lost to Follow-up|1
152575|NCT00702143|486080|P2|Overall Study|Lost to Follow-up|0
152576|NCT00702143|486081|P1|Overall Study|Lost to Follow-up|0
152577|NCT00702208|486093|P1|Overall Study|Unsatisfactory colposcopy|2
152578|NCT00702208|486093|P1|Overall Study|Did not self-lavage|1
152579|NCT00702208|486093|P1|Overall Study|Lost to Follow-up|28
152580|NCT00702221|486101|P2|Overall Study|Adverse Event|3
152581|NCT00702221|486102|P1|Overall Study|Adverse Event|4
152582|NCT00702325|486152|P2|Overall Study|Incorrectly Discontinued|1
152583|NCT00702325|486153|P1|Overall Study|Incorrectly Discontinued|0
152584|NCT00702325|486152|P2|Overall Study|Withdrew consent|1
152585|NCT00702325|486153|P1|Overall Study|Withdrew consent|0
152586|NCT00702325|486152|P2|Overall Study|Didn't follow study medication dosage|2
152587|NCT00702325|486153|P1|Overall Study|Didn't follow study medication dosage|0
152588|NCT00702325|486152|P2|Overall Study|Termination due to lab results|0
152589|NCT00702325|486153|P1|Overall Study|Termination due to lab results|1
152590|NCT00702325|486152|P2|Overall Study|Severe noncompliance to protocol|3
152591|NCT00702325|486153|P1|Overall Study|Severe noncompliance to protocol|3
152592|NCT00702325|486152|P2|Overall Study|Developed study discontinuation criteria|28
152593|NCT00702325|486153|P1|Overall Study|Developed study discontinuation criteria|18
152594|NCT00702325|486152|P2|Overall Study|Incorrect enrollment|7
152595|NCT00702325|486153|P1|Overall Study|Incorrect enrollment|5
152596|NCT00702325|486152|P2|Overall Study|Lost to Follow-up|4
152597|NCT00702325|486153|P1|Overall Study|Lost to Follow-up|3
152598|NCT00702325|486152|P2|Overall Study|Withdrawal by Subject|7
152599|NCT00702325|486153|P1|Overall Study|Withdrawal by Subject|7
152600|NCT00702325|486152|P2|Overall Study|Adverse Event|0
152601|NCT00702325|486153|P1|Overall Study|Adverse Event|1
152602|NCT00702403|486249|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
152603|NCT00702403|486249|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
152604|NCT00702403|486249|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
152605|NCT00702403|486249|P1|From Engraftment to Study Completion|Suicide|1
152606|NCT00702403|486249|P1|From Engraftment to Study Completion|Liver GVHD|1
152607|NCT00702403|486249|P1|From Engraftment to Study Completion|Adenocarcinoma|1
152608|NCT00702403|486249|P1|From Engraftment to Study Completion|Non-compliance|2
152609|NCT00702403|486249|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
152610|NCT00702403|486249|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
152611|NCT00702403|486249|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
152612|NCT00702403|486249|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
152613|NCT00702403|486249|P1|From Consent to Engraftment|Myocardial infarction|1
152614|NCT00702403|486249|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
152615|NCT00702403|486249|P1|From Consent to Engraftment|Critically ill|2
152616|NCT00702403|486249|P1|From Consent to Engraftment|Progressive leukemia|6
152617|NCT00702845|486281|P2|Overall Study|Not randomized|1
152618|NCT00702845|486282|P1|Overall Study|Not randomized|0
152619|NCT00702845|486281|P2|Overall Study|Patient's decision|1
152620|NCT00702845|486282|P1|Overall Study|Patient's decision|2
152621|NCT00702845|486281|P2|Overall Study|No or abnormal fertilization|2
152622|NCT00702845|486282|P1|Overall Study|No or abnormal fertilization|4
152623|NCT00702845|486281|P2|Overall Study|No/too few/bad quality embryos retrieved|1
152624|NCT00702845|486282|P1|Overall Study|No/too few/bad quality embryos retrieved|7
152625|NCT00702845|486281|P2|Overall Study|Insufficient ovarian response|0
152626|NCT00702845|486282|P1|Overall Study|Insufficient ovarian response|1
152627|NCT00702845|486281|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
152628|NCT00702845|486282|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
152629|NCT00702845|486281|P2|Overall Study|Too high ovarian response|1
152630|NCT00702845|486282|P1|Overall Study|Too high ovarian response|5
152631|NCT00702845|486281|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
152632|NCT00702845|486282|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
152633|NCT00702923|486332|P1|Overall Study|Adverse Event|1
152634|NCT00702949|486344|P3|Overall Study|Other Medical Reason/unknown|3
152635|NCT00702949|486345|P2|Overall Study|Other Medical Reason/unknown|1
152636|NCT00702949|486346|P1|Overall Study|Other Medical Reason/unknown|1
152637|NCT00702949|486344|P3|Overall Study|Adverse Event|3
152638|NCT00702949|486345|P2|Overall Study|Adverse Event|6
152639|NCT00702949|486346|P1|Overall Study|Adverse Event|1
152640|NCT00702949|486344|P3|Overall Study|Refusal|2
152641|NCT00702949|486345|P2|Overall Study|Refusal|2
152642|NCT00702949|486346|P1|Overall Study|Refusal|3
152727|NCT00704184|486980|P1|Open-Label Treatment|Physician Decision|0
152643|NCT00703014|486373|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
152644|NCT00703014|486374|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
152645|NCT00703014|486375|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
152646|NCT00703014|486376|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
152647|NCT00703014|486373|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
152648|NCT00703014|486374|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
152649|NCT00703014|486375|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
152650|NCT00703014|486376|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
152651|NCT00703092|486595|P1|Overall Study|Withdrawal by Subject|2
152652|NCT00703118|486602|P3|Overall Study|Not specified|1
152653|NCT00703118|486603|P2|Overall Study|Not specified|0
152654|NCT00703118|486604|P1|Overall Study|Not specified|0
152655|NCT00703118|486602|P3|Overall Study|Withdrawal by Subject|13
152656|NCT00703118|486603|P2|Overall Study|Withdrawal by Subject|7
152657|NCT00703118|486604|P1|Overall Study|Withdrawal by Subject|8
152658|NCT00703118|486602|P3|Overall Study|Lost to Follow-up|4
152659|NCT00703118|486603|P2|Overall Study|Lost to Follow-up|4
152660|NCT00703118|486604|P1|Overall Study|Lost to Follow-up|6
152661|NCT00703118|486602|P3|Overall Study|Subject Ineligible To Continue The Trial|2
152662|NCT00703118|486603|P2|Overall Study|Subject Ineligible To Continue The Trial|3
152663|NCT00703118|486604|P1|Overall Study|Subject Ineligible To Continue The Trial|6
152664|NCT00703118|486602|P3|Overall Study|Adverse Event|2
152665|NCT00703118|486603|P2|Overall Study|Adverse Event|2
152666|NCT00703118|486604|P1|Overall Study|Adverse Event|1
152667|NCT00703157|486637|P2|Overall Study|source data permanently lost/ other|1
152668|NCT00703157|486638|P1|Overall Study|source data permanently lost/ other|4
152669|NCT00703157|486637|P2|Overall Study|Lost to Follow-up|1
152670|NCT00703157|486638|P1|Overall Study|Lost to Follow-up|0
152671|NCT00703326|486681|P2|Overall Study|Withdrawal by Subject|20
152672|NCT00703326|486682|P1|Overall Study|Withdrawal by Subject|42
152673|NCT00703326|486681|P2|Overall Study|Lost to Follow-up|8
152674|NCT00703326|486682|P1|Overall Study|Lost to Follow-up|25
152675|NCT00703326|486681|P2|Overall Study|Still on study|197
152676|NCT00703326|486682|P1|Overall Study|Still on study|380
152677|NCT00703534|486767|P2|Overall Study|Severe Non Compliance|5
152678|NCT00703534|486768|P1|Overall Study|Severe Non Compliance|1
152679|NCT00703534|486767|P2|Overall Study|Lost to Follow-up|4
152680|NCT00703534|486768|P1|Overall Study|Lost to Follow-up|1
152681|NCT00703534|486767|P2|Overall Study|Incorrect Enrollment|6
152682|NCT00703534|486768|P1|Overall Study|Incorrect Enrollment|6
152683|NCT00703534|486767|P2|Overall Study|Withdrawal by Subject|7
152684|NCT00703534|486768|P1|Overall Study|Withdrawal by Subject|8
152685|NCT00703534|486767|P2|Overall Study|Adverse Event|3
152686|NCT00703534|486768|P1|Overall Study|Adverse Event|14
152687|NCT00703677|486774|P1|Overall Study|Dropout-withdrawal not related to drug|3
152688|NCT00703781|486826|P2|Overall Study|Cancelled surgery|0
152689|NCT00703781|486827|P1|Overall Study|Cancelled surgery|1
152690|NCT00703781|486826|P2|Overall Study|Withdrawal by Subject|2
152691|NCT00703781|486827|P1|Overall Study|Withdrawal by Subject|1
152692|NCT00703846|486835|P1|Overall Study|Did Not Receive Study Drug|2
152693|NCT00703846|486835|P1|Overall Study|Other|14
152694|NCT00703846|486835|P1|Overall Study|Death|1
152695|NCT00703846|486835|P1|Overall Study|Withdrawal by Subject|40
152696|NCT00703846|486835|P1|Overall Study|Noncompliance with Study Treatment|2
152697|NCT00703846|486835|P1|Overall Study|Lack of Efficacy|15
152698|NCT00703846|486835|P1|Overall Study|Lost to Follow-up|55
152699|NCT00703846|486835|P1|Overall Study|Adverse Event|8
152700|NCT00703911|486854|P1|Overall Study|Withdrawal by Subject|2
152701|NCT00703911|486854|P1|Overall Study|Lost to Follow-up|1
152702|NCT00703911|486854|P1|Overall Study|Physician Decision|6
152703|NCT00703911|486854|P1|Overall Study|Death|1
152704|NCT00703924|486884|P2|Overall Study|Withdrawal by Subject|1
152705|NCT00703924|486885|P1|Overall Study|Withdrawal by Subject|1
152706|NCT00703963|486912|P2|Overall Study|Physician Decision|1
152707|NCT00703963|486913|P1|Overall Study|Physician Decision|0
152708|NCT00703963|486912|P2|Overall Study|Withdrawal by Subject|13
152709|NCT00703963|486913|P1|Overall Study|Withdrawal by Subject|7
152710|NCT00704132|486945|P2|Overall Study|Withdrawal by Subject|1
152711|NCT00704132|486946|P1|Overall Study|Withdrawal by Subject|0
152712|NCT00704132|486945|P2|Overall Study|Lack of Efficacy|1
152713|NCT00704132|486946|P1|Overall Study|Lack of Efficacy|0
152714|NCT00704132|486945|P2|Overall Study|Clinical Adverse Experience|0
152715|NCT00704132|486946|P1|Overall Study|Clinical Adverse Experience|1
152716|NCT00704171|486954|P2|Overall Study|Withdrawal by Subject|0
152717|NCT00704171|486955|P1|Overall Study|Withdrawal by Subject|1
152718|NCT00704184|486976|P5|Open-Label Treatment|Withdrawal by Subject|0
152719|NCT00704184|486977|P4|Open-Label Treatment|Withdrawal by Subject|3
152720|NCT00704184|486978|P3|Open-Label Treatment|Withdrawal by Subject|0
152721|NCT00704184|486979|P2|Open-Label Treatment|Withdrawal by Subject|0
152722|NCT00704184|486980|P1|Open-Label Treatment|Withdrawal by Subject|1
152723|NCT00704184|486976|P5|Open-Label Treatment|Physician Decision|1
152724|NCT00704184|486977|P4|Open-Label Treatment|Physician Decision|0
152725|NCT00704184|486978|P3|Open-Label Treatment|Physician Decision|0
152726|NCT00704184|486979|P2|Open-Label Treatment|Physician Decision|0
152728|NCT00704184|486976|P5|Open-Label Treatment|Lack of Efficacy|1
152729|NCT00704184|486977|P4|Open-Label Treatment|Lack of Efficacy|2
152730|NCT00704184|486978|P3|Open-Label Treatment|Lack of Efficacy|2
152731|NCT00704184|486979|P2|Open-Label Treatment|Lack of Efficacy|2
152732|NCT00704184|486980|P1|Open-Label Treatment|Lack of Efficacy|0
152733|NCT00704184|486976|P5|Open-Label Treatment|Adverse Event|1
152734|NCT00704184|486977|P4|Open-Label Treatment|Adverse Event|0
152735|NCT00704184|486978|P3|Open-Label Treatment|Adverse Event|2
152736|NCT00704184|486979|P2|Open-Label Treatment|Adverse Event|0
152737|NCT00704184|486980|P1|Open-Label Treatment|Adverse Event|0
152738|NCT00704184|486976|P5|Double-Blind Treatment|Withdrawal by Subject|0
152739|NCT00704184|486977|P4|Double-Blind Treatment|Withdrawal by Subject|0
152740|NCT00704184|486978|P3|Double-Blind Treatment|Withdrawal by Subject|0
152741|NCT00704184|486979|P2|Double-Blind Treatment|Withdrawal by Subject|0
152742|NCT00704184|486980|P1|Double-Blind Treatment|Withdrawal by Subject|1
152743|NCT00704340|487019|P2|Overall Study|Death|1
152744|NCT00704340|487020|P1|Overall Study|Death|0
152745|NCT00704340|487019|P2|Overall Study|Lost to Follow-up|1
152746|NCT00704340|487020|P1|Overall Study|Lost to Follow-up|2
152747|NCT00704405|487063|P5|Overall Study (C Population)|Lost to Follow-up|0
152748|NCT00704405|487064|P4|Overall Study (C Population)|Lost to Follow-up|0
152749|NCT00704405|487065|P3|Overall Study (C Population)|Lost to Follow-up|0
152750|NCT00704405|487066|P2|Overall Study (C Population)|Lost to Follow-up|2
152751|NCT00704405|487067|P1|Overall Study (C Population)|Lost to Follow-up|0
152752|NCT00704405|487063|P5|Overall Study (C Population)|Withdrawal by Subject|0
152753|NCT00704405|487064|P4|Overall Study (C Population)|Withdrawal by Subject|1
152754|NCT00704405|487065|P3|Overall Study (C Population)|Withdrawal by Subject|1
152755|NCT00704405|487066|P2|Overall Study (C Population)|Withdrawal by Subject|1
152756|NCT00704405|487067|P1|Overall Study (C Population)|Withdrawal by Subject|1
152757|NCT00704405|487063|P5|Overall Study (NC Population)|Other|1
152758|NCT00704405|487064|P4|Overall Study (NC Population)|Other|0
152759|NCT00704405|487065|P3|Overall Study (NC Population)|Other|0
152760|NCT00704405|487066|P2|Overall Study (NC Population)|Other|0
152761|NCT00704405|487067|P1|Overall Study (NC Population)|Other|0
152762|NCT00704405|487063|P5|Overall Study (NC Population)|Withdrawal by Subject|2
152763|NCT00704405|487064|P4|Overall Study (NC Population)|Withdrawal by Subject|2
152764|NCT00704405|487065|P3|Overall Study (NC Population)|Withdrawal by Subject|2
152765|NCT00704405|487066|P2|Overall Study (NC Population)|Withdrawal by Subject|3
152766|NCT00704405|487067|P1|Overall Study (NC Population)|Withdrawal by Subject|2
152767|NCT00704405|487063|P5|Overall Study (NC Population)|Lost to Follow-up|2
152768|NCT00704405|487064|P4|Overall Study (NC Population)|Lost to Follow-up|2
152769|NCT00704405|487065|P3|Overall Study (NC Population)|Lost to Follow-up|1
152770|NCT00704405|487066|P2|Overall Study (NC Population)|Lost to Follow-up|1
152771|NCT00704405|487067|P1|Overall Study (NC Population)|Lost to Follow-up|2
152772|NCT00704405|487063|P5|Overall Study (NC Population)|Adverse Event|0
152773|NCT00704405|487064|P4|Overall Study (NC Population)|Adverse Event|0
152774|NCT00704405|487065|P3|Overall Study (NC Population)|Adverse Event|0
152775|NCT00704405|487066|P2|Overall Study (NC Population)|Adverse Event|0
152776|NCT00704405|487067|P1|Overall Study (NC Population)|Adverse Event|1
152777|NCT00704418|487097|P2|Overall Study|Over-enrolled/surgery postponed|6
152778|NCT00704418|487098|P1|Overall Study|Over-enrolled/surgery postponed|3
152779|NCT00704418|487097|P2|Overall Study|Withdrawal by Subject|0
152780|NCT00704418|487098|P1|Overall Study|Withdrawal by Subject|2
152781|NCT00704522|487108|P2|Overall Study|No information on therapy end|2
152782|NCT00704522|487109|P1|Overall Study|No information on therapy end|27
152783|NCT00704522|487108|P2|Overall Study|Undefined causes|7
152784|NCT00704522|487109|P1|Overall Study|Undefined causes|9
152785|NCT00704522|487108|P2|Overall Study|Adverse Event|1
152786|NCT00704522|487109|P1|Overall Study|Adverse Event|9
152787|NCT00704522|487108|P2|Overall Study|Withdrawal by Subject|8
152788|NCT00704522|487109|P1|Overall Study|Withdrawal by Subject|17
152789|NCT00704522|487108|P2|Overall Study|Failure to appear again at hospital|10
152790|NCT00704522|487109|P1|Overall Study|Failure to appear again at hospital|56
152791|NCT00704522|487108|P2|Overall Study|Lack of Efficacy|17
152792|NCT00704522|487109|P1|Overall Study|Lack of Efficacy|65
152793|NCT00704535|487116|P1|Overall Study|Completed status not on Case Report Form|124
152794|NCT00704535|487116|P1|Overall Study|Protocol Violation|10
152795|NCT00704535|487116|P1|Overall Study|Lost to Follow-up|8
152796|NCT00704535|487116|P1|Overall Study|Death|2
152797|NCT00704535|487116|P1|Overall Study|Adverse Event|2
152798|NCT00704730|487133|P2|Overall Study|Withdrawal by Subject|13
152799|NCT00704730|487134|P1|Overall Study|Withdrawal by Subject|9
152800|NCT00704730|487133|P2|Overall Study|data unavailable|0
152801|NCT00704730|487134|P1|Overall Study|data unavailable|1
152802|NCT00704730|487133|P2|Overall Study|Disease progression per PI|67
152803|NCT00704730|487134|P1|Overall Study|Disease progression per PI|58
152804|NCT00704730|487133|P2|Overall Study|Did not receive drug|2
152805|NCT00704730|487134|P1|Overall Study|Did not receive drug|5
152806|NCT00704730|487133|P2|Overall Study|Physician Decision|0
152807|NCT00704730|487134|P1|Overall Study|Physician Decision|2
152808|NCT00704730|487133|P2|Overall Study|Death|5
152809|NCT00704730|487134|P1|Overall Study|Death|11
152810|NCT00704730|487133|P2|Overall Study|Adverse Event|9
152811|NCT00704730|487134|P1|Overall Study|Adverse Event|35
152812|NCT00704808|487155|P1|Overall Study|Treatment change|1
152813|NCT00704808|487155|P1|Overall Study|Lost to Follow-up|1
152814|NCT00704808|487155|P1|Overall Study|Adverse Event|1
152815|NCT00704808|487155|P1|Overall Study|Early therapy discontinuation|16
152816|NCT00704808|487155|P1|Overall Study|Patient's decision|11
152817|NCT00704808|487155|P1|Overall Study|Tumor progression|80
152818|NCT00704808|487155|P1|Overall Study|Death|7
152819|NCT00704808|487155|P1|Overall Study|Discontinued prior to starting treatment|14
152820|NCT00704964|487203|P1|Overall Study|Not completed on time|328
152821|NCT00705016|487236|P3|Overall Study|Unspecified|6
152822|NCT00705016|487237|P2|Overall Study|Unspecified|6
152823|NCT00705016|487238|P1|Overall Study|Unspecified|9
152824|NCT00705016|487236|P3|Overall Study|Symptomatic Deterioration|1
152825|NCT00705016|487237|P2|Overall Study|Symptomatic Deterioration|1
152826|NCT00705016|487238|P1|Overall Study|Symptomatic Deterioration|3
152827|NCT00705016|487236|P3|Overall Study|Progressive Disease|33
152828|NCT00705016|487237|P2|Overall Study|Progressive Disease|29
152829|NCT00705016|487238|P1|Overall Study|Progressive Disease|33
152830|NCT00705016|487236|P3|Overall Study|Withdrawal by Subject|2
152831|NCT00705016|487237|P2|Overall Study|Withdrawal by Subject|3
152832|NCT00705016|487238|P1|Overall Study|Withdrawal by Subject|4
152833|NCT00705016|487236|P3|Overall Study|Protocol Violation|1
152834|NCT00705016|487237|P2|Overall Study|Protocol Violation|1
152835|NCT00705016|487238|P1|Overall Study|Protocol Violation|0
152836|NCT00705016|487236|P3|Overall Study|Death|5
152837|NCT00705016|487237|P2|Overall Study|Death|7
152838|NCT00705016|487238|P1|Overall Study|Death|5
152839|NCT00705016|487236|P3|Overall Study|Adverse Event|10
152840|NCT00705016|487237|P2|Overall Study|Adverse Event|11
152841|NCT00705016|487238|P1|Overall Study|Adverse Event|6
152842|NCT00705146|487284|P2|Overall Study|Lost to Follow-up|1
152843|NCT00705146|487285|P1|Overall Study|Lost to Follow-up|1
152844|NCT00705159|487297|P4|Overall Study|Screen Failure|1
152845|NCT00705159|487298|P3|Overall Study|Screen Failure|0
152846|NCT00705159|487299|P2|Overall Study|Screen Failure|0
152847|NCT00705159|487300|P1|Overall Study|Screen Failure|0
152848|NCT00705159|487297|P4|Overall Study|Lost to Follow-up|2
152849|NCT00705159|487298|P3|Overall Study|Lost to Follow-up|3
152850|NCT00705159|487299|P2|Overall Study|Lost to Follow-up|0
152851|NCT00705159|487300|P1|Overall Study|Lost to Follow-up|0
152852|NCT00705159|487297|P4|Overall Study|Adverse Event|0
152853|NCT00705159|487298|P3|Overall Study|Adverse Event|1
152854|NCT00705159|487299|P2|Overall Study|Adverse Event|0
152855|NCT00705159|487300|P1|Overall Study|Adverse Event|0
152856|NCT00705159|487297|P4|Overall Study|Protocol Violation|0
152857|NCT00705159|487298|P3|Overall Study|Protocol Violation|0
152858|NCT00705159|487299|P2|Overall Study|Protocol Violation|1
152859|NCT00705159|487300|P1|Overall Study|Protocol Violation|0
152860|NCT00705159|487297|P4|Overall Study|Withdrawal by Subject|1
152861|NCT00705159|487298|P3|Overall Study|Withdrawal by Subject|1
152862|NCT00705159|487299|P2|Overall Study|Withdrawal by Subject|1
152863|NCT00705159|487300|P1|Overall Study|Withdrawal by Subject|0
152864|NCT00705224|487318|P1|Overall Study|Lost to Follow-up|5
152865|NCT00705224|487318|P1|Overall Study|Withdrawal by Subject|3
152866|NCT00705224|487318|P1|Overall Study|Lack of Efficacy|2
152867|NCT00705224|487318|P1|Overall Study|Adverse Event|1
152868|NCT00692406|487330|P1|Overall Study|PI dropped, bad data|57
152869|NCT00692770|487363|P2|Overall Study|Randomized but not treated|4
152870|NCT00692770|487364|P1|Overall Study|Randomized but not treated|3
152871|NCT00692770|487363|P2|Overall Study|Study terminated by sponsor|2
152872|NCT00692770|487364|P1|Overall Study|Study terminated by sponsor|2
152873|NCT00692770|487363|P2|Overall Study|Clinical endpoint reached|43
152874|NCT00692770|487364|P1|Overall Study|Clinical endpoint reached|16
152875|NCT00692770|487363|P2|Overall Study|Radiological and clinical progression|8
152876|NCT00692770|487364|P1|Overall Study|Radiological and clinical progression|8
152877|NCT00692770|487363|P2|Overall Study|Completed all planned assessments|101
152878|NCT00692770|487364|P1|Overall Study|Completed all planned assessments|79
152879|NCT00692770|487363|P2|Overall Study|Protocol driven decision point|7
152880|NCT00692770|487364|P1|Overall Study|Protocol driven decision point|3
152881|NCT00692770|487363|P2|Overall Study|Disease progression, recurrence/relapse|279
152882|NCT00692770|487364|P1|Overall Study|Disease progression, recurrence/relapse|170
152883|NCT00692770|487363|P2|Overall Study|Physician decision not protocol driven|14
152884|NCT00692770|487364|P1|Overall Study|Physician decision not protocol driven|10
152885|NCT00692770|487363|P2|Overall Study|Progression by clinical judgment|3
152886|NCT00692770|487364|P1|Overall Study|Progression by clinical judgment|2
152887|NCT00692770|487363|P2|Overall Study|Non-compliant with study medication|5
152888|NCT00692770|487364|P1|Overall Study|Non-compliant with study medication|11
152889|NCT00692770|487363|P2|Overall Study|Lost to Follow-up|3
152890|NCT00692770|487364|P1|Overall Study|Lost to Follow-up|7
152891|NCT00692770|487363|P2|Overall Study|Death|5
152892|NCT00692770|487364|P1|Overall Study|Death|10
152893|NCT00692770|487363|P2|Overall Study|Adverse Event|41
152894|NCT00692770|487364|P1|Overall Study|Adverse Event|136
152895|NCT00692770|487363|P2|Overall Study|Withdrawal by Subject|36
152896|NCT00692770|487364|P1|Overall Study|Withdrawal by Subject|97
152897|NCT00692770|487363|P2|Overall Study|Protocol Violation|7
152898|NCT00692770|487364|P1|Overall Study|Protocol Violation|2
152899|NCT00692913|487384|P2|Overall Study|Withdrawal by Subject|20
152900|NCT00692913|487385|P1|Overall Study|Withdrawal by Subject|15
152901|NCT00692913|487384|P2|Overall Study|Protocol Violation|1
152902|NCT00692913|487385|P1|Overall Study|Protocol Violation|1
152903|NCT00692913|487384|P2|Overall Study|Physician Decision|0
152904|NCT00692913|487385|P1|Overall Study|Physician Decision|2
152905|NCT00692913|487384|P2|Overall Study|Lost to Follow-up|5
152906|NCT00692913|487385|P1|Overall Study|Lost to Follow-up|3
152907|NCT00692913|487384|P2|Overall Study|Adverse Event|4
152908|NCT00692913|487385|P1|Overall Study|Adverse Event|8
152909|NCT00693017|487407|P2|Overall Study|Death|1
152910|NCT00693017|487408|P1|Overall Study|Death|0
152911|NCT00693017|487407|P2|Overall Study|Sponsor Decision|1
152912|NCT00693017|487408|P1|Overall Study|Sponsor Decision|2
152913|NCT00693225|487429|P2|Overall Study|Adverse Event|3
152914|NCT00693225|487430|P1|Overall Study|Adverse Event|1
152915|NCT00693225|487429|P2|Overall Study|Lost to Follow-up|2
152916|NCT00693225|487430|P1|Overall Study|Lost to Follow-up|1
152917|NCT00693420|487455|P2|Overall Study|Personal Reasons|4
152918|NCT00693420|487456|P1|Overall Study|Personal Reasons|1
152919|NCT00693420|487455|P2|Overall Study|Sponsor Request - Conflict of Interest|2
152920|NCT00693420|487456|P1|Overall Study|Sponsor Request - Conflict of Interest|0
152921|NCT00693420|487455|P2|Overall Study|Protocol Violation|2
152922|NCT00693420|487456|P1|Overall Study|Protocol Violation|0
152923|NCT00693420|487455|P2|Overall Study|Withdrawal by Subject|0
152924|NCT00693420|487456|P1|Overall Study|Withdrawal by Subject|1
152925|NCT00693420|487455|P2|Overall Study|Lost to Follow-up|3
152926|NCT00693420|487456|P1|Overall Study|Lost to Follow-up|0
152927|NCT00693420|487455|P2|Overall Study|Adverse Event|4
152928|NCT00693420|487456|P1|Overall Study|Adverse Event|4
152929|NCT00693472|487484|P4|Part 2|Withdrew - reason unrelated to treatment|2
152930|NCT00693472|487485|P3|Part 2|Withdrew - reason unrelated to treatment|1
152931|NCT00693472|487486|P2|Part 2|Withdrew - reason unrelated to treatment|0
152932|NCT00693472|487487|P1|Part 2|Withdrew - reason unrelated to treatment|0
152933|NCT00693472|487484|P4|Part 2|Adverse Event|0
152934|NCT00693472|487485|P3|Part 2|Adverse Event|1
152935|NCT00693472|487486|P2|Part 2|Adverse Event|0
152936|NCT00693472|487487|P1|Part 2|Adverse Event|0
152937|NCT00693472|487484|P4|Part 1|Withdrew - reason unrelated to treatment|0
152938|NCT00693472|487485|P3|Part 1|Withdrew - reason unrelated to treatment|0
152939|NCT00693472|487486|P2|Part 1|Withdrew - reason unrelated to treatment|2
152940|NCT00693472|487487|P1|Part 1|Withdrew - reason unrelated to treatment|5
152941|NCT00693472|487484|P4|Part 1|Lost to Follow-up|0
152942|NCT00693472|487485|P3|Part 1|Lost to Follow-up|0
152943|NCT00693472|487486|P2|Part 1|Lost to Follow-up|1
152944|NCT00693472|487487|P1|Part 1|Lost to Follow-up|0
152945|NCT00693472|487484|P4|Part 1|Adverse Event|0
152946|NCT00693472|487485|P3|Part 1|Adverse Event|0
152947|NCT00693472|487486|P2|Part 1|Adverse Event|1
152948|NCT00693472|487487|P1|Part 1|Adverse Event|1
152949|NCT00693693|487553|P3|Overall Study|Lost to Follow-up|2
152950|NCT00693693|487554|P2|Overall Study|Lost to Follow-up|1
152951|NCT00693693|487555|P1|Overall Study|Lost to Follow-up|1
152952|NCT00693706|487565|P2|Overall Study|Protocol Violation|1
152953|NCT00693706|487566|P1|Overall Study|Protocol Violation|0
152954|NCT00693784|487595|P1|Overall Study|Withdrawal by Subject|2
152955|NCT00693784|487595|P1|Overall Study|Lost to Follow-up|2
152956|NCT00699582|487653|P3|Overall Study|Randomized, Not Treated|0
152957|NCT00699582|487654|P2|Overall Study|Randomized, Not Treated|1
152958|NCT00699582|487655|P1|Overall Study|Randomized, Not Treated|2
152959|NCT00699582|487653|P3|Overall Study|Administrative/Other|0
152960|NCT00699582|487654|P2|Overall Study|Administrative/Other|3
152961|NCT00699582|487655|P1|Overall Study|Administrative/Other|4
152962|NCT00699582|487653|P3|Overall Study|Progressive Disease|0
152963|NCT00699582|487654|P2|Overall Study|Progressive Disease|0
152964|NCT00699582|487655|P1|Overall Study|Progressive Disease|1
152965|NCT00699582|487653|P3|Overall Study|Lack of Efficacy|1
152966|NCT00699582|487654|P2|Overall Study|Lack of Efficacy|0
152967|NCT00699582|487655|P1|Overall Study|Lack of Efficacy|1
152968|NCT00699582|487653|P3|Overall Study|Withdrawal by Subject|4
152969|NCT00699582|487654|P2|Overall Study|Withdrawal by Subject|7
152970|NCT00699582|487655|P1|Overall Study|Withdrawal by Subject|6
152971|NCT00699582|487653|P3|Overall Study|Adverse Event|23
152972|NCT00699582|487654|P2|Overall Study|Adverse Event|11
152973|NCT00699582|487655|P1|Overall Study|Adverse Event|4
152974|NCT00705250|487669|P1|Overall Study|Patient died in car accident|1
152975|NCT00705250|487669|P1|Overall Study|Withdrawal by Subject|1
152976|NCT00705263|487673|P1|Overall Study|Withdrawal by Subject|2
152977|NCT00705289|487677|P1|Overall Study|Subject or treating physician's choice|131
152978|NCT00705341|487703|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
152979|NCT00705341|487704|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
152980|NCT00705341|487705|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
152981|NCT00705341|487706|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
152982|NCT00705341|487703|P4|Phase 2: Trial|Withdrawal by Subject|4
152983|NCT00705341|487704|P3|Phase 2: Trial|Withdrawal by Subject|6
152984|NCT00705341|487705|P2|Phase 2: Trial|Withdrawal by Subject|0
152985|NCT00705341|487706|P1|Phase 2: Trial|Withdrawal by Subject|0
152986|NCT00705367|487716|P2|Long-term Extension Period|Administrative reason by sponsor|0
152987|NCT00705367|487717|P1|Long-term Extension Period|Administrative reason by sponsor|3
152988|NCT00705367|487716|P2|Long-term Extension Period|No longer met study criteria|0
152989|NCT00705367|487717|P1|Long-term Extension Period|No longer met study criteria|1
152990|NCT00705367|487716|P2|Long-term Extension Period|Lack of Efficacy|0
152991|NCT00705367|487717|P1|Long-term Extension Period|Lack of Efficacy|1
152992|NCT00705367|487716|P2|Long-term Extension Period|Withdrawal by Subject|0
152993|NCT00705367|487717|P1|Long-term Extension Period|Withdrawal by Subject|2
152994|NCT00705367|487716|P2|Long-term Extension Period|Adverse Event|0
152995|NCT00705367|487717|P1|Long-term Extension Period|Adverse Event|2
152996|NCT00705406|487744|P2|Overall Study|Did not receive study drug|2
152997|NCT00705406|487745|P1|Overall Study|Did not receive study drug|1
152998|NCT00705406|487744|P2|Overall Study|Lost to Follow-up|3
152999|NCT00705406|487745|P1|Overall Study|Lost to Follow-up|3
153000|NCT00705432|487773|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
153001|NCT00705432|487774|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
153002|NCT00705432|487775|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
153003|NCT00705432|487776|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
153004|NCT00705432|487777|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
153005|NCT00705432|487778|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
153006|NCT00705432|487773|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
153007|NCT00705432|487774|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
153008|NCT00705432|487775|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
153009|NCT00705432|487776|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
153010|NCT00705432|487777|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
153011|NCT00705432|487778|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
153012|NCT00705432|487773|P6|Treatment Period|Non medical reason|7
153013|NCT00705432|487774|P5|Treatment Period|Non medical reason|7
153014|NCT00705432|487775|P4|Treatment Period|Non medical reason|4
153015|NCT00705432|487776|P3|Treatment Period|Non medical reason|37
153016|NCT00705432|487777|P2|Treatment Period|Non medical reason|32
153017|NCT00705432|487778|P1|Treatment Period|Non medical reason|26
153018|NCT00705432|487773|P6|Treatment Period|Treatment failure|14
153019|NCT00705432|487774|P5|Treatment Period|Treatment failure|13
153020|NCT00705432|487775|P4|Treatment Period|Treatment failure|25
153021|NCT00705432|487776|P3|Treatment Period|Treatment failure|33
153022|NCT00705432|487777|P2|Treatment Period|Treatment failure|42
153023|NCT00705432|487778|P1|Treatment Period|Treatment failure|92
153024|NCT00705432|487773|P6|Treatment Period|Adverse Event|9
153025|NCT00705432|487774|P5|Treatment Period|Adverse Event|8
153026|NCT00705432|487775|P4|Treatment Period|Adverse Event|12
153027|NCT00705432|487776|P3|Treatment Period|Adverse Event|51
153028|NCT00705432|487777|P2|Treatment Period|Adverse Event|37
153029|NCT00705432|487778|P1|Treatment Period|Adverse Event|45
153030|NCT00705523|487815|P2|Overall Study|Lost to Follow-up|3
153031|NCT00705523|487816|P1|Overall Study|Lost to Follow-up|2
153032|NCT00705536|487826|P4|Start Period 1|Withdrawal by Subject|1
153033|NCT00705536|487827|P3|Start Period 1|Withdrawal by Subject|0
153034|NCT00705536|487828|P2|Start Period 1|Withdrawal by Subject|0
153035|NCT00705536|487829|P1|Start Period 1|Withdrawal by Subject|0
153036|NCT00705575|487890|P2|Overall Study|Withdrawal by Subject|10
153037|NCT00705575|487891|P1|Overall Study|Withdrawal by Subject|5
153038|NCT00705575|487890|P2|Overall Study|Protocol Violation|2
153039|NCT00705575|487891|P1|Overall Study|Protocol Violation|2
153040|NCT00705575|487890|P2|Overall Study|Lost to Follow-up|4
153041|NCT00705575|487891|P1|Overall Study|Lost to Follow-up|3
153042|NCT00705575|487890|P2|Overall Study|Adverse Event|15
153043|NCT00705575|487891|P1|Overall Study|Adverse Event|11
153044|NCT00705575|487890|P2|Overall Study|Abnormal test procedure result(s)|12
153045|NCT00705575|487891|P1|Overall Study|Abnormal test procedure result(s)|2
153046|NCT00705575|487890|P2|Overall Study|Abnormal laboratory value(s)|3
153047|NCT00705575|487891|P1|Overall Study|Abnormal laboratory value(s)|0
153048|NCT00708305|487903|P4|Period 3|Other Reason|0
153049|NCT00708305|487904|P3|Period 3|Other Reason|0
153050|NCT00708305|487905|P2|Period 3|Other Reason|0
153051|NCT00708305|487906|P1|Period 3|Other Reason|1
153052|NCT00708305|487903|P4|Period 3|Protocol Violation|0
153053|NCT00708305|487904|P3|Period 3|Protocol Violation|0
153054|NCT00708305|487905|P2|Period 3|Protocol Violation|2
153055|NCT00708305|487906|P1|Period 3|Protocol Violation|0
153056|NCT00708305|487903|P4|Period 2|Other Reason|1
153057|NCT00708305|487904|P3|Period 2|Other Reason|0
153058|NCT00708305|487905|P2|Period 2|Other Reason|0
153059|NCT00708305|487906|P1|Period 2|Other Reason|1
153060|NCT00708305|487903|P4|Period 2|Protocol Violation|0
153061|NCT00708305|487904|P3|Period 2|Protocol Violation|0
153062|NCT00708305|487905|P2|Period 2|Protocol Violation|1
153063|NCT00708305|487906|P1|Period 2|Protocol Violation|0
153064|NCT00708305|487903|P4|Period 2|Lost to Follow-up|0
153065|NCT00708305|487904|P3|Period 2|Lost to Follow-up|0
153066|NCT00708305|487905|P2|Period 2|Lost to Follow-up|1
153067|NCT00708305|487906|P1|Period 2|Lost to Follow-up|0
153068|NCT00708305|487903|P4|Period 1|Other Reason|2
153069|NCT00708305|487904|P3|Period 1|Other Reason|0
153070|NCT00708305|487905|P2|Period 1|Other Reason|0
153071|NCT00708305|487906|P1|Period 1|Other Reason|0
153072|NCT00708305|487903|P4|Period 1|Protocol Violation|0
153073|NCT00708305|487904|P3|Period 1|Protocol Violation|1
153074|NCT00708305|487905|P2|Period 1|Protocol Violation|0
153075|NCT00708305|487906|P1|Period 1|Protocol Violation|1
153076|NCT00708422|487940|P2|Overall Study|Withdrawal by Subject|0
153077|NCT00708422|487941|P1|Overall Study|Withdrawal by Subject|1
153078|NCT00708422|487940|P2|Overall Study|Adverse Event|1
153079|NCT00708422|487941|P1|Overall Study|Adverse Event|3
153080|NCT00708435|487951|P2|Overall Study|Refused hospitalization|0
153081|NCT00708435|487952|P1|Overall Study|Refused hospitalization|1
153082|NCT00708435|487951|P2|Overall Study|Intervention by primary care physician|0
153083|NCT00708435|487952|P1|Overall Study|Intervention by primary care physician|1
153084|NCT00708435|487951|P2|Overall Study|Protocol Violation|1
153085|NCT00708435|487952|P1|Overall Study|Protocol Violation|0
153086|NCT00708435|487951|P2|Overall Study|Adverse Event|0
153087|NCT00708435|487952|P1|Overall Study|Adverse Event|1
153088|NCT00708435|487951|P2|Overall Study|Withdrawal by Subject|7
153089|NCT00708435|487952|P1|Overall Study|Withdrawal by Subject|3
153090|NCT00708435|487951|P2|Overall Study|Lost to Follow-up|4
153091|NCT00708435|487952|P1|Overall Study|Lost to Follow-up|9
153092|NCT00708435|487951|P2|Overall Study|Death / Serious Adverse Event|5
153093|NCT00708435|487952|P1|Overall Study|Death / Serious Adverse Event|10
153094|NCT00708461|487979|P2|Overall Study|left workforce|180
153095|NCT00708461|487980|P1|Overall Study|left workforce|115
153096|NCT00708461|487979|P2|Overall Study|Withdrawal by Subject|9
153097|NCT00708461|487980|P1|Overall Study|Withdrawal by Subject|8
153098|NCT00708461|487979|P2|Overall Study|Lost to Follow-up|11
153099|NCT00708461|487980|P1|Overall Study|Lost to Follow-up|18
153100|NCT00708500|487989|P3|FOLLOWUP|Non-compliance with protocol|1
153101|NCT00708500|487990|P2|FOLLOWUP|Non-compliance with protocol|0
153102|NCT00708500|487991|P1|FOLLOWUP|Non-compliance with protocol|5
153103|NCT00708500|487989|P3|FOLLOWUP|Subject withdrew consent|5
153104|NCT00708500|487990|P2|FOLLOWUP|Subject withdrew consent|4
153105|NCT00708500|487991|P1|FOLLOWUP|Subject withdrew consent|31
153106|NCT00708500|487989|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
153107|NCT00708500|487990|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
153108|NCT00708500|487991|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
153109|NCT00708500|487989|P3|FOLLOWUP|Lost to Follow-up|4
153110|NCT00708500|487990|P2|FOLLOWUP|Lost to Follow-up|6
153111|NCT00708500|487991|P1|FOLLOWUP|Lost to Follow-up|1
153112|NCT00708500|487989|P3|FOLLOWUP|Adverse Event|0
153113|NCT00708500|487990|P2|FOLLOWUP|Adverse Event|1
153114|NCT00708500|487991|P1|FOLLOWUP|Adverse Event|0
153115|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
153116|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
153117|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
153118|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
153119|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
153120|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
153121|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
153122|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
153123|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
153124|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
153125|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
153126|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
153127|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
153128|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
153129|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
153130|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
153131|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
153132|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
153133|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
153134|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
153135|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
153136|NCT00708500|487989|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
153137|NCT00708500|487990|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
153138|NCT00708500|487991|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
153139|NCT00708500|487989|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
153140|NCT00708500|487990|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
153141|NCT00708500|487991|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
153142|NCT00708500|487989|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
153143|NCT00708500|487990|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
153144|NCT00708500|487991|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
153145|NCT00708500|487989|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
153146|NCT00708500|487990|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
153147|NCT00708500|487991|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
153148|NCT00708500|487989|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
153149|NCT00708500|487990|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
153150|NCT00708500|487991|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
153151|NCT00708500|487989|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
153152|NCT00708500|487990|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
153153|NCT00708500|487991|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
153154|NCT00708643|488021|P2|Overall Study|Adverse Event|1
153155|NCT00708643|488022|P1|Overall Study|Adverse Event|0
153156|NCT00708682|488038|P1|Toddler Dose|Failed to Return|4
153157|NCT00708682|488038|P1|Toddler Dose|Lost to Follow-up|3
153158|NCT00708682|488038|P1|Toddler Dose|Parent/Legal Guardian Request|1
153159|NCT00708682|488038|P1|After Infant Series|Parent/Legal Guardian Request|1
153160|NCT00708682|488038|P1|Infant Series|Not Specified|19
153161|NCT00708682|488038|P1|Infant Series|Failed to return|2
153162|NCT00708682|488038|P1|Infant Series|Parent/legal guardian request|6
153163|NCT00708682|488038|P1|Infant Series|Protocol Violation|1
153164|NCT00708682|488038|P1|Infant Series|Lost to Follow-up|4
153165|NCT00708682|488038|P1|Infant Series|Adverse Event|1
153166|NCT00708708|488057|P1|Overall Study|Missing values|392
153167|NCT00708708|488057|P1|Overall Study|Adverse Event|3
153168|NCT00708708|488057|P1|Overall Study|Pregnancy|3
153169|NCT00708708|488057|P1|Overall Study|Lack of compliance|3
153170|NCT00708708|488057|P1|Overall Study|Lack of effectiveness|4
153171|NCT00708708|488057|P1|Overall Study|Administrative reasons|7
153172|NCT00708708|488057|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
153173|NCT00708708|488057|P1|Overall Study|Good effectiveness|9
153174|NCT00708708|488057|P1|Overall Study|Other unspecified|11
153175|NCT00708708|488057|P1|Overall Study|Another therapy along with Enbrel|15
153176|NCT00708708|488057|P1|Overall Study|Intolerance|42
153177|NCT00708708|488057|P1|Overall Study|Withdrawal by Subject|51
153178|NCT00708708|488057|P1|Overall Study|Lost to Follow-up|52
153179|NCT00708708|488057|P1|Overall Study|Another therapy instead of Enbrel|141
153180|NCT00708734|488121|P1|Overall Study|leg fracture|1
153181|NCT00708734|488121|P1|Overall Study|vertigo|1
153182|NCT00708734|488121|P1|Overall Study|knee replacement|1
153183|NCT00708734|488121|P1|Overall Study|leg injury|1
153184|NCT00708734|488121|P1|Overall Study|moved|1
153185|NCT00708734|488121|P1|Overall Study|scheduling conflict|2
153186|NCT00709059|488168|P1|Overall Study|Serious side effects|11
153187|NCT00709059|488168|P1|Overall Study|Side effects|20
153188|NCT00709059|488168|P1|Overall Study|Disease complication|3
153189|NCT00709059|488168|P1|Overall Study|Physician Decision|7
153190|NCT00709059|488168|P1|Overall Study|Withdrawal by Subject|19
153191|NCT00709059|488168|P1|Overall Study|Lost to Follow-up|34
153192|NCT00709098|488175|P3|Open-label Period|Lost to Follow-up|1
153193|NCT00709098|488176|P2|Open-label Period|Lost to Follow-up|0
153194|NCT00709098|488177|P1|Open-label Period|Lost to Follow-up|0
153195|NCT00709098|488175|P3|Open-label Period|Death|1
153196|NCT00709098|488176|P2|Open-label Period|Death|0
153197|NCT00709098|488177|P1|Open-label Period|Death|0
153198|NCT00709098|488175|P3|Open-label Period|Administrative reason|5
153199|NCT00709098|488176|P2|Open-label Period|Administrative reason|0
153200|NCT00709098|488177|P1|Open-label Period|Administrative reason|0
153201|NCT00709098|488175|P3|Open-label Period|Withdrawal of consent|7
153202|NCT00709098|488176|P2|Open-label Period|Withdrawal of consent|0
153203|NCT00709098|488177|P1|Open-label Period|Withdrawal of consent|0
153204|NCT00709098|488175|P3|Double-blind Period|Lost to Follow-up|0
153205|NCT00709098|488176|P2|Double-blind Period|Lost to Follow-up|1
153206|NCT00709098|488177|P1|Double-blind Period|Lost to Follow-up|1
153207|NCT00709098|488175|P3|Double-blind Period|Death|0
153208|NCT00709098|488176|P2|Double-blind Period|Death|1
153209|NCT00709098|488177|P1|Double-blind Period|Death|1
153210|NCT00709098|488175|P3|Double-blind Period|Administrative reason|0
153211|NCT00709098|488176|P2|Double-blind Period|Administrative reason|3
153212|NCT00709098|488177|P1|Double-blind Period|Administrative reason|1
153213|NCT00709098|488175|P3|Double-blind Period|Withdrawal of consent|0
153214|NCT00709098|488176|P2|Double-blind Period|Withdrawal of consent|3
153215|NCT00709098|488177|P1|Double-blind Period|Withdrawal of consent|3
153216|NCT00709111|488196|P1|Overall Study|Unable to attend clinic visits|1
153217|NCT00709111|488196|P1|Overall Study|Withdrawal by Subject|1
153218|NCT00709124|488236|P2|Overall Study|encephalopathy; can't do assessment|0
153219|NCT00709124|488237|P1|Overall Study|encephalopathy; can't do assessment|1
153220|NCT00709124|488236|P2|Overall Study|Death|1
153221|NCT00709124|488237|P1|Overall Study|Death|3
153222|NCT00709228|488243|P1|Overall Study|Non-compliance|5
153223|NCT00709228|488243|P1|Overall Study|Lost to Follow-up|6
153224|NCT00709228|488243|P1|Overall Study|Disease progression|1
153225|NCT00709228|488243|P1|Overall Study|Discontinued follow-up|5
153226|NCT00709228|488243|P1|Overall Study|Did not enter follow-up|4
153227|NCT00709228|488243|P1|Overall Study|Discontinued treatment|14
153228|NCT00709228|488243|P1|Overall Study|Adverse events|2
153229|NCT00709228|488243|P1|Overall Study|Eligibility criteria not met|281
153230|NCT00709228|488243|P1|Overall Study|Not treated|14
153231|NCT00709319|488247|P1|Overall Study|Withdrawal by Subject|2
153232|NCT00709319|488247|P1|Overall Study|Death|4
153233|NCT00709592|488257|P2|Overall Study|Unable to proceed to transplant|1
153234|NCT00709592|488258|P1|Overall Study|Unable to proceed to transplant|0
153235|NCT00709618|488278|P1|Overall Study|Study Closed/Terminated|25
153236|NCT00709618|488278|P1|Overall Study|Lost to Follow-up|1
153237|NCT00709618|488278|P1|Overall Study|Withdrawal by Subject|4
153238|NCT00709722|488288|P1|Overall Study|Adverse Event|1
153239|NCT00709735|488296|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
153240|NCT00709735|488297|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
153241|NCT00709735|488296|P2|Overall Study|Relapse into Opioid Abuse|1
153242|NCT00709735|488297|P1|Overall Study|Relapse into Opioid Abuse|0
153243|NCT00709735|488296|P2|Overall Study|Lost to Follow-up|1
153244|NCT00709735|488297|P1|Overall Study|Lost to Follow-up|1
153245|NCT00709761|488305|P1|Overall Study|Ongoing|40
153246|NCT00709761|488305|P1|Overall Study|Withdrawal by Subject|7
153247|NCT00709852|488325|P2|Period 2|No 72-hour follow-up|0
153248|NCT00709852|488326|P1|Period 2|No 72-hour follow-up|3
153249|NCT00709852|488325|P2|Period 2|Lost to Follow-up|0
153250|NCT00709852|488326|P1|Period 2|Lost to Follow-up|1
153251|NCT00709852|488325|P2|Period 2|Adverse Event|1
153252|NCT00709852|488326|P1|Period 2|Adverse Event|1
153253|NCT00709852|488325|P2|Period 2|Protocol Violation|1
153254|NCT00709852|488326|P1|Period 2|Protocol Violation|4
153255|NCT00709852|488325|P2|Period 1|Lost to Follow-up|0
153256|NCT00709852|488326|P1|Period 1|Lost to Follow-up|1
153257|NCT00709852|488325|P2|Period 1|Defective scanner|1
153258|NCT00709852|488326|P1|Period 1|Defective scanner|0
153259|NCT00709852|488325|P2|Period 1|Protocol Violation|0
153260|NCT00709852|488326|P1|Period 1|Protocol Violation|1
153261|NCT00709852|488325|P2|Period 1|Withdrawal by Subject|2
153262|NCT00709852|488326|P1|Period 1|Withdrawal by Subject|4
153263|NCT00709852|488325|P2|Period 1|Adverse Event|0
153264|NCT00709852|488326|P1|Period 1|Adverse Event|2
153265|NCT00709956|488503|P2|Overall Study|Inclusion/exclusion criteria violation|3
153266|NCT00709956|488504|P1|Overall Study|Inclusion/exclusion criteria violation|2
153267|NCT00709956|488503|P2|Overall Study|Withdrawal by Subject|1
153268|NCT00709956|488504|P1|Overall Study|Withdrawal by Subject|1
153269|NCT00710021|488515|P3|Overall Study|Physician Decision|0
153270|NCT00710021|488516|P2|Overall Study|Physician Decision|1
153271|NCT00710021|488517|P1|Overall Study|Physician Decision|0
153272|NCT00710021|488515|P3|Overall Study|Subject misrandomized|1
153273|NCT00710021|488516|P2|Overall Study|Subject misrandomized|1
153274|NCT00710021|488517|P1|Overall Study|Subject misrandomized|0
153275|NCT00710021|488515|P3|Overall Study|Subject's Decision|0
153276|NCT00710021|488516|P2|Overall Study|Subject's Decision|1
153277|NCT00710021|488517|P1|Overall Study|Subject's Decision|0
153278|NCT00710021|488515|P3|Overall Study|Lost to Follow-up|0
153279|NCT00710021|488516|P2|Overall Study|Lost to Follow-up|0
153280|NCT00710021|488517|P1|Overall Study|Lost to Follow-up|1
153281|NCT00710385|488656|P1|Overall Study|Undisclosed excessive methadone use|1
153282|NCT00710385|488656|P1|Overall Study|Physician Decision|1
153283|NCT00710385|488656|P1|Overall Study|Undisclosed back pain|1
153284|NCT00710385|488656|P1|Overall Study|Withdrawal by Subject|1
153285|NCT00710385|488656|P1|Overall Study|Did not qualify|1
153286|NCT00710424|488675|P2|Overall Study|Felt good so stopped treatment|1
153287|NCT00710424|488676|P1|Overall Study|Felt good so stopped treatment|0
153288|NCT00710424|488675|P2|Overall Study|Subject preferred paracetamol|1
153289|NCT00710424|488676|P1|Overall Study|Subject preferred paracetamol|0
153290|NCT00710424|488675|P2|Overall Study|Ceased treatment due to travel|0
153291|NCT00710424|488676|P1|Overall Study|Ceased treatment due to travel|1
153292|NCT00710424|488675|P2|Overall Study|Subject thought medication changed|0
153293|NCT00710424|488676|P1|Overall Study|Subject thought medication changed|1
153294|NCT00710424|488675|P2|Overall Study|Did not meet entry criteria at visit 1|0
153295|NCT00710424|488676|P1|Overall Study|Did not meet entry criteria at visit 1|1
153296|NCT00710424|488675|P2|Overall Study|Non-compliance with stable analgesia|0
153297|NCT00710424|488676|P1|Overall Study|Non-compliance with stable analgesia|1
153298|NCT00710424|488675|P2|Overall Study|Refused medication, no side effects|0
153299|NCT00710424|488676|P1|Overall Study|Refused medication, no side effects|1
153300|NCT00710424|488675|P2|Overall Study|Lost to Follow-up|1
153301|NCT00710424|488676|P1|Overall Study|Lost to Follow-up|0
153302|NCT00710424|488675|P2|Overall Study|Withdrawal by Subject|3
153303|NCT00710424|488676|P1|Overall Study|Withdrawal by Subject|5
153304|NCT00710424|488675|P2|Overall Study|Lack of Efficacy|5
153305|NCT00710424|488676|P1|Overall Study|Lack of Efficacy|4
153306|NCT00710424|488675|P2|Overall Study|Adverse Event|12
153307|NCT00710424|488676|P1|Overall Study|Adverse Event|30
153308|NCT00710554|488702|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
153309|NCT00710554|488703|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
153310|NCT00710554|488702|P2|Overall Study|Lack of Efficacy|12
153311|NCT00710554|488703|P1|Overall Study|Lack of Efficacy|11
153312|NCT00710554|488702|P2|Overall Study|Lost to Follow-up|1
153313|NCT00710554|488703|P1|Overall Study|Lost to Follow-up|7
153314|NCT00710554|488702|P2|Overall Study|Withdrawal by Subject|3
153315|NCT00710554|488703|P1|Overall Study|Withdrawal by Subject|7
153316|NCT00710554|488702|P2|Overall Study|Adverse Event|7
153317|NCT00710554|488703|P1|Overall Study|Adverse Event|24
153318|NCT00710593|488731|P2|Overall Study|Prem disc vaccine, completed all visits|2
153319|NCT00710593|488732|P1|Overall Study|Prem disc vaccine, completed all visits|6
153320|NCT00710593|488731|P2|Overall Study|Protocol Violation|1
153321|NCT00710593|488732|P1|Overall Study|Protocol Violation|1
153322|NCT00710593|488731|P2|Overall Study|Failure to adhere or complete study eval|1
153323|NCT00710593|488732|P1|Overall Study|Failure to adhere or complete study eval|1
153324|NCT00710593|488731|P2|Overall Study|Moved out of area|0
153325|NCT00710593|488732|P1|Overall Study|Moved out of area|1
153326|NCT00710593|488731|P2|Overall Study|Lost to Follow-up|1
153327|NCT00710593|488732|P1|Overall Study|Lost to Follow-up|3
153328|NCT00710593|488731|P2|Overall Study|Unable to complete Wk 48 within window|0
153329|NCT00710593|488732|P1|Overall Study|Unable to complete Wk 48 within window|2
153330|NCT00710593|488731|P2|Overall Study|Incarceration|0
153331|NCT00710593|488732|P1|Overall Study|Incarceration|1
153332|NCT00710606|488775|P2|Overall Study|Adverse Event|2
153333|NCT00710606|488776|P1|Overall Study|Adverse Event|0
153334|NCT00702507|488811|P1|Follow-up Phase|Late Enrollment|1
153335|NCT00702507|488811|P1|Follow-up Phase|Lost to Follow-up|23
153336|NCT00702507|488811|P1|Follow-up Phase|Protocol Violation|2
153337|NCT00702507|488811|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
153338|NCT00702507|488811|P1|Initial Treatment Phase|Negative Candida Culture|34
153339|NCT00702507|488811|P1|Initial Treatment Phase|Lost to Follow-up|2
153340|NCT00702507|488811|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
153341|NCT00702507|488811|P1|Initial Treatment Phase|Adverse Event|2
153342|NCT00702520|488825|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
153343|NCT00702520|488826|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
153344|NCT00702520|488827|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
153345|NCT00702520|488828|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
153346|NCT00702520|488825|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
153347|NCT00702520|488826|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
153348|NCT00702520|488827|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
153349|NCT00702520|488828|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
153350|NCT00702520|488825|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
153351|NCT00702520|488826|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
153352|NCT00702520|488827|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
153353|NCT00702520|488828|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
153354|NCT00702650|488886|P1|Overall Study|Adverse Event|3
153355|NCT00702650|488886|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
153356|NCT00702650|488886|P1|Overall Study|Sponsor Request|1
153357|NCT00702650|488886|P1|Overall Study|Non-Compliance with Site Directives|1
153358|NCT00702650|488886|P1|Overall Study|Lost to Follow-up|2
153359|NCT00702650|488886|P1|Overall Study|Non-Compliance of Study Drug|3
153360|NCT00702650|488886|P1|Overall Study|Withdrawal by Subject|9
153361|NCT00702689|488904|P1|Overall Study|Adverse Event|1
153362|NCT00702689|488904|P1|Overall Study|Recurrent malignancy|1
153363|NCT00702689|488904|P1|Overall Study|Withdrawal by Subject|4
153364|NCT00702702|488918|P1|Overall Study|Study prematurely terminated|56
153365|NCT00702715|488928|P2|Overall Study|Lost to Follow-up|0
153366|NCT00702715|488929|P1|Overall Study|Lost to Follow-up|1
153367|NCT00710749|488939|P2|First Intervention|Withdrawal by Subject|0
153368|NCT00710749|488940|P1|First Intervention|Withdrawal by Subject|1
153369|NCT00710762|488950|P2|Overall Study|Reason other than listed above|2
153370|NCT00710762|488951|P1|Overall Study|Reason other than listed above|2
153371|NCT00710762|488950|P2|Overall Study|Lost to Follow-up|0
153372|NCT00710762|488951|P1|Overall Study|Lost to Follow-up|1
153373|NCT00710762|488950|P2|Overall Study|Other Adverse Event|7
153374|NCT00710762|488951|P1|Overall Study|Other Adverse Event|7
153375|NCT00710762|488950|P2|Overall Study|Adverse Event other disease worsening|1
153376|NCT00710762|488951|P1|Overall Study|Adverse Event other disease worsening|2
153377|NCT00710762|488950|P2|Overall Study|Progressive disease|30
153378|NCT00710762|488951|P1|Overall Study|Progressive disease|27
153379|NCT00710866|488993|P2|Overall Study|Failed to meet eligibility|1
153380|NCT00710866|488994|P1|Overall Study|Failed to meet eligibility|1
153381|NCT00710866|488993|P2|Overall Study|Lost to Follow-up|0
153382|NCT00710866|488994|P1|Overall Study|Lost to Follow-up|1
153383|NCT00710866|488993|P2|Overall Study|Withdrawal by Subject|1
153384|NCT00710866|488994|P1|Overall Study|Withdrawal by Subject|2
153385|NCT00710866|488993|P2|Overall Study|Protocol Violation|4
153386|NCT00710866|488994|P1|Overall Study|Protocol Violation|5
153387|NCT00710879|489016|P2|Overall Study|Protocol Violation|3
153388|NCT00710879|489017|P1|Overall Study|Protocol Violation|0
153389|NCT00710879|489016|P2|Overall Study|Lost to Follow-up|1
153390|NCT00710879|489017|P1|Overall Study|Lost to Follow-up|2
153391|NCT00710970|489048|P1|Overall Study|Never took drug|2
153392|NCT00710970|489048|P1|Overall Study|Lost to Follow-up|8
153393|NCT00711009|489067|P2|Overall Study|Dose adjustment|0
153394|NCT00711009|489068|P1|Overall Study|Dose adjustment|1
153395|NCT00711009|489067|P2|Overall Study|Site closing|1
153396|NCT00711009|489068|P1|Overall Study|Site closing|0
153397|NCT00711009|489067|P2|Overall Study|Pregnancy|0
153398|NCT00711009|489068|P1|Overall Study|Pregnancy|1
153399|NCT00711009|489067|P2|Overall Study|Virologic Failure|1
153400|NCT00711009|489068|P1|Overall Study|Virologic Failure|2
153401|NCT00711009|489067|P2|Overall Study|Participant Noncompliant|1
153402|NCT00711009|489068|P1|Overall Study|Participant Noncompliant|0
153403|NCT00711009|489067|P2|Overall Study|Lost to Follow-up|9
153404|NCT00711009|489068|P1|Overall Study|Lost to Follow-up|3
153405|NCT00711009|489067|P2|Overall Study|Withdrawal by Subject|2
153406|NCT00711009|489068|P1|Overall Study|Withdrawal by Subject|4
153407|NCT00711009|489067|P2|Overall Study|Adverse Event/HIV-Related Event|5
153408|NCT00711009|489068|P1|Overall Study|Adverse Event/HIV-Related Event|4
153409|NCT00711958|489242|P2|Overall Study|Progression of disease|0
153410|NCT00711958|489243|P1|Overall Study|Progression of disease|1
153411|NCT00711958|489242|P2|Overall Study|Death|5
153412|NCT00711958|489243|P1|Overall Study|Death|10
153413|NCT00711958|489242|P2|Overall Study|Lost to Follow-up|2
153414|NCT00711958|489243|P1|Overall Study|Lost to Follow-up|2
153415|NCT00711958|489242|P2|Overall Study|Protocol Violation|0
153416|NCT00711958|489243|P1|Overall Study|Protocol Violation|1
153417|NCT00711958|489242|P2|Overall Study|Adverse Event|7
153418|NCT00711958|489243|P1|Overall Study|Adverse Event|9
153419|NCT00711958|489242|P2|Overall Study|Clinical deterioration|0
153420|NCT00711958|489243|P1|Overall Study|Clinical deterioration|1
153421|NCT00711958|489242|P2|Overall Study|Lack of Efficacy|1
153422|NCT00711958|489243|P1|Overall Study|Lack of Efficacy|3
153423|NCT00711958|489242|P2|Overall Study|Withdrawal by Subject|8
153424|NCT00711958|489243|P1|Overall Study|Withdrawal by Subject|6
153425|NCT00711971|489252|P3|Overall Study|Lost to Follow-up|1
153426|NCT00711971|489253|P2|Overall Study|Lost to Follow-up|4
153427|NCT00711971|489254|P1|Overall Study|Lost to Follow-up|3
153428|NCT00712010|489299|P1|Washout (7 Days)|Withdrawal by Subject|1
153429|NCT00712166|489343|P2|Overall Study|Noncompliance|1
153430|NCT00712166|489344|P1|Overall Study|Noncompliance|0
153431|NCT00712335|489426|P5|Overall Study|Other Reason|0
153432|NCT00712335|489427|P4|Overall Study|Other Reason|0
153433|NCT00712335|489428|P3|Overall Study|Other Reason|1
153434|NCT00712335|489429|P2|Overall Study|Other Reason|3
153435|NCT00712335|489430|P1|Overall Study|Other Reason|0
153436|NCT00712335|489426|P5|Overall Study|Lack of Efficacy|0
153437|NCT00712335|489427|P4|Overall Study|Lack of Efficacy|1
153438|NCT00712335|489428|P3|Overall Study|Lack of Efficacy|1
153439|NCT00712335|489429|P2|Overall Study|Lack of Efficacy|0
153440|NCT00712335|489430|P1|Overall Study|Lack of Efficacy|0
153441|NCT00712335|489426|P5|Overall Study|Protocol Violation|0
153442|NCT00712335|489427|P4|Overall Study|Protocol Violation|0
153443|NCT00712335|489428|P3|Overall Study|Protocol Violation|1
153444|NCT00712335|489429|P2|Overall Study|Protocol Violation|2
153445|NCT00712335|489430|P1|Overall Study|Protocol Violation|1
153446|NCT00712335|489426|P5|Overall Study|Lost to Follow-up|0
153447|NCT00712335|489427|P4|Overall Study|Lost to Follow-up|1
153448|NCT00712335|489428|P3|Overall Study|Lost to Follow-up|0
153449|NCT00712335|489429|P2|Overall Study|Lost to Follow-up|5
153450|NCT00712335|489430|P1|Overall Study|Lost to Follow-up|2
153451|NCT00712335|489426|P5|Overall Study|Withdrawal by Subject|0
153452|NCT00712335|489427|P4|Overall Study|Withdrawal by Subject|3
153453|NCT00712335|489428|P3|Overall Study|Withdrawal by Subject|2
153454|NCT00712335|489429|P2|Overall Study|Withdrawal by Subject|7
153455|NCT00712335|489430|P1|Overall Study|Withdrawal by Subject|0
153456|NCT00712348|489472|P1|Overall Study|Withdrawal by Subject|1
153457|NCT00712543|489509|P2|Day 8-14|Lost to Follow-up|2
153458|NCT00712543|489510|P1|Day 8-14|Lost to Follow-up|0
153459|NCT00712673|489519|P4|Overall Study|Protocol Violation|0
153460|NCT00712673|489520|P3|Overall Study|Protocol Violation|2
153461|NCT00712673|489521|P2|Overall Study|Protocol Violation|0
153462|NCT00712673|489522|P1|Overall Study|Protocol Violation|0
153463|NCT00712673|489519|P4|Overall Study|Investigator's Decision|0
153464|NCT00712673|489520|P3|Overall Study|Investigator's Decision|0
153465|NCT00712673|489521|P2|Overall Study|Investigator's Decision|0
153466|NCT00712673|489522|P1|Overall Study|Investigator's Decision|1
153467|NCT00712673|489519|P4|Overall Study|Familial and Personal Reasons|2
153468|NCT00712673|489520|P3|Overall Study|Familial and Personal Reasons|5
153469|NCT00712673|489521|P2|Overall Study|Familial and Personal Reasons|0
153470|NCT00712673|489522|P1|Overall Study|Familial and Personal Reasons|5
153471|NCT00712673|489519|P4|Overall Study|Withdrawal by Subject|20
153472|NCT00712673|489520|P3|Overall Study|Withdrawal by Subject|15
153473|NCT00712673|489521|P2|Overall Study|Withdrawal by Subject|7
153474|NCT00712673|489522|P1|Overall Study|Withdrawal by Subject|6
153475|NCT00712673|489519|P4|Overall Study|Lost to Follow-up|0
153476|NCT00712673|489520|P3|Overall Study|Lost to Follow-up|2
153477|NCT00712673|489521|P2|Overall Study|Lost to Follow-up|0
153478|NCT00712673|489522|P1|Overall Study|Lost to Follow-up|1
153479|NCT00712673|489519|P4|Overall Study|Poor Compliance to Protocol|16
153480|NCT00712673|489520|P3|Overall Study|Poor Compliance to Protocol|4
153481|NCT00712673|489521|P2|Overall Study|Poor Compliance to Protocol|3
153482|NCT00712673|489522|P1|Overall Study|Poor Compliance to Protocol|3
153483|NCT00712673|489519|P4|Overall Study|Lack of Efficacy|6
153484|NCT00712673|489520|P3|Overall Study|Lack of Efficacy|8
153485|NCT00712673|489521|P2|Overall Study|Lack of Efficacy|8
153486|NCT00712673|489522|P1|Overall Study|Lack of Efficacy|2
153487|NCT00712673|489519|P4|Overall Study|Adverse Event|26
153488|NCT00712673|489520|P3|Overall Study|Adverse Event|21
153489|NCT00712673|489521|P2|Overall Study|Adverse Event|3
153490|NCT00712673|489522|P1|Overall Study|Adverse Event|3
153491|NCT00712725|489592|P8|Overall Study|Protocol Specified Criteria|1
153492|NCT00712725|489593|P7|Overall Study|Protocol Specified Criteria|2
153493|NCT00712725|489594|P6|Overall Study|Protocol Specified Criteria|0
153494|NCT00712725|489595|P5|Overall Study|Protocol Specified Criteria|1
153495|NCT00712725|489596|P4|Overall Study|Protocol Specified Criteria|2
153496|NCT00712725|489597|P3|Overall Study|Protocol Specified Criteria|1
153497|NCT00712725|489598|P2|Overall Study|Protocol Specified Criteria|0
153498|NCT00712725|489599|P1|Overall Study|Protocol Specified Criteria|3
153499|NCT00712725|489592|P8|Overall Study|Lack of Qualifying Event|6
153500|NCT00712725|489593|P7|Overall Study|Lack of Qualifying Event|11
153501|NCT00712725|489594|P6|Overall Study|Lack of Qualifying Event|13
153502|NCT00712725|489595|P5|Overall Study|Lack of Qualifying Event|11
153503|NCT00712725|489596|P4|Overall Study|Lack of Qualifying Event|8
153504|NCT00712725|489597|P3|Overall Study|Lack of Qualifying Event|6
153505|NCT00712725|489598|P2|Overall Study|Lack of Qualifying Event|2
153506|NCT00712725|489599|P1|Overall Study|Lack of Qualifying Event|16
153507|NCT00712725|489592|P8|Overall Study|Withdrawal by Subject|2
153508|NCT00712725|489593|P7|Overall Study|Withdrawal by Subject|1
153509|NCT00712725|489594|P6|Overall Study|Withdrawal by Subject|1
153510|NCT00712725|489595|P5|Overall Study|Withdrawal by Subject|1
153511|NCT00712725|489596|P4|Overall Study|Withdrawal by Subject|2
153512|NCT00712725|489597|P3|Overall Study|Withdrawal by Subject|1
153513|NCT00712725|489598|P2|Overall Study|Withdrawal by Subject|1
153514|NCT00712725|489599|P1|Overall Study|Withdrawal by Subject|2
153515|NCT00712725|489592|P8|Overall Study|Protocol Violation|1
153516|NCT00712725|489593|P7|Overall Study|Protocol Violation|1
153517|NCT00712725|489594|P6|Overall Study|Protocol Violation|0
153518|NCT00712725|489595|P5|Overall Study|Protocol Violation|2
153519|NCT00712725|489596|P4|Overall Study|Protocol Violation|3
153520|NCT00712725|489597|P3|Overall Study|Protocol Violation|1
153521|NCT00712725|489598|P2|Overall Study|Protocol Violation|0
153522|NCT00712725|489599|P1|Overall Study|Protocol Violation|2
153523|NCT00712725|489592|P8|Overall Study|Pregnancy|0
153524|NCT00712725|489593|P7|Overall Study|Pregnancy|2
153525|NCT00712725|489594|P6|Overall Study|Pregnancy|0
153526|NCT00712725|489595|P5|Overall Study|Pregnancy|1
153527|NCT00712725|489596|P4|Overall Study|Pregnancy|0
153528|NCT00712725|489597|P3|Overall Study|Pregnancy|0
153529|NCT00712725|489598|P2|Overall Study|Pregnancy|1
153530|NCT00712725|489599|P1|Overall Study|Pregnancy|0
153531|NCT00712725|489592|P8|Overall Study|Physician Decision|0
153532|NCT00712725|489593|P7|Overall Study|Physician Decision|2
153533|NCT00712725|489594|P6|Overall Study|Physician Decision|0
153534|NCT00712725|489595|P5|Overall Study|Physician Decision|1
153535|NCT00712725|489596|P4|Overall Study|Physician Decision|0
153536|NCT00712725|489597|P3|Overall Study|Physician Decision|0
153537|NCT00712725|489598|P2|Overall Study|Physician Decision|0
153538|NCT00712725|489599|P1|Overall Study|Physician Decision|2
153539|NCT00712725|489592|P8|Overall Study|Lost to Follow-up|1
153540|NCT00712725|489593|P7|Overall Study|Lost to Follow-up|3
153541|NCT00712725|489594|P6|Overall Study|Lost to Follow-up|2
153542|NCT00712725|489595|P5|Overall Study|Lost to Follow-up|2
153543|NCT00712725|489596|P4|Overall Study|Lost to Follow-up|1
153544|NCT00712725|489597|P3|Overall Study|Lost to Follow-up|1
153545|NCT00712725|489598|P2|Overall Study|Lost to Follow-up|2
153546|NCT00712725|489599|P1|Overall Study|Lost to Follow-up|3
153547|NCT00712725|489592|P8|Overall Study|Adverse Event|0
153548|NCT00712725|489593|P7|Overall Study|Adverse Event|0
153549|NCT00712725|489594|P6|Overall Study|Adverse Event|0
153550|NCT00712725|489595|P5|Overall Study|Adverse Event|0
153551|NCT00712725|489596|P4|Overall Study|Adverse Event|1
153552|NCT00712725|489597|P3|Overall Study|Adverse Event|0
153553|NCT00712725|489598|P2|Overall Study|Adverse Event|0
153554|NCT00712725|489599|P1|Overall Study|Adverse Event|1
153555|NCT00712920|489660|P3|Overall Study|Non-compliance|0
153556|NCT00712920|489661|P2|Overall Study|Non-compliance|0
153557|NCT00712920|489662|P1|Overall Study|Non-compliance|3
153558|NCT00712920|489660|P3|Overall Study|Other|3
153559|NCT00712920|489661|P2|Overall Study|Other|7
153560|NCT00712920|489662|P1|Overall Study|Other|5
153561|NCT00712920|489660|P3|Overall Study|Lack of Efficacy|1
153562|NCT00712920|489661|P2|Overall Study|Lack of Efficacy|0
153563|NCT00712920|489662|P1|Overall Study|Lack of Efficacy|1
153564|NCT00712920|489660|P3|Overall Study|Lost to Follow-up|0
153565|NCT00712920|489661|P2|Overall Study|Lost to Follow-up|4
153566|NCT00712920|489662|P1|Overall Study|Lost to Follow-up|1
153567|NCT00712920|489660|P3|Overall Study|Withdrawal by Subject|1
153568|NCT00712920|489661|P2|Overall Study|Withdrawal by Subject|2
153569|NCT00712920|489662|P1|Overall Study|Withdrawal by Subject|4
153570|NCT00712920|489660|P3|Overall Study|Adverse Event|7
153571|NCT00712920|489661|P2|Overall Study|Adverse Event|4
153572|NCT00712920|489662|P1|Overall Study|Adverse Event|3
153573|NCT00712959|489684|P2|Overall Study|Withdrawal by Subject|0
153574|NCT00712959|489685|P1|Overall Study|Withdrawal by Subject|3
153575|NCT00712959|489684|P2|Overall Study|Lost to Follow-up|2
153576|NCT00712959|489685|P1|Overall Study|Lost to Follow-up|13
153577|NCT00712959|489684|P2|Overall Study|Protocol Violation|1
153578|NCT00712959|489685|P1|Overall Study|Protocol Violation|3
153579|NCT00712985|489703|P1|Overall Study|Lack of Efficacy|3
153580|NCT00712985|489703|P1|Overall Study|1 patient moved out of state|1
153581|NCT00712985|489703|P1|Overall Study|1 withdrew prior to start of drug|1
153582|NCT00713206|489709|P2|Overall Study|Adverse Event|1
153583|NCT00713206|489710|P1|Overall Study|Adverse Event|2
153584|NCT00713206|489709|P2|Overall Study|Lost to Follow-up|2
153585|NCT00713206|489710|P1|Overall Study|Lost to Follow-up|5
153586|NCT00713219|489716|P1|Overall Study|Protocol Violation|1
153587|NCT00713219|489716|P1|Overall Study|Death|1
153588|NCT00713258|489722|P2|Overall Study|Other|1
153589|NCT00713258|489723|P1|Overall Study|Other|1
153590|NCT00713258|489722|P2|Overall Study|Non-Compliance|1
153591|NCT00713258|489723|P1|Overall Study|Non-Compliance|2
153592|NCT00713258|489722|P2|Overall Study|Adverse Event|4
153593|NCT00713258|489723|P1|Overall Study|Adverse Event|2
153594|NCT00713310|489733|P2|Overall Study|Withdrawal by Subject|2
153595|NCT00713310|489734|P1|Overall Study|Withdrawal by Subject|0
153596|NCT00713310|489733|P2|Overall Study|Lack of Efficacy|2
153597|NCT00713310|489734|P1|Overall Study|Lack of Efficacy|0
153598|NCT00713310|489733|P2|Overall Study|Adverse Event|2
153599|NCT00713310|489734|P1|Overall Study|Adverse Event|5
153600|NCT00713323|489742|P1|Overall Study|Treatment that may interact with Sativex|1
153601|NCT00713323|489742|P1|Overall Study|Subject travelling to Dominica Republic|1
153602|NCT00713323|489742|P1|Overall Study|Subject travelling to USA|1
153603|NCT00713323|489742|P1|Overall Study|Pain resolved|1
153604|NCT00713323|489742|P1|Overall Study|Non-compliance|1
153605|NCT00713323|489742|P1|Overall Study|Pain free|1
153606|NCT00713323|489742|P1|Overall Study|Surgery cured allodynic pain|1
153607|NCT00713323|489742|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
153608|NCT00713323|489742|P1|Overall Study|Low creatine clearance at screening|1
153609|NCT00713323|489742|P1|Overall Study|Lack of Efficacy|36
153610|NCT00713323|489742|P1|Overall Study|Lost to Follow-up|11
153611|NCT00713323|489742|P1|Overall Study|Withdrawal by Subject|15
153612|NCT00713323|489742|P1|Overall Study|Adverse Event|75
153613|NCT00713349|489753|P1|Overall Study|Protocol Violation|1
153614|NCT00713544|489778|P6|Overall Study|Hepatotoxicity - not an AE|0
153615|NCT00713544|489779|P5|Overall Study|Hepatotoxicity - not an AE|1
153616|NCT00713544|489780|P4|Overall Study|Hepatotoxicity - not an AE|0
153617|NCT00713544|489781|P3|Overall Study|Hepatotoxicity - not an AE|0
153618|NCT00713544|489782|P2|Overall Study|Hepatotoxicity - not an AE|0
153619|NCT00713544|489783|P1|Overall Study|Hepatotoxicity - not an AE|0
153620|NCT00713544|489778|P6|Overall Study|Incorrect enrollment|0
153621|NCT00713544|489779|P5|Overall Study|Incorrect enrollment|0
153622|NCT00713544|489780|P4|Overall Study|Incorrect enrollment|0
153623|NCT00713544|489781|P3|Overall Study|Incorrect enrollment|0
153624|NCT00713544|489782|P2|Overall Study|Incorrect enrollment|1
153625|NCT00713544|489783|P1|Overall Study|Incorrect enrollment|0
153626|NCT00713544|489778|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
153627|NCT00713544|489779|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
153628|NCT00713544|489780|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
153629|NCT00713544|489781|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
153630|NCT00713544|489782|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
153631|NCT00713544|489783|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
153632|NCT00713544|489778|P6|Overall Study|Lost to Follow-up|0
153633|NCT00713544|489779|P5|Overall Study|Lost to Follow-up|0
153634|NCT00713544|489780|P4|Overall Study|Lost to Follow-up|0
153635|NCT00713544|489781|P3|Overall Study|Lost to Follow-up|1
153636|NCT00713544|489782|P2|Overall Study|Lost to Follow-up|0
153637|NCT00713544|489783|P1|Overall Study|Lost to Follow-up|0
153638|NCT00713544|489778|P6|Overall Study|Lack of Efficacy|0
153639|NCT00713544|489779|P5|Overall Study|Lack of Efficacy|1
153640|NCT00713544|489780|P4|Overall Study|Lack of Efficacy|1
153641|NCT00713544|489781|P3|Overall Study|Lack of Efficacy|0
153642|NCT00713544|489782|P2|Overall Study|Lack of Efficacy|1
153643|NCT00713544|489783|P1|Overall Study|Lack of Efficacy|0
153644|NCT00713544|489778|P6|Overall Study|Physician Decision|2
153645|NCT00713544|489779|P5|Overall Study|Physician Decision|0
153646|NCT00713544|489780|P4|Overall Study|Physician Decision|0
153647|NCT00713544|489781|P3|Overall Study|Physician Decision|0
153648|NCT00713544|489782|P2|Overall Study|Physician Decision|0
153649|NCT00713544|489783|P1|Overall Study|Physician Decision|0
153650|NCT00713544|489778|P6|Overall Study|Protocol Violation|1
153651|NCT00713544|489779|P5|Overall Study|Protocol Violation|0
153652|NCT00713544|489780|P4|Overall Study|Protocol Violation|0
153653|NCT00713544|489781|P3|Overall Study|Protocol Violation|0
153654|NCT00713544|489782|P2|Overall Study|Protocol Violation|0
153655|NCT00713544|489783|P1|Overall Study|Protocol Violation|0
153656|NCT00713544|489778|P6|Overall Study|Withdrawal by Subject|1
153657|NCT00713544|489779|P5|Overall Study|Withdrawal by Subject|3
153658|NCT00713544|489780|P4|Overall Study|Withdrawal by Subject|2
153659|NCT00713544|489781|P3|Overall Study|Withdrawal by Subject|3
153660|NCT00713544|489782|P2|Overall Study|Withdrawal by Subject|0
153661|NCT00713544|489783|P1|Overall Study|Withdrawal by Subject|2
153662|NCT00713544|489778|P6|Overall Study|Adverse Event|5
153663|NCT00713544|489779|P5|Overall Study|Adverse Event|3
153664|NCT00713544|489780|P4|Overall Study|Adverse Event|7
153665|NCT00713544|489781|P3|Overall Study|Adverse Event|7
153666|NCT00713544|489782|P2|Overall Study|Adverse Event|3
153667|NCT00713544|489783|P1|Overall Study|Adverse Event|5
153668|NCT00713596|489824|P3|Overall Study|Study was terminated|2
153669|NCT00713596|489825|P2|Overall Study|Study was terminated|3
153670|NCT00713596|489826|P1|Overall Study|Study was terminated|2
153671|NCT00713609|489843|P6|Overall Study|Protocol Violation|0
153672|NCT00713609|489844|P5|Overall Study|Protocol Violation|2
153673|NCT00713609|489845|P4|Overall Study|Protocol Violation|1
153674|NCT00713609|489846|P3|Overall Study|Protocol Violation|1
153675|NCT00713609|489847|P2|Overall Study|Protocol Violation|3
153676|NCT00713609|489848|P1|Overall Study|Protocol Violation|6
153677|NCT00713609|489843|P6|Overall Study|Withdrawal by Subject|7
153678|NCT00713609|489844|P5|Overall Study|Withdrawal by Subject|5
153679|NCT00713609|489845|P4|Overall Study|Withdrawal by Subject|1
153680|NCT00713609|489846|P3|Overall Study|Withdrawal by Subject|5
153681|NCT00713609|489847|P2|Overall Study|Withdrawal by Subject|1
153682|NCT00713609|489848|P1|Overall Study|Withdrawal by Subject|6
153683|NCT00713609|489843|P6|Overall Study|Non-Compliance with Study Treatment|0
153684|NCT00713609|489844|P5|Overall Study|Non-Compliance with Study Treatment|1
153685|NCT00713609|489845|P4|Overall Study|Non-Compliance with Study Treatment|0
153686|NCT00713609|489846|P3|Overall Study|Non-Compliance with Study Treatment|2
153687|NCT00713609|489847|P2|Overall Study|Non-Compliance with Study Treatment|1
153688|NCT00713609|489848|P1|Overall Study|Non-Compliance with Study Treatment|1
153689|NCT00713609|489843|P6|Overall Study|Lack of Efficacy|0
153690|NCT00713609|489844|P5|Overall Study|Lack of Efficacy|1
153691|NCT00713609|489845|P4|Overall Study|Lack of Efficacy|0
153692|NCT00713609|489846|P3|Overall Study|Lack of Efficacy|0
153693|NCT00713609|489847|P2|Overall Study|Lack of Efficacy|3
153694|NCT00713609|489848|P1|Overall Study|Lack of Efficacy|1
153695|NCT00713609|489843|P6|Overall Study|Lost to Follow-up|0
153696|NCT00713609|489844|P5|Overall Study|Lost to Follow-up|7
153697|NCT00713609|489845|P4|Overall Study|Lost to Follow-up|5
153698|NCT00713609|489846|P3|Overall Study|Lost to Follow-up|5
153699|NCT00713609|489847|P2|Overall Study|Lost to Follow-up|7
153700|NCT00713609|489848|P1|Overall Study|Lost to Follow-up|5
153701|NCT00713609|489843|P6|Overall Study|Adverse Event|1
153702|NCT00713609|489844|P5|Overall Study|Adverse Event|3
153703|NCT00713609|489845|P4|Overall Study|Adverse Event|2
153704|NCT00713609|489846|P3|Overall Study|Adverse Event|2
153705|NCT00713609|489847|P2|Overall Study|Adverse Event|0
153706|NCT00713609|489848|P1|Overall Study|Adverse Event|2
153707|NCT00713648|489880|P1|Overall Study|Development of antibodies|3
153708|NCT00713648|489880|P1|Overall Study|According to Protocol|2
153709|NCT00713648|489880|P1|Overall Study|Unclassified|2
153710|NCT00713648|489880|P1|Overall Study|Adverse Event|1
153711|NCT00713700|489908|P1|Overall Study|Withdrawal by Subject|1
153712|NCT00713700|489908|P1|Overall Study|Lost to Follow-up|3
153713|NCT00713830|489936|P2|Overall Study|Sponsor Decision|10
153714|NCT00713830|489937|P1|Overall Study|Sponsor Decision|4
153715|NCT00713830|489936|P2|Overall Study|Familial and Personal Reasons|34
153716|NCT00713830|489937|P1|Overall Study|Familial and Personal Reasons|9
153717|NCT00713830|489936|P2|Overall Study|Poor Compliance to Protocol|14
153718|NCT00713830|489937|P1|Overall Study|Poor Compliance to Protocol|7
153719|NCT00713830|489936|P2|Overall Study|Withdrawal by Subject|23
153720|NCT00713830|489937|P1|Overall Study|Withdrawal by Subject|13
153721|NCT00713830|489936|P2|Overall Study|Lost to Follow-up|9
153722|NCT00713830|489937|P1|Overall Study|Lost to Follow-up|2
153723|NCT00713830|489936|P2|Overall Study|Lack of Efficacy|16
153724|NCT00713830|489937|P1|Overall Study|Lack of Efficacy|24
153725|NCT00713830|489936|P2|Overall Study|Adverse Event|71
153726|NCT00713830|489937|P1|Overall Study|Adverse Event|23
153727|NCT00714051|489975|P2|Overall Study|Death|1
153728|NCT00714051|489976|P1|Overall Study|Death|0
153729|NCT00714051|489975|P2|Overall Study|Withdrawal by Subject|0
153730|NCT00714051|489976|P1|Overall Study|Withdrawal by Subject|1
153731|NCT00714168|489984|P2|Overall Study|Non-study medical condition|2
153732|NCT00714168|489985|P1|Overall Study|Non-study medical condition|3
153733|NCT00714168|489984|P2|Overall Study|Relocation|3
153734|NCT00714168|489985|P1|Overall Study|Relocation|4
153735|NCT00714168|489984|P2|Overall Study|Lost to Follow-up|50
153736|NCT00714168|489985|P1|Overall Study|Lost to Follow-up|32
153737|NCT00714168|489984|P2|Overall Study|Pregnancy|4
153738|NCT00714168|489985|P1|Overall Study|Pregnancy|5
153739|NCT00714259|490033|P1|Overall Study|Death|2
153740|NCT00714285|490047|P4|Overall Study|Migrated/moved from study area|0
153741|NCT00714285|490048|P3|Overall Study|Migrated/moved from study area|0
153742|NCT00714285|490049|P2|Overall Study|Migrated/moved from study area|1
153743|NCT00714285|490050|P1|Overall Study|Migrated/moved from study area|0
153744|NCT00714285|490047|P4|Overall Study|Lost to Follow-up|1
153745|NCT00714285|490048|P3|Overall Study|Lost to Follow-up|0
153746|NCT00714285|490049|P2|Overall Study|Lost to Follow-up|2
153747|NCT00714285|490050|P1|Overall Study|Lost to Follow-up|0
153748|NCT00705679|490119|P5|Overall Study|Withdrawal by Subject|33
153749|NCT00705679|490120|P4|Overall Study|Withdrawal by Subject|47
153750|NCT00705679|490121|P3|Overall Study|Withdrawal by Subject|68
153751|NCT00705679|490122|P2|Overall Study|Withdrawal by Subject|77
153752|NCT00705679|490123|P1|Overall Study|Withdrawal by Subject|32
153753|NCT00705679|490119|P5|Overall Study|Physician Decision|0
153754|NCT00705679|490120|P4|Overall Study|Physician Decision|1
153755|NCT00705679|490121|P3|Overall Study|Physician Decision|0
153756|NCT00705679|490122|P2|Overall Study|Physician Decision|1
153757|NCT00705679|490123|P1|Overall Study|Physician Decision|0
153758|NCT00705679|490119|P5|Overall Study|Lost to Follow-up|35
153759|NCT00705679|490120|P4|Overall Study|Lost to Follow-up|30
153760|NCT00705679|490121|P3|Overall Study|Lost to Follow-up|44
153761|NCT00705679|490122|P2|Overall Study|Lost to Follow-up|60
153762|NCT00705679|490123|P1|Overall Study|Lost to Follow-up|32
153763|NCT00705679|490119|P5|Overall Study|Death|1
153764|NCT00705679|490120|P4|Overall Study|Death|2
153765|NCT00705679|490121|P3|Overall Study|Death|3
153766|NCT00705679|490122|P2|Overall Study|Death|0
153767|NCT00705679|490123|P1|Overall Study|Death|0
153768|NCT00705679|490119|P5|Overall Study|Adverse Event|0
153769|NCT00705679|490120|P4|Overall Study|Adverse Event|0
153770|NCT00705679|490121|P3|Overall Study|Adverse Event|0
153771|NCT00705679|490122|P2|Overall Study|Adverse Event|1
153772|NCT00705679|490123|P1|Overall Study|Adverse Event|1
153773|NCT00705718|490160|P2|Overall Study|Follow up not done|4
153774|NCT00705718|490161|P1|Overall Study|Follow up not done|1
153775|NCT00705718|490160|P2|Overall Study|Not due for Visit|12
153776|NCT00705718|490161|P1|Overall Study|Not due for Visit|0
153777|NCT00705718|490160|P2|Overall Study|Death|6
153778|NCT00705718|490161|P1|Overall Study|Death|6
153779|NCT00705757|490180|P3|Overall Study|Withdrawal by Subject|2
153780|NCT00705757|490181|P2|Overall Study|Withdrawal by Subject|1
153781|NCT00705757|490182|P1|Overall Study|Withdrawal by Subject|1
153782|NCT00705757|490180|P3|Overall Study|Lost to Follow-up|6
153783|NCT00705757|490181|P2|Overall Study|Lost to Follow-up|6
153784|NCT00705757|490182|P1|Overall Study|Lost to Follow-up|7
153785|NCT00705757|490180|P3|Overall Study|Lack of Efficacy|3
153786|NCT00705757|490181|P2|Overall Study|Lack of Efficacy|1
153787|NCT00705757|490182|P1|Overall Study|Lack of Efficacy|5
153788|NCT00705783|490192|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
153789|NCT00705783|490193|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
153790|NCT00705783|490194|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
153791|NCT00705783|490192|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
153792|NCT00705783|490193|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
153793|NCT00705783|490194|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
153794|NCT00705783|490192|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
153795|NCT00705783|490193|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
153796|NCT00705783|490194|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
153797|NCT00705783|490192|P3|Depot Maintenance Phase|Protocol Deviation|0
153798|NCT00705783|490193|P2|Depot Maintenance Phase|Protocol Deviation|2
153799|NCT00705783|490194|P1|Depot Maintenance Phase|Protocol Deviation|0
153800|NCT00705783|490192|P3|Depot Maintenance Phase|Withdrew Consent|4
153801|NCT00705783|490193|P2|Depot Maintenance Phase|Withdrew Consent|14
153802|NCT00705783|490194|P1|Depot Maintenance Phase|Withdrew Consent|0
153803|NCT00705783|490192|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
153804|NCT00705783|490193|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
153805|NCT00705783|490194|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
153806|NCT00705783|490192|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
153807|NCT00705783|490193|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
153808|NCT00705783|490194|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
153809|NCT00705783|490192|P3|Depot Maintenance Phase|Lost to Follow-up|3
153810|NCT00705783|490193|P2|Depot Maintenance Phase|Lost to Follow-up|5
153811|NCT00705783|490194|P1|Depot Maintenance Phase|Lost to Follow-up|0
153812|NCT00705783|490192|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
153813|NCT00705783|490193|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
153814|NCT00705783|490194|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
153815|NCT00705783|490192|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
153816|NCT00705783|490193|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
153817|NCT00705783|490194|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
153818|NCT00705783|490192|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
153819|NCT00705783|490193|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
153820|NCT00705783|490194|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
153821|NCT00705783|490192|P3|Depot Stabilization Phase|Adverse Event|0
153822|NCT00705783|490193|P2|Depot Stabilization Phase|Adverse Event|0
153823|NCT00705783|490194|P1|Depot Stabilization Phase|Adverse Event|17
153824|NCT00705783|490192|P3|Depot Stabilization Phase|Withdrew Consent|0
153825|NCT00705783|490193|P2|Depot Stabilization Phase|Withdrew Consent|0
153826|NCT00705783|490194|P1|Depot Stabilization Phase|Withdrew Consent|29
153827|NCT00705783|490192|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
153828|NCT00705783|490193|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
153829|NCT00705783|490194|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
153830|NCT00705783|490192|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
153831|NCT00705783|490193|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
153832|NCT00705783|490194|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
153833|NCT00705783|490192|P3|Depot Stabilization Phase|Lost to Follow-up|0
153834|NCT00705783|490193|P2|Depot Stabilization Phase|Lost to Follow-up|0
153835|NCT00705783|490194|P1|Depot Stabilization Phase|Lost to Follow-up|11
153836|NCT00705783|490192|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
153837|NCT00705783|490193|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
153838|NCT00705783|490194|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
153839|NCT00705783|490192|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
153840|NCT00705783|490193|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
153841|NCT00705783|490194|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
153842|NCT00705783|490192|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
153843|NCT00705783|490193|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
153844|NCT00705783|490194|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
153845|NCT00705783|490192|P3|Oral Stabilization Phase|Adverse Event|0
153846|NCT00705783|490193|P2|Oral Stabilization Phase|Adverse Event|0
153847|NCT00705783|490194|P1|Oral Stabilization Phase|Adverse Event|14
153848|NCT00705783|490192|P3|Oral Stabilization Phase|Withdrew Consent|0
153849|NCT00705783|490193|P2|Oral Stabilization Phase|Withdrew Consent|0
153850|NCT00705783|490194|P1|Oral Stabilization Phase|Withdrew Consent|29
153851|NCT00705783|490192|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
153852|NCT00705783|490193|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
153853|NCT00705783|490194|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
153854|NCT00705783|490192|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
153855|NCT00705783|490193|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
153856|NCT00705783|490194|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
153857|NCT00705783|490192|P3|Oral Stabilization Phase|Lost to Follow-up|0
153858|NCT00705783|490193|P2|Oral Stabilization Phase|Lost to Follow-up|0
153859|NCT00705783|490194|P1|Oral Stabilization Phase|Lost to Follow-up|7
153860|NCT00705783|490192|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
153861|NCT00705783|490193|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
153862|NCT00705783|490194|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
153863|NCT00705783|490192|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
153864|NCT00705783|490193|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
153865|NCT00705783|490194|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
153866|NCT00705783|490192|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
153867|NCT00705783|490193|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
153868|NCT00705783|490194|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
153869|NCT00705783|490192|P3|Conversion Phase|Adverse Event|0
153870|NCT00705783|490193|P2|Conversion Phase|Adverse Event|0
153871|NCT00705783|490194|P1|Conversion Phase|Adverse Event|11
153872|NCT00705783|490192|P3|Conversion Phase|Protocol Deviation|0
153873|NCT00705783|490193|P2|Conversion Phase|Protocol Deviation|0
153874|NCT00705783|490194|P1|Conversion Phase|Protocol Deviation|2
153875|NCT00705783|490192|P3|Conversion Phase|Withdrew Consent|0
153876|NCT00705783|490193|P2|Conversion Phase|Withdrew Consent|0
153877|NCT00705783|490194|P1|Conversion Phase|Withdrew Consent|24
153878|NCT00705783|490192|P3|Conversion Phase|Withdrawn by Investigator|0
153879|NCT00705783|490193|P2|Conversion Phase|Withdrawn by Investigator|0
153880|NCT00705783|490194|P1|Conversion Phase|Withdrawn by Investigator|4
153881|NCT00705783|490192|P3|Conversion Phase|Met Withdrawal Criteria|0
153882|NCT00705783|490193|P2|Conversion Phase|Met Withdrawal Criteria|0
153883|NCT00705783|490194|P1|Conversion Phase|Met Withdrawal Criteria|4
153884|NCT00705783|490192|P3|Conversion Phase|Lost to Follow-up|0
153885|NCT00705783|490193|P2|Conversion Phase|Lost to Follow-up|0
153886|NCT00705783|490194|P1|Conversion Phase|Lost to Follow-up|13
153887|NCT00705783|490192|P3|Conversion Phase|Sponsor Discontinued Study|0
153888|NCT00705783|490193|P2|Conversion Phase|Sponsor Discontinued Study|0
153889|NCT00705783|490194|P1|Conversion Phase|Sponsor Discontinued Study|54
153890|NCT00705939|490253|P3|Overall Study|Physician Decision|0
153891|NCT00705939|490254|P2|Overall Study|Physician Decision|1
153892|NCT00705939|490255|P1|Overall Study|Physician Decision|0
153893|NCT00705939|490253|P3|Overall Study|Withdrawal by Subject|3
153894|NCT00705939|490254|P2|Overall Study|Withdrawal by Subject|1
153895|NCT00705939|490255|P1|Overall Study|Withdrawal by Subject|0
153896|NCT00705939|490253|P3|Overall Study|Protocol Violation|1
153897|NCT00705939|490254|P2|Overall Study|Protocol Violation|0
153898|NCT00705939|490255|P1|Overall Study|Protocol Violation|0
153899|NCT00706004|490278|P1|Overall Study|Did not meet eligibility criteria|2
153900|NCT00706095|490306|P3|Overall Study|Withdrawal by Subject|0
153901|NCT00706095|490307|P2|Overall Study|Withdrawal by Subject|0
153902|NCT00706095|490308|P1|Overall Study|Withdrawal by Subject|1
153903|NCT00706095|490306|P3|Overall Study|Clinical Progression|2
153904|NCT00706095|490307|P2|Overall Study|Clinical Progression|2
153905|NCT00706095|490308|P1|Overall Study|Clinical Progression|1
153906|NCT00706095|490306|P3|Overall Study|Progressive Disease|3
153907|NCT00706095|490307|P2|Overall Study|Progressive Disease|5
153908|NCT00706095|490308|P1|Overall Study|Progressive Disease|4
153909|NCT00706134|490359|P4|Overall Study|Did not meet study criteria|0
153910|NCT00706134|490360|P3|Overall Study|Did not meet study criteria|0
153911|NCT00706134|490361|P2|Overall Study|Did not meet study criteria|0
153912|NCT00706134|490362|P1|Overall Study|Did not meet study criteria|2
153913|NCT00706134|490359|P4|Overall Study|Unsatisfactory therapeutic effect|5
153914|NCT00706134|490360|P3|Overall Study|Unsatisfactory therapeutic effect|3
153915|NCT00706134|490361|P2|Overall Study|Unsatisfactory therapeutic effect|3
153916|NCT00706134|490362|P1|Overall Study|Unsatisfactory therapeutic effect|9
153917|NCT00706134|490359|P4|Overall Study|Withdrawal by Subject|0
153918|NCT00706134|490360|P3|Overall Study|Withdrawal by Subject|1
153919|NCT00706134|490361|P2|Overall Study|Withdrawal by Subject|2
153920|NCT00706134|490362|P1|Overall Study|Withdrawal by Subject|1
153921|NCT00706134|490359|P4|Overall Study|Protocol Violation|3
153922|NCT00706134|490360|P3|Overall Study|Protocol Violation|0
153923|NCT00706134|490361|P2|Overall Study|Protocol Violation|6
153924|NCT00706134|490362|P1|Overall Study|Protocol Violation|0
153925|NCT00706134|490359|P4|Overall Study|Lost to Follow-up|0
153926|NCT00706134|490360|P3|Overall Study|Lost to Follow-up|0
153927|NCT00706134|490361|P2|Overall Study|Lost to Follow-up|1
153928|NCT00706134|490362|P1|Overall Study|Lost to Follow-up|0
153929|NCT00706134|490359|P4|Overall Study|Adverse Event|3
153930|NCT00706134|490360|P3|Overall Study|Adverse Event|2
153931|NCT00706134|490361|P2|Overall Study|Adverse Event|7
153932|NCT00706134|490362|P1|Overall Study|Adverse Event|8
153933|NCT00706342|490396|P1|Overall Study|WIthdrawal of consent|1
153934|NCT00706342|490396|P1|Overall Study|Ongoing|6
153935|NCT00706342|490396|P1|Overall Study|Non-responder Week 12|1
153936|NCT00706342|490396|P1|Overall Study|Investigator discretion|2
153937|NCT00706342|490396|P1|Overall Study|Withdrew from the study on his own.|1
153938|NCT00706342|490396|P1|Overall Study|Death|1
153939|NCT00706342|490396|P1|Overall Study|Withdrawn due to failure to respond|1
153940|NCT00706342|490396|P1|Overall Study|Not responding to treatment|2
153941|NCT00706342|490396|P1|Overall Study|Adverse Event|3
153942|NCT00706355|490409|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
153943|NCT00706355|490410|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
153944|NCT00706355|490411|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
153945|NCT00706355|490412|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
153946|NCT00706355|490409|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
153947|NCT00706355|490410|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
153948|NCT00706355|490411|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
153949|NCT00706355|490412|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
153950|NCT00706355|490409|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
153951|NCT00706355|490410|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
153952|NCT00706355|490411|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
153953|NCT00706355|490412|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
153954|NCT00706355|490409|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
153955|NCT00706355|490410|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
153956|NCT00706355|490411|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
153957|NCT00706355|490412|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
153958|NCT00706355|490409|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
153959|NCT00706355|490410|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
153960|NCT00706355|490411|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
153961|NCT00706355|490412|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
153962|NCT00706355|490409|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
153963|NCT00706355|490410|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
153964|NCT00706355|490411|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
153965|NCT00706355|490412|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
153966|NCT00706355|490409|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
153967|NCT00706355|490410|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
153968|NCT00706355|490411|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
153969|NCT00706355|490412|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
153970|NCT00706355|490409|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
153971|NCT00706355|490410|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
153972|NCT00706355|490411|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
153973|NCT00706355|490412|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
153974|NCT00706355|490409|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
153975|NCT00706355|490410|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
153976|NCT00706355|490411|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
153977|NCT00706355|490412|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
153978|NCT00706433|490468|P4|Overall Study|new job|1
153979|NCT00706433|490469|P3|Overall Study|new job|0
153980|NCT00706433|490470|P2|Overall Study|new job|0
153981|NCT00706433|490471|P1|Overall Study|new job|0
153982|NCT00706433|490468|P4|Overall Study|Protocol Violation|0
153983|NCT00706433|490469|P3|Overall Study|Protocol Violation|0
153984|NCT00706433|490470|P2|Overall Study|Protocol Violation|0
153985|NCT00706433|490471|P1|Overall Study|Protocol Violation|1
153986|NCT00706433|490468|P4|Overall Study|Adverse Event|0
153987|NCT00706433|490469|P3|Overall Study|Adverse Event|1
153988|NCT00706433|490470|P2|Overall Study|Adverse Event|0
153989|NCT00706433|490471|P1|Overall Study|Adverse Event|0
153990|NCT00706433|490468|P4|Overall Study|Withdrawal by Subject|1
153991|NCT00706433|490469|P3|Overall Study|Withdrawal by Subject|3
153992|NCT00706433|490470|P2|Overall Study|Withdrawal by Subject|2
153993|NCT00706433|490471|P1|Overall Study|Withdrawal by Subject|1
153994|NCT00706433|490468|P4|Overall Study|Lost to Follow-up|0
153995|NCT00706433|490469|P3|Overall Study|Lost to Follow-up|6
153996|NCT00706433|490470|P2|Overall Study|Lost to Follow-up|1
153997|NCT00706433|490471|P1|Overall Study|Lost to Follow-up|3
153998|NCT00706628|490897|P4|Overall Study|Not treated|0
153999|NCT00706628|490898|P3|Overall Study|Not treated|0
154000|NCT00706628|490899|P2|Overall Study|Not treated|1
154001|NCT00706628|490900|P1|Overall Study|Not treated|1
154002|NCT00706628|490897|P4|Overall Study|Other than those stated above|0
154003|NCT00706628|490898|P3|Overall Study|Other than those stated above|0
154004|NCT00706628|490899|P2|Overall Study|Other than those stated above|0
154005|NCT00706628|490900|P1|Overall Study|Other than those stated above|4
154006|NCT00706628|490897|P4|Overall Study|Progressive disease|1
154007|NCT00706628|490898|P3|Overall Study|Progressive disease|8
154008|NCT00706628|490899|P2|Overall Study|Progressive disease|13
154009|NCT00706628|490900|P1|Overall Study|Progressive disease|20
154010|NCT00706628|490897|P4|Overall Study|Consent withdrawn|0
154011|NCT00706628|490898|P3|Overall Study|Consent withdrawn|3
154012|NCT00706628|490899|P2|Overall Study|Consent withdrawn|1
154013|NCT00706628|490900|P1|Overall Study|Consent withdrawn|6
154014|NCT00706628|490897|P4|Overall Study|Non compliant with protocol|0
154015|NCT00706628|490898|P3|Overall Study|Non compliant with protocol|0
154016|NCT00706628|490899|P2|Overall Study|Non compliant with protocol|1
154017|NCT00706628|490900|P1|Overall Study|Non compliant with protocol|0
154018|NCT00706628|490897|P4|Overall Study|Other Adverse Event|2
154019|NCT00706628|490898|P3|Overall Study|Other Adverse Event|5
154020|NCT00706628|490899|P2|Overall Study|Other Adverse Event|5
154021|NCT00706628|490900|P1|Overall Study|Other Adverse Event|16
154022|NCT00706641|490948|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
154023|NCT00706641|490948|P1|Dasatinib Administration|Ineligible after start of therapy|1
154024|NCT00706641|490948|P1|Dasatinib Administration|Withdrawal by Subject|1
154025|NCT00706654|490961|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
154026|NCT00706654|490962|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
154027|NCT00706654|490963|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
154028|NCT00706654|490964|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
154029|NCT00706654|490961|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
154030|NCT00706654|490962|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
154031|NCT00706654|490963|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
154032|NCT00706654|490964|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
154033|NCT00706654|490961|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
154034|NCT00706654|490962|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
154035|NCT00706654|490963|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
154036|NCT00706654|490964|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
154037|NCT00706654|490961|P4|Depot Maintenance Phase|Protocol Deviation|1
154038|NCT00706654|490962|P3|Depot Maintenance Phase|Protocol Deviation|3
154039|NCT00706654|490963|P2|Depot Maintenance Phase|Protocol Deviation|2
154040|NCT00706654|490964|P1|Depot Maintenance Phase|Protocol Deviation|0
154041|NCT00706654|490961|P4|Depot Maintenance Phase|Withdrew Consent|14
154042|NCT00706654|490962|P3|Depot Maintenance Phase|Withdrew Consent|29
154043|NCT00706654|490963|P2|Depot Maintenance Phase|Withdrew Consent|21
154044|NCT00706654|490964|P1|Depot Maintenance Phase|Withdrew Consent|0
154045|NCT00706654|490961|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
154046|NCT00706654|490962|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
154047|NCT00706654|490963|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
154048|NCT00706654|490964|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
154049|NCT00706654|490961|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
154050|NCT00706654|490962|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
154051|NCT00706654|490963|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
154052|NCT00706654|490964|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
154053|NCT00706654|490961|P4|Depot Maintenance Phase|Lost to Follow-up|6
154054|NCT00706654|490962|P3|Depot Maintenance Phase|Lost to Follow-up|10
154055|NCT00706654|490963|P2|Depot Maintenance Phase|Lost to Follow-up|4
154056|NCT00706654|490964|P1|Depot Maintenance Phase|Lost to Follow-up|0
154057|NCT00706654|490961|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
154058|NCT00706654|490962|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
154059|NCT00706654|490963|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
154060|NCT00706654|490964|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
154061|NCT00706654|490961|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
154062|NCT00706654|490962|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
154063|NCT00706654|490963|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
154064|NCT00706654|490964|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
154065|NCT00706654|490961|P4|Oral Stabilization Phase|Adverse Event|0
154066|NCT00706654|490962|P3|Oral Stabilization Phase|Adverse Event|0
154067|NCT00706654|490963|P2|Oral Stabilization Phase|Adverse Event|0
154068|NCT00706654|490964|P1|Oral Stabilization Phase|Adverse Event|21
154069|NCT00706654|490961|P4|Oral Stabilization Phase|Protocol Deviation|0
154070|NCT00706654|490962|P3|Oral Stabilization Phase|Protocol Deviation|0
154071|NCT00706654|490963|P2|Oral Stabilization Phase|Protocol Deviation|0
154072|NCT00706654|490964|P1|Oral Stabilization Phase|Protocol Deviation|2
154073|NCT00706654|490961|P4|Oral Stabilization Phase|Withdrew consent|0
154074|NCT00706654|490962|P3|Oral Stabilization Phase|Withdrew consent|0
154075|NCT00706654|490963|P2|Oral Stabilization Phase|Withdrew consent|0
154076|NCT00706654|490964|P1|Oral Stabilization Phase|Withdrew consent|55
154077|NCT00706654|490961|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
154078|NCT00706654|490962|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
154079|NCT00706654|490963|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
154080|NCT00706654|490964|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
154081|NCT00706654|490961|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
154082|NCT00706654|490962|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
154083|NCT00706654|490963|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
154084|NCT00706654|490964|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
154085|NCT00706654|490961|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
154086|NCT00706654|490962|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
154087|NCT00706654|490963|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
154088|NCT00706654|490964|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
154089|NCT00706654|490961|P4|Oral Stabilization Phase|Lost to Follow-up|0
154090|NCT00706654|490962|P3|Oral Stabilization Phase|Lost to Follow-up|0
154091|NCT00706654|490963|P2|Oral Stabilization Phase|Lost to Follow-up|0
154092|NCT00706654|490964|P1|Oral Stabilization Phase|Lost to Follow-up|17
154093|NCT00706654|490961|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
154094|NCT00706654|490962|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
154095|NCT00706654|490963|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
154096|NCT00706654|490964|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
154097|NCT00706654|490961|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
154098|NCT00706654|490962|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
154099|NCT00706654|490963|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
154100|NCT00706654|490964|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
154101|NCT00706654|490961|P4|Conversion Phase|Adverse Event|0
154102|NCT00706654|490962|P3|Conversion Phase|Adverse Event|0
154103|NCT00706654|490963|P2|Conversion Phase|Adverse Event|0
154104|NCT00706654|490964|P1|Conversion Phase|Adverse Event|18
154105|NCT00706654|490961|P4|Conversion Phase|Withdrew Consent|0
154106|NCT00706654|490962|P3|Conversion Phase|Withdrew Consent|0
154107|NCT00706654|490963|P2|Conversion Phase|Withdrew Consent|0
154108|NCT00706654|490964|P1|Conversion Phase|Withdrew Consent|38
154109|NCT00706654|490961|P4|Conversion Phase|Withdrawn by Investigator|0
154110|NCT00706654|490962|P3|Conversion Phase|Withdrawn by Investigator|0
154111|NCT00706654|490963|P2|Conversion Phase|Withdrawn by Investigator|0
154112|NCT00706654|490964|P1|Conversion Phase|Withdrawn by Investigator|14
154113|NCT00706654|490961|P4|Conversion Phase|Met Withdrawal Criteria|0
154114|NCT00706654|490962|P3|Conversion Phase|Met Withdrawal Criteria|0
154115|NCT00706654|490963|P2|Conversion Phase|Met Withdrawal Criteria|0
154116|NCT00706654|490964|P1|Conversion Phase|Met Withdrawal Criteria|2
154117|NCT00706654|490961|P4|Conversion Phase|Sponsor Discontinued Trial|0
154118|NCT00706654|490962|P3|Conversion Phase|Sponsor Discontinued Trial|0
154119|NCT00706654|490963|P2|Conversion Phase|Sponsor Discontinued Trial|0
154120|NCT00706654|490964|P1|Conversion Phase|Sponsor Discontinued Trial|8
154121|NCT00706654|490961|P4|Conversion Phase|Lost to Follow-up|0
154122|NCT00706654|490962|P3|Conversion Phase|Lost to Follow-up|0
154123|NCT00706654|490963|P2|Conversion Phase|Lost to Follow-up|0
154124|NCT00706654|490964|P1|Conversion Phase|Lost to Follow-up|4
154125|NCT00706706|490983|P1|Overall Study|Study endpoint had reached|45
154126|NCT00706706|490983|P1|Overall Study|Lost to Follow-up|7
154127|NCT00706706|490983|P1|Overall Study|Death|53
154128|NCT00706797|491021|P2|Overall Study|Unspecified|0
154129|NCT00706797|491022|P1|Overall Study|Unspecified|1
154130|NCT00706797|491021|P2|Overall Study|Lost to Follow-up|2
154131|NCT00706797|491022|P1|Overall Study|Lost to Follow-up|1
154132|NCT00706797|491021|P2|Overall Study|Protocol Violation|2
154133|NCT00706797|491022|P1|Overall Study|Protocol Violation|3
154134|NCT00706797|491021|P2|Overall Study|Discontinuation of study by sponsor|63
154135|NCT00706797|491022|P1|Overall Study|Discontinuation of study by sponsor|52
154136|NCT00706797|491021|P2|Overall Study|Death|0
154137|NCT00706797|491022|P1|Overall Study|Death|1
154138|NCT00706797|491021|P2|Overall Study|Withdrawal by Subject|1
154139|NCT00706797|491022|P1|Overall Study|Withdrawal by Subject|8
154140|NCT00706797|491021|P2|Overall Study|Adverse Event|3
154141|NCT00706797|491022|P1|Overall Study|Adverse Event|0
154142|NCT00706797|491021|P2|Overall Study|Lack of Efficacy|0
154143|NCT00706797|491022|P1|Overall Study|Lack of Efficacy|3
154144|NCT00706849|491096|P2|Follow-up Period|Protocol non-compliance|1
154145|NCT00706849|491097|P1|Follow-up Period|Protocol non-compliance|0
154146|NCT00706849|491096|P2|Follow-up Period|Withdrawal by Subject|2
154147|NCT00706849|491097|P1|Follow-up Period|Withdrawal by Subject|0
154148|NCT00706849|491096|P2|Treatment Period|Other|1
154149|NCT00706849|491097|P1|Treatment Period|Other|0
154150|NCT00706849|491096|P2|Treatment Period|Adverse Event|9
154151|NCT00706849|491097|P1|Treatment Period|Adverse Event|0
154152|NCT00706901|491144|P3|Overall Study|Death|0
154153|NCT00706901|491145|P2|Overall Study|Death|0
154154|NCT00706901|491146|P1|Overall Study|Death|1
154155|NCT00706901|491144|P3|Overall Study|In Jail|1
154156|NCT00706901|491145|P2|Overall Study|In Jail|0
154157|NCT00706901|491146|P1|Overall Study|In Jail|1
154158|NCT00706901|491144|P3|Overall Study|Withdrawal by Subject|5
154159|NCT00706901|491145|P2|Overall Study|Withdrawal by Subject|2
154160|NCT00706901|491146|P1|Overall Study|Withdrawal by Subject|4
154161|NCT00706901|491144|P3|Overall Study|Lost to Follow-up|2
154162|NCT00706901|491145|P2|Overall Study|Lost to Follow-up|3
154163|NCT00706901|491146|P1|Overall Study|Lost to Follow-up|2
154164|NCT00706914|491172|P3|Overall Study|Protocol Violation|1
154165|NCT00706914|491173|P2|Overall Study|Protocol Violation|1
154166|NCT00706914|491174|P1|Overall Study|Protocol Violation|3
154167|NCT00706914|491172|P3|Overall Study|Adverse Event|0
154168|NCT00706914|491173|P2|Overall Study|Adverse Event|2
154169|NCT00706914|491174|P1|Overall Study|Adverse Event|2
154170|NCT00706914|491172|P3|Overall Study|Lost to Follow-up|0
154171|NCT00706914|491173|P2|Overall Study|Lost to Follow-up|0
154172|NCT00706914|491174|P1|Overall Study|Lost to Follow-up|1
154173|NCT00706914|491172|P3|Overall Study|Lack of Efficacy|0
154174|NCT00706914|491173|P2|Overall Study|Lack of Efficacy|1
154175|NCT00706914|491174|P1|Overall Study|Lack of Efficacy|0
154176|NCT00706966|491194|P1|Overall Study|Adverse Event|1
154177|NCT00706992|491249|P7|Overall Study|Disease progression before treatment|0
154178|NCT00706992|491250|P6|Overall Study|Disease progression before treatment|0
154179|NCT00706992|491251|P5|Overall Study|Disease progression before treatment|1
154180|NCT00706992|491252|P4|Overall Study|Disease progression before treatment|0
154181|NCT00706992|491253|P3|Overall Study|Disease progression before treatment|0
154182|NCT00706992|491254|P2|Overall Study|Disease progression before treatment|0
154183|NCT00706992|491255|P1|Overall Study|Disease progression before treatment|0
154184|NCT00706992|491249|P7|Overall Study|Study termination|3
154185|NCT00706992|491250|P6|Overall Study|Study termination|2
154186|NCT00706992|491251|P5|Overall Study|Study termination|3
154187|NCT00706992|491252|P4|Overall Study|Study termination|2
154188|NCT00706992|491253|P3|Overall Study|Study termination|6
154189|NCT00706992|491254|P2|Overall Study|Study termination|5
154190|NCT00706992|491255|P1|Overall Study|Study termination|5
154191|NCT00707031|491274|P2|Overall Study|Sponsor Decision|8
154192|NCT00707031|491275|P1|Overall Study|Sponsor Decision|9
154193|NCT00707031|491274|P2|Overall Study|Serious Noncompliance|3
154194|NCT00707031|491275|P1|Overall Study|Serious Noncompliance|2
154195|NCT00707031|491274|P2|Overall Study|Familial or Personal Reasons|15
154196|NCT00707031|491275|P1|Overall Study|Familial or Personal Reasons|12
154197|NCT00707031|491274|P2|Overall Study|Poor Compliance to Protocol|13
154198|NCT00707031|491275|P1|Overall Study|Poor Compliance to Protocol|7
154199|NCT00707031|491274|P2|Overall Study|Withdrawal by Subject|8
154200|NCT00707031|491275|P1|Overall Study|Withdrawal by Subject|7
154201|NCT00707031|491274|P2|Overall Study|Protocol Violation|0
154202|NCT00707031|491275|P1|Overall Study|Protocol Violation|1
154203|NCT00707031|491274|P2|Overall Study|Lost to Follow-up|1
154204|NCT00707031|491275|P1|Overall Study|Lost to Follow-up|2
154205|NCT00707031|491274|P2|Overall Study|Lack of Efficacy|6
154206|NCT00707031|491275|P1|Overall Study|Lack of Efficacy|19
154207|NCT00707031|491274|P2|Overall Study|Adverse Event|45
154208|NCT00707031|491275|P1|Overall Study|Adverse Event|45
154209|NCT00707057|491299|P2|Overall Study|Dosed incorrectly|1
154210|NCT00707057|491300|P1|Overall Study|Dosed incorrectly|0
154211|NCT00707057|491299|P2|Overall Study|Withdrawal by Subject|3
154212|NCT00707057|491300|P1|Overall Study|Withdrawal by Subject|8
154213|NCT00707161|491332|P1|Overall Study|Physician Decision|6
154214|NCT00707174|491338|P2|Overall Study|Withdrawal by Subject|1
154215|NCT00707174|491339|P1|Overall Study|Withdrawal by Subject|4
154216|NCT00707174|491338|P2|Overall Study|Adverse Event|6
154217|NCT00707174|491339|P1|Overall Study|Adverse Event|1
154218|NCT00707239|491348|P3|Overall Study|Unspecified|5
154219|NCT00707239|491349|P2|Overall Study|Unspecified|3
154220|NCT00707239|491350|P1|Overall Study|Unspecified|8
154221|NCT00707239|491348|P3|Overall Study|Randomized, but not treated|1
154222|NCT00707239|491349|P2|Overall Study|Randomized, but not treated|1
154223|NCT00707239|491350|P1|Overall Study|Randomized, but not treated|1
154224|NCT00707239|491348|P3|Overall Study|Lack of Efficacy|0
154225|NCT00707239|491349|P2|Overall Study|Lack of Efficacy|2
154226|NCT00707239|491350|P1|Overall Study|Lack of Efficacy|1
154227|NCT00707239|491348|P3|Overall Study|Protocol Violation|1
154228|NCT00707239|491349|P2|Overall Study|Protocol Violation|0
154229|NCT00707239|491350|P1|Overall Study|Protocol Violation|0
154230|NCT00707239|491348|P3|Overall Study|Physician Decision|2
154231|NCT00707239|491349|P2|Overall Study|Physician Decision|1
154232|NCT00707239|491350|P1|Overall Study|Physician Decision|1
154233|NCT00707239|491348|P3|Overall Study|Death|3
154234|NCT00707239|491349|P2|Overall Study|Death|1
154235|NCT00707239|491350|P1|Overall Study|Death|3
154236|NCT00707239|491348|P3|Overall Study|Adverse Event|2
154237|NCT00707239|491349|P2|Overall Study|Adverse Event|3
154238|NCT00707239|491350|P1|Overall Study|Adverse Event|5
154239|NCT00707486|491427|P1|Overall Study|Withdrawal by Subject|1
154240|NCT00707577|491438|P2|Overall Study|Pregnancy|1
154241|NCT00707577|491439|P1|Overall Study|Pregnancy|4
154242|NCT00707577|491438|P2|Overall Study|Left employment|10
154243|NCT00707577|491439|P1|Overall Study|Left employment|13
154244|NCT00707577|491438|P2|Overall Study|Lost to Follow-up|25
154245|NCT00707577|491439|P1|Overall Study|Lost to Follow-up|34
154246|NCT00707577|491438|P2|Overall Study|Withdrawal by Subject|2
154247|NCT00707577|491439|P1|Overall Study|Withdrawal by Subject|3
154248|NCT00707746|491460|P2|Treatment Period|Ineligibility|1
154249|NCT00707746|491461|P1|Treatment Period|Ineligibility|0
154250|NCT00707746|491460|P2|Treatment Period|Adverse Event|4
154251|NCT00707746|491461|P1|Treatment Period|Adverse Event|2
154252|NCT00707954|491539|P5|Overall Study|Physician Decision|1
154253|NCT00707954|491540|P4|Overall Study|Physician Decision|0
154254|NCT00707954|491541|P3|Overall Study|Physician Decision|0
154255|NCT00707954|491542|P2|Overall Study|Physician Decision|0
154256|NCT00707954|491543|P1|Overall Study|Physician Decision|0
154257|NCT00707980|491619|P1|Overall Study|Other|39
154258|NCT00707980|491619|P1|Overall Study|Lost to Follow-up|59
154259|NCT00707980|491619|P1|Overall Study|Withdrawal of Consent|81
154260|NCT00707980|491619|P1|Overall Study|Protocol Deviations|19
154261|NCT00707980|491619|P1|Overall Study|Non-Compliance with Study Drug|28
154262|NCT00707980|491619|P1|Overall Study|Lack of Efficacy|35
154263|NCT00707980|491619|P1|Overall Study|Adverse Event|49
154264|NCT00707993|491636|P2|Overall Study|Other|0
154265|NCT00707993|491637|P1|Overall Study|Other|2
154266|NCT00707993|491636|P2|Overall Study|Hyperglycemic Rescue|47
154267|NCT00707993|491637|P1|Overall Study|Hyperglycemic Rescue|55
154268|NCT00707993|491636|P2|Overall Study|Withdrawal by Subject|16
154269|NCT00707993|491637|P1|Overall Study|Withdrawal by Subject|12
154270|NCT00707993|491636|P2|Overall Study|Lost to Follow-up|4
154271|NCT00707993|491637|P1|Overall Study|Lost to Follow-up|0
154272|NCT00707993|491636|P2|Overall Study|Protocol Violation|7
154273|NCT00707993|491637|P1|Overall Study|Protocol Violation|4
154274|NCT00707993|491636|P2|Overall Study|Adverse Event|20
154275|NCT00707993|491637|P1|Overall Study|Adverse Event|16
154276|NCT00708032|491692|P2|Overall Study|Withdrawal by Subject|1
154277|NCT00708032|491693|P1|Overall Study|Withdrawal by Subject|0
154278|NCT00708032|491692|P2|Overall Study|Protocol Violation|1
154279|NCT00708032|491693|P1|Overall Study|Protocol Violation|4
154280|NCT00708032|491692|P2|Overall Study|Did not meet protocol criteria|2
154281|NCT00708032|491693|P1|Overall Study|Did not meet protocol criteria|1
154282|NCT00708032|491692|P2|Overall Study|Visit out of range at month 12|1
154283|NCT00708032|491693|P1|Overall Study|Visit out of range at month 12|4
154284|NCT00708032|491692|P2|Overall Study|Poor vision|6
154285|NCT00708032|491693|P1|Overall Study|Poor vision|0
154286|NCT00708032|491692|P2|Overall Study|Pregnancy|1
154287|NCT00708032|491693|P1|Overall Study|Pregnancy|0
154288|NCT00708032|491692|P2|Overall Study|Lost to Follow-up|2
154289|NCT00708032|491693|P1|Overall Study|Lost to Follow-up|1
154290|NCT00708032|491692|P2|Overall Study|Adverse Event|2
154291|NCT00708032|491693|P1|Overall Study|Adverse Event|0
154292|NCT00708097|491785|P5|Period 2|Protocol Violation|0
154293|NCT00708097|491786|P4|Period 2|Protocol Violation|1
154294|NCT00708097|491787|P3|Period 2|Protocol Violation|1
154295|NCT00708097|491788|P2|Period 2|Protocol Violation|1
154296|NCT00708097|491789|P1|Period 2|Protocol Violation|0
154297|NCT00708097|491785|P5|Period 1|Other Reason|1
154298|NCT00708097|491786|P4|Period 1|Other Reason|0
154299|NCT00708097|491787|P3|Period 1|Other Reason|0
154300|NCT00708097|491788|P2|Period 1|Other Reason|0
154301|NCT00708097|491789|P1|Period 1|Other Reason|0
154302|NCT00708097|491785|P5|Period 1|Protocol Violation|0
154303|NCT00708097|491786|P4|Period 1|Protocol Violation|2
154304|NCT00708097|491787|P3|Period 1|Protocol Violation|0
154305|NCT00708097|491788|P2|Period 1|Protocol Violation|1
154306|NCT00708097|491789|P1|Period 1|Protocol Violation|0
154307|NCT00708123|491932|P5|Period 4|Protocol Violation|0
154308|NCT00708123|491933|P4|Period 4|Protocol Violation|0
154309|NCT00708123|491934|P3|Period 4|Protocol Violation|0
154310|NCT00708123|491935|P2|Period 4|Protocol Violation|1
154311|NCT00708123|491936|P1|Period 4|Protocol Violation|0
154312|NCT00708123|491932|P5|Period 3|Lost to Follow-up|0
154313|NCT00708123|491933|P4|Period 3|Lost to Follow-up|1
154314|NCT00708123|491934|P3|Period 3|Lost to Follow-up|1
154315|NCT00708123|491935|P2|Period 3|Lost to Follow-up|0
154316|NCT00708123|491936|P1|Period 3|Lost to Follow-up|0
154317|NCT00708123|491932|P5|Period 2|Other Reason|0
154318|NCT00708123|491933|P4|Period 2|Other Reason|0
154319|NCT00708123|491934|P3|Period 2|Other Reason|0
154320|NCT00708123|491935|P2|Period 2|Other Reason|0
154321|NCT00708123|491936|P1|Period 2|Other Reason|1
154322|NCT00708123|491932|P5|Period 2|Protocol Violation|0
154323|NCT00708123|491933|P4|Period 2|Protocol Violation|1
154324|NCT00708123|491934|P3|Period 2|Protocol Violation|0
154325|NCT00708123|491935|P2|Period 2|Protocol Violation|0
154326|NCT00708123|491936|P1|Period 2|Protocol Violation|0
154327|NCT00708123|491932|P5|Period 1|Adverse Event|0
154328|NCT00708123|491933|P4|Period 1|Adverse Event|0
154329|NCT00708123|491934|P3|Period 1|Adverse Event|1
154330|NCT00708123|491935|P2|Period 1|Adverse Event|0
154331|NCT00708123|491936|P1|Period 1|Adverse Event|0
154332|NCT00708123|491932|P5|Period 1|Protocol Violation|0
154333|NCT00708123|491933|P4|Period 1|Protocol Violation|1
154334|NCT00708123|491934|P3|Period 1|Protocol Violation|0
154335|NCT00708123|491935|P2|Period 1|Protocol Violation|1
154336|NCT00708123|491936|P1|Period 1|Protocol Violation|0
154337|NCT00708162|491958|P2|Open-Label Phase|Other|0
154338|NCT00708162|491959|P1|Open-Label Phase|Other|1
154339|NCT00708162|491958|P2|Open-Label Phase|Adverse Event|2
154340|NCT00708162|491959|P1|Open-Label Phase|Adverse Event|1
154341|NCT00708162|491958|P2|Open-Label Phase|Death|1
154342|NCT00708162|491959|P1|Open-Label Phase|Death|3
154343|NCT00708162|491958|P2|Open-Label Phase|Investigator's Discretion|2
154344|NCT00708162|491959|P1|Open-Label Phase|Investigator's Discretion|3
154345|NCT00708162|491958|P2|Open-Label Phase|Lack of Efficacy|4
154346|NCT00708162|491959|P1|Open-Label Phase|Lack of Efficacy|7
154347|NCT00708162|491958|P2|Open-Label Phase|Participant Noncompliance|7
154348|NCT00708162|491959|P1|Open-Label Phase|Participant Noncompliance|7
154349|NCT00708162|491958|P2|Open-Label Phase|Withdrew Consent|6
154350|NCT00708162|491959|P1|Open-Label Phase|Withdrew Consent|12
154351|NCT00708162|491958|P2|Open-Label Phase|Lost to Follow-up|8
154352|NCT00708162|491959|P1|Open-Label Phase|Lost to Follow-up|10
154353|NCT00708162|491958|P2|Randomized Phase|Pregnancy|0
154354|NCT00708162|491959|P1|Randomized Phase|Pregnancy|3
154355|NCT00708162|491958|P2|Randomized Phase|Death|9
154356|NCT00708162|491959|P1|Randomized Phase|Death|2
154357|NCT00708162|491958|P2|Randomized Phase|Investigator’s Discretion|10
154358|NCT00708162|491959|P1|Randomized Phase|Investigator’s Discretion|7
154359|NCT00708162|491958|P2|Randomized Phase|Adverse Event|12
154360|NCT00708162|491959|P1|Randomized Phase|Adverse Event|8
154361|NCT00708162|491958|P2|Randomized Phase|Protocol Violation|11
154362|NCT00708162|491959|P1|Randomized Phase|Protocol Violation|10
154363|NCT00708162|491958|P2|Randomized Phase|Lack of Efficacy|19
154364|NCT00708162|491959|P1|Randomized Phase|Lack of Efficacy|14
154365|NCT00708162|491958|P2|Randomized Phase|Withdrew Consent|22
154366|NCT00708162|491959|P1|Randomized Phase|Withdrew Consent|31
154367|NCT00708162|491958|P2|Randomized Phase|Lost to Follow-up|34
154368|NCT00708162|491959|P1|Randomized Phase|Lost to Follow-up|34
154369|NCT00708162|491958|P2|Randomized Phase|Participant Noncompliance|32
154370|NCT00708162|491959|P1|Randomized Phase|Participant Noncompliance|40
154371|NCT00708162|491958|P2|Randomized Phase|Randomized but Not Treated|5
154372|NCT00708162|491959|P1|Randomized Phase|Randomized but Not Treated|7
154373|NCT00708175|492002|P2|Overall Study|BMD loss >7%|3
154374|NCT00708175|492003|P1|Overall Study|BMD loss >7%|2
154375|NCT00708175|492002|P2|Overall Study|Withdrawal by Subject|7
154376|NCT00708175|492003|P1|Overall Study|Withdrawal by Subject|5
154377|NCT00708175|492002|P2|Overall Study|Lost to Follow-up|3
154378|NCT00708175|492003|P1|Overall Study|Lost to Follow-up|5
154379|NCT00708175|492002|P2|Overall Study|Protocol Violation|3
154380|NCT00708175|492003|P1|Overall Study|Protocol Violation|2
154381|NCT00708175|492002|P2|Overall Study|Adverse Event|5
154382|NCT00708175|492003|P1|Overall Study|Adverse Event|4
154383|NCT00708201|492019|P2|Overall Study|Protocol Violation|1
154384|NCT00708201|492020|P1|Overall Study|Protocol Violation|0
154385|NCT00708201|492019|P2|Overall Study|Lost to Follow-up|0
154386|NCT00708201|492020|P1|Overall Study|Lost to Follow-up|2
154387|NCT00708201|492019|P2|Overall Study|Withdrawal by Subject|1
154388|NCT00708201|492020|P1|Overall Study|Withdrawal by Subject|1
154389|NCT00708201|492019|P2|Overall Study|Adverse Event|4
154390|NCT00708201|492020|P1|Overall Study|Adverse Event|4
154391|NCT00708214|492045|P3|Overall Study|Progressive Disease|5
154392|NCT00708214|492046|P2|Overall Study|Progressive Disease|6
154393|NCT00708214|492047|P1|Overall Study|Progressive Disease|4
154394|NCT00708214|492045|P3|Overall Study|Other|1
154395|NCT00708214|492046|P2|Overall Study|Other|1
154396|NCT00708214|492047|P1|Overall Study|Other|0
154397|NCT00708214|492045|P3|Overall Study|Other Adverse Event|2
154398|NCT00708214|492046|P2|Overall Study|Other Adverse Event|6
154399|NCT00708214|492047|P1|Overall Study|Other Adverse Event|3
154400|NCT00714493|492088|P1|Overall Study|OTHER|2
154401|NCT00714493|492088|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
154402|NCT00714493|492088|P1|Overall Study|Protocol Violation|12
154403|NCT00714493|492088|P1|Overall Study|Lost to Follow-up|3
154404|NCT00714493|492088|P1|Overall Study|Lack of Efficacy|10
154405|NCT00714493|492088|P1|Overall Study|Death|3
154406|NCT00714493|492088|P1|Overall Study|Adverse Event|11
154407|NCT00714688|492126|P3|Overall Study|Other|5
154408|NCT00714688|492127|P2|Overall Study|Other|6
154409|NCT00714688|492128|P1|Overall Study|Other|1
154410|NCT00714688|492126|P3|Overall Study|Sponsor's Decision|0
154411|NCT00714688|492127|P2|Overall Study|Sponsor's Decision|2
154412|NCT00714688|492128|P1|Overall Study|Sponsor's Decision|0
154413|NCT00714688|492126|P3|Overall Study|Ineligible to Continue the Study|1
154414|NCT00714688|492127|P2|Overall Study|Ineligible to Continue the Study|1
154415|NCT00714688|492128|P1|Overall Study|Ineligible to Continue the Study|0
154416|NCT00714688|492126|P3|Overall Study|Subject Non-compliant|5
154417|NCT00714688|492127|P2|Overall Study|Subject Non-compliant|5
154418|NCT00714688|492128|P1|Overall Study|Subject Non-compliant|3
154419|NCT00714688|492126|P3|Overall Study|Adverse Event|19
154420|NCT00714688|492127|P2|Overall Study|Adverse Event|15
154421|NCT00714688|492128|P1|Overall Study|Adverse Event|2
154422|NCT00714688|492126|P3|Overall Study|Lost to Follow-up|0
154423|NCT00714688|492127|P2|Overall Study|Lost to Follow-up|2
154424|NCT00714688|492128|P1|Overall Study|Lost to Follow-up|5
154425|NCT00714688|492126|P3|Overall Study|Withdrawal by Subject|3
154426|NCT00714688|492127|P2|Overall Study|Withdrawal by Subject|3
154427|NCT00714688|492128|P1|Overall Study|Withdrawal by Subject|4
154428|NCT00714688|492126|P3|Overall Study|Lack of Efficacy|4
154429|NCT00714688|492127|P2|Overall Study|Lack of Efficacy|1
154430|NCT00714688|492128|P1|Overall Study|Lack of Efficacy|14
154431|NCT00714714|492145|P1|Overall Study|Adverse Event|1
154432|NCT00715299|492151|P1|Overall Study|failed the pre-screen exercise test|2
154433|NCT00715299|492151|P1|Overall Study|Adverse Event|3
154434|NCT00715299|492151|P1|Overall Study|Withdrawal by Subject|1
154435|NCT00715403|492166|P7|Overall Study|Other reason not defined above|0
154436|NCT00715403|492167|P6|Overall Study|Other reason not defined above|1
154437|NCT00715403|492168|P5|Overall Study|Other reason not defined above|1
154438|NCT00715403|492169|P4|Overall Study|Other reason not defined above|0
154439|NCT00715403|492170|P3|Overall Study|Other reason not defined above|1
154440|NCT00715403|492171|P2|Overall Study|Other reason not defined above|0
154441|NCT00715403|492172|P1|Overall Study|Other reason not defined above|0
154442|NCT00715403|492166|P7|Overall Study|Protocol Violation|0
154443|NCT00715403|492167|P6|Overall Study|Protocol Violation|1
154444|NCT00715403|492168|P5|Overall Study|Protocol Violation|0
154445|NCT00715403|492169|P4|Overall Study|Protocol Violation|0
154446|NCT00715403|492170|P3|Overall Study|Protocol Violation|0
154447|NCT00715403|492171|P2|Overall Study|Protocol Violation|0
154448|NCT00715403|492172|P1|Overall Study|Protocol Violation|0
154449|NCT00715403|492166|P7|Overall Study|Other Adverse Event than DLT|0
154450|NCT00715403|492167|P6|Overall Study|Other Adverse Event than DLT|2
154451|NCT00715403|492168|P5|Overall Study|Other Adverse Event than DLT|0
154452|NCT00715403|492169|P4|Overall Study|Other Adverse Event than DLT|0
154453|NCT00715403|492170|P3|Overall Study|Other Adverse Event than DLT|0
154454|NCT00715403|492171|P2|Overall Study|Other Adverse Event than DLT|0
154455|NCT00715403|492172|P1|Overall Study|Other Adverse Event than DLT|1
154456|NCT00715403|492166|P7|Overall Study|Dose limiting Toxicity (DLT)|0
154457|NCT00715403|492167|P6|Overall Study|Dose limiting Toxicity (DLT)|1
154458|NCT00715403|492168|P5|Overall Study|Dose limiting Toxicity (DLT)|0
154459|NCT00715403|492169|P4|Overall Study|Dose limiting Toxicity (DLT)|0
154460|NCT00715403|492170|P3|Overall Study|Dose limiting Toxicity (DLT)|0
154461|NCT00715403|492171|P2|Overall Study|Dose limiting Toxicity (DLT)|0
154462|NCT00715403|492172|P1|Overall Study|Dose limiting Toxicity (DLT)|0
154463|NCT00715403|492166|P7|Overall Study|Progressive disease|1
154464|NCT00715403|492167|P6|Overall Study|Progressive disease|14
154465|NCT00715403|492168|P5|Overall Study|Progressive disease|5
154466|NCT00715403|492169|P4|Overall Study|Progressive disease|9
154467|NCT00715403|492170|P3|Overall Study|Progressive disease|3
154468|NCT00715403|492171|P2|Overall Study|Progressive disease|1
154469|NCT00715403|492172|P1|Overall Study|Progressive disease|0
154470|NCT00715559|492307|P1|Overall Study|medication not tolerated - nausea|1
154471|NCT00715624|492316|P2|Overall Study|Other|1
154472|NCT00715624|492317|P1|Overall Study|Other|0
154473|NCT00715624|492316|P2|Overall Study|Incorrect randomization (not treated)|1
154474|NCT00715624|492317|P1|Overall Study|Incorrect randomization (not treated)|0
154475|NCT00715624|492316|P2|Overall Study|Sponsor decision|4
154476|NCT00715624|492317|P1|Overall Study|Sponsor decision|0
154477|NCT00715624|492316|P2|Overall Study|Poor compliance|13
154478|NCT00715624|492317|P1|Overall Study|Poor compliance|6
154479|NCT00715624|492316|P2|Overall Study|Familial and personal reasons|22
154480|NCT00715624|492317|P1|Overall Study|Familial and personal reasons|10
154481|NCT00715624|492316|P2|Overall Study|Withdrawal by Subject|25
154482|NCT00715624|492317|P1|Overall Study|Withdrawal by Subject|11
154483|NCT00715624|492316|P2|Overall Study|Protocol Violation|0
154484|NCT00715624|492317|P1|Overall Study|Protocol Violation|1
154485|NCT00715624|492316|P2|Overall Study|Lost to Follow-up|2
154486|NCT00715624|492317|P1|Overall Study|Lost to Follow-up|1
154487|NCT00715624|492316|P2|Overall Study|Lack of Efficacy|11
154488|NCT00715624|492317|P1|Overall Study|Lack of Efficacy|11
154489|NCT00715624|492316|P2|Overall Study|Adverse Event|37
154490|NCT00715624|492317|P1|Overall Study|Adverse Event|12
154491|NCT00715676|492363|P3|Overall Study|Elevated Blood Glucose|0
154492|NCT00715676|492364|P2|Overall Study|Elevated Blood Glucose|1
154493|NCT00715676|492365|P1|Overall Study|Elevated Blood Glucose|0
154494|NCT00715676|492363|P3|Overall Study|Use of Exclusionary Medication|1
154495|NCT00715676|492364|P2|Overall Study|Use of Exclusionary Medication|0
154496|NCT00715676|492365|P1|Overall Study|Use of Exclusionary Medication|0
154497|NCT00715676|492363|P3|Overall Study|Did Not Meet Entry Criteria|1
154498|NCT00715676|492364|P2|Overall Study|Did Not Meet Entry Criteria|0
154499|NCT00715676|492365|P1|Overall Study|Did Not Meet Entry Criteria|0
154500|NCT00715676|492363|P3|Overall Study|Terminated by Sponsor|0
154501|NCT00715676|492364|P2|Overall Study|Terminated by Sponsor|0
154502|NCT00715676|492365|P1|Overall Study|Terminated by Sponsor|1
154503|NCT00715676|492363|P3|Overall Study|Lost to Follow-up|1
154504|NCT00715676|492364|P2|Overall Study|Lost to Follow-up|2
154505|NCT00715676|492365|P1|Overall Study|Lost to Follow-up|1
154506|NCT00715676|492363|P3|Overall Study|Withdrawal by Subject|8
154507|NCT00715676|492364|P2|Overall Study|Withdrawal by Subject|3
154508|NCT00715676|492365|P1|Overall Study|Withdrawal by Subject|1
154509|NCT00715676|492363|P3|Overall Study|Adverse Event|21
154510|NCT00715676|492364|P2|Overall Study|Adverse Event|5
154511|NCT00715676|492365|P1|Overall Study|Adverse Event|3
154512|NCT00715910|492475|P6|Booster and ESFU Phase|Unspecified|0
154513|NCT00715910|492476|P5|Booster and ESFU Phase|Unspecified|1
154514|NCT00715910|492477|P4|Booster and ESFU Phase|Unspecified|5
154515|NCT00715910|492478|P3|Booster and ESFU Phase|Unspecified|0
154516|NCT00715910|492479|P2|Booster and ESFU Phase|Unspecified|0
154517|NCT00715910|492480|P1|Booster and ESFU Phase|Unspecified|0
154518|NCT00715910|492475|P6|Booster and ESFU Phase|Lost to Follow-up|13
154519|NCT00715910|492476|P5|Booster and ESFU Phase|Lost to Follow-up|1
154520|NCT00715910|492477|P4|Booster and ESFU Phase|Lost to Follow-up|6
154521|NCT00715910|492478|P3|Booster and ESFU Phase|Lost to Follow-up|0
154522|NCT00715910|492479|P2|Booster and ESFU Phase|Lost to Follow-up|0
154523|NCT00715910|492480|P1|Booster and ESFU Phase|Lost to Follow-up|0
154524|NCT00715949|492554|P1|Overall Study|could not finish first test|4
154525|NCT00716092|492585|P3|Overall Study|Other incl. Lack of Efficacy|0
154526|NCT00716092|492586|P2|Overall Study|Other incl. Lack of Efficacy|1
154527|NCT00716092|492587|P1|Overall Study|Other incl. Lack of Efficacy|2
154528|NCT00716417|492626|P10|Overall Study|On patient request due to toxicities|0
154529|NCT00716417|492627|P9|Overall Study|On patient request due to toxicities|0
154530|NCT00716417|492628|P8|Overall Study|On patient request due to toxicities|1
154531|NCT00716417|492629|P7|Overall Study|On patient request due to toxicities|0
154532|NCT00716417|492630|P6|Overall Study|On patient request due to toxicities|0
154533|NCT00716417|492631|P5|Overall Study|On patient request due to toxicities|0
154534|NCT00716417|492632|P4|Overall Study|On patient request due to toxicities|0
154535|NCT00716417|492633|P3|Overall Study|On patient request due to toxicities|0
154536|NCT00716417|492634|P2|Overall Study|On patient request due to toxicities|0
154537|NCT00716417|492635|P1|Overall Study|On patient request due to toxicities|0
154538|NCT00716417|492626|P10|Overall Study|Dose limiting toxicity (DLT)|0
154539|NCT00716417|492627|P9|Overall Study|Dose limiting toxicity (DLT)|0
154540|NCT00716417|492628|P8|Overall Study|Dose limiting toxicity (DLT)|0
154541|NCT00716417|492629|P7|Overall Study|Dose limiting toxicity (DLT)|0
154542|NCT00716417|492630|P6|Overall Study|Dose limiting toxicity (DLT)|0
154543|NCT00716417|492631|P5|Overall Study|Dose limiting toxicity (DLT)|1
154544|NCT00716417|492632|P4|Overall Study|Dose limiting toxicity (DLT)|0
154545|NCT00716417|492633|P3|Overall Study|Dose limiting toxicity (DLT)|0
154546|NCT00716417|492634|P2|Overall Study|Dose limiting toxicity (DLT)|0
154547|NCT00716417|492635|P1|Overall Study|Dose limiting toxicity (DLT)|0
154548|NCT00716417|492626|P10|Overall Study|Progressive disease|0
154549|NCT00716417|492627|P9|Overall Study|Progressive disease|5
154550|NCT00716417|492628|P8|Overall Study|Progressive disease|1
154551|NCT00716417|492629|P7|Overall Study|Progressive disease|3
154552|NCT00716417|492630|P6|Overall Study|Progressive disease|3
154553|NCT00716417|492631|P5|Overall Study|Progressive disease|0
154554|NCT00716417|492632|P4|Overall Study|Progressive disease|8
154555|NCT00716417|492633|P3|Overall Study|Progressive disease|3
154556|NCT00716417|492634|P2|Overall Study|Progressive disease|5
154557|NCT00716417|492635|P1|Overall Study|Progressive disease|3
154558|NCT00716417|492626|P10|Overall Study|Withdrawal by Subject|0
154559|NCT00716417|492627|P9|Overall Study|Withdrawal by Subject|0
154560|NCT00716417|492628|P8|Overall Study|Withdrawal by Subject|0
154561|NCT00716417|492629|P7|Overall Study|Withdrawal by Subject|1
154562|NCT00716417|492630|P6|Overall Study|Withdrawal by Subject|0
154563|NCT00716417|492631|P5|Overall Study|Withdrawal by Subject|0
154564|NCT00716417|492632|P4|Overall Study|Withdrawal by Subject|2
154565|NCT00716417|492633|P3|Overall Study|Withdrawal by Subject|0
154566|NCT00716417|492634|P2|Overall Study|Withdrawal by Subject|1
154567|NCT00716417|492635|P1|Overall Study|Withdrawal by Subject|0
154568|NCT00716417|492626|P10|Overall Study|Adverse Event|3
154569|NCT00716417|492627|P9|Overall Study|Adverse Event|0
154570|NCT00716417|492628|P8|Overall Study|Adverse Event|1
154571|NCT00716417|492629|P7|Overall Study|Adverse Event|3
154572|NCT00716417|492630|P6|Overall Study|Adverse Event|0
154573|NCT00716417|492631|P5|Overall Study|Adverse Event|0
154574|NCT00716417|492632|P4|Overall Study|Adverse Event|1
154575|NCT00716417|492633|P3|Overall Study|Adverse Event|2
154576|NCT00716417|492634|P2|Overall Study|Adverse Event|0
154577|NCT00716417|492635|P1|Overall Study|Adverse Event|0
154578|NCT00716456|492715|P3|Overall Study|Adverse Event|0
154579|NCT00716456|492716|P2|Overall Study|Adverse Event|2
154580|NCT00716456|492717|P1|Overall Study|Adverse Event|0
154581|NCT00716482|492725|P1|Overall Study|inclusion/exclusion criteria not met|25
154582|NCT00716482|492725|P1|Overall Study|technical/machine error|28
154583|NCT00716482|492725|P1|Overall Study|no pathology obtained|10
154584|NCT00716482|492725|P1|Overall Study|Inadequate acquisition or analysis|50
154585|NCT00716482|492725|P1|Overall Study|Lost to Follow-up|6
154586|NCT00716625|492735|P1|Overall Study|Safety was not Assessable|1
154587|NCT00716859|492823|P2|Overall Study|Not treated|1
154588|NCT00716859|492824|P1|Overall Study|Not treated|1
154589|NCT00716859|492823|P2|Overall Study|Withdrawal by Subject|3
154590|NCT00716859|492824|P1|Overall Study|Withdrawal by Subject|1
154591|NCT00716859|492823|P2|Overall Study|Lack of Efficacy|0
154592|NCT00716859|492824|P1|Overall Study|Lack of Efficacy|3
154593|NCT00716859|492823|P2|Overall Study|Adverse Event|1
154594|NCT00716859|492824|P1|Overall Study|Adverse Event|4
154595|NCT00716976|492866|P2|Overall Study|Ineligibles|2
154596|NCT00716976|492867|P1|Overall Study|Ineligibles|4
154597|NCT00716976|492866|P2|Overall Study|Radiation during protocol|0
154598|NCT00716976|492867|P1|Overall Study|Radiation during protocol|1
154599|NCT00716976|492866|P2|Overall Study|Premature discontinuation cisplatin|4
154600|NCT00716976|492867|P1|Overall Study|Premature discontinuation cisplatin|5
154601|NCT00716976|492866|P2|Overall Study|Withdrawal by Subject|1
154602|NCT00716976|492867|P1|Overall Study|Withdrawal by Subject|5
154603|NCT00716976|492866|P2|Overall Study|Physician Decision|2
154604|NCT00716976|492867|P1|Overall Study|Physician Decision|2
154605|NCT00716976|492866|P2|Overall Study|Death|0
154606|NCT00716976|492867|P1|Overall Study|Death|1
154607|NCT00716976|492866|P2|Overall Study|Adverse Event|0
154608|NCT00716976|492867|P1|Overall Study|Adverse Event|2
154609|NCT00717067|492915|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
154610|NCT00717067|492916|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
154611|NCT00717067|492917|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
154612|NCT00717067|492918|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
154613|NCT00717067|492919|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
154614|NCT00717093|493003|P2|Overall Study|Randomized but not treated|0
154615|NCT00717093|493004|P1|Overall Study|Randomized but not treated|1
154616|NCT00717093|493003|P2|Overall Study|Unspecified|1
154617|NCT00717093|493004|P1|Overall Study|Unspecified|0
154618|NCT00717093|493003|P2|Overall Study|Withdrawal by Subject|19
154619|NCT00717093|493004|P1|Overall Study|Withdrawal by Subject|12
154620|NCT00717093|493003|P2|Overall Study|Lost to Follow-up|6
154621|NCT00717093|493004|P1|Overall Study|Lost to Follow-up|9
154622|NCT00717093|493003|P2|Overall Study|Lack of Efficacy|13
154623|NCT00717093|493004|P1|Overall Study|Lack of Efficacy|3
154624|NCT00717093|493003|P2|Overall Study|Adverse Event|9
154625|NCT00717093|493004|P1|Overall Study|Adverse Event|19
154626|NCT00717197|493016|P1|Overall Study|Physician Decision|1
154627|NCT00717197|493016|P1|Overall Study|Tumor Progression|1
154628|NCT00717197|493016|P1|Overall Study|Unable to purchase study drug|5
154629|NCT00717236|493022|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
154630|NCT00717236|493023|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
154631|NCT00717236|493022|P2|Open-Label Period|Other: Completion Accidently Performed|0
154632|NCT00717236|493023|P1|Open-Label Period|Other: Completion Accidently Performed|1
154633|NCT00717236|493022|P2|Open-Label Period|Other: Administration of Golimumab|0
154634|NCT00717236|493023|P1|Open-Label Period|Other: Administration of Golimumab|1
154635|NCT00717236|493022|P2|Open-Label Period|Other: Cataract Surgery|0
154636|NCT00717236|493023|P1|Open-Label Period|Other: Cataract Surgery|1
154637|NCT00717236|493022|P2|Open-Label Period|Other: Sponsor Request|0
154638|NCT00717236|493023|P1|Open-Label Period|Other: Sponsor Request|3
154639|NCT00717236|493022|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
154640|NCT00717236|493023|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
154641|NCT00717236|493022|P2|Open-Label Period|Other: Investigator Decision|0
154642|NCT00717236|493023|P1|Open-Label Period|Other: Investigator Decision|1
154643|NCT00717236|493022|P2|Open-Label Period|Other: Moved|0
154644|NCT00717236|493023|P1|Open-Label Period|Other: Moved|1
154645|NCT00717236|493022|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
154646|NCT00717236|493023|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
154647|NCT00717236|493022|P2|Open-Label Period|Other: Lack of Compliance|1
154648|NCT00717236|493023|P1|Open-Label Period|Other: Lack of Compliance|1
154649|NCT00717236|493022|P2|Open-Label Period|Other: Peripheral Neuropathy|1
154650|NCT00717236|493023|P1|Open-Label Period|Other: Peripheral Neuropathy|0
154651|NCT00717236|493022|P2|Open-Label Period|Loss of Efficacy|1
154652|NCT00717236|493023|P1|Open-Label Period|Loss of Efficacy|6
154653|NCT00717236|493022|P2|Open-Label Period|Withdrawal by Subject|2
154654|NCT00717236|493023|P1|Open-Label Period|Withdrawal by Subject|20
154655|NCT00717236|493022|P2|Open-Label Period|Lost to Follow-up|4
154656|NCT00717236|493023|P1|Open-Label Period|Lost to Follow-up|28
154657|NCT00717236|493022|P2|Open-Label Period|Lack of Efficacy|8
154658|NCT00717236|493023|P1|Open-Label Period|Lack of Efficacy|30
154659|NCT00717236|493022|P2|Open-Label Period|Adverse Event|4
154660|NCT00717236|493023|P1|Open-Label Period|Adverse Event|29
154661|NCT00717236|493022|P2|Double-Blind Period|Other: Investigator Decision|1
154662|NCT00717236|493023|P1|Double-Blind Period|Other: Investigator Decision|0
154663|NCT00717236|493022|P2|Double-Blind Period|Other: Transportation problems|1
154664|NCT00717236|493023|P1|Double-Blind Period|Other: Transportation problems|0
154665|NCT00717236|493022|P2|Double-Blind Period|Other: Prohibited medication taken|2
154666|NCT00717236|493023|P1|Double-Blind Period|Other: Prohibited medication taken|2
154667|NCT00717236|493022|P2|Double-Blind Period|Other: Stopped taking DMARD|0
154668|NCT00717236|493023|P1|Double-Blind Period|Other: Stopped taking DMARD|1
154669|NCT00717236|493022|P2|Double-Blind Period|Other: Subject moved|1
154670|NCT00717236|493023|P1|Double-Blind Period|Other: Subject moved|1
154671|NCT00717236|493022|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
154672|NCT00717236|493023|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
154673|NCT00717236|493022|P2|Double-Blind Period|Other: Inappropriate randomization|0
154674|NCT00717236|493023|P1|Double-Blind Period|Other: Inappropriate randomization|1
154675|NCT00717236|493022|P2|Double-Blind Period|Other: Sponsor request|0
154676|NCT00717236|493023|P1|Double-Blind Period|Other: Sponsor request|1
154677|NCT00717236|493022|P2|Double-Blind Period|Other: History of cancer|0
154678|NCT00717236|493023|P1|Double-Blind Period|Other: History of cancer|1
154679|NCT00717236|493022|P2|Double-Blind Period|Other: History of adenoid grown|0
154680|NCT00717236|493023|P1|Double-Blind Period|Other: History of adenoid grown|1
154681|NCT00717236|493022|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
154682|NCT00717236|493023|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
154683|NCT00717236|493022|P2|Double-Blind Period|Other: subject withdrew consent|1
154684|NCT00717236|493023|P1|Double-Blind Period|Other: subject withdrew consent|1
154685|NCT00717236|493022|P2|Double-Blind Period|Other: Screening failure|0
154686|NCT00717236|493023|P1|Double-Blind Period|Other: Screening failure|1
154687|NCT00717236|493022|P2|Double-Blind Period|Other: Site withdrew|0
154688|NCT00717236|493023|P1|Double-Blind Period|Other: Site withdrew|2
154689|NCT00717236|493022|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
154690|NCT00717236|493023|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
154691|NCT00717236|493022|P2|Double-Blind Period|Other: Protocol Violation|0
154692|NCT00717236|493023|P1|Double-Blind Period|Other: Protocol Violation|2
154693|NCT00717236|493022|P2|Double-Blind Period|Other: Pregnancy|0
154694|NCT00717236|493023|P1|Double-Blind Period|Other: Pregnancy|1
154695|NCT00717236|493022|P2|Double-Blind Period|Other: Death|0
154696|NCT00717236|493023|P1|Double-Blind Period|Other: Death|1
154697|NCT00717236|493022|P2|Double-Blind Period|Loss of efficacy|0
154698|NCT00717236|493023|P1|Double-Blind Period|Loss of efficacy|3
154699|NCT00717236|493022|P2|Double-Blind Period|Withdrawal by Subject|2
154700|NCT00717236|493023|P1|Double-Blind Period|Withdrawal by Subject|10
154701|NCT00717236|493022|P2|Double-Blind Period|Lost to Follow-up|5
154702|NCT00717236|493023|P1|Double-Blind Period|Lost to Follow-up|3
154703|NCT00717236|493022|P2|Double-Blind Period|Lack of Efficacy|6
154704|NCT00717236|493023|P1|Double-Blind Period|Lack of Efficacy|6
154705|NCT00717236|493022|P2|Double-Blind Period|Adverse Event|6
154706|NCT00717236|493023|P1|Double-Blind Period|Adverse Event|33
154707|NCT00717249|493094|P2|Overall Study|Headaches|0
154708|NCT00717249|493095|P1|Overall Study|Headaches|1
154709|NCT00717249|493094|P2|Overall Study|Subject relocated|0
154710|NCT00717249|493095|P1|Overall Study|Subject relocated|1
154711|NCT00717249|493094|P2|Overall Study|Diagnosed with Multiple Scletosis|0
154712|NCT00717249|493095|P1|Overall Study|Diagnosed with Multiple Scletosis|1
154713|NCT00717249|493094|P2|Overall Study|Diagnosed with Diabetes|0
154714|NCT00717249|493095|P1|Overall Study|Diagnosed with Diabetes|1
154715|NCT00717249|493094|P2|Overall Study|Gastric Surgery|1
154716|NCT00717249|493095|P1|Overall Study|Gastric Surgery|0
154717|NCT00717249|493094|P2|Overall Study|Unsatisfactory Physiological Response|1
154718|NCT00717249|493095|P1|Overall Study|Unsatisfactory Physiological Response|0
154719|NCT00717249|493094|P2|Overall Study|Subject became Ineligible|1
154720|NCT00717249|493095|P1|Overall Study|Subject became Ineligible|1
154721|NCT00717249|493094|P2|Overall Study|Protocol Violation|2
154722|NCT00717249|493095|P1|Overall Study|Protocol Violation|0
154723|NCT00717249|493094|P2|Overall Study|Pregnancy|3
154724|NCT00717249|493095|P1|Overall Study|Pregnancy|6
154725|NCT00717249|493094|P2|Overall Study|Withdrawal by Subject|2
154726|NCT00717249|493095|P1|Overall Study|Withdrawal by Subject|1
154727|NCT00717249|493094|P2|Overall Study|Lost to Follow-up|0
154728|NCT00717249|493095|P1|Overall Study|Lost to Follow-up|2
154729|NCT00717249|493094|P2|Overall Study|Adverse Event|2
154730|NCT00717249|493095|P1|Overall Study|Adverse Event|4
154731|NCT00717249|493094|P2|Overall Study|Unsatisfactory visual Response|2
154732|NCT00717249|493095|P1|Overall Study|Unsatisfactory visual Response|0
154733|NCT00717249|493094|P2|Overall Study|Lens Discomfort|1
154734|NCT00717249|493095|P1|Overall Study|Lens Discomfort|4
154735|NCT00717275|493107|P1|Overall Study|Premature study termination.|3
154736|NCT00717314|493132|P2|Overall Study|Withdrawal by Subject|3
154737|NCT00717314|493133|P1|Overall Study|Withdrawal by Subject|1
154738|NCT00717314|493132|P2|Overall Study|Lost to Follow-up|5
154739|NCT00717314|493133|P1|Overall Study|Lost to Follow-up|1
154740|NCT00717314|493132|P2|Overall Study|Protocol Violation|0
154741|NCT00717314|493133|P1|Overall Study|Protocol Violation|1
154742|NCT00717314|493132|P2|Overall Study|Adverse Event|2
154743|NCT00717314|493133|P1|Overall Study|Adverse Event|3
154744|NCT00717522|493180|P1|Overall Study|Death|1
154745|NCT00717522|493180|P1|Overall Study|Adverse Event|1
154746|NCT00717522|493180|P1|Overall Study|Disease Progression|5
154747|NCT00717756|493194|P1|Overall Study|Withdrawal by Subject|1
154748|NCT00705614|493200|P2|Switch to Remicade|Administrative Reason|9
154749|NCT00705614|493201|P1|Switch to Remicade|Administrative Reason|0
154750|NCT00705614|493200|P2|Switch to Remicade|Withdrawal by Subject|12
154751|NCT00705614|493201|P1|Switch to Remicade|Withdrawal by Subject|0
154752|NCT00705614|493200|P2|Switch to Remicade|Lost to Follow-up|23
154753|NCT00705614|493201|P1|Switch to Remicade|Lost to Follow-up|0
154754|NCT00705614|493200|P2|Switch to Remicade|Adverse Event|5
154755|NCT00705614|493201|P1|Switch to Remicade|Adverse Event|0
154756|NCT00705614|493200|P2|Initial Intervention|Status completion unknown|0
154757|NCT00705614|493201|P1|Initial Intervention|Status completion unknown|3
154758|NCT00705614|493200|P2|Initial Intervention|Administrative Reason|38
154759|NCT00705614|493201|P1|Initial Intervention|Administrative Reason|51
154760|NCT00705614|493200|P2|Initial Intervention|Withdrawal by Subject|71
154761|NCT00705614|493201|P1|Initial Intervention|Withdrawal by Subject|114
154762|NCT00705614|493200|P2|Initial Intervention|Lost to Follow-up|191
154763|NCT00705614|493201|P1|Initial Intervention|Lost to Follow-up|310
154764|NCT00705614|493200|P2|Initial Intervention|Adverse Event|21
154765|NCT00705614|493201|P1|Initial Intervention|Adverse Event|40
154766|NCT00705666|493253|P1|Overall Study|Untreated|5
154767|NCT00705666|493253|P1|Overall Study|Lack of data|3
154768|NCT00705666|493253|P1|Overall Study|Other|2
154769|NCT00705666|493253|P1|Overall Study|Not specified|12
154770|NCT00705666|493253|P1|Overall Study|Adverse Event|4
154771|NCT00705666|493253|P1|Overall Study|Death|1
154772|NCT00705666|493253|P1|Overall Study|Lost to Follow-up|5
154773|NCT00705666|493253|P1|Overall Study|Physician Decision|7
154774|NCT00705666|493253|P1|Overall Study|Withdrawal by Subject|21
154775|NCT00705666|493253|P1|Overall Study|No post-treatment questionnaire|279
154776|NCT00711087|493259|P2|Overall Study|Lost to Follow-up|0
154777|NCT00711087|493260|P1|Overall Study|Lost to Follow-up|1
154778|NCT00711100|493266|P1|Overall Study|Withdrawal by Subject|8
154779|NCT00711100|493266|P1|Overall Study|Lack of Efficacy|5
154780|NCT00711113|493282|P1|Overall Study|Implant lost|2
154781|NCT00711113|493282|P1|Overall Study|Lost to Follow-up|9
154782|NCT00711191|493291|P3|Overall Study|Withdrawal by Subject|3
154783|NCT00711191|493292|P2|Overall Study|Withdrawal by Subject|1
154784|NCT00711191|493293|P1|Overall Study|Withdrawal by Subject|0
154785|NCT00711191|493291|P3|Overall Study|Objective progression or relapse|7
154786|NCT00711191|493292|P2|Overall Study|Objective progression or relapse|3
154787|NCT00711191|493293|P1|Overall Study|Objective progression or relapse|2
154788|NCT00711191|493291|P3|Overall Study|Adverse Event|2
154789|NCT00711191|493292|P2|Overall Study|Adverse Event|1
154790|NCT00711191|493293|P1|Overall Study|Adverse Event|1
154791|NCT00711425|493349|P1|Overall Study|Lost to Follow-up|1
154792|NCT00711425|493349|P1|Overall Study|Death|2
154793|NCT00711425|493349|P1|Overall Study|Protocol Violation|1
154794|NCT00711477|493357|P2|Overall Study|Noncompliance|1
154795|NCT00711477|493358|P1|Overall Study|Noncompliance|0
154796|NCT00711477|493357|P2|Overall Study|Lost to Follow-up|1
154797|NCT00711477|493358|P1|Overall Study|Lost to Follow-up|0
154798|NCT00711477|493357|P2|Overall Study|Adverse Event|1
154799|NCT00711477|493358|P1|Overall Study|Adverse Event|3
154800|NCT00711516|493399|P2|Overall Study|Protocol Violation|1
154801|NCT00711516|493400|P1|Overall Study|Protocol Violation|0
154802|NCT00711516|493399|P2|Overall Study|Withdrawal by Subject|1
154803|NCT00711516|493400|P1|Overall Study|Withdrawal by Subject|0
154804|NCT00711516|493399|P2|Overall Study|Adverse Event|1
154805|NCT00711516|493400|P1|Overall Study|Adverse Event|1
154806|NCT00711529|493496|P2|Overall Study|Withdrawal by Subject|6
154807|NCT00711529|493497|P1|Overall Study|Withdrawal by Subject|2
154808|NCT00711529|493496|P2|Overall Study|Protocol Violation|0
154809|NCT00711529|493497|P1|Overall Study|Protocol Violation|2
154810|NCT00711555|493519|P1|Overall Study|Adverse Event|3
154811|NCT00711594|493530|P4|Overall Study|Withdrawal by Subject|2
154812|NCT00711594|493531|P3|Overall Study|Withdrawal by Subject|0
154813|NCT00711594|493532|P2|Overall Study|Withdrawal by Subject|1
154814|NCT00711594|493533|P1|Overall Study|Withdrawal by Subject|0
154815|NCT00711594|493530|P4|Overall Study|Other Adverse Event|16
154816|NCT00711594|493531|P3|Overall Study|Other Adverse Event|0
154817|NCT00711594|493532|P2|Overall Study|Other Adverse Event|0
154818|NCT00711594|493533|P1|Overall Study|Other Adverse Event|1
154819|NCT00711594|493530|P4|Overall Study|Progressive disease|44
154820|NCT00711594|493531|P3|Overall Study|Progressive disease|6
154821|NCT00711594|493532|P2|Overall Study|Progressive disease|2
154822|NCT00711594|493533|P1|Overall Study|Progressive disease|2
154823|NCT00711646|493572|P2|Overall Study|patient non-compliance|0
154824|NCT00711646|493573|P1|Overall Study|patient non-compliance|1
154825|NCT00711646|493572|P2|Overall Study|administrative decision|1
154826|NCT00711646|493573|P1|Overall Study|administrative decision|0
154827|NCT00711646|493572|P2|Overall Study|Lost to Follow-up|0
154828|NCT00711646|493573|P1|Overall Study|Lost to Follow-up|1
154829|NCT00711646|493572|P2|Overall Study|Protocol Violation|1
154830|NCT00711646|493573|P1|Overall Study|Protocol Violation|0
154831|NCT00711646|493572|P2|Overall Study|Withdrawal by Subject|0
154832|NCT00711646|493573|P1|Overall Study|Withdrawal by Subject|4
154833|NCT00711646|493572|P2|Overall Study|Adverse Event|1
154834|NCT00711646|493573|P1|Overall Study|Adverse Event|6
154835|NCT00711802|493599|P8|Overall Study|Reason not reported|0
154836|NCT00711802|493600|P7|Overall Study|Reason not reported|1
154837|NCT00711802|493601|P6|Overall Study|Reason not reported|0
154838|NCT00711802|493602|P5|Overall Study|Reason not reported|1
154839|NCT00711802|493603|P4|Overall Study|Reason not reported|0
154840|NCT00711802|493604|P3|Overall Study|Reason not reported|1
154841|NCT00711802|493605|P2|Overall Study|Reason not reported|1
154842|NCT00711802|493606|P1|Overall Study|Reason not reported|0
154843|NCT00711802|493599|P8|Overall Study|Lost to Follow-up|2
154844|NCT00711802|493600|P7|Overall Study|Lost to Follow-up|4
154845|NCT00711802|493601|P6|Overall Study|Lost to Follow-up|6
154846|NCT00711802|493602|P5|Overall Study|Lost to Follow-up|10
154847|NCT00711802|493603|P4|Overall Study|Lost to Follow-up|1
154848|NCT00711802|493604|P3|Overall Study|Lost to Follow-up|3
154849|NCT00711802|493605|P2|Overall Study|Lost to Follow-up|0
154850|NCT00711802|493606|P1|Overall Study|Lost to Follow-up|0
154851|NCT00711802|493599|P8|Overall Study|Withdrawal by Subject|0
154852|NCT00711802|493600|P7|Overall Study|Withdrawal by Subject|0
154853|NCT00711802|493601|P6|Overall Study|Withdrawal by Subject|0
154854|NCT00711802|493602|P5|Overall Study|Withdrawal by Subject|0
154855|NCT00711802|493603|P4|Overall Study|Withdrawal by Subject|1
154856|NCT00711802|493604|P3|Overall Study|Withdrawal by Subject|0
154857|NCT00711802|493605|P2|Overall Study|Withdrawal by Subject|1
154858|NCT00711802|493606|P1|Overall Study|Withdrawal by Subject|0
154859|NCT00711802|493599|P8|Overall Study|Physician Decision|0
154860|NCT00711802|493600|P7|Overall Study|Physician Decision|0
154861|NCT00711802|493601|P6|Overall Study|Physician Decision|0
154862|NCT00711802|493602|P5|Overall Study|Physician Decision|0
154863|NCT00711802|493603|P4|Overall Study|Physician Decision|0
154864|NCT00711802|493604|P3|Overall Study|Physician Decision|0
154865|NCT00711802|493605|P2|Overall Study|Physician Decision|2
154866|NCT00711802|493606|P1|Overall Study|Physician Decision|0
154867|NCT00711802|493599|P8|Overall Study|Protocol Violation|0
154868|NCT00711802|493600|P7|Overall Study|Protocol Violation|0
154869|NCT00711802|493601|P6|Overall Study|Protocol Violation|0
154870|NCT00711802|493602|P5|Overall Study|Protocol Violation|0
154871|NCT00711802|493603|P4|Overall Study|Protocol Violation|1
154872|NCT00711802|493604|P3|Overall Study|Protocol Violation|0
154873|NCT00711802|493605|P2|Overall Study|Protocol Violation|0
154874|NCT00711802|493606|P1|Overall Study|Protocol Violation|0
154875|NCT00711802|493599|P8|Overall Study|Microbiological failure|0
154876|NCT00711802|493600|P7|Overall Study|Microbiological failure|0
154877|NCT00711802|493601|P6|Overall Study|Microbiological failure|1
154878|NCT00711802|493602|P5|Overall Study|Microbiological failure|0
154879|NCT00711802|493603|P4|Overall Study|Microbiological failure|0
154880|NCT00711802|493604|P3|Overall Study|Microbiological failure|0
154881|NCT00711802|493605|P2|Overall Study|Microbiological failure|1
154882|NCT00711802|493606|P1|Overall Study|Microbiological failure|0
154883|NCT00711802|493599|P8|Overall Study|Adverse Event|0
154884|NCT00711802|493600|P7|Overall Study|Adverse Event|0
154885|NCT00711802|493601|P6|Overall Study|Adverse Event|1
154886|NCT00711802|493602|P5|Overall Study|Adverse Event|1
154887|NCT00711802|493603|P4|Overall Study|Adverse Event|0
154888|NCT00711802|493604|P3|Overall Study|Adverse Event|0
154889|NCT00711802|493605|P2|Overall Study|Adverse Event|0
154890|NCT00711802|493606|P1|Overall Study|Adverse Event|0
154891|NCT00711802|493599|P8|Overall Study|Not treated (no further detail)|0
154892|NCT00711802|493600|P7|Overall Study|Not treated (no further detail)|0
154893|NCT00711802|493601|P6|Overall Study|Not treated (no further detail)|0
154894|NCT00711802|493602|P5|Overall Study|Not treated (no further detail)|2
154895|NCT00711802|493603|P4|Overall Study|Not treated (no further detail)|0
154896|NCT00711802|493604|P3|Overall Study|Not treated (no further detail)|2
154897|NCT00711802|493605|P2|Overall Study|Not treated (no further detail)|1
154898|NCT00711802|493606|P1|Overall Study|Not treated (no further detail)|2
154899|NCT00711880|493656|P2|Overall Study|Lack of Efficacy|5
154900|NCT00711880|493657|P1|Overall Study|Lack of Efficacy|1
154901|NCT00711880|493656|P2|Overall Study|Patient non-compliance|0
154902|NCT00711880|493657|P1|Overall Study|Patient non-compliance|1
154903|NCT00711880|493656|P2|Overall Study|Adverse Event|2
154904|NCT00711880|493657|P1|Overall Study|Adverse Event|11
154905|NCT00717860|493695|P2|Overall Study|Withdrew consent|3
154906|NCT00717860|493696|P1|Overall Study|Withdrew consent|7
154907|NCT00717860|493695|P2|Overall Study|Discontinued for other reason|1
154908|NCT00717860|493696|P1|Overall Study|Discontinued for other reason|6
154909|NCT00717860|493695|P2|Overall Study|Lack of Efficacy|13
154910|NCT00717860|493696|P1|Overall Study|Lack of Efficacy|7
154911|NCT00717860|493695|P2|Overall Study|Laboratory adverse experience|2
154912|NCT00717860|493696|P1|Overall Study|Laboratory adverse experience|2
154913|NCT00717860|493695|P2|Overall Study|Clinical adverse experience|9
154914|NCT00717860|493696|P1|Overall Study|Clinical adverse experience|5
154915|NCT00717886|493715|P1|Overall Study|Treatment Failure|1
154916|NCT00717886|493715|P1|Overall Study|Withdrawal by Subject|3
154917|NCT00718042|493769|P6|Donor Follow-up|Lost to Follow-up|0
154918|NCT00718042|493770|P5|Donor Follow-up|Lost to Follow-up|19
154919|NCT00718042|493771|P4|Donor Follow-up|Lost to Follow-up|0
154920|NCT00718042|493772|P3|Donor Follow-up|Lost to Follow-up|0
154921|NCT00718042|493773|P2|Donor Follow-up|Lost to Follow-up|0
154922|NCT00718042|493774|P1|Donor Follow-up|Lost to Follow-up|13
154923|NCT00718042|493769|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
154924|NCT00718042|493770|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
154925|NCT00718042|493771|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
154926|NCT00718042|493772|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
154927|NCT00718042|493773|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
154928|NCT00718042|493774|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
154929|NCT00718042|493769|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
154930|NCT00718042|493770|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
154931|NCT00718042|493771|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
154932|NCT00718042|493772|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
154933|NCT00718042|493773|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
154934|NCT00718042|493774|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
154935|NCT00718042|493769|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
154936|NCT00718042|493770|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
154937|NCT00718042|493771|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
154938|NCT00718042|493772|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
154939|NCT00718042|493773|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
154940|NCT00718042|493774|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
154941|NCT00718042|493769|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
154942|NCT00718042|493770|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
154943|NCT00718042|493771|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
154944|NCT00718042|493772|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
154945|NCT00718042|493773|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
154946|NCT00718042|493774|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
154947|NCT00718081|493789|P3|Overall Study|Lack of Efficacy|21
154948|NCT00718081|493790|P2|Overall Study|Lack of Efficacy|3
154949|NCT00718081|493791|P1|Overall Study|Lack of Efficacy|7
154950|NCT00718081|493789|P3|Overall Study|Adverse Event|0
154951|NCT00718081|493790|P2|Overall Study|Adverse Event|1
154952|NCT00718081|493791|P1|Overall Study|Adverse Event|0
154953|NCT00718523|493804|P2|Overall Study|Death|17
154954|NCT00718523|493805|P1|Overall Study|Death|13
154955|NCT00718523|493804|P2|Overall Study|Withdrawal by Subject|7
154956|NCT00718523|493805|P1|Overall Study|Withdrawal by Subject|5
154957|NCT00718640|493815|P1|Overall Study|Unresolved toxicity after 2 weeks|2
154958|NCT00718640|493815|P1|Overall Study|Death|1
154959|NCT00718640|493815|P1|Overall Study|Adverse Event|4
154960|NCT00718770|493827|P1|Overall Study|Adverse Event|1
154961|NCT00718770|493827|P1|Overall Study|Lack of Efficacy|1
154962|NCT00718770|493827|P1|Overall Study|Adverse Event|1
154963|NCT00718770|493827|P1|Overall Study|Lack of Efficacy|1
154964|NCT00718770|493827|P1|Overall Study|Adverse Event|1
154965|NCT00718770|493827|P1|Overall Study|Lack of Efficacy|1
154966|NCT00718770|493827|P1|Overall Study|Lack of Efficacy|1
154967|NCT00718770|493827|P1|Overall Study|Adverse Event|1
154968|NCT00718809|493833|P2|Overall Study|Noncompliance|0
154969|NCT00718809|493834|P1|Overall Study|Noncompliance|1
154970|NCT00718809|493833|P2|Overall Study|Lost to Follow-up|0
154971|NCT00718809|493834|P1|Overall Study|Lost to Follow-up|1
154972|NCT00718809|493833|P2|Overall Study|Withdrawal by Subject|1
154973|NCT00718809|493834|P1|Overall Study|Withdrawal by Subject|0
154974|NCT00718809|493833|P2|Overall Study|Adverse Event|1
154975|NCT00718809|493834|P1|Overall Study|Adverse Event|1
154976|NCT00718809|493833|P2|Overall Study|Disease progression|7
154977|NCT00718809|493834|P1|Overall Study|Disease progression|9
154978|NCT00718861|493850|P2|Overall Study|Death|5
154979|NCT00718861|493851|P1|Overall Study|Death|1
154980|NCT00718861|493850|P2|Overall Study|Administrative Problems|1
154981|NCT00718861|493851|P1|Overall Study|Administrative Problems|1
154982|NCT00718861|493850|P2|Overall Study|Lost to Follow-up|1
154983|NCT00718861|493851|P1|Overall Study|Lost to Follow-up|2
154984|NCT00718861|493850|P2|Overall Study|Adverse Event|1
154985|NCT00718861|493851|P1|Overall Study|Adverse Event|2
154986|NCT00718861|493850|P2|Overall Study|Withdrawal by Subject|10
154987|NCT00718861|493851|P1|Overall Study|Withdrawal by Subject|15
154988|NCT00718887|493879|P2|Overall Study|Not identified|7
154989|NCT00718887|493880|P1|Overall Study|Not identified|2
154990|NCT00718887|493879|P2|Overall Study|Withdrawal by Subject|2
154991|NCT00718887|493880|P1|Overall Study|Withdrawal by Subject|3
154992|NCT00719043|493909|P7|Overall Study|Withdrawal by Subject|14
154993|NCT00719043|493910|P6|Overall Study|Withdrawal by Subject|18
154994|NCT00719043|493911|P5|Overall Study|Withdrawal by Subject|16
154995|NCT00719043|493912|P4|Overall Study|Withdrawal by Subject|10
154996|NCT00719043|493913|P3|Overall Study|Withdrawal by Subject|9
154997|NCT00719043|493914|P2|Overall Study|Withdrawal by Subject|14
154998|NCT00719043|493915|P1|Overall Study|Withdrawal by Subject|12
154999|NCT00719043|493909|P7|Overall Study|Unspecified|1
155000|NCT00719043|493910|P6|Overall Study|Unspecified|2
155001|NCT00719043|493911|P5|Overall Study|Unspecified|0
155002|NCT00719043|493912|P4|Overall Study|Unspecified|2
155003|NCT00719043|493913|P3|Overall Study|Unspecified|1
155004|NCT00719043|493914|P2|Overall Study|Unspecified|0
155005|NCT00719043|493915|P1|Overall Study|Unspecified|1
155006|NCT00719043|493909|P7|Overall Study|Protocol Violation|0
155007|NCT00719043|493910|P6|Overall Study|Protocol Violation|1
155008|NCT00719043|493911|P5|Overall Study|Protocol Violation|0
155009|NCT00719043|493912|P4|Overall Study|Protocol Violation|0
155010|NCT00719043|493913|P3|Overall Study|Protocol Violation|0
155011|NCT00719043|493914|P2|Overall Study|Protocol Violation|0
155012|NCT00719043|493915|P1|Overall Study|Protocol Violation|0
155013|NCT00719043|493909|P7|Overall Study|Lost to Follow-up|9
155014|NCT00719043|493910|P6|Overall Study|Lost to Follow-up|9
155015|NCT00719043|493911|P5|Overall Study|Lost to Follow-up|10
155016|NCT00719043|493912|P4|Overall Study|Lost to Follow-up|9
155017|NCT00719043|493913|P3|Overall Study|Lost to Follow-up|8
155018|NCT00719043|493914|P2|Overall Study|Lost to Follow-up|10
155019|NCT00719043|493915|P1|Overall Study|Lost to Follow-up|14
155020|NCT00719043|493909|P7|Overall Study|Adverse Event|4
155021|NCT00719043|493910|P6|Overall Study|Adverse Event|4
155022|NCT00719043|493911|P5|Overall Study|Adverse Event|1
155023|NCT00719043|493912|P4|Overall Study|Adverse Event|2
155024|NCT00719043|493913|P3|Overall Study|Adverse Event|2
155025|NCT00719043|493914|P2|Overall Study|Adverse Event|1
155026|NCT00719043|493915|P1|Overall Study|Adverse Event|5
155027|NCT00719212|494066|P1|Overall Study|Withdrawal by Subject|1
155028|NCT00719212|494066|P1|Overall Study|Lost to Follow-up|2
155029|NCT00719212|494066|P1|Overall Study|Death|41
155030|NCT00719264|494078|P2|Overall Study|Disease Progression|107
155031|NCT00719264|494079|P1|Overall Study|Disease Progression|104
155032|NCT00719264|494078|P2|Overall Study|New Cancer Therapy|2
155033|NCT00719264|494079|P1|Overall Study|New Cancer Therapy|4
155034|NCT00719264|494078|P2|Overall Study|Protocol Deviation|3
155035|NCT00719264|494079|P1|Overall Study|Protocol Deviation|1
155036|NCT00719264|494078|P2|Overall Study|Withdrawal by Subject|7
155037|NCT00719264|494079|P1|Overall Study|Withdrawal by Subject|12
155038|NCT00719264|494078|P2|Overall Study|Lost to Follow-up|1
155039|NCT00719264|494079|P1|Overall Study|Lost to Follow-up|1
155040|NCT00719264|494078|P2|Overall Study|Administrative Problems|4
155041|NCT00719264|494079|P1|Overall Study|Administrative Problems|6
155042|NCT00719264|494078|P2|Overall Study|Death|10
155043|NCT00719264|494079|P1|Overall Study|Death|13
155044|NCT00719264|494078|P2|Overall Study|Adverse Event|49
155045|NCT00719264|494079|P1|Overall Study|Adverse Event|41
155046|NCT00719355|494119|P2|Overall Study|Moved|1
155047|NCT00719355|494120|P1|Overall Study|Moved|0
155048|NCT00719355|494119|P2|Overall Study|Compliance|6
155049|NCT00719355|494120|P1|Overall Study|Compliance|4
155050|NCT00719355|494119|P2|Overall Study|Medical|5
155051|NCT00719355|494120|P1|Overall Study|Medical|14
155052|NCT00719355|494119|P2|Overall Study|Death|1
155053|NCT00719355|494120|P1|Overall Study|Death|0
155054|NCT00719472|494128|P1|Received Cycle 2 Treatment|Various Reasons|25
155055|NCT00719472|494128|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
155056|NCT00719472|494128|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
155057|NCT00719472|494128|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
155058|NCT00719472|494128|P1|Received Cycle 2 Treatment|Disease progression|3
155059|NCT00719472|494128|P1|Received Cycle 2 Treatment|Death|6
155060|NCT00719472|494128|P1|Received Cycle 2 Treatment|Adverse Event|12
155061|NCT00719472|494128|P1|Received Cycle 1 Treatment|Various Reasons|13
155062|NCT00719472|494128|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
155063|NCT00719472|494128|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
155064|NCT00719472|494128|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
155065|NCT00719472|494128|P1|Received Cycle 1 Treatment|Death|5
155066|NCT00719472|494128|P1|Received Cycle 1 Treatment|Adverse Event|8
155067|NCT00719472|494128|P1|Enrolled in Study|Various Reasons|17
155068|NCT00719472|494128|P1|Enrolled in Study|Subject decision to withdraw|8
155069|NCT00719472|494128|P1|Enrolled in Study|Physician decision to withdraw patient|1
155070|NCT00719537|494139|P2|Overall Study|Lost to Follow-up|1
155071|NCT00719537|494140|P1|Overall Study|Lost to Follow-up|0
155072|NCT00719537|494139|P2|Overall Study|Withdrawal by Subject|0
155073|NCT00719537|494140|P1|Overall Study|Withdrawal by Subject|1
155074|NCT00719563|494148|P2|Overall Study|Lost to Follow-up|3
155075|NCT00719563|494149|P1|Overall Study|Lost to Follow-up|5
155076|NCT00719563|494148|P2|Overall Study|Noncompliant|1
155077|NCT00719563|494149|P1|Overall Study|Noncompliant|1
155078|NCT00719563|494148|P2|Overall Study|Unknown reasons|6
155079|NCT00719563|494149|P1|Overall Study|Unknown reasons|4
155080|NCT00719563|494148|P2|Overall Study|Personal reasons|7
155081|NCT00719563|494149|P1|Overall Study|Personal reasons|6
155082|NCT00719563|494148|P2|Overall Study|Lack of Efficacy|7
155083|NCT00719563|494149|P1|Overall Study|Lack of Efficacy|3
155084|NCT00719563|494148|P2|Overall Study|Medical condition changed|5
155085|NCT00719563|494149|P1|Overall Study|Medical condition changed|3
155086|NCT00719563|494148|P2|Overall Study|Adverse Event|13
155087|NCT00719563|494149|P1|Overall Study|Adverse Event|16
155088|NCT00719680|494192|P1|Overall Study|Withdrawal by Subject|3
155089|NCT00719680|494192|P1|Overall Study|Lost to Follow-up|1
155090|NCT00719680|494192|P1|Overall Study|Adverse Event|1
155091|NCT00719706|494214|P2|Overall Study|Protocol Violation|0
155092|NCT00719706|494215|P1|Overall Study|Protocol Violation|3
155093|NCT00719706|494214|P2|Overall Study|Withdrawal by Subject|2
155094|NCT00719706|494215|P1|Overall Study|Withdrawal by Subject|1
155095|NCT00719706|494214|P2|Overall Study|Adverse Event|4
155096|NCT00719706|494215|P1|Overall Study|Adverse Event|5
155097|NCT00719732|494229|P1|Overall Study|Illness not associated with device|1
155098|NCT00719732|494229|P1|Overall Study|Unilateral (not bilateral) implantation|1
155099|NCT00719732|494229|P1|Overall Study|Lost to Follow-up|20
155100|NCT00719810|494236|P3|Overall Study|Withdrawal by Subject|2
155101|NCT00719810|494237|P2|Overall Study|Withdrawal by Subject|1
155102|NCT00719810|494238|P1|Overall Study|Withdrawal by Subject|1
155103|NCT00719810|494236|P3|Overall Study|Physician Decision|0
155104|NCT00719810|494237|P2|Overall Study|Physician Decision|1
155105|NCT00719810|494238|P1|Overall Study|Physician Decision|0
155106|NCT00719810|494236|P3|Overall Study|Lost to Follow-up|3
155107|NCT00719810|494237|P2|Overall Study|Lost to Follow-up|0
155108|NCT00719810|494238|P1|Overall Study|Lost to Follow-up|2
155109|NCT00719810|494236|P3|Overall Study|Adverse Event|3
155110|NCT00719810|494237|P2|Overall Study|Adverse Event|2
155111|NCT00719810|494238|P1|Overall Study|Adverse Event|0
155112|NCT00719849|494251|P2|Overall Study|Death|1
155113|NCT00719849|494252|P1|Overall Study|Death|0
155114|NCT00719862|494290|P2|Overall Study|Other|3
155115|NCT00719862|494291|P1|Overall Study|Other|2
155116|NCT00719862|494290|P2|Overall Study|Lost to Follow-up|1
155117|NCT00719862|494291|P1|Overall Study|Lost to Follow-up|0
155118|NCT00719862|494290|P2|Overall Study|Withdrawal by Subject|0
155119|NCT00719862|494291|P1|Overall Study|Withdrawal by Subject|1
155120|NCT00719862|494290|P2|Overall Study|Non-Compliance|0
155121|NCT00719862|494291|P1|Overall Study|Non-Compliance|1
155122|NCT00719862|494290|P2|Overall Study|Lack of Efficacy|0
155123|NCT00719862|494291|P1|Overall Study|Lack of Efficacy|3
155124|NCT00719862|494290|P2|Overall Study|Adverse Event|2
155125|NCT00719862|494291|P1|Overall Study|Adverse Event|1
155126|NCT00719901|494307|P1|Overall Study|Availability of Study Drug|1
155127|NCT00719901|494307|P1|Overall Study|Disease Progression|3
155128|NCT00719901|494307|P1|Overall Study|Alternate Treatment|1
155129|NCT00719901|494307|P1|Overall Study|Withdrawal by Subject|1
155130|NCT00719901|494307|P1|Overall Study|Adverse Event|5
155131|NCT00719953|494326|P1|Overall Study|Adverse Event|4
155132|NCT00720057|494332|P2|Overall Study|Withdrawal by Subject|1
155133|NCT00720057|494333|P1|Overall Study|Withdrawal by Subject|0
155134|NCT00720057|494332|P2|Overall Study|Protocol Violation|0
155135|NCT00720057|494333|P1|Overall Study|Protocol Violation|1
155136|NCT00720057|494332|P2|Overall Study|Lost to Follow-up|2
155137|NCT00720057|494333|P1|Overall Study|Lost to Follow-up|0
155138|NCT00720083|494351|P2|Overall Study|Ineligible|2
155139|NCT00720083|494352|P1|Overall Study|Ineligible|1
155140|NCT00720096|494360|P2|Overall Study|Withdrawal by Subject|2
155141|NCT00720096|494361|P1|Overall Study|Withdrawal by Subject|0
155142|NCT00720109|494369|P3|Risk Stratification Period|Development of second malignant neoplasm|0
155143|NCT00720109|494370|P2|Risk Stratification Period|Development of second malignant neoplasm|1
155144|NCT00720109|494371|P1|Risk Stratification Period|Development of second malignant neoplasm|0
155145|NCT00720109|494369|P3|Risk Stratification Period|Disease progression or relapse|0
155146|NCT00720109|494370|P2|Risk Stratification Period|Disease progression or relapse|2
155147|NCT00720109|494371|P1|Risk Stratification Period|Disease progression or relapse|0
155148|NCT00720109|494369|P3|Risk Stratification Period|Bone marrow transplant|7
155149|NCT00720109|494370|P2|Risk Stratification Period|Bone marrow transplant|9
155150|NCT00720109|494371|P1|Risk Stratification Period|Bone marrow transplant|0
155151|NCT00720109|494369|P3|Risk Stratification Period|Physician Decision|1
155152|NCT00720109|494370|P2|Risk Stratification Period|Physician Decision|2
155153|NCT00720109|494371|P1|Risk Stratification Period|Physician Decision|0
155154|NCT00720109|494369|P3|Risk Stratification Period|Adverse Event|0
155155|NCT00720109|494370|P2|Risk Stratification Period|Adverse Event|1
155156|NCT00720109|494371|P1|Risk Stratification Period|Adverse Event|0
155157|NCT00720109|494369|P3|Induction Period|Physician Decision|0
155158|NCT00720109|494370|P2|Induction Period|Physician Decision|0
155159|NCT00720109|494371|P1|Induction Period|Physician Decision|1
155160|NCT00720109|494369|P3|Induction Period|Bone Marrow Transplant|0
155161|NCT00720109|494370|P2|Induction Period|Bone Marrow Transplant|0
155162|NCT00720109|494371|P1|Induction Period|Bone Marrow Transplant|2
155163|NCT00720109|494369|P3|Induction Period|Did not meet eligibility criteria|0
155164|NCT00720109|494370|P2|Induction Period|Did not meet eligibility criteria|0
155165|NCT00720109|494371|P1|Induction Period|Did not meet eligibility criteria|3
155166|NCT00720122|494389|P1|Overall Study|Withdrawal by Subject|7
155167|NCT00720122|494389|P1|Overall Study|Physician Decision|1
155168|NCT00720122|494389|P1|Overall Study|Lost to Follow-up|1
155169|NCT00720226|494395|P2|Overall Study|Withdrawal by Subject|4
155170|NCT00720226|494396|P1|Overall Study|Withdrawal by Subject|7
155171|NCT00720278|494407|P3|Overall Study|eligibility criteria violation|1
155172|NCT00720278|494408|P2|Overall Study|eligibility criteria violation|0
155173|NCT00720278|494409|P1|Overall Study|eligibility criteria violation|1
155174|NCT00720278|494407|P3|Overall Study|Non-compliance|0
155175|NCT00720278|494408|P2|Overall Study|Non-compliance|0
155176|NCT00720278|494409|P1|Overall Study|Non-compliance|1
155177|NCT00720278|494407|P3|Overall Study|Lost to Follow-up|1
155178|NCT00720278|494408|P2|Overall Study|Lost to Follow-up|0
155179|NCT00720278|494409|P1|Overall Study|Lost to Follow-up|0
155180|NCT00720278|494407|P3|Overall Study|Withdrawal by Subject|0
155181|NCT00720278|494408|P2|Overall Study|Withdrawal by Subject|1
155182|NCT00720278|494409|P1|Overall Study|Withdrawal by Subject|0
155183|NCT00720278|494407|P3|Overall Study|Adverse Event|4
155184|NCT00720278|494408|P2|Overall Study|Adverse Event|3
155185|NCT00720278|494409|P1|Overall Study|Adverse Event|5
155186|NCT00720343|494454|P1|Overall Study|No data|3
155187|NCT00720343|494454|P1|Overall Study|Physician Decision|3
155188|NCT00720382|494473|P2|Overall Study|administrative|5
155189|NCT00720382|494474|P1|Overall Study|administrative|14
155190|NCT00720382|494473|P2|Overall Study|Lost to Follow-up|14
155191|NCT00720382|494474|P1|Overall Study|Lost to Follow-up|28
155192|NCT00720382|494473|P2|Overall Study|Withdrawal by Subject|11
155193|NCT00720382|494474|P1|Overall Study|Withdrawal by Subject|47
155194|NCT00720382|494473|P2|Overall Study|Non-Compliance|5
155195|NCT00720382|494474|P1|Overall Study|Non-Compliance|15
155196|NCT00720382|494473|P2|Overall Study|Lack of Efficacy|7
155197|NCT00720382|494474|P1|Overall Study|Lack of Efficacy|18
155198|NCT00720382|494473|P2|Overall Study|Adverse Event|17
155199|NCT00720382|494474|P1|Overall Study|Adverse Event|54
155200|NCT00720434|494486|P4|Open-Label Period (Week 5-72)|Unspecified|2
155201|NCT00720434|494487|P3|Open-Label Period (Week 5-72)|Unspecified|3
155202|NCT00720434|494488|P2|Open-Label Period (Week 5-72)|Unspecified|3
155203|NCT00720434|494489|P1|Open-Label Period (Week 5-72)|Unspecified|4
155204|NCT00720434|494486|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
155205|NCT00720434|494487|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
155206|NCT00720434|494488|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
155207|NCT00720434|494489|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
155380|NCT00723450|495282|P1|Open-Label Phase|Lost to Follow-up|7
155208|NCT00720434|494486|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
155209|NCT00720434|494487|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
155210|NCT00720434|494488|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
155211|NCT00720434|494489|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
155212|NCT00720434|494486|P4|Open-Label Period (Week 5-72)|Adverse Event|2
155213|NCT00720434|494487|P3|Open-Label Period (Week 5-72)|Adverse Event|0
155214|NCT00720434|494488|P2|Open-Label Period (Week 5-72)|Adverse Event|0
155215|NCT00720434|494489|P1|Open-Label Period (Week 5-72)|Adverse Event|0
155216|NCT00720434|494486|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
155217|NCT00720434|494487|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
155218|NCT00720434|494488|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
155219|NCT00720434|494489|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
155220|NCT00720499|494538|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
155221|NCT00720499|494539|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
155222|NCT00720499|494538|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
155223|NCT00720499|494539|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
155224|NCT00720499|494538|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
155225|NCT00720499|494539|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
155226|NCT00720759|494615|P4|Overall Study|Lost to Follow-up|0
155227|NCT00720759|494616|P3|Overall Study|Lost to Follow-up|1
155228|NCT00720759|494617|P2|Overall Study|Lost to Follow-up|1
155229|NCT00720759|494618|P1|Overall Study|Lost to Follow-up|0
155230|NCT00720798|494628|P1|Overall Study|Reason not Specified|83
155231|NCT00720798|494628|P1|Overall Study|Failure to Return|46
155232|NCT00720798|494628|P1|Overall Study|Refused Treatment|151
155233|NCT00720798|494628|P1|Overall Study|Protocol Violation|4
155234|NCT00720798|494628|P1|Overall Study|Insufficient Therapeutic Response|129
155235|NCT00720798|494628|P1|Overall Study|Death|39
155236|NCT00720798|494628|P1|Overall Study|Adverse Event|304
155237|NCT00714870|494658|P2|Overall Study|did not attend minimum of 4 sessions|0
155238|NCT00714870|494659|P1|Overall Study|did not attend minimum of 4 sessions|4
155239|NCT00714870|494658|P2|Overall Study|patient unable to come b/c back pain|0
155240|NCT00714870|494659|P1|Overall Study|patient unable to come b/c back pain|1
155241|NCT00714870|494658|P2|Overall Study|Lost to Follow-up|5
155242|NCT00714870|494659|P1|Overall Study|Lost to Follow-up|22
155243|NCT00714948|494665|P1|Overall Study|Adverse Event|2
155244|NCT00715026|494669|P1|Overall Study|Surgery done on non-study consented hip|1
155245|NCT00715026|494669|P1|Overall Study|Protocol Violation|1
155246|NCT00715026|494669|P1|Overall Study|Lost to Follow-up|3
155247|NCT00715026|494669|P1|Overall Study|Withdrawal by Subject|5
155248|NCT00715078|494677|P3|Overall Study|Unable to start due to disease prog.|1
155249|NCT00715078|494678|P2|Overall Study|Unable to start due to disease prog.|0
155250|NCT00715078|494679|P1|Overall Study|Unable to start due to disease prog.|0
155251|NCT00715078|494677|P3|Overall Study|Withdrawal by Subject|1
155252|NCT00715078|494678|P2|Overall Study|Withdrawal by Subject|0
155253|NCT00715078|494679|P1|Overall Study|Withdrawal by Subject|1
155254|NCT00715078|494677|P3|Overall Study|Death|36
155255|NCT00715078|494678|P2|Overall Study|Death|36
155256|NCT00715078|494679|P1|Overall Study|Death|29
155257|NCT00715117|494743|P2|Overall Study|Crohn's flare and rescue with steroids|1
155258|NCT00715117|494744|P1|Overall Study|Crohn's flare and rescue with steroids|0
155259|NCT00715208|494757|P2|Overall Study|Lack of Efficacy|2
155260|NCT00715208|494758|P1|Overall Study|Lack of Efficacy|0
155261|NCT00715208|494757|P2|Overall Study|Adverse Event|6
155262|NCT00715208|494758|P1|Overall Study|Adverse Event|0
155263|NCT00715208|494757|P2|Overall Study|Withdrawal by Subject|1
155264|NCT00715208|494758|P1|Overall Study|Withdrawal by Subject|1
155265|NCT00720941|494774|P2|Overall Study|Ongoing|23
155266|NCT00720941|494775|P1|Overall Study|Ongoing|34
155267|NCT00720941|494774|P2|Overall Study|Withdrawal by Subject|35
155268|NCT00720941|494775|P1|Overall Study|Withdrawal by Subject|27
155269|NCT00720941|494774|P2|Overall Study|Physician Decision|5
155270|NCT00720941|494775|P1|Overall Study|Physician Decision|1
155271|NCT00720941|494774|P2|Overall Study|Lost to Follow-up|15
155272|NCT00720941|494775|P1|Overall Study|Lost to Follow-up|17
155273|NCT00720941|494774|P2|Overall Study|Protocol Violation|2
155274|NCT00720941|494775|P1|Overall Study|Protocol Violation|0
155275|NCT00720941|494774|P2|Overall Study|Death|335
155276|NCT00720941|494775|P1|Overall Study|Death|334
155277|NCT00721110|494819|P4|Overall Study|vertical incision|0
155278|NCT00721110|494820|P3|Overall Study|vertical incision|1
155279|NCT00721110|494821|P2|Overall Study|vertical incision|0
155280|NCT00721110|494822|P1|Overall Study|vertical incision|0
155281|NCT00721110|494819|P4|Overall Study|Ultram use|0
155282|NCT00721110|494820|P3|Overall Study|Ultram use|0
155283|NCT00721110|494821|P2|Overall Study|Ultram use|0
155284|NCT00721110|494822|P1|Overall Study|Ultram use|1
155285|NCT00721123|494848|P1|Overall Study|Withdrawal by Subject|5
155286|NCT00721123|494848|P1|Overall Study|Failure to Return|9
155287|NCT00721123|494848|P1|Overall Study|Refused Treatment|41
155288|NCT00721123|494848|P1|Overall Study|Protocol Violation|1
155289|NCT00721123|494848|P1|Overall Study|Insufficient Therapeutic Response|21
155290|NCT00721123|494848|P1|Overall Study|Death|10
155291|NCT00721123|494848|P1|Overall Study|Adverse Event|96
155292|NCT00721149|494947|P1|Overall Study|Physician Decision|1
155293|NCT00721214|494995|P1|Overall Study|Death|3
155294|NCT00721214|494995|P1|Overall Study|Chose another center for transplant|1
155295|NCT00721227|495008|P2|Overall Study|Noncompliance with scheduled visits.|0
155296|NCT00721227|495009|P1|Overall Study|Noncompliance with scheduled visits.|1
155297|NCT00721227|495008|P2|Overall Study|Lost to Follow-up|0
155298|NCT00721227|495009|P1|Overall Study|Lost to Follow-up|3
155299|NCT00722761|495053|P2|Overall Study|Withdrawal by Subject|2
155300|NCT00722761|495054|P1|Overall Study|Withdrawal by Subject|5
155301|NCT00722761|495053|P2|Overall Study|Lost to Follow-up|4
155302|NCT00722761|495054|P1|Overall Study|Lost to Follow-up|1
155303|NCT00722800|495064|P2|Overall Study|Physician Decision|0
155304|NCT00722800|495065|P1|Overall Study|Physician Decision|1
155305|NCT00722800|495064|P2|Overall Study|Withdrawal by Subject|0
155306|NCT00722800|495065|P1|Overall Study|Withdrawal by Subject|1
155307|NCT00723008|495085|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
155308|NCT00723008|495086|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
155309|NCT00723008|495085|P2|4-Week Unblinded Treatment|Adverse Event|0
155310|NCT00723008|495086|P1|4-Week Unblinded Treatment|Adverse Event|1
155311|NCT00723008|495085|P2|4-Week Double Blinded|Lost to Follow-up|3
155312|NCT00723008|495086|P1|4-Week Double Blinded|Lost to Follow-up|4
155313|NCT00723008|495085|P2|4-Week Double Blinded|Withdrawal by Subject|1
155314|NCT00723008|495086|P1|4-Week Double Blinded|Withdrawal by Subject|1
155315|NCT00723008|495085|P2|4-Week Double Blinded|Lack of Efficacy|1
155316|NCT00723008|495086|P1|4-Week Double Blinded|Lack of Efficacy|0
155317|NCT00723008|495085|P2|Enrollment|Lost to Follow-up|0
155318|NCT00723008|495086|P1|Enrollment|Lost to Follow-up|1
155319|NCT00723021|495108|P5|Intervention Period 4|Adverse Event|1
155320|NCT00723021|495109|P4|Intervention Period 4|Adverse Event|0
155321|NCT00723021|495110|P3|Intervention Period 4|Adverse Event|0
155322|NCT00723021|495111|P2|Intervention Period 4|Adverse Event|0
155323|NCT00723021|495112|P1|Intervention Period 4|Adverse Event|0
155324|NCT00723125|495193|P2|Overall Study|Adverse Event|0
155325|NCT00723125|495194|P1|Overall Study|Adverse Event|2
155326|NCT00723125|495193|P2|Overall Study|Withdrawal by Subject|6
155327|NCT00723125|495194|P1|Overall Study|Withdrawal by Subject|15
155328|NCT00723125|495193|P2|Overall Study|Met Dx|0
155329|NCT00723125|495194|P1|Overall Study|Met Dx|1
155330|NCT00723190|495220|P1|Overall Study|Other-Not included in safety population|2
155331|NCT00723190|495220|P1|Overall Study|Other-Premature Discontinuation|9
155332|NCT00723190|495220|P1|Overall Study|Protocol Violation|15
155333|NCT00723190|495220|P1|Overall Study|Lack of Efficacy|16
155334|NCT00723190|495220|P1|Overall Study|Adverse Event|18
155335|NCT00723190|495220|P1|Overall Study|Lost to Follow-up|37
155336|NCT00723190|495220|P1|Overall Study|Withdrawal by Subject|45
155337|NCT00723203|495235|P1|Overall Study|Withdrawal by Subject|3
155338|NCT00723229|495241|P2|First Intervention|Lost to Follow-up|3
155339|NCT00723229|495242|P1|First Intervention|Lost to Follow-up|7
155340|NCT00723255|495254|P1|Overall Study|Ineligible: Wrong Primary|2
155341|NCT00723255|495254|P1|Overall Study|Ineligible: Second primary|1
155342|NCT00723255|495254|P1|Overall Study|Ineligible: Inadequate pathology|1
155343|NCT00723294|495273|P1|Overall Study|No treatment due to probe failure|1
155344|NCT00723294|495273|P1|Overall Study|Withdrawal by Subject|1
155345|NCT00723294|495273|P1|Overall Study|Benign lesion|1
155346|NCT00723294|495273|P1|Overall Study|Treated by non-credentialed surgeon|1
155347|NCT00723294|495273|P1|Overall Study|Treated prior to registration|1
155348|NCT00723294|495273|P1|Overall Study|Did not undergo surgery|1
155349|NCT00723294|495273|P1|Overall Study|No cryoabalation|2
155350|NCT00723294|495273|P1|Overall Study|1.0-Tesla MRI|1
155351|NCT00723294|495273|P1|Overall Study|No MRI tumor enhancement|1
155352|NCT00723294|495273|P1|Overall Study|>25% intraductal component|1
155353|NCT00723294|495273|P1|Overall Study|Lobular histology|2
155354|NCT00723450|495280|P3|Randomized Phase|Withdrawal by Subject|22
155355|NCT00723450|495281|P2|Randomized Phase|Withdrawal by Subject|14
155356|NCT00723450|495282|P1|Randomized Phase|Withdrawal by Subject|0
155357|NCT00723450|495280|P3|Randomized Phase|Physician Decision|1
155358|NCT00723450|495281|P2|Randomized Phase|Physician Decision|3
155359|NCT00723450|495282|P1|Randomized Phase|Physician Decision|0
155360|NCT00723450|495280|P3|Randomized Phase|Lost to Follow-up|3
155361|NCT00723450|495281|P2|Randomized Phase|Lost to Follow-up|2
155362|NCT00723450|495282|P1|Randomized Phase|Lost to Follow-up|0
155363|NCT00723450|495280|P3|Randomized Phase|Protocol Violation|13
155364|NCT00723450|495281|P2|Randomized Phase|Protocol Violation|9
155365|NCT00723450|495282|P1|Randomized Phase|Protocol Violation|0
155366|NCT00723450|495280|P3|Randomized Phase|Lack of Efficacy|11
155367|NCT00723450|495281|P2|Randomized Phase|Lack of Efficacy|11
155368|NCT00723450|495282|P1|Randomized Phase|Lack of Efficacy|0
155369|NCT00723450|495280|P3|Randomized Phase|Adverse Event|17
155370|NCT00723450|495281|P2|Randomized Phase|Adverse Event|26
155371|NCT00723450|495282|P1|Randomized Phase|Adverse Event|0
155372|NCT00723450|495280|P3|Open-Label Phase|Withdrawal by Subject|0
155373|NCT00723450|495281|P2|Open-Label Phase|Withdrawal by Subject|0
155374|NCT00723450|495282|P1|Open-Label Phase|Withdrawal by Subject|37
155375|NCT00723450|495280|P3|Open-Label Phase|Physician Decision|0
155376|NCT00723450|495281|P2|Open-Label Phase|Physician Decision|0
155377|NCT00723450|495282|P1|Open-Label Phase|Physician Decision|2
155378|NCT00723450|495280|P3|Open-Label Phase|Lost to Follow-up|0
155379|NCT00723450|495281|P2|Open-Label Phase|Lost to Follow-up|0
155381|NCT00723450|495280|P3|Open-Label Phase|Protocol Violation|0
155382|NCT00723450|495281|P2|Open-Label Phase|Protocol Violation|0
155383|NCT00723450|495282|P1|Open-Label Phase|Protocol Violation|35
155384|NCT00723450|495280|P3|Open-Label Phase|Lack of Efficacy|0
155385|NCT00723450|495281|P2|Open-Label Phase|Lack of Efficacy|0
155386|NCT00723450|495282|P1|Open-Label Phase|Lack of Efficacy|18
155387|NCT00723450|495280|P3|Open-Label Phase|Adverse Event|0
155388|NCT00723450|495281|P2|Open-Label Phase|Adverse Event|0
155389|NCT00723450|495282|P1|Open-Label Phase|Adverse Event|26
155390|NCT00723489|495327|P4|Overall Study|Samples Collected Out of Window|0
155391|NCT00723489|495328|P3|Overall Study|Samples Collected Out of Window|0
155392|NCT00723489|495329|P2|Overall Study|Samples Collected Out of Window|3
155393|NCT00723489|495330|P1|Overall Study|Samples Collected Out of Window|0
155394|NCT00723489|495327|P4|Overall Study|Prohibited Medication|1
155395|NCT00723489|495328|P3|Overall Study|Prohibited Medication|0
155396|NCT00723489|495329|P2|Overall Study|Prohibited Medication|0
155397|NCT00723489|495330|P1|Overall Study|Prohibited Medication|0
155398|NCT00723489|495327|P4|Overall Study|Seropositive at baseline|0
155399|NCT00723489|495328|P3|Overall Study|Seropositive at baseline|0
155400|NCT00723489|495329|P2|Overall Study|Seropositive at baseline|0
155401|NCT00723489|495330|P1|Overall Study|Seropositive at baseline|1
155402|NCT00723489|495327|P4|Overall Study|Withdrawal by Subject|1
155403|NCT00723489|495328|P3|Overall Study|Withdrawal by Subject|0
155404|NCT00723489|495329|P2|Overall Study|Withdrawal by Subject|0
155405|NCT00723489|495330|P1|Overall Study|Withdrawal by Subject|0
155406|NCT00723489|495327|P4|Overall Study|Pregnancy|1
155407|NCT00723489|495328|P3|Overall Study|Pregnancy|0
155408|NCT00723489|495329|P2|Overall Study|Pregnancy|0
155409|NCT00723489|495330|P1|Overall Study|Pregnancy|0
155410|NCT00723489|495327|P4|Overall Study|Physician Decision|0
155411|NCT00723489|495328|P3|Overall Study|Physician Decision|0
155412|NCT00723489|495329|P2|Overall Study|Physician Decision|1
155413|NCT00723489|495330|P1|Overall Study|Physician Decision|0
155414|NCT00723528|495359|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
155415|NCT00723528|495360|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
155416|NCT00723528|495361|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
155417|NCT00723528|495362|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
155418|NCT00723528|495363|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
155419|NCT00723528|495364|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
155420|NCT00723528|495365|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
155421|NCT00723528|495359|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
155422|NCT00723528|495360|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
155423|NCT00723528|495361|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
155424|NCT00723528|495362|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
155496|NCT00723554|495423|P1|Overall Study|Investigator's judgement|5
155425|NCT00723528|495363|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
155426|NCT00723528|495364|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
155427|NCT00723528|495365|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
155428|NCT00723528|495359|P7|Period 2: After Controlled Period|Adverse Event|1
155429|NCT00723528|495360|P6|Period 2: After Controlled Period|Adverse Event|0
155430|NCT00723528|495361|P5|Period 2: After Controlled Period|Adverse Event|1
155431|NCT00723528|495362|P4|Period 2: After Controlled Period|Adverse Event|0
155432|NCT00723528|495363|P3|Period 2: After Controlled Period|Adverse Event|0
155433|NCT00723528|495364|P2|Period 2: After Controlled Period|Adverse Event|0
155434|NCT00723528|495365|P1|Period 2: After Controlled Period|Adverse Event|0
155435|NCT00723528|495359|P7|Period 2: After Controlled Period|Unspecified|0
155436|NCT00723528|495360|P6|Period 2: After Controlled Period|Unspecified|4
155437|NCT00723528|495361|P5|Period 2: After Controlled Period|Unspecified|1
155438|NCT00723528|495362|P4|Period 2: After Controlled Period|Unspecified|0
155439|NCT00723528|495363|P3|Period 2: After Controlled Period|Unspecified|0
155440|NCT00723528|495364|P2|Period 2: After Controlled Period|Unspecified|0
155441|NCT00723528|495365|P1|Period 2: After Controlled Period|Unspecified|0
155442|NCT00723528|495359|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
155443|NCT00723528|495360|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
155444|NCT00723528|495361|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
155445|NCT00723528|495362|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
155446|NCT00723528|495363|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
155447|NCT00723528|495364|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
155448|NCT00723528|495365|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
155449|NCT00723528|495359|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
155450|NCT00723528|495360|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
155451|NCT00723528|495361|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
155452|NCT00723528|495362|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
155453|NCT00723528|495363|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
155454|NCT00723528|495364|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
155455|NCT00723528|495365|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
155456|NCT00723528|495359|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
155457|NCT00723528|495360|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
155458|NCT00723528|495361|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
155459|NCT00723528|495362|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
155460|NCT00723528|495363|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
155461|NCT00723528|495364|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
155462|NCT00723528|495365|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
155463|NCT00723528|495359|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
155464|NCT00723528|495360|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
155465|NCT00723528|495361|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
155466|NCT00723528|495362|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
155467|NCT00723528|495363|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
155468|NCT00723528|495364|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
155469|NCT00723528|495365|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
155470|NCT00723528|495359|P7|Period 1: Controlled Period (CP)|Physician Decision|0
155471|NCT00723528|495360|P6|Period 1: Controlled Period (CP)|Physician Decision|0
155472|NCT00723528|495361|P5|Period 1: Controlled Period (CP)|Physician Decision|0
155473|NCT00723528|495362|P4|Period 1: Controlled Period (CP)|Physician Decision|0
155474|NCT00723528|495363|P3|Period 1: Controlled Period (CP)|Physician Decision|1
155475|NCT00723528|495364|P2|Period 1: Controlled Period (CP)|Physician Decision|0
155476|NCT00723528|495365|P1|Period 1: Controlled Period (CP)|Physician Decision|0
155477|NCT00723528|495359|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
155478|NCT00723528|495360|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
155479|NCT00723528|495361|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
155480|NCT00723528|495362|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
155481|NCT00723528|495363|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
155482|NCT00723528|495364|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
155483|NCT00723528|495365|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
155484|NCT00723528|495359|P7|Period 1: Controlled Period (CP)|Adverse Event|0
155485|NCT00723528|495360|P6|Period 1: Controlled Period (CP)|Adverse Event|0
155486|NCT00723528|495361|P5|Period 1: Controlled Period (CP)|Adverse Event|0
155487|NCT00723528|495362|P4|Period 1: Controlled Period (CP)|Adverse Event|0
155488|NCT00723528|495363|P3|Period 1: Controlled Period (CP)|Adverse Event|1
155489|NCT00723528|495364|P2|Period 1: Controlled Period (CP)|Adverse Event|0
155490|NCT00723528|495365|P1|Period 1: Controlled Period (CP)|Adverse Event|0
155491|NCT00723554|495423|P1|Overall Study|Non-compliance|1
155492|NCT00723554|495423|P1|Overall Study|Lost to Follow-up|1
155493|NCT00723554|495423|P1|Overall Study|Not specified|3
155494|NCT00723554|495423|P1|Overall Study|Withdrawal of consent|3
155495|NCT00723554|495423|P1|Overall Study|Inhaled medication other than iloprost|4
155497|NCT00723554|495423|P1|Overall Study|Adverse Event|12
155498|NCT00723606|495476|P2|Overall Study|Withdrawal by Subject|2
155499|NCT00723606|495477|P1|Overall Study|Withdrawal by Subject|0
155500|NCT00723606|495476|P2|Overall Study|Unspecified|0
155501|NCT00723606|495477|P1|Overall Study|Unspecified|2
155502|NCT00723606|495476|P2|Overall Study|Adverse Event|5
155503|NCT00723606|495477|P1|Overall Study|Adverse Event|2
155504|NCT00723697|495504|P1|Overall Study|Other exclusion criteria applied|6
155505|NCT00723697|495504|P1|Overall Study|Missing Informed Consent Form|10
155506|NCT00723697|495504|P1|Overall Study|Physician questionnaires not received|2
155507|NCT00723710|495512|P1|Overall Study|Physician Decision|2
155508|NCT00723710|495512|P1|Overall Study|Withdrawal by Subject|36
155509|NCT00723710|495512|P1|Overall Study|Adverse Event|88
155510|NCT00723710|495512|P1|Overall Study|Disease progression|48
155511|NCT00723801|495535|P2|Overall Study|Protocol Violation|1
155512|NCT00723801|495536|P1|Overall Study|Protocol Violation|2
155513|NCT00723801|495535|P2|Overall Study|Lost to Follow-up|2
155514|NCT00723801|495536|P1|Overall Study|Lost to Follow-up|1
155515|NCT00723840|495552|P1|Overall Study|Unspecified reason|2
155516|NCT00723840|495552|P1|Overall Study|Other Medical Event|2
155517|NCT00723840|495552|P1|Overall Study|Serious Adverse Events|3
155518|NCT00723840|495552|P1|Overall Study|Withdrawal by Subject|55
155519|NCT00723840|495552|P1|Overall Study|Failure to return|18
155520|NCT00723840|495552|P1|Overall Study|Lost to Follow-up|2
155521|NCT00723892|495565|P2|Overall Study|Drug addiction|0
155522|NCT00723892|495566|P1|Overall Study|Drug addiction|1
155523|NCT00723892|495565|P2|Overall Study|Intercurrent infection|0
155524|NCT00723892|495566|P1|Overall Study|Intercurrent infection|2
155525|NCT00723892|495565|P2|Overall Study|Alcohol abuse|1
155526|NCT00723892|495566|P1|Overall Study|Alcohol abuse|0
155527|NCT00723892|495565|P2|Overall Study|Weight loss|3
155528|NCT00723892|495566|P1|Overall Study|Weight loss|1
155529|NCT00723892|495565|P2|Overall Study|Study end|3
155530|NCT00723892|495566|P1|Overall Study|Study end|1
155531|NCT00723892|495565|P2|Overall Study|Not specified|3
155532|NCT00723892|495566|P1|Overall Study|Not specified|6
155533|NCT00723892|495565|P2|Overall Study|Multiple reasons|12
155534|NCT00723892|495566|P1|Overall Study|Multiple reasons|17
155535|NCT00723892|495565|P2|Overall Study|Bad tolerance|5
155536|NCT00723892|495566|P1|Overall Study|Bad tolerance|5
155537|NCT00723892|495565|P2|Overall Study|End planned|7
155538|NCT00723892|495566|P1|Overall Study|End planned|11
155539|NCT00723892|495565|P2|Overall Study|Withdrawal by Subject|9
155540|NCT00723892|495566|P1|Overall Study|Withdrawal by Subject|6
155541|NCT00723892|495565|P2|Overall Study|Virological criterion|9
155542|NCT00723892|495566|P1|Overall Study|Virological criterion|24
155543|NCT00723892|495565|P2|Overall Study|Participant not tracked|35
155544|NCT00723892|495566|P1|Overall Study|Participant not tracked|33
155545|NCT00723944|495580|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
155546|NCT00723944|495581|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
155547|NCT00723944|495580|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
155548|NCT00723944|495581|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
155549|NCT00723944|495580|P2|Permanent Prosthesis Placement|Adverse Event|7
155550|NCT00723944|495581|P1|Permanent Prosthesis Placement|Adverse Event|1
155551|NCT00723957|495589|P2|Overall Study|Never received treatment|3
155552|NCT00723957|495590|P1|Overall Study|Never received treatment|3
155553|NCT00723957|495589|P2|Overall Study|Reason not analyzed|0
155554|NCT00723957|495590|P1|Overall Study|Reason not analyzed|1
155555|NCT00723957|495589|P2|Overall Study|Withdrawal by Subject|5
155556|NCT00723957|495590|P1|Overall Study|Withdrawal by Subject|7
155557|NCT00723957|495589|P2|Overall Study|Study drug toxicity|6
155558|NCT00723957|495590|P1|Overall Study|Study drug toxicity|4
155559|NCT00723957|495589|P2|Overall Study|Investigator decision|1
155560|NCT00723957|495590|P1|Overall Study|Investigator decision|1
155561|NCT00723957|495589|P2|Overall Study|Maximum clinical benefit|5
155562|NCT00723957|495590|P1|Overall Study|Maximum clinical benefit|4
155563|NCT00723957|495589|P2|Overall Study|Disease progression|25
155564|NCT00723957|495590|P1|Overall Study|Disease progression|27
155565|NCT00723957|495589|P2|Overall Study|Death|4
155566|NCT00723957|495590|P1|Overall Study|Death|3
155567|NCT00723957|495589|P2|Overall Study|Adverse event unrelated to study drug|4
155568|NCT00723957|495590|P1|Overall Study|Adverse event unrelated to study drug|1
155569|NCT00724061|495623|P1|Dose Escalation Phase|Disease Progression|3
155570|NCT00724061|495623|P1|Dose Escalation Phase|Adverse Event|2
155571|NCT00724126|495629|P2|Overall Study|Subject had to leave vicinity of site|1
155572|NCT00724126|495630|P1|Overall Study|Subject had to leave vicinity of site|0
155573|NCT00724126|495629|P2|Overall Study|Subject randomized although ineligible|1
155574|NCT00724126|495630|P1|Overall Study|Subject randomized although ineligible|1
155575|NCT00724126|495629|P2|Overall Study|Noncompliance|1
155576|NCT00724126|495630|P1|Overall Study|Noncompliance|2
155577|NCT00724126|495629|P2|Overall Study|Lost to Follow-up|6
155578|NCT00724126|495630|P1|Overall Study|Lost to Follow-up|6
155579|NCT00724126|495629|P2|Overall Study|Withdrawal by Subject|6
155580|NCT00724126|495630|P1|Overall Study|Withdrawal by Subject|8
155581|NCT00724126|495629|P2|Overall Study|Adverse Event|0
155582|NCT00724126|495630|P1|Overall Study|Adverse Event|2
155583|NCT00724152|495643|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
156729|NCT00725985|499522|P2|OLMP|Death|0
155584|NCT00724152|495644|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
155585|NCT00724152|495645|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
155586|NCT00724152|495643|P3|Two-arm Study Period|Withdrawal by Subject|0
155587|NCT00724152|495644|P2|Two-arm Study Period|Withdrawal by Subject|2
155588|NCT00724152|495645|P1|Two-arm Study Period|Withdrawal by Subject|3
155589|NCT00724243|495660|P1|Overall Study|Adverse Event|5
155590|NCT00724243|495660|P1|Overall Study|Lack of Efficacy|10
155591|NCT00724282|495665|P1|Overall Study|Physician Decision|1
155592|NCT00724282|495665|P1|Overall Study|Withdrawal by Subject|3
155593|NCT00724373|495682|P1|Overall Study|Tolerability|23
155594|NCT00724373|495682|P1|Overall Study|Drug Relapse|1
155595|NCT00724373|495682|P1|Overall Study|Acute HCV infection|1
155596|NCT00724373|495682|P1|Overall Study|Viral Relapse|1
155597|NCT00724373|495682|P1|Overall Study|Only to have 24 week regimen|1
155598|NCT00724373|495682|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
155599|NCT00724373|495682|P1|Overall Study|Participant moved away|1
155600|NCT00724373|495682|P1|Overall Study|HCV RNA negative after 4 weeks|9
155601|NCT00724373|495682|P1|Overall Study|Non-compliance|2
155602|NCT00724373|495682|P1|Overall Study|Lost to Follow-up|7
155603|NCT00724373|495682|P1|Overall Study|Lack of Efficacy|82
155604|NCT00724373|495682|P1|Overall Study|Adverse Event|41
155605|NCT00724451|495686|P1|Overall Study|Investigator + Participant Decision|13
155606|NCT00724451|495686|P1|Overall Study|Withdrawal by Subject|45
155607|NCT00724451|495686|P1|Overall Study|Physician Decision|116
155608|NCT00724451|495686|P1|Overall Study|Unknown; No Data Sources Available|9
155609|NCT00724451|495686|P1|Overall Study|Never Started Treatment|89
155610|NCT00724451|495686|P1|Overall Study|Participant Refused Treatment|89
155611|NCT00724451|495686|P1|Overall Study|Not Eligible for Treatment|431
155612|NCT00724451|495686|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
155613|NCT00724451|495686|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
155614|NCT00724698|495744|P1|Overall Study|No Info|25
155615|NCT00724698|495744|P1|Overall Study|Lost to Follow-up|36
155616|NCT00724698|495744|P1|Overall Study|Poor Compliance|16
155617|NCT00724698|495744|P1|Overall Study|Failure of Therapy|4
155618|NCT00724698|495744|P1|Overall Study|Adverse Event|9
155619|NCT00724711|495749|P2|Overall Study|Protocol Violation|0
155620|NCT00724711|495750|P1|Overall Study|Protocol Violation|1
155621|NCT00724711|495749|P2|Overall Study|Lost to Follow-up|5
155622|NCT00724711|495750|P1|Overall Study|Lost to Follow-up|4
155623|NCT00724711|495749|P2|Overall Study|Withdrawal by Subject|4
155624|NCT00724711|495750|P1|Overall Study|Withdrawal by Subject|5
155625|NCT00724711|495749|P2|Overall Study|Physician Decision|3
155626|NCT00724711|495750|P1|Overall Study|Physician Decision|0
155627|NCT00724711|495749|P2|Overall Study|Lack of Efficacy|1
155628|NCT00724711|495750|P1|Overall Study|Lack of Efficacy|0
155629|NCT00724711|495749|P2|Overall Study|Pregnancy|1
155630|NCT00724711|495750|P1|Overall Study|Pregnancy|0
155631|NCT00724711|495749|P2|Overall Study|Adverse Event|3
155632|NCT00724711|495750|P1|Overall Study|Adverse Event|7
155633|NCT00724815|495803|P2|Overall Study|Other Various|5
155634|NCT00724815|495804|P1|Overall Study|Other Various|3
155635|NCT00724815|495803|P2|Overall Study|Lost to Follow-up|1
155636|NCT00724815|495804|P1|Overall Study|Lost to Follow-up|4
155637|NCT00724815|495803|P2|Overall Study|Adverse Event|3
155638|NCT00724815|495804|P1|Overall Study|Adverse Event|5
155639|NCT00724815|495803|P2|Overall Study|Randomized, not treated|30
155640|NCT00724815|495804|P1|Overall Study|Randomized, not treated|31
155641|NCT00724854|495818|P2|Overall Study|Adverse event + lack of efficacy|1
155642|NCT00724854|495819|P1|Overall Study|Adverse event + lack of efficacy|2
155643|NCT00724854|495818|P2|Overall Study|Withdrawal by Subject|0
155644|NCT00724854|495819|P1|Overall Study|Withdrawal by Subject|5
155645|NCT00724854|495818|P2|Overall Study|Change of treatment|0
155646|NCT00724854|495819|P1|Overall Study|Change of treatment|7
155647|NCT00724854|495818|P2|Overall Study|Death|0
155648|NCT00724854|495819|P1|Overall Study|Death|11
155649|NCT00724854|495818|P2|Overall Study|Not specified|3
155650|NCT00724854|495819|P1|Overall Study|Not specified|42
155651|NCT00724854|495818|P2|Overall Study|Adverse Event|4
155652|NCT00724854|495819|P1|Overall Study|Adverse Event|62
155653|NCT00724854|495818|P2|Overall Study|Lost to Follow-up|10
155654|NCT00724854|495819|P1|Overall Study|Lost to Follow-up|87
155655|NCT00724854|495818|P2|Overall Study|Lack of Efficacy|13
155656|NCT00724854|495819|P1|Overall Study|Lack of Efficacy|187
155657|NCT00724867|495834|P1|Overall Study|Elected to exit due to site closure|2
155658|NCT00724867|495834|P1|Overall Study|Subject moved out of state|1
155659|NCT00724867|495834|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
155660|NCT00724867|495834|P1|Overall Study|Subject incarcerated|1
155661|NCT00724867|495834|P1|Overall Study|Sponsor decision to end study|14
155662|NCT00724867|495834|P1|Overall Study|Withdrawal by Subject|31
155663|NCT00724867|495834|P1|Overall Study|Protocol Violation|1
155664|NCT00724867|495834|P1|Overall Study|Physician Decision|17
155665|NCT00724867|495834|P1|Overall Study|Non-compliance with study drug|6
155666|NCT00724867|495834|P1|Overall Study|Lost to Follow-up|12
155667|NCT00724867|495834|P1|Overall Study|Lack of Efficacy|14
155668|NCT00724867|495834|P1|Overall Study|Adverse Event|25
155669|NCT00724893|495874|P2|Overall Study|Unknown, missing data|1
155670|NCT00724893|495875|P1|Overall Study|Unknown, missing data|1
155671|NCT00724893|495874|P2|Overall Study|Lost to Follow-up|52
155672|NCT00724893|495875|P1|Overall Study|Lost to Follow-up|0
155673|NCT00724893|495874|P2|Overall Study|Assigned shorter treatment|2
155674|NCT00724893|495875|P1|Overall Study|Assigned shorter treatment|0
155675|NCT00724893|495874|P2|Overall Study|Financial reasons|2
155676|NCT00724893|495875|P1|Overall Study|Financial reasons|0
155677|NCT00724893|495874|P2|Overall Study|Substance abuse|3
155678|NCT00724893|495875|P1|Overall Study|Substance abuse|0
155679|NCT00724893|495874|P2|Overall Study|Incarceration|9
155680|NCT00724893|495875|P1|Overall Study|Incarceration|0
155681|NCT00724893|495874|P2|Overall Study|Geographic reasons|11
155682|NCT00724893|495875|P1|Overall Study|Geographic reasons|0
155683|NCT00724893|495874|P2|Overall Study|Patient choice|26
155684|NCT00724893|495875|P1|Overall Study|Patient choice|0
155685|NCT00724893|495874|P2|Overall Study|Reason not specified|7
155686|NCT00724893|495875|P1|Overall Study|Reason not specified|193
155687|NCT00724893|495874|P2|Overall Study|Lack of virologic response|202
155688|NCT00724893|495875|P1|Overall Study|Lack of virologic response|94
155689|NCT00724893|495874|P2|Overall Study|Withdrawal by Subject|1
155690|NCT00724893|495875|P1|Overall Study|Withdrawal by Subject|0
155691|NCT00724893|495874|P2|Overall Study|Adverse Event|142
155692|NCT00724893|495875|P1|Overall Study|Adverse Event|76
155693|NCT00724932|495945|P2|Overall Study|Not treated|3
155694|NCT00724932|495946|P1|Overall Study|Not treated|4
155695|NCT00724932|495945|P2|Overall Study|Lost to Follow-up|0
155696|NCT00724932|495946|P1|Overall Study|Lost to Follow-up|1
155697|NCT00724945|496015|P2|Period 2|lens physiology issue|0
155698|NCT00724945|496016|P1|Period 2|lens physiology issue|1
155699|NCT00724945|496015|P2|Period 2|lens comfort issue|0
155700|NCT00724945|496016|P1|Period 2|lens comfort issue|3
155701|NCT00724945|496015|P2|Period 1|Lost to Follow-up|0
155702|NCT00724945|496016|P1|Period 1|Lost to Follow-up|1
155703|NCT00724945|496015|P2|Period 1|Adverse Event|1
155704|NCT00724945|496016|P1|Period 1|Adverse Event|1
155705|NCT00724945|496015|P2|Period 1|non-compliance|0
155706|NCT00724945|496016|P1|Period 1|non-compliance|1
155707|NCT00724958|496026|P1|Overall Study|No documentation for end of therapy|13
155708|NCT00724958|496026|P1|Overall Study|Other Reason|76
155709|NCT00724958|496026|P1|Overall Study|Remission|7
155710|NCT00724958|496026|P1|Overall Study|No Response|18
155711|NCT00724958|496026|P1|Overall Study|Loss of Response|40
155712|NCT00724958|496026|P1|Overall Study|Adverse Event|28
155713|NCT00725010|496060|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
155714|NCT00725010|496060|P1|Overall Study|No further documentation|1
155715|NCT00725010|496060|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
155716|NCT00725010|496060|P1|Overall Study|Hepatopathy probably not Temodal-related|1
155717|NCT00725010|496060|P1|Overall Study|Lost to Follow-up|1
155718|NCT00725010|496060|P1|Overall Study|Death|1
155719|NCT00725010|496060|P1|Overall Study|Withdrawal by Subject|2
155720|NCT00725010|496060|P1|Overall Study|Tumor Progression|7
155721|NCT00725010|496060|P1|Overall Study|Toxicity|9
155722|NCT00718237|496100|P2|Overall Study|Withdrawal by Subject|10
155723|NCT00718237|496101|P1|Overall Study|Withdrawal by Subject|9
155724|NCT00718237|496100|P2|Overall Study|Physician Decision|0
155725|NCT00718237|496101|P1|Overall Study|Physician Decision|1
155726|NCT00718237|496100|P2|Overall Study|Lost to Follow-up|2
155727|NCT00718237|496101|P1|Overall Study|Lost to Follow-up|2
155728|NCT00718237|496100|P2|Overall Study|Adverse Event|3
155729|NCT00718237|496101|P1|Overall Study|Adverse Event|1
155730|NCT00718315|496131|P3|Overall Study|Use of ATB and Corticoids|2
155731|NCT00718315|496132|P2|Overall Study|Use of ATB and Corticoids|1
155732|NCT00718315|496133|P1|Overall Study|Use of ATB and Corticoids|0
155733|NCT00718315|496131|P3|Overall Study|Other|1
155734|NCT00718315|496132|P2|Overall Study|Other|0
155735|NCT00718315|496133|P1|Overall Study|Other|0
155736|NCT00718315|496131|P3|Overall Study|Disease progression|1
155737|NCT00718315|496132|P2|Overall Study|Disease progression|1
155738|NCT00718315|496133|P1|Overall Study|Disease progression|0
155739|NCT00718315|496131|P3|Overall Study|Use of Minocyclin|1
155740|NCT00718315|496132|P2|Overall Study|Use of Minocyclin|1
155741|NCT00718315|496133|P1|Overall Study|Use of Minocyclin|1
155742|NCT00718315|496131|P3|Overall Study|Erlotinib dose decreased|1
155743|NCT00718315|496132|P2|Overall Study|Erlotinib dose decreased|3
155744|NCT00718315|496133|P1|Overall Study|Erlotinib dose decreased|4
155745|NCT00718315|496131|P3|Overall Study|Protocol Violation|3
155746|NCT00718315|496132|P2|Overall Study|Protocol Violation|5
155747|NCT00718315|496133|P1|Overall Study|Protocol Violation|5
155748|NCT00718315|496131|P3|Overall Study|Lost to Follow-up|4
155749|NCT00718315|496132|P2|Overall Study|Lost to Follow-up|3
155750|NCT00718315|496133|P1|Overall Study|Lost to Follow-up|2
155751|NCT00718315|496131|P3|Overall Study|Death|5
155752|NCT00718315|496132|P2|Overall Study|Death|6
155753|NCT00718315|496133|P1|Overall Study|Death|6
155754|NCT00718315|496131|P3|Overall Study|Adverse Event|3
155755|NCT00718315|496132|P2|Overall Study|Adverse Event|2
155756|NCT00718315|496133|P1|Overall Study|Adverse Event|1
155757|NCT00718328|496167|P2|Overall Study|Lost to Follow-up|0
155758|NCT00718328|496168|P1|Overall Study|Lost to Follow-up|1
155759|NCT00725075|496177|P3|Overall Study|Other|0
155760|NCT00725075|496178|P2|Overall Study|Other|0
155761|NCT00725075|496179|P1|Overall Study|Other|1
155762|NCT00725075|496177|P3|Overall Study|Inclusion/Exclusion Criteria|1
155763|NCT00725075|496178|P2|Overall Study|Inclusion/Exclusion Criteria|0
155764|NCT00725075|496179|P1|Overall Study|Inclusion/Exclusion Criteria|1
155765|NCT00725075|496177|P3|Overall Study|Worsening of Disease|2
155766|NCT00725075|496178|P2|Overall Study|Worsening of Disease|1
155767|NCT00725075|496179|P1|Overall Study|Worsening of Disease|2
155768|NCT00725075|496177|P3|Overall Study|Adverse Event|1
155769|NCT00725075|496178|P2|Overall Study|Adverse Event|1
155770|NCT00725075|496179|P1|Overall Study|Adverse Event|2
155771|NCT00725075|496177|P3|Overall Study|Withdrawal by Subject|4
155772|NCT00725075|496178|P2|Overall Study|Withdrawal by Subject|5
155773|NCT00725075|496179|P1|Overall Study|Withdrawal by Subject|4
155774|NCT00725075|496177|P3|Overall Study|Lost to Follow-up|0
155775|NCT00725075|496178|P2|Overall Study|Lost to Follow-up|0
155776|NCT00725075|496179|P1|Overall Study|Lost to Follow-up|1
155777|NCT00725075|496177|P3|Overall Study|Protocol Violation|1
155778|NCT00725075|496178|P2|Overall Study|Protocol Violation|0
155779|NCT00725075|496179|P1|Overall Study|Protocol Violation|0
155780|NCT00725075|496177|P3|Overall Study|Use of Excluded Medication|0
155781|NCT00725075|496178|P2|Overall Study|Use of Excluded Medication|1
155782|NCT00725075|496179|P1|Overall Study|Use of Excluded Medication|0
155783|NCT00725101|496223|P1|Overall Study|not specified/no reason given|11
155784|NCT00725101|496223|P1|Overall Study|Withdrawal by Subject|127
155785|NCT00725101|496223|P1|Overall Study|Protocol Violation|1
155786|NCT00725101|496223|P1|Overall Study|Lost to Follow-up|353
155787|NCT00725101|496223|P1|Overall Study|Death|3
155788|NCT00725205|496250|P1|Overall Study|Treatment Failure|41
155789|NCT00725205|496250|P1|Overall Study|Protocol Defined Clinical Event|1
155790|NCT00725205|496250|P1|Overall Study|Other|8
155791|NCT00725205|496250|P1|Overall Study|Non-compliance With Protocol|14
155792|NCT00725205|496250|P1|Overall Study|Investigator Discontinued|1
155793|NCT00725205|496250|P1|Overall Study|Adverse Event|22
155794|NCT00725296|496267|P1|Overall Study|Not Specified|38
155795|NCT00725296|496267|P1|Overall Study|Lost to Follow-up|1
155796|NCT00725296|496267|P1|Overall Study|Non-Compliance|2
155797|NCT00725296|496267|P1|Overall Study|Withdrawal by Subject|3
155798|NCT00725296|496267|P1|Overall Study|Lack of Efficacy|7
155799|NCT00725296|496267|P1|Overall Study|Adverse Event|11
155800|NCT00727402|496301|P1|Overall Study|Physician Decision|116
155801|NCT00727506|496311|P6|Overall Study|Other reason not described above|1
155802|NCT00727506|496312|P5|Overall Study|Other reason not described above|1
155803|NCT00727506|496313|P4|Overall Study|Other reason not described above|4
155804|NCT00727506|496314|P3|Overall Study|Other reason not described above|1
155805|NCT00727506|496315|P2|Overall Study|Other reason not described above|0
155806|NCT00727506|496316|P1|Overall Study|Other reason not described above|0
155807|NCT00727506|496311|P6|Overall Study|Refused to continue medication|2
155808|NCT00727506|496312|P5|Overall Study|Refused to continue medication|1
155809|NCT00727506|496313|P4|Overall Study|Refused to continue medication|3
155810|NCT00727506|496314|P3|Overall Study|Refused to continue medication|2
155811|NCT00727506|496315|P2|Overall Study|Refused to continue medication|1
155812|NCT00727506|496316|P1|Overall Study|Refused to continue medication|0
155813|NCT00727506|496311|P6|Overall Study|Progressive disease|28
155814|NCT00727506|496312|P5|Overall Study|Progressive disease|38
155815|NCT00727506|496313|P4|Overall Study|Progressive disease|28
155816|NCT00727506|496314|P3|Overall Study|Progressive disease|9
155817|NCT00727506|496315|P2|Overall Study|Progressive disease|7
155818|NCT00727506|496316|P1|Overall Study|Progressive disease|4
155819|NCT00727506|496311|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
155820|NCT00727506|496312|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
155821|NCT00727506|496313|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
155822|NCT00727506|496314|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
155823|NCT00727506|496315|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
155824|NCT00727506|496316|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
155825|NCT00727506|496311|P6|Overall Study|Adverse Event|8
155826|NCT00727506|496312|P5|Overall Study|Adverse Event|1
155827|NCT00727506|496313|P4|Overall Study|Adverse Event|4
155828|NCT00727506|496314|P3|Overall Study|Adverse Event|4
155829|NCT00727506|496315|P2|Overall Study|Adverse Event|0
155830|NCT00727506|496316|P1|Overall Study|Adverse Event|0
155831|NCT00727558|496411|P2|Overall Study|Lost to Follow-up|0
155832|NCT00727558|496412|P1|Overall Study|Lost to Follow-up|1
155833|NCT00727558|496411|P2|Overall Study|Subject unable to return for follow-up|1
155834|NCT00727558|496412|P1|Overall Study|Subject unable to return for follow-up|1
155835|NCT00727558|496411|P2|Overall Study|Adverse Event|1
155836|NCT00727558|496412|P1|Overall Study|Adverse Event|0
155837|NCT00727558|496411|P2|Overall Study|Lens issue|1
155838|NCT00727558|496412|P1|Overall Study|Lens issue|0
155839|NCT00727571|496434|P4|Overall Study|Other|0
155840|NCT00727571|496435|P3|Overall Study|Other|6
155841|NCT00727571|496436|P2|Overall Study|Other|4
155842|NCT00727571|496437|P1|Overall Study|Other|0
155843|NCT00727571|496434|P4|Overall Study|AE not leading to hospitalization|0
155844|NCT00727571|496435|P3|Overall Study|AE not leading to hospitalization|2
155845|NCT00727571|496436|P2|Overall Study|AE not leading to hospitalization|0
155846|NCT00727571|496437|P1|Overall Study|AE not leading to hospitalization|0
155847|NCT00727571|496434|P4|Overall Study|Hospitalization|1
155848|NCT00727571|496435|P3|Overall Study|Hospitalization|0
155849|NCT00727571|496436|P2|Overall Study|Hospitalization|1
155850|NCT00727571|496437|P1|Overall Study|Hospitalization|0
155851|NCT00727571|496434|P4|Overall Study|Dismissed from nursing home|0
155852|NCT00727571|496435|P3|Overall Study|Dismissed from nursing home|5
155853|NCT00727571|496436|P2|Overall Study|Dismissed from nursing home|9
155854|NCT00727571|496437|P1|Overall Study|Dismissed from nursing home|0
155855|NCT00727571|496434|P4|Overall Study|Subject Non Compliance|4
155856|NCT00727571|496435|P3|Overall Study|Subject Non Compliance|0
155857|NCT00727571|496436|P2|Overall Study|Subject Non Compliance|6
155858|NCT00727571|496437|P1|Overall Study|Subject Non Compliance|0
155859|NCT00727571|496434|P4|Overall Study|Withdrawal by Subject|0
155860|NCT00727571|496435|P3|Overall Study|Withdrawal by Subject|11
155861|NCT00727571|496436|P2|Overall Study|Withdrawal by Subject|10
155862|NCT00727571|496437|P1|Overall Study|Withdrawal by Subject|0
155863|NCT00727571|496434|P4|Overall Study|Physician Decision|0
155864|NCT00727571|496435|P3|Overall Study|Physician Decision|0
155865|NCT00727571|496436|P2|Overall Study|Physician Decision|5
155866|NCT00727571|496437|P1|Overall Study|Physician Decision|0
155867|NCT00727571|496434|P4|Overall Study|Death|1
155868|NCT00727571|496435|P3|Overall Study|Death|5
155869|NCT00727571|496436|P2|Overall Study|Death|19
155870|NCT00727571|496437|P1|Overall Study|Death|0
155871|NCT00727571|496434|P4|Overall Study|Ineligibility determined|0
155872|NCT00727571|496435|P3|Overall Study|Ineligibility determined|1
155873|NCT00727571|496436|P2|Overall Study|Ineligibility determined|1
155874|NCT00727571|496437|P1|Overall Study|Ineligibility determined|1
155875|NCT00727649|496490|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
155876|NCT00727649|496491|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
155877|NCT00727649|496490|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
155878|NCT00727649|496491|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
155879|NCT00727649|496490|P2|Second Intervention (4-weeks)|Death|0
155880|NCT00727649|496491|P1|Second Intervention (4-weeks)|Death|1
155881|NCT00727649|496490|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
155882|NCT00727649|496491|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
155883|NCT00727649|496490|P2|Wash-out (2-weeks)|Lost to Follow-up|1
155884|NCT00727649|496491|P1|Wash-out (2-weeks)|Lost to Follow-up|3
155885|NCT00727649|496490|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
155886|NCT00727649|496491|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
155887|NCT00727649|496490|P2|First Intervention (4-weeks)|Lost to Follow-up|2
155888|NCT00727649|496491|P1|First Intervention (4-weeks)|Lost to Follow-up|1
155889|NCT00727714|496503|P1|Overall Study|Lost to Follow-up|2
155890|NCT00727844|496522|P4|Initial Randomization|Physician Decision|0
155891|NCT00727844|496523|P3|Initial Randomization|Physician Decision|0
155892|NCT00727844|496524|P2|Initial Randomization|Physician Decision|0
155893|NCT00727844|496525|P1|Initial Randomization|Physician Decision|2
155894|NCT00727909|496621|P4|Overall Study|Death|0
155895|NCT00727909|496622|P3|Overall Study|Death|1
155896|NCT00727909|496623|P2|Overall Study|Death|0
155897|NCT00727909|496624|P1|Overall Study|Death|0
155898|NCT00727909|496621|P4|Overall Study|Withdrawal by Subject|5
155899|NCT00727909|496622|P3|Overall Study|Withdrawal by Subject|8
155900|NCT00727909|496623|P2|Overall Study|Withdrawal by Subject|11
155901|NCT00727909|496624|P1|Overall Study|Withdrawal by Subject|5
155902|NCT00727961|496628|P1|Overall Study|Progression|30
155903|NCT00727961|496628|P1|Overall Study|Patient's refusal|2
155904|NCT00727961|496628|P1|Overall Study|Adverse Event|4
155905|NCT00727961|496628|P1|Overall Study|Lost to Follow-up|1
155906|NCT00728130|496638|P1|Overall Study|Physician Decision|1
155907|NCT00728130|496638|P1|Overall Study|Paperwork not completed in time|1
155908|NCT00728130|496638|P1|Overall Study|Withdrawal by Subject|1
155909|NCT00728182|496645|P2|Overall Study|Protocol Noncompliance|1
155910|NCT00728182|496646|P1|Overall Study|Protocol Noncompliance|0
155911|NCT00728182|496645|P2|Overall Study|Death|2
155912|NCT00728182|496646|P1|Overall Study|Death|0
155913|NCT00728182|496645|P2|Overall Study|Lost to Follow-up|0
155914|NCT00728182|496646|P1|Overall Study|Lost to Follow-up|2
155915|NCT00728182|496645|P2|Overall Study|Adverse Event|0
155916|NCT00728182|496646|P1|Overall Study|Adverse Event|1
155917|NCT00728416|496682|P2|Overall Study|Withdrawal by Subject|0
155918|NCT00728416|496683|P1|Overall Study|Withdrawal by Subject|1
155919|NCT00728416|496682|P2|Overall Study|Treatment Failure|1
155920|NCT00728416|496683|P1|Overall Study|Treatment Failure|0
155921|NCT00728416|496682|P2|Overall Study|Adverse Event|1
155922|NCT00728416|496683|P1|Overall Study|Adverse Event|1
155923|NCT00728468|496691|P1|Overall Study|Study terminated by sponsor|1
155924|NCT00728468|496691|P1|Overall Study|Objective progression or relapse|9
155925|NCT00728468|496691|P1|Overall Study|Protocol Violation|4
155926|NCT00728468|496691|P1|Overall Study|Death|1
155927|NCT00728468|496691|P1|Overall Study|Enrolled but not treated|1
155928|NCT00728481|496715|P2|Overall Study|Incorrectly assigned to opposite arm|0
155929|NCT00728481|496716|P1|Overall Study|Incorrectly assigned to opposite arm|1
155930|NCT00728481|496715|P2|Overall Study|Study medication non-compliance|2
155931|NCT00728481|496716|P1|Overall Study|Study medication non-compliance|0
155932|NCT00728481|496715|P2|Overall Study|Adverse Event|1
155933|NCT00728481|496716|P1|Overall Study|Adverse Event|0
155934|NCT00728481|496715|P2|Overall Study|Withdrawal by Subject|1
155935|NCT00728481|496716|P1|Overall Study|Withdrawal by Subject|0
155936|NCT00728494|496734|P2|Overall Study|No data available|1
155937|NCT00728494|496735|P1|Overall Study|No data available|0
155938|NCT00728494|496734|P2|Overall Study|Lack of Efficacy|4
155939|NCT00728494|496735|P1|Overall Study|Lack of Efficacy|2
155940|NCT00728494|496734|P2|Overall Study|Withdrawal by Subject|2
155941|NCT00728494|496735|P1|Overall Study|Withdrawal by Subject|0
155942|NCT00728494|496734|P2|Overall Study|Adverse Event|0
155943|NCT00728494|496735|P1|Overall Study|Adverse Event|7
155944|NCT00728689|496764|P2|Washout Period (Days 4 - 10)|Death in family|0
155945|NCT00728689|496765|P1|Washout Period (Days 4 - 10)|Death in family|1
155946|NCT00728754|496804|P2|One Year Post Placement Follow-up|Adverse Event|0
155947|NCT00728754|496805|P1|One Year Post Placement Follow-up|Adverse Event|1
155948|NCT00728754|496804|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
155949|NCT00728754|496805|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
155950|NCT00728754|496804|P2|Permanent Prosthesis Placement|Adverse Event|1
155951|NCT00728754|496805|P1|Permanent Prosthesis Placement|Adverse Event|1
155952|NCT00728884|496828|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
155953|NCT00728884|496828|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
155954|NCT00728962|496849|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
155955|NCT00728962|496849|P1|Permanent Prosthesis Placement|Adverse Event|3
155956|NCT00728962|496849|P1|Implant Placement Surgery|Protocol Violation|1
155957|NCT00728962|496849|P1|Implant Placement Surgery|Lost to Follow-up|1
155958|NCT00728962|496849|P1|Implant Placement Surgery|Adverse Event|8
155959|NCT00728988|496855|P2|Overall Study|Withdrawal by Subject|6
155960|NCT00728988|496856|P1|Overall Study|Withdrawal by Subject|2
155961|NCT00728988|496855|P2|Overall Study|Unspecified|77
155962|NCT00728988|496856|P1|Overall Study|Unspecified|85
155963|NCT00728988|496855|P2|Overall Study|Adverse Event|2
155964|NCT00728988|496856|P1|Overall Study|Adverse Event|3
155965|NCT00728988|496855|P2|Overall Study|Death|1
155966|NCT00728988|496856|P1|Overall Study|Death|1
155967|NCT00728988|496855|P2|Overall Study|Not Treated|2
155968|NCT00728988|496856|P1|Overall Study|Not Treated|2
155969|NCT00729157|496874|P1|Overall Study|Withdrawal by Subject|1
155970|NCT00729183|496884|P2|Overall Study|Withdrawal by Subject|7
155971|NCT00729183|496885|P1|Overall Study|Withdrawal by Subject|9
155972|NCT00729183|496884|P2|Overall Study|Protocol Violation|0
155973|NCT00729183|496885|P1|Overall Study|Protocol Violation|1
155974|NCT00729183|496884|P2|Overall Study|Physician Decision|1
155975|NCT00729183|496885|P1|Overall Study|Physician Decision|1
155976|NCT00729183|496884|P2|Overall Study|Lost to Follow-up|1
155977|NCT00729183|496885|P1|Overall Study|Lost to Follow-up|3
155978|NCT00729183|496884|P2|Overall Study|Lack of Efficacy|1
155979|NCT00729183|496885|P1|Overall Study|Lack of Efficacy|0
155980|NCT00729183|496884|P2|Overall Study|Adverse Event|5
155981|NCT00729183|496885|P1|Overall Study|Adverse Event|11
155982|NCT00729248|496917|P1|Overall Study|Physician Decision|2
155983|NCT00729326|496924|P2|Overall Study|Sponsor Decision|2
155984|NCT00729326|496925|P1|Overall Study|Sponsor Decision|1
155985|NCT00729326|496924|P2|Overall Study|Subject Decision|4
155986|NCT00729326|496925|P1|Overall Study|Subject Decision|4
155987|NCT00729326|496924|P2|Overall Study|Protocol Violation|2
155988|NCT00729326|496925|P1|Overall Study|Protocol Violation|3
155989|NCT00729326|496924|P2|Overall Study|Physician Decision|1
155990|NCT00729326|496925|P1|Overall Study|Physician Decision|0
155991|NCT00729326|496924|P2|Overall Study|Lost to Follow-up|0
155992|NCT00729326|496925|P1|Overall Study|Lost to Follow-up|2
155993|NCT00729365|496970|P3|Overall Study|Physician Decision|7
155994|NCT00729365|496971|P2|Overall Study|Physician Decision|6
155995|NCT00729365|496972|P1|Overall Study|Physician Decision|33
155996|NCT00729469|497000|P2|Overall Study|Other-Not mentioned|4
155997|NCT00729469|497001|P1|Overall Study|Other-Not mentioned|9
155998|NCT00729469|497000|P2|Overall Study|Withdrawal by Subject|8
155999|NCT00729469|497001|P1|Overall Study|Withdrawal by Subject|19
156000|NCT00729469|497000|P2|Overall Study|Protocol Violation|1
156001|NCT00729469|497001|P1|Overall Study|Protocol Violation|2
156002|NCT00729469|497000|P2|Overall Study|Lost to Follow-up|9
156003|NCT00729469|497001|P1|Overall Study|Lost to Follow-up|9
156004|NCT00729469|497000|P2|Overall Study|Adverse Event|25
156005|NCT00729469|497001|P1|Overall Study|Adverse Event|14
156006|NCT00729560|497057|P1|Overall Study|Withdrawal by Subject|3
156007|NCT00729612|497061|P1|Overall Study|Non evaluable for response|10
156008|NCT00729651|497070|P2|Overall Study|Subject’s private reason|0
156009|NCT00729651|497071|P1|Overall Study|Subject’s private reason|2
156010|NCT00729651|497070|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
156011|NCT00729651|497071|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
156012|NCT00729651|497070|P2|Overall Study|Adverse Event|3
156013|NCT00729651|497071|P1|Overall Study|Adverse Event|7
156014|NCT00729651|497070|P2|Overall Study|Protocol Violation|1
156015|NCT00729651|497071|P1|Overall Study|Protocol Violation|0
156016|NCT00729651|497070|P2|Overall Study|Lost to Follow-up|4
156017|NCT00729651|497071|P1|Overall Study|Lost to Follow-up|5
156018|NCT00729651|497070|P2|Overall Study|Withdrawal by Subject|6
156019|NCT00729651|497071|P1|Overall Study|Withdrawal by Subject|5
156020|NCT00729690|497097|P3|Overall Study|IT Catheter Malfunction|2
156021|NCT00729690|497098|P2|Overall Study|IT Catheter Malfunction|2
156022|NCT00729690|497099|P1|Overall Study|IT Catheter Malfunction|0
156023|NCT00721279|497142|P2|Overall Study|Other|16
156024|NCT00721279|497143|P1|Overall Study|Other|12
156025|NCT00721279|497142|P2|Overall Study|Withdrawal by Subject|3
156026|NCT00721279|497143|P1|Overall Study|Withdrawal by Subject|13
156027|NCT00721279|497142|P2|Overall Study|Tolerability insufficient|2
156028|NCT00721279|497143|P1|Overall Study|Tolerability insufficient|5
156029|NCT00721279|497142|P2|Overall Study|Lack of Efficacy|3
156030|NCT00721279|497143|P1|Overall Study|Lack of Efficacy|6
156031|NCT00721396|497168|P4|Overall Study|Administrative reason|0
156032|NCT00721396|497169|P3|Overall Study|Administrative reason|1
156033|NCT00721396|497170|P2|Overall Study|Administrative reason|0
156034|NCT00721396|497171|P1|Overall Study|Administrative reason|3
156035|NCT00721396|497168|P4|Overall Study|Inappropriate enrollment|0
156036|NCT00721396|497169|P3|Overall Study|Inappropriate enrollment|0
156037|NCT00721396|497170|P2|Overall Study|Inappropriate enrollment|2
156038|NCT00721396|497171|P1|Overall Study|Inappropriate enrollment|0
156039|NCT00721396|497168|P4|Overall Study|Protocol Violation|0
156040|NCT00721396|497169|P3|Overall Study|Protocol Violation|1
156041|NCT00721396|497170|P2|Overall Study|Protocol Violation|3
156042|NCT00721396|497171|P1|Overall Study|Protocol Violation|4
156043|NCT00721396|497168|P4|Overall Study|Lost to Follow-up|3
156044|NCT00721396|497169|P3|Overall Study|Lost to Follow-up|3
156045|NCT00721396|497170|P2|Overall Study|Lost to Follow-up|9
156046|NCT00721396|497171|P1|Overall Study|Lost to Follow-up|7
156047|NCT00721396|497168|P4|Overall Study|Withdrawal by Subject|7
156048|NCT00721396|497169|P3|Overall Study|Withdrawal by Subject|3
156049|NCT00721396|497170|P2|Overall Study|Withdrawal by Subject|15
156050|NCT00721396|497171|P1|Overall Study|Withdrawal by Subject|12
156051|NCT00721396|497168|P4|Overall Study|Adverse Event|0
156052|NCT00721396|497169|P3|Overall Study|Adverse Event|2
156053|NCT00721396|497170|P2|Overall Study|Adverse Event|7
156054|NCT00721396|497171|P1|Overall Study|Adverse Event|4
156055|NCT00721409|497210|P3|Overall Study|Death|0
156056|NCT00721409|497211|P2|Overall Study|Death|1
156057|NCT00721409|497212|P1|Overall Study|Death|0
156058|NCT00721409|497210|P3|Overall Study|Adverse Event|2
156059|NCT00721409|497211|P2|Overall Study|Adverse Event|11
156060|NCT00721409|497212|P1|Overall Study|Adverse Event|0
156061|NCT00721409|497210|P3|Overall Study|Reason not specified|5
156062|NCT00721409|497211|P2|Overall Study|Reason not specified|1
156063|NCT00721409|497212|P1|Overall Study|Reason not specified|0
156064|NCT00721409|497210|P3|Overall Study|Withdrawal by Subject|6
156065|NCT00721409|497211|P2|Overall Study|Withdrawal by Subject|5
156066|NCT00721409|497212|P1|Overall Study|Withdrawal by Subject|1
156067|NCT00721409|497210|P3|Overall Study|Objective progression or relapse|57
156068|NCT00721409|497211|P2|Overall Study|Objective progression or relapse|42
156069|NCT00721409|497212|P1|Overall Study|Objective progression or relapse|7
156070|NCT00721409|497210|P3|Overall Study|Global deterioration of health status|3
156071|NCT00721409|497211|P2|Overall Study|Global deterioration of health status|5
156072|NCT00721409|497212|P1|Overall Study|Global deterioration of health status|2
156073|NCT00721409|497210|P3|Overall Study|Ongoing at date of cutoff|8
156074|NCT00721409|497211|P2|Overall Study|Ongoing at date of cutoff|19
156075|NCT00721409|497212|P1|Overall Study|Ongoing at date of cutoff|2
156076|NCT00721578|497363|P2|Overall Study|Withdrawal by Subject|1
156077|NCT00721578|497364|P1|Overall Study|Withdrawal by Subject|1
156078|NCT00721578|497363|P2|Overall Study|Death|1
156079|NCT00721578|497364|P1|Overall Study|Death|1
156080|NCT00721630|497400|P1|Overall Study|Participant found to be ineligible|1
156081|NCT00721734|497410|P5|Overall Study|Other|0
156082|NCT00721734|497411|P4|Overall Study|Other|1
156083|NCT00721734|497412|P3|Overall Study|Other|0
156084|NCT00721734|497413|P2|Overall Study|Other|0
156085|NCT00721734|497414|P1|Overall Study|Other|0
156086|NCT00721734|497410|P5|Overall Study|Withdrawal by Subject|1
156087|NCT00721734|497411|P4|Overall Study|Withdrawal by Subject|0
156088|NCT00721734|497412|P3|Overall Study|Withdrawal by Subject|0
156089|NCT00721734|497413|P2|Overall Study|Withdrawal by Subject|1
156090|NCT00721734|497414|P1|Overall Study|Withdrawal by Subject|2
156091|NCT00721734|497410|P5|Overall Study|Adverse Event|3
156092|NCT00721734|497411|P4|Overall Study|Adverse Event|0
156093|NCT00721734|497412|P3|Overall Study|Adverse Event|4
156094|NCT00721734|497413|P2|Overall Study|Adverse Event|1
156095|NCT00721734|497414|P1|Overall Study|Adverse Event|3
156096|NCT00721734|497410|P5|Overall Study|Progressive Disease|2
156097|NCT00721734|497411|P4|Overall Study|Progressive Disease|5
156098|NCT00721734|497412|P3|Overall Study|Progressive Disease|4
156099|NCT00721734|497413|P2|Overall Study|Progressive Disease|10
156100|NCT00721734|497414|P1|Overall Study|Progressive Disease|3
156101|NCT00721955|497529|P3|Overall Study|Adverse Event|2
156102|NCT00721955|497530|P2|Overall Study|Adverse Event|0
156103|NCT00721955|497531|P1|Overall Study|Adverse Event|0
156104|NCT00721968|497547|P2|Overall Study|Lost to Follow-up|0
156105|NCT00721968|497548|P1|Overall Study|Lost to Follow-up|2
156106|NCT00722137|497586|P2|Overall Study|Randomized But Not Treated|2
156107|NCT00722137|497587|P1|Overall Study|Randomized But Not Treated|3
156108|NCT00722137|497586|P2|Overall Study|Other Reason Uknown|3
156109|NCT00722137|497587|P1|Overall Study|Other Reason Uknown|4
156110|NCT00722137|497586|P2|Overall Study|Withdrawal by Subject|6
156730|NCT00725985|499523|P1|OLMP|Death|0
156111|NCT00722137|497587|P1|Overall Study|Withdrawal by Subject|9
156112|NCT00722137|497586|P2|Overall Study|Death|12
156113|NCT00722137|497587|P1|Overall Study|Death|7
156114|NCT00722137|497586|P2|Overall Study|Adverse Event|17
156115|NCT00722137|497587|P1|Overall Study|Adverse Event|21
156116|NCT00722137|497586|P2|Overall Study|Overt Disease Progression|5
156117|NCT00722137|497587|P1|Overall Study|Overt Disease Progression|4
156118|NCT00722371|497618|P7|Overall Study|Withdrawal by Subject|26
156119|NCT00722371|497619|P6|Overall Study|Withdrawal by Subject|18
156120|NCT00722371|497620|P5|Overall Study|Withdrawal by Subject|19
156121|NCT00722371|497621|P4|Overall Study|Withdrawal by Subject|23
156122|NCT00722371|497622|P3|Overall Study|Withdrawal by Subject|19
156123|NCT00722371|497623|P2|Overall Study|Withdrawal by Subject|27
156124|NCT00722371|497624|P1|Overall Study|Withdrawal by Subject|18
156125|NCT00722371|497618|P7|Overall Study|Protocol Violation|1
156126|NCT00722371|497619|P6|Overall Study|Protocol Violation|2
156127|NCT00722371|497620|P5|Overall Study|Protocol Violation|4
156128|NCT00722371|497621|P4|Overall Study|Protocol Violation|1
156129|NCT00722371|497622|P3|Overall Study|Protocol Violation|0
156130|NCT00722371|497623|P2|Overall Study|Protocol Violation|1
156131|NCT00722371|497624|P1|Overall Study|Protocol Violation|6
156132|NCT00722371|497618|P7|Overall Study|Pregnancy|0
156133|NCT00722371|497619|P6|Overall Study|Pregnancy|1
156134|NCT00722371|497620|P5|Overall Study|Pregnancy|0
156135|NCT00722371|497621|P4|Overall Study|Pregnancy|0
156136|NCT00722371|497622|P3|Overall Study|Pregnancy|0
156137|NCT00722371|497623|P2|Overall Study|Pregnancy|1
156138|NCT00722371|497624|P1|Overall Study|Pregnancy|1
156139|NCT00722371|497618|P7|Overall Study|Physician Decision|4
156140|NCT00722371|497619|P6|Overall Study|Physician Decision|3
156141|NCT00722371|497620|P5|Overall Study|Physician Decision|2
156142|NCT00722371|497621|P4|Overall Study|Physician Decision|5
156143|NCT00722371|497622|P3|Overall Study|Physician Decision|2
156144|NCT00722371|497623|P2|Overall Study|Physician Decision|2
156145|NCT00722371|497624|P1|Overall Study|Physician Decision|5
156146|NCT00722371|497618|P7|Overall Study|Lost to Follow-up|13
156147|NCT00722371|497619|P6|Overall Study|Lost to Follow-up|16
156148|NCT00722371|497620|P5|Overall Study|Lost to Follow-up|8
156149|NCT00722371|497621|P4|Overall Study|Lost to Follow-up|13
156150|NCT00722371|497622|P3|Overall Study|Lost to Follow-up|21
156151|NCT00722371|497623|P2|Overall Study|Lost to Follow-up|14
156152|NCT00722371|497624|P1|Overall Study|Lost to Follow-up|11
156153|NCT00722371|497618|P7|Overall Study|Lack of Efficacy|0
156154|NCT00722371|497619|P6|Overall Study|Lack of Efficacy|3
156155|NCT00722371|497620|P5|Overall Study|Lack of Efficacy|2
156156|NCT00722371|497621|P4|Overall Study|Lack of Efficacy|6
156157|NCT00722371|497622|P3|Overall Study|Lack of Efficacy|6
156158|NCT00722371|497623|P2|Overall Study|Lack of Efficacy|6
156159|NCT00722371|497624|P1|Overall Study|Lack of Efficacy|4
156160|NCT00722371|497618|P7|Overall Study|Hypoglycemia|0
156161|NCT00722371|497619|P6|Overall Study|Hypoglycemia|0
156162|NCT00722371|497620|P5|Overall Study|Hypoglycemia|0
156163|NCT00722371|497621|P4|Overall Study|Hypoglycemia|0
156164|NCT00722371|497622|P3|Overall Study|Hypoglycemia|0
156165|NCT00722371|497623|P2|Overall Study|Hypoglycemia|0
156166|NCT00722371|497624|P1|Overall Study|Hypoglycemia|1
156167|NCT00722371|497618|P7|Overall Study|Hyperglycemia|1
156168|NCT00722371|497619|P6|Overall Study|Hyperglycemia|1
156169|NCT00722371|497620|P5|Overall Study|Hyperglycemia|5
156170|NCT00722371|497621|P4|Overall Study|Hyperglycemia|2
156171|NCT00722371|497622|P3|Overall Study|Hyperglycemia|4
156172|NCT00722371|497623|P2|Overall Study|Hyperglycemia|6
156173|NCT00722371|497624|P1|Overall Study|Hyperglycemia|2
156174|NCT00722371|497618|P7|Overall Study|Excluded medication|1
156175|NCT00722371|497619|P6|Overall Study|Excluded medication|0
156176|NCT00722371|497620|P5|Overall Study|Excluded medication|0
156177|NCT00722371|497621|P4|Overall Study|Excluded medication|0
156178|NCT00722371|497622|P3|Overall Study|Excluded medication|1
156179|NCT00722371|497623|P2|Overall Study|Excluded medication|1
156180|NCT00722371|497624|P1|Overall Study|Excluded medication|0
156181|NCT00722371|497618|P7|Overall Study|Creatinine / Creatinine clearance|1
156182|NCT00722371|497619|P6|Overall Study|Creatinine / Creatinine clearance|1
156183|NCT00722371|497620|P5|Overall Study|Creatinine / Creatinine clearance|2
156184|NCT00722371|497621|P4|Overall Study|Creatinine / Creatinine clearance|3
156185|NCT00722371|497622|P3|Overall Study|Creatinine / Creatinine clearance|2
156186|NCT00722371|497623|P2|Overall Study|Creatinine / Creatinine clearance|1
156187|NCT00722371|497624|P1|Overall Study|Creatinine / Creatinine clearance|2
156188|NCT00722371|497618|P7|Overall Study|Contraindication|0
156189|NCT00722371|497619|P6|Overall Study|Contraindication|0
156190|NCT00722371|497620|P5|Overall Study|Contraindication|0
156191|NCT00722371|497621|P4|Overall Study|Contraindication|0
156192|NCT00722371|497622|P3|Overall Study|Contraindication|1
156193|NCT00722371|497623|P2|Overall Study|Contraindication|0
156194|NCT00722371|497624|P1|Overall Study|Contraindication|0
156195|NCT00722371|497618|P7|Overall Study|Adverse Event|4
156196|NCT00722371|497619|P6|Overall Study|Adverse Event|8
156197|NCT00722371|497620|P5|Overall Study|Adverse Event|6
156198|NCT00722371|497621|P4|Overall Study|Adverse Event|10
156199|NCT00722371|497622|P3|Overall Study|Adverse Event|9
156200|NCT00722371|497623|P2|Overall Study|Adverse Event|13
156201|NCT00722371|497624|P1|Overall Study|Adverse Event|6
156202|NCT00722423|497677|P2|Overall Study|Protocol Violation|1
156203|NCT00722423|497678|P1|Overall Study|Protocol Violation|0
156204|NCT00729833|497701|P4|Overall Study|Unspecified Reasons|1
156205|NCT00729833|497702|P3|Overall Study|Unspecified Reasons|5
156206|NCT00729833|497703|P2|Overall Study|Unspecified Reasons|5
156207|NCT00729833|497704|P1|Overall Study|Unspecified Reasons|11
156208|NCT00729833|497701|P4|Overall Study|Withdrawal by Subject|0
156209|NCT00729833|497702|P3|Overall Study|Withdrawal by Subject|3
156210|NCT00729833|497703|P2|Overall Study|Withdrawal by Subject|1
156211|NCT00729833|497704|P1|Overall Study|Withdrawal by Subject|3
156212|NCT00729833|497701|P4|Overall Study|Lost to Follow-up|0
156213|NCT00729833|497702|P3|Overall Study|Lost to Follow-up|0
156214|NCT00729833|497703|P2|Overall Study|Lost to Follow-up|0
156215|NCT00729833|497704|P1|Overall Study|Lost to Follow-up|1
156216|NCT00729833|497701|P4|Overall Study|Study Terminated by Sponsor|0
156217|NCT00729833|497702|P3|Overall Study|Study Terminated by Sponsor|1
156218|NCT00729833|497703|P2|Overall Study|Study Terminated by Sponsor|0
156219|NCT00729833|497704|P1|Overall Study|Study Terminated by Sponsor|0
156220|NCT00729833|497701|P4|Overall Study|Death|5
156221|NCT00729833|497702|P3|Overall Study|Death|3
156222|NCT00729833|497703|P2|Overall Study|Death|1
156223|NCT00729833|497704|P1|Overall Study|Death|5
156224|NCT00729859|497755|P3|Overall Study|Withdrawal by Subject|0
156225|NCT00729859|497756|P2|Overall Study|Withdrawal by Subject|1
156226|NCT00729859|497757|P1|Overall Study|Withdrawal by Subject|0
156227|NCT00729859|497755|P3|Overall Study|Adverse Event|0
156228|NCT00729859|497756|P2|Overall Study|Adverse Event|1
156229|NCT00729859|497757|P1|Overall Study|Adverse Event|0
156230|NCT00729937|497805|P6|Overall Study|Incarcerated|0
156231|NCT00729937|497806|P5|Overall Study|Incarcerated|0
156232|NCT00729937|497807|P4|Overall Study|Incarcerated|1
156233|NCT00729937|497808|P3|Overall Study|Incarcerated|1
156234|NCT00729937|497809|P2|Overall Study|Incarcerated|2
156235|NCT00729937|497810|P1|Overall Study|Incarcerated|0
156236|NCT00729937|497805|P6|Overall Study|Did not meet eligibility criteria|0
156237|NCT00729937|497806|P5|Overall Study|Did not meet eligibility criteria|0
156238|NCT00729937|497807|P4|Overall Study|Did not meet eligibility criteria|0
156239|NCT00729937|497808|P3|Overall Study|Did not meet eligibility criteria|0
156240|NCT00729937|497809|P2|Overall Study|Did not meet eligibility criteria|1
156241|NCT00729937|497810|P1|Overall Study|Did not meet eligibility criteria|2
156242|NCT00729937|497805|P6|Overall Study|Randomized but not treated|3
156243|NCT00729937|497806|P5|Overall Study|Randomized but not treated|1
156244|NCT00729937|497807|P4|Overall Study|Randomized but not treated|0
156245|NCT00729937|497808|P3|Overall Study|Randomized but not treated|1
156246|NCT00729937|497809|P2|Overall Study|Randomized but not treated|6
156247|NCT00729937|497810|P1|Overall Study|Randomized but not treated|12
156248|NCT00729937|497805|P6|Overall Study|Withdrawal by Subject|2
156249|NCT00729937|497806|P5|Overall Study|Withdrawal by Subject|4
156250|NCT00729937|497807|P4|Overall Study|Withdrawal by Subject|0
156251|NCT00729937|497808|P3|Overall Study|Withdrawal by Subject|6
156252|NCT00729937|497809|P2|Overall Study|Withdrawal by Subject|5
156253|NCT00729937|497810|P1|Overall Study|Withdrawal by Subject|3
156254|NCT00729937|497805|P6|Overall Study|Death|1
156255|NCT00729937|497806|P5|Overall Study|Death|0
156256|NCT00729937|497807|P4|Overall Study|Death|0
156257|NCT00729937|497808|P3|Overall Study|Death|1
156258|NCT00729937|497809|P2|Overall Study|Death|0
156259|NCT00729937|497810|P1|Overall Study|Death|1
156260|NCT00729937|497805|P6|Overall Study|Physician Decision|8
156261|NCT00729937|497806|P5|Overall Study|Physician Decision|5
156262|NCT00729937|497807|P4|Overall Study|Physician Decision|0
156263|NCT00729937|497808|P3|Overall Study|Physician Decision|2
156264|NCT00729937|497809|P2|Overall Study|Physician Decision|16
156265|NCT00729937|497810|P1|Overall Study|Physician Decision|7
156266|NCT00729937|497805|P6|Overall Study|Lost to Follow-up|23
156267|NCT00729937|497806|P5|Overall Study|Lost to Follow-up|18
156268|NCT00729937|497807|P4|Overall Study|Lost to Follow-up|33
156269|NCT00729937|497808|P3|Overall Study|Lost to Follow-up|18
156270|NCT00729937|497809|P2|Overall Study|Lost to Follow-up|58
156271|NCT00729937|497810|P1|Overall Study|Lost to Follow-up|49
156272|NCT00730015|498007|P3|Overall Study|Other Reason|1
156273|NCT00730015|498008|P2|Overall Study|Other Reason|0
156274|NCT00730015|498009|P1|Overall Study|Other Reason|1
156275|NCT00730015|498007|P3|Overall Study|Lack of Efficacy|8
156276|NCT00730015|498008|P2|Overall Study|Lack of Efficacy|2
156277|NCT00730015|498009|P1|Overall Study|Lack of Efficacy|1
156278|NCT00730015|498007|P3|Overall Study|Lost to Follow-up|3
156279|NCT00730015|498008|P2|Overall Study|Lost to Follow-up|10
156280|NCT00730015|498009|P1|Overall Study|Lost to Follow-up|4
156281|NCT00730015|498007|P3|Overall Study|Withdrawal by Subject|8
156282|NCT00730015|498008|P2|Overall Study|Withdrawal by Subject|12
156283|NCT00730015|498009|P1|Overall Study|Withdrawal by Subject|12
156284|NCT00730015|498007|P3|Overall Study|Protocol Violation|4
156285|NCT00730015|498008|P2|Overall Study|Protocol Violation|6
156286|NCT00730015|498009|P1|Overall Study|Protocol Violation|2
156287|NCT00730015|498007|P3|Overall Study|Adverse Event|8
156288|NCT00730015|498008|P2|Overall Study|Adverse Event|10
156289|NCT00730015|498009|P1|Overall Study|Adverse Event|11
156290|NCT00730028|498048|P5|Overall Study|Randomization Error|2
156291|NCT00730028|498049|P4|Overall Study|Randomization Error|0
156292|NCT00730028|498050|P3|Overall Study|Randomization Error|0
156293|NCT00730028|498051|P2|Overall Study|Randomization Error|0
156294|NCT00730028|498052|P1|Overall Study|Randomization Error|1
156295|NCT00730028|498048|P5|Overall Study|Treatment Failure|1
156296|NCT00730028|498049|P4|Overall Study|Treatment Failure|0
156297|NCT00730028|498050|P3|Overall Study|Treatment Failure|0
156298|NCT00730028|498051|P2|Overall Study|Treatment Failure|5
156299|NCT00730028|498052|P1|Overall Study|Treatment Failure|5
156300|NCT00730028|498048|P5|Overall Study|Physician Decision|2
156301|NCT00730028|498049|P4|Overall Study|Physician Decision|3
156302|NCT00730028|498050|P3|Overall Study|Physician Decision|2
156303|NCT00730028|498051|P2|Overall Study|Physician Decision|3
156304|NCT00730028|498052|P1|Overall Study|Physician Decision|3
156305|NCT00730028|498048|P5|Overall Study|Withdrawal by Subject|9
156306|NCT00730028|498049|P4|Overall Study|Withdrawal by Subject|5
156307|NCT00730028|498050|P3|Overall Study|Withdrawal by Subject|4
156308|NCT00730028|498051|P2|Overall Study|Withdrawal by Subject|5
156309|NCT00730028|498052|P1|Overall Study|Withdrawal by Subject|9
156310|NCT00730028|498048|P5|Overall Study|Protocol Violation|0
156311|NCT00730028|498049|P4|Overall Study|Protocol Violation|2
156312|NCT00730028|498050|P3|Overall Study|Protocol Violation|1
156313|NCT00730028|498051|P2|Overall Study|Protocol Violation|1
156314|NCT00730028|498052|P1|Overall Study|Protocol Violation|6
156315|NCT00730028|498048|P5|Overall Study|Lost to Follow-up|25
156316|NCT00730028|498049|P4|Overall Study|Lost to Follow-up|26
156317|NCT00730028|498050|P3|Overall Study|Lost to Follow-up|22
156318|NCT00730028|498051|P2|Overall Study|Lost to Follow-up|26
156319|NCT00730028|498052|P1|Overall Study|Lost to Follow-up|13
156320|NCT00730028|498048|P5|Overall Study|Adverse Event|43
156321|NCT00730028|498049|P4|Overall Study|Adverse Event|20
156322|NCT00730028|498050|P3|Overall Study|Adverse Event|16
156323|NCT00730028|498051|P2|Overall Study|Adverse Event|26
156324|NCT00730028|498052|P1|Overall Study|Adverse Event|23
156325|NCT00730041|498101|P2|Overall Study|Lost to Follow-up|2
156326|NCT00730041|498102|P1|Overall Study|Lost to Follow-up|0
156327|NCT00730132|498120|P1|Overall Study|Death|1
156328|NCT00730132|498120|P1|Overall Study|Protocol Violation|154
156329|NCT00731666|498164|P1|Overall Study|Withdrawal by Subject|2
156330|NCT00731666|498164|P1|Overall Study|Lost to Follow-up|8
156331|NCT00731666|498164|P1|Overall Study|Adverse Event|2
156332|NCT00731679|498172|P2|Overall Study|Pregnancy|1
156333|NCT00731679|498173|P1|Overall Study|Pregnancy|0
156334|NCT00731679|498172|P2|Overall Study|Noncompliance|1
156335|NCT00731679|498173|P1|Overall Study|Noncompliance|0
156336|NCT00731679|498172|P2|Overall Study|Lost to Follow-up|8
156337|NCT00731679|498173|P1|Overall Study|Lost to Follow-up|7
156338|NCT00731679|498172|P2|Overall Study|Withdrawal by Subject|8
156339|NCT00731679|498173|P1|Overall Study|Withdrawal by Subject|8
156340|NCT00731679|498172|P2|Overall Study|Adverse Event|8
156341|NCT00731679|498173|P1|Overall Study|Adverse Event|7
156342|NCT00731692|498184|P3|Extension Phase|Adverse Event|15
156343|NCT00731692|498185|P2|Extension Phase|Adverse Event|1
156344|NCT00731692|498186|P1|Extension Phase|Adverse Event|1
156345|NCT00731692|498184|P3|Extension Phase|Withdrawal by Subject|3
156346|NCT00731692|498185|P2|Extension Phase|Withdrawal by Subject|5
156347|NCT00731692|498186|P1|Extension Phase|Withdrawal by Subject|4
156348|NCT00731692|498184|P3|Extension Phase|Lost to Follow-up|4
156349|NCT00731692|498185|P2|Extension Phase|Lost to Follow-up|1
156350|NCT00731692|498186|P1|Extension Phase|Lost to Follow-up|0
156351|NCT00731692|498184|P3|Extension Phase|Abnormal lab values|1
156352|NCT00731692|498185|P2|Extension Phase|Abnormal lab values|0
156353|NCT00731692|498186|P1|Extension Phase|Abnormal lab values|0
156354|NCT00731692|498184|P3|Extension Phase|Abnormal test procedure|1
156355|NCT00731692|498185|P2|Extension Phase|Abnormal test procedure|0
156356|NCT00731692|498186|P1|Extension Phase|Abnormal test procedure|0
156357|NCT00731692|498184|P3|Extension Phase|Admin Problems: Terminated # patients|277
156358|NCT00731692|498185|P2|Extension Phase|Admin Problems: Terminated # patients|189
156359|NCT00731692|498186|P1|Extension Phase|Admin Problems: Terminated # patients|69
156360|NCT00731692|498184|P3|Core Study (36 Months)|Withdrawal by Subject|46
156361|NCT00731692|498185|P2|Core Study (36 Months)|Withdrawal by Subject|32
156362|NCT00731692|498186|P1|Core Study (36 Months)|Withdrawal by Subject|12
156363|NCT00731692|498184|P3|Core Study (36 Months)|Adverse Event|29
156364|NCT00731692|498185|P2|Core Study (36 Months)|Adverse Event|28
156365|NCT00731692|498186|P1|Core Study (36 Months)|Adverse Event|25
156366|NCT00731692|498184|P3|Core Study (36 Months)|Abnormal Lab values|5
156367|NCT00731692|498185|P2|Core Study (36 Months)|Abnormal Lab values|19
156368|NCT00731692|498186|P1|Core Study (36 Months)|Abnormal Lab values|6
156369|NCT00731692|498184|P3|Core Study (36 Months)|Protocol Violation|8
156370|NCT00731692|498185|P2|Core Study (36 Months)|Protocol Violation|5
156371|NCT00731692|498186|P1|Core Study (36 Months)|Protocol Violation|4
156372|NCT00731692|498184|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
156373|NCT00731692|498185|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
156374|NCT00731692|498186|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
156375|NCT00731692|498184|P3|Core Study (36 Months)|Administrative|6
156376|NCT00731692|498185|P2|Core Study (36 Months)|Administrative|2
156377|NCT00731692|498186|P1|Core Study (36 Months)|Administrative|2
156378|NCT00731692|498184|P3|Core Study (36 Months)|Lost to Follow-up|3
156379|NCT00731692|498185|P2|Core Study (36 Months)|Lost to Follow-up|3
156380|NCT00731692|498186|P1|Core Study (36 Months)|Lost to Follow-up|1
156381|NCT00731692|498184|P3|Core Study (36 Months)|Death|2
156382|NCT00731692|498185|P2|Core Study (36 Months)|Death|1
156383|NCT00731692|498186|P1|Core Study (36 Months)|Death|2
156384|NCT00731692|498184|P3|Core Study (36 Months)|Physician Decision|2
156385|NCT00731692|498185|P2|Core Study (36 Months)|Physician Decision|0
156386|NCT00731692|498186|P1|Core Study (36 Months)|Physician Decision|1
156387|NCT00731692|498184|P3|Core Study (36 Months)|Lack of Efficacy|64
156388|NCT00731692|498185|P2|Core Study (36 Months)|Lack of Efficacy|23
156389|NCT00731692|498186|P1|Core Study (36 Months)|Lack of Efficacy|11
156390|NCT00731731|498233|P3|Overall Study|Cancel prior to treatment|2
156391|NCT00731731|498234|P2|Overall Study|Cancel prior to treatment|0
156392|NCT00731731|498235|P1|Overall Study|Cancel prior to treatment|0
156393|NCT00731731|498233|P3|Overall Study|Protocol Violation|1
156394|NCT00731731|498234|P2|Overall Study|Protocol Violation|0
156395|NCT00731731|498235|P1|Overall Study|Protocol Violation|0
156396|NCT00731783|498252|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
156397|NCT00731783|498253|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
156398|NCT00731783|498252|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
156399|NCT00731783|498253|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
156400|NCT00731783|498252|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
156401|NCT00731783|498253|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
156402|NCT00731783|498252|P2|One Month Follow-Up Visit|Lost to Follow-up|22
156403|NCT00731783|498253|P1|One Month Follow-Up Visit|Lost to Follow-up|14
156404|NCT00731822|498275|P2|Overall Study|Lost to Follow-up|0
156405|NCT00731822|498276|P1|Overall Study|Lost to Follow-up|1
156406|NCT00731822|498275|P2|Overall Study|Protocol Violation|0
156407|NCT00731822|498276|P1|Overall Study|Protocol Violation|1
156408|NCT00731822|498275|P2|Overall Study|Adverse Event|1
156409|NCT00731822|498276|P1|Overall Study|Adverse Event|2
156410|NCT00731939|498299|P1|Overall Study|Did not meet enrollment criteria|2
156411|NCT00731939|498299|P1|Overall Study|Withdrawal by Subject|2
156412|NCT00731939|498299|P1|Overall Study|Not implanted with study device|9
156413|NCT00731939|498299|P1|Overall Study|Lost to Follow-up|15
156414|NCT00731939|498299|P1|Overall Study|Adverse Event|6
156415|NCT00732069|498354|P6|Washout After First Study Drug|Adverse Event|0
156416|NCT00732069|498355|P5|Washout After First Study Drug|Adverse Event|0
156417|NCT00732069|498356|P4|Washout After First Study Drug|Adverse Event|0
156418|NCT00732069|498357|P3|Washout After First Study Drug|Adverse Event|0
156419|NCT00732069|498358|P2|Washout After First Study Drug|Adverse Event|0
156420|NCT00732069|498359|P1|Washout After First Study Drug|Adverse Event|1
156421|NCT00732160|498374|P4|Overall Study|scheduling|1
156422|NCT00732160|498375|P3|Overall Study|scheduling|2
156423|NCT00732160|498376|P2|Overall Study|scheduling|4
156424|NCT00732160|498377|P1|Overall Study|scheduling|4
156425|NCT00732160|498374|P4|Overall Study|Adverse Event|1
156426|NCT00732160|498375|P3|Overall Study|Adverse Event|1
156427|NCT00732160|498376|P2|Overall Study|Adverse Event|0
156428|NCT00732160|498377|P1|Overall Study|Adverse Event|1
156429|NCT00732199|498393|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
156430|NCT00732199|498394|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
156431|NCT00732199|498393|P2|Overall Study|Withdrawal by Subject|18
156432|NCT00732199|498394|P1|Overall Study|Withdrawal by Subject|25
156433|NCT00732238|498498|P2|Overall Study|Asymptomatic bacteriuria|0
156434|NCT00732238|498499|P1|Overall Study|Asymptomatic bacteriuria|1
156435|NCT00732238|498498|P2|Overall Study|Bacteremia|1
156436|NCT00732238|498499|P1|Overall Study|Bacteremia|4
156437|NCT00732303|498507|P1|Overall Study|Study Terminated|2
156438|NCT00732381|498515|P2|Overall Study|Treatment Failure|1
156439|NCT00732381|498516|P1|Overall Study|Treatment Failure|1
156440|NCT00732381|498515|P2|Overall Study|Adverse Event|0
156441|NCT00732381|498516|P1|Overall Study|Adverse Event|1
156442|NCT00732472|498528|P4|Overall Study|Withdrawal by Subject|1
156443|NCT00732472|498529|P3|Overall Study|Withdrawal by Subject|0
156444|NCT00732472|498530|P2|Overall Study|Withdrawal by Subject|2
156445|NCT00732472|498531|P1|Overall Study|Withdrawal by Subject|0
156446|NCT00732472|498528|P4|Overall Study|Protocol Violation|1
156447|NCT00732472|498529|P3|Overall Study|Protocol Violation|0
156448|NCT00732472|498530|P2|Overall Study|Protocol Violation|0
156449|NCT00732472|498531|P1|Overall Study|Protocol Violation|0
156450|NCT00732472|498528|P4|Overall Study|Adverse Event|1
156451|NCT00732472|498529|P3|Overall Study|Adverse Event|1
156452|NCT00732472|498530|P2|Overall Study|Adverse Event|1
156453|NCT00732472|498531|P1|Overall Study|Adverse Event|0
156454|NCT00732615|498631|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
156455|NCT00732615|498632|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
156456|NCT00732615|498631|P2|Overall Study|Physician Decision|0
156457|NCT00732615|498632|P1|Overall Study|Physician Decision|3
156458|NCT00732615|498631|P2|Overall Study|Adverse Event|2
156459|NCT00732615|498632|P1|Overall Study|Adverse Event|0
156460|NCT00732615|498631|P2|Overall Study|Lost to Follow-up|1
156461|NCT00732615|498632|P1|Overall Study|Lost to Follow-up|0
156462|NCT00732615|498631|P2|Overall Study|Withdrawal by Subject|1
156463|NCT00732615|498632|P1|Overall Study|Withdrawal by Subject|3
156464|NCT00732641|498646|P2|Overall Study|Not Specified|5
156465|NCT00732641|498647|P1|Overall Study|Not Specified|18
156466|NCT00732641|498646|P2|Overall Study|Unable to Complete|1
156467|NCT00732641|498647|P1|Overall Study|Unable to Complete|1
156468|NCT00732641|498646|P2|Overall Study|Withdrawal by Subject|2
156469|NCT00732641|498647|P1|Overall Study|Withdrawal by Subject|4
156470|NCT00732641|498646|P2|Overall Study|Physician Decision|0
156471|NCT00732641|498647|P1|Overall Study|Physician Decision|6
156472|NCT00732641|498646|P2|Overall Study|Serious Adverse Events|3
156473|NCT00732641|498647|P1|Overall Study|Serious Adverse Events|12
156474|NCT00732641|498646|P2|Overall Study|Relapse or Progressive Disease|101
156475|NCT00732641|498647|P1|Overall Study|Relapse or Progressive Disease|65
156476|NCT00732758|498693|P2|Overall Study|Lost to Follow-up|16
156477|NCT00732758|498694|P1|Overall Study|Lost to Follow-up|8
156478|NCT00732875|498706|P1|Overall Study|Lack of Efficacy|13
156479|NCT00732875|498706|P1|Overall Study|Withdrawal by Subject|6
156480|NCT00732875|498706|P1|Overall Study|Adverse Event|16
156481|NCT00732940|498727|P2|Overall Study|Lost to Follow-up|0
156482|NCT00732940|498728|P1|Overall Study|Lost to Follow-up|1
156483|NCT00732940|498727|P2|Overall Study|Adverse Event|1
156484|NCT00732940|498728|P1|Overall Study|Adverse Event|0
156485|NCT00732940|498727|P2|Overall Study|Withdrawal by Subject|2
156486|NCT00732940|498728|P1|Overall Study|Withdrawal by Subject|1
156487|NCT00732992|498798|P2|Overall Study|Withdrawal by Subject|0
156488|NCT00732992|498799|P1|Overall Study|Withdrawal by Subject|1
156489|NCT00732992|498798|P2|Overall Study|Global Deterioration of Health Status|0
156490|NCT00732992|498799|P1|Overall Study|Global Deterioration of Health Status|1
156491|NCT00732992|498798|P2|Overall Study|Objective Progression or Relapse|5
156492|NCT00732992|498799|P1|Overall Study|Objective Progression or Relapse|3
156493|NCT00732992|498798|P2|Overall Study|Adverse Event|1
156494|NCT00732992|498799|P1|Overall Study|Adverse Event|1
156495|NCT00733005|498818|P2|Overall Study|Protocol Violation|0
156496|NCT00733005|498819|P1|Overall Study|Protocol Violation|2
156497|NCT00733005|498818|P2|Overall Study|Withdrawal by Subject|1
156498|NCT00733005|498819|P1|Overall Study|Withdrawal by Subject|0
156499|NCT00733005|498818|P2|Overall Study|Treatment Failure|1
156500|NCT00733005|498819|P1|Overall Study|Treatment Failure|0
156501|NCT00733005|498818|P2|Overall Study|Adverse Event|1
156502|NCT00733005|498819|P1|Overall Study|Adverse Event|0
156503|NCT00733226|498860|P2|Overall Study|moved to another place|0
156504|NCT00733226|498861|P1|Overall Study|moved to another place|2
156505|NCT00733226|498860|P2|Overall Study|Lost to Follow-up|0
156506|NCT00733226|498861|P1|Overall Study|Lost to Follow-up|2
156507|NCT00733226|498860|P2|Overall Study|Withdrawal by Subject|0
156508|NCT00733226|498861|P1|Overall Study|Withdrawal by Subject|1
156509|NCT00733291|498884|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
156510|NCT00733291|498885|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
156511|NCT00733291|498886|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
156512|NCT00733291|498887|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
156513|NCT00733369|498996|P2|Overall Study|Protocol Violation|4
156514|NCT00733369|498997|P1|Overall Study|Protocol Violation|4
156515|NCT00733369|498996|P2|Overall Study|Adverse Event|4
156516|NCT00733369|498997|P1|Overall Study|Adverse Event|4
156517|NCT00733369|498996|P2|Overall Study|Lost to Follow-up|1
156518|NCT00733369|498997|P1|Overall Study|Lost to Follow-up|2
156519|NCT00733421|499115|P2|Overall Study|Withdrawal by Subject|1
156520|NCT00733421|499116|P1|Overall Study|Withdrawal by Subject|1
156521|NCT00733499|499140|P2|24 Months Follow-up|Death|1
156522|NCT00733499|499141|P1|24 Months Follow-up|Death|0
156523|NCT00733499|499140|P2|12 Months Follow-up|Death|1
156524|NCT00733499|499141|P1|12 Months Follow-up|Death|2
156525|NCT00733499|499140|P2|6 Months Follow-up|Adverse Event|1
156526|NCT00733499|499141|P1|6 Months Follow-up|Adverse Event|0
156527|NCT00733499|499140|P2|6 Months Follow-up|Death|2
156528|NCT00733499|499141|P1|6 Months Follow-up|Death|0
156529|NCT00733499|499140|P2|3 Months Follow-up|Death|2
156530|NCT00733499|499141|P1|3 Months Follow-up|Death|1
156531|NCT00733499|499140|P2|Pre-operative|Protocol Violation|1
156532|NCT00733499|499141|P1|Pre-operative|Protocol Violation|0
156533|NCT00733746|499152|P1|Overall Study|Ineligible|5
156534|NCT00733824|499165|P5|Phase I|Withdrawal by Subject|0
156535|NCT00733824|499166|P4|Phase I|Withdrawal by Subject|0
156536|NCT00733824|499167|P3|Phase I|Withdrawal by Subject|0
156537|NCT00733824|499168|P2|Phase I|Withdrawal by Subject|0
156538|NCT00733824|499169|P1|Phase I|Withdrawal by Subject|1
156539|NCT00733954|499190|P2|Overall Study|Withdrawal by Subject|0
156540|NCT00733954|499191|P1|Overall Study|Withdrawal by Subject|2
156541|NCT00733954|499190|P2|Overall Study|Protocol Violation|0
156542|NCT00733954|499191|P1|Overall Study|Protocol Violation|1
156543|NCT00733954|499190|P2|Overall Study|Lost to Follow-up|2
156544|NCT00733954|499191|P1|Overall Study|Lost to Follow-up|5
156545|NCT00734071|499271|P2|Overall Study|Other|2
156546|NCT00734071|499272|P1|Overall Study|Other|1
156547|NCT00734071|499271|P2|Overall Study|Lost to Follow-up|8
156548|NCT00734071|499272|P1|Overall Study|Lost to Follow-up|16
156549|NCT00734071|499271|P2|Overall Study|Voluntary Withdrawal|7
156550|NCT00734071|499272|P1|Overall Study|Voluntary Withdrawal|9
156551|NCT00734071|499271|P2|Overall Study|Protocol Deviations|4
156552|NCT00734071|499272|P1|Overall Study|Protocol Deviations|3
156553|NCT00734071|499271|P2|Overall Study|Noncompliance|2
156554|NCT00734071|499272|P1|Overall Study|Noncompliance|2
156555|NCT00734071|499271|P2|Overall Study|Lack of Efficacy|1
156556|NCT00734071|499272|P1|Overall Study|Lack of Efficacy|3
156557|NCT00734071|499271|P2|Overall Study|Adverse Event|3
156558|NCT00734071|499272|P1|Overall Study|Adverse Event|4
156559|NCT00725452|499326|P1|Overall Study|Lost to Follow-up|1
156560|NCT00725452|499326|P1|Overall Study|Withdrawal by Subject|3
156561|NCT00725452|499326|P1|Overall Study|Physician Decision|1
156562|NCT00725452|499326|P1|Overall Study|Reason not specified|1
156563|NCT00725452|499326|P1|Overall Study|Lack of Efficacy|2
156564|NCT00725452|499326|P1|Overall Study|Adverse Event|3
156565|NCT00725491|499337|P2|Overall Study|No/too few embryos/ bad quality embryos|2
156566|NCT00725491|499338|P1|Overall Study|No/too few embryos/ bad quality embryos|3
156567|NCT00725491|499337|P2|Overall Study|Fertilization failure|1
156568|NCT00725491|499338|P1|Overall Study|Fertilization failure|0
156569|NCT00725491|499337|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
156570|NCT00725491|499338|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
156571|NCT00725491|499337|P2|Overall Study|Risk for hyperstimulation|9
156572|NCT00725491|499338|P1|Overall Study|Risk for hyperstimulation|2
156573|NCT00725491|499337|P2|Overall Study|Pregnancy|3
156574|NCT00725491|499338|P1|Overall Study|Pregnancy|0
156575|NCT00725491|499337|P2|Overall Study|Adverse Event|2
156576|NCT00725491|499338|P1|Overall Study|Adverse Event|3
156577|NCT00725543|499358|P1|Overall Study|Not specified|119
156578|NCT00725543|499358|P1|Overall Study|Non-compliance|2
156579|NCT00725543|499358|P1|Overall Study|Lost to Follow-up|4
156580|NCT00725543|499358|P1|Overall Study|Physician Decision|5
156581|NCT00725543|499358|P1|Overall Study|Withdrawal by Subject|10
156582|NCT00725543|499358|P1|Overall Study|Lack of Efficacy|3
156583|NCT00725543|499358|P1|Overall Study|Adverse Event|10
156584|NCT00725608|499367|P1|Overall Study|Other|7
156585|NCT00725608|499367|P1|Overall Study|Individual reasons|86
156586|NCT00725608|499367|P1|Overall Study|Adverse Event|14
156587|NCT00725608|499367|P1|Overall Study|Lost to Follow-up|60
156588|NCT00725621|499373|P1|Overall Study|Reason not specified|55
156589|NCT00725621|499373|P1|Overall Study|Prepared for elective surgery|1
156590|NCT00725621|499373|P1|Overall Study|Switched to other drug|1
156591|NCT00725621|499373|P1|Overall Study|Switched to other study|1
156592|NCT00725621|499373|P1|Overall Study|Continued treatment by other physician|6
156593|NCT00725621|499373|P1|Overall Study|Non-compliance|8
156594|NCT00725621|499373|P1|Overall Study|Lost to Follow-up|52
156595|NCT00725621|499373|P1|Overall Study|Physician Decision|19
156596|NCT00725621|499373|P1|Overall Study|Withdrawal by Subject|57
156597|NCT00725621|499373|P1|Overall Study|Lack of Efficacy|46
156598|NCT00725621|499373|P1|Overall Study|Adverse Event|25
156599|NCT00725712|499398|P2|Overall Study|Hospitalized, unable to continue|1
156600|NCT00725712|499399|P1|Overall Study|Hospitalized, unable to continue|0
156601|NCT00725712|499398|P2|Overall Study|Other: Death|0
156602|NCT00725712|499399|P1|Overall Study|Other: Death|1
156603|NCT00725712|499398|P2|Overall Study|Death|0
156604|NCT00725712|499399|P1|Overall Study|Death|2
156605|NCT00725712|499398|P2|Overall Study|Adverse Event|5
156606|NCT00725712|499399|P1|Overall Study|Adverse Event|5
156607|NCT00725712|499398|P2|Overall Study|Clinical progression not based on RECIST|3
156608|NCT00725712|499399|P1|Overall Study|Clinical progression not based on RECIST|0
156609|NCT00725712|499398|P2|Overall Study|Progressive disease|16
156610|NCT00725712|499399|P1|Overall Study|Progressive disease|37
156611|NCT00725712|499398|P2|Overall Study|Protocol Violation|0
156612|NCT00725712|499399|P1|Overall Study|Protocol Violation|1
156613|NCT00725712|499398|P2|Overall Study|Withdrawal by Subject|1
156614|NCT00725712|499399|P1|Overall Study|Withdrawal by Subject|2
156615|NCT00725725|499438|P3|Overall Study|Protocol Violation|0
156616|NCT00725725|499439|P2|Overall Study|Protocol Violation|1
156617|NCT00725725|499440|P1|Overall Study|Protocol Violation|0
156618|NCT00725725|499438|P3|Overall Study|Withdrawal by Subject|1
156619|NCT00725725|499439|P2|Overall Study|Withdrawal by Subject|0
156620|NCT00725725|499440|P1|Overall Study|Withdrawal by Subject|1
156621|NCT00725725|499438|P3|Overall Study|Lost to Follow-up|2
156622|NCT00725725|499439|P2|Overall Study|Lost to Follow-up|0
156623|NCT00725725|499440|P1|Overall Study|Lost to Follow-up|2
156624|NCT00725725|499438|P3|Overall Study|Adverse Event|2
156625|NCT00725725|499439|P2|Overall Study|Adverse Event|3
156626|NCT00725725|499440|P1|Overall Study|Adverse Event|1
156627|NCT00725842|499493|P1|Overall Study|No Visit 1 data|1
156628|NCT00725842|499493|P1|Overall Study|Inclusion criterion not met|1
156629|NCT00725842|499493|P1|Overall Study|Consent date prior to study start date|5
156630|NCT00725842|499493|P1|Overall Study|Positive HCV-RNA at Visit 2|13
156631|NCT00725842|499493|P1|Overall Study|Death|1
156632|NCT00725842|499493|P1|Overall Study|Lost to Follow-up|19
156633|NCT00725920|499502|P2|Overall Study|Lack of Efficacy|6
156634|NCT00725920|499503|P1|Overall Study|Lack of Efficacy|3
156635|NCT00725985|499512|P12|LTFU (No Cladribine Treatment)|Unspecified|14
156636|NCT00725985|499513|P11|LTFU (No Cladribine Treatment)|Unspecified|36
156637|NCT00725985|499514|P10|LTFU (No Cladribine Treatment)|Unspecified|34
156638|NCT00725985|499515|P9|LTFU (No Cladribine Treatment)|Unspecified|0
156639|NCT00725985|499516|P8|LTFU (No Cladribine Treatment)|Unspecified|0
156640|NCT00725985|499517|P7|LTFU (No Cladribine Treatment)|Unspecified|0
156641|NCT00725985|499518|P6|LTFU (No Cladribine Treatment)|Unspecified|0
156642|NCT00725985|499519|P5|LTFU (No Cladribine Treatment)|Unspecified|0
156643|NCT00725985|499520|P4|LTFU (No Cladribine Treatment)|Unspecified|0
156644|NCT00725985|499521|P3|LTFU (No Cladribine Treatment)|Unspecified|0
156645|NCT00725985|499522|P2|LTFU (No Cladribine Treatment)|Unspecified|0
156646|NCT00725985|499523|P1|LTFU (No Cladribine Treatment)|Unspecified|0
156647|NCT00725985|499512|P12|LTFU (With Cladribine Treatment)|Unspecified|0
156648|NCT00725985|499513|P11|LTFU (With Cladribine Treatment)|Unspecified|0
156649|NCT00725985|499514|P10|LTFU (With Cladribine Treatment)|Unspecified|0
156650|NCT00725985|499515|P9|LTFU (With Cladribine Treatment)|Unspecified|16
156651|NCT00725985|499516|P8|LTFU (With Cladribine Treatment)|Unspecified|8
156652|NCT00725985|499517|P7|LTFU (With Cladribine Treatment)|Unspecified|9
156653|NCT00725985|499518|P6|LTFU (With Cladribine Treatment)|Unspecified|0
156654|NCT00725985|499519|P5|LTFU (With Cladribine Treatment)|Unspecified|0
156655|NCT00725985|499520|P4|LTFU (With Cladribine Treatment)|Unspecified|0
156656|NCT00725985|499521|P3|LTFU (With Cladribine Treatment)|Unspecified|0
156657|NCT00725985|499522|P2|LTFU (With Cladribine Treatment)|Unspecified|0
156658|NCT00725985|499523|P1|LTFU (With Cladribine Treatment)|Unspecified|0
156659|NCT00725985|499512|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156660|NCT00725985|499513|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156661|NCT00725985|499514|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156662|NCT00725985|499515|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
156663|NCT00725985|499516|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156664|NCT00725985|499517|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156665|NCT00725985|499518|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156666|NCT00725985|499519|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156667|NCT00725985|499520|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156668|NCT00725985|499521|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156669|NCT00725985|499522|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156670|NCT00725985|499523|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
156671|NCT00725985|499512|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
156672|NCT00725985|499513|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
156673|NCT00725985|499514|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
156674|NCT00725985|499515|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
156675|NCT00725985|499516|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
156676|NCT00725985|499517|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
156677|NCT00725985|499518|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
156678|NCT00725985|499519|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
156679|NCT00725985|499520|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
156680|NCT00725985|499521|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
156681|NCT00725985|499522|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
156682|NCT00725985|499523|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
156683|NCT00725985|499512|P12|OLMP|Unspecified|0
156684|NCT00725985|499513|P11|OLMP|Unspecified|0
156685|NCT00725985|499514|P10|OLMP|Unspecified|0
156686|NCT00725985|499515|P9|OLMP|Unspecified|0
156687|NCT00725985|499516|P8|OLMP|Unspecified|0
156688|NCT00725985|499517|P7|OLMP|Unspecified|0
156689|NCT00725985|499518|P6|OLMP|Unspecified|44
156690|NCT00725985|499519|P5|OLMP|Unspecified|20
156691|NCT00725985|499520|P4|OLMP|Unspecified|15
156692|NCT00725985|499521|P3|OLMP|Unspecified|0
156693|NCT00725985|499522|P2|OLMP|Unspecified|0
156694|NCT00725985|499523|P1|OLMP|Unspecified|0
156695|NCT00725985|499512|P12|OLMP|Disease progression|0
156696|NCT00725985|499513|P11|OLMP|Disease progression|0
156697|NCT00725985|499514|P10|OLMP|Disease progression|0
156698|NCT00725985|499515|P9|OLMP|Disease progression|0
156699|NCT00725985|499516|P8|OLMP|Disease progression|0
156700|NCT00725985|499517|P7|OLMP|Disease progression|0
156701|NCT00725985|499518|P6|OLMP|Disease progression|4
156702|NCT00725985|499519|P5|OLMP|Disease progression|0
156703|NCT00725985|499520|P4|OLMP|Disease progression|0
156704|NCT00725985|499521|P3|OLMP|Disease progression|0
156705|NCT00725985|499522|P2|OLMP|Disease progression|0
156706|NCT00725985|499523|P1|OLMP|Disease progression|0
156707|NCT00725985|499512|P12|OLMP|Lost to Follow-up|0
156708|NCT00725985|499513|P11|OLMP|Lost to Follow-up|0
156709|NCT00725985|499514|P10|OLMP|Lost to Follow-up|0
156710|NCT00725985|499515|P9|OLMP|Lost to Follow-up|0
156711|NCT00725985|499516|P8|OLMP|Lost to Follow-up|0
156712|NCT00725985|499517|P7|OLMP|Lost to Follow-up|0
156713|NCT00725985|499518|P6|OLMP|Lost to Follow-up|0
156714|NCT00725985|499519|P5|OLMP|Lost to Follow-up|0
156715|NCT00725985|499520|P4|OLMP|Lost to Follow-up|1
156716|NCT00725985|499521|P3|OLMP|Lost to Follow-up|0
156717|NCT00725985|499522|P2|OLMP|Lost to Follow-up|0
156718|NCT00725985|499523|P1|OLMP|Lost to Follow-up|0
156719|NCT00725985|499512|P12|OLMP|Death|0
156720|NCT00725985|499513|P11|OLMP|Death|0
156721|NCT00725985|499514|P10|OLMP|Death|0
156722|NCT00725985|499515|P9|OLMP|Death|0
156723|NCT00725985|499516|P8|OLMP|Death|0
156724|NCT00725985|499517|P7|OLMP|Death|0
156725|NCT00725985|499518|P6|OLMP|Death|0
156726|NCT00725985|499519|P5|OLMP|Death|1
156727|NCT00725985|499520|P4|OLMP|Death|0
156728|NCT00725985|499521|P3|OLMP|Death|0
156731|NCT00725985|499512|P12|OLMP|Adverse Event|0
156732|NCT00725985|499513|P11|OLMP|Adverse Event|0
156733|NCT00725985|499514|P10|OLMP|Adverse Event|0
156734|NCT00725985|499515|P9|OLMP|Adverse Event|0
156735|NCT00725985|499516|P8|OLMP|Adverse Event|0
156736|NCT00725985|499517|P7|OLMP|Adverse Event|0
156737|NCT00725985|499518|P6|OLMP|Adverse Event|5
156738|NCT00725985|499519|P5|OLMP|Adverse Event|2
156739|NCT00725985|499520|P4|OLMP|Adverse Event|2
156740|NCT00725985|499521|P3|OLMP|Adverse Event|0
156741|NCT00725985|499522|P2|OLMP|Adverse Event|0
156742|NCT00725985|499523|P1|OLMP|Adverse Event|0
156743|NCT00725985|499512|P12|ITP (Up to 96 Weeks)|Unspecified|0
156744|NCT00725985|499513|P11|ITP (Up to 96 Weeks)|Unspecified|0
156745|NCT00725985|499514|P10|ITP (Up to 96 Weeks)|Unspecified|0
156746|NCT00725985|499515|P9|ITP (Up to 96 Weeks)|Unspecified|0
156747|NCT00725985|499516|P8|ITP (Up to 96 Weeks)|Unspecified|0
156748|NCT00725985|499517|P7|ITP (Up to 96 Weeks)|Unspecified|0
156749|NCT00725985|499518|P6|ITP (Up to 96 Weeks)|Unspecified|0
156750|NCT00725985|499519|P5|ITP (Up to 96 Weeks)|Unspecified|0
156751|NCT00725985|499520|P4|ITP (Up to 96 Weeks)|Unspecified|0
156752|NCT00725985|499521|P3|ITP (Up to 96 Weeks)|Unspecified|24
156753|NCT00725985|499522|P2|ITP (Up to 96 Weeks)|Unspecified|38
156754|NCT00725985|499523|P1|ITP (Up to 96 Weeks)|Unspecified|50
156755|NCT00725985|499512|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
156756|NCT00725985|499513|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
156757|NCT00725985|499514|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
156758|NCT00725985|499515|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
156759|NCT00725985|499516|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
156760|NCT00725985|499517|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
156761|NCT00725985|499518|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
156762|NCT00725985|499519|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
156763|NCT00725985|499520|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
156764|NCT00725985|499521|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
156765|NCT00725985|499522|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
156766|NCT00725985|499523|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
156767|NCT00725985|499512|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
156768|NCT00725985|499513|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
156769|NCT00725985|499514|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
156770|NCT00725985|499515|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
156771|NCT00725985|499516|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
156772|NCT00725985|499517|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
156773|NCT00725985|499518|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
156774|NCT00725985|499519|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
156775|NCT00725985|499520|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
156776|NCT00725985|499521|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
156777|NCT00725985|499522|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
156778|NCT00725985|499523|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
156779|NCT00725985|499512|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156780|NCT00725985|499513|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156781|NCT00725985|499514|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156782|NCT00725985|499515|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156783|NCT00725985|499516|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156784|NCT00725985|499517|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156785|NCT00725985|499518|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156786|NCT00725985|499519|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156787|NCT00725985|499520|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156788|NCT00725985|499521|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
156789|NCT00725985|499522|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156790|NCT00725985|499523|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
156791|NCT00725985|499512|P12|ITP (Up to 96 Weeks)|Adverse Event|0
156792|NCT00725985|499513|P11|ITP (Up to 96 Weeks)|Adverse Event|0
156793|NCT00725985|499514|P10|ITP (Up to 96 Weeks)|Adverse Event|0
156794|NCT00725985|499515|P9|ITP (Up to 96 Weeks)|Adverse Event|0
156795|NCT00725985|499516|P8|ITP (Up to 96 Weeks)|Adverse Event|0
156796|NCT00725985|499517|P7|ITP (Up to 96 Weeks)|Adverse Event|0
156797|NCT00725985|499518|P6|ITP (Up to 96 Weeks)|Adverse Event|0
156798|NCT00725985|499519|P5|ITP (Up to 96 Weeks)|Adverse Event|0
156799|NCT00725985|499520|P4|ITP (Up to 96 Weeks)|Adverse Event|0
156800|NCT00725985|499521|P3|ITP (Up to 96 Weeks)|Adverse Event|5
156801|NCT00725985|499522|P2|ITP (Up to 96 Weeks)|Adverse Event|10
156802|NCT00725985|499523|P1|ITP (Up to 96 Weeks)|Adverse Event|20
156803|NCT00726063|499556|P2|Overall Study|Adverse Event|7
156804|NCT00726063|499557|P1|Overall Study|Adverse Event|9
156805|NCT00726232|499573|P6|Overall Study|No response|1
156806|NCT00726232|499574|P5|Overall Study|No response|3
156807|NCT00726232|499575|P4|Overall Study|No response|0
156808|NCT00726232|499576|P3|Overall Study|No response|0
156809|NCT00726232|499577|P2|Overall Study|No response|0
156810|NCT00726232|499578|P1|Overall Study|No response|1
156811|NCT00726232|499573|P6|Overall Study|Disease progression|0
156812|NCT00726232|499574|P5|Overall Study|Disease progression|0
156813|NCT00726232|499575|P4|Overall Study|Disease progression|0
156814|NCT00726232|499576|P3|Overall Study|Disease progression|0
156815|NCT00726232|499577|P2|Overall Study|Disease progression|0
156816|NCT00726232|499578|P1|Overall Study|Disease progression|1
156817|NCT00726232|499573|P6|Overall Study|Adverse Event|1
156818|NCT00726232|499574|P5|Overall Study|Adverse Event|2
156819|NCT00726232|499575|P4|Overall Study|Adverse Event|1
156820|NCT00726232|499576|P3|Overall Study|Adverse Event|0
156821|NCT00726232|499577|P2|Overall Study|Adverse Event|1
156822|NCT00726232|499578|P1|Overall Study|Adverse Event|1
156823|NCT00726232|499573|P6|Overall Study|Withdrawal by Subject|2
156824|NCT00726232|499574|P5|Overall Study|Withdrawal by Subject|0
156825|NCT00726232|499575|P4|Overall Study|Withdrawal by Subject|0
156826|NCT00726232|499576|P3|Overall Study|Withdrawal by Subject|0
156827|NCT00726232|499577|P2|Overall Study|Withdrawal by Subject|0
156828|NCT00726232|499578|P1|Overall Study|Withdrawal by Subject|2
156829|NCT00726453|499640|P2|38 mm Length Group|Death|3
156830|NCT00726453|499641|P1|38 mm Length Group|Death|0
156831|NCT00726453|499640|P2|Primary Enrollment Group|Withdrawal by Subject|0
156832|NCT00726453|499641|P1|Primary Enrollment Group|Withdrawal by Subject|13
156833|NCT00726453|499640|P2|Primary Enrollment Group|Death|0
156834|NCT00726453|499641|P1|Primary Enrollment Group|Death|18
156835|NCT00726557|499651|P1|Overall Study|Inclusion criteria not met|15
156836|NCT00726557|499651|P1|Overall Study|Treatment less than 3 months|17
156837|NCT00726557|499651|P1|Overall Study|No follow-up documentation available|55
156838|NCT00726557|499651|P1|Overall Study|No end of treatment documentation|37
156839|NCT00726557|499651|P1|Overall Study|Screening failure|4
156840|NCT00726609|499656|P1|Overall Study|Other|3
156841|NCT00726609|499656|P1|Overall Study|Missing|42
156842|NCT00726609|499656|P1|Overall Study|Not specified|16
156843|NCT00726609|499656|P1|Overall Study|Lack of Efficacy|25
156844|NCT00726609|499656|P1|Overall Study|Withdrawal by Subject|2
156845|NCT00726609|499656|P1|Overall Study|Adverse Event|10
156846|NCT00726622|499662|P2|Overall Study|Metastasis|0
156847|NCT00726622|499663|P1|Overall Study|Metastasis|2
156848|NCT00726622|499662|P2|Overall Study|Physician Decision|1
156849|NCT00726622|499663|P1|Overall Study|Physician Decision|0
156850|NCT00726622|499662|P2|Overall Study|Withdrawal by Subject|2
156851|NCT00726622|499663|P1|Overall Study|Withdrawal by Subject|16
156852|NCT00726661|499683|P2|Overall Study|Not specified|35
156853|NCT00726661|499684|P1|Overall Study|Not specified|47
156854|NCT00726661|499683|P2|Overall Study|Physician Decision|13
156855|NCT00726661|499684|P1|Overall Study|Physician Decision|25
156856|NCT00726661|499683|P2|Overall Study|Death|159
156857|NCT00726661|499684|P1|Overall Study|Death|475
156858|NCT00726661|499683|P2|Overall Study|Trial terminated by sponsor|187
156859|NCT00726661|499684|P1|Overall Study|Trial terminated by sponsor|214
156860|NCT00726661|499683|P2|Overall Study|Withdrawal by Subject|13
156861|NCT00726661|499684|P1|Overall Study|Withdrawal by Subject|17
156862|NCT00726661|499683|P2|Overall Study|Lost to Follow-up|11
156863|NCT00726661|499684|P1|Overall Study|Lost to Follow-up|36
156864|NCT00726752|499745|P1|Overall Study|Lack of Efficacy|6
156865|NCT00726882|499768|P1|Overall Study|Not Specified|10
156866|NCT00726882|499768|P1|Overall Study|Lost to Follow-up|7
156867|NCT00726882|499768|P1|Overall Study|Withdrawal by Subject|5
156868|NCT00726895|499774|P2|Washout Period of 7 Days|Withdrawal by Subject|1
156869|NCT00726895|499775|P1|Washout Period of 7 Days|Withdrawal by Subject|0
156870|NCT00726986|499788|P1|Maintenance Phase|Lack of Efficacy|2
156871|NCT00726986|499788|P1|Maintenance Phase|Adverse Event|1
156872|NCT00726986|499788|P1|Induction Phase|Secondary Disease|2
156873|NCT00726986|499788|P1|Induction Phase|Lack of Efficacy|5
156874|NCT00726986|499788|P1|Induction Phase|Death|2
156875|NCT00726986|499788|P1|Induction Phase|Withdrawal by Subject|2
156876|NCT00726986|499788|P1|Induction Phase|Adverse Event|4
156877|NCT00726999|499797|P2|Overall Study|Protocol Violation|0
156878|NCT00726999|499798|P1|Overall Study|Protocol Violation|1
156879|NCT00726999|499797|P2|Overall Study|Withdrawal by Subject|0
156880|NCT00726999|499798|P1|Overall Study|Withdrawal by Subject|2
156881|NCT00726999|499797|P2|Overall Study|Physician Decision|1
156882|NCT00726999|499798|P1|Overall Study|Physician Decision|0
156883|NCT00727025|499808|P1|Overall Study|Physician Decision|23
156884|NCT00727194|499856|P3|Treatment Period 2|Lack of Efficacy|0
156885|NCT00727194|499857|P2|Treatment Period 2|Lack of Efficacy|1
156886|NCT00727194|499858|P1|Treatment Period 2|Lack of Efficacy|0
156887|NCT00727194|499856|P3|Screening Period|History of thymoma|1
156888|NCT00727194|499857|P2|Screening Period|History of thymoma|0
156889|NCT00727194|499858|P1|Screening Period|History of thymoma|0
156890|NCT00727194|499856|P3|Screening Period|Severe infections|2
156891|NCT00727194|499857|P2|Screening Period|Severe infections|0
156892|NCT00727194|499858|P1|Screening Period|Severe infections|0
156893|NCT00727194|499856|P3|Screening Period|Not stable on concomitant MG therapy|2
156894|NCT00727194|499857|P2|Screening Period|Not stable on concomitant MG therapy|0
156895|NCT00727194|499858|P1|Screening Period|Not stable on concomitant MG therapy|0
156896|NCT00727194|499856|P3|Screening Period|Lacked AChR antibodies|5
156897|NCT00727194|499857|P2|Screening Period|Lacked AChR antibodies|0
156898|NCT00727194|499858|P1|Screening Period|Lacked AChR antibodies|0
156899|NCT00727194|499856|P3|Screening Period|Low QMG scores|6
156900|NCT00727194|499857|P2|Screening Period|Low QMG scores|0
156901|NCT00727194|499858|P1|Screening Period|Low QMG scores|0
156902|NCT00727246|499905|P4|Overall Study|withdrawn|0
156903|NCT00727246|499906|P3|Overall Study|withdrawn|1
156904|NCT00727246|499907|P2|Overall Study|withdrawn|0
156905|NCT00727246|499908|P1|Overall Study|withdrawn|0
156906|NCT00727246|499905|P4|Overall Study|incidental finding|1
156907|NCT00727246|499906|P3|Overall Study|incidental finding|0
156908|NCT00727246|499907|P2|Overall Study|incidental finding|0
156909|NCT00727246|499908|P1|Overall Study|incidental finding|0
156910|NCT00727246|499905|P4|Overall Study|could not complete MRI|1
156911|NCT00727246|499906|P3|Overall Study|could not complete MRI|0
156912|NCT00727246|499907|P2|Overall Study|could not complete MRI|1
156913|NCT00727246|499908|P1|Overall Study|could not complete MRI|0
156914|NCT00727259|499922|P1|Overall Study|Not all questionnaires completed|1055
156915|NCT00727272|499927|P3|Washout Period B|Withdrawal by Subject|1
156916|NCT00727272|499928|P2|Washout Period B|Withdrawal by Subject|0
156917|NCT00727272|499929|P1|Washout Period B|Withdrawal by Subject|0
156918|NCT00727272|499927|P3|Washout Period A|Adverse Event|1
156919|NCT00727272|499928|P2|Washout Period A|Adverse Event|0
156920|NCT00727272|499929|P1|Washout Period A|Adverse Event|0
156921|NCT00727311|499952|P1|Overall Study|Multiple reasons|39
156922|NCT00727311|499952|P1|Overall Study|not specified|97
156923|NCT00727311|499952|P1|Overall Study|Withdrawal by Subject|77
156924|NCT00727311|499952|P1|Overall Study|Lost to Follow-up|73
156925|NCT00727311|499952|P1|Overall Study|Lack of Efficacy|242
156926|NCT00727311|499952|P1|Overall Study|Adverse Event|58
156927|NCT00727311|499952|P1|Overall Study|Missing end of therapy data|205
156928|NCT00727311|499952|P1|Overall Study|Did not receive drug|316
156929|NCT00734097|499959|P1|Open Label|Protocol Violation|4
156930|NCT00734097|499959|P1|Open Label|Withdrawal by Subject|5
156931|NCT00734097|499959|P1|Open Label|Lost to Follow-up|7
156932|NCT00734097|499959|P1|Screening|Unconfirmed pregnancy|1
156933|NCT00734097|499959|P1|Screening|Lost to Follow-up|2
156934|NCT00734097|499959|P1|Screening|Withdrawal by Subject|5
156935|NCT00734097|499959|P1|Screening|Protocol Violation|12
156936|NCT00734149|499974|P1|Overall Study|Withdrawal by Subject|1
156937|NCT00734162|499985|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
156938|NCT00734162|499986|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
156939|NCT00734162|499987|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
156940|NCT00734162|499988|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
156941|NCT00734162|499985|P4|Open-Label Phase|Lost to Follow-up|1
156942|NCT00734162|499986|P3|Open-Label Phase|Lost to Follow-up|0
156943|NCT00734162|499987|P2|Open-Label Phase|Lost to Follow-up|2
156944|NCT00734162|499988|P1|Open-Label Phase|Lost to Follow-up|1
156945|NCT00734162|499985|P4|Open-Label Phase|Withdrew Consent|1
156946|NCT00734162|499986|P3|Open-Label Phase|Withdrew Consent|1
156947|NCT00734162|499987|P2|Open-Label Phase|Withdrew Consent|0
156948|NCT00734162|499988|P1|Open-Label Phase|Withdrew Consent|1
156949|NCT00734162|499985|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
156950|NCT00734162|499986|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
156951|NCT00734162|499987|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
156952|NCT00734162|499988|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
156953|NCT00734162|499985|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
156954|NCT00734162|499986|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
156955|NCT00734162|499987|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
156956|NCT00734162|499988|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
156957|NCT00734162|499985|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
156958|NCT00734162|499986|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
156959|NCT00734162|499987|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
156960|NCT00734162|499988|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
156961|NCT00734214|500214|P2|Overall Study|MD withdrawal|0
156962|NCT00734214|500215|P1|Overall Study|MD withdrawal|1
156963|NCT00734214|500214|P2|Overall Study|Withdrawal by Subject|4
156964|NCT00734214|500215|P1|Overall Study|Withdrawal by Subject|3
156965|NCT00734851|500353|P1|Overall Study|Physician Decision|18
156966|NCT00734851|500353|P1|Overall Study|Lost to Follow-up|1
156967|NCT00734851|500353|P1|Overall Study|Withdrawal by Subject|2
156968|NCT00734929|500365|P2|Overall Study|No intervention/ screen fail|3
156969|NCT00734929|500366|P1|Overall Study|No intervention/ screen fail|5
156970|NCT00734929|500365|P2|Overall Study|Lost to Follow-up|2
156971|NCT00734929|500366|P1|Overall Study|Lost to Follow-up|1
156972|NCT00734994|500407|P1|Overall Study|Withdrawal by Subject|1
156973|NCT00735007|500412|P1|Overall Study|Protocol Violation|1
156974|NCT00735007|500412|P1|Overall Study|Adverse Event|4
156975|NCT00735072|500439|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
156976|NCT00735072|500440|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
156977|NCT00735072|500439|P2|Overall Study|interrupted study med during ARV change|0
156978|NCT00735072|500440|P1|Overall Study|interrupted study med during ARV change|1
156979|NCT00735371|500456|P4|Overall Study|Exclusion criteria|0
156980|NCT00735371|500457|P3|Overall Study|Exclusion criteria|0
156981|NCT00735371|500458|P2|Overall Study|Exclusion criteria|0
156982|NCT00735371|500459|P1|Overall Study|Exclusion criteria|1
156983|NCT00735371|500456|P4|Overall Study|Prior Vyvanse Exposure|0
156984|NCT00735371|500457|P3|Overall Study|Prior Vyvanse Exposure|0
156985|NCT00735371|500458|P2|Overall Study|Prior Vyvanse Exposure|1
156986|NCT00735371|500459|P1|Overall Study|Prior Vyvanse Exposure|1
156987|NCT00735371|500456|P4|Overall Study|Protocol Violation|0
156988|NCT00735371|500457|P3|Overall Study|Protocol Violation|2
156989|NCT00735371|500458|P2|Overall Study|Protocol Violation|1
156990|NCT00735371|500459|P1|Overall Study|Protocol Violation|0
156991|NCT00735371|500456|P4|Overall Study|Sponsor Decision|1
156992|NCT00735371|500457|P3|Overall Study|Sponsor Decision|0
156993|NCT00735371|500458|P2|Overall Study|Sponsor Decision|1
156994|NCT00735371|500459|P1|Overall Study|Sponsor Decision|3
156995|NCT00735371|500456|P4|Overall Study|Lack of Efficacy|4
156996|NCT00735371|500457|P3|Overall Study|Lack of Efficacy|0
156997|NCT00735371|500458|P2|Overall Study|Lack of Efficacy|2
156998|NCT00735371|500459|P1|Overall Study|Lack of Efficacy|4
156999|NCT00735371|500456|P4|Overall Study|Lost to Follow-up|1
157000|NCT00735371|500457|P3|Overall Study|Lost to Follow-up|3
157001|NCT00735371|500458|P2|Overall Study|Lost to Follow-up|1
157002|NCT00735371|500459|P1|Overall Study|Lost to Follow-up|1
157003|NCT00735371|500456|P4|Overall Study|Withdrawal by Subject|0
157004|NCT00735371|500457|P3|Overall Study|Withdrawal by Subject|2
157005|NCT00735371|500458|P2|Overall Study|Withdrawal by Subject|2
157006|NCT00735371|500459|P1|Overall Study|Withdrawal by Subject|0
157007|NCT00735371|500456|P4|Overall Study|Protocol Violation|3
157008|NCT00735371|500457|P3|Overall Study|Protocol Violation|0
157009|NCT00735371|500458|P2|Overall Study|Protocol Violation|2
157010|NCT00735371|500459|P1|Overall Study|Protocol Violation|2
157011|NCT00735371|500456|P4|Overall Study|Adverse Event|1
157012|NCT00735371|500457|P3|Overall Study|Adverse Event|4
157013|NCT00735371|500458|P2|Overall Study|Adverse Event|3
157014|NCT00735371|500459|P1|Overall Study|Adverse Event|3
157015|NCT00735397|500477|P1|Overall Study|Administrative/Other|502
157016|NCT00735397|500477|P1|Overall Study|Inadequate therapeutic effect|202
157017|NCT00735397|500477|P1|Overall Study|Participant choice|252
157018|NCT00735397|500477|P1|Overall Study|Lost to Follow-up|33
157019|NCT00735397|500477|P1|Overall Study|Adverse Event|194
157020|NCT00735475|500531|P2|Overall Study|Withdrawal by Subject|5
157021|NCT00735475|500532|P1|Overall Study|Withdrawal by Subject|4
157022|NCT00735475|500531|P2|Overall Study|Physician Decision|1
157023|NCT00735475|500532|P1|Overall Study|Physician Decision|0
157024|NCT00735475|500531|P2|Overall Study|Lost to Follow-up|3
157025|NCT00735475|500532|P1|Overall Study|Lost to Follow-up|3
157026|NCT00735475|500531|P2|Overall Study|Death|1
157027|NCT00735475|500532|P1|Overall Study|Death|1
157028|NCT00735475|500531|P2|Overall Study|Adverse Event|1
157029|NCT00735475|500532|P1|Overall Study|Adverse Event|0
157030|NCT00735553|500553|P1|Overall Study|Study prematurely terminated|77
157031|NCT00735644|500570|P5|Overall Study|Withdrawal by Subject|0
157032|NCT00735644|500571|P4|Overall Study|Withdrawal by Subject|1
157033|NCT00735644|500572|P3|Overall Study|Withdrawal by Subject|1
157034|NCT00735644|500573|P2|Overall Study|Withdrawal by Subject|1
157035|NCT00735644|500574|P1|Overall Study|Withdrawal by Subject|0
157036|NCT00735644|500570|P5|Overall Study|Did not receive study vaccine|0
157037|NCT00735644|500571|P4|Overall Study|Did not receive study vaccine|0
157038|NCT00735644|500572|P3|Overall Study|Did not receive study vaccine|0
157039|NCT00735644|500573|P2|Overall Study|Did not receive study vaccine|1
157040|NCT00735644|500574|P1|Overall Study|Did not receive study vaccine|0
157041|NCT00735696|500622|P1|Overall Study|Enrolled but never Treated|1
157042|NCT00735696|500622|P1|Overall Study|Withdrawal by Subject|1
157043|NCT00735709|500638|P4|Overall Study|Excluded medication|1
157044|NCT00735709|500639|P3|Overall Study|Excluded medication|0
157045|NCT00735709|500640|P2|Overall Study|Excluded medication|0
157046|NCT00735709|500641|P1|Overall Study|Excluded medication|1
157047|NCT00735709|500638|P4|Overall Study|Lost to Follow-up|1
157048|NCT00735709|500639|P3|Overall Study|Lost to Follow-up|1
157049|NCT00735709|500640|P2|Overall Study|Lost to Follow-up|1
157050|NCT00735709|500641|P1|Overall Study|Lost to Follow-up|0
157051|NCT00735709|500638|P4|Overall Study|Voluntary Withdrawal|7
157052|NCT00735709|500639|P3|Overall Study|Voluntary Withdrawal|5
157053|NCT00735709|500640|P2|Overall Study|Voluntary Withdrawal|3
157054|NCT00735709|500641|P1|Overall Study|Voluntary Withdrawal|1
157055|NCT00735709|500638|P4|Overall Study|Protocol deviations|1
157056|NCT00735709|500639|P3|Overall Study|Protocol deviations|1
157057|NCT00735709|500640|P2|Overall Study|Protocol deviations|2
157058|NCT00735709|500641|P1|Overall Study|Protocol deviations|1
157059|NCT00735709|500638|P4|Overall Study|Noncompliance|0
157060|NCT00735709|500639|P3|Overall Study|Noncompliance|1
157061|NCT00735709|500640|P2|Overall Study|Noncompliance|0
157062|NCT00735709|500641|P1|Overall Study|Noncompliance|0
157063|NCT00735709|500638|P4|Overall Study|Lack of Efficacy|3
157064|NCT00735709|500639|P3|Overall Study|Lack of Efficacy|2
157065|NCT00735709|500640|P2|Overall Study|Lack of Efficacy|4
157066|NCT00735709|500641|P1|Overall Study|Lack of Efficacy|8
157067|NCT00735709|500638|P4|Overall Study|Adverse Event|5
157068|NCT00735709|500639|P3|Overall Study|Adverse Event|1
157069|NCT00735709|500640|P2|Overall Study|Adverse Event|3
157070|NCT00735709|500641|P1|Overall Study|Adverse Event|2
157071|NCT00735904|500809|P1|Overall Study|Unspecified|8
157072|NCT00735904|500809|P1|Overall Study|Study Terminated by Sponsor|5
157073|NCT00735904|500809|P1|Overall Study|Withdrawal by Subject|1
157074|NCT00735904|500809|P1|Overall Study|Protocol Violation|1
157075|NCT00735904|500809|P1|Overall Study|Death|20
157076|NCT00735904|500809|P1|Overall Study|Adverse Event|3
157077|NCT00735943|500824|P1|Overall Study|Adverse Event|1
157078|NCT00735943|500824|P1|Overall Study|Lost to Follow-up|1
157079|NCT00736034|500845|P1|Overall Study|Adverse Event|2
157080|NCT00736099|500864|P2|Overall Study|Other reason|10
157081|NCT00736099|500865|P1|Overall Study|Other reason|43
157082|NCT00736099|500864|P2|Overall Study|Lack of Efficacy|8
157083|NCT00736099|500865|P1|Overall Study|Lack of Efficacy|15
157084|NCT00736099|500864|P2|Overall Study|Withdrawal by Subject|13
157085|NCT00736099|500865|P1|Overall Study|Withdrawal by Subject|42
157086|NCT00736099|500864|P2|Overall Study|Lost to Follow-up|5
157087|NCT00736099|500865|P1|Overall Study|Lost to Follow-up|12
157088|NCT00736099|500864|P2|Overall Study|Protocol Violation|4
157089|NCT00736099|500865|P1|Overall Study|Protocol Violation|10
157090|NCT00736099|500864|P2|Overall Study|Adverse Event|18
157091|NCT00736099|500865|P1|Overall Study|Adverse Event|61
157092|NCT00736190|500972|P1|Overall Study|Adverse Event|1
157093|NCT00736190|500972|P1|Overall Study|Withdrawal by Subject|1
157094|NCT00736190|500972|P1|Overall Study|Pregnancy|1
157095|NCT00736255|501016|P2|Overall Study|Non-compliance|1
157096|NCT00736255|501017|P1|Overall Study|Non-compliance|1
157097|NCT00736255|501016|P2|Overall Study|Physician Decision|0
157098|NCT00736255|501017|P1|Overall Study|Physician Decision|1
157099|NCT00736255|501016|P2|Overall Study|Adverse Event|0
157100|NCT00736255|501017|P1|Overall Study|Adverse Event|1
157101|NCT00736333|501027|P1|Overall Study|Not Specified|4
157102|NCT00736333|501027|P1|Overall Study|Death|7
157103|NCT00736333|501027|P1|Overall Study|Withdrawal by Subject|10
157104|NCT00736333|501027|P1|Overall Study|Toxicity|6
157105|NCT00736333|501027|P1|Overall Study|Tumor Progression|75
157106|NCT00736333|501027|P1|Overall Study|Data Missing|2
157107|NCT00736333|501027|P1|Overall Study|Did Not Receive Drug or Not Documented|7
157108|NCT00736385|501038|P2|Overall Study|Adverse Event|1
157109|NCT00736385|501039|P1|Overall Study|Adverse Event|0
157110|NCT00736385|501038|P2|Overall Study|Withdrawal by Subject|2
157111|NCT00736385|501039|P1|Overall Study|Withdrawal by Subject|2
157112|NCT00736476|501053|P2|Overall Study|Adverse Event|0
157113|NCT00736476|501054|P1|Overall Study|Adverse Event|1
157114|NCT00736489|501074|P6|Period 1|Withdrawal by Subject|1
157115|NCT00736489|501075|P5|Period 1|Withdrawal by Subject|0
157116|NCT00736489|501076|P4|Period 1|Withdrawal by Subject|0
157117|NCT00736489|501077|P3|Period 1|Withdrawal by Subject|0
157118|NCT00736489|501078|P2|Period 1|Withdrawal by Subject|0
157119|NCT00736489|501079|P1|Period 1|Withdrawal by Subject|0
157120|NCT00736489|501074|P6|Period 1|Lost to Follow-up|0
157121|NCT00736489|501075|P5|Period 1|Lost to Follow-up|0
157122|NCT00736489|501076|P4|Period 1|Lost to Follow-up|0
157123|NCT00736489|501077|P3|Period 1|Lost to Follow-up|0
157124|NCT00736489|501078|P2|Period 1|Lost to Follow-up|0
157125|NCT00736489|501079|P1|Period 1|Lost to Follow-up|1
157126|NCT00736502|501231|P1|Overall Study|Lost to Follow-up|27
157127|NCT00736502|501231|P1|Overall Study|Lack of Efficacy|16
157128|NCT00736502|501231|P1|Overall Study|Adverse Event|22
157129|NCT00736723|501248|P2|Overall Study|Withdrawal by Subject|3
157130|NCT00736723|501249|P1|Overall Study|Withdrawal by Subject|4
157131|NCT00736840|501255|P1|Overall Study|Lost to Follow-up|13
157132|NCT00736853|501260|P3|Double-Blind Period|Ineligible to participate the study|0
157133|NCT00736853|501261|P2|Double-Blind Period|Ineligible to participate the study|1
157134|NCT00736853|501262|P1|Double-Blind Period|Ineligible to participate the study|0
157135|NCT00736853|501260|P3|Double-Blind Period|Withdrawal by Subject|4
157136|NCT00736853|501261|P2|Double-Blind Period|Withdrawal by Subject|1
157137|NCT00736853|501262|P1|Double-Blind Period|Withdrawal by Subject|0
157138|NCT00736853|501260|P3|Double-Blind Period|Adverse Event|2
157139|NCT00736853|501261|P2|Double-Blind Period|Adverse Event|3
157140|NCT00736853|501262|P1|Double-Blind Period|Adverse Event|0
157141|NCT00736853|501260|P3|Double-Blind Period|Lack of Efficacy|42
157142|NCT00736853|501261|P2|Double-Blind Period|Lack of Efficacy|19
157143|NCT00736853|501262|P1|Double-Blind Period|Lack of Efficacy|0
157144|NCT00736853|501260|P3|Open-Label Period|Unable to attend hospital appointments|0
157145|NCT00736853|501261|P2|Open-Label Period|Unable to attend hospital appointments|0
157146|NCT00736853|501262|P1|Open-Label Period|Unable to attend hospital appointments|1
157147|NCT00736853|501260|P3|Open-Label Period|Failed to meet the transfer criteria|0
157148|NCT00736853|501261|P2|Open-Label Period|Failed to meet the transfer criteria|0
157149|NCT00736853|501262|P1|Open-Label Period|Failed to meet the transfer criteria|40
157150|NCT00736853|501260|P3|Open-Label Period|Started but not treated|0
157151|NCT00736853|501261|P2|Open-Label Period|Started but not treated|0
157152|NCT00736853|501262|P1|Open-Label Period|Started but not treated|42
157153|NCT00736853|501260|P3|Open-Label Period|Withdrawal by Subject|0
157154|NCT00736853|501261|P2|Open-Label Period|Withdrawal by Subject|0
157155|NCT00736853|501262|P1|Open-Label Period|Withdrawal by Subject|16
157156|NCT00736853|501260|P3|Open-Label Period|Adverse Event|0
157157|NCT00736853|501261|P2|Open-Label Period|Adverse Event|0
157158|NCT00736853|501262|P1|Open-Label Period|Adverse Event|31
157159|NCT00736853|501260|P3|Open-Label Period|Physician Decision|0
157160|NCT00736853|501261|P2|Open-Label Period|Physician Decision|0
157161|NCT00736853|501262|P1|Open-Label Period|Physician Decision|2
157162|NCT00736879|501306|P4|Follow up Period - No Drug Treatment|non-specified|0
157163|NCT00736879|501307|P3|Follow up Period - No Drug Treatment|non-specified|0
157164|NCT00736879|501308|P2|Follow up Period - No Drug Treatment|non-specified|2
157165|NCT00736879|501309|P1|Follow up Period - No Drug Treatment|non-specified|1
157166|NCT00736879|501306|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
157167|NCT00736879|501307|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
157168|NCT00736879|501308|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
157169|NCT00736879|501309|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
157170|NCT00736879|501306|P4|Double Blind Treatment Period|non-specified|0
157171|NCT00736879|501307|P3|Double Blind Treatment Period|non-specified|0
157172|NCT00736879|501308|P2|Double Blind Treatment Period|non-specified|1
157173|NCT00736879|501309|P1|Double Blind Treatment Period|non-specified|0
157174|NCT00736879|501306|P4|Double Blind Treatment Period|No longer met criteria|0
157175|NCT00736879|501307|P3|Double Blind Treatment Period|No longer met criteria|0
157176|NCT00736879|501308|P2|Double Blind Treatment Period|No longer met criteria|1
157177|NCT00736879|501309|P1|Double Blind Treatment Period|No longer met criteria|0
157178|NCT00736879|501306|P4|Double Blind Treatment Period|Poor non-compliance|1
157179|NCT00736879|501307|P3|Double Blind Treatment Period|Poor non-compliance|1
157180|NCT00736879|501308|P2|Double Blind Treatment Period|Poor non-compliance|0
157181|NCT00736879|501309|P1|Double Blind Treatment Period|Poor non-compliance|0
157182|NCT00736879|501306|P4|Double Blind Treatment Period|Lost to Follow-up|1
157183|NCT00736879|501307|P3|Double Blind Treatment Period|Lost to Follow-up|2
157184|NCT00736879|501308|P2|Double Blind Treatment Period|Lost to Follow-up|0
157185|NCT00736879|501309|P1|Double Blind Treatment Period|Lost to Follow-up|0
157186|NCT00736879|501306|P4|Double Blind Treatment Period|Withdrawal by Subject|3
157187|NCT00736879|501307|P3|Double Blind Treatment Period|Withdrawal by Subject|3
157188|NCT00736879|501308|P2|Double Blind Treatment Period|Withdrawal by Subject|1
157189|NCT00736879|501309|P1|Double Blind Treatment Period|Withdrawal by Subject|2
157190|NCT00736879|501306|P4|Double Blind Treatment Period|Adverse Event|0
157191|NCT00736879|501307|P3|Double Blind Treatment Period|Adverse Event|1
157192|NCT00736879|501308|P2|Double Blind Treatment Period|Adverse Event|1
157193|NCT00736879|501309|P1|Double Blind Treatment Period|Adverse Event|0
157194|NCT00736879|501306|P4|Double Blind Treatment Period|Lack of Efficacy|0
157195|NCT00736879|501307|P3|Double Blind Treatment Period|Lack of Efficacy|0
157196|NCT00736879|501308|P2|Double Blind Treatment Period|Lack of Efficacy|0
157197|NCT00736879|501309|P1|Double Blind Treatment Period|Lack of Efficacy|1
157198|NCT00736944|501363|P1|Definitive Treatment|Physician Decision|1
157199|NCT00736944|501363|P1|Induction|Death|1
157200|NCT00736957|501390|P1|Overall Study|Physician Decision|5
157201|NCT00736957|501390|P1|Overall Study|not eligible for Treatment Period I|22
157202|NCT00736957|501390|P1|Overall Study|did not attend hospital appointments|1
157203|NCT00736957|501390|P1|Overall Study|violation of eligibility criteria|2
157204|NCT00736957|501390|P1|Overall Study|Withdrawal by Subject|49
157205|NCT00736957|501390|P1|Overall Study|Adverse Event|43
157206|NCT00736996|501403|P3|Overall Study|Lost to Follow-up|2
157207|NCT00736996|501404|P2|Overall Study|Lost to Follow-up|9
157208|NCT00736996|501405|P1|Overall Study|Lost to Follow-up|1
157209|NCT00737048|501422|P3|Overall Study|Worsening of the symptoms|3
157210|NCT00737048|501423|P2|Overall Study|Worsening of the symptoms|5
157211|NCT00737048|501424|P1|Overall Study|Worsening of the symptoms|3
157212|NCT00737048|501422|P3|Overall Study|Adverse Event|0
157213|NCT00737048|501423|P2|Overall Study|Adverse Event|1
157214|NCT00737048|501424|P1|Overall Study|Adverse Event|0
157215|NCT00737048|501422|P3|Overall Study|Physician Decision|1
157216|NCT00737048|501423|P2|Overall Study|Physician Decision|0
157217|NCT00737048|501424|P1|Overall Study|Physician Decision|0
157218|NCT00737061|501465|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
157219|NCT00737061|501465|P1|1 Year Wearing Period|Discontinued reilance|3
157220|NCT00737061|501465|P1|1 Year Wearing Period|Withdrawal by Subject|2
157221|NCT00737061|501465|P1|1 Year Wearing Period|Lost to Follow-up|11
157222|NCT00737061|501465|P1|Waiting Period|Elected surgical tubal ligation|5
157223|NCT00737061|501465|P1|Waiting Period|Alternative contraception failure|3
157224|NCT00737061|501465|P1|Waiting Period|Deemed patent following HSG|26
157225|NCT00737061|501465|P1|Waiting Period|Bilateral placement failure|34
157226|NCT00737061|501465|P1|Waiting Period|Withdrawal by Subject|1
157227|NCT00737061|501465|P1|Waiting Period|Lost to Follow-up|6
157228|NCT00737100|501482|P3|Overall Study|Reason discontinued not explained above|1
157229|NCT00737100|501483|P2|Overall Study|Reason discontinued not explained above|1
157230|NCT00737100|501484|P1|Overall Study|Reason discontinued not explained above|1
157231|NCT00737100|501482|P3|Overall Study|Withdrawal by Subject|3
157232|NCT00737100|501483|P2|Overall Study|Withdrawal by Subject|0
157233|NCT00737100|501484|P1|Overall Study|Withdrawal by Subject|0
157234|NCT00737100|501482|P3|Overall Study|Lost to Follow-up|0
157235|NCT00737100|501483|P2|Overall Study|Lost to Follow-up|1
157236|NCT00737100|501484|P1|Overall Study|Lost to Follow-up|0
157237|NCT00737100|501482|P3|Overall Study|Adverse Event|3
157238|NCT00737100|501483|P2|Overall Study|Adverse Event|5
157239|NCT00737100|501484|P1|Overall Study|Adverse Event|6
157240|NCT00730236|501562|P1|Overall Study|Non-compliance|1
157241|NCT00730236|501562|P1|Overall Study|Withdrawal by Subject|1
157242|NCT00730236|501562|P1|Overall Study|Adverse Event|4
157243|NCT00730275|501581|P4|Overall Study|Withdrawal by Subject|1
157244|NCT00730275|501582|P3|Overall Study|Withdrawal by Subject|0
157245|NCT00730275|501583|P2|Overall Study|Withdrawal by Subject|0
157246|NCT00730275|501584|P1|Overall Study|Withdrawal by Subject|0
157247|NCT00730327|501612|P2|Overall Study|Subject withdrew (reason not specified)|7
157248|NCT00730327|501613|P1|Overall Study|Subject withdrew (reason not specified)|2
157249|NCT00730327|501612|P2|Overall Study|Withdrawal by Subject|13
157250|NCT00730327|501613|P1|Overall Study|Withdrawal by Subject|3
157251|NCT00730327|501612|P2|Overall Study|Adverse Event|1
157252|NCT00730327|501613|P1|Overall Study|Adverse Event|8
157253|NCT00730327|501612|P2|Overall Study|Lost to Follow-up|16
157254|NCT00730327|501613|P1|Overall Study|Lost to Follow-up|14
157255|NCT00730639|501655|P5|Overall Study|Treatment on-going|4
157256|NCT00730639|501656|P4|Overall Study|Treatment on-going|4
157257|NCT00730639|501657|P3|Overall Study|Treatment on-going|5
157258|NCT00730639|501658|P2|Overall Study|Treatment on-going|5
157259|NCT00730639|501659|P1|Overall Study|Treatment on-going|2
157260|NCT00730639|501655|P5|Overall Study|Withdrawal by Subject|4
157261|NCT00730639|501656|P4|Overall Study|Withdrawal by Subject|3
157262|NCT00730639|501657|P3|Overall Study|Withdrawal by Subject|6
157263|NCT00730639|501658|P2|Overall Study|Withdrawal by Subject|0
157264|NCT00730639|501659|P1|Overall Study|Withdrawal by Subject|0
157265|NCT00730639|501655|P5|Overall Study|Protocol Violation|0
157266|NCT00730639|501656|P4|Overall Study|Protocol Violation|0
157267|NCT00730639|501657|P3|Overall Study|Protocol Violation|1
157268|NCT00730639|501658|P2|Overall Study|Protocol Violation|0
157269|NCT00730639|501659|P1|Overall Study|Protocol Violation|0
157270|NCT00730639|501655|P5|Overall Study|non-specified|3
157271|NCT00730639|501656|P4|Overall Study|non-specified|2
157272|NCT00730639|501657|P3|Overall Study|non-specified|4
157273|NCT00730639|501658|P2|Overall Study|non-specified|0
157274|NCT00730639|501659|P1|Overall Study|non-specified|0
157275|NCT00730639|501655|P5|Overall Study|Disease Progression|88
157276|NCT00730639|501656|P4|Overall Study|Disease Progression|32
157277|NCT00730639|501657|P3|Overall Study|Disease Progression|48
157278|NCT00730639|501658|P2|Overall Study|Disease Progression|13
157279|NCT00730639|501659|P1|Overall Study|Disease Progression|12
157280|NCT00730639|501655|P5|Overall Study|Death|2
157281|NCT00730639|501656|P4|Overall Study|Death|0
157282|NCT00730639|501657|P3|Overall Study|Death|0
157283|NCT00730639|501658|P2|Overall Study|Death|0
157284|NCT00730639|501659|P1|Overall Study|Death|0
157285|NCT00730639|501655|P5|Overall Study|Completed Maximum Cycles|6
157286|NCT00730639|501656|P4|Overall Study|Completed Maximum Cycles|3
157287|NCT00730639|501657|P3|Overall Study|Completed Maximum Cycles|11
157288|NCT00730639|501658|P2|Overall Study|Completed Maximum Cycles|0
157289|NCT00730639|501659|P1|Overall Study|Completed Maximum Cycles|0
157290|NCT00730639|501655|P5|Overall Study|Complete Response|1
157291|NCT00730639|501656|P4|Overall Study|Complete Response|2
157292|NCT00730639|501657|P3|Overall Study|Complete Response|2
157293|NCT00730639|501658|P2|Overall Study|Complete Response|0
157294|NCT00730639|501659|P1|Overall Study|Complete Response|0
157295|NCT00730639|501655|P5|Overall Study|Adverse Event|23
157296|NCT00730639|501656|P4|Overall Study|Adverse Event|8
157297|NCT00730639|501657|P3|Overall Study|Adverse Event|9
157298|NCT00730639|501658|P2|Overall Study|Adverse Event|0
157299|NCT00730639|501659|P1|Overall Study|Adverse Event|3
157300|NCT00730691|501728|P5|Overall Study|Other|2
157301|NCT00730691|501729|P4|Overall Study|Other|2
157302|NCT00730691|501730|P3|Overall Study|Other|1
157303|NCT00730691|501731|P2|Overall Study|Other|1
157304|NCT00730691|501732|P1|Overall Study|Other|1
157305|NCT00730691|501728|P5|Overall Study|Lost to Follow-up|13
157306|NCT00730691|501729|P4|Overall Study|Lost to Follow-up|15
157307|NCT00730691|501730|P3|Overall Study|Lost to Follow-up|13
157308|NCT00730691|501731|P2|Overall Study|Lost to Follow-up|8
157309|NCT00730691|501732|P1|Overall Study|Lost to Follow-up|11
157310|NCT00730691|501728|P5|Overall Study|Withdrawal of Consent|3
157311|NCT00730691|501729|P4|Overall Study|Withdrawal of Consent|6
157312|NCT00730691|501730|P3|Overall Study|Withdrawal of Consent|3
157313|NCT00730691|501731|P2|Overall Study|Withdrawal of Consent|9
157314|NCT00730691|501732|P1|Overall Study|Withdrawal of Consent|7
157315|NCT00730691|501728|P5|Overall Study|Protocol Deviations|5
157316|NCT00730691|501729|P4|Overall Study|Protocol Deviations|7
157317|NCT00730691|501730|P3|Overall Study|Protocol Deviations|3
157318|NCT00730691|501731|P2|Overall Study|Protocol Deviations|5
157319|NCT00730691|501732|P1|Overall Study|Protocol Deviations|3
157320|NCT00730691|501728|P5|Overall Study|Non-compliance with Study Drug|3
157321|NCT00730691|501729|P4|Overall Study|Non-compliance with Study Drug|3
157322|NCT00730691|501730|P3|Overall Study|Non-compliance with Study Drug|6
157323|NCT00730691|501731|P2|Overall Study|Non-compliance with Study Drug|1
157324|NCT00730691|501732|P1|Overall Study|Non-compliance with Study Drug|6
157325|NCT00730691|501728|P5|Overall Study|Lack of Efficacy|1
157326|NCT00730691|501729|P4|Overall Study|Lack of Efficacy|1
157327|NCT00730691|501730|P3|Overall Study|Lack of Efficacy|2
157328|NCT00730691|501731|P2|Overall Study|Lack of Efficacy|4
157329|NCT00730691|501732|P1|Overall Study|Lack of Efficacy|4
157330|NCT00730691|501728|P5|Overall Study|Adverse Event|23
157331|NCT00730691|501729|P4|Overall Study|Adverse Event|11
157332|NCT00730691|501730|P3|Overall Study|Adverse Event|11
157333|NCT00730691|501731|P2|Overall Study|Adverse Event|8
157334|NCT00730691|501732|P1|Overall Study|Adverse Event|4
157335|NCT00730756|501828|P2|Overall Study|Withdrew Consent|1
157336|NCT00730756|501829|P1|Overall Study|Withdrew Consent|0
157337|NCT00730756|501828|P2|Overall Study|Lost to Follow-up|1
157338|NCT00730756|501829|P1|Overall Study|Lost to Follow-up|0
157339|NCT00730756|501828|P2|Overall Study|Protocol Deviation|2
157340|NCT00730756|501829|P1|Overall Study|Protocol Deviation|1
157341|NCT00730756|501828|P2|Overall Study|Lack of Efficacy|1
157342|NCT00730756|501829|P1|Overall Study|Lack of Efficacy|1
157343|NCT00730756|501828|P2|Overall Study|Adverse Event|0
157344|NCT00730756|501829|P1|Overall Study|Adverse Event|2
157345|NCT00730847|501851|P1|Overall Study|Unspecified|24
157346|NCT00730847|501851|P1|Overall Study|Unknown completion status|21
157347|NCT00730847|501851|P1|Overall Study|Lost to Follow-up|67
157348|NCT00730847|501851|P1|Overall Study|Withdrawal by Subject|16
157349|NCT00730847|501851|P1|Overall Study|Protocol Violation|2
157350|NCT00730847|501851|P1|Overall Study|Adverse Event|1
157351|NCT00730912|501861|P3|Overall Study|Discontinued|1
157352|NCT00730912|501862|P2|Overall Study|Discontinued|0
157353|NCT00730912|501863|P1|Overall Study|Discontinued|0
157354|NCT00730925|501874|P1|Overall Study|Other|1
157355|NCT00730925|501874|P1|Overall Study|Switch to combination therapy|8
157356|NCT00730925|501874|P1|Overall Study|Withdrawal by Subject|1
157357|NCT00730925|501874|P1|Overall Study|Protocol Violation|1
157358|NCT00730925|501874|P1|Overall Study|Other Averse Event|7
157359|NCT00730925|501874|P1|Overall Study|Dose reducing Event|2
157360|NCT00730925|501874|P1|Overall Study|Progressive Disease|21
157361|NCT00731042|501888|P2|Second Intervention|Did not meet inclusion criteria|2
157362|NCT00731042|501889|P1|Second Intervention|Did not meet inclusion criteria|0
157363|NCT00731120|501978|P3|Overall Study|Other|1
157364|NCT00731120|501979|P2|Overall Study|Other|0
157365|NCT00731120|501980|P1|Overall Study|Other|4
157366|NCT00731120|501978|P3|Overall Study|Lost to Follow-up|17
157367|NCT00731120|501979|P2|Overall Study|Lost to Follow-up|15
157368|NCT00731120|501980|P1|Overall Study|Lost to Follow-up|10
157369|NCT00731120|501978|P3|Overall Study|Withdrawal of Consent|4
157370|NCT00731120|501979|P2|Overall Study|Withdrawal of Consent|8
157371|NCT00731120|501980|P1|Overall Study|Withdrawal of Consent|13
157372|NCT00731120|501978|P3|Overall Study|Protocol Deviations|1
157373|NCT00731120|501979|P2|Overall Study|Protocol Deviations|6
157374|NCT00731120|501980|P1|Overall Study|Protocol Deviations|1
157375|NCT00731120|501978|P3|Overall Study|Noncompliance with Study Drug|1
157376|NCT00731120|501979|P2|Overall Study|Noncompliance with Study Drug|3
157377|NCT00731120|501980|P1|Overall Study|Noncompliance with Study Drug|3
157378|NCT00731120|501978|P3|Overall Study|Lack of Efficacy|4
157379|NCT00731120|501979|P2|Overall Study|Lack of Efficacy|5
157380|NCT00731120|501980|P1|Overall Study|Lack of Efficacy|4
157381|NCT00731120|501978|P3|Overall Study|Adverse Event|8
157382|NCT00731120|501979|P2|Overall Study|Adverse Event|6
157383|NCT00731120|501980|P1|Overall Study|Adverse Event|7
157384|NCT00731133|502015|P1|Overall Study|Withdrawal by Subject|10
157385|NCT00731549|502047|P1|Overall Study|Lack of efficacy without AE|6
157386|NCT00731549|502047|P1|Overall Study|Lack of efficacy with AE|37
157387|NCT00731549|502047|P1|Overall Study|Adverse Event|31
157388|NCT00731549|502047|P1|Overall Study|Protocol deviation|1
157389|NCT00731549|502047|P1|Overall Study|Withdrawal by Subject|89
157390|NCT00731549|502047|P1|Overall Study|Physician Decision|16
157391|NCT00731549|502047|P1|Overall Study|Met withdrawal criteria|24
157392|NCT00731549|502047|P1|Overall Study|Lost to Follow-up|19
157393|NCT00737282|502062|P1|Overall Study|Study prematurely terminated|175
157394|NCT00737438|502075|P1|Overall Study|Patient ineligible|1
157395|NCT00737438|502075|P1|Overall Study|Withdrawal by Subject|2
157396|NCT00737464|502079|P1|Overall Study|Other reasons|4
157397|NCT00737464|502079|P1|Overall Study|Refused Treatment / Withdrew Consent|6
157398|NCT00737464|502079|P1|Overall Study|Other - Failure to Return|1
157399|NCT00737464|502079|P1|Overall Study|Death|6
157400|NCT00737464|502079|P1|Overall Study|Adverse Event|1
157401|NCT00737477|502100|P1|Overall Study|Not Specified|4
157402|NCT00737477|502100|P1|Overall Study|Renal Transplantation|10
157403|NCT00737477|502100|P1|Overall Study|Withdrawal by Subject|1
157404|NCT00737477|502100|P1|Overall Study|Treatment Refusal|1
157405|NCT00737477|502100|P1|Overall Study|Death|9
157406|NCT00737477|502100|P1|Overall Study|Adverse Event|9
157407|NCT00737529|502116|P1|Overall Study|Unspecified|2
157408|NCT00737529|502116|P1|Overall Study|Protocol Violation|1
157409|NCT00737529|502116|P1|Overall Study|Death|3
157410|NCT00737529|502116|P1|Overall Study|Withdrawal by Subject|3
157411|NCT00737529|502116|P1|Overall Study|Adverse Event|23
157412|NCT00737529|502116|P1|Overall Study|Disease Progression|80
157413|NCT00737568|502132|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
157414|NCT00737568|502133|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
157415|NCT00737568|502132|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
157416|NCT00737568|502133|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
157417|NCT00737568|502132|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
157418|NCT00737568|502133|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
157419|NCT00737568|502132|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
157420|NCT00737568|502133|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
157421|NCT00737568|502132|P2|Treatment Period Through Week 240|Protocol Violation|3
157422|NCT00737568|502133|P1|Treatment Period Through Week 240|Protocol Violation|2
157423|NCT00737568|502132|P2|Treatment Period Through Week 240|Lost to Follow-up|3
157424|NCT00737568|502133|P1|Treatment Period Through Week 240|Lost to Follow-up|3
157425|NCT00737568|502132|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
157426|NCT00737568|502133|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
157427|NCT00737568|502132|P2|Treatment Period Through Week 240|Withdrew Consent|6
157428|NCT00737568|502133|P1|Treatment Period Through Week 240|Withdrew Consent|5
157429|NCT00737568|502132|P2|Treatment Period Through Week 240|Investigator’s Discretion|5
157430|NCT00737568|502133|P1|Treatment Period Through Week 240|Investigator’s Discretion|6
157431|NCT00740714|502179|P3|Overall Study|Withdrawal by Subject|29
157432|NCT00740714|502180|P2|Overall Study|Withdrawal by Subject|19
157433|NCT00740714|502181|P1|Overall Study|Withdrawal by Subject|17
157434|NCT00740779|502264|P3|Overall Study|Lost to Follow-up|5
157435|NCT00740779|502265|P2|Overall Study|Lost to Follow-up|3
157436|NCT00740779|502266|P1|Overall Study|Lost to Follow-up|2
157437|NCT00740779|502264|P3|Overall Study|Withdrawal by Subject|2
157438|NCT00740779|502265|P2|Overall Study|Withdrawal by Subject|4
157439|NCT00740779|502266|P1|Overall Study|Withdrawal by Subject|2
157440|NCT00740779|502264|P3|Overall Study|Lack of Efficacy|2
157441|NCT00740779|502265|P2|Overall Study|Lack of Efficacy|0
157442|NCT00740779|502266|P1|Overall Study|Lack of Efficacy|0
157443|NCT00740779|502264|P3|Overall Study|Protocol Violation|1
157444|NCT00740779|502265|P2|Overall Study|Protocol Violation|1
157445|NCT00740779|502266|P1|Overall Study|Protocol Violation|1
157446|NCT00740779|502264|P3|Overall Study|Adverse Event|3
157447|NCT00740779|502265|P2|Overall Study|Adverse Event|6
157448|NCT00740779|502266|P1|Overall Study|Adverse Event|4
157449|NCT00740792|502278|P4|Overall Study|administrative|2
157450|NCT00740792|502279|P3|Overall Study|administrative|8
157451|NCT00740792|502280|P2|Overall Study|administrative|3
157452|NCT00740792|502281|P1|Overall Study|administrative|3
157453|NCT00740792|502278|P4|Overall Study|Withdrawal by Subject|0
157454|NCT00740792|502279|P3|Overall Study|Withdrawal by Subject|0
157455|NCT00740792|502280|P2|Overall Study|Withdrawal by Subject|1
157456|NCT00740792|502281|P1|Overall Study|Withdrawal by Subject|1
157457|NCT00740792|502278|P4|Overall Study|Protocol Violation|2
157458|NCT00740792|502279|P3|Overall Study|Protocol Violation|0
157459|NCT00740792|502280|P2|Overall Study|Protocol Violation|1
157460|NCT00740792|502281|P1|Overall Study|Protocol Violation|0
157461|NCT00740792|502278|P4|Overall Study|Lost to Follow-up|0
157462|NCT00740792|502279|P3|Overall Study|Lost to Follow-up|0
157463|NCT00740792|502280|P2|Overall Study|Lost to Follow-up|1
157464|NCT00740792|502281|P1|Overall Study|Lost to Follow-up|2
157465|NCT00740792|502278|P4|Overall Study|Lack of Efficacy|3
157466|NCT00740792|502279|P3|Overall Study|Lack of Efficacy|0
157467|NCT00740792|502280|P2|Overall Study|Lack of Efficacy|1
157468|NCT00740792|502281|P1|Overall Study|Lack of Efficacy|1
157469|NCT00740792|502278|P4|Overall Study|Adverse Event|3
157470|NCT00740792|502279|P3|Overall Study|Adverse Event|1
157471|NCT00740792|502280|P2|Overall Study|Adverse Event|1
157472|NCT00740792|502281|P1|Overall Study|Adverse Event|3
157473|NCT00740857|502324|P3|Overall Study|Withdrawal by Subject|0
157474|NCT00740857|502325|P2|Overall Study|Withdrawal by Subject|0
157475|NCT00740857|502326|P1|Overall Study|Withdrawal by Subject|1
157476|NCT00740870|502355|P1|Overall Study|Further testing contraindicated implant|17
157477|NCT00740870|502355|P1|Overall Study|Not Catheterized|4
157478|NCT00741013|502370|P3|Overall Study|Discovered failed screen after enrolled|0
157479|NCT00741013|502371|P2|Overall Study|Discovered failed screen after enrolled|2
157480|NCT00741013|502372|P1|Overall Study|Discovered failed screen after enrolled|0
157481|NCT00741013|502370|P3|Overall Study|Withdrawal by Subject|1
157482|NCT00741013|502371|P2|Overall Study|Withdrawal by Subject|0
157483|NCT00741013|502372|P1|Overall Study|Withdrawal by Subject|0
157484|NCT00741013|502370|P3|Overall Study|Adverse Event|0
157485|NCT00741013|502371|P2|Overall Study|Adverse Event|0
157486|NCT00741013|502372|P1|Overall Study|Adverse Event|1
157487|NCT00741039|502413|P2|Overall Study|Patient non-compliance|0
157488|NCT00741039|502414|P1|Overall Study|Patient non-compliance|2
157489|NCT00741091|502420|P1|Overall Study|Missed Visit|22
157490|NCT00741091|502420|P1|Overall Study|Withdrawal by Subject|6
157491|NCT00741091|502420|P1|Overall Study|Lost to Follow-up|16
157492|NCT00741091|502420|P1|Overall Study|Death|13
157493|NCT00741286|502471|P2|Overall Study|Primary Outcome|1
157494|NCT00741286|502472|P1|Overall Study|Primary Outcome|1
157495|NCT00741286|502471|P2|Overall Study|Protocol Violation|2
157496|NCT00741286|502472|P1|Overall Study|Protocol Violation|3
157497|NCT00741286|502471|P2|Overall Study|Adverse Event|6
157498|NCT00741286|502472|P1|Overall Study|Adverse Event|1
157499|NCT00741286|502471|P2|Overall Study|Lost to Follow-up|10
157500|NCT00741286|502472|P1|Overall Study|Lost to Follow-up|15
157501|NCT00741338|502482|P2|Overall Study|Adverse Event|1
157502|NCT00741338|502483|P1|Overall Study|Adverse Event|0
157503|NCT00741598|502523|P2|Overall Study|Withdrawal by Subject|2
157504|NCT00741598|502524|P1|Overall Study|Withdrawal by Subject|3
157505|NCT00741598|502523|P2|Overall Study|Pregnancy|0
157506|NCT00741598|502524|P1|Overall Study|Pregnancy|1
157507|NCT00741598|502523|P2|Overall Study|Physician Decision|1
157508|NCT00741598|502524|P1|Overall Study|Physician Decision|1
157509|NCT00741598|502523|P2|Overall Study|Lack of Efficacy|2
157510|NCT00741598|502524|P1|Overall Study|Lack of Efficacy|1
157511|NCT00741598|502523|P2|Overall Study|Lost to Follow-up|4
157512|NCT00741598|502524|P1|Overall Study|Lost to Follow-up|3
157513|NCT00741611|502541|P3|Overall Study|Withdrawal by Subject|2
157514|NCT00741611|502542|P2|Overall Study|Withdrawal by Subject|2
157515|NCT00741611|502543|P1|Overall Study|Withdrawal by Subject|0
157516|NCT00741611|502541|P3|Overall Study|Death|1
157517|NCT00741611|502542|P2|Overall Study|Death|0
157518|NCT00741611|502543|P1|Overall Study|Death|0
157519|NCT00741819|502560|P1|Overall Study|Disease progression|1
157520|NCT00741819|502560|P1|Overall Study|Death|1
157521|NCT00741819|502560|P1|Overall Study|Withdrawal by Subject|3
157522|NCT00741819|502560|P1|Overall Study|Adverse Event|3
157523|NCT00741936|502582|P2|Overall Study|Low compliance|0
157524|NCT00741936|502583|P1|Overall Study|Low compliance|3
157525|NCT00741936|502582|P2|Overall Study|Lack of Efficacy|2
157526|NCT00741936|502583|P1|Overall Study|Lack of Efficacy|0
157527|NCT00741936|502582|P2|Overall Study|Protocol Violation|0
157528|NCT00741936|502583|P1|Overall Study|Protocol Violation|2
157529|NCT00741936|502582|P2|Overall Study|Pregnancy|1
157530|NCT00741936|502583|P1|Overall Study|Pregnancy|0
157531|NCT00741936|502582|P2|Overall Study|Adverse Event|4
157532|NCT00741936|502583|P1|Overall Study|Adverse Event|3
157533|NCT00741936|502582|P2|Overall Study|Lost to Follow-up|1
157534|NCT00741936|502583|P1|Overall Study|Lost to Follow-up|1
157535|NCT00741988|502611|P2|Overall Study|Lack of Efficacy|0
157536|NCT00741988|502612|P1|Overall Study|Lack of Efficacy|2
157537|NCT00741988|502611|P2|Overall Study|Adverse Event|4
157538|NCT00741988|502612|P1|Overall Study|Adverse Event|2
157539|NCT00742079|502628|P2|Overall Study|Lost to Follow-up|1
157540|NCT00742079|502629|P1|Overall Study|Lost to Follow-up|0
157541|NCT00742183|502648|P2|Overall Study|Lack of Efficacy|3
157542|NCT00742183|502649|P1|Overall Study|Lack of Efficacy|0
157543|NCT00742183|502648|P2|Overall Study|Withdrawal by Subject|0
157544|NCT00742183|502649|P1|Overall Study|Withdrawal by Subject|1
157545|NCT00742183|502648|P2|Overall Study|Required skin-graft|1
157546|NCT00742183|502649|P1|Overall Study|Required skin-graft|1
157547|NCT00742183|502648|P2|Overall Study|Lost to Follow-up|4
157548|NCT00742183|502649|P1|Overall Study|Lost to Follow-up|4
157549|NCT00742183|502648|P2|Overall Study|Physician Decision|2
157550|NCT00742183|502649|P1|Overall Study|Physician Decision|0
157551|NCT00742183|502648|P2|Overall Study|Death|0
157552|NCT00742183|502649|P1|Overall Study|Death|1
157553|NCT00742183|502648|P2|Overall Study|Adverse Event|2
157554|NCT00742183|502649|P1|Overall Study|Adverse Event|2
157555|NCT00742209|502660|P5|Overall Study|Investigator Discretion|1
157556|NCT00742209|502661|P4|Overall Study|Investigator Discretion|1
157557|NCT00742209|502662|P3|Overall Study|Investigator Discretion|5
157558|NCT00742209|502663|P2|Overall Study|Investigator Discretion|0
157559|NCT00742209|502664|P1|Overall Study|Investigator Discretion|0
157560|NCT00742209|502660|P5|Overall Study|Lack of Efficacy|1
157561|NCT00742209|502661|P4|Overall Study|Lack of Efficacy|3
157562|NCT00742209|502662|P3|Overall Study|Lack of Efficacy|1
157563|NCT00742209|502663|P2|Overall Study|Lack of Efficacy|1
157564|NCT00742209|502664|P1|Overall Study|Lack of Efficacy|6
157565|NCT00742209|502660|P5|Overall Study|Lost to Follow-up|3
157566|NCT00742209|502661|P4|Overall Study|Lost to Follow-up|5
157567|NCT00742209|502662|P3|Overall Study|Lost to Follow-up|5
157568|NCT00742209|502663|P2|Overall Study|Lost to Follow-up|4
157569|NCT00742209|502664|P1|Overall Study|Lost to Follow-up|3
157570|NCT00742209|502660|P5|Overall Study|Protocol Violation|3
157571|NCT00742209|502661|P4|Overall Study|Protocol Violation|5
157572|NCT00742209|502662|P3|Overall Study|Protocol Violation|4
157573|NCT00742209|502663|P2|Overall Study|Protocol Violation|5
157574|NCT00742209|502664|P1|Overall Study|Protocol Violation|6
157575|NCT00742209|502660|P5|Overall Study|Participant Withdrew Consent|4
157576|NCT00742209|502661|P4|Overall Study|Participant Withdrew Consent|7
157577|NCT00742209|502662|P3|Overall Study|Participant Withdrew Consent|14
157578|NCT00742209|502663|P2|Overall Study|Participant Withdrew Consent|4
157579|NCT00742209|502664|P1|Overall Study|Participant Withdrew Consent|8
157580|NCT00742209|502660|P5|Overall Study|Adverse Event|13
157581|NCT00742209|502661|P4|Overall Study|Adverse Event|16
157582|NCT00742209|502662|P3|Overall Study|Adverse Event|17
157583|NCT00742209|502663|P2|Overall Study|Adverse Event|4
157584|NCT00742209|502664|P1|Overall Study|Adverse Event|11
157585|NCT00742235|502767|P2|Overall Study|Lost to Follow-up|31
157586|NCT00742235|502768|P1|Overall Study|Lost to Follow-up|0
157587|NCT00742274|502778|P2|Overall Study|Removed for medical reasons|1
157588|NCT00742274|502779|P1|Overall Study|Removed for medical reasons|1
157589|NCT00742274|502778|P2|Overall Study|Withdrawal by Subject|2
157590|NCT00742274|502779|P1|Overall Study|Withdrawal by Subject|1
157591|NCT00742274|502778|P2|Overall Study|Death|0
157592|NCT00742274|502779|P1|Overall Study|Death|1
157593|NCT00742326|502796|P2|Overall Study|Physician Decision|1
157594|NCT00742326|502797|P1|Overall Study|Physician Decision|0
157595|NCT00742391|502807|P2|Overall Study|Protocol Violation|0
157596|NCT00742391|502808|P1|Overall Study|Protocol Violation|1
157597|NCT00742391|502807|P2|Overall Study|Lost to Follow-up|0
157598|NCT00742391|502808|P1|Overall Study|Lost to Follow-up|1
157599|NCT00742391|502807|P2|Overall Study|Adverse Event|1
157600|NCT00742391|502808|P1|Overall Study|Adverse Event|2
157601|NCT00742417|502818|P2|Intensive Period|Adverse Event|0
157602|NCT00742417|502819|P1|Intensive Period|Adverse Event|2
157603|NCT00742417|502818|P2|Intensive Period|Withdrawal by Subject|1
157604|NCT00742417|502819|P1|Intensive Period|Withdrawal by Subject|1
157605|NCT00742417|502818|P2|Randomized|Physician Decision|0
157606|NCT00742417|502819|P1|Randomized|Physician Decision|1
157607|NCT00742417|502818|P2|Randomized|Withdrawal by Subject|0
157608|NCT00742417|502819|P1|Randomized|Withdrawal by Subject|1
157609|NCT00742417|502818|P2|Randomized|Withdrawal by legal representative|1
157610|NCT00742417|502819|P1|Randomized|Withdrawal by legal representative|0
157611|NCT00742508|502843|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
157612|NCT00742508|502844|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
157613|NCT00742508|502843|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
157614|NCT00742508|502844|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
157615|NCT00742508|502843|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
157616|NCT00742508|502844|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
157617|NCT00742508|502843|P2|8-Week Primary Evaluation Period|Protocol Violation|0
157618|NCT00742508|502844|P1|8-Week Primary Evaluation Period|Protocol Violation|1
157619|NCT00742508|502843|P2|8-Week Primary Evaluation Period|Adverse Event|4
157620|NCT00742508|502844|P1|8-Week Primary Evaluation Period|Adverse Event|2
157621|NCT00742625|502906|P1|Consolidation|Non protocol therapy|13
157622|NCT00742625|502906|P1|Consolidation|Refused|1
157623|NCT00742625|502906|P1|Consolidation|Death|1
157624|NCT00742625|502906|P1|Consolidation|Adverse Event|1
157625|NCT00742625|502906|P1|Consolidation|Progression|5
157626|NCT00742625|502906|P1|Remission Induction|Other, not specified|5
157627|NCT00742625|502906|P1|Remission Induction|Non protocol treatment|17
157628|NCT00742625|502906|P1|Remission Induction|Refusal|5
157629|NCT00742625|502906|P1|Remission Induction|Death|10
157630|NCT00742625|502906|P1|Remission Induction|Adverse Event|3
157631|NCT00742625|502906|P1|Remission Induction|Failed induction|8
157632|NCT00742625|502906|P1|Remission Induction|Progression|6
157633|NCT00742781|502915|P1|Overall Study|Withdrawal by Subject|3
157634|NCT00742885|502935|P2|Overall Study|Lost to Follow-up|0
157635|NCT00742885|502936|P1|Overall Study|Lost to Follow-up|1
157636|NCT00742924|502986|P4|Overall Study|Withdrawal by Subject|0
157637|NCT00742924|502987|P3|Overall Study|Withdrawal by Subject|1
157638|NCT00742924|502988|P2|Overall Study|Withdrawal by Subject|1
157639|NCT00742924|502989|P1|Overall Study|Withdrawal by Subject|0
157640|NCT00742924|502986|P4|Overall Study|Physician Decision|1
157641|NCT00742924|502987|P3|Overall Study|Physician Decision|0
157642|NCT00742924|502988|P2|Overall Study|Physician Decision|0
157643|NCT00742924|502989|P1|Overall Study|Physician Decision|0
157644|NCT00742924|502986|P4|Overall Study|Lack of Efficacy|4
157645|NCT00742924|502987|P3|Overall Study|Lack of Efficacy|2
157646|NCT00742924|502988|P2|Overall Study|Lack of Efficacy|1
157647|NCT00742924|502989|P1|Overall Study|Lack of Efficacy|5
157648|NCT00742924|502986|P4|Overall Study|Adverse Event|1
157649|NCT00742924|502987|P3|Overall Study|Adverse Event|1
157650|NCT00742924|502988|P2|Overall Study|Adverse Event|0
157651|NCT00742924|502989|P1|Overall Study|Adverse Event|0
157652|NCT00743106|503012|P2|Overall Study|Met intraoperative exclusion criterion|5
157653|NCT00743106|503013|P1|Overall Study|Met intraoperative exclusion criterion|8
157654|NCT00734474|503028|P9|Overall Study|Lack of Efficacy|6
157655|NCT00734474|503029|P8|Overall Study|Lack of Efficacy|4
157656|NCT00734474|503030|P7|Overall Study|Lack of Efficacy|0
157657|NCT00734474|503031|P6|Overall Study|Lack of Efficacy|0
157658|NCT00734474|503032|P5|Overall Study|Lack of Efficacy|0
157659|NCT00734474|503033|P4|Overall Study|Lack of Efficacy|0
157660|NCT00734474|503034|P3|Overall Study|Lack of Efficacy|4
157661|NCT00734474|503035|P2|Overall Study|Lack of Efficacy|0
157662|NCT00734474|503036|P1|Overall Study|Lack of Efficacy|0
157663|NCT00734474|503028|P9|Overall Study|Death|1
157664|NCT00734474|503029|P8|Overall Study|Death|2
157665|NCT00734474|503030|P7|Overall Study|Death|0
157666|NCT00734474|503031|P6|Overall Study|Death|0
157667|NCT00734474|503032|P5|Overall Study|Death|0
157668|NCT00734474|503033|P4|Overall Study|Death|0
157669|NCT00734474|503034|P3|Overall Study|Death|1
157670|NCT00734474|503035|P2|Overall Study|Death|0
157671|NCT00734474|503036|P1|Overall Study|Death|0
157672|NCT00734474|503028|P9|Overall Study|Sponsor Decision|0
157673|NCT00734474|503029|P8|Overall Study|Sponsor Decision|0
157674|NCT00734474|503030|P7|Overall Study|Sponsor Decision|0
157675|NCT00734474|503031|P6|Overall Study|Sponsor Decision|0
157676|NCT00734474|503032|P5|Overall Study|Sponsor Decision|2
157677|NCT00734474|503033|P4|Overall Study|Sponsor Decision|0
157678|NCT00734474|503034|P3|Overall Study|Sponsor Decision|0
157679|NCT00734474|503035|P2|Overall Study|Sponsor Decision|0
157680|NCT00734474|503036|P1|Overall Study|Sponsor Decision|0
157681|NCT00734474|503028|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
157682|NCT00734474|503029|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
157683|NCT00734474|503030|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
157684|NCT00734474|503031|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
157685|NCT00734474|503032|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
157686|NCT00734474|503033|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
157687|NCT00734474|503034|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
157688|NCT00734474|503035|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
157689|NCT00734474|503036|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
157690|NCT00734474|503028|P9|Overall Study|Protocol Violation|1
157691|NCT00734474|503029|P8|Overall Study|Protocol Violation|3
157692|NCT00734474|503030|P7|Overall Study|Protocol Violation|0
157693|NCT00734474|503031|P6|Overall Study|Protocol Violation|0
157694|NCT00734474|503032|P5|Overall Study|Protocol Violation|3
157695|NCT00734474|503033|P4|Overall Study|Protocol Violation|0
157696|NCT00734474|503034|P3|Overall Study|Protocol Violation|4
157697|NCT00734474|503035|P2|Overall Study|Protocol Violation|0
157698|NCT00734474|503036|P1|Overall Study|Protocol Violation|0
157699|NCT00734474|503028|P9|Overall Study|Adverse Event|39
157700|NCT00734474|503029|P8|Overall Study|Adverse Event|65
157701|NCT00734474|503030|P7|Overall Study|Adverse Event|1
157702|NCT00734474|503031|P6|Overall Study|Adverse Event|0
157703|NCT00734474|503032|P5|Overall Study|Adverse Event|64
157704|NCT00734474|503033|P4|Overall Study|Adverse Event|1
157705|NCT00734474|503034|P3|Overall Study|Adverse Event|63
157706|NCT00734474|503035|P2|Overall Study|Adverse Event|4
157707|NCT00734474|503036|P1|Overall Study|Adverse Event|4
157708|NCT00734474|503028|P9|Overall Study|Physician Decision|9
157709|NCT00734474|503029|P8|Overall Study|Physician Decision|9
157710|NCT00734474|503030|P7|Overall Study|Physician Decision|0
157711|NCT00734474|503031|P6|Overall Study|Physician Decision|0
157712|NCT00734474|503032|P5|Overall Study|Physician Decision|11
157713|NCT00734474|503033|P4|Overall Study|Physician Decision|1
157714|NCT00734474|503034|P3|Overall Study|Physician Decision|4
157715|NCT00734474|503035|P2|Overall Study|Physician Decision|0
157716|NCT00734474|503036|P1|Overall Study|Physician Decision|0
157717|NCT00734474|503028|P9|Overall Study|Withdrawal by Subject|21
157718|NCT00734474|503029|P8|Overall Study|Withdrawal by Subject|36
157719|NCT00734474|503030|P7|Overall Study|Withdrawal by Subject|0
157720|NCT00734474|503031|P6|Overall Study|Withdrawal by Subject|2
157721|NCT00734474|503032|P5|Overall Study|Withdrawal by Subject|24
157722|NCT00734474|503033|P4|Overall Study|Withdrawal by Subject|0
157723|NCT00734474|503034|P3|Overall Study|Withdrawal by Subject|18
157724|NCT00734474|503035|P2|Overall Study|Withdrawal by Subject|1
157725|NCT00734474|503036|P1|Overall Study|Withdrawal by Subject|2
157726|NCT00734474|503028|P9|Overall Study|Lost to Follow-up|4
157727|NCT00734474|503029|P8|Overall Study|Lost to Follow-up|9
157728|NCT00734474|503030|P7|Overall Study|Lost to Follow-up|0
157729|NCT00734474|503031|P6|Overall Study|Lost to Follow-up|1
157730|NCT00734474|503032|P5|Overall Study|Lost to Follow-up|11
157731|NCT00734474|503033|P4|Overall Study|Lost to Follow-up|0
157732|NCT00734474|503034|P3|Overall Study|Lost to Follow-up|13
157733|NCT00734474|503035|P2|Overall Study|Lost to Follow-up|0
157734|NCT00734474|503036|P1|Overall Study|Lost to Follow-up|1
157735|NCT00734474|503028|P9|Overall Study|Entry Criteria Not Met|1
157736|NCT00734474|503029|P8|Overall Study|Entry Criteria Not Met|1
157737|NCT00734474|503030|P7|Overall Study|Entry Criteria Not Met|0
157738|NCT00734474|503031|P6|Overall Study|Entry Criteria Not Met|1
157739|NCT00734474|503032|P5|Overall Study|Entry Criteria Not Met|3
157740|NCT00734474|503033|P4|Overall Study|Entry Criteria Not Met|0
157741|NCT00734474|503034|P3|Overall Study|Entry Criteria Not Met|5
157742|NCT00734474|503035|P2|Overall Study|Entry Criteria Not Met|0
157743|NCT00734474|503036|P1|Overall Study|Entry Criteria Not Met|0
157744|NCT00734539|503210|P2|Main Study|Enrolled in error; ineligible|0
157745|NCT00734539|503211|P1|Main Study|Enrolled in error; ineligible|1
157746|NCT00734539|503210|P2|Main Study|Withdrawal by Subject|3
157747|NCT00734539|503211|P1|Main Study|Withdrawal by Subject|1
157748|NCT00734539|503210|P2|Main Study|Physician Decision|0
157749|NCT00734539|503211|P1|Main Study|Physician Decision|2
157750|NCT00734539|503210|P2|Main Study|Death|32
157751|NCT00734539|503211|P1|Main Study|Death|33
157752|NCT00734578|503242|P3|Overall Study|Exclusion criteria|0
157753|NCT00734578|503243|P2|Overall Study|Exclusion criteria|0
157754|NCT00734578|503244|P1|Overall Study|Exclusion criteria|1
157755|NCT00734578|503242|P3|Overall Study|Randomized in error|0
157756|NCT00734578|503243|P2|Overall Study|Randomized in error|0
157757|NCT00734578|503244|P1|Overall Study|Randomized in error|1
157758|NCT00734578|503242|P3|Overall Study|Lack of Efficacy|5
157759|NCT00734578|503243|P2|Overall Study|Lack of Efficacy|2
157760|NCT00734578|503244|P1|Overall Study|Lack of Efficacy|3
157761|NCT00734578|503242|P3|Overall Study|Lost to Follow-up|5
157762|NCT00734578|503243|P2|Overall Study|Lost to Follow-up|3
157763|NCT00734578|503244|P1|Overall Study|Lost to Follow-up|9
157764|NCT00734578|503242|P3|Overall Study|Withdrawal by Subject|11
157765|NCT00734578|503243|P2|Overall Study|Withdrawal by Subject|8
157766|NCT00734578|503244|P1|Overall Study|Withdrawal by Subject|7
157767|NCT00734578|503242|P3|Overall Study|Protocol Violation|3
157768|NCT00734578|503243|P2|Overall Study|Protocol Violation|6
157769|NCT00734578|503244|P1|Overall Study|Protocol Violation|8
157770|NCT00734578|503242|P3|Overall Study|Adverse Event|1
157771|NCT00734578|503243|P2|Overall Study|Adverse Event|6
157772|NCT00734578|503244|P1|Overall Study|Adverse Event|4
157773|NCT00734591|503278|P2|Prospective Period|Unspecified|2
157774|NCT00734591|503279|P1|Prospective Period|Unspecified|2
157775|NCT00734591|503278|P2|Prospective Period|Study Terminated|0
157776|NCT00734591|503279|P1|Prospective Period|Study Terminated|1
157777|NCT00734591|503278|P2|Prospective Period|Lost to Follow-up|33
157778|NCT00734591|503279|P1|Prospective Period|Lost to Follow-up|37
157779|NCT00734591|503278|P2|Prospective Period|Withdrawal by Subject|9
157780|NCT00734591|503279|P1|Prospective Period|Withdrawal by Subject|11
157781|NCT00734591|503278|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
157782|NCT00734591|503279|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
157783|NCT00734591|503278|P2|Screening for Prospective Period|Site did not participate|1488
157784|NCT00734591|503279|P1|Screening for Prospective Period|Site did not participate|1604
157785|NCT00734604|503297|P6|Overall Study|Lack of Efficacy|0
157786|NCT00734604|503298|P5|Overall Study|Lack of Efficacy|0
157787|NCT00734604|503299|P4|Overall Study|Lack of Efficacy|0
157788|NCT00734604|503300|P3|Overall Study|Lack of Efficacy|1
157789|NCT00734604|503301|P2|Overall Study|Lack of Efficacy|1
157790|NCT00734604|503302|P1|Overall Study|Lack of Efficacy|0
157791|NCT00734604|503297|P6|Overall Study|Withdrawal by Subject|1
157792|NCT00734604|503298|P5|Overall Study|Withdrawal by Subject|2
157793|NCT00734604|503299|P4|Overall Study|Withdrawal by Subject|1
157794|NCT00734604|503300|P3|Overall Study|Withdrawal by Subject|0
157795|NCT00734604|503301|P2|Overall Study|Withdrawal by Subject|2
157796|NCT00734604|503302|P1|Overall Study|Withdrawal by Subject|0
157797|NCT00734604|503297|P6|Overall Study|Sponsor Decision|0
157798|NCT00734604|503298|P5|Overall Study|Sponsor Decision|2
157799|NCT00734604|503299|P4|Overall Study|Sponsor Decision|0
157800|NCT00734604|503300|P3|Overall Study|Sponsor Decision|1
157801|NCT00734604|503301|P2|Overall Study|Sponsor Decision|2
157802|NCT00734604|503302|P1|Overall Study|Sponsor Decision|1
157803|NCT00734604|503297|P6|Overall Study|Protocol Violation|0
157804|NCT00734604|503298|P5|Overall Study|Protocol Violation|1
157805|NCT00734604|503299|P4|Overall Study|Protocol Violation|0
157806|NCT00734604|503300|P3|Overall Study|Protocol Violation|0
157807|NCT00734604|503301|P2|Overall Study|Protocol Violation|2
157808|NCT00734604|503302|P1|Overall Study|Protocol Violation|0
157809|NCT00734604|503297|P6|Overall Study|Physician Decision|0
157810|NCT00734604|503298|P5|Overall Study|Physician Decision|0
157811|NCT00734604|503299|P4|Overall Study|Physician Decision|0
157812|NCT00734604|503300|P3|Overall Study|Physician Decision|1
157813|NCT00734604|503301|P2|Overall Study|Physician Decision|1
157814|NCT00734604|503302|P1|Overall Study|Physician Decision|0
157815|NCT00734604|503297|P6|Overall Study|Lost to Follow-up|3
157816|NCT00734604|503298|P5|Overall Study|Lost to Follow-up|2
157817|NCT00734604|503299|P4|Overall Study|Lost to Follow-up|4
157818|NCT00734604|503300|P3|Overall Study|Lost to Follow-up|2
157819|NCT00734604|503301|P2|Overall Study|Lost to Follow-up|2
157820|NCT00734604|503302|P1|Overall Study|Lost to Follow-up|1
157821|NCT00734604|503297|P6|Overall Study|Serious Adverse Event|1
157822|NCT00734604|503298|P5|Overall Study|Serious Adverse Event|0
157823|NCT00734604|503299|P4|Overall Study|Serious Adverse Event|2
157824|NCT00734604|503300|P3|Overall Study|Serious Adverse Event|1
157825|NCT00734604|503301|P2|Overall Study|Serious Adverse Event|0
157826|NCT00734604|503302|P1|Overall Study|Serious Adverse Event|1
157827|NCT00734604|503297|P6|Overall Study|Adverse Event|1
157828|NCT00734604|503298|P5|Overall Study|Adverse Event|1
157829|NCT00734604|503299|P4|Overall Study|Adverse Event|2
157830|NCT00734604|503300|P3|Overall Study|Adverse Event|0
157831|NCT00734604|503301|P2|Overall Study|Adverse Event|2
157832|NCT00734604|503302|P1|Overall Study|Adverse Event|0
157833|NCT00734617|503352|P2|Overall Study|Withdrawal by Subject|95
157834|NCT00734617|503353|P1|Overall Study|Withdrawal by Subject|103
157835|NCT00734617|503352|P2|Overall Study|Adverse Event|7
157836|NCT00734617|503353|P1|Overall Study|Adverse Event|4
157837|NCT00734630|503361|P2|Overall Study|Poor Compliance|1
157838|NCT00734630|503362|P1|Overall Study|Poor Compliance|1
157839|NCT00734630|503361|P2|Overall Study|Tested Positive for Illegal Drug Use|1
157840|NCT00734630|503362|P1|Overall Study|Tested Positive for Illegal Drug Use|1
157841|NCT00734630|503361|P2|Overall Study|Randomized in Error|1
157842|NCT00734630|503362|P1|Overall Study|Randomized in Error|0
157843|NCT00734630|503361|P2|Overall Study|Adverse Event|6
157844|NCT00734630|503362|P1|Overall Study|Adverse Event|3
157845|NCT00734630|503361|P2|Overall Study|Inclusion/Exclusion criteria not met|1
157846|NCT00734630|503362|P1|Overall Study|Inclusion/Exclusion criteria not met|0
157847|NCT00734630|503361|P2|Overall Study|Protocol Violation|3
157848|NCT00734630|503362|P1|Overall Study|Protocol Violation|0
157849|NCT00734630|503361|P2|Overall Study|Lost to Follow-up|7
157850|NCT00734630|503362|P1|Overall Study|Lost to Follow-up|13
157851|NCT00734630|503361|P2|Overall Study|Withdrawal by Subject|9
157852|NCT00734630|503362|P1|Overall Study|Withdrawal by Subject|7
157853|NCT00734630|503361|P2|Overall Study|Lack of Efficacy|4
157854|NCT00734630|503362|P1|Overall Study|Lack of Efficacy|4
157855|NCT00734656|503370|P4|Lab Session 4|Withdrawal by Subject|1
157856|NCT00734656|503371|P3|Lab Session 4|Withdrawal by Subject|0
157857|NCT00734656|503372|P2|Lab Session 4|Withdrawal by Subject|0
157858|NCT00734656|503373|P1|Lab Session 4|Withdrawal by Subject|0
157859|NCT00734656|503370|P4|Washout 3|Withdrawal by Subject|1
157860|NCT00734656|503371|P3|Washout 3|Withdrawal by Subject|0
157861|NCT00734656|503372|P2|Washout 3|Withdrawal by Subject|0
157862|NCT00734656|503373|P1|Washout 3|Withdrawal by Subject|1
157863|NCT00734656|503370|P4|Washout 2|Withdrawal by Subject|0
157864|NCT00734656|503371|P3|Washout 2|Withdrawal by Subject|1
157865|NCT00734656|503372|P2|Washout 2|Withdrawal by Subject|1
157866|NCT00734656|503373|P1|Washout 2|Withdrawal by Subject|1
157867|NCT00734656|503370|P4|Lab Session 2|Withdrawal by Subject|1
157868|NCT00734656|503371|P3|Lab Session 2|Withdrawal by Subject|0
157869|NCT00734656|503372|P2|Lab Session 2|Withdrawal by Subject|0
157870|NCT00734656|503373|P1|Lab Session 2|Withdrawal by Subject|1
157871|NCT00734656|503370|P4|Washout 1|Withdrawal by Subject|3
157872|NCT00734656|503371|P3|Washout 1|Withdrawal by Subject|2
157873|NCT00734656|503372|P2|Washout 1|Withdrawal by Subject|5
157874|NCT00734656|503373|P1|Washout 1|Withdrawal by Subject|1
157875|NCT00734656|503370|P4|Lab Session 1|Withdrawal by Subject|0
157876|NCT00734656|503371|P3|Lab Session 1|Withdrawal by Subject|0
157877|NCT00734656|503372|P2|Lab Session 1|Withdrawal by Subject|0
157878|NCT00734656|503373|P1|Lab Session 1|Withdrawal by Subject|2
157879|NCT00734747|503402|P1|6 Month Follow-up|Did not meet inclusion criteria|3
157880|NCT00734747|503402|P1|SRS Procedure|No staples placed|3
157881|NCT00743197|503411|P2|Overall Study|Study terminated due to departure of PI.|2
157882|NCT00743197|503412|P1|Overall Study|Study terminated due to departure of PI.|1
157883|NCT00743249|503420|P2|Overall Study|Unsuccessful insertion of stent|1
157884|NCT00743249|503421|P1|Overall Study|Unsuccessful insertion of stent|2
157885|NCT00743249|503420|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
157886|NCT00743249|503421|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
157887|NCT00743249|503420|P2|Overall Study|Adverse Event|4
157888|NCT00743249|503421|P1|Overall Study|Adverse Event|0
157889|NCT00743275|503437|P2|Overall Study|Protocol Violation|1
157890|NCT00743275|503438|P1|Overall Study|Protocol Violation|0
157891|NCT00743288|503450|P7|Overall Study|Worsening of condition (Not PD)|0
157892|NCT00743288|503451|P6|Overall Study|Worsening of condition (Not PD)|0
157893|NCT00743288|503452|P5|Overall Study|Worsening of condition (Not PD)|0
157894|NCT00743288|503453|P4|Overall Study|Worsening of condition (Not PD)|1
157895|NCT00743288|503454|P3|Overall Study|Worsening of condition (Not PD)|1
157896|NCT00743288|503455|P2|Overall Study|Worsening of condition (Not PD)|2
157897|NCT00743288|503456|P1|Overall Study|Worsening of condition (Not PD)|0
157898|NCT00743288|503450|P7|Overall Study|Progressive disease (PD)|6
157899|NCT00743288|503451|P6|Overall Study|Progressive disease (PD)|3
157900|NCT00743288|503452|P5|Overall Study|Progressive disease (PD)|5
157901|NCT00743288|503453|P4|Overall Study|Progressive disease (PD)|4
157902|NCT00743288|503454|P3|Overall Study|Progressive disease (PD)|1
157903|NCT00743288|503455|P2|Overall Study|Progressive disease (PD)|0
157904|NCT00743288|503456|P1|Overall Study|Progressive disease (PD)|2
157905|NCT00743288|503450|P7|Overall Study|Withdrawal by Subject|1
157906|NCT00743288|503451|P6|Overall Study|Withdrawal by Subject|1
157907|NCT00743288|503452|P5|Overall Study|Withdrawal by Subject|0
157908|NCT00743288|503453|P4|Overall Study|Withdrawal by Subject|0
157909|NCT00743288|503454|P3|Overall Study|Withdrawal by Subject|1
157910|NCT00743288|503455|P2|Overall Study|Withdrawal by Subject|0
157911|NCT00743288|503456|P1|Overall Study|Withdrawal by Subject|0
157912|NCT00743288|503450|P7|Overall Study|Adverse Event|2
157913|NCT00743288|503451|P6|Overall Study|Adverse Event|1
157914|NCT00743288|503452|P5|Overall Study|Adverse Event|1
157915|NCT00743288|503453|P4|Overall Study|Adverse Event|2
157916|NCT00743288|503454|P3|Overall Study|Adverse Event|2
157917|NCT00743288|503455|P2|Overall Study|Adverse Event|1
157918|NCT00743288|503456|P1|Overall Study|Adverse Event|1
157919|NCT00743366|503468|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
157920|NCT00743366|503469|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
157921|NCT00743431|503475|P1|Overall Study|No documentation available|13
157922|NCT00743431|503475|P1|Overall Study|Reason for discontinuation not specified|29
157923|NCT00743431|503475|P1|Overall Study|Death|9
157924|NCT00743431|503475|P1|Overall Study|Withdrawal by Subject|13
157925|NCT00743431|503475|P1|Overall Study|Tumor progression|56
157926|NCT00743431|503475|P1|Overall Study|Toxicity|6
157927|NCT00743444|503479|P2|Washout Period|Adverse Event|1
157928|NCT00743444|503480|P1|Washout Period|Adverse Event|0
157929|NCT00743444|503479|P2|First Intervention|Catheter placement problems|1
157930|NCT00743444|503480|P1|First Intervention|Catheter placement problems|0
157931|NCT00745368|503489|P1|Overall Study|Unable to provide sample|3
157932|NCT00745498|503503|P3|Overall Study|Edophthalmitis after preoperative IVB|0
157933|NCT00745498|503504|P2|Overall Study|Edophthalmitis after preoperative IVB|0
157934|NCT00745498|503505|P1|Overall Study|Edophthalmitis after preoperative IVB|1
157935|NCT00745498|503503|P3|Overall Study|Non-PDR related VH|1
157936|NCT00745498|503504|P2|Overall Study|Non-PDR related VH|1
157937|NCT00745498|503505|P1|Overall Study|Non-PDR related VH|0
157938|NCT00745498|503503|P3|Overall Study|Injection of intravitreal silicone oil o|4
157939|NCT00745498|503504|P2|Overall Study|Injection of intravitreal silicone oil o|4
157940|NCT00745498|503505|P1|Overall Study|Injection of intravitreal silicone oil o|3
157941|NCT00745498|503503|P3|Overall Study|Lost to Follow-up|3
157942|NCT00745498|503504|P2|Overall Study|Lost to Follow-up|1
157943|NCT00745498|503505|P1|Overall Study|Lost to Follow-up|1
157944|NCT00745823|503521|P2|Overall Study|Study Terminated by Sponsor|349
157945|NCT00745823|503522|P1|Overall Study|Study Terminated by Sponsor|326
157946|NCT00745823|503521|P2|Overall Study|Withdrawal by Subject|8
157947|NCT00745823|503522|P1|Overall Study|Withdrawal by Subject|14
157948|NCT00745823|503521|P2|Overall Study|Pregnancy|4
157949|NCT00745823|503522|P1|Overall Study|Pregnancy|0
157950|NCT00745823|503521|P2|Overall Study|Physician Decision|5
157951|NCT00745823|503522|P1|Overall Study|Physician Decision|10
157952|NCT00745823|503521|P2|Overall Study|Lost to Follow-up|11
157953|NCT00745823|503522|P1|Overall Study|Lost to Follow-up|10
157954|NCT00745823|503521|P2|Overall Study|Lack of Efficacy|6
157955|NCT00745823|503522|P1|Overall Study|Lack of Efficacy|20
157956|NCT00745823|503521|P2|Overall Study|Adverse Event|3
157957|NCT00745823|503522|P1|Overall Study|Adverse Event|5
157958|NCT00745875|503548|P2|Overall Study|Continuing study treatment|4
157959|NCT00745875|503549|P1|Overall Study|Continuing study treatment|4
157960|NCT00745901|503559|P2|Overall Study|Patient didn't take any study medication|3
157961|NCT00745901|503560|P1|Overall Study|Patient didn't take any study medication|7
157962|NCT00745901|503559|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
157963|NCT00745901|503560|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
157964|NCT00745901|503559|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
157965|NCT00745901|503560|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
157966|NCT00745901|503559|P2|Overall Study|Patient's next menses did not start with|0
157967|NCT00745901|503560|P1|Overall Study|Patient's next menses did not start with|1
157968|NCT00745901|503559|P2|Overall Study|Lack of compliance|2
157969|NCT00745901|503560|P1|Overall Study|Lack of compliance|2
157970|NCT00745901|503559|P2|Overall Study|Pregnancy|4
157971|NCT00745901|503560|P1|Overall Study|Pregnancy|2
157972|NCT00745901|503559|P2|Overall Study|Lost to Follow-up|4
157973|NCT00745901|503560|P1|Overall Study|Lost to Follow-up|7
157974|NCT00745901|503559|P2|Overall Study|Withdrawal by Subject|0
157975|NCT00745901|503560|P1|Overall Study|Withdrawal by Subject|1
157976|NCT00745901|503559|P2|Overall Study|Protocol Violation|1
157977|NCT00745901|503560|P1|Overall Study|Protocol Violation|0
157978|NCT00745901|503559|P2|Overall Study|Adverse Event|4
157979|NCT00745901|503560|P1|Overall Study|Adverse Event|3
157980|NCT00746096|503623|P2|Overall Study|No study drug treatment|1
157981|NCT00746096|503624|P1|Overall Study|No study drug treatment|1
157982|NCT00746096|503623|P2|Overall Study|Protocol Violation|0
157983|NCT00746096|503624|P1|Overall Study|Protocol Violation|1
157984|NCT00746096|503623|P2|Overall Study|Lost to Follow-up|1
157985|NCT00746096|503624|P1|Overall Study|Lost to Follow-up|2
157986|NCT00746096|503623|P2|Overall Study|Withdrawal by Subject|1
157987|NCT00746096|503624|P1|Overall Study|Withdrawal by Subject|5
157988|NCT00746096|503623|P2|Overall Study|Adverse Event|0
157989|NCT00746096|503624|P1|Overall Study|Adverse Event|1
157990|NCT00746330|503649|P4|Period 1|Abnormal test procedure result|0
157991|NCT00746330|503650|P3|Period 1|Abnormal test procedure result|1
157992|NCT00746330|503651|P2|Period 1|Abnormal test procedure result|0
157993|NCT00746330|503652|P1|Period 1|Abnormal test procedure result|0
157994|NCT00746356|503680|P2|Overall Study|Patient relocated|0
157995|NCT00746356|503681|P1|Overall Study|Patient relocated|1
157996|NCT00746356|503680|P2|Overall Study|Removal of Device|1
157997|NCT00746356|503681|P1|Overall Study|Removal of Device|0
157998|NCT00746356|503680|P2|Overall Study|Lost to Follow-up|0
157999|NCT00746356|503681|P1|Overall Study|Lost to Follow-up|1
158000|NCT00746356|503680|P2|Overall Study|Death|3
158001|NCT00746356|503681|P1|Overall Study|Death|7
158002|NCT00746356|503680|P2|Overall Study|Withdrawal by Subject|3
158003|NCT00746356|503681|P1|Overall Study|Withdrawal by Subject|2
158004|NCT00746551|503734|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
158005|NCT00746551|503735|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
158006|NCT00746551|503734|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
158007|NCT00746551|503735|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
158008|NCT00746551|503734|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
158009|NCT00746551|503735|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
158010|NCT00746564|503743|P1|Overall Study|Required Pacemaker/ICD Implant|2
158011|NCT00746590|503756|P1|Overall Study|Death|1
158012|NCT00746733|503784|P2|Third Intervention|Withdrawal by Subject|1
158013|NCT00746733|503785|P1|Third Intervention|Withdrawal by Subject|1
158014|NCT00746733|503784|P2|Second Intervention|Adverse Event|0
158015|NCT00746733|503785|P1|Second Intervention|Adverse Event|1
158016|NCT00746785|503848|P3|Overall Study|Lost to Follow-up|27
158017|NCT00746785|503849|P2|Overall Study|Lost to Follow-up|25
158018|NCT00746785|503850|P1|Overall Study|Lost to Follow-up|29
158019|NCT00746798|503862|P4|Overall Study|Participant unable to return for visit|0
158020|NCT00746798|503863|P3|Overall Study|Participant unable to return for visit|0
158021|NCT00746798|503864|P2|Overall Study|Participant unable to return for visit|0
158022|NCT00746798|503865|P1|Overall Study|Participant unable to return for visit|1
158023|NCT00746798|503862|P4|Overall Study|Death|0
158024|NCT00746798|503863|P3|Overall Study|Death|2
158025|NCT00746798|503864|P2|Overall Study|Death|0
158026|NCT00746798|503865|P1|Overall Study|Death|0
158027|NCT00746798|503862|P4|Overall Study|Withdrawal by Subject|0
158028|NCT00746798|503863|P3|Overall Study|Withdrawal by Subject|1
158029|NCT00746798|503864|P2|Overall Study|Withdrawal by Subject|1
158030|NCT00746798|503865|P1|Overall Study|Withdrawal by Subject|0
158031|NCT00746798|503862|P4|Overall Study|Protocol Violation|0
158032|NCT00746798|503863|P3|Overall Study|Protocol Violation|0
158033|NCT00746798|503864|P2|Overall Study|Protocol Violation|1
158034|NCT00746798|503865|P1|Overall Study|Protocol Violation|0
158035|NCT00746941|503919|P4|Overall Study|Adverse Event|1
158036|NCT00746941|503920|P3|Overall Study|Adverse Event|0
158037|NCT00746941|503921|P2|Overall Study|Adverse Event|0
158038|NCT00746941|503922|P1|Overall Study|Adverse Event|0
158039|NCT00746941|503919|P4|Overall Study|Other, reason not provided|4
158040|NCT00746941|503920|P3|Overall Study|Other, reason not provided|0
158041|NCT00746941|503921|P2|Overall Study|Other, reason not provided|4
158042|NCT00746941|503922|P1|Overall Study|Other, reason not provided|2
158043|NCT00746941|503919|P4|Overall Study|Withdrawal by Subject|2
158044|NCT00746941|503920|P3|Overall Study|Withdrawal by Subject|0
158045|NCT00746941|503921|P2|Overall Study|Withdrawal by Subject|0
158046|NCT00746941|503922|P1|Overall Study|Withdrawal by Subject|3
158047|NCT00746941|503919|P4|Overall Study|Physician Decision|0
158048|NCT00746941|503920|P3|Overall Study|Physician Decision|2
158049|NCT00746941|503921|P2|Overall Study|Physician Decision|0
158050|NCT00746941|503922|P1|Overall Study|Physician Decision|0
158051|NCT00746941|503919|P4|Overall Study|Death|6
158052|NCT00746941|503920|P3|Overall Study|Death|0
158053|NCT00746941|503921|P2|Overall Study|Death|0
158054|NCT00746941|503922|P1|Overall Study|Death|2
158055|NCT00747006|503959|P3|Overall Study|Physician Decision|1
158056|NCT00747006|503960|P2|Overall Study|Physician Decision|0
158057|NCT00747006|503961|P1|Overall Study|Physician Decision|2
158058|NCT00747006|503959|P3|Overall Study|Lost to Follow-up|0
158059|NCT00747006|503960|P2|Overall Study|Lost to Follow-up|1
158060|NCT00747006|503961|P1|Overall Study|Lost to Follow-up|0
158061|NCT00747006|503959|P3|Overall Study|Adverse Event|0
158062|NCT00747006|503960|P2|Overall Study|Adverse Event|0
158063|NCT00747006|503961|P1|Overall Study|Adverse Event|1
158064|NCT00747149|504029|P2|Overall Study|Not reported|4
158065|NCT00747149|504030|P1|Overall Study|Not reported|1
158066|NCT00747149|504029|P2|Overall Study|Severe non-compliance to protocol|1
158067|NCT00747149|504030|P1|Overall Study|Severe non-compliance to protocol|0
158068|NCT00747149|504029|P2|Overall Study|Incorrect enrollment|6
158069|NCT00747149|504030|P1|Overall Study|Incorrect enrollment|0
158070|NCT00747149|504029|P2|Overall Study|Did not receive treatment|1
158071|NCT00747149|504030|P1|Overall Study|Did not receive treatment|0
158072|NCT00747149|504029|P2|Overall Study|Withdrawal by Subject|6
158073|NCT00747149|504030|P1|Overall Study|Withdrawal by Subject|0
158074|NCT00747149|504029|P2|Overall Study|Lost to Follow-up|10
158075|NCT00747149|504030|P1|Overall Study|Lost to Follow-up|0
158076|NCT00747149|504029|P2|Overall Study|Adverse Event|15
158077|NCT00747149|504030|P1|Overall Study|Adverse Event|0
158078|NCT00747227|504059|P2|Overall Study|Illness|1
158079|NCT00747227|504060|P1|Overall Study|Illness|1
158080|NCT00747227|504059|P2|Overall Study|Lost to Follow-up|2
158081|NCT00747227|504060|P1|Overall Study|Lost to Follow-up|1
158082|NCT00747227|504059|P2|Overall Study|Withdrawal by Subject|0
158083|NCT00747227|504060|P1|Overall Study|Withdrawal by Subject|1
158084|NCT00747227|504059|P2|Overall Study|Death|1
158085|NCT00747227|504060|P1|Overall Study|Death|3
158086|NCT00747344|504074|P4|After Controlled Period|Adverse Event|1
158087|NCT00747344|504075|P3|After Controlled Period|Adverse Event|0
158088|NCT00747344|504076|P2|After Controlled Period|Adverse Event|0
158089|NCT00747344|504077|P1|After Controlled Period|Adverse Event|0
158090|NCT00747344|504074|P4|Controlled Period|Other|0
158091|NCT00747344|504075|P3|Controlled Period|Other|0
158092|NCT00747344|504076|P2|Controlled Period|Other|3
158093|NCT00747344|504077|P1|Controlled Period|Other|0
158094|NCT00747344|504074|P4|Controlled Period|Lack of Efficacy|0
158095|NCT00747344|504075|P3|Controlled Period|Lack of Efficacy|0
158096|NCT00747344|504076|P2|Controlled Period|Lack of Efficacy|1
158097|NCT00747344|504077|P1|Controlled Period|Lack of Efficacy|2
158098|NCT00747344|504074|P4|Controlled Period|Adverse Event|0
158099|NCT00747344|504075|P3|Controlled Period|Adverse Event|0
158100|NCT00747344|504076|P2|Controlled Period|Adverse Event|0
158101|NCT00747344|504077|P1|Controlled Period|Adverse Event|3
158102|NCT00747435|504089|P1|Overall Study|Still undergoing follow up|1
158103|NCT00747435|504089|P1|Overall Study|Withdrawal by Subject|3
158104|NCT00747435|504089|P1|Overall Study|Lost to Follow-up|2
158105|NCT00747461|504097|P1|Overall Study|study terminated by sponsor|5
158106|NCT00747474|504102|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158107|NCT00747474|504103|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158108|NCT00747474|504104|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158109|NCT00747474|504105|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158110|NCT00747474|504106|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
158111|NCT00747474|504107|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158112|NCT00747474|504108|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158113|NCT00747474|504109|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158114|NCT00747474|504110|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158115|NCT00747474|504111|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158116|NCT00747474|504112|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158196|NCT00738673|504323|P1|Overall Study|Lack of Efficacy|19
158117|NCT00747474|504113|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
158118|NCT00747565|504146|P2|Overall Study|Lost to Follow-up|1
158119|NCT00747565|504147|P1|Overall Study|Lost to Follow-up|4
158120|NCT00747565|504146|P2|Overall Study|Withdrawal by Subject|6
158121|NCT00747565|504147|P1|Overall Study|Withdrawal by Subject|10
158122|NCT00747617|504157|P2|Overall Study|Lost to Follow-up|1
158123|NCT00747617|504158|P1|Overall Study|Lost to Follow-up|3
158124|NCT00747643|504166|P2|Overall Study|Withdrawal by Subject|27
158125|NCT00747643|504167|P1|Overall Study|Withdrawal by Subject|36
158126|NCT00738283|504207|P1|Overall Study|Discharge home prior to end of study|1
158127|NCT00738283|504207|P1|Overall Study|Transfer to another facility|2
158128|NCT00738283|504207|P1|Overall Study|Death|1
158129|NCT00738374|504220|P4|Maintenance Treatment/Observation Phase|Not Specified|0
158130|NCT00738374|504221|P3|Maintenance Treatment/Observation Phase|Not Specified|0
158131|NCT00738374|504222|P2|Maintenance Treatment/Observation Phase|Not Specified|1
158132|NCT00738374|504223|P1|Maintenance Treatment/Observation Phase|Not Specified|0
158133|NCT00738374|504220|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
158134|NCT00738374|504221|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
158135|NCT00738374|504222|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
158136|NCT00738374|504223|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
158137|NCT00738374|504220|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
158138|NCT00738374|504221|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
158139|NCT00738374|504222|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
158140|NCT00738374|504223|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
158141|NCT00738374|504220|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
158142|NCT00738374|504221|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
158143|NCT00738374|504222|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
158144|NCT00738374|504223|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
158145|NCT00738374|504220|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
158146|NCT00738374|504221|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
158147|NCT00738374|504222|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
158148|NCT00738374|504223|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
158149|NCT00738374|504220|P4|Induction Treatment Phase|Withdrawal by Subject|0
158150|NCT00738374|504221|P3|Induction Treatment Phase|Withdrawal by Subject|0
158151|NCT00738374|504222|P2|Induction Treatment Phase|Withdrawal by Subject|0
158152|NCT00738374|504223|P1|Induction Treatment Phase|Withdrawal by Subject|1
158153|NCT00738374|504220|P4|Induction Treatment Phase|Non-compliance|0
158154|NCT00738374|504221|P3|Induction Treatment Phase|Non-compliance|0
158155|NCT00738374|504222|P2|Induction Treatment Phase|Non-compliance|0
158156|NCT00738374|504223|P1|Induction Treatment Phase|Non-compliance|1
158157|NCT00738374|504220|P4|Induction Treatment Phase|Protocol Violation|0
158158|NCT00738374|504221|P3|Induction Treatment Phase|Protocol Violation|0
158159|NCT00738374|504222|P2|Induction Treatment Phase|Protocol Violation|0
158160|NCT00738374|504223|P1|Induction Treatment Phase|Protocol Violation|2
158161|NCT00738374|504220|P4|Induction Treatment Phase|Physician Decision|0
158162|NCT00738374|504221|P3|Induction Treatment Phase|Physician Decision|0
158163|NCT00738374|504222|P2|Induction Treatment Phase|Physician Decision|0
158164|NCT00738374|504223|P1|Induction Treatment Phase|Physician Decision|2
158165|NCT00738374|504220|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
158166|NCT00738374|504221|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
158167|NCT00738374|504222|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
158168|NCT00738374|504223|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
158169|NCT00738374|504220|P4|Induction Treatment Phase|Adverse Event|0
158170|NCT00738374|504221|P3|Induction Treatment Phase|Adverse Event|0
158171|NCT00738374|504222|P2|Induction Treatment Phase|Adverse Event|0
158172|NCT00738374|504223|P1|Induction Treatment Phase|Adverse Event|14
158173|NCT00738400|504257|P2|Overall Study|Non-compliant with study medication|1
158174|NCT00738400|504258|P1|Overall Study|Non-compliant with study medication|0
158175|NCT00738400|504257|P2|Overall Study|Protocol Violation|0
158176|NCT00738400|504258|P1|Overall Study|Protocol Violation|1
158177|NCT00738400|504257|P2|Overall Study|Lost to Follow-up|3
158178|NCT00738400|504258|P1|Overall Study|Lost to Follow-up|0
158179|NCT00738400|504257|P2|Overall Study|Lack of Efficacy|1
158180|NCT00738400|504258|P1|Overall Study|Lack of Efficacy|0
158181|NCT00738400|504257|P2|Overall Study|Withdrawal by Subject|1
158182|NCT00738400|504258|P1|Overall Study|Withdrawal by Subject|0
158183|NCT00738400|504257|P2|Overall Study|Adverse Event|1
158184|NCT00738400|504258|P1|Overall Study|Adverse Event|3
158185|NCT00738530|504287|P2|Overall Study|Withdrawal by Subject|8
158186|NCT00738530|504288|P1|Overall Study|Withdrawal by Subject|6
158187|NCT00738530|504287|P2|Overall Study|Lost to Follow-up|6
158188|NCT00738530|504288|P1|Overall Study|Lost to Follow-up|8
158189|NCT00738530|504287|P2|Overall Study|Death|224
158190|NCT00738530|504288|P1|Overall Study|Death|220
158191|NCT00738673|504322|P2|Overall Study|Withdrawal by Subject|1
158192|NCT00738673|504323|P1|Overall Study|Withdrawal by Subject|3
158193|NCT00738673|504322|P2|Overall Study|Protocol Violation|2
158194|NCT00738673|504323|P1|Overall Study|Protocol Violation|1
158195|NCT00738673|504322|P2|Overall Study|Lack of Efficacy|8
158197|NCT00738673|504322|P2|Overall Study|Adverse Event|0
158198|NCT00738673|504323|P1|Overall Study|Adverse Event|1
158199|NCT00738699|504353|P2|Overall Study|Not specified|0
158200|NCT00738699|504354|P1|Overall Study|Not specified|2
158201|NCT00738699|504353|P2|Overall Study|Discontinuation of study by Sponsor|72
158202|NCT00738699|504354|P1|Overall Study|Discontinuation of study by Sponsor|123
158203|NCT00738699|504353|P2|Overall Study|Death|68
158204|NCT00738699|504354|P1|Overall Study|Death|144
158205|NCT00738699|504353|P2|Overall Study|Lost to Follow-up|0
158206|NCT00738699|504354|P1|Overall Study|Lost to Follow-up|1
158207|NCT00738699|504353|P2|Overall Study|Withdrawal by Subject|0
158208|NCT00738699|504354|P1|Overall Study|Withdrawal by Subject|5
158209|NCT00738881|504372|P2|Overall Study|Withdrawal by Subject|2
158210|NCT00738881|504373|P1|Overall Study|Withdrawal by Subject|0
158211|NCT00739063|504424|P1|Overall Study|Screen failures|8
158212|NCT00739102|504428|P1|Overall Study|Withdrawal by Subject|10
158213|NCT00739102|504428|P1|Overall Study|Death|5
158214|NCT00739297|504444|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
158215|NCT00739297|504445|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
158216|NCT00739297|504446|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
158217|NCT00739297|504447|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
158218|NCT00739297|504448|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
158219|NCT00739297|504449|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
158220|NCT00739297|504450|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
158221|NCT00739297|504444|P7|First Washout Period of 4-7 Days|Adverse Event|2
158222|NCT00739297|504445|P6|First Washout Period of 4-7 Days|Adverse Event|0
158223|NCT00739297|504446|P5|First Washout Period of 4-7 Days|Adverse Event|0
158224|NCT00739297|504447|P4|First Washout Period of 4-7 Days|Adverse Event|2
158225|NCT00739297|504448|P3|First Washout Period of 4-7 Days|Adverse Event|0
158226|NCT00739297|504449|P2|First Washout Period of 4-7 Days|Adverse Event|0
158227|NCT00739297|504450|P1|First Washout Period of 4-7 Days|Adverse Event|0
158228|NCT00739310|504478|P1|Overall Study|Lost to Follow-up|2
158229|NCT00739310|504478|P1|Overall Study|Withdrawal by Subject|1
158317|NCT00739908|504624|P2|Overall Study|Withdrawal by Subject|2
158230|NCT00739310|504478|P1|Overall Study|Poor adherance to prescribed therapy|4
158231|NCT00739596|504513|P2|Overall Study|Protocol Deviation|1
158232|NCT00739596|504514|P1|Overall Study|Protocol Deviation|1
158233|NCT00739596|504513|P2|Overall Study|Lost to Follow-up|2
158234|NCT00739596|504514|P1|Overall Study|Lost to Follow-up|0
158235|NCT00739596|504513|P2|Overall Study|Patient Withdrew Consent|8
158236|NCT00739596|504514|P1|Overall Study|Patient Withdrew Consent|8
158237|NCT00739596|504513|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
158238|NCT00739596|504514|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
158239|NCT00739596|504513|P2|Overall Study|Adverse Event|6
158240|NCT00739596|504514|P1|Overall Study|Adverse Event|12
158241|NCT00739648|504530|P2|Overall Study|Do not know|6
158242|NCT00739648|504531|P1|Overall Study|Do not know|4
158243|NCT00739648|504530|P2|Overall Study|Death|0
158244|NCT00739648|504531|P1|Overall Study|Death|2
158245|NCT00739648|504530|P2|Overall Study|Lost to Follow-up|7
158246|NCT00739648|504531|P1|Overall Study|Lost to Follow-up|4
158247|NCT00739648|504530|P2|Overall Study|Withdrawal by Subject|25
158248|NCT00739648|504531|P1|Overall Study|Withdrawal by Subject|13
158249|NCT00739648|504530|P2|Overall Study|Adverse Event|15
158250|NCT00739648|504531|P1|Overall Study|Adverse Event|3
158251|NCT00739661|504545|P2|Overall Study|Reason for discontinuation not available|1
158252|NCT00739661|504546|P1|Overall Study|Reason for discontinuation not available|1
158253|NCT00739661|504545|P2|Overall Study|Disease progression, radiographic|37
158254|NCT00739661|504546|P1|Overall Study|Disease progression, radiographic|33
158255|NCT00739661|504545|P2|Overall Study|Patient decision to withdraw|4
158256|NCT00739661|504546|P1|Overall Study|Patient decision to withdraw|9
158257|NCT00739661|504545|P2|Overall Study|Physician decision to withdraw patient|0
158258|NCT00739661|504546|P1|Overall Study|Physician decision to withdraw patient|1
158259|NCT00739661|504545|P2|Overall Study|Adverse Event|0
158260|NCT00739661|504546|P1|Overall Study|Adverse Event|2
158261|NCT00739674|504558|P2|Overall Study|Erectile dysfunction|1
158262|NCT00739674|504559|P1|Overall Study|Erectile dysfunction|0
158263|NCT00739674|504558|P2|Overall Study|Home monitoring off meds|0
158264|NCT00739674|504559|P1|Overall Study|Home monitoring off meds|1
158265|NCT00739674|504558|P2|Overall Study|Unable to attend visit|1
158266|NCT00739674|504559|P1|Overall Study|Unable to attend visit|3
158267|NCT00739674|504558|P2|Overall Study|Non compliant|0
158268|NCT00739674|504559|P1|Overall Study|Non compliant|4
158269|NCT00739674|504558|P2|Overall Study|Patient moved|2
158270|NCT00739674|504559|P1|Overall Study|Patient moved|3
158271|NCT00739674|504558|P2|Overall Study|Clinic closed|4
158272|NCT00739674|504559|P1|Overall Study|Clinic closed|6
158273|NCT00739674|504558|P2|Overall Study|Reason missing|0
158274|NCT00739674|504559|P1|Overall Study|Reason missing|2
158275|NCT00739674|504558|P2|Overall Study|Withdrawal by Subject|9
158276|NCT00739674|504559|P1|Overall Study|Withdrawal by Subject|9
158277|NCT00739674|504558|P2|Overall Study|Protocol Violation|5
158278|NCT00739674|504559|P1|Overall Study|Protocol Violation|5
158279|NCT00739674|504558|P2|Overall Study|Lost to Follow-up|30
158280|NCT00739674|504559|P1|Overall Study|Lost to Follow-up|52
158281|NCT00739674|504558|P2|Overall Study|Lack of Efficacy|0
158282|NCT00739674|504559|P1|Overall Study|Lack of Efficacy|1
158283|NCT00739674|504558|P2|Overall Study|Death|0
158284|NCT00739674|504559|P1|Overall Study|Death|1
158285|NCT00739674|504558|P2|Overall Study|Adverse Event|13
158286|NCT00739674|504559|P1|Overall Study|Adverse Event|22
158287|NCT00739674|504558|P2|Overall Study|Dietician consultation >30 days|9
158288|NCT00739674|504559|P1|Overall Study|Dietician consultation >30 days|1
158289|NCT00739674|504558|P2|Overall Study|No follow-up data|18
158290|NCT00739674|504559|P1|Overall Study|No follow-up data|33
158291|NCT00739674|504558|P2|Overall Study|Site 212 removal|13
158292|NCT00739674|504559|P1|Overall Study|Site 212 removal|19
158293|NCT00739674|504558|P2|Overall Study|Screening failures|17
158294|NCT00739674|504559|P1|Overall Study|Screening failures|19
158295|NCT00739882|504603|P2|Open-label Period|Other|5
158296|NCT00739882|504604|P1|Open-label Period|Other|9
158297|NCT00739882|504603|P2|Open-label Period|Adverse Event|0
158298|NCT00739882|504604|P1|Open-label Period|Adverse Event|1
158299|NCT00739882|504603|P2|Double-blind Period|Not specified|8
158300|NCT00739882|504604|P1|Double-blind Period|Not specified|16
158301|NCT00739882|504603|P2|Double-blind Period|Lack of Efficacy|1
158302|NCT00739882|504604|P1|Double-blind Period|Lack of Efficacy|1
158303|NCT00739882|504603|P2|Double-blind Period|Protocol Violation|0
158304|NCT00739882|504604|P1|Double-blind Period|Protocol Violation|1
158305|NCT00739882|504603|P2|Double-blind Period|Adverse Event|2
158306|NCT00739882|504604|P1|Double-blind Period|Adverse Event|1
158307|NCT00739908|504624|P2|Overall Study|Relocation|1
158308|NCT00739908|504625|P1|Overall Study|Relocation|0
158309|NCT00739908|504624|P2|Overall Study|Lack of Efficacy|1
158310|NCT00739908|504625|P1|Overall Study|Lack of Efficacy|0
158311|NCT00739908|504624|P2|Overall Study|Non-Compliance With Study Medication|3
158312|NCT00739908|504625|P1|Overall Study|Non-Compliance With Study Medication|0
158313|NCT00739908|504624|P2|Overall Study|Non-Compliance With Study Procedures|3
158314|NCT00739908|504625|P1|Overall Study|Non-Compliance With Study Procedures|2
158315|NCT00739908|504624|P2|Overall Study|Lost to Follow-up|9
158316|NCT00739908|504625|P1|Overall Study|Lost to Follow-up|14
158318|NCT00739908|504625|P1|Overall Study|Withdrawal by Subject|4
158319|NCT00739908|504624|P2|Overall Study|Adverse Event|6
158320|NCT00739908|504625|P1|Overall Study|Adverse Event|5
158321|NCT00739934|504643|P1|Voriconazole Oral|unspecified|3
158322|NCT00739934|504643|P1|Voriconazole IV|Adverse Event|6
158323|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158324|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158325|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
158326|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158327|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158328|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158329|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158330|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
158331|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
158332|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
158333|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
158334|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
158335|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
158336|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
158337|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
158338|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
158339|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
158340|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
158341|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158342|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158343|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
158344|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158345|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158346|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158347|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158348|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158349|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
158350|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
158351|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
158352|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
158353|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
158354|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
158355|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
158356|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
158357|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
158358|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
158359|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
158360|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
158361|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
158362|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
158363|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
158364|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
158365|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
158366|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
158367|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
158368|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158369|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158370|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158371|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158372|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158373|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158374|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
158375|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158376|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
158377|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
158378|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
158379|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
158380|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
158381|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
158382|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
158383|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
158384|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
158385|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
158386|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158387|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158388|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158389|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158390|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158391|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158392|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
158393|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
158394|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
158395|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158396|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
158397|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158398|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158399|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
158400|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158401|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158402|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158403|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
158404|NCT00739973|504672|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
158405|NCT00739973|504673|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
158406|NCT00739973|504674|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
158407|NCT00739973|504675|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
158408|NCT00739973|504676|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
158409|NCT00739973|504677|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
158410|NCT00739973|504678|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
158411|NCT00739973|504679|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
158412|NCT00739973|504680|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
158413|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158414|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158415|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158416|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158417|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158418|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158419|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158420|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
158421|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
158422|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158423|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158424|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158425|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158426|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158427|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158428|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158429|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
158430|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
158431|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158432|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158433|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158434|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158435|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158436|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158437|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158438|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
158439|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
158440|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158441|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158442|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158443|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158444|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158445|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158446|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158447|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
158448|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
158449|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158450|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158451|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158452|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158453|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158454|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158455|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158456|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
158457|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
158458|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158459|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158460|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158461|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158462|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158463|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158464|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158465|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
158466|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
158467|NCT00739973|504672|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158468|NCT00739973|504673|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158469|NCT00739973|504674|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158470|NCT00739973|504675|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158471|NCT00739973|504676|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158472|NCT00739973|504677|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158473|NCT00739973|504678|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158474|NCT00739973|504679|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
158475|NCT00739973|504680|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
158476|NCT00740051|504842|P2|Overall Study|Other reason (not specified)|1
158477|NCT00740051|504843|P1|Overall Study|Other reason (not specified)|4
158478|NCT00740051|504842|P2|Overall Study|Withdrawal by Subject|8
158479|NCT00740051|504843|P1|Overall Study|Withdrawal by Subject|6
158480|NCT00740051|504842|P2|Overall Study|Lost to Follow-up|8
158481|NCT00740051|504843|P1|Overall Study|Lost to Follow-up|3
158482|NCT00740051|504842|P2|Overall Study|Protocol Violation|6
158483|NCT00740051|504843|P1|Overall Study|Protocol Violation|2
158484|NCT00740051|504842|P2|Overall Study|Adverse Event|4
158485|NCT00740051|504843|P1|Overall Study|Adverse Event|1
158486|NCT00740051|504842|P2|Overall Study|Lack of Efficacy|5
158487|NCT00740051|504843|P1|Overall Study|Lack of Efficacy|2
158488|NCT00740220|504882|P1|Overall Study|screen failures (non-COPD patients)|9
158489|NCT00740480|504886|P1|Overall Study|Physician Decision|1
158490|NCT00740480|504886|P1|Overall Study|Adverse Event|1
158491|NCT00740584|504890|P1|Overall Study|Withdrawal by Subject|1
158492|NCT00740597|504894|P1|Overall Study|insurance would not cover treatment|1
158493|NCT00740636|504900|P2|Overall Study|Death|0
158494|NCT00740636|504901|P1|Overall Study|Death|1
158495|NCT00740636|504900|P2|Overall Study|Progressive Disease|0
158496|NCT00740636|504901|P1|Overall Study|Progressive Disease|1
158497|NCT00740636|504900|P2|Overall Study|Patient Not Treated|1
158498|NCT00740636|504901|P1|Overall Study|Patient Not Treated|0
158499|NCT00740636|504900|P2|Overall Study|Patient Ineligible|1
158500|NCT00740636|504901|P1|Overall Study|Patient Ineligible|0
158501|NCT00740636|504900|P2|Overall Study|Adverse Event|2
158502|NCT00740636|504901|P1|Overall Study|Adverse Event|0
158503|NCT00747812|504909|P2|Overall Study|Research Site Staff Relocation|3
158504|NCT00747812|504910|P1|Overall Study|Research Site Staff Relocation|5
158505|NCT00748098|504937|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
158506|NCT00748098|504938|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
158507|NCT00748098|504937|P2|Second Treatment Intervention Period|Lost to Follow-up|1
158508|NCT00748098|504938|P1|Second Treatment Intervention Period|Lost to Follow-up|1
158509|NCT00748098|504937|P2|Second Treatment Intervention Period|Adverse Event|1
158510|NCT00748098|504938|P1|Second Treatment Intervention Period|Adverse Event|4
158511|NCT00748098|504937|P2|1-Week Washout Period|Withdrawal by Subject|0
158512|NCT00748098|504938|P1|1-Week Washout Period|Withdrawal by Subject|2
158513|NCT00748098|504937|P2|1-Week Washout Period|Adverse Event|1
158514|NCT00748098|504938|P1|1-Week Washout Period|Adverse Event|0
158515|NCT00748098|504937|P2|First Taper Period|Protocol Stopping Criteria Met|1
158516|NCT00748098|504938|P1|First Taper Period|Protocol Stopping Criteria Met|0
158517|NCT00748098|504937|P2|First Taper Period|Withdrawal by Subject|0
158518|NCT00748098|504938|P1|First Taper Period|Withdrawal by Subject|2
158519|NCT00748098|504937|P2|First Taper Period|Protocol Violation|0
158520|NCT00748098|504938|P1|First Taper Period|Protocol Violation|1
158521|NCT00748098|504937|P2|First Treatment Intervention Period|Withdrawal by Subject|0
158522|NCT00748098|504938|P1|First Treatment Intervention Period|Withdrawal by Subject|2
158523|NCT00748098|504937|P2|First Treatment Intervention Period|Lost to Follow-up|0
158524|NCT00748098|504938|P1|First Treatment Intervention Period|Lost to Follow-up|1
158525|NCT00748098|504937|P2|First Treatment Intervention Period|Protocol Violation|0
158526|NCT00748098|504938|P1|First Treatment Intervention Period|Protocol Violation|1
158527|NCT00748098|504937|P2|First Treatment Intervention Period|Adverse Event|1
158528|NCT00748098|504938|P1|First Treatment Intervention Period|Adverse Event|1
158529|NCT00749190|505077|P7|Overall Study|Other reason not defined above|0
158530|NCT00749190|505078|P6|Overall Study|Other reason not defined above|0
158531|NCT00749190|505079|P5|Overall Study|Other reason not defined above|0
158532|NCT00749190|505080|P4|Overall Study|Other reason not defined above|1
158533|NCT00749190|505081|P3|Overall Study|Other reason not defined above|0
158534|NCT00749190|505082|P2|Overall Study|Other reason not defined above|0
158535|NCT00749190|505083|P1|Overall Study|Other reason not defined above|0
158536|NCT00749190|505077|P7|Overall Study|Protocol Violation|1
158537|NCT00749190|505078|P6|Overall Study|Protocol Violation|0
158538|NCT00749190|505079|P5|Overall Study|Protocol Violation|0
158539|NCT00749190|505080|P4|Overall Study|Protocol Violation|0
158540|NCT00749190|505081|P3|Overall Study|Protocol Violation|0
158541|NCT00749190|505082|P2|Overall Study|Protocol Violation|1
158542|NCT00749190|505083|P1|Overall Study|Protocol Violation|0
158543|NCT00749190|505077|P7|Overall Study|Withdrawal by Subject|0
158544|NCT00749190|505078|P6|Overall Study|Withdrawal by Subject|1
158545|NCT00749190|505079|P5|Overall Study|Withdrawal by Subject|0
158546|NCT00749190|505080|P4|Overall Study|Withdrawal by Subject|0
158547|NCT00749190|505081|P3|Overall Study|Withdrawal by Subject|0
158548|NCT00749190|505082|P2|Overall Study|Withdrawal by Subject|1
158549|NCT00749190|505083|P1|Overall Study|Withdrawal by Subject|2
158550|NCT00749190|505077|P7|Overall Study|Lack of Efficacy|0
158551|NCT00749190|505078|P6|Overall Study|Lack of Efficacy|1
158552|NCT00749190|505079|P5|Overall Study|Lack of Efficacy|0
158553|NCT00749190|505080|P4|Overall Study|Lack of Efficacy|0
158554|NCT00749190|505081|P3|Overall Study|Lack of Efficacy|1
158555|NCT00749190|505082|P2|Overall Study|Lack of Efficacy|1
158556|NCT00749190|505083|P1|Overall Study|Lack of Efficacy|3
158557|NCT00749190|505077|P7|Overall Study|Adverse Event|0
158558|NCT00749190|505078|P6|Overall Study|Adverse Event|3
158559|NCT00749190|505079|P5|Overall Study|Adverse Event|0
158560|NCT00749190|505080|P4|Overall Study|Adverse Event|4
158561|NCT00749190|505081|P3|Overall Study|Adverse Event|0
158562|NCT00749190|505082|P2|Overall Study|Adverse Event|2
158563|NCT00749190|505083|P1|Overall Study|Adverse Event|0
158564|NCT00749398|505187|P1|Overall Study|Unknown reason|1
158565|NCT00749398|505187|P1|Overall Study|Reason not specified|2
158566|NCT00749398|505187|P1|Overall Study|Lost to Follow-up|11
158567|NCT00749398|505187|P1|Overall Study|Withdrawal by Subject|17
158568|NCT00749398|505187|P1|Overall Study|Serious adverse event|11
158569|NCT00749398|505187|P1|Overall Study|Adverse Event|4
158570|NCT00749398|505187|P1|Overall Study|Lack of Efficacy|7
158571|NCT00749463|505204|P3|Overall Study|Withdrawal by Subject|0
158572|NCT00749463|505205|P2|Overall Study|Withdrawal by Subject|0
158573|NCT00749463|505206|P1|Overall Study|Withdrawal by Subject|1
158574|NCT00749463|505204|P3|Overall Study|Adverse Event|1
158575|NCT00749463|505205|P2|Overall Study|Adverse Event|4
158576|NCT00749463|505206|P1|Overall Study|Adverse Event|0
158577|NCT00749580|505238|P2|Overall Study|Adverse Event|1
158578|NCT00749580|505239|P1|Overall Study|Adverse Event|0
158579|NCT00749580|505238|P2|Overall Study|Lost to Follow-up|8
158580|NCT00749580|505239|P1|Overall Study|Lost to Follow-up|4
158581|NCT00749684|505258|P1|Overall Study|Missing|9
158582|NCT00749684|505258|P1|Overall Study|AE+discontinuation on participants wish|1
158583|NCT00749684|505258|P1|Overall Study|Therapy according to protocol + AE|2
158584|NCT00749684|505258|P1|Overall Study|Progressive Desease|31
158585|NCT00749684|505258|P1|Overall Study|Not Documented|1
158586|NCT00749684|505258|P1|Overall Study|Participant's Wish|10
158587|NCT00749684|505258|P1|Overall Study|Adverse Event|27
158588|NCT00749684|505258|P1|Overall Study|Death|1
158589|NCT00749775|505263|P1|Overall Study|No drug administration|3
158590|NCT00749775|505263|P1|Overall Study|No visit after first day of treatment|44
158591|NCT00749775|505263|P1|Overall Study|Lost to Follow-up|36
158592|NCT00749775|505263|P1|Overall Study|Protocol Violation|24
158593|NCT00749944|505294|P2|Overall Study|Withdrawal by Subject|0
158594|NCT00749944|505295|P1|Overall Study|Withdrawal by Subject|2
158595|NCT00749944|505294|P2|Overall Study|Not specified|0
158596|NCT00749944|505295|P1|Overall Study|Not specified|1
158597|NCT00749944|505294|P2|Overall Study|Lost to Follow-up|1
158598|NCT00749944|505295|P1|Overall Study|Lost to Follow-up|2
158599|NCT00749996|505376|P2|Overall Study|Death|0
158600|NCT00749996|505377|P1|Overall Study|Death|1
158601|NCT00749996|505376|P2|Overall Study|Adverse Event|0
158602|NCT00749996|505377|P1|Overall Study|Adverse Event|1
158603|NCT00749996|505376|P2|Overall Study|Pregnancy|2
158604|NCT00749996|505377|P1|Overall Study|Pregnancy|0
158605|NCT00749996|505376|P2|Overall Study|Physician Decision|0
158606|NCT00749996|505377|P1|Overall Study|Physician Decision|2
158607|NCT00749996|505376|P2|Overall Study|Protocol Violation|3
158608|NCT00749996|505377|P1|Overall Study|Protocol Violation|2
158609|NCT00749996|505376|P2|Overall Study|Withdrawal by Subject|4
158610|NCT00749996|505377|P1|Overall Study|Withdrawal by Subject|5
158611|NCT00749996|505376|P2|Overall Study|Lost to Follow-up|4
158612|NCT00749996|505377|P1|Overall Study|Lost to Follow-up|7
158613|NCT00750061|505387|P2|Overall Study|Physician Decision|1
158614|NCT00750061|505388|P1|Overall Study|Physician Decision|0
158615|NCT00750061|505387|P2|Overall Study|Withdrawal by Subject|1
158616|NCT00750061|505388|P1|Overall Study|Withdrawal by Subject|0
158617|NCT00750061|505387|P2|Overall Study|Adverse Event|0
158618|NCT00750061|505388|P1|Overall Study|Adverse Event|2
158619|NCT00750139|505400|P4|Overall Study|Non-specific|33
158620|NCT00750139|505401|P3|Overall Study|Non-specific|79
158621|NCT00750139|505402|P2|Overall Study|Non-specific|42
158622|NCT00750139|505403|P1|Overall Study|Non-specific|62
158623|NCT00750139|505400|P4|Overall Study|Termination by sponsor|1
158624|NCT00750139|505401|P3|Overall Study|Termination by sponsor|0
158625|NCT00750139|505402|P2|Overall Study|Termination by sponsor|0
158626|NCT00750139|505403|P1|Overall Study|Termination by sponsor|4
158627|NCT00750139|505400|P4|Overall Study|Non-compliance|3
158628|NCT00750139|505401|P3|Overall Study|Non-compliance|1
158629|NCT00750139|505402|P2|Overall Study|Non-compliance|0
158630|NCT00750139|505403|P1|Overall Study|Non-compliance|1
158631|NCT00750139|505400|P4|Overall Study|Physician Decision|0
158632|NCT00750139|505401|P3|Overall Study|Physician Decision|0
158633|NCT00750139|505402|P2|Overall Study|Physician Decision|1
158634|NCT00750139|505403|P1|Overall Study|Physician Decision|1
158635|NCT00750139|505400|P4|Overall Study|Withdrawal by Subject|2
158636|NCT00750139|505401|P3|Overall Study|Withdrawal by Subject|6
158637|NCT00750139|505402|P2|Overall Study|Withdrawal by Subject|2
158638|NCT00750139|505403|P1|Overall Study|Withdrawal by Subject|3
158639|NCT00750139|505400|P4|Overall Study|Lost to Follow-up|6
158640|NCT00750139|505401|P3|Overall Study|Lost to Follow-up|15
158641|NCT00750139|505402|P2|Overall Study|Lost to Follow-up|12
158642|NCT00750139|505403|P1|Overall Study|Lost to Follow-up|17
158643|NCT00750139|505400|P4|Overall Study|Adverse Event|1
158644|NCT00750139|505401|P3|Overall Study|Adverse Event|0
158645|NCT00750139|505402|P2|Overall Study|Adverse Event|2
158646|NCT00750139|505403|P1|Overall Study|Adverse Event|1
158647|NCT00750152|505419|P2|Overall Study|Not specified|8
158648|NCT00750152|505420|P1|Overall Study|Not specified|7
158649|NCT00750152|505419|P2|Overall Study|Termination by sponsor|0
158650|NCT00750152|505420|P1|Overall Study|Termination by sponsor|1
158651|NCT00750152|505419|P2|Overall Study|Non-compliance|1
158652|NCT00750152|505420|P1|Overall Study|Non-compliance|0
158653|NCT00750152|505419|P2|Overall Study|Physician Decision|1
158654|NCT00750152|505420|P1|Overall Study|Physician Decision|1
158655|NCT00750152|505419|P2|Overall Study|Withdrawal by Subject|3
158656|NCT00750152|505420|P1|Overall Study|Withdrawal by Subject|3
158657|NCT00750152|505419|P2|Overall Study|Lost to Follow-up|13
158658|NCT00750152|505420|P1|Overall Study|Lost to Follow-up|8
158659|NCT00750152|505419|P2|Overall Study|Adverse Event|1
158660|NCT00750152|505420|P1|Overall Study|Adverse Event|2
158661|NCT00750204|505445|P2|Overall Study|study halted prematurely|1
158662|NCT00750204|505446|P1|Overall Study|study halted prematurely|1
158663|NCT00750269|505457|P5|Overall Study|Fiducials could not be placed|1
158664|NCT00750269|505458|P4|Overall Study|Fiducials could not be placed|0
158665|NCT00750269|505459|P3|Overall Study|Fiducials could not be placed|0
158666|NCT00750269|505460|P2|Overall Study|Fiducials could not be placed|0
158667|NCT00750269|505461|P1|Overall Study|Fiducials could not be placed|0
158668|NCT00750269|505457|P5|Overall Study|SBRT plan could not be drawn|1
158669|NCT00750269|505458|P4|Overall Study|SBRT plan could not be drawn|0
158670|NCT00750269|505459|P3|Overall Study|SBRT plan could not be drawn|0
158671|NCT00750269|505460|P2|Overall Study|SBRT plan could not be drawn|0
158672|NCT00750269|505461|P1|Overall Study|SBRT plan could not be drawn|0
158673|NCT00750269|505457|P5|Overall Study|Site error|0
158674|NCT00750269|505458|P4|Overall Study|Site error|1
158675|NCT00750269|505459|P3|Overall Study|Site error|0
158676|NCT00750269|505460|P2|Overall Study|Site error|0
158677|NCT00750269|505461|P1|Overall Study|Site error|0
158678|NCT00750269|505457|P5|Overall Study|Patient too large for positioning|0
158679|NCT00750269|505458|P4|Overall Study|Patient too large for positioning|0
158680|NCT00750269|505459|P3|Overall Study|Patient too large for positioning|1
158681|NCT00750269|505460|P2|Overall Study|Patient too large for positioning|0
158682|NCT00750269|505461|P1|Overall Study|Patient too large for positioning|0
158683|NCT00750269|505457|P5|Overall Study|Physician Decision|2
158684|NCT00750269|505458|P4|Overall Study|Physician Decision|0
158685|NCT00750269|505459|P3|Overall Study|Physician Decision|0
158686|NCT00750269|505460|P2|Overall Study|Physician Decision|0
158687|NCT00750269|505461|P1|Overall Study|Physician Decision|0
158688|NCT00750269|505457|P5|Overall Study|Withdrawal by Subject|2
158689|NCT00750269|505458|P4|Overall Study|Withdrawal by Subject|2
158690|NCT00750269|505459|P3|Overall Study|Withdrawal by Subject|2
158691|NCT00750269|505460|P2|Overall Study|Withdrawal by Subject|0
158692|NCT00750269|505461|P1|Overall Study|Withdrawal by Subject|0
158693|NCT00750269|505457|P5|Overall Study|Protocol Violation|4
158694|NCT00750269|505458|P4|Overall Study|Protocol Violation|2
158695|NCT00750269|505459|P3|Overall Study|Protocol Violation|1
158696|NCT00750269|505460|P2|Overall Study|Protocol Violation|1
158697|NCT00750269|505461|P1|Overall Study|Protocol Violation|0
158698|NCT00750308|505537|P12|Third Treatment|Withdrawal by Subject|0
158699|NCT00750308|505538|P11|Third Treatment|Withdrawal by Subject|0
158700|NCT00750308|505539|P10|Third Treatment|Withdrawal by Subject|0
158701|NCT00750308|505540|P9|Third Treatment|Withdrawal by Subject|0
158702|NCT00750308|505541|P8|Third Treatment|Withdrawal by Subject|0
158703|NCT00750308|505542|P7|Third Treatment|Withdrawal by Subject|0
158704|NCT00750308|505543|P6|Third Treatment|Withdrawal by Subject|0
158705|NCT00750308|505544|P5|Third Treatment|Withdrawal by Subject|0
158706|NCT00750308|505545|P4|Third Treatment|Withdrawal by Subject|0
158707|NCT00750308|505546|P3|Third Treatment|Withdrawal by Subject|0
158708|NCT00750308|505547|P2|Third Treatment|Withdrawal by Subject|1
158709|NCT00750308|505548|P1|Third Treatment|Withdrawal by Subject|0
158710|NCT00750308|505537|P12|Second Treatment|Withdrawal by Subject|0
158711|NCT00750308|505538|P11|Second Treatment|Withdrawal by Subject|0
158712|NCT00750308|505539|P10|Second Treatment|Withdrawal by Subject|0
158713|NCT00750308|505540|P9|Second Treatment|Withdrawal by Subject|0
158714|NCT00750308|505541|P8|Second Treatment|Withdrawal by Subject|0
158715|NCT00750308|505542|P7|Second Treatment|Withdrawal by Subject|0
158716|NCT00750308|505543|P6|Second Treatment|Withdrawal by Subject|0
158717|NCT00750308|505544|P5|Second Treatment|Withdrawal by Subject|1
158718|NCT00750308|505545|P4|Second Treatment|Withdrawal by Subject|0
158719|NCT00750308|505546|P3|Second Treatment|Withdrawal by Subject|0
158720|NCT00750308|505547|P2|Second Treatment|Withdrawal by Subject|0
158721|NCT00750308|505548|P1|Second Treatment|Withdrawal by Subject|0
158722|NCT00750308|505537|P12|Second Treatment|Adverse Event|0
158723|NCT00750308|505538|P11|Second Treatment|Adverse Event|0
158724|NCT00750308|505539|P10|Second Treatment|Adverse Event|0
158725|NCT00750308|505540|P9|Second Treatment|Adverse Event|1
158726|NCT00750308|505541|P8|Second Treatment|Adverse Event|0
158727|NCT00750308|505542|P7|Second Treatment|Adverse Event|0
158728|NCT00750308|505543|P6|Second Treatment|Adverse Event|1
158729|NCT00750308|505544|P5|Second Treatment|Adverse Event|0
158730|NCT00750308|505545|P4|Second Treatment|Adverse Event|0
158731|NCT00750308|505546|P3|Second Treatment|Adverse Event|0
158732|NCT00750308|505547|P2|Second Treatment|Adverse Event|0
158733|NCT00750308|505548|P1|Second Treatment|Adverse Event|0
158734|NCT00750308|505537|P12|First Treatment|Withdrawal by Subject|0
158735|NCT00750308|505538|P11|First Treatment|Withdrawal by Subject|0
158736|NCT00750308|505539|P10|First Treatment|Withdrawal by Subject|0
158737|NCT00750308|505540|P9|First Treatment|Withdrawal by Subject|0
158738|NCT00750308|505541|P8|First Treatment|Withdrawal by Subject|1
158739|NCT00750308|505542|P7|First Treatment|Withdrawal by Subject|0
158740|NCT00750308|505543|P6|First Treatment|Withdrawal by Subject|0
158741|NCT00750308|505544|P5|First Treatment|Withdrawal by Subject|0
158742|NCT00750308|505545|P4|First Treatment|Withdrawal by Subject|1
158743|NCT00750308|505546|P3|First Treatment|Withdrawal by Subject|0
158744|NCT00750308|505547|P2|First Treatment|Withdrawal by Subject|0
158745|NCT00750308|505548|P1|First Treatment|Withdrawal by Subject|0
158746|NCT00750308|505537|P12|First Treatment|Adverse Event|1
158747|NCT00750308|505538|P11|First Treatment|Adverse Event|1
158748|NCT00750308|505539|P10|First Treatment|Adverse Event|0
158749|NCT00750308|505540|P9|First Treatment|Adverse Event|0
158750|NCT00750308|505541|P8|First Treatment|Adverse Event|0
158751|NCT00750308|505542|P7|First Treatment|Adverse Event|0
158752|NCT00750308|505543|P6|First Treatment|Adverse Event|0
158753|NCT00750308|505544|P5|First Treatment|Adverse Event|0
158754|NCT00750308|505545|P4|First Treatment|Adverse Event|0
158755|NCT00750308|505546|P3|First Treatment|Adverse Event|0
158756|NCT00750308|505547|P2|First Treatment|Adverse Event|1
158757|NCT00750308|505548|P1|First Treatment|Adverse Event|0
158758|NCT00750737|505616|P2|Overall Study|Withdrawal by Subject|3
158759|NCT00750737|505617|P1|Overall Study|Withdrawal by Subject|3
158760|NCT00750867|505639|P1|Overall Study|Adverse Event|2
158761|NCT00750880|505644|P1|Overall Study|Administrative|11
158762|NCT00750880|505644|P1|Overall Study|Physician Decision|20
158763|NCT00750880|505644|P1|Overall Study|Withdrawal by Subject|33
158764|NCT00750880|505644|P1|Overall Study|Protocol Violation|15
158765|NCT00750880|505644|P1|Overall Study|Lost to Follow-up|10
158766|NCT00750880|505644|P1|Overall Study|Lack of Efficacy|46
158767|NCT00750880|505644|P1|Overall Study|Death|4
158768|NCT00750880|505644|P1|Overall Study|Adverse Event|76
158769|NCT00750893|505667|P1|Overall Study|Unspecified|17
158770|NCT00750893|505667|P1|Overall Study|Lost to Follow-up|510
158771|NCT00750893|505667|P1|Overall Study|Withdrawal by Subject|10
158772|NCT00750893|505667|P1|Overall Study|Adverse Event|5
158773|NCT00750919|505682|P1|Overall Study|Unspecified|36
158774|NCT00750919|505682|P1|Overall Study|Could not cooperate, unrelated to trial|4
158775|NCT00750919|505682|P1|Overall Study|Lack of Efficacy|8
158776|NCT00750919|505682|P1|Overall Study|Withdrawal by Subject|1
158777|NCT00750919|505682|P1|Overall Study|Adverse Event|9
158778|NCT00751036|505692|P2|Overall Study|Missing end of Treatment Page|3
158779|NCT00751036|505693|P1|Overall Study|Missing end of Treatment Page|2
158780|NCT00751036|505692|P2|Overall Study|Protocol Violation|0
158781|NCT00751036|505693|P1|Overall Study|Protocol Violation|1
158782|NCT00751036|505692|P2|Overall Study|Lost to Follow-up|1
158783|NCT00751036|505693|P1|Overall Study|Lost to Follow-up|0
158784|NCT00751036|505692|P2|Overall Study|Death|3
158785|NCT00751036|505693|P1|Overall Study|Death|3
158786|NCT00751036|505692|P2|Overall Study|Withdrawal by Subject|2
158787|NCT00751036|505693|P1|Overall Study|Withdrawal by Subject|5
158788|NCT00751036|505692|P2|Overall Study|Administrative Problems|4
158789|NCT00751036|505693|P1|Overall Study|Administrative Problems|3
158790|NCT00751036|505692|P2|Overall Study|Adverse Event|4
158791|NCT00751036|505693|P1|Overall Study|Adverse Event|6
158792|NCT00751036|505692|P2|Overall Study|Disease Progression|29
158793|NCT00751036|505693|P1|Overall Study|Disease Progression|28
158794|NCT00751114|505707|P2|Overall Study|Move to another city|0
158795|NCT00751114|505708|P1|Overall Study|Move to another city|1
158796|NCT00751114|505707|P2|Overall Study|Out of country for 2 months|0
158797|NCT00751114|505708|P1|Overall Study|Out of country for 2 months|1
158798|NCT00751114|505707|P2|Overall Study|Not Treated|1
158799|NCT00751114|505708|P1|Overall Study|Not Treated|13
158800|NCT00751114|505707|P2|Overall Study|Lack of Efficacy|7
158801|NCT00751114|505708|P1|Overall Study|Lack of Efficacy|0
158802|NCT00751114|505707|P2|Overall Study|Lost to Follow-up|7
158803|NCT00751114|505708|P1|Overall Study|Lost to Follow-up|4
158804|NCT00751114|505707|P2|Overall Study|Withdrawal by Subject|4
158805|NCT00751114|505708|P1|Overall Study|Withdrawal by Subject|9
158806|NCT00751114|505707|P2|Overall Study|Protocol Violation|9
158807|NCT00751114|505708|P1|Overall Study|Protocol Violation|8
158808|NCT00751114|505707|P2|Overall Study|Adverse Event|4
158809|NCT00751114|505708|P1|Overall Study|Adverse Event|2
158810|NCT00751140|505731|P1|Overall Study|benign angioma excluded from analysis|1
158811|NCT00751296|505762|P1|Overall Study|Adverse Event|2
158812|NCT00737633|505769|P2|Overall Study|protocol non-compliance|1
158813|NCT00737633|505770|P1|Overall Study|protocol non-compliance|0
158814|NCT00737633|505769|P2|Overall Study|Lost to Follow-up|1
158815|NCT00737633|505770|P1|Overall Study|Lost to Follow-up|0
158816|NCT00737633|505769|P2|Overall Study|Study terminated by sponsor|55
158817|NCT00737633|505770|P1|Overall Study|Study terminated by sponsor|44
158818|NCT00737672|505780|P2|Overall Study|Physician Decision|2
158819|NCT00737672|505781|P1|Overall Study|Physician Decision|0
158820|NCT00737672|505780|P2|Overall Study|Miscellaneous|1
158821|NCT00737672|505781|P1|Overall Study|Miscellaneous|7
158822|NCT00737672|505780|P2|Overall Study|Lost to Follow-up|0
158823|NCT00737672|505781|P1|Overall Study|Lost to Follow-up|1
158824|NCT00737672|505780|P2|Overall Study|Withdrawal by Subject|2
158825|NCT00737672|505781|P1|Overall Study|Withdrawal by Subject|1
158826|NCT00737672|505780|P2|Overall Study|Death|22
158827|NCT00737672|505781|P1|Overall Study|Death|23
158828|NCT00737672|505780|P2|Overall Study|Graft Abandonment|56
158829|NCT00737672|505781|P1|Overall Study|Graft Abandonment|48
158830|NCT00737711|505817|P1|Overall Study|Other|5
158831|NCT00737711|505817|P1|Overall Study|Blood transfusion|6
158832|NCT00737711|505817|P1|Overall Study|Withdrawal by Subject|5
158833|NCT00737711|505817|P1|Overall Study|Protocol Violation|1
158834|NCT00737711|505817|P1|Overall Study|Failure to return|4
158835|NCT00737711|505817|P1|Overall Study|Death|8
158836|NCT00737711|505817|P1|Overall Study|Adverse Event|2
158837|NCT00738062|505888|P3|Open-Label Extension|Study Terminated|0
158838|NCT00738062|505889|P2|Open-Label Extension|Study Terminated|0
158839|NCT00738062|505890|P1|Open-Label Extension|Study Terminated|2
158840|NCT00738062|505888|P3|Open-Label Extension|Protocol Violation|0
158841|NCT00738062|505889|P2|Open-Label Extension|Protocol Violation|0
158842|NCT00738062|505890|P1|Open-Label Extension|Protocol Violation|1
158843|NCT00738062|505888|P3|Open-Label Extension|Withdrawal by Subject|0
158844|NCT00738062|505889|P2|Open-Label Extension|Withdrawal by Subject|0
158845|NCT00738062|505890|P1|Open-Label Extension|Withdrawal by Subject|6
158846|NCT00738062|505888|P3|Open-Label Extension|Lack of Efficacy|0
158847|NCT00738062|505889|P2|Open-Label Extension|Lack of Efficacy|0
158848|NCT00738062|505890|P1|Open-Label Extension|Lack of Efficacy|2
158849|NCT00738062|505888|P3|Open-Label Extension|Physician Decision|0
158850|NCT00738062|505889|P2|Open-Label Extension|Physician Decision|0
158851|NCT00738062|505890|P1|Open-Label Extension|Physician Decision|1
158852|NCT00738062|505888|P3|Open-Label Extension|Adverse Event|0
158853|NCT00738062|505889|P2|Open-Label Extension|Adverse Event|0
158854|NCT00738062|505890|P1|Open-Label Extension|Adverse Event|5
158855|NCT00738062|505888|P3|Open Label Treatment|Investigator Decision|0
158856|NCT00738062|505889|P2|Open Label Treatment|Investigator Decision|0
158857|NCT00738062|505890|P1|Open Label Treatment|Investigator Decision|1
158858|NCT00738062|505888|P3|Open Label Treatment|Withdrawal by Subject|0
158859|NCT00738062|505889|P2|Open Label Treatment|Withdrawal by Subject|0
158860|NCT00738062|505890|P1|Open Label Treatment|Withdrawal by Subject|9
158861|NCT00738062|505888|P3|Open Label Treatment|Protocol Violation|0
158862|NCT00738062|505889|P2|Open Label Treatment|Protocol Violation|0
158863|NCT00738062|505890|P1|Open Label Treatment|Protocol Violation|2
158864|NCT00738062|505888|P3|Open Label Treatment|Adverse Event|0
158865|NCT00738062|505889|P2|Open Label Treatment|Adverse Event|0
158866|NCT00738062|505890|P1|Open Label Treatment|Adverse Event|11
158867|NCT00738062|505888|P3|Open Label Treatment|Lack of Efficacy|0
158868|NCT00738062|505889|P2|Open Label Treatment|Lack of Efficacy|0
158869|NCT00738062|505890|P1|Open Label Treatment|Lack of Efficacy|5
158870|NCT00743483|505915|P1|Treatment Period|Adverse Event|1
158871|NCT00743483|505915|P1|Baseline Period|Physician Decision|1
158872|NCT00743509|505919|P1|Overall Study|Withdrawal by Subject|2
158873|NCT00743652|505938|P5|Overall Study|Lost to Follow-up|0
158874|NCT00743652|505939|P4|Overall Study|Lost to Follow-up|0
158875|NCT00743652|505940|P3|Overall Study|Lost to Follow-up|0
158876|NCT00743652|505941|P2|Overall Study|Lost to Follow-up|0
158877|NCT00743652|505942|P1|Overall Study|Lost to Follow-up|1
158878|NCT00743652|505938|P5|Overall Study|Unspecified|0
158879|NCT00743652|505939|P4|Overall Study|Unspecified|0
158880|NCT00743652|505940|P3|Overall Study|Unspecified|0
158881|NCT00743652|505941|P2|Overall Study|Unspecified|1
158882|NCT00743652|505942|P1|Overall Study|Unspecified|1
158883|NCT00743652|505938|P5|Overall Study|Investigator Request|0
158884|NCT00743652|505939|P4|Overall Study|Investigator Request|2
158885|NCT00743652|505940|P3|Overall Study|Investigator Request|0
158886|NCT00743652|505941|P2|Overall Study|Investigator Request|0
158887|NCT00743652|505942|P1|Overall Study|Investigator Request|0
158888|NCT00743652|505938|P5|Overall Study|Death|0
158889|NCT00743652|505939|P4|Overall Study|Death|0
158890|NCT00743652|505940|P3|Overall Study|Death|0
158891|NCT00743652|505941|P2|Overall Study|Death|0
158892|NCT00743652|505942|P1|Overall Study|Death|2
158893|NCT00743652|505938|P5|Overall Study|Adverse Event|0
158894|NCT00743652|505939|P4|Overall Study|Adverse Event|0
158895|NCT00743652|505940|P3|Overall Study|Adverse Event|0
158896|NCT00743652|505941|P2|Overall Study|Adverse Event|0
158897|NCT00743652|505942|P1|Overall Study|Adverse Event|3
158898|NCT00743652|505938|P5|Overall Study|Parent/Legal Guardian Request|0
158899|NCT00743652|505939|P4|Overall Study|Parent/Legal Guardian Request|2
158900|NCT00743652|505940|P3|Overall Study|Parent/Legal Guardian Request|2
158901|NCT00743652|505941|P2|Overall Study|Parent/Legal Guardian Request|2
158902|NCT00743652|505942|P1|Overall Study|Parent/Legal Guardian Request|3
158903|NCT00744042|506042|P1|Overall Study|Withdrawal by Subject|1
158904|NCT00744055|506057|P2|Overall Study|Lost to Follow-up|1
158905|NCT00744055|506058|P1|Overall Study|Lost to Follow-up|0
158906|NCT00744055|506057|P2|Overall Study|Protocol Violation|1
158907|NCT00744055|506058|P1|Overall Study|Protocol Violation|1
158908|NCT00744055|506057|P2|Overall Study|Physician Decision|2
158909|NCT00744055|506058|P1|Overall Study|Physician Decision|0
158910|NCT00744055|506057|P2|Overall Study|Lack of Efficacy|1
158911|NCT00744055|506058|P1|Overall Study|Lack of Efficacy|0
158912|NCT00744055|506057|P2|Overall Study|Withdrawal by Subject|9
158913|NCT00744055|506058|P1|Overall Study|Withdrawal by Subject|6
158914|NCT00744237|506069|P3|Overall Study|Adverse Event|5
158915|NCT00744237|506070|P2|Overall Study|Adverse Event|13
158916|NCT00744237|506071|P1|Overall Study|Adverse Event|9
158917|NCT00744237|506069|P3|Overall Study|Administrative. Site Closed|1
158918|NCT00744237|506070|P2|Overall Study|Administrative. Site Closed|1
158919|NCT00744237|506071|P1|Overall Study|Administrative. Site Closed|1
158920|NCT00744237|506069|P3|Overall Study|Poor Compliance|0
158921|NCT00744237|506070|P2|Overall Study|Poor Compliance|2
158922|NCT00744237|506071|P1|Overall Study|Poor Compliance|0
158923|NCT00744237|506069|P3|Overall Study|Prohibited Concomitant Medication|1
158924|NCT00744237|506070|P2|Overall Study|Prohibited Concomitant Medication|0
158925|NCT00744237|506071|P1|Overall Study|Prohibited Concomitant Medication|0
158926|NCT00744237|506069|P3|Overall Study|Study Drug Error|0
158927|NCT00744237|506070|P2|Overall Study|Study Drug Error|0
158928|NCT00744237|506071|P1|Overall Study|Study Drug Error|1
158929|NCT00744237|506069|P3|Overall Study|Dosing Error|1
158930|NCT00744237|506070|P2|Overall Study|Dosing Error|0
158931|NCT00744237|506071|P1|Overall Study|Dosing Error|1
158932|NCT00744237|506069|P3|Overall Study|Inclusion/Exclusion criteria not met|0
158933|NCT00744237|506070|P2|Overall Study|Inclusion/Exclusion criteria not met|0
158934|NCT00744237|506071|P1|Overall Study|Inclusion/Exclusion criteria not met|1
158935|NCT00744237|506069|P3|Overall Study|Protocol Violation|3
158936|NCT00744237|506070|P2|Overall Study|Protocol Violation|4
158937|NCT00744237|506071|P1|Overall Study|Protocol Violation|3
158938|NCT00744237|506069|P3|Overall Study|Lost to Follow-up|1
158939|NCT00744237|506070|P2|Overall Study|Lost to Follow-up|1
158940|NCT00744237|506071|P1|Overall Study|Lost to Follow-up|1
158941|NCT00744237|506069|P3|Overall Study|Withdrawal by Subject|3
158942|NCT00744237|506070|P2|Overall Study|Withdrawal by Subject|5
158943|NCT00744237|506071|P1|Overall Study|Withdrawal by Subject|9
158944|NCT00744237|506069|P3|Overall Study|Lack of Efficacy|0
158945|NCT00744237|506070|P2|Overall Study|Lack of Efficacy|1
158946|NCT00744237|506071|P1|Overall Study|Lack of Efficacy|1
158947|NCT00744263|506084|P2|Overall Study|Unspecified|2
158948|NCT00744263|506085|P1|Overall Study|Unspecified|2
158949|NCT00744263|506084|P2|Overall Study|Adverse Event|0
158950|NCT00744263|506085|P1|Overall Study|Adverse Event|1
158951|NCT00744263|506084|P2|Overall Study|Protocol Violation|5
158952|NCT00744263|506085|P1|Overall Study|Protocol Violation|3
158953|NCT00744263|506084|P2|Overall Study|Physician Decision|23
158954|NCT00744263|506085|P1|Overall Study|Physician Decision|20
158955|NCT00744263|506084|P2|Overall Study|Withdrawal by Subject|150
158956|NCT00744263|506085|P1|Overall Study|Withdrawal by Subject|166
158957|NCT00744263|506084|P2|Overall Study|Lost to Follow-up|2135
158958|NCT00744263|506085|P1|Overall Study|Lost to Follow-up|2038
158959|NCT00744263|506084|P2|Overall Study|Death|3005
158960|NCT00744263|506085|P1|Overall Study|Death|3006
158961|NCT00744328|506108|P3|Overall Study|Found ineligible after randomization|1
158962|NCT00744328|506109|P2|Overall Study|Found ineligible after randomization|0
158963|NCT00744328|506110|P1|Overall Study|Found ineligible after randomization|0
158964|NCT00744328|506108|P3|Overall Study|Withdrawal by Subject|4
158965|NCT00744328|506109|P2|Overall Study|Withdrawal by Subject|3
158966|NCT00744328|506110|P1|Overall Study|Withdrawal by Subject|5
158967|NCT00744328|506108|P3|Overall Study|Lost to Follow-up|3
158968|NCT00744328|506109|P2|Overall Study|Lost to Follow-up|5
158969|NCT00744328|506110|P1|Overall Study|Lost to Follow-up|2
158970|NCT00744497|506143|P2|Overall Study|Not defined|13
158971|NCT00744497|506144|P1|Overall Study|Not defined|19
158972|NCT00744497|506143|P2|Overall Study|Maximum clinical benefit|142
158973|NCT00744497|506144|P1|Overall Study|Maximum clinical benefit|141
158974|NCT00744497|506143|P2|Overall Study|Patient requested to stop study drug|80
158975|NCT00744497|506144|P1|Overall Study|Patient requested to stop study drug|65
158976|NCT00744497|506143|P2|Overall Study|Adverse event unrelated to study drug|122
158977|NCT00744497|506144|P1|Overall Study|Adverse event unrelated to study drug|78
158978|NCT00744497|506143|P2|Overall Study|Study drug toxicity|141
158979|NCT00744497|506144|P1|Overall Study|Study drug toxicity|68
158980|NCT00744497|506143|P2|Overall Study|Disease progression|219
158981|NCT00744497|506144|P1|Overall Study|Disease progression|312
158982|NCT00744497|506143|P2|Overall Study|Administrative Reason By Sponsor|8
158983|NCT00744497|506144|P1|Overall Study|Administrative Reason By Sponsor|25
158984|NCT00744497|506143|P2|Overall Study|No longer meets study criteria|3
158985|NCT00744497|506144|P1|Overall Study|No longer meets study criteria|7
158986|NCT00744497|506143|P2|Overall Study|Poor compliance/noncompliance|5
158987|NCT00744497|506144|P1|Overall Study|Poor compliance/noncompliance|9
158988|NCT00744497|506143|P2|Overall Study|Lost to Follow-up|2
158989|NCT00744497|506144|P1|Overall Study|Lost to Follow-up|4
158990|NCT00744497|506143|P2|Overall Study|Death|9
158991|NCT00744497|506144|P1|Overall Study|Death|11
158992|NCT00744497|506143|P2|Overall Study|Withdrawal by Subject|18
158993|NCT00744497|506144|P1|Overall Study|Withdrawal by Subject|21
158994|NCT00744523|506180|P2|30 Days After the Procedure|Insufficient follow-up|5
158995|NCT00744523|506181|P1|30 Days After the Procedure|Insufficient follow-up|0
158996|NCT00744627|506201|P2|Overall Study|Other|0
158997|NCT00744627|506202|P1|Overall Study|Other|1
158998|NCT00744627|506201|P2|Overall Study|Lost to Follow-up|1
158999|NCT00744627|506202|P1|Overall Study|Lost to Follow-up|2
159000|NCT00744627|506201|P2|Overall Study|Voluntary Withdrawal|6
159001|NCT00744627|506202|P1|Overall Study|Voluntary Withdrawal|9
159002|NCT00744627|506201|P2|Overall Study|Protocol Deviations|2
159003|NCT00744627|506202|P1|Overall Study|Protocol Deviations|0
159004|NCT00744627|506201|P2|Overall Study|Noncompliance|1
159005|NCT00744627|506202|P1|Overall Study|Noncompliance|0
159006|NCT00744627|506201|P2|Overall Study|Lack of Efficacy|3
159007|NCT00744627|506202|P1|Overall Study|Lack of Efficacy|7
159008|NCT00744627|506201|P2|Overall Study|Adverse Event|9
159009|NCT00744627|506202|P1|Overall Study|Adverse Event|6
159010|NCT00744653|506256|P1|Overall Study|Physician Decision|3
159011|NCT00744653|506256|P1|Overall Study|Lost to Follow-up|1
159012|NCT00744653|506256|P1|Overall Study|Death|1
159013|NCT00744653|506256|P1|Overall Study|antineoplastic treatment|11
159014|NCT00744757|506274|P1|Overall Study|Adverse Event|2
159015|NCT00744757|506274|P1|Overall Study|Death|6
159016|NCT00744757|506274|P1|Overall Study|Withdrawal by Subject|1
159017|NCT00744757|506274|P1|Overall Study|Physician Decision|5
159018|NCT00744757|506274|P1|Overall Study|Objective disease progression|7
159019|NCT00744874|506296|P1|Overall Study|Unable to accomodate schedule|1
159189|NCT00752609|506746|P1|Overall Study|Withdrawal by Subject|3
159020|NCT00744874|506296|P1|Overall Study|Study Device not available at procedure|1
159021|NCT00744874|506296|P1|Overall Study|Withdrawal by Subject|1
159022|NCT00744874|506296|P1|Overall Study|Lost to Follow-up|1
159023|NCT00744939|506316|P1|Overall Study|incorrect race|1
159024|NCT00744939|506316|P1|Overall Study|coma|1
159025|NCT00744939|506316|P1|Overall Study|Failed inclusion/exclusion criteria|19
159026|NCT00744939|506316|P1|Overall Study|Did not receive Magnevist|7
159027|NCT00744939|506316|P1|Overall Study|Medical history exclusionary|1
159028|NCT00744939|506316|P1|Overall Study|Lost to Follow-up|12
159029|NCT00744939|506316|P1|Overall Study|distance|4
159030|NCT00744939|506316|P1|Overall Study|Death|24
159031|NCT00744939|506316|P1|Overall Study|Protocol Violation|13
159032|NCT00744939|506316|P1|Overall Study|Withdrawal by Subject|9
159033|NCT00744978|506354|P2|Period 2|Adverse Event|1
159034|NCT00744978|506355|P1|Period 2|Adverse Event|0
159035|NCT00744978|506354|P2|Period 1|Randomized but not Treated|1
159036|NCT00744978|506355|P1|Period 1|Randomized but not Treated|1
159037|NCT00744978|506354|P2|Period 1|Adverse Event|0
159038|NCT00744978|506355|P1|Period 1|Adverse Event|4
159039|NCT00744978|506354|P2|Period 1|Unspecified|2
159040|NCT00744978|506355|P1|Period 1|Unspecified|0
159041|NCT00744978|506354|P2|Period 1|Withdrawal by Subject|2
159042|NCT00744978|506355|P1|Period 1|Withdrawal by Subject|0
159043|NCT00744978|506354|P2|Period 1|Lost to Follow-up|0
159044|NCT00744978|506355|P1|Period 1|Lost to Follow-up|1
159045|NCT00745095|506418|P6|Overall Study|Ineligible due to GFR criteria|28
159046|NCT00745095|506419|P5|Overall Study|Ineligible due to GFR criteria|30
159047|NCT00745095|506420|P4|Overall Study|Ineligible due to GFR criteria|3
159048|NCT00745095|506421|P3|Overall Study|Ineligible due to GFR criteria|3
159049|NCT00745095|506422|P2|Overall Study|Ineligible due to GFR criteria|2
159050|NCT00745095|506423|P1|Overall Study|Ineligible due to GFR criteria|0
159051|NCT00745095|506418|P6|Overall Study|Declined to participate|95
159052|NCT00745095|506419|P5|Overall Study|Declined to participate|92
159053|NCT00745095|506420|P4|Overall Study|Declined to participate|0
159054|NCT00745095|506421|P3|Overall Study|Declined to participate|0
159055|NCT00745095|506422|P2|Overall Study|Declined to participate|0
159056|NCT00745095|506423|P1|Overall Study|Declined to participate|1
159057|NCT00745251|506445|P2|Overall Study|Withdrawal by Subject|1
159058|NCT00745251|506446|P1|Overall Study|Withdrawal by Subject|1
159059|NCT00745251|506445|P2|Overall Study|Adverse Event|2
159060|NCT00745251|506446|P1|Overall Study|Adverse Event|1
159061|NCT00751348|506465|P2|Overall Study|Migration from study area|0
159062|NCT00751348|506466|P1|Overall Study|Migration from study area|1
159063|NCT00751348|506465|P2|Overall Study|Withdrawal by Subject|2
159064|NCT00751348|506466|P1|Overall Study|Withdrawal by Subject|5
159065|NCT00751400|506488|P1|Overall Study|Lost to Follow-up|10
159066|NCT00751621|506518|P1|Overall Study|Poor adherence to asthma treatment|1
159067|NCT00751621|506518|P1|Overall Study|Subject moved to another country|1
159068|NCT00751621|506518|P1|Overall Study|Withdrawal by Subject|1
159069|NCT00751621|506518|P1|Overall Study|Adverse Event|1
159070|NCT00751790|506556|P1|Overall Study|Withdrawal by Subject|1
159071|NCT00751790|506556|P1|Overall Study|Death|3
159072|NCT00751790|506556|P1|Overall Study|Lost to Follow-up|1
159073|NCT00751881|506563|P3|Extension Study Period|Other than specified above|18
159074|NCT00751881|506564|P2|Extension Study Period|Other than specified above|30
159075|NCT00751881|506565|P1|Extension Study Period|Other than specified above|26
159076|NCT00751881|506563|P3|Extension Study Period|Poor Compliance to Protocol|1
159077|NCT00751881|506564|P2|Extension Study Period|Poor Compliance to Protocol|2
159078|NCT00751881|506565|P1|Extension Study Period|Poor Compliance to Protocol|3
159079|NCT00751881|506563|P3|Extension Study Period|Lost to Follow-up|6
159080|NCT00751881|506564|P2|Extension Study Period|Lost to Follow-up|9
159081|NCT00751881|506565|P1|Extension Study Period|Lost to Follow-up|4
159082|NCT00751881|506563|P3|Extension Study Period|Lack of Efficacy|20
159083|NCT00751881|506564|P2|Extension Study Period|Lack of Efficacy|10
159084|NCT00751881|506565|P1|Extension Study Period|Lack of Efficacy|14
159085|NCT00751881|506563|P3|Extension Study Period|Adverse Event|21
159086|NCT00751881|506564|P2|Extension Study Period|Adverse Event|20
159087|NCT00751881|506565|P1|Extension Study Period|Adverse Event|18
159088|NCT00751881|506563|P3|Core Treatment Period|Other:participant's decision/unspecified|16
159089|NCT00751881|506564|P2|Core Treatment Period|Other:participant's decision/unspecified|22
159090|NCT00751881|506565|P1|Core Treatment Period|Other:participant's decision/unspecified|19
159091|NCT00751881|506563|P3|Core Treatment Period|Other: tolerability complaints|0
159092|NCT00751881|506564|P2|Core Treatment Period|Other: tolerability complaints|0
159093|NCT00751881|506565|P1|Core Treatment Period|Other: tolerability complaints|2
159094|NCT00751881|506563|P3|Core Treatment Period|Other: MS treatment change|4
159095|NCT00751881|506564|P2|Core Treatment Period|Other: MS treatment change|4
159096|NCT00751881|506565|P1|Core Treatment Period|Other: MS treatment change|6
159097|NCT00751881|506563|P3|Core Treatment Period|Other: personal/family constraints|10
159098|NCT00751881|506564|P2|Core Treatment Period|Other: personal/family constraints|7
159099|NCT00751881|506565|P1|Core Treatment Period|Other: personal/family constraints|6
159100|NCT00751881|506563|P3|Core Treatment Period|Other: wish to parent|4
159101|NCT00751881|506564|P2|Core Treatment Period|Other: wish to parent|7
159102|NCT00751881|506565|P1|Core Treatment Period|Other: wish to parent|5
159103|NCT00751881|506563|P3|Core Treatment Period|Other: protocol deviation|7
159104|NCT00751881|506564|P2|Core Treatment Period|Other: protocol deviation|3
159105|NCT00751881|506565|P1|Core Treatment Period|Other: protocol deviation|3
159106|NCT00751881|506563|P3|Core Treatment Period|Lost to Follow-up|3
159107|NCT00751881|506564|P2|Core Treatment Period|Lost to Follow-up|4
159108|NCT00751881|506565|P1|Core Treatment Period|Lost to Follow-up|6
159109|NCT00751881|506563|P3|Core Treatment Period|Poor compliance to protocol|4
159110|NCT00751881|506564|P2|Core Treatment Period|Poor compliance to protocol|3
159111|NCT00751881|506565|P1|Core Treatment Period|Poor compliance to protocol|15
159112|NCT00751881|506563|P3|Core Treatment Period|Lack of Efficacy|20
159113|NCT00751881|506564|P2|Core Treatment Period|Lack of Efficacy|30
159114|NCT00751881|506565|P1|Core Treatment Period|Lack of Efficacy|37
159115|NCT00751881|506563|P3|Core Treatment Period|Adverse Event|58
159116|NCT00751881|506564|P2|Core Treatment Period|Adverse Event|54
159117|NCT00751881|506565|P1|Core Treatment Period|Adverse Event|26
159118|NCT00751881|506563|P3|Core Treatment Period|Not treated|2
159119|NCT00751881|506564|P2|Core Treatment Period|Not treated|1
159120|NCT00751881|506565|P1|Core Treatment Period|Not treated|1
159121|NCT00751933|506612|P4|Overall Study|Physician Decision|1
159122|NCT00751933|506613|P3|Overall Study|Physician Decision|1
159123|NCT00751933|506614|P2|Overall Study|Physician Decision|0
159124|NCT00751933|506615|P1|Overall Study|Physician Decision|0
159125|NCT00751933|506612|P4|Overall Study|Withdrawal by Subject|0
159126|NCT00751933|506613|P3|Overall Study|Withdrawal by Subject|0
159127|NCT00751933|506614|P2|Overall Study|Withdrawal by Subject|1
159128|NCT00751933|506615|P1|Overall Study|Withdrawal by Subject|0
159129|NCT00751998|506635|P1|Overall Study|Withdrawal by Subject|2
159130|NCT00751998|506635|P1|Overall Study|Death|11
159131|NCT00751998|506635|P1|Overall Study|Lost to Follow-up|7
159132|NCT00752089|506639|P1|Overall Study|Cannot continue the study|1
159133|NCT00752089|506639|P1|Overall Study|Not capable of wearing partial denture|1
159134|NCT00752089|506639|P1|Overall Study|Could not attend visit 9|1
159135|NCT00752089|506639|P1|Overall Study|Protocol Deviation|2
159136|NCT00752089|506639|P1|Overall Study|Adverse Event|1
159137|NCT00752128|506653|P1|Overall Study|Withdrawal by Subject|4
159138|NCT00752232|506665|P7|Overall Study|Caregiver could not attend the subject|0
159139|NCT00752232|506666|P6|Overall Study|Caregiver could not attend the subject|0
159140|NCT00752232|506667|P5|Overall Study|Caregiver could not attend the subject|1
159141|NCT00752232|506668|P4|Overall Study|Caregiver could not attend the subject|0
159142|NCT00752232|506669|P3|Overall Study|Caregiver could not attend the subject|0
159143|NCT00752232|506670|P2|Overall Study|Caregiver could not attend the subject|0
159144|NCT00752232|506671|P1|Overall Study|Caregiver could not attend the subject|0
159145|NCT00752232|506665|P7|Overall Study|Group home admission|0
159146|NCT00752232|506666|P6|Overall Study|Group home admission|0
159147|NCT00752232|506667|P5|Overall Study|Group home admission|0
159148|NCT00752232|506668|P4|Overall Study|Group home admission|1
159149|NCT00752232|506669|P3|Overall Study|Group home admission|0
159150|NCT00752232|506670|P2|Overall Study|Group home admission|0
159151|NCT00752232|506671|P1|Overall Study|Group home admission|0
159152|NCT00752232|506665|P7|Overall Study|Subject request|0
159153|NCT00752232|506666|P6|Overall Study|Subject request|0
159154|NCT00752232|506667|P5|Overall Study|Subject request|0
159155|NCT00752232|506668|P4|Overall Study|Subject request|0
159156|NCT00752232|506669|P3|Overall Study|Subject request|1
159157|NCT00752232|506670|P2|Overall Study|Subject request|0
159158|NCT00752232|506671|P1|Overall Study|Subject request|0
159159|NCT00752232|506665|P7|Overall Study|Investigator request|0
159160|NCT00752232|506666|P6|Overall Study|Investigator request|0
159161|NCT00752232|506667|P5|Overall Study|Investigator request|1
159162|NCT00752232|506668|P4|Overall Study|Investigator request|0
159163|NCT00752232|506669|P3|Overall Study|Investigator request|0
159164|NCT00752232|506670|P2|Overall Study|Investigator request|0
159165|NCT00752232|506671|P1|Overall Study|Investigator request|0
159166|NCT00752232|506665|P7|Overall Study|Caregiver request|0
159167|NCT00752232|506666|P6|Overall Study|Caregiver request|0
159168|NCT00752232|506667|P5|Overall Study|Caregiver request|1
159169|NCT00752232|506668|P4|Overall Study|Caregiver request|0
159170|NCT00752232|506669|P3|Overall Study|Caregiver request|0
159171|NCT00752232|506670|P2|Overall Study|Caregiver request|0
159172|NCT00752232|506671|P1|Overall Study|Caregiver request|2
159173|NCT00752232|506665|P7|Overall Study|Protocol Violation|0
159174|NCT00752232|506666|P6|Overall Study|Protocol Violation|1
159175|NCT00752232|506667|P5|Overall Study|Protocol Violation|0
159176|NCT00752232|506668|P4|Overall Study|Protocol Violation|0
159177|NCT00752232|506669|P3|Overall Study|Protocol Violation|0
159178|NCT00752232|506670|P2|Overall Study|Protocol Violation|0
159179|NCT00752232|506671|P1|Overall Study|Protocol Violation|0
159180|NCT00752609|506745|P2|Overall Study|Received Aranesp in error|0
159181|NCT00752609|506746|P1|Overall Study|Received Aranesp in error|1
159182|NCT00752609|506745|P2|Overall Study|Met exclusion criteria|0
159183|NCT00752609|506746|P1|Overall Study|Met exclusion criteria|1
159184|NCT00752609|506745|P2|Overall Study|Death|0
159185|NCT00752609|506746|P1|Overall Study|Death|1
159186|NCT00752609|506745|P2|Overall Study|Physician Decision|0
159187|NCT00752609|506746|P1|Overall Study|Physician Decision|1
159188|NCT00752609|506745|P2|Overall Study|Withdrawal by Subject|0
159190|NCT00752609|506745|P2|Overall Study|Adverse Event|2
159191|NCT00752609|506746|P1|Overall Study|Adverse Event|2
159192|NCT00752622|506765|P1|Interventional Phase|Premature Study Termination|5
159193|NCT00752622|506765|P1|Interventional Phase|Physician Decision|1
159194|NCT00752622|506765|P1|Interventional Phase|Non-responder|2
159195|NCT00752622|506765|P1|Observational Phase|Unspecified|2
159196|NCT00752622|506765|P1|Observational Phase|Adverse Event|1
159197|NCT00752622|506765|P1|Observational Phase|Withdrawal by Subject|2
159198|NCT00752622|506765|P1|Observational Phase|Non-responder|2
159199|NCT00752622|506765|P1|Observational Phase|Premature Study Termination|36
159200|NCT00752622|506765|P1|Induction Phase|Premature study termination|14
159201|NCT00752622|506765|P1|Induction Phase|Withdrawal by Subject|1
159202|NCT00752622|506765|P1|Induction Phase|Non-responder|14
159203|NCT00752622|506765|P1|Induction Phase|Unspecified|3
159204|NCT00752622|506765|P1|Induction Phase|Adverse Event|3
159205|NCT00752726|506778|P2|Overall Study|Other Reason|2
159206|NCT00752726|506779|P1|Overall Study|Other Reason|1
159207|NCT00752726|506778|P2|Overall Study|Withdrawal by Subject|10
159208|NCT00752726|506779|P1|Overall Study|Withdrawal by Subject|5
159209|NCT00752726|506778|P2|Overall Study|Adverse Event|0
159210|NCT00752726|506779|P1|Overall Study|Adverse Event|3
159211|NCT00752726|506778|P2|Overall Study|Lost to Follow-up|1
159212|NCT00752726|506779|P1|Overall Study|Lost to Follow-up|2
159213|NCT00752791|506804|P1|Overall Study|Protocol deviation|1
159214|NCT00752791|506804|P1|Overall Study|Switched to hemodialysis|2
159215|NCT00752791|506804|P1|Overall Study|Renal transplant|3
159216|NCT00752791|506804|P1|Overall Study|Death|1
159217|NCT00752791|506804|P1|Overall Study|Physician Decision|1
159218|NCT00752791|506804|P1|Overall Study|Withdrawal by Subject|1
159219|NCT00752791|506804|P1|Overall Study|Adverse Event|7
159220|NCT00752895|506816|P2|Overall Study|Withdrawal by Subject|3
159221|NCT00752895|506817|P1|Overall Study|Withdrawal by Subject|8
159222|NCT00752986|506838|P3|Overall Study|Protocol Violation|0
159223|NCT00752986|506839|P2|Overall Study|Protocol Violation|0
159224|NCT00752986|506840|P1|Overall Study|Protocol Violation|3
159225|NCT00752986|506838|P3|Overall Study|Withdrawal by Subject|2
159226|NCT00752986|506839|P2|Overall Study|Withdrawal by Subject|1
159227|NCT00752986|506840|P1|Overall Study|Withdrawal by Subject|2
159228|NCT00753012|506859|P2|Overall Study|Confounded endpoint data|0
159229|NCT00753012|506860|P1|Overall Study|Confounded endpoint data|1
159230|NCT00753012|506859|P2|Overall Study|Lost to Follow-up|0
159231|NCT00753012|506860|P1|Overall Study|Lost to Follow-up|4
159232|NCT00753012|506859|P2|Overall Study|Withdrawal by Subject|1
159233|NCT00753012|506860|P1|Overall Study|Withdrawal by Subject|0
159234|NCT00753012|506859|P2|Overall Study|Adverse Event|0
159235|NCT00753012|506860|P1|Overall Study|Adverse Event|2
159236|NCT00753012|506859|P2|Overall Study|Ineligible, abnormal cardiac histo|0
159237|NCT00753012|506860|P1|Overall Study|Ineligible, abnormal cardiac histo|1
159238|NCT00753272|506889|P2|Overall Study|Unspecified|1088
159239|NCT00753272|506890|P1|Overall Study|Unspecified|1104
159240|NCT00753272|506889|P2|Overall Study|Lost to Follow-up|497
159241|NCT00753272|506890|P1|Overall Study|Lost to Follow-up|491
159242|NCT00753272|506889|P2|Overall Study|Withdrawal by Subject|2407
159243|NCT00753272|506890|P1|Overall Study|Withdrawal by Subject|2481
159244|NCT00753272|506889|P2|Overall Study|Protocol Violation|46
159245|NCT00753272|506890|P1|Overall Study|Protocol Violation|28
159246|NCT00753272|506889|P2|Overall Study|Adverse Event|869
159247|NCT00753272|506890|P1|Overall Study|Adverse Event|878
159248|NCT00753415|507007|P10|Part B|Disease progression|1
159249|NCT00753415|507008|P9|Part B|Disease progression|2
159250|NCT00753415|507009|P8|Part B|Disease progression|0
159251|NCT00753415|507010|P7|Part B|Disease progression|0
159252|NCT00753415|507011|P6|Part B|Disease progression|0
159253|NCT00753415|507012|P5|Part B|Disease progression|0
159254|NCT00753415|507013|P4|Part B|Disease progression|0
159255|NCT00753415|507014|P3|Part B|Disease progression|0
159256|NCT00753415|507015|P2|Part B|Disease progression|0
159257|NCT00753415|507016|P1|Part B|Disease progression|0
159258|NCT00753415|507007|P10|Part B|Lost to Follow-up|0
159259|NCT00753415|507008|P9|Part B|Lost to Follow-up|1
159260|NCT00753415|507009|P8|Part B|Lost to Follow-up|1
159261|NCT00753415|507010|P7|Part B|Lost to Follow-up|0
159262|NCT00753415|507011|P6|Part B|Lost to Follow-up|0
159263|NCT00753415|507012|P5|Part B|Lost to Follow-up|0
159264|NCT00753415|507013|P4|Part B|Lost to Follow-up|0
159265|NCT00753415|507014|P3|Part B|Lost to Follow-up|0
159266|NCT00753415|507015|P2|Part B|Lost to Follow-up|0
159267|NCT00753415|507016|P1|Part B|Lost to Follow-up|0
159268|NCT00753415|507007|P10|Part A|Withdrawal by Subject|0
159269|NCT00753415|507008|P9|Part A|Withdrawal by Subject|0
159270|NCT00753415|507009|P8|Part A|Withdrawal by Subject|0
159271|NCT00753415|507010|P7|Part A|Withdrawal by Subject|0
159272|NCT00753415|507011|P6|Part A|Withdrawal by Subject|0
159273|NCT00753415|507012|P5|Part A|Withdrawal by Subject|0
159274|NCT00753415|507013|P4|Part A|Withdrawal by Subject|0
159275|NCT00753415|507014|P3|Part A|Withdrawal by Subject|1
159276|NCT00753415|507015|P2|Part A|Withdrawal by Subject|0
159277|NCT00753415|507016|P1|Part A|Withdrawal by Subject|0
159278|NCT00753415|507007|P10|Part A|Disease progression|0
159279|NCT00753415|507008|P9|Part A|Disease progression|0
159280|NCT00753415|507009|P8|Part A|Disease progression|0
159281|NCT00753415|507010|P7|Part A|Disease progression|0
159282|NCT00753415|507011|P6|Part A|Disease progression|0
159283|NCT00753415|507012|P5|Part A|Disease progression|0
159284|NCT00753415|507013|P4|Part A|Disease progression|2
159285|NCT00753415|507014|P3|Part A|Disease progression|1
159286|NCT00753415|507015|P2|Part A|Disease progression|0
159287|NCT00753415|507016|P1|Part A|Disease progression|1
159288|NCT00753454|507058|P1|Overall Study|Investigator Decision|1
159289|NCT00753454|507058|P1|Overall Study|Withdrawal by Subject|5
159290|NCT00753454|507058|P1|Overall Study|Lost to Follow-up|3
159291|NCT00753454|507058|P1|Overall Study|Lack of Efficacy|1
159292|NCT00753454|507058|P1|Overall Study|Adverse Event|4
159293|NCT00753506|507089|P2|Overall Study|Other reason|1
159294|NCT00753506|507090|P1|Overall Study|Other reason|1
159295|NCT00753506|507089|P2|Overall Study|Lost to Follow-up|0
159296|NCT00753506|507090|P1|Overall Study|Lost to Follow-up|2
159297|NCT00753506|507089|P2|Overall Study|Withdrawal by Subject|1
159298|NCT00753506|507090|P1|Overall Study|Withdrawal by Subject|4
159299|NCT00753519|507098|P2|Overall Study|Withdrawal by Subject|2
159300|NCT00753519|507099|P1|Overall Study|Withdrawal by Subject|0
159301|NCT00753545|507121|P2|Overall Study|Voluntary Discontinuation of Patient|3
159302|NCT00753545|507122|P1|Overall Study|Voluntary Discontinuation of Patient|7
159303|NCT00753545|507121|P2|Overall Study|Protocol Violation|0
159304|NCT00753545|507122|P1|Overall Study|Protocol Violation|1
159305|NCT00753545|507121|P2|Overall Study|Lost to Follow-up|3
159306|NCT00753545|507122|P1|Overall Study|Lost to Follow-up|2
159307|NCT00753545|507121|P2|Overall Study|Death|112
159308|NCT00753545|507122|P1|Overall Study|Death|98
159309|NCT00753623|507160|P2|Phase II (14 Days)|Physician Decision|1
159310|NCT00753623|507161|P1|Phase II (14 Days)|Physician Decision|0
159311|NCT00753623|507160|P2|Washout (7 Days)|Physician Decision|0
159312|NCT00753623|507161|P1|Washout (7 Days)|Physician Decision|1
159313|NCT00753623|507160|P2|Phase I (14 Days)|Adverse Event|1
159314|NCT00753623|507161|P1|Phase I (14 Days)|Adverse Event|0
159315|NCT00753623|507160|P2|Phase I (14 Days)|Physician Decision|2
159316|NCT00753623|507161|P1|Phase I (14 Days)|Physician Decision|1
159317|NCT00753623|507160|P2|Phase I (14 Days)|Withdrawal by Subject|1
159318|NCT00753623|507161|P1|Phase I (14 Days)|Withdrawal by Subject|1
159319|NCT00753649|507179|P2|Overall Study|Protocol Violation|0
159320|NCT00753649|507180|P1|Overall Study|Protocol Violation|2
159321|NCT00753649|507179|P2|Overall Study|Lost to follow-up-complete vaccination|0
159322|NCT00753649|507180|P1|Overall Study|Lost to follow-up-complete vaccination|1
159323|NCT00753649|507179|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
159324|NCT00753649|507180|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
159325|NCT00753649|507179|P2|Overall Study|Migrated/moved from study area|0
159326|NCT00753649|507180|P1|Overall Study|Migrated/moved from study area|1
159327|NCT00753675|507203|P3|Overall Study|Lost to Follow-up|0
159328|NCT00753675|507204|P2|Overall Study|Lost to Follow-up|0
159329|NCT00753675|507205|P1|Overall Study|Lost to Follow-up|1
159330|NCT00753675|507203|P3|Overall Study|Withdrawal by Subject|0
159331|NCT00753675|507204|P2|Overall Study|Withdrawal by Subject|1
159332|NCT00753675|507205|P1|Overall Study|Withdrawal by Subject|0
159333|NCT00753675|507203|P3|Overall Study|Objective progression of disease|35
159334|NCT00753675|507204|P2|Overall Study|Objective progression of disease|35
159335|NCT00753675|507205|P1|Overall Study|Objective progression of disease|35
159336|NCT00753675|507203|P3|Overall Study|Adverse Event|4
159337|NCT00753675|507204|P2|Overall Study|Adverse Event|9
159338|NCT00753675|507205|P1|Overall Study|Adverse Event|11
159339|NCT00753675|507203|P3|Overall Study|Death|4
159340|NCT00753675|507204|P2|Overall Study|Death|2
159341|NCT00753675|507205|P1|Overall Study|Death|1
159342|NCT00753675|507203|P3|Overall Study|other reason|13
159343|NCT00753675|507204|P2|Overall Study|other reason|12
159344|NCT00753675|507205|P1|Overall Study|other reason|11
159345|NCT00753688|507227|P2|Overall Study|Adverse Event|1
159346|NCT00753688|507228|P1|Overall Study|Adverse Event|0
159347|NCT00753688|507227|P2|Overall Study|Ongoing - in Follow-up|31
159348|NCT00753688|507228|P1|Overall Study|Ongoing - in Follow-up|15
159349|NCT00753688|507227|P2|Overall Study|Participant Withdrew Consent|2
159350|NCT00753688|507228|P1|Overall Study|Participant Withdrew Consent|2
159351|NCT00753688|507227|P2|Overall Study|Missing|9
159352|NCT00753688|507228|P1|Overall Study|Missing|4
159353|NCT00753688|507227|P2|Overall Study|Death|203
159354|NCT00753688|507228|P1|Overall Study|Death|102
159355|NCT00753714|507256|P2|Overall Study|not specified|5
159356|NCT00753714|507257|P1|Overall Study|not specified|7
159357|NCT00753714|507256|P2|Overall Study|Death|3
159358|NCT00753714|507257|P1|Overall Study|Death|3
159359|NCT00753714|507256|P2|Overall Study|Withdrawal by Subject|1
159360|NCT00753714|507257|P1|Overall Study|Withdrawal by Subject|2
159361|NCT00753714|507256|P2|Overall Study|Lost to Follow-up|1
159362|NCT00753714|507257|P1|Overall Study|Lost to Follow-up|0
159363|NCT00753714|507256|P2|Overall Study|Protocol Violation|0
159364|NCT00753714|507257|P1|Overall Study|Protocol Violation|1
159365|NCT00753714|507256|P2|Overall Study|Adverse Event|18
159366|NCT00753714|507257|P1|Overall Study|Adverse Event|26
159367|NCT00753714|507256|P2|Overall Study|Lack of Efficacy|34
159368|NCT00753714|507257|P1|Overall Study|Lack of Efficacy|21
159369|NCT00753766|507273|P2|Overall Study|Physician Decision|0
159370|NCT00753766|507274|P1|Overall Study|Physician Decision|1
159371|NCT00753896|507282|P1|Overall Study|Entry Criteria Not Met|4
159372|NCT00753896|507282|P1|Overall Study|Withdrawal by Subject|4
159373|NCT00753896|507282|P1|Overall Study|Protocol Violation|1
159374|NCT00753896|507282|P1|Overall Study|Lost to Follow-up|2
159375|NCT00753896|507282|P1|Overall Study|Death|1
159376|NCT00753896|507282|P1|Overall Study|Adverse Event|4
159377|NCT00753922|507300|P4|Overall Study|Discontinuation Due to Explantation|4
159378|NCT00753922|507301|P3|Overall Study|Discontinuation Due to Explantation|14
159379|NCT00753922|507302|P2|Overall Study|Discontinuation Due to Explantation|14
159380|NCT00753922|507303|P1|Overall Study|Discontinuation Due to Explantation|14
159381|NCT00753922|507300|P4|Overall Study|Death|1
159382|NCT00753922|507301|P3|Overall Study|Death|2
159383|NCT00753922|507302|P2|Overall Study|Death|23
159384|NCT00753922|507303|P1|Overall Study|Death|2
159385|NCT00753922|507300|P4|Overall Study|Patients Not Completing Visit|0
159386|NCT00753922|507301|P3|Overall Study|Patients Not Completing Visit|1
159387|NCT00753922|507302|P2|Overall Study|Patients Not Completing Visit|0
159388|NCT00753922|507303|P1|Overall Study|Patients Not Completing Visit|11
159389|NCT00753922|507300|P4|Overall Study|Patient Non-compliance|11
159390|NCT00753922|507301|P3|Overall Study|Patient Non-compliance|14
159391|NCT00753922|507302|P2|Overall Study|Patient Non-compliance|22
159392|NCT00753922|507303|P1|Overall Study|Patient Non-compliance|55
159393|NCT00753922|507300|P4|Overall Study|Withdrawal by Subject|2
159394|NCT00753922|507301|P3|Overall Study|Withdrawal by Subject|4
159395|NCT00753922|507302|P2|Overall Study|Withdrawal by Subject|11
159396|NCT00753922|507303|P1|Overall Study|Withdrawal by Subject|9
159397|NCT00753922|507300|P4|Overall Study|Lost to Follow-up|5
159398|NCT00753922|507301|P3|Overall Study|Lost to Follow-up|28
159399|NCT00753922|507302|P2|Overall Study|Lost to Follow-up|24
159400|NCT00753922|507303|P1|Overall Study|Lost to Follow-up|155
159401|NCT00754013|507348|P2|Overall Study|didn't return after study termed|4
159402|NCT00754013|507349|P1|Overall Study|didn't return after study termed|3
159403|NCT00754013|507348|P2|Overall Study|Lost to Follow-up|1
159404|NCT00754013|507349|P1|Overall Study|Lost to Follow-up|1
159405|NCT00754065|507359|P2|Overall Study|Reason not specified or unknown, etc.|27
159406|NCT00754065|507360|P1|Overall Study|Reason not specified or unknown, etc.|21
159407|NCT00754065|507359|P2|Overall Study|Pregnancy|0
159408|NCT00754065|507360|P1|Overall Study|Pregnancy|6
159409|NCT00754065|507359|P2|Overall Study|Withdrawal by Subject|5
159410|NCT00754065|507360|P1|Overall Study|Withdrawal by Subject|4
159411|NCT00754065|507359|P2|Overall Study|Protocol Violation|10
159412|NCT00754065|507360|P1|Overall Study|Protocol Violation|12
159413|NCT00754065|507359|P2|Overall Study|Lost to Follow-up|11
159414|NCT00754065|507360|P1|Overall Study|Lost to Follow-up|7
159415|NCT00754065|507359|P2|Overall Study|Adverse Event|25
159416|NCT00754065|507360|P1|Overall Study|Adverse Event|19
159417|NCT00754065|507359|P2|Overall Study|Never received treatment|2
159418|NCT00754065|507360|P1|Overall Study|Never received treatment|12
159419|NCT00754234|507671|P1|Overall Study|Withdrawal by Subject|3
159420|NCT00748189|507677|P2|Overall Study|Ongoing|162
159421|NCT00748189|507678|P1|Overall Study|Ongoing|155
159422|NCT00748189|507677|P2|Overall Study|Study terminated by Sponsor|1
159423|NCT00748189|507678|P1|Overall Study|Study terminated by Sponsor|0
159424|NCT00748189|507677|P2|Overall Study|Lost to Follow-up|4
159425|NCT00748189|507678|P1|Overall Study|Lost to Follow-up|2
159426|NCT00748189|507677|P2|Overall Study|Physician Decision|4
159427|NCT00748189|507678|P1|Overall Study|Physician Decision|13
159428|NCT00748189|507677|P2|Overall Study|Withdrawal by Subject|16
159429|NCT00748189|507678|P1|Overall Study|Withdrawal by Subject|15
159430|NCT00748189|507677|P2|Overall Study|Death|34
159431|NCT00748189|507678|P1|Overall Study|Death|40
159432|NCT00748241|507732|P1|Overall Study|Death|2
159433|NCT00748241|507732|P1|Overall Study|Lost to Follow-up|5
159434|NCT00748241|507732|P1|Overall Study|Implant failure|1
159435|NCT00748553|507742|P2|Overall Study|noncompliance|0
159436|NCT00748553|507743|P1|Overall Study|noncompliance|1
159437|NCT00748553|507742|P2|Overall Study|disease progression|0
159438|NCT00748553|507743|P1|Overall Study|disease progression|2
159439|NCT00748553|507742|P2|Overall Study|Adverse Event|1
159440|NCT00748553|507743|P1|Overall Study|Adverse Event|0
159441|NCT00748566|507750|P1|Overall Study|Unspecified|9
159442|NCT00748566|507750|P1|Overall Study|Study terminated by sponsor|5
159443|NCT00748566|507750|P1|Overall Study|Withdrawal by Subject|22
159444|NCT00748566|507750|P1|Overall Study|Protocol Violation|13
159445|NCT00748566|507750|P1|Overall Study|Lost to Follow-up|1
159446|NCT00748566|507750|P1|Overall Study|Lack of Efficacy|12
159447|NCT00748566|507750|P1|Overall Study|Death|1
159448|NCT00748566|507750|P1|Overall Study|Adverse Event|49
159449|NCT00748709|507793|P1|Overall Study|Other Reasons|1
159450|NCT00748709|507793|P1|Overall Study|Withdrawal by Subject|1
159451|NCT00748709|507793|P1|Overall Study|Other Adverse Event|1
159452|NCT00748709|507793|P1|Overall Study|Drug reducing Toxity|2
159453|NCT00748709|507793|P1|Overall Study|Progressive disease|15
159454|NCT00754325|507807|P2|Initial Treatment|Disease Progression|35
159455|NCT00754325|507808|P1|Initial Treatment|Disease Progression|35
159456|NCT00754325|507807|P2|Initial Treatment|Sponsor Request|1
159457|NCT00754325|507808|P1|Initial Treatment|Sponsor Request|0
159458|NCT00754325|507807|P2|Initial Treatment|Physician Decision|0
159459|NCT00754325|507808|P1|Initial Treatment|Physician Decision|2
159460|NCT00754325|507807|P2|Initial Treatment|Withdrawal by Subject|2
159461|NCT00754325|507808|P1|Initial Treatment|Withdrawal by Subject|2
159462|NCT00754325|507807|P2|Initial Treatment|Adverse Event|6
159463|NCT00754325|507808|P1|Initial Treatment|Adverse Event|7
159464|NCT00754325|507807|P2|Initial Treatment|Continuing Active Treatment|5
159465|NCT00754325|507808|P1|Initial Treatment|Continuing Active Treatment|4
159466|NCT00754338|507831|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
159467|NCT00754338|507832|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
159468|NCT00754338|507833|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
159469|NCT00754338|507834|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
159470|NCT00754338|507831|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
159471|NCT00754338|507832|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
159472|NCT00754338|507833|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
159473|NCT00754338|507834|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
159474|NCT00754390|507875|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
159475|NCT00754390|507875|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
159476|NCT00754390|507875|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
159477|NCT00754390|507875|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
159478|NCT00754442|507884|P2|Overall Study|Withdrawal by Subject|3
159479|NCT00754442|507885|P1|Overall Study|Withdrawal by Subject|5
159480|NCT00754559|507966|P1|Overall Study|Withdrawal by Subject|3
159481|NCT00754559|507966|P1|Overall Study|Other|5
159482|NCT00754559|507966|P1|Overall Study|Administrative reason|1
159483|NCT00754559|507966|P1|Overall Study|Lost to Follow-up|2
159484|NCT00754559|507966|P1|Overall Study|Lack of Efficacy|10
159485|NCT00754559|507966|P1|Overall Study|Protocol Violation|11
159486|NCT00754559|507966|P1|Overall Study|Adverse Event|15
159487|NCT00754572|507990|P1|Overall Study|Lost to Follow-up|1
159488|NCT00754572|507990|P1|Overall Study|Administrative Reason|3
159489|NCT00754572|507990|P1|Overall Study|Death|1
159490|NCT00754572|507990|P1|Overall Study|Lack of Efficacy|2
159491|NCT00754572|507990|P1|Overall Study|Withdrawal by Subject|3
159492|NCT00754572|507990|P1|Overall Study|Protocol Violation|3
159493|NCT00754572|507990|P1|Overall Study|Unspecified|39
159494|NCT00754572|507990|P1|Overall Study|Adverse Event|19
159495|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Not specified|0
159496|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Not specified|1
159497|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
159498|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
159499|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
159500|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
159501|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
159502|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
159503|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
159504|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
159505|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
159506|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
159507|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
159508|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
159509|NCT00757588|508026|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
159510|NCT00757588|508027|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
159511|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Not specified|1
159512|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Not specified|0
159513|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
159514|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
159515|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
159516|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
159517|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
159518|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
159519|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Death|0
159520|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Death|1
159521|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
159522|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
159523|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
159524|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
159525|NCT00757588|508026|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
159526|NCT00757588|508027|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
159527|NCT00757627|508179|P1|Overall Study|Unspecified|1
159528|NCT00757627|508179|P1|Overall Study|Withdrawal by Subject|27
159529|NCT00757627|508179|P1|Overall Study|Lost to Follow-up|28
159530|NCT00757627|508179|P1|Overall Study|Lack of Efficacy|10
159531|NCT00757627|508179|P1|Overall Study|Adverse Event|15
159532|NCT00757705|508209|P1|Overall Study|Unspecified|18
159533|NCT00757705|508209|P1|Overall Study|Non-compliant|9
159534|NCT00757705|508209|P1|Overall Study|Ineligible to continue|8
159535|NCT00757705|508209|P1|Overall Study|Insufficient Response|26
159536|NCT00757705|508209|P1|Overall Study|Withdrawal by Subject|25
159537|NCT00757705|508209|P1|Overall Study|Lost to Follow-up|16
159538|NCT00757705|508209|P1|Overall Study|Adverse Event|19
159539|NCT00757783|508223|P2|Overall Study|Unspecified|2
159540|NCT00757783|508224|P1|Overall Study|Unspecified|1
159541|NCT00757783|508223|P2|Overall Study|Withdrawal by Subject|1
159542|NCT00757783|508224|P1|Overall Study|Withdrawal by Subject|2
159543|NCT00757783|508223|P2|Overall Study|Protocol Violation|0
159544|NCT00757783|508224|P1|Overall Study|Protocol Violation|1
159545|NCT00757783|508223|P2|Overall Study|Lost to Follow-up|1
159546|NCT00757783|508224|P1|Overall Study|Lost to Follow-up|1
159547|NCT00757783|508223|P2|Overall Study|Adverse Event|2
159548|NCT00757783|508224|P1|Overall Study|Adverse Event|0
159549|NCT00757848|508285|P2|Overall Study|Incorrect enrolment|0
159550|NCT00757848|508286|P1|Overall Study|Incorrect enrolment|1
159551|NCT00757848|508285|P2|Overall Study|Adverse Event|2
159552|NCT00757848|508286|P1|Overall Study|Adverse Event|1
159553|NCT00757848|508285|P2|Overall Study|Voluntary discontinuation|0
159554|NCT00757848|508286|P1|Overall Study|Voluntary discontinuation|1
159555|NCT00758043|508334|P4|Overall Study|Other Reasons|5
159556|NCT00758043|508335|P3|Overall Study|Other Reasons|0
159557|NCT00758043|508336|P2|Overall Study|Other Reasons|1
159558|NCT00758043|508337|P1|Overall Study|Other Reasons|0
159559|NCT00758043|508334|P4|Overall Study|Non-Compliant With study Drug|1
159560|NCT00758043|508335|P3|Overall Study|Non-Compliant With study Drug|0
159561|NCT00758043|508336|P2|Overall Study|Non-Compliant With study Drug|0
159562|NCT00758043|508337|P1|Overall Study|Non-Compliant With study Drug|0
159563|NCT00758043|508334|P4|Overall Study|Required Prohibited Medication|3
159564|NCT00758043|508335|P3|Overall Study|Required Prohibited Medication|1
159565|NCT00758043|508336|P2|Overall Study|Required Prohibited Medication|0
159566|NCT00758043|508337|P1|Overall Study|Required Prohibited Medication|0
159567|NCT00758043|508334|P4|Overall Study|Withdrawal by Subject|4
159568|NCT00758043|508335|P3|Overall Study|Withdrawal by Subject|1
159569|NCT00758043|508336|P2|Overall Study|Withdrawal by Subject|1
159570|NCT00758043|508337|P1|Overall Study|Withdrawal by Subject|0
159571|NCT00758043|508334|P4|Overall Study|Lost to Follow-up|5
159572|NCT00758043|508335|P3|Overall Study|Lost to Follow-up|2
159573|NCT00758043|508336|P2|Overall Study|Lost to Follow-up|2
159574|NCT00758043|508337|P1|Overall Study|Lost to Follow-up|0
159575|NCT00758043|508334|P4|Overall Study|Refused Further Treatment|8
159576|NCT00758043|508335|P3|Overall Study|Refused Further Treatment|5
159577|NCT00758043|508336|P2|Overall Study|Refused Further Treatment|11
159578|NCT00758043|508337|P1|Overall Study|Refused Further Treatment|0
159579|NCT00758043|508334|P4|Overall Study|Lack of Efficacy|12
159580|NCT00758043|508335|P3|Overall Study|Lack of Efficacy|18
159581|NCT00758043|508336|P2|Overall Study|Lack of Efficacy|6
159582|NCT00758043|508337|P1|Overall Study|Lack of Efficacy|0
159583|NCT00758043|508334|P4|Overall Study|Adverse Event|62
159584|NCT00758043|508335|P3|Overall Study|Adverse Event|12
159585|NCT00758043|508336|P2|Overall Study|Adverse Event|20
159586|NCT00758043|508337|P1|Overall Study|Adverse Event|1
159587|NCT00758069|508366|P3|Overall Study|Incorrect Study Drug|0
159588|NCT00758069|508367|P2|Overall Study|Incorrect Study Drug|0
159589|NCT00758069|508368|P1|Overall Study|Incorrect Study Drug|1
159590|NCT00758069|508366|P3|Overall Study|Lack of Efficacy|1
159591|NCT00758069|508367|P2|Overall Study|Lack of Efficacy|0
159592|NCT00758069|508368|P1|Overall Study|Lack of Efficacy|0
159593|NCT00758160|508379|P1|Overall Study|Withdrawal by Subject|8
159594|NCT00758160|508379|P1|Overall Study|Protocol Violation|12
159595|NCT00758160|508379|P1|Overall Study|Lost to Follow-up|14
159596|NCT00758160|508379|P1|Overall Study|Lack of Efficacy|10
159597|NCT00758160|508379|P1|Overall Study|Adverse Event|15
159598|NCT00758160|508379|P1|Overall Study|Administration Problems|3
159599|NCT00758160|508379|P1|Overall Study|No Longer Requires Study Medication|4
159600|NCT00758394|508417|P4|3rd Intervention|Lost to Follow-up|1
159601|NCT00758394|508418|P3|3rd Intervention|Lost to Follow-up|0
159602|NCT00758394|508419|P2|3rd Intervention|Lost to Follow-up|0
159603|NCT00758394|508420|P1|3rd Intervention|Lost to Follow-up|1
159604|NCT00758394|508417|P4|2nd Intervention Order|Lost to Follow-up|0
159605|NCT00758394|508418|P3|2nd Intervention Order|Lost to Follow-up|0
159606|NCT00758394|508419|P2|2nd Intervention Order|Lost to Follow-up|1
159607|NCT00758394|508420|P1|2nd Intervention Order|Lost to Follow-up|0
159608|NCT00758459|508441|P2|Overall Study|Withdrawal by Subject|1
159609|NCT00758459|508442|P1|Overall Study|Withdrawal by Subject|0
159610|NCT00758459|508441|P2|Overall Study|Protocol Violation|1
159611|NCT00758459|508442|P1|Overall Study|Protocol Violation|0
159612|NCT00758459|508441|P2|Overall Study|Adverse Event|2
159613|NCT00758459|508442|P1|Overall Study|Adverse Event|3
159614|NCT00758485|508476|P2|Overall Study|Not Treated|2
159615|NCT00758485|508477|P1|Overall Study|Not Treated|1
159616|NCT00758485|508476|P2|Overall Study|Lost to Follow-up|1
159617|NCT00758485|508477|P1|Overall Study|Lost to Follow-up|0
159618|NCT00758498|508490|P3|Overall Study|Noncompliance to study procedures|1
159619|NCT00758498|508491|P2|Overall Study|Noncompliance to study procedures|0
159620|NCT00758498|508492|P1|Overall Study|Noncompliance to study procedures|0
159621|NCT00758498|508490|P3|Overall Study|Withdrawal by Subject|1
159622|NCT00758498|508491|P2|Overall Study|Withdrawal by Subject|0
159623|NCT00758498|508492|P1|Overall Study|Withdrawal by Subject|0
159624|NCT00758498|508490|P3|Overall Study|Subject legally detained out of state|0
159625|NCT00758498|508491|P2|Overall Study|Subject legally detained out of state|0
159626|NCT00758498|508492|P1|Overall Study|Subject legally detained out of state|1
159627|NCT00758498|508490|P3|Overall Study|Adverse Event|3
159628|NCT00758498|508491|P2|Overall Study|Adverse Event|2
159629|NCT00758498|508492|P1|Overall Study|Adverse Event|2
159630|NCT00758589|508603|P4|Overall Study|Palm stopped to work|1
159631|NCT00758589|508604|P3|Overall Study|Palm stopped to work|0
159632|NCT00758589|508605|P2|Overall Study|Palm stopped to work|0
159633|NCT00758589|508606|P1|Overall Study|Palm stopped to work|0
159634|NCT00758589|508603|P4|Overall Study|Withdrawal by Subject|1
159635|NCT00758589|508604|P3|Overall Study|Withdrawal by Subject|1
159636|NCT00758589|508605|P2|Overall Study|Withdrawal by Subject|1
159637|NCT00758589|508606|P1|Overall Study|Withdrawal by Subject|0
159638|NCT00758589|508603|P4|Overall Study|Adverse Event|4
159639|NCT00758589|508604|P3|Overall Study|Adverse Event|5
159640|NCT00758589|508605|P2|Overall Study|Adverse Event|2
159641|NCT00758589|508606|P1|Overall Study|Adverse Event|3
159642|NCT00758602|508674|P2|Overall Study|Reason not specified|3
159643|NCT00758602|508675|P1|Overall Study|Reason not specified|3
159644|NCT00758602|508674|P2|Overall Study|Death|1
159645|NCT00758602|508675|P1|Overall Study|Death|0
159646|NCT00758602|508674|P2|Overall Study|Protocol Violation|2
159647|NCT00758602|508675|P1|Overall Study|Protocol Violation|0
159648|NCT00758602|508674|P2|Overall Study|Withdrawal by Subject|3
159649|NCT00758602|508675|P1|Overall Study|Withdrawal by Subject|1
159650|NCT00758602|508674|P2|Overall Study|Lost to Follow-up|3
159651|NCT00758602|508675|P1|Overall Study|Lost to Follow-up|4
159652|NCT00758602|508674|P2|Overall Study|Adverse Event|10
159653|NCT00758602|508675|P1|Overall Study|Adverse Event|11
159654|NCT00758680|508708|P10|Overall Study|Withdrawal by Subject|0
159655|NCT00758680|508709|P9|Overall Study|Withdrawal by Subject|1
159656|NCT00758680|508710|P8|Overall Study|Withdrawal by Subject|0
159657|NCT00758680|508711|P7|Overall Study|Withdrawal by Subject|1
159658|NCT00758680|508712|P6|Overall Study|Withdrawal by Subject|0
159659|NCT00758680|508713|P5|Overall Study|Withdrawal by Subject|0
159660|NCT00758680|508714|P4|Overall Study|Withdrawal by Subject|0
159661|NCT00758680|508715|P3|Overall Study|Withdrawal by Subject|0
159662|NCT00758680|508716|P2|Overall Study|Withdrawal by Subject|0
159663|NCT00758680|508717|P1|Overall Study|Withdrawal by Subject|0
159664|NCT00758680|508708|P10|Overall Study|Laboratory Adverse Event|0
159665|NCT00758680|508709|P9|Overall Study|Laboratory Adverse Event|1
159666|NCT00758680|508710|P8|Overall Study|Laboratory Adverse Event|0
159667|NCT00758680|508711|P7|Overall Study|Laboratory Adverse Event|0
159668|NCT00758680|508712|P6|Overall Study|Laboratory Adverse Event|0
159669|NCT00758680|508713|P5|Overall Study|Laboratory Adverse Event|0
159670|NCT00758680|508714|P4|Overall Study|Laboratory Adverse Event|0
159671|NCT00758680|508715|P3|Overall Study|Laboratory Adverse Event|0
159672|NCT00758680|508716|P2|Overall Study|Laboratory Adverse Event|0
159673|NCT00758680|508717|P1|Overall Study|Laboratory Adverse Event|0
159674|NCT00758680|508708|P10|Overall Study|Adverse Event|1
159675|NCT00758680|508709|P9|Overall Study|Adverse Event|0
159676|NCT00758680|508710|P8|Overall Study|Adverse Event|1
159677|NCT00758680|508711|P7|Overall Study|Adverse Event|0
159678|NCT00758680|508712|P6|Overall Study|Adverse Event|0
159679|NCT00758680|508713|P5|Overall Study|Adverse Event|0
159680|NCT00758680|508714|P4|Overall Study|Adverse Event|0
159681|NCT00758680|508715|P3|Overall Study|Adverse Event|0
159682|NCT00758680|508716|P2|Overall Study|Adverse Event|0
159683|NCT00758680|508717|P1|Overall Study|Adverse Event|0
159684|NCT00758706|508759|P2|Overall Study|Adverse Event|4
159685|NCT00758706|508760|P1|Overall Study|Adverse Event|4
159686|NCT00758771|508848|P2|Overall Study|Did not meet eligibility criteria|4
159687|NCT00758771|508849|P1|Overall Study|Did not meet eligibility criteria|2
159688|NCT00758771|508848|P2|Overall Study|Withdrawal by Subject|1
159689|NCT00758771|508849|P1|Overall Study|Withdrawal by Subject|1
159690|NCT00759031|508886|P2|First Intervention (1 Day)|Screening failure|0
159691|NCT00759031|508887|P1|First Intervention (1 Day)|Screening failure|1
159692|NCT00759031|508886|P2|First Intervention (1 Day)|Withdrawal by Subject|1
159693|NCT00759031|508887|P1|First Intervention (1 Day)|Withdrawal by Subject|0
159694|NCT00759031|508886|P2|First Intervention (1 Day)|Physician Decision|0
159695|NCT00759031|508887|P1|First Intervention (1 Day)|Physician Decision|1
159696|NCT00759109|508899|P2|Overall Study|Lost during study|0
159697|NCT00759109|508900|P1|Overall Study|Lost during study|1
159698|NCT00759109|508899|P2|Overall Study|Participant had a liver transplant|1
159699|NCT00759109|508900|P1|Overall Study|Participant had a liver transplant|0
159700|NCT00759109|508899|P2|Overall Study|Participant moved to a different city|1
159701|NCT00759109|508900|P1|Overall Study|Participant moved to a different city|0
159702|NCT00759109|508899|P2|Overall Study|HCV RNA negative|0
159703|NCT00759109|508900|P1|Overall Study|HCV RNA negative|1
159704|NCT00759109|508899|P2|Overall Study|Started new therapy|6
159705|NCT00759109|508900|P1|Overall Study|Started new therapy|2
159706|NCT00759109|508899|P2|Overall Study|Lost to Follow-up|6
159707|NCT00759109|508900|P1|Overall Study|Lost to Follow-up|4
159708|NCT00759109|508899|P2|Overall Study|Death|3
159709|NCT00759109|508900|P1|Overall Study|Death|4
159710|NCT00759109|508899|P2|Overall Study|Withdrawal by Subject|5
159711|NCT00759109|508900|P1|Overall Study|Withdrawal by Subject|9
159712|NCT00759109|508899|P2|Overall Study|Inability to comply|1
159713|NCT00759109|508900|P1|Overall Study|Inability to comply|1
159714|NCT00759109|508899|P2|Overall Study|Adverse Event|12
159715|NCT00759109|508900|P1|Overall Study|Adverse Event|17
159716|NCT00759174|508942|P2|Overall Study|Unspecified|2
159717|NCT00759174|508943|P1|Overall Study|Unspecified|0
159718|NCT00759356|509020|P2|Overall Study|Subject was unable to return|0
159719|NCT00759356|509021|P1|Overall Study|Subject was unable to return|1
159720|NCT00759356|509020|P2|Overall Study|Withdrawal by Subject|2
159721|NCT00759356|509021|P1|Overall Study|Withdrawal by Subject|0
159722|NCT00759356|509020|P2|Overall Study|Adverse Event|1
159723|NCT00759356|509021|P1|Overall Study|Adverse Event|0
159724|NCT00759395|509035|P2|Overall Study|Lack of Efficacy|2
159725|NCT00759395|509036|P1|Overall Study|Lack of Efficacy|0
159726|NCT00759395|509035|P2|Overall Study|Withdrawal by Subject|0
159727|NCT00759395|509036|P1|Overall Study|Withdrawal by Subject|1
159728|NCT00759395|509035|P2|Overall Study|Adverse Event|0
159729|NCT00759395|509036|P1|Overall Study|Adverse Event|1
159730|NCT00759564|509083|P5|Washout Period (at Least 14 Days)|Adverse Event|1
159731|NCT00759564|509084|P4|Washout Period (at Least 14 Days)|Adverse Event|0
159732|NCT00759564|509085|P3|Washout Period (at Least 14 Days)|Adverse Event|0
159733|NCT00759564|509086|P2|Washout Period (at Least 14 Days)|Adverse Event|0
159734|NCT00759564|509087|P1|Washout Period (at Least 14 Days)|Adverse Event|0
159735|NCT00759655|509239|P1|Overall Study|Termination of the study by sponsor|1
159736|NCT00759681|509271|P2|Overall Study|Lost to Follow-up|5
159737|NCT00759681|509272|P1|Overall Study|Lost to Follow-up|8
159738|NCT00759681|509271|P2|Overall Study|Death|5
159739|NCT00759681|509272|P1|Overall Study|Death|2
159740|NCT00759759|509286|P2|Overall Study|Withdrawal by Subject|1
159741|NCT00759759|509287|P1|Overall Study|Withdrawal by Subject|2
159742|NCT00759759|509286|P2|Overall Study|Didn't receive drug in period 2|0
159743|NCT00759759|509287|P1|Overall Study|Didn't receive drug in period 2|1
159744|NCT00759759|509286|P2|Overall Study|didn't return for period 2|0
159745|NCT00759759|509287|P1|Overall Study|didn't return for period 2|1
159746|NCT00759785|509310|P2|Overall Study|Withdrawal by Subject|1
159747|NCT00759785|509311|P1|Overall Study|Withdrawal by Subject|0
159748|NCT00759785|509310|P2|Overall Study|Physician Decision|1
159749|NCT00759785|509311|P1|Overall Study|Physician Decision|0
159750|NCT00759785|509310|P2|Overall Study|Protocol Violation|0
159751|NCT00759785|509311|P1|Overall Study|Protocol Violation|1
159752|NCT00759785|509310|P2|Overall Study|Participant sample lost|1
159753|NCT00759785|509311|P1|Overall Study|Participant sample lost|0
159754|NCT00759785|509310|P2|Overall Study|Participant sample not evaluable|2
159755|NCT00759785|509311|P1|Overall Study|Participant sample not evaluable|11
159756|NCT00759863|509334|P2|Overall Study|Death, moved, or lost contact|18
159757|NCT00759863|509335|P1|Overall Study|Death, moved, or lost contact|20
159758|NCT00759902|509347|P2|Overall Study|Adverse Event|1
159759|NCT00759902|509348|P1|Overall Study|Adverse Event|0
159760|NCT00759915|509362|P2|Overall Study|Adverse Event|1
159761|NCT00759915|509363|P1|Overall Study|Adverse Event|0
159762|NCT00759915|509362|P2|Overall Study|Withdrawal by Subject|0
159763|NCT00759915|509363|P1|Overall Study|Withdrawal by Subject|1
159764|NCT00759941|509377|P2|Overall Study|Exited in error by site|1
159765|NCT00759941|509378|P1|Overall Study|Exited in error by site|1
159766|NCT00759941|509377|P2|Overall Study|Adverse Event|0
159767|NCT00759941|509378|P1|Overall Study|Adverse Event|1
159768|NCT00759941|509377|P2|Overall Study|Use of medication|0
159769|NCT00759941|509378|P1|Overall Study|Use of medication|1
159770|NCT00759954|509392|P2|Overall Study|Adverse Event|2
159771|NCT00759954|509393|P1|Overall Study|Adverse Event|1
159772|NCT00759954|509392|P2|Overall Study|Personal reason|0
159773|NCT00759954|509393|P1|Overall Study|Personal reason|1
159774|NCT00760084|509433|P1|Overall Study|Progressive Disease|3
159775|NCT00760084|509433|P1|Overall Study|Withdrawal by Subject|2
159776|NCT00760084|509433|P1|Overall Study|Physician Decision|5
159777|NCT00760214|509440|P3|Overall Study|Other|6
159778|NCT00760214|509441|P2|Overall Study|Other|4
159779|NCT00760214|509442|P1|Overall Study|Other|3
159780|NCT00760214|509440|P3|Overall Study|Physician Decision|1
159781|NCT00760214|509441|P2|Overall Study|Physician Decision|1
159782|NCT00760214|509442|P1|Overall Study|Physician Decision|1
159783|NCT00760214|509440|P3|Overall Study|Pregnancy|1
159784|NCT00760214|509441|P2|Overall Study|Pregnancy|0
159785|NCT00760214|509442|P1|Overall Study|Pregnancy|0
159786|NCT00760214|509440|P3|Overall Study|Lack of Efficacy|4
159787|NCT00760214|509441|P2|Overall Study|Lack of Efficacy|2
159788|NCT00760214|509442|P1|Overall Study|Lack of Efficacy|3
159789|NCT00760214|509440|P3|Overall Study|Withdrawal by Subject|13
159790|NCT00760214|509441|P2|Overall Study|Withdrawal by Subject|14
159791|NCT00760214|509442|P1|Overall Study|Withdrawal by Subject|12
159792|NCT00760214|509440|P3|Overall Study|Lost to Follow-up|1
159793|NCT00760214|509441|P2|Overall Study|Lost to Follow-up|0
159794|NCT00760214|509442|P1|Overall Study|Lost to Follow-up|0
159795|NCT00760214|509440|P3|Overall Study|Protocol Violation|3
159796|NCT00760214|509441|P2|Overall Study|Protocol Violation|0
159797|NCT00760214|509442|P1|Overall Study|Protocol Violation|3
159798|NCT00760214|509440|P3|Overall Study|Adverse Event|12
159799|NCT00760214|509441|P2|Overall Study|Adverse Event|9
159800|NCT00760214|509442|P1|Overall Study|Adverse Event|8
159801|NCT00760266|509485|P2|Overall Study|Administrative Problems|1
159802|NCT00760266|509486|P1|Overall Study|Administrative Problems|0
159803|NCT00760266|509485|P2|Overall Study|Lost to Follow-up|1
159804|NCT00760266|509486|P1|Overall Study|Lost to Follow-up|2
159805|NCT00760266|509485|P2|Overall Study|Patient withdrew consent|3
159806|NCT00760266|509486|P1|Overall Study|Patient withdrew consent|3
159807|NCT00760266|509485|P2|Overall Study|Protocol deviation|4
159808|NCT00760266|509486|P1|Overall Study|Protocol deviation|2
159809|NCT00760266|509485|P2|Overall Study|Lack of Efficacy|2
159810|NCT00760266|509486|P1|Overall Study|Lack of Efficacy|2
159811|NCT00760266|509485|P2|Overall Study|Abnormal test procedure result(s)|0
159812|NCT00760266|509486|P1|Overall Study|Abnormal test procedure result(s)|1
159813|NCT00760266|509485|P2|Overall Study|Abnormal laboratory value(s)|0
159814|NCT00760266|509486|P1|Overall Study|Abnormal laboratory value(s)|1
159815|NCT00760266|509485|P2|Overall Study|Adverse Event|7
159816|NCT00760266|509486|P1|Overall Study|Adverse Event|13
159817|NCT00761735|509500|P1|Overall Study|Administrative|1
159818|NCT00761735|509500|P1|Overall Study|Non-compliance with protocol|1
159819|NCT00761735|509500|P1|Overall Study|Withdrawal by Subject|6
159820|NCT00761735|509500|P1|Overall Study|Lost to Follow-up|6
159821|NCT00761748|509512|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
159822|NCT00761748|509513|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
159823|NCT00761748|509512|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
159824|NCT00761748|509513|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
159825|NCT00761761|509521|P2|Overall Study|Withdrawal by Subject|0
159826|NCT00761761|509522|P1|Overall Study|Withdrawal by Subject|3
159827|NCT00761761|509521|P2|Overall Study|Lost to Follow-up|1
159828|NCT00761761|509522|P1|Overall Study|Lost to Follow-up|3
159829|NCT00761865|509536|P2|Overall Study|Lost to Follow-up|7
159830|NCT00761865|509537|P1|Overall Study|Lost to Follow-up|8
159831|NCT00761956|509566|P2|Overall Study|Adverse Event|34
159832|NCT00761956|509567|P1|Overall Study|Adverse Event|26
159833|NCT00761956|509566|P2|Overall Study|Death|1
159834|NCT00761956|509567|P1|Overall Study|Death|0
159835|NCT00761956|509566|P2|Overall Study|Withdrawal by Subject|8
159836|NCT00761956|509567|P1|Overall Study|Withdrawal by Subject|3
159837|NCT00761956|509566|P2|Overall Study|Lost to Follow-up|11
159838|NCT00761956|509567|P1|Overall Study|Lost to Follow-up|6
159839|NCT00761969|509577|P2|Overall Study|Lost to Follow-up|93
159840|NCT00761969|509578|P1|Overall Study|Lost to Follow-up|88
159841|NCT00761969|509577|P2|Overall Study|Death|47
159842|NCT00761969|509578|P1|Overall Study|Death|112
159843|NCT00762034|509601|P2|Maintenance Period|Other|1
159844|NCT00762034|509602|P1|Maintenance Period|Other|1
159845|NCT00762034|509601|P2|Maintenance Period|Death due to study disease|3
159846|NCT00762034|509602|P1|Maintenance Period|Death due to study disease|3
159847|NCT00762034|509601|P2|Maintenance Period|Death not due to study disease|5
159848|NCT00762034|509602|P1|Maintenance Period|Death not due to study disease|2
159849|NCT00762034|509601|P2|Maintenance Period|Withdrawal by Subject|14
159850|NCT00762034|509602|P1|Maintenance Period|Withdrawal by Subject|34
159851|NCT00762034|509601|P2|Maintenance Period|Physician Decision|20
159852|NCT00762034|509602|P1|Maintenance Period|Physician Decision|25
159853|NCT00762034|509601|P2|Maintenance Period|Progressive Disease|224
159854|NCT00762034|509602|P1|Maintenance Period|Progressive Disease|186
159855|NCT00762034|509601|P2|Maintenance Period|Adverse Event|26
159856|NCT00762034|509602|P1|Maintenance Period|Adverse Event|42
159857|NCT00762034|509601|P2|Maintenance Period|Entry Criterion Not Met|2
159858|NCT00762034|509602|P1|Maintenance Period|Entry Criterion Not Met|0
159859|NCT00762034|509601|P2|Maintenance Period|Protocol Violation|3
159860|NCT00762034|509602|P1|Maintenance Period|Protocol Violation|1
159861|NCT00762034|509601|P2|Induction Period|Deaths Due to Study Disease|9
159862|NCT00762034|509602|P1|Induction Period|Deaths Due to Study Disease|9
159863|NCT00762034|509601|P2|Induction Period|Deaths Not Due to Study Disease|14
159864|NCT00762034|509602|P1|Induction Period|Deaths Not Due to Study Disease|19
159865|NCT00762034|509601|P2|Induction Period|Withdrawal by Subject|19
159866|NCT00762034|509602|P1|Induction Period|Withdrawal by Subject|15
159867|NCT00762034|509601|P2|Induction Period|Physician Decision|20
159868|NCT00762034|509602|P1|Induction Period|Physician Decision|21
159869|NCT00762034|509601|P2|Induction Period|Progressive Disease|55
159870|NCT00762034|509602|P1|Induction Period|Progressive Disease|73
159871|NCT00762034|509601|P2|Induction Period|Lost to Follow-up|1
159872|NCT00762034|509602|P1|Induction Period|Lost to Follow-up|1
159873|NCT00762034|509601|P2|Induction Period|Adverse Event|38
159874|NCT00762034|509602|P1|Induction Period|Adverse Event|27
159875|NCT00762034|509601|P2|Induction Period|Entry Criterion Not Met|11
159876|NCT00762034|509602|P1|Induction Period|Entry Criterion Not Met|12
159877|NCT00762034|509601|P2|Induction Period|Protocol Violation|2
159878|NCT00762034|509602|P1|Induction Period|Protocol Violation|1
159879|NCT00762073|509663|P4|Overall Study|Not on treatment for >/= 77 days|0
159880|NCT00762073|509664|P3|Overall Study|Not on treatment for >/= 77 days|0
159881|NCT00762073|509665|P2|Overall Study|Not on treatment for >/= 77 days|0
159882|NCT00762073|509666|P1|Overall Study|Not on treatment for >/= 77 days|1
159883|NCT00762073|509663|P4|Overall Study|Withdrawal by Subject|1
159884|NCT00762073|509664|P3|Overall Study|Withdrawal by Subject|1
159885|NCT00762073|509665|P2|Overall Study|Withdrawal by Subject|2
159886|NCT00762073|509666|P1|Overall Study|Withdrawal by Subject|1
159887|NCT00762073|509663|P4|Overall Study|Significant Subject Noncompliance|1
159888|NCT00762073|509664|P3|Overall Study|Significant Subject Noncompliance|0
159889|NCT00762073|509665|P2|Overall Study|Significant Subject Noncompliance|1
159890|NCT00762073|509666|P1|Overall Study|Significant Subject Noncompliance|0
159891|NCT00762073|509663|P4|Overall Study|Adverse Event|1
159892|NCT00762073|509664|P3|Overall Study|Adverse Event|1
159893|NCT00762073|509665|P2|Overall Study|Adverse Event|0
159894|NCT00762073|509666|P1|Overall Study|Adverse Event|1
159895|NCT00762073|509663|P4|Overall Study|Lack of Efficacy|0
159896|NCT00762073|509664|P3|Overall Study|Lack of Efficacy|0
159897|NCT00762073|509665|P2|Overall Study|Lack of Efficacy|1
159898|NCT00762073|509666|P1|Overall Study|Lack of Efficacy|1
159899|NCT00762086|509730|P2|Overall Study|Ineligible to participate in the study|0
159900|NCT00762086|509731|P1|Overall Study|Ineligible to participate in the study|1
159901|NCT00762086|509730|P2|Overall Study|Withdrawal by Subject|2
159902|NCT00762086|509731|P1|Overall Study|Withdrawal by Subject|2
159903|NCT00762086|509730|P2|Overall Study|Non compliance|0
159904|NCT00762086|509731|P1|Overall Study|Non compliance|1
159905|NCT00762086|509730|P2|Overall Study|Lost to Follow-up|2
159906|NCT00762086|509731|P1|Overall Study|Lost to Follow-up|0
159907|NCT00762086|509730|P2|Overall Study|Adverse Event|0
159908|NCT00762086|509731|P1|Overall Study|Adverse Event|2
159909|NCT00762164|509739|P2|Overall Study|Withdrawal by Subject|1
159910|NCT00762164|509740|P1|Overall Study|Withdrawal by Subject|0
159911|NCT00762164|509739|P2|Overall Study|Discontinued medication|0
159912|NCT00762164|509740|P1|Overall Study|Discontinued medication|2
159913|NCT00762164|509739|P2|Overall Study|Lost to Follow-up|1
159914|NCT00762164|509740|P1|Overall Study|Lost to Follow-up|1
159915|NCT00762229|509837|P2|Overall Study|did not recveive intervention|1
159916|NCT00762229|509838|P1|Overall Study|did not recveive intervention|0
159917|NCT00762229|509837|P2|Overall Study|Lost to Follow-up|1
159918|NCT00762229|509838|P1|Overall Study|Lost to Follow-up|1
159919|NCT00762268|509848|P2|Overall Study|Protocol Violation|2
159920|NCT00762268|509849|P1|Overall Study|Protocol Violation|1
159921|NCT00762359|509872|P2|Overall Study|Withdrew consent|0
159922|NCT00762359|509873|P1|Overall Study|Withdrew consent|1
159923|NCT00762359|509872|P2|Overall Study|Removal|1
159924|NCT00762359|509873|P1|Overall Study|Removal|0
159925|NCT00762359|509872|P2|Overall Study|Physician Decision|3
159926|NCT00762359|509873|P1|Overall Study|Physician Decision|2
159927|NCT00762359|509872|P2|Overall Study|Institution closed|3
159928|NCT00762359|509873|P1|Overall Study|Institution closed|2
159929|NCT00762359|509872|P2|Overall Study|Lack of Efficacy|4
159930|NCT00762359|509873|P1|Overall Study|Lack of Efficacy|0
159931|NCT00762359|509872|P2|Overall Study|Withdrawal by Subject|10
159932|NCT00762359|509873|P1|Overall Study|Withdrawal by Subject|13
159933|NCT00762359|509872|P2|Overall Study|Protocol Violation|13
159934|NCT00762359|509873|P1|Overall Study|Protocol Violation|21
159935|NCT00762359|509872|P2|Overall Study|Adverse Event|23
159936|NCT00762359|509873|P1|Overall Study|Adverse Event|20
159937|NCT00762385|509973|P2|Second Intervention|Protocol Violation|3
159938|NCT00762385|509974|P1|Second Intervention|Protocol Violation|3
159939|NCT00762385|509973|P2|First Intervention|Protocol Violation|1
159940|NCT00762385|509974|P1|First Intervention|Protocol Violation|0
159941|NCT00762385|509973|P2|First Intervention|Ineligible|0
159942|NCT00762385|509974|P1|First Intervention|Ineligible|1
159943|NCT00762385|509973|P2|First Intervention|Lost to Follow-up|2
159944|NCT00762385|509974|P1|First Intervention|Lost to Follow-up|0
159945|NCT00762385|509973|P2|First Intervention|Lens Issue|1
159946|NCT00762385|509974|P1|First Intervention|Lens Issue|1
159947|NCT00762411|509986|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
159948|NCT00762411|509987|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
159949|NCT00762411|509986|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
159950|NCT00762411|509987|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
159951|NCT00762411|509986|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
159952|NCT00762411|509987|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
159953|NCT00762411|509986|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
159954|NCT00762411|509987|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
159955|NCT00762411|509986|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
159956|NCT00762411|509987|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
159957|NCT00762411|509986|P2|Safety Follow Up (SFU)-Optional|Death|8
159958|NCT00762411|509987|P1|Safety Follow Up (SFU)-Optional|Death|1
159959|NCT00762411|509986|P2|Delayed Start|Caregiver Decision|1
159960|NCT00762411|509987|P1|Delayed Start|Caregiver Decision|1
159961|NCT00762411|509986|P2|Delayed Start|Sponsor Decision|20
159962|NCT00762411|509987|P1|Delayed Start|Sponsor Decision|16
159963|NCT00762411|509986|P2|Delayed Start|Protocol Violation|1
159964|NCT00762411|509987|P1|Delayed Start|Protocol Violation|0
159965|NCT00762411|509986|P2|Delayed Start|Adverse Event|4
159966|NCT00762411|509987|P1|Delayed Start|Adverse Event|0
159967|NCT00762411|509986|P2|Initial Treatment|Entry Criteria Exclusion|1
159968|NCT00762411|509987|P1|Initial Treatment|Entry Criteria Exclusion|0
159969|NCT00762411|509986|P2|Initial Treatment|Abnormal Lab/ECG Result|4
159970|NCT00762411|509987|P1|Initial Treatment|Abnormal Lab/ECG Result|6
159971|NCT00762411|509986|P2|Initial Treatment|Caregiver Decision|16
159972|NCT00762411|509987|P1|Initial Treatment|Caregiver Decision|21
159973|NCT00762411|509986|P2|Initial Treatment|Lost to Follow-up|0
159974|NCT00762411|509987|P1|Initial Treatment|Lost to Follow-up|5
159975|NCT00762411|509986|P2|Initial Treatment|Sponsor Decision|401
159976|NCT00762411|509987|P1|Initial Treatment|Sponsor Decision|293
159977|NCT00762411|509986|P2|Initial Treatment|Physician Decision|0
159978|NCT00762411|509987|P1|Initial Treatment|Physician Decision|1
159979|NCT00762411|509986|P2|Initial Treatment|Withdrawal by Subject|52
159980|NCT00762411|509987|P1|Initial Treatment|Withdrawal by Subject|65
159981|NCT00762411|509986|P2|Initial Treatment|Protocol Violation|1
159982|NCT00762411|509987|P1|Initial Treatment|Protocol Violation|4
159983|NCT00762411|509986|P2|Initial Treatment|Adverse Event|40
159984|NCT00762411|509987|P1|Initial Treatment|Adverse Event|132
159985|NCT00762411|509986|P2|Initial Treatment|Death|6
159986|NCT00762411|509987|P1|Initial Treatment|Death|7
159987|NCT00762463|510075|P4|Extension Phase (Week 6 to Week 12)|Not specified|1
159988|NCT00762463|510076|P3|Extension Phase (Week 6 to Week 12)|Not specified|0
159989|NCT00762463|510077|P2|Extension Phase (Week 6 to Week 12)|Not specified|0
159990|NCT00762463|510078|P1|Extension Phase (Week 6 to Week 12)|Not specified|0
159991|NCT00762463|510075|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
159992|NCT00762463|510076|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
159993|NCT00762463|510077|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
159994|NCT00762463|510078|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
159995|NCT00762463|510075|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
159996|NCT00762463|510076|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
159997|NCT00762463|510077|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
159998|NCT00762463|510078|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
159999|NCT00762463|510075|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
160000|NCT00762463|510076|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
160001|NCT00762463|510077|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
160002|NCT00762463|510078|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
160003|NCT00762463|510075|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
160004|NCT00762463|510076|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
160005|NCT00762463|510077|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
160006|NCT00762463|510078|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
160007|NCT00762463|510075|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
160008|NCT00762463|510076|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
160009|NCT00762463|510077|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
160010|NCT00762463|510078|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
160011|NCT00762463|510075|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
160012|NCT00762463|510076|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
160013|NCT00762463|510077|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
160014|NCT00762463|510078|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
160015|NCT00762463|510075|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
160016|NCT00762463|510076|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
160017|NCT00762463|510077|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
160018|NCT00762463|510078|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
160019|NCT00762476|510162|P2|Overall Study|Seasonal allergies|0
160020|NCT00762476|510163|P1|Overall Study|Seasonal allergies|1
160021|NCT00762476|510162|P2|Overall Study|non-compliance with study visits|2
160022|NCT00762476|510163|P1|Overall Study|non-compliance with study visits|0
160023|NCT00762476|510162|P2|Overall Study|antibiotic use|1
160024|NCT00762476|510163|P1|Overall Study|antibiotic use|0
160025|NCT00762476|510162|P2|Overall Study|Withdrawal by Subject|12
160026|NCT00762476|510163|P1|Overall Study|Withdrawal by Subject|6
160027|NCT00762476|510162|P2|Overall Study|Physician Decision|14
160028|NCT00762476|510163|P1|Overall Study|Physician Decision|2
160029|NCT00762476|510162|P2|Overall Study|Protocol Violation|6
160030|NCT00762476|510163|P1|Overall Study|Protocol Violation|5
160031|NCT00762476|510162|P2|Overall Study|Lost to Follow-up|0
160032|NCT00762476|510163|P1|Overall Study|Lost to Follow-up|2
160033|NCT00762476|510162|P2|Overall Study|Adverse Event|1
160034|NCT00762476|510163|P1|Overall Study|Adverse Event|7
160035|NCT00762502|510176|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
160036|NCT00762502|510177|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
160037|NCT00762502|510178|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
160038|NCT00762502|510176|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
160039|NCT00762502|510177|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
160040|NCT00762502|510178|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
160041|NCT00762502|510176|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
160042|NCT00762502|510177|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
160043|NCT00762502|510178|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
160044|NCT00762606|510226|P2|Overall Study|Lost to Follow-up|13
160045|NCT00762606|510227|P1|Overall Study|Lost to Follow-up|18
160046|NCT00762723|510392|P3|Overall Study|Study Terminated slow enrollement|3
160047|NCT00762723|510393|P2|Overall Study|Study Terminated slow enrollement|5
160048|NCT00762723|510394|P1|Overall Study|Study Terminated slow enrollement|5
160049|NCT00762762|510404|P2|Overall Study|Did not report for appointments|10
160050|NCT00762762|510405|P1|Overall Study|Did not report for appointments|8
160051|NCT00762788|510425|P6|Overall Study|Lost to Follow-up|21
160052|NCT00762788|510426|P5|Overall Study|Lost to Follow-up|13
160053|NCT00762788|510427|P4|Overall Study|Lost to Follow-up|26
160054|NCT00762788|510428|P3|Overall Study|Lost to Follow-up|21
160055|NCT00762788|510429|P2|Overall Study|Lost to Follow-up|37
160056|NCT00762788|510430|P1|Overall Study|Lost to Follow-up|26
160057|NCT00762892|510461|P2|Overall Study|Incarceration|0
160058|NCT00762892|510462|P1|Overall Study|Incarceration|1
160059|NCT00762892|510461|P2|Overall Study|Pregnancy|0
160060|NCT00762892|510462|P1|Overall Study|Pregnancy|1
160061|NCT00762892|510461|P2|Overall Study|Death|0
160062|NCT00762892|510462|P1|Overall Study|Death|1
160063|NCT00762892|510461|P2|Overall Study|Withdrawal by Subject|1
160064|NCT00762892|510462|P1|Overall Study|Withdrawal by Subject|0
160065|NCT00762892|510461|P2|Overall Study|Lost to Follow-up|5
160066|NCT00762892|510462|P1|Overall Study|Lost to Follow-up|2
160067|NCT00762970|510479|P3|Overall Study|Difficulty of handling lens|0
160068|NCT00762970|510480|P2|Overall Study|Difficulty of handling lens|2
160069|NCT00762970|510481|P1|Overall Study|Difficulty of handling lens|1
160070|NCT00762970|510479|P3|Overall Study|Lost to Follow-up|0
160071|NCT00762970|510480|P2|Overall Study|Lost to Follow-up|2
160072|NCT00762970|510481|P1|Overall Study|Lost to Follow-up|1
160073|NCT00762970|510479|P3|Overall Study|Protocol Violation|1
160074|NCT00762970|510480|P2|Overall Study|Protocol Violation|1
160075|NCT00762970|510481|P1|Overall Study|Protocol Violation|3
160076|NCT00762970|510479|P3|Overall Study|Withdrawal by Subject|0
160077|NCT00762970|510480|P2|Overall Study|Withdrawal by Subject|4
160078|NCT00762970|510481|P1|Overall Study|Withdrawal by Subject|7
160079|NCT00762996|510492|P4|Period One|Withdrawal by Subject|0
160080|NCT00762996|510493|P3|Period One|Withdrawal by Subject|1
160081|NCT00762996|510494|P2|Period One|Withdrawal by Subject|0
160082|NCT00762996|510495|P1|Period One|Withdrawal by Subject|0
160083|NCT00762996|510492|P4|Period One|Adverse Event|0
160084|NCT00762996|510493|P3|Period One|Adverse Event|1
160085|NCT00762996|510494|P2|Period One|Adverse Event|0
160086|NCT00762996|510495|P1|Period One|Adverse Event|0
160087|NCT00762996|510492|P4|Period One|ineligible|1
160088|NCT00762996|510493|P3|Period One|ineligible|1
160089|NCT00762996|510494|P2|Period One|ineligible|0
160090|NCT00762996|510495|P1|Period One|ineligible|0
160091|NCT00762996|510492|P4|Period One|Protocol Violation|0
160092|NCT00762996|510493|P3|Period One|Protocol Violation|1
160093|NCT00762996|510494|P2|Period One|Protocol Violation|0
160094|NCT00762996|510495|P1|Period One|Protocol Violation|0
160095|NCT00763009|510505|P1|Overall Study|Coronary Anatomy unsuitable|1
160096|NCT00763139|510551|P2|Overall Study|med change not allowed by protocol|0
160097|NCT00763139|510552|P1|Overall Study|med change not allowed by protocol|1
160098|NCT00763139|510551|P2|Overall Study|Withdrawal by Subject|1
160099|NCT00763139|510552|P1|Overall Study|Withdrawal by Subject|0
160100|NCT00763139|510551|P2|Overall Study|Adverse Event|2
160101|NCT00763139|510552|P1|Overall Study|Adverse Event|4
160102|NCT00763256|510596|P2|Overall Study|Didn't return for appointments|10
160103|NCT00763256|510597|P1|Overall Study|Didn't return for appointments|7
160104|NCT00763269|510613|P2|Overall Study|Lost to Follow-up|13
160105|NCT00763269|510614|P1|Overall Study|Lost to Follow-up|12
160106|NCT00763282|510628|P2|Overall Study|Lost to Follow-up|26
160107|NCT00763282|510629|P1|Overall Study|Lost to Follow-up|22
160108|NCT00763282|510628|P2|Overall Study|Death|3
160109|NCT00763282|510629|P1|Overall Study|Death|4
160110|NCT00763282|510628|P2|Overall Study|Withdrawal by Subject|5
160111|NCT00763282|510629|P1|Overall Study|Withdrawal by Subject|6
160112|NCT00763321|510646|P3|Double-blind Period|Not specified|3
160113|NCT00763321|510647|P2|Double-blind Period|Not specified|2
160114|NCT00763321|510648|P1|Double-blind Period|Not specified|0
160115|NCT00763321|510646|P3|Double-blind Period|Withdrawal by Subject|3
160116|NCT00763321|510647|P2|Double-blind Period|Withdrawal by Subject|2
160117|NCT00763321|510648|P1|Double-blind Period|Withdrawal by Subject|0
160118|NCT00763321|510646|P3|Double-blind Period|Lost to Follow-up|2
160119|NCT00763321|510647|P2|Double-blind Period|Lost to Follow-up|4
160120|NCT00763321|510648|P1|Double-blind Period|Lost to Follow-up|0
160121|NCT00763321|510646|P3|Double-blind Period|Adverse Event|4
160122|NCT00763321|510647|P2|Double-blind Period|Adverse Event|4
160123|NCT00763321|510648|P1|Double-blind Period|Adverse Event|0
160124|NCT00763321|510646|P3|Double-blind Period|Lack of Efficacy|17
160125|NCT00763321|510647|P2|Double-blind Period|Lack of Efficacy|9
160126|NCT00763321|510648|P1|Double-blind Period|Lack of Efficacy|0
160127|NCT00763321|510646|P3|Open-label Period|Not specified|0
160128|NCT00763321|510647|P2|Open-label Period|Not specified|0
160129|NCT00763321|510648|P1|Open-label Period|Not specified|4
160130|NCT00763321|510646|P3|Open-label Period|Lack of Efficacy|0
160131|NCT00763321|510647|P2|Open-label Period|Lack of Efficacy|0
160132|NCT00763321|510648|P1|Open-label Period|Lack of Efficacy|2
160133|NCT00763321|510646|P3|Open-label Period|Did not meet DB randomization criteria|0
160134|NCT00763321|510647|P2|Open-label Period|Did not meet DB randomization criteria|0
160135|NCT00763321|510648|P1|Open-label Period|Did not meet DB randomization criteria|5
160136|NCT00763321|510646|P3|Open-label Period|Subject noncompliant|0
160137|NCT00763321|510647|P2|Open-label Period|Subject noncompliant|0
160138|NCT00763321|510648|P1|Open-label Period|Subject noncompliant|7
160139|NCT00763321|510646|P3|Open-label Period|Withdrawal by Subject|0
160140|NCT00763321|510647|P2|Open-label Period|Withdrawal by Subject|0
160141|NCT00763321|510648|P1|Open-label Period|Withdrawal by Subject|7
160142|NCT00763321|510646|P3|Open-label Period|Lost to Follow-up|0
160143|NCT00763321|510647|P2|Open-label Period|Lost to Follow-up|0
160144|NCT00763321|510648|P1|Open-label Period|Lost to Follow-up|14
160145|NCT00763321|510646|P3|Open-label Period|Adverse Event|0
160146|NCT00763321|510647|P2|Open-label Period|Adverse Event|0
160147|NCT00763321|510648|P1|Open-label Period|Adverse Event|24
160148|NCT00763386|510681|P2|Overall Study|Study Prosthesis Removed|0
160149|NCT00763386|510682|P1|Overall Study|Study Prosthesis Removed|1
160150|NCT00763386|510681|P2|Overall Study|CRF missing|1
160151|NCT00763386|510682|P1|Overall Study|CRF missing|0
160152|NCT00763386|510681|P2|Overall Study|Withdrawal by Subject|1
160153|NCT00763386|510682|P1|Overall Study|Withdrawal by Subject|0
160154|NCT00763386|510681|P2|Overall Study|Lost to Follow-up|3
160155|NCT00763386|510682|P1|Overall Study|Lost to Follow-up|3
160156|NCT00763386|510681|P2|Overall Study|Death|2
160157|NCT00763386|510682|P1|Overall Study|Death|1
160158|NCT00763386|510681|P2|Overall Study|Adverse Event|33
160159|NCT00763386|510682|P1|Overall Study|Adverse Event|43
160160|NCT00763451|510719|P4|Overall Study|Study Site Reason|1
160161|NCT00763451|510720|P3|Overall Study|Study Site Reason|1
160162|NCT00763451|510721|P2|Overall Study|Study Site Reason|1
160163|NCT00763451|510722|P1|Overall Study|Study Site Reason|0
160164|NCT00763451|510719|P4|Overall Study|Randomized but not Treated|0
160165|NCT00763451|510720|P3|Overall Study|Randomized but not Treated|0
160166|NCT00763451|510721|P2|Overall Study|Randomized but not Treated|1
160167|NCT00763451|510722|P1|Overall Study|Randomized but not Treated|1
160168|NCT00763451|510719|P4|Overall Study|Familial and Personal Reasons|4
160169|NCT00763451|510720|P3|Overall Study|Familial and Personal Reasons|5
160170|NCT00763451|510721|P2|Overall Study|Familial and Personal Reasons|3
160171|NCT00763451|510722|P1|Overall Study|Familial and Personal Reasons|5
160172|NCT00763451|510719|P4|Overall Study|Poor Compliance to Protocol|2
160173|NCT00763451|510720|P3|Overall Study|Poor Compliance to Protocol|2
160174|NCT00763451|510721|P2|Overall Study|Poor Compliance to Protocol|1
160175|NCT00763451|510722|P1|Overall Study|Poor Compliance to Protocol|1
160176|NCT00763451|510719|P4|Overall Study|Protocol Violation|0
160177|NCT00763451|510720|P3|Overall Study|Protocol Violation|1
160178|NCT00763451|510721|P2|Overall Study|Protocol Violation|0
160179|NCT00763451|510722|P1|Overall Study|Protocol Violation|0
160180|NCT00763451|510719|P4|Overall Study|Withdrawal by Subject|7
160181|NCT00763451|510720|P3|Overall Study|Withdrawal by Subject|9
160182|NCT00763451|510721|P2|Overall Study|Withdrawal by Subject|6
160183|NCT00763451|510722|P1|Overall Study|Withdrawal by Subject|1
160184|NCT00763451|510719|P4|Overall Study|Lack of Efficacy|2
160185|NCT00763451|510720|P3|Overall Study|Lack of Efficacy|3
160186|NCT00763451|510721|P2|Overall Study|Lack of Efficacy|4
160187|NCT00763451|510722|P1|Overall Study|Lack of Efficacy|1
160188|NCT00763451|510719|P4|Overall Study|Adverse Event|14
160189|NCT00763451|510720|P3|Overall Study|Adverse Event|19
160190|NCT00763451|510721|P2|Overall Study|Adverse Event|6
160191|NCT00763451|510722|P1|Overall Study|Adverse Event|4
160192|NCT00763698|510761|P1|Overall Study|Withdrawal by Subject|1
160193|NCT00763698|510761|P1|Overall Study|Death|4
160194|NCT00763698|510761|P1|Overall Study|Unsuccessful Implant|5
160195|NCT00763815|510773|P2|Overall Study|Sponsor's Decision|1
160196|NCT00763815|510774|P1|Overall Study|Sponsor's Decision|0
160197|NCT00763815|510773|P2|Overall Study|Protocol Violation|5
160198|NCT00763815|510774|P1|Overall Study|Protocol Violation|2
160199|NCT00763815|510773|P2|Overall Study|Withdrawal by Subject|12
160200|NCT00763815|510774|P1|Overall Study|Withdrawal by Subject|7
160201|NCT00763815|510773|P2|Overall Study|Physician Decision|0
160202|NCT00763815|510774|P1|Overall Study|Physician Decision|1
160203|NCT00763815|510773|P2|Overall Study|Familial and Personal Reasons|16
160204|NCT00763815|510774|P1|Overall Study|Familial and Personal Reasons|9
160205|NCT00763815|510773|P2|Overall Study|Early Termination|0
160206|NCT00763815|510774|P1|Overall Study|Early Termination|1
160207|NCT00763815|510773|P2|Overall Study|Lost to Follow-up|4
160208|NCT00763815|510774|P1|Overall Study|Lost to Follow-up|2
160209|NCT00763815|510773|P2|Overall Study|Poor Compliance to Protocol|6
160210|NCT00763815|510774|P1|Overall Study|Poor Compliance to Protocol|6
160211|NCT00763815|510773|P2|Overall Study|Lack of Efficacy|11
160212|NCT00763815|510774|P1|Overall Study|Lack of Efficacy|10
160213|NCT00763815|510773|P2|Overall Study|Adverse Event|29
160214|NCT00763815|510774|P1|Overall Study|Adverse Event|14
160215|NCT00763958|510923|P2|Overall Study|Believed they were receiving placebo|5
160216|NCT00763958|510924|P1|Overall Study|Believed they were receiving placebo|0
160217|NCT00763958|510923|P2|Overall Study|Lost to Follow-up|2
160218|NCT00763958|510924|P1|Overall Study|Lost to Follow-up|10
160219|NCT00763958|510923|P2|Overall Study|did not meet final criteria|4
160220|NCT00763958|510924|P1|Overall Study|did not meet final criteria|4
160221|NCT00763971|510937|P3|Overall Study|Participation in 489-326 required|0
160222|NCT00763971|510938|P2|Overall Study|Participation in 489-326 required|0
160223|NCT00763971|510939|P1|Overall Study|Participation in 489-326 required|1
160224|NCT00763971|510937|P3|Overall Study|Performed final visit on phone|0
160225|NCT00763971|510938|P2|Overall Study|Performed final visit on phone|1
160226|NCT00763971|510939|P1|Overall Study|Performed final visit on phone|0
160227|NCT00763971|510937|P3|Overall Study|Lack of availability|0
160228|NCT00763971|510938|P2|Overall Study|Lack of availability|1
160229|NCT00763971|510939|P1|Overall Study|Lack of availability|0
160230|NCT00763971|510937|P3|Overall Study|Subject wanted dose reduction|0
160231|NCT00763971|510938|P2|Overall Study|Subject wanted dose reduction|1
160232|NCT00763971|510939|P1|Overall Study|Subject wanted dose reduction|0
160233|NCT00763971|510937|P3|Overall Study|Moved to another country|0
160234|NCT00763971|510938|P2|Overall Study|Moved to another country|1
160235|NCT00763971|510939|P1|Overall Study|Moved to another country|0
160236|NCT00763971|510937|P3|Overall Study|Medical monitor decision|1
160237|NCT00763971|510938|P2|Overall Study|Medical monitor decision|0
160238|NCT00763971|510939|P1|Overall Study|Medical monitor decision|0
160239|NCT00763971|510937|P3|Overall Study|Randomization error|1
160240|NCT00763971|510938|P2|Overall Study|Randomization error|0
160241|NCT00763971|510939|P1|Overall Study|Randomization error|0
160242|NCT00763971|510937|P3|Overall Study|Due to holiday season|1
160243|NCT00763971|510938|P2|Overall Study|Due to holiday season|0
160244|NCT00763971|510939|P1|Overall Study|Due to holiday season|2
160245|NCT00763971|510937|P3|Overall Study|Sponsor decision|0
160246|NCT00763971|510938|P2|Overall Study|Sponsor decision|0
160247|NCT00763971|510939|P1|Overall Study|Sponsor decision|1
160248|NCT00763971|510937|P3|Overall Study|Exclusion criteria met|0
160249|NCT00763971|510938|P2|Overall Study|Exclusion criteria met|0
160250|NCT00763971|510939|P1|Overall Study|Exclusion criteria met|1
160251|NCT00763971|510937|P3|Overall Study|Personal reason|0
160252|NCT00763971|510938|P2|Overall Study|Personal reason|0
160253|NCT00763971|510939|P1|Overall Study|Personal reason|3
160254|NCT00763971|510937|P3|Overall Study|Unable to swallow capsule|1
160255|NCT00763971|510938|P2|Overall Study|Unable to swallow capsule|1
160256|NCT00763971|510939|P1|Overall Study|Unable to swallow capsule|2
160257|NCT00763971|510937|P3|Overall Study|Lack of Efficacy|54
160258|NCT00763971|510938|P2|Overall Study|Lack of Efficacy|22
160259|NCT00763971|510939|P1|Overall Study|Lack of Efficacy|11
160260|NCT00763971|510937|P3|Overall Study|Lost to Follow-up|0
160261|NCT00763971|510938|P2|Overall Study|Lost to Follow-up|1
160262|NCT00763971|510939|P1|Overall Study|Lost to Follow-up|0
160263|NCT00763971|510937|P3|Overall Study|Withdrawal by Subject|5
160264|NCT00763971|510938|P2|Overall Study|Withdrawal by Subject|5
160265|NCT00763971|510939|P1|Overall Study|Withdrawal by Subject|4
160266|NCT00763971|510937|P3|Overall Study|Protocol Violation|2
160267|NCT00763971|510938|P2|Overall Study|Protocol Violation|3
160268|NCT00763971|510939|P1|Overall Study|Protocol Violation|3
160269|NCT00763971|510937|P3|Overall Study|Adverse Event|4
160270|NCT00763971|510938|P2|Overall Study|Adverse Event|2
160271|NCT00763971|510939|P1|Overall Study|Adverse Event|5
160272|NCT00755079|510981|P2|Overall Study|Withdrawal by Subject|2
160273|NCT00755079|510982|P1|Overall Study|Withdrawal by Subject|0
160274|NCT00755079|510981|P2|Overall Study|Adverse Event|1
160275|NCT00755079|510982|P1|Overall Study|Adverse Event|0
160276|NCT00755079|510981|P2|Overall Study|Lost to Follow-up|3
160277|NCT00755079|510982|P1|Overall Study|Lost to Follow-up|1
160278|NCT00755105|510993|P3|Overall Study|Withdrawal by Subject|4
160279|NCT00755105|510994|P2|Overall Study|Withdrawal by Subject|11
160280|NCT00755105|510995|P1|Overall Study|Withdrawal by Subject|9
160281|NCT00755196|511016|P1|Overall Study|Lack of Efficiency|1
160282|NCT00755196|511016|P1|Overall Study|Lost to Follow-up|1
160283|NCT00755222|511023|P2|Overall Study|Protocol Violation|0
160284|NCT00755222|511024|P1|Overall Study|Protocol Violation|2
160285|NCT00755222|511023|P2|Overall Study|Adverse Event|0
160286|NCT00755222|511024|P1|Overall Study|Adverse Event|2
160287|NCT00755222|511023|P2|Overall Study|Withdrawal by Subject|2
160288|NCT00755222|511024|P1|Overall Study|Withdrawal by Subject|4
160289|NCT00755417|511079|P3|Overall Study|Not specified or missing data|12
160290|NCT00755417|511080|P2|Overall Study|Not specified or missing data|18
160291|NCT00755417|511081|P1|Overall Study|Not specified or missing data|9
160292|NCT00755417|511079|P3|Overall Study|Withdrawal by Subject|12
160293|NCT00755417|511080|P2|Overall Study|Withdrawal by Subject|12
160294|NCT00755417|511081|P1|Overall Study|Withdrawal by Subject|12
160295|NCT00755417|511079|P3|Overall Study|Lost to Follow-up|1
160296|NCT00755417|511080|P2|Overall Study|Lost to Follow-up|0
160297|NCT00755417|511081|P1|Overall Study|Lost to Follow-up|3
160298|NCT00755417|511079|P3|Overall Study|Protocol Violation|1
160299|NCT00755417|511080|P2|Overall Study|Protocol Violation|1
160300|NCT00755417|511081|P1|Overall Study|Protocol Violation|2
160301|NCT00755417|511079|P3|Overall Study|Lack of Efficacy|9
160302|NCT00755417|511080|P2|Overall Study|Lack of Efficacy|4
160303|NCT00755417|511081|P1|Overall Study|Lack of Efficacy|8
160304|NCT00755417|511079|P3|Overall Study|Adverse Event|7
160305|NCT00755417|511080|P2|Overall Study|Adverse Event|20
160306|NCT00755417|511081|P1|Overall Study|Adverse Event|28
160307|NCT00755716|511101|P3|Overall Study|work schedule issues|1
160308|NCT00755716|511102|P2|Overall Study|work schedule issues|1
160309|NCT00755716|511103|P1|Overall Study|work schedule issues|0
160310|NCT00755716|511101|P3|Overall Study|Lost to Follow-up|1
160311|NCT00755716|511102|P2|Overall Study|Lost to Follow-up|3
160312|NCT00755716|511103|P1|Overall Study|Lost to Follow-up|5
160313|NCT00755716|511101|P3|Overall Study|Lack of Efficacy|0
160314|NCT00755716|511102|P2|Overall Study|Lack of Efficacy|0
160315|NCT00755716|511103|P1|Overall Study|Lack of Efficacy|2
160316|NCT00755716|511101|P3|Overall Study|Adverse Event|1
160317|NCT00755716|511102|P2|Overall Study|Adverse Event|4
160318|NCT00755716|511103|P1|Overall Study|Adverse Event|1
160319|NCT00755807|511132|P2|Open-label Extension Phase|Sponsor Decision|1
160320|NCT00755807|511133|P1|Open-label Extension Phase|Sponsor Decision|0
160321|NCT00755807|511132|P2|Open-label Extension Phase|Lost to Follow-up|0
160322|NCT00755807|511133|P1|Open-label Extension Phase|Lost to Follow-up|2
160323|NCT00755807|511132|P2|Open-label Extension Phase|Withdrawal by Subject|3
160324|NCT00755807|511133|P1|Open-label Extension Phase|Withdrawal by Subject|1
160325|NCT00755807|511132|P2|Open-label Extension Phase|Lack of Efficacy|3
160326|NCT00755807|511133|P1|Open-label Extension Phase|Lack of Efficacy|3
160327|NCT00755807|511132|P2|Open-label Extension Phase|Protocol Violation|2
160328|NCT00755807|511133|P1|Open-label Extension Phase|Protocol Violation|5
160329|NCT00755807|511132|P2|Open-label Extension Phase|Adverse Event|7
160330|NCT00755807|511133|P1|Open-label Extension Phase|Adverse Event|7
160331|NCT00755807|511132|P2|Acute Phase|Physician Decision|1
160332|NCT00755807|511133|P1|Acute Phase|Physician Decision|0
160333|NCT00755807|511132|P2|Acute Phase|Lack of Efficacy|1
160334|NCT00755807|511133|P1|Acute Phase|Lack of Efficacy|0
160335|NCT00755807|511132|P2|Acute Phase|Withdrawal by Subject|2
160336|NCT00755807|511133|P1|Acute Phase|Withdrawal by Subject|1
160337|NCT00755807|511132|P2|Acute Phase|Protocol Violation|3
160338|NCT00755807|511133|P1|Acute Phase|Protocol Violation|1
160339|NCT00755807|511132|P2|Acute Phase|Adverse Event|5
160340|NCT00755807|511133|P1|Acute Phase|Adverse Event|16
160341|NCT00755846|511200|P6|Overall Study|Participant Non-compliance|0
160342|NCT00755846|511201|P5|Overall Study|Participant Non-compliance|1
160343|NCT00755846|511202|P4|Overall Study|Participant Non-compliance|0
160344|NCT00755846|511203|P3|Overall Study|Participant Non-compliance|0
160345|NCT00755846|511204|P2|Overall Study|Participant Non-compliance|0
160346|NCT00755846|511205|P1|Overall Study|Participant Non-compliance|0
160347|NCT00755846|511200|P6|Overall Study|Administrative Error|0
160348|NCT00755846|511201|P5|Overall Study|Administrative Error|0
160349|NCT00755846|511202|P4|Overall Study|Administrative Error|0
160350|NCT00755846|511203|P3|Overall Study|Administrative Error|0
160351|NCT00755846|511204|P2|Overall Study|Administrative Error|1
160352|NCT00755846|511205|P1|Overall Study|Administrative Error|0
160353|NCT00755846|511200|P6|Overall Study|Physician Decision|1
160354|NCT00755846|511201|P5|Overall Study|Physician Decision|0
160355|NCT00755846|511202|P4|Overall Study|Physician Decision|1
160356|NCT00755846|511203|P3|Overall Study|Physician Decision|0
160357|NCT00755846|511204|P2|Overall Study|Physician Decision|3
160358|NCT00755846|511205|P1|Overall Study|Physician Decision|1
160359|NCT00755846|511200|P6|Overall Study|Hyperglycemic Rescue|7
160360|NCT00755846|511201|P5|Overall Study|Hyperglycemic Rescue|8
160361|NCT00755846|511202|P4|Overall Study|Hyperglycemic Rescue|8
160362|NCT00755846|511203|P3|Overall Study|Hyperglycemic Rescue|5
160363|NCT00755846|511204|P2|Overall Study|Hyperglycemic Rescue|7
160364|NCT00755846|511205|P1|Overall Study|Hyperglycemic Rescue|21
160365|NCT00755846|511200|P6|Overall Study|Withdrawal by Subject|1
160366|NCT00755846|511201|P5|Overall Study|Withdrawal by Subject|0
160367|NCT00755846|511202|P4|Overall Study|Withdrawal by Subject|2
160368|NCT00755846|511203|P3|Overall Study|Withdrawal by Subject|5
160369|NCT00755846|511204|P2|Overall Study|Withdrawal by Subject|3
160370|NCT00755846|511205|P1|Overall Study|Withdrawal by Subject|2
160371|NCT00755846|511200|P6|Overall Study|Lost to Follow-up|2
160372|NCT00755846|511201|P5|Overall Study|Lost to Follow-up|4
160373|NCT00755846|511202|P4|Overall Study|Lost to Follow-up|0
160374|NCT00755846|511203|P3|Overall Study|Lost to Follow-up|1
160375|NCT00755846|511204|P2|Overall Study|Lost to Follow-up|2
160376|NCT00755846|511205|P1|Overall Study|Lost to Follow-up|0
160377|NCT00755846|511200|P6|Overall Study|Protocol Violation|1
160378|NCT00755846|511201|P5|Overall Study|Protocol Violation|1
160379|NCT00755846|511202|P4|Overall Study|Protocol Violation|1
160380|NCT00755846|511203|P3|Overall Study|Protocol Violation|1
160381|NCT00755846|511204|P2|Overall Study|Protocol Violation|1
160382|NCT00755846|511205|P1|Overall Study|Protocol Violation|1
160383|NCT00755846|511200|P6|Overall Study|Adverse Event|2
160384|NCT00755846|511201|P5|Overall Study|Adverse Event|3
160385|NCT00755846|511202|P4|Overall Study|Adverse Event|1
160386|NCT00755846|511203|P3|Overall Study|Adverse Event|0
160387|NCT00755846|511204|P2|Overall Study|Adverse Event|0
160388|NCT00755846|511205|P1|Overall Study|Adverse Event|0
160389|NCT00755937|511314|P1|Observational Follow-up|Lost to Follow-up|148
160390|NCT00755937|511314|P1|Recruitment|Unknown if infliximab received|164
160391|NCT00756002|511326|P2|Double-Blind Treatment Period|Not Specified|2
160392|NCT00756002|511327|P1|Double-Blind Treatment Period|Not Specified|2
160393|NCT00756002|511326|P2|Double-Blind Treatment Period|Protocol Violation|5
160394|NCT00756002|511327|P1|Double-Blind Treatment Period|Protocol Violation|6
160395|NCT00756002|511326|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
160396|NCT00756002|511327|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
160397|NCT00756002|511326|P2|Double-Blind Treatment Period|Lost to Follow-up|1
160398|NCT00756002|511327|P1|Double-Blind Treatment Period|Lost to Follow-up|0
160399|NCT00756002|511326|P2|Double-Blind Treatment Period|Lack of Efficacy|1
160400|NCT00756002|511327|P1|Double-Blind Treatment Period|Lack of Efficacy|1
160401|NCT00756314|511449|P2|Overall Study|Lost to Follow-up|59
160402|NCT00756314|511450|P1|Overall Study|Lost to Follow-up|2
160403|NCT00756444|511466|P2|Overall Study|Ineligibility Determined|0
160404|NCT00756444|511467|P1|Overall Study|Ineligibility Determined|1
160405|NCT00756444|511466|P2|Overall Study|Disease Progression|7
160406|NCT00756444|511467|P1|Overall Study|Disease Progression|2
160407|NCT00756444|511466|P2|Overall Study|Death|4
160408|NCT00756444|511467|P1|Overall Study|Death|5
160409|NCT00756444|511466|P2|Overall Study|Lost to Follow-up|1
160410|NCT00756444|511467|P1|Overall Study|Lost to Follow-up|0
160411|NCT00756444|511466|P2|Overall Study|Withdrawal by Subject|8
160412|NCT00756444|511467|P1|Overall Study|Withdrawal by Subject|6
160413|NCT00756444|511466|P2|Overall Study|Adverse Event|1
160414|NCT00756444|511467|P1|Overall Study|Adverse Event|1
160415|NCT00756457|511478|P2|Overall Study|Lost to Follow-up|2
160416|NCT00756457|511479|P1|Overall Study|Lost to Follow-up|1
160417|NCT00756470|511507|P1|Overall Study|Adverse Event|4
160418|NCT00756470|511507|P1|Overall Study|Withdrawal by Subject|1
160419|NCT00756574|511548|P2|Overall Study|Lost to Follow-up|4
160420|NCT00756574|511549|P1|Overall Study|Lost to Follow-up|4
160421|NCT00756574|511548|P2|Overall Study|Withdrawal by Subject|7
160422|NCT00756574|511549|P1|Overall Study|Withdrawal by Subject|9
160423|NCT00756730|511572|P2|Overall Study|persistent low-level viremmia|1
160424|NCT00756730|511573|P1|Overall Study|persistent low-level viremmia|0
160425|NCT00756730|511572|P2|Overall Study|discontinued due to rash prior to week 4|1
160426|NCT00756730|511573|P1|Overall Study|discontinued due to rash prior to week 4|0
160427|NCT00756886|511595|P2|Overall Study|Ineligible|4
160428|NCT00756886|511596|P1|Overall Study|Ineligible|9
160429|NCT00756886|511595|P2|Overall Study|Lack of Efficacy|0
160430|NCT00756886|511596|P1|Overall Study|Lack of Efficacy|1
160431|NCT00756886|511595|P2|Overall Study|Adverse Event|3
160432|NCT00756886|511596|P1|Overall Study|Adverse Event|0
160433|NCT00756886|511595|P2|Overall Study|Lost to Follow-up|0
160434|NCT00756886|511596|P1|Overall Study|Lost to Follow-up|1
160435|NCT00756938|511605|P4|Optional Extension|Adverse Event|1
160436|NCT00756938|511606|P3|Optional Extension|Adverse Event|0
160437|NCT00756938|511607|P2|Optional Extension|Adverse Event|0
160438|NCT00756938|511608|P1|Optional Extension|Adverse Event|0
160439|NCT00756938|511605|P4|Optional Extension|Withdrawal by Subject|10
160440|NCT00756938|511606|P3|Optional Extension|Withdrawal by Subject|0
160441|NCT00756938|511607|P2|Optional Extension|Withdrawal by Subject|0
160442|NCT00756938|511608|P1|Optional Extension|Withdrawal by Subject|0
160443|NCT00756938|511605|P4|Optional Extension|Protocol Violation|1
160444|NCT00756938|511606|P3|Optional Extension|Protocol Violation|0
160445|NCT00756938|511607|P2|Optional Extension|Protocol Violation|0
160446|NCT00756938|511608|P1|Optional Extension|Protocol Violation|0
160447|NCT00756938|511605|P4|Optional Extension|Lost to Follow-up|1
160448|NCT00756938|511606|P3|Optional Extension|Lost to Follow-up|0
160449|NCT00756938|511607|P2|Optional Extension|Lost to Follow-up|0
160450|NCT00756938|511608|P1|Optional Extension|Lost to Follow-up|0
160451|NCT00756938|511605|P4|Optional Extension|Physician Decision|3
160452|NCT00756938|511606|P3|Optional Extension|Physician Decision|0
160453|NCT00756938|511607|P2|Optional Extension|Physician Decision|0
160454|NCT00756938|511608|P1|Optional Extension|Physician Decision|0
160455|NCT00756938|511605|P4|Optional Extension|Protocol-specific criteria met|9
160456|NCT00756938|511606|P3|Optional Extension|Protocol-specific criteria met|0
160457|NCT00756938|511607|P2|Optional Extension|Protocol-specific criteria met|0
160458|NCT00756938|511608|P1|Optional Extension|Protocol-specific criteria met|0
160459|NCT00756938|511605|P4|Optional Extension|End of Study|11
160460|NCT00756938|511606|P3|Optional Extension|End of Study|0
160461|NCT00756938|511607|P2|Optional Extension|End of Study|0
160462|NCT00756938|511608|P1|Optional Extension|End of Study|0
160463|NCT00756938|511605|P4|Optional Extension|Lack of Efficacy|1
160464|NCT00756938|511606|P3|Optional Extension|Lack of Efficacy|0
160465|NCT00756938|511607|P2|Optional Extension|Lack of Efficacy|0
160466|NCT00756938|511608|P1|Optional Extension|Lack of Efficacy|0
160467|NCT00756938|511605|P4|12-week Base Study|Lost to Follow-up|0
160468|NCT00756938|511606|P3|12-week Base Study|Lost to Follow-up|0
160469|NCT00756938|511607|P2|12-week Base Study|Lost to Follow-up|0
160470|NCT00756938|511608|P1|12-week Base Study|Lost to Follow-up|1
160471|NCT00756938|511605|P4|12-week Base Study|Protocol Violation|0
160472|NCT00756938|511606|P3|12-week Base Study|Protocol Violation|1
160473|NCT00756938|511607|P2|12-week Base Study|Protocol Violation|0
160474|NCT00756938|511608|P1|12-week Base Study|Protocol Violation|0
160475|NCT00756938|511605|P4|12-week Base Study|Protocol-specific Criteria Met|0
160476|NCT00756938|511606|P3|12-week Base Study|Protocol-specific Criteria Met|1
160477|NCT00756938|511607|P2|12-week Base Study|Protocol-specific Criteria Met|0
160478|NCT00756938|511608|P1|12-week Base Study|Protocol-specific Criteria Met|1
160479|NCT00757003|511672|P1|Overall Study|Not implanted|1
160480|NCT00757003|511672|P1|Overall Study|Surgically explanted|2
160481|NCT00757003|511672|P1|Overall Study|Withdrawal by Subject|4
160482|NCT00757003|511672|P1|Overall Study|Lost to Follow-up|9
160483|NCT00757003|511672|P1|Overall Study|Death|33
160484|NCT00757172|511678|P1|Overall Study|Progression|4
160485|NCT00757172|511678|P1|Overall Study|Physician Decision|3
160486|NCT00757172|511678|P1|Overall Study|Withdrawal by Subject|4
160487|NCT00757237|511688|P2|Overall Study|Other|2
160488|NCT00757237|511689|P1|Overall Study|Other|0
160489|NCT00757237|511688|P2|Overall Study|Safety or Tolerability|5
160490|NCT00757237|511689|P1|Overall Study|Safety or Tolerability|3
160491|NCT00757237|511688|P2|Overall Study|Withdrawal by Subject|12
160492|NCT00757237|511689|P1|Overall Study|Withdrawal by Subject|8
160493|NCT00757237|511688|P2|Overall Study|Physician Decision|3
160494|NCT00757237|511689|P1|Overall Study|Physician Decision|2
160495|NCT00757237|511688|P2|Overall Study|Protocol Violation|2
160496|NCT00757237|511689|P1|Overall Study|Protocol Violation|0
160497|NCT00757237|511688|P2|Overall Study|Lost to Follow-up|1
160498|NCT00757237|511689|P1|Overall Study|Lost to Follow-up|0
160499|NCT00764322|511726|P1|Overall Study|No CYP2D6 genotyping|9
160500|NCT00764322|511726|P1|Overall Study|Withdrawal by Subject|11
160501|NCT00764361|511745|P2|Overall Study|Adverse Event|1
160502|NCT00764361|511746|P1|Overall Study|Adverse Event|0
160503|NCT00764361|511745|P2|Overall Study|Withdrawal by Subject|3
160504|NCT00764361|511746|P1|Overall Study|Withdrawal by Subject|2
160505|NCT00764465|511758|P6|Overall Study|Withdrawal by Subject|0
160506|NCT00764465|511759|P5|Overall Study|Withdrawal by Subject|0
160507|NCT00764465|511760|P4|Overall Study|Withdrawal by Subject|0
160508|NCT00764465|511761|P3|Overall Study|Withdrawal by Subject|1
160509|NCT00764465|511762|P2|Overall Study|Withdrawal by Subject|1
160510|NCT00764465|511763|P1|Overall Study|Withdrawal by Subject|0
160511|NCT00764465|511758|P6|Overall Study|Adverse Event|1
160512|NCT00764465|511759|P5|Overall Study|Adverse Event|1
160513|NCT00764465|511760|P4|Overall Study|Adverse Event|1
160514|NCT00764465|511761|P3|Overall Study|Adverse Event|0
160515|NCT00764465|511762|P2|Overall Study|Adverse Event|0
160516|NCT00764465|511763|P1|Overall Study|Adverse Event|2
160517|NCT00764478|511792|P3|Overall Study|Protocol Violation|1
160518|NCT00764478|511793|P2|Overall Study|Protocol Violation|1
160519|NCT00764478|511794|P1|Overall Study|Protocol Violation|0
160520|NCT00764478|511792|P3|Overall Study|Lost to Follow-up|5
160521|NCT00764478|511793|P2|Overall Study|Lost to Follow-up|8
160522|NCT00764478|511794|P1|Overall Study|Lost to Follow-up|7
160523|NCT00764478|511792|P3|Overall Study|Withdrawal by Subject|1
160524|NCT00764478|511793|P2|Overall Study|Withdrawal by Subject|12
160525|NCT00764478|511794|P1|Overall Study|Withdrawal by Subject|7
160526|NCT00764478|511792|P3|Overall Study|Adverse Event|1
160527|NCT00764478|511793|P2|Overall Study|Adverse Event|1
160528|NCT00764478|511794|P1|Overall Study|Adverse Event|1
160529|NCT00764504|511871|P3|Overall Study|Lost to Follow-up|72
160530|NCT00764504|511872|P2|Overall Study|Lost to Follow-up|34
160531|NCT00764504|511873|P1|Overall Study|Lost to Follow-up|40
160532|NCT00764504|511871|P3|Overall Study|Withdrawal by Subject|4
160533|NCT00764504|511872|P2|Overall Study|Withdrawal by Subject|7
160534|NCT00764504|511873|P1|Overall Study|Withdrawal by Subject|1
160535|NCT00764504|511871|P3|Overall Study|Physician Decision|0
160536|NCT00764504|511872|P2|Overall Study|Physician Decision|0
160537|NCT00764504|511873|P1|Overall Study|Physician Decision|1
160538|NCT00764504|511871|P3|Overall Study|Revision of Device|14
160539|NCT00764504|511872|P2|Overall Study|Revision of Device|23
160540|NCT00764504|511873|P1|Overall Study|Revision of Device|12
160541|NCT00764504|511871|P3|Overall Study|Death|13
160542|NCT00764504|511872|P2|Overall Study|Death|6
160543|NCT00764504|511873|P1|Overall Study|Death|12
160544|NCT00767000|511904|P5|Optional 104-week Extension|Study terminated by sponsor|4
160545|NCT00767000|511905|P4|Optional 104-week Extension|Study terminated by sponsor|2
160546|NCT00767000|511906|P3|Optional 104-week Extension|Study terminated by sponsor|7
160547|NCT00767000|511907|P2|Optional 104-week Extension|Study terminated by sponsor|3
160548|NCT00767000|511908|P1|Optional 104-week Extension|Study terminated by sponsor|7
160549|NCT00767000|511904|P5|54-week Study|Reason not reported|0
160550|NCT00767000|511905|P4|54-week Study|Reason not reported|1
160551|NCT00767000|511906|P3|54-week Study|Reason not reported|0
160552|NCT00767000|511907|P2|54-week Study|Reason not reported|0
160553|NCT00767000|511908|P1|54-week Study|Reason not reported|0
160554|NCT00767000|511904|P5|54-week Study|Study terminated by sponsor|194
160555|NCT00767000|511905|P4|54-week Study|Study terminated by sponsor|196
160556|NCT00767000|511906|P3|54-week Study|Study terminated by sponsor|89
160557|NCT00767000|511907|P2|54-week Study|Study terminated by sponsor|102
160558|NCT00767000|511908|P1|54-week Study|Study terminated by sponsor|90
160559|NCT00767000|511904|P5|54-week Study|Withdrawal by Subject|13
160560|NCT00767000|511905|P4|54-week Study|Withdrawal by Subject|11
160561|NCT00767000|511906|P3|54-week Study|Withdrawal by Subject|5
160562|NCT00767000|511907|P2|54-week Study|Withdrawal by Subject|3
160563|NCT00767000|511908|P1|54-week Study|Withdrawal by Subject|2
160564|NCT00767000|511904|P5|54-week Study|Protocol Violation|0
160565|NCT00767000|511905|P4|54-week Study|Protocol Violation|2
160566|NCT00767000|511906|P3|54-week Study|Protocol Violation|1
160567|NCT00767000|511907|P2|54-week Study|Protocol Violation|0
160568|NCT00767000|511908|P1|54-week Study|Protocol Violation|0
160569|NCT00767000|511904|P5|54-week Study|Progressive disease|0
160570|NCT00767000|511905|P4|54-week Study|Progressive disease|0
160571|NCT00767000|511906|P3|54-week Study|Progressive disease|1
160572|NCT00767000|511907|P2|54-week Study|Progressive disease|0
160573|NCT00767000|511908|P1|54-week Study|Progressive disease|0
160574|NCT00767000|511904|P5|54-week Study|Physician Decision|1
160575|NCT00767000|511905|P4|54-week Study|Physician Decision|1
160576|NCT00767000|511906|P3|54-week Study|Physician Decision|1
160577|NCT00767000|511907|P2|54-week Study|Physician Decision|0
160578|NCT00767000|511908|P1|54-week Study|Physician Decision|4
160579|NCT00767000|511904|P5|54-week Study|Lost to Follow-up|2
160580|NCT00767000|511905|P4|54-week Study|Lost to Follow-up|4
160581|NCT00767000|511906|P3|54-week Study|Lost to Follow-up|1
160582|NCT00767000|511907|P2|54-week Study|Lost to Follow-up|0
160583|NCT00767000|511908|P1|54-week Study|Lost to Follow-up|4
160584|NCT00767000|511904|P5|54-week Study|Lack of Efficacy|5
160585|NCT00767000|511905|P4|54-week Study|Lack of Efficacy|0
160586|NCT00767000|511906|P3|54-week Study|Lack of Efficacy|1
160587|NCT00767000|511907|P2|54-week Study|Lack of Efficacy|0
160588|NCT00767000|511908|P1|54-week Study|Lack of Efficacy|2
160589|NCT00767000|511904|P5|54-week Study|Interruption of study medication|0
160590|NCT00767000|511905|P4|54-week Study|Interruption of study medication|0
160591|NCT00767000|511906|P3|54-week Study|Interruption of study medication|1
160592|NCT00767000|511907|P2|54-week Study|Interruption of study medication|0
160593|NCT00767000|511908|P1|54-week Study|Interruption of study medication|0
160594|NCT00767000|511904|P5|54-week Study|Hypoglycemia|0
160595|NCT00767000|511905|P4|54-week Study|Hypoglycemia|0
160596|NCT00767000|511906|P3|54-week Study|Hypoglycemia|0
160597|NCT00767000|511907|P2|54-week Study|Hypoglycemia|1
160598|NCT00767000|511908|P1|54-week Study|Hypoglycemia|0
160599|NCT00767000|511904|P5|54-week Study|Hyperglycemia|1
160600|NCT00767000|511905|P4|54-week Study|Hyperglycemia|0
160601|NCT00767000|511906|P3|54-week Study|Hyperglycemia|1
160602|NCT00767000|511907|P2|54-week Study|Hyperglycemia|0
160603|NCT00767000|511908|P1|54-week Study|Hyperglycemia|0
160604|NCT00767000|511904|P5|54-week Study|Creaninine/creatinine clearance|4
160605|NCT00767000|511905|P4|54-week Study|Creaninine/creatinine clearance|2
160606|NCT00767000|511906|P3|54-week Study|Creaninine/creatinine clearance|2
160607|NCT00767000|511907|P2|54-week Study|Creaninine/creatinine clearance|1
160608|NCT00767000|511908|P1|54-week Study|Creaninine/creatinine clearance|2
160609|NCT00767000|511904|P5|54-week Study|Adverse Event|4
160610|NCT00767000|511905|P4|54-week Study|Adverse Event|8
160611|NCT00767000|511906|P3|54-week Study|Adverse Event|6
160612|NCT00767000|511907|P2|54-week Study|Adverse Event|6
160613|NCT00767000|511908|P1|54-week Study|Adverse Event|4
160614|NCT00767039|511952|P2|Overall Study|Death|2
160615|NCT00767039|511953|P1|Overall Study|Death|5
160616|NCT00767104|511981|P2|Overall Study|Lost to Follow-up|2
160617|NCT00767104|511982|P1|Overall Study|Lost to Follow-up|1
160618|NCT00767325|511990|P1|Overall Study|Missed visit due to family reasons|1
160619|NCT00767325|511990|P1|Overall Study|No longer met study criteria|2
160620|NCT00767325|511990|P1|Overall Study|Lost to Follow-up|3
160621|NCT00767325|511990|P1|Overall Study|Adverse Event|7
160622|NCT00767325|511990|P1|Overall Study|Lack of Efficacy|2
160623|NCT00767455|512027|P1|Overall Study|Investigator error|19
160624|NCT00767520|512066|P2|Overall Study|Randomized in error and Never treated|2
160625|NCT00767520|512067|P1|Overall Study|Randomized in error and Never treated|0
160626|NCT00767520|512066|P2|Overall Study|Participants still on treatment|15
160627|NCT00767520|512067|P1|Overall Study|Participants still on treatment|11
160628|NCT00767676|512106|P1|Overall Study|Investigator error|54
160629|NCT00767806|512133|P2|Overall Study|Sponsor Decision|1
160630|NCT00767806|512134|P1|Overall Study|Sponsor Decision|0
160631|NCT00767806|512133|P2|Overall Study|Entry Criteria Not Met|1
160632|NCT00767806|512134|P1|Overall Study|Entry Criteria Not Met|1
160633|NCT00767806|512133|P2|Overall Study|Lost to Follow-up|4
160634|NCT00767806|512134|P1|Overall Study|Lost to Follow-up|1
160635|NCT00767806|512133|P2|Overall Study|Physician Decision|3
160636|NCT00767806|512134|P1|Overall Study|Physician Decision|4
160637|NCT00767806|512133|P2|Overall Study|Lack of Efficacy|9
160638|NCT00767806|512134|P1|Overall Study|Lack of Efficacy|1
160639|NCT00767806|512133|P2|Overall Study|Protocol Violation|5
160640|NCT00767806|512134|P1|Overall Study|Protocol Violation|6
160641|NCT00767806|512133|P2|Overall Study|Withdrawal by Subject|13
160642|NCT00767806|512134|P1|Overall Study|Withdrawal by Subject|8
160643|NCT00767806|512133|P2|Overall Study|Adverse Event|11
160644|NCT00767806|512134|P1|Overall Study|Adverse Event|30
160645|NCT00768040|512192|P2|Overall Study|Abnormal laboratory value|1
160646|NCT00768040|512193|P1|Overall Study|Abnormal laboratory value|1
160647|NCT00768040|512192|P2|Overall Study|Adverse Event|2
160648|NCT00768040|512193|P1|Overall Study|Adverse Event|3
160649|NCT00768053|512199|P1|Overall Study|Lost to Follow-up|1
160650|NCT00768053|512199|P1|Overall Study|Adverse Event|10
160651|NCT00768066|512231|P3|Overall Study|Did not receive study product injection.|0
160652|NCT00768066|512232|P2|Overall Study|Did not receive study product injection.|3
160653|NCT00768066|512233|P1|Overall Study|Did not receive study product injection.|3
160654|NCT00768144|512269|P1|Overall Study|Pt Withdrew Consent|1
160655|NCT00768144|512269|P1|Overall Study|Patient or MD Decision to End Treatment|1
160656|NCT00768144|512269|P1|Overall Study|Progressive Disease|21
160657|NCT00768144|512269|P1|Overall Study|Adverse Event|13
160658|NCT00768222|512277|P2|Overall Study|Protocol Violation|2
160659|NCT00768222|512278|P1|Overall Study|Protocol Violation|0
160660|NCT00768222|512277|P2|Overall Study|Withdrawal by Subject|1
160661|NCT00768222|512278|P1|Overall Study|Withdrawal by Subject|3
160662|NCT00768222|512277|P2|Overall Study|Lost to Follow-up|1
160663|NCT00768222|512278|P1|Overall Study|Lost to Follow-up|1
160664|NCT00768300|512302|P2|Overall Study|Missing data|0
160665|NCT00768300|512303|P1|Overall Study|Missing data|1
160666|NCT00768300|512302|P2|Overall Study|Treated but never dosed with Study drug|0
160667|NCT00768300|512303|P1|Overall Study|Treated but never dosed with Study drug|1
160668|NCT00768300|512302|P2|Overall Study|Began prohibited concomitant medication|1
160669|NCT00768300|512303|P1|Overall Study|Began prohibited concomitant medication|0
160670|NCT00768300|512302|P2|Overall Study|Lost to Follow-up|1
160671|NCT00768300|512303|P1|Overall Study|Lost to Follow-up|0
160672|NCT00768300|512302|P2|Overall Study|Received lung transplant|1
160673|NCT00768300|512303|P1|Overall Study|Received lung transplant|1
160674|NCT00768300|512302|P2|Overall Study|Screen failure following randomization|0
160675|NCT00768300|512303|P1|Overall Study|Screen failure following randomization|1
160676|NCT00768300|512302|P2|Overall Study|Subject moved to pursue lung transplant|1
160677|NCT00768300|512303|P1|Overall Study|Subject moved to pursue lung transplant|1
160678|NCT00768300|512302|P2|Overall Study|Death|5
160679|NCT00768300|512303|P1|Overall Study|Death|21
160680|NCT00768300|512302|P2|Overall Study|Study discontinued by Sponsor|140
160681|NCT00768300|512303|P1|Overall Study|Study discontinued by Sponsor|271
160682|NCT00768300|512302|P2|Overall Study|Physician Decision|3
160683|NCT00768300|512303|P1|Overall Study|Physician Decision|2
160684|NCT00768300|512302|P2|Overall Study|Withdrawal by Subject|7
160685|NCT00768300|512303|P1|Overall Study|Withdrawal by Subject|13
160686|NCT00768300|512302|P2|Overall Study|Protocol Violation|1
160687|NCT00768300|512303|P1|Overall Study|Protocol Violation|6
160688|NCT00768300|512302|P2|Overall Study|Adverse Event|2
160689|NCT00768300|512303|P1|Overall Study|Adverse Event|10
160690|NCT00768300|512302|P2|Overall Study|Randomized but not treated|1
160691|NCT00768300|512303|P1|Overall Study|Randomized but not treated|1
160692|NCT00768430|512327|P2|7 Day Endpoint|Withdrawal by Subject|3
160693|NCT00768430|512328|P1|7 Day Endpoint|Withdrawal by Subject|2
160694|NCT00768560|512349|P6|Intervention Set 1|Adverse Event|0
160695|NCT00768560|512350|P5|Intervention Set 1|Adverse Event|0
160696|NCT00768560|512351|P4|Intervention Set 1|Adverse Event|0
160697|NCT00768560|512352|P3|Intervention Set 1|Adverse Event|0
160698|NCT00768560|512353|P2|Intervention Set 1|Adverse Event|1
160699|NCT00768560|512354|P1|Intervention Set 1|Adverse Event|0
160700|NCT00768651|512408|P1|Overall Study|Withdrawal by Subject|1
160701|NCT00768755|512417|P4|Phase 2|Randomized but not treated|2
160702|NCT00768755|512418|P3|Phase 2|Randomized but not treated|0
160703|NCT00768755|512419|P2|Phase 2|Randomized but not treated|0
160704|NCT00768755|512420|P1|Phase 2|Randomized but not treated|0
160705|NCT00768755|512417|P4|Phase 2|Study Terminated by Sponsor|14
160706|NCT00768755|512418|P3|Phase 2|Study Terminated by Sponsor|7
160707|NCT00768755|512419|P2|Phase 2|Study Terminated by Sponsor|13
160708|NCT00768755|512420|P1|Phase 2|Study Terminated by Sponsor|0
160709|NCT00768755|512417|P4|Phase 2|Unspecified|4
160710|NCT00768755|512418|P3|Phase 2|Unspecified|2
160711|NCT00768755|512419|P2|Phase 2|Unspecified|1
160712|NCT00768755|512420|P1|Phase 2|Unspecified|0
160713|NCT00768755|512417|P4|Phase 2|Withdrawal by Subject|1
160714|NCT00768755|512418|P3|Phase 2|Withdrawal by Subject|0
160715|NCT00768755|512419|P2|Phase 2|Withdrawal by Subject|1
160716|NCT00768755|512420|P1|Phase 2|Withdrawal by Subject|0
160717|NCT00768755|512417|P4|Phase 2|Lost to Follow-up|4
160718|NCT00768755|512418|P3|Phase 2|Lost to Follow-up|1
160719|NCT00768755|512419|P2|Phase 2|Lost to Follow-up|1
160720|NCT00768755|512420|P1|Phase 2|Lost to Follow-up|0
160721|NCT00768755|512417|P4|Phase 2|Protocol Violation|1
160722|NCT00768755|512418|P3|Phase 2|Protocol Violation|0
160723|NCT00768755|512419|P2|Phase 2|Protocol Violation|2
160724|NCT00768755|512420|P1|Phase 2|Protocol Violation|0
160725|NCT00768755|512417|P4|Phase 2|Death|31
160726|NCT00768755|512418|P3|Phase 2|Death|48
160727|NCT00768755|512419|P2|Phase 2|Death|37
160728|NCT00768755|512420|P1|Phase 2|Death|0
160729|NCT00768755|512417|P4|Phase 1|Unspecified|0
160730|NCT00768755|512418|P3|Phase 1|Unspecified|0
160731|NCT00768755|512419|P2|Phase 1|Unspecified|0
160732|NCT00768755|512420|P1|Phase 1|Unspecified|4
160733|NCT00768755|512417|P4|Phase 1|Death|0
160734|NCT00768755|512418|P3|Phase 1|Death|0
160735|NCT00768755|512419|P2|Phase 1|Death|0
160736|NCT00768755|512420|P1|Phase 1|Death|6
160737|NCT00768898|512444|P1|Overall Study|Headache|1
160738|NCT00768898|512444|P1|Overall Study|Unrelated injury|1
160739|NCT00768989|512466|P2|On or After Week 36|Sponsor Termination|26
160740|NCT00768989|512467|P1|On or After Week 36|Sponsor Termination|45
160741|NCT00768989|512466|P2|On or After Week 36|Did not attend termination visit|0
160742|NCT00768989|512467|P1|On or After Week 36|Did not attend termination visit|2
160743|NCT00768989|512466|P2|On or After Week 36|Protocol Violation|0
160744|NCT00768989|512467|P1|On or After Week 36|Protocol Violation|1
160745|NCT00768989|512466|P2|On or After Week 36|Poor Compliance|0
160746|NCT00768989|512467|P1|On or After Week 36|Poor Compliance|1
160747|NCT00768989|512466|P2|On or After Week 36|Lost to Follow-up|0
160748|NCT00768989|512467|P1|On or After Week 36|Lost to Follow-up|1
160749|NCT00768989|512466|P2|On or After Week 36|Adverse Event|1
160750|NCT00768989|512467|P1|On or After Week 36|Adverse Event|0
160751|NCT00768989|512466|P2|On or After Week 36|Lack of Efficacy|0
160752|NCT00768989|512467|P1|On or After Week 36|Lack of Efficacy|1
160753|NCT00768989|512466|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
160754|NCT00768989|512467|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
160755|NCT00768989|512466|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
160756|NCT00768989|512467|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
160757|NCT00768989|512466|P2|Week 24 to Prior to Week 36|Adverse Event|0
160758|NCT00768989|512467|P1|Week 24 to Prior to Week 36|Adverse Event|1
160759|NCT00768989|512466|P2|Prior to Week 24|Protocol Violation|2
160760|NCT00768989|512467|P1|Prior to Week 24|Protocol Violation|0
160761|NCT00768989|512466|P2|Prior to Week 24|Lost to Follow-up|1
160762|NCT00768989|512467|P1|Prior to Week 24|Lost to Follow-up|0
160763|NCT00768989|512466|P2|Prior to Week 24|Adverse Event|0
160764|NCT00768989|512467|P1|Prior to Week 24|Adverse Event|3
160765|NCT00768989|512466|P2|Prior to Week 24|Withdrawal by Subject|0
160766|NCT00768989|512467|P1|Prior to Week 24|Withdrawal by Subject|1
160767|NCT00769067|512538|P2|Overall Study|Withdrawal by Subject|1
160768|NCT00769067|512539|P1|Overall Study|Withdrawal by Subject|0
160769|NCT00769067|512538|P2|Overall Study|Unspecified|3
160770|NCT00769067|512539|P1|Overall Study|Unspecified|1
160771|NCT00769067|512538|P2|Overall Study|Study terminated by sponsor|3
160772|NCT00769067|512539|P1|Overall Study|Study terminated by sponsor|1
160773|NCT00769067|512538|P2|Overall Study|Lost to Follow-up|1
160774|NCT00769067|512539|P1|Overall Study|Lost to Follow-up|3
160775|NCT00769067|512538|P2|Overall Study|Death|86
160776|NCT00769067|512539|P1|Overall Study|Death|89
160777|NCT00769119|512566|P2|Overall Study|Disallowed medication|0
160778|NCT00769119|512567|P1|Overall Study|Disallowed medication|1
160779|NCT00769119|512566|P2|Overall Study|Adverse Event|1
160780|NCT00769119|512567|P1|Overall Study|Adverse Event|1
160781|NCT00769119|512566|P2|Overall Study|Voluntary discontinuation|2
160782|NCT00769119|512567|P1|Overall Study|Voluntary discontinuation|0
160783|NCT00769132|512611|P4|Period 4|Withdrawal by Subject|0
160784|NCT00769132|512612|P3|Period 4|Withdrawal by Subject|0
160785|NCT00769132|512613|P2|Period 4|Withdrawal by Subject|1
160786|NCT00769132|512614|P1|Period 4|Withdrawal by Subject|0
160787|NCT00769132|512611|P4|Period 3|Withdrawal by Subject|0
160788|NCT00769132|512612|P3|Period 3|Withdrawal by Subject|0
160789|NCT00769132|512613|P2|Period 3|Withdrawal by Subject|0
160790|NCT00769132|512614|P1|Period 3|Withdrawal by Subject|1
160791|NCT00769132|512611|P4|Period 2|Withdrawal by Subject|1
160792|NCT00769132|512612|P3|Period 2|Withdrawal by Subject|0
160793|NCT00769132|512613|P2|Period 2|Withdrawal by Subject|0
160794|NCT00769132|512614|P1|Period 2|Withdrawal by Subject|0
160795|NCT00769132|512611|P4|Period 1|Adverse Event|1
160796|NCT00769132|512612|P3|Period 1|Adverse Event|0
160797|NCT00769132|512613|P2|Period 1|Adverse Event|0
160798|NCT00769132|512614|P1|Period 1|Adverse Event|1
160799|NCT00769184|512628|P2|No Treatment (6 Weeks)|Adverse Event|1
160800|NCT00769184|512629|P1|No Treatment (6 Weeks)|Adverse Event|1
160801|NCT00769184|512628|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
160802|NCT00769184|512629|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
160803|NCT00769184|512628|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
160804|NCT00769184|512629|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
160805|NCT00754624|512666|P1|Overall Study|Lost to Follow-up|3
160806|NCT00754624|512666|P1|Overall Study|Various|12
160807|NCT00754624|512666|P1|Overall Study|Withdrawal by Subject|28
160808|NCT00754624|512666|P1|Overall Study|Protocol Violation|1
160809|NCT00754624|512666|P1|Overall Study|Physician Decision|8
160810|NCT00754624|512666|P1|Overall Study|Death|1
160811|NCT00754624|512666|P1|Overall Study|Adverse Event|16
160812|NCT00754650|512676|P1|Overall Study|Disease Progression|2
160813|NCT00754741|512684|P3|Overall Study|Died or disenrolled|54
160814|NCT00754741|512685|P2|Overall Study|Died or disenrolled|69
160815|NCT00754741|512686|P1|Overall Study|Died or disenrolled|57
160816|NCT00754793|512744|P2|Overall Study|voluntary withdrawn from study|1
160817|NCT00754793|512745|P1|Overall Study|voluntary withdrawn from study|0
160818|NCT00760383|512769|P2|Overall Study|moved away; withdrew; medical reasons|7
160819|NCT00760383|512770|P1|Overall Study|moved away; withdrew; medical reasons|5
160820|NCT00760474|512799|P2|Period 2 (P2)|Adverse Event|1
160821|NCT00760474|512800|P1|Period 2 (P2)|Adverse Event|0
160822|NCT00760474|512799|P2|Period 2 (P2)|Lost to Follow-up|0
160823|NCT00760474|512800|P1|Period 2 (P2)|Lost to Follow-up|1
160824|NCT00760474|512799|P2|Placebo Washout Period|Unspecified|1
160825|NCT00760474|512800|P1|Placebo Washout Period|Unspecified|0
160826|NCT00760474|512799|P2|Period 1 (P1)|Discontinued then re-entered|1
160827|NCT00760474|512800|P1|Period 1 (P1)|Discontinued then re-entered|1
160828|NCT00760487|512836|P1|Overall Study|Unilateral implantation|3
160829|NCT00760552|512872|P2|Overall Study|Lost to Follow-up|10
160830|NCT00760552|512873|P1|Overall Study|Lost to Follow-up|11
160831|NCT00760552|512872|P2|Overall Study|Death|0
160832|NCT00760552|512873|P1|Overall Study|Death|2
160833|NCT00760617|512923|P3|Overall Study|Lost to Follow-up|5
160834|NCT00760617|512924|P2|Overall Study|Lost to Follow-up|0
160835|NCT00760617|512925|P1|Overall Study|Lost to Follow-up|0
160836|NCT00760617|512923|P3|Overall Study|Adverse Event|0
160837|NCT00760617|512924|P2|Overall Study|Adverse Event|2
160838|NCT00760617|512925|P1|Overall Study|Adverse Event|5
160839|NCT00760669|512996|P1|Overall Study|Took drug before entering in contract|5
160840|NCT00760669|512996|P1|Overall Study|Participants with overlapping cases|1
160841|NCT00760669|512996|P1|Overall Study|Participants missing efficacy assessment|6
160842|NCT00760669|512996|P1|Overall Study|Not assessed for overall improvement|18
160843|NCT00760747|513012|P2|Study Period III|Physician Decision|1
160844|NCT00760747|513013|P1|Study Period III|Physician Decision|0
160845|NCT00760747|513012|P2|Study Period III|Protocol Violation|1
160846|NCT00760747|513013|P1|Study Period III|Protocol Violation|1
160847|NCT00760747|513012|P2|Study Period III|Parent/Caregiver Decision|1
160848|NCT00760747|513013|P1|Study Period III|Parent/Caregiver Decision|0
160849|NCT00760747|513012|P2|Study Period III|Lack of Efficacy|0
160850|NCT00760747|513013|P1|Study Period III|Lack of Efficacy|1
160851|NCT00760747|513012|P2|Study Period III|Adverse Event|0
160852|NCT00760747|513013|P1|Study Period III|Adverse Event|1
160853|NCT00760747|513012|P2|Study Period II|No drug administered|1
160854|NCT00760747|513013|P1|Study Period II|No drug administered|0
160855|NCT00760747|513012|P2|Study Period II|Withdrawal by Subject|0
160856|NCT00760747|513013|P1|Study Period II|Withdrawal by Subject|1
160857|NCT00760747|513012|P2|Study Period II|Protocol Violation|3
160858|NCT00760747|513013|P1|Study Period II|Protocol Violation|6
160859|NCT00760747|513012|P2|Study Period II|Parent/Caregiver Decision|0
160860|NCT00760747|513013|P1|Study Period II|Parent/Caregiver Decision|3
160861|NCT00760747|513012|P2|Study Period II|Lack of Efficacy|6
160862|NCT00760747|513013|P1|Study Period II|Lack of Efficacy|0
160863|NCT00760747|513012|P2|Study Period II|Adverse Event|4
160864|NCT00760747|513013|P1|Study Period II|Adverse Event|3
160865|NCT00760838|513043|P2|Overall Study|Withdrawal by Subject|1
160866|NCT00760838|513044|P1|Overall Study|Withdrawal by Subject|1
160867|NCT00760838|513043|P2|Overall Study|Lost to Follow-up|0
160868|NCT00760838|513044|P1|Overall Study|Lost to Follow-up|2
160869|NCT00760838|513043|P2|Overall Study|Lack of Efficacy|0
160870|NCT00760838|513044|P1|Overall Study|Lack of Efficacy|1
160871|NCT00760838|513043|P2|Overall Study|Adverse Event|1
160872|NCT00760838|513044|P1|Overall Study|Adverse Event|1
160873|NCT00760877|513062|P2|Overall Study|Treatment failure|0
160874|NCT00760877|513063|P1|Overall Study|Treatment failure|1
160875|NCT00760877|513062|P2|Overall Study|Participants transferred to AMN107A2408|1
160876|NCT00760877|513063|P1|Overall Study|Participants transferred to AMN107A2408|11
160877|NCT00760877|513062|P2|Overall Study|Physician Decision|2
160878|NCT00760877|513063|P1|Overall Study|Physician Decision|1
160879|NCT00760877|513062|P2|Overall Study|Participant not eligible to cross-over|1
160880|NCT00760877|513063|P1|Overall Study|Participant not eligible to cross-over|0
160881|NCT00760877|513062|P2|Overall Study|Participant diagnosed with AML|1
160882|NCT00760877|513063|P1|Overall Study|Participant diagnosed with AML|0
160883|NCT00760877|513062|P2|Overall Study|Adverse Event|12
160884|NCT00760877|513063|P1|Overall Study|Adverse Event|19
160885|NCT00760877|513062|P2|Overall Study|Withdrawal by Subject|3
160886|NCT00760877|513063|P1|Overall Study|Withdrawal by Subject|7
160887|NCT00760877|513062|P2|Overall Study|Death|1
160888|NCT00760877|513063|P1|Overall Study|Death|2
160889|NCT00760877|513062|P2|Overall Study|Pregnancy|4
160890|NCT00760877|513063|P1|Overall Study|Pregnancy|1
160891|NCT00760877|513062|P2|Overall Study|Non-compliance with protocol treatment|1
160892|NCT00760877|513063|P1|Overall Study|Non-compliance with protocol treatment|2
160893|NCT00760877|513062|P2|Overall Study|Protocol Violation|0
160894|NCT00760877|513063|P1|Overall Study|Protocol Violation|1
160895|NCT00761150|513122|P3|Double-blind Period|Not specified|3
160896|NCT00761150|513123|P2|Double-blind Period|Not specified|3
160897|NCT00761150|513124|P1|Double-blind Period|Not specified|0
160898|NCT00761150|513122|P3|Double-blind Period|Noncompliance|0
160899|NCT00761150|513123|P2|Double-blind Period|Noncompliance|1
160900|NCT00761150|513124|P1|Double-blind Period|Noncompliance|0
160901|NCT00761150|513122|P3|Double-blind Period|Did not meet DB randomization criteria|1
160902|NCT00761150|513123|P2|Double-blind Period|Did not meet DB randomization criteria|0
160903|NCT00761150|513124|P1|Double-blind Period|Did not meet DB randomization criteria|0
160904|NCT00761150|513122|P3|Double-blind Period|Lost to Follow-up|1
160905|NCT00761150|513123|P2|Double-blind Period|Lost to Follow-up|2
160906|NCT00761150|513124|P1|Double-blind Period|Lost to Follow-up|0
160907|NCT00761150|513122|P3|Double-blind Period|Withdrawal by Subject|2
160908|NCT00761150|513123|P2|Double-blind Period|Withdrawal by Subject|3
160909|NCT00761150|513124|P1|Double-blind Period|Withdrawal by Subject|0
160910|NCT00761150|513122|P3|Double-blind Period|Adverse Event|3
160911|NCT00761150|513123|P2|Double-blind Period|Adverse Event|3
160912|NCT00761150|513124|P1|Double-blind Period|Adverse Event|0
160913|NCT00761150|513122|P3|Double-blind Period|Lack of Efficacy|19
160914|NCT00761150|513123|P2|Double-blind Period|Lack of Efficacy|2
160915|NCT00761150|513124|P1|Double-blind Period|Lack of Efficacy|0
160916|NCT00761150|513122|P3|Open-label Period|Not specified|0
160917|NCT00761150|513123|P2|Open-label Period|Not specified|0
160918|NCT00761150|513124|P1|Open-label Period|Not specified|5
160919|NCT00761150|513122|P3|Open-label Period|Noncompliance|0
160920|NCT00761150|513123|P2|Open-label Period|Noncompliance|0
160921|NCT00761150|513124|P1|Open-label Period|Noncompliance|2
160922|NCT00761150|513122|P3|Open-label Period|Withdrawal by Subject|0
160923|NCT00761150|513123|P2|Open-label Period|Withdrawal by Subject|0
160924|NCT00761150|513124|P1|Open-label Period|Withdrawal by Subject|5
160925|NCT00761150|513122|P3|Open-label Period|Lack of Efficacy|0
160926|NCT00761150|513123|P2|Open-label Period|Lack of Efficacy|0
160927|NCT00761150|513124|P1|Open-label Period|Lack of Efficacy|4
160928|NCT00761150|513122|P3|Open-label Period|Lost to Follow-up|0
160929|NCT00761150|513123|P2|Open-label Period|Lost to Follow-up|0
160930|NCT00761150|513124|P1|Open-label Period|Lost to Follow-up|7
160931|NCT00761150|513122|P3|Open-label Period|Did not meet DB randomization criteria|0
160932|NCT00761150|513123|P2|Open-label Period|Did not meet DB randomization criteria|0
160933|NCT00761150|513124|P1|Open-label Period|Did not meet DB randomization criteria|11
160934|NCT00761150|513122|P3|Open-label Period|Adverse Event|0
160935|NCT00761150|513123|P2|Open-label Period|Adverse Event|0
160936|NCT00761150|513124|P1|Open-label Period|Adverse Event|36
160937|NCT00761176|513135|P2|Overall Study|Withdrawal by Subject|1
160938|NCT00761176|513136|P1|Overall Study|Withdrawal by Subject|1
160939|NCT00761176|513135|P2|Overall Study|Death|0
160940|NCT00761176|513136|P1|Overall Study|Death|1
160941|NCT00761189|513142|P1|Overall Study|Unspecified|13
160942|NCT00761189|513142|P1|Overall Study|Withdrawal by Subject|49
160943|NCT00761189|513142|P1|Overall Study|Lost to Follow-up|36
160944|NCT00761189|513142|P1|Overall Study|Lack of Efficacy|45
160945|NCT00761189|513142|P1|Overall Study|Adverse Event|42
160946|NCT00761215|513179|P3|Overall Study|Bacteremia|0
160947|NCT00761215|513180|P2|Overall Study|Bacteremia|0
160948|NCT00761215|513181|P1|Overall Study|Bacteremia|1
160949|NCT00761215|513179|P3|Overall Study|Withdrawal by Subject|0
160950|NCT00761215|513180|P2|Overall Study|Withdrawal by Subject|0
160951|NCT00761215|513181|P1|Overall Study|Withdrawal by Subject|1
160952|NCT00761215|513179|P3|Overall Study|Lost to Follow-up|6
160953|NCT00761215|513180|P2|Overall Study|Lost to Follow-up|3
160954|NCT00761215|513181|P1|Overall Study|Lost to Follow-up|6
160955|NCT00761215|513179|P3|Overall Study|Randomized but didn't receive drug|2
160956|NCT00761215|513180|P2|Overall Study|Randomized but didn't receive drug|1
160957|NCT00761215|513181|P1|Overall Study|Randomized but didn't receive drug|1
160958|NCT00761280|513206|P2|First Dose to End of Study|Lost to Follow-up|1
160959|NCT00761280|513207|P1|First Dose to End of Study|Lost to Follow-up|0
160960|NCT00761280|513206|P2|First Dose to End of Study|Death|0
160961|NCT00761280|513207|P1|First Dose to End of Study|Death|1
160962|NCT00761280|513206|P2|First Dose to End of Study|Sponsor decision|2
160963|NCT00761280|513207|P1|First Dose to End of Study|Sponsor decision|1
160964|NCT00761280|513206|P2|First Dose to End of Study|Progressive disease|3
160965|NCT00761280|513207|P1|First Dose to End of Study|Progressive disease|5
160966|NCT00761280|513206|P2|First Dose to End of Study|End of trial|5
160967|NCT00761280|513207|P1|First Dose to End of Study|End of trial|5
160968|NCT00761280|513206|P2|Randomization to First Dose|Other|0
160969|NCT00761280|513207|P1|Randomization to First Dose|Other|1
160970|NCT00761280|513206|P2|Randomization to First Dose|Sponsor decision|0
160971|NCT00761280|513207|P1|Randomization to First Dose|Sponsor decision|1
160972|NCT00761280|513206|P2|Randomization to First Dose|Withdrawal by Subject|2
160973|NCT00761280|513207|P1|Randomization to First Dose|Withdrawal by Subject|0
160974|NCT00761306|513235|P1|Overall Study|Administrative or Other Reasons|5
160975|NCT00761306|513235|P1|Overall Study|Lost to Follow-up|1
160976|NCT00761306|513235|P1|Overall Study|Withdrawal of Consent|3
160977|NCT00761306|513235|P1|Overall Study|Protocol Violation|2
160978|NCT00761306|513235|P1|Overall Study|Lack of Efficacy|4
160979|NCT00761306|513235|P1|Overall Study|Adverse Event|5
160980|NCT00761319|513246|P2|Overall Study|Missing|0
160981|NCT00761319|513247|P1|Overall Study|Missing|1
160982|NCT00761319|513246|P2|Overall Study|Nonspecified|2
160983|NCT00761319|513247|P1|Overall Study|Nonspecified|2
160984|NCT00761319|513246|P2|Overall Study|Lost to Follow-up|1
160985|NCT00761319|513247|P1|Overall Study|Lost to Follow-up|1
160986|NCT00761319|513246|P2|Overall Study|Noncompliance|3
160987|NCT00761319|513247|P1|Overall Study|Noncompliance|4
160988|NCT00761319|513246|P2|Overall Study|Withdrawal by Subject|7
160989|NCT00761319|513247|P1|Overall Study|Withdrawal by Subject|8
160990|NCT00761319|513246|P2|Overall Study|Adverse Event|7
160991|NCT00761319|513247|P1|Overall Study|Adverse Event|11
160992|NCT00761319|513246|P2|Overall Study|Protocol Violation|14
160993|NCT00761319|513247|P1|Overall Study|Protocol Violation|21
160994|NCT00761462|513261|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
160995|NCT00761462|513262|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
160996|NCT00761462|513261|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
160997|NCT00761462|513262|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
160998|NCT00761462|513261|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
160999|NCT00761462|513262|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
161000|NCT00761462|513261|P2|Treatment|Subjects never received study medication|12
161001|NCT00761462|513262|P1|Treatment|Subjects never received study medication|23
161002|NCT00761514|513270|P1|Overall Study|Unable to pay for medications|1
161003|NCT00761514|513270|P1|Overall Study|Problem complying with study visit|1
161004|NCT00761514|513270|P1|Overall Study|Health insurance didn't cover study drug|1
161005|NCT00761514|513270|P1|Overall Study|Lost to Follow-up|1
161006|NCT00761514|513270|P1|Overall Study|Withdrawal by Subject|2
161007|NCT00761514|513270|P1|Overall Study|Adverse Event|1
161008|NCT00761527|513275|P1|Overall Study|Unknown reason|2
161009|NCT00761527|513275|P1|Overall Study|Lost to Follow-up|9
161010|NCT00761527|513275|P1|Overall Study|Poor Compliance|8
161011|NCT00761527|513275|P1|Overall Study|Adverse Event|3
161012|NCT00761579|513282|P1|Overall Study|Intake of prohibited concomitant drug|1
161013|NCT00761579|513282|P1|Overall Study|Lost survey form|1
161014|NCT00761579|513282|P1|Overall Study|Aggravation of symptoms by changing drug|1
161015|NCT00761579|513282|P1|Overall Study|Aggravation of depression|1
161016|NCT00761579|513282|P1|Overall Study|Drug overdose|1
161017|NCT00761579|513282|P1|Overall Study|Protocol deviation|1
161018|NCT00761579|513282|P1|Overall Study|Lack of compliance|2
161019|NCT00761579|513282|P1|Overall Study|Withdrawal by Subject|34
161020|NCT00761579|513282|P1|Overall Study|Pregnancy|1
161021|NCT00761579|513282|P1|Overall Study|Lost to Follow-up|16
161022|NCT00761579|513282|P1|Overall Study|Lack of Efficacy|21
161023|NCT00761579|513282|P1|Overall Study|Death|2
161024|NCT00761579|513282|P1|Overall Study|Adverse Event|10
161025|NCT00761605|513332|P1|Overall Study|Unspecified|21
161026|NCT00761605|513332|P1|Overall Study|Withdrawal by Subject|37
161027|NCT00761605|513332|P1|Overall Study|Lost to Follow-up|29
161028|NCT00761605|513332|P1|Overall Study|Lack of Efficacy|26
161029|NCT00761605|513332|P1|Overall Study|Death|2
161030|NCT00761605|513332|P1|Overall Study|Adverse Event|26
161031|NCT00761631|513363|P6|Overall Study|Unspecified|1
161032|NCT00761631|513364|P5|Overall Study|Unspecified|1
161033|NCT00761631|513365|P4|Overall Study|Unspecified|0
161034|NCT00761631|513366|P3|Overall Study|Unspecified|0
161035|NCT00761631|513367|P2|Overall Study|Unspecified|0
161036|NCT00761631|513368|P1|Overall Study|Unspecified|0
161037|NCT00761631|513363|P6|Overall Study|Physician Decision|0
161038|NCT00761631|513364|P5|Overall Study|Physician Decision|0
161039|NCT00761631|513365|P4|Overall Study|Physician Decision|0
161040|NCT00761631|513366|P3|Overall Study|Physician Decision|0
161041|NCT00761631|513367|P2|Overall Study|Physician Decision|0
161042|NCT00761631|513368|P1|Overall Study|Physician Decision|1
161043|NCT00761631|513363|P6|Overall Study|Failed to return|2
161044|NCT00761631|513364|P5|Overall Study|Failed to return|5
161045|NCT00761631|513365|P4|Overall Study|Failed to return|1
161046|NCT00761631|513366|P3|Overall Study|Failed to return|1
161047|NCT00761631|513367|P2|Overall Study|Failed to return|0
161048|NCT00761631|513368|P1|Overall Study|Failed to return|1
161049|NCT00761631|513363|P6|Overall Study|Randomized, not treated|0
161050|NCT00761631|513364|P5|Overall Study|Randomized, not treated|0
161051|NCT00761631|513365|P4|Overall Study|Randomized, not treated|0
161052|NCT00761631|513366|P3|Overall Study|Randomized, not treated|0
161053|NCT00761631|513367|P2|Overall Study|Randomized, not treated|0
161054|NCT00761631|513368|P1|Overall Study|Randomized, not treated|1
161055|NCT00761631|513363|P6|Overall Study|Protocol Violation|1
161056|NCT00761631|513364|P5|Overall Study|Protocol Violation|5
161057|NCT00761631|513365|P4|Overall Study|Protocol Violation|1
161058|NCT00761631|513366|P3|Overall Study|Protocol Violation|0
161059|NCT00761631|513367|P2|Overall Study|Protocol Violation|0
161060|NCT00761631|513368|P1|Overall Study|Protocol Violation|2
161061|NCT00761631|513363|P6|Overall Study|Lost to Follow-up|1
161062|NCT00761631|513364|P5|Overall Study|Lost to Follow-up|6
161063|NCT00761631|513365|P4|Overall Study|Lost to Follow-up|1
161064|NCT00761631|513366|P3|Overall Study|Lost to Follow-up|7
161065|NCT00761631|513367|P2|Overall Study|Lost to Follow-up|4
161066|NCT00761631|513368|P1|Overall Study|Lost to Follow-up|2
161067|NCT00761631|513363|P6|Overall Study|Parent/legal guardian request|0
161068|NCT00761631|513364|P5|Overall Study|Parent/legal guardian request|5
161069|NCT00761631|513365|P4|Overall Study|Parent/legal guardian request|0
161070|NCT00761631|513366|P3|Overall Study|Parent/legal guardian request|8
161071|NCT00761631|513367|P2|Overall Study|Parent/legal guardian request|3
161072|NCT00761631|513368|P1|Overall Study|Parent/legal guardian request|8
161073|NCT00769561|513405|P2|Overall Study|Lost to Follow-up|3
161074|NCT00769561|513406|P1|Overall Study|Lost to Follow-up|1
161075|NCT00769561|513405|P2|Overall Study|Withdrawal by Subject|2
161076|NCT00769561|513406|P1|Overall Study|Withdrawal by Subject|2
161077|NCT00769704|513441|P2|Overall Study|Other|2
161078|NCT00769704|513442|P1|Overall Study|Other|1
161079|NCT00769704|513441|P2|Overall Study|Withdrawal by Subject|5
161080|NCT00769704|513442|P1|Overall Study|Withdrawal by Subject|12
161081|NCT00769704|513441|P2|Overall Study|Death|190
161082|NCT00769704|513442|P1|Overall Study|Death|95
161083|NCT00769704|513441|P2|Overall Study|Lost to Follow-up|2
161084|NCT00769704|513442|P1|Overall Study|Lost to Follow-up|3
161085|NCT00770029|513462|P2|Overall Study|Adverse Event|0
161086|NCT00770029|513463|P1|Overall Study|Adverse Event|1
161087|NCT00770029|513462|P2|Overall Study|Withdrawal by Subject|3
161088|NCT00770029|513463|P1|Overall Study|Withdrawal by Subject|3
161089|NCT00770029|513462|P2|Overall Study|Lost to Follow-up|0
161090|NCT00770029|513463|P1|Overall Study|Lost to Follow-up|2
161091|NCT00770120|513477|P1|Overall Study|Reason under Review|1
161092|NCT00770120|513477|P1|Overall Study|Never Received Treatment/Not Analyzable|1
161093|NCT00770120|513477|P1|Overall Study|Ineligible|1
161094|NCT00770120|513477|P1|Overall Study|Withdrawal by Subject|2
161095|NCT00770120|513477|P1|Overall Study|Death|3
161096|NCT00770120|513477|P1|Overall Study|Not Protocol Specified|11
161097|NCT00770120|513477|P1|Overall Study|Adverse Event|11
161098|NCT00770120|513477|P1|Overall Study|Progression|31
161099|NCT00770146|513486|P2|Follow-up Period|Other|5
161100|NCT00770146|513487|P1|Follow-up Period|Other|4
161101|NCT00770146|513486|P2|Follow-up Period|Adverse Event|2
161102|NCT00770146|513487|P1|Follow-up Period|Adverse Event|0
161103|NCT00770146|513486|P2|Follow-up Period|Withdrawal by Subject|13
161104|NCT00770146|513487|P1|Follow-up Period|Withdrawal by Subject|7
161105|NCT00770146|513486|P2|Treatment Period|Protocol non-compliance|1
161106|NCT00770146|513487|P1|Treatment Period|Protocol non-compliance|0
161107|NCT00770146|513486|P2|Treatment Period|Other|5
161108|NCT00770146|513487|P1|Treatment Period|Other|1
161109|NCT00770146|513486|P2|Treatment Period|Adverse Event|26
161110|NCT00770146|513487|P1|Treatment Period|Adverse Event|2
161111|NCT00770146|513486|P2|Treatment Period|Withdrawal by Subject|13
161112|NCT00770146|513487|P1|Treatment Period|Withdrawal by Subject|6
161113|NCT00770211|513533|P2|Overall Study|Withdrawal by Subject|2
161114|NCT00770211|513534|P1|Overall Study|Withdrawal by Subject|0
161115|NCT00770211|513533|P2|Overall Study|Lost to Follow-up|0
161116|NCT00770211|513534|P1|Overall Study|Lost to Follow-up|1
161117|NCT00770289|513548|P1|Overall Study|Unspecified|6
161118|NCT00770315|513561|P4|Overall Study|Noncompliance with Protocol|9
161119|NCT00770315|513562|P3|Overall Study|Noncompliance with Protocol|7
161120|NCT00770315|513563|P2|Overall Study|Noncompliance with Protocol|4
161121|NCT00770315|513564|P1|Overall Study|Noncompliance with Protocol|7
161122|NCT00770315|513561|P4|Overall Study|Withdrawal by Subject|20
161123|NCT00770315|513562|P3|Overall Study|Withdrawal by Subject|24
161124|NCT00770315|513563|P2|Overall Study|Withdrawal by Subject|17
161125|NCT00770315|513564|P1|Overall Study|Withdrawal by Subject|13
161126|NCT00770315|513561|P4|Overall Study|Lost to Follow-up|3
161127|NCT00770315|513562|P3|Overall Study|Lost to Follow-up|10
161128|NCT00770315|513563|P2|Overall Study|Lost to Follow-up|5
161129|NCT00770315|513564|P1|Overall Study|Lost to Follow-up|9
161130|NCT00770315|513561|P4|Overall Study|Adverse Event|6
161131|NCT00770315|513562|P3|Overall Study|Adverse Event|16
161132|NCT00770315|513563|P2|Overall Study|Adverse Event|17
161133|NCT00770315|513564|P1|Overall Study|Adverse Event|11
161134|NCT00770341|513593|P3|Overall Study|Not treated|0
161135|NCT00770341|513594|P2|Overall Study|Not treated|0
161136|NCT00770341|513595|P1|Overall Study|Not treated|1
161137|NCT00770341|513593|P3|Overall Study|Not specified|0
161138|NCT00770341|513594|P2|Overall Study|Not specified|0
161139|NCT00770341|513595|P1|Overall Study|Not specified|1
161140|NCT00770341|513593|P3|Overall Study|Lack of Efficacy|1
161141|NCT00770341|513594|P2|Overall Study|Lack of Efficacy|0
161142|NCT00770341|513595|P1|Overall Study|Lack of Efficacy|3
161143|NCT00770341|513593|P3|Overall Study|Laboratory adverse event|0
161144|NCT00770341|513594|P2|Overall Study|Laboratory adverse event|3
161145|NCT00770341|513595|P1|Overall Study|Laboratory adverse event|3
161146|NCT00770341|513593|P3|Overall Study|Clinical Adverse Event|2
161147|NCT00770341|513594|P2|Overall Study|Clinical Adverse Event|1
161148|NCT00770341|513595|P1|Overall Study|Clinical Adverse Event|3
161149|NCT00770341|513593|P3|Overall Study|Withdrawal by Subject|0
161150|NCT00770341|513594|P2|Overall Study|Withdrawal by Subject|1
161151|NCT00770341|513595|P1|Overall Study|Withdrawal by Subject|0
161152|NCT00770341|513593|P3|Overall Study|Did not meet eligibility criteria|0
161153|NCT00770341|513594|P2|Overall Study|Did not meet eligibility criteria|0
161154|NCT00770341|513595|P1|Overall Study|Did not meet eligibility criteria|1
161155|NCT00770367|513621|P2|Second Intervention|Lost to Follow-up|0
161156|NCT00770367|513622|P1|Second Intervention|Lost to Follow-up|2
161157|NCT00770367|513621|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
161158|NCT00770367|513622|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
161159|NCT00770367|513621|P2|First Intervention|Withdrawal by Subject|2
161160|NCT00770367|513622|P1|First Intervention|Withdrawal by Subject|0
161161|NCT00770432|513630|P2|Overall Study|Non-compliance|1
161162|NCT00770432|513631|P1|Overall Study|Non-compliance|0
161163|NCT00770432|513630|P2|Overall Study|Not specified|6
161164|NCT00770432|513631|P1|Overall Study|Not specified|4
161165|NCT00770484|513639|P2|Overall Study|Withdrawal by Subject|0
161166|NCT00770484|513640|P1|Overall Study|Withdrawal by Subject|1
161167|NCT00770510|513646|P1|Overall Study|Withdrawal by Subject|2
161168|NCT00770510|513646|P1|Overall Study|Pregnancy|1
161169|NCT00770510|513646|P1|Overall Study|Lost to Follow-up|2
161170|NCT00770562|513685|P2|Overall Study|Did not take treatment|1
161171|NCT00770562|513686|P1|Overall Study|Did not take treatment|1
161172|NCT00770588|513699|P2|Overall Study|Withdrawal by Subject|1
161173|NCT00770588|513700|P1|Overall Study|Withdrawal by Subject|1
161174|NCT00770588|513699|P2|Overall Study|Lost to Follow-up|1
161175|NCT00770588|513700|P1|Overall Study|Lost to Follow-up|1
161176|NCT00770588|513699|P2|Overall Study|Death caused by progression of disease|91
161177|NCT00770588|513700|P1|Overall Study|Death caused by progression of disease|70
161178|NCT00770588|513699|P2|Overall Study|Adverse Event|2
161179|NCT00770588|513700|P1|Overall Study|Adverse Event|9
161180|NCT00770653|513716|P2|Overall Study|Physician Decision|0
161181|NCT00770653|513717|P1|Overall Study|Physician Decision|1
161182|NCT00770653|513716|P2|Overall Study|Lost to Follow-up|2
161183|NCT00770653|513717|P1|Overall Study|Lost to Follow-up|1
161184|NCT00770653|513716|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
161185|NCT00770653|513717|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
161186|NCT00770653|513716|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
161187|NCT00770653|513717|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
161188|NCT00770653|513716|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
161189|NCT00770653|513717|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
161190|NCT00770653|513716|P2|Overall Study|Lack of Compliance|4
161191|NCT00770653|513717|P1|Overall Study|Lack of Compliance|1
161192|NCT00770653|513716|P2|Overall Study|Withdrawal by Subject|7
161193|NCT00770653|513717|P1|Overall Study|Withdrawal by Subject|4
161194|NCT00770653|513716|P2|Overall Study|Protocol Violation|6
161195|NCT00770653|513717|P1|Overall Study|Protocol Violation|8
161196|NCT00770653|513716|P2|Overall Study|Adverse Event|5
161197|NCT00770653|513717|P1|Overall Study|Adverse Event|13
161198|NCT00770692|513789|P4|Overall Study|Investigator judgment|1
161199|NCT00770692|513790|P3|Overall Study|Investigator judgment|1
161200|NCT00770692|513791|P2|Overall Study|Investigator judgment|0
161201|NCT00770692|513792|P1|Overall Study|Investigator judgment|2
161202|NCT00770692|513789|P4|Overall Study|Adverse Event|4
161203|NCT00770692|513790|P3|Overall Study|Adverse Event|4
161204|NCT00770692|513791|P2|Overall Study|Adverse Event|0
161205|NCT00770692|513792|P1|Overall Study|Adverse Event|3
161206|NCT00770692|513789|P4|Overall Study|Withdrawal by Subject|6
161207|NCT00770692|513790|P3|Overall Study|Withdrawal by Subject|9
161208|NCT00770692|513791|P2|Overall Study|Withdrawal by Subject|9
161209|NCT00770692|513792|P1|Overall Study|Withdrawal by Subject|7
161210|NCT00770770|513828|P2|Overall Study|Study Terminated|0
161211|NCT00770770|513829|P1|Overall Study|Study Terminated|8
161212|NCT00770770|513828|P2|Overall Study|Death|1
161213|NCT00770770|513829|P1|Overall Study|Death|0
161214|NCT00770770|513828|P2|Overall Study|Withdrawal by Subject|0
161215|NCT00770770|513829|P1|Overall Study|Withdrawal by Subject|1
161216|NCT00770770|513828|P2|Overall Study|Lost to Follow-up|0
161217|NCT00770770|513829|P1|Overall Study|Lost to Follow-up|1
161218|NCT00770809|513838|P3|Overall Study|Other Medical Reasons|3
161219|NCT00770809|513839|P2|Overall Study|Other Medical Reasons|4
161220|NCT00770809|513840|P1|Overall Study|Other Medical Reasons|2
161221|NCT00770809|513838|P3|Overall Study|Complicating illness|1
161222|NCT00770809|513839|P2|Overall Study|Complicating illness|0
161223|NCT00770809|513840|P1|Overall Study|Complicating illness|0
161224|NCT00770809|513838|P3|Overall Study|Progression|0
161225|NCT00770809|513839|P2|Overall Study|Progression|2
161226|NCT00770809|513840|P1|Overall Study|Progression|2
161227|NCT00770809|513838|P3|Overall Study|Withdrawal by Subject|7
161228|NCT00770809|513839|P2|Overall Study|Withdrawal by Subject|3
161229|NCT00770809|513840|P1|Overall Study|Withdrawal by Subject|3
161230|NCT00770809|513838|P3|Overall Study|Death|0
161231|NCT00770809|513839|P2|Overall Study|Death|0
161232|NCT00770809|513840|P1|Overall Study|Death|1
161233|NCT00770809|513838|P3|Overall Study|Adverse Event|12
161234|NCT00770809|513839|P2|Overall Study|Adverse Event|1
161235|NCT00770809|513840|P1|Overall Study|Adverse Event|9
161236|NCT00770913|513862|P3|Overall Study|Incorrect drug was allocated|0
161237|NCT00770913|513863|P2|Overall Study|Incorrect drug was allocated|0
161238|NCT00770913|513864|P1|Overall Study|Incorrect drug was allocated|1
161239|NCT00770913|513862|P3|Overall Study|Protocol Violation|1
161240|NCT00770913|513863|P2|Overall Study|Protocol Violation|0
161241|NCT00770913|513864|P1|Overall Study|Protocol Violation|3
161242|NCT00770913|513862|P3|Overall Study|Physician Decision|1
161243|NCT00770913|513863|P2|Overall Study|Physician Decision|1
161244|NCT00770913|513864|P1|Overall Study|Physician Decision|0
161245|NCT00770913|513862|P3|Overall Study|Refusal to continue participation|5
161246|NCT00770913|513863|P2|Overall Study|Refusal to continue participation|4
161247|NCT00770913|513864|P1|Overall Study|Refusal to continue participation|6
161248|NCT00770913|513862|P3|Overall Study|Adverse Event|6
161249|NCT00770913|513863|P2|Overall Study|Adverse Event|3
161250|NCT00770913|513864|P1|Overall Study|Adverse Event|1
161251|NCT00770965|513876|P4|Excluded Set|Withdrawal by Subject|3
161252|NCT00770965|513877|P3|Excluded Set|Withdrawal by Subject|2
161253|NCT00770965|513878|P2|Excluded Set|Withdrawal by Subject|1
161254|NCT00770965|513879|P1|Excluded Set|Withdrawal by Subject|1
161255|NCT00770965|513876|P4|Excluded Set|Administrative problems|10
161256|NCT00770965|513877|P3|Excluded Set|Administrative problems|12
161257|NCT00770965|513878|P2|Excluded Set|Administrative problems|12
161258|NCT00770965|513879|P1|Excluded Set|Administrative problems|14
161259|NCT00770965|513876|P4|Safety Set|Protocol deviation|0
161260|NCT00770965|513877|P3|Safety Set|Protocol deviation|1
161261|NCT00770965|513878|P2|Safety Set|Protocol deviation|0
161262|NCT00770965|513879|P1|Safety Set|Protocol deviation|0
161263|NCT00770965|513876|P4|Safety Set|Withdrawal by Subject|1
161264|NCT00770965|513877|P3|Safety Set|Withdrawal by Subject|0
161265|NCT00770965|513878|P2|Safety Set|Withdrawal by Subject|0
161266|NCT00770965|513879|P1|Safety Set|Withdrawal by Subject|0
161267|NCT00770991|513899|P2|Overall Study|Pregnancy|0
161268|NCT00770991|513900|P1|Overall Study|Pregnancy|1
161269|NCT00770991|513899|P2|Overall Study|Adverse Event|5
161270|NCT00770991|513900|P1|Overall Study|Adverse Event|1
161271|NCT00770991|513899|P2|Overall Study|Withdrawal by Subject|0
161272|NCT00770991|513900|P1|Overall Study|Withdrawal by Subject|1
161273|NCT00770991|513899|P2|Overall Study|Physician Decision|0
161274|NCT00770991|513900|P1|Overall Study|Physician Decision|2
161275|NCT00771316|513954|P2|Overall Study|Discontinued due to early termination|0
161276|NCT00771316|513955|P1|Overall Study|Discontinued due to early termination|1
161277|NCT00771316|513954|P2|Overall Study|Patient withdrew consent|0
161278|NCT00771316|513955|P1|Overall Study|Patient withdrew consent|1
161279|NCT00771316|513954|P2|Overall Study|Adverse Event|1
161280|NCT00771316|513955|P1|Overall Study|Adverse Event|0
161281|NCT00771472|513974|P2|Overall Study|Protocol Violation|0
161282|NCT00771472|513975|P1|Overall Study|Protocol Violation|1
161283|NCT00771472|513974|P2|Overall Study|Progressive Disease|1
161284|NCT00771472|513975|P1|Overall Study|Progressive Disease|3
161285|NCT00771472|513974|P2|Overall Study|Physician Decision|3
161286|NCT00771472|513975|P1|Overall Study|Physician Decision|2
161287|NCT00771615|514063|P9|Overall Study|Lost to Follow-up|0
161288|NCT00771615|514064|P8|Overall Study|Lost to Follow-up|0
161289|NCT00771615|514065|P7|Overall Study|Lost to Follow-up|1
161290|NCT00771615|514066|P6|Overall Study|Lost to Follow-up|1
161291|NCT00771615|514067|P5|Overall Study|Lost to Follow-up|0
161292|NCT00771615|514068|P4|Overall Study|Lost to Follow-up|1
161293|NCT00771615|514069|P3|Overall Study|Lost to Follow-up|1
161294|NCT00771615|514070|P2|Overall Study|Lost to Follow-up|1
161295|NCT00771615|514071|P1|Overall Study|Lost to Follow-up|1
161296|NCT00771615|514063|P9|Overall Study|Withdrawal by Subject|0
161297|NCT00771615|514064|P8|Overall Study|Withdrawal by Subject|1
161298|NCT00771615|514065|P7|Overall Study|Withdrawal by Subject|0
161299|NCT00771615|514066|P6|Overall Study|Withdrawal by Subject|0
161300|NCT00771615|514067|P5|Overall Study|Withdrawal by Subject|0
161301|NCT00771615|514068|P4|Overall Study|Withdrawal by Subject|0
161302|NCT00771615|514069|P3|Overall Study|Withdrawal by Subject|0
161303|NCT00771615|514070|P2|Overall Study|Withdrawal by Subject|1
161304|NCT00771615|514071|P1|Overall Study|Withdrawal by Subject|0
161305|NCT00771667|514266|P10|Maintenance Phase|Other|3
161306|NCT00771667|514267|P9|Maintenance Phase|Other|3
161307|NCT00771667|514268|P8|Maintenance Phase|Other|2
161308|NCT00771667|514269|P7|Maintenance Phase|Other|2
161309|NCT00771667|514270|P6|Maintenance Phase|Other|1
161310|NCT00771667|514271|P5|Maintenance Phase|Other|0
161311|NCT00771667|514272|P4|Maintenance Phase|Other|0
161312|NCT00771667|514273|P3|Maintenance Phase|Other|0
161313|NCT00771667|514274|P2|Maintenance Phase|Other|0
161314|NCT00771667|514275|P1|Maintenance Phase|Other|0
161315|NCT00771667|514266|P10|Maintenance Phase|Lack of Efficacy|7
161316|NCT00771667|514267|P9|Maintenance Phase|Lack of Efficacy|11
161317|NCT00771667|514268|P8|Maintenance Phase|Lack of Efficacy|2
161318|NCT00771667|514269|P7|Maintenance Phase|Lack of Efficacy|3
161319|NCT00771667|514270|P6|Maintenance Phase|Lack of Efficacy|3
161320|NCT00771667|514271|P5|Maintenance Phase|Lack of Efficacy|1
161321|NCT00771667|514272|P4|Maintenance Phase|Lack of Efficacy|0
161322|NCT00771667|514273|P3|Maintenance Phase|Lack of Efficacy|0
161323|NCT00771667|514274|P2|Maintenance Phase|Lack of Efficacy|0
161324|NCT00771667|514275|P1|Maintenance Phase|Lack of Efficacy|0
161325|NCT00771667|514266|P10|Maintenance Phase|Adverse Event|7
161326|NCT00771667|514267|P9|Maintenance Phase|Adverse Event|8
161327|NCT00771667|514268|P8|Maintenance Phase|Adverse Event|1
161328|NCT00771667|514269|P7|Maintenance Phase|Adverse Event|5
161329|NCT00771667|514270|P6|Maintenance Phase|Adverse Event|3
161330|NCT00771667|514271|P5|Maintenance Phase|Adverse Event|1
161331|NCT00771667|514272|P4|Maintenance Phase|Adverse Event|0
161332|NCT00771667|514273|P3|Maintenance Phase|Adverse Event|0
161333|NCT00771667|514274|P2|Maintenance Phase|Adverse Event|0
161334|NCT00771667|514275|P1|Maintenance Phase|Adverse Event|0
161335|NCT00771667|514266|P10|Induction Phase|Other|0
161336|NCT00771667|514267|P9|Induction Phase|Other|0
161337|NCT00771667|514268|P8|Induction Phase|Other|0
161338|NCT00771667|514269|P7|Induction Phase|Other|0
161339|NCT00771667|514270|P6|Induction Phase|Other|0
161340|NCT00771667|514271|P5|Induction Phase|Other|0
161341|NCT00771667|514272|P4|Induction Phase|Other|4
161342|NCT00771667|514273|P3|Induction Phase|Other|3
161343|NCT00771667|514274|P2|Induction Phase|Other|6
161344|NCT00771667|514275|P1|Induction Phase|Other|4
161345|NCT00771667|514266|P10|Induction Phase|Lost to Follow-up|0
161346|NCT00771667|514267|P9|Induction Phase|Lost to Follow-up|0
161347|NCT00771667|514268|P8|Induction Phase|Lost to Follow-up|0
161348|NCT00771667|514269|P7|Induction Phase|Lost to Follow-up|0
161349|NCT00771667|514270|P6|Induction Phase|Lost to Follow-up|0
161350|NCT00771667|514271|P5|Induction Phase|Lost to Follow-up|0
161351|NCT00771667|514272|P4|Induction Phase|Lost to Follow-up|0
161352|NCT00771667|514273|P3|Induction Phase|Lost to Follow-up|1
161353|NCT00771667|514274|P2|Induction Phase|Lost to Follow-up|0
161354|NCT00771667|514275|P1|Induction Phase|Lost to Follow-up|1
161355|NCT00771667|514266|P10|Induction Phase|Lack of Efficacy|0
161356|NCT00771667|514267|P9|Induction Phase|Lack of Efficacy|0
161357|NCT00771667|514268|P8|Induction Phase|Lack of Efficacy|0
161358|NCT00771667|514269|P7|Induction Phase|Lack of Efficacy|0
161359|NCT00771667|514270|P6|Induction Phase|Lack of Efficacy|0
161360|NCT00771667|514271|P5|Induction Phase|Lack of Efficacy|0
161361|NCT00771667|514272|P4|Induction Phase|Lack of Efficacy|3
161362|NCT00771667|514273|P3|Induction Phase|Lack of Efficacy|4
161363|NCT00771667|514274|P2|Induction Phase|Lack of Efficacy|2
161364|NCT00771667|514275|P1|Induction Phase|Lack of Efficacy|9
161365|NCT00771667|514266|P10|Induction Phase|Adverse Event|0
161366|NCT00771667|514267|P9|Induction Phase|Adverse Event|0
161367|NCT00771667|514268|P8|Induction Phase|Adverse Event|0
161368|NCT00771667|514269|P7|Induction Phase|Adverse Event|0
161369|NCT00771667|514270|P6|Induction Phase|Adverse Event|0
161370|NCT00771667|514271|P5|Induction Phase|Adverse Event|0
161371|NCT00771667|514272|P4|Induction Phase|Adverse Event|1
161372|NCT00771667|514273|P3|Induction Phase|Adverse Event|4
161373|NCT00771667|514274|P2|Induction Phase|Adverse Event|2
161374|NCT00771667|514275|P1|Induction Phase|Adverse Event|5
161375|NCT00771758|514323|P3|Overall Study|Other|0
161376|NCT00771758|514324|P2|Overall Study|Other|2
161377|NCT00771758|514325|P1|Overall Study|Other|3
161378|NCT00771758|514323|P3|Overall Study|Withdrawal by Subject|0
161379|NCT00771758|514324|P2|Overall Study|Withdrawal by Subject|0
161380|NCT00771758|514325|P1|Overall Study|Withdrawal by Subject|1
161381|NCT00771758|514323|P3|Overall Study|Protocol Violation|0
161382|NCT00771758|514324|P2|Overall Study|Protocol Violation|0
161383|NCT00771758|514325|P1|Overall Study|Protocol Violation|1
161384|NCT00771758|514323|P3|Overall Study|Lost to Follow-up|0
161385|NCT00771758|514324|P2|Overall Study|Lost to Follow-up|0
161386|NCT00771758|514325|P1|Overall Study|Lost to Follow-up|1
161387|NCT00771758|514323|P3|Overall Study|Lack of Efficacy|1
161388|NCT00771758|514324|P2|Overall Study|Lack of Efficacy|2
161389|NCT00771758|514325|P1|Overall Study|Lack of Efficacy|0
161390|NCT00771758|514323|P3|Overall Study|Adverse Event|1
161391|NCT00771758|514324|P2|Overall Study|Adverse Event|8
161392|NCT00771758|514325|P1|Overall Study|Adverse Event|2
161393|NCT00771810|514476|P3|Overall Study|Other|1
161394|NCT00771810|514477|P2|Overall Study|Other|0
161395|NCT00771810|514478|P1|Overall Study|Other|0
161396|NCT00771810|514476|P3|Overall Study|Withdrawal by Subject|0
161397|NCT00771810|514477|P2|Overall Study|Withdrawal by Subject|2
161398|NCT00771810|514478|P1|Overall Study|Withdrawal by Subject|1
161399|NCT00771810|514476|P3|Overall Study|Protocol Violation|1
161400|NCT00771810|514477|P2|Overall Study|Protocol Violation|1
161401|NCT00771810|514478|P1|Overall Study|Protocol Violation|0
161402|NCT00771810|514476|P3|Overall Study|Physician Decision|2
161403|NCT00771810|514477|P2|Overall Study|Physician Decision|2
161404|NCT00771810|514478|P1|Overall Study|Physician Decision|1
161405|NCT00771810|514476|P3|Overall Study|Lost to Follow-up|1
161406|NCT00771810|514477|P2|Overall Study|Lost to Follow-up|0
161407|NCT00771810|514478|P1|Overall Study|Lost to Follow-up|0
161408|NCT00771810|514476|P3|Overall Study|Adverse Event|2
161409|NCT00771810|514477|P2|Overall Study|Adverse Event|0
161410|NCT00771810|514478|P1|Overall Study|Adverse Event|3
161411|NCT00771849|514515|P2|Overall Study|Not vaccinated|1
161412|NCT00771849|514516|P1|Overall Study|Not vaccinated|0
161413|NCT00771849|514515|P2|Overall Study|Withdrawal by Subject|1
161414|NCT00771849|514516|P1|Overall Study|Withdrawal by Subject|1
161415|NCT00771849|514515|P2|Overall Study|Lost to Follow-up|2
161416|NCT00771849|514516|P1|Overall Study|Lost to Follow-up|1
161417|NCT00771914|514559|P4|Overall Study|Lost to Follow-up|1
161418|NCT00771914|514560|P3|Overall Study|Lost to Follow-up|0
161419|NCT00771914|514561|P2|Overall Study|Lost to Follow-up|0
161420|NCT00771914|514562|P1|Overall Study|Lost to Follow-up|0
161421|NCT00771914|514559|P4|Overall Study|Physician Decision|1
161422|NCT00771914|514560|P3|Overall Study|Physician Decision|0
161423|NCT00771914|514561|P2|Overall Study|Physician Decision|0
161424|NCT00771914|514562|P1|Overall Study|Physician Decision|0
161425|NCT00771927|514574|P2|Overall Study|Other reason|27
161426|NCT00771927|514575|P1|Overall Study|Other reason|23
161427|NCT00771927|514574|P2|Overall Study|Withdrawal by Subject|17
161428|NCT00771927|514575|P1|Overall Study|Withdrawal by Subject|16
161429|NCT00771927|514574|P2|Overall Study|Lost to Follow-up|46
161430|NCT00771927|514575|P1|Overall Study|Lost to Follow-up|46
161431|NCT00771927|514574|P2|Overall Study|Lack of Efficacy|42
161432|NCT00771927|514575|P1|Overall Study|Lack of Efficacy|70
161433|NCT00771927|514574|P2|Overall Study|Adverse Event|105
161434|NCT00771927|514575|P1|Overall Study|Adverse Event|100
161435|NCT00771953|514585|P2|Overall Study|Withdrawal by Subject|3
161436|NCT00771953|514586|P1|Overall Study|Withdrawal by Subject|0
161437|NCT00771953|514585|P2|Overall Study|Other complicating disease|0
161438|NCT00771953|514586|P1|Overall Study|Other complicating disease|1
161439|NCT00771953|514585|P2|Overall Study|Sponsor decision|0
161440|NCT00771953|514586|P1|Overall Study|Sponsor decision|1
161441|NCT00771953|514585|P2|Overall Study|Progression before active Tx|2
161442|NCT00771953|514586|P1|Overall Study|Progression before active Tx|1
161443|NCT00771953|514585|P2|Overall Study|Death|2
161444|NCT00771953|514586|P1|Overall Study|Death|2
161445|NCT00771953|514585|P2|Overall Study|Adverse Event|3
161446|NCT00771953|514586|P1|Overall Study|Adverse Event|5
161447|NCT00772005|514598|P4|Overall Study|Non-compliance with drug administration|1
161448|NCT00772005|514599|P3|Overall Study|Non-compliance with drug administration|1
161449|NCT00772005|514600|P2|Overall Study|Non-compliance with drug administration|0
161450|NCT00772005|514601|P1|Overall Study|Non-compliance with drug administration|3
161451|NCT00772005|514598|P4|Overall Study|Non-compliance with study procedures|1
161452|NCT00772005|514599|P3|Overall Study|Non-compliance with study procedures|0
161453|NCT00772005|514600|P2|Overall Study|Non-compliance with study procedures|1
161454|NCT00772005|514601|P1|Overall Study|Non-compliance with study procedures|1
161455|NCT00772005|514598|P4|Overall Study|Lost to Follow-up|3
161456|NCT00772005|514599|P3|Overall Study|Lost to Follow-up|6
161457|NCT00772005|514600|P2|Overall Study|Lost to Follow-up|3
161458|NCT00772005|514601|P1|Overall Study|Lost to Follow-up|7
161459|NCT00772005|514598|P4|Overall Study|Protocol Violation|6
161460|NCT00772005|514599|P3|Overall Study|Protocol Violation|1
161461|NCT00772005|514600|P2|Overall Study|Protocol Violation|4
161462|NCT00772005|514601|P1|Overall Study|Protocol Violation|2
161463|NCT00772005|514598|P4|Overall Study|Withdrawal by Subject|2
161464|NCT00772005|514599|P3|Overall Study|Withdrawal by Subject|10
161465|NCT00772005|514600|P2|Overall Study|Withdrawal by Subject|7
161466|NCT00772005|514601|P1|Overall Study|Withdrawal by Subject|3
161467|NCT00772005|514598|P4|Overall Study|Lack of Efficacy|0
161468|NCT00772005|514599|P3|Overall Study|Lack of Efficacy|0
161469|NCT00772005|514600|P2|Overall Study|Lack of Efficacy|1
161470|NCT00772005|514601|P1|Overall Study|Lack of Efficacy|0
161471|NCT00772005|514598|P4|Overall Study|Adverse Event|13
161472|NCT00772005|514599|P3|Overall Study|Adverse Event|10
161473|NCT00772005|514600|P2|Overall Study|Adverse Event|14
161474|NCT00772005|514601|P1|Overall Study|Adverse Event|9
161475|NCT00772031|515289|P2|Overall Study|Lost to Follow-up|33
161476|NCT00772031|515290|P1|Overall Study|Lost to Follow-up|20
161477|NCT00772031|515289|P2|Overall Study|Early termination of trial|10
161478|NCT00772031|515290|P1|Overall Study|Early termination of trial|12
161479|NCT00772070|515314|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
161480|NCT00772070|515315|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
161481|NCT00772070|515314|P2|Overall Study|Withdrawal by Subject|2
161482|NCT00772070|515315|P1|Overall Study|Withdrawal by Subject|0
161483|NCT00772070|515314|P2|Overall Study|Lost to Follow-up|8
161484|NCT00772070|515315|P1|Overall Study|Lost to Follow-up|0
161485|NCT00772109|515329|P4|Overall Study|Withdrawal by Subject|16
161486|NCT00772109|515330|P3|Overall Study|Withdrawal by Subject|6
161487|NCT00772109|515331|P2|Overall Study|Withdrawal by Subject|8
161488|NCT00772109|515332|P1|Overall Study|Withdrawal by Subject|8
161489|NCT00772109|515329|P4|Overall Study|Lost to Follow-up|9
161490|NCT00772109|515330|P3|Overall Study|Lost to Follow-up|5
161491|NCT00772109|515331|P2|Overall Study|Lost to Follow-up|3
161492|NCT00772109|515332|P1|Overall Study|Lost to Follow-up|7
161493|NCT00772109|515329|P4|Overall Study|Protocol Violation|6
161494|NCT00772109|515330|P3|Overall Study|Protocol Violation|7
161495|NCT00772109|515331|P2|Overall Study|Protocol Violation|8
161496|NCT00772109|515332|P1|Overall Study|Protocol Violation|5
161497|NCT00772109|515329|P4|Overall Study|Serious adverse event|0
161498|NCT00772109|515330|P3|Overall Study|Serious adverse event|1
161499|NCT00772109|515331|P2|Overall Study|Serious adverse event|0
161500|NCT00772109|515332|P1|Overall Study|Serious adverse event|1
161501|NCT00772148|515356|P2|Maintenance Phase (Week 52)|Administrative/other|2
161502|NCT00772148|515357|P1|Maintenance Phase (Week 52)|Administrative/other|1
161503|NCT00772148|515356|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
161504|NCT00772148|515357|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
161505|NCT00772148|515356|P2|Maintenance Phase (Week 52)|Adverse Event|0
161506|NCT00772148|515357|P1|Maintenance Phase (Week 52)|Adverse Event|1
161507|NCT00772148|515356|P2|Maintenance Phase (Week 52)|Death|2
161508|NCT00772148|515357|P1|Maintenance Phase (Week 52)|Death|2
161509|NCT00772148|515356|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
161510|NCT00772148|515357|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
161511|NCT00772148|515356|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
161512|NCT00772148|515357|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
161513|NCT00772148|515356|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
161514|NCT00772148|515357|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
161515|NCT00772369|515377|P1|Overall Study|Did not return record release form|1
161516|NCT00772382|515382|P1|Overall Study|Other Reasons|10
161517|NCT00772382|515382|P1|Overall Study|Withdrawal by Subject|10
161518|NCT00772382|515382|P1|Overall Study|Protocol Violation|1
161519|NCT00772382|515382|P1|Overall Study|Physician Decision|5
161520|NCT00772382|515382|P1|Overall Study|Lack of Efficacy|4
161521|NCT00772382|515382|P1|Overall Study|Death|6
161522|NCT00772382|515382|P1|Overall Study|Adverse Event|19
161523|NCT00772447|515389|P2|Overall Study|all others|2
161524|NCT00772447|515390|P1|Overall Study|all others|2
161525|NCT00772447|515389|P2|Overall Study|Protocol Violation|1
161526|NCT00772447|515390|P1|Overall Study|Protocol Violation|0
161527|NCT00772447|515389|P2|Overall Study|incorrect enrolment|4
161528|NCT00772447|515390|P1|Overall Study|incorrect enrolment|3
161529|NCT00772447|515389|P2|Overall Study|Lost to Follow-up|4
161530|NCT00772447|515390|P1|Overall Study|Lost to Follow-up|2
161531|NCT00772447|515389|P2|Overall Study|Physician Decision|8
161532|NCT00772447|515390|P1|Overall Study|Physician Decision|4
161533|NCT00772447|515389|P2|Overall Study|Withdrawal by Subject|5
161534|NCT00772447|515390|P1|Overall Study|Withdrawal by Subject|9
161535|NCT00764660|515420|P2|Overall Study|Did Not Meet Protocol Eligibility|0
161536|NCT00764660|515421|P1|Overall Study|Did Not Meet Protocol Eligibility|1
161537|NCT00764660|515420|P2|Overall Study|Noncompliance With Protocol|1
161538|NCT00764660|515421|P1|Overall Study|Noncompliance With Protocol|5
161539|NCT00764660|515420|P2|Overall Study|Withdrawal by Subject|3
161540|NCT00764660|515421|P1|Overall Study|Withdrawal by Subject|7
161541|NCT00764660|515420|P2|Overall Study|Lost to Follow-up|4
161542|NCT00764660|515421|P1|Overall Study|Lost to Follow-up|3
161543|NCT00764660|515420|P2|Overall Study|Adverse Event|3
161544|NCT00764660|515421|P1|Overall Study|Adverse Event|6
161545|NCT00764673|515453|P1|Overall Study|Revision of Device|2
161546|NCT00764673|515453|P1|Overall Study|Withdrawal by Subject|6
161547|NCT00764673|515453|P1|Overall Study|Lost to Follow-up|3
161548|NCT00764673|515453|P1|Overall Study|Death|1
161549|NCT00764790|515464|P3|Overall Study|Lost to Follow-up|23
161550|NCT00764790|515465|P2|Overall Study|Lost to Follow-up|29
161551|NCT00764790|515466|P1|Overall Study|Lost to Follow-up|28
161552|NCT00764790|515464|P3|Overall Study|Withdrawal by Subject|6
161553|NCT00764790|515465|P2|Overall Study|Withdrawal by Subject|12
161554|NCT00764790|515466|P1|Overall Study|Withdrawal by Subject|10
161555|NCT00764790|515464|P3|Overall Study|Protocol Violation|1
161556|NCT00764790|515465|P2|Overall Study|Protocol Violation|0
161557|NCT00764790|515466|P1|Overall Study|Protocol Violation|0
161558|NCT00764868|515498|P1|Overall Study|Sponsor requested withdrawal|1
161559|NCT00764868|515498|P1|Overall Study|Positive drug screen|2
161560|NCT00764868|515498|P1|Overall Study|Met an exclusion criteria|1
161561|NCT00764868|515498|P1|Overall Study|Subject sent to boarding school|1
161562|NCT00764868|515498|P1|Overall Study|Misuse and compliance of study drug|1
161563|NCT00764868|515498|P1|Overall Study|Out of town|1
161564|NCT00764868|515498|P1|Overall Study|Prohibited medication|1
161565|NCT00764868|515498|P1|Overall Study|Pregnancy|3
161566|NCT00764868|515498|P1|Overall Study|Subject moved|7
161567|NCT00764868|515498|P1|Overall Study|Lack of Efficacy|5
161568|NCT00764868|515498|P1|Overall Study|Lost to Follow-up|25
161569|NCT00764868|515498|P1|Overall Study|Non-compliance|16
161570|NCT00764868|515498|P1|Overall Study|Withdrawal by Subject|31
161571|NCT00764868|515498|P1|Overall Study|Adverse Event|18
161572|NCT00764881|515506|P2|Overall Study|no treatment or no observation|2
161573|NCT00764881|515507|P1|Overall Study|no treatment or no observation|2
161574|NCT00764881|515506|P2|Overall Study|Possibly noncompliant (study drug)|2
161575|NCT00764881|515507|P1|Overall Study|Possibly noncompliant (study drug)|0
161576|NCT00764881|515506|P2|Overall Study|Carcinoma detected|0
161577|NCT00764881|515507|P1|Overall Study|Carcinoma detected|1
161578|NCT00764881|515506|P2|Overall Study|Wished to become pregnant|0
161579|NCT00764881|515507|P1|Overall Study|Wished to become pregnant|1
161580|NCT00764881|515506|P2|Overall Study|Accidentally discontinued study drug|0
161581|NCT00764881|515507|P1|Overall Study|Accidentally discontinued study drug|1
161582|NCT00764881|515506|P2|Overall Study|Noncompliant|0
161583|NCT00764881|515507|P1|Overall Study|Noncompliant|1
161584|NCT00764881|515506|P2|Overall Study|Lost to Follow-up|0
161585|NCT00764881|515507|P1|Overall Study|Lost to Follow-up|2
161586|NCT00764881|515506|P2|Overall Study|Protocol Violation|2
161587|NCT00764881|515507|P1|Overall Study|Protocol Violation|2
161588|NCT00764881|515506|P2|Overall Study|Withdrawal by Subject|3
161589|NCT00764881|515507|P1|Overall Study|Withdrawal by Subject|1
161590|NCT00764881|515506|P2|Overall Study|Adverse Event|1
161591|NCT00764881|515507|P1|Overall Study|Adverse Event|5
161592|NCT00764946|515734|P3|Overall Study|Never Treated|1
161593|NCT00764946|515735|P2|Overall Study|Never Treated|1
161594|NCT00764946|515736|P1|Overall Study|Never Treated|1
161595|NCT00764946|515734|P3|Overall Study|Withdrawal by Subject|2
161596|NCT00764946|515735|P2|Overall Study|Withdrawal by Subject|6
161597|NCT00764946|515736|P1|Overall Study|Withdrawal by Subject|3
161598|NCT00764946|515734|P3|Overall Study|Adverse Event|1
161599|NCT00764946|515735|P2|Overall Study|Adverse Event|2
161600|NCT00764946|515736|P1|Overall Study|Adverse Event|3
161601|NCT00764946|515734|P3|Overall Study|Physician Decision|0
161602|NCT00764946|515735|P2|Overall Study|Physician Decision|4
161603|NCT00764946|515736|P1|Overall Study|Physician Decision|2
161604|NCT00764946|515734|P3|Overall Study|Lost to Follow-up|0
161605|NCT00764946|515735|P2|Overall Study|Lost to Follow-up|4
161606|NCT00764946|515736|P1|Overall Study|Lost to Follow-up|3
161607|NCT00764946|515734|P3|Overall Study|Lack of Efficacy|0
161608|NCT00764946|515735|P2|Overall Study|Lack of Efficacy|0
161609|NCT00764946|515736|P1|Overall Study|Lack of Efficacy|1
161610|NCT00765037|515762|P1|Overall Study|Adverse Event|1
161611|NCT00765037|515762|P1|Overall Study|Lost to Follow-up|5
161612|NCT00765063|515766|P1|Overall Study|Adverse Event|4
161613|NCT00765063|515766|P1|Overall Study|Protocol Violation|6
161614|NCT00765063|515766|P1|Overall Study|Unspecified|16
161615|NCT00765063|515766|P1|Overall Study|Withdrawal by Subject|1
161616|NCT00765063|515766|P1|Overall Study|Lack of Efficacy|5
161617|NCT00765076|515785|P3|Overall Study|Withdrawal by Subject|1
161618|NCT00765076|515786|P2|Overall Study|Withdrawal by Subject|0
161619|NCT00765076|515787|P1|Overall Study|Withdrawal by Subject|0
161620|NCT00765076|515785|P3|Overall Study|Adverse Event|0
161621|NCT00765076|515786|P2|Overall Study|Adverse Event|0
161622|NCT00765076|515787|P1|Overall Study|Adverse Event|1
161623|NCT00765102|515840|P1|Overall Study|Protocol Violation|1
161624|NCT00765102|515840|P1|Overall Study|Withdrawal by Subject|2
161625|NCT00765102|515840|P1|Overall Study|Physician Decision|4
161626|NCT00765102|515840|P1|Overall Study|Adverse Event|6
161627|NCT00765102|515840|P1|Overall Study|Progressive disease|18
161628|NCT00765245|515900|P2|Overall Study|Death|0
161629|NCT00765245|515901|P1|Overall Study|Death|1
161630|NCT00765245|515900|P2|Overall Study|Physician Decision|0
161631|NCT00765245|515901|P1|Overall Study|Physician Decision|1
161632|NCT00765245|515900|P2|Overall Study|Adverse Event|0
161633|NCT00765245|515901|P1|Overall Study|Adverse Event|5
161634|NCT00765245|515900|P2|Overall Study|Withdrawal by Subject|0
161635|NCT00765245|515901|P1|Overall Study|Withdrawal by Subject|3
161636|NCT00765245|515900|P2|Overall Study|disease progression|2
161637|NCT00765245|515901|P1|Overall Study|disease progression|3
161638|NCT00765336|515913|P2|Overall Study|Adverse Event|1
161639|NCT00765336|515914|P1|Overall Study|Adverse Event|2
161640|NCT00765336|515913|P2|Overall Study|Lost to Follow-up|9
161641|NCT00765336|515914|P1|Overall Study|Lost to Follow-up|7
161642|NCT00765336|515913|P2|Overall Study|Withdrawal by Subject|4
161643|NCT00765336|515914|P1|Overall Study|Withdrawal by Subject|6
161644|NCT00765336|515913|P2|Overall Study|Protocol Violation|2
161645|NCT00765336|515914|P1|Overall Study|Protocol Violation|4
161646|NCT00765362|515920|P1|Overall Study|Lost to Follow-up|95
161647|NCT00765362|515920|P1|Overall Study|Withdrawal by Subject|13
161648|NCT00765362|515920|P1|Overall Study|Protocol Violation|18
161649|NCT00765362|515920|P1|Overall Study|Adverse Event|2
161650|NCT00765362|515920|P1|Overall Study|Death|9
161651|NCT00765388|515932|P2|Period 1|Hip operation|1
161652|NCT00765388|515933|P1|Period 1|Hip operation|0
161653|NCT00765388|515932|P2|Period 1|Herpes Zoster|1
161654|NCT00765388|515933|P1|Period 1|Herpes Zoster|0
161655|NCT00765388|515932|P2|Period 1|Lost to Follow-up|1
161656|NCT00765388|515933|P1|Period 1|Lost to Follow-up|0
161657|NCT00765388|515932|P2|Period 1|Lack of Efficacy|2
161658|NCT00765388|515933|P1|Period 1|Lack of Efficacy|1
161659|NCT00765674|516010|P4|Overall Study|Randomized in Error - No Study Drug|1
161660|NCT00765674|516011|P3|Overall Study|Randomized in Error - No Study Drug|0
161661|NCT00765674|516012|P2|Overall Study|Randomized in Error - No Study Drug|1
161662|NCT00765674|516013|P1|Overall Study|Randomized in Error - No Study Drug|0
161663|NCT00765674|516010|P4|Overall Study|Lost to Follow-up|1
161664|NCT00765674|516011|P3|Overall Study|Lost to Follow-up|2
161665|NCT00765674|516012|P2|Overall Study|Lost to Follow-up|6
161666|NCT00765674|516013|P1|Overall Study|Lost to Follow-up|4
161667|NCT00765674|516010|P4|Overall Study|Withdrawal by Subject|8
161668|NCT00765674|516011|P3|Overall Study|Withdrawal by Subject|3
161669|NCT00765674|516012|P2|Overall Study|Withdrawal by Subject|7
161670|NCT00765674|516013|P1|Overall Study|Withdrawal by Subject|5
161671|NCT00765674|516010|P4|Overall Study|Protocol Violation|0
161672|NCT00765674|516011|P3|Overall Study|Protocol Violation|1
161673|NCT00765674|516012|P2|Overall Study|Protocol Violation|0
161674|NCT00765674|516013|P1|Overall Study|Protocol Violation|2
161675|NCT00765674|516010|P4|Overall Study|Lack of Efficacy|2
161676|NCT00765674|516011|P3|Overall Study|Lack of Efficacy|1
161677|NCT00765674|516012|P2|Overall Study|Lack of Efficacy|3
161678|NCT00765674|516013|P1|Overall Study|Lack of Efficacy|2
161679|NCT00765674|516010|P4|Overall Study|Abnormal Test Procedure Result(s)|2
161680|NCT00765674|516011|P3|Overall Study|Abnormal Test Procedure Result(s)|1
161681|NCT00765674|516012|P2|Overall Study|Abnormal Test Procedure Result(s)|3
161682|NCT00765674|516013|P1|Overall Study|Abnormal Test Procedure Result(s)|1
161683|NCT00765674|516010|P4|Overall Study|Abnormal Laboratory Value(s)|0
161684|NCT00765674|516011|P3|Overall Study|Abnormal Laboratory Value(s)|1
161685|NCT00765674|516012|P2|Overall Study|Abnormal Laboratory Value(s)|0
161686|NCT00765674|516013|P1|Overall Study|Abnormal Laboratory Value(s)|0
161687|NCT00765674|516010|P4|Overall Study|Adverse Event|11
161688|NCT00765674|516011|P3|Overall Study|Adverse Event|8
161689|NCT00765674|516012|P2|Overall Study|Adverse Event|2
161690|NCT00765674|516013|P1|Overall Study|Adverse Event|7
161691|NCT00765726|516035|P1|Overall Study|Discontinuation of study by sponsor|8
161692|NCT00765726|516035|P1|Overall Study|Withdrawal by Subject|1
161693|NCT00765817|516051|P2|Overall Study|Subject decision|11
161694|NCT00765817|516052|P1|Overall Study|Subject decision|7
161695|NCT00765817|516051|P2|Overall Study|Protocol Violation|1
161696|NCT00765817|516052|P1|Overall Study|Protocol Violation|1
161697|NCT00765817|516051|P2|Overall Study|Physician Decision|1
161698|NCT00765817|516052|P1|Overall Study|Physician Decision|2
161699|NCT00765817|516051|P2|Overall Study|Lost to Follow-up|3
161700|NCT00765817|516052|P1|Overall Study|Lost to Follow-up|1
161701|NCT00765817|516051|P2|Overall Study|Loss of glucose control|2
161702|NCT00765817|516052|P1|Overall Study|Loss of glucose control|0
161703|NCT00765817|516051|P2|Overall Study|Entry criteria not met|2
161704|NCT00765817|516052|P1|Overall Study|Entry criteria not met|2
161705|NCT00765817|516051|P2|Overall Study|Death|1
161706|NCT00765817|516052|P1|Overall Study|Death|0
161707|NCT00765817|516051|P2|Overall Study|Adverse Event|1
161708|NCT00765817|516052|P1|Overall Study|Adverse Event|13
161709|NCT00765843|516093|P3|Overall Study|Adverse Event|1
161710|NCT00765843|516094|P2|Overall Study|Adverse Event|0
161711|NCT00765843|516095|P1|Overall Study|Adverse Event|0
161712|NCT00765843|516093|P3|Overall Study|did not return to receive intervention|0
161713|NCT00765843|516094|P2|Overall Study|did not return to receive intervention|1
161714|NCT00765843|516095|P1|Overall Study|did not return to receive intervention|0
161715|NCT00765843|516093|P3|Overall Study|Lost to Follow-up|2
161716|NCT00765843|516094|P2|Overall Study|Lost to Follow-up|3
161717|NCT00765843|516095|P1|Overall Study|Lost to Follow-up|1
161718|NCT00765882|516106|P3|Overall Study|Other Reason|2
161719|NCT00765882|516107|P2|Overall Study|Other Reason|1
161720|NCT00765882|516108|P1|Overall Study|Other Reason|3
161721|NCT00765882|516106|P3|Overall Study|Lost to Follow-up|6
161722|NCT00765882|516107|P2|Overall Study|Lost to Follow-up|9
161723|NCT00765882|516108|P1|Overall Study|Lost to Follow-up|1
161724|NCT00765882|516106|P3|Overall Study|Withdrawal by Subject|6
161725|NCT00765882|516107|P2|Overall Study|Withdrawal by Subject|6
161726|NCT00765882|516108|P1|Overall Study|Withdrawal by Subject|2
161727|NCT00765882|516106|P3|Overall Study|Protocol Violation|1
161728|NCT00765882|516107|P2|Overall Study|Protocol Violation|3
161729|NCT00765882|516108|P1|Overall Study|Protocol Violation|4
161730|NCT00765882|516106|P3|Overall Study|Lack of Efficacy|1
161731|NCT00765882|516107|P2|Overall Study|Lack of Efficacy|0
161732|NCT00765882|516108|P1|Overall Study|Lack of Efficacy|4
161733|NCT00765882|516106|P3|Overall Study|Adverse Event|20
161734|NCT00765882|516107|P2|Overall Study|Adverse Event|21
161735|NCT00765882|516108|P1|Overall Study|Adverse Event|10
161736|NCT00766051|516157|P2|Overall Study|Withdrawal by Subject|0
161737|NCT00766051|516158|P1|Overall Study|Withdrawal by Subject|2
161738|NCT00766090|516170|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161739|NCT00766090|516171|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161740|NCT00766090|516172|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161741|NCT00766090|516173|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161742|NCT00766090|516174|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161743|NCT00766090|516175|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161744|NCT00766090|516176|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161745|NCT00766090|516177|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
161746|NCT00766090|516178|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161747|NCT00766090|516179|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161748|NCT00766090|516180|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161749|NCT00766090|516181|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
161750|NCT00766090|516170|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
161751|NCT00766090|516171|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161752|NCT00766090|516172|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161753|NCT00766090|516173|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161754|NCT00766090|516174|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161755|NCT00766090|516175|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161756|NCT00766090|516176|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161757|NCT00766090|516177|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161758|NCT00766090|516178|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
161759|NCT00766090|516179|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161760|NCT00766090|516180|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
161761|NCT00766090|516181|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
161762|NCT00766090|516170|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
161763|NCT00766090|516171|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
161764|NCT00766090|516172|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
161765|NCT00766090|516173|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
161766|NCT00766090|516174|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
161767|NCT00766090|516175|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
161768|NCT00766090|516176|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
161769|NCT00766090|516177|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
161770|NCT00766090|516178|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
161771|NCT00766090|516179|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
161772|NCT00766090|516180|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
161773|NCT00766090|516181|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
161774|NCT00766090|516170|P12|Washout Period 2 (14 Days)|Physician Decision|0
161775|NCT00766090|516171|P11|Washout Period 2 (14 Days)|Physician Decision|0
161776|NCT00766090|516172|P10|Washout Period 2 (14 Days)|Physician Decision|0
161777|NCT00766090|516173|P9|Washout Period 2 (14 Days)|Physician Decision|0
161778|NCT00766090|516174|P8|Washout Period 2 (14 Days)|Physician Decision|0
161779|NCT00766090|516175|P7|Washout Period 2 (14 Days)|Physician Decision|0
161780|NCT00766090|516176|P6|Washout Period 2 (14 Days)|Physician Decision|0
161781|NCT00766090|516177|P5|Washout Period 2 (14 Days)|Physician Decision|0
161782|NCT00766090|516178|P4|Washout Period 2 (14 Days)|Physician Decision|0
161783|NCT00766090|516179|P3|Washout Period 2 (14 Days)|Physician Decision|1
161784|NCT00766090|516180|P2|Washout Period 2 (14 Days)|Physician Decision|0
161785|NCT00766090|516181|P1|Washout Period 2 (14 Days)|Physician Decision|0
161786|NCT00766090|516170|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161787|NCT00766090|516171|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161788|NCT00766090|516172|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161789|NCT00766090|516173|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161790|NCT00766090|516174|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161791|NCT00766090|516175|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161792|NCT00766090|516176|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161793|NCT00766090|516177|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161794|NCT00766090|516178|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161795|NCT00766090|516179|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
161796|NCT00766090|516180|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161797|NCT00766090|516181|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
161798|NCT00766090|516170|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161799|NCT00766090|516171|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161800|NCT00766090|516172|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161801|NCT00766090|516173|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161802|NCT00766090|516174|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161803|NCT00766090|516175|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161804|NCT00766090|516176|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161805|NCT00766090|516177|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
161806|NCT00766090|516178|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161807|NCT00766090|516179|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161808|NCT00766090|516180|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161809|NCT00766090|516181|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
161810|NCT00766090|516170|P12|Washout Period 1 (14 Days)|Protocol Violation|0
161811|NCT00766090|516171|P11|Washout Period 1 (14 Days)|Protocol Violation|0
161812|NCT00766090|516172|P10|Washout Period 1 (14 Days)|Protocol Violation|0
161813|NCT00766090|516173|P9|Washout Period 1 (14 Days)|Protocol Violation|0
161814|NCT00766090|516174|P8|Washout Period 1 (14 Days)|Protocol Violation|0
161815|NCT00766090|516175|P7|Washout Period 1 (14 Days)|Protocol Violation|0
161816|NCT00766090|516176|P6|Washout Period 1 (14 Days)|Protocol Violation|0
161817|NCT00766090|516177|P5|Washout Period 1 (14 Days)|Protocol Violation|0
161818|NCT00766090|516178|P4|Washout Period 1 (14 Days)|Protocol Violation|0
161819|NCT00766090|516179|P3|Washout Period 1 (14 Days)|Protocol Violation|1
161820|NCT00766090|516180|P2|Washout Period 1 (14 Days)|Protocol Violation|0
161821|NCT00766090|516181|P1|Washout Period 1 (14 Days)|Protocol Violation|0
161822|NCT00766090|516170|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161823|NCT00766090|516171|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161824|NCT00766090|516172|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161825|NCT00766090|516173|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161826|NCT00766090|516174|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161827|NCT00766090|516175|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161828|NCT00766090|516176|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161829|NCT00766090|516177|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161830|NCT00766090|516178|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
161831|NCT00766090|516179|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161832|NCT00766090|516180|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
161833|NCT00766090|516181|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
161834|NCT00766090|516170|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161835|NCT00766090|516171|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161836|NCT00766090|516172|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161837|NCT00766090|516173|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161838|NCT00766090|516174|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161839|NCT00766090|516175|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161840|NCT00766090|516176|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161841|NCT00766090|516177|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161842|NCT00766090|516178|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161843|NCT00766090|516179|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161844|NCT00766090|516180|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
161845|NCT00766090|516181|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
161846|NCT00766090|516170|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161847|NCT00766090|516171|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161848|NCT00766090|516172|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161849|NCT00766090|516173|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
161850|NCT00766090|516174|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161851|NCT00766090|516175|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161852|NCT00766090|516176|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161853|NCT00766090|516177|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161854|NCT00766090|516178|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161855|NCT00766090|516179|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161856|NCT00766090|516180|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161857|NCT00766090|516181|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
161858|NCT00766363|516224|P4|Overall Study|Adverse Event Prior to Randomization|0
161859|NCT00766363|516225|P3|Overall Study|Adverse Event Prior to Randomization|0
161860|NCT00766363|516226|P2|Overall Study|Adverse Event Prior to Randomization|1
161861|NCT00766363|516227|P1|Overall Study|Adverse Event Prior to Randomization|0
161862|NCT00766363|516224|P4|Overall Study|Withdrawal by Subject|0
161863|NCT00766363|516225|P3|Overall Study|Withdrawal by Subject|0
161864|NCT00766363|516226|P2|Overall Study|Withdrawal by Subject|0
161865|NCT00766363|516227|P1|Overall Study|Withdrawal by Subject|1
161866|NCT00766376|516264|P1|Overall Study|Withdrawal by Subject|27
161867|NCT00766415|516271|P2|Overall Study|Withdrawal by Subject|1
161868|NCT00766415|516272|P1|Overall Study|Withdrawal by Subject|0
161869|NCT00766467|516322|P2|Overall Study|Physician Decision|0
161870|NCT00766467|516323|P1|Overall Study|Physician Decision|1
161871|NCT00766467|516322|P2|Overall Study|Tumor Progression on Study|1
161872|NCT00766467|516323|P1|Overall Study|Tumor Progression on Study|0
161873|NCT00766467|516322|P2|Overall Study|Protocol Violation|4
161874|NCT00766467|516323|P1|Overall Study|Protocol Violation|2
161875|NCT00766467|516322|P2|Overall Study|Adverse Event|1
161876|NCT00766467|516323|P1|Overall Study|Adverse Event|1
161877|NCT00766467|516322|P2|Overall Study|Withdrawal by Subject|2
161878|NCT00766467|516323|P1|Overall Study|Withdrawal by Subject|7
161879|NCT00766493|516333|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
161880|NCT00766493|516333|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
161881|NCT00766493|516333|P1|30 Days Post-Procedure|Discontinued|7
161882|NCT00766506|516343|P2|Overall Study|Unspecified|2
161883|NCT00766506|516344|P1|Overall Study|Unspecified|2
161884|NCT00766506|516343|P2|Overall Study|Use rescue medication after 3 hours|0
161885|NCT00766506|516344|P1|Overall Study|Use rescue medication after 3 hours|3
161886|NCT00766532|516368|P1|Overall Study|Protocol Violation|2
161887|NCT00766597|516372|P1|Overall Study|Without CCR5-tropic virus|5
161888|NCT00766597|516372|P1|Overall Study|Unexpected closure of study|4
161889|NCT00766636|516386|P2|Overall Study|Disease Progression|0
161890|NCT00766636|516387|P1|Overall Study|Disease Progression|1
161891|NCT00766636|516386|P2|Overall Study|Adverse Event|0
161892|NCT00766636|516387|P1|Overall Study|Adverse Event|1
161893|NCT00766636|516386|P2|Overall Study|Incomplete Treatment|1
161894|NCT00766636|516387|P1|Overall Study|Incomplete Treatment|0
161895|NCT00766636|516386|P2|Overall Study|Withdrawal by Subject|1
161896|NCT00766636|516387|P1|Overall Study|Withdrawal by Subject|1
161897|NCT00766675|516405|P1|Overall Study|Insufficient therapy|1
161898|NCT00766675|516405|P1|Overall Study|Receive other anti-neoplastic treatment|1
161899|NCT00766675|516405|P1|Overall Study|Participant took prohibited medication|1
161900|NCT00766675|516405|P1|Overall Study|Protocol Violation|8
161901|NCT00766675|516405|P1|Overall Study|Withdrawal by Subject|11
161902|NCT00766675|516405|P1|Overall Study|Lost to Follow-up|2
161903|NCT00766675|516405|P1|Overall Study|Adverse Event|16
161904|NCT00766831|516432|P1|Overall Study|Not specified|28
161905|NCT00766831|516432|P1|Overall Study|Non cooperation by participants|14
161906|NCT00766831|516432|P1|Overall Study|Withdrawal of consent|26
161907|NCT00766831|516432|P1|Overall Study|Physician Decision|5
161908|NCT00766831|516432|P1|Overall Study|Protocol Violation|15
161909|NCT00766831|516432|P1|Overall Study|Adverse Event|20
161910|NCT00766831|516432|P1|Overall Study|Lost to Follow-up|3
161911|NCT00766831|516432|P1|Overall Study|Withdrawal by Subject|4
161912|NCT00772538|516450|P2|Overall Study|Other|7
161913|NCT00772538|516451|P1|Overall Study|Other|7
161914|NCT00772538|516450|P2|Overall Study|Lack of Efficacy|1
161915|NCT00772538|516451|P1|Overall Study|Lack of Efficacy|0
161916|NCT00772538|516450|P2|Overall Study|Withdrawal by Subject|8
161917|NCT00772538|516451|P1|Overall Study|Withdrawal by Subject|3
161918|NCT00772538|516450|P2|Overall Study|Lost to Follow-up|1
161919|NCT00772538|516451|P1|Overall Study|Lost to Follow-up|1
161920|NCT00772538|516450|P2|Overall Study|Protocol Violation|3
161921|NCT00772538|516451|P1|Overall Study|Protocol Violation|3
161922|NCT00772538|516450|P2|Overall Study|Adverse Event|6
161923|NCT00772538|516451|P1|Overall Study|Adverse Event|6
161924|NCT00772577|516523|P2|Overall Study|Protocol Deviation|2
161925|NCT00772577|516524|P1|Overall Study|Protocol Deviation|3
161926|NCT00772577|516523|P2|Overall Study|Administrative problems|1
161927|NCT00772577|516524|P1|Overall Study|Administrative problems|2
161928|NCT00772577|516523|P2|Overall Study|Lost to Follow-up|3
161929|NCT00772577|516524|P1|Overall Study|Lost to Follow-up|4
161930|NCT00772577|516523|P2|Overall Study|Patient withdrew consent|5
161931|NCT00772577|516524|P1|Overall Study|Patient withdrew consent|8
161932|NCT00772577|516523|P2|Overall Study|Unsatisfactory therapeutic effect|8
161933|NCT00772577|516524|P1|Overall Study|Unsatisfactory therapeutic effect|0
161934|NCT00772577|516523|P2|Overall Study|Abnormal laboratory values|1
161935|NCT00772577|516524|P1|Overall Study|Abnormal laboratory values|0
161936|NCT00772577|516523|P2|Overall Study|Adverse Event|3
161937|NCT00772577|516524|P1|Overall Study|Adverse Event|6
161938|NCT00772603|516558|P3|Overall Study|Other|2
161939|NCT00772603|516559|P2|Overall Study|Other|0
161940|NCT00772603|516560|P1|Overall Study|Other|2
161941|NCT00772603|516558|P3|Overall Study|Physician Decision|1
161942|NCT00772603|516559|P2|Overall Study|Physician Decision|0
161943|NCT00772603|516560|P1|Overall Study|Physician Decision|0
161944|NCT00772603|516558|P3|Overall Study|Lost to Follow-up|2
161945|NCT00772603|516559|P2|Overall Study|Lost to Follow-up|5
161946|NCT00772603|516560|P1|Overall Study|Lost to Follow-up|1
161947|NCT00772603|516558|P3|Overall Study|Protocol Violation|1
161948|NCT00772603|516559|P2|Overall Study|Protocol Violation|1
161949|NCT00772603|516560|P1|Overall Study|Protocol Violation|0
161950|NCT00772603|516558|P3|Overall Study|Subject Non-compliance|4
161951|NCT00772603|516559|P2|Overall Study|Subject Non-compliance|6
161952|NCT00772603|516560|P1|Overall Study|Subject Non-compliance|1
161953|NCT00772603|516558|P3|Overall Study|Adverse Event|10
161954|NCT00772603|516559|P2|Overall Study|Adverse Event|18
161955|NCT00772603|516560|P1|Overall Study|Adverse Event|37
161956|NCT00772603|516558|P3|Overall Study|Withdrawal by Subject|6
161957|NCT00772603|516559|P2|Overall Study|Withdrawal by Subject|10
161958|NCT00772603|516560|P1|Overall Study|Withdrawal by Subject|11
161959|NCT00772629|516582|P2|Overall Study|Subject was not vaccinated|0
161960|NCT00772629|516583|P1|Overall Study|Subject was not vaccinated|1
161961|NCT00772668|516589|P1|Overall Study|Physician Decision|3
161962|NCT00772707|516593|P1|Overall Study|Withdrawn|3
161963|NCT00772941|516603|P1|Overall Study|GPSP Violation|90
161964|NCT00772941|516603|P1|Overall Study|Poor Compliance|7
161965|NCT00772941|516603|P1|Overall Study|Missed Visits|374
161966|NCT00772941|516603|P1|Overall Study|Study not completed|16
161967|NCT00772941|516603|P1|Overall Study|CRFs not available|195
161968|NCT00772954|516635|P3|Overall Study|Adverse Event|1
161969|NCT00772954|516636|P2|Overall Study|Adverse Event|0
161970|NCT00772954|516637|P1|Overall Study|Adverse Event|0
161971|NCT00772967|516645|P6|Crossover Treatment 3|Adverse Event|0
161972|NCT00772967|516646|P5|Crossover Treatment 3|Adverse Event|1
161973|NCT00772967|516647|P4|Crossover Treatment 3|Adverse Event|0
161974|NCT00772967|516648|P3|Crossover Treatment 3|Adverse Event|0
161975|NCT00772967|516649|P2|Crossover Treatment 3|Adverse Event|0
161976|NCT00772967|516650|P1|Crossover Treatment 3|Adverse Event|0
161977|NCT00772967|516645|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
161978|NCT00772967|516646|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
161979|NCT00772967|516647|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
161980|NCT00772967|516648|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
161981|NCT00772967|516649|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
161982|NCT00772967|516650|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
161983|NCT00772967|516645|P6|Crossover Treatment 1|Adverse Event (Pain)|0
161984|NCT00772967|516646|P5|Crossover Treatment 1|Adverse Event (Pain)|0
161985|NCT00772967|516647|P4|Crossover Treatment 1|Adverse Event (Pain)|1
161986|NCT00772967|516648|P3|Crossover Treatment 1|Adverse Event (Pain)|0
161987|NCT00772967|516649|P2|Crossover Treatment 1|Adverse Event (Pain)|0
161988|NCT00772967|516650|P1|Crossover Treatment 1|Adverse Event (Pain)|0
161989|NCT00773097|516667|P1|Overall Study|Physician Decision|6
161990|NCT00773097|516667|P1|Overall Study|Withdrawal by Subject|1
161991|NCT00773136|516673|P1|Overall Study|Physician Decision|2
161992|NCT00773253|516680|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
161993|NCT00773253|516681|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
161994|NCT00773279|516687|P2|Period 2|Unclassified|2
161995|NCT00773279|516688|P1|Period 2|Unclassified|2
161996|NCT00773279|516687|P2|Period 2|Protocol Violation|3
161997|NCT00773279|516688|P1|Period 2|Protocol Violation|0
161998|NCT00773279|516687|P2|Period 2|Lack of Efficacy|0
161999|NCT00773279|516688|P1|Period 2|Lack of Efficacy|1
162000|NCT00773279|516687|P2|Period 2|Adverse Event|1
162001|NCT00773279|516688|P1|Period 2|Adverse Event|0
162002|NCT00773279|516687|P2|Period 1|Unclassified|1
162003|NCT00773279|516688|P1|Period 1|Unclassified|5
162004|NCT00773279|516687|P2|Period 1|Lack of Efficacy|2
162005|NCT00773279|516688|P1|Period 1|Lack of Efficacy|0
162006|NCT00773279|516687|P2|Period 1|Adverse Event|1
162007|NCT00773279|516688|P1|Period 1|Adverse Event|2
162008|NCT00773383|516722|P1|Overall Study|No study dose received|1
162009|NCT00773383|516722|P1|Overall Study|not specified|2
162010|NCT00773383|516722|P1|Overall Study|Progression of Disease|23
162011|NCT00773383|516722|P1|Overall Study|Death|1
162012|NCT00773383|516722|P1|Overall Study|Adverse Event|4
162013|NCT00773461|516744|P2|Overall Study|Withdrawal by Subject|1
162014|NCT00773461|516745|P1|Overall Study|Withdrawal by Subject|4
162015|NCT00773461|516744|P2|Overall Study|Adverse Event|3
162016|NCT00773461|516745|P1|Overall Study|Adverse Event|1
162017|NCT00773734|516794|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
162018|NCT00773734|516795|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
162019|NCT00773734|516796|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
162020|NCT00773734|516797|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
162021|NCT00773734|516798|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
162022|NCT00773734|516799|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
162023|NCT00773734|516794|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
162024|NCT00773734|516795|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
162025|NCT00773734|516796|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
162026|NCT00773734|516797|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
162027|NCT00773734|516798|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
162028|NCT00773734|516799|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
162029|NCT00773734|516794|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
162030|NCT00773734|516795|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
162031|NCT00773734|516796|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
162032|NCT00773734|516797|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
162033|NCT00773734|516798|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
162034|NCT00773734|516799|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
162035|NCT00773734|516794|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
162036|NCT00773734|516795|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
162037|NCT00773734|516796|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
162038|NCT00773734|516797|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
162039|NCT00773734|516798|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
162040|NCT00773734|516799|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
162041|NCT00773734|516794|P6|Extension: Active Treatment Week 24-52|Unspecified|1
162042|NCT00773734|516795|P5|Extension: Active Treatment Week 24-52|Unspecified|0
162043|NCT00773734|516796|P4|Extension: Active Treatment Week 24-52|Unspecified|2
162044|NCT00773734|516797|P3|Extension: Active Treatment Week 24-52|Unspecified|1
162045|NCT00773734|516798|P2|Extension: Active Treatment Week 24-52|Unspecified|0
162046|NCT00773734|516799|P1|Extension: Active Treatment Week 24-52|Unspecified|0
162047|NCT00773734|516794|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
162048|NCT00773734|516795|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
162049|NCT00773734|516796|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
162050|NCT00773734|516797|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
162051|NCT00773734|516798|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
162052|NCT00773734|516799|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
162053|NCT00773734|516794|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
162054|NCT00773734|516795|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
162055|NCT00773734|516796|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
162056|NCT00773734|516797|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
162057|NCT00773734|516798|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
162058|NCT00773734|516799|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
162059|NCT00773734|516794|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
162060|NCT00773734|516795|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
162061|NCT00773734|516796|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
162062|NCT00773734|516797|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
162063|NCT00773734|516798|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
162064|NCT00773734|516799|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
162065|NCT00773734|516794|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
162066|NCT00773734|516795|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
162067|NCT00773734|516796|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
162068|NCT00773734|516797|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
162069|NCT00773734|516798|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
162070|NCT00773734|516799|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
162071|NCT00773734|516794|P6|Core: Active Treatment Phase Week 16-24|Unspecified|0
162072|NCT00773734|516795|P5|Core: Active Treatment Phase Week 16-24|Unspecified|0
162073|NCT00773734|516796|P4|Core: Active Treatment Phase Week 16-24|Unspecified|0
162074|NCT00773734|516797|P3|Core: Active Treatment Phase Week 16-24|Unspecified|0
162075|NCT00773734|516798|P2|Core: Active Treatment Phase Week 16-24|Unspecified|1
162076|NCT00773734|516799|P1|Core: Active Treatment Phase Week 16-24|Unspecified|0
162077|NCT00773734|516794|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
162078|NCT00773734|516795|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
162079|NCT00773734|516796|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
162080|NCT00773734|516797|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
162081|NCT00773734|516798|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
162082|NCT00773734|516799|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
162083|NCT00773734|516794|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
162084|NCT00773734|516795|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
162085|NCT00773734|516796|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
162086|NCT00773734|516797|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
162087|NCT00773734|516798|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
162088|NCT00773734|516799|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
162089|NCT00773734|516794|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
162090|NCT00773734|516795|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
162091|NCT00773734|516796|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
162092|NCT00773734|516797|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
162093|NCT00773734|516798|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
162094|NCT00773734|516799|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
162095|NCT00773734|516794|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
162096|NCT00773734|516795|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
162097|NCT00773734|516796|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
162098|NCT00773734|516797|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
162099|NCT00773734|516798|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
162100|NCT00773734|516799|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
162101|NCT00773734|516794|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
162102|NCT00773734|516795|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
162103|NCT00773734|516796|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
162104|NCT00773734|516797|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
162105|NCT00773734|516798|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
162106|NCT00773734|516799|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
162107|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
162108|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Unspecified|0
162109|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
162110|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
162111|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
162112|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Unspecified|1
162113|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
162114|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
162115|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
162116|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
162117|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
162118|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
162119|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
162120|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
162121|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
162122|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
162123|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
162124|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
162125|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
162126|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
162127|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
162128|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
162129|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
162130|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
162131|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
162132|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
162133|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
162134|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
162135|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
162136|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
162137|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
162138|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
162139|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
162140|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
162141|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
162142|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
162143|NCT00773734|516794|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
162144|NCT00773734|516795|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
162145|NCT00773734|516796|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
162146|NCT00773734|516797|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
162147|NCT00773734|516798|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
162148|NCT00773734|516799|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
162149|NCT00773968|517379|P1|Overall Study|Unspecified|8
162150|NCT00773968|517379|P1|Overall Study|Screen Failure|17
162151|NCT00773968|517379|P1|Overall Study|Withdrawal by Subject|11
162152|NCT00773968|517379|P1|Overall Study|Protocol Violation|1
162153|NCT00773968|517379|P1|Overall Study|Lack of Efficacy|3
162154|NCT00773968|517379|P1|Overall Study|Failure to Return|2
162155|NCT00773968|517379|P1|Overall Study|Death|1
162156|NCT00773968|517379|P1|Overall Study|Adverse Event|2
162157|NCT00774046|517388|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
162158|NCT00774046|517388|P1|Enrollment|Desired other therapy/refused|28
162159|NCT00774046|517388|P1|Screening|Not eligible|56
162160|NCT00774306|517460|P4|Overall Study|Death|0
162161|NCT00774306|517461|P3|Overall Study|Death|0
162162|NCT00774306|517462|P2|Overall Study|Death|1
162163|NCT00774306|517463|P1|Overall Study|Death|1
162164|NCT00774306|517460|P4|Overall Study|Lost to Follow-up|5
162165|NCT00774306|517461|P3|Overall Study|Lost to Follow-up|4
162166|NCT00774306|517462|P2|Overall Study|Lost to Follow-up|0
162167|NCT00774306|517463|P1|Overall Study|Lost to Follow-up|6
162168|NCT00774306|517460|P4|Overall Study|Withdrawal by Subject|0
162169|NCT00774306|517461|P3|Overall Study|Withdrawal by Subject|1
162170|NCT00774306|517462|P2|Overall Study|Withdrawal by Subject|1
162171|NCT00774306|517463|P1|Overall Study|Withdrawal by Subject|6
162172|NCT00774306|517460|P4|Overall Study|Protocol Violation|0
162173|NCT00774306|517461|P3|Overall Study|Protocol Violation|3
162174|NCT00774306|517462|P2|Overall Study|Protocol Violation|0
162175|NCT00774306|517463|P1|Overall Study|Protocol Violation|2
162176|NCT00774306|517460|P4|Overall Study|Adverse Event|0
162177|NCT00774306|517461|P3|Overall Study|Adverse Event|0
162178|NCT00774306|517462|P2|Overall Study|Adverse Event|0
162179|NCT00774306|517463|P1|Overall Study|Adverse Event|3
162180|NCT00774397|517480|P7|Overall Study|Other than those stated above|1
162181|NCT00774397|517481|P6|Overall Study|Other than those stated above|0
162182|NCT00774397|517482|P5|Overall Study|Other than those stated above|2
162183|NCT00774397|517483|P4|Overall Study|Other than those stated above|2
162184|NCT00774397|517484|P3|Overall Study|Other than those stated above|3
162185|NCT00774397|517485|P2|Overall Study|Other than those stated above|1
162186|NCT00774397|517486|P1|Overall Study|Other than those stated above|1
162187|NCT00774397|517480|P7|Overall Study|Not treated|1
162188|NCT00774397|517481|P6|Overall Study|Not treated|0
162189|NCT00774397|517482|P5|Overall Study|Not treated|1
162190|NCT00774397|517483|P4|Overall Study|Not treated|0
162191|NCT00774397|517484|P3|Overall Study|Not treated|0
162192|NCT00774397|517485|P2|Overall Study|Not treated|0
162193|NCT00774397|517486|P1|Overall Study|Not treated|0
162194|NCT00774397|517480|P7|Overall Study|Refused to continue trial medication|3
162195|NCT00774397|517481|P6|Overall Study|Refused to continue trial medication|2
162196|NCT00774397|517482|P5|Overall Study|Refused to continue trial medication|6
162197|NCT00774397|517483|P4|Overall Study|Refused to continue trial medication|2
162198|NCT00774397|517484|P3|Overall Study|Refused to continue trial medication|2
162199|NCT00774397|517485|P2|Overall Study|Refused to continue trial medication|3
162200|NCT00774397|517486|P1|Overall Study|Refused to continue trial medication|1
162201|NCT00774397|517480|P7|Overall Study|Lost to Follow-up|0
162202|NCT00774397|517481|P6|Overall Study|Lost to Follow-up|1
162203|NCT00774397|517482|P5|Overall Study|Lost to Follow-up|0
162204|NCT00774397|517483|P4|Overall Study|Lost to Follow-up|1
162205|NCT00774397|517484|P3|Overall Study|Lost to Follow-up|1
162206|NCT00774397|517485|P2|Overall Study|Lost to Follow-up|1
162207|NCT00774397|517486|P1|Overall Study|Lost to Follow-up|0
162208|NCT00774397|517480|P7|Overall Study|Protocol Violation|0
162209|NCT00774397|517481|P6|Overall Study|Protocol Violation|1
162210|NCT00774397|517482|P5|Overall Study|Protocol Violation|2
162211|NCT00774397|517483|P4|Overall Study|Protocol Violation|1
162212|NCT00774397|517484|P3|Overall Study|Protocol Violation|3
162213|NCT00774397|517485|P2|Overall Study|Protocol Violation|1
162214|NCT00774397|517486|P1|Overall Study|Protocol Violation|0
162215|NCT00774397|517480|P7|Overall Study|Lack of Efficacy|9
162216|NCT00774397|517481|P6|Overall Study|Lack of Efficacy|15
162217|NCT00774397|517482|P5|Overall Study|Lack of Efficacy|27
162218|NCT00774397|517483|P4|Overall Study|Lack of Efficacy|3
162219|NCT00774397|517484|P3|Overall Study|Lack of Efficacy|5
162220|NCT00774397|517485|P2|Overall Study|Lack of Efficacy|4
162221|NCT00774397|517486|P1|Overall Study|Lack of Efficacy|11
162222|NCT00774397|517480|P7|Overall Study|Adverse Event|16
162223|NCT00774397|517481|P6|Overall Study|Adverse Event|3
162224|NCT00774397|517482|P5|Overall Study|Adverse Event|8
162225|NCT00774397|517483|P4|Overall Study|Adverse Event|8
162226|NCT00774397|517484|P3|Overall Study|Adverse Event|16
162227|NCT00774397|517485|P2|Overall Study|Adverse Event|3
162228|NCT00774397|517486|P1|Overall Study|Adverse Event|1
162229|NCT00774748|517718|P1|Overall Study|Lost to Follow-up|3
162230|NCT00774787|517726|P1|Overall Study|Lost to Follow-up|1
162231|NCT00774800|517733|P1|Intervention 4|Withdrawal by Subject|1
162232|NCT00774852|517757|P2|Overall Study|Subject received prohibited medication|0
162233|NCT00774852|517758|P1|Overall Study|Subject received prohibited medication|1
162234|NCT00774852|517757|P2|Overall Study|Protocol Violation|0
162235|NCT00774852|517758|P1|Overall Study|Protocol Violation|1
162236|NCT00774852|517757|P2|Overall Study|Subject non-compliance|1
162237|NCT00774852|517758|P1|Overall Study|Subject non-compliance|0
162238|NCT00774852|517757|P2|Overall Study|Non-responder|11
162239|NCT00774852|517758|P1|Overall Study|Non-responder|15
162240|NCT00774852|517757|P2|Overall Study|Withdrawal by Subject|2
162241|NCT00774852|517758|P1|Overall Study|Withdrawal by Subject|2
162242|NCT00774852|517757|P2|Overall Study|Pregnancy|2
162243|NCT00774852|517758|P1|Overall Study|Pregnancy|1
162244|NCT00774852|517757|P2|Overall Study|Physician Decision|6
162245|NCT00774852|517758|P1|Overall Study|Physician Decision|2
162246|NCT00774852|517757|P2|Overall Study|Lost to Follow-up|5
162247|NCT00774852|517758|P1|Overall Study|Lost to Follow-up|9
162248|NCT00774852|517757|P2|Overall Study|Lack of Efficacy|7
162249|NCT00774852|517758|P1|Overall Study|Lack of Efficacy|3
162250|NCT00774852|517757|P2|Overall Study|Death|1
162251|NCT00774852|517758|P1|Overall Study|Death|2
162252|NCT00774852|517757|P2|Overall Study|Adverse Event|6
162253|NCT00774852|517758|P1|Overall Study|Adverse Event|9
162254|NCT00774930|517808|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
162255|NCT00774930|517809|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
162256|NCT00774930|517808|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
162257|NCT00774930|517809|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
162258|NCT00774930|517808|P2|LTOLE Phase|Disease Progression|5
162259|NCT00774930|517809|P1|LTOLE Phase|Disease Progression|2
162260|NCT00774930|517808|P2|LTOLE Phase|Sponsor decision|1
162261|NCT00774930|517809|P1|LTOLE Phase|Sponsor decision|2
162262|NCT00774930|517808|P2|LTOLE Phase|Physician Decision|1
162263|NCT00774930|517809|P1|LTOLE Phase|Physician Decision|4
162264|NCT00774930|517808|P2|LTOLE Phase|Subject decision|5
162265|NCT00774930|517809|P1|LTOLE Phase|Subject decision|0
162266|NCT00774930|517808|P2|LTOLE Phase|Adverse Event|3
162267|NCT00774930|517809|P1|LTOLE Phase|Adverse Event|7
162268|NCT00774930|517808|P2|IOL Phase|Brain radiation|1
162269|NCT00774930|517809|P1|IOL Phase|Brain radiation|0
162270|NCT00774930|517808|P2|IOL Phase|Unspecified|0
162271|NCT00774930|517809|P1|IOL Phase|Unspecified|1
162272|NCT00774930|517808|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
162273|NCT00774930|517809|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
162274|NCT00774930|517808|P2|IOL Phase|Subject Consumed Prohibited Medication|0
162275|NCT00774930|517809|P1|IOL Phase|Subject Consumed Prohibited Medication|1
162276|NCT00774930|517808|P2|IOL Phase|Disease Progression|1
162277|NCT00774930|517809|P1|IOL Phase|Disease Progression|2
162278|NCT00774930|517808|P2|IOL Phase|Sponsor Decision|0
162279|NCT00774930|517809|P1|IOL Phase|Sponsor Decision|1
162280|NCT00774930|517808|P2|IOL Phase|Physician Decision|2
162281|NCT00774930|517809|P1|IOL Phase|Physician Decision|3
162282|NCT00774930|517808|P2|IOL Phase|Subject Decision|3
162283|NCT00774930|517809|P1|IOL Phase|Subject Decision|4
162284|NCT00774930|517808|P2|IOL Phase|Adverse Event|1
162285|NCT00774930|517809|P1|IOL Phase|Adverse Event|1
162286|NCT00774930|517808|P2|DB Phase|Started Nonprotocol Radiation therapy|1
162287|NCT00774930|517809|P1|DB Phase|Started Nonprotocol Radiation therapy|0
162288|NCT00774930|517808|P2|DB Phase|Disease Progression|1
162289|NCT00774930|517809|P1|DB Phase|Disease Progression|1
162290|NCT00774930|517808|P2|DB Phase|Sponsor Decision|1
162291|NCT00774930|517809|P1|DB Phase|Sponsor Decision|0
162292|NCT00774930|517808|P2|DB Phase|Subject Decision|5
162293|NCT00774930|517809|P1|DB Phase|Subject Decision|1
162294|NCT00774930|517808|P2|DB Phase|Adverse Event|2
162295|NCT00774930|517809|P1|DB Phase|Adverse Event|1
162296|NCT00774930|517808|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
162297|NCT00774930|517809|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
162298|NCT00774995|517839|P4|Overall Study|Protocol Violation|0
162299|NCT00774995|517840|P3|Overall Study|Protocol Violation|1
162300|NCT00774995|517841|P2|Overall Study|Protocol Violation|0
162301|NCT00774995|517842|P1|Overall Study|Protocol Violation|0
162302|NCT00775021|517880|P2|Second Intervention|Adverse Event|1
162303|NCT00775021|517881|P1|Second Intervention|Adverse Event|0
162304|NCT00775021|517880|P2|First Intervention|Lost to Follow-up|0
162305|NCT00775021|517881|P1|First Intervention|Lost to Follow-up|1
162306|NCT00775190|517897|P2|Overall Study|Protocol Violation|0
162307|NCT00775190|517898|P1|Overall Study|Protocol Violation|1
162308|NCT00775190|517897|P2|Overall Study|Withdrawal by Subject|2
162309|NCT00775190|517898|P1|Overall Study|Withdrawal by Subject|1
162310|NCT00775190|517897|P2|Overall Study|Lost to Follow-up|3
162311|NCT00775190|517898|P1|Overall Study|Lost to Follow-up|2
162312|NCT00775203|517922|P2|Overall Study|Physician Decision|1
162313|NCT00775203|517923|P1|Overall Study|Physician Decision|0
162314|NCT00775203|517922|P2|Overall Study|Entered other study|0
162315|NCT00775203|517923|P1|Overall Study|Entered other study|1
162316|NCT00775203|517922|P2|Overall Study|Protocol Violation|1
162317|NCT00775203|517923|P1|Overall Study|Protocol Violation|0
162318|NCT00775203|517922|P2|Overall Study|Noncompliance|2
162319|NCT00775203|517923|P1|Overall Study|Noncompliance|4
162320|NCT00775203|517922|P2|Overall Study|Administrative reason|0
162321|NCT00775203|517923|P1|Overall Study|Administrative reason|2
162322|NCT00775203|517922|P2|Overall Study|Lost to Follow-up|15
162323|NCT00775203|517923|P1|Overall Study|Lost to Follow-up|11
162324|NCT00775203|517922|P2|Overall Study|Withdrawal by Subject|9
162325|NCT00775203|517923|P1|Overall Study|Withdrawal by Subject|11
162326|NCT00775203|517922|P2|Overall Study|Lack of Efficacy|9
162327|NCT00775203|517923|P1|Overall Study|Lack of Efficacy|8
162328|NCT00775203|517922|P2|Overall Study|Adverse Event|6
162329|NCT00775203|517923|P1|Overall Study|Adverse Event|25
162330|NCT00775437|517978|P1|Overall Study|Lost to Follow-up|1
162331|NCT00775437|517978|P1|Overall Study|Withdrawal by Subject|3
162332|NCT00775437|517978|P1|Overall Study|Loss of efficacy|2
162333|NCT00769860|518030|P2|Overall Study|Withdrawal by Subject|0
162334|NCT00769860|518031|P1|Overall Study|Withdrawal by Subject|2
162335|NCT00775450|518062|P5|Overall Study|Withdrawal by Subject|1
162336|NCT00775450|518063|P4|Overall Study|Withdrawal by Subject|0
162337|NCT00775450|518064|P3|Overall Study|Withdrawal by Subject|0
162338|NCT00775450|518065|P2|Overall Study|Withdrawal by Subject|0
162339|NCT00775450|518066|P1|Overall Study|Withdrawal by Subject|1
162340|NCT00775450|518062|P5|Overall Study|Protocol Violation|1
162341|NCT00775450|518063|P4|Overall Study|Protocol Violation|0
162342|NCT00775450|518064|P3|Overall Study|Protocol Violation|0
162343|NCT00775450|518065|P2|Overall Study|Protocol Violation|0
162344|NCT00775450|518066|P1|Overall Study|Protocol Violation|0
162345|NCT00775450|518062|P5|Overall Study|Serious Adverse Event|0
162346|NCT00775450|518063|P4|Overall Study|Serious Adverse Event|0
162347|NCT00775450|518064|P3|Overall Study|Serious Adverse Event|0
162348|NCT00775450|518065|P2|Overall Study|Serious Adverse Event|0
162349|NCT00775450|518066|P1|Overall Study|Serious Adverse Event|2
162350|NCT00775463|518095|P2|Overall Study|Lack of Efficacy|1
162351|NCT00775463|518096|P1|Overall Study|Lack of Efficacy|1
162352|NCT00775463|518095|P2|Overall Study|Lost to Follow-up|0
162353|NCT00775463|518096|P1|Overall Study|Lost to Follow-up|1
162354|NCT00775463|518095|P2|Overall Study|Protocol Violation|2
162355|NCT00775463|518096|P1|Overall Study|Protocol Violation|2
162356|NCT00775463|518095|P2|Overall Study|Adverse Event|9
162357|NCT00775463|518096|P1|Overall Study|Adverse Event|7
162358|NCT00775463|518095|P2|Overall Study|Withdrawal by Subject|1
162359|NCT00775463|518096|P1|Overall Study|Withdrawal by Subject|0
162360|NCT00775528|518128|P1|Overall Study|Protocol Violation|1
162361|NCT00775593|518135|P1|Overall Study|Death|1
162362|NCT00775593|518135|P1|Overall Study|Unmet eligibility criteria|6
162363|NCT00775606|518144|P2|Overall Study|Study sponsor terminated funding|0
162364|NCT00775606|518145|P1|Overall Study|Study sponsor terminated funding|3
162365|NCT00776230|518201|P3|Overall Study|Subject missed Visit 4|0
162366|NCT00776230|518202|P2|Overall Study|Subject missed Visit 4|1
162367|NCT00776230|518203|P1|Overall Study|Subject missed Visit 4|0
162368|NCT00776230|518201|P3|Overall Study|Withdrawal by Subject|0
162369|NCT00776230|518202|P2|Overall Study|Withdrawal by Subject|1
162370|NCT00776230|518203|P1|Overall Study|Withdrawal by Subject|0
162371|NCT00776230|518201|P3|Overall Study|Not vaccinated at Day 0|0
162372|NCT00776230|518202|P2|Overall Study|Not vaccinated at Day 0|0
162373|NCT00776230|518203|P1|Overall Study|Not vaccinated at Day 0|1
162374|NCT00776230|518201|P3|Overall Study|Lost to Follow-up|5
162375|NCT00776230|518202|P2|Overall Study|Lost to Follow-up|1
162376|NCT00776230|518203|P1|Overall Study|Lost to Follow-up|2
162377|NCT00776555|518218|P2|Overall Study|Study terminated|0
162378|NCT00776555|518219|P1|Overall Study|Study terminated|3
162379|NCT00776659|518244|P1|Overall Study|Study Terminated by Sponsor|1
162380|NCT00776659|518244|P1|Overall Study|Withdrawal by Subject|10
162381|NCT00776659|518244|P1|Overall Study|Lost to Follow-up|15
162382|NCT00776789|518256|P2|Overall Study|Poor quality video|1
162383|NCT00776789|518257|P1|Overall Study|Poor quality video|1
162384|NCT00776789|518256|P2|Overall Study|Consent refusal|2
162385|NCT00776789|518257|P1|Overall Study|Consent refusal|2
162386|NCT00776919|518273|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
162387|NCT00776919|518274|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
162388|NCT00776919|518275|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
162389|NCT00776919|518276|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
162390|NCT00776919|518273|P4|Overall Study|Protocol Violation|1
162391|NCT00776919|518274|P3|Overall Study|Protocol Violation|0
162392|NCT00776919|518275|P2|Overall Study|Protocol Violation|2
162393|NCT00776919|518276|P1|Overall Study|Protocol Violation|1
162394|NCT00776919|518273|P4|Overall Study|Adverse Event|2
162395|NCT00776919|518274|P3|Overall Study|Adverse Event|2
162396|NCT00776919|518275|P2|Overall Study|Adverse Event|0
162397|NCT00776919|518276|P1|Overall Study|Adverse Event|1
162398|NCT00776919|518273|P4|Overall Study|Lost to Follow-up|8
162399|NCT00776919|518274|P3|Overall Study|Lost to Follow-up|11
162400|NCT00776919|518275|P2|Overall Study|Lost to Follow-up|12
162401|NCT00776919|518276|P1|Overall Study|Lost to Follow-up|8
162402|NCT00776919|518273|P4|Overall Study|Withdrawal by Subject|26
162403|NCT00776919|518274|P3|Overall Study|Withdrawal by Subject|15
162404|NCT00776919|518275|P2|Overall Study|Withdrawal by Subject|14
162405|NCT00776919|518276|P1|Overall Study|Withdrawal by Subject|16
162406|NCT00776984|518340|P2|Overall Study|Other|9
162407|NCT00776984|518341|P1|Overall Study|Other|5
162408|NCT00776984|518340|P2|Overall Study|Lack of Efficacy|1
162409|NCT00776984|518341|P1|Overall Study|Lack of Efficacy|0
162410|NCT00776984|518340|P2|Overall Study|Withdrawal by Subject|7
162411|NCT00776984|518341|P1|Overall Study|Withdrawal by Subject|12
162412|NCT00776984|518340|P2|Overall Study|Lost to Follow-up|0
162413|NCT00776984|518341|P1|Overall Study|Lost to Follow-up|2
162414|NCT00776984|518340|P2|Overall Study|Protocol Violation|2
162415|NCT00776984|518341|P1|Overall Study|Protocol Violation|4
162416|NCT00776984|518340|P2|Overall Study|Adverse Event|2
162417|NCT00776984|518341|P1|Overall Study|Adverse Event|8
162418|NCT00776997|518411|P1|Overall Study|Adverse Event|2
162419|NCT00777023|518421|P3|Overall Study|Last dose date unknown|1
162420|NCT00777023|518422|P2|Overall Study|Last dose date unknown|3
162421|NCT00777023|518423|P1|Overall Study|Last dose date unknown|3
162422|NCT00777023|518421|P3|Overall Study|Reasons not specified|2
162423|NCT00777023|518422|P2|Overall Study|Reasons not specified|4
162424|NCT00777023|518423|P1|Overall Study|Reasons not specified|4
162425|NCT00777023|518421|P3|Overall Study|Missing data|0
162426|NCT00777023|518422|P2|Overall Study|Missing data|1
162427|NCT00777023|518423|P1|Overall Study|Missing data|1
162428|NCT00777023|518421|P3|Overall Study|Withdrawal by Subject|8
162429|NCT00777023|518422|P2|Overall Study|Withdrawal by Subject|7
162430|NCT00777023|518423|P1|Overall Study|Withdrawal by Subject|7
162431|NCT00777023|518421|P3|Overall Study|Death|0
162432|NCT00777023|518422|P2|Overall Study|Death|1
162433|NCT00777023|518423|P1|Overall Study|Death|0
162434|NCT00777023|518421|P3|Overall Study|Lost to Follow-up|3
162435|NCT00777023|518422|P2|Overall Study|Lost to Follow-up|3
162436|NCT00777023|518423|P1|Overall Study|Lost to Follow-up|2
162437|NCT00777023|518421|P3|Overall Study|Protocol Violation|1
162438|NCT00777023|518422|P2|Overall Study|Protocol Violation|1
162439|NCT00777023|518423|P1|Overall Study|Protocol Violation|2
162440|NCT00777023|518421|P3|Overall Study|Lack of Efficacy|14
162441|NCT00777023|518422|P2|Overall Study|Lack of Efficacy|0
162442|NCT00777023|518423|P1|Overall Study|Lack of Efficacy|1
162443|NCT00777023|518421|P3|Overall Study|Adverse Event|8
162444|NCT00777023|518422|P2|Overall Study|Adverse Event|21
162445|NCT00777023|518423|P1|Overall Study|Adverse Event|15
162446|NCT00777049|518442|P2|Overall Study|No treatment (elevated liver enzymes)|1
162447|NCT00777049|518443|P1|Overall Study|No treatment (elevated liver enzymes)|0
162448|NCT00777049|518442|P2|Overall Study|Withdrawal by Subject|0
162449|NCT00777049|518443|P1|Overall Study|Withdrawal by Subject|1
162450|NCT00777153|518463|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
162451|NCT00777153|518464|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
162452|NCT00777153|518465|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
162453|NCT00777153|518463|P3|Overall Study|Withdrawal by Subject|3
162454|NCT00777153|518464|P2|Overall Study|Withdrawal by Subject|4
162455|NCT00777153|518465|P1|Overall Study|Withdrawal by Subject|3
162456|NCT00777153|518463|P3|Overall Study|Death|33
162457|NCT00777153|518464|P2|Overall Study|Death|73
162458|NCT00777153|518465|P1|Overall Study|Death|85
162459|NCT00777153|518463|P3|Overall Study|Lost to Follow-up|0
162460|NCT00777153|518464|P2|Overall Study|Lost to Follow-up|1
162461|NCT00777153|518465|P1|Overall Study|Lost to Follow-up|1
162462|NCT00777205|518507|P2|Overall Study|Protocol Violation|56
162463|NCT00777205|518508|P1|Overall Study|Protocol Violation|0
162464|NCT00777205|518507|P2|Overall Study|Death|2
162465|NCT00777205|518508|P1|Overall Study|Death|0
162466|NCT00777205|518507|P2|Overall Study|Withdrawal by Subject|4
162467|NCT00777205|518508|P1|Overall Study|Withdrawal by Subject|6
162468|NCT00777205|518507|P2|Overall Study|Lost to Follow-up|9
162469|NCT00777205|518508|P1|Overall Study|Lost to Follow-up|25
162470|NCT00777257|518525|P3|Overall Study|Withdrawal by Subject|5
162471|NCT00777257|518526|P2|Overall Study|Withdrawal by Subject|6
162472|NCT00777257|518527|P1|Overall Study|Withdrawal by Subject|3
162473|NCT00777257|518525|P3|Overall Study|Protocol Violation|2
162474|NCT00777257|518526|P2|Overall Study|Protocol Violation|2
162475|NCT00777257|518527|P1|Overall Study|Protocol Violation|2
162476|NCT00777257|518525|P3|Overall Study|Lost to Follow-up|2
162477|NCT00777257|518526|P2|Overall Study|Lost to Follow-up|3
162478|NCT00777257|518527|P1|Overall Study|Lost to Follow-up|3
162479|NCT00777257|518525|P3|Overall Study|Adverse Event|0
162480|NCT00777257|518526|P2|Overall Study|Adverse Event|1
162481|NCT00777257|518527|P1|Overall Study|Adverse Event|3
162482|NCT00777556|518555|P1|Overall Study|Did not complete all 3 follow-up visits|20
162483|NCT00777556|518555|P1|Overall Study|Dispensed but did not use product|12
162484|NCT00777556|518555|P1|Overall Study|Inappropriate self-selection|34
162485|NCT00777608|518564|P2|Overall Study|Investigator Decision|2
162486|NCT00777608|518565|P1|Overall Study|Investigator Decision|1
162487|NCT00777608|518564|P2|Overall Study|Protocol Violation|0
162488|NCT00777608|518565|P1|Overall Study|Protocol Violation|1
162489|NCT00777608|518564|P2|Overall Study|Withdrawal by Subject|3
162490|NCT00777608|518565|P1|Overall Study|Withdrawal by Subject|1
162491|NCT00777608|518564|P2|Overall Study|Lost to Follow-up|1
162492|NCT00777608|518565|P1|Overall Study|Lost to Follow-up|1
162493|NCT00777803|518622|P2|Overall Study|Non-compliance|2
162494|NCT00777803|518623|P1|Overall Study|Non-compliance|2
162495|NCT00777803|518622|P2|Overall Study|Adverse Event|0
162496|NCT00777803|518623|P1|Overall Study|Adverse Event|1
162497|NCT00777803|518622|P2|Overall Study|Lost to Follow-up|5
162498|NCT00777803|518623|P1|Overall Study|Lost to Follow-up|12
162499|NCT00777946|518668|P3|Overall Study|Randomized in error|0
162500|NCT00777946|518669|P2|Overall Study|Randomized in error|1
162501|NCT00777946|518670|P1|Overall Study|Randomized in error|1
162502|NCT00777946|518668|P3|Overall Study|Protocol deviation|1
162503|NCT00777946|518669|P2|Overall Study|Protocol deviation|1
162504|NCT00777946|518670|P1|Overall Study|Protocol deviation|2
162505|NCT00777946|518668|P3|Overall Study|Lost to Follow-up|0
162506|NCT00777946|518669|P2|Overall Study|Lost to Follow-up|1
162507|NCT00777946|518670|P1|Overall Study|Lost to Follow-up|3
162508|NCT00777946|518668|P3|Overall Study|Patient withdrew consent|3
162509|NCT00777946|518669|P2|Overall Study|Patient withdrew consent|2
162510|NCT00777946|518670|P1|Overall Study|Patient withdrew consent|3
162511|NCT00777946|518668|P3|Overall Study|Condition no longer required study drug|0
162512|NCT00777946|518669|P2|Overall Study|Condition no longer required study drug|0
162513|NCT00777946|518670|P1|Overall Study|Condition no longer required study drug|1
162514|NCT00777946|518668|P3|Overall Study|Lack of Efficacy|9
162515|NCT00777946|518669|P2|Overall Study|Lack of Efficacy|0
162516|NCT00777946|518670|P1|Overall Study|Lack of Efficacy|0
162517|NCT00777946|518668|P3|Overall Study|Adverse Event|3
162518|NCT00777946|518669|P2|Overall Study|Adverse Event|1
162519|NCT00777946|518670|P1|Overall Study|Adverse Event|11
162520|NCT00778102|518695|P2|Overall Study|Administrative Reason|10
162521|NCT00778102|518696|P1|Overall Study|Administrative Reason|7
162522|NCT00778102|518695|P2|Overall Study|Withdrawal by Subject|1
162523|NCT00778102|518696|P1|Overall Study|Withdrawal by Subject|1
162524|NCT00778102|518695|P2|Overall Study|Refused Treatment|3
162525|NCT00778102|518696|P1|Overall Study|Refused Treatment|2
162526|NCT00778102|518695|P2|Overall Study|Protocol Violation|1
162527|NCT00778102|518696|P1|Overall Study|Protocol Violation|0
162528|NCT00778102|518695|P2|Overall Study|Violation of Selection Criteria|1
162529|NCT00778102|518696|P1|Overall Study|Violation of Selection Criteria|1
162530|NCT00778102|518695|P2|Overall Study|Lost to Follow-up|0
162531|NCT00778102|518696|P1|Overall Study|Lost to Follow-up|1
162532|NCT00778102|518695|P2|Overall Study|Death|1
162533|NCT00778102|518696|P1|Overall Study|Death|1
162534|NCT00778102|518695|P2|Overall Study|Adverse Event|5
162535|NCT00778102|518696|P1|Overall Study|Adverse Event|8
162536|NCT00778258|518750|P9|Overall Study|Unspecified|0
162537|NCT00778258|518751|P8|Overall Study|Unspecified|0
162538|NCT00778258|518752|P7|Overall Study|Unspecified|1
162539|NCT00778258|518753|P6|Overall Study|Unspecified|0
162540|NCT00778258|518754|P5|Overall Study|Unspecified|0
162541|NCT00778258|518755|P4|Overall Study|Unspecified|0
162542|NCT00778258|518756|P3|Overall Study|Unspecified|0
162543|NCT00778258|518757|P2|Overall Study|Unspecified|0
162544|NCT00778258|518758|P1|Overall Study|Unspecified|0
162545|NCT00778258|518750|P9|Overall Study|Non-compliance|0
162546|NCT00778258|518751|P8|Overall Study|Non-compliance|0
162547|NCT00778258|518752|P7|Overall Study|Non-compliance|0
162548|NCT00778258|518753|P6|Overall Study|Non-compliance|0
162549|NCT00778258|518754|P5|Overall Study|Non-compliance|0
162550|NCT00778258|518755|P4|Overall Study|Non-compliance|1
162551|NCT00778258|518756|P3|Overall Study|Non-compliance|0
162552|NCT00778258|518757|P2|Overall Study|Non-compliance|0
162553|NCT00778258|518758|P1|Overall Study|Non-compliance|0
162554|NCT00778258|518750|P9|Overall Study|New Contraindication|0
162555|NCT00778258|518751|P8|Overall Study|New Contraindication|1
162556|NCT00778258|518752|P7|Overall Study|New Contraindication|0
162557|NCT00778258|518753|P6|Overall Study|New Contraindication|0
162558|NCT00778258|518754|P5|Overall Study|New Contraindication|0
162559|NCT00778258|518755|P4|Overall Study|New Contraindication|0
162560|NCT00778258|518756|P3|Overall Study|New Contraindication|0
162561|NCT00778258|518757|P2|Overall Study|New Contraindication|0
162562|NCT00778258|518758|P1|Overall Study|New Contraindication|0
162563|NCT00778258|518750|P9|Overall Study|Withdrawal by Subject|4
162564|NCT00778258|518751|P8|Overall Study|Withdrawal by Subject|12
162565|NCT00778258|518752|P7|Overall Study|Withdrawal by Subject|12
162566|NCT00778258|518753|P6|Overall Study|Withdrawal by Subject|6
162567|NCT00778258|518754|P5|Overall Study|Withdrawal by Subject|0
162568|NCT00778258|518755|P4|Overall Study|Withdrawal by Subject|2
162569|NCT00778258|518756|P3|Overall Study|Withdrawal by Subject|8
162570|NCT00778258|518757|P2|Overall Study|Withdrawal by Subject|2
162571|NCT00778258|518758|P1|Overall Study|Withdrawal by Subject|6
162572|NCT00778258|518750|P9|Overall Study|Lost to Follow-up|0
162573|NCT00778258|518751|P8|Overall Study|Lost to Follow-up|2
162574|NCT00778258|518752|P7|Overall Study|Lost to Follow-up|2
162575|NCT00778258|518753|P6|Overall Study|Lost to Follow-up|3
162576|NCT00778258|518754|P5|Overall Study|Lost to Follow-up|0
162577|NCT00778258|518755|P4|Overall Study|Lost to Follow-up|0
162578|NCT00778258|518756|P3|Overall Study|Lost to Follow-up|2
162579|NCT00778258|518757|P2|Overall Study|Lost to Follow-up|0
162580|NCT00778258|518758|P1|Overall Study|Lost to Follow-up|0
162581|NCT00778258|518750|P9|Overall Study|Adverse Event|0
162582|NCT00778258|518751|P8|Overall Study|Adverse Event|0
162583|NCT00778258|518752|P7|Overall Study|Adverse Event|0
162584|NCT00778258|518753|P6|Overall Study|Adverse Event|1
162585|NCT00778258|518754|P5|Overall Study|Adverse Event|0
162586|NCT00778258|518755|P4|Overall Study|Adverse Event|0
162587|NCT00778258|518756|P3|Overall Study|Adverse Event|0
162588|NCT00778258|518757|P2|Overall Study|Adverse Event|0
162589|NCT00778258|518758|P1|Overall Study|Adverse Event|1
162590|NCT00778336|518825|P4|3 Month Follow Up|Death|0
162591|NCT00778336|518826|P3|3 Month Follow Up|Death|2
162592|NCT00778336|518827|P2|3 Month Follow Up|Death|3
162593|NCT00778336|518828|P1|3 Month Follow Up|Death|8
162594|NCT00778336|518825|P4|3 Month Follow Up|Lost to Follow-up|0
162595|NCT00778336|518826|P3|3 Month Follow Up|Lost to Follow-up|3
162596|NCT00778336|518827|P2|3 Month Follow Up|Lost to Follow-up|20
162597|NCT00778336|518828|P1|3 Month Follow Up|Lost to Follow-up|15
162598|NCT00778336|518825|P4|Index Procedure-Discharge|Death|0
162599|NCT00778336|518826|P3|Index Procedure-Discharge|Death|2
162600|NCT00778336|518827|P2|Index Procedure-Discharge|Death|3
162601|NCT00778336|518828|P1|Index Procedure-Discharge|Death|6
162602|NCT00778375|518846|P1|Overall Study|Ineligible|3
162603|NCT00772889|518859|P3|Overall Study|Lost to Follow-up|7
162604|NCT00772889|518860|P2|Overall Study|Lost to Follow-up|6
162605|NCT00772889|518861|P1|Overall Study|Lost to Follow-up|6
162606|NCT00772889|518859|P3|Overall Study|Withdrawal by Subject|9
162607|NCT00772889|518860|P2|Overall Study|Withdrawal by Subject|8
162608|NCT00772889|518861|P1|Overall Study|Withdrawal by Subject|9
162609|NCT00772889|518859|P3|Overall Study|Adverse Event|0
162610|NCT00772889|518860|P2|Overall Study|Adverse Event|4
162611|NCT00772889|518861|P1|Overall Study|Adverse Event|7
162612|NCT00772928|518920|P2|Overall Study|Did not receive vaccine|1
162613|NCT00772928|518921|P1|Overall Study|Did not receive vaccine|0
162614|NCT00772928|518920|P2|Overall Study|Withdrawal by Subject|22
162615|NCT00772928|518921|P1|Overall Study|Withdrawal by Subject|25
162616|NCT00772928|518920|P2|Overall Study|Protocol Violation|12
162617|NCT00772928|518921|P1|Overall Study|Protocol Violation|10
162618|NCT00772928|518920|P2|Overall Study|Lost to Follow-up|6
162619|NCT00772928|518921|P1|Overall Study|Lost to Follow-up|9
162620|NCT00778622|518934|P3|Overall Study|unspecified|1
162621|NCT00778622|518935|P2|Overall Study|unspecified|0
162622|NCT00778622|518936|P1|Overall Study|unspecified|1
162623|NCT00778622|518934|P3|Overall Study|immigration|0
162624|NCT00778622|518935|P2|Overall Study|immigration|0
162625|NCT00778622|518936|P1|Overall Study|immigration|1
162626|NCT00778622|518934|P3|Overall Study|Lack of Efficacy|0
162627|NCT00778622|518935|P2|Overall Study|Lack of Efficacy|0
162628|NCT00778622|518936|P1|Overall Study|Lack of Efficacy|2
162629|NCT00778622|518934|P3|Overall Study|Protocol Violation|0
162630|NCT00778622|518935|P2|Overall Study|Protocol Violation|3
162631|NCT00778622|518936|P1|Overall Study|Protocol Violation|0
162632|NCT00778622|518934|P3|Overall Study|Lost to Follow-up|2
162633|NCT00778622|518935|P2|Overall Study|Lost to Follow-up|3
162634|NCT00778622|518936|P1|Overall Study|Lost to Follow-up|3
162635|NCT00778622|518934|P3|Overall Study|Withdrawal by Subject|5
162636|NCT00778622|518935|P2|Overall Study|Withdrawal by Subject|5
162637|NCT00778622|518936|P1|Overall Study|Withdrawal by Subject|4
162638|NCT00778622|518934|P3|Overall Study|Adverse Event|7
162639|NCT00778622|518935|P2|Overall Study|Adverse Event|4
162640|NCT00778622|518936|P1|Overall Study|Adverse Event|5
162641|NCT00778817|518998|P1|Overall Study|Withdrawal by Subject|2
162642|NCT00778817|518998|P1|Overall Study|Adverse Event|2
162643|NCT00778830|519015|P2|Overall Study|Ongoing at data cut-off|1
162644|NCT00778830|519016|P1|Overall Study|Ongoing at data cut-off|0
162645|NCT00778895|519035|P3|ESFU Phase|Unspecified|0
162646|NCT00778895|519036|P2|ESFU Phase|Unspecified|0
162647|NCT00778895|519037|P1|ESFU Phase|Unspecified|2
162648|NCT00778895|519035|P3|ESFU Phase|Lost to Follow-up|2
162649|NCT00778895|519036|P2|ESFU Phase|Lost to Follow-up|7
162650|NCT00778895|519037|P1|ESFU Phase|Lost to Follow-up|6
162651|NCT00778895|519035|P3|ESFU Phase|Withdrawal by Subject|0
162652|NCT00778895|519036|P2|ESFU Phase|Withdrawal by Subject|4
162653|NCT00778895|519037|P1|ESFU Phase|Withdrawal by Subject|1
162654|NCT00778895|519035|P3|ESFU Phase|Adverse Event|0
162655|NCT00778895|519036|P2|ESFU Phase|Adverse Event|1
162656|NCT00778895|519037|P1|ESFU Phase|Adverse Event|2
162657|NCT00778895|519035|P3|Active Phase|Unspecified|0
162658|NCT00778895|519036|P2|Active Phase|Unspecified|0
162659|NCT00778895|519037|P1|Active Phase|Unspecified|2
162660|NCT00778895|519035|P3|Active Phase|Lost to Follow-up|0
162661|NCT00778895|519036|P2|Active Phase|Lost to Follow-up|1
162662|NCT00778895|519037|P1|Active Phase|Lost to Follow-up|1
162663|NCT00778895|519035|P3|Active Phase|Withdrawal by Subject|0
162664|NCT00778895|519036|P2|Active Phase|Withdrawal by Subject|4
162665|NCT00778895|519037|P1|Active Phase|Withdrawal by Subject|1
162666|NCT00778895|519035|P3|Active Phase|Adverse Event|0
162667|NCT00778895|519036|P2|Active Phase|Adverse Event|1
162668|NCT00778895|519037|P1|Active Phase|Adverse Event|3
162669|NCT00778921|519078|P3|Overall Study|Not treated|2
162670|NCT00778921|519079|P2|Overall Study|Not treated|2
162671|NCT00778921|519080|P1|Overall Study|Not treated|0
162672|NCT00778921|519078|P3|Overall Study|Protocol Violation|2
162673|NCT00778921|519079|P2|Overall Study|Protocol Violation|0
162674|NCT00778921|519080|P1|Overall Study|Protocol Violation|3
162675|NCT00778921|519078|P3|Overall Study|Administrative Problems|0
162676|NCT00778921|519079|P2|Overall Study|Administrative Problems|2
162677|NCT00778921|519080|P1|Overall Study|Administrative Problems|1
162678|NCT00778921|519078|P3|Overall Study|Lost to Follow-up|1
162679|NCT00778921|519079|P2|Overall Study|Lost to Follow-up|2
162680|NCT00778921|519080|P1|Overall Study|Lost to Follow-up|0
162681|NCT00778921|519078|P3|Overall Study|Patient withdrew request|6
162682|NCT00778921|519079|P2|Overall Study|Patient withdrew request|1
162683|NCT00778921|519080|P1|Overall Study|Patient withdrew request|3
162684|NCT00778921|519078|P3|Overall Study|Patient No Longer Requires Study Drug|0
162685|NCT00778921|519079|P2|Overall Study|Patient No Longer Requires Study Drug|1
162686|NCT00778921|519080|P1|Overall Study|Patient No Longer Requires Study Drug|0
162687|NCT00778921|519078|P3|Overall Study|Unsatisfactory therapeutic response|1
162688|NCT00778921|519079|P2|Overall Study|Unsatisfactory therapeutic response|1
162689|NCT00778921|519080|P1|Overall Study|Unsatisfactory therapeutic response|1
162690|NCT00778921|519078|P3|Overall Study|Abnormal Test Procedure Result(s)|2
162691|NCT00778921|519079|P2|Overall Study|Abnormal Test Procedure Result(s)|0
162692|NCT00778921|519080|P1|Overall Study|Abnormal Test Procedure Result(s)|0
162693|NCT00778921|519078|P3|Overall Study|Abnormal Laboratory Value(s)|0
162694|NCT00778921|519079|P2|Overall Study|Abnormal Laboratory Value(s)|0
162695|NCT00778921|519080|P1|Overall Study|Abnormal Laboratory Value(s)|1
162696|NCT00778921|519078|P3|Overall Study|Adverse Event|14
162697|NCT00778921|519079|P2|Overall Study|Adverse Event|10
162698|NCT00778921|519080|P1|Overall Study|Adverse Event|9
162699|NCT00780416|519135|P2|Overall Study|Withdrawal by Subject|6
162700|NCT00780416|519136|P1|Overall Study|Withdrawal by Subject|8
162701|NCT00780416|519135|P2|Overall Study|Protocol Violation|0
162702|NCT00780416|519136|P1|Overall Study|Protocol Violation|1
162703|NCT00780416|519135|P2|Overall Study|Physician Decision|3
162704|NCT00780416|519136|P1|Overall Study|Physician Decision|3
162705|NCT00780910|519215|P1|Overall Study|Adverse Event|2
162706|NCT00781274|519230|P1|Overall Study|Withdrawal by Subject|2
162707|NCT00781326|519234|P1|Phase I|Physician Decision|2
162708|NCT00781326|519234|P1|Phase I|Withdrawal by Subject|1
162709|NCT00781326|519234|P1|Phase I|Adverse Event|1
162710|NCT00781365|519240|P2|Overall Study|Language barrier|0
162711|NCT00781365|519241|P1|Overall Study|Language barrier|1
162712|NCT00781365|519240|P2|Overall Study|Did Not Attend Visit|28
162713|NCT00781365|519241|P1|Overall Study|Did Not Attend Visit|20
162714|NCT00781365|519240|P2|Overall Study|Withdrawal by Subject|8
162715|NCT00781365|519241|P1|Overall Study|Withdrawal by Subject|13
162716|NCT00781391|519254|P3|Overall Study|Lost to Follow-up|1
162717|NCT00781391|519255|P2|Overall Study|Lost to Follow-up|0
162718|NCT00781391|519256|P1|Overall Study|Lost to Follow-up|0
162719|NCT00781391|519254|P3|Overall Study|Withdrawal by Subject|25
162720|NCT00781391|519255|P2|Overall Study|Withdrawal by Subject|37
162721|NCT00781391|519256|P1|Overall Study|Withdrawal by Subject|47
162722|NCT00781391|519254|P3|Overall Study|Death|706
162723|NCT00781391|519255|P2|Overall Study|Death|730
162724|NCT00781391|519256|P1|Overall Study|Death|789
162725|NCT00781391|519254|P3|Overall Study|Protocol Violation|20
162726|NCT00781391|519255|P2|Overall Study|Protocol Violation|17
162727|NCT00781391|519256|P1|Overall Study|Protocol Violation|19
162728|NCT00781391|519254|P3|Overall Study|never received study drug|32
162729|NCT00781391|519255|P2|Overall Study|never received study drug|23
162730|NCT00781391|519256|P1|Overall Study|never received study drug|24
162731|NCT00781456|519290|P2|Overall Study|Other Reason, Unknown|1
162732|NCT00781456|519291|P1|Overall Study|Other Reason, Unknown|0
162733|NCT00781456|519290|P2|Overall Study|Lost to Follow-up|5
162734|NCT00781456|519291|P1|Overall Study|Lost to Follow-up|10
162735|NCT00781456|519290|P2|Overall Study|Noncompliance With Protocol|1
162736|NCT00781456|519291|P1|Overall Study|Noncompliance With Protocol|1
162737|NCT00781456|519290|P2|Overall Study|Protocol Violation|1
162738|NCT00781456|519291|P1|Overall Study|Protocol Violation|4
162739|NCT00781456|519290|P2|Overall Study|Withdrawal by Subject|5
162740|NCT00781456|519291|P1|Overall Study|Withdrawal by Subject|3
162741|NCT00781456|519290|P2|Overall Study|Adverse Event|3
162742|NCT00781456|519291|P1|Overall Study|Adverse Event|3
162743|NCT00781599|519324|P2|Overall Study|Lost to Follow-up|4
162744|NCT00781599|519325|P1|Overall Study|Lost to Follow-up|7
162745|NCT00781859|519339|P2|Overall Study|Death|0
162746|NCT00781859|519340|P1|Overall Study|Death|3
162747|NCT00781859|519339|P2|Overall Study|Lost to Follow-up|3
162748|NCT00781859|519340|P1|Overall Study|Lost to Follow-up|6
162749|NCT00781859|519339|P2|Overall Study|Withdrawal by Subject|4
162750|NCT00781859|519340|P1|Overall Study|Withdrawal by Subject|8
162751|NCT00781859|519339|P2|Overall Study|Adverse Event|2
162752|NCT00781859|519340|P1|Overall Study|Adverse Event|2
162753|NCT00781937|519350|P2|Follow up Period (Week 56-68)|Unclassified|4
162754|NCT00781937|519351|P1|Follow up Period (Week 56-68)|Unclassified|5
162755|NCT00781937|519350|P2|Follow up Period (Week 56-68)|Protocol Violation|1
162756|NCT00781937|519351|P1|Follow up Period (Week 56-68)|Protocol Violation|1
162757|NCT00781937|519350|P2|Main Trial Period Through Week 56|Unclassified|15
162758|NCT00781937|519351|P1|Main Trial Period Through Week 56|Unclassified|10
162759|NCT00781937|519350|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
162760|NCT00781937|519351|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
162761|NCT00781937|519350|P2|Main Trial Period Through Week 56|Protocol Violation|5
162762|NCT00781937|519351|P1|Main Trial Period Through Week 56|Protocol Violation|8
162763|NCT00781937|519350|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
162764|NCT00781937|519351|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
162765|NCT00781937|519350|P2|Main Trial Period Through Week 56|Adverse Event|18
162766|NCT00781937|519351|P1|Main Trial Period Through Week 56|Adverse Event|18
162767|NCT00781963|519421|P3|Overall Study|Refused follow-up|0
162768|NCT00781963|519422|P2|Overall Study|Refused follow-up|5
162769|NCT00781963|519423|P1|Overall Study|Refused follow-up|4
162770|NCT00781963|519421|P3|Overall Study|Withdrawal by Subject|1
162771|NCT00781963|519422|P2|Overall Study|Withdrawal by Subject|3
162772|NCT00781963|519423|P1|Overall Study|Withdrawal by Subject|0
162773|NCT00781963|519421|P3|Overall Study|Lost to Follow-up|1
162774|NCT00781963|519422|P2|Overall Study|Lost to Follow-up|1
162775|NCT00781963|519423|P1|Overall Study|Lost to Follow-up|1
162776|NCT00781963|519421|P3|Overall Study|Death|0
162777|NCT00781963|519422|P2|Overall Study|Death|0
162778|NCT00781963|519423|P1|Overall Study|Death|3
162779|NCT00782067|519431|P1|Overall Study|Disease progression|44
162780|NCT00782067|519431|P1|Overall Study|Withdrawal by Subject|10
162781|NCT00782067|519431|P1|Overall Study|Adverse Event|28
162782|NCT00782067|519431|P1|Overall Study|Death|8
162783|NCT00782067|519431|P1|Overall Study|Protocol deviation|2
162784|NCT00782067|519431|P1|Overall Study|Lost to Follow-up|1
162785|NCT00782067|519431|P1|Overall Study|Administrative problems|1
162786|NCT00782067|519431|P1|Overall Study|Abnormal procedure results|1
162787|NCT00782171|519440|P2|Overall Study|not eligible|6
162788|NCT00782171|519441|P1|Overall Study|not eligible|8
162789|NCT00782171|519440|P2|Overall Study|others|9
162790|NCT00782171|519441|P1|Overall Study|others|7
162791|NCT00782171|519440|P2|Overall Study|complications|1
162792|NCT00782171|519441|P1|Overall Study|complications|3
162793|NCT00782171|519440|P2|Overall Study|Withdrawal by Subject|1
162794|NCT00782171|519441|P1|Overall Study|Withdrawal by Subject|2
162795|NCT00782171|519440|P2|Overall Study|Lost to Follow-up|2
162796|NCT00782171|519441|P1|Overall Study|Lost to Follow-up|2
162797|NCT00782184|519475|P2|Overall Study|Withdrawal by Subject|2
162798|NCT00782184|519476|P1|Overall Study|Withdrawal by Subject|3
162799|NCT00782184|519475|P2|Overall Study|Protocol Violation|1
162800|NCT00782184|519476|P1|Overall Study|Protocol Violation|0
162801|NCT00782184|519475|P2|Overall Study|Adverse Event|2
162802|NCT00782184|519476|P1|Overall Study|Adverse Event|1
162803|NCT00782210|519514|P3|Overall Study|Other reason not described above|3
162804|NCT00782210|519515|P2|Overall Study|Other reason not described above|2
162805|NCT00782210|519516|P1|Overall Study|Other reason not described above|3
162806|NCT00782210|519514|P3|Overall Study|Lack of Efficacy|1
162807|NCT00782210|519515|P2|Overall Study|Lack of Efficacy|4
162808|NCT00782210|519516|P1|Overall Study|Lack of Efficacy|13
162809|NCT00782210|519514|P3|Overall Study|Non compliance with protocol|2
162810|NCT00782210|519515|P2|Overall Study|Non compliance with protocol|3
162811|NCT00782210|519516|P1|Overall Study|Non compliance with protocol|0
162812|NCT00782210|519514|P3|Overall Study|Withdrawal by Subject|11
162813|NCT00782210|519515|P2|Overall Study|Withdrawal by Subject|8
162814|NCT00782210|519516|P1|Overall Study|Withdrawal by Subject|11
162815|NCT00782210|519514|P3|Overall Study|Lost to Follow-up|2
162816|NCT00782210|519515|P2|Overall Study|Lost to Follow-up|1
162817|NCT00782210|519516|P1|Overall Study|Lost to Follow-up|2
162818|NCT00782210|519514|P3|Overall Study|Adverse Event|16
162819|NCT00782210|519515|P2|Overall Study|Adverse Event|17
162820|NCT00782210|519516|P1|Overall Study|Adverse Event|21
162821|NCT00782340|519757|P3|Open Label Titration|Randomized in error|0
162822|NCT00782340|519758|P2|Open Label Titration|Randomized in error|0
162823|NCT00782340|519759|P1|Open Label Titration|Randomized in error|6
162824|NCT00782340|519757|P3|Open Label Titration|Lost to Follow-up|0
162825|NCT00782340|519758|P2|Open Label Titration|Lost to Follow-up|0
162826|NCT00782340|519759|P1|Open Label Titration|Lost to Follow-up|5
162827|NCT00782340|519757|P3|Open Label Titration|Did not meet responder criteria|0
162828|NCT00782340|519758|P2|Open Label Titration|Did not meet responder criteria|0
162829|NCT00782340|519759|P1|Open Label Titration|Did not meet responder criteria|2
162830|NCT00782340|519757|P3|Open Label Titration|Enrollment capped|0
162831|NCT00782340|519758|P2|Open Label Titration|Enrollment capped|0
162832|NCT00782340|519759|P1|Open Label Titration|Enrollment capped|16
162833|NCT00782340|519757|P3|Open Label Titration|Withdrawal by Subject|0
162834|NCT00782340|519758|P2|Open Label Titration|Withdrawal by Subject|0
162835|NCT00782340|519759|P1|Open Label Titration|Withdrawal by Subject|5
162836|NCT00782340|519757|P3|Open Label Titration|Protocol Violation|0
162837|NCT00782340|519758|P2|Open Label Titration|Protocol Violation|0
162838|NCT00782340|519759|P1|Open Label Titration|Protocol Violation|5
162839|NCT00782340|519757|P3|Open Label Titration|Treatment failure|0
162840|NCT00782340|519758|P2|Open Label Titration|Treatment failure|0
162841|NCT00782340|519759|P1|Open Label Titration|Treatment failure|50
162842|NCT00782340|519757|P3|Open Label Titration|Adverse Event|0
162843|NCT00782340|519758|P2|Open Label Titration|Adverse Event|0
162844|NCT00782340|519759|P1|Open Label Titration|Adverse Event|12
162845|NCT00782418|519796|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
162846|NCT00782418|519797|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
162847|NCT00782418|519798|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
162848|NCT00782418|519799|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
162849|NCT00782418|519800|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
162850|NCT00782418|519801|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
162851|NCT00782418|519802|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
162852|NCT00782418|519796|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
162853|NCT00782418|519797|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
162854|NCT00782418|519798|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
162855|NCT00782418|519799|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
162856|NCT00782418|519800|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
162857|NCT00782418|519801|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
162858|NCT00782418|519802|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
162859|NCT00782483|519822|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
162860|NCT00782496|519828|P2|Overall Study|Lost to Follow-up|15
162861|NCT00782496|519829|P1|Overall Study|Lost to Follow-up|14
162862|NCT00782509|519839|P3|Overall Study|Lack of Efficacy|2
162863|NCT00782509|519840|P2|Overall Study|Lack of Efficacy|5
162864|NCT00782509|519841|P1|Overall Study|Lack of Efficacy|10
162865|NCT00782509|519839|P3|Overall Study|Other reasons not stated above|3
162866|NCT00782509|519840|P2|Overall Study|Other reasons not stated above|2
162867|NCT00782509|519841|P1|Overall Study|Other reasons not stated above|5
162868|NCT00782509|519839|P3|Overall Study|Non compliance with protocol|0
162869|NCT00782509|519840|P2|Overall Study|Non compliance with protocol|0
162870|NCT00782509|519841|P1|Overall Study|Non compliance with protocol|2
162871|NCT00782509|519839|P3|Overall Study|Withdrawal by Subject|8
162872|NCT00782509|519840|P2|Overall Study|Withdrawal by Subject|5
162873|NCT00782509|519841|P1|Overall Study|Withdrawal by Subject|3
162874|NCT00782509|519839|P3|Overall Study|Lost to Follow-up|3
162875|NCT00782509|519840|P2|Overall Study|Lost to Follow-up|2
162876|NCT00782509|519841|P1|Overall Study|Lost to Follow-up|1
162877|NCT00782509|519839|P3|Overall Study|Adverse Event|20
162878|NCT00782509|519840|P2|Overall Study|Adverse Event|10
162879|NCT00782509|519841|P1|Overall Study|Adverse Event|20
162880|NCT00782626|520032|P1|Overall Study|Other Complicating Disease|1
162881|NCT00782626|520032|P1|Overall Study|Progressive Disease|5
162882|NCT00782626|520032|P1|Overall Study|Adverse Event|1
162883|NCT00782717|520057|P2|Overall Study|Exited in error|2
162884|NCT00782717|520058|P1|Overall Study|Exited in error|0
162885|NCT00782717|520057|P2|Overall Study|Did not meet entrance criteria|3
162886|NCT00782717|520058|P1|Overall Study|Did not meet entrance criteria|1
162887|NCT00782717|520057|P2|Overall Study|Enrollment close prior to surgery|0
162888|NCT00782717|520058|P1|Overall Study|Enrollment close prior to surgery|1
162889|NCT00782717|520057|P2|Overall Study|Treatment failure|14
162890|NCT00782717|520058|P1|Overall Study|Treatment failure|3
162891|NCT00782717|520057|P2|Overall Study|Noncompliance|1
162892|NCT00782717|520058|P1|Overall Study|Noncompliance|2
162893|NCT00782717|520057|P2|Overall Study|Patient decision unrelated to AE|3
162894|NCT00782717|520058|P1|Overall Study|Patient decision unrelated to AE|6
162895|NCT00782717|520057|P2|Overall Study|Adverse Event|5
162896|NCT00782717|520058|P1|Overall Study|Adverse Event|2
162897|NCT00775983|520101|P2|Overall Study|Protocol Violation|2
162898|NCT00775983|520102|P1|Overall Study|Protocol Violation|1
162899|NCT00776009|520116|P6|Period 3: Third Intervention|Withdrawal by Subject|0
162900|NCT00776009|520117|P5|Period 3: Third Intervention|Withdrawal by Subject|0
162901|NCT00776009|520118|P4|Period 3: Third Intervention|Withdrawal by Subject|0
162902|NCT00776009|520119|P3|Period 3: Third Intervention|Withdrawal by Subject|0
162903|NCT00776009|520120|P2|Period 3: Third Intervention|Withdrawal by Subject|0
162904|NCT00776009|520121|P1|Period 3: Third Intervention|Withdrawal by Subject|1
162905|NCT00776009|520116|P6|Period 2: Second Intervention|Protocol Violation|0
162906|NCT00776009|520117|P5|Period 2: Second Intervention|Protocol Violation|0
162907|NCT00776009|520118|P4|Period 2: Second Intervention|Protocol Violation|0
162908|NCT00776009|520119|P3|Period 2: Second Intervention|Protocol Violation|1
162909|NCT00776009|520120|P2|Period 2: Second Intervention|Protocol Violation|0
162910|NCT00776009|520121|P1|Period 2: Second Intervention|Protocol Violation|1
162911|NCT00776009|520116|P6|Period 2: Second Intervention|Withdrawal by Subject|1
162912|NCT00776009|520117|P5|Period 2: Second Intervention|Withdrawal by Subject|0
162913|NCT00776009|520118|P4|Period 2: Second Intervention|Withdrawal by Subject|0
162914|NCT00776009|520119|P3|Period 2: Second Intervention|Withdrawal by Subject|0
162915|NCT00776009|520120|P2|Period 2: Second Intervention|Withdrawal by Subject|0
162916|NCT00776009|520121|P1|Period 2: Second Intervention|Withdrawal by Subject|0
162917|NCT00776009|520116|P6|Period 1: First Intervention|Protocol Violation|0
162918|NCT00776009|520117|P5|Period 1: First Intervention|Protocol Violation|1
162919|NCT00776009|520118|P4|Period 1: First Intervention|Protocol Violation|0
162920|NCT00776009|520119|P3|Period 1: First Intervention|Protocol Violation|0
162921|NCT00776009|520120|P2|Period 1: First Intervention|Protocol Violation|1
162922|NCT00776009|520121|P1|Period 1: First Intervention|Protocol Violation|0
162923|NCT00776009|520116|P6|Period 1: First Intervention|Withdrawal by Subject|0
162924|NCT00776009|520117|P5|Period 1: First Intervention|Withdrawal by Subject|1
162925|NCT00776009|520118|P4|Period 1: First Intervention|Withdrawal by Subject|0
162926|NCT00776009|520119|P3|Period 1: First Intervention|Withdrawal by Subject|1
162927|NCT00776009|520120|P2|Period 1: First Intervention|Withdrawal by Subject|0
162928|NCT00776009|520121|P1|Period 1: First Intervention|Withdrawal by Subject|0
162929|NCT00776100|520143|P2|Overall Study|Disease Progression|0
162930|NCT00776100|520144|P1|Overall Study|Disease Progression|1
162931|NCT00782834|520193|P1|Treatment Phase|fibrous tumor not GIST|1
162932|NCT00783094|520201|P3|Open-Label Extension Period|Lack of Efficacy|0
162933|NCT00783094|520202|P2|Open-Label Extension Period|Lack of Efficacy|4
162934|NCT00783094|520203|P1|Open-Label Extension Period|Lack of Efficacy|1
162935|NCT00783094|520201|P3|Open-Label Extension Period|Physician Decision|3
162936|NCT00783094|520202|P2|Open-Label Extension Period|Physician Decision|2
162937|NCT00783094|520203|P1|Open-Label Extension Period|Physician Decision|4
162938|NCT00783094|520201|P3|Open-Label Extension Period|Withdrawal by Subject|3
162939|NCT00783094|520202|P2|Open-Label Extension Period|Withdrawal by Subject|1
162940|NCT00783094|520203|P1|Open-Label Extension Period|Withdrawal by Subject|1
162941|NCT00783094|520201|P3|Open-Label Extension Period|Protocol Violation|7
162942|NCT00783094|520202|P2|Open-Label Extension Period|Protocol Violation|5
162943|NCT00783094|520203|P1|Open-Label Extension Period|Protocol Violation|4
162944|NCT00783094|520201|P3|Open-Label Extension Period|Death|1
162945|NCT00783094|520202|P2|Open-Label Extension Period|Death|0
162946|NCT00783094|520203|P1|Open-Label Extension Period|Death|0
162947|NCT00783094|520201|P3|Open-Label Extension Period|Adverse Event|16
162948|NCT00783094|520202|P2|Open-Label Extension Period|Adverse Event|7
162949|NCT00783094|520203|P1|Open-Label Extension Period|Adverse Event|12
162950|NCT00783094|520201|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
162951|NCT00783094|520202|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
162952|NCT00783094|520203|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
162953|NCT00783094|520201|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
162954|NCT00783094|520202|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
162955|NCT00783094|520203|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
162956|NCT00783094|520201|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
162957|NCT00783094|520202|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
162958|NCT00783094|520203|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
162959|NCT00783094|520201|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
162960|NCT00783094|520202|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
162961|NCT00783094|520203|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
162962|NCT00783094|520201|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
162963|NCT00783094|520202|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
162964|NCT00783094|520203|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
162965|NCT00783692|520299|P7|Maintenance Phase|Other|1
162966|NCT00783692|520300|P6|Maintenance Phase|Other|1
162967|NCT00783692|520301|P5|Maintenance Phase|Other|0
162968|NCT00783692|520302|P4|Maintenance Phase|Other|1
162969|NCT00783692|520303|P3|Maintenance Phase|Other|0
162970|NCT00783692|520304|P2|Maintenance Phase|Other|0
162971|NCT00783692|520305|P1|Maintenance Phase|Other|0
162972|NCT00783692|520299|P7|Maintenance Phase|Lost to Follow-up|5
162973|NCT00783692|520300|P6|Maintenance Phase|Lost to Follow-up|2
162974|NCT00783692|520301|P5|Maintenance Phase|Lost to Follow-up|3
162975|NCT00783692|520302|P4|Maintenance Phase|Lost to Follow-up|1
162976|NCT00783692|520303|P3|Maintenance Phase|Lost to Follow-up|0
162977|NCT00783692|520304|P2|Maintenance Phase|Lost to Follow-up|0
162978|NCT00783692|520305|P1|Maintenance Phase|Lost to Follow-up|2
162979|NCT00783692|520299|P7|Maintenance Phase|Withdrawal by Subject|24
162980|NCT00783692|520300|P6|Maintenance Phase|Withdrawal by Subject|9
162981|NCT00783692|520301|P5|Maintenance Phase|Withdrawal by Subject|6
162982|NCT00783692|520302|P4|Maintenance Phase|Withdrawal by Subject|7
162983|NCT00783692|520303|P3|Maintenance Phase|Withdrawal by Subject|0
162984|NCT00783692|520304|P2|Maintenance Phase|Withdrawal by Subject|0
162985|NCT00783692|520305|P1|Maintenance Phase|Withdrawal by Subject|7
162986|NCT00783692|520299|P7|Maintenance Phase|Lack of Efficacy|177
162987|NCT00783692|520300|P6|Maintenance Phase|Lack of Efficacy|48
162988|NCT00783692|520301|P5|Maintenance Phase|Lack of Efficacy|58
162989|NCT00783692|520302|P4|Maintenance Phase|Lack of Efficacy|64
162990|NCT00783692|520303|P3|Maintenance Phase|Lack of Efficacy|0
162991|NCT00783692|520304|P2|Maintenance Phase|Lack of Efficacy|0
162992|NCT00783692|520305|P1|Maintenance Phase|Lack of Efficacy|79
162993|NCT00783692|520299|P7|Maintenance Phase|Protocol Violation|4
162994|NCT00783692|520300|P6|Maintenance Phase|Protocol Violation|3
162995|NCT00783692|520301|P5|Maintenance Phase|Protocol Violation|2
162996|NCT00783692|520302|P4|Maintenance Phase|Protocol Violation|1
162997|NCT00783692|520303|P3|Maintenance Phase|Protocol Violation|0
162998|NCT00783692|520304|P2|Maintenance Phase|Protocol Violation|0
162999|NCT00783692|520305|P1|Maintenance Phase|Protocol Violation|0
163000|NCT00783692|520299|P7|Maintenance Phase|Adverse Event|38
163001|NCT00783692|520300|P6|Maintenance Phase|Adverse Event|9
163002|NCT00783692|520301|P5|Maintenance Phase|Adverse Event|12
163003|NCT00783692|520302|P4|Maintenance Phase|Adverse Event|15
163004|NCT00783692|520303|P3|Maintenance Phase|Adverse Event|0
163005|NCT00783692|520304|P2|Maintenance Phase|Adverse Event|0
163006|NCT00783692|520305|P1|Maintenance Phase|Adverse Event|7
163007|NCT00783692|520299|P7|Induction Phase|Other|0
163008|NCT00783692|520300|P6|Induction Phase|Other|0
163009|NCT00783692|520301|P5|Induction Phase|Other|0
163010|NCT00783692|520302|P4|Induction Phase|Other|0
163011|NCT00783692|520303|P3|Induction Phase|Other|2
163012|NCT00783692|520304|P2|Induction Phase|Other|0
163013|NCT00783692|520305|P1|Induction Phase|Other|0
163014|NCT00783692|520299|P7|Induction Phase|Lost to Follow-up|0
163015|NCT00783692|520300|P6|Induction Phase|Lost to Follow-up|0
163016|NCT00783692|520301|P5|Induction Phase|Lost to Follow-up|0
163017|NCT00783692|520302|P4|Induction Phase|Lost to Follow-up|0
163018|NCT00783692|520303|P3|Induction Phase|Lost to Follow-up|3
163019|NCT00783692|520304|P2|Induction Phase|Lost to Follow-up|0
163020|NCT00783692|520305|P1|Induction Phase|Lost to Follow-up|0
163021|NCT00783692|520299|P7|Induction Phase|Withdrawal by Subject|0
163022|NCT00783692|520300|P6|Induction Phase|Withdrawal by Subject|0
163023|NCT00783692|520301|P5|Induction Phase|Withdrawal by Subject|0
163024|NCT00783692|520302|P4|Induction Phase|Withdrawal by Subject|0
163025|NCT00783692|520303|P3|Induction Phase|Withdrawal by Subject|16
163026|NCT00783692|520304|P2|Induction Phase|Withdrawal by Subject|9
163027|NCT00783692|520305|P1|Induction Phase|Withdrawal by Subject|3
163028|NCT00783692|520299|P7|Induction Phase|Lack of Efficacy|0
163029|NCT00783692|520300|P6|Induction Phase|Lack of Efficacy|0
163030|NCT00783692|520301|P5|Induction Phase|Lack of Efficacy|0
163031|NCT00783692|520302|P4|Induction Phase|Lack of Efficacy|0
163032|NCT00783692|520303|P3|Induction Phase|Lack of Efficacy|28
163033|NCT00783692|520304|P2|Induction Phase|Lack of Efficacy|3
163034|NCT00783692|520305|P1|Induction Phase|Lack of Efficacy|1
163035|NCT00783692|520299|P7|Induction Phase|Protocol Violation|0
163036|NCT00783692|520300|P6|Induction Phase|Protocol Violation|0
163037|NCT00783692|520301|P5|Induction Phase|Protocol Violation|0
163038|NCT00783692|520302|P4|Induction Phase|Protocol Violation|0
163039|NCT00783692|520303|P3|Induction Phase|Protocol Violation|1
163040|NCT00783692|520304|P2|Induction Phase|Protocol Violation|0
163041|NCT00783692|520305|P1|Induction Phase|Protocol Violation|0
163042|NCT00783692|520299|P7|Induction Phase|Adverse Event|0
163043|NCT00783692|520300|P6|Induction Phase|Adverse Event|0
163044|NCT00783692|520301|P5|Induction Phase|Adverse Event|0
163045|NCT00783692|520302|P4|Induction Phase|Adverse Event|0
163046|NCT00783692|520303|P3|Induction Phase|Adverse Event|24
163047|NCT00783692|520304|P2|Induction Phase|Adverse Event|9
163048|NCT00783692|520305|P1|Induction Phase|Adverse Event|7
163049|NCT00783705|520330|P2|Overall Study|Lost to Follow-up|3
163050|NCT00783705|520331|P1|Overall Study|Lost to Follow-up|1
163051|NCT00783705|520330|P2|Overall Study|Withdrawal by Subject|2
163052|NCT00783705|520331|P1|Overall Study|Withdrawal by Subject|3
163053|NCT00783705|520330|P2|Overall Study|Adverse Event|0
163054|NCT00783705|520331|P1|Overall Study|Adverse Event|2
163055|NCT00783718|520376|P7|Maintenance Phase|Lost to Follow-up|2
163056|NCT00783718|520377|P6|Maintenance Phase|Lost to Follow-up|0
163057|NCT00783718|520378|P5|Maintenance Phase|Lost to Follow-up|2
163058|NCT00783718|520379|P4|Maintenance Phase|Lost to Follow-up|0
163059|NCT00783718|520380|P3|Maintenance Phase|Lost to Follow-up|0
163060|NCT00783718|520381|P2|Maintenance Phase|Lost to Follow-up|0
163061|NCT00783718|520382|P1|Maintenance Phase|Lost to Follow-up|3
163062|NCT00783718|520376|P7|Maintenance Phase|Withdrawal by Subject|20
163063|NCT00783718|520377|P6|Maintenance Phase|Withdrawal by Subject|2
163064|NCT00783718|520378|P5|Maintenance Phase|Withdrawal by Subject|5
163065|NCT00783718|520379|P4|Maintenance Phase|Withdrawal by Subject|2
163066|NCT00783718|520380|P3|Maintenance Phase|Withdrawal by Subject|0
163067|NCT00783718|520381|P2|Maintenance Phase|Withdrawal by Subject|0
163068|NCT00783718|520382|P1|Maintenance Phase|Withdrawal by Subject|6
163069|NCT00783718|520376|P7|Maintenance Phase|Lack of Efficacy|155
163070|NCT00783718|520377|P6|Maintenance Phase|Lack of Efficacy|33
163071|NCT00783718|520378|P5|Maintenance Phase|Lack of Efficacy|31
163072|NCT00783718|520379|P4|Maintenance Phase|Lack of Efficacy|61
163073|NCT00783718|520380|P3|Maintenance Phase|Lack of Efficacy|0
163074|NCT00783718|520381|P2|Maintenance Phase|Lack of Efficacy|0
163075|NCT00783718|520382|P1|Maintenance Phase|Lack of Efficacy|83
163076|NCT00783718|520376|P7|Maintenance Phase|Protocol Violation|2
163077|NCT00783718|520377|P6|Maintenance Phase|Protocol Violation|0
163078|NCT00783718|520378|P5|Maintenance Phase|Protocol Violation|0
163079|NCT00783718|520379|P4|Maintenance Phase|Protocol Violation|0
163080|NCT00783718|520380|P3|Maintenance Phase|Protocol Violation|0
163081|NCT00783718|520381|P2|Maintenance Phase|Protocol Violation|0
163082|NCT00783718|520382|P1|Maintenance Phase|Protocol Violation|1
163083|NCT00783718|520376|P7|Maintenance Phase|Adverse Event|16
163084|NCT00783718|520377|P6|Maintenance Phase|Adverse Event|6
163085|NCT00783718|520378|P5|Maintenance Phase|Adverse Event|7
163086|NCT00783718|520379|P4|Maintenance Phase|Adverse Event|15
163087|NCT00783718|520380|P3|Maintenance Phase|Adverse Event|0
163088|NCT00783718|520381|P2|Maintenance Phase|Adverse Event|0
163089|NCT00783718|520382|P1|Maintenance Phase|Adverse Event|12
163090|NCT00783718|520376|P7|Induction Phase|Lost to Follow-up|0
163091|NCT00783718|520377|P6|Induction Phase|Lost to Follow-up|0
163092|NCT00783718|520378|P5|Induction Phase|Lost to Follow-up|0
163093|NCT00783718|520379|P4|Induction Phase|Lost to Follow-up|0
163094|NCT00783718|520380|P3|Induction Phase|Lost to Follow-up|1
163095|NCT00783718|520381|P2|Induction Phase|Lost to Follow-up|0
163096|NCT00783718|520382|P1|Induction Phase|Lost to Follow-up|1
163097|NCT00783718|520376|P7|Induction Phase|Withdrawal by Subject|0
163098|NCT00783718|520377|P6|Induction Phase|Withdrawal by Subject|0
163099|NCT00783718|520378|P5|Induction Phase|Withdrawal by Subject|0
163100|NCT00783718|520379|P4|Induction Phase|Withdrawal by Subject|0
163101|NCT00783718|520380|P3|Induction Phase|Withdrawal by Subject|8
163102|NCT00783718|520381|P2|Induction Phase|Withdrawal by Subject|4
163103|NCT00783718|520382|P1|Induction Phase|Withdrawal by Subject|3
163104|NCT00783718|520376|P7|Induction Phase|Lack of Efficacy|0
163105|NCT00783718|520377|P6|Induction Phase|Lack of Efficacy|0
163106|NCT00783718|520378|P5|Induction Phase|Lack of Efficacy|0
163107|NCT00783718|520379|P4|Induction Phase|Lack of Efficacy|0
163108|NCT00783718|520380|P3|Induction Phase|Lack of Efficacy|14
163109|NCT00783718|520381|P2|Induction Phase|Lack of Efficacy|2
163110|NCT00783718|520382|P1|Induction Phase|Lack of Efficacy|5
163111|NCT00783718|520376|P7|Induction Phase|Protocol Violation|0
163112|NCT00783718|520377|P6|Induction Phase|Protocol Violation|0
163113|NCT00783718|520378|P5|Induction Phase|Protocol Violation|0
163114|NCT00783718|520379|P4|Induction Phase|Protocol Violation|0
163115|NCT00783718|520380|P3|Induction Phase|Protocol Violation|6
163116|NCT00783718|520381|P2|Induction Phase|Protocol Violation|1
163117|NCT00783718|520382|P1|Induction Phase|Protocol Violation|1
163118|NCT00783718|520376|P7|Induction Phase|Adverse Event|0
163119|NCT00783718|520377|P6|Induction Phase|Adverse Event|0
163120|NCT00783718|520378|P5|Induction Phase|Adverse Event|0
163121|NCT00783718|520379|P4|Induction Phase|Adverse Event|0
163122|NCT00783718|520380|P3|Induction Phase|Adverse Event|7
163123|NCT00783718|520381|P2|Induction Phase|Adverse Event|0
163124|NCT00783718|520382|P1|Induction Phase|Adverse Event|4
163125|NCT00783796|520408|P1|Overall Study|Received commercial XIENCE V stent|1
163126|NCT00783796|520408|P1|Overall Study|Received non-XIENCE V stent|1
163127|NCT00783796|520408|P1|Overall Study|Did not receive any stent|4
163128|NCT00783835|520510|P1|Overall Study|Participant not Adherent|3
163129|NCT00783835|520510|P1|Overall Study|Lost to Follow-up|1
163130|NCT00783835|520510|P1|Overall Study|Withdrawal by Subject|2
163131|NCT00783835|520510|P1|Overall Study|Medical Criteria|1
163132|NCT00783835|520510|P1|Overall Study|Adverse Event|3
163133|NCT00784134|520574|P2|Overall Study|Lost to Follow-up|6
163134|NCT00784134|520575|P1|Overall Study|Lost to Follow-up|3
163135|NCT00784147|520673|P2|Overall Study|Death|0
163136|NCT00784147|520674|P1|Overall Study|Death|2
163137|NCT00784147|520673|P2|Overall Study|Protocol Violation|1
163138|NCT00784147|520674|P1|Overall Study|Protocol Violation|1
163139|NCT00784147|520673|P2|Overall Study|Physician Decision|1
163140|NCT00784147|520674|P1|Overall Study|Physician Decision|2
163141|NCT00784147|520673|P2|Overall Study|Withdrawal by Subject|3
163142|NCT00784147|520674|P1|Overall Study|Withdrawal by Subject|1
163143|NCT00784147|520673|P2|Overall Study|Lost to Follow-up|4
163144|NCT00784147|520674|P1|Overall Study|Lost to Follow-up|2
163145|NCT00784238|520692|P1|Overall Study|Unspecified|14
163146|NCT00784238|520692|P1|Overall Study|Withdrawal by Subject|26
163147|NCT00784238|520692|P1|Overall Study|Pregnancy|1
163148|NCT00784238|520692|P1|Overall Study|Lost to Follow-up|29
163149|NCT00784238|520692|P1|Overall Study|Lack of Efficacy|33
163150|NCT00784238|520692|P1|Overall Study|Death|2
163151|NCT00784238|520692|P1|Overall Study|Adverse Event|14
163152|NCT00784277|520737|P7|ER Treatment|Other|2
163153|NCT00784277|520738|P6|ER Treatment|Other|3
163154|NCT00784277|520739|P5|ER Treatment|Other|1
163155|NCT00784277|520740|P4|ER Treatment|Other|0
163156|NCT00784277|520741|P3|ER Treatment|Other|0
163157|NCT00784277|520742|P2|ER Treatment|Other|0
163158|NCT00784277|520743|P1|ER Treatment|Other|0
163159|NCT00784277|520737|P7|ER Treatment|Study Medication Non-Compliant|3
163160|NCT00784277|520738|P6|ER Treatment|Study Medication Non-Compliant|3
163161|NCT00784277|520739|P5|ER Treatment|Study Medication Non-Compliant|2
163162|NCT00784277|520740|P4|ER Treatment|Study Medication Non-Compliant|0
163163|NCT00784277|520741|P3|ER Treatment|Study Medication Non-Compliant|0
163164|NCT00784277|520742|P2|ER Treatment|Study Medication Non-Compliant|0
163165|NCT00784277|520743|P1|ER Treatment|Study Medication Non-Compliant|0
163166|NCT00784277|520737|P7|ER Treatment|Withdrawal by Subject|3
163167|NCT00784277|520738|P6|ER Treatment|Withdrawal by Subject|5
163168|NCT00784277|520739|P5|ER Treatment|Withdrawal by Subject|2
163169|NCT00784277|520740|P4|ER Treatment|Withdrawal by Subject|0
163170|NCT00784277|520741|P3|ER Treatment|Withdrawal by Subject|0
163171|NCT00784277|520742|P2|ER Treatment|Withdrawal by Subject|0
163172|NCT00784277|520743|P1|ER Treatment|Withdrawal by Subject|0
163173|NCT00784277|520737|P7|ER Treatment|Lost to Follow-up|0
163174|NCT00784277|520738|P6|ER Treatment|Lost to Follow-up|2
163175|NCT00784277|520739|P5|ER Treatment|Lost to Follow-up|0
163176|NCT00784277|520740|P4|ER Treatment|Lost to Follow-up|0
163177|NCT00784277|520741|P3|ER Treatment|Lost to Follow-up|0
163178|NCT00784277|520742|P2|ER Treatment|Lost to Follow-up|0
163179|NCT00784277|520743|P1|ER Treatment|Lost to Follow-up|0
163180|NCT00784277|520737|P7|ER Treatment|Lack of Efficacy|0
163181|NCT00784277|520738|P6|ER Treatment|Lack of Efficacy|4
163182|NCT00784277|520739|P5|ER Treatment|Lack of Efficacy|3
163183|NCT00784277|520740|P4|ER Treatment|Lack of Efficacy|0
163184|NCT00784277|520741|P3|ER Treatment|Lack of Efficacy|0
163185|NCT00784277|520742|P2|ER Treatment|Lack of Efficacy|0
163186|NCT00784277|520743|P1|ER Treatment|Lack of Efficacy|0
163187|NCT00784277|520737|P7|ER Treatment|Adverse Event|7
163188|NCT00784277|520738|P6|ER Treatment|Adverse Event|7
163189|NCT00784277|520739|P5|ER Treatment|Adverse Event|1
163190|NCT00784277|520740|P4|ER Treatment|Adverse Event|0
163191|NCT00784277|520741|P3|ER Treatment|Adverse Event|0
163192|NCT00784277|520742|P2|ER Treatment|Adverse Event|0
163193|NCT00784277|520743|P1|ER Treatment|Adverse Event|0
163194|NCT00784277|520737|P7|IR Treatment|Other|0
163195|NCT00784277|520738|P6|IR Treatment|Other|0
163196|NCT00784277|520739|P5|IR Treatment|Other|0
163197|NCT00784277|520740|P4|IR Treatment|Other|2
163198|NCT00784277|520741|P3|IR Treatment|Other|3
163199|NCT00784277|520742|P2|IR Treatment|Other|3
163200|NCT00784277|520743|P1|IR Treatment|Other|2
163201|NCT00784277|520737|P7|IR Treatment|Resolution Of Pain|0
163202|NCT00784277|520738|P6|IR Treatment|Resolution Of Pain|0
163203|NCT00784277|520739|P5|IR Treatment|Resolution Of Pain|0
163204|NCT00784277|520740|P4|IR Treatment|Resolution Of Pain|0
163205|NCT00784277|520741|P3|IR Treatment|Resolution Of Pain|0
163206|NCT00784277|520742|P2|IR Treatment|Resolution Of Pain|1
163207|NCT00784277|520743|P1|IR Treatment|Resolution Of Pain|0
163208|NCT00784277|520737|P7|IR Treatment|Withdrawal by Subject|0
163209|NCT00784277|520738|P6|IR Treatment|Withdrawal by Subject|0
163210|NCT00784277|520739|P5|IR Treatment|Withdrawal by Subject|0
163211|NCT00784277|520740|P4|IR Treatment|Withdrawal by Subject|6
163212|NCT00784277|520741|P3|IR Treatment|Withdrawal by Subject|4
163213|NCT00784277|520742|P2|IR Treatment|Withdrawal by Subject|1
163214|NCT00784277|520743|P1|IR Treatment|Withdrawal by Subject|5
163215|NCT00784277|520737|P7|IR Treatment|Lost to Follow-up|0
163216|NCT00784277|520738|P6|IR Treatment|Lost to Follow-up|0
163217|NCT00784277|520739|P5|IR Treatment|Lost to Follow-up|0
163218|NCT00784277|520740|P4|IR Treatment|Lost to Follow-up|0
163219|NCT00784277|520741|P3|IR Treatment|Lost to Follow-up|1
163220|NCT00784277|520742|P2|IR Treatment|Lost to Follow-up|0
163221|NCT00784277|520743|P1|IR Treatment|Lost to Follow-up|1
163222|NCT00784277|520737|P7|IR Treatment|Lack of Efficacy|0
163223|NCT00784277|520738|P6|IR Treatment|Lack of Efficacy|0
163224|NCT00784277|520739|P5|IR Treatment|Lack of Efficacy|0
163225|NCT00784277|520740|P4|IR Treatment|Lack of Efficacy|0
163226|NCT00784277|520741|P3|IR Treatment|Lack of Efficacy|1
163227|NCT00784277|520742|P2|IR Treatment|Lack of Efficacy|4
163228|NCT00784277|520743|P1|IR Treatment|Lack of Efficacy|4
163229|NCT00784277|520737|P7|IR Treatment|Adverse Event|0
163230|NCT00784277|520738|P6|IR Treatment|Adverse Event|0
163231|NCT00784277|520739|P5|IR Treatment|Adverse Event|0
163232|NCT00784277|520740|P4|IR Treatment|Adverse Event|35
163233|NCT00784277|520741|P3|IR Treatment|Adverse Event|19
163234|NCT00784277|520742|P2|IR Treatment|Adverse Event|8
163235|NCT00784277|520743|P1|IR Treatment|Adverse Event|4
163236|NCT00784368|520763|P3|Overall Study|Withdrawal of informed consent|0
163237|NCT00784368|520764|P2|Overall Study|Withdrawal of informed consent|1
163238|NCT00784368|520765|P1|Overall Study|Withdrawal of informed consent|0
163239|NCT00784368|520763|P3|Overall Study|Worsening of symptoms|0
163240|NCT00784368|520764|P2|Overall Study|Worsening of symptoms|1
163241|NCT00784368|520765|P1|Overall Study|Worsening of symptoms|0
163242|NCT00784368|520763|P3|Overall Study|Worsening of complications|1
163243|NCT00784368|520764|P2|Overall Study|Worsening of complications|0
163244|NCT00784368|520765|P1|Overall Study|Worsening of complications|0
163245|NCT00784368|520763|P3|Overall Study|Diagnosis of fever|1
163246|NCT00784368|520764|P2|Overall Study|Diagnosis of fever|0
163247|NCT00784368|520765|P1|Overall Study|Diagnosis of fever|0
163248|NCT00784368|520763|P3|Overall Study|Adverse Event|2
163249|NCT00784368|520764|P2|Overall Study|Adverse Event|9
163250|NCT00784368|520765|P1|Overall Study|Adverse Event|6
163251|NCT00784368|520763|P3|Overall Study|Lack of Efficacy|1
163252|NCT00784368|520764|P2|Overall Study|Lack of Efficacy|0
163253|NCT00784368|520765|P1|Overall Study|Lack of Efficacy|2
163254|NCT00784368|520763|P3|Overall Study|Physician Decision|6
163255|NCT00784368|520764|P2|Overall Study|Physician Decision|0
163256|NCT00784368|520765|P1|Overall Study|Physician Decision|0
163257|NCT00784459|520801|P2|Overall Study|Adverse Event|2
163258|NCT00784459|520802|P1|Overall Study|Adverse Event|0
163259|NCT00784550|520812|P2|Overall Study|Withdrawal by Subject|13
163260|NCT00784550|520813|P1|Overall Study|Withdrawal by Subject|4
163261|NCT00784550|520812|P2|Overall Study|Physician Decision|3
163262|NCT00784550|520813|P1|Overall Study|Physician Decision|2
163263|NCT00784550|520812|P2|Overall Study|Lost to Follow-up|5
163264|NCT00784550|520813|P1|Overall Study|Lost to Follow-up|8
163265|NCT00784550|520812|P2|Overall Study|Protocol Violation|10
163266|NCT00784550|520813|P1|Overall Study|Protocol Violation|10
163267|NCT00784550|520812|P2|Overall Study|Lack of Efficacy|1
163268|NCT00784550|520813|P1|Overall Study|Lack of Efficacy|0
163269|NCT00784550|520812|P2|Overall Study|Adverse Event|10
163270|NCT00784550|520813|P1|Overall Study|Adverse Event|12
163271|NCT00784563|520832|P3|Year 3|Adverse Event|1
163272|NCT00784563|520833|P2|Year 3|Adverse Event|0
163273|NCT00784563|520834|P1|Year 3|Adverse Event|0
163274|NCT00784563|520832|P3|Year 3|Withdrawal by Subject|2
163275|NCT00784563|520833|P2|Year 3|Withdrawal by Subject|0
163276|NCT00784563|520834|P1|Year 3|Withdrawal by Subject|0
163277|NCT00784563|520832|P3|Years 1 & 2|Adverse Event|0
163278|NCT00784563|520833|P2|Years 1 & 2|Adverse Event|3
163279|NCT00784563|520834|P1|Years 1 & 2|Adverse Event|0
163280|NCT00784563|520832|P3|Years 1 & 2|Withdrawal by Subject|0
163281|NCT00784563|520833|P2|Years 1 & 2|Withdrawal by Subject|2
163282|NCT00784563|520834|P1|Years 1 & 2|Withdrawal by Subject|3
163283|NCT00784654|520850|P3|Randomized Withdrawal Period|Family reasons|1
163284|NCT00784654|520851|P2|Randomized Withdrawal Period|Family reasons|0
163285|NCT00784654|520852|P1|Randomized Withdrawal Period|Family reasons|0
163286|NCT00784654|520850|P3|Randomized Withdrawal Period|Did not complete a visit|0
163287|NCT00784654|520851|P2|Randomized Withdrawal Period|Did not complete a visit|1
163288|NCT00784654|520852|P1|Randomized Withdrawal Period|Did not complete a visit|0
163289|NCT00784654|520850|P3|Randomized Withdrawal Period|Adverse Event|1
163290|NCT00784654|520851|P2|Randomized Withdrawal Period|Adverse Event|1
163291|NCT00784654|520852|P1|Randomized Withdrawal Period|Adverse Event|0
163292|NCT00784654|520850|P3|Randomized Withdrawal Period|Protocol Violation|1
163293|NCT00784654|520851|P2|Randomized Withdrawal Period|Protocol Violation|2
163294|NCT00784654|520852|P1|Randomized Withdrawal Period|Protocol Violation|0
163295|NCT00784654|520850|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
163296|NCT00784654|520851|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
163297|NCT00784654|520852|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
163298|NCT00784654|520850|P3|Randomized Withdrawal Period|Lack of Efficacy|18
163299|NCT00784654|520851|P2|Randomized Withdrawal Period|Lack of Efficacy|5
163300|NCT00784654|520852|P1|Randomized Withdrawal Period|Lack of Efficacy|0
163301|NCT00784654|520850|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
163302|NCT00784654|520851|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
163303|NCT00784654|520852|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
163304|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
163305|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
163306|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
163307|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
163308|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
163309|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
163310|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
163311|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
163312|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
163313|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
163314|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
163315|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
163316|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
163317|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
163318|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
163319|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
163320|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
163321|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
163322|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
163323|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
163324|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
163325|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
163326|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
163327|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
163328|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
163329|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
163330|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
163331|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
163332|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
163333|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
163334|NCT00784654|520850|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
163335|NCT00784654|520851|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
163336|NCT00784654|520852|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
163337|NCT00784719|520891|P7|Overall Study|Withdrawal by Subject|1
163338|NCT00784719|520892|P6|Overall Study|Withdrawal by Subject|0
163339|NCT00784719|520893|P5|Overall Study|Withdrawal by Subject|2
163340|NCT00784719|520894|P4|Overall Study|Withdrawal by Subject|0
163341|NCT00784719|520895|P3|Overall Study|Withdrawal by Subject|0
163342|NCT00784719|520896|P2|Overall Study|Withdrawal by Subject|0
163343|NCT00784719|520897|P1|Overall Study|Withdrawal by Subject|1
163344|NCT00784719|520891|P7|Overall Study|Unspecified|3
163345|NCT00784719|520892|P6|Overall Study|Unspecified|1
163346|NCT00784719|520893|P5|Overall Study|Unspecified|2
163347|NCT00784719|520894|P4|Overall Study|Unspecified|0
163348|NCT00784719|520895|P3|Overall Study|Unspecified|1
163349|NCT00784719|520896|P2|Overall Study|Unspecified|1
163350|NCT00784719|520897|P1|Overall Study|Unspecified|2
163351|NCT00784719|520891|P7|Overall Study|Lost to Follow-up|0
163352|NCT00784719|520892|P6|Overall Study|Lost to Follow-up|1
163353|NCT00784719|520893|P5|Overall Study|Lost to Follow-up|1
163354|NCT00784719|520894|P4|Overall Study|Lost to Follow-up|0
163355|NCT00784719|520895|P3|Overall Study|Lost to Follow-up|0
163356|NCT00784719|520896|P2|Overall Study|Lost to Follow-up|0
163357|NCT00784719|520897|P1|Overall Study|Lost to Follow-up|0
163358|NCT00784719|520891|P7|Overall Study|Adverse Event|1
163359|NCT00784719|520892|P6|Overall Study|Adverse Event|1
163360|NCT00784719|520893|P5|Overall Study|Adverse Event|1
163361|NCT00784719|520894|P4|Overall Study|Adverse Event|0
163362|NCT00784719|520895|P3|Overall Study|Adverse Event|0
163363|NCT00784719|520896|P2|Overall Study|Adverse Event|2
163364|NCT00784719|520897|P1|Overall Study|Adverse Event|0
163365|NCT00784784|521069|P2|Overall Study|Withdrawal by Subject|2
163366|NCT00784784|521070|P1|Overall Study|Withdrawal by Subject|2
163367|NCT00784810|521080|P2|Overall Study|Lost to Follow-up|1
163368|NCT00784810|521081|P1|Overall Study|Lost to Follow-up|1
163369|NCT00784810|521080|P2|Overall Study|Administrative|8
163370|NCT00784810|521081|P1|Overall Study|Administrative|5
163371|NCT00784810|521080|P2|Overall Study|Withdrawal by Subject|9
163372|NCT00784810|521081|P1|Overall Study|Withdrawal by Subject|11
163373|NCT00784810|521080|P2|Overall Study|Lack of Efficacy|11
163374|NCT00784810|521081|P1|Overall Study|Lack of Efficacy|14
163375|NCT00784810|521080|P2|Overall Study|Adverse Event|20
163376|NCT00784810|521081|P1|Overall Study|Adverse Event|32
163377|NCT00784836|521089|P1|Overall Study|Early Study Termination|3
163378|NCT00784875|521104|P4|Period D|Lost to Follow-up|1
163379|NCT00784875|521105|P3|Period D|Lost to Follow-up|1
163380|NCT00784875|521106|P2|Period D|Lost to Follow-up|0
163381|NCT00784875|521107|P1|Period D|Lost to Follow-up|1
163382|NCT00784875|521104|P4|Period D|Sponsor Decision|0
163383|NCT00784875|521105|P3|Period D|Sponsor Decision|1
163384|NCT00784875|521106|P2|Period D|Sponsor Decision|1
163385|NCT00784875|521107|P1|Period D|Sponsor Decision|1
163386|NCT00784875|521104|P4|Period D|Physician Decision|0
163387|NCT00784875|521105|P3|Period D|Physician Decision|0
163388|NCT00784875|521106|P2|Period D|Physician Decision|1
163389|NCT00784875|521107|P1|Period D|Physician Decision|0
163390|NCT00784875|521104|P4|Period D|Withdrawal by Subject|0
163391|NCT00784875|521105|P3|Period D|Withdrawal by Subject|2
163392|NCT00784875|521106|P2|Period D|Withdrawal by Subject|0
163393|NCT00784875|521107|P1|Period D|Withdrawal by Subject|2
163394|NCT00784875|521104|P4|Period D|Protocol Violation|0
163395|NCT00784875|521105|P3|Period D|Protocol Violation|0
163396|NCT00784875|521106|P2|Period D|Protocol Violation|0
163397|NCT00784875|521107|P1|Period D|Protocol Violation|1
163398|NCT00784875|521104|P4|Period D|Adverse Event|0
163399|NCT00784875|521105|P3|Period D|Adverse Event|2
163400|NCT00784875|521106|P2|Period D|Adverse Event|2
163401|NCT00784875|521107|P1|Period D|Adverse Event|0
163402|NCT00784875|521104|P4|Period C|Sponsor Decision|2
163403|NCT00784875|521105|P3|Period C|Sponsor Decision|4
163404|NCT00784875|521106|P2|Period C|Sponsor Decision|5
163405|NCT00784875|521107|P1|Period C|Sponsor Decision|5
163406|NCT00784875|521104|P4|Period C|Physician Decision|1
163407|NCT00784875|521105|P3|Period C|Physician Decision|1
163408|NCT00784875|521106|P2|Period C|Physician Decision|0
163409|NCT00784875|521107|P1|Period C|Physician Decision|0
163410|NCT00784875|521104|P4|Period C|Withdrawal by Subject|0
163411|NCT00784875|521105|P3|Period C|Withdrawal by Subject|2
163412|NCT00784875|521106|P2|Period C|Withdrawal by Subject|1
163413|NCT00784875|521107|P1|Period C|Withdrawal by Subject|1
163414|NCT00784875|521104|P4|Period C|Lack of Efficacy|0
163415|NCT00784875|521105|P3|Period C|Lack of Efficacy|1
163416|NCT00784875|521106|P2|Period C|Lack of Efficacy|0
163417|NCT00784875|521107|P1|Period C|Lack of Efficacy|0
163418|NCT00784875|521104|P4|Period C|Protocol Violation|2
163419|NCT00784875|521105|P3|Period C|Protocol Violation|1
163420|NCT00784875|521106|P2|Period C|Protocol Violation|0
163421|NCT00784875|521107|P1|Period C|Protocol Violation|0
163422|NCT00784875|521104|P4|Period C|Adverse Event|2
163423|NCT00784875|521105|P3|Period C|Adverse Event|4
163424|NCT00784875|521106|P2|Period C|Adverse Event|0
163425|NCT00784875|521107|P1|Period C|Adverse Event|1
163426|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
163427|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
163428|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
163429|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
163430|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
163431|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
163432|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
163433|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
163434|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Physician Decision|0
163435|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Physician Decision|1
163436|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Physician Decision|0
163437|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Physician Decision|0
163438|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
163439|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
163440|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
163441|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
163442|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
163443|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
163444|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
163445|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
163446|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Protocol Violation|3
163447|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Protocol Violation|2
163448|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Protocol Violation|1
163449|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Protocol Violation|1
163450|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Adverse Event|1
163451|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Adverse Event|2
163452|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Adverse Event|3
163453|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Adverse Event|0
163454|NCT00784875|521104|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
163455|NCT00784875|521105|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
163456|NCT00784875|521106|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
163457|NCT00784875|521107|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
163458|NCT00784875|521104|P4|Period A - Baseline|Lost to Follow-up|2
163459|NCT00784875|521105|P3|Period A - Baseline|Lost to Follow-up|0
163460|NCT00784875|521106|P2|Period A - Baseline|Lost to Follow-up|0
163461|NCT00784875|521107|P1|Period A - Baseline|Lost to Follow-up|0
163462|NCT00784875|521104|P4|Period A - Baseline|Sponsor Decision|113
163463|NCT00784875|521105|P3|Period A - Baseline|Sponsor Decision|0
163464|NCT00784875|521106|P2|Period A - Baseline|Sponsor Decision|0
163465|NCT00784875|521107|P1|Period A - Baseline|Sponsor Decision|0
163466|NCT00784875|521104|P4|Period A - Baseline|Physician Decision|2
163467|NCT00784875|521105|P3|Period A - Baseline|Physician Decision|0
163468|NCT00784875|521106|P2|Period A - Baseline|Physician Decision|0
163469|NCT00784875|521107|P1|Period A - Baseline|Physician Decision|0
163470|NCT00784875|521104|P4|Period A - Baseline|Withdrawal by Subject|27
163471|NCT00784875|521105|P3|Period A - Baseline|Withdrawal by Subject|0
163472|NCT00784875|521106|P2|Period A - Baseline|Withdrawal by Subject|0
163473|NCT00784875|521107|P1|Period A - Baseline|Withdrawal by Subject|0
163474|NCT00784875|521104|P4|Period A - Baseline|Protocol Violation|25
163475|NCT00784875|521105|P3|Period A - Baseline|Protocol Violation|0
163476|NCT00784875|521106|P2|Period A - Baseline|Protocol Violation|0
163477|NCT00784875|521107|P1|Period A - Baseline|Protocol Violation|0
163478|NCT00784875|521104|P4|Period A - Baseline|Adverse Event|8
163479|NCT00784875|521105|P3|Period A - Baseline|Adverse Event|0
163480|NCT00784875|521106|P2|Period A - Baseline|Adverse Event|0
163481|NCT00784875|521107|P1|Period A - Baseline|Adverse Event|0
163482|NCT00784875|521104|P4|Period A - Baseline|Entry Criteria Not Met|5
163483|NCT00784875|521105|P3|Period A - Baseline|Entry Criteria Not Met|0
163484|NCT00784875|521106|P2|Period A - Baseline|Entry Criteria Not Met|0
163485|NCT00784875|521107|P1|Period A - Baseline|Entry Criteria Not Met|0
163486|NCT00784927|521221|P1|Overall Study|Ineligible|1
163487|NCT00784927|521221|P1|Overall Study|Protocol Violation|1
163488|NCT00784927|521221|P1|Overall Study|Cancel Prior to Initiating Treatment|1
163489|NCT00784979|521229|P1|Overall Study|incomplete data|6
163490|NCT00785044|521233|P1|Overall Study|Withdrawal by Subject|1
163491|NCT00785044|521233|P1|Overall Study|Lost to Follow-up|266
163492|NCT00785044|521233|P1|Overall Study|Death|77
163493|NCT00785044|521233|P1|Overall Study|Dosed at non-participating sites|152
163494|NCT00785213|521238|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
163495|NCT00785213|521238|P1|Quinine Sulfate Alone|Adverse Event|4
163496|NCT00785291|521252|P3|Overall Study|Other Medical Reasons|15
163497|NCT00785291|521253|P2|Overall Study|Other Medical Reasons|25
163498|NCT00785291|521254|P1|Overall Study|Other Medical Reasons|29
163499|NCT00785291|521252|P3|Overall Study|Complicating illness|4
163500|NCT00785291|521253|P2|Overall Study|Complicating illness|4
163501|NCT00785291|521254|P1|Overall Study|Complicating illness|6
163502|NCT00785291|521252|P3|Overall Study|Alternative Therapy|7
163503|NCT00785291|521253|P2|Overall Study|Alternative Therapy|6
163504|NCT00785291|521254|P1|Overall Study|Alternative Therapy|12
163505|NCT00785291|521252|P3|Overall Study|Withdrawal by Subject|17
163506|NCT00785291|521253|P2|Overall Study|Withdrawal by Subject|36
163507|NCT00785291|521254|P1|Overall Study|Withdrawal by Subject|35
163508|NCT00785291|521252|P3|Overall Study|Death|3
163509|NCT00785291|521253|P2|Overall Study|Death|4
163510|NCT00785291|521254|P1|Overall Study|Death|7
163511|NCT00785291|521252|P3|Overall Study|Adverse Event|56
163512|NCT00785291|521253|P2|Overall Study|Adverse Event|70
163513|NCT00785291|521254|P1|Overall Study|Adverse Event|39
163514|NCT00785291|521252|P3|Overall Study|Never began treatment|4
163515|NCT00785291|521253|P2|Overall Study|Never began treatment|4
163516|NCT00785291|521254|P1|Overall Study|Never began treatment|8
163517|NCT00785356|521277|P1|Overall Study|Study prematurely terminated|8
163518|NCT00785486|521285|P1|Midazolam Alone|Withdrawal by Subject|1
163519|NCT00785512|521308|P2|Overall Study|Lack of compliance|1
163520|NCT00785512|521309|P1|Overall Study|Lack of compliance|0
163521|NCT00785512|521308|P2|Overall Study|Physician Decision|0
163522|NCT00785512|521309|P1|Overall Study|Physician Decision|0
163523|NCT00785512|521308|P2|Overall Study|IVRS Programing Error|0
163524|NCT00785512|521309|P1|Overall Study|IVRS Programing Error|0
163525|NCT00785512|521308|P2|Overall Study|Precedure Refused|0
163526|NCT00785512|521309|P1|Overall Study|Precedure Refused|0
163527|NCT00785512|521308|P2|Overall Study|Lost to Follow-up|0
163528|NCT00785512|521309|P1|Overall Study|Lost to Follow-up|3
163529|NCT00785512|521308|P2|Overall Study|Withdrawal by Subject|1
163530|NCT00785512|521309|P1|Overall Study|Withdrawal by Subject|0
163531|NCT00785512|521308|P2|Overall Study|Lack of Efficacy|2
163532|NCT00785512|521309|P1|Overall Study|Lack of Efficacy|0
163533|NCT00785512|521308|P2|Overall Study|Adverse Event|0
163534|NCT00785512|521309|P1|Overall Study|Adverse Event|0
163535|NCT00785512|521308|P2|Overall Study|Inclusion/Exclusion not meet|0
163536|NCT00785512|521309|P1|Overall Study|Inclusion/Exclusion not meet|0
163537|NCT00785577|521323|P5|Study Period 3: 1-Week Washout Phase|Death|1
163538|NCT00785577|521324|P4|Study Period 3: 1-Week Washout Phase|Death|0
163539|NCT00785577|521325|P3|Study Period 3: 1-Week Washout Phase|Death|0
163540|NCT00785577|521326|P2|Study Period 3: 1-Week Washout Phase|Death|0
163541|NCT00785577|521327|P1|Study Period 3: 1-Week Washout Phase|Death|0
163542|NCT00785577|521323|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
163543|NCT00785577|521324|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
163544|NCT00785577|521325|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
163545|NCT00785577|521326|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
163546|NCT00785577|521327|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
163547|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
163548|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
163549|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
163550|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
163551|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
163552|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
163553|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
163554|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
163555|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
163556|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
163557|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
163558|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
163559|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
163560|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
163561|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
163562|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Protocol Violation|1
163563|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Protocol Violation|0
163564|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Protocol Violation|1
163565|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Protocol Violation|1
163566|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Protocol Violation|1
163567|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Physician Decision|0
163568|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Physician Decision|0
163569|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Physician Decision|0
163570|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Physician Decision|0
163571|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Physician Decision|1
163652|NCT00779259|521573|P1|Quinine Alone|Adverse Event|2
163572|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
163573|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
163574|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
163575|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
163576|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
163577|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
163578|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
163579|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
163580|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
163581|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
163582|NCT00785577|521323|P5|Study Period 2: Therapy Phase|Adverse Event|17
163583|NCT00785577|521324|P4|Study Period 2: Therapy Phase|Adverse Event|10
163584|NCT00785577|521325|P3|Study Period 2: Therapy Phase|Adverse Event|14
163585|NCT00785577|521326|P2|Study Period 2: Therapy Phase|Adverse Event|7
163586|NCT00785577|521327|P1|Study Period 2: Therapy Phase|Adverse Event|5
163587|NCT00785629|521467|P4|Overall Study|Withdrawal by Subject|2
163588|NCT00785629|521468|P3|Overall Study|Withdrawal by Subject|2
163589|NCT00785629|521469|P2|Overall Study|Withdrawal by Subject|1
163590|NCT00785629|521470|P1|Overall Study|Withdrawal by Subject|0
163591|NCT00785629|521467|P4|Overall Study|administrative decision|4
163592|NCT00785629|521468|P3|Overall Study|administrative decision|3
163593|NCT00785629|521469|P2|Overall Study|administrative decision|1
163594|NCT00785629|521470|P1|Overall Study|administrative decision|5
163595|NCT00785629|521467|P4|Overall Study|Protocol Violation|5
163596|NCT00785629|521468|P3|Overall Study|Protocol Violation|4
163597|NCT00785629|521469|P2|Overall Study|Protocol Violation|2
163598|NCT00785629|521470|P1|Overall Study|Protocol Violation|1
163599|NCT00785629|521467|P4|Overall Study|Adverse Event|5
163600|NCT00785629|521468|P3|Overall Study|Adverse Event|1
163601|NCT00785629|521469|P2|Overall Study|Adverse Event|1
163602|NCT00785629|521470|P1|Overall Study|Adverse Event|2
163603|NCT00785707|521478|P1|Overall Study|Lost to Follow-up|7
163604|NCT00785785|521491|P2|Optional Extension Phase|Study terminated by sponsor|37
163605|NCT00785785|521492|P1|Optional Extension Phase|Study terminated by sponsor|3
163606|NCT00785785|521491|P2|Optional Extension Phase|Protocol deviation|2
163607|NCT00785785|521492|P1|Optional Extension Phase|Protocol deviation|0
163608|NCT00785785|521491|P2|Optional Extension Phase|Disease progression|70
163609|NCT00785785|521492|P1|Optional Extension Phase|Disease progression|22
163610|NCT00785785|521491|P2|Optional Extension Phase|Death|5
163611|NCT00785785|521492|P1|Optional Extension Phase|Death|1
163612|NCT00785785|521491|P2|Optional Extension Phase|Administrative problems|0
163613|NCT00785785|521492|P1|Optional Extension Phase|Administrative problems|2
163614|NCT00785785|521491|P2|Optional Extension Phase|Lost to Follow-up|0
163615|NCT00785785|521492|P1|Optional Extension Phase|Lost to Follow-up|1
163616|NCT00785785|521491|P2|Optional Extension Phase|Withdrawal by Subject|6
163617|NCT00785785|521492|P1|Optional Extension Phase|Withdrawal by Subject|6
163618|NCT00785785|521491|P2|Optional Extension Phase|Adverse Event|5
163619|NCT00785785|521492|P1|Optional Extension Phase|Adverse Event|4
163620|NCT00785785|521491|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
163621|NCT00785785|521492|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
163622|NCT00785785|521491|P2|Core Phase up to 36 Months|Protocol deviation|6
163623|NCT00785785|521492|P1|Core Phase up to 36 Months|Protocol deviation|5
163624|NCT00785785|521491|P2|Core Phase up to 36 Months|Disease progression|119
163625|NCT00785785|521492|P1|Core Phase up to 36 Months|Disease progression|139
163626|NCT00785785|521491|P2|Core Phase up to 36 Months|Death|8
163627|NCT00785785|521492|P1|Core Phase up to 36 Months|Death|5
163628|NCT00785785|521491|P2|Core Phase up to 36 Months|Administrative problems|3
163629|NCT00785785|521492|P1|Core Phase up to 36 Months|Administrative problems|3
163630|NCT00785785|521491|P2|Core Phase up to 36 Months|Lost to Follow-up|7
163631|NCT00785785|521492|P1|Core Phase up to 36 Months|Lost to Follow-up|3
163632|NCT00785785|521491|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
163633|NCT00785785|521492|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
163634|NCT00785785|521491|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
163635|NCT00785785|521492|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
163636|NCT00785785|521491|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
163637|NCT00785785|521492|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
163638|NCT00785785|521491|P2|Core Phase up to 36 Months|Adverse Event|21
163639|NCT00785785|521492|P1|Core Phase up to 36 Months|Adverse Event|31
163640|NCT00785785|521491|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
163641|NCT00785785|521492|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
163642|NCT00785980|521505|P1|7 Day Washout Period|Protocol Violation|3
163643|NCT00778999|521518|P2|Overall Study|Did not receive recFSH|20
163644|NCT00778999|521519|P1|Overall Study|Did not receive recFSH|14
163645|NCT00778999|521518|P2|Overall Study|Discontinuation: no embryo transfer|14
163646|NCT00778999|521519|P1|Overall Study|Discontinuation: no embryo transfer|14
163647|NCT00779025|521525|P1|Overall Study|Withdrawal by Subject|1
163648|NCT00779038|521534|P1|Overall Study|Study Prematurely Terminated|13
163649|NCT00779142|521551|P1|Overall Study|Screen Failures|3
163650|NCT00779246|521566|P2|Overall Study|Missing sufficient data for analysis|53
163651|NCT00779246|521567|P1|Overall Study|Missing sufficient data for analysis|33
163653|NCT00779467|521631|P4|Overall Study|unavailable research staff|1
163654|NCT00779467|521632|P3|Overall Study|unavailable research staff|0
163655|NCT00779467|521633|P2|Overall Study|unavailable research staff|0
163656|NCT00779467|521634|P1|Overall Study|unavailable research staff|0
163657|NCT00779467|521631|P4|Overall Study|technical issue|1
163658|NCT00779467|521632|P3|Overall Study|technical issue|2
163659|NCT00779467|521633|P2|Overall Study|technical issue|0
163660|NCT00779467|521634|P1|Overall Study|technical issue|0
163661|NCT00779467|521631|P4|Overall Study|missing data|4
163662|NCT00779467|521632|P3|Overall Study|missing data|1
163663|NCT00779467|521633|P2|Overall Study|missing data|0
163664|NCT00779467|521634|P1|Overall Study|missing data|1
163665|NCT00779467|521631|P4|Overall Study|failed inclusion criteria|2
163666|NCT00779467|521632|P3|Overall Study|failed inclusion criteria|1
163667|NCT00779467|521633|P2|Overall Study|failed inclusion criteria|3
163668|NCT00779467|521634|P1|Overall Study|failed inclusion criteria|3
163669|NCT00779467|521631|P4|Overall Study|Lack of Efficacy|11
163670|NCT00779467|521632|P3|Overall Study|Lack of Efficacy|6
163671|NCT00779467|521633|P2|Overall Study|Lack of Efficacy|2
163672|NCT00779467|521634|P1|Overall Study|Lack of Efficacy|11
163673|NCT00779506|521672|P1|Overall Study|Lost to Follow-up|1
163674|NCT00779506|521672|P1|Overall Study|Withdrawal by Subject|6
163675|NCT00779506|521672|P1|Overall Study|Protocol Violation|5
163676|NCT00779506|521672|P1|Overall Study|Lack of Efficacy|11
163677|NCT00779506|521672|P1|Overall Study|Adverse Event|4
163678|NCT00779506|521672|P1|Overall Study|Screening Failed|2
163679|NCT00779584|521708|P9|Overall Study|Ongoing in Study|0
163680|NCT00779584|521709|P8|Overall Study|Ongoing in Study|0
163681|NCT00779584|521710|P7|Overall Study|Ongoing in Study|0
163682|NCT00779584|521711|P6|Overall Study|Ongoing in Study|1
163683|NCT00779584|521712|P5|Overall Study|Ongoing in Study|1
163684|NCT00779584|521713|P4|Overall Study|Ongoing in Study|0
163685|NCT00779584|521714|P3|Overall Study|Ongoing in Study|0
163686|NCT00779584|521715|P2|Overall Study|Ongoing in Study|0
163687|NCT00779584|521716|P1|Overall Study|Ongoing in Study|0
163688|NCT00779584|521708|P9|Overall Study|Symptomatic Deterioration|0
163689|NCT00779584|521709|P8|Overall Study|Symptomatic Deterioration|0
163690|NCT00779584|521710|P7|Overall Study|Symptomatic Deterioration|1
163691|NCT00779584|521711|P6|Overall Study|Symptomatic Deterioration|1
163692|NCT00779584|521712|P5|Overall Study|Symptomatic Deterioration|0
163693|NCT00779584|521713|P4|Overall Study|Symptomatic Deterioration|0
163694|NCT00779584|521714|P3|Overall Study|Symptomatic Deterioration|1
163695|NCT00779584|521715|P2|Overall Study|Symptomatic Deterioration|1
163696|NCT00779584|521716|P1|Overall Study|Symptomatic Deterioration|1
163697|NCT00779584|521708|P9|Overall Study|Adverse Event|1
163698|NCT00779584|521709|P8|Overall Study|Adverse Event|1
163699|NCT00779584|521710|P7|Overall Study|Adverse Event|2
163700|NCT00779584|521711|P6|Overall Study|Adverse Event|0
163701|NCT00779584|521712|P5|Overall Study|Adverse Event|0
163702|NCT00779584|521713|P4|Overall Study|Adverse Event|0
163703|NCT00779584|521714|P3|Overall Study|Adverse Event|2
163704|NCT00779584|521715|P2|Overall Study|Adverse Event|0
163705|NCT00779584|521716|P1|Overall Study|Adverse Event|1
163706|NCT00779584|521708|P9|Overall Study|Progression of Disease|1
163707|NCT00779584|521709|P8|Overall Study|Progression of Disease|2
163708|NCT00779584|521710|P7|Overall Study|Progression of Disease|4
163709|NCT00779584|521711|P6|Overall Study|Progression of Disease|1
163710|NCT00779584|521712|P5|Overall Study|Progression of Disease|5
163711|NCT00779584|521713|P4|Overall Study|Progression of Disease|6
163712|NCT00779584|521714|P3|Overall Study|Progression of Disease|2
163713|NCT00779584|521715|P2|Overall Study|Progression of Disease|1
163714|NCT00779584|521716|P1|Overall Study|Progression of Disease|0
163715|NCT00779584|521708|P9|Overall Study|Lost to Follow-up|0
163716|NCT00779584|521709|P8|Overall Study|Lost to Follow-up|0
163717|NCT00779584|521710|P7|Overall Study|Lost to Follow-up|0
163718|NCT00779584|521711|P6|Overall Study|Lost to Follow-up|0
163719|NCT00779584|521712|P5|Overall Study|Lost to Follow-up|1
163720|NCT00779584|521713|P4|Overall Study|Lost to Follow-up|0
163721|NCT00779584|521714|P3|Overall Study|Lost to Follow-up|0
163722|NCT00779584|521715|P2|Overall Study|Lost to Follow-up|0
163723|NCT00779584|521716|P1|Overall Study|Lost to Follow-up|0
163724|NCT00779584|521708|P9|Overall Study|Withdrawal by Subject|0
163725|NCT00779584|521709|P8|Overall Study|Withdrawal by Subject|0
163726|NCT00779584|521710|P7|Overall Study|Withdrawal by Subject|1
163727|NCT00779584|521711|P6|Overall Study|Withdrawal by Subject|2
163728|NCT00779584|521712|P5|Overall Study|Withdrawal by Subject|0
163729|NCT00779584|521713|P4|Overall Study|Withdrawal by Subject|0
163730|NCT00779584|521714|P3|Overall Study|Withdrawal by Subject|2
163731|NCT00779584|521715|P2|Overall Study|Withdrawal by Subject|1
163732|NCT00779584|521716|P1|Overall Study|Withdrawal by Subject|1
163733|NCT00779584|521708|P9|Overall Study|Protocol Violation|0
163734|NCT00779584|521709|P8|Overall Study|Protocol Violation|0
163735|NCT00779584|521710|P7|Overall Study|Protocol Violation|0
163736|NCT00779584|521711|P6|Overall Study|Protocol Violation|1
163737|NCT00779584|521712|P5|Overall Study|Protocol Violation|0
163738|NCT00779584|521713|P4|Overall Study|Protocol Violation|0
163739|NCT00779584|521714|P3|Overall Study|Protocol Violation|0
163740|NCT00779584|521715|P2|Overall Study|Protocol Violation|0
163741|NCT00779584|521716|P1|Overall Study|Protocol Violation|0
163742|NCT00779675|521790|P1|Extended Treatment Period|Lost to Follow-up|6
163743|NCT00779675|521790|P1|Extended Treatment Period|Protocol defined clinical event|1
163744|NCT00779675|521790|P1|Extended Treatment Period|Treatment Failure|11
163745|NCT00779675|521790|P1|Extended Treatment Period|Adverse Event|6
163746|NCT00779675|521790|P1|Extended Treatment Period|Protocol Violation|13
163747|NCT00779675|521790|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
163748|NCT00779675|521790|P1|Treatment Period|Administrative|3
163749|NCT00779675|521790|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
163750|NCT00779675|521790|P1|Treatment Period|Protocol Violation|54
163751|NCT00779675|521790|P1|Treatment Period|Withdrawal by Subject|46
163752|NCT00779675|521790|P1|Treatment Period|Lost to Follow-up|23
163753|NCT00779675|521790|P1|Treatment Period|Transferred to Another Study|38
163754|NCT00779675|521790|P1|Treatment Period|Treatment Failure|80
163755|NCT00779675|521790|P1|Treatment Period|Adverse Event|87
163756|NCT00779766|521815|P2|Overall Study|Withdrawal by Subject|67
163757|NCT00779766|521816|P1|Overall Study|Withdrawal by Subject|84
163758|NCT00779766|521815|P2|Overall Study|Protocol Violation|1
163759|NCT00779766|521816|P1|Overall Study|Protocol Violation|1
163760|NCT00779779|521894|P1|Overall Study|Lost to Follow-up|5
163761|NCT00779779|521894|P1|Overall Study|Withdrawal by Subject|4
163762|NCT00779779|521894|P1|Overall Study|Protocol Violation|14
163763|NCT00779779|521894|P1|Overall Study|Adverse Event|1
163764|NCT00779857|521901|P1|Overall Study|Missed Visit|2
163765|NCT00779857|521901|P1|Overall Study|Withdrawal by Subject|3
163766|NCT00779857|521901|P1|Overall Study|Death|1
163767|NCT00780273|521906|P1|Overall Study|Lost to Follow-up|1
163768|NCT00780273|521906|P1|Overall Study|Death|1
163769|NCT00786032|521915|P1|Overall Study|Did not complete in the timeframe|6
163770|NCT00786032|521915|P1|Overall Study|Withdrawal by Subject|14
163771|NCT00786032|521915|P1|Overall Study|Death|4
163772|NCT00786188|521927|P2|Overall Study|Withdrawal by Subject|0
163773|NCT00786188|521928|P1|Overall Study|Withdrawal by Subject|2
163774|NCT00786188|521927|P2|Overall Study|Adverse Event|1
163775|NCT00786188|521928|P1|Overall Study|Adverse Event|3
163776|NCT00793780|521956|P2|Overall Study|Withdrawal by Subject|1
163777|NCT00793780|521957|P1|Overall Study|Withdrawal by Subject|2
163778|NCT00793793|521985|P12|Overall Study|reason not specified|4
163779|NCT00793793|521986|P11|Overall Study|reason not specified|2
163780|NCT00793793|521987|P10|Overall Study|reason not specified|6
163781|NCT00793793|521988|P9|Overall Study|reason not specified|7
163782|NCT00793793|521989|P8|Overall Study|reason not specified|0
163783|NCT00793793|521990|P7|Overall Study|reason not specified|2
163784|NCT00793793|521991|P6|Overall Study|reason not specified|1
163785|NCT00793793|521992|P5|Overall Study|reason not specified|1
163786|NCT00793793|521993|P4|Overall Study|reason not specified|1
163787|NCT00793793|521994|P3|Overall Study|reason not specified|0
163788|NCT00793793|521995|P2|Overall Study|reason not specified|1
163789|NCT00793793|521996|P1|Overall Study|reason not specified|0
163790|NCT00793793|521985|P12|Overall Study|Withdrawal by Subject|0
163791|NCT00793793|521986|P11|Overall Study|Withdrawal by Subject|0
163792|NCT00793793|521987|P10|Overall Study|Withdrawal by Subject|0
163793|NCT00793793|521988|P9|Overall Study|Withdrawal by Subject|1
163794|NCT00793793|521989|P8|Overall Study|Withdrawal by Subject|0
163795|NCT00793793|521990|P7|Overall Study|Withdrawal by Subject|0
163796|NCT00793793|521991|P6|Overall Study|Withdrawal by Subject|0
163797|NCT00793793|521992|P5|Overall Study|Withdrawal by Subject|1
163798|NCT00793793|521993|P4|Overall Study|Withdrawal by Subject|0
163799|NCT00793793|521994|P3|Overall Study|Withdrawal by Subject|0
163800|NCT00793793|521995|P2|Overall Study|Withdrawal by Subject|0
163801|NCT00793793|521996|P1|Overall Study|Withdrawal by Subject|0
163802|NCT00793793|521985|P12|Overall Study|Lost to Follow-up|0
163803|NCT00793793|521986|P11|Overall Study|Lost to Follow-up|1
163804|NCT00793793|521987|P10|Overall Study|Lost to Follow-up|3
163805|NCT00793793|521988|P9|Overall Study|Lost to Follow-up|1
163806|NCT00793793|521989|P8|Overall Study|Lost to Follow-up|0
163807|NCT00793793|521990|P7|Overall Study|Lost to Follow-up|0
163808|NCT00793793|521991|P6|Overall Study|Lost to Follow-up|0
163809|NCT00793793|521992|P5|Overall Study|Lost to Follow-up|0
163810|NCT00793793|521993|P4|Overall Study|Lost to Follow-up|0
163811|NCT00793793|521994|P3|Overall Study|Lost to Follow-up|1
163812|NCT00793793|521995|P2|Overall Study|Lost to Follow-up|0
163813|NCT00793793|521996|P1|Overall Study|Lost to Follow-up|0
163814|NCT00793793|521985|P12|Overall Study|Protocol Violation|0
163815|NCT00793793|521986|P11|Overall Study|Protocol Violation|0
163816|NCT00793793|521987|P10|Overall Study|Protocol Violation|0
163817|NCT00793793|521988|P9|Overall Study|Protocol Violation|0
163818|NCT00793793|521989|P8|Overall Study|Protocol Violation|0
163819|NCT00793793|521990|P7|Overall Study|Protocol Violation|0
163820|NCT00793793|521991|P6|Overall Study|Protocol Violation|0
163821|NCT00793793|521992|P5|Overall Study|Protocol Violation|0
163822|NCT00793793|521993|P4|Overall Study|Protocol Violation|1
163823|NCT00793793|521994|P3|Overall Study|Protocol Violation|0
163824|NCT00793793|521995|P2|Overall Study|Protocol Violation|0
163825|NCT00793793|521996|P1|Overall Study|Protocol Violation|0
163826|NCT00793793|521985|P12|Overall Study|Adverse Event|2
163827|NCT00793793|521986|P11|Overall Study|Adverse Event|0
163828|NCT00793793|521987|P10|Overall Study|Adverse Event|0
163829|NCT00793793|521988|P9|Overall Study|Adverse Event|0
163830|NCT00793793|521989|P8|Overall Study|Adverse Event|0
163831|NCT00793793|521990|P7|Overall Study|Adverse Event|2
163832|NCT00793793|521991|P6|Overall Study|Adverse Event|1
163833|NCT00793793|521992|P5|Overall Study|Adverse Event|0
163834|NCT00793793|521993|P4|Overall Study|Adverse Event|1
163835|NCT00793793|521994|P3|Overall Study|Adverse Event|1
163836|NCT00793793|521995|P2|Overall Study|Adverse Event|0
163837|NCT00793793|521996|P1|Overall Study|Adverse Event|0
163838|NCT00793819|522371|P2|Overall Study|Lost to Follow-up|1
163839|NCT00793819|522372|P1|Overall Study|Lost to Follow-up|1
163840|NCT00793819|522371|P2|Overall Study|Withdrawal by Subject|3
163841|NCT00793819|522372|P1|Overall Study|Withdrawal by Subject|4
163842|NCT00793819|522371|P2|Overall Study|Lack of Efficacy|1
163843|NCT00793819|522372|P1|Overall Study|Lack of Efficacy|1
163844|NCT00793819|522371|P2|Overall Study|Adverse Event|4
163845|NCT00793819|522372|P1|Overall Study|Adverse Event|8
163846|NCT00793871|522378|P1|Overall Study|Study terminated by the Sponsor|7
163847|NCT00793871|522378|P1|Overall Study|Lost to Follow-up|3
163848|NCT00793871|522378|P1|Overall Study|Death|50
163849|NCT00793910|522392|P2|Overall Study|Withdrawal by Subject|1
163850|NCT00793910|522393|P1|Overall Study|Withdrawal by Subject|0
163851|NCT00793910|522392|P2|Overall Study|decided to undergo LASIK instead of PRK|1
163852|NCT00793910|522393|P1|Overall Study|decided to undergo LASIK instead of PRK|2
163853|NCT00793910|522392|P2|Overall Study|ineligible based on entry criteria|3
163854|NCT00793910|522393|P1|Overall Study|ineligible based on entry criteria|2
163855|NCT00793910|522392|P2|Overall Study|did not pick up medications|1
163856|NCT00793910|522393|P1|Overall Study|did not pick up medications|1
163857|NCT00793910|522392|P2|Overall Study|discarded study pills|1
163858|NCT00793910|522393|P1|Overall Study|discarded study pills|0
163859|NCT00794118|522407|P1|Overall Study|Changed hospital center|2
163860|NCT00794118|522407|P1|Overall Study|Withdrawal by Subject|9
163861|NCT00794118|522407|P1|Overall Study|Lost to Follow-up|16
163862|NCT00794157|522475|P3|Overall Study|Protocol deviation|1
163863|NCT00794157|522476|P2|Overall Study|Protocol deviation|1
163864|NCT00794157|522477|P1|Overall Study|Protocol deviation|0
163865|NCT00794157|522475|P3|Overall Study|Abnormal test procedure result(s)|0
163866|NCT00794157|522476|P2|Overall Study|Abnormal test procedure result(s)|1
163867|NCT00794157|522477|P1|Overall Study|Abnormal test procedure result(s)|0
163868|NCT00794157|522475|P3|Overall Study|Administrative problems|4
163869|NCT00794157|522476|P2|Overall Study|Administrative problems|7
163870|NCT00794157|522477|P1|Overall Study|Administrative problems|1
163871|NCT00794157|522475|P3|Overall Study|Unsatisfactory therapeutic effect|2
163872|NCT00794157|522476|P2|Overall Study|Unsatisfactory therapeutic effect|0
163873|NCT00794157|522477|P1|Overall Study|Unsatisfactory therapeutic effect|1
163874|NCT00794157|522475|P3|Overall Study|Lost to Follow-up|1
163875|NCT00794157|522476|P2|Overall Study|Lost to Follow-up|0
163876|NCT00794157|522477|P1|Overall Study|Lost to Follow-up|2
163877|NCT00794157|522475|P3|Overall Study|Subject withdrew consent|3
163878|NCT00794157|522476|P2|Overall Study|Subject withdrew consent|0
163879|NCT00794157|522477|P1|Overall Study|Subject withdrew consent|2
163880|NCT00794157|522475|P3|Overall Study|Adverse Event|8
163881|NCT00794157|522476|P2|Overall Study|Adverse Event|1
163882|NCT00794157|522477|P1|Overall Study|Adverse Event|4
163883|NCT00794196|522508|P2|Overall Study|Lost to Follow-up|23
163884|NCT00794196|522509|P1|Overall Study|Lost to Follow-up|5
163885|NCT00794365|522530|P1|Overall Study|Lack of Efficacy|3
163886|NCT00794365|522530|P1|Overall Study|Adverse Event|10
163887|NCT00794365|522530|P1|Overall Study|Poor Compliance|11
163888|NCT00794365|522530|P1|Overall Study|Unspecified|17
163889|NCT00794365|522530|P1|Overall Study|Lost to Follow-up|38
163890|NCT00794664|522578|P2|Follow-up Period|Protocol non-compliance|1
163891|NCT00794664|522579|P1|Follow-up Period|Protocol non-compliance|0
163892|NCT00794664|522578|P2|Follow-up Period|Withdrawal by Subject|2
163893|NCT00794664|522579|P1|Follow-up Period|Withdrawal by Subject|0
163894|NCT00794664|522578|P2|Follow-up Period|Not specified|2
163895|NCT00794664|522579|P1|Follow-up Period|Not specified|1
163896|NCT00794664|522578|P2|Treatment Period|Adverse Event|8
163897|NCT00794664|522579|P1|Treatment Period|Adverse Event|1
163898|NCT00794664|522578|P2|Treatment Period|Not specified|1
163899|NCT00794664|522579|P1|Treatment Period|Not specified|0
163900|NCT00794664|522578|P2|Treatment Period|Protocol non-compliance|1
163901|NCT00794664|522579|P1|Treatment Period|Protocol non-compliance|0
163902|NCT00794664|522578|P2|Treatment Period|Withdrawal by Subject|2
163903|NCT00794664|522579|P1|Treatment Period|Withdrawal by Subject|0
163904|NCT00794677|522625|P2|First Intervention|Withdrawal by Subject|0
163905|NCT00794677|522626|P1|First Intervention|Withdrawal by Subject|2
163906|NCT00794820|522646|P1|Overall Study|Ineligible/Screen Failure|1
163907|NCT00794820|522646|P1|Overall Study|Resistant Disease|2
163908|NCT00794820|522646|P1|Overall Study|Secondary Malignancies|2
163909|NCT00794820|522646|P1|Overall Study|Adverse Event|11
163910|NCT00794924|522654|P2|Overall Study|Adverse Event|2
163911|NCT00794924|522655|P1|Overall Study|Adverse Event|6
163912|NCT00794924|522654|P2|Overall Study|Withdrawal by Subject|60
163913|NCT00794924|522655|P1|Overall Study|Withdrawal by Subject|48
163914|NCT00794924|522654|P2|Overall Study|Lost to Follow-up|8
163915|NCT00794924|522655|P1|Overall Study|Lost to Follow-up|6
163916|NCT00794963|522661|P2|Overall Study|Withdrawal by Subject|4
163917|NCT00794963|522662|P1|Overall Study|Withdrawal by Subject|1
163918|NCT00795132|522677|P1|Overall Study|Relapse|2
163919|NCT00795132|522677|P1|Overall Study|Death|1
163920|NCT00795184|522741|P2|Overall Study|Tissue sampling incomplete/conclusive|13
163921|NCT00795184|522742|P1|Overall Study|Tissue sampling incomplete/conclusive|8
163922|NCT00795509|522802|P1|Overall Study|Protocol Violation|31
163923|NCT00795535|522807|P1|Overall Study|incomplete data and technical problems|20
163924|NCT00795600|522816|P2|Overall Study|Unclassified|1
163925|NCT00795600|522817|P1|Overall Study|Unclassified|1
163926|NCT00795600|522816|P2|Overall Study|Withdrawal by Subject|0
163927|NCT00795600|522817|P1|Overall Study|Withdrawal by Subject|1
163928|NCT00795600|522816|P2|Overall Study|Protocol Violation|2
163929|NCT00795600|522817|P1|Overall Study|Protocol Violation|1
163930|NCT00795600|522816|P2|Overall Study|Adverse Event|1
163931|NCT00795600|522817|P1|Overall Study|Adverse Event|1
163932|NCT00795639|522939|P2|Overall Study|Randomized and not treated|1
163933|NCT00795639|522940|P1|Overall Study|Randomized and not treated|0
163934|NCT00795639|522939|P2|Overall Study|Terminated by sponsor|12
163935|NCT00795639|522940|P1|Overall Study|Terminated by sponsor|13
163936|NCT00795639|522939|P2|Overall Study|Unspecified|2
163937|NCT00795639|522940|P1|Overall Study|Unspecified|0
163938|NCT00795639|522939|P2|Overall Study|Adverse Event|2
163939|NCT00795639|522940|P1|Overall Study|Adverse Event|5
163940|NCT00795639|522939|P2|Overall Study|Pregnancy|0
163941|NCT00795639|522940|P1|Overall Study|Pregnancy|1
163942|NCT00795639|522939|P2|Overall Study|Withdrawal by Subject|3
163943|NCT00795639|522940|P1|Overall Study|Withdrawal by Subject|1
163944|NCT00795639|522939|P2|Overall Study|Death|6
163945|NCT00795639|522940|P1|Overall Study|Death|1
163946|NCT00795704|522952|P2|Overall Study|Adverse Event|1
163947|NCT00795704|522953|P1|Overall Study|Adverse Event|1
163948|NCT00795704|522952|P2|Overall Study|Withdrawal by Subject|2
163949|NCT00795704|522953|P1|Overall Study|Withdrawal by Subject|3
163950|NCT00795717|522965|P2|Phase II|too busy|1
163951|NCT00795717|522966|P1|Phase II|too busy|0
163952|NCT00795717|522965|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
163953|NCT00795717|522966|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
163954|NCT00795717|522965|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
163955|NCT00795717|522966|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
163956|NCT00795717|522965|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
163957|NCT00795717|522966|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
163958|NCT00795886|522980|P1|Overall Study|Death|10
163959|NCT00795951|522986|P1|Overall Study|Withdrawal by Subject|1
163960|NCT00795951|522986|P1|Overall Study|Lost to Follow-up|1
163961|NCT00796003|523025|P2|Overall Study|Participants Not treated|2
163962|NCT00796003|523026|P1|Overall Study|Participants Not treated|0
163963|NCT00796003|523025|P2|Overall Study|Unspecified|1
163964|NCT00796003|523026|P1|Overall Study|Unspecified|0
163965|NCT00796003|523025|P2|Overall Study|Withdrawal by Subject|1
163966|NCT00796003|523026|P1|Overall Study|Withdrawal by Subject|0
163967|NCT00796003|523025|P2|Overall Study|Physician Decision|4
163968|NCT00796003|523026|P1|Overall Study|Physician Decision|0
163969|NCT00796003|523025|P2|Overall Study|Specified organ function not met|1
163970|NCT00796003|523026|P1|Overall Study|Specified organ function not met|0
163971|NCT00796003|523025|P2|Overall Study|Adverse Event|7
163972|NCT00796003|523026|P1|Overall Study|Adverse Event|1
163973|NCT00796003|523025|P2|Overall Study|Disease Progression|13
163974|NCT00796003|523026|P1|Overall Study|Disease Progression|2
163975|NCT00796120|523049|P2|Overall Study|Randomized but not treated|3
163976|NCT00796120|523050|P1|Overall Study|Randomized but not treated|0
163977|NCT00796120|523049|P2|Overall Study|Physician Decision|17
163978|NCT00796120|523050|P1|Overall Study|Physician Decision|16
163979|NCT00796120|523049|P2|Overall Study|unspecified|17
163980|NCT00796120|523050|P1|Overall Study|unspecified|6
163981|NCT00796120|523049|P2|Overall Study|Participant refusal|4
163982|NCT00796120|523050|P1|Overall Study|Participant refusal|3
163983|NCT00796120|523049|P2|Overall Study|Progressive disease|13
163984|NCT00796120|523050|P1|Overall Study|Progressive disease|22
163985|NCT00796120|523049|P2|Overall Study|Adverse Event|6
163986|NCT00796120|523050|P1|Overall Study|Adverse Event|11
163987|NCT00796120|523049|P2|Overall Study|Death|0
163988|NCT00796120|523050|P1|Overall Study|Death|3
163989|NCT00783198|523067|P3|Overall Study|Administrative|2
163990|NCT00783198|523068|P2|Overall Study|Administrative|1
163991|NCT00783198|523069|P1|Overall Study|Administrative|2
163992|NCT00783198|523067|P3|Overall Study|Did not meet protocol eligibility|0
163993|NCT00783198|523068|P2|Overall Study|Did not meet protocol eligibility|1
163994|NCT00783198|523069|P1|Overall Study|Did not meet protocol eligibility|0
163995|NCT00783198|523067|P3|Overall Study|Noncompliance with protocol|10
163996|NCT00783198|523068|P2|Overall Study|Noncompliance with protocol|7
163997|NCT00783198|523069|P1|Overall Study|Noncompliance with protocol|7
163998|NCT00783198|523067|P3|Overall Study|Withdrawal by Subject|20
163999|NCT00783198|523068|P2|Overall Study|Withdrawal by Subject|14
164000|NCT00783198|523069|P1|Overall Study|Withdrawal by Subject|22
164001|NCT00783198|523067|P3|Overall Study|Lost to Follow-up|7
164002|NCT00783198|523068|P2|Overall Study|Lost to Follow-up|1
164003|NCT00783198|523069|P1|Overall Study|Lost to Follow-up|11
164004|NCT00783198|523067|P3|Overall Study|Adverse Event|3
164005|NCT00783198|523068|P2|Overall Study|Adverse Event|19
164006|NCT00783198|523069|P1|Overall Study|Adverse Event|15
164007|NCT00783224|523093|P4|Overall Study|Inappropriate as a study subject|1
164008|NCT00783224|523094|P3|Overall Study|Inappropriate as a study subject|0
164009|NCT00783224|523095|P2|Overall Study|Inappropriate as a study subject|0
164010|NCT00783224|523096|P1|Overall Study|Inappropriate as a study subject|0
164011|NCT00783224|523093|P4|Overall Study|Discarded the Investigational Drug Used|1
164012|NCT00783224|523094|P3|Overall Study|Discarded the Investigational Drug Used|0
164013|NCT00783224|523095|P2|Overall Study|Discarded the Investigational Drug Used|0
164014|NCT00783224|523096|P1|Overall Study|Discarded the Investigational Drug Used|0
164015|NCT00783224|523093|P4|Overall Study|Adverse Event|0
164016|NCT00783224|523094|P3|Overall Study|Adverse Event|1
164017|NCT00783224|523095|P2|Overall Study|Adverse Event|0
164018|NCT00783224|523096|P1|Overall Study|Adverse Event|0
164019|NCT00783263|523109|P4|Overall Study|Withdrawal by Subject|2
164020|NCT00783263|523110|P3|Overall Study|Withdrawal by Subject|1
164021|NCT00783263|523111|P2|Overall Study|Withdrawal by Subject|1
164022|NCT00783263|523112|P1|Overall Study|Withdrawal by Subject|0
164023|NCT00783263|523109|P4|Overall Study|Lost to Follow-up|0
164024|NCT00783263|523110|P3|Overall Study|Lost to Follow-up|0
164025|NCT00783263|523111|P2|Overall Study|Lost to Follow-up|1
164026|NCT00783263|523112|P1|Overall Study|Lost to Follow-up|1
164027|NCT00783263|523109|P4|Overall Study|Adverse Event|1
164028|NCT00783263|523110|P3|Overall Study|Adverse Event|2
164029|NCT00783263|523111|P2|Overall Study|Adverse Event|0
164030|NCT00783263|523112|P1|Overall Study|Adverse Event|3
164031|NCT00783302|523138|P1|Overall Study|Withdrawal by Subject|3
164032|NCT00783302|523138|P1|Overall Study|Physician Decision|1
164033|NCT00783302|523138|P1|Overall Study|Protocol Violation|3
164034|NCT00783302|523138|P1|Overall Study|Technical Problems|11
164035|NCT00783302|523138|P1|Overall Study|Lost to Follow-up|17
164036|NCT00783432|523158|P2|Overall Study|Protocol Violation|9
164037|NCT00783432|523159|P1|Overall Study|Protocol Violation|6
164038|NCT00783432|523158|P2|Overall Study|subject moved|5
164039|NCT00783432|523159|P1|Overall Study|subject moved|3
164040|NCT00783432|523158|P2|Overall Study|Withdrawal by Subject|20
164041|NCT00783432|523159|P1|Overall Study|Withdrawal by Subject|23
164042|NCT00783432|523158|P2|Overall Study|Lost to Follow-up|6
164043|NCT00783432|523159|P1|Overall Study|Lost to Follow-up|11
164044|NCT00783432|523158|P2|Overall Study|Lack of Efficacy|21
164045|NCT00783432|523159|P1|Overall Study|Lack of Efficacy|20
164046|NCT00783432|523158|P2|Overall Study|Adverse Event|17
164047|NCT00783432|523159|P1|Overall Study|Adverse Event|22
164048|NCT00796224|523171|P2|Overall Study|Protocol Violation|1
164049|NCT00796224|523172|P1|Overall Study|Protocol Violation|0
164050|NCT00796224|523171|P2|Overall Study|Adverse Event|0
164051|NCT00796224|523172|P1|Overall Study|Adverse Event|1
164052|NCT00796315|523205|P3|Overall Study|Protocol Violation|0
164053|NCT00796315|523206|P2|Overall Study|Protocol Violation|1
164054|NCT00796315|523207|P1|Overall Study|Protocol Violation|0
164055|NCT00796328|523218|P1|Overall Study|experienced hypotension requiring tx|6
164056|NCT00796367|523225|P3|Overall Study|other|3
164057|NCT00796367|523226|P2|Overall Study|other|4
164058|NCT00796367|523227|P1|Overall Study|other|2
164059|NCT00796367|523225|P3|Overall Study|Requirement for restricted medication|2
164060|NCT00796367|523226|P2|Overall Study|Requirement for restricted medication|0
164061|NCT00796367|523227|P1|Overall Study|Requirement for restricted medication|2
164062|NCT00796367|523225|P3|Overall Study|Pregnancy|1
164063|NCT00796367|523226|P2|Overall Study|Pregnancy|0
164064|NCT00796367|523227|P1|Overall Study|Pregnancy|1
164065|NCT00796367|523225|P3|Overall Study|non compliance|1
164066|NCT00796367|523226|P2|Overall Study|non compliance|1
164067|NCT00796367|523227|P1|Overall Study|non compliance|3
164068|NCT00796367|523225|P3|Overall Study|Lack of Efficacy|0
164069|NCT00796367|523226|P2|Overall Study|Lack of Efficacy|1
164070|NCT00796367|523227|P1|Overall Study|Lack of Efficacy|2
164071|NCT00796367|523225|P3|Overall Study|Withdrawal by Subject|12
164072|NCT00796367|523226|P2|Overall Study|Withdrawal by Subject|11
164073|NCT00796367|523227|P1|Overall Study|Withdrawal by Subject|9
164074|NCT00796367|523225|P3|Overall Study|Lost to Follow-up|21
164075|NCT00796367|523226|P2|Overall Study|Lost to Follow-up|4
164076|NCT00796367|523227|P1|Overall Study|Lost to Follow-up|5
164077|NCT00796367|523225|P3|Overall Study|Adverse Event|7
164078|NCT00796367|523226|P2|Overall Study|Adverse Event|4
164079|NCT00796367|523227|P1|Overall Study|Adverse Event|6
164080|NCT00796419|523240|P2|Overall Study|Death|1
164081|NCT00796419|523241|P1|Overall Study|Death|0
164082|NCT00796510|523253|P2|Overall Study|Study Terminated|0
164083|NCT00796510|523254|P1|Overall Study|Study Terminated|2
164084|NCT00796510|523253|P2|Overall Study|Death|0
164085|NCT00796510|523254|P1|Overall Study|Death|1
164086|NCT00796523|523266|P2|Overall Study|Lost to Follow-up|7
164087|NCT00796523|523267|P1|Overall Study|Lost to Follow-up|9
164088|NCT00796549|523275|P1|Overall Study|Progressive disease|56
164089|NCT00796549|523275|P1|Overall Study|Other|2
164090|NCT00796549|523275|P1|Overall Study|not entered|149
164091|NCT00796549|523275|P1|Overall Study|Adverse Event|11
164092|NCT00796991|523293|P3|Overall Study|Withdrawal by Subject|1
164093|NCT00796991|523294|P2|Overall Study|Withdrawal by Subject|0
164094|NCT00796991|523295|P1|Overall Study|Withdrawal by Subject|0
164095|NCT00796991|523293|P3|Overall Study|Study Drug Toxicity|5
164096|NCT00796991|523294|P2|Overall Study|Study Drug Toxicity|3
164097|NCT00796991|523295|P1|Overall Study|Study Drug Toxicity|3
164098|NCT00796991|523293|P3|Overall Study|Disease Progression|7
164099|NCT00796991|523294|P2|Overall Study|Disease Progression|9
164100|NCT00796991|523295|P1|Overall Study|Disease Progression|10
164101|NCT00796991|523293|P3|Overall Study|Death|0
164102|NCT00796991|523294|P2|Overall Study|Death|0
164103|NCT00796991|523295|P1|Overall Study|Death|2
164104|NCT00796991|523293|P3|Overall Study|Adverse Event|1
164105|NCT00796991|523294|P2|Overall Study|Adverse Event|0
164106|NCT00796991|523295|P1|Overall Study|Adverse Event|0
164107|NCT00797108|523396|P3|Overall Study|Randomized but not Treated|0
164108|NCT00797108|523397|P2|Overall Study|Randomized but not Treated|0
164109|NCT00797108|523398|P1|Overall Study|Randomized but not Treated|2
164110|NCT00797108|523396|P3|Overall Study|Unspecified|2
164111|NCT00797108|523397|P2|Overall Study|Unspecified|0
164112|NCT00797108|523398|P1|Overall Study|Unspecified|0
164113|NCT00797108|523396|P3|Overall Study|Lack of Efficacy|1
164114|NCT00797108|523397|P2|Overall Study|Lack of Efficacy|0
164115|NCT00797108|523398|P1|Overall Study|Lack of Efficacy|1
164116|NCT00797108|523396|P3|Overall Study|Global Deterioration of Health Status|0
164117|NCT00797108|523397|P2|Overall Study|Global Deterioration of Health Status|1
164118|NCT00797108|523398|P1|Overall Study|Global Deterioration of Health Status|0
164119|NCT00797108|523396|P3|Overall Study|Did Not Meet Entrance Criteria|0
164120|NCT00797108|523397|P2|Overall Study|Did Not Meet Entrance Criteria|1
164121|NCT00797108|523398|P1|Overall Study|Did Not Meet Entrance Criteria|0
164122|NCT00797108|523396|P3|Overall Study|Adverse Event|3
164123|NCT00797108|523397|P2|Overall Study|Adverse Event|0
164124|NCT00797108|523398|P1|Overall Study|Adverse Event|1
164125|NCT00797316|523449|P2|Overall Study|Unsatisfactory therapeutic effect|13
164126|NCT00797316|523450|P1|Overall Study|Unsatisfactory therapeutic effect|0
164127|NCT00797316|523449|P2|Overall Study|Patient withdrew consent|6
164128|NCT00797316|523450|P1|Overall Study|Patient withdrew consent|12
164129|NCT00797316|523449|P2|Overall Study|Protocol Deviation|2
164130|NCT00797316|523450|P1|Overall Study|Protocol Deviation|1
164131|NCT00797316|523449|P2|Overall Study|Lost to Follow-up|8
164132|NCT00797316|523450|P1|Overall Study|Lost to Follow-up|4
164133|NCT00797316|523449|P2|Overall Study|Adverse Event|3
164134|NCT00797316|523450|P1|Overall Study|Adverse Event|5
164135|NCT00797316|523449|P2|Overall Study|Administrative problems|0
164136|NCT00797316|523450|P1|Overall Study|Administrative problems|1
164137|NCT00797511|523472|P1|Overall Study|Withdrawal by Subject|1
164138|NCT00797563|523480|P1|Overall Study|Adverse Event|1
164139|NCT00797667|523489|P3|Overall Study|Adverse Event|8
164140|NCT00797667|523490|P2|Overall Study|Adverse Event|8
164141|NCT00797667|523491|P1|Overall Study|Adverse Event|19
164142|NCT00797667|523489|P3|Overall Study|Withdrawal by Subject|2
164143|NCT00797667|523490|P2|Overall Study|Withdrawal by Subject|14
164144|NCT00797667|523491|P1|Overall Study|Withdrawal by Subject|9
164145|NCT00797667|523489|P3|Overall Study|Study Terminated by Sponsor|115
164146|NCT00797667|523490|P2|Overall Study|Study Terminated by Sponsor|216
164147|NCT00797667|523491|P1|Overall Study|Study Terminated by Sponsor|217
164148|NCT00797667|523489|P3|Overall Study|Protocol Violation|0
164149|NCT00797667|523490|P2|Overall Study|Protocol Violation|7
164150|NCT00797667|523491|P1|Overall Study|Protocol Violation|2
164151|NCT00797667|523489|P3|Overall Study|Pregnancy|0
164152|NCT00797667|523490|P2|Overall Study|Pregnancy|0
164153|NCT00797667|523491|P1|Overall Study|Pregnancy|2
164154|NCT00797667|523489|P3|Overall Study|Physician Decision|0
164155|NCT00797667|523490|P2|Overall Study|Physician Decision|1
164156|NCT00797667|523491|P1|Overall Study|Physician Decision|3
164157|NCT00797667|523489|P3|Overall Study|Lost to Follow-up|2
164158|NCT00797667|523490|P2|Overall Study|Lost to Follow-up|12
164159|NCT00797667|523491|P1|Overall Study|Lost to Follow-up|8
164160|NCT00797667|523489|P3|Overall Study|Lack of Efficacy|0
164161|NCT00797667|523490|P2|Overall Study|Lack of Efficacy|1
164162|NCT00797667|523491|P1|Overall Study|Lack of Efficacy|0
164163|NCT00797823|523531|P3|First Period (Initial Randomization)|Physician Decision|0
164164|NCT00797823|523532|P2|First Period (Initial Randomization)|Physician Decision|0
164165|NCT00797823|523533|P1|First Period (Initial Randomization)|Physician Decision|1
164166|NCT00797862|523545|P3|Overall Study|Mis-randomized|1
164167|NCT00797862|523546|P2|Overall Study|Mis-randomized|3
164168|NCT00797862|523547|P1|Overall Study|Mis-randomized|3
164169|NCT00797862|523545|P3|Overall Study|Protocol Violation|8
164170|NCT00797862|523546|P2|Overall Study|Protocol Violation|6
164171|NCT00797862|523547|P1|Overall Study|Protocol Violation|4
164172|NCT00797862|523545|P3|Overall Study|Administrative Problem|0
164173|NCT00797862|523546|P2|Overall Study|Administrative Problem|0
164174|NCT00797862|523547|P1|Overall Study|Administrative Problem|4
164175|NCT00797862|523545|P3|Overall Study|Lost to Follow-up|5
164176|NCT00797862|523546|P2|Overall Study|Lost to Follow-up|0
164177|NCT00797862|523547|P1|Overall Study|Lost to Follow-up|11
164178|NCT00797862|523545|P3|Overall Study|Withdrawal by Subject|7
164179|NCT00797862|523546|P2|Overall Study|Withdrawal by Subject|7
164180|NCT00797862|523547|P1|Overall Study|Withdrawal by Subject|14
164181|NCT00797862|523545|P3|Overall Study|No longer required study medication|0
164182|NCT00797862|523546|P2|Overall Study|No longer required study medication|0
164183|NCT00797862|523547|P1|Overall Study|No longer required study medication|1
164184|NCT00797862|523545|P3|Overall Study|Lack of Efficacy|6
164185|NCT00797862|523546|P2|Overall Study|Lack of Efficacy|7
164186|NCT00797862|523547|P1|Overall Study|Lack of Efficacy|1
164187|NCT00797862|523545|P3|Overall Study|Abnormal Test Procedure Result|1
164188|NCT00797862|523546|P2|Overall Study|Abnormal Test Procedure Result|1
164189|NCT00797862|523547|P1|Overall Study|Abnormal Test Procedure Result|0
164190|NCT00797862|523545|P3|Overall Study|Adverse Event|58
164191|NCT00797862|523546|P2|Overall Study|Adverse Event|44
164192|NCT00797862|523547|P1|Overall Study|Adverse Event|86
164193|NCT00797966|523577|P6|Phase A+|Protocol deviation|4
164194|NCT00797966|523578|P5|Phase A+|Protocol deviation|0
164195|NCT00797966|523579|P4|Phase A+|Protocol deviation|0
164196|NCT00797966|523580|P3|Phase A+|Protocol deviation|0
164197|NCT00797966|523581|P2|Phase A+|Protocol deviation|0
164198|NCT00797966|523582|P1|Phase A+|Protocol deviation|0
164199|NCT00797966|523577|P6|Phase A+|Adverse Event|4
164200|NCT00797966|523578|P5|Phase A+|Adverse Event|0
164201|NCT00797966|523579|P4|Phase A+|Adverse Event|0
164202|NCT00797966|523580|P3|Phase A+|Adverse Event|0
164203|NCT00797966|523581|P2|Phase A+|Adverse Event|0
164204|NCT00797966|523582|P1|Phase A+|Adverse Event|0
164205|NCT00797966|523577|P6|Phase A+|Withdrawal by Subject|6
164206|NCT00797966|523578|P5|Phase A+|Withdrawal by Subject|0
164207|NCT00797966|523579|P4|Phase A+|Withdrawal by Subject|0
164208|NCT00797966|523580|P3|Phase A+|Withdrawal by Subject|0
164209|NCT00797966|523581|P2|Phase A+|Withdrawal by Subject|0
164210|NCT00797966|523582|P1|Phase A+|Withdrawal by Subject|0
164211|NCT00797966|523577|P6|Phase A+|Met withdrawal criteria|5
164212|NCT00797966|523578|P5|Phase A+|Met withdrawal criteria|0
164213|NCT00797966|523579|P4|Phase A+|Met withdrawal criteria|0
164214|NCT00797966|523580|P3|Phase A+|Met withdrawal criteria|0
164215|NCT00797966|523581|P2|Phase A+|Met withdrawal criteria|0
164216|NCT00797966|523582|P1|Phase A+|Met withdrawal criteria|0
164217|NCT00797966|523577|P6|Phase A+|Lost to Follow-up|9
164218|NCT00797966|523578|P5|Phase A+|Lost to Follow-up|0
164219|NCT00797966|523579|P4|Phase A+|Lost to Follow-up|0
164220|NCT00797966|523580|P3|Phase A+|Lost to Follow-up|0
164221|NCT00797966|523581|P2|Phase A+|Lost to Follow-up|0
164222|NCT00797966|523582|P1|Phase A+|Lost to Follow-up|0
164223|NCT00797966|523577|P6|Phase B|Lack of Efficacy|0
164224|NCT00797966|523578|P5|Phase B|Lack of Efficacy|0
164225|NCT00797966|523579|P4|Phase B|Lack of Efficacy|4
164226|NCT00797966|523580|P3|Phase B|Lack of Efficacy|1
164227|NCT00797966|523581|P2|Phase B|Lack of Efficacy|1
164228|NCT00797966|523582|P1|Phase B|Lack of Efficacy|0
164229|NCT00797966|523577|P6|Phase B|Protocol Deviation|0
164230|NCT00797966|523578|P5|Phase B|Protocol Deviation|0
164231|NCT00797966|523579|P4|Phase B|Protocol Deviation|6
164232|NCT00797966|523580|P3|Phase B|Protocol Deviation|2
164233|NCT00797966|523581|P2|Phase B|Protocol Deviation|8
164234|NCT00797966|523582|P1|Phase B|Protocol Deviation|4
164235|NCT00797966|523577|P6|Phase B|Withdrawal by Subject|0
164236|NCT00797966|523578|P5|Phase B|Withdrawal by Subject|0
164237|NCT00797966|523579|P4|Phase B|Withdrawal by Subject|3
164238|NCT00797966|523580|P3|Phase B|Withdrawal by Subject|3
164239|NCT00797966|523581|P2|Phase B|Withdrawal by Subject|4
164240|NCT00797966|523582|P1|Phase B|Withdrawal by Subject|1
164241|NCT00797966|523577|P6|Phase B|Physician Decision|0
164242|NCT00797966|523578|P5|Phase B|Physician Decision|0
164243|NCT00797966|523579|P4|Phase B|Physician Decision|1
164244|NCT00797966|523580|P3|Phase B|Physician Decision|3
164245|NCT00797966|523581|P2|Phase B|Physician Decision|0
164246|NCT00797966|523582|P1|Phase B|Physician Decision|1
164247|NCT00797966|523577|P6|Phase B|Met Withdrawal Criteria|0
164248|NCT00797966|523578|P5|Phase B|Met Withdrawal Criteria|0
164249|NCT00797966|523579|P4|Phase B|Met Withdrawal Criteria|1
164250|NCT00797966|523580|P3|Phase B|Met Withdrawal Criteria|6
164251|NCT00797966|523581|P2|Phase B|Met Withdrawal Criteria|3
164252|NCT00797966|523582|P1|Phase B|Met Withdrawal Criteria|3
164253|NCT00797966|523577|P6|Phase B|Adverse Event|0
164254|NCT00797966|523578|P5|Phase B|Adverse Event|0
164255|NCT00797966|523579|P4|Phase B|Adverse Event|1
164256|NCT00797966|523580|P3|Phase B|Adverse Event|3
164257|NCT00797966|523581|P2|Phase B|Adverse Event|1
164258|NCT00797966|523582|P1|Phase B|Adverse Event|2
164259|NCT00797966|523577|P6|Phase B|Lost to Follow-up|0
164260|NCT00797966|523578|P5|Phase B|Lost to Follow-up|0
164261|NCT00797966|523579|P4|Phase B|Lost to Follow-up|0
164262|NCT00797966|523580|P3|Phase B|Lost to Follow-up|3
164263|NCT00797966|523581|P2|Phase B|Lost to Follow-up|1
164264|NCT00797966|523582|P1|Phase B|Lost to Follow-up|0
164265|NCT00797966|523577|P6|Phase A|Protocol deviation|0
164266|NCT00797966|523578|P5|Phase A|Protocol deviation|56
164267|NCT00797966|523579|P4|Phase A|Protocol deviation|0
164268|NCT00797966|523580|P3|Phase A|Protocol deviation|0
164269|NCT00797966|523581|P2|Phase A|Protocol deviation|0
164270|NCT00797966|523582|P1|Phase A|Protocol deviation|0
164271|NCT00797966|523577|P6|Phase A|Withdrawal by Subject|0
164272|NCT00797966|523578|P5|Phase A|Withdrawal by Subject|33
164273|NCT00797966|523579|P4|Phase A|Withdrawal by Subject|0
164274|NCT00797966|523580|P3|Phase A|Withdrawal by Subject|0
164275|NCT00797966|523581|P2|Phase A|Withdrawal by Subject|0
164276|NCT00797966|523582|P1|Phase A|Withdrawal by Subject|0
164277|NCT00797966|523577|P6|Phase A|Physician Decision|0
164278|NCT00797966|523578|P5|Phase A|Physician Decision|13
164279|NCT00797966|523579|P4|Phase A|Physician Decision|0
164280|NCT00797966|523580|P3|Phase A|Physician Decision|0
164281|NCT00797966|523581|P2|Phase A|Physician Decision|0
164282|NCT00797966|523582|P1|Phase A|Physician Decision|0
164283|NCT00797966|523577|P6|Phase A|Met withdrawal criteria|0
164284|NCT00797966|523578|P5|Phase A|Met withdrawal criteria|4
164285|NCT00797966|523579|P4|Phase A|Met withdrawal criteria|0
164286|NCT00797966|523580|P3|Phase A|Met withdrawal criteria|0
164287|NCT00797966|523581|P2|Phase A|Met withdrawal criteria|0
164288|NCT00797966|523582|P1|Phase A|Met withdrawal criteria|0
164289|NCT00797966|523577|P6|Phase A|Adverse Event|0
164290|NCT00797966|523578|P5|Phase A|Adverse Event|46
164291|NCT00797966|523579|P4|Phase A|Adverse Event|0
164292|NCT00797966|523580|P3|Phase A|Adverse Event|0
164293|NCT00797966|523581|P2|Phase A|Adverse Event|0
164294|NCT00797966|523582|P1|Phase A|Adverse Event|0
164295|NCT00797966|523577|P6|Phase A|Lost to Follow-up|0
164296|NCT00797966|523578|P5|Phase A|Lost to Follow-up|33
164297|NCT00797966|523579|P4|Phase A|Lost to Follow-up|0
164298|NCT00797966|523580|P3|Phase A|Lost to Follow-up|0
164299|NCT00797966|523581|P2|Phase A|Lost to Follow-up|0
164300|NCT00797966|523582|P1|Phase A|Lost to Follow-up|0
164301|NCT00798096|523661|P1|Overall Study|Ongoing|2
164302|NCT00798135|523668|P1|Overall Study|Physician Decision|1
164303|NCT00798135|523668|P1|Overall Study|Disease progression, refractory|1
164304|NCT00798135|523668|P1|Overall Study|Disease progression, relapse|11
164305|NCT00798161|523681|P7|Overall Study|Other reason (incl. lack of efficacy)|5
164306|NCT00798161|523682|P6|Overall Study|Other reason (incl. lack of efficacy)|4
164307|NCT00798161|523683|P5|Overall Study|Other reason (incl. lack of efficacy)|2
164308|NCT00798161|523684|P4|Overall Study|Other reason (incl. lack of efficacy)|5
164309|NCT00798161|523685|P3|Overall Study|Other reason (incl. lack of efficacy)|3
164310|NCT00798161|523686|P2|Overall Study|Other reason (incl. lack of efficacy)|5
164311|NCT00798161|523687|P1|Overall Study|Other reason (incl. lack of efficacy)|7
164312|NCT00798161|523681|P7|Overall Study|Withdrawal by Subject|1
164313|NCT00798161|523682|P6|Overall Study|Withdrawal by Subject|3
164314|NCT00798161|523683|P5|Overall Study|Withdrawal by Subject|2
164315|NCT00798161|523684|P4|Overall Study|Withdrawal by Subject|4
164316|NCT00798161|523685|P3|Overall Study|Withdrawal by Subject|5
164317|NCT00798161|523686|P2|Overall Study|Withdrawal by Subject|4
164318|NCT00798161|523687|P1|Overall Study|Withdrawal by Subject|5
164319|NCT00798161|523681|P7|Overall Study|Lost to Follow-up|0
164320|NCT00798161|523682|P6|Overall Study|Lost to Follow-up|0
164321|NCT00798161|523683|P5|Overall Study|Lost to Follow-up|4
164322|NCT00798161|523684|P4|Overall Study|Lost to Follow-up|3
164323|NCT00798161|523685|P3|Overall Study|Lost to Follow-up|4
164324|NCT00798161|523686|P2|Overall Study|Lost to Follow-up|3
164325|NCT00798161|523687|P1|Overall Study|Lost to Follow-up|1
164326|NCT00798161|523681|P7|Overall Study|Protocol Violation|0
164327|NCT00798161|523682|P6|Overall Study|Protocol Violation|2
164328|NCT00798161|523683|P5|Overall Study|Protocol Violation|3
164329|NCT00798161|523684|P4|Overall Study|Protocol Violation|3
164330|NCT00798161|523685|P3|Overall Study|Protocol Violation|3
164331|NCT00798161|523686|P2|Overall Study|Protocol Violation|1
164332|NCT00798161|523687|P1|Overall Study|Protocol Violation|2
164333|NCT00798161|523681|P7|Overall Study|Adverse Event|4
164334|NCT00798161|523682|P6|Overall Study|Adverse Event|2
164335|NCT00798161|523683|P5|Overall Study|Adverse Event|5
164336|NCT00798161|523684|P4|Overall Study|Adverse Event|6
164337|NCT00798161|523685|P3|Overall Study|Adverse Event|6
164338|NCT00798161|523686|P2|Overall Study|Adverse Event|4
164339|NCT00798161|523687|P1|Overall Study|Adverse Event|3
164340|NCT00798304|523797|P3|Overall Study|Discontinuation by Sponsor|9
164341|NCT00798304|523798|P2|Overall Study|Discontinuation by Sponsor|21
164342|NCT00798304|523799|P1|Overall Study|Discontinuation by Sponsor|14
164343|NCT00798304|523797|P3|Overall Study|Adverse Event|1
164344|NCT00798304|523798|P2|Overall Study|Adverse Event|1
164345|NCT00798304|523799|P1|Overall Study|Adverse Event|0
164346|NCT00798317|523827|P2|Overall Study|Death|0
164347|NCT00798317|523828|P1|Overall Study|Death|1
164348|NCT00798317|523827|P2|Overall Study|Adverse Event|0
164349|NCT00798317|523828|P1|Overall Study|Adverse Event|2
164350|NCT00798317|523827|P2|Overall Study|Lost to Follow-up|2
164351|NCT00798317|523828|P1|Overall Study|Lost to Follow-up|2
164352|NCT00798317|523827|P2|Overall Study|Withdrawal by Subject|4
164353|NCT00798317|523828|P1|Overall Study|Withdrawal by Subject|5
164354|NCT00798317|523827|P2|Overall Study|Physician Decision|1
164355|NCT00798317|523828|P1|Overall Study|Physician Decision|0
164356|NCT00798369|523842|P6|Overall Study|Adminstrative problems|1
164357|NCT00798369|523843|P5|Overall Study|Adminstrative problems|0
164358|NCT00798369|523844|P4|Overall Study|Adminstrative problems|0
164359|NCT00798369|523845|P3|Overall Study|Adminstrative problems|0
164360|NCT00798369|523846|P2|Overall Study|Adminstrative problems|0
164361|NCT00798369|523847|P1|Overall Study|Adminstrative problems|0
164362|NCT00798369|523842|P6|Overall Study|Lost to Follow-up|0
164363|NCT00798369|523843|P5|Overall Study|Lost to Follow-up|1
164364|NCT00798369|523844|P4|Overall Study|Lost to Follow-up|0
164365|NCT00798369|523845|P3|Overall Study|Lost to Follow-up|1
164366|NCT00798369|523846|P2|Overall Study|Lost to Follow-up|1
164367|NCT00798369|523847|P1|Overall Study|Lost to Follow-up|1
164368|NCT00798369|523842|P6|Overall Study|Subject withdrew consent|2
164369|NCT00798369|523843|P5|Overall Study|Subject withdrew consent|0
164370|NCT00798369|523844|P4|Overall Study|Subject withdrew consent|1
164371|NCT00798369|523845|P3|Overall Study|Subject withdrew consent|1
164372|NCT00798369|523846|P2|Overall Study|Subject withdrew consent|0
164373|NCT00798369|523847|P1|Overall Study|Subject withdrew consent|0
164374|NCT00798434|523894|P2|Open-Label|Not Treated|1
164375|NCT00798434|523895|P1|Open-Label|Not Treated|0
164376|NCT00798434|523894|P2|Open-Label|Not Specified|2
164377|NCT00798434|523895|P1|Open-Label|Not Specified|1
164378|NCT00798434|523894|P2|Open-Label|Protocol Violation|0
164379|NCT00798434|523895|P1|Open-Label|Protocol Violation|1
164380|NCT00798434|523894|P2|Open-Label|Withdrawal by Subject|7
164381|NCT00798434|523895|P1|Open-Label|Withdrawal by Subject|2
164382|NCT00798434|523894|P2|Open-Label|Lack of Efficacy|11
164383|NCT00798434|523895|P1|Open-Label|Lack of Efficacy|5
164384|NCT00798434|523894|P2|Open-Label|Adverse Event|11
164385|NCT00798434|523895|P1|Open-Label|Adverse Event|33
164386|NCT00798434|523894|P2|Double-Blind|Not Treated|6
164387|NCT00798434|523895|P1|Double-Blind|Not Treated|3
164388|NCT00798434|523894|P2|Double-Blind|Not Specified|0
164389|NCT00798434|523895|P1|Double-Blind|Not Specified|1
164390|NCT00798434|523894|P2|Double-Blind|Did Not Meet Entrance Criteria|1
164391|NCT00798434|523895|P1|Double-Blind|Did Not Meet Entrance Criteria|2
164392|NCT00798434|523894|P2|Double-Blind|Protocol Violation|4
164393|NCT00798434|523895|P1|Double-Blind|Protocol Violation|1
164394|NCT00798434|523894|P2|Double-Blind|Withdrawal by Subject|14
164395|NCT00798434|523895|P1|Double-Blind|Withdrawal by Subject|17
164396|NCT00798434|523894|P2|Double-Blind|Lack of Efficacy|12
164397|NCT00798434|523895|P1|Double-Blind|Lack of Efficacy|8
164398|NCT00798434|523894|P2|Double-Blind|Lost to Follow-up|0
164399|NCT00798434|523895|P1|Double-Blind|Lost to Follow-up|1
164400|NCT00798434|523894|P2|Double-Blind|Death|1
164401|NCT00798434|523895|P1|Double-Blind|Death|0
164402|NCT00798434|523894|P2|Double-Blind|Adverse Event|46
164403|NCT00798434|523895|P1|Double-Blind|Adverse Event|22
164404|NCT00798590|524001|P2|Overall Study|P.I, Left institution. Study terminated|8
164405|NCT00798590|524002|P1|Overall Study|P.I, Left institution. Study terminated|11
164406|NCT00798603|524010|P1|Overall Study|Lack of insurance coverage|1
164407|NCT00798603|524010|P1|Overall Study|Physician Decision|1
164408|NCT00798603|524010|P1|Overall Study|Adverse Event|22
164409|NCT00798603|524010|P1|Overall Study|Withdrawal by Subject|10
164410|NCT00798603|524010|P1|Overall Study|Still on treatment as of 11/6/2012|1
164411|NCT00798655|524030|P1|Overall Study|Did not receive at least one dose of pan|2
164412|NCT00798707|524038|P3|Overall Study|Randomized not treated|1
164413|NCT00798707|524039|P2|Overall Study|Randomized not treated|5
164414|NCT00798707|524040|P1|Overall Study|Randomized not treated|4
164415|NCT00798707|524038|P3|Overall Study|Withdrawal by Subject|2
164416|NCT00798707|524039|P2|Overall Study|Withdrawal by Subject|8
164417|NCT00798707|524040|P1|Overall Study|Withdrawal by Subject|3
164418|NCT00798707|524038|P3|Overall Study|Protocol Violation|2
164419|NCT00798707|524039|P2|Overall Study|Protocol Violation|0
164420|NCT00798707|524040|P1|Overall Study|Protocol Violation|4
164421|NCT00798707|524038|P3|Overall Study|Unspecified|0
164422|NCT00798707|524039|P2|Overall Study|Unspecified|1
164423|NCT00798707|524040|P1|Overall Study|Unspecified|0
164424|NCT00798707|524038|P3|Overall Study|Lost to Follow-up|6
164425|NCT00798707|524039|P2|Overall Study|Lost to Follow-up|6
164426|NCT00798707|524040|P1|Overall Study|Lost to Follow-up|5
164427|NCT00798707|524038|P3|Overall Study|Lack of Efficacy|1
164428|NCT00798707|524039|P2|Overall Study|Lack of Efficacy|2
164429|NCT00798707|524040|P1|Overall Study|Lack of Efficacy|2
164430|NCT00798707|524038|P3|Overall Study|Investigator|2
164431|NCT00798707|524039|P2|Overall Study|Investigator|1
164432|NCT00798707|524040|P1|Overall Study|Investigator|0
164433|NCT00798707|524038|P3|Overall Study|Failed to return|0
164434|NCT00798707|524039|P2|Overall Study|Failed to return|2
164435|NCT00798707|524040|P1|Overall Study|Failed to return|2
164436|NCT00798707|524038|P3|Overall Study|Adverse Event|8
164437|NCT00798707|524039|P2|Overall Study|Adverse Event|8
164438|NCT00798707|524040|P1|Overall Study|Adverse Event|6
164439|NCT00798759|524099|P2|Overall Study|Not specified|1
164440|NCT00798759|524100|P1|Overall Study|Not specified|0
164441|NCT00798759|524099|P2|Overall Study|Protocol Violation|8
164442|NCT00798759|524100|P1|Overall Study|Protocol Violation|4
164443|NCT00798759|524099|P2|Overall Study|Lost to Follow-up|1
164444|NCT00798759|524100|P1|Overall Study|Lost to Follow-up|1
164445|NCT00798759|524099|P2|Overall Study|Adverse Event|3
164446|NCT00798759|524100|P1|Overall Study|Adverse Event|3
164447|NCT00798889|524108|P1|Overall Study|Enrolled, Not treated|3
164448|NCT00798889|524108|P1|Overall Study|Decision of Sponsor|11
164449|NCT00798889|524108|P1|Overall Study|Lack of Efficacy|213
164450|NCT00798889|524108|P1|Overall Study|Lost to Follow-up|1
164451|NCT00798889|524108|P1|Overall Study|Withdrawal by Subject|31
164452|NCT00798889|524108|P1|Overall Study|Protocol Violation|2
164453|NCT00798889|524108|P1|Overall Study|Adverse Event|53
164454|NCT00798967|524114|P2|Overall Study|Randomized in error by site|0
164455|NCT00798967|524115|P1|Overall Study|Randomized in error by site|1
164456|NCT00798967|524114|P2|Overall Study|Physician Decision|0
164457|NCT00798967|524115|P1|Overall Study|Physician Decision|1
164458|NCT00798967|524114|P2|Overall Study|Withdrawal by Subject|1
164459|NCT00798967|524115|P1|Overall Study|Withdrawal by Subject|0
164460|NCT00798967|524114|P2|Overall Study|Adverse Event|3
164461|NCT00798967|524115|P1|Overall Study|Adverse Event|2
164462|NCT00799396|524137|P1|Clopidogrel Plus Aspirin|Physician Decision|4
164463|NCT00799396|524137|P1|Clopidogrel Plus Aspirin|Adverse Event|2
164464|NCT00799396|524137|P1|Clopidogrel Treatment|Withdrawal by Subject|2
164465|NCT00799396|524137|P1|Clopidogrel Treatment|Physician Decision|5
164466|NCT00799396|524137|P1|Clopidogrel Treatment|Adverse Event|6
164467|NCT00799409|524145|P3|Overall Study|medication compliance|0
164468|NCT00799409|524146|P2|Overall Study|medication compliance|0
164469|NCT00799409|524147|P1|Overall Study|medication compliance|1
164470|NCT00799409|524145|P3|Overall Study|Did not attend lab school day 1|0
164471|NCT00799409|524146|P2|Overall Study|Did not attend lab school day 1|0
164472|NCT00799409|524147|P1|Overall Study|Did not attend lab school day 1|1
164473|NCT00799409|524145|P3|Overall Study|Failure to follow study protocol)|0
164474|NCT00799409|524146|P2|Overall Study|Failure to follow study protocol)|0
164475|NCT00799409|524147|P1|Overall Study|Failure to follow study protocol)|1
164476|NCT00799409|524145|P3|Overall Study|Optimal Dose Not Achieved|0
164477|NCT00799409|524146|P2|Overall Study|Optimal Dose Not Achieved|0
164478|NCT00799409|524147|P1|Overall Study|Optimal Dose Not Achieved|2
164479|NCT00799409|524145|P3|Overall Study|Lost to Follow-up|0
164480|NCT00799409|524146|P2|Overall Study|Lost to Follow-up|0
164481|NCT00799409|524147|P1|Overall Study|Lost to Follow-up|1
164482|NCT00799409|524145|P3|Overall Study|Withdrawal by Subject|0
164483|NCT00799409|524146|P2|Overall Study|Withdrawal by Subject|0
164484|NCT00799409|524147|P1|Overall Study|Withdrawal by Subject|1
164485|NCT00799422|524227|P6|First Week of Wear|Adverse Event|0
164486|NCT00799422|524228|P5|First Week of Wear|Adverse Event|0
164487|NCT00799422|524229|P4|First Week of Wear|Adverse Event|1
164488|NCT00799422|524230|P3|First Week of Wear|Adverse Event|0
164489|NCT00799422|524231|P2|First Week of Wear|Adverse Event|0
164490|NCT00799422|524232|P1|First Week of Wear|Adverse Event|0
164491|NCT00799422|524227|P6|First Week of Wear|Lost to Follow-up|0
164492|NCT00799422|524228|P5|First Week of Wear|Lost to Follow-up|0
164493|NCT00799422|524229|P4|First Week of Wear|Lost to Follow-up|0
164494|NCT00799422|524230|P3|First Week of Wear|Lost to Follow-up|1
164495|NCT00799422|524231|P2|First Week of Wear|Lost to Follow-up|0
164496|NCT00799422|524232|P1|First Week of Wear|Lost to Follow-up|0
164497|NCT00799487|524255|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
164498|NCT00799487|524256|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
164499|NCT00799487|524257|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
164500|NCT00799487|524255|P3|Double-Blind Assessment Period|Subject was out of the state|1
164501|NCT00799487|524256|P2|Double-Blind Assessment Period|Subject was out of the state|0
164502|NCT00799487|524257|P1|Double-Blind Assessment Period|Subject was out of the state|0
164503|NCT00799487|524255|P3|Double-Blind Assessment Period|Lost to Follow-up|1
164504|NCT00799487|524256|P2|Double-Blind Assessment Period|Lost to Follow-up|0
164505|NCT00799487|524257|P1|Double-Blind Assessment Period|Lost to Follow-up|0
164506|NCT00799487|524255|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
164507|NCT00799487|524256|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
164508|NCT00799487|524257|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
164509|NCT00799487|524255|P3|Dose Adjustment Period|Missed laboratory day 1|0
164510|NCT00799487|524256|P2|Dose Adjustment Period|Missed laboratory day 1|0
164511|NCT00799487|524257|P1|Dose Adjustment Period|Missed laboratory day 1|1
164512|NCT00799487|524255|P3|Dose Adjustment Period|Child too young (exclusion)|0
164513|NCT00799487|524256|P2|Dose Adjustment Period|Child too young (exclusion)|0
164514|NCT00799487|524257|P1|Dose Adjustment Period|Child too young (exclusion)|1
164515|NCT00799487|524255|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
164516|NCT00799487|524256|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
164517|NCT00799487|524257|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
164518|NCT00799487|524255|P3|Dose Adjustment Period|Withdrawal by Subject|0
164519|NCT00799487|524256|P2|Dose Adjustment Period|Withdrawal by Subject|0
164520|NCT00799487|524257|P1|Dose Adjustment Period|Withdrawal by Subject|3
164521|NCT00799487|524255|P3|Dose Adjustment Period|Investigator Discretion|0
164522|NCT00799487|524256|P2|Dose Adjustment Period|Investigator Discretion|0
164523|NCT00799487|524257|P1|Dose Adjustment Period|Investigator Discretion|2
164524|NCT00799487|524255|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
164525|NCT00799487|524256|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
164526|NCT00799487|524257|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
164527|NCT00799487|524255|P3|Dose Adjustment Period|Adverse Event|0
164528|NCT00799487|524256|P2|Dose Adjustment Period|Adverse Event|0
164529|NCT00799487|524257|P1|Dose Adjustment Period|Adverse Event|2
164530|NCT00799487|524255|P3|Dose Adjustment Period|Lost to Follow-up|0
164531|NCT00799487|524256|P2|Dose Adjustment Period|Lost to Follow-up|0
164532|NCT00799487|524257|P1|Dose Adjustment Period|Lost to Follow-up|1
164533|NCT00786422|524337|P1|Follow-up Period|End-of-study done up to 4 days early|2
164534|NCT00786422|524337|P1|Follow-up Period|Death|1
164535|NCT00786422|524337|P1|Rivaroxaban Treatment|Adverse Event|2
164536|NCT00786422|524337|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
164537|NCT00786422|524337|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
164538|NCT00786422|524337|P1|Rivaroxaban Treatment|Physician Decision|1
164539|NCT00786422|524337|P1|Rivaroxaban Treatment|Lack of Efficacy|1
164540|NCT00786422|524337|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
164541|NCT00786422|524337|P1|Rivaroxaban Treatment|Death|2
164542|NCT00786474|524355|P2|Overall Study|Not Specified|4
164543|NCT00786474|524356|P1|Overall Study|Not Specified|4
164544|NCT00786474|524355|P2|Overall Study|Physician Decision|1
164545|NCT00786474|524356|P1|Overall Study|Physician Decision|2
164546|NCT00786474|524355|P2|Overall Study|Lost to Follow-up|3
164547|NCT00786474|524356|P1|Overall Study|Lost to Follow-up|3
164548|NCT00786474|524355|P2|Overall Study|Withdrawal by Subject|31
164549|NCT00786474|524356|P1|Overall Study|Withdrawal by Subject|23
164550|NCT00786474|524355|P2|Overall Study|Death|4
164551|NCT00786474|524356|P1|Overall Study|Death|5
164552|NCT00786565|524385|P1|Post Surgery|Adapt AO implanted posterior side up|1
164553|NCT00786565|524385|P1|Post Surgery|Abnormal macular pucker|1
164554|NCT00786565|524385|P1|Enrollment Prior to Surgery|Protocol Violation|3
164555|NCT00786565|524385|P1|Enrollment Prior to Surgery|Site Closed|3
164556|NCT00786799|524444|P2|Overall Study|Lost to Follow-up|1
164557|NCT00786799|524445|P1|Overall Study|Lost to Follow-up|1
164558|NCT00786838|524456|P1|Overall Study|Withdrawal by Subject|4
164559|NCT00786838|524456|P1|Overall Study|Progressive disease|31
164560|NCT00786838|524456|P1|Overall Study|Adverse Event|6
164561|NCT00786838|524456|P1|Overall Study|Death|4
164562|NCT00786838|524456|P1|Overall Study|Physician Decision|4
164563|NCT00786864|524483|P2|Overall Study|Sustained serious back injury|0
164564|NCT00786864|524484|P1|Overall Study|Sustained serious back injury|1
164565|NCT00786864|524483|P2|Overall Study|Lost to Follow-up|1
164566|NCT00786864|524484|P1|Overall Study|Lost to Follow-up|0
164567|NCT00787137|524552|P3|Overall Study|Study Termination|1
164568|NCT00787137|524553|P2|Overall Study|Study Termination|0
164569|NCT00787137|524554|P1|Overall Study|Study Termination|0
164570|NCT00787150|524577|P3|Overall Study|Dosing incorrect study durg|0
164571|NCT00787150|524578|P2|Overall Study|Dosing incorrect study durg|0
164572|NCT00787150|524579|P1|Overall Study|Dosing incorrect study durg|2
164573|NCT00787150|524577|P3|Overall Study|Withdrawal by Subject|0
164574|NCT00787150|524578|P2|Overall Study|Withdrawal by Subject|1
164575|NCT00787150|524579|P1|Overall Study|Withdrawal by Subject|2
164576|NCT00787150|524577|P3|Overall Study|Physician Decision|1
164577|NCT00787150|524578|P2|Overall Study|Physician Decision|2
164578|NCT00787150|524579|P1|Overall Study|Physician Decision|1
164579|NCT00787150|524577|P3|Overall Study|Adverse Event|4
164580|NCT00787150|524578|P2|Overall Study|Adverse Event|4
164581|NCT00787150|524579|P1|Overall Study|Adverse Event|4
164582|NCT00787189|524623|P2|Overall Study|Lost to Follow-up|2
164583|NCT00787189|524624|P1|Overall Study|Lost to Follow-up|2
164584|NCT00787202|524635|P5|Overall Study|Randomized, not treated|0
164585|NCT00787202|524636|P4|Overall Study|Randomized, not treated|0
164586|NCT00787202|524637|P3|Overall Study|Randomized, not treated|0
164587|NCT00787202|524638|P2|Overall Study|Randomized, not treated|0
164588|NCT00787202|524639|P1|Overall Study|Randomized, not treated|1
164589|NCT00787202|524635|P5|Overall Study|Protocol Violation|1
164590|NCT00787202|524636|P4|Overall Study|Protocol Violation|0
164591|NCT00787202|524637|P3|Overall Study|Protocol Violation|0
164592|NCT00787202|524638|P2|Overall Study|Protocol Violation|1
164593|NCT00787202|524639|P1|Overall Study|Protocol Violation|2
164594|NCT00787202|524635|P5|Overall Study|Withdrawal by Subject|0
164595|NCT00787202|524636|P4|Overall Study|Withdrawal by Subject|0
164596|NCT00787202|524637|P3|Overall Study|Withdrawal by Subject|2
164597|NCT00787202|524638|P2|Overall Study|Withdrawal by Subject|2
164598|NCT00787202|524639|P1|Overall Study|Withdrawal by Subject|2
164599|NCT00787202|524635|P5|Overall Study|Lost to Follow-up|0
164600|NCT00787202|524636|P4|Overall Study|Lost to Follow-up|0
164601|NCT00787202|524637|P3|Overall Study|Lost to Follow-up|0
164602|NCT00787202|524638|P2|Overall Study|Lost to Follow-up|0
164603|NCT00787202|524639|P1|Overall Study|Lost to Follow-up|1
164604|NCT00787202|524635|P5|Overall Study|Lack of Efficacy|1
164605|NCT00787202|524636|P4|Overall Study|Lack of Efficacy|2
164606|NCT00787202|524637|P3|Overall Study|Lack of Efficacy|5
164607|NCT00787202|524638|P2|Overall Study|Lack of Efficacy|6
164608|NCT00787202|524639|P1|Overall Study|Lack of Efficacy|5
164609|NCT00787202|524635|P5|Overall Study|Adverse Event|2
164610|NCT00787202|524636|P4|Overall Study|Adverse Event|0
164611|NCT00787202|524637|P3|Overall Study|Adverse Event|0
164612|NCT00787202|524638|P2|Overall Study|Adverse Event|2
164613|NCT00787202|524639|P1|Overall Study|Adverse Event|3
164614|NCT00787254|524711|P2|Overall Study|Physician Decision|8
164615|NCT00787254|524712|P1|Overall Study|Physician Decision|4
164616|NCT00787254|524711|P2|Overall Study|Institution closed|0
164617|NCT00787254|524712|P1|Overall Study|Institution closed|1
164618|NCT00787254|524711|P2|Overall Study|NSAIDs discontinuation|2
164619|NCT00787254|524712|P1|Overall Study|NSAIDs discontinuation|1
164620|NCT00787254|524711|P2|Overall Study|Lack of Efficacy|15
164621|NCT00787254|524712|P1|Overall Study|Lack of Efficacy|4
164622|NCT00787254|524711|P2|Overall Study|Withdrawal by Subject|11
164623|NCT00787254|524712|P1|Overall Study|Withdrawal by Subject|16
164624|NCT00787254|524711|P2|Overall Study|Protocol Violation|23
164625|NCT00787254|524712|P1|Overall Study|Protocol Violation|26
164626|NCT00787254|524711|P2|Overall Study|Adverse Event|23
164627|NCT00787254|524712|P1|Overall Study|Adverse Event|24
164628|NCT00787267|524812|P1|Overall Study|Withdrawal by Subject|1
164629|NCT00787267|524812|P1|Overall Study|No Reason Provided|1
164630|NCT00787267|524812|P1|Overall Study|Screen failure/Ineligible|10
164631|NCT00787319|524820|P1|Overall Study|Inactive disease|5
164632|NCT00787319|524820|P1|Overall Study|Stabilized disease findings|3
164633|NCT00787319|524820|P1|Overall Study|No health insurance reimbursement|2
164634|NCT00787319|524820|P1|Overall Study|Unresponsiveness to visit invitation|1
164635|NCT00787319|524820|P1|Overall Study|Budget exhausted/exceeded|1
164636|NCT00787319|524820|P1|Overall Study|Lack of Efficacy|1
164637|NCT00787319|524820|P1|Overall Study|Objective progression or relapse|30
164638|NCT00787319|524820|P1|Overall Study|Adverse Event|3
164639|NCT00787319|524820|P1|Overall Study|Withdrawal by Subject|15
164640|NCT00787319|524820|P1|Overall Study|Lost to Follow-up|2
164641|NCT00787527|524841|P1|Overall Study|Toxicity|3
164642|NCT00787566|524852|P3|Overall Study|AE related to chemotherapy|0
164643|NCT00787566|524853|P2|Overall Study|AE related to chemotherapy|1
164644|NCT00787566|524854|P1|Overall Study|AE related to chemotherapy|0
164645|NCT00787605|524864|P2|Overall Study|Lack of Efficacy|9
164646|NCT00787605|524865|P1|Overall Study|Lack of Efficacy|13
164647|NCT00787605|524864|P2|Overall Study|Withdrawal by Subject|13
164648|NCT00787605|524865|P1|Overall Study|Withdrawal by Subject|6
164649|NCT00787605|524864|P2|Overall Study|Protocol Violation|3
164650|NCT00787605|524865|P1|Overall Study|Protocol Violation|7
164651|NCT00787605|524864|P2|Overall Study|Lost to Follow-up|6
164652|NCT00787605|524865|P1|Overall Study|Lost to Follow-up|3
164653|NCT00787605|524864|P2|Overall Study|Adverse Event|25
164654|NCT00787605|524865|P1|Overall Study|Adverse Event|14
164655|NCT00787605|524864|P2|Overall Study|Administrative Problems|0
164656|NCT00787605|524865|P1|Overall Study|Administrative Problems|3
164657|NCT00787644|524896|P2|Overall Study|Withdrawal by Subject|1
164658|NCT00787644|524897|P1|Overall Study|Withdrawal by Subject|1
164659|NCT00787644|524896|P2|Overall Study|Lost to Follow-up|1
164660|NCT00787644|524897|P1|Overall Study|Lost to Follow-up|1
164661|NCT00787787|524914|P1|Overall Study|Adverse Event|3
164662|NCT00787787|524914|P1|Overall Study|Lack of Efficacy|4
164663|NCT00787800|524922|P2|Overall Study|Death|2
164664|NCT00787800|524923|P1|Overall Study|Death|0
164665|NCT00787800|524922|P2|Overall Study|Withdrawal by Subject|5
164666|NCT00787800|524923|P1|Overall Study|Withdrawal by Subject|3
164667|NCT00787891|524941|P2|Maintenance Double-blind Phase (Part 2)|Not specified|2
164668|NCT00787891|524942|P1|Maintenance Double-blind Phase (Part 2)|Not specified|5
164669|NCT00787891|524941|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
164670|NCT00787891|524942|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
164671|NCT00787891|524941|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
164672|NCT00787891|524942|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
164673|NCT00787891|524941|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
164674|NCT00787891|524942|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
164675|NCT00787891|524941|P2|Short-term Double-blind Phase (Part 1)|Not specified|2
164676|NCT00787891|524942|P1|Short-term Double-blind Phase (Part 1)|Not specified|0
164677|NCT00787891|524941|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
164678|NCT00787891|524942|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
164679|NCT00787891|524941|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
164680|NCT00787891|524942|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
164681|NCT00787891|524941|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
164682|NCT00787891|524942|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
164683|NCT00787891|524941|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
164684|NCT00787891|524942|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
164685|NCT00787891|524941|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
164686|NCT00787891|524942|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
164687|NCT00787917|524973|P2|Open Label|Administrative problems|0
164688|NCT00787917|524974|P1|Open Label|Administrative problems|3
164689|NCT00787917|524973|P2|Open Label|Unsatisfactory therapeutic effect|0
164690|NCT00787917|524974|P1|Open Label|Unsatisfactory therapeutic effect|1
164691|NCT00787917|524973|P2|Blinded Treatment|Administrative problems|2
164692|NCT00787917|524974|P1|Blinded Treatment|Administrative problems|3
164693|NCT00787917|524973|P2|Blinded Treatment|Lack of Efficacy|0
164694|NCT00787917|524974|P1|Blinded Treatment|Lack of Efficacy|1
164695|NCT00787917|524973|P2|Blinded Treatment|Adverse Event|0
164696|NCT00787917|524974|P1|Blinded Treatment|Adverse Event|1
164697|NCT00787930|524991|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
164698|NCT00788073|525023|P2|Placebo Then STX209|Protocol Violation|1
164699|NCT00788073|525024|P1|Placebo Then STX209|Protocol Violation|0
164700|NCT00788073|525023|P2|Placebo Then STX209|Adverse Event|0
164701|NCT00788073|525024|P1|Placebo Then STX209|Adverse Event|2
164702|NCT00788073|525023|P2|STX209 Then Placebo|unable to return due to travel|1
164703|NCT00788073|525024|P1|STX209 Then Placebo|unable to return due to travel|0
164704|NCT00788073|525023|P2|STX209 Then Placebo|Withdrawal by Subject|1
164705|NCT00788073|525024|P1|STX209 Then Placebo|Withdrawal by Subject|0
164706|NCT00788073|525023|P2|STX209 Then Placebo|Lost to Follow-up|1
164707|NCT00788073|525024|P1|STX209 Then Placebo|Lost to Follow-up|0
164708|NCT00788073|525023|P2|STX209 Then Placebo|Adverse Event|0
164709|NCT00788073|525024|P1|STX209 Then Placebo|Adverse Event|1
164710|NCT00788372|525045|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
164711|NCT00788372|525045|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
164712|NCT00788372|525045|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
164713|NCT00788372|525045|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
164714|NCT00788372|525045|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
164715|NCT00788372|525045|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
164716|NCT00788372|525045|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
164717|NCT00788593|525059|P3|Second Intervention Period|Unspecified|1
164718|NCT00788593|525060|P2|Second Intervention Period|Unspecified|0
164719|NCT00788593|525061|P1|Second Intervention Period|Unspecified|0
164720|NCT00788593|525059|P3|Second Intervention Period|Lost to Follow-up|0
164721|NCT00788593|525060|P2|Second Intervention Period|Lost to Follow-up|1
164722|NCT00788593|525061|P1|Second Intervention Period|Lost to Follow-up|0
164723|NCT00788593|525059|P3|First Intervention Period|Adverse Event|0
164724|NCT00788593|525060|P2|First Intervention Period|Adverse Event|1
164725|NCT00788593|525061|P1|First Intervention Period|Adverse Event|0
164726|NCT00788593|525059|P3|Placebo Run-in Phase|Protocol Violation|0
164727|NCT00788593|525060|P2|Placebo Run-in Phase|Protocol Violation|0
164728|NCT00788593|525061|P1|Placebo Run-in Phase|Protocol Violation|2
164729|NCT00788593|525059|P3|Placebo Run-in Phase|Withdrawal by Subject|0
164730|NCT00788593|525060|P2|Placebo Run-in Phase|Withdrawal by Subject|0
164731|NCT00788593|525061|P1|Placebo Run-in Phase|Withdrawal by Subject|2
164732|NCT00788593|525059|P3|Placebo Run-in Phase|Adverse Event|0
164733|NCT00788593|525060|P2|Placebo Run-in Phase|Adverse Event|0
164734|NCT00788593|525061|P1|Placebo Run-in Phase|Adverse Event|2
164735|NCT00788697|525078|P1|Overall Study|Indeterminate diagnosis from truth stand|17
164736|NCT00788697|525078|P1|Overall Study|Technically inadequate truth standard|1
164737|NCT00788697|525078|P1|Overall Study|no truth standard procedure available|5
164738|NCT00788697|525078|P1|Overall Study|Training Patients|74
164739|NCT00788697|525078|P1|Overall Study|No study drug administered|12
164740|NCT00788710|525128|P3|Overall Study|Withdrawal by Subject|0
164741|NCT00788710|525129|P2|Overall Study|Withdrawal by Subject|2
164742|NCT00788710|525130|P1|Overall Study|Withdrawal by Subject|2
164743|NCT00788710|525128|P3|Overall Study|Protocol Violation|1
164744|NCT00788710|525129|P2|Overall Study|Protocol Violation|1
164745|NCT00788710|525130|P1|Overall Study|Protocol Violation|0
164746|NCT00788710|525128|P3|Overall Study|Physician Decision|0
164747|NCT00788710|525129|P2|Overall Study|Physician Decision|1
164748|NCT00788710|525130|P1|Overall Study|Physician Decision|2
164749|NCT00788710|525128|P3|Overall Study|Lost to Follow-up|0
164750|NCT00788710|525129|P2|Overall Study|Lost to Follow-up|1
164751|NCT00788710|525130|P1|Overall Study|Lost to Follow-up|0
164752|NCT00788710|525128|P3|Overall Study|Lack of Efficacy|1
164753|NCT00788710|525129|P2|Overall Study|Lack of Efficacy|0
164754|NCT00788710|525130|P1|Overall Study|Lack of Efficacy|0
164755|NCT00788710|525128|P3|Overall Study|Adverse Event|4
164756|NCT00788710|525129|P2|Overall Study|Adverse Event|3
164757|NCT00788710|525130|P1|Overall Study|Adverse Event|1
164758|NCT00788775|525146|P2|Overall Study|Patient's measurable disease resected.|0
164759|NCT00788775|525147|P1|Overall Study|Patient's measurable disease resected.|1
164760|NCT00788775|525146|P2|Overall Study|Patient Non-Compliance|0
164761|NCT00788775|525147|P1|Overall Study|Patient Non-Compliance|1
164762|NCT00788775|525146|P2|Overall Study|Withdrawal by Subject|2
164763|NCT00788775|525147|P1|Overall Study|Withdrawal by Subject|0
164764|NCT00788775|525146|P2|Overall Study|Progressive Disease|6
164765|NCT00788775|525147|P1|Overall Study|Progressive Disease|8
164766|NCT00788957|525163|P6|Part 3|On-study at time of data cut-off|0
164767|NCT00788957|525164|P5|Part 3|On-study at time of data cut-off|1
164768|NCT00788957|525165|P4|Part 3|On-study at time of data cut-off|0
164769|NCT00788957|525166|P3|Part 3|On-study at time of data cut-off|0
164770|NCT00788957|525167|P2|Part 3|On-study at time of data cut-off|0
164771|NCT00788957|525168|P1|Part 3|On-study at time of data cut-off|0
164772|NCT00788957|525163|P6|Part 3|Death|9
164773|NCT00788957|525164|P5|Part 3|Death|8
164774|NCT00788957|525165|P4|Part 3|Death|0
164775|NCT00788957|525166|P3|Part 3|Death|0
164776|NCT00788957|525167|P2|Part 3|Death|0
164777|NCT00788957|525168|P1|Part 3|Death|0
164778|NCT00788957|525163|P6|Part 3|Withdrawal by Subject|2
164779|NCT00788957|525164|P5|Part 3|Withdrawal by Subject|0
164780|NCT00788957|525165|P4|Part 3|Withdrawal by Subject|0
164781|NCT00788957|525166|P3|Part 3|Withdrawal by Subject|0
164782|NCT00788957|525167|P2|Part 3|Withdrawal by Subject|0
164783|NCT00788957|525168|P1|Part 3|Withdrawal by Subject|0
164784|NCT00788957|525163|P6|Part 2|On-study at time of data cut-off|0
164785|NCT00788957|525164|P5|Part 2|On-study at time of data cut-off|0
164786|NCT00788957|525165|P4|Part 2|On-study at time of data cut-off|1
164787|NCT00788957|525166|P3|Part 2|On-study at time of data cut-off|1
164788|NCT00788957|525167|P2|Part 2|On-study at time of data cut-off|1
164789|NCT00788957|525168|P1|Part 2|On-study at time of data cut-off|0
164790|NCT00788957|525163|P6|Part 2|Lost to Follow-up|0
164791|NCT00788957|525164|P5|Part 2|Lost to Follow-up|0
164792|NCT00788957|525165|P4|Part 2|Lost to Follow-up|0
164793|NCT00788957|525166|P3|Part 2|Lost to Follow-up|3
164794|NCT00788957|525167|P2|Part 2|Lost to Follow-up|0
164795|NCT00788957|525168|P1|Part 2|Lost to Follow-up|0
164796|NCT00788957|525163|P6|Part 2|Death|0
164797|NCT00788957|525164|P5|Part 2|Death|0
164798|NCT00788957|525165|P4|Part 2|Death|37
164799|NCT00788957|525166|P3|Part 2|Death|35
164800|NCT00788957|525167|P2|Part 2|Death|32
164801|NCT00788957|525168|P1|Part 2|Death|0
164802|NCT00788957|525163|P6|Part 2|Withdrawal by Subject|0
164803|NCT00788957|525164|P5|Part 2|Withdrawal by Subject|0
164804|NCT00788957|525165|P4|Part 2|Withdrawal by Subject|3
164805|NCT00788957|525166|P3|Part 2|Withdrawal by Subject|5
164806|NCT00788957|525167|P2|Part 2|Withdrawal by Subject|9
164807|NCT00788957|525168|P1|Part 2|Withdrawal by Subject|0
164808|NCT00788957|525163|P6|Part 1|Lost to Follow-up|0
164809|NCT00788957|525164|P5|Part 1|Lost to Follow-up|0
164810|NCT00788957|525165|P4|Part 1|Lost to Follow-up|0
164811|NCT00788957|525166|P3|Part 1|Lost to Follow-up|0
164812|NCT00788957|525167|P2|Part 1|Lost to Follow-up|0
164813|NCT00788957|525168|P1|Part 1|Lost to Follow-up|1
164814|NCT00788957|525163|P6|Part 1|Death|0
164815|NCT00788957|525164|P5|Part 1|Death|0
164816|NCT00788957|525165|P4|Part 1|Death|0
164817|NCT00788957|525166|P3|Part 1|Death|0
164818|NCT00788957|525167|P2|Part 1|Death|0
164819|NCT00788957|525168|P1|Part 1|Death|8
164820|NCT00789035|525227|P5|Overall Study|Other reason not defined above|1
164821|NCT00789035|525228|P4|Overall Study|Other reason not defined above|0
164822|NCT00789035|525229|P3|Overall Study|Other reason not defined above|1
164823|NCT00789035|525230|P2|Overall Study|Other reason not defined above|3
164824|NCT00789035|525231|P1|Overall Study|Other reason not defined above|2
164825|NCT00789035|525227|P5|Overall Study|Withdrawal by Subject|0
164826|NCT00789035|525228|P4|Overall Study|Withdrawal by Subject|0
164827|NCT00789035|525229|P3|Overall Study|Withdrawal by Subject|0
164828|NCT00789035|525230|P2|Overall Study|Withdrawal by Subject|2
164829|NCT00789035|525231|P1|Overall Study|Withdrawal by Subject|0
164830|NCT00789035|525227|P5|Overall Study|Protocol Violation|0
164831|NCT00789035|525228|P4|Overall Study|Protocol Violation|0
164832|NCT00789035|525229|P3|Overall Study|Protocol Violation|0
164833|NCT00789035|525230|P2|Overall Study|Protocol Violation|0
164834|NCT00789035|525231|P1|Overall Study|Protocol Violation|1
164835|NCT00789035|525227|P5|Overall Study|Lack of Efficacy|2
164836|NCT00789035|525228|P4|Overall Study|Lack of Efficacy|0
164837|NCT00789035|525229|P3|Overall Study|Lack of Efficacy|0
164838|NCT00789035|525230|P2|Overall Study|Lack of Efficacy|0
164839|NCT00789035|525231|P1|Overall Study|Lack of Efficacy|3
164840|NCT00789035|525227|P5|Overall Study|Adverse Event|3
164841|NCT00789035|525228|P4|Overall Study|Adverse Event|1
164842|NCT00789035|525229|P3|Overall Study|Adverse Event|0
164843|NCT00789035|525230|P2|Overall Study|Adverse Event|2
164844|NCT00789035|525231|P1|Overall Study|Adverse Event|0
164845|NCT00789191|525312|P2|Overall Study|Unclassified|3
164846|NCT00789191|525313|P1|Overall Study|Unclassified|5
164847|NCT00789191|525312|P2|Overall Study|Withdrawal Criteria|4
164848|NCT00789191|525313|P1|Overall Study|Withdrawal Criteria|2
164849|NCT00789191|525312|P2|Overall Study|Protocol Violation|3
164850|NCT00789191|525313|P1|Overall Study|Protocol Violation|5
164851|NCT00789191|525312|P2|Overall Study|Lack of Efficacy|5
164852|NCT00789191|525313|P1|Overall Study|Lack of Efficacy|0
164853|NCT00789191|525312|P2|Overall Study|Adverse Event|4
164854|NCT00789191|525313|P1|Overall Study|Adverse Event|2
164855|NCT00789321|525352|P2|Overall Study|Adverse Event|1
164856|NCT00789321|525353|P1|Overall Study|Adverse Event|0
164857|NCT00789373|525361|P3|Maintenance|Participants On-Going at Data Cut-Off|0
164858|NCT00789373|525362|P2|Maintenance|Participants On-Going at Data Cut-Off|4
164859|NCT00789373|525363|P1|Maintenance|Participants On-Going at Data Cut-Off|0
164860|NCT00789373|525361|P3|Maintenance|Sponsor Decision|2
164861|NCT00789373|525362|P2|Maintenance|Sponsor Decision|0
164862|NCT00789373|525363|P1|Maintenance|Sponsor Decision|0
164863|NCT00789373|525361|P3|Maintenance|Withdrawal by Subject|8
164864|NCT00789373|525362|P2|Maintenance|Withdrawal by Subject|21
164865|NCT00789373|525363|P1|Maintenance|Withdrawal by Subject|0
164866|NCT00789373|525361|P3|Maintenance|Progressive Disease|152
164867|NCT00789373|525362|P2|Maintenance|Progressive Disease|253
164868|NCT00789373|525363|P1|Maintenance|Progressive Disease|0
164869|NCT00789373|525361|P3|Maintenance|Lost to Follow-up|0
164870|NCT00789373|525362|P2|Maintenance|Lost to Follow-up|2
164871|NCT00789373|525363|P1|Maintenance|Lost to Follow-up|0
164872|NCT00789373|525361|P3|Maintenance|Protocol entry criteria not met|0
164873|NCT00789373|525362|P2|Maintenance|Protocol entry criteria not met|2
164874|NCT00789373|525363|P1|Maintenance|Protocol entry criteria not met|0
164875|NCT00789373|525361|P3|Maintenance|Investigator Decision|2
164876|NCT00789373|525362|P2|Maintenance|Investigator Decision|4
164877|NCT00789373|525363|P1|Maintenance|Investigator Decision|0
164878|NCT00789373|525361|P3|Maintenance|Death due to toxicity|2
164879|NCT00789373|525362|P2|Maintenance|Death due to toxicity|1
164880|NCT00789373|525363|P1|Maintenance|Death due to toxicity|0
164881|NCT00789373|525361|P3|Maintenance|Death due to adverse event|1
164882|NCT00789373|525362|P2|Maintenance|Death due to adverse event|4
164883|NCT00789373|525363|P1|Maintenance|Death due to adverse event|0
164884|NCT00789373|525361|P3|Maintenance|Death due to study disease|1
164885|NCT00789373|525362|P2|Maintenance|Death due to study disease|3
164886|NCT00789373|525363|P1|Maintenance|Death due to study disease|0
164887|NCT00789373|525361|P3|Maintenance|Adverse Event|12
164888|NCT00789373|525362|P2|Maintenance|Adverse Event|65
164889|NCT00789373|525363|P1|Maintenance|Adverse Event|0
164890|NCT00789373|525361|P3|Induction|Withdrawal by Subject|0
164891|NCT00789373|525362|P2|Induction|Withdrawal by Subject|0
164892|NCT00789373|525363|P1|Induction|Withdrawal by Subject|37
164893|NCT00789373|525361|P3|Induction|Progressive Disease|0
164894|NCT00789373|525362|P2|Induction|Progressive Disease|0
164895|NCT00789373|525363|P1|Induction|Progressive Disease|220
164896|NCT00789373|525361|P3|Induction|Protocol Violation|0
164897|NCT00789373|525362|P2|Induction|Protocol Violation|0
164898|NCT00789373|525363|P1|Induction|Protocol Violation|1
164899|NCT00789373|525361|P3|Induction|Lost to Follow-up|0
164900|NCT00789373|525362|P2|Induction|Lost to Follow-up|0
164901|NCT00789373|525363|P1|Induction|Lost to Follow-up|6
164902|NCT00789373|525361|P3|Induction|Protocol entry criteria not met|0
164903|NCT00789373|525362|P2|Induction|Protocol entry criteria not met|0
164904|NCT00789373|525363|P1|Induction|Protocol entry criteria not met|9
164905|NCT00789373|525361|P3|Induction|Investigator decision|0
164906|NCT00789373|525362|P2|Induction|Investigator decision|0
164907|NCT00789373|525363|P1|Induction|Investigator decision|7
164908|NCT00789373|525361|P3|Induction|Death due to procedure|0
164909|NCT00789373|525362|P2|Induction|Death due to procedure|0
164910|NCT00789373|525363|P1|Induction|Death due to procedure|1
164911|NCT00789373|525361|P3|Induction|Death due to toxicity|0
164912|NCT00789373|525362|P2|Induction|Death due to toxicity|0
164913|NCT00789373|525363|P1|Induction|Death due to toxicity|11
164914|NCT00789373|525361|P3|Induction|Death due to adverse event|0
164915|NCT00789373|525362|P2|Induction|Death due to adverse event|0
164916|NCT00789373|525363|P1|Induction|Death due to adverse event|19
164917|NCT00789373|525361|P3|Induction|Death Due to study disease|0
164918|NCT00789373|525362|P2|Induction|Death Due to study disease|0
164919|NCT00789373|525363|P1|Induction|Death Due to study disease|24
164920|NCT00789373|525361|P3|Induction|Adverse Event|0
164921|NCT00789373|525362|P2|Induction|Adverse Event|0
164922|NCT00789373|525363|P1|Induction|Adverse Event|64
164923|NCT00789477|525406|P5|Overall Study|Other|0
164924|NCT00789477|525407|P4|Overall Study|Other|3
164925|NCT00789477|525408|P3|Overall Study|Other|1
164926|NCT00789477|525409|P2|Overall Study|Other|0
164927|NCT00789477|525410|P1|Overall Study|Other|2
164928|NCT00789477|525406|P5|Overall Study|Lack of Efficacy|0
164929|NCT00789477|525407|P4|Overall Study|Lack of Efficacy|0
164930|NCT00789477|525408|P3|Overall Study|Lack of Efficacy|0
164931|NCT00789477|525409|P2|Overall Study|Lack of Efficacy|0
164932|NCT00789477|525410|P1|Overall Study|Lack of Efficacy|2
164933|NCT00789477|525406|P5|Overall Study|Lost to Follow-up|4
164934|NCT00789477|525407|P4|Overall Study|Lost to Follow-up|2
164935|NCT00789477|525408|P3|Overall Study|Lost to Follow-up|4
164936|NCT00789477|525409|P2|Overall Study|Lost to Follow-up|1
164937|NCT00789477|525410|P1|Overall Study|Lost to Follow-up|0
164938|NCT00789477|525406|P5|Overall Study|Death|0
164939|NCT00789477|525407|P4|Overall Study|Death|2
164940|NCT00789477|525408|P3|Overall Study|Death|2
164941|NCT00789477|525409|P2|Overall Study|Death|1
164942|NCT00789477|525410|P1|Overall Study|Death|1
164943|NCT00789477|525406|P5|Overall Study|Adverse Event|0
164944|NCT00789477|525407|P4|Overall Study|Adverse Event|0
164945|NCT00789477|525408|P3|Overall Study|Adverse Event|1
164946|NCT00789477|525409|P2|Overall Study|Adverse Event|3
164947|NCT00789477|525410|P1|Overall Study|Adverse Event|3
164948|NCT00789477|525406|P5|Overall Study|Protocol Violation|0
164949|NCT00789477|525407|P4|Overall Study|Protocol Violation|1
164950|NCT00789477|525408|P3|Overall Study|Protocol Violation|0
164951|NCT00789477|525409|P2|Overall Study|Protocol Violation|0
164952|NCT00789477|525410|P1|Overall Study|Protocol Violation|1
164953|NCT00789477|525406|P5|Overall Study|Withdrawal by Subject|3
164954|NCT00789477|525407|P4|Overall Study|Withdrawal by Subject|2
164955|NCT00789477|525408|P3|Overall Study|Withdrawal by Subject|3
164956|NCT00789477|525409|P2|Overall Study|Withdrawal by Subject|1
164957|NCT00789477|525410|P1|Overall Study|Withdrawal by Subject|2
164958|NCT00789529|525444|P2|Overall Study|Other Reason|0
164959|NCT00789529|525445|P1|Overall Study|Other Reason|1
164960|NCT00789529|525444|P2|Overall Study|Withdrawal by Subject|1
164961|NCT00789529|525445|P1|Overall Study|Withdrawal by Subject|0
164962|NCT00789555|525456|P3|Overall Study|Protocol Violation|13
164963|NCT00789555|525457|P2|Overall Study|Protocol Violation|9
164964|NCT00789555|525458|P1|Overall Study|Protocol Violation|6
164965|NCT00789555|525456|P3|Overall Study|Treatment failure|12
164966|NCT00789555|525457|P2|Overall Study|Treatment failure|8
164967|NCT00789555|525458|P1|Overall Study|Treatment failure|11
164968|NCT00789555|525456|P3|Overall Study|Patient decision unnrelated to adv event|26
164969|NCT00789555|525457|P2|Overall Study|Patient decision unnrelated to adv event|29
164970|NCT00789555|525458|P1|Overall Study|Patient decision unnrelated to adv event|38
164971|NCT00789555|525456|P3|Overall Study|Lost to Follow-up|18
164972|NCT00789555|525457|P2|Overall Study|Lost to Follow-up|10
164973|NCT00789555|525458|P1|Overall Study|Lost to Follow-up|9
164974|NCT00789555|525456|P3|Overall Study|Adverse Event|10
164975|NCT00789555|525457|P2|Overall Study|Adverse Event|7
164976|NCT00789555|525458|P1|Overall Study|Adverse Event|17
164977|NCT00789555|525456|P3|Overall Study|Protocol Amendment|80
164978|NCT00789555|525457|P2|Overall Study|Protocol Amendment|76
164979|NCT00789555|525458|P1|Overall Study|Protocol Amendment|78
164980|NCT00789581|525483|P2|Adjuvant Therapy|Not Specified|1
164981|NCT00789581|525484|P1|Adjuvant Therapy|Not Specified|0
164982|NCT00789581|525483|P2|Adjuvant Therapy|Protocol Violation|1
164983|NCT00789581|525484|P1|Adjuvant Therapy|Protocol Violation|1
164984|NCT00789581|525483|P2|Adjuvant Therapy|Intercurrent Illness|3
164985|NCT00789581|525484|P1|Adjuvant Therapy|Intercurrent Illness|1
164986|NCT00789581|525483|P2|Adjuvant Therapy|Disease recurrence|1
164987|NCT00789581|525484|P1|Adjuvant Therapy|Disease recurrence|2
164988|NCT00789581|525483|P2|Adjuvant Therapy|Withdrawal by Subject|5
164989|NCT00789581|525484|P1|Adjuvant Therapy|Withdrawal by Subject|14
164990|NCT00789581|525483|P2|Adjuvant Therapy|Adverse Event|44
164991|NCT00789581|525484|P1|Adjuvant Therapy|Adverse Event|20
164992|NCT00789581|525483|P2|Adjuvant Therapy|Never treated|2
164993|NCT00789581|525484|P1|Adjuvant Therapy|Never treated|2
164994|NCT00789581|525483|P2|AC Therapy|Not specified|2
164995|NCT00789581|525484|P1|AC Therapy|Not specified|0
164996|NCT00789581|525483|P2|AC Therapy|Never Treated|4
164997|NCT00789581|525484|P1|AC Therapy|Never Treated|1
164998|NCT00789581|525483|P2|AC Therapy|Intercurrent Illness|0
164999|NCT00789581|525484|P1|AC Therapy|Intercurrent Illness|1
165000|NCT00789581|525483|P2|AC Therapy|Disease recurrence|1
165001|NCT00789581|525484|P1|AC Therapy|Disease recurrence|3
165002|NCT00789581|525483|P2|AC Therapy|Withdrawal by Subject|7
165003|NCT00789581|525484|P1|AC Therapy|Withdrawal by Subject|4
165004|NCT00789581|525483|P2|AC Therapy|Adverse Event|3
165005|NCT00789581|525484|P1|AC Therapy|Adverse Event|2
165006|NCT00789698|525535|P4|Overall Study|Administrative|1
165007|NCT00789698|525536|P3|Overall Study|Administrative|3
165008|NCT00789698|525537|P2|Overall Study|Administrative|3
165009|NCT00789698|525538|P1|Overall Study|Administrative|0
165010|NCT00789698|525535|P4|Overall Study|Withdrawal by Subject|19
165011|NCT00789698|525536|P3|Overall Study|Withdrawal by Subject|12
165012|NCT00789698|525537|P2|Overall Study|Withdrawal by Subject|15
165013|NCT00789698|525538|P1|Overall Study|Withdrawal by Subject|14
165014|NCT00789698|525535|P4|Overall Study|Protocol Violation|1
165015|NCT00789698|525536|P3|Overall Study|Protocol Violation|2
165016|NCT00789698|525537|P2|Overall Study|Protocol Violation|1
165017|NCT00789698|525538|P1|Overall Study|Protocol Violation|6
165018|NCT00789698|525535|P4|Overall Study|Lost to Follow-up|9
165019|NCT00789698|525536|P3|Overall Study|Lost to Follow-up|2
165020|NCT00789698|525537|P2|Overall Study|Lost to Follow-up|5
165021|NCT00789698|525538|P1|Overall Study|Lost to Follow-up|5
165022|NCT00789698|525535|P4|Overall Study|Adverse Event|4
165023|NCT00789698|525536|P3|Overall Study|Adverse Event|3
165024|NCT00789698|525537|P2|Overall Study|Adverse Event|5
165025|NCT00789698|525538|P1|Overall Study|Adverse Event|5
165026|NCT00789698|525535|P4|Overall Study|Lack of Efficacy|18
165027|NCT00789698|525536|P3|Overall Study|Lack of Efficacy|5
165028|NCT00789698|525537|P2|Overall Study|Lack of Efficacy|4
165029|NCT00789698|525538|P1|Overall Study|Lack of Efficacy|10
165030|NCT00789737|525563|P2|Overall Study|not specified|7
165031|NCT00789737|525564|P1|Overall Study|not specified|11
165032|NCT00789737|525563|P2|Overall Study|hyperglycemia that met protocol-specifie|4
165033|NCT00789737|525564|P1|Overall Study|hyperglycemia that met protocol-specifie|0
165034|NCT00789737|525563|P2|Overall Study|Lack of Efficacy|0
165035|NCT00789737|525564|P1|Overall Study|Lack of Efficacy|3
165036|NCT00789737|525563|P2|Overall Study|Protocol Violation|0
165037|NCT00789737|525564|P1|Overall Study|Protocol Violation|3
165038|NCT00789737|525563|P2|Overall Study|Adverse Event|8
165039|NCT00789737|525564|P1|Overall Study|Adverse Event|8
165040|NCT00789737|525563|P2|Overall Study|Lost to Follow-up|14
165041|NCT00789737|525564|P1|Overall Study|Lost to Follow-up|10
165042|NCT00789737|525563|P2|Overall Study|Withdrawal by Subject|22
165043|NCT00789737|525564|P1|Overall Study|Withdrawal by Subject|13
165044|NCT00789815|525654|P2|Overall Study|Intubation due to massive bleeding|0
165045|NCT00789815|525655|P1|Overall Study|Intubation due to massive bleeding|1
165046|NCT00789815|525654|P2|Overall Study|Protocol Violation|1
165047|NCT00789815|525655|P1|Overall Study|Protocol Violation|6
165048|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
165049|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
165050|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|Disease progression|0
165051|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|Disease progression|1
165052|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|Death|0
165053|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|Death|1
165054|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|Administrative problems|0
165055|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|Administrative problems|7
165056|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
165057|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
165058|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
165059|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
165060|NCT00789828|525677|P2|Open-label Extension Period (4 Years)|Adverse Event|0
165061|NCT00789828|525678|P1|Open-label Extension Period (4 Years)|Adverse Event|10
165062|NCT00789828|525677|P2|Core Period (48 Weeks)|Lost to Follow-up|1
165063|NCT00789828|525678|P1|Core Period (48 Weeks)|Lost to Follow-up|0
165064|NCT00789828|525677|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
165065|NCT00789828|525678|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
165066|NCT00789828|525677|P2|Core Period (48 Weeks)|Administrative problems|1
165067|NCT00789828|525678|P1|Core Period (48 Weeks)|Administrative problems|0
165068|NCT00789854|525713|P3|Overall Study|Other|5
165069|NCT00789854|525714|P2|Overall Study|Other|0
165070|NCT00789854|525715|P1|Overall Study|Other|6
165071|NCT00789854|525713|P3|Overall Study|Safety reasons|2
165072|NCT00789854|525714|P2|Overall Study|Safety reasons|0
165073|NCT00789854|525715|P1|Overall Study|Safety reasons|0
165074|NCT00789854|525713|P3|Overall Study|Severe non-compliance to the protocol|0
165075|NCT00789854|525714|P2|Overall Study|Severe non-compliance to the protocol|0
165076|NCT00789854|525715|P1|Overall Study|Severe non-compliance to the protocol|3
165077|NCT00789854|525713|P3|Overall Study|Eligibility criteria not fulfilled|1
165078|NCT00789854|525714|P2|Overall Study|Eligibility criteria not fulfilled|5
165079|NCT00789854|525715|P1|Overall Study|Eligibility criteria not fulfilled|2
165080|NCT00789854|525713|P3|Overall Study|Withdrawal by Subject|17
165081|NCT00789854|525714|P2|Overall Study|Withdrawal by Subject|6
165082|NCT00789854|525715|P1|Overall Study|Withdrawal by Subject|9
165083|NCT00789854|525713|P3|Overall Study|Lost to Follow-up|4
165084|NCT00789854|525714|P2|Overall Study|Lost to Follow-up|1
165085|NCT00789854|525715|P1|Overall Study|Lost to Follow-up|1
165086|NCT00789854|525713|P3|Overall Study|Adverse Event|18
165087|NCT00789854|525714|P2|Overall Study|Adverse Event|23
165088|NCT00789854|525715|P1|Overall Study|Adverse Event|28
165089|NCT00789880|525816|P6|Overall Study|Withdrawal by Subject|0
165090|NCT00789880|525817|P5|Overall Study|Withdrawal by Subject|2
165091|NCT00789880|525818|P4|Overall Study|Withdrawal by Subject|0
165092|NCT00789880|525819|P3|Overall Study|Withdrawal by Subject|0
165093|NCT00789880|525820|P2|Overall Study|Withdrawal by Subject|0
165094|NCT00789880|525821|P1|Overall Study|Withdrawal by Subject|1
165095|NCT00789880|525816|P6|Overall Study|Protocol Violation|0
165096|NCT00789880|525817|P5|Overall Study|Protocol Violation|0
165097|NCT00789880|525818|P4|Overall Study|Protocol Violation|1
165098|NCT00789880|525819|P3|Overall Study|Protocol Violation|0
165099|NCT00789880|525820|P2|Overall Study|Protocol Violation|1
165100|NCT00789880|525821|P1|Overall Study|Protocol Violation|0
165101|NCT00789880|525816|P6|Overall Study|Adverse Event|0
165102|NCT00789880|525817|P5|Overall Study|Adverse Event|1
165103|NCT00789880|525818|P4|Overall Study|Adverse Event|0
165104|NCT00789880|525819|P3|Overall Study|Adverse Event|0
165105|NCT00789880|525820|P2|Overall Study|Adverse Event|0
165106|NCT00789880|525821|P1|Overall Study|Adverse Event|0
165107|NCT00789958|525847|P1|Overall Study|Not eligible/not analyzable|26
165108|NCT00789958|525847|P1|Overall Study|not protocol specified|1
165109|NCT00789958|525847|P1|Overall Study|Progression|3
165110|NCT00789958|525847|P1|Overall Study|Withdrawal by Subject|4
165111|NCT00789958|525847|P1|Overall Study|Adverse Event|3
165112|NCT00790023|525874|P3|Overall Study|Not specified|8
165113|NCT00790023|525875|P2|Overall Study|Not specified|5
165114|NCT00790023|525876|P1|Overall Study|Not specified|5
165115|NCT00790023|525874|P3|Overall Study|Lost to Follow-up|1
165116|NCT00790023|525875|P2|Overall Study|Lost to Follow-up|0
165117|NCT00790023|525876|P1|Overall Study|Lost to Follow-up|0
165118|NCT00790023|525874|P3|Overall Study|Withdrawal by Subject|6
165119|NCT00790023|525875|P2|Overall Study|Withdrawal by Subject|0
165120|NCT00790023|525876|P1|Overall Study|Withdrawal by Subject|2
165121|NCT00790023|525874|P3|Overall Study|Protocol Violation|2
165122|NCT00790023|525875|P2|Overall Study|Protocol Violation|4
165123|NCT00790023|525876|P1|Overall Study|Protocol Violation|2
165124|NCT00790023|525874|P3|Overall Study|Adverse Event|4
165125|NCT00790023|525875|P2|Overall Study|Adverse Event|1
165126|NCT00790023|525876|P1|Overall Study|Adverse Event|2
165127|NCT00790036|525966|P2|Overall Study|Subject/guardian decision|7
165128|NCT00790036|525967|P1|Overall Study|Subject/guardian decision|20
165129|NCT00790036|525966|P2|Overall Study|Withdrawal by Subject|7
165130|NCT00790036|525967|P1|Overall Study|Withdrawal by Subject|18
165131|NCT00790036|525966|P2|Overall Study|Protocol Violation|2
165132|NCT00790036|525967|P1|Overall Study|Protocol Violation|10
165133|NCT00790036|525966|P2|Overall Study|Lost to Follow-up|2
165134|NCT00790036|525967|P1|Overall Study|Lost to Follow-up|1
165135|NCT00790036|525966|P2|Overall Study|Disease progression|48
165136|NCT00790036|525967|P1|Overall Study|Disease progression|24
165137|NCT00790036|525966|P2|Overall Study|Death|0
165138|NCT00790036|525967|P1|Overall Study|Death|1
165139|NCT00790036|525966|P2|Overall Study|Adverse Event|44
165140|NCT00790036|525967|P1|Overall Study|Adverse Event|113
165141|NCT00790036|525966|P2|Overall Study|Administrative problems|9
165142|NCT00790036|525967|P1|Overall Study|Administrative problems|5
165143|NCT00790036|525966|P2|Overall Study|Abnormal lab values|2
165144|NCT00790036|525967|P1|Overall Study|Abnormal lab values|3
165145|NCT00790205|526035|P2|Overall Study|Withdrawal by Subject|363
165146|NCT00790205|526036|P1|Overall Study|Withdrawal by Subject|299
165147|NCT00790205|526035|P2|Overall Study|Lost to Follow-up|71
165148|NCT00790205|526036|P1|Overall Study|Lost to Follow-up|61
165149|NCT00790218|526076|P3|Overall Study|Death|0
165150|NCT00790218|526077|P2|Overall Study|Death|0
165151|NCT00790218|526078|P1|Overall Study|Death|1
165152|NCT00790296|526104|P2|Overall Study|Adverse Event|1
165153|NCT00790296|526105|P1|Overall Study|Adverse Event|0
165154|NCT00790296|526104|P2|Overall Study|Did not meet study eligibility criteria|1
165155|NCT00790296|526105|P1|Overall Study|Did not meet study eligibility criteria|1
165156|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|New treatment|0
165157|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|New treatment|2
165158|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
165159|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
165160|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Disease progression|0
165161|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Disease progression|5
165162|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Death|0
165163|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Death|1
165164|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Administrative problems|0
165165|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Administrative problems|2
165166|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
165167|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
165168|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
165169|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
165170|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
165171|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
165172|NCT00790400|526113|P2|Everolimus Period (Core or Extension)|Adverse Event|0
165173|NCT00790400|526114|P1|Everolimus Period (Core or Extension)|Adverse Event|9
165174|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Death|0
165175|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Death|1
165176|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Administrative problems|0
165177|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Administrative problems|1
165178|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
165179|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
165180|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
165181|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
165182|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Adverse Event|4
165183|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Adverse Event|2
165184|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Progressive disease|9
165185|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Progressive disease|0
165186|NCT00790400|526113|P2|Double-blind Period (Core Phase)|Protocol Violation|0
165187|NCT00790400|526114|P1|Double-blind Period (Core Phase)|Protocol Violation|1
165188|NCT00790452|526143|P2|Overall Study|Drug supply issue|0
165189|NCT00790452|526144|P1|Overall Study|Drug supply issue|1
165190|NCT00790556|526150|P2|Treatment Period 1|Withdrawal by Subject|0
165191|NCT00790556|526151|P1|Treatment Period 1|Withdrawal by Subject|1
165192|NCT00790556|526150|P2|Treatment Period 1|Physician Decision|0
165193|NCT00790556|526151|P1|Treatment Period 1|Physician Decision|1
165194|NCT00790569|526164|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
165195|NCT00790569|526165|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
165196|NCT00790569|526166|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
165197|NCT00790569|526164|P3|End of Treatment (6 Month Interview)|Incarcerated|3
165198|NCT00790569|526165|P2|End of Treatment (6 Month Interview)|Incarcerated|0
165199|NCT00790569|526166|P1|End of Treatment (6 Month Interview)|Incarcerated|0
165200|NCT00790569|526164|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
165201|NCT00790569|526165|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
165202|NCT00790569|526166|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
165203|NCT00790569|526164|P3|End of Treatment (6 Month Interview)|Hospitalized|0
165204|NCT00790569|526165|P2|End of Treatment (6 Month Interview)|Hospitalized|0
165205|NCT00790569|526166|P1|End of Treatment (6 Month Interview)|Hospitalized|2
165206|NCT00790569|526164|P3|End of Treatment (6 Month Interview)|Death|1
165207|NCT00790569|526165|P2|End of Treatment (6 Month Interview)|Death|2
165208|NCT00790569|526166|P1|End of Treatment (6 Month Interview)|Death|0
165209|NCT00790569|526164|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
165210|NCT00790569|526165|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
165211|NCT00790569|526166|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
165212|NCT00790647|526189|P1|Overall Study|Adverse Event|1
165213|NCT00791258|526213|P1|Overall Study|Lack of Efficacy|1
165214|NCT00791258|526213|P1|Overall Study|Subject required restricted medication|1
165215|NCT00791258|526213|P1|Overall Study|Subject incarcerated|1
165216|NCT00791258|526213|P1|Overall Study|non-compliance|3
165217|NCT00791258|526213|P1|Overall Study|subject left area|2
165218|NCT00791258|526213|P1|Overall Study|Did not take medication for >3 days|1
165219|NCT00791258|526213|P1|Overall Study|Withdrawal by Subject|40
165220|NCT00791258|526213|P1|Overall Study|Protocol Violation|109
165221|NCT00791258|526213|P1|Overall Study|Lost to Follow-up|18
165222|NCT00791258|526213|P1|Overall Study|Adverse Event|87
165223|NCT00791388|526295|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
165224|NCT00791388|526296|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
165225|NCT00791388|526297|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
165226|NCT00791388|526298|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
165227|NCT00791388|526299|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
165228|NCT00791388|526295|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
165229|NCT00791388|526296|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
165230|NCT00791388|526297|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
165231|NCT00791388|526298|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
165232|NCT00791388|526299|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
165233|NCT00791388|526295|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
165234|NCT00791388|526296|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
165235|NCT00791388|526297|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
165236|NCT00791388|526298|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
165237|NCT00791388|526299|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
165238|NCT00791479|526332|P6|Overall Study|Withdrawal by Subject|1
165239|NCT00791479|526333|P5|Overall Study|Withdrawal by Subject|0
165240|NCT00791479|526334|P4|Overall Study|Withdrawal by Subject|1
165241|NCT00791479|526335|P3|Overall Study|Withdrawal by Subject|0
165242|NCT00791479|526336|P2|Overall Study|Withdrawal by Subject|0
165243|NCT00791479|526337|P1|Overall Study|Withdrawal by Subject|0
165244|NCT00791479|526332|P6|Overall Study|Protocol Violation|0
165245|NCT00791479|526333|P5|Overall Study|Protocol Violation|0
165246|NCT00791479|526334|P4|Overall Study|Protocol Violation|1
165247|NCT00791479|526335|P3|Overall Study|Protocol Violation|0
165248|NCT00791479|526336|P2|Overall Study|Protocol Violation|1
165249|NCT00791479|526337|P1|Overall Study|Protocol Violation|2
165250|NCT00791479|526332|P6|Overall Study|Lost to Follow-up|1
165251|NCT00791479|526333|P5|Overall Study|Lost to Follow-up|0
165252|NCT00791479|526334|P4|Overall Study|Lost to Follow-up|0
165253|NCT00791479|526335|P3|Overall Study|Lost to Follow-up|0
165254|NCT00791479|526336|P2|Overall Study|Lost to Follow-up|1
165255|NCT00791479|526337|P1|Overall Study|Lost to Follow-up|0
165256|NCT00791479|526332|P6|Overall Study|Adverse Event|1
165257|NCT00791479|526333|P5|Overall Study|Adverse Event|0
165258|NCT00791479|526334|P4|Overall Study|Adverse Event|2
165259|NCT00791479|526335|P3|Overall Study|Adverse Event|0
165260|NCT00791479|526336|P2|Overall Study|Adverse Event|1
165261|NCT00791479|526337|P1|Overall Study|Adverse Event|0
165262|NCT00791479|526332|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
165263|NCT00791479|526333|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
165264|NCT00791479|526334|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
165265|NCT00791479|526335|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
165266|NCT00791479|526336|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
165267|NCT00791479|526337|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
165268|NCT00791492|526433|P2|Overall Study|Liver transplantation|1
165269|NCT00791492|526434|P1|Overall Study|Liver transplantation|5
165270|NCT00791492|526433|P2|Overall Study|Withdrawal by Subject|2
165271|NCT00791492|526434|P1|Overall Study|Withdrawal by Subject|1
165272|NCT00791518|526476|P1|Overall Study|Protocol Violation|93
165273|NCT00791557|526502|P1|Overall Study|Adverse Event|1
165274|NCT00791648|526508|P2|Overall Study|Withdrawal by Subject|1
165275|NCT00791648|526509|P1|Overall Study|Withdrawal by Subject|0
165276|NCT00791648|526508|P2|Overall Study|Physician Decision|1
165277|NCT00791648|526509|P1|Overall Study|Physician Decision|0
165278|NCT00791661|526528|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
165279|NCT00791661|526529|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
165280|NCT00791661|526530|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
165281|NCT00791661|526528|P3|7 Day Wash-out|Adverse Event|1
165282|NCT00791661|526529|P2|7 Day Wash-out|Adverse Event|0
165283|NCT00791661|526530|P1|7 Day Wash-out|Adverse Event|0
165284|NCT00791700|526625|P4|Overall Study|Blood sampling not done before Stage 1|1
165285|NCT00791700|526626|P3|Overall Study|Blood sampling not done before Stage 1|0
165286|NCT00791700|526627|P2|Overall Study|Blood sampling not done before Stage 1|0
165287|NCT00791700|526628|P1|Overall Study|Blood sampling not done before Stage 1|0
165288|NCT00791700|526625|P4|Overall Study|Non-compliance with study treatment|2
165289|NCT00791700|526626|P3|Overall Study|Non-compliance with study treatment|0
165290|NCT00791700|526627|P2|Overall Study|Non-compliance with study treatment|0
165291|NCT00791700|526628|P1|Overall Study|Non-compliance with study treatment|1
165292|NCT00791700|526625|P4|Overall Study|No longer willing to participate|1
165293|NCT00791700|526626|P3|Overall Study|No longer willing to participate|0
165294|NCT00791700|526627|P2|Overall Study|No longer willing to participate|1
165295|NCT00791700|526628|P1|Overall Study|No longer willing to participate|0
165296|NCT00791700|526625|P4|Overall Study|Adverse Event|1
165297|NCT00791700|526626|P3|Overall Study|Adverse Event|1
165298|NCT00791700|526627|P2|Overall Study|Adverse Event|0
165299|NCT00791700|526628|P1|Overall Study|Adverse Event|0
165300|NCT00791700|526625|P4|Overall Study|Insufficient clinical response|13
165301|NCT00791700|526626|P3|Overall Study|Insufficient clinical response|3
165302|NCT00791700|526627|P2|Overall Study|Insufficient clinical response|4
165303|NCT00791700|526628|P1|Overall Study|Insufficient clinical response|3
165304|NCT00791765|526715|P2|Weeks 13 to 24|Other|1
165305|NCT00791765|526716|P1|Weeks 13 to 24|Other|0
165306|NCT00791765|526715|P2|Weeks 13 to 24|Lost to Follow-up|2
165307|NCT00791765|526716|P1|Weeks 13 to 24|Lost to Follow-up|1
165308|NCT00791765|526715|P2|Weeks 13 to 24|Disease progression|1
165309|NCT00791765|526716|P1|Weeks 13 to 24|Disease progression|0
165310|NCT00791765|526715|P2|Weeks 13 to 24|Withdrawal by Subject|1
165311|NCT00791765|526716|P1|Weeks 13 to 24|Withdrawal by Subject|2
165312|NCT00791765|526715|P2|Weeks 13 to 24|Adverse Event|3
165313|NCT00791765|526716|P1|Weeks 13 to 24|Adverse Event|0
165314|NCT00791765|526715|P2|Weeks 13 to 24|Protocol deviation|0
165315|NCT00791765|526716|P1|Weeks 13 to 24|Protocol deviation|2
165316|NCT00791765|526715|P2|Weeks 1 to 12|Ineligibility determined|3
165317|NCT00791765|526716|P1|Weeks 1 to 12|Ineligibility determined|0
165318|NCT00791765|526715|P2|Weeks 1 to 12|Disease progression|0
165319|NCT00791765|526716|P1|Weeks 1 to 12|Disease progression|3
165320|NCT00791765|526715|P2|Weeks 1 to 12|Physician Decision|0
165321|NCT00791765|526716|P1|Weeks 1 to 12|Physician Decision|1
165322|NCT00791765|526715|P2|Weeks 1 to 12|Withdrawal by Subject|0
165323|NCT00791765|526716|P1|Weeks 1 to 12|Withdrawal by Subject|3
165324|NCT00791765|526715|P2|Weeks 1 to 12|Lost to Follow-up|0
165325|NCT00791765|526716|P1|Weeks 1 to 12|Lost to Follow-up|1
165326|NCT00791765|526715|P2|Weeks 1 to 12|Adverse Event|1
165327|NCT00791765|526716|P1|Weeks 1 to 12|Adverse Event|0
165328|NCT00791778|526729|P2|Follow-up|Lost to Follow-up|1
165329|NCT00791778|526730|P1|Follow-up|Lost to Follow-up|2
165330|NCT00791778|526729|P2|Follow-up|Withdrawal by Subject|0
165331|NCT00791778|526730|P1|Follow-up|Withdrawal by Subject|3
165332|NCT00791778|526729|P2|Double-blind Treatment|Non-compliant with study medication|0
165333|NCT00791778|526730|P1|Double-blind Treatment|Non-compliant with study medication|2
165334|NCT00791778|526729|P2|Double-blind Treatment|Withdrawal by Subject|9
165335|NCT00791778|526730|P1|Double-blind Treatment|Withdrawal by Subject|20
165336|NCT00791778|526729|P2|Double-blind Treatment|Protocol Violation|4
165337|NCT00791778|526730|P1|Double-blind Treatment|Protocol Violation|0
165338|NCT00791778|526729|P2|Double-blind Treatment|Physician Decision|26
165339|NCT00791778|526730|P1|Double-blind Treatment|Physician Decision|6
165340|NCT00791778|526729|P2|Double-blind Treatment|Adverse Event|9
165341|NCT00791778|526730|P1|Double-blind Treatment|Adverse Event|49
165342|NCT00791921|526801|P2|Overall Study|Reason other than those above|1
165343|NCT00791921|526802|P1|Overall Study|Reason other than those above|0
165344|NCT00791921|526801|P2|Overall Study|Lack of study drug administration|1
165345|NCT00791921|526802|P1|Overall Study|Lack of study drug administration|1
165346|NCT00791921|526801|P2|Overall Study|Lack of Efficacy|2
165347|NCT00791921|526802|P1|Overall Study|Lack of Efficacy|0
165348|NCT00791921|526801|P2|Overall Study|Adverse Event|2
165349|NCT00791921|526802|P1|Overall Study|Adverse Event|8
165350|NCT00791921|526801|P2|Overall Study|Withdrawal by Subject|2
165351|NCT00791921|526802|P1|Overall Study|Withdrawal by Subject|1
165352|NCT00791921|526801|P2|Overall Study|Protocol planed|88
165353|NCT00791921|526802|P1|Overall Study|Protocol planed|24
165354|NCT00791934|526810|P1|Overall Study|Did not consent for extended follow-up|13
165355|NCT00791934|526810|P1|Overall Study|Withdrawal by Subject|2
165356|NCT00791999|526833|P4|Overall Study|Reason other than those above|0
165357|NCT00791999|526834|P3|Overall Study|Reason other than those above|1
165358|NCT00791999|526835|P2|Overall Study|Reason other than those above|0
165359|NCT00791999|526836|P1|Overall Study|Reason other than those above|1
165360|NCT00791999|526833|P4|Overall Study|Lack of Efficacy|2
165361|NCT00791999|526834|P3|Overall Study|Lack of Efficacy|0
165362|NCT00791999|526835|P2|Overall Study|Lack of Efficacy|1
165363|NCT00791999|526836|P1|Overall Study|Lack of Efficacy|0
165364|NCT00791999|526833|P4|Overall Study|Adverse Event|3
165365|NCT00791999|526834|P3|Overall Study|Adverse Event|7
165366|NCT00791999|526835|P2|Overall Study|Adverse Event|3
165367|NCT00791999|526836|P1|Overall Study|Adverse Event|3
165368|NCT00791999|526833|P4|Overall Study|Protocol Violation|0
165369|NCT00791999|526834|P3|Overall Study|Protocol Violation|1
165370|NCT00791999|526835|P2|Overall Study|Protocol Violation|0
165371|NCT00791999|526836|P1|Overall Study|Protocol Violation|3
165372|NCT00791999|526833|P4|Overall Study|Withdrawal by Subject|2
165373|NCT00791999|526834|P3|Overall Study|Withdrawal by Subject|0
165374|NCT00791999|526835|P2|Overall Study|Withdrawal by Subject|1
165375|NCT00791999|526836|P1|Overall Study|Withdrawal by Subject|0
165376|NCT00791999|526833|P4|Overall Study|Protocol planed withdrawal|45
165377|NCT00791999|526834|P3|Overall Study|Protocol planed withdrawal|11
165378|NCT00791999|526835|P2|Overall Study|Protocol planed withdrawal|11
165379|NCT00791999|526836|P1|Overall Study|Protocol planed withdrawal|14
165380|NCT00792103|526850|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
165381|NCT00792103|526850|P1|Overall Study|Protocol Violation|10
165382|NCT00792103|526850|P1|Overall Study|Withdrawal by Subject|52
165383|NCT00792103|526850|P1|Overall Study|Adverse Event|25
165384|NCT00792103|526850|P1|Overall Study|Lost to Follow-up|17
165385|NCT00792103|526850|P1|Overall Study|Enrolled, not treated|15
165386|NCT00792116|526860|P2|Overall Study|Discontnued intervention|0
165387|NCT00792116|526861|P1|Overall Study|Discontnued intervention|1
165388|NCT00792116|526860|P2|Overall Study|Lost to Follow-up|1
165389|NCT00792116|526861|P1|Overall Study|Lost to Follow-up|0
165390|NCT00792259|526874|P3|Overall Study|Poor Quality Scans|0
165391|NCT00792259|526875|P2|Overall Study|Poor Quality Scans|0
165392|NCT00792259|526876|P1|Overall Study|Poor Quality Scans|1
165393|NCT00792298|526884|P8|Treatment Period 2|Withdrawal by Subject|2
165394|NCT00792298|526885|P7|Treatment Period 2|Withdrawal by Subject|0
165395|NCT00792298|526886|P6|Treatment Period 2|Withdrawal by Subject|0
165396|NCT00792298|526887|P5|Treatment Period 2|Withdrawal by Subject|1
165397|NCT00792298|526888|P4|Treatment Period 2|Withdrawal by Subject|2
165398|NCT00792298|526889|P3|Treatment Period 2|Withdrawal by Subject|0
165399|NCT00792298|526890|P2|Treatment Period 2|Withdrawal by Subject|1
165400|NCT00792298|526891|P1|Treatment Period 2|Withdrawal by Subject|1
165401|NCT00792298|526884|P8|Treatment Period 2|Pregnancy|0
165402|NCT00792298|526885|P7|Treatment Period 2|Pregnancy|0
165403|NCT00792298|526886|P6|Treatment Period 2|Pregnancy|0
165404|NCT00792298|526887|P5|Treatment Period 2|Pregnancy|0
165405|NCT00792298|526888|P4|Treatment Period 2|Pregnancy|0
165406|NCT00792298|526889|P3|Treatment Period 2|Pregnancy|1
165407|NCT00792298|526890|P2|Treatment Period 2|Pregnancy|0
165408|NCT00792298|526891|P1|Treatment Period 2|Pregnancy|0
165409|NCT00792298|526884|P8|Treatment Period 2|Physician Decision|0
165410|NCT00792298|526885|P7|Treatment Period 2|Physician Decision|1
165411|NCT00792298|526886|P6|Treatment Period 2|Physician Decision|0
165412|NCT00792298|526887|P5|Treatment Period 2|Physician Decision|0
165413|NCT00792298|526888|P4|Treatment Period 2|Physician Decision|0
165414|NCT00792298|526889|P3|Treatment Period 2|Physician Decision|0
165415|NCT00792298|526890|P2|Treatment Period 2|Physician Decision|0
165416|NCT00792298|526891|P1|Treatment Period 2|Physician Decision|0
165417|NCT00792298|526884|P8|Treatment Period 2|Lack of Efficacy|0
165418|NCT00792298|526885|P7|Treatment Period 2|Lack of Efficacy|0
165419|NCT00792298|526886|P6|Treatment Period 2|Lack of Efficacy|0
165420|NCT00792298|526887|P5|Treatment Period 2|Lack of Efficacy|1
165421|NCT00792298|526888|P4|Treatment Period 2|Lack of Efficacy|0
165422|NCT00792298|526889|P3|Treatment Period 2|Lack of Efficacy|0
165423|NCT00792298|526890|P2|Treatment Period 2|Lack of Efficacy|0
165424|NCT00792298|526891|P1|Treatment Period 2|Lack of Efficacy|0
165425|NCT00792298|526884|P8|Washout|Withdrawal by Subject|0
165426|NCT00792298|526885|P7|Washout|Withdrawal by Subject|0
165427|NCT00792298|526886|P6|Washout|Withdrawal by Subject|1
165428|NCT00792298|526887|P5|Washout|Withdrawal by Subject|0
165429|NCT00792298|526888|P4|Washout|Withdrawal by Subject|0
165430|NCT00792298|526889|P3|Washout|Withdrawal by Subject|1
165431|NCT00792298|526890|P2|Washout|Withdrawal by Subject|0
165432|NCT00792298|526891|P1|Washout|Withdrawal by Subject|0
165433|NCT00792298|526884|P8|Washout|Adverse Event|0
165434|NCT00792298|526885|P7|Washout|Adverse Event|0
165435|NCT00792298|526886|P6|Washout|Adverse Event|1
165436|NCT00792298|526887|P5|Washout|Adverse Event|0
165437|NCT00792298|526888|P4|Washout|Adverse Event|0
165438|NCT00792298|526889|P3|Washout|Adverse Event|0
165439|NCT00792298|526890|P2|Washout|Adverse Event|0
165440|NCT00792298|526891|P1|Washout|Adverse Event|0
165441|NCT00792298|526884|P8|Treatment Period 1|Protocol Violation|1
165442|NCT00792298|526885|P7|Treatment Period 1|Protocol Violation|0
165443|NCT00792298|526886|P6|Treatment Period 1|Protocol Violation|0
165444|NCT00792298|526887|P5|Treatment Period 1|Protocol Violation|0
165445|NCT00792298|526888|P4|Treatment Period 1|Protocol Violation|0
165446|NCT00792298|526889|P3|Treatment Period 1|Protocol Violation|0
165447|NCT00792298|526890|P2|Treatment Period 1|Protocol Violation|0
165448|NCT00792298|526891|P1|Treatment Period 1|Protocol Violation|0
165449|NCT00792298|526884|P8|Treatment Period 1|Physician Decision|0
165450|NCT00792298|526885|P7|Treatment Period 1|Physician Decision|1
165451|NCT00792298|526886|P6|Treatment Period 1|Physician Decision|0
165452|NCT00792298|526887|P5|Treatment Period 1|Physician Decision|0
165453|NCT00792298|526888|P4|Treatment Period 1|Physician Decision|1
165454|NCT00792298|526889|P3|Treatment Period 1|Physician Decision|0
165455|NCT00792298|526890|P2|Treatment Period 1|Physician Decision|0
165456|NCT00792298|526891|P1|Treatment Period 1|Physician Decision|0
165457|NCT00792298|526884|P8|Treatment Period 1|Lost to Follow-up|0
165458|NCT00792298|526885|P7|Treatment Period 1|Lost to Follow-up|1
165459|NCT00792298|526886|P6|Treatment Period 1|Lost to Follow-up|0
165460|NCT00792298|526887|P5|Treatment Period 1|Lost to Follow-up|0
165461|NCT00792298|526888|P4|Treatment Period 1|Lost to Follow-up|0
165462|NCT00792298|526889|P3|Treatment Period 1|Lost to Follow-up|0
165463|NCT00792298|526890|P2|Treatment Period 1|Lost to Follow-up|0
165464|NCT00792298|526891|P1|Treatment Period 1|Lost to Follow-up|0
165465|NCT00792298|526884|P8|Treatment Period 1|Withdrawal by Subject|0
165466|NCT00792298|526885|P7|Treatment Period 1|Withdrawal by Subject|1
165467|NCT00792298|526886|P6|Treatment Period 1|Withdrawal by Subject|2
165468|NCT00792298|526887|P5|Treatment Period 1|Withdrawal by Subject|0
165469|NCT00792298|526888|P4|Treatment Period 1|Withdrawal by Subject|2
165470|NCT00792298|526889|P3|Treatment Period 1|Withdrawal by Subject|1
165471|NCT00792298|526890|P2|Treatment Period 1|Withdrawal by Subject|0
165472|NCT00792298|526891|P1|Treatment Period 1|Withdrawal by Subject|1
165473|NCT00792298|526884|P8|Treatment Period 1|Lack of Efficacy|0
165474|NCT00792298|526885|P7|Treatment Period 1|Lack of Efficacy|0
165475|NCT00792298|526886|P6|Treatment Period 1|Lack of Efficacy|0
165476|NCT00792298|526887|P5|Treatment Period 1|Lack of Efficacy|0
165477|NCT00792298|526888|P4|Treatment Period 1|Lack of Efficacy|0
165478|NCT00792298|526889|P3|Treatment Period 1|Lack of Efficacy|1
165479|NCT00792298|526890|P2|Treatment Period 1|Lack of Efficacy|0
165480|NCT00792298|526891|P1|Treatment Period 1|Lack of Efficacy|0
165481|NCT00792298|526884|P8|Treatment Period 1|Adverse Event|0
165482|NCT00792298|526885|P7|Treatment Period 1|Adverse Event|1
165483|NCT00792298|526886|P6|Treatment Period 1|Adverse Event|1
165484|NCT00792298|526887|P5|Treatment Period 1|Adverse Event|0
165485|NCT00792298|526888|P4|Treatment Period 1|Adverse Event|1
165486|NCT00792298|526889|P3|Treatment Period 1|Adverse Event|0
165487|NCT00792298|526890|P2|Treatment Period 1|Adverse Event|1
165488|NCT00792298|526891|P1|Treatment Period 1|Adverse Event|0
165489|NCT00792623|526933|P1|Overall Study|Withdrawal by Subject|5
165490|NCT00792623|526933|P1|Overall Study|Adverse Event|2
165491|NCT00792636|526949|P3|Overall Study|Investigator Discretion|2
165492|NCT00792636|526950|P2|Overall Study|Investigator Discretion|0
165493|NCT00792636|526951|P1|Overall Study|Investigator Discretion|2
165494|NCT00792636|526949|P3|Overall Study|Adverse Event|3
165495|NCT00792636|526950|P2|Overall Study|Adverse Event|2
165496|NCT00792636|526951|P1|Overall Study|Adverse Event|4
165497|NCT00792636|526949|P3|Overall Study|Lack of Efficacy|13
165498|NCT00792636|526950|P2|Overall Study|Lack of Efficacy|4
165499|NCT00792636|526951|P1|Overall Study|Lack of Efficacy|3
165500|NCT00792636|526949|P3|Overall Study|Withdrew Consent|9
165501|NCT00792636|526950|P2|Overall Study|Withdrew Consent|13
165502|NCT00792636|526951|P1|Overall Study|Withdrew Consent|10
165503|NCT00792636|526949|P3|Overall Study|Lost to Follow-up|14
165504|NCT00792636|526950|P2|Overall Study|Lost to Follow-up|19
165505|NCT00792636|526951|P1|Overall Study|Lost to Follow-up|13
165506|NCT00792636|526949|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
165507|NCT00792636|526950|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
165508|NCT00792636|526951|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
165509|NCT00792636|526949|P3|Overall Study|Protocol Violation|20
165510|NCT00792636|526950|P2|Overall Study|Protocol Violation|23
165511|NCT00792636|526951|P1|Overall Study|Protocol Violation|17
165512|NCT00792701|527006|P2|Overall Study|Not protocol specified|0
165513|NCT00792701|527007|P1|Overall Study|Not protocol specified|17
165514|NCT00792701|527006|P2|Overall Study|Withdrawal by Subject|19
165515|NCT00792701|527007|P1|Overall Study|Withdrawal by Subject|1
165516|NCT00792701|527006|P2|Overall Study|Ineligible|3
165517|NCT00792701|527007|P1|Overall Study|Ineligible|1
165518|NCT00792701|527006|P2|Overall Study|Adverse Event|22
165519|NCT00792701|527007|P1|Overall Study|Adverse Event|0
165520|NCT00792805|527021|P3|Overall Study|Protocol deviation|1
165521|NCT00792805|527022|P2|Overall Study|Protocol deviation|1
165522|NCT00792805|527023|P1|Overall Study|Protocol deviation|0
165523|NCT00792805|527021|P3|Overall Study|Abnormal laboratory value(s)|1
165524|NCT00792805|527022|P2|Overall Study|Abnormal laboratory value(s)|0
165525|NCT00792805|527023|P1|Overall Study|Abnormal laboratory value(s)|0
165526|NCT00792805|527021|P3|Overall Study|Lost to Follow-up|6
165527|NCT00792805|527022|P2|Overall Study|Lost to Follow-up|1
165528|NCT00792805|527023|P1|Overall Study|Lost to Follow-up|1
165529|NCT00792805|527021|P3|Overall Study|Unsatisfactory therapeutic effect|6
165530|NCT00792805|527022|P2|Overall Study|Unsatisfactory therapeutic effect|6
165531|NCT00792805|527023|P1|Overall Study|Unsatisfactory therapeutic effect|1
165532|NCT00792805|527021|P3|Overall Study|Abnormal test procedure result(s)|0
165533|NCT00792805|527022|P2|Overall Study|Abnormal test procedure result(s)|2
165534|NCT00792805|527023|P1|Overall Study|Abnormal test procedure result(s)|1
165535|NCT00792805|527021|P3|Overall Study|Administrative problems|4
165536|NCT00792805|527022|P2|Overall Study|Administrative problems|0
165537|NCT00792805|527023|P1|Overall Study|Administrative problems|2
165538|NCT00792805|527021|P3|Overall Study|Subject withdrew consent|5
165539|NCT00792805|527022|P2|Overall Study|Subject withdrew consent|6
165540|NCT00792805|527023|P1|Overall Study|Subject withdrew consent|5
165541|NCT00792805|527021|P3|Overall Study|Adverse Event|10
165542|NCT00792805|527022|P2|Overall Study|Adverse Event|10
165543|NCT00792805|527023|P1|Overall Study|Adverse Event|12
165544|NCT00792935|527054|P2|Overall Study|Withdrawal by Subject|1
165545|NCT00792935|527055|P1|Overall Study|Withdrawal by Subject|0
165546|NCT00792935|527054|P2|Overall Study|Protocol Violation|0
165547|NCT00792935|527055|P1|Overall Study|Protocol Violation|2
165548|NCT00792935|527054|P2|Overall Study|Lost to Follow-up|1
165549|NCT00792935|527055|P1|Overall Study|Lost to Follow-up|0
165550|NCT00792935|527054|P2|Overall Study|Adverse Event|1
165551|NCT00792935|527055|P1|Overall Study|Adverse Event|2
165552|NCT00792948|527063|P1|Overall Study|Protocol Violation|1
165553|NCT00792948|527063|P1|Overall Study|Physician Decision|11
165554|NCT00792948|527063|P1|Overall Study|Insurance denial - not treated|1
165555|NCT00792948|527063|P1|Overall Study|Ineligible|2
165556|NCT00792948|527063|P1|Overall Study|Withdrawal by Subject|3
165557|NCT00792948|527063|P1|Overall Study|Death|4
165558|NCT00792948|527063|P1|Overall Study|Adverse Event|6
165559|NCT00793104|527072|P1|Overall Study|Lost to Follow-up|1
165560|NCT00793325|527084|P1|Overall Study|Lost to Follow-up|1
165561|NCT00793325|527084|P1|Overall Study|Protocol Violation|18
165562|NCT00793403|527108|P1|Overall Study|Unspecified|73
165563|NCT00793546|527179|P2|Overall Study|Unspecified|0
165564|NCT00793546|527180|P1|Overall Study|Unspecified|1
165565|NCT00793546|527179|P2|Overall Study|Study Terminated by Sponsor|27
165566|NCT00793546|527180|P1|Overall Study|Study Terminated by Sponsor|8
165567|NCT00793546|527179|P2|Overall Study|Withdrawal by Subject|1
165568|NCT00793546|527180|P1|Overall Study|Withdrawal by Subject|1
165569|NCT00793546|527179|P2|Overall Study|Lost to Follow-up|0
165570|NCT00793546|527180|P1|Overall Study|Lost to Follow-up|1
165571|NCT00793546|527179|P2|Overall Study|Death|0
165572|NCT00793546|527180|P1|Overall Study|Death|3
165573|NCT00793585|527219|P2|Overall Study|Protocol Violation|2
165574|NCT00793585|527220|P1|Overall Study|Protocol Violation|1
165575|NCT00793585|527219|P2|Overall Study|Adverse Event|1
165576|NCT00793585|527220|P1|Overall Study|Adverse Event|1
165577|NCT00793624|527245|P4|Overall Study|Other reason not described above|3
165578|NCT00793624|527246|P3|Overall Study|Other reason not described above|6
165579|NCT00793624|527247|P2|Overall Study|Other reason not described above|4
165580|NCT00793624|527248|P1|Overall Study|Other reason not described above|6
165581|NCT00793624|527245|P4|Overall Study|Non compliance with protocol|3
165582|NCT00793624|527246|P3|Overall Study|Non compliance with protocol|2
165583|NCT00793624|527247|P2|Overall Study|Non compliance with protocol|3
165584|NCT00793624|527248|P1|Overall Study|Non compliance with protocol|2
165585|NCT00793624|527245|P4|Overall Study|Lack of Efficacy|3
165586|NCT00793624|527246|P3|Overall Study|Lack of Efficacy|1
165587|NCT00793624|527247|P2|Overall Study|Lack of Efficacy|2
165588|NCT00793624|527248|P1|Overall Study|Lack of Efficacy|9
165589|NCT00793624|527245|P4|Overall Study|Withdrawal by Subject|14
165590|NCT00793624|527246|P3|Overall Study|Withdrawal by Subject|11
165591|NCT00793624|527247|P2|Overall Study|Withdrawal by Subject|9
165592|NCT00793624|527248|P1|Overall Study|Withdrawal by Subject|20
165593|NCT00793624|527245|P4|Overall Study|Lost to Follow-up|0
165594|NCT00793624|527246|P3|Overall Study|Lost to Follow-up|4
165595|NCT00793624|527247|P2|Overall Study|Lost to Follow-up|2
165596|NCT00793624|527248|P1|Overall Study|Lost to Follow-up|2
165597|NCT00793624|527245|P4|Overall Study|Adverse Event|20
165598|NCT00793624|527246|P3|Overall Study|Adverse Event|15
165599|NCT00793624|527247|P2|Overall Study|Adverse Event|16
165600|NCT00793624|527248|P1|Overall Study|Adverse Event|18
165601|NCT00787839|527525|P1|Overall Study|Failure to have the OGTT was most common|404
165602|NCT00799591|527559|P1|Overall Study|Infectious origin not probable|1
165603|NCT00799591|527559|P1|Overall Study|Antibiotic changed, no apparent reason|1
165604|NCT00799591|527559|P1|Overall Study|Persistance of fever undetermined origin|1
165605|NCT00799591|527559|P1|Overall Study|Resistance germ and technical failure|2
165606|NCT00799591|527559|P1|Overall Study|New infection|4
165607|NCT00799591|527559|P1|Overall Study|Resistant germ|11
165608|NCT00799591|527559|P1|Overall Study|Technical failure|12
165609|NCT00799591|527559|P1|Overall Study|Death|14
165610|NCT00799591|527559|P1|Overall Study|De-escalation of doses|20
165611|NCT00799617|527601|P2|Anemia Trial|Withdrawal by Subject|3
165612|NCT00799617|527602|P1|Anemia Trial|Withdrawal by Subject|3
165613|NCT00799617|527601|P2|Cognitive Function Trial|Lost to Follow-up|1
165614|NCT00799617|527602|P1|Cognitive Function Trial|Lost to Follow-up|0
165615|NCT00799617|527601|P2|Bone Trial|Month 12 scan not available|16
165616|NCT00799617|527602|P1|Bone Trial|Month 12 scan not available|6
165617|NCT00799617|527601|P2|Cardiovascular Trial|Baseline scan not analyzable|2
165618|NCT00799617|527602|P1|Cardiovascular Trial|Baseline scan not analyzable|0
165619|NCT00799617|527601|P2|Cardiovascular Trial|Month 12 scan not available|15
165620|NCT00799617|527602|P1|Cardiovascular Trial|Month 12 scan not available|15
165621|NCT00799617|527601|P2|Vitality Trial|Lost to Follow-up|22
165622|NCT00799617|527602|P1|Vitality Trial|Lost to Follow-up|7
165623|NCT00799617|527601|P2|Physical Function Trial|Lost to Follow-up|11
165624|NCT00799617|527602|P1|Physical Function Trial|Lost to Follow-up|6
165625|NCT00799617|527601|P2|Sexual Funtion Trial|No Baseline Data|7
165626|NCT00799617|527602|P1|Sexual Funtion Trial|No Baseline Data|4
165627|NCT00799617|527601|P2|Sexual Funtion Trial|Lost to Follow-up|14
165628|NCT00799617|527602|P1|Sexual Funtion Trial|Lost to Follow-up|12
165629|NCT00799617|527601|P2|Main Testosterone Trial|Lost to Follow-up|20
165630|NCT00799617|527602|P1|Main Testosterone Trial|Lost to Follow-up|18
165631|NCT00799617|527601|P2|Main Testosterone Trial|Randomized in error|1
165632|NCT00799617|527602|P1|Main Testosterone Trial|Randomized in error|1
165633|NCT00799708|527694|P3|Overall Study|non-compliance|0
165634|NCT00799708|527695|P2|Overall Study|non-compliance|0
165635|NCT00799708|527696|P1|Overall Study|non-compliance|1
165636|NCT00799825|527737|P1|Overall Study|Pregnancy|3
165637|NCT00799825|527737|P1|Overall Study|Lost to Follow-up|38
165638|NCT00799825|527737|P1|Overall Study|Withdrawal by Subject|6
165639|NCT00799825|527737|P1|Overall Study|Adverse Event|1
165640|NCT00800384|527750|P2|Overall Study|Lost to Follow-up|26
165641|NCT00800384|527751|P1|Overall Study|Lost to Follow-up|17
165642|NCT00800384|527750|P2|Overall Study|Withdrawal by Subject|17
165643|NCT00800384|527751|P1|Overall Study|Withdrawal by Subject|24
165644|NCT00800436|527766|P7|Overall Study|Withdrawal by Subject|0
165645|NCT00800436|527767|P6|Overall Study|Withdrawal by Subject|0
165646|NCT00800436|527768|P5|Overall Study|Withdrawal by Subject|0
165647|NCT00800436|527769|P4|Overall Study|Withdrawal by Subject|1
165648|NCT00800436|527770|P3|Overall Study|Withdrawal by Subject|1
165649|NCT00800436|527771|P2|Overall Study|Withdrawal by Subject|0
165650|NCT00800436|527772|P1|Overall Study|Withdrawal by Subject|0
165651|NCT00800540|527816|P2|Period 2: 6 Weeks|Adverse Event|1
165652|NCT00800540|527817|P1|Period 2: 6 Weeks|Adverse Event|0
165653|NCT00800540|527816|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
165654|NCT00800540|527817|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
165655|NCT00800540|527816|P2|Period One: 6 Weeks|Noncompliance|0
165656|NCT00800540|527817|P1|Period One: 6 Weeks|Noncompliance|1
165657|NCT00800683|527847|P2|Overall Study|Not specified|2
165658|NCT00800683|527848|P1|Overall Study|Not specified|1
165659|NCT00800683|527847|P2|Overall Study|Lack of Efficacy|1
165660|NCT00800683|527848|P1|Overall Study|Lack of Efficacy|1
165661|NCT00800683|527847|P2|Overall Study|Withdrawal by Subject|7
165662|NCT00800683|527848|P1|Overall Study|Withdrawal by Subject|1
165663|NCT00800683|527847|P2|Overall Study|Lost to Follow-up|1
165664|NCT00800683|527848|P1|Overall Study|Lost to Follow-up|3
165665|NCT00800683|527847|P2|Overall Study|Adverse Event|8
165666|NCT00800683|527848|P1|Overall Study|Adverse Event|11
165667|NCT00800735|527894|P1|Overall Study|Withdrew Consent|3
165668|NCT00800735|527894|P1|Overall Study|Violation of Selection Criteria at Entry|7
165669|NCT00800735|527894|P1|Overall Study|Insufficient Therapeutic Response|2
165670|NCT00800735|527894|P1|Overall Study|Administrative/Other|2
165671|NCT00800982|527920|P2|Overall Study|Patient moved out of state|0
165672|NCT00800982|527921|P1|Overall Study|Patient moved out of state|1
165673|NCT00800982|527920|P2|Overall Study|Withdrawal by Subject|1
165674|NCT00800982|527921|P1|Overall Study|Withdrawal by Subject|0
165675|NCT00800982|527920|P2|Overall Study|Lost to Follow-up|2
165676|NCT00800982|527921|P1|Overall Study|Lost to Follow-up|1
165677|NCT00801099|527927|P1|Overall Study|Lost to Follow-up|101
165678|NCT00801229|527962|P2|Received Study Drug/Placebo|Adverse Event|1
165679|NCT00801229|527963|P1|Received Study Drug/Placebo|Adverse Event|1
165680|NCT00801229|527962|P2|Received Study Drug/Placebo|Lost to Follow-up|1
165681|NCT00801229|527963|P1|Received Study Drug/Placebo|Lost to Follow-up|0
165682|NCT00801229|527962|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
165683|NCT00801229|527963|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
165684|NCT00801229|527962|P2|Received Study Drug/Placebo|Simulator sickness|1
165685|NCT00801229|527963|P1|Received Study Drug/Placebo|Simulator sickness|1
165686|NCT00801229|527962|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
165687|NCT00801229|527963|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
165688|NCT00801229|527962|P2|Received Study Drug/Placebo|Elevated SGOT level|0
165689|NCT00801229|527963|P1|Received Study Drug/Placebo|Elevated SGOT level|1
165690|NCT00801229|527962|P2|Signed Consent|Found Ineligible|1
165691|NCT00801229|527963|P1|Signed Consent|Found Ineligible|1
165692|NCT00801229|527962|P2|Signed Consent|Withdrawal by Subject|2
165693|NCT00801229|527963|P1|Signed Consent|Withdrawal by Subject|2
165694|NCT00801242|527969|P1|Overall Study|Miscellaneous reasons|20
165695|NCT00801242|527969|P1|Overall Study|Lost to Follow-up|1
165696|NCT00801242|527969|P1|Overall Study|Physician Decision|3
165697|NCT00801242|527969|P1|Overall Study|Protocol Violation|5
165698|NCT00801242|527969|P1|Overall Study|Withdrawal by Subject|13
165699|NCT00801242|527969|P1|Overall Study|Adverse Event|10
165700|NCT00801632|527980|P1|Overall Study|Re-transplant|1
165701|NCT00801983|528033|P2|Period 2|Withdrawal by Subject|1
165702|NCT00801983|528034|P1|Period 2|Withdrawal by Subject|2
165703|NCT00801983|528033|P2|Period 1|Withdrawal by Subject|8
165704|NCT00801983|528034|P1|Period 1|Withdrawal by Subject|2
165705|NCT00801983|528033|P2|Period 1|Lost to Follow-up|0
165706|NCT00801983|528034|P1|Period 1|Lost to Follow-up|2
165707|NCT00802074|528046|P6|Overall Study|Withdrawal by Subject|0
165708|NCT00802074|528047|P5|Overall Study|Withdrawal by Subject|0
165709|NCT00802074|528048|P4|Overall Study|Withdrawal by Subject|0
165710|NCT00802074|528049|P3|Overall Study|Withdrawal by Subject|0
165711|NCT00802074|528050|P2|Overall Study|Withdrawal by Subject|0
165712|NCT00802074|528051|P1|Overall Study|Withdrawal by Subject|1
165713|NCT00802074|528046|P6|Overall Study|Adverse Event|0
165714|NCT00802074|528047|P5|Overall Study|Adverse Event|0
165715|NCT00802074|528048|P4|Overall Study|Adverse Event|0
165716|NCT00802074|528049|P3|Overall Study|Adverse Event|1
165717|NCT00802074|528050|P2|Overall Study|Adverse Event|1
165718|NCT00802074|528051|P1|Overall Study|Adverse Event|1
165719|NCT00802178|528097|P1|Overall Study|Patients wish and other reason|1
165720|NCT00802178|528097|P1|Overall Study|IT and patient wish|8
165721|NCT00802178|528097|P1|Overall Study|Lack of efficacy and patient wish|1
165722|NCT00802178|528097|P1|Overall Study|Other|32
165723|NCT00802178|528097|P1|Overall Study|Withdrawal by Subject|18
165724|NCT00802178|528097|P1|Overall Study|Insufficient tolerability (IT)|17
165725|NCT00802178|528097|P1|Overall Study|Lack of Efficacy|36
165726|NCT00802360|528135|P4|Overall Study|Unspecified|3
165727|NCT00802360|528136|P3|Overall Study|Unspecified|6
165728|NCT00802360|528137|P2|Overall Study|Unspecified|3
165729|NCT00802360|528138|P1|Overall Study|Unspecified|2
165730|NCT00802360|528135|P4|Overall Study|Pregnancy loss/miscarriage|3
165731|NCT00802360|528136|P3|Overall Study|Pregnancy loss/miscarriage|0
165732|NCT00802360|528137|P2|Overall Study|Pregnancy loss/miscarriage|2
165733|NCT00802360|528138|P1|Overall Study|Pregnancy loss/miscarriage|0
165734|NCT00802360|528135|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
165735|NCT00802360|528136|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
165736|NCT00802360|528137|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
165737|NCT00802360|528138|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
165738|NCT00802360|528135|P4|Overall Study|No positive serum pregnancy|10
165739|NCT00802360|528136|P3|Overall Study|No positive serum pregnancy|14
165740|NCT00802360|528137|P2|Overall Study|No positive serum pregnancy|20
165741|NCT00802360|528138|P1|Overall Study|No positive serum pregnancy|17
165742|NCT00802360|528135|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
165743|NCT00802360|528136|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
165744|NCT00802360|528137|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
165745|NCT00802360|528138|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
165746|NCT00802360|528135|P4|Overall Study|Cycle cancelled|1
165747|NCT00802360|528136|P3|Overall Study|Cycle cancelled|1
165748|NCT00802360|528137|P2|Overall Study|Cycle cancelled|1
165749|NCT00802360|528138|P1|Overall Study|Cycle cancelled|0
165750|NCT00802360|528135|P4|Overall Study|Inadequate number of oocytes retrieved|1
165751|NCT00802360|528136|P3|Overall Study|Inadequate number of oocytes retrieved|0
165752|NCT00802360|528137|P2|Overall Study|Inadequate number of oocytes retrieved|0
165753|NCT00802360|528138|P1|Overall Study|Inadequate number of oocytes retrieved|0
165754|NCT00802360|528135|P4|Overall Study|Stimulation failure|3
165755|NCT00802360|528136|P3|Overall Study|Stimulation failure|3
165756|NCT00802360|528137|P2|Overall Study|Stimulation failure|0
165757|NCT00802360|528138|P1|Overall Study|Stimulation failure|4
165758|NCT00802529|528216|P2|Overall Study|Lost to Follow-up|1
165759|NCT00802529|528217|P1|Overall Study|Lost to Follow-up|0
165760|NCT00802659|528242|P4|Overall Study|Physician Decision|0
165761|NCT00802659|528243|P3|Overall Study|Physician Decision|0
165762|NCT00802659|528244|P2|Overall Study|Physician Decision|1
165763|NCT00802659|528245|P1|Overall Study|Physician Decision|0
165764|NCT00802672|528274|P3|Overall Study|other|2
165765|NCT00802672|528275|P2|Overall Study|other|1
165766|NCT00802672|528276|P1|Overall Study|other|3
165767|NCT00802672|528274|P3|Overall Study|Withdrawal by Subject|2
165768|NCT00802672|528275|P2|Overall Study|Withdrawal by Subject|1
165769|NCT00802672|528276|P1|Overall Study|Withdrawal by Subject|1
165770|NCT00802672|528274|P3|Overall Study|Lost to Follow-up|3
165771|NCT00802672|528275|P2|Overall Study|Lost to Follow-up|5
165772|NCT00802672|528276|P1|Overall Study|Lost to Follow-up|5
165773|NCT00802672|528274|P3|Overall Study|Protocol Violation|1
165774|NCT00802672|528275|P2|Overall Study|Protocol Violation|1
165775|NCT00802672|528276|P1|Overall Study|Protocol Violation|2
165776|NCT00802672|528274|P3|Overall Study|Adverse Event|1
165777|NCT00802672|528275|P2|Overall Study|Adverse Event|1
165778|NCT00802672|528276|P1|Overall Study|Adverse Event|1
165779|NCT00802672|528274|P3|Overall Study|Lack of fungal pathogen at baseline|25
165780|NCT00802672|528275|P2|Overall Study|Lack of fungal pathogen at baseline|43
165781|NCT00802672|528276|P1|Overall Study|Lack of fungal pathogen at baseline|56
165782|NCT00802737|528304|P3|Overall Study|Participant too Unwell|0
165783|NCT00802737|528305|P2|Overall Study|Participant too Unwell|2
165784|NCT00802737|528306|P1|Overall Study|Participant too Unwell|0
165785|NCT00802737|528304|P3|Overall Study|Ongoing CLL-Treatment|0
165786|NCT00802737|528305|P2|Overall Study|Ongoing CLL-Treatment|1
165787|NCT00802737|528306|P1|Overall Study|Ongoing CLL-Treatment|0
165788|NCT00802737|528304|P3|Overall Study|Received Prohibited Therapy|0
165789|NCT00802737|528305|P2|Overall Study|Received Prohibited Therapy|0
165790|NCT00802737|528306|P1|Overall Study|Received Prohibited Therapy|1
165791|NCT00802737|528304|P3|Overall Study|Adverse Event|0
165792|NCT00802737|528305|P2|Overall Study|Adverse Event|0
165793|NCT00802737|528306|P1|Overall Study|Adverse Event|1
165794|NCT00802737|528304|P3|Overall Study|Death|1
165795|NCT00802737|528305|P2|Overall Study|Death|5
165796|NCT00802737|528306|P1|Overall Study|Death|6
165797|NCT00802737|528304|P3|Overall Study|Withdrawn due to Disease Progression|0
165798|NCT00802737|528305|P2|Overall Study|Withdrawn due to Disease Progression|3
165799|NCT00802737|528306|P1|Overall Study|Withdrawn due to Disease Progression|9
165800|NCT00790751|528369|P4|Overall Study|Physician Decision|1
165801|NCT00790751|528370|P3|Overall Study|Physician Decision|0
165802|NCT00790751|528371|P2|Overall Study|Physician Decision|0
165803|NCT00790751|528372|P1|Overall Study|Physician Decision|0
165804|NCT00790751|528369|P4|Overall Study|Death|0
165805|NCT00790751|528370|P3|Overall Study|Death|1
165806|NCT00790751|528371|P2|Overall Study|Death|0
165807|NCT00790751|528372|P1|Overall Study|Death|0
165808|NCT00790751|528369|P4|Overall Study|Requirement for restricted medication|0
165809|NCT00790751|528370|P3|Overall Study|Requirement for restricted medication|0
165810|NCT00790751|528371|P2|Overall Study|Requirement for restricted medication|2
165811|NCT00790751|528372|P1|Overall Study|Requirement for restricted medication|0
165812|NCT00790751|528369|P4|Overall Study|Adverse Event|4
165813|NCT00790751|528370|P3|Overall Study|Adverse Event|5
165814|NCT00790751|528371|P2|Overall Study|Adverse Event|3
165815|NCT00790751|528372|P1|Overall Study|Adverse Event|5
165816|NCT00790751|528369|P4|Overall Study|Lost to Follow-up|5
165817|NCT00790751|528370|P3|Overall Study|Lost to Follow-up|4
165818|NCT00790751|528371|P2|Overall Study|Lost to Follow-up|9
165819|NCT00790751|528372|P1|Overall Study|Lost to Follow-up|4
165820|NCT00790751|528369|P4|Overall Study|Protocol non-compliance|11
165821|NCT00790751|528370|P3|Overall Study|Protocol non-compliance|10
165822|NCT00790751|528371|P2|Overall Study|Protocol non-compliance|16
165823|NCT00790751|528372|P1|Overall Study|Protocol non-compliance|16
165824|NCT00790790|528393|P3|Study Period 2: Therapy Phase|Physician Decision|0
165825|NCT00790790|528394|P2|Study Period 2: Therapy Phase|Physician Decision|1
165826|NCT00790790|528395|P1|Study Period 2: Therapy Phase|Physician Decision|0
165827|NCT00790790|528393|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
165828|NCT00790790|528394|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
165829|NCT00790790|528395|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
165830|NCT00790790|528393|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
165831|NCT00790790|528394|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
165832|NCT00790790|528395|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
165833|NCT00790790|528393|P3|Study Period 2: Therapy Phase|Protocol Violation|0
165834|NCT00790790|528394|P2|Study Period 2: Therapy Phase|Protocol Violation|1
165835|NCT00790790|528395|P1|Study Period 2: Therapy Phase|Protocol Violation|1
165836|NCT00790790|528393|P3|Study Period 2: Therapy Phase|Adverse Event|16
165837|NCT00790790|528394|P2|Study Period 2: Therapy Phase|Adverse Event|16
165838|NCT00790790|528395|P1|Study Period 2: Therapy Phase|Adverse Event|3
165839|NCT00790907|528484|P3|Overall Study|Did Not Receive Study Drug|0
165840|NCT00790907|528485|P2|Overall Study|Did Not Receive Study Drug|0
165841|NCT00790907|528486|P1|Overall Study|Did Not Receive Study Drug|10
165842|NCT00790907|528484|P3|Overall Study|Verbatim Reason on the Case Report Form|29
165843|NCT00790907|528485|P2|Overall Study|Verbatim Reason on the Case Report Form|20
165844|NCT00790907|528486|P1|Overall Study|Verbatim Reason on the Case Report Form|74
165845|NCT00790907|528484|P3|Overall Study|Qualifying Condition Not Present|16
165846|NCT00790907|528485|P2|Overall Study|Qualifying Condition Not Present|14
165847|NCT00790907|528486|P1|Overall Study|Qualifying Condition Not Present|29
165848|NCT00790907|528484|P3|Overall Study|Required Protocol-prohibited Therapy|7
165849|NCT00790907|528485|P2|Overall Study|Required Protocol-prohibited Therapy|5
165850|NCT00790907|528486|P1|Overall Study|Required Protocol-prohibited Therapy|17
165851|NCT00790907|528484|P3|Overall Study|Bleeding Event|21
165852|NCT00790907|528485|P2|Overall Study|Bleeding Event|16
165853|NCT00790907|528486|P1|Overall Study|Bleeding Event|11
165854|NCT00790907|528484|P3|Overall Study|Withdrawal by Subject|5
165855|NCT00790907|528485|P2|Overall Study|Withdrawal by Subject|7
165856|NCT00790907|528486|P1|Overall Study|Withdrawal by Subject|1
165857|NCT00790907|528484|P3|Overall Study|Physician Decision|255
165858|NCT00790907|528485|P2|Overall Study|Physician Decision|271
165859|NCT00790907|528486|P1|Overall Study|Physician Decision|304
165860|NCT00790907|528484|P3|Overall Study|Adverse Event|6
165861|NCT00790907|528485|P2|Overall Study|Adverse Event|7
165862|NCT00790907|528486|P1|Overall Study|Adverse Event|9
165863|NCT00791076|528514|P1|Overall Study|Study was terminated,PI left institution|8
165864|NCT00791128|528548|P1|Overall Study|abdominal tumor, unrelated to device|1
165865|NCT00791128|528548|P1|Overall Study|non-compliance by subject|2
165866|NCT00791128|528548|P1|Overall Study|Device migration|2
165867|NCT00791128|528548|P1|Overall Study|Adverse Event|4
165868|NCT00796614|528557|P4|Overall Study|Other than stated|0
165869|NCT00796614|528558|P3|Overall Study|Other than stated|0
165870|NCT00796614|528559|P2|Overall Study|Other than stated|0
165871|NCT00796614|528560|P1|Overall Study|Other than stated|1
165872|NCT00796614|528557|P4|Overall Study|Withdrawal by Subject|1
165873|NCT00796614|528558|P3|Overall Study|Withdrawal by Subject|0
165874|NCT00796614|528559|P2|Overall Study|Withdrawal by Subject|0
165875|NCT00796614|528560|P1|Overall Study|Withdrawal by Subject|1
165876|NCT00796614|528557|P4|Overall Study|Lost to Follow-up|0
165877|NCT00796614|528558|P3|Overall Study|Lost to Follow-up|1
165878|NCT00796614|528559|P2|Overall Study|Lost to Follow-up|2
165879|NCT00796614|528560|P1|Overall Study|Lost to Follow-up|2
165880|NCT00796614|528557|P4|Overall Study|Protocol Violation|0
165881|NCT00796614|528558|P3|Overall Study|Protocol Violation|2
165882|NCT00796614|528559|P2|Overall Study|Protocol Violation|0
165883|NCT00796614|528560|P1|Overall Study|Protocol Violation|0
165884|NCT00796614|528557|P4|Overall Study|Adverse Event|0
165885|NCT00796614|528558|P3|Overall Study|Adverse Event|0
165886|NCT00796614|528559|P2|Overall Study|Adverse Event|2
165887|NCT00796614|528560|P1|Overall Study|Adverse Event|1
165888|NCT00796653|528606|P4|Overall Study|Other reason not described above|4
165889|NCT00796653|528607|P3|Overall Study|Other reason not described above|7
165890|NCT00796653|528608|P2|Overall Study|Other reason not described above|9
165891|NCT00796653|528609|P1|Overall Study|Other reason not described above|4
165892|NCT00796653|528606|P4|Overall Study|Non compliance with protocol|2
165893|NCT00796653|528607|P3|Overall Study|Non compliance with protocol|0
165894|NCT00796653|528608|P2|Overall Study|Non compliance with protocol|2
165895|NCT00796653|528609|P1|Overall Study|Non compliance with protocol|2
165896|NCT00796653|528606|P4|Overall Study|Lack of Efficacy|2
165897|NCT00796653|528607|P3|Overall Study|Lack of Efficacy|3
165898|NCT00796653|528608|P2|Overall Study|Lack of Efficacy|1
165899|NCT00796653|528609|P1|Overall Study|Lack of Efficacy|8
165900|NCT00796653|528606|P4|Overall Study|Withdrawal by Subject|13
165901|NCT00796653|528607|P3|Overall Study|Withdrawal by Subject|8
165902|NCT00796653|528608|P2|Overall Study|Withdrawal by Subject|8
165903|NCT00796653|528609|P1|Overall Study|Withdrawal by Subject|16
165904|NCT00796653|528606|P4|Overall Study|Lost to Follow-up|3
165905|NCT00796653|528607|P3|Overall Study|Lost to Follow-up|2
165906|NCT00796653|528608|P2|Overall Study|Lost to Follow-up|1
165907|NCT00796653|528609|P1|Overall Study|Lost to Follow-up|2
165908|NCT00796653|528606|P4|Overall Study|Adverse Event|16
165909|NCT00796653|528607|P3|Overall Study|Adverse Event|16
165910|NCT00796653|528608|P2|Overall Study|Adverse Event|16
165911|NCT00796653|528609|P1|Overall Study|Adverse Event|19
165912|NCT00796666|528877|P2|Overall Study|Randomized and not treated|0
165913|NCT00796666|528878|P1|Overall Study|Randomized and not treated|1
165914|NCT00796666|528877|P2|Overall Study|Terminated by sponsor|55
165915|NCT00796666|528878|P1|Overall Study|Terminated by sponsor|53
165916|NCT00796666|528877|P2|Overall Study|Unspecified|0
165917|NCT00796666|528878|P1|Overall Study|Unspecified|1
165918|NCT00796666|528877|P2|Overall Study|Protocol Violation|0
165919|NCT00796666|528878|P1|Overall Study|Protocol Violation|1
165920|NCT00796666|528877|P2|Overall Study|Adverse Event|5
165921|NCT00796666|528878|P1|Overall Study|Adverse Event|7
165922|NCT00796666|528877|P2|Overall Study|Withdrawal by Subject|0
165923|NCT00796666|528878|P1|Overall Study|Withdrawal by Subject|2
165924|NCT00796666|528877|P2|Overall Study|Death|4
165925|NCT00796666|528878|P1|Overall Study|Death|2
165926|NCT00796718|528951|P1|Overall Study|Withdrawal by Informed Consent|1
165927|NCT00796718|528951|P1|Overall Study|Lost to Follow-up|5
165928|NCT00796718|528951|P1|Overall Study|Exclusion Criteria|1
165929|NCT00796718|528951|P1|Overall Study|Adverse Event|2
165930|NCT00796757|528980|P1|Overall Study|Not specified|7
165931|NCT00796757|528980|P1|Overall Study|Investigator's decision|2
165932|NCT00796757|528980|P1|Overall Study|Participant noncompliance|1
165933|NCT00796757|528980|P1|Overall Study|Protocol Violation|1
165934|NCT00796757|528980|P1|Overall Study|Death|61
165935|NCT00796757|528980|P1|Overall Study|Withdrawal by Subject|14
165936|NCT00796822|528994|P2|Overall Study|Adverse Event|0
165937|NCT00796822|528995|P1|Overall Study|Adverse Event|1
165938|NCT00796822|528994|P2|Overall Study|Lost to Follow-up|0
165939|NCT00796822|528995|P1|Overall Study|Lost to Follow-up|2
165940|NCT00802841|529012|P2|Overall Study|Treatment duration completed|76
165941|NCT00802841|529013|P1|Overall Study|Treatment duration completed|66
165942|NCT00802841|529012|P2|Overall Study|Protocol deviation|6
165943|NCT00802841|529013|P1|Overall Study|Protocol deviation|2
165944|NCT00802841|529012|P2|Overall Study|Withdrawal by Subject|5
165945|NCT00802841|529013|P1|Overall Study|Withdrawal by Subject|9
165946|NCT00802841|529012|P2|Overall Study|Disease progression|3
165947|NCT00802841|529013|P1|Overall Study|Disease progression|7
165948|NCT00802841|529012|P2|Overall Study|Adverse Event|2
165949|NCT00802841|529013|P1|Overall Study|Adverse Event|8
165950|NCT00802841|529012|P2|Overall Study|Death|2
165951|NCT00802841|529013|P1|Overall Study|Death|1
165952|NCT00802841|529012|P2|Overall Study|Lost to Follow-up|1
165953|NCT00802841|529013|P1|Overall Study|Lost to Follow-up|2
165954|NCT00802841|529012|P2|Overall Study|Administrative problems|0
165955|NCT00802841|529013|P1|Overall Study|Administrative problems|1
165956|NCT00802867|529035|P1|Overall Study|Withdrawal by Subject|1
165957|NCT00802867|529035|P1|Overall Study|Protocol Violation|6
165958|NCT00802867|529035|P1|Overall Study|Lost to Follow-up|6
165959|NCT00802893|529062|P1|Overall Study|study terminated|3
165960|NCT00803023|529097|P4|Overall Study|Lack of Efficacy|1
165961|NCT00803023|529098|P3|Overall Study|Lack of Efficacy|1
165962|NCT00803023|529099|P2|Overall Study|Lack of Efficacy|1
165963|NCT00803023|529100|P1|Overall Study|Lack of Efficacy|0
165964|NCT00803023|529097|P4|Overall Study|Lost to Follow-up|1
165965|NCT00803023|529098|P3|Overall Study|Lost to Follow-up|2
165966|NCT00803023|529099|P2|Overall Study|Lost to Follow-up|1
165967|NCT00803023|529100|P1|Overall Study|Lost to Follow-up|0
165968|NCT00803023|529097|P4|Overall Study|Withdrawal by Subject|0
165969|NCT00803023|529098|P3|Overall Study|Withdrawal by Subject|0
165970|NCT00803023|529099|P2|Overall Study|Withdrawal by Subject|2
165971|NCT00803023|529100|P1|Overall Study|Withdrawal by Subject|0
165972|NCT00803023|529097|P4|Overall Study|Adverse Event|6
165973|NCT00803023|529098|P3|Overall Study|Adverse Event|8
165974|NCT00803023|529099|P2|Overall Study|Adverse Event|4
165975|NCT00803023|529100|P1|Overall Study|Adverse Event|5
165976|NCT00803049|529114|P4|Overall Study|Other than Specified Above|5
165977|NCT00803049|529115|P3|Overall Study|Other than Specified Above|2
165978|NCT00803049|529116|P2|Overall Study|Other than Specified Above|9
165979|NCT00803049|529117|P1|Overall Study|Other than Specified Above|3
165980|NCT00803049|529114|P4|Overall Study|Randomized and Not Treated|2
165981|NCT00803049|529115|P3|Overall Study|Randomized and Not Treated|0
165982|NCT00803049|529116|P2|Overall Study|Randomized and Not Treated|0
165983|NCT00803049|529117|P1|Overall Study|Randomized and Not Treated|0
165984|NCT00803049|529114|P4|Overall Study|Protocol Violation|0
165985|NCT00803049|529115|P3|Overall Study|Protocol Violation|1
165986|NCT00803049|529116|P2|Overall Study|Protocol Violation|1
165987|NCT00803049|529117|P1|Overall Study|Protocol Violation|0
165988|NCT00803049|529114|P4|Overall Study|Withdrawal by Subject|44
165989|NCT00803049|529115|P3|Overall Study|Withdrawal by Subject|16
165990|NCT00803049|529116|P2|Overall Study|Withdrawal by Subject|43
165991|NCT00803049|529117|P1|Overall Study|Withdrawal by Subject|19
165992|NCT00803049|529114|P4|Overall Study|Progressive Disease|6
165993|NCT00803049|529115|P3|Overall Study|Progressive Disease|6
165994|NCT00803049|529116|P2|Overall Study|Progressive Disease|10
165995|NCT00803049|529117|P1|Overall Study|Progressive Disease|6
165996|NCT00803049|529114|P4|Overall Study|Death|2
165997|NCT00803049|529115|P3|Overall Study|Death|0
165998|NCT00803049|529116|P2|Overall Study|Death|1
165999|NCT00803049|529117|P1|Overall Study|Death|2
166000|NCT00803049|529114|P4|Overall Study|Lost to Follow-up|3
166001|NCT00803049|529115|P3|Overall Study|Lost to Follow-up|0
166002|NCT00803049|529116|P2|Overall Study|Lost to Follow-up|2
166003|NCT00803049|529117|P1|Overall Study|Lost to Follow-up|0
166004|NCT00803049|529114|P4|Overall Study|Lack of Efficacy|13
166005|NCT00803049|529115|P3|Overall Study|Lack of Efficacy|6
166006|NCT00803049|529116|P2|Overall Study|Lack of Efficacy|19
166007|NCT00803049|529117|P1|Overall Study|Lack of Efficacy|10
166008|NCT00803049|529114|P4|Overall Study|Adverse Event|27
166009|NCT00803049|529115|P3|Overall Study|Adverse Event|13
166010|NCT00803049|529116|P2|Overall Study|Adverse Event|33
166011|NCT00803049|529117|P1|Overall Study|Adverse Event|21
166012|NCT00803101|529174|P2|Overall Study|Patient did not have surgery|1
166013|NCT00803101|529175|P1|Overall Study|Patient did not have surgery|1
166014|NCT00803101|529174|P2|Overall Study|Patient did not attend scheduled visit|1
166015|NCT00803101|529175|P1|Overall Study|Patient did not attend scheduled visit|2
166016|NCT00803101|529174|P2|Overall Study|Patient died outside SAE report period|0
166017|NCT00803101|529175|P1|Overall Study|Patient died outside SAE report period|1
166018|NCT00803101|529174|P2|Overall Study|Surgery finished outside protocol window|1
166019|NCT00803101|529175|P1|Overall Study|Surgery finished outside protocol window|1
166020|NCT00803101|529174|P2|Overall Study|Protocol Violation|7
166021|NCT00803101|529175|P1|Overall Study|Protocol Violation|1
166022|NCT00803101|529174|P2|Overall Study|Lost to Follow-up|2
166023|NCT00803101|529175|P1|Overall Study|Lost to Follow-up|2
166024|NCT00803101|529174|P2|Overall Study|Withdrawal by Subject|4
166025|NCT00803101|529175|P1|Overall Study|Withdrawal by Subject|6
166026|NCT00803101|529174|P2|Overall Study|Death / Serious Adverse Event|6
166027|NCT00803101|529175|P1|Overall Study|Death / Serious Adverse Event|4
166028|NCT00803179|529206|P1|Overall Study|Lost to Follow-up|3
166029|NCT00803244|529212|P2|Overall Study|Any other reason not above-mentioned|10
166030|NCT00803244|529213|P1|Overall Study|Any other reason not above-mentioned|4
166031|NCT00803244|529212|P2|Overall Study|Withdrawal by Subject|3
166032|NCT00803244|529213|P1|Overall Study|Withdrawal by Subject|2
166033|NCT00803244|529212|P2|Overall Study|Adverse Event|2
166034|NCT00803244|529213|P1|Overall Study|Adverse Event|1
166035|NCT00803270|529223|P2|Overall Study|Lost to Follow-up|2
166036|NCT00803270|529224|P1|Overall Study|Lost to Follow-up|1
166037|NCT00803361|529261|P2|Overall Study|Withdrawal by Subject|6
166038|NCT00803361|529262|P1|Overall Study|Withdrawal by Subject|5
166039|NCT00803361|529261|P2|Overall Study|Protocol Violation|4
166040|NCT00803361|529262|P1|Overall Study|Protocol Violation|2
166041|NCT00803361|529261|P2|Overall Study|Physician Decision|0
166042|NCT00803361|529262|P1|Overall Study|Physician Decision|1
166043|NCT00803361|529261|P2|Overall Study|Lost to Follow-up|2
166044|NCT00803361|529262|P1|Overall Study|Lost to Follow-up|1
166045|NCT00803361|529261|P2|Overall Study|Lack of Efficacy|13
166046|NCT00803361|529262|P1|Overall Study|Lack of Efficacy|4
166047|NCT00803361|529261|P2|Overall Study|Adverse Event|3
166048|NCT00803361|529262|P1|Overall Study|Adverse Event|13
166049|NCT00803595|529337|P3|Overall Study|Withdrawal by Subject|3
166050|NCT00803595|529338|P2|Overall Study|Withdrawal by Subject|2
166051|NCT00803595|529339|P1|Overall Study|Withdrawal by Subject|5
166052|NCT00803595|529337|P3|Overall Study|Protocol Violation|12
166053|NCT00803595|529338|P2|Overall Study|Protocol Violation|2
166054|NCT00803595|529339|P1|Overall Study|Protocol Violation|7
166055|NCT00803595|529337|P3|Overall Study|Adverse Event|1
166056|NCT00803595|529338|P2|Overall Study|Adverse Event|4
166057|NCT00803595|529339|P1|Overall Study|Adverse Event|3
166058|NCT00803634|529352|P2|Overall Study|Death|2
166059|NCT00803634|529353|P1|Overall Study|Death|3
166060|NCT00803634|529352|P2|Overall Study|Lost to Follow-up|3
166061|NCT00803634|529353|P1|Overall Study|Lost to Follow-up|2
166062|NCT00803634|529352|P2|Overall Study|Withdrew Consent|0
166063|NCT00803634|529353|P1|Overall Study|Withdrew Consent|1
166064|NCT00803712|529413|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
166065|NCT00803712|529414|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
166066|NCT00803712|529413|P2|Overall Study|Administrative decision|3
166067|NCT00803712|529414|P1|Overall Study|Administrative decision|2
166068|NCT00803712|529413|P2|Overall Study|Protocol criteria (renal transplant)|8
166069|NCT00803712|529414|P1|Overall Study|Protocol criteria (renal transplant)|12
166070|NCT00803712|529413|P2|Overall Study|Protocol criteria (other)|2
166071|NCT00803712|529414|P1|Overall Study|Protocol criteria (other)|0
166072|NCT00803712|529413|P2|Overall Study|"Other in electronic Case Report Form"|1
166073|NCT00803712|529414|P1|Overall Study|"Other in electronic Case Report Form"|0
166074|NCT00803712|529413|P2|Overall Study|Withdrawal by Subject|4
166075|NCT00803712|529414|P1|Overall Study|Withdrawal by Subject|2
166076|NCT00803712|529413|P2|Overall Study|Lost to Follow-up|1
166077|NCT00803712|529414|P1|Overall Study|Lost to Follow-up|3
166078|NCT00803712|529413|P2|Overall Study|Death|7
166079|NCT00803712|529414|P1|Overall Study|Death|8
166080|NCT00803712|529413|P2|Overall Study|Adverse Event|0
166081|NCT00803712|529414|P1|Overall Study|Adverse Event|5
166082|NCT00803712|529413|P2|Overall Study|Noncompliance|0
166083|NCT00803712|529414|P1|Overall Study|Noncompliance|3
166084|NCT00803738|529480|P2|Overall Study|Positive Results for STD or abnormal PAP|8
166085|NCT00803738|529481|P1|Overall Study|Positive Results for STD or abnormal PAP|2
166086|NCT00803738|529480|P2|Overall Study|Negative Baseline Culture of Candida|63
166087|NCT00803738|529481|P1|Overall Study|Negative Baseline Culture of Candida|56
166088|NCT00803738|529480|P2|Overall Study|Lack of Efficacy|16
166089|NCT00803738|529481|P1|Overall Study|Lack of Efficacy|10
166090|NCT00803738|529480|P2|Overall Study|Withdrawal by Subject|4
166091|NCT00803738|529481|P1|Overall Study|Withdrawal by Subject|1
166092|NCT00803738|529480|P2|Overall Study|Protocol Violation|10
166093|NCT00803738|529481|P1|Overall Study|Protocol Violation|18
166094|NCT00803738|529480|P2|Overall Study|Lost to Follow-up|4
166095|NCT00803738|529481|P1|Overall Study|Lost to Follow-up|4
166096|NCT00803738|529480|P2|Overall Study|Adverse Event|5
166097|NCT00803738|529481|P1|Overall Study|Adverse Event|3
166098|NCT00803790|529520|P4|Period 2|Positive Drug Screen or Personal Reasons|0
166099|NCT00803790|529521|P3|Period 2|Positive Drug Screen or Personal Reasons|0
166100|NCT00803790|529522|P2|Period 2|Positive Drug Screen or Personal Reasons|0
166101|NCT00803790|529523|P1|Period 2|Positive Drug Screen or Personal Reasons|1
166102|NCT00803790|529520|P4|Period 2|Withdrawal by Subject|0
166103|NCT00803790|529521|P3|Period 2|Withdrawal by Subject|0
166104|NCT00803790|529522|P2|Period 2|Withdrawal by Subject|0
166105|NCT00803790|529523|P1|Period 2|Withdrawal by Subject|1
166106|NCT00803790|529520|P4|Period 2|Adverse Event|1
166107|NCT00803790|529521|P3|Period 2|Adverse Event|1
166108|NCT00803790|529522|P2|Period 2|Adverse Event|0
166109|NCT00803790|529523|P1|Period 2|Adverse Event|0
166110|NCT00803790|529520|P4|Period 1|Protocol Violation|0
166111|NCT00803790|529521|P3|Period 1|Protocol Violation|1
166112|NCT00803790|529522|P2|Period 1|Protocol Violation|0
166113|NCT00803790|529523|P1|Period 1|Protocol Violation|0
166114|NCT00803790|529520|P4|Period 1|positive drug screen or personal reasons|4
166115|NCT00803790|529521|P3|Period 1|positive drug screen or personal reasons|0
166116|NCT00803790|529522|P2|Period 1|positive drug screen or personal reasons|3
166117|NCT00803790|529523|P1|Period 1|positive drug screen or personal reasons|0
166118|NCT00803790|529520|P4|Period 1|Withdrawal by Subject|0
166119|NCT00803790|529521|P3|Period 1|Withdrawal by Subject|0
166120|NCT00803790|529522|P2|Period 1|Withdrawal by Subject|6
166121|NCT00803790|529523|P1|Period 1|Withdrawal by Subject|8
166122|NCT00803790|529520|P4|Period 1|Lost to Follow-up|0
166123|NCT00803790|529521|P3|Period 1|Lost to Follow-up|0
166124|NCT00803790|529522|P2|Period 1|Lost to Follow-up|2
166125|NCT00803790|529523|P1|Period 1|Lost to Follow-up|1
166126|NCT00803790|529520|P4|Period 1|Adverse Event|0
166127|NCT00803790|529521|P3|Period 1|Adverse Event|0
166128|NCT00803790|529522|P2|Period 1|Adverse Event|1
166129|NCT00803790|529523|P1|Period 1|Adverse Event|0
166130|NCT00804193|529570|P3|Overall Study|Withdrawal by Subject|2
166131|NCT00804193|529571|P2|Overall Study|Withdrawal by Subject|1
166132|NCT00804193|529572|P1|Overall Study|Withdrawal by Subject|3
166133|NCT00804193|529570|P3|Overall Study|Lost to Follow-up|4
166134|NCT00804193|529571|P2|Overall Study|Lost to Follow-up|3
166135|NCT00804193|529572|P1|Overall Study|Lost to Follow-up|3
166136|NCT00804193|529570|P3|Overall Study|Protocol Violation|2
166137|NCT00804193|529571|P2|Overall Study|Protocol Violation|8
166138|NCT00804193|529572|P1|Overall Study|Protocol Violation|0
166139|NCT00804193|529570|P3|Overall Study|Lack of Efficacy|3
166140|NCT00804193|529571|P2|Overall Study|Lack of Efficacy|1
166141|NCT00804193|529572|P1|Overall Study|Lack of Efficacy|1
166142|NCT00804193|529570|P3|Overall Study|Adverse Event|2
166143|NCT00804193|529571|P2|Overall Study|Adverse Event|0
166144|NCT00804193|529572|P1|Overall Study|Adverse Event|0
166145|NCT00804193|529570|P3|Overall Study|Lack of baseline fungus|19
166146|NCT00804193|529571|P2|Overall Study|Lack of baseline fungus|31
166147|NCT00804193|529572|P1|Overall Study|Lack of baseline fungus|32
166148|NCT00804570|529588|P2|Overall Study|Withdrawal by Subject|38
166149|NCT00804570|529589|P1|Overall Study|Withdrawal by Subject|21
166150|NCT00804570|529588|P2|Overall Study|Sponsor decision|4
166151|NCT00804570|529589|P1|Overall Study|Sponsor decision|1
166152|NCT00804570|529588|P2|Overall Study|Physician Decision|2
166153|NCT00804570|529589|P1|Overall Study|Physician Decision|1
166154|NCT00804570|529588|P2|Overall Study|Protocol Violation|16
166155|NCT00804570|529589|P1|Overall Study|Protocol Violation|12
166156|NCT00804570|529588|P2|Overall Study|Entry criteria not met|5
166157|NCT00804570|529589|P1|Overall Study|Entry criteria not met|5
166158|NCT00804570|529588|P2|Overall Study|Lost to Follow-up|21
166159|NCT00804570|529589|P1|Overall Study|Lost to Follow-up|18
166160|NCT00804570|529588|P2|Overall Study|Lack of Efficacy|1
166161|NCT00804570|529589|P1|Overall Study|Lack of Efficacy|0
166162|NCT00804570|529588|P2|Overall Study|Adverse Event|7
166163|NCT00804570|529589|P1|Overall Study|Adverse Event|14
166164|NCT00804687|529705|P6|Period 5: Treatment Period|Positive drug test|0
166165|NCT00804687|529706|P5|Period 5: Treatment Period|Positive drug test|0
166166|NCT00804687|529707|P4|Period 5: Treatment Period|Positive drug test|0
166167|NCT00804687|529708|P3|Period 5: Treatment Period|Positive drug test|0
166168|NCT00804687|529709|P2|Period 5: Treatment Period|Positive drug test|0
166169|NCT00804687|529710|P1|Period 5: Treatment Period|Positive drug test|1
166170|NCT00804687|529705|P6|Period 5: Treatment Period|Positive drugs of abuse|0
166171|NCT00804687|529706|P5|Period 5: Treatment Period|Positive drugs of abuse|0
166172|NCT00804687|529707|P4|Period 5: Treatment Period|Positive drugs of abuse|0
166173|NCT00804687|529708|P3|Period 5: Treatment Period|Positive drugs of abuse|1
166174|NCT00804687|529709|P2|Period 5: Treatment Period|Positive drugs of abuse|0
166175|NCT00804687|529710|P1|Period 5: Treatment Period|Positive drugs of abuse|0
166176|NCT00804687|529705|P6|Period 5: Treatment Period|Withdrawal by Subject|0
166177|NCT00804687|529706|P5|Period 5: Treatment Period|Withdrawal by Subject|1
166178|NCT00804687|529707|P4|Period 5: Treatment Period|Withdrawal by Subject|0
166179|NCT00804687|529708|P3|Period 5: Treatment Period|Withdrawal by Subject|0
166180|NCT00804687|529709|P2|Period 5: Treatment Period|Withdrawal by Subject|0
166181|NCT00804687|529710|P1|Period 5: Treatment Period|Withdrawal by Subject|0
166182|NCT00804687|529705|P6|Period 3: Treatment Period|Positive Drug screen|0
166183|NCT00804687|529706|P5|Period 3: Treatment Period|Positive Drug screen|0
166184|NCT00804687|529707|P4|Period 3: Treatment Period|Positive Drug screen|1
166185|NCT00804687|529708|P3|Period 3: Treatment Period|Positive Drug screen|0
166186|NCT00804687|529709|P2|Period 3: Treatment Period|Positive Drug screen|0
166187|NCT00804687|529710|P1|Period 3: Treatment Period|Positive Drug screen|0
166188|NCT00804843|529737|P2|Overall Study|Withdrawal by Subject|2
166189|NCT00804843|529738|P1|Overall Study|Withdrawal by Subject|1
166190|NCT00804843|529737|P2|Overall Study|Adverse Event|5
166191|NCT00804843|529738|P1|Overall Study|Adverse Event|8
166192|NCT00804843|529737|P2|Overall Study|Protocol Violation|0
166193|NCT00804843|529738|P1|Overall Study|Protocol Violation|1
166194|NCT00804908|529751|P3|Overall Study|Not specified|114
166195|NCT00804908|529752|P2|Overall Study|Not specified|116
166196|NCT00804908|529753|P1|Overall Study|Not specified|115
166197|NCT00804986|529788|P6|Overall Study|Physician Decision|0
166198|NCT00804986|529789|P5|Overall Study|Physician Decision|0
166199|NCT00804986|529790|P4|Overall Study|Physician Decision|0
166200|NCT00804986|529791|P3|Overall Study|Physician Decision|0
166201|NCT00804986|529792|P2|Overall Study|Physician Decision|0
166202|NCT00804986|529793|P1|Overall Study|Physician Decision|1
166203|NCT00804986|529788|P6|Overall Study|Sponsor Decision|0
166204|NCT00804986|529789|P5|Overall Study|Sponsor Decision|0
166205|NCT00804986|529790|P4|Overall Study|Sponsor Decision|0
166206|NCT00804986|529791|P3|Overall Study|Sponsor Decision|0
166207|NCT00804986|529792|P2|Overall Study|Sponsor Decision|1
166208|NCT00804986|529793|P1|Overall Study|Sponsor Decision|0
166209|NCT00804986|529788|P6|Overall Study|Inclusion/Exclusion criteria not met|1
166210|NCT00804986|529789|P5|Overall Study|Inclusion/Exclusion criteria not met|0
166211|NCT00804986|529790|P4|Overall Study|Inclusion/Exclusion criteria not met|1
166212|NCT00804986|529791|P3|Overall Study|Inclusion/Exclusion criteria not met|0
166213|NCT00804986|529792|P2|Overall Study|Inclusion/Exclusion criteria not met|2
166214|NCT00804986|529793|P1|Overall Study|Inclusion/Exclusion criteria not met|0
166215|NCT00804986|529788|P6|Overall Study|Withdrawal by Subject|3
166216|NCT00804986|529789|P5|Overall Study|Withdrawal by Subject|5
166217|NCT00804986|529790|P4|Overall Study|Withdrawal by Subject|3
166218|NCT00804986|529791|P3|Overall Study|Withdrawal by Subject|0
166219|NCT00804986|529792|P2|Overall Study|Withdrawal by Subject|3
166220|NCT00804986|529793|P1|Overall Study|Withdrawal by Subject|0
166221|NCT00804986|529788|P6|Overall Study|Protocol Violation|0
166222|NCT00804986|529789|P5|Overall Study|Protocol Violation|0
166223|NCT00804986|529790|P4|Overall Study|Protocol Violation|1
166224|NCT00804986|529791|P3|Overall Study|Protocol Violation|0
166225|NCT00804986|529792|P2|Overall Study|Protocol Violation|1
166226|NCT00804986|529793|P1|Overall Study|Protocol Violation|0
166227|NCT00804986|529788|P6|Overall Study|Lost to Follow-up|3
166228|NCT00804986|529789|P5|Overall Study|Lost to Follow-up|1
166229|NCT00804986|529790|P4|Overall Study|Lost to Follow-up|1
166230|NCT00804986|529791|P3|Overall Study|Lost to Follow-up|0
166231|NCT00804986|529792|P2|Overall Study|Lost to Follow-up|0
166232|NCT00804986|529793|P1|Overall Study|Lost to Follow-up|0
166233|NCT00804986|529788|P6|Overall Study|Lack of Efficacy|3
166234|NCT00804986|529789|P5|Overall Study|Lack of Efficacy|0
166235|NCT00804986|529790|P4|Overall Study|Lack of Efficacy|1
166236|NCT00804986|529791|P3|Overall Study|Lack of Efficacy|0
166237|NCT00804986|529792|P2|Overall Study|Lack of Efficacy|0
166238|NCT00804986|529793|P1|Overall Study|Lack of Efficacy|0
166239|NCT00804986|529788|P6|Overall Study|Adverse Event|0
166240|NCT00804986|529789|P5|Overall Study|Adverse Event|3
166241|NCT00804986|529790|P4|Overall Study|Adverse Event|1
166242|NCT00804986|529791|P3|Overall Study|Adverse Event|2
166243|NCT00804986|529792|P2|Overall Study|Adverse Event|1
166244|NCT00804986|529793|P1|Overall Study|Adverse Event|0
166245|NCT00805025|529885|P1|Overall Study|Physician Decision|1
166246|NCT00805025|529885|P1|Overall Study|Withdrawal by Subject|2
166247|NCT00805025|529885|P1|Overall Study|Adverse Event|4
166248|NCT00805025|529885|P1|Overall Study|Screened but not enrolled/treated|42
166249|NCT00805142|529902|P2|Maintenance Period|Unspecified|1
166250|NCT00805142|529903|P1|Maintenance Period|Unspecified|0
166251|NCT00805142|529902|P2|Maintenance Period|Adverse Event|1
166252|NCT00805142|529903|P1|Maintenance Period|Adverse Event|0
166253|NCT00805142|529902|P2|Titration Period|Unspecified|3
166254|NCT00805142|529903|P1|Titration Period|Unspecified|0
166255|NCT00805142|529902|P2|Titration Period|Withdrawal of consent|1
166256|NCT00805142|529903|P1|Titration Period|Withdrawal of consent|0
166257|NCT00805142|529902|P2|Titration Period|Disease Progression|1
166258|NCT00805142|529903|P1|Titration Period|Disease Progression|2
166259|NCT00805142|529902|P2|Titration Period|Lost to Follow-up|1
166260|NCT00805142|529903|P1|Titration Period|Lost to Follow-up|0
166261|NCT00805142|529902|P2|Titration Period|Lack of Efficacy|1
166262|NCT00805142|529903|P1|Titration Period|Lack of Efficacy|1
166263|NCT00805142|529902|P2|Titration Period|Adverse Event|3
166264|NCT00805142|529903|P1|Titration Period|Adverse Event|3
166265|NCT00805194|529929|P2|Overall Study|Reasons other than stated above|16
166266|NCT00805194|529930|P1|Overall Study|Reasons other than stated above|20
166267|NCT00805194|529929|P2|Overall Study|Not treated|4
166268|NCT00805194|529930|P1|Overall Study|Not treated|3
166269|NCT00805194|529929|P2|Overall Study|Withdrawal by Subject|42
166270|NCT00805194|529930|P1|Overall Study|Withdrawal by Subject|60
166271|NCT00805194|529929|P2|Overall Study|Lost to Follow-up|5
166272|NCT00805194|529930|P1|Overall Study|Lost to Follow-up|5
166273|NCT00805194|529929|P2|Overall Study|Protocol Violation|9
166274|NCT00805194|529930|P1|Overall Study|Protocol Violation|9
166275|NCT00805194|529929|P2|Overall Study|Other AE|73
166276|NCT00805194|529930|P1|Overall Study|Other AE|84
166277|NCT00805194|529929|P2|Overall Study|Worsening or AE of underlying disease|70
166278|NCT00805194|529930|P1|Overall Study|Worsening or AE of underlying disease|64
166279|NCT00805194|529929|P2|Overall Study|Progressive disease (modified RECIST)|435
166280|NCT00805194|529930|P1|Overall Study|Progressive disease (modified RECIST)|404
166281|NCT00805285|529962|P1|Overall Study|Lack of Efficacy|1
166282|NCT00805389|529975|P5|Overall Study|Withdrawal by Subject|4
166283|NCT00805389|529976|P4|Overall Study|Withdrawal by Subject|5
166284|NCT00805389|529977|P3|Overall Study|Withdrawal by Subject|4
166285|NCT00805389|529978|P2|Overall Study|Withdrawal by Subject|2
166286|NCT00805389|529979|P1|Overall Study|Withdrawal by Subject|3
166287|NCT00805389|529975|P5|Overall Study|Protocol Violation|0
166288|NCT00805389|529976|P4|Overall Study|Protocol Violation|0
166289|NCT00805389|529977|P3|Overall Study|Protocol Violation|1
166290|NCT00805389|529978|P2|Overall Study|Protocol Violation|0
166291|NCT00805389|529979|P1|Overall Study|Protocol Violation|0
166292|NCT00805389|529975|P5|Overall Study|Lost to Follow-up|9
166293|NCT00805389|529976|P4|Overall Study|Lost to Follow-up|10
166294|NCT00805389|529977|P3|Overall Study|Lost to Follow-up|6
166295|NCT00805389|529978|P2|Overall Study|Lost to Follow-up|3
166296|NCT00805389|529979|P1|Overall Study|Lost to Follow-up|4
166297|NCT00805389|529975|P5|Overall Study|Adverse Event|0
166298|NCT00805389|529976|P4|Overall Study|Adverse Event|2
166299|NCT00805389|529977|P3|Overall Study|Adverse Event|1
166300|NCT00805389|529978|P2|Overall Study|Adverse Event|0
166301|NCT00805389|529979|P1|Overall Study|Adverse Event|0
166302|NCT00805467|530225|P4|Overall Study|Not reported|7
166303|NCT00805467|530226|P3|Overall Study|Not reported|3
166304|NCT00805467|530227|P2|Overall Study|Not reported|0
166305|NCT00805467|530228|P1|Overall Study|Not reported|0
166306|NCT00805467|530225|P4|Overall Study|Physician Decision|6
166307|NCT00805467|530226|P3|Overall Study|Physician Decision|2
166308|NCT00805467|530227|P2|Overall Study|Physician Decision|1
166309|NCT00805467|530228|P1|Overall Study|Physician Decision|0
166310|NCT00805467|530225|P4|Overall Study|Death|5
166311|NCT00805467|530226|P3|Overall Study|Death|7
166312|NCT00805467|530227|P2|Overall Study|Death|2
166313|NCT00805467|530228|P1|Overall Study|Death|0
166314|NCT00805467|530225|P4|Overall Study|Adverse Event|57
166315|NCT00805467|530226|P3|Overall Study|Adverse Event|26
166316|NCT00805467|530227|P2|Overall Study|Adverse Event|13
166317|NCT00805467|530228|P1|Overall Study|Adverse Event|0
166318|NCT00805467|530225|P4|Overall Study|Protocol Violation|5
166319|NCT00805467|530226|P3|Overall Study|Protocol Violation|0
166320|NCT00805467|530227|P2|Overall Study|Protocol Violation|3
166321|NCT00805467|530228|P1|Overall Study|Protocol Violation|0
166322|NCT00805467|530225|P4|Overall Study|Withdrawal by Subject|50
166323|NCT00805467|530226|P3|Overall Study|Withdrawal by Subject|45
166324|NCT00805467|530227|P2|Overall Study|Withdrawal by Subject|6
166325|NCT00805467|530228|P1|Overall Study|Withdrawal by Subject|0
166326|NCT00805467|530225|P4|Overall Study|Lost to Follow-up|21
166327|NCT00805467|530226|P3|Overall Study|Lost to Follow-up|7
166328|NCT00805467|530227|P2|Overall Study|Lost to Follow-up|1
166329|NCT00805467|530228|P1|Overall Study|Lost to Follow-up|0
166330|NCT00805467|530225|P4|Overall Study|Lack of Efficacy|86
166331|NCT00805467|530226|P3|Overall Study|Lack of Efficacy|13
166332|NCT00805467|530227|P2|Overall Study|Lack of Efficacy|8
166333|NCT00805467|530228|P1|Overall Study|Lack of Efficacy|0
166334|NCT00805480|530250|P4|Overall Study|Adverse Event|0
166335|NCT00805480|530251|P3|Overall Study|Adverse Event|1
166336|NCT00805480|530252|P2|Overall Study|Adverse Event|0
166337|NCT00805480|530253|P1|Overall Study|Adverse Event|0
166338|NCT00805480|530250|P4|Overall Study|Lost to Follow-up|0
166339|NCT00805480|530251|P3|Overall Study|Lost to Follow-up|0
166340|NCT00805480|530252|P2|Overall Study|Lost to Follow-up|2
166341|NCT00805480|530253|P1|Overall Study|Lost to Follow-up|1
166342|NCT00805480|530250|P4|Overall Study|Withdrawal by Subject|5
166343|NCT00805480|530251|P3|Overall Study|Withdrawal by Subject|11
166344|NCT00805480|530252|P2|Overall Study|Withdrawal by Subject|5
166345|NCT00805480|530253|P1|Overall Study|Withdrawal by Subject|13
166346|NCT00805545|530296|P2|Overall Study|Protocol Violation|1
166347|NCT00805545|530297|P1|Overall Study|Protocol Violation|3
166348|NCT00805545|530296|P2|Overall Study|Protocol Violation|2
166349|NCT00805545|530297|P1|Overall Study|Protocol Violation|3
166350|NCT00799903|530305|P2|Overall Study|Lost to Follow-up|80
166351|NCT00799903|530306|P1|Overall Study|Lost to Follow-up|69
166352|NCT00799903|530305|P2|Overall Study|Withdrawal by Subject|175
166353|NCT00799903|530306|P1|Overall Study|Withdrawal by Subject|179
166354|NCT00799903|530305|P2|Overall Study|Investigator Site Closed|23
166355|NCT00799903|530306|P1|Overall Study|Investigator Site Closed|25
166356|NCT00800202|530328|P2|Overall Study|Disease Progression|18
166357|NCT00800202|530329|P1|Overall Study|Disease Progression|54
166358|NCT00800202|530328|P2|Overall Study|Unspecified|0
166359|NCT00800202|530329|P1|Overall Study|Unspecified|5
166360|NCT00800202|530328|P2|Overall Study|Death|0
166361|NCT00800202|530329|P1|Overall Study|Death|1
166362|NCT00800202|530328|P2|Overall Study|Adverse Event|6
166363|NCT00800202|530329|P1|Overall Study|Adverse Event|7
166364|NCT00805675|530373|P3|Overall Study|Adverse Event|1
166365|NCT00805675|530374|P2|Overall Study|Adverse Event|0
166366|NCT00805675|530375|P1|Overall Study|Adverse Event|0
166367|NCT00805740|530409|P2|Overall Study|Randomized, but not treated|0
166368|NCT00805740|530410|P1|Overall Study|Randomized, but not treated|2
166369|NCT00805740|530409|P2|Overall Study|Lost to Follow-up|0
166370|NCT00805740|530410|P1|Overall Study|Lost to Follow-up|1
166371|NCT00805740|530409|P2|Overall Study|Withdrawal by Subject|0
166372|NCT00805740|530410|P1|Overall Study|Withdrawal by Subject|1
166373|NCT00805740|530409|P2|Overall Study|Death|4
166374|NCT00805740|530410|P1|Overall Study|Death|7
166375|NCT00805766|530432|P1|Increased Dose Period|Withdrawal by Subject|1
166376|NCT00805766|530432|P1|Increased Dose Period|Pregnancy|1
166377|NCT00805766|530432|P1|Increased Dose Period|Lack of Efficacy|7
166378|NCT00805766|530432|P1|Increased Dose Period|Adverse Event|4
166379|NCT00805766|530432|P1|Screening Period|Responder|2
166380|NCT00805766|530432|P1|Screening Period|Pregnancy|1
166381|NCT00805766|530432|P1|Screening Period|Lack of Efficacy|2
166382|NCT00805766|530432|P1|Screening Period|Adverse Event|1
166383|NCT00805792|530439|P1|Overall Study|Lost to Follow-up|2
166384|NCT00805792|530439|P1|Overall Study|Death|3
166385|NCT00805935|530466|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
166386|NCT00805935|530467|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
166387|NCT00805935|530468|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
166388|NCT00805935|530469|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
166389|NCT00805935|530466|P4|Overall Study|Ectopic pregnancy|0
166390|NCT00805935|530467|P3|Overall Study|Ectopic pregnancy|1
166391|NCT00805935|530468|P2|Overall Study|Ectopic pregnancy|0
166392|NCT00805935|530469|P1|Overall Study|Ectopic pregnancy|0
166393|NCT00805935|530466|P4|Overall Study|Chemical pregnancy|2
166394|NCT00805935|530467|P3|Overall Study|Chemical pregnancy|3
166395|NCT00805935|530468|P2|Overall Study|Chemical pregnancy|5
166396|NCT00805935|530469|P1|Overall Study|Chemical pregnancy|0
166397|NCT00805935|530466|P4|Overall Study|Biochemical pregnancy|0
166398|NCT00805935|530467|P3|Overall Study|Biochemical pregnancy|0
166399|NCT00805935|530468|P2|Overall Study|Biochemical pregnancy|1
166400|NCT00805935|530469|P1|Overall Study|Biochemical pregnancy|0
166401|NCT00805935|530466|P4|Overall Study|Pregnancy loss/miscarriage|0
166402|NCT00805935|530467|P3|Overall Study|Pregnancy loss/miscarriage|0
166403|NCT00805935|530468|P2|Overall Study|Pregnancy loss/miscarriage|0
166404|NCT00805935|530469|P1|Overall Study|Pregnancy loss/miscarriage|2
166405|NCT00805935|530466|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
166406|NCT00805935|530467|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
166407|NCT00805935|530468|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
166408|NCT00805935|530469|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
166409|NCT00805935|530466|P4|Overall Study|No positive serum pregnancy|5
166410|NCT00805935|530467|P3|Overall Study|No positive serum pregnancy|6
166411|NCT00805935|530468|P2|Overall Study|No positive serum pregnancy|7
166412|NCT00805935|530469|P1|Overall Study|No positive serum pregnancy|8
166413|NCT00805935|530466|P4|Overall Study|Lost to Follow-up|0
166414|NCT00805935|530467|P3|Overall Study|Lost to Follow-up|0
166415|NCT00805935|530468|P2|Overall Study|Lost to Follow-up|0
166416|NCT00805935|530469|P1|Overall Study|Lost to Follow-up|1
166417|NCT00805935|530466|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
166418|NCT00805935|530467|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
166419|NCT00805935|530468|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
166420|NCT00805935|530469|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
166421|NCT00805935|530466|P4|Overall Study|Cycle cancellation for risk of OHSS|0
166422|NCT00805935|530467|P3|Overall Study|Cycle cancellation for risk of OHSS|1
166423|NCT00805935|530468|P2|Overall Study|Cycle cancellation for risk of OHSS|0
166424|NCT00805935|530469|P1|Overall Study|Cycle cancellation for risk of OHSS|1
166425|NCT00805935|530466|P4|Overall Study|Cycle cancelled|0
166426|NCT00805935|530467|P3|Overall Study|Cycle cancelled|2
166427|NCT00805935|530468|P2|Overall Study|Cycle cancelled|0
166428|NCT00805935|530469|P1|Overall Study|Cycle cancelled|0
166429|NCT00805935|530466|P4|Overall Study|Stimulation Failure|2
166430|NCT00805935|530467|P3|Overall Study|Stimulation Failure|2
166431|NCT00805935|530468|P2|Overall Study|Stimulation Failure|5
166432|NCT00805935|530469|P1|Overall Study|Stimulation Failure|1
166433|NCT00805961|530521|P1|Maintenance Treatment|Withdrawn Consent|1
166434|NCT00805961|530521|P1|Maintenance Treatment|Symptomatic Deterioration|2
166435|NCT00805961|530521|P1|Maintenance Treatment|Withdrawal by Subject|5
166436|NCT00805961|530521|P1|Maintenance Treatment|Adverse Event|6
166437|NCT00805961|530521|P1|Maintenance Treatment|Intercurrent Illness|7
166438|NCT00805961|530521|P1|Maintenance Treatment|Lack of Efficacy|13
166439|NCT00805961|530521|P1|Treatment-Free Interval|Lack of Efficacy|1
166440|NCT00805961|530521|P1|Treatment-Free Interval|Physician Decision|1
166441|NCT00805961|530521|P1|Treatment-Free Interval|Intercurrent Illness|2
166442|NCT00805961|530521|P1|Treatment-Free Interval|Adverse Event|3
166443|NCT00805961|530521|P1|Modality Therapy|Disease Progression|2
166444|NCT00805961|530521|P1|Modality Therapy|Adverse Event|1
166445|NCT00805961|530521|P1|Modality Therapy|Withdrawal by Subject|1
166446|NCT00807846|530529|P2|Overall Study|Not Specified|2
166447|NCT00807846|530530|P1|Overall Study|Not Specified|1
166448|NCT00807846|530529|P2|Overall Study|Withdrawal by Subject|1
166449|NCT00807846|530530|P1|Overall Study|Withdrawal by Subject|2
166450|NCT00807846|530529|P2|Overall Study|Protocol Violation|1
166451|NCT00807846|530530|P1|Overall Study|Protocol Violation|2
166452|NCT00807846|530529|P2|Overall Study|Lack of Efficacy|0
166453|NCT00807846|530530|P1|Overall Study|Lack of Efficacy|2
166454|NCT00807846|530529|P2|Overall Study|Adverse Event|0
166455|NCT00807846|530530|P1|Overall Study|Adverse Event|5
166456|NCT00807885|530571|P9|Overall Study|Lost to Follow-up|0
166457|NCT00807885|530572|P8|Overall Study|Lost to Follow-up|0
166458|NCT00807885|530573|P7|Overall Study|Lost to Follow-up|0
166459|NCT00807885|530574|P6|Overall Study|Lost to Follow-up|1
166460|NCT00807885|530575|P5|Overall Study|Lost to Follow-up|0
166461|NCT00807885|530576|P4|Overall Study|Lost to Follow-up|0
166462|NCT00807885|530577|P3|Overall Study|Lost to Follow-up|0
166463|NCT00807885|530578|P2|Overall Study|Lost to Follow-up|0
166464|NCT00807885|530579|P1|Overall Study|Lost to Follow-up|0
166465|NCT00807937|530630|P4|Overall Study|All other reasons (not provided)|1
166466|NCT00807937|530631|P3|Overall Study|All other reasons (not provided)|0
166467|NCT00807937|530632|P2|Overall Study|All other reasons (not provided)|4
166468|NCT00807937|530633|P1|Overall Study|All other reasons (not provided)|2
166469|NCT00807937|530630|P4|Overall Study|Intake of prohibited medicine|0
166470|NCT00807937|530631|P3|Overall Study|Intake of prohibited medicine|2
166471|NCT00807937|530632|P2|Overall Study|Intake of prohibited medicine|0
166472|NCT00807937|530633|P1|Overall Study|Intake of prohibited medicine|0
166473|NCT00807937|530630|P4|Overall Study|Lack of Efficacy|2
166474|NCT00807937|530631|P3|Overall Study|Lack of Efficacy|1
166475|NCT00807937|530632|P2|Overall Study|Lack of Efficacy|0
166476|NCT00807937|530633|P1|Overall Study|Lack of Efficacy|0
166477|NCT00807937|530630|P4|Overall Study|Lost to Follow-up|1
166478|NCT00807937|530631|P3|Overall Study|Lost to Follow-up|2
166479|NCT00807937|530632|P2|Overall Study|Lost to Follow-up|0
166480|NCT00807937|530633|P1|Overall Study|Lost to Follow-up|4
166481|NCT00807937|530630|P4|Overall Study|Withdrawal by Subject|4
166482|NCT00807937|530631|P3|Overall Study|Withdrawal by Subject|1
166483|NCT00807937|530632|P2|Overall Study|Withdrawal by Subject|4
166484|NCT00807937|530633|P1|Overall Study|Withdrawal by Subject|5
166485|NCT00807937|530630|P4|Overall Study|Protocol Violation|3
166486|NCT00807937|530631|P3|Overall Study|Protocol Violation|3
166487|NCT00807937|530632|P2|Overall Study|Protocol Violation|5
166488|NCT00807937|530633|P1|Overall Study|Protocol Violation|4
166489|NCT00807937|530630|P4|Overall Study|Adverse Event|4
166490|NCT00807937|530631|P3|Overall Study|Adverse Event|5
166491|NCT00807937|530632|P2|Overall Study|Adverse Event|12
166492|NCT00807937|530633|P1|Overall Study|Adverse Event|12
166493|NCT00808015|530672|P1|Overall Study|Enrolled but not treated|4
166494|NCT00808015|530672|P1|Overall Study|Unspecified|25
166495|NCT00808015|530672|P1|Overall Study|Adverse Event|22
166496|NCT00808015|530672|P1|Overall Study|Participants not willing to participate|158
166497|NCT00808015|530672|P1|Overall Study|Lost to Follow-up|76
166498|NCT00808015|530672|P1|Overall Study|Lack of Efficacy|58
166499|NCT00808015|530672|P1|Overall Study|Death|1
166500|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
166501|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
166502|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
166503|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
166504|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Death|0
166505|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Death|1
166506|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Death|0
166507|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Death|0
166508|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
166509|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
166510|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
166511|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
166512|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Unspecified|1
166513|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Unspecified|1
166514|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Unspecified|0
166515|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Unspecified|0
166516|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
166517|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
166518|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
166519|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
166520|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
166521|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
166522|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
166523|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
166524|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
166525|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
166526|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
166527|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
166528|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
166529|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
166530|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
166531|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
166532|NCT00808028|530688|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
166533|NCT00808028|530689|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
166534|NCT00808028|530690|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
166535|NCT00808028|530691|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
166536|NCT00808028|530688|P4|Stage 1 (6 Months)|Protocol Violation|1
166537|NCT00808028|530689|P3|Stage 1 (6 Months)|Protocol Violation|0
166538|NCT00808028|530690|P2|Stage 1 (6 Months)|Protocol Violation|0
166539|NCT00808028|530691|P1|Stage 1 (6 Months)|Protocol Violation|0
166540|NCT00808028|530688|P4|Stage 1 (6 Months)|Lost to Follow-up|0
166541|NCT00808028|530689|P3|Stage 1 (6 Months)|Lost to Follow-up|1
166542|NCT00808028|530690|P2|Stage 1 (6 Months)|Lost to Follow-up|0
166543|NCT00808028|530691|P1|Stage 1 (6 Months)|Lost to Follow-up|1
166544|NCT00808028|530688|P4|Stage 1 (6 Months)|Adverse Event|2
166545|NCT00808028|530689|P3|Stage 1 (6 Months)|Adverse Event|1
166546|NCT00808028|530690|P2|Stage 1 (6 Months)|Adverse Event|0
166547|NCT00808028|530691|P1|Stage 1 (6 Months)|Adverse Event|0
166548|NCT00808028|530688|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
166549|NCT00808028|530689|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
166550|NCT00808028|530690|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
166551|NCT00808028|530691|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
166552|NCT00808028|530688|P4|Stage 1 (6 Months)|Unspecified|4
166553|NCT00808028|530689|P3|Stage 1 (6 Months)|Unspecified|2
166554|NCT00808028|530690|P2|Stage 1 (6 Months)|Unspecified|0
166555|NCT00808028|530691|P1|Stage 1 (6 Months)|Unspecified|1
166556|NCT00808028|530688|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
166557|NCT00808028|530689|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
166558|NCT00808028|530690|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
166559|NCT00808028|530691|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
166560|NCT00808067|530729|P2|Overall Study|Excluded from analysis|19
166561|NCT00808067|530730|P1|Overall Study|Excluded from analysis|13
166562|NCT00808067|530729|P2|Overall Study|Other reason not defined above|5
166563|NCT00808067|530730|P1|Overall Study|Other reason not defined above|5
166564|NCT00808067|530729|P2|Overall Study|Site closed for cause|19
166565|NCT00808067|530730|P1|Overall Study|Site closed for cause|19
166566|NCT00808067|530729|P2|Overall Study|Patient elected|9
166567|NCT00808067|530730|P1|Overall Study|Patient elected|7
166568|NCT00808067|530729|P2|Overall Study|Protocol Violation|11
166569|NCT00808067|530730|P1|Overall Study|Protocol Violation|3
166570|NCT00808067|530729|P2|Overall Study|Physician Decision|38
166571|NCT00808067|530730|P1|Overall Study|Physician Decision|47
166572|NCT00808067|530729|P2|Overall Study|Site closed|3
166573|NCT00808067|530730|P1|Overall Study|Site closed|4
166574|NCT00808067|530729|P2|Overall Study|Withdrawal by Subject|25
166575|NCT00808067|530730|P1|Overall Study|Withdrawal by Subject|21
166576|NCT00808067|530729|P2|Overall Study|Procedure|7
166577|NCT00808067|530730|P1|Overall Study|Procedure|6
166578|NCT00808067|530729|P2|Overall Study|Death|1
166579|NCT00808067|530730|P1|Overall Study|Death|1
166580|NCT00808067|530729|P2|Overall Study|Missing|0
166581|NCT00808067|530730|P1|Overall Study|Missing|1
166582|NCT00808067|530729|P2|Overall Study|Patient refused to take study medication|76
166583|NCT00808067|530730|P1|Overall Study|Patient refused to take study medication|65
166584|NCT00808067|530729|P2|Overall Study|Elevated LFT results|3
166585|NCT00808067|530730|P1|Overall Study|Elevated LFT results|7
166586|NCT00808067|530729|P2|Overall Study|Reduced creatinine clearance|55
166587|NCT00808067|530730|P1|Overall Study|Reduced creatinine clearance|53
166588|NCT00808067|530729|P2|Overall Study|Hospitalization due to surgery|40
166589|NCT00808067|530730|P1|Overall Study|Hospitalization due to surgery|37
166590|NCT00808067|530729|P2|Overall Study|Hospitalization (not including surgery)|17
166591|NCT00808067|530730|P1|Overall Study|Hospitalization (not including surgery)|18
166592|NCT00808067|530729|P2|Overall Study|Adverse Event|121
166593|NCT00808067|530730|P1|Overall Study|Adverse Event|111
166594|NCT00808067|530729|P2|Overall Study|Outcome event - other|25
166595|NCT00808067|530730|P1|Overall Study|Outcome event - other|33
166596|NCT00808067|530729|P2|Overall Study|Major/minor bleed|44
166597|NCT00808067|530730|P1|Overall Study|Major/minor bleed|30
166598|NCT00808080|530762|P1|Overall Study|Patients Became Ineligible for infusion|6
166599|NCT00808132|530771|P5|Overall Study|Unsatisfactory response|12
166600|NCT00808132|530772|P4|Overall Study|Unsatisfactory response|4
166601|NCT00808132|530773|P3|Overall Study|Unsatisfactory response|6
166602|NCT00808132|530774|P2|Overall Study|Unsatisfactory response|6
166603|NCT00808132|530775|P1|Overall Study|Unsatisfactory response|5
166604|NCT00808132|530771|P5|Overall Study|Randomized, but not treated|9
166605|NCT00808132|530772|P4|Overall Study|Randomized, but not treated|8
166606|NCT00808132|530773|P3|Overall Study|Randomized, but not treated|9
166607|NCT00808132|530774|P2|Overall Study|Randomized, but not treated|7
166608|NCT00808132|530775|P1|Overall Study|Randomized, but not treated|10
166609|NCT00808132|530771|P5|Overall Study|Unspecified|15
166610|NCT00808132|530772|P4|Overall Study|Unspecified|2
166611|NCT00808132|530773|P3|Overall Study|Unspecified|6
166612|NCT00808132|530774|P2|Overall Study|Unspecified|4
166613|NCT00808132|530775|P1|Overall Study|Unspecified|6
166614|NCT00808132|530771|P5|Overall Study|Withdrawal by Subject|16
166615|NCT00808132|530772|P4|Overall Study|Withdrawal by Subject|7
166616|NCT00808132|530773|P3|Overall Study|Withdrawal by Subject|2
166617|NCT00808132|530774|P2|Overall Study|Withdrawal by Subject|18
166618|NCT00808132|530775|P1|Overall Study|Withdrawal by Subject|27
166619|NCT00808132|530771|P5|Overall Study|Protocol Violation|5
166620|NCT00808132|530772|P4|Overall Study|Protocol Violation|9
166621|NCT00808132|530773|P3|Overall Study|Protocol Violation|4
166622|NCT00808132|530774|P2|Overall Study|Protocol Violation|9
166623|NCT00808132|530775|P1|Overall Study|Protocol Violation|8
166624|NCT00808132|530771|P5|Overall Study|Lost to Follow-up|9
166625|NCT00808132|530772|P4|Overall Study|Lost to Follow-up|8
166626|NCT00808132|530773|P3|Overall Study|Lost to Follow-up|11
166627|NCT00808132|530774|P2|Overall Study|Lost to Follow-up|10
166628|NCT00808132|530775|P1|Overall Study|Lost to Follow-up|8
166629|NCT00808132|530771|P5|Overall Study|Physician Decision|0
166630|NCT00808132|530772|P4|Overall Study|Physician Decision|0
166631|NCT00808132|530773|P3|Overall Study|Physician Decision|0
166632|NCT00808132|530774|P2|Overall Study|Physician Decision|1
166633|NCT00808132|530775|P1|Overall Study|Physician Decision|0
166634|NCT00808132|530771|P5|Overall Study|Death|1
166635|NCT00808132|530772|P4|Overall Study|Death|0
166636|NCT00808132|530773|P3|Overall Study|Death|0
166637|NCT00808132|530774|P2|Overall Study|Death|0
166638|NCT00808132|530775|P1|Overall Study|Death|0
166639|NCT00808132|530771|P5|Overall Study|Adverse Event|33
166640|NCT00808132|530772|P4|Overall Study|Adverse Event|31
166641|NCT00808132|530773|P3|Overall Study|Adverse Event|16
166642|NCT00808132|530774|P2|Overall Study|Adverse Event|33
166643|NCT00808132|530775|P1|Overall Study|Adverse Event|34
166644|NCT00808236|530849|P2|Overall Study|Death|30
166645|NCT00808236|530850|P1|Overall Study|Death|18
166646|NCT00808236|530849|P2|Overall Study|Physician Decision|1
166647|NCT00808236|530850|P1|Overall Study|Physician Decision|0
166648|NCT00808236|530849|P2|Overall Study|Lost to Follow-up|1
166649|NCT00808236|530850|P1|Overall Study|Lost to Follow-up|1
166650|NCT00808236|530849|P2|Overall Study|Pre-defined exclusion|3
166651|NCT00808236|530850|P1|Overall Study|Pre-defined exclusion|13
166652|NCT00808236|530849|P2|Overall Study|Was not resuscitated|56
166653|NCT00808236|530850|P1|Overall Study|Was not resuscitated|50
166654|NCT00808249|530882|P4|Overall Study|All other reasons|1
166655|NCT00808249|530883|P3|Overall Study|All other reasons|3
166656|NCT00808249|530884|P2|Overall Study|All other reasons|1
166657|NCT00808249|530885|P1|Overall Study|All other reasons|2
166658|NCT00808249|530882|P4|Overall Study|study specific discontinuation criteria|0
166659|NCT00808249|530883|P3|Overall Study|study specific discontinuation criteria|1
166660|NCT00808249|530884|P2|Overall Study|study specific discontinuation criteria|0
166661|NCT00808249|530885|P1|Overall Study|study specific discontinuation criteria|1
166662|NCT00808249|530882|P4|Overall Study|Lack of Efficacy|0
166663|NCT00808249|530883|P3|Overall Study|Lack of Efficacy|0
166664|NCT00808249|530884|P2|Overall Study|Lack of Efficacy|1
166665|NCT00808249|530885|P1|Overall Study|Lack of Efficacy|1
166666|NCT00808249|530882|P4|Overall Study|Protocol Violation|0
166667|NCT00808249|530883|P3|Overall Study|Protocol Violation|3
166668|NCT00808249|530884|P2|Overall Study|Protocol Violation|3
166669|NCT00808249|530885|P1|Overall Study|Protocol Violation|3
166670|NCT00808249|530882|P4|Overall Study|Withdrawal by Subject|4
166671|NCT00808249|530883|P3|Overall Study|Withdrawal by Subject|2
166672|NCT00808249|530884|P2|Overall Study|Withdrawal by Subject|0
166673|NCT00808249|530885|P1|Overall Study|Withdrawal by Subject|4
166674|NCT00808249|530882|P4|Overall Study|Lost to Follow-up|5
166675|NCT00808249|530883|P3|Overall Study|Lost to Follow-up|3
166676|NCT00808249|530884|P2|Overall Study|Lost to Follow-up|3
166677|NCT00808249|530885|P1|Overall Study|Lost to Follow-up|2
166678|NCT00808249|530882|P4|Overall Study|Adverse Event|6
166679|NCT00808249|530883|P3|Overall Study|Adverse Event|10
166680|NCT00808249|530884|P2|Overall Study|Adverse Event|7
166681|NCT00808249|530885|P1|Overall Study|Adverse Event|4
166682|NCT00808444|530946|P2|Overall Study|Lost to Follow-up|1
166683|NCT00808444|530947|P1|Overall Study|Lost to Follow-up|0
166684|NCT00808444|530946|P2|Overall Study|Withdrawal by Subject|0
166685|NCT00808444|530947|P1|Overall Study|Withdrawal by Subject|1
166686|NCT00808483|531002|P2|From 5 Months to 12 Months|Lack of Efficacy|0
166687|NCT00808483|531003|P1|From 5 Months to 12 Months|Lack of Efficacy|1
166688|NCT00808483|531002|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
166689|NCT00808483|531003|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
166690|NCT00808483|531002|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
166691|NCT00808483|531003|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
166692|NCT00808509|531025|P2|Randomized Phase|Patient refused rescue therapy|3
166693|NCT00808509|531026|P1|Randomized Phase|Patient refused rescue therapy|0
166694|NCT00808509|531025|P2|Randomized Phase|Reduced methotrexate dose|2
166695|NCT00808509|531026|P1|Randomized Phase|Reduced methotrexate dose|1
166696|NCT00808509|531025|P2|Randomized Phase|Did not meet eligibility criteria|0
166697|NCT00808509|531026|P1|Randomized Phase|Did not meet eligibility criteria|1
166698|NCT00808639|531122|P1|Overall Study|Disease progression before surgery.|1
166699|NCT00808808|531138|P3|Overall Study|Employee was not vaccinated.|2255
166700|NCT00808808|531139|P2|Overall Study|Employee was not vaccinated.|2268
166701|NCT00808808|531140|P1|Overall Study|Employee was not vaccinated.|2686
166702|NCT00808808|531138|P3|Overall Study|Vaccinated; survey not completed|302
166703|NCT00808808|531139|P2|Overall Study|Vaccinated; survey not completed|169
166704|NCT00808808|531140|P1|Overall Study|Vaccinated; survey not completed|131
166705|NCT00808899|531173|P1|Overall Study|Physician Decision|3
166706|NCT00808899|531173|P1|Overall Study|Death|1
166707|NCT00809094|531206|P2|Overall Study|Lost to Follow-up|1
166708|NCT00809094|531207|P1|Overall Study|Lost to Follow-up|0
166709|NCT00809133|531239|P14|Overall Study|Other not mentioned above|0
166710|NCT00809133|531240|P13|Overall Study|Other not mentioned above|0
166711|NCT00809133|531241|P12|Overall Study|Other not mentioned above|0
166712|NCT00809133|531242|P11|Overall Study|Other not mentioned above|0
166713|NCT00809133|531243|P10|Overall Study|Other not mentioned above|0
166714|NCT00809133|531244|P9|Overall Study|Other not mentioned above|0
166715|NCT00809133|531245|P8|Overall Study|Other not mentioned above|0
166716|NCT00809133|531246|P7|Overall Study|Other not mentioned above|0
166717|NCT00809133|531247|P6|Overall Study|Other not mentioned above|1
166718|NCT00809133|531248|P5|Overall Study|Other not mentioned above|0
166719|NCT00809133|531249|P4|Overall Study|Other not mentioned above|0
166720|NCT00809133|531250|P3|Overall Study|Other not mentioned above|0
166721|NCT00809133|531251|P2|Overall Study|Other not mentioned above|1
166722|NCT00809133|531252|P1|Overall Study|Other not mentioned above|0
166723|NCT00809133|531239|P14|Overall Study|Consent withdrawn|0
166724|NCT00809133|531240|P13|Overall Study|Consent withdrawn|0
166725|NCT00809133|531241|P12|Overall Study|Consent withdrawn|0
166726|NCT00809133|531242|P11|Overall Study|Consent withdrawn|0
166727|NCT00809133|531243|P10|Overall Study|Consent withdrawn|0
166728|NCT00809133|531244|P9|Overall Study|Consent withdrawn|0
166729|NCT00809133|531245|P8|Overall Study|Consent withdrawn|0
166730|NCT00809133|531246|P7|Overall Study|Consent withdrawn|0
166731|NCT00809133|531247|P6|Overall Study|Consent withdrawn|0
166732|NCT00809133|531248|P5|Overall Study|Consent withdrawn|1
166733|NCT00809133|531249|P4|Overall Study|Consent withdrawn|0
166734|NCT00809133|531250|P3|Overall Study|Consent withdrawn|0
166735|NCT00809133|531251|P2|Overall Study|Consent withdrawn|0
166736|NCT00809133|531252|P1|Overall Study|Consent withdrawn|0
166737|NCT00809133|531239|P14|Overall Study|Lost to Follow-up|0
166738|NCT00809133|531240|P13|Overall Study|Lost to Follow-up|0
166739|NCT00809133|531241|P12|Overall Study|Lost to Follow-up|0
166740|NCT00809133|531242|P11|Overall Study|Lost to Follow-up|0
166741|NCT00809133|531243|P10|Overall Study|Lost to Follow-up|0
166742|NCT00809133|531244|P9|Overall Study|Lost to Follow-up|0
166743|NCT00809133|531245|P8|Overall Study|Lost to Follow-up|0
166744|NCT00809133|531246|P7|Overall Study|Lost to Follow-up|0
166745|NCT00809133|531247|P6|Overall Study|Lost to Follow-up|1
166746|NCT00809133|531248|P5|Overall Study|Lost to Follow-up|0
166747|NCT00809133|531249|P4|Overall Study|Lost to Follow-up|0
166748|NCT00809133|531250|P3|Overall Study|Lost to Follow-up|0
166749|NCT00809133|531251|P2|Overall Study|Lost to Follow-up|0
166750|NCT00809133|531252|P1|Overall Study|Lost to Follow-up|0
166751|NCT00809133|531239|P14|Overall Study|Other adverse event|1
166752|NCT00809133|531240|P13|Overall Study|Other adverse event|0
166753|NCT00809133|531241|P12|Overall Study|Other adverse event|1
166754|NCT00809133|531242|P11|Overall Study|Other adverse event|1
166755|NCT00809133|531243|P10|Overall Study|Other adverse event|0
166756|NCT00809133|531244|P9|Overall Study|Other adverse event|0
166757|NCT00809133|531245|P8|Overall Study|Other adverse event|4
166758|NCT00809133|531246|P7|Overall Study|Other adverse event|2
166759|NCT00809133|531247|P6|Overall Study|Other adverse event|3
166760|NCT00809133|531248|P5|Overall Study|Other adverse event|0
166761|NCT00809133|531249|P4|Overall Study|Other adverse event|0
166762|NCT00809133|531250|P3|Overall Study|Other adverse event|1
166763|NCT00809133|531251|P2|Overall Study|Other adverse event|1
166764|NCT00809133|531252|P1|Overall Study|Other adverse event|1
166765|NCT00809133|531239|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
166766|NCT00809133|531240|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
166767|NCT00809133|531241|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
166768|NCT00809133|531242|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
166769|NCT00809133|531243|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
166770|NCT00809133|531244|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
166771|NCT00809133|531245|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
166772|NCT00809133|531246|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
166773|NCT00809133|531247|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
166774|NCT00809133|531248|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
166775|NCT00809133|531249|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
166776|NCT00809133|531250|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
166777|NCT00809133|531251|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
166778|NCT00809133|531252|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
166779|NCT00809133|531239|P14|Overall Study|Progressive disease|4
166780|NCT00809133|531240|P13|Overall Study|Progressive disease|5
166781|NCT00809133|531241|P12|Overall Study|Progressive disease|7
166782|NCT00809133|531242|P11|Overall Study|Progressive disease|5
166783|NCT00809133|531243|P10|Overall Study|Progressive disease|9
166784|NCT00809133|531244|P9|Overall Study|Progressive disease|3
166785|NCT00809133|531245|P8|Overall Study|Progressive disease|3
166786|NCT00809133|531246|P7|Overall Study|Progressive disease|3
166787|NCT00809133|531247|P6|Overall Study|Progressive disease|1
166788|NCT00809133|531248|P5|Overall Study|Progressive disease|4
166789|NCT00809133|531249|P4|Overall Study|Progressive disease|3
166790|NCT00809133|531250|P3|Overall Study|Progressive disease|5
166791|NCT00809133|531251|P2|Overall Study|Progressive disease|5
166792|NCT00809133|531252|P1|Overall Study|Progressive disease|2
166793|NCT00809159|531435|P6|Part 1 and 2|Withdrawal by Subject|1
166794|NCT00809159|531436|P5|Part 1 and 2|Withdrawal by Subject|0
166795|NCT00809159|531437|P4|Part 1 and 2|Withdrawal by Subject|0
166796|NCT00809159|531438|P3|Part 1 and 2|Withdrawal by Subject|4
166797|NCT00809159|531439|P2|Part 1 and 2|Withdrawal by Subject|0
166798|NCT00809159|531440|P1|Part 1 and 2|Withdrawal by Subject|0
166799|NCT00809159|531435|P6|Part 1 and 2|Lost to Follow-up|0
166800|NCT00809159|531436|P5|Part 1 and 2|Lost to Follow-up|0
166801|NCT00809159|531437|P4|Part 1 and 2|Lost to Follow-up|1
166802|NCT00809159|531438|P3|Part 1 and 2|Lost to Follow-up|1
166803|NCT00809159|531439|P2|Part 1 and 2|Lost to Follow-up|0
166804|NCT00809159|531440|P1|Part 1 and 2|Lost to Follow-up|0
166805|NCT00809159|531435|P6|Part 1 and 2|Adverse Event|1
166806|NCT00809159|531436|P5|Part 1 and 2|Adverse Event|1
166807|NCT00809159|531437|P4|Part 1 and 2|Adverse Event|0
166808|NCT00809159|531438|P3|Part 1 and 2|Adverse Event|1
166809|NCT00809159|531439|P2|Part 1 and 2|Adverse Event|0
166810|NCT00809159|531440|P1|Part 1 and 2|Adverse Event|0
166811|NCT00809159|531435|P6|Part 1 and 2|Administrative problems|0
166812|NCT00809159|531436|P5|Part 1 and 2|Administrative problems|0
166813|NCT00809159|531437|P4|Part 1 and 2|Administrative problems|1
166814|NCT00809159|531438|P3|Part 1 and 2|Administrative problems|0
166815|NCT00809159|531439|P2|Part 1 and 2|Administrative problems|0
166816|NCT00809159|531440|P1|Part 1 and 2|Administrative problems|0
166817|NCT00809159|531435|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
166818|NCT00809159|531436|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
166819|NCT00809159|531437|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
166820|NCT00809159|531438|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
166821|NCT00809159|531439|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
166822|NCT00809159|531440|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
166823|NCT00809159|531435|P6|Part 1|Unsatisfactory therapeutic effect|0
166824|NCT00809159|531436|P5|Part 1|Unsatisfactory therapeutic effect|0
166825|NCT00809159|531437|P4|Part 1|Unsatisfactory therapeutic effect|0
166826|NCT00809159|531438|P3|Part 1|Unsatisfactory therapeutic effect|0
166827|NCT00809159|531439|P2|Part 1|Unsatisfactory therapeutic effect|1
166828|NCT00809159|531440|P1|Part 1|Unsatisfactory therapeutic effect|3
166829|NCT00809159|531435|P6|Part 1|Withdrawal by Subject|0
166830|NCT00809159|531436|P5|Part 1|Withdrawal by Subject|0
166831|NCT00809159|531437|P4|Part 1|Withdrawal by Subject|0
166832|NCT00809159|531438|P3|Part 1|Withdrawal by Subject|0
166833|NCT00809159|531439|P2|Part 1|Withdrawal by Subject|1
166834|NCT00809159|531440|P1|Part 1|Withdrawal by Subject|3
166835|NCT00809159|531435|P6|Part 1|Lost to Follow-up|0
166836|NCT00809159|531436|P5|Part 1|Lost to Follow-up|0
166837|NCT00809159|531437|P4|Part 1|Lost to Follow-up|0
166838|NCT00809159|531438|P3|Part 1|Lost to Follow-up|0
166839|NCT00809159|531439|P2|Part 1|Lost to Follow-up|0
166840|NCT00809159|531440|P1|Part 1|Lost to Follow-up|1
166841|NCT00809159|531435|P6|Part 1|Adverse Event|0
166842|NCT00809159|531436|P5|Part 1|Adverse Event|0
166843|NCT00809159|531437|P4|Part 1|Adverse Event|0
166844|NCT00809159|531438|P3|Part 1|Adverse Event|0
166845|NCT00809159|531439|P2|Part 1|Adverse Event|1
166846|NCT00809159|531440|P1|Part 1|Adverse Event|1
166847|NCT00809328|531512|P1|Overall Study|Withdrawal by Subject|2
166848|NCT00809328|531512|P1|Overall Study|Protocol Violation|3
166849|NCT00809328|531512|P1|Overall Study|Adverse Event|6
166850|NCT00809328|531512|P1|Overall Study|Lack of Efficacy|18
166851|NCT00809445|531523|P3|6 Month Follow-up|Withdrew consent|1
166852|NCT00809445|531524|P2|6 Month Follow-up|Withdrew consent|0
166853|NCT00809445|531525|P1|6 Month Follow-up|Withdrew consent|0
166854|NCT00809445|531523|P3|6 Month Follow-up|Incarcerated|8
166855|NCT00809445|531524|P2|6 Month Follow-up|Incarcerated|8
166856|NCT00809445|531525|P1|6 Month Follow-up|Incarcerated|6
166857|NCT00809445|531523|P3|6 Month Follow-up|Death|1
166858|NCT00809445|531524|P2|6 Month Follow-up|Death|1
166859|NCT00809445|531525|P1|6 Month Follow-up|Death|2
166860|NCT00809445|531523|P3|6 Month Follow-up|Lost contact|14
166861|NCT00809445|531524|P2|6 Month Follow-up|Lost contact|14
166862|NCT00809445|531525|P1|6 Month Follow-up|Lost contact|16
166863|NCT00809445|531523|P3|1 Month Follow-up|Incarcerated|1
166864|NCT00809445|531524|P2|1 Month Follow-up|Incarcerated|0
166865|NCT00809445|531525|P1|1 Month Follow-up|Incarcerated|0
166866|NCT00809445|531523|P3|1 Month Follow-up|Death|1
166867|NCT00809445|531524|P2|1 Month Follow-up|Death|1
166868|NCT00809445|531525|P1|1 Month Follow-up|Death|0
166869|NCT00809445|531523|P3|1 Month Follow-up|Withdrew consent|1
166870|NCT00809445|531524|P2|1 Month Follow-up|Withdrew consent|1
166871|NCT00809445|531525|P1|1 Month Follow-up|Withdrew consent|1
166872|NCT00809445|531523|P3|1 Month Follow-up|Lost contact|1
166873|NCT00809445|531524|P2|1 Month Follow-up|Lost contact|2
166874|NCT00809445|531525|P1|1 Month Follow-up|Lost contact|1
166875|NCT00809471|531558|P3|Overall Study|Requirement for restricted medication|0
166876|NCT00809471|531559|P2|Overall Study|Requirement for restricted medication|1
166877|NCT00809471|531560|P1|Overall Study|Requirement for restricted medication|1
166878|NCT00809471|531558|P3|Overall Study|Adverse Event|2
166879|NCT00809471|531559|P2|Overall Study|Adverse Event|2
166880|NCT00809471|531560|P1|Overall Study|Adverse Event|0
166881|NCT00809471|531558|P3|Overall Study|Lost to Follow-up|9
166882|NCT00809471|531559|P2|Overall Study|Lost to Follow-up|2
166883|NCT00809471|531560|P1|Overall Study|Lost to Follow-up|4
166884|NCT00809471|531558|P3|Overall Study|Protocol non-compliance|6
166885|NCT00809471|531559|P2|Overall Study|Protocol non-compliance|15
166886|NCT00809471|531560|P1|Overall Study|Protocol non-compliance|15
166887|NCT00809614|531589|P2|Overall Study|Withdrawal by Subject|1
166888|NCT00809614|531590|P1|Overall Study|Withdrawal by Subject|1
166889|NCT00809614|531589|P2|Overall Study|Lack of Efficacy|3
166890|NCT00809614|531590|P1|Overall Study|Lack of Efficacy|2
166891|NCT00809757|531621|P3|Overall Study|Noncompliance with Medication|1
166892|NCT00809757|531622|P2|Overall Study|Noncompliance with Medication|0
166893|NCT00809757|531623|P1|Overall Study|Noncompliance with Medication|0
166894|NCT00809757|531621|P3|Overall Study|Subject Uncooperative|2
166895|NCT00809757|531622|P2|Overall Study|Subject Uncooperative|0
166896|NCT00809757|531623|P1|Overall Study|Subject Uncooperative|1
166897|NCT00809757|531621|P3|Overall Study|Withdrawal by Subject|3
166898|NCT00809757|531622|P2|Overall Study|Withdrawal by Subject|1
166899|NCT00809757|531623|P1|Overall Study|Withdrawal by Subject|2
166900|NCT00809757|531621|P3|Overall Study|Protocol Violation|1
166901|NCT00809757|531622|P2|Overall Study|Protocol Violation|1
166902|NCT00809757|531623|P1|Overall Study|Protocol Violation|1
166903|NCT00809757|531621|P3|Overall Study|Lost to Follow-up|1
166904|NCT00809757|531622|P2|Overall Study|Lost to Follow-up|0
166905|NCT00809757|531623|P1|Overall Study|Lost to Follow-up|0
166906|NCT00809757|531621|P3|Overall Study|Adverse Event|3
166907|NCT00809757|531622|P2|Overall Study|Adverse Event|3
166908|NCT00809757|531623|P1|Overall Study|Adverse Event|2
166909|NCT00809835|531719|P4|Overall Study|Withdrawal by Subject|0
166910|NCT00809835|531720|P3|Overall Study|Withdrawal by Subject|1
166911|NCT00809835|531721|P2|Overall Study|Withdrawal by Subject|1
166912|NCT00809835|531722|P1|Overall Study|Withdrawal by Subject|1
166913|NCT00809835|531719|P4|Overall Study|Lost to Follow-up|2
166914|NCT00809835|531720|P3|Overall Study|Lost to Follow-up|10
166915|NCT00809835|531721|P2|Overall Study|Lost to Follow-up|6
166916|NCT00809835|531722|P1|Overall Study|Lost to Follow-up|7
166917|NCT00809926|531768|P2|Overall Study|Protocol deviation|2
166918|NCT00809926|531769|P1|Overall Study|Protocol deviation|0
166919|NCT00809926|531768|P2|Overall Study|Administrative Problems|1
166920|NCT00809926|531769|P1|Overall Study|Administrative Problems|0
166921|NCT00809926|531768|P2|Overall Study|Lost to Follow-up|1
166922|NCT00809926|531769|P1|Overall Study|Lost to Follow-up|2
166923|NCT00809926|531768|P2|Overall Study|Patient withdrew consent|6
166924|NCT00809926|531769|P1|Overall Study|Patient withdrew consent|8
166925|NCT00809926|531768|P2|Overall Study|Unsatisfactory therapeutic effect|3
166926|NCT00809926|531769|P1|Overall Study|Unsatisfactory therapeutic effect|3
166927|NCT00809926|531768|P2|Overall Study|Adverse Event|10
166928|NCT00809926|531769|P1|Overall Study|Adverse Event|18
166929|NCT00809965|531796|P3|Overall Study|Other Reason|189
166930|NCT00809965|531797|P2|Overall Study|Other Reason|170
166931|NCT00809965|531798|P1|Overall Study|Other Reason|167
166932|NCT00809965|531796|P3|Overall Study|Withdrawal by Subject|441
166933|NCT00809965|531797|P2|Overall Study|Withdrawal by Subject|448
166934|NCT00809965|531798|P1|Overall Study|Withdrawal by Subject|405
166935|NCT00809965|531796|P3|Overall Study|Lost to Follow-up|18
166936|NCT00809965|531797|P2|Overall Study|Lost to Follow-up|10
166937|NCT00809965|531798|P1|Overall Study|Lost to Follow-up|17
166938|NCT00809965|531796|P3|Overall Study|Death|196
166939|NCT00809965|531797|P2|Overall Study|Death|147
166940|NCT00809965|531798|P1|Overall Study|Death|194
166941|NCT00810043|531820|P3|Overall Study|No longer met enrollment criteria|3
166942|NCT00810043|531821|P2|Overall Study|No longer met enrollment criteria|0
166943|NCT00810043|531822|P1|Overall Study|No longer met enrollment criteria|0
166944|NCT00810043|531820|P3|Overall Study|Non-medical problem|1
166945|NCT00810043|531821|P2|Overall Study|Non-medical problem|0
166946|NCT00810043|531822|P1|Overall Study|Non-medical problem|0
166947|NCT00810043|531820|P3|Overall Study|Unrelated medical problem|0
166948|NCT00810043|531821|P2|Overall Study|Unrelated medical problem|1
166949|NCT00810043|531822|P1|Overall Study|Unrelated medical problem|0
166950|NCT00810043|531820|P3|Overall Study|Death|0
166951|NCT00810043|531821|P2|Overall Study|Death|0
166952|NCT00810043|531822|P1|Overall Study|Death|2
166953|NCT00810043|531820|P3|Overall Study|Physician Decision|2
166954|NCT00810043|531821|P2|Overall Study|Physician Decision|0
166955|NCT00810043|531822|P1|Overall Study|Physician Decision|0
166956|NCT00810043|531820|P3|Overall Study|Lost to Follow-up|0
166957|NCT00810043|531821|P2|Overall Study|Lost to Follow-up|0
166958|NCT00810043|531822|P1|Overall Study|Lost to Follow-up|1
166959|NCT00810043|531820|P3|Overall Study|Withdrawal by Subject|2
166960|NCT00810043|531821|P2|Overall Study|Withdrawal by Subject|0
166961|NCT00810043|531822|P1|Overall Study|Withdrawal by Subject|1
166962|NCT00810069|531843|P3|Double-Blind Period II|Protocol Violation|6
166963|NCT00810069|531844|P2|Double-Blind Period II|Protocol Violation|7
166964|NCT00810069|531845|P1|Double-Blind Period II|Protocol Violation|0
166965|NCT00810069|531843|P3|Double-Blind Period II|Clinical relapse|0
166966|NCT00810069|531844|P2|Double-Blind Period II|Clinical relapse|3
166967|NCT00810069|531845|P1|Double-Blind Period II|Clinical relapse|0
166968|NCT00810069|531843|P3|Double-Blind Period II|Protocol entry criterion not met|1
166969|NCT00810069|531844|P2|Double-Blind Period II|Protocol entry criterion not met|0
166970|NCT00810069|531845|P1|Double-Blind Period II|Protocol entry criterion not met|0
166971|NCT00810069|531843|P3|Double-Blind Period II|Withdrawal by Subject|35
166972|NCT00810069|531844|P2|Double-Blind Period II|Withdrawal by Subject|21
166973|NCT00810069|531845|P1|Double-Blind Period II|Withdrawal by Subject|0
166974|NCT00810069|531843|P3|Double-Blind Period II|Physician Decision|1
166975|NCT00810069|531844|P2|Double-Blind Period II|Physician Decision|0
166976|NCT00810069|531845|P1|Double-Blind Period II|Physician Decision|0
166977|NCT00810069|531843|P3|Double-Blind Period II|Lost to Follow-up|9
166978|NCT00810069|531844|P2|Double-Blind Period II|Lost to Follow-up|9
166979|NCT00810069|531845|P1|Double-Blind Period II|Lost to Follow-up|0
166980|NCT00810069|531843|P3|Double-Blind Period II|Lack of Efficacy|12
166981|NCT00810069|531844|P2|Double-Blind Period II|Lack of Efficacy|7
166982|NCT00810069|531845|P1|Double-Blind Period II|Lack of Efficacy|0
166983|NCT00810069|531843|P3|Double-Blind Period II|Adverse Event|8
166984|NCT00810069|531844|P2|Double-Blind Period II|Adverse Event|9
166985|NCT00810069|531845|P1|Double-Blind Period II|Adverse Event|0
166986|NCT00810069|531843|P3|Lead-in Period I|Randomization criteria not met|0
166987|NCT00810069|531844|P2|Lead-in Period I|Randomization criteria not met|0
166988|NCT00810069|531845|P1|Lead-in Period I|Randomization criteria not met|158
166989|NCT00810069|531843|P3|Lead-in Period I|Protocol entry criterion not met|0
166990|NCT00810069|531844|P2|Lead-in Period I|Protocol entry criterion not met|0
166991|NCT00810069|531845|P1|Lead-in Period I|Protocol entry criterion not met|5
166992|NCT00810069|531843|P3|Lead-in Period I|Withdrawal by Subject|0
166993|NCT00810069|531844|P2|Lead-in Period I|Withdrawal by Subject|0
166994|NCT00810069|531845|P1|Lead-in Period I|Withdrawal by Subject|46
166995|NCT00810069|531843|P3|Lead-in Period I|Protocol Violation|0
166996|NCT00810069|531844|P2|Lead-in Period I|Protocol Violation|0
166997|NCT00810069|531845|P1|Lead-in Period I|Protocol Violation|1
166998|NCT00810069|531843|P3|Lead-in Period I|Physician Decision|0
166999|NCT00810069|531844|P2|Lead-in Period I|Physician Decision|0
167000|NCT00810069|531845|P1|Lead-in Period I|Physician Decision|1
167001|NCT00810069|531843|P3|Lead-in Period I|Lost to Follow-up|0
167002|NCT00810069|531844|P2|Lead-in Period I|Lost to Follow-up|0
167003|NCT00810069|531845|P1|Lead-in Period I|Lost to Follow-up|19
167004|NCT00810069|531843|P3|Lead-in Period I|Lack of Efficacy|0
167005|NCT00810069|531844|P2|Lead-in Period I|Lack of Efficacy|0
167006|NCT00810069|531845|P1|Lead-in Period I|Lack of Efficacy|1
167007|NCT00810069|531843|P3|Lead-in Period I|Adverse Event|0
167008|NCT00810069|531844|P2|Lead-in Period I|Adverse Event|0
167009|NCT00810069|531845|P1|Lead-in Period I|Adverse Event|43
167010|NCT00810082|531890|P2|Overall Study|Lost to Follow-up|4
167011|NCT00810082|531891|P1|Overall Study|Lost to Follow-up|0
167012|NCT00810108|531906|P2|Overall Study|Withdrawal by Subject|0
167013|NCT00810108|531907|P1|Overall Study|Withdrawal by Subject|1
167014|NCT00810199|531914|P2|Overall Study|Did not receive study drug|1
167015|NCT00810199|531915|P1|Overall Study|Did not receive study drug|2
167016|NCT00810199|531914|P2|Overall Study|Failure to return|4
167017|NCT00810199|531915|P1|Overall Study|Failure to return|1
167018|NCT00810199|531914|P2|Overall Study|Protocol Violation|6
167019|NCT00810199|531915|P1|Overall Study|Protocol Violation|2
167020|NCT00810199|531914|P2|Overall Study|Administrative/Other|6
167021|NCT00810199|531915|P1|Overall Study|Administrative/Other|5
167022|NCT00810199|531914|P2|Overall Study|Refused treatment/Did not cooperate|7
167023|NCT00810199|531915|P1|Overall Study|Refused treatment/Did not cooperate|7
167024|NCT00810199|531914|P2|Overall Study|Insufficient therapeutic response|14
167025|NCT00810199|531915|P1|Overall Study|Insufficient therapeutic response|5
167026|NCT00810199|531914|P2|Overall Study|Withdrew consent|12
167027|NCT00810199|531915|P1|Overall Study|Withdrew consent|9
167028|NCT00810199|531914|P2|Overall Study|Death|6
167029|NCT00810199|531915|P1|Overall Study|Death|4
167030|NCT00810199|531914|P2|Overall Study|Adverse Event|26
167031|NCT00810199|531915|P1|Overall Study|Adverse Event|24
167032|NCT00810277|531991|P1|Overall Study|Adverse Event|1
167033|NCT00810342|532031|P2|12-month Followup|Lost to Follow-up|1
167034|NCT00810342|532032|P1|12-month Followup|Lost to Follow-up|3
167035|NCT00810342|532031|P2|12-month Followup|Pregnancy|10
167036|NCT00810342|532032|P1|12-month Followup|Pregnancy|9
167037|NCT00810342|532031|P2|6-month Follow-up|Pregnancy|2
167038|NCT00810342|532032|P1|6-month Follow-up|Pregnancy|6
167039|NCT00810342|532031|P2|6-month Follow-up|Lost to Follow-up|6
167040|NCT00810342|532032|P1|6-month Follow-up|Lost to Follow-up|18
167041|NCT00810342|532031|P2|Month 1 Follow-up|Pregnancy|0
167042|NCT00810342|532032|P1|Month 1 Follow-up|Pregnancy|1
167043|NCT00810342|532031|P2|Month 1 Follow-up|Lost to Follow-up|2
167044|NCT00810342|532032|P1|Month 1 Follow-up|Lost to Follow-up|4
167045|NCT00810355|532043|P3|Overall Study|Withdrawal by Subject|0
167046|NCT00810355|532044|P2|Overall Study|Withdrawal by Subject|0
167047|NCT00810355|532045|P1|Overall Study|Withdrawal by Subject|1
167048|NCT00810355|532043|P3|Overall Study|Lost to Follow-up|11
167049|NCT00810355|532044|P2|Overall Study|Lost to Follow-up|17
167050|NCT00810355|532045|P1|Overall Study|Lost to Follow-up|13
167051|NCT00810368|532061|P2|Overall Study|Lack of Efficacy|0
167052|NCT00810368|532062|P1|Overall Study|Lack of Efficacy|2
167053|NCT00810368|532061|P2|Overall Study|Lost to Follow-up|2
167054|NCT00810368|532062|P1|Overall Study|Lost to Follow-up|4
167055|NCT00810394|532080|P1|Overall Study|Withdrawal by Subject|3
167056|NCT00811655|532086|P1|Overall Study|Physician Decision|1
167057|NCT00811720|532100|P2|All Treated Patients|Other Reason|4
167058|NCT00811720|532101|P1|All Treated Patients|Other Reason|7
167059|NCT00811720|532100|P2|All Treated Patients|Lost to Follow-up|16
167060|NCT00811720|532101|P1|All Treated Patients|Lost to Follow-up|10
167061|NCT00811720|532100|P2|All Treated Patients|Withdrawal by Subject|34
167062|NCT00811720|532101|P1|All Treated Patients|Withdrawal by Subject|28
167063|NCT00811720|532100|P2|All Treated Patients|Protocol Violation|16
167064|NCT00811720|532101|P1|All Treated Patients|Protocol Violation|9
167065|NCT00811720|532100|P2|All Treated Patients|Non-compliance|14
167066|NCT00811720|532101|P1|All Treated Patients|Non-compliance|0
167067|NCT00811720|532100|P2|All Treated Patients|Lack of Efficacy|18
167068|NCT00811720|532101|P1|All Treated Patients|Lack of Efficacy|22
167069|NCT00811720|532100|P2|All Treated Patients|Adverse Event|62
167070|NCT00811720|532101|P1|All Treated Patients|Adverse Event|20
167071|NCT00811720|532100|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
167072|NCT00811720|532101|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
167073|NCT00811733|532121|P2|Overall Study|Withdrawal by Subject|2
167074|NCT00811733|532122|P1|Overall Study|Withdrawal by Subject|1
167075|NCT00811733|532121|P2|Overall Study|Investigator Discretion|8
167076|NCT00811733|532122|P1|Overall Study|Investigator Discretion|10
167077|NCT00811928|532194|P2|Overall Study|Poor Compliance|5
167078|NCT00811928|532195|P1|Overall Study|Poor Compliance|2
167079|NCT00811928|532194|P2|Overall Study|Investigator Decision|1
167080|NCT00811928|532195|P1|Overall Study|Investigator Decision|2
167081|NCT00811928|532194|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
167082|NCT00811928|532195|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
167083|NCT00811928|532194|P2|Overall Study|Did Not Take Study Drug|0
167084|NCT00811928|532195|P1|Overall Study|Did Not Take Study Drug|3
167085|NCT00811928|532194|P2|Overall Study|Withdrawal by Subject|12
167086|NCT00811928|532195|P1|Overall Study|Withdrawal by Subject|18
167087|NCT00811928|532194|P2|Overall Study|AEs and SAEs Including Death|11
167088|NCT00811928|532195|P1|Overall Study|AEs and SAEs Including Death|7
167089|NCT00811941|532215|P2|All Treated Patients|Other Reason|14
167090|NCT00811941|532216|P1|All Treated Patients|Other Reason|4
167091|NCT00811941|532215|P2|All Treated Patients|Lost to Follow-up|12
167092|NCT00811941|532216|P1|All Treated Patients|Lost to Follow-up|3
167093|NCT00811941|532215|P2|All Treated Patients|Withdrawal by Subject|94
167094|NCT00811941|532216|P1|All Treated Patients|Withdrawal by Subject|35
167095|NCT00811941|532215|P2|All Treated Patients|Protocol Violation|17
167096|NCT00811941|532216|P1|All Treated Patients|Protocol Violation|5
167097|NCT00811941|532215|P2|All Treated Patients|Non-compliance|8
167098|NCT00811941|532216|P1|All Treated Patients|Non-compliance|1
167099|NCT00811941|532215|P2|All Treated Patients|Lack of Efficacy|3
167100|NCT00811941|532216|P1|All Treated Patients|Lack of Efficacy|2
167101|NCT00811941|532215|P2|All Treated Patients|Adverse Event|43
167102|NCT00811941|532216|P1|All Treated Patients|Adverse Event|2
167103|NCT00811941|532215|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
167104|NCT00811941|532216|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
167105|NCT00811954|532255|P3|Overall Study|Complete Protocol: No follow-up|1
167106|NCT00811954|532256|P2|Overall Study|Complete Protocol: No follow-up|0
167107|NCT00811954|532257|P1|Overall Study|Complete Protocol: No follow-up|0
167108|NCT00811954|532255|P3|Overall Study|Severe Debilitation|1
167109|NCT00811954|532256|P2|Overall Study|Severe Debilitation|0
167110|NCT00811954|532257|P1|Overall Study|Severe Debilitation|2
167111|NCT00811954|532255|P3|Overall Study|Site Closure|1
167112|NCT00811954|532256|P2|Overall Study|Site Closure|0
167113|NCT00811954|532257|P1|Overall Study|Site Closure|4
167114|NCT00811954|532255|P3|Overall Study|Withdraw consent prior study completion|5
167115|NCT00811954|532256|P2|Overall Study|Withdraw consent prior study completion|6
167116|NCT00811954|532257|P1|Overall Study|Withdraw consent prior study completion|4
167117|NCT00811954|532255|P3|Overall Study|Not willing to adhere to requirements|16
167118|NCT00811954|532256|P2|Overall Study|Not willing to adhere to requirements|2
167119|NCT00811954|532257|P1|Overall Study|Not willing to adhere to requirements|12
167120|NCT00811954|532255|P3|Overall Study|Not able to get to clinic|30
167121|NCT00811954|532256|P2|Overall Study|Not able to get to clinic|35
167122|NCT00811954|532257|P1|Overall Study|Not able to get to clinic|28
167123|NCT00811954|532255|P3|Overall Study|Lost to Follow-up|34
167124|NCT00811954|532256|P2|Overall Study|Lost to Follow-up|23
167125|NCT00811954|532257|P1|Overall Study|Lost to Follow-up|29
167126|NCT00811954|532255|P3|Overall Study|Death|13
167127|NCT00811954|532256|P2|Overall Study|Death|6
167128|NCT00811954|532257|P1|Overall Study|Death|10
167129|NCT00812006|532322|P3|Overall Study|Lack of Qualifying Event|2
167130|NCT00812006|532323|P2|Overall Study|Lack of Qualifying Event|2
167131|NCT00812006|532324|P1|Overall Study|Lack of Qualifying Event|4
167132|NCT00812006|532322|P3|Overall Study|Withdrawal by Subject|1
167133|NCT00812006|532323|P2|Overall Study|Withdrawal by Subject|1
167134|NCT00812006|532324|P1|Overall Study|Withdrawal by Subject|2
167135|NCT00812006|532322|P3|Overall Study|Physician Decision|1
167136|NCT00812006|532323|P2|Overall Study|Physician Decision|0
167137|NCT00812006|532324|P1|Overall Study|Physician Decision|0
167138|NCT00812006|532322|P3|Overall Study|Lost to Follow-up|2
167139|NCT00812006|532323|P2|Overall Study|Lost to Follow-up|0
167140|NCT00812006|532324|P1|Overall Study|Lost to Follow-up|0
167141|NCT00812097|532342|P4|Overall Study|Unknown reasons and patient/doctor moves|5
167142|NCT00812097|532343|P3|Overall Study|Unknown reasons and patient/doctor moves|15
167143|NCT00812097|532344|P2|Overall Study|Unknown reasons and patient/doctor moves|24
167144|NCT00812097|532345|P1|Overall Study|Unknown reasons and patient/doctor moves|111
167145|NCT00812097|532342|P4|Overall Study|Explantation of study device(s)|20
167146|NCT00812097|532343|P3|Overall Study|Explantation of study device(s)|14
167147|NCT00812097|532344|P2|Overall Study|Explantation of study device(s)|29
167148|NCT00812097|532345|P1|Overall Study|Explantation of study device(s)|27
167149|NCT00812097|532342|P4|Overall Study|Lost to Follow-up|5
167150|NCT00812097|532343|P3|Overall Study|Lost to Follow-up|17
167151|NCT00812097|532344|P2|Overall Study|Lost to Follow-up|14
167152|NCT00812097|532345|P1|Overall Study|Lost to Follow-up|90
167153|NCT00812097|532342|P4|Overall Study|Withdrawal by Subject|2
167154|NCT00812097|532343|P3|Overall Study|Withdrawal by Subject|8
167155|NCT00812097|532344|P2|Overall Study|Withdrawal by Subject|12
167156|NCT00812097|532345|P1|Overall Study|Withdrawal by Subject|14
167157|NCT00812097|532342|P4|Overall Study|Death|3
167158|NCT00812097|532343|P3|Overall Study|Death|3
167159|NCT00812097|532344|P2|Overall Study|Death|10
167160|NCT00812097|532345|P1|Overall Study|Death|3
167161|NCT00812253|532378|P2|Overall Study|Lost to Follow-up|0
167162|NCT00812253|532379|P1|Overall Study|Lost to Follow-up|2
167163|NCT00812253|532378|P2|Overall Study|Protocol Violation|1
167164|NCT00812253|532379|P1|Overall Study|Protocol Violation|1
167165|NCT00812253|532378|P2|Overall Study|Withdrawal by Subject|2
167166|NCT00812253|532379|P1|Overall Study|Withdrawal by Subject|3
167167|NCT00812331|532394|P5|Overall Study|Adverse Event|0
167168|NCT00812331|532395|P4|Overall Study|Adverse Event|0
167169|NCT00812331|532396|P3|Overall Study|Adverse Event|0
167170|NCT00812331|532397|P2|Overall Study|Adverse Event|0
167171|NCT00812331|532398|P1|Overall Study|Adverse Event|1
167172|NCT00812461|532473|P2|All Treated Patients|Other Reason|21
167173|NCT00812461|532474|P1|All Treated Patients|Other Reason|13
167174|NCT00812461|532473|P2|All Treated Patients|Lost to Follow-up|14
167175|NCT00812461|532474|P1|All Treated Patients|Lost to Follow-up|11
167176|NCT00812461|532473|P2|All Treated Patients|Withdrawal by Subject|54
167177|NCT00812461|532474|P1|All Treated Patients|Withdrawal by Subject|45
167178|NCT00812461|532473|P2|All Treated Patients|Protocol Violation|27
167179|NCT00812461|532474|P1|All Treated Patients|Protocol Violation|36
167180|NCT00812461|532473|P2|All Treated Patients|Non-compliance|9
167181|NCT00812461|532474|P1|All Treated Patients|Non-compliance|6
167182|NCT00812461|532473|P2|All Treated Patients|Lack of Efficacy|7
167183|NCT00812461|532474|P1|All Treated Patients|Lack of Efficacy|13
167184|NCT00812461|532473|P2|All Treated Patients|Adverse Event|15
167185|NCT00812461|532474|P1|All Treated Patients|Adverse Event|8
167186|NCT00812461|532473|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
167187|NCT00812461|532474|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
167188|NCT00812487|532494|P2|Overall Study|Protocol Violation|1
167189|NCT00812487|532495|P1|Overall Study|Protocol Violation|0
167190|NCT00812487|532494|P2|Overall Study|Transfer to ICU prior to intervention|0
167191|NCT00812487|532495|P1|Overall Study|Transfer to ICU prior to intervention|1
167192|NCT00812487|532494|P2|Overall Study|Withdrawal by Subject|2
167193|NCT00812487|532495|P1|Overall Study|Withdrawal by Subject|3
167194|NCT00812487|532494|P2|Overall Study|Lost to Follow-up|0
167195|NCT00812487|532495|P1|Overall Study|Lost to Follow-up|2
167196|NCT00812565|532527|P8|Overall Study|Reason Not Specified|0
167197|NCT00812565|532528|P7|Overall Study|Reason Not Specified|0
167198|NCT00812565|532529|P6|Overall Study|Reason Not Specified|1
167199|NCT00812565|532530|P5|Overall Study|Reason Not Specified|0
167200|NCT00812565|532531|P4|Overall Study|Reason Not Specified|0
167201|NCT00812565|532532|P3|Overall Study|Reason Not Specified|0
167202|NCT00812565|532533|P2|Overall Study|Reason Not Specified|0
167203|NCT00812565|532534|P1|Overall Study|Reason Not Specified|0
167204|NCT00812565|532527|P8|Overall Study|Withdrawal of Consent|0
167205|NCT00812565|532528|P7|Overall Study|Withdrawal of Consent|0
167206|NCT00812565|532529|P6|Overall Study|Withdrawal of Consent|0
167207|NCT00812565|532530|P5|Overall Study|Withdrawal of Consent|1
167208|NCT00812565|532531|P4|Overall Study|Withdrawal of Consent|0
167209|NCT00812565|532532|P3|Overall Study|Withdrawal of Consent|0
167210|NCT00812565|532533|P2|Overall Study|Withdrawal of Consent|0
167211|NCT00812565|532534|P1|Overall Study|Withdrawal of Consent|1
167212|NCT00812565|532527|P8|Overall Study|Did Not Come to Study Visit|0
167213|NCT00812565|532528|P7|Overall Study|Did Not Come to Study Visit|0
167214|NCT00812565|532529|P6|Overall Study|Did Not Come to Study Visit|0
167215|NCT00812565|532530|P5|Overall Study|Did Not Come to Study Visit|0
167216|NCT00812565|532531|P4|Overall Study|Did Not Come to Study Visit|0
167217|NCT00812565|532532|P3|Overall Study|Did Not Come to Study Visit|0
167218|NCT00812565|532533|P2|Overall Study|Did Not Come to Study Visit|0
167219|NCT00812565|532534|P1|Overall Study|Did Not Come to Study Visit|1
167220|NCT00812565|532527|P8|Overall Study|Adverse Event|1
167221|NCT00812565|532528|P7|Overall Study|Adverse Event|0
167222|NCT00812565|532529|P6|Overall Study|Adverse Event|0
167223|NCT00812565|532530|P5|Overall Study|Adverse Event|0
167224|NCT00812565|532531|P4|Overall Study|Adverse Event|2
167225|NCT00812565|532532|P3|Overall Study|Adverse Event|0
167226|NCT00812565|532533|P2|Overall Study|Adverse Event|0
167227|NCT00812565|532534|P1|Overall Study|Adverse Event|0
167228|NCT00812565|532527|P8|Overall Study|Did Not Receive Study Medication|0
167229|NCT00812565|532528|P7|Overall Study|Did Not Receive Study Medication|0
167230|NCT00812565|532529|P6|Overall Study|Did Not Receive Study Medication|0
167231|NCT00812565|532530|P5|Overall Study|Did Not Receive Study Medication|0
167232|NCT00812565|532531|P4|Overall Study|Did Not Receive Study Medication|0
167233|NCT00812565|532532|P3|Overall Study|Did Not Receive Study Medication|0
167234|NCT00812565|532533|P2|Overall Study|Did Not Receive Study Medication|1
167235|NCT00812565|532534|P1|Overall Study|Did Not Receive Study Medication|1
167236|NCT00812812|532669|P2|Overall Study|Withdrawal by Subject|2
167237|NCT00812812|532670|P1|Overall Study|Withdrawal by Subject|0
167238|NCT00812812|532669|P2|Overall Study|Lost to Follow-up|1
167239|NCT00812812|532670|P1|Overall Study|Lost to Follow-up|0
167240|NCT00812812|532669|P2|Overall Study|Lack of Efficacy|0
167241|NCT00812812|532670|P1|Overall Study|Lack of Efficacy|1
167242|NCT00812812|532669|P2|Overall Study|Adverse Event|1
167243|NCT00812812|532670|P1|Overall Study|Adverse Event|2
167244|NCT00812955|532707|P4|Overall Study|randomized in error|0
167245|NCT00812955|532708|P3|Overall Study|randomized in error|1
167246|NCT00812955|532709|P2|Overall Study|randomized in error|0
167247|NCT00812955|532710|P1|Overall Study|randomized in error|0
167248|NCT00812955|532707|P4|Overall Study|Withdrawal by Subject|2
167249|NCT00812955|532708|P3|Overall Study|Withdrawal by Subject|1
167250|NCT00812955|532709|P2|Overall Study|Withdrawal by Subject|0
167251|NCT00812955|532710|P1|Overall Study|Withdrawal by Subject|1
167252|NCT00812955|532707|P4|Overall Study|Lost to Follow-up|2
167253|NCT00812955|532708|P3|Overall Study|Lost to Follow-up|1
167254|NCT00812955|532709|P2|Overall Study|Lost to Follow-up|1
167255|NCT00812955|532710|P1|Overall Study|Lost to Follow-up|2
167256|NCT00812955|532707|P4|Overall Study|Adverse Event|4
167257|NCT00812955|532708|P3|Overall Study|Adverse Event|3
167258|NCT00812955|532709|P2|Overall Study|Adverse Event|6
167259|NCT00812955|532710|P1|Overall Study|Adverse Event|7
167260|NCT00812968|532730|P1|Overall Study|Study closed due to marketing approval|3
167261|NCT00812968|532730|P1|Overall Study|No further treatment required|1
167262|NCT00812968|532730|P1|Overall Study|Disease progression|1
167263|NCT00812968|532730|P1|Overall Study|Relapse after erythroid response|6
167264|NCT00812981|532763|P2|Overall Study|Unspecified|1
167265|NCT00812981|532764|P1|Overall Study|Unspecified|0
167266|NCT00813098|532805|P3|Overall Study|Withdrew Consent|0
167267|NCT00813098|532806|P2|Overall Study|Withdrew Consent|1
167268|NCT00813098|532807|P1|Overall Study|Withdrew Consent|0
167269|NCT00813098|532805|P3|Overall Study|Principal Investigator decision|0
167270|NCT00813098|532806|P2|Overall Study|Principal Investigator decision|1
167271|NCT00813098|532807|P1|Overall Study|Principal Investigator decision|0
167272|NCT00813098|532805|P3|Overall Study|Protocol Violation|1
167273|NCT00813098|532806|P2|Overall Study|Protocol Violation|0
167274|NCT00813098|532807|P1|Overall Study|Protocol Violation|0
167275|NCT00813098|532805|P3|Overall Study|Lost to Follow-up|0
167276|NCT00813098|532806|P2|Overall Study|Lost to Follow-up|1
167277|NCT00813098|532807|P1|Overall Study|Lost to Follow-up|0
167278|NCT00813098|532805|P3|Overall Study|Inability to complete study procedures|0
167279|NCT00813098|532806|P2|Overall Study|Inability to complete study procedures|0
167280|NCT00813098|532807|P1|Overall Study|Inability to complete study procedures|1
167281|NCT00813098|532805|P3|Overall Study|Withdrawal by Subject|0
167282|NCT00813098|532806|P2|Overall Study|Withdrawal by Subject|1
167283|NCT00813098|532807|P1|Overall Study|Withdrawal by Subject|0
167284|NCT00813098|532805|P3|Overall Study|Adverse Event|1
167285|NCT00813098|532806|P2|Overall Study|Adverse Event|4
167286|NCT00813098|532807|P1|Overall Study|Adverse Event|2
167287|NCT00813150|532841|P2|Long Term Follow-up|Progression/Relapse|24
167288|NCT00813150|532842|P1|Long Term Follow-up|Progression/Relapse|22
167289|NCT00813150|532841|P2|Long Term Follow-up|Lost to Follow-up|0
167290|NCT00813150|532842|P1|Long Term Follow-up|Lost to Follow-up|2
167291|NCT00813150|532841|P2|Long Term Follow-up|Not specified|3
167292|NCT00813150|532842|P1|Long Term Follow-up|Not specified|0
167293|NCT00813150|532841|P2|Long Term Follow-up|Death|4
167294|NCT00813150|532842|P1|Long Term Follow-up|Death|0
167295|NCT00813150|532841|P2|Treatment Period|Data not available|2
167296|NCT00813150|532842|P1|Treatment Period|Data not available|1
167297|NCT00813150|532841|P2|Treatment Period|Reason not specified|4
167298|NCT00813150|532842|P1|Treatment Period|Reason not specified|3
167299|NCT00813150|532841|P2|Treatment Period|Non compliance|1
167300|NCT00813150|532842|P1|Treatment Period|Non compliance|0
167301|NCT00813150|532841|P2|Treatment Period|Withdrawal by Subject|3
167302|NCT00813150|532842|P1|Treatment Period|Withdrawal by Subject|5
167303|NCT00813150|532841|P2|Treatment Period|Protocol Violation|4
167304|NCT00813150|532842|P1|Treatment Period|Protocol Violation|3
167305|NCT00813150|532841|P2|Treatment Period|Stable disease|2
167306|NCT00813150|532842|P1|Treatment Period|Stable disease|1
167307|NCT00813150|532841|P2|Treatment Period|Complete response|1
167308|NCT00813150|532842|P1|Treatment Period|Complete response|0
167309|NCT00813150|532841|P2|Treatment Period|Progressive disease|0
167310|NCT00813150|532842|P1|Treatment Period|Progressive disease|1
167311|NCT00813150|532841|P2|Treatment Period|Death|0
167312|NCT00813150|532842|P1|Treatment Period|Death|2
167313|NCT00813150|532841|P2|Treatment Period|Adverse Event|15
167314|NCT00813150|532842|P1|Treatment Period|Adverse Event|16
167315|NCT00813488|532867|P2|Open-label Extension|Not specified|0
167316|NCT00813488|532868|P1|Open-label Extension|Not specified|1
167317|NCT00813488|532867|P2|Open-label Extension|Non-compliance study procedures|1
167318|NCT00813488|532868|P1|Open-label Extension|Non-compliance study procedures|2
167319|NCT00813488|532867|P2|Open-label Extension|Non-compliance study medication|0
167320|NCT00813488|532868|P1|Open-label Extension|Non-compliance study medication|4
167321|NCT00813488|532867|P2|Open-label Extension|Protocol Violation|2
167322|NCT00813488|532868|P1|Open-label Extension|Protocol Violation|1
167323|NCT00813488|532867|P2|Open-label Extension|Withdrawal by Subject|2
167324|NCT00813488|532868|P1|Open-label Extension|Withdrawal by Subject|0
167325|NCT00813488|532867|P2|Open-label Extension|Lack of Efficacy|0
167326|NCT00813488|532868|P1|Open-label Extension|Lack of Efficacy|3
167327|NCT00813488|532867|P2|Open-label Extension|Adverse Event|2
167328|NCT00813488|532868|P1|Open-label Extension|Adverse Event|1
167329|NCT00813488|532867|P2|Double-blind Treatment Period 2|Not Specified|0
167330|NCT00813488|532868|P1|Double-blind Treatment Period 2|Not Specified|1
167331|NCT00813488|532867|P2|Double-blind Treatment Period 2|Protocol Violation|0
167332|NCT00813488|532868|P1|Double-blind Treatment Period 2|Protocol Violation|2
167333|NCT00813488|532867|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
167334|NCT00813488|532868|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
167335|NCT00813488|532867|P2|Double-blind Treatment Period 2|Adverse Event|0
167336|NCT00813488|532868|P1|Double-blind Treatment Period 2|Adverse Event|1
167337|NCT00813488|532867|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
167338|NCT00813488|532868|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
167339|NCT00813488|532867|P2|Double-blind Treatment Period 1|Protocol Violation|2
167340|NCT00813488|532868|P1|Double-blind Treatment Period 1|Protocol Violation|0
167341|NCT00813488|532867|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
167342|NCT00813488|532868|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
167343|NCT00813488|532867|P2|Double-blind Treatment Period 1|Adverse Event|1
167344|NCT00813488|532868|P1|Double-blind Treatment Period 1|Adverse Event|1
167345|NCT00813488|532867|P2|Titration Period 2|Non-compliance with study procedures|1
167346|NCT00813488|532868|P1|Titration Period 2|Non-compliance with study procedures|2
167347|NCT00813488|532867|P2|Titration Period 2|Lost to Follow-up|0
167348|NCT00813488|532868|P1|Titration Period 2|Lost to Follow-up|1
167349|NCT00813488|532867|P2|Titration Period 2|Protocol Violation|2
167350|NCT00813488|532868|P1|Titration Period 2|Protocol Violation|3
167351|NCT00813488|532867|P2|Titration Period 2|Lack of Efficacy|4
167352|NCT00813488|532868|P1|Titration Period 2|Lack of Efficacy|8
167353|NCT00813488|532867|P2|Titration Period 2|Adverse Event|3
167354|NCT00813488|532868|P1|Titration Period 2|Adverse Event|2
167355|NCT00813488|532867|P2|Titration Period 1|Technical Difficulties|1
167356|NCT00813488|532868|P1|Titration Period 1|Technical Difficulties|0
167357|NCT00813488|532867|P2|Titration Period 1|Non-compliance to study procedures|2
167358|NCT00813488|532868|P1|Titration Period 1|Non-compliance to study procedures|2
167359|NCT00813488|532867|P2|Titration Period 1|Non-compliance to study medication|1
167360|NCT00813488|532868|P1|Titration Period 1|Non-compliance to study medication|4
167361|NCT00813488|532867|P2|Titration Period 1|Protocol Violation|3
167362|NCT00813488|532868|P1|Titration Period 1|Protocol Violation|4
167363|NCT00813488|532867|P2|Titration Period 1|Withdrawal by Subject|2
167364|NCT00813488|532868|P1|Titration Period 1|Withdrawal by Subject|2
167365|NCT00813488|532867|P2|Titration Period 1|Lack of Efficacy|7
167366|NCT00813488|532868|P1|Titration Period 1|Lack of Efficacy|9
167367|NCT00813488|532867|P2|Titration Period 1|Adverse Event|1
167368|NCT00813488|532868|P1|Titration Period 1|Adverse Event|6
167369|NCT00813592|532964|P1|Overall Study|Disease assessment was not completed per|2
167370|NCT00813709|532976|P6|Open Label Period|Unspecified|6
167371|NCT00813709|532977|P5|Open Label Period|Unspecified|5
167372|NCT00813709|532978|P4|Open Label Period|Unspecified|11
167373|NCT00813709|532979|P3|Open Label Period|Unspecified|0
167374|NCT00813709|532980|P2|Open Label Period|Unspecified|0
167375|NCT00813709|532981|P1|Open Label Period|Unspecified|0
167376|NCT00813709|532976|P6|Open Label Period|Randomized but not treated|1
167377|NCT00813709|532977|P5|Open Label Period|Randomized but not treated|0
167378|NCT00813709|532978|P4|Open Label Period|Randomized but not treated|1
167379|NCT00813709|532979|P3|Open Label Period|Randomized but not treated|0
167380|NCT00813709|532980|P2|Open Label Period|Randomized but not treated|0
167381|NCT00813709|532981|P1|Open Label Period|Randomized but not treated|0
167382|NCT00813709|532976|P6|Open Label Period|Lack of Efficacy|1
167383|NCT00813709|532977|P5|Open Label Period|Lack of Efficacy|1
167384|NCT00813709|532978|P4|Open Label Period|Lack of Efficacy|3
167385|NCT00813709|532979|P3|Open Label Period|Lack of Efficacy|0
167386|NCT00813709|532980|P2|Open Label Period|Lack of Efficacy|0
167387|NCT00813709|532981|P1|Open Label Period|Lack of Efficacy|0
167388|NCT00813709|532976|P6|Open Label Period|Adverse Event|3
167389|NCT00813709|532977|P5|Open Label Period|Adverse Event|4
167390|NCT00813709|532978|P4|Open Label Period|Adverse Event|5
167391|NCT00813709|532979|P3|Open Label Period|Adverse Event|0
167392|NCT00813709|532980|P2|Open Label Period|Adverse Event|0
167393|NCT00813709|532981|P1|Open Label Period|Adverse Event|0
167394|NCT00813709|532976|P6|Double Blind Period|Unspecified|0
167395|NCT00813709|532977|P5|Double Blind Period|Unspecified|0
167396|NCT00813709|532978|P4|Double Blind Period|Unspecified|0
167397|NCT00813709|532979|P3|Double Blind Period|Unspecified|6
167398|NCT00813709|532980|P2|Double Blind Period|Unspecified|9
167399|NCT00813709|532981|P1|Double Blind Period|Unspecified|14
167400|NCT00813709|532976|P6|Double Blind Period|Randomized but not treated|0
167401|NCT00813709|532977|P5|Double Blind Period|Randomized but not treated|0
167402|NCT00813709|532978|P4|Double Blind Period|Randomized but not treated|0
167403|NCT00813709|532979|P3|Double Blind Period|Randomized but not treated|1
167404|NCT00813709|532980|P2|Double Blind Period|Randomized but not treated|3
167405|NCT00813709|532981|P1|Double Blind Period|Randomized but not treated|1
167406|NCT00813709|532976|P6|Double Blind Period|Switched to open label phase|0
167407|NCT00813709|532977|P5|Double Blind Period|Switched to open label phase|0
167408|NCT00813709|532978|P4|Double Blind Period|Switched to open label phase|0
167409|NCT00813709|532979|P3|Double Blind Period|Switched to open label phase|18
167410|NCT00813709|532980|P2|Double Blind Period|Switched to open label phase|26
167411|NCT00813709|532981|P1|Double Blind Period|Switched to open label phase|9
167412|NCT00813709|532976|P6|Double Blind Period|Lost to Follow-up|0
167413|NCT00813709|532977|P5|Double Blind Period|Lost to Follow-up|0
167414|NCT00813709|532978|P4|Double Blind Period|Lost to Follow-up|0
167415|NCT00813709|532979|P3|Double Blind Period|Lost to Follow-up|2
167416|NCT00813709|532980|P2|Double Blind Period|Lost to Follow-up|2
167417|NCT00813709|532981|P1|Double Blind Period|Lost to Follow-up|3
167418|NCT00813709|532976|P6|Double Blind Period|Adverse Event|0
167419|NCT00813709|532977|P5|Double Blind Period|Adverse Event|0
167420|NCT00813709|532978|P4|Double Blind Period|Adverse Event|0
167421|NCT00813709|532979|P3|Double Blind Period|Adverse Event|4
167422|NCT00813709|532980|P2|Double Blind Period|Adverse Event|1
167423|NCT00813709|532981|P1|Double Blind Period|Adverse Event|4
167424|NCT00813748|533063|P2|Skin Test Substudy|Physician Decision|1
167425|NCT00813748|533064|P1|Skin Test Substudy|Physician Decision|0
167426|NCT00813761|533092|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
167427|NCT00813761|533093|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
167428|NCT00813761|533094|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
167429|NCT00813761|533095|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
167430|NCT00813761|533092|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
167431|NCT00813761|533093|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
167432|NCT00813761|533094|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
167433|NCT00813761|533095|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
167434|NCT00813761|533092|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
167435|NCT00813761|533093|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
167436|NCT00813761|533094|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
167437|NCT00813761|533095|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
167438|NCT00813761|533092|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
167439|NCT00813761|533093|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
167440|NCT00813761|533094|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
167441|NCT00813761|533095|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
167442|NCT00813761|533092|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
167443|NCT00813761|533093|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
167444|NCT00813761|533094|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
167445|NCT00813761|533095|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
167446|NCT00813761|533092|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
167447|NCT00813761|533093|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
167448|NCT00813761|533094|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
167449|NCT00813761|533095|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
167450|NCT00813761|533092|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
167451|NCT00813761|533093|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
167452|NCT00813761|533094|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
167453|NCT00813761|533095|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
167454|NCT00813761|533092|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
167455|NCT00813761|533093|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
167456|NCT00813761|533094|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
167457|NCT00813761|533095|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
167458|NCT00813761|533092|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
167459|NCT00813761|533093|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
167460|NCT00813761|533094|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
167461|NCT00813761|533095|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
167462|NCT00813761|533092|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
167463|NCT00813761|533093|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
167464|NCT00813761|533094|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
167465|NCT00813761|533095|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
167466|NCT00813761|533092|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
167467|NCT00813761|533093|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
167468|NCT00813761|533094|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
167469|NCT00813761|533095|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
167470|NCT00813761|533092|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
167471|NCT00813761|533093|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
167472|NCT00813761|533094|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
167473|NCT00813761|533095|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
167474|NCT00813800|533143|P1|Overall Study|Physician Decision|1
167475|NCT00813800|533143|P1|Overall Study|Worsening of depression|2
167476|NCT00813800|533143|P1|Overall Study|Adverse Event|1
167477|NCT00813800|533143|P1|Overall Study|Screen Failure after Consent|2
167478|NCT00813813|533151|P2|Overall Study|Other|1
167479|NCT00813813|533152|P1|Overall Study|Other|0
167480|NCT00813813|533151|P2|Overall Study|Lost to Follow-up|7
167481|NCT00813813|533152|P1|Overall Study|Lost to Follow-up|2
167482|NCT00813813|533151|P2|Overall Study|Withdrawal by Subject|1
167483|NCT00813813|533152|P1|Overall Study|Withdrawal by Subject|1
167484|NCT00813904|533168|P1|Overall Study|Death|1
167485|NCT00813917|533176|P2|Overall Study|Lost to Follow-up|1
167486|NCT00813917|533177|P1|Overall Study|Lost to Follow-up|3
167487|NCT00813917|533176|P2|Overall Study|Withdrawal by Subject|4
167488|NCT00813917|533177|P1|Overall Study|Withdrawal by Subject|3
167489|NCT00813917|533176|P2|Overall Study|Adverse Event|1
167490|NCT00813917|533177|P1|Overall Study|Adverse Event|0
167491|NCT00813943|533186|P3|Overall Study|Ongoing at cut-off date|3
167492|NCT00813943|533187|P2|Overall Study|Ongoing at cut-off date|5
167493|NCT00813943|533188|P1|Overall Study|Ongoing at cut-off date|5
167494|NCT00813995|533224|P2|Overall Study|Withdrawal by Subject|5
167495|NCT00813995|533225|P1|Overall Study|Withdrawal by Subject|0
167496|NCT00813995|533224|P2|Overall Study|Subject moved|0
167497|NCT00813995|533225|P1|Overall Study|Subject moved|4
167498|NCT00813995|533224|P2|Overall Study|Protocol Violation|2
167499|NCT00813995|533225|P1|Overall Study|Protocol Violation|3
167500|NCT00813995|533224|P2|Overall Study|Other reason|2
167501|NCT00813995|533225|P1|Overall Study|Other reason|2
167502|NCT00813995|533224|P2|Overall Study|Lost to Follow-up|2
167503|NCT00813995|533225|P1|Overall Study|Lost to Follow-up|4
167504|NCT00813995|533224|P2|Overall Study|Lack of Efficacy|0
167505|NCT00813995|533225|P1|Overall Study|Lack of Efficacy|1
167506|NCT00813995|533224|P2|Overall Study|Laboratory adverse event|2
167507|NCT00813995|533225|P1|Overall Study|Laboratory adverse event|0
167508|NCT00813995|533224|P2|Overall Study|Clinical adverse event|3
167509|NCT00813995|533225|P1|Overall Study|Clinical adverse event|9
167510|NCT00806026|533245|P6|Overall Study|Adverse Event|9
167511|NCT00806026|533246|P5|Overall Study|Adverse Event|9
167512|NCT00806026|533247|P4|Overall Study|Adverse Event|17
167513|NCT00806026|533248|P3|Overall Study|Adverse Event|44
167514|NCT00806026|533249|P2|Overall Study|Adverse Event|35
167515|NCT00806026|533250|P1|Overall Study|Adverse Event|52
167516|NCT00806026|533245|P6|Overall Study|Protocol Violation|3
167517|NCT00806026|533246|P5|Overall Study|Protocol Violation|2
167518|NCT00806026|533247|P4|Overall Study|Protocol Violation|0
167519|NCT00806026|533248|P3|Overall Study|Protocol Violation|9
167520|NCT00806026|533249|P2|Overall Study|Protocol Violation|9
167521|NCT00806026|533250|P1|Overall Study|Protocol Violation|6
167522|NCT00806026|533245|P6|Overall Study|Unspecified|4
167523|NCT00806026|533246|P5|Overall Study|Unspecified|0
167524|NCT00806026|533247|P4|Overall Study|Unspecified|2
167525|NCT00806026|533248|P3|Overall Study|Unspecified|8
167526|NCT00806026|533249|P2|Overall Study|Unspecified|6
167527|NCT00806026|533250|P1|Overall Study|Unspecified|3
167528|NCT00806026|533245|P6|Overall Study|Withdrawal by Subject|3
167529|NCT00806026|533246|P5|Overall Study|Withdrawal by Subject|5
167530|NCT00806026|533247|P4|Overall Study|Withdrawal by Subject|2
167531|NCT00806026|533248|P3|Overall Study|Withdrawal by Subject|9
167532|NCT00806026|533249|P2|Overall Study|Withdrawal by Subject|17
167533|NCT00806026|533250|P1|Overall Study|Withdrawal by Subject|14
167534|NCT00806026|533245|P6|Overall Study|Lost to Follow-up|6
167535|NCT00806026|533246|P5|Overall Study|Lost to Follow-up|6
167536|NCT00806026|533247|P4|Overall Study|Lost to Follow-up|2
167537|NCT00806026|533248|P3|Overall Study|Lost to Follow-up|8
167538|NCT00806026|533249|P2|Overall Study|Lost to Follow-up|15
167539|NCT00806026|533250|P1|Overall Study|Lost to Follow-up|8
167540|NCT00806026|533245|P6|Overall Study|Lack of Efficacy|7
167541|NCT00806026|533246|P5|Overall Study|Lack of Efficacy|8
167542|NCT00806026|533247|P4|Overall Study|Lack of Efficacy|4
167543|NCT00806026|533248|P3|Overall Study|Lack of Efficacy|13
167544|NCT00806026|533249|P2|Overall Study|Lack of Efficacy|18
167545|NCT00806026|533250|P1|Overall Study|Lack of Efficacy|5
167546|NCT00806026|533245|P6|Overall Study|Did not meet entrance criteria|0
167547|NCT00806026|533246|P5|Overall Study|Did not meet entrance criteria|0
167548|NCT00806026|533247|P4|Overall Study|Did not meet entrance criteria|1
167549|NCT00806026|533248|P3|Overall Study|Did not meet entrance criteria|2
167550|NCT00806026|533249|P2|Overall Study|Did not meet entrance criteria|1
167551|NCT00806026|533250|P1|Overall Study|Did not meet entrance criteria|4
167552|NCT00806026|533245|P6|Overall Study|Death|0
167553|NCT00806026|533246|P5|Overall Study|Death|0
167554|NCT00806026|533247|P4|Overall Study|Death|1
167555|NCT00806026|533248|P3|Overall Study|Death|0
167556|NCT00806026|533249|P2|Overall Study|Death|0
167557|NCT00806026|533250|P1|Overall Study|Death|0
167558|NCT00806195|533362|P4|Overall Study|Protocol Violation|9
167559|NCT00806195|533363|P3|Overall Study|Protocol Violation|26
167560|NCT00806195|533364|P2|Overall Study|Protocol Violation|24
167561|NCT00806195|533365|P1|Overall Study|Protocol Violation|34
167562|NCT00806195|533362|P4|Overall Study|Administrative Reason|26
167563|NCT00806195|533363|P3|Overall Study|Administrative Reason|66
167564|NCT00806195|533364|P2|Overall Study|Administrative Reason|35
167565|NCT00806195|533365|P1|Overall Study|Administrative Reason|113
167566|NCT00806195|533362|P4|Overall Study|Inappropriate Enrollment|0
167567|NCT00806195|533363|P3|Overall Study|Inappropriate Enrollment|0
167568|NCT00806195|533364|P2|Overall Study|Inappropriate Enrollment|1
167569|NCT00806195|533365|P1|Overall Study|Inappropriate Enrollment|0
167570|NCT00806195|533362|P4|Overall Study|Lost to Follow-up|34
167571|NCT00806195|533363|P3|Overall Study|Lost to Follow-up|90
167572|NCT00806195|533364|P2|Overall Study|Lost to Follow-up|66
167573|NCT00806195|533365|P1|Overall Study|Lost to Follow-up|217
167574|NCT00806195|533362|P4|Overall Study|Withdrawal by Subject|35
167575|NCT00806195|533363|P3|Overall Study|Withdrawal by Subject|76
167576|NCT00806195|533364|P2|Overall Study|Withdrawal by Subject|31
167577|NCT00806195|533365|P1|Overall Study|Withdrawal by Subject|119
167578|NCT00806195|533362|P4|Overall Study|Adverse Event|2
167579|NCT00806195|533363|P3|Overall Study|Adverse Event|11
167580|NCT00806195|533364|P2|Overall Study|Adverse Event|5
167581|NCT00806195|533365|P1|Overall Study|Adverse Event|25
167582|NCT00806195|533362|P4|Overall Study|Death|0
167583|NCT00806195|533363|P3|Overall Study|Death|1
167584|NCT00806195|533364|P2|Overall Study|Death|0
167585|NCT00806195|533365|P1|Overall Study|Death|6
167586|NCT00806260|533412|P6|Period 3|Pregnancy|0
167587|NCT00806260|533413|P5|Period 3|Pregnancy|0
167588|NCT00806260|533414|P4|Period 3|Pregnancy|0
167589|NCT00806260|533415|P3|Period 3|Pregnancy|0
167590|NCT00806260|533416|P2|Period 3|Pregnancy|0
167591|NCT00806260|533417|P1|Period 3|Pregnancy|1
167592|NCT00806260|533412|P6|Period 3|Protocol Violation|0
167593|NCT00806260|533413|P5|Period 3|Protocol Violation|0
167594|NCT00806260|533414|P4|Period 3|Protocol Violation|0
167595|NCT00806260|533415|P3|Period 3|Protocol Violation|1
167596|NCT00806260|533416|P2|Period 3|Protocol Violation|1
167597|NCT00806260|533417|P1|Period 3|Protocol Violation|0
167598|NCT00806260|533412|P6|Period 2|sponsor request|0
167599|NCT00806260|533413|P5|Period 2|sponsor request|0
167600|NCT00806260|533414|P4|Period 2|sponsor request|1
167601|NCT00806260|533415|P3|Period 2|sponsor request|1
167602|NCT00806260|533416|P2|Period 2|sponsor request|0
167603|NCT00806260|533417|P1|Period 2|sponsor request|0
167604|NCT00806260|533412|P6|Period 2|Need to take concomitant medication|0
167605|NCT00806260|533413|P5|Period 2|Need to take concomitant medication|0
167606|NCT00806260|533414|P4|Period 2|Need to take concomitant medication|0
167607|NCT00806260|533415|P3|Period 2|Need to take concomitant medication|0
167608|NCT00806260|533416|P2|Period 2|Need to take concomitant medication|0
167609|NCT00806260|533417|P1|Period 2|Need to take concomitant medication|1
167610|NCT00806260|533412|P6|Period 2|Protocol Violation|0
167611|NCT00806260|533413|P5|Period 2|Protocol Violation|0
167612|NCT00806260|533414|P4|Period 2|Protocol Violation|0
167613|NCT00806260|533415|P3|Period 2|Protocol Violation|1
167614|NCT00806260|533416|P2|Period 2|Protocol Violation|0
167615|NCT00806260|533417|P1|Period 2|Protocol Violation|1
167616|NCT00806260|533412|P6|Period 2|Adverse Event|0
167617|NCT00806260|533413|P5|Period 2|Adverse Event|0
167618|NCT00806260|533414|P4|Period 2|Adverse Event|1
167619|NCT00806260|533415|P3|Period 2|Adverse Event|0
167620|NCT00806260|533416|P2|Period 2|Adverse Event|0
167621|NCT00806260|533417|P1|Period 2|Adverse Event|0
167622|NCT00806260|533412|P6|Period 1 (1 Day)|Adverse Event|0
167623|NCT00806260|533413|P5|Period 1 (1 Day)|Adverse Event|3
167624|NCT00806260|533414|P4|Period 1 (1 Day)|Adverse Event|0
167625|NCT00806260|533415|P3|Period 1 (1 Day)|Adverse Event|0
167626|NCT00806260|533416|P2|Period 1 (1 Day)|Adverse Event|0
167627|NCT00806260|533417|P1|Period 1 (1 Day)|Adverse Event|0
167628|NCT00806351|533431|P2|Overall Study|Death|4
167629|NCT00806351|533432|P1|Overall Study|Death|5
167630|NCT00806403|533474|P2|Overall Study|Death|3
167631|NCT00806403|533475|P1|Overall Study|Death|4
167632|NCT00806416|533489|P4|Period 1 - Part II|Withdrawal by Subject|2
167633|NCT00806416|533490|P3|Period 1 - Part II|Withdrawal by Subject|0
167634|NCT00806416|533491|P2|Period 1 - Part II|Withdrawal by Subject|0
167635|NCT00806416|533492|P1|Period 1 - Part II|Withdrawal by Subject|0
167636|NCT00806416|533489|P4|Period 1 - Part I|Withdrawal by Subject|0
167637|NCT00806416|533490|P3|Period 1 - Part I|Withdrawal by Subject|0
167638|NCT00806416|533491|P2|Period 1 - Part I|Withdrawal by Subject|1
167639|NCT00806416|533492|P1|Period 1 - Part I|Withdrawal by Subject|3
167640|NCT00806416|533489|P4|Period 1 - Part I|Lost to Follow-up|0
167641|NCT00806416|533490|P3|Period 1 - Part I|Lost to Follow-up|0
167642|NCT00806416|533491|P2|Period 1 - Part I|Lost to Follow-up|2
167643|NCT00806416|533492|P1|Period 1 - Part I|Lost to Follow-up|0
167644|NCT00806416|533489|P4|Period 1 - Part I|Adverse Event|0
167645|NCT00806416|533490|P3|Period 1 - Part I|Adverse Event|0
167646|NCT00806416|533491|P2|Period 1 - Part I|Adverse Event|1
167647|NCT00806416|533492|P1|Period 1 - Part I|Adverse Event|0
167648|NCT00806442|533503|P2|Overall Study|Withdrawal by Subject|5
167649|NCT00806442|533504|P1|Overall Study|Withdrawal by Subject|1
167650|NCT00806442|533503|P2|Overall Study|Lost to Follow-up|2
167651|NCT00806442|533504|P1|Overall Study|Lost to Follow-up|3
167652|NCT00806494|533524|P1|Overall Study|Withdrawal by Subject|5
167653|NCT00806494|533524|P1|Overall Study|Unspecified|30
167654|NCT00806494|533524|P1|Overall Study|Lost to Follow-up|10
167655|NCT00806494|533524|P1|Overall Study|Lack of Efficacy|6
167656|NCT00806494|533524|P1|Overall Study|Adverse Event|29
167657|NCT00806546|533548|P1|Overall Study|Various|42
167658|NCT00806546|533548|P1|Overall Study|Protocol Violation|49
167659|NCT00806546|533548|P1|Overall Study|Withdrawal by Subject|75
167660|NCT00806546|533548|P1|Overall Study|Adverse Event|74
167661|NCT00806546|533548|P1|Overall Study|Lost to Follow-up|32
167662|NCT00806546|533548|P1|Overall Study|Enrolled, not treated|35
167663|NCT00806585|533557|P5|Overall Study|Completion status unknown|12
167664|NCT00806585|533558|P4|Overall Study|Completion status unknown|4
167665|NCT00806585|533559|P3|Overall Study|Completion status unknown|12
167666|NCT00806585|533560|P2|Overall Study|Completion status unknown|14
167667|NCT00806585|533561|P1|Overall Study|Completion status unknown|15
167668|NCT00806585|533557|P5|Overall Study|Withdrawal by Subject|11
167669|NCT00806585|533558|P4|Overall Study|Withdrawal by Subject|3
167670|NCT00806585|533559|P3|Overall Study|Withdrawal by Subject|9
167671|NCT00806585|533560|P2|Overall Study|Withdrawal by Subject|8
167672|NCT00806585|533561|P1|Overall Study|Withdrawal by Subject|10
167673|NCT00806585|533557|P5|Overall Study|Adverse Event|2
167674|NCT00806585|533558|P4|Overall Study|Adverse Event|4
167675|NCT00806585|533559|P3|Overall Study|Adverse Event|3
167676|NCT00806585|533560|P2|Overall Study|Adverse Event|5
167677|NCT00806585|533561|P1|Overall Study|Adverse Event|1
167678|NCT00806585|533557|P5|Overall Study|Lack of Efficacy|0
167679|NCT00806585|533558|P4|Overall Study|Lack of Efficacy|0
167680|NCT00806585|533559|P3|Overall Study|Lack of Efficacy|0
167681|NCT00806585|533560|P2|Overall Study|Lack of Efficacy|0
167682|NCT00806585|533561|P1|Overall Study|Lack of Efficacy|1
167683|NCT00806585|533557|P5|Overall Study|Lost to Follow-up|5
167684|NCT00806585|533558|P4|Overall Study|Lost to Follow-up|2
167685|NCT00806585|533559|P3|Overall Study|Lost to Follow-up|2
167686|NCT00806585|533560|P2|Overall Study|Lost to Follow-up|1
167687|NCT00806585|533561|P1|Overall Study|Lost to Follow-up|2
167688|NCT00806585|533557|P5|Overall Study|Physician Decision|1
167689|NCT00806585|533558|P4|Overall Study|Physician Decision|0
167690|NCT00806585|533559|P3|Overall Study|Physician Decision|3
167691|NCT00806585|533560|P2|Overall Study|Physician Decision|2
167692|NCT00806585|533561|P1|Overall Study|Physician Decision|0
167693|NCT00806585|533557|P5|Overall Study|Protocol Violation|0
167694|NCT00806585|533558|P4|Overall Study|Protocol Violation|0
167695|NCT00806585|533559|P3|Overall Study|Protocol Violation|2
167696|NCT00806585|533560|P2|Overall Study|Protocol Violation|1
167697|NCT00806585|533561|P1|Overall Study|Protocol Violation|3
167698|NCT00806585|533557|P5|Overall Study|Study terminated by Sponsor|0
167699|NCT00806585|533558|P4|Overall Study|Study terminated by Sponsor|2
167700|NCT00806585|533559|P3|Overall Study|Study terminated by Sponsor|1
167701|NCT00806585|533560|P2|Overall Study|Study terminated by Sponsor|0
167702|NCT00806585|533561|P1|Overall Study|Study terminated by Sponsor|0
167703|NCT00806624|533600|P3|Overall Study|discontinued before start of treatment|1
167704|NCT00806624|533601|P2|Overall Study|discontinued before start of treatment|0
167705|NCT00806624|533602|P1|Overall Study|discontinued before start of treatment|0
167706|NCT00806624|533600|P3|Overall Study|Withdrawal by Subject|3
167707|NCT00806624|533601|P2|Overall Study|Withdrawal by Subject|3
167708|NCT00806624|533602|P1|Overall Study|Withdrawal by Subject|6
167709|NCT00806624|533600|P3|Overall Study|Lost to Follow-up|1
167710|NCT00806624|533601|P2|Overall Study|Lost to Follow-up|0
167711|NCT00806624|533602|P1|Overall Study|Lost to Follow-up|1
167712|NCT00806624|533600|P3|Overall Study|Death|1
167713|NCT00806624|533601|P2|Overall Study|Death|1
167714|NCT00806624|533602|P1|Overall Study|Death|0
167715|NCT00806624|533600|P3|Overall Study|Adverse Event|0
167716|NCT00806624|533601|P2|Overall Study|Adverse Event|8
167717|NCT00806624|533602|P1|Overall Study|Adverse Event|2
167718|NCT00806819|533646|P2|Overall Study|Reasons other than stated above|41
167719|NCT00806819|533647|P1|Overall Study|Reasons other than stated above|25
167720|NCT00806819|533646|P2|Overall Study|Not treated|3
167721|NCT00806819|533647|P1|Overall Study|Not treated|6
167722|NCT00806819|533646|P2|Overall Study|Withdrawal by Subject|29
167723|NCT00806819|533647|P1|Overall Study|Withdrawal by Subject|32
167724|NCT00806819|533646|P2|Overall Study|Lost to Follow-up|0
167725|NCT00806819|533647|P1|Overall Study|Lost to Follow-up|1
167726|NCT00806819|533646|P2|Overall Study|Protocol Violation|4
167727|NCT00806819|533647|P1|Overall Study|Protocol Violation|9
167728|NCT00806819|533646|P2|Overall Study|Other AE|40
167729|NCT00806819|533647|P1|Overall Study|Other AE|38
167730|NCT00806819|533646|P2|Overall Study|Worsening or AE of underlying disease|25
167731|NCT00806819|533647|P1|Overall Study|Worsening or AE of underlying disease|18
167732|NCT00806819|533646|P2|Overall Study|progressive disease (modified RECIST )|216
167733|NCT00806819|533647|P1|Overall Study|progressive disease (modified RECIST )|217
167734|NCT00806988|533681|P2|Overall Study|Lost to Follow-up|19
167735|NCT00806988|533682|P1|Overall Study|Lost to Follow-up|4
167736|NCT00806988|533681|P2|Overall Study|Withdrawal by Subject|8
167737|NCT00806988|533682|P1|Overall Study|Withdrawal by Subject|8
167738|NCT00806988|533681|P2|Overall Study|Death|16
167739|NCT00806988|533682|P1|Overall Study|Death|15
167740|NCT00807001|533695|P5|Overall Study|Non-compliance|0
167741|NCT00807001|533696|P4|Overall Study|Non-compliance|0
167742|NCT00807001|533697|P3|Overall Study|Non-compliance|0
167743|NCT00807001|533698|P2|Overall Study|Non-compliance|1
167744|NCT00807001|533699|P1|Overall Study|Non-compliance|0
167745|NCT00807014|533718|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
167746|NCT00807014|533719|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
167747|NCT00807014|533718|P2|Overall Study|Recovery|0
167748|NCT00807014|533719|P1|Overall Study|Recovery|1
167749|NCT00807014|533718|P2|Overall Study|Lost to Follow-up|7
167750|NCT00807014|533719|P1|Overall Study|Lost to Follow-up|9
167751|NCT00807014|533718|P2|Overall Study|Adverse Event|2
167752|NCT00807014|533719|P1|Overall Study|Adverse Event|0
167753|NCT00807014|533718|P2|Overall Study|Protocol Violation|8
167754|NCT00807014|533719|P1|Overall Study|Protocol Violation|2
167755|NCT00807014|533718|P2|Overall Study|Participant Considered Disease Not Cured|7
167756|NCT00807014|533719|P1|Overall Study|Participant Considered Disease Not Cured|2
167757|NCT00807014|533718|P2|Overall Study|Participant Considered Disease Cured|2
167758|NCT00807014|533719|P1|Overall Study|Participant Considered Disease Cured|13
167759|NCT00807040|533747|P2|Overall Study|Lost to Follow-up|6
167760|NCT00807040|533748|P1|Overall Study|Lost to Follow-up|4
167761|NCT00807040|533747|P2|Overall Study|Withdrawal by Subject|6
167762|NCT00807040|533748|P1|Overall Study|Withdrawal by Subject|8
167763|NCT00807040|533747|P2|Overall Study|Death|29
167764|NCT00807040|533748|P1|Overall Study|Death|24
167765|NCT00807092|533758|P2|Overall Study|CGMS data collection failed|1
167766|NCT00807092|533759|P1|Overall Study|CGMS data collection failed|0
167767|NCT00807092|533758|P2|Overall Study|Withdrawal by Subject|0
167768|NCT00807092|533759|P1|Overall Study|Withdrawal by Subject|1
167769|NCT00807092|533758|P2|Overall Study|Protocol Violation|2
167770|NCT00807092|533759|P1|Overall Study|Protocol Violation|0
167771|NCT00807092|533758|P2|Overall Study|Adverse Event|1
167772|NCT00807092|533759|P1|Overall Study|Adverse Event|0
167773|NCT00807235|533802|P2|Overall Study|Adverse Event|0
167774|NCT00807235|533803|P1|Overall Study|Adverse Event|1
167775|NCT00807248|533837|P4|Overall Study|Other Reason|0
167776|NCT00807248|533838|P3|Overall Study|Other Reason|2
167777|NCT00807248|533839|P2|Overall Study|Other Reason|0
167778|NCT00807248|533840|P1|Overall Study|Other Reason|0
167779|NCT00807248|533837|P4|Overall Study|Lost to Follow-up|0
167780|NCT00807248|533838|P3|Overall Study|Lost to Follow-up|0
167781|NCT00807248|533839|P2|Overall Study|Lost to Follow-up|0
167782|NCT00807248|533840|P1|Overall Study|Lost to Follow-up|1
167783|NCT00807248|533837|P4|Overall Study|Withdrawal of Consent|5
167784|NCT00807248|533838|P3|Overall Study|Withdrawal of Consent|5
167785|NCT00807248|533839|P2|Overall Study|Withdrawal of Consent|5
167786|NCT00807248|533840|P1|Overall Study|Withdrawal of Consent|5
167787|NCT00807248|533837|P4|Overall Study|Protocol Violation|0
167788|NCT00807248|533838|P3|Overall Study|Protocol Violation|1
167789|NCT00807248|533839|P2|Overall Study|Protocol Violation|1
167790|NCT00807248|533840|P1|Overall Study|Protocol Violation|0
167791|NCT00807248|533837|P4|Overall Study|Lack of Efficacy|3
167792|NCT00807248|533838|P3|Overall Study|Lack of Efficacy|8
167793|NCT00807248|533839|P2|Overall Study|Lack of Efficacy|4
167794|NCT00807248|533840|P1|Overall Study|Lack of Efficacy|14
167795|NCT00807248|533837|P4|Overall Study|Adverse Event|6
167796|NCT00807248|533838|P3|Overall Study|Adverse Event|2
167797|NCT00807248|533839|P2|Overall Study|Adverse Event|2
167798|NCT00807248|533840|P1|Overall Study|Adverse Event|1
167799|NCT00807365|533882|P1|Overall Study|Study Terminated|5
167800|NCT00807573|533927|P1|Overall Study|Adverse Event|1
167801|NCT00807573|533927|P1|Overall Study|Withdrawal by Subject|1
167802|NCT00814164|533952|P1|Overall Study|Death|5
167803|NCT00814164|533952|P1|Overall Study|not stated|7
167804|NCT00814164|533952|P1|Overall Study|Progression|7
167805|NCT00814307|534001|P4|Overall Study|Death|0
167806|NCT00814307|534002|P3|Overall Study|Death|0
167807|NCT00814307|534003|P2|Overall Study|Death|1
167808|NCT00814307|534004|P1|Overall Study|Death|0
167809|NCT00814307|534001|P4|Overall Study|Withdrawal by Subject|2
167810|NCT00814307|534002|P3|Overall Study|Withdrawal by Subject|0
167811|NCT00814307|534003|P2|Overall Study|Withdrawal by Subject|6
167812|NCT00814307|534004|P1|Overall Study|Withdrawal by Subject|4
167813|NCT00814307|534001|P4|Overall Study|Protocol Violation|1
167814|NCT00814307|534002|P3|Overall Study|Protocol Violation|1
167815|NCT00814307|534003|P2|Overall Study|Protocol Violation|8
167816|NCT00814307|534004|P1|Overall Study|Protocol Violation|2
167817|NCT00814307|534001|P4|Overall Study|Unspecified|1
167818|NCT00814307|534002|P3|Overall Study|Unspecified|0
167819|NCT00814307|534003|P2|Overall Study|Unspecified|2
167820|NCT00814307|534004|P1|Overall Study|Unspecified|1
167821|NCT00814307|534001|P4|Overall Study|Lack of Efficacy|4
167822|NCT00814307|534002|P3|Overall Study|Lack of Efficacy|3
167823|NCT00814307|534003|P2|Overall Study|Lack of Efficacy|1
167824|NCT00814307|534004|P1|Overall Study|Lack of Efficacy|1
167825|NCT00814307|534001|P4|Overall Study|Adverse Event|2
167826|NCT00814307|534002|P3|Overall Study|Adverse Event|3
167827|NCT00814307|534003|P2|Overall Study|Adverse Event|9
167828|NCT00814307|534004|P1|Overall Study|Adverse Event|3
167829|NCT00814307|534001|P4|Overall Study|Randomized but not treated|0
167830|NCT00814307|534002|P3|Overall Study|Randomized but not treated|0
167831|NCT00814307|534003|P2|Overall Study|Randomized but not treated|0
167832|NCT00814307|534004|P1|Overall Study|Randomized but not treated|1
167833|NCT00814320|534168|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
167834|NCT00814320|534169|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
168006|NCT00810693|535016|P3|Treatment Period|Lost to Follow-up|0
167835|NCT00814320|534168|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
167836|NCT00814320|534169|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
167837|NCT00814320|534168|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
167838|NCT00814320|534169|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
167839|NCT00814320|534168|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
167840|NCT00814320|534169|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
167841|NCT00814320|534168|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
167842|NCT00814320|534169|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
167843|NCT00814320|534168|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
167844|NCT00814320|534169|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
167845|NCT00814320|534168|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
167846|NCT00814320|534169|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
167847|NCT00814320|534168|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
167848|NCT00814320|534169|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
167849|NCT00814320|534168|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
167850|NCT00814320|534169|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
167851|NCT00814320|534168|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
167852|NCT00814320|534169|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
167853|NCT00814333|534299|P2|Enrollment|Lost to Follow-up|0
167854|NCT00814333|534300|P1|Enrollment|Lost to Follow-up|1
167855|NCT00814346|534308|P2|Open Phase (17 Months)|Not otherwise specified|0
167856|NCT00814346|534309|P1|Open Phase (17 Months)|Not otherwise specified|1
167857|NCT00814346|534308|P2|Open Phase (17 Months)|Lost to Follow-up|0
167858|NCT00814346|534309|P1|Open Phase (17 Months)|Lost to Follow-up|2
167859|NCT00814346|534308|P2|Open Phase (17 Months)|Consent|0
167860|NCT00814346|534309|P1|Open Phase (17 Months)|Consent|2
167861|NCT00814346|534308|P2|Open Phase (17 Months)|Adverse Event|0
167862|NCT00814346|534309|P1|Open Phase (17 Months)|Adverse Event|5
167863|NCT00814346|534308|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
167864|NCT00814346|534309|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
167865|NCT00814346|534308|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
167866|NCT00814346|534309|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
167867|NCT00814463|534373|P1|Overall Study|Lost to Follow-up|1
167868|NCT00815191|534388|P2|Overall Study|Protocol Violation|1
167869|NCT00815191|534389|P1|Overall Study|Protocol Violation|1
167870|NCT00815295|534398|P3|Overall Study|Cetuximab hypersensitivity reaction|3
167871|NCT00815295|534399|P2|Overall Study|Cetuximab hypersensitivity reaction|1
167872|NCT00815295|534400|P1|Overall Study|Cetuximab hypersensitivity reaction|0
167873|NCT00815308|534410|P1|Overall Study|Protocol Violation|6
167874|NCT00815308|534410|P1|Overall Study|Withdrawal by Subject|0
167875|NCT00815308|534410|P1|Overall Study|Adverse Event|4
167876|NCT00815516|534454|P2|Overall Study|Physician Decision|0
167877|NCT00815516|534455|P1|Overall Study|Physician Decision|1
167878|NCT00815516|534454|P2|Overall Study|Death|1
167879|NCT00815516|534455|P1|Overall Study|Death|3
167880|NCT00815659|534484|P1|Overall Study|Protocol Violation|1
167881|NCT00815659|534484|P1|Overall Study|Lost to Follow-up|4
167882|NCT00815659|534484|P1|Overall Study|Withdrawal by Subject|9
167883|NCT00815659|534484|P1|Overall Study|Adverse Event|9
167884|NCT00815919|534562|P1|Overall Study|Lack of Efficacy|2
167885|NCT00815919|534562|P1|Overall Study|AML Relapse|1
167886|NCT00815919|534562|P1|Overall Study|Unrelated Fungal Infection|1
167887|NCT00816023|534574|P4|Overall Study|Randomized Not Treated|11
167888|NCT00816023|534575|P3|Overall Study|Randomized Not Treated|6
167889|NCT00816023|534576|P2|Overall Study|Randomized Not Treated|4
167890|NCT00816023|534577|P1|Overall Study|Randomized Not Treated|6
167891|NCT00816023|534574|P4|Overall Study|assessments complete prior to window|1
167892|NCT00816023|534575|P3|Overall Study|assessments complete prior to window|2
167893|NCT00816023|534576|P2|Overall Study|assessments complete prior to window|1
167894|NCT00816023|534577|P1|Overall Study|assessments complete prior to window|1
167895|NCT00816023|534574|P4|Overall Study|Physician Decision|0
167896|NCT00816023|534575|P3|Overall Study|Physician Decision|1
167897|NCT00816023|534576|P2|Overall Study|Physician Decision|0
167898|NCT00816023|534577|P1|Overall Study|Physician Decision|0
167899|NCT00816023|534574|P4|Overall Study|Withdrawal by Subject|0
167900|NCT00816023|534575|P3|Overall Study|Withdrawal by Subject|0
167901|NCT00816023|534576|P2|Overall Study|Withdrawal by Subject|0
167902|NCT00816023|534577|P1|Overall Study|Withdrawal by Subject|1
167903|NCT00816023|534574|P4|Overall Study|Lost to Follow-up|0
167904|NCT00816023|534575|P3|Overall Study|Lost to Follow-up|0
167905|NCT00816023|534576|P2|Overall Study|Lost to Follow-up|1
167906|NCT00816023|534577|P1|Overall Study|Lost to Follow-up|1
167907|NCT00816036|534593|P2|Overall Study|Withdrawal by Subject|23
167908|NCT00816036|534594|P1|Overall Study|Withdrawal by Subject|54
167909|NCT00816036|534593|P2|Overall Study|Lost to Follow-up|57
167910|NCT00816036|534594|P1|Overall Study|Lost to Follow-up|75
167911|NCT00816036|534593|P2|Overall Study|Death|28
167912|NCT00816036|534594|P1|Overall Study|Death|47
167913|NCT00816166|534625|P2|Overall Study|Death|2
167914|NCT00816166|534626|P1|Overall Study|Death|4
167915|NCT00816166|534625|P2|Overall Study|Lost to Follow-up|10
167916|NCT00816166|534626|P1|Overall Study|Lost to Follow-up|6
167917|NCT00816400|534645|P9|Overall Study|In hospice care at the end of the study|0
167918|NCT00816400|534646|P8|Overall Study|In hospice care at the end of the study|0
167919|NCT00816400|534647|P7|Overall Study|In hospice care at the end of the study|0
167920|NCT00816400|534648|P6|Overall Study|In hospice care at the end of the study|0
167921|NCT00816400|534649|P5|Overall Study|In hospice care at the end of the study|0
167922|NCT00816400|534650|P4|Overall Study|In hospice care at the end of the study|0
167923|NCT00816400|534651|P3|Overall Study|In hospice care at the end of the study|2
167924|NCT00816400|534652|P2|Overall Study|In hospice care at the end of the study|0
167925|NCT00816400|534653|P1|Overall Study|In hospice care at the end of the study|0
167926|NCT00816400|534645|P9|Overall Study|Death|6
167927|NCT00816400|534646|P8|Overall Study|Death|5
167928|NCT00816400|534647|P7|Overall Study|Death|2
167929|NCT00816400|534648|P6|Overall Study|Death|3
167930|NCT00816400|534649|P5|Overall Study|Death|2
167931|NCT00816400|534650|P4|Overall Study|Death|3
167932|NCT00816400|534651|P3|Overall Study|Death|3
167933|NCT00816400|534652|P2|Overall Study|Death|3
167934|NCT00816400|534653|P1|Overall Study|Death|2
167935|NCT00816556|534840|P3|Overall Study|Lost to Follow-up|1
167936|NCT00816556|534841|P2|Overall Study|Lost to Follow-up|0
167937|NCT00816556|534842|P1|Overall Study|Lost to Follow-up|0
167938|NCT00816556|534840|P3|Overall Study|Withdrawal by Subject|1
167939|NCT00816556|534841|P2|Overall Study|Withdrawal by Subject|1
167940|NCT00816556|534842|P1|Overall Study|Withdrawal by Subject|1
167941|NCT00816556|534840|P3|Overall Study|Adverse Event|1
167942|NCT00816556|534841|P2|Overall Study|Adverse Event|1
167943|NCT00816556|534842|P1|Overall Study|Adverse Event|1
167944|NCT00816595|534858|P2|Overall Study|Withdrawal by Subject|0
167945|NCT00816595|534859|P1|Overall Study|Withdrawal by Subject|2
167946|NCT00817206|534930|P2|Overall Study|Physician Decision|0
167947|NCT00817206|534931|P1|Overall Study|Physician Decision|2
167948|NCT00817206|534930|P2|Overall Study|Withdrawal by Subject|3
167949|NCT00817206|534931|P1|Overall Study|Withdrawal by Subject|7
167950|NCT00817206|534930|P2|Overall Study|Death|0
167951|NCT00817206|534931|P1|Overall Study|Death|2
167952|NCT00817206|534930|P2|Overall Study|Lost to Follow-up|1
167953|NCT00817206|534931|P1|Overall Study|Lost to Follow-up|0
167954|NCT00817206|534930|P2|Overall Study|Protocol Violation|2
167955|NCT00817206|534931|P1|Overall Study|Protocol Violation|0
167956|NCT00817206|534930|P2|Overall Study|Adverse Event|3
167957|NCT00817206|534931|P1|Overall Study|Adverse Event|10
167958|NCT00817336|534952|P2|Overall Study|Withdrawal by Subject|1
167959|NCT00817336|534953|P1|Overall Study|Withdrawal by Subject|1
167960|NCT00817479|534966|P2|Overall Study|Physician Decision|1
167961|NCT00817479|534967|P1|Overall Study|Physician Decision|1
167962|NCT00817531|534975|P1|Overall Study|Lack of Efficacy|1
167963|NCT00817531|534975|P1|Overall Study|Adverse Event|1
167964|NCT00810511|534981|P2|Overall Study|deposits on contact lens|1
167965|NCT00810511|534982|P1|Overall Study|deposits on contact lens|0
167966|NCT00810511|534981|P2|Overall Study|Lost to Follow-up|0
167967|NCT00810511|534982|P1|Overall Study|Lost to Follow-up|1
167968|NCT00810511|534981|P2|Overall Study|death in the family|1
167969|NCT00810511|534982|P1|Overall Study|death in the family|0
167970|NCT00810511|534981|P2|Overall Study|Lack of Efficacy|1
167971|NCT00810511|534982|P1|Overall Study|Lack of Efficacy|9
167972|NCT00810511|534981|P2|Overall Study|Protocol Violation|1
167973|NCT00810511|534982|P1|Overall Study|Protocol Violation|0
167974|NCT00810602|534992|P2|Overall Study|Withdrawal by Subject|3
167975|NCT00810602|534993|P1|Overall Study|Withdrawal by Subject|8
167976|NCT00810641|535003|P3|Overall Study|Withdrawal by Subject|2
167977|NCT00810641|535004|P2|Overall Study|Withdrawal by Subject|1
167978|NCT00810641|535005|P1|Overall Study|Withdrawal by Subject|0
167979|NCT00810693|535016|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
167980|NCT00810693|535017|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
167981|NCT00810693|535018|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
167982|NCT00810693|535016|P3|Follow-up Period (FUP)|Protocol Violation|0
167983|NCT00810693|535017|P2|Follow-up Period (FUP)|Protocol Violation|1
167984|NCT00810693|535018|P1|Follow-up Period (FUP)|Protocol Violation|0
167985|NCT00810693|535016|P3|Follow-up Period (FUP)|Lost to Follow-up|2
167986|NCT00810693|535017|P2|Follow-up Period (FUP)|Lost to Follow-up|0
167987|NCT00810693|535018|P1|Follow-up Period (FUP)|Lost to Follow-up|1
167988|NCT00810693|535016|P3|Follow-up Period (FUP)|Death|1
167989|NCT00810693|535017|P2|Follow-up Period (FUP)|Death|0
167990|NCT00810693|535018|P1|Follow-up Period (FUP)|Death|2
167991|NCT00810693|535016|P3|Follow-up Period (FUP)|Adverse Event|1
167992|NCT00810693|535017|P2|Follow-up Period (FUP)|Adverse Event|1
167993|NCT00810693|535018|P1|Follow-up Period (FUP)|Adverse Event|3
167994|NCT00810693|535016|P3|Treatment Period|Not treated|1
167995|NCT00810693|535017|P2|Treatment Period|Not treated|1
167996|NCT00810693|535018|P1|Treatment Period|Not treated|0
167997|NCT00810693|535016|P3|Treatment Period|Withdrawal by Subject|3
167998|NCT00810693|535017|P2|Treatment Period|Withdrawal by Subject|2
167999|NCT00810693|535018|P1|Treatment Period|Withdrawal by Subject|6
168000|NCT00810693|535016|P3|Treatment Period|Protocol Violation|2
168001|NCT00810693|535017|P2|Treatment Period|Protocol Violation|2
168002|NCT00810693|535018|P1|Treatment Period|Protocol Violation|1
168003|NCT00810693|535016|P3|Treatment Period|Non-compliance|0
168004|NCT00810693|535017|P2|Treatment Period|Non-compliance|0
168005|NCT00810693|535018|P1|Treatment Period|Non-compliance|1
168007|NCT00810693|535017|P2|Treatment Period|Lost to Follow-up|0
168008|NCT00810693|535018|P1|Treatment Period|Lost to Follow-up|1
168009|NCT00810693|535016|P3|Treatment Period|Lack of Efficacy|1
168010|NCT00810693|535017|P2|Treatment Period|Lack of Efficacy|0
168011|NCT00810693|535018|P1|Treatment Period|Lack of Efficacy|0
168012|NCT00810693|535016|P3|Treatment Period|Death|2
168013|NCT00810693|535017|P2|Treatment Period|Death|1
168014|NCT00810693|535018|P1|Treatment Period|Death|0
168015|NCT00810693|535016|P3|Treatment Period|Adverse Event|7
168016|NCT00810693|535017|P2|Treatment Period|Adverse Event|1
168017|NCT00810693|535018|P1|Treatment Period|Adverse Event|8
168018|NCT00810901|535080|P2|Overall Study|Lost to Follow-up|58
168019|NCT00810901|535081|P1|Overall Study|Lost to Follow-up|88
168020|NCT00811018|535089|P1|Overall Study|Unspecified|26
168021|NCT00811018|535089|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
168022|NCT00811018|535089|P1|Overall Study|Withdrawal by Subject|70
168023|NCT00811018|535089|P1|Overall Study|Sponsor Decision|450
168024|NCT00811018|535089|P1|Overall Study|Pregnancy|6
168025|NCT00811018|535089|P1|Overall Study|Lost to Follow-up|19
168026|NCT00811018|535089|P1|Overall Study|Investigator Decision|57
168027|NCT00811018|535089|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
168028|NCT00811018|535089|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
168029|NCT00811018|535089|P1|Overall Study|Death|147
168030|NCT00811018|535089|P1|Overall Study|Adverse Event|79
168031|NCT00811018|535089|P1|Overall Study|Additional Chronic Treatment|31
168032|NCT00811057|535108|P3|Overall Study|Protocol Violation|10
168033|NCT00811057|535109|P2|Overall Study|Protocol Violation|10
168034|NCT00811057|535110|P1|Overall Study|Protocol Violation|5
168035|NCT00811070|535127|P6|Overall Study|Physician Decision|1
168036|NCT00811070|535128|P5|Overall Study|Physician Decision|0
168037|NCT00811070|535129|P4|Overall Study|Physician Decision|0
168038|NCT00811070|535130|P3|Overall Study|Physician Decision|0
168039|NCT00811070|535131|P2|Overall Study|Physician Decision|0
168040|NCT00811070|535132|P1|Overall Study|Physician Decision|0
168041|NCT00811070|535127|P6|Overall Study|Withdrawal by Subject|0
168042|NCT00811070|535128|P5|Overall Study|Withdrawal by Subject|0
168043|NCT00811070|535129|P4|Overall Study|Withdrawal by Subject|0
168044|NCT00811070|535130|P3|Overall Study|Withdrawal by Subject|0
168045|NCT00811070|535131|P2|Overall Study|Withdrawal by Subject|1
168046|NCT00811070|535132|P1|Overall Study|Withdrawal by Subject|0
168047|NCT00811070|535127|P6|Overall Study|Unspecified|0
168048|NCT00811070|535128|P5|Overall Study|Unspecified|0
168049|NCT00811070|535129|P4|Overall Study|Unspecified|0
168050|NCT00811070|535130|P3|Overall Study|Unspecified|0
168051|NCT00811070|535131|P2|Overall Study|Unspecified|0
168052|NCT00811070|535132|P1|Overall Study|Unspecified|1
168053|NCT00811070|535127|P6|Overall Study|Death|0
168054|NCT00811070|535128|P5|Overall Study|Death|5
168055|NCT00811070|535129|P4|Overall Study|Death|2
168056|NCT00811070|535130|P3|Overall Study|Death|0
168057|NCT00811070|535131|P2|Overall Study|Death|0
168058|NCT00811070|535132|P1|Overall Study|Death|0
168059|NCT00811135|535189|P1|Overall Study|Ongoing|59
168060|NCT00811135|535189|P1|Overall Study|Administrative/Other Unspecified|11
168061|NCT00811135|535189|P1|Overall Study|Withdrawal by Subject|3
168062|NCT00811135|535189|P1|Overall Study|Refused Treatment|1
168063|NCT00811135|535189|P1|Overall Study|Violation of Selection Criteria|1
168064|NCT00811135|535189|P1|Overall Study|Protocol Violation|2
168065|NCT00811135|535189|P1|Overall Study|Death|3
168066|NCT00811135|535189|P1|Overall Study|Adverse Event/Intercurrent Illness|8
168067|NCT00811174|535201|P1|Overall Study|Sponsors Decision|1
168068|NCT00811174|535201|P1|Overall Study|Protocol Violation|2
168069|NCT00811252|535215|P3|Overall Study|Administrative or Other Reasons|2
168070|NCT00811252|535216|P2|Overall Study|Administrative or Other Reasons|3
168071|NCT00811252|535217|P1|Overall Study|Administrative or Other Reasons|0
168072|NCT00811252|535215|P3|Overall Study|Lost to Follow-up|2
168073|NCT00811252|535216|P2|Overall Study|Lost to Follow-up|0
168074|NCT00811252|535217|P1|Overall Study|Lost to Follow-up|0
168075|NCT00811252|535215|P3|Overall Study|Withdrawal of Consent|2
168076|NCT00811252|535216|P2|Overall Study|Withdrawal of Consent|2
168077|NCT00811252|535217|P1|Overall Study|Withdrawal of Consent|1
168078|NCT00811252|535215|P3|Overall Study|Protocol Violation|2
168079|NCT00811252|535216|P2|Overall Study|Protocol Violation|3
168080|NCT00811252|535217|P1|Overall Study|Protocol Violation|3
168081|NCT00811252|535215|P3|Overall Study|Lack of Efficacy|0
168082|NCT00811252|535216|P2|Overall Study|Lack of Efficacy|2
168083|NCT00811252|535217|P1|Overall Study|Lack of Efficacy|7
168084|NCT00811252|535215|P3|Overall Study|Adverse Event|15
168085|NCT00811252|535216|P2|Overall Study|Adverse Event|10
168086|NCT00811252|535217|P1|Overall Study|Adverse Event|6
168087|NCT00811395|535282|P6|Extension Treatment|Other than above|0
168088|NCT00811395|535283|P5|Extension Treatment|Other than above|0
168089|NCT00811395|535284|P4|Extension Treatment|Other than above|0
168090|NCT00811395|535285|P3|Extension Treatment|Other than above|1
168091|NCT00811395|535286|P2|Extension Treatment|Other than above|0
168092|NCT00811395|535287|P1|Extension Treatment|Other than above|0
168093|NCT00811395|535282|P6|Extension Treatment|Participant did not wish to continue|1
168094|NCT00811395|535283|P5|Extension Treatment|Participant did not wish to continue|0
168095|NCT00811395|535284|P4|Extension Treatment|Participant did not wish to continue|1
168096|NCT00811395|535285|P3|Extension Treatment|Participant did not wish to continue|0
168097|NCT00811395|535286|P2|Extension Treatment|Participant did not wish to continue|3
168098|NCT00811395|535287|P1|Extension Treatment|Participant did not wish to continue|0
168099|NCT00811395|535282|P6|Extension Treatment|Progressive disease|0
168100|NCT00811395|535283|P5|Extension Treatment|Progressive disease|0
168101|NCT00811395|535284|P4|Extension Treatment|Progressive disease|0
168102|NCT00811395|535285|P3|Extension Treatment|Progressive disease|0
168103|NCT00811395|535286|P2|Extension Treatment|Progressive disease|1
168104|NCT00811395|535287|P1|Extension Treatment|Progressive disease|1
168105|NCT00811395|535282|P6|Extension Treatment|Adverse Event|1
168106|NCT00811395|535283|P5|Extension Treatment|Adverse Event|0
168107|NCT00811395|535284|P4|Extension Treatment|Adverse Event|2
168108|NCT00811395|535285|P3|Extension Treatment|Adverse Event|2
168109|NCT00811395|535286|P2|Extension Treatment|Adverse Event|2
168110|NCT00811395|535287|P1|Extension Treatment|Adverse Event|1
168111|NCT00811473|535360|P2|Overall Study|Safety Reasons|0
168112|NCT00811473|535361|P1|Overall Study|Safety Reasons|1
168113|NCT00811473|535360|P2|Overall Study|Incorrect Enrollment|0
168114|NCT00811473|535361|P1|Overall Study|Incorrect Enrollment|1
168115|NCT00811473|535360|P2|Overall Study|Other 2|1
168116|NCT00811473|535361|P1|Overall Study|Other 2|4
168117|NCT00811473|535360|P2|Overall Study|Condition under investigation worsened|3
168118|NCT00811473|535361|P1|Overall Study|Condition under investigation worsened|1
168119|NCT00811473|535360|P2|Overall Study|Lack of therapeutic response|1
168120|NCT00811473|535361|P1|Overall Study|Lack of therapeutic response|4
168121|NCT00811473|535360|P2|Overall Study|Severe non-compliance to protocol|4
168122|NCT00811473|535361|P1|Overall Study|Severe non-compliance to protocol|2
168123|NCT00811473|535360|P2|Overall Study|Withdrawal by Subject|4
168124|NCT00811473|535361|P1|Overall Study|Withdrawal by Subject|2
168125|NCT00811473|535360|P2|Overall Study|Lost to Follow-up|1
168126|NCT00811473|535361|P1|Overall Study|Lost to Follow-up|5
168127|NCT00811473|535360|P2|Overall Study|Adverse Event|12
168128|NCT00811473|535361|P1|Overall Study|Adverse Event|3
168129|NCT00811577|535388|P2|Overall Study|Withdrawal by Subject|0
168130|NCT00811577|535389|P1|Overall Study|Withdrawal by Subject|3
168131|NCT00811577|535388|P2|Overall Study|Lost to Follow-up|1
168132|NCT00811577|535389|P1|Overall Study|Lost to Follow-up|7
168133|NCT00811642|535442|P1|Overall Study|Cumulative use of antifungal agent|2
168134|NCT00811642|535442|P1|Overall Study|Withdrawal by Subject|7
168135|NCT00811642|535442|P1|Overall Study|Death|2
168136|NCT00811642|535442|P1|Overall Study|Protocol Violation|1
168137|NCT00811642|535442|P1|Overall Study|Adverse Event|3
168138|NCT00817778|535458|P2|Overall Study|Poor venous access|0
168139|NCT00817778|535459|P1|Overall Study|Poor venous access|1
168140|NCT00817778|535458|P2|Overall Study|Study-specific discontinuation criteria|1
168141|NCT00817778|535459|P1|Overall Study|Study-specific discontinuation criteria|0
168142|NCT00817778|535458|P2|Overall Study|Protocol Violation|1
168143|NCT00817778|535459|P1|Overall Study|Protocol Violation|0
168144|NCT00817778|535458|P2|Overall Study|Withdrawal by Subject|1
168145|NCT00817778|535459|P1|Overall Study|Withdrawal by Subject|1
168146|NCT00817778|535458|P2|Overall Study|Adverse Event|0
168147|NCT00817778|535459|P1|Overall Study|Adverse Event|1
168148|NCT00818519|535501|P2|Overall Study|participant will leave for long tme|0
168149|NCT00818519|535502|P1|Overall Study|participant will leave for long tme|1
168150|NCT00818519|535501|P2|Overall Study|participant recovered completely|0
168151|NCT00818519|535502|P1|Overall Study|participant recovered completely|1
168152|NCT00818519|535501|P2|Overall Study|Withdrawal by Subject|9
168153|NCT00818519|535502|P1|Overall Study|Withdrawal by Subject|4
168154|NCT00818519|535501|P2|Overall Study|Pregnancy|1
168155|NCT00818519|535502|P1|Overall Study|Pregnancy|0
168156|NCT00818519|535501|P2|Overall Study|Protocol Violation|1
168157|NCT00818519|535502|P1|Overall Study|Protocol Violation|2
168158|NCT00818519|535501|P2|Overall Study|Lost to Follow-up|6
168159|NCT00818519|535502|P1|Overall Study|Lost to Follow-up|4
168160|NCT00818519|535501|P2|Overall Study|Adverse Event|2
168161|NCT00818519|535502|P1|Overall Study|Adverse Event|2
168162|NCT00818623|535540|P8|Overall Study|Disease progression|0
168163|NCT00818623|535541|P7|Overall Study|Disease progression|1
168164|NCT00818623|535542|P6|Overall Study|Disease progression|0
168165|NCT00818623|535543|P5|Overall Study|Disease progression|0
168166|NCT00818623|535544|P4|Overall Study|Disease progression|0
168167|NCT00818623|535545|P3|Overall Study|Disease progression|0
168168|NCT00818623|535546|P2|Overall Study|Disease progression|0
168169|NCT00818623|535547|P1|Overall Study|Disease progression|0
168170|NCT00818623|535540|P8|Overall Study|Lack of trial drug at site|0
168171|NCT00818623|535541|P7|Overall Study|Lack of trial drug at site|1
168172|NCT00818623|535542|P6|Overall Study|Lack of trial drug at site|0
168173|NCT00818623|535543|P5|Overall Study|Lack of trial drug at site|2
168174|NCT00818623|535544|P4|Overall Study|Lack of trial drug at site|0
168175|NCT00818623|535545|P3|Overall Study|Lack of trial drug at site|0
168176|NCT00818623|535546|P2|Overall Study|Lack of trial drug at site|0
168177|NCT00818623|535547|P1|Overall Study|Lack of trial drug at site|0
168178|NCT00818623|535540|P8|Overall Study|Need of additional treatment|0
168179|NCT00818623|535541|P7|Overall Study|Need of additional treatment|0
168180|NCT00818623|535542|P6|Overall Study|Need of additional treatment|0
168181|NCT00818623|535543|P5|Overall Study|Need of additional treatment|1
168182|NCT00818623|535544|P4|Overall Study|Need of additional treatment|0
168183|NCT00818623|535545|P3|Overall Study|Need of additional treatment|0
168184|NCT00818623|535546|P2|Overall Study|Need of additional treatment|0
168185|NCT00818623|535547|P1|Overall Study|Need of additional treatment|0
168186|NCT00818623|535540|P8|Overall Study|Protocol Violation|0
168187|NCT00818623|535541|P7|Overall Study|Protocol Violation|1
168188|NCT00818623|535542|P6|Overall Study|Protocol Violation|0
168189|NCT00818623|535543|P5|Overall Study|Protocol Violation|1
168190|NCT00818623|535544|P4|Overall Study|Protocol Violation|0
168191|NCT00818623|535545|P3|Overall Study|Protocol Violation|0
168192|NCT00818623|535546|P2|Overall Study|Protocol Violation|0
168193|NCT00818623|535547|P1|Overall Study|Protocol Violation|1
168194|NCT00818623|535540|P8|Overall Study|Withdrawal by Subject|1
168195|NCT00818623|535541|P7|Overall Study|Withdrawal by Subject|1
168196|NCT00818623|535542|P6|Overall Study|Withdrawal by Subject|1
168197|NCT00818623|535543|P5|Overall Study|Withdrawal by Subject|0
168198|NCT00818623|535544|P4|Overall Study|Withdrawal by Subject|0
168199|NCT00818623|535545|P3|Overall Study|Withdrawal by Subject|1
168200|NCT00818623|535546|P2|Overall Study|Withdrawal by Subject|1
168201|NCT00818623|535547|P1|Overall Study|Withdrawal by Subject|0
168202|NCT00818623|535540|P8|Overall Study|Bad prostate specific antigen response|0
168203|NCT00818623|535541|P7|Overall Study|Bad prostate specific antigen response|0
168204|NCT00818623|535542|P6|Overall Study|Bad prostate specific antigen response|1
168205|NCT00818623|535543|P5|Overall Study|Bad prostate specific antigen response|0
168206|NCT00818623|535544|P4|Overall Study|Bad prostate specific antigen response|5
168207|NCT00818623|535545|P3|Overall Study|Bad prostate specific antigen response|2
168208|NCT00818623|535546|P2|Overall Study|Bad prostate specific antigen response|3
168209|NCT00818623|535547|P1|Overall Study|Bad prostate specific antigen response|0
168210|NCT00818623|535540|P8|Overall Study|Adverse Event|0
168211|NCT00818623|535541|P7|Overall Study|Adverse Event|0
168212|NCT00818623|535542|P6|Overall Study|Adverse Event|1
168213|NCT00818623|535543|P5|Overall Study|Adverse Event|0
168214|NCT00818623|535544|P4|Overall Study|Adverse Event|0
168215|NCT00818623|535545|P3|Overall Study|Adverse Event|1
168216|NCT00818623|535546|P2|Overall Study|Adverse Event|0
168217|NCT00818623|535547|P1|Overall Study|Adverse Event|1
168218|NCT00818649|535621|P1|Overall Study|Adverse Event|1
168219|NCT00818649|535621|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
168220|NCT00818649|535621|P1|Overall Study|Declining performance status|2
168221|NCT00818662|535631|P4|Overall Study|Admitted to long term nursing care|0
168222|NCT00818662|535632|P3|Overall Study|Admitted to long term nursing care|0
168223|NCT00818662|535633|P2|Overall Study|Admitted to long term nursing care|1
168224|NCT00818662|535634|P1|Overall Study|Admitted to long term nursing care|0
168225|NCT00818662|535631|P4|Overall Study|Study partner decision|1
168226|NCT00818662|535632|P3|Overall Study|Study partner decision|0
168227|NCT00818662|535633|P2|Overall Study|Study partner decision|0
168228|NCT00818662|535634|P1|Overall Study|Study partner decision|0
168229|NCT00818662|535631|P4|Overall Study|Change in living situation|1
168230|NCT00818662|535632|P3|Overall Study|Change in living situation|0
168231|NCT00818662|535633|P2|Overall Study|Change in living situation|0
168232|NCT00818662|535634|P1|Overall Study|Change in living situation|0
168233|NCT00818662|535631|P4|Overall Study|Declined move to another study site|0
168234|NCT00818662|535632|P3|Overall Study|Declined move to another study site|0
168235|NCT00818662|535633|P2|Overall Study|Declined move to another study site|0
168236|NCT00818662|535634|P1|Overall Study|Declined move to another study site|1
168237|NCT00818662|535631|P4|Overall Study|Moving out of state|1
168238|NCT00818662|535632|P3|Overall Study|Moving out of state|0
168239|NCT00818662|535633|P2|Overall Study|Moving out of state|0
168240|NCT00818662|535634|P1|Overall Study|Moving out of state|0
168241|NCT00818662|535631|P4|Overall Study|Caregiver to pursue other treatment|0
168242|NCT00818662|535632|P3|Overall Study|Caregiver to pursue other treatment|0
168243|NCT00818662|535633|P2|Overall Study|Caregiver to pursue other treatment|1
168244|NCT00818662|535634|P1|Overall Study|Caregiver to pursue other treatment|0
168245|NCT00818662|535631|P4|Overall Study|Participant's health declined|1
168246|NCT00818662|535632|P3|Overall Study|Participant's health declined|0
168247|NCT00818662|535633|P2|Overall Study|Participant's health declined|0
168248|NCT00818662|535634|P1|Overall Study|Participant's health declined|0
168249|NCT00818662|535631|P4|Overall Study|Study Partner Unwilling or Unable|1
168250|NCT00818662|535632|P3|Overall Study|Study Partner Unwilling or Unable|1
168251|NCT00818662|535633|P2|Overall Study|Study Partner Unwilling or Unable|2
168252|NCT00818662|535634|P1|Overall Study|Study Partner Unwilling or Unable|3
168253|NCT00818662|535631|P4|Overall Study|Safety Risk|1
168254|NCT00818662|535632|P3|Overall Study|Safety Risk|0
168255|NCT00818662|535633|P2|Overall Study|Safety Risk|1
168256|NCT00818662|535634|P1|Overall Study|Safety Risk|1
168257|NCT00818662|535631|P4|Overall Study|Requires a Prohibited Medication|0
168258|NCT00818662|535632|P3|Overall Study|Requires a Prohibited Medication|0
168259|NCT00818662|535633|P2|Overall Study|Requires a Prohibited Medication|0
168260|NCT00818662|535634|P1|Overall Study|Requires a Prohibited Medication|1
168261|NCT00818662|535631|P4|Overall Study|Protocol Violation|0
168262|NCT00818662|535632|P3|Overall Study|Protocol Violation|0
168263|NCT00818662|535633|P2|Overall Study|Protocol Violation|1
168264|NCT00818662|535634|P1|Overall Study|Protocol Violation|1
168265|NCT00818662|535631|P4|Overall Study|Unwilling or Unable to Participate|4
168266|NCT00818662|535632|P3|Overall Study|Unwilling or Unable to Participate|2
168267|NCT00818662|535633|P2|Overall Study|Unwilling or Unable to Participate|6
168268|NCT00818662|535634|P1|Overall Study|Unwilling or Unable to Participate|4
168269|NCT00818662|535631|P4|Overall Study|Lost to Follow-up|1
168270|NCT00818662|535632|P3|Overall Study|Lost to Follow-up|0
168271|NCT00818662|535633|P2|Overall Study|Lost to Follow-up|0
168272|NCT00818662|535634|P1|Overall Study|Lost to Follow-up|0
168273|NCT00818662|535631|P4|Overall Study|Physician Decision|0
168274|NCT00818662|535632|P3|Overall Study|Physician Decision|0
168275|NCT00818662|535633|P2|Overall Study|Physician Decision|0
168276|NCT00818662|535634|P1|Overall Study|Physician Decision|1
168277|NCT00818662|535631|P4|Overall Study|Death|0
168278|NCT00818662|535632|P3|Overall Study|Death|0
168279|NCT00818662|535633|P2|Overall Study|Death|3
168280|NCT00818662|535634|P1|Overall Study|Death|1
168281|NCT00818662|535631|P4|Overall Study|Withdrawal by Subject|2
168282|NCT00818662|535632|P3|Overall Study|Withdrawal by Subject|2
168283|NCT00818662|535633|P2|Overall Study|Withdrawal by Subject|4
168284|NCT00818662|535634|P1|Overall Study|Withdrawal by Subject|5
168285|NCT00818662|535631|P4|Overall Study|Adverse Event|3
168286|NCT00818662|535632|P3|Overall Study|Adverse Event|4
168287|NCT00818662|535633|P2|Overall Study|Adverse Event|14
168288|NCT00818662|535634|P1|Overall Study|Adverse Event|5
168289|NCT00818753|535723|P3|Overall Study|Randomised and not treated|0
168290|NCT00818753|535724|P2|Overall Study|Randomised and not treated|0
168291|NCT00818753|535725|P1|Overall Study|Randomised and not treated|2
168292|NCT00818753|535723|P3|Overall Study|Other reason (not specified)|1
168293|NCT00818753|535724|P2|Overall Study|Other reason (not specified)|0
168294|NCT00818753|535725|P1|Overall Study|Other reason (not specified)|0
168295|NCT00818753|535723|P3|Overall Study|Protocol Violation|0
168296|NCT00818753|535724|P2|Overall Study|Protocol Violation|0
168297|NCT00818753|535725|P1|Overall Study|Protocol Violation|1
168298|NCT00818766|535747|P2|Overall Study|Did not Receive Allocated Intervention|0
168299|NCT00818766|535748|P1|Overall Study|Did not Receive Allocated Intervention|3
168300|NCT00818766|535747|P2|Overall Study|Death|0
168301|NCT00818766|535748|P1|Overall Study|Death|1
168302|NCT00818766|535747|P2|Overall Study|Could not be Contacted on Day 28|10
168303|NCT00818766|535748|P1|Overall Study|Could not be Contacted on Day 28|11
168304|NCT00818779|535776|P2|Overall Study|Adverse Event|1
168305|NCT00818779|535777|P1|Overall Study|Adverse Event|4
168306|NCT00818779|535776|P2|Overall Study|Lost to Follow-up|0
168307|NCT00818779|535777|P1|Overall Study|Lost to Follow-up|1
168308|NCT00818779|535776|P2|Overall Study|Protocol Violation|0
168309|NCT00818779|535777|P1|Overall Study|Protocol Violation|1
168310|NCT00818883|535796|P2|Overall Study|Other|7
168311|NCT00818883|535797|P1|Overall Study|Other|2
168312|NCT00818883|535796|P2|Overall Study|Lack of Efficacy|2
168313|NCT00818883|535797|P1|Overall Study|Lack of Efficacy|0
168314|NCT00818883|535796|P2|Overall Study|Withdrawal by Subject|14
168315|NCT00818883|535797|P1|Overall Study|Withdrawal by Subject|16
168316|NCT00818883|535796|P2|Overall Study|Lost to Follow-up|2
168317|NCT00818883|535797|P1|Overall Study|Lost to Follow-up|3
168318|NCT00818883|535796|P2|Overall Study|Protocol Violation|2
168319|NCT00818883|535797|P1|Overall Study|Protocol Violation|2
168320|NCT00818883|535796|P2|Overall Study|Adverse Event|19
168321|NCT00818883|535797|P1|Overall Study|Adverse Event|28
168322|NCT00819013|535849|P4|Overall Study|Death|1
168323|NCT00819013|535850|P3|Overall Study|Death|0
168324|NCT00819013|535851|P2|Overall Study|Death|0
168325|NCT00819013|535852|P1|Overall Study|Death|0
168326|NCT00819013|535849|P4|Overall Study|Lost to Follow-up|2
168327|NCT00819013|535850|P3|Overall Study|Lost to Follow-up|1
168328|NCT00819013|535851|P2|Overall Study|Lost to Follow-up|0
168329|NCT00819013|535852|P1|Overall Study|Lost to Follow-up|0
168330|NCT00819013|535849|P4|Overall Study|Withdrawal by Subject|0
168331|NCT00819013|535850|P3|Overall Study|Withdrawal by Subject|1
168332|NCT00819013|535851|P2|Overall Study|Withdrawal by Subject|0
168333|NCT00819013|535852|P1|Overall Study|Withdrawal by Subject|1
168334|NCT00819013|535849|P4|Overall Study|Adverse Event|0
168335|NCT00819013|535850|P3|Overall Study|Adverse Event|1
168336|NCT00819013|535851|P2|Overall Study|Adverse Event|0
168337|NCT00819013|535852|P1|Overall Study|Adverse Event|0
168338|NCT00819013|535849|P4|Overall Study|Not meeting continuing study eligibility|1
168339|NCT00819013|535850|P3|Overall Study|Not meeting continuing study eligibility|2
168340|NCT00819013|535851|P2|Overall Study|Not meeting continuing study eligibility|1
168341|NCT00819013|535852|P1|Overall Study|Not meeting continuing study eligibility|2
168342|NCT00819039|535905|P3|Overall Study|Protocol Violation|0
168343|NCT00819039|535906|P2|Overall Study|Protocol Violation|0
168344|NCT00819039|535907|P1|Overall Study|Protocol Violation|1
168345|NCT00819039|535905|P3|Overall Study|Physician Decision|1
168346|NCT00819039|535906|P2|Overall Study|Physician Decision|0
168347|NCT00819039|535907|P1|Overall Study|Physician Decision|1
168348|NCT00819052|535935|P2|Overall Study|Death or events leading to death|0
168349|NCT00819052|535936|P1|Overall Study|Death or events leading to death|1
168350|NCT00819052|535935|P2|Overall Study|Pregnancy|2
168351|NCT00819052|535936|P1|Overall Study|Pregnancy|1
168352|NCT00819052|535935|P2|Overall Study|Lack of Efficacy|1
168353|NCT00819052|535936|P1|Overall Study|Lack of Efficacy|1
168354|NCT00819052|535935|P2|Overall Study|Withdrawal by Subject|2
168355|NCT00819052|535936|P1|Overall Study|Withdrawal by Subject|1
168356|NCT00819052|535935|P2|Overall Study|Lost to Follow-up|2
168357|NCT00819052|535936|P1|Overall Study|Lost to Follow-up|1
168358|NCT00819052|535935|P2|Overall Study|Protocol Violation|2
168359|NCT00819052|535936|P1|Overall Study|Protocol Violation|1
168360|NCT00819052|535935|P2|Overall Study|Adverse Event|5
168361|NCT00819052|535936|P1|Overall Study|Adverse Event|0
168362|NCT00819091|536050|P2|Overall Study|Not Specified|2
168363|NCT00819091|536051|P1|Overall Study|Not Specified|1
168364|NCT00819091|536050|P2|Overall Study|Withdrawal by Subject|2
168365|NCT00819091|536051|P1|Overall Study|Withdrawal by Subject|1
168366|NCT00819091|536050|P2|Overall Study|Lost to Follow-up|0
168367|NCT00819091|536051|P1|Overall Study|Lost to Follow-up|2
168368|NCT00819091|536050|P2|Overall Study|Protocol Violation|1
168369|NCT00819091|536051|P1|Overall Study|Protocol Violation|0
168370|NCT00819091|536050|P2|Overall Study|Adverse Event|5
168371|NCT00819091|536051|P1|Overall Study|Adverse Event|3
168372|NCT00819156|536081|P6|Overall Study|Prostate-specific antigen progression|0
168373|NCT00819156|536082|P5|Overall Study|Prostate-specific antigen progression|1
168374|NCT00819156|536083|P4|Overall Study|Prostate-specific antigen progression|0
168375|NCT00819156|536084|P3|Overall Study|Prostate-specific antigen progression|0
168376|NCT00819156|536085|P2|Overall Study|Prostate-specific antigen progression|0
168377|NCT00819156|536086|P1|Overall Study|Prostate-specific antigen progression|0
168378|NCT00819156|536081|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
168379|NCT00819156|536082|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
168380|NCT00819156|536083|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
168381|NCT00819156|536084|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
168382|NCT00819156|536085|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
168383|NCT00819156|536086|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
168384|NCT00819156|536081|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
168385|NCT00819156|536082|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
168386|NCT00819156|536083|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
168387|NCT00819156|536084|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
168388|NCT00819156|536085|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
168389|NCT00819156|536086|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
168390|NCT00819156|536081|P6|Overall Study|Lost to Follow-up|2
168391|NCT00819156|536082|P5|Overall Study|Lost to Follow-up|0
168392|NCT00819156|536083|P4|Overall Study|Lost to Follow-up|0
168393|NCT00819156|536084|P3|Overall Study|Lost to Follow-up|0
168394|NCT00819156|536085|P2|Overall Study|Lost to Follow-up|1
168395|NCT00819156|536086|P1|Overall Study|Lost to Follow-up|0
168396|NCT00819156|536081|P6|Overall Study|Protocol Violation|1
168397|NCT00819156|536082|P5|Overall Study|Protocol Violation|0
168398|NCT00819156|536083|P4|Overall Study|Protocol Violation|0
168399|NCT00819156|536084|P3|Overall Study|Protocol Violation|1
168400|NCT00819156|536085|P2|Overall Study|Protocol Violation|0
168401|NCT00819156|536086|P1|Overall Study|Protocol Violation|1
168402|NCT00819156|536081|P6|Overall Study|Withdrawal by Subject|0
168403|NCT00819156|536082|P5|Overall Study|Withdrawal by Subject|1
168404|NCT00819156|536083|P4|Overall Study|Withdrawal by Subject|0
168405|NCT00819156|536084|P3|Overall Study|Withdrawal by Subject|2
168406|NCT00819156|536085|P2|Overall Study|Withdrawal by Subject|3
168407|NCT00819156|536086|P1|Overall Study|Withdrawal by Subject|0
168408|NCT00819156|536081|P6|Overall Study|Adverse Event|3
168409|NCT00819156|536082|P5|Overall Study|Adverse Event|2
168410|NCT00819156|536083|P4|Overall Study|Adverse Event|1
168411|NCT00819156|536084|P3|Overall Study|Adverse Event|2
168412|NCT00819156|536085|P2|Overall Study|Adverse Event|4
168413|NCT00819156|536086|P1|Overall Study|Adverse Event|1
168414|NCT00819234|536209|P10|Overall Study|Lost to Follow-up|2
168415|NCT00819234|536210|P9|Overall Study|Lost to Follow-up|1
168416|NCT00819234|536211|P8|Overall Study|Lost to Follow-up|1
168417|NCT00819234|536212|P7|Overall Study|Lost to Follow-up|1
168418|NCT00819234|536213|P6|Overall Study|Lost to Follow-up|1
168419|NCT00819234|536214|P5|Overall Study|Lost to Follow-up|1
168420|NCT00819234|536215|P4|Overall Study|Lost to Follow-up|2
168421|NCT00819234|536216|P3|Overall Study|Lost to Follow-up|0
168422|NCT00819234|536217|P2|Overall Study|Lost to Follow-up|2
168423|NCT00819234|536218|P1|Overall Study|Lost to Follow-up|2
168424|NCT00819234|536209|P10|Overall Study|Protocol Violation|0
168425|NCT00819234|536210|P9|Overall Study|Protocol Violation|0
168426|NCT00819234|536211|P8|Overall Study|Protocol Violation|0
168427|NCT00819234|536212|P7|Overall Study|Protocol Violation|0
168428|NCT00819234|536213|P6|Overall Study|Protocol Violation|0
168429|NCT00819234|536214|P5|Overall Study|Protocol Violation|0
168430|NCT00819234|536215|P4|Overall Study|Protocol Violation|0
168431|NCT00819234|536216|P3|Overall Study|Protocol Violation|1
168432|NCT00819234|536217|P2|Overall Study|Protocol Violation|0
168433|NCT00819234|536218|P1|Overall Study|Protocol Violation|0
168434|NCT00819234|536209|P10|Overall Study|Physician Decision|2
168435|NCT00819234|536210|P9|Overall Study|Physician Decision|0
168436|NCT00819234|536211|P8|Overall Study|Physician Decision|0
168437|NCT00819234|536212|P7|Overall Study|Physician Decision|0
168438|NCT00819234|536213|P6|Overall Study|Physician Decision|0
168439|NCT00819234|536214|P5|Overall Study|Physician Decision|0
168440|NCT00819234|536215|P4|Overall Study|Physician Decision|1
168441|NCT00819234|536216|P3|Overall Study|Physician Decision|0
168442|NCT00819234|536217|P2|Overall Study|Physician Decision|0
168443|NCT00819234|536218|P1|Overall Study|Physician Decision|0
168444|NCT00819234|536209|P10|Overall Study|Adverse Event|0
168445|NCT00819234|536210|P9|Overall Study|Adverse Event|0
168446|NCT00819234|536211|P8|Overall Study|Adverse Event|0
168447|NCT00819234|536212|P7|Overall Study|Adverse Event|0
168448|NCT00819234|536213|P6|Overall Study|Adverse Event|2
168449|NCT00819234|536214|P5|Overall Study|Adverse Event|0
168450|NCT00819234|536215|P4|Overall Study|Adverse Event|0
168451|NCT00819234|536216|P3|Overall Study|Adverse Event|1
168452|NCT00819234|536217|P2|Overall Study|Adverse Event|0
168453|NCT00819234|536218|P1|Overall Study|Adverse Event|0
168454|NCT00819234|536209|P10|Overall Study|Withdrawal by Subject|3
168455|NCT00819234|536210|P9|Overall Study|Withdrawal by Subject|5
168456|NCT00819234|536211|P8|Overall Study|Withdrawal by Subject|8
168457|NCT00819234|536212|P7|Overall Study|Withdrawal by Subject|4
168458|NCT00819234|536213|P6|Overall Study|Withdrawal by Subject|4
168459|NCT00819234|536214|P5|Overall Study|Withdrawal by Subject|0
168460|NCT00819234|536215|P4|Overall Study|Withdrawal by Subject|3
168461|NCT00819234|536216|P3|Overall Study|Withdrawal by Subject|6
168462|NCT00819234|536217|P2|Overall Study|Withdrawal by Subject|13
168463|NCT00819234|536218|P1|Overall Study|Withdrawal by Subject|8
168464|NCT00819247|536379|P3|Overall Study|not specified|0
168465|NCT00819247|536380|P2|Overall Study|not specified|0
168466|NCT00819247|536381|P1|Overall Study|not specified|1
168467|NCT00819247|536379|P3|Overall Study|Bad prostate-specific antigen response|0
168468|NCT00819247|536380|P2|Overall Study|Bad prostate-specific antigen response|2
168469|NCT00819247|536381|P1|Overall Study|Bad prostate-specific antigen response|3
168470|NCT00819247|536379|P3|Overall Study|Mistakenly withdrawn|0
168471|NCT00819247|536380|P2|Overall Study|Mistakenly withdrawn|1
168472|NCT00819247|536381|P1|Overall Study|Mistakenly withdrawn|0
168473|NCT00819247|536379|P3|Overall Study|Protocol Violation|1
168474|NCT00819247|536380|P2|Overall Study|Protocol Violation|0
168475|NCT00819247|536381|P1|Overall Study|Protocol Violation|1
168476|NCT00819247|536379|P3|Overall Study|Withdrawal by Subject|0
168477|NCT00819247|536380|P2|Overall Study|Withdrawal by Subject|0
168478|NCT00819247|536381|P1|Overall Study|Withdrawal by Subject|1
168479|NCT00819247|536379|P3|Overall Study|Insufficient testosterone response|10
168480|NCT00819247|536380|P2|Overall Study|Insufficient testosterone response|8
168481|NCT00819247|536381|P1|Overall Study|Insufficient testosterone response|5
168482|NCT00819247|536379|P3|Overall Study|Adverse Event|3
168483|NCT00819247|536380|P2|Overall Study|Adverse Event|5
168484|NCT00819247|536381|P1|Overall Study|Adverse Event|0
168485|NCT00819390|536434|P4|Overall Study|Adverse Event|0
168486|NCT00819390|536435|P3|Overall Study|Adverse Event|1
168487|NCT00819390|536436|P2|Overall Study|Adverse Event|0
168488|NCT00819390|536437|P1|Overall Study|Adverse Event|0
168489|NCT00819390|536434|P4|Overall Study|Withdrawal by Subject|0
168490|NCT00819390|536435|P3|Overall Study|Withdrawal by Subject|0
168491|NCT00819390|536436|P2|Overall Study|Withdrawal by Subject|0
168492|NCT00819390|536437|P1|Overall Study|Withdrawal by Subject|2
168493|NCT00819390|536434|P4|Overall Study|Lost to Follow-up|0
168494|NCT00819390|536435|P3|Overall Study|Lost to Follow-up|0
168495|NCT00819390|536436|P2|Overall Study|Lost to Follow-up|1
168496|NCT00819390|536437|P1|Overall Study|Lost to Follow-up|1
168497|NCT00819585|536570|P7|Overall Study|Protocol Violation|3
168498|NCT00819585|536571|P6|Overall Study|Protocol Violation|1
168499|NCT00819585|536572|P5|Overall Study|Protocol Violation|0
168500|NCT00819585|536573|P4|Overall Study|Protocol Violation|0
168501|NCT00819585|536574|P3|Overall Study|Protocol Violation|1
168502|NCT00819585|536575|P2|Overall Study|Protocol Violation|0
168503|NCT00819585|536576|P1|Overall Study|Protocol Violation|0
168504|NCT00819585|536570|P7|Overall Study|Death|1
168505|NCT00819585|536571|P6|Overall Study|Death|0
168506|NCT00819585|536572|P5|Overall Study|Death|0
168507|NCT00819585|536573|P4|Overall Study|Death|0
168508|NCT00819585|536574|P3|Overall Study|Death|0
168509|NCT00819585|536575|P2|Overall Study|Death|0
168510|NCT00819585|536576|P1|Overall Study|Death|0
168511|NCT00819585|536570|P7|Overall Study|Administrative problems|2
168512|NCT00819585|536571|P6|Overall Study|Administrative problems|0
168513|NCT00819585|536572|P5|Overall Study|Administrative problems|0
168514|NCT00819585|536573|P4|Overall Study|Administrative problems|0
168515|NCT00819585|536574|P3|Overall Study|Administrative problems|0
168516|NCT00819585|536575|P2|Overall Study|Administrative problems|0
168517|NCT00819585|536576|P1|Overall Study|Administrative problems|0
168518|NCT00819585|536570|P7|Overall Study|Lost to Follow-up|1
168519|NCT00819585|536571|P6|Overall Study|Lost to Follow-up|1
168520|NCT00819585|536572|P5|Overall Study|Lost to Follow-up|1
168521|NCT00819585|536573|P4|Overall Study|Lost to Follow-up|0
168522|NCT00819585|536574|P3|Overall Study|Lost to Follow-up|2
168523|NCT00819585|536575|P2|Overall Study|Lost to Follow-up|1
168524|NCT00819585|536576|P1|Overall Study|Lost to Follow-up|2
168525|NCT00819585|536570|P7|Overall Study|Subject withdrew consent|3
168526|NCT00819585|536571|P6|Overall Study|Subject withdrew consent|0
168527|NCT00819585|536572|P5|Overall Study|Subject withdrew consent|0
168528|NCT00819585|536573|P4|Overall Study|Subject withdrew consent|1
168529|NCT00819585|536574|P3|Overall Study|Subject withdrew consent|2
168530|NCT00819585|536575|P2|Overall Study|Subject withdrew consent|3
168531|NCT00819585|536576|P1|Overall Study|Subject withdrew consent|0
168532|NCT00819585|536570|P7|Overall Study|Subject no longer requires study drug|0
168533|NCT00819585|536571|P6|Overall Study|Subject no longer requires study drug|0
168534|NCT00819585|536572|P5|Overall Study|Subject no longer requires study drug|1
168535|NCT00819585|536573|P4|Overall Study|Subject no longer requires study drug|0
168536|NCT00819585|536574|P3|Overall Study|Subject no longer requires study drug|0
168537|NCT00819585|536575|P2|Overall Study|Subject no longer requires study drug|0
168538|NCT00819585|536576|P1|Overall Study|Subject no longer requires study drug|0
168539|NCT00819585|536570|P7|Overall Study|Unsatisfactory therapeutic effect|1
168540|NCT00819585|536571|P6|Overall Study|Unsatisfactory therapeutic effect|0
168541|NCT00819585|536572|P5|Overall Study|Unsatisfactory therapeutic effect|0
168542|NCT00819585|536573|P4|Overall Study|Unsatisfactory therapeutic effect|0
168543|NCT00819585|536574|P3|Overall Study|Unsatisfactory therapeutic effect|0
168544|NCT00819585|536575|P2|Overall Study|Unsatisfactory therapeutic effect|1
168545|NCT00819585|536576|P1|Overall Study|Unsatisfactory therapeutic effect|0
168546|NCT00819585|536570|P7|Overall Study|Abnormal laboratory value(s)|0
168547|NCT00819585|536571|P6|Overall Study|Abnormal laboratory value(s)|0
168548|NCT00819585|536572|P5|Overall Study|Abnormal laboratory value(s)|0
168549|NCT00819585|536573|P4|Overall Study|Abnormal laboratory value(s)|0
168550|NCT00819585|536574|P3|Overall Study|Abnormal laboratory value(s)|0
168551|NCT00819585|536575|P2|Overall Study|Abnormal laboratory value(s)|0
168552|NCT00819585|536576|P1|Overall Study|Abnormal laboratory value(s)|2
168553|NCT00819585|536570|P7|Overall Study|Adverse Event|2
168554|NCT00819585|536571|P6|Overall Study|Adverse Event|0
168555|NCT00819585|536572|P5|Overall Study|Adverse Event|1
168556|NCT00819585|536573|P4|Overall Study|Adverse Event|4
168557|NCT00819585|536574|P3|Overall Study|Adverse Event|1
168558|NCT00819585|536575|P2|Overall Study|Adverse Event|1
168559|NCT00819585|536576|P1|Overall Study|Adverse Event|2
168560|NCT00819741|536648|P2|Overall Study|Reasons unknown|3
168561|NCT00819741|536649|P1|Overall Study|Reasons unknown|3
168562|NCT00819741|536648|P2|Overall Study|Unclassified|0
168563|NCT00819741|536649|P1|Overall Study|Unclassified|6
168564|NCT00819741|536648|P2|Overall Study|Withdrawal by Subject|2
168565|NCT00819741|536649|P1|Overall Study|Withdrawal by Subject|2
168566|NCT00819741|536648|P2|Overall Study|Protocol Violation|4
168567|NCT00819741|536649|P1|Overall Study|Protocol Violation|3
168568|NCT00819741|536648|P2|Overall Study|Lost to Follow-up|1
168569|NCT00819741|536649|P1|Overall Study|Lost to Follow-up|3
168570|NCT00819741|536648|P2|Overall Study|Lack of Efficacy|2
168571|NCT00819741|536649|P1|Overall Study|Lack of Efficacy|0
168572|NCT00819741|536648|P2|Overall Study|Adverse Event|2
168573|NCT00819741|536649|P1|Overall Study|Adverse Event|5
168574|NCT00819767|536685|P2|Overall Study|Unsatisfactory therapeutic effect|2
168575|NCT00819767|536686|P1|Overall Study|Unsatisfactory therapeutic effect|1
168576|NCT00819780|536698|P2|Overall Study|Still in treatment|17
168577|NCT00819780|536699|P1|Overall Study|Still in treatment|25
168578|NCT00819780|536698|P2|Overall Study|Did not receive study drug|4
168579|NCT00819780|536699|P1|Overall Study|Did not receive study drug|3
168580|NCT00819832|536737|P6|Overall Study|Sponsor Termination of Study|0
168581|NCT00819832|536738|P5|Overall Study|Sponsor Termination of Study|0
168582|NCT00819832|536739|P4|Overall Study|Sponsor Termination of Study|0
168583|NCT00819832|536740|P3|Overall Study|Sponsor Termination of Study|0
168584|NCT00819832|536741|P2|Overall Study|Sponsor Termination of Study|0
168585|NCT00819832|536742|P1|Overall Study|Sponsor Termination of Study|3
168586|NCT00819910|536760|P4|Overall Study|Lost to Follow-up|0
168587|NCT00819910|536761|P3|Overall Study|Lost to Follow-up|0
168588|NCT00819910|536762|P2|Overall Study|Lost to Follow-up|0
168589|NCT00819910|536763|P1|Overall Study|Lost to Follow-up|1
168590|NCT00819910|536760|P4|Overall Study|Withdrawal by Subject|0
168591|NCT00819910|536761|P3|Overall Study|Withdrawal by Subject|1
168592|NCT00819910|536762|P2|Overall Study|Withdrawal by Subject|1
168593|NCT00819910|536763|P1|Overall Study|Withdrawal by Subject|1
168594|NCT00819910|536760|P4|Overall Study|Adverse Event|1
168595|NCT00819910|536761|P3|Overall Study|Adverse Event|2
168596|NCT00819910|536762|P2|Overall Study|Adverse Event|0
168597|NCT00819910|536763|P1|Overall Study|Adverse Event|0
168598|NCT00820222|536791|P2|Overall Study|Ongoing|191
168599|NCT00820222|536792|P1|Overall Study|Ongoing|185
168600|NCT00820222|536791|P2|Overall Study|Sponsor Terminated Study|1
168601|NCT00820222|536792|P1|Overall Study|Sponsor Terminated Study|0
168602|NCT00820222|536791|P2|Overall Study|Physician Decision|6
168603|NCT00820222|536792|P1|Overall Study|Physician Decision|4
168604|NCT00820222|536791|P2|Overall Study|Withdrawal by Subject|9
168605|NCT00820222|536792|P1|Overall Study|Withdrawal by Subject|8
168606|NCT00820222|536791|P2|Overall Study|Lost to Follow-up|4
168607|NCT00820222|536792|P1|Overall Study|Lost to Follow-up|4
168608|NCT00820248|536820|P2|Overall Study|No treated|1
168609|NCT00820248|536821|P1|Overall Study|No treated|4
168610|NCT00820755|536899|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
168695|NCT00814879|537286|P1|By Week 24|Cancer Diagnosis|1
168611|NCT00820755|536900|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
168612|NCT00820755|536901|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
168613|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Unspecified|0
168614|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Unspecified|0
168615|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Unspecified|11
168616|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
168617|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
168618|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
168619|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Progressive disease|0
168620|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Progressive disease|0
168621|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Progressive disease|114
168622|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
168623|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
168624|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
168625|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
168626|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
168627|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
168628|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
168629|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
168630|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
168631|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Death|0
168632|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Death|0
168633|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Death|28
168634|NCT00820755|536899|P3|Period 1: Combination Therapy Phase|Adverse Event|0
168635|NCT00820755|536900|P2|Period 1: Combination Therapy Phase|Adverse Event|0
168636|NCT00820755|536901|P1|Period 1: Combination Therapy Phase|Adverse Event|77
168637|NCT00814489|536929|P3|Overall Study|Unspecified|1
168638|NCT00814489|536930|P2|Overall Study|Unspecified|0
168639|NCT00814489|536931|P1|Overall Study|Unspecified|2
168640|NCT00814502|536965|P2|Overall Study|Withdrawal by Subject|2
168641|NCT00814502|536966|P1|Overall Study|Withdrawal by Subject|0
168642|NCT00814502|536965|P2|Overall Study|Adverse Event|0
168643|NCT00814502|536966|P1|Overall Study|Adverse Event|1
168644|NCT00814580|536978|P2|Overall Study|Did Not Take Drug|2
168645|NCT00814580|536979|P1|Overall Study|Did Not Take Drug|2
168646|NCT00814580|536978|P2|Overall Study|Other|3
168647|NCT00814580|536979|P1|Overall Study|Other|1
168648|NCT00814580|536978|P2|Overall Study|Withdrawal by Subject|2
168649|NCT00814580|536979|P1|Overall Study|Withdrawal by Subject|2
168650|NCT00814580|536978|P2|Overall Study|Protocol Violation|0
168651|NCT00814580|536979|P1|Overall Study|Protocol Violation|2
168652|NCT00814580|536978|P2|Overall Study|Lack of Efficacy|25
168653|NCT00814580|536979|P1|Overall Study|Lack of Efficacy|18
168654|NCT00814580|536978|P2|Overall Study|Adverse Event|15
168655|NCT00814580|536979|P1|Overall Study|Adverse Event|6
168656|NCT00814632|537107|P1|Overall Study|Lack of Efficacy|2
168657|NCT00814658|537113|P2|Overall Study|Adverse Event|3
168658|NCT00814658|537114|P1|Overall Study|Adverse Event|3
168659|NCT00814658|537113|P2|Overall Study|Physician Decision|0
168660|NCT00814658|537114|P1|Overall Study|Physician Decision|1
168661|NCT00814658|537113|P2|Overall Study|Lost to Follow-up|1
168662|NCT00814658|537114|P1|Overall Study|Lost to Follow-up|0
168663|NCT00814710|537202|P2|Overall Study|Lost to Follow-up|3
168664|NCT00814710|537203|P1|Overall Study|Lost to Follow-up|7
168665|NCT00814710|537202|P2|Overall Study|Adverse Event|0
168666|NCT00814710|537203|P1|Overall Study|Adverse Event|1
168667|NCT00814801|537261|P3|Overall Study|Not specified|4
168668|NCT00814801|537262|P2|Overall Study|Not specified|6
168669|NCT00814801|537263|P1|Overall Study|Not specified|2
168670|NCT00814801|537261|P3|Overall Study|Non-compliance|1
168671|NCT00814801|537262|P2|Overall Study|Non-compliance|1
168672|NCT00814801|537263|P1|Overall Study|Non-compliance|0
168673|NCT00814801|537261|P3|Overall Study|Missing or change of caregiver|4
168674|NCT00814801|537262|P2|Overall Study|Missing or change of caregiver|2
168675|NCT00814801|537263|P1|Overall Study|Missing or change of caregiver|6
168676|NCT00814801|537261|P3|Overall Study|Change of patients for CIBIC plus-J|0
168677|NCT00814801|537262|P2|Overall Study|Change of patients for CIBIC plus-J|1
168678|NCT00814801|537263|P1|Overall Study|Change of patients for CIBIC plus-J|1
168679|NCT00814801|537261|P3|Overall Study|Inappropriate as a subject|1
168680|NCT00814801|537262|P2|Overall Study|Inappropriate as a subject|1
168681|NCT00814801|537263|P1|Overall Study|Inappropriate as a subject|1
168682|NCT00814801|537261|P3|Overall Study|Withdrawal by Subject|14
168683|NCT00814801|537262|P2|Overall Study|Withdrawal by Subject|11
168684|NCT00814801|537263|P1|Overall Study|Withdrawal by Subject|9
168685|NCT00814801|537261|P3|Overall Study|Adverse Event|19
168686|NCT00814801|537262|P2|Overall Study|Adverse Event|16
168687|NCT00814801|537263|P1|Overall Study|Adverse Event|15
168688|NCT00814879|537285|P2|By Week 48|Death|1
168689|NCT00814879|537286|P1|By Week 48|Death|0
168690|NCT00814879|537285|P2|By Week 48|Lost to Follow-up|2
168691|NCT00814879|537286|P1|By Week 48|Lost to Follow-up|2
168692|NCT00814879|537285|P2|By Week 24|Incarceration|1
168693|NCT00814879|537286|P1|By Week 24|Incarceration|0
168694|NCT00814879|537285|P2|By Week 24|Cancer Diagnosis|0
168696|NCT00814892|537302|P1|Overall Study|Study Termination|1
168697|NCT00814892|537302|P1|Overall Study|Disease Progression|1
168698|NCT00814983|537335|P2|Overall Study|Graft failure|0
168699|NCT00814983|537336|P1|Overall Study|Graft failure|1
168700|NCT00814983|537335|P2|Overall Study|Withdrawal by Subject|0
168701|NCT00814983|537336|P1|Overall Study|Withdrawal by Subject|1
168702|NCT00814983|537335|P2|Overall Study|Screen failure|0
168703|NCT00814983|537336|P1|Overall Study|Screen failure|1
168704|NCT00821093|537379|P2|Overall Study|Administrative problems|2
168705|NCT00821093|537380|P1|Overall Study|Administrative problems|1
168706|NCT00821093|537379|P2|Overall Study|Abnormal test procedure result(s)|1
168707|NCT00821093|537380|P1|Overall Study|Abnormal test procedure result(s)|1
168708|NCT00821093|537379|P2|Overall Study|Death|1
168709|NCT00821093|537380|P1|Overall Study|Death|2
168710|NCT00821093|537379|P2|Overall Study|Lack of Efficacy|2
168711|NCT00821093|537380|P1|Overall Study|Lack of Efficacy|2
168712|NCT00821093|537379|P2|Overall Study|Abnormal laboratory value(s)|0
168713|NCT00821093|537380|P1|Overall Study|Abnormal laboratory value(s)|2
168714|NCT00821093|537379|P2|Overall Study|Protocol deviation|6
168715|NCT00821093|537380|P1|Overall Study|Protocol deviation|3
168716|NCT00821093|537379|P2|Overall Study|Lost to Follow-up|3
168717|NCT00821093|537380|P1|Overall Study|Lost to Follow-up|9
168718|NCT00821093|537379|P2|Overall Study|Withdrawal by Subject|13
168719|NCT00821093|537380|P1|Overall Study|Withdrawal by Subject|9
168720|NCT00821093|537379|P2|Overall Study|Adverse Event|12
168721|NCT00821093|537380|P1|Overall Study|Adverse Event|20
168722|NCT00821236|537413|P1|Overall Study|Lost to Follow-up|3
168723|NCT00821327|537427|P1|Overall Study|Other/Unknown|5
168724|NCT00821327|537427|P1|Overall Study|Disease Progression|13
168725|NCT00821327|537427|P1|Overall Study|Sponsor Request|1
168726|NCT00821327|537427|P1|Overall Study|Investigator Request|2
168727|NCT00821327|537427|P1|Overall Study|Patient Request|1
168728|NCT00821327|537427|P1|Overall Study|Adverse Event|13
168729|NCT00822692|537523|P2|Overall Study|Lost to Follow-up|25
168730|NCT00822692|537524|P1|Overall Study|Lost to Follow-up|17
168731|NCT00822900|537549|P2|Overall Study|Became a ward of the state|1
168732|NCT00822900|537550|P1|Overall Study|Became a ward of the state|2
168733|NCT00822900|537549|P2|Overall Study|Death|69
168734|NCT00822900|537550|P1|Overall Study|Death|83
168735|NCT00822900|537549|P2|Overall Study|Lost to Follow-up|9
168736|NCT00822900|537550|P1|Overall Study|Lost to Follow-up|9
168737|NCT00822900|537549|P2|Overall Study|Withdrawal by Subject|14
168738|NCT00822900|537550|P1|Overall Study|Withdrawal by Subject|14
168739|NCT00822926|537580|P2|Second Injection Visit|Withdrawal by Subject|1
168740|NCT00822926|537581|P1|Second Injection Visit|Withdrawal by Subject|0
168741|NCT00822926|537580|P2|Second Injection Visit|Lost to Follow-up|0
168742|NCT00822926|537581|P1|Second Injection Visit|Lost to Follow-up|1
168743|NCT00823199|537654|P1|Overall Study|Withdrawal by Subject|2
168744|NCT00823212|537662|P2|Overall Study|Missed 12-month visit|21
168745|NCT00823212|537663|P1|Overall Study|Missed 12-month visit|21
168746|NCT00823212|537662|P2|Overall Study|Incarcerated|1
168747|NCT00823212|537663|P1|Overall Study|Incarcerated|0
168748|NCT00823212|537662|P2|Overall Study|Withdrawal by Subject|1
168749|NCT00823212|537663|P1|Overall Study|Withdrawal by Subject|6
168750|NCT00823212|537662|P2|Overall Study|Death|10
168751|NCT00823212|537663|P1|Overall Study|Death|8
168752|NCT00823264|537747|P2|Overall Study|Protocol Violation|0
168753|NCT00823264|537748|P1|Overall Study|Protocol Violation|2
168754|NCT00823472|537765|P2|Overall Study|Physician Decision|28
168755|NCT00823472|537766|P1|Overall Study|Physician Decision|24
168756|NCT00823615|537774|P2|Period 2|Time/Job Conflict|2
168757|NCT00823615|537775|P1|Period 2|Time/Job Conflict|1
168758|NCT00823615|537774|P2|Period 2|Lost to Follow-up|0
168759|NCT00823615|537775|P1|Period 2|Lost to Follow-up|2
168760|NCT00823719|537785|P2|Overall Study|Disease Progression|4
168761|NCT00823719|537786|P1|Overall Study|Disease Progression|4
168762|NCT00823719|537785|P2|Overall Study|Withdrawal by Subject|1
168763|NCT00823719|537786|P1|Overall Study|Withdrawal by Subject|0
168764|NCT00823719|537785|P2|Overall Study|Physician Decision|4
168765|NCT00823719|537786|P1|Overall Study|Physician Decision|1
168766|NCT00823719|537785|P2|Overall Study|Adverse Event|2
168767|NCT00823719|537786|P1|Overall Study|Adverse Event|1
168768|NCT00823823|537855|P2|Overall Study|Protocol Violation|5
168769|NCT00823823|537856|P1|Overall Study|Protocol Violation|5
168770|NCT00823823|537855|P2|Overall Study|Lost to Follow-up|1
168771|NCT00823823|537856|P1|Overall Study|Lost to Follow-up|3
168772|NCT00823836|537866|P2|Long-term Phase|Withdrawal by Subject|1
168773|NCT00823836|537867|P1|Long-term Phase|Withdrawal by Subject|1
168774|NCT00823836|537866|P2|Long-term Phase|Physician Decision|2
168775|NCT00823836|537867|P1|Long-term Phase|Physician Decision|1
168776|NCT00823836|537866|P2|Long-term Phase|Adverse Event|2
168777|NCT00823836|537867|P1|Long-term Phase|Adverse Event|3
168778|NCT00823836|537866|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
168779|NCT00823836|537867|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
168780|NCT00823836|537866|P2|NV and PR/XR Switching Phases|Physician Decision|2
168781|NCT00823836|537867|P1|NV and PR/XR Switching Phases|Physician Decision|5
168782|NCT00823836|537866|P2|NV and PR/XR Switching Phases|Protocol Violation|1
168783|NCT00823836|537867|P1|NV and PR/XR Switching Phases|Protocol Violation|1
168784|NCT00823836|537866|P2|NV and PR/XR Switching Phases|Adverse Event|21
168785|NCT00823836|537867|P1|NV and PR/XR Switching Phases|Adverse Event|22
168786|NCT00823901|537973|P2|Overall Study|Lost to Follow-up|1
168787|NCT00823901|537974|P1|Overall Study|Lost to Follow-up|2
168788|NCT00823901|537973|P2|Overall Study|Lack of Efficacy|0
168789|NCT00823901|537974|P1|Overall Study|Lack of Efficacy|1
168790|NCT00823901|537973|P2|Overall Study|Adverse Event|1
168791|NCT00823901|537974|P1|Overall Study|Adverse Event|1
168792|NCT00823979|537988|P3|Overall Study|Study Terminated by Sponsor|7
168793|NCT00823979|537989|P2|Overall Study|Study Terminated by Sponsor|5
168794|NCT00823979|537990|P1|Overall Study|Study Terminated by Sponsor|5
168795|NCT00823979|537988|P3|Overall Study|Randomized but not Treated|1
168796|NCT00823979|537989|P2|Overall Study|Randomized but not Treated|3
168797|NCT00823979|537990|P1|Overall Study|Randomized but not Treated|4
168798|NCT00823979|537988|P3|Overall Study|Unspecified|1
168799|NCT00823979|537989|P2|Overall Study|Unspecified|0
168800|NCT00823979|537990|P1|Overall Study|Unspecified|2
168801|NCT00823979|537988|P3|Overall Study|Adverse Event|4
168802|NCT00823979|537989|P2|Overall Study|Adverse Event|2
168803|NCT00823979|537990|P1|Overall Study|Adverse Event|0
168804|NCT00823979|537988|P3|Overall Study|Pregnancy|0
168805|NCT00823979|537989|P2|Overall Study|Pregnancy|1
168806|NCT00823979|537990|P1|Overall Study|Pregnancy|0
168807|NCT00823979|537988|P3|Overall Study|Protocol Violation|0
168808|NCT00823979|537989|P2|Overall Study|Protocol Violation|1
168809|NCT00823979|537990|P1|Overall Study|Protocol Violation|1
168810|NCT00823979|537988|P3|Overall Study|Withdrawal by Subject|2
168811|NCT00823979|537989|P2|Overall Study|Withdrawal by Subject|3
168812|NCT00823979|537990|P1|Overall Study|Withdrawal by Subject|2
168813|NCT00823979|537988|P3|Overall Study|Lost to Follow-up|0
168814|NCT00823979|537989|P2|Overall Study|Lost to Follow-up|1
168815|NCT00823979|537990|P1|Overall Study|Lost to Follow-up|2
168816|NCT00823979|537988|P3|Overall Study|Lack of Efficacy|9
168817|NCT00823979|537989|P2|Overall Study|Lack of Efficacy|16
168818|NCT00823979|537990|P1|Overall Study|Lack of Efficacy|13
168819|NCT00824005|538030|P2|Overall Study|Lost to Follow-up|1
168820|NCT00824005|538031|P1|Overall Study|Lost to Follow-up|0
168821|NCT00824005|538030|P2|Overall Study|Death|1
168822|NCT00824005|538031|P1|Overall Study|Death|0
168823|NCT00824161|538085|P1|Overall Study|Screen Failure|1
168824|NCT00824161|538085|P1|Overall Study|Withdrawal by Subject|1
168825|NCT00824265|538093|P2|Overall Study|Withdrawal by Subject|15
168826|NCT00824265|538094|P1|Overall Study|Withdrawal by Subject|6
168827|NCT00824265|538093|P2|Overall Study|Physician Decision|12
168828|NCT00824265|538094|P1|Overall Study|Physician Decision|6
168829|NCT00824265|538093|P2|Overall Study|Lost to Follow-up|1
168830|NCT00824265|538094|P1|Overall Study|Lost to Follow-up|1
168831|NCT00824265|538093|P2|Overall Study|Protocol Violation|0
168832|NCT00824265|538094|P1|Overall Study|Protocol Violation|1
168833|NCT00824265|538093|P2|Overall Study|Adverse Event,non-fatal|52
168834|NCT00824265|538094|P1|Overall Study|Adverse Event,non-fatal|50
168835|NCT00824291|538155|P2|Overall Study|Participant on prohibited medication|0
168836|NCT00824291|538156|P1|Overall Study|Participant on prohibited medication|1
168837|NCT00824291|538155|P2|Overall Study|Lack of Efficacy|8
168838|NCT00824291|538156|P1|Overall Study|Lack of Efficacy|7
168839|NCT00824291|538155|P2|Overall Study|Withdrawal by Subject|8
168840|NCT00824291|538156|P1|Overall Study|Withdrawal by Subject|14
168841|NCT00824291|538155|P2|Overall Study|Protocol Violation|1
168842|NCT00824291|538156|P1|Overall Study|Protocol Violation|4
168843|NCT00824291|538155|P2|Overall Study|Non-compliance|1
168844|NCT00824291|538156|P1|Overall Study|Non-compliance|1
168845|NCT00824291|538155|P2|Overall Study|Lost to Follow-up|9
168846|NCT00824291|538156|P1|Overall Study|Lost to Follow-up|11
168847|NCT00824291|538155|P2|Overall Study|Discontinuation of Study by Sponsor|2
168848|NCT00824291|538156|P1|Overall Study|Discontinuation of Study by Sponsor|1
168849|NCT00824291|538155|P2|Overall Study|Adverse Event|6
168850|NCT00824291|538156|P1|Overall Study|Adverse Event|15
168851|NCT00824369|538182|P6|Overall Study|Lost to Follow-up|0
168852|NCT00824369|538183|P5|Overall Study|Lost to Follow-up|1
168853|NCT00824369|538184|P4|Overall Study|Lost to Follow-up|0
168854|NCT00824369|538185|P3|Overall Study|Lost to Follow-up|0
168855|NCT00824369|538186|P2|Overall Study|Lost to Follow-up|0
168856|NCT00824369|538187|P1|Overall Study|Lost to Follow-up|0
168857|NCT00824369|538182|P6|Overall Study|Nolonger willing to participate in study|1
168858|NCT00824369|538183|P5|Overall Study|Nolonger willing to participate in study|0
168859|NCT00824369|538184|P4|Overall Study|Nolonger willing to participate in study|2
168860|NCT00824369|538185|P3|Overall Study|Nolonger willing to participate in study|1
168861|NCT00824369|538186|P2|Overall Study|Nolonger willing to participate in study|0
168862|NCT00824369|538187|P1|Overall Study|Nolonger willing to participate in study|1
168863|NCT00824382|538229|P4|Overall Study|Investigator's decision|0
168864|NCT00824382|538230|P3|Overall Study|Investigator's decision|2
168865|NCT00824382|538231|P2|Overall Study|Investigator's decision|1
168866|NCT00824382|538232|P1|Overall Study|Investigator's decision|0
168867|NCT00824382|538229|P4|Overall Study|Protocol Violation|1
168868|NCT00824382|538230|P3|Overall Study|Protocol Violation|0
168869|NCT00824382|538231|P2|Overall Study|Protocol Violation|0
168870|NCT00824382|538232|P1|Overall Study|Protocol Violation|1
168871|NCT00824382|538229|P4|Overall Study|Adverse Event|4
168872|NCT00824382|538230|P3|Overall Study|Adverse Event|1
168873|NCT00824382|538231|P2|Overall Study|Adverse Event|1
168874|NCT00824382|538232|P1|Overall Study|Adverse Event|4
168875|NCT00824408|538307|P5|Randomized Phase|Other reason not defined above|4
168876|NCT00824408|538308|P4|Randomized Phase|Other reason not defined above|2
168877|NCT00824408|538309|P3|Randomized Phase|Other reason not defined above|4
168878|NCT00824408|538310|P2|Randomized Phase|Other reason not defined above|0
168879|NCT00824408|538311|P1|Randomized Phase|Other reason not defined above|0
168880|NCT00824408|538307|P5|Randomized Phase|Refused to continue medication|2
168881|NCT00824408|538308|P4|Randomized Phase|Refused to continue medication|2
168882|NCT00824408|538309|P3|Randomized Phase|Refused to continue medication|2
168883|NCT00824408|538310|P2|Randomized Phase|Refused to continue medication|0
168884|NCT00824408|538311|P1|Randomized Phase|Refused to continue medication|0
168885|NCT00824408|538307|P5|Randomized Phase|Adverse Event|5
168886|NCT00824408|538308|P4|Randomized Phase|Adverse Event|5
168887|NCT00824408|538309|P3|Randomized Phase|Adverse Event|4
168888|NCT00824408|538310|P2|Randomized Phase|Adverse Event|0
168889|NCT00824408|538311|P1|Randomized Phase|Adverse Event|0
168890|NCT00824408|538307|P5|Randomized Phase|Progressive disease|34
168891|NCT00824408|538308|P4|Randomized Phase|Progressive disease|36
168892|NCT00824408|538309|P3|Randomized Phase|Progressive disease|25
168893|NCT00824408|538310|P2|Randomized Phase|Progressive disease|0
168894|NCT00824408|538311|P1|Randomized Phase|Progressive disease|0
168895|NCT00824408|538307|P5|Randomized Phase|Not treated|1
168896|NCT00824408|538308|P4|Randomized Phase|Not treated|1
168897|NCT00824408|538309|P3|Randomized Phase|Not treated|1
168898|NCT00824408|538310|P2|Randomized Phase|Not treated|0
168899|NCT00824408|538311|P1|Randomized Phase|Not treated|0
168900|NCT00824408|538307|P5|Run-in Phase|Other reason not defined above|0
168901|NCT00824408|538308|P4|Run-in Phase|Other reason not defined above|0
168902|NCT00824408|538309|P3|Run-in Phase|Other reason not defined above|0
168903|NCT00824408|538310|P2|Run-in Phase|Other reason not defined above|1
168904|NCT00824408|538311|P1|Run-in Phase|Other reason not defined above|0
168905|NCT00824408|538307|P5|Run-in Phase|Refused to continue medication|0
168906|NCT00824408|538308|P4|Run-in Phase|Refused to continue medication|0
168907|NCT00824408|538309|P3|Run-in Phase|Refused to continue medication|0
168908|NCT00824408|538310|P2|Run-in Phase|Refused to continue medication|0
168909|NCT00824408|538311|P1|Run-in Phase|Refused to continue medication|1
168910|NCT00824408|538307|P5|Run-in Phase|Adverse Event|0
168911|NCT00824408|538308|P4|Run-in Phase|Adverse Event|0
168912|NCT00824408|538309|P3|Run-in Phase|Adverse Event|0
168913|NCT00824408|538310|P2|Run-in Phase|Adverse Event|1
168914|NCT00824408|538311|P1|Run-in Phase|Adverse Event|1
168915|NCT00824408|538307|P5|Run-in Phase|Progressive disease|0
168916|NCT00824408|538308|P4|Run-in Phase|Progressive disease|0
168917|NCT00824408|538309|P3|Run-in Phase|Progressive disease|0
168918|NCT00824408|538310|P2|Run-in Phase|Progressive disease|4
168919|NCT00824408|538311|P1|Run-in Phase|Progressive disease|4
168920|NCT00824421|538362|P3|Overall Study|Unspecified|0
168921|NCT00824421|538363|P2|Overall Study|Unspecified|1
168922|NCT00824421|538364|P1|Overall Study|Unspecified|0
168923|NCT00824421|538362|P3|Overall Study|Randomized but not Treated|0
168924|NCT00824421|538363|P2|Overall Study|Randomized but not Treated|1
168925|NCT00824421|538364|P1|Overall Study|Randomized but not Treated|1
168926|NCT00824421|538362|P3|Overall Study|Withdrawal by Subject|3
168927|NCT00824421|538363|P2|Overall Study|Withdrawal by Subject|3
168928|NCT00824421|538364|P1|Overall Study|Withdrawal by Subject|2
168929|NCT00824421|538362|P3|Overall Study|Pregnancy|1
168930|NCT00824421|538363|P2|Overall Study|Pregnancy|0
168931|NCT00824421|538364|P1|Overall Study|Pregnancy|1
168932|NCT00824421|538362|P3|Overall Study|Lost to Follow-up|0
168933|NCT00824421|538363|P2|Overall Study|Lost to Follow-up|3
168934|NCT00824421|538364|P1|Overall Study|Lost to Follow-up|2
168935|NCT00824421|538362|P3|Overall Study|Lack of Efficacy|4
168936|NCT00824421|538363|P2|Overall Study|Lack of Efficacy|7
168937|NCT00824421|538364|P1|Overall Study|Lack of Efficacy|5
168938|NCT00824421|538362|P3|Overall Study|Death|0
168939|NCT00824421|538363|P2|Overall Study|Death|1
168940|NCT00824421|538364|P1|Overall Study|Death|0
168941|NCT00824421|538362|P3|Overall Study|Adverse Event|6
168942|NCT00824421|538363|P2|Overall Study|Adverse Event|6
168943|NCT00824421|538364|P1|Overall Study|Adverse Event|6
168944|NCT00824473|538474|P2|Overall Study|Other|1
168945|NCT00824473|538475|P1|Overall Study|Other|1
168946|NCT00824473|538474|P2|Overall Study|Withdrawal by Subject|3
168947|NCT00824473|538475|P1|Overall Study|Withdrawal by Subject|2
168948|NCT00824473|538474|P2|Overall Study|Non-Compliance|2
168949|NCT00824473|538475|P1|Overall Study|Non-Compliance|4
168950|NCT00824473|538474|P2|Overall Study|Protocol Violation|0
168951|NCT00824473|538475|P1|Overall Study|Protocol Violation|2
168952|NCT00824473|538474|P2|Overall Study|Lack of Efficacy|2
168953|NCT00824473|538475|P1|Overall Study|Lack of Efficacy|2
168954|NCT00824473|538474|P2|Overall Study|Adverse Event|5
168955|NCT00824473|538475|P1|Overall Study|Adverse Event|4
168956|NCT00824564|538550|P2|Overall Study|Randomized, but not treated|0
168957|NCT00824564|538551|P1|Overall Study|Randomized, but not treated|1
168958|NCT00824564|538550|P2|Overall Study|Unspecified|2
168959|NCT00824564|538551|P1|Overall Study|Unspecified|1
168960|NCT00824564|538550|P2|Overall Study|Withdrawal by Subject|1
168961|NCT00824564|538551|P1|Overall Study|Withdrawal by Subject|1
168962|NCT00824564|538550|P2|Overall Study|Lost to Follow-up|7
168963|NCT00824564|538551|P1|Overall Study|Lost to Follow-up|5
168964|NCT00824616|538571|P2|Overall Study|Withdrawal by Subject|1
168965|NCT00824616|538572|P1|Overall Study|Withdrawal by Subject|1
168966|NCT00824616|538571|P2|Overall Study|Lost to Follow-up|1
168967|NCT00824616|538572|P1|Overall Study|Lost to Follow-up|0
168968|NCT00824616|538571|P2|Overall Study|Lack of Efficacy|1
168969|NCT00824616|538572|P1|Overall Study|Lack of Efficacy|2
168970|NCT00824616|538571|P2|Overall Study|Hyperglycemia|1
168971|NCT00824616|538572|P1|Overall Study|Hyperglycemia|1
168972|NCT00824616|538571|P2|Overall Study|Creatinine/Creatinine Clearance|2
168973|NCT00824616|538572|P1|Overall Study|Creatinine/Creatinine Clearance|0
168974|NCT00824616|538571|P2|Overall Study|Adverse Event|1
168975|NCT00824616|538572|P1|Overall Study|Adverse Event|2
168976|NCT00824655|538582|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
168977|NCT00824655|538583|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
168978|NCT00824655|538582|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
168979|NCT00824655|538583|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
168980|NCT00824720|538604|P3|Overall Study|Protocol Violation|1
168981|NCT00824720|538605|P2|Overall Study|Protocol Violation|0
168982|NCT00824720|538606|P1|Overall Study|Protocol Violation|0
168983|NCT00824720|538604|P3|Overall Study|failed plug insertion|0
168984|NCT00824720|538605|P2|Overall Study|failed plug insertion|1
168985|NCT00824720|538606|P1|Overall Study|failed plug insertion|3
168986|NCT00824772|538632|P1|Overall Study|Withdrawal by Subject|8
168987|NCT00824850|538648|P2|Overall Study|Withdrawal by Subject|1
168988|NCT00824850|538649|P1|Overall Study|Withdrawal by Subject|0
168989|NCT00818168|538708|P1|Overall Study|Participant Moved|2
168990|NCT00818168|538708|P1|Overall Study|Reason for Non-completion Not reported|6
168991|NCT00818168|538708|P1|Overall Study|Adverse Event|19
168992|NCT00818168|538708|P1|Overall Study|Lost to Follow-up|7
168993|NCT00818168|538708|P1|Overall Study|Withdrawal by Subject|16
168994|NCT00818168|538708|P1|Overall Study|Pregnancy|2
168995|NCT00818168|538708|P1|Overall Study|Lack of Efficacy|18
168996|NCT00818207|538718|P2|Overall Study|Death|5
168997|NCT00818207|538719|P1|Overall Study|Death|3
168998|NCT00818207|538718|P2|Overall Study|Withdrawal by Subject|104
168999|NCT00818207|538719|P1|Overall Study|Withdrawal by Subject|42
169000|NCT00818207|538718|P2|Overall Study|Multiple reasons|12
169001|NCT00818207|538719|P1|Overall Study|Multiple reasons|11
169002|NCT00818207|538718|P2|Overall Study|Lost to Follow-up|146
169003|NCT00818207|538719|P1|Overall Study|Lost to Follow-up|160
169004|NCT00818207|538718|P2|Overall Study|Adverse Event|0
169005|NCT00818207|538719|P1|Overall Study|Adverse Event|6
169006|NCT00818246|538733|P1|Overall Study|Impossible to match pictures|5
169007|NCT00818259|538747|P9|Part V|Adverse Event|0
169008|NCT00818259|538748|P8|Part V|Adverse Event|1
169009|NCT00818259|538749|P7|Part V|Adverse Event|0
169010|NCT00818259|538750|P6|Part V|Adverse Event|0
169011|NCT00818259|538751|P5|Part V|Adverse Event|0
169012|NCT00818259|538752|P4|Part V|Adverse Event|0
169013|NCT00818259|538753|P3|Part V|Adverse Event|0
169014|NCT00818259|538754|P2|Part V|Adverse Event|0
169015|NCT00818259|538755|P1|Part V|Adverse Event|0
169016|NCT00818259|538747|P9|Part IV|Physician Decision|0
169017|NCT00818259|538748|P8|Part IV|Physician Decision|0
169018|NCT00818259|538749|P7|Part IV|Physician Decision|0
169019|NCT00818259|538750|P6|Part IV|Physician Decision|1
169020|NCT00818259|538751|P5|Part IV|Physician Decision|0
169021|NCT00818259|538752|P4|Part IV|Physician Decision|0
169022|NCT00818259|538753|P3|Part IV|Physician Decision|0
169023|NCT00818259|538754|P2|Part IV|Physician Decision|0
169024|NCT00818259|538755|P1|Part IV|Physician Decision|0
169025|NCT00818259|538747|P9|Part II|Not Treated|0
169026|NCT00818259|538748|P8|Part II|Not Treated|0
169027|NCT00818259|538749|P7|Part II|Not Treated|0
169028|NCT00818259|538750|P6|Part II|Not Treated|0
169029|NCT00818259|538751|P5|Part II|Not Treated|0
169030|NCT00818259|538752|P4|Part II|Not Treated|1
169031|NCT00818259|538753|P3|Part II|Not Treated|0
169032|NCT00818259|538754|P2|Part II|Not Treated|0
169033|NCT00818259|538755|P1|Part II|Not Treated|0
169034|NCT00818259|538747|P9|Part II|Lack of Efficacy|0
169035|NCT00818259|538748|P8|Part II|Lack of Efficacy|0
169036|NCT00818259|538749|P7|Part II|Lack of Efficacy|0
169037|NCT00818259|538750|P6|Part II|Lack of Efficacy|0
169038|NCT00818259|538751|P5|Part II|Lack of Efficacy|0
169039|NCT00818259|538752|P4|Part II|Lack of Efficacy|1
169040|NCT00818259|538753|P3|Part II|Lack of Efficacy|0
169041|NCT00818259|538754|P2|Part II|Lack of Efficacy|0
169042|NCT00818259|538755|P1|Part II|Lack of Efficacy|0
169043|NCT00818259|538747|P9|Part II|Physician Decision|0
169044|NCT00818259|538748|P8|Part II|Physician Decision|0
169045|NCT00818259|538749|P7|Part II|Physician Decision|0
169046|NCT00818259|538750|P6|Part II|Physician Decision|0
169047|NCT00818259|538751|P5|Part II|Physician Decision|0
169048|NCT00818259|538752|P4|Part II|Physician Decision|0
169049|NCT00818259|538753|P3|Part II|Physician Decision|1
169050|NCT00818259|538754|P2|Part II|Physician Decision|0
169051|NCT00818259|538755|P1|Part II|Physician Decision|0
169052|NCT00818259|538747|P9|Part I|Withdrawal by Subject|0
169053|NCT00818259|538748|P8|Part I|Withdrawal by Subject|0
169054|NCT00818259|538749|P7|Part I|Withdrawal by Subject|0
169055|NCT00818259|538750|P6|Part I|Withdrawal by Subject|0
169056|NCT00818259|538751|P5|Part I|Withdrawal by Subject|0
169057|NCT00818259|538752|P4|Part I|Withdrawal by Subject|0
169058|NCT00818259|538753|P3|Part I|Withdrawal by Subject|0
169059|NCT00818259|538754|P2|Part I|Withdrawal by Subject|0
169060|NCT00818259|538755|P1|Part I|Withdrawal by Subject|1
169061|NCT00818389|538847|P2|Overall Study|Adverse Event|1
169062|NCT00818389|538848|P1|Overall Study|Adverse Event|0
169063|NCT00818389|538847|P2|Overall Study|Withdrawal by Subject|2
169064|NCT00818389|538848|P1|Overall Study|Withdrawal by Subject|2
169065|NCT00818389|538847|P2|Overall Study|ALS Disease Progression|0
169066|NCT00818389|538848|P1|Overall Study|ALS Disease Progression|1
169067|NCT00818389|538847|P2|Overall Study|Death|3
169068|NCT00818389|538848|P1|Overall Study|Death|1
169069|NCT00818441|538860|P2|Overall Study|Study terminated by sponsor|2
169070|NCT00818441|538861|P1|Overall Study|Study terminated by sponsor|11
169071|NCT00818441|538860|P2|Overall Study|Adverse Event|1
169072|NCT00818441|538861|P1|Overall Study|Adverse Event|0
169073|NCT00818441|538860|P2|Overall Study|Withdrawal by Subject|0
169074|NCT00818441|538861|P1|Overall Study|Withdrawal by Subject|2
169075|NCT00818441|538860|P2|Overall Study|Lost to Follow-up|1
169076|NCT00818441|538861|P1|Overall Study|Lost to Follow-up|2
169077|NCT00818441|538860|P2|Overall Study|Unspecified|0
169078|NCT00818441|538861|P1|Overall Study|Unspecified|5
169079|NCT00818441|538860|P2|Overall Study|Death|26
169080|NCT00818441|538861|P1|Overall Study|Death|69
169081|NCT00818454|538881|P4|Treatment Period 3|Adverse Event|1
169082|NCT00818454|538882|P3|Treatment Period 3|Adverse Event|0
169083|NCT00818454|538883|P2|Treatment Period 3|Adverse Event|0
169084|NCT00818454|538884|P1|Treatment Period 3|Adverse Event|0
169085|NCT00818454|538881|P4|Treatment Period 2|not specified|0
169086|NCT00818454|538882|P3|Treatment Period 2|not specified|0
169087|NCT00818454|538883|P2|Treatment Period 2|not specified|1
169088|NCT00818454|538884|P1|Treatment Period 2|not specified|2
169089|NCT00818454|538881|P4|Washout Period of 1 Week|not specified|0
169090|NCT00818454|538882|P3|Washout Period of 1 Week|not specified|0
169091|NCT00818454|538883|P2|Washout Period of 1 Week|not specified|2
169092|NCT00818454|538884|P1|Washout Period of 1 Week|not specified|1
169093|NCT00818454|538881|P4|Washout Period of 1 Week|Protocol Violation|0
169094|NCT00818454|538882|P3|Washout Period of 1 Week|Protocol Violation|0
169095|NCT00818454|538883|P2|Washout Period of 1 Week|Protocol Violation|0
169096|NCT00818454|538884|P1|Washout Period of 1 Week|Protocol Violation|2
169097|NCT00818454|538881|P4|Washout Period of 1 Week|Adverse Event|0
169098|NCT00818454|538882|P3|Washout Period of 1 Week|Adverse Event|0
169099|NCT00818454|538883|P2|Washout Period of 1 Week|Adverse Event|1
169100|NCT00818454|538884|P1|Washout Period of 1 Week|Adverse Event|1
169101|NCT00818454|538881|P4|Treatment Period 1|not specified|0
169102|NCT00818454|538882|P3|Treatment Period 1|not specified|0
169103|NCT00818454|538883|P2|Treatment Period 1|not specified|0
169104|NCT00818454|538884|P1|Treatment Period 1|not specified|3
169105|NCT00818454|538881|P4|Treatment Period 1|Adverse Event|0
169106|NCT00818454|538882|P3|Treatment Period 1|Adverse Event|0
169107|NCT00818454|538883|P2|Treatment Period 1|Adverse Event|1
169108|NCT00818454|538884|P1|Treatment Period 1|Adverse Event|0
169109|NCT00825162|538913|P3|Overall Study|Unable to attend the study visit|0
169110|NCT00825162|538914|P2|Overall Study|Unable to attend the study visit|2
169111|NCT00825162|538915|P1|Overall Study|Unable to attend the study visit|5
169112|NCT00825162|538913|P3|Overall Study|Move away from the study area|0
169113|NCT00825162|538914|P2|Overall Study|Move away from the study area|0
169114|NCT00825162|538915|P1|Overall Study|Move away from the study area|1
169115|NCT00825162|538913|P3|Overall Study|Physician Decision|0
169116|NCT00825162|538914|P2|Overall Study|Physician Decision|0
169117|NCT00825162|538915|P1|Overall Study|Physician Decision|2
169118|NCT00825162|538913|P3|Overall Study|Lost to Follow-up|3
169119|NCT00825162|538914|P2|Overall Study|Lost to Follow-up|6
169120|NCT00825162|538915|P1|Overall Study|Lost to Follow-up|9
169121|NCT00825162|538913|P3|Overall Study|Withdrawal by Subject|3
169122|NCT00825162|538914|P2|Overall Study|Withdrawal by Subject|13
169123|NCT00825162|538915|P1|Overall Study|Withdrawal by Subject|11
169124|NCT00825175|538941|P2|Overall Study|Withdrawal by Subject|5
169125|NCT00825175|538942|P1|Overall Study|Withdrawal by Subject|0
169126|NCT00825682|538972|P2|Overall Study|personal reasons/ inconvenience|5
169127|NCT00825682|538973|P1|Overall Study|personal reasons/ inconvenience|13
169128|NCT00825812|539018|P4|Overall Study|Administrative|5
169129|NCT00825812|539019|P3|Overall Study|Administrative|3
169130|NCT00825812|539020|P2|Overall Study|Administrative|1
169131|NCT00825812|539021|P1|Overall Study|Administrative|0
169132|NCT00825812|539018|P4|Overall Study|Non-compliance with protocol|1
169133|NCT00825812|539019|P3|Overall Study|Non-compliance with protocol|0
169134|NCT00825812|539020|P2|Overall Study|Non-compliance with protocol|0
169135|NCT00825812|539021|P1|Overall Study|Non-compliance with protocol|0
169136|NCT00825812|539018|P4|Overall Study|Subject withdrew consent|2
169137|NCT00825812|539019|P3|Overall Study|Subject withdrew consent|3
169138|NCT00825812|539020|P2|Overall Study|Subject withdrew consent|0
169139|NCT00825812|539021|P1|Overall Study|Subject withdrew consent|0
169140|NCT00825812|539018|P4|Overall Study|Adverse Event|1
169141|NCT00825812|539019|P3|Overall Study|Adverse Event|0
169142|NCT00825812|539020|P2|Overall Study|Adverse Event|0
169143|NCT00825812|539021|P1|Overall Study|Adverse Event|0
169144|NCT00825812|539018|P4|Overall Study|Never entered follow up|1
169145|NCT00825812|539019|P3|Overall Study|Never entered follow up|0
169146|NCT00825812|539020|P2|Overall Study|Never entered follow up|0
169147|NCT00825812|539021|P1|Overall Study|Never entered follow up|0
169148|NCT00825825|539035|P6|Third Medication Period (14 Days)|poor data quality|0
169149|NCT00825825|539036|P5|Third Medication Period (14 Days)|poor data quality|0
169150|NCT00825825|539037|P4|Third Medication Period (14 Days)|poor data quality|0
169151|NCT00825825|539038|P3|Third Medication Period (14 Days)|poor data quality|0
169152|NCT00825825|539039|P2|Third Medication Period (14 Days)|poor data quality|1
169153|NCT00825825|539040|P1|Third Medication Period (14 Days)|poor data quality|0
169154|NCT00825825|539035|P6|Third Medication Period (14 Days)|Protocol Violation|2
169155|NCT00825825|539036|P5|Third Medication Period (14 Days)|Protocol Violation|0
169156|NCT00825825|539037|P4|Third Medication Period (14 Days)|Protocol Violation|0
169157|NCT00825825|539038|P3|Third Medication Period (14 Days)|Protocol Violation|0
169158|NCT00825825|539039|P2|Third Medication Period (14 Days)|Protocol Violation|0
169159|NCT00825825|539040|P1|Third Medication Period (14 Days)|Protocol Violation|0
169160|NCT00825825|539035|P6|Third Medication Period (14 Days)|Adverse Event|0
169161|NCT00825825|539036|P5|Third Medication Period (14 Days)|Adverse Event|0
169162|NCT00825825|539037|P4|Third Medication Period (14 Days)|Adverse Event|0
169163|NCT00825825|539038|P3|Third Medication Period (14 Days)|Adverse Event|0
169164|NCT00825825|539039|P2|Third Medication Period (14 Days)|Adverse Event|1
169165|NCT00825825|539040|P1|Third Medication Period (14 Days)|Adverse Event|0
169166|NCT00825825|539035|P6|Second Medication Period (14 Days)|Protocol Violation|0
169167|NCT00825825|539036|P5|Second Medication Period (14 Days)|Protocol Violation|1
169168|NCT00825825|539037|P4|Second Medication Period (14 Days)|Protocol Violation|0
169169|NCT00825825|539038|P3|Second Medication Period (14 Days)|Protocol Violation|0
169170|NCT00825825|539039|P2|Second Medication Period (14 Days)|Protocol Violation|0
169171|NCT00825825|539040|P1|Second Medication Period (14 Days)|Protocol Violation|1
169172|NCT00825825|539035|P6|Second Medication Period (14 Days)|Physician Decision|0
169173|NCT00825825|539036|P5|Second Medication Period (14 Days)|Physician Decision|0
169174|NCT00825825|539037|P4|Second Medication Period (14 Days)|Physician Decision|2
169175|NCT00825825|539038|P3|Second Medication Period (14 Days)|Physician Decision|0
169176|NCT00825825|539039|P2|Second Medication Period (14 Days)|Physician Decision|0
169177|NCT00825825|539040|P1|Second Medication Period (14 Days)|Physician Decision|1
169178|NCT00825825|539035|P6|First Medication Period (14 Days)|Physician Decision|1
169179|NCT00825825|539036|P5|First Medication Period (14 Days)|Physician Decision|0
169180|NCT00825825|539037|P4|First Medication Period (14 Days)|Physician Decision|0
169181|NCT00825825|539038|P3|First Medication Period (14 Days)|Physician Decision|1
169182|NCT00825825|539039|P2|First Medication Period (14 Days)|Physician Decision|0
169183|NCT00825825|539040|P1|First Medication Period (14 Days)|Physician Decision|2
169184|NCT00825825|539035|P6|First Medication Period (14 Days)|Adverse Event|1
169185|NCT00825825|539036|P5|First Medication Period (14 Days)|Adverse Event|0
169186|NCT00825825|539037|P4|First Medication Period (14 Days)|Adverse Event|0
169187|NCT00825825|539038|P3|First Medication Period (14 Days)|Adverse Event|0
169188|NCT00825825|539039|P2|First Medication Period (14 Days)|Adverse Event|0
169189|NCT00825825|539040|P1|First Medication Period (14 Days)|Adverse Event|1
169190|NCT00825916|539055|P3|Overall Study|Lost to Follow-up|1
169191|NCT00825916|539056|P2|Overall Study|Lost to Follow-up|2
169192|NCT00825916|539057|P1|Overall Study|Lost to Follow-up|4
169193|NCT00825994|539098|P1|Overall Study|Placebo Responder at V2|1
169194|NCT00825994|539098|P1|Overall Study|Protocol Violation|1
169195|NCT00825994|539098|P1|Overall Study|Lost to Follow-up|1
169196|NCT00825994|539098|P1|Overall Study|Withdrawal by Subject|2
169197|NCT00826111|539113|P2|Overall Study|Physician Decision|1
169198|NCT00826111|539114|P1|Overall Study|Physician Decision|1
169199|NCT00826111|539113|P2|Overall Study|Withdrawal by Subject|0
169200|NCT00826111|539114|P1|Overall Study|Withdrawal by Subject|5
169201|NCT00826111|539113|P2|Overall Study|Protocol Violation|0
169202|NCT00826111|539114|P1|Overall Study|Protocol Violation|1
169203|NCT00826111|539113|P2|Overall Study|Lost to Follow-up|1
169204|NCT00826111|539114|P1|Overall Study|Lost to Follow-up|0
169205|NCT00826176|539138|P2|Overall Study|Administrative|0
169206|NCT00826176|539139|P1|Overall Study|Administrative|9
169207|NCT00826176|539138|P2|Overall Study|Subject Withdrew Consent|0
169208|NCT00826176|539139|P1|Overall Study|Subject Withdrew Consent|3
169209|NCT00826176|539138|P2|Overall Study|Lost to Follow-up|0
169210|NCT00826176|539139|P1|Overall Study|Lost to Follow-up|1
169211|NCT00826228|539164|P1|Overall Study|Withdrawal by Subject|1
169212|NCT00826267|539172|P3|Overall Study|Other Adverse Event|0
169213|NCT00826267|539173|P2|Overall Study|Other Adverse Event|0
169214|NCT00826267|539174|P1|Overall Study|Other Adverse Event|1
169215|NCT00826280|539195|P3|Overall Study|One or more non-interpretable scan|1
169216|NCT00826280|539196|P2|Overall Study|One or more non-interpretable scan|1
169217|NCT00826280|539197|P1|Overall Study|One or more non-interpretable scan|0
169218|NCT00826280|539195|P3|Overall Study|Machine Failure|0
169219|NCT00826280|539196|P2|Overall Study|Machine Failure|1
169220|NCT00826280|539197|P1|Overall Study|Machine Failure|1
169221|NCT00826280|539195|P3|Overall Study|Interpretation Failure|0
169222|NCT00826280|539196|P2|Overall Study|Interpretation Failure|0
169223|NCT00826280|539197|P1|Overall Study|Interpretation Failure|1
169224|NCT00826280|539195|P3|Overall Study|Reversible ischemic defect not present|44
169225|NCT00826280|539196|P2|Overall Study|Reversible ischemic defect not present|40
169226|NCT00826280|539197|P1|Overall Study|Reversible ischemic defect not present|43
169227|NCT00826280|539195|P3|Overall Study|Sponsor discontinued subject or study|0
169228|NCT00826280|539196|P2|Overall Study|Sponsor discontinued subject or study|0
169229|NCT00826280|539197|P1|Overall Study|Sponsor discontinued subject or study|1
169230|NCT00826280|539195|P3|Overall Study|Lost to Follow-up|0
169231|NCT00826280|539196|P2|Overall Study|Lost to Follow-up|1
169232|NCT00826280|539197|P1|Overall Study|Lost to Follow-up|0
169233|NCT00826280|539195|P3|Overall Study|Adverse Event|0
169234|NCT00826280|539196|P2|Overall Study|Adverse Event|3
169235|NCT00826280|539197|P1|Overall Study|Adverse Event|1
169236|NCT00826280|539195|P3|Overall Study|Randomized but drug not received|1
169237|NCT00826280|539196|P2|Overall Study|Randomized but drug not received|0
169238|NCT00826280|539197|P1|Overall Study|Randomized but drug not received|1
169239|NCT00826449|539225|P1|Overall Study|Withdrawal by Subject|1
169240|NCT00826449|539225|P1|Overall Study|Disease Progression|4
169241|NCT00826540|539231|P1|Overall Study|Withdrawal by Subject|1
169242|NCT00826540|539231|P1|Overall Study|ineligible|3
169243|NCT00826618|539235|P1|Overall Study|Withdrawal by Subject|1
169244|NCT00826943|539243|P6|Overall Study|Withdrawal by Subject|0
169245|NCT00826943|539244|P5|Overall Study|Withdrawal by Subject|1
169246|NCT00826943|539245|P4|Overall Study|Withdrawal by Subject|0
169247|NCT00826943|539246|P3|Overall Study|Withdrawal by Subject|0
169248|NCT00826943|539247|P2|Overall Study|Withdrawal by Subject|0
169249|NCT00826943|539248|P1|Overall Study|Withdrawal by Subject|0
169250|NCT00827112|539284|P2|Overall Study|Unspecified|3
169251|NCT00827112|539285|P1|Overall Study|Unspecified|1
169252|NCT00827112|539284|P2|Overall Study|Randomized but not treated|3
169253|NCT00827112|539285|P1|Overall Study|Randomized but not treated|5
169254|NCT00827112|539284|P2|Overall Study|Withdrawal by Subject|1
169255|NCT00827112|539285|P1|Overall Study|Withdrawal by Subject|2
169256|NCT00827112|539284|P2|Overall Study|Protocol Violation|2
169257|NCT00827112|539285|P1|Overall Study|Protocol Violation|0
169258|NCT00827112|539284|P2|Overall Study|Pregnancy|1
169259|NCT00827112|539285|P1|Overall Study|Pregnancy|0
169260|NCT00827112|539284|P2|Overall Study|Lost to Follow-up|2
169261|NCT00827112|539285|P1|Overall Study|Lost to Follow-up|3
169262|NCT00827112|539284|P2|Overall Study|Lack of Efficacy|0
169263|NCT00827112|539285|P1|Overall Study|Lack of Efficacy|2
169264|NCT00827112|539284|P2|Overall Study|Adverse Event|0
169265|NCT00827112|539285|P1|Overall Study|Adverse Event|2
169266|NCT00827242|539320|P2|Overall Study|Lack of Efficacy|0
169267|NCT00827242|539321|P1|Overall Study|Lack of Efficacy|1
169268|NCT00827242|539320|P2|Overall Study|Death|0
169269|NCT00827242|539321|P1|Overall Study|Death|1
169270|NCT00827242|539320|P2|Overall Study|Physician Decision|0
169271|NCT00827242|539321|P1|Overall Study|Physician Decision|2
169272|NCT00827242|539320|P2|Overall Study|Entry Criteria Not Met|1
169273|NCT00827242|539321|P1|Overall Study|Entry Criteria Not Met|4
169274|NCT00827242|539320|P2|Overall Study|Adverse Event Excluding Death|1
169275|NCT00827242|539321|P1|Overall Study|Adverse Event Excluding Death|2
169276|NCT00827242|539320|P2|Overall Study|Lost to Follow-up|3
169277|NCT00827242|539321|P1|Overall Study|Lost to Follow-up|0
169278|NCT00827242|539320|P2|Overall Study|Protocol Violation|3
169279|NCT00827242|539321|P1|Overall Study|Protocol Violation|1
169280|NCT00827242|539320|P2|Overall Study|Withdrawal by Subject|4
169281|NCT00827242|539321|P1|Overall Study|Withdrawal by Subject|2
169282|NCT00827372|539362|P1|Overall Study|Lack of Efficacy|3
169283|NCT00827372|539362|P1|Overall Study|Adverse Event|5
169284|NCT00827502|539370|P1|Overall Study|Withdrawal by Subject|5
169285|NCT00827502|539370|P1|Overall Study|Lost to Follow-up|4
169286|NCT00827502|539370|P1|Overall Study|Adverse Event|1
169287|NCT00827502|539370|P1|Overall Study|randomized but not treated|11
169288|NCT00827541|539378|P2|Overall Study|Lack of effectiveness|0
169289|NCT00827541|539379|P1|Overall Study|Lack of effectiveness|1
169290|NCT00827541|539378|P2|Overall Study|Pathogen not susceptible|0
169291|NCT00827541|539379|P1|Overall Study|Pathogen not susceptible|1
169292|NCT00827541|539378|P2|Overall Study|Unspecified|3
169293|NCT00827541|539379|P1|Overall Study|Unspecified|1
169294|NCT00827541|539378|P2|Overall Study|Exitus|8
169295|NCT00827541|539379|P1|Overall Study|Exitus|1
169296|NCT00827567|539391|P1|Overall Study|Progression of Disease/Screen Failure|4
169297|NCT00827606|539397|P2|Overall Study|Adverse Event|2
169298|NCT00827606|539398|P1|Overall Study|Adverse Event|4
169299|NCT00827606|539397|P2|Overall Study|LDL below 2.59 mmol/L|12
169300|NCT00827606|539398|P1|Overall Study|LDL below 2.59 mmol/L|4
169301|NCT00827606|539397|P2|Overall Study|Not specified|13
169302|NCT00827606|539398|P1|Overall Study|Not specified|5
169303|NCT00827606|539397|P2|Overall Study|Pregnancy|1
169304|NCT00827606|539398|P1|Overall Study|Pregnancy|0
169305|NCT00827606|539397|P2|Overall Study|Withdrawal by Subject|6
169306|NCT00827606|539398|P1|Overall Study|Withdrawal by Subject|7
169307|NCT00827606|539397|P2|Overall Study|Lost to Follow-up|1
169308|NCT00827606|539398|P1|Overall Study|Lost to Follow-up|3
169309|NCT00827606|539397|P2|Overall Study|Protocol Violation|3
169310|NCT00827606|539398|P1|Overall Study|Protocol Violation|4
169311|NCT00827632|539461|P2|Overall Study|Early withdrawal|11
169312|NCT00827632|539462|P1|Overall Study|Early withdrawal|14
169313|NCT00827632|539461|P2|Overall Study|Lost to Follow-up|12
169314|NCT00827632|539462|P1|Overall Study|Lost to Follow-up|8
169315|NCT00827827|539470|P2|Overall Study|Burned with water at home|0
169316|NCT00827827|539471|P1|Overall Study|Burned with water at home|1
169317|NCT00827827|539470|P2|Overall Study|Transportation issues|0
169318|NCT00827827|539471|P1|Overall Study|Transportation issues|1
169319|NCT00827827|539470|P2|Overall Study|Gout|0
169320|NCT00827827|539471|P1|Overall Study|Gout|1
169321|NCT00827827|539470|P2|Overall Study|Another cerebrovascular accident (CVA)|0
169322|NCT00827827|539471|P1|Overall Study|Another cerebrovascular accident (CVA)|1
169323|NCT00827827|539470|P2|Overall Study|Fall at home- hospitalization|0
169324|NCT00827827|539471|P1|Overall Study|Fall at home- hospitalization|1
169325|NCT00827827|539470|P2|Overall Study|Lost to Follow-up|0
169326|NCT00827827|539471|P1|Overall Study|Lost to Follow-up|3
169327|NCT00827918|539516|P3|Overall Study|Withdrawal by Subject|6
169328|NCT00827918|539517|P2|Overall Study|Withdrawal by Subject|2
169329|NCT00827918|539518|P1|Overall Study|Withdrawal by Subject|6
169330|NCT00827918|539516|P3|Overall Study|Protocol Violation|0
169331|NCT00827918|539517|P2|Overall Study|Protocol Violation|1
169332|NCT00827918|539518|P1|Overall Study|Protocol Violation|0
169333|NCT00827918|539516|P3|Overall Study|Progressive Disease|0
169334|NCT00827918|539517|P2|Overall Study|Progressive Disease|1
169335|NCT00827918|539518|P1|Overall Study|Progressive Disease|1
169336|NCT00827918|539516|P3|Overall Study|Pregnancy|0
169337|NCT00827918|539517|P2|Overall Study|Pregnancy|1
169338|NCT00827918|539518|P1|Overall Study|Pregnancy|0
169339|NCT00827918|539516|P3|Overall Study|Physician Decision|0
169340|NCT00827918|539517|P2|Overall Study|Physician Decision|0
169341|NCT00827918|539518|P1|Overall Study|Physician Decision|1
169342|NCT00827918|539516|P3|Overall Study|Lack of Efficacy|15
169343|NCT00827918|539517|P2|Overall Study|Lack of Efficacy|4
169344|NCT00827918|539518|P1|Overall Study|Lack of Efficacy|16
169345|NCT00827918|539516|P3|Overall Study|Adverse Event|0
169346|NCT00827918|539517|P2|Overall Study|Adverse Event|0
169347|NCT00827918|539518|P1|Overall Study|Adverse Event|4
169348|NCT00827931|539546|P2|Overall Study|Unspecified|0
169349|NCT00827931|539547|P1|Overall Study|Unspecified|1
169350|NCT00827931|539546|P2|Overall Study|Withdrawal by Subject|1
169351|NCT00827931|539547|P1|Overall Study|Withdrawal by Subject|0
169352|NCT00827931|539546|P2|Overall Study|Lost to Follow-up|0
169353|NCT00827931|539547|P1|Overall Study|Lost to Follow-up|1
169354|NCT00827931|539546|P2|Overall Study|Adverse Event|0
169355|NCT00827931|539547|P1|Overall Study|Adverse Event|1
169356|NCT00827931|539546|P2|Overall Study|Death|5
169357|NCT00827931|539547|P1|Overall Study|Death|3
169358|NCT00821431|539601|P2|Overall Study|Physician Decision|1
169359|NCT00821431|539602|P1|Overall Study|Physician Decision|0
169360|NCT00821431|539601|P2|Overall Study|Protocol Violation|1
169361|NCT00821431|539602|P1|Overall Study|Protocol Violation|3
169362|NCT00821431|539601|P2|Overall Study|Lost to Follow-up|0
169363|NCT00821431|539602|P1|Overall Study|Lost to Follow-up|1
169364|NCT00821431|539601|P2|Overall Study|Withdrawal by Subject|0
169365|NCT00821431|539602|P1|Overall Study|Withdrawal by Subject|5
169366|NCT00821431|539601|P2|Overall Study|Adverse Event|3
169367|NCT00821431|539602|P1|Overall Study|Adverse Event|6
169368|NCT00821509|539613|P3|Overall Study|Withdrawal by Subject|34
169369|NCT00821509|539614|P2|Overall Study|Withdrawal by Subject|11
169370|NCT00821509|539615|P1|Overall Study|Withdrawal by Subject|12
169371|NCT00821587|539628|P2|Overall Study|Physician Decision|1
169372|NCT00821587|539629|P1|Overall Study|Physician Decision|0
169373|NCT00821678|539637|P2|Overall Study|Death|2
169374|NCT00821678|539638|P1|Overall Study|Death|0
169375|NCT00821678|539637|P2|Overall Study|Lost to Follow-up|12
169376|NCT00821678|539638|P1|Overall Study|Lost to Follow-up|13
169377|NCT00821678|539637|P2|Overall Study|Withdrawal by Subject|0
169378|NCT00821678|539638|P1|Overall Study|Withdrawal by Subject|8
169379|NCT00821873|539669|P1|Overall Study|Lost to Follow-up|4
169380|NCT00822172|539692|P2|Overall Study|Other|1
169381|NCT00822172|539693|P1|Overall Study|Other|0
169382|NCT00822172|539692|P2|Overall Study|site closed|1
169383|NCT00822172|539693|P1|Overall Study|site closed|0
169384|NCT00822172|539692|P2|Overall Study|Withdrawal by Subject|4
169385|NCT00822172|539693|P1|Overall Study|Withdrawal by Subject|1
169386|NCT00822172|539692|P2|Overall Study|Lost to Follow-up|1
169387|NCT00822172|539693|P1|Overall Study|Lost to Follow-up|3
169388|NCT00822172|539692|P2|Overall Study|Death|0
169389|NCT00822172|539693|P1|Overall Study|Death|1
169390|NCT00822172|539692|P2|Overall Study|Adverse Event|12
169391|NCT00822172|539693|P1|Overall Study|Adverse Event|10
169392|NCT00822237|539775|P2|Dose 2 Vaccination|Lost to Follow-up|9
169393|NCT00822237|539776|P1|Dose 2 Vaccination|Lost to Follow-up|2
169394|NCT00822237|539775|P2|Dose 2 Vaccination|Withdrawal by Subject|2
169395|NCT00822237|539776|P1|Dose 2 Vaccination|Withdrawal by Subject|2
169396|NCT00822237|539775|P2|Dose 1 Vaccination|Lost to Follow-up|12
169397|NCT00822237|539776|P1|Dose 1 Vaccination|Lost to Follow-up|9
169398|NCT00822237|539775|P2|Dose 1 Vaccination|Withdrawal by Subject|14
169399|NCT00822237|539776|P1|Dose 1 Vaccination|Withdrawal by Subject|13
169400|NCT00822237|539775|P2|Dose 1 Vaccination|Not vaccinated|0
169401|NCT00822237|539776|P1|Dose 1 Vaccination|Not vaccinated|3
169402|NCT00828113|539857|P2|Overall Study|Lost to Follow-up|5
169403|NCT00828113|539858|P1|Overall Study|Lost to Follow-up|3
169404|NCT00828113|539857|P2|Overall Study|Withdrawal by Subject|26
169405|NCT00828113|539858|P1|Overall Study|Withdrawal by Subject|27
169406|NCT00828139|539868|P4|Overall Study|Not specified|2
169407|NCT00828139|539869|P3|Overall Study|Not specified|5
169408|NCT00828139|539870|P2|Overall Study|Not specified|2
169409|NCT00828139|539871|P1|Overall Study|Not specified|4
169410|NCT00828139|539868|P4|Overall Study|Disease Progression|39
169411|NCT00828139|539869|P3|Overall Study|Disease Progression|35
169412|NCT00828139|539870|P2|Overall Study|Disease Progression|33
169413|NCT00828139|539871|P1|Overall Study|Disease Progression|24
169414|NCT00828139|539868|P4|Overall Study|Refusal unrelated to toxicity|3
169415|NCT00828139|539869|P3|Overall Study|Refusal unrelated to toxicity|5
169416|NCT00828139|539870|P2|Overall Study|Refusal unrelated to toxicity|4
169417|NCT00828139|539871|P1|Overall Study|Refusal unrelated to toxicity|3
169418|NCT00828139|539868|P4|Overall Study|Death|2
169419|NCT00828139|539869|P3|Overall Study|Death|0
169420|NCT00828139|539870|P2|Overall Study|Death|1
169421|NCT00828139|539871|P1|Overall Study|Death|2
169422|NCT00828139|539868|P4|Overall Study|Adverse Event|5
169423|NCT00828139|539869|P3|Overall Study|Adverse Event|10
169424|NCT00828139|539870|P2|Overall Study|Adverse Event|1
169425|NCT00828139|539871|P1|Overall Study|Adverse Event|8
169426|NCT00828204|539917|P2|Extension Study|Physician Decision|2
169427|NCT00828204|539918|P1|Extension Study|Physician Decision|0
169428|NCT00828204|539917|P2|Extension Study|Lost to Follow-up|1
169429|NCT00828204|539918|P1|Extension Study|Lost to Follow-up|0
169430|NCT00828204|539917|P2|Main Study: After Study Restart|Noncompliance|1
169431|NCT00828204|539918|P1|Main Study: After Study Restart|Noncompliance|0
169432|NCT00828204|539917|P2|Main Study: After Study Restart|Adverse Event|2
169433|NCT00828204|539918|P1|Main Study: After Study Restart|Adverse Event|0
169434|NCT00828204|539917|P2|Main Study: Prior to Study Suspension|Study Suspension|0
169435|NCT00828204|539918|P1|Main Study: Prior to Study Suspension|Study Suspension|11
169436|NCT00828204|539917|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
169437|NCT00828204|539918|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
169438|NCT00828204|539917|P2|Main Study: Prior to Study Suspension|Adverse Event|0
169439|NCT00828204|539918|P1|Main Study: Prior to Study Suspension|Adverse Event|1
169440|NCT00828321|539952|P2|Second Intervention|Protocol Violation|1
169441|NCT00828321|539953|P1|Second Intervention|Protocol Violation|0
169442|NCT00828321|539952|P2|Washout of 42 Days|Withdrawal by Subject|0
169443|NCT00828321|539953|P1|Washout of 42 Days|Withdrawal by Subject|2
169444|NCT00829166|539976|P2|Overall Study|Reason Not Specified|3
169445|NCT00829166|539977|P1|Overall Study|Reason Not Specified|3
169446|NCT00829166|539976|P2|Overall Study|Sponsor’s Decision|98
169447|NCT00829166|539977|P1|Overall Study|Sponsor’s Decision|137
169448|NCT00829166|539976|P2|Overall Study|Subject's Decision|55
169449|NCT00829166|539977|P1|Overall Study|Subject's Decision|41
169450|NCT00829166|539976|P2|Overall Study|Physician's Decision|3
169451|NCT00829166|539977|P1|Overall Study|Physician's Decision|4
169452|NCT00829166|539976|P2|Overall Study|Lost to Follow-up|4
169453|NCT00829166|539977|P1|Overall Study|Lost to Follow-up|5
169454|NCT00829166|539976|P2|Overall Study|Death|333
169455|NCT00829166|539977|P1|Overall Study|Death|305
169456|NCT00829179|540016|P1|Overall Study|Withdrawal by Subject|1
169457|NCT00829244|540022|P2|Overall Study|No embryo cleavage|2
169458|NCT00829244|540023|P1|Overall Study|No embryo cleavage|0
169459|NCT00829244|540022|P2|Overall Study|All embryos discarded|3
169460|NCT00829244|540023|P1|Overall Study|All embryos discarded|0
169461|NCT00829244|540022|P2|Overall Study|No fertilization|2
169462|NCT00829244|540023|P1|Overall Study|No fertilization|2
169463|NCT00829244|540022|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
169464|NCT00829244|540023|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
169465|NCT00829244|540022|P2|Overall Study|Lack of ovarian response to stimulation|5
169466|NCT00829244|540023|P1|Overall Study|Lack of ovarian response to stimulation|9
169467|NCT00829244|540022|P2|Overall Study|Protocol Violation|0
169468|NCT00829244|540023|P1|Overall Study|Protocol Violation|1
169469|NCT00829244|540022|P2|Overall Study|Adverse Event|3
169470|NCT00829244|540023|P1|Overall Study|Adverse Event|1
169471|NCT00829283|540055|P2|Overall Study|Lost to Follow-up|25
169472|NCT00829283|540056|P1|Overall Study|Lost to Follow-up|7
169473|NCT00829296|540066|P2|Overall Study|Adverse Event|4
169474|NCT00829296|540067|P1|Overall Study|Adverse Event|5
169475|NCT00829309|540081|P2|Washout: 7 Days|Protocol Violation|0
169476|NCT00829309|540082|P1|Washout: 7 Days|Protocol Violation|1
169477|NCT00829387|540092|P2|Overall Study|Disqualified by PI|0
169478|NCT00829387|540093|P1|Overall Study|Disqualified by PI|1
169479|NCT00829387|540092|P2|Overall Study|Withdrawal by Subject|3
169480|NCT00829387|540093|P1|Overall Study|Withdrawal by Subject|2
169481|NCT00829426|540111|P2|Washout: 7 Days|Withdrawal by Subject|0
169482|NCT00829426|540112|P1|Washout: 7 Days|Withdrawal by Subject|1
169483|NCT00829439|540120|P4|Overall Study|Adverse Event|0
169484|NCT00829439|540121|P3|Overall Study|Adverse Event|1
169485|NCT00829439|540122|P2|Overall Study|Adverse Event|0
169486|NCT00829439|540123|P1|Overall Study|Adverse Event|0
169487|NCT00829452|540129|P2|Second Intervention|Physician Decision|1
169488|NCT00829452|540130|P1|Second Intervention|Physician Decision|0
169489|NCT00829452|540129|P2|Washout of 42 Days|Withdrawal by Subject|1
169490|NCT00829452|540130|P1|Washout of 42 Days|Withdrawal by Subject|0
169491|NCT00829452|540129|P2|First Intervention|Withdrawal by Subject|1
169492|NCT00829452|540130|P1|First Intervention|Withdrawal by Subject|0
169493|NCT00829504|540144|P2|Second Intervention|Physician Decision|0
169494|NCT00829504|540145|P1|Second Intervention|Physician Decision|1
169495|NCT00829504|540144|P2|Washout of 7 Days|Withdrawal by Subject|0
169496|NCT00829504|540145|P1|Washout of 7 Days|Withdrawal by Subject|1
169497|NCT00829504|540144|P2|First Intervention|Adverse Event|0
169498|NCT00829504|540145|P1|First Intervention|Adverse Event|1
169499|NCT00829530|540155|P2|Second Intervention|Intolerance to Venopuncture|0
169500|NCT00829530|540156|P1|Second Intervention|Intolerance to Venopuncture|1
169501|NCT00829530|540155|P2|First Intervention|Intolerance to Venopuncture|1
169502|NCT00829530|540156|P1|First Intervention|Intolerance to Venopuncture|0
169503|NCT00829530|540155|P2|First Intervention|Adverse Event|1
169504|NCT00829530|540156|P1|First Intervention|Adverse Event|0
169505|NCT00829621|540170|P2|Overall Study|Lost to Follow-up|4
169506|NCT00829621|540171|P1|Overall Study|Lost to Follow-up|3
169507|NCT00829621|540170|P2|Overall Study|Death|0
169508|NCT00829621|540171|P1|Overall Study|Death|1
169509|NCT00829673|540179|P2|Washout of 7 Days|Withdrawal by Subject|0
169510|NCT00829673|540180|P1|Washout of 7 Days|Withdrawal by Subject|1
169511|NCT00829712|540199|P2|Washout of 7 Days|Withdrawal by Subject|1
169512|NCT00829712|540200|P1|Washout of 7 Days|Withdrawal by Subject|0
169513|NCT00829764|540226|P2|First Intervention|Withdrawal by Subject|1
169514|NCT00829764|540227|P1|First Intervention|Withdrawal by Subject|1
169515|NCT00829764|540226|P2|First Intervention|Adverse Event|0
169516|NCT00829764|540227|P1|First Intervention|Adverse Event|1
169517|NCT00829790|540237|P2|Washout of 14 Days|Withdrawal by Subject|1
169518|NCT00829790|540238|P1|Washout of 14 Days|Withdrawal by Subject|0
169519|NCT00829829|540249|P3|Overall Study|Other than specified above|1
169520|NCT00829829|540250|P2|Overall Study|Other than specified above|2
169521|NCT00829829|540251|P1|Overall Study|Other than specified above|2
169522|NCT00829829|540249|P3|Overall Study|Lost to Follow-up|3
169523|NCT00829829|540250|P2|Overall Study|Lost to Follow-up|3
169524|NCT00829829|540251|P1|Overall Study|Lost to Follow-up|7
169525|NCT00829829|540249|P3|Overall Study|Decision by the Sponsor|2
169526|NCT00829829|540250|P2|Overall Study|Decision by the Sponsor|0
169527|NCT00829829|540251|P1|Overall Study|Decision by the Sponsor|1
169528|NCT00829829|540249|P3|Overall Study|Withdrawal by Subject|2
169529|NCT00829829|540250|P2|Overall Study|Withdrawal by Subject|4
169530|NCT00829829|540251|P1|Overall Study|Withdrawal by Subject|8
169531|NCT00829829|540249|P3|Overall Study|Adverse Event|3
169532|NCT00829829|540250|P2|Overall Study|Adverse Event|4
169533|NCT00829829|540251|P1|Overall Study|Adverse Event|4
169534|NCT00829829|540249|P3|Overall Study|Protocol Violation|0
169535|NCT00829829|540250|P2|Overall Study|Protocol Violation|3
169536|NCT00829829|540251|P1|Overall Study|Protocol Violation|0
169537|NCT00829868|540276|P2|Washout|Physician Decision|0
169538|NCT00829868|540277|P1|Washout|Physician Decision|1
169539|NCT00829933|540289|P4|Overall Study|withdrew before treatment started|9
169540|NCT00829933|540290|P3|Overall Study|withdrew before treatment started|2
169541|NCT00829933|540291|P2|Overall Study|withdrew before treatment started|1
169542|NCT00829933|540292|P1|Overall Study|withdrew before treatment started|5
169543|NCT00829933|540289|P4|Overall Study|Protocol Violation|0
169544|NCT00829933|540290|P3|Overall Study|Protocol Violation|0
169545|NCT00829933|540291|P2|Overall Study|Protocol Violation|1
169546|NCT00829933|540292|P1|Overall Study|Protocol Violation|2
169547|NCT00829933|540289|P4|Overall Study|Pregnancy|2
169548|NCT00829933|540290|P3|Overall Study|Pregnancy|0
169549|NCT00829933|540291|P2|Overall Study|Pregnancy|0
169550|NCT00829933|540292|P1|Overall Study|Pregnancy|0
169551|NCT00829933|540289|P4|Overall Study|Physician Decision|1
169552|NCT00829933|540290|P3|Overall Study|Physician Decision|8
169553|NCT00829933|540291|P2|Overall Study|Physician Decision|7
169554|NCT00829933|540292|P1|Overall Study|Physician Decision|5
169555|NCT00829933|540289|P4|Overall Study|Lack of Efficacy|0
169556|NCT00829933|540290|P3|Overall Study|Lack of Efficacy|0
169557|NCT00829933|540291|P2|Overall Study|Lack of Efficacy|1
169558|NCT00829933|540292|P1|Overall Study|Lack of Efficacy|0
169559|NCT00829933|540289|P4|Overall Study|Death|1
169560|NCT00829933|540290|P3|Overall Study|Death|1
169561|NCT00829933|540291|P2|Overall Study|Death|0
169562|NCT00829933|540292|P1|Overall Study|Death|0
169563|NCT00829933|540289|P4|Overall Study|Adverse Event|1
169564|NCT00829933|540290|P3|Overall Study|Adverse Event|2
169565|NCT00829933|540291|P2|Overall Study|Adverse Event|3
169566|NCT00829933|540292|P1|Overall Study|Adverse Event|2
169567|NCT00829998|540321|P2|Washout|Adverse Event|1
169568|NCT00829998|540322|P1|Washout|Adverse Event|0
169569|NCT00830024|540332|P2|Washout: 7 Days|Withdrawal by Subject|0
169570|NCT00830024|540333|P1|Washout: 7 Days|Withdrawal by Subject|1
169571|NCT00830037|540343|P2|Overall Study|Active when terminated by DSMB|14
169572|NCT00830037|540344|P1|Overall Study|Active when terminated by DSMB|15
169573|NCT00830037|540343|P2|Overall Study|Lost to Follow-up|2
169574|NCT00830037|540344|P1|Overall Study|Lost to Follow-up|1
169575|NCT00830037|540343|P2|Overall Study|Withdrawal by Subject|3
169576|NCT00830037|540344|P1|Overall Study|Withdrawal by Subject|2
169577|NCT00830115|540361|P1|Overall Study|Improvement/recovery|1
169578|NCT00830115|540361|P1|Overall Study|Adverse Event|2
169579|NCT00830128|540377|P1|Overall Study|Operating a vehicle|1
169580|NCT00830128|540377|P1|Overall Study|Work obligation|1
169581|NCT00830128|540377|P1|Overall Study|Relocation|1
169582|NCT00830128|540377|P1|Overall Study|Family obligation|1
169583|NCT00830128|540377|P1|Overall Study|Withdrawal by Subject|2
169584|NCT00830128|540377|P1|Overall Study|Protocol Violation|1
169585|NCT00830128|540377|P1|Overall Study|Lack of Efficacy|7
169586|NCT00830128|540377|P1|Overall Study|Adverse Event|5
169587|NCT00830167|540394|P2|Overall Study|Other|2
169588|NCT00830167|540395|P1|Overall Study|Other|2
169589|NCT00830167|540394|P2|Overall Study|Protocol Violation|1
169590|NCT00830167|540395|P1|Overall Study|Protocol Violation|0
169591|NCT00830167|540394|P2|Overall Study|Lost to Follow-up|1
169592|NCT00830167|540395|P1|Overall Study|Lost to Follow-up|0
169593|NCT00830167|540394|P2|Overall Study|Withdrawal by Subject|0
169594|NCT00830167|540395|P1|Overall Study|Withdrawal by Subject|2
169595|NCT00830167|540394|P2|Overall Study|Not meeting entrance criteria|5
169596|NCT00830167|540395|P1|Overall Study|Not meeting entrance criteria|2
169597|NCT00830167|540394|P2|Overall Study|Adverse Event|24
169598|NCT00830167|540395|P1|Overall Study|Adverse Event|8
169599|NCT00830167|540394|P2|Overall Study|Lack of Efficacy|10
169600|NCT00830167|540395|P1|Overall Study|Lack of Efficacy|26
169601|NCT00830206|540467|P2|Washout: 21 Days|Withdrawal by Subject|1
169602|NCT00830206|540468|P1|Washout: 21 Days|Withdrawal by Subject|1
169603|NCT00830219|540478|P2|Washout of 7 Days|Withdrawal by Subject|1
169604|NCT00830219|540479|P1|Washout of 7 Days|Withdrawal by Subject|1
169605|NCT00830258|540498|P2|Washout: 7 Days|Protocol Violation|0
169606|NCT00830258|540499|P1|Washout: 7 Days|Protocol Violation|1
169607|NCT00830258|540498|P2|First Intervention|Adverse Event|0
169608|NCT00830258|540499|P1|First Intervention|Adverse Event|1
169609|NCT00830336|540526|P2|Washout: 21 Days|Withdrawal by Subject|0
169610|NCT00830336|540527|P1|Washout: 21 Days|Withdrawal by Subject|1
169611|NCT00830375|540544|P1|Overall Study|Lost to Follow-up|1
169612|NCT00830440|540555|P2|Overall Study|Adverse Event|0
169613|NCT00830440|540556|P1|Overall Study|Adverse Event|2
169614|NCT00830440|540555|P2|Overall Study|unsuccessful procedure|0
169615|NCT00830440|540556|P1|Overall Study|unsuccessful procedure|4
169616|NCT00830440|540555|P2|Overall Study|Withdrawal by Subject|0
169617|NCT00830440|540556|P1|Overall Study|Withdrawal by Subject|1
169618|NCT00830440|540555|P2|Overall Study|Protocol Violation|0
169619|NCT00830440|540556|P1|Overall Study|Protocol Violation|1
169620|NCT00830765|540568|P2|Overall Study|Protocol Violation|2
169621|NCT00830765|540569|P1|Overall Study|Protocol Violation|3
169622|NCT00830804|540633|P1|Overall Study|Unwilling to adhere to study requirement|1
169623|NCT00830804|540633|P1|Overall Study|Consent withdrawn|2
169624|NCT00830804|540633|P1|Overall Study|Unable to get to clinic|7
169625|NCT00830804|540633|P1|Overall Study|Death|1
169626|NCT00830804|540633|P1|Overall Study|Lost to Follow-up|4
169627|NCT00830947|540655|P2|Overall Study|Lost to Follow-up|4
169628|NCT00830947|540656|P1|Overall Study|Lost to Follow-up|4
169629|NCT00830960|540668|P6|Overall Study|No study drug received|7
169630|NCT00830960|540669|P5|Overall Study|No study drug received|5
169631|NCT00830960|540670|P4|Overall Study|No study drug received|3
169632|NCT00830960|540671|P3|Overall Study|No study drug received|4
169633|NCT00830960|540672|P2|Overall Study|No study drug received|2
169634|NCT00830960|540673|P1|Overall Study|No study drug received|7
169635|NCT00830960|540668|P6|Overall Study|Sponsor Decision|7
169636|NCT00830960|540669|P5|Overall Study|Sponsor Decision|5
169637|NCT00830960|540670|P4|Overall Study|Sponsor Decision|4
169638|NCT00830960|540671|P3|Overall Study|Sponsor Decision|3
169639|NCT00830960|540672|P2|Overall Study|Sponsor Decision|2
169640|NCT00830960|540673|P1|Overall Study|Sponsor Decision|1
169641|NCT00830960|540668|P6|Overall Study|Withdrawal by Subject|21
169642|NCT00830960|540669|P5|Overall Study|Withdrawal by Subject|16
169643|NCT00830960|540670|P4|Overall Study|Withdrawal by Subject|23
169644|NCT00830960|540671|P3|Overall Study|Withdrawal by Subject|18
169645|NCT00830960|540672|P2|Overall Study|Withdrawal by Subject|19
169646|NCT00830960|540673|P1|Overall Study|Withdrawal by Subject|19
169647|NCT00830960|540668|P6|Overall Study|Lost to Follow-up|1
169648|NCT00830960|540669|P5|Overall Study|Lost to Follow-up|0
169649|NCT00830960|540670|P4|Overall Study|Lost to Follow-up|0
169650|NCT00830960|540671|P3|Overall Study|Lost to Follow-up|1
169651|NCT00830960|540672|P2|Overall Study|Lost to Follow-up|1
169652|NCT00830960|540673|P1|Overall Study|Lost to Follow-up|1
169653|NCT00830960|540668|P6|Overall Study|Death|1
169654|NCT00830960|540669|P5|Overall Study|Death|6
169655|NCT00830960|540670|P4|Overall Study|Death|2
169656|NCT00830960|540671|P3|Overall Study|Death|3
169657|NCT00830960|540672|P2|Overall Study|Death|4
169658|NCT00830960|540673|P1|Overall Study|Death|5
169659|NCT00831129|540789|P2|Overall Study|9 lost to follow-up reasons uknown|9
169660|NCT00831129|540790|P1|Overall Study|9 lost to follow-up reasons uknown|0
169661|NCT00831129|540789|P2|Overall Study|Adverse Event|1
169662|NCT00831129|540790|P1|Overall Study|Adverse Event|0
169663|NCT00831233|540828|P2|Overall Study|Selection Criteria Not Met|0
169664|NCT00831233|540829|P1|Overall Study|Selection Criteria Not Met|2
169665|NCT00831233|540828|P2|Overall Study|Protocol Violation|0
169666|NCT00831233|540829|P1|Overall Study|Protocol Violation|1
169667|NCT00831233|540828|P2|Overall Study|Adverse Event|1
169668|NCT00831233|540829|P1|Overall Study|Adverse Event|0
169669|NCT00831311|540872|P2|Overall Study|Withdrawal by Subject|4
169670|NCT00831311|540873|P1|Overall Study|Withdrawal by Subject|6
169671|NCT00831311|540872|P2|Overall Study|Physician Decision|1
169672|NCT00831311|540873|P1|Overall Study|Physician Decision|0
169673|NCT00831311|540872|P2|Overall Study|Lost to Follow-up|0
169674|NCT00831311|540873|P1|Overall Study|Lost to Follow-up|3
169675|NCT00831311|540872|P2|Overall Study|Definitive Contraindication|3
169676|NCT00831311|540873|P1|Overall Study|Definitive Contraindication|3
169677|NCT00831389|540891|P1|Overall Study|Withdrawal by Subject|1
169678|NCT00831415|540915|P1|Overall Study|Death|1
169679|NCT00831415|540915|P1|Overall Study|Unsatisfactory response - Efficacy|4
169680|NCT00831415|540915|P1|Overall Study|Withdrawal by Subject|35
169681|NCT00831415|540915|P1|Overall Study|Protocol Violation|3
169682|NCT00831415|540915|P1|Overall Study|Lost to Follow-up|9
169683|NCT00831415|540915|P1|Overall Study|Physician Decision|6
169684|NCT00831415|540915|P1|Overall Study|Failed to return|3
169685|NCT00831415|540915|P1|Overall Study|Adverse Event|14
169686|NCT00831441|540928|P2|Follow Up (30 Days)|missing end of study status|1
169687|NCT00831441|540929|P1|Follow Up (30 Days)|missing end of study status|0
169688|NCT00831441|540928|P2|Follow Up (30 Days)|non-specified|26
169689|NCT00831441|540929|P1|Follow Up (30 Days)|non-specified|16
169690|NCT00831441|540928|P2|Follow Up (30 Days)|Death|86
169691|NCT00831441|540929|P1|Follow Up (30 Days)|Death|63
169692|NCT00831441|540928|P2|Follow Up (30 Days)|Lost to Follow-up|27
169693|NCT00831441|540929|P1|Follow Up (30 Days)|Lost to Follow-up|13
169694|NCT00831441|540928|P2|Follow Up (30 Days)|Withdrawal by Subject|34
169695|NCT00831441|540929|P1|Follow Up (30 Days)|Withdrawal by Subject|41
169696|NCT00831441|540928|P2|Randomized|non-specified|266
169697|NCT00831441|540929|P1|Randomized|non-specified|276
169698|NCT00831441|540928|P2|Randomized|poor/non-compliance|38
169699|NCT00831441|540929|P1|Randomized|poor/non-compliance|30
169700|NCT00831441|540928|P2|Randomized|Administrative reason by sponsor|2671
169701|NCT00831441|540929|P1|Randomized|Administrative reason by sponsor|2780
169702|NCT00831441|540928|P2|Randomized|Lost to Follow-up|35
169703|NCT00831441|540929|P1|Randomized|Lost to Follow-up|26
169704|NCT00831441|540928|P2|Randomized|Withdrawal by Subject|212
169705|NCT00831441|540929|P1|Randomized|Withdrawal by Subject|178
169706|NCT00831441|540928|P2|Randomized|No longer met criteria|19
169707|NCT00831441|540929|P1|Randomized|No longer met criteria|13
169708|NCT00831441|540928|P2|Randomized|Physician Decision|35
169709|NCT00831441|540929|P1|Randomized|Physician Decision|26
169710|NCT00831441|540928|P2|Randomized|Elective procedure|25
169711|NCT00831441|540929|P1|Randomized|Elective procedure|26
169712|NCT00831441|540928|P2|Randomized|Emergency procedure|2
169713|NCT00831441|540929|P1|Randomized|Emergency procedure|2
169714|NCT00831441|540928|P2|Randomized|Adverse Event|321
169715|NCT00831441|540929|P1|Randomized|Adverse Event|248
169716|NCT00831441|540928|P2|Randomized|Death|81
169717|NCT00831441|540929|P1|Randomized|Death|82
169718|NCT00831493|540961|P1|Overall Study|Intractable nausea and vomiting|1
169719|NCT00825305|540989|P2|Overall Study|Can not be classified|1
169720|NCT00825305|540990|P1|Overall Study|Can not be classified|0
169721|NCT00825305|540989|P2|Overall Study|Protocol Violation|9
169722|NCT00825305|540990|P1|Overall Study|Protocol Violation|9
169723|NCT00825305|540989|P2|Overall Study|Inappropriate inclusion|0
169724|NCT00825305|540990|P1|Overall Study|Inappropriate inclusion|1
169725|NCT00825305|540989|P2|Overall Study|Withdrawal by Subject|12
169726|NCT00825305|540990|P1|Overall Study|Withdrawal by Subject|6
169727|NCT00825305|540989|P2|Overall Study|Adverse Event|1
169728|NCT00825305|540990|P1|Overall Study|Adverse Event|1
169729|NCT00831701|541056|P2|Overall Study|Lost to Follow-up|3
169730|NCT00831701|541057|P1|Overall Study|Lost to Follow-up|1
169731|NCT00831701|541056|P2|Overall Study|Stone expulsion before first medication|2
169732|NCT00831701|541057|P1|Overall Study|Stone expulsion before first medication|2
169733|NCT00831701|541056|P2|Overall Study|Withdrawal by Subject|0
169734|NCT00831701|541057|P1|Overall Study|Withdrawal by Subject|2
169735|NCT00831779|541097|P2|Overall Study|No longer met criteria|1
169736|NCT00831779|541098|P1|Overall Study|No longer met criteria|0
169737|NCT00831779|541097|P2|Overall Study|Lost to Follow-up|0
169738|NCT00831779|541098|P1|Overall Study|Lost to Follow-up|1
169739|NCT00831844|541116|P10|Overall Study|Ineligible|0
169740|NCT00831844|541117|P9|Overall Study|Ineligible|0
169741|NCT00831844|541118|P8|Overall Study|Ineligible|0
169742|NCT00831844|541119|P7|Overall Study|Ineligible|0
169743|NCT00831844|541120|P6|Overall Study|Ineligible|0
169744|NCT00831844|541121|P5|Overall Study|Ineligible|1
169745|NCT00831844|541122|P4|Overall Study|Ineligible|0
169746|NCT00831844|541123|P3|Overall Study|Ineligible|1
169747|NCT00831844|541124|P2|Overall Study|Ineligible|1
169748|NCT00831844|541125|P1|Overall Study|Ineligible|0
169749|NCT00831844|541116|P10|Overall Study|Withdrawal by Subject|0
169750|NCT00831844|541117|P9|Overall Study|Withdrawal by Subject|1
169751|NCT00831844|541118|P8|Overall Study|Withdrawal by Subject|1
169752|NCT00831844|541119|P7|Overall Study|Withdrawal by Subject|0
169753|NCT00831844|541120|P6|Overall Study|Withdrawal by Subject|0
169754|NCT00831844|541121|P5|Overall Study|Withdrawal by Subject|0
169755|NCT00831844|541122|P4|Overall Study|Withdrawal by Subject|0
169756|NCT00831844|541123|P3|Overall Study|Withdrawal by Subject|1
169757|NCT00831844|541124|P2|Overall Study|Withdrawal by Subject|0
169758|NCT00831844|541125|P1|Overall Study|Withdrawal by Subject|0
169759|NCT00831844|541116|P10|Overall Study|Physician Decision|0
169760|NCT00831844|541117|P9|Overall Study|Physician Decision|1
169761|NCT00831844|541118|P8|Overall Study|Physician Decision|0
169762|NCT00831844|541119|P7|Overall Study|Physician Decision|0
169763|NCT00831844|541120|P6|Overall Study|Physician Decision|1
169764|NCT00831844|541121|P5|Overall Study|Physician Decision|1
169765|NCT00831844|541122|P4|Overall Study|Physician Decision|1
169766|NCT00831844|541123|P3|Overall Study|Physician Decision|3
169767|NCT00831844|541124|P2|Overall Study|Physician Decision|1
169768|NCT00831844|541125|P1|Overall Study|Physician Decision|0
169769|NCT00831844|541116|P10|Overall Study|Lack of Efficacy|0
169770|NCT00831844|541117|P9|Overall Study|Lack of Efficacy|7
169771|NCT00831844|541118|P8|Overall Study|Lack of Efficacy|9
169772|NCT00831844|541119|P7|Overall Study|Lack of Efficacy|8
169773|NCT00831844|541120|P6|Overall Study|Lack of Efficacy|17
169774|NCT00831844|541121|P5|Overall Study|Lack of Efficacy|11
169775|NCT00831844|541122|P4|Overall Study|Lack of Efficacy|8
169776|NCT00831844|541123|P3|Overall Study|Lack of Efficacy|15
169777|NCT00831844|541124|P2|Overall Study|Lack of Efficacy|10
169778|NCT00831844|541125|P1|Overall Study|Lack of Efficacy|8
169779|NCT00831844|541116|P10|Overall Study|Death|0
169780|NCT00831844|541117|P9|Overall Study|Death|0
169781|NCT00831844|541118|P8|Overall Study|Death|0
169782|NCT00831844|541119|P7|Overall Study|Death|0
169783|NCT00831844|541120|P6|Overall Study|Death|0
169784|NCT00831844|541121|P5|Overall Study|Death|0
169785|NCT00831844|541122|P4|Overall Study|Death|1
169786|NCT00831844|541123|P3|Overall Study|Death|0
169787|NCT00831844|541124|P2|Overall Study|Death|0
169788|NCT00831844|541125|P1|Overall Study|Death|0
169789|NCT00831844|541116|P10|Overall Study|Adverse Event|0
169790|NCT00831844|541117|P9|Overall Study|Adverse Event|0
169791|NCT00831844|541118|P8|Overall Study|Adverse Event|0
169792|NCT00831844|541119|P7|Overall Study|Adverse Event|2
169793|NCT00831844|541120|P6|Overall Study|Adverse Event|1
169794|NCT00831844|541121|P5|Overall Study|Adverse Event|1
169795|NCT00831844|541122|P4|Overall Study|Adverse Event|0
169796|NCT00831844|541123|P3|Overall Study|Adverse Event|0
169797|NCT00831844|541124|P2|Overall Study|Adverse Event|0
169798|NCT00831844|541125|P1|Overall Study|Adverse Event|2
169799|NCT00832819|541150|P3|Overall Study|Protocol Violation|1
169800|NCT00832819|541151|P2|Overall Study|Protocol Violation|0
169801|NCT00832819|541152|P1|Overall Study|Protocol Violation|0
169802|NCT00832819|541150|P3|Overall Study|Adverse Event|0
169803|NCT00832819|541151|P2|Overall Study|Adverse Event|1
169804|NCT00832819|541152|P1|Overall Study|Adverse Event|0
169805|NCT00832975|541164|P1|Overall Study|Other reasons|14
169806|NCT00832975|541164|P1|Overall Study|Withdrawal by Subject|3
169807|NCT00832975|541164|P1|Overall Study|Physician Decision|4
169808|NCT00832975|541164|P1|Overall Study|Death|5
169809|NCT00832975|541164|P1|Overall Study|Protocol Violation|6
169810|NCT00832975|541164|P1|Overall Study|Lost to Follow-up|7
169811|NCT00833027|541169|P1|Overall Study|Missing|10
169812|NCT00833027|541169|P1|Overall Study|Withdrawal by Subject|16
169813|NCT00833027|541169|P1|Overall Study|Protocol Violation|115
169814|NCT00833027|541169|P1|Overall Study|Lost to Follow-up|24
169815|NCT00833027|541169|P1|Overall Study|Lack of Efficacy|12
169816|NCT00833027|541169|P1|Overall Study|Death|1
169817|NCT00833027|541169|P1|Overall Study|Adverse Event|33
169818|NCT00833040|541174|P6|Overall Study|Adverse Event|1
169819|NCT00833040|541175|P5|Overall Study|Adverse Event|0
169820|NCT00833040|541176|P4|Overall Study|Adverse Event|0
169821|NCT00833040|541177|P3|Overall Study|Adverse Event|0
169822|NCT00833040|541178|P2|Overall Study|Adverse Event|0
169823|NCT00833040|541179|P1|Overall Study|Adverse Event|0
169824|NCT00833053|541186|P2|Overall Study|Protocol Violation|1
169825|NCT00833053|541187|P1|Overall Study|Protocol Violation|2
169826|NCT00833053|541186|P2|Overall Study|Withdrawal by Subject|1
169827|NCT00833053|541187|P1|Overall Study|Withdrawal by Subject|0
169828|NCT00833053|541186|P2|Overall Study|Treatment Failure|1
169829|NCT00833053|541187|P1|Overall Study|Treatment Failure|3
169830|NCT00833053|541186|P2|Overall Study|Adverse Event|0
169831|NCT00833053|541187|P1|Overall Study|Adverse Event|4
169832|NCT00833092|541207|P2|Overall Study|constipation|1
169833|NCT00833092|541208|P1|Overall Study|constipation|0
169834|NCT00833092|541207|P2|Overall Study|Diarrhea|2
169835|NCT00833092|541208|P1|Overall Study|Diarrhea|0
169836|NCT00833092|541207|P2|Overall Study|Protocol Violation|1
169837|NCT00833092|541208|P1|Overall Study|Protocol Violation|2
169838|NCT00833092|541207|P2|Overall Study|Withdrawal by Subject|3
169839|NCT00833092|541208|P1|Overall Study|Withdrawal by Subject|2
169840|NCT00833248|541216|P2|Overall Study|Withdrawal by Subject|1
169841|NCT00833248|541217|P1|Overall Study|Withdrawal by Subject|0
169842|NCT00833248|541216|P2|Overall Study|Protocol Violation|2
169843|NCT00833248|541217|P1|Overall Study|Protocol Violation|1
169844|NCT00833248|541216|P2|Overall Study|Adverse Event|0
169845|NCT00833248|541217|P1|Overall Study|Adverse Event|3
169846|NCT00833417|541252|P2|Overall Study|Reason Not Specified|1
169847|NCT00833417|541253|P1|Overall Study|Reason Not Specified|0
169848|NCT00833417|541252|P2|Overall Study|Disease Progression|17
169849|NCT00833417|541253|P1|Overall Study|Disease Progression|18
169850|NCT00833417|541252|P2|Overall Study|Sponsor Decision to Terminate Study|2
169851|NCT00833417|541253|P1|Overall Study|Sponsor Decision to Terminate Study|1
169852|NCT00833417|541252|P2|Overall Study|Patient Decision to Withdraw|23
169853|NCT00833417|541253|P1|Overall Study|Patient Decision to Withdraw|4
169854|NCT00833417|541252|P2|Overall Study|Physician Decision to Withdraw Patient|7
169855|NCT00833417|541253|P1|Overall Study|Physician Decision to Withdraw Patient|3
169856|NCT00833417|541252|P2|Overall Study|Lost to Follow-up|2
169857|NCT00833417|541253|P1|Overall Study|Lost to Follow-up|1
169858|NCT00833417|541252|P2|Overall Study|Death|3
169859|NCT00833417|541253|P1|Overall Study|Death|1
169860|NCT00833417|541252|P2|Overall Study|Adverse Event|16
169861|NCT00833417|541253|P1|Overall Study|Adverse Event|5
169862|NCT00833469|541281|P1|Overall Study|Lost to Follow-up|1
169863|NCT00833469|541281|P1|Overall Study|Withdrawal by Subject|1
169864|NCT00833482|541289|P6|Days 21-30|Withdrawal by Subject|0
169865|NCT00833482|541290|P5|Days 21-30|Withdrawal by Subject|1
169866|NCT00833482|541291|P4|Days 21-30|Withdrawal by Subject|0
169867|NCT00833482|541292|P3|Days 21-30|Withdrawal by Subject|0
169868|NCT00833482|541293|P2|Days 21-30|Withdrawal by Subject|0
169869|NCT00833482|541294|P1|Days 21-30|Withdrawal by Subject|0
169870|NCT00833482|541289|P6|Days 21-30|Adverse Event|0
169871|NCT00833482|541290|P5|Days 21-30|Adverse Event|0
169872|NCT00833482|541291|P4|Days 21-30|Adverse Event|0
169873|NCT00833482|541292|P3|Days 21-30|Adverse Event|1
169874|NCT00833482|541293|P2|Days 21-30|Adverse Event|0
169875|NCT00833482|541294|P1|Days 21-30|Adverse Event|0
169876|NCT00833482|541289|P6|Days 11-20|Withdrawal by Subject|0
169877|NCT00833482|541290|P5|Days 11-20|Withdrawal by Subject|0
169878|NCT00833482|541291|P4|Days 11-20|Withdrawal by Subject|0
169879|NCT00833482|541292|P3|Days 11-20|Withdrawal by Subject|0
169880|NCT00833482|541293|P2|Days 11-20|Withdrawal by Subject|1
169881|NCT00833482|541294|P1|Days 11-20|Withdrawal by Subject|0
169882|NCT00833482|541289|P6|Days 11-20|Adverse Event|0
169883|NCT00833482|541290|P5|Days 11-20|Adverse Event|0
169884|NCT00833482|541291|P4|Days 11-20|Adverse Event|0
169885|NCT00833482|541292|P3|Days 11-20|Adverse Event|0
169886|NCT00833482|541293|P2|Days 11-20|Adverse Event|2
169887|NCT00833482|541294|P1|Days 11-20|Adverse Event|0
169888|NCT00833547|541363|P2|Overall Study|Withdrawal by Subject|2
169889|NCT00833547|541364|P1|Overall Study|Withdrawal by Subject|2
169890|NCT00833560|541372|P1|Overall Study|Not specified|5
169891|NCT00833560|541372|P1|Overall Study|Pregression of other disease|1
169892|NCT00833560|541372|P1|Overall Study|Death|2
169893|NCT00833560|541372|P1|Overall Study|Lack of Efficacy|4
169894|NCT00833560|541372|P1|Overall Study|Protocol Violation|6
169895|NCT00833560|541372|P1|Overall Study|Adverse Event|11
169896|NCT00833560|541372|P1|Overall Study|Toxicity|13
169897|NCT00833638|541393|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
169898|NCT00833638|541394|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
169899|NCT00833638|541395|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
169900|NCT00833638|541393|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
169901|NCT00833638|541394|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
169902|NCT00833638|541395|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
169903|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
169904|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
169905|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
169906|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
169907|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
169908|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
169909|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
169910|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
169911|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
169912|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
169913|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
169914|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
169915|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
169916|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
169917|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
169918|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
169919|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
169920|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
169921|NCT00833638|541393|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
169922|NCT00833638|541394|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
169923|NCT00833638|541395|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
169924|NCT00833690|541449|P3|Overall Study|Discontinued study drug|0
169925|NCT00833690|541450|P2|Overall Study|Discontinued study drug|2
169926|NCT00833690|541451|P1|Overall Study|Discontinued study drug|3
169927|NCT00833690|541449|P3|Overall Study|Withdrawal by Subject|0
169928|NCT00833690|541450|P2|Overall Study|Withdrawal by Subject|0
169929|NCT00833690|541451|P1|Overall Study|Withdrawal by Subject|1
169930|NCT00833703|541575|P2|Overall Study|Parent(s)/guardian(s)'s request|1
169931|NCT00833703|541576|P1|Overall Study|Parent(s)/guardian(s)'s request|0
169932|NCT00833755|541590|P4|Overall Study|Subject had scheduling issues|0
169933|NCT00833755|541591|P3|Overall Study|Subject had scheduling issues|0
169934|NCT00833755|541592|P2|Overall Study|Subject had scheduling issues|1
169935|NCT00833755|541593|P1|Overall Study|Subject had scheduling issues|0
169936|NCT00833755|541590|P4|Overall Study|Physician Decision|6
169937|NCT00833755|541591|P3|Overall Study|Physician Decision|2
169938|NCT00833755|541592|P2|Overall Study|Physician Decision|4
169939|NCT00833755|541593|P1|Overall Study|Physician Decision|4
169940|NCT00833794|541627|P2|Double-blind Phase|Administrative reason|3
169941|NCT00833794|541628|P1|Double-blind Phase|Administrative reason|1
169942|NCT00833794|541627|P2|Double-blind Phase|Physician Decision|7
169943|NCT00833794|541628|P1|Double-blind Phase|Physician Decision|4
169944|NCT00833794|541627|P2|Double-blind Phase|Withdrawal by Subject|6
169945|NCT00833794|541628|P1|Double-blind Phase|Withdrawal by Subject|23
169946|NCT00833794|541627|P2|Double-blind Phase|Lack of Efficacy|22
169947|NCT00833794|541628|P1|Double-blind Phase|Lack of Efficacy|34
169948|NCT00833794|541627|P2|Double-blind Phase|Adverse Event|11
169949|NCT00833794|541628|P1|Double-blind Phase|Adverse Event|44
169950|NCT00833794|541627|P2|Open-label Phase|enrolled in error (immediately D/C)|0
169951|NCT00833794|541628|P1|Open-label Phase|enrolled in error (immediately D/C)|1
169952|NCT00833794|541627|P2|Open-label Phase|Did not complete wash-out period|0
169953|NCT00833794|541628|P1|Open-label Phase|Did not complete wash-out period|12
169954|NCT00833794|541627|P2|Open-label Phase|Protocol Violation|0
169955|NCT00833794|541628|P1|Open-label Phase|Protocol Violation|47
169956|NCT00833794|541627|P2|Open-label Phase|Administrative reason|0
169957|NCT00833794|541628|P1|Open-label Phase|Administrative reason|1
169958|NCT00833794|541627|P2|Open-label Phase|Physician Decision|0
169959|NCT00833794|541628|P1|Open-label Phase|Physician Decision|20
169960|NCT00833794|541627|P2|Open-label Phase|Withdrawal by Subject|0
169961|NCT00833794|541628|P1|Open-label Phase|Withdrawal by Subject|48
169962|NCT00833794|541627|P2|Open-label Phase|Lack of Efficacy|0
169963|NCT00833794|541628|P1|Open-label Phase|Lack of Efficacy|28
169964|NCT00833794|541627|P2|Open-label Phase|Adverse Event|0
169965|NCT00833794|541628|P1|Open-label Phase|Adverse Event|225
169966|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
169967|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
169968|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
169969|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
169970|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
169971|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
169972|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Unspecified|3
169973|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Unspecified|4
169974|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Unspecified|0
169975|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Unspecified|0
169976|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Unspecified|0
169977|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Unspecified|0
169978|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
169979|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
169980|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
169981|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
169982|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
169983|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
169984|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
169985|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
169986|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
169987|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
169988|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
169989|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
169990|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Death|9
169991|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Death|8
169992|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Death|0
169993|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Death|0
169994|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Death|0
169995|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Death|0
169996|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
169997|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
169998|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
169999|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
170000|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
170001|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
170002|NCT00833833|541660|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
170003|NCT00833833|541661|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
170004|NCT00833833|541662|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
170005|NCT00833833|541663|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
170006|NCT00833833|541664|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
170007|NCT00833833|541665|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
170008|NCT00833833|541660|P6|Phase 1 (as of 01 April 2011)|Unspecified|0
170009|NCT00833833|541661|P5|Phase 1 (as of 01 April 2011)|Unspecified|0
170010|NCT00833833|541662|P4|Phase 1 (as of 01 April 2011)|Unspecified|1
170011|NCT00833833|541663|P3|Phase 1 (as of 01 April 2011)|Unspecified|0
170012|NCT00833833|541664|P2|Phase 1 (as of 01 April 2011)|Unspecified|3
170013|NCT00833833|541665|P1|Phase 1 (as of 01 April 2011)|Unspecified|1
170014|NCT00833833|541660|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
170015|NCT00833833|541661|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
170016|NCT00833833|541662|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
170017|NCT00833833|541663|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
170018|NCT00833833|541664|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
170019|NCT00833833|541665|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
170020|NCT00833833|541660|P6|Phase 1 (as of 01 April 2011)|Death|0
170021|NCT00833833|541661|P5|Phase 1 (as of 01 April 2011)|Death|0
170022|NCT00833833|541662|P4|Phase 1 (as of 01 April 2011)|Death|0
170023|NCT00833833|541663|P3|Phase 1 (as of 01 April 2011)|Death|2
170024|NCT00833833|541664|P2|Phase 1 (as of 01 April 2011)|Death|1
170025|NCT00833833|541665|P1|Phase 1 (as of 01 April 2011)|Death|0
170026|NCT00833833|541660|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
170027|NCT00833833|541661|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
170028|NCT00833833|541662|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
170029|NCT00833833|541663|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
170030|NCT00833833|541664|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
170031|NCT00833833|541665|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
170032|NCT00833833|541660|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
170033|NCT00833833|541661|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
170034|NCT00833833|541662|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
170035|NCT00833833|541663|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
170036|NCT00833833|541664|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
170037|NCT00833833|541665|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
170038|NCT00833833|541660|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
170039|NCT00833833|541661|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
170040|NCT00833833|541662|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
170041|NCT00833833|541663|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
170042|NCT00833833|541664|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
170043|NCT00833833|541665|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
170044|NCT00833898|541709|P2|Overall Study|Patient did not receive transplant|2
170045|NCT00833898|541710|P1|Overall Study|Patient did not receive transplant|0
170046|NCT00833898|541709|P2|Overall Study|Lost to Follow-up|7
170047|NCT00833898|541710|P1|Overall Study|Lost to Follow-up|7
170048|NCT00833898|541709|P2|Overall Study|Withdrawal by Subject|27
170049|NCT00833898|541710|P1|Overall Study|Withdrawal by Subject|33
170050|NCT00833911|541756|P1|Maintenance Phase II|Lack of Efficacy|1
170051|NCT00833911|541756|P1|Maintenance Phase II|Withdrawal by Subject|1
170052|NCT00833911|541756|P1|Maintenance Phase II|Physician Decision|2
170053|NCT00833911|541756|P1|Maintenance Phase II|Adverse Event|6
170054|NCT00833911|541756|P1|Maintenance Phase I|Lack of Efficacy|4
170055|NCT00833911|541756|P1|Maintenance Phase I|Physician Decision|10
170056|NCT00833911|541756|P1|Maintenance Phase I|Withdrawal by Subject|11
170057|NCT00833911|541756|P1|Maintenance Phase I|Adverse Event|73
170058|NCT00833911|541756|P1|Titration|Withdrawal by Subject|3
170059|NCT00833911|541756|P1|Titration|Adverse Event|18
170060|NCT00833924|541764|P1|Overall Study|In study follow-up|71
170061|NCT00833924|541764|P1|Overall Study|Withdrawal by Subject|13
170062|NCT00833924|541764|P1|Overall Study|Lost to Follow-up|2
170063|NCT00833924|541764|P1|Overall Study|Conversion|2
170064|NCT00833924|541764|P1|Overall Study|Death|21
170065|NCT00833937|541771|P2|Washout|Withdrawal by Subject|0
170066|NCT00833937|541772|P1|Washout|Withdrawal by Subject|1
170067|NCT00833976|541780|P1|Overall Study|Physician Decision|1
170068|NCT00833976|541780|P1|Overall Study|Did not meet eligibility criteria|41
170069|NCT00833976|541780|P1|Overall Study|Lost to Follow-up|4
170070|NCT00833976|541780|P1|Overall Study|Withdrawal by Subject|5
170071|NCT00834041|541788|P2|Overall Study|Lost to Follow-up|1
170072|NCT00834041|541789|P1|Overall Study|Lost to Follow-up|0
170073|NCT00834041|541788|P2|Overall Study|Withdrawal by Subject|0
170074|NCT00834041|541789|P1|Overall Study|Withdrawal by Subject|1
170075|NCT00834067|541805|P2|Washout of 21 Days|Protocol Violation|1
170076|NCT00834067|541806|P1|Washout of 21 Days|Protocol Violation|0
170077|NCT00834080|541826|P1|Overall Study|Subject Relocated|1
170078|NCT00834080|541826|P1|Overall Study|Physician Decision|1
170079|NCT00834080|541826|P1|Overall Study|Other - False positive tests of the UDS|1
170080|NCT00834080|541826|P1|Overall Study|Other - Pregnancy|1
170081|NCT00834080|541826|P1|Overall Study|Withdrawal by Subject|5
170082|NCT00834080|541826|P1|Overall Study|Lost to Follow-up|7
170083|NCT00834080|541826|P1|Overall Study|Adverse Event|7
170084|NCT00834249|541887|P2|Second Intervention|Adverse Event|0
170085|NCT00834249|541888|P1|Second Intervention|Adverse Event|1
170086|NCT00834249|541887|P2|Washout: 7 Days|Withdrawal by Subject|1
170087|NCT00834249|541888|P1|Washout: 7 Days|Withdrawal by Subject|1
170088|NCT00834340|541938|P2|Washout|Withdrawal by Subject|0
170089|NCT00834340|541939|P1|Washout|Withdrawal by Subject|1
170090|NCT00834340|541938|P2|Washout|Adverse Event|0
170091|NCT00834340|541939|P1|Washout|Adverse Event|1
170092|NCT00834366|541949|P2|Treatment Period 1|Adverse Event|1
170093|NCT00834366|541950|P1|Treatment Period 1|Adverse Event|1
170094|NCT00834418|541975|P2|Overall Study|Adverse Event|2
170095|NCT00834418|541976|P1|Overall Study|Adverse Event|0
170096|NCT00834431|541984|P2|Washout of 7 Days|Withdrawal by Subject|1
170097|NCT00834431|541985|P1|Washout of 7 Days|Withdrawal by Subject|0
170098|NCT00834431|541984|P2|First Intervention|Adverse Event|1
170099|NCT00834431|541985|P1|First Intervention|Adverse Event|0
170100|NCT00834444|541995|P2|Second Intervention|Adverse Event|0
170101|NCT00834444|541996|P1|Second Intervention|Adverse Event|1
170102|NCT00834444|541995|P2|Washout of 7 Days|Withdrawal by Subject|1
170103|NCT00834444|541996|P1|Washout of 7 Days|Withdrawal by Subject|0
170104|NCT00834444|541995|P2|First Intervention|Intolerance to Venopuncture|1
170105|NCT00834444|541996|P1|First Intervention|Intolerance to Venopuncture|0
170106|NCT00834444|541995|P2|First Intervention|Adverse Event|0
170107|NCT00834444|541996|P1|First Intervention|Adverse Event|1
170108|NCT00834522|542019|P2|Washout|Withdrawal by Subject|1
170109|NCT00834522|542020|P1|Washout|Withdrawal by Subject|2
170110|NCT00834522|542019|P2|Washout|Adverse Event|0
170111|NCT00834522|542020|P1|Washout|Adverse Event|1
170112|NCT00834587|542063|P2|Washout: 7 Days|Withdrawal by Subject|0
170113|NCT00834587|542064|P1|Washout: 7 Days|Withdrawal by Subject|1
170114|NCT00834613|542080|P2|First Intervention|Protocol Violation|0
170115|NCT00834613|542081|P1|First Intervention|Protocol Violation|1
170116|NCT00834639|542098|P2|Second Intervention|Physician Decision|2
170117|NCT00834639|542099|P1|Second Intervention|Physician Decision|0
170118|NCT00834717|542120|P2|First Intervention|Withdrawal by Subject|1
170119|NCT00834717|542121|P1|First Intervention|Withdrawal by Subject|0
170120|NCT00834717|542120|P2|First Intervention|Adverse Event|0
170121|NCT00834717|542121|P1|First Intervention|Adverse Event|1
170122|NCT00834743|542131|P2|Second Intervention|Withdrawal by Subject|0
170123|NCT00834743|542132|P1|Second Intervention|Withdrawal by Subject|1
170124|NCT00834756|542142|P2|Washout: 21 Days|Withdrawal by Subject|0
170125|NCT00834756|542143|P1|Washout: 21 Days|Withdrawal by Subject|1
170126|NCT00834756|542142|P2|First Intervention|Adverse Event|0
170127|NCT00834756|542143|P1|First Intervention|Adverse Event|1
170128|NCT00834795|542153|P2|Second Intervention|Adverse Event|0
170129|NCT00834795|542154|P1|Second Intervention|Adverse Event|1
170130|NCT00834795|542153|P2|Washout: 7 Days|Withdrawal by Subject|1
170131|NCT00834795|542154|P1|Washout: 7 Days|Withdrawal by Subject|0
170132|NCT00834834|542189|P2|Overall Study|Withdrawal by Subject|3
170133|NCT00834834|542190|P1|Overall Study|Withdrawal by Subject|4
170134|NCT00834873|542200|P2|First Intervention|Adverse Event|1
170135|NCT00834873|542201|P1|First Intervention|Adverse Event|0
170136|NCT00834899|542236|P2|Overall Study|Withdrawal by Subject|1
170137|NCT00834899|542237|P1|Overall Study|Withdrawal by Subject|1
170138|NCT00834912|542255|P6|Treatment Period 2|Withdrawal by Subject|0
170139|NCT00834912|542256|P5|Treatment Period 2|Withdrawal by Subject|1
170140|NCT00834912|542257|P4|Treatment Period 2|Withdrawal by Subject|0
170141|NCT00834912|542258|P3|Treatment Period 2|Withdrawal by Subject|1
170142|NCT00834912|542259|P2|Treatment Period 2|Withdrawal by Subject|0
170143|NCT00834912|542260|P1|Treatment Period 2|Withdrawal by Subject|0
170144|NCT00834912|542255|P6|Treatment Period 1|Adverse Event|0
170145|NCT00834912|542256|P5|Treatment Period 1|Adverse Event|0
170146|NCT00834912|542257|P4|Treatment Period 1|Adverse Event|1
170147|NCT00834912|542258|P3|Treatment Period 1|Adverse Event|0
170148|NCT00834912|542259|P2|Treatment Period 1|Adverse Event|1
170149|NCT00834912|542260|P1|Treatment Period 1|Adverse Event|0
170150|NCT00835042|542342|P2|Washout of 21 Days|Withdrawal by Subject|2
170151|NCT00835042|542343|P1|Washout of 21 Days|Withdrawal by Subject|0
170152|NCT00835042|542342|P2|First Intervention|Adverse Event|2
170153|NCT00835042|542343|P1|First Intervention|Adverse Event|1
170154|NCT00835042|542342|P2|First Intervention|Withdrawal by Subject|0
170155|NCT00835042|542343|P1|First Intervention|Withdrawal by Subject|3
170156|NCT00835068|542365|P2|Overall Study|Withdrawal by Subject|0
170157|NCT00835068|542366|P1|Overall Study|Withdrawal by Subject|1
170158|NCT00835068|542365|P2|Overall Study|Unspecified|0
170159|NCT00835068|542366|P1|Overall Study|Unspecified|8
170160|NCT00835068|542365|P2|Overall Study|Adverse Event|1
170161|NCT00835068|542366|P1|Overall Study|Adverse Event|0
170162|NCT00835068|542365|P2|Overall Study|Death|0
170163|NCT00835068|542366|P1|Overall Study|Death|1
170164|NCT00835081|542386|P2|Washout of 7 Days|Withdrawal by Subject|0
170165|NCT00835081|542387|P1|Washout of 7 Days|Withdrawal by Subject|1
170166|NCT00835120|542395|P1|Overall Study|Withdrawal by Subject|2
170167|NCT00835120|542395|P1|Overall Study|Adverse Event|2
170168|NCT00835120|542395|P1|Overall Study|Lost to Follow-up|3
170169|NCT00835120|542395|P1|Overall Study|Lack of Efficacy|1
170170|NCT00828464|542421|P1|Overall Study|Withdrawal by Subject|1
170171|NCT00828516|542438|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
170172|NCT00828568|542455|P3|Treated - Received at Least One Dose|Protocol Violation|3
170173|NCT00828568|542456|P2|Treated - Received at Least One Dose|Protocol Violation|5
170174|NCT00828568|542457|P1|Treated - Received at Least One Dose|Protocol Violation|9
170175|NCT00828568|542455|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
170176|NCT00828568|542456|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
170177|NCT00828568|542457|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
170178|NCT00828568|542455|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
170179|NCT00828568|542456|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
170180|NCT00828568|542457|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
170181|NCT00828568|542455|P3|Treated - Received at Least One Dose|Adverse Event|1
170182|NCT00828568|542456|P2|Treated - Received at Least One Dose|Adverse Event|8
170183|NCT00828568|542457|P1|Treated - Received at Least One Dose|Adverse Event|11
170184|NCT00828568|542455|P3|Randomized|Withdrawal by Subject|2
170185|NCT00828568|542456|P2|Randomized|Withdrawal by Subject|0
170186|NCT00828568|542457|P1|Randomized|Withdrawal by Subject|1
170187|NCT00828711|542473|P3|Overall Study|Lost to Follow-up|0
170188|NCT00828711|542474|P2|Overall Study|Lost to Follow-up|0
170189|NCT00828711|542475|P1|Overall Study|Lost to Follow-up|1
170190|NCT00828750|542504|P1|Overall Study|Normal PC Remained While No Treatment|1
170191|NCT00828750|542504|P1|Overall Study|Lack of Efficacy|3
170192|NCT00828945|542533|P1|Overall Study|Unspecified|36
170193|NCT00828945|542533|P1|Overall Study|Participant was missing|1
170194|NCT00828945|542533|P1|Overall Study|Death|4
170195|NCT00828984|542550|P3|Overall Study|ConMed|1
170196|NCT00828984|542551|P2|Overall Study|ConMed|1
170197|NCT00828984|542552|P1|Overall Study|ConMed|1
170198|NCT00828984|542550|P3|Overall Study|Noncompliant|3
170199|NCT00828984|542551|P2|Overall Study|Noncompliant|2
170200|NCT00828984|542552|P1|Overall Study|Noncompliant|1
170201|NCT00828984|542550|P3|Overall Study|Medical Contraindication|0
170202|NCT00828984|542551|P2|Overall Study|Medical Contraindication|1
170203|NCT00828984|542552|P1|Overall Study|Medical Contraindication|0
170204|NCT00828984|542550|P3|Overall Study|Ineligable|0
170205|NCT00828984|542551|P2|Overall Study|Ineligable|2
170206|NCT00828984|542552|P1|Overall Study|Ineligable|1
170207|NCT00828984|542550|P3|Overall Study|Withdrawal by Subject|4
170208|NCT00828984|542551|P2|Overall Study|Withdrawal by Subject|4
170209|NCT00828984|542552|P1|Overall Study|Withdrawal by Subject|4
170210|NCT00828984|542550|P3|Overall Study|Lost to Follow-up|1
170211|NCT00828984|542551|P2|Overall Study|Lost to Follow-up|3
170212|NCT00828984|542552|P1|Overall Study|Lost to Follow-up|5
170213|NCT00828984|542550|P3|Overall Study|Adverse Event|0
170214|NCT00828984|542551|P2|Overall Study|Adverse Event|3
170215|NCT00828984|542552|P1|Overall Study|Adverse Event|2
170216|NCT00829010|542580|P5|Overall Study|Migrated/Moved from study area|0
170217|NCT00829010|542581|P4|Overall Study|Migrated/Moved from study area|5
170218|NCT00829010|542582|P3|Overall Study|Migrated/Moved from study area|0
170219|NCT00829010|542583|P2|Overall Study|Migrated/Moved from study area|4
170220|NCT00829010|542584|P1|Overall Study|Migrated/Moved from study area|3
170221|NCT00829010|542580|P5|Overall Study|Fatality|0
170222|NCT00829010|542581|P4|Overall Study|Fatality|3
170223|NCT00829010|542582|P3|Overall Study|Fatality|0
170224|NCT00829010|542583|P2|Overall Study|Fatality|4
170225|NCT00829010|542584|P1|Overall Study|Fatality|5
170226|NCT00829010|542580|P5|Overall Study|Lost to Follow-up|0
170227|NCT00829010|542581|P4|Overall Study|Lost to Follow-up|0
170228|NCT00829010|542582|P3|Overall Study|Lost to Follow-up|2
170229|NCT00829010|542583|P2|Overall Study|Lost to Follow-up|0
170230|NCT00829010|542584|P1|Overall Study|Lost to Follow-up|1
170231|NCT00829010|542580|P5|Overall Study|Withdrawal by Subject|2
170232|NCT00829010|542581|P4|Overall Study|Withdrawal by Subject|0
170233|NCT00829010|542582|P3|Overall Study|Withdrawal by Subject|1
170234|NCT00829010|542583|P2|Overall Study|Withdrawal by Subject|1
170235|NCT00829010|542584|P1|Overall Study|Withdrawal by Subject|0
170236|NCT00829010|542580|P5|Overall Study|Adverse Event|0
170237|NCT00829010|542581|P4|Overall Study|Adverse Event|0
170238|NCT00829010|542582|P3|Overall Study|Adverse Event|0
170239|NCT00829010|542583|P2|Overall Study|Adverse Event|0
170240|NCT00829010|542584|P1|Overall Study|Adverse Event|1
170241|NCT00835172|542776|P2|Washout|Protocol Violation|1
170242|NCT00835172|542777|P1|Washout|Protocol Violation|0
170243|NCT00835211|542823|P2|Washout: 7 Days|Withdrawal by Subject|0
170244|NCT00835211|542824|P1|Washout: 7 Days|Withdrawal by Subject|1
170245|NCT00835211|542823|P2|Washout: 7 Days|Adverse Event|1
170246|NCT00835211|542824|P1|Washout: 7 Days|Adverse Event|2
170247|NCT00835211|542823|P2|First Intervention|Withdrawal by Subject|1
170248|NCT00835211|542824|P1|First Intervention|Withdrawal by Subject|0
170249|NCT00835237|542848|P2|Overall Study|Withdrawal by Subject|0
170250|NCT00835237|542849|P1|Overall Study|Withdrawal by Subject|2
170251|NCT00835237|542848|P2|Overall Study|Lost to Follow-up|0
170252|NCT00835237|542849|P1|Overall Study|Lost to Follow-up|4
170253|NCT00835263|542875|P2|Second Intervention|Adverse Event|0
170254|NCT00835263|542876|P1|Second Intervention|Adverse Event|1
170255|NCT00835341|542897|P2|Overall Study|Lost to Follow-up|12
170256|NCT00835341|542898|P1|Overall Study|Lost to Follow-up|3
170257|NCT00835354|542906|P2|First Intervention|Adverse Event|1
170258|NCT00835354|542907|P1|First Intervention|Adverse Event|0
170259|NCT00835367|542917|P2|Second Intervention|Adverse Event|1
170260|NCT00835367|542918|P1|Second Intervention|Adverse Event|1
170261|NCT00835367|542917|P2|Washout|Withdrawal by Subject|0
170262|NCT00835367|542918|P1|Washout|Withdrawal by Subject|1
170263|NCT00835367|542917|P2|Washout|Adverse Event|0
170264|NCT00835367|542918|P1|Washout|Adverse Event|2
170265|NCT00835380|542938|P1|Overall Study|Withdrawal by Subject|2
170266|NCT00835406|542945|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
170267|NCT00835406|542946|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
170268|NCT00835406|542945|P2|Period: First Intervention|Withdrawal by Subject|0
170269|NCT00835406|542946|P1|Period: First Intervention|Withdrawal by Subject|2
170270|NCT00835406|542945|P2|Period: First Intervention|Adverse Event|1
170271|NCT00835406|542946|P1|Period: First Intervention|Adverse Event|0
170272|NCT00835978|543018|P4|Overall Study|Study terminated by sponsor|0
170273|NCT00835978|543019|P3|Overall Study|Study terminated by sponsor|30
170274|NCT00835978|543020|P2|Overall Study|Study terminated by sponsor|8
170275|NCT00835978|543021|P1|Overall Study|Study terminated by sponsor|12
170276|NCT00835978|543018|P4|Overall Study|Withdrawal by Subject|5
170277|NCT00835978|543019|P3|Overall Study|Withdrawal by Subject|0
170278|NCT00835978|543020|P2|Overall Study|Withdrawal by Subject|3
170279|NCT00835978|543021|P1|Overall Study|Withdrawal by Subject|0
170280|NCT00835978|543018|P4|Overall Study|Adverse Event|0
170281|NCT00835978|543019|P3|Overall Study|Adverse Event|1
170282|NCT00835978|543020|P2|Overall Study|Adverse Event|0
170283|NCT00835978|543021|P1|Overall Study|Adverse Event|1
170284|NCT00835978|543018|P4|Overall Study|Objective progression or relapse|0
170285|NCT00835978|543019|P3|Overall Study|Objective progression or relapse|1
170286|NCT00835978|543020|P2|Overall Study|Objective progression or relapse|0
170287|NCT00835978|543021|P1|Overall Study|Objective progression or relapse|2
170288|NCT00835978|543018|P4|Overall Study|Not Specified|0
170289|NCT00835978|543019|P3|Overall Study|Not Specified|8
170290|NCT00835978|543020|P2|Overall Study|Not Specified|1
170291|NCT00835978|543021|P1|Overall Study|Not Specified|5
170292|NCT00835978|543018|P4|Overall Study|Lost to Follow-up|1
170293|NCT00835978|543019|P3|Overall Study|Lost to Follow-up|2
170294|NCT00835978|543020|P2|Overall Study|Lost to Follow-up|4
170295|NCT00835978|543021|P1|Overall Study|Lost to Follow-up|3
170296|NCT00835978|543018|P4|Overall Study|Death|4
170297|NCT00835978|543019|P3|Overall Study|Death|49
170298|NCT00835978|543020|P2|Overall Study|Death|40
170299|NCT00835978|543021|P1|Overall Study|Death|33
170300|NCT00835991|543081|P2|Washout|Withdrawal by Subject|1
170301|NCT00835991|543082|P1|Washout|Withdrawal by Subject|3
170302|NCT00835991|543081|P2|Washout|Protocol Violation|2
170303|NCT00835991|543082|P1|Washout|Protocol Violation|0
170304|NCT00835991|543081|P2|First Intervention|Adverse Event|1
170305|NCT00835991|543082|P1|First Intervention|Adverse Event|0
170306|NCT00836056|543117|P2|First Intervention|Adverse Event|0
170307|NCT00836056|543118|P1|First Intervention|Adverse Event|1
170308|NCT00836095|543128|P2|Overall Study|Physician Decision|3
170309|NCT00836095|543129|P1|Overall Study|Physician Decision|0
170310|NCT00836277|543137|P1|Overall Study|Not evaluable for response|6
170311|NCT00836472|543210|P2|Washout|Withdrawal by Subject|1
170312|NCT00836472|543211|P1|Washout|Withdrawal by Subject|1
170313|NCT00836472|543210|P2|Washout|Adverse Event|2
170314|NCT00836472|543211|P1|Washout|Adverse Event|1
170315|NCT00836498|543227|P2|Overall Study|Withdrawal by Subject|1
170316|NCT00836498|543228|P1|Overall Study|Withdrawal by Subject|2
170317|NCT00836498|543227|P2|Overall Study|Lost to Follow-up|0
170318|NCT00836498|543228|P1|Overall Study|Lost to Follow-up|1
170319|NCT00836498|543227|P2|Overall Study|Adverse Event|0
170320|NCT00836498|543228|P1|Overall Study|Adverse Event|1
170321|NCT00836693|543270|P2|Overall Study|Lost to Follow-up|0
170322|NCT00836693|543271|P1|Overall Study|Lost to Follow-up|1
170323|NCT00836693|543270|P2|Overall Study|Protocol Violation|0
170324|NCT00836693|543271|P1|Overall Study|Protocol Violation|1
170325|NCT00836693|543270|P2|Overall Study|Withdrawal by Subject|4
170326|NCT00836693|543271|P1|Overall Study|Withdrawal by Subject|9
170327|NCT00836693|543270|P2|Overall Study|Physician Decision|0
170328|NCT00836693|543271|P1|Overall Study|Physician Decision|2
170329|NCT00836693|543270|P2|Overall Study|Sponsor Decision|1
170330|NCT00836693|543271|P1|Overall Study|Sponsor Decision|0
170331|NCT00836693|543270|P2|Overall Study|Adverse Event|1
170332|NCT00836693|543271|P1|Overall Study|Adverse Event|4
170333|NCT00836706|543313|P2|Washout: 7 Days|Withdrawal by Subject|1
170334|NCT00836706|543314|P1|Washout: 7 Days|Withdrawal by Subject|0
170335|NCT00836745|543327|P1|Overall Study|Unspecified|2
170336|NCT00836745|543327|P1|Overall Study|Objective progression or relapse|4
170337|NCT00836745|543327|P1|Overall Study|Adverse Event|3
170338|NCT00836745|543327|P1|Overall Study|Lost to Follow-up|10
170339|NCT00836745|543327|P1|Overall Study|Death|2
170340|NCT00836875|543336|P2|Overall Study|Withdrawal by Subject|1
170341|NCT00836875|543337|P1|Overall Study|Withdrawal by Subject|0
170342|NCT00836875|543336|P2|Overall Study|Death|2
170343|NCT00836875|543337|P1|Overall Study|Death|3
170344|NCT00836901|543353|P2|First Intervention|Withdrawal by Subject|0
170345|NCT00836901|543354|P1|First Intervention|Withdrawal by Subject|1
170346|NCT00836953|543368|P1|Overall Study|Lost to Follow-up|1
170347|NCT00836953|543368|P1|Overall Study|Withdrawal by Subject|1
170348|NCT00837148|543380|P1|Overall Study|Death|1
170349|NCT00837148|543380|P1|Overall Study|Adverse Event|1
170350|NCT00837161|543384|P1|Overall Study|refused hysterectomy|2
170351|NCT00837213|543400|P2|Overall Study|not stated|1
170352|NCT00837213|543401|P1|Overall Study|not stated|1
170353|NCT00837213|543400|P2|Overall Study|Withdrawal by Subject|2
170354|NCT00837213|543401|P1|Overall Study|Withdrawal by Subject|2
170355|NCT00837213|543400|P2|Overall Study|Lost to Follow-up|2
170356|NCT00837213|543401|P1|Overall Study|Lost to Follow-up|3
170357|NCT00837330|543438|P2|Overall Study|Lost to Follow-up|3
170358|NCT00837330|543439|P1|Overall Study|Lost to Follow-up|1
170359|NCT00837434|543447|P2|Overall Study|Unable to obtain study drug|0
170360|NCT00837434|543448|P1|Overall Study|Unable to obtain study drug|1
170361|NCT00837434|543447|P2|Overall Study|Baseline assessments not done in time|0
170362|NCT00837434|543448|P1|Overall Study|Baseline assessments not done in time|1
170363|NCT00837434|543447|P2|Overall Study|Noncompliant|0
170364|NCT00837434|543448|P1|Overall Study|Noncompliant|2
170365|NCT00837434|543447|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
170366|NCT00837434|543448|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
170367|NCT00837434|543447|P2|Overall Study|Lost to Follow-up|1
170368|NCT00837434|543448|P1|Overall Study|Lost to Follow-up|1
170369|NCT00837434|543447|P2|Overall Study|Physician Decision|0
170370|NCT00837434|543448|P1|Overall Study|Physician Decision|3
170371|NCT00837486|543473|P2|Long-term Follow-up Phase - Open Label|Death|0
170372|NCT00837486|543474|P1|Long-term Follow-up Phase - Open Label|Death|1
170373|NCT00837486|543473|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
170374|NCT00837486|543474|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
170375|NCT00837486|543473|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
170376|NCT00837486|543474|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
170377|NCT00837486|543473|P2|Blinded-treatment Phase|Physician Decision|0
170378|NCT00837486|543474|P1|Blinded-treatment Phase|Physician Decision|1
170379|NCT00837577|543495|P2|Open-label Period|Other Reason|1
170380|NCT00837577|543496|P1|Open-label Period|Other Reason|1
170381|NCT00837577|543495|P2|Open-label Period|Withdrawal by Subject|2
170382|NCT00837577|543496|P1|Open-label Period|Withdrawal by Subject|1
170383|NCT00837577|543495|P2|Open-label Period|Lack of Efficacy|3
170384|NCT00837577|543496|P1|Open-label Period|Lack of Efficacy|4
170385|NCT00837577|543495|P2|Open-label Period|Laboratory Adverse Event|1
170386|NCT00837577|543496|P1|Open-label Period|Laboratory Adverse Event|0
170387|NCT00837577|543495|P2|Open-label Period|Clinical Adverse Event|2
170388|NCT00837577|543496|P1|Open-label Period|Clinical Adverse Event|2
170389|NCT00837577|543495|P2|Double-blind Period|Withdrawal by Subject|0
170390|NCT00837577|543496|P1|Double-blind Period|Withdrawal by Subject|1
170391|NCT00837577|543495|P2|Double-blind Period|Clinical Adverse Event|0
170392|NCT00837577|543496|P1|Double-blind Period|Clinical Adverse Event|1
170393|NCT00837616|543509|P2|Overall Study|Withdrawal by Subject|1
170394|NCT00837616|543510|P1|Overall Study|Withdrawal by Subject|0
170395|NCT00837759|543534|P1|Overall Study|Lost to Follow-up|1
170396|NCT00837759|543534|P1|Overall Study|Protocol Violation|3
170397|NCT00837876|543555|P1|Overall Study|disease progression|24
170398|NCT00837876|543555|P1|Overall Study|Withdrawal by Subject|3
170399|NCT00837876|543555|P1|Overall Study|Physician Decision|1
170400|NCT00837876|543555|P1|Overall Study|Adverse Event|7
170401|NCT00837876|543555|P1|Overall Study|Death|2
170402|NCT00837967|543562|P2|Washout Period of 7 - 14 Days|Adverse Event|0
170403|NCT00837967|543563|P1|Washout Period of 7 - 14 Days|Adverse Event|2
170404|NCT00838097|543579|P1|Overall Study|Protocol-specified criteria|142
170405|NCT00838097|543579|P1|Overall Study|Death|6
170406|NCT00838097|543579|P1|Overall Study|Lost to Follow-up|11
170407|NCT00838097|543579|P1|Overall Study|Physician Decision|4
170408|NCT00838097|543579|P1|Overall Study|Requirement for alternative therapy|2
170409|NCT00838097|543579|P1|Overall Study|Withdrawal by Subject|3
170410|NCT00838097|543579|P1|Overall Study|Adverse Event|2
170411|NCT00838097|543579|P1|Overall Study|Ineligibility determined|6
170412|NCT00838110|543589|P4|Overall Study|Randomized but not treated|0
170413|NCT00838110|543590|P3|Overall Study|Randomized but not treated|0
170414|NCT00838110|543591|P2|Overall Study|Randomized but not treated|1
170415|NCT00838110|543592|P1|Overall Study|Randomized but not treated|0
170416|NCT00838110|543589|P4|Overall Study|Did not meet eligibility criteria|2
170417|NCT00838110|543590|P3|Overall Study|Did not meet eligibility criteria|1
170418|NCT00838110|543591|P2|Overall Study|Did not meet eligibility criteria|0
170419|NCT00838110|543592|P1|Overall Study|Did not meet eligibility criteria|0
170420|NCT00838110|543589|P4|Overall Study|Lost to Follow-up|0
170421|NCT00838110|543590|P3|Overall Study|Lost to Follow-up|0
170422|NCT00838110|543591|P2|Overall Study|Lost to Follow-up|0
170423|NCT00838110|543592|P1|Overall Study|Lost to Follow-up|3
170424|NCT00838110|543589|P4|Overall Study|Protocol Violation|1
170425|NCT00838110|543590|P3|Overall Study|Protocol Violation|1
170426|NCT00838110|543591|P2|Overall Study|Protocol Violation|2
170427|NCT00838110|543592|P1|Overall Study|Protocol Violation|0
170428|NCT00838110|543589|P4|Overall Study|Unspecified|2
170429|NCT00838110|543590|P3|Overall Study|Unspecified|3
170430|NCT00838110|543591|P2|Overall Study|Unspecified|3
170431|NCT00838110|543592|P1|Overall Study|Unspecified|3
170432|NCT00838110|543589|P4|Overall Study|Withdrawal by Subject|4
170433|NCT00838110|543590|P3|Overall Study|Withdrawal by Subject|3
170434|NCT00838110|543591|P2|Overall Study|Withdrawal by Subject|6
170435|NCT00838110|543592|P1|Overall Study|Withdrawal by Subject|5
170436|NCT00838110|543589|P4|Overall Study|Adverse Event|7
170437|NCT00838110|543590|P3|Overall Study|Adverse Event|8
170438|NCT00838110|543591|P2|Overall Study|Adverse Event|10
170439|NCT00838110|543592|P1|Overall Study|Adverse Event|11
170440|NCT00838110|543589|P4|Overall Study|Death|2
170441|NCT00838110|543590|P3|Overall Study|Death|1
170442|NCT00838110|543591|P2|Overall Study|Death|0
170443|NCT00838110|543592|P1|Overall Study|Death|0
170444|NCT00838201|543674|P2|Overall Study|Death|13
170445|NCT00838201|543675|P1|Overall Study|Death|11
170446|NCT00838201|543674|P2|Overall Study|Adverse Event|9
170447|NCT00838201|543675|P1|Overall Study|Adverse Event|5
170448|NCT00838201|543674|P2|Overall Study|Lost to Follow-up|3
170449|NCT00838201|543675|P1|Overall Study|Lost to Follow-up|4
170450|NCT00838201|543674|P2|Overall Study|Consetn withdrawn|19
170451|NCT00838201|543675|P1|Overall Study|Consetn withdrawn|16
170452|NCT00838201|543674|P2|Overall Study|Disease progression|3
170453|NCT00838201|543675|P1|Overall Study|Disease progression|3
170454|NCT00838201|543674|P2|Overall Study|Administrative decision|2
170455|NCT00838201|543675|P1|Overall Study|Administrative decision|1
170456|NCT00838201|543674|P2|Overall Study|Noncompliance|1
170457|NCT00838201|543675|P1|Overall Study|Noncompliance|0
170458|NCT00838201|543674|P2|Overall Study|Investigator decision, or other reasons|3
170459|NCT00838201|543675|P1|Overall Study|Investigator decision, or other reasons|2
170460|NCT00838279|543683|P2|Washout|Withdrawal by Subject|1
170461|NCT00838279|543684|P1|Washout|Withdrawal by Subject|0
170462|NCT00838279|543683|P2|Washout|Protocol Violation|0
170463|NCT00838279|543684|P1|Washout|Protocol Violation|1
170464|NCT00832000|543707|P2|Overall Study|No calls to IVR in period 2|0
170465|NCT00832000|543708|P1|Overall Study|No calls to IVR in period 2|2
170466|NCT00832000|543707|P2|Overall Study|No calls to IVR in either period|1
170467|NCT00832000|543708|P1|Overall Study|No calls to IVR in either period|1
170468|NCT00832000|543707|P2|Overall Study|Withdrawal by Subject|0
170469|NCT00832000|543708|P1|Overall Study|Withdrawal by Subject|1
170470|NCT00832000|543707|P2|Overall Study|Adverse Event|0
170471|NCT00832000|543708|P1|Overall Study|Adverse Event|2
170472|NCT00832078|543744|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
170473|NCT00832078|543745|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
170474|NCT00832078|543744|P2|Test Day 1-2 Period|Lack of Efficacy|2
170475|NCT00832078|543745|P1|Test Day 1-2 Period|Lack of Efficacy|0
170476|NCT00832091|543753|P2|Overall Study|Prohibited Medication|0
170477|NCT00832091|543754|P1|Overall Study|Prohibited Medication|1
170478|NCT00832091|543753|P2|Overall Study|Withdrawal by Subject|1
170479|NCT00832091|543754|P1|Overall Study|Withdrawal by Subject|2
170480|NCT00832091|543753|P2|Overall Study|Protocol Violation|0
170481|NCT00832091|543754|P1|Overall Study|Protocol Violation|1
170482|NCT00832091|543753|P2|Overall Study|Adverse Event|1
170483|NCT00832091|543754|P1|Overall Study|Adverse Event|1
170484|NCT00832117|543764|P1|Overall Study|Disease Progression|11
170485|NCT00832117|543764|P1|Overall Study|Death|1
170486|NCT00832377|543817|P1|Overall Study|Protocol Violation|1
170487|NCT00832416|543841|P4|Overall Study|Death|0
170488|NCT00832416|543842|P3|Overall Study|Death|0
170489|NCT00832416|543843|P2|Overall Study|Death|0
170490|NCT00832416|543844|P1|Overall Study|Death|1
170491|NCT00832416|543841|P4|Overall Study|Adverse Event|10
170492|NCT00832416|543842|P3|Overall Study|Adverse Event|41
170493|NCT00832416|543843|P2|Overall Study|Adverse Event|19
170494|NCT00832416|543844|P1|Overall Study|Adverse Event|21
170495|NCT00832416|543841|P4|Overall Study|Administrative|1
170496|NCT00832416|543842|P3|Overall Study|Administrative|0
170497|NCT00832416|543843|P2|Overall Study|Administrative|0
170498|NCT00832416|543844|P1|Overall Study|Administrative|0
170499|NCT00832416|543841|P4|Overall Study|Physician Decision|10
170500|NCT00832416|543842|P3|Overall Study|Physician Decision|5
170501|NCT00832416|543843|P2|Overall Study|Physician Decision|12
170502|NCT00832416|543844|P1|Overall Study|Physician Decision|2
170503|NCT00832416|543841|P4|Overall Study|Withdrawal by Subject|10
170504|NCT00832416|543842|P3|Overall Study|Withdrawal by Subject|2
170505|NCT00832416|543843|P2|Overall Study|Withdrawal by Subject|7
170506|NCT00832416|543844|P1|Overall Study|Withdrawal by Subject|5
170507|NCT00832416|543841|P4|Overall Study|Lack of Efficacy|52
170508|NCT00832416|543842|P3|Overall Study|Lack of Efficacy|13
170509|NCT00832416|543843|P2|Overall Study|Lack of Efficacy|15
170510|NCT00832416|543844|P1|Overall Study|Lack of Efficacy|17
170511|NCT00832455|543882|P1|Overall Study|Patient moved|1
170512|NCT00832455|543882|P1|Overall Study|No improvement|3
170513|NCT00832455|543882|P1|Overall Study|Parent dissatisfied|1
170514|NCT00832455|543882|P1|Overall Study|Parent misunderstood study|1
170515|NCT00832455|543882|P1|Overall Study|Stopped Medication|4
170516|NCT00832455|543882|P1|Overall Study|Screening Failure|2
170517|NCT00832455|543882|P1|Overall Study|Withdrawal by Subject|17
170518|NCT00832455|543882|P1|Overall Study|Protocol Violation|4
170519|NCT00832455|543882|P1|Overall Study|Lost to Follow-up|26
170520|NCT00832455|543882|P1|Overall Study|Adverse Event|13
170521|NCT00832585|543921|P1|Overall Study|Lost to Follow-up|1
170522|NCT00832585|543921|P1|Overall Study|Withdrawal by Subject|1
170523|NCT00832624|543926|P1|Overall Study|Study Terminated|10
170524|NCT00832650|543941|P3|Overall Study|Randomized but not treated|1
170525|NCT00832650|543942|P2|Overall Study|Randomized but not treated|0
170526|NCT00832650|543943|P1|Overall Study|Randomized but not treated|0
170527|NCT00838331|543975|P1|Aged Blood Transfusion|Withdrawal by Subject|9
170528|NCT00838513|543979|P1|Post Treatment Period (Patients Who Disc|Death|1
170529|NCT00838513|543979|P1|Extension Treatment Period|Death|1
170530|NCT00838513|543979|P1|Screening Period|Screen Failure|3
170531|NCT00838526|543997|P2|Overall Study|Not specified|7
170532|NCT00838526|543998|P1|Overall Study|Not specified|11
170533|NCT00838526|543997|P2|Overall Study|Lack of Efficacy|3
170534|NCT00838526|543998|P1|Overall Study|Lack of Efficacy|2
170535|NCT00838526|543997|P2|Overall Study|Withdrawal by Subject|5
170536|NCT00838526|543998|P1|Overall Study|Withdrawal by Subject|4
170537|NCT00838526|543997|P2|Overall Study|Lost to Follow-up|12
170538|NCT00838526|543998|P1|Overall Study|Lost to Follow-up|4
170539|NCT00838526|543997|P2|Overall Study|Adverse Event|12
170540|NCT00838526|543998|P1|Overall Study|Adverse Event|3
170541|NCT00838578|544006|P1|Overall Study|Protocol Violation|2
170542|NCT00838630|544016|P2|Washout: 7 Days|Protocol Violation|0
170543|NCT00838630|544017|P1|Washout: 7 Days|Protocol Violation|1
170544|NCT00838630|544016|P2|First Intervention|Adverse Event|0
170545|NCT00838630|544017|P1|First Intervention|Adverse Event|1
170546|NCT00842985|544025|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
170547|NCT00842985|544025|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
170548|NCT00842985|544025|P1|First Intervention|Protocol Violation|3
170549|NCT00842985|544025|P1|First Intervention|Withdrawal by Subject|3
170550|NCT00842985|544025|P1|Screening|Did not meet entrance requirements|27
170551|NCT00843024|544036|P6|Double-blind Treatment Phase|Lack of Efficacy|0
170552|NCT00843024|544037|P5|Double-blind Treatment Phase|Lack of Efficacy|1
170553|NCT00843024|544038|P4|Double-blind Treatment Phase|Lack of Efficacy|0
170554|NCT00843024|544039|P3|Double-blind Treatment Phase|Lack of Efficacy|0
170555|NCT00843024|544040|P2|Double-blind Treatment Phase|Lack of Efficacy|0
170556|NCT00843024|544041|P1|Double-blind Treatment Phase|Lack of Efficacy|0
170557|NCT00843024|544036|P6|Double-blind Treatment Phase|Adverse Event|1
170558|NCT00843024|544037|P5|Double-blind Treatment Phase|Adverse Event|1
170559|NCT00843024|544038|P4|Double-blind Treatment Phase|Adverse Event|0
170560|NCT00843024|544039|P3|Double-blind Treatment Phase|Adverse Event|0
170561|NCT00843024|544040|P2|Double-blind Treatment Phase|Adverse Event|0
170562|NCT00843024|544041|P1|Double-blind Treatment Phase|Adverse Event|0
170563|NCT00843024|544036|P6|Double-blind Treatment Phase|Physician Decision|1
170564|NCT00843024|544037|P5|Double-blind Treatment Phase|Physician Decision|1
170565|NCT00843024|544038|P4|Double-blind Treatment Phase|Physician Decision|3
170566|NCT00843024|544039|P3|Double-blind Treatment Phase|Physician Decision|0
170567|NCT00843024|544040|P2|Double-blind Treatment Phase|Physician Decision|0
170568|NCT00843024|544041|P1|Double-blind Treatment Phase|Physician Decision|0
170569|NCT00843024|544036|P6|Double-blind Treatment Phase|Protocol Violation|3
170570|NCT00843024|544037|P5|Double-blind Treatment Phase|Protocol Violation|0
170571|NCT00843024|544038|P4|Double-blind Treatment Phase|Protocol Violation|0
170572|NCT00843024|544039|P3|Double-blind Treatment Phase|Protocol Violation|3
170573|NCT00843024|544040|P2|Double-blind Treatment Phase|Protocol Violation|0
170574|NCT00843024|544041|P1|Double-blind Treatment Phase|Protocol Violation|0
170575|NCT00843024|544036|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
170576|NCT00843024|544037|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
170577|NCT00843024|544038|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
170578|NCT00843024|544039|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
170579|NCT00843024|544040|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
170580|NCT00843024|544041|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
170581|NCT00843024|544036|P6|Double-blind Treatment Phase|Lost to Follow-up|4
170582|NCT00843024|544037|P5|Double-blind Treatment Phase|Lost to Follow-up|4
170583|NCT00843024|544038|P4|Double-blind Treatment Phase|Lost to Follow-up|4
170584|NCT00843024|544039|P3|Double-blind Treatment Phase|Lost to Follow-up|8
170585|NCT00843024|544040|P2|Double-blind Treatment Phase|Lost to Follow-up|0
170586|NCT00843024|544041|P1|Double-blind Treatment Phase|Lost to Follow-up|0
170587|NCT00843024|544036|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
170588|NCT00843024|544037|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
170589|NCT00843024|544038|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
170590|NCT00843024|544039|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
170591|NCT00843024|544040|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
170592|NCT00843024|544041|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
170593|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Other|0
170594|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Other|0
170595|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Other|0
170596|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Other|0
170597|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Other|1
170598|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Other|0
170599|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
170600|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
170601|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
170602|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
170603|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
170604|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
170605|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
170606|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
170607|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
170608|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
170609|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
170610|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
170611|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
170612|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
170613|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
170614|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
170615|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
170616|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
170617|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
170618|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
170619|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
170620|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
170621|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
170622|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
170623|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
170624|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
170625|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
170626|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
170627|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
170628|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
170629|NCT00843024|544036|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
170630|NCT00843024|544037|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
170631|NCT00843024|544038|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
170632|NCT00843024|544039|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
170633|NCT00843024|544040|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
170634|NCT00843024|544041|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
170635|NCT00843115|544112|P1|Overall Study|Syndrome De Glissement|1
170636|NCT00843115|544112|P1|Overall Study|week 12 not done|1
170637|NCT00843115|544112|P1|Overall Study|hospitalized due to deterioration|1
170638|NCT00843115|544112|P1|Overall Study|patient never took the medication|1
170639|NCT00843115|544112|P1|Overall Study|patient took for 2 days then stopped|1
170640|NCT00843115|544112|P1|Overall Study|Family discontinued meds|1
170641|NCT00843115|544112|P1|Overall Study|Physician Decision|1
170642|NCT00843115|544112|P1|Overall Study|Does not meet entrance criteria|1
170643|NCT00843115|544112|P1|Overall Study|Patient forgot to take meds|1
170644|NCT00843115|544112|P1|Overall Study|Family does not want continuation|1
170645|NCT00843115|544112|P1|Overall Study|Family wanted meds stopped|1
170646|NCT00843115|544112|P1|Overall Study|Withdrawal by Subject|17
170647|NCT00843115|544112|P1|Overall Study|Lost to Follow-up|4
170648|NCT00843115|544112|P1|Overall Study|Adverse Event|30
170649|NCT00843115|544112|P1|Overall Study|Death|4
170650|NCT00843167|544160|P2|Treatment Period|Withdrawal by Subject|3
170651|NCT00843167|544161|P1|Treatment Period|Withdrawal by Subject|2
170652|NCT00843167|544160|P2|Treatment Period|Adverse Event|5
170653|NCT00843167|544161|P1|Treatment Period|Adverse Event|1
170654|NCT00843284|544189|P1|Overall Study|Death|3
170655|NCT00843284|544189|P1|Overall Study|Withdrawal by Subject|4
170656|NCT00843284|544189|P1|Overall Study|Other|10
170657|NCT00843284|544189|P1|Overall Study|Lost to Follow-up|11
170658|NCT00843284|544189|P1|Overall Study|Lack of Efficacy|5
170659|NCT00843284|544189|P1|Overall Study|Adverse Event|39
170660|NCT00843492|544252|P2|Overall Study|Deep-vein Thrombosis|0
170661|NCT00843492|544253|P1|Overall Study|Deep-vein Thrombosis|1
170662|NCT00843492|544252|P2|Overall Study|Visit Not Performed|0
170663|NCT00843492|544253|P1|Overall Study|Visit Not Performed|1
170664|NCT00843492|544252|P2|Overall Study|Orthopedic Surgery|2
170665|NCT00843492|544253|P1|Overall Study|Orthopedic Surgery|0
170666|NCT00843492|544252|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
170667|NCT00843492|544253|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
170668|NCT00843492|544252|P2|Overall Study|Immobilization Stopped|0
170669|NCT00843492|544253|P1|Overall Study|Immobilization Stopped|1
170670|NCT00843492|544252|P2|Overall Study|Withdrawal by Subject|4
170671|NCT00843492|544253|P1|Overall Study|Withdrawal by Subject|0
170672|NCT00843492|544252|P2|Overall Study|Lost to Follow-up|4
170673|NCT00843492|544253|P1|Overall Study|Lost to Follow-up|4
170674|NCT00843492|544252|P2|Overall Study|Adverse Event|3
170675|NCT00843492|544253|P1|Overall Study|Adverse Event|0
170676|NCT00843635|544283|P3|Overall Study|Adverse Event|0
170677|NCT00843635|544284|P2|Overall Study|Adverse Event|2
170678|NCT00843635|544285|P1|Overall Study|Adverse Event|2
170679|NCT00843778|544312|P1|Overall Study|Withdrawal by Subject|4
170680|NCT00843778|544312|P1|Overall Study|Loss of efficacy|2
170681|NCT00843778|544312|P1|Overall Study|Lack of Efficacy|14
170682|NCT00843778|544312|P1|Overall Study|Adverse Event|15
170683|NCT00843843|544352|P2|Overall Study|Protocol Violation|1
170684|NCT00843843|544353|P1|Overall Study|Protocol Violation|1
170685|NCT00843843|544352|P2|Overall Study|Physician Decision|1
170686|NCT00843843|544353|P1|Overall Study|Physician Decision|1
170687|NCT00844194|544412|P2|Overall Study|Other reason (not specified)|0
170688|NCT00844194|544413|P1|Overall Study|Other reason (not specified)|1
170689|NCT00844194|544412|P2|Overall Study|Lack of Efficacy|0
170690|NCT00844194|544413|P1|Overall Study|Lack of Efficacy|3
170691|NCT00844194|544412|P2|Overall Study|Withdrawal by Subject|1
170692|NCT00844194|544413|P1|Overall Study|Withdrawal by Subject|2
170693|NCT00844194|544412|P2|Overall Study|Lost to Follow-up|1
170694|NCT00844194|544413|P1|Overall Study|Lost to Follow-up|1
170695|NCT00844194|544412|P2|Overall Study|Protocol Violation|1
170696|NCT00844194|544413|P1|Overall Study|Protocol Violation|1
170697|NCT00844194|544412|P2|Overall Study|Adverse Event|5
170698|NCT00844194|544413|P1|Overall Study|Adverse Event|17
170699|NCT00844376|544621|P2|Period 1: First Intervention|Withdrawal by Subject|0
170700|NCT00844376|544622|P1|Period 1: First Intervention|Withdrawal by Subject|1
170701|NCT00844415|544640|P1|Overall Study|Withdrawal by Subject|1
170702|NCT00844428|544654|P1|Post Treatment Period (Patients Who Disc|Death|1
170703|NCT00844428|544654|P1|Extension Treatment Period|Death|1
170704|NCT00844428|544654|P1|Screening Period|Screen Failure|3
170705|NCT00844480|544672|P2|Overall Study|Withdrawal by Subject|3
170706|NCT00844480|544673|P1|Overall Study|Withdrawal by Subject|2
170707|NCT00844519|544683|P2|Overall Study|Adverse Event|0
170708|NCT00844519|544684|P1|Overall Study|Adverse Event|1
170709|NCT00844519|544683|P2|Overall Study|Withdrawal by Subject|1
170710|NCT00844519|544684|P1|Overall Study|Withdrawal by Subject|1
170711|NCT00844532|544690|P1|Overall Study|Lost to Follow-up|7
170712|NCT00844532|544690|P1|Overall Study|Withdrawal by Subject|16
170713|NCT00844532|544690|P1|Overall Study|Death|16
170714|NCT00844545|544774|P1|Post Treatment Period|Withdrawal by Subject|1
170715|NCT00844545|544774|P1|Extension Treatment Period|Adverse Event|2
170716|NCT00844545|544774|P1|Treatment Period (26 Weeks)|Protocol Violation|1
170717|NCT00844545|544774|P1|Treatment Period (26 Weeks)|Adverse Event|1
170718|NCT00844558|544790|P2|Overall Study|Physician Decision|0
170719|NCT00844558|544791|P1|Overall Study|Physician Decision|1
170720|NCT00844558|544790|P2|Overall Study|Lost to Follow-up|1
170721|NCT00844558|544791|P1|Overall Study|Lost to Follow-up|0
170722|NCT00844558|544790|P2|Overall Study|Protocol Violation|1
170723|NCT00844558|544791|P1|Overall Study|Protocol Violation|1
170724|NCT00844558|544790|P2|Overall Study|Death|0
170725|NCT00844558|544791|P1|Overall Study|Death|1
170726|NCT00844558|544790|P2|Overall Study|Withdrawal by Subject|2
170727|NCT00844558|544791|P1|Overall Study|Withdrawal by Subject|9
170728|NCT00844597|544813|P6|Overall Study|Adverse Event|0
170729|NCT00844597|544814|P5|Overall Study|Adverse Event|0
170730|NCT00844597|544815|P4|Overall Study|Adverse Event|1
170731|NCT00844597|544816|P3|Overall Study|Adverse Event|0
170732|NCT00844597|544817|P2|Overall Study|Adverse Event|0
170733|NCT00844597|544818|P1|Overall Study|Adverse Event|0
170734|NCT00844649|544838|P2|Overall Study|Withdrew prior to starting treatment|27
170735|NCT00844649|544839|P1|Overall Study|Withdrew prior to starting treatment|11
170736|NCT00844649|544838|P2|Overall Study|Unspecified|10
170737|NCT00844649|544839|P1|Overall Study|Unspecified|7
170738|NCT00844649|544838|P2|Overall Study|Withdrawal by Subject|39
170739|NCT00844649|544839|P1|Overall Study|Withdrawal by Subject|28
170740|NCT00844649|544838|P2|Overall Study|Protocol Violation|6
170741|NCT00844649|544839|P1|Overall Study|Protocol Violation|10
170742|NCT00844649|544838|P2|Overall Study|Physician Decision|18
170743|NCT00844649|544839|P1|Overall Study|Physician Decision|25
170744|NCT00844649|544838|P2|Overall Study|Adverse Event|73
170745|NCT00844649|544839|P1|Overall Study|Adverse Event|128
170746|NCT00844649|544838|P2|Overall Study|Progressive Disease|245
170747|NCT00844649|544839|P1|Overall Study|Progressive Disease|196
170748|NCT00844753|544865|P4|Overall Study|Withdrawal by Subject|3
170749|NCT00844753|544866|P3|Overall Study|Withdrawal by Subject|0
170750|NCT00844753|544867|P2|Overall Study|Withdrawal by Subject|0
170751|NCT00844753|544868|P1|Overall Study|Withdrawal by Subject|1
170752|NCT00844753|544865|P4|Overall Study|could not swallow medication|0
170753|NCT00844753|544866|P3|Overall Study|could not swallow medication|0
170754|NCT00844753|544867|P2|Overall Study|could not swallow medication|0
170755|NCT00844753|544868|P1|Overall Study|could not swallow medication|2
170756|NCT00844753|544865|P4|Overall Study|Lost to Follow-up|1
170757|NCT00844753|544866|P3|Overall Study|Lost to Follow-up|0
170758|NCT00844753|544867|P2|Overall Study|Lost to Follow-up|1
170759|NCT00844753|544868|P1|Overall Study|Lost to Follow-up|1
170760|NCT00844753|544865|P4|Overall Study|Adverse Event|5
170761|NCT00844753|544866|P3|Overall Study|Adverse Event|5
170762|NCT00844753|544867|P2|Overall Study|Adverse Event|2
170763|NCT00844753|544868|P1|Overall Study|Adverse Event|3
170764|NCT00844753|544865|P4|Overall Study|Lack of Efficacy|2
170765|NCT00844753|544866|P3|Overall Study|Lack of Efficacy|2
170766|NCT00844753|544867|P2|Overall Study|Lack of Efficacy|0
170767|NCT00844753|544868|P1|Overall Study|Lack of Efficacy|1
170768|NCT00844805|544882|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
170769|NCT00844805|544883|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
170770|NCT00844805|544884|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
170771|NCT00844805|544885|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
170772|NCT00844805|544882|P4|Follow-Up Phase|Relapse/Recurrence|4
170773|NCT00844805|544883|P3|Follow-Up Phase|Relapse/Recurrence|2
170774|NCT00844805|544884|P2|Follow-Up Phase|Relapse/Recurrence|0
170775|NCT00844805|544885|P1|Follow-Up Phase|Relapse/Recurrence|0
170776|NCT00844805|544882|P4|Follow-Up Phase|Noncompliance With Protocol|1
170777|NCT00844805|544883|P3|Follow-Up Phase|Noncompliance With Protocol|0
170778|NCT00844805|544884|P2|Follow-Up Phase|Noncompliance With Protocol|0
170779|NCT00844805|544885|P1|Follow-Up Phase|Noncompliance With Protocol|0
170780|NCT00844805|544882|P4|Follow-Up Phase|Withdrawal by Subject|3
170781|NCT00844805|544883|P3|Follow-Up Phase|Withdrawal by Subject|6
170782|NCT00844805|544884|P2|Follow-Up Phase|Withdrawal by Subject|0
170783|NCT00844805|544885|P1|Follow-Up Phase|Withdrawal by Subject|0
170784|NCT00844805|544882|P4|Follow-Up Phase|Adverse Event|0
170785|NCT00844805|544883|P3|Follow-Up Phase|Adverse Event|1
170786|NCT00844805|544884|P2|Follow-Up Phase|Adverse Event|0
170787|NCT00844805|544885|P1|Follow-Up Phase|Adverse Event|0
170788|NCT00844805|544882|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
170789|NCT00844805|544883|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
170790|NCT00844805|544884|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
170791|NCT00844805|544885|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
170792|NCT00844805|544882|P4|Treatment Phase|Noncompliance With Protocol|0
170793|NCT00844805|544883|P3|Treatment Phase|Noncompliance With Protocol|0
170794|NCT00844805|544884|P2|Treatment Phase|Noncompliance With Protocol|0
170795|NCT00844805|544885|P1|Treatment Phase|Noncompliance With Protocol|1
170796|NCT00844805|544882|P4|Treatment Phase|Withdrawal by Subject|0
170797|NCT00844805|544883|P3|Treatment Phase|Withdrawal by Subject|0
170798|NCT00844805|544884|P2|Treatment Phase|Withdrawal by Subject|4
170799|NCT00844805|544885|P1|Treatment Phase|Withdrawal by Subject|3
170800|NCT00844805|544882|P4|Treatment Phase|Adverse Event|0
170801|NCT00844805|544883|P3|Treatment Phase|Adverse Event|0
170802|NCT00844805|544884|P2|Treatment Phase|Adverse Event|1
170803|NCT00844805|544885|P1|Treatment Phase|Adverse Event|5
170804|NCT00844831|544925|P1|Overall Study|Physician Decision|1
170805|NCT00844831|544925|P1|Overall Study|Adverse Event|1
170806|NCT00844831|544925|P1|Overall Study|Withdrawal by Subject|4
170807|NCT00844844|544933|P1|Post Treatment Period|Withdrawal by Subject|1
170808|NCT00844844|544933|P1|Extension Treatment Period|Adverse Event|2
170809|NCT00844844|544933|P1|Treatment Period (26 Weeks)|Protocol Violation|1
170810|NCT00844844|544933|P1|Treatment Period (26 Weeks)|Adverse Event|1
170811|NCT00844857|544949|P2|Overall Study|Good Clinical Practice Violations|11
170812|NCT00844857|544950|P1|Overall Study|Good Clinical Practice Violations|21
170813|NCT00844857|544949|P2|Overall Study|Did Not Take Study Drug|1
170814|NCT00844857|544950|P1|Overall Study|Did Not Take Study Drug|3
170815|NCT00844857|544949|P2|Overall Study|Lost to Follow-up|3
170816|NCT00844857|544950|P1|Overall Study|Lost to Follow-up|2
170817|NCT00844857|544949|P2|Overall Study|Entry Criteria Not Met|1
170818|NCT00844857|544950|P1|Overall Study|Entry Criteria Not Met|0
170819|NCT00844857|544949|P2|Overall Study|Clinical Relapse|1
170820|NCT00844857|544950|P1|Overall Study|Clinical Relapse|0
170821|NCT00844857|544949|P2|Overall Study|Lack of Efficacy|5
170822|NCT00844857|544950|P1|Overall Study|Lack of Efficacy|5
170823|NCT00844857|544949|P2|Overall Study|Protocol Violation|0
170824|NCT00844857|544950|P1|Overall Study|Protocol Violation|6
170825|NCT00844857|544949|P2|Overall Study|Withdrawal by Subject|7
170826|NCT00844857|544950|P1|Overall Study|Withdrawal by Subject|8
170827|NCT00844857|544949|P2|Overall Study|Parent/Caregiver Decision|2
170828|NCT00844857|544950|P1|Overall Study|Parent/Caregiver Decision|6
170829|NCT00844857|544949|P2|Overall Study|Physician Decision|0
170830|NCT00844857|544950|P1|Overall Study|Physician Decision|2
170831|NCT00844857|544949|P2|Overall Study|Sponsor Decision|1
170832|NCT00844857|544950|P1|Overall Study|Sponsor Decision|1
170833|NCT00844857|544949|P2|Overall Study|Adverse Event|5
170834|NCT00844857|544950|P1|Overall Study|Adverse Event|24
170835|NCT00844883|544994|P1|Overall Study|Bridged to resection|1
170836|NCT00844883|544994|P1|Overall Study|Bridged to liver transplant|3
170837|NCT00844896|545006|P2|Overall Study|Parents did not have time to complete|1
170838|NCT00844896|545007|P1|Overall Study|Parents did not have time to complete|0
170839|NCT00844896|545006|P2|Overall Study|Lost to Follow-up|16
170840|NCT00844896|545007|P1|Overall Study|Lost to Follow-up|12
170841|NCT00845065|545059|P2|Overall Study|Non-Medical Reasons|11
170842|NCT00845065|545060|P1|Overall Study|Non-Medical Reasons|1
170843|NCT00845065|545059|P2|Overall Study|Lack of Efficacy|21
170844|NCT00845065|545060|P1|Overall Study|Lack of Efficacy|43
170845|NCT00845065|545059|P2|Overall Study|Adverse Event|23
170846|NCT00845065|545060|P1|Overall Study|Adverse Event|3
170847|NCT00845182|545088|P3|Overall Study|Physician Decision|1
170848|NCT00845182|545089|P2|Overall Study|Physician Decision|0
170849|NCT00845182|545090|P1|Overall Study|Physician Decision|0
170850|NCT00845182|545088|P3|Overall Study|Adverse Event|1
170851|NCT00845182|545089|P2|Overall Study|Adverse Event|1
170852|NCT00845182|545090|P1|Overall Study|Adverse Event|0
170853|NCT00845182|545088|P3|Overall Study|Lost to Follow-up|4
170854|NCT00845182|545089|P2|Overall Study|Lost to Follow-up|3
170855|NCT00845182|545090|P1|Overall Study|Lost to Follow-up|3
170856|NCT00845429|545119|P3|Overall Study|Serious adverse event|1
170857|NCT00845429|545120|P2|Overall Study|Serious adverse event|0
170858|NCT00845429|545121|P1|Overall Study|Serious adverse event|0
170859|NCT00845429|545119|P3|Overall Study|Withdrawal by Subject|2
170860|NCT00845429|545120|P2|Overall Study|Withdrawal by Subject|2
170861|NCT00845429|545121|P1|Overall Study|Withdrawal by Subject|2
170862|NCT00845429|545119|P3|Overall Study|Lost to Follow-up|10
170863|NCT00845429|545120|P2|Overall Study|Lost to Follow-up|9
170864|NCT00845429|545121|P1|Overall Study|Lost to Follow-up|7
170865|NCT00845429|545119|P3|Overall Study|Protocol Violation|7
170866|NCT00845429|545120|P2|Overall Study|Protocol Violation|4
170867|NCT00845429|545121|P1|Overall Study|Protocol Violation|5
170868|NCT00835536|545191|P2|Washout of 5 Weeks|Withdrawal by Subject|0
170869|NCT00835536|545192|P1|Washout of 5 Weeks|Withdrawal by Subject|1
170870|NCT00835549|545200|P2|Washout of 7 Days|Withdrawal by Subject|0
170871|NCT00835549|545201|P1|Washout of 7 Days|Withdrawal by Subject|2
170872|NCT00835575|545211|P2|Washout of 14 Days|Withdrawal by Subject|0
170873|NCT00835575|545212|P1|Washout of 14 Days|Withdrawal by Subject|1
170874|NCT00835640|545244|P2|Second Intervention|Protocol Violation|0
170875|NCT00835640|545245|P1|Second Intervention|Protocol Violation|1
170876|NCT00835666|545255|P2|Washout|Withdrawal by Subject|0
170877|NCT00835666|545256|P1|Washout|Withdrawal by Subject|1
170878|NCT00835666|545255|P2|Washout|Protocol Violation|0
170879|NCT00835666|545256|P1|Washout|Protocol Violation|1
170880|NCT00835679|545268|P4|Overall Study|Withdrawal by Subject|0
170881|NCT00835679|545269|P3|Overall Study|Withdrawal by Subject|0
170882|NCT00835679|545270|P2|Overall Study|Withdrawal by Subject|0
170883|NCT00835679|545271|P1|Overall Study|Withdrawal by Subject|1
170884|NCT00835692|545295|P2|First Intervention|Withdrawal by Subject|0
170885|NCT00835692|545296|P1|First Intervention|Withdrawal by Subject|1
170886|NCT00835705|545306|P2|Second Intervention|Difficulty with vein|0
170887|NCT00835705|545307|P1|Second Intervention|Difficulty with vein|1
170888|NCT00835705|545306|P2|First Intervention|Difficulty with vein|0
170889|NCT00835705|545307|P1|First Intervention|Difficulty with vein|1
170890|NCT00835731|545323|P2|Overall Study|Physician Decision|1
170891|NCT00835731|545324|P1|Overall Study|Physician Decision|1
170892|NCT00835731|545323|P2|Overall Study|Withdrawal by Subject|0
170893|NCT00835731|545324|P1|Overall Study|Withdrawal by Subject|1
170894|NCT00835796|545340|P2|First Intervention|Withdrawal by Subject|1
170895|NCT00835796|545341|P1|First Intervention|Withdrawal by Subject|0
170896|NCT00845676|545400|P1|Overall Study|Adverse Event|1
170897|NCT00845676|545400|P1|Overall Study|Virologic breakthrough at week 20|1
170898|NCT00845728|545412|P2|Overall Study|Withdrawal by Subject|108
170899|NCT00845728|545413|P1|Overall Study|Withdrawal by Subject|105
170900|NCT00845728|545412|P2|Overall Study|Adverse Event|96
170901|NCT00845728|545413|P1|Overall Study|Adverse Event|101
170902|NCT00845728|545412|P2|Overall Study|Lack of Efficacy|39
170903|NCT00845728|545413|P1|Overall Study|Lack of Efficacy|51
170904|NCT00845728|545412|P2|Overall Study|Protocol Violation|24
170905|NCT00845728|545413|P1|Overall Study|Protocol Violation|36
170906|NCT00845728|545412|P2|Overall Study|Administrative Problems|26
170907|NCT00845728|545413|P1|Overall Study|Administrative Problems|34
170908|NCT00845728|545412|P2|Overall Study|Death|26
170909|NCT00845728|545413|P1|Overall Study|Death|24
170910|NCT00845728|545412|P2|Overall Study|Lost to Follow-up|13
170911|NCT00845728|545413|P1|Overall Study|Lost to Follow-up|22
170912|NCT00845728|545412|P2|Overall Study|Abnormal test procedure result (s)|2
170913|NCT00845728|545413|P1|Overall Study|Abnormal test procedure result (s)|7
170914|NCT00845728|545412|P2|Overall Study|Patient's inability to use the device|6
170915|NCT00845728|545413|P1|Overall Study|Patient's inability to use the device|4
170916|NCT00845728|545412|P2|Overall Study|Abnormal laboratory value (s)|2
170917|NCT00845728|545413|P1|Overall Study|Abnormal laboratory value (s)|2
170918|NCT00845832|545424|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
170919|NCT00845832|545425|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
170920|NCT00845832|545426|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
170921|NCT00845832|545424|P3|Safety Follow-Up|Withdrawal by Subject|0
170922|NCT00845832|545425|P2|Safety Follow-Up|Withdrawal by Subject|0
170923|NCT00845832|545426|P1|Safety Follow-Up|Withdrawal by Subject|1
170924|NCT00845832|545424|P3|Treatment Period|Protocol Violation|0
170925|NCT00845832|545425|P2|Treatment Period|Protocol Violation|1
170926|NCT00845832|545426|P1|Treatment Period|Protocol Violation|1
170927|NCT00845832|545424|P3|Treatment Period|Adverse Event|0
170928|NCT00845832|545425|P2|Treatment Period|Adverse Event|2
170929|NCT00845832|545426|P1|Treatment Period|Adverse Event|0
170930|NCT00846027|545483|P1|Overall Study|Subject Not Treated|7
170931|NCT00846027|545483|P1|Overall Study|Protocol Violation|2
170932|NCT00846027|545483|P1|Overall Study|Investigator Discretion|29
170933|NCT00846027|545483|P1|Overall Study|Patient Decision|7
170934|NCT00846027|545483|P1|Overall Study|Toxicity|12
170935|NCT00846027|545483|P1|Overall Study|Disease Progression|30
170936|NCT00846027|545483|P1|Overall Study|Death|3
170937|NCT00846365|545519|P3|Overall Study|Other|6
170938|NCT00846365|545520|P2|Overall Study|Other|1
170939|NCT00846365|545521|P1|Overall Study|Other|9
170940|NCT00846365|545519|P3|Overall Study|Lack of Efficacy|2
170941|NCT00846365|545520|P2|Overall Study|Lack of Efficacy|1
170942|NCT00846365|545521|P1|Overall Study|Lack of Efficacy|1
170943|NCT00846365|545519|P3|Overall Study|Pregnancy|0
170944|NCT00846365|545520|P2|Overall Study|Pregnancy|0
170945|NCT00846365|545521|P1|Overall Study|Pregnancy|1
170946|NCT00846365|545519|P3|Overall Study|Withdrawal by Subject|9
170947|NCT00846365|545520|P2|Overall Study|Withdrawal by Subject|11
170948|NCT00846365|545521|P1|Overall Study|Withdrawal by Subject|11
170949|NCT00846365|545519|P3|Overall Study|Lost to Follow-up|5
170950|NCT00846365|545520|P2|Overall Study|Lost to Follow-up|2
170951|NCT00846365|545521|P1|Overall Study|Lost to Follow-up|8
170952|NCT00846365|545519|P3|Overall Study|Protocol Violation|0
170953|NCT00846365|545520|P2|Overall Study|Protocol Violation|4
170954|NCT00846365|545521|P1|Overall Study|Protocol Violation|5
170955|NCT00846365|545519|P3|Overall Study|Adverse Event|11
170956|NCT00846365|545520|P2|Overall Study|Adverse Event|30
170957|NCT00846365|545521|P1|Overall Study|Adverse Event|20
170958|NCT00846391|545577|P3|Overall Study|Study Terminated by Sponsor|2
170959|NCT00846391|545578|P2|Overall Study|Study Terminated by Sponsor|2
170960|NCT00846391|545579|P1|Overall Study|Study Terminated by Sponsor|1
170961|NCT00846391|545577|P3|Overall Study|Physician Decision|1
170962|NCT00846391|545578|P2|Overall Study|Physician Decision|0
170963|NCT00846391|545579|P1|Overall Study|Physician Decision|0
170964|NCT00846495|545589|P2|Overall Study|Physician Decision|0
170965|NCT00846495|545590|P1|Overall Study|Physician Decision|1
170966|NCT00846495|545589|P2|Overall Study|Lack of Efficacy|2
170967|NCT00846495|545590|P1|Overall Study|Lack of Efficacy|1
170968|NCT00846495|545589|P2|Overall Study|Adverse Event|1
170969|NCT00846495|545590|P1|Overall Study|Adverse Event|5
170970|NCT00846495|545589|P2|Overall Study|Lost to Follow-up|0
170971|NCT00846495|545590|P1|Overall Study|Lost to Follow-up|1
170972|NCT00846521|545610|P1|Overall Study|Protocol Violation|1
170973|NCT00846521|545610|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
170974|NCT00846521|545610|P1|Overall Study|Withdrawal by Subject|5
170975|NCT00846586|545635|P2|Overall Study|Unsatisfactory therapeutic effect|1
170976|NCT00846586|545636|P1|Overall Study|Unsatisfactory therapeutic effect|0
170977|NCT00846586|545635|P2|Overall Study|Lost to Follow-up|4
170978|NCT00846586|545636|P1|Overall Study|Lost to Follow-up|1
170979|NCT00846586|545635|P2|Overall Study|Abnormal test procedure result(s)|0
170980|NCT00846586|545636|P1|Overall Study|Abnormal test procedure result(s)|1
170981|NCT00846586|545635|P2|Overall Study|Protocol deviation|6
170982|NCT00846586|545636|P1|Overall Study|Protocol deviation|2
170983|NCT00846586|545635|P2|Overall Study|Death|0
170984|NCT00846586|545636|P1|Overall Study|Death|2
170985|NCT00846586|545635|P2|Overall Study|Administrative problems|4
170986|NCT00846586|545636|P1|Overall Study|Administrative problems|5
170987|NCT00846586|545635|P2|Overall Study|Subject withdrew consent|10
170988|NCT00846586|545636|P1|Overall Study|Subject withdrew consent|8
170989|NCT00846586|545635|P2|Overall Study|Adverse Event|10
170990|NCT00846586|545636|P1|Overall Study|Adverse Event|20
170991|NCT00846768|545669|P4|Overall Study|Adverse Event|0
170992|NCT00846768|545670|P3|Overall Study|Adverse Event|0
170993|NCT00846768|545671|P2|Overall Study|Adverse Event|1
170994|NCT00846768|545672|P1|Overall Study|Adverse Event|0
170995|NCT00846807|545742|P1|Overall Study|Other|60
170996|NCT00846807|545742|P1|Overall Study|No prescription after hospital discharge|56
170997|NCT00846807|545742|P1|Overall Study|Switch to other anticoagulants|89
170998|NCT00846807|545742|P1|Overall Study|Non compliant with European label|7
170999|NCT00846807|545742|P1|Overall Study|Withdrawal by Subject|56
171000|NCT00846807|545742|P1|Overall Study|Lost to Follow-up|94
171001|NCT00846807|545742|P1|Overall Study|Adverse Event|270
171002|NCT00846846|545750|P1|Overall Study|Withdrawal by Subject|19
171003|NCT00846846|545750|P1|Overall Study|Death|56
171004|NCT00847015|545777|P1|Overall Study|partial cystectomy vs radical cystectomy|1
171005|NCT00847015|545777|P1|Overall Study|declined any surgery|1
171006|NCT00847015|545777|P1|Overall Study|Withdrawal by Subject|1
171007|NCT00847132|545785|P2|Overall Study|Death|1
171008|NCT00847132|545786|P1|Overall Study|Death|1
171009|NCT00847145|545802|P8|Overall Study|Protocol Violation|1
171010|NCT00847145|545803|P7|Overall Study|Protocol Violation|0
171011|NCT00847145|545804|P6|Overall Study|Protocol Violation|0
171012|NCT00847145|545805|P5|Overall Study|Protocol Violation|1
171013|NCT00847145|545806|P4|Overall Study|Protocol Violation|0
171014|NCT00847145|545807|P3|Overall Study|Protocol Violation|3
171015|NCT00847145|545808|P2|Overall Study|Protocol Violation|0
171016|NCT00847145|545809|P1|Overall Study|Protocol Violation|0
171017|NCT00847145|545802|P8|Overall Study|Inappropriate enrollment|0
171018|NCT00847145|545803|P7|Overall Study|Inappropriate enrollment|0
171019|NCT00847145|545804|P6|Overall Study|Inappropriate enrollment|0
171020|NCT00847145|545805|P5|Overall Study|Inappropriate enrollment|1
171021|NCT00847145|545806|P4|Overall Study|Inappropriate enrollment|0
171022|NCT00847145|545807|P3|Overall Study|Inappropriate enrollment|0
171023|NCT00847145|545808|P2|Overall Study|Inappropriate enrollment|0
171024|NCT00847145|545809|P1|Overall Study|Inappropriate enrollment|0
171025|NCT00847145|545802|P8|Overall Study|Lost to Follow-up|2
171026|NCT00847145|545803|P7|Overall Study|Lost to Follow-up|8
171027|NCT00847145|545804|P6|Overall Study|Lost to Follow-up|4
171028|NCT00847145|545805|P5|Overall Study|Lost to Follow-up|4
171029|NCT00847145|545806|P4|Overall Study|Lost to Follow-up|0
171030|NCT00847145|545807|P3|Overall Study|Lost to Follow-up|1
171031|NCT00847145|545808|P2|Overall Study|Lost to Follow-up|1
171032|NCT00847145|545809|P1|Overall Study|Lost to Follow-up|3
171033|NCT00847145|545802|P8|Overall Study|Withdrawal by Subject|1
171034|NCT00847145|545803|P7|Overall Study|Withdrawal by Subject|1
171035|NCT00847145|545804|P6|Overall Study|Withdrawal by Subject|0
171036|NCT00847145|545805|P5|Overall Study|Withdrawal by Subject|0
171037|NCT00847145|545806|P4|Overall Study|Withdrawal by Subject|1
171038|NCT00847145|545807|P3|Overall Study|Withdrawal by Subject|6
171039|NCT00847145|545808|P2|Overall Study|Withdrawal by Subject|4
171040|NCT00847145|545809|P1|Overall Study|Withdrawal by Subject|3
171041|NCT00847145|545802|P8|Overall Study|AE or Death|0
171042|NCT00847145|545803|P7|Overall Study|AE or Death|0
171043|NCT00847145|545804|P6|Overall Study|AE or Death|0
171044|NCT00847145|545805|P5|Overall Study|AE or Death|0
171045|NCT00847145|545806|P4|Overall Study|AE or Death|0
171046|NCT00847145|545807|P3|Overall Study|AE or Death|1
171047|NCT00847145|545808|P2|Overall Study|AE or Death|1
171048|NCT00847145|545809|P1|Overall Study|AE or Death|0
171049|NCT00847197|545859|P2|Overall Study|Withdrawal by Subject|1
171050|NCT00847197|545860|P1|Overall Study|Withdrawal by Subject|3
171051|NCT00847197|545859|P2|Overall Study|Protocol Violation|1
171052|NCT00847197|545860|P1|Overall Study|Protocol Violation|0
171053|NCT00847197|545859|P2|Overall Study|Adverse Event|3
171054|NCT00847197|545860|P1|Overall Study|Adverse Event|21
171055|NCT00847301|545908|P1|Overall Study|Other reason not defined above|1
171056|NCT00847301|545908|P1|Overall Study|No prescription after hospital discharge|1
171057|NCT00847301|545908|P1|Overall Study|Lost to Follow-up|1
171058|NCT00847301|545908|P1|Overall Study|Switch to other anticoagulants|16
171059|NCT00847301|545908|P1|Overall Study|Adverse Event|35
171060|NCT00847405|545918|P2|Washout of 7 Days|Withdrawal by Subject|0
171061|NCT00847405|545919|P1|Washout of 7 Days|Withdrawal by Subject|1
171062|NCT00847405|545918|P2|First Intervention|Adverse Event|1
171063|NCT00847405|545919|P1|First Intervention|Adverse Event|0
171064|NCT00847535|545931|P3|Overall Study|Lost to Follow-up|0
171065|NCT00847535|545932|P2|Overall Study|Lost to Follow-up|1
171066|NCT00847535|545933|P1|Overall Study|Lost to Follow-up|0
171067|NCT00847535|545931|P3|Overall Study|Withdrawal by Subject|1
171068|NCT00847535|545932|P2|Overall Study|Withdrawal by Subject|1
171069|NCT00847535|545933|P1|Overall Study|Withdrawal by Subject|2
171070|NCT00847561|545943|P2|Overall Study|Unable to schedule|1
171071|NCT00847561|545944|P1|Overall Study|Unable to schedule|9
171072|NCT00847561|545943|P2|Overall Study|Withdrawal by Subject|3
171073|NCT00847561|545944|P1|Overall Study|Withdrawal by Subject|4
171074|NCT00847613|545965|P4|Overall Study|Unspecified|0
171075|NCT00847613|545966|P3|Overall Study|Unspecified|2
171076|NCT00847613|545967|P2|Overall Study|Unspecified|1
171077|NCT00847613|545968|P1|Overall Study|Unspecified|1
171078|NCT00847613|545965|P4|Overall Study|Randomized, but not treated|0
171079|NCT00847613|545966|P3|Overall Study|Randomized, but not treated|0
171080|NCT00847613|545967|P2|Overall Study|Randomized, but not treated|3
171081|NCT00847613|545968|P1|Overall Study|Randomized, but not treated|0
171082|NCT00847613|545965|P4|Overall Study|Sponsor request|0
171083|NCT00847613|545966|P3|Overall Study|Sponsor request|0
171084|NCT00847613|545967|P2|Overall Study|Sponsor request|1
171085|NCT00847613|545968|P1|Overall Study|Sponsor request|0
171086|NCT00847613|545965|P4|Overall Study|Participant moved|0
171087|NCT00847613|545966|P3|Overall Study|Participant moved|0
171088|NCT00847613|545967|P2|Overall Study|Participant moved|1
171089|NCT00847613|545968|P1|Overall Study|Participant moved|4
171090|NCT00847613|545965|P4|Overall Study|Withdrawal by Subject|2
171091|NCT00847613|545966|P3|Overall Study|Withdrawal by Subject|2
171092|NCT00847613|545967|P2|Overall Study|Withdrawal by Subject|11
171093|NCT00847613|545968|P1|Overall Study|Withdrawal by Subject|8
171094|NCT00847613|545965|P4|Overall Study|Site closure|1
171095|NCT00847613|545966|P3|Overall Study|Site closure|0
171096|NCT00847613|545967|P2|Overall Study|Site closure|0
171097|NCT00847613|545968|P1|Overall Study|Site closure|1
171098|NCT00847613|545965|P4|Overall Study|Pregnancy|0
171099|NCT00847613|545966|P3|Overall Study|Pregnancy|0
171100|NCT00847613|545967|P2|Overall Study|Pregnancy|1
171101|NCT00847613|545968|P1|Overall Study|Pregnancy|1
171102|NCT00847613|545965|P4|Overall Study|Protocol Violation|1
171103|NCT00847613|545966|P3|Overall Study|Protocol Violation|3
171104|NCT00847613|545967|P2|Overall Study|Protocol Violation|6
171105|NCT00847613|545968|P1|Overall Study|Protocol Violation|6
171106|NCT00847613|545965|P4|Overall Study|Lost to Follow-up|3
171107|NCT00847613|545966|P3|Overall Study|Lost to Follow-up|0
171108|NCT00847613|545967|P2|Overall Study|Lost to Follow-up|0
171109|NCT00847613|545968|P1|Overall Study|Lost to Follow-up|5
171110|NCT00847613|545965|P4|Overall Study|Study terminated by Sponsor|1
171111|NCT00847613|545966|P3|Overall Study|Study terminated by Sponsor|2
171112|NCT00847613|545967|P2|Overall Study|Study terminated by Sponsor|0
171113|NCT00847613|545968|P1|Overall Study|Study terminated by Sponsor|1
171114|NCT00847613|545965|P4|Overall Study|Lack of Efficacy|1
171115|NCT00847613|545966|P3|Overall Study|Lack of Efficacy|3
171116|NCT00847613|545967|P2|Overall Study|Lack of Efficacy|3
171117|NCT00847613|545968|P1|Overall Study|Lack of Efficacy|7
171118|NCT00847613|545965|P4|Overall Study|Adverse Event|6
171119|NCT00847613|545966|P3|Overall Study|Adverse Event|5
171120|NCT00847613|545967|P2|Overall Study|Adverse Event|26
171121|NCT00847613|545968|P1|Overall Study|Adverse Event|36
171122|NCT00847613|545965|P4|Overall Study|Death|0
171123|NCT00847613|545966|P3|Overall Study|Death|0
171124|NCT00847613|545967|P2|Overall Study|Death|1
171125|NCT00847613|545968|P1|Overall Study|Death|1
171126|NCT00847613|545965|P4|Overall Study|Ongoing at cut-off date|64
171127|NCT00847613|545966|P3|Overall Study|Ongoing at cut-off date|64
171128|NCT00847613|545967|P2|Overall Study|Ongoing at cut-off date|265
171129|NCT00847613|545968|P1|Overall Study|Ongoing at cut-off date|250
171130|NCT00847626|546217|P11|Overall Study|Other|3
171131|NCT00847626|546218|P10|Overall Study|Other|1
171132|NCT00847626|546219|P9|Overall Study|Other|1
171133|NCT00847626|546220|P8|Overall Study|Other|3
171134|NCT00847626|546221|P7|Overall Study|Other|2
171135|NCT00847626|546222|P6|Overall Study|Other|2
171136|NCT00847626|546223|P5|Overall Study|Other|2
171137|NCT00847626|546224|P4|Overall Study|Other|1
171138|NCT00847626|546225|P3|Overall Study|Other|4
171139|NCT00847626|546226|P2|Overall Study|Other|5
171140|NCT00847626|546227|P1|Overall Study|Other|1
171141|NCT00847626|546217|P11|Overall Study|Lack of Efficacy|7
171142|NCT00847626|546218|P10|Overall Study|Lack of Efficacy|1
171143|NCT00847626|546219|P9|Overall Study|Lack of Efficacy|5
171144|NCT00847626|546220|P8|Overall Study|Lack of Efficacy|2
171145|NCT00847626|546221|P7|Overall Study|Lack of Efficacy|6
171146|NCT00847626|546222|P6|Overall Study|Lack of Efficacy|0
171147|NCT00847626|546223|P5|Overall Study|Lack of Efficacy|2
171148|NCT00847626|546224|P4|Overall Study|Lack of Efficacy|1
171149|NCT00847626|546225|P3|Overall Study|Lack of Efficacy|0
171150|NCT00847626|546226|P2|Overall Study|Lack of Efficacy|1
171151|NCT00847626|546227|P1|Overall Study|Lack of Efficacy|3
171152|NCT00847626|546217|P11|Overall Study|Withdrawal by Subject|2
171153|NCT00847626|546218|P10|Overall Study|Withdrawal by Subject|5
171154|NCT00847626|546219|P9|Overall Study|Withdrawal by Subject|4
171155|NCT00847626|546220|P8|Overall Study|Withdrawal by Subject|4
171156|NCT00847626|546221|P7|Overall Study|Withdrawal by Subject|8
171157|NCT00847626|546222|P6|Overall Study|Withdrawal by Subject|9
171158|NCT00847626|546223|P5|Overall Study|Withdrawal by Subject|12
171159|NCT00847626|546224|P4|Overall Study|Withdrawal by Subject|8
171160|NCT00847626|546225|P3|Overall Study|Withdrawal by Subject|3
171161|NCT00847626|546226|P2|Overall Study|Withdrawal by Subject|5
171162|NCT00847626|546227|P1|Overall Study|Withdrawal by Subject|5
171163|NCT00847626|546217|P11|Overall Study|Lost to Follow-up|1
171164|NCT00847626|546218|P10|Overall Study|Lost to Follow-up|0
171165|NCT00847626|546219|P9|Overall Study|Lost to Follow-up|1
171166|NCT00847626|546220|P8|Overall Study|Lost to Follow-up|3
171167|NCT00847626|546221|P7|Overall Study|Lost to Follow-up|1
171168|NCT00847626|546222|P6|Overall Study|Lost to Follow-up|3
171169|NCT00847626|546223|P5|Overall Study|Lost to Follow-up|0
171170|NCT00847626|546224|P4|Overall Study|Lost to Follow-up|1
171171|NCT00847626|546225|P3|Overall Study|Lost to Follow-up|1
171172|NCT00847626|546226|P2|Overall Study|Lost to Follow-up|1
171173|NCT00847626|546227|P1|Overall Study|Lost to Follow-up|0
171174|NCT00847626|546217|P11|Overall Study|Protocol Violation|1
171175|NCT00847626|546218|P10|Overall Study|Protocol Violation|1
171176|NCT00847626|546219|P9|Overall Study|Protocol Violation|0
171177|NCT00847626|546220|P8|Overall Study|Protocol Violation|1
171178|NCT00847626|546221|P7|Overall Study|Protocol Violation|1
171179|NCT00847626|546222|P6|Overall Study|Protocol Violation|1
171180|NCT00847626|546223|P5|Overall Study|Protocol Violation|1
171181|NCT00847626|546224|P4|Overall Study|Protocol Violation|1
171182|NCT00847626|546225|P3|Overall Study|Protocol Violation|2
171183|NCT00847626|546226|P2|Overall Study|Protocol Violation|1
171184|NCT00847626|546227|P1|Overall Study|Protocol Violation|2
171185|NCT00847626|546217|P11|Overall Study|Adverse Event|6
171186|NCT00847626|546218|P10|Overall Study|Adverse Event|6
171187|NCT00847626|546219|P9|Overall Study|Adverse Event|3
171188|NCT00847626|546220|P8|Overall Study|Adverse Event|6
171189|NCT00847626|546221|P7|Overall Study|Adverse Event|4
171190|NCT00847626|546222|P6|Overall Study|Adverse Event|22
171191|NCT00847626|546223|P5|Overall Study|Adverse Event|11
171192|NCT00847626|546224|P4|Overall Study|Adverse Event|19
171193|NCT00847626|546225|P3|Overall Study|Adverse Event|6
171194|NCT00847626|546226|P2|Overall Study|Adverse Event|10
171195|NCT00847626|546227|P1|Overall Study|Adverse Event|10
171196|NCT00847665|546424|P2|Overall Study|Withdrawal by Subject|0
171197|NCT00847665|546425|P1|Overall Study|Withdrawal by Subject|1
171198|NCT00847704|546437|P1|Overall Study|Withdrawal by Subject|1
171199|NCT00847808|546446|P1|Overall Study|Participant Took Excluded Medication|1
171200|NCT00847808|546446|P1|Overall Study|Participant Reported Lack of Efficacy|1
171201|NCT00847808|546446|P1|Overall Study|Withdrawal by Subject|4
171202|NCT00847808|546446|P1|Overall Study|Lost to Follow-up|1
171203|NCT00847808|546446|P1|Overall Study|Protocol Violation|1
171204|NCT00847808|546446|P1|Overall Study|Adverse Event|7
171205|NCT00847886|546465|P2|Overall Study|Adverse Event|1
171206|NCT00847886|546466|P1|Overall Study|Adverse Event|0
171207|NCT00847912|546494|P2|Overall Study|Withdrawal by Subject|6
171208|NCT00847912|546495|P1|Overall Study|Withdrawal by Subject|3
171209|NCT00847912|546494|P2|Overall Study|Protocol Violation|7
171210|NCT00847912|546495|P1|Overall Study|Protocol Violation|6
171211|NCT00848042|546512|P3|Overall Study|Other Therapy|0
171212|NCT00848042|546513|P2|Overall Study|Other Therapy|0
171213|NCT00848042|546514|P1|Overall Study|Other Therapy|3
171214|NCT00848042|546512|P3|Overall Study|Death|0
171215|NCT00848042|546513|P2|Overall Study|Death|2
171216|NCT00848042|546514|P1|Overall Study|Death|1
171217|NCT00848081|546527|P2|Overall Study|Withdrawal by Subject|3
171218|NCT00848081|546528|P1|Overall Study|Withdrawal by Subject|5
171219|NCT00848081|546527|P2|Overall Study|Physician Decision|3
171220|NCT00848081|546528|P1|Overall Study|Physician Decision|0
171221|NCT00848081|546527|P2|Overall Study|Lost to Follow-up|0
171222|NCT00848081|546528|P1|Overall Study|Lost to Follow-up|1
171223|NCT00848081|546527|P2|Overall Study|Protocol Violation|5
171224|NCT00848081|546528|P1|Overall Study|Protocol Violation|8
171225|NCT00848081|546527|P2|Overall Study|Adverse Event|7
171226|NCT00848081|546528|P1|Overall Study|Adverse Event|6
171227|NCT00848107|546542|P1|Overall Study|Pregnancy|1
171228|NCT00848107|546542|P1|Overall Study|Death|1
171229|NCT00848107|546542|P1|Overall Study|Adverse Event|9
171230|NCT00848107|546542|P1|Overall Study|Withdrawal by Subject|8
171231|NCT00848107|546542|P1|Overall Study|Lost to Follow-up|2
171232|NCT00848120|546550|P1|Overall Study|Adverse Event|1
171233|NCT00848198|546589|P1|Overall Study|Incomplete Case Report Forms|15
171234|NCT00848211|546631|P4|Overall Study|Adverse Event|0
171235|NCT00848211|546632|P3|Overall Study|Adverse Event|0
171236|NCT00848211|546633|P2|Overall Study|Adverse Event|0
171237|NCT00848211|546634|P1|Overall Study|Adverse Event|0
171238|NCT00848211|546631|P4|Overall Study|Protocol Violation|0
171239|NCT00848211|546632|P3|Overall Study|Protocol Violation|1
171240|NCT00848211|546633|P2|Overall Study|Protocol Violation|1
171241|NCT00848211|546634|P1|Overall Study|Protocol Violation|0
171242|NCT00848250|546663|P2|Overall Study|surgery was completed without cardiopulm|1
171243|NCT00848250|546664|P1|Overall Study|surgery was completed without cardiopulm|0
171244|NCT00848354|546684|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
171245|NCT00848354|546685|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
171246|NCT00848354|546684|P2|Phase 2 Year 2|Subject Request|1
171247|NCT00848354|546685|P1|Phase 2 Year 2|Subject Request|1
171248|NCT00848354|546684|P2|Phase 2 Year 2|Protocol Violation|1
171249|NCT00848354|546685|P1|Phase 2 Year 2|Protocol Violation|1
171250|NCT00848354|546684|P2|Phase 2 Year 2|Unspecified Reason|0
171251|NCT00848354|546685|P1|Phase 2 Year 2|Unspecified Reason|1
171252|NCT00848354|546684|P2|Phase 2 Year 2|Lost to Follow-up|3
171253|NCT00848354|546685|P1|Phase 2 Year 2|Lost to Follow-up|1
171254|NCT00848354|546684|P2|Phase 2 Year 2|Failed to return|0
171255|NCT00848354|546685|P1|Phase 2 Year 2|Failed to return|3
171256|NCT00848354|546684|P2|Phase 2 Year 2|Death|0
171257|NCT00848354|546685|P1|Phase 2 Year 2|Death|2
171258|NCT00848354|546684|P2|Phase 2 Year 2|Adverse Event|2
171259|NCT00848354|546685|P1|Phase 2 Year 2|Adverse Event|12
171260|NCT00848354|546684|P2|Phase 2 Year 1|Subject Request|2
171261|NCT00848354|546685|P1|Phase 2 Year 1|Subject Request|1
171262|NCT00848354|546684|P2|Phase 2 Year 1|Protocol Violation|1
171263|NCT00848354|546685|P1|Phase 2 Year 1|Protocol Violation|4
171264|NCT00848354|546684|P2|Phase 2 Year 1|Unspecified Reason|0
171265|NCT00848354|546685|P1|Phase 2 Year 1|Unspecified Reason|3
171266|NCT00848354|546684|P2|Phase 2 Year 1|Lost to Follow-up|0
171267|NCT00848354|546685|P1|Phase 2 Year 1|Lost to Follow-up|1
171268|NCT00848354|546684|P2|Phase 2 Year 1|Failed to Return|1
171269|NCT00848354|546685|P1|Phase 2 Year 1|Failed to Return|1
171270|NCT00848354|546684|P2|Phase 2 Year 1|Death|0
171271|NCT00848354|546685|P1|Phase 2 Year 1|Death|1
171272|NCT00848354|546684|P2|Phase 2 Year 1|Adverse Event|2
171273|NCT00848354|546685|P1|Phase 2 Year 1|Adverse Event|7
171274|NCT00848354|546684|P2|Phase 1|Lack of Efficacy|1
171275|NCT00848354|546685|P1|Phase 1|Lack of Efficacy|0
171276|NCT00848354|546684|P2|Phase 1|Withdrawal by Subject|4
171277|NCT00848354|546685|P1|Phase 1|Withdrawal by Subject|2
171278|NCT00848354|546684|P2|Phase 1|Protocol Violation|1
171279|NCT00848354|546685|P1|Phase 1|Protocol Violation|1
171280|NCT00848354|546684|P2|Phase 1|Unspecified Reason|1
171281|NCT00848354|546685|P1|Phase 1|Unspecified Reason|1
171282|NCT00848354|546684|P2|Phase 1|Lost to Follow-up|1
171283|NCT00848354|546685|P1|Phase 1|Lost to Follow-up|1
171284|NCT00848354|546684|P2|Phase 1|Failed to return|1
171285|NCT00848354|546685|P1|Phase 1|Failed to return|0
171286|NCT00848354|546684|P2|Phase 1|Discontinuation of study by sponsor|1
171287|NCT00848354|546685|P1|Phase 1|Discontinuation of study by sponsor|2
171288|NCT00848354|546684|P2|Phase 1|Adverse Event|4
171289|NCT00848354|546685|P1|Phase 1|Adverse Event|5
171290|NCT00840632|546848|P2|Washout|Withdrawal by Subject|1
171291|NCT00840632|546849|P1|Washout|Withdrawal by Subject|1
171292|NCT00840632|546848|P2|First Intervention|Withdrawal by Subject|1
171293|NCT00840632|546849|P1|First Intervention|Withdrawal by Subject|0
171294|NCT00840658|546867|P4|Overall Study|Lost to Follow-up|1
171295|NCT00840658|546868|P3|Overall Study|Lost to Follow-up|2
171296|NCT00840658|546869|P2|Overall Study|Lost to Follow-up|1
171297|NCT00840658|546870|P1|Overall Study|Lost to Follow-up|3
171298|NCT00840658|546867|P4|Overall Study|Death|3
171299|NCT00840658|546868|P3|Overall Study|Death|3
171300|NCT00840658|546869|P2|Overall Study|Death|2
171301|NCT00840658|546870|P1|Overall Study|Death|2
171302|NCT00840879|546910|P2|Second Intervention|Withdrawal by Subject|0
171303|NCT00840879|546911|P1|Second Intervention|Withdrawal by Subject|1
171304|NCT00840996|546921|P2|Overall Study|Withdrawal by Subject|0
171305|NCT00840996|546922|P1|Overall Study|Withdrawal by Subject|1
171306|NCT00841035|546940|P1|Phase 1 Overall Study|Physician Decision|13
171307|NCT00841321|546985|P2|Overall Study|Adverse Event|2
171308|NCT00841321|546986|P1|Overall Study|Adverse Event|0
171309|NCT00841321|546985|P2|Overall Study|Lost to Follow-up|1
171310|NCT00841321|546986|P1|Overall Study|Lost to Follow-up|1
171311|NCT00841542|547005|P2|Period 1|Adverse Event|0
171312|NCT00841542|547006|P1|Period 1|Adverse Event|1
171313|NCT00841659|547029|P2|Washout: 2 Weeks|Protocol Violation|0
171314|NCT00841659|547030|P1|Washout: 2 Weeks|Protocol Violation|1
171315|NCT00841672|547040|P2|Overall Study|Protocol Deviation|1
171316|NCT00841672|547041|P1|Overall Study|Protocol Deviation|0
171317|NCT00841672|547040|P2|Overall Study|Misrandomized|0
171318|NCT00841672|547041|P1|Overall Study|Misrandomized|1
171319|NCT00841672|547040|P2|Overall Study|Administrative problems|9
171320|NCT00841672|547041|P1|Overall Study|Administrative problems|9
171321|NCT00841672|547040|P2|Overall Study|Lost to Follow-up|1
171322|NCT00841672|547041|P1|Overall Study|Lost to Follow-up|1
171323|NCT00841672|547040|P2|Overall Study|Subject withdrew consent|4
171324|NCT00841672|547041|P1|Overall Study|Subject withdrew consent|2
171325|NCT00841672|547040|P2|Overall Study|Abnormal test procedure result(s)|1
171326|NCT00841672|547041|P1|Overall Study|Abnormal test procedure result(s)|0
171327|NCT00841672|547040|P2|Overall Study|Adverse Event|16
171328|NCT00841672|547041|P1|Overall Study|Adverse Event|7
171329|NCT00841698|547057|P2|First Intervention|Withdrawal by Subject|0
171330|NCT00841698|547058|P1|First Intervention|Withdrawal by Subject|1
171331|NCT00841763|547068|P4|Overall Study|Unable to Classify|0
171332|NCT00841763|547069|P3|Overall Study|Unable to Classify|0
171333|NCT00841763|547070|P2|Overall Study|Unable to Classify|1
171334|NCT00841763|547071|P1|Overall Study|Unable to Classify|7
171335|NCT00841763|547068|P4|Overall Study|Administrative Reasons|0
171336|NCT00841763|547069|P3|Overall Study|Administrative Reasons|0
171337|NCT00841763|547070|P2|Overall Study|Administrative Reasons|1
171338|NCT00841763|547071|P1|Overall Study|Administrative Reasons|3
171339|NCT00841763|547068|P4|Overall Study|Protocol Violation|0
171340|NCT00841763|547069|P3|Overall Study|Protocol Violation|1
171341|NCT00841763|547070|P2|Overall Study|Protocol Violation|3
171342|NCT00841763|547071|P1|Overall Study|Protocol Violation|20
171343|NCT00841763|547068|P4|Overall Study|Lost to Follow-up|0
171344|NCT00841763|547069|P3|Overall Study|Lost to Follow-up|0
171345|NCT00841763|547070|P2|Overall Study|Lost to Follow-up|25
171346|NCT00841763|547071|P1|Overall Study|Lost to Follow-up|63
171347|NCT00841763|547068|P4|Overall Study|Adverse Event|2
171348|NCT00841763|547069|P3|Overall Study|Adverse Event|3
171349|NCT00841763|547070|P2|Overall Study|Adverse Event|10
171350|NCT00841763|547071|P1|Overall Study|Adverse Event|9
171351|NCT00841763|547068|P4|Overall Study|Withdrawal by Subject|1
171352|NCT00841763|547069|P3|Overall Study|Withdrawal by Subject|4
171353|NCT00841763|547070|P2|Overall Study|Withdrawal by Subject|17
171354|NCT00841763|547071|P1|Overall Study|Withdrawal by Subject|60
171355|NCT00841776|547133|P2|Overall Study|Withdrawal by Subject|1
171356|NCT00841776|547134|P1|Overall Study|Withdrawal by Subject|0
171357|NCT00841776|547133|P2|Overall Study|Lost to Follow-up|1
171358|NCT00841776|547134|P1|Overall Study|Lost to Follow-up|2
171359|NCT00841776|547133|P2|Overall Study|Lack of Efficacy|1
171360|NCT00841776|547134|P1|Overall Study|Lack of Efficacy|0
171361|NCT00841815|547152|P2|Washout|Withdrawal by Subject|1
171362|NCT00841815|547153|P1|Washout|Withdrawal by Subject|0
171363|NCT00841906|547163|P2|Overall Study|Withdrawal by Subject|0
171364|NCT00841906|547164|P1|Overall Study|Withdrawal by Subject|2
171365|NCT00842153|547213|P2|Overall Study|Lost to Follow-up|2
171366|NCT00842153|547214|P1|Overall Study|Lost to Follow-up|1
171367|NCT00842153|547213|P2|Overall Study|Adverse Event|1
171368|NCT00842153|547214|P1|Overall Study|Adverse Event|0
171369|NCT00842244|547258|P1|Overall Study|Unspecified|17
171370|NCT00842244|547258|P1|Overall Study|Withdrawal by Subject|1
171371|NCT00842244|547258|P1|Overall Study|Death|3
171372|NCT00842257|547277|P1|Overall Study|Adverse Event|1
171373|NCT00842348|547293|P2|Study 729|Surgical resection|0
171374|NCT00842348|547294|P1|Study 729|Surgical resection|1
171375|NCT00842348|547293|P2|Study 729|Sponsor's decision|0
171376|NCT00842348|547294|P1|Study 729|Sponsor's decision|1
171377|NCT00842348|547293|P2|Study 729|Due to non-availability of IP|1
171378|NCT00842348|547294|P1|Study 729|Due to non-availability of IP|0
171379|NCT00842348|547293|P2|Study 729|Due to Sponsor stopping the study|1
171380|NCT00842348|547294|P1|Study 729|Due to Sponsor stopping the study|1
171381|NCT00842348|547293|P2|Study 729|Withdrawal by Subject|4
171382|NCT00842348|547294|P1|Study 729|Withdrawal by Subject|2
171383|NCT00842348|547293|P2|Study 729|Protocol Violation|1
171384|NCT00842348|547294|P1|Study 729|Protocol Violation|1
171385|NCT00842348|547293|P2|Study 729|Adverse Event|1
171386|NCT00842348|547294|P1|Study 729|Adverse Event|1
171387|NCT00842348|547293|P2|Study 729|Disease progression/death|30
171388|NCT00842348|547294|P1|Study 729|Disease progression/death|19
171389|NCT00842348|547293|P2|Patients Randomised in Study 726|Did not enter Study 729|56
171390|NCT00842348|547294|P1|Patients Randomised in Study 726|Did not enter Study 729|59
171391|NCT00842361|547306|P2|Overall Study|Unclassified|2
171392|NCT00842361|547307|P1|Overall Study|Unclassified|0
171393|NCT00842361|547306|P2|Overall Study|Protocol Violation|0
171394|NCT00842361|547307|P1|Overall Study|Protocol Violation|1
171395|NCT00842543|547329|P4|Overall Study|Withdrawal by Subject|4
171396|NCT00842543|547330|P3|Overall Study|Withdrawal by Subject|3
171397|NCT00842543|547331|P2|Overall Study|Withdrawal by Subject|0
171398|NCT00842543|547332|P1|Overall Study|Withdrawal by Subject|2
171399|NCT00842712|547376|P7|Randomized Part|Ongoing at cut-off date|2
171400|NCT00842712|547377|P6|Randomized Part|Ongoing at cut-off date|0
171401|NCT00842712|547378|P5|Randomized Part|Ongoing at cut-off date|0
171402|NCT00842712|547379|P4|Randomized Part|Ongoing at cut-off date|0
171403|NCT00842712|547380|P3|Randomized Part|Ongoing at cut-off date|0
171404|NCT00842712|547381|P2|Randomized Part|Ongoing at cut-off date|0
171405|NCT00842712|547382|P1|Randomized Part|Ongoing at cut-off date|0
171406|NCT00842712|547376|P7|Randomized Part|Randomized but not treated|4
171407|NCT00842712|547377|P6|Randomized Part|Randomized but not treated|1
171408|NCT00842712|547378|P5|Randomized Part|Randomized but not treated|0
171409|NCT00842712|547379|P4|Randomized Part|Randomized but not treated|0
171410|NCT00842712|547380|P3|Randomized Part|Randomized but not treated|0
171411|NCT00842712|547381|P2|Randomized Part|Randomized but not treated|0
171412|NCT00842712|547382|P1|Randomized Part|Randomized but not treated|0
171413|NCT00842712|547376|P7|Safety Run-in Part|Progressive disease|0
171414|NCT00842712|547377|P6|Safety Run-in Part|Progressive disease|0
171415|NCT00842712|547378|P5|Safety Run-in Part|Progressive disease|0
171416|NCT00842712|547379|P4|Safety Run-in Part|Progressive disease|1
171417|NCT00842712|547380|P3|Safety Run-in Part|Progressive disease|0
171418|NCT00842712|547381|P2|Safety Run-in Part|Progressive disease|1
171419|NCT00842712|547382|P1|Safety Run-in Part|Progressive disease|3
171420|NCT00842712|547376|P7|Safety Run-in Part|Adverse Event|0
171421|NCT00842712|547377|P6|Safety Run-in Part|Adverse Event|0
171422|NCT00842712|547378|P5|Safety Run-in Part|Adverse Event|0
171423|NCT00842712|547379|P4|Safety Run-in Part|Adverse Event|0
171424|NCT00842712|547380|P3|Safety Run-in Part|Adverse Event|0
171425|NCT00842712|547381|P2|Safety Run-in Part|Adverse Event|1
171426|NCT00842712|547382|P1|Safety Run-in Part|Adverse Event|0
171427|NCT00842829|547426|P3|Continuation Period|Non-compliance to study drug|1
171428|NCT00842829|547427|P2|Continuation Period|Non-compliance to study drug|0
171429|NCT00842829|547428|P1|Continuation Period|Non-compliance to study drug|0
171430|NCT00842829|547426|P3|Continuation Period|Non-compliance to study procedures|2
171431|NCT00842829|547427|P2|Continuation Period|Non-compliance to study procedures|0
171432|NCT00842829|547428|P1|Continuation Period|Non-compliance to study procedures|0
171433|NCT00842829|547426|P3|Continuation Period|Not specified|7
171434|NCT00842829|547427|P2|Continuation Period|Not specified|0
171435|NCT00842829|547428|P1|Continuation Period|Not specified|0
171436|NCT00842829|547426|P3|Continuation Period|Withdrawal by Subject|10
171437|NCT00842829|547427|P2|Continuation Period|Withdrawal by Subject|0
171438|NCT00842829|547428|P1|Continuation Period|Withdrawal by Subject|0
171439|NCT00842829|547426|P3|Continuation Period|Unstable persistent cancer pain|3
171440|NCT00842829|547427|P2|Continuation Period|Unstable persistent cancer pain|0
171441|NCT00842829|547428|P1|Continuation Period|Unstable persistent cancer pain|0
171442|NCT00842829|547426|P3|Continuation Period|Lack of Efficacy|6
171443|NCT00842829|547427|P2|Continuation Period|Lack of Efficacy|0
171444|NCT00842829|547428|P1|Continuation Period|Lack of Efficacy|0
171445|NCT00842829|547426|P3|Continuation Period|Adverse Event|32
171446|NCT00842829|547427|P2|Continuation Period|Adverse Event|0
171447|NCT00842829|547428|P1|Continuation Period|Adverse Event|0
171448|NCT00842829|547426|P3|Treatment Period|Unclear completion status|1
171449|NCT00842829|547427|P2|Treatment Period|Unclear completion status|0
171450|NCT00842829|547428|P1|Treatment Period|Unclear completion status|0
171451|NCT00842829|547426|P3|Treatment Period|Non-compliance to study procedures|4
171452|NCT00842829|547427|P2|Treatment Period|Non-compliance to study procedures|0
171453|NCT00842829|547428|P1|Treatment Period|Non-compliance to study procedures|0
171454|NCT00842829|547426|P3|Treatment Period|Not specified|18
171455|NCT00842829|547427|P2|Treatment Period|Not specified|0
171456|NCT00842829|547428|P1|Treatment Period|Not specified|0
171457|NCT00842829|547426|P3|Treatment Period|Protocol Violation|2
171458|NCT00842829|547427|P2|Treatment Period|Protocol Violation|0
171459|NCT00842829|547428|P1|Treatment Period|Protocol Violation|0
171460|NCT00842829|547426|P3|Treatment Period|Consistently >4 BTP episodes daily|1
171461|NCT00842829|547427|P2|Treatment Period|Consistently >4 BTP episodes daily|0
171462|NCT00842829|547428|P1|Treatment Period|Consistently >4 BTP episodes daily|0
171463|NCT00842829|547426|P3|Treatment Period|Withdrawal by Subject|11
171464|NCT00842829|547427|P2|Treatment Period|Withdrawal by Subject|0
171465|NCT00842829|547428|P1|Treatment Period|Withdrawal by Subject|0
171466|NCT00842829|547426|P3|Treatment Period|Unstable persistent cancer pain|5
171467|NCT00842829|547427|P2|Treatment Period|Unstable persistent cancer pain|0
171468|NCT00842829|547428|P1|Treatment Period|Unstable persistent cancer pain|0
171469|NCT00842829|547426|P3|Treatment Period|Lack of Efficacy|6
171470|NCT00842829|547427|P2|Treatment Period|Lack of Efficacy|0
171471|NCT00842829|547428|P1|Treatment Period|Lack of Efficacy|0
171472|NCT00842829|547426|P3|Treatment Period|Adverse Event|15
171473|NCT00842829|547427|P2|Treatment Period|Adverse Event|0
171474|NCT00842829|547428|P1|Treatment Period|Adverse Event|0
171475|NCT00842829|547426|P3|Dose Titration Period|Non-compliance to study drug|0
171476|NCT00842829|547427|P2|Dose Titration Period|Non-compliance to study drug|1
171477|NCT00842829|547428|P1|Dose Titration Period|Non-compliance to study drug|2
171478|NCT00842829|547426|P3|Dose Titration Period|Non-compliance to study procedures|0
171479|NCT00842829|547427|P2|Dose Titration Period|Non-compliance to study procedures|1
171480|NCT00842829|547428|P1|Dose Titration Period|Non-compliance to study procedures|1
171481|NCT00842829|547426|P3|Dose Titration Period|Not specified|0
171482|NCT00842829|547427|P2|Dose Titration Period|Not specified|4
171483|NCT00842829|547428|P1|Dose Titration Period|Not specified|5
171484|NCT00842829|547426|P3|Dose Titration Period|Withdrawal by Subject|0
171485|NCT00842829|547427|P2|Dose Titration Period|Withdrawal by Subject|6
171486|NCT00842829|547428|P1|Dose Titration Period|Withdrawal by Subject|2
171487|NCT00842829|547426|P3|Dose Titration Period|Unstable persistent cancer pain|0
171488|NCT00842829|547427|P2|Dose Titration Period|Unstable persistent cancer pain|0
171489|NCT00842829|547428|P1|Dose Titration Period|Unstable persistent cancer pain|1
171490|NCT00842829|547426|P3|Dose Titration Period|Lack of Efficacy|0
171491|NCT00842829|547427|P2|Dose Titration Period|Lack of Efficacy|1
171492|NCT00842829|547428|P1|Dose Titration Period|Lack of Efficacy|4
171493|NCT00842829|547426|P3|Dose Titration Period|Adverse Event|0
171494|NCT00842829|547427|P2|Dose Titration Period|Adverse Event|10
171495|NCT00842829|547428|P1|Dose Titration Period|Adverse Event|11
171496|NCT00848484|547473|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
171497|NCT00848484|547474|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
171498|NCT00848484|547473|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
171499|NCT00848484|547474|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
171500|NCT00848484|547473|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
171501|NCT00848484|547474|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
171502|NCT00848484|547473|P2|First Intervention (Treatment Period 1)|Physician Decision|1
171503|NCT00848484|547474|P1|First Intervention (Treatment Period 1)|Physician Decision|0
171504|NCT00848484|547473|P2|First Intervention (Treatment Period 1)|Adverse Event|1
171505|NCT00848484|547474|P1|First Intervention (Treatment Period 1)|Adverse Event|2
171506|NCT00848497|547492|P2|Overall Study|Withdrawal by Subject|1
171507|NCT00848497|547493|P1|Overall Study|Withdrawal by Subject|0
171508|NCT00848497|547492|P2|Overall Study|Screen failure|0
171509|NCT00848497|547493|P1|Overall Study|Screen failure|2
171510|NCT00848536|547560|P2|Overall Study|Patient Moved|2
171511|NCT00848536|547561|P1|Overall Study|Patient Moved|0
171512|NCT00848536|547560|P2|Overall Study|Inadequate Control of IOP|1
171513|NCT00848536|547561|P1|Overall Study|Inadequate Control of IOP|1
171514|NCT00848536|547560|P2|Overall Study|Noncompliance|0
171515|NCT00848536|547561|P1|Overall Study|Noncompliance|1
171516|NCT00848536|547560|P2|Overall Study|Protocol Violation|1
171517|NCT00848536|547561|P1|Overall Study|Protocol Violation|0
171518|NCT00848536|547560|P2|Overall Study|Withdrawal by Subject|1
171519|NCT00848536|547561|P1|Overall Study|Withdrawal by Subject|0
171520|NCT00848536|547560|P2|Overall Study|Adverse Event|2
171521|NCT00848536|547561|P1|Overall Study|Adverse Event|2
171522|NCT00848549|547573|P2|E2090-E044-314 (Extension Study)|Not Specified|6
171523|NCT00848549|547574|P1|E2090-E044-314 (Extension Study)|Not Specified|5
171524|NCT00848549|547573|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
171525|NCT00848549|547574|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
171526|NCT00848549|547573|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
171527|NCT00848549|547574|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
171528|NCT00848549|547573|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
171529|NCT00848549|547574|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
171530|NCT00848549|547573|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
171531|NCT00848549|547574|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
171532|NCT00848549|547573|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
171533|NCT00848549|547574|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
171534|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
171535|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
171536|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Not Specified|3
171537|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Not Specified|4
171538|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
171539|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
171540|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
171541|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
171542|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
171543|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
171544|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
171545|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
171546|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
171547|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
171548|NCT00848549|547573|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
171549|NCT00848549|547574|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
171550|NCT00849472|547606|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
171551|NCT00849472|547606|P1|Pazopanib Postsurgery Treatment|Moved|1
171552|NCT00849472|547606|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
171553|NCT00849472|547606|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
171554|NCT00849472|547606|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
171555|NCT00849472|547606|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
171556|NCT00849472|547606|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
171557|NCT00849472|547606|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
171558|NCT00849472|547606|P1|Weekly Paclitaxel|Physician Decision|3
171559|NCT00849472|547606|P1|Weekly Paclitaxel|Withdrawal by Subject|1
171560|NCT00849472|547606|P1|Weekly Paclitaxel|Adverse Event|11
171561|NCT00849472|547606|P1|Weekly Paclitaxel|Disease Progression|1
171562|NCT00849472|547606|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
171563|NCT00849472|547606|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
171564|NCT00849472|547606|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
171565|NCT00849472|547606|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
171566|NCT00849472|547606|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
171567|NCT00849524|547631|P1|Overall Study|Lack of Efficacy|3
171568|NCT00849680|547645|P8|Overall Study|Subject unable to comply with protocol|0
171569|NCT00849680|547646|P7|Overall Study|Subject unable to comply with protocol|0
171570|NCT00849680|547647|P6|Overall Study|Subject unable to comply with protocol|0
171571|NCT00849680|547648|P5|Overall Study|Subject unable to comply with protocol|0
171572|NCT00849680|547649|P4|Overall Study|Subject unable to comply with protocol|0
171573|NCT00849680|547650|P3|Overall Study|Subject unable to comply with protocol|0
171574|NCT00849680|547651|P2|Overall Study|Subject unable to comply with protocol|0
171575|NCT00849680|547652|P1|Overall Study|Subject unable to comply with protocol|1
171576|NCT00849680|547645|P8|Overall Study|Withdrawal by Subject|1
171577|NCT00849680|547646|P7|Overall Study|Withdrawal by Subject|1
171578|NCT00849680|547647|P6|Overall Study|Withdrawal by Subject|2
171579|NCT00849680|547648|P5|Overall Study|Withdrawal by Subject|2
171580|NCT00849680|547649|P4|Overall Study|Withdrawal by Subject|2
171581|NCT00849680|547650|P3|Overall Study|Withdrawal by Subject|0
171582|NCT00849680|547651|P2|Overall Study|Withdrawal by Subject|0
171583|NCT00849680|547652|P1|Overall Study|Withdrawal by Subject|2
171584|NCT00849680|547645|P8|Overall Study|Subject moved|2
171585|NCT00849680|547646|P7|Overall Study|Subject moved|2
171586|NCT00849680|547647|P6|Overall Study|Subject moved|2
171587|NCT00849680|547648|P5|Overall Study|Subject moved|0
171588|NCT00849680|547649|P4|Overall Study|Subject moved|1
171589|NCT00849680|547650|P3|Overall Study|Subject moved|3
171590|NCT00849680|547651|P2|Overall Study|Subject moved|0
171591|NCT00849680|547652|P1|Overall Study|Subject moved|1
171592|NCT00849680|547645|P8|Overall Study|Lost to Follow-up|5
171593|NCT00849680|547646|P7|Overall Study|Lost to Follow-up|12
171594|NCT00849680|547647|P6|Overall Study|Lost to Follow-up|11
171595|NCT00849680|547648|P5|Overall Study|Lost to Follow-up|8
171596|NCT00849680|547649|P4|Overall Study|Lost to Follow-up|11
171597|NCT00849680|547650|P3|Overall Study|Lost to Follow-up|12
171598|NCT00849680|547651|P2|Overall Study|Lost to Follow-up|3
171599|NCT00849680|547652|P1|Overall Study|Lost to Follow-up|7
171600|NCT00849680|547645|P8|Overall Study|Adverse Event|0
171601|NCT00849680|547646|P7|Overall Study|Adverse Event|2
171602|NCT00849680|547647|P6|Overall Study|Adverse Event|0
171603|NCT00849680|547648|P5|Overall Study|Adverse Event|0
171604|NCT00849680|547649|P4|Overall Study|Adverse Event|0
171605|NCT00849680|547650|P3|Overall Study|Adverse Event|0
171606|NCT00849680|547651|P2|Overall Study|Adverse Event|0
171607|NCT00849680|547652|P1|Overall Study|Adverse Event|0
171608|NCT00849693|547698|P4|Extension Phase|Lack of Efficacy|1
171609|NCT00849693|547699|P3|Extension Phase|Lack of Efficacy|2
171610|NCT00849693|547700|P2|Extension Phase|Lack of Efficacy|2
171611|NCT00849693|547701|P1|Extension Phase|Lack of Efficacy|2
171612|NCT00849693|547698|P4|Extension Phase|Sponsor decision|1
171613|NCT00849693|547699|P3|Extension Phase|Sponsor decision|0
171614|NCT00849693|547700|P2|Extension Phase|Sponsor decision|0
171615|NCT00849693|547701|P1|Extension Phase|Sponsor decision|1
171616|NCT00849693|547698|P4|Extension Phase|Physician Decision|0
171617|NCT00849693|547699|P3|Extension Phase|Physician Decision|2
171618|NCT00849693|547700|P2|Extension Phase|Physician Decision|1
171619|NCT00849693|547701|P1|Extension Phase|Physician Decision|1
171620|NCT00849693|547698|P4|Extension Phase|Parent or caregiver decision|5
171621|NCT00849693|547699|P3|Extension Phase|Parent or caregiver decision|10
171622|NCT00849693|547700|P2|Extension Phase|Parent or caregiver decision|4
171623|NCT00849693|547701|P1|Extension Phase|Parent or caregiver decision|9
171624|NCT00849693|547698|P4|Extension Phase|Withdrawal by Subject|15
171625|NCT00849693|547699|P3|Extension Phase|Withdrawal by Subject|10
171626|NCT00849693|547700|P2|Extension Phase|Withdrawal by Subject|9
171627|NCT00849693|547701|P1|Extension Phase|Withdrawal by Subject|6
171628|NCT00849693|547698|P4|Extension Phase|Protocol Violation|3
171629|NCT00849693|547699|P3|Extension Phase|Protocol Violation|2
171630|NCT00849693|547700|P2|Extension Phase|Protocol Violation|3
171631|NCT00849693|547701|P1|Extension Phase|Protocol Violation|0
171632|NCT00849693|547698|P4|Extension Phase|Lost to Follow-up|6
171633|NCT00849693|547699|P3|Extension Phase|Lost to Follow-up|6
171634|NCT00849693|547700|P2|Extension Phase|Lost to Follow-up|5
171635|NCT00849693|547701|P1|Extension Phase|Lost to Follow-up|7
171636|NCT00849693|547698|P4|Extension Phase|Adverse Event|7
171637|NCT00849693|547699|P3|Extension Phase|Adverse Event|3
171638|NCT00849693|547700|P2|Extension Phase|Adverse Event|6
171639|NCT00849693|547701|P1|Extension Phase|Adverse Event|4
171640|NCT00849693|547698|P4|Acute Treatment Phase|Lack of Efficacy|2
171641|NCT00849693|547699|P3|Acute Treatment Phase|Lack of Efficacy|1
171642|NCT00849693|547700|P2|Acute Treatment Phase|Lack of Efficacy|3
171643|NCT00849693|547701|P1|Acute Treatment Phase|Lack of Efficacy|1
171644|NCT00849693|547698|P4|Acute Treatment Phase|Sponsor decision|0
171645|NCT00849693|547699|P3|Acute Treatment Phase|Sponsor decision|1
171646|NCT00849693|547700|P2|Acute Treatment Phase|Sponsor decision|0
171647|NCT00849693|547701|P1|Acute Treatment Phase|Sponsor decision|0
171648|NCT00849693|547698|P4|Acute Treatment Phase|Physician Decision|1
171649|NCT00849693|547699|P3|Acute Treatment Phase|Physician Decision|2
171650|NCT00849693|547700|P2|Acute Treatment Phase|Physician Decision|1
171651|NCT00849693|547701|P1|Acute Treatment Phase|Physician Decision|2
171652|NCT00849693|547698|P4|Acute Treatment Phase|Parent or caregiver decision|7
171653|NCT00849693|547699|P3|Acute Treatment Phase|Parent or caregiver decision|7
171654|NCT00849693|547700|P2|Acute Treatment Phase|Parent or caregiver decision|6
171655|NCT00849693|547701|P1|Acute Treatment Phase|Parent or caregiver decision|7
171656|NCT00849693|547698|P4|Acute Treatment Phase|Withdrawal by Subject|8
171657|NCT00849693|547699|P3|Acute Treatment Phase|Withdrawal by Subject|3
171658|NCT00849693|547700|P2|Acute Treatment Phase|Withdrawal by Subject|5
171659|NCT00849693|547701|P1|Acute Treatment Phase|Withdrawal by Subject|5
171660|NCT00849693|547698|P4|Acute Treatment Phase|Protocol Violation|6
171661|NCT00849693|547699|P3|Acute Treatment Phase|Protocol Violation|2
171662|NCT00849693|547700|P2|Acute Treatment Phase|Protocol Violation|5
171663|NCT00849693|547701|P1|Acute Treatment Phase|Protocol Violation|1
171664|NCT00849693|547698|P4|Acute Treatment Phase|Lost to Follow-up|9
171665|NCT00849693|547699|P3|Acute Treatment Phase|Lost to Follow-up|11
171666|NCT00849693|547700|P2|Acute Treatment Phase|Lost to Follow-up|8
171667|NCT00849693|547701|P1|Acute Treatment Phase|Lost to Follow-up|5
171668|NCT00849693|547698|P4|Acute Treatment Phase|Adverse Event|4
171669|NCT00849693|547699|P3|Acute Treatment Phase|Adverse Event|6
171670|NCT00849693|547700|P2|Acute Treatment Phase|Adverse Event|7
171671|NCT00849693|547701|P1|Acute Treatment Phase|Adverse Event|12
171672|NCT00849797|547762|P2|Washout: One Week|Withdrawal by Subject|2
171673|NCT00849797|547763|P1|Washout: One Week|Withdrawal by Subject|0
171674|NCT00849797|547762|P2|First Intervention|Adverse Event|1
171675|NCT00849797|547763|P1|First Intervention|Adverse Event|0
171676|NCT00849797|547762|P2|First Intervention|bad veins|0
171677|NCT00849797|547763|P1|First Intervention|bad veins|1
171678|NCT00849875|547795|P1|Overall Study|Lost to Follow-up|2
171679|NCT00849875|547795|P1|Overall Study|Others|6
171680|NCT00849875|547795|P1|Overall Study|Ongoing (unknown completion status)|11
171681|NCT00849875|547795|P1|Overall Study|Death|28
171682|NCT00849901|547878|P3|Extension Phase|Lack of Efficacy|1
171683|NCT00849901|547879|P2|Extension Phase|Lack of Efficacy|4
171684|NCT00849901|547880|P1|Extension Phase|Lack of Efficacy|2
171685|NCT00849901|547878|P3|Extension Phase|Physician Decision|0
171686|NCT00849901|547879|P2|Extension Phase|Physician Decision|2
171687|NCT00849901|547880|P1|Extension Phase|Physician Decision|1
171688|NCT00849901|547878|P3|Extension Phase|Parent or Caregiver Decision|4
171689|NCT00849901|547879|P2|Extension Phase|Parent or Caregiver Decision|4
171690|NCT00849901|547880|P1|Extension Phase|Parent or Caregiver Decision|10
171691|NCT00849901|547878|P3|Extension Phase|Withdrawal by Subject|3
171692|NCT00849901|547879|P2|Extension Phase|Withdrawal by Subject|6
171693|NCT00849901|547880|P1|Extension Phase|Withdrawal by Subject|7
171694|NCT00849901|547878|P3|Extension Phase|Protocol Violation|4
171695|NCT00849901|547879|P2|Extension Phase|Protocol Violation|2
171696|NCT00849901|547880|P1|Extension Phase|Protocol Violation|2
171697|NCT00849901|547878|P3|Extension Phase|Lost to Follow-up|1
171698|NCT00849901|547879|P2|Extension Phase|Lost to Follow-up|0
171699|NCT00849901|547880|P1|Extension Phase|Lost to Follow-up|3
171700|NCT00849901|547878|P3|Extension Phase|Adverse Event|4
171701|NCT00849901|547879|P2|Extension Phase|Adverse Event|8
171702|NCT00849901|547880|P1|Extension Phase|Adverse Event|2
171703|NCT00849901|547878|P3|Acute Treatment Phase|Lack of Efficacy|2
171704|NCT00849901|547879|P2|Acute Treatment Phase|Lack of Efficacy|3
171705|NCT00849901|547880|P1|Acute Treatment Phase|Lack of Efficacy|2
171706|NCT00849901|547878|P3|Acute Treatment Phase|Sponsor Decision|0
171707|NCT00849901|547879|P2|Acute Treatment Phase|Sponsor Decision|0
171708|NCT00849901|547880|P1|Acute Treatment Phase|Sponsor Decision|1
171709|NCT00849901|547878|P3|Acute Treatment Phase|Physician Decision|1
171710|NCT00849901|547879|P2|Acute Treatment Phase|Physician Decision|1
171711|NCT00849901|547880|P1|Acute Treatment Phase|Physician Decision|1
171712|NCT00849901|547878|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
171713|NCT00849901|547879|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
171714|NCT00849901|547880|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
171715|NCT00849901|547878|P3|Acute Treatment Phase|Withdrawal by Subject|4
171716|NCT00849901|547879|P2|Acute Treatment Phase|Withdrawal by Subject|10
171717|NCT00849901|547880|P1|Acute Treatment Phase|Withdrawal by Subject|4
171718|NCT00849901|547878|P3|Acute Treatment Phase|Protocol Violation|1
171719|NCT00849901|547879|P2|Acute Treatment Phase|Protocol Violation|2
171720|NCT00849901|547880|P1|Acute Treatment Phase|Protocol Violation|0
171721|NCT00849901|547878|P3|Acute Treatment Phase|Lost to Follow-up|1
171722|NCT00849901|547879|P2|Acute Treatment Phase|Lost to Follow-up|4
171723|NCT00849901|547880|P1|Acute Treatment Phase|Lost to Follow-up|2
171724|NCT00849901|547878|P3|Acute Treatment Phase|Adverse Event|3
171725|NCT00849901|547879|P2|Acute Treatment Phase|Adverse Event|1
171726|NCT00849901|547880|P1|Acute Treatment Phase|Adverse Event|9
171727|NCT00849940|547924|P1|Overall Study|Physician Decision|4
171728|NCT00850070|547939|P2|Overall Study|Adverse Event|0
171729|NCT00850070|547940|P1|Overall Study|Adverse Event|2
171730|NCT00850070|547939|P2|Overall Study|Lack of Efficacy|1
171731|NCT00850070|547940|P1|Overall Study|Lack of Efficacy|1
171732|NCT00850135|547967|P1|Overall Study|Physician Decision|1
171733|NCT00850174|547975|P2|Second Intervention|Withdrawal by Subject|0
171734|NCT00850174|547976|P1|Second Intervention|Withdrawal by Subject|1
171735|NCT00850174|547975|P2|Washout: One Week|Withdrawal by Subject|2
171736|NCT00850174|547976|P1|Washout: One Week|Withdrawal by Subject|0
171737|NCT00850200|547990|P1|Overall Study|Withdrawal by Subject|1
171738|NCT00850343|548000|P4|Overall Study|Physician Decision|1
171739|NCT00850343|548001|P3|Overall Study|Physician Decision|1
171740|NCT00850343|548002|P2|Overall Study|Physician Decision|1
171741|NCT00850343|548003|P1|Overall Study|Physician Decision|2
171742|NCT00850343|548000|P4|Overall Study|Non-compliance with Study Procedures|1
171743|NCT00850343|548001|P3|Overall Study|Non-compliance with Study Procedures|1
171744|NCT00850343|548002|P2|Overall Study|Non-compliance with Study Procedures|0
171745|NCT00850343|548003|P1|Overall Study|Non-compliance with Study Procedures|1
171746|NCT00850343|548000|P4|Overall Study|Lack of Efficacy|2
171747|NCT00850343|548001|P3|Overall Study|Lack of Efficacy|3
171748|NCT00850343|548002|P2|Overall Study|Lack of Efficacy|0
171749|NCT00850343|548003|P1|Overall Study|Lack of Efficacy|17
171750|NCT00850343|548000|P4|Overall Study|Pregnancy|1
171751|NCT00850343|548001|P3|Overall Study|Pregnancy|0
171752|NCT00850343|548002|P2|Overall Study|Pregnancy|0
171753|NCT00850343|548003|P1|Overall Study|Pregnancy|0
171754|NCT00850343|548000|P4|Overall Study|Adverse Event|6
171755|NCT00850343|548001|P3|Overall Study|Adverse Event|6
171756|NCT00850343|548002|P2|Overall Study|Adverse Event|2
171757|NCT00850343|548003|P1|Overall Study|Adverse Event|15
171758|NCT00850343|548000|P4|Overall Study|Withdrawal by Subject|2
171759|NCT00850343|548001|P3|Overall Study|Withdrawal by Subject|3
171760|NCT00850343|548002|P2|Overall Study|Withdrawal by Subject|0
171761|NCT00850343|548003|P1|Overall Study|Withdrawal by Subject|11
171762|NCT00850395|548033|P1|Overall Study|Unspecified|5
171763|NCT00850395|548033|P1|Overall Study|Insufficient clinical response|3
171764|NCT00850395|548033|P1|Overall Study|Adverse Event|1
171765|NCT00850395|548033|P1|Overall Study|Death|1
171766|NCT00850460|548055|P2|Overall Study|Lost to Follow-up|4
171767|NCT00850460|548056|P1|Overall Study|Lost to Follow-up|4
171768|NCT00850499|548066|P2|Overall Study|Lack of Efficacy|1
171769|NCT00850499|548067|P1|Overall Study|Lack of Efficacy|0
171770|NCT00850499|548066|P2|Overall Study|Adverse Event|1
171771|NCT00850499|548067|P1|Overall Study|Adverse Event|3
171772|NCT00850538|548075|P1|Overall Study|Protocol Violation|2
171773|NCT00850538|548075|P1|Overall Study|radiology error|2
171774|NCT00850538|548075|P1|Overall Study|Withdrawal by Subject|3
171775|NCT00850538|548075|P1|Overall Study|specimen unusable|7
171776|NCT00850538|548075|P1|Overall Study|specimen missed due to scheduling error|14
171777|NCT00850538|548075|P1|Overall Study|unable/unwilling to complete MRI|13
171778|NCT00850564|548079|P1|Overall Study|Withdrawal by Subject|2
171779|NCT00850759|548123|P4|Overall Study|Lost to Follow-up|3
171780|NCT00850759|548124|P3|Overall Study|Lost to Follow-up|5
171781|NCT00850759|548125|P2|Overall Study|Lost to Follow-up|5
171782|NCT00850759|548126|P1|Overall Study|Lost to Follow-up|7
171783|NCT00851084|548178|P2|Overall Study|Not specified|1
171784|NCT00851084|548179|P1|Overall Study|Not specified|7
171785|NCT00851084|548178|P2|Overall Study|Metastatic surgery|6
171786|NCT00851084|548179|P1|Overall Study|Metastatic surgery|6
171787|NCT00851084|548178|P2|Overall Study|Withdrawal by Subject|12
171788|NCT00851084|548179|P1|Overall Study|Withdrawal by Subject|11
171789|NCT00851084|548178|P2|Overall Study|Consent withdrawn|2
171790|NCT00851084|548179|P1|Overall Study|Consent withdrawn|0
171791|NCT00851084|548178|P2|Overall Study|Physician Decision|14
171792|NCT00851084|548179|P1|Overall Study|Physician Decision|13
171793|NCT00851084|548178|P2|Overall Study|Poor compliance to protocol|1
171794|NCT00851084|548179|P1|Overall Study|Poor compliance to protocol|1
171795|NCT00851084|548178|P2|Overall Study|Disease progression|47
171796|NCT00851084|548179|P1|Overall Study|Disease progression|52
171797|NCT00851084|548178|P2|Overall Study|Adverse Event|36
171798|NCT00851084|548179|P1|Overall Study|Adverse Event|26
171799|NCT00851084|548178|P2|Overall Study|Randomized but not treated|0
171800|NCT00851084|548179|P1|Overall Study|Randomized but not treated|1
171801|NCT00851318|548203|P4|Overall Study|Physician Decision|1
171802|NCT00851318|548204|P3|Overall Study|Physician Decision|1
171803|NCT00851318|548205|P2|Overall Study|Physician Decision|0
171804|NCT00851318|548206|P1|Overall Study|Physician Decision|0
171890|NCT00851799|548416|P3|Overall Study|Not able to get to clinic|9
171805|NCT00851318|548203|P4|Overall Study|Non-compliance with Study Procedures|0
171806|NCT00851318|548204|P3|Overall Study|Non-compliance with Study Procedures|1
171807|NCT00851318|548205|P2|Overall Study|Non-compliance with Study Procedures|0
171808|NCT00851318|548206|P1|Overall Study|Non-compliance with Study Procedures|2
171809|NCT00851318|548203|P4|Overall Study|Lack of Efficacy|2
171810|NCT00851318|548204|P3|Overall Study|Lack of Efficacy|4
171811|NCT00851318|548205|P2|Overall Study|Lack of Efficacy|2
171812|NCT00851318|548206|P1|Overall Study|Lack of Efficacy|8
171813|NCT00851318|548203|P4|Overall Study|Pregnancy|1
171814|NCT00851318|548204|P3|Overall Study|Pregnancy|1
171815|NCT00851318|548205|P2|Overall Study|Pregnancy|0
171816|NCT00851318|548206|P1|Overall Study|Pregnancy|0
171817|NCT00851318|548203|P4|Overall Study|Adverse Event|12
171818|NCT00851318|548204|P3|Overall Study|Adverse Event|9
171819|NCT00851318|548205|P2|Overall Study|Adverse Event|2
171820|NCT00851318|548206|P1|Overall Study|Adverse Event|13
171821|NCT00851318|548203|P4|Overall Study|Withdrawal by Subject|3
171822|NCT00851318|548204|P3|Overall Study|Withdrawal by Subject|5
171823|NCT00851318|548205|P2|Overall Study|Withdrawal by Subject|1
171824|NCT00851318|548206|P1|Overall Study|Withdrawal by Subject|7
171825|NCT00851552|548241|P1|Overall Study|Disease Progression|4
171826|NCT00851552|548241|P1|Overall Study|Adverse Event|1
171827|NCT00851552|548241|P1|Overall Study|Death|2
171828|NCT00851591|548248|P2|Overall Study|Withdrawal by Subject|0
171829|NCT00851591|548249|P1|Overall Study|Withdrawal by Subject|2
171830|NCT00851630|548257|P2|Overall Study|Clinical failure|1
171831|NCT00851630|548258|P1|Overall Study|Clinical failure|0
171832|NCT00851630|548257|P2|Overall Study|Death|1
171833|NCT00851630|548258|P1|Overall Study|Death|2
171834|NCT00851643|548276|P6|Extension Study (Up to 36 Months)|Moved|1
171835|NCT00851643|548277|P5|Extension Study (Up to 36 Months)|Moved|0
171836|NCT00851643|548278|P4|Extension Study (Up to 36 Months)|Moved|1
171837|NCT00851643|548279|P3|Extension Study (Up to 36 Months)|Moved|1
171838|NCT00851643|548280|P2|Extension Study (Up to 36 Months)|Moved|2
171839|NCT00851643|548281|P1|Extension Study (Up to 36 Months)|Moved|0
171840|NCT00851643|548276|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
171841|NCT00851643|548277|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
171842|NCT00851643|548278|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
171843|NCT00851643|548279|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
171844|NCT00851643|548280|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
171845|NCT00851643|548281|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
171846|NCT00851643|548276|P6|Base Study (Up to 12 Months)|Unspecified|1
171847|NCT00851643|548277|P5|Base Study (Up to 12 Months)|Unspecified|0
171848|NCT00851643|548278|P4|Base Study (Up to 12 Months)|Unspecified|0
171849|NCT00851643|548279|P3|Base Study (Up to 12 Months)|Unspecified|0
171850|NCT00851643|548280|P2|Base Study (Up to 12 Months)|Unspecified|0
171851|NCT00851643|548281|P1|Base Study (Up to 12 Months)|Unspecified|0
171852|NCT00851643|548276|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
171853|NCT00851643|548277|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
171854|NCT00851643|548278|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
171855|NCT00851643|548279|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
171856|NCT00851643|548280|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
171857|NCT00851643|548281|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
171858|NCT00851682|548302|P2|Overall Study|screen failure|0
171859|NCT00851682|548303|P1|Overall Study|screen failure|5
171860|NCT00851721|548313|P2|Overall Study|Adverse Event|1
171861|NCT00851721|548314|P1|Overall Study|Adverse Event|0
171862|NCT00851721|548313|P2|Overall Study|Death|0
171863|NCT00851721|548314|P1|Overall Study|Death|1
171864|NCT00851721|548313|P2|Overall Study|planned surgery|0
171865|NCT00851721|548314|P1|Overall Study|planned surgery|1
171866|NCT00851786|548404|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
171867|NCT00851786|548405|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
171868|NCT00851786|548404|P2|Overall Study|Site Closure|0
171869|NCT00851786|548405|P1|Overall Study|Site Closure|1
171870|NCT00851786|548404|P2|Overall Study|Incarceration|0
171871|NCT00851786|548405|P1|Overall Study|Incarceration|1
171872|NCT00851786|548404|P2|Overall Study|Lost to Follow-up|0
171873|NCT00851786|548405|P1|Overall Study|Lost to Follow-up|1
171874|NCT00851786|548404|P2|Overall Study|Protocol Violation|1
171875|NCT00851786|548405|P1|Overall Study|Protocol Violation|0
171876|NCT00851786|548404|P2|Overall Study|Withdrawal by Subject|1
171877|NCT00851786|548405|P1|Overall Study|Withdrawal by Subject|0
171878|NCT00851799|548416|P3|Overall Study|Completed protocol due to pregnancy|1
171879|NCT00851799|548417|P2|Overall Study|Completed protocol due to pregnancy|0
171880|NCT00851799|548418|P1|Overall Study|Completed protocol due to pregnancy|0
171881|NCT00851799|548416|P3|Overall Study|Severe Debilitation|0
171882|NCT00851799|548417|P2|Overall Study|Severe Debilitation|1
171883|NCT00851799|548418|P1|Overall Study|Severe Debilitation|0
171884|NCT00851799|548416|P3|Overall Study|Withdrew consent prior study completion|1
171885|NCT00851799|548417|P2|Overall Study|Withdrew consent prior study completion|2
171886|NCT00851799|548418|P1|Overall Study|Withdrew consent prior study completion|1
171887|NCT00851799|548416|P3|Overall Study|Not willing to adhere to requirements|2
171888|NCT00851799|548417|P2|Overall Study|Not willing to adhere to requirements|2
171889|NCT00851799|548418|P1|Overall Study|Not willing to adhere to requirements|1
171891|NCT00851799|548417|P2|Overall Study|Not able to get to clinic|5
171892|NCT00851799|548418|P1|Overall Study|Not able to get to clinic|8
171893|NCT00851799|548416|P3|Overall Study|Lost to Follow-up|10
171894|NCT00851799|548417|P2|Overall Study|Lost to Follow-up|3
171895|NCT00851799|548418|P1|Overall Study|Lost to Follow-up|5
171896|NCT00851799|548416|P3|Overall Study|Death|1
171897|NCT00851799|548417|P2|Overall Study|Death|0
171898|NCT00851799|548418|P1|Overall Study|Death|1
171899|NCT00851890|548508|P4|Overall Study|Lost to Follow-up|1
171900|NCT00851890|548509|P3|Overall Study|Lost to Follow-up|0
171901|NCT00851890|548510|P2|Overall Study|Lost to Follow-up|1
171902|NCT00851890|548511|P1|Overall Study|Lost to Follow-up|0
171903|NCT00851903|548568|P1|Overall Study|Withdrawal by Subject|2
171904|NCT00838682|548580|P2|Overall Study|Withdrawal by Subject|1
171905|NCT00838682|548581|P1|Overall Study|Withdrawal by Subject|0
171906|NCT00838682|548580|P2|Overall Study|Protocol Violation|1
171907|NCT00838682|548581|P1|Overall Study|Protocol Violation|0
171908|NCT00838682|548580|P2|Overall Study|detection of exclusion criteria|3
171909|NCT00838682|548581|P1|Overall Study|detection of exclusion criteria|4
171910|NCT00838682|548580|P2|Overall Study|Lost to Follow-up|14
171911|NCT00838682|548581|P1|Overall Study|Lost to Follow-up|21
171912|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Missing|1
171913|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Missing|1
171914|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Missing|2
171915|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Missing|1
171916|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
171917|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
171918|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
171919|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
171920|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
171921|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
171922|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
171923|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
171924|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
171925|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
171926|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
171927|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
171928|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
171929|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
171930|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
171931|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
171932|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Physician Decision|1
171933|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Physician Decision|1
171934|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Physician Decision|1
171935|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Physician Decision|1
171936|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
171937|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
171938|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
171939|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
171940|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
171941|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
171942|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
171943|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
171944|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
171945|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
171946|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
171947|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
171948|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Noncompliance|5
171949|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Noncompliance|5
171950|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Noncompliance|8
171951|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Noncompliance|2
171952|NCT00838903|548601|P4|Follow-up Period (8 Weeks)|Adverse Event|1
171953|NCT00838903|548602|P3|Follow-up Period (8 Weeks)|Adverse Event|3
171954|NCT00838903|548603|P2|Follow-up Period (8 Weeks)|Adverse Event|0
171955|NCT00838903|548604|P1|Follow-up Period (8 Weeks)|Adverse Event|0
171956|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
171957|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
171958|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
171959|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
171960|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
171961|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
171962|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
171963|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
171964|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
171965|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
171966|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
171967|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
171968|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Site closed|0
171969|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Site closed|1
171970|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Site closed|0
171971|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Site closed|0
171972|NCT00838903|548601|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
171973|NCT00838903|548602|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
171974|NCT00838903|548603|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
171975|NCT00838903|548604|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
171976|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Pregnancy|0
171977|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Pregnancy|1
171978|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Pregnancy|0
171979|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Pregnancy|0
171980|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
171981|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
171982|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
171983|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
171984|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
171985|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
171986|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
171987|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
171988|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
171989|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
171990|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
171991|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
171992|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
171993|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
171994|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
171995|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
171996|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Physician Decision|2
171997|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Physician Decision|1
171998|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Physician Decision|2
171999|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Physician Decision|1
172000|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
172001|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
172002|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
172003|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
172004|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
172005|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
172006|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
172007|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
172008|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
172009|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
172010|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
172011|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
172012|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Noncompliance|6
172013|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Noncompliance|12
172014|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Noncompliance|13
172015|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Noncompliance|9
172016|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Protocol Violation|5
172017|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Protocol Violation|6
172018|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Protocol Violation|6
172019|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Protocol Violation|1
172020|NCT00838903|548601|P4|Treatment Period (156 Weeks)|Adverse Event|25
172021|NCT00838903|548602|P3|Treatment Period (156 Weeks)|Adverse Event|17
172022|NCT00838903|548603|P2|Treatment Period (156 Weeks)|Adverse Event|13
172023|NCT00838903|548604|P1|Treatment Period (156 Weeks)|Adverse Event|5
172024|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Missing|0
172025|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Missing|3
172026|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
172027|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
172028|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
172029|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
172030|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Physician Decision|0
172031|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Physician Decision|2
172032|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
172033|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
172034|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
172035|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
172036|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
172037|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
172038|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Noncompliance|5
172039|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Noncompliance|6
172040|NCT00838916|548648|P2|Follow-up Period (8 Weeks)|Adverse Event|5
172041|NCT00838916|548649|P1|Follow-up Period (8 Weeks)|Adverse Event|10
172042|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Pregnancy|0
172043|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Pregnancy|2
172044|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Missing|1
172045|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Missing|3
172046|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
172047|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
172048|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Physician Decision|1
172049|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Physician Decision|6
172050|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
172051|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
172052|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
172053|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
172054|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
172055|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
172056|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Noncompliance|14
172057|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Noncompliance|21
172058|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Protocol Violation|3
172059|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Protocol Violation|12
172060|NCT00838916|548648|P2|Treatment Period (156 Weeks)|Adverse Event|11
172061|NCT00838916|548649|P1|Treatment Period (156 Weeks)|Adverse Event|50
172062|NCT00838929|548677|P3|Overall Study|Disease progression|1
172063|NCT00838929|548678|P2|Overall Study|Disease progression|2
172064|NCT00838929|548679|P1|Overall Study|Disease progression|0
172065|NCT00838929|548677|P3|Overall Study|Protocol Violation|0
172066|NCT00838929|548678|P2|Overall Study|Protocol Violation|1
172067|NCT00838929|548679|P1|Overall Study|Protocol Violation|0
172068|NCT00839072|548685|P2|Second Intervention Period|Withdrawal by Subject|0
172069|NCT00839072|548686|P1|Second Intervention Period|Withdrawal by Subject|1
172070|NCT00839072|548685|P2|First Intervention Period|Adverse Event|1
172071|NCT00839072|548686|P1|First Intervention Period|Adverse Event|1
172072|NCT00839072|548685|P2|First Intervention Period|Withdrawal by Subject|0
172073|NCT00839072|548686|P1|First Intervention Period|Withdrawal by Subject|1
172074|NCT00839098|548705|P3|Overall Study|Withdrawal by Subject|7
172075|NCT00839098|548706|P2|Overall Study|Withdrawal by Subject|1
172076|NCT00839098|548707|P1|Overall Study|Withdrawal by Subject|2
172077|NCT00839306|548822|P2|Overall Study|Not specified|18
172078|NCT00839306|548823|P1|Overall Study|Not specified|6
172079|NCT00839306|548822|P2|Overall Study|Lack of Efficacy|4
172080|NCT00839306|548823|P1|Overall Study|Lack of Efficacy|5
172081|NCT00839306|548822|P2|Overall Study|Withdrawal by Subject|7
172082|NCT00839306|548823|P1|Overall Study|Withdrawal by Subject|5
172083|NCT00839306|548822|P2|Overall Study|Lost to Follow-up|9
172084|NCT00839306|548823|P1|Overall Study|Lost to Follow-up|6
172085|NCT00839306|548822|P2|Overall Study|Adverse Event|5
172086|NCT00839306|548823|P1|Overall Study|Adverse Event|3
172087|NCT00839423|548871|P4|Overall Study|Administrative or other reasons|0
172088|NCT00839423|548872|P3|Overall Study|Administrative or other reasons|1
172089|NCT00839423|548873|P2|Overall Study|Administrative or other reasons|0
172090|NCT00839423|548874|P1|Overall Study|Administrative or other reasons|3
172091|NCT00839423|548871|P4|Overall Study|Lost to Follow-up|0
172092|NCT00839423|548872|P3|Overall Study|Lost to Follow-up|1
172093|NCT00839423|548873|P2|Overall Study|Lost to Follow-up|0
172094|NCT00839423|548874|P1|Overall Study|Lost to Follow-up|1
172095|NCT00839423|548871|P4|Overall Study|Withdrawal of consent|1
172096|NCT00839423|548872|P3|Overall Study|Withdrawal of consent|4
172097|NCT00839423|548873|P2|Overall Study|Withdrawal of consent|0
172098|NCT00839423|548874|P1|Overall Study|Withdrawal of consent|4
172099|NCT00839423|548871|P4|Overall Study|Protocol Violation|0
172100|NCT00839423|548872|P3|Overall Study|Protocol Violation|2
172101|NCT00839423|548873|P2|Overall Study|Protocol Violation|1
172102|NCT00839423|548874|P1|Overall Study|Protocol Violation|0
172103|NCT00839423|548871|P4|Overall Study|Non-compliance|1
172104|NCT00839423|548872|P3|Overall Study|Non-compliance|0
172105|NCT00839423|548873|P2|Overall Study|Non-compliance|0
172106|NCT00839423|548874|P1|Overall Study|Non-compliance|0
172107|NCT00839423|548871|P4|Overall Study|Lack of Efficacy|2
172108|NCT00839423|548872|P3|Overall Study|Lack of Efficacy|3
172109|NCT00839423|548873|P2|Overall Study|Lack of Efficacy|6
172110|NCT00839423|548874|P1|Overall Study|Lack of Efficacy|6
172111|NCT00839423|548871|P4|Overall Study|Adverse Event|16
172112|NCT00839423|548872|P3|Overall Study|Adverse Event|7
172113|NCT00839423|548873|P2|Overall Study|Adverse Event|3
172114|NCT00839423|548874|P1|Overall Study|Adverse Event|4
172115|NCT00839436|548915|P3|Overall Study|Study drug no longer available|1
172116|NCT00839436|548916|P2|Overall Study|Study drug no longer available|0
172117|NCT00839436|548917|P1|Overall Study|Study drug no longer available|0
172118|NCT00839436|548915|P3|Overall Study|Withdrawal by Subject|0
172119|NCT00839436|548916|P2|Overall Study|Withdrawal by Subject|1
172120|NCT00839436|548917|P1|Overall Study|Withdrawal by Subject|0
172121|NCT00839436|548915|P3|Overall Study|Developed exclusionary condition|0
172122|NCT00839436|548916|P2|Overall Study|Developed exclusionary condition|0
172123|NCT00839436|548917|P1|Overall Study|Developed exclusionary condition|1
172124|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
172125|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
172126|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
172127|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
172128|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
172129|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
172130|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
172131|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
172132|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
172133|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
172134|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
172135|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
172136|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
172137|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
172138|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
172139|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
172140|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
172141|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
172142|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
172143|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
172144|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
172145|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
172146|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
172147|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
172148|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
172149|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
172150|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
172151|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
172152|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
172153|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
172154|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
172155|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
172156|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
172157|NCT00839527|548928|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
172158|NCT00839527|548929|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
172159|NCT00839527|548930|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
172160|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
172161|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
172162|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
172163|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
172164|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
172165|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
172166|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
172167|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
172168|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
172169|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
172170|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
172171|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
172172|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Missing|0
172173|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Missing|1
172174|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Missing|0
172175|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
172176|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
172177|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
172178|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
172179|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
172180|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
172181|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
172182|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
172183|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
172184|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
172185|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
172186|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
172187|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
172188|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
172189|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
172190|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
172191|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
172192|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
172193|NCT00839527|548928|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
172194|NCT00839527|548929|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
172195|NCT00839527|548930|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
172284|NCT00853385|549303|P4|Overall Study|Lost to Follow-up|0
172196|NCT00839800|548977|P2|Overall Study|Severe Non-Compliance to Protocol|7
172197|NCT00839800|548978|P1|Overall Study|Severe Non-Compliance to Protocol|7
172198|NCT00839800|548977|P2|Overall Study|Not Specified|14
172199|NCT00839800|548978|P1|Overall Study|Not Specified|8
172200|NCT00839800|548977|P2|Overall Study|Safety Reasons|1
172201|NCT00839800|548978|P1|Overall Study|Safety Reasons|2
172202|NCT00839800|548977|P2|Overall Study|Study-Specific Discontinuation Criteria|13
172203|NCT00839800|548978|P1|Overall Study|Study-Specific Discontinuation Criteria|6
172204|NCT00839800|548977|P2|Overall Study|Incorrect Enrolment|3
172205|NCT00839800|548978|P1|Overall Study|Incorrect Enrolment|3
172206|NCT00839800|548977|P2|Overall Study|Withdrawal by Subject|34
172207|NCT00839800|548978|P1|Overall Study|Withdrawal by Subject|28
172208|NCT00839800|548977|P2|Overall Study|Lost to Follow-up|26
172209|NCT00839800|548978|P1|Overall Study|Lost to Follow-up|31
172210|NCT00839800|548977|P2|Overall Study|Adverse Event|12
172211|NCT00839800|548978|P1|Overall Study|Adverse Event|8
172212|NCT00839917|549010|P2|Overall Study|Did not receive vaccine|1
172213|NCT00839917|549011|P1|Overall Study|Did not receive vaccine|0
172214|NCT00839917|549010|P2|Overall Study|Lost to Follow-up|0
172215|NCT00839917|549011|P1|Overall Study|Lost to Follow-up|1
172216|NCT00839956|549058|P1|Overall Study|Withdrawal by Subject|3
172217|NCT00839956|549058|P1|Overall Study|Physician Decision|1
172218|NCT00839956|549058|P1|Overall Study|Lack of Efficacy|6
172219|NCT00839956|549058|P1|Overall Study|Adverse Event|2
172220|NCT00840060|549084|P2|Overall Study|Change in emotional/behavioral status|1
172221|NCT00840060|549085|P1|Overall Study|Change in emotional/behavioral status|0
172222|NCT00840060|549084|P2|Overall Study|Withdrawal by Subject|0
172223|NCT00840060|549085|P1|Overall Study|Withdrawal by Subject|1
172224|NCT00840073|549095|P2|Second Intervention|Missed 72 hour blood draw|1
172225|NCT00840073|549096|P1|Second Intervention|Missed 72 hour blood draw|1
172226|NCT00840086|549108|P1|Overall Study|Lost to Follow-up|1
172227|NCT00840086|549108|P1|Overall Study|Protocol Violation|2
172228|NCT00840086|549108|P1|Overall Study|Adverse Event|1
172229|NCT00840203|549134|P2|Washout|Protocol Violation|0
172230|NCT00840203|549135|P1|Washout|Protocol Violation|1
172231|NCT00840203|549134|P2|First Intervention|Protocol Violation|1
172232|NCT00840203|549135|P1|First Intervention|Protocol Violation|1
172233|NCT00840216|549151|P2|Washout: 7 Days|Withdrawal by Subject|0
172234|NCT00840216|549152|P1|Washout: 7 Days|Withdrawal by Subject|1
172235|NCT00840294|549173|P2|Overall Study|Illness|1
172236|NCT00840294|549174|P1|Overall Study|Illness|0
172237|NCT00840294|549173|P2|Overall Study|Protocol Violation|3
172238|NCT00840294|549174|P1|Overall Study|Protocol Violation|1
172239|NCT00840294|549173|P2|Overall Study|Withdrawal by Subject|1
172240|NCT00840294|549174|P1|Overall Study|Withdrawal by Subject|2
172241|NCT00840411|549184|P2|Washout|Withdrawal by Subject|0
172242|NCT00840411|549185|P1|Washout|Withdrawal by Subject|1
172243|NCT00840411|549184|P2|First Intervention|Adverse Event|0
172244|NCT00840411|549185|P1|First Intervention|Adverse Event|1
172245|NCT00840450|549193|P1|Overall Study|Lack of Efficacy|2
172246|NCT00840450|549193|P1|Overall Study|Adverse Event|1
172247|NCT00845845|549212|P2|Overall Study|Lost to Follow-up|4
172248|NCT00845845|549213|P1|Overall Study|Lost to Follow-up|0
172249|NCT00845858|549224|P3|Overall Study|not eligible|2
172250|NCT00845858|549225|P2|Overall Study|not eligible|3
172251|NCT00845858|549226|P1|Overall Study|not eligible|0
172252|NCT00845858|549224|P3|Overall Study|Protocol Violation|1
172253|NCT00845858|549225|P2|Overall Study|Protocol Violation|0
172254|NCT00845858|549226|P1|Overall Study|Protocol Violation|0
172255|NCT00845858|549224|P3|Overall Study|Adverse Event|4
172256|NCT00845858|549225|P2|Overall Study|Adverse Event|8
172257|NCT00845858|549226|P1|Overall Study|Adverse Event|3
172258|NCT00845858|549224|P3|Overall Study|Withdrawal by Subject|1
172259|NCT00845858|549225|P2|Overall Study|Withdrawal by Subject|1
172260|NCT00845858|549226|P1|Overall Study|Withdrawal by Subject|5
172261|NCT00845897|549240|P3|Overall Study|Too ill to participate|0
172262|NCT00845897|549241|P2|Overall Study|Too ill to participate|1
172263|NCT00845897|549242|P1|Overall Study|Too ill to participate|0
172264|NCT00845897|549240|P3|Overall Study|Ulcer did not heal|1
172265|NCT00845897|549241|P2|Overall Study|Ulcer did not heal|0
172266|NCT00845897|549242|P1|Overall Study|Ulcer did not heal|1
172267|NCT00845897|549240|P3|Overall Study|Withdrawal by Subject|2
172268|NCT00845897|549241|P2|Overall Study|Withdrawal by Subject|3
172269|NCT00845897|549242|P1|Overall Study|Withdrawal by Subject|0
172270|NCT00845897|549240|P3|Overall Study|Lost to Follow-up|0
172271|NCT00845897|549241|P2|Overall Study|Lost to Follow-up|1
172272|NCT00845897|549242|P1|Overall Study|Lost to Follow-up|1
172273|NCT00853385|549302|P5|Overall Study|Unspecified|12
172274|NCT00853385|549303|P4|Overall Study|Unspecified|4
172275|NCT00853385|549304|P3|Overall Study|Unspecified|4
172276|NCT00853385|549305|P2|Overall Study|Unspecified|9
172277|NCT00853385|549306|P1|Overall Study|Unspecified|18
172278|NCT00853385|549302|P5|Overall Study|Withdrawal by Subject|1
172279|NCT00853385|549303|P4|Overall Study|Withdrawal by Subject|1
172280|NCT00853385|549304|P3|Overall Study|Withdrawal by Subject|0
172281|NCT00853385|549305|P2|Overall Study|Withdrawal by Subject|2
172282|NCT00853385|549306|P1|Overall Study|Withdrawal by Subject|4
172283|NCT00853385|549302|P5|Overall Study|Lost to Follow-up|0
172285|NCT00853385|549304|P3|Overall Study|Lost to Follow-up|0
172286|NCT00853385|549305|P2|Overall Study|Lost to Follow-up|1
172287|NCT00853385|549306|P1|Overall Study|Lost to Follow-up|2
172288|NCT00853385|549302|P5|Overall Study|Lack of Efficacy|6
172289|NCT00853385|549303|P4|Overall Study|Lack of Efficacy|3
172290|NCT00853385|549304|P3|Overall Study|Lack of Efficacy|3
172291|NCT00853385|549305|P2|Overall Study|Lack of Efficacy|7
172292|NCT00853385|549306|P1|Overall Study|Lack of Efficacy|6
172293|NCT00853385|549302|P5|Overall Study|Adverse Event|22
172294|NCT00853385|549303|P4|Overall Study|Adverse Event|5
172295|NCT00853385|549304|P3|Overall Study|Adverse Event|2
172296|NCT00853385|549305|P2|Overall Study|Adverse Event|24
172297|NCT00853385|549306|P1|Overall Study|Adverse Event|24
172298|NCT00853385|549302|P5|Overall Study|Death|1
172299|NCT00853385|549303|P4|Overall Study|Death|0
172300|NCT00853385|549304|P3|Overall Study|Death|0
172301|NCT00853385|549305|P2|Overall Study|Death|0
172302|NCT00853385|549306|P1|Overall Study|Death|0
172303|NCT00853567|549522|P1|Overall Study|Study prematurely terminated|71
172304|NCT00853593|549530|P1|Overall Study|Implant not attempted|4
172305|NCT00853593|549530|P1|Overall Study|Model 4396 lead not attempted|29
172306|NCT00853593|549530|P1|Overall Study|Subjects did not receive a 4396 lead|12
172307|NCT00853658|549564|P3|Overall Study|Missing study completion information|6
172308|NCT00853658|549565|P2|Overall Study|Missing study completion information|4
172309|NCT00853658|549566|P1|Overall Study|Missing study completion information|5
172310|NCT00853658|549564|P3|Overall Study|Patient's request|11
172311|NCT00853658|549565|P2|Overall Study|Patient's request|17
172312|NCT00853658|549566|P1|Overall Study|Patient's request|21
172313|NCT00853658|549564|P3|Overall Study|Vital Status at study end N/A|10
172314|NCT00853658|549565|P2|Overall Study|Vital Status at study end N/A|10
172315|NCT00853658|549566|P1|Overall Study|Vital Status at study end N/A|8
172316|NCT00853658|549564|P3|Overall Study|Vital Status unknown at study end|0
172317|NCT00853658|549565|P2|Overall Study|Vital Status unknown at study end|1
172318|NCT00853658|549566|P1|Overall Study|Vital Status unknown at study end|1
172319|NCT00853658|549564|P3|Overall Study|Vital Status known (alive) at study end|3
172320|NCT00853658|549565|P2|Overall Study|Vital Status known (alive) at study end|3
172321|NCT00853658|549566|P1|Overall Study|Vital Status known (alive) at study end|2
172322|NCT00853658|549564|P3|Overall Study|IRB request|2
172323|NCT00853658|549565|P2|Overall Study|IRB request|0
172324|NCT00853658|549566|P1|Overall Study|IRB request|0
172325|NCT00853658|549564|P3|Overall Study|H.A. Request|19
172326|NCT00853658|549565|P2|Overall Study|H.A. Request|23
172327|NCT00853658|549566|P1|Overall Study|H.A. Request|26
172328|NCT00853658|549564|P3|Overall Study|Lost to Follow-up|11
172329|NCT00853658|549565|P2|Overall Study|Lost to Follow-up|6
172330|NCT00853658|549566|P1|Overall Study|Lost to Follow-up|11
172331|NCT00853658|549564|P3|Overall Study|Death|753
172332|NCT00853658|549565|P2|Overall Study|Death|768
172333|NCT00853658|549566|P1|Overall Study|Death|713
172334|NCT00853723|549583|P3|Overall Study|Protocol Violation|1
172335|NCT00853723|549584|P2|Overall Study|Protocol Violation|2
172336|NCT00853723|549585|P1|Overall Study|Protocol Violation|1
172337|NCT00853723|549583|P3|Overall Study|Withdrawal by Subject|0
172338|NCT00853723|549584|P2|Overall Study|Withdrawal by Subject|1
172339|NCT00853723|549585|P1|Overall Study|Withdrawal by Subject|2
172340|NCT00853723|549583|P3|Overall Study|Adverse Event|1
172341|NCT00853723|549584|P2|Overall Study|Adverse Event|4
172342|NCT00853723|549585|P1|Overall Study|Adverse Event|3
172343|NCT00853749|549631|P2|Overall Study|Lost to Follow-up|1
172344|NCT00853749|549632|P1|Overall Study|Lost to Follow-up|0
172345|NCT00853762|549654|P4|Overall Study|Randomised but not Treated|0
172346|NCT00853762|549655|P3|Overall Study|Randomised but not Treated|2
172347|NCT00853762|549656|P2|Overall Study|Randomised but not Treated|2
172348|NCT00853762|549657|P1|Overall Study|Randomised but not Treated|0
172349|NCT00853762|549654|P4|Overall Study|Unspecified|0
172350|NCT00853762|549655|P3|Overall Study|Unspecified|0
172351|NCT00853762|549656|P2|Overall Study|Unspecified|2
172352|NCT00853762|549657|P1|Overall Study|Unspecified|0
172353|NCT00853762|549654|P4|Overall Study|Withdrawal by Subject|0
172354|NCT00853762|549655|P3|Overall Study|Withdrawal by Subject|1
172355|NCT00853762|549656|P2|Overall Study|Withdrawal by Subject|0
172356|NCT00853762|549657|P1|Overall Study|Withdrawal by Subject|0
172357|NCT00853762|549654|P4|Overall Study|Protocol Violation|1
172358|NCT00853762|549655|P3|Overall Study|Protocol Violation|0
172359|NCT00853762|549656|P2|Overall Study|Protocol Violation|0
172360|NCT00853762|549657|P1|Overall Study|Protocol Violation|0
172361|NCT00853762|549654|P4|Overall Study|Premature Termination|21
172362|NCT00853762|549655|P3|Overall Study|Premature Termination|14
172363|NCT00853762|549656|P2|Overall Study|Premature Termination|15
172364|NCT00853762|549657|P1|Overall Study|Premature Termination|16
172365|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Death|6
172366|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Death|1
172367|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Administrative problems|56
172368|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Administrative problems|45
172369|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
172370|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
172371|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
172372|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
172373|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
172374|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
172375|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|1
172376|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Patient’s no longer requires study drug|3
172377|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
172378|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
172379|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
172380|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
172381|NCT00853827|549725|P2|Double Blind Period (103 Weeks)|Adverse Event|14
172382|NCT00853827|549726|P1|Double Blind Period (103 Weeks)|Adverse Event|25
172383|NCT00853827|549725|P2|Single Blind Period (1 Week)|Protocol Violation|0
172384|NCT00853827|549726|P1|Single Blind Period (1 Week)|Protocol Violation|12
172385|NCT00853827|549725|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
172386|NCT00853827|549726|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
172387|NCT00853827|549725|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
172388|NCT00853827|549726|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
172389|NCT00853827|549725|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
172390|NCT00853827|549726|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
172391|NCT00853827|549725|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
172392|NCT00853827|549726|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
172393|NCT00853827|549725|P2|Single Blind Period (1 Week)|Adverse Event|0
172394|NCT00853827|549726|P1|Single Blind Period (1 Week)|Adverse Event|9
172395|NCT00853827|549725|P2|Single Blind Period (1 Week)|Other|0
172396|NCT00853827|549726|P1|Single Blind Period (1 Week)|Other|4
172397|NCT00853905|549756|P2|Overall Study|never had surgery|0
172398|NCT00853905|549757|P1|Overall Study|never had surgery|1
172399|NCT00853905|549756|P2|Overall Study|Withdrawal by Subject|1
172400|NCT00853905|549757|P1|Overall Study|Withdrawal by Subject|0
172401|NCT00853905|549756|P2|Overall Study|Lost to Follow-up|3
172402|NCT00853905|549757|P1|Overall Study|Lost to Follow-up|1
172403|NCT00853957|549765|P2|Overall Study|Protocol deviation|3
172404|NCT00853957|549766|P1|Overall Study|Protocol deviation|0
172405|NCT00853957|549765|P2|Overall Study|Lost to Follow-up|6
172406|NCT00853957|549766|P1|Overall Study|Lost to Follow-up|1
172407|NCT00853957|549765|P2|Overall Study|Subject withdrew consent|5
172408|NCT00853957|549766|P1|Overall Study|Subject withdrew consent|4
172409|NCT00853957|549765|P2|Overall Study|Unsatisfactory therapeutic effect|2
172410|NCT00853957|549766|P1|Overall Study|Unsatisfactory therapeutic effect|0
172411|NCT00853957|549765|P2|Overall Study|Adverse Event|3
172412|NCT00853957|549766|P1|Overall Study|Adverse Event|9
172413|NCT00853970|549784|P2|Overall Study|Cancelled surgery|2
172414|NCT00853970|549785|P1|Overall Study|Cancelled surgery|4
172415|NCT00853970|549784|P2|Overall Study|Withdrawal by Subject|1
172416|NCT00853970|549785|P1|Overall Study|Withdrawal by Subject|2
172417|NCT00854113|549823|P11|Overall Study|Withdrawal by Subject|0
172418|NCT00854113|549824|P10|Overall Study|Withdrawal by Subject|0
172419|NCT00854113|549825|P9|Overall Study|Withdrawal by Subject|1
172420|NCT00854113|549826|P8|Overall Study|Withdrawal by Subject|1
172421|NCT00854113|549827|P7|Overall Study|Withdrawal by Subject|0
172422|NCT00854113|549828|P6|Overall Study|Withdrawal by Subject|0
172423|NCT00854113|549829|P5|Overall Study|Withdrawal by Subject|0
172424|NCT00854113|549830|P4|Overall Study|Withdrawal by Subject|0
172425|NCT00854113|549831|P3|Overall Study|Withdrawal by Subject|0
172426|NCT00854113|549832|P2|Overall Study|Withdrawal by Subject|0
172427|NCT00854113|549833|P1|Overall Study|Withdrawal by Subject|0
172428|NCT00854113|549823|P11|Overall Study|Adverse Event|0
172429|NCT00854113|549824|P10|Overall Study|Adverse Event|0
172430|NCT00854113|549825|P9|Overall Study|Adverse Event|0
172431|NCT00854113|549826|P8|Overall Study|Adverse Event|2
172432|NCT00854113|549827|P7|Overall Study|Adverse Event|0
172433|NCT00854113|549828|P6|Overall Study|Adverse Event|0
172434|NCT00854113|549829|P5|Overall Study|Adverse Event|0
172435|NCT00854113|549830|P4|Overall Study|Adverse Event|0
172436|NCT00854113|549831|P3|Overall Study|Adverse Event|0
172437|NCT00854113|549832|P2|Overall Study|Adverse Event|0
172438|NCT00854113|549833|P1|Overall Study|Adverse Event|0
172439|NCT00854308|549936|P2|Overall Study|Sponsor's decision to terminate study|1
172440|NCT00854308|549937|P1|Overall Study|Sponsor's decision to terminate study|0
172441|NCT00854308|549936|P2|Overall Study|Withdrawal by Subject|2
172442|NCT00854308|549937|P1|Overall Study|Withdrawal by Subject|4
172443|NCT00854308|549936|P2|Overall Study|Physician Decision|6
172444|NCT00854308|549937|P1|Overall Study|Physician Decision|6
172445|NCT00854308|549936|P2|Overall Study|Death|5
172446|NCT00854308|549937|P1|Overall Study|Death|2
172447|NCT00854308|549936|P2|Overall Study|Adverse Event|3
172448|NCT00854308|549937|P1|Overall Study|Adverse Event|8
172449|NCT00854308|549936|P2|Overall Study|Disease progression|50
172450|NCT00854308|549937|P1|Overall Study|Disease progression|42
172451|NCT00854360|549955|P4|Overall Study|Other|3
172452|NCT00854360|549956|P3|Overall Study|Other|0
172453|NCT00854360|549957|P2|Overall Study|Other|0
172454|NCT00854360|549958|P1|Overall Study|Other|0
172455|NCT00854360|549955|P4|Overall Study|Lack of Efficacy|0
172456|NCT00854360|549956|P3|Overall Study|Lack of Efficacy|0
172457|NCT00854360|549957|P2|Overall Study|Lack of Efficacy|1
172458|NCT00854360|549958|P1|Overall Study|Lack of Efficacy|2
172459|NCT00854360|549955|P4|Overall Study|Pregnancy|0
172460|NCT00854360|549956|P3|Overall Study|Pregnancy|0
172461|NCT00854360|549957|P2|Overall Study|Pregnancy|1
172462|NCT00854360|549958|P1|Overall Study|Pregnancy|0
172463|NCT00854360|549955|P4|Overall Study|Withdrawal by Subject|1
172464|NCT00854360|549956|P3|Overall Study|Withdrawal by Subject|0
172465|NCT00854360|549957|P2|Overall Study|Withdrawal by Subject|0
172466|NCT00854360|549958|P1|Overall Study|Withdrawal by Subject|0
172467|NCT00854360|549955|P4|Overall Study|Adverse Event|6
172468|NCT00854360|549956|P3|Overall Study|Adverse Event|2
172469|NCT00854360|549957|P2|Overall Study|Adverse Event|1
172470|NCT00854360|549958|P1|Overall Study|Adverse Event|0
172471|NCT00854373|549990|P2|Overall Study|Forgot to take study drug|1
172472|NCT00854373|549991|P1|Overall Study|Forgot to take study drug|1
172473|NCT00854373|549990|P2|Overall Study|Withdrawal by Subject|3
172474|NCT00854373|549991|P1|Overall Study|Withdrawal by Subject|1
172475|NCT00854607|550021|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
172476|NCT00854620|550054|P1|Overall Study|Adverse Event|1
172477|NCT00854724|550060|P2|Second Intervention|Physician Decision|1
172478|NCT00854724|550061|P1|Second Intervention|Physician Decision|0
172479|NCT00854724|550060|P2|Second Intervention|Protocol Violation|0
172480|NCT00854724|550061|P1|Second Intervention|Protocol Violation|1
172481|NCT00854724|550060|P2|Washout|Withdrawal by Subject|1
172482|NCT00854724|550061|P1|Washout|Withdrawal by Subject|0
172483|NCT00854724|550060|P2|Washout|Protocol Violation|0
172484|NCT00854724|550061|P1|Washout|Protocol Violation|1
172485|NCT00854724|550060|P2|First Intervention|Withdrawal by Subject|1
172486|NCT00854724|550061|P1|First Intervention|Withdrawal by Subject|1
172487|NCT00854906|550067|P1|Overall Study|One person had no ocular history|1
172488|NCT00855062|550076|P2|Step2|Initiation of antiretroviral therapy/ART|1
172489|NCT00855062|550077|P1|Step2|Initiation of antiretroviral therapy/ART|0
172490|NCT00855062|550076|P2|Step2|Adverse Event|3
172491|NCT00855062|550077|P1|Step2|Adverse Event|0
172492|NCT00855062|550076|P2|Step2|Early Study Closure|2
172493|NCT00855062|550077|P1|Step2|Early Study Closure|6
172494|NCT00855062|550076|P2|Step1|Withdrawal by Subject|3
172495|NCT00855062|550077|P1|Step1|Withdrawal by Subject|2
172496|NCT00855062|550076|P2|Step1|Pregnancy|0
172497|NCT00855062|550077|P1|Step1|Pregnancy|1
172498|NCT00855062|550076|P2|Step1|Protocol Violation|0
172499|NCT00855062|550077|P1|Step1|Protocol Violation|1
172500|NCT00855062|550076|P2|Step1|Adverse Event|1
172501|NCT00855062|550077|P1|Step1|Adverse Event|1
172502|NCT00855062|550076|P2|Step1|Early Study Closure|7
172503|NCT00855062|550077|P1|Step1|Early Study Closure|5
172504|NCT00855166|550103|P2|Overall Study|Subject no longer meets study criteria|1
172505|NCT00855166|550104|P1|Overall Study|Subject no longer meets study criteria|1
172506|NCT00855166|550103|P2|Overall Study|Administrative reasons by sponsor|0
172507|NCT00855166|550104|P1|Overall Study|Administrative reasons by sponsor|1
172508|NCT00855166|550103|P2|Overall Study|Poor/non-compliance|0
172509|NCT00855166|550104|P1|Overall Study|Poor/non-compliance|2
172510|NCT00855166|550103|P2|Overall Study|Withdrawal by Subject|4
172511|NCT00855166|550104|P1|Overall Study|Withdrawal by Subject|1
172512|NCT00855166|550103|P2|Overall Study|Death|1
172513|NCT00855166|550104|P1|Overall Study|Death|0
172514|NCT00855166|550103|P2|Overall Study|Adverse Event|2
172515|NCT00855166|550104|P1|Overall Study|Adverse Event|0
172516|NCT00855218|550124|P2|Overall Study|Clinical endpoint reached|13
172517|NCT00855218|550125|P1|Overall Study|Clinical endpoint reached|10
172518|NCT00855218|550124|P2|Overall Study|Progression measurement proven|15
172519|NCT00855218|550125|P1|Overall Study|Progression measurement proven|7
172520|NCT00855218|550124|P2|Overall Study|Second malignancy|1
172521|NCT00855218|550125|P1|Overall Study|Second malignancy|0
172522|NCT00855218|550124|P2|Overall Study|Untreatable disease progression|67
172523|NCT00855218|550125|P1|Overall Study|Untreatable disease progression|54
172524|NCT00855218|550124|P2|Overall Study|Still treated with study medication|1
172525|NCT00855218|550125|P1|Overall Study|Still treated with study medication|0
172526|NCT00855218|550124|P2|Overall Study|technical problems|1
172527|NCT00855218|550125|P1|Overall Study|technical problems|2
172528|NCT00855218|550124|P2|Overall Study|patient convenience|0
172529|NCT00855218|550125|P1|Overall Study|patient convenience|2
172530|NCT00855218|550124|P2|Overall Study|non-compliant with study drug|1
172531|NCT00855218|550125|P1|Overall Study|non-compliant with study drug|3
172532|NCT00855218|550124|P2|Overall Study|Protocol Violation|9
172533|NCT00855218|550125|P1|Overall Study|Protocol Violation|5
172534|NCT00855218|550124|P2|Overall Study|Lost to Follow-up|1
172535|NCT00855218|550125|P1|Overall Study|Lost to Follow-up|0
172536|NCT00855218|550124|P2|Overall Study|Physician Decision|11
172537|NCT00855218|550125|P1|Overall Study|Physician Decision|18
172538|NCT00855218|550124|P2|Overall Study|Withdrawal by Subject|6
172539|NCT00855218|550125|P1|Overall Study|Withdrawal by Subject|10
172540|NCT00855218|550124|P2|Overall Study|Adverse Event|27
172541|NCT00855218|550125|P1|Overall Study|Adverse Event|43
172542|NCT00855309|550143|P2|Overall Study|patient never recieved drug|0
172543|NCT00855309|550144|P1|Overall Study|patient never recieved drug|1
172544|NCT00855439|550152|P2|Overall Study|Pregnancy|0
172545|NCT00855439|550153|P1|Overall Study|Pregnancy|1
172546|NCT00855439|550152|P2|Overall Study|Withdrawal by Subject|0
172547|NCT00855439|550153|P1|Overall Study|Withdrawal by Subject|2
172548|NCT00855465|550167|P2|Follow-up Period (FUP)|Missing|0
172549|NCT00855465|550168|P1|Follow-up Period (FUP)|Missing|1
172550|NCT00855465|550167|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
172551|NCT00855465|550168|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
172552|NCT00855465|550167|P2|Follow-up Period (FUP)|Lost to Follow-up|0
172553|NCT00855465|550168|P1|Follow-up Period (FUP)|Lost to Follow-up|3
172554|NCT00855465|550167|P2|Follow-up Period (FUP)|Death|1
172555|NCT00855465|550168|P1|Follow-up Period (FUP)|Death|0
172556|NCT00855465|550167|P2|Follow-up Period (FUP)|Adverse Event|1
172557|NCT00855465|550168|P1|Follow-up Period (FUP)|Adverse Event|0
172558|NCT00855465|550167|P2|Treatment Period|Not treated|0
172559|NCT00855465|550168|P1|Treatment Period|Not treated|1
172560|NCT00855465|550167|P2|Treatment Period|Withdrawal by Subject|0
172561|NCT00855465|550168|P1|Treatment Period|Withdrawal by Subject|2
172562|NCT00855465|550167|P2|Treatment Period|Protocol Violation|0
172563|NCT00855465|550168|P1|Treatment Period|Protocol Violation|2
172564|NCT00855465|550167|P2|Treatment Period|Non-compliance|0
172565|NCT00855465|550168|P1|Treatment Period|Non-compliance|1
172566|NCT00855465|550167|P2|Treatment Period|Lack of Efficacy|1
172567|NCT00855465|550168|P1|Treatment Period|Lack of Efficacy|2
172568|NCT00855465|550167|P2|Treatment Period|Death|2
172569|NCT00855465|550168|P1|Treatment Period|Death|2
172570|NCT00855465|550167|P2|Treatment Period|Adverse Event|2
172571|NCT00855465|550168|P1|Treatment Period|Adverse Event|4
172572|NCT00855582|550259|P3|Overall Study|Withdrawal by Subject|8
172573|NCT00855582|550260|P2|Overall Study|Withdrawal by Subject|4
172574|NCT00855582|550261|P1|Overall Study|Withdrawal by Subject|7
172575|NCT00855582|550259|P3|Overall Study|Entry Criteria Not Met|3
172576|NCT00855582|550260|P2|Overall Study|Entry Criteria Not Met|6
172577|NCT00855582|550261|P1|Overall Study|Entry Criteria Not Met|8
172578|NCT00855582|550259|P3|Overall Study|Protocol Violation|6
172579|NCT00855582|550260|P2|Overall Study|Protocol Violation|2
172580|NCT00855582|550261|P1|Overall Study|Protocol Violation|6
172581|NCT00855582|550259|P3|Overall Study|Physician Decision|1
172582|NCT00855582|550260|P2|Overall Study|Physician Decision|0
172583|NCT00855582|550261|P1|Overall Study|Physician Decision|0
172584|NCT00855582|550259|P3|Overall Study|Lost to Follow-up|1
172585|NCT00855582|550260|P2|Overall Study|Lost to Follow-up|3
172586|NCT00855582|550261|P1|Overall Study|Lost to Follow-up|1
172587|NCT00855582|550259|P3|Overall Study|Lack of Efficacy|8
172588|NCT00855582|550260|P2|Overall Study|Lack of Efficacy|3
172589|NCT00855582|550261|P1|Overall Study|Lack of Efficacy|1
172590|NCT00855582|550259|P3|Overall Study|Death|0
172591|NCT00855582|550260|P2|Overall Study|Death|0
172592|NCT00855582|550261|P1|Overall Study|Death|1
172593|NCT00855582|550259|P3|Overall Study|Adverse Event|3
172594|NCT00855582|550260|P2|Overall Study|Adverse Event|6
172595|NCT00855582|550261|P1|Overall Study|Adverse Event|2
172596|NCT00855595|550350|P2|Overall Study|patient left country|1
172597|NCT00855595|550351|P1|Overall Study|patient left country|0
172598|NCT00855595|550350|P2|Overall Study|patient moved out of state|0
172599|NCT00855595|550351|P1|Overall Study|patient moved out of state|1
172600|NCT00855595|550350|P2|Overall Study|Adverse Event|1
172601|NCT00855595|550351|P1|Overall Study|Adverse Event|1
172602|NCT00855595|550350|P2|Overall Study|Lost to Follow-up|3
172603|NCT00855595|550351|P1|Overall Study|Lost to Follow-up|3
172604|NCT00855595|550350|P2|Overall Study|Withdrawal by Subject|2
172605|NCT00855595|550351|P1|Overall Study|Withdrawal by Subject|1
172606|NCT00855738|550387|P1|Overall Study|Death|1
172607|NCT00855738|550387|P1|Overall Study|Subject Defaulted|1
172608|NCT00855738|550387|P1|Overall Study|Adverse Event|1
172609|NCT00855738|550387|P1|Overall Study|Lost to Follow-up|2
172610|NCT00848926|550413|P1|Follow-up Period|Not specified|2
172611|NCT00848926|550413|P1|Follow-up Period|Withdrawal by Subject|3
172612|NCT00848926|550413|P1|Follow-up Period|Lost to Follow-up|7
172613|NCT00848926|550413|P1|Treatment Period|Withdrawal by Subject|7
172614|NCT00848926|550413|P1|Treatment Period|Physician Decision|12
172615|NCT00848926|550413|P1|Treatment Period|Adverse Event|20
172616|NCT00848926|550413|P1|Treatment Period|Progressive disease|45
172617|NCT00848965|550429|P1|Overall Study|Withdrawal by Subject|1
172618|NCT00848965|550429|P1|Overall Study|Adverse Event|1
172619|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
172620|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
172621|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
172622|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
172623|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
172624|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
172625|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Physician Decision|1
172626|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Physician Decision|1
172627|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Physician Decision|0
172628|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
172629|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
172630|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
172794|NCT00856206|550714|P2|Overall Study|Adverse Event|46
172631|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
172632|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
172633|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
172634|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
172635|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
172636|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
172637|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Noncompliance|0
172638|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Noncompliance|1
172639|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Noncompliance|2
172640|NCT00849017|550474|P3|Follow-up Period (8 Weeks)|Adverse Event|0
172641|NCT00849017|550475|P2|Follow-up Period (8 Weeks)|Adverse Event|0
172642|NCT00849017|550476|P1|Follow-up Period (8 Weeks)|Adverse Event|1
172643|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
172644|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
172645|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
172646|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Pregnancy|1
172647|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Pregnancy|0
172648|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Pregnancy|1
172649|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
172650|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
172651|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
172652|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
172653|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
172654|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
172655|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
172656|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
172657|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
172658|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
172659|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
172660|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
172661|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Physician Decision|1
172662|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Physician Decision|2
172663|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Physician Decision|0
172664|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
172665|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
172666|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
172667|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
172668|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
172669|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
172670|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Noncompliance|4
172671|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Noncompliance|3
172672|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Noncompliance|3
172673|NCT00849017|550474|P3|Treatment Period (156 Weeks)|Adverse Event|15
172674|NCT00849017|550475|P2|Treatment Period (156 Weeks)|Adverse Event|6
172675|NCT00849017|550476|P1|Treatment Period (156 Weeks)|Adverse Event|5
172676|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
172677|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
172678|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
172679|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
172680|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
172681|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
172682|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
172683|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
172684|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
172685|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
172686|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
172687|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
172688|NCT00849056|550521|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
172689|NCT00849056|550522|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
172690|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
172691|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
172692|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
172693|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
172694|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
172695|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
172696|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
172697|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
172698|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
172699|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
172700|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
172701|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
172702|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
172703|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
172704|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
172705|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
172706|NCT00849056|550521|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
172707|NCT00849056|550522|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
172708|NCT00849108|550547|P2|Cohort 2 Efficacy|Not specified|9
172709|NCT00849108|550548|P1|Cohort 2 Efficacy|Not specified|0
172710|NCT00849108|550547|P2|Cohort 2 Efficacy|Adverse Event|1
172711|NCT00849108|550548|P1|Cohort 2 Efficacy|Adverse Event|0
172712|NCT00849108|550547|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
172713|NCT00849108|550548|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
172714|NCT00849147|550571|P1|Overall Study|Disease Relapse/Progression|2
172715|NCT00849147|550571|P1|Overall Study|Protocol Violation|2
172716|NCT00849147|550571|P1|Overall Study|Withdrawal by Subject|1
172717|NCT00849186|550586|P1|Overall Study|Other|1
172718|NCT00849186|550586|P1|Overall Study|not treated|6
172719|NCT00849186|550586|P1|Overall Study|Withdrawal by Subject|1
172720|NCT00849186|550586|P1|Overall Study|Adverse Event|2
172721|NCT00849212|550592|P1|Overall Study|Miscellaneous|1
172722|NCT00849212|550592|P1|Overall Study|Adverse Event|2
172723|NCT00849212|550592|P1|Overall Study|Withdrawal by Subject|3
172724|NCT00849212|550592|P1|Overall Study|Lack of Efficacy|1
172725|NCT00849290|550597|P1|Overall Study|Disease Progression|20
172726|NCT00849290|550597|P1|Overall Study|Protocol Violation|5
172727|NCT00849290|550597|P1|Overall Study|Lost to Follow-up|2
172728|NCT00849290|550597|P1|Overall Study|Withdrawal by Subject|11
172729|NCT00849290|550597|P1|Overall Study|Death|14
172730|NCT00849290|550597|P1|Overall Study|Adverse Event|3
172731|NCT00849381|550601|P1|Overall Study|Unspecified|4
172732|NCT00849381|550601|P1|Overall Study|Withdrawal by Subject|6
172733|NCT00849381|550601|P1|Overall Study|Protocol Violation|5
172734|NCT00849381|550601|P1|Overall Study|Lost to Follow-up|129
172735|NCT00849381|550601|P1|Overall Study|Adverse Event|1
172736|NCT00855816|550609|P2|Overall Study|Became ineligible|1
172737|NCT00855816|550610|P1|Overall Study|Became ineligible|0
172738|NCT00855816|550609|P2|Overall Study|Death|0
172739|NCT00855816|550610|P1|Overall Study|Death|1
172740|NCT00855816|550609|P2|Overall Study|Lost to Follow-up|5
172741|NCT00855816|550610|P1|Overall Study|Lost to Follow-up|3
172742|NCT00855816|550609|P2|Overall Study|Withdrawal by Subject|15
172743|NCT00855816|550610|P1|Overall Study|Withdrawal by Subject|22
172744|NCT00855894|550629|P1|Overall Study|Disease progression|1
172745|NCT00855894|550629|P1|Overall Study|Patient's decision|1
172746|NCT00855894|550629|P1|Overall Study|Death|31
172747|NCT00855920|550640|P3|Overall Study|Other than specified above|1
172748|NCT00855920|550641|P2|Overall Study|Other than specified above|1
172749|NCT00855920|550642|P1|Overall Study|Other than specified above|1
172750|NCT00855920|550640|P3|Overall Study|Decision by the sponsor|1
172751|NCT00855920|550641|P2|Overall Study|Decision by the sponsor|1
172752|NCT00855920|550642|P1|Overall Study|Decision by the sponsor|0
172753|NCT00855920|550640|P3|Overall Study|Death|0
172754|NCT00855920|550641|P2|Overall Study|Death|1
172755|NCT00855920|550642|P1|Overall Study|Death|0
172756|NCT00855920|550640|P3|Overall Study|Lost to Follow-up|2
172757|NCT00855920|550641|P2|Overall Study|Lost to Follow-up|0
172758|NCT00855920|550642|P1|Overall Study|Lost to Follow-up|1
172759|NCT00855920|550640|P3|Overall Study|Withdrawal by Subject|2
172760|NCT00855920|550641|P2|Overall Study|Withdrawal by Subject|3
172761|NCT00855920|550642|P1|Overall Study|Withdrawal by Subject|2
172762|NCT00855920|550640|P3|Overall Study|Lack of Efficacy|2
172763|NCT00855920|550641|P2|Overall Study|Lack of Efficacy|2
172764|NCT00855920|550642|P1|Overall Study|Lack of Efficacy|2
172765|NCT00855920|550640|P3|Overall Study|Adverse Event|1
172766|NCT00855920|550641|P2|Overall Study|Adverse Event|1
172767|NCT00855920|550642|P1|Overall Study|Adverse Event|2
172768|NCT00855920|550640|P3|Overall Study|Protocol Violation|2
172769|NCT00855920|550641|P2|Overall Study|Protocol Violation|0
172770|NCT00855920|550642|P1|Overall Study|Protocol Violation|0
172771|NCT00855933|550661|P2|Overall Study|Withdrawal by Subject|1
172772|NCT00855933|550662|P1|Overall Study|Withdrawal by Subject|0
172773|NCT00855959|550668|P1|Overall Study|Incorrect enrolment|1
172774|NCT00855959|550668|P1|Overall Study|Pregnancy|1
172775|NCT00855959|550668|P1|Overall Study|Withdrawal by Subject|3
172776|NCT00855959|550668|P1|Overall Study|Lost to Follow-up|2
172777|NCT00855959|550668|P1|Overall Study|Adverse Event|2
172778|NCT00856193|550699|P2|Period 2|Lost to Follow-up|1
172779|NCT00856193|550700|P1|Period 2|Lost to Follow-up|0
172780|NCT00856193|550699|P2|Period 2|Abnormal test procedure results|1
172781|NCT00856193|550700|P1|Period 2|Abnormal test procedure results|0
172782|NCT00856206|550714|P2|Overall Study|Other than specified above|10
172783|NCT00856206|550715|P1|Overall Study|Other than specified above|3
172784|NCT00856206|550714|P2|Overall Study|Decision by the Sponsor|8
172785|NCT00856206|550715|P1|Overall Study|Decision by the Sponsor|4
172786|NCT00856206|550714|P2|Overall Study|Death|2
172787|NCT00856206|550715|P1|Overall Study|Death|2
172788|NCT00856206|550714|P2|Overall Study|Lost to Follow-up|39
172789|NCT00856206|550715|P1|Overall Study|Lost to Follow-up|13
172790|NCT00856206|550714|P2|Overall Study|Withdrawal by Subject|36
172791|NCT00856206|550715|P1|Overall Study|Withdrawal by Subject|15
172792|NCT00856206|550714|P2|Overall Study|Lack of Efficacy|2
172793|NCT00856206|550715|P1|Overall Study|Lack of Efficacy|1
172795|NCT00856206|550715|P1|Overall Study|Adverse Event|10
172796|NCT00856206|550714|P2|Overall Study|Protocol Violation|18
172797|NCT00856206|550715|P1|Overall Study|Protocol Violation|6
172798|NCT00856245|550745|P1|Overall Study|Was not transplanted|5
172799|NCT00856284|550753|P3|Overall Study|Randomized in error|1
172800|NCT00856284|550754|P2|Overall Study|Randomized in error|0
172801|NCT00856284|550755|P1|Overall Study|Randomized in error|0
172802|NCT00856284|550753|P3|Overall Study|Other|14
172803|NCT00856284|550754|P2|Overall Study|Other|17
172804|NCT00856284|550755|P1|Overall Study|Other|15
172805|NCT00856284|550753|P3|Overall Study|Investigator discretion|10
172806|NCT00856284|550754|P2|Overall Study|Investigator discretion|8
172807|NCT00856284|550755|P1|Overall Study|Investigator discretion|9
172808|NCT00856284|550753|P3|Overall Study|Pregnancy|0
172809|NCT00856284|550754|P2|Overall Study|Pregnancy|2
172810|NCT00856284|550755|P1|Overall Study|Pregnancy|1
172811|NCT00856284|550753|P3|Overall Study|Voluntary withdrawal|62
172812|NCT00856284|550754|P2|Overall Study|Voluntary withdrawal|52
172813|NCT00856284|550755|P1|Overall Study|Voluntary withdrawal|48
172814|NCT00856284|550753|P3|Overall Study|Lost to Follow-up|28
172815|NCT00856284|550754|P2|Overall Study|Lost to Follow-up|22
172816|NCT00856284|550755|P1|Overall Study|Lost to Follow-up|20
172817|NCT00856284|550753|P3|Overall Study|Major protocol deviation|15
172818|NCT00856284|550754|P2|Overall Study|Major protocol deviation|16
172819|NCT00856284|550755|P1|Overall Study|Major protocol deviation|24
172820|NCT00856284|550753|P3|Overall Study|Adverse Event|82
172821|NCT00856284|550754|P2|Overall Study|Adverse Event|74
172822|NCT00856284|550755|P1|Overall Study|Adverse Event|60
172823|NCT00856284|550753|P3|Overall Study|Hyperglycemic rescue|235
172824|NCT00856284|550754|P2|Overall Study|Hyperglycemic rescue|201
172825|NCT00856284|550755|P1|Overall Study|Hyperglycemic rescue|231
172826|NCT00856297|550786|P5|Overall Study|Unable to classify|0
172827|NCT00856297|550787|P4|Overall Study|Unable to classify|0
172828|NCT00856297|550788|P3|Overall Study|Unable to classify|0
172829|NCT00856297|550789|P2|Overall Study|Unable to classify|0
172830|NCT00856297|550790|P1|Overall Study|Unable to classify|2
172831|NCT00856323|550820|P1|Overall Study|Withdrawal by Subject|2
172832|NCT00856349|550827|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
172833|NCT00856349|550827|P1|Overall Study|Site closure|78
172834|NCT00856349|550827|P1|Overall Study|Device explant|33
172835|NCT00856349|550827|P1|Overall Study|Subject relocation|104
172836|NCT00856349|550827|P1|Overall Study|Physician Decision|13
172837|NCT00856349|550827|P1|Overall Study|Protocol Violation|38
172838|NCT00856349|550827|P1|Overall Study|Lost to Follow-up|91
172839|NCT00856349|550827|P1|Overall Study|Withdrawal by Subject|116
172840|NCT00856349|550827|P1|Overall Study|Death|418
172841|NCT00856388|550836|P1|Overall Study|Not Specified|1
172842|NCT00856492|550858|P3|Overall Study|Ineligible or withdrew consent|2
172843|NCT00856492|550859|P2|Overall Study|Ineligible or withdrew consent|1
172844|NCT00856492|550860|P1|Overall Study|Ineligible or withdrew consent|1
172845|NCT00856518|550876|P2|Overall Study|Lost to Follow-up|2
172846|NCT00856518|550877|P1|Overall Study|Lost to Follow-up|4
172847|NCT00856544|550891|P4|Overall Study|Withdrawal by Subject|1
172848|NCT00856544|550892|P3|Overall Study|Withdrawal by Subject|0
172849|NCT00856544|550893|P2|Overall Study|Withdrawal by Subject|5
172850|NCT00856544|550894|P1|Overall Study|Withdrawal by Subject|8
172851|NCT00856544|550891|P4|Overall Study|Lost to Follow-up|0
172852|NCT00856544|550892|P3|Overall Study|Lost to Follow-up|2
172853|NCT00856544|550893|P2|Overall Study|Lost to Follow-up|2
172854|NCT00856544|550894|P1|Overall Study|Lost to Follow-up|1
172855|NCT00856544|550891|P4|Overall Study|Unspecified|6
172856|NCT00856544|550892|P3|Overall Study|Unspecified|1
172857|NCT00856544|550893|P2|Overall Study|Unspecified|16
172858|NCT00856544|550894|P1|Overall Study|Unspecified|9
172859|NCT00856544|550891|P4|Overall Study|Lack of Efficacy|3
172860|NCT00856544|550892|P3|Overall Study|Lack of Efficacy|3
172861|NCT00856544|550893|P2|Overall Study|Lack of Efficacy|12
172862|NCT00856544|550894|P1|Overall Study|Lack of Efficacy|16
172863|NCT00856544|550891|P4|Overall Study|Adverse Event|3
172864|NCT00856544|550892|P3|Overall Study|Adverse Event|2
172865|NCT00856544|550893|P2|Overall Study|Adverse Event|29
172866|NCT00856544|550894|P1|Overall Study|Adverse Event|20
172867|NCT00856544|550891|P4|Overall Study|Death|0
172868|NCT00856544|550892|P3|Overall Study|Death|0
172869|NCT00856544|550893|P2|Overall Study|Death|2
172870|NCT00856544|550894|P1|Overall Study|Death|0
172871|NCT00856544|550891|P4|Overall Study|Randomized but not treated|0
172872|NCT00856544|550892|P3|Overall Study|Randomized but not treated|0
172873|NCT00856544|550893|P2|Overall Study|Randomized but not treated|0
172874|NCT00856544|550894|P1|Overall Study|Randomized but not treated|3
172875|NCT00856557|551073|P2|Overall Study|No patients with contextual flags|16
172876|NCT00856557|551074|P1|Overall Study|No patients with contextual flags|12
172877|NCT00856583|551086|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
172878|NCT00856583|551087|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
172879|NCT00856583|551086|P2|Overall Study|Other|104
172880|NCT00856583|551087|P1|Overall Study|Other|92
172881|NCT00856583|551086|P2|Overall Study|Pregnancy|5
172882|NCT00856583|551087|P1|Overall Study|Pregnancy|14
172883|NCT00856583|551086|P2|Overall Study|Physician Decision|82
172884|NCT00856583|551087|P1|Overall Study|Physician Decision|59
172885|NCT00856583|551086|P2|Overall Study|Withdrawal by Subject|919
172886|NCT00856583|551087|P1|Overall Study|Withdrawal by Subject|1092
172887|NCT00856583|551086|P2|Overall Study|Non-compliance|262
172888|NCT00856583|551087|P1|Overall Study|Non-compliance|305
172889|NCT00856583|551086|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
172890|NCT00856583|551087|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
172891|NCT00856583|551086|P2|Overall Study|Serious Adverse Event (SAE)|65
172892|NCT00856583|551087|P1|Overall Study|Serious Adverse Event (SAE)|99
172893|NCT00856583|551086|P2|Overall Study|Lack of Efficacy|377
172894|NCT00856583|551087|P1|Overall Study|Lack of Efficacy|389
172895|NCT00856635|551117|P2|Overall Study|Discontinued at Randomization|2
172896|NCT00856635|551118|P1|Overall Study|Discontinued at Randomization|2
172897|NCT00856635|551117|P2|Overall Study|Other|0
172898|NCT00856635|551118|P1|Overall Study|Other|1
172899|NCT00856635|551117|P2|Overall Study|Serious Adverse Event|0
172900|NCT00856635|551118|P1|Overall Study|Serious Adverse Event|1
172901|NCT00856635|551117|P2|Overall Study|Withdrawal by Subject|1
172902|NCT00856635|551118|P1|Overall Study|Withdrawal by Subject|3
172903|NCT00856635|551117|P2|Overall Study|Pregnancy|0
172904|NCT00856635|551118|P1|Overall Study|Pregnancy|1
172905|NCT00856635|551117|P2|Overall Study|Lost to Follow-up|5
172906|NCT00856635|551118|P1|Overall Study|Lost to Follow-up|2
172907|NCT00856661|551126|P2|Overall Study|Physician Judgement|5
172908|NCT00856661|551127|P1|Overall Study|Physician Judgement|8
172909|NCT00856661|551126|P2|Overall Study|Lost to Follow-up|3
172910|NCT00856661|551127|P1|Overall Study|Lost to Follow-up|1
172911|NCT00856661|551126|P2|Overall Study|Withdrawal by Subject|2
172912|NCT00856661|551127|P1|Overall Study|Withdrawal by Subject|1
172913|NCT00856661|551126|P2|Overall Study|Protocol Violation|1
172914|NCT00856661|551127|P1|Overall Study|Protocol Violation|2
172915|NCT00856661|551126|P2|Overall Study|Death|18
172916|NCT00856661|551127|P1|Overall Study|Death|15
172917|NCT00856778|551155|P1|Overall Study|Lost to Follow-up|5
172918|NCT00856778|551155|P1|Overall Study|Study deviation|2
172919|NCT00856778|551155|P1|Overall Study|Withdrawal by Subject|10
172920|NCT00856778|551155|P1|Overall Study|Adverse Event|7
172921|NCT00856830|551180|P4|Irinotecan & Bendamustine|Physician Decision|1
172922|NCT00856830|551181|P3|Irinotecan & Bendamustine|Physician Decision|0
172923|NCT00856830|551182|P2|Irinotecan & Bendamustine|Physician Decision|0
172924|NCT00856830|551183|P1|Irinotecan & Bendamustine|Physician Decision|0
172925|NCT00856830|551180|P4|Irinotecan & Bendamustine|Death|2
172926|NCT00856830|551181|P3|Irinotecan & Bendamustine|Death|0
172927|NCT00856830|551182|P2|Irinotecan & Bendamustine|Death|0
172928|NCT00856830|551183|P1|Irinotecan & Bendamustine|Death|0
172929|NCT00856843|551191|P2|Overall Study|Lack of Efficacy|0
172930|NCT00856843|551192|P1|Overall Study|Lack of Efficacy|1
172931|NCT00856843|551191|P2|Overall Study|Withdrawal by Subject|5
172932|NCT00856843|551192|P1|Overall Study|Withdrawal by Subject|1
172933|NCT00856908|551226|P2|Overall Study|Lost to Follow-up|0
172934|NCT00856908|551227|P1|Overall Study|Lost to Follow-up|1
172935|NCT00856973|551268|P3|Overall Study|Other|13
172936|NCT00856973|551269|P2|Overall Study|Other|12
172937|NCT00856973|551270|P1|Overall Study|Other|11
172938|NCT00856973|551268|P3|Overall Study|Withdrawal by Subject|15
172939|NCT00856973|551269|P2|Overall Study|Withdrawal by Subject|16
172940|NCT00856973|551270|P1|Overall Study|Withdrawal by Subject|13
172941|NCT00856973|551268|P3|Overall Study|Protocol Violation|1
172942|NCT00856973|551269|P2|Overall Study|Protocol Violation|2
172943|NCT00856973|551270|P1|Overall Study|Protocol Violation|1
172944|NCT00856973|551268|P3|Overall Study|Physician Decision|1
172945|NCT00856973|551269|P2|Overall Study|Physician Decision|3
172946|NCT00856973|551270|P1|Overall Study|Physician Decision|0
172947|NCT00856973|551268|P3|Overall Study|Lost to Follow-up|5
172948|NCT00856973|551269|P2|Overall Study|Lost to Follow-up|3
172949|NCT00856973|551270|P1|Overall Study|Lost to Follow-up|6
172950|NCT00856973|551268|P3|Overall Study|Adverse Event|3
172951|NCT00856973|551269|P2|Overall Study|Adverse Event|5
172952|NCT00856973|551270|P1|Overall Study|Adverse Event|5
172953|NCT00856986|551340|P5|Extension Period, Weeks 26-52|Unclassified|0
172954|NCT00856986|551341|P4|Extension Period, Weeks 26-52|Unclassified|0
172955|NCT00856986|551342|P3|Extension Period, Weeks 26-52|Unclassified|11
172956|NCT00856986|551343|P2|Extension Period, Weeks 26-52|Unclassified|2
172957|NCT00856986|551344|P1|Extension Period, Weeks 26-52|Unclassified|4
172958|NCT00856986|551340|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
172959|NCT00856986|551341|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
172960|NCT00856986|551342|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
172961|NCT00856986|551343|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
172962|NCT00856986|551344|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
172963|NCT00856986|551340|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
172964|NCT00856986|551341|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
172965|NCT00856986|551342|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
172966|NCT00856986|551343|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
172967|NCT00856986|551344|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
172968|NCT00856986|551340|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
172969|NCT00856986|551341|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
172970|NCT00856986|551342|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
172971|NCT00856986|551343|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
172972|NCT00856986|551344|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
172973|NCT00856986|551340|P5|Extension Period, Weeks 26-52|Protocol Violation|0
172974|NCT00856986|551341|P4|Extension Period, Weeks 26-52|Protocol Violation|0
172975|NCT00856986|551342|P3|Extension Period, Weeks 26-52|Protocol Violation|5
172976|NCT00856986|551343|P2|Extension Period, Weeks 26-52|Protocol Violation|2
172977|NCT00856986|551344|P1|Extension Period, Weeks 26-52|Protocol Violation|6
172978|NCT00856986|551340|P5|Extension Period, Weeks 26-52|Adverse Event|0
172979|NCT00856986|551341|P4|Extension Period, Weeks 26-52|Adverse Event|0
172980|NCT00856986|551342|P3|Extension Period, Weeks 26-52|Adverse Event|10
172981|NCT00856986|551343|P2|Extension Period, Weeks 26-52|Adverse Event|3
172982|NCT00856986|551344|P1|Extension Period, Weeks 26-52|Adverse Event|3
172983|NCT00856986|551340|P5|Main Period, Weeks 0-26|Unclassified|0
172984|NCT00856986|551341|P4|Main Period, Weeks 0-26|Unclassified|0
172985|NCT00856986|551342|P3|Main Period, Weeks 0-26|Unclassified|7
172986|NCT00856986|551343|P2|Main Period, Weeks 0-26|Unclassified|6
172987|NCT00856986|551344|P1|Main Period, Weeks 0-26|Unclassified|7
172988|NCT00856986|551340|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
172989|NCT00856986|551341|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
172990|NCT00856986|551342|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
172991|NCT00856986|551343|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
172992|NCT00856986|551344|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
172993|NCT00856986|551340|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
172994|NCT00856986|551341|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
172995|NCT00856986|551342|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
172996|NCT00856986|551343|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
172997|NCT00856986|551344|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
172998|NCT00856986|551340|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
172999|NCT00856986|551341|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
173000|NCT00856986|551342|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
173001|NCT00856986|551343|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
173002|NCT00856986|551344|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
173003|NCT00856986|551340|P5|Main Period, Weeks 0-26|Protocol Violation|0
173004|NCT00856986|551341|P4|Main Period, Weeks 0-26|Protocol Violation|0
173005|NCT00856986|551342|P3|Main Period, Weeks 0-26|Protocol Violation|7
173006|NCT00856986|551343|P2|Main Period, Weeks 0-26|Protocol Violation|5
173007|NCT00856986|551344|P1|Main Period, Weeks 0-26|Protocol Violation|4
173008|NCT00856986|551340|P5|Main Period, Weeks 0-26|Adverse Event|0
173009|NCT00856986|551341|P4|Main Period, Weeks 0-26|Adverse Event|0
173010|NCT00856986|551342|P3|Main Period, Weeks 0-26|Adverse Event|9
173011|NCT00856986|551343|P2|Main Period, Weeks 0-26|Adverse Event|4
173012|NCT00856986|551344|P1|Main Period, Weeks 0-26|Adverse Event|6
173013|NCT00856986|551340|P5|Run-in Period, Weeks -12-0|Unclassified|0
173014|NCT00856986|551341|P4|Run-in Period, Weeks -12-0|Unclassified|24
173015|NCT00856986|551342|P3|Run-in Period, Weeks -12-0|Unclassified|0
173016|NCT00856986|551343|P2|Run-in Period, Weeks -12-0|Unclassified|0
173017|NCT00856986|551344|P1|Run-in Period, Weeks -12-0|Unclassified|0
173018|NCT00856986|551340|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
173019|NCT00856986|551341|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
173020|NCT00856986|551342|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
173021|NCT00856986|551343|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
173022|NCT00856986|551344|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
173023|NCT00856986|551340|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
173024|NCT00856986|551341|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
173025|NCT00856986|551342|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
173026|NCT00856986|551343|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
173027|NCT00856986|551344|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
173028|NCT00856986|551340|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
173029|NCT00856986|551341|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
173030|NCT00856986|551342|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
173031|NCT00856986|551343|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
173032|NCT00856986|551344|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
173033|NCT00856986|551340|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
173034|NCT00856986|551341|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
173035|NCT00856986|551342|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
173036|NCT00856986|551343|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
173037|NCT00856986|551344|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
173038|NCT00856986|551340|P5|Run-in Period, Weeks -12-0|Adverse Event|0
173039|NCT00856986|551341|P4|Run-in Period, Weeks -12-0|Adverse Event|92
173040|NCT00856986|551342|P3|Run-in Period, Weeks -12-0|Adverse Event|0
173041|NCT00856986|551343|P2|Run-in Period, Weeks -12-0|Adverse Event|0
173042|NCT00856986|551344|P1|Run-in Period, Weeks -12-0|Adverse Event|0
173043|NCT00857220|551511|P1|Overall Study|Miscellaneous|8
173044|NCT00857220|551511|P1|Overall Study|Site Closed|5
173045|NCT00857220|551511|P1|Overall Study|Clinical Hold|6
173046|NCT00857220|551511|P1|Overall Study|Withdrawal by Subject|67
173047|NCT00857220|551511|P1|Overall Study|Protocol Violation|16
173048|NCT00857220|551511|P1|Overall Study|Physician Decision|4
173049|NCT00857220|551511|P1|Overall Study|Lost to Follow-up|30
173050|NCT00857220|551511|P1|Overall Study|Lack of Efficacy|11
173051|NCT00857220|551511|P1|Overall Study|Death|1
173052|NCT00857220|551511|P1|Overall Study|Adverse Event|35
173053|NCT00857233|551528|P1|Overall Study|Other Reasons|2
173054|NCT00857233|551528|P1|Overall Study|Nursing Home Placement|14
173055|NCT00857233|551528|P1|Overall Study|Lost to Follow-up|4
173056|NCT00857233|551528|P1|Overall Study|Withdrawal of Consent|9
173057|NCT00857233|551528|P1|Overall Study|Non-compliance|1
173058|NCT00857233|551528|P1|Overall Study|Lack of Efficacy|1
173059|NCT00857233|551528|P1|Overall Study|Adverse Event|24
173060|NCT00857246|551537|P1|ChemoRT|Adverse Event|2
173061|NCT00857246|551537|P1|ChemoRT|Withdrawal by Subject|1
173062|NCT00857246|551537|P1|Surgery (Curative)|disease progression|6
173063|NCT00857246|551537|P1|Induction Regimen|Withdrawal by Subject|1
173064|NCT00857246|551537|P1|Induction Regimen|disease-related complications|1
173065|NCT00857246|551537|P1|Induction Regimen|Adverse Event|1
173066|NCT00857259|551550|P3|Overall Study|Protocol Violation|1
173067|NCT00857259|551551|P2|Overall Study|Protocol Violation|0
173068|NCT00857259|551552|P1|Overall Study|Protocol Violation|1
173069|NCT00857285|551573|P2|Overall Study|Randomization criteria not met|1
173070|NCT00857285|551574|P1|Overall Study|Randomization criteria not met|1
173071|NCT00857285|551573|P2|Overall Study|Withdrawal by Subject|0
173072|NCT00857285|551574|P1|Overall Study|Withdrawal by Subject|4
173073|NCT00857285|551573|P2|Overall Study|Protocol Violation|1
173074|NCT00857285|551574|P1|Overall Study|Protocol Violation|3
173075|NCT00857285|551573|P2|Overall Study|Lack of Efficacy|2
173076|NCT00857285|551574|P1|Overall Study|Lack of Efficacy|0
173077|NCT00857285|551573|P2|Overall Study|Adverse Event|2
173078|NCT00857285|551574|P1|Overall Study|Adverse Event|4
173079|NCT00857311|551582|P4|Overall Study|Lost to Follow-up|0
173080|NCT00857311|551583|P3|Overall Study|Lost to Follow-up|0
173081|NCT00857311|551584|P2|Overall Study|Lost to Follow-up|0
173082|NCT00857311|551585|P1|Overall Study|Lost to Follow-up|1
173083|NCT00857415|551597|P2|Overall Study|Deceased with no autopsy|0
173084|NCT00857415|551598|P1|Overall Study|Deceased with no autopsy|2
173085|NCT00857415|551597|P2|Overall Study|Subject still living at end of study|0
173086|NCT00857415|551598|P1|Overall Study|Subject still living at end of study|110
173087|NCT00857415|551597|P2|Overall Study|Invalid image or not imaged|0
173088|NCT00857415|551598|P1|Overall Study|Invalid image or not imaged|3
173089|NCT00857415|551597|P2|Overall Study|Image acquisition failure|0
173090|NCT00857415|551598|P1|Overall Study|Image acquisition failure|2
173091|NCT00857454|551605|P1|Overall Study|MTE09 enrollment criteria not met|6
173092|NCT00857454|551605|P1|Overall Study|Total Testosterone <300 ng/dL|8
173093|NCT00857454|551605|P1|Overall Study|Total Testosterone >1050 ng/dL|1
173094|NCT00857454|551605|P1|Overall Study|Adverse Event|2
173095|NCT00857454|551605|P1|Overall Study|Lost to Follow-up|1
173096|NCT00857454|551605|P1|Overall Study|Withdrawal by Subject|2
173097|NCT00857584|551657|P2|Overall Study|Physician Decision|1
173098|NCT00857584|551658|P1|Overall Study|Physician Decision|1
173099|NCT00857584|551657|P2|Overall Study|Adverse Event|2
173100|NCT00857584|551658|P1|Overall Study|Adverse Event|2
173101|NCT00857584|551657|P2|Overall Study|Lack of Efficacy|2
173102|NCT00857584|551658|P1|Overall Study|Lack of Efficacy|1
173103|NCT00857623|551700|P2|Overall Study|Positive for HEP C|1
173104|NCT00857623|551701|P1|Overall Study|Positive for HEP C|0
173105|NCT00857623|551700|P2|Overall Study|Intake of prohibited medication|1
173106|NCT00857623|551701|P1|Overall Study|Intake of prohibited medication|0
173107|NCT00857623|551700|P2|Overall Study|Severe non-compliance to protocol|1
173108|NCT00857623|551701|P1|Overall Study|Severe non-compliance to protocol|1
173109|NCT00857623|551700|P2|Overall Study|Lack of Efficacy|1
173110|NCT00857623|551701|P1|Overall Study|Lack of Efficacy|1
173111|NCT00857623|551700|P2|Overall Study|Withdrawal by Subject|1
173112|NCT00857623|551701|P1|Overall Study|Withdrawal by Subject|2
173113|NCT00857623|551700|P2|Overall Study|Study-specific discontinuation criteria|3
173114|NCT00857623|551701|P1|Overall Study|Study-specific discontinuation criteria|5
173115|NCT00857623|551700|P2|Overall Study|Adverse Event|2
173116|NCT00857623|551701|P1|Overall Study|Adverse Event|5
173117|NCT00857649|551725|P2|Overall Study|Other Reasons|3
173118|NCT00857649|551726|P1|Overall Study|Other Reasons|1
173119|NCT00857649|551725|P2|Overall Study|Nursing Home Placement|9
173120|NCT00857649|551726|P1|Overall Study|Nursing Home Placement|2
173121|NCT00857649|551725|P2|Overall Study|Withdrawal of Consent|7
173122|NCT00857649|551726|P1|Overall Study|Withdrawal of Consent|10
173123|NCT00857649|551725|P2|Overall Study|Protocol Violation|2
173124|NCT00857649|551726|P1|Overall Study|Protocol Violation|2
173125|NCT00857649|551725|P2|Overall Study|Non-compliance|1
173126|NCT00857649|551726|P1|Overall Study|Non-compliance|1
173127|NCT00857649|551725|P2|Overall Study|Adverse Event|10
173128|NCT00857649|551726|P1|Overall Study|Adverse Event|15
173129|NCT00857766|551747|P2|Overall Study|Participant Withdrew Consent|4
173130|NCT00857766|551748|P1|Overall Study|Participant Withdrew Consent|4
173131|NCT00857766|551747|P2|Overall Study|Investigator Discretion|3
173132|NCT00857766|551748|P1|Overall Study|Investigator Discretion|2
173133|NCT00857766|551747|P2|Overall Study|Lost to Follow-up|0
173134|NCT00857766|551748|P1|Overall Study|Lost to Follow-up|1
173135|NCT00857766|551747|P2|Overall Study|Protocol Violation|11
173136|NCT00857766|551748|P1|Overall Study|Protocol Violation|11
173137|NCT00857766|551747|P2|Overall Study|Adverse Event|12
173138|NCT00857766|551748|P1|Overall Study|Adverse Event|13
173222|NCT00852397|552051|P3|Overall Study|Protocol Violation|1
173139|NCT00857792|551758|P1|Overall Study|inadequate image quality for analysis|12
173140|NCT00857818|551764|P2|Overall Study|Investigator decision|0
173141|NCT00857818|551765|P1|Overall Study|Investigator decision|1
173142|NCT00857818|551764|P2|Overall Study|Sponsor terminated study|4
173143|NCT00857818|551765|P1|Overall Study|Sponsor terminated study|6
173144|NCT00857818|551764|P2|Overall Study|Withdrawal by Subject|4
173145|NCT00857818|551765|P1|Overall Study|Withdrawal by Subject|0
173146|NCT00857818|551764|P2|Overall Study|Adverse Event|0
173147|NCT00857818|551765|P1|Overall Study|Adverse Event|3
173148|NCT00857818|551764|P2|Overall Study|Lack of Efficacy|0
173149|NCT00857818|551765|P1|Overall Study|Lack of Efficacy|1
173150|NCT00857896|551793|P1|Baseline to Week 4|Withdrawal by Subject|1
173151|NCT00857948|551809|P4|Overall Study|Protocol Violation|0
173152|NCT00857948|551810|P3|Overall Study|Protocol Violation|1
173153|NCT00857948|551811|P2|Overall Study|Protocol Violation|0
173154|NCT00857948|551812|P1|Overall Study|Protocol Violation|1
173155|NCT00857948|551809|P4|Overall Study|Withdrawal by Subject|0
173156|NCT00857948|551810|P3|Overall Study|Withdrawal by Subject|0
173157|NCT00857948|551811|P2|Overall Study|Withdrawal by Subject|0
173158|NCT00857948|551812|P1|Overall Study|Withdrawal by Subject|2
173159|NCT00858143|551885|P1|Overall Study|Other|23
173160|NCT00858143|551885|P1|Overall Study|Death|7
173161|NCT00858143|551885|P1|Overall Study|Lack of Efficacy|4
173162|NCT00858143|551885|P1|Overall Study|Adverse Event|16
173163|NCT00858208|551934|P1|Overall Study|Unspecified|10
173164|NCT00858208|551934|P1|Overall Study|Participant refused|40
173165|NCT00858208|551934|P1|Overall Study|Lost to Follow-up|26
173166|NCT00858208|551934|P1|Overall Study|Adverse Event|3
173167|NCT00858247|551953|P2|Week 12 Follow-up|Withdrawal by Subject|1
173168|NCT00858247|551954|P1|Week 12 Follow-up|Withdrawal by Subject|0
173169|NCT00858247|551953|P2|Baseline Assessment|Protocol Violation|1
173170|NCT00858247|551954|P1|Baseline Assessment|Protocol Violation|0
173171|NCT00858247|551953|P2|Baseline Assessment|Poor IV access|0
173172|NCT00858247|551954|P1|Baseline Assessment|Poor IV access|1
173173|NCT00858247|551953|P2|Baseline Assessment|Withdrawal by Subject|1
173174|NCT00858247|551954|P1|Baseline Assessment|Withdrawal by Subject|1
173175|NCT00858403|551979|P1|Overall Study|Disease Progression|1
173176|NCT00858403|551979|P1|Overall Study|Death|3
173177|NCT00858403|551979|P1|Overall Study|Withdrawal by Subject|1
173178|NCT00858442|551991|P2|Compression:Start to Finish|Lost to Follow-up|3
173179|NCT00858442|551992|P1|Compression:Start to Finish|Lost to Follow-up|1
173180|NCT00858637|552033|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
173181|NCT00858637|552034|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
173182|NCT00858637|552035|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
173183|NCT00858637|552036|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
173184|NCT00858637|552037|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
173185|NCT00858637|552038|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
173186|NCT00858637|552033|P6|Placebo-controlled Withdrawal Phase|Death|0
173187|NCT00858637|552034|P5|Placebo-controlled Withdrawal Phase|Death|1
173188|NCT00858637|552035|P4|Placebo-controlled Withdrawal Phase|Death|0
173189|NCT00858637|552036|P3|Placebo-controlled Withdrawal Phase|Death|1
173190|NCT00858637|552037|P2|Placebo-controlled Withdrawal Phase|Death|0
173191|NCT00858637|552038|P1|Placebo-controlled Withdrawal Phase|Death|0
173192|NCT00858637|552033|P6|Active Comparison Phase|Other Reasons|0
173193|NCT00858637|552034|P5|Active Comparison Phase|Other Reasons|0
173194|NCT00858637|552035|P4|Active Comparison Phase|Other Reasons|1
173195|NCT00858637|552036|P3|Active Comparison Phase|Other Reasons|0
173196|NCT00858637|552037|P2|Active Comparison Phase|Other Reasons|0
173197|NCT00858637|552038|P1|Active Comparison Phase|Other Reasons|1
173198|NCT00858637|552033|P6|Active Comparison Phase|Withdrawal by Subject|0
173199|NCT00858637|552034|P5|Active Comparison Phase|Withdrawal by Subject|0
173200|NCT00858637|552035|P4|Active Comparison Phase|Withdrawal by Subject|6
173201|NCT00858637|552036|P3|Active Comparison Phase|Withdrawal by Subject|0
173202|NCT00858637|552037|P2|Active Comparison Phase|Withdrawal by Subject|0
173203|NCT00858637|552038|P1|Active Comparison Phase|Withdrawal by Subject|7
173204|NCT00858637|552033|P6|Active Comparison Phase|Physician Decision|0
173205|NCT00858637|552034|P5|Active Comparison Phase|Physician Decision|0
173206|NCT00858637|552035|P4|Active Comparison Phase|Physician Decision|1
173207|NCT00858637|552036|P3|Active Comparison Phase|Physician Decision|0
173208|NCT00858637|552037|P2|Active Comparison Phase|Physician Decision|0
173209|NCT00858637|552038|P1|Active Comparison Phase|Physician Decision|1
173210|NCT00858637|552033|P6|Active Comparison Phase|Death|0
173211|NCT00858637|552034|P5|Active Comparison Phase|Death|0
173212|NCT00858637|552035|P4|Active Comparison Phase|Death|1
173213|NCT00858637|552036|P3|Active Comparison Phase|Death|0
173214|NCT00858637|552037|P2|Active Comparison Phase|Death|0
173215|NCT00858637|552038|P1|Active Comparison Phase|Death|1
173216|NCT00858637|552033|P6|Active Comparison Phase|Adverse Event|0
173217|NCT00858637|552034|P5|Active Comparison Phase|Adverse Event|0
173218|NCT00858637|552035|P4|Active Comparison Phase|Adverse Event|9
173219|NCT00858637|552036|P3|Active Comparison Phase|Adverse Event|0
173220|NCT00858637|552037|P2|Active Comparison Phase|Adverse Event|0
173221|NCT00858637|552038|P1|Active Comparison Phase|Adverse Event|14
173223|NCT00852397|552052|P2|Overall Study|Protocol Violation|0
173224|NCT00852397|552053|P1|Overall Study|Protocol Violation|0
173225|NCT00852397|552051|P3|Overall Study|Difficulty in study site visit|0
173226|NCT00852397|552052|P2|Overall Study|Difficulty in study site visit|0
173227|NCT00852397|552053|P1|Overall Study|Difficulty in study site visit|1
173228|NCT00852397|552051|P3|Overall Study|Study terminated by sponsor|6
173229|NCT00852397|552052|P2|Overall Study|Study terminated by sponsor|1
173230|NCT00852397|552053|P1|Overall Study|Study terminated by sponsor|2
173231|NCT00852397|552051|P3|Overall Study|Withdrawal by Subject|2
173232|NCT00852397|552052|P2|Overall Study|Withdrawal by Subject|1
173233|NCT00852397|552053|P1|Overall Study|Withdrawal by Subject|4
173234|NCT00852397|552051|P3|Overall Study|Death|1
173235|NCT00852397|552052|P2|Overall Study|Death|0
173236|NCT00852397|552053|P1|Overall Study|Death|0
173237|NCT00852397|552051|P3|Overall Study|Adverse Event|4
173238|NCT00852397|552052|P2|Overall Study|Adverse Event|6
173239|NCT00852397|552053|P1|Overall Study|Adverse Event|4
173240|NCT00852475|552084|P2|Overall Study|Lost to Follow-up|4
173241|NCT00852475|552085|P1|Overall Study|Lost to Follow-up|3
173242|NCT00852540|552101|P2|Overall Study|Did Not Receive Study Drug|3
173243|NCT00852540|552102|P1|Overall Study|Did Not Receive Study Drug|3
173244|NCT00852540|552101|P2|Overall Study|Withdrawal by Subject|1
173245|NCT00852540|552102|P1|Overall Study|Withdrawal by Subject|3
173246|NCT00852540|552101|P2|Overall Study|Investigator Discretion|3
173247|NCT00852540|552102|P1|Overall Study|Investigator Discretion|2
173248|NCT00852540|552101|P2|Overall Study|Lost to Follow-up|3
173249|NCT00852540|552102|P1|Overall Study|Lost to Follow-up|2
173250|NCT00852540|552101|P2|Overall Study|Protocol Violation|2
173251|NCT00852540|552102|P1|Overall Study|Protocol Violation|1
173252|NCT00852540|552101|P2|Overall Study|Lack of Efficacy|3
173253|NCT00852540|552102|P1|Overall Study|Lack of Efficacy|15
173254|NCT00852540|552101|P2|Overall Study|Adverse Event|3
173255|NCT00852540|552102|P1|Overall Study|Adverse Event|10
173256|NCT00852917|552194|P4|Overall Study|Death|1
173257|NCT00852917|552195|P3|Overall Study|Death|0
173258|NCT00852917|552196|P2|Overall Study|Death|0
173259|NCT00852917|552197|P1|Overall Study|Death|0
173260|NCT00852917|552194|P4|Overall Study|Physician Decision|19
173261|NCT00852917|552195|P3|Overall Study|Physician Decision|2
173262|NCT00852917|552196|P2|Overall Study|Physician Decision|7
173263|NCT00852917|552197|P1|Overall Study|Physician Decision|6
173264|NCT00852917|552194|P4|Overall Study|Withdrawal by Subject|9
173265|NCT00852917|552195|P3|Overall Study|Withdrawal by Subject|10
173266|NCT00852917|552196|P2|Overall Study|Withdrawal by Subject|8
173267|NCT00852917|552197|P1|Overall Study|Withdrawal by Subject|4
173268|NCT00852917|552194|P4|Overall Study|Lack of Efficacy|47
173269|NCT00852917|552195|P3|Overall Study|Lack of Efficacy|11
173270|NCT00852917|552196|P2|Overall Study|Lack of Efficacy|11
173271|NCT00852917|552197|P1|Overall Study|Lack of Efficacy|21
173272|NCT00852917|552194|P4|Overall Study|Adverse Event|17
173273|NCT00852917|552195|P3|Overall Study|Adverse Event|35
173274|NCT00852917|552196|P2|Overall Study|Adverse Event|20
173275|NCT00852917|552197|P1|Overall Study|Adverse Event|13
173276|NCT00852930|552238|P3|Overall Study|Physician Decision|1
173277|NCT00852930|552239|P2|Overall Study|Physician Decision|0
173278|NCT00852930|552240|P1|Overall Study|Physician Decision|0
173279|NCT00852930|552238|P3|Overall Study|Withdrawal by Subject|1
173280|NCT00852930|552239|P2|Overall Study|Withdrawal by Subject|1
173281|NCT00852930|552240|P1|Overall Study|Withdrawal by Subject|1
173282|NCT00852969|552259|P2|Overall Study|Lost to Follow-up|1
173283|NCT00852969|552260|P1|Overall Study|Lost to Follow-up|0
173284|NCT00852969|552259|P2|Overall Study|Adverse Event|1
173285|NCT00852969|552260|P1|Overall Study|Adverse Event|0
173286|NCT00852995|552273|P5|Overall Study|Moved Out of Area|0
173287|NCT00852995|552274|P4|Overall Study|Moved Out of Area|0
173288|NCT00852995|552275|P3|Overall Study|Moved Out of Area|0
173289|NCT00852995|552276|P2|Overall Study|Moved Out of Area|0
173290|NCT00852995|552277|P1|Overall Study|Moved Out of Area|1
173291|NCT00852995|552273|P5|Overall Study|Protocol Violation|1
173292|NCT00852995|552274|P4|Overall Study|Protocol Violation|0
173293|NCT00852995|552275|P3|Overall Study|Protocol Violation|0
173294|NCT00852995|552276|P2|Overall Study|Protocol Violation|0
173295|NCT00852995|552277|P1|Overall Study|Protocol Violation|0
173296|NCT00852995|552273|P5|Overall Study|Physician Decision|0
173297|NCT00852995|552274|P4|Overall Study|Physician Decision|0
173298|NCT00852995|552275|P3|Overall Study|Physician Decision|0
173299|NCT00852995|552276|P2|Overall Study|Physician Decision|0
173300|NCT00852995|552277|P1|Overall Study|Physician Decision|1
173301|NCT00852995|552273|P5|Overall Study|Progressive Disease|1
173302|NCT00852995|552274|P4|Overall Study|Progressive Disease|2
173303|NCT00852995|552275|P3|Overall Study|Progressive Disease|0
173304|NCT00852995|552276|P2|Overall Study|Progressive Disease|0
173305|NCT00852995|552277|P1|Overall Study|Progressive Disease|1
173306|NCT00852995|552273|P5|Overall Study|Non-Compliance|0
173307|NCT00852995|552274|P4|Overall Study|Non-Compliance|2
173308|NCT00852995|552275|P3|Overall Study|Non-Compliance|0
173309|NCT00852995|552276|P2|Overall Study|Non-Compliance|0
173310|NCT00852995|552277|P1|Overall Study|Non-Compliance|0
173311|NCT00852995|552273|P5|Overall Study|Withdrawal by Subject|2
173312|NCT00852995|552274|P4|Overall Study|Withdrawal by Subject|1
173313|NCT00852995|552275|P3|Overall Study|Withdrawal by Subject|0
173314|NCT00852995|552276|P2|Overall Study|Withdrawal by Subject|0
173315|NCT00852995|552277|P1|Overall Study|Withdrawal by Subject|4
173316|NCT00852995|552273|P5|Overall Study|Lost to Follow-up|0
173317|NCT00852995|552274|P4|Overall Study|Lost to Follow-up|0
173318|NCT00852995|552275|P3|Overall Study|Lost to Follow-up|1
173319|NCT00852995|552276|P2|Overall Study|Lost to Follow-up|1
173320|NCT00852995|552277|P1|Overall Study|Lost to Follow-up|0
173321|NCT00852995|552273|P5|Overall Study|Adverse Event|0
173322|NCT00852995|552274|P4|Overall Study|Adverse Event|0
173323|NCT00852995|552275|P3|Overall Study|Adverse Event|4
173324|NCT00852995|552276|P2|Overall Study|Adverse Event|0
173325|NCT00852995|552277|P1|Overall Study|Adverse Event|1
173326|NCT00853021|552319|P1|Overall Study|Death|1
173327|NCT00853021|552319|P1|Overall Study|Withdrawal by Subject|2
173328|NCT00853021|552319|P1|Overall Study|Adverse Event|2
173329|NCT00853073|552328|P2|Overall Study|Withdrawal by Subject|2
173330|NCT00853073|552329|P1|Overall Study|Withdrawal by Subject|3
173331|NCT00853099|552338|P4|Double-blind + Open-label Periods|Not Specified|6
173332|NCT00853099|552339|P3|Double-blind + Open-label Periods|Not Specified|0
173333|NCT00853099|552340|P2|Double-blind + Open-label Periods|Not Specified|0
173334|NCT00853099|552341|P1|Double-blind + Open-label Periods|Not Specified|0
173335|NCT00853099|552338|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
173336|NCT00853099|552339|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
173337|NCT00853099|552340|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
173338|NCT00853099|552341|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
173339|NCT00853099|552338|P4|Double-blind + Open-label Periods|Adverse Event|47
173340|NCT00853099|552339|P3|Double-blind + Open-label Periods|Adverse Event|0
173341|NCT00853099|552340|P2|Double-blind + Open-label Periods|Adverse Event|0
173342|NCT00853099|552341|P1|Double-blind + Open-label Periods|Adverse Event|0
173343|NCT00853099|552338|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
173344|NCT00853099|552339|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
173345|NCT00853099|552340|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
173346|NCT00853099|552341|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
173347|NCT00853099|552338|P4|Double-blind Period|Mistreated with rescue study drug|0
173348|NCT00853099|552339|P3|Double-blind Period|Mistreated with rescue study drug|1
173349|NCT00853099|552340|P2|Double-blind Period|Mistreated with rescue study drug|0
173350|NCT00853099|552341|P1|Double-blind Period|Mistreated with rescue study drug|0
173351|NCT00853099|552338|P4|Double-blind Period|Not Specified|0
173352|NCT00853099|552339|P3|Double-blind Period|Not Specified|1
173353|NCT00853099|552340|P2|Double-blind Period|Not Specified|0
173354|NCT00853099|552341|P1|Double-blind Period|Not Specified|0
173355|NCT00853099|552338|P4|Double-blind Period|Lack of Efficacy|0
173356|NCT00853099|552339|P3|Double-blind Period|Lack of Efficacy|16
173357|NCT00853099|552340|P2|Double-blind Period|Lack of Efficacy|17
173358|NCT00853099|552341|P1|Double-blind Period|Lack of Efficacy|14
173359|NCT00853099|552338|P4|Double-blind Period|Withdrawal by Subject|0
173360|NCT00853099|552339|P3|Double-blind Period|Withdrawal by Subject|0
173361|NCT00853099|552340|P2|Double-blind Period|Withdrawal by Subject|3
173362|NCT00853099|552341|P1|Double-blind Period|Withdrawal by Subject|2
173363|NCT00853099|552338|P4|Double-blind Period|Adverse Event|0
173364|NCT00853099|552339|P3|Double-blind Period|Adverse Event|13
173365|NCT00853099|552340|P2|Double-blind Period|Adverse Event|9
173366|NCT00853099|552341|P1|Double-blind Period|Adverse Event|7
173367|NCT00853151|552385|P4|Overall Study|Sponsor Decision|0
173368|NCT00853151|552386|P3|Overall Study|Sponsor Decision|0
173369|NCT00853151|552387|P2|Overall Study|Sponsor Decision|3
173370|NCT00853151|552388|P1|Overall Study|Sponsor Decision|0
173371|NCT00853151|552385|P4|Overall Study|Physician Decision|0
173372|NCT00853151|552386|P3|Overall Study|Physician Decision|1
173373|NCT00853151|552387|P2|Overall Study|Physician Decision|2
173374|NCT00853151|552388|P1|Overall Study|Physician Decision|0
173375|NCT00853151|552385|P4|Overall Study|Withdrawal by Subject|1
173376|NCT00853151|552386|P3|Overall Study|Withdrawal by Subject|2
173377|NCT00853151|552387|P2|Overall Study|Withdrawal by Subject|4
173378|NCT00853151|552388|P1|Overall Study|Withdrawal by Subject|5
173379|NCT00853151|552385|P4|Overall Study|Protocol Violation|1
173380|NCT00853151|552386|P3|Overall Study|Protocol Violation|0
173381|NCT00853151|552387|P2|Overall Study|Protocol Violation|0
173382|NCT00853151|552388|P1|Overall Study|Protocol Violation|0
173383|NCT00853151|552385|P4|Overall Study|Death|1
173384|NCT00853151|552386|P3|Overall Study|Death|0
173385|NCT00853151|552387|P2|Overall Study|Death|0
173386|NCT00853151|552388|P1|Overall Study|Death|1
173387|NCT00853151|552385|P4|Overall Study|Lost to Follow-up|0
173388|NCT00853151|552386|P3|Overall Study|Lost to Follow-up|3
173389|NCT00853151|552387|P2|Overall Study|Lost to Follow-up|0
173390|NCT00853151|552388|P1|Overall Study|Lost to Follow-up|2
173391|NCT00853151|552385|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
173392|NCT00853151|552386|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
173393|NCT00853151|552387|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
173394|NCT00853151|552388|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
173395|NCT00853151|552385|P4|Overall Study|Adverse Event|0
173396|NCT00853151|552386|P3|Overall Study|Adverse Event|2
173397|NCT00853151|552387|P2|Overall Study|Adverse Event|4
173398|NCT00853151|552388|P1|Overall Study|Adverse Event|1
173399|NCT00853229|552532|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
173400|NCT00853229|552533|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
173401|NCT00853242|552546|P7|Overall Study|Unspecified|2
173402|NCT00853242|552547|P6|Overall Study|Unspecified|1
173403|NCT00853242|552548|P5|Overall Study|Unspecified|0
173404|NCT00853242|552549|P4|Overall Study|Unspecified|0
173405|NCT00853242|552550|P3|Overall Study|Unspecified|2
173406|NCT00853242|552551|P2|Overall Study|Unspecified|0
173407|NCT00853242|552552|P1|Overall Study|Unspecified|2
173408|NCT00853242|552546|P7|Overall Study|Withdrawal by Subject|2
173409|NCT00853242|552547|P6|Overall Study|Withdrawal by Subject|0
173410|NCT00853242|552548|P5|Overall Study|Withdrawal by Subject|0
173411|NCT00853242|552549|P4|Overall Study|Withdrawal by Subject|4
173412|NCT00853242|552550|P3|Overall Study|Withdrawal by Subject|0
173413|NCT00853242|552551|P2|Overall Study|Withdrawal by Subject|2
173414|NCT00853242|552552|P1|Overall Study|Withdrawal by Subject|1
173415|NCT00853242|552546|P7|Overall Study|Noncompliant|0
173416|NCT00853242|552547|P6|Overall Study|Noncompliant|0
173417|NCT00853242|552548|P5|Overall Study|Noncompliant|1
173418|NCT00853242|552549|P4|Overall Study|Noncompliant|0
173419|NCT00853242|552550|P3|Overall Study|Noncompliant|0
173420|NCT00853242|552551|P2|Overall Study|Noncompliant|0
173421|NCT00853242|552552|P1|Overall Study|Noncompliant|0
173422|NCT00853242|552546|P7|Overall Study|Adverse Event|1
173423|NCT00853242|552547|P6|Overall Study|Adverse Event|1
173424|NCT00853242|552548|P5|Overall Study|Adverse Event|3
173425|NCT00853242|552549|P4|Overall Study|Adverse Event|0
173426|NCT00853242|552550|P3|Overall Study|Adverse Event|1
173427|NCT00853242|552551|P2|Overall Study|Adverse Event|1
173428|NCT00853242|552552|P1|Overall Study|Adverse Event|0
173429|NCT00858702|552599|P2|Overall Study|Withdrawal by Subject|0
173430|NCT00858702|552600|P1|Overall Study|Withdrawal by Subject|1
173431|NCT00858702|552599|P2|Overall Study|Other|1
173432|NCT00858702|552600|P1|Overall Study|Other|2
173433|NCT00858702|552599|P2|Overall Study|Protocol Violation|1
173434|NCT00858702|552600|P1|Overall Study|Protocol Violation|1
173435|NCT00858702|552599|P2|Overall Study|Lack of Efficacy|0
173436|NCT00858702|552600|P1|Overall Study|Lack of Efficacy|1
173437|NCT00858780|552610|P5|OL Re-Treatment (Failure to Week 48)|Unspecified|1
173438|NCT00858780|552611|P4|OL Re-Treatment (Failure to Week 48)|Unspecified|0
173439|NCT00858780|552612|P3|OL Re-Treatment (Failure to Week 48)|Unspecified|0
173440|NCT00858780|552613|P2|OL Re-Treatment (Failure to Week 48)|Unspecified|0
173441|NCT00858780|552614|P1|OL Re-Treatment (Failure to Week 48)|Unspecified|0
173442|NCT00858780|552610|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
173443|NCT00858780|552611|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
173444|NCT00858780|552612|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
173445|NCT00858780|552613|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
173446|NCT00858780|552614|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
173447|NCT00858780|552610|P5|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
173448|NCT00858780|552611|P4|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
173449|NCT00858780|552612|P3|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
173450|NCT00858780|552613|P2|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|1
173451|NCT00858780|552614|P1|Double-Blind (Week 0 to Failure/Week 48)|Unspecified|0
173452|NCT00858780|552610|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
173453|NCT00858780|552611|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
173454|NCT00858780|552612|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
173455|NCT00858780|552613|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
173456|NCT00858780|552614|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
173457|NCT00858780|552610|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
173458|NCT00858780|552611|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
173459|NCT00858780|552612|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
173460|NCT00858780|552613|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
173461|NCT00858780|552614|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
173462|NCT00858780|552610|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
173463|NCT00858780|552611|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
173464|NCT00858780|552612|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
173465|NCT00858780|552613|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
173466|NCT00858780|552614|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
173467|NCT00858832|552689|P2|Overall Study|Adverse Event|1
173468|NCT00858832|552690|P1|Overall Study|Adverse Event|0
173469|NCT00858832|552689|P2|Overall Study|became ineligible: delivered vaginally|0
173470|NCT00858832|552690|P1|Overall Study|became ineligible: delivered vaginally|1
173471|NCT00858845|552696|P1|Overall Study|Patient underwent heart transplant.|1
173472|NCT00859014|552708|P1|Overall Study|Lost to Follow-up|1
173473|NCT00859014|552708|P1|Overall Study|Death|4
173474|NCT00859430|552715|P2|First Intervention|Withdrawal by Subject|1
173475|NCT00859430|552716|P1|First Intervention|Withdrawal by Subject|0
173476|NCT00859469|552724|P1|Overall Study|Death|16
173477|NCT00859469|552724|P1|Overall Study|Withdrawal by Subject|1
173478|NCT00859469|552724|P1|Overall Study|Lack of Efficacy|9
173479|NCT00859469|552724|P1|Overall Study|Adverse Event|2
173480|NCT00859521|552741|P2|Washout|Withdrawal by Subject|1
173481|NCT00859521|552742|P1|Washout|Withdrawal by Subject|0
173482|NCT00859547|552750|P1|Overall Study|Parent withdrew consent|1
173483|NCT00859547|552750|P1|Overall Study|Lost to Follow-up|1
173484|NCT00859573|552763|P2|Overall Study|Physician Decision|1
173485|NCT00859573|552764|P1|Overall Study|Physician Decision|1
173486|NCT00859573|552763|P2|Overall Study|Withdrawal by Subject|1
173487|NCT00859573|552764|P1|Overall Study|Withdrawal by Subject|4
173488|NCT00859586|552770|P1|Overall Study|Donors|4
173489|NCT00859638|552776|P2|Overall Study|Ill health|1
173490|NCT00859638|552777|P1|Overall Study|Ill health|1
173491|NCT00859638|552776|P2|Overall Study|Withdrawal by Subject|2
173492|NCT00859638|552777|P1|Overall Study|Withdrawal by Subject|3
173493|NCT00859638|552776|P2|Overall Study|Lost to Follow-up|1
173494|NCT00859638|552777|P1|Overall Study|Lost to Follow-up|6
173495|NCT00859898|552791|P3|Overall Study|non-specified|1
173496|NCT00859898|552792|P2|Overall Study|non-specified|1
173497|NCT00859898|552793|P1|Overall Study|non-specified|1
173498|NCT00859898|552791|P3|Overall Study|No longer meets criteria|0
173499|NCT00859898|552792|P2|Overall Study|No longer meets criteria|1
173500|NCT00859898|552793|P1|Overall Study|No longer meets criteria|0
173501|NCT00859898|552791|P3|Overall Study|poor/non-compliance|0
173502|NCT00859898|552792|P2|Overall Study|poor/non-compliance|0
173503|NCT00859898|552793|P1|Overall Study|poor/non-compliance|2
173504|NCT00859898|552791|P3|Overall Study|Lost to Follow-up|5
173505|NCT00859898|552792|P2|Overall Study|Lost to Follow-up|11
173506|NCT00859898|552793|P1|Overall Study|Lost to Follow-up|10
173507|NCT00859898|552791|P3|Overall Study|Death|1
173508|NCT00859898|552792|P2|Overall Study|Death|0
173509|NCT00859898|552793|P1|Overall Study|Death|0
173510|NCT00859898|552791|P3|Overall Study|Withdrawal by Subject|11
173511|NCT00859898|552792|P2|Overall Study|Withdrawal by Subject|8
173512|NCT00859898|552793|P1|Overall Study|Withdrawal by Subject|11
173513|NCT00859898|552791|P3|Overall Study|Adverse Event|8
173514|NCT00859898|552792|P2|Overall Study|Adverse Event|9
173515|NCT00859898|552793|P1|Overall Study|Adverse Event|4
173516|NCT00859898|552791|P3|Overall Study|Lack of Efficacy|1
173517|NCT00859898|552792|P2|Overall Study|Lack of Efficacy|1
173518|NCT00859898|552793|P1|Overall Study|Lack of Efficacy|0
173519|NCT00859937|552836|P2|Overall Study|Protocol Violation|0
173520|NCT00859937|552837|P1|Overall Study|Protocol Violation|1
173521|NCT00860028|552860|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
173522|NCT00860028|552861|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
173523|NCT00860067|552874|P3|Overall Study|Pregnancy|0
173524|NCT00860067|552875|P2|Overall Study|Pregnancy|0
173525|NCT00860067|552876|P1|Overall Study|Pregnancy|1
173526|NCT00860067|552874|P3|Overall Study|Withdrawal by Subject|0
173527|NCT00860067|552875|P2|Overall Study|Withdrawal by Subject|0
173528|NCT00860067|552876|P1|Overall Study|Withdrawal by Subject|4
173529|NCT00860067|552874|P3|Overall Study|Lost to Follow-up|9
173530|NCT00860067|552875|P2|Overall Study|Lost to Follow-up|9
173531|NCT00860067|552876|P1|Overall Study|Lost to Follow-up|46
173532|NCT00860158|552934|P1|Overall Study|Study Terminated|1
173533|NCT00860249|552945|P3|Overall Study|trial was terminated prior to completion|21
173534|NCT00860249|552946|P2|Overall Study|trial was terminated prior to completion|18
173535|NCT00860249|552947|P1|Overall Study|trial was terminated prior to completion|21
173536|NCT00860262|552961|P3|Overall Study|Not Specified|1
173537|NCT00860262|552962|P2|Overall Study|Not Specified|3
173538|NCT00860262|552963|P1|Overall Study|Not Specified|5
173539|NCT00860262|552961|P3|Overall Study|Lack of Efficacy|3
173540|NCT00860262|552962|P2|Overall Study|Lack of Efficacy|4
173541|NCT00860262|552963|P1|Overall Study|Lack of Efficacy|0
173542|NCT00860262|552961|P3|Overall Study|Withdrawal by Subject|6
173543|NCT00860262|552962|P2|Overall Study|Withdrawal by Subject|8
173544|NCT00860262|552963|P1|Overall Study|Withdrawal by Subject|4
173545|NCT00860262|552961|P3|Overall Study|Lost to Follow-up|1
173546|NCT00860262|552962|P2|Overall Study|Lost to Follow-up|0
173547|NCT00860262|552963|P1|Overall Study|Lost to Follow-up|2
173548|NCT00860262|552961|P3|Overall Study|Protocol Violation|0
173549|NCT00860262|552962|P2|Overall Study|Protocol Violation|1
173550|NCT00860262|552963|P1|Overall Study|Protocol Violation|0
173551|NCT00860262|552961|P3|Overall Study|Adverse Event|7
173552|NCT00860262|552962|P2|Overall Study|Adverse Event|6
173553|NCT00860262|552963|P1|Overall Study|Adverse Event|9
173554|NCT00860405|553090|P2|Overall Study|Main reason: Follow-up data not complete|4
173555|NCT00860405|553091|P1|Overall Study|Main reason: Follow-up data not complete|5
173556|NCT00860470|553119|P2|Overall Study|Lost to Follow-up|39
173557|NCT00860470|553120|P1|Overall Study|Lost to Follow-up|34
173558|NCT00860470|553119|P2|Overall Study|Moved away|10
173559|NCT00860470|553120|P1|Overall Study|Moved away|8
173560|NCT00860470|553119|P2|Overall Study|Death|10
173561|NCT00860470|553120|P1|Overall Study|Death|6
173562|NCT00860743|553155|P2|Overall Study|Withdrawal by Subject|0
173563|NCT00860743|553156|P1|Overall Study|Withdrawal by Subject|3
173564|NCT00860951|553192|P1|Overall Study|Lost to Follow-up|5
173565|NCT00860951|553192|P1|Overall Study|Withdrawal by Subject|2
173566|NCT00861198|553211|P1|Overall Study|SpyGlass Failed|5
173567|NCT00861341|553219|P1|Overall Study|Withdrawal by Subject|2
173568|NCT00861471|553224|P1|Overall Study|Physician Decision|2
173569|NCT00861471|553224|P1|Overall Study|treatment for lumbar laminectomy|1
173570|NCT00861471|553224|P1|Overall Study|Lack of Efficacy|3
173571|NCT00861471|553224|P1|Overall Study|Adverse Event|2
173572|NCT00861471|553224|P1|Overall Study|Withdrawal by Subject|1
173573|NCT00861614|553289|P2|Overall Study|Unspecified|22
173574|NCT00861614|553290|P1|Overall Study|Unspecified|17
173575|NCT00861614|553289|P2|Overall Study|Withdrawal by Subject|35
173576|NCT00861614|553290|P1|Overall Study|Withdrawal by Subject|34
173577|NCT00861614|553289|P2|Overall Study|Adverse Event|23
173578|NCT00861614|553290|P1|Overall Study|Adverse Event|27
173579|NCT00861614|553289|P2|Overall Study|Death|19
173580|NCT00861614|553290|P1|Overall Study|Death|32
173581|NCT00861614|553289|P2|Overall Study|Study Drug Toxicity|6
173582|NCT00861614|553290|P1|Overall Study|Study Drug Toxicity|79
173583|NCT00861614|553289|P2|Overall Study|Disease Progression|263
173584|NCT00861614|553290|P1|Overall Study|Disease Progression|182
173585|NCT00861692|553320|P1|Overall Study|Death|6
173586|NCT00861705|553334|P4|Overall Study|Never Began Treatment|1
173587|NCT00861705|553335|P3|Overall Study|Never Began Treatment|0
173588|NCT00861705|553336|P2|Overall Study|Never Began Treatment|3
173589|NCT00861705|553337|P1|Overall Study|Never Began Treatment|7
173590|NCT00861744|553357|P4|Overall Study|Blood draws|1
173591|NCT00861744|553358|P3|Overall Study|Blood draws|0
173592|NCT00861744|553359|P2|Overall Study|Blood draws|0
173593|NCT00861744|553360|P1|Overall Study|Blood draws|0
173594|NCT00861744|553357|P4|Overall Study|Migration from study area|0
173595|NCT00861744|553358|P3|Overall Study|Migration from study area|1
173596|NCT00861744|553359|P2|Overall Study|Migration from study area|3
173597|NCT00861744|553360|P1|Overall Study|Migration from study area|0
173598|NCT00861744|553357|P4|Overall Study|Protocol Violation|0
173599|NCT00861744|553358|P3|Overall Study|Protocol Violation|0
173600|NCT00861744|553359|P2|Overall Study|Protocol Violation|1
173601|NCT00861744|553360|P1|Overall Study|Protocol Violation|0
173602|NCT00861744|553357|P4|Overall Study|Withdrawal by Subject|19
173603|NCT00861744|553358|P3|Overall Study|Withdrawal by Subject|6
173604|NCT00861744|553359|P2|Overall Study|Withdrawal by Subject|6
173605|NCT00861744|553360|P1|Overall Study|Withdrawal by Subject|10
173606|NCT00861744|553357|P4|Overall Study|Lost to Follow-up|12
173607|NCT00861744|553358|P3|Overall Study|Lost to Follow-up|17
173608|NCT00861744|553359|P2|Overall Study|Lost to Follow-up|19
173609|NCT00861744|553360|P1|Overall Study|Lost to Follow-up|7
173610|NCT00861744|553357|P4|Overall Study|Adverse Event|1
173611|NCT00861744|553358|P3|Overall Study|Adverse Event|0
173612|NCT00861744|553359|P2|Overall Study|Adverse Event|0
173613|NCT00861744|553360|P1|Overall Study|Adverse Event|0
173614|NCT00861757|553542|P4|Overall Study|Withdrawal by Subject|2
173615|NCT00861757|553543|P3|Overall Study|Withdrawal by Subject|5
173616|NCT00861757|553544|P2|Overall Study|Withdrawal by Subject|5
173617|NCT00861757|553545|P1|Overall Study|Withdrawal by Subject|1
173618|NCT00861757|553542|P4|Overall Study|Protocol Violation|1
173619|NCT00861757|553543|P3|Overall Study|Protocol Violation|4
173620|NCT00861757|553544|P2|Overall Study|Protocol Violation|2
173621|NCT00861757|553545|P1|Overall Study|Protocol Violation|2
173622|NCT00861757|553542|P4|Overall Study|Physician Decision|1
173623|NCT00861757|553543|P3|Overall Study|Physician Decision|0
173624|NCT00861757|553544|P2|Overall Study|Physician Decision|0
173625|NCT00861757|553545|P1|Overall Study|Physician Decision|0
173626|NCT00861757|553542|P4|Overall Study|Lost to Follow-up|1
173627|NCT00861757|553543|P3|Overall Study|Lost to Follow-up|1
173628|NCT00861757|553544|P2|Overall Study|Lost to Follow-up|0
173629|NCT00861757|553545|P1|Overall Study|Lost to Follow-up|1
173630|NCT00861757|553542|P4|Overall Study|Lack of Efficacy|1
173631|NCT00861757|553543|P3|Overall Study|Lack of Efficacy|0
173632|NCT00861757|553544|P2|Overall Study|Lack of Efficacy|1
173633|NCT00861757|553545|P1|Overall Study|Lack of Efficacy|3
173634|NCT00861757|553542|P4|Overall Study|Entry Criteria Not Met|1
173635|NCT00861757|553543|P3|Overall Study|Entry Criteria Not Met|1
173636|NCT00861757|553544|P2|Overall Study|Entry Criteria Not Met|2
173637|NCT00861757|553545|P1|Overall Study|Entry Criteria Not Met|1
173638|NCT00861757|553542|P4|Overall Study|Adverse Event|2
173639|NCT00861757|553543|P3|Overall Study|Adverse Event|7
173640|NCT00861757|553544|P2|Overall Study|Adverse Event|5
173641|NCT00861757|553545|P1|Overall Study|Adverse Event|1
173642|NCT00856180|553599|P1|Overall Study|Progressive Disease|16
173643|NCT00856180|553599|P1|Overall Study|Adverse Event|4
173644|NCT00862082|553618|P2|Overall Study|Withdrawal by Subject|1
173645|NCT00862082|553619|P1|Overall Study|Withdrawal by Subject|0
173646|NCT00862082|553618|P2|Overall Study|Sponsor decision to terminate the study|0
173647|NCT00862082|553619|P1|Overall Study|Sponsor decision to terminate the study|5
173648|NCT00862121|553664|P2|Overall Study|Incorrect randomisation|1
173649|NCT00862121|553665|P1|Overall Study|Incorrect randomisation|0
173650|NCT00862121|553664|P2|Overall Study|Exclusion criterion violation|1
173651|NCT00862121|553665|P1|Overall Study|Exclusion criterion violation|0
173652|NCT00862121|553664|P2|Overall Study|Protocol Violation|1
173653|NCT00862121|553665|P1|Overall Study|Protocol Violation|0
173654|NCT00862121|553664|P2|Overall Study|Lack of Efficacy|3
173655|NCT00862121|553665|P1|Overall Study|Lack of Efficacy|0
173656|NCT00862121|553664|P2|Overall Study|Adverse Event|2
173657|NCT00862121|553665|P1|Overall Study|Adverse Event|1
173658|NCT00862134|553683|P2|Overall Study|Withdrew prior to dosing|0
173659|NCT00862134|553684|P1|Overall Study|Withdrew prior to dosing|2
173660|NCT00862134|553683|P2|Overall Study|Adverse Event|2
173661|NCT00862134|553684|P1|Overall Study|Adverse Event|2
173662|NCT00862134|553683|P2|Overall Study|Sponsor terminated study|7
173663|NCT00862134|553684|P1|Overall Study|Sponsor terminated study|5
173664|NCT00862134|553683|P2|Overall Study|Withdrawal by Subject|2
173665|NCT00862134|553684|P1|Overall Study|Withdrawal by Subject|1
173666|NCT00862134|553683|P2|Overall Study|Physician Decision|1
173667|NCT00862134|553684|P1|Overall Study|Physician Decision|0
173668|NCT00862134|553683|P2|Overall Study|Death|0
173669|NCT00862134|553684|P1|Overall Study|Death|1
173670|NCT00864851|553702|P3|Overall Study|Patient uncooperative|0
173671|NCT00864851|553703|P2|Overall Study|Patient uncooperative|0
173672|NCT00864851|553704|P1|Overall Study|Patient uncooperative|1
173673|NCT00864851|553702|P3|Overall Study|Death|0
173674|NCT00864851|553703|P2|Overall Study|Death|0
173675|NCT00864851|553704|P1|Overall Study|Death|1
173676|NCT00864851|553702|P3|Overall Study|Physician Decision|0
173677|NCT00864851|553703|P2|Overall Study|Physician Decision|0
173678|NCT00864851|553704|P1|Overall Study|Physician Decision|1
173679|NCT00864851|553702|P3|Overall Study|Withdrawal by Subject|0
173680|NCT00864851|553703|P2|Overall Study|Withdrawal by Subject|1
173681|NCT00864851|553704|P1|Overall Study|Withdrawal by Subject|0
173682|NCT00864916|553740|P2|Overall Study|Withdrawal by Subject|0
173683|NCT00864916|553741|P1|Overall Study|Withdrawal by Subject|1
173684|NCT00864916|553740|P2|Overall Study|Protocol Violation|0
173685|NCT00864916|553741|P1|Overall Study|Protocol Violation|1
173686|NCT00864916|553740|P2|Overall Study|Lost to Follow-up|4
173687|NCT00864916|553741|P1|Overall Study|Lost to Follow-up|4
173688|NCT00865020|553749|P2|Overall Study|Randomized but discontinued|4
173689|NCT00865020|553750|P1|Overall Study|Randomized but discontinued|2
173690|NCT00865020|553749|P2|Overall Study|Death|1
173691|NCT00865020|553750|P1|Overall Study|Death|0
173692|NCT00865020|553749|P2|Overall Study|Abnormal laboratory value(s)|1
173693|NCT00865020|553750|P1|Overall Study|Abnormal laboratory value(s)|0
173694|NCT00865020|553749|P2|Overall Study|Administrative problems|2
173695|NCT00865020|553750|P1|Overall Study|Administrative problems|0
173696|NCT00865020|553749|P2|Overall Study|Protocol deviation|1
173697|NCT00865020|553750|P1|Overall Study|Protocol deviation|4
173698|NCT00865020|553749|P2|Overall Study|Lost to Follow-up|4
173699|NCT00865020|553750|P1|Overall Study|Lost to Follow-up|6
173700|NCT00865020|553749|P2|Overall Study|Abnormal test procedure result(s)|8
173701|NCT00865020|553750|P1|Overall Study|Abnormal test procedure result(s)|6
173702|NCT00865020|553749|P2|Overall Study|Adverse Event|14
173703|NCT00865020|553750|P1|Overall Study|Adverse Event|9
173704|NCT00865020|553749|P2|Overall Study|Withdrawal by Subject|16
173705|NCT00865020|553750|P1|Overall Study|Withdrawal by Subject|22
173706|NCT00865046|553767|P3|Overall Study|Withdrawal by Subject|0
173707|NCT00865046|553768|P2|Overall Study|Withdrawal by Subject|0
173708|NCT00865046|553769|P1|Overall Study|Withdrawal by Subject|5
173709|NCT00865046|553767|P3|Overall Study|Death|1
173710|NCT00865046|553768|P2|Overall Study|Death|1
173711|NCT00865046|553769|P1|Overall Study|Death|0
173712|NCT00865046|553767|P3|Overall Study|Lost to Follow-up|0
173713|NCT00865046|553768|P2|Overall Study|Lost to Follow-up|4
173714|NCT00865046|553769|P1|Overall Study|Lost to Follow-up|1
173715|NCT00865098|553777|P1|Overall Study|Progressive disease|1
173716|NCT00865124|553789|P3|Overall Study|Withdrawn consent|0
173717|NCT00865124|553790|P2|Overall Study|Withdrawn consent|0
173718|NCT00865124|553791|P1|Overall Study|Withdrawn consent|2
173719|NCT00865124|553789|P3|Overall Study|Physician Decision|0
173720|NCT00865124|553790|P2|Overall Study|Physician Decision|1
173721|NCT00865124|553791|P1|Overall Study|Physician Decision|2
173722|NCT00865189|553810|P2|Overall Study|Withdrawal by Subject|0
173723|NCT00865189|553811|P1|Overall Study|Withdrawal by Subject|1
173724|NCT00865189|553810|P2|Overall Study|Lost to Follow-up|6
173725|NCT00865189|553811|P1|Overall Study|Lost to Follow-up|6
173726|NCT00865189|553810|P2|Overall Study|Death|11
173727|NCT00865189|553811|P1|Overall Study|Death|4
173728|NCT00865189|553810|P2|Overall Study|Unspecified|2
173729|NCT00865189|553811|P1|Overall Study|Unspecified|1
173730|NCT00865306|553855|P2|Controlled Trial|Withdrawal by Subject|1
173731|NCT00865306|553856|P1|Controlled Trial|Withdrawal by Subject|0
173732|NCT00865306|553855|P2|Controlled Trial|Sought treatment for conduct disorder|0
173733|NCT00865306|553856|P1|Controlled Trial|Sought treatment for conduct disorder|1
173734|NCT00865306|553855|P2|Controlled Trial|Improved btw baseline and first session|0
173735|NCT00865306|553856|P1|Controlled Trial|Improved btw baseline and first session|1
173736|NCT00865306|553855|P2|Controlled Trial|Difficulty commuting|0
173737|NCT00865306|553856|P1|Controlled Trial|Difficulty commuting|2
173738|NCT00865306|553855|P2|Controlled Trial|Lost to Follow-up|1
173739|NCT00865306|553856|P1|Controlled Trial|Lost to Follow-up|1
173740|NCT00865345|553866|P1|Overall Study|Withdrawal by Subject|2
173741|NCT00865514|553871|P1|Overall Study|Infusion cost exceeded funding|2
173742|NCT00865709|553878|P2|Treatment|Surgery|3
173743|NCT00865709|553879|P1|Treatment|Surgery|8
173744|NCT00865709|553878|P2|Treatment|Physician Decision|2
173745|NCT00865709|553879|P1|Treatment|Physician Decision|3
173746|NCT00865709|553878|P2|Treatment|Withdrawal by Subject|7
173747|NCT00865709|553879|P1|Treatment|Withdrawal by Subject|10
173748|NCT00865709|553878|P2|Treatment|Adverse Event|6
173749|NCT00865709|553879|P1|Treatment|Adverse Event|9
173750|NCT00865904|553900|P5|Overall Study|Randomized but not Treated|1
173751|NCT00865904|553901|P4|Overall Study|Randomized but not Treated|1
173752|NCT00865904|553902|P3|Overall Study|Randomized but not Treated|0
173753|NCT00865904|553903|P2|Overall Study|Randomized but not Treated|0
173754|NCT00865904|553904|P1|Overall Study|Randomized but not Treated|2
173755|NCT00866047|553970|P1|Follow-up Period|Lost to Follow-up|5
173756|NCT00866047|553970|P1|Treatment Period|Withdrawal by Subject|5
173757|NCT00866047|553970|P1|Treatment Period|Physician Decision|14
173758|NCT00866047|553970|P1|Treatment Period|Adverse Event|16
173759|NCT00866047|553970|P1|Treatment Period|Progressive disease|13
173760|NCT00866177|553986|P1|Overall Study|Not Treated|151
173761|NCT00866177|553986|P1|Overall Study|Withdrawal by Subject|1
173762|NCT00866281|553992|P2|Overall Study|New cancer therapy|4
173763|NCT00866281|553993|P1|Overall Study|New cancer therapy|0
173764|NCT00866281|553992|P2|Overall Study|Disease progression|11
173765|NCT00866281|553993|P1|Overall Study|Disease progression|3
173766|NCT00866281|553992|P2|Overall Study|Withdrawal by participants|0
173767|NCT00866281|553993|P1|Overall Study|Withdrawal by participants|3
173768|NCT00866281|553992|P2|Overall Study|Adverse Event|0
173769|NCT00866281|553993|P1|Overall Study|Adverse Event|1
173770|NCT00866294|554012|P3|Overall Study|Physician Decision|1
173771|NCT00866294|554013|P2|Overall Study|Physician Decision|2
173772|NCT00866294|554014|P1|Overall Study|Physician Decision|6
173773|NCT00866294|554012|P3|Overall Study|Lost to Follow-up|0
173774|NCT00866294|554013|P2|Overall Study|Lost to Follow-up|3
173775|NCT00866294|554014|P1|Overall Study|Lost to Follow-up|1
173776|NCT00866294|554012|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
173777|NCT00866294|554013|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
173778|NCT00866294|554014|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
173779|NCT00866294|554012|P3|Overall Study|Protocol Violation|0
173780|NCT00866294|554013|P2|Overall Study|Protocol Violation|0
173781|NCT00866294|554014|P1|Overall Study|Protocol Violation|2
173782|NCT00866294|554012|P3|Overall Study|Lack of Efficacy|0
173783|NCT00866294|554013|P2|Overall Study|Lack of Efficacy|1
173784|NCT00866294|554014|P1|Overall Study|Lack of Efficacy|7
173785|NCT00866294|554012|P3|Overall Study|Adverse Event|9
173786|NCT00866294|554013|P2|Overall Study|Adverse Event|13
173787|NCT00866294|554014|P1|Overall Study|Adverse Event|12
173788|NCT00866307|554041|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
173789|NCT00866307|554042|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
173790|NCT00866307|554043|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
173791|NCT00866307|554041|P3|Consolidation/Maintenance|Non-compliance|1
173792|NCT00866307|554042|P2|Consolidation/Maintenance|Non-compliance|0
173793|NCT00866307|554043|P1|Consolidation/Maintenance|Non-compliance|0
173794|NCT00866307|554041|P3|Consolidation/Maintenance|Therapy error|0
173795|NCT00866307|554042|P2|Consolidation/Maintenance|Therapy error|1
173796|NCT00866307|554043|P1|Consolidation/Maintenance|Therapy error|0
173797|NCT00866307|554041|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
173798|NCT00866307|554042|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
173799|NCT00866307|554043|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
173800|NCT00866307|554041|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
173801|NCT00866307|554042|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
173802|NCT00866307|554043|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
173803|NCT00866307|554041|P3|Consolidation/Maintenance|Withdrawal by Subject|1
173804|NCT00866307|554042|P2|Consolidation/Maintenance|Withdrawal by Subject|1
173805|NCT00866307|554043|P1|Consolidation/Maintenance|Withdrawal by Subject|0
173806|NCT00866307|554041|P3|Consolidation/Maintenance|Physician Decision|2
173807|NCT00866307|554042|P2|Consolidation/Maintenance|Physician Decision|3
173808|NCT00866307|554043|P1|Consolidation/Maintenance|Physician Decision|0
173809|NCT00866307|554041|P3|Consolidation/Maintenance|Death|1
173810|NCT00866307|554042|P2|Consolidation/Maintenance|Death|0
173811|NCT00866307|554043|P1|Consolidation/Maintenance|Death|0
173812|NCT00866307|554041|P3|Consolidation/Maintenance|Adverse Event|8
173813|NCT00866307|554042|P2|Consolidation/Maintenance|Adverse Event|0
173814|NCT00866307|554043|P1|Consolidation/Maintenance|Adverse Event|0
173815|NCT00866307|554041|P3|Induction|Study was closed at the time|0
173816|NCT00866307|554042|P2|Induction|Study was closed at the time|0
173817|NCT00866307|554043|P1|Induction|Study was closed at the time|1
173818|NCT00866307|554041|P3|Induction|Improper post-induction consent|0
173819|NCT00866307|554042|P2|Induction|Improper post-induction consent|0
173820|NCT00866307|554043|P1|Induction|Improper post-induction consent|2
173821|NCT00866307|554041|P3|Induction|Inadequate cytognetic samples th|0
173822|NCT00866307|554042|P2|Induction|Inadequate cytognetic samples th|0
173823|NCT00866307|554043|P1|Induction|Inadequate cytognetic samples th|1
173824|NCT00866307|554041|P3|Induction|Identification of Patients with Day 29 M|0
173825|NCT00866307|554042|P2|Induction|Identification of Patients with Day 29 M|0
173826|NCT00866307|554043|P1|Induction|Identification of Patients with Day 29 M|3
173827|NCT00866307|554041|P3|Induction|Progressive Disease|0
173828|NCT00866307|554042|P2|Induction|Progressive Disease|0
173829|NCT00866307|554043|P1|Induction|Progressive Disease|1
173830|NCT00866307|554041|P3|Induction|Physician Decision|0
173831|NCT00866307|554042|P2|Induction|Physician Decision|0
173832|NCT00866307|554043|P1|Induction|Physician Decision|5
173833|NCT00866307|554041|P3|Induction|Death|0
173834|NCT00866307|554042|P2|Induction|Death|0
173835|NCT00866307|554043|P1|Induction|Death|2
173836|NCT00866307|554041|P3|Induction|Adverse Event|0
173837|NCT00866307|554042|P2|Induction|Adverse Event|0
173838|NCT00866307|554043|P1|Induction|Adverse Event|5
173839|NCT00866320|554050|P1|Overall Study|Death|2
173840|NCT00866320|554050|P1|Overall Study|Withdrawal by Subject|4
173841|NCT00866359|554059|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
173842|NCT00866359|554060|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
173843|NCT00866359|554061|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
173844|NCT00866359|554062|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
173845|NCT00866359|554059|P4|Treatment Phase (Days 1 to 85)|Unspecified|0
173846|NCT00866359|554060|P3|Treatment Phase (Days 1 to 85)|Unspecified|0
173847|NCT00866359|554061|P2|Treatment Phase (Days 1 to 85)|Unspecified|0
173848|NCT00866359|554062|P1|Treatment Phase (Days 1 to 85)|Unspecified|1
173849|NCT00866359|554059|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
173850|NCT00866359|554060|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
173851|NCT00866359|554061|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
173852|NCT00866359|554062|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
173853|NCT00866359|554059|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
173854|NCT00866359|554060|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
173855|NCT00866359|554061|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
173856|NCT00866359|554062|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
173857|NCT00866359|554059|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
173858|NCT00866359|554060|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
173859|NCT00866359|554061|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
173860|NCT00866359|554062|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
173861|NCT00866359|554059|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
173862|NCT00866359|554060|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
173863|NCT00866359|554061|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
173864|NCT00866359|554062|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
173865|NCT00866606|554115|P1|Overall Study|Adverse Event|1
173866|NCT00866606|554115|P1|Overall Study|Lost to Follow-up|3
173867|NCT00866658|554129|P2|Overall Study|Familial and Personal Reasons|5
173868|NCT00866658|554130|P1|Overall Study|Familial and Personal Reasons|4
173869|NCT00866658|554129|P2|Overall Study|Protocol Violation|1
173870|NCT00866658|554130|P1|Overall Study|Protocol Violation|1
173871|NCT00866658|554129|P2|Overall Study|Withdrawal by Subject|0
173872|NCT00866658|554130|P1|Overall Study|Withdrawal by Subject|1
173873|NCT00866658|554129|P2|Overall Study|Lack of Efficacy|1
173874|NCT00866658|554130|P1|Overall Study|Lack of Efficacy|2
173875|NCT00866658|554129|P2|Overall Study|Adverse Event|14
173876|NCT00866658|554130|P1|Overall Study|Adverse Event|5
173877|NCT00866697|554160|P2|Overall Study|Ongoing|312
173878|NCT00866697|554161|P1|Overall Study|Ongoing|335
173879|NCT00866697|554160|P2|Overall Study|Withdrawal by Subject|53
173880|NCT00866697|554161|P1|Overall Study|Withdrawal by Subject|28
173881|NCT00866697|554160|P2|Overall Study|Physician Decision|4
173882|NCT00866697|554161|P1|Overall Study|Physician Decision|3
173883|NCT00866697|554160|P2|Overall Study|Lost to Follow-up|8
173884|NCT00866697|554161|P1|Overall Study|Lost to Follow-up|7
173885|NCT00866723|554203|P1|Overall Study|Disease Progression|4
173886|NCT00866723|554203|P1|Overall Study|Withdrawal by Subject|1
173887|NCT00866775|554210|P2|Overall Study|discontinued due to communication error|1
173888|NCT00866775|554211|P1|Overall Study|discontinued due to communication error|0
173889|NCT00866775|554210|P2|Overall Study|met exit criteria|17
173890|NCT00866775|554211|P1|Overall Study|met exit criteria|23
173891|NCT00866775|554210|P2|Overall Study|Withdrawal by Subject|4
173892|NCT00866775|554211|P1|Overall Study|Withdrawal by Subject|4
173893|NCT00866775|554210|P2|Overall Study|Protocol Violation|4
173894|NCT00866775|554211|P1|Overall Study|Protocol Violation|3
173895|NCT00866775|554210|P2|Overall Study|Physician Decision|3
173896|NCT00866775|554211|P1|Overall Study|Physician Decision|0
173897|NCT00866775|554210|P2|Overall Study|Lost to Follow-up|4
173898|NCT00866775|554211|P1|Overall Study|Lost to Follow-up|0
173899|NCT00866775|554210|P2|Overall Study|Death|0
173900|NCT00866775|554211|P1|Overall Study|Death|1
173901|NCT00866775|554210|P2|Overall Study|Adverse Event|19
173902|NCT00866775|554211|P1|Overall Study|Adverse Event|5
173903|NCT00866788|554251|P4|Overall Study|Physician Decision|1
173904|NCT00866788|554252|P3|Overall Study|Physician Decision|1
173905|NCT00866788|554253|P2|Overall Study|Physician Decision|0
173906|NCT00866788|554254|P1|Overall Study|Physician Decision|0
173907|NCT00866788|554251|P4|Overall Study|Disease progression|0
173908|NCT00866788|554252|P3|Overall Study|Disease progression|1
173909|NCT00866788|554253|P2|Overall Study|Disease progression|1
173910|NCT00866788|554254|P1|Overall Study|Disease progression|3
173911|NCT00866788|554251|P4|Overall Study|Pregnancy|0
173912|NCT00866788|554252|P3|Overall Study|Pregnancy|0
173913|NCT00866788|554253|P2|Overall Study|Pregnancy|1
173914|NCT00866788|554254|P1|Overall Study|Pregnancy|0
173915|NCT00866788|554251|P4|Overall Study|Withdrawal by Subject|1
173916|NCT00866788|554252|P3|Overall Study|Withdrawal by Subject|0
173917|NCT00866788|554253|P2|Overall Study|Withdrawal by Subject|1
173918|NCT00866788|554254|P1|Overall Study|Withdrawal by Subject|2
173919|NCT00866788|554251|P4|Overall Study|Lost to Follow-up|2
173920|NCT00866788|554252|P3|Overall Study|Lost to Follow-up|0
173921|NCT00866788|554253|P2|Overall Study|Lost to Follow-up|1
173922|NCT00866788|554254|P1|Overall Study|Lost to Follow-up|1
173923|NCT00866788|554251|P4|Overall Study|Adverse Event|1
173924|NCT00866788|554252|P3|Overall Study|Adverse Event|0
173925|NCT00866788|554253|P2|Overall Study|Adverse Event|2
173926|NCT00866788|554254|P1|Overall Study|Adverse Event|0
173927|NCT00866814|554300|P1|Overall Study|Moved to area without study site|1
173928|NCT00866814|554300|P1|Overall Study|Unable to meet follow-up requirements|2
173929|NCT00866814|554300|P1|Overall Study|No longer wished to participate|1
173930|NCT00866814|554300|P1|Overall Study|Death|1
173931|NCT00866814|554300|P1|Overall Study|Physician Decision|1
173932|NCT00866814|554300|P1|Overall Study|Adverse Event|2
173933|NCT00866814|554300|P1|Overall Study|Lost to Follow-up|12
173934|NCT00866918|554316|P2|Overall Study|Secondary malignancy|0
173935|NCT00866918|554317|P1|Overall Study|Secondary malignancy|1
173936|NCT00866918|554316|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
173937|NCT00866918|554317|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
173938|NCT00866918|554316|P2|Overall Study|Ineligible|4
173939|NCT00866918|554317|P1|Overall Study|Ineligible|2
173940|NCT00866918|554316|P2|Overall Study|Physician Decision|2
173941|NCT00866918|554317|P1|Overall Study|Physician Decision|10
173942|NCT00866918|554316|P2|Overall Study|Lack of Efficacy|1
173943|NCT00866918|554317|P1|Overall Study|Lack of Efficacy|1
173944|NCT00866918|554316|P2|Overall Study|Death|5
173945|NCT00866918|554317|P1|Overall Study|Death|1
173946|NCT00867009|554329|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
173947|NCT00867009|554329|P1|Induction Period|Progressive Disease (PD)|25
173948|NCT00867009|554329|P1|Induction Period|Physician Decision|3
173949|NCT00867009|554329|P1|Induction Period|Withdrawal by Subject|8
173950|NCT00867009|554329|P1|Induction Period|Protocol Violation|1
173951|NCT00867009|554329|P1|Induction Period|Death due to Study Disease|4
173952|NCT00867009|554329|P1|Induction Period|Death due to serious adverse event|6
173953|NCT00867009|554329|P1|Induction Period|Serious Adverse Event|10
173954|NCT00867009|554329|P1|Induction Period|Nonserious Adverse Event|5
173955|NCT00867035|554338|P2|Baseline to 1 Week|Withdrawal by Subject|0
173956|NCT00867035|554339|P1|Baseline to 1 Week|Withdrawal by Subject|1
173957|NCT00867035|554338|P2|Baseline to 1 Hour|Withdrawal by Subject|1
173958|NCT00867035|554339|P1|Baseline to 1 Hour|Withdrawal by Subject|1
173959|NCT00867087|554365|P1|Overall Study|Death|37
173960|NCT00867087|554365|P1|Overall Study|Withdrawal by Subject|4
173961|NCT00867087|554365|P1|Overall Study|Unspecified|1
173962|NCT00867165|554427|P2|Overall Study|Withdrawal by Subject|0
173963|NCT00867165|554428|P1|Overall Study|Withdrawal by Subject|1
173964|NCT00867165|554427|P2|Overall Study|Adverse Event|0
173965|NCT00867165|554428|P1|Overall Study|Adverse Event|3
173966|NCT00859222|554627|P5|Overall Study|DLT|0
173967|NCT00859222|554628|P4|Overall Study|DLT|0
173968|NCT00859222|554629|P3|Overall Study|DLT|0
173969|NCT00859222|554630|P2|Overall Study|DLT|0
173970|NCT00859222|554631|P1|Overall Study|DLT|1
173971|NCT00859222|554627|P5|Overall Study|Adverse Event|15
173972|NCT00859222|554628|P4|Overall Study|Adverse Event|24
173973|NCT00859222|554629|P3|Overall Study|Adverse Event|6
173974|NCT00859222|554630|P2|Overall Study|Adverse Event|3
173975|NCT00859222|554631|P1|Overall Study|Adverse Event|2
173976|NCT00859313|554656|P1|Overall Study|staff error|1
173977|NCT00859313|554656|P1|Overall Study|Adverse Event|1
173978|NCT00859313|554656|P1|Overall Study|Lack of Efficacy|2
173979|NCT00867360|554696|P2|Overall Study|Physician Decision|1
173980|NCT00867360|554697|P1|Overall Study|Physician Decision|0
173981|NCT00867360|554696|P2|Overall Study|Withdrawal by Subject|0
173982|NCT00867360|554697|P1|Overall Study|Withdrawal by Subject|1
173983|NCT00867490|554730|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
173984|NCT00867490|554730|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
173985|NCT00867490|554730|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
173986|NCT00867490|554730|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
173987|NCT00867490|554730|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
173988|NCT00867503|554747|P1|Overall Study|Withdrawal by Subject|1
173989|NCT00867568|554758|P1|Overall Study|Withdrawal by Subject|1
173990|NCT00867568|554758|P1|Overall Study|Adverse Event|4
173991|NCT00867568|554758|P1|Overall Study|Lack of Efficacy|10
173992|NCT00869362|554782|P2|Overall Study|Lost to Follow-up|3
173993|NCT00869362|554783|P1|Overall Study|Lost to Follow-up|1
173994|NCT00869362|554782|P2|Overall Study|Death|2
173995|NCT00869362|554783|P1|Overall Study|Death|0
173996|NCT00869401|554805|P5|Overall Study|Withdrawal by Subject|3
173997|NCT00869401|554806|P4|Overall Study|Withdrawal by Subject|5
173998|NCT00869401|554807|P3|Overall Study|Withdrawal by Subject|0
173999|NCT00869401|554808|P2|Overall Study|Withdrawal by Subject|0
174000|NCT00869401|554809|P1|Overall Study|Withdrawal by Subject|0
174001|NCT00869518|554840|P2|Overall Study|Lost to Follow-up|1
174002|NCT00869518|554841|P1|Overall Study|Lost to Follow-up|1
174003|NCT00869557|554855|P2|Extension Phase|Withdrew Consent|0
174004|NCT00869557|554856|P1|Extension Phase|Withdrew Consent|2
174005|NCT00869557|554855|P2|Extension Phase|Investigator's Discretion|0
174006|NCT00869557|554856|P1|Extension Phase|Investigator's Discretion|2
174007|NCT00869557|554855|P2|Extension Phase|Lost to Follow-up|1
174008|NCT00869557|554856|P1|Extension Phase|Lost to Follow-up|3
174009|NCT00869557|554855|P2|Extension Phase|Lack of Efficacy|0
174010|NCT00869557|554856|P1|Extension Phase|Lack of Efficacy|1
174011|NCT00869557|554855|P2|Extension Phase|Adverse Event|2
174012|NCT00869557|554856|P1|Extension Phase|Adverse Event|2
174013|NCT00869557|554855|P2|Randomized Phase|Withdrew Consent|1
174014|NCT00869557|554856|P1|Randomized Phase|Withdrew Consent|0
174015|NCT00869557|554855|P2|Randomized Phase|Investigator's Discretion|0
174016|NCT00869557|554856|P1|Randomized Phase|Investigator's Discretion|1
174017|NCT00869557|554855|P2|Randomized Phase|Lost to Follow-up|1
174018|NCT00869557|554856|P1|Randomized Phase|Lost to Follow-up|2
174019|NCT00869778|554914|P3|Overall Study|Unblinding|0
174020|NCT00869778|554915|P2|Overall Study|Unblinding|0
174021|NCT00869778|554916|P1|Overall Study|Unblinding|1
174022|NCT00869778|554914|P3|Overall Study|Protocol Violation|5
174023|NCT00869778|554915|P2|Overall Study|Protocol Violation|3
174024|NCT00869778|554916|P1|Overall Study|Protocol Violation|5
174025|NCT00869778|554914|P3|Overall Study|Pregnancy|0
174026|NCT00869778|554915|P2|Overall Study|Pregnancy|0
174027|NCT00869778|554916|P1|Overall Study|Pregnancy|1
174028|NCT00869778|554914|P3|Overall Study|Withdrawal by Subject|5
174029|NCT00869778|554915|P2|Overall Study|Withdrawal by Subject|4
174030|NCT00869778|554916|P1|Overall Study|Withdrawal by Subject|3
174031|NCT00869778|554914|P3|Overall Study|Adverse Event|0
174032|NCT00869778|554915|P2|Overall Study|Adverse Event|0
174033|NCT00869778|554916|P1|Overall Study|Adverse Event|2
174034|NCT00869960|554986|P1|Overall Study|Lost to Follow-up|2
174035|NCT00869999|554997|P1|Overall Study|removed prior to starting therapy|1
174036|NCT00869999|554997|P1|Overall Study|Withdrawal by Subject|1
174037|NCT00870103|555003|P1|Overall Study|Lost to Follow-up|2
174038|NCT00870103|555003|P1|Overall Study|Physician Decision|2
174039|NCT00870194|555010|P2|Overall Study|Subject Decision|2
174040|NCT00870194|555011|P1|Overall Study|Subject Decision|7
174041|NCT00870194|555010|P2|Overall Study|Entry Criteria Not Met|2
174042|NCT00870194|555011|P1|Overall Study|Entry Criteria Not Met|1
174043|NCT00870194|555010|P2|Overall Study|Protocol Violation|3
174044|NCT00870194|555011|P1|Overall Study|Protocol Violation|3
174045|NCT00870194|555010|P2|Overall Study|Physician Decision|1
174046|NCT00870194|555011|P1|Overall Study|Physician Decision|3
174047|NCT00870194|555010|P2|Overall Study|Lost to Follow-up|0
174048|NCT00870194|555011|P1|Overall Study|Lost to Follow-up|2
174049|NCT00870194|555010|P2|Overall Study|Lack of Efficacy|1
174050|NCT00870194|555011|P1|Overall Study|Lack of Efficacy|0
174051|NCT00870194|555010|P2|Overall Study|Adverse Event|5
174052|NCT00870194|555011|P1|Overall Study|Adverse Event|10
174053|NCT00870584|555152|P2|Overall Study|Protocol Deviation|2
174054|NCT00870584|555153|P1|Overall Study|Protocol Deviation|2
174055|NCT00870584|555152|P2|Overall Study|Lost to Follow-up|1
174056|NCT00870584|555153|P1|Overall Study|Lost to Follow-up|5
174057|NCT00870584|555152|P2|Overall Study|Withdrawal by Subject|7
174058|NCT00870584|555153|P1|Overall Study|Withdrawal by Subject|6
174059|NCT00870584|555152|P2|Overall Study|Adverse Event|3
174060|NCT00870584|555153|P1|Overall Study|Adverse Event|3
174061|NCT00870688|555161|P1|Overall Study|Granules in the Stools|1
174062|NCT00870688|555161|P1|Overall Study|Death, Unrelated|1
174063|NCT00870688|555161|P1|Overall Study|Lost to Follow-up|2
174064|NCT00870740|555170|P6|Overall Study|Not Specified|5
174065|NCT00870740|555171|P5|Overall Study|Not Specified|3
174066|NCT00870740|555172|P4|Overall Study|Not Specified|4
174067|NCT00870740|555173|P3|Overall Study|Not Specified|2
174068|NCT00870740|555174|P2|Overall Study|Not Specified|5
174069|NCT00870740|555175|P1|Overall Study|Not Specified|2
174070|NCT00870740|555170|P6|Overall Study|Death|0
174071|NCT00870740|555171|P5|Overall Study|Death|1
174072|NCT00870740|555172|P4|Overall Study|Death|0
174073|NCT00870740|555173|P3|Overall Study|Death|0
174074|NCT00870740|555174|P2|Overall Study|Death|0
174075|NCT00870740|555175|P1|Overall Study|Death|0
174076|NCT00870740|555170|P6|Overall Study|Subject Non-compliance|1
174077|NCT00870740|555171|P5|Overall Study|Subject Non-compliance|0
174078|NCT00870740|555172|P4|Overall Study|Subject Non-compliance|0
174079|NCT00870740|555173|P3|Overall Study|Subject Non-compliance|0
174080|NCT00870740|555174|P2|Overall Study|Subject Non-compliance|0
174081|NCT00870740|555175|P1|Overall Study|Subject Non-compliance|0
174082|NCT00870740|555170|P6|Overall Study|Investigator Decision|0
174083|NCT00870740|555171|P5|Overall Study|Investigator Decision|0
174084|NCT00870740|555172|P4|Overall Study|Investigator Decision|0
174085|NCT00870740|555173|P3|Overall Study|Investigator Decision|1
174086|NCT00870740|555174|P2|Overall Study|Investigator Decision|0
174087|NCT00870740|555175|P1|Overall Study|Investigator Decision|2
174088|NCT00870740|555170|P6|Overall Study|Consent Withdrawn|5
174089|NCT00870740|555171|P5|Overall Study|Consent Withdrawn|6
174090|NCT00870740|555172|P4|Overall Study|Consent Withdrawn|6
174091|NCT00870740|555173|P3|Overall Study|Consent Withdrawn|4
174092|NCT00870740|555174|P2|Overall Study|Consent Withdrawn|3
174093|NCT00870740|555175|P1|Overall Study|Consent Withdrawn|6
174094|NCT00870740|555170|P6|Overall Study|Adverse Event|6
174095|NCT00870740|555171|P5|Overall Study|Adverse Event|1
174096|NCT00870740|555172|P4|Overall Study|Adverse Event|2
174097|NCT00870740|555173|P3|Overall Study|Adverse Event|3
174098|NCT00870740|555174|P2|Overall Study|Adverse Event|1
174099|NCT00870740|555175|P1|Overall Study|Adverse Event|2
174100|NCT00871000|555257|P2|Overall Study|Withdrawal by Subject|0
174101|NCT00871000|555258|P1|Overall Study|Withdrawal by Subject|1
174102|NCT00871117|555302|P2|Overall Study|Lost to Follow-up|10
174103|NCT00871117|555303|P1|Overall Study|Lost to Follow-up|5
174104|NCT00871169|555354|P1|Overall Study|Patient did not receive study treatment|2
174105|NCT00871169|555354|P1|Overall Study|Protocol Violation|1
174106|NCT00871234|555359|P1|Overall Study|Lost to Follow-up|3
174107|NCT00871234|555359|P1|Overall Study|Adverse Event|2
174108|NCT00871338|555376|P2|Prior to Booster|Lost to Follow-up|0
174109|NCT00871338|555377|P1|Prior to Booster|Lost to Follow-up|1
174110|NCT00871338|555376|P2|Prior to Booster|Withdrawal by Subject|3
174111|NCT00871338|555377|P1|Prior to Booster|Withdrawal by Subject|1
174112|NCT00871351|555458|P3|Overall Study|Adverse Event|0
174113|NCT00871351|555459|P2|Overall Study|Adverse Event|1
174114|NCT00871351|555460|P1|Overall Study|Adverse Event|3
174115|NCT00871351|555458|P3|Overall Study|Withdrawal by Subject|0
174116|NCT00871351|555459|P2|Overall Study|Withdrawal by Subject|0
174117|NCT00871351|555460|P1|Overall Study|Withdrawal by Subject|1
174118|NCT00871377|555480|P6|Third Intervention (10 Weeks)|Death|0
174119|NCT00871377|555481|P5|Third Intervention (10 Weeks)|Death|0
174120|NCT00871377|555482|P4|Third Intervention (10 Weeks)|Death|1
174121|NCT00871377|555483|P3|Third Intervention (10 Weeks)|Death|0
174122|NCT00871377|555484|P2|Third Intervention (10 Weeks)|Death|0
174123|NCT00871377|555485|P1|Third Intervention (10 Weeks)|Death|0
174124|NCT00871377|555480|P6|Washout (6 Weeks)|Withdrawal by Subject|1
174125|NCT00871377|555481|P5|Washout (6 Weeks)|Withdrawal by Subject|0
174126|NCT00871377|555482|P4|Washout (6 Weeks)|Withdrawal by Subject|0
174127|NCT00871377|555483|P3|Washout (6 Weeks)|Withdrawal by Subject|0
174128|NCT00871377|555484|P2|Washout (6 Weeks)|Withdrawal by Subject|0
174129|NCT00871377|555485|P1|Washout (6 Weeks)|Withdrawal by Subject|0
174130|NCT00871377|555480|P6|Washout (6 Weeks)|Withdrawal by Subject|0
174131|NCT00871377|555481|P5|Washout (6 Weeks)|Withdrawal by Subject|0
174132|NCT00871377|555482|P4|Washout (6 Weeks)|Withdrawal by Subject|0
174133|NCT00871377|555483|P3|Washout (6 Weeks)|Withdrawal by Subject|0
174134|NCT00871377|555484|P2|Washout (6 Weeks)|Withdrawal by Subject|0
174135|NCT00871377|555485|P1|Washout (6 Weeks)|Withdrawal by Subject|1
174136|NCT00871377|555480|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
174137|NCT00871377|555481|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
174138|NCT00871377|555482|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
174139|NCT00871377|555483|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
174140|NCT00871377|555484|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
174141|NCT00871377|555485|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
174142|NCT00871377|555480|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
174143|NCT00871377|555481|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
174144|NCT00871377|555482|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
174145|NCT00871377|555483|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
174146|NCT00871377|555484|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
174147|NCT00871377|555485|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
174148|NCT00871403|555496|P3|Monotherapy Treatment Phase|Adverse Event|0
174149|NCT00871403|555497|P2|Monotherapy Treatment Phase|Adverse Event|4
174150|NCT00871403|555498|P1|Monotherapy Treatment Phase|Adverse Event|0
174151|NCT00871403|555496|P3|Monotherapy Treatment Phase|Disease Progression|1
174152|NCT00871403|555497|P2|Monotherapy Treatment Phase|Disease Progression|9
174153|NCT00871403|555498|P1|Monotherapy Treatment Phase|Disease Progression|0
174154|NCT00871403|555496|P3|Combination Treatment Phase|Physician Decision|3
174155|NCT00871403|555497|P2|Combination Treatment Phase|Physician Decision|1
174156|NCT00871403|555498|P1|Combination Treatment Phase|Physician Decision|0
174157|NCT00871403|555496|P3|Combination Treatment Phase|Withdrawal by Subject|1
174158|NCT00871403|555497|P2|Combination Treatment Phase|Withdrawal by Subject|3
174159|NCT00871403|555498|P1|Combination Treatment Phase|Withdrawal by Subject|0
174160|NCT00871403|555496|P3|Combination Treatment Phase|Disease Progression|5
174161|NCT00871403|555497|P2|Combination Treatment Phase|Disease Progression|8
174162|NCT00871403|555498|P1|Combination Treatment Phase|Disease Progression|0
174163|NCT00871403|555496|P3|Combination Treatment Phase|Adverse Event|2
174164|NCT00871403|555497|P2|Combination Treatment Phase|Adverse Event|17
174165|NCT00871403|555498|P1|Combination Treatment Phase|Adverse Event|0
174166|NCT00871403|555496|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
174167|NCT00871403|555497|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
174168|NCT00871403|555498|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
174169|NCT00871403|555496|P3|Combination Treatment Phase|Randomized but Not Treated|1
174170|NCT00871403|555497|P2|Combination Treatment Phase|Randomized but Not Treated|1
174171|NCT00871403|555498|P1|Combination Treatment Phase|Randomized but Not Treated|1
174172|NCT00871429|555511|P1|Overall Study|Questionnaire not completed|1
174173|NCT00871429|555511|P1|Overall Study|Withdrawal by Subject|17
174174|NCT00871429|555511|P1|Overall Study|Lost to Follow-up|6
174175|NCT00871494|555519|P1|Overall Study|Lost to Follow-up|1
174176|NCT00871494|555519|P1|Overall Study|Adverse Event|4
174177|NCT00871494|555519|P1|Overall Study|Lack of Efficacy|4
174178|NCT00871494|555519|P1|Overall Study|Protocol Violation|5
174179|NCT00871715|555549|P3|Overall Study|Lost to Follow-up|9
174180|NCT00871715|555550|P2|Overall Study|Lost to Follow-up|6
174181|NCT00871715|555551|P1|Overall Study|Lost to Follow-up|3
174182|NCT00871715|555549|P3|Overall Study|Physician Decision|2
174183|NCT00871715|555550|P2|Overall Study|Physician Decision|0
174184|NCT00871715|555551|P1|Overall Study|Physician Decision|6
174185|NCT00871715|555549|P3|Overall Study|Withdrawal by Subject|15
174186|NCT00871715|555550|P2|Overall Study|Withdrawal by Subject|10
174187|NCT00871715|555551|P1|Overall Study|Withdrawal by Subject|6
174188|NCT00871728|555569|P1|Overall Study|Withdrawal of Informed Consent|5
174189|NCT00871728|555569|P1|Overall Study|Participant Non-compliance|1
174190|NCT00871728|555569|P1|Overall Study|Failed to Visit Hospital|4
174191|NCT00871728|555569|P1|Overall Study|Lost to Follow-up|2
174192|NCT00871728|555569|P1|Overall Study|Protocol Violation|7
174193|NCT00871728|555569|P1|Overall Study|Adverse Event|1
174194|NCT00871741|555581|P2|Overall Study|Premature study termination|7
174195|NCT00871741|555582|P1|Overall Study|Premature study termination|9
174196|NCT00871780|555596|P1|Overall Study|Physician Decision|1
174197|NCT00871780|555596|P1|Overall Study|Death|1
174198|NCT00871780|555596|P1|Overall Study|Voluntary Discontinuation|4
174199|NCT00871780|555596|P1|Overall Study|Adverse Event|6
174200|NCT00871780|555596|P1|Overall Study|Withdrawal by Subject|9
174201|NCT00871780|555596|P1|Overall Study|Enrolled But Not Treated|6
174202|NCT00862251|555621|P3|Overall Study|Withdrawal by Subject|6
174203|NCT00862251|555622|P2|Overall Study|Withdrawal by Subject|2
174204|NCT00862251|555623|P1|Overall Study|Withdrawal by Subject|9
174205|NCT00862251|555621|P3|Overall Study|Protocol Violation|1
174206|NCT00862251|555622|P2|Overall Study|Protocol Violation|0
174207|NCT00862251|555623|P1|Overall Study|Protocol Violation|2
174208|NCT00862251|555621|P3|Overall Study|Lost to Follow-up|1
174209|NCT00862251|555622|P2|Overall Study|Lost to Follow-up|0
174210|NCT00862251|555623|P1|Overall Study|Lost to Follow-up|0
174211|NCT00862251|555621|P3|Overall Study|Adverse Event|1
174212|NCT00862251|555622|P2|Overall Study|Adverse Event|3
174213|NCT00862251|555623|P1|Overall Study|Adverse Event|8
174214|NCT00862277|555679|P3|Overall Study|Protocol Violation|5
174215|NCT00862277|555680|P2|Overall Study|Protocol Violation|2
174216|NCT00862277|555681|P1|Overall Study|Protocol Violation|1
174217|NCT00862459|555695|P3|Overall Study|Administrative problems|0
174218|NCT00862459|555696|P2|Overall Study|Administrative problems|1
174219|NCT00862459|555697|P1|Overall Study|Administrative problems|0
174220|NCT00862459|555695|P3|Overall Study|Inclusion/exclusion criteria not met|0
174221|NCT00862459|555696|P2|Overall Study|Inclusion/exclusion criteria not met|1
174222|NCT00862459|555697|P1|Overall Study|Inclusion/exclusion criteria not met|0
174223|NCT00862459|555695|P3|Overall Study|Unable to hold still for imaging|0
174224|NCT00862459|555696|P2|Overall Study|Unable to hold still for imaging|1
174225|NCT00862459|555697|P1|Overall Study|Unable to hold still for imaging|0
174226|NCT00862459|555695|P3|Overall Study|Intravenous (IV) site problems|1
174227|NCT00862459|555696|P2|Overall Study|Intravenous (IV) site problems|0
174228|NCT00862459|555697|P1|Overall Study|Intravenous (IV) site problems|1
174229|NCT00862459|555695|P3|Overall Study|Operation|0
174230|NCT00862459|555696|P2|Overall Study|Operation|1
174231|NCT00862459|555697|P1|Overall Study|Operation|1
174232|NCT00862459|555695|P3|Overall Study|Personal reasons|0
174233|NCT00862459|555696|P2|Overall Study|Personal reasons|0
174234|NCT00862459|555697|P1|Overall Study|Personal reasons|1
174235|NCT00862459|555695|P3|Overall Study|Adverse Event|0
174236|NCT00862459|555696|P2|Overall Study|Adverse Event|1
174237|NCT00862459|555697|P1|Overall Study|Adverse Event|0
174238|NCT00862459|555695|P3|Overall Study|Withdrawal by Subject|3
174239|NCT00862459|555696|P2|Overall Study|Withdrawal by Subject|1
174240|NCT00862459|555697|P1|Overall Study|Withdrawal by Subject|1
174241|NCT00862459|555695|P3|Overall Study|Protocol Violation|0
174242|NCT00862459|555696|P2|Overall Study|Protocol Violation|0
174243|NCT00862459|555697|P1|Overall Study|Protocol Violation|1
174244|NCT00862459|555695|P3|Overall Study|Lost to Follow-up|2
174245|NCT00862459|555696|P2|Overall Study|Lost to Follow-up|2
174246|NCT00862459|555697|P1|Overall Study|Lost to Follow-up|1
174247|NCT00862641|555894|P4|Overall Study|Randomized, but drug not received|4
174248|NCT00862641|555895|P3|Overall Study|Randomized, but drug not received|1
174249|NCT00862641|555896|P2|Overall Study|Randomized, but drug not received|4
174250|NCT00862641|555897|P1|Overall Study|Randomized, but drug not received|1
174251|NCT00862654|555943|P4|Overall Study|Included after end of inclusions|0
174252|NCT00862654|555944|P3|Overall Study|Included after end of inclusions|1
174253|NCT00862654|555945|P2|Overall Study|Included after end of inclusions|0
174254|NCT00862654|555946|P1|Overall Study|Included after end of inclusions|0
174255|NCT00862654|555943|P4|Overall Study|Never used study drugs|0
174256|NCT00862654|555944|P3|Overall Study|Never used study drugs|0
174257|NCT00862654|555945|P2|Overall Study|Never used study drugs|0
174258|NCT00862654|555946|P1|Overall Study|Never used study drugs|1
174259|NCT00862654|555943|P4|Overall Study|Familly constraint|0
174260|NCT00862654|555944|P3|Overall Study|Familly constraint|0
174261|NCT00862654|555945|P2|Overall Study|Familly constraint|1
174262|NCT00862654|555946|P1|Overall Study|Familly constraint|0
174263|NCT00862654|555943|P4|Overall Study|Subject mistake|0
174264|NCT00862654|555944|P3|Overall Study|Subject mistake|0
174265|NCT00862654|555945|P2|Overall Study|Subject mistake|1
174266|NCT00862654|555946|P1|Overall Study|Subject mistake|0
174267|NCT00862654|555943|P4|Overall Study|Withdrawal by Subject|3
174268|NCT00862654|555944|P3|Overall Study|Withdrawal by Subject|2
174269|NCT00862654|555945|P2|Overall Study|Withdrawal by Subject|2
174270|NCT00862654|555946|P1|Overall Study|Withdrawal by Subject|2
174271|NCT00862654|555943|P4|Overall Study|Pregnancy|0
174272|NCT00862654|555944|P3|Overall Study|Pregnancy|0
174273|NCT00862654|555945|P2|Overall Study|Pregnancy|1
174274|NCT00862654|555946|P1|Overall Study|Pregnancy|1
174275|NCT00862654|555943|P4|Overall Study|Adverse Event|0
174276|NCT00862654|555944|P3|Overall Study|Adverse Event|1
174277|NCT00862654|555945|P2|Overall Study|Adverse Event|1
174278|NCT00862654|555946|P1|Overall Study|Adverse Event|0
174279|NCT00862654|555943|P4|Overall Study|Lost to Follow-up|3
174280|NCT00862654|555944|P3|Overall Study|Lost to Follow-up|1
174281|NCT00862654|555945|P2|Overall Study|Lost to Follow-up|2
174282|NCT00862654|555946|P1|Overall Study|Lost to Follow-up|1
174283|NCT00862654|555943|P4|Overall Study|Lack of Efficacy|0
174284|NCT00862654|555944|P3|Overall Study|Lack of Efficacy|1
174285|NCT00862654|555945|P2|Overall Study|Lack of Efficacy|0
174286|NCT00862654|555946|P1|Overall Study|Lack of Efficacy|1
174287|NCT00862719|555960|P4|Overall Study|Veno-Occlusive Disease|0
174288|NCT00862719|555961|P3|Overall Study|Veno-Occlusive Disease|1
174289|NCT00862719|555962|P2|Overall Study|Veno-Occlusive Disease|0
174290|NCT00862719|555963|P1|Overall Study|Veno-Occlusive Disease|0
174291|NCT00862719|555960|P4|Overall Study|Engraftment failure|0
174292|NCT00862719|555961|P3|Overall Study|Engraftment failure|1
174293|NCT00862719|555962|P2|Overall Study|Engraftment failure|0
174294|NCT00862719|555963|P1|Overall Study|Engraftment failure|0
174295|NCT00862719|555960|P4|Overall Study|Death|1
174296|NCT00862719|555961|P3|Overall Study|Death|1
174297|NCT00862719|555962|P2|Overall Study|Death|6
174298|NCT00862719|555963|P1|Overall Study|Death|5
174299|NCT00862719|555960|P4|Overall Study|Disease Progression|0
174300|NCT00862719|555961|P3|Overall Study|Disease Progression|1
174301|NCT00862719|555962|P2|Overall Study|Disease Progression|0
174302|NCT00862719|555963|P1|Overall Study|Disease Progression|5
174303|NCT00862823|556020|P2|First Intervention|Withdrawal by Subject|1
174304|NCT00862823|556021|P1|First Intervention|Withdrawal by Subject|1
174305|NCT00862836|556028|P1|Overall Study|Withdrawal by Subject|1
174306|NCT00862849|556039|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
174307|NCT00862849|556040|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
174308|NCT00862849|556041|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
174309|NCT00862849|556042|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
174310|NCT00862849|556043|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
174311|NCT00862849|556044|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
174312|NCT00862849|556039|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
174313|NCT00862849|556040|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
174314|NCT00862849|556041|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
174315|NCT00862849|556042|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
174316|NCT00862849|556043|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
174317|NCT00862849|556044|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
174318|NCT00862940|556069|P2|Overall Study|Administrative or other reason(s)|3
174319|NCT00862940|556070|P1|Overall Study|Administrative or other reason(s)|4
174320|NCT00862940|556069|P2|Overall Study|Lost to Follow-up|1
174321|NCT00862940|556070|P1|Overall Study|Lost to Follow-up|0
174322|NCT00862940|556069|P2|Overall Study|Non-compliance|0
174323|NCT00862940|556070|P1|Overall Study|Non-compliance|4
174324|NCT00862940|556069|P2|Overall Study|Withdrawal by Subject|6
174325|NCT00862940|556070|P1|Overall Study|Withdrawal by Subject|4
174326|NCT00862940|556069|P2|Overall Study|Protocol Violation|5
174327|NCT00862940|556070|P1|Overall Study|Protocol Violation|2
174328|NCT00862940|556069|P2|Overall Study|Lack of Efficacy|3
174329|NCT00862940|556070|P1|Overall Study|Lack of Efficacy|1
174330|NCT00862940|556069|P2|Overall Study|Adverse Event|12
174331|NCT00862940|556070|P1|Overall Study|Adverse Event|15
174332|NCT00863057|556086|P4|Period 2 (Weeks 6-10)|Physician Decision|1
174333|NCT00863057|556087|P3|Period 2 (Weeks 6-10)|Physician Decision|0
174334|NCT00863057|556088|P2|Period 2 (Weeks 6-10)|Physician Decision|0
174335|NCT00863057|556089|P1|Period 2 (Weeks 6-10)|Physician Decision|0
174336|NCT00863057|556086|P4|Period 2 (Weeks 6-10)|Adverse Event|0
174337|NCT00863057|556087|P3|Period 2 (Weeks 6-10)|Adverse Event|1
174338|NCT00863057|556088|P2|Period 2 (Weeks 6-10)|Adverse Event|1
174339|NCT00863057|556089|P1|Period 2 (Weeks 6-10)|Adverse Event|0
174340|NCT00863057|556086|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
174341|NCT00863057|556087|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
174342|NCT00863057|556088|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
174343|NCT00863057|556089|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
174344|NCT00863057|556086|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
174345|NCT00863057|556087|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
174346|NCT00863057|556088|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
174347|NCT00863057|556089|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
174348|NCT00863317|556144|P2|Overall Study|Lost to Follow-up|9
174349|NCT00863317|556145|P1|Overall Study|Lost to Follow-up|8
174350|NCT00863330|556151|P1|Overall Study|study terminated early due to administra|6
174351|NCT00863512|556182|P2|Overall Study|Physician Decision|0
174352|NCT00863512|556183|P1|Overall Study|Physician Decision|1
174353|NCT00863512|556182|P2|Overall Study|Withdrawal by Subject|0
174354|NCT00863512|556183|P1|Overall Study|Withdrawal by Subject|11
174355|NCT00863512|556182|P2|Overall Study|Adverse Event|0
174356|NCT00863512|556183|P1|Overall Study|Adverse Event|2
174357|NCT00863655|556199|P2|Overall Study|Treatment completed as per protocol|1
174358|NCT00863655|556200|P1|Overall Study|Treatment completed as per protocol|5
174359|NCT00863655|556199|P2|Overall Study|Disease progression|221
174360|NCT00863655|556200|P1|Overall Study|Disease progression|364
174361|NCT00863655|556199|P2|Overall Study|New cancer therapy|1
174362|NCT00863655|556200|P1|Overall Study|New cancer therapy|5
174363|NCT00863655|556199|P2|Overall Study|Death|1
174364|NCT00863655|556200|P1|Overall Study|Death|7
174365|NCT00863655|556199|P2|Overall Study|Administrative problems|0
174366|NCT00863655|556200|P1|Overall Study|Administrative problems|1
174367|NCT00863655|556199|P2|Overall Study|Withdrawal by Subject|7
174368|NCT00863655|556200|P1|Overall Study|Withdrawal by Subject|47
174369|NCT00863655|556199|P2|Overall Study|Adverse Event|8
174370|NCT00863655|556200|P1|Overall Study|Adverse Event|52
174371|NCT00863655|556199|P2|Overall Study|Protocol Violation|0
174372|NCT00863655|556200|P1|Overall Study|Protocol Violation|4
174373|NCT00863707|556229|P2|Overall Study|Randomized, but drug not received|3
174374|NCT00863707|556230|P1|Overall Study|Randomized, but drug not received|4
174375|NCT00863746|556238|P2|Survival Follow up|Consent Withdrawn|8
174376|NCT00863746|556239|P1|Survival Follow up|Consent Withdrawn|7
174377|NCT00863746|556238|P2|Survival Follow up|Lost to Follow-up|1
174378|NCT00863746|556239|P1|Survival Follow up|Lost to Follow-up|2
174379|NCT00863746|556238|P2|Survival Follow up|Death|271
174380|NCT00863746|556239|P1|Survival Follow up|Death|244
174381|NCT00863746|556238|P2|Treatment|not available|0
174382|NCT00863746|556239|P1|Treatment|not available|1
174383|NCT00863746|556238|P2|Treatment|Protocol Violation|3
174384|NCT00863746|556239|P1|Treatment|Protocol Violation|5
174385|NCT00863746|556238|P2|Treatment|Lost to Follow-up|0
174386|NCT00863746|556239|P1|Treatment|Lost to Follow-up|1
174387|NCT00863746|556238|P2|Treatment|Consent withdrawn|14
174388|NCT00863746|556239|P1|Treatment|Consent withdrawn|15
174389|NCT00863746|556238|P2|Treatment|non-compliant with study medication|0
174390|NCT00863746|556239|P1|Treatment|non-compliant with study medication|4
174391|NCT00863746|556238|P2|Treatment|Adverse Event|16
174392|NCT00863746|556239|P1|Treatment|Adverse Event|41
174393|NCT00863746|556238|P2|Treatment|Not treated|2
174394|NCT00863746|556239|P1|Treatment|Not treated|4
174395|NCT00863798|556266|P3|Overall Study|Randomized not treated|3
174396|NCT00863798|556267|P2|Overall Study|Randomized not treated|2
174397|NCT00863798|556268|P1|Overall Study|Randomized not treated|4
174398|NCT00863798|556266|P3|Overall Study|Withdrawal by Subject|4
174399|NCT00863798|556267|P2|Overall Study|Withdrawal by Subject|7
174400|NCT00863798|556268|P1|Overall Study|Withdrawal by Subject|8
174401|NCT00863798|556266|P3|Overall Study|Protocol Violation|1
174402|NCT00863798|556267|P2|Overall Study|Protocol Violation|1
174403|NCT00863798|556268|P1|Overall Study|Protocol Violation|0
174404|NCT00863798|556266|P3|Overall Study|Unspecified|1
174405|NCT00863798|556267|P2|Overall Study|Unspecified|3
174406|NCT00863798|556268|P1|Overall Study|Unspecified|2
174407|NCT00863798|556266|P3|Overall Study|Lost to Follow-up|5
174408|NCT00863798|556267|P2|Overall Study|Lost to Follow-up|9
174409|NCT00863798|556268|P1|Overall Study|Lost to Follow-up|6
174410|NCT00863798|556266|P3|Overall Study|Lack of Efficacy|6
174411|NCT00863798|556267|P2|Overall Study|Lack of Efficacy|3
174412|NCT00863798|556268|P1|Overall Study|Lack of Efficacy|4
174413|NCT00863798|556266|P3|Overall Study|Investigator request|1
174414|NCT00863798|556267|P2|Overall Study|Investigator request|2
174415|NCT00863798|556268|P1|Overall Study|Investigator request|1
174416|NCT00863798|556266|P3|Overall Study|Participant failed to return|0
174417|NCT00863798|556267|P2|Overall Study|Participant failed to return|1
174418|NCT00863798|556268|P1|Overall Study|Participant failed to return|2
174419|NCT00863798|556266|P3|Overall Study|Adverse Event|4
174420|NCT00863798|556267|P2|Overall Study|Adverse Event|2
174421|NCT00863798|556268|P1|Overall Study|Adverse Event|5
174422|NCT00864227|556362|P1|Overall Study|Disease Relapse/Progression|3
174423|NCT00864227|556362|P1|Overall Study|Withdrawal by Subject|1
174424|NCT00864253|556379|P2|Overall Study|Untreated|7
174425|NCT00864253|556380|P1|Overall Study|Untreated|7
174426|NCT00864253|556379|P2|Overall Study|Ongoing|3
174427|NCT00864253|556380|P1|Overall Study|Ongoing|2
174428|NCT00864253|556379|P2|Overall Study|Death|0
174429|NCT00864253|556380|P1|Overall Study|Death|1
174430|NCT00864253|556379|P2|Overall Study|Withdrawal by Subject|18
174431|NCT00864253|556380|P1|Overall Study|Withdrawal by Subject|18
174432|NCT00864253|556379|P2|Overall Study|Lost to Follow-up|1
174433|NCT00864253|556380|P1|Overall Study|Lost to Follow-up|1
174434|NCT00864253|556379|P2|Overall Study|Protocol Violation|2
174435|NCT00864253|556380|P1|Overall Study|Protocol Violation|0
174436|NCT00864253|556379|P2|Overall Study|Physician Decision|15
174437|NCT00864253|556380|P1|Overall Study|Physician Decision|11
174438|NCT00864253|556379|P2|Overall Study|Unrelated Adverse Event|1
174439|NCT00864253|556380|P1|Overall Study|Unrelated Adverse Event|3
174440|NCT00864253|556379|P2|Overall Study|Adverse Event|11
174441|NCT00864253|556380|P1|Overall Study|Adverse Event|56
174442|NCT00864513|556447|P1|Overall Study|Withdrawal by Subject|3
174443|NCT00864682|556482|P3|Overall Study|Protocol Violation|2
174444|NCT00864682|556483|P2|Overall Study|Protocol Violation|1
174445|NCT00864682|556484|P1|Overall Study|Protocol Violation|2
174446|NCT00871871|556509|P4|Part II|Protocol Violation|1
174447|NCT00871871|556510|P3|Part II|Protocol Violation|0
174448|NCT00871871|556511|P2|Part II|Protocol Violation|0
174449|NCT00871871|556512|P1|Part II|Protocol Violation|0
174450|NCT00871871|556509|P4|Part II|Adverse Event|2
174451|NCT00871871|556510|P3|Part II|Adverse Event|1
174452|NCT00871871|556511|P2|Part II|Adverse Event|0
174453|NCT00871871|556512|P1|Part II|Adverse Event|0
174454|NCT00871871|556509|P4|Part II|Withdrawal by Subject|1
174455|NCT00871871|556510|P3|Part II|Withdrawal by Subject|2
174456|NCT00871871|556511|P2|Part II|Withdrawal by Subject|0
174457|NCT00871871|556512|P1|Part II|Withdrawal by Subject|0
174458|NCT00871871|556509|P4|Part II|Lack of Efficacy|0
174459|NCT00871871|556510|P3|Part II|Lack of Efficacy|1
174460|NCT00871871|556511|P2|Part II|Lack of Efficacy|0
174461|NCT00871871|556512|P1|Part II|Lack of Efficacy|0
174462|NCT00871871|556509|P4|Part I|Laboratory abnormality|0
174463|NCT00871871|556510|P3|Part I|Laboratory abnormality|0
174464|NCT00871871|556511|P2|Part I|Laboratory abnormality|1
174465|NCT00871871|556512|P1|Part I|Laboratory abnormality|0
174466|NCT00871871|556509|P4|Part I|Withdrawal by Subject|0
174467|NCT00871871|556510|P3|Part I|Withdrawal by Subject|0
174468|NCT00871871|556511|P2|Part I|Withdrawal by Subject|0
174469|NCT00871871|556512|P1|Part I|Withdrawal by Subject|3
174470|NCT00871871|556509|P4|Part I|Adverse Event|0
174471|NCT00871871|556510|P3|Part I|Adverse Event|0
174472|NCT00871871|556511|P2|Part I|Adverse Event|2
174473|NCT00871871|556512|P1|Part I|Adverse Event|0
174474|NCT00871975|556532|P1|Overall Study|Motion artifact, tracing uninterpretable|5
174475|NCT00871975|556532|P1|Overall Study|Patient unable to void/insufficient vol|13
174476|NCT00871975|556532|P1|Overall Study|Catheters could not be inserted|1
174477|NCT00871975|556532|P1|Overall Study|Technical difficulty w155-1ith equipment|3
174478|NCT00872001|556538|P2|Overall Study|Administrative|15
174479|NCT00872001|556539|P1|Overall Study|Administrative|23
174480|NCT00872001|556538|P2|Overall Study|Did Not Meet Protocol Eligibility|36
174481|NCT00872001|556539|P1|Overall Study|Did Not Meet Protocol Eligibility|38
174482|NCT00872001|556538|P2|Overall Study|Protocol Violation|8
174483|NCT00872001|556539|P1|Overall Study|Protocol Violation|5
174484|NCT00872001|556538|P2|Overall Study|Withdrawal by Subject|30
174485|NCT00872001|556539|P1|Overall Study|Withdrawal by Subject|18
174486|NCT00872001|556538|P2|Overall Study|Lost to Follow-up|12
174487|NCT00872001|556539|P1|Overall Study|Lost to Follow-up|13
174488|NCT00872001|556538|P2|Overall Study|Protocol Defined Clinical Event|7
174489|NCT00872001|556539|P1|Overall Study|Protocol Defined Clinical Event|5
174490|NCT00872001|556538|P2|Overall Study|Adverse Event|23
174491|NCT00872001|556539|P1|Overall Study|Adverse Event|34
174492|NCT00872170|556562|P2|Overall Study|Adverse Event|0
174493|NCT00872170|556563|P1|Overall Study|Adverse Event|1
174494|NCT00872521|556604|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
174495|NCT00872521|556605|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
174496|NCT00872521|556606|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
174497|NCT00872521|556604|P3|Completed 3-month Follow up|Physician Decision|0
174498|NCT00872521|556605|P2|Completed 3-month Follow up|Physician Decision|1
174499|NCT00872521|556606|P1|Completed 3-month Follow up|Physician Decision|0
174500|NCT00872521|556604|P3|Completed 3-month Follow up|Not specified|0
174501|NCT00872521|556605|P2|Completed 3-month Follow up|Not specified|2
174502|NCT00872521|556606|P1|Completed 3-month Follow up|Not specified|0
174503|NCT00872521|556604|P3|Primary Endpoint Analysis|Patient response missing|1
174504|NCT00872521|556605|P2|Primary Endpoint Analysis|Patient response missing|0
174505|NCT00872521|556606|P1|Primary Endpoint Analysis|Patient response missing|0
174506|NCT00872521|556604|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
174507|NCT00872521|556605|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
174508|NCT00872521|556606|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
174509|NCT00872521|556604|P3|Primary Endpoint Analysis|Patient choice|0
174510|NCT00872521|556605|P2|Primary Endpoint Analysis|Patient choice|1
174511|NCT00872521|556606|P1|Primary Endpoint Analysis|Patient choice|0
174512|NCT00872521|556604|P3|Primary Endpoint Analysis|Not specified|0
174513|NCT00872521|556605|P2|Primary Endpoint Analysis|Not specified|2
174514|NCT00872521|556606|P1|Primary Endpoint Analysis|Not specified|1
174515|NCT00872521|556604|P3|Completed PAD Induction|Death|0
174516|NCT00872521|556605|P2|Completed PAD Induction|Death|1
174517|NCT00872521|556606|P1|Completed PAD Induction|Death|1
174518|NCT00872521|556604|P3|Completed PAD Induction|Adverse Event|0
174519|NCT00872521|556605|P2|Completed PAD Induction|Adverse Event|0
174520|NCT00872521|556606|P1|Completed PAD Induction|Adverse Event|4
174521|NCT00872521|556604|P3|Completed PAD Induction|Disease progression|0
174522|NCT00872521|556605|P2|Completed PAD Induction|Disease progression|2
174523|NCT00872521|556606|P1|Completed PAD Induction|Disease progression|0
174524|NCT00872521|556604|P3|Completed PAD Induction|Patient choice|0
174525|NCT00872521|556605|P2|Completed PAD Induction|Patient choice|1
174526|NCT00872521|556606|P1|Completed PAD Induction|Patient choice|0
174527|NCT00872599|556661|P2|Second Washout Period|Adverse Event|1
174528|NCT00872599|556662|P1|Second Washout Period|Adverse Event|1
174529|NCT00872898|556713|P2|Part Two - Double Blind|Other reasons|0
174530|NCT00872898|556714|P1|Part Two - Double Blind|Other reasons|2
174531|NCT00872898|556713|P2|Part Two - Double Blind|Lost to Follow-up|2
174532|NCT00872898|556714|P1|Part Two - Double Blind|Lost to Follow-up|0
174533|NCT00872898|556713|P2|Part Two - Double Blind|Withdrawal by Subject|1
174534|NCT00872898|556714|P1|Part Two - Double Blind|Withdrawal by Subject|3
174535|NCT00872898|556713|P2|Part Two - Double Blind|Protocol Violation|0
174536|NCT00872898|556714|P1|Part Two - Double Blind|Protocol Violation|1
174537|NCT00872898|556713|P2|Part Two - Double Blind|Lack of Efficacy|0
174538|NCT00872898|556714|P1|Part Two - Double Blind|Lack of Efficacy|1
174539|NCT00872898|556713|P2|Part Two - Double Blind|Adverse Event|3
174540|NCT00872898|556714|P1|Part Two - Double Blind|Adverse Event|4
174541|NCT00872989|556750|P2|Overall Study|Not protocol specified|8
174542|NCT00872989|556751|P1|Overall Study|Not protocol specified|3
174543|NCT00872989|556750|P2|Overall Study|Progression/relapse|35
174544|NCT00872989|556751|P1|Overall Study|Progression/relapse|47
174545|NCT00872989|556750|P2|Overall Study|Withdrawal by Subject|5
174546|NCT00872989|556751|P1|Overall Study|Withdrawal by Subject|8
174547|NCT00872989|556750|P2|Overall Study|Adverse Event|15
174548|NCT00872989|556751|P1|Overall Study|Adverse Event|7
174549|NCT00873015|556771|P4|Overall Study|Withdrawal by Subject|0
174550|NCT00873015|556772|P3|Overall Study|Withdrawal by Subject|0
174551|NCT00873015|556773|P2|Overall Study|Withdrawal by Subject|1
174552|NCT00873015|556774|P1|Overall Study|Withdrawal by Subject|0
174553|NCT00873041|556784|P3|Extension Study|Administrative reasons|1
174554|NCT00873041|556785|P2|Extension Study|Administrative reasons|0
174555|NCT00873041|556786|P1|Extension Study|Administrative reasons|0
174556|NCT00873041|556784|P3|Extension Study|Adverse Event|1
174557|NCT00873041|556785|P2|Extension Study|Adverse Event|0
174558|NCT00873041|556786|P1|Extension Study|Adverse Event|1
174559|NCT00873041|556784|P3|Core Study|Protocol deviation|1
174560|NCT00873041|556785|P2|Core Study|Protocol deviation|0
174561|NCT00873041|556786|P1|Core Study|Protocol deviation|1
174562|NCT00873041|556784|P3|Core Study|Abnormal laboratory value|1
174563|NCT00873041|556785|P2|Core Study|Abnormal laboratory value|0
174564|NCT00873041|556786|P1|Core Study|Abnormal laboratory value|0
174565|NCT00873041|556784|P3|Core Study|Lost to Follow-up|0
174566|NCT00873041|556785|P2|Core Study|Lost to Follow-up|1
174567|NCT00873041|556786|P1|Core Study|Lost to Follow-up|3
174568|NCT00873041|556784|P3|Core Study|Withdrawal by Subject|2
174569|NCT00873041|556785|P2|Core Study|Withdrawal by Subject|2
174570|NCT00873041|556786|P1|Core Study|Withdrawal by Subject|1
174571|NCT00873041|556784|P3|Core Study|Adverse Event|1
174572|NCT00873041|556785|P2|Core Study|Adverse Event|3
174573|NCT00873041|556786|P1|Core Study|Adverse Event|2
174574|NCT00873093|556845|P5|Overall Study|Ineligible|0
174575|NCT00873093|556846|P4|Overall Study|Ineligible|1
174576|NCT00873093|556847|P3|Overall Study|Ineligible|0
174577|NCT00873093|556848|P2|Overall Study|Ineligible|1
174578|NCT00873093|556849|P1|Overall Study|Ineligible|0
174579|NCT00873093|556845|P5|Overall Study|Withdrawal by Subject|0
174580|NCT00873093|556846|P4|Overall Study|Withdrawal by Subject|0
174581|NCT00873093|556847|P3|Overall Study|Withdrawal by Subject|4
174582|NCT00873093|556848|P2|Overall Study|Withdrawal by Subject|4
174583|NCT00873093|556849|P1|Overall Study|Withdrawal by Subject|1
174584|NCT00873093|556845|P5|Overall Study|Physician Decision|2
174585|NCT00873093|556846|P4|Overall Study|Physician Decision|10
174586|NCT00873093|556847|P3|Overall Study|Physician Decision|10
174587|NCT00873093|556848|P2|Overall Study|Physician Decision|17
174588|NCT00873093|556849|P1|Overall Study|Physician Decision|0
174589|NCT00873093|556845|P5|Overall Study|Death|0
174590|NCT00873093|556846|P4|Overall Study|Death|0
174591|NCT00873093|556847|P3|Overall Study|Death|2
174592|NCT00873093|556848|P2|Overall Study|Death|3
174593|NCT00873093|556849|P1|Overall Study|Death|0
174594|NCT00873093|556845|P5|Overall Study|Adverse Event|0
174595|NCT00873093|556846|P4|Overall Study|Adverse Event|0
174596|NCT00873093|556847|P3|Overall Study|Adverse Event|0
174597|NCT00873093|556848|P2|Overall Study|Adverse Event|2
174598|NCT00873093|556849|P1|Overall Study|Adverse Event|0
174599|NCT00873119|556905|P2|Overall Study|Not treated|0
174600|NCT00873119|556906|P1|Overall Study|Not treated|2
174601|NCT00873119|556905|P2|Overall Study|Other|5
174602|NCT00873119|556906|P1|Overall Study|Other|2
174603|NCT00873119|556905|P2|Overall Study|Death|1
174604|NCT00873119|556906|P1|Overall Study|Death|2
174605|NCT00873119|556905|P2|Overall Study|Progressive disease|18
174606|NCT00873119|556906|P1|Overall Study|Progressive disease|26
174607|NCT00873119|556905|P2|Overall Study|Adverse Event|0
174608|NCT00873119|556906|P1|Overall Study|Adverse Event|8
174609|NCT00873119|556905|P2|Overall Study|Patient request|2
174610|NCT00873119|556906|P1|Overall Study|Patient request|4
174611|NCT00873730|556935|P2|Overall Study|Sponsor decision|0
174612|NCT00873730|556936|P1|Overall Study|Sponsor decision|1
174613|NCT00873730|556935|P2|Overall Study|Withdrawal by Subject|1
174614|NCT00873730|556936|P1|Overall Study|Withdrawal by Subject|0
174615|NCT00873730|556935|P2|Overall Study|Adverse Event|2
174616|NCT00873730|556936|P1|Overall Study|Adverse Event|0
174617|NCT00873730|556935|P2|Overall Study|Protocol Deviation|2
174618|NCT00873730|556936|P1|Overall Study|Protocol Deviation|5
174619|NCT00873860|556993|P4|Overall Study|Unspecified|0
174620|NCT00873860|556994|P3|Overall Study|Unspecified|1
174621|NCT00873860|556995|P2|Overall Study|Unspecified|0
174622|NCT00873860|556996|P1|Overall Study|Unspecified|1
174623|NCT00873860|556993|P4|Overall Study|Death|0
174624|NCT00873860|556994|P3|Overall Study|Death|0
174625|NCT00873860|556995|P2|Overall Study|Death|0
174626|NCT00873860|556996|P1|Overall Study|Death|1
174627|NCT00873860|556993|P4|Overall Study|Withdrawal by Subject|0
174628|NCT00873860|556994|P3|Overall Study|Withdrawal by Subject|2
174629|NCT00873860|556995|P2|Overall Study|Withdrawal by Subject|0
174630|NCT00873860|556996|P1|Overall Study|Withdrawal by Subject|1
174631|NCT00873860|556993|P4|Overall Study|Lost to Follow-up|1
174632|NCT00873860|556994|P3|Overall Study|Lost to Follow-up|0
174633|NCT00873860|556995|P2|Overall Study|Lost to Follow-up|0
174634|NCT00873860|556996|P1|Overall Study|Lost to Follow-up|1
174635|NCT00873912|557088|P2|Overall Study|Lost to Follow-up|0
174636|NCT00873912|557089|P1|Overall Study|Lost to Follow-up|2
174637|NCT00873912|557088|P2|Overall Study|Withdrawal by Subject|0
174638|NCT00873912|557089|P1|Overall Study|Withdrawal by Subject|1
174639|NCT00874029|557103|P1|Overall Study|Lost to Follow-up|5
174640|NCT00874029|557103|P1|Overall Study|Adverse Event|1
174641|NCT00874029|557103|P1|Overall Study|Physician Decision|1
174642|NCT00874029|557103|P1|Overall Study|Pregnancy|4
174643|NCT00874029|557103|P1|Overall Study|Withdrawal by Subject|10
174644|NCT00874120|557126|P2|Second Intervention|Protocol Violation|0
174645|NCT00874120|557127|P1|Second Intervention|Protocol Violation|1
174646|NCT00874120|557126|P2|Second Intervention|Withdrawal by Subject|0
174647|NCT00874120|557127|P1|Second Intervention|Withdrawal by Subject|1
174648|NCT00874120|557126|P2|First Intervention|positive drug test|0
174649|NCT00874120|557127|P1|First Intervention|positive drug test|1
174650|NCT00874120|557126|P2|First Intervention|Protocol Violation|0
174651|NCT00874120|557127|P1|First Intervention|Protocol Violation|3
174652|NCT00874120|557126|P2|First Intervention|Lost to Follow-up|1
174653|NCT00874120|557127|P1|First Intervention|Lost to Follow-up|0
174654|NCT00874120|557126|P2|First Intervention|Withdrawal by Subject|0
174655|NCT00874120|557127|P1|First Intervention|Withdrawal by Subject|2
174656|NCT00874120|557126|P2|First Intervention|Adverse Event|1
174657|NCT00874120|557127|P1|First Intervention|Adverse Event|0
174658|NCT00874276|557147|P2|Overall Study|Withdrawal by Subject|1
174659|NCT00874276|557148|P1|Overall Study|Withdrawal by Subject|1
174660|NCT00874497|557158|P2|Overall Study|Withdrawal by Subject|4
174661|NCT00874497|557159|P1|Overall Study|Withdrawal by Subject|5
174662|NCT00874497|557158|P2|Overall Study|Physician Decision|1
174663|NCT00874497|557159|P1|Overall Study|Physician Decision|1
174664|NCT00874497|557158|P2|Overall Study|Met Withdrawal Criteria|2
174665|NCT00874497|557159|P1|Overall Study|Met Withdrawal Criteria|4
174666|NCT00874497|557158|P2|Overall Study|Sponsor Discontinued Trial|3
174667|NCT00874497|557159|P1|Overall Study|Sponsor Discontinued Trial|7
174668|NCT00874497|557158|P2|Overall Study|Adverse Event|4
174669|NCT00874497|557159|P1|Overall Study|Adverse Event|9
174670|NCT00874497|557158|P2|Overall Study|Lost to Follow-up|4
174671|NCT00874497|557159|P1|Overall Study|Lost to Follow-up|2
174672|NCT00874549|557210|P4|Overall Study|Withdrawal by Subject|1
174673|NCT00874549|557211|P3|Overall Study|Withdrawal by Subject|0
174674|NCT00874549|557212|P2|Overall Study|Withdrawal by Subject|1
174675|NCT00874549|557213|P1|Overall Study|Withdrawal by Subject|0
174676|NCT00874549|557210|P4|Overall Study|Lost to Follow-up|0
174677|NCT00874549|557211|P3|Overall Study|Lost to Follow-up|1
174678|NCT00874549|557212|P2|Overall Study|Lost to Follow-up|0
174679|NCT00874549|557213|P1|Overall Study|Lost to Follow-up|0
174680|NCT00874549|557210|P4|Overall Study|Protocol Violation|1
174681|NCT00874549|557211|P3|Overall Study|Protocol Violation|2
174682|NCT00874549|557212|P2|Overall Study|Protocol Violation|0
174683|NCT00874549|557213|P1|Overall Study|Protocol Violation|1
174684|NCT00874549|557210|P4|Overall Study|Adverse Event|0
174685|NCT00874549|557211|P3|Overall Study|Adverse Event|1
174686|NCT00874549|557212|P2|Overall Study|Adverse Event|0
174687|NCT00874549|557213|P1|Overall Study|Adverse Event|0
174688|NCT00868192|557318|P1|Overall Study|Ineligible|4
174689|NCT00868231|557358|P6|Treatment Period 3|Adverse Event|0
174690|NCT00868231|557359|P5|Treatment Period 3|Adverse Event|0
174691|NCT00868231|557360|P4|Treatment Period 3|Adverse Event|0
174692|NCT00868231|557361|P3|Treatment Period 3|Adverse Event|1
174693|NCT00868231|557362|P2|Treatment Period 3|Adverse Event|0
174694|NCT00868231|557363|P1|Treatment Period 3|Adverse Event|0
174695|NCT00868231|557358|P6|Treatment Period 2|Adverse Event|0
174696|NCT00868231|557359|P5|Treatment Period 2|Adverse Event|0
174697|NCT00868231|557360|P4|Treatment Period 2|Adverse Event|0
174698|NCT00868231|557361|P3|Treatment Period 2|Adverse Event|0
174699|NCT00868231|557362|P2|Treatment Period 2|Adverse Event|0
174700|NCT00868231|557363|P1|Treatment Period 2|Adverse Event|1
174701|NCT00868231|557358|P6|Treatment Period 1|Adverse Event|0
174702|NCT00868231|557359|P5|Treatment Period 1|Adverse Event|1
174703|NCT00868231|557360|P4|Treatment Period 1|Adverse Event|0
174704|NCT00868231|557361|P3|Treatment Period 1|Adverse Event|0
174705|NCT00868231|557362|P2|Treatment Period 1|Adverse Event|0
174706|NCT00868231|557363|P1|Treatment Period 1|Adverse Event|0
174707|NCT00868296|557406|P2|Overall Study|Withdrawal by Subject|1
174708|NCT00868296|557407|P1|Overall Study|Withdrawal by Subject|0
174709|NCT00868296|557406|P2|Overall Study|Adverse Event|2
174710|NCT00868296|557407|P1|Overall Study|Adverse Event|0
174711|NCT00868439|557456|P2|Overall Study|Withdrawal by Subject|1
174712|NCT00868439|557457|P1|Overall Study|Withdrawal by Subject|0
174713|NCT00868439|557456|P2|Overall Study|Physician Decision|0
174714|NCT00868439|557457|P1|Overall Study|Physician Decision|1
174715|NCT00868439|557456|P2|Overall Study|Protocol Violation|1
174716|NCT00868439|557457|P1|Overall Study|Protocol Violation|1
174717|NCT00868439|557456|P2|Overall Study|Death|1
174718|NCT00868439|557457|P1|Overall Study|Death|0
174719|NCT00868439|557456|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
174720|NCT00868439|557457|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
174721|NCT00868439|557456|P2|Overall Study|Adverse Event|3
174722|NCT00868439|557457|P1|Overall Study|Adverse Event|4
174723|NCT00868517|557489|P3|Overall Study|Protocol Violation|0
174724|NCT00868517|557490|P2|Overall Study|Protocol Violation|1
174725|NCT00868517|557491|P1|Overall Study|Protocol Violation|1
174726|NCT00868517|557489|P3|Overall Study|Withdrawal by Subject|2
174727|NCT00868517|557490|P2|Overall Study|Withdrawal by Subject|3
174728|NCT00868517|557491|P1|Overall Study|Withdrawal by Subject|3
174729|NCT00868530|557514|P1|Overall Study|Lost to Follow-up|1
174730|NCT00868530|557514|P1|Overall Study|Adverse Event|3
174731|NCT00868790|557569|P14|Post-study|Excluded Medication|0
174732|NCT00868790|557570|P13|Post-study|Excluded Medication|0
174733|NCT00868790|557571|P12|Post-study|Excluded Medication|0
174734|NCT00868790|557572|P11|Post-study|Excluded Medication|0
174735|NCT00868790|557573|P10|Post-study|Excluded Medication|1
174736|NCT00868790|557574|P9|Post-study|Excluded Medication|0
174737|NCT00868790|557575|P8|Post-study|Excluded Medication|2
174738|NCT00868790|557576|P7|Post-study|Excluded Medication|0
174739|NCT00868790|557577|P6|Post-study|Excluded Medication|0
174740|NCT00868790|557578|P5|Post-study|Excluded Medication|0
174741|NCT00868790|557579|P4|Post-study|Excluded Medication|0
174742|NCT00868790|557580|P3|Post-study|Excluded Medication|0
174743|NCT00868790|557581|P2|Post-study|Excluded Medication|0
174744|NCT00868790|557582|P1|Post-study|Excluded Medication|0
174745|NCT00868790|557569|P14|Post-study|Withdrawal by Subject|0
174746|NCT00868790|557570|P13|Post-study|Withdrawal by Subject|0
174747|NCT00868790|557571|P12|Post-study|Withdrawal by Subject|0
174748|NCT00868790|557572|P11|Post-study|Withdrawal by Subject|0
174749|NCT00868790|557573|P10|Post-study|Withdrawal by Subject|0
174750|NCT00868790|557574|P9|Post-study|Withdrawal by Subject|0
174751|NCT00868790|557575|P8|Post-study|Withdrawal by Subject|0
174752|NCT00868790|557576|P7|Post-study|Withdrawal by Subject|0
174753|NCT00868790|557577|P6|Post-study|Withdrawal by Subject|0
174754|NCT00868790|557578|P5|Post-study|Withdrawal by Subject|1
174755|NCT00868790|557579|P4|Post-study|Withdrawal by Subject|0
174756|NCT00868790|557580|P3|Post-study|Withdrawal by Subject|0
174757|NCT00868790|557581|P2|Post-study|Withdrawal by Subject|0
174758|NCT00868790|557582|P1|Post-study|Withdrawal by Subject|0
174759|NCT00868790|557569|P14|Period 4|Abnormal ALT/AST|0
174760|NCT00868790|557570|P13|Period 4|Abnormal ALT/AST|0
174761|NCT00868790|557571|P12|Period 4|Abnormal ALT/AST|0
174762|NCT00868790|557572|P11|Period 4|Abnormal ALT/AST|0
174763|NCT00868790|557573|P10|Period 4|Abnormal ALT/AST|0
174764|NCT00868790|557574|P9|Period 4|Abnormal ALT/AST|0
174765|NCT00868790|557575|P8|Period 4|Abnormal ALT/AST|0
174766|NCT00868790|557576|P7|Period 4|Abnormal ALT/AST|0
174767|NCT00868790|557577|P6|Period 4|Abnormal ALT/AST|0
174768|NCT00868790|557578|P5|Period 4|Abnormal ALT/AST|0
174769|NCT00868790|557579|P4|Period 4|Abnormal ALT/AST|0
174770|NCT00868790|557580|P3|Period 4|Abnormal ALT/AST|1
174771|NCT00868790|557581|P2|Period 4|Abnormal ALT/AST|0
174772|NCT00868790|557582|P1|Period 4|Abnormal ALT/AST|0
174773|NCT00868790|557569|P14|Period 4|Study Terminated by Sponsor|1
174774|NCT00868790|557570|P13|Period 4|Study Terminated by Sponsor|0
174775|NCT00868790|557571|P12|Period 4|Study Terminated by Sponsor|1
174776|NCT00868790|557572|P11|Period 4|Study Terminated by Sponsor|2
174777|NCT00868790|557573|P10|Period 4|Study Terminated by Sponsor|0
174778|NCT00868790|557574|P9|Period 4|Study Terminated by Sponsor|2
174779|NCT00868790|557575|P8|Period 4|Study Terminated by Sponsor|1
174780|NCT00868790|557576|P7|Period 4|Study Terminated by Sponsor|0
174781|NCT00868790|557577|P6|Period 4|Study Terminated by Sponsor|0
174782|NCT00868790|557578|P5|Period 4|Study Terminated by Sponsor|0
174783|NCT00868790|557579|P4|Period 4|Study Terminated by Sponsor|0
174784|NCT00868790|557580|P3|Period 4|Study Terminated by Sponsor|0
174785|NCT00868790|557581|P2|Period 4|Study Terminated by Sponsor|0
174786|NCT00868790|557582|P1|Period 4|Study Terminated by Sponsor|2
174787|NCT00868790|557569|P14|Period 4|Lost to Follow-up|0
174788|NCT00868790|557570|P13|Period 4|Lost to Follow-up|0
174789|NCT00868790|557571|P12|Period 4|Lost to Follow-up|0
174790|NCT00868790|557572|P11|Period 4|Lost to Follow-up|0
174791|NCT00868790|557573|P10|Period 4|Lost to Follow-up|0
174792|NCT00868790|557574|P9|Period 4|Lost to Follow-up|0
174793|NCT00868790|557575|P8|Period 4|Lost to Follow-up|1
174794|NCT00868790|557576|P7|Period 4|Lost to Follow-up|0
174795|NCT00868790|557577|P6|Period 4|Lost to Follow-up|0
174796|NCT00868790|557578|P5|Period 4|Lost to Follow-up|0
174797|NCT00868790|557579|P4|Period 4|Lost to Follow-up|0
174798|NCT00868790|557580|P3|Period 4|Lost to Follow-up|0
174799|NCT00868790|557581|P2|Period 4|Lost to Follow-up|0
174800|NCT00868790|557582|P1|Period 4|Lost to Follow-up|0
174801|NCT00868790|557569|P14|Period 4|Adverse Event|0
174802|NCT00868790|557570|P13|Period 4|Adverse Event|1
174803|NCT00868790|557571|P12|Period 4|Adverse Event|0
174804|NCT00868790|557572|P11|Period 4|Adverse Event|1
174805|NCT00868790|557573|P10|Period 4|Adverse Event|0
174806|NCT00868790|557574|P9|Period 4|Adverse Event|0
174807|NCT00868790|557575|P8|Period 4|Adverse Event|1
174808|NCT00868790|557576|P7|Period 4|Adverse Event|0
174809|NCT00868790|557577|P6|Period 4|Adverse Event|0
174810|NCT00868790|557578|P5|Period 4|Adverse Event|0
174811|NCT00868790|557579|P4|Period 4|Adverse Event|0
174812|NCT00868790|557580|P3|Period 4|Adverse Event|0
174813|NCT00868790|557581|P2|Period 4|Adverse Event|0
174814|NCT00868790|557582|P1|Period 4|Adverse Event|0
174815|NCT00868790|557569|P14|Period 3|Study Terminated by Sponsor|0
174816|NCT00868790|557570|P13|Period 3|Study Terminated by Sponsor|0
174817|NCT00868790|557571|P12|Period 3|Study Terminated by Sponsor|0
174818|NCT00868790|557572|P11|Period 3|Study Terminated by Sponsor|0
174819|NCT00868790|557573|P10|Period 3|Study Terminated by Sponsor|0
174820|NCT00868790|557574|P9|Period 3|Study Terminated by Sponsor|0
174821|NCT00868790|557575|P8|Period 3|Study Terminated by Sponsor|0
174822|NCT00868790|557576|P7|Period 3|Study Terminated by Sponsor|0
174823|NCT00868790|557577|P6|Period 3|Study Terminated by Sponsor|0
174824|NCT00868790|557578|P5|Period 3|Study Terminated by Sponsor|0
174825|NCT00868790|557579|P4|Period 3|Study Terminated by Sponsor|1
174826|NCT00868790|557580|P3|Period 3|Study Terminated by Sponsor|0
174827|NCT00868790|557581|P2|Period 3|Study Terminated by Sponsor|0
174828|NCT00868790|557582|P1|Period 3|Study Terminated by Sponsor|0
174829|NCT00868790|557569|P14|Period 3|Protocol Violation|0
174830|NCT00868790|557570|P13|Period 3|Protocol Violation|0
174831|NCT00868790|557571|P12|Period 3|Protocol Violation|0
174832|NCT00868790|557572|P11|Period 3|Protocol Violation|1
174833|NCT00868790|557573|P10|Period 3|Protocol Violation|0
174834|NCT00868790|557574|P9|Period 3|Protocol Violation|0
174835|NCT00868790|557575|P8|Period 3|Protocol Violation|0
174836|NCT00868790|557576|P7|Period 3|Protocol Violation|0
174837|NCT00868790|557577|P6|Period 3|Protocol Violation|0
174838|NCT00868790|557578|P5|Period 3|Protocol Violation|0
174839|NCT00868790|557579|P4|Period 3|Protocol Violation|0
174840|NCT00868790|557580|P3|Period 3|Protocol Violation|0
174841|NCT00868790|557581|P2|Period 3|Protocol Violation|0
174842|NCT00868790|557582|P1|Period 3|Protocol Violation|0
174843|NCT00868790|557569|P14|Period 3|Adverse Event|0
174844|NCT00868790|557570|P13|Period 3|Adverse Event|0
174845|NCT00868790|557571|P12|Period 3|Adverse Event|0
174846|NCT00868790|557572|P11|Period 3|Adverse Event|0
174847|NCT00868790|557573|P10|Period 3|Adverse Event|1
174848|NCT00868790|557574|P9|Period 3|Adverse Event|0
174849|NCT00868790|557575|P8|Period 3|Adverse Event|0
174850|NCT00868790|557576|P7|Period 3|Adverse Event|0
174851|NCT00868790|557577|P6|Period 3|Adverse Event|0
174852|NCT00868790|557578|P5|Period 3|Adverse Event|0
174853|NCT00868790|557579|P4|Period 3|Adverse Event|0
174854|NCT00868790|557580|P3|Period 3|Adverse Event|0
174855|NCT00868790|557581|P2|Period 3|Adverse Event|0
174856|NCT00868790|557582|P1|Period 3|Adverse Event|0
174857|NCT00868790|557569|P14|Period 2|Withdrawal by Subject|1
174858|NCT00868790|557570|P13|Period 2|Withdrawal by Subject|0
174859|NCT00868790|557571|P12|Period 2|Withdrawal by Subject|0
174860|NCT00868790|557572|P11|Period 2|Withdrawal by Subject|0
174861|NCT00868790|557573|P10|Period 2|Withdrawal by Subject|0
174862|NCT00868790|557574|P9|Period 2|Withdrawal by Subject|1
174863|NCT00868790|557575|P8|Period 2|Withdrawal by Subject|0
174864|NCT00868790|557576|P7|Period 2|Withdrawal by Subject|0
174865|NCT00868790|557577|P6|Period 2|Withdrawal by Subject|0
174866|NCT00868790|557578|P5|Period 2|Withdrawal by Subject|0
174867|NCT00868790|557579|P4|Period 2|Withdrawal by Subject|0
174868|NCT00868790|557580|P3|Period 2|Withdrawal by Subject|0
174869|NCT00868790|557581|P2|Period 2|Withdrawal by Subject|0
174870|NCT00868790|557582|P1|Period 2|Withdrawal by Subject|0
174871|NCT00868790|557569|P14|Period 2|Lost to Follow-up|0
174872|NCT00868790|557570|P13|Period 2|Lost to Follow-up|0
174873|NCT00868790|557571|P12|Period 2|Lost to Follow-up|0
174874|NCT00868790|557572|P11|Period 2|Lost to Follow-up|0
174875|NCT00868790|557573|P10|Period 2|Lost to Follow-up|0
174876|NCT00868790|557574|P9|Period 2|Lost to Follow-up|0
174877|NCT00868790|557575|P8|Period 2|Lost to Follow-up|0
174878|NCT00868790|557576|P7|Period 2|Lost to Follow-up|0
174879|NCT00868790|557577|P6|Period 2|Lost to Follow-up|1
174880|NCT00868790|557578|P5|Period 2|Lost to Follow-up|0
174881|NCT00868790|557579|P4|Period 2|Lost to Follow-up|0
174882|NCT00868790|557580|P3|Period 2|Lost to Follow-up|0
174883|NCT00868790|557581|P2|Period 2|Lost to Follow-up|1
174884|NCT00868790|557582|P1|Period 2|Lost to Follow-up|0
174885|NCT00868790|557569|P14|Period 2|Adverse Event|0
174886|NCT00868790|557570|P13|Period 2|Adverse Event|0
174887|NCT00868790|557571|P12|Period 2|Adverse Event|0
174888|NCT00868790|557572|P11|Period 2|Adverse Event|0
174889|NCT00868790|557573|P10|Period 2|Adverse Event|0
174890|NCT00868790|557574|P9|Period 2|Adverse Event|1
174891|NCT00868790|557575|P8|Period 2|Adverse Event|0
174892|NCT00868790|557576|P7|Period 2|Adverse Event|0
174893|NCT00868790|557577|P6|Period 2|Adverse Event|0
174894|NCT00868790|557578|P5|Period 2|Adverse Event|0
174895|NCT00868790|557579|P4|Period 2|Adverse Event|0
174896|NCT00868790|557580|P3|Period 2|Adverse Event|0
174897|NCT00868790|557581|P2|Period 2|Adverse Event|0
174898|NCT00868790|557582|P1|Period 2|Adverse Event|0
174899|NCT00868790|557569|P14|Period 1|Lost to Follow-up|0
174900|NCT00868790|557570|P13|Period 1|Lost to Follow-up|0
174901|NCT00868790|557571|P12|Period 1|Lost to Follow-up|0
174902|NCT00868790|557572|P11|Period 1|Lost to Follow-up|0
174903|NCT00868790|557573|P10|Period 1|Lost to Follow-up|0
174904|NCT00868790|557574|P9|Period 1|Lost to Follow-up|0
174905|NCT00868790|557575|P8|Period 1|Lost to Follow-up|0
174906|NCT00868790|557576|P7|Period 1|Lost to Follow-up|0
174907|NCT00868790|557577|P6|Period 1|Lost to Follow-up|1
174908|NCT00868790|557578|P5|Period 1|Lost to Follow-up|0
174909|NCT00868790|557579|P4|Period 1|Lost to Follow-up|0
174910|NCT00868790|557580|P3|Period 1|Lost to Follow-up|0
174911|NCT00868790|557581|P2|Period 1|Lost to Follow-up|0
174912|NCT00868790|557582|P1|Period 1|Lost to Follow-up|0
174913|NCT00868790|557569|P14|Period 1|Abnormal Triglycerides|0
174914|NCT00868790|557570|P13|Period 1|Abnormal Triglycerides|0
174915|NCT00868790|557571|P12|Period 1|Abnormal Triglycerides|0
174916|NCT00868790|557572|P11|Period 1|Abnormal Triglycerides|0
174917|NCT00868790|557573|P10|Period 1|Abnormal Triglycerides|0
174918|NCT00868790|557574|P9|Period 1|Abnormal Triglycerides|0
174919|NCT00868790|557575|P8|Period 1|Abnormal Triglycerides|0
174920|NCT00868790|557576|P7|Period 1|Abnormal Triglycerides|0
174921|NCT00868790|557577|P6|Period 1|Abnormal Triglycerides|0
174922|NCT00868790|557578|P5|Period 1|Abnormal Triglycerides|1
174923|NCT00868790|557579|P4|Period 1|Abnormal Triglycerides|0
174924|NCT00868790|557580|P3|Period 1|Abnormal Triglycerides|0
174925|NCT00868790|557581|P2|Period 1|Abnormal Triglycerides|0
174926|NCT00868790|557582|P1|Period 1|Abnormal Triglycerides|0
174927|NCT00868790|557569|P14|Period 1|Withdrawal by Subject|1
174928|NCT00868790|557570|P13|Period 1|Withdrawal by Subject|0
174929|NCT00868790|557571|P12|Period 1|Withdrawal by Subject|0
174930|NCT00868790|557572|P11|Period 1|Withdrawal by Subject|0
174931|NCT00868790|557573|P10|Period 1|Withdrawal by Subject|0
174932|NCT00868790|557574|P9|Period 1|Withdrawal by Subject|0
174933|NCT00868790|557575|P8|Period 1|Withdrawal by Subject|0
174934|NCT00868790|557576|P7|Period 1|Withdrawal by Subject|0
174935|NCT00868790|557577|P6|Period 1|Withdrawal by Subject|0
174936|NCT00868790|557578|P5|Period 1|Withdrawal by Subject|0
174937|NCT00868790|557579|P4|Period 1|Withdrawal by Subject|0
174938|NCT00868790|557580|P3|Period 1|Withdrawal by Subject|0
174939|NCT00868790|557581|P2|Period 1|Withdrawal by Subject|1
174940|NCT00868790|557582|P1|Period 1|Withdrawal by Subject|0
174941|NCT00868790|557569|P14|Period 1|Protocol Violation|0
174942|NCT00868790|557570|P13|Period 1|Protocol Violation|0
174943|NCT00868790|557571|P12|Period 1|Protocol Violation|0
174944|NCT00868790|557572|P11|Period 1|Protocol Violation|0
174945|NCT00868790|557573|P10|Period 1|Protocol Violation|0
174946|NCT00868790|557574|P9|Period 1|Protocol Violation|0
174947|NCT00868790|557575|P8|Period 1|Protocol Violation|0
174948|NCT00868790|557576|P7|Period 1|Protocol Violation|0
174949|NCT00868790|557577|P6|Period 1|Protocol Violation|0
174950|NCT00868790|557578|P5|Period 1|Protocol Violation|0
174951|NCT00868790|557579|P4|Period 1|Protocol Violation|0
174952|NCT00868790|557580|P3|Period 1|Protocol Violation|0
174953|NCT00868790|557581|P2|Period 1|Protocol Violation|0
174954|NCT00868790|557582|P1|Period 1|Protocol Violation|1
174955|NCT00868790|557569|P14|Period 1|Adverse Event|1
174956|NCT00868790|557570|P13|Period 1|Adverse Event|0
174957|NCT00868790|557571|P12|Period 1|Adverse Event|0
174958|NCT00868790|557572|P11|Period 1|Adverse Event|0
174959|NCT00868790|557573|P10|Period 1|Adverse Event|0
174960|NCT00868790|557574|P9|Period 1|Adverse Event|1
174961|NCT00868790|557575|P8|Period 1|Adverse Event|3
174962|NCT00868790|557576|P7|Period 1|Adverse Event|0
174963|NCT00868790|557577|P6|Period 1|Adverse Event|0
174964|NCT00868790|557578|P5|Period 1|Adverse Event|0
174965|NCT00868790|557579|P4|Period 1|Adverse Event|0
174966|NCT00868790|557580|P3|Period 1|Adverse Event|0
174967|NCT00868790|557581|P2|Period 1|Adverse Event|0
174968|NCT00868790|557582|P1|Period 1|Adverse Event|1
174969|NCT00868998|557625|P1|Overall Study|Death|1
174970|NCT00868998|557625|P1|Overall Study|Progression of disease|2
174971|NCT00868998|557625|P1|Overall Study|Withdrawal by Subject|1
174972|NCT00868998|557625|P1|Overall Study|Screen Failure|1
174973|NCT00869050|557630|P1|Overall Study|Screen Failure|3
174974|NCT00869089|557635|P1|Overall Study|Screen Fail|1
174975|NCT00869089|557635|P1|Overall Study|Withdrawal by Subject|1
174976|NCT00869089|557635|P1|Overall Study|Lost to Follow-up|1
174977|NCT00869128|557639|P2|Overall Study|lack of Compliance|6
174978|NCT00869128|557640|P1|Overall Study|lack of Compliance|6
174979|NCT00869258|557674|P1|Overall Study|Physician Decision|1
174980|NCT00869323|557678|P1|Maintenance Therapy|concurrent illness|1
174981|NCT00874770|557690|P4|Overall Study|Subject no Longer Meets Study Criteria|0
174982|NCT00874770|557691|P3|Overall Study|Subject no Longer Meets Study Criteria|0
174983|NCT00874770|557692|P2|Overall Study|Subject no Longer Meets Study Criteria|0
174984|NCT00874770|557693|P1|Overall Study|Subject no Longer Meets Study Criteria|1
174985|NCT00874770|557690|P4|Overall Study|Lost to Follow-up|1
174986|NCT00874770|557691|P3|Overall Study|Lost to Follow-up|0
174987|NCT00874770|557692|P2|Overall Study|Lost to Follow-up|0
174988|NCT00874770|557693|P1|Overall Study|Lost to Follow-up|1
174989|NCT00874770|557690|P4|Overall Study|Adverse Event|2
174990|NCT00874770|557691|P3|Overall Study|Adverse Event|4
174991|NCT00874770|557692|P2|Overall Study|Adverse Event|1
174992|NCT00874770|557693|P1|Overall Study|Adverse Event|1
174993|NCT00874770|557690|P4|Overall Study|Lack of Efficacy|2
174994|NCT00874770|557691|P3|Overall Study|Lack of Efficacy|0
174995|NCT00874770|557692|P2|Overall Study|Lack of Efficacy|0
174996|NCT00874770|557693|P1|Overall Study|Lack of Efficacy|2
174997|NCT00874822|557727|P1|Overall Study|excluded by criteria|8
174998|NCT00874848|557733|P2|Overall Study|Physician Decision|2
174999|NCT00874848|557734|P1|Overall Study|Physician Decision|0
175000|NCT00874848|557733|P2|Overall Study|Failure to comply with protocol|1
175001|NCT00874848|557734|P1|Overall Study|Failure to comply with protocol|0
175002|NCT00874848|557733|P2|Overall Study|Noncompliance|1
175003|NCT00874848|557734|P1|Overall Study|Noncompliance|1
175004|NCT00874848|557733|P2|Overall Study|Withdrawal by Subject|4
175005|NCT00874848|557734|P1|Overall Study|Withdrawal by Subject|7
175006|NCT00874848|557733|P2|Overall Study|Progressive neoplastic disease|18
175007|NCT00874848|557734|P1|Overall Study|Progressive neoplastic disease|38
175008|NCT00874848|557733|P2|Overall Study|Adverse Event|2
175009|NCT00874848|557734|P1|Overall Study|Adverse Event|13
175010|NCT00874939|557767|P1|Overall Study|Study terminated|4
175011|NCT00875017|557787|P6|Fourth Intervention|Inability to comply with fasting|1
175012|NCT00875017|557788|P5|Fourth Intervention|Inability to comply with fasting|0
175013|NCT00875017|557789|P4|Fourth Intervention|Inability to comply with fasting|0
175014|NCT00875017|557790|P3|Fourth Intervention|Inability to comply with fasting|0
175015|NCT00875017|557791|P2|Fourth Intervention|Inability to comply with fasting|0
175016|NCT00875017|557792|P1|Fourth Intervention|Inability to comply with fasting|0
175017|NCT00875017|557787|P6|Washout|Withdrawal by Subject|0
175018|NCT00875017|557788|P5|Washout|Withdrawal by Subject|1
175019|NCT00875017|557789|P4|Washout|Withdrawal by Subject|0
175020|NCT00875017|557790|P3|Washout|Withdrawal by Subject|0
175021|NCT00875017|557791|P2|Washout|Withdrawal by Subject|0
175022|NCT00875017|557792|P1|Washout|Withdrawal by Subject|0
175023|NCT00875017|557787|P6|Third Intervention|Adverse Event|0
175024|NCT00875017|557788|P5|Third Intervention|Adverse Event|0
175025|NCT00875017|557789|P4|Third Intervention|Adverse Event|0
175026|NCT00875017|557790|P3|Third Intervention|Adverse Event|1
175027|NCT00875017|557791|P2|Third Intervention|Adverse Event|1
175028|NCT00875017|557792|P1|Third Intervention|Adverse Event|0
175029|NCT00875017|557787|P6|Washout|Problems collecting rectal effluent|0
175030|NCT00875017|557788|P5|Washout|Problems collecting rectal effluent|0
175031|NCT00875017|557789|P4|Washout|Problems collecting rectal effluent|0
175032|NCT00875017|557790|P3|Washout|Problems collecting rectal effluent|0
175033|NCT00875017|557791|P2|Washout|Problems collecting rectal effluent|1
175034|NCT00875017|557792|P1|Washout|Problems collecting rectal effluent|0
175035|NCT00875017|557787|P6|Second Intervention|Adverse Event|0
175036|NCT00875017|557788|P5|Second Intervention|Adverse Event|0
175037|NCT00875017|557789|P4|Second Intervention|Adverse Event|1
175038|NCT00875017|557790|P3|Second Intervention|Adverse Event|0
175039|NCT00875017|557791|P2|Second Intervention|Adverse Event|0
175040|NCT00875017|557792|P1|Second Intervention|Adverse Event|0
175041|NCT00875017|557787|P6|Washout|Problem collecting rectal effluent|0
175042|NCT00875017|557788|P5|Washout|Problem collecting rectal effluent|0
175043|NCT00875017|557789|P4|Washout|Problem collecting rectal effluent|0
175044|NCT00875017|557790|P3|Washout|Problem collecting rectal effluent|1
175045|NCT00875017|557791|P2|Washout|Problem collecting rectal effluent|0
175046|NCT00875017|557792|P1|Washout|Problem collecting rectal effluent|0
175047|NCT00875017|557787|P6|First Intervention|Intolerance to nasogastric tube|0
175048|NCT00875017|557788|P5|First Intervention|Intolerance to nasogastric tube|1
175049|NCT00875017|557789|P4|First Intervention|Intolerance to nasogastric tube|0
175050|NCT00875017|557790|P3|First Intervention|Intolerance to nasogastric tube|0
175051|NCT00875017|557791|P2|First Intervention|Intolerance to nasogastric tube|0
175052|NCT00875017|557792|P1|First Intervention|Intolerance to nasogastric tube|0
175053|NCT00875017|557787|P6|First Intervention|Problems collecting rectal effluent|0
175054|NCT00875017|557788|P5|First Intervention|Problems collecting rectal effluent|0
175055|NCT00875017|557789|P4|First Intervention|Problems collecting rectal effluent|0
175056|NCT00875017|557790|P3|First Intervention|Problems collecting rectal effluent|0
175057|NCT00875017|557791|P2|First Intervention|Problems collecting rectal effluent|0
175058|NCT00875017|557792|P1|First Intervention|Problems collecting rectal effluent|1
175059|NCT00875017|557787|P6|First Intervention|Adverse Event|0
175060|NCT00875017|557788|P5|First Intervention|Adverse Event|0
175061|NCT00875017|557789|P4|First Intervention|Adverse Event|1
175062|NCT00875017|557790|P3|First Intervention|Adverse Event|0
175063|NCT00875017|557791|P2|First Intervention|Adverse Event|0
175064|NCT00875017|557792|P1|First Intervention|Adverse Event|0
175065|NCT00875017|557787|P6|First Intervention|Withdrawal by Subject|0
175066|NCT00875017|557788|P5|First Intervention|Withdrawal by Subject|0
175067|NCT00875017|557789|P4|First Intervention|Withdrawal by Subject|0
175068|NCT00875017|557790|P3|First Intervention|Withdrawal by Subject|1
175069|NCT00875017|557791|P2|First Intervention|Withdrawal by Subject|0
175070|NCT00875017|557792|P1|First Intervention|Withdrawal by Subject|1
175071|NCT00875420|557811|P5|Overall Study|Withdrawal by Subject|0
175072|NCT00875420|557812|P4|Overall Study|Withdrawal by Subject|0
175073|NCT00875420|557813|P3|Overall Study|Withdrawal by Subject|1
175074|NCT00875420|557814|P2|Overall Study|Withdrawal by Subject|0
175075|NCT00875420|557815|P1|Overall Study|Withdrawal by Subject|0
175076|NCT00875420|557811|P5|Overall Study|Sponsor decision|0
175077|NCT00875420|557812|P4|Overall Study|Sponsor decision|0
175078|NCT00875420|557813|P3|Overall Study|Sponsor decision|0
175079|NCT00875420|557814|P2|Overall Study|Sponsor decision|1
175080|NCT00875420|557815|P1|Overall Study|Sponsor decision|0
175081|NCT00875420|557811|P5|Overall Study|Prohibited medication|0
175082|NCT00875420|557812|P4|Overall Study|Prohibited medication|1
175083|NCT00875420|557813|P3|Overall Study|Prohibited medication|0
175084|NCT00875420|557814|P2|Overall Study|Prohibited medication|0
175085|NCT00875420|557815|P1|Overall Study|Prohibited medication|0
175086|NCT00875420|557811|P5|Overall Study|Personal reason|1
175087|NCT00875420|557812|P4|Overall Study|Personal reason|0
175088|NCT00875420|557813|P3|Overall Study|Personal reason|0
175089|NCT00875420|557814|P2|Overall Study|Personal reason|0
175090|NCT00875420|557815|P1|Overall Study|Personal reason|0
175091|NCT00875420|557811|P5|Overall Study|Lost to Follow-up|0
175092|NCT00875420|557812|P4|Overall Study|Lost to Follow-up|0
175093|NCT00875420|557813|P3|Overall Study|Lost to Follow-up|0
175094|NCT00875420|557814|P2|Overall Study|Lost to Follow-up|0
175095|NCT00875420|557815|P1|Overall Study|Lost to Follow-up|1
175096|NCT00875420|557811|P5|Overall Study|Inability to complete study procedures|1
175097|NCT00875420|557812|P4|Overall Study|Inability to complete study procedures|1
175098|NCT00875420|557813|P3|Overall Study|Inability to complete study procedures|1
175099|NCT00875420|557814|P2|Overall Study|Inability to complete study procedures|0
175100|NCT00875420|557815|P1|Overall Study|Inability to complete study procedures|1
175101|NCT00875420|557811|P5|Overall Study|Adverse Event|0
175102|NCT00875420|557812|P4|Overall Study|Adverse Event|0
175103|NCT00875420|557813|P3|Overall Study|Adverse Event|1
175104|NCT00875420|557814|P2|Overall Study|Adverse Event|1
175105|NCT00875420|557815|P1|Overall Study|Adverse Event|0
175106|NCT00875433|557842|P1|Overall Study|Not specified|3
175107|NCT00875433|557842|P1|Overall Study|Withdrawal by Subject|2
175108|NCT00875433|557842|P1|Overall Study|Other Adverse Event|14
175109|NCT00875433|557842|P1|Overall Study|Progressive disease|41
175110|NCT00875485|557869|P2|Challenge Dose Epoch|Pregnancy|0
175111|NCT00875485|557870|P1|Challenge Dose Epoch|Pregnancy|1
175112|NCT00875563|557929|P1|Overall Study|Still be eligible for follow-up|7
175113|NCT00875563|557929|P1|Overall Study|No long-term (3-5 year) consent|6
175114|NCT00875563|557929|P1|Overall Study|Withdrawal by Subject|7
175115|NCT00875563|557929|P1|Overall Study|Death|4
175116|NCT00875615|557942|P1|Overall Study|Withdrawal by Subject|1
175117|NCT00875706|557950|P3|Overall Study|Withdrawal by Subject|0
175118|NCT00875706|557951|P2|Overall Study|Withdrawal by Subject|0
175119|NCT00875706|557952|P1|Overall Study|Withdrawal by Subject|1
175120|NCT00875797|557971|P2|Overall Study|Protocol Violation|3
175121|NCT00875797|557972|P1|Overall Study|Protocol Violation|6
175122|NCT00875810|557982|P1|Overall Study|Device explanted|1
175123|NCT00875810|557982|P1|Overall Study|Patient enroled but not implanted|2
175124|NCT00875810|557982|P1|Overall Study|Lost to Follow-up|39
175125|NCT00875810|557982|P1|Overall Study|Physician Decision|3
175126|NCT00875810|557982|P1|Overall Study|Withdrawal by Subject|1
175127|NCT00875979|558004|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
175128|NCT00875979|558005|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
175129|NCT00875979|558004|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
175130|NCT00875979|558005|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
175131|NCT00875979|558004|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
175132|NCT00875979|558005|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
175133|NCT00875979|558004|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
175134|NCT00875979|558005|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
175135|NCT00875979|558004|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
175136|NCT00875979|558005|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
175137|NCT00875979|558004|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
175138|NCT00875979|558005|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
175139|NCT00875979|558004|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
175140|NCT00875979|558005|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
175141|NCT00875979|558004|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
175142|NCT00875979|558005|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
175143|NCT00875979|558004|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
175144|NCT00875979|558005|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
175145|NCT00876018|558018|P3|Overall Study|Withdrew Consent due to Adverse Event|2
175146|NCT00876018|558019|P2|Overall Study|Withdrew Consent due to Adverse Event|4
175147|NCT00876018|558020|P1|Overall Study|Withdrew Consent due to Adverse Event|5
175148|NCT00876018|558018|P3|Overall Study|Lost to Follow-up|1
175149|NCT00876018|558019|P2|Overall Study|Lost to Follow-up|1
175150|NCT00876018|558020|P1|Overall Study|Lost to Follow-up|0
175151|NCT00876265|558073|P1|Overall Study|Withdrawal by Subject|2
175152|NCT00876265|558073|P1|Overall Study|Lost to Follow-up|6
175153|NCT00876265|558073|P1|Overall Study|Miscellaneous reasons|4
175154|NCT00876343|558082|P3|Overall Study|Change of residence or other commitments|3
175155|NCT00876343|558083|P2|Overall Study|Change of residence or other commitments|2
175156|NCT00876343|558084|P1|Overall Study|Change of residence or other commitments|2
175157|NCT00876343|558082|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
175158|NCT00876343|558083|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
175159|NCT00876343|558084|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
175160|NCT00876343|558082|P3|Overall Study|Physician Decision|1
175161|NCT00876343|558083|P2|Overall Study|Physician Decision|1
175162|NCT00876343|558084|P1|Overall Study|Physician Decision|0
175163|NCT00876343|558082|P3|Overall Study|Protocol Violation|1
175164|NCT00876343|558083|P2|Overall Study|Protocol Violation|1
175165|NCT00876343|558084|P1|Overall Study|Protocol Violation|4
175166|NCT00876343|558082|P3|Overall Study|Lack of Efficacy|1
175167|NCT00876343|558083|P2|Overall Study|Lack of Efficacy|0
175168|NCT00876343|558084|P1|Overall Study|Lack of Efficacy|0
175169|NCT00876343|558082|P3|Overall Study|Withdrawal by Subject|3
175170|NCT00876343|558083|P2|Overall Study|Withdrawal by Subject|4
175171|NCT00876343|558084|P1|Overall Study|Withdrawal by Subject|4
175172|NCT00876343|558082|P3|Overall Study|Adverse Event|2
175173|NCT00876343|558083|P2|Overall Study|Adverse Event|8
175174|NCT00876343|558084|P1|Overall Study|Adverse Event|7
175175|NCT00876447|558100|P2|Overall Study|Adverse Event|8
175176|NCT00876447|558101|P1|Overall Study|Adverse Event|4
175177|NCT00876447|558100|P2|Overall Study|Lack of Efficacy|3
175178|NCT00876447|558101|P1|Overall Study|Lack of Efficacy|5
175179|NCT00876447|558100|P2|Overall Study|Pregnancy|2
175180|NCT00876447|558101|P1|Overall Study|Pregnancy|4
175181|NCT00876447|558100|P2|Overall Study|Lost to Follow-up|15
175182|NCT00876447|558101|P1|Overall Study|Lost to Follow-up|6
175183|NCT00876447|558100|P2|Overall Study|Personal reasons|28
175184|NCT00876447|558101|P1|Overall Study|Personal reasons|30
175185|NCT00876447|558100|P2|Overall Study|Protocol Violation|3
175186|NCT00876447|558101|P1|Overall Study|Protocol Violation|9
175187|NCT00876447|558100|P2|Overall Study|Site closure|14
175188|NCT00876447|558101|P1|Overall Study|Site closure|19
175189|NCT00876447|558100|P2|Overall Study|Other miscellaneous reasons|8
175190|NCT00876447|558101|P1|Overall Study|Other miscellaneous reasons|3
175191|NCT00876460|558167|P8|Mono Therapy Phase|Adverse Event|0
175192|NCT00876460|558168|P7|Mono Therapy Phase|Adverse Event|0
175193|NCT00876460|558169|P6|Mono Therapy Phase|Adverse Event|0
175194|NCT00876460|558170|P5|Mono Therapy Phase|Adverse Event|0
175195|NCT00876460|558171|P4|Mono Therapy Phase|Adverse Event|1
175196|NCT00876460|558172|P3|Mono Therapy Phase|Adverse Event|0
175197|NCT00876460|558173|P2|Mono Therapy Phase|Adverse Event|0
175198|NCT00876460|558174|P1|Mono Therapy Phase|Adverse Event|0
175199|NCT00876460|558167|P8|Mono Therapy Phase|Withdrawal by Subject|0
175200|NCT00876460|558168|P7|Mono Therapy Phase|Withdrawal by Subject|0
175201|NCT00876460|558169|P6|Mono Therapy Phase|Withdrawal by Subject|0
175202|NCT00876460|558170|P5|Mono Therapy Phase|Withdrawal by Subject|0
175203|NCT00876460|558171|P4|Mono Therapy Phase|Withdrawal by Subject|0
175204|NCT00876460|558172|P3|Mono Therapy Phase|Withdrawal by Subject|0
175205|NCT00876460|558173|P2|Mono Therapy Phase|Withdrawal by Subject|1
175206|NCT00876460|558174|P1|Mono Therapy Phase|Withdrawal by Subject|0
175207|NCT00876460|558167|P8|Mono Therapy Phase|Progressive disease|3
175208|NCT00876460|558168|P7|Mono Therapy Phase|Progressive disease|1
175209|NCT00876460|558169|P6|Mono Therapy Phase|Progressive disease|0
175210|NCT00876460|558170|P5|Mono Therapy Phase|Progressive disease|2
175211|NCT00876460|558171|P4|Mono Therapy Phase|Progressive disease|0
175212|NCT00876460|558172|P3|Mono Therapy Phase|Progressive disease|0
175213|NCT00876460|558173|P2|Mono Therapy Phase|Progressive disease|0
175214|NCT00876460|558174|P1|Mono Therapy Phase|Progressive disease|0
175215|NCT00876460|558167|P8|Combination Therapy Phase|Not treated|0
175216|NCT00876460|558168|P7|Combination Therapy Phase|Not treated|1
175217|NCT00876460|558169|P6|Combination Therapy Phase|Not treated|0
175218|NCT00876460|558170|P5|Combination Therapy Phase|Not treated|0
175219|NCT00876460|558171|P4|Combination Therapy Phase|Not treated|0
175220|NCT00876460|558172|P3|Combination Therapy Phase|Not treated|0
175221|NCT00876460|558173|P2|Combination Therapy Phase|Not treated|0
175222|NCT00876460|558174|P1|Combination Therapy Phase|Not treated|0
175223|NCT00876460|558167|P8|Combination Therapy Phase|Other reason not defined above|2
175224|NCT00876460|558168|P7|Combination Therapy Phase|Other reason not defined above|1
175225|NCT00876460|558169|P6|Combination Therapy Phase|Other reason not defined above|0
175226|NCT00876460|558170|P5|Combination Therapy Phase|Other reason not defined above|0
175227|NCT00876460|558171|P4|Combination Therapy Phase|Other reason not defined above|0
175309|NCT00877006|558416|P2|Treatment Period|Adverse Event|3
175228|NCT00876460|558172|P3|Combination Therapy Phase|Other reason not defined above|0
175229|NCT00876460|558173|P2|Combination Therapy Phase|Other reason not defined above|0
175230|NCT00876460|558174|P1|Combination Therapy Phase|Other reason not defined above|0
175231|NCT00876460|558167|P8|Combination Therapy Phase|Withdrawal by Subject|0
175232|NCT00876460|558168|P7|Combination Therapy Phase|Withdrawal by Subject|0
175233|NCT00876460|558169|P6|Combination Therapy Phase|Withdrawal by Subject|0
175234|NCT00876460|558170|P5|Combination Therapy Phase|Withdrawal by Subject|1
175235|NCT00876460|558171|P4|Combination Therapy Phase|Withdrawal by Subject|0
175236|NCT00876460|558172|P3|Combination Therapy Phase|Withdrawal by Subject|0
175237|NCT00876460|558173|P2|Combination Therapy Phase|Withdrawal by Subject|1
175238|NCT00876460|558174|P1|Combination Therapy Phase|Withdrawal by Subject|1
175239|NCT00876460|558167|P8|Combination Therapy Phase|Adverse Event|2
175240|NCT00876460|558168|P7|Combination Therapy Phase|Adverse Event|3
175241|NCT00876460|558169|P6|Combination Therapy Phase|Adverse Event|0
175242|NCT00876460|558170|P5|Combination Therapy Phase|Adverse Event|2
175243|NCT00876460|558171|P4|Combination Therapy Phase|Adverse Event|2
175244|NCT00876460|558172|P3|Combination Therapy Phase|Adverse Event|0
175245|NCT00876460|558173|P2|Combination Therapy Phase|Adverse Event|2
175246|NCT00876460|558174|P1|Combination Therapy Phase|Adverse Event|0
175247|NCT00876460|558167|P8|Combination Therapy Phase|Dose limiting toxicity|1
175248|NCT00876460|558168|P7|Combination Therapy Phase|Dose limiting toxicity|2
175249|NCT00876460|558169|P6|Combination Therapy Phase|Dose limiting toxicity|2
175250|NCT00876460|558170|P5|Combination Therapy Phase|Dose limiting toxicity|1
175251|NCT00876460|558171|P4|Combination Therapy Phase|Dose limiting toxicity|1
175252|NCT00876460|558172|P3|Combination Therapy Phase|Dose limiting toxicity|0
175253|NCT00876460|558173|P2|Combination Therapy Phase|Dose limiting toxicity|1
175254|NCT00876460|558174|P1|Combination Therapy Phase|Dose limiting toxicity|0
175255|NCT00876460|558167|P8|Combination Therapy Phase|Progressive disease|1
175256|NCT00876460|558168|P7|Combination Therapy Phase|Progressive disease|1
175257|NCT00876460|558169|P6|Combination Therapy Phase|Progressive disease|1
175258|NCT00876460|558170|P5|Combination Therapy Phase|Progressive disease|3
175259|NCT00876460|558171|P4|Combination Therapy Phase|Progressive disease|3
175260|NCT00876460|558172|P3|Combination Therapy Phase|Progressive disease|3
175261|NCT00876460|558173|P2|Combination Therapy Phase|Progressive disease|3
175262|NCT00876460|558174|P1|Combination Therapy Phase|Progressive disease|2
175263|NCT00876694|558246|P2|Overall Study|Death|0
175264|NCT00876694|558247|P1|Overall Study|Death|1
175265|NCT00876694|558246|P2|Overall Study|Administrative problems|1
175266|NCT00876694|558247|P1|Overall Study|Administrative problems|1
175267|NCT00876694|558246|P2|Overall Study|Abnormal test procedure result(s)|0
175268|NCT00876694|558247|P1|Overall Study|Abnormal test procedure result(s)|1
175269|NCT00876694|558246|P2|Overall Study|Unsatisfactory therapeutic effect|0
175270|NCT00876694|558247|P1|Overall Study|Unsatisfactory therapeutic effect|2
175271|NCT00876694|558246|P2|Overall Study|Subject withdrew consent|4
175272|NCT00876694|558247|P1|Overall Study|Subject withdrew consent|6
175273|NCT00876694|558246|P2|Overall Study|Adverse Event|7
175274|NCT00876694|558247|P1|Overall Study|Adverse Event|10
175275|NCT00876733|558269|P4|Overall Study|Data not available|1
175276|NCT00876733|558270|P3|Overall Study|Data not available|7
175277|NCT00876733|558271|P2|Overall Study|Data not available|3
175278|NCT00876733|558272|P1|Overall Study|Data not available|14
175279|NCT00876733|558269|P4|Overall Study|Lost to Follow-up|2
175280|NCT00876733|558270|P3|Overall Study|Lost to Follow-up|3
175281|NCT00876733|558271|P2|Overall Study|Lost to Follow-up|10
175282|NCT00876733|558272|P1|Overall Study|Lost to Follow-up|26
175283|NCT00876733|558269|P4|Overall Study|Lack of Efficacy|1
175284|NCT00876733|558270|P3|Overall Study|Lack of Efficacy|10
175285|NCT00876733|558271|P2|Overall Study|Lack of Efficacy|9
175286|NCT00876733|558272|P1|Overall Study|Lack of Efficacy|17
175287|NCT00876733|558269|P4|Overall Study|Adverse Event|3
175288|NCT00876733|558270|P3|Overall Study|Adverse Event|10
175289|NCT00876733|558271|P2|Overall Study|Adverse Event|20
175290|NCT00876733|558272|P1|Overall Study|Adverse Event|34
175291|NCT00876928|558405|P2|Overall Study|Hypokalemia-affects insulin secretion|0
175292|NCT00876928|558406|P1|Overall Study|Hypokalemia-affects insulin secretion|1
175293|NCT00876928|558405|P2|Overall Study|Lost to Follow-up|5
175294|NCT00876928|558406|P1|Overall Study|Lost to Follow-up|2
175295|NCT00877006|558416|P2|Treatment Period|Randomized but Not Treated|8
175296|NCT00877006|558417|P1|Treatment Period|Randomized but Not Treated|3
175297|NCT00877006|558416|P2|Treatment Period|Not Specified|4
175298|NCT00877006|558417|P1|Treatment Period|Not Specified|4
175299|NCT00877006|558416|P2|Treatment Period|Started New Treatment Regimen|5
175300|NCT00877006|558417|P1|Treatment Period|Started New Treatment Regimen|1
175301|NCT00877006|558416|P2|Treatment Period|Disease Progression|2
175302|NCT00877006|558417|P1|Treatment Period|Disease Progression|0
175303|NCT00877006|558416|P2|Treatment Period|Lost to Follow-up|1
175304|NCT00877006|558417|P1|Treatment Period|Lost to Follow-up|0
175305|NCT00877006|558416|P2|Treatment Period|Protocol Violation|0
175306|NCT00877006|558417|P1|Treatment Period|Protocol Violation|1
175307|NCT00877006|558416|P2|Treatment Period|Withdrawal by Subject|3
175308|NCT00877006|558417|P1|Treatment Period|Withdrawal by Subject|2
175310|NCT00877006|558417|P1|Treatment Period|Adverse Event|9
175311|NCT00877006|558416|P2|Treatment Period|Death|1
175312|NCT00877006|558417|P1|Treatment Period|Death|1
175313|NCT00877032|558450|P7|Overall Study|Did not meet entrance criteria|2
175314|NCT00877032|558451|P6|Overall Study|Did not meet entrance criteria|0
175315|NCT00877032|558452|P5|Overall Study|Did not meet entrance criteria|0
175316|NCT00877032|558453|P4|Overall Study|Did not meet entrance criteria|1
175317|NCT00877032|558454|P3|Overall Study|Did not meet entrance criteria|0
175318|NCT00877032|558455|P2|Overall Study|Did not meet entrance criteria|0
175319|NCT00877032|558456|P1|Overall Study|Did not meet entrance criteria|0
175320|NCT00877071|558574|P1|Overall Study|disease progression|2
175321|NCT00877383|558587|P2|Overall Study|Death|2
175322|NCT00877383|558588|P1|Overall Study|Death|1
175323|NCT00877383|558587|P2|Overall Study|Unsatisfactory therapeutic effect|0
175324|NCT00877383|558588|P1|Overall Study|Unsatisfactory therapeutic effect|1
175325|NCT00877383|558587|P2|Overall Study|Protocol deviation|6
175326|NCT00877383|558588|P1|Overall Study|Protocol deviation|2
175327|NCT00877383|558587|P2|Overall Study|Administrative problems|0
175328|NCT00877383|558588|P1|Overall Study|Administrative problems|2
175329|NCT00877383|558587|P2|Overall Study|Subject no longer requires study drug|0
175330|NCT00877383|558588|P1|Overall Study|Subject no longer requires study drug|2
175331|NCT00877383|558587|P2|Overall Study|Subject withdrew consent|12
175332|NCT00877383|558588|P1|Overall Study|Subject withdrew consent|3
175333|NCT00877383|558587|P2|Overall Study|Lost to Follow-up|3
175334|NCT00877383|558588|P1|Overall Study|Lost to Follow-up|5
175335|NCT00877383|558587|P2|Overall Study|Adverse Event|14
175336|NCT00877383|558588|P1|Overall Study|Adverse Event|13
175337|NCT00877487|558640|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
175338|NCT00877487|558641|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
175339|NCT00877487|558640|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
175340|NCT00877487|558641|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
175341|NCT00877487|558640|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
175342|NCT00877487|558641|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
175343|NCT00877487|558640|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
175344|NCT00877487|558641|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
175345|NCT00877487|558640|P2|Open-label Treatment Phase|Out of country for business|0
175346|NCT00877487|558641|P1|Open-label Treatment Phase|Out of country for business|1
175347|NCT00877487|558640|P2|Open-label Treatment Phase|Lost to Follow-up|0
175348|NCT00877487|558641|P1|Open-label Treatment Phase|Lost to Follow-up|1
175349|NCT00877487|558640|P2|Open-label Treatment Phase|Withdrawal by Subject|0
175350|NCT00877487|558641|P1|Open-label Treatment Phase|Withdrawal by Subject|1
175351|NCT00877487|558640|P2|Open-label Treatment Phase|Protocol Violation|0
175352|NCT00877487|558641|P1|Open-label Treatment Phase|Protocol Violation|3
175353|NCT00877487|558640|P2|Open-label Treatment Phase|Adverse Event|0
175354|NCT00877487|558641|P1|Open-label Treatment Phase|Adverse Event|1
175355|NCT00877773|558660|P1|Overall Study|Disease Progression|44
175356|NCT00877799|558669|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
175357|NCT00877799|558670|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
175358|NCT00877799|558671|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
175359|NCT00877799|558672|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
175360|NCT00877799|558673|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
175361|NCT00877799|558669|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
175362|NCT00877799|558670|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
175363|NCT00877799|558671|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
175364|NCT00877799|558672|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
175365|NCT00877799|558673|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
175366|NCT00877799|558669|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
175367|NCT00877799|558670|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
175368|NCT00877799|558671|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
175369|NCT00877799|558672|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
175370|NCT00877799|558673|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
175371|NCT00877799|558669|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
175372|NCT00877799|558670|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
175373|NCT00877799|558671|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
175374|NCT00877799|558672|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
175375|NCT00877799|558673|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
175376|NCT00877799|558669|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
175377|NCT00877799|558670|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
175378|NCT00877799|558671|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
175379|NCT00877799|558672|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
175380|NCT00877799|558673|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
175381|NCT00877890|558716|P2|Overall Study|Loss of Glucose Control|4
175382|NCT00877890|558717|P1|Overall Study|Loss of Glucose Control|3
175383|NCT00877890|558716|P2|Overall Study|Investigator Decision|2
175384|NCT00877890|558717|P1|Overall Study|Investigator Decision|0
175385|NCT00877890|558716|P2|Overall Study|Withdrawal of Consent|12
175386|NCT00877890|558717|P1|Overall Study|Withdrawal of Consent|6
175387|NCT00877890|558716|P2|Overall Study|Protocol Violation|1
175388|NCT00877890|558717|P1|Overall Study|Protocol Violation|0
175389|NCT00877890|558716|P2|Overall Study|Lost to Follow-up|5
175390|NCT00877890|558717|P1|Overall Study|Lost to Follow-up|5
175391|NCT00877890|558716|P2|Overall Study|Adverse Event|6
175392|NCT00877890|558717|P1|Overall Study|Adverse Event|6
175393|NCT00877929|558753|P2|Overall Study|Other reason (not specified)|6
175394|NCT00877929|558754|P1|Overall Study|Other reason (not specified)|2
175395|NCT00877929|558753|P2|Overall Study|Lack of Efficacy|1
175396|NCT00877929|558754|P1|Overall Study|Lack of Efficacy|0
175397|NCT00877929|558753|P2|Overall Study|Withdrawal by Subject|4
175398|NCT00877929|558754|P1|Overall Study|Withdrawal by Subject|4
175399|NCT00877929|558753|P2|Overall Study|Lost to Follow-up|1
175400|NCT00877929|558754|P1|Overall Study|Lost to Follow-up|0
175401|NCT00877929|558753|P2|Overall Study|Protocol Violation|3
175402|NCT00877929|558754|P1|Overall Study|Protocol Violation|3
175403|NCT00877929|558753|P2|Overall Study|Adverse Event|20
175404|NCT00877929|558754|P1|Overall Study|Adverse Event|11
175405|NCT00878501|558843|P3|Overall Study|Administrative|1
175406|NCT00878501|558844|P2|Overall Study|Administrative|0
175407|NCT00878501|558845|P1|Overall Study|Administrative|0
175408|NCT00878501|558843|P3|Overall Study|Mis-randomisation of patient|0
175409|NCT00878501|558844|P2|Overall Study|Mis-randomisation of patient|0
175410|NCT00878501|558845|P1|Overall Study|Mis-randomisation of patient|1
175411|NCT00878501|558843|P3|Overall Study|Intake of prohibited concom. medication|1
175412|NCT00878501|558844|P2|Overall Study|Intake of prohibited concom. medication|0
175413|NCT00878501|558845|P1|Overall Study|Intake of prohibited concom. medication|0
175414|NCT00878501|558843|P3|Overall Study|Incorrect enrolment|0
175415|NCT00878501|558844|P2|Overall Study|Incorrect enrolment|2
175416|NCT00878501|558845|P1|Overall Study|Incorrect enrolment|1
175417|NCT00878501|558843|P3|Overall Study|Protocol Violation|1
175418|NCT00878501|558844|P2|Overall Study|Protocol Violation|0
175419|NCT00878501|558845|P1|Overall Study|Protocol Violation|0
175420|NCT00878501|558843|P3|Overall Study|Withdrawal by Subject|2
175421|NCT00878501|558844|P2|Overall Study|Withdrawal by Subject|1
175422|NCT00878501|558845|P1|Overall Study|Withdrawal by Subject|2
175423|NCT00878501|558843|P3|Overall Study|Lack of Efficacy|0
175424|NCT00878501|558844|P2|Overall Study|Lack of Efficacy|1
175425|NCT00878501|558845|P1|Overall Study|Lack of Efficacy|2
175426|NCT00878501|558843|P3|Overall Study|Adverse Event|3
175427|NCT00878501|558844|P2|Overall Study|Adverse Event|3
175428|NCT00878501|558845|P1|Overall Study|Adverse Event|11
175429|NCT00878553|558866|P5|PK Study|Withdrawal by Subject|0
175430|NCT00878553|558867|P4|PK Study|Withdrawal by Subject|1
175431|NCT00878553|558868|P3|PK Study|Withdrawal by Subject|0
175432|NCT00878553|558869|P2|PK Study|Withdrawal by Subject|0
175433|NCT00878553|558870|P1|PK Study|Withdrawal by Subject|0
175434|NCT00878553|558866|P5|Sleep Study|family emergency|0
175435|NCT00878553|558867|P4|Sleep Study|family emergency|0
175436|NCT00878553|558868|P3|Sleep Study|family emergency|0
175437|NCT00878553|558869|P2|Sleep Study|family emergency|0
175438|NCT00878553|558870|P1|Sleep Study|family emergency|1
175439|NCT00878553|558866|P5|Sleep Study|car accident|0
175440|NCT00878553|558867|P4|Sleep Study|car accident|0
175441|NCT00878553|558868|P3|Sleep Study|car accident|0
175442|NCT00878553|558869|P2|Sleep Study|car accident|0
175443|NCT00878553|558870|P1|Sleep Study|car accident|1
175444|NCT00878553|558866|P5|Sleep Study|Lost to Follow-up|0
175445|NCT00878553|558867|P4|Sleep Study|Lost to Follow-up|0
175446|NCT00878553|558868|P3|Sleep Study|Lost to Follow-up|0
175447|NCT00878553|558869|P2|Sleep Study|Lost to Follow-up|0
175448|NCT00878553|558870|P1|Sleep Study|Lost to Follow-up|1
175449|NCT00878553|558866|P5|Sleep Study|Withdrawal by Subject|0
175450|NCT00878553|558867|P4|Sleep Study|Withdrawal by Subject|0
175451|NCT00878553|558868|P3|Sleep Study|Withdrawal by Subject|0
175452|NCT00878553|558869|P2|Sleep Study|Withdrawal by Subject|0
175453|NCT00878553|558870|P1|Sleep Study|Withdrawal by Subject|2
175454|NCT00878722|558951|P8|Overall Study|Relapse|0
175455|NCT00878722|558952|P7|Overall Study|Relapse|0
175456|NCT00878722|558953|P6|Overall Study|Relapse|0
175457|NCT00878722|558954|P5|Overall Study|Relapse|0
175458|NCT00878722|558955|P4|Overall Study|Relapse|1
175459|NCT00878722|558956|P3|Overall Study|Relapse|0
175460|NCT00878722|558957|P2|Overall Study|Relapse|0
175461|NCT00878722|558958|P1|Overall Study|Relapse|0
175462|NCT00878722|558951|P8|Overall Study|Withdrawal by Subject|2
175463|NCT00878722|558952|P7|Overall Study|Withdrawal by Subject|0
175464|NCT00878722|558953|P6|Overall Study|Withdrawal by Subject|0
175465|NCT00878722|558954|P5|Overall Study|Withdrawal by Subject|0
175466|NCT00878722|558955|P4|Overall Study|Withdrawal by Subject|0
175467|NCT00878722|558956|P3|Overall Study|Withdrawal by Subject|0
175468|NCT00878722|558957|P2|Overall Study|Withdrawal by Subject|0
175469|NCT00878722|558958|P1|Overall Study|Withdrawal by Subject|0
175470|NCT00878722|558951|P8|Overall Study|Adverse Event|0
175471|NCT00878722|558952|P7|Overall Study|Adverse Event|2
175472|NCT00878722|558953|P6|Overall Study|Adverse Event|0
175473|NCT00878722|558954|P5|Overall Study|Adverse Event|0
175474|NCT00878722|558955|P4|Overall Study|Adverse Event|0
175475|NCT00878722|558956|P3|Overall Study|Adverse Event|0
175476|NCT00878722|558957|P2|Overall Study|Adverse Event|0
175477|NCT00878722|558958|P1|Overall Study|Adverse Event|0
175478|NCT00878722|558951|P8|Overall Study|Death|2
175479|NCT00878722|558952|P7|Overall Study|Death|0
175480|NCT00878722|558953|P6|Overall Study|Death|1
175481|NCT00878722|558954|P5|Overall Study|Death|0
175482|NCT00878722|558955|P4|Overall Study|Death|1
175483|NCT00878722|558956|P3|Overall Study|Death|0
175484|NCT00878722|558957|P2|Overall Study|Death|0
175485|NCT00878722|558958|P1|Overall Study|Death|0
175486|NCT00878722|558951|P8|Overall Study|Progressive disease|3
175487|NCT00878722|558952|P7|Overall Study|Progressive disease|4
175488|NCT00878722|558953|P6|Overall Study|Progressive disease|1
175489|NCT00878722|558954|P5|Overall Study|Progressive disease|7
175490|NCT00878722|558955|P4|Overall Study|Progressive disease|7
175491|NCT00878722|558956|P3|Overall Study|Progressive disease|3
175492|NCT00878722|558957|P2|Overall Study|Progressive disease|3
175493|NCT00878722|558958|P1|Overall Study|Progressive disease|3
175494|NCT00878800|559046|P5|Overall Study|Other|1
175495|NCT00878800|559047|P4|Overall Study|Other|0
175496|NCT00878800|559048|P3|Overall Study|Other|0
175497|NCT00878800|559049|P2|Overall Study|Other|1
175498|NCT00878800|559050|P1|Overall Study|Other|1
175499|NCT00878800|559046|P5|Overall Study|Death|0
175500|NCT00878800|559047|P4|Overall Study|Death|0
175501|NCT00878800|559048|P3|Overall Study|Death|1
175502|NCT00878800|559049|P2|Overall Study|Death|0
175503|NCT00878800|559050|P1|Overall Study|Death|0
175504|NCT00878800|559046|P5|Overall Study|Withdrew consent|1
175505|NCT00878800|559047|P4|Overall Study|Withdrew consent|1
175506|NCT00878800|559048|P3|Overall Study|Withdrew consent|0
175507|NCT00878800|559049|P2|Overall Study|Withdrew consent|1
175508|NCT00878800|559050|P1|Overall Study|Withdrew consent|1
175509|NCT00878800|559046|P5|Overall Study|Progressive disease|13
175510|NCT00878800|559047|P4|Overall Study|Progressive disease|5
175511|NCT00878800|559048|P3|Overall Study|Progressive disease|6
175512|NCT00878800|559049|P2|Overall Study|Progressive disease|5
175513|NCT00878800|559050|P1|Overall Study|Progressive disease|1
175514|NCT00878800|559046|P5|Overall Study|Adverse Event|1
175515|NCT00878800|559047|P4|Overall Study|Adverse Event|0
175516|NCT00878800|559048|P3|Overall Study|Adverse Event|2
175517|NCT00878800|559049|P2|Overall Study|Adverse Event|0
175518|NCT00878800|559050|P1|Overall Study|Adverse Event|0
175519|NCT00878969|559115|P3|Overall Study|Pregnancy|0
175520|NCT00878969|559116|P2|Overall Study|Pregnancy|1
175521|NCT00878969|559117|P1|Overall Study|Pregnancy|0
175522|NCT00878969|559115|P3|Overall Study|Death|2
175523|NCT00878969|559116|P2|Overall Study|Death|0
175524|NCT00878969|559117|P1|Overall Study|Death|0
175525|NCT00878969|559115|P3|Overall Study|Protocol Violation|0
175526|NCT00878969|559116|P2|Overall Study|Protocol Violation|0
175527|NCT00878969|559117|P1|Overall Study|Protocol Violation|2
175528|NCT00878969|559115|P3|Overall Study|Lost to Follow-up|0
175529|NCT00878969|559116|P2|Overall Study|Lost to Follow-up|1
175530|NCT00878969|559117|P1|Overall Study|Lost to Follow-up|2
175531|NCT00878969|559115|P3|Overall Study|Adverse Event|2
175532|NCT00878969|559116|P2|Overall Study|Adverse Event|1
175533|NCT00878969|559117|P1|Overall Study|Adverse Event|3
175534|NCT00878969|559115|P3|Overall Study|kidney transplant|2
175535|NCT00878969|559116|P2|Overall Study|kidney transplant|3
175536|NCT00878969|559117|P1|Overall Study|kidney transplant|2
175537|NCT00878969|559115|P3|Overall Study|Withdrawal by Subject|3
175538|NCT00878969|559116|P2|Overall Study|Withdrawal by Subject|6
175539|NCT00878969|559117|P1|Overall Study|Withdrawal by Subject|1
175540|NCT00878969|559115|P3|Overall Study|Physician Decision|2
175541|NCT00878969|559116|P2|Overall Study|Physician Decision|3
175542|NCT00878969|559117|P1|Overall Study|Physician Decision|5
175543|NCT00879229|559149|P2|Overall Study|Other|0
175544|NCT00879229|559150|P1|Overall Study|Other|1
175545|NCT00879229|559149|P2|Overall Study|Clinical status did not improve|0
175546|NCT00879229|559150|P1|Overall Study|Clinical status did not improve|1
175547|NCT00879229|559149|P2|Overall Study|Withdrawal by Subject|0
175548|NCT00879229|559150|P1|Overall Study|Withdrawal by Subject|1
175549|NCT00879229|559149|P2|Overall Study|Adverse Event|0
175550|NCT00879229|559150|P1|Overall Study|Adverse Event|2
175551|NCT00879229|559149|P2|Overall Study|Death|2
175552|NCT00879229|559150|P1|Overall Study|Death|4
175553|NCT00879229|559149|P2|Overall Study|Study terminated by Sponsor|12
175554|NCT00879229|559150|P1|Overall Study|Study terminated by Sponsor|13
175555|NCT00879333|559189|P2|Overall Study|Protocol Violation|1
175556|NCT00879333|559190|P1|Overall Study|Protocol Violation|1
175557|NCT00879333|559189|P2|Overall Study|Disease Progression|169
175558|NCT00879333|559190|P1|Overall Study|Disease Progression|292
175559|NCT00879333|559189|P2|Overall Study|Death|5
175560|NCT00879333|559190|P1|Overall Study|Death|16
175561|NCT00879333|559189|P2|Overall Study|Administrative Problems|0
175562|NCT00879333|559190|P1|Overall Study|Administrative Problems|2
175563|NCT00879333|559189|P2|Overall Study|Lost to Follow-up|1
175564|NCT00879333|559190|P1|Overall Study|Lost to Follow-up|2
175565|NCT00879333|559189|P2|Overall Study|Withdrawal by Subject|7
175566|NCT00879333|559190|P1|Overall Study|Withdrawal by Subject|20
175567|NCT00879333|559189|P2|Overall Study|Abnormal Laboratory Value|0
175568|NCT00879333|559190|P1|Overall Study|Abnormal Laboratory Value|1
175569|NCT00879333|559189|P2|Overall Study|Adverse Event|34
175570|NCT00879333|559190|P1|Overall Study|Adverse Event|94
175571|NCT00879398|559214|P1|Overall Study|Other Reasons|171
175572|NCT00879398|559214|P1|Overall Study|Adverse Event|41
175573|NCT00879398|559214|P1|Overall Study|Lack of Efficacy|64
175574|NCT00879398|559214|P1|Overall Study|Visit Stop|399
175575|NCT00879411|559224|P1|Overall Study|lost to follow-up (non-AE)|162
175576|NCT00879645|559243|P4|Overall Study|Adverse Event|0
175577|NCT00879645|559244|P3|Overall Study|Adverse Event|0
175578|NCT00879645|559245|P2|Overall Study|Adverse Event|0
175579|NCT00879645|559246|P1|Overall Study|Adverse Event|1
175580|NCT00879684|559264|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
175581|NCT00879684|559265|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
175582|NCT00879684|559266|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
175583|NCT00879684|559267|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
175584|NCT00879684|559268|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
175585|NCT00879684|559269|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
175586|NCT00879684|559270|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
175587|NCT00879684|559264|P7|Stage 2: Expanded Cohort|Progressive Disease|11
175588|NCT00879684|559265|P6|Stage 2: Expanded Cohort|Progressive Disease|0
175589|NCT00879684|559266|P5|Stage 2: Expanded Cohort|Progressive Disease|0
175590|NCT00879684|559267|P4|Stage 2: Expanded Cohort|Progressive Disease|0
175591|NCT00879684|559268|P3|Stage 2: Expanded Cohort|Progressive Disease|0
175592|NCT00879684|559269|P2|Stage 2: Expanded Cohort|Progressive Disease|0
175593|NCT00879684|559270|P1|Stage 2: Expanded Cohort|Progressive Disease|0
175594|NCT00879684|559264|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
175595|NCT00879684|559265|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
175596|NCT00879684|559266|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
175597|NCT00879684|559267|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
175598|NCT00879684|559268|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
175599|NCT00879684|559269|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
175600|NCT00879684|559270|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
175601|NCT00879684|559264|P7|Stage 1: Dose Escalation|Death|0
175602|NCT00879684|559265|P6|Stage 1: Dose Escalation|Death|0
175603|NCT00879684|559266|P5|Stage 1: Dose Escalation|Death|0
175604|NCT00879684|559267|P4|Stage 1: Dose Escalation|Death|0
175605|NCT00879684|559268|P3|Stage 1: Dose Escalation|Death|1
175606|NCT00879684|559269|P2|Stage 1: Dose Escalation|Death|0
175607|NCT00879684|559270|P1|Stage 1: Dose Escalation|Death|0
175608|NCT00879684|559264|P7|Stage 1: Dose Escalation|Investigator declined participation|0
175609|NCT00879684|559265|P6|Stage 1: Dose Escalation|Investigator declined participation|0
175610|NCT00879684|559266|P5|Stage 1: Dose Escalation|Investigator declined participation|0
175611|NCT00879684|559267|P4|Stage 1: Dose Escalation|Investigator declined participation|2
175612|NCT00879684|559268|P3|Stage 1: Dose Escalation|Investigator declined participation|2
175613|NCT00879684|559269|P2|Stage 1: Dose Escalation|Investigator declined participation|0
175614|NCT00879684|559270|P1|Stage 1: Dose Escalation|Investigator declined participation|0
175615|NCT00879684|559264|P7|Stage 1: Dose Escalation|Progressive Disease|0
175616|NCT00879684|559265|P6|Stage 1: Dose Escalation|Progressive Disease|3
175617|NCT00879684|559266|P5|Stage 1: Dose Escalation|Progressive Disease|3
175618|NCT00879684|559267|P4|Stage 1: Dose Escalation|Progressive Disease|4
175619|NCT00879684|559268|P3|Stage 1: Dose Escalation|Progressive Disease|0
175620|NCT00879684|559269|P2|Stage 1: Dose Escalation|Progressive Disease|3
175621|NCT00879684|559270|P1|Stage 1: Dose Escalation|Progressive Disease|2
175622|NCT00879684|559264|P7|Stage 1: Dose Escalation|Adverse Event|0
175623|NCT00879684|559265|P6|Stage 1: Dose Escalation|Adverse Event|0
175624|NCT00879684|559266|P5|Stage 1: Dose Escalation|Adverse Event|0
175625|NCT00879684|559267|P4|Stage 1: Dose Escalation|Adverse Event|0
175626|NCT00879684|559268|P3|Stage 1: Dose Escalation|Adverse Event|0
175627|NCT00879684|559269|P2|Stage 1: Dose Escalation|Adverse Event|0
175628|NCT00879684|559270|P1|Stage 1: Dose Escalation|Adverse Event|1
175629|NCT00879697|559334|P2|Overall Study|Physician Decision|2
175630|NCT00879697|559335|P1|Overall Study|Physician Decision|2
175631|NCT00879710|559343|P4|Phase 1 - 6 Weeks|Adverse Event|0
175632|NCT00879710|559344|P3|Phase 1 - 6 Weeks|Adverse Event|1
175633|NCT00879710|559345|P2|Phase 1 - 6 Weeks|Adverse Event|0
175634|NCT00879710|559346|P1|Phase 1 - 6 Weeks|Adverse Event|0
175635|NCT00879710|559343|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
175636|NCT00879710|559344|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
175637|NCT00879710|559345|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
175638|NCT00879710|559346|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
175639|NCT00879775|559356|P2|Overall Study|Lost to Follow-up|1
175640|NCT00879775|559357|P1|Overall Study|Lost to Follow-up|2
175641|NCT00879814|559375|P4|Overall Study|Unspecified|0
175642|NCT00879814|559376|P3|Overall Study|Unspecified|1
175643|NCT00879814|559377|P2|Overall Study|Unspecified|0
175644|NCT00879814|559378|P1|Overall Study|Unspecified|0
175645|NCT00879814|559375|P4|Overall Study|Physician Decision|0
175646|NCT00879814|559376|P3|Overall Study|Physician Decision|1
175647|NCT00879814|559377|P2|Overall Study|Physician Decision|0
175648|NCT00879814|559378|P1|Overall Study|Physician Decision|0
175649|NCT00879814|559375|P4|Overall Study|Withdrawal by Subject|2
175650|NCT00879814|559376|P3|Overall Study|Withdrawal by Subject|1
175651|NCT00879814|559377|P2|Overall Study|Withdrawal by Subject|1
175652|NCT00879814|559378|P1|Overall Study|Withdrawal by Subject|3
175653|NCT00879814|559375|P4|Overall Study|Participant Failed to Return|1
175654|NCT00879814|559376|P3|Overall Study|Participant Failed to Return|0
175655|NCT00879814|559377|P2|Overall Study|Participant Failed to Return|0
175656|NCT00879814|559378|P1|Overall Study|Participant Failed to Return|0
175657|NCT00879814|559375|P4|Overall Study|Lost to Follow-up|2
175658|NCT00879814|559376|P3|Overall Study|Lost to Follow-up|0
175659|NCT00879814|559377|P2|Overall Study|Lost to Follow-up|0
175660|NCT00879814|559378|P1|Overall Study|Lost to Follow-up|1
175661|NCT00879814|559375|P4|Overall Study|Adverse Event|0
175662|NCT00879814|559376|P3|Overall Study|Adverse Event|0
175663|NCT00879814|559377|P2|Overall Study|Adverse Event|1
175664|NCT00879814|559378|P1|Overall Study|Adverse Event|0
175665|NCT00879879|559484|P1|Overall Study|Physician Decision|1
175666|NCT00879879|559484|P1|Overall Study|Withdrawal by Subject|1
175667|NCT00879879|559484|P1|Overall Study|Death|1
175668|NCT00879970|559491|P5|Period 2 Vitamin D Randomization|Death|0
175669|NCT00879970|559492|P4|Period 2 Vitamin D Randomization|Death|2
175670|NCT00879970|559493|P3|Period 2 Vitamin D Randomization|Death|0
175671|NCT00879970|559494|P2|Period 2 Vitamin D Randomization|Death|0
175672|NCT00879970|559495|P1|Period 2 Vitamin D Randomization|Death|0
175673|NCT00879970|559491|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
175674|NCT00879970|559492|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
175675|NCT00879970|559493|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
175676|NCT00879970|559494|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
175677|NCT00879970|559495|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
175678|NCT00879970|559491|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
175679|NCT00879970|559492|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
175680|NCT00879970|559493|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
175681|NCT00879970|559494|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
175682|NCT00879970|559495|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
175683|NCT00879970|559491|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
175684|NCT00879970|559492|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
175685|NCT00879970|559493|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
175686|NCT00879970|559494|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
175687|NCT00879970|559495|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
175688|NCT00879970|559491|P5|Period 1 TZD Randomization|Death|0
175689|NCT00879970|559492|P4|Period 1 TZD Randomization|Death|0
175690|NCT00879970|559493|P3|Period 1 TZD Randomization|Death|0
175691|NCT00879970|559494|P2|Period 1 TZD Randomization|Death|1
175692|NCT00879970|559495|P1|Period 1 TZD Randomization|Death|2
175693|NCT00879970|559491|P5|Period 1 TZD Randomization|Lost to Follow-up|0
175694|NCT00879970|559492|P4|Period 1 TZD Randomization|Lost to Follow-up|0
175695|NCT00879970|559493|P3|Period 1 TZD Randomization|Lost to Follow-up|1
175696|NCT00879970|559494|P2|Period 1 TZD Randomization|Lost to Follow-up|0
175697|NCT00879970|559495|P1|Period 1 TZD Randomization|Lost to Follow-up|1
175698|NCT00879970|559491|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
175699|NCT00879970|559492|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
175700|NCT00879970|559493|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
175701|NCT00879970|559494|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
175702|NCT00879970|559495|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
175703|NCT00879996|559579|P2|Overall Study|put on parole|0
175704|NCT00879996|559580|P1|Overall Study|put on parole|1
175705|NCT00879996|559579|P2|Overall Study|psychiatric problem|1
175706|NCT00879996|559580|P1|Overall Study|psychiatric problem|0
175707|NCT00879996|559579|P2|Overall Study|Physician Decision|2
175708|NCT00879996|559580|P1|Overall Study|Physician Decision|1
175709|NCT00879996|559579|P2|Overall Study|non-compliance|4
175710|NCT00879996|559580|P1|Overall Study|non-compliance|6
175711|NCT00879996|559579|P2|Overall Study|Lost to Follow-up|6
175712|NCT00879996|559580|P1|Overall Study|Lost to Follow-up|7
175713|NCT00880009|559592|P1|Overall Study|Protocol Violation|1
175714|NCT00880009|559592|P1|Overall Study|Withdrawal by Subject|1
175715|NCT00880009|559592|P1|Overall Study|Study terminated by sponsor|14
175716|NCT00880100|559623|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
175717|NCT00880100|559623|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
175718|NCT00880100|559623|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
175719|NCT00880165|559636|P2|Overall Study|Lost to follow|15
175720|NCT00880165|559637|P1|Overall Study|Lost to follow|9
175721|NCT00880165|559636|P2|Overall Study|Required BIPAP or oxygen treatment|4
175722|NCT00880165|559637|P1|Overall Study|Required BIPAP or oxygen treatment|12
175723|NCT00880165|559636|P2|Overall Study|Not diagnosed with OSA|8
175724|NCT00880165|559637|P1|Overall Study|Not diagnosed with OSA|14
175725|NCT00880165|559636|P2|Overall Study|Withdrawal by Subject|23
175726|NCT00880165|559637|P1|Overall Study|Withdrawal by Subject|27
175727|NCT00880191|559649|P2|Overall Study|Hospitalization/efficacy|1
175728|NCT00880191|559650|P1|Overall Study|Hospitalization/efficacy|1
175729|NCT00880191|559649|P2|Overall Study|Adverse Event|6
175730|NCT00880191|559650|P1|Overall Study|Adverse Event|8
175731|NCT00880191|559649|P2|Overall Study|Refused further treatment|1
175732|NCT00880191|559650|P1|Overall Study|Refused further treatment|4
175733|NCT00880256|559688|P1|Overall Study|Lost to Follow-up|28
175734|NCT00880269|559695|P2|Overall Study|Adverse Event|9
175735|NCT00880269|559696|P1|Overall Study|Adverse Event|10
175736|NCT00880269|559695|P2|Overall Study|Withdrawal by Subject|4
175737|NCT00880269|559696|P1|Overall Study|Withdrawal by Subject|3
175738|NCT00880269|559695|P2|Overall Study|Lost to Follow-up|1
175739|NCT00880269|559696|P1|Overall Study|Lost to Follow-up|0
175740|NCT00880269|559695|P2|Overall Study|Death|2
175741|NCT00880269|559696|P1|Overall Study|Death|4
175742|NCT00880269|559695|P2|Overall Study|New Cancer Therapy|0
175743|NCT00880269|559696|P1|Overall Study|New Cancer Therapy|1
175744|NCT00880269|559695|P2|Overall Study|Disease Progression|11
175745|NCT00880269|559696|P1|Overall Study|Disease Progression|13
175746|NCT00880269|559695|P2|Overall Study|Protocol Violation|0
175747|NCT00880269|559696|P1|Overall Study|Protocol Violation|1
175748|NCT00880334|559714|P2|Overall Study|Brain Metastasis|1
175749|NCT00880334|559715|P1|Overall Study|Brain Metastasis|0
175750|NCT00880334|559714|P2|Overall Study|Inadequate Labs|1
175751|NCT00880334|559715|P1|Overall Study|Inadequate Labs|1
175752|NCT00880334|559714|P2|Overall Study|Withdrawal by Subject|1
175753|NCT00880334|559715|P1|Overall Study|Withdrawal by Subject|2
175754|NCT00880334|559714|P2|Overall Study|Physician Decision|0
175755|NCT00880334|559715|P1|Overall Study|Physician Decision|1
175756|NCT00880542|559742|P1|REP: Surgical Resection|progressive disease|1
175757|NCT00880542|559742|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
175758|NCT00880542|559742|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
175759|NCT00880555|559750|P6|Overall Study|Lost to Follow-up|0
175760|NCT00880555|559751|P5|Overall Study|Lost to Follow-up|0
175761|NCT00880555|559752|P4|Overall Study|Lost to Follow-up|0
175762|NCT00880555|559753|P3|Overall Study|Lost to Follow-up|0
175763|NCT00880555|559754|P2|Overall Study|Lost to Follow-up|1
175764|NCT00880555|559755|P1|Overall Study|Lost to Follow-up|0
175765|NCT00880555|559750|P6|Overall Study|Death|1
175766|NCT00880555|559751|P5|Overall Study|Death|0
175767|NCT00880555|559752|P4|Overall Study|Death|0
175768|NCT00880555|559753|P3|Overall Study|Death|0
175769|NCT00880555|559754|P2|Overall Study|Death|0
175770|NCT00880555|559755|P1|Overall Study|Death|0
175771|NCT00880555|559750|P6|Overall Study|Lack of resources (hired rater)|0
175772|NCT00880555|559751|P5|Overall Study|Lack of resources (hired rater)|0
175773|NCT00880555|559752|P4|Overall Study|Lack of resources (hired rater)|0
175774|NCT00880555|559753|P3|Overall Study|Lack of resources (hired rater)|5
175775|NCT00880555|559754|P2|Overall Study|Lack of resources (hired rater)|7
175776|NCT00880555|559755|P1|Overall Study|Lack of resources (hired rater)|9
175777|NCT00880555|559750|P6|Overall Study|Withdrawal by Subject|0
175778|NCT00880555|559751|P5|Overall Study|Withdrawal by Subject|0
175779|NCT00880555|559752|P4|Overall Study|Withdrawal by Subject|0
175780|NCT00880555|559753|P3|Overall Study|Withdrawal by Subject|0
175781|NCT00880555|559754|P2|Overall Study|Withdrawal by Subject|1
175782|NCT00880555|559755|P1|Overall Study|Withdrawal by Subject|1
175783|NCT00880555|559750|P6|Overall Study|Physician Decision|0
175784|NCT00880555|559751|P5|Overall Study|Physician Decision|1
175785|NCT00880555|559752|P4|Overall Study|Physician Decision|2
175786|NCT00880555|559753|P3|Overall Study|Physician Decision|0
175787|NCT00880555|559754|P2|Overall Study|Physician Decision|8
175788|NCT00880555|559755|P1|Overall Study|Physician Decision|0
175789|NCT00880568|559775|P9|Overall Study|Withdrawal by Subject|0
175790|NCT00880568|559776|P8|Overall Study|Withdrawal by Subject|1
175791|NCT00880568|559777|P7|Overall Study|Withdrawal by Subject|0
175792|NCT00880568|559778|P6|Overall Study|Withdrawal by Subject|0
175793|NCT00880568|559779|P5|Overall Study|Withdrawal by Subject|0
175794|NCT00880568|559780|P4|Overall Study|Withdrawal by Subject|0
175795|NCT00880568|559781|P3|Overall Study|Withdrawal by Subject|0
175796|NCT00880568|559782|P2|Overall Study|Withdrawal by Subject|0
175797|NCT00880568|559783|P1|Overall Study|Withdrawal by Subject|0
175798|NCT00880568|559775|P9|Overall Study|Adverse Event|0
175799|NCT00880568|559776|P8|Overall Study|Adverse Event|1
175800|NCT00880568|559777|P7|Overall Study|Adverse Event|1
175801|NCT00880568|559778|P6|Overall Study|Adverse Event|0
175802|NCT00880568|559779|P5|Overall Study|Adverse Event|0
175803|NCT00880568|559780|P4|Overall Study|Adverse Event|0
175804|NCT00880568|559781|P3|Overall Study|Adverse Event|0
175805|NCT00880568|559782|P2|Overall Study|Adverse Event|0
175806|NCT00880568|559783|P1|Overall Study|Adverse Event|0
175807|NCT00880568|559775|P9|Overall Study|Disease progression|3
175808|NCT00880568|559776|P8|Overall Study|Disease progression|0
175809|NCT00880568|559777|P7|Overall Study|Disease progression|5
175810|NCT00880568|559778|P6|Overall Study|Disease progression|3
175811|NCT00880568|559779|P5|Overall Study|Disease progression|3
175812|NCT00880568|559780|P4|Overall Study|Disease progression|1
175813|NCT00880568|559781|P3|Overall Study|Disease progression|3
175814|NCT00880568|559782|P2|Overall Study|Disease progression|3
175815|NCT00880568|559783|P1|Overall Study|Disease progression|3
175816|NCT00880620|559835|P4|Overall Study|Not specified|2
175817|NCT00880620|559836|P3|Overall Study|Not specified|2
175818|NCT00880620|559837|P2|Overall Study|Not specified|1
175819|NCT00880620|559838|P1|Overall Study|Not specified|1
175820|NCT00880620|559835|P4|Overall Study|Noncompliance|1
175821|NCT00880620|559836|P3|Overall Study|Noncompliance|1
175822|NCT00880620|559837|P2|Overall Study|Noncompliance|0
175823|NCT00880620|559838|P1|Overall Study|Noncompliance|0
175824|NCT00880620|559835|P4|Overall Study|Withdrawal by Subject|3
175825|NCT00880620|559836|P3|Overall Study|Withdrawal by Subject|1
175826|NCT00880620|559837|P2|Overall Study|Withdrawal by Subject|3
175827|NCT00880620|559838|P1|Overall Study|Withdrawal by Subject|4
175828|NCT00880620|559835|P4|Overall Study|Protocol Violation|2
175829|NCT00880620|559836|P3|Overall Study|Protocol Violation|0
175830|NCT00880620|559837|P2|Overall Study|Protocol Violation|1
175831|NCT00880620|559838|P1|Overall Study|Protocol Violation|0
175832|NCT00880620|559835|P4|Overall Study|Lost to Follow-up|0
175833|NCT00880620|559836|P3|Overall Study|Lost to Follow-up|1
175834|NCT00880620|559837|P2|Overall Study|Lost to Follow-up|1
175835|NCT00880620|559838|P1|Overall Study|Lost to Follow-up|0
175836|NCT00880620|559835|P4|Overall Study|Lack of Efficacy|1
175837|NCT00880620|559836|P3|Overall Study|Lack of Efficacy|0
175838|NCT00880620|559837|P2|Overall Study|Lack of Efficacy|4
175839|NCT00880620|559838|P1|Overall Study|Lack of Efficacy|12
175840|NCT00880620|559835|P4|Overall Study|Death|0
175841|NCT00880620|559836|P3|Overall Study|Death|1
175842|NCT00880620|559837|P2|Overall Study|Death|0
175843|NCT00880620|559838|P1|Overall Study|Death|0
175844|NCT00880620|559835|P4|Overall Study|Adverse Event|15
175845|NCT00880620|559836|P3|Overall Study|Adverse Event|15
175846|NCT00880620|559837|P2|Overall Study|Adverse Event|5
175847|NCT00880620|559838|P1|Overall Study|Adverse Event|4
175848|NCT00880685|559852|P1|Memantine 20mg|Withdrawal by Subject|1
175849|NCT00880685|559852|P1|Memantine 10mg|Lost to Follow-up|2
175850|NCT00880698|559864|P4|Overall Study|Lost to Follow-up|1
175851|NCT00880698|559865|P3|Overall Study|Lost to Follow-up|0
175852|NCT00880698|559866|P2|Overall Study|Lost to Follow-up|3
175853|NCT00880698|559867|P1|Overall Study|Lost to Follow-up|1
175854|NCT00880698|559864|P4|Overall Study|Death|2
175855|NCT00880698|559865|P3|Overall Study|Death|1
175856|NCT00880698|559866|P2|Overall Study|Death|0
175857|NCT00880698|559867|P1|Overall Study|Death|0
175858|NCT00880750|559895|P2|Second Intervention|Unable to collect urine|0
175859|NCT00880750|559896|P1|Second Intervention|Unable to collect urine|1
175860|NCT00880750|559895|P2|Second Intervention|Protocol Violation|0
175861|NCT00880750|559896|P1|Second Intervention|Protocol Violation|1
175862|NCT00880750|559895|P2|Second Intervention|Withdrawal by Subject|2
175863|NCT00880750|559896|P1|Second Intervention|Withdrawal by Subject|2
175864|NCT00880750|559895|P2|First Intervention|Lost to Follow-up|0
175865|NCT00880750|559896|P1|First Intervention|Lost to Follow-up|2
175866|NCT00880750|559895|P2|First Intervention|Withdrawal by Subject|0
175867|NCT00880750|559896|P1|First Intervention|Withdrawal by Subject|2
175868|NCT00880750|559895|P2|First Intervention|Non-compliance with meals|1
175869|NCT00880750|559896|P1|First Intervention|Non-compliance with meals|0
175870|NCT00880750|559895|P2|First Intervention|Unable to collect urine|0
175871|NCT00880750|559896|P1|First Intervention|Unable to collect urine|4
175872|NCT00880750|559895|P2|First Intervention|Adverse Event|0
175873|NCT00880750|559896|P1|First Intervention|Adverse Event|1
175874|NCT00880763|559914|P4|Extension Period (Part 2)|Lack of Efficacy|1
175875|NCT00880763|559915|P3|Extension Period (Part 2)|Lack of Efficacy|0
175876|NCT00880763|559916|P2|Extension Period (Part 2)|Lack of Efficacy|0
175877|NCT00880763|559917|P1|Extension Period (Part 2)|Lack of Efficacy|0
175878|NCT00880763|559914|P4|Extension Period (Part 2)|Physician Decision|0
175879|NCT00880763|559915|P3|Extension Period (Part 2)|Physician Decision|1
175880|NCT00880763|559916|P2|Extension Period (Part 2)|Physician Decision|1
175881|NCT00880763|559917|P1|Extension Period (Part 2)|Physician Decision|0
175882|NCT00880763|559914|P4|Extension Period (Part 2)|Withdrawal by Subject|1
175883|NCT00880763|559915|P3|Extension Period (Part 2)|Withdrawal by Subject|1
175884|NCT00880763|559916|P2|Extension Period (Part 2)|Withdrawal by Subject|2
175885|NCT00880763|559917|P1|Extension Period (Part 2)|Withdrawal by Subject|0
175886|NCT00880763|559914|P4|Extension Period (Part 2)|Adverse Event|1
175887|NCT00880763|559915|P3|Extension Period (Part 2)|Adverse Event|1
175888|NCT00880763|559916|P2|Extension Period (Part 2)|Adverse Event|0
175889|NCT00880763|559917|P1|Extension Period (Part 2)|Adverse Event|0
175890|NCT00880906|559949|P2|Overall Study|Did not meet criteria following patholog|6
175891|NCT00880906|559950|P1|Overall Study|Did not meet criteria following patholog|12
175892|NCT00880906|559949|P2|Overall Study|Lost to Follow-up|1
175893|NCT00880906|559950|P1|Overall Study|Lost to Follow-up|0
175894|NCT00881205|560023|P2|Overall Study|Condition no longer requires drug|0
175895|NCT00881205|560024|P1|Overall Study|Condition no longer requires drug|1
175896|NCT00881205|560023|P2|Overall Study|Administrative problems|1
175897|NCT00881205|560024|P1|Overall Study|Administrative problems|1
175898|NCT00881205|560023|P2|Overall Study|Lost to Follow-up|1
175899|NCT00881205|560024|P1|Overall Study|Lost to Follow-up|0
175900|NCT00881205|560023|P2|Overall Study|Withdrawal by Subject|2
175901|NCT00881205|560024|P1|Overall Study|Withdrawal by Subject|1
175902|NCT00881205|560023|P2|Overall Study|Adverse Event|3
175903|NCT00881205|560024|P1|Overall Study|Adverse Event|8
175904|NCT00882713|560100|P1|Overall Study|Other - Reasons|2
175905|NCT00882713|560100|P1|Overall Study|Failure to return|2
175906|NCT00882713|560100|P1|Overall Study|Insufficient therapeutic response|3
175907|NCT00882713|560100|P1|Overall Study|Blood transfusion|2
175908|NCT00882713|560100|P1|Overall Study|refused treatment/withdrew consent|4
175909|NCT00882713|560100|P1|Overall Study|Administrative reasons|4
175910|NCT00882713|560100|P1|Overall Study|Death|3
175911|NCT00882713|560100|P1|Overall Study|Adverse Event|2
175912|NCT00882908|560158|P5|Overall Study|Study terminated in error|0
175913|NCT00882908|560159|P4|Overall Study|Study terminated in error|1
175914|NCT00882908|560160|P3|Overall Study|Study terminated in error|0
175915|NCT00882908|560161|P2|Overall Study|Study terminated in error|0
175916|NCT00882908|560162|P1|Overall Study|Study terminated in error|0
175917|NCT00882908|560158|P5|Overall Study|Subject reached a virologic endpoint|1
175918|NCT00882908|560159|P4|Overall Study|Subject reached a virologic endpoint|0
175919|NCT00882908|560160|P3|Overall Study|Subject reached a virologic endpoint|0
175920|NCT00882908|560161|P2|Overall Study|Subject reached a virologic endpoint|0
175921|NCT00882908|560162|P1|Overall Study|Subject reached a virologic endpoint|0
175922|NCT00882908|560158|P5|Overall Study|Withdrawal by Subject|2
175923|NCT00882908|560159|P4|Overall Study|Withdrawal by Subject|5
175924|NCT00882908|560160|P3|Overall Study|Withdrawal by Subject|3
175925|NCT00882908|560161|P2|Overall Study|Withdrawal by Subject|0
175926|NCT00882908|560162|P1|Overall Study|Withdrawal by Subject|0
175927|NCT00882908|560158|P5|Overall Study|Protocol Violation|0
175928|NCT00882908|560159|P4|Overall Study|Protocol Violation|0
175929|NCT00882908|560160|P3|Overall Study|Protocol Violation|0
175930|NCT00882908|560161|P2|Overall Study|Protocol Violation|1
175931|NCT00882908|560162|P1|Overall Study|Protocol Violation|0
175932|NCT00882908|560158|P5|Overall Study|Lost to Follow-up|2
175933|NCT00882908|560159|P4|Overall Study|Lost to Follow-up|1
175934|NCT00882908|560160|P3|Overall Study|Lost to Follow-up|3
175935|NCT00882908|560161|P2|Overall Study|Lost to Follow-up|5
175936|NCT00882908|560162|P1|Overall Study|Lost to Follow-up|3
175937|NCT00882908|560158|P5|Overall Study|Adverse Event|1
175938|NCT00882908|560159|P4|Overall Study|Adverse Event|0
175939|NCT00882908|560160|P3|Overall Study|Adverse Event|1
175940|NCT00882908|560161|P2|Overall Study|Adverse Event|0
175941|NCT00882908|560162|P1|Overall Study|Adverse Event|0
175942|NCT00882921|560237|P1|Overall Study|Withdrawal Of Consent|1
175943|NCT00882921|560237|P1|Overall Study|Termination By Investigator|3
175944|NCT00882921|560237|P1|Overall Study|Lost to Follow-up|2
175945|NCT00882921|560237|P1|Overall Study|Not specified|3
175946|NCT00882921|560237|P1|Overall Study|Death|2
175947|NCT00883090|560242|P1|Overall Study|Withdrawal by Subject|1
175948|NCT00883090|560242|P1|Overall Study|Sponsor's decision|1
175949|NCT00883116|560268|P2|Overall Study|No longer meets study criteria|2
175950|NCT00883116|560269|P1|Overall Study|No longer meets study criteria|2
175951|NCT00883116|560268|P2|Overall Study|Withdrawal by Subject|8
175952|NCT00883116|560269|P1|Overall Study|Withdrawal by Subject|14
175953|NCT00883116|560268|P2|Overall Study|Study drug toxicity|16
175954|NCT00883116|560269|P1|Overall Study|Study drug toxicity|36
175955|NCT00883116|560268|P2|Overall Study|Not identified|6
175956|NCT00883116|560269|P1|Overall Study|Not identified|3
175957|NCT00883116|560268|P2|Overall Study|Maximum clinical benefit|46
175958|NCT00883116|560269|P1|Overall Study|Maximum clinical benefit|13
175959|NCT00883116|560268|P2|Overall Study|Lost to Follow-up|1
175960|NCT00883116|560269|P1|Overall Study|Lost to Follow-up|0
175961|NCT00883116|560268|P2|Overall Study|Disease progression|128
175962|NCT00883116|560269|P1|Overall Study|Disease progression|130
175963|NCT00883116|560268|P2|Overall Study|Death|2
175964|NCT00883116|560269|P1|Overall Study|Death|6
175965|NCT00883116|560268|P2|Overall Study|Adverse event unrelated to study drug|10
175966|NCT00883116|560269|P1|Overall Study|Adverse event unrelated to study drug|5
175967|NCT00883129|560284|P2|Overall Study|Defined Treatment Failure|2
175968|NCT00883129|560285|P1|Overall Study|Defined Treatment Failure|0
175969|NCT00883129|560284|P2|Overall Study|Death|2
175970|NCT00883129|560285|P1|Overall Study|Death|1
175971|NCT00883129|560284|P2|Overall Study|Lost to Follow-up|2
175972|NCT00883129|560285|P1|Overall Study|Lost to Follow-up|1
175973|NCT00883129|560284|P2|Overall Study|Non-compliance|6
175974|NCT00883129|560285|P1|Overall Study|Non-compliance|3
175975|NCT00883129|560284|P2|Overall Study|Withdrawal by Subject|9
175976|NCT00883129|560285|P1|Overall Study|Withdrawal by Subject|8
175977|NCT00883129|560284|P2|Overall Study|Adverse Event|15
175978|NCT00883129|560285|P1|Overall Study|Adverse Event|7
175979|NCT00883181|560332|P1|Overall Study|Noncompliance|3
175980|NCT00883181|560332|P1|Overall Study|Protocol Deviation|3
175981|NCT00883181|560332|P1|Overall Study|Other|38
175982|NCT00883181|560332|P1|Overall Study|Death|31
175983|NCT00883181|560332|P1|Overall Study|Withdrawal by Subject|4
175984|NCT00883181|560332|P1|Overall Study|Administrative Reason|24
175985|NCT00883181|560332|P1|Overall Study|Disease Progression|94
175986|NCT00883181|560332|P1|Overall Study|Non-hematological Adverse Event|55
175987|NCT00883181|560332|P1|Overall Study|Hematological Adverse Event|26
175988|NCT00883337|560579|P3|Extension Treatment Period|Other than above|5
175989|NCT00883337|560580|P2|Extension Treatment Period|Other than above|9
175990|NCT00883337|560581|P1|Extension Treatment Period|Other than above|10
175991|NCT00883337|560579|P3|Extension Treatment Period|Lost to Follow-up|0
175992|NCT00883337|560580|P2|Extension Treatment Period|Lost to Follow-up|0
175993|NCT00883337|560581|P1|Extension Treatment Period|Lost to Follow-up|1
175994|NCT00883337|560579|P3|Extension Treatment Period|Poor compliance to protocol|1
175995|NCT00883337|560580|P2|Extension Treatment Period|Poor compliance to protocol|1
175996|NCT00883337|560581|P1|Extension Treatment Period|Poor compliance to protocol|1
175997|NCT00883337|560579|P3|Extension Treatment Period|Lack of Efficacy|8
175998|NCT00883337|560580|P2|Extension Treatment Period|Lack of Efficacy|8
175999|NCT00883337|560581|P1|Extension Treatment Period|Lack of Efficacy|8
176000|NCT00883337|560579|P3|Extension Treatment Period|Adverse Event|5
176001|NCT00883337|560580|P2|Extension Treatment Period|Adverse Event|5
176002|NCT00883337|560581|P1|Extension Treatment Period|Adverse Event|8
176003|NCT00883337|560579|P3|Core Treatment Period|Other than above|1
176004|NCT00883337|560580|P2|Core Treatment Period|Other than above|1
176005|NCT00883337|560581|P1|Core Treatment Period|Other than above|0
176006|NCT00883337|560579|P3|Core Treatment Period|Poor compliance to protocol|1
176007|NCT00883337|560580|P2|Core Treatment Period|Poor compliance to protocol|0
176008|NCT00883337|560581|P1|Core Treatment Period|Poor compliance to protocol|0
176009|NCT00883337|560579|P3|Core Treatment Period|Wish to be pregnant|1
176010|NCT00883337|560580|P2|Core Treatment Period|Wish to be pregnant|2
176011|NCT00883337|560581|P1|Core Treatment Period|Wish to be pregnant|1
176012|NCT00883337|560579|P3|Core Treatment Period|Withdrawal by Subject|6
176013|NCT00883337|560580|P2|Core Treatment Period|Withdrawal by Subject|2
176014|NCT00883337|560581|P1|Core Treatment Period|Withdrawal by Subject|2
176015|NCT00883337|560579|P3|Core Treatment Period|Lost to Follow-up|0
176016|NCT00883337|560580|P2|Core Treatment Period|Lost to Follow-up|1
176017|NCT00883337|560581|P1|Core Treatment Period|Lost to Follow-up|1
176018|NCT00883337|560579|P3|Core Treatment Period|Lack of Efficacy|2
176019|NCT00883337|560580|P2|Core Treatment Period|Lack of Efficacy|4
176020|NCT00883337|560581|P1|Core Treatment Period|Lack of Efficacy|7
176021|NCT00883337|560579|P3|Core Treatment Period|Adverse Event|22
176022|NCT00883337|560580|P2|Core Treatment Period|Adverse Event|12
176023|NCT00883337|560581|P1|Core Treatment Period|Adverse Event|9
176024|NCT00883493|560619|P2|Overall Study|Not specified|3
176025|NCT00883493|560620|P1|Overall Study|Not specified|5
176026|NCT00883493|560619|P2|Overall Study|Study specific disc. criteria|0
176027|NCT00883493|560620|P1|Overall Study|Study specific disc. criteria|2
176028|NCT00883493|560619|P2|Overall Study|Eligibility Criteria not fullfilled|6
176029|NCT00883493|560620|P1|Overall Study|Eligibility Criteria not fullfilled|6
176030|NCT00883493|560619|P2|Overall Study|Withdrawal by Subject|20
176031|NCT00883493|560620|P1|Overall Study|Withdrawal by Subject|11
176032|NCT00883493|560619|P2|Overall Study|Lost to Follow-up|6
176033|NCT00883493|560620|P1|Overall Study|Lost to Follow-up|7
176034|NCT00883493|560619|P2|Overall Study|Lack of Efficacy|3
176035|NCT00883493|560620|P1|Overall Study|Lack of Efficacy|4
176036|NCT00883493|560619|P2|Overall Study|Adverse Event|12
176037|NCT00883493|560620|P1|Overall Study|Adverse Event|11
176038|NCT00883558|560644|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
176039|NCT00883558|560645|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
176040|NCT00883558|560646|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
176041|NCT00883558|560644|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
176042|NCT00883558|560645|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
176043|NCT00883558|560646|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
176044|NCT00883558|560644|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
176045|NCT00883558|560645|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
176046|NCT00883558|560646|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
176047|NCT00883558|560644|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
176048|NCT00883558|560645|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
176049|NCT00883558|560646|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
176050|NCT00883558|560644|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
176051|NCT00883558|560645|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
176052|NCT00883558|560646|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
176053|NCT00883740|560660|P2|Second Intervention|No longer willing to participate|1
176054|NCT00883740|560661|P1|Second Intervention|No longer willing to participate|0
176055|NCT00883740|560660|P2|Second Intervention|Protocol Violation|0
176056|NCT00883740|560661|P1|Second Intervention|Protocol Violation|1
176057|NCT00883740|560660|P2|First Intervention|Adverse Event|2
176058|NCT00883740|560661|P1|First Intervention|Adverse Event|1
176059|NCT00883740|560660|P2|First Intervention|Protocol Violation|6
176060|NCT00883740|560661|P1|First Intervention|Protocol Violation|3
176061|NCT00883740|560660|P2|First Intervention|No longer willing to participate|0
176062|NCT00883740|560661|P1|First Intervention|No longer willing to participate|2
176063|NCT00883740|560660|P2|First Intervention|Lost to Follow-up|0
176064|NCT00883740|560661|P1|First Intervention|Lost to Follow-up|1
176065|NCT00883753|560701|P1|Overall Study|Administrative/Other|8
176066|NCT00883753|560701|P1|Overall Study|Investigator's decision|17
176067|NCT00883753|560701|P1|Overall Study|Withdrew consent|10
176068|NCT00883753|560701|P1|Overall Study|Refused treatment|4
176069|NCT00883753|560701|P1|Overall Study|Protocol Violation|2
176070|NCT00883753|560701|P1|Overall Study|Violation of selection criteria at entry|7
176071|NCT00883753|560701|P1|Overall Study|Lost to Follow-up|4
176072|NCT00883753|560701|P1|Overall Study|Insufficient therapeutic response|16
176073|NCT00883753|560701|P1|Overall Study|Death|2
176074|NCT00883753|560701|P1|Overall Study|Adverse Event|37
176075|NCT00883779|560743|P2|Off-study Phase|Unspecified|21
176076|NCT00883779|560744|P1|Off-study Phase|Unspecified|18
176077|NCT00883779|560743|P2|Off-study Phase|Failure to return|6
176078|NCT00883779|560744|P1|Off-study Phase|Failure to return|5
176079|NCT00883779|560743|P2|Off-study Phase|Refused treatment|1
176080|NCT00883779|560744|P1|Off-study Phase|Refused treatment|1
176081|NCT00883779|560743|P2|Off-study Phase|Death|174
176082|NCT00883779|560744|P1|Off-study Phase|Death|185
176083|NCT00883779|560743|P2|Post-Study Treatment Phase|Ongoing in the study|6
176084|NCT00883779|560744|P1|Post-Study Treatment Phase|Ongoing in the study|0
176085|NCT00883779|560743|P2|Post-Study Treatment Phase|Unspecified|0
176086|NCT00883779|560744|P1|Post-Study Treatment Phase|Unspecified|3
176087|NCT00883779|560743|P2|Post-Study Treatment Phase|Disease progression|122
176088|NCT00883779|560744|P1|Post-Study Treatment Phase|Disease progression|103
176089|NCT00883779|560743|P2|Post-Study Treatment Phase|Refused Treatment|0
176090|NCT00883779|560744|P1|Post-Study Treatment Phase|Refused Treatment|3
176091|NCT00883779|560743|P2|Post-Study Treatment Phase|Protocol Violation|1
176092|NCT00883779|560744|P1|Post-Study Treatment Phase|Protocol Violation|0
176093|NCT00883779|560743|P2|Post-Study Treatment Phase|Death|3
176094|NCT00883779|560744|P1|Post-Study Treatment Phase|Death|1
176095|NCT00883779|560743|P2|Post-Study Treatment Phase|Adverse Event|3
176096|NCT00883779|560744|P1|Post-Study Treatment Phase|Adverse Event|2
176097|NCT00883779|560743|P2|Primary Study Treatment Phase|Unspecified|0
176098|NCT00883779|560744|P1|Primary Study Treatment Phase|Unspecified|3
176099|NCT00883779|560743|P2|Primary Study Treatment Phase|Refused Treatment|4
176100|NCT00883779|560744|P1|Primary Study Treatment Phase|Refused Treatment|5
176101|NCT00883779|560743|P2|Primary Study Treatment Phase|Death|3
176102|NCT00883779|560744|P1|Primary Study Treatment Phase|Death|2
176103|NCT00883779|560743|P2|Primary Study Treatment Phase|Adverse Event|16
176104|NCT00883779|560744|P1|Primary Study Treatment Phase|Adverse Event|16
176105|NCT00883779|560743|P2|Primary Study Treatment Phase|Disease progression|59
176106|NCT00883779|560744|P1|Primary Study Treatment Phase|Disease progression|75
176107|NCT00883779|560743|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
176108|NCT00883779|560744|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
176109|NCT00884039|560782|P2|Overall Study|Lack of Efficacy|0
176110|NCT00884039|560783|P1|Overall Study|Lack of Efficacy|2
176111|NCT00884039|560782|P2|Overall Study|Withdrawal by Subject|1
176112|NCT00884039|560783|P1|Overall Study|Withdrawal by Subject|0
176113|NCT00884117|560808|P1|Overall Study|Not Specified|12
176114|NCT00884117|560808|P1|Overall Study|Lost to Follow-up|143
176115|NCT00884117|560808|P1|Overall Study|Death|3
176116|NCT00884117|560808|P1|Overall Study|Withdrawal by Subject|89
176117|NCT00884117|560808|P1|Overall Study|Adverse Event|2
176118|NCT00884221|560852|P2|Overall Study|Cancellation of Cycle and Other Reason|13
176119|NCT00884221|560853|P1|Overall Study|Cancellation of Cycle and Other Reason|12
176120|NCT00884221|560852|P2|Overall Study|Protocol Violation|13
176121|NCT00884221|560853|P1|Overall Study|Protocol Violation|16
176122|NCT00884221|560852|P2|Overall Study|Adverse Event|3
176123|NCT00884221|560853|P1|Overall Study|Adverse Event|6
176124|NCT00884221|560852|P2|Overall Study|Withdrawal by Subject|3
176125|NCT00884221|560853|P1|Overall Study|Withdrawal by Subject|0
176126|NCT00884273|560891|P2|Overall Study|Practical reasons|0
176127|NCT00884273|560892|P1|Overall Study|Practical reasons|1
176128|NCT00884273|560891|P2|Overall Study|Protocol Violation|3
176129|NCT00884273|560892|P1|Overall Study|Protocol Violation|1
176130|NCT00884273|560891|P2|Overall Study|Adverse Event|2
176131|NCT00884273|560892|P1|Overall Study|Adverse Event|0
176132|NCT00884325|560918|P2|Overall Study|Not provided|0
176133|NCT00884325|560919|P1|Overall Study|Not provided|1
176134|NCT00884325|560918|P2|Overall Study|Withdrawal by Subject|1
176135|NCT00884325|560919|P1|Overall Study|Withdrawal by Subject|1
176136|NCT00884325|560918|P2|Overall Study|Lack of Efficacy|1
176137|NCT00884325|560919|P1|Overall Study|Lack of Efficacy|0
176138|NCT00884325|560918|P2|Overall Study|Lost to Follow-up|2
176139|NCT00884325|560919|P1|Overall Study|Lost to Follow-up|1
176140|NCT00884377|560929|P2|Overall Study|Physician Decision|1
176141|NCT00884377|560930|P1|Overall Study|Physician Decision|0
176142|NCT00884377|560929|P2|Overall Study|Could not confirm diagnosis|0
176143|NCT00884377|560930|P1|Overall Study|Could not confirm diagnosis|1
176144|NCT00884377|560929|P2|Overall Study|Withdrawal by Subject|0
176145|NCT00884377|560930|P1|Overall Study|Withdrawal by Subject|1
176146|NCT00884390|560952|P2|Overall Study|Not specified|1
176147|NCT00884390|560953|P1|Overall Study|Not specified|11
176148|NCT00884390|560952|P2|Overall Study|Discontinuation of Study by Sponsor|2
176149|NCT00884390|560953|P1|Overall Study|Discontinuation of Study by Sponsor|2
176150|NCT00884390|560952|P2|Overall Study|Withdrawal by Subject|1
176151|NCT00884390|560953|P1|Overall Study|Withdrawal by Subject|4
176152|NCT00884390|560952|P2|Overall Study|Protocol Violation|1
176153|NCT00884390|560953|P1|Overall Study|Protocol Violation|4
176154|NCT00884390|560952|P2|Overall Study|Physician Decision|1
176155|NCT00884390|560953|P1|Overall Study|Physician Decision|2
176156|NCT00884390|560952|P2|Overall Study|Lost to Follow-up|1
176157|NCT00884390|560953|P1|Overall Study|Lost to Follow-up|0
176158|NCT00884390|560952|P2|Overall Study|Adverse Event|1
176159|NCT00884390|560953|P1|Overall Study|Adverse Event|0
176160|NCT00884741|560987|P4|Randomization|Protocol Violation|8
176161|NCT00884741|560988|P3|Randomization|Protocol Violation|8
176162|NCT00884741|560989|P2|Randomization|Protocol Violation|0
176163|NCT00884741|560990|P1|Randomization|Protocol Violation|0
176164|NCT00884741|560987|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
176165|NCT00884741|560988|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
176166|NCT00884741|560989|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
176167|NCT00884741|560990|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
176168|NCT00884741|560987|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
176169|NCT00884741|560988|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
176170|NCT00884741|560989|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
176171|NCT00884741|560990|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
176172|NCT00884741|560987|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
176173|NCT00884741|560988|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
176174|NCT00884741|560989|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
176175|NCT00884741|560990|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
176176|NCT00884741|560987|P4|Step 2 Registration: Tissue Analysis|Death|0
176177|NCT00884741|560988|P3|Step 2 Registration: Tissue Analysis|Death|0
176178|NCT00884741|560989|P2|Step 2 Registration: Tissue Analysis|Death|1
176179|NCT00884741|560990|P1|Step 2 Registration: Tissue Analysis|Death|0
176180|NCT00884741|560987|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
176181|NCT00884741|560988|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
176182|NCT00884741|560989|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
176183|NCT00884741|560990|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
176184|NCT00884741|560987|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
176185|NCT00884741|560988|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
176186|NCT00884741|560989|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
176187|NCT00884741|560990|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
176188|NCT00884741|560987|P4|Step 1 Registration: Tissue Screening|Disease progression|0
176189|NCT00884741|560988|P3|Step 1 Registration: Tissue Screening|Disease progression|0
176190|NCT00884741|560989|P2|Step 1 Registration: Tissue Screening|Disease progression|0
176191|NCT00884741|560990|P1|Step 1 Registration: Tissue Screening|Disease progression|12
176192|NCT00884741|560987|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
176193|NCT00884741|560988|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
176194|NCT00884741|560989|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
176195|NCT00884741|560990|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
176196|NCT00884741|560987|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
176197|NCT00884741|560988|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
176198|NCT00884741|560989|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
176199|NCT00884741|560990|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
176200|NCT00884741|560987|P4|Step 1 Registration: Tissue Screening|Death|0
176201|NCT00884741|560988|P3|Step 1 Registration: Tissue Screening|Death|0
176202|NCT00884741|560989|P2|Step 1 Registration: Tissue Screening|Death|0
176203|NCT00884741|560990|P1|Step 1 Registration: Tissue Screening|Death|3
176204|NCT00884741|560987|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
176205|NCT00884741|560988|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
176206|NCT00884741|560989|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
176207|NCT00884741|560990|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
176208|NCT00884793|561010|P1|Overall Study|Withdrawal by Subject|1
176209|NCT00884832|561024|P2|Overall Study|Withdrawal by Subject|1
176210|NCT00884832|561025|P1|Overall Study|Withdrawal by Subject|0
176211|NCT00884949|561071|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
176212|NCT00884949|561071|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
176213|NCT00885105|561127|P2|Overall Study|Protocol Violation|2
176214|NCT00885105|561128|P1|Overall Study|Protocol Violation|0
176215|NCT00885105|561127|P2|Overall Study|Adverse Event|0
176216|NCT00885105|561128|P1|Overall Study|Adverse Event|1
176217|NCT00885105|561127|P2|Overall Study|Withdrawal by Subject|8
176218|NCT00885105|561128|P1|Overall Study|Withdrawal by Subject|0
176219|NCT00885118|561149|P5|Overall Study|Other reason not defined above|0
176220|NCT00885118|561150|P4|Overall Study|Other reason not defined above|0
176221|NCT00885118|561151|P3|Overall Study|Other reason not defined above|1
176222|NCT00885118|561152|P2|Overall Study|Other reason not defined above|0
176223|NCT00885118|561153|P1|Overall Study|Other reason not defined above|0
176224|NCT00885118|561149|P5|Overall Study|Withdrawal by Subject|1
176225|NCT00885118|561150|P4|Overall Study|Withdrawal by Subject|0
176226|NCT00885118|561151|P3|Overall Study|Withdrawal by Subject|0
176227|NCT00885118|561152|P2|Overall Study|Withdrawal by Subject|0
176228|NCT00885118|561153|P1|Overall Study|Withdrawal by Subject|0
176229|NCT00885118|561149|P5|Overall Study|Adverse Event|0
176230|NCT00885118|561150|P4|Overall Study|Adverse Event|0
176231|NCT00885118|561151|P3|Overall Study|Adverse Event|0
176232|NCT00885118|561152|P2|Overall Study|Adverse Event|0
176233|NCT00885118|561153|P1|Overall Study|Adverse Event|1
176234|NCT00885170|561292|P2|Overall Study|Withdrawal by Subject|13
176235|NCT00885170|561293|P1|Overall Study|Withdrawal by Subject|13
176236|NCT00885170|561292|P2|Overall Study|Protocol Violation|1
176237|NCT00885170|561293|P1|Overall Study|Protocol Violation|3
176238|NCT00885170|561292|P2|Overall Study|Physician Decision|1
176239|NCT00885170|561293|P1|Overall Study|Physician Decision|2
176240|NCT00885170|561292|P2|Overall Study|Lost to Follow-up|1
176241|NCT00885170|561293|P1|Overall Study|Lost to Follow-up|2
176242|NCT00885170|561292|P2|Overall Study|Excessive bone loss|3
176243|NCT00885170|561293|P1|Overall Study|Excessive bone loss|6
176244|NCT00885170|561292|P2|Overall Study|Adverse Event|4
176245|NCT00885170|561293|P1|Overall Study|Adverse Event|12
176246|NCT00885352|561349|P2|Overall Study|Lab abnormalities|1
176247|NCT00885352|561350|P1|Overall Study|Lab abnormalities|1
176248|NCT00885352|561349|P2|Overall Study|Excluded medication|2
176249|NCT00885352|561350|P1|Overall Study|Excluded medication|2
176250|NCT00885352|561349|P2|Overall Study|Contradiction to study medication|2
176251|NCT00885352|561350|P1|Overall Study|Contradiction to study medication|0
176252|NCT00885352|561349|P2|Overall Study|Withdrawal by Subject|5
176253|NCT00885352|561350|P1|Overall Study|Withdrawal by Subject|1
176254|NCT00885352|561349|P2|Overall Study|Protocol Violation|2
176255|NCT00885352|561350|P1|Overall Study|Protocol Violation|0
176256|NCT00885352|561349|P2|Overall Study|Physician Decision|3
176257|NCT00885352|561350|P1|Overall Study|Physician Decision|0
176258|NCT00885352|561349|P2|Overall Study|Lost to Follow-up|2
176259|NCT00885352|561350|P1|Overall Study|Lost to Follow-up|2
176260|NCT00885352|561349|P2|Overall Study|Adverse Event|3
176261|NCT00885352|561350|P1|Overall Study|Adverse Event|2
176262|NCT00885365|561362|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
176263|NCT00885365|561363|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
176264|NCT00885365|561362|P2|4 Weeks ON Treatment|Protocol Violation|2
176265|NCT00885365|561363|P1|4 Weeks ON Treatment|Protocol Violation|1
176266|NCT00885365|561362|P2|4 Weeks ON Treatment|Adverse Event|4
176267|NCT00885365|561363|P1|4 Weeks ON Treatment|Adverse Event|2
176268|NCT00885378|561399|P2|Overall Study|Protocol Violation|0
176269|NCT00885378|561400|P1|Overall Study|Protocol Violation|2
176270|NCT00885378|561399|P2|Overall Study|Poor/Noncompliance|2
176271|NCT00885378|561400|P1|Overall Study|Poor/Noncompliance|2
176272|NCT00885378|561399|P2|Overall Study|Lost to Follow-up|2
176273|NCT00885378|561400|P1|Overall Study|Lost to Follow-up|1
176274|NCT00885378|561399|P2|Overall Study|Withdrawal by Subject|2
176275|NCT00885378|561400|P1|Overall Study|Withdrawal by Subject|1
176276|NCT00885378|561399|P2|Overall Study|Lack of Efficacy|2
176277|NCT00885378|561400|P1|Overall Study|Lack of Efficacy|2
176278|NCT00885677|561438|P2|Overall Study|Inclusion/exclusion not met|27
176279|NCT00885677|561439|P1|Overall Study|Inclusion/exclusion not met|25
176280|NCT00885677|561438|P2|Overall Study|Heart transplantation|0
176281|NCT00885677|561439|P1|Overall Study|Heart transplantation|1
176282|NCT00885677|561438|P2|Overall Study|device/lead revision or replacement|6
176283|NCT00885677|561439|P1|Overall Study|device/lead revision or replacement|7
176284|NCT00885677|561438|P2|Overall Study|premature study closure|44
176285|NCT00885677|561439|P1|Overall Study|premature study closure|41
176286|NCT00885677|561438|P2|Overall Study|Protocol Violation|54
176287|NCT00885677|561439|P1|Overall Study|Protocol Violation|54
176288|NCT00885677|561438|P2|Overall Study|Lost to Follow-up|13
176289|NCT00885677|561439|P1|Overall Study|Lost to Follow-up|15
176290|NCT00885677|561438|P2|Overall Study|Death|34
176291|NCT00885677|561439|P1|Overall Study|Death|40
176292|NCT00885755|561461|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
176293|NCT00885755|561462|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
176294|NCT00885755|561463|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
176295|NCT00885755|561461|P3|Part I: Trastuzumab+Taxane|Death|1
176296|NCT00885755|561462|P2|Part I: Trastuzumab+Taxane|Death|0
176297|NCT00885755|561463|P1|Part I: Trastuzumab+Taxane|Death|0
176298|NCT00885755|561461|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
176299|NCT00885755|561462|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
176300|NCT00885755|561463|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
176301|NCT00885755|561461|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
176302|NCT00885755|561462|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
176303|NCT00885755|561463|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
176304|NCT00885755|561461|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
176305|NCT00885755|561462|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
176306|NCT00885755|561463|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
176307|NCT00885846|561495|P3|Overall Study|Withdrawal by Subject|2
176308|NCT00885846|561496|P2|Overall Study|Withdrawal by Subject|5
176309|NCT00885846|561497|P1|Overall Study|Withdrawal by Subject|2
176310|NCT00886015|561507|P2|Overall Study|Death|2
176311|NCT00886015|561508|P1|Overall Study|Death|0
176312|NCT00886119|561524|P2|Period 1|Did not meet inclusion criteria|0
176313|NCT00886119|561525|P1|Period 1|Did not meet inclusion criteria|1
176314|NCT00886288|561539|P2|Overall Study|Lost to Follow-up|0
176315|NCT00886288|561540|P1|Overall Study|Lost to Follow-up|86
176316|NCT00886288|561539|P2|Overall Study|no respect of the 12 weeks period|227
176317|NCT00886288|561540|P1|Overall Study|no respect of the 12 weeks period|657
176318|NCT00886340|561558|P2|Overall Study|Withdrawal by Subject|7
176319|NCT00886340|561559|P1|Overall Study|Withdrawal by Subject|0
176320|NCT00886483|561567|P2|Overall Study|Distance to center, poor grades|0
176321|NCT00886483|561568|P1|Overall Study|Distance to center, poor grades|1
176322|NCT00886483|561567|P2|Overall Study|Pursue medications|2
176323|NCT00886483|561568|P1|Overall Study|Pursue medications|1
176324|NCT00886483|561567|P2|Overall Study|Lost to Follow-up|1
176325|NCT00886483|561568|P1|Overall Study|Lost to Follow-up|0
176326|NCT00886587|561586|P2|Overall Study|Withdrawal by Subject|1
176327|NCT00886587|561587|P1|Overall Study|Withdrawal by Subject|0
176328|NCT00886587|561586|P2|Overall Study|Protocol Violation|0
176329|NCT00886587|561587|P1|Overall Study|Protocol Violation|2
176330|NCT00886587|561586|P2|Overall Study|Adverse Event|1
176331|NCT00886587|561587|P1|Overall Study|Adverse Event|2
176332|NCT00886600|561603|P4|Combination Therapy Period|Protocol Violation|0
176333|NCT00886600|561604|P3|Combination Therapy Period|Protocol Violation|1
176334|NCT00886600|561605|P2|Combination Therapy Period|Protocol Violation|0
176335|NCT00886600|561606|P1|Combination Therapy Period|Protocol Violation|0
176336|NCT00886600|561603|P4|Combination Therapy Period|Adverse Event|0
176337|NCT00886600|561604|P3|Combination Therapy Period|Adverse Event|1
176338|NCT00886600|561605|P2|Combination Therapy Period|Adverse Event|0
176339|NCT00886600|561606|P1|Combination Therapy Period|Adverse Event|0
176340|NCT00886600|561603|P4|Double-blind Monotherapy|Withdrawal by Subject|0
176341|NCT00886600|561604|P3|Double-blind Monotherapy|Withdrawal by Subject|0
176342|NCT00886600|561605|P2|Double-blind Monotherapy|Withdrawal by Subject|0
176343|NCT00886600|561606|P1|Double-blind Monotherapy|Withdrawal by Subject|1
176344|NCT00886600|561603|P4|Double-blind Monotherapy|Protocol Violation|1
176345|NCT00886600|561604|P3|Double-blind Monotherapy|Protocol Violation|0
176346|NCT00886600|561605|P2|Double-blind Monotherapy|Protocol Violation|0
176347|NCT00886600|561606|P1|Double-blind Monotherapy|Protocol Violation|0
176348|NCT00886600|561603|P4|Double-blind Monotherapy|Adverse Event|1
176349|NCT00886600|561604|P3|Double-blind Monotherapy|Adverse Event|1
176350|NCT00886600|561605|P2|Double-blind Monotherapy|Adverse Event|1
176351|NCT00886600|561606|P1|Double-blind Monotherapy|Adverse Event|1
176352|NCT00886613|561631|P3|Overall Study|Subject withdrew consent (Part A)|2
176353|NCT00886613|561632|P2|Overall Study|Subject withdrew consent (Part A)|0
176354|NCT00886613|561633|P1|Overall Study|Subject withdrew consent (Part A)|0
176355|NCT00886613|561631|P3|Overall Study|Lost to follow-up (Part B)|1
176356|NCT00886613|561632|P2|Overall Study|Lost to follow-up (Part B)|0
176357|NCT00886613|561633|P1|Overall Study|Lost to follow-up (Part B)|1
176358|NCT00886613|561631|P3|Overall Study|Protocol deviation (Part B)|0
176359|NCT00886613|561632|P2|Overall Study|Protocol deviation (Part B)|0
176360|NCT00886613|561633|P1|Overall Study|Protocol deviation (Part B)|1
176361|NCT00886639|561658|P1|Overall Study|non-compliance|2
176362|NCT00886639|561658|P1|Overall Study|acute exacerbation|14
176363|NCT00886743|561673|P1|Overall Study|Unspecified|1
176364|NCT00886743|561673|P1|Overall Study|Adverse Event|3
176365|NCT00886769|561683|P2|Overall Study|Unsatisfactory therapeutic effect|37
176366|NCT00886769|561684|P1|Overall Study|Unsatisfactory therapeutic effect|6
176367|NCT00886795|561708|P1|Overall Study|Lack of Efficacy|1
176368|NCT00886821|561727|P14|Stage 2|Lost to Follow-up|1
176369|NCT00886821|561728|P13|Stage 2|Lost to Follow-up|2
176370|NCT00886821|561729|P12|Stage 2|Lost to Follow-up|0
176371|NCT00886821|561730|P11|Stage 2|Lost to Follow-up|0
176372|NCT00886821|561731|P10|Stage 2|Lost to Follow-up|0
176373|NCT00886821|561732|P9|Stage 2|Lost to Follow-up|0
176374|NCT00886821|561733|P8|Stage 2|Lost to Follow-up|0
176375|NCT00886821|561734|P7|Stage 2|Lost to Follow-up|0
176376|NCT00886821|561735|P6|Stage 2|Lost to Follow-up|0
176377|NCT00886821|561736|P5|Stage 2|Lost to Follow-up|0
176378|NCT00886821|561737|P4|Stage 2|Lost to Follow-up|0
176379|NCT00886821|561738|P3|Stage 2|Lost to Follow-up|0
176380|NCT00886821|561739|P2|Stage 2|Lost to Follow-up|0
176381|NCT00886821|561740|P1|Stage 2|Lost to Follow-up|0
176382|NCT00886821|561727|P14|Stage 2|Adverse Event|0
176383|NCT00886821|561728|P13|Stage 2|Adverse Event|3
176384|NCT00886821|561729|P12|Stage 2|Adverse Event|1
176385|NCT00886821|561730|P11|Stage 2|Adverse Event|0
176386|NCT00886821|561731|P10|Stage 2|Adverse Event|0
176387|NCT00886821|561732|P9|Stage 2|Adverse Event|0
176388|NCT00886821|561733|P8|Stage 2|Adverse Event|0
176389|NCT00886821|561734|P7|Stage 2|Adverse Event|0
176390|NCT00886821|561735|P6|Stage 2|Adverse Event|0
176391|NCT00886821|561736|P5|Stage 2|Adverse Event|0
176392|NCT00886821|561737|P4|Stage 2|Adverse Event|0
176393|NCT00886821|561738|P3|Stage 2|Adverse Event|0
176394|NCT00886821|561739|P2|Stage 2|Adverse Event|0
176395|NCT00886821|561740|P1|Stage 2|Adverse Event|0
176396|NCT00886834|561967|P2|Overall Study|Protocol Violation|3
176397|NCT00886834|561968|P1|Overall Study|Protocol Violation|0
176398|NCT00886938|561983|P1|Overall Study|Withdrawal by Subject|1
176399|NCT00886938|561983|P1|Overall Study|Adverse Event|1
176400|NCT00887159|561990|P3|Overall Study|Never started assigned therapy|4
176401|NCT00887159|561991|P2|Overall Study|Never started assigned therapy|3
176402|NCT00887159|561992|P1|Overall Study|Never started assigned therapy|3
176403|NCT00887159|561990|P3|Overall Study|Ineligible|0
176404|NCT00887159|561991|P2|Overall Study|Ineligible|1
176405|NCT00887159|561992|P1|Overall Study|Ineligible|5
176406|NCT00887159|561990|P3|Overall Study|Received more tx instead of observation|0
176407|NCT00887159|561991|P2|Overall Study|Received more tx instead of observation|0
176408|NCT00887159|561992|P1|Overall Study|Received more tx instead of observation|1
176409|NCT00887159|561990|P3|Overall Study|Pt had PD but was SD when re-measured|0
176410|NCT00887159|561991|P2|Overall Study|Pt had PD but was SD when re-measured|1
176411|NCT00887159|561992|P1|Overall Study|Pt had PD but was SD when re-measured|0
176412|NCT00887159|561990|P3|Overall Study|Treatment delayed|0
176413|NCT00887159|561991|P2|Overall Study|Treatment delayed|1
176414|NCT00887159|561992|P1|Overall Study|Treatment delayed|1
176415|NCT00887159|561990|P3|Overall Study|Sympomatic deterioration|0
176416|NCT00887159|561991|P2|Overall Study|Sympomatic deterioration|0
176417|NCT00887159|561992|P1|Overall Study|Sympomatic deterioration|1
176418|NCT00887159|561990|P3|Overall Study|Physician Decision|0
176419|NCT00887159|561991|P2|Overall Study|Physician Decision|1
176420|NCT00887159|561992|P1|Overall Study|Physician Decision|1
176421|NCT00887159|561990|P3|Overall Study|Alternative therapy|0
176422|NCT00887159|561991|P2|Overall Study|Alternative therapy|0
176423|NCT00887159|561992|P1|Overall Study|Alternative therapy|2
176424|NCT00887159|561990|P3|Overall Study|Withdrawal by Subject|2
176425|NCT00887159|561991|P2|Overall Study|Withdrawal by Subject|4
176426|NCT00887159|561992|P1|Overall Study|Withdrawal by Subject|4
176427|NCT00887159|561990|P3|Overall Study|Death|0
176428|NCT00887159|561991|P2|Overall Study|Death|2
176429|NCT00887159|561992|P1|Overall Study|Death|2
176430|NCT00887159|561990|P3|Overall Study|Adverse Event|17
176431|NCT00887159|561991|P2|Overall Study|Adverse Event|4
176432|NCT00887159|561992|P1|Overall Study|Adverse Event|3
176433|NCT00887159|561990|P3|Overall Study|Disease progression|33
176434|NCT00887159|561991|P2|Overall Study|Disease progression|39
176435|NCT00887159|561992|P1|Overall Study|Disease progression|6
176436|NCT00887198|562010|P2|Overall Study|Lost to Follow-up|3
176437|NCT00887198|562011|P1|Overall Study|Lost to Follow-up|4
176438|NCT00887198|562010|P2|Overall Study|Withdrawal by Subject|41
176439|NCT00887198|562011|P1|Overall Study|Withdrawal by Subject|28
176440|NCT00887198|562010|P2|Overall Study|Death|387
176441|NCT00887198|562011|P1|Overall Study|Death|352
176442|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
176443|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
176444|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
176445|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
176446|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
176447|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
176448|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Unspecified|12
176449|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Unspecified|11
176450|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Unspecified|0
176451|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
176452|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
176453|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
176454|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
176455|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
176456|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
176457|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
176458|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
176459|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
176460|NCT00887224|562042|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
176461|NCT00887224|562043|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
176462|NCT00887224|562044|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
176463|NCT00887224|562042|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
176464|NCT00887224|562043|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
176465|NCT00887224|562044|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
176466|NCT00887224|562042|P3|Double-blind (DB) Phase|Protocol Violation|5
176467|NCT00887224|562043|P2|Double-blind (DB) Phase|Protocol Violation|8
176468|NCT00887224|562044|P1|Double-blind (DB) Phase|Protocol Violation|0
176469|NCT00887224|562042|P3|Double-blind (DB) Phase|Unspecified|0
176470|NCT00887224|562043|P2|Double-blind (DB) Phase|Unspecified|2
176471|NCT00887224|562044|P1|Double-blind (DB) Phase|Unspecified|0
176472|NCT00887224|562042|P3|Double-blind (DB) Phase|Lost to Follow-up|8
176473|NCT00887224|562043|P2|Double-blind (DB) Phase|Lost to Follow-up|8
176474|NCT00887224|562044|P1|Double-blind (DB) Phase|Lost to Follow-up|0
176475|NCT00887224|562042|P3|Double-blind (DB) Phase|Lack of Efficacy|33
176476|NCT00887224|562043|P2|Double-blind (DB) Phase|Lack of Efficacy|67
176477|NCT00887224|562044|P1|Double-blind (DB) Phase|Lack of Efficacy|0
176478|NCT00887224|562042|P3|Double-blind (DB) Phase|Failed to return|2
176479|NCT00887224|562043|P2|Double-blind (DB) Phase|Failed to return|2
176480|NCT00887224|562044|P1|Double-blind (DB) Phase|Failed to return|0
176481|NCT00887224|562042|P3|Double-blind (DB) Phase|Adverse Event|2
176482|NCT00887224|562043|P2|Double-blind (DB) Phase|Adverse Event|7
176483|NCT00887224|562044|P1|Double-blind (DB) Phase|Adverse Event|0
176484|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
176485|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
176486|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
176487|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
176488|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
176489|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
176490|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Unspecified|0
176491|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Unspecified|0
176492|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Unspecified|30
176493|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
176494|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
176495|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
176496|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
176497|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
176498|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
176499|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Failed to return|0
176500|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Failed to return|0
176501|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Failed to return|17
176502|NCT00887224|562042|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
176503|NCT00887224|562043|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
176504|NCT00887224|562044|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
176505|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
176506|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
176507|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
176508|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
176509|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
176510|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
176511|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Unspecified|0
176512|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Unspecified|0
176513|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Unspecified|1
176514|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
176515|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
176516|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
176517|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
176518|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
176519|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
176520|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Failed to return|0
176521|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Failed to return|0
176522|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Failed to return|3
176523|NCT00887224|562042|P3|Open-label Stability (OLS) Phase|Adverse Event|0
176524|NCT00887224|562043|P2|Open-label Stability (OLS) Phase|Adverse Event|0
176525|NCT00887224|562044|P1|Open-label Stability (OLS) Phase|Adverse Event|22
176526|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
176527|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
176528|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
176529|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Protocol Violation|0
176530|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Protocol Violation|0
176531|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Protocol Violation|12
176532|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Unspecified|0
176533|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Unspecified|0
176534|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Unspecified|1
176535|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
176536|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
176537|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
176538|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
176539|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
176540|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
176541|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Failed to return|0
176542|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Failed to return|0
176543|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Failed to return|6
176544|NCT00887224|562042|P3|Open-label Response (OLR) Phase|Adverse Event|0
176545|NCT00887224|562043|P2|Open-label Response (OLR) Phase|Adverse Event|0
176546|NCT00887224|562044|P1|Open-label Response (OLR) Phase|Adverse Event|46
176547|NCT00887250|562072|P3|Overall Study|Patient uncooperative|1
176548|NCT00887250|562073|P2|Overall Study|Patient uncooperative|0
176549|NCT00887250|562074|P1|Overall Study|Patient uncooperative|0
176550|NCT00887250|562072|P3|Overall Study|Withdrawal by Subject|2
176551|NCT00887250|562073|P2|Overall Study|Withdrawal by Subject|1
176552|NCT00887250|562074|P1|Overall Study|Withdrawal by Subject|2
176553|NCT00887250|562072|P3|Overall Study|Protocol Violation|1
176554|NCT00887250|562073|P2|Overall Study|Protocol Violation|2
176555|NCT00887250|562074|P1|Overall Study|Protocol Violation|2
176556|NCT00887250|562072|P3|Overall Study|Lost to Follow-up|1
176557|NCT00887250|562073|P2|Overall Study|Lost to Follow-up|3
176558|NCT00887250|562074|P1|Overall Study|Lost to Follow-up|2
176559|NCT00887250|562072|P3|Overall Study|Lack of Efficacy|1
176560|NCT00887250|562073|P2|Overall Study|Lack of Efficacy|6
176561|NCT00887250|562074|P1|Overall Study|Lack of Efficacy|9
176562|NCT00887250|562072|P3|Overall Study|Adverse Event|7
176563|NCT00887250|562073|P2|Overall Study|Adverse Event|0
176564|NCT00887250|562074|P1|Overall Study|Adverse Event|3
176565|NCT00887289|562094|P1|Overall Study|not specified|20
176566|NCT00887289|562094|P1|Overall Study|Lost to Follow-up|8
176567|NCT00887289|562094|P1|Overall Study|Withdrawal by Subject|26
176568|NCT00887289|562094|P1|Overall Study|Adverse Event|27
176569|NCT00887289|562094|P1|Overall Study|Lack of Efficacy|14
176570|NCT00887315|562105|P2|Overall Study|Study termination|4
176571|NCT00887315|562106|P1|Overall Study|Study termination|7
176572|NCT00887341|562116|P2|Overall Study|Lost to Follow-up|1
176573|NCT00887341|562117|P1|Overall Study|Lost to Follow-up|0
176574|NCT00887341|562116|P2|Overall Study|Adverse Event|1
176575|NCT00887341|562117|P1|Overall Study|Adverse Event|0
176576|NCT00887341|562116|P2|Overall Study|Withdrawal by Subject|1
176577|NCT00887341|562117|P1|Overall Study|Withdrawal by Subject|1
176578|NCT00887341|562116|P2|Overall Study|Refused treatment|0
176579|NCT00887341|562117|P1|Overall Study|Refused treatment|1
176580|NCT00887354|562153|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
176581|NCT00887354|562154|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
176582|NCT00887354|562153|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
176583|NCT00887354|562154|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
176584|NCT00887354|562153|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
176585|NCT00887354|562154|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
176586|NCT00887354|562153|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
176587|NCT00887354|562154|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
176588|NCT00887354|562153|P2|Open Label Phase (Week 26 to Week 78)|Death|2
176589|NCT00887354|562154|P1|Open Label Phase (Week 26 to Week 78)|Death|0
176590|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
176591|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
176592|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
176593|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
176594|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
176595|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
176596|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
176597|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
176598|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
176599|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
176600|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
176601|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
176602|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
176603|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
176604|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
176605|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
176606|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
176607|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
176608|NCT00887354|562153|P2|Treatment Phase (Week 0 to Week 26)|Death|1
176609|NCT00887354|562154|P1|Treatment Phase (Week 0 to Week 26)|Death|0
176610|NCT00887484|562192|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
176611|NCT00887484|562192|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
176612|NCT00887484|562192|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
176613|NCT00887549|562267|P1|Maintenance Therapy|Death due to adverse event|1
176614|NCT00887549|562267|P1|Maintenance Therapy|Progressive Disease|25
176615|NCT00887549|562267|P1|Maintenance Therapy|Physician Decision|1
176616|NCT00887549|562267|P1|Maintenance Therapy|Adverse Event|16
176617|NCT00887549|562267|P1|Induction Therapy|Death due to Study Drug Toxicity|1
176618|NCT00887549|562267|P1|Induction Therapy|Death due to Study Disease|4
176619|NCT00887549|562267|P1|Induction Therapy|Progressive Disease|13
176620|NCT00887549|562267|P1|Induction Therapy|Physician Decision|1
176621|NCT00887549|562267|P1|Induction Therapy|Adverse Event|8
176622|NCT00887588|562305|P2|Extension Period|Lost to Follow-up|0
176623|NCT00887588|562306|P1|Extension Period|Lost to Follow-up|1
176624|NCT00887588|562305|P2|Extension Period|Protocol deviation|0
176625|NCT00887588|562306|P1|Extension Period|Protocol deviation|1
176626|NCT00887588|562305|P2|Extension Period|Death|1
176627|NCT00887588|562306|P1|Extension Period|Death|0
176628|NCT00887588|562305|P2|Extension Period|Adverse Event|4
176629|NCT00887588|562306|P1|Extension Period|Adverse Event|4
176630|NCT00887588|562305|P2|Core Period|Adverse Event|11
176631|NCT00887588|562306|P1|Core Period|Adverse Event|9
176632|NCT00887588|562305|P2|Core Period|Withdrawal by Subject|8
176633|NCT00887588|562306|P1|Core Period|Withdrawal by Subject|6
176634|NCT00887588|562305|P2|Core Period|Lost to Follow-up|1
176635|NCT00887588|562306|P1|Core Period|Lost to Follow-up|3
176636|NCT00887588|562305|P2|Core Period|Death|1
176637|NCT00887588|562306|P1|Core Period|Death|1
176638|NCT00887679|562377|P1|Overall Study|Physician Decision|5
176639|NCT00887679|562377|P1|Overall Study|Lost to Follow-up|4
176640|NCT00887679|562377|P1|Overall Study|Withdrawal by Subject|1
176641|NCT00887744|562386|P1|Overall Study|Various reasons|9
176642|NCT00887744|562386|P1|Overall Study|Withdrawal by Subject|18
176643|NCT00887744|562386|P1|Overall Study|Lost to Follow-up|3
176644|NCT00887744|562386|P1|Overall Study|Death|1
176645|NCT00887744|562386|P1|Overall Study|Adverse Event|3
176646|NCT00887809|562397|P2|Overall Study|Death|0
176647|NCT00887809|562398|P1|Overall Study|Death|1
176648|NCT00887809|562397|P2|Overall Study|Patient Not Treated|0
176649|NCT00887809|562398|P1|Overall Study|Patient Not Treated|3
176650|NCT00887822|562406|P2|Overall Study|Randomized but not treated|1
176651|NCT00887822|562407|P1|Overall Study|Randomized but not treated|0
176652|NCT00887822|562406|P2|Overall Study|Protocol Violation|1
176653|NCT00887822|562407|P1|Overall Study|Protocol Violation|0
176654|NCT00887822|562406|P2|Overall Study|Death|3
176655|NCT00887822|562407|P1|Overall Study|Death|2
176656|NCT00887822|562406|P2|Overall Study|Administrative/Other than specified|4
176657|NCT00887822|562407|P1|Overall Study|Administrative/Other than specified|5
176658|NCT00887822|562406|P2|Overall Study|Refused treatment/Did not cooperate|10
176659|NCT00887822|562407|P1|Overall Study|Refused treatment/Did not cooperate|12
176660|NCT00887822|562406|P2|Overall Study|Failure to return|11
176661|NCT00887822|562407|P1|Overall Study|Failure to return|11
176662|NCT00887822|562406|P2|Overall Study|Adverse Event|17
176663|NCT00887822|562407|P1|Overall Study|Adverse Event|14
176664|NCT00887822|562406|P2|Overall Study|Insufficient therapeutic response|55
176665|NCT00887822|562407|P1|Overall Study|Insufficient therapeutic response|53
176666|NCT00887913|562437|P1|Overall Study|Withdrawal by Subject|6
176667|NCT00887978|562475|P2|Overall Study|Lost to Follow-up|1
176668|NCT00887978|562476|P1|Overall Study|Lost to Follow-up|0
176669|NCT00887978|562475|P2|Overall Study|Withdrawal by Subject|2
176670|NCT00887978|562476|P1|Overall Study|Withdrawal by Subject|1
176671|NCT00887978|562475|P2|Overall Study|Death|3
176672|NCT00887978|562476|P1|Overall Study|Death|2
176673|NCT00887978|562475|P2|Overall Study|Clinical Worsening|4
176674|NCT00887978|562476|P1|Overall Study|Clinical Worsening|4
176675|NCT00887978|562475|P2|Overall Study|Adverse Event|5
176676|NCT00887978|562476|P1|Overall Study|Adverse Event|18
176677|NCT00881335|562514|P2|Overall Study|Lost to Follow-up|2
176678|NCT00881335|562515|P1|Overall Study|Lost to Follow-up|3
176679|NCT00881504|562546|P1|Overall Study|Withdrawal by Subject|1
176680|NCT00881530|562557|P6|Overall Study|Other reason not defined above|2
176681|NCT00881530|562558|P5|Overall Study|Other reason not defined above|0
176682|NCT00881530|562559|P4|Overall Study|Other reason not defined above|0
176683|NCT00881530|562560|P3|Overall Study|Other reason not defined above|2
176684|NCT00881530|562561|P2|Overall Study|Other reason not defined above|1
176685|NCT00881530|562562|P1|Overall Study|Other reason not defined above|1
176686|NCT00881530|562557|P6|Overall Study|Refused to continue medication|0
176687|NCT00881530|562558|P5|Overall Study|Refused to continue medication|0
176688|NCT00881530|562559|P4|Overall Study|Refused to continue medication|2
176689|NCT00881530|562560|P3|Overall Study|Refused to continue medication|1
176690|NCT00881530|562561|P2|Overall Study|Refused to continue medication|2
176691|NCT00881530|562562|P1|Overall Study|Refused to continue medication|7
176692|NCT00881530|562557|P6|Overall Study|Lost to Follow-up|0
176693|NCT00881530|562558|P5|Overall Study|Lost to Follow-up|1
176694|NCT00881530|562559|P4|Overall Study|Lost to Follow-up|3
176695|NCT00881530|562560|P3|Overall Study|Lost to Follow-up|1
176696|NCT00881530|562561|P2|Overall Study|Lost to Follow-up|1
176697|NCT00881530|562562|P1|Overall Study|Lost to Follow-up|0
176698|NCT00881530|562557|P6|Overall Study|Not compliant with the protocol|0
176699|NCT00881530|562558|P5|Overall Study|Not compliant with the protocol|2
176700|NCT00881530|562559|P4|Overall Study|Not compliant with the protocol|0
176701|NCT00881530|562560|P3|Overall Study|Not compliant with the protocol|0
176702|NCT00881530|562561|P2|Overall Study|Not compliant with the protocol|0
176703|NCT00881530|562562|P1|Overall Study|Not compliant with the protocol|0
176704|NCT00881530|562557|P6|Overall Study|Lack of Efficacy|1
176705|NCT00881530|562558|P5|Overall Study|Lack of Efficacy|1
176706|NCT00881530|562559|P4|Overall Study|Lack of Efficacy|0
176707|NCT00881530|562560|P3|Overall Study|Lack of Efficacy|0
176708|NCT00881530|562561|P2|Overall Study|Lack of Efficacy|0
176709|NCT00881530|562562|P1|Overall Study|Lack of Efficacy|1
176710|NCT00881530|562557|P6|Overall Study|Adverse Event|2
176711|NCT00881530|562558|P5|Overall Study|Adverse Event|10
176712|NCT00881530|562559|P4|Overall Study|Adverse Event|4
176713|NCT00881530|562560|P3|Overall Study|Adverse Event|1
176714|NCT00881530|562561|P2|Overall Study|Adverse Event|1
176715|NCT00881530|562562|P1|Overall Study|Adverse Event|5
176716|NCT00881608|562623|P1|Overall Study|Study prematurely terminated|11
176717|NCT00881621|562640|P1|Overall Study|Physician Decision|34
176718|NCT00881712|562663|P3|Overall Study|Withdrawal by Subject|0
176719|NCT00881712|562664|P2|Overall Study|Withdrawal by Subject|0
176720|NCT00881712|562665|P1|Overall Study|Withdrawal by Subject|1
176721|NCT00881712|562663|P3|Overall Study|Death|0
176722|NCT00881712|562664|P2|Overall Study|Death|0
176723|NCT00881712|562665|P1|Overall Study|Death|1
176724|NCT00881868|562687|P2|Overall Study|Protocol Violation|0
176725|NCT00881868|562688|P1|Overall Study|Protocol Violation|2
176726|NCT00881868|562687|P2|Overall Study|Physician Decision|0
176727|NCT00881868|562688|P1|Overall Study|Physician Decision|4
176728|NCT00881868|562687|P2|Overall Study|Lost to Follow-up|1
176729|NCT00881868|562688|P1|Overall Study|Lost to Follow-up|2
176730|NCT00881868|562687|P2|Overall Study|Adverse Event|1
176731|NCT00881868|562688|P1|Overall Study|Adverse Event|0
176732|NCT00881894|562702|P2|Overall Study|Other reasons for premature termination|2
176733|NCT00881894|562703|P1|Overall Study|Other reasons for premature termination|1
176734|NCT00881894|562702|P2|Overall Study|Consent withdrawn|1
176735|NCT00881894|562703|P1|Overall Study|Consent withdrawn|0
176736|NCT00881959|562735|P2|Overall Study|Lost to Follow-up|4
176737|NCT00881959|562736|P1|Overall Study|Lost to Follow-up|2
176738|NCT00882310|562753|P1|Overall Study|Adverse Event|1
176739|NCT00882310|562753|P1|Overall Study|Progression of disease|4
176740|NCT00882310|562753|P1|Overall Study|Death|6
176741|NCT00882310|562753|P1|Overall Study|Never received treatment|1
176742|NCT00882310|562753|P1|Overall Study|Screen Failure|10
176743|NCT00882362|562761|P2|Overall Study|change of residence or other commitments|0
176744|NCT00882362|562762|P1|Overall Study|change of residence or other commitments|5
176745|NCT00882362|562761|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
176746|NCT00882362|562762|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
176747|NCT00882362|562761|P2|Overall Study|Physician Decision|1
176748|NCT00882362|562762|P1|Overall Study|Physician Decision|5
176749|NCT00882362|562761|P2|Overall Study|Pregnancy|0
176750|NCT00882362|562762|P1|Overall Study|Pregnancy|1
176751|NCT00882362|562761|P2|Overall Study|Protocol Violation|2
176752|NCT00882362|562762|P1|Overall Study|Protocol Violation|7
176753|NCT00882362|562761|P2|Overall Study|Lack of Efficacy|0
176754|NCT00882362|562762|P1|Overall Study|Lack of Efficacy|3
176755|NCT00882362|562761|P2|Overall Study|Withdrawal by Subject|10
176756|NCT00882362|562762|P1|Overall Study|Withdrawal by Subject|13
176757|NCT00882362|562761|P2|Overall Study|Adverse Event|10
176758|NCT00882362|562762|P1|Overall Study|Adverse Event|13
176759|NCT00882440|562775|P7|Overall Study|Patient Uncooperative|0
176760|NCT00882440|562776|P6|Overall Study|Patient Uncooperative|0
176761|NCT00882440|562777|P5|Overall Study|Patient Uncooperative|1
176762|NCT00882440|562778|P4|Overall Study|Patient Uncooperative|0
176763|NCT00882440|562779|P3|Overall Study|Patient Uncooperative|0
176764|NCT00882440|562780|P2|Overall Study|Patient Uncooperative|0
176765|NCT00882440|562781|P1|Overall Study|Patient Uncooperative|2
176766|NCT00882440|562775|P7|Overall Study|Withdrawal by Subject|1
176767|NCT00882440|562776|P6|Overall Study|Withdrawal by Subject|0
176768|NCT00882440|562777|P5|Overall Study|Withdrawal by Subject|6
176769|NCT00882440|562778|P4|Overall Study|Withdrawal by Subject|0
176770|NCT00882440|562779|P3|Overall Study|Withdrawal by Subject|1
176771|NCT00882440|562780|P2|Overall Study|Withdrawal by Subject|1
176772|NCT00882440|562781|P1|Overall Study|Withdrawal by Subject|2
176773|NCT00882440|562775|P7|Overall Study|Protocol Violation|0
176774|NCT00882440|562776|P6|Overall Study|Protocol Violation|0
176775|NCT00882440|562777|P5|Overall Study|Protocol Violation|1
176776|NCT00882440|562778|P4|Overall Study|Protocol Violation|1
176777|NCT00882440|562779|P3|Overall Study|Protocol Violation|1
176778|NCT00882440|562780|P2|Overall Study|Protocol Violation|0
176779|NCT00882440|562781|P1|Overall Study|Protocol Violation|0
176780|NCT00882440|562775|P7|Overall Study|Lost to Follow-up|1
176781|NCT00882440|562776|P6|Overall Study|Lost to Follow-up|0
176782|NCT00882440|562777|P5|Overall Study|Lost to Follow-up|1
176783|NCT00882440|562778|P4|Overall Study|Lost to Follow-up|1
176784|NCT00882440|562779|P3|Overall Study|Lost to Follow-up|1
176785|NCT00882440|562780|P2|Overall Study|Lost to Follow-up|0
176786|NCT00882440|562781|P1|Overall Study|Lost to Follow-up|2
176787|NCT00882440|562775|P7|Overall Study|Lack of Efficacy|0
176788|NCT00882440|562776|P6|Overall Study|Lack of Efficacy|3
176789|NCT00882440|562777|P5|Overall Study|Lack of Efficacy|0
176790|NCT00882440|562778|P4|Overall Study|Lack of Efficacy|0
176791|NCT00882440|562779|P3|Overall Study|Lack of Efficacy|2
176792|NCT00882440|562780|P2|Overall Study|Lack of Efficacy|5
176793|NCT00882440|562781|P1|Overall Study|Lack of Efficacy|3
176794|NCT00882440|562775|P7|Overall Study|Adverse Event|2
176795|NCT00882440|562776|P6|Overall Study|Adverse Event|4
176796|NCT00882440|562777|P5|Overall Study|Adverse Event|1
176797|NCT00882440|562778|P4|Overall Study|Adverse Event|1
176798|NCT00882440|562779|P3|Overall Study|Adverse Event|2
176799|NCT00882440|562780|P2|Overall Study|Adverse Event|2
176800|NCT00882440|562781|P1|Overall Study|Adverse Event|2
176801|NCT00882518|562806|P2|Overall Study|Allocating random number by mistake|1
176802|NCT00882518|562807|P1|Overall Study|Allocating random number by mistake|0
176803|NCT00882518|562806|P2|Overall Study|Central lab closure for National day|0
176804|NCT00882518|562807|P1|Overall Study|Central lab closure for National day|1
176805|NCT00882518|562806|P2|Overall Study|Incorrect enrolment|2
176806|NCT00882518|562807|P1|Overall Study|Incorrect enrolment|4
176807|NCT00882518|562806|P2|Overall Study|Severe non-compliance to protocol|1
176808|NCT00882518|562807|P1|Overall Study|Severe non-compliance to protocol|3
176809|NCT00882518|562806|P2|Overall Study|Lack of Efficacy|9
176810|NCT00882518|562807|P1|Overall Study|Lack of Efficacy|12
176811|NCT00882518|562806|P2|Overall Study|Withdrawal by Subject|13
176812|NCT00882518|562807|P1|Overall Study|Withdrawal by Subject|9
176813|NCT00882518|562806|P2|Overall Study|Adverse Event|18
176814|NCT00882518|562807|P1|Overall Study|Adverse Event|9
176815|NCT00882557|562831|P2|Overall Study|Randomized Not Treated|1
176816|NCT00882557|562832|P1|Overall Study|Randomized Not Treated|0
176817|NCT00882557|562831|P2|Overall Study|Trouble with Vein Access|0
176818|NCT00882557|562832|P1|Overall Study|Trouble with Vein Access|1
176819|NCT00882557|562831|P2|Overall Study|Withdrawal by Subject|0
176820|NCT00882557|562832|P1|Overall Study|Withdrawal by Subject|1
176821|NCT00882583|562852|P2|Overall Study|Adverse Event|1
176822|NCT00882583|562853|P1|Overall Study|Adverse Event|0
176823|NCT00882583|562852|P2|Overall Study|Physician Decision|0
176824|NCT00882583|562853|P1|Overall Study|Physician Decision|1
176825|NCT00888134|562859|P1|Follow-up|being followed for long-term survival|1
176826|NCT00888134|562859|P1|Treatment With Study Drug|Withdrawal by Subject|1
176827|NCT00888238|562867|P3|Washout Period After Period 2|Adverse Event|1
176828|NCT00888238|562868|P2|Washout Period After Period 2|Adverse Event|0
176829|NCT00888238|562869|P1|Washout Period After Period 2|Adverse Event|0
176830|NCT00888329|562879|P2|Overall Study|Physician Decision|9
176831|NCT00888329|562880|P1|Overall Study|Physician Decision|6
176832|NCT00888355|562890|P4|Overall Study|Withdrawal by Subject|3
176833|NCT00888355|562891|P3|Overall Study|Withdrawal by Subject|1
176834|NCT00888355|562892|P2|Overall Study|Withdrawal by Subject|3
176835|NCT00888355|562893|P1|Overall Study|Withdrawal by Subject|0
176836|NCT00888355|562890|P4|Overall Study|Protocol Violation|2
176837|NCT00888355|562891|P3|Overall Study|Protocol Violation|1
176838|NCT00888355|562892|P2|Overall Study|Protocol Violation|2
176839|NCT00888355|562893|P1|Overall Study|Protocol Violation|3
176840|NCT00888355|562890|P4|Overall Study|Lost to Follow-up|0
176841|NCT00888355|562891|P3|Overall Study|Lost to Follow-up|2
176842|NCT00888355|562892|P2|Overall Study|Lost to Follow-up|2
176843|NCT00888355|562893|P1|Overall Study|Lost to Follow-up|0
176844|NCT00888355|562890|P4|Overall Study|Lack of Efficacy|2
176845|NCT00888355|562891|P3|Overall Study|Lack of Efficacy|5
176846|NCT00888355|562892|P2|Overall Study|Lack of Efficacy|2
176847|NCT00888355|562893|P1|Overall Study|Lack of Efficacy|9
176848|NCT00888355|562890|P4|Overall Study|Adverse Event|3
176849|NCT00888355|562891|P3|Overall Study|Adverse Event|3
176850|NCT00888355|562892|P2|Overall Study|Adverse Event|0
176851|NCT00888355|562893|P1|Overall Study|Adverse Event|10
176852|NCT00888381|562949|P2|Overall Study|Lost to Follow-up|1
176853|NCT00888381|562950|P1|Overall Study|Lost to Follow-up|0
176854|NCT00888654|562972|P1|Overall Study|Stopped meds due to headaches|1
176855|NCT00888654|562972|P1|Overall Study|Change in surg date|1
176856|NCT00888654|562972|P1|Overall Study|Inelig. due to contraindication of med|1
176857|NCT00888654|562972|P1|Overall Study|Withdrawal by Subject|1
176858|NCT00888654|562972|P1|Overall Study|Surgery aborted|2
176859|NCT00888654|562972|P1|Overall Study|Not enough oral meds before surgery|3
176860|NCT00888654|562972|P1|Overall Study|Problems swallowing oral meds.|1
176861|NCT00888849|562978|P2|Overall Study|Lost to Follow-up|2
176862|NCT00888849|562979|P1|Overall Study|Lost to Follow-up|1
176863|NCT00888849|562978|P2|Overall Study|Death|7
176864|NCT00888849|562979|P1|Overall Study|Death|4
176865|NCT00888940|562991|P2|Overall Study|Randomized Not Treated|13
176866|NCT00888940|562992|P1|Overall Study|Randomized Not Treated|11
176867|NCT00888940|562991|P2|Overall Study|Lost to Follow-up|5
176868|NCT00888940|562992|P1|Overall Study|Lost to Follow-up|5
176869|NCT00888940|562991|P2|Overall Study|Adverse Event|3
176870|NCT00888940|562992|P1|Overall Study|Adverse Event|12
176871|NCT00889252|563025|P2|Overall Study|Protocol Violation|0
176872|NCT00889252|563026|P1|Overall Study|Protocol Violation|2
176873|NCT00889252|563025|P2|Overall Study|Withdrawal by Subject|0
176874|NCT00889252|563026|P1|Overall Study|Withdrawal by Subject|3
176875|NCT00889252|563025|P2|Overall Study|Adverse Event|4
176876|NCT00889252|563026|P1|Overall Study|Adverse Event|2
176877|NCT00889265|563068|P1|Overall Study|Protocol Violation|1
176878|NCT00889265|563068|P1|Overall Study|Lost to Follow-up|5
176879|NCT00889265|563068|P1|Overall Study|Adverse Event|1
176880|NCT00889421|563106|P1|Overall Study|Lack of Efficacy|3
176881|NCT00889603|563123|P1|Overall Study|Not Specified|4
176882|NCT00889603|563123|P1|Overall Study|No longer willing to participant in stud|4
176883|NCT00889603|563123|P1|Overall Study|Lost to Follow-up|19
176884|NCT00889603|563123|P1|Overall Study|Death|3
176885|NCT00889603|563123|P1|Overall Study|Adverse Event|7
176886|NCT00889681|563136|P1|Overall Study|Insurance disapproval|1
176887|NCT00889681|563136|P1|Overall Study|Not meeting qualification Criteria|2
176888|NCT00889707|563145|P2|Overall Study|Lack of Efficacy|5
176889|NCT00889707|563146|P1|Overall Study|Lack of Efficacy|2
176890|NCT00889707|563145|P2|Overall Study|Lost to Follow-up|2
176891|NCT00889707|563146|P1|Overall Study|Lost to Follow-up|0
176892|NCT00889707|563145|P2|Overall Study|Withdrawal by Subject|3
176893|NCT00889707|563146|P1|Overall Study|Withdrawal by Subject|4
176894|NCT00889707|563145|P2|Overall Study|Adverse Event|0
176895|NCT00889707|563146|P1|Overall Study|Adverse Event|1
176896|NCT00889720|563154|P1|Overall Study|Unspecified|4
176897|NCT00889720|563154|P1|Overall Study|Withdrawal by Subject|4
176898|NCT00889863|563183|P2|Part II: Randomized Double Blind|Protocol deviation|1
176899|NCT00889863|563184|P1|Part II: Randomized Double Blind|Protocol deviation|0
176900|NCT00889863|563183|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
176901|NCT00889863|563184|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
176902|NCT00889863|563183|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
176903|NCT00889863|563184|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
176904|NCT00889863|563183|P2|Part II: Randomized Double Blind|Adverse Event|4
176905|NCT00889863|563184|P1|Part II: Randomized Double Blind|Adverse Event|0
176906|NCT00889863|563183|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
176907|NCT00889863|563184|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
176908|NCT00889863|563183|P2|Part I: Open Label|Adverse Event|0
176909|NCT00889863|563184|P1|Part I: Open Label|Adverse Event|4
176910|NCT00889863|563183|P2|Part I: Open Label|Death|0
176911|NCT00889863|563184|P1|Part I: Open Label|Death|1
176912|NCT00890084|563235|P1|Overall Study|Lost to Follow-up|126
176913|NCT00890084|563235|P1|Overall Study|Adverse Event|16
176914|NCT00890097|563249|P3|Overall Study|Protocol Deviation|1
176915|NCT00890097|563250|P2|Overall Study|Protocol Deviation|1
176916|NCT00890097|563251|P1|Overall Study|Protocol Deviation|1
176917|NCT00890097|563249|P3|Overall Study|Subject Moved|0
176918|NCT00890097|563250|P2|Overall Study|Subject Moved|4
176919|NCT00890097|563251|P1|Overall Study|Subject Moved|0
176920|NCT00890097|563249|P3|Overall Study|Transportation|0
176921|NCT00890097|563250|P2|Overall Study|Transportation|2
176922|NCT00890097|563251|P1|Overall Study|Transportation|0
176923|NCT00890097|563249|P3|Overall Study|Failed inclusion criteria|0
176924|NCT00890097|563250|P2|Overall Study|Failed inclusion criteria|4
176925|NCT00890097|563251|P1|Overall Study|Failed inclusion criteria|3
176926|NCT00890097|563249|P3|Overall Study|Randomization Error|0
176927|NCT00890097|563250|P2|Overall Study|Randomization Error|0
176928|NCT00890097|563251|P1|Overall Study|Randomization Error|2
176929|NCT00890097|563249|P3|Overall Study|Subject Decision|6
176930|NCT00890097|563250|P2|Overall Study|Subject Decision|2
176931|NCT00890097|563251|P1|Overall Study|Subject Decision|3
176932|NCT00890097|563249|P3|Overall Study|Did not attend final visit|0
176933|NCT00890097|563250|P2|Overall Study|Did not attend final visit|3
176934|NCT00890097|563251|P1|Overall Study|Did not attend final visit|2
176935|NCT00890097|563249|P3|Overall Study|Sponsor Decision|7
176936|NCT00890097|563250|P2|Overall Study|Sponsor Decision|11
176937|NCT00890097|563251|P1|Overall Study|Sponsor Decision|7
176938|NCT00890097|563249|P3|Overall Study|Noncompliance|4
176939|NCT00890097|563250|P2|Overall Study|Noncompliance|4
176940|NCT00890097|563251|P1|Overall Study|Noncompliance|0
176941|NCT00890097|563249|P3|Overall Study|Lost to Follow-up|5
176942|NCT00890097|563250|P2|Overall Study|Lost to Follow-up|5
176943|NCT00890097|563251|P1|Overall Study|Lost to Follow-up|5
176944|NCT00890097|563249|P3|Overall Study|Withdrew Consent|9
176945|NCT00890097|563250|P2|Overall Study|Withdrew Consent|6
176946|NCT00890097|563251|P1|Overall Study|Withdrew Consent|9
176947|NCT00890097|563249|P3|Overall Study|Decision Unrelated to an Adverse Event|17
176948|NCT00890097|563250|P2|Overall Study|Decision Unrelated to an Adverse Event|12
176949|NCT00890097|563251|P1|Overall Study|Decision Unrelated to an Adverse Event|15
176950|NCT00890097|563249|P3|Overall Study|Adverse Event|28
176951|NCT00890097|563250|P2|Overall Study|Adverse Event|32
176952|NCT00890097|563251|P1|Overall Study|Adverse Event|21
176953|NCT00890201|563261|P2|Overall Study|Protocol Violation|56
176954|NCT00890201|563262|P1|Overall Study|Protocol Violation|5
176955|NCT00890409|563270|P2|Overall Study|Lost to Follow-up|21
176956|NCT00890409|563271|P1|Overall Study|Lost to Follow-up|20
176957|NCT00890552|563279|P1|On-treatment|Early prog disease/ death|10
176958|NCT00890552|563279|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
176959|NCT00890591|563286|P1|Overall Study|Lack of Efficacy|20
176960|NCT00890695|563307|P2|Overall Study|Protocol Violation|0
176961|NCT00890695|563308|P1|Overall Study|Protocol Violation|1
176962|NCT00890929|563337|P1|Overall Study|Physician Decision|1
176963|NCT00890929|563337|P1|Overall Study|Withdrawal by Subject|3
176964|NCT00890929|563337|P1|Overall Study|Death before treatment|2
176965|NCT00891020|563385|P3|Long-term Extension Period|Administrative|2
176966|NCT00891020|563386|P2|Long-term Extension Period|Administrative|2
176967|NCT00891020|563387|P1|Long-term Extension Period|Administrative|1
176968|NCT00891020|563385|P3|Long-term Extension Period|Failure to return|3
176969|NCT00891020|563386|P2|Long-term Extension Period|Failure to return|2
176970|NCT00891020|563387|P1|Long-term Extension Period|Failure to return|0
176971|NCT00891020|563385|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
176972|NCT00891020|563386|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
176973|NCT00891020|563387|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
176974|NCT00891020|563385|P3|Long-term Extension Period|Protocol Violation|1
176975|NCT00891020|563386|P2|Long-term Extension Period|Protocol Violation|1
176976|NCT00891020|563387|P1|Long-term Extension Period|Protocol Violation|0
176977|NCT00891020|563385|P3|Long-term Extension Period|Insufficient therapeutic response|2
176978|NCT00891020|563386|P2|Long-term Extension Period|Insufficient therapeutic response|2
176979|NCT00891020|563387|P1|Long-term Extension Period|Insufficient therapeutic response|3
176980|NCT00891020|563385|P3|Long-term Extension Period|Death|1
176981|NCT00891020|563386|P2|Long-term Extension Period|Death|0
176982|NCT00891020|563387|P1|Long-term Extension Period|Death|0
176983|NCT00891020|563385|P3|Long-term Extension Period|Adverse Event|10
176984|NCT00891020|563386|P2|Long-term Extension Period|Adverse Event|11
176985|NCT00891020|563387|P1|Long-term Extension Period|Adverse Event|1
176986|NCT00891020|563385|P3|24 Week Treatment Period|Administrative/Other|1
176987|NCT00891020|563386|P2|24 Week Treatment Period|Administrative/Other|6
176988|NCT00891020|563387|P1|24 Week Treatment Period|Administrative/Other|5
176989|NCT00891020|563385|P3|24 Week Treatment Period|Withdrew consent|15
176990|NCT00891020|563386|P2|24 Week Treatment Period|Withdrew consent|3
176991|NCT00891020|563387|P1|24 Week Treatment Period|Withdrew consent|6
176992|NCT00891020|563385|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
176993|NCT00891020|563386|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
176994|NCT00891020|563387|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
176995|NCT00891020|563385|P3|24 Week Treatment Period|Other protocol violation|2
176996|NCT00891020|563386|P2|24 Week Treatment Period|Other protocol violation|1
176997|NCT00891020|563387|P1|24 Week Treatment Period|Other protocol violation|1
176998|NCT00891020|563385|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
176999|NCT00891020|563386|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
177000|NCT00891020|563387|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
177001|NCT00891020|563385|P3|24 Week Treatment Period|Failure to return|5
177002|NCT00891020|563386|P2|24 Week Treatment Period|Failure to return|5
177003|NCT00891020|563387|P1|24 Week Treatment Period|Failure to return|4
177004|NCT00891020|563385|P3|24 Week Treatment Period|Insufficient therapeutic response|15
177005|NCT00891020|563386|P2|24 Week Treatment Period|Insufficient therapeutic response|9
177006|NCT00891020|563387|P1|24 Week Treatment Period|Insufficient therapeutic response|6
177007|NCT00891020|563385|P3|24 Week Treatment Period|Death|0
177008|NCT00891020|563386|P2|24 Week Treatment Period|Death|2
177009|NCT00891020|563387|P1|24 Week Treatment Period|Death|0
177010|NCT00891020|563385|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
177011|NCT00891020|563386|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
177012|NCT00891020|563387|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
177013|NCT00885482|563418|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
177014|NCT00885482|563418|P1|Overall Study|Death|1
177015|NCT00885482|563418|P1|Overall Study|Lack of Efficacy|1
177016|NCT00885482|563418|P1|Overall Study|Pregnancy|1
177017|NCT00885534|563422|P1|Overall Study|Patient deemed ineligible|1
177018|NCT00891046|563431|P5|Overall Study|Lost to Follow-up|1
177019|NCT00891046|563432|P4|Overall Study|Lost to Follow-up|0
177020|NCT00891046|563433|P3|Overall Study|Lost to Follow-up|0
177021|NCT00891046|563434|P2|Overall Study|Lost to Follow-up|0
177022|NCT00891046|563435|P1|Overall Study|Lost to Follow-up|0
177023|NCT00891046|563431|P5|Overall Study|Withdrawal by Subject|1
177024|NCT00891046|563432|P4|Overall Study|Withdrawal by Subject|1
177025|NCT00891046|563433|P3|Overall Study|Withdrawal by Subject|2
177026|NCT00891046|563434|P2|Overall Study|Withdrawal by Subject|1
177027|NCT00891046|563435|P1|Overall Study|Withdrawal by Subject|2
177028|NCT00891046|563431|P5|Overall Study|Adverse Event|14
177029|NCT00891046|563432|P4|Overall Study|Adverse Event|0
177030|NCT00891046|563433|P3|Overall Study|Adverse Event|2
177031|NCT00891046|563434|P2|Overall Study|Adverse Event|3
177032|NCT00891046|563435|P1|Overall Study|Adverse Event|4
177033|NCT00891046|563431|P5|Overall Study|Participant no longer required drug|1
177034|NCT00891046|563432|P4|Overall Study|Participant no longer required drug|0
177035|NCT00891046|563433|P3|Overall Study|Participant no longer required drug|0
177036|NCT00891046|563434|P2|Overall Study|Participant no longer required drug|2
177037|NCT00891046|563435|P1|Overall Study|Participant no longer required drug|0
177038|NCT00891046|563431|P5|Overall Study|Administrative problems|1
177039|NCT00891046|563432|P4|Overall Study|Administrative problems|0
177040|NCT00891046|563433|P3|Overall Study|Administrative problems|0
177041|NCT00891046|563434|P2|Overall Study|Administrative problems|0
177042|NCT00891046|563435|P1|Overall Study|Administrative problems|0
177043|NCT00891046|563431|P5|Overall Study|Unsatisfactory therapeutic effect|20
177044|NCT00891046|563432|P4|Overall Study|Unsatisfactory therapeutic effect|2
177045|NCT00891046|563433|P3|Overall Study|Unsatisfactory therapeutic effect|19
177046|NCT00891046|563434|P2|Overall Study|Unsatisfactory therapeutic effect|2
177047|NCT00891046|563435|P1|Overall Study|Unsatisfactory therapeutic effect|5
177048|NCT00891046|563431|P5|Overall Study|Protocol Violation|1
177049|NCT00891046|563432|P4|Overall Study|Protocol Violation|0
177050|NCT00891046|563433|P3|Overall Study|Protocol Violation|0
177051|NCT00891046|563434|P2|Overall Study|Protocol Violation|1
177052|NCT00891046|563435|P1|Overall Study|Protocol Violation|1
177053|NCT00891202|563643|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
177054|NCT00891202|563644|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
177055|NCT00891202|563645|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
177056|NCT00891202|563646|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
177057|NCT00891202|563643|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
177058|NCT00891202|563644|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
177059|NCT00891202|563645|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
177060|NCT00891202|563646|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
177061|NCT00891202|563643|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
177062|NCT00891202|563644|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
177063|NCT00891202|563645|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
177064|NCT00891202|563646|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
177065|NCT00891202|563643|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
177066|NCT00891202|563644|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
177067|NCT00891202|563645|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
177068|NCT00891202|563646|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
177069|NCT00891293|563668|P1|Overall Study|Sponsor termination|62
177070|NCT00891293|563668|P1|Overall Study|Subject withdrew consent|7
177071|NCT00891293|563668|P1|Overall Study|Lost to Follow-up|7
177072|NCT00891293|563668|P1|Overall Study|Laboratory abnormality|4
177073|NCT00891293|563668|P1|Overall Study|Protocol Violation|2
177074|NCT00891293|563668|P1|Overall Study|Adverse Event|2
177075|NCT00891371|563680|P1|Treatment|Lost to Follow-up|1
177076|NCT00891371|563680|P1|Treatment|Death|1
177077|NCT00891371|563680|P1|Treatment|Adverse Event|2
177078|NCT00891371|563680|P1|Treatment|Lack of Efficacy|5
177079|NCT00891371|563680|P1|Pre-assignment|Consent withdrawal|1
177080|NCT00891371|563680|P1|Pre-assignment|Inclusion/exclusion|5
177081|NCT00891774|563689|P1|Overall Study|Protocol Violation|4
177082|NCT00891774|563689|P1|Overall Study|Withdrawal by Subject|2
177083|NCT00891774|563689|P1|Overall Study|Illness (Self/Mother)|3
177084|NCT00891774|563689|P1|Overall Study|Lost to Follow-up|5
177085|NCT00891813|563693|P1|Overall Study|Protocol Violation|2
177086|NCT00891813|563693|P1|Overall Study|Patient Noncompliance|6
177087|NCT00891813|563693|P1|Overall Study|Withdrawal by Subject|1
177088|NCT00891813|563693|P1|Overall Study|Adverse Event|3
177089|NCT00891839|563699|P1|Overall Study|Disease progression|3
177090|NCT00891839|563699|P1|Overall Study|Withdrawal by Subject|2
177091|NCT00891839|563699|P1|Overall Study|Adverse Event|2
177092|NCT00891904|563708|P1|Overall Study|Adverse Event|1
177093|NCT00891904|563708|P1|Overall Study|Death|1
177094|NCT00891930|563715|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
177095|NCT00891930|563715|P1|Part 2: Panitumumab + Ganitumab|Death|30
177096|NCT00891930|563715|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
177097|NCT00891930|563715|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
177098|NCT00891930|563715|P1|Part 1: Panitumumab +Irinotecan|Death|38
177099|NCT00892008|563808|P1|Overall Study|Adverse Event|37
177100|NCT00892008|563808|P1|Overall Study|unspecified|378
177101|NCT00892008|563808|P1|Overall Study|Lost to Follow-up|142
177102|NCT00892008|563808|P1|Overall Study|Lack of Efficacy|3
177103|NCT00892008|563808|P1|Overall Study|Death|5
177104|NCT00892047|563824|P2|Overall Study|Lack of Efficacy|2
177105|NCT00892047|563825|P1|Overall Study|Lack of Efficacy|0
177106|NCT00892047|563824|P2|Overall Study|subject burden|3
177107|NCT00892047|563825|P1|Overall Study|subject burden|2
177108|NCT00892047|563824|P2|Overall Study|Adverse Event|2
177109|NCT00892047|563825|P1|Overall Study|Adverse Event|2
177110|NCT00892099|563844|P3|Overall Study|Lost to Follow-up|1
177111|NCT00892099|563845|P2|Overall Study|Lost to Follow-up|0
177112|NCT00892099|563846|P1|Overall Study|Lost to Follow-up|0
177113|NCT00892099|563844|P3|Overall Study|investigator decision|1
177114|NCT00892099|563845|P2|Overall Study|investigator decision|0
177115|NCT00892099|563846|P1|Overall Study|investigator decision|0
177116|NCT00892099|563844|P3|Overall Study|kidney function recovered|0
177117|NCT00892099|563845|P2|Overall Study|kidney function recovered|1
177118|NCT00892099|563846|P1|Overall Study|kidney function recovered|0
177119|NCT00892099|563844|P3|Overall Study|no further details|1
177120|NCT00892099|563845|P2|Overall Study|no further details|0
177121|NCT00892099|563846|P1|Overall Study|no further details|1
177122|NCT00892099|563844|P3|Overall Study|Prolonged hospitalization|1
177123|NCT00892099|563845|P2|Overall Study|Prolonged hospitalization|0
177124|NCT00892099|563846|P1|Overall Study|Prolonged hospitalization|1
177125|NCT00892099|563844|P3|Overall Study|replocated|2
177126|NCT00892099|563845|P2|Overall Study|replocated|0
177127|NCT00892099|563846|P1|Overall Study|replocated|1
177128|NCT00892099|563844|P3|Overall Study|Adverse Event|0
177129|NCT00892099|563845|P2|Overall Study|Adverse Event|0
177130|NCT00892099|563846|P1|Overall Study|Adverse Event|1
177131|NCT00892099|563844|P3|Overall Study|Death|1
177132|NCT00892099|563845|P2|Overall Study|Death|0
177133|NCT00892099|563846|P1|Overall Study|Death|1
177134|NCT00892151|563854|P1|Overall Study|Protocol Violation|1
177135|NCT00892177|563863|P6|Phase II|Withdrawal by Subject|1
177136|NCT00892177|563864|P5|Phase II|Withdrawal by Subject|4
177137|NCT00892177|563865|P4|Phase II|Withdrawal by Subject|0
177138|NCT00892177|563866|P3|Phase II|Withdrawal by Subject|0
177139|NCT00892177|563867|P2|Phase II|Withdrawal by Subject|0
177140|NCT00892177|563868|P1|Phase II|Withdrawal by Subject|0
177141|NCT00892177|563863|P6|Phase II|Ineligible|1
177142|NCT00892177|563864|P5|Phase II|Ineligible|1
177143|NCT00892177|563865|P4|Phase II|Ineligible|0
177144|NCT00892177|563866|P3|Phase II|Ineligible|0
177145|NCT00892177|563867|P2|Phase II|Ineligible|0
177146|NCT00892177|563868|P1|Phase II|Ineligible|0
177147|NCT00892281|563895|P2|Overall Study|Visit 4 date out of window|0
177148|NCT00892281|563896|P1|Overall Study|Visit 4 date out of window|1
177149|NCT00892281|563895|P2|Overall Study|Rash on hand|0
177150|NCT00892281|563896|P1|Overall Study|Rash on hand|1
177151|NCT00892281|563895|P2|Overall Study|Subject had history of drug abuse|0
177152|NCT00892281|563896|P1|Overall Study|Subject had history of drug abuse|1
177153|NCT00892281|563895|P2|Overall Study|Non-compliant with visits as scheduled|0
177154|NCT00892281|563896|P1|Overall Study|Non-compliant with visits as scheduled|1
177155|NCT00892281|563895|P2|Overall Study|Missed visits rescheduled out of window|0
177156|NCT00892281|563896|P1|Overall Study|Missed visits rescheduled out of window|1
177157|NCT00892281|563895|P2|Overall Study|Missed multiple visits|0
177158|NCT00892281|563896|P1|Overall Study|Missed multiple visits|1
177159|NCT00892281|563895|P2|Overall Study|No show Visit 2; prescription not filled|0
177160|NCT00892281|563896|P1|Overall Study|No show Visit 2; prescription not filled|1
177161|NCT00892281|563895|P2|Overall Study|Subject not seen by PI at final visit|0
177162|NCT00892281|563896|P1|Overall Study|Subject not seen by PI at final visit|1
177163|NCT00892281|563895|P2|Overall Study|Lack of efficacy of study product|0
177164|NCT00892281|563896|P1|Overall Study|Lack of efficacy of study product|2
177165|NCT00892281|563895|P2|Overall Study|Death in family|0
177166|NCT00892281|563896|P1|Overall Study|Death in family|1
177167|NCT00892281|563895|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
177168|NCT00892281|563896|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
177169|NCT00892281|563895|P2|Overall Study|Subject lost interest in program|1
177170|NCT00892281|563896|P1|Overall Study|Subject lost interest in program|0
177171|NCT00892281|563895|P2|Overall Study|PI complained of inadequate compensation|0
177172|NCT00892281|563896|P1|Overall Study|PI complained of inadequate compensation|3
177173|NCT00892281|563895|P2|Overall Study|Scheduled for knee replacement|1
177174|NCT00892281|563896|P1|Overall Study|Scheduled for knee replacement|0
177175|NCT00892281|563895|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
177176|NCT00892281|563896|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
177177|NCT00892281|563895|P2|Overall Study|Subject missed several visits/lost meds|0
177178|NCT00892281|563896|P1|Overall Study|Subject missed several visits/lost meds|1
177179|NCT00892281|563895|P2|Overall Study|Subject did not return for any visits|0
177180|NCT00892281|563896|P1|Overall Study|Subject did not return for any visits|1
177181|NCT00892281|563895|P2|Overall Study|Subject not good candidate for study|0
177182|NCT00892281|563896|P1|Overall Study|Subject not good candidate for study|1
177183|NCT00892281|563895|P2|Overall Study|Unable to redeem the drug voucher|0
177184|NCT00892281|563896|P1|Overall Study|Unable to redeem the drug voucher|1
177185|NCT00892281|563895|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
177186|NCT00892281|563896|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
177187|NCT00892281|563895|P2|Overall Study|Did not meet incl/excl criteria|0
177188|NCT00892281|563896|P1|Overall Study|Did not meet incl/excl criteria|1
177189|NCT00892281|563895|P2|Overall Study|Last visit not done - death in family|0
177190|NCT00892281|563896|P1|Overall Study|Last visit not done - death in family|1
177191|NCT00892281|563895|P2|Overall Study|Family emergency|0
177192|NCT00892281|563896|P1|Overall Study|Family emergency|1
177193|NCT00892281|563895|P2|Overall Study|Subject completed day after study closed|0
177194|NCT00892281|563896|P1|Overall Study|Subject completed day after study closed|1
177195|NCT00892281|563895|P2|Overall Study|Final visit completed 4 weeks late|1
177196|NCT00892281|563896|P1|Overall Study|Final visit completed 4 weeks late|0
177197|NCT00892281|563895|P2|Overall Study|Subject unable to keep follow-up visits|0
177198|NCT00892281|563896|P1|Overall Study|Subject unable to keep follow-up visits|1
177199|NCT00892281|563895|P2|Overall Study|Subject failed to return for final visit|0
177200|NCT00892281|563896|P1|Overall Study|Subject failed to return for final visit|2
177201|NCT00892281|563895|P2|Overall Study|Withdrawal by Subject|14
177202|NCT00892281|563896|P1|Overall Study|Withdrawal by Subject|86
177203|NCT00892281|563895|P2|Overall Study|Protocol Violation|2
177204|NCT00892281|563896|P1|Overall Study|Protocol Violation|7
177205|NCT00892281|563895|P2|Overall Study|Pregnancy|0
177206|NCT00892281|563896|P1|Overall Study|Pregnancy|1
177207|NCT00892281|563895|P2|Overall Study|Lost to Follow-up|8
177208|NCT00892281|563896|P1|Overall Study|Lost to Follow-up|81
177209|NCT00892281|563895|P2|Overall Study|Adverse Event|8
177210|NCT00892281|563896|P1|Overall Study|Adverse Event|65
177211|NCT00892437|563908|P2|Open-Label Extension Phase|Withdrew Consent|1
177212|NCT00892437|563909|P1|Open-Label Extension Phase|Withdrew Consent|3
177213|NCT00892437|563908|P2|Open-Label Extension Phase|Investigator's Discretion|0
177214|NCT00892437|563909|P1|Open-Label Extension Phase|Investigator's Discretion|1
177215|NCT00892437|563908|P2|Open-Label Extension Phase|Lost to Follow-up|1
177216|NCT00892437|563909|P1|Open-Label Extension Phase|Lost to Follow-up|3
177217|NCT00892437|563908|P2|Open-Label Extension Phase|Lack of Efficacy|0
177218|NCT00892437|563909|P1|Open-Label Extension Phase|Lack of Efficacy|1
177219|NCT00892437|563908|P2|Open-Label Extension Phase|Adverse Event|2
177220|NCT00892437|563909|P1|Open-Label Extension Phase|Adverse Event|4
177221|NCT00892437|563908|P2|Randomized Phase|Withdrew Consent|0
177222|NCT00892437|563909|P1|Randomized Phase|Withdrew Consent|1
177223|NCT00892437|563908|P2|Randomized Phase|Investigator’s Discretion|0
177224|NCT00892437|563909|P1|Randomized Phase|Investigator’s Discretion|1
177225|NCT00892437|563908|P2|Randomized Phase|Lost to Follow-up|3
177226|NCT00892437|563909|P1|Randomized Phase|Lost to Follow-up|1
177227|NCT00892437|563908|P2|Randomized Phase|Adverse Event|2
177228|NCT00892437|563909|P1|Randomized Phase|Adverse Event|2
177229|NCT00892437|563908|P2|Randomized Phase|Randomized but not treated|0
177230|NCT00892437|563909|P1|Randomized Phase|Randomized but not treated|6
177231|NCT00892723|563975|P3|Overall Study|Withdrawal by Subject|1
177232|NCT00892723|563976|P2|Overall Study|Withdrawal by Subject|1
177233|NCT00892723|563977|P1|Overall Study|Withdrawal by Subject|1
177234|NCT00892723|563975|P3|Overall Study|Lost to Follow-up|1
177235|NCT00892723|563976|P2|Overall Study|Lost to Follow-up|3
177236|NCT00892723|563977|P1|Overall Study|Lost to Follow-up|1
177237|NCT00892957|564020|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
177238|NCT00892957|564021|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
177239|NCT00892957|564020|P2|Between Postoperative Day 1 and Day 14|Death|2
177240|NCT00892957|564021|P1|Between Postoperative Day 1 and Day 14|Death|0
177241|NCT00893113|564127|P2|Overall Study|Withdrew Consent|7
177242|NCT00893113|564128|P1|Overall Study|Withdrew Consent|8
177243|NCT00893113|564127|P2|Overall Study|Early Termination|1
177244|NCT00893113|564128|P1|Overall Study|Early Termination|1
177245|NCT00893113|564127|P2|Overall Study|Lost to Follow-up|8
177246|NCT00893113|564128|P1|Overall Study|Lost to Follow-up|4
177247|NCT00893464|564155|P8|Overall Study|Did not complete therapy/experience PD|2
177248|NCT00893464|564156|P7|Overall Study|Did not complete therapy/experience PD|2
177249|NCT00893464|564157|P6|Overall Study|Did not complete therapy/experience PD|0
177250|NCT00893464|564158|P5|Overall Study|Did not complete therapy/experience PD|0
177251|NCT00893464|564159|P4|Overall Study|Did not complete therapy/experience PD|0
177252|NCT00893464|564160|P3|Overall Study|Did not complete therapy/experience PD|0
177253|NCT00893464|564161|P2|Overall Study|Did not complete therapy/experience PD|0
177254|NCT00893464|564162|P1|Overall Study|Did not complete therapy/experience PD|0
177255|NCT00893737|564278|P1|Overall Study|Lost to Follow-up|6
177256|NCT00893737|564278|P1|Overall Study|Withdrawal by Subject|2
177257|NCT00893737|564278|P1|Overall Study|Adverse Event|4
177258|NCT00893763|564286|P2|Overall Study|extubated|110
177259|NCT00893763|564287|P1|Overall Study|extubated|110
177260|NCT00893789|564299|P4|Overall Study|Lost to Follow-up|1
177261|NCT00893789|564300|P3|Overall Study|Lost to Follow-up|0
177262|NCT00893789|564301|P2|Overall Study|Lost to Follow-up|0
177263|NCT00893789|564302|P1|Overall Study|Lost to Follow-up|0
177264|NCT00893789|564299|P4|Overall Study|Protocol Violation|4
177265|NCT00893789|564300|P3|Overall Study|Protocol Violation|1
177266|NCT00893789|564301|P2|Overall Study|Protocol Violation|1
177267|NCT00893789|564302|P1|Overall Study|Protocol Violation|0
177268|NCT00893789|564299|P4|Overall Study|Adverse Event|5
177269|NCT00893789|564300|P3|Overall Study|Adverse Event|1
177270|NCT00893789|564301|P2|Overall Study|Adverse Event|2
177271|NCT00893789|564302|P1|Overall Study|Adverse Event|0
177272|NCT00893789|564299|P4|Overall Study|Taking Excluded Concomitant Medication|0
177273|NCT00893789|564300|P3|Overall Study|Taking Excluded Concomitant Medication|1
177274|NCT00893789|564301|P2|Overall Study|Taking Excluded Concomitant Medication|0
177275|NCT00893789|564302|P1|Overall Study|Taking Excluded Concomitant Medication|1
177276|NCT00893789|564299|P4|Overall Study|Noncompliance With Study Procedures|0
177277|NCT00893789|564300|P3|Overall Study|Noncompliance With Study Procedures|0
177278|NCT00893789|564301|P2|Overall Study|Noncompliance With Study Procedures|0
177279|NCT00893789|564302|P1|Overall Study|Noncompliance With Study Procedures|1
177280|NCT00893789|564299|P4|Overall Study|Noncompliance With Study Drug|2
177281|NCT00893789|564300|P3|Overall Study|Noncompliance With Study Drug|1
177282|NCT00893789|564301|P2|Overall Study|Noncompliance With Study Drug|0
177283|NCT00893789|564302|P1|Overall Study|Noncompliance With Study Drug|1
177284|NCT00893789|564299|P4|Overall Study|Withdrawal by Subject|1
177285|NCT00893789|564300|P3|Overall Study|Withdrawal by Subject|3
177286|NCT00893789|564301|P2|Overall Study|Withdrawal by Subject|1
177287|NCT00893789|564302|P1|Overall Study|Withdrawal by Subject|3
177288|NCT00893971|564384|P1|Overall Study|Physician Decision|3
177289|NCT00894166|564515|P8|Overall Study|Death|0
177290|NCT00894166|564516|P7|Overall Study|Death|0
177291|NCT00894166|564517|P6|Overall Study|Death|0
177292|NCT00894166|564518|P5|Overall Study|Death|0
177293|NCT00894166|564519|P4|Overall Study|Death|1
177294|NCT00894166|564520|P3|Overall Study|Death|0
177295|NCT00894166|564521|P2|Overall Study|Death|0
177296|NCT00894166|564522|P1|Overall Study|Death|0
177297|NCT00894166|564515|P8|Overall Study|Withdrew or Lost to Follow-Up|34
177298|NCT00894166|564516|P7|Overall Study|Withdrew or Lost to Follow-Up|16
177299|NCT00894166|564517|P6|Overall Study|Withdrew or Lost to Follow-Up|16
177300|NCT00894166|564518|P5|Overall Study|Withdrew or Lost to Follow-Up|24
177301|NCT00894166|564519|P4|Overall Study|Withdrew or Lost to Follow-Up|68
177302|NCT00894166|564520|P3|Overall Study|Withdrew or Lost to Follow-Up|62
177303|NCT00894166|564521|P2|Overall Study|Withdrew or Lost to Follow-Up|63
177304|NCT00894166|564522|P1|Overall Study|Withdrew or Lost to Follow-Up|61
177305|NCT00888433|564558|P2|Overall Study|Missed Visit|1
177306|NCT00888433|564559|P1|Overall Study|Missed Visit|2
177307|NCT00888433|564558|P2|Overall Study|Withdrawal by Subject|2
177308|NCT00888433|564559|P1|Overall Study|Withdrawal by Subject|1
177309|NCT00894322|564577|P3|Overall Study|Withdrawal by Subject|0
177310|NCT00894322|564578|P2|Overall Study|Withdrawal by Subject|0
177311|NCT00894322|564579|P1|Overall Study|Withdrawal by Subject|1
177312|NCT00894361|564620|P2|Overall Study|deaths and less than 2 yr followup|64
177313|NCT00894361|564621|P1|Overall Study|deaths and less than 2 yr followup|24
177314|NCT00894387|564629|P2|Overall Study|GCP non-compliance|2
177315|NCT00894387|564630|P1|Overall Study|GCP non-compliance|0
177316|NCT00894387|564629|P2|Overall Study|Mis-randomized|9
177317|NCT00894387|564630|P1|Overall Study|Mis-randomized|13
177318|NCT00894387|564629|P2|Overall Study|Other (Missing)|3
177319|NCT00894387|564630|P1|Overall Study|Other (Missing)|5
177320|NCT00894387|564629|P2|Overall Study|Patient's request|30
177321|NCT00894387|564630|P1|Overall Study|Patient's request|25
177322|NCT00894387|564629|P2|Overall Study|Protocol Deviation|0
177323|NCT00894387|564630|P1|Overall Study|Protocol Deviation|4
177324|NCT00894387|564629|P2|Overall Study|Death|76
177325|NCT00894387|564630|P1|Overall Study|Death|77
177326|NCT00894387|564629|P2|Overall Study|Administrative problems|2
177327|NCT00894387|564630|P1|Overall Study|Administrative problems|2
177328|NCT00894387|564629|P2|Overall Study|Lost to Follow-up|5
177329|NCT00894387|564630|P1|Overall Study|Lost to Follow-up|3
177330|NCT00894387|564629|P2|Overall Study|Unsatisfactory therapeutic effect|1
177331|NCT00894387|564630|P1|Overall Study|Unsatisfactory therapeutic effect|0
177332|NCT00894387|564629|P2|Overall Study|Abnormal Laboratory values|2
177333|NCT00894387|564630|P1|Overall Study|Abnormal Laboratory values|2
177334|NCT00894387|564629|P2|Overall Study|Adverse Event|45
177335|NCT00894387|564630|P1|Overall Study|Adverse Event|44
177336|NCT00894543|564692|P2|Week 4 to Week 8|No diary or lost or withdrew|2
177337|NCT00894543|564693|P1|Week 4 to Week 8|No diary or lost or withdrew|4
177338|NCT00894543|564692|P2|Baseline to Week 4|No diary or lost or withdrew|2
177339|NCT00894543|564693|P1|Baseline to Week 4|No diary or lost or withdrew|3
177340|NCT00894556|564718|P4|Treatment Phase|Lack of Qualifying Event|0
177341|NCT00894556|564719|P3|Treatment Phase|Lack of Qualifying Event|0
177342|NCT00894556|564720|P2|Treatment Phase|Lack of Qualifying Event|1
177343|NCT00894556|564721|P1|Treatment Phase|Lack of Qualifying Event|2
177344|NCT00894556|564718|P4|Treatment Phase|Lost to Follow-up|0
177345|NCT00894556|564719|P3|Treatment Phase|Lost to Follow-up|1
177346|NCT00894556|564720|P2|Treatment Phase|Lost to Follow-up|3
177347|NCT00894556|564721|P1|Treatment Phase|Lost to Follow-up|2
177348|NCT00894556|564718|P4|Baseline Phase|Did not meet Randomization Criteria|85
177349|NCT00894556|564719|P3|Baseline Phase|Did not meet Randomization Criteria|0
177350|NCT00894556|564720|P2|Baseline Phase|Did not meet Randomization Criteria|0
177351|NCT00894556|564721|P1|Baseline Phase|Did not meet Randomization Criteria|0
177352|NCT00895453|564733|P3|Overall Study|Lost to Follow-up|23
177353|NCT00895453|564734|P2|Overall Study|Lost to Follow-up|25
177354|NCT00895453|564735|P1|Overall Study|Lost to Follow-up|25
177355|NCT00895583|564754|P2|Overall Study|Not specified|1
177356|NCT00895583|564755|P1|Overall Study|Not specified|0
177357|NCT00895583|564754|P2|Overall Study|Lack of Efficacy|0
177358|NCT00895583|564755|P1|Overall Study|Lack of Efficacy|5
177359|NCT00895583|564754|P2|Overall Study|Withdrawal by Subject|2
177360|NCT00895583|564755|P1|Overall Study|Withdrawal by Subject|4
177361|NCT00895583|564754|P2|Overall Study|Protocol Violation|0
177362|NCT00895583|564755|P1|Overall Study|Protocol Violation|1
177363|NCT00895583|564754|P2|Overall Study|Lost to Follow-up|3
177364|NCT00895583|564755|P1|Overall Study|Lost to Follow-up|1
177365|NCT00895583|564754|P2|Overall Study|Physician Decision|1
177366|NCT00895583|564755|P1|Overall Study|Physician Decision|3
177367|NCT00895583|564754|P2|Overall Study|Death|1
177368|NCT00895583|564755|P1|Overall Study|Death|2
177369|NCT00895583|564754|P2|Overall Study|Adverse Event|4
177370|NCT00895583|564755|P1|Overall Study|Adverse Event|28
177371|NCT00895661|564833|P1|Overall Study|reason unknown|2
177372|NCT00895661|564833|P1|Overall Study|Death|1
177373|NCT00895843|564883|P2|Overall Study|Protocol Violation|12
177374|NCT00895843|564884|P1|Overall Study|Protocol Violation|12
177375|NCT00895895|564895|P5|Period 2|unsatisfactory response-efficacy|0
177376|NCT00895895|564896|P4|Period 2|unsatisfactory response-efficacy|0
177377|NCT00895895|564897|P3|Period 2|unsatisfactory response-efficacy|0
177378|NCT00895895|564898|P2|Period 2|unsatisfactory response-efficacy|1
177379|NCT00895895|564899|P1|Period 2|unsatisfactory response-efficacy|2
177380|NCT00895895|564895|P5|Period 2|Withdrawal by Subject|5
177381|NCT00895895|564896|P4|Period 2|Withdrawal by Subject|3
177382|NCT00895895|564897|P3|Period 2|Withdrawal by Subject|0
177383|NCT00895895|564898|P2|Period 2|Withdrawal by Subject|2
177384|NCT00895895|564899|P1|Period 2|Withdrawal by Subject|0
177385|NCT00895895|564895|P5|Period 2|Protocol Violation|1
177386|NCT00895895|564896|P4|Period 2|Protocol Violation|1
177387|NCT00895895|564897|P3|Period 2|Protocol Violation|1
177388|NCT00895895|564898|P2|Period 2|Protocol Violation|0
177389|NCT00895895|564899|P1|Period 2|Protocol Violation|1
177390|NCT00895895|564895|P5|Period 2|unspecified|1
177391|NCT00895895|564896|P4|Period 2|unspecified|1
177392|NCT00895895|564897|P3|Period 2|unspecified|3
177393|NCT00895895|564898|P2|Period 2|unspecified|1
177394|NCT00895895|564899|P1|Period 2|unspecified|1
177395|NCT00895895|564895|P5|Period 2|Lost to Follow-up|0
177396|NCT00895895|564896|P4|Period 2|Lost to Follow-up|1
177397|NCT00895895|564897|P3|Period 2|Lost to Follow-up|1
177398|NCT00895895|564898|P2|Period 2|Lost to Follow-up|2
177399|NCT00895895|564899|P1|Period 2|Lost to Follow-up|1
177400|NCT00895895|564895|P5|Period 2|investigator request|0
177401|NCT00895895|564896|P4|Period 2|investigator request|0
177402|NCT00895895|564897|P3|Period 2|investigator request|0
177403|NCT00895895|564898|P2|Period 2|investigator request|0
177404|NCT00895895|564899|P1|Period 2|investigator request|2
177405|NCT00895895|564895|P5|Period 2|failed to return|0
177406|NCT00895895|564896|P4|Period 2|failed to return|0
177407|NCT00895895|564897|P3|Period 2|failed to return|0
177408|NCT00895895|564898|P2|Period 2|failed to return|0
177409|NCT00895895|564899|P1|Period 2|failed to return|2
177410|NCT00895895|564895|P5|Period 2|discontinued by sponsor|37
177411|NCT00895895|564896|P4|Period 2|discontinued by sponsor|46
177412|NCT00895895|564897|P3|Period 2|discontinued by sponsor|38
177413|NCT00895895|564898|P2|Period 2|discontinued by sponsor|44
177414|NCT00895895|564899|P1|Period 2|discontinued by sponsor|44
177415|NCT00895895|564895|P5|Period 2|Death|0
177416|NCT00895895|564896|P4|Period 2|Death|0
177417|NCT00895895|564897|P3|Period 2|Death|1
177418|NCT00895895|564898|P2|Period 2|Death|0
177419|NCT00895895|564899|P1|Period 2|Death|0
177420|NCT00895895|564895|P5|Period 2|Adverse Event|5
177421|NCT00895895|564896|P4|Period 2|Adverse Event|2
177422|NCT00895895|564897|P3|Period 2|Adverse Event|5
177423|NCT00895895|564898|P2|Period 2|Adverse Event|3
177424|NCT00895895|564899|P1|Period 2|Adverse Event|3
177425|NCT00895895|564895|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
177426|NCT00895895|564896|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
177427|NCT00895895|564897|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
177428|NCT00895895|564898|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
177429|NCT00895895|564899|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
177430|NCT00895895|564895|P5|After Period 1, Prior to Period 2|Protocol Violation|1
177431|NCT00895895|564896|P4|After Period 1, Prior to Period 2|Protocol Violation|0
177432|NCT00895895|564897|P3|After Period 1, Prior to Period 2|Protocol Violation|0
177433|NCT00895895|564898|P2|After Period 1, Prior to Period 2|Protocol Violation|0
177434|NCT00895895|564899|P1|After Period 1, Prior to Period 2|Protocol Violation|0
177435|NCT00895895|564895|P5|After Period 1, Prior to Period 2|unspecified|0
177436|NCT00895895|564896|P4|After Period 1, Prior to Period 2|unspecified|0
177437|NCT00895895|564897|P3|After Period 1, Prior to Period 2|unspecified|1
177438|NCT00895895|564898|P2|After Period 1, Prior to Period 2|unspecified|0
177439|NCT00895895|564899|P1|After Period 1, Prior to Period 2|unspecified|0
177440|NCT00895895|564895|P5|After Period 1, Prior to Period 2|Adverse Event|0
177441|NCT00895895|564896|P4|After Period 1, Prior to Period 2|Adverse Event|0
177442|NCT00895895|564897|P3|After Period 1, Prior to Period 2|Adverse Event|1
177443|NCT00895895|564898|P2|After Period 1, Prior to Period 2|Adverse Event|0
177444|NCT00895895|564899|P1|After Period 1, Prior to Period 2|Adverse Event|0
177445|NCT00895895|564895|P5|Period 1|randomized and not treated|2
177446|NCT00895895|564896|P4|Period 1|randomized and not treated|1
177447|NCT00895895|564897|P3|Period 1|randomized and not treated|1
177448|NCT00895895|564898|P2|Period 1|randomized and not treated|3
177449|NCT00895895|564899|P1|Period 1|randomized and not treated|1
177450|NCT00895895|564895|P5|Period 1|unsatisfactory response-efficacy|0
177451|NCT00895895|564896|P4|Period 1|unsatisfactory response-efficacy|0
177452|NCT00895895|564897|P3|Period 1|unsatisfactory response-efficacy|0
177453|NCT00895895|564898|P2|Period 1|unsatisfactory response-efficacy|0
177454|NCT00895895|564899|P1|Period 1|unsatisfactory response-efficacy|2
177455|NCT00895895|564895|P5|Period 1|Withdrawal by Subject|4
177456|NCT00895895|564896|P4|Period 1|Withdrawal by Subject|2
177457|NCT00895895|564897|P3|Period 1|Withdrawal by Subject|8
177458|NCT00895895|564898|P2|Period 1|Withdrawal by Subject|6
177459|NCT00895895|564899|P1|Period 1|Withdrawal by Subject|6
177460|NCT00895895|564895|P5|Period 1|Protocol Violation|0
177461|NCT00895895|564896|P4|Period 1|Protocol Violation|0
177462|NCT00895895|564897|P3|Period 1|Protocol Violation|0
177463|NCT00895895|564898|P2|Period 1|Protocol Violation|1
177464|NCT00895895|564899|P1|Period 1|Protocol Violation|0
177465|NCT00895895|564895|P5|Period 1|unspecified|1
177466|NCT00895895|564896|P4|Period 1|unspecified|1
177467|NCT00895895|564897|P3|Period 1|unspecified|1
177468|NCT00895895|564898|P2|Period 1|unspecified|2
177469|NCT00895895|564899|P1|Period 1|unspecified|1
177470|NCT00895895|564895|P5|Period 1|Lost to Follow-up|3
177471|NCT00895895|564896|P4|Period 1|Lost to Follow-up|2
177472|NCT00895895|564897|P3|Period 1|Lost to Follow-up|3
177473|NCT00895895|564898|P2|Period 1|Lost to Follow-up|1
177474|NCT00895895|564899|P1|Period 1|Lost to Follow-up|2
177475|NCT00895895|564895|P5|Period 1|investigator request|0
177476|NCT00895895|564896|P4|Period 1|investigator request|0
177477|NCT00895895|564897|P3|Period 1|investigator request|0
177478|NCT00895895|564898|P2|Period 1|investigator request|1
177479|NCT00895895|564899|P1|Period 1|investigator request|0
177480|NCT00895895|564895|P5|Period 1|failed to return|1
177481|NCT00895895|564896|P4|Period 1|failed to return|0
177482|NCT00895895|564897|P3|Period 1|failed to return|1
177483|NCT00895895|564898|P2|Period 1|failed to return|0
177484|NCT00895895|564899|P1|Period 1|failed to return|0
177485|NCT00895895|564895|P5|Period 1|discontinued by sponsor|1
177486|NCT00895895|564896|P4|Period 1|discontinued by sponsor|1
177487|NCT00895895|564897|P3|Period 1|discontinued by sponsor|2
177488|NCT00895895|564898|P2|Period 1|discontinued by sponsor|1
177489|NCT00895895|564899|P1|Period 1|discontinued by sponsor|2
177490|NCT00895895|564895|P5|Period 1|Death|1
177491|NCT00895895|564896|P4|Period 1|Death|0
177492|NCT00895895|564897|P3|Period 1|Death|0
177493|NCT00895895|564898|P2|Period 1|Death|0
177494|NCT00895895|564899|P1|Period 1|Death|0
177495|NCT00895895|564895|P5|Period 1|Adverse Event|7
177496|NCT00895895|564896|P4|Period 1|Adverse Event|6
177497|NCT00895895|564897|P3|Period 1|Adverse Event|4
177498|NCT00895895|564898|P2|Period 1|Adverse Event|6
177499|NCT00895895|564899|P1|Period 1|Adverse Event|7
177500|NCT00895934|565013|P2|Overall Study|ineligible|0
177501|NCT00895934|565014|P1|Overall Study|ineligible|1
177502|NCT00895934|565013|P2|Overall Study|Death|1
177503|NCT00895934|565014|P1|Overall Study|Death|0
177504|NCT00895934|565013|P2|Overall Study|Lack of Efficacy|24
177505|NCT00895934|565014|P1|Overall Study|Lack of Efficacy|5
177506|NCT00895947|565022|P2|Overall Study|Withdrawal by Subject|0
177507|NCT00895947|565023|P1|Overall Study|Withdrawal by Subject|2
177508|NCT00895947|565022|P2|Overall Study|Protocol Violation|2
177509|NCT00895947|565023|P1|Overall Study|Protocol Violation|4
177510|NCT00895947|565022|P2|Overall Study|Lost to Follow-up|4
177511|NCT00895947|565023|P1|Overall Study|Lost to Follow-up|3
177512|NCT00895947|565022|P2|Overall Study|Adverse Event|4
177513|NCT00895947|565023|P1|Overall Study|Adverse Event|3
177514|NCT00896051|565086|P2|Overall Study|Not specified|1
177515|NCT00896051|565087|P1|Overall Study|Not specified|1
177516|NCT00896051|565086|P2|Overall Study|Subject noncompliant|3
177517|NCT00896051|565087|P1|Overall Study|Subject noncompliant|1
177518|NCT00896051|565086|P2|Overall Study|Withdrawal by Subject|2
177519|NCT00896051|565087|P1|Overall Study|Withdrawal by Subject|3
177520|NCT00896051|565086|P2|Overall Study|Lost to Follow-up|2
177521|NCT00896051|565087|P1|Overall Study|Lost to Follow-up|3
177522|NCT00896051|565086|P2|Overall Study|Adverse Event|1
177523|NCT00896051|565087|P1|Overall Study|Adverse Event|2
177524|NCT00896168|565160|P2|Overall Study|Unspecified|1
177525|NCT00896168|565161|P1|Overall Study|Unspecified|1
177526|NCT00896168|565160|P2|Overall Study|Lost to Follow-up|1
177527|NCT00896168|565161|P1|Overall Study|Lost to Follow-up|1
177528|NCT00896168|565160|P2|Overall Study|Treatment failure|10
177529|NCT00896168|565161|P1|Overall Study|Treatment failure|8
177530|NCT00896168|565160|P2|Overall Study|Adverse Event|7
177531|NCT00896168|565161|P1|Overall Study|Adverse Event|4
177532|NCT00896233|565189|P1|Overall Study|Claustrophobia during MRI|1
177533|NCT00896337|565200|P1|Overall Study|Lost to Follow-up|11
177534|NCT00896337|565200|P1|Overall Study|Withdrawal by Subject|7
177535|NCT00896337|565200|P1|Overall Study|Death|7
177536|NCT00896454|565267|P1|Overall Study|Withdrawal by Subject|1
177537|NCT00896454|565267|P1|Overall Study|Ongoing in study|2
177538|NCT00896454|565267|P1|Overall Study|Requirement for alternative therapy|3
177539|NCT00896454|565267|P1|Overall Study|Other|4
177540|NCT00896454|565267|P1|Overall Study|Disease Progression|5
177541|NCT00896454|565267|P1|Overall Study|Adverse Event|8
177542|NCT00896454|565267|P1|Overall Study|Death|10
177543|NCT00896649|565279|P1|Overall Study|technical difficulties|2
177544|NCT00896649|565279|P1|Overall Study|missing documentation|1
177545|NCT00896649|565279|P1|Overall Study|Pregnancy|1
177546|NCT00896649|565279|P1|Overall Study|Physician Decision|1
177547|NCT00897104|565296|P3|Overall Study|Withdrawal by Subject|1
177548|NCT00897104|565297|P2|Overall Study|Withdrawal by Subject|0
177549|NCT00897104|565298|P1|Overall Study|Withdrawal by Subject|0
177550|NCT00897104|565296|P3|Overall Study|Protocol Violation|0
177551|NCT00897104|565297|P2|Overall Study|Protocol Violation|0
177552|NCT00897104|565298|P1|Overall Study|Protocol Violation|1
177553|NCT00897104|565296|P3|Overall Study|Not Specified|0
177554|NCT00897104|565297|P2|Overall Study|Not Specified|0
177555|NCT00897104|565298|P1|Overall Study|Not Specified|3
177556|NCT00897104|565296|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
177557|NCT00897104|565297|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
177558|NCT00897104|565298|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
177559|NCT00897104|565296|P3|Overall Study|Lack of Migraine Attack|1
177560|NCT00897104|565297|P2|Overall Study|Lack of Migraine Attack|22
177561|NCT00897104|565298|P1|Overall Study|Lack of Migraine Attack|20
177562|NCT00897104|565296|P3|Overall Study|Need for Concom. Med.|1
177563|NCT00897104|565297|P2|Overall Study|Need for Concom. Med.|1
177564|NCT00897104|565298|P1|Overall Study|Need for Concom. Med.|0
177565|NCT00897104|565296|P3|Overall Study|Abnormal Baseline ECG|0
177566|NCT00897104|565297|P2|Overall Study|Abnormal Baseline ECG|2
177567|NCT00897104|565298|P1|Overall Study|Abnormal Baseline ECG|2
177568|NCT00897104|565296|P3|Overall Study|Abnormal Prestudy Labs|0
177569|NCT00897104|565297|P2|Overall Study|Abnormal Prestudy Labs|0
177570|NCT00897104|565298|P1|Overall Study|Abnormal Prestudy Labs|2
177571|NCT00897104|565296|P3|Overall Study|Withdrawal by Subject|3
177572|NCT00897104|565297|P2|Overall Study|Withdrawal by Subject|27
177573|NCT00897104|565298|P1|Overall Study|Withdrawal by Subject|23
177574|NCT00897104|565296|P3|Overall Study|Protocol Violation|0
177575|NCT00897104|565297|P2|Overall Study|Protocol Violation|1
177576|NCT00897104|565298|P1|Overall Study|Protocol Violation|0
177577|NCT00897104|565296|P3|Overall Study|Pregnancy|0
177578|NCT00897104|565297|P2|Overall Study|Pregnancy|1
177579|NCT00897104|565298|P1|Overall Study|Pregnancy|0
177580|NCT00897104|565296|P3|Overall Study|Lost to Follow-up|2
177581|NCT00897104|565297|P2|Overall Study|Lost to Follow-up|17
177582|NCT00897104|565298|P1|Overall Study|Lost to Follow-up|12
177583|NCT00897390|565324|P1|Overall Study|Did not Return for the Clinic Visit|2
177584|NCT00897390|565324|P1|Overall Study|Personal Reasons|1
177585|NCT00897390|565324|P1|Overall Study|No Longer Met Study Criteria|1
177586|NCT00897390|565324|P1|Overall Study|Adverse Event|2
177587|NCT00897715|565413|P2|Overall Study|increased risk of infection|0
177588|NCT00897715|565414|P1|Overall Study|increased risk of infection|1
177589|NCT00897715|565413|P2|Overall Study|Physician Decision|0
177590|NCT00897715|565414|P1|Overall Study|Physician Decision|1
177591|NCT00897715|565413|P2|Overall Study|Lost to Follow-up|1
177592|NCT00897715|565414|P1|Overall Study|Lost to Follow-up|0
177593|NCT00897949|565434|P3|Overall Study|Did not take study drug|4
177594|NCT00897949|565435|P2|Overall Study|Did not take study drug|3
177595|NCT00897949|565436|P1|Overall Study|Did not take study drug|9
177596|NCT00897949|565434|P3|Overall Study|Lack of Migraine Attack|19
177597|NCT00897949|565435|P2|Overall Study|Lack of Migraine Attack|30
177598|NCT00897949|565436|P1|Overall Study|Lack of Migraine Attack|29
177599|NCT00897949|565434|P3|Overall Study|Need for Concom. Med.|1
177600|NCT00897949|565435|P2|Overall Study|Need for Concom. Med.|1
177601|NCT00897949|565436|P1|Overall Study|Need for Concom. Med.|0
177602|NCT00897949|565434|P3|Overall Study|Abnormal Baseline ECG|4
177603|NCT00897949|565435|P2|Overall Study|Abnormal Baseline ECG|2
177604|NCT00897949|565436|P1|Overall Study|Abnormal Baseline ECG|2
177605|NCT00897949|565434|P3|Overall Study|Abnormal Prestudy Labs|4
177606|NCT00897949|565435|P2|Overall Study|Abnormal Prestudy Labs|3
177607|NCT00897949|565436|P1|Overall Study|Abnormal Prestudy Labs|2
177608|NCT00897949|565434|P3|Overall Study|Withdrawal by Subject|17
177609|NCT00897949|565435|P2|Overall Study|Withdrawal by Subject|31
177610|NCT00897949|565436|P1|Overall Study|Withdrawal by Subject|24
177611|NCT00897949|565434|P3|Overall Study|Lost to Follow-up|17
177612|NCT00897949|565435|P2|Overall Study|Lost to Follow-up|23
177613|NCT00897949|565436|P1|Overall Study|Lost to Follow-up|30
177614|NCT00897949|565434|P3|Overall Study|Patient Uncoorperative|1
177615|NCT00897949|565435|P2|Overall Study|Patient Uncoorperative|2
177616|NCT00897949|565436|P1|Overall Study|Patient Uncoorperative|0
177617|NCT00897949|565434|P3|Overall Study|Withdrawal by Subject|0
177618|NCT00897949|565435|P2|Overall Study|Withdrawal by Subject|2
177619|NCT00897949|565436|P1|Overall Study|Withdrawal by Subject|1
177620|NCT00897949|565434|P3|Overall Study|Protocol Violation|1
177621|NCT00897949|565435|P2|Overall Study|Protocol Violation|3
177622|NCT00897949|565436|P1|Overall Study|Protocol Violation|6
177623|NCT00897949|565434|P3|Overall Study|Lost to Follow-up|1
177624|NCT00897949|565435|P2|Overall Study|Lost to Follow-up|2
177625|NCT00897949|565436|P1|Overall Study|Lost to Follow-up|0
177626|NCT00897949|565434|P3|Overall Study|Adverse Event|0
177627|NCT00897949|565435|P2|Overall Study|Adverse Event|1
177628|NCT00897949|565436|P1|Overall Study|Adverse Event|1
177629|NCT00891462|565473|P3|Overall Study|Lost to Follow-up|0
177630|NCT00891462|565474|P2|Overall Study|Lost to Follow-up|2
177631|NCT00891462|565475|P1|Overall Study|Lost to Follow-up|0
177632|NCT00891462|565473|P3|Overall Study|Inclusion/exclusion criteria|2
177633|NCT00891462|565474|P2|Overall Study|Inclusion/exclusion criteria|2
177634|NCT00891462|565475|P1|Overall Study|Inclusion/exclusion criteria|0
177635|NCT00891462|565473|P3|Overall Study|Protocol Violation|3
177636|NCT00891462|565474|P2|Overall Study|Protocol Violation|1
177637|NCT00891462|565475|P1|Overall Study|Protocol Violation|2
177638|NCT00891462|565473|P3|Overall Study|Other Reason|3
177639|NCT00891462|565474|P2|Overall Study|Other Reason|5
177640|NCT00891462|565475|P1|Overall Study|Other Reason|2
177641|NCT00891462|565473|P3|Overall Study|COPD exacerbation|1
177642|NCT00891462|565474|P2|Overall Study|COPD exacerbation|4
177643|NCT00891462|565475|P1|Overall Study|COPD exacerbation|7
177644|NCT00891462|565473|P3|Overall Study|Lack of Efficacy|1
177645|NCT00891462|565474|P2|Overall Study|Lack of Efficacy|5
177646|NCT00891462|565475|P1|Overall Study|Lack of Efficacy|10
177647|NCT00891462|565473|P3|Overall Study|Adverse Event|7
177648|NCT00891462|565474|P2|Overall Study|Adverse Event|8
177649|NCT00891462|565475|P1|Overall Study|Adverse Event|7
177650|NCT00891462|565473|P3|Overall Study|Withdrawal by Subject|7
177651|NCT00891462|565474|P2|Overall Study|Withdrawal by Subject|6
177652|NCT00891462|565475|P1|Overall Study|Withdrawal by Subject|9
177653|NCT00891527|565486|P1|Overall Study|Withdrawal by Subject|2
177654|NCT00891618|565492|P1|Overall Study|Withdrawal by Subject|1
177655|NCT00891657|565498|P2|Overall Study|Withdrawal by Subject|1
177656|NCT00891657|565499|P1|Overall Study|Withdrawal by Subject|1
177657|NCT00891735|565515|P4|Overall Study|Patient's decision to withdraw|8
177658|NCT00891735|565516|P3|Overall Study|Patient's decision to withdraw|4
177659|NCT00891735|565517|P2|Overall Study|Patient's decision to withdraw|9
177660|NCT00891735|565518|P1|Overall Study|Patient's decision to withdraw|4
177661|NCT00891735|565515|P4|Overall Study|Physician's decision to withdraw patient|0
177662|NCT00891735|565516|P3|Overall Study|Physician's decision to withdraw patient|0
177663|NCT00891735|565517|P2|Overall Study|Physician's decision to withdraw patient|0
177664|NCT00891735|565518|P1|Overall Study|Physician's decision to withdraw patient|1
177665|NCT00891735|565515|P4|Overall Study|Lost to Follow-up|2
177666|NCT00891735|565516|P3|Overall Study|Lost to Follow-up|2
177667|NCT00891735|565517|P2|Overall Study|Lost to Follow-up|2
177668|NCT00891735|565518|P1|Overall Study|Lost to Follow-up|2
177669|NCT00891735|565515|P4|Overall Study|Death|5
177670|NCT00891735|565516|P3|Overall Study|Death|4
177671|NCT00891735|565517|P2|Overall Study|Death|5
177672|NCT00891735|565518|P1|Overall Study|Death|8
177673|NCT00891735|565515|P4|Overall Study|Adverse Event|0
177674|NCT00891735|565516|P3|Overall Study|Adverse Event|2
177675|NCT00891735|565517|P2|Overall Study|Adverse Event|0
177676|NCT00891735|565518|P1|Overall Study|Adverse Event|2
177677|NCT00899353|565560|P1|Overall Study|Withdrawal by Subject|2
177678|NCT00899353|565560|P1|Overall Study|Lost to Follow-up|1
177679|NCT00899353|565560|P1|Overall Study|Adverse Event|2
177680|NCT00899379|565586|P5|Overall Study|Inc/Exc Criteria Not Met|0
177681|NCT00899379|565587|P4|Overall Study|Inc/Exc Criteria Not Met|0
177682|NCT00899379|565588|P3|Overall Study|Inc/Exc Criteria Not Met|1
177683|NCT00899379|565589|P2|Overall Study|Inc/Exc Criteria Not Met|0
177684|NCT00899379|565590|P1|Overall Study|Inc/Exc Criteria Not Met|0
177685|NCT00899379|565586|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
177686|NCT00899379|565587|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
177687|NCT00899379|565588|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
177688|NCT00899379|565589|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
177689|NCT00899379|565590|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
177690|NCT00899379|565586|P5|Overall Study|No Attack Pretreatment|4
177691|NCT00899379|565587|P4|Overall Study|No Attack Pretreatment|6
177692|NCT00899379|565588|P3|Overall Study|No Attack Pretreatment|5
177693|NCT00899379|565589|P2|Overall Study|No Attack Pretreatment|5
177694|NCT00899379|565590|P1|Overall Study|No Attack Pretreatment|3
177695|NCT00899379|565586|P5|Overall Study|Abnormal Baseline ECG|0
177696|NCT00899379|565587|P4|Overall Study|Abnormal Baseline ECG|1
177697|NCT00899379|565588|P3|Overall Study|Abnormal Baseline ECG|1
177698|NCT00899379|565589|P2|Overall Study|Abnormal Baseline ECG|0
177699|NCT00899379|565590|P1|Overall Study|Abnormal Baseline ECG|0
177700|NCT00899379|565586|P5|Overall Study|Abnormal Prestudy Labs|2
177701|NCT00899379|565587|P4|Overall Study|Abnormal Prestudy Labs|0
177702|NCT00899379|565588|P3|Overall Study|Abnormal Prestudy Labs|0
177703|NCT00899379|565589|P2|Overall Study|Abnormal Prestudy Labs|0
177704|NCT00899379|565590|P1|Overall Study|Abnormal Prestudy Labs|0
177705|NCT00899379|565586|P5|Overall Study|Patient Uncooperative|0
177706|NCT00899379|565587|P4|Overall Study|Patient Uncooperative|1
177707|NCT00899379|565588|P3|Overall Study|Patient Uncooperative|0
177708|NCT00899379|565589|P2|Overall Study|Patient Uncooperative|0
177709|NCT00899379|565590|P1|Overall Study|Patient Uncooperative|0
177710|NCT00899379|565586|P5|Overall Study|Pregnancy|0
177711|NCT00899379|565587|P4|Overall Study|Pregnancy|0
177712|NCT00899379|565588|P3|Overall Study|Pregnancy|0
177713|NCT00899379|565589|P2|Overall Study|Pregnancy|0
177714|NCT00899379|565590|P1|Overall Study|Pregnancy|1
177715|NCT00899379|565586|P5|Overall Study|Withdrawal by Subject|2
177716|NCT00899379|565587|P4|Overall Study|Withdrawal by Subject|7
177717|NCT00899379|565588|P3|Overall Study|Withdrawal by Subject|4
177718|NCT00899379|565589|P2|Overall Study|Withdrawal by Subject|7
177719|NCT00899379|565590|P1|Overall Study|Withdrawal by Subject|4
177720|NCT00899379|565586|P5|Overall Study|Lost to Follow-up|5
177721|NCT00899379|565587|P4|Overall Study|Lost to Follow-up|2
177722|NCT00899379|565588|P3|Overall Study|Lost to Follow-up|0
177723|NCT00899379|565589|P2|Overall Study|Lost to Follow-up|1
177724|NCT00899379|565590|P1|Overall Study|Lost to Follow-up|3
177725|NCT00899379|565586|P5|Overall Study|Study Terminated|1
177726|NCT00899379|565587|P4|Overall Study|Study Terminated|3
177727|NCT00899379|565588|P3|Overall Study|Study Terminated|3
177728|NCT00899379|565589|P2|Overall Study|Study Terminated|0
177729|NCT00899379|565590|P1|Overall Study|Study Terminated|3
177730|NCT00899379|565586|P5|Overall Study|Not Completed/Entered Extn|3
177731|NCT00899379|565587|P4|Overall Study|Not Completed/Entered Extn|4
177732|NCT00899379|565588|P3|Overall Study|Not Completed/Entered Extn|6
177733|NCT00899379|565589|P2|Overall Study|Not Completed/Entered Extn|1
177734|NCT00899379|565590|P1|Overall Study|Not Completed/Entered Extn|5
177735|NCT00899379|565586|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
177736|NCT00899379|565587|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
177737|NCT00899379|565588|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
177738|NCT00899379|565589|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
177739|NCT00899379|565590|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
177740|NCT00899379|565586|P5|Overall Study|Abnormal Baseline ECG|0
177741|NCT00899379|565587|P4|Overall Study|Abnormal Baseline ECG|1
177742|NCT00899379|565588|P3|Overall Study|Abnormal Baseline ECG|0
177743|NCT00899379|565589|P2|Overall Study|Abnormal Baseline ECG|0
177744|NCT00899379|565590|P1|Overall Study|Abnormal Baseline ECG|0
177745|NCT00899379|565586|P5|Overall Study|Patient Uncooperative|2
177746|NCT00899379|565587|P4|Overall Study|Patient Uncooperative|1
177747|NCT00899379|565588|P3|Overall Study|Patient Uncooperative|0
177748|NCT00899379|565589|P2|Overall Study|Patient Uncooperative|1
177749|NCT00899379|565590|P1|Overall Study|Patient Uncooperative|0
177750|NCT00899379|565586|P5|Overall Study|Pregnancy|1
177751|NCT00899379|565587|P4|Overall Study|Pregnancy|0
177752|NCT00899379|565588|P3|Overall Study|Pregnancy|1
177753|NCT00899379|565589|P2|Overall Study|Pregnancy|0
177754|NCT00899379|565590|P1|Overall Study|Pregnancy|0
177755|NCT00899379|565586|P5|Overall Study|Withdrawal by Subject|6
177756|NCT00899379|565587|P4|Overall Study|Withdrawal by Subject|3
177757|NCT00899379|565588|P3|Overall Study|Withdrawal by Subject|2
177758|NCT00899379|565589|P2|Overall Study|Withdrawal by Subject|4
177759|NCT00899379|565590|P1|Overall Study|Withdrawal by Subject|2
177760|NCT00899379|565586|P5|Overall Study|Protocol Violation|0
177761|NCT00899379|565587|P4|Overall Study|Protocol Violation|1
177762|NCT00899379|565588|P3|Overall Study|Protocol Violation|1
177763|NCT00899379|565589|P2|Overall Study|Protocol Violation|0
177764|NCT00899379|565590|P1|Overall Study|Protocol Violation|0
177765|NCT00899379|565586|P5|Overall Study|Lost to Follow-up|2
177766|NCT00899379|565587|P4|Overall Study|Lost to Follow-up|6
177767|NCT00899379|565588|P3|Overall Study|Lost to Follow-up|0
177768|NCT00899379|565589|P2|Overall Study|Lost to Follow-up|3
177769|NCT00899379|565590|P1|Overall Study|Lost to Follow-up|9
177770|NCT00899379|565586|P5|Overall Study|Lack of Efficacy|1
177771|NCT00899379|565587|P4|Overall Study|Lack of Efficacy|0
177772|NCT00899379|565588|P3|Overall Study|Lack of Efficacy|3
177773|NCT00899379|565589|P2|Overall Study|Lack of Efficacy|4
177774|NCT00899379|565590|P1|Overall Study|Lack of Efficacy|0
177775|NCT00899379|565586|P5|Overall Study|Adverse Event|2
177776|NCT00899379|565587|P4|Overall Study|Adverse Event|1
177777|NCT00899379|565588|P3|Overall Study|Adverse Event|1
177778|NCT00899379|565589|P2|Overall Study|Adverse Event|2
177779|NCT00899379|565590|P1|Overall Study|Adverse Event|2
177780|NCT00899392|565604|P2|Overall Study|Subject didn't finish/partial pilot data|24
177781|NCT00899392|565605|P1|Overall Study|Subject didn't finish/partial pilot data|21
177782|NCT00899678|565713|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
177783|NCT00899678|565714|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
177784|NCT00899678|565715|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
177785|NCT00899678|565713|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
177786|NCT00899678|565714|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
177787|NCT00899678|565715|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
177788|NCT00899678|565713|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
177789|NCT00899678|565714|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
177790|NCT00899678|565715|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
177791|NCT00899678|565713|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
177792|NCT00899678|565714|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
177793|NCT00899678|565715|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
177794|NCT00899678|565713|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
177795|NCT00899678|565714|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
177796|NCT00899678|565715|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
177797|NCT00899678|565713|P3|Induction Period (Weeks 0 to 6)|Other reason|0
177798|NCT00899678|565714|P2|Induction Period (Weeks 0 to 6)|Other reason|0
177799|NCT00899678|565715|P1|Induction Period (Weeks 0 to 6)|Other reason|1
177800|NCT00899678|565713|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
177801|NCT00899678|565714|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
177802|NCT00899678|565715|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
177803|NCT00899678|565713|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
177804|NCT00899678|565714|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
177805|NCT00899678|565715|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
177806|NCT00899678|565713|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
177807|NCT00899678|565714|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
177808|NCT00899678|565715|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
177809|NCT00900029|565765|P5|Overall Study|Death|0
177810|NCT00900029|565766|P4|Overall Study|Death|1
177811|NCT00900029|565767|P3|Overall Study|Death|0
177812|NCT00900029|565768|P2|Overall Study|Death|0
177813|NCT00900029|565769|P1|Overall Study|Death|1
177814|NCT00900029|565765|P5|Overall Study|Adverse Event|1
177815|NCT00900029|565766|P4|Overall Study|Adverse Event|1
177816|NCT00900029|565767|P3|Overall Study|Adverse Event|1
177817|NCT00900029|565768|P2|Overall Study|Adverse Event|0
177818|NCT00900029|565769|P1|Overall Study|Adverse Event|0
177819|NCT00900029|565765|P5|Overall Study|Withdrawal by Subject|1
177820|NCT00900029|565766|P4|Overall Study|Withdrawal by Subject|1
177821|NCT00900029|565767|P3|Overall Study|Withdrawal by Subject|1
177822|NCT00900029|565768|P2|Overall Study|Withdrawal by Subject|2
177823|NCT00900029|565769|P1|Overall Study|Withdrawal by Subject|2
177824|NCT00900029|565765|P5|Overall Study|Lost to Follow-up|4
177825|NCT00900029|565766|P4|Overall Study|Lost to Follow-up|4
177826|NCT00900029|565767|P3|Overall Study|Lost to Follow-up|1
177827|NCT00900029|565768|P2|Overall Study|Lost to Follow-up|2
177828|NCT00900029|565769|P1|Overall Study|Lost to Follow-up|0
177829|NCT00900146|565791|P5|Intermediate: Period III|Administrative problems|163
177830|NCT00900146|565792|P4|Intermediate: Period III|Administrative problems|90
177831|NCT00900146|565793|P3|Intermediate: Period III|Administrative problems|84
177832|NCT00900146|565794|P2|Intermediate: Period III|Administrative problems|92
177833|NCT00900146|565795|P1|Intermediate: Period III|Administrative problems|85
177834|NCT00900146|565791|P5|Intermediate: Period III|Lost to Follow-up|1
177835|NCT00900146|565792|P4|Intermediate: Period III|Lost to Follow-up|0
177836|NCT00900146|565793|P3|Intermediate: Period III|Lost to Follow-up|0
177837|NCT00900146|565794|P2|Intermediate: Period III|Lost to Follow-up|0
177838|NCT00900146|565795|P1|Intermediate: Period III|Lost to Follow-up|2
177839|NCT00900146|565791|P5|Intermediate: Period III|Withdrawal by Subject|3
177840|NCT00900146|565792|P4|Intermediate: Period III|Withdrawal by Subject|0
177841|NCT00900146|565793|P3|Intermediate: Period III|Withdrawal by Subject|0
177842|NCT00900146|565794|P2|Intermediate: Period III|Withdrawal by Subject|1
177843|NCT00900146|565795|P1|Intermediate: Period III|Withdrawal by Subject|0
177844|NCT00900146|565791|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
177845|NCT00900146|565792|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
177846|NCT00900146|565793|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
177847|NCT00900146|565794|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
177848|NCT00900146|565795|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
177849|NCT00900146|565791|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
177850|NCT00900146|565792|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
177851|NCT00900146|565793|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
177852|NCT00900146|565794|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
177853|NCT00900146|565795|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
177854|NCT00900146|565791|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
177855|NCT00900146|565792|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
177856|NCT00900146|565793|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
177857|NCT00900146|565794|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
177858|NCT00900146|565795|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
177859|NCT00900159|565909|P2|Second Intervention|disempanelled for inappropriate behavior|0
177860|NCT00900159|565910|P1|Second Intervention|disempanelled for inappropriate behavior|1
177861|NCT00900627|565941|P6|Overall Study|Death|24
177862|NCT00900627|565942|P5|Overall Study|Death|28
177863|NCT00900627|565943|P4|Overall Study|Death|0
177864|NCT00900627|565944|P3|Overall Study|Death|0
177865|NCT00900627|565945|P2|Overall Study|Death|0
177866|NCT00900627|565946|P1|Overall Study|Death|0
177867|NCT00900627|565941|P6|Overall Study|Adverse Event|0
177868|NCT00900627|565942|P5|Overall Study|Adverse Event|0
177869|NCT00900627|565943|P4|Overall Study|Adverse Event|3
177870|NCT00900627|565944|P3|Overall Study|Adverse Event|0
177871|NCT00900627|565945|P2|Overall Study|Adverse Event|2
177872|NCT00900627|565946|P1|Overall Study|Adverse Event|1
177873|NCT00900627|565941|P6|Overall Study|Withdrawal by Subject|2
177874|NCT00900627|565942|P5|Overall Study|Withdrawal by Subject|1
177875|NCT00900627|565943|P4|Overall Study|Withdrawal by Subject|0
177876|NCT00900627|565944|P3|Overall Study|Withdrawal by Subject|1
177877|NCT00900627|565945|P2|Overall Study|Withdrawal by Subject|0
177878|NCT00900627|565946|P1|Overall Study|Withdrawal by Subject|1
177879|NCT00900627|565941|P6|Overall Study|Condition under investigation worsened|0
177880|NCT00900627|565942|P5|Overall Study|Condition under investigation worsened|0
177881|NCT00900627|565943|P4|Overall Study|Condition under investigation worsened|3
177882|NCT00900627|565944|P3|Overall Study|Condition under investigation worsened|5
177883|NCT00900627|565945|P2|Overall Study|Condition under investigation worsened|0
177884|NCT00900627|565946|P1|Overall Study|Condition under investigation worsened|4
177885|NCT00900731|565977|P2|Overall Study|Death|2
177886|NCT00900731|565978|P1|Overall Study|Death|0
177887|NCT00900731|565977|P2|Overall Study|Lack of Efficacy|3
177888|NCT00900731|565978|P1|Overall Study|Lack of Efficacy|1
177889|NCT00900731|565977|P2|Overall Study|Lost to Follow-up|3
177890|NCT00900731|565978|P1|Overall Study|Lost to Follow-up|2
177891|NCT00900731|565977|P2|Overall Study|Abnormal Laboratory Value(s)|4
177892|NCT00900731|565978|P1|Overall Study|Abnormal Laboratory Value(s)|2
177893|NCT00900731|565977|P2|Overall Study|Abnormal Test Procedure Result(s)|0
177894|NCT00900731|565978|P1|Overall Study|Abnormal Test Procedure Result(s)|3
177895|NCT00900731|565977|P2|Overall Study|Administrative Problems|4
177896|NCT00900731|565978|P1|Overall Study|Administrative Problems|5
177897|NCT00900731|565977|P2|Overall Study|Protocol Deviation|11
177898|NCT00900731|565978|P1|Overall Study|Protocol Deviation|8
177899|NCT00900731|565977|P2|Overall Study|Withdrawal by Subject|7
177900|NCT00900731|565978|P1|Overall Study|Withdrawal by Subject|8
177901|NCT00900731|565977|P2|Overall Study|Adverse Event|27
177902|NCT00900731|565978|P1|Overall Study|Adverse Event|31
177903|NCT00900757|565998|P1|Overall Study|screen failure|19
177904|NCT00900796|566006|P1|Phase 2|Lost to Follow-up|5
177905|NCT00900796|566006|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
177906|NCT00900796|566006|P1|Phase 1|Missing information at Week 16|7
177907|NCT00900796|566006|P1|Phase 1|Lacked sufficient information|4
177908|NCT00901186|566042|P2|Overall Study|Protocol deviations|4
177909|NCT00901186|566043|P1|Overall Study|Protocol deviations|5
177910|NCT00901186|566042|P2|Overall Study|Administration problems|1
177911|NCT00901186|566043|P1|Overall Study|Administration problems|0
177912|NCT00901186|566042|P2|Overall Study|Adverse Event|4
177913|NCT00901186|566043|P1|Overall Study|Adverse Event|2
177914|NCT00901186|566042|P2|Overall Study|Lost to Follow-up|0
177915|NCT00901186|566043|P1|Overall Study|Lost to Follow-up|2
177916|NCT00901186|566042|P2|Overall Study|Abnormal laboratory values|1
177917|NCT00901186|566043|P1|Overall Study|Abnormal laboratory values|0
177918|NCT00901186|566042|P2|Overall Study|Lack of Efficacy|1
177919|NCT00901186|566043|P1|Overall Study|Lack of Efficacy|0
177920|NCT00901342|566077|P1|Overall Study|Withdrawal by Subject|9
177921|NCT00901342|566077|P1|Overall Study|Disease progression|1
177922|NCT00901342|566077|P1|Overall Study|Death|4
177923|NCT00901342|566077|P1|Overall Study|Adverse Event|1
177924|NCT00901459|566081|P1|Overall Study|Withdrawal by Subject|6
177925|NCT00894647|566094|P2|Overall Study|Other, not due to AE|2
177926|NCT00894647|566095|P1|Overall Study|Other, not due to AE|1
177927|NCT00894647|566094|P2|Overall Study|Non-compliance with study procedures|2
177928|NCT00894647|566095|P1|Overall Study|Non-compliance with study procedures|0
177929|NCT00894647|566094|P2|Overall Study|Lost to Follow-up|2
177930|NCT00894647|566095|P1|Overall Study|Lost to Follow-up|0
177931|NCT00894647|566094|P2|Overall Study|Withdrawal by Subject|4
177932|NCT00894647|566095|P1|Overall Study|Withdrawal by Subject|4
177933|NCT00894647|566094|P2|Overall Study|Adverse Event|4
177934|NCT00894647|566095|P1|Overall Study|Adverse Event|5
177935|NCT00894790|566116|P2|Overall Study|Did not meet entrance criteria|0
177936|NCT00894790|566117|P1|Overall Study|Did not meet entrance criteria|1
177937|NCT00894790|566116|P2|Overall Study|Lost to Follow-up|1
177938|NCT00894790|566117|P1|Overall Study|Lost to Follow-up|0
177939|NCT00894790|566116|P2|Overall Study|Protocol Violation|1
177940|NCT00894790|566117|P1|Overall Study|Protocol Violation|0
177941|NCT00894803|566141|P2|Overall Study|Lost to Follow-up|1
177942|NCT00894803|566142|P1|Overall Study|Lost to Follow-up|0
177943|NCT00894803|566141|P2|Overall Study|Death|4
177944|NCT00894803|566142|P1|Overall Study|Death|20
178030|NCT00903331|566440|P1|Overall Study|Lung transplant|0
177945|NCT00894933|566176|P1|Overall Study|Did not meeting incl/excl criteria|1
177946|NCT00894933|566176|P1|Overall Study|Cancelled Procedure|1
177947|NCT00894933|566176|P1|Overall Study|Lost to Follow-up|2
177948|NCT00895011|566195|P3|Overall Study|schedule conflict|0
177949|NCT00895011|566196|P2|Overall Study|schedule conflict|0
177950|NCT00895011|566197|P1|Overall Study|schedule conflict|1
177951|NCT00895011|566195|P3|Overall Study|Adverse Event|2
177952|NCT00895011|566196|P2|Overall Study|Adverse Event|2
177953|NCT00895011|566197|P1|Overall Study|Adverse Event|1
177954|NCT00895011|566195|P3|Overall Study|Protocol Violation|3
177955|NCT00895011|566196|P2|Overall Study|Protocol Violation|1
177956|NCT00895011|566197|P1|Overall Study|Protocol Violation|3
177957|NCT00895011|566195|P3|Overall Study|Lost to Follow-up|1
177958|NCT00895011|566196|P2|Overall Study|Lost to Follow-up|4
177959|NCT00895011|566197|P1|Overall Study|Lost to Follow-up|5
177960|NCT00895011|566195|P3|Overall Study|Withdrawal by Subject|2
177961|NCT00895011|566196|P2|Overall Study|Withdrawal by Subject|7
177962|NCT00895011|566197|P1|Overall Study|Withdrawal by Subject|14
177963|NCT00895245|566280|P1|Overall Study|Lack of Efficacy|6
177964|NCT00895310|566296|P1|Overall Study|Withdrawal by Subject|1
177965|NCT00901576|566309|P6|Second Intervention|Physician Decision|0
177966|NCT00901576|566310|P5|Second Intervention|Physician Decision|0
177967|NCT00901576|566311|P4|Second Intervention|Physician Decision|0
177968|NCT00901576|566312|P3|Second Intervention|Physician Decision|0
177969|NCT00901576|566313|P2|Second Intervention|Physician Decision|0
177970|NCT00901576|566314|P1|Second Intervention|Physician Decision|1
177971|NCT00901576|566309|P6|Second Intervention|Withdrawal by Subject|1
177972|NCT00901576|566310|P5|Second Intervention|Withdrawal by Subject|0
177973|NCT00901576|566311|P4|Second Intervention|Withdrawal by Subject|1
177974|NCT00901576|566312|P3|Second Intervention|Withdrawal by Subject|0
177975|NCT00901576|566313|P2|Second Intervention|Withdrawal by Subject|0
177976|NCT00901576|566314|P1|Second Intervention|Withdrawal by Subject|0
177977|NCT00901628|566337|P2|Overall Study|peroneal nerve palsy|1
177978|NCT00901628|566338|P1|Overall Study|peroneal nerve palsy|0
177979|NCT00901628|566337|P2|Overall Study|disconnection of drain|1
177980|NCT00901628|566338|P1|Overall Study|disconnection of drain|0
177981|NCT00901628|566337|P2|Overall Study|disconnection of catheter|8
177982|NCT00901628|566338|P1|Overall Study|disconnection of catheter|4
177983|NCT00902668|566354|P1|Overall Study|Protocol stopped due to slow accrual.|3
177984|NCT00902746|566358|P1|Overall Study|Physician Decision|2
177985|NCT00902746|566358|P1|Overall Study|Lost to Follow-up|3
177986|NCT00902746|566358|P1|Overall Study|Adverse Event|8
177987|NCT00902746|566358|P1|Overall Study|Withdrawal by Subject|16
177988|NCT00902746|566358|P1|Overall Study|Protocol Violation|7
177989|NCT00902850|566365|P2|Overall Study|Physician Decision|2
177990|NCT00902850|566366|P1|Overall Study|Physician Decision|2
177991|NCT00903006|566376|P4|Overall Study|Progressive Disease|0
177992|NCT00903006|566377|P3|Overall Study|Progressive Disease|1
177993|NCT00903006|566378|P2|Overall Study|Progressive Disease|3
177994|NCT00903006|566379|P1|Overall Study|Progressive Disease|0
177995|NCT00903006|566376|P4|Overall Study|Withdrawal by Subject|0
177996|NCT00903006|566377|P3|Overall Study|Withdrawal by Subject|0
177997|NCT00903006|566378|P2|Overall Study|Withdrawal by Subject|0
177998|NCT00903006|566379|P1|Overall Study|Withdrawal by Subject|2
177999|NCT00903032|566391|P2|Overall Study|Lost to Follow-up|2
178000|NCT00903032|566392|P1|Overall Study|Lost to Follow-up|2
178001|NCT00903032|566391|P2|Overall Study|Withdrawal by Subject|3
178002|NCT00903032|566392|P1|Overall Study|Withdrawal by Subject|5
178003|NCT00903175|566406|P2|Period 2 - Second Line|Death|2
178004|NCT00903175|566407|P1|Period 2 - Second Line|Death|5
178005|NCT00903175|566406|P2|Period 2 - Second Line|Administrative problems|9
178006|NCT00903175|566407|P1|Period 2 - Second Line|Administrative problems|19
178007|NCT00903175|566406|P2|Period 2 - Second Line|Lost to Follow-up|0
178008|NCT00903175|566407|P1|Period 2 - Second Line|Lost to Follow-up|1
178009|NCT00903175|566406|P2|Period 2 - Second Line|Withdrawal by Subject|5
178010|NCT00903175|566407|P1|Period 2 - Second Line|Withdrawal by Subject|7
178011|NCT00903175|566406|P2|Period 2 - Second Line|Adverse Event|20
178012|NCT00903175|566407|P1|Period 2 - Second Line|Adverse Event|16
178013|NCT00903175|566406|P2|Period 2 - Second Line|Missing|0
178014|NCT00903175|566407|P1|Period 2 - Second Line|Missing|1
178015|NCT00903175|566406|P2|Period 1 - First Line|Death|10
178016|NCT00903175|566407|P1|Period 1 - First Line|Death|17
178017|NCT00903175|566406|P2|Period 1 - First Line|Administrative problems|13
178018|NCT00903175|566407|P1|Period 1 - First Line|Administrative problems|12
178019|NCT00903175|566406|P2|Period 1 - First Line|Withdrawal by Subject|12
178020|NCT00903175|566407|P1|Period 1 - First Line|Withdrawal by Subject|8
178021|NCT00903175|566406|P2|Period 1 - First Line|Protocol Violation|3
178022|NCT00903175|566407|P1|Period 1 - First Line|Protocol Violation|3
178023|NCT00903175|566406|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
178024|NCT00903175|566407|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
178025|NCT00903175|566406|P2|Period 1 - First Line|Abnormal lab value(s)|1
178026|NCT00903175|566407|P1|Period 1 - First Line|Abnormal lab value(s)|0
178027|NCT00903175|566406|P2|Period 1 - First Line|Adverse Event|50
178028|NCT00903175|566407|P1|Period 1 - First Line|Adverse Event|36
178029|NCT00903331|566439|P2|Overall Study|Lung transplant|2
178031|NCT00903331|566439|P2|Overall Study|Withdrawal of consent|8
178032|NCT00903331|566440|P1|Overall Study|Withdrawal of consent|1
178033|NCT00903331|566439|P2|Overall Study|Death|8
178034|NCT00903331|566440|P1|Overall Study|Death|4
178035|NCT00903344|566450|P2|Overall Study|Lost to Follow-up|0
178036|NCT00903344|566451|P1|Overall Study|Lost to Follow-up|3
178037|NCT00903344|566450|P2|Overall Study|Pregnancy|3
178038|NCT00903344|566451|P1|Overall Study|Pregnancy|2
178039|NCT00903357|566467|P2|Second Intervention|Lost to Follow-up|0
178040|NCT00903357|566468|P1|Second Intervention|Lost to Follow-up|1
178041|NCT00903357|566467|P2|Wash Out Period of 2 Weeks|Flu|1
178042|NCT00903357|566468|P1|Wash Out Period of 2 Weeks|Flu|0
178043|NCT00903357|566467|P2|First Intervention|Flu|1
178044|NCT00903357|566468|P1|First Intervention|Flu|0
178045|NCT00903357|566467|P2|First Intervention|Withdrawal by Subject|3
178046|NCT00903357|566468|P1|First Intervention|Withdrawal by Subject|5
178047|NCT00903370|566480|P2|Overall Study|Lost to Follow-up|8
178048|NCT00903370|566481|P1|Overall Study|Lost to Follow-up|6
178049|NCT00903370|566480|P2|Overall Study|Withdrawal by Subject|6
178050|NCT00903370|566481|P1|Overall Study|Withdrawal by Subject|9
178051|NCT00903370|566480|P2|Overall Study|Death|10
178052|NCT00903370|566481|P1|Overall Study|Death|13
178053|NCT00903383|566493|P4|Overall Study|Patient Decision|1
178054|NCT00903383|566494|P3|Overall Study|Patient Decision|0
178055|NCT00903383|566495|P2|Overall Study|Patient Decision|0
178056|NCT00903383|566496|P1|Overall Study|Patient Decision|0
178057|NCT00903383|566493|P4|Overall Study|Patient Decision - Lack of Efficacy|0
178058|NCT00903383|566494|P3|Overall Study|Patient Decision - Lack of Efficacy|0
178059|NCT00903383|566495|P2|Overall Study|Patient Decision - Lack of Efficacy|1
178060|NCT00903383|566496|P1|Overall Study|Patient Decision - Lack of Efficacy|0
178061|NCT00903383|566493|P4|Overall Study|Withdrawal by Subject|2
178062|NCT00903383|566494|P3|Overall Study|Withdrawal by Subject|0
178063|NCT00903383|566495|P2|Overall Study|Withdrawal by Subject|1
178064|NCT00903383|566496|P1|Overall Study|Withdrawal by Subject|4
178065|NCT00903383|566493|P4|Overall Study|Decision of Sponsor|0
178066|NCT00903383|566494|P3|Overall Study|Decision of Sponsor|0
178067|NCT00903383|566495|P2|Overall Study|Decision of Sponsor|0
178068|NCT00903383|566496|P1|Overall Study|Decision of Sponsor|1
178069|NCT00903383|566493|P4|Overall Study|Lost to Follow-up|1
178070|NCT00903383|566494|P3|Overall Study|Lost to Follow-up|0
178071|NCT00903383|566495|P2|Overall Study|Lost to Follow-up|0
178072|NCT00903383|566496|P1|Overall Study|Lost to Follow-up|0
178073|NCT00903383|566493|P4|Overall Study|Physician Decision|0
178074|NCT00903383|566494|P3|Overall Study|Physician Decision|0
178075|NCT00903383|566495|P2|Overall Study|Physician Decision|2
178076|NCT00903383|566496|P1|Overall Study|Physician Decision|1
178077|NCT00903383|566493|P4|Overall Study|Adverse Event|1
178078|NCT00903383|566494|P3|Overall Study|Adverse Event|3
178079|NCT00903383|566495|P2|Overall Study|Adverse Event|2
178080|NCT00903383|566496|P1|Overall Study|Adverse Event|1
178081|NCT00903409|566561|P2|Overall Study|Lost to Follow-up|6
178082|NCT00903409|566562|P1|Overall Study|Lost to Follow-up|2
178083|NCT00903409|566561|P2|Overall Study|Not specified|3
178084|NCT00903409|566562|P1|Overall Study|Not specified|2
178085|NCT00903409|566561|P2|Overall Study|Withdrawal by Subject|8
178086|NCT00903409|566562|P1|Overall Study|Withdrawal by Subject|8
178087|NCT00903409|566561|P2|Overall Study|Laboratory Abnormality|0
178088|NCT00903409|566562|P1|Overall Study|Laboratory Abnormality|2
178089|NCT00903409|566561|P2|Overall Study|Non-compliance with Protocol|1
178090|NCT00903409|566562|P1|Overall Study|Non-compliance with Protocol|1
178091|NCT00903409|566561|P2|Overall Study|Adverse Event|9
178092|NCT00903409|566562|P1|Overall Study|Adverse Event|11
178093|NCT00903630|566586|P3|Phase 2|Adverse Event|1
178094|NCT00903630|566587|P2|Phase 2|Adverse Event|0
178095|NCT00903630|566588|P1|Phase 2|Adverse Event|0
178096|NCT00903682|566604|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
178097|NCT00903682|566605|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
178098|NCT00903682|566604|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
178099|NCT00903682|566605|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
178100|NCT00903682|566604|P2|Overall Study|Subject Non-Compliant|0
178101|NCT00903682|566605|P1|Overall Study|Subject Non-Compliant|1
178102|NCT00903682|566604|P2|Overall Study|Subject Reached A Virologic Endpoint|1
178103|NCT00903682|566605|P1|Overall Study|Subject Reached A Virologic Endpoint|1
178104|NCT00903682|566604|P2|Overall Study|Pregnancy|1
178105|NCT00903682|566605|P1|Overall Study|Pregnancy|0
178106|NCT00903682|566604|P2|Overall Study|Withdrawal by Subject|0
178107|NCT00903682|566605|P1|Overall Study|Withdrawal by Subject|5
178108|NCT00903682|566604|P2|Overall Study|Lost to Follow-up|0
178109|NCT00903682|566605|P1|Overall Study|Lost to Follow-up|1
178110|NCT00903682|566604|P2|Overall Study|Adverse Event|13
178111|NCT00903682|566605|P1|Overall Study|Adverse Event|6
178112|NCT00903695|566625|P2|Overall Study|lung cancer|0
178113|NCT00903695|566626|P1|Overall Study|lung cancer|1
178114|NCT00903695|566625|P2|Overall Study|medical exclusion after 1st testing|0
178115|NCT00903695|566626|P1|Overall Study|medical exclusion after 1st testing|1
178116|NCT00903877|566646|P1|Overall Study|Participation put on hold|4
178117|NCT00903877|566646|P1|Overall Study|Lost to Follow-up|1
178118|NCT00903877|566646|P1|Overall Study|Adverse Event|2
178119|NCT00903877|566646|P1|Overall Study|Withdrawal by Subject|3
178120|NCT00903877|566646|P1|Overall Study|Did not meet study criteria|33
178121|NCT00903929|566650|P4|Overall Study|Adverse Event|1
178122|NCT00903929|566651|P3|Overall Study|Adverse Event|0
178123|NCT00903929|566652|P2|Overall Study|Adverse Event|0
178124|NCT00903929|566653|P1|Overall Study|Adverse Event|0
178125|NCT00903929|566650|P4|Overall Study|Withdrawal by Subject|2
178126|NCT00903929|566651|P3|Overall Study|Withdrawal by Subject|1
178127|NCT00903929|566652|P2|Overall Study|Withdrawal by Subject|0
178128|NCT00903929|566653|P1|Overall Study|Withdrawal by Subject|0
178129|NCT00904150|566670|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
178130|NCT00904150|566671|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
178131|NCT00904150|566670|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
178132|NCT00904150|566671|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
178133|NCT00904215|566694|P1|Overall Study|Other|28
178134|NCT00904215|566694|P1|Overall Study|Withdrawal by Subject|9
178135|NCT00904215|566694|P1|Overall Study|Lost to Follow-up|63
178136|NCT00904215|566694|P1|Overall Study|Protocol Violation|10
178137|NCT00904215|566694|P1|Overall Study|Adverse Event|25
178138|NCT00904371|566701|P1|Overall Study|Continued with Tritace|1
178139|NCT00904371|566701|P1|Overall Study|Discontinued at target blood pressure|2
178140|NCT00904371|566701|P1|Overall Study|Lost to Follow-up|4
178141|NCT00904371|566701|P1|Overall Study|Adverse Event|2
178142|NCT00904670|566731|P2|Open Label Phase|Lost to Follow-up|0
178143|NCT00904670|566732|P1|Open Label Phase|Lost to Follow-up|1
178144|NCT00904670|566731|P2|Open Label Phase|Lack of Efficacy|0
178145|NCT00904670|566732|P1|Open Label Phase|Lack of Efficacy|1
178146|NCT00904670|566731|P2|Open Label Phase|Adverse Event|0
178147|NCT00904670|566732|P1|Open Label Phase|Adverse Event|2
178148|NCT00904670|566731|P2|Open Label Phase|Withdrawal by Subject|0
178149|NCT00904670|566732|P1|Open Label Phase|Withdrawal by Subject|2
178150|NCT00904722|566753|P1|Overall Study|Physician Decision|1
178151|NCT00904748|566758|P6|Overall Study|Adverse Event|0
178152|NCT00904748|566759|P5|Overall Study|Adverse Event|1
178153|NCT00904748|566760|P4|Overall Study|Adverse Event|0
178154|NCT00904748|566761|P3|Overall Study|Adverse Event|0
178155|NCT00904748|566762|P2|Overall Study|Adverse Event|0
178156|NCT00904748|566763|P1|Overall Study|Adverse Event|0
178157|NCT00904748|566758|P6|Overall Study|Withdrawal by Subject|0
178158|NCT00904748|566759|P5|Overall Study|Withdrawal by Subject|0
178159|NCT00904748|566760|P4|Overall Study|Withdrawal by Subject|2
178160|NCT00904748|566761|P3|Overall Study|Withdrawal by Subject|1
178161|NCT00904748|566762|P2|Overall Study|Withdrawal by Subject|1
178162|NCT00904748|566763|P1|Overall Study|Withdrawal by Subject|1
178163|NCT00904839|566801|P3|Overall Study|Other than above|7
178164|NCT00904839|566802|P2|Overall Study|Other than above|9
178165|NCT00904839|566803|P1|Overall Study|Other than above|0
178166|NCT00904839|566801|P3|Overall Study|Not treated|1
178167|NCT00904839|566802|P2|Overall Study|Not treated|0
178168|NCT00904839|566803|P1|Overall Study|Not treated|1
178169|NCT00904839|566801|P3|Overall Study|Withdrawal by Subject|0
178170|NCT00904839|566802|P2|Overall Study|Withdrawal by Subject|2
178171|NCT00904839|566803|P1|Overall Study|Withdrawal by Subject|0
178172|NCT00904839|566801|P3|Overall Study|Lost to Follow-up|2
178173|NCT00904839|566802|P2|Overall Study|Lost to Follow-up|1
178174|NCT00904839|566803|P1|Overall Study|Lost to Follow-up|0
178175|NCT00904839|566801|P3|Overall Study|Protocol Violation|1
178176|NCT00904839|566802|P2|Overall Study|Protocol Violation|1
178177|NCT00904839|566803|P1|Overall Study|Protocol Violation|0
178178|NCT00904839|566801|P3|Overall Study|Adverse Event|4
178179|NCT00904839|566802|P2|Overall Study|Adverse Event|5
178180|NCT00904839|566803|P1|Overall Study|Adverse Event|0
178181|NCT00904917|566841|P4|Overall Study|Lost to Follow-up|2
178182|NCT00904917|566842|P3|Overall Study|Lost to Follow-up|2
178183|NCT00904917|566843|P2|Overall Study|Lost to Follow-up|2
178184|NCT00904917|566844|P1|Overall Study|Lost to Follow-up|2
178185|NCT00904982|566875|P4|Overall Study|Withdrawal by Subject|0
178186|NCT00904982|566876|P3|Overall Study|Withdrawal by Subject|0
178187|NCT00904982|566877|P2|Overall Study|Withdrawal by Subject|0
178188|NCT00904982|566878|P1|Overall Study|Withdrawal by Subject|2
178189|NCT00905021|566897|P1|Overall Study|Adverse Event|2
178190|NCT00905034|566902|P1|Overall Study|Withdrawal by Subject|1
178191|NCT00898443|566947|P2|Overall Study|Withdrawal by Subject|0
178192|NCT00898443|566948|P1|Overall Study|Withdrawal by Subject|1
178193|NCT00898677|566970|P4|Overall Study|Not Treated: Other (Not Specified)|0
178194|NCT00898677|566971|P3|Overall Study|Not Treated: Other (Not Specified)|2
178195|NCT00898677|566972|P2|Overall Study|Not Treated: Other (Not Specified)|0
178196|NCT00898677|566973|P1|Overall Study|Not Treated: Other (Not Specified)|0
178197|NCT00898677|566970|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
178198|NCT00898677|566971|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
178199|NCT00898677|566972|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
178200|NCT00898677|566973|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
178201|NCT00898677|566970|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
178202|NCT00898677|566971|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
178203|NCT00898677|566972|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
178204|NCT00898677|566973|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
178205|NCT00898677|566970|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
178206|NCT00898677|566971|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
178207|NCT00898677|566972|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
178208|NCT00898677|566973|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
178209|NCT00898677|566970|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
178210|NCT00898677|566971|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
178211|NCT00898677|566972|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
178212|NCT00898677|566973|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
178213|NCT00898677|566970|P4|Overall Study|Not Treated: Patient uncooperative|0
178214|NCT00898677|566971|P3|Overall Study|Not Treated: Patient uncooperative|1
178215|NCT00898677|566972|P2|Overall Study|Not Treated: Patient uncooperative|3
178216|NCT00898677|566973|P1|Overall Study|Not Treated: Patient uncooperative|2
178217|NCT00898677|566970|P4|Overall Study|Not Treated: Withdraw by Subject|3
178218|NCT00898677|566971|P3|Overall Study|Not Treated: Withdraw by Subject|11
178219|NCT00898677|566972|P2|Overall Study|Not Treated: Withdraw by Subject|16
178220|NCT00898677|566973|P1|Overall Study|Not Treated: Withdraw by Subject|2
178221|NCT00898677|566970|P4|Overall Study|Not Treated: Protocol Violation|0
178222|NCT00898677|566971|P3|Overall Study|Not Treated: Protocol Violation|2
178223|NCT00898677|566972|P2|Overall Study|Not Treated: Protocol Violation|0
178224|NCT00898677|566973|P1|Overall Study|Not Treated: Protocol Violation|2
178225|NCT00898677|566970|P4|Overall Study|Not Treated: Pregnancy|0
178226|NCT00898677|566971|P3|Overall Study|Not Treated: Pregnancy|1
178227|NCT00898677|566972|P2|Overall Study|Not Treated: Pregnancy|0
178228|NCT00898677|566973|P1|Overall Study|Not Treated: Pregnancy|0
178229|NCT00898677|566970|P4|Overall Study|Not Treated: Lost to Follow-Up|2
178230|NCT00898677|566971|P3|Overall Study|Not Treated: Lost to Follow-Up|5
178231|NCT00898677|566972|P2|Overall Study|Not Treated: Lost to Follow-Up|5
178232|NCT00898677|566973|P1|Overall Study|Not Treated: Lost to Follow-Up|0
178233|NCT00898677|566970|P4|Overall Study|Not Treated: Adverse Event|0
178234|NCT00898677|566971|P3|Overall Study|Not Treated: Adverse Event|1
178235|NCT00898677|566972|P2|Overall Study|Not Treated: Adverse Event|2
178236|NCT00898677|566973|P1|Overall Study|Not Treated: Adverse Event|0
178237|NCT00898677|566970|P4|Overall Study|Withdrawal by Subject|1
178238|NCT00898677|566971|P3|Overall Study|Withdrawal by Subject|0
178239|NCT00898677|566972|P2|Overall Study|Withdrawal by Subject|0
178240|NCT00898677|566973|P1|Overall Study|Withdrawal by Subject|0
178241|NCT00898677|566970|P4|Overall Study|Protocol Violation|0
178242|NCT00898677|566971|P3|Overall Study|Protocol Violation|2
178243|NCT00898677|566972|P2|Overall Study|Protocol Violation|1
178244|NCT00898677|566973|P1|Overall Study|Protocol Violation|1
178245|NCT00898677|566970|P4|Overall Study|Lost to Follow-up|0
178246|NCT00898677|566971|P3|Overall Study|Lost to Follow-up|2
178247|NCT00898677|566972|P2|Overall Study|Lost to Follow-up|0
178248|NCT00898677|566973|P1|Overall Study|Lost to Follow-up|0
178249|NCT00898677|566970|P4|Overall Study|Adverse Event|0
178250|NCT00898677|566971|P3|Overall Study|Adverse Event|1
178251|NCT00898677|566972|P2|Overall Study|Adverse Event|0
178252|NCT00898677|566973|P1|Overall Study|Adverse Event|0
178253|NCT00898807|567001|P2|Overall Study|Death|1
178254|NCT00898807|567002|P1|Overall Study|Death|0
178255|NCT00898807|567001|P2|Overall Study|Lost to Follow-up|3
178256|NCT00898807|567002|P1|Overall Study|Lost to Follow-up|1
178257|NCT00898807|567001|P2|Overall Study|Family pressure to discontinue|2
178258|NCT00898807|567002|P1|Overall Study|Family pressure to discontinue|2
178259|NCT00898807|567001|P2|Overall Study|Withdrawal by Subject|3
178260|NCT00898807|567002|P1|Overall Study|Withdrawal by Subject|5
178261|NCT00905164|567016|P2|Period 1|Protocol Violation|1
178262|NCT00905164|567017|P1|Period 1|Protocol Violation|0
178263|NCT00905255|567027|P2|Overall Study|Familial and Personal Reasons|0
178264|NCT00905255|567028|P1|Overall Study|Familial and Personal Reasons|1
178265|NCT00905255|567027|P2|Overall Study|Withdrawal by Subject|4
178266|NCT00905255|567028|P1|Overall Study|Withdrawal by Subject|5
178267|NCT00905255|567027|P2|Overall Study|Adverse Event|5
178268|NCT00905255|567028|P1|Overall Study|Adverse Event|7
178269|NCT00905307|567087|P6|Overall Study|Lack of Efficacy|8
178270|NCT00905307|567088|P5|Overall Study|Lack of Efficacy|4
178271|NCT00905307|567089|P4|Overall Study|Lack of Efficacy|4
178272|NCT00905307|567090|P3|Overall Study|Lack of Efficacy|5
178273|NCT00905307|567091|P2|Overall Study|Lack of Efficacy|3
178274|NCT00905307|567092|P1|Overall Study|Lack of Efficacy|6
178275|NCT00905307|567087|P6|Overall Study|Protocol Violation|0
178276|NCT00905307|567088|P5|Overall Study|Protocol Violation|0
178277|NCT00905307|567089|P4|Overall Study|Protocol Violation|0
178278|NCT00905307|567090|P3|Overall Study|Protocol Violation|1
178279|NCT00905307|567091|P2|Overall Study|Protocol Violation|0
178280|NCT00905307|567092|P1|Overall Study|Protocol Violation|1
178281|NCT00905307|567087|P6|Overall Study|Withdrawal by Subject|13
178282|NCT00905307|567088|P5|Overall Study|Withdrawal by Subject|4
178283|NCT00905307|567089|P4|Overall Study|Withdrawal by Subject|11
178284|NCT00905307|567090|P3|Overall Study|Withdrawal by Subject|15
178285|NCT00905307|567091|P2|Overall Study|Withdrawal by Subject|13
178286|NCT00905307|567092|P1|Overall Study|Withdrawal by Subject|5
178287|NCT00905307|567087|P6|Overall Study|Adverse Event|5
178288|NCT00905307|567088|P5|Overall Study|Adverse Event|3
178289|NCT00905307|567089|P4|Overall Study|Adverse Event|11
178290|NCT00905307|567090|P3|Overall Study|Adverse Event|5
178291|NCT00905307|567091|P2|Overall Study|Adverse Event|4
178292|NCT00905307|567092|P1|Overall Study|Adverse Event|3
178293|NCT00905307|567087|P6|Overall Study|Lost to Follow-up|1
178294|NCT00905307|567088|P5|Overall Study|Lost to Follow-up|1
178295|NCT00905307|567089|P4|Overall Study|Lost to Follow-up|0
178296|NCT00905307|567090|P3|Overall Study|Lost to Follow-up|0
178297|NCT00905307|567091|P2|Overall Study|Lost to Follow-up|0
178298|NCT00905307|567092|P1|Overall Study|Lost to Follow-up|0
178299|NCT00905307|567087|P6|Overall Study|Switched to Open Label Rescue|15
178300|NCT00905307|567088|P5|Overall Study|Switched to Open Label Rescue|4
178301|NCT00905307|567089|P4|Overall Study|Switched to Open Label Rescue|11
178302|NCT00905307|567090|P3|Overall Study|Switched to Open Label Rescue|11
178303|NCT00905307|567091|P2|Overall Study|Switched to Open Label Rescue|17
178304|NCT00905307|567092|P1|Overall Study|Switched to Open Label Rescue|7
178305|NCT00905346|567150|P2|Period 1|Withdrawal by Subject|0
178306|NCT00905346|567151|P1|Period 1|Withdrawal by Subject|1
178307|NCT00905359|567161|P2|Overall Study|Withdrawal consent|6
178308|NCT00905359|567162|P1|Overall Study|Withdrawal consent|5
178309|NCT00905359|567161|P2|Overall Study|Death|0
178310|NCT00905359|567162|P1|Overall Study|Death|2
178311|NCT00905359|567161|P2|Overall Study|Lost to Follow-up|10
178312|NCT00905359|567162|P1|Overall Study|Lost to Follow-up|17
178313|NCT00905424|567198|P2|Overall Study|Non-adherence to visit schedule|1
178314|NCT00905424|567199|P1|Overall Study|Non-adherence to visit schedule|0
178315|NCT00905424|567198|P2|Overall Study|Positive urine drug screen|1
178316|NCT00905424|567199|P1|Overall Study|Positive urine drug screen|0
178317|NCT00905424|567198|P2|Overall Study|Sponsor decision|0
178318|NCT00905424|567199|P1|Overall Study|Sponsor decision|1
178319|NCT00905424|567198|P2|Overall Study|Non-compliance with study medication|0
178320|NCT00905424|567199|P1|Overall Study|Non-compliance with study medication|2
178321|NCT00905424|567198|P2|Overall Study|Adverse Event|2
178322|NCT00905424|567199|P1|Overall Study|Adverse Event|4
178323|NCT00905424|567198|P2|Overall Study|Withdrawal by Subject|2
178324|NCT00905424|567199|P1|Overall Study|Withdrawal by Subject|1
178325|NCT00905424|567198|P2|Overall Study|Lost to Follow-up|3
178326|NCT00905424|567199|P1|Overall Study|Lost to Follow-up|3
178327|NCT00905437|567241|P2|Overall Study|Unspecified|6
178328|NCT00905437|567242|P1|Overall Study|Unspecified|5
178329|NCT00905437|567241|P2|Overall Study|Withdrawal by Subject|1
178330|NCT00905437|567242|P1|Overall Study|Withdrawal by Subject|0
178331|NCT00905437|567241|P2|Overall Study|Lost to Follow-up|1
178332|NCT00905437|567242|P1|Overall Study|Lost to Follow-up|0
178333|NCT00905437|567241|P2|Overall Study|Adverse Event|2
178334|NCT00905437|567242|P1|Overall Study|Adverse Event|3
178335|NCT00905489|567260|P1|Optional Extension Phase (OEP)|Adverse Event|1
178336|NCT00905489|567260|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
178337|NCT00905489|567260|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
178338|NCT00907517|567312|P5|Overall Study|Symptomatic Deterioration|1
178339|NCT00907517|567313|P4|Overall Study|Symptomatic Deterioration|0
178340|NCT00907517|567314|P3|Overall Study|Symptomatic Deterioration|0
178341|NCT00907517|567315|P2|Overall Study|Symptomatic Deterioration|0
178342|NCT00907517|567316|P1|Overall Study|Symptomatic Deterioration|0
178343|NCT00907517|567312|P5|Overall Study|Progressive Disease|4
178344|NCT00907517|567313|P4|Overall Study|Progressive Disease|4
178345|NCT00907517|567314|P3|Overall Study|Progressive Disease|4
178346|NCT00907517|567315|P2|Overall Study|Progressive Disease|3
178347|NCT00907517|567316|P1|Overall Study|Progressive Disease|3
178348|NCT00907621|567340|P2|Overall Study|intercurrent febrile illness|1
178349|NCT00907621|567341|P1|Overall Study|intercurrent febrile illness|1
178350|NCT00907621|567340|P2|Overall Study|Lost to Follow-up|3
178351|NCT00907621|567341|P1|Overall Study|Lost to Follow-up|6
178352|NCT00907738|567354|P5|Overall Study|Disease progression|2
178353|NCT00907738|567355|P4|Overall Study|Disease progression|4
178354|NCT00907738|567356|P3|Overall Study|Disease progression|6
178355|NCT00907738|567357|P2|Overall Study|Disease progression|1
178356|NCT00907738|567358|P1|Overall Study|Disease progression|8
178357|NCT00907738|567354|P5|Overall Study|not specified or withdrew consent|0
178358|NCT00907738|567355|P4|Overall Study|not specified or withdrew consent|0
178359|NCT00907738|567356|P3|Overall Study|not specified or withdrew consent|0
178360|NCT00907738|567357|P2|Overall Study|not specified or withdrew consent|0
178361|NCT00907738|567358|P1|Overall Study|not specified or withdrew consent|3
178362|NCT00907738|567354|P5|Overall Study|Adverse Event|0
178363|NCT00907738|567355|P4|Overall Study|Adverse Event|0
178364|NCT00907738|567356|P3|Overall Study|Adverse Event|1
178365|NCT00907738|567357|P2|Overall Study|Adverse Event|0
178366|NCT00907738|567358|P1|Overall Study|Adverse Event|2
178367|NCT00907777|567376|P2|Overall Study|Withdrawal by Subject|1
178368|NCT00907777|567377|P1|Overall Study|Withdrawal by Subject|0
178369|NCT00907803|567402|P3|Overall Study|Protocol Violation|0
178370|NCT00907803|567403|P2|Overall Study|Protocol Violation|1
178371|NCT00907803|567404|P1|Overall Study|Protocol Violation|0
178372|NCT00907803|567402|P3|Overall Study|Lost to Follow-up|0
178373|NCT00907803|567403|P2|Overall Study|Lost to Follow-up|1
178374|NCT00907803|567404|P1|Overall Study|Lost to Follow-up|0
178375|NCT00907803|567402|P3|Overall Study|Withdrawal by Subject|0
178376|NCT00907803|567403|P2|Overall Study|Withdrawal by Subject|1
178377|NCT00907803|567404|P1|Overall Study|Withdrawal by Subject|0
178378|NCT00907803|567402|P3|Overall Study|Adverse Event|0
178379|NCT00907803|567403|P2|Overall Study|Adverse Event|0
178380|NCT00907803|567404|P1|Overall Study|Adverse Event|2
178381|NCT00907803|567402|P3|Overall Study|Withdrawal of consent - long commute|0
178382|NCT00907803|567403|P2|Overall Study|Withdrawal of consent - long commute|0
178383|NCT00907803|567404|P1|Overall Study|Withdrawal of consent - long commute|1
178384|NCT00907881|567433|P1|Overall Study|Missing discontinuation information|15
178385|NCT00907881|567433|P1|Overall Study|Protocol Violation|1
178386|NCT00907881|567433|P1|Overall Study|Withdrawal by Subject|5
178387|NCT00907881|567433|P1|Overall Study|Noncompliance|5
178388|NCT00907881|567433|P1|Overall Study|Lost to Follow-up|59
178389|NCT00908011|567453|P2|Overall Study|Withdrawal by Subject|2
178390|NCT00908011|567454|P1|Overall Study|Withdrawal by Subject|2
178391|NCT00908037|567467|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178392|NCT00908037|567468|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
178393|NCT00908037|567469|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178394|NCT00908037|567470|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178395|NCT00908037|567471|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178396|NCT00908037|567472|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178397|NCT00908037|567473|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178398|NCT00908037|567474|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178399|NCT00908037|567475|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178400|NCT00908037|567476|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178401|NCT00908037|567477|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178402|NCT00908037|567478|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
178403|NCT00908037|567467|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178404|NCT00908037|567468|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178405|NCT00908037|567469|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
178406|NCT00908037|567470|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178407|NCT00908037|567471|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178408|NCT00908037|567472|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178409|NCT00908037|567473|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178410|NCT00908037|567474|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178411|NCT00908037|567475|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178412|NCT00908037|567476|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178413|NCT00908037|567477|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178414|NCT00908037|567478|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
178415|NCT00908037|567467|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178416|NCT00908037|567468|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
178417|NCT00908037|567469|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178418|NCT00908037|567470|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178419|NCT00908037|567471|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178420|NCT00908037|567472|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178421|NCT00908037|567473|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178422|NCT00908037|567474|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178423|NCT00908037|567475|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178424|NCT00908037|567476|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178425|NCT00908037|567477|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178426|NCT00908037|567478|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
178427|NCT00908037|567467|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178428|NCT00908037|567468|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178429|NCT00908037|567469|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
178430|NCT00908037|567470|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178431|NCT00908037|567471|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178432|NCT00908037|567472|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178433|NCT00908037|567473|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178434|NCT00908037|567474|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178435|NCT00908037|567475|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178436|NCT00908037|567476|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178437|NCT00908037|567477|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178438|NCT00908037|567478|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
178439|NCT00908037|567467|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
178440|NCT00908037|567468|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178441|NCT00908037|567469|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
178442|NCT00908037|567470|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178443|NCT00908037|567471|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178444|NCT00908037|567472|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178445|NCT00908037|567473|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178446|NCT00908037|567474|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178447|NCT00908037|567475|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178448|NCT00908037|567476|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178449|NCT00908037|567477|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178450|NCT00908037|567478|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
178451|NCT00908037|567467|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
178452|NCT00908037|567468|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178453|NCT00908037|567469|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178454|NCT00908037|567470|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178455|NCT00908037|567471|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178456|NCT00908037|567472|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178457|NCT00908037|567473|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178458|NCT00908037|567474|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178459|NCT00908037|567475|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178460|NCT00908037|567476|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178461|NCT00908037|567477|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178462|NCT00908037|567478|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
178463|NCT00908037|567467|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178464|NCT00908037|567468|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178465|NCT00908037|567469|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178466|NCT00908037|567470|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178467|NCT00908037|567471|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178468|NCT00908037|567472|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
178469|NCT00908037|567473|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178470|NCT00908037|567474|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178471|NCT00908037|567475|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
178472|NCT00908037|567476|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178473|NCT00908037|567477|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178474|NCT00908037|567478|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
178475|NCT00908037|567467|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178476|NCT00908037|567468|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178477|NCT00908037|567469|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178478|NCT00908037|567470|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
178479|NCT00908037|567471|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178480|NCT00908037|567472|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178481|NCT00908037|567473|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178482|NCT00908037|567474|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
178483|NCT00908037|567475|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178484|NCT00908037|567476|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178485|NCT00908037|567477|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178486|NCT00908037|567478|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
178487|NCT00908037|567467|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178488|NCT00908037|567468|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178489|NCT00908037|567469|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178490|NCT00908037|567470|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
178491|NCT00908037|567471|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178492|NCT00908037|567472|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
178493|NCT00908037|567473|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178494|NCT00908037|567474|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
178495|NCT00908037|567475|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178496|NCT00908037|567476|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178497|NCT00908037|567477|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178498|NCT00908037|567478|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
178499|NCT00908076|567627|P2|Overall Study|Lack of Efficacy|1
178500|NCT00908076|567628|P1|Overall Study|Lack of Efficacy|1
178501|NCT00908115|567634|P1|Overall Study|Unspecified|14
178502|NCT00908141|567653|P2|Overall Study|Withdrawal by Subject|1
178503|NCT00908141|567654|P1|Overall Study|Withdrawal by Subject|0
178504|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
178505|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
178506|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
178507|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
178508|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Other|0
178509|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Other|0
178510|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Other|1
178511|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Other|3
178512|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
178513|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
178514|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
178515|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
178516|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
178517|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
178518|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
178519|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
178520|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
178521|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
178522|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
178523|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
178524|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Death|0
178525|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Death|0
178526|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Death|0
178527|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Death|2
178528|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
178529|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
178530|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
178531|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
178532|NCT00908232|567660|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
178533|NCT00908232|567661|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
178534|NCT00908232|567662|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
178535|NCT00908232|567663|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
178536|NCT00908232|567660|P4|Cycle 1 to 4|not specified|0
178537|NCT00908232|567661|P3|Cycle 1 to 4|not specified|0
178538|NCT00908232|567662|P2|Cycle 1 to 4|not specified|0
178539|NCT00908232|567663|P1|Cycle 1 to 4|not specified|1
178540|NCT00908232|567660|P4|Cycle 1 to 4|Adverse Event|0
178541|NCT00908232|567661|P3|Cycle 1 to 4|Adverse Event|0
178542|NCT00908232|567662|P2|Cycle 1 to 4|Adverse Event|0
178543|NCT00908232|567663|P1|Cycle 1 to 4|Adverse Event|12
178544|NCT00908232|567660|P4|Cycle 1 to 4|Progressive Disease|0
178545|NCT00908232|567661|P3|Cycle 1 to 4|Progressive Disease|0
178546|NCT00908232|567662|P2|Cycle 1 to 4|Progressive Disease|0
178547|NCT00908232|567663|P1|Cycle 1 to 4|Progressive Disease|6
178548|NCT00908232|567660|P4|Cycle 1 to 4|Withdrawal by Subject|0
178549|NCT00908232|567661|P3|Cycle 1 to 4|Withdrawal by Subject|0
178550|NCT00908232|567662|P2|Cycle 1 to 4|Withdrawal by Subject|0
178551|NCT00908232|567663|P1|Cycle 1 to 4|Withdrawal by Subject|4
178552|NCT00908232|567660|P4|Cycle 1 to 4|Death|0
178553|NCT00908232|567661|P3|Cycle 1 to 4|Death|0
178554|NCT00908232|567662|P2|Cycle 1 to 4|Death|0
178555|NCT00908232|567663|P1|Cycle 1 to 4|Death|5
178556|NCT00908310|567679|P1|Overall Study|Other reasons|4
178557|NCT00908310|567679|P1|Overall Study|Screening failure|5
178558|NCT00908310|567679|P1|Overall Study|Lost to Follow-up|7
178559|NCT00908310|567679|P1|Overall Study|Withdrawal by Subject|7
178560|NCT00908310|567679|P1|Overall Study|Death|37
178561|NCT00908349|567683|P1|Overall Study|Various|6
178562|NCT00908349|567683|P1|Overall Study|Lost to Follow-up|5
178563|NCT00908349|567683|P1|Overall Study|Physician Decision|5
178564|NCT00908349|567683|P1|Overall Study|Withdrawal by Subject|9
178565|NCT00908349|567683|P1|Overall Study|Adverse Event|10
178566|NCT00908375|567689|P2|Overall Study|Lost to Follow-up|6
178567|NCT00908375|567690|P1|Overall Study|Lost to Follow-up|8
178568|NCT00908375|567689|P2|Overall Study|Withdrawal by Subject|4
178569|NCT00908375|567690|P1|Overall Study|Withdrawal by Subject|2
178570|NCT00908583|567708|P1|Phase 5|Adverse Event|3
178571|NCT00908583|567708|P1|Phase 4|Physician Decision|1
178572|NCT00908583|567708|P1|Phase 4|Adverse Event|1
178573|NCT00908583|567708|P1|Phase 3|Adverse Event|2
178574|NCT00908583|567708|P1|Phase 2|Adverse Event|1
178575|NCT00908583|567708|P1|Phase 2|Physician Decision|1
178576|NCT00908583|567708|P1|Phase 1|Adverse Event|4
178577|NCT00908583|567708|P1|Phase 1|Withdrawal by Subject|1
178578|NCT00908596|567730|P4|Overall Study|Withdrawal by Subject|1
178579|NCT00908596|567731|P3|Overall Study|Withdrawal by Subject|3
178580|NCT00908596|567732|P2|Overall Study|Withdrawal by Subject|1
178581|NCT00908596|567733|P1|Overall Study|Withdrawal by Subject|0
178582|NCT00908596|567730|P4|Overall Study|Protocol Violation|0
178583|NCT00908596|567731|P3|Overall Study|Protocol Violation|0
178584|NCT00908596|567732|P2|Overall Study|Protocol Violation|0
178585|NCT00908596|567733|P1|Overall Study|Protocol Violation|1
178586|NCT00908596|567730|P4|Overall Study|Death|32
178587|NCT00908596|567731|P3|Overall Study|Death|57
178588|NCT00908596|567732|P2|Overall Study|Death|5
178589|NCT00908596|567733|P1|Overall Study|Death|0
178590|NCT00908596|567730|P4|Overall Study|Lost to Follow-up|4
178591|NCT00908596|567731|P3|Overall Study|Lost to Follow-up|12
178592|NCT00908596|567732|P2|Overall Study|Lost to Follow-up|1
178593|NCT00908596|567733|P1|Overall Study|Lost to Follow-up|0
178594|NCT00908596|567730|P4|Overall Study|Other reasons|0
178595|NCT00908596|567731|P3|Overall Study|Other reasons|2
178596|NCT00908596|567732|P2|Overall Study|Other reasons|6
178597|NCT00908596|567733|P1|Overall Study|Other reasons|46
178598|NCT00908895|567826|P2|Overall Study|Adverse Event|1
178599|NCT00908895|567827|P1|Overall Study|Adverse Event|1
178600|NCT00908895|567826|P2|Overall Study|algodystrophy|2
178601|NCT00908895|567827|P1|Overall Study|algodystrophy|2
178602|NCT00908895|567826|P2|Overall Study|Lost to Follow-up|3
178603|NCT00908895|567827|P1|Overall Study|Lost to Follow-up|1
178604|NCT00908960|567844|P3|Overall Study|excluded from analysis|2
178605|NCT00908960|567845|P2|Overall Study|excluded from analysis|1
178606|NCT00908960|567846|P1|Overall Study|excluded from analysis|1
178607|NCT00909038|567854|P1|Overall Study|Non-evaluable Subjects|230
178608|NCT00909038|567854|P1|Overall Study|Protocol Violation|187
178609|NCT00909181|567885|P3|Overall Study|Lost to Follow-up|33
178610|NCT00909181|567886|P2|Overall Study|Lost to Follow-up|18
178611|NCT00909181|567887|P1|Overall Study|Lost to Follow-up|39
178612|NCT00909389|567908|P1|Overall Study|No Information|103
178613|NCT00909389|567908|P1|Overall Study|Lost to Follow-up|4
178614|NCT00909389|567908|P1|Overall Study|Poor Compliance|16
178615|NCT00909389|567908|P1|Overall Study|Death|4
178616|NCT00909389|567908|P1|Overall Study|Adverse Event|6
178617|NCT00909428|567915|P3|Overall Study|Lost to Follow-up|9
178618|NCT00909428|567916|P2|Overall Study|Lost to Follow-up|10
178619|NCT00909428|567917|P1|Overall Study|Lost to Follow-up|13
178620|NCT00909480|567926|P2|Overall Study|Unclassified|19
178621|NCT00909480|567927|P1|Overall Study|Unclassified|18
178622|NCT00909480|567926|P2|Overall Study|Withdrawal criteria|11
178623|NCT00909480|567927|P1|Overall Study|Withdrawal criteria|9
178624|NCT00909480|567926|P2|Overall Study|Protocol Violation|8
178625|NCT00909480|567927|P1|Overall Study|Protocol Violation|6
178626|NCT00909480|567926|P2|Overall Study|Adverse Event|3
178627|NCT00909480|567927|P1|Overall Study|Adverse Event|5
178628|NCT00909532|567961|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
178629|NCT00909532|567962|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
178630|NCT00909532|567961|P2|Overall Study|Wrong Genotype|0
178631|NCT00909532|567962|P1|Overall Study|Wrong Genotype|1
178632|NCT00909532|567961|P2|Overall Study|Physician Decision|0
178633|NCT00909532|567962|P1|Overall Study|Physician Decision|1
178634|NCT00909532|567961|P2|Overall Study|Noncompliance with Study Requirements|2
178635|NCT00909532|567962|P1|Overall Study|Noncompliance with Study Requirements|0
178636|NCT00909532|567961|P2|Overall Study|Withdrawal of Consent|1
178637|NCT00909532|567962|P1|Overall Study|Withdrawal of Consent|1
178638|NCT00909532|567961|P2|Overall Study|Prohibited Medication|1
178639|NCT00909532|567962|P1|Overall Study|Prohibited Medication|2
178640|NCT00909532|567961|P2|Overall Study|Pregnancy|1
178641|NCT00909532|567962|P1|Overall Study|Pregnancy|0
178642|NCT00909532|567961|P2|Overall Study|Adverse Event|1
178643|NCT00909532|567962|P1|Overall Study|Adverse Event|4
178644|NCT00909610|568121|P2|Period: Second Intervention|Adverse Event|0
178645|NCT00909610|568122|P1|Period: Second Intervention|Adverse Event|1
178646|NCT00909610|568121|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
178647|NCT00909610|568122|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
178648|NCT00909610|568121|P2|Period: First Intervention|Adverse Event|1
178649|NCT00909610|568122|P1|Period: First Intervention|Adverse Event|0
178650|NCT00909727|568149|P2|Overall Study|Prohibited Medication|0
178651|NCT00909727|568150|P1|Overall Study|Prohibited Medication|1
178652|NCT00909727|568149|P2|Overall Study|Withdrawal of Consent|0
178653|NCT00909727|568150|P1|Overall Study|Withdrawal of Consent|1
178654|NCT00909727|568149|P2|Overall Study|Wrong Genotype|0
178655|NCT00909727|568150|P1|Overall Study|Wrong Genotype|1
178656|NCT00909727|568149|P2|Overall Study|Adverse Event|0
178657|NCT00909727|568150|P1|Overall Study|Adverse Event|1
178658|NCT00909753|568166|P2|Period: Second Intervention|Protocol Violation|0
178659|NCT00909753|568167|P1|Period: Second Intervention|Protocol Violation|1
178660|NCT00909753|568166|P2|Period: Washout of 28 Days|Protocol Violation|3
178661|NCT00909753|568167|P1|Period: Washout of 28 Days|Protocol Violation|2
178662|NCT00909779|568187|P2|Overall Study|Randomized in error|1
178663|NCT00909779|568188|P1|Overall Study|Randomized in error|1
178664|NCT00909779|568187|P2|Overall Study|Noncompliance|1
178665|NCT00909779|568188|P1|Overall Study|Noncompliance|1
178666|NCT00909779|568187|P2|Overall Study|Medical Monitor Decision|0
178667|NCT00909779|568188|P1|Overall Study|Medical Monitor Decision|1
178668|NCT00909779|568187|P2|Overall Study|Site Ceasing Operation|2
178669|NCT00909779|568188|P1|Overall Study|Site Ceasing Operation|2
178670|NCT00909779|568187|P2|Overall Study|Withdrawal by Subject|80
178671|NCT00909779|568188|P1|Overall Study|Withdrawal by Subject|116
178672|NCT00909779|568187|P2|Overall Study|Protocol Violation|5
178673|NCT00909779|568188|P1|Overall Study|Protocol Violation|2
178674|NCT00909779|568187|P2|Overall Study|Physician Decision|2
178675|NCT00909779|568188|P1|Overall Study|Physician Decision|8
178676|NCT00909779|568187|P2|Overall Study|Lost to Follow-up|15
178677|NCT00909779|568188|P1|Overall Study|Lost to Follow-up|19
178678|NCT00909779|568187|P2|Overall Study|Lack of Efficacy|4
178679|NCT00909779|568188|P1|Overall Study|Lack of Efficacy|7
178680|NCT00909779|568187|P2|Overall Study|Adverse Event|55
178681|NCT00909779|568188|P1|Overall Study|Adverse Event|53
178682|NCT00909792|568210|P2|Period 2|Lost to Follow-up|1
178683|NCT00909792|568211|P1|Period 2|Lost to Follow-up|0
178684|NCT00909792|568210|P2|Period 2|Biomicroscopy|0
178685|NCT00909792|568211|P1|Period 2|Biomicroscopy|1
178686|NCT00909792|568210|P2|Period 1|Did not meet inclusion criteria|1
178687|NCT00909792|568211|P1|Period 1|Did not meet inclusion criteria|0
178688|NCT00909844|568217|P1|Overall Study|Lost to Follow-up|2
178689|NCT00909844|568217|P1|Overall Study|Withdrawal by Subject|1
178690|NCT00909844|568217|P1|Overall Study|Adverse Event|1
178691|NCT00909857|568237|P2|Overall Study|Did not receive study medication|24
178692|NCT00909857|568238|P1|Overall Study|Did not receive study medication|19
178693|NCT00909857|568237|P2|Overall Study|Other|0
178694|NCT00909857|568238|P1|Overall Study|Other|1
178695|NCT00909857|568237|P2|Overall Study|Pregnancy|0
178696|NCT00909857|568238|P1|Overall Study|Pregnancy|1
178697|NCT00909857|568237|P2|Overall Study|Protocol Violation|1
178698|NCT00909857|568238|P1|Overall Study|Protocol Violation|2
178699|NCT00909857|568237|P2|Overall Study|Lost to Follow-up|5
178700|NCT00909857|568238|P1|Overall Study|Lost to Follow-up|2
178701|NCT00909857|568237|P2|Overall Study|Adverse Event|5
178702|NCT00909857|568238|P1|Overall Study|Adverse Event|5
178703|NCT00909857|568237|P2|Overall Study|Withdrawal by Subject|10
178704|NCT00909857|568238|P1|Overall Study|Withdrawal by Subject|6
178705|NCT00909870|568380|P2|Overall Study|Other|5
178706|NCT00909870|568381|P1|Overall Study|Other|1
178707|NCT00909870|568380|P2|Overall Study|Physician Decision|2
178708|NCT00909870|568381|P1|Overall Study|Physician Decision|0
178709|NCT00909870|568380|P2|Overall Study|Lost to Follow-up|3
178710|NCT00909870|568381|P1|Overall Study|Lost to Follow-up|3
178711|NCT00909870|568380|P2|Overall Study|Withdrawal by Subject|8
178712|NCT00909870|568381|P1|Overall Study|Withdrawal by Subject|5
178713|NCT00909870|568380|P2|Overall Study|Protocol Violation|2
178714|NCT00909870|568381|P1|Overall Study|Protocol Violation|1
178715|NCT00909870|568380|P2|Overall Study|Adverse Event|7
178716|NCT00909870|568381|P1|Overall Study|Adverse Event|13
178717|NCT00910000|568397|P6|Overall Study|Withdrawal by Subject|0
178718|NCT00910000|568398|P5|Overall Study|Withdrawal by Subject|1
178719|NCT00910000|568399|P4|Overall Study|Withdrawal by Subject|0
178720|NCT00910000|568400|P3|Overall Study|Withdrawal by Subject|1
178721|NCT00910000|568401|P2|Overall Study|Withdrawal by Subject|0
178722|NCT00910000|568402|P1|Overall Study|Withdrawal by Subject|0
178723|NCT00910000|568397|P6|Overall Study|Adverse Event|1
178724|NCT00910000|568398|P5|Overall Study|Adverse Event|0
178725|NCT00910000|568399|P4|Overall Study|Adverse Event|2
178726|NCT00910000|568400|P3|Overall Study|Adverse Event|2
178727|NCT00910000|568401|P2|Overall Study|Adverse Event|3
178728|NCT00910000|568402|P1|Overall Study|Adverse Event|0
178729|NCT00910039|568418|P1|Overall Study|Physician Decision|1
178730|NCT00901901|568431|P2|Follow-up Period|Lost to Follow-up|8
178731|NCT00901901|568432|P1|Follow-up Period|Lost to Follow-up|12
178732|NCT00901901|568431|P2|Follow-up Period|Withdrawal by Subject|9
178733|NCT00901901|568432|P1|Follow-up Period|Withdrawal by Subject|6
178734|NCT00901901|568431|P2|Follow-up Period|Protocol driven decision point|35
178735|NCT00901901|568432|P1|Follow-up Period|Protocol driven decision point|47
178736|NCT00901901|568431|P2|Follow-up Period|Death|207
178737|NCT00901901|568432|P1|Follow-up Period|Death|181
178738|NCT00901901|568431|P2|Treatment Period|Never treated|3
178739|NCT00901901|568432|P1|Treatment Period|Never treated|0
178740|NCT00901901|568431|P2|Treatment Period|Missing|1
178741|NCT00901901|568432|P1|Treatment Period|Missing|1
178742|NCT00901901|568431|P2|Treatment Period|Protocol Violation|9
178743|NCT00901901|568432|P1|Treatment Period|Protocol Violation|4
178744|NCT00901901|568431|P2|Treatment Period|Noncompliance with study medication|1
178745|NCT00901901|568432|P1|Treatment Period|Noncompliance with study medication|4
178746|NCT00901901|568431|P2|Treatment Period|Lost to Follow-up|5
178747|NCT00901901|568432|P1|Treatment Period|Lost to Follow-up|3
178748|NCT00901901|568431|P2|Treatment Period|Physician Decision|2
178749|NCT00901901|568432|P1|Treatment Period|Physician Decision|2
178750|NCT00901901|568431|P2|Treatment Period|Withdrawal by Subject|24
178751|NCT00901901|568432|P1|Treatment Period|Withdrawal by Subject|26
178752|NCT00901901|568431|P2|Treatment Period|Adverse Event|123
178753|NCT00901901|568432|P1|Treatment Period|Adverse Event|117
178754|NCT00902174|568473|P2|Overall Study|Administration problem|1
178755|NCT00902174|568474|P1|Overall Study|Administration problem|0
178756|NCT00902174|568473|P2|Overall Study|Protocol Violation|1
178757|NCT00902174|568474|P1|Overall Study|Protocol Violation|1
178758|NCT00902174|568473|P2|Overall Study|Abnormal labs|1
178759|NCT00902174|568474|P1|Overall Study|Abnormal labs|1
178760|NCT00902174|568473|P2|Overall Study|Withdrawal by Subject|1
178761|NCT00902174|568474|P1|Overall Study|Withdrawal by Subject|2
178762|NCT00902174|568473|P2|Overall Study|Death|2
178763|NCT00902174|568474|P1|Overall Study|Death|2
178764|NCT00902174|568473|P2|Overall Study|Lack of Efficacy|5
178765|NCT00902174|568474|P1|Overall Study|Lack of Efficacy|1
178766|NCT00902174|568473|P2|Overall Study|Adverse Event|7
178767|NCT00902174|568474|P1|Overall Study|Adverse Event|27
178768|NCT00902265|568520|P1|Overall Study|Protocol Violation|1
178769|NCT00902265|568520|P1|Overall Study|Lack of Efficacy|2
178770|NCT00902265|568520|P1|Overall Study|Adverse Event|2
178771|NCT00902265|568520|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
178772|NCT00902304|568535|P3|Overall Study|includes pregnancy|2
178773|NCT00902304|568536|P2|Overall Study|includes pregnancy|9
178774|NCT00902304|568537|P1|Overall Study|includes pregnancy|3
178775|NCT00902304|568535|P3|Overall Study|Withdrawal by Subject|43
178776|NCT00902304|568536|P2|Overall Study|Withdrawal by Subject|22
178777|NCT00902304|568537|P1|Overall Study|Withdrawal by Subject|32
178778|NCT00902304|568535|P3|Overall Study|Protocol Violation|20
178779|NCT00902304|568536|P2|Overall Study|Protocol Violation|18
178780|NCT00902304|568537|P1|Overall Study|Protocol Violation|9
178781|NCT00902304|568535|P3|Overall Study|Lost to Follow-up|7
178782|NCT00902304|568536|P2|Overall Study|Lost to Follow-up|7
178783|NCT00902304|568537|P1|Overall Study|Lost to Follow-up|7
178784|NCT00902304|568535|P3|Overall Study|Investigator discretion|13
178785|NCT00902304|568536|P2|Overall Study|Investigator discretion|5
178786|NCT00902304|568537|P1|Overall Study|Investigator discretion|3
178787|NCT00902304|568535|P3|Overall Study|Adverse Event|25
178788|NCT00902304|568536|P2|Overall Study|Adverse Event|10
178789|NCT00902304|568537|P1|Overall Study|Adverse Event|4
178790|NCT00902330|568584|P2|Overall Study|No post baseline data|0
178791|NCT00902330|568585|P1|Overall Study|No post baseline data|1
178792|NCT00902330|568584|P2|Overall Study|Adverse Event|0
178793|NCT00902330|568585|P1|Overall Study|Adverse Event|1
178794|NCT00902330|568584|P2|Overall Study|Too overwhelmed by treatment|5
178795|NCT00902330|568585|P1|Overall Study|Too overwhelmed by treatment|2
178796|NCT00902538|568622|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
178797|NCT00902538|568623|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
178798|NCT00902538|568624|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
178799|NCT00902538|568625|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
178800|NCT00902538|568626|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
178801|NCT00902538|568627|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
178802|NCT00902538|568622|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
178803|NCT00902538|568623|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
178804|NCT00902538|568624|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
178805|NCT00902538|568625|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
178806|NCT00902538|568626|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
178807|NCT00902538|568627|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
178808|NCT00902538|568622|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
178809|NCT00902538|568623|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
178810|NCT00902538|568624|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
178811|NCT00902538|568625|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
178812|NCT00902538|568626|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
178813|NCT00902538|568627|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
178814|NCT00902538|568622|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
178815|NCT00902538|568623|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
178816|NCT00902538|568624|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
178817|NCT00902538|568625|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
178818|NCT00902538|568626|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
178819|NCT00902538|568627|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
178820|NCT00902538|568622|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
178821|NCT00902538|568623|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
178822|NCT00902538|568624|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
178823|NCT00902538|568625|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
178824|NCT00902538|568626|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
178825|NCT00902538|568627|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
178826|NCT00902538|568622|P6|3-Single-blind, Single Treatment|Protocol Violation|0
178827|NCT00902538|568623|P5|3-Single-blind, Single Treatment|Protocol Violation|0
178900|NCT00910091|568672|P1|Treatment and Survival|Adverse Event|1
178828|NCT00902538|568624|P4|3-Single-blind, Single Treatment|Protocol Violation|0
178829|NCT00902538|568625|P3|3-Single-blind, Single Treatment|Protocol Violation|0
178830|NCT00902538|568626|P2|3-Single-blind, Single Treatment|Protocol Violation|5
178831|NCT00902538|568627|P1|3-Single-blind, Single Treatment|Protocol Violation|0
178832|NCT00902538|568622|P6|3-Single-blind, Single Treatment|Adverse Event|0
178833|NCT00902538|568623|P5|3-Single-blind, Single Treatment|Adverse Event|0
178834|NCT00902538|568624|P4|3-Single-blind, Single Treatment|Adverse Event|0
178835|NCT00902538|568625|P3|3-Single-blind, Single Treatment|Adverse Event|0
178836|NCT00902538|568626|P2|3-Single-blind, Single Treatment|Adverse Event|5
178837|NCT00902538|568627|P1|3-Single-blind, Single Treatment|Adverse Event|0
178838|NCT00902538|568622|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
178839|NCT00902538|568623|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
178840|NCT00902538|568624|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
178841|NCT00902538|568625|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
178842|NCT00902538|568626|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
178843|NCT00902538|568627|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
178844|NCT00902538|568622|P6|2-Randomized Double-blind 3 Treatments|Other|0
178845|NCT00902538|568623|P5|2-Randomized Double-blind 3 Treatments|Other|0
178846|NCT00902538|568624|P4|2-Randomized Double-blind 3 Treatments|Other|0
178847|NCT00902538|568625|P3|2-Randomized Double-blind 3 Treatments|Other|0
178848|NCT00902538|568626|P2|2-Randomized Double-blind 3 Treatments|Other|1
178849|NCT00902538|568627|P1|2-Randomized Double-blind 3 Treatments|Other|2
178850|NCT00902538|568622|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
178851|NCT00902538|568623|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
178852|NCT00902538|568624|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
178853|NCT00902538|568625|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
178854|NCT00902538|568626|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
178855|NCT00902538|568627|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
178856|NCT00902538|568622|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
178857|NCT00902538|568623|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
178858|NCT00902538|568624|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
178859|NCT00902538|568625|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
178860|NCT00902538|568626|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
178861|NCT00902538|568627|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
178862|NCT00902538|568622|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
178863|NCT00902538|568623|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
178864|NCT00902538|568624|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
178865|NCT00902538|568625|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
178866|NCT00902538|568626|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
178867|NCT00902538|568627|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
178868|NCT00902538|568622|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
178869|NCT00902538|568623|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
178870|NCT00902538|568624|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
178871|NCT00902538|568625|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
178872|NCT00902538|568626|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
178873|NCT00902538|568627|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
178874|NCT00902538|568622|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
178875|NCT00902538|568623|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
178876|NCT00902538|568624|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
178877|NCT00902538|568625|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
178878|NCT00902538|568626|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
178879|NCT00902538|568627|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
178880|NCT00902538|568622|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
178881|NCT00902538|568623|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
178882|NCT00902538|568624|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
178883|NCT00902538|568625|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
178884|NCT00902538|568626|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
178885|NCT00902538|568627|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
178886|NCT00902538|568622|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
178887|NCT00902538|568623|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
178888|NCT00902538|568624|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
178889|NCT00902538|568625|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
178890|NCT00902538|568626|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
178891|NCT00902538|568627|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
178892|NCT00902538|568622|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
178893|NCT00902538|568623|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
178894|NCT00902538|568624|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
178895|NCT00902538|568625|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
178896|NCT00902538|568626|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
178897|NCT00902538|568627|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
178898|NCT00902564|568657|P1|Overall Study|Withdrawal by Subject|2
178899|NCT00910091|568671|P2|Treatment and Survival|Adverse Event|0
178901|NCT00910091|568671|P2|Treatment and Survival|Withdrawal by Subject|4
178902|NCT00910091|568672|P1|Treatment and Survival|Withdrawal by Subject|3
178903|NCT00910091|568671|P2|Pre-assignment|Withdrawal by Subject|2
178904|NCT00910091|568672|P1|Pre-assignment|Withdrawal by Subject|0
178905|NCT00910273|568702|P2|Overall Study|Lost to Follow-up|1
178906|NCT00910273|568703|P1|Overall Study|Lost to Follow-up|1
178907|NCT00910273|568702|P2|Overall Study|Protocol Violation|0
178908|NCT00910273|568703|P1|Overall Study|Protocol Violation|1
178909|NCT00910273|568702|P2|Overall Study|Discontinuation of study by sponsor|2
178910|NCT00910273|568703|P1|Overall Study|Discontinuation of study by sponsor|8
178911|NCT00910273|568702|P2|Overall Study|Withdrawal by Subject|0
178912|NCT00910273|568703|P1|Overall Study|Withdrawal by Subject|1
178913|NCT00910273|568702|P2|Overall Study|Adverse Event|1
178914|NCT00910273|568703|P1|Overall Study|Adverse Event|1
178915|NCT00910273|568702|P2|Overall Study|Lack of Efficacy|9
178916|NCT00910273|568703|P1|Overall Study|Lack of Efficacy|6
178917|NCT00910299|568755|P2|Overall Study|Didn't receive any study drug|1
178918|NCT00910299|568756|P1|Overall Study|Didn't receive any study drug|2
178919|NCT00910299|568755|P2|Overall Study|Sponsor Decision|60
178920|NCT00910299|568756|P1|Overall Study|Sponsor Decision|58
178921|NCT00910299|568755|P2|Overall Study|Withdrawal by Subject|13
178922|NCT00910299|568756|P1|Overall Study|Withdrawal by Subject|16
178923|NCT00913380|568805|P2|Clinical Outcomes|Lost to Follow-up|6
178924|NCT00913380|568806|P1|Clinical Outcomes|Lost to Follow-up|6
178925|NCT00913458|568832|P7|Phase 3|Unsatisfactory Response per Investigator|4
178926|NCT00913458|568833|P6|Phase 3|Unsatisfactory Response per Investigator|11
178927|NCT00913458|568834|P5|Phase 3|Unsatisfactory Response per Investigator|14
178928|NCT00913458|568835|P4|Phase 3|Unsatisfactory Response per Investigator|0
178929|NCT00913458|568836|P3|Phase 3|Unsatisfactory Response per Investigator|0
178930|NCT00913458|568837|P2|Phase 3|Unsatisfactory Response per Investigator|0
178931|NCT00913458|568838|P1|Phase 3|Unsatisfactory Response per Investigator|0
178932|NCT00913458|568832|P7|Phase 3|Withdrawal by Subject|0
178933|NCT00913458|568833|P6|Phase 3|Withdrawal by Subject|2
178934|NCT00913458|568834|P5|Phase 3|Withdrawal by Subject|1
178935|NCT00913458|568835|P4|Phase 3|Withdrawal by Subject|0
178936|NCT00913458|568836|P3|Phase 3|Withdrawal by Subject|0
178937|NCT00913458|568837|P2|Phase 3|Withdrawal by Subject|0
178938|NCT00913458|568838|P1|Phase 3|Withdrawal by Subject|0
178939|NCT00913458|568832|P7|Phase 3|Non-Responder|3
178940|NCT00913458|568833|P6|Phase 3|Non-Responder|1
178941|NCT00913458|568834|P5|Phase 3|Non-Responder|0
178942|NCT00913458|568835|P4|Phase 3|Non-Responder|0
178943|NCT00913458|568836|P3|Phase 3|Non-Responder|0
178944|NCT00913458|568837|P2|Phase 3|Non-Responder|0
178945|NCT00913458|568838|P1|Phase 3|Non-Responder|0
178946|NCT00913458|568832|P7|Phase 3|Lost to Follow-up|0
178947|NCT00913458|568833|P6|Phase 3|Lost to Follow-up|0
178948|NCT00913458|568834|P5|Phase 3|Lost to Follow-up|2
178949|NCT00913458|568835|P4|Phase 3|Lost to Follow-up|0
178950|NCT00913458|568836|P3|Phase 3|Lost to Follow-up|0
178951|NCT00913458|568837|P2|Phase 3|Lost to Follow-up|0
178952|NCT00913458|568838|P1|Phase 3|Lost to Follow-up|0
178953|NCT00913458|568832|P7|Phase 3|Adverse Event|1
178954|NCT00913458|568833|P6|Phase 3|Adverse Event|4
178955|NCT00913458|568834|P5|Phase 3|Adverse Event|5
178956|NCT00913458|568835|P4|Phase 3|Adverse Event|0
178957|NCT00913458|568836|P3|Phase 3|Adverse Event|0
178958|NCT00913458|568837|P2|Phase 3|Adverse Event|0
178959|NCT00913458|568838|P1|Phase 3|Adverse Event|0
178960|NCT00913458|568832|P7|Phase 2|Unsatisfactory Response per Investigator|0
178961|NCT00913458|568833|P6|Phase 2|Unsatisfactory Response per Investigator|0
178962|NCT00913458|568834|P5|Phase 2|Unsatisfactory Response per Investigator|0
178963|NCT00913458|568835|P4|Phase 2|Unsatisfactory Response per Investigator|17
178964|NCT00913458|568836|P3|Phase 2|Unsatisfactory Response per Investigator|11
178965|NCT00913458|568837|P2|Phase 2|Unsatisfactory Response per Investigator|0
178966|NCT00913458|568838|P1|Phase 2|Unsatisfactory Response per Investigator|0
178967|NCT00913458|568832|P7|Phase 2|Protocol Violation|0
178968|NCT00913458|568833|P6|Phase 2|Protocol Violation|0
178969|NCT00913458|568834|P5|Phase 2|Protocol Violation|0
178970|NCT00913458|568835|P4|Phase 2|Protocol Violation|0
178971|NCT00913458|568836|P3|Phase 2|Protocol Violation|0
178972|NCT00913458|568837|P2|Phase 2|Protocol Violation|2
178973|NCT00913458|568838|P1|Phase 2|Protocol Violation|0
178974|NCT00913458|568832|P7|Phase 2|Lost to Follow-up|0
178975|NCT00913458|568833|P6|Phase 2|Lost to Follow-up|0
178976|NCT00913458|568834|P5|Phase 2|Lost to Follow-up|0
178977|NCT00913458|568835|P4|Phase 2|Lost to Follow-up|1
178978|NCT00913458|568836|P3|Phase 2|Lost to Follow-up|0
178979|NCT00913458|568837|P2|Phase 2|Lost to Follow-up|0
178980|NCT00913458|568838|P1|Phase 2|Lost to Follow-up|0
178981|NCT00913458|568832|P7|Phase 2|Adverse Event|0
178982|NCT00913458|568833|P6|Phase 2|Adverse Event|0
178983|NCT00913458|568834|P5|Phase 2|Adverse Event|0
178984|NCT00913458|568835|P4|Phase 2|Adverse Event|1
178985|NCT00913458|568836|P3|Phase 2|Adverse Event|0
178986|NCT00913458|568837|P2|Phase 2|Adverse Event|3
178987|NCT00913458|568838|P1|Phase 2|Adverse Event|0
178988|NCT00913458|568832|P7|Phase 2|Subject Request|0
178989|NCT00913458|568833|P6|Phase 2|Subject Request|0
178990|NCT00913458|568834|P5|Phase 2|Subject Request|0
178991|NCT00913458|568835|P4|Phase 2|Subject Request|2
178992|NCT00913458|568836|P3|Phase 2|Subject Request|1
178993|NCT00913458|568837|P2|Phase 2|Subject Request|0
178994|NCT00913458|568838|P1|Phase 2|Subject Request|0
178995|NCT00913458|568832|P7|Phase 2|Non-Responder|0
178996|NCT00913458|568833|P6|Phase 2|Non-Responder|0
178997|NCT00913458|568834|P5|Phase 2|Non-Responder|0
178998|NCT00913458|568835|P4|Phase 2|Non-Responder|12
178999|NCT00913458|568836|P3|Phase 2|Non-Responder|7
179000|NCT00913458|568837|P2|Phase 2|Non-Responder|5
179001|NCT00913458|568838|P1|Phase 2|Non-Responder|0
179002|NCT00913458|568832|P7|Phase 1|Unsatisfactory Response per Investigator|0
179003|NCT00913458|568833|P6|Phase 1|Unsatisfactory Response per Investigator|0
179004|NCT00913458|568834|P5|Phase 1|Unsatisfactory Response per Investigator|0
179005|NCT00913458|568835|P4|Phase 1|Unsatisfactory Response per Investigator|0
179006|NCT00913458|568836|P3|Phase 1|Unsatisfactory Response per Investigator|0
179007|NCT00913458|568837|P2|Phase 1|Unsatisfactory Response per Investigator|0
179008|NCT00913458|568838|P1|Phase 1|Unsatisfactory Response per Investigator|7
179009|NCT00913458|568832|P7|Phase 1|Sponsor|0
179010|NCT00913458|568833|P6|Phase 1|Sponsor|0
179011|NCT00913458|568834|P5|Phase 1|Sponsor|0
179012|NCT00913458|568835|P4|Phase 1|Sponsor|0
179013|NCT00913458|568836|P3|Phase 1|Sponsor|0
179014|NCT00913458|568837|P2|Phase 1|Sponsor|0
179015|NCT00913458|568838|P1|Phase 1|Sponsor|2
179016|NCT00913458|568832|P7|Phase 1|Protocol Violation|0
179017|NCT00913458|568833|P6|Phase 1|Protocol Violation|0
179018|NCT00913458|568834|P5|Phase 1|Protocol Violation|0
179019|NCT00913458|568835|P4|Phase 1|Protocol Violation|0
179020|NCT00913458|568836|P3|Phase 1|Protocol Violation|0
179021|NCT00913458|568837|P2|Phase 1|Protocol Violation|0
179022|NCT00913458|568838|P1|Phase 1|Protocol Violation|10
179023|NCT00913458|568832|P7|Phase 1|Lost to Follow-up|0
179024|NCT00913458|568833|P6|Phase 1|Lost to Follow-up|0
179025|NCT00913458|568834|P5|Phase 1|Lost to Follow-up|0
179026|NCT00913458|568835|P4|Phase 1|Lost to Follow-up|0
179027|NCT00913458|568836|P3|Phase 1|Lost to Follow-up|0
179028|NCT00913458|568837|P2|Phase 1|Lost to Follow-up|0
179029|NCT00913458|568838|P1|Phase 1|Lost to Follow-up|2
179030|NCT00913458|568832|P7|Phase 1|Adverse Event|0
179031|NCT00913458|568833|P6|Phase 1|Adverse Event|0
179032|NCT00913458|568834|P5|Phase 1|Adverse Event|0
179033|NCT00913458|568835|P4|Phase 1|Adverse Event|0
179034|NCT00913458|568836|P3|Phase 1|Adverse Event|0
179035|NCT00913458|568837|P2|Phase 1|Adverse Event|0
179036|NCT00913458|568838|P1|Phase 1|Adverse Event|20
179037|NCT00913458|568832|P7|Phase 1|Subject Request|0
179038|NCT00913458|568833|P6|Phase 1|Subject Request|0
179039|NCT00913458|568834|P5|Phase 1|Subject Request|0
179040|NCT00913458|568835|P4|Phase 1|Subject Request|0
179041|NCT00913458|568836|P3|Phase 1|Subject Request|0
179042|NCT00913458|568837|P2|Phase 1|Subject Request|0
179043|NCT00913458|568838|P1|Phase 1|Subject Request|17
179044|NCT00913458|568832|P7|Phase 1|Non-Responder|0
179045|NCT00913458|568833|P6|Phase 1|Non-Responder|0
179046|NCT00913458|568834|P5|Phase 1|Non-Responder|0
179047|NCT00913458|568835|P4|Phase 1|Non-Responder|0
179048|NCT00913458|568836|P3|Phase 1|Non-Responder|0
179049|NCT00913458|568837|P2|Phase 1|Non-Responder|0
179050|NCT00913458|568838|P1|Phase 1|Non-Responder|54
179051|NCT00913523|568941|P3|Overall Study|Inadequate Number of Tampons Used|3
179052|NCT00913523|568942|P2|Overall Study|Inadequate Number of Tampons Used|2
179053|NCT00913523|568943|P1|Overall Study|Inadequate Number of Tampons Used|7
179054|NCT00913523|568941|P3|Overall Study|Pregnancy|0
179055|NCT00913523|568942|P2|Overall Study|Pregnancy|3
179056|NCT00913523|568943|P1|Overall Study|Pregnancy|1
179057|NCT00913523|568941|P3|Overall Study|Protocol Violation|8
179058|NCT00913523|568942|P2|Overall Study|Protocol Violation|8
179059|NCT00913523|568943|P1|Overall Study|Protocol Violation|5
179060|NCT00913523|568941|P3|Overall Study|Adverse Event|0
179061|NCT00913523|568942|P2|Overall Study|Adverse Event|0
179062|NCT00913523|568943|P1|Overall Study|Adverse Event|1
179063|NCT00913523|568941|P3|Overall Study|Lost to Follow-up|1
179064|NCT00913523|568942|P2|Overall Study|Lost to Follow-up|1
179065|NCT00913523|568943|P1|Overall Study|Lost to Follow-up|1
179066|NCT00913523|568941|P3|Overall Study|Withdrawal by Subject|2
179067|NCT00913523|568942|P2|Overall Study|Withdrawal by Subject|2
179068|NCT00913523|568943|P1|Overall Study|Withdrawal by Subject|3
179069|NCT00913692|568966|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
179070|NCT00913692|568966|P1|Screening (4 Months)|Not eligible after screening phase.|6
179071|NCT00913692|568966|P1|Screening (4 Months)|Physician Decision|3
179072|NCT00913744|568978|P2|Overall Study|Death|0
179073|NCT00913744|568979|P1|Overall Study|Death|1
179074|NCT00913744|568978|P2|Overall Study|Withdrawal by Subject|1
179075|NCT00913744|568979|P1|Overall Study|Withdrawal by Subject|2
179076|NCT00913744|568978|P2|Overall Study|Adverse Event|0
179077|NCT00913744|568979|P1|Overall Study|Adverse Event|2
179078|NCT00913770|568988|P3|Overall Study|Refused|8
179079|NCT00913770|568989|P2|Overall Study|Refused|10
179080|NCT00913770|568990|P1|Overall Study|Refused|11
179081|NCT00913770|568988|P3|Overall Study|Unable to contact|13
179082|NCT00913770|568989|P2|Overall Study|Unable to contact|19
179083|NCT00913770|568990|P1|Overall Study|Unable to contact|24
179084|NCT00913835|569003|P2|Lip Dox: Olaratumab Monotherapy|Not Specified|3
179085|NCT00913835|569004|P1|Lip Dox: Olaratumab Monotherapy|Not Specified|0
179086|NCT00913835|569003|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
179087|NCT00913835|569004|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
179088|NCT00913835|569003|P2|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|3
179089|NCT00913835|569004|P1|Olara+Lip Dox and Lip Dox Monotherapy|Not Specified|4
179090|NCT00913835|569003|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
179091|NCT00913835|569004|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
179092|NCT00913835|569003|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
179093|NCT00913835|569004|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
179094|NCT00914316|569107|P4|Phase 2|Withdrawal by Subject|0
179095|NCT00914316|569108|P3|Phase 2|Withdrawal by Subject|1
179096|NCT00914316|569109|P2|Phase 2|Withdrawal by Subject|0
179097|NCT00914316|569110|P1|Phase 2|Withdrawal by Subject|1
179098|NCT00914316|569107|P4|Phase 1|Adverse Event|0
179099|NCT00914316|569108|P3|Phase 1|Adverse Event|0
179100|NCT00914316|569109|P2|Phase 1|Adverse Event|0
179101|NCT00914316|569110|P1|Phase 1|Adverse Event|1
179102|NCT00914316|569107|P4|Phase 1|Withdrawal by Subject|0
179103|NCT00914316|569108|P3|Phase 1|Withdrawal by Subject|4
179104|NCT00914316|569109|P2|Phase 1|Withdrawal by Subject|2
179105|NCT00914316|569110|P1|Phase 1|Withdrawal by Subject|0
179106|NCT00914316|569107|P4|Phase 1|Physician Decision|2
179107|NCT00914316|569108|P3|Phase 1|Physician Decision|1
179108|NCT00914316|569109|P2|Phase 1|Physician Decision|0
179109|NCT00914316|569110|P1|Phase 1|Physician Decision|4
179110|NCT00914459|569126|P2|Overall Study|Parent/Legal guardian request|0
179111|NCT00914459|569127|P1|Overall Study|Parent/Legal guardian request|1
179112|NCT00914459|569126|P2|Overall Study|Protocol Violation|1
179113|NCT00914459|569127|P1|Overall Study|Protocol Violation|0
179114|NCT00914589|569160|P3|Overall Study|Death|1
179115|NCT00914589|569161|P2|Overall Study|Death|1
179116|NCT00914589|569162|P1|Overall Study|Death|0
179117|NCT00914589|569160|P3|Overall Study|unclassified|7
179118|NCT00914589|569161|P2|Overall Study|unclassified|9
179119|NCT00914589|569162|P1|Overall Study|unclassified|16
179120|NCT00914589|569160|P3|Overall Study|Protocol Violation|3
179121|NCT00914589|569161|P2|Overall Study|Protocol Violation|6
179122|NCT00914589|569162|P1|Overall Study|Protocol Violation|8
179123|NCT00914589|569160|P3|Overall Study|Adverse Event|1
179124|NCT00914589|569161|P2|Overall Study|Adverse Event|0
179125|NCT00914589|569162|P1|Overall Study|Adverse Event|1
179126|NCT00914810|569184|P2|Overall Study|Hospitalized and unable to follow up.|1
179127|NCT00914810|569185|P1|Overall Study|Hospitalized and unable to follow up.|0
179128|NCT00914810|569184|P2|Overall Study|Relocated out of state|0
179129|NCT00914810|569185|P1|Overall Study|Relocated out of state|1
179130|NCT00914810|569184|P2|Overall Study|Withdrawal by Subject|0
179131|NCT00914810|569185|P1|Overall Study|Withdrawal by Subject|1
179132|NCT00914849|569195|P2|Overall Study|Not eligible|1
179133|NCT00914849|569196|P1|Overall Study|Not eligible|0
179134|NCT00914849|569195|P2|Overall Study|Withdrawal by Subject|0
179135|NCT00914849|569196|P1|Overall Study|Withdrawal by Subject|1
179136|NCT00914966|569309|P1|Step 2: 2000 Units|Withdrawal by Subject|1
179137|NCT00914966|569309|P1|Step 1: 1500 Units|Physician Decision|1
179138|NCT00914966|569309|P1|Step 1: 1500 Units|Withdrawal by Subject|1
179139|NCT00915278|569332|P6|Overall Study|Admission to hospice|0
179140|NCT00915278|569333|P5|Overall Study|Admission to hospice|0
179141|NCT00915278|569334|P4|Overall Study|Admission to hospice|0
179142|NCT00915278|569335|P3|Overall Study|Admission to hospice|1
179143|NCT00915278|569336|P2|Overall Study|Admission to hospice|0
179144|NCT00915278|569337|P1|Overall Study|Admission to hospice|0
179145|NCT00915278|569332|P6|Overall Study|Infusion related AEs|2
179146|NCT00915278|569333|P5|Overall Study|Infusion related AEs|0
179147|NCT00915278|569334|P4|Overall Study|Infusion related AEs|0
179148|NCT00915278|569335|P3|Overall Study|Infusion related AEs|0
179149|NCT00915278|569336|P2|Overall Study|Infusion related AEs|0
179150|NCT00915278|569337|P1|Overall Study|Infusion related AEs|0
179151|NCT00915278|569332|P6|Overall Study|Progressive disease/clinical progression|2
179152|NCT00915278|569333|P5|Overall Study|Progressive disease/clinical progression|1
179153|NCT00915278|569334|P4|Overall Study|Progressive disease/clinical progression|3
179154|NCT00915278|569335|P3|Overall Study|Progressive disease/clinical progression|0
179155|NCT00915278|569336|P2|Overall Study|Progressive disease/clinical progression|0
179156|NCT00915278|569337|P1|Overall Study|Progressive disease/clinical progression|0
179157|NCT00915278|569332|P6|Overall Study|Adverse Event|0
179158|NCT00915278|569333|P5|Overall Study|Adverse Event|0
179159|NCT00915278|569334|P4|Overall Study|Adverse Event|0
179160|NCT00915278|569335|P3|Overall Study|Adverse Event|0
179161|NCT00915278|569336|P2|Overall Study|Adverse Event|1
179162|NCT00915278|569337|P1|Overall Study|Adverse Event|4
179163|NCT00915278|569332|P6|Overall Study|Withdrawal by Subject|4
179164|NCT00915278|569333|P5|Overall Study|Withdrawal by Subject|1
179165|NCT00915278|569334|P4|Overall Study|Withdrawal by Subject|0
179166|NCT00915278|569335|P3|Overall Study|Withdrawal by Subject|0
179167|NCT00915278|569336|P2|Overall Study|Withdrawal by Subject|1
179168|NCT00915278|569337|P1|Overall Study|Withdrawal by Subject|0
179169|NCT00915278|569332|P6|Overall Study|Lost to Follow-up|0
179170|NCT00915278|569333|P5|Overall Study|Lost to Follow-up|0
179171|NCT00915278|569334|P4|Overall Study|Lost to Follow-up|0
179172|NCT00915278|569335|P3|Overall Study|Lost to Follow-up|0
179173|NCT00915278|569336|P2|Overall Study|Lost to Follow-up|1
179174|NCT00915278|569337|P1|Overall Study|Lost to Follow-up|0
179175|NCT00915278|569332|P6|Overall Study|Death|0
179176|NCT00915278|569333|P5|Overall Study|Death|0
179177|NCT00915278|569334|P4|Overall Study|Death|0
179178|NCT00915278|569335|P3|Overall Study|Death|0
179179|NCT00915278|569336|P2|Overall Study|Death|0
179180|NCT00915278|569337|P1|Overall Study|Death|1
179181|NCT00915343|569483|P3|Part B - Open Label Period|Did not attend the last visit|1
179182|NCT00915343|569484|P2|Part B - Open Label Period|Did not attend the last visit|0
179183|NCT00915343|569485|P1|Part B - Open Label Period|Did not attend the last visit|0
179184|NCT00915343|569483|P3|Part B - Open Label Period|Treatment switch|1
179185|NCT00915343|569484|P2|Part B - Open Label Period|Treatment switch|0
179186|NCT00915343|569485|P1|Part B - Open Label Period|Treatment switch|0
179187|NCT00915356|569569|P5|Overall Study|Withdrawal by Subject|0
179188|NCT00915356|569570|P4|Overall Study|Withdrawal by Subject|0
179189|NCT00915356|569571|P3|Overall Study|Withdrawal by Subject|0
179190|NCT00915356|569572|P2|Overall Study|Withdrawal by Subject|0
179191|NCT00915356|569573|P1|Overall Study|Withdrawal by Subject|1
179192|NCT00905567|569661|P2|Washout|Withdrawal by Subject|1
179193|NCT00905567|569662|P1|Washout|Withdrawal by Subject|0
179194|NCT00905606|569687|P2|Washout|Withdrawal by Subject|0
179195|NCT00905606|569688|P1|Washout|Withdrawal by Subject|1
179196|NCT00905606|569687|P2|Period 1|Adverse Event|1
179197|NCT00905606|569688|P1|Period 1|Adverse Event|0
179198|NCT00905632|569703|P7|Overall Study|Adverse Event|4
179199|NCT00905632|569704|P6|Overall Study|Adverse Event|1
179200|NCT00905632|569705|P5|Overall Study|Adverse Event|0
179201|NCT00905632|569706|P4|Overall Study|Adverse Event|0
179202|NCT00905632|569707|P3|Overall Study|Adverse Event|0
179203|NCT00905632|569708|P2|Overall Study|Adverse Event|0
179204|NCT00905632|569709|P1|Overall Study|Adverse Event|0
179205|NCT00905840|569860|P1|Overall Study|Adverse Event|1
179206|NCT00905840|569860|P1|Overall Study|Withdrawal by Subject|1
179207|NCT00905840|569860|P1|Overall Study|Death|3
179208|NCT00905840|569860|P1|Overall Study|Lost to Follow-up|11
179209|NCT00906087|569896|P1|Initial Washout|Physician Decision|1
179210|NCT00906087|569896|P1|Initial Washout|Withdrawal by Subject|1
179211|NCT00906204|569920|P2|Secondary Endpoints (Long-term Safety)|Death|1
179212|NCT00906204|569921|P1|Secondary Endpoints (Long-term Safety)|Death|0
179213|NCT00906204|569920|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
179214|NCT00906204|569921|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
179215|NCT00906204|569920|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
179216|NCT00906204|569921|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
179217|NCT00906204|569920|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
179218|NCT00906204|569921|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
179219|NCT00906204|569920|P2|Primary Endpoint (Early Safety)|Physician Decision|0
179220|NCT00906204|569921|P1|Primary Endpoint (Early Safety)|Physician Decision|1
179221|NCT00906282|569941|P1|Preoperative Chemotherapy|Toxicity|1
179222|NCT00906282|569941|P1|Preoperative Chemotherapy|Progressive disease|6
179223|NCT00906282|569941|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
179224|NCT00906282|569941|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
179225|NCT00906347|569951|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
179226|NCT00906347|569952|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
179227|NCT00906347|569951|P2|Received Study Drug|Refused study drug|0
179228|NCT00906347|569952|P1|Received Study Drug|Refused study drug|1
179229|NCT00906347|569951|P2|Received Study Drug|Nonreassuring fetal heart rate|1
179230|NCT00906347|569952|P1|Received Study Drug|Nonreassuring fetal heart rate|13
179231|NCT00906347|569951|P2|Received Study Drug|8 cm prior to initiation of study drug|30
179232|NCT00906347|569952|P1|Received Study Drug|8 cm prior to initiation of study drug|18
179233|NCT00906399|569975|P7|Year 2|Not specified|0
179234|NCT00906399|569976|P6|Year 2|Not specified|1
179235|NCT00906399|569977|P5|Year 2|Not specified|3
179236|NCT00906399|569978|P4|Year 2|Not specified|2
179237|NCT00906399|569979|P3|Year 2|Not specified|0
179238|NCT00906399|569980|P2|Year 2|Not specified|0
179239|NCT00906399|569981|P1|Year 2|Not specified|0
179240|NCT00906399|569975|P7|Year 2|Death|3
179241|NCT00906399|569976|P6|Year 2|Death|0
179242|NCT00906399|569977|P5|Year 2|Death|0
179243|NCT00906399|569978|P4|Year 2|Death|1
179244|NCT00906399|569979|P3|Year 2|Death|0
179245|NCT00906399|569980|P2|Year 2|Death|0
179246|NCT00906399|569981|P1|Year 2|Death|0
179247|NCT00906399|569975|P7|Year 2|Physician Decision|3
179248|NCT00906399|569976|P6|Year 2|Physician Decision|6
179249|NCT00906399|569977|P5|Year 2|Physician Decision|2
179250|NCT00906399|569978|P4|Year 2|Physician Decision|0
179251|NCT00906399|569979|P3|Year 2|Physician Decision|0
179252|NCT00906399|569980|P2|Year 2|Physician Decision|0
179253|NCT00906399|569981|P1|Year 2|Physician Decision|0
179254|NCT00906399|569975|P7|Year 2|Withdrawal by Subject|13
179255|NCT00906399|569976|P6|Year 2|Withdrawal by Subject|27
179256|NCT00906399|569977|P5|Year 2|Withdrawal by Subject|18
179257|NCT00906399|569978|P4|Year 2|Withdrawal by Subject|17
179258|NCT00906399|569979|P3|Year 2|Withdrawal by Subject|0
179259|NCT00906399|569980|P2|Year 2|Withdrawal by Subject|0
179260|NCT00906399|569981|P1|Year 2|Withdrawal by Subject|0
179261|NCT00906399|569975|P7|Year 2|Lost to Follow-up|4
179262|NCT00906399|569976|P6|Year 2|Lost to Follow-up|2
179263|NCT00906399|569977|P5|Year 2|Lost to Follow-up|4
179264|NCT00906399|569978|P4|Year 2|Lost to Follow-up|1
179265|NCT00906399|569979|P3|Year 2|Lost to Follow-up|0
179266|NCT00906399|569980|P2|Year 2|Lost to Follow-up|0
179267|NCT00906399|569981|P1|Year 2|Lost to Follow-up|0
179268|NCT00906399|569975|P7|Year 2|Adverse Event|6
179269|NCT00906399|569976|P6|Year 2|Adverse Event|11
179270|NCT00906399|569977|P5|Year 2|Adverse Event|8
179271|NCT00906399|569978|P4|Year 2|Adverse Event|9
179272|NCT00906399|569979|P3|Year 2|Adverse Event|0
179273|NCT00906399|569980|P2|Year 2|Adverse Event|0
179274|NCT00906399|569981|P1|Year 2|Adverse Event|0
179275|NCT00906399|569975|P7|Year 1|Not specified|0
179276|NCT00906399|569976|P6|Year 1|Not specified|0
179277|NCT00906399|569977|P5|Year 1|Not specified|0
179278|NCT00906399|569978|P4|Year 1|Not specified|0
179279|NCT00906399|569979|P3|Year 1|Not specified|7
179280|NCT00906399|569980|P2|Year 1|Not specified|2
179281|NCT00906399|569981|P1|Year 1|Not specified|4
179282|NCT00906399|569975|P7|Year 1|Death|0
179283|NCT00906399|569976|P6|Year 1|Death|0
179284|NCT00906399|569977|P5|Year 1|Death|0
179285|NCT00906399|569978|P4|Year 1|Death|0
179286|NCT00906399|569979|P3|Year 1|Death|1
179287|NCT00906399|569980|P2|Year 1|Death|1
179288|NCT00906399|569981|P1|Year 1|Death|2
179289|NCT00906399|569975|P7|Year 1|Physician Decision|0
179290|NCT00906399|569976|P6|Year 1|Physician Decision|0
179291|NCT00906399|569977|P5|Year 1|Physician Decision|0
179292|NCT00906399|569978|P4|Year 1|Physician Decision|0
179293|NCT00906399|569979|P3|Year 1|Physician Decision|3
179294|NCT00906399|569980|P2|Year 1|Physician Decision|1
179295|NCT00906399|569981|P1|Year 1|Physician Decision|0
179296|NCT00906399|569975|P7|Year 1|Withdrawal by Subject|0
179297|NCT00906399|569976|P6|Year 1|Withdrawal by Subject|0
179298|NCT00906399|569977|P5|Year 1|Withdrawal by Subject|0
179299|NCT00906399|569978|P4|Year 1|Withdrawal by Subject|0
179300|NCT00906399|569979|P3|Year 1|Withdrawal by Subject|36
179301|NCT00906399|569980|P2|Year 1|Withdrawal by Subject|32
179302|NCT00906399|569981|P1|Year 1|Withdrawal by Subject|30
179303|NCT00906399|569975|P7|Year 1|Lost to Follow-up|0
179304|NCT00906399|569976|P6|Year 1|Lost to Follow-up|0
179305|NCT00906399|569977|P5|Year 1|Lost to Follow-up|0
179306|NCT00906399|569978|P4|Year 1|Lost to Follow-up|0
179307|NCT00906399|569979|P3|Year 1|Lost to Follow-up|2
179308|NCT00906399|569980|P2|Year 1|Lost to Follow-up|4
179309|NCT00906399|569981|P1|Year 1|Lost to Follow-up|4
179310|NCT00906399|569975|P7|Year 1|Adverse Event|0
179311|NCT00906399|569976|P6|Year 1|Adverse Event|0
179312|NCT00906399|569977|P5|Year 1|Adverse Event|0
179313|NCT00906399|569978|P4|Year 1|Adverse Event|0
179314|NCT00906399|569979|P3|Year 1|Adverse Event|24
179315|NCT00906399|569980|P2|Year 1|Adverse Event|22
179316|NCT00906399|569981|P1|Year 1|Adverse Event|4
179317|NCT00906399|569975|P7|Year 1|Randomized But Not Treated|0
179318|NCT00906399|569976|P6|Year 1|Randomized But Not Treated|0
179319|NCT00906399|569977|P5|Year 1|Randomized But Not Treated|0
179320|NCT00906399|569978|P4|Year 1|Randomized But Not Treated|0
179321|NCT00906399|569979|P3|Year 1|Randomized But Not Treated|3
179322|NCT00906399|569980|P2|Year 1|Randomized But Not Treated|1
179323|NCT00906399|569981|P1|Year 1|Randomized But Not Treated|0
179324|NCT00906698|570025|P6|Overall Study|incl. non compliance, lost to follow-up|0
179325|NCT00906698|570026|P5|Overall Study|incl. non compliance, lost to follow-up|0
179326|NCT00906698|570027|P4|Overall Study|incl. non compliance, lost to follow-up|0
179327|NCT00906698|570028|P3|Overall Study|incl. non compliance, lost to follow-up|0
179328|NCT00906698|570029|P2|Overall Study|incl. non compliance, lost to follow-up|1
179329|NCT00906698|570030|P1|Overall Study|incl. non compliance, lost to follow-up|0
179330|NCT00906698|570025|P6|Overall Study|Withdrawal by Subject|0
179331|NCT00906698|570026|P5|Overall Study|Withdrawal by Subject|1
179332|NCT00906698|570027|P4|Overall Study|Withdrawal by Subject|0
179333|NCT00906698|570028|P3|Overall Study|Withdrawal by Subject|0
179334|NCT00906698|570029|P2|Overall Study|Withdrawal by Subject|0
179335|NCT00906698|570030|P1|Overall Study|Withdrawal by Subject|0
179336|NCT00906698|570025|P6|Overall Study|Disease progression|4
179337|NCT00906698|570026|P5|Overall Study|Disease progression|12
179338|NCT00906698|570027|P4|Overall Study|Disease progression|4
179339|NCT00906698|570028|P3|Overall Study|Disease progression|4
179340|NCT00906698|570029|P2|Overall Study|Disease progression|12
179341|NCT00906698|570030|P1|Overall Study|Disease progression|3
179342|NCT00906698|570025|P6|Overall Study|Adverse Event|1
179343|NCT00906698|570026|P5|Overall Study|Adverse Event|4
179344|NCT00906698|570027|P4|Overall Study|Adverse Event|0
179345|NCT00906698|570028|P3|Overall Study|Adverse Event|2
179346|NCT00906698|570029|P2|Overall Study|Adverse Event|0
179347|NCT00906698|570030|P1|Overall Study|Adverse Event|0
179348|NCT00906698|570025|P6|Overall Study|Dose-limiting toxicity (DLT)|0
179349|NCT00906698|570026|P5|Overall Study|Dose-limiting toxicity (DLT)|1
179350|NCT00906698|570027|P4|Overall Study|Dose-limiting toxicity (DLT)|0
179351|NCT00906698|570028|P3|Overall Study|Dose-limiting toxicity (DLT)|0
179352|NCT00906698|570029|P2|Overall Study|Dose-limiting toxicity (DLT)|6
179353|NCT00906698|570030|P1|Overall Study|Dose-limiting toxicity (DLT)|0
179354|NCT00906945|570144|P6|Overall Study|Physician Decision|1
179355|NCT00906945|570145|P5|Overall Study|Physician Decision|0
179356|NCT00906945|570146|P4|Overall Study|Physician Decision|0
179357|NCT00906945|570147|P3|Overall Study|Physician Decision|0
179358|NCT00906945|570148|P2|Overall Study|Physician Decision|0
179359|NCT00906945|570149|P1|Overall Study|Physician Decision|0
179360|NCT00906945|570144|P6|Overall Study|Found to be not eligible|1
179361|NCT00906945|570145|P5|Overall Study|Found to be not eligible|1
179362|NCT00906945|570146|P4|Overall Study|Found to be not eligible|1
179363|NCT00906945|570147|P3|Overall Study|Found to be not eligible|0
179364|NCT00906945|570148|P2|Overall Study|Found to be not eligible|0
179365|NCT00906945|570149|P1|Overall Study|Found to be not eligible|0
179366|NCT00906971|570178|P2|Overall Study|Lost to Follow-up|1
179367|NCT00906971|570179|P1|Overall Study|Lost to Follow-up|0
179368|NCT00906971|570178|P2|Overall Study|Withdrawal by Subject|2
179369|NCT00906971|570179|P1|Overall Study|Withdrawal by Subject|8
179370|NCT00907257|570210|P2|Overall Study|Personal Reasons|1
179371|NCT00907257|570211|P1|Overall Study|Personal Reasons|6
179372|NCT00907257|570210|P2|Overall Study|Moved|0
179373|NCT00907257|570211|P1|Overall Study|Moved|1
179374|NCT00907257|570210|P2|Overall Study|Per IRB-Subject became vulnerable|0
179375|NCT00907257|570211|P1|Overall Study|Per IRB-Subject became vulnerable|1
179376|NCT00907257|570210|P2|Overall Study|Withdrawal by Subject|2
179377|NCT00907257|570211|P1|Overall Study|Withdrawal by Subject|1
179378|NCT00907257|570210|P2|Overall Study|Lost to Follow-up|3
179379|NCT00907257|570211|P1|Overall Study|Lost to Follow-up|3
179380|NCT00907257|570210|P2|Overall Study|Protocol Violation|2
179381|NCT00907257|570211|P1|Overall Study|Protocol Violation|1
179382|NCT00907257|570210|P2|Overall Study|Adverse Event|4
179383|NCT00907257|570211|P1|Overall Study|Adverse Event|0
179384|NCT00907335|570223|P2|Overall Study|Lost to Follow-up|0
179385|NCT00907335|570224|P1|Overall Study|Lost to Follow-up|2
179386|NCT00907335|570223|P2|Overall Study|Adverse Event|1
179387|NCT00907335|570224|P1|Overall Study|Adverse Event|4
179388|NCT00907335|570223|P2|Overall Study|Withdrawal by Subject|0
179389|NCT00907335|570224|P1|Overall Study|Withdrawal by Subject|2
179390|NCT00907374|570242|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
179391|NCT00907374|570243|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
179392|NCT00907478|570278|P3|Overall Study|Other|1
179393|NCT00907478|570279|P2|Overall Study|Other|0
179394|NCT00907478|570280|P1|Overall Study|Other|3
179395|NCT00907478|570278|P3|Overall Study|Lost to Follow-up|0
179396|NCT00907478|570279|P2|Overall Study|Lost to Follow-up|0
179397|NCT00907478|570280|P1|Overall Study|Lost to Follow-up|1
179398|NCT00907478|570278|P3|Overall Study|Pregnancy|1
179399|NCT00907478|570279|P2|Overall Study|Pregnancy|1
179400|NCT00907478|570280|P1|Overall Study|Pregnancy|0
179401|NCT00907478|570278|P3|Overall Study|Protocol-specified criteria|3
179402|NCT00907478|570279|P2|Overall Study|Protocol-specified criteria|2
179403|NCT00907478|570280|P1|Overall Study|Protocol-specified criteria|5
179404|NCT00907478|570278|P3|Overall Study|Death|1
179405|NCT00907478|570279|P2|Overall Study|Death|2
179406|NCT00907478|570280|P1|Overall Study|Death|4
179407|NCT00907478|570278|P3|Overall Study|Physician Decision|3
179408|NCT00907478|570279|P2|Overall Study|Physician Decision|0
179409|NCT00907478|570280|P1|Overall Study|Physician Decision|2
179410|NCT00907478|570278|P3|Overall Study|Requirement for alternative therapy|3
179411|NCT00907478|570279|P2|Overall Study|Requirement for alternative therapy|2
179412|NCT00907478|570280|P1|Overall Study|Requirement for alternative therapy|1
179413|NCT00907478|570278|P3|Overall Study|Withdrawal by Subject|6
179414|NCT00907478|570279|P2|Overall Study|Withdrawal by Subject|9
179415|NCT00907478|570280|P1|Overall Study|Withdrawal by Subject|8
179416|NCT00907478|570278|P3|Overall Study|Adverse Event|2
179417|NCT00907478|570279|P2|Overall Study|Adverse Event|1
179418|NCT00907478|570280|P1|Overall Study|Adverse Event|3
179419|NCT00907478|570278|P3|Overall Study|Noncompliance|1
179420|NCT00907478|570279|P2|Overall Study|Noncompliance|0
179421|NCT00907478|570280|P1|Overall Study|Noncompliance|0
179422|NCT00907478|570278|P3|Overall Study|Ineligibility determined|1
179423|NCT00907478|570279|P2|Overall Study|Ineligibility determined|0
179424|NCT00907478|570280|P1|Overall Study|Ineligibility determined|0
179425|NCT00915473|570310|P2|4-week Follow Up|Lost to Follow-up|5
179426|NCT00915473|570311|P1|4-week Follow Up|Lost to Follow-up|1
179427|NCT00915473|570310|P2|Screening|Withdrawal by Subject|0
179428|NCT00915473|570311|P1|Screening|Withdrawal by Subject|1
179429|NCT00915525|570336|P2|Overall Study|Patient Moved|9
179430|NCT00915525|570337|P1|Overall Study|Patient Moved|15
179431|NCT00915525|570336|P2|Overall Study|Non-Compliance|1
179432|NCT00915525|570337|P1|Overall Study|Non-Compliance|3
179433|NCT00915525|570336|P2|Overall Study|Study Burden|12
179434|NCT00915525|570337|P1|Overall Study|Study Burden|28
179435|NCT00915525|570336|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
179436|NCT00915525|570337|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
179437|NCT00915525|570336|P2|Overall Study|Site Closed|9
179438|NCT00915525|570337|P1|Overall Study|Site Closed|27
179439|NCT00915525|570336|P2|Overall Study|Other Reason|12
179440|NCT00915525|570337|P1|Overall Study|Other Reason|35
179441|NCT00915525|570336|P2|Overall Study|Missing|1
179442|NCT00915525|570337|P1|Overall Study|Missing|12
179443|NCT00915525|570336|P2|Overall Study|Adverse Event|13
179444|NCT00915525|570337|P1|Overall Study|Adverse Event|29
179445|NCT00915525|570336|P2|Overall Study|Lack of Efficacy|32
179446|NCT00915525|570337|P1|Overall Study|Lack of Efficacy|15
179447|NCT00915525|570336|P2|Overall Study|Pregnancy|0
179448|NCT00915525|570337|P1|Overall Study|Pregnancy|2
179449|NCT00915525|570336|P2|Overall Study|Lost to Follow-up|16
179450|NCT00915525|570337|P1|Overall Study|Lost to Follow-up|27
179451|NCT00915525|570336|P2|Overall Study|Withdrawal by Subject|21
179452|NCT00915525|570337|P1|Overall Study|Withdrawal by Subject|59
179453|NCT00915525|570336|P2|Overall Study|Protocol Violation|4
179454|NCT00915525|570337|P1|Overall Study|Protocol Violation|9
179455|NCT00915551|570440|P2|Overall Study|Withdrawal by Subject|1
179456|NCT00915551|570441|P1|Overall Study|Withdrawal by Subject|0
179457|NCT00915772|570504|P3|Overall Study|Any other reason|7
179458|NCT00915772|570505|P2|Overall Study|Any other reason|7
179459|NCT00915772|570506|P1|Overall Study|Any other reason|4
179460|NCT00915772|570504|P3|Overall Study|Refused to continue trial medication|4
179461|NCT00915772|570505|P2|Overall Study|Refused to continue trial medication|8
179462|NCT00915772|570506|P1|Overall Study|Refused to continue trial medication|6
179463|NCT00915772|570504|P3|Overall Study|Lack of Efficacy|3
179464|NCT00915772|570505|P2|Overall Study|Lack of Efficacy|15
179465|NCT00915772|570506|P1|Overall Study|Lack of Efficacy|9
179466|NCT00915772|570504|P3|Overall Study|Lost to Follow-up|2
179467|NCT00915772|570505|P2|Overall Study|Lost to Follow-up|2
179468|NCT00915772|570506|P1|Overall Study|Lost to Follow-up|1
179469|NCT00915772|570504|P3|Overall Study|Protocol Violation|2
179470|NCT00915772|570505|P2|Overall Study|Protocol Violation|1
179471|NCT00915772|570506|P1|Overall Study|Protocol Violation|4
179472|NCT00915772|570504|P3|Overall Study|Adverse Event|11
179473|NCT00915772|570505|P2|Overall Study|Adverse Event|13
179474|NCT00915772|570506|P1|Overall Study|Adverse Event|12
179475|NCT00918346|570578|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
179476|NCT00918346|570579|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
179477|NCT00918385|570595|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
179478|NCT00918385|570596|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
179479|NCT00918385|570595|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
179480|NCT00918385|570596|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
179481|NCT00918385|570595|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
179482|NCT00918385|570596|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
179483|NCT00918385|570595|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
179484|NCT00918385|570596|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
179485|NCT00918385|570595|P2|Monotherapy|Complicating illness|0
179486|NCT00918385|570596|P1|Monotherapy|Complicating illness|1
179487|NCT00918385|570595|P2|Monotherapy|Adverse Event|6
179488|NCT00918385|570596|P1|Monotherapy|Adverse Event|1
179489|NCT00918580|570605|P1|After 6-month FU to 1-year FU|Failed to Return|2
179490|NCT00918580|570605|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
179491|NCT00918580|570605|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
179492|NCT00918580|570605|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
179493|NCT00918580|570605|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
179494|NCT00918580|570605|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
179495|NCT00918580|570605|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
179496|NCT00918684|570628|P1|Treatment Phase|Withdrawal by Subject|8
179497|NCT00918684|570628|P1|Treatment Phase|Protocol Violation|1
179498|NCT00918684|570628|P1|Treatment Phase|Physician Decision|8
179499|NCT00918684|570628|P1|Treatment Phase|Lost to Follow-up|2
179500|NCT00918684|570628|P1|Treatment Phase|Lack of Efficacy|6
179501|NCT00918684|570628|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
179502|NCT00918736|570634|P1|Overall Study|Withdrawal by Subject|4
179503|NCT00918749|570641|P3|Overall Study|No Study Medication Taken|0
179504|NCT00918749|570642|P2|Overall Study|No Study Medication Taken|0
179505|NCT00918749|570643|P1|Overall Study|No Study Medication Taken|1
179506|NCT00918749|570641|P3|Overall Study|Withdrawal by Subject|5
179507|NCT00918749|570642|P2|Overall Study|Withdrawal by Subject|3
179508|NCT00918749|570643|P1|Overall Study|Withdrawal by Subject|5
179509|NCT00918749|570641|P3|Overall Study|Lost to Follow-up|1
179510|NCT00918749|570642|P2|Overall Study|Lost to Follow-up|0
179511|NCT00918749|570643|P1|Overall Study|Lost to Follow-up|0
179512|NCT00918749|570641|P3|Overall Study|Adverse Event|1
179513|NCT00918749|570642|P2|Overall Study|Adverse Event|0
179514|NCT00918749|570643|P1|Overall Study|Adverse Event|1
179515|NCT00918879|570694|P2|Overall Study|Severe non-compliance to protocol|1
179516|NCT00918879|570695|P1|Overall Study|Severe non-compliance to protocol|1
179517|NCT00918879|570694|P2|Overall Study|Lost to Follow-up|1
179518|NCT00918879|570695|P1|Overall Study|Lost to Follow-up|1
179519|NCT00918879|570694|P2|Overall Study|Withdrawal by Subject|4
179520|NCT00918879|570695|P1|Overall Study|Withdrawal by Subject|4
179521|NCT00918957|570713|P2|Overall Study|Withdrawal by Subject|0
179522|NCT00918957|570714|P1|Overall Study|Withdrawal by Subject|1
179523|NCT00918957|570713|P2|Overall Study|Adverse Event|0
179524|NCT00918957|570714|P1|Overall Study|Adverse Event|2
179525|NCT00919061|570747|P1|Overall Study|Withdrawal by Subject|1
179526|NCT00919061|570747|P1|Overall Study|Adverse Event|1
179527|NCT00919633|570823|P4|Overall Study|Viral rebound outside protocol timepoint|0
179528|NCT00919633|570824|P3|Overall Study|Viral rebound outside protocol timepoint|1
179529|NCT00919633|570825|P2|Overall Study|Viral rebound outside protocol timepoint|0
179530|NCT00919633|570826|P1|Overall Study|Viral rebound outside protocol timepoint|0
179531|NCT00919633|570823|P4|Overall Study|Request of withdrawal w/o future contact|0
179532|NCT00919633|570824|P3|Overall Study|Request of withdrawal w/o future contact|1
179533|NCT00919633|570825|P2|Overall Study|Request of withdrawal w/o future contact|0
179534|NCT00919633|570826|P1|Overall Study|Request of withdrawal w/o future contact|0
179535|NCT00919633|570823|P4|Overall Study|Physician Decision|1
179536|NCT00919633|570824|P3|Overall Study|Physician Decision|0
179537|NCT00919633|570825|P2|Overall Study|Physician Decision|0
179538|NCT00919633|570826|P1|Overall Study|Physician Decision|0
179539|NCT00919633|570823|P4|Overall Study|Protocol Violation|1
179540|NCT00919633|570824|P3|Overall Study|Protocol Violation|0
179541|NCT00919633|570825|P2|Overall Study|Protocol Violation|0
179542|NCT00919633|570826|P1|Overall Study|Protocol Violation|0
179543|NCT00919633|570823|P4|Overall Study|Withdraw consent post transition to SOC|1
179544|NCT00919633|570824|P3|Overall Study|Withdraw consent post transition to SOC|1
179545|NCT00919633|570825|P2|Overall Study|Withdraw consent post transition to SOC|0
179546|NCT00919633|570826|P1|Overall Study|Withdraw consent post transition to SOC|0
179547|NCT00919633|570823|P4|Overall Study|Lost to Follow-up|2
179548|NCT00919633|570824|P3|Overall Study|Lost to Follow-up|0
179549|NCT00919633|570825|P2|Overall Study|Lost to Follow-up|1
179550|NCT00919633|570826|P1|Overall Study|Lost to Follow-up|3
179551|NCT00919633|570823|P4|Overall Study|Withdrawal by Subject|3
179552|NCT00919633|570824|P3|Overall Study|Withdrawal by Subject|4
179553|NCT00919633|570825|P2|Overall Study|Withdrawal by Subject|2
179554|NCT00919633|570826|P1|Overall Study|Withdrawal by Subject|1
179555|NCT00919633|570823|P4|Overall Study|Lack of Efficacy|3
179556|NCT00919633|570824|P3|Overall Study|Lack of Efficacy|2
179557|NCT00919633|570825|P2|Overall Study|Lack of Efficacy|3
179558|NCT00919633|570826|P1|Overall Study|Lack of Efficacy|17
179559|NCT00919633|570823|P4|Overall Study|Death|0
179560|NCT00919633|570824|P3|Overall Study|Death|2
179561|NCT00919633|570825|P2|Overall Study|Death|0
179562|NCT00919633|570826|P1|Overall Study|Death|0
179563|NCT00919633|570823|P4|Overall Study|Adverse Event|10
179564|NCT00919633|570824|P3|Overall Study|Adverse Event|12
179565|NCT00919633|570825|P2|Overall Study|Adverse Event|9
179566|NCT00919633|570826|P1|Overall Study|Adverse Event|1
179567|NCT00919711|570846|P2|Overall Study|Noncompliance|0
179568|NCT00919711|570847|P1|Overall Study|Noncompliance|1
179569|NCT00919711|570846|P2|Overall Study|Death|0
179570|NCT00919711|570847|P1|Overall Study|Death|1
179571|NCT00919711|570846|P2|Overall Study|Lost to Follow-up|0
179572|NCT00919711|570847|P1|Overall Study|Lost to Follow-up|2
179573|NCT00919711|570846|P2|Overall Study|Administrative Decision|1
179574|NCT00919711|570847|P1|Overall Study|Administrative Decision|0
179575|NCT00919711|570846|P2|Overall Study|Other|2
179576|NCT00919711|570847|P1|Overall Study|Other|1
179577|NCT00919711|570846|P2|Overall Study|Adverse Event|3
179578|NCT00919711|570847|P1|Overall Study|Adverse Event|13
179579|NCT00919711|570846|P2|Overall Study|Withdrawal by Subject|7
179580|NCT00919711|570847|P1|Overall Study|Withdrawal by Subject|15
179581|NCT00919854|570886|P1|Overall Study|Adverse Event|1
179582|NCT00919867|570901|P6|First Intervention|Physician Decision|1
179583|NCT00919867|570902|P5|First Intervention|Physician Decision|0
179584|NCT00919867|570903|P4|First Intervention|Physician Decision|0
179585|NCT00919867|570904|P3|First Intervention|Physician Decision|0
179586|NCT00919867|570905|P2|First Intervention|Physician Decision|0
179587|NCT00919867|570906|P1|First Intervention|Physician Decision|0
179588|NCT00919867|570901|P6|First Intervention|Withdrawal by Subject|0
179589|NCT00919867|570902|P5|First Intervention|Withdrawal by Subject|0
179590|NCT00919867|570903|P4|First Intervention|Withdrawal by Subject|0
179591|NCT00919867|570904|P3|First Intervention|Withdrawal by Subject|1
179592|NCT00919867|570905|P2|First Intervention|Withdrawal by Subject|0
179593|NCT00919867|570906|P1|First Intervention|Withdrawal by Subject|0
179594|NCT00919893|570929|P2|Overall Study|Protocol Violation|9
179595|NCT00919893|570930|P1|Overall Study|Protocol Violation|19
179596|NCT00920140|570963|P5|Phase 2|Withdrawal by Subject|1
179597|NCT00920140|570964|P4|Phase 2|Withdrawal by Subject|2
179598|NCT00920140|570965|P3|Phase 2|Withdrawal by Subject|4
179599|NCT00920140|570966|P2|Phase 2|Withdrawal by Subject|0
179600|NCT00920140|570967|P1|Phase 2|Withdrawal by Subject|0
179601|NCT00920140|570963|P5|Phase 2|Physician Decision|2
179602|NCT00920140|570964|P4|Phase 2|Physician Decision|3
179603|NCT00920140|570965|P3|Phase 2|Physician Decision|3
179604|NCT00920140|570966|P2|Phase 2|Physician Decision|0
179605|NCT00920140|570967|P1|Phase 2|Physician Decision|0
179606|NCT00920140|570963|P5|Phase 2|Lost to Follow-up|0
179607|NCT00920140|570964|P4|Phase 2|Lost to Follow-up|1
179608|NCT00920140|570965|P3|Phase 2|Lost to Follow-up|0
179609|NCT00920140|570966|P2|Phase 2|Lost to Follow-up|0
179610|NCT00920140|570967|P1|Phase 2|Lost to Follow-up|0
179611|NCT00920140|570963|P5|Phase 2|Lack of Efficacy|5
179612|NCT00920140|570964|P4|Phase 2|Lack of Efficacy|14
179613|NCT00920140|570965|P3|Phase 2|Lack of Efficacy|29
179614|NCT00920140|570966|P2|Phase 2|Lack of Efficacy|0
179615|NCT00920140|570967|P1|Phase 2|Lack of Efficacy|0
179616|NCT00920140|570963|P5|Phase 2|Adverse Event|3
179617|NCT00920140|570964|P4|Phase 2|Adverse Event|2
179618|NCT00920140|570965|P3|Phase 2|Adverse Event|14
179619|NCT00920140|570966|P2|Phase 2|Adverse Event|0
179620|NCT00920140|570967|P1|Phase 2|Adverse Event|0
179621|NCT00920140|570963|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
179622|NCT00920140|570964|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
179623|NCT00920140|570965|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
179624|NCT00920140|570966|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
179625|NCT00920140|570967|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
179626|NCT00920140|570963|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
179627|NCT00920140|570964|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
179628|NCT00920140|570965|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
179629|NCT00920140|570966|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
179630|NCT00920140|570967|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
179631|NCT00920140|570963|P5|Phase 1 (Dose Escalation)|Adverse Event|0
179632|NCT00920140|570964|P4|Phase 1 (Dose Escalation)|Adverse Event|0
179633|NCT00920140|570965|P3|Phase 1 (Dose Escalation)|Adverse Event|0
179634|NCT00920140|570966|P2|Phase 1 (Dose Escalation)|Adverse Event|3
179635|NCT00920140|570967|P1|Phase 1 (Dose Escalation)|Adverse Event|3
179636|NCT00920621|571058|P4|Overall Study|Blood sample not collected|0
179637|NCT00920621|571059|P3|Overall Study|Blood sample not collected|0
179638|NCT00920621|571060|P2|Overall Study|Blood sample not collected|14
179639|NCT00920621|571061|P1|Overall Study|Blood sample not collected|22
179640|NCT00920621|571058|P4|Overall Study|Fetal/neonatal deaths|14
179641|NCT00920621|571059|P3|Overall Study|Fetal/neonatal deaths|16
179642|NCT00920621|571060|P2|Overall Study|Fetal/neonatal deaths|14
179643|NCT00920621|571061|P1|Overall Study|Fetal/neonatal deaths|16
179644|NCT00920621|571058|P4|Overall Study|Lost to Follow-up|21
179645|NCT00920621|571059|P3|Overall Study|Lost to Follow-up|19
179646|NCT00920621|571060|P2|Overall Study|Lost to Follow-up|17
179647|NCT00920621|571061|P1|Overall Study|Lost to Follow-up|16
179648|NCT00920686|571143|P3|Overall Study|Study drug dosing criteria not met|12
179649|NCT00920686|571144|P2|Overall Study|Study drug dosing criteria not met|19
179650|NCT00920686|571145|P1|Overall Study|Study drug dosing criteria not met|17
179651|NCT00920686|571143|P3|Overall Study|Lost to Follow-up|1
179652|NCT00920686|571144|P2|Overall Study|Lost to Follow-up|3
179653|NCT00920686|571145|P1|Overall Study|Lost to Follow-up|2
179654|NCT00920790|571165|P1|Overall Study|aggravation of general condition|14
179655|NCT00910624|571191|P4|Follow-Up Phase|Administrative|0
179656|NCT00910624|571192|P3|Follow-Up Phase|Administrative|1
179657|NCT00910624|571193|P2|Follow-Up Phase|Administrative|1
179658|NCT00910624|571194|P1|Follow-Up Phase|Administrative|0
179659|NCT00910624|571191|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
179660|NCT00910624|571192|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
179661|NCT00910624|571193|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
179662|NCT00910624|571194|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
179663|NCT00910624|571191|P4|Follow-Up Phase|Withdrawal by Subject|0
179664|NCT00910624|571192|P3|Follow-Up Phase|Withdrawal by Subject|0
179665|NCT00910624|571193|P2|Follow-Up Phase|Withdrawal by Subject|0
179666|NCT00910624|571194|P1|Follow-Up Phase|Withdrawal by Subject|1
179667|NCT00910624|571191|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
179668|NCT00910624|571192|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
179669|NCT00910624|571193|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
179670|NCT00910624|571194|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
179671|NCT00910624|571191|P4|Follow-Up Phase|Lost to Follow-up|0
179672|NCT00910624|571192|P3|Follow-Up Phase|Lost to Follow-up|2
179673|NCT00910624|571193|P2|Follow-Up Phase|Lost to Follow-up|1
179674|NCT00910624|571194|P1|Follow-Up Phase|Lost to Follow-up|3
179675|NCT00910624|571191|P4|Follow-Up Phase|Adverse Event|0
179676|NCT00910624|571192|P3|Follow-Up Phase|Adverse Event|1
179677|NCT00910624|571193|P2|Follow-Up Phase|Adverse Event|0
179678|NCT00910624|571194|P1|Follow-Up Phase|Adverse Event|0
179679|NCT00910624|571191|P4|Treatment Phase|Non-Compliance With Protocol|0
179680|NCT00910624|571192|P3|Treatment Phase|Non-Compliance With Protocol|1
179681|NCT00910624|571193|P2|Treatment Phase|Non-Compliance With Protocol|1
179682|NCT00910624|571194|P1|Treatment Phase|Non-Compliance With Protocol|0
179683|NCT00910624|571191|P4|Treatment Phase|Withdrawal by Subject|0
179684|NCT00910624|571192|P3|Treatment Phase|Withdrawal by Subject|0
179685|NCT00910624|571193|P2|Treatment Phase|Withdrawal by Subject|1
179686|NCT00910624|571194|P1|Treatment Phase|Withdrawal by Subject|2
179687|NCT00910624|571191|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
179688|NCT00910624|571192|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
179689|NCT00910624|571193|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
179690|NCT00910624|571194|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
179691|NCT00910624|571191|P4|Treatment Phase|Lost to Follow-up|0
179692|NCT00910624|571192|P3|Treatment Phase|Lost to Follow-up|1
179693|NCT00910624|571193|P2|Treatment Phase|Lost to Follow-up|0
179694|NCT00910624|571194|P1|Treatment Phase|Lost to Follow-up|0
179695|NCT00910624|571191|P4|Treatment Phase|Treatment Failure|0
179696|NCT00910624|571192|P3|Treatment Phase|Treatment Failure|0
179697|NCT00910624|571193|P2|Treatment Phase|Treatment Failure|10
179698|NCT00910624|571194|P1|Treatment Phase|Treatment Failure|23
179699|NCT00910624|571191|P4|Treatment Phase|Adverse Event|0
179700|NCT00910624|571192|P3|Treatment Phase|Adverse Event|6
179701|NCT00910624|571193|P2|Treatment Phase|Adverse Event|6
179702|NCT00910624|571194|P1|Treatment Phase|Adverse Event|2
179703|NCT00910663|571208|P2|Period 1|Withdrawal by Subject|1
179704|NCT00910663|571209|P1|Period 1|Withdrawal by Subject|0
179705|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
179706|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
179707|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
179708|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
179709|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
179710|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
179711|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
179712|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
179713|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Time Demands|0
179714|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Time Demands|0
179715|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Time Demands|1
179716|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Time Demands|2
179717|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
179718|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
179719|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
179720|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
179721|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
179722|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
179723|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
179724|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
179725|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
179726|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
179727|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
179728|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
179729|NCT00910689|571223|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
179730|NCT00910689|571224|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
179731|NCT00910689|571225|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
179732|NCT00910689|571226|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
179733|NCT00910689|571223|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
179734|NCT00910689|571224|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
179735|NCT00910689|571225|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
179736|NCT00910689|571226|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
179737|NCT00910689|571223|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
179738|NCT00910689|571224|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
179739|NCT00910689|571225|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
179740|NCT00910689|571226|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
179741|NCT00910689|571223|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
179742|NCT00910689|571224|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
179743|NCT00910689|571225|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
179744|NCT00910689|571226|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
179745|NCT00910689|571223|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
179746|NCT00910689|571224|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
179747|NCT00910689|571225|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
179748|NCT00910689|571226|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
179749|NCT00910689|571223|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
179750|NCT00910689|571224|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
179751|NCT00910689|571225|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
179752|NCT00910689|571226|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
179753|NCT00910689|571223|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
179754|NCT00910689|571224|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
179755|NCT00910689|571225|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
179756|NCT00910689|571226|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
179757|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Protocol Violation|0
179758|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Protocol Violation|0
179759|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Protocol Violation|0
179760|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Protocol Violation|1
179761|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Pregnancy|0
179762|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Pregnancy|0
179763|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Pregnancy|2
179764|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Pregnancy|0
179765|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
179766|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
179767|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
179768|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
179769|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
179770|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
179771|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
179772|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
179773|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Time Demands|8
179774|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Time Demands|4
179775|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Time Demands|0
179776|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Time Demands|1
179777|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Adverse Event|0
179778|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Adverse Event|2
179779|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Adverse Event|3
179780|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Adverse Event|2
179781|NCT00910689|571223|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
179782|NCT00910689|571224|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
179783|NCT00910689|571225|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
179784|NCT00910689|571226|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
179785|NCT00910689|571223|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
179786|NCT00910689|571224|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
179787|NCT00910689|571225|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
179788|NCT00910689|571226|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
179789|NCT00910715|571259|P3|Overall Study|Lost to Follow-up|0
179790|NCT00910715|571260|P2|Overall Study|Lost to Follow-up|26
179791|NCT00910715|571261|P1|Overall Study|Lost to Follow-up|22
179792|NCT00910728|571280|P9|Overall Study|Adverse Event|1
179793|NCT00910728|571281|P8|Overall Study|Adverse Event|1
179794|NCT00910728|571282|P7|Overall Study|Adverse Event|2
179795|NCT00910728|571283|P6|Overall Study|Adverse Event|0
179796|NCT00910728|571284|P5|Overall Study|Adverse Event|0
179797|NCT00910728|571285|P4|Overall Study|Adverse Event|1
179798|NCT00910728|571286|P3|Overall Study|Adverse Event|1
179799|NCT00910728|571287|P2|Overall Study|Adverse Event|0
179800|NCT00910728|571288|P1|Overall Study|Adverse Event|2
179801|NCT00910728|571280|P9|Overall Study|(not specified)|0
179802|NCT00910728|571281|P8|Overall Study|(not specified)|0
179803|NCT00910728|571282|P7|Overall Study|(not specified)|0
179804|NCT00910728|571283|P6|Overall Study|(not specified)|0
179805|NCT00910728|571284|P5|Overall Study|(not specified)|1
179806|NCT00910728|571285|P4|Overall Study|(not specified)|0
179807|NCT00910728|571286|P3|Overall Study|(not specified)|1
179808|NCT00910728|571287|P2|Overall Study|(not specified)|0
179809|NCT00910728|571288|P1|Overall Study|(not specified)|2
179810|NCT00910728|571280|P9|Overall Study|Withdrawal by Subject|0
179811|NCT00910728|571281|P8|Overall Study|Withdrawal by Subject|0
179812|NCT00910728|571282|P7|Overall Study|Withdrawal by Subject|2
179813|NCT00910728|571283|P6|Overall Study|Withdrawal by Subject|1
179814|NCT00910728|571284|P5|Overall Study|Withdrawal by Subject|3
179815|NCT00910728|571285|P4|Overall Study|Withdrawal by Subject|0
179816|NCT00910728|571286|P3|Overall Study|Withdrawal by Subject|0
179817|NCT00910728|571287|P2|Overall Study|Withdrawal by Subject|0
179818|NCT00910728|571288|P1|Overall Study|Withdrawal by Subject|0
179819|NCT00910728|571280|P9|Overall Study|Lack of Efficacy|2
179820|NCT00910728|571281|P8|Overall Study|Lack of Efficacy|2
179821|NCT00910728|571282|P7|Overall Study|Lack of Efficacy|2
179822|NCT00910728|571283|P6|Overall Study|Lack of Efficacy|0
179823|NCT00910728|571284|P5|Overall Study|Lack of Efficacy|1
179824|NCT00910728|571285|P4|Overall Study|Lack of Efficacy|2
179825|NCT00910728|571286|P3|Overall Study|Lack of Efficacy|1
179826|NCT00910728|571287|P2|Overall Study|Lack of Efficacy|3
179827|NCT00910728|571288|P1|Overall Study|Lack of Efficacy|2
179828|NCT00910858|571423|P3|Combined Treatment Phase|Other|1
179829|NCT00910858|571424|P2|Combined Treatment Phase|Other|2
179830|NCT00910858|571425|P1|Combined Treatment Phase|Other|0
179831|NCT00910858|571423|P3|Combined Treatment Phase|Protocol Violation|0
179832|NCT00910858|571424|P2|Combined Treatment Phase|Protocol Violation|0
179833|NCT00910858|571425|P1|Combined Treatment Phase|Protocol Violation|1
179834|NCT00910858|571423|P3|Combined Treatment Phase|Withdrawal by Subject|0
179835|NCT00910858|571424|P2|Combined Treatment Phase|Withdrawal by Subject|2
179836|NCT00910858|571425|P1|Combined Treatment Phase|Withdrawal by Subject|0
179837|NCT00910858|571423|P3|Combined Treatment Phase|Lack of therapeutic effect|3
179838|NCT00910858|571424|P2|Combined Treatment Phase|Lack of therapeutic effect|6
179839|NCT00910858|571425|P1|Combined Treatment Phase|Lack of therapeutic effect|8
179840|NCT00910858|571423|P3|Monotherapy Phase|Other|2
179841|NCT00910858|571424|P2|Monotherapy Phase|Other|4
179842|NCT00910858|571425|P1|Monotherapy Phase|Other|3
179843|NCT00910858|571423|P3|Monotherapy Phase|Protocol Violation|0
179844|NCT00910858|571424|P2|Monotherapy Phase|Protocol Violation|0
179845|NCT00910858|571425|P1|Monotherapy Phase|Protocol Violation|1
179846|NCT00910858|571423|P3|Monotherapy Phase|Withdrawal by Subject|1
179847|NCT00910858|571424|P2|Monotherapy Phase|Withdrawal by Subject|3
179848|NCT00910858|571425|P1|Monotherapy Phase|Withdrawal by Subject|1
179849|NCT00910858|571423|P3|Monotherapy Phase|Lack of therapeutic effect|4
179850|NCT00910858|571424|P2|Monotherapy Phase|Lack of therapeutic effect|6
179851|NCT00910858|571425|P1|Monotherapy Phase|Lack of therapeutic effect|9
179852|NCT00910858|571423|P3|Monotherapy Phase|Adverse Event|0
179853|NCT00910858|571424|P2|Monotherapy Phase|Adverse Event|2
179854|NCT00910858|571425|P1|Monotherapy Phase|Adverse Event|3
179855|NCT00910858|571423|P3|Pharmacokinetic Phase|Adverse Event|0
179856|NCT00910858|571424|P2|Pharmacokinetic Phase|Adverse Event|0
179857|NCT00910858|571425|P1|Pharmacokinetic Phase|Adverse Event|1
179858|NCT00910871|571448|P1|Overall Study|Undefined|1
179859|NCT00910871|571448|P1|Overall Study|Subject didn’t meet eligibility criteria|5
179860|NCT00910871|571448|P1|Overall Study|Withdrawal by Subject|12
179861|NCT00910871|571448|P1|Overall Study|Protocol Violation|11
179862|NCT00910871|571448|P1|Overall Study|Lost to Follow-up|8
179863|NCT00910871|571448|P1|Overall Study|Death|12
179864|NCT00910871|571448|P1|Overall Study|Adverse Event|5
179865|NCT00910910|571455|P2|Overall Study|Untreated before cycle 1|2
179866|NCT00910910|571456|P1|Overall Study|Untreated before cycle 1|1
179867|NCT00910910|571455|P2|Overall Study|Unspecified|32
179868|NCT00910910|571456|P1|Overall Study|Unspecified|114
179869|NCT00910910|571455|P2|Overall Study|Completed 13 cycles of treatment|118
179870|NCT00910910|571456|P1|Overall Study|Completed 13 cycles of treatment|0
179871|NCT00910910|571455|P2|Overall Study|Protocol Violation|2
179872|NCT00910910|571456|P1|Overall Study|Protocol Violation|2
179873|NCT00910910|571455|P2|Overall Study|Death|3
179874|NCT00910910|571456|P1|Overall Study|Death|9
179875|NCT00910910|571455|P2|Overall Study|Lost to Follow-up|2
179876|NCT00910910|571456|P1|Overall Study|Lost to Follow-up|2
179877|NCT00910910|571455|P2|Overall Study|Withdrawal by Subject|5
179878|NCT00910910|571456|P1|Overall Study|Withdrawal by Subject|7
179879|NCT00910910|571455|P2|Overall Study|PD with histologic change|2
179880|NCT00910910|571456|P1|Overall Study|PD with histologic change|0
179881|NCT00910910|571455|P2|Overall Study|PD without histologic change|23
179882|NCT00910910|571456|P1|Overall Study|PD without histologic change|27
179883|NCT00910910|571455|P2|Overall Study|Adverse Event|35
179884|NCT00910910|571456|P1|Overall Study|Adverse Event|63
179885|NCT00910988|571494|P4|Overall Study|Lost to Follow-up|0
179886|NCT00910988|571495|P3|Overall Study|Lost to Follow-up|3
179887|NCT00910988|571496|P2|Overall Study|Lost to Follow-up|4
179888|NCT00910988|571497|P1|Overall Study|Lost to Follow-up|2
179889|NCT00911144|571541|P2|Overall Study|Withdrawal by Subject|5
179890|NCT00911144|571542|P1|Overall Study|Withdrawal by Subject|16
179891|NCT00911157|571568|P2|Overall Study|Need to treat for lung cancer|0
179892|NCT00911157|571569|P1|Overall Study|Need to treat for lung cancer|1
179893|NCT00911157|571568|P2|Overall Study|Need for prohibited drug (heparin)|0
179894|NCT00911157|571569|P1|Overall Study|Need for prohibited drug (heparin)|1
179895|NCT00911157|571568|P2|Overall Study|Withdrawal by Subject|1
179896|NCT00911157|571569|P1|Overall Study|Withdrawal by Subject|1
179897|NCT00911157|571568|P2|Overall Study|Adverse Event|1
179898|NCT00911157|571569|P1|Overall Study|Adverse Event|4
179899|NCT00911170|571585|P2|Long Term Follow-Up|Death|121
179900|NCT00911170|571586|P1|Long Term Follow-Up|Death|116
179901|NCT00911170|571585|P2|Long Term Follow-Up|Lost to Follow-up|7
179902|NCT00911170|571586|P1|Long Term Follow-Up|Lost to Follow-up|8
179903|NCT00911170|571585|P2|Long Term Follow-Up|Physician Decision|4
179904|NCT00911170|571586|P1|Long Term Follow-Up|Physician Decision|5
179905|NCT00911170|571585|P2|Long Term Follow-Up|Withdrawal by Subject|21
179906|NCT00911170|571586|P1|Long Term Follow-Up|Withdrawal by Subject|20
179907|NCT00911170|571585|P2|Long Term Follow-Up|Continuing in study|269
179908|NCT00911170|571586|P1|Long Term Follow-Up|Continuing in study|274
179909|NCT00911170|571585|P2|Treatment Period|Death|9
179910|NCT00911170|571586|P1|Treatment Period|Death|6
179911|NCT00911170|571585|P2|Treatment Period|Lost to Follow-up|1
179912|NCT00911170|571586|P1|Treatment Period|Lost to Follow-up|0
179913|NCT00911170|571585|P2|Treatment Period|Physician Decision|5
179914|NCT00911170|571586|P1|Treatment Period|Physician Decision|5
179915|NCT00911170|571585|P2|Treatment Period|Disease progression|2
179916|NCT00911170|571586|P1|Treatment Period|Disease progression|0
179917|NCT00911170|571585|P2|Treatment Period|Withdrawal by Subject|4
179918|NCT00911170|571586|P1|Treatment Period|Withdrawal by Subject|4
179919|NCT00911170|571585|P2|Treatment Period|Adverse Event|10
179920|NCT00911170|571586|P1|Treatment Period|Adverse Event|9
179921|NCT00911170|571585|P2|Treatment Period|Protocol deviation|2
179922|NCT00911170|571586|P1|Treatment Period|Protocol deviation|1
179923|NCT00911170|571585|P2|Treatment Period|Ineligibility determined|3
179924|NCT00911170|571586|P1|Treatment Period|Ineligibility determined|1
179925|NCT00911170|571585|P2|Treatment Period|Randomized in error|1
179926|NCT00911170|571586|P1|Treatment Period|Randomized in error|1
179927|NCT00911300|571621|P2|Overall Study|Randomized; No Study Medication Received|2
179928|NCT00911300|571622|P1|Overall Study|Randomized; No Study Medication Received|0
179929|NCT00911300|571621|P2|Overall Study|Treatment Stopped by Mistake|1
179930|NCT00911300|571622|P1|Overall Study|Treatment Stopped by Mistake|0
179931|NCT00911300|571621|P2|Overall Study|Physician Decision|1
179932|NCT00911300|571622|P1|Overall Study|Physician Decision|0
179933|NCT00911300|571621|P2|Overall Study|Underlying Disease (Myocarditis)|1
179934|NCT00911300|571622|P1|Overall Study|Underlying Disease (Myocarditis)|0
179935|NCT00911300|571621|P2|Overall Study|Participant Refused Hospital Consulation|1
179936|NCT00911300|571622|P1|Overall Study|Participant Refused Hospital Consulation|0
179937|NCT00911300|571621|P2|Overall Study|International Normalized Ratio Too High|1
179938|NCT00911300|571622|P1|Overall Study|International Normalized Ratio Too High|0
179939|NCT00911300|571621|P2|Overall Study|Investigator's Decision; New AF Episode|1
179940|NCT00911300|571622|P1|Overall Study|Investigator's Decision; New AF Episode|0
179941|NCT00911300|571621|P2|Overall Study|Participant Could Not Stay in Hospital|1
179942|NCT00911300|571622|P1|Overall Study|Participant Could Not Stay in Hospital|0
179943|NCT00911300|571621|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
179944|NCT00911300|571622|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
179945|NCT00911300|571621|P2|Overall Study|Nurse Unavailable in Participant's City|0
179946|NCT00911300|571622|P1|Overall Study|Nurse Unavailable in Participant's City|1
179947|NCT00911300|571621|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
179948|NCT00911300|571622|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
179949|NCT00911300|571621|P2|Overall Study|Recurrent Tachyarrhythmia|1
179950|NCT00911300|571622|P1|Overall Study|Recurrent Tachyarrhythmia|1
179951|NCT00911300|571621|P2|Overall Study|Received Commercial Treatment|0
179952|NCT00911300|571622|P1|Overall Study|Received Commercial Treatment|1
179953|NCT00911300|571621|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
179954|NCT00911300|571622|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
179955|NCT00911300|571621|P2|Overall Study|Coronary Angiography Performed|0
179956|NCT00911300|571622|P1|Overall Study|Coronary Angiography Performed|1
179957|NCT00911300|571621|P2|Overall Study|Consent Withdrawn|12
179958|NCT00911300|571622|P1|Overall Study|Consent Withdrawn|4
179959|NCT00911300|571621|P2|Overall Study|Protocol Violation|2
179960|NCT00911300|571622|P1|Overall Study|Protocol Violation|3
179961|NCT00911300|571621|P2|Overall Study|Adverse Event|6
179962|NCT00911300|571622|P1|Overall Study|Adverse Event|14
179963|NCT00911300|571621|P2|Overall Study|Thrombus Persistant in Second TEE|7
179964|NCT00911300|571622|P1|Overall Study|Thrombus Persistant in Second TEE|3
179965|NCT00911300|571621|P2|Overall Study|Death|0
179966|NCT00911300|571622|P1|Overall Study|Death|1
179967|NCT00911300|571621|P2|Overall Study|Primary Endpoint Component Occurred|2
179968|NCT00911300|571622|P1|Overall Study|Primary Endpoint Component Occurred|1
179969|NCT00911534|571689|P2|Overall Study|Not specified|2
179970|NCT00911534|571690|P1|Overall Study|Not specified|2
179971|NCT00911534|571689|P2|Overall Study|Withdrawal of consent|4
179972|NCT00911534|571690|P1|Overall Study|Withdrawal of consent|1
179973|NCT00911534|571689|P2|Overall Study|Lack of Efficacy|1
179974|NCT00911534|571690|P1|Overall Study|Lack of Efficacy|4
179975|NCT00911534|571689|P2|Overall Study|Withdrawal by Subject|1
179976|NCT00911534|571690|P1|Overall Study|Withdrawal by Subject|2
179977|NCT00911534|571689|P2|Overall Study|Lost to Follow-up|4
179978|NCT00911534|571690|P1|Overall Study|Lost to Follow-up|2
179979|NCT00911534|571689|P2|Overall Study|Adverse Event|4
179980|NCT00911534|571690|P1|Overall Study|Adverse Event|4
179981|NCT00911547|571706|P4|Overall Study|Withdrawal by Subject|8
179982|NCT00911547|571707|P3|Overall Study|Withdrawal by Subject|4
179983|NCT00911547|571708|P2|Overall Study|Withdrawal by Subject|10
179984|NCT00911547|571709|P1|Overall Study|Withdrawal by Subject|3
179985|NCT00911547|571706|P4|Overall Study|Protocol Violation|1
179986|NCT00911547|571707|P3|Overall Study|Protocol Violation|5
179987|NCT00911547|571708|P2|Overall Study|Protocol Violation|5
179988|NCT00911547|571709|P1|Overall Study|Protocol Violation|0
179989|NCT00911547|571706|P4|Overall Study|Lost to Follow-up|1
179990|NCT00911547|571707|P3|Overall Study|Lost to Follow-up|2
179991|NCT00911547|571708|P2|Overall Study|Lost to Follow-up|0
179992|NCT00911547|571709|P1|Overall Study|Lost to Follow-up|0
179993|NCT00911547|571706|P4|Overall Study|Adverse Event|6
179994|NCT00911547|571707|P3|Overall Study|Adverse Event|11
179995|NCT00911547|571708|P2|Overall Study|Adverse Event|27
179996|NCT00911547|571709|P1|Overall Study|Adverse Event|8
179997|NCT00911625|571754|P2|Overall Study|Lost to Follow-up|0
179998|NCT00911625|571755|P1|Overall Study|Lost to Follow-up|7
179999|NCT00911768|571782|P2|Overall Study|Withdrawal by Subject|0
180000|NCT00911768|571783|P1|Overall Study|Withdrawal by Subject|1
180001|NCT00911768|571782|P2|Overall Study|Protocol Violation|4
180002|NCT00911768|571783|P1|Overall Study|Protocol Violation|5
180003|NCT00911807|571796|P3|Overall Study|Organizational reasons|1
180004|NCT00911807|571797|P2|Overall Study|Organizational reasons|3
180005|NCT00911807|571798|P1|Overall Study|Organizational reasons|1
180006|NCT00911807|571796|P3|Overall Study|Withdrawal by Subject|7
180007|NCT00911807|571797|P2|Overall Study|Withdrawal by Subject|10
180008|NCT00911807|571798|P1|Overall Study|Withdrawal by Subject|8
180009|NCT00911807|571796|P3|Overall Study|Protocol Violation|9
180010|NCT00911807|571797|P2|Overall Study|Protocol Violation|4
180011|NCT00911807|571798|P1|Overall Study|Protocol Violation|6
180012|NCT00911807|571796|P3|Overall Study|Death|1
180013|NCT00911807|571797|P2|Overall Study|Death|0
180014|NCT00911807|571798|P1|Overall Study|Death|0
180015|NCT00911807|571796|P3|Overall Study|Adverse Event|5
180016|NCT00911807|571797|P2|Overall Study|Adverse Event|1
180017|NCT00911807|571798|P1|Overall Study|Adverse Event|2
180018|NCT00911859|571809|P3|Follow-up Period|Study terminated by sponsor|27
180019|NCT00911859|571810|P2|Follow-up Period|Study terminated by sponsor|33
180020|NCT00911859|571811|P1|Follow-up Period|Study terminated by sponsor|5
180021|NCT00911859|571809|P3|Follow-up Period|Withdrawal by Subject|4
180022|NCT00911859|571810|P2|Follow-up Period|Withdrawal by Subject|4
180023|NCT00911859|571811|P1|Follow-up Period|Withdrawal by Subject|0
180024|NCT00911859|571809|P3|Follow-up Period|Lost to Follow-up|0
180025|NCT00911859|571810|P2|Follow-up Period|Lost to Follow-up|1
180026|NCT00911859|571811|P1|Follow-up Period|Lost to Follow-up|1
180027|NCT00911859|571809|P3|Follow-up Period|Death|10
180028|NCT00911859|571810|P2|Follow-up Period|Death|8
180029|NCT00911859|571811|P1|Follow-up Period|Death|5
180030|NCT00911859|571809|P3|Maintainance Period|Withdrawal by Subject|3
180031|NCT00911859|571810|P2|Maintainance Period|Withdrawal by Subject|0
180032|NCT00911859|571811|P1|Maintainance Period|Withdrawal by Subject|0
180033|NCT00911859|571809|P3|Maintainance Period|Physician Decision|9
180034|NCT00911859|571810|P2|Maintainance Period|Physician Decision|0
180035|NCT00911859|571811|P1|Maintainance Period|Physician Decision|0
180036|NCT00911859|571809|P3|Maintainance Period|Lack of Efficacy|9
180037|NCT00911859|571810|P2|Maintainance Period|Lack of Efficacy|0
180038|NCT00911859|571811|P1|Maintainance Period|Lack of Efficacy|0
180039|NCT00911859|571809|P3|Treatment Period|Did not receive study treatment|0
180040|NCT00911859|571810|P2|Treatment Period|Did not receive study treatment|1
180041|NCT00911859|571811|P1|Treatment Period|Did not receive study treatment|0
180042|NCT00911859|571809|P3|Treatment Period|Withdrawal by Subject|5
180043|NCT00911859|571810|P2|Treatment Period|Withdrawal by Subject|4
180044|NCT00911859|571811|P1|Treatment Period|Withdrawal by Subject|0
180045|NCT00911859|571809|P3|Treatment Period|Physician Decision|3
180046|NCT00911859|571810|P2|Treatment Period|Physician Decision|3
180047|NCT00911859|571811|P1|Treatment Period|Physician Decision|3
180048|NCT00911859|571809|P3|Treatment Period|Lack of Efficacy|5
180049|NCT00911859|571810|P2|Treatment Period|Lack of Efficacy|7
180050|NCT00911859|571811|P1|Treatment Period|Lack of Efficacy|1
180051|NCT00911859|571809|P3|Treatment Period|Death|5
180052|NCT00911859|571810|P2|Treatment Period|Death|3
180053|NCT00911859|571811|P1|Treatment Period|Death|1
180054|NCT00911859|571809|P3|Treatment Period|Adverse Event|7
180055|NCT00911859|571810|P2|Treatment Period|Adverse Event|3
180056|NCT00911859|571811|P1|Treatment Period|Adverse Event|3
180057|NCT00911937|571841|P2|Overall Study|Unspecified|5
180058|NCT00911937|571842|P1|Overall Study|Unspecified|9
180059|NCT00911937|571841|P2|Overall Study|Randomized but not treated|13
180060|NCT00911937|571842|P1|Overall Study|Randomized but not treated|13
180061|NCT00911937|571841|P2|Overall Study|Protocol Violation|23
180062|NCT00911937|571842|P1|Overall Study|Protocol Violation|14
180063|NCT00911937|571841|P2|Overall Study|Did not meet inclusion criteria|11
180064|NCT00911937|571842|P1|Overall Study|Did not meet inclusion criteria|9
180065|NCT00911937|571841|P2|Overall Study|Lack of Efficacy|6
180066|NCT00911937|571842|P1|Overall Study|Lack of Efficacy|11
180067|NCT00911937|571841|P2|Overall Study|Adverse Event|25
180068|NCT00911937|571842|P1|Overall Study|Adverse Event|11
180069|NCT00911937|571841|P2|Overall Study|Withdrawn due to pregnancy|0
180070|NCT00911937|571842|P1|Overall Study|Withdrawn due to pregnancy|1
180071|NCT00911937|571841|P2|Overall Study|Withdrawal by Subject|7
180072|NCT00911937|571842|P1|Overall Study|Withdrawal by Subject|10
180073|NCT00911937|571841|P2|Overall Study|Lost to Follow-up|5
180074|NCT00911937|571842|P1|Overall Study|Lost to Follow-up|8
180075|NCT00911937|571841|P2|Overall Study|Death|0
180076|NCT00911937|571842|P1|Overall Study|Death|1
180077|NCT00911989|571902|P1|Overall Study|Adverse Event|1
180078|NCT00912015|571916|P4|Overall Study|Adverse Event|1
180079|NCT00912015|571917|P3|Overall Study|Adverse Event|0
180080|NCT00912015|571918|P2|Overall Study|Adverse Event|0
180081|NCT00912015|571919|P1|Overall Study|Adverse Event|6
180082|NCT00912015|571916|P4|Overall Study|Protocol Violation|1
180083|NCT00912015|571917|P3|Overall Study|Protocol Violation|0
180084|NCT00912015|571918|P2|Overall Study|Protocol Violation|0
180085|NCT00912015|571919|P1|Overall Study|Protocol Violation|1
180086|NCT00912015|571916|P4|Overall Study|Withdrawal by Subject|0
180087|NCT00912015|571917|P3|Overall Study|Withdrawal by Subject|3
180088|NCT00912015|571918|P2|Overall Study|Withdrawal by Subject|8
180089|NCT00912015|571919|P1|Overall Study|Withdrawal by Subject|8
180090|NCT00912015|571916|P4|Overall Study|Lack of Efficacy|0
180091|NCT00912015|571917|P3|Overall Study|Lack of Efficacy|0
180092|NCT00912015|571918|P2|Overall Study|Lack of Efficacy|0
180093|NCT00912015|571919|P1|Overall Study|Lack of Efficacy|1
180094|NCT00912028|571932|P5|Overall Study|Withdrawal by Subject|0
180095|NCT00912028|571933|P4|Overall Study|Withdrawal by Subject|0
180096|NCT00912028|571934|P3|Overall Study|Withdrawal by Subject|0
180097|NCT00912028|571935|P2|Overall Study|Withdrawal by Subject|0
180098|NCT00912028|571936|P1|Overall Study|Withdrawal by Subject|3
180099|NCT00912028|571932|P5|Overall Study|Lost to Follow-up|3
180100|NCT00912028|571933|P4|Overall Study|Lost to Follow-up|1
180101|NCT00912028|571934|P3|Overall Study|Lost to Follow-up|0
180102|NCT00912028|571935|P2|Overall Study|Lost to Follow-up|3
180103|NCT00912028|571936|P1|Overall Study|Lost to Follow-up|2
180104|NCT00912093|571966|P5|The Controlled Phase|Lost to Follow-up|1
180105|NCT00912093|571967|P4|The Controlled Phase|Lost to Follow-up|0
180106|NCT00912093|571968|P3|The Controlled Phase|Lost to Follow-up|0
180107|NCT00912093|571969|P2|The Controlled Phase|Lost to Follow-up|0
180108|NCT00912093|571970|P1|The Controlled Phase|Lost to Follow-up|0
180109|NCT00912093|571966|P5|The Controlled Phase|Medical Condition|0
180110|NCT00912093|571967|P4|The Controlled Phase|Medical Condition|0
180111|NCT00912093|571968|P3|The Controlled Phase|Medical Condition|0
180112|NCT00912093|571969|P2|The Controlled Phase|Medical Condition|1
180113|NCT00912093|571970|P1|The Controlled Phase|Medical Condition|0
180114|NCT00912093|571966|P5|The Controlled Phase|Death|0
180115|NCT00912093|571967|P4|The Controlled Phase|Death|0
180116|NCT00912093|571968|P3|The Controlled Phase|Death|0
180117|NCT00912093|571969|P2|The Controlled Phase|Death|1
180118|NCT00912093|571970|P1|The Controlled Phase|Death|0
180119|NCT00912223|571996|P1|Overall Study|Transformed disease|1
180120|NCT00912223|571996|P1|Overall Study|Not transplanted|1
180121|NCT00912223|571996|P1|Overall Study|Withdrawal by Subject|1
180122|NCT00912288|572014|P2|Overall Study|Unspecified|0
180123|NCT00912288|572015|P1|Overall Study|Unspecified|1
180124|NCT00912288|572014|P2|Overall Study|Study terminated by sponsor|35
180125|NCT00912288|572015|P1|Overall Study|Study terminated by sponsor|34
180126|NCT00912288|572014|P2|Overall Study|Withdrawal by Subject|3
180127|NCT00912288|572015|P1|Overall Study|Withdrawal by Subject|3
180128|NCT00912288|572014|P2|Overall Study|Protocol Violation|0
180129|NCT00912288|572015|P1|Overall Study|Protocol Violation|1
180130|NCT00912288|572014|P2|Overall Study|Lost to Follow-up|0
180131|NCT00912288|572015|P1|Overall Study|Lost to Follow-up|1
180132|NCT00912288|572014|P2|Overall Study|Adverse Event|1
180133|NCT00912288|572015|P1|Overall Study|Adverse Event|1
180134|NCT00912288|572014|P2|Overall Study|Death|1
180135|NCT00912288|572015|P1|Overall Study|Death|0
180136|NCT00912405|572062|P1|Overall Study|Lost to Follow-up|5
180137|NCT00912509|572071|P2|Overall Study|Lack of Efficacy|3
180138|NCT00912509|572072|P1|Overall Study|Lack of Efficacy|4
180139|NCT00912509|572071|P2|Overall Study|Lost to Follow-up|0
180140|NCT00912509|572072|P1|Overall Study|Lost to Follow-up|1
180141|NCT00912743|572080|P2|Overall Study|End of treatment form was not collected|0
180142|NCT00912743|572081|P1|Overall Study|End of treatment form was not collected|1
180143|NCT00912743|572080|P2|Overall Study|Toxicity|1
180144|NCT00912743|572081|P1|Overall Study|Toxicity|0
180145|NCT00912743|572080|P2|Overall Study|Lack of Efficacy|18
180146|NCT00912743|572081|P1|Overall Study|Lack of Efficacy|9
180147|NCT00912743|572080|P2|Overall Study|Adverse Event|1
180148|NCT00912743|572081|P1|Overall Study|Adverse Event|3
180149|NCT00912782|572093|P2|Overall Study|Relocated before study completion|1
180150|NCT00912782|572094|P1|Overall Study|Relocated before study completion|0
180151|NCT00912782|572093|P2|Overall Study|Did not receive vascular access type|2
180152|NCT00912782|572094|P1|Overall Study|Did not receive vascular access type|1
180153|NCT00912782|572093|P2|Overall Study|Lost to Follow-up|1
180154|NCT00912782|572094|P1|Overall Study|Lost to Follow-up|0
180155|NCT00912782|572093|P2|Overall Study|Death|1
180156|NCT00912782|572094|P1|Overall Study|Death|2
180157|NCT00912912|572128|P1|Overall Study|Disease Progression|3
180158|NCT00912912|572128|P1|Overall Study|Withdrawal by Subject|1
180159|NCT00912964|572156|P3|Overall Study|Randomized but never received study drug|0
180160|NCT00912964|572157|P2|Overall Study|Randomized but never received study drug|1
180161|NCT00912964|572158|P1|Overall Study|Randomized but never received study drug|0
180162|NCT00912964|572156|P3|Overall Study|Violation of exclusion criterion|2
180163|NCT00912964|572157|P2|Overall Study|Violation of exclusion criterion|0
180164|NCT00912964|572158|P1|Overall Study|Violation of exclusion criterion|0
180165|NCT00912964|572156|P3|Overall Study|Non-compliance with study procedures|0
180166|NCT00912964|572157|P2|Overall Study|Non-compliance with study procedures|0
180167|NCT00912964|572158|P1|Overall Study|Non-compliance with study procedures|2
180168|NCT00912964|572156|P3|Overall Study|Medical History|0
180169|NCT00912964|572157|P2|Overall Study|Medical History|0
180170|NCT00912964|572158|P1|Overall Study|Medical History|1
180171|NCT00912964|572156|P3|Overall Study|Taking exclusionary medications|8
180172|NCT00912964|572157|P2|Overall Study|Taking exclusionary medications|4
180173|NCT00912964|572158|P1|Overall Study|Taking exclusionary medications|7
180174|NCT00912964|572156|P3|Overall Study|Protocol Violation|8
180175|NCT00912964|572157|P2|Overall Study|Protocol Violation|3
180176|NCT00912964|572158|P1|Overall Study|Protocol Violation|5
180177|NCT00912964|572156|P3|Overall Study|Lost to Follow-up|3
180178|NCT00912964|572157|P2|Overall Study|Lost to Follow-up|3
180179|NCT00912964|572158|P1|Overall Study|Lost to Follow-up|4
180180|NCT00912964|572156|P3|Overall Study|Withdrawal by Subject|18
180181|NCT00912964|572157|P2|Overall Study|Withdrawal by Subject|12
180182|NCT00912964|572158|P1|Overall Study|Withdrawal by Subject|20
180183|NCT00912964|572156|P3|Overall Study|Lack of Efficacy|3
180184|NCT00912964|572157|P2|Overall Study|Lack of Efficacy|4
180185|NCT00912964|572158|P1|Overall Study|Lack of Efficacy|11
180186|NCT00912964|572156|P3|Overall Study|Adverse Event|12
180187|NCT00912964|572157|P2|Overall Study|Adverse Event|18
180188|NCT00912964|572158|P1|Overall Study|Adverse Event|15
180189|NCT00912964|572156|P3|Overall Study|Eligibility criterion not met|0
180190|NCT00912964|572157|P2|Overall Study|Eligibility criterion not met|1
180191|NCT00912964|572158|P1|Overall Study|Eligibility criterion not met|1
180192|NCT00920816|572284|P4|Overall Study|Ongoing|36
180193|NCT00920816|572285|P3|Overall Study|Ongoing|70
180194|NCT00920816|572286|P2|Overall Study|Ongoing|56
180195|NCT00920816|572287|P1|Overall Study|Ongoing|106
180196|NCT00920816|572284|P4|Overall Study|Withdrawal by Subject|1
180197|NCT00920816|572285|P3|Overall Study|Withdrawal by Subject|1
180198|NCT00920816|572286|P2|Overall Study|Withdrawal by Subject|2
180199|NCT00920816|572287|P1|Overall Study|Withdrawal by Subject|7
180200|NCT00920816|572284|P4|Overall Study|Objective progression or relapse|0
180201|NCT00920816|572285|P3|Overall Study|Objective progression or relapse|2
180202|NCT00920816|572286|P2|Overall Study|Objective progression or relapse|0
180203|NCT00920816|572287|P1|Overall Study|Objective progression or relapse|0
180204|NCT00920816|572284|P4|Overall Study|Lost to Follow-up|4
180205|NCT00920816|572285|P3|Overall Study|Lost to Follow-up|3
180206|NCT00920816|572286|P2|Overall Study|Lost to Follow-up|2
180207|NCT00920816|572287|P1|Overall Study|Lost to Follow-up|1
180208|NCT00920816|572284|P4|Overall Study|Adverse Event|0
180209|NCT00920816|572285|P3|Overall Study|Adverse Event|1
180210|NCT00920816|572286|P2|Overall Study|Adverse Event|0
180211|NCT00920816|572287|P1|Overall Study|Adverse Event|1
180212|NCT00920816|572284|P4|Overall Study|Death|28
180213|NCT00920816|572285|P3|Overall Study|Death|58
180214|NCT00920816|572286|P2|Overall Study|Death|36
180215|NCT00920816|572287|P1|Overall Study|Death|77
180216|NCT00920855|572328|P3|Overall Study|Response plateau; started maintenance|1
180217|NCT00920855|572329|P2|Overall Study|Response plateau; started maintenance|0
180218|NCT00920855|572330|P1|Overall Study|Response plateau; started maintenance|0
180219|NCT00920855|572328|P3|Overall Study|Noncompliance to study medication|1
180220|NCT00920855|572329|P2|Overall Study|Noncompliance to study medication|0
180221|NCT00920855|572330|P1|Overall Study|Noncompliance to study medication|0
180222|NCT00920855|572328|P3|Overall Study|Disease progression|10
180223|NCT00920855|572329|P2|Overall Study|Disease progression|1
180224|NCT00920855|572330|P1|Overall Study|Disease progression|2
180225|NCT00920855|572328|P3|Overall Study|Withdrawal by Subject|6
180226|NCT00920855|572329|P2|Overall Study|Withdrawal by Subject|1
180227|NCT00920855|572330|P1|Overall Study|Withdrawal by Subject|2
180228|NCT00920855|572328|P3|Overall Study|Adverse Event|4
180229|NCT00920855|572329|P2|Overall Study|Adverse Event|1
180230|NCT00920855|572330|P1|Overall Study|Adverse Event|1
180231|NCT00920907|572354|P2|Maintenance Period|Adverse Event|1
180232|NCT00920907|572355|P1|Maintenance Period|Adverse Event|0
180233|NCT00920907|572354|P2|Maintenance Period|Withdrawal by Subject|0
180234|NCT00920907|572355|P1|Maintenance Period|Withdrawal by Subject|1
180235|NCT00920907|572354|P2|Maintenance Period|Death|1
180236|NCT00920907|572355|P1|Maintenance Period|Death|1
180237|NCT00920907|572354|P2|Maintenance Period|Study Drug Toxicity|2
180238|NCT00920907|572355|P1|Maintenance Period|Study Drug Toxicity|0
180239|NCT00920907|572354|P2|Maintenance Period|Administrative (study closure)|2
180240|NCT00920907|572355|P1|Maintenance Period|Administrative (study closure)|7
180241|NCT00920907|572354|P2|Maintenance Period|Disease Progression|7
180242|NCT00920907|572355|P1|Maintenance Period|Disease Progression|3
180243|NCT00920907|572354|P2|Induction Period|Withdrawal by Subject|1
180244|NCT00920907|572355|P1|Induction Period|Withdrawal by Subject|1
180245|NCT00920907|572354|P2|Induction Period|No longer meets study criteria|1
180246|NCT00920907|572355|P1|Induction Period|No longer meets study criteria|0
180247|NCT00920907|572354|P2|Induction Period|Study Drug Toxicity|6
180248|NCT00920907|572355|P1|Induction Period|Study Drug Toxicity|8
180249|NCT00920907|572354|P2|Induction Period|Disease Progression|11
180250|NCT00920907|572355|P1|Induction Period|Disease Progression|12
180251|NCT00920907|572354|P2|Induction Period|Death|1
180252|NCT00920907|572355|P1|Induction Period|Death|1
180253|NCT00920907|572354|P2|Induction Period|Adverse Event|2
180254|NCT00920907|572355|P1|Induction Period|Adverse Event|0
180255|NCT00921024|572395|P2|Overall Study|Withdrawal by Subject|3
180256|NCT00921024|572396|P1|Overall Study|Withdrawal by Subject|0
180257|NCT00921024|572395|P2|Overall Study|Received concomittant therapy|0
180258|NCT00921024|572396|P1|Overall Study|Received concomittant therapy|2
180259|NCT00921024|572395|P2|Overall Study|Lost to Follow-up|0
180260|NCT00921024|572396|P1|Overall Study|Lost to Follow-up|2
180261|NCT00923091|572416|P13|Period VI (Open-Label)|Other Reason|0
180262|NCT00923091|572417|P12|Period VI (Open-Label)|Other Reason|0
180263|NCT00923091|572418|P11|Period VI (Open-Label)|Other Reason|0
180264|NCT00923091|572419|P10|Period VI (Open-Label)|Other Reason|0
180265|NCT00923091|572420|P9|Period VI (Open-Label)|Other Reason|0
180266|NCT00923091|572421|P8|Period VI (Open-Label)|Other Reason|0
180267|NCT00923091|572422|P7|Period VI (Open-Label)|Other Reason|0
180268|NCT00923091|572423|P6|Period VI (Open-Label)|Other Reason|0
180269|NCT00923091|572424|P5|Period VI (Open-Label)|Other Reason|1
180270|NCT00923091|572425|P4|Period VI (Open-Label)|Other Reason|1
180271|NCT00923091|572426|P3|Period VI (Open-Label)|Other Reason|0
180272|NCT00923091|572427|P2|Period VI (Open-Label)|Other Reason|0
180273|NCT00923091|572428|P1|Period VI (Open-Label)|Other Reason|0
180274|NCT00923091|572416|P13|Period VI (Open-Label)|Lost to Follow-up|0
180275|NCT00923091|572417|P12|Period VI (Open-Label)|Lost to Follow-up|0
180276|NCT00923091|572418|P11|Period VI (Open-Label)|Lost to Follow-up|0
180277|NCT00923091|572419|P10|Period VI (Open-Label)|Lost to Follow-up|0
180278|NCT00923091|572420|P9|Period VI (Open-Label)|Lost to Follow-up|0
180279|NCT00923091|572421|P8|Period VI (Open-Label)|Lost to Follow-up|0
180280|NCT00923091|572422|P7|Period VI (Open-Label)|Lost to Follow-up|0
180281|NCT00923091|572423|P6|Period VI (Open-Label)|Lost to Follow-up|0
180282|NCT00923091|572424|P5|Period VI (Open-Label)|Lost to Follow-up|0
180283|NCT00923091|572425|P4|Period VI (Open-Label)|Lost to Follow-up|0
180284|NCT00923091|572426|P3|Period VI (Open-Label)|Lost to Follow-up|1
180285|NCT00923091|572427|P2|Period VI (Open-Label)|Lost to Follow-up|0
180286|NCT00923091|572428|P1|Period VI (Open-Label)|Lost to Follow-up|1
180287|NCT00923091|572416|P13|Period VI (Open-Label)|Protocol Violation|0
180288|NCT00923091|572417|P12|Period VI (Open-Label)|Protocol Violation|0
180289|NCT00923091|572418|P11|Period VI (Open-Label)|Protocol Violation|0
180290|NCT00923091|572419|P10|Period VI (Open-Label)|Protocol Violation|0
180291|NCT00923091|572420|P9|Period VI (Open-Label)|Protocol Violation|0
180292|NCT00923091|572421|P8|Period VI (Open-Label)|Protocol Violation|0
180293|NCT00923091|572422|P7|Period VI (Open-Label)|Protocol Violation|0
180294|NCT00923091|572423|P6|Period VI (Open-Label)|Protocol Violation|0
180295|NCT00923091|572424|P5|Period VI (Open-Label)|Protocol Violation|4
180296|NCT00923091|572425|P4|Period VI (Open-Label)|Protocol Violation|1
180297|NCT00923091|572426|P3|Period VI (Open-Label)|Protocol Violation|3
180298|NCT00923091|572427|P2|Period VI (Open-Label)|Protocol Violation|1
180299|NCT00923091|572428|P1|Period VI (Open-Label)|Protocol Violation|6
180300|NCT00923091|572416|P13|Period VI (Open-Label)|Withdrawal by Subject|0
180301|NCT00923091|572417|P12|Period VI (Open-Label)|Withdrawal by Subject|0
180302|NCT00923091|572418|P11|Period VI (Open-Label)|Withdrawal by Subject|0
180303|NCT00923091|572419|P10|Period VI (Open-Label)|Withdrawal by Subject|0
180304|NCT00923091|572420|P9|Period VI (Open-Label)|Withdrawal by Subject|0
180305|NCT00923091|572421|P8|Period VI (Open-Label)|Withdrawal by Subject|0
180306|NCT00923091|572422|P7|Period VI (Open-Label)|Withdrawal by Subject|0
180307|NCT00923091|572423|P6|Period VI (Open-Label)|Withdrawal by Subject|0
180308|NCT00923091|572424|P5|Period VI (Open-Label)|Withdrawal by Subject|1
180309|NCT00923091|572425|P4|Period VI (Open-Label)|Withdrawal by Subject|0
180310|NCT00923091|572426|P3|Period VI (Open-Label)|Withdrawal by Subject|5
180311|NCT00923091|572427|P2|Period VI (Open-Label)|Withdrawal by Subject|7
180312|NCT00923091|572428|P1|Period VI (Open-Label)|Withdrawal by Subject|15
180313|NCT00923091|572416|P13|Period VI (Open-Label)|Adverse Event|0
180314|NCT00923091|572417|P12|Period VI (Open-Label)|Adverse Event|0
180315|NCT00923091|572418|P11|Period VI (Open-Label)|Adverse Event|0
180316|NCT00923091|572419|P10|Period VI (Open-Label)|Adverse Event|0
180317|NCT00923091|572420|P9|Period VI (Open-Label)|Adverse Event|0
180318|NCT00923091|572421|P8|Period VI (Open-Label)|Adverse Event|0
180319|NCT00923091|572422|P7|Period VI (Open-Label)|Adverse Event|0
180320|NCT00923091|572423|P6|Period VI (Open-Label)|Adverse Event|0
180321|NCT00923091|572424|P5|Period VI (Open-Label)|Adverse Event|1
180322|NCT00923091|572425|P4|Period VI (Open-Label)|Adverse Event|1
180323|NCT00923091|572426|P3|Period VI (Open-Label)|Adverse Event|4
180324|NCT00923091|572427|P2|Period VI (Open-Label)|Adverse Event|0
180325|NCT00923091|572428|P1|Period VI (Open-Label)|Adverse Event|17
180326|NCT00923091|572416|P13|Period V (Double -Blind)|Lost to Follow-up|0
180327|NCT00923091|572417|P12|Period V (Double -Blind)|Lost to Follow-up|0
180328|NCT00923091|572418|P11|Period V (Double -Blind)|Lost to Follow-up|1
180329|NCT00923091|572419|P10|Period V (Double -Blind)|Lost to Follow-up|0
180330|NCT00923091|572420|P9|Period V (Double -Blind)|Lost to Follow-up|0
180331|NCT00923091|572421|P8|Period V (Double -Blind)|Lost to Follow-up|0
180332|NCT00923091|572422|P7|Period V (Double -Blind)|Lost to Follow-up|0
180333|NCT00923091|572423|P6|Period V (Double -Blind)|Lost to Follow-up|0
180334|NCT00923091|572424|P5|Period V (Double -Blind)|Lost to Follow-up|0
180335|NCT00923091|572425|P4|Period V (Double -Blind)|Lost to Follow-up|0
180336|NCT00923091|572426|P3|Period V (Double -Blind)|Lost to Follow-up|0
180337|NCT00923091|572427|P2|Period V (Double -Blind)|Lost to Follow-up|0
180338|NCT00923091|572428|P1|Period V (Double -Blind)|Lost to Follow-up|0
180339|NCT00923091|572416|P13|Period V (Double -Blind)|Protocol Violation|1
180340|NCT00923091|572417|P12|Period V (Double -Blind)|Protocol Violation|0
180341|NCT00923091|572418|P11|Period V (Double -Blind)|Protocol Violation|0
180342|NCT00923091|572419|P10|Period V (Double -Blind)|Protocol Violation|0
180343|NCT00923091|572420|P9|Period V (Double -Blind)|Protocol Violation|0
180344|NCT00923091|572421|P8|Period V (Double -Blind)|Protocol Violation|0
180345|NCT00923091|572422|P7|Period V (Double -Blind)|Protocol Violation|0
180346|NCT00923091|572423|P6|Period V (Double -Blind)|Protocol Violation|0
180347|NCT00923091|572424|P5|Period V (Double -Blind)|Protocol Violation|0
180348|NCT00923091|572425|P4|Period V (Double -Blind)|Protocol Violation|0
180349|NCT00923091|572426|P3|Period V (Double -Blind)|Protocol Violation|0
180350|NCT00923091|572427|P2|Period V (Double -Blind)|Protocol Violation|0
180351|NCT00923091|572428|P1|Period V (Double -Blind)|Protocol Violation|0
180352|NCT00923091|572416|P13|Period V (Double -Blind)|Withdrawal by Subject|1
180353|NCT00923091|572417|P12|Period V (Double -Blind)|Withdrawal by Subject|0
180354|NCT00923091|572418|P11|Period V (Double -Blind)|Withdrawal by Subject|0
180355|NCT00923091|572419|P10|Period V (Double -Blind)|Withdrawal by Subject|0
180356|NCT00923091|572420|P9|Period V (Double -Blind)|Withdrawal by Subject|1
180357|NCT00923091|572421|P8|Period V (Double -Blind)|Withdrawal by Subject|0
180358|NCT00923091|572422|P7|Period V (Double -Blind)|Withdrawal by Subject|0
180359|NCT00923091|572423|P6|Period V (Double -Blind)|Withdrawal by Subject|0
180360|NCT00923091|572424|P5|Period V (Double -Blind)|Withdrawal by Subject|0
180361|NCT00923091|572425|P4|Period V (Double -Blind)|Withdrawal by Subject|0
180362|NCT00923091|572426|P3|Period V (Double -Blind)|Withdrawal by Subject|0
180363|NCT00923091|572427|P2|Period V (Double -Blind)|Withdrawal by Subject|0
180364|NCT00923091|572428|P1|Period V (Double -Blind)|Withdrawal by Subject|0
180365|NCT00923091|572416|P13|Period IV (Double-Blind)|Protocol Violation|0
180366|NCT00923091|572417|P12|Period IV (Double-Blind)|Protocol Violation|0
180367|NCT00923091|572418|P11|Period IV (Double-Blind)|Protocol Violation|0
180368|NCT00923091|572419|P10|Period IV (Double-Blind)|Protocol Violation|0
180369|NCT00923091|572420|P9|Period IV (Double-Blind)|Protocol Violation|0
180370|NCT00923091|572421|P8|Period IV (Double-Blind)|Protocol Violation|0
180371|NCT00923091|572422|P7|Period IV (Double-Blind)|Protocol Violation|0
180372|NCT00923091|572423|P6|Period IV (Double-Blind)|Protocol Violation|0
180373|NCT00923091|572424|P5|Period IV (Double-Blind)|Protocol Violation|0
180374|NCT00923091|572425|P4|Period IV (Double-Blind)|Protocol Violation|0
180375|NCT00923091|572426|P3|Period IV (Double-Blind)|Protocol Violation|0
180376|NCT00923091|572427|P2|Period IV (Double-Blind)|Protocol Violation|1
180377|NCT00923091|572428|P1|Period IV (Double-Blind)|Protocol Violation|0
180378|NCT00923091|572416|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
180379|NCT00923091|572417|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
180380|NCT00923091|572418|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
180381|NCT00923091|572419|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
180382|NCT00923091|572420|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
180383|NCT00923091|572421|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
180384|NCT00923091|572422|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
180385|NCT00923091|572423|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
180386|NCT00923091|572424|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
180387|NCT00923091|572425|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
180388|NCT00923091|572426|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
180389|NCT00923091|572427|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
180390|NCT00923091|572428|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
180391|NCT00923091|572416|P13|Period IV (Double-Blind)|Adverse Event|0
180392|NCT00923091|572417|P12|Period IV (Double-Blind)|Adverse Event|0
180393|NCT00923091|572418|P11|Period IV (Double-Blind)|Adverse Event|0
180394|NCT00923091|572419|P10|Period IV (Double-Blind)|Adverse Event|0
180395|NCT00923091|572420|P9|Period IV (Double-Blind)|Adverse Event|0
180396|NCT00923091|572421|P8|Period IV (Double-Blind)|Adverse Event|0
180397|NCT00923091|572422|P7|Period IV (Double-Blind)|Adverse Event|0
180398|NCT00923091|572423|P6|Period IV (Double-Blind)|Adverse Event|0
180399|NCT00923091|572424|P5|Period IV (Double-Blind)|Adverse Event|0
180400|NCT00923091|572425|P4|Period IV (Double-Blind)|Adverse Event|0
180401|NCT00923091|572426|P3|Period IV (Double-Blind)|Adverse Event|0
180402|NCT00923091|572427|P2|Period IV (Double-Blind)|Adverse Event|0
180403|NCT00923091|572428|P1|Period IV (Double-Blind)|Adverse Event|2
180404|NCT00923091|572416|P13|Period III (Single-Blind)|Lost to Follow-up|0
180405|NCT00923091|572417|P12|Period III (Single-Blind)|Lost to Follow-up|0
180406|NCT00923091|572418|P11|Period III (Single-Blind)|Lost to Follow-up|0
180407|NCT00923091|572419|P10|Period III (Single-Blind)|Lost to Follow-up|0
180408|NCT00923091|572420|P9|Period III (Single-Blind)|Lost to Follow-up|0
180409|NCT00923091|572421|P8|Period III (Single-Blind)|Lost to Follow-up|0
180410|NCT00923091|572422|P7|Period III (Single-Blind)|Lost to Follow-up|0
180411|NCT00923091|572423|P6|Period III (Single-Blind)|Lost to Follow-up|0
180412|NCT00923091|572424|P5|Period III (Single-Blind)|Lost to Follow-up|0
180413|NCT00923091|572425|P4|Period III (Single-Blind)|Lost to Follow-up|0
180414|NCT00923091|572426|P3|Period III (Single-Blind)|Lost to Follow-up|0
180415|NCT00923091|572427|P2|Period III (Single-Blind)|Lost to Follow-up|0
180416|NCT00923091|572428|P1|Period III (Single-Blind)|Lost to Follow-up|2
180417|NCT00923091|572416|P13|Period III (Single-Blind)|Protocol Violation|0
180418|NCT00923091|572417|P12|Period III (Single-Blind)|Protocol Violation|0
180419|NCT00923091|572418|P11|Period III (Single-Blind)|Protocol Violation|0
180420|NCT00923091|572419|P10|Period III (Single-Blind)|Protocol Violation|0
180421|NCT00923091|572420|P9|Period III (Single-Blind)|Protocol Violation|0
180422|NCT00923091|572421|P8|Period III (Single-Blind)|Protocol Violation|0
180423|NCT00923091|572422|P7|Period III (Single-Blind)|Protocol Violation|0
180424|NCT00923091|572423|P6|Period III (Single-Blind)|Protocol Violation|0
180425|NCT00923091|572424|P5|Period III (Single-Blind)|Protocol Violation|0
180426|NCT00923091|572425|P4|Period III (Single-Blind)|Protocol Violation|0
180427|NCT00923091|572426|P3|Period III (Single-Blind)|Protocol Violation|0
180428|NCT00923091|572427|P2|Period III (Single-Blind)|Protocol Violation|0
180429|NCT00923091|572428|P1|Period III (Single-Blind)|Protocol Violation|3
180430|NCT00923091|572416|P13|Period III (Single-Blind)|Withdrawal by Subject|0
180431|NCT00923091|572417|P12|Period III (Single-Blind)|Withdrawal by Subject|0
180432|NCT00923091|572418|P11|Period III (Single-Blind)|Withdrawal by Subject|0
180433|NCT00923091|572419|P10|Period III (Single-Blind)|Withdrawal by Subject|0
180434|NCT00923091|572420|P9|Period III (Single-Blind)|Withdrawal by Subject|0
180435|NCT00923091|572421|P8|Period III (Single-Blind)|Withdrawal by Subject|0
180436|NCT00923091|572422|P7|Period III (Single-Blind)|Withdrawal by Subject|0
180437|NCT00923091|572423|P6|Period III (Single-Blind)|Withdrawal by Subject|0
180438|NCT00923091|572424|P5|Period III (Single-Blind)|Withdrawal by Subject|0
180439|NCT00923091|572425|P4|Period III (Single-Blind)|Withdrawal by Subject|0
180440|NCT00923091|572426|P3|Period III (Single-Blind)|Withdrawal by Subject|0
180441|NCT00923091|572427|P2|Period III (Single-Blind)|Withdrawal by Subject|0
180442|NCT00923091|572428|P1|Period III (Single-Blind)|Withdrawal by Subject|10
180443|NCT00923091|572416|P13|Period III (Single-Blind)|Adverse Event|0
180444|NCT00923091|572417|P12|Period III (Single-Blind)|Adverse Event|0
180445|NCT00923091|572418|P11|Period III (Single-Blind)|Adverse Event|0
180446|NCT00923091|572419|P10|Period III (Single-Blind)|Adverse Event|0
180447|NCT00923091|572420|P9|Period III (Single-Blind)|Adverse Event|0
180448|NCT00923091|572421|P8|Period III (Single-Blind)|Adverse Event|0
180449|NCT00923091|572422|P7|Period III (Single-Blind)|Adverse Event|0
180450|NCT00923091|572423|P6|Period III (Single-Blind)|Adverse Event|0
180451|NCT00923091|572424|P5|Period III (Single-Blind)|Adverse Event|0
180452|NCT00923091|572425|P4|Period III (Single-Blind)|Adverse Event|0
180453|NCT00923091|572426|P3|Period III (Single-Blind)|Adverse Event|0
180454|NCT00923091|572427|P2|Period III (Single-Blind)|Adverse Event|0
180455|NCT00923091|572428|P1|Period III (Single-Blind)|Adverse Event|5
180456|NCT00923091|572416|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180457|NCT00923091|572417|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180458|NCT00923091|572418|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180459|NCT00923091|572419|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180460|NCT00923091|572420|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180461|NCT00923091|572421|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180462|NCT00923091|572422|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180463|NCT00923091|572423|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
180464|NCT00923091|572424|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180465|NCT00923091|572425|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
180466|NCT00923091|572426|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180467|NCT00923091|572427|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
180468|NCT00923091|572428|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
180469|NCT00923091|572416|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180470|NCT00923091|572417|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180471|NCT00923091|572418|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180472|NCT00923091|572419|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180473|NCT00923091|572420|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180474|NCT00923091|572421|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180475|NCT00923091|572422|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180476|NCT00923091|572423|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
180477|NCT00923091|572424|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180478|NCT00923091|572425|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180479|NCT00923091|572426|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180480|NCT00923091|572427|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180481|NCT00923091|572428|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
180482|NCT00923091|572416|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
180483|NCT00923091|572417|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
180484|NCT00923091|572418|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
180485|NCT00923091|572419|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
180486|NCT00923091|572420|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
180487|NCT00923091|572421|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
180488|NCT00923091|572422|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
180489|NCT00923091|572423|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
180490|NCT00923091|572424|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
180491|NCT00923091|572425|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
180492|NCT00923091|572426|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
180493|NCT00923091|572427|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
180494|NCT00923091|572428|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
180495|NCT00923091|572416|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
180496|NCT00923091|572417|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
180497|NCT00923091|572418|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
180498|NCT00923091|572419|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
180499|NCT00923091|572420|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
180500|NCT00923091|572421|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
180501|NCT00923091|572422|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
180502|NCT00923091|572423|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
180503|NCT00923091|572424|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
180504|NCT00923091|572425|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
180505|NCT00923091|572426|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
180506|NCT00923091|572427|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
180507|NCT00923091|572428|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
180508|NCT00923091|572416|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
180509|NCT00923091|572417|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
180510|NCT00923091|572418|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
180511|NCT00923091|572419|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
180512|NCT00923091|572420|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
180513|NCT00923091|572421|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
180514|NCT00923091|572422|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
180515|NCT00923091|572423|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
180516|NCT00923091|572424|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
180517|NCT00923091|572425|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
180518|NCT00923091|572426|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
180519|NCT00923091|572427|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
180520|NCT00923091|572428|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
180521|NCT00923130|572486|P1|Overall Study|Refused further treatment|2
180522|NCT00923130|572486|P1|Overall Study|Switched to alternative treatment|2
180523|NCT00923130|572486|P1|Overall Study|Discontinued treatment due to toxicities|3
180524|NCT00923130|572486|P1|Overall Study|Death|1
180525|NCT00923130|572486|P1|Overall Study|Stopped treatment due to progression|17
180526|NCT00923156|572505|P3|Overall Study|Lack of Efficacy|1
180527|NCT00923156|572506|P2|Overall Study|Lack of Efficacy|0
180528|NCT00923156|572507|P1|Overall Study|Lack of Efficacy|0
180529|NCT00923156|572505|P3|Overall Study|Death|0
180530|NCT00923156|572506|P2|Overall Study|Death|1
180531|NCT00923156|572507|P1|Overall Study|Death|0
180532|NCT00923156|572505|P3|Overall Study|Withdrawal by Subject|0
180533|NCT00923156|572506|P2|Overall Study|Withdrawal by Subject|1
180534|NCT00923156|572507|P1|Overall Study|Withdrawal by Subject|0
180535|NCT00923156|572505|P3|Overall Study|Abnormal laboratory values|1
180536|NCT00923156|572506|P2|Overall Study|Abnormal laboratory values|0
180537|NCT00923156|572507|P1|Overall Study|Abnormal laboratory values|0
180538|NCT00923156|572505|P3|Overall Study|Adverse Event|1
180539|NCT00923156|572506|P2|Overall Study|Adverse Event|2
180540|NCT00923156|572507|P1|Overall Study|Adverse Event|0
180541|NCT00923195|572535|P2|Overall Study|Death|1
180542|NCT00923195|572536|P1|Overall Study|Death|0
180543|NCT00923260|572575|P2|Overall Study|Lost to Follow-up|1
180544|NCT00923260|572576|P1|Overall Study|Lost to Follow-up|1
180545|NCT00923273|572713|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
180546|NCT00923273|572714|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
180547|NCT00923273|572715|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
180548|NCT00923273|572716|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
180549|NCT00923273|572717|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
180550|NCT00923273|572713|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
180551|NCT00923273|572714|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
180552|NCT00923273|572715|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
180553|NCT00923273|572716|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
180554|NCT00923273|572717|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
180555|NCT00923351|572742|P3|Overall Study|no apheresis/adequate tumor sample|12
180556|NCT00923351|572743|P2|Overall Study|no apheresis/adequate tumor sample|0
180557|NCT00923351|572744|P1|Overall Study|no apheresis/adequate tumor sample|0
180558|NCT00923845|572759|P2|Induction Therapy|Poor performance status|2
180559|NCT00923845|572760|P1|Induction Therapy|Poor performance status|0
180560|NCT00923936|572796|P2|Overall Study|Continuing in follow up period|1
180561|NCT00923936|572797|P1|Overall Study|Continuing in follow up period|2
180562|NCT00923936|572796|P2|Overall Study|Lost to follow up|0
180563|NCT00923936|572797|P1|Overall Study|Lost to follow up|2
180564|NCT00923936|572796|P2|Overall Study|Adverse Event|1
180565|NCT00923936|572797|P1|Overall Study|Adverse Event|2
180566|NCT00923936|572796|P2|Overall Study|progressive disease on study|1
180567|NCT00923936|572797|P1|Overall Study|progressive disease on study|2
180568|NCT00923975|572821|P1|Overall Study|Did not meet inclusion criteria|1
180569|NCT00924287|572909|P1|Overall Study|Death|1
180570|NCT00924313|572915|P1|Overall Study|not imaged due to failed tracer imaging|1
180571|NCT00924404|572943|P2|Overall Study|Lost to Follow-up|4
180572|NCT00924404|572944|P1|Overall Study|Lost to Follow-up|6
180573|NCT00924443|572950|P1|Overall Study|Protocol Violation|1
180574|NCT00924443|572950|P1|Overall Study|Physician Decision|2
180575|NCT00924469|572960|P2|Overall Study|Lost to Follow-up|1
180576|NCT00924469|572961|P1|Overall Study|Lost to Follow-up|0
180577|NCT00924469|572960|P2|Overall Study|Withdrawal by Subject|1
180578|NCT00924469|572961|P1|Overall Study|Withdrawal by Subject|0
180579|NCT00924469|572960|P2|Overall Study|Adverse Event|0
180580|NCT00924469|572961|P1|Overall Study|Adverse Event|2
180581|NCT00924508|572988|P1|Overall Study|Withdrawal by Subject|3
180582|NCT00924560|572998|P3|Overall Study|Miscellaneous Reasons|10
180583|NCT00924560|572999|P2|Overall Study|Miscellaneous Reasons|10
180584|NCT00924560|573000|P1|Overall Study|Miscellaneous Reasons|13
180585|NCT00924560|572998|P3|Overall Study|Lost to Follow-up|45
180586|NCT00924560|572999|P2|Overall Study|Lost to Follow-up|94
180587|NCT00924560|573000|P1|Overall Study|Lost to Follow-up|78
180588|NCT00924560|572998|P3|Overall Study|Pregnancy|1
180589|NCT00924560|572999|P2|Overall Study|Pregnancy|7
180590|NCT00924560|573000|P1|Overall Study|Pregnancy|5
180591|NCT00924560|572998|P3|Overall Study|Adverse Event|0
180592|NCT00924560|572999|P2|Overall Study|Adverse Event|33
180593|NCT00924560|573000|P1|Overall Study|Adverse Event|39
180594|NCT00924560|572998|P3|Overall Study|Withdrawal by Subject|18
180595|NCT00924560|572999|P2|Overall Study|Withdrawal by Subject|44
180596|NCT00924560|573000|P1|Overall Study|Withdrawal by Subject|50
180597|NCT00924560|572998|P3|Overall Study|Physician Decision|4
180598|NCT00924560|572999|P2|Overall Study|Physician Decision|3
180599|NCT00924560|573000|P1|Overall Study|Physician Decision|2
180600|NCT00924560|572998|P3|Overall Study|Non Compliance with the Protocol|4
180601|NCT00924560|572999|P2|Overall Study|Non Compliance with the Protocol|15
180602|NCT00924560|573000|P1|Overall Study|Non Compliance with the Protocol|20
180603|NCT00924560|572998|P3|Overall Study|Did Not Meet Protocol Requirements|1
180604|NCT00924560|572999|P2|Overall Study|Did Not Meet Protocol Requirements|2
180605|NCT00924560|573000|P1|Overall Study|Did Not Meet Protocol Requirements|4
180606|NCT00924638|573046|P2|Overall Study|Physician Decision|3
180607|NCT00924638|573047|P1|Overall Study|Physician Decision|3
180608|NCT00924638|573046|P2|Overall Study|Withdrawal by Subject|7
180609|NCT00924638|573047|P1|Overall Study|Withdrawal by Subject|5
180610|NCT00924638|573046|P2|Overall Study|Lost to Follow-up|1
180611|NCT00924638|573047|P1|Overall Study|Lost to Follow-up|1
180612|NCT00924638|573046|P2|Overall Study|Death|2
180613|NCT00924638|573047|P1|Overall Study|Death|3
180614|NCT00924651|573068|P2|Overall Study|Incomplete Form|1
180615|NCT00924651|573069|P1|Overall Study|Incomplete Form|2
180616|NCT00924651|573068|P2|Overall Study|Changed Mind|1
180617|NCT00924651|573069|P1|Overall Study|Changed Mind|10
180618|NCT00924651|573068|P2|Overall Study|Medical|3
180619|NCT00924651|573069|P1|Overall Study|Medical|1
180620|NCT00924651|573068|P2|Overall Study|Noncompliant|4
180621|NCT00924651|573069|P1|Overall Study|Noncompliant|1
180622|NCT00924651|573068|P2|Overall Study|Overwhelmed|6
180623|NCT00924651|573069|P1|Overall Study|Overwhelmed|6
180624|NCT00924651|573068|P2|Overall Study|No Reason|7
180625|NCT00924651|573069|P1|Overall Study|No Reason|3
180626|NCT00924651|573068|P2|Overall Study|Chemo started too soon|3
180627|NCT00924651|573069|P1|Overall Study|Chemo started too soon|2
180628|NCT00924729|573077|P2|Overall Study|Protocol Violation|0
180629|NCT00924729|573078|P1|Overall Study|Protocol Violation|1
180630|NCT00924729|573077|P2|Overall Study|insufficient volume for analysis|0
180631|NCT00924729|573078|P1|Overall Study|insufficient volume for analysis|1
180632|NCT00924781|573088|P2|Overall Study|Study terminated by sponsor|10
180633|NCT00924781|573089|P1|Overall Study|Study terminated by sponsor|12
180634|NCT00924898|573144|P1|Overall Study|Withdrawal by Subject|2
180635|NCT00924950|573153|P1|Overall Study|Lost to Follow-up|2
180636|NCT00925015|573161|P3|Overall Study|Withdrawal by Subject|1
180637|NCT00925015|573162|P2|Overall Study|Withdrawal by Subject|0
180638|NCT00925015|573163|P1|Overall Study|Withdrawal by Subject|0
180639|NCT00925015|573161|P3|Overall Study|Progressive Disease|4
180640|NCT00925015|573162|P2|Overall Study|Progressive Disease|3
180641|NCT00925015|573163|P1|Overall Study|Progressive Disease|7
180642|NCT00925015|573161|P3|Overall Study|Physician Decision|0
180643|NCT00925015|573162|P2|Overall Study|Physician Decision|1
180644|NCT00925015|573163|P1|Overall Study|Physician Decision|0
180645|NCT00925015|573161|P3|Overall Study|Adverse Event|1
180646|NCT00925015|573162|P2|Overall Study|Adverse Event|2
180647|NCT00925015|573163|P1|Overall Study|Adverse Event|1
180648|NCT00925132|573219|P5|Overall Study|Removed due to disease progression|4
180649|NCT00925132|573220|P4|Overall Study|Removed due to disease progression|0
180650|NCT00925132|573221|P3|Overall Study|Removed due to disease progression|0
180651|NCT00925132|573222|P2|Overall Study|Removed due to disease progression|0
180652|NCT00925132|573223|P1|Overall Study|Removed due to disease progression|0
180653|NCT00925132|573219|P5|Overall Study|Withdrawal by Subject|1
180654|NCT00925132|573220|P4|Overall Study|Withdrawal by Subject|0
180655|NCT00925132|573221|P3|Overall Study|Withdrawal by Subject|0
180656|NCT00925132|573222|P2|Overall Study|Withdrawal by Subject|0
180657|NCT00925132|573223|P1|Overall Study|Withdrawal by Subject|2
180658|NCT00925288|573231|P2|Overall Study|Lost to Follow-up|7
180659|NCT00925288|573232|P1|Overall Study|Lost to Follow-up|9
180660|NCT00925353|573244|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
180661|NCT00925548|573254|P2|Overall Study|Discontinuation of trial by sponsor|5
180662|NCT00925548|573255|P1|Overall Study|Discontinuation of trial by sponsor|10
180663|NCT00925587|573283|P2|Overall Study|Lost to Follow-up|1
180664|NCT00925587|573284|P1|Overall Study|Lost to Follow-up|0
180665|NCT00925587|573283|P2|Overall Study|Adverse Event|2
180666|NCT00925587|573284|P1|Overall Study|Adverse Event|6
180667|NCT00925587|573283|P2|Overall Study|Death|5
180668|NCT00925587|573284|P1|Overall Study|Death|5
180669|NCT00925587|573283|P2|Overall Study|Withdrawal by Subject|6
180670|NCT00925587|573284|P1|Overall Study|Withdrawal by Subject|9
180671|NCT00925587|573283|P2|Overall Study|Protocol Violation|4
180672|NCT00925587|573284|P1|Overall Study|Protocol Violation|6
180673|NCT00925587|573283|P2|Overall Study|Physician Decision|1
180674|NCT00925587|573284|P1|Overall Study|Physician Decision|4
180675|NCT00925587|573283|P2|Overall Study|Protocol Specified Criteria|6
180676|NCT00925587|573284|P1|Overall Study|Protocol Specified Criteria|6
180677|NCT00925600|573398|P2|Overall Study|Adverse Event|2
180678|NCT00925600|573399|P1|Overall Study|Adverse Event|1
180679|NCT00925600|573398|P2|Overall Study|Other|1
180680|NCT00925600|573399|P1|Overall Study|Other|3
180681|NCT00925600|573398|P2|Overall Study|Requirement for Alternative Therapy|1
180682|NCT00925600|573399|P1|Overall Study|Requirement for Alternative Therapy|0
180683|NCT00925600|573398|P2|Overall Study|Protocol Deviation|1
180684|NCT00925600|573399|P1|Overall Study|Protocol Deviation|0
180685|NCT00925600|573398|P2|Overall Study|Ineligibility Determined|0
180686|NCT00925600|573399|P1|Overall Study|Ineligibility Determined|2
180687|NCT00925600|573398|P2|Overall Study|Noncompliance|0
180688|NCT00925600|573399|P1|Overall Study|Noncompliance|2
180689|NCT00925600|573398|P2|Overall Study|Administrative Decision|1
180690|NCT00925600|573399|P1|Overall Study|Administrative Decision|1
180691|NCT00925600|573398|P2|Overall Study|Disease Progression|3
180692|NCT00925600|573399|P1|Overall Study|Disease Progression|1
180693|NCT00925600|573398|P2|Overall Study|Lost to Follow-up|2
180694|NCT00925600|573399|P1|Overall Study|Lost to Follow-up|2
180695|NCT00925600|573398|P2|Overall Study|Death|3
180696|NCT00925600|573399|P1|Overall Study|Death|4
180697|NCT00925600|573398|P2|Overall Study|Withdrawal by Subject|14
180698|NCT00925600|573399|P1|Overall Study|Withdrawal by Subject|16
180699|NCT00915876|573421|P2|Overall Study|Adverse Event|1
180700|NCT00915876|573422|P1|Overall Study|Adverse Event|0
180701|NCT00916006|573441|P2|Overall Study|Protocol Violation|1
180702|NCT00916006|573442|P1|Overall Study|Protocol Violation|0
180703|NCT00916006|573441|P2|Overall Study|Withdrawal by Subject|5
180704|NCT00916006|573442|P1|Overall Study|Withdrawal by Subject|2
180705|NCT00916006|573441|P2|Overall Study|Adverse Event|1
180706|NCT00916006|573442|P1|Overall Study|Adverse Event|1
180707|NCT00916279|573502|P1|Overall Study|Lost to Follow-up|2
180708|NCT00916279|573502|P1|Overall Study|Death|2
180709|NCT00916305|573512|P2|Overall Study|Withdrawal by Subject|1
180710|NCT00916305|573513|P1|Overall Study|Withdrawal by Subject|0
180711|NCT00916305|573512|P2|Overall Study|Lost to Follow-up|27
180712|NCT00916305|573513|P1|Overall Study|Lost to Follow-up|21
180713|NCT00916344|573521|P1|Overall Study|Drop-out|5
180714|NCT00916344|573521|P1|Overall Study|ICD upgrade|1
180715|NCT00916344|573521|P1|Overall Study|Death|2
180716|NCT00916357|573526|P6|Period 2|Weight loss > 3 kilograms (kg)|0
180717|NCT00916357|573527|P5|Period 2|Weight loss > 3 kilograms (kg)|0
180718|NCT00916357|573528|P4|Period 2|Weight loss > 3 kilograms (kg)|1
180719|NCT00916357|573529|P3|Period 2|Weight loss > 3 kilograms (kg)|0
180720|NCT00916357|573530|P2|Period 2|Weight loss > 3 kilograms (kg)|0
180721|NCT00916357|573531|P1|Period 2|Weight loss > 3 kilograms (kg)|0
180722|NCT00916357|573526|P6|Period 1|Withdrawal by Subject|0
180723|NCT00916357|573527|P5|Period 1|Withdrawal by Subject|0
180724|NCT00916357|573528|P4|Period 1|Withdrawal by Subject|0
180725|NCT00916357|573529|P3|Period 1|Withdrawal by Subject|0
180726|NCT00916357|573530|P2|Period 1|Withdrawal by Subject|0
180727|NCT00916357|573531|P1|Period 1|Withdrawal by Subject|1
180728|NCT00916370|573571|P2|Overall Study|Physician Decision|1
180729|NCT00916370|573572|P1|Overall Study|Physician Decision|0
180730|NCT00916370|573571|P2|Overall Study|Withdrawal by Subject|0
180731|NCT00916370|573572|P1|Overall Study|Withdrawal by Subject|2
180732|NCT00916370|573571|P2|Overall Study|Death|1
180733|NCT00916370|573572|P1|Overall Study|Death|3
180734|NCT00916383|573746|P1|Overall Study|Protocol Violation|1
180735|NCT00916383|573746|P1|Overall Study|Death|1
180736|NCT00916383|573746|P1|Overall Study|Adverse Event|1
180737|NCT00916617|573801|P4|Overall Study|Not specified|2
180738|NCT00916617|573802|P3|Overall Study|Not specified|0
180739|NCT00916617|573803|P2|Overall Study|Not specified|0
180740|NCT00916617|573804|P1|Overall Study|Not specified|2
180741|NCT00916617|573801|P4|Overall Study|Lack of Efficacy|0
180742|NCT00916617|573802|P3|Overall Study|Lack of Efficacy|0
180743|NCT00916617|573803|P2|Overall Study|Lack of Efficacy|0
180744|NCT00916617|573804|P1|Overall Study|Lack of Efficacy|1
180745|NCT00916617|573801|P4|Overall Study|Lost to Follow-up|0
180746|NCT00916617|573802|P3|Overall Study|Lost to Follow-up|0
180747|NCT00916617|573803|P2|Overall Study|Lost to Follow-up|1
180748|NCT00916617|573804|P1|Overall Study|Lost to Follow-up|2
180749|NCT00916617|573801|P4|Overall Study|Discontinuation of Study by Sponsor|1
180750|NCT00916617|573802|P3|Overall Study|Discontinuation of Study by Sponsor|3
180751|NCT00916617|573803|P2|Overall Study|Discontinuation of Study by Sponsor|13
180752|NCT00916617|573804|P1|Overall Study|Discontinuation of Study by Sponsor|8
180753|NCT00916617|573801|P4|Overall Study|Physician Decision|0
180754|NCT00916617|573802|P3|Overall Study|Physician Decision|0
180755|NCT00916617|573803|P2|Overall Study|Physician Decision|1
180756|NCT00916617|573804|P1|Overall Study|Physician Decision|1
180757|NCT00916617|573801|P4|Overall Study|Caregiver Request|0
180758|NCT00916617|573802|P3|Overall Study|Caregiver Request|1
180759|NCT00916617|573803|P2|Overall Study|Caregiver Request|2
180760|NCT00916617|573804|P1|Overall Study|Caregiver Request|3
180761|NCT00916617|573801|P4|Overall Study|Withdrawal by Subject|1
180762|NCT00916617|573802|P3|Overall Study|Withdrawal by Subject|0
180763|NCT00916617|573803|P2|Overall Study|Withdrawal by Subject|2
180764|NCT00916617|573804|P1|Overall Study|Withdrawal by Subject|3
180765|NCT00916617|573801|P4|Overall Study|Adverse Event|3
180766|NCT00916617|573802|P3|Overall Study|Adverse Event|6
180767|NCT00916617|573803|P2|Overall Study|Adverse Event|2
180768|NCT00916617|573804|P1|Overall Study|Adverse Event|3
180769|NCT00916721|573827|P2|Overall Study|Protocol Violation|4
180770|NCT00916721|573828|P1|Overall Study|Protocol Violation|2
180771|NCT00916721|573827|P2|Overall Study|Withdrawal by Subject|2
180772|NCT00916721|573828|P1|Overall Study|Withdrawal by Subject|2
180773|NCT00916721|573827|P2|Overall Study|Adverse Event|3
180774|NCT00916721|573828|P1|Overall Study|Adverse Event|6
180775|NCT00916721|573827|P2|Overall Study|Lost to Follow-up|1
180776|NCT00916721|573828|P1|Overall Study|Lost to Follow-up|0
180777|NCT00916929|573842|P2|Overall Study|Device unable to process impedance data|7
180778|NCT00916929|573843|P1|Overall Study|Device unable to process impedance data|0
180779|NCT00916929|573842|P2|Overall Study|Moved to another state|1
180780|NCT00916929|573843|P1|Overall Study|Moved to another state|0
180781|NCT00916929|573842|P2|Overall Study|System explant|0
180782|NCT00916929|573843|P1|Overall Study|System explant|1
180783|NCT00916929|573842|P2|Overall Study|Transferred to hospice care|1
180784|NCT00916929|573843|P1|Overall Study|Transferred to hospice care|1
180785|NCT00916929|573842|P2|Overall Study|Left ventricular epicardial lead|2
180786|NCT00916929|573843|P1|Overall Study|Left ventricular epicardial lead|1
180787|NCT00916929|573842|P2|Overall Study|Withdrawal by Subject|5
180788|NCT00916929|573843|P1|Overall Study|Withdrawal by Subject|1
180789|NCT00916929|573842|P2|Overall Study|Death|10
180790|NCT00916929|573843|P1|Overall Study|Death|5
180791|NCT00916929|573842|P2|Overall Study|Lost to Follow-up|3
180792|NCT00916929|573843|P1|Overall Study|Lost to Follow-up|1
180793|NCT00917124|573853|P2|Overall Study|Protocol Violation|6
180794|NCT00917124|573854|P1|Overall Study|Protocol Violation|4
180795|NCT00917267|573864|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
180796|NCT00917267|573865|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
180797|NCT00917267|573864|P2|Overall Study|Sponsor Decision|5
180798|NCT00917267|573865|P1|Overall Study|Sponsor Decision|5
180799|NCT00917267|573864|P2|Overall Study|Entry Criteria Not Met|0
180800|NCT00917267|573865|P1|Overall Study|Entry Criteria Not Met|1
180801|NCT00917267|573864|P2|Overall Study|Lost to follow up|2
180802|NCT00917267|573865|P1|Overall Study|Lost to follow up|0
180803|NCT00917267|573864|P2|Overall Study|Withdrawal by Subject|12
180804|NCT00917267|573865|P1|Overall Study|Withdrawal by Subject|5
180805|NCT00917267|573864|P2|Overall Study|Protocol Violation|18
180806|NCT00917267|573865|P1|Overall Study|Protocol Violation|9
180807|NCT00917267|573864|P2|Overall Study|Physician Decision|4
180808|NCT00917267|573865|P1|Overall Study|Physician Decision|2
180809|NCT00917267|573864|P2|Overall Study|Adverse Event|36
180810|NCT00917267|573865|P1|Overall Study|Adverse Event|15
180811|NCT00917384|573893|P2|Overall Study|Withdrawal by Subject|2
180812|NCT00917384|573894|P1|Overall Study|Withdrawal by Subject|10
180813|NCT00917384|573893|P2|Overall Study|Lost to Follow-up|2
180814|NCT00917384|573894|P1|Overall Study|Lost to Follow-up|4
180815|NCT00917501|573918|P2|Overall Study|trouble swollowing capsules|1
180816|NCT00917501|573919|P1|Overall Study|trouble swollowing capsules|0
180817|NCT00917501|573918|P2|Overall Study|Lack of Efficacy|2
180818|NCT00917501|573919|P1|Overall Study|Lack of Efficacy|1
180819|NCT00917501|573918|P2|Overall Study|Withdrawal by Subject|1
180820|NCT00917501|573919|P1|Overall Study|Withdrawal by Subject|3
180821|NCT00917501|573918|P2|Overall Study|Lost to Follow-up|1
180822|NCT00917501|573919|P1|Overall Study|Lost to Follow-up|4
180823|NCT00917579|573925|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
180824|NCT00917579|573926|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
180825|NCT00917579|573925|P2|Washout >= 2 Weeks|Adverse Event|0
180826|NCT00917579|573926|P1|Washout >= 2 Weeks|Adverse Event|1
180827|NCT00917644|573940|P2|Period 2: Second Intervention|family emergency|0
180828|NCT00917644|573941|P1|Period 2: Second Intervention|family emergency|1
180829|NCT00917644|573940|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
180830|NCT00917644|573941|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
180831|NCT00917644|573940|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
180832|NCT00917644|573941|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
180833|NCT00917852|573968|P1|Overall Study|Death|6
180834|NCT00918138|574000|P2|Overall Study|Death|0
180835|NCT00918138|574001|P1|Overall Study|Death|1
180836|NCT00918138|574000|P2|Overall Study|Subject withdrew consent|1
180837|NCT00918138|574001|P1|Overall Study|Subject withdrew consent|1
180838|NCT00918203|574017|P3|Crossover to Olaratumab Monotherapy|Other Therapy Started|1
180839|NCT00918203|574018|P2|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
180840|NCT00918203|574019|P1|Crossover to Olaratumab Monotherapy|Other Therapy Started|0
180841|NCT00918203|574017|P3|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|2
180842|NCT00918203|574018|P2|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
180843|NCT00918203|574019|P1|Crossover to Olaratumab Monotherapy|Withdrawal by Subject|0
180844|NCT00918203|574017|P3|Treatment With or Without Olaratumab|On Treatment|0
180845|NCT00918203|574018|P2|Treatment With or Without Olaratumab|On Treatment|0
180846|NCT00918203|574019|P1|Treatment With or Without Olaratumab|On Treatment|1
180847|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Physician Decision|0
180848|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Physician Decision|1
180849|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Physician Decision|0
180850|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
180851|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Off Study Treatment/Alive|1
180852|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Off Study Treatment/Alive|0
180853|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Never Treated|0
180854|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Never Treated|1
180855|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Never Treated|2
180856|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Adverse Event|0
180857|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Adverse Event|1
180858|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Adverse Event|1
180859|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
180860|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
180861|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
180862|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
180863|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Lost to Follow-up|0
180864|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
180865|NCT00918203|574017|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
180866|NCT00918203|574018|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|9
180867|NCT00918203|574019|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|0
180868|NCT00918255|574051|P3|Overall Study|Investigator discretion|0
180869|NCT00918255|574052|P2|Overall Study|Investigator discretion|0
180870|NCT00918255|574053|P1|Overall Study|Investigator discretion|1
180871|NCT00918255|574051|P3|Overall Study|Non-compliance|0
180872|NCT00918255|574052|P2|Overall Study|Non-compliance|0
180873|NCT00918255|574053|P1|Overall Study|Non-compliance|1
180874|NCT00918255|574051|P3|Overall Study|Exceeded allowed number of interventions|1
180875|NCT00918255|574052|P2|Overall Study|Exceeded allowed number of interventions|0
180876|NCT00918255|574053|P1|Overall Study|Exceeded allowed number of interventions|0
180877|NCT00918255|574051|P3|Overall Study|Lost to Follow-up|2
180878|NCT00918255|574052|P2|Overall Study|Lost to Follow-up|0
180879|NCT00918255|574053|P1|Overall Study|Lost to Follow-up|1
180880|NCT00918255|574051|P3|Overall Study|Lack of Efficacy|0
180881|NCT00918255|574052|P2|Overall Study|Lack of Efficacy|0
180882|NCT00918255|574053|P1|Overall Study|Lack of Efficacy|1
180883|NCT00918255|574051|P3|Overall Study|Withdrawal by Subject|2
180884|NCT00918255|574052|P2|Overall Study|Withdrawal by Subject|0
180885|NCT00918255|574053|P1|Overall Study|Withdrawal by Subject|1
180886|NCT00918255|574051|P3|Overall Study|Adverse Event|0
180887|NCT00918255|574052|P2|Overall Study|Adverse Event|0
180888|NCT00918255|574053|P1|Overall Study|Adverse Event|1
180889|NCT00918281|574079|P1|Overall Study|Physician Decision|29
180890|NCT00925704|574092|P6|Third Intervention|Withdrew consent|1
180891|NCT00925704|574093|P5|Third Intervention|Withdrew consent|0
180892|NCT00925704|574094|P4|Third Intervention|Withdrew consent|0
180893|NCT00925704|574095|P3|Third Intervention|Withdrew consent|0
180894|NCT00925704|574096|P2|Third Intervention|Withdrew consent|0
180895|NCT00925704|574097|P1|Third Intervention|Withdrew consent|0
180896|NCT00925704|574092|P6|Second Intervention|Withdrawal by Subject|0
180897|NCT00925704|574093|P5|Second Intervention|Withdrawal by Subject|1
180898|NCT00925704|574094|P4|Second Intervention|Withdrawal by Subject|0
180899|NCT00925704|574095|P3|Second Intervention|Withdrawal by Subject|0
180900|NCT00925704|574096|P2|Second Intervention|Withdrawal by Subject|0
180901|NCT00925704|574097|P1|Second Intervention|Withdrawal by Subject|1
180902|NCT00925704|574092|P6|First Intervention|Withdrew consent|0
180903|NCT00925704|574093|P5|First Intervention|Withdrew consent|1
180904|NCT00925704|574094|P4|First Intervention|Withdrew consent|1
180905|NCT00925704|574095|P3|First Intervention|Withdrew consent|0
180906|NCT00925704|574096|P2|First Intervention|Withdrew consent|0
180907|NCT00925704|574097|P1|First Intervention|Withdrew consent|0
180908|NCT00925769|574108|P6|Overall Study|Adverse Event|0
180909|NCT00925769|574109|P5|Overall Study|Adverse Event|1
180910|NCT00925769|574110|P4|Overall Study|Adverse Event|0
180911|NCT00925769|574111|P3|Overall Study|Adverse Event|0
180912|NCT00925769|574112|P2|Overall Study|Adverse Event|0
180913|NCT00925769|574113|P1|Overall Study|Adverse Event|0
180914|NCT00925769|574108|P6|Overall Study|Participant is unable to swallow drug|0
180915|NCT00925769|574109|P5|Overall Study|Participant is unable to swallow drug|0
180916|NCT00925769|574110|P4|Overall Study|Participant is unable to swallow drug|1
180917|NCT00925769|574111|P3|Overall Study|Participant is unable to swallow drug|0
180918|NCT00925769|574112|P2|Overall Study|Participant is unable to swallow drug|0
180919|NCT00925769|574113|P1|Overall Study|Participant is unable to swallow drug|0
180920|NCT00925769|574108|P6|Overall Study|End of study visit not done|0
180921|NCT00925769|574109|P5|Overall Study|End of study visit not done|0
180922|NCT00925769|574110|P4|Overall Study|End of study visit not done|0
180923|NCT00925769|574111|P3|Overall Study|End of study visit not done|1
180924|NCT00925769|574112|P2|Overall Study|End of study visit not done|0
180925|NCT00925769|574113|P1|Overall Study|End of study visit not done|0
180926|NCT00925769|574108|P6|Overall Study|Missing documentation|0
180927|NCT00925769|574109|P5|Overall Study|Missing documentation|0
180928|NCT00925769|574110|P4|Overall Study|Missing documentation|0
180929|NCT00925769|574111|P3|Overall Study|Missing documentation|0
180930|NCT00925769|574112|P2|Overall Study|Missing documentation|1
180931|NCT00925769|574113|P1|Overall Study|Missing documentation|0
180932|NCT00925769|574108|P6|Overall Study|Physician Decision|0
180933|NCT00925769|574109|P5|Overall Study|Physician Decision|0
180934|NCT00925769|574110|P4|Overall Study|Physician Decision|0
180935|NCT00925769|574111|P3|Overall Study|Physician Decision|0
180936|NCT00925769|574112|P2|Overall Study|Physician Decision|0
180937|NCT00925769|574113|P1|Overall Study|Physician Decision|1
180938|NCT00925769|574108|P6|Overall Study|Death|0
180939|NCT00925769|574109|P5|Overall Study|Death|0
180940|NCT00925769|574110|P4|Overall Study|Death|0
180941|NCT00925769|574111|P3|Overall Study|Death|1
180942|NCT00925769|574112|P2|Overall Study|Death|0
180943|NCT00925769|574113|P1|Overall Study|Death|0
180944|NCT00925769|574108|P6|Overall Study|Disease progression|3
180945|NCT00925769|574109|P5|Overall Study|Disease progression|2
180946|NCT00925769|574110|P4|Overall Study|Disease progression|4
180947|NCT00925769|574111|P3|Overall Study|Disease progression|3
180948|NCT00925769|574112|P2|Overall Study|Disease progression|5
180949|NCT00925769|574113|P1|Overall Study|Disease progression|4
180950|NCT00925769|574108|P6|Overall Study|Major toxicity|0
180951|NCT00925769|574109|P5|Overall Study|Major toxicity|0
180952|NCT00925769|574110|P4|Overall Study|Major toxicity|1
180953|NCT00925769|574111|P3|Overall Study|Major toxicity|1
180954|NCT00925769|574112|P2|Overall Study|Major toxicity|0
180955|NCT00925769|574113|P1|Overall Study|Major toxicity|1
180956|NCT00925899|574187|P2|Part 1|Withdrawal by Subject|9
180957|NCT00925899|574188|P1|Part 1|Withdrawal by Subject|10
180958|NCT00925899|574187|P2|Part 1|Death|2
180959|NCT00925899|574188|P1|Part 1|Death|1
180960|NCT00926211|574252|P1|Overall Study|Lost to Follow-up|1
180961|NCT00926289|574295|P2|Overall Study|not specified|3
180962|NCT00926289|574296|P1|Overall Study|not specified|1
180963|NCT00926289|574295|P2|Overall Study|Withdrawal by Subject|4
180964|NCT00926289|574296|P1|Overall Study|Withdrawal by Subject|4
180965|NCT00926289|574295|P2|Overall Study|Lost to Follow-up|6
180966|NCT00926289|574296|P1|Overall Study|Lost to Follow-up|3
180967|NCT00926289|574295|P2|Overall Study|Protocol Violation|12
180968|NCT00926289|574296|P1|Overall Study|Protocol Violation|8
180969|NCT00926289|574295|P2|Overall Study|Adverse Event|11
180970|NCT00926289|574296|P1|Overall Study|Adverse Event|9
180971|NCT00926328|574332|P2|Overall Study|Lost to Follow-up|14
180972|NCT00926328|574333|P1|Overall Study|Lost to Follow-up|12
180973|NCT00926367|574343|P2|Overall Study|Skin Irritation|2
180974|NCT00926367|574344|P1|Overall Study|Skin Irritation|1
180975|NCT00926367|574343|P2|Overall Study|Lost to Follow-up|0
180976|NCT00926367|574344|P1|Overall Study|Lost to Follow-up|1
180977|NCT00926367|574343|P2|Overall Study|Withdrawal by Subject|1
180978|NCT00926367|574344|P1|Overall Study|Withdrawal by Subject|0
180979|NCT00926393|574386|P2|Overall Study|Adverse Event|1
180980|NCT00926393|574387|P1|Overall Study|Adverse Event|1
180981|NCT00926393|574386|P2|Overall Study|Withdrawal by Subject|2
180982|NCT00926393|574387|P1|Overall Study|Withdrawal by Subject|1
180983|NCT00926536|574430|P2|Overall Study|Physician Decision|2
180984|NCT00926536|574431|P1|Overall Study|Physician Decision|1
180985|NCT00926575|574441|P2|Overall Study|Withdrawal by Subject|9
180986|NCT00926575|574442|P1|Overall Study|Withdrawal by Subject|8
180987|NCT00926575|574441|P2|Overall Study|Protocol Violation|0
180988|NCT00926575|574442|P1|Overall Study|Protocol Violation|1
180989|NCT00926575|574441|P2|Overall Study|Physician Decision|2
180990|NCT00926575|574442|P1|Overall Study|Physician Decision|1
180991|NCT00926575|574441|P2|Overall Study|Lost to Follow-up|1
180992|NCT00926575|574442|P1|Overall Study|Lost to Follow-up|1
180993|NCT00926575|574441|P2|Overall Study|Death|4
180994|NCT00926575|574442|P1|Overall Study|Death|4
180995|NCT00926575|574441|P2|Overall Study|Adverse Event|1
180996|NCT00926575|574442|P1|Overall Study|Adverse Event|1
180997|NCT00926783|574463|P2|Overall Study|Incomplete CFAE Procedures|3
180998|NCT00926783|574464|P1|Overall Study|Incomplete CFAE Procedures|3
180999|NCT00926796|574482|P2|Overall Study|Withdrawal by Subject|0
181000|NCT00926796|574483|P1|Overall Study|Withdrawal by Subject|1
181001|NCT00926796|574482|P2|Overall Study|Protocol Violation|11
181002|NCT00926796|574483|P1|Overall Study|Protocol Violation|15
181003|NCT00926796|574482|P2|Overall Study|Lost to Follow-up|13
181004|NCT00926796|574483|P1|Overall Study|Lost to Follow-up|22
181005|NCT00926796|574482|P2|Overall Study|Adverse Event|14
181006|NCT00926796|574483|P1|Overall Study|Adverse Event|7
181007|NCT00926796|574482|P2|Overall Study|Ineligible, but positive for gonorrhea|1
181008|NCT00926796|574483|P1|Overall Study|Ineligible, but positive for gonorrhea|1
181009|NCT00926796|574482|P2|Overall Study|Ineligible, negative for gonorrhea|60
181010|NCT00926796|574483|P1|Overall Study|Ineligible, negative for gonorrhea|57
181011|NCT00926796|574482|P2|Overall Study|Did not receive randomized treatment|7
181012|NCT00926796|574483|P1|Overall Study|Did not receive randomized treatment|4
181013|NCT00927069|574529|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
181014|NCT00927069|574530|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
181015|NCT00927069|574531|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
181016|NCT00927069|574532|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
181017|NCT00927069|574529|P4|Week 12 to Week 24|Withdrawal by Subject|0
181018|NCT00927069|574530|P3|Week 12 to Week 24|Withdrawal by Subject|0
181019|NCT00927069|574531|P2|Week 12 to Week 24|Withdrawal by Subject|0
181020|NCT00927069|574532|P1|Week 12 to Week 24|Withdrawal by Subject|1
181021|NCT00927069|574529|P4|Week 12 to Week 24|Lost to Follow-up|0
181022|NCT00927069|574530|P3|Week 12 to Week 24|Lost to Follow-up|1
181023|NCT00927069|574531|P2|Week 12 to Week 24|Lost to Follow-up|0
181024|NCT00927069|574532|P1|Week 12 to Week 24|Lost to Follow-up|0
181025|NCT00927069|574529|P4|Week 12 to Week 24|Lack of Efficacy|3
181026|NCT00927069|574530|P3|Week 12 to Week 24|Lack of Efficacy|2
181027|NCT00927069|574531|P2|Week 12 to Week 24|Lack of Efficacy|0
181028|NCT00927069|574532|P1|Week 12 to Week 24|Lack of Efficacy|0
181029|NCT00927069|574529|P4|Week 0 to Week 12|Worsening of psoriasis|0
181030|NCT00927069|574530|P3|Week 0 to Week 12|Worsening of psoriasis|0
181031|NCT00927069|574531|P2|Week 0 to Week 12|Worsening of psoriasis|1
181032|NCT00927069|574532|P1|Week 0 to Week 12|Worsening of psoriasis|1
181033|NCT00927082|574546|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
181034|NCT00927082|574547|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
181035|NCT00927082|574548|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
181036|NCT00927082|574549|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
181037|NCT00927082|574546|P4|Overall Study|Death|0
181038|NCT00927082|574547|P3|Overall Study|Death|1
181039|NCT00927082|574548|P2|Overall Study|Death|0
181040|NCT00927082|574549|P1|Overall Study|Death|0
181041|NCT00927082|574546|P4|Overall Study|Withdrawal by Subject|2
181042|NCT00927082|574547|P3|Overall Study|Withdrawal by Subject|7
181043|NCT00927082|574548|P2|Overall Study|Withdrawal by Subject|2
181044|NCT00927082|574549|P1|Overall Study|Withdrawal by Subject|3
181045|NCT00927082|574546|P4|Overall Study|Lost to Follow-up|16
181046|NCT00927082|574547|P3|Overall Study|Lost to Follow-up|12
181047|NCT00927082|574548|P2|Overall Study|Lost to Follow-up|8
181048|NCT00927082|574549|P1|Overall Study|Lost to Follow-up|9
181049|NCT00927095|574614|P3|Overall Study|Physician Decision|1
181050|NCT00927095|574615|P2|Overall Study|Physician Decision|2
181051|NCT00927095|574616|P1|Overall Study|Physician Decision|1
181052|NCT00927095|574614|P3|Overall Study|Withdrawal by Subject|1
181053|NCT00927095|574615|P2|Overall Study|Withdrawal by Subject|1
181054|NCT00927095|574616|P1|Overall Study|Withdrawal by Subject|2
181055|NCT00927095|574614|P3|Overall Study|Adverse Event|0
181056|NCT00927095|574615|P2|Overall Study|Adverse Event|1
181057|NCT00927095|574616|P1|Overall Study|Adverse Event|3
181058|NCT00927186|574637|P2|12 Months Primary Study|Withdrawal by Subject|1
181059|NCT00927186|574638|P1|12 Months Primary Study|Withdrawal by Subject|1
181060|NCT00927186|574637|P2|12 Months Primary Study|Protocol Violation|1
181061|NCT00927186|574638|P1|12 Months Primary Study|Protocol Violation|0
181062|NCT00927186|574637|P2|12 Months Primary Study|Lost to Follow-up|0
181063|NCT00927186|574638|P1|12 Months Primary Study|Lost to Follow-up|1
181064|NCT00927186|574637|P2|12 Months Primary Study|Adverse Event|2
181065|NCT00927186|574638|P1|12 Months Primary Study|Adverse Event|5
181066|NCT00927251|574754|P1|Overall Study|Patients not implanted with 4296 lead|8
181067|NCT00927355|574777|P2|Overall Study|Adverse Event|1
181068|NCT00927355|574778|P1|Overall Study|Adverse Event|1
181069|NCT00927368|574799|P3|Overall Study|cancellation of surgery|2
181070|NCT00927368|574800|P2|Overall Study|cancellation of surgery|1
181071|NCT00927368|574801|P1|Overall Study|cancellation of surgery|0
181072|NCT00927368|574799|P3|Overall Study|ineligible post randomization|1
181073|NCT00927368|574800|P2|Overall Study|ineligible post randomization|3
181074|NCT00927368|574801|P1|Overall Study|ineligible post randomization|0
181075|NCT00927368|574799|P3|Overall Study|equipment failure|0
181076|NCT00927368|574800|P2|Overall Study|equipment failure|0
181077|NCT00927368|574801|P1|Overall Study|equipment failure|1
181078|NCT00927368|574799|P3|Overall Study|Lost to Follow-up|0
181079|NCT00927368|574800|P2|Overall Study|Lost to Follow-up|0
181080|NCT00927368|574801|P1|Overall Study|Lost to Follow-up|4
181081|NCT00927368|574799|P3|Overall Study|enrollment in another study|2
181082|NCT00927368|574800|P2|Overall Study|enrollment in another study|1
181083|NCT00927368|574801|P1|Overall Study|enrollment in another study|1
181084|NCT00927394|574820|P2|Overall Study|Randomized in error|1
181085|NCT00927394|574821|P1|Overall Study|Randomized in error|0
181086|NCT00927394|574820|P2|Overall Study|Protocol deviation|13
181087|NCT00927394|574821|P1|Overall Study|Protocol deviation|16
181088|NCT00927394|574820|P2|Overall Study|Death|1
181089|NCT00927394|574821|P1|Overall Study|Death|1
181090|NCT00927394|574820|P2|Overall Study|Administrative Problem|0
181091|NCT00927394|574821|P1|Overall Study|Administrative Problem|1
181092|NCT00927394|574820|P2|Overall Study|Lost to Follow-up|14
181093|NCT00927394|574821|P1|Overall Study|Lost to Follow-up|8
181094|NCT00927394|574820|P2|Overall Study|Withdrawal by Subject|24
181095|NCT00927394|574821|P1|Overall Study|Withdrawal by Subject|20
181096|NCT00927394|574820|P2|Overall Study|Unsatisfactory therapeutic effect|23
181097|NCT00927394|574821|P1|Overall Study|Unsatisfactory therapeutic effect|17
181098|NCT00927394|574820|P2|Overall Study|Adverse Event|9
181099|NCT00927394|574821|P1|Overall Study|Adverse Event|14
181100|NCT00927472|574851|P2|Overall Study|Post treatment Assessment out of window|4
181101|NCT00927472|574852|P1|Overall Study|Post treatment Assessment out of window|0
181102|NCT00927472|574851|P2|Overall Study|Protocol Violation|1
181103|NCT00927472|574852|P1|Overall Study|Protocol Violation|0
181104|NCT00927472|574851|P2|Overall Study|Lost to Follow-up|6
181105|NCT00927472|574852|P1|Overall Study|Lost to Follow-up|1
181106|NCT00927472|574851|P2|Overall Study|Withdrawal by Subject|11
181107|NCT00927472|574852|P1|Overall Study|Withdrawal by Subject|10
181108|NCT00927563|574876|P1|Overall Study|Withdrawal by Subject|1
181109|NCT00927563|574876|P1|Overall Study|Lost to Follow-up|1
181110|NCT00927589|574890|P1|Overall Study|Non-compliance|1
181111|NCT00927589|574890|P1|Overall Study|Disease Progression|8
181112|NCT00927589|574890|P1|Overall Study|Adverse Event|2
181113|NCT00927589|574890|P1|Overall Study|Withdrawal by Subject|3
181114|NCT00927589|574890|P1|Overall Study|Physician Decision|1
181115|NCT00927589|574890|P1|Overall Study|Death|1
181116|NCT00927758|574912|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
181117|NCT00927758|574913|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
181118|NCT00927758|574914|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
181119|NCT00927758|574915|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
181120|NCT00927758|574916|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
181121|NCT00927758|574917|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
181122|NCT00927758|574912|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
181123|NCT00927758|574913|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
181124|NCT00927758|574914|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
181125|NCT00927758|574915|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
181126|NCT00927758|574916|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
181127|NCT00927758|574917|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
181128|NCT00927823|574925|P4|Continuous Dosing Period|Unspecified|3
181129|NCT00927823|574926|P3|Continuous Dosing Period|Unspecified|9
181130|NCT00927823|574927|P2|Continuous Dosing Period|Unspecified|2
181131|NCT00927823|574928|P1|Continuous Dosing Period|Unspecified|1
181132|NCT00927823|574925|P4|Continuous Dosing Period|Withdrawal by Subject|2
181133|NCT00927823|574926|P3|Continuous Dosing Period|Withdrawal by Subject|2
181134|NCT00927823|574927|P2|Continuous Dosing Period|Withdrawal by Subject|0
181135|NCT00927823|574928|P1|Continuous Dosing Period|Withdrawal by Subject|1
181136|NCT00927823|574925|P4|Continuous Dosing Period|Lost to Follow-up|0
181137|NCT00927823|574926|P3|Continuous Dosing Period|Lost to Follow-up|9
181138|NCT00927823|574927|P2|Continuous Dosing Period|Lost to Follow-up|1
181139|NCT00927823|574928|P1|Continuous Dosing Period|Lost to Follow-up|1
181140|NCT00927823|574925|P4|Continuous Dosing Period|Death|0
181141|NCT00927823|574926|P3|Continuous Dosing Period|Death|6
181142|NCT00927823|574927|P2|Continuous Dosing Period|Death|0
181143|NCT00927823|574928|P1|Continuous Dosing Period|Death|0
181144|NCT00927862|575007|P2|Overall Study|Missing data needed for endpt analyses|45
181145|NCT00927862|575008|P1|Overall Study|Missing data needed for endpt analyses|27
181146|NCT00927901|575041|P4|Treatment Period 4|Subject withdrew consent|0
181147|NCT00927901|575042|P3|Treatment Period 4|Subject withdrew consent|1
181148|NCT00927901|575043|P2|Treatment Period 4|Subject withdrew consent|0
181149|NCT00927901|575044|P1|Treatment Period 4|Subject withdrew consent|0
181150|NCT00927901|575041|P4|Treatment Period 4|Adverse Event|1
181151|NCT00927901|575042|P3|Treatment Period 4|Adverse Event|0
181152|NCT00927901|575043|P2|Treatment Period 4|Adverse Event|0
181153|NCT00927901|575044|P1|Treatment Period 4|Adverse Event|0
181154|NCT00927901|575041|P4|Treatment Period 1|Subject withdrew consent|0
181155|NCT00927901|575042|P3|Treatment Period 1|Subject withdrew consent|1
181156|NCT00927901|575043|P2|Treatment Period 1|Subject withdrew consent|0
181157|NCT00927901|575044|P1|Treatment Period 1|Subject withdrew consent|0
181158|NCT00927927|575087|P15|Overall Study|Withdrawal by Subject|0
181159|NCT00927927|575088|P14|Overall Study|Withdrawal by Subject|0
181160|NCT00927927|575089|P13|Overall Study|Withdrawal by Subject|0
181161|NCT00927927|575090|P12|Overall Study|Withdrawal by Subject|2
181162|NCT00927927|575091|P11|Overall Study|Withdrawal by Subject|0
181163|NCT00927927|575092|P10|Overall Study|Withdrawal by Subject|0
181164|NCT00927927|575093|P9|Overall Study|Withdrawal by Subject|0
181165|NCT00927927|575094|P8|Overall Study|Withdrawal by Subject|2
181166|NCT00927927|575095|P7|Overall Study|Withdrawal by Subject|0
181167|NCT00927927|575096|P6|Overall Study|Withdrawal by Subject|0
181168|NCT00927927|575097|P5|Overall Study|Withdrawal by Subject|0
181169|NCT00927927|575098|P4|Overall Study|Withdrawal by Subject|0
181170|NCT00927927|575099|P3|Overall Study|Withdrawal by Subject|0
181171|NCT00927927|575100|P2|Overall Study|Withdrawal by Subject|0
181172|NCT00927927|575101|P1|Overall Study|Withdrawal by Subject|0
181173|NCT00927940|575148|P1|Overall Study|Death|1
181174|NCT00927953|575155|P2|Overall Study|Death|1
181175|NCT00927953|575156|P1|Overall Study|Death|2
181176|NCT00928018|575182|P2|Overall Study|Withdrawal by Subject|0
181177|NCT00928018|575183|P1|Overall Study|Withdrawal by Subject|1
181178|NCT00928057|575203|P2|Overall Study|Protocol Violation|1
181179|NCT00928057|575204|P1|Overall Study|Protocol Violation|0
181180|NCT00928057|575203|P2|Overall Study|Lost to Follow-up|1
181181|NCT00928057|575204|P1|Overall Study|Lost to Follow-up|0
181182|NCT00928057|575203|P2|Overall Study|Withdrawal by Subject|0
181183|NCT00928057|575204|P1|Overall Study|Withdrawal by Subject|1
181184|NCT00928057|575203|P2|Overall Study|Adverse Event|2
181185|NCT00928057|575204|P1|Overall Study|Adverse Event|1
181186|NCT00928070|575229|P2|Overall Study|Unspecified|5
181187|NCT00928070|575230|P1|Overall Study|Unspecified|5
181188|NCT00928070|575229|P2|Overall Study|Randomized but not treated|2
181189|NCT00928070|575230|P1|Overall Study|Randomized but not treated|2
181190|NCT00928070|575229|P2|Overall Study|Protocol Violation|5
181191|NCT00928070|575230|P1|Overall Study|Protocol Violation|6
181192|NCT00928070|575229|P2|Overall Study|Did not meet entrance criteria|9
181193|NCT00928070|575230|P1|Overall Study|Did not meet entrance criteria|16
181194|NCT00928070|575229|P2|Overall Study|Lack of Efficacy|5
181195|NCT00928070|575230|P1|Overall Study|Lack of Efficacy|9
181196|NCT00928070|575229|P2|Overall Study|Adverse Event|26
181197|NCT00928070|575230|P1|Overall Study|Adverse Event|14
181198|NCT00928070|575229|P2|Overall Study|Withdrawal by Subject|3
181199|NCT00928070|575230|P1|Overall Study|Withdrawal by Subject|10
181200|NCT00928070|575229|P2|Overall Study|Lost to Follow-up|2
181201|NCT00928070|575230|P1|Overall Study|Lost to Follow-up|1
181202|NCT00928187|575413|P3|Overall Study|Protocol Violation|0
181203|NCT00928187|575414|P2|Overall Study|Protocol Violation|1
181204|NCT00928187|575415|P1|Overall Study|Protocol Violation|0
181205|NCT00928187|575413|P3|Overall Study|Withdrawal by Subject|1
181206|NCT00928187|575414|P2|Overall Study|Withdrawal by Subject|1
181207|NCT00928187|575415|P1|Overall Study|Withdrawal by Subject|0
181208|NCT00928187|575413|P3|Overall Study|Lost to Follow-up|1
181209|NCT00928187|575414|P2|Overall Study|Lost to Follow-up|2
181210|NCT00928187|575415|P1|Overall Study|Lost to Follow-up|1
181211|NCT00928187|575413|P3|Overall Study|Death|3
181212|NCT00928187|575414|P2|Overall Study|Death|2
181213|NCT00928187|575415|P1|Overall Study|Death|1
181214|NCT00928252|575459|P1|Overall Study|Physician Decision|3
181215|NCT00928408|575482|P1|Overall Study|Lost to Follow-up|12
181216|NCT00928408|575482|P1|Overall Study|Death|5
181217|NCT00928408|575482|P1|Overall Study|Withdrawal by Subject|4
181218|NCT00928408|575482|P1|Overall Study|Other|2
181219|NCT00928434|575518|P3|Overall Study|Other (not meeting above criteria)|2
181220|NCT00928434|575519|P2|Overall Study|Other (not meeting above criteria)|1
181221|NCT00928434|575520|P1|Overall Study|Other (not meeting above criteria)|5
181222|NCT00928434|575518|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
181223|NCT00928434|575519|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
181224|NCT00928434|575520|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
181225|NCT00928434|575518|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
181226|NCT00928434|575519|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
181227|NCT00928434|575520|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
181228|NCT00928434|575518|P3|Overall Study|Withdrawal by Subject|2
181229|NCT00928434|575519|P2|Overall Study|Withdrawal by Subject|3
181230|NCT00928434|575520|P1|Overall Study|Withdrawal by Subject|5
181231|NCT00928434|575518|P3|Overall Study|Lost to Follow-up|3
181232|NCT00928434|575519|P2|Overall Study|Lost to Follow-up|0
181233|NCT00928434|575520|P1|Overall Study|Lost to Follow-up|1
181234|NCT00928434|575518|P3|Overall Study|Physician Decision|3
181235|NCT00928434|575519|P2|Overall Study|Physician Decision|0
181236|NCT00928434|575520|P1|Overall Study|Physician Decision|2
181237|NCT00928434|575518|P3|Overall Study|Protocol Violation|8
181238|NCT00928434|575519|P2|Overall Study|Protocol Violation|0
181239|NCT00928434|575520|P1|Overall Study|Protocol Violation|5
181240|NCT00928434|575518|P3|Overall Study|Adverse Event|18
181241|NCT00928434|575519|P2|Overall Study|Adverse Event|5
181242|NCT00928434|575520|P1|Overall Study|Adverse Event|14
181243|NCT00928486|575592|P1|Overall Study|Withdrawal by Subject|1
181244|NCT00928486|575592|P1|Overall Study|Disease Progression|7
181245|NCT00928486|575592|P1|Overall Study|Adverse Event|2
181246|NCT00928512|575603|P5|Overall Study|Administrative Problems|0
181247|NCT00928512|575604|P4|Overall Study|Administrative Problems|0
181248|NCT00928512|575605|P3|Overall Study|Administrative Problems|0
181249|NCT00928512|575606|P2|Overall Study|Administrative Problems|1
181250|NCT00928512|575607|P1|Overall Study|Administrative Problems|0
181251|NCT00928512|575603|P5|Overall Study|Lost to Follow-up|3
181252|NCT00928512|575604|P4|Overall Study|Lost to Follow-up|1
181253|NCT00928512|575605|P3|Overall Study|Lost to Follow-up|2
181254|NCT00928512|575606|P2|Overall Study|Lost to Follow-up|1
181255|NCT00928512|575607|P1|Overall Study|Lost to Follow-up|1
181256|NCT00928512|575603|P5|Overall Study|Withdrawal by Subject|0
181257|NCT00928512|575604|P4|Overall Study|Withdrawal by Subject|4
181258|NCT00928512|575605|P3|Overall Study|Withdrawal by Subject|3
181259|NCT00928512|575606|P2|Overall Study|Withdrawal by Subject|0
181260|NCT00928512|575607|P1|Overall Study|Withdrawal by Subject|3
181261|NCT00928512|575603|P5|Overall Study|Protocol Violation|3
181262|NCT00928512|575604|P4|Overall Study|Protocol Violation|1
181263|NCT00928512|575605|P3|Overall Study|Protocol Violation|0
181264|NCT00928512|575606|P2|Overall Study|Protocol Violation|1
181265|NCT00928512|575607|P1|Overall Study|Protocol Violation|0
181266|NCT00928512|575603|P5|Overall Study|Lack of Efficacy|3
181267|NCT00928512|575604|P4|Overall Study|Lack of Efficacy|7
181268|NCT00928512|575605|P3|Overall Study|Lack of Efficacy|4
181269|NCT00928512|575606|P2|Overall Study|Lack of Efficacy|0
181270|NCT00928512|575607|P1|Overall Study|Lack of Efficacy|2
181271|NCT00928512|575603|P5|Overall Study|Adverse Event|6
181272|NCT00928512|575604|P4|Overall Study|Adverse Event|8
181273|NCT00928512|575605|P3|Overall Study|Adverse Event|2
181274|NCT00928512|575606|P2|Overall Study|Adverse Event|3
181275|NCT00928512|575607|P1|Overall Study|Adverse Event|4
181276|NCT00921557|575758|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
181277|NCT00921557|575759|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
181278|NCT00921557|575760|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
181279|NCT00921557|575758|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
181280|NCT00921557|575759|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
181281|NCT00921557|575760|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
181282|NCT00921557|575758|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
181283|NCT00921557|575759|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
181284|NCT00921557|575760|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
181285|NCT00921557|575758|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
181286|NCT00921557|575759|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
181287|NCT00921557|575760|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
181288|NCT00921557|575758|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
181289|NCT00921557|575759|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
181290|NCT00921557|575760|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
181291|NCT00922116|575851|P1|Overall Study|Unspecified|5
181292|NCT00922116|575851|P1|Overall Study|Withdrawal by Subject|4
181293|NCT00922116|575851|P1|Overall Study|Lost to Follow-up|1
181294|NCT00922116|575851|P1|Overall Study|Death|1
181295|NCT00922116|575851|P1|Overall Study|Adverse Event|4
181296|NCT00922207|575873|P3|Overall Study|Abnormality of Laboratory Test|1
181297|NCT00922207|575874|P2|Overall Study|Abnormality of Laboratory Test|1
181298|NCT00922207|575875|P1|Overall Study|Abnormality of Laboratory Test|0
181299|NCT00922207|575873|P3|Overall Study|Withdrew Consent|2
181300|NCT00922207|575874|P2|Overall Study|Withdrew Consent|5
181301|NCT00922207|575875|P1|Overall Study|Withdrew Consent|2
181302|NCT00922207|575873|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
181303|NCT00922207|575874|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
181304|NCT00922207|575875|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
181305|NCT00922207|575873|P3|Overall Study|Violation of Selection Criteria at Entry|0
181306|NCT00922207|575874|P2|Overall Study|Violation of Selection Criteria at Entry|1
181307|NCT00922207|575875|P1|Overall Study|Violation of Selection Criteria at Entry|0
181308|NCT00922207|575873|P3|Overall Study|Insufficient Therapeutic Response|1
181309|NCT00922207|575874|P2|Overall Study|Insufficient Therapeutic Response|0
181310|NCT00922207|575875|P1|Overall Study|Insufficient Therapeutic Response|0
181311|NCT00922207|575873|P3|Overall Study|Adverse Event/Intercurrent Illness|0
181312|NCT00922207|575874|P2|Overall Study|Adverse Event/Intercurrent Illness|0
181313|NCT00922207|575875|P1|Overall Study|Adverse Event/Intercurrent Illness|3
181314|NCT00922272|575907|P2|Double-blind Phase|Positive urine drug screen|1
181315|NCT00922272|575908|P1|Double-blind Phase|Positive urine drug screen|1
181316|NCT00922272|575907|P2|Double-blind Phase|Noncompliance|1
181317|NCT00922272|575908|P1|Double-blind Phase|Noncompliance|1
181318|NCT00922272|575907|P2|Double-blind Phase|Withdrawal criteria met|1
181319|NCT00922272|575908|P1|Double-blind Phase|Withdrawal criteria met|1
181320|NCT00922272|575907|P2|Double-blind Phase|Lost to Follow-up|1
181321|NCT00922272|575908|P1|Double-blind Phase|Lost to Follow-up|2
181322|NCT00922272|575907|P2|Double-blind Phase|Withdrawal by Subject|1
181323|NCT00922272|575908|P1|Double-blind Phase|Withdrawal by Subject|1
181324|NCT00922272|575907|P2|Double-blind Phase|Adverse Event|1
181325|NCT00922272|575908|P1|Double-blind Phase|Adverse Event|1
181326|NCT00922272|575907|P2|Open-label Phase|Withdrawal criteria met|0
181327|NCT00922272|575908|P1|Open-label Phase|Withdrawal criteria met|5
181328|NCT00922272|575907|P2|Open-label Phase|Failure to meet randomization criteria|0
181329|NCT00922272|575908|P1|Open-label Phase|Failure to meet randomization criteria|1
181330|NCT00922272|575907|P2|Open-label Phase|Withdrawal by Subject|0
181331|NCT00922272|575908|P1|Open-label Phase|Withdrawal by Subject|11
181332|NCT00922272|575907|P2|Open-label Phase|Protocol Violation|0
181333|NCT00922272|575908|P1|Open-label Phase|Protocol Violation|1
181334|NCT00922272|575907|P2|Open-label Phase|Adverse Event|0
181335|NCT00922272|575908|P1|Open-label Phase|Adverse Event|5
181336|NCT00922428|575964|P1|Overall Study|no medication use or questionable use|13
181337|NCT00922428|575964|P1|Overall Study|retrospective/extremely implausible data|2
181338|NCT00922623|575993|P1|Overall Study|Lost to Follow-up|1
181339|NCT00922623|575993|P1|Overall Study|Other|4
181340|NCT00922636|576004|P5|Overall Study|Lost to Follow-up|4
181341|NCT00922636|576005|P4|Overall Study|Lost to Follow-up|2
181342|NCT00922636|576006|P3|Overall Study|Lost to Follow-up|2
181343|NCT00922636|576007|P2|Overall Study|Lost to Follow-up|2
181344|NCT00922636|576008|P1|Overall Study|Lost to Follow-up|1
181345|NCT00922636|576004|P5|Overall Study|Parent/Caregiver Decision|2
181346|NCT00922636|576005|P4|Overall Study|Parent/Caregiver Decision|5
181347|NCT00922636|576006|P3|Overall Study|Parent/Caregiver Decision|3
181348|NCT00922636|576007|P2|Overall Study|Parent/Caregiver Decision|4
181349|NCT00922636|576008|P1|Overall Study|Parent/Caregiver Decision|2
181350|NCT00922636|576004|P5|Overall Study|Entry Criteria Not Met|0
181351|NCT00922636|576005|P4|Overall Study|Entry Criteria Not Met|1
181352|NCT00922636|576006|P3|Overall Study|Entry Criteria Not Met|1
181353|NCT00922636|576007|P2|Overall Study|Entry Criteria Not Met|0
181354|NCT00922636|576008|P1|Overall Study|Entry Criteria Not Met|0
181355|NCT00922636|576004|P5|Overall Study|Protocol Violation|0
181356|NCT00922636|576005|P4|Overall Study|Protocol Violation|2
181357|NCT00922636|576006|P3|Overall Study|Protocol Violation|2
181358|NCT00922636|576007|P2|Overall Study|Protocol Violation|0
181359|NCT00922636|576008|P1|Overall Study|Protocol Violation|0
181360|NCT00922636|576004|P5|Overall Study|Withdrawal by Subject|4
181361|NCT00922636|576005|P4|Overall Study|Withdrawal by Subject|2
181362|NCT00922636|576006|P3|Overall Study|Withdrawal by Subject|5
181363|NCT00922636|576007|P2|Overall Study|Withdrawal by Subject|0
181364|NCT00922636|576008|P1|Overall Study|Withdrawal by Subject|0
181365|NCT00922636|576004|P5|Overall Study|Sponsor Decision|0
181366|NCT00922636|576005|P4|Overall Study|Sponsor Decision|0
181367|NCT00922636|576006|P3|Overall Study|Sponsor Decision|2
181368|NCT00922636|576007|P2|Overall Study|Sponsor Decision|0
181369|NCT00922636|576008|P1|Overall Study|Sponsor Decision|0
181370|NCT00922636|576004|P5|Overall Study|Lack of Efficacy|4
181371|NCT00922636|576005|P4|Overall Study|Lack of Efficacy|2
181372|NCT00922636|576006|P3|Overall Study|Lack of Efficacy|3
181373|NCT00922636|576007|P2|Overall Study|Lack of Efficacy|7
181374|NCT00922636|576008|P1|Overall Study|Lack of Efficacy|1
181375|NCT00922636|576004|P5|Overall Study|Adverse Event|2
181376|NCT00922636|576005|P4|Overall Study|Adverse Event|3
181377|NCT00922636|576006|P3|Overall Study|Adverse Event|2
181378|NCT00922636|576007|P2|Overall Study|Adverse Event|3
181379|NCT00922636|576008|P1|Overall Study|Adverse Event|3
181380|NCT00922766|576159|P1|Overall Study|Adverse Event|1
181381|NCT00922766|576159|P1|Overall Study|Unspecified|1
181382|NCT00922766|576159|P1|Overall Study|Withdrawal by Subject|2
181383|NCT00922766|576159|P1|Overall Study|Death|3
181384|NCT00922779|576168|P1|Overall Study|Missing|1874
181385|NCT00922779|576168|P1|Overall Study|Unspecified|27
181386|NCT00922779|576168|P1|Overall Study|Lost to Follow-up|44
181387|NCT00922779|576168|P1|Overall Study|Withdrawal by Subject|308
181388|NCT00922779|576168|P1|Overall Study|Pregnancy|7
181389|NCT00922779|576168|P1|Overall Study|Adverse Event|67
181390|NCT00922935|576178|P3|Overall Study|Lost to Follow-up|0
181391|NCT00922935|576179|P2|Overall Study|Lost to Follow-up|1
181392|NCT00922935|576180|P1|Overall Study|Lost to Follow-up|0
181393|NCT00922935|576178|P3|Overall Study|Physician Decision|0
181394|NCT00922935|576179|P2|Overall Study|Physician Decision|1
181395|NCT00922935|576180|P1|Overall Study|Physician Decision|1
181396|NCT00922935|576178|P3|Overall Study|Protocol Violation|0
181397|NCT00922935|576179|P2|Overall Study|Protocol Violation|3
181398|NCT00922935|576180|P1|Overall Study|Protocol Violation|0
181399|NCT00922987|576188|P1|Overall Study|Adverse Event|1
181400|NCT00922987|576188|P1|Overall Study|Protocol Violation|2
181401|NCT00922987|576188|P1|Overall Study|Insufficient clinical response|1
181402|NCT00928668|576200|P5|Overall Study|Other reasons not listed above|0
181403|NCT00928668|576201|P4|Overall Study|Other reasons not listed above|1
181404|NCT00928668|576202|P3|Overall Study|Other reasons not listed above|0
181405|NCT00928668|576203|P2|Overall Study|Other reasons not listed above|0
181406|NCT00928668|576204|P1|Overall Study|Other reasons not listed above|0
181407|NCT00928668|576200|P5|Overall Study|Withdrawal by Subject|0
181408|NCT00928668|576201|P4|Overall Study|Withdrawal by Subject|0
181409|NCT00928668|576202|P3|Overall Study|Withdrawal by Subject|1
181410|NCT00928668|576203|P2|Overall Study|Withdrawal by Subject|1
181411|NCT00928668|576204|P1|Overall Study|Withdrawal by Subject|0
181412|NCT00928668|576200|P5|Overall Study|Protocol Violation|1
181413|NCT00928668|576201|P4|Overall Study|Protocol Violation|0
181414|NCT00928668|576202|P3|Overall Study|Protocol Violation|0
181415|NCT00928668|576203|P2|Overall Study|Protocol Violation|0
181416|NCT00928668|576204|P1|Overall Study|Protocol Violation|0
181417|NCT00928668|576200|P5|Overall Study|Adverse Event|0
181418|NCT00928668|576201|P4|Overall Study|Adverse Event|0
181419|NCT00928668|576202|P3|Overall Study|Adverse Event|0
181420|NCT00928668|576203|P2|Overall Study|Adverse Event|0
181421|NCT00928668|576204|P1|Overall Study|Adverse Event|1
181422|NCT00928746|576268|P1|Overall Study|Other|2
181423|NCT00928746|576268|P1|Overall Study|Withdrawal by Subject|1
181424|NCT00928746|576268|P1|Overall Study|Protocol Violation|1
181425|NCT00928746|576268|P1|Overall Study|Adverse Event|2
181426|NCT00928889|576312|P2|Overall Study|Other|0
181427|NCT00928889|576313|P1|Overall Study|Other|1
181428|NCT00928889|576312|P2|Overall Study|Adverse Event|0
181429|NCT00928889|576313|P1|Overall Study|Adverse Event|1
181430|NCT00928889|576312|P2|Overall Study|Protocol Violation|1
181431|NCT00928889|576313|P1|Overall Study|Protocol Violation|0
181432|NCT00928889|576312|P2|Overall Study|Lost to Follow-up|1
181433|NCT00928889|576313|P1|Overall Study|Lost to Follow-up|3
181434|NCT00929526|576442|P2|Overall Study|Unspecified|6
181435|NCT00929526|576443|P1|Overall Study|Unspecified|8
181436|NCT00929526|576442|P2|Overall Study|Lost to Follow-up|12
181437|NCT00929526|576443|P1|Overall Study|Lost to Follow-up|8
181438|NCT00929526|576442|P2|Overall Study|Withdrawal by Subject|11
181439|NCT00929526|576443|P1|Overall Study|Withdrawal by Subject|1
181440|NCT00929643|576488|P1|Overall Study|Protocol Violation|2
181441|NCT00929656|576499|P2|Overall Study|Lost to Follow-up|1
181442|NCT00929656|576500|P1|Overall Study|Lost to Follow-up|0
181443|NCT00929695|576516|P2|Overall Study|incorrect stratification|0
181444|NCT00929695|576517|P1|Overall Study|incorrect stratification|2
181445|NCT00929695|576516|P2|Overall Study|discharge home|3
181446|NCT00929695|576517|P1|Overall Study|discharge home|4
181447|NCT00929695|576516|P2|Overall Study|Withdrawal by Subject|2
181448|NCT00929695|576517|P1|Overall Study|Withdrawal by Subject|0
181449|NCT00929695|576516|P2|Overall Study|Death|1
181450|NCT00929695|576517|P1|Overall Study|Death|2
181451|NCT00929708|576552|P5|Overall Study|Lost to Follow-up|0
181452|NCT00929708|576553|P4|Overall Study|Lost to Follow-up|1
181453|NCT00929708|576554|P3|Overall Study|Lost to Follow-up|0
181454|NCT00929708|576555|P2|Overall Study|Lost to Follow-up|0
181455|NCT00929708|576556|P1|Overall Study|Lost to Follow-up|0
181456|NCT00929708|576552|P5|Overall Study|Physician Decision|1
181457|NCT00929708|576553|P4|Overall Study|Physician Decision|2
181458|NCT00929708|576554|P3|Overall Study|Physician Decision|2
181459|NCT00929708|576555|P2|Overall Study|Physician Decision|2
181460|NCT00929708|576556|P1|Overall Study|Physician Decision|0
181461|NCT00929708|576552|P5|Overall Study|Adverse Event|3
181462|NCT00929708|576553|P4|Overall Study|Adverse Event|0
181463|NCT00929708|576554|P3|Overall Study|Adverse Event|0
181464|NCT00929708|576555|P2|Overall Study|Adverse Event|0
181465|NCT00929708|576556|P1|Overall Study|Adverse Event|0
181466|NCT00929708|576552|P5|Overall Study|Withdrawal by Subject|1
181467|NCT00929708|576553|P4|Overall Study|Withdrawal by Subject|2
181468|NCT00929708|576554|P3|Overall Study|Withdrawal by Subject|0
181469|NCT00929708|576555|P2|Overall Study|Withdrawal by Subject|0
181470|NCT00929708|576556|P1|Overall Study|Withdrawal by Subject|2
181471|NCT00929708|576552|P5|Overall Study|Protocol Violation|1
181472|NCT00929708|576553|P4|Overall Study|Protocol Violation|1
181473|NCT00929708|576554|P3|Overall Study|Protocol Violation|1
181474|NCT00929708|576555|P2|Overall Study|Protocol Violation|1
181475|NCT00929708|576556|P1|Overall Study|Protocol Violation|2
181476|NCT00929734|576610|P2|Overall Study|Withdrawal by Subject|2
181477|NCT00929734|576611|P1|Overall Study|Withdrawal by Subject|0
181478|NCT00929734|576610|P2|Overall Study|Lost to Follow-up|1
181479|NCT00929734|576611|P1|Overall Study|Lost to Follow-up|2
181480|NCT00929864|576644|P2|Overall Study|Non-specified|7
181481|NCT00929864|576645|P1|Overall Study|Non-specified|2
181482|NCT00929864|576644|P2|Overall Study|Administrative reason by Sponsor|1
181483|NCT00929864|576645|P1|Overall Study|Administrative reason by Sponsor|1
181484|NCT00929864|576644|P2|Overall Study|Pregnancy|3
181485|NCT00929864|576645|P1|Overall Study|Pregnancy|0
181486|NCT00929864|576644|P2|Overall Study|Poor or non-compliance|3
181487|NCT00929864|576645|P1|Overall Study|Poor or non-compliance|3
181488|NCT00929864|576644|P2|Overall Study|No longer met criteria|1
181489|NCT00929864|576645|P1|Overall Study|No longer met criteria|2
181490|NCT00929864|576644|P2|Overall Study|Withdrawal by Subject|9
181491|NCT00929864|576645|P1|Overall Study|Withdrawal by Subject|20
181492|NCT00929864|576644|P2|Overall Study|Lost to Follow-up|12
181493|NCT00929864|576645|P1|Overall Study|Lost to Follow-up|7
181494|NCT00929864|576644|P2|Overall Study|Lack of Efficacy|16
181495|NCT00929864|576645|P1|Overall Study|Lack of Efficacy|19
181496|NCT00929864|576644|P2|Overall Study|Adverse Event|30
181497|NCT00929864|576645|P1|Overall Study|Adverse Event|11
181498|NCT00929864|576644|P2|Overall Study|Death|1
181499|NCT00929864|576645|P1|Overall Study|Death|1
181500|NCT00930176|576673|P1|Overall Study|Death|1
181501|NCT00930553|576689|P1|Overall Study|Other than specified above|28
181502|NCT00930553|576689|P1|Overall Study|Study terminated by sponsor|24
181503|NCT00930553|576689|P1|Overall Study|Death|9
181504|NCT00930553|576689|P1|Overall Study|Lost to Follow-up|25
181505|NCT00930553|576689|P1|Overall Study|Withdrawal by Subject|88
181506|NCT00930553|576689|P1|Overall Study|Pregnancy|1
181507|NCT00930553|576689|P1|Overall Study|Protocol Violation|1
181508|NCT00930553|576689|P1|Overall Study|Physician Decision|39
181509|NCT00930553|576689|P1|Overall Study|Lack of Efficacy|7
181510|NCT00930553|576689|P1|Overall Study|Adverse Event|1
181511|NCT00930644|576755|P1|Overall Study|Adverse Event|16
181512|NCT00930644|576755|P1|Overall Study|Death|1
181513|NCT00930644|576755|P1|Overall Study|Physician Decision|2
181514|NCT00930644|576755|P1|Overall Study|Withdrawal by Subject|4
181515|NCT00930722|576768|P1|Overall Study|Study terminated by sponsor|2
181516|NCT00930722|576768|P1|Overall Study|No longer willing to participate|9
181517|NCT00930722|576768|P1|Overall Study|Lost to Follow-up|16
181518|NCT00930761|576785|P2|Overall Study|less than 3 music therapy sessions|3
181519|NCT00930761|576786|P1|Overall Study|less than 3 music therapy sessions|0
181520|NCT00930761|576785|P2|Overall Study|3 newborns died; 1 mother quit the study|0
181521|NCT00930761|576786|P1|Overall Study|3 newborns died; 1 mother quit the study|4
181522|NCT00930774|576802|P4|Overall Study|Withdrawal by Subject|0
181523|NCT00930774|576803|P3|Overall Study|Withdrawal by Subject|2
181524|NCT00930774|576804|P2|Overall Study|Withdrawal by Subject|9
181525|NCT00930774|576805|P1|Overall Study|Withdrawal by Subject|1
181526|NCT00930813|576854|P2|Overall Study|Lost to Follow-up|4
181527|NCT00930813|576855|P1|Overall Study|Lost to Follow-up|2
181528|NCT00930813|576854|P2|Overall Study|Withdrawal by Subject|5
181529|NCT00930813|576855|P1|Overall Study|Withdrawal by Subject|2
181530|NCT00930813|576854|P2|Overall Study|Death|5
181531|NCT00930813|576855|P1|Overall Study|Death|4
181532|NCT00930930|576865|P2|Overall Study|patients not compliant|1
181533|NCT00930930|576866|P1|Overall Study|patients not compliant|1
181534|NCT00930930|576865|P2|Overall Study|excessive lapse btw txs, not eligible|1
181535|NCT00930930|576866|P1|Overall Study|excessive lapse btw txs, not eligible|0
181536|NCT00930930|576865|P2|Overall Study|Disease progression|3
181537|NCT00930930|576866|P1|Overall Study|Disease progression|2
181538|NCT00930930|576865|P2|Overall Study|Withdrawal by Subject|1
181539|NCT00930930|576866|P1|Overall Study|Withdrawal by Subject|3
181540|NCT00930930|576865|P2|Overall Study|Adverse Event|3
181541|NCT00930930|576866|P1|Overall Study|Adverse Event|13
181542|NCT00930930|576865|P2|Overall Study|Physician Decision|0
181543|NCT00930930|576866|P1|Overall Study|Physician Decision|1
181544|NCT00930930|576865|P2|Overall Study|Death|0
181545|NCT00930930|576866|P1|Overall Study|Death|1
181546|NCT00930969|576878|P1|Overall Study|Withdrawal by Subject|19
181547|NCT00930969|576878|P1|Overall Study|Physician Decision|13
181548|NCT00930969|576878|P1|Overall Study|Lost to Follow-up|1
181549|NCT00930969|576878|P1|Overall Study|Death|5
181550|NCT00930982|576888|P2|Overall Study|Withdrawal by Subject|1
181551|NCT00930982|576889|P1|Overall Study|Withdrawal by Subject|1
181552|NCT00930982|576888|P2|Overall Study|Protocol Violation|5
181553|NCT00930982|576889|P1|Overall Study|Protocol Violation|1
181554|NCT00930982|576888|P2|Overall Study|Adverse Event|23
181555|NCT00930982|576889|P1|Overall Study|Adverse Event|19
181556|NCT00931268|576936|P1|Overall Study|Lost to Follow-up|6
181557|NCT00931307|576946|P1|Overall Study|Biomicroscopy|1
181558|NCT00931307|576946|P1|Overall Study|Lack of Efficacy|12
181559|NCT00931385|576965|P4|Overall Study|Lost to Follow-up|1
181560|NCT00931385|576966|P3|Overall Study|Lost to Follow-up|0
181561|NCT00931385|576967|P2|Overall Study|Lost to Follow-up|0
181562|NCT00931385|576968|P1|Overall Study|Lost to Follow-up|0
181563|NCT00931385|576965|P4|Overall Study|Withdrawal by Subject|1
181564|NCT00931385|576966|P3|Overall Study|Withdrawal by Subject|0
181565|NCT00931385|576967|P2|Overall Study|Withdrawal by Subject|1
181566|NCT00931385|576968|P1|Overall Study|Withdrawal by Subject|0
181567|NCT00931385|576965|P4|Overall Study|Protocol Violation|0
181568|NCT00931385|576966|P3|Overall Study|Protocol Violation|1
181569|NCT00931385|576967|P2|Overall Study|Protocol Violation|0
181570|NCT00931385|576968|P1|Overall Study|Protocol Violation|0
181571|NCT00931385|576965|P4|Overall Study|Adverse Event|3
181572|NCT00931385|576966|P3|Overall Study|Adverse Event|0
181573|NCT00931385|576967|P2|Overall Study|Adverse Event|1
181574|NCT00931385|576968|P1|Overall Study|Adverse Event|2
181575|NCT00931411|577024|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
181576|NCT00931411|577025|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
181577|NCT00931411|577024|P2|First Intervention - 42 Days|Lost to Follow-up|0
181578|NCT00931411|577025|P1|First Intervention - 42 Days|Lost to Follow-up|2
181579|NCT00931411|577024|P2|First Intervention - 42 Days|Adverse Event|3
181580|NCT00931411|577025|P1|First Intervention - 42 Days|Adverse Event|2
181581|NCT00931463|577048|P2|Overall Study|Lost to Follow-up|1
181582|NCT00931463|577049|P1|Overall Study|Lost to Follow-up|4
181583|NCT00931463|577048|P2|Overall Study|Withdrawal by Subject|0
181584|NCT00931463|577049|P1|Overall Study|Withdrawal by Subject|5
181585|NCT00931463|577048|P2|Overall Study|Death|4
181586|NCT00931463|577049|P1|Overall Study|Death|8
181587|NCT00931515|577087|P2|Overall Study|Lost to Follow-up|5
181588|NCT00931515|577088|P1|Overall Study|Lost to Follow-up|2
181589|NCT00931528|577096|P2|Overall Study|Assessment outside of Time Frame|23
181590|NCT00931528|577097|P1|Overall Study|Assessment outside of Time Frame|22
181591|NCT00931528|577096|P2|Overall Study|Lost to Follow-up|13
181592|NCT00931528|577097|P1|Overall Study|Lost to Follow-up|6
181593|NCT00931528|577096|P2|Overall Study|Withdrawal by Subject|12
181594|NCT00931528|577097|P1|Overall Study|Withdrawal by Subject|4
181595|NCT00931528|577096|P2|Overall Study|Protocol Violation|12
181596|NCT00931528|577097|P1|Overall Study|Protocol Violation|9
181597|NCT00931632|577105|P2|Overall Study|Adverse Event|15
181598|NCT00931632|577106|P1|Overall Study|Adverse Event|19
181599|NCT00931632|577105|P2|Overall Study|Withdrawal by Subject|3
181600|NCT00931632|577106|P1|Overall Study|Withdrawal by Subject|2
181601|NCT00931710|577114|P2|Overall Study|Protocol deviation|2
181602|NCT00931710|577115|P1|Overall Study|Protocol deviation|1
181603|NCT00931710|577114|P2|Overall Study|Lost to Follow-up|5
181604|NCT00931710|577115|P1|Overall Study|Lost to Follow-up|6
181605|NCT00931710|577114|P2|Overall Study|Patient withdrew consent|9
181606|NCT00931710|577115|P1|Overall Study|Patient withdrew consent|4
181607|NCT00931710|577114|P2|Overall Study|Unsatisfactory therapeutic effects|12
181608|NCT00931710|577115|P1|Overall Study|Unsatisfactory therapeutic effects|5
181609|NCT00931710|577114|P2|Overall Study|Abnormal test procedure results|0
181610|NCT00931710|577115|P1|Overall Study|Abnormal test procedure results|2
181611|NCT00931710|577114|P2|Overall Study|Adverse Event|10
181612|NCT00931710|577115|P1|Overall Study|Adverse Event|16
181613|NCT00931723|577133|P2|Overall Study|Late hospital discharge|0
181614|NCT00931723|577134|P1|Overall Study|Late hospital discharge|1
181615|NCT00931723|577133|P2|Overall Study|Sponsor decision|0
181616|NCT00931723|577134|P1|Overall Study|Sponsor decision|1
181617|NCT00931723|577133|P2|Overall Study|Lack or insufficient theraputic response|5
181618|NCT00931723|577134|P1|Overall Study|Lack or insufficient theraputic response|2
181619|NCT00931723|577133|P2|Overall Study|Took prohibited concomitant medication|1
181620|NCT00931723|577134|P1|Overall Study|Took prohibited concomitant medication|0
181621|NCT00931723|577133|P2|Overall Study|Safety reasons|1
181622|NCT00931723|577134|P1|Overall Study|Safety reasons|0
181623|NCT00931723|577133|P2|Overall Study|Severe non-compliance to protocol|0
181624|NCT00931723|577134|P1|Overall Study|Severe non-compliance to protocol|2
181625|NCT00931723|577133|P2|Overall Study|Study-specific discontinuation criteria|1
181626|NCT00931723|577134|P1|Overall Study|Study-specific discontinuation criteria|1
181627|NCT00931723|577133|P2|Overall Study|Lost to Follow-up|2
181628|NCT00931723|577134|P1|Overall Study|Lost to Follow-up|1
181629|NCT00931723|577133|P2|Overall Study|Condition under investigation worsened|2
181630|NCT00931723|577134|P1|Overall Study|Condition under investigation worsened|1
181631|NCT00931723|577133|P2|Overall Study|Lithium found in blood|1
181632|NCT00931723|577134|P1|Overall Study|Lithium found in blood|0
181633|NCT00931723|577133|P2|Overall Study|Adverse Event|13
181634|NCT00931723|577134|P1|Overall Study|Adverse Event|6
181635|NCT00931723|577133|P2|Overall Study|Withdrawal by Subject|13
181636|NCT00931723|577134|P1|Overall Study|Withdrawal by Subject|11
181637|NCT00931801|577183|P3|Overall Study|Confirmed Virologic Failure|3
181638|NCT00931801|577184|P2|Overall Study|Confirmed Virologic Failure|0
181639|NCT00931801|577185|P1|Overall Study|Confirmed Virologic Failure|0
181640|NCT00931801|577183|P3|Overall Study|Withdrawal by Subject|0
181641|NCT00931801|577184|P2|Overall Study|Withdrawal by Subject|0
181642|NCT00931801|577185|P1|Overall Study|Withdrawal by Subject|1
181643|NCT00931801|577183|P3|Overall Study|Lost to Follow-up|0
181644|NCT00931801|577184|P2|Overall Study|Lost to Follow-up|1
181645|NCT00931801|577185|P1|Overall Study|Lost to Follow-up|0
181646|NCT00931801|577183|P3|Overall Study|Adverse Event|1
181647|NCT00931801|577184|P2|Overall Study|Adverse Event|0
181648|NCT00931801|577185|P1|Overall Study|Adverse Event|0
181649|NCT00925990|577208|P2|Overall Study|moved out of state, missed medication|2
181650|NCT00925990|577209|P1|Overall Study|moved out of state, missed medication|0
181651|NCT00925990|577208|P2|Overall Study|Physician Decision|1
181652|NCT00925990|577209|P1|Overall Study|Physician Decision|1
181653|NCT00925990|577208|P2|Overall Study|Lost to Follow-up|3
181654|NCT00925990|577209|P1|Overall Study|Lost to Follow-up|1
181655|NCT00925990|577208|P2|Overall Study|Withdrawal by Subject|2
181656|NCT00925990|577209|P1|Overall Study|Withdrawal by Subject|2
181657|NCT00925990|577208|P2|Overall Study|Adverse Event|3
181658|NCT00925990|577209|P1|Overall Study|Adverse Event|1
181659|NCT00926029|577220|P3|Overall Study|Lost to Follow-up|1
181660|NCT00926029|577221|P2|Overall Study|Lost to Follow-up|1
181661|NCT00926029|577222|P1|Overall Study|Lost to Follow-up|2
181662|NCT00931918|577260|P2|Overall Study|Did not receive study drug|2
181663|NCT00931918|577261|P1|Overall Study|Did not receive study drug|3
181664|NCT00931918|577260|P2|Overall Study|Other Reason not Specified|4
181665|NCT00931918|577261|P1|Overall Study|Other Reason not Specified|4
181666|NCT00931918|577260|P2|Overall Study|Withdrawal by Patient|4
181667|NCT00931918|577261|P1|Overall Study|Withdrawal by Patient|3
181668|NCT00931918|577260|P2|Overall Study|Symptomatic Deterioration|0
181669|NCT00931918|577261|P1|Overall Study|Symptomatic Deterioration|1
181670|NCT00931918|577260|P2|Overall Study|Progressive Disease|1
181671|NCT00931918|577261|P1|Overall Study|Progressive Disease|2
181672|NCT00931918|577260|P2|Overall Study|Adverse Event|6
181673|NCT00931918|577261|P1|Overall Study|Adverse Event|4
181674|NCT00932113|577321|P2|Overall Study|Lost to Follow-up|0
181675|NCT00932113|577322|P1|Overall Study|Lost to Follow-up|1
181676|NCT00932126|577338|P8|Overall Study|Other|2
181677|NCT00932126|577339|P7|Overall Study|Other|1
181678|NCT00932126|577340|P6|Overall Study|Other|0
181679|NCT00932126|577341|P5|Overall Study|Other|1
181680|NCT00932126|577342|P4|Overall Study|Other|0
181681|NCT00932126|577343|P3|Overall Study|Other|0
181682|NCT00932126|577344|P2|Overall Study|Other|0
181683|NCT00932126|577345|P1|Overall Study|Other|0
181684|NCT00932126|577338|P8|Overall Study|Objective progression or relapse|5
181685|NCT00932126|577339|P7|Overall Study|Objective progression or relapse|3
181686|NCT00932126|577340|P6|Overall Study|Objective progression or relapse|3
181687|NCT00932126|577341|P5|Overall Study|Objective progression or relapse|3
181688|NCT00932126|577342|P4|Overall Study|Objective progression or relapse|3
181689|NCT00932126|577343|P3|Overall Study|Objective progression or relapse|2
181690|NCT00932126|577344|P2|Overall Study|Objective progression or relapse|3
181691|NCT00932126|577345|P1|Overall Study|Objective progression or relapse|3
181692|NCT00932126|577338|P8|Overall Study|Withdrawal by Subject|1
181693|NCT00932126|577339|P7|Overall Study|Withdrawal by Subject|0
181694|NCT00932126|577340|P6|Overall Study|Withdrawal by Subject|0
181695|NCT00932126|577341|P5|Overall Study|Withdrawal by Subject|0
181696|NCT00932126|577342|P4|Overall Study|Withdrawal by Subject|0
181697|NCT00932126|577343|P3|Overall Study|Withdrawal by Subject|1
181698|NCT00932126|577344|P2|Overall Study|Withdrawal by Subject|0
181699|NCT00932126|577345|P1|Overall Study|Withdrawal by Subject|0
181700|NCT00932126|577338|P8|Overall Study|Protocol Violation|0
181701|NCT00932126|577339|P7|Overall Study|Protocol Violation|0
181702|NCT00932126|577340|P6|Overall Study|Protocol Violation|0
181703|NCT00932126|577341|P5|Overall Study|Protocol Violation|1
181704|NCT00932126|577342|P4|Overall Study|Protocol Violation|0
181705|NCT00932126|577343|P3|Overall Study|Protocol Violation|0
181706|NCT00932126|577344|P2|Overall Study|Protocol Violation|0
181707|NCT00932126|577345|P1|Overall Study|Protocol Violation|0
181708|NCT00932126|577338|P8|Overall Study|Adverse Event|2
181709|NCT00932126|577339|P7|Overall Study|Adverse Event|1
181710|NCT00932126|577340|P6|Overall Study|Adverse Event|0
181711|NCT00932126|577341|P5|Overall Study|Adverse Event|0
181712|NCT00932126|577342|P4|Overall Study|Adverse Event|0
181713|NCT00932126|577343|P3|Overall Study|Adverse Event|0
181714|NCT00932126|577344|P2|Overall Study|Adverse Event|0
181715|NCT00932126|577345|P1|Overall Study|Adverse Event|0
181716|NCT00932165|577388|P1|Overall Study|Lost to Follow-up|1
181717|NCT00935701|577407|P1|Overall Study|Failure to Transition to Acupuncture|1
181718|NCT00935818|577449|P2|Overall Study|Physician Decision|1
181719|NCT00935818|577450|P1|Overall Study|Physician Decision|0
181720|NCT00935818|577449|P2|Overall Study|Adverse Event|7
181721|NCT00935818|577450|P1|Overall Study|Adverse Event|6
181722|NCT00935818|577449|P2|Overall Study|Lost to Follow-up|42
181723|NCT00935818|577450|P1|Overall Study|Lost to Follow-up|40
181724|NCT00935818|577449|P2|Overall Study|Withdrawal by Subject|50
181725|NCT00935818|577450|P1|Overall Study|Withdrawal by Subject|45
181726|NCT00935883|577483|P2|Treatment Period|Withdrawal by Subject|2
181727|NCT00935883|577484|P1|Treatment Period|Withdrawal by Subject|0
181728|NCT00935883|577483|P2|Treatment Period|Physician Decision|0
181729|NCT00935883|577484|P1|Treatment Period|Physician Decision|1
181730|NCT00936065|577499|P3|Overall Study|Withdrawal by Subject|4
181731|NCT00936065|577500|P2|Overall Study|Withdrawal by Subject|2
181732|NCT00936065|577501|P1|Overall Study|Withdrawal by Subject|0
181733|NCT00936065|577499|P3|Overall Study|Protocol Violation|1
181734|NCT00936065|577500|P2|Overall Study|Protocol Violation|2
181735|NCT00936065|577501|P1|Overall Study|Protocol Violation|1
181736|NCT00936065|577499|P3|Overall Study|Lost to Follow-up|0
181737|NCT00936065|577500|P2|Overall Study|Lost to Follow-up|0
181738|NCT00936065|577501|P1|Overall Study|Lost to Follow-up|1
181739|NCT00936065|577499|P3|Overall Study|Lack of Efficacy|1
181740|NCT00936065|577500|P2|Overall Study|Lack of Efficacy|0
181741|NCT00936065|577501|P1|Overall Study|Lack of Efficacy|1
181742|NCT00936065|577499|P3|Overall Study|Adverse Event|1
181743|NCT00936065|577500|P2|Overall Study|Adverse Event|0
181744|NCT00936065|577501|P1|Overall Study|Adverse Event|1
181745|NCT00936117|577605|P1|Overall Study|Unable to continue oral medication|3
181746|NCT00936117|577605|P1|Overall Study|Adverse Event|7
181747|NCT00936208|577612|P2|Overall Study|Protocol Violation|22
181748|NCT00936208|577613|P1|Overall Study|Protocol Violation|37
181749|NCT00936221|577633|P2|Overall Study|Withdrawal by Subject|1
181750|NCT00936221|577634|P1|Overall Study|Withdrawal by Subject|1
181751|NCT00936598|577725|P2|Overall Study|Ineligible after consent|0
181752|NCT00936598|577726|P1|Overall Study|Ineligible after consent|1
181753|NCT00936598|577725|P2|Overall Study|Withdrawal by Subject|0
181754|NCT00936598|577726|P1|Overall Study|Withdrawal by Subject|1
181755|NCT00936702|577736|P1|Overall Study|Unspecified|1
181756|NCT00936702|577736|P1|Overall Study|Alternative Treatment|1
181757|NCT00936702|577736|P1|Overall Study|Withdrawal by Subject|2
181758|NCT00936702|577736|P1|Overall Study|Adverse Event|8
181759|NCT00936702|577736|P1|Overall Study|Disease progression|34
181760|NCT00936715|577744|P1|Overall Study|Safety or Tolerability Reasons|4
181761|NCT00936715|577744|P1|Overall Study|Protocol Violation|1
181762|NCT00936715|577744|P1|Overall Study|Investigators Discretion|1
181763|NCT00936897|577755|P2|Overall Study|Death|1
181764|NCT00936897|577756|P1|Overall Study|Death|0
181765|NCT00936897|577755|P2|Overall Study|Noncompliance|2
181766|NCT00936897|577756|P1|Overall Study|Noncompliance|0
181767|NCT00936897|577755|P2|Overall Study|Ineligibility Determined|3
181768|NCT00936897|577756|P1|Overall Study|Ineligibility Determined|0
181769|NCT00936897|577755|P2|Overall Study|Protocol Violation|1
181770|NCT00936897|577756|P1|Overall Study|Protocol Violation|1
181771|NCT00936897|577755|P2|Overall Study|Administrative Decision|2
181772|NCT00936897|577756|P1|Overall Study|Administrative Decision|1
181773|NCT00936897|577755|P2|Overall Study|Lost to Follow-up|10
181774|NCT00936897|577756|P1|Overall Study|Lost to Follow-up|1
181775|NCT00936897|577755|P2|Overall Study|Other|9
181776|NCT00936897|577756|P1|Overall Study|Other|3
181777|NCT00936897|577755|P2|Overall Study|Adverse Event|13
181778|NCT00936897|577756|P1|Overall Study|Adverse Event|4
181779|NCT00936897|577755|P2|Overall Study|Withdrawal by Subject|19
181780|NCT00936897|577756|P1|Overall Study|Withdrawal by Subject|9
181781|NCT00936975|577768|P1|Overall Study|Post-Tx scan uninterpretable|2
181782|NCT00936975|577768|P1|Overall Study|Disease progression|3
181783|NCT00936975|577768|P1|Overall Study|Withdrawal by Subject|1
181784|NCT00937040|577779|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
181785|NCT00937040|577780|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
181786|NCT00937040|577779|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
181787|NCT00937040|577780|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
181788|NCT00937040|577779|P2|Overall Study|Withdrawal by Subject|7
181789|NCT00937040|577780|P1|Overall Study|Withdrawal by Subject|13
181790|NCT00937040|577779|P2|Overall Study|Protocol Violation|0
181791|NCT00937040|577780|P1|Overall Study|Protocol Violation|3
181792|NCT00937040|577779|P2|Overall Study|Lost to Follow-up|12
181793|NCT00937040|577780|P1|Overall Study|Lost to Follow-up|12
181794|NCT00937040|577779|P2|Overall Study|Adverse Event|8
181795|NCT00937040|577780|P1|Overall Study|Adverse Event|5
181796|NCT00937157|577847|P1|Overall Study|Lost to Follow-up|3
181797|NCT00937157|577847|P1|Overall Study|Pregnancy|1
181798|NCT00937391|577853|P1|Stage 2|Withdrawal by Subject|1
181799|NCT00937495|577904|P1|Overall Study|Protocol Violation|2
181800|NCT00937521|577918|P8|Booster Phase|Protocol Deviation|0
181801|NCT00937521|577919|P7|Booster Phase|Protocol Deviation|1
181802|NCT00937521|577920|P6|Booster Phase|Protocol Deviation|0
181803|NCT00937521|577921|P5|Booster Phase|Protocol Deviation|0
181804|NCT00937521|577922|P4|Booster Phase|Protocol Deviation|0
181805|NCT00937521|577923|P3|Booster Phase|Protocol Deviation|0
181806|NCT00937521|577924|P2|Booster Phase|Protocol Deviation|0
181807|NCT00937521|577925|P1|Booster Phase|Protocol Deviation|0
181808|NCT00937521|577918|P8|Booster Phase|Administrative Reason|0
181809|NCT00937521|577919|P7|Booster Phase|Administrative Reason|0
181810|NCT00937521|577920|P6|Booster Phase|Administrative Reason|1
181811|NCT00937521|577921|P5|Booster Phase|Administrative Reason|1
181812|NCT00937521|577922|P4|Booster Phase|Administrative Reason|0
181813|NCT00937521|577923|P3|Booster Phase|Administrative Reason|1
181814|NCT00937521|577924|P2|Booster Phase|Administrative Reason|0
181815|NCT00937521|577925|P1|Booster Phase|Administrative Reason|0
181816|NCT00937521|577918|P8|Booster Phase|Lost to Follow-up|0
181817|NCT00937521|577919|P7|Booster Phase|Lost to Follow-up|3
181818|NCT00937521|577920|P6|Booster Phase|Lost to Follow-up|4
181819|NCT00937521|577921|P5|Booster Phase|Lost to Follow-up|4
181820|NCT00937521|577922|P4|Booster Phase|Lost to Follow-up|2
181821|NCT00937521|577923|P3|Booster Phase|Lost to Follow-up|4
181822|NCT00937521|577924|P2|Booster Phase|Lost to Follow-up|2
181823|NCT00937521|577925|P1|Booster Phase|Lost to Follow-up|2
181824|NCT00937521|577918|P8|Booster Phase|Withdrawal by Subject|2
181825|NCT00937521|577919|P7|Booster Phase|Withdrawal by Subject|0
181826|NCT00937521|577920|P6|Booster Phase|Withdrawal by Subject|0
181827|NCT00937521|577921|P5|Booster Phase|Withdrawal by Subject|0
181828|NCT00937521|577922|P4|Booster Phase|Withdrawal by Subject|1
181829|NCT00937521|577923|P3|Booster Phase|Withdrawal by Subject|0
181830|NCT00937521|577924|P2|Booster Phase|Withdrawal by Subject|0
181831|NCT00937521|577925|P1|Booster Phase|Withdrawal by Subject|1
181832|NCT00937521|577918|P8|Booster Phase|Adverse Event|0
181833|NCT00937521|577919|P7|Booster Phase|Adverse Event|1
181834|NCT00937521|577920|P6|Booster Phase|Adverse Event|0
181835|NCT00937521|577921|P5|Booster Phase|Adverse Event|0
181836|NCT00937521|577922|P4|Booster Phase|Adverse Event|0
181837|NCT00937521|577923|P3|Booster Phase|Adverse Event|0
181838|NCT00937521|577924|P2|Booster Phase|Adverse Event|0
181839|NCT00937521|577925|P1|Booster Phase|Adverse Event|0
181840|NCT00937521|577918|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
181841|NCT00937521|577919|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
181842|NCT00937521|577920|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
181843|NCT00937521|577921|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
181844|NCT00937521|577922|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
181845|NCT00937521|577923|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
181846|NCT00937521|577924|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
181847|NCT00937521|577925|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
181848|NCT00937521|577918|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
181849|NCT00937521|577919|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
181850|NCT00937521|577920|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
181851|NCT00937521|577921|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
181852|NCT00937521|577922|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
181853|NCT00937521|577923|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
181854|NCT00937521|577924|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
181855|NCT00937521|577925|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
181856|NCT00937521|577918|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
181857|NCT00937521|577919|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
181858|NCT00937521|577920|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
181859|NCT00937521|577921|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
181860|NCT00937521|577922|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
181861|NCT00937521|577923|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
181862|NCT00937521|577924|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
181863|NCT00937521|577925|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
181864|NCT00937521|577918|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
181865|NCT00937521|577919|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
181866|NCT00937521|577920|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
181867|NCT00937521|577921|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
181868|NCT00937521|577922|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
181869|NCT00937521|577923|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
181870|NCT00937521|577924|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
181871|NCT00937521|577925|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
181872|NCT00937521|577918|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
181873|NCT00937521|577919|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
181874|NCT00937521|577920|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
181875|NCT00937521|577921|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
181876|NCT00937521|577922|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
181877|NCT00937521|577923|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
181878|NCT00937521|577924|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
181879|NCT00937521|577925|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
181880|NCT00937547|578034|P3|Overall Study|misdiagnosis|7
181881|NCT00937547|578035|P2|Overall Study|misdiagnosis|6
181882|NCT00937547|578036|P1|Overall Study|misdiagnosis|1
181883|NCT00937560|578065|P1|Maintenance Treatment|According to protocol|1
181884|NCT00937560|578065|P1|Maintenance Treatment|Withdraw consent|5
181885|NCT00937560|578065|P1|Maintenance Treatment|Death|12
181886|NCT00937560|578065|P1|Initial Treatment|No end of study page|10
181887|NCT00937560|578065|P1|Initial Treatment|Lost to Follow-up|1
181888|NCT00937560|578065|P1|Initial Treatment|Adverse Event|1
181889|NCT00937560|578065|P1|Initial Treatment|Withdraw consent|3
181890|NCT00937560|578065|P1|Initial Treatment|Death|6
181891|NCT00937768|578075|P2|Overall Study|No Further Funding|4
181892|NCT00937768|578076|P1|Overall Study|No Further Funding|4
181893|NCT00937768|578075|P2|Overall Study|Alternate Treatment|1
181894|NCT00937768|578076|P1|Overall Study|Alternate Treatment|0
181895|NCT00937768|578075|P2|Overall Study|Disease Progression|1
181896|NCT00937768|578076|P1|Overall Study|Disease Progression|1
181897|NCT00937768|578075|P2|Overall Study|Refused Further Treatment|2
181898|NCT00937768|578076|P1|Overall Study|Refused Further Treatment|3
181899|NCT00937833|578089|P2|Overall Study|Withdrawal by Subject|6
181900|NCT00937833|578090|P1|Overall Study|Withdrawal by Subject|4
181901|NCT00937833|578089|P2|Overall Study|Lost to Follow-up|8
181902|NCT00937833|578090|P1|Overall Study|Lost to Follow-up|10
181903|NCT00937833|578089|P2|Overall Study|Procedure delayed; enrollment closed|1
181904|NCT00937833|578090|P1|Overall Study|Procedure delayed; enrollment closed|0
181905|NCT00937833|578089|P2|Overall Study|Protocol Violation|2
181906|NCT00937833|578090|P1|Overall Study|Protocol Violation|1
181907|NCT00937937|578096|P1|Overall Study|Not specified|2
181908|NCT00937937|578096|P1|Overall Study|Death|1
181909|NCT00937937|578096|P1|Overall Study|Progression/relapse|61
181910|NCT00937937|578096|P1|Overall Study|Withdrawal by Subject|2
181911|NCT00937937|578096|P1|Overall Study|Adverse Event|6
181912|NCT00937950|578103|P1|Overall Study|Others|18
181913|NCT00937950|578103|P1|Overall Study|Missing confirmed|4
181914|NCT00937950|578103|P1|Overall Study|Lost to Follow-up|144
181915|NCT00937950|578103|P1|Overall Study|Migrated/moved from study area|27
181916|NCT00937950|578103|P1|Overall Study|Withdrawal by Subject|23
181917|NCT00938015|578119|P1|Overall Study|Reason not related to Etanercept|29
181918|NCT00938015|578119|P1|Overall Study|Non-responder|52
181919|NCT00938015|578119|P1|Overall Study|Adverse Event|32
181920|NCT00938015|578119|P1|Overall Study|Lost to Follow-up|32
181921|NCT00938015|578119|P1|Overall Study|Death|2
181922|NCT00938041|578135|P1|Overall Study|Adrenal Insufficiency|3
181923|NCT00938041|578135|P1|Overall Study|Death|12
181924|NCT00938041|578135|P1|Overall Study|Progressive Disease|5
181925|NCT00938041|578135|P1|Overall Study|Received Alternative Therapy|1
181926|NCT00938041|578135|P1|Overall Study|Lost to Follow-up|6
181927|NCT00929110|578154|P3|Overall Study|Patient inability to use the device|0
181928|NCT00929110|578155|P2|Overall Study|Patient inability to use the device|1
181929|NCT00929110|578156|P1|Overall Study|Patient inability to use the device|0
181930|NCT00929110|578154|P3|Overall Study|Abnormal test procedure result(s)|1
181931|NCT00929110|578155|P2|Overall Study|Abnormal test procedure result(s)|1
181932|NCT00929110|578156|P1|Overall Study|Abnormal test procedure result(s)|0
181933|NCT00929110|578154|P3|Overall Study|Abnormal laboratory value(s)|0
181934|NCT00929110|578155|P2|Overall Study|Abnormal laboratory value(s)|1
181935|NCT00929110|578156|P1|Overall Study|Abnormal laboratory value(s)|0
181936|NCT00929110|578154|P3|Overall Study|Death|2
181937|NCT00929110|578155|P2|Overall Study|Death|2
181938|NCT00929110|578156|P1|Overall Study|Death|2
181939|NCT00929110|578154|P3|Overall Study|Administrative problems|2
181940|NCT00929110|578155|P2|Overall Study|Administrative problems|1
181941|NCT00929110|578156|P1|Overall Study|Administrative problems|4
181942|NCT00929110|578154|P3|Overall Study|Protocol deviation|4
181943|NCT00929110|578155|P2|Overall Study|Protocol deviation|2
181944|NCT00929110|578156|P1|Overall Study|Protocol deviation|5
181945|NCT00929110|578154|P3|Overall Study|Lost to Follow-up|3
181946|NCT00929110|578155|P2|Overall Study|Lost to Follow-up|7
181947|NCT00929110|578156|P1|Overall Study|Lost to Follow-up|7
181948|NCT00929110|578154|P3|Overall Study|Unsatisfactory therapeutic effect|6
181949|NCT00929110|578155|P2|Overall Study|Unsatisfactory therapeutic effect|9
181950|NCT00929110|578156|P1|Overall Study|Unsatisfactory therapeutic effect|20
181951|NCT00929110|578154|P3|Overall Study|Subject withdrew consent|26
181952|NCT00929110|578155|P2|Overall Study|Subject withdrew consent|23
181953|NCT00929110|578156|P1|Overall Study|Subject withdrew consent|40
181954|NCT00929110|578154|P3|Overall Study|Adverse Event|18
181955|NCT00929110|578155|P2|Overall Study|Adverse Event|29
181956|NCT00929110|578156|P1|Overall Study|Adverse Event|40
181957|NCT00929162|578223|P2|Overall Study|Other termination reason|6
181958|NCT00929162|578224|P1|Overall Study|Other termination reason|5
181959|NCT00929162|578223|P2|Overall Study|Protocol Violation|30
181960|NCT00929162|578224|P1|Overall Study|Protocol Violation|32
181961|NCT00929162|578223|P2|Overall Study|Withdrawal by Subject|1
181962|NCT00929162|578224|P1|Overall Study|Withdrawal by Subject|3
181963|NCT00929162|578223|P2|Overall Study|Adverse Event|5
181964|NCT00929162|578224|P1|Overall Study|Adverse Event|8
181965|NCT00929201|578234|P2|Period 1|Withdrawal by Subject|1
181966|NCT00929201|578235|P1|Period 1|Withdrawal by Subject|0
181967|NCT00929240|578243|P3|Maintenance Phase|Participant not treated|0
181968|NCT00929240|578244|P2|Maintenance Phase|Participant not treated|2
181969|NCT00929240|578245|P1|Maintenance Phase|Participant not treated|0
181970|NCT00929240|578243|P3|Maintenance Phase|Treatment ongoing at study closure|10
181971|NCT00929240|578244|P2|Maintenance Phase|Treatment ongoing at study closure|0
181972|NCT00929240|578245|P1|Maintenance Phase|Treatment ongoing at study closure|0
181973|NCT00929240|578243|P3|Maintenance Phase|Change of treatment|0
181974|NCT00929240|578244|P2|Maintenance Phase|Change of treatment|4
181975|NCT00929240|578245|P1|Maintenance Phase|Change of treatment|0
181976|NCT00929240|578243|P3|Maintenance Phase|Physician Decision|1
181977|NCT00929240|578244|P2|Maintenance Phase|Physician Decision|2
181978|NCT00929240|578245|P1|Maintenance Phase|Physician Decision|0
181979|NCT00929240|578243|P3|Maintenance Phase|Health authority/Study termination|2
181980|NCT00929240|578244|P2|Maintenance Phase|Health authority/Study termination|1
181981|NCT00929240|578245|P1|Maintenance Phase|Health authority/Study termination|0
181982|NCT00929240|578243|P3|Maintenance Phase|Protocol Violation|0
181983|NCT00929240|578244|P2|Maintenance Phase|Protocol Violation|1
181984|NCT00929240|578245|P1|Maintenance Phase|Protocol Violation|0
181985|NCT00929240|578243|P3|Maintenance Phase|Withdrawal by Subject|6
181986|NCT00929240|578244|P2|Maintenance Phase|Withdrawal by Subject|2
181987|NCT00929240|578245|P1|Maintenance Phase|Withdrawal by Subject|0
181988|NCT00929240|578243|P3|Maintenance Phase|Adverse Event|12
181989|NCT00929240|578244|P2|Maintenance Phase|Adverse Event|9
181990|NCT00929240|578245|P1|Maintenance Phase|Adverse Event|0
181991|NCT00929240|578243|P3|Maintenance Phase|Disease progression|60
181992|NCT00929240|578244|P2|Maintenance Phase|Disease progression|73
181993|NCT00929240|578245|P1|Maintenance Phase|Disease progression|0
181994|NCT00929240|578243|P3|Initial Treatment Phase|Physician Decision|0
181995|NCT00929240|578244|P2|Initial Treatment Phase|Physician Decision|0
181996|NCT00929240|578245|P1|Initial Treatment Phase|Physician Decision|4
181997|NCT00929240|578243|P3|Initial Treatment Phase|Health authority/Study termination|0
181998|NCT00929240|578244|P2|Initial Treatment Phase|Health authority/Study termination|0
181999|NCT00929240|578245|P1|Initial Treatment Phase|Health authority/Study termination|3
182000|NCT00929240|578243|P3|Initial Treatment Phase|Death|0
182001|NCT00929240|578244|P2|Initial Treatment Phase|Death|0
182002|NCT00929240|578245|P1|Initial Treatment Phase|Death|2
182003|NCT00929240|578243|P3|Initial Treatment Phase|Protocol Violation|0
182004|NCT00929240|578244|P2|Initial Treatment Phase|Protocol Violation|0
182005|NCT00929240|578245|P1|Initial Treatment Phase|Protocol Violation|5
182006|NCT00929240|578243|P3|Initial Treatment Phase|Withdrawal by Subject|0
182007|NCT00929240|578244|P2|Initial Treatment Phase|Withdrawal by Subject|0
182008|NCT00929240|578245|P1|Initial Treatment Phase|Withdrawal by Subject|13
182009|NCT00929240|578243|P3|Initial Treatment Phase|Disease progression|0
182010|NCT00929240|578244|P2|Initial Treatment Phase|Disease progression|0
182011|NCT00929240|578245|P1|Initial Treatment Phase|Disease progression|41
182012|NCT00929240|578243|P3|Initial Treatment Phase|Adverse Event|0
182013|NCT00929240|578244|P2|Initial Treatment Phase|Adverse Event|0
182014|NCT00929240|578245|P1|Initial Treatment Phase|Adverse Event|31
182015|NCT00938327|578344|P1|Overall Study|Vaccine not received as out of stock|9
182016|NCT00938327|578344|P1|Overall Study|2nd dose received outside of the study|7
182017|NCT00938327|578344|P1|Overall Study|Lost to Follow-up|37
182018|NCT00938327|578344|P1|Overall Study|Withdrawal by Subject|4
182019|NCT00938327|578344|P1|Overall Study|Protocol Violation|1
182020|NCT00938327|578344|P1|Overall Study|Adverse Event|2
182021|NCT00938366|578353|P2|Overall Study|Withdrawal by Subject|0
182022|NCT00938366|578354|P1|Overall Study|Withdrawal by Subject|1
182023|NCT00938392|578376|P2|Overall Study|Lost to Follow-up|2
182024|NCT00938392|578377|P1|Overall Study|Lost to Follow-up|2
182025|NCT00938392|578376|P2|Overall Study|Withdrawal by Subject|1
182026|NCT00938392|578377|P1|Overall Study|Withdrawal by Subject|0
182027|NCT00938392|578376|P2|Overall Study|Adverse Event|1
182028|NCT00938392|578377|P1|Overall Study|Adverse Event|0
182029|NCT00938431|578404|P3|Overall Study|Reached maximum dose early|1
182030|NCT00938431|578405|P2|Overall Study|Reached maximum dose early|0
182031|NCT00938431|578406|P1|Overall Study|Reached maximum dose early|0
182032|NCT00938431|578404|P3|Overall Study|Dosing compliance issue|1
182033|NCT00938431|578405|P2|Overall Study|Dosing compliance issue|0
182034|NCT00938431|578406|P1|Overall Study|Dosing compliance issue|0
182035|NCT00938431|578404|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
182036|NCT00938431|578405|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
182037|NCT00938431|578406|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
182038|NCT00938431|578404|P3|Overall Study|Lack of Efficacy|0
182039|NCT00938431|578405|P2|Overall Study|Lack of Efficacy|1
182040|NCT00938431|578406|P1|Overall Study|Lack of Efficacy|0
182041|NCT00938431|578404|P3|Overall Study|Adverse Event|6
182042|NCT00938431|578405|P2|Overall Study|Adverse Event|8
182043|NCT00938431|578406|P1|Overall Study|Adverse Event|5
182044|NCT00938860|578433|P2|Overall Study|Protocol Violation|1
182045|NCT00938860|578434|P1|Overall Study|Protocol Violation|3
182046|NCT00938860|578433|P2|Overall Study|Death|1
182047|NCT00938860|578434|P1|Overall Study|Death|1
182048|NCT00938860|578433|P2|Overall Study|Administration problems|0
182049|NCT00938860|578434|P1|Overall Study|Administration problems|2
182050|NCT00938860|578433|P2|Overall Study|Lost to Follow-up|4
182051|NCT00938860|578434|P1|Overall Study|Lost to Follow-up|4
182052|NCT00938860|578433|P2|Overall Study|Withdrawal by Subject|8
182053|NCT00938860|578434|P1|Overall Study|Withdrawal by Subject|11
182054|NCT00938860|578433|P2|Overall Study|Abnormal laboratory values|2
182055|NCT00938860|578434|P1|Overall Study|Abnormal laboratory values|2
182056|NCT00938860|578433|P2|Overall Study|Adverse Event|1
182057|NCT00938860|578434|P1|Overall Study|Adverse Event|2
182058|NCT00938886|578458|P2|Overall Study|Lost to Follow-up|2
182059|NCT00938886|578459|P1|Overall Study|Lost to Follow-up|3
182060|NCT00938886|578458|P2|Overall Study|Withdrawal by Subject|7
182061|NCT00938886|578459|P1|Overall Study|Withdrawal by Subject|4
182062|NCT00938886|578458|P2|Overall Study|Death|1
182063|NCT00938886|578459|P1|Overall Study|Death|0
182064|NCT00938964|578469|P2|Overall Study|Found to Meet Exclusion Criteria|4
182065|NCT00938964|578470|P1|Overall Study|Found to Meet Exclusion Criteria|3
182066|NCT00938964|578469|P2|Overall Study|Withdrawal by Subject|18
182067|NCT00938964|578470|P1|Overall Study|Withdrawal by Subject|22
182068|NCT00938964|578469|P2|Overall Study|Lost to Follow-up|3
182069|NCT00938964|578470|P1|Overall Study|Lost to Follow-up|2
182070|NCT00938964|578469|P2|Overall Study|Death|3
182071|NCT00938964|578470|P1|Overall Study|Death|3
182072|NCT00939003|578510|P2|Open-label Treatment Period|Site Closure|4
182073|NCT00939003|578511|P1|Open-label Treatment Period|Site Closure|3
182074|NCT00939003|578510|P2|Open-label Treatment Period|Exclusion Criteria|0
182075|NCT00939003|578511|P1|Open-label Treatment Period|Exclusion Criteria|1
182076|NCT00939003|578510|P2|Open-label Treatment Period|Pregnancy|1
182077|NCT00939003|578511|P1|Open-label Treatment Period|Pregnancy|1
182078|NCT00939003|578510|P2|Open-label Treatment Period|Lack of Efficacy|9
182079|NCT00939003|578511|P1|Open-label Treatment Period|Lack of Efficacy|6
182080|NCT00939003|578510|P2|Open-label Treatment Period|Withdrawal by Subject|7
182081|NCT00939003|578511|P1|Open-label Treatment Period|Withdrawal by Subject|14
182082|NCT00939003|578510|P2|Open-label Treatment Period|Adverse Event|8
182083|NCT00939003|578511|P1|Open-label Treatment Period|Adverse Event|4
182084|NCT00939003|578510|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
182085|NCT00939003|578511|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
182086|NCT00939003|578510|P2|Double-blind Treatment Period|Pregnancy|1
182087|NCT00939003|578511|P1|Double-blind Treatment Period|Pregnancy|0
182088|NCT00939003|578510|P2|Double-blind Treatment Period|Lack of Efficacy|1
182089|NCT00939003|578511|P1|Double-blind Treatment Period|Lack of Efficacy|0
182090|NCT00939003|578510|P2|Double-blind Treatment Period|Adverse Event|1
182091|NCT00939003|578511|P1|Double-blind Treatment Period|Adverse Event|1
182092|NCT00939029|578548|P2|Overall Study|Adverse Event|1
182093|NCT00939029|578549|P1|Overall Study|Adverse Event|0
182094|NCT00939029|578548|P2|Overall Study|Lost to Follow-up|4
182095|NCT00939029|578549|P1|Overall Study|Lost to Follow-up|3
182096|NCT00939029|578548|P2|Overall Study|Withdrawal by Subject|7
182097|NCT00939029|578549|P1|Overall Study|Withdrawal by Subject|3
182098|NCT00939055|578561|P2|Overall Study|Discontinuation prior to procedure|0
182099|NCT00939055|578562|P1|Overall Study|Discontinuation prior to procedure|4
182100|NCT00939094|578572|P2|Overall Study|Abnormal ECG findings|0
182101|NCT00939094|578573|P1|Overall Study|Abnormal ECG findings|1
182102|NCT00939094|578572|P2|Overall Study|Study stopped by sponsor|2
182103|NCT00939094|578573|P1|Overall Study|Study stopped by sponsor|0
182104|NCT00939094|578572|P2|Overall Study|Severe non-compliance to protocol|1
182105|NCT00939094|578573|P1|Overall Study|Severe non-compliance to protocol|0
182106|NCT00939094|578572|P2|Overall Study|Eligibility criteria not fulfilled|0
182107|NCT00939094|578573|P1|Overall Study|Eligibility criteria not fulfilled|2
182108|NCT00939094|578572|P2|Overall Study|Lost to Follow-up|1
182109|NCT00939094|578573|P1|Overall Study|Lost to Follow-up|1
182110|NCT00939094|578572|P2|Overall Study|Withdrawal by Subject|6
182111|NCT00939094|578573|P1|Overall Study|Withdrawal by Subject|1
182112|NCT00939094|578572|P2|Overall Study|Adverse Event|0
182113|NCT00939094|578573|P1|Overall Study|Adverse Event|9
182114|NCT00939107|578595|P2|Overall Study|Lost to Follow-up|12
182115|NCT00939107|578596|P1|Overall Study|Lost to Follow-up|14
182116|NCT00939185|578637|P1|Overall Study|Randomized But Did Not Receive Treatment|10
182117|NCT00939185|578637|P1|Overall Study|Withdrawal by Subject|2
182118|NCT00939185|578637|P1|Overall Study|Unspecified|3
182119|NCT00939185|578637|P1|Overall Study|Lost to Follow-up|6
182120|NCT00939185|578637|P1|Overall Study|Lack of Efficacy|1
182121|NCT00939185|578637|P1|Overall Study|Adverse Event|3
182122|NCT00939341|578706|P1|Overall Study|Incorrect enrolment|8
182123|NCT00939341|578706|P1|Overall Study|Protocol Violation|6
182124|NCT00939341|578706|P1|Overall Study|Withdrawal by Subject|13
182125|NCT00939341|578706|P1|Overall Study|Lost to Follow-up|23
182126|NCT00939341|578706|P1|Overall Study|Pregnancy|1
182127|NCT00939341|578706|P1|Overall Study|Adverse Event|15
182128|NCT00939393|578739|P2|Overall Study|Lost to Follow-up|0
182129|NCT00939393|578740|P1|Overall Study|Lost to Follow-up|3
182130|NCT00939393|578739|P2|Overall Study|Withdrawal by Subject|0
182131|NCT00939393|578740|P1|Overall Study|Withdrawal by Subject|1
182132|NCT00939484|578774|P3|Overall Study|Progression/Relapse|3
182133|NCT00939484|578775|P2|Overall Study|Progression/Relapse|20
182134|NCT00939484|578776|P1|Overall Study|Progression/Relapse|8
182135|NCT00939510|578789|P1|Overall Study|Withdrawal by Subject|1
182136|NCT00939627|578819|P3|Overall Study|No off-tx reason given|0
182137|NCT00939627|578820|P2|Overall Study|No off-tx reason given|2
182138|NCT00939627|578821|P1|Overall Study|No off-tx reason given|0
182139|NCT00939627|578819|P3|Overall Study|Not compliant|0
182140|NCT00939627|578820|P2|Overall Study|Not compliant|0
182141|NCT00939627|578821|P1|Overall Study|Not compliant|2
182142|NCT00939627|578819|P3|Overall Study|Other complicating disease|0
182143|NCT00939627|578820|P2|Overall Study|Other complicating disease|1
182144|NCT00939627|578821|P1|Overall Study|Other complicating disease|1
182145|NCT00939627|578819|P3|Overall Study|Withdrawal by Subject|0
182146|NCT00939627|578820|P2|Overall Study|Withdrawal by Subject|4
182147|NCT00939627|578821|P1|Overall Study|Withdrawal by Subject|2
182148|NCT00939627|578819|P3|Overall Study|Death|0
182149|NCT00939627|578820|P2|Overall Study|Death|2
182150|NCT00939627|578821|P1|Overall Study|Death|0
182151|NCT00939627|578819|P3|Overall Study|Adverse Event|0
182152|NCT00939627|578820|P2|Overall Study|Adverse Event|7
182153|NCT00939627|578821|P1|Overall Study|Adverse Event|6
182154|NCT00939627|578819|P3|Overall Study|Disease Progression|0
182155|NCT00939627|578820|P2|Overall Study|Disease Progression|12
182156|NCT00939627|578821|P1|Overall Study|Disease Progression|16
182157|NCT00939692|578837|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
182158|NCT00939692|578838|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
182159|NCT00939692|578837|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
182160|NCT00939692|578838|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
182161|NCT00939783|578880|P1|Overall Study|Enrolled but not treated|1
182162|NCT00939783|578880|P1|Overall Study|Protocol Violation|3
182163|NCT00939783|578880|P1|Overall Study|Lost to Follow-up|8
182164|NCT00939783|578880|P1|Overall Study|Unspecified|16
182165|NCT00939783|578880|P1|Overall Study|Withdrawal by Subject|78
182166|NCT00939783|578880|P1|Overall Study|Study Terminated by Sponsor|498
182167|NCT00939783|578880|P1|Overall Study|Adverse Event|39
182168|NCT00939783|578880|P1|Overall Study|Death|6
182169|NCT00939809|578893|P1|Overall Study|Death|1
182170|NCT00939809|578893|P1|Overall Study|Adverse Event|2
182171|NCT00940017|578938|P1|Overall Study|Adverse Event|1
182172|NCT00940017|578938|P1|Overall Study|did not meet entrance criteria|3
182173|NCT00940108|578961|P4|Overall Study|Diagnosed with H1N1|1
182174|NCT00940108|578962|P3|Overall Study|Diagnosed with H1N1|0
182175|NCT00940108|578963|P2|Overall Study|Diagnosed with H1N1|0
182176|NCT00940108|578964|P1|Overall Study|Diagnosed with H1N1|0
182177|NCT00940108|578961|P4|Overall Study|Viral illness after Dose 1|0
182178|NCT00940108|578962|P3|Overall Study|Viral illness after Dose 1|0
182179|NCT00940108|578963|P2|Overall Study|Viral illness after Dose 1|1
182180|NCT00940108|578964|P1|Overall Study|Viral illness after Dose 1|0
182181|NCT00940108|578961|P4|Overall Study|Refused - pyrexia after Dose 1|0
182182|NCT00940108|578962|P3|Overall Study|Refused - pyrexia after Dose 1|0
182183|NCT00940108|578963|P2|Overall Study|Refused - pyrexia after Dose 1|1
182184|NCT00940108|578964|P1|Overall Study|Refused - pyrexia after Dose 1|0
182185|NCT00940108|578961|P4|Overall Study|Declined further vaccination|0
182186|NCT00940108|578962|P3|Overall Study|Declined further vaccination|3
182187|NCT00940108|578963|P2|Overall Study|Declined further vaccination|1
182188|NCT00940108|578964|P1|Overall Study|Declined further vaccination|0
182189|NCT00940108|578961|P4|Overall Study|Dose 2 contraindicated|1
182190|NCT00940108|578962|P3|Overall Study|Dose 2 contraindicated|0
182191|NCT00940108|578963|P2|Overall Study|Dose 2 contraindicated|1
182192|NCT00940108|578964|P1|Overall Study|Dose 2 contraindicated|1
182193|NCT00940108|578961|P4|Overall Study|Withdrew Consent|1
182194|NCT00940108|578962|P3|Overall Study|Withdrew Consent|0
182195|NCT00940108|578963|P2|Overall Study|Withdrew Consent|1
182196|NCT00940108|578964|P1|Overall Study|Withdrew Consent|2
182197|NCT00940108|578961|P4|Overall Study|Adverse Event|2
182198|NCT00940108|578962|P3|Overall Study|Adverse Event|0
182199|NCT00940108|578963|P2|Overall Study|Adverse Event|4
182200|NCT00940108|578964|P1|Overall Study|Adverse Event|2
182201|NCT00940485|579033|P2|Overall Study|Others|1
182202|NCT00940485|579034|P1|Overall Study|Others|1
182203|NCT00940485|579033|P2|Overall Study|Withdrawal by Subject|1
182204|NCT00940485|579034|P1|Overall Study|Withdrawal by Subject|1
182205|NCT00940485|579033|P2|Overall Study|Adverse Event|0
182206|NCT00940485|579034|P1|Overall Study|Adverse Event|8
182207|NCT00940485|579033|P2|Overall Study|Lost to Follow-up|3
182208|NCT00940485|579034|P1|Overall Study|Lost to Follow-up|2
182209|NCT00940485|579033|P2|Overall Study|HBeAb positive at Baseline|2
182210|NCT00940485|579034|P1|Overall Study|HBeAb positive at Baseline|3
182211|NCT00940875|579080|P2|Post-Study Treatment|Disease Progression|2
182212|NCT00940875|579081|P1|Post-Study Treatment|Disease Progression|0
182213|NCT00940875|579080|P2|Post-Study Treatment|Death|1
182214|NCT00940875|579081|P1|Post-Study Treatment|Death|0
182215|NCT00940875|579080|P2|Treatment Phase|Physician Decision|0
182216|NCT00940875|579081|P1|Treatment Phase|Physician Decision|1
182217|NCT00940875|579080|P2|Treatment Phase|Disease progression|11
182218|NCT00940875|579081|P1|Treatment Phase|Disease progression|9
182219|NCT00940875|579080|P2|Treatment Phase|Withdrawal by Subject|0
182220|NCT00940875|579081|P1|Treatment Phase|Withdrawal by Subject|3
182221|NCT00940875|579080|P2|Treatment Phase|Lack of Efficacy|0
182222|NCT00940875|579081|P1|Treatment Phase|Lack of Efficacy|1
182223|NCT00940875|579080|P2|Treatment Phase|Death|5
182224|NCT00940875|579081|P1|Treatment Phase|Death|3
182225|NCT00940875|579080|P2|Treatment Phase|Adverse Event|3
182226|NCT00940875|579081|P1|Treatment Phase|Adverse Event|9
182227|NCT00940888|579099|P1|Overall Study|Lost to Follow-up|6
182228|NCT00940888|579099|P1|Overall Study|Withdrawn - Non-Death|364
182229|NCT00940888|579099|P1|Overall Study|Death|461
182230|NCT00940888|579099|P1|Overall Study|Unsuccessful Implant|4
182231|NCT00940992|579125|P3|Overall Study|Lost to Follow-up|1
182232|NCT00940992|579126|P2|Overall Study|Lost to Follow-up|1
182233|NCT00940992|579127|P1|Overall Study|Lost to Follow-up|0
182234|NCT00940992|579125|P3|Overall Study|subject request|0
182235|NCT00940992|579126|P2|Overall Study|subject request|1
182236|NCT00940992|579127|P1|Overall Study|subject request|2
182237|NCT00940992|579125|P3|Overall Study|Adverse Event|1
182238|NCT00940992|579126|P2|Overall Study|Adverse Event|0
182239|NCT00940992|579127|P1|Overall Study|Adverse Event|2
182240|NCT00941031|579142|P7|Maintenance Period|Lack of Efficacy|13
182241|NCT00941031|579143|P6|Maintenance Period|Lack of Efficacy|0
182242|NCT00941031|579144|P5|Maintenance Period|Lack of Efficacy|0
182243|NCT00941031|579145|P4|Maintenance Period|Lack of Efficacy|0
182244|NCT00941031|579146|P3|Maintenance Period|Lack of Efficacy|0
182245|NCT00941031|579147|P2|Maintenance Period|Lack of Efficacy|0
182246|NCT00941031|579148|P1|Maintenance Period|Lack of Efficacy|0
182247|NCT00941031|579142|P7|Maintenance Period|Lost to Follow-up|7
182248|NCT00941031|579143|P6|Maintenance Period|Lost to Follow-up|2
182249|NCT00941031|579144|P5|Maintenance Period|Lost to Follow-up|2
182250|NCT00941031|579145|P4|Maintenance Period|Lost to Follow-up|0
182251|NCT00941031|579146|P3|Maintenance Period|Lost to Follow-up|0
182252|NCT00941031|579147|P2|Maintenance Period|Lost to Follow-up|0
182253|NCT00941031|579148|P1|Maintenance Period|Lost to Follow-up|0
182254|NCT00941031|579142|P7|Maintenance Period|Adverse Event|8
182255|NCT00941031|579143|P6|Maintenance Period|Adverse Event|2
182256|NCT00941031|579144|P5|Maintenance Period|Adverse Event|0
182257|NCT00941031|579145|P4|Maintenance Period|Adverse Event|0
182258|NCT00941031|579146|P3|Maintenance Period|Adverse Event|0
182259|NCT00941031|579147|P2|Maintenance Period|Adverse Event|0
182260|NCT00941031|579148|P1|Maintenance Period|Adverse Event|0
182261|NCT00941031|579142|P7|Maintenance Period|Protocol Violation|1
182262|NCT00941031|579143|P6|Maintenance Period|Protocol Violation|0
182263|NCT00941031|579144|P5|Maintenance Period|Protocol Violation|0
182264|NCT00941031|579145|P4|Maintenance Period|Protocol Violation|0
182265|NCT00941031|579146|P3|Maintenance Period|Protocol Violation|0
182266|NCT00941031|579147|P2|Maintenance Period|Protocol Violation|0
182267|NCT00941031|579148|P1|Maintenance Period|Protocol Violation|0
182268|NCT00941031|579142|P7|Maintenance Period|Administrative Problems|1
182269|NCT00941031|579143|P6|Maintenance Period|Administrative Problems|0
182270|NCT00941031|579144|P5|Maintenance Period|Administrative Problems|1
182271|NCT00941031|579145|P4|Maintenance Period|Administrative Problems|0
182272|NCT00941031|579146|P3|Maintenance Period|Administrative Problems|0
182273|NCT00941031|579147|P2|Maintenance Period|Administrative Problems|0
182274|NCT00941031|579148|P1|Maintenance Period|Administrative Problems|0
182275|NCT00941031|579142|P7|Maintenance Period|Withdrawal by Subject|13
182276|NCT00941031|579143|P6|Maintenance Period|Withdrawal by Subject|2
182277|NCT00941031|579144|P5|Maintenance Period|Withdrawal by Subject|6
182278|NCT00941031|579145|P4|Maintenance Period|Withdrawal by Subject|0
182279|NCT00941031|579146|P3|Maintenance Period|Withdrawal by Subject|0
182280|NCT00941031|579147|P2|Maintenance Period|Withdrawal by Subject|0
182281|NCT00941031|579148|P1|Maintenance Period|Withdrawal by Subject|0
182282|NCT00941031|579142|P7|Induction Period|Adverse Event|0
182283|NCT00941031|579143|P6|Induction Period|Adverse Event|0
182284|NCT00941031|579144|P5|Induction Period|Adverse Event|0
182285|NCT00941031|579145|P4|Induction Period|Adverse Event|2
182286|NCT00941031|579146|P3|Induction Period|Adverse Event|3
182287|NCT00941031|579147|P2|Induction Period|Adverse Event|0
182288|NCT00941031|579148|P1|Induction Period|Adverse Event|1
182289|NCT00941031|579142|P7|Induction Period|Adminstative Problems|0
182290|NCT00941031|579143|P6|Induction Period|Adminstative Problems|0
182291|NCT00941031|579144|P5|Induction Period|Adminstative Problems|0
182292|NCT00941031|579145|P4|Induction Period|Adminstative Problems|0
182293|NCT00941031|579146|P3|Induction Period|Adminstative Problems|1
182294|NCT00941031|579147|P2|Induction Period|Adminstative Problems|1
182295|NCT00941031|579148|P1|Induction Period|Adminstative Problems|1
182296|NCT00941031|579142|P7|Induction Period|Withdrawal by Subject|0
182297|NCT00941031|579143|P6|Induction Period|Withdrawal by Subject|0
182298|NCT00941031|579144|P5|Induction Period|Withdrawal by Subject|0
182299|NCT00941031|579145|P4|Induction Period|Withdrawal by Subject|2
182300|NCT00941031|579146|P3|Induction Period|Withdrawal by Subject|2
182301|NCT00941031|579147|P2|Induction Period|Withdrawal by Subject|2
182302|NCT00941031|579148|P1|Induction Period|Withdrawal by Subject|1
182303|NCT00941031|579142|P7|Induction Period|Lack of Efficacy|0
182304|NCT00941031|579143|P6|Induction Period|Lack of Efficacy|0
182305|NCT00941031|579144|P5|Induction Period|Lack of Efficacy|0
182306|NCT00941031|579145|P4|Induction Period|Lack of Efficacy|5
182307|NCT00941031|579146|P3|Induction Period|Lack of Efficacy|0
182308|NCT00941031|579147|P2|Induction Period|Lack of Efficacy|1
182309|NCT00941031|579148|P1|Induction Period|Lack of Efficacy|2
182310|NCT00941070|579171|P1|Overall Study|Patient non-compliant|1
182311|NCT00933166|579185|P1|Overall Study|Withdrawal by Subject|1
182312|NCT00933166|579185|P1|Overall Study|Unavailable|4
182313|NCT00933166|579185|P1|Overall Study|Lack of Efficacy|9
182314|NCT00933166|579185|P1|Overall Study|Lost to Follow-up|4
182315|NCT00933244|579192|P3|Overall Study|Withdrawal by Subject|3
182316|NCT00933244|579193|P2|Overall Study|Withdrawal by Subject|1
182317|NCT00933244|579194|P1|Overall Study|Withdrawal by Subject|5
182318|NCT00933270|579211|P1|Overall Study|Moved or would not return|10
182319|NCT00933270|579211|P1|Overall Study|Death|24
182320|NCT00933270|579211|P1|Overall Study|Missed Visit|2
182321|NCT00933270|579211|P1|Overall Study|Adverse Event|1
182322|NCT00933270|579211|P1|Overall Study|Lost to Follow-up|14
182323|NCT00933270|579211|P1|Overall Study|Insufficient Follow-up|10
182324|NCT00933270|579211|P1|Overall Study|Withdrawal by Subject|26
182325|NCT00933335|579304|P2|Overall Study|Co-morbid Illness|0
182326|NCT00933335|579305|P1|Overall Study|Co-morbid Illness|1
182327|NCT00933335|579304|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
182328|NCT00933335|579305|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
182329|NCT00933335|579304|P2|Overall Study|Progressive Disease|11
182330|NCT00933335|579305|P1|Overall Study|Progressive Disease|0
182331|NCT00933335|579304|P2|Overall Study|Withdrawal by Subject|1
182332|NCT00933335|579305|P1|Overall Study|Withdrawal by Subject|0
182333|NCT00933335|579304|P2|Overall Study|Lost to Follow-up|3
182334|NCT00933335|579305|P1|Overall Study|Lost to Follow-up|1
182335|NCT00933543|579388|P2|Overall Study|Not known|1
182336|NCT00933543|579389|P1|Overall Study|Not known|1
182337|NCT00933543|579388|P2|Overall Study|Lack of Efficacy|3
182338|NCT00933543|579389|P1|Overall Study|Lack of Efficacy|0
182339|NCT00933543|579388|P2|Overall Study|Withdrawal by Subject|1
182340|NCT00933543|579389|P1|Overall Study|Withdrawal by Subject|0
182341|NCT00933543|579388|P2|Overall Study|Lost to Follow-up|1
182342|NCT00933543|579389|P1|Overall Study|Lost to Follow-up|0
182343|NCT00933543|579388|P2|Overall Study|Adverse Event|1
182344|NCT00933543|579389|P1|Overall Study|Adverse Event|2
182345|NCT00933608|579447|P2|Overall Study|Physician Decision|0
182346|NCT00933608|579448|P1|Overall Study|Physician Decision|1
182347|NCT00933608|579447|P2|Overall Study|Adverse Event|2
182348|NCT00933608|579448|P1|Overall Study|Adverse Event|4
182349|NCT00933686|579456|P2|Overall Study|Failure to show up at endpoint visits|2
182350|NCT00933686|579457|P1|Overall Study|Failure to show up at endpoint visits|0
182351|NCT00933686|579456|P2|Overall Study|Physician Decision|0
182352|NCT00933686|579457|P1|Overall Study|Physician Decision|1
182353|NCT00933686|579456|P2|Overall Study|Adverse Event|1
182354|NCT00933686|579457|P1|Overall Study|Adverse Event|1
182355|NCT00933686|579456|P2|Overall Study|Withdrawal by Subject|5
182356|NCT00933686|579457|P1|Overall Study|Withdrawal by Subject|6
182357|NCT00933686|579456|P2|Overall Study|Lost to Follow-up|2
182358|NCT00933686|579457|P1|Overall Study|Lost to Follow-up|2
182359|NCT00933686|579456|P2|Overall Study|Protocol Violation|1
182360|NCT00933686|579457|P1|Overall Study|Protocol Violation|0
182361|NCT00933933|579480|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
182362|NCT00933933|579481|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
182363|NCT00933933|579482|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
182364|NCT00933933|579480|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
182365|NCT00933933|579481|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
182366|NCT00933933|579482|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
182367|NCT00934050|579504|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
182368|NCT00934050|579505|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
182369|NCT00934050|579506|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
182370|NCT00934050|579507|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
182371|NCT00934050|579508|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
182372|NCT00934050|579509|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
182373|NCT00934050|579504|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
182374|NCT00934050|579505|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
182375|NCT00934050|579506|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
182376|NCT00934050|579507|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
182377|NCT00934050|579508|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
182378|NCT00934050|579509|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
182379|NCT00934050|579504|P6|Enrolled After 15 Dec 2009|Death|1
182380|NCT00934050|579505|P5|Enrolled After 15 Dec 2009|Death|0
182381|NCT00934050|579506|P4|Enrolled After 15 Dec 2009|Death|0
182382|NCT00934050|579507|P3|Enrolled After 15 Dec 2009|Death|0
182383|NCT00934050|579508|P2|Enrolled After 15 Dec 2009|Death|0
182384|NCT00934050|579509|P1|Enrolled After 15 Dec 2009|Death|0
182385|NCT00934050|579504|P6|Enrolled After 15 Dec 2009|Adverse Event|0
182386|NCT00934050|579505|P5|Enrolled After 15 Dec 2009|Adverse Event|3
182387|NCT00934050|579506|P4|Enrolled After 15 Dec 2009|Adverse Event|0
182388|NCT00934050|579507|P3|Enrolled After 15 Dec 2009|Adverse Event|0
182389|NCT00934050|579508|P2|Enrolled After 15 Dec 2009|Adverse Event|0
182390|NCT00934050|579509|P1|Enrolled After 15 Dec 2009|Adverse Event|0
182391|NCT00934050|579504|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
182392|NCT00934050|579505|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
182393|NCT00934050|579506|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
182394|NCT00934050|579507|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
182395|NCT00934050|579508|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
182396|NCT00934050|579509|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
182397|NCT00934050|579504|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
182398|NCT00934050|579505|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
182399|NCT00934050|579506|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
182400|NCT00934050|579507|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
182401|NCT00934050|579508|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
182402|NCT00934050|579509|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
182403|NCT00934050|579504|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
182404|NCT00934050|579505|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
182405|NCT00934050|579506|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
182406|NCT00934050|579507|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
182407|NCT00934050|579508|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
182408|NCT00934050|579509|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
182409|NCT00934102|579519|P3|Period 1, One Night of Wear|Personal Reasons|0
182410|NCT00934102|579520|P2|Period 1, One Night of Wear|Personal Reasons|0
182411|NCT00934102|579521|P1|Period 1, One Night of Wear|Personal Reasons|1
182412|NCT00934128|579531|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
182413|NCT00934128|579532|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
182414|NCT00934128|579531|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
182415|NCT00934128|579532|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
182416|NCT00934128|579531|P2|Washout Period (1 Hour)|Too tired|0
182417|NCT00934128|579532|P1|Washout Period (1 Hour)|Too tired|1
182418|NCT00934128|579531|P2|Washout Period (1 Hour)|Pain|0
182419|NCT00934128|579532|P1|Washout Period (1 Hour)|Pain|1
182420|NCT00934128|579531|P2|Washout Period (1 Hour)|Patient preference|3
182421|NCT00934128|579532|P1|Washout Period (1 Hour)|Patient preference|1
182422|NCT00934128|579531|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
182423|NCT00934128|579532|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
182424|NCT00934128|579531|P2|First Intervention (2 Hours)|Adverse Event|1
182425|NCT00934128|579532|P1|First Intervention (2 Hours)|Adverse Event|4
182426|NCT00934128|579531|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
182427|NCT00934128|579532|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
182428|NCT00934362|579582|P2|Overall Study|Adverse Event|0
182429|NCT00934362|579583|P1|Overall Study|Adverse Event|1
182430|NCT00934440|579600|P1|Overall Study|Lost to Follow-up|1
182431|NCT00934544|579607|P2|Overall Study|Entered Extension phase INC424|18
182432|NCT00934544|579608|P1|Overall Study|Entered Extension phase INC424|29
182433|NCT00934544|579607|P2|Overall Study|Other Reasons|7
182434|NCT00934544|579608|P1|Overall Study|Other Reasons|7
182435|NCT00934544|579607|P2|Overall Study|Non-compliance with study procedures|1
182436|NCT00934544|579608|P1|Overall Study|Non-compliance with study procedures|0
182437|NCT00934544|579607|P2|Overall Study|Non-compliance with study Medication|0
182438|NCT00934544|579608|P1|Overall Study|Non-compliance with study Medication|2
182439|NCT00934544|579607|P2|Overall Study|Disease Progression|3
182440|NCT00934544|579608|P1|Overall Study|Disease Progression|1
182441|NCT00934544|579607|P2|Overall Study|Protocol Violation|0
182442|NCT00934544|579608|P1|Overall Study|Protocol Violation|2
182443|NCT00934544|579607|P2|Overall Study|Withdrawal by Subject|9
182444|NCT00934544|579608|P1|Overall Study|Withdrawal by Subject|2
182445|NCT00934544|579607|P2|Overall Study|Adverse Event|4
182446|NCT00934544|579608|P1|Overall Study|Adverse Event|12
182447|NCT00934622|579653|P1|Overall Study|2nd Intraoperative exclusion criteria|1
182448|NCT00934622|579653|P1|Overall Study|Lost to Follow-up|7
182449|NCT00934648|579695|P1|Overall Study|Withdrawal by Subject|1
182450|NCT00934648|579695|P1|Overall Study|Failure to return|8
182451|NCT00934791|579704|P2|Overall Study|Withdrawal by Subject|0
182452|NCT00934791|579705|P1|Overall Study|Withdrawal by Subject|1
182453|NCT00934843|579713|P2|Overall Study|Protocol Violation|1
182454|NCT00934843|579714|P1|Overall Study|Protocol Violation|0
182455|NCT00934856|579734|P6|Extension Part|Non-compliance with drug|1
182456|NCT00934856|579735|P5|Extension Part|Non-compliance with drug|0
182457|NCT00934856|579736|P4|Extension Part|Non-compliance with drug|0
182458|NCT00934856|579737|P3|Extension Part|Non-compliance with drug|0
182459|NCT00934856|579738|P2|Extension Part|Non-compliance with drug|0
182460|NCT00934856|579739|P1|Extension Part|Non-compliance with drug|0
182461|NCT00934856|579734|P6|Extension Part|Progressive disease|0
182462|NCT00934856|579735|P5|Extension Part|Progressive disease|0
182463|NCT00934856|579736|P4|Extension Part|Progressive disease|1
182464|NCT00934856|579737|P3|Extension Part|Progressive disease|0
182465|NCT00934856|579738|P2|Extension Part|Progressive disease|0
182466|NCT00934856|579739|P1|Extension Part|Progressive disease|0
182467|NCT00934856|579734|P6|Extension Part|Adverse Event|4
182468|NCT00934856|579735|P5|Extension Part|Adverse Event|4
182469|NCT00934856|579736|P4|Extension Part|Adverse Event|1
182470|NCT00934856|579737|P3|Extension Part|Adverse Event|0
182471|NCT00934856|579738|P2|Extension Part|Adverse Event|0
182472|NCT00934856|579739|P1|Extension Part|Adverse Event|0
182473|NCT00934856|579734|P6|Feasibility Part|Withdrawal by Subject|1
182474|NCT00934856|579735|P5|Feasibility Part|Withdrawal by Subject|0
182475|NCT00934856|579736|P4|Feasibility Part|Withdrawal by Subject|1
182476|NCT00934856|579737|P3|Feasibility Part|Withdrawal by Subject|0
182477|NCT00934856|579738|P2|Feasibility Part|Withdrawal by Subject|0
182478|NCT00934856|579739|P1|Feasibility Part|Withdrawal by Subject|0
182479|NCT00934856|579734|P6|Feasibility Part|Adverse Event|2
182480|NCT00934856|579735|P5|Feasibility Part|Adverse Event|0
182481|NCT00934856|579736|P4|Feasibility Part|Adverse Event|1
182482|NCT00934856|579737|P3|Feasibility Part|Adverse Event|0
182483|NCT00934856|579738|P2|Feasibility Part|Adverse Event|1
182484|NCT00934856|579739|P1|Feasibility Part|Adverse Event|1
182485|NCT00934856|579734|P6|Feasibility Part|Physician Decision|0
182486|NCT00934856|579735|P5|Feasibility Part|Physician Decision|0
182487|NCT00934856|579736|P4|Feasibility Part|Physician Decision|0
182488|NCT00934856|579737|P3|Feasibility Part|Physician Decision|1
182489|NCT00934856|579738|P2|Feasibility Part|Physician Decision|0
182490|NCT00934856|579739|P1|Feasibility Part|Physician Decision|0
182491|NCT00934856|579734|P6|Feasibility Part|Progressive disease|0
182492|NCT00934856|579735|P5|Feasibility Part|Progressive disease|0
182493|NCT00934856|579736|P4|Feasibility Part|Progressive disease|3
182494|NCT00934856|579737|P3|Feasibility Part|Progressive disease|2
182495|NCT00934856|579738|P2|Feasibility Part|Progressive disease|4
182496|NCT00934856|579739|P1|Feasibility Part|Progressive disease|4
182497|NCT00934947|579848|P2|Overall Study|Adverse Event|2
182498|NCT00934947|579849|P1|Overall Study|Adverse Event|0
182499|NCT00935220|579872|P1|Overall Study|Other reason (not specified)|1
182500|NCT00935220|579872|P1|Overall Study|Adverse Event|1
182501|NCT00935259|579884|P2|Period 1|Administrative (scheduling conflict)|1
182502|NCT00935259|579885|P1|Period 1|Administrative (scheduling conflict)|1
182503|NCT00935272|579901|P2|Overall Study|Protocol Violation|1
182504|NCT00935272|579902|P1|Overall Study|Protocol Violation|0
182505|NCT00935272|579901|P2|Overall Study|Physician Decision|0
182506|NCT00935272|579902|P1|Overall Study|Physician Decision|1
182507|NCT00935272|579901|P2|Overall Study|Withdrawal by Subject|2
182508|NCT00935272|579902|P1|Overall Study|Withdrawal by Subject|8
182509|NCT00935272|579901|P2|Overall Study|Lost to Follow-up|3
182510|NCT00935272|579902|P1|Overall Study|Lost to Follow-up|10
182511|NCT00935493|579936|P3|Overall Study|Treatment Discontinued|0
182512|NCT00935493|579937|P2|Overall Study|Treatment Discontinued|1
182513|NCT00935493|579938|P1|Overall Study|Treatment Discontinued|0
182514|NCT00935493|579936|P3|Overall Study|Lost to Follow-up|1
182515|NCT00935493|579937|P2|Overall Study|Lost to Follow-up|1
182516|NCT00935493|579938|P1|Overall Study|Lost to Follow-up|1
182517|NCT00935532|579954|P2|Overall Study|Loss Glucose Control|0
182518|NCT00935532|579955|P1|Overall Study|Loss Glucose Control|4
182519|NCT00935532|579954|P2|Overall Study|Sponsor Decision|1
182520|NCT00935532|579955|P1|Overall Study|Sponsor Decision|0
182521|NCT00935532|579954|P2|Overall Study|Subject Decision|1
182522|NCT00935532|579955|P1|Overall Study|Subject Decision|2
182523|NCT00935532|579954|P2|Overall Study|Protocol Violation|1
182524|NCT00935532|579955|P1|Overall Study|Protocol Violation|2
182525|NCT00935532|579954|P2|Overall Study|Physician Decision|2
182526|NCT00935532|579955|P1|Overall Study|Physician Decision|1
182527|NCT00935532|579954|P2|Overall Study|Lost to Follow-up|0
182528|NCT00935532|579955|P1|Overall Study|Lost to Follow-up|1
182529|NCT00935532|579954|P2|Overall Study|Death|0
182530|NCT00935532|579955|P1|Overall Study|Death|1
182531|NCT00935532|579954|P2|Overall Study|Adverse Event|6
182532|NCT00935532|579955|P1|Overall Study|Adverse Event|11
182533|NCT00935584|579983|P2|Overall Study|Provider dropped out of study|4
182534|NCT00935584|579984|P1|Overall Study|Provider dropped out of study|14
182535|NCT00935584|579983|P2|Overall Study|Patient changed provider|0
182536|NCT00935584|579984|P1|Overall Study|Patient changed provider|3
182537|NCT00935584|579983|P2|Overall Study|Relocated|0
182538|NCT00935584|579984|P1|Overall Study|Relocated|3
182539|NCT00935584|579983|P2|Overall Study|No show|0
182540|NCT00935584|579984|P1|Overall Study|No show|9
182541|NCT00935584|579983|P2|Overall Study|Lost to Follow-up|0
182542|NCT00935584|579984|P1|Overall Study|Lost to Follow-up|8
182543|NCT00935584|579983|P2|Overall Study|Death|0
182544|NCT00935584|579984|P1|Overall Study|Death|3
182545|NCT00935584|579983|P2|Overall Study|Withdrawal by Subject|0
182546|NCT00935584|579984|P1|Overall Study|Withdrawal by Subject|9
182547|NCT00941304|579999|P5|Overall Study|Lost to Follow-up|0
182548|NCT00941304|580000|P4|Overall Study|Lost to Follow-up|0
182549|NCT00941304|580001|P3|Overall Study|Lost to Follow-up|0
182550|NCT00941304|580002|P2|Overall Study|Lost to Follow-up|0
182551|NCT00941304|580003|P1|Overall Study|Lost to Follow-up|1
182552|NCT00941330|580067|P2|Overall Study|Physician Decision|2
182553|NCT00941330|580068|P1|Overall Study|Physician Decision|0
182554|NCT00941330|580067|P2|Overall Study|Other|0
182555|NCT00941330|580068|P1|Overall Study|Other|1
182556|NCT00941603|580082|P6|Overall Study|Did not meet protocol eligibility|0
182557|NCT00941603|580083|P5|Overall Study|Did not meet protocol eligibility|0
182558|NCT00941603|580084|P4|Overall Study|Did not meet protocol eligibility|0
182559|NCT00941603|580085|P3|Overall Study|Did not meet protocol eligibility|0
182560|NCT00941603|580086|P2|Overall Study|Did not meet protocol eligibility|0
182561|NCT00941603|580087|P1|Overall Study|Did not meet protocol eligibility|1
182562|NCT00941603|580082|P6|Overall Study|Protocol Violation|0
182563|NCT00941603|580083|P5|Overall Study|Protocol Violation|0
182564|NCT00941603|580084|P4|Overall Study|Protocol Violation|0
182565|NCT00941603|580085|P3|Overall Study|Protocol Violation|0
182566|NCT00941603|580086|P2|Overall Study|Protocol Violation|1
182567|NCT00941603|580087|P1|Overall Study|Protocol Violation|0
182568|NCT00941603|580082|P6|Overall Study|Withdrawal by Subject|1
182569|NCT00941603|580083|P5|Overall Study|Withdrawal by Subject|0
182570|NCT00941603|580084|P4|Overall Study|Withdrawal by Subject|2
182571|NCT00941603|580085|P3|Overall Study|Withdrawal by Subject|0
182572|NCT00941603|580086|P2|Overall Study|Withdrawal by Subject|0
182573|NCT00941603|580087|P1|Overall Study|Withdrawal by Subject|0
182574|NCT00941603|580082|P6|Overall Study|Lost to Follow-up|2
182575|NCT00941603|580083|P5|Overall Study|Lost to Follow-up|0
182576|NCT00941603|580084|P4|Overall Study|Lost to Follow-up|1
182577|NCT00941603|580085|P3|Overall Study|Lost to Follow-up|0
182578|NCT00941603|580086|P2|Overall Study|Lost to Follow-up|0
182579|NCT00941603|580087|P1|Overall Study|Lost to Follow-up|0
182580|NCT00941603|580082|P6|Overall Study|Adverse Event|0
182581|NCT00941603|580083|P5|Overall Study|Adverse Event|4
182582|NCT00941603|580084|P4|Overall Study|Adverse Event|1
182583|NCT00941603|580085|P3|Overall Study|Adverse Event|5
182584|NCT00941603|580086|P2|Overall Study|Adverse Event|15
182585|NCT00941603|580087|P1|Overall Study|Adverse Event|10
182586|NCT00941798|580109|P2|Overall Study|Death|1
182587|NCT00941798|580110|P1|Overall Study|Death|0
182588|NCT00941798|580109|P2|Overall Study|Abnormal laboratory values|2
182589|NCT00941798|580110|P1|Overall Study|Abnormal laboratory values|1
182590|NCT00941798|580109|P2|Overall Study|Abnormal test procedure results|1
182591|NCT00941798|580110|P1|Overall Study|Abnormal test procedure results|3
182592|NCT00941798|580109|P2|Overall Study|Patient's inability to use device|1
182593|NCT00941798|580110|P1|Overall Study|Patient's inability to use device|6
182594|NCT00941798|580109|P2|Overall Study|Lack of Efficacy|17
182595|NCT00941798|580110|P1|Overall Study|Lack of Efficacy|10
182596|NCT00941798|580109|P2|Overall Study|Administrative problems|23
182597|NCT00941798|580110|P1|Overall Study|Administrative problems|13
182598|NCT00941798|580109|P2|Overall Study|Protocol Violation|20
182599|NCT00941798|580110|P1|Overall Study|Protocol Violation|17
182600|NCT00941798|580109|P2|Overall Study|Lost to Follow-up|23
182601|NCT00941798|580110|P1|Overall Study|Lost to Follow-up|29
182602|NCT00941798|580109|P2|Overall Study|Adverse Event|23
182603|NCT00941798|580110|P1|Overall Study|Adverse Event|43
182604|NCT00941798|580109|P2|Overall Study|Withdrawal by Subject|74
182605|NCT00941798|580110|P1|Overall Study|Withdrawal by Subject|72
182606|NCT00941863|580143|P5|Continued After PCD|Disease progression, recurrence, relapse|18
182607|NCT00941863|580144|P4|Continued After PCD|Disease progression, recurrence, relapse|0
182608|NCT00941863|580145|P3|Continued After PCD|Disease progression, recurrence, relapse|0
182609|NCT00941863|580146|P2|Continued After PCD|Disease progression, recurrence, relapse|0
182610|NCT00941863|580147|P1|Continued After PCD|Disease progression, recurrence, relapse|0
182611|NCT00941863|580143|P5|Continued After PCD|Withdrawal by Subject|1
182612|NCT00941863|580144|P4|Continued After PCD|Withdrawal by Subject|0
182613|NCT00941863|580145|P3|Continued After PCD|Withdrawal by Subject|0
182614|NCT00941863|580146|P2|Continued After PCD|Withdrawal by Subject|0
182615|NCT00941863|580147|P1|Continued After PCD|Withdrawal by Subject|0
182616|NCT00941863|580143|P5|Until Primary Completion Date (PCD)|Disease progression|73
182617|NCT00941863|580144|P4|Until Primary Completion Date (PCD)|Disease progression|14
182618|NCT00941863|580145|P3|Until Primary Completion Date (PCD)|Disease progression|8
182619|NCT00941863|580146|P2|Until Primary Completion Date (PCD)|Disease progression|1
182620|NCT00941863|580147|P1|Until Primary Completion Date (PCD)|Disease progression|6
182621|NCT00941863|580143|P5|Until Primary Completion Date (PCD)|Death|7
182622|NCT00941863|580144|P4|Until Primary Completion Date (PCD)|Death|2
182623|NCT00941863|580145|P3|Until Primary Completion Date (PCD)|Death|1
182624|NCT00941863|580146|P2|Until Primary Completion Date (PCD)|Death|0
182625|NCT00941863|580147|P1|Until Primary Completion Date (PCD)|Death|0
182626|NCT00941863|580143|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
182627|NCT00941863|580144|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
182628|NCT00941863|580145|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
182629|NCT00941863|580146|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
182630|NCT00941863|580147|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
182631|NCT00941863|580143|P5|Until Primary Completion Date (PCD)|Physician Decision|1
182632|NCT00941863|580144|P4|Until Primary Completion Date (PCD)|Physician Decision|0
182633|NCT00941863|580145|P3|Until Primary Completion Date (PCD)|Physician Decision|0
182634|NCT00941863|580146|P2|Until Primary Completion Date (PCD)|Physician Decision|0
182635|NCT00941863|580147|P1|Until Primary Completion Date (PCD)|Physician Decision|0
182636|NCT00941863|580143|P5|Until Primary Completion Date (PCD)|Adverse Event|5
182637|NCT00941863|580144|P4|Until Primary Completion Date (PCD)|Adverse Event|1
182638|NCT00941863|580145|P3|Until Primary Completion Date (PCD)|Adverse Event|2
182639|NCT00941863|580146|P2|Until Primary Completion Date (PCD)|Adverse Event|2
182640|NCT00941863|580147|P1|Until Primary Completion Date (PCD)|Adverse Event|1
182641|NCT00941928|580181|P1|Overall Study|Disease Progression|1
182642|NCT00941928|580181|P1|Overall Study|Withdrawal by Subject|1
182643|NCT00942084|580193|P1|Overall Study|Death|2
182644|NCT00942175|580210|P4|Overall Study|Low Platelet Count|0
182645|NCT00942175|580211|P3|Overall Study|Low Platelet Count|0
182646|NCT00942175|580212|P2|Overall Study|Low Platelet Count|2
182647|NCT00942175|580213|P1|Overall Study|Low Platelet Count|0
182648|NCT00942175|580210|P4|Overall Study|Elevated Alanine Amino Transferase|1
182649|NCT00942175|580211|P3|Overall Study|Elevated Alanine Amino Transferase|0
182650|NCT00942175|580212|P2|Overall Study|Elevated Alanine Amino Transferase|0
182651|NCT00942175|580213|P1|Overall Study|Elevated Alanine Amino Transferase|0
182652|NCT00942175|580210|P4|Overall Study|Pregnancy|1
182653|NCT00942175|580211|P3|Overall Study|Pregnancy|0
182654|NCT00942175|580212|P2|Overall Study|Pregnancy|0
182655|NCT00942175|580213|P1|Overall Study|Pregnancy|0
182656|NCT00942175|580210|P4|Overall Study|Protocol Violation|0
182657|NCT00942175|580211|P3|Overall Study|Protocol Violation|2
182658|NCT00942175|580212|P2|Overall Study|Protocol Violation|1
182659|NCT00942175|580213|P1|Overall Study|Protocol Violation|0
182660|NCT00942175|580210|P4|Overall Study|Adverse Event|0
182661|NCT00942175|580211|P3|Overall Study|Adverse Event|0
182662|NCT00942175|580212|P2|Overall Study|Adverse Event|1
182663|NCT00942175|580213|P1|Overall Study|Adverse Event|2
182664|NCT00942266|580265|P2|Overall Study|medical deterioration (pneumonia)|1
182665|NCT00942266|580266|P1|Overall Study|medical deterioration (pneumonia)|0
182666|NCT00942266|580265|P2|Overall Study|Physician Decision|0
182667|NCT00942266|580266|P1|Overall Study|Physician Decision|2
182668|NCT00942266|580265|P2|Overall Study|Intercurrent illness|1
182669|NCT00942266|580266|P1|Overall Study|Intercurrent illness|0
182670|NCT00942266|580265|P2|Overall Study|Failure to thrive and pt withdrawal|1
182671|NCT00942266|580266|P1|Overall Study|Failure to thrive and pt withdrawal|0
182672|NCT00942266|580265|P2|Overall Study|Disease Progression|11
182673|NCT00942266|580266|P1|Overall Study|Disease Progression|38
182674|NCT00942266|580265|P2|Overall Study|Adverse Event|1
182675|NCT00942266|580266|P1|Overall Study|Adverse Event|2
182676|NCT00942266|580265|P2|Overall Study|Withdrawal by Subject|0
182677|NCT00942266|580266|P1|Overall Study|Withdrawal by Subject|1
182678|NCT00942409|580284|P1|Overall Study|study drug unavailable|2
182679|NCT00942409|580284|P1|Overall Study|Lack of Efficacy|1
182680|NCT00942422|580288|P1|Overall Study|Progressive diease|1
182681|NCT00942422|580288|P1|Overall Study|Death|1
182682|NCT00942422|580288|P1|Overall Study|Withdrawal by Subject|1
182683|NCT00942604|580363|P2|Overall Study|Patient relocation|1
182684|NCT00942604|580364|P1|Overall Study|Patient relocation|1
182685|NCT00942604|580363|P2|Overall Study|Withdrawal by Subject|1
182686|NCT00942604|580364|P1|Overall Study|Withdrawal by Subject|0
182687|NCT00942604|580363|P2|Overall Study|Adverse Event|1
182688|NCT00942604|580364|P1|Overall Study|Adverse Event|0
182689|NCT00942604|580363|P2|Overall Study|Protocol Violation|1
182690|NCT00942604|580364|P1|Overall Study|Protocol Violation|1
182691|NCT00942734|580372|P1|Overall Study|Physician Decision|1
182692|NCT00942734|580372|P1|Overall Study|Disease Progression|2
182693|NCT00942734|580372|P1|Overall Study|Protocol Violation|3
182694|NCT00942734|580372|P1|Overall Study|Adverse Event|2
182695|NCT00942968|580410|P1|Overall Study|Deep vein thrombosis (DVT)|2
182696|NCT00942968|580410|P1|Overall Study|Participant required pancreatic biopsy|1
182697|NCT00942968|580410|P1|Overall Study|Pulmonary embolism (PE)|1
182698|NCT00942968|580410|P1|Overall Study|Inferior vena cava filter placement|4
182699|NCT00942968|580410|P1|Overall Study|Progression of disease|12
182700|NCT00942968|580410|P1|Overall Study|Physician Decision|11
182701|NCT00942968|580410|P1|Overall Study|Sponsor request|5
182702|NCT00942968|580410|P1|Overall Study|Withdrawal by Subject|44
182703|NCT00942968|580410|P1|Overall Study|Lost to Follow-up|4
182704|NCT00942968|580410|P1|Overall Study|Protocol Violation|9
182705|NCT00942968|580410|P1|Overall Study|Death|76
182706|NCT00942968|580410|P1|Overall Study|Adverse Event|60
182707|NCT00942994|580433|P2|Overall Study|Protocol deviation|2
182708|NCT00942994|580434|P1|Overall Study|Protocol deviation|1
182709|NCT00942994|580433|P2|Overall Study|Lost to Follow-up|4
182710|NCT00942994|580434|P1|Overall Study|Lost to Follow-up|1
182711|NCT00942994|580433|P2|Overall Study|Patient withdrew consent|8
182712|NCT00942994|580434|P1|Overall Study|Patient withdrew consent|5
182713|NCT00942994|580433|P2|Overall Study|Unsatisfactory therapeutic effect|1
182714|NCT00942994|580434|P1|Overall Study|Unsatisfactory therapeutic effect|1
182715|NCT00942994|580433|P2|Overall Study|Abnormal laboratory value(s)|0
182716|NCT00942994|580434|P1|Overall Study|Abnormal laboratory value(s)|1
182717|NCT00942994|580433|P2|Overall Study|Adverse Event|4
182718|NCT00942994|580434|P1|Overall Study|Adverse Event|7
182719|NCT00943072|580452|P2|Overall Study|Other|1
182720|NCT00943072|580453|P1|Overall Study|Other|1
182721|NCT00943072|580452|P2|Overall Study|Lack of Efficacy|4
182722|NCT00943072|580453|P1|Overall Study|Lack of Efficacy|0
182723|NCT00943072|580452|P2|Overall Study|Lost to Follow-up|2
182724|NCT00943072|580453|P1|Overall Study|Lost to Follow-up|1
182725|NCT00943072|580452|P2|Overall Study|Protocol Violation|1
182726|NCT00943072|580453|P1|Overall Study|Protocol Violation|0
182727|NCT00943072|580452|P2|Overall Study|Withdrawal by Subject|1
182728|NCT00943072|580453|P1|Overall Study|Withdrawal by Subject|3
182729|NCT00943072|580452|P2|Overall Study|Death|2
182730|NCT00943072|580453|P1|Overall Study|Death|0
182731|NCT00943072|580452|P2|Overall Study|Adverse Event|3
182732|NCT00943072|580453|P1|Overall Study|Adverse Event|0
182733|NCT00943111|580506|P3|5 Years Long-term Treatment Period|Other than specified above|2
182734|NCT00943111|580507|P2|5 Years Long-term Treatment Period|Other than specified above|0
182735|NCT00943111|580508|P1|5 Years Long-term Treatment Period|Other than specified above|0
182736|NCT00943111|580506|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
182737|NCT00943111|580507|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
182738|NCT00943111|580508|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
182739|NCT00943111|580506|P3|5 Years Long-term Treatment Period|Pregnancy|4
182740|NCT00943111|580507|P2|5 Years Long-term Treatment Period|Pregnancy|0
182741|NCT00943111|580508|P1|5 Years Long-term Treatment Period|Pregnancy|0
182742|NCT00943111|580506|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
182743|NCT00943111|580507|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
182744|NCT00943111|580508|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
182745|NCT00943111|580506|P3|5 Years Long-term Treatment Period|Adverse Event|9
182746|NCT00943111|580507|P2|5 Years Long-term Treatment Period|Adverse Event|0
182747|NCT00943111|580508|P1|5 Years Long-term Treatment Period|Adverse Event|0
182748|NCT00943111|580506|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
182749|NCT00943111|580507|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
182750|NCT00943111|580508|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
182751|NCT00943111|580506|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
182752|NCT00943111|580507|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
182753|NCT00943111|580508|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
182754|NCT00943111|580506|P3|52-Weeks Primary Analysis Period|Adverse Event|0
182755|NCT00943111|580507|P2|52-Weeks Primary Analysis Period|Adverse Event|1
182756|NCT00943111|580508|P1|52-Weeks Primary Analysis Period|Adverse Event|2
182757|NCT00943124|580539|P2|Period 1|Personal Reasons|1
182758|NCT00943124|580540|P1|Period 1|Personal Reasons|0
182759|NCT00943124|580539|P2|Period 1|Did Not Follow Study Procedures|0
182760|NCT00943124|580540|P1|Period 1|Did Not Follow Study Procedures|1
182761|NCT00943124|580539|P2|Period 1|Withdrawal by Subject|1
182762|NCT00943124|580540|P1|Period 1|Withdrawal by Subject|1
182763|NCT00943384|580805|P1|Overall Study|Withdrawal by Subject|5
182764|NCT00943384|580805|P1|Overall Study|Lost to Follow-up|16
182765|NCT00943384|580805|P1|Overall Study|Treated off protocol-protocol violation|5
182766|NCT00943384|580805|P1|Overall Study|Dispositioned prior to treatment|23
182767|NCT00943397|580821|P2|Overall Study|Site terminated and other|56
182768|NCT00943397|580822|P1|Overall Study|Site terminated and other|12
182769|NCT00943397|580821|P2|Overall Study|Withdrawal by Subject|1
182770|NCT00943397|580822|P1|Overall Study|Withdrawal by Subject|1
182771|NCT00943397|580821|P2|Overall Study|Protocol Violation|5
182772|NCT00943397|580822|P1|Overall Study|Protocol Violation|2
182773|NCT00943397|580821|P2|Overall Study|Lost to Follow-up|4
182774|NCT00943397|580822|P1|Overall Study|Lost to Follow-up|0
182775|NCT00943397|580821|P2|Overall Study|Adverse Event|6
182776|NCT00943397|580822|P1|Overall Study|Adverse Event|0
182777|NCT00943579|580910|P2|Overall Study|Lack of Efficacy|2
182778|NCT00943579|580911|P1|Overall Study|Lack of Efficacy|2
182779|NCT00943579|580910|P2|Overall Study|Adverse Event|3
182780|NCT00943579|580911|P1|Overall Study|Adverse Event|4
182781|NCT00943592|580923|P1|Overall Study|Death|3
182782|NCT00943605|580936|P2|Overall Study|Study termination|30
182783|NCT00943605|580937|P1|Overall Study|Study termination|30
182784|NCT00943670|581000|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
182785|NCT00943670|581000|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
182786|NCT00943670|581000|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
182787|NCT00943670|581000|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
182788|NCT00943670|581000|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
182789|NCT00943670|581000|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
182790|NCT00943670|581000|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
182791|NCT00943670|581000|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
182792|NCT00943670|581000|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
182793|NCT00943670|581000|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
182794|NCT00943683|581036|P2|Overall Study|Patient Moved|0
182795|NCT00943683|581037|P1|Overall Study|Patient Moved|1
182796|NCT00943683|581036|P2|Overall Study|Withdrawal by Subject|0
182797|NCT00943683|581037|P1|Overall Study|Withdrawal by Subject|1
182798|NCT00943683|581036|P2|Overall Study|Protocol Violation|2
182799|NCT00943683|581037|P1|Overall Study|Protocol Violation|1
182800|NCT00943683|581036|P2|Overall Study|Lost to Follow-up|1
182801|NCT00943683|581037|P1|Overall Study|Lost to Follow-up|1
182802|NCT00943683|581036|P2|Overall Study|Adverse Event|3
182803|NCT00943683|581037|P1|Overall Study|Adverse Event|3
182804|NCT00943722|581048|P5|Overall Study|Withdrawal by Subject|8
182805|NCT00943722|581049|P4|Overall Study|Withdrawal by Subject|13
182806|NCT00943722|581050|P3|Overall Study|Withdrawal by Subject|2
182807|NCT00943722|581051|P2|Overall Study|Withdrawal by Subject|13
182808|NCT00943722|581052|P1|Overall Study|Withdrawal by Subject|12
182809|NCT00943722|581048|P5|Overall Study|Protocol Violation|2
182810|NCT00943722|581049|P4|Overall Study|Protocol Violation|0
182811|NCT00943722|581050|P3|Overall Study|Protocol Violation|0
182812|NCT00943722|581051|P2|Overall Study|Protocol Violation|1
182813|NCT00943722|581052|P1|Overall Study|Protocol Violation|0
182814|NCT00943722|581048|P5|Overall Study|Pregnancy|0
182815|NCT00943722|581049|P4|Overall Study|Pregnancy|0
182816|NCT00943722|581050|P3|Overall Study|Pregnancy|1
182817|NCT00943722|581051|P2|Overall Study|Pregnancy|0
182818|NCT00943722|581052|P1|Overall Study|Pregnancy|0
182819|NCT00943722|581048|P5|Overall Study|Physician Decision|1
182820|NCT00943722|581049|P4|Overall Study|Physician Decision|0
182821|NCT00943722|581050|P3|Overall Study|Physician Decision|0
182822|NCT00943722|581051|P2|Overall Study|Physician Decision|0
182823|NCT00943722|581052|P1|Overall Study|Physician Decision|1
182824|NCT00943722|581048|P5|Overall Study|Lost to Follow-up|11
182825|NCT00943722|581049|P4|Overall Study|Lost to Follow-up|8
182826|NCT00943722|581050|P3|Overall Study|Lost to Follow-up|10
182827|NCT00943722|581051|P2|Overall Study|Lost to Follow-up|8
182828|NCT00943722|581052|P1|Overall Study|Lost to Follow-up|12
182829|NCT00943722|581048|P5|Overall Study|Adverse Event|0
182830|NCT00943722|581049|P4|Overall Study|Adverse Event|1
182831|NCT00943722|581050|P3|Overall Study|Adverse Event|0
182832|NCT00943722|581051|P2|Overall Study|Adverse Event|0
182833|NCT00943722|581052|P1|Overall Study|Adverse Event|0
182834|NCT00943735|581080|P1|Overall Study|Other|3
182835|NCT00943735|581080|P1|Overall Study|Unspecified|8
182836|NCT00943735|581080|P1|Overall Study|Death|1
182837|NCT00943735|581080|P1|Overall Study|Withdrawal by Subject|8
182838|NCT00943735|581080|P1|Overall Study|Adverse Event|12
182839|NCT00943761|581115|P2|Overall Study|Withdrawal by Subject|1
182840|NCT00943761|581116|P1|Overall Study|Withdrawal by Subject|2
182841|NCT00943761|581115|P2|Overall Study|Lost to Follow-up|0
182842|NCT00943761|581116|P1|Overall Study|Lost to Follow-up|2
182843|NCT00943787|581128|P1|Overall Study|Withdrawal by Subject|3
182844|NCT00943787|581128|P1|Overall Study|Physician Decision|4
182845|NCT00943826|581135|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
182846|NCT00943826|581136|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
182847|NCT00943826|581135|P2|After Primary Overall Survival Analysis|Progression of Disease|4
182848|NCT00943826|581136|P1|After Primary Overall Survival Analysis|Progression of Disease|2
182849|NCT00943826|581135|P2|After Primary Overall Survival Analysis|Administrative reasons|16
182850|NCT00943826|581136|P1|After Primary Overall Survival Analysis|Administrative reasons|10
182851|NCT00943826|581135|P2|After Primary Overall Survival Analysis|Adverse Event|0
182852|NCT00943826|581136|P1|After Primary Overall Survival Analysis|Adverse Event|11
182853|NCT00943826|581135|P2|Monotherapy Phase|Failure to return|1
182854|NCT00943826|581136|P1|Monotherapy Phase|Failure to return|2
182855|NCT00943826|581135|P2|Monotherapy Phase|Withdrew Consent|3
182856|NCT00943826|581136|P1|Monotherapy Phase|Withdrew Consent|2
182857|NCT00943826|581135|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
182858|NCT00943826|581136|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
182859|NCT00943826|581135|P2|Monotherapy Phase|Administrative reasons|5
182860|NCT00943826|581136|P1|Monotherapy Phase|Administrative reasons|11
182861|NCT00943826|581135|P2|Monotherapy Phase|Adverse Event|5
182862|NCT00943826|581136|P1|Monotherapy Phase|Adverse Event|42
182863|NCT00943826|581135|P2|Maintenance Phase|Failure to return|1
182864|NCT00943826|581136|P1|Maintenance Phase|Failure to return|0
182865|NCT00943826|581135|P2|Maintenance Phase|Administrative reasons|1
182866|NCT00943826|581136|P1|Maintenance Phase|Administrative reasons|4
182867|NCT00943826|581135|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
182868|NCT00943826|581136|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
182869|NCT00943826|581135|P2|Maintenance Phase|Withdrew consent|4
182870|NCT00943826|581136|P1|Maintenance Phase|Withdrew consent|2
182871|NCT00943826|581135|P2|Maintenance Phase|Adverse Event|30
182872|NCT00943826|581136|P1|Maintenance Phase|Adverse Event|31
182873|NCT00943826|581135|P2|Concurrent Phase|Protocol Violation|0
182874|NCT00943826|581136|P1|Concurrent Phase|Protocol Violation|1
182875|NCT00943826|581135|P2|Concurrent Phase|Administrative reasons|1
182876|NCT00943826|581136|P1|Concurrent Phase|Administrative reasons|2
182877|NCT00943826|581135|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
182878|NCT00943826|581136|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
182879|NCT00943826|581135|P2|Concurrent Phase|Withdrew consent|7
182880|NCT00943826|581136|P1|Concurrent Phase|Withdrew consent|3
182881|NCT00943826|581135|P2|Concurrent Phase|Adverse Event|27
182882|NCT00943826|581136|P1|Concurrent Phase|Adverse Event|50
182883|NCT00943852|581154|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
182884|NCT00943852|581155|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
182885|NCT00943852|581156|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
182886|NCT00943852|581157|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
182887|NCT00943852|581158|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
182888|NCT00943852|581159|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
182889|NCT00943852|581160|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
182890|NCT00943852|581161|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
182891|NCT00943852|581162|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
182892|NCT00943852|581163|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
182893|NCT00943852|581154|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182894|NCT00943852|581155|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182895|NCT00943852|581156|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
182896|NCT00943852|581157|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182897|NCT00943852|581158|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182898|NCT00943852|581159|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182899|NCT00943852|581160|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182900|NCT00943852|581161|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182901|NCT00943852|581162|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182902|NCT00943852|581163|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
182903|NCT00943852|581154|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182904|NCT00943852|581155|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182905|NCT00943852|581156|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182906|NCT00943852|581157|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
182907|NCT00943852|581158|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182908|NCT00943852|581159|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182909|NCT00943852|581160|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182910|NCT00943852|581161|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182911|NCT00943852|581162|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182912|NCT00943852|581163|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
182913|NCT00943852|581154|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
182914|NCT00943852|581155|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
182915|NCT00943852|581156|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
182916|NCT00943852|581157|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
182917|NCT00943852|581158|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
182918|NCT00943852|581159|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
182919|NCT00943852|581160|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
182920|NCT00943852|581161|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
182921|NCT00943852|581162|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
182922|NCT00943852|581163|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
182923|NCT00943852|581154|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182924|NCT00943852|581155|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182925|NCT00943852|581156|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182926|NCT00943852|581157|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
183010|NCT00943917|581320|P13|Stage II|Pregnancy|0
182927|NCT00943852|581158|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182928|NCT00943852|581159|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182929|NCT00943852|581160|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
182930|NCT00943852|581161|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182931|NCT00943852|581162|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182932|NCT00943852|581163|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
182933|NCT00943917|581318|P15|Stage II Continuation|A1C elevation|0
182934|NCT00943917|581319|P14|Stage II Continuation|A1C elevation|1
182935|NCT00943917|581320|P13|Stage II Continuation|A1C elevation|0
182936|NCT00943917|581321|P12|Stage II Continuation|A1C elevation|0
182937|NCT00943917|581322|P11|Stage II Continuation|A1C elevation|0
182938|NCT00943917|581323|P10|Stage II Continuation|A1C elevation|0
182939|NCT00943917|581324|P9|Stage II Continuation|A1C elevation|0
182940|NCT00943917|581325|P8|Stage II Continuation|A1C elevation|0
182941|NCT00943917|581326|P7|Stage II Continuation|A1C elevation|0
182942|NCT00943917|581327|P6|Stage II Continuation|A1C elevation|0
182943|NCT00943917|581328|P5|Stage II Continuation|A1C elevation|0
182944|NCT00943917|581329|P4|Stage II Continuation|A1C elevation|0
182945|NCT00943917|581330|P3|Stage II Continuation|A1C elevation|0
182946|NCT00943917|581331|P2|Stage II Continuation|A1C elevation|0
182947|NCT00943917|581332|P1|Stage II Continuation|A1C elevation|0
182948|NCT00943917|581318|P15|Stage II Continuation|hypoglycemia|0
182949|NCT00943917|581319|P14|Stage II Continuation|hypoglycemia|0
182950|NCT00943917|581320|P13|Stage II Continuation|hypoglycemia|1
182951|NCT00943917|581321|P12|Stage II Continuation|hypoglycemia|0
182952|NCT00943917|581322|P11|Stage II Continuation|hypoglycemia|0
182953|NCT00943917|581323|P10|Stage II Continuation|hypoglycemia|0
182954|NCT00943917|581324|P9|Stage II Continuation|hypoglycemia|0
182955|NCT00943917|581325|P8|Stage II Continuation|hypoglycemia|0
182956|NCT00943917|581326|P7|Stage II Continuation|hypoglycemia|0
182957|NCT00943917|581327|P6|Stage II Continuation|hypoglycemia|0
182958|NCT00943917|581328|P5|Stage II Continuation|hypoglycemia|0
182959|NCT00943917|581329|P4|Stage II Continuation|hypoglycemia|0
182960|NCT00943917|581330|P3|Stage II Continuation|hypoglycemia|0
182961|NCT00943917|581331|P2|Stage II Continuation|hypoglycemia|0
182962|NCT00943917|581332|P1|Stage II Continuation|hypoglycemia|0
182963|NCT00943917|581318|P15|Stage II Continuation|Protocol Violation|0
182964|NCT00943917|581319|P14|Stage II Continuation|Protocol Violation|0
182965|NCT00943917|581320|P13|Stage II Continuation|Protocol Violation|0
182966|NCT00943917|581321|P12|Stage II Continuation|Protocol Violation|1
182967|NCT00943917|581322|P11|Stage II Continuation|Protocol Violation|0
182968|NCT00943917|581323|P10|Stage II Continuation|Protocol Violation|1
182969|NCT00943917|581324|P9|Stage II Continuation|Protocol Violation|0
182970|NCT00943917|581325|P8|Stage II Continuation|Protocol Violation|0
182971|NCT00943917|581326|P7|Stage II Continuation|Protocol Violation|0
182972|NCT00943917|581327|P6|Stage II Continuation|Protocol Violation|0
182973|NCT00943917|581328|P5|Stage II Continuation|Protocol Violation|0
182974|NCT00943917|581329|P4|Stage II Continuation|Protocol Violation|0
182975|NCT00943917|581330|P3|Stage II Continuation|Protocol Violation|0
182976|NCT00943917|581331|P2|Stage II Continuation|Protocol Violation|0
182977|NCT00943917|581332|P1|Stage II Continuation|Protocol Violation|0
182978|NCT00943917|581318|P15|Stage II Continuation|Withdrawal by Subject|3
182979|NCT00943917|581319|P14|Stage II Continuation|Withdrawal by Subject|1
182980|NCT00943917|581320|P13|Stage II Continuation|Withdrawal by Subject|0
182981|NCT00943917|581321|P12|Stage II Continuation|Withdrawal by Subject|0
182982|NCT00943917|581322|P11|Stage II Continuation|Withdrawal by Subject|0
182983|NCT00943917|581323|P10|Stage II Continuation|Withdrawal by Subject|0
182984|NCT00943917|581324|P9|Stage II Continuation|Withdrawal by Subject|0
182985|NCT00943917|581325|P8|Stage II Continuation|Withdrawal by Subject|0
182986|NCT00943917|581326|P7|Stage II Continuation|Withdrawal by Subject|0
182987|NCT00943917|581327|P6|Stage II Continuation|Withdrawal by Subject|0
182988|NCT00943917|581328|P5|Stage II Continuation|Withdrawal by Subject|0
182989|NCT00943917|581329|P4|Stage II Continuation|Withdrawal by Subject|0
182990|NCT00943917|581330|P3|Stage II Continuation|Withdrawal by Subject|0
182991|NCT00943917|581331|P2|Stage II Continuation|Withdrawal by Subject|0
182992|NCT00943917|581332|P1|Stage II Continuation|Withdrawal by Subject|0
182993|NCT00943917|581318|P15|Stage II Continuation|Adverse Event|1
182994|NCT00943917|581319|P14|Stage II Continuation|Adverse Event|1
182995|NCT00943917|581320|P13|Stage II Continuation|Adverse Event|2
182996|NCT00943917|581321|P12|Stage II Continuation|Adverse Event|1
182997|NCT00943917|581322|P11|Stage II Continuation|Adverse Event|0
182998|NCT00943917|581323|P10|Stage II Continuation|Adverse Event|0
182999|NCT00943917|581324|P9|Stage II Continuation|Adverse Event|0
183000|NCT00943917|581325|P8|Stage II Continuation|Adverse Event|0
183001|NCT00943917|581326|P7|Stage II Continuation|Adverse Event|0
183002|NCT00943917|581327|P6|Stage II Continuation|Adverse Event|0
183003|NCT00943917|581328|P5|Stage II Continuation|Adverse Event|0
183004|NCT00943917|581329|P4|Stage II Continuation|Adverse Event|0
183005|NCT00943917|581330|P3|Stage II Continuation|Adverse Event|0
183006|NCT00943917|581331|P2|Stage II Continuation|Adverse Event|0
183007|NCT00943917|581332|P1|Stage II Continuation|Adverse Event|0
183008|NCT00943917|581318|P15|Stage II|Pregnancy|0
183009|NCT00943917|581319|P14|Stage II|Pregnancy|0
183011|NCT00943917|581321|P12|Stage II|Pregnancy|0
183012|NCT00943917|581322|P11|Stage II|Pregnancy|0
183013|NCT00943917|581323|P10|Stage II|Pregnancy|0
183014|NCT00943917|581324|P9|Stage II|Pregnancy|0
183015|NCT00943917|581325|P8|Stage II|Pregnancy|0
183016|NCT00943917|581326|P7|Stage II|Pregnancy|0
183017|NCT00943917|581327|P6|Stage II|Pregnancy|1
183018|NCT00943917|581328|P5|Stage II|Pregnancy|0
183019|NCT00943917|581329|P4|Stage II|Pregnancy|0
183020|NCT00943917|581330|P3|Stage II|Pregnancy|0
183021|NCT00943917|581331|P2|Stage II|Pregnancy|0
183022|NCT00943917|581332|P1|Stage II|Pregnancy|0
183023|NCT00943917|581318|P15|Stage II|Withdrawal by Subject|0
183024|NCT00943917|581319|P14|Stage II|Withdrawal by Subject|0
183025|NCT00943917|581320|P13|Stage II|Withdrawal by Subject|0
183026|NCT00943917|581321|P12|Stage II|Withdrawal by Subject|0
183027|NCT00943917|581322|P11|Stage II|Withdrawal by Subject|0
183028|NCT00943917|581323|P10|Stage II|Withdrawal by Subject|0
183029|NCT00943917|581324|P9|Stage II|Withdrawal by Subject|0
183030|NCT00943917|581325|P8|Stage II|Withdrawal by Subject|0
183031|NCT00943917|581326|P7|Stage II|Withdrawal by Subject|0
183032|NCT00943917|581327|P6|Stage II|Withdrawal by Subject|1
183033|NCT00943917|581328|P5|Stage II|Withdrawal by Subject|0
183034|NCT00943917|581329|P4|Stage II|Withdrawal by Subject|0
183035|NCT00943917|581330|P3|Stage II|Withdrawal by Subject|0
183036|NCT00943917|581331|P2|Stage II|Withdrawal by Subject|0
183037|NCT00943917|581332|P1|Stage II|Withdrawal by Subject|0
183038|NCT00943917|581318|P15|Stage II|Adverse Event|0
183039|NCT00943917|581319|P14|Stage II|Adverse Event|0
183040|NCT00943917|581320|P13|Stage II|Adverse Event|0
183041|NCT00943917|581321|P12|Stage II|Adverse Event|0
183042|NCT00943917|581322|P11|Stage II|Adverse Event|0
183043|NCT00943917|581323|P10|Stage II|Adverse Event|0
183044|NCT00943917|581324|P9|Stage II|Adverse Event|1
183045|NCT00943917|581325|P8|Stage II|Adverse Event|0
183046|NCT00943917|581326|P7|Stage II|Adverse Event|3
183047|NCT00943917|581327|P6|Stage II|Adverse Event|1
183048|NCT00943917|581328|P5|Stage II|Adverse Event|0
183049|NCT00943917|581329|P4|Stage II|Adverse Event|0
183050|NCT00943917|581330|P3|Stage II|Adverse Event|0
183051|NCT00943917|581331|P2|Stage II|Adverse Event|0
183052|NCT00943917|581332|P1|Stage II|Adverse Event|0
183053|NCT00943917|581318|P15|Stage I|Withdrawal by Subject|0
183054|NCT00943917|581319|P14|Stage I|Withdrawal by Subject|0
183055|NCT00943917|581320|P13|Stage I|Withdrawal by Subject|0
183056|NCT00943917|581321|P12|Stage I|Withdrawal by Subject|0
183057|NCT00943917|581322|P11|Stage I|Withdrawal by Subject|0
183058|NCT00943917|581323|P10|Stage I|Withdrawal by Subject|0
183059|NCT00943917|581324|P9|Stage I|Withdrawal by Subject|0
183060|NCT00943917|581325|P8|Stage I|Withdrawal by Subject|0
183061|NCT00943917|581326|P7|Stage I|Withdrawal by Subject|0
183062|NCT00943917|581327|P6|Stage I|Withdrawal by Subject|0
183063|NCT00943917|581328|P5|Stage I|Withdrawal by Subject|0
183064|NCT00943917|581329|P4|Stage I|Withdrawal by Subject|0
183065|NCT00943917|581330|P3|Stage I|Withdrawal by Subject|2
183066|NCT00943917|581331|P2|Stage I|Withdrawal by Subject|1
183067|NCT00943917|581332|P1|Stage I|Withdrawal by Subject|2
183068|NCT00943917|581318|P15|Stage I|A1C elevation|0
183069|NCT00943917|581319|P14|Stage I|A1C elevation|0
183070|NCT00943917|581320|P13|Stage I|A1C elevation|0
183071|NCT00943917|581321|P12|Stage I|A1C elevation|0
183072|NCT00943917|581322|P11|Stage I|A1C elevation|0
183073|NCT00943917|581323|P10|Stage I|A1C elevation|0
183074|NCT00943917|581324|P9|Stage I|A1C elevation|0
183075|NCT00943917|581325|P8|Stage I|A1C elevation|0
183076|NCT00943917|581326|P7|Stage I|A1C elevation|0
183077|NCT00943917|581327|P6|Stage I|A1C elevation|0
183078|NCT00943917|581328|P5|Stage I|A1C elevation|0
183079|NCT00943917|581329|P4|Stage I|A1C elevation|0
183080|NCT00943917|581330|P3|Stage I|A1C elevation|0
183081|NCT00943917|581331|P2|Stage I|A1C elevation|0
183082|NCT00943917|581332|P1|Stage I|A1C elevation|1
183083|NCT00943917|581318|P15|Stage I|hyperglycemia|0
183084|NCT00943917|581319|P14|Stage I|hyperglycemia|0
183085|NCT00943917|581320|P13|Stage I|hyperglycemia|0
183086|NCT00943917|581321|P12|Stage I|hyperglycemia|0
183087|NCT00943917|581322|P11|Stage I|hyperglycemia|0
183088|NCT00943917|581323|P10|Stage I|hyperglycemia|0
183089|NCT00943917|581324|P9|Stage I|hyperglycemia|0
183090|NCT00943917|581325|P8|Stage I|hyperglycemia|0
183091|NCT00943917|581326|P7|Stage I|hyperglycemia|0
183092|NCT00943917|581327|P6|Stage I|hyperglycemia|0
183093|NCT00943917|581328|P5|Stage I|hyperglycemia|0
183094|NCT00943917|581329|P4|Stage I|hyperglycemia|0
183095|NCT00943917|581330|P3|Stage I|hyperglycemia|1
183096|NCT00943917|581331|P2|Stage I|hyperglycemia|0
183097|NCT00943917|581332|P1|Stage I|hyperglycemia|0
183098|NCT00943917|581318|P15|Stage I|Lost to Follow-up|0
183099|NCT00943917|581319|P14|Stage I|Lost to Follow-up|0
183100|NCT00943917|581320|P13|Stage I|Lost to Follow-up|0
183101|NCT00943917|581321|P12|Stage I|Lost to Follow-up|0
183102|NCT00943917|581322|P11|Stage I|Lost to Follow-up|0
183103|NCT00943917|581323|P10|Stage I|Lost to Follow-up|0
183104|NCT00943917|581324|P9|Stage I|Lost to Follow-up|0
183105|NCT00943917|581325|P8|Stage I|Lost to Follow-up|0
183106|NCT00943917|581326|P7|Stage I|Lost to Follow-up|0
183107|NCT00943917|581327|P6|Stage I|Lost to Follow-up|0
183108|NCT00943917|581328|P5|Stage I|Lost to Follow-up|0
183109|NCT00943917|581329|P4|Stage I|Lost to Follow-up|0
183110|NCT00943917|581330|P3|Stage I|Lost to Follow-up|1
183111|NCT00943917|581331|P2|Stage I|Lost to Follow-up|0
183112|NCT00943917|581332|P1|Stage I|Lost to Follow-up|0
183113|NCT00943917|581318|P15|Stage I|Adverse Event|0
183114|NCT00943917|581319|P14|Stage I|Adverse Event|0
183115|NCT00943917|581320|P13|Stage I|Adverse Event|0
183116|NCT00943917|581321|P12|Stage I|Adverse Event|0
183117|NCT00943917|581322|P11|Stage I|Adverse Event|0
183118|NCT00943917|581323|P10|Stage I|Adverse Event|0
183119|NCT00943917|581324|P9|Stage I|Adverse Event|0
183120|NCT00943917|581325|P8|Stage I|Adverse Event|0
183121|NCT00943917|581326|P7|Stage I|Adverse Event|0
183122|NCT00943917|581327|P6|Stage I|Adverse Event|0
183123|NCT00943917|581328|P5|Stage I|Adverse Event|0
183124|NCT00943917|581329|P4|Stage I|Adverse Event|0
183125|NCT00943917|581330|P3|Stage I|Adverse Event|2
183126|NCT00943917|581331|P2|Stage I|Adverse Event|2
183127|NCT00943917|581332|P1|Stage I|Adverse Event|1
183128|NCT00944034|581457|P12|Overall Study|Administrative reason|0
183129|NCT00944034|581458|P11|Overall Study|Administrative reason|0
183130|NCT00944034|581459|P10|Overall Study|Administrative reason|0
183131|NCT00944034|581460|P9|Overall Study|Administrative reason|0
183132|NCT00944034|581461|P8|Overall Study|Administrative reason|0
183133|NCT00944034|581462|P7|Overall Study|Administrative reason|1
183134|NCT00944034|581463|P6|Overall Study|Administrative reason|0
183135|NCT00944034|581464|P5|Overall Study|Administrative reason|0
183136|NCT00944034|581465|P4|Overall Study|Administrative reason|0
183137|NCT00944034|581466|P3|Overall Study|Administrative reason|0
183138|NCT00944034|581467|P2|Overall Study|Administrative reason|0
183139|NCT00944034|581468|P1|Overall Study|Administrative reason|0
183140|NCT00944034|581457|P12|Overall Study|Unable to classify|0
183141|NCT00944034|581458|P11|Overall Study|Unable to classify|0
183142|NCT00944034|581459|P10|Overall Study|Unable to classify|0
183143|NCT00944034|581460|P9|Overall Study|Unable to classify|0
183144|NCT00944034|581461|P8|Overall Study|Unable to classify|1
183145|NCT00944034|581462|P7|Overall Study|Unable to classify|1
183146|NCT00944034|581463|P6|Overall Study|Unable to classify|1
183147|NCT00944034|581464|P5|Overall Study|Unable to classify|0
183148|NCT00944034|581465|P4|Overall Study|Unable to classify|0
183149|NCT00944034|581466|P3|Overall Study|Unable to classify|0
183150|NCT00944034|581467|P2|Overall Study|Unable to classify|0
183151|NCT00944034|581468|P1|Overall Study|Unable to classify|0
183152|NCT00944034|581457|P12|Overall Study|Protocol Violation|0
183153|NCT00944034|581458|P11|Overall Study|Protocol Violation|0
183154|NCT00944034|581459|P10|Overall Study|Protocol Violation|4
183155|NCT00944034|581460|P9|Overall Study|Protocol Violation|1
183156|NCT00944034|581461|P8|Overall Study|Protocol Violation|1
183157|NCT00944034|581462|P7|Overall Study|Protocol Violation|0
183158|NCT00944034|581463|P6|Overall Study|Protocol Violation|3
183159|NCT00944034|581464|P5|Overall Study|Protocol Violation|2
183160|NCT00944034|581465|P4|Overall Study|Protocol Violation|1
183161|NCT00944034|581466|P3|Overall Study|Protocol Violation|0
183162|NCT00944034|581467|P2|Overall Study|Protocol Violation|0
183163|NCT00944034|581468|P1|Overall Study|Protocol Violation|2
183164|NCT00944034|581457|P12|Overall Study|Death|0
183165|NCT00944034|581458|P11|Overall Study|Death|0
183166|NCT00944034|581459|P10|Overall Study|Death|0
183167|NCT00944034|581460|P9|Overall Study|Death|0
183168|NCT00944034|581461|P8|Overall Study|Death|0
183169|NCT00944034|581462|P7|Overall Study|Death|0
183170|NCT00944034|581463|P6|Overall Study|Death|0
183171|NCT00944034|581464|P5|Overall Study|Death|0
183172|NCT00944034|581465|P4|Overall Study|Death|0
183173|NCT00944034|581466|P3|Overall Study|Death|1
183174|NCT00944034|581467|P2|Overall Study|Death|0
183175|NCT00944034|581468|P1|Overall Study|Death|0
183176|NCT00944034|581457|P12|Overall Study|Lost to Follow-up|0
183177|NCT00944034|581458|P11|Overall Study|Lost to Follow-up|1
183178|NCT00944034|581459|P10|Overall Study|Lost to Follow-up|1
183179|NCT00944034|581460|P9|Overall Study|Lost to Follow-up|5
183180|NCT00944034|581461|P8|Overall Study|Lost to Follow-up|1
183181|NCT00944034|581462|P7|Overall Study|Lost to Follow-up|0
183182|NCT00944034|581463|P6|Overall Study|Lost to Follow-up|7
183183|NCT00944034|581464|P5|Overall Study|Lost to Follow-up|5
183184|NCT00944034|581465|P4|Overall Study|Lost to Follow-up|0
183185|NCT00944034|581466|P3|Overall Study|Lost to Follow-up|2
183186|NCT00944034|581467|P2|Overall Study|Lost to Follow-up|4
183187|NCT00944034|581468|P1|Overall Study|Lost to Follow-up|0
183188|NCT00944034|581457|P12|Overall Study|Withdrawal by Subject|4
183189|NCT00944034|581458|P11|Overall Study|Withdrawal by Subject|0
183190|NCT00944034|581459|P10|Overall Study|Withdrawal by Subject|4
183191|NCT00944034|581460|P9|Overall Study|Withdrawal by Subject|3
183192|NCT00944034|581461|P8|Overall Study|Withdrawal by Subject|2
183193|NCT00944034|581462|P7|Overall Study|Withdrawal by Subject|2
183194|NCT00944034|581463|P6|Overall Study|Withdrawal by Subject|8
183195|NCT00944034|581464|P5|Overall Study|Withdrawal by Subject|5
183196|NCT00944034|581465|P4|Overall Study|Withdrawal by Subject|2
183197|NCT00944034|581466|P3|Overall Study|Withdrawal by Subject|6
183198|NCT00944034|581467|P2|Overall Study|Withdrawal by Subject|2
183199|NCT00944034|581468|P1|Overall Study|Withdrawal by Subject|3
183200|NCT00944034|581457|P12|Overall Study|Inappropriate enrollment|0
183201|NCT00944034|581458|P11|Overall Study|Inappropriate enrollment|0
183202|NCT00944034|581459|P10|Overall Study|Inappropriate enrollment|1
183203|NCT00944034|581460|P9|Overall Study|Inappropriate enrollment|1
183204|NCT00944034|581461|P8|Overall Study|Inappropriate enrollment|0
183205|NCT00944034|581462|P7|Overall Study|Inappropriate enrollment|0
183206|NCT00944034|581463|P6|Overall Study|Inappropriate enrollment|1
183207|NCT00944034|581464|P5|Overall Study|Inappropriate enrollment|2
183208|NCT00944034|581465|P4|Overall Study|Inappropriate enrollment|1
183209|NCT00944034|581466|P3|Overall Study|Inappropriate enrollment|0
183210|NCT00944034|581467|P2|Overall Study|Inappropriate enrollment|1
183211|NCT00944034|581468|P1|Overall Study|Inappropriate enrollment|0
183212|NCT00944125|581614|P2|6 Months to Study Completion|Withdrawal by Subject|2
183213|NCT00944125|581615|P1|6 Months to Study Completion|Withdrawal by Subject|0
183214|NCT00944125|581614|P2|3 to 6 Months|Withdrawal by Subject|2
183215|NCT00944125|581615|P1|3 to 6 Months|Withdrawal by Subject|0
183216|NCT00944229|581621|P1|Overall Study|Physician Decision|14
183217|NCT00944229|581621|P1|Overall Study|Withdrawal by Subject|11
183218|NCT00932373|581649|P11|Overall Study|Lack of Efficacy|0
183219|NCT00932373|581650|P10|Overall Study|Lack of Efficacy|1
183220|NCT00932373|581651|P9|Overall Study|Lack of Efficacy|0
183221|NCT00932373|581652|P8|Overall Study|Lack of Efficacy|0
183222|NCT00932373|581653|P7|Overall Study|Lack of Efficacy|0
183223|NCT00932373|581654|P6|Overall Study|Lack of Efficacy|0
183224|NCT00932373|581655|P5|Overall Study|Lack of Efficacy|0
183225|NCT00932373|581656|P4|Overall Study|Lack of Efficacy|0
183226|NCT00932373|581657|P3|Overall Study|Lack of Efficacy|0
183227|NCT00932373|581658|P2|Overall Study|Lack of Efficacy|0
183228|NCT00932373|581659|P1|Overall Study|Lack of Efficacy|0
183229|NCT00932373|581649|P11|Overall Study|Clinical progression|0
183230|NCT00932373|581650|P10|Overall Study|Clinical progression|0
183231|NCT00932373|581651|P9|Overall Study|Clinical progression|0
183232|NCT00932373|581652|P8|Overall Study|Clinical progression|0
183233|NCT00932373|581653|P7|Overall Study|Clinical progression|1
183234|NCT00932373|581654|P6|Overall Study|Clinical progression|0
183235|NCT00932373|581655|P5|Overall Study|Clinical progression|0
183236|NCT00932373|581656|P4|Overall Study|Clinical progression|0
183237|NCT00932373|581657|P3|Overall Study|Clinical progression|0
183238|NCT00932373|581658|P2|Overall Study|Clinical progression|0
183239|NCT00932373|581659|P1|Overall Study|Clinical progression|0
183240|NCT00932373|581649|P11|Overall Study|Withdrawal by Subject|0
183241|NCT00932373|581650|P10|Overall Study|Withdrawal by Subject|0
183242|NCT00932373|581651|P9|Overall Study|Withdrawal by Subject|1
183243|NCT00932373|581652|P8|Overall Study|Withdrawal by Subject|0
183244|NCT00932373|581653|P7|Overall Study|Withdrawal by Subject|0
183245|NCT00932373|581654|P6|Overall Study|Withdrawal by Subject|0
183246|NCT00932373|581655|P5|Overall Study|Withdrawal by Subject|0
183247|NCT00932373|581656|P4|Overall Study|Withdrawal by Subject|0
183248|NCT00932373|581657|P3|Overall Study|Withdrawal by Subject|0
183249|NCT00932373|581658|P2|Overall Study|Withdrawal by Subject|0
183250|NCT00932373|581659|P1|Overall Study|Withdrawal by Subject|0
183251|NCT00932373|581649|P11|Overall Study|Dose limiting toxicity|0
183252|NCT00932373|581650|P10|Overall Study|Dose limiting toxicity|0
183253|NCT00932373|581651|P9|Overall Study|Dose limiting toxicity|0
183254|NCT00932373|581652|P8|Overall Study|Dose limiting toxicity|0
183255|NCT00932373|581653|P7|Overall Study|Dose limiting toxicity|0
183256|NCT00932373|581654|P6|Overall Study|Dose limiting toxicity|1
183257|NCT00932373|581655|P5|Overall Study|Dose limiting toxicity|0
183258|NCT00932373|581656|P4|Overall Study|Dose limiting toxicity|0
183259|NCT00932373|581657|P3|Overall Study|Dose limiting toxicity|0
183260|NCT00932373|581658|P2|Overall Study|Dose limiting toxicity|0
183261|NCT00932373|581659|P1|Overall Study|Dose limiting toxicity|0
183262|NCT00932373|581649|P11|Overall Study|Physician Decision|0
183263|NCT00932373|581650|P10|Overall Study|Physician Decision|1
183264|NCT00932373|581651|P9|Overall Study|Physician Decision|0
183265|NCT00932373|581652|P8|Overall Study|Physician Decision|0
183266|NCT00932373|581653|P7|Overall Study|Physician Decision|0
183267|NCT00932373|581654|P6|Overall Study|Physician Decision|0
183268|NCT00932373|581655|P5|Overall Study|Physician Decision|2
183269|NCT00932373|581656|P4|Overall Study|Physician Decision|0
183270|NCT00932373|581657|P3|Overall Study|Physician Decision|1
183271|NCT00932373|581658|P2|Overall Study|Physician Decision|0
183272|NCT00932373|581659|P1|Overall Study|Physician Decision|0
183273|NCT00932373|581649|P11|Overall Study|Adverse Event|1
183274|NCT00932373|581650|P10|Overall Study|Adverse Event|2
183275|NCT00932373|581651|P9|Overall Study|Adverse Event|0
183276|NCT00932373|581652|P8|Overall Study|Adverse Event|1
183277|NCT00932373|581653|P7|Overall Study|Adverse Event|0
183278|NCT00932373|581654|P6|Overall Study|Adverse Event|1
183279|NCT00932373|581655|P5|Overall Study|Adverse Event|2
183280|NCT00932373|581656|P4|Overall Study|Adverse Event|0
183281|NCT00932373|581657|P3|Overall Study|Adverse Event|0
183282|NCT00932373|581658|P2|Overall Study|Adverse Event|0
183283|NCT00932373|581659|P1|Overall Study|Adverse Event|0
183284|NCT00932373|581649|P11|Overall Study|Progressive disease|2
183285|NCT00932373|581650|P10|Overall Study|Progressive disease|9
183286|NCT00932373|581651|P9|Overall Study|Progressive disease|1
183287|NCT00932373|581652|P8|Overall Study|Progressive disease|2
183288|NCT00932373|581653|P7|Overall Study|Progressive disease|0
183289|NCT00932373|581654|P6|Overall Study|Progressive disease|1
183290|NCT00932373|581655|P5|Overall Study|Progressive disease|10
183291|NCT00932373|581656|P4|Overall Study|Progressive disease|0
183292|NCT00932373|581657|P3|Overall Study|Progressive disease|0
183293|NCT00932373|581658|P2|Overall Study|Progressive disease|1
183294|NCT00932373|581659|P1|Overall Study|Progressive disease|3
183295|NCT00932425|581770|P2|Overall Study|Withdrawal by Subject|1
183296|NCT00932425|581771|P1|Overall Study|Withdrawal by Subject|0
183297|NCT00932425|581770|P2|Overall Study|Lost to Follow-up|1
183298|NCT00932425|581771|P1|Overall Study|Lost to Follow-up|0
183299|NCT00932451|581784|P1|Overall Study|Other reasons|5
183300|NCT00932451|581784|P1|Overall Study|Death|726
183301|NCT00932451|581784|P1|Overall Study|Lost to Follow-up|22
183302|NCT00932451|581784|P1|Overall Study|Withdrawal by Subject|69
183303|NCT00932646|581839|P4|Overall Study|Withdrawal by Subject|0
183304|NCT00932646|581840|P3|Overall Study|Withdrawal by Subject|3
183305|NCT00932646|581841|P2|Overall Study|Withdrawal by Subject|1
183306|NCT00932646|581842|P1|Overall Study|Withdrawal by Subject|1
183307|NCT00932646|581839|P4|Overall Study|Lost to Follow-up|0
183308|NCT00932646|581840|P3|Overall Study|Lost to Follow-up|0
183309|NCT00932646|581841|P2|Overall Study|Lost to Follow-up|1
183310|NCT00932646|581842|P1|Overall Study|Lost to Follow-up|2
183311|NCT00932646|581839|P4|Overall Study|Adverse Event|1
183312|NCT00932646|581840|P3|Overall Study|Adverse Event|1
183313|NCT00932646|581841|P2|Overall Study|Adverse Event|1
183314|NCT00932646|581842|P1|Overall Study|Adverse Event|2
183315|NCT00932893|581903|P2|Overall Study|Unspecified|144
183316|NCT00932893|581904|P1|Overall Study|Unspecified|5
183317|NCT00932893|581903|P2|Overall Study|Withdrawal by Subject|2
183318|NCT00932893|581904|P1|Overall Study|Withdrawal by Subject|5
183319|NCT00932893|581903|P2|Overall Study|Lost to Follow-up|0
183320|NCT00932893|581904|P1|Overall Study|Lost to Follow-up|8
183321|NCT00932893|581903|P2|Overall Study|Death|24
183322|NCT00932893|581904|P1|Overall Study|Death|115
183323|NCT00938470|581950|P2|Overall Study|Other Reason|1
183324|NCT00938470|581951|P1|Overall Study|Other Reason|0
183325|NCT00938470|581950|P2|Overall Study|Death|2
183326|NCT00938470|581951|P1|Overall Study|Death|3
183327|NCT00938470|581950|P2|Overall Study|Alternate Treatment|0
183328|NCT00938470|581951|P1|Overall Study|Alternate Treatment|1
183329|NCT00938470|581950|P2|Overall Study|Disease Progression|0
183330|NCT00938470|581951|P1|Overall Study|Disease Progression|3
183331|NCT00938639|581980|P2|Overall Study|Participant noncompliance|0
183332|NCT00938639|581981|P1|Overall Study|Participant noncompliance|1
183333|NCT00938639|581980|P2|Overall Study|Family issues|1
183334|NCT00938639|581981|P1|Overall Study|Family issues|1
183335|NCT00938639|581980|P2|Overall Study|Lost to Follow-up|2
183336|NCT00938639|581981|P1|Overall Study|Lost to Follow-up|1
183337|NCT00938639|581980|P2|Overall Study|Moved away from study area|1
183338|NCT00938639|581981|P1|Overall Study|Moved away from study area|0
183339|NCT00938717|582068|P2|Overall Study|Other reason|2
183340|NCT00938717|582069|P1|Overall Study|Other reason|5
183341|NCT00938717|582068|P2|Overall Study|Lack of Efficacy|15
183342|NCT00938717|582069|P1|Overall Study|Lack of Efficacy|33
183343|NCT00938717|582068|P2|Overall Study|Lost to Follow-up|18
183344|NCT00938717|582069|P1|Overall Study|Lost to Follow-up|13
183345|NCT00938717|582068|P2|Overall Study|Withdrawal by Subject|24
183346|NCT00938717|582069|P1|Overall Study|Withdrawal by Subject|26
183347|NCT00938717|582068|P2|Overall Study|Protocol Violation|8
183348|NCT00938717|582069|P1|Overall Study|Protocol Violation|11
183349|NCT00938717|582068|P2|Overall Study|Adverse Event|41
183350|NCT00938717|582069|P1|Overall Study|Adverse Event|10
183351|NCT00948389|582133|P5|Overall Study|Both Progression and Toxicity|0
183352|NCT00948389|582134|P4|Overall Study|Both Progression and Toxicity|0
183353|NCT00948389|582135|P3|Overall Study|Both Progression and Toxicity|0
183354|NCT00948389|582136|P2|Overall Study|Both Progression and Toxicity|0
183355|NCT00948389|582137|P1|Overall Study|Both Progression and Toxicity|1
183356|NCT00948389|582133|P5|Overall Study|Thrombocytopenia, Grade 4|0
183357|NCT00948389|582134|P4|Overall Study|Thrombocytopenia, Grade 4|1
183358|NCT00948389|582135|P3|Overall Study|Thrombocytopenia, Grade 4|0
183359|NCT00948389|582136|P2|Overall Study|Thrombocytopenia, Grade 4|0
183360|NCT00948389|582137|P1|Overall Study|Thrombocytopenia, Grade 4|2
183361|NCT00948389|582133|P5|Overall Study|Disease Progression/Relapse/Death|1
183362|NCT00948389|582134|P4|Overall Study|Disease Progression/Relapse/Death|8
183363|NCT00948389|582135|P3|Overall Study|Disease Progression/Relapse/Death|7
183364|NCT00948389|582136|P2|Overall Study|Disease Progression/Relapse/Death|3
183365|NCT00948389|582137|P1|Overall Study|Disease Progression/Relapse/Death|3
183366|NCT00948441|582176|P2|Overall Study|no longer meet inclusion criteria|4
183367|NCT00948441|582177|P1|Overall Study|no longer meet inclusion criteria|1
183368|NCT00948506|582187|P2|Overall Study|Withdrawal by Subject|1
183369|NCT00948506|582188|P1|Overall Study|Withdrawal by Subject|3
183370|NCT00948675|582199|P2|Overall Study|Treatment ongoing|4
183371|NCT00948675|582200|P1|Overall Study|Treatment ongoing|5
183372|NCT00948675|582199|P2|Overall Study|Lost to Follow-up|0
183373|NCT00948675|582200|P1|Overall Study|Lost to Follow-up|2
183374|NCT00948688|582214|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
183375|NCT00948688|582215|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
183376|NCT00948688|582214|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
183377|NCT00948688|582215|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
183378|NCT00948688|582214|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
183379|NCT00948688|582215|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
183380|NCT00948766|582229|P2|Extension Study|Death|0
183381|NCT00948766|582230|P1|Extension Study|Death|4
183382|NCT00948766|582229|P2|Extension Study|Administrative Problems|0
183383|NCT00948766|582230|P1|Extension Study|Administrative Problems|1
183384|NCT00948766|582229|P2|Extension Study|Lost to Follow-up|0
183385|NCT00948766|582230|P1|Extension Study|Lost to Follow-up|8
183386|NCT00948766|582229|P2|Extension Study|Patient Withdrew Consent|0
183387|NCT00948766|582230|P1|Extension Study|Patient Withdrew Consent|32
183388|NCT00948766|582229|P2|Extension Study|Study Drug No Longer Required|0
183389|NCT00948766|582230|P1|Extension Study|Study Drug No Longer Required|1
183390|NCT00948766|582229|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
183391|NCT00948766|582230|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
183392|NCT00948766|582229|P2|Extension Study|Adverse Event|0
183393|NCT00948766|582230|P1|Extension Study|Adverse Event|43
183394|NCT00948766|582229|P2|Core Study|Protocol Deviation|10
183395|NCT00948766|582230|P1|Core Study|Protocol Deviation|8
183396|NCT00948766|582229|P2|Core Study|Death|1
183397|NCT00948766|582230|P1|Core Study|Death|1
183398|NCT00948766|582229|P2|Core Study|Administrative Problems|2
183399|NCT00948766|582230|P1|Core Study|Administrative Problems|2
183400|NCT00948766|582229|P2|Core Study|Lost to Follow-up|2
183401|NCT00948766|582230|P1|Core Study|Lost to Follow-up|3
183402|NCT00948766|582229|P2|Core Study|Patient Withdrew Consent|46
183403|NCT00948766|582230|P1|Core Study|Patient Withdrew Consent|27
183404|NCT00948766|582229|P2|Core Study|Unsatisfactory Therapeutic Effect|14
183405|NCT00948766|582230|P1|Core Study|Unsatisfactory Therapeutic Effect|13
183406|NCT00948766|582229|P2|Core Study|Adverse Event|51
183407|NCT00948766|582230|P1|Core Study|Adverse Event|73
183408|NCT00948818|582258|P2|Overall Study|Other Reason|5
183409|NCT00948818|582259|P1|Overall Study|Other Reason|4
183410|NCT00948818|582258|P2|Overall Study|Lack of Efficacy|5
183411|NCT00948818|582259|P1|Overall Study|Lack of Efficacy|4
183412|NCT00948818|582258|P2|Overall Study|Lost to Follow-up|17
183413|NCT00948818|582259|P1|Overall Study|Lost to Follow-up|10
183414|NCT00948818|582258|P2|Overall Study|Withdrawal by Subject|25
183415|NCT00948818|582259|P1|Overall Study|Withdrawal by Subject|25
183416|NCT00948818|582258|P2|Overall Study|Protocol Violation|10
183417|NCT00948818|582259|P1|Overall Study|Protocol Violation|9
183418|NCT00948818|582258|P2|Overall Study|Adverse Event|32
183419|NCT00948818|582259|P1|Overall Study|Adverse Event|10
183420|NCT00948857|582296|P2|Overall Study|Lost to Follow-up|0
183421|NCT00948857|582297|P1|Overall Study|Lost to Follow-up|1
183422|NCT00948896|582311|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183423|NCT00948896|582312|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183424|NCT00948896|582313|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183425|NCT00948896|582314|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183426|NCT00948896|582315|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
183427|NCT00948896|582316|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183428|NCT00948896|582317|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183429|NCT00948896|582318|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
183430|NCT00948896|582311|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
183431|NCT00948896|582312|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
183432|NCT00948896|582313|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
183433|NCT00948896|582314|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
183434|NCT00948896|582315|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
183435|NCT00948896|582316|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
183436|NCT00948896|582317|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
183437|NCT00948896|582318|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
183438|NCT00948896|582311|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
183439|NCT00948896|582312|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
183440|NCT00948896|582313|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
183441|NCT00948896|582314|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
183442|NCT00948896|582315|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
183443|NCT00948896|582316|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
183444|NCT00948896|582317|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
183445|NCT00948896|582318|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
183446|NCT00948896|582311|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
183447|NCT00948896|582312|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
183448|NCT00948896|582313|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
183449|NCT00948896|582314|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
183450|NCT00948896|582315|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
183451|NCT00948896|582316|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
183452|NCT00948896|582317|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
183453|NCT00948896|582318|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
183454|NCT00948896|582311|P8|24 Months of Age to 36 Months of Age|Death|0
183455|NCT00948896|582312|P7|24 Months of Age to 36 Months of Age|Death|0
183456|NCT00948896|582313|P6|24 Months of Age to 36 Months of Age|Death|1
183457|NCT00948896|582314|P5|24 Months of Age to 36 Months of Age|Death|0
183458|NCT00948896|582315|P4|24 Months of Age to 36 Months of Age|Death|0
183459|NCT00948896|582316|P3|24 Months of Age to 36 Months of Age|Death|2
183460|NCT00948896|582317|P2|24 Months of Age to 36 Months of Age|Death|2
183461|NCT00948896|582318|P1|24 Months of Age to 36 Months of Age|Death|0
183462|NCT00948896|582311|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
183463|NCT00948896|582312|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
183464|NCT00948896|582313|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
183465|NCT00948896|582314|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
183466|NCT00948896|582315|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
183467|NCT00948896|582316|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
183468|NCT00948896|582317|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
183469|NCT00948896|582318|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
183470|NCT00948896|582311|P8|Randomization to 24 Months of Age|Protocol Violation|1
183471|NCT00948896|582312|P7|Randomization to 24 Months of Age|Protocol Violation|1
183472|NCT00948896|582313|P6|Randomization to 24 Months of Age|Protocol Violation|0
183473|NCT00948896|582314|P5|Randomization to 24 Months of Age|Protocol Violation|0
183474|NCT00948896|582315|P4|Randomization to 24 Months of Age|Protocol Violation|1
183475|NCT00948896|582316|P3|Randomization to 24 Months of Age|Protocol Violation|0
183476|NCT00948896|582317|P2|Randomization to 24 Months of Age|Protocol Violation|1
183477|NCT00948896|582318|P1|Randomization to 24 Months of Age|Protocol Violation|0
183478|NCT00948896|582311|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
183479|NCT00948896|582312|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
183480|NCT00948896|582313|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
183481|NCT00948896|582314|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
183482|NCT00948896|582315|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
183483|NCT00948896|582316|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
183484|NCT00948896|582317|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
183485|NCT00948896|582318|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
183486|NCT00948896|582311|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
183487|NCT00948896|582312|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
183488|NCT00948896|582313|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
183489|NCT00948896|582314|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
183490|NCT00948896|582315|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
183491|NCT00948896|582316|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
183492|NCT00948896|582317|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
183493|NCT00948896|582318|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
183494|NCT00948896|582311|P8|Randomization to 24 Months of Age|Death|1
183495|NCT00948896|582312|P7|Randomization to 24 Months of Age|Death|2
183496|NCT00948896|582313|P6|Randomization to 24 Months of Age|Death|1
183497|NCT00948896|582314|P5|Randomization to 24 Months of Age|Death|2
183498|NCT00948896|582315|P4|Randomization to 24 Months of Age|Death|0
183499|NCT00948896|582316|P3|Randomization to 24 Months of Age|Death|0
183500|NCT00948896|582317|P2|Randomization to 24 Months of Age|Death|0
183501|NCT00948896|582318|P1|Randomization to 24 Months of Age|Death|1
183502|NCT00949117|582379|P2|Overall Study|Adverse Event|1
183503|NCT00949117|582380|P1|Overall Study|Adverse Event|0
183504|NCT00949117|582379|P2|Overall Study|Protocol Violation|1
183505|NCT00949117|582380|P1|Overall Study|Protocol Violation|1
183506|NCT00949117|582379|P2|Overall Study|Lack of Efficacy|3
183507|NCT00949117|582380|P1|Overall Study|Lack of Efficacy|2
183508|NCT00949533|582396|P2|Overall Study|Lost to Follow-up|1
183509|NCT00949533|582397|P1|Overall Study|Lost to Follow-up|0
183510|NCT00949650|582411|P2|Overall Study|Other|0
183511|NCT00949650|582412|P1|Overall Study|Other|1
183512|NCT00949650|582411|P2|Overall Study|Not treated|4
183513|NCT00949650|582412|P1|Overall Study|Not treated|1
183514|NCT00949650|582411|P2|Overall Study|Withdrawal by Subject|11
183515|NCT00949650|582412|P1|Overall Study|Withdrawal by Subject|6
183516|NCT00949650|582411|P2|Overall Study|Protocol Violation|4
183517|NCT00949650|582412|P1|Overall Study|Protocol Violation|1
183518|NCT00949650|582411|P2|Overall Study|Other Adverse Event|17
183519|NCT00949650|582412|P1|Overall Study|Other Adverse Event|23
183520|NCT00949650|582411|P2|Overall Study|Progressive disease|19
183521|NCT00949650|582412|P1|Overall Study|Progressive disease|133
183522|NCT00949702|582448|P1|Overall Study|Withdrawal of consent|1
183523|NCT00949702|582448|P1|Overall Study|Disease progression|7
183524|NCT00949702|582448|P1|Overall Study|Death|40
183525|NCT00949715|582465|P2|Overall Study|Missing 24 month LVEF measurement|0
183526|NCT00949715|582466|P1|Overall Study|Missing 24 month LVEF measurement|2
183527|NCT00949715|582465|P2|Overall Study|Lost to Follow-up|0
183528|NCT00949715|582466|P1|Overall Study|Lost to Follow-up|1
183529|NCT00949715|582465|P2|Overall Study|Physician Decision|0
183530|NCT00949715|582466|P1|Overall Study|Physician Decision|1
183531|NCT00949884|582480|P3|Overall Study|Study terminated by sponsor|1
183532|NCT00949884|582481|P2|Overall Study|Study terminated by sponsor|0
183533|NCT00949884|582482|P1|Overall Study|Study terminated by sponsor|0
183534|NCT00949884|582480|P3|Overall Study|Lack of Efficacy|7
183535|NCT00949884|582481|P2|Overall Study|Lack of Efficacy|2
183536|NCT00949884|582482|P1|Overall Study|Lack of Efficacy|4
183537|NCT00949884|582480|P3|Overall Study|Withdrawal by Subject|16
183538|NCT00949884|582481|P2|Overall Study|Withdrawal by Subject|4
183539|NCT00949884|582482|P1|Overall Study|Withdrawal by Subject|13
183540|NCT00949884|582480|P3|Overall Study|Treatment non-compliance|8
183541|NCT00949884|582481|P2|Overall Study|Treatment non-compliance|0
183542|NCT00949884|582482|P1|Overall Study|Treatment non-compliance|5
183543|NCT00949884|582480|P3|Overall Study|Physician Decision|6
183544|NCT00949884|582481|P2|Overall Study|Physician Decision|0
183545|NCT00949884|582482|P1|Overall Study|Physician Decision|5
183546|NCT00949884|582480|P3|Overall Study|Lost to Follow-up|5
183547|NCT00949884|582481|P2|Overall Study|Lost to Follow-up|5
183548|NCT00949884|582482|P1|Overall Study|Lost to Follow-up|7
183549|NCT00949884|582480|P3|Overall Study|Did not meet inclusion/exclusion|3
183550|NCT00949884|582481|P2|Overall Study|Did not meet inclusion/exclusion|1
183551|NCT00949884|582482|P1|Overall Study|Did not meet inclusion/exclusion|2
183552|NCT00949884|582480|P3|Overall Study|Adverse Event|12
183553|NCT00949884|582481|P2|Overall Study|Adverse Event|3
183554|NCT00949884|582482|P1|Overall Study|Adverse Event|14
183555|NCT00949910|582535|P1|Overall Study|No Data|9
183556|NCT00949910|582535|P1|Overall Study|Other|4
183557|NCT00949910|582535|P1|Overall Study|Physician/Participant Decision|7
183558|NCT00949910|582535|P1|Overall Study|Serious Adverse Event|6
183559|NCT00949910|582535|P1|Overall Study|Adverse Event|83
183560|NCT00949910|582535|P1|Overall Study|Prolonged Dosing Interruption|4
183561|NCT00949910|582535|P1|Overall Study|Non-Compliance|10
183562|NCT00949910|582535|P1|Overall Study|Logistical Reasons|13
183563|NCT00949910|582535|P1|Overall Study|Violation of Eligibility|23
183564|NCT00949910|582535|P1|Overall Study|Switched to Commercial Treatment|4
183565|NCT00949910|582535|P1|Overall Study|Switched to Compassionate/Other Use|174
183566|NCT00949910|582535|P1|Overall Study|Unspecified Progression/Deterioration|13
183567|NCT00949910|582535|P1|Overall Study|Death from Unknown Cause|5
183568|NCT00949910|582535|P1|Overall Study|Death Due to Toxicity|3
183569|NCT00949910|582535|P1|Overall Study|Death Due to Adverse Event|115
183570|NCT00949910|582535|P1|Overall Study|Death Due to Progression/Deterioration|4
183571|NCT00949910|582535|P1|Overall Study|Death Due to Malignant Disease|456
183572|NCT00949910|582535|P1|Overall Study|Participant Refusal|390
183573|NCT00949910|582535|P1|Overall Study|Study Drug-Related Adverse Event|315
183574|NCT00949910|582535|P1|Overall Study|Lost to Follow-up|100
183575|NCT00949910|582535|P1|Overall Study|Symptomatic Deterioration|1088
183576|NCT00949910|582535|P1|Overall Study|Progressive Disease|3750
183577|NCT00949975|582549|P4|Overall Study|Other|0
183578|NCT00949975|582550|P3|Overall Study|Other|0
183579|NCT00949975|582551|P2|Overall Study|Other|0
183580|NCT00949975|582552|P1|Overall Study|Other|1
183581|NCT00949975|582549|P4|Overall Study|Lost to Follow-up|3
183582|NCT00949975|582550|P3|Overall Study|Lost to Follow-up|1
183583|NCT00949975|582551|P2|Overall Study|Lost to Follow-up|0
183584|NCT00949975|582552|P1|Overall Study|Lost to Follow-up|1
183585|NCT00949975|582549|P4|Overall Study|Severe non-compliance|2
183586|NCT00949975|582550|P3|Overall Study|Severe non-compliance|0
183587|NCT00949975|582551|P2|Overall Study|Severe non-compliance|1
183588|NCT00949975|582552|P1|Overall Study|Severe non-compliance|3
183589|NCT00949975|582549|P4|Overall Study|Incorrect enrolment|7
183590|NCT00949975|582550|P3|Overall Study|Incorrect enrolment|4
183591|NCT00949975|582551|P2|Overall Study|Incorrect enrolment|10
183592|NCT00949975|582552|P1|Overall Study|Incorrect enrolment|5
183593|NCT00949975|582549|P4|Overall Study|Study-specific criteria|0
183594|NCT00949975|582550|P3|Overall Study|Study-specific criteria|1
183595|NCT00949975|582551|P2|Overall Study|Study-specific criteria|1
183596|NCT00949975|582552|P1|Overall Study|Study-specific criteria|0
183597|NCT00949975|582549|P4|Overall Study|Safety reason|0
183598|NCT00949975|582550|P3|Overall Study|Safety reason|0
183599|NCT00949975|582551|P2|Overall Study|Safety reason|1
183600|NCT00949975|582552|P1|Overall Study|Safety reason|0
183601|NCT00949975|582549|P4|Overall Study|Adverse Event|10
183602|NCT00949975|582550|P3|Overall Study|Adverse Event|10
183603|NCT00949975|582551|P2|Overall Study|Adverse Event|11
183604|NCT00949975|582552|P1|Overall Study|Adverse Event|11
183605|NCT00949975|582549|P4|Overall Study|Voluntary discontinuation|6
183606|NCT00949975|582550|P3|Overall Study|Voluntary discontinuation|3
183607|NCT00949975|582551|P2|Overall Study|Voluntary discontinuation|5
183608|NCT00949975|582552|P1|Overall Study|Voluntary discontinuation|6
183609|NCT00950300|582693|P2|SFU Period|Participant Refusal/Withdrawal|6
183610|NCT00950300|582694|P1|SFU Period|Participant Refusal/Withdrawal|2
183611|NCT00950300|582693|P2|SFU Period|Lost to Follow-up|9
183612|NCT00950300|582694|P1|SFU Period|Lost to Follow-up|11
183613|NCT00950300|582693|P2|SFU Period|Death|21
183614|NCT00950300|582694|P1|SFU Period|Death|28
183615|NCT00950300|582693|P2|SFU Period|Ongoing in SFU|18
183616|NCT00950300|582694|P1|SFU Period|Ongoing in SFU|12
183617|NCT00950300|582693|P2|TFFU Period|Not Specified|1
183618|NCT00950300|582694|P1|TFFU Period|Not Specified|1
183619|NCT00950300|582693|P2|TFFU Period|Recurrence of Disease|55
183620|NCT00950300|582694|P1|TFFU Period|Recurrence of Disease|48
183621|NCT00950300|582693|P2|TFFU Period|Lost to Follow-up|4
183622|NCT00950300|582694|P1|TFFU Period|Lost to Follow-up|6
183623|NCT00950300|582693|P2|TFFU Period|Participant Refusal/Withdrawal|8
183624|NCT00950300|582694|P1|TFFU Period|Participant Refusal/Withdrawal|5
183625|NCT00950300|582693|P2|TFFU Period|Death|0
183626|NCT00950300|582694|P1|TFFU Period|Death|1
183627|NCT00950300|582693|P2|TFFU Period|Adverse Event or Intercurrent Illness|1
183628|NCT00950300|582694|P1|TFFU Period|Adverse Event or Intercurrent Illness|1
183629|NCT00950300|582693|P2|TFFU Period|Ongoing in TFFU|183
183630|NCT00950300|582694|P1|TFFU Period|Ongoing in TFFU|192
183631|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
183632|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Not Specified|1
183633|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
183634|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
183635|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
183636|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
183637|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
183638|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
183639|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
183640|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
183641|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
183642|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
183643|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
183644|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
183645|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
183646|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
183647|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
183648|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
183649|NCT00950300|582693|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
183650|NCT00950300|582694|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
183651|NCT00950599|582764|P10|Follow-Up Period|Subject withdrew Consent|1
183652|NCT00950599|582765|P9|Follow-Up Period|Subject withdrew Consent|2
183653|NCT00950599|582766|P8|Follow-Up Period|Subject withdrew Consent|0
183654|NCT00950599|582767|P7|Follow-Up Period|Subject withdrew Consent|0
183655|NCT00950599|582768|P6|Follow-Up Period|Subject withdrew Consent|0
183656|NCT00950599|582769|P5|Follow-Up Period|Subject withdrew Consent|0
183657|NCT00950599|582770|P4|Follow-Up Period|Subject withdrew Consent|0
183658|NCT00950599|582771|P3|Follow-Up Period|Subject withdrew Consent|0
183659|NCT00950599|582772|P2|Follow-Up Period|Subject withdrew Consent|0
183660|NCT00950599|582773|P1|Follow-Up Period|Subject withdrew Consent|0
183661|NCT00950599|582764|P10|Follow-Up Period|Poor/Noncompliance|0
183662|NCT00950599|582765|P9|Follow-Up Period|Poor/Noncompliance|1
183663|NCT00950599|582766|P8|Follow-Up Period|Poor/Noncompliance|0
183664|NCT00950599|582767|P7|Follow-Up Period|Poor/Noncompliance|0
183665|NCT00950599|582768|P6|Follow-Up Period|Poor/Noncompliance|0
183666|NCT00950599|582769|P5|Follow-Up Period|Poor/Noncompliance|0
183667|NCT00950599|582770|P4|Follow-Up Period|Poor/Noncompliance|0
183668|NCT00950599|582771|P3|Follow-Up Period|Poor/Noncompliance|0
183669|NCT00950599|582772|P2|Follow-Up Period|Poor/Noncompliance|0
183670|NCT00950599|582773|P1|Follow-Up Period|Poor/Noncompliance|0
183671|NCT00950599|582764|P10|Follow-Up Period|Physician Decision|0
183672|NCT00950599|582765|P9|Follow-Up Period|Physician Decision|1
183673|NCT00950599|582766|P8|Follow-Up Period|Physician Decision|0
183674|NCT00950599|582767|P7|Follow-Up Period|Physician Decision|0
183675|NCT00950599|582768|P6|Follow-Up Period|Physician Decision|0
183676|NCT00950599|582769|P5|Follow-Up Period|Physician Decision|0
183677|NCT00950599|582770|P4|Follow-Up Period|Physician Decision|0
183678|NCT00950599|582771|P3|Follow-Up Period|Physician Decision|0
183679|NCT00950599|582772|P2|Follow-Up Period|Physician Decision|0
183680|NCT00950599|582773|P1|Follow-Up Period|Physician Decision|0
183681|NCT00950599|582764|P10|Follow-Up Period|Lost to Follow-up|1
183682|NCT00950599|582765|P9|Follow-Up Period|Lost to Follow-up|5
183683|NCT00950599|582766|P8|Follow-Up Period|Lost to Follow-up|0
183684|NCT00950599|582767|P7|Follow-Up Period|Lost to Follow-up|0
183685|NCT00950599|582768|P6|Follow-Up Period|Lost to Follow-up|0
183686|NCT00950599|582769|P5|Follow-Up Period|Lost to Follow-up|0
183687|NCT00950599|582770|P4|Follow-Up Period|Lost to Follow-up|0
183688|NCT00950599|582771|P3|Follow-Up Period|Lost to Follow-up|0
183689|NCT00950599|582772|P2|Follow-Up Period|Lost to Follow-up|0
183690|NCT00950599|582773|P1|Follow-Up Period|Lost to Follow-up|0
183691|NCT00950599|582764|P10|Follow-Up Period|Lack of Efficacy|0
183692|NCT00950599|582765|P9|Follow-Up Period|Lack of Efficacy|3
183693|NCT00950599|582766|P8|Follow-Up Period|Lack of Efficacy|0
183694|NCT00950599|582767|P7|Follow-Up Period|Lack of Efficacy|0
183695|NCT00950599|582768|P6|Follow-Up Period|Lack of Efficacy|0
183696|NCT00950599|582769|P5|Follow-Up Period|Lack of Efficacy|0
183697|NCT00950599|582770|P4|Follow-Up Period|Lack of Efficacy|0
183698|NCT00950599|582771|P3|Follow-Up Period|Lack of Efficacy|0
183699|NCT00950599|582772|P2|Follow-Up Period|Lack of Efficacy|0
183700|NCT00950599|582773|P1|Follow-Up Period|Lack of Efficacy|0
183701|NCT00950599|582764|P10|Follow-Up Period|Adverse Event|0
183702|NCT00950599|582765|P9|Follow-Up Period|Adverse Event|1
183703|NCT00950599|582766|P8|Follow-Up Period|Adverse Event|0
183704|NCT00950599|582767|P7|Follow-Up Period|Adverse Event|0
183705|NCT00950599|582768|P6|Follow-Up Period|Adverse Event|0
183706|NCT00950599|582769|P5|Follow-Up Period|Adverse Event|0
183707|NCT00950599|582770|P4|Follow-Up Period|Adverse Event|0
183708|NCT00950599|582771|P3|Follow-Up Period|Adverse Event|0
183709|NCT00950599|582772|P2|Follow-Up Period|Adverse Event|0
183710|NCT00950599|582773|P1|Follow-Up Period|Adverse Event|0
183711|NCT00950599|582764|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
183712|NCT00950599|582765|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
183713|NCT00950599|582766|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
183714|NCT00950599|582767|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
183715|NCT00950599|582768|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
183716|NCT00950599|582769|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
183717|NCT00950599|582770|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
183718|NCT00950599|582771|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
183719|NCT00950599|582772|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
183720|NCT00950599|582773|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
183721|NCT00950599|582764|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183722|NCT00950599|582765|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183723|NCT00950599|582766|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183724|NCT00950599|582767|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183725|NCT00950599|582768|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
183726|NCT00950599|582769|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
183727|NCT00950599|582770|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183728|NCT00950599|582771|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183729|NCT00950599|582772|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183730|NCT00950599|582773|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
183731|NCT00950599|582764|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
183732|NCT00950599|582765|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
183733|NCT00950599|582766|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
183734|NCT00950599|582767|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
183735|NCT00950599|582768|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
183736|NCT00950599|582769|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
183737|NCT00950599|582770|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
183738|NCT00950599|582771|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
183739|NCT00950599|582772|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
183740|NCT00950599|582773|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
183741|NCT00950599|582764|P10|Double-Blind Treatment Period|Lost to Follow-up|0
183742|NCT00950599|582765|P9|Double-Blind Treatment Period|Lost to Follow-up|0
183743|NCT00950599|582766|P8|Double-Blind Treatment Period|Lost to Follow-up|1
183744|NCT00950599|582767|P7|Double-Blind Treatment Period|Lost to Follow-up|0
183745|NCT00950599|582768|P6|Double-Blind Treatment Period|Lost to Follow-up|2
183746|NCT00950599|582769|P5|Double-Blind Treatment Period|Lost to Follow-up|1
183747|NCT00950599|582770|P4|Double-Blind Treatment Period|Lost to Follow-up|1
183748|NCT00950599|582771|P3|Double-Blind Treatment Period|Lost to Follow-up|0
183749|NCT00950599|582772|P2|Double-Blind Treatment Period|Lost to Follow-up|0
183750|NCT00950599|582773|P1|Double-Blind Treatment Period|Lost to Follow-up|0
183751|NCT00950599|582764|P10|Double-Blind Treatment Period|Lack of Efficacy|0
183752|NCT00950599|582765|P9|Double-Blind Treatment Period|Lack of Efficacy|0
183753|NCT00950599|582766|P8|Double-Blind Treatment Period|Lack of Efficacy|1
183754|NCT00950599|582767|P7|Double-Blind Treatment Period|Lack of Efficacy|0
183755|NCT00950599|582768|P6|Double-Blind Treatment Period|Lack of Efficacy|6
183756|NCT00950599|582769|P5|Double-Blind Treatment Period|Lack of Efficacy|3
183757|NCT00950599|582770|P4|Double-Blind Treatment Period|Lack of Efficacy|7
183758|NCT00950599|582771|P3|Double-Blind Treatment Period|Lack of Efficacy|5
183759|NCT00950599|582772|P2|Double-Blind Treatment Period|Lack of Efficacy|5
183760|NCT00950599|582773|P1|Double-Blind Treatment Period|Lack of Efficacy|2
183761|NCT00950599|582764|P10|Double-Blind Treatment Period|Adverse Event|0
183762|NCT00950599|582765|P9|Double-Blind Treatment Period|Adverse Event|0
183763|NCT00950599|582766|P8|Double-Blind Treatment Period|Adverse Event|0
183764|NCT00950599|582767|P7|Double-Blind Treatment Period|Adverse Event|0
183765|NCT00950599|582768|P6|Double-Blind Treatment Period|Adverse Event|1
183766|NCT00950599|582769|P5|Double-Blind Treatment Period|Adverse Event|1
183767|NCT00950599|582770|P4|Double-Blind Treatment Period|Adverse Event|1
183768|NCT00950599|582771|P3|Double-Blind Treatment Period|Adverse Event|1
183769|NCT00950599|582772|P2|Double-Blind Treatment Period|Adverse Event|1
183770|NCT00950599|582773|P1|Double-Blind Treatment Period|Adverse Event|0
183771|NCT00950599|582764|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
183772|NCT00950599|582765|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
183773|NCT00950599|582766|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
183774|NCT00950599|582767|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
183775|NCT00950599|582768|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
183776|NCT00950599|582769|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
183777|NCT00950599|582770|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
183778|NCT00950599|582771|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
183779|NCT00950599|582772|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
183780|NCT00950599|582773|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
183781|NCT00950651|583376|P2|Overall Study|Withdrawal by Subject|9
183782|NCT00950651|583377|P1|Overall Study|Withdrawal by Subject|8
183783|NCT00950651|583376|P2|Overall Study|Protocol Violation|4
183784|NCT00950651|583377|P1|Overall Study|Protocol Violation|3
183785|NCT00950651|583376|P2|Overall Study|Lack of Efficacy|2
183786|NCT00950651|583377|P1|Overall Study|Lack of Efficacy|2
183787|NCT00950651|583376|P2|Overall Study|Death|0
183788|NCT00950651|583377|P1|Overall Study|Death|1
183789|NCT00950651|583376|P2|Overall Study|Adverse Event|20
183790|NCT00950651|583377|P1|Overall Study|Adverse Event|17
183791|NCT00950664|583425|P2|First Intervention|Withdrawal by Subject|2
183792|NCT00950664|583426|P1|First Intervention|Withdrawal by Subject|2
183793|NCT00950664|583425|P2|First Intervention|Lost to Follow-up|3
183794|NCT00950664|583426|P1|First Intervention|Lost to Follow-up|1
183795|NCT00950690|583444|P1|Overall Study|Not known|163
183796|NCT00950690|583444|P1|Overall Study|Lost to Follow-up|40
183797|NCT00950690|583444|P1|Overall Study|Lack of Efficacy|22
183798|NCT00950690|583444|P1|Overall Study|Adverse Event|15
183799|NCT00950690|583444|P1|Overall Study|Death|4
183800|NCT00950742|583456|P2|Overall Study|Dose limiting toxicity|0
183801|NCT00950742|583457|P1|Overall Study|Dose limiting toxicity|6
183802|NCT00950742|583456|P2|Overall Study|Progressive Disease|2
183803|NCT00950742|583457|P1|Overall Study|Progressive Disease|6
183804|NCT00950742|583456|P2|Overall Study|Withdrawal by Subject|0
183805|NCT00950742|583457|P1|Overall Study|Withdrawal by Subject|3
183806|NCT00950742|583456|P2|Overall Study|Other Adverse Event|0
183807|NCT00950742|583457|P1|Overall Study|Other Adverse Event|1
183808|NCT00950755|583473|P1|Long-Term Follow-Up|Death|8
183809|NCT00950755|583473|P1|Long-Term Follow-Up|Lost to Follow-up|1
183810|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
183811|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
183812|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
183813|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
183814|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Death|1
183815|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
183816|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
183817|NCT00950755|583473|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
183818|NCT00941655|583499|P2|Overall Study|off study prior to trmt/noncompliance|1
183819|NCT00941655|583500|P1|Overall Study|off study prior to trmt/noncompliance|0
183820|NCT00941655|583499|P2|Overall Study|withdrew consent|3
183821|NCT00941655|583500|P1|Overall Study|withdrew consent|0
183822|NCT00941655|583499|P2|Overall Study|stopped chemo/decided to have surgery|1
183823|NCT00941655|583500|P1|Overall Study|stopped chemo/decided to have surgery|0
183824|NCT00941655|583499|P2|Overall Study|progressed while on chemo|2
183825|NCT00941655|583500|P1|Overall Study|progressed while on chemo|0
183826|NCT00941655|583499|P2|Overall Study|not meet criteria for chemo foll surgery|0
183827|NCT00941655|583500|P1|Overall Study|not meet criteria for chemo foll surgery|4
183828|NCT00941655|583499|P2|Overall Study|received some chemo, 4 and 9 cycles|0
183829|NCT00941655|583500|P1|Overall Study|received some chemo, 4 and 9 cycles|2
183830|NCT00941720|583547|P1|Overall Study|ineligible|2
183831|NCT00941720|583547|P1|Overall Study|Insurance denied participation|11
183832|NCT00941720|583547|P1|Overall Study|Withdrawal by Subject|1
183833|NCT00941733|583555|P2|Overall Study|Protocol Violation|6
183834|NCT00941733|583556|P1|Overall Study|Protocol Violation|15
183835|NCT00941733|583555|P2|Overall Study|Lost to Follow-up|2
183836|NCT00941733|583556|P1|Overall Study|Lost to Follow-up|1
183837|NCT00941733|583555|P2|Overall Study|Adverse Event|4
183838|NCT00941733|583556|P1|Overall Study|Adverse Event|20
183839|NCT00941733|583555|P2|Overall Study|Withdrawal by Subject|6
183840|NCT00941733|583556|P1|Overall Study|Withdrawal by Subject|14
183841|NCT00941733|583555|P2|Overall Study|Death|10
183842|NCT00941733|583556|P1|Overall Study|Death|24
183843|NCT00950807|583596|P10|Treatment Period 3|Adverse Event|0
183844|NCT00950807|583597|P9|Treatment Period 3|Adverse Event|0
183845|NCT00950807|583598|P8|Treatment Period 3|Adverse Event|0
183846|NCT00950807|583599|P7|Treatment Period 3|Adverse Event|1
183847|NCT00950807|583600|P6|Treatment Period 3|Adverse Event|0
183848|NCT00950807|583601|P5|Treatment Period 3|Adverse Event|0
183849|NCT00950807|583602|P4|Treatment Period 3|Adverse Event|0
183850|NCT00950807|583603|P3|Treatment Period 3|Adverse Event|0
183851|NCT00950807|583604|P2|Treatment Period 3|Adverse Event|0
183852|NCT00950807|583605|P1|Treatment Period 3|Adverse Event|0
183853|NCT00950807|583596|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
183854|NCT00950807|583597|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
183855|NCT00950807|583598|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
183856|NCT00950807|583599|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
183857|NCT00950807|583600|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
183858|NCT00950807|583601|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
183859|NCT00950807|583602|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
183860|NCT00950807|583603|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
183861|NCT00950807|583604|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
183862|NCT00950807|583605|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
183863|NCT00950807|583596|P10|Treatment Period 3|Withdrawal by Subject|1
183864|NCT00950807|583597|P9|Treatment Period 3|Withdrawal by Subject|0
183865|NCT00950807|583598|P8|Treatment Period 3|Withdrawal by Subject|0
183866|NCT00950807|583599|P7|Treatment Period 3|Withdrawal by Subject|0
183867|NCT00950807|583600|P6|Treatment Period 3|Withdrawal by Subject|0
183868|NCT00950807|583601|P5|Treatment Period 3|Withdrawal by Subject|0
183869|NCT00950807|583602|P4|Treatment Period 3|Withdrawal by Subject|0
183870|NCT00950807|583603|P3|Treatment Period 3|Withdrawal by Subject|0
183871|NCT00950807|583604|P2|Treatment Period 3|Withdrawal by Subject|0
183872|NCT00950807|583605|P1|Treatment Period 3|Withdrawal by Subject|0
183873|NCT00950807|583596|P10|Washout Period 2|Adverse Event|0
183874|NCT00950807|583597|P9|Washout Period 2|Adverse Event|0
183875|NCT00950807|583598|P8|Washout Period 2|Adverse Event|0
183876|NCT00950807|583599|P7|Washout Period 2|Adverse Event|0
183877|NCT00950807|583600|P6|Washout Period 2|Adverse Event|0
183878|NCT00950807|583601|P5|Washout Period 2|Adverse Event|0
183879|NCT00950807|583602|P4|Washout Period 2|Adverse Event|1
183880|NCT00950807|583603|P3|Washout Period 2|Adverse Event|0
183881|NCT00950807|583604|P2|Washout Period 2|Adverse Event|0
183882|NCT00950807|583605|P1|Washout Period 2|Adverse Event|3
183883|NCT00950807|583596|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
183884|NCT00950807|583597|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
183885|NCT00950807|583598|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
183886|NCT00950807|583599|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
183887|NCT00950807|583600|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
183888|NCT00950807|583601|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
183889|NCT00950807|583602|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
183890|NCT00950807|583603|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
183891|NCT00950807|583604|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
183892|NCT00950807|583605|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
183893|NCT00950807|583596|P10|Washout Period 2|Lack of Efficacy|0
183894|NCT00950807|583597|P9|Washout Period 2|Lack of Efficacy|0
183895|NCT00950807|583598|P8|Washout Period 2|Lack of Efficacy|0
183896|NCT00950807|583599|P7|Washout Period 2|Lack of Efficacy|0
183897|NCT00950807|583600|P6|Washout Period 2|Lack of Efficacy|0
183898|NCT00950807|583601|P5|Washout Period 2|Lack of Efficacy|0
183899|NCT00950807|583602|P4|Washout Period 2|Lack of Efficacy|0
183900|NCT00950807|583603|P3|Washout Period 2|Lack of Efficacy|0
183901|NCT00950807|583604|P2|Washout Period 2|Lack of Efficacy|0
183902|NCT00950807|583605|P1|Washout Period 2|Lack of Efficacy|1
183903|NCT00950807|583596|P10|Treatment Period 2|Adverse Event|0
183904|NCT00950807|583597|P9|Treatment Period 2|Adverse Event|0
183905|NCT00950807|583598|P8|Treatment Period 2|Adverse Event|1
183906|NCT00950807|583599|P7|Treatment Period 2|Adverse Event|0
183907|NCT00950807|583600|P6|Treatment Period 2|Adverse Event|1
183908|NCT00950807|583601|P5|Treatment Period 2|Adverse Event|0
183909|NCT00950807|583602|P4|Treatment Period 2|Adverse Event|1
183910|NCT00950807|583603|P3|Treatment Period 2|Adverse Event|0
183911|NCT00950807|583604|P2|Treatment Period 2|Adverse Event|1
183912|NCT00950807|583605|P1|Treatment Period 2|Adverse Event|0
183913|NCT00950807|583596|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
183914|NCT00950807|583597|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
183915|NCT00950807|583598|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
183916|NCT00950807|583599|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
183917|NCT00950807|583600|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
183918|NCT00950807|583601|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
183919|NCT00950807|583602|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
183920|NCT00950807|583603|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
183921|NCT00950807|583604|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
183922|NCT00950807|583605|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
183923|NCT00950807|583596|P10|Treatment Period 2|Withdrawal by Subject|0
183924|NCT00950807|583597|P9|Treatment Period 2|Withdrawal by Subject|0
183925|NCT00950807|583598|P8|Treatment Period 2|Withdrawal by Subject|2
183926|NCT00950807|583599|P7|Treatment Period 2|Withdrawal by Subject|1
183927|NCT00950807|583600|P6|Treatment Period 2|Withdrawal by Subject|0
183928|NCT00950807|583601|P5|Treatment Period 2|Withdrawal by Subject|0
183929|NCT00950807|583602|P4|Treatment Period 2|Withdrawal by Subject|0
183930|NCT00950807|583603|P3|Treatment Period 2|Withdrawal by Subject|0
183931|NCT00950807|583604|P2|Treatment Period 2|Withdrawal by Subject|0
183932|NCT00950807|583605|P1|Treatment Period 2|Withdrawal by Subject|0
183933|NCT00950807|583596|P10|Treatment Period 2|Lack of Efficacy|0
183934|NCT00950807|583597|P9|Treatment Period 2|Lack of Efficacy|0
183935|NCT00950807|583598|P8|Treatment Period 2|Lack of Efficacy|0
183936|NCT00950807|583599|P7|Treatment Period 2|Lack of Efficacy|0
183937|NCT00950807|583600|P6|Treatment Period 2|Lack of Efficacy|0
183938|NCT00950807|583601|P5|Treatment Period 2|Lack of Efficacy|0
183939|NCT00950807|583602|P4|Treatment Period 2|Lack of Efficacy|0
183940|NCT00950807|583603|P3|Treatment Period 2|Lack of Efficacy|0
183941|NCT00950807|583604|P2|Treatment Period 2|Lack of Efficacy|0
183942|NCT00950807|583605|P1|Treatment Period 2|Lack of Efficacy|1
183943|NCT00950807|583596|P10|Washout Period 1|Adverse Event|0
183944|NCT00950807|583597|P9|Washout Period 1|Adverse Event|0
183945|NCT00950807|583598|P8|Washout Period 1|Adverse Event|0
183946|NCT00950807|583599|P7|Washout Period 1|Adverse Event|0
183947|NCT00950807|583600|P6|Washout Period 1|Adverse Event|0
183948|NCT00950807|583601|P5|Washout Period 1|Adverse Event|1
183949|NCT00950807|583602|P4|Washout Period 1|Adverse Event|1
183950|NCT00950807|583603|P3|Washout Period 1|Adverse Event|0
183951|NCT00950807|583604|P2|Washout Period 1|Adverse Event|0
183952|NCT00950807|583605|P1|Washout Period 1|Adverse Event|2
183953|NCT00950807|583596|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
183954|NCT00950807|583597|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
183955|NCT00950807|583598|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
183956|NCT00950807|583599|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
183957|NCT00950807|583600|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
183958|NCT00950807|583601|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
183959|NCT00950807|583602|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
183960|NCT00950807|583603|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
183961|NCT00950807|583604|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
183962|NCT00950807|583605|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
183963|NCT00950807|583596|P10|Washout Period 1|Withdrawal by Subject|0
183964|NCT00950807|583597|P9|Washout Period 1|Withdrawal by Subject|1
183965|NCT00950807|583598|P8|Washout Period 1|Withdrawal by Subject|0
183966|NCT00950807|583599|P7|Washout Period 1|Withdrawal by Subject|0
183967|NCT00950807|583600|P6|Washout Period 1|Withdrawal by Subject|0
183968|NCT00950807|583601|P5|Washout Period 1|Withdrawal by Subject|0
183969|NCT00950807|583602|P4|Washout Period 1|Withdrawal by Subject|0
183970|NCT00950807|583603|P3|Washout Period 1|Withdrawal by Subject|0
183971|NCT00950807|583604|P2|Washout Period 1|Withdrawal by Subject|0
183972|NCT00950807|583605|P1|Washout Period 1|Withdrawal by Subject|0
183973|NCT00950807|583596|P10|Washout Period 1|Lack of Efficacy|0
183974|NCT00950807|583597|P9|Washout Period 1|Lack of Efficacy|0
183975|NCT00950807|583598|P8|Washout Period 1|Lack of Efficacy|0
183976|NCT00950807|583599|P7|Washout Period 1|Lack of Efficacy|1
183977|NCT00950807|583600|P6|Washout Period 1|Lack of Efficacy|0
183978|NCT00950807|583601|P5|Washout Period 1|Lack of Efficacy|0
183979|NCT00950807|583602|P4|Washout Period 1|Lack of Efficacy|0
183980|NCT00950807|583603|P3|Washout Period 1|Lack of Efficacy|0
183981|NCT00950807|583604|P2|Washout Period 1|Lack of Efficacy|0
183982|NCT00950807|583605|P1|Washout Period 1|Lack of Efficacy|0
183983|NCT00950807|583596|P10|Treatment Period 1|Adverse Event|0
183984|NCT00950807|583597|P9|Treatment Period 1|Adverse Event|0
183985|NCT00950807|583598|P8|Treatment Period 1|Adverse Event|0
183986|NCT00950807|583599|P7|Treatment Period 1|Adverse Event|0
183987|NCT00950807|583600|P6|Treatment Period 1|Adverse Event|1
183988|NCT00950807|583601|P5|Treatment Period 1|Adverse Event|0
183989|NCT00950807|583602|P4|Treatment Period 1|Adverse Event|0
183990|NCT00950807|583603|P3|Treatment Period 1|Adverse Event|0
183991|NCT00950807|583604|P2|Treatment Period 1|Adverse Event|0
183992|NCT00950807|583605|P1|Treatment Period 1|Adverse Event|0
183993|NCT00950807|583596|P10|Treatment Period 1|Withdrawal by Subject|0
183994|NCT00950807|583597|P9|Treatment Period 1|Withdrawal by Subject|1
183995|NCT00950807|583598|P8|Treatment Period 1|Withdrawal by Subject|0
183996|NCT00950807|583599|P7|Treatment Period 1|Withdrawal by Subject|0
183997|NCT00950807|583600|P6|Treatment Period 1|Withdrawal by Subject|0
183998|NCT00950807|583601|P5|Treatment Period 1|Withdrawal by Subject|1
183999|NCT00950807|583602|P4|Treatment Period 1|Withdrawal by Subject|0
184000|NCT00950807|583603|P3|Treatment Period 1|Withdrawal by Subject|0
184001|NCT00950807|583604|P2|Treatment Period 1|Withdrawal by Subject|0
184002|NCT00950807|583605|P1|Treatment Period 1|Withdrawal by Subject|1
184003|NCT00950807|583596|P10|Treatment Period 1|Lost to Follow-up|0
184004|NCT00950807|583597|P9|Treatment Period 1|Lost to Follow-up|0
184005|NCT00950807|583598|P8|Treatment Period 1|Lost to Follow-up|0
184006|NCT00950807|583599|P7|Treatment Period 1|Lost to Follow-up|0
184007|NCT00950807|583600|P6|Treatment Period 1|Lost to Follow-up|0
184008|NCT00950807|583601|P5|Treatment Period 1|Lost to Follow-up|0
184009|NCT00950807|583602|P4|Treatment Period 1|Lost to Follow-up|0
184010|NCT00950807|583603|P3|Treatment Period 1|Lost to Follow-up|1
184011|NCT00950807|583604|P2|Treatment Period 1|Lost to Follow-up|0
184012|NCT00950807|583605|P1|Treatment Period 1|Lost to Follow-up|0
184013|NCT00950807|583596|P10|Treatment Period 1|Protocol Violation|0
184014|NCT00950807|583597|P9|Treatment Period 1|Protocol Violation|0
184015|NCT00950807|583598|P8|Treatment Period 1|Protocol Violation|0
184016|NCT00950807|583599|P7|Treatment Period 1|Protocol Violation|0
184017|NCT00950807|583600|P6|Treatment Period 1|Protocol Violation|0
184018|NCT00950807|583601|P5|Treatment Period 1|Protocol Violation|0
184019|NCT00950807|583602|P4|Treatment Period 1|Protocol Violation|0
184020|NCT00950807|583603|P3|Treatment Period 1|Protocol Violation|0
184021|NCT00950807|583604|P2|Treatment Period 1|Protocol Violation|0
184022|NCT00950807|583605|P1|Treatment Period 1|Protocol Violation|1
184023|NCT00950807|583596|P10|Treatment Period 1|Lack of Efficacy|0
184024|NCT00950807|583597|P9|Treatment Period 1|Lack of Efficacy|0
184025|NCT00950807|583598|P8|Treatment Period 1|Lack of Efficacy|0
184026|NCT00950807|583599|P7|Treatment Period 1|Lack of Efficacy|0
184027|NCT00950807|583600|P6|Treatment Period 1|Lack of Efficacy|1
184028|NCT00950807|583601|P5|Treatment Period 1|Lack of Efficacy|0
184029|NCT00950807|583602|P4|Treatment Period 1|Lack of Efficacy|0
184030|NCT00950807|583603|P3|Treatment Period 1|Lack of Efficacy|0
184031|NCT00950807|583604|P2|Treatment Period 1|Lack of Efficacy|0
184032|NCT00950807|583605|P1|Treatment Period 1|Lack of Efficacy|1
184033|NCT00950859|583708|P2|Overall Study|Lost to Follow-up|3
184034|NCT00950859|583709|P1|Overall Study|Lost to Follow-up|0
184035|NCT00950859|583708|P2|Overall Study|Protocol Violation|1
184036|NCT00950859|583709|P1|Overall Study|Protocol Violation|1
184037|NCT00950859|583708|P2|Overall Study|Insufficient Viral Load Response|3
184038|NCT00950859|583709|P1|Overall Study|Insufficient Viral Load Response|12
184039|NCT00950859|583708|P2|Overall Study|Adverse Event|3
184040|NCT00950859|583709|P1|Overall Study|Adverse Event|3
184041|NCT00950872|583749|P1|Overall Study|Did not have surgery|2
184042|NCT00950872|583749|P1|Overall Study|Withdrawal by Subject|1
184043|NCT00950911|583758|P2|Overall Study|Poor performance status|1
184044|NCT00950911|583759|P1|Overall Study|Poor performance status|0
184045|NCT00950911|583758|P2|Overall Study|Noncompliance|0
184046|NCT00950911|583759|P1|Overall Study|Noncompliance|1
184047|NCT00950911|583758|P2|Overall Study|Ineligibility determined|0
184048|NCT00950911|583759|P1|Overall Study|Ineligibility determined|1
184049|NCT00950911|583758|P2|Overall Study|Administrative decision|1
184050|NCT00950911|583759|P1|Overall Study|Administrative decision|3
184051|NCT00950911|583758|P2|Overall Study|Consent withdrawn|3
184052|NCT00950911|583759|P1|Overall Study|Consent withdrawn|1
184053|NCT00950911|583758|P2|Overall Study|Disease progression|2
184054|NCT00950911|583759|P1|Overall Study|Disease progression|2
184055|NCT00950911|583758|P2|Overall Study|Death|6
184056|NCT00950911|583759|P1|Overall Study|Death|4
184057|NCT00950911|583758|P2|Overall Study|Adverse Event|2
184058|NCT00950911|583759|P1|Overall Study|Adverse Event|0
184059|NCT00950963|583786|P2|Overall Study|Lost to Follow-up|24
184060|NCT00950963|583787|P1|Overall Study|Lost to Follow-up|29
184061|NCT00951015|583805|P4|Overall Study|Ongoing|8
184062|NCT00951015|583806|P3|Overall Study|Ongoing|46
184063|NCT00951015|583807|P2|Overall Study|Ongoing|45
184064|NCT00951015|583808|P1|Overall Study|Ongoing|47
184065|NCT00951015|583805|P4|Overall Study|Withdrawal by Subject|2
184066|NCT00951015|583806|P3|Overall Study|Withdrawal by Subject|1
184067|NCT00951015|583807|P2|Overall Study|Withdrawal by Subject|1
184068|NCT00951015|583808|P1|Overall Study|Withdrawal by Subject|3
184069|NCT00951015|583805|P4|Overall Study|Lost to Follow-up|2
184070|NCT00951015|583806|P3|Overall Study|Lost to Follow-up|1
184071|NCT00951015|583807|P2|Overall Study|Lost to Follow-up|2
184072|NCT00951015|583808|P1|Overall Study|Lost to Follow-up|0
184073|NCT00951015|583805|P4|Overall Study|Protocol-Defined Stopping Criteria|1
184074|NCT00951015|583806|P3|Overall Study|Protocol-Defined Stopping Criteria|0
184075|NCT00951015|583807|P2|Overall Study|Protocol-Defined Stopping Criteria|0
184076|NCT00951015|583808|P1|Overall Study|Protocol-Defined Stopping Criteria|0
184077|NCT00951015|583805|P4|Overall Study|Protocol Violation|0
184078|NCT00951015|583806|P3|Overall Study|Protocol Violation|1
184079|NCT00951015|583807|P2|Overall Study|Protocol Violation|1
184080|NCT00951015|583808|P1|Overall Study|Protocol Violation|1
184081|NCT00951015|583805|P4|Overall Study|Lack of Efficacy|0
184082|NCT00951015|583806|P3|Overall Study|Lack of Efficacy|0
184083|NCT00951015|583807|P2|Overall Study|Lack of Efficacy|1
184084|NCT00951015|583808|P1|Overall Study|Lack of Efficacy|1
184085|NCT00951015|583805|P4|Overall Study|Adverse Event|5
184086|NCT00951015|583806|P3|Overall Study|Adverse Event|2
184087|NCT00951015|583807|P2|Overall Study|Adverse Event|1
184088|NCT00951015|583808|P1|Overall Study|Adverse Event|1
184089|NCT00952419|583933|P3|Overall Study|Withdrawal by Subject|0
184090|NCT00952419|583934|P2|Overall Study|Withdrawal by Subject|3
184091|NCT00952419|583935|P1|Overall Study|Withdrawal by Subject|1
184092|NCT00952419|583933|P3|Overall Study|Protocol Violation|0
184093|NCT00952419|583934|P2|Overall Study|Protocol Violation|7
184094|NCT00952419|583935|P1|Overall Study|Protocol Violation|3
184095|NCT00952419|583933|P3|Overall Study|Adverse Event|0
184096|NCT00952419|583934|P2|Overall Study|Adverse Event|0
184097|NCT00952419|583935|P1|Overall Study|Adverse Event|2
184098|NCT00952484|583970|P3|Overall Study|Withdrawal by Subject|0
184099|NCT00952484|583971|P2|Overall Study|Withdrawal by Subject|1
184100|NCT00952484|583972|P1|Overall Study|Withdrawal by Subject|0
184101|NCT00952523|583996|P1|Overall Study|Withdrawal by Subject|7
184102|NCT00952588|584004|P2|Overall Study|Lack of Efficacy|2
184103|NCT00952588|584005|P1|Overall Study|Lack of Efficacy|2
184104|NCT00952588|584004|P2|Overall Study|Physician Decision|1
184105|NCT00952588|584005|P1|Overall Study|Physician Decision|0
184106|NCT00952588|584004|P2|Overall Study|Lost to Follow-up|0
184107|NCT00952588|584005|P1|Overall Study|Lost to Follow-up|2
184108|NCT00952588|584004|P2|Overall Study|Adverse Event|3
184109|NCT00952588|584005|P1|Overall Study|Adverse Event|2
184110|NCT00952588|584004|P2|Overall Study|Withdrawal by Subject|5
184111|NCT00952588|584005|P1|Overall Study|Withdrawal by Subject|2
184112|NCT00952588|584004|P2|Overall Study|Death|13
184113|NCT00952588|584005|P1|Overall Study|Death|28
184114|NCT00952614|584023|P1|Overall Study|other reason|1
184115|NCT00952614|584023|P1|Overall Study|Lost to Follow-up|3
184116|NCT00952614|584023|P1|Overall Study|Death|3
184117|NCT00952705|584056|P3|Overall Study|Exclusion criteria not met pre dose|0
184118|NCT00952705|584057|P2|Overall Study|Exclusion criteria not met pre dose|1
184119|NCT00952705|584058|P1|Overall Study|Exclusion criteria not met pre dose|0
184120|NCT00952705|584056|P3|Overall Study|Incarcerated post dose|0
184121|NCT00952705|584057|P2|Overall Study|Incarcerated post dose|0
184122|NCT00952705|584058|P1|Overall Study|Incarcerated post dose|5
184123|NCT00952705|584056|P3|Overall Study|Death|0
184124|NCT00952705|584057|P2|Overall Study|Death|0
184125|NCT00952705|584058|P1|Overall Study|Death|2
184126|NCT00952705|584056|P3|Overall Study|Withdrawal by Subject|1
184127|NCT00952705|584057|P2|Overall Study|Withdrawal by Subject|1
184128|NCT00952705|584058|P1|Overall Study|Withdrawal by Subject|2
184129|NCT00952705|584056|P3|Overall Study|Lost to Follow-up|9
184130|NCT00952705|584057|P2|Overall Study|Lost to Follow-up|8
184131|NCT00952705|584058|P1|Overall Study|Lost to Follow-up|24
184132|NCT00952731|584122|P2|Overall Study|Drug supply expired|0
184133|NCT00952731|584123|P1|Overall Study|Drug supply expired|1
184134|NCT00952822|584139|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
184135|NCT00952822|584140|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
184136|NCT00952822|584141|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
184137|NCT00952822|584142|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
184138|NCT00952822|584139|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
184139|NCT00952822|584140|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
184140|NCT00952822|584141|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
184141|NCT00952822|584142|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
184142|NCT00952848|584172|P1|Overall Study|Withdrawal by Subject|4
184143|NCT00953017|584183|P4|Overall Study|Brown stool prior to procedure|0
184144|NCT00953017|584184|P3|Overall Study|Brown stool prior to procedure|1
184145|NCT00953017|584185|P2|Overall Study|Brown stool prior to procedure|0
184146|NCT00953017|584186|P1|Overall Study|Brown stool prior to procedure|0
184147|NCT00953017|584183|P4|Overall Study|Procedure incomplete due to pain/looping|1
184148|NCT00953017|584184|P3|Overall Study|Procedure incomplete due to pain/looping|0
184149|NCT00953017|584185|P2|Overall Study|Procedure incomplete due to pain/looping|1
184150|NCT00953017|584186|P1|Overall Study|Procedure incomplete due to pain/looping|0
184151|NCT00953017|584183|P4|Overall Study|Incomplete data|0
184152|NCT00953017|584184|P3|Overall Study|Incomplete data|0
184153|NCT00953017|584185|P2|Overall Study|Incomplete data|1
184154|NCT00953017|584186|P1|Overall Study|Incomplete data|1
184155|NCT00953017|584183|P4|Overall Study|DId not show up for colonoscopy|4
184156|NCT00953017|584184|P3|Overall Study|DId not show up for colonoscopy|5
184157|NCT00953017|584185|P2|Overall Study|DId not show up for colonoscopy|4
184158|NCT00953017|584186|P1|Overall Study|DId not show up for colonoscopy|4
184159|NCT00953043|584210|P2|Overall Study|Physician Decision|2
184160|NCT00953043|584211|P1|Overall Study|Physician Decision|0
184161|NCT00953043|584210|P2|Overall Study|Withdrawal by Subject|0
184162|NCT00953043|584211|P1|Overall Study|Withdrawal by Subject|4
184163|NCT00953056|584237|P6|Overall Study|Serious Adverse Event|1
184164|NCT00953056|584238|P5|Overall Study|Serious Adverse Event|0
184165|NCT00953056|584239|P4|Overall Study|Serious Adverse Event|0
184166|NCT00953056|584240|P3|Overall Study|Serious Adverse Event|0
184167|NCT00953056|584241|P2|Overall Study|Serious Adverse Event|0
184168|NCT00953056|584242|P1|Overall Study|Serious Adverse Event|0
184169|NCT00953056|584237|P6|Overall Study|Withdrew Consent|3
184170|NCT00953056|584238|P5|Overall Study|Withdrew Consent|2
184171|NCT00953056|584239|P4|Overall Study|Withdrew Consent|0
184172|NCT00953056|584240|P3|Overall Study|Withdrew Consent|0
184173|NCT00953056|584241|P2|Overall Study|Withdrew Consent|0
184174|NCT00953056|584242|P1|Overall Study|Withdrew Consent|0
184175|NCT00953147|584292|P3|Overall Study|Other|13
184176|NCT00953147|584293|P2|Overall Study|Other|11
184177|NCT00953147|584294|P1|Overall Study|Other|4
184178|NCT00953147|584292|P3|Overall Study|Physician Decision|3
184179|NCT00953147|584293|P2|Overall Study|Physician Decision|7
184180|NCT00953147|584294|P1|Overall Study|Physician Decision|2
184181|NCT00953147|584292|P3|Overall Study|Lost to Follow-up|4
184182|NCT00953147|584293|P2|Overall Study|Lost to Follow-up|9
184183|NCT00953147|584294|P1|Overall Study|Lost to Follow-up|8
184184|NCT00953147|584292|P3|Overall Study|Withdrawal by Subject|12
184185|NCT00953147|584293|P2|Overall Study|Withdrawal by Subject|15
184186|NCT00953147|584294|P1|Overall Study|Withdrawal by Subject|13
184187|NCT00953147|584292|P3|Overall Study|Protocol Violation|4
184188|NCT00953147|584293|P2|Overall Study|Protocol Violation|8
184189|NCT00953147|584294|P1|Overall Study|Protocol Violation|2
184190|NCT00953147|584292|P3|Overall Study|Adverse Event|6
184191|NCT00953147|584293|P2|Overall Study|Adverse Event|16
184192|NCT00953147|584294|P1|Overall Study|Adverse Event|8
184193|NCT00953160|584341|P1|Overall Study|Withdrawal by Subject|4
184194|NCT00953160|584341|P1|Overall Study|Lost to Follow-up|23
184195|NCT00953225|584349|P2|Overall Study|Withdrawal by Subject|0
184196|NCT00953225|584350|P1|Overall Study|Withdrawal by Subject|2
184197|NCT00953329|584365|P1|Overall Study|Lack of Efficacy|1
184198|NCT00953407|584374|P5|Overall Study|Lost to Follow-up|0
184199|NCT00953407|584375|P4|Overall Study|Lost to Follow-up|1
184200|NCT00953407|584376|P3|Overall Study|Lost to Follow-up|0
184201|NCT00953407|584377|P2|Overall Study|Lost to Follow-up|0
184202|NCT00953407|584378|P1|Overall Study|Lost to Follow-up|0
184203|NCT00953407|584374|P5|Overall Study|Failed inclusion criteria|1
184204|NCT00953407|584375|P4|Overall Study|Failed inclusion criteria|1
184205|NCT00953407|584376|P3|Overall Study|Failed inclusion criteria|1
184206|NCT00953407|584377|P2|Overall Study|Failed inclusion criteria|1
184207|NCT00953407|584378|P1|Overall Study|Failed inclusion criteria|1
184208|NCT00953524|584394|P4|Overall Study|Withdrawal by Subject|0
184209|NCT00953524|584395|P3|Overall Study|Withdrawal by Subject|1
184210|NCT00953524|584396|P2|Overall Study|Withdrawal by Subject|4
184211|NCT00953524|584397|P1|Overall Study|Withdrawal by Subject|2
184212|NCT00953524|584394|P4|Overall Study|Lost to Follow-up|0
184213|NCT00953524|584395|P3|Overall Study|Lost to Follow-up|1
184214|NCT00953524|584396|P2|Overall Study|Lost to Follow-up|1
184215|NCT00953524|584397|P1|Overall Study|Lost to Follow-up|0
184216|NCT00953524|584394|P4|Overall Study|Protocol Violation|6
184217|NCT00953524|584395|P3|Overall Study|Protocol Violation|11
184218|NCT00953524|584396|P2|Overall Study|Protocol Violation|10
184219|NCT00953524|584397|P1|Overall Study|Protocol Violation|18
184220|NCT00953524|584394|P4|Overall Study|Adverse Event|2
184221|NCT00953524|584395|P3|Overall Study|Adverse Event|1
184222|NCT00953524|584396|P2|Overall Study|Adverse Event|0
184223|NCT00953524|584397|P1|Overall Study|Adverse Event|2
184224|NCT00953615|584435|P1|Overall Study|Adverse Event|1
184225|NCT00953667|584458|P1|Overall Study|poor venous access,unable to draw blood|4
184226|NCT00953667|584458|P1|Overall Study|Adverse Event|10
184227|NCT00953667|584458|P1|Overall Study|Withdrawal by Subject|63
184228|NCT00953667|584458|P1|Overall Study|Physician Decision|35
184229|NCT00953667|584458|P1|Overall Study|Lost to Follow-up|11
184230|NCT00953680|584463|P2|Period 1|Withdrawal by Subject|1
184231|NCT00953680|584464|P1|Period 1|Withdrawal by Subject|0
184232|NCT00953706|584478|P4|Part B (96-Week Open-Label Extension)|Unspecified|2
184233|NCT00953706|584479|P3|Part B (96-Week Open-Label Extension)|Unspecified|0
184234|NCT00953706|584480|P2|Part B (96-Week Open-Label Extension)|Unspecified|0
184235|NCT00953706|584481|P1|Part B (96-Week Open-Label Extension)|Unspecified|0
184236|NCT00953706|584478|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
184237|NCT00953706|584479|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
184238|NCT00953706|584480|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
184239|NCT00953706|584481|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
184240|NCT00953706|584478|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
184241|NCT00953706|584479|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
184242|NCT00953706|584480|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
184243|NCT00953706|584481|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
184244|NCT00953706|584478|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
184245|NCT00953706|584479|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
184246|NCT00953706|584480|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
184247|NCT00953706|584481|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
184248|NCT00953706|584478|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
184249|NCT00953706|584479|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
184250|NCT00953706|584480|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
184251|NCT00953706|584481|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
184252|NCT00953706|584478|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
184253|NCT00953706|584479|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
184254|NCT00953706|584480|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
184255|NCT00953706|584481|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
184256|NCT00953706|584478|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
184257|NCT00953706|584479|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
184258|NCT00953706|584480|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
184259|NCT00953706|584481|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
184260|NCT00953706|584478|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
184261|NCT00953706|584479|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
184262|NCT00953706|584480|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
184263|NCT00953706|584481|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
184264|NCT00953706|584478|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
184265|NCT00953706|584479|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
184266|NCT00953706|584480|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
184267|NCT00953706|584481|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
184268|NCT00953706|584478|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
184269|NCT00953706|584479|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
184270|NCT00953706|584480|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
184271|NCT00953706|584481|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
184272|NCT00953706|584478|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
184273|NCT00953706|584479|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
184274|NCT00953706|584480|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
184275|NCT00953706|584481|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
184276|NCT00953927|584573|P2|Overall Study|Other study discontinuation|1
184277|NCT00953927|584574|P1|Overall Study|Other study discontinuation|1
184278|NCT00953927|584573|P2|Overall Study|Death|4
184279|NCT00953927|584574|P1|Overall Study|Death|7
184280|NCT00953927|584573|P2|Overall Study|Withdrawal by Subject|25
184281|NCT00953927|584574|P1|Overall Study|Withdrawal by Subject|36
184282|NCT00953927|584573|P2|Overall Study|Lost to Follow-up|65
184283|NCT00953927|584574|P1|Overall Study|Lost to Follow-up|61
184284|NCT00954122|584597|P1|Overall Study|Safety Reason|1
184285|NCT00954122|584597|P1|Overall Study|Adverse Event|1
184286|NCT00954122|584597|P1|Overall Study|Withdrawal by Subject|5
184287|NCT00954421|584647|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
184288|NCT00954421|584647|P1|6 Months of DBS|Withdrawal by Subject|1
184289|NCT00954421|584647|P1|Screening|screen failures|3
184290|NCT00954447|584655|P2|Overall Study|Other|18
184291|NCT00954447|584656|P1|Overall Study|Other|21
184292|NCT00954447|584655|P2|Overall Study|Withdrawal by Subject|21
184293|NCT00954447|584656|P1|Overall Study|Withdrawal by Subject|26
184294|NCT00954447|584655|P2|Overall Study|Lost to Follow-up|14
184295|NCT00954447|584656|P1|Overall Study|Lost to Follow-up|8
184296|NCT00954447|584655|P2|Overall Study|Protocol Violation|7
184297|NCT00954447|584656|P1|Overall Study|Protocol Violation|5
184298|NCT00954447|584655|P2|Overall Study|Lack of Efficacy|3
184299|NCT00954447|584656|P1|Overall Study|Lack of Efficacy|17
184300|NCT00954447|584655|P2|Overall Study|Adverse Event|25
184301|NCT00954447|584656|P1|Overall Study|Adverse Event|33
184302|NCT00954512|584698|P6|Overall Study|Progression of Disease|1
184303|NCT00954512|584699|P5|Overall Study|Progression of Disease|1
184304|NCT00954512|584700|P4|Overall Study|Progression of Disease|1
184305|NCT00954512|584701|P3|Overall Study|Progression of Disease|0
184306|NCT00954512|584702|P2|Overall Study|Progression of Disease|1
184307|NCT00954512|584703|P1|Overall Study|Progression of Disease|2
184308|NCT00954512|584698|P6|Overall Study|Symptomatic Deterioration|0
184309|NCT00954512|584699|P5|Overall Study|Symptomatic Deterioration|2
184310|NCT00954512|584700|P4|Overall Study|Symptomatic Deterioration|0
184311|NCT00954512|584701|P3|Overall Study|Symptomatic Deterioration|0
184312|NCT00954512|584702|P2|Overall Study|Symptomatic Deterioration|1
184313|NCT00954512|584703|P1|Overall Study|Symptomatic Deterioration|0
184314|NCT00954512|584698|P6|Overall Study|Physician Decision|0
184315|NCT00954512|584699|P5|Overall Study|Physician Decision|0
184316|NCT00954512|584700|P4|Overall Study|Physician Decision|1
184317|NCT00954512|584701|P3|Overall Study|Physician Decision|0
184318|NCT00954512|584702|P2|Overall Study|Physician Decision|1
184319|NCT00954512|584703|P1|Overall Study|Physician Decision|0
184320|NCT00954512|584698|P6|Overall Study|Adverse Event|2
184321|NCT00954512|584699|P5|Overall Study|Adverse Event|1
184322|NCT00954512|584700|P4|Overall Study|Adverse Event|0
184323|NCT00954512|584701|P3|Overall Study|Adverse Event|0
184324|NCT00954512|584702|P2|Overall Study|Adverse Event|0
184325|NCT00954512|584703|P1|Overall Study|Adverse Event|0
184326|NCT00954512|584698|P6|Overall Study|Withdrawal by Subject|1
184327|NCT00954512|584699|P5|Overall Study|Withdrawal by Subject|0
184328|NCT00954512|584700|P4|Overall Study|Withdrawal by Subject|0
184329|NCT00954512|584701|P3|Overall Study|Withdrawal by Subject|0
184330|NCT00954512|584702|P2|Overall Study|Withdrawal by Subject|0
184331|NCT00954512|584703|P1|Overall Study|Withdrawal by Subject|0
184332|NCT00954538|584724|P6|Part III|Withdrawal by Subject|0
184333|NCT00954538|584725|P5|Part III|Withdrawal by Subject|1
184334|NCT00954538|584726|P4|Part III|Withdrawal by Subject|0
184335|NCT00954538|584727|P3|Part III|Withdrawal by Subject|0
184336|NCT00954538|584728|P2|Part III|Withdrawal by Subject|0
184337|NCT00954538|584729|P1|Part III|Withdrawal by Subject|0
184338|NCT00954707|584740|P1|Overall Study|Lost to Follow-up|33
184339|NCT00954707|584740|P1|Overall Study|Withdrawal by Subject|100
184340|NCT00954707|584740|P1|Overall Study|Death|34
184341|NCT00954733|584756|P1|Overall Study|blood gas machine did not work|1
184342|NCT00944645|584768|P2|Period 2|Withdrawal by Subject|6
184343|NCT00944645|584769|P1|Period 2|Withdrawal by Subject|7
184344|NCT00944645|584768|P2|Period 2|Lost to Follow-up|3
184345|NCT00944645|584769|P1|Period 2|Lost to Follow-up|0
184346|NCT00944645|584768|P2|Period 2|Adverse Event|0
184347|NCT00944645|584769|P1|Period 2|Adverse Event|1
184348|NCT00944697|584807|P2|Overall Study|Administrative|1
184349|NCT00944697|584808|P1|Overall Study|Administrative|1
184350|NCT00944697|584807|P2|Overall Study|Adverse Event|3
184351|NCT00944697|584808|P1|Overall Study|Adverse Event|0
184352|NCT00944697|584807|P2|Overall Study|Withdrawal by Subject|1
184353|NCT00944697|584808|P1|Overall Study|Withdrawal by Subject|1
184354|NCT00945243|584963|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
184355|NCT00945321|585001|P6|Period 4|Lost to Follow-up|1
184356|NCT00945321|585002|P5|Period 4|Lost to Follow-up|0
184357|NCT00945321|585003|P4|Period 4|Lost to Follow-up|0
184358|NCT00945321|585004|P3|Period 4|Lost to Follow-up|0
184359|NCT00945321|585005|P2|Period 4|Lost to Follow-up|0
184360|NCT00945321|585006|P1|Period 4|Lost to Follow-up|0
184361|NCT00945321|585001|P6|Period 1|Adverse Event|0
184362|NCT00945321|585002|P5|Period 1|Adverse Event|1
184363|NCT00945321|585003|P4|Period 1|Adverse Event|0
184364|NCT00945321|585004|P3|Period 1|Adverse Event|0
184365|NCT00945321|585005|P2|Period 1|Adverse Event|0
184366|NCT00945321|585006|P1|Period 1|Adverse Event|0
184367|NCT00945477|585037|P1|Overall Study|Withdrawal by Subject|1
184368|NCT00945477|585037|P1|Overall Study|Lack of Efficacy|2
184369|NCT00945477|585037|P1|Overall Study|Adverse Event|3
184370|NCT00945555|585042|P1|Overall Study|Other|1
184371|NCT00945555|585042|P1|Overall Study|Death|18
184372|NCT00945555|585042|P1|Overall Study|Participant continued treatment at home|1
184373|NCT00945555|585042|P1|Overall Study|Withdrawal by Subject|2
184374|NCT00945555|585042|P1|Overall Study|Worsening condition, intensive care unit|1
184375|NCT00945555|585042|P1|Overall Study|Referred to another hospital|5
184376|NCT00945815|585077|P1|Overall Study|Did not begin protocol therapy|1
184377|NCT00945815|585077|P1|Overall Study|Ineligible|3
184378|NCT00945815|585077|P1|Overall Study|Not protocol specified|1
184379|NCT00945815|585077|P1|Overall Study|Death|3
184380|NCT00945893|585097|P2|Overall Study|Withdrawal of consent|2
184381|NCT00945893|585098|P1|Overall Study|Withdrawal of consent|1
184382|NCT00945893|585097|P2|Overall Study|Lost to Follow-up|8
184383|NCT00945893|585098|P1|Overall Study|Lost to Follow-up|2
184384|NCT00945906|585162|P1|Overall Study|Moved to another country|2
184385|NCT00945906|585162|P1|Overall Study|Unable to return for last visit|2
184386|NCT00945906|585162|P1|Overall Study|Did not want to return for last visit|2
184387|NCT00945906|585162|P1|Overall Study|Withdrawal by Subject|1
184388|NCT00945945|585173|P2|Overall Study|Entry Criteria Not Met|1
184389|NCT00945945|585174|P1|Overall Study|Entry Criteria Not Met|0
184390|NCT00945945|585173|P2|Overall Study|Protocol Violation|2
184391|NCT00945945|585174|P1|Overall Study|Protocol Violation|4
184392|NCT00945945|585173|P2|Overall Study|Lack of Efficacy|2
184393|NCT00945945|585174|P1|Overall Study|Lack of Efficacy|6
184394|NCT00945945|585173|P2|Overall Study|Lost to Follow-up|5
184395|NCT00945945|585174|P1|Overall Study|Lost to Follow-up|4
184396|NCT00945945|585173|P2|Overall Study|Withdrawal by Subject|10
184397|NCT00945945|585174|P1|Overall Study|Withdrawal by Subject|7
184398|NCT00945945|585173|P2|Overall Study|Adverse Event|35
184399|NCT00945945|585174|P1|Overall Study|Adverse Event|15
184400|NCT00946088|585207|P2|Overall Study|Withdrawal by Subject|1
184401|NCT00946088|585208|P1|Overall Study|Withdrawal by Subject|0
184402|NCT00946101|585232|P2|Overall Study|Physician Decision|1
184403|NCT00946101|585233|P1|Overall Study|Physician Decision|0
184404|NCT00946101|585232|P2|Overall Study|Withdrawal of consent|0
184405|NCT00946101|585233|P1|Overall Study|Withdrawal of consent|2
184406|NCT00946101|585232|P2|Overall Study|Lost to Follow-up|1
184407|NCT00946101|585233|P1|Overall Study|Lost to Follow-up|2
184408|NCT00946114|585299|P2|Overall Study|Withdrawal by Subject|0
184409|NCT00946114|585300|P1|Overall Study|Withdrawal by Subject|2
184410|NCT00946114|585299|P2|Overall Study|Unspecified|0
184411|NCT00946114|585300|P1|Overall Study|Unspecified|1
184412|NCT00946114|585299|P2|Overall Study|Death|2
184413|NCT00946114|585300|P1|Overall Study|Death|5
184414|NCT00946296|585308|P2|Overall Study|Physician Decision|0
184415|NCT00946296|585309|P1|Overall Study|Physician Decision|3
184416|NCT00946309|585317|P2|Overall Study|Procedure cancelled/discontinued|3
184417|NCT00946309|585318|P1|Overall Study|Procedure cancelled/discontinued|0
184418|NCT00946309|585317|P2|Overall Study|Lost to Follow-up|1
184419|NCT00946309|585318|P1|Overall Study|Lost to Follow-up|0
184420|NCT00946309|585317|P2|Overall Study|Protocol Violation|0
184421|NCT00946309|585318|P1|Overall Study|Protocol Violation|1
184422|NCT00946322|585334|P1|Post-treatment|participant failure to follow up|2
184423|NCT00946322|585334|P1|Pre-treatment|participant failure to follow up|1
184424|NCT00946530|585367|P4|Overall Study|Physician Decision|1
184425|NCT00946530|585368|P3|Overall Study|Physician Decision|1
184426|NCT00946530|585369|P2|Overall Study|Physician Decision|1
184427|NCT00946530|585370|P1|Overall Study|Physician Decision|1
184428|NCT00946530|585367|P4|Overall Study|Withdrawal by Subject|3
184429|NCT00946530|585368|P3|Overall Study|Withdrawal by Subject|0
184430|NCT00946530|585369|P2|Overall Study|Withdrawal by Subject|3
184431|NCT00946530|585370|P1|Overall Study|Withdrawal by Subject|0
184432|NCT00946920|585386|P2|Overall Study|Miscellaneous reasons|3
184433|NCT00946920|585387|P1|Overall Study|Miscellaneous reasons|18
184434|NCT00946920|585386|P2|Overall Study|Protocol Violation|8
184435|NCT00946920|585387|P1|Overall Study|Protocol Violation|16
184436|NCT00946920|585386|P2|Overall Study|Adverse Event|14
184437|NCT00946920|585387|P1|Overall Study|Adverse Event|41
184438|NCT00946920|585386|P2|Overall Study|Physician Decision|2
184439|NCT00946920|585387|P1|Overall Study|Physician Decision|5
184440|NCT00946920|585386|P2|Overall Study|Lost to Follow-up|2
184441|NCT00946920|585387|P1|Overall Study|Lost to Follow-up|2
184442|NCT00946920|585386|P2|Overall Study|Withdrawal by Subject|15
184443|NCT00946920|585387|P1|Overall Study|Withdrawal by Subject|28
184444|NCT00946985|585402|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
184445|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
184446|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
184447|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
184448|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
184449|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
184450|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
184451|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
184452|NCT00946985|585402|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
184453|NCT00947011|585406|P1|Overall Study|Study was terminated,PI left institution|12
184454|NCT00947115|585417|P3|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|8
184455|NCT00947115|585418|P2|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|12
184456|NCT00947115|585419|P1|Year 0 (Month 0) - Year 10 (Month 120)|Lost to Follow-up|11
184457|NCT00947115|585417|P3|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|4
184458|NCT00947115|585418|P2|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|3
184459|NCT00947115|585419|P1|Year 0 (Month 0) - Year 10 (Month 120)|Withdrawal by Subject|1
184460|NCT00947115|585417|P3|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
184461|NCT00947115|585418|P2|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|0
184462|NCT00947115|585419|P1|Year 0 (Month 0) - Year 10 (Month 120)|Migrated from study area|2
184463|NCT00947115|585417|P3|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
184464|NCT00947115|585418|P2|Year 0 (Month 0) - Year 10 (Month 120)|Death|1
184465|NCT00947115|585419|P1|Year 0 (Month 0) - Year 10 (Month 120)|Death|0
184466|NCT00947115|585417|P3|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
184467|NCT00947115|585418|P2|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|2
184468|NCT00947115|585419|P1|Year 0 (Month 0) - Year 10 (Month 120)|Physician Decision|0
184469|NCT00947115|585417|P3|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|2
184470|NCT00947115|585418|P2|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|4
184471|NCT00947115|585419|P1|Year 0 (Month 0) - Year 10 (Month 120)|Missed reporting interval|3
184472|NCT00947154|585481|P1|Overall Study|Lost to Follow-up|1
184473|NCT00947349|585574|P4|Overall Study Standard of Care|not specified|1
184474|NCT00947349|585575|P3|Overall Study Standard of Care|not specified|0
184475|NCT00947349|585576|P2|Overall Study Standard of Care|not specified|0
184476|NCT00947349|585577|P1|Overall Study Standard of Care|not specified|0
184477|NCT00947349|585574|P4|Overall Study Standard of Care|Withdrawal by Subject|0
184478|NCT00947349|585575|P3|Overall Study Standard of Care|Withdrawal by Subject|1
184479|NCT00947349|585576|P2|Overall Study Standard of Care|Withdrawal by Subject|0
184480|NCT00947349|585577|P1|Overall Study Standard of Care|Withdrawal by Subject|0
184481|NCT00947349|585574|P4|Overall Study Standard of Care|Lack of Efficacy|1
184482|NCT00947349|585575|P3|Overall Study Standard of Care|Lack of Efficacy|1
184483|NCT00947349|585576|P2|Overall Study Standard of Care|Lack of Efficacy|0
184484|NCT00947349|585577|P1|Overall Study Standard of Care|Lack of Efficacy|0
184485|NCT00947349|585574|P4|Triple Treatment Combination Period|Adverse Event|0
184486|NCT00947349|585575|P3|Triple Treatment Combination Period|Adverse Event|0
184487|NCT00947349|585576|P2|Triple Treatment Combination Period|Adverse Event|1
184488|NCT00947349|585577|P1|Triple Treatment Combination Period|Adverse Event|0
184489|NCT00947427|585711|P2|Overall Study|Protocol Violation|1
184490|NCT00947427|585712|P1|Overall Study|Protocol Violation|0
184491|NCT00947427|585711|P2|Overall Study|Withdrawal by Subject|3
184492|NCT00947427|585712|P1|Overall Study|Withdrawal by Subject|1
184493|NCT00947531|585745|P2|Overall Study|Other|1
184494|NCT00947531|585746|P1|Overall Study|Other|1
184495|NCT00947531|585745|P2|Overall Study|Lack of Efficacy|0
184496|NCT00947531|585746|P1|Overall Study|Lack of Efficacy|1
184497|NCT00947531|585745|P2|Overall Study|Adverse Event|2
184498|NCT00947531|585746|P1|Overall Study|Adverse Event|2
184499|NCT00947531|585745|P2|Overall Study|Administrative Reason|1
184500|NCT00947531|585746|P1|Overall Study|Administrative Reason|0
184501|NCT00947531|585745|P2|Overall Study|Withdrawal by Subject|7
184502|NCT00947531|585746|P1|Overall Study|Withdrawal by Subject|10
184503|NCT00947544|585752|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
184504|NCT00947544|585753|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
184505|NCT00947856|585841|P2|Follow-up Period|Withdrawal by Subject|0
184506|NCT00947856|585842|P1|Follow-up Period|Withdrawal by Subject|1
184507|NCT00947856|585841|P2|Follow-up Period|Patient unavailable for site visits|0
184508|NCT00947856|585842|P1|Follow-up Period|Patient unavailable for site visits|1
184509|NCT00947856|585841|P2|Follow-up Period|Lost to Follow-up|0
184510|NCT00947856|585842|P1|Follow-up Period|Lost to Follow-up|7
184511|NCT00947856|585841|P2|Follow-up Period|Re-enrolled for Retreatment|3
184512|NCT00947856|585842|P1|Follow-up Period|Re-enrolled for Retreatment|2
184513|NCT00947856|585841|P2|Follow-up Period|Study Stopped by Sponsor|20
184514|NCT00947856|585842|P1|Follow-up Period|Study Stopped by Sponsor|40
184515|NCT00947856|585841|P2|Treatment Period|Withdrawal by Subject|1
184516|NCT00947856|585842|P1|Treatment Period|Withdrawal by Subject|12
184517|NCT00947856|585841|P2|Treatment Period|Study Stopped by Sponsor|4
184518|NCT00947856|585842|P1|Treatment Period|Study Stopped by Sponsor|4
184519|NCT00947856|585841|P2|Treatment Period|Physician Decision|6
184520|NCT00947856|585842|P1|Treatment Period|Physician Decision|14
184521|NCT00947856|585841|P2|Treatment Period|Adverse Event|9
184522|NCT00947856|585842|P1|Treatment Period|Adverse Event|15
184523|NCT00947856|585841|P2|Treatment Period|Progressive Disease|12
184524|NCT00947856|585842|P1|Treatment Period|Progressive Disease|33
184525|NCT00947882|585873|P4|Overall Study|Trial Terminated by Sponsor|70
184526|NCT00947882|585874|P3|Overall Study|Trial Terminated by Sponsor|62
184527|NCT00947882|585875|P2|Overall Study|Trial Terminated by Sponsor|61
184528|NCT00947882|585876|P1|Overall Study|Trial Terminated by Sponsor|62
184529|NCT00947882|585873|P4|Overall Study|Other/Unknown|6
184530|NCT00947882|585874|P3|Overall Study|Other/Unknown|3
184531|NCT00947882|585875|P2|Overall Study|Other/Unknown|13
184532|NCT00947882|585876|P1|Overall Study|Other/Unknown|10
184533|NCT00947882|585873|P4|Overall Study|Lost to Follow-up|0
184534|NCT00947882|585874|P3|Overall Study|Lost to Follow-up|1
184535|NCT00947882|585875|P2|Overall Study|Lost to Follow-up|2
184536|NCT00947882|585876|P1|Overall Study|Lost to Follow-up|0
184537|NCT00947882|585873|P4|Overall Study|Protocol Violation|0
184538|NCT00947882|585874|P3|Overall Study|Protocol Violation|1
184539|NCT00947882|585875|P2|Overall Study|Protocol Violation|0
184540|NCT00947882|585876|P1|Overall Study|Protocol Violation|0
184541|NCT00947882|585873|P4|Overall Study|Withdrawal by Subject|2
184542|NCT00947882|585874|P3|Overall Study|Withdrawal by Subject|8
184543|NCT00947882|585875|P2|Overall Study|Withdrawal by Subject|0
184544|NCT00947882|585876|P1|Overall Study|Withdrawal by Subject|2
184545|NCT00947882|585873|P4|Overall Study|Adverse Event|4
184546|NCT00947882|585874|P3|Overall Study|Adverse Event|4
184547|NCT00947882|585875|P2|Overall Study|Adverse Event|1
184548|NCT00947882|585876|P1|Overall Study|Adverse Event|0
184549|NCT00948064|585905|P3|Phase II|Withdrawal by Subject|0
184550|NCT00948064|585906|P2|Phase II|Withdrawal by Subject|1
184551|NCT00948064|585907|P1|Phase II|Withdrawal by Subject|0
184552|NCT00948064|585905|P3|Phase II|Physician Decision|1
184553|NCT00948064|585906|P2|Phase II|Physician Decision|0
184554|NCT00948064|585907|P1|Phase II|Physician Decision|0
184555|NCT00948064|585905|P3|Phase I|No treatment received|0
184556|NCT00948064|585906|P2|Phase I|No treatment received|0
184557|NCT00948064|585907|P1|Phase I|No treatment received|1
184558|NCT00948155|585944|P2|Washout 14 Days|Lost to Follow-up|2
184559|NCT00948155|585945|P1|Washout 14 Days|Lost to Follow-up|1
184560|NCT00948155|585944|P2|First Intervention 21 Days|Lost to Follow-up|2
184561|NCT00948155|585945|P1|First Intervention 21 Days|Lost to Follow-up|2
184562|NCT00948246|585965|P1|Overall Study|Withdrawal by Subject|1
184563|NCT00948246|585965|P1|Overall Study|Death|1
184564|NCT00948246|585965|P1|Overall Study|Adverse Event|11
184565|NCT00948246|585965|P1|Overall Study|Lost to Follow-up|11
184566|NCT00954941|585974|P2|Overall Study|Adverse Event|1
184567|NCT00954941|585975|P1|Overall Study|Adverse Event|0
184568|NCT00954941|585974|P2|Overall Study|Ineligible|2
184569|NCT00954941|585975|P1|Overall Study|Ineligible|2
184570|NCT00954941|585974|P2|Overall Study|Physician Decision|2
184571|NCT00954941|585975|P1|Overall Study|Physician Decision|2
184572|NCT00954941|585974|P2|Overall Study|Insurance Denial|2
184573|NCT00954941|585975|P1|Overall Study|Insurance Denial|2
184574|NCT00954941|585974|P2|Overall Study|Withdrawal by Subject|0
184575|NCT00954941|585975|P1|Overall Study|Withdrawal by Subject|1
184576|NCT00954941|585974|P2|Overall Study|Received treatment at home|0
184577|NCT00954941|585975|P1|Overall Study|Received treatment at home|1
184578|NCT00955110|586016|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
184579|NCT00955110|586016|P1|Treatment Phase|Non-compliance with study restrictions|1
184580|NCT00955110|586016|P1|Treatment Phase|Administrative reasons|2
184581|NCT00955110|586016|P1|Treatment Phase|Adverse Event|2
184582|NCT00955110|586016|P1|Qualification Phase|Did not meet eligibility criteria|24
184583|NCT00956293|586044|P3|Follow-up Period|Follow-up period was terminated.|0
184584|NCT00956293|586045|P2|Follow-up Period|Follow-up period was terminated.|32
184585|NCT00956293|586046|P1|Follow-up Period|Follow-up period was terminated.|20
184586|NCT00956293|586044|P3|Main Period (Randomization)|Adverse Event|0
184587|NCT00956293|586045|P2|Main Period (Randomization)|Adverse Event|15
184588|NCT00956293|586046|P1|Main Period (Randomization)|Adverse Event|0
184589|NCT00956293|586044|P3|Main Period (Randomization)|Lack of Efficacy|0
184590|NCT00956293|586045|P2|Main Period (Randomization)|Lack of Efficacy|10
184591|NCT00956293|586046|P1|Main Period (Randomization)|Lack of Efficacy|1
184592|NCT00956293|586044|P3|Main Period (Randomization)|Abnormal laboratory value|0
184593|NCT00956293|586045|P2|Main Period (Randomization)|Abnormal laboratory value|2
184594|NCT00956293|586046|P1|Main Period (Randomization)|Abnormal laboratory value|0
184595|NCT00956293|586044|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
184596|NCT00956293|586045|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
184597|NCT00956293|586046|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
184598|NCT00956293|586044|P3|Main Period (Pre-randomization)|Adverse Event|36
184599|NCT00956293|586045|P2|Main Period (Pre-randomization)|Adverse Event|0
184600|NCT00956293|586046|P1|Main Period (Pre-randomization)|Adverse Event|0
184601|NCT00956293|586044|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
184602|NCT00956293|586045|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
184603|NCT00956293|586046|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
184604|NCT00956293|586044|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
184605|NCT00956293|586045|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
184606|NCT00956293|586046|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
184607|NCT00956293|586044|P3|Main Period (Pre-randomization)|Graft loss|7
184608|NCT00956293|586045|P2|Main Period (Pre-randomization)|Graft loss|0
184609|NCT00956293|586046|P1|Main Period (Pre-randomization)|Graft loss|0
184610|NCT00956293|586044|P3|Main Period (Pre-randomization)|Administrative problems|6
184697|NCT00957372|586372|P1|PART II|Withdrawal by Subject|0
184611|NCT00956293|586045|P2|Main Period (Pre-randomization)|Administrative problems|0
184612|NCT00956293|586046|P1|Main Period (Pre-randomization)|Administrative problems|0
184613|NCT00956293|586044|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
184614|NCT00956293|586045|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
184615|NCT00956293|586046|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
184616|NCT00956293|586044|P3|Main Period (Pre-randomization)|Protocol Violation|1
184617|NCT00956293|586045|P2|Main Period (Pre-randomization)|Protocol Violation|0
184618|NCT00956293|586046|P1|Main Period (Pre-randomization)|Protocol Violation|0
184619|NCT00956293|586044|P3|Main Period (Pre-randomization)|Death|1
184620|NCT00956293|586045|P2|Main Period (Pre-randomization)|Death|0
184621|NCT00956293|586046|P1|Main Period (Pre-randomization)|Death|0
184622|NCT00956293|586044|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
184623|NCT00956293|586045|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
184624|NCT00956293|586046|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
184625|NCT00956592|586089|P2|Overall Study|Protocol Violation|3
184626|NCT00956592|586090|P1|Overall Study|Protocol Violation|1
184627|NCT00956813|586133|P2|Flaxseed and Placebo|Ineligible|1
184628|NCT00956813|586134|P1|Flaxseed and Placebo|Ineligible|3
184629|NCT00956813|586133|P2|Flaxseed and Placebo|Withdrawal by Subject|4
184630|NCT00956813|586134|P1|Flaxseed and Placebo|Withdrawal by Subject|5
184631|NCT00956839|586152|P3|Overall Study|Lost to Follow-up|3
184632|NCT00956839|586153|P2|Overall Study|Lost to Follow-up|0
184633|NCT00956839|586154|P1|Overall Study|Lost to Follow-up|3
184634|NCT00956943|586167|P2|Overall Study|Lost to Follow-up|10
184635|NCT00956943|586168|P1|Overall Study|Lost to Follow-up|9
184636|NCT00957008|586180|P4|Overall Study|Relocated; Family conflict|3
184637|NCT00957008|586181|P3|Overall Study|Relocated; Family conflict|1
184638|NCT00957008|586182|P2|Overall Study|Relocated; Family conflict|1
184639|NCT00957008|586183|P1|Overall Study|Relocated; Family conflict|4
184640|NCT00957008|586180|P4|Overall Study|Physician Decision|1
184641|NCT00957008|586181|P3|Overall Study|Physician Decision|1
184642|NCT00957008|586182|P2|Overall Study|Physician Decision|0
184643|NCT00957008|586183|P1|Overall Study|Physician Decision|1
184644|NCT00957008|586180|P4|Overall Study|Lost to Follow-up|4
184645|NCT00957008|586181|P3|Overall Study|Lost to Follow-up|3
184646|NCT00957008|586182|P2|Overall Study|Lost to Follow-up|1
184647|NCT00957008|586183|P1|Overall Study|Lost to Follow-up|3
184648|NCT00957008|586180|P4|Overall Study|Withdrawal by Subject|16
184649|NCT00957008|586181|P3|Overall Study|Withdrawal by Subject|12
184650|NCT00957008|586182|P2|Overall Study|Withdrawal by Subject|10
184651|NCT00957008|586183|P1|Overall Study|Withdrawal by Subject|13
184652|NCT00957021|586197|P1|Overall Study|Termination due to language issue|2
184653|NCT00957021|586197|P1|Overall Study|Surgery Cancelled|9
184654|NCT00957021|586197|P1|Overall Study|Site Termination by the 2 yr visit|16
184655|NCT00957021|586197|P1|Overall Study|Revised study component by 2 yr visit|8
184656|NCT00957021|586197|P1|Overall Study|No 2 yr ROM data|35
184657|NCT00957021|586197|P1|Overall Study|Withdrawal by Subject|34
184658|NCT00957021|586197|P1|Overall Study|Lost to Follow-up|8
184659|NCT00957021|586197|P1|Overall Study|Death|5
184660|NCT00957034|586209|P3|Overall Study|Withdrawal by Subject|0
184661|NCT00957034|586210|P2|Overall Study|Withdrawal by Subject|2
184662|NCT00957034|586211|P1|Overall Study|Withdrawal by Subject|0
184663|NCT00957034|586209|P3|Overall Study|Sponsor Terminated Study|5
184664|NCT00957034|586210|P2|Overall Study|Sponsor Terminated Study|1
184665|NCT00957034|586211|P1|Overall Study|Sponsor Terminated Study|6
184666|NCT00957034|586209|P3|Overall Study|Adverse Event|1
184667|NCT00957034|586210|P2|Overall Study|Adverse Event|1
184668|NCT00957034|586211|P1|Overall Study|Adverse Event|0
184669|NCT00957268|586296|P5|Overall Study|Voluntary Withdrawal|0
184670|NCT00957268|586297|P4|Overall Study|Voluntary Withdrawal|0
184671|NCT00957268|586298|P3|Overall Study|Voluntary Withdrawal|1
184672|NCT00957268|586299|P2|Overall Study|Voluntary Withdrawal|0
184673|NCT00957268|586300|P1|Overall Study|Voluntary Withdrawal|0
184674|NCT00957372|586369|P4|PART II|Patient non-compliance|4
184675|NCT00957372|586370|P3|PART II|Patient non-compliance|0
184676|NCT00957372|586371|P2|PART II|Patient non-compliance|0
184677|NCT00957372|586372|P1|PART II|Patient non-compliance|0
184678|NCT00957372|586369|P4|PART II|Adverse Event|10
184679|NCT00957372|586370|P3|PART II|Adverse Event|0
184680|NCT00957372|586371|P2|PART II|Adverse Event|0
184681|NCT00957372|586372|P1|PART II|Adverse Event|0
184682|NCT00957372|586369|P4|PART II|Not Know|20
184683|NCT00957372|586370|P3|PART II|Not Know|0
184684|NCT00957372|586371|P2|PART II|Not Know|0
184685|NCT00957372|586372|P1|PART II|Not Know|0
184686|NCT00957372|586369|P4|PART II|Pregnancy|1
184687|NCT00957372|586370|P3|PART II|Pregnancy|0
184688|NCT00957372|586371|P2|PART II|Pregnancy|0
184689|NCT00957372|586372|P1|PART II|Pregnancy|0
184690|NCT00957372|586369|P4|PART II|Physician Decision|1
184691|NCT00957372|586370|P3|PART II|Physician Decision|0
184692|NCT00957372|586371|P2|PART II|Physician Decision|0
184693|NCT00957372|586372|P1|PART II|Physician Decision|0
184694|NCT00957372|586369|P4|PART II|Withdrawal by Subject|8
184695|NCT00957372|586370|P3|PART II|Withdrawal by Subject|0
184696|NCT00957372|586371|P2|PART II|Withdrawal by Subject|0
184698|NCT00957372|586369|P4|PART I|Lost to Follow-up|0
184699|NCT00957372|586370|P3|PART I|Lost to Follow-up|1
184700|NCT00957372|586371|P2|PART I|Lost to Follow-up|0
184701|NCT00957372|586372|P1|PART I|Lost to Follow-up|0
184702|NCT00957424|586388|P1|Overall Study|Withdrawal by Subject|1
184703|NCT00957424|586388|P1|Overall Study|Protocol Violation|3
184704|NCT00957424|586388|P1|Overall Study|Lost to Follow-up|19
184705|NCT00957528|586398|P3|Overall Study|Withdrawal by Subject|1
184706|NCT00957528|586399|P2|Overall Study|Withdrawal by Subject|0
184707|NCT00957528|586400|P1|Overall Study|Withdrawal by Subject|0
184708|NCT00957528|586398|P3|Overall Study|Protocol Violation|0
184709|NCT00957528|586399|P2|Overall Study|Protocol Violation|1
184710|NCT00957528|586400|P1|Overall Study|Protocol Violation|0
184711|NCT00957580|586426|P3|Overall Study|Enrolled but not treated|0
184712|NCT00957580|586427|P2|Overall Study|Enrolled but not treated|1
184713|NCT00957580|586428|P1|Overall Study|Enrolled but not treated|0
184714|NCT00957580|586426|P3|Overall Study|Ongoing at data cut-off|0
184715|NCT00957580|586427|P2|Overall Study|Ongoing at data cut-off|1
184716|NCT00957580|586428|P1|Overall Study|Ongoing at data cut-off|0
184717|NCT00957658|586581|P1|Overall Study|Protocol Violation|5
184718|NCT00957658|586581|P1|Overall Study|surgery cancelled|2
184719|NCT00957658|586581|P1|Overall Study|unwilling/unable to return|2
184720|NCT00957658|586581|P1|Overall Study|Site termination|10
184721|NCT00957658|586581|P1|Overall Study|Incomplete 2 yr data|28
184722|NCT00957658|586581|P1|Overall Study|Revision|1
184723|NCT00957658|586581|P1|Overall Study|Withdrawal by Subject|12
184724|NCT00957658|586581|P1|Overall Study|Lost to Follow-up|4
184725|NCT00957658|586581|P1|Overall Study|Death|1
184726|NCT00957723|586612|P1|Overall Study|2yr ROM Data Not Evaluable|25
184727|NCT00957723|586612|P1|Overall Study|Intercurrent Illness|2
184728|NCT00957723|586612|P1|Overall Study|Investigative Site Terminated|55
184729|NCT00957723|586612|P1|Overall Study|Did not undergo surgery|3
184730|NCT00957723|586612|P1|Overall Study|Withdrawal by Subject|23
184731|NCT00957723|586612|P1|Overall Study|Lost to Follow-up|7
184732|NCT00957723|586612|P1|Overall Study|Revision/ Removal of Study Implant|3
184733|NCT00957723|586612|P1|Overall Study|Death|3
184734|NCT00957905|586625|P2|Part B|Protocol Violation|1
184735|NCT00957905|586626|P1|Part B|Protocol Violation|0
184736|NCT00957905|586625|P2|Part B|Death|1
184737|NCT00957905|586626|P1|Part B|Death|0
184738|NCT00957905|586625|P2|Part B|Physician Decision|1
184739|NCT00957905|586626|P1|Part B|Physician Decision|0
184740|NCT00957905|586625|P2|Part B|Not Treated|1
184741|NCT00957905|586626|P1|Part B|Not Treated|0
184742|NCT00957944|586634|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
184743|NCT00957944|586635|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
184744|NCT00957996|586671|P2|Overall Study|Noncompliance; Protocol Deviations|6
184745|NCT00957996|586672|P1|Overall Study|Noncompliance; Protocol Deviations|5
184746|NCT00957996|586671|P2|Overall Study|Missing|0
184747|NCT00957996|586672|P1|Overall Study|Missing|1
184748|NCT00957996|586671|P2|Overall Study|Influenza-related complication|1
184749|NCT00957996|586672|P1|Overall Study|Influenza-related complication|0
184750|NCT00957996|586671|P2|Overall Study|Physician Decision|1
184751|NCT00957996|586672|P1|Overall Study|Physician Decision|1
184752|NCT00957996|586671|P2|Overall Study|Adverse Event|1
184753|NCT00957996|586672|P1|Overall Study|Adverse Event|2
184754|NCT00957996|586671|P2|Overall Study|Withdrawal by Subject|2
184755|NCT00957996|586672|P1|Overall Study|Withdrawal by Subject|9
184756|NCT00957996|586671|P2|Overall Study|Lost to Follow-up|7
184757|NCT00957996|586672|P1|Overall Study|Lost to Follow-up|4
184758|NCT00957996|586671|P2|Overall Study|Death|10
184759|NCT00957996|586672|P1|Overall Study|Death|4
184760|NCT00958009|586702|P1|Overall Study|Subject found device difficult to use|1
184761|NCT00958009|586702|P1|Overall Study|Adverse Event|1
184762|NCT00958074|586718|P2|Overall Study|Withdrawal by Subject|1
184763|NCT00958074|586719|P1|Overall Study|Withdrawal by Subject|0
184764|NCT00958126|586733|P8|Overall Study|Other Reason|0
184765|NCT00958126|586734|P7|Overall Study|Other Reason|0
184766|NCT00958126|586735|P6|Overall Study|Other Reason|1
184767|NCT00958126|586736|P5|Overall Study|Other Reason|0
184768|NCT00958126|586737|P4|Overall Study|Other Reason|1
184769|NCT00958126|586738|P3|Overall Study|Other Reason|0
184770|NCT00958126|586739|P2|Overall Study|Other Reason|0
184771|NCT00958126|586740|P1|Overall Study|Other Reason|0
184772|NCT00958126|586733|P8|Overall Study|Sponsor/Investigator decision|0
184773|NCT00958126|586734|P7|Overall Study|Sponsor/Investigator decision|0
184774|NCT00958126|586735|P6|Overall Study|Sponsor/Investigator decision|0
184775|NCT00958126|586736|P5|Overall Study|Sponsor/Investigator decision|0
184776|NCT00958126|586737|P4|Overall Study|Sponsor/Investigator decision|1
184777|NCT00958126|586738|P3|Overall Study|Sponsor/Investigator decision|0
184778|NCT00958126|586739|P2|Overall Study|Sponsor/Investigator decision|0
184779|NCT00958126|586740|P1|Overall Study|Sponsor/Investigator decision|0
184780|NCT00958126|586733|P8|Overall Study|Lost to Follow-up|0
184781|NCT00958126|586734|P7|Overall Study|Lost to Follow-up|0
184782|NCT00958126|586735|P6|Overall Study|Lost to Follow-up|0
184783|NCT00958126|586736|P5|Overall Study|Lost to Follow-up|0
184784|NCT00958126|586737|P4|Overall Study|Lost to Follow-up|8
184785|NCT00958126|586738|P3|Overall Study|Lost to Follow-up|9
184786|NCT00958126|586739|P2|Overall Study|Lost to Follow-up|5
184787|NCT00958126|586740|P1|Overall Study|Lost to Follow-up|1
184788|NCT00958126|586733|P8|Overall Study|Moved away from study area|0
184789|NCT00958126|586734|P7|Overall Study|Moved away from study area|0
184790|NCT00958126|586735|P6|Overall Study|Moved away from study area|0
184791|NCT00958126|586736|P5|Overall Study|Moved away from study area|0
184792|NCT00958126|586737|P4|Overall Study|Moved away from study area|1
184793|NCT00958126|586738|P3|Overall Study|Moved away from study area|1
184794|NCT00958126|586739|P2|Overall Study|Moved away from study area|0
184795|NCT00958126|586740|P1|Overall Study|Moved away from study area|0
184796|NCT00958126|586733|P8|Overall Study|Withdrawal by Subject|0
184797|NCT00958126|586734|P7|Overall Study|Withdrawal by Subject|0
184798|NCT00958126|586735|P6|Overall Study|Withdrawal by Subject|0
184799|NCT00958126|586736|P5|Overall Study|Withdrawal by Subject|0
184800|NCT00958126|586737|P4|Overall Study|Withdrawal by Subject|0
184801|NCT00958126|586738|P3|Overall Study|Withdrawal by Subject|0
184802|NCT00958126|586739|P2|Overall Study|Withdrawal by Subject|2
184803|NCT00958126|586740|P1|Overall Study|Withdrawal by Subject|0
184804|NCT00958126|586733|P8|Overall Study|Serious Adverse Event|0
184805|NCT00958126|586734|P7|Overall Study|Serious Adverse Event|1
184806|NCT00958126|586735|P6|Overall Study|Serious Adverse Event|0
184807|NCT00958126|586736|P5|Overall Study|Serious Adverse Event|0
184808|NCT00958126|586737|P4|Overall Study|Serious Adverse Event|0
184809|NCT00958126|586738|P3|Overall Study|Serious Adverse Event|0
184810|NCT00958126|586739|P2|Overall Study|Serious Adverse Event|2
184811|NCT00958126|586740|P1|Overall Study|Serious Adverse Event|0
184812|NCT00958165|586810|P1|Overall Study|Not eligible|9
184813|NCT00958165|586810|P1|Overall Study|Lost to Follow-up|5
184814|NCT00958191|586814|P1|Overall Study|No 5 yr x-rays|56
184815|NCT00958191|586814|P1|Overall Study|Site termination|11
184816|NCT00958191|586814|P1|Overall Study|Revision of study device|4
184817|NCT00958191|586814|P1|Overall Study|Did not receive study device|1
184818|NCT00958191|586814|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
184819|NCT00958191|586814|P1|Overall Study|Inadequate 5 yr x-ray quality|10
184820|NCT00958191|586814|P1|Overall Study|Lost to Follow-up|5
184821|NCT00958191|586814|P1|Overall Study|Death|4
184822|NCT00958217|586829|P2|Overall Study|Inpatient hospitalization|1
184823|NCT00958217|586830|P1|Overall Study|Inpatient hospitalization|0
184824|NCT00958217|586829|P2|Overall Study|Moved out of area|1
184825|NCT00958217|586830|P1|Overall Study|Moved out of area|1
184826|NCT00958217|586829|P2|Overall Study|Lost to Follow-up|19
184827|NCT00958217|586830|P1|Overall Study|Lost to Follow-up|17
184828|NCT00958217|586829|P2|Overall Study|Withdrawal by Subject|3
184829|NCT00958217|586830|P1|Overall Study|Withdrawal by Subject|4
184830|NCT00958217|586829|P2|Overall Study|Death|1
184831|NCT00958217|586830|P1|Overall Study|Death|2
184832|NCT00958243|586847|P6|Overall Study|Lost to Follow-up|5
184833|NCT00958243|586848|P5|Overall Study|Lost to Follow-up|8
184834|NCT00958243|586849|P4|Overall Study|Lost to Follow-up|2
184835|NCT00958243|586850|P3|Overall Study|Lost to Follow-up|11
184836|NCT00958243|586851|P2|Overall Study|Lost to Follow-up|5
184837|NCT00958243|586852|P1|Overall Study|Lost to Follow-up|2
184838|NCT00958243|586847|P6|Overall Study|Withdrawal by Subject|5
184839|NCT00958243|586848|P5|Overall Study|Withdrawal by Subject|1
184840|NCT00958243|586849|P4|Overall Study|Withdrawal by Subject|1
184841|NCT00958243|586850|P3|Overall Study|Withdrawal by Subject|3
184842|NCT00958243|586851|P2|Overall Study|Withdrawal by Subject|1
184843|NCT00958243|586852|P1|Overall Study|Withdrawal by Subject|0
184844|NCT00958256|586908|P1|Overall Study|Adverse Event|3
184845|NCT00958347|586949|P1|Overall Study|study termination|135
184846|NCT00958347|586949|P1|Overall Study|revision/removal|10
184847|NCT00958347|586949|P1|Overall Study|Lost to Follow-up|15
184848|NCT00958347|586949|P1|Overall Study|Withdrawal by Subject|23
184849|NCT00958347|586949|P1|Overall Study|Death|43
184850|NCT00958360|586955|P2|Overall Study|Lost to Follow-up|1
184851|NCT00958360|586956|P1|Overall Study|Lost to Follow-up|0
184852|NCT00958360|586955|P2|Overall Study|Physician Decision|1
184853|NCT00958360|586956|P1|Overall Study|Physician Decision|2
184854|NCT00958360|586955|P2|Overall Study|Death|7
184855|NCT00958360|586956|P1|Overall Study|Death|6
184856|NCT00958360|586955|P2|Overall Study|Withdrawal by Subject|1
184857|NCT00958360|586956|P1|Overall Study|Withdrawal by Subject|3
184858|NCT00958438|586973|P3|Overall Study|Other than specified above|2
184859|NCT00958438|586974|P2|Overall Study|Other than specified above|3
184860|NCT00958438|586975|P1|Overall Study|Other than specified above|2
184861|NCT00958438|586973|P3|Overall Study|Physician Decision|1
184862|NCT00958438|586974|P2|Overall Study|Physician Decision|0
184863|NCT00958438|586975|P1|Overall Study|Physician Decision|1
184864|NCT00958438|586973|P3|Overall Study|Adverse Event|0
184865|NCT00958438|586974|P2|Overall Study|Adverse Event|3
184866|NCT00958438|586975|P1|Overall Study|Adverse Event|0
184867|NCT00958438|586973|P3|Overall Study|Withdrawal by Subject|1
184868|NCT00958438|586974|P2|Overall Study|Withdrawal by Subject|2
184869|NCT00958438|586975|P1|Overall Study|Withdrawal by Subject|4
184870|NCT00958438|586973|P3|Overall Study|Protocol Violation|2
184871|NCT00958438|586974|P2|Overall Study|Protocol Violation|2
184872|NCT00958438|586975|P1|Overall Study|Protocol Violation|3
184873|NCT00951171|587153|P2|Overall Study|Adverse Event|0
184874|NCT00951171|587154|P1|Overall Study|Adverse Event|2
184875|NCT00951275|587160|P1|Overall Study|Protocol Violation|1
184876|NCT00951275|587160|P1|Overall Study|Withdrawal by Subject|4
184877|NCT00951275|587160|P1|Overall Study|Adverse Event|7
184878|NCT00951275|587160|P1|Overall Study|Administrative Reason|1
184879|NCT00951379|587192|P2|Overall Study|Disease Progression|1
184880|NCT00951379|587193|P1|Overall Study|Disease Progression|0
184881|NCT00951379|587192|P2|Overall Study|Noncompliance|0
184882|NCT00951379|587193|P1|Overall Study|Noncompliance|1
184883|NCT00951379|587192|P2|Overall Study|Withdrawal by Subject|0
184884|NCT00951379|587193|P1|Overall Study|Withdrawal by Subject|1
184885|NCT00951379|587192|P2|Overall Study|Adverse Event|1
184886|NCT00951379|587193|P1|Overall Study|Adverse Event|4
184887|NCT00951483|587237|P2|Overall Study|Withdrawal by Subject|0
184888|NCT00951483|587238|P1|Overall Study|Withdrawal by Subject|15
184889|NCT00951483|587237|P2|Overall Study|Physician Decision|0
184890|NCT00951483|587238|P1|Overall Study|Physician Decision|4
184891|NCT00951509|587256|P1|Overall Study|Withdrawal by Subject|2
184892|NCT00951665|587278|P6|Phase 2a|Disease Progression|5
184893|NCT00951665|587279|P5|Phase 2a|Disease Progression|6
184894|NCT00951665|587280|P4|Phase 2a|Disease Progression|0
184895|NCT00951665|587281|P3|Phase 2a|Disease Progression|0
184896|NCT00951665|587282|P2|Phase 2a|Disease Progression|0
184897|NCT00951665|587283|P1|Phase 2a|Disease Progression|0
184898|NCT00951665|587278|P6|Phase 2a|Withdrawal by Subject|0
184899|NCT00951665|587279|P5|Phase 2a|Withdrawal by Subject|2
184900|NCT00951665|587280|P4|Phase 2a|Withdrawal by Subject|0
184901|NCT00951665|587281|P3|Phase 2a|Withdrawal by Subject|0
184902|NCT00951665|587282|P2|Phase 2a|Withdrawal by Subject|0
184903|NCT00951665|587283|P1|Phase 2a|Withdrawal by Subject|0
184904|NCT00951665|587278|P6|Phase 2a|Physician Decision|1
184905|NCT00951665|587279|P5|Phase 2a|Physician Decision|0
184906|NCT00951665|587280|P4|Phase 2a|Physician Decision|0
184907|NCT00951665|587281|P3|Phase 2a|Physician Decision|0
184908|NCT00951665|587282|P2|Phase 2a|Physician Decision|0
184909|NCT00951665|587283|P1|Phase 2a|Physician Decision|0
184910|NCT00951665|587278|P6|Phase 2a|Lost to Follow-up|0
184911|NCT00951665|587279|P5|Phase 2a|Lost to Follow-up|1
184912|NCT00951665|587280|P4|Phase 2a|Lost to Follow-up|0
184913|NCT00951665|587281|P3|Phase 2a|Lost to Follow-up|0
184914|NCT00951665|587282|P2|Phase 2a|Lost to Follow-up|0
184915|NCT00951665|587283|P1|Phase 2a|Lost to Follow-up|0
184916|NCT00951665|587278|P6|Phase 2a|Death|1
184917|NCT00951665|587279|P5|Phase 2a|Death|1
184918|NCT00951665|587280|P4|Phase 2a|Death|0
184919|NCT00951665|587281|P3|Phase 2a|Death|0
184920|NCT00951665|587282|P2|Phase 2a|Death|0
184921|NCT00951665|587283|P1|Phase 2a|Death|0
184922|NCT00951665|587278|P6|Phase 2a|Adverse Event|0
184923|NCT00951665|587279|P5|Phase 2a|Adverse Event|2
184924|NCT00951665|587280|P4|Phase 2a|Adverse Event|0
184925|NCT00951665|587281|P3|Phase 2a|Adverse Event|0
184926|NCT00951665|587282|P2|Phase 2a|Adverse Event|0
184927|NCT00951665|587283|P1|Phase 2a|Adverse Event|0
184928|NCT00951665|587278|P6|Phase 1b|Protocol Violation|0
184929|NCT00951665|587279|P5|Phase 1b|Protocol Violation|0
184930|NCT00951665|587280|P4|Phase 1b|Protocol Violation|0
184931|NCT00951665|587281|P3|Phase 1b|Protocol Violation|0
184932|NCT00951665|587282|P2|Phase 1b|Protocol Violation|0
184933|NCT00951665|587283|P1|Phase 1b|Protocol Violation|2
184934|NCT00951665|587278|P6|Phase 1b|Disease Progression|0
184935|NCT00951665|587279|P5|Phase 1b|Disease Progression|0
184936|NCT00951665|587280|P4|Phase 1b|Disease Progression|0
184937|NCT00951665|587281|P3|Phase 1b|Disease Progression|14
184938|NCT00951665|587282|P2|Phase 1b|Disease Progression|2
184939|NCT00951665|587283|P1|Phase 1b|Disease Progression|13
184940|NCT00951665|587278|P6|Phase 1b|Withdrawal by Subject|0
184941|NCT00951665|587279|P5|Phase 1b|Withdrawal by Subject|0
184942|NCT00951665|587280|P4|Phase 1b|Withdrawal by Subject|0
184943|NCT00951665|587281|P3|Phase 1b|Withdrawal by Subject|0
184944|NCT00951665|587282|P2|Phase 1b|Withdrawal by Subject|1
184945|NCT00951665|587283|P1|Phase 1b|Withdrawal by Subject|0
184946|NCT00951665|587278|P6|Phase 1b|Physician Decision|0
184947|NCT00951665|587279|P5|Phase 1b|Physician Decision|0
184948|NCT00951665|587280|P4|Phase 1b|Physician Decision|0
184949|NCT00951665|587281|P3|Phase 1b|Physician Decision|1
184950|NCT00951665|587282|P2|Phase 1b|Physician Decision|0
184951|NCT00951665|587283|P1|Phase 1b|Physician Decision|4
184952|NCT00951665|587278|P6|Phase 1b|Death|0
184953|NCT00951665|587279|P5|Phase 1b|Death|0
184954|NCT00951665|587280|P4|Phase 1b|Death|0
184955|NCT00951665|587281|P3|Phase 1b|Death|2
184956|NCT00951665|587282|P2|Phase 1b|Death|0
184957|NCT00951665|587283|P1|Phase 1b|Death|1
184958|NCT00951665|587278|P6|Phase 1b|Adverse Event|0
184959|NCT00951665|587279|P5|Phase 1b|Adverse Event|0
184960|NCT00951665|587280|P4|Phase 1b|Adverse Event|1
184961|NCT00951665|587281|P3|Phase 1b|Adverse Event|0
184962|NCT00951665|587282|P2|Phase 1b|Adverse Event|1
184963|NCT00951665|587283|P1|Phase 1b|Adverse Event|2
184964|NCT00951912|587431|P3|Overall Study|Other: Stroke|0
184965|NCT00951912|587432|P2|Overall Study|Other: Stroke|1
184966|NCT00951912|587433|P1|Overall Study|Other: Stroke|0
184967|NCT00951912|587431|P3|Overall Study|Other: Colon cancer|0
184968|NCT00951912|587432|P2|Overall Study|Other: Colon cancer|0
184969|NCT00951912|587433|P1|Overall Study|Other: Colon cancer|1
184970|NCT00951912|587431|P3|Overall Study|Other:Depression|0
184971|NCT00951912|587432|P2|Overall Study|Other:Depression|0
184972|NCT00951912|587433|P1|Overall Study|Other:Depression|1
184973|NCT00951912|587431|P3|Overall Study|Withdrawal by Subject|0
184974|NCT00951912|587432|P2|Overall Study|Withdrawal by Subject|1
184975|NCT00951912|587433|P1|Overall Study|Withdrawal by Subject|1
184976|NCT00951912|587431|P3|Overall Study|Physician Decision|1
184977|NCT00951912|587432|P2|Overall Study|Physician Decision|0
184978|NCT00951912|587433|P1|Overall Study|Physician Decision|1
184979|NCT00951912|587431|P3|Overall Study|Lost to Follow-up|0
184980|NCT00951912|587432|P2|Overall Study|Lost to Follow-up|2
184981|NCT00951912|587433|P1|Overall Study|Lost to Follow-up|2
184982|NCT00951912|587431|P3|Overall Study|Adverse Event|1
184983|NCT00951912|587432|P2|Overall Study|Adverse Event|1
184984|NCT00951912|587433|P1|Overall Study|Adverse Event|0
184985|NCT00951912|587431|P3|Overall Study|Lack of Efficacy|0
184986|NCT00951912|587432|P2|Overall Study|Lack of Efficacy|0
184987|NCT00951912|587433|P1|Overall Study|Lack of Efficacy|1
184988|NCT00952068|587483|P1|Overall Study|Withdrawal by Subject|4
184989|NCT00952068|587483|P1|Overall Study|Adverse Event|3
184990|NCT00952276|587535|P5|Overall Study|Withdrawal by Subject|0
184991|NCT00952276|587536|P4|Overall Study|Withdrawal by Subject|1
184992|NCT00952276|587537|P3|Overall Study|Withdrawal by Subject|0
184993|NCT00952276|587538|P2|Overall Study|Withdrawal by Subject|0
184994|NCT00952276|587539|P1|Overall Study|Withdrawal by Subject|1
184995|NCT00952289|587588|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
184996|NCT00952289|587589|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
184997|NCT00952289|587588|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
184998|NCT00952289|587589|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
184999|NCT00952289|587588|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
185000|NCT00952289|587589|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
185001|NCT00952289|587588|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
185002|NCT00952289|587589|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
185003|NCT00952289|587588|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
185004|NCT00952289|587589|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
185005|NCT00952289|587588|P2|All Participants|Data lost during site relocation|1
185006|NCT00952289|587589|P1|All Participants|Data lost during site relocation|0
185007|NCT00952289|587588|P2|All Participants|Withdrawal by Subject|10
185008|NCT00952289|587589|P1|All Participants|Withdrawal by Subject|1
185009|NCT00952289|587588|P2|All Participants|Disease progression|12
185010|NCT00952289|587589|P1|All Participants|Disease progression|3
185011|NCT00952289|587588|P2|All Participants|Adverse Event|8
185012|NCT00952289|587589|P1|All Participants|Adverse Event|8
185013|NCT00952289|587588|P2|All Participants|Death|9
185014|NCT00952289|587589|P1|All Participants|Death|9
185015|NCT00952341|587615|P2|Cycle 2|Progressive Disease|1
185016|NCT00952341|587616|P1|Cycle 2|Progressive Disease|0
185017|NCT00952341|587615|P2|Cycle 2|Physician Decision|1
185018|NCT00952341|587616|P1|Cycle 2|Physician Decision|1
185019|NCT00952341|587615|P2|Cycle 2|Lost to Follow-up|9
185020|NCT00952341|587616|P1|Cycle 2|Lost to Follow-up|6
185021|NCT00952341|587615|P2|Cycle 2|Protocol Violation|0
185022|NCT00952341|587616|P1|Cycle 2|Protocol Violation|1
185023|NCT00952341|587615|P2|Cycle 2|Withdrawal by Subject|1
185024|NCT00952341|587616|P1|Cycle 2|Withdrawal by Subject|1
185025|NCT00952341|587615|P2|Cycle 1|Physician Decision|1
185026|NCT00952341|587616|P1|Cycle 1|Physician Decision|0
185027|NCT00952341|587615|P2|Cycle 1|Lost to Follow-up|2
185028|NCT00952341|587616|P1|Cycle 1|Lost to Follow-up|11
185029|NCT00952341|587615|P2|Cycle 1|Protocol Violation|1
185030|NCT00952341|587616|P1|Cycle 1|Protocol Violation|2
185031|NCT00952341|587615|P2|Cycle 1|Withdrawal by Subject|8
185032|NCT00952341|587616|P1|Cycle 1|Withdrawal by Subject|3
185033|NCT00952341|587615|P2|Cycle 1|Adverse Event|1
185034|NCT00952341|587616|P1|Cycle 1|Adverse Event|4
185035|NCT00952367|587636|P1|Overall Study|Protocol Violation|3
185036|NCT00952367|587636|P1|Overall Study|Noncoordination|1
185037|NCT00952367|587636|P1|Overall Study|Withdrawal by Subject|2
185038|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
185039|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
185040|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
185041|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
185042|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
185043|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
185044|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
185045|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
185046|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
185047|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
185048|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
185049|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
185050|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
185051|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
185052|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
185053|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
185054|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
185055|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
185056|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
185057|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
185058|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
185059|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
185060|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
185061|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
185062|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
185063|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
185064|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
185065|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
185066|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
185067|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
185068|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
185069|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
185070|NCT00958568|587649|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
185071|NCT00958568|587650|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
185072|NCT00958568|587651|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
185073|NCT00958568|587652|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
185074|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
185075|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
185076|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
185077|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
185078|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
185079|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
185080|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
185081|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
185082|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
185083|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
185084|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
185085|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
185086|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
185087|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
185088|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
185089|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
185090|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
185091|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
185092|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
185093|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
185094|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
185095|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
185096|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
185097|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
185098|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
185099|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
185100|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
185101|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
185102|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
185103|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
185104|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
185105|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
185106|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
185107|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
185108|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
185109|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
185110|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
185111|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
185112|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
185113|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
185114|NCT00958568|587649|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
185115|NCT00958568|587650|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
185116|NCT00958568|587651|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
185117|NCT00958568|587652|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
185118|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
185119|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
185120|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
185121|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
185122|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
185123|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
185124|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
185125|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
185126|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
185127|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
185128|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
185129|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
185130|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
185131|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
185132|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
185133|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
185134|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
185135|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
185136|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
185137|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
185138|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
185139|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
185140|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
185141|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
185142|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
185143|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
185144|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
185145|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
185146|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
185147|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
185148|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
185149|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
185150|NCT00958568|587649|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
185151|NCT00958568|587650|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
185152|NCT00958568|587651|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
185153|NCT00958568|587652|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
185154|NCT00958776|587735|P2|Overall Study|Missing|1
185155|NCT00958776|587736|P1|Overall Study|Missing|1
185156|NCT00958776|587735|P2|Overall Study|Noncompliance; Protocol Deviations|3
185157|NCT00958776|587736|P1|Overall Study|Noncompliance; Protocol Deviations|2
185158|NCT00958776|587735|P2|Overall Study|Death|1
185159|NCT00958776|587736|P1|Overall Study|Death|2
185160|NCT00958776|587735|P2|Overall Study|Protocol Violation|1
185161|NCT00958776|587736|P1|Overall Study|Protocol Violation|1
185162|NCT00958776|587735|P2|Overall Study|Withdrawal by Subject|16
185163|NCT00958776|587736|P1|Overall Study|Withdrawal by Subject|7
185164|NCT00958776|587735|P2|Overall Study|Lost to Follow-up|6
185165|NCT00958776|587736|P1|Overall Study|Lost to Follow-up|2
185166|NCT00958776|587735|P2|Overall Study|Physician Decision|0
185167|NCT00958776|587736|P1|Overall Study|Physician Decision|1
185168|NCT00958776|587735|P2|Overall Study|Adverse Event|1
185169|NCT00958776|587736|P1|Overall Study|Adverse Event|0
185170|NCT00958789|587766|P1|Overall Study|Revision|8
185171|NCT00958789|587766|P1|Overall Study|Subject terminated|3
185172|NCT00958789|587766|P1|Overall Study|2 yr. Knee Society Score not calculable|2
185173|NCT00958789|587766|P1|Overall Study|No 2 yr. Knee Society Score data|12
185174|NCT00958789|587766|P1|Overall Study|Withdrawal by Subject|16
185175|NCT00958789|587766|P1|Overall Study|Lost to Follow-up|7
185176|NCT00958789|587766|P1|Overall Study|Death|3
185177|NCT00958828|587770|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
185178|NCT00958828|587771|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
185179|NCT00958828|587770|P2|Period 1, 1 Week of Wear|Randomization break|1
185180|NCT00958828|587771|P1|Period 1, 1 Week of Wear|Randomization break|0
185181|NCT00958841|587777|P1|Overall Study|Discontinued prior to M*|28
185182|NCT00958841|587777|P1|Overall Study|Completed M6/did not enter extension|27
185183|NCT00958841|587777|P1|Overall Study|Unsatisfactory therapeutic effect|22
185184|NCT00958841|587777|P1|Overall Study|Withdrawal by Subject|1
185185|NCT00958841|587777|P1|Overall Study|New cancer therapy|5
185186|NCT00958841|587777|P1|Overall Study|Adverse Event|8
185187|NCT00958841|587777|P1|Overall Study|Administrative problems|1
185188|NCT00958841|587777|P1|Overall Study|Abnormal test procedure result(s)|3
185189|NCT00958841|587777|P1|Overall Study|Abnormal laboratory value(s)|1
185190|NCT00958880|587797|P2|Overall Study|Lost to Follow-up|2
185191|NCT00958880|587798|P1|Overall Study|Lost to Follow-up|2
185192|NCT00958893|587806|P1|Overall Study|Study prematurely terminated|4
185193|NCT00962741|587810|P1|Overall Study|drug ineffective+prohibited drug taken|1
185194|NCT00962741|587810|P1|Overall Study|Lack of Efficacy|1
185195|NCT00962741|587810|P1|Overall Study|Withdrawal by Subject|1
185196|NCT00962741|587810|P1|Overall Study|Lost to Follow-up|2
185197|NCT00962741|587810|P1|Overall Study|Failed to return|3
185198|NCT00962780|587916|P2|Overall Study|Unspecified|1
185199|NCT00962780|587917|P1|Overall Study|Unspecified|0
185200|NCT00962780|587916|P2|Overall Study|Withdrawal by Subject|8
185201|NCT00962780|587917|P1|Overall Study|Withdrawal by Subject|1
185202|NCT00962780|587916|P2|Overall Study|Protocol Violation|4
185203|NCT00962780|587917|P1|Overall Study|Protocol Violation|9
185204|NCT00962780|587916|P2|Overall Study|Death|1
185205|NCT00962780|587917|P1|Overall Study|Death|0
185206|NCT00963235|588201|P1|Overall Study|Unspecified|1
185207|NCT00963235|588201|P1|Overall Study|Physician Decision|2
185208|NCT00963235|588201|P1|Overall Study|Adverse Event|5
185209|NCT00963235|588201|P1|Overall Study|Protocol Violation|7
185210|NCT00963235|588201|P1|Overall Study|Failed to return|9
185211|NCT00963235|588201|P1|Overall Study|Lost to Follow-up|14
185212|NCT00963235|588201|P1|Overall Study|Withdrawal by Subject|22
185213|NCT00963469|588264|P3|Overall Study|Site closed (local pollen Season ended)|3
185214|NCT00963469|588265|P2|Overall Study|Site closed (local pollen Season ended)|1
185215|NCT00963469|588266|P1|Overall Study|Site closed (local pollen Season ended)|4
185216|NCT00963469|588264|P3|Overall Study|Moved|0
185217|NCT00963469|588265|P2|Overall Study|Moved|0
185218|NCT00963469|588266|P1|Overall Study|Moved|1
185219|NCT00963469|588264|P3|Overall Study|Pre-randomization Adverse Event|0
185220|NCT00963469|588265|P2|Overall Study|Pre-randomization Adverse Event|2
185221|NCT00963469|588266|P1|Overall Study|Pre-randomization Adverse Event|1
185222|NCT00963469|588264|P3|Overall Study|Withdrawal by Subject|1
185223|NCT00963469|588265|P2|Overall Study|Withdrawal by Subject|1
185224|NCT00963469|588266|P1|Overall Study|Withdrawal by Subject|4
185225|NCT00963469|588264|P3|Overall Study|Protocol Violation|3
185226|NCT00963469|588265|P2|Overall Study|Protocol Violation|5
185227|NCT00963469|588266|P1|Overall Study|Protocol Violation|5
185228|NCT00963469|588264|P3|Overall Study|Lost to Follow-up|0
185229|NCT00963469|588265|P2|Overall Study|Lost to Follow-up|1
185230|NCT00963469|588266|P1|Overall Study|Lost to Follow-up|1
185231|NCT00963469|588264|P3|Overall Study|Lack of Efficacy|2
185232|NCT00963469|588265|P2|Overall Study|Lack of Efficacy|7
185233|NCT00963469|588266|P1|Overall Study|Lack of Efficacy|10
185234|NCT00963469|588264|P3|Overall Study|Adverse Event|1
185235|NCT00963469|588265|P2|Overall Study|Adverse Event|11
185236|NCT00963469|588266|P1|Overall Study|Adverse Event|15
185237|NCT00963599|588329|P4|Overall Study|Withdrawal by Subject|3
185238|NCT00963599|588330|P3|Overall Study|Withdrawal by Subject|3
185239|NCT00963599|588331|P2|Overall Study|Withdrawal by Subject|1
185240|NCT00963599|588332|P1|Overall Study|Withdrawal by Subject|2
185241|NCT00963599|588329|P4|Overall Study|Protocol Violation|4
185242|NCT00963599|588330|P3|Overall Study|Protocol Violation|3
185243|NCT00963599|588331|P2|Overall Study|Protocol Violation|2
185244|NCT00963599|588332|P1|Overall Study|Protocol Violation|2
185245|NCT00963599|588329|P4|Overall Study|Lost to Follow-up|1
185246|NCT00963599|588330|P3|Overall Study|Lost to Follow-up|1
185247|NCT00963599|588331|P2|Overall Study|Lost to Follow-up|1
185248|NCT00963599|588332|P1|Overall Study|Lost to Follow-up|0
185249|NCT00963599|588329|P4|Overall Study|Lack of Efficacy|4
185250|NCT00963599|588330|P3|Overall Study|Lack of Efficacy|1
185251|NCT00963599|588331|P2|Overall Study|Lack of Efficacy|2
185252|NCT00963599|588332|P1|Overall Study|Lack of Efficacy|0
185253|NCT00963599|588329|P4|Overall Study|Adverse Event|2
185254|NCT00963599|588330|P3|Overall Study|Adverse Event|1
185255|NCT00963599|588331|P2|Overall Study|Adverse Event|0
185256|NCT00963599|588332|P1|Overall Study|Adverse Event|2
185257|NCT00963807|588406|P1|Overall Study|Disease progression|15
185258|NCT00963807|588406|P1|Overall Study|Reaction to study chemotherapy regimen|1
185259|NCT00963807|588406|P1|Overall Study|Physician Decision|2
185260|NCT00963820|588415|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
185261|NCT00963820|588416|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
185262|NCT00963820|588417|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
185263|NCT00963820|588418|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
185264|NCT00963820|588419|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
185265|NCT00963820|588420|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
185266|NCT00963820|588421|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
185267|NCT00963820|588422|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
185268|NCT00963820|588423|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
185269|NCT00963820|588424|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
185270|NCT00963820|588425|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
185271|NCT00963820|588426|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
185272|NCT00963820|588415|P12|Expansion Phase|Withdrawal by Subject|1
185273|NCT00963820|588416|P11|Expansion Phase|Withdrawal by Subject|1
185274|NCT00963820|588417|P10|Expansion Phase|Withdrawal by Subject|0
185275|NCT00963820|588418|P9|Expansion Phase|Withdrawal by Subject|1
185276|NCT00963820|588419|P8|Expansion Phase|Withdrawal by Subject|0
185277|NCT00963820|588420|P7|Expansion Phase|Withdrawal by Subject|0
185278|NCT00963820|588421|P6|Expansion Phase|Withdrawal by Subject|0
185279|NCT00963820|588422|P5|Expansion Phase|Withdrawal by Subject|0
185280|NCT00963820|588423|P4|Expansion Phase|Withdrawal by Subject|0
185281|NCT00963820|588424|P3|Expansion Phase|Withdrawal by Subject|0
185282|NCT00963820|588425|P2|Expansion Phase|Withdrawal by Subject|0
185283|NCT00963820|588426|P1|Expansion Phase|Withdrawal by Subject|0
185284|NCT00963820|588415|P12|Expansion Phase|Adverse Event|0
185285|NCT00963820|588416|P11|Expansion Phase|Adverse Event|0
185286|NCT00963820|588417|P10|Expansion Phase|Adverse Event|3
185287|NCT00963820|588418|P9|Expansion Phase|Adverse Event|1
185288|NCT00963820|588419|P8|Expansion Phase|Adverse Event|0
185289|NCT00963820|588420|P7|Expansion Phase|Adverse Event|0
185290|NCT00963820|588421|P6|Expansion Phase|Adverse Event|0
185291|NCT00963820|588422|P5|Expansion Phase|Adverse Event|0
185292|NCT00963820|588423|P4|Expansion Phase|Adverse Event|0
185293|NCT00963820|588424|P3|Expansion Phase|Adverse Event|0
185294|NCT00963820|588425|P2|Expansion Phase|Adverse Event|0
185295|NCT00963820|588426|P1|Expansion Phase|Adverse Event|0
185296|NCT00963820|588415|P12|Expansion Phase|Progressive Disease|2
185297|NCT00963820|588416|P11|Expansion Phase|Progressive Disease|4
185298|NCT00963820|588417|P10|Expansion Phase|Progressive Disease|6
185299|NCT00963820|588418|P9|Expansion Phase|Progressive Disease|8
185300|NCT00963820|588419|P8|Expansion Phase|Progressive Disease|0
185301|NCT00963820|588420|P7|Expansion Phase|Progressive Disease|0
185302|NCT00963820|588421|P6|Expansion Phase|Progressive Disease|0
185303|NCT00963820|588422|P5|Expansion Phase|Progressive Disease|0
185304|NCT00963820|588423|P4|Expansion Phase|Progressive Disease|0
185305|NCT00963820|588424|P3|Expansion Phase|Progressive Disease|0
185306|NCT00963820|588425|P2|Expansion Phase|Progressive Disease|0
185307|NCT00963820|588426|P1|Expansion Phase|Progressive Disease|0
185308|NCT00963820|588415|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185309|NCT00963820|588416|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185310|NCT00963820|588417|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185311|NCT00963820|588418|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185312|NCT00963820|588419|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185313|NCT00963820|588420|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
185314|NCT00963820|588421|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185315|NCT00963820|588422|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185316|NCT00963820|588423|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185317|NCT00963820|588424|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185318|NCT00963820|588425|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185319|NCT00963820|588426|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
185320|NCT00963820|588415|P12|Dose Escalation Phase|Withdrawal by Subject|0
185321|NCT00963820|588416|P11|Dose Escalation Phase|Withdrawal by Subject|0
185322|NCT00963820|588417|P10|Dose Escalation Phase|Withdrawal by Subject|0
185323|NCT00963820|588418|P9|Dose Escalation Phase|Withdrawal by Subject|0
185324|NCT00963820|588419|P8|Dose Escalation Phase|Withdrawal by Subject|2
185325|NCT00963820|588420|P7|Dose Escalation Phase|Withdrawal by Subject|1
185326|NCT00963820|588421|P6|Dose Escalation Phase|Withdrawal by Subject|0
185327|NCT00963820|588422|P5|Dose Escalation Phase|Withdrawal by Subject|0
185328|NCT00963820|588423|P4|Dose Escalation Phase|Withdrawal by Subject|0
185329|NCT00963820|588424|P3|Dose Escalation Phase|Withdrawal by Subject|0
185330|NCT00963820|588425|P2|Dose Escalation Phase|Withdrawal by Subject|0
185331|NCT00963820|588426|P1|Dose Escalation Phase|Withdrawal by Subject|0
185332|NCT00963820|588415|P12|Dose Escalation Phase|Adverse Event|0
185333|NCT00963820|588416|P11|Dose Escalation Phase|Adverse Event|0
185334|NCT00963820|588417|P10|Dose Escalation Phase|Adverse Event|0
185335|NCT00963820|588418|P9|Dose Escalation Phase|Adverse Event|0
185336|NCT00963820|588419|P8|Dose Escalation Phase|Adverse Event|1
185337|NCT00963820|588420|P7|Dose Escalation Phase|Adverse Event|3
185338|NCT00963820|588421|P6|Dose Escalation Phase|Adverse Event|0
185339|NCT00963820|588422|P5|Dose Escalation Phase|Adverse Event|0
185340|NCT00963820|588423|P4|Dose Escalation Phase|Adverse Event|0
185341|NCT00963820|588424|P3|Dose Escalation Phase|Adverse Event|0
185342|NCT00963820|588425|P2|Dose Escalation Phase|Adverse Event|0
185343|NCT00963820|588426|P1|Dose Escalation Phase|Adverse Event|0
185344|NCT00963820|588415|P12|Dose Escalation Phase|Progressive Disease|0
185345|NCT00963820|588416|P11|Dose Escalation Phase|Progressive Disease|0
185346|NCT00963820|588417|P10|Dose Escalation Phase|Progressive Disease|0
185347|NCT00963820|588418|P9|Dose Escalation Phase|Progressive Disease|0
185348|NCT00963820|588419|P8|Dose Escalation Phase|Progressive Disease|2
185349|NCT00963820|588420|P7|Dose Escalation Phase|Progressive Disease|3
185350|NCT00963820|588421|P6|Dose Escalation Phase|Progressive Disease|3
185351|NCT00963820|588422|P5|Dose Escalation Phase|Progressive Disease|4
185352|NCT00963820|588423|P4|Dose Escalation Phase|Progressive Disease|3
185353|NCT00963820|588424|P3|Dose Escalation Phase|Progressive Disease|3
185354|NCT00963820|588425|P2|Dose Escalation Phase|Progressive Disease|3
185355|NCT00963820|588426|P1|Dose Escalation Phase|Progressive Disease|3
185356|NCT00963924|588616|P2|Overall Study|Lost to Follow-up|1
185357|NCT00963924|588617|P1|Overall Study|Lost to Follow-up|0
185358|NCT00963924|588616|P2|Overall Study|Changed antipsychotic|1
185359|NCT00963924|588617|P1|Overall Study|Changed antipsychotic|0
185360|NCT00963924|588616|P2|Overall Study|Withdrawal by Subject|1
185361|NCT00963924|588617|P1|Overall Study|Withdrawal by Subject|0
185362|NCT00963924|588616|P2|Overall Study|Adverse Event|0
185363|NCT00963924|588617|P1|Overall Study|Adverse Event|1
185364|NCT00963937|588636|P3|Overall Study|Physician Decision|4
185365|NCT00963937|588637|P2|Overall Study|Physician Decision|10
185366|NCT00963937|588638|P1|Overall Study|Physician Decision|18
185367|NCT00963937|588636|P3|Overall Study|Protocol Violation|0
185368|NCT00963937|588637|P2|Overall Study|Protocol Violation|1
185369|NCT00963937|588638|P1|Overall Study|Protocol Violation|1
185370|NCT00964028|588676|P2|Overall Study|Withdrawal by Subject|1
185371|NCT00964028|588677|P1|Overall Study|Withdrawal by Subject|0
185372|NCT00964223|588693|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
185373|NCT00964366|588760|P2|Overall Study|Withdrawal by Subject|1
185374|NCT00964366|588761|P1|Overall Study|Withdrawal by Subject|0
185375|NCT00964366|588760|P2|Overall Study|Did not qualify at Day 1|0
185376|NCT00964366|588761|P1|Overall Study|Did not qualify at Day 1|1
185377|NCT00964392|588777|P2|Overall Study|Not completed|168
185378|NCT00964392|588778|P1|Overall Study|Not completed|44
185379|NCT00964392|588777|P2|Overall Study|Early Termination, non-study arrhythmia|6
185380|NCT00964392|588778|P1|Overall Study|Early Termination, non-study arrhythmia|1
185381|NCT00964392|588777|P2|Overall Study|Lost to Follow-up|10
185382|NCT00964392|588778|P1|Overall Study|Lost to Follow-up|4
185383|NCT00964392|588777|P2|Overall Study|Withdrawal by Subject|6
185384|NCT00964392|588778|P1|Overall Study|Withdrawal by Subject|4
185385|NCT00964678|588841|P1|Overall Study|Physician Decision|4
185386|NCT00964743|588848|P1|Overall Study|Neither patient completed 8 weeks of tre|2
185387|NCT00964795|588856|P1|Overall Study|Other|23
185388|NCT00964795|588856|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
185389|NCT00964795|588856|P1|Overall Study|Termination of Study by Sponsor|169
185390|NCT00964795|588856|P1|Overall Study|Lost to Follow-up|7
185391|NCT00964795|588856|P1|Overall Study|Death|14
185392|NCT00964795|588856|P1|Overall Study|Adverse Event|12
185393|NCT00964795|588856|P1|Overall Study|Withdrawal by Subject|79
185394|NCT00964860|588865|P2|Overall Study|Withdrawal by Subject|1
185395|NCT00964860|588866|P1|Overall Study|Withdrawal by Subject|0
185396|NCT00964886|588878|P4|Overall Study|Protocol Violation|0
185397|NCT00964886|588879|P3|Overall Study|Protocol Violation|0
185398|NCT00964886|588880|P2|Overall Study|Protocol Violation|2
185399|NCT00964886|588881|P1|Overall Study|Protocol Violation|0
185400|NCT00964886|588878|P4|Overall Study|Adverse Event|2
185401|NCT00964886|588879|P3|Overall Study|Adverse Event|5
185402|NCT00964886|588880|P2|Overall Study|Adverse Event|1
185403|NCT00964886|588881|P1|Overall Study|Adverse Event|3
185404|NCT00964886|588878|P4|Overall Study|Withdrawal by Subject|3
185405|NCT00964886|588879|P3|Overall Study|Withdrawal by Subject|5
185406|NCT00964886|588880|P2|Overall Study|Withdrawal by Subject|2
185407|NCT00964886|588881|P1|Overall Study|Withdrawal by Subject|6
185408|NCT00964886|588878|P4|Overall Study|Lost to Follow-up|4
185409|NCT00964886|588879|P3|Overall Study|Lost to Follow-up|6
185410|NCT00964886|588880|P2|Overall Study|Lost to Follow-up|2
185411|NCT00964886|588881|P1|Overall Study|Lost to Follow-up|2
185412|NCT00965081|588897|P2|Overall Study|Switched to Rescue Arm|12
185413|NCT00965081|588898|P1|Overall Study|Switched to Rescue Arm|5
185414|NCT00965081|588897|P2|Overall Study|Withdrawal by Subject|7
185415|NCT00965081|588898|P1|Overall Study|Withdrawal by Subject|4
185416|NCT00965081|588897|P2|Overall Study|Sponsor Decision|0
185417|NCT00965081|588898|P1|Overall Study|Sponsor Decision|1
185418|NCT00965081|588897|P2|Overall Study|Protocol Violation|5
185419|NCT00965081|588898|P1|Overall Study|Protocol Violation|2
185420|NCT00965081|588897|P2|Overall Study|Physician Decision|0
185421|NCT00965081|588898|P1|Overall Study|Physician Decision|2
185422|NCT00965081|588897|P2|Overall Study|Lost to Follow-up|5
185423|NCT00965081|588898|P1|Overall Study|Lost to Follow-up|4
185424|NCT00965081|588897|P2|Overall Study|Lack of Efficacy|5
185425|NCT00965081|588898|P1|Overall Study|Lack of Efficacy|2
185426|NCT00965081|588897|P2|Overall Study|Adverse Event|9
185427|NCT00965081|588898|P1|Overall Study|Adverse Event|14
185428|NCT00965094|588923|P2|Overall Study|Lost to Follow-up|1
185429|NCT00965094|588924|P1|Overall Study|Lost to Follow-up|0
185430|NCT00965094|588923|P2|Overall Study|Adverse Event|0
185431|NCT00965094|588924|P1|Overall Study|Adverse Event|5
185432|NCT00965146|588938|P1|Overall Study|Overall Study Termination|145
185433|NCT00965146|588938|P1|Overall Study|Revision / Removal of Study Implant|6
185434|NCT00965146|588938|P1|Overall Study|Intercurrent illness|1
185435|NCT00965146|588938|P1|Overall Study|Unwilling to return|11
185436|NCT00965146|588938|P1|Overall Study|Unable to return|1
185437|NCT00965146|588938|P1|Overall Study|Withdrawal by Subject|17
185438|NCT00965146|588938|P1|Overall Study|Lost to Follow-up|22
185439|NCT00965146|588938|P1|Overall Study|Death|7
185440|NCT00965185|588944|P2|Overall Study|Withdrawal by Subject|1
185441|NCT00965185|588945|P1|Overall Study|Withdrawal by Subject|0
185442|NCT00965185|588944|P2|Overall Study|Lost to Follow-up|0
185443|NCT00965185|588945|P1|Overall Study|Lost to Follow-up|2
185444|NCT00955279|589009|P3|Overall Study|Withdrawal by Subject|3
185445|NCT00955279|589010|P2|Overall Study|Withdrawal by Subject|0
185446|NCT00955279|589011|P1|Overall Study|Withdrawal by Subject|2
185447|NCT00955279|589009|P3|Overall Study|Lost to Follow-up|1
185448|NCT00955279|589010|P2|Overall Study|Lost to Follow-up|3
185449|NCT00955279|589011|P1|Overall Study|Lost to Follow-up|0
185450|NCT00955279|589009|P3|Overall Study|Death|1
185451|NCT00955279|589010|P2|Overall Study|Death|1
185452|NCT00955279|589011|P1|Overall Study|Death|1
185453|NCT00955279|589009|P3|Overall Study|Unspecified|3
185454|NCT00955279|589010|P2|Overall Study|Unspecified|0
185455|NCT00955279|589011|P1|Overall Study|Unspecified|0
185456|NCT00955305|589033|P2|Overall Study|Ineligible|7
185457|NCT00955305|589034|P1|Overall Study|Ineligible|5
185458|NCT00955305|589033|P2|Overall Study|Never started protocol treatment|5
185459|NCT00955305|589034|P1|Overall Study|Never started protocol treatment|5
185460|NCT00955305|589033|P2|Overall Study|No off-treatment reason submitted|0
185461|NCT00955305|589034|P1|Overall Study|No off-treatment reason submitted|1
185462|NCT00955305|589033|P2|Overall Study|Lost to Follow-up|1
185463|NCT00955305|589034|P1|Overall Study|Lost to Follow-up|0
185464|NCT00955305|589033|P2|Overall Study|Maximum response achieved|1
185465|NCT00955305|589034|P1|Overall Study|Maximum response achieved|0
185466|NCT00955305|589033|P2|Overall Study|Functional decline|0
185467|NCT00955305|589034|P1|Overall Study|Functional decline|2
185468|NCT00955305|589033|P2|Overall Study|Continued presence of residual disease|1
185469|NCT00955305|589034|P1|Overall Study|Continued presence of residual disease|0
185470|NCT00955305|589033|P2|Overall Study|Physician Decision|0
185471|NCT00955305|589034|P1|Overall Study|Physician Decision|1
185472|NCT00955305|589033|P2|Overall Study|Other complicating disease|4
185473|NCT00955305|589034|P1|Overall Study|Other complicating disease|2
185474|NCT00955305|589033|P2|Overall Study|Alternative therapy|0
185475|NCT00955305|589034|P1|Overall Study|Alternative therapy|4
185476|NCT00955305|589033|P2|Overall Study|Withdrawal by Subject|4
185477|NCT00955305|589034|P1|Overall Study|Withdrawal by Subject|5
185478|NCT00955305|589033|P2|Overall Study|Death|1
185479|NCT00955305|589034|P1|Overall Study|Death|2
185480|NCT00955305|589033|P2|Overall Study|Adverse Event|22
185481|NCT00955305|589034|P1|Overall Study|Adverse Event|22
185482|NCT00955305|589033|P2|Overall Study|Disease progression|41
185483|NCT00955305|589034|P1|Overall Study|Disease progression|39
185484|NCT00955357|589046|P2|Maintenance Phase|Non compliance to study procedures|0
185485|NCT00955357|589047|P1|Maintenance Phase|Non compliance to study procedures|1
185486|NCT00955357|589046|P2|Maintenance Phase|Patient moving out of area|1
185487|NCT00955357|589047|P1|Maintenance Phase|Patient moving out of area|0
185488|NCT00955357|589046|P2|Maintenance Phase|Withdrawal by Subject|4
185489|NCT00955357|589047|P1|Maintenance Phase|Withdrawal by Subject|4
185490|NCT00955357|589046|P2|Maintenance Phase|Lost to Follow-up|7
185491|NCT00955357|589047|P1|Maintenance Phase|Lost to Follow-up|2
185492|NCT00955357|589046|P2|Maintenance Phase|Protocol Violation|6
185493|NCT00955357|589047|P1|Maintenance Phase|Protocol Violation|2
185494|NCT00955357|589046|P2|Maintenance Phase|Lack of Efficacy|4
185495|NCT00955357|589047|P1|Maintenance Phase|Lack of Efficacy|0
185496|NCT00955357|589046|P2|Maintenance Phase|Adverse Event|23
185497|NCT00955357|589047|P1|Maintenance Phase|Adverse Event|3
185498|NCT00955357|589046|P2|Titration Phase|Non compliance to study procedures|1
185499|NCT00955357|589047|P1|Titration Phase|Non compliance to study procedures|0
185500|NCT00955357|589046|P2|Titration Phase|Study medication not tolerated|1
185501|NCT00955357|589047|P1|Titration Phase|Study medication not tolerated|0
185502|NCT00955357|589046|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
185503|NCT00955357|589047|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
185504|NCT00955357|589046|P2|Titration Phase|Withdrawal by Subject|5
185505|NCT00955357|589047|P1|Titration Phase|Withdrawal by Subject|3
185506|NCT00955357|589046|P2|Titration Phase|Lost to Follow-up|3
185507|NCT00955357|589047|P1|Titration Phase|Lost to Follow-up|1
185508|NCT00955357|589046|P2|Titration Phase|Protocol Violation|7
185509|NCT00955357|589047|P1|Titration Phase|Protocol Violation|3
185510|NCT00955357|589046|P2|Titration Phase|Lack of Efficacy|2
185511|NCT00955357|589047|P1|Titration Phase|Lack of Efficacy|0
185512|NCT00955357|589046|P2|Titration Phase|Adverse Event|46
185513|NCT00955357|589047|P1|Titration Phase|Adverse Event|9
185514|NCT00955474|589055|P2|Overall Study|Physician Decision|5
185515|NCT00955474|589056|P1|Overall Study|Physician Decision|7
185516|NCT00955617|589142|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
185517|NCT00955617|589143|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
185518|NCT00955617|589142|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
185519|NCT00955617|589143|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
185520|NCT00955617|589142|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
185521|NCT00955617|589143|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
185522|NCT00955617|589142|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
185523|NCT00955617|589143|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
185524|NCT00955721|589155|P2|Overall Study|Withdrawal by Subject|0
185525|NCT00955721|589156|P1|Overall Study|Withdrawal by Subject|1
185526|NCT00955721|589155|P2|Overall Study|Death|0
185527|NCT00955721|589156|P1|Overall Study|Death|1
185528|NCT00955721|589155|P2|Overall Study|Physician Decision|0
185529|NCT00955721|589156|P1|Overall Study|Physician Decision|1
185530|NCT00955825|589175|P2|Overall Study|Any other reason not above-mentioned|9
185531|NCT00955825|589176|P1|Overall Study|Any other reason not above-mentioned|7
185532|NCT00955825|589175|P2|Overall Study|Withdrawal by Subject|6
185533|NCT00955825|589176|P1|Overall Study|Withdrawal by Subject|4
185534|NCT00955825|589175|P2|Overall Study|Adverse Event|2
185535|NCT00955825|589176|P1|Overall Study|Adverse Event|15
185536|NCT00955955|589210|P3|Overall Study|Lost to Follow-up|0
185537|NCT00955955|589211|P2|Overall Study|Lost to Follow-up|0
185538|NCT00955955|589212|P1|Overall Study|Lost to Follow-up|2
185539|NCT00965341|589243|P2|Overall Study|Transportation issues|3
185540|NCT00965341|589244|P1|Overall Study|Transportation issues|4
185541|NCT00965341|589243|P2|Overall Study|Lost to Follow-up|0
185542|NCT00965341|589244|P1|Overall Study|Lost to Follow-up|1
185543|NCT00965341|589243|P2|Overall Study|Withdrew consent|5
185544|NCT00965341|589244|P1|Overall Study|Withdrew consent|1
185545|NCT00965458|589254|P2|Overall Study|Withdrawal by Subject|1
185546|NCT00965458|589255|P1|Overall Study|Withdrawal by Subject|0
185547|NCT00965458|589254|P2|Overall Study|Lost to Follow-up|3
185548|NCT00965458|589255|P1|Overall Study|Lost to Follow-up|1
185549|NCT00965458|589254|P2|Overall Study|Adverse Event|0
185550|NCT00965458|589255|P1|Overall Study|Adverse Event|1
185551|NCT00965484|589271|P1|Overall Study|Withdrawal by Subject|1
185552|NCT00965484|589271|P1|Overall Study|Protocol Violation|1
185553|NCT00965497|589278|P1|Overall Study|Physician Decision|1
185554|NCT00965523|589283|P1|Study 224|Physician Decision|1
185555|NCT00965523|589283|P1|Study 224|Progressive Disease|5
185556|NCT00965523|589283|P1|Study 221|Physician Decision|3
185557|NCT00965523|589283|P1|Study 221|Progressive Disease|4
185558|NCT00965562|589291|P3|Overall Study|Withdrawal by Subject|0
185559|NCT00965562|589292|P2|Overall Study|Withdrawal by Subject|2
185560|NCT00965562|589293|P1|Overall Study|Withdrawal by Subject|2
185561|NCT00965562|589291|P3|Overall Study|Lost to Follow-up|3
185562|NCT00965562|589292|P2|Overall Study|Lost to Follow-up|2
185563|NCT00965562|589293|P1|Overall Study|Lost to Follow-up|1
185564|NCT00966264|589373|P2|Overall Study|Lost to Follow-up|3
185565|NCT00966264|589374|P1|Overall Study|Lost to Follow-up|4
185566|NCT00966277|589382|P2|Overall Study|Treatment Plan Changed|1
185567|NCT00966277|589383|P1|Overall Study|Treatment Plan Changed|0
185568|NCT00966277|589382|P2|Overall Study|Ineligible|3
185569|NCT00966277|589383|P1|Overall Study|Ineligible|1
185570|NCT00966277|589382|P2|Overall Study|Withdrawal by Subject|0
185571|NCT00966277|589383|P1|Overall Study|Withdrawal by Subject|3
185572|NCT00966654|589424|P1|Overall Study|Study was terminated,PI left institution|12
185573|NCT00966875|589449|P9|Part B|Entry Criteria|1
185574|NCT00966875|589450|P8|Part B|Entry Criteria|0
185575|NCT00966875|589451|P7|Part B|Entry Criteria|1
185576|NCT00966875|589452|P6|Part B|Entry Criteria|0
185577|NCT00966875|589453|P5|Part B|Entry Criteria|0
185578|NCT00966875|589454|P4|Part B|Entry Criteria|0
185579|NCT00966875|589455|P3|Part B|Entry Criteria|0
185580|NCT00966875|589456|P2|Part B|Entry Criteria|0
185581|NCT00966875|589457|P1|Part B|Entry Criteria|0
185582|NCT00966875|589449|P9|Part B|Withdrawal by Subject|5
185583|NCT00966875|589450|P8|Part B|Withdrawal by Subject|5
185584|NCT00966875|589451|P7|Part B|Withdrawal by Subject|4
185585|NCT00966875|589452|P6|Part B|Withdrawal by Subject|1
185586|NCT00966875|589453|P5|Part B|Withdrawal by Subject|2
185587|NCT00966875|589454|P4|Part B|Withdrawal by Subject|1
185588|NCT00966875|589455|P3|Part B|Withdrawal by Subject|2
185589|NCT00966875|589456|P2|Part B|Withdrawal by Subject|1
185590|NCT00966875|589457|P1|Part B|Withdrawal by Subject|2
185591|NCT00966875|589449|P9|Part B|Sponsor Decision|1
185592|NCT00966875|589450|P8|Part B|Sponsor Decision|2
185593|NCT00966875|589451|P7|Part B|Sponsor Decision|0
185594|NCT00966875|589452|P6|Part B|Sponsor Decision|1
185595|NCT00966875|589453|P5|Part B|Sponsor Decision|0
185596|NCT00966875|589454|P4|Part B|Sponsor Decision|0
185597|NCT00966875|589455|P3|Part B|Sponsor Decision|0
185598|NCT00966875|589456|P2|Part B|Sponsor Decision|0
185599|NCT00966875|589457|P1|Part B|Sponsor Decision|1
185600|NCT00966875|589449|P9|Part B|Physician Decision|2
185601|NCT00966875|589450|P8|Part B|Physician Decision|0
185602|NCT00966875|589451|P7|Part B|Physician Decision|0
185603|NCT00966875|589452|P6|Part B|Physician Decision|1
185604|NCT00966875|589453|P5|Part B|Physician Decision|2
185605|NCT00966875|589454|P4|Part B|Physician Decision|0
185606|NCT00966875|589455|P3|Part B|Physician Decision|1
185607|NCT00966875|589456|P2|Part B|Physician Decision|0
185608|NCT00966875|589457|P1|Part B|Physician Decision|0
185609|NCT00966875|589449|P9|Part B|Lost to Follow-up|1
185610|NCT00966875|589450|P8|Part B|Lost to Follow-up|0
185611|NCT00966875|589451|P7|Part B|Lost to Follow-up|0
185612|NCT00966875|589452|P6|Part B|Lost to Follow-up|0
185613|NCT00966875|589453|P5|Part B|Lost to Follow-up|0
185614|NCT00966875|589454|P4|Part B|Lost to Follow-up|1
185615|NCT00966875|589455|P3|Part B|Lost to Follow-up|0
185616|NCT00966875|589456|P2|Part B|Lost to Follow-up|0
185617|NCT00966875|589457|P1|Part B|Lost to Follow-up|0
185618|NCT00966875|589449|P9|Part B|Lack of Efficacy|6
185619|NCT00966875|589450|P8|Part B|Lack of Efficacy|9
185620|NCT00966875|589451|P7|Part B|Lack of Efficacy|12
185621|NCT00966875|589452|P6|Part B|Lack of Efficacy|3
185622|NCT00966875|589453|P5|Part B|Lack of Efficacy|2
185623|NCT00966875|589454|P4|Part B|Lack of Efficacy|1
185624|NCT00966875|589455|P3|Part B|Lack of Efficacy|1
185625|NCT00966875|589456|P2|Part B|Lack of Efficacy|1
185626|NCT00966875|589457|P1|Part B|Lack of Efficacy|2
185627|NCT00966875|589449|P9|Part B|Death|0
185628|NCT00966875|589450|P8|Part B|Death|1
185629|NCT00966875|589451|P7|Part B|Death|0
185630|NCT00966875|589452|P6|Part B|Death|0
185631|NCT00966875|589453|P5|Part B|Death|0
185632|NCT00966875|589454|P4|Part B|Death|0
185633|NCT00966875|589455|P3|Part B|Death|1
185634|NCT00966875|589456|P2|Part B|Death|0
185635|NCT00966875|589457|P1|Part B|Death|0
185636|NCT00966875|589449|P9|Part B|Adverse Event|2
185637|NCT00966875|589450|P8|Part B|Adverse Event|2
185638|NCT00966875|589451|P7|Part B|Adverse Event|5
185639|NCT00966875|589452|P6|Part B|Adverse Event|0
185640|NCT00966875|589453|P5|Part B|Adverse Event|1
185641|NCT00966875|589454|P4|Part B|Adverse Event|0
185642|NCT00966875|589455|P3|Part B|Adverse Event|1
185643|NCT00966875|589456|P2|Part B|Adverse Event|1
185644|NCT00966875|589457|P1|Part B|Adverse Event|0
185645|NCT00966875|589449|P9|Part A|Protocol Violation|1
185646|NCT00966875|589450|P8|Part A|Protocol Violation|1
185647|NCT00966875|589451|P7|Part A|Protocol Violation|2
185648|NCT00966875|589452|P6|Part A|Protocol Violation|0
185649|NCT00966875|589453|P5|Part A|Protocol Violation|0
185650|NCT00966875|589454|P4|Part A|Protocol Violation|0
185651|NCT00966875|589455|P3|Part A|Protocol Violation|0
185652|NCT00966875|589456|P2|Part A|Protocol Violation|0
185653|NCT00966875|589457|P1|Part A|Protocol Violation|0
185654|NCT00966875|589449|P9|Part A|Withdrawal by Subject|1
185655|NCT00966875|589450|P8|Part A|Withdrawal by Subject|1
185656|NCT00966875|589451|P7|Part A|Withdrawal by Subject|5
185657|NCT00966875|589452|P6|Part A|Withdrawal by Subject|0
185658|NCT00966875|589453|P5|Part A|Withdrawal by Subject|3
185659|NCT00966875|589454|P4|Part A|Withdrawal by Subject|1
185660|NCT00966875|589455|P3|Part A|Withdrawal by Subject|1
185661|NCT00966875|589456|P2|Part A|Withdrawal by Subject|2
185662|NCT00966875|589457|P1|Part A|Withdrawal by Subject|2
185663|NCT00966875|589449|P9|Part A|Sponsor Decision|1
185664|NCT00966875|589450|P8|Part A|Sponsor Decision|2
185665|NCT00966875|589451|P7|Part A|Sponsor Decision|0
185666|NCT00966875|589452|P6|Part A|Sponsor Decision|0
185667|NCT00966875|589453|P5|Part A|Sponsor Decision|1
185668|NCT00966875|589454|P4|Part A|Sponsor Decision|0
185669|NCT00966875|589455|P3|Part A|Sponsor Decision|1
185670|NCT00966875|589456|P2|Part A|Sponsor Decision|0
185671|NCT00966875|589457|P1|Part A|Sponsor Decision|0
185672|NCT00966875|589449|P9|Part A|Physician Decision|2
185673|NCT00966875|589450|P8|Part A|Physician Decision|0
185674|NCT00966875|589451|P7|Part A|Physician Decision|1
185675|NCT00966875|589452|P6|Part A|Physician Decision|0
185676|NCT00966875|589453|P5|Part A|Physician Decision|1
185677|NCT00966875|589454|P4|Part A|Physician Decision|0
185678|NCT00966875|589455|P3|Part A|Physician Decision|0
185679|NCT00966875|589456|P2|Part A|Physician Decision|0
185680|NCT00966875|589457|P1|Part A|Physician Decision|0
185681|NCT00966875|589449|P9|Part A|Parent/Caregiver Decision|0
185682|NCT00966875|589450|P8|Part A|Parent/Caregiver Decision|0
185683|NCT00966875|589451|P7|Part A|Parent/Caregiver Decision|0
185684|NCT00966875|589452|P6|Part A|Parent/Caregiver Decision|0
185685|NCT00966875|589453|P5|Part A|Parent/Caregiver Decision|0
185686|NCT00966875|589454|P4|Part A|Parent/Caregiver Decision|1
185687|NCT00966875|589455|P3|Part A|Parent/Caregiver Decision|0
185688|NCT00966875|589456|P2|Part A|Parent/Caregiver Decision|0
185689|NCT00966875|589457|P1|Part A|Parent/Caregiver Decision|0
185690|NCT00966875|589449|P9|Part A|Lost to Follow-up|0
185691|NCT00966875|589450|P8|Part A|Lost to Follow-up|0
185692|NCT00966875|589451|P7|Part A|Lost to Follow-up|0
185693|NCT00966875|589452|P6|Part A|Lost to Follow-up|1
185694|NCT00966875|589453|P5|Part A|Lost to Follow-up|0
185695|NCT00966875|589454|P4|Part A|Lost to Follow-up|0
185696|NCT00966875|589455|P3|Part A|Lost to Follow-up|0
185697|NCT00966875|589456|P2|Part A|Lost to Follow-up|0
185698|NCT00966875|589457|P1|Part A|Lost to Follow-up|2
185699|NCT00966875|589449|P9|Part A|Lack of Efficacy|0
185700|NCT00966875|589450|P8|Part A|Lack of Efficacy|0
185701|NCT00966875|589451|P7|Part A|Lack of Efficacy|4
185702|NCT00966875|589452|P6|Part A|Lack of Efficacy|0
185703|NCT00966875|589453|P5|Part A|Lack of Efficacy|0
185704|NCT00966875|589454|P4|Part A|Lack of Efficacy|0
185705|NCT00966875|589455|P3|Part A|Lack of Efficacy|0
185706|NCT00966875|589456|P2|Part A|Lack of Efficacy|1
185707|NCT00966875|589457|P1|Part A|Lack of Efficacy|0
185708|NCT00966875|589449|P9|Part A|Entry Criteria|0
185709|NCT00966875|589450|P8|Part A|Entry Criteria|0
185710|NCT00966875|589451|P7|Part A|Entry Criteria|0
185711|NCT00966875|589452|P6|Part A|Entry Criteria|2
185712|NCT00966875|589453|P5|Part A|Entry Criteria|0
185713|NCT00966875|589454|P4|Part A|Entry Criteria|0
185714|NCT00966875|589455|P3|Part A|Entry Criteria|0
185715|NCT00966875|589456|P2|Part A|Entry Criteria|0
185716|NCT00966875|589457|P1|Part A|Entry Criteria|0
185717|NCT00966875|589449|P9|Part A|Adverse Event|3
185718|NCT00966875|589450|P8|Part A|Adverse Event|3
185719|NCT00966875|589451|P7|Part A|Adverse Event|0
185720|NCT00966875|589452|P6|Part A|Adverse Event|1
185721|NCT00966875|589453|P5|Part A|Adverse Event|0
185722|NCT00966875|589454|P4|Part A|Adverse Event|1
185723|NCT00966875|589455|P3|Part A|Adverse Event|0
185724|NCT00966875|589456|P2|Part A|Adverse Event|1
185725|NCT00966875|589457|P1|Part A|Adverse Event|2
185726|NCT00966940|589778|P2|Period 1, First 6 Weeks|Protocol Violation|0
185727|NCT00966940|589779|P1|Period 1, First 6 Weeks|Protocol Violation|1
185728|NCT00966940|589778|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
185729|NCT00966940|589779|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
185730|NCT00967005|589831|P2|Overall Study|Lost to Follow-up|10
185731|NCT00967005|589832|P1|Overall Study|Lost to Follow-up|7
185732|NCT00967018|589884|P1|Overall Study|Miscellaneous Reasons|9
185733|NCT00967018|589884|P1|Overall Study|Withdrawal by Subject|1
185734|NCT00967018|589884|P1|Overall Study|Lost to Follow-up|2
185735|NCT00967018|589884|P1|Overall Study|Physician Decision|7
185736|NCT00967018|589884|P1|Overall Study|Adverse Event|2
185737|NCT00967226|589897|P2|Overall Study|Physician Decision|1
185738|NCT00967226|589898|P1|Overall Study|Physician Decision|0
185739|NCT00967226|589897|P2|Overall Study|Protocol Violation|0
185740|NCT00967226|589898|P1|Overall Study|Protocol Violation|2
185741|NCT00967226|589897|P2|Overall Study|Adverse Event|5
185742|NCT00967226|589898|P1|Overall Study|Adverse Event|0
185743|NCT00967330|589930|P2|Overall Study|Severe protocol deviation|1
185744|NCT00967330|589931|P1|Overall Study|Severe protocol deviation|0
185745|NCT00967330|589930|P2|Overall Study|Death|51
185746|NCT00967330|589931|P1|Overall Study|Death|102
185747|NCT00967330|589930|P2|Overall Study|Lost to Follow-up|1
185748|NCT00967330|589931|P1|Overall Study|Lost to Follow-up|1
185749|NCT00967330|589930|P2|Overall Study|Withdrawal by Subject|0
185750|NCT00967330|589931|P1|Overall Study|Withdrawal by Subject|6
185751|NCT00967330|589930|P2|Overall Study|Regular|3
185752|NCT00967330|589931|P1|Overall Study|Regular|10
185753|NCT00967330|589930|P2|Overall Study|Protocol Violation|4
185754|NCT00967330|589931|P1|Overall Study|Protocol Violation|3
185755|NCT00967668|589995|P3|Overall Study|Pregnancy|0
185756|NCT00967668|589996|P2|Overall Study|Pregnancy|0
185757|NCT00967668|589997|P1|Overall Study|Pregnancy|1
185758|NCT00967668|589995|P3|Overall Study|Refused 12-mo assessment|9
185759|NCT00967668|589996|P2|Overall Study|Refused 12-mo assessment|1
185760|NCT00967668|589997|P1|Overall Study|Refused 12-mo assessment|3
185761|NCT00967668|589995|P3|Overall Study|Lost to Follow-up|16
185762|NCT00967668|589996|P2|Overall Study|Lost to Follow-up|9
185763|NCT00967668|589997|P1|Overall Study|Lost to Follow-up|15
185764|NCT00967668|589995|P3|Overall Study|Lost to follow-up at 12-mo|26
185765|NCT00967668|589996|P2|Overall Study|Lost to follow-up at 12-mo|29
185766|NCT00967668|589997|P1|Overall Study|Lost to follow-up at 12-mo|27
185767|NCT00967668|589995|P3|Overall Study|Refused Year 2|4
185768|NCT00967668|589996|P2|Overall Study|Refused Year 2|6
185769|NCT00967668|589997|P1|Overall Study|Refused Year 2|11
185770|NCT00967668|589995|P3|Overall Study|Removed due to behavior|2
185771|NCT00967668|589996|P2|Overall Study|Removed due to behavior|1
185772|NCT00967668|589997|P1|Overall Study|Removed due to behavior|1
185773|NCT00967668|589995|P3|Overall Study|Death|4
185774|NCT00967668|589996|P2|Overall Study|Death|2
185775|NCT00967668|589997|P1|Overall Study|Death|0
185776|NCT00967668|589995|P3|Overall Study|Withdrawal by Subject|8
185777|NCT00967668|589996|P2|Overall Study|Withdrawal by Subject|8
185778|NCT00967668|589997|P1|Overall Study|Withdrawal by Subject|13
185779|NCT00967694|590008|P1|Overall Study|Withdrawal by Subject|6
185780|NCT00968149|590047|P2|Overall Study|Withdrawal by Subject|0
185781|NCT00968149|590048|P1|Overall Study|Withdrawal by Subject|2
185782|NCT00968149|590047|P2|Overall Study|Protocol Violation|0
185783|NCT00968149|590048|P1|Overall Study|Protocol Violation|4
185784|NCT00968149|590047|P2|Overall Study|Lost to Follow-up|1
185785|NCT00968149|590048|P1|Overall Study|Lost to Follow-up|0
185786|NCT00968149|590047|P2|Overall Study|Lack of Efficacy|4
185787|NCT00968149|590048|P1|Overall Study|Lack of Efficacy|0
185788|NCT00968149|590047|P2|Overall Study|Adverse Event|1
185789|NCT00968149|590048|P1|Overall Study|Adverse Event|5
185790|NCT00968201|590070|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
185791|NCT00968201|590071|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
185792|NCT00968201|590072|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
185793|NCT00968201|590070|P3|Extension Study - (Period III)|Not Specified|2
185794|NCT00968201|590071|P2|Extension Study - (Period III)|Not Specified|0
185795|NCT00968201|590072|P1|Extension Study - (Period III)|Not Specified|0
185796|NCT00968201|590070|P3|Extension Study - (Period III)|Noncompliance|3
185797|NCT00968201|590071|P2|Extension Study - (Period III)|Noncompliance|0
185798|NCT00968201|590072|P1|Extension Study - (Period III)|Noncompliance|0
185799|NCT00968201|590070|P3|Extension Study - (Period III)|Patient Relocated|1
185800|NCT00968201|590071|P2|Extension Study - (Period III)|Patient Relocated|1
185801|NCT00968201|590072|P1|Extension Study - (Period III)|Patient Relocated|0
185802|NCT00968201|590070|P3|Extension Study - (Period III)|Withdrawal by Subject|40
185803|NCT00968201|590071|P2|Extension Study - (Period III)|Withdrawal by Subject|20
185804|NCT00968201|590072|P1|Extension Study - (Period III)|Withdrawal by Subject|0
185805|NCT00968201|590070|P3|Extension Study - (Period III)|Protocol Violation|14
185806|NCT00968201|590071|P2|Extension Study - (Period III)|Protocol Violation|17
185807|NCT00968201|590072|P1|Extension Study - (Period III)|Protocol Violation|0
185808|NCT00968201|590070|P3|Extension Study - (Period III)|Lost to Follow-up|13
185809|NCT00968201|590071|P2|Extension Study - (Period III)|Lost to Follow-up|7
185810|NCT00968201|590072|P1|Extension Study - (Period III)|Lost to Follow-up|0
185811|NCT00968201|590070|P3|Extension Study - (Period III)|Adverse Event|22
185812|NCT00968201|590071|P2|Extension Study - (Period III)|Adverse Event|5
185813|NCT00968201|590072|P1|Extension Study - (Period III)|Adverse Event|0
185814|NCT00968201|590070|P3|Base Study - (Period II)|Site Error|1
185815|NCT00968201|590071|P2|Base Study - (Period II)|Site Error|0
185816|NCT00968201|590072|P1|Base Study - (Period II)|Site Error|0
185817|NCT00968201|590070|P3|Base Study - (Period II)|Withdrawal by Subject|8
185818|NCT00968201|590071|P2|Base Study - (Period II)|Withdrawal by Subject|0
185819|NCT00968201|590072|P1|Base Study - (Period II)|Withdrawal by Subject|4
185820|NCT00968201|590070|P3|Base Study - (Period II)|Protocol Violation|12
185821|NCT00968201|590071|P2|Base Study - (Period II)|Protocol Violation|0
185822|NCT00968201|590072|P1|Base Study - (Period II)|Protocol Violation|12
185823|NCT00968201|590070|P3|Base Study - (Period II)|Lost to Follow-up|7
185824|NCT00968201|590071|P2|Base Study - (Period II)|Lost to Follow-up|0
185825|NCT00968201|590072|P1|Base Study - (Period II)|Lost to Follow-up|2
185826|NCT00968201|590070|P3|Base Study - (Period II)|Lack of Efficacy|1
185827|NCT00968201|590071|P2|Base Study - (Period II)|Lack of Efficacy|0
185828|NCT00968201|590072|P1|Base Study - (Period II)|Lack of Efficacy|0
185829|NCT00968201|590070|P3|Base Study - (Period II)|Adverse Event|16
185830|NCT00968201|590071|P2|Base Study - (Period II)|Adverse Event|0
185831|NCT00968201|590072|P1|Base Study - (Period II)|Adverse Event|8
185832|NCT00960297|590136|P1|Overall Study|Disease progression|1
185833|NCT00960297|590136|P1|Overall Study|Venous port infection|1
185834|NCT00960297|590136|P1|Overall Study|Physician Decision|1
185835|NCT00960323|590140|P1|Atorvastatin Alone|Withdrawal by Subject|1
185836|NCT00960375|590153|P2|Overall Study|Lost to Follow-up|22
185837|NCT00960375|590154|P1|Overall Study|Lost to Follow-up|20
185838|NCT00960440|590166|P4|Overall Study|Unspecified|0
185839|NCT00960440|590167|P3|Overall Study|Unspecified|1
185840|NCT00960440|590168|P2|Overall Study|Unspecified|1
185841|NCT00960440|590169|P1|Overall Study|Unspecified|1
185842|NCT00960440|590166|P4|Overall Study|Withdrawal by Subject|1
185843|NCT00960440|590167|P3|Overall Study|Withdrawal by Subject|2
185844|NCT00960440|590168|P2|Overall Study|Withdrawal by Subject|5
185845|NCT00960440|590169|P1|Overall Study|Withdrawal by Subject|9
185846|NCT00960440|590166|P4|Overall Study|Protocol Violation|4
185847|NCT00960440|590167|P3|Overall Study|Protocol Violation|3
185848|NCT00960440|590168|P2|Overall Study|Protocol Violation|8
185849|NCT00960440|590169|P1|Overall Study|Protocol Violation|2
185850|NCT00960440|590166|P4|Overall Study|Lack of Efficacy|8
185851|NCT00960440|590167|P3|Overall Study|Lack of Efficacy|3
185852|NCT00960440|590168|P2|Overall Study|Lack of Efficacy|5
185853|NCT00960440|590169|P1|Overall Study|Lack of Efficacy|2
185854|NCT00960440|590166|P4|Overall Study|Adverse Event|4
185855|NCT00960440|590167|P3|Overall Study|Adverse Event|4
185856|NCT00960440|590168|P2|Overall Study|Adverse Event|12
185857|NCT00960440|590169|P1|Overall Study|Adverse Event|12
185858|NCT00960440|590166|P4|Overall Study|Death|1
185859|NCT00960440|590167|P3|Overall Study|Death|0
185860|NCT00960440|590168|P2|Overall Study|Death|0
185861|NCT00960440|590169|P1|Overall Study|Death|0
185862|NCT00960531|590349|P10|Overall Study|Reason not Specified|1
185863|NCT00960531|590350|P9|Overall Study|Reason not Specified|8
185864|NCT00960531|590351|P8|Overall Study|Reason not Specified|0
185865|NCT00960531|590352|P7|Overall Study|Reason not Specified|16
185866|NCT00960531|590353|P6|Overall Study|Reason not Specified|0
185867|NCT00960531|590354|P5|Overall Study|Reason not Specified|2
185868|NCT00960531|590355|P4|Overall Study|Reason not Specified|1
185869|NCT00960531|590356|P3|Overall Study|Reason not Specified|13
185870|NCT00960531|590357|P2|Overall Study|Reason not Specified|1
185871|NCT00960531|590358|P1|Overall Study|Reason not Specified|2
185872|NCT00960531|590349|P10|Overall Study|Adverse Event (AE)|0
185873|NCT00960531|590350|P9|Overall Study|Adverse Event (AE)|2
185874|NCT00960531|590351|P8|Overall Study|Adverse Event (AE)|0
185875|NCT00960531|590352|P7|Overall Study|Adverse Event (AE)|2
185876|NCT00960531|590353|P6|Overall Study|Adverse Event (AE)|1
185877|NCT00960531|590354|P5|Overall Study|Adverse Event (AE)|0
185878|NCT00960531|590355|P4|Overall Study|Adverse Event (AE)|0
185879|NCT00960531|590356|P3|Overall Study|Adverse Event (AE)|0
185880|NCT00960531|590357|P2|Overall Study|Adverse Event (AE)|0
185881|NCT00960531|590358|P1|Overall Study|Adverse Event (AE)|2
185882|NCT00960531|590349|P10|Overall Study|Failed to Return|0
185883|NCT00960531|590350|P9|Overall Study|Failed to Return|0
185884|NCT00960531|590351|P8|Overall Study|Failed to Return|2
185885|NCT00960531|590352|P7|Overall Study|Failed to Return|0
185886|NCT00960531|590353|P6|Overall Study|Failed to Return|0
185887|NCT00960531|590354|P5|Overall Study|Failed to Return|0
185888|NCT00960531|590355|P4|Overall Study|Failed to Return|0
185889|NCT00960531|590356|P3|Overall Study|Failed to Return|0
185890|NCT00960531|590357|P2|Overall Study|Failed to Return|0
185891|NCT00960531|590358|P1|Overall Study|Failed to Return|2
185892|NCT00960531|590349|P10|Overall Study|Lost to Follow-up|0
185893|NCT00960531|590350|P9|Overall Study|Lost to Follow-up|0
185894|NCT00960531|590351|P8|Overall Study|Lost to Follow-up|0
185895|NCT00960531|590352|P7|Overall Study|Lost to Follow-up|1
185896|NCT00960531|590353|P6|Overall Study|Lost to Follow-up|0
185897|NCT00960531|590354|P5|Overall Study|Lost to Follow-up|0
185898|NCT00960531|590355|P4|Overall Study|Lost to Follow-up|0
185899|NCT00960531|590356|P3|Overall Study|Lost to Follow-up|1
185900|NCT00960531|590357|P2|Overall Study|Lost to Follow-up|0
185901|NCT00960531|590358|P1|Overall Study|Lost to Follow-up|0
185902|NCT00960531|590349|P10|Overall Study|Discontinuation of Study by Sponsor|0
185903|NCT00960531|590350|P9|Overall Study|Discontinuation of Study by Sponsor|0
185904|NCT00960531|590351|P8|Overall Study|Discontinuation of Study by Sponsor|1
185905|NCT00960531|590352|P7|Overall Study|Discontinuation of Study by Sponsor|0
185906|NCT00960531|590353|P6|Overall Study|Discontinuation of Study by Sponsor|0
185907|NCT00960531|590354|P5|Overall Study|Discontinuation of Study by Sponsor|0
185908|NCT00960531|590355|P4|Overall Study|Discontinuation of Study by Sponsor|0
185909|NCT00960531|590356|P3|Overall Study|Discontinuation of Study by Sponsor|0
185910|NCT00960531|590357|P2|Overall Study|Discontinuation of Study by Sponsor|0
185911|NCT00960531|590358|P1|Overall Study|Discontinuation of Study by Sponsor|0
185912|NCT00960531|590349|P10|Overall Study|Investigator Request|0
185913|NCT00960531|590350|P9|Overall Study|Investigator Request|0
185914|NCT00960531|590351|P8|Overall Study|Investigator Request|0
185915|NCT00960531|590352|P7|Overall Study|Investigator Request|0
185916|NCT00960531|590353|P6|Overall Study|Investigator Request|0
185917|NCT00960531|590354|P5|Overall Study|Investigator Request|0
185918|NCT00960531|590355|P4|Overall Study|Investigator Request|0
185919|NCT00960531|590356|P3|Overall Study|Investigator Request|1
185920|NCT00960531|590357|P2|Overall Study|Investigator Request|0
185921|NCT00960531|590358|P1|Overall Study|Investigator Request|0
185922|NCT00960531|590349|P10|Overall Study|Caregiver Request|0
185923|NCT00960531|590350|P9|Overall Study|Caregiver Request|3
185924|NCT00960531|590351|P8|Overall Study|Caregiver Request|1
185925|NCT00960531|590352|P7|Overall Study|Caregiver Request|3
185926|NCT00960531|590353|P6|Overall Study|Caregiver Request|2
185927|NCT00960531|590354|P5|Overall Study|Caregiver Request|0
185928|NCT00960531|590355|P4|Overall Study|Caregiver Request|5
185929|NCT00960531|590356|P3|Overall Study|Caregiver Request|6
185930|NCT00960531|590357|P2|Overall Study|Caregiver Request|0
185931|NCT00960531|590358|P1|Overall Study|Caregiver Request|2
185932|NCT00960531|590349|P10|Overall Study|Withdrawal by Subject|0
185933|NCT00960531|590350|P9|Overall Study|Withdrawal by Subject|1
185934|NCT00960531|590351|P8|Overall Study|Withdrawal by Subject|0
185935|NCT00960531|590352|P7|Overall Study|Withdrawal by Subject|2
185936|NCT00960531|590353|P6|Overall Study|Withdrawal by Subject|0
185937|NCT00960531|590354|P5|Overall Study|Withdrawal by Subject|0
185938|NCT00960531|590355|P4|Overall Study|Withdrawal by Subject|2
185939|NCT00960531|590356|P3|Overall Study|Withdrawal by Subject|5
185940|NCT00960531|590357|P2|Overall Study|Withdrawal by Subject|0
185941|NCT00960531|590358|P1|Overall Study|Withdrawal by Subject|1
185942|NCT00960531|590349|P10|Overall Study|Lack of Efficacy|0
185943|NCT00960531|590350|P9|Overall Study|Lack of Efficacy|0
185944|NCT00960531|590351|P8|Overall Study|Lack of Efficacy|0
185945|NCT00960531|590352|P7|Overall Study|Lack of Efficacy|0
185946|NCT00960531|590353|P6|Overall Study|Lack of Efficacy|0
185947|NCT00960531|590354|P5|Overall Study|Lack of Efficacy|0
185948|NCT00960531|590355|P4|Overall Study|Lack of Efficacy|0
185949|NCT00960531|590356|P3|Overall Study|Lack of Efficacy|0
185950|NCT00960531|590357|P2|Overall Study|Lack of Efficacy|0
185951|NCT00960531|590358|P1|Overall Study|Lack of Efficacy|1
185952|NCT00960570|590402|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
185953|NCT00960570|590402|P1|1 Day Period Between Dosing|Adverse Event|2
185954|NCT00960570|590402|P1|21 Day Washout Period|Withdrawal by Subject|1
185955|NCT00960570|590402|P1|21 Day Washout Period|Adverse Event|1
185956|NCT00960661|590424|P3|Interventional Phase|Lack of Efficacy|0
185957|NCT00960661|590425|P2|Interventional Phase|Lack of Efficacy|2
185958|NCT00960661|590426|P1|Interventional Phase|Lack of Efficacy|0
185959|NCT00960661|590424|P3|Interventional Phase|sponsor decision|0
185960|NCT00960661|590425|P2|Interventional Phase|sponsor decision|1
185961|NCT00960661|590426|P1|Interventional Phase|sponsor decision|0
185962|NCT00960661|590424|P3|Interventional Phase|Physician Decision|5
185963|NCT00960661|590425|P2|Interventional Phase|Physician Decision|3
185964|NCT00960661|590426|P1|Interventional Phase|Physician Decision|0
185965|NCT00960661|590424|P3|Interventional Phase|Withdrawal by Subject|29
185966|NCT00960661|590425|P2|Interventional Phase|Withdrawal by Subject|18
185967|NCT00960661|590426|P1|Interventional Phase|Withdrawal by Subject|0
185968|NCT00960661|590424|P3|Interventional Phase|Protocol Violation|2
185969|NCT00960661|590425|P2|Interventional Phase|Protocol Violation|7
185970|NCT00960661|590426|P1|Interventional Phase|Protocol Violation|0
185971|NCT00960661|590424|P3|Interventional Phase|entry criteria not met|0
185972|NCT00960661|590425|P2|Interventional Phase|entry criteria not met|3
185973|NCT00960661|590426|P1|Interventional Phase|entry criteria not met|0
185974|NCT00960661|590424|P3|Interventional Phase|Lost to Follow-up|2
185975|NCT00960661|590425|P2|Interventional Phase|Lost to Follow-up|0
185976|NCT00960661|590426|P1|Interventional Phase|Lost to Follow-up|0
185977|NCT00960661|590424|P3|Interventional Phase|Death|0
185978|NCT00960661|590425|P2|Interventional Phase|Death|1
185979|NCT00960661|590426|P1|Interventional Phase|Death|0
185980|NCT00960661|590424|P3|Interventional Phase|Adverse Event|8
185981|NCT00960661|590425|P2|Interventional Phase|Adverse Event|17
185982|NCT00960661|590426|P1|Interventional Phase|Adverse Event|0
185983|NCT00960661|590424|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
185984|NCT00960661|590425|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
185985|NCT00960661|590426|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
185986|NCT00960661|590424|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
185987|NCT00960661|590425|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
185988|NCT00960661|590426|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
185989|NCT00960661|590424|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
185990|NCT00960661|590425|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
185991|NCT00960661|590426|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
185992|NCT00960661|590424|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
185993|NCT00960661|590425|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
185994|NCT00960661|590426|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
185995|NCT00960661|590424|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
185996|NCT00960661|590425|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
185997|NCT00960661|590426|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
185998|NCT00960661|590424|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
185999|NCT00960661|590425|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
186000|NCT00960661|590426|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
186001|NCT00960687|590456|P2|Washout Period of 7 Days|Withdrawal by Subject|1
186002|NCT00960687|590457|P1|Washout Period of 7 Days|Withdrawal by Subject|1
186003|NCT00960687|590456|P2|Washout Period of 7 Days|Adverse Event|2
186004|NCT00960687|590457|P1|Washout Period of 7 Days|Adverse Event|3
186005|NCT00960843|590469|P2|Overall Study|Repeated needle dislodgment|1
186006|NCT00960843|590470|P1|Overall Study|Repeated needle dislodgment|0
186007|NCT00960843|590469|P2|Overall Study|Protocol Violation|4
186008|NCT00960843|590470|P1|Overall Study|Protocol Violation|0
186009|NCT00960843|590469|P2|Overall Study|Lost to Follow-up|0
186010|NCT00960843|590470|P1|Overall Study|Lost to Follow-up|2
186011|NCT00960856|590480|P4|Washout Period of 7 Days|Adverse Event|0
186012|NCT00960856|590481|P3|Washout Period of 7 Days|Adverse Event|1
186013|NCT00960856|590482|P2|Washout Period of 7 Days|Adverse Event|0
186014|NCT00960856|590483|P1|Washout Period of 7 Days|Adverse Event|0
186015|NCT00960856|590480|P4|Washout Period of 7 Days|Withdrawal by Subject|0
186016|NCT00960856|590481|P3|Washout Period of 7 Days|Withdrawal by Subject|0
186017|NCT00960856|590482|P2|Washout Period of 7 Days|Withdrawal by Subject|2
186018|NCT00960856|590483|P1|Washout Period of 7 Days|Withdrawal by Subject|0
186019|NCT00960869|590503|P2|Overall Study|Misc|18
186020|NCT00960869|590504|P1|Overall Study|Misc|19
186021|NCT00960869|590503|P2|Overall Study|Lost to Follow-up|4
186022|NCT00960869|590504|P1|Overall Study|Lost to Follow-up|1
186023|NCT00960869|590503|P2|Overall Study|Withdrawal by Subject|14
186024|NCT00960869|590504|P1|Overall Study|Withdrawal by Subject|16
186025|NCT00960869|590503|P2|Overall Study|Adverse Event|26
186026|NCT00960869|590504|P1|Overall Study|Adverse Event|17
186027|NCT00960934|590524|P6|Overall Study|Study Terminated by Sponsor|49
186028|NCT00960934|590525|P5|Overall Study|Study Terminated by Sponsor|49
186029|NCT00960934|590526|P4|Overall Study|Study Terminated by Sponsor|50
186030|NCT00960934|590527|P3|Overall Study|Study Terminated by Sponsor|52
186031|NCT00960934|590528|P2|Overall Study|Study Terminated by Sponsor|46
186032|NCT00960934|590529|P1|Overall Study|Study Terminated by Sponsor|50
186033|NCT00960934|590524|P6|Overall Study|Withdrawal by Subject|7
186034|NCT00960934|590525|P5|Overall Study|Withdrawal by Subject|5
186035|NCT00960934|590526|P4|Overall Study|Withdrawal by Subject|5
186036|NCT00960934|590527|P3|Overall Study|Withdrawal by Subject|4
186037|NCT00960934|590528|P2|Overall Study|Withdrawal by Subject|6
186038|NCT00960934|590529|P1|Overall Study|Withdrawal by Subject|5
186039|NCT00960934|590524|P6|Overall Study|Protocol Violation|2
186040|NCT00960934|590525|P5|Overall Study|Protocol Violation|3
186041|NCT00960934|590526|P4|Overall Study|Protocol Violation|3
186042|NCT00960934|590527|P3|Overall Study|Protocol Violation|0
186043|NCT00960934|590528|P2|Overall Study|Protocol Violation|4
186044|NCT00960934|590529|P1|Overall Study|Protocol Violation|3
186045|NCT00960934|590524|P6|Overall Study|Progressive Disease|1
186046|NCT00960934|590525|P5|Overall Study|Progressive Disease|1
186047|NCT00960934|590526|P4|Overall Study|Progressive Disease|0
186048|NCT00960934|590527|P3|Overall Study|Progressive Disease|0
186049|NCT00960934|590528|P2|Overall Study|Progressive Disease|1
186050|NCT00960934|590529|P1|Overall Study|Progressive Disease|1
186051|NCT00960934|590524|P6|Overall Study|Physician Decision|0
186052|NCT00960934|590525|P5|Overall Study|Physician Decision|0
186053|NCT00960934|590526|P4|Overall Study|Physician Decision|0
186054|NCT00960934|590527|P3|Overall Study|Physician Decision|0
186055|NCT00960934|590528|P2|Overall Study|Physician Decision|1
186056|NCT00960934|590529|P1|Overall Study|Physician Decision|0
186057|NCT00960934|590524|P6|Overall Study|Not Specified|2
186058|NCT00960934|590525|P5|Overall Study|Not Specified|2
186059|NCT00960934|590526|P4|Overall Study|Not Specified|4
186060|NCT00960934|590527|P3|Overall Study|Not Specified|5
186061|NCT00960934|590528|P2|Overall Study|Not Specified|1
186062|NCT00960934|590529|P1|Overall Study|Not Specified|2
186063|NCT00960934|590524|P6|Overall Study|Lost to Follow-up|0
186064|NCT00960934|590525|P5|Overall Study|Lost to Follow-up|0
186065|NCT00960934|590526|P4|Overall Study|Lost to Follow-up|0
186066|NCT00960934|590527|P3|Overall Study|Lost to Follow-up|0
186067|NCT00960934|590528|P2|Overall Study|Lost to Follow-up|1
186068|NCT00960934|590529|P1|Overall Study|Lost to Follow-up|0
186069|NCT00960934|590524|P6|Overall Study|Lack of Efficacy|0
186070|NCT00960934|590525|P5|Overall Study|Lack of Efficacy|0
186071|NCT00960934|590526|P4|Overall Study|Lack of Efficacy|0
186072|NCT00960934|590527|P3|Overall Study|Lack of Efficacy|0
186073|NCT00960934|590528|P2|Overall Study|Lack of Efficacy|0
186074|NCT00960934|590529|P1|Overall Study|Lack of Efficacy|1
186075|NCT00960934|590524|P6|Overall Study|Adverse Event|3
186076|NCT00960934|590525|P5|Overall Study|Adverse Event|4
186077|NCT00960934|590526|P4|Overall Study|Adverse Event|2
186078|NCT00960934|590527|P3|Overall Study|Adverse Event|3
186079|NCT00960934|590528|P2|Overall Study|Adverse Event|3
186080|NCT00960934|590529|P1|Overall Study|Adverse Event|2
186081|NCT00960986|590643|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
186082|NCT00960986|590644|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
186083|NCT00960986|590645|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
186084|NCT00960986|590646|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
186085|NCT00960986|590643|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
186086|NCT00960986|590644|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
186087|NCT00960986|590645|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
186088|NCT00960986|590646|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
186089|NCT00960986|590643|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
186090|NCT00960986|590644|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
186091|NCT00960986|590645|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
186092|NCT00960986|590646|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
186093|NCT00960986|590643|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
186094|NCT00960986|590644|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
186095|NCT00960986|590645|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
186096|NCT00960986|590646|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
186097|NCT00960986|590643|P4|Period 3 (7-week Therapy Period)|Death|0
186098|NCT00960986|590644|P3|Period 3 (7-week Therapy Period)|Death|1
186099|NCT00960986|590645|P2|Period 3 (7-week Therapy Period)|Death|0
186100|NCT00960986|590646|P1|Period 3 (7-week Therapy Period)|Death|0
186101|NCT00960986|590643|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
186102|NCT00960986|590644|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
186103|NCT00960986|590645|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
186104|NCT00960986|590646|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
186105|NCT00960986|590643|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
186106|NCT00960986|590644|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
186107|NCT00960986|590645|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
186108|NCT00960986|590646|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
186109|NCT00960986|590643|P4|Period 1 (Screening and Washout)|Protocol Violation|0
186110|NCT00960986|590644|P3|Period 1 (Screening and Washout)|Protocol Violation|0
186111|NCT00960986|590645|P2|Period 1 (Screening and Washout)|Protocol Violation|0
186112|NCT00960986|590646|P1|Period 1 (Screening and Washout)|Protocol Violation|1
186113|NCT00960986|590643|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
186114|NCT00960986|590644|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
186115|NCT00960986|590645|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
186116|NCT00960986|590646|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
186117|NCT00960986|590643|P4|Period 1 (Screening and Washout)|Adverse Event|1
186118|NCT00960986|590644|P3|Period 1 (Screening and Washout)|Adverse Event|1
186119|NCT00960986|590645|P2|Period 1 (Screening and Washout)|Adverse Event|2
186120|NCT00960986|590646|P1|Period 1 (Screening and Washout)|Adverse Event|1
186121|NCT00960999|590718|P2|Overall Study|RT dose constraints not met|0
186122|NCT00960999|590719|P1|Overall Study|RT dose constraints not met|2
186123|NCT00960999|590718|P2|Overall Study|Protocol Violation|2
186124|NCT00960999|590719|P1|Overall Study|Protocol Violation|5
186125|NCT00960999|590718|P2|Overall Study|Withdrawal by Subject|0
186126|NCT00960999|590719|P1|Overall Study|Withdrawal by Subject|1
186127|NCT00961116|590736|P2|Washout Period of 7 Days|Protocol Violation|1
186128|NCT00961116|590737|P1|Washout Period of 7 Days|Protocol Violation|0
186129|NCT00961116|590736|P2|Washout Period of 7 Days|Withdrawal by Subject|1
186130|NCT00961116|590737|P1|Washout Period of 7 Days|Withdrawal by Subject|1
186131|NCT00961116|590736|P2|Washout Period of 7 Days|Adverse Event|1
186132|NCT00961116|590737|P1|Washout Period of 7 Days|Adverse Event|1
186133|NCT00961181|590747|P1|Overall Study|Lost to Follow-up|1
186134|NCT00961181|590747|P1|Overall Study|Withdrawal by Subject|2
186135|NCT00961181|590747|P1|Overall Study|Death|2
186136|NCT00961220|590760|P1|Overall Study|Complete Response prior to 12 courses|1
186137|NCT00961220|590760|P1|Overall Study|O6BG no longer supplied|1
186138|NCT00961220|590760|P1|Overall Study|No IV access for O6BG|1
186139|NCT00961220|590760|P1|Overall Study|Lack of Efficacy|1
186140|NCT00961220|590760|P1|Overall Study|Adverse Event|3
186141|NCT00961259|590787|P3|Washout Period of 7 Days|due to concomitant medication used|0
186142|NCT00961259|590788|P2|Washout Period of 7 Days|due to concomitant medication used|1
186143|NCT00961259|590789|P1|Washout Period of 7 Days|due to concomitant medication used|0
186144|NCT00961298|590806|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
186145|NCT00961298|590806|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
186146|NCT00961298|590806|P1|Two Week Placebo Run in|Withdrawal by Subject|1
186147|NCT00961350|590822|P2|Overall Study|Misc|21
186148|NCT00961350|590823|P1|Overall Study|Misc|16
186149|NCT00961350|590822|P2|Overall Study|Lost to Follow-up|3
186150|NCT00961350|590823|P1|Overall Study|Lost to Follow-up|3
186151|NCT00961350|590822|P2|Overall Study|Withdrawal by Subject|10
186152|NCT00961350|590823|P1|Overall Study|Withdrawal by Subject|10
186153|NCT00961350|590822|P2|Overall Study|Adverse Event|33
186154|NCT00961350|590823|P1|Overall Study|Adverse Event|18
186155|NCT00961415|590854|P3|Maintenance Treatment Phase|Other reason|3
186156|NCT00961415|590855|P2|Maintenance Treatment Phase|Other reason|1
186157|NCT00961415|590856|P1|Maintenance Treatment Phase|Other reason|0
186158|NCT00961415|590854|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
186159|NCT00961415|590855|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
186160|NCT00961415|590856|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
186161|NCT00961415|590854|P3|Maintenance Treatment Phase|Investigators decision|0
186162|NCT00961415|590855|P2|Maintenance Treatment Phase|Investigators decision|2
186163|NCT00961415|590856|P1|Maintenance Treatment Phase|Investigators decision|0
186164|NCT00961415|590854|P3|Maintenance Treatment Phase|Death|34
186165|NCT00961415|590855|P2|Maintenance Treatment Phase|Death|42
186166|NCT00961415|590856|P1|Maintenance Treatment Phase|Death|0
186167|NCT00961415|590854|P3|Induction Treatment Phase|Other Reason|0
186168|NCT00961415|590855|P2|Induction Treatment Phase|Other Reason|0
186169|NCT00961415|590856|P1|Induction Treatment Phase|Other Reason|5
186170|NCT00961415|590854|P3|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
186171|NCT00961415|590855|P2|Induction Treatment Phase|Didn’t meet maintenance phase criteria|0
186172|NCT00961415|590856|P1|Induction Treatment Phase|Didn’t meet maintenance phase criteria|27
186173|NCT00961415|590854|P3|Induction Treatment Phase|Physician Decision|0
186174|NCT00961415|590855|P2|Induction Treatment Phase|Physician Decision|0
186175|NCT00961415|590856|P1|Induction Treatment Phase|Physician Decision|2
186176|NCT00961415|590854|P3|Induction Treatment Phase|Protocol Violation|0
186177|NCT00961415|590855|P2|Induction Treatment Phase|Protocol Violation|0
186178|NCT00961415|590856|P1|Induction Treatment Phase|Protocol Violation|1
186179|NCT00961415|590854|P3|Induction Treatment Phase|Death|0
186180|NCT00961415|590855|P2|Induction Treatment Phase|Death|0
186181|NCT00961415|590856|P1|Induction Treatment Phase|Death|77
186182|NCT00961415|590854|P3|Induction Treatment Phase|Withdrawal by Subject|0
186183|NCT00961415|590855|P2|Induction Treatment Phase|Withdrawal by Subject|0
186184|NCT00961415|590856|P1|Induction Treatment Phase|Withdrawal by Subject|11
186185|NCT00961571|590901|P1|Overall Study|Physician Decision|39
186186|NCT00961636|590908|P3|Overall Study|Withdrawal by Subject|13
186187|NCT00961636|590909|P2|Overall Study|Withdrawal by Subject|22
186188|NCT00961636|590910|P1|Overall Study|Withdrawal by Subject|29
186189|NCT00961636|590908|P3|Overall Study|Protocol Violation|1
186190|NCT00961636|590909|P2|Overall Study|Protocol Violation|5
186191|NCT00961636|590910|P1|Overall Study|Protocol Violation|9
186192|NCT00961636|590908|P3|Overall Study|Physician Decision|1
186193|NCT00961636|590909|P2|Overall Study|Physician Decision|1
186194|NCT00961636|590910|P1|Overall Study|Physician Decision|3
186195|NCT00961636|590908|P3|Overall Study|Lost to Follow-up|1
186196|NCT00961636|590909|P2|Overall Study|Lost to Follow-up|3
186197|NCT00961636|590910|P1|Overall Study|Lost to Follow-up|2
186198|NCT00961636|590908|P3|Overall Study|Flushing Symptoms|3
186199|NCT00961636|590909|P2|Overall Study|Flushing Symptoms|46
186200|NCT00961636|590910|P1|Overall Study|Flushing Symptoms|29
186201|NCT00961636|590908|P3|Overall Study|Adverse Event|13
186202|NCT00961636|590909|P2|Overall Study|Adverse Event|54
186203|NCT00961636|590910|P1|Overall Study|Adverse Event|35
186204|NCT00961649|590925|P4|Overall Study|Study terminated by sponsor|1
186205|NCT00961649|590926|P3|Overall Study|Study terminated by sponsor|4
186206|NCT00961649|590927|P2|Overall Study|Study terminated by sponsor|4
186207|NCT00961649|590928|P1|Overall Study|Study terminated by sponsor|4
186208|NCT00961649|590925|P4|Overall Study|Patient left to Mexico-family emergency|0
186295|NCT00962585|591175|P4|Overall Study|Adverse Event|0
186209|NCT00961649|590926|P3|Overall Study|Patient left to Mexico-family emergency|0
186210|NCT00961649|590927|P2|Overall Study|Patient left to Mexico-family emergency|0
186211|NCT00961649|590928|P1|Overall Study|Patient left to Mexico-family emergency|1
186212|NCT00961649|590925|P4|Overall Study|Patient has travel plans during holidays|0
186213|NCT00961649|590926|P3|Overall Study|Patient has travel plans during holidays|1
186214|NCT00961649|590927|P2|Overall Study|Patient has travel plans during holidays|0
186215|NCT00961649|590928|P1|Overall Study|Patient has travel plans during holidays|0
186216|NCT00961649|590925|P4|Overall Study|Inadequate control of IOP|1
186217|NCT00961649|590926|P3|Overall Study|Inadequate control of IOP|0
186218|NCT00961649|590927|P2|Overall Study|Inadequate control of IOP|0
186219|NCT00961649|590928|P1|Overall Study|Inadequate control of IOP|0
186220|NCT00961649|590925|P4|Overall Study|Adverse Event|2
186221|NCT00961649|590926|P3|Overall Study|Adverse Event|0
186222|NCT00961649|590927|P2|Overall Study|Adverse Event|0
186223|NCT00961649|590928|P1|Overall Study|Adverse Event|4
186224|NCT00961896|590986|P3|Overall Study|Abnormal laboratory value|1
186225|NCT00961896|590987|P2|Overall Study|Abnormal laboratory value|0
186226|NCT00961896|590988|P1|Overall Study|Abnormal laboratory value|0
186227|NCT00962013|591018|P1|Overall Study|No 5 year evaluation|6
186228|NCT00962013|591018|P1|Overall Study|Site Termination|24
186229|NCT00962013|591018|P1|Overall Study|Removal of study device|3
186230|NCT00962013|591018|P1|Overall Study|Withdrawal by Subject|8
186231|NCT00962013|591018|P1|Overall Study|Unable/Unwilling to return|6
186232|NCT00962013|591018|P1|Overall Study|Lost to Follow-up|12
186233|NCT00962013|591018|P1|Overall Study|Death|8
186234|NCT00962013|591018|P1|Overall Study|Did not have surgery|1
186235|NCT00962104|591057|P2|Overall Study|Other|0
186236|NCT00962104|591058|P1|Overall Study|Other|2
186237|NCT00962104|591057|P2|Overall Study|Withdrawal by Subject|6
186238|NCT00962104|591058|P1|Overall Study|Withdrawal by Subject|10
186239|NCT00962104|591057|P2|Overall Study|Sponsor Decision|1
186240|NCT00962104|591058|P1|Overall Study|Sponsor Decision|0
186241|NCT00962104|591057|P2|Overall Study|Protocol Violation|8
186242|NCT00962104|591058|P1|Overall Study|Protocol Violation|6
186243|NCT00962104|591057|P2|Overall Study|Physician Decision|0
186244|NCT00962104|591058|P1|Overall Study|Physician Decision|1
186245|NCT00962104|591057|P2|Overall Study|Lost to Follow-up|4
186246|NCT00962104|591058|P1|Overall Study|Lost to Follow-up|10
186247|NCT00962104|591057|P2|Overall Study|Lack of Efficacy|1
186248|NCT00962104|591058|P1|Overall Study|Lack of Efficacy|0
186249|NCT00962104|591057|P2|Overall Study|Entry Criteria Not Met|2
186250|NCT00962104|591058|P1|Overall Study|Entry Criteria Not Met|1
186251|NCT00962104|591057|P2|Overall Study|Adverse Event|3
186252|NCT00962104|591058|P1|Overall Study|Adverse Event|10
186253|NCT00962208|591086|P2|Overall Study|Lost to Follow-up|9
186254|NCT00962208|591087|P1|Overall Study|Lost to Follow-up|0
186255|NCT00962208|591086|P2|Overall Study|Contraindicated to continue study|1
186256|NCT00962208|591087|P1|Overall Study|Contraindicated to continue study|5
186257|NCT00962208|591086|P2|Overall Study|Could not achieve good vision|0
186258|NCT00962208|591087|P1|Overall Study|Could not achieve good vision|9
186259|NCT00962247|591093|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
186260|NCT00962247|591093|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
186261|NCT00962247|591093|P1|Usual Sedentary|Withdrawal by Subject|5
186262|NCT00962247|591093|P1|Usual Sedentary|Protocol Violation|13
186263|NCT00962390|591106|P4|Overall Study|Withdrawal by Subject|0
186264|NCT00962390|591107|P3|Overall Study|Withdrawal by Subject|1
186265|NCT00962390|591108|P2|Overall Study|Withdrawal by Subject|1
186266|NCT00962390|591109|P1|Overall Study|Withdrawal by Subject|1
186267|NCT00962390|591106|P4|Overall Study|Protocol Violation|0
186268|NCT00962390|591107|P3|Overall Study|Protocol Violation|0
186269|NCT00962390|591108|P2|Overall Study|Protocol Violation|0
186270|NCT00962390|591109|P1|Overall Study|Protocol Violation|1
186271|NCT00962390|591106|P4|Overall Study|Lost to Follow-up|0
186272|NCT00962390|591107|P3|Overall Study|Lost to Follow-up|0
186273|NCT00962390|591108|P2|Overall Study|Lost to Follow-up|2
186274|NCT00962390|591109|P1|Overall Study|Lost to Follow-up|2
186275|NCT00962390|591106|P4|Overall Study|Adverse Event|1
186276|NCT00962390|591107|P3|Overall Study|Adverse Event|3
186277|NCT00962390|591108|P2|Overall Study|Adverse Event|0
186278|NCT00962390|591109|P1|Overall Study|Adverse Event|0
186279|NCT00962585|591175|P4|Overall Study|Withdrew Consent|0
186280|NCT00962585|591176|P3|Overall Study|Withdrew Consent|0
186281|NCT00962585|591177|P2|Overall Study|Withdrew Consent|0
186282|NCT00962585|591178|P1|Overall Study|Withdrew Consent|2
186283|NCT00962585|591175|P4|Overall Study|Withdrawal by Subject|0
186284|NCT00962585|591176|P3|Overall Study|Withdrawal by Subject|0
186285|NCT00962585|591177|P2|Overall Study|Withdrawal by Subject|0
186286|NCT00962585|591178|P1|Overall Study|Withdrawal by Subject|1
186287|NCT00962585|591175|P4|Overall Study|Protocol Violation|0
186288|NCT00962585|591176|P3|Overall Study|Protocol Violation|1
186289|NCT00962585|591177|P2|Overall Study|Protocol Violation|0
186290|NCT00962585|591178|P1|Overall Study|Protocol Violation|0
186291|NCT00962585|591175|P4|Overall Study|Lost to Follow-up|0
186292|NCT00962585|591176|P3|Overall Study|Lost to Follow-up|1
186293|NCT00962585|591177|P2|Overall Study|Lost to Follow-up|0
186294|NCT00962585|591178|P1|Overall Study|Lost to Follow-up|3
186296|NCT00962585|591176|P3|Overall Study|Adverse Event|1
186297|NCT00962585|591177|P2|Overall Study|Adverse Event|2
186298|NCT00962585|591178|P1|Overall Study|Adverse Event|0
186299|NCT00962598|591238|P2|Overall Study|discontinued prior to getting treatment|3
186300|NCT00962598|591239|P1|Overall Study|discontinued prior to getting treatment|0
186301|NCT00962598|591238|P2|Overall Study|Pregnancy|0
186302|NCT00962598|591239|P1|Overall Study|Pregnancy|1
186303|NCT00962598|591238|P2|Overall Study|Withdrawal by Subject|3
186304|NCT00962598|591239|P1|Overall Study|Withdrawal by Subject|1
186305|NCT00962598|591238|P2|Overall Study|Physician Decision|0
186306|NCT00962598|591239|P1|Overall Study|Physician Decision|1
186307|NCT00962598|591238|P2|Overall Study|Lost to Follow-up|0
186308|NCT00962598|591239|P1|Overall Study|Lost to Follow-up|2
186309|NCT00962598|591238|P2|Overall Study|Adverse Event|0
186310|NCT00962598|591239|P1|Overall Study|Adverse Event|1
186311|NCT00962650|591247|P1|Overall Study|Transgastric DP was not completed|2
186312|NCT00968617|591251|P1|Overall Study|Study terminated by sponsor|6
186313|NCT00968669|591267|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
186314|NCT00968669|591268|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
186315|NCT00968669|591269|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
186316|NCT00968669|591270|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
186317|NCT00968669|591267|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
186318|NCT00968669|591268|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
186319|NCT00968669|591269|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
186320|NCT00968669|591270|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
186321|NCT00968669|591267|P4|Overall Study|SUBJECT INCARCERATED|0
186322|NCT00968669|591268|P3|Overall Study|SUBJECT INCARCERATED|0
186323|NCT00968669|591269|P2|Overall Study|SUBJECT INCARCERATED|1
186324|NCT00968669|591270|P1|Overall Study|SUBJECT INCARCERATED|0
186325|NCT00968669|591267|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
186326|NCT00968669|591268|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
186327|NCT00968669|591269|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
186328|NCT00968669|591270|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
186329|NCT00968669|591267|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
186330|NCT00968669|591268|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
186331|NCT00968669|591269|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
186332|NCT00968669|591270|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
186333|NCT00968669|591267|P4|Overall Study|SPONSOR DECISION|0
186334|NCT00968669|591268|P3|Overall Study|SPONSOR DECISION|0
186335|NCT00968669|591269|P2|Overall Study|SPONSOR DECISION|1
186336|NCT00968669|591270|P1|Overall Study|SPONSOR DECISION|0
186337|NCT00968669|591267|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
186338|NCT00968669|591268|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
186339|NCT00968669|591269|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
186340|NCT00968669|591270|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
186341|NCT00968669|591267|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
186342|NCT00968669|591268|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
186343|NCT00968669|591269|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
186344|NCT00968669|591270|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
186345|NCT00968669|591267|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
186346|NCT00968669|591268|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
186347|NCT00968669|591269|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
186348|NCT00968669|591270|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
186349|NCT00968669|591267|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
186350|NCT00968669|591268|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
186351|NCT00968669|591269|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
186352|NCT00968669|591270|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
186353|NCT00968669|591267|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
186354|NCT00968669|591268|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
186355|NCT00968669|591269|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
186356|NCT00968669|591270|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
186357|NCT00968669|591267|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
186358|NCT00968669|591268|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
186359|NCT00968669|591269|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
186360|NCT00968669|591270|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
186361|NCT00968669|591267|P4|Overall Study|EARLY WITHDRAWAL|0
186362|NCT00968669|591268|P3|Overall Study|EARLY WITHDRAWAL|0
186363|NCT00968669|591269|P2|Overall Study|EARLY WITHDRAWAL|1
186364|NCT00968669|591270|P1|Overall Study|EARLY WITHDRAWAL|0
186365|NCT00968669|591267|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
186366|NCT00968669|591268|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
186367|NCT00968669|591269|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
186368|NCT00968669|591270|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
186369|NCT00968669|591267|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
186370|NCT00968669|591268|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
186371|NCT00968669|591269|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
186372|NCT00968669|591270|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
186373|NCT00968669|591267|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
186374|NCT00968669|591268|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
186375|NCT00968669|591269|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
186376|NCT00968669|591270|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
186377|NCT00968669|591267|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
186378|NCT00968669|591268|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
186379|NCT00968669|591269|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
186380|NCT00968669|591270|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
186381|NCT00968669|591267|P4|Overall Study|AE|0
186382|NCT00968669|591268|P3|Overall Study|AE|0
186383|NCT00968669|591269|P2|Overall Study|AE|0
186384|NCT00968669|591270|P1|Overall Study|AE|1
186385|NCT00968669|591267|P4|Overall Study|Pregnancy|0
186386|NCT00968669|591268|P3|Overall Study|Pregnancy|2
186387|NCT00968669|591269|P2|Overall Study|Pregnancy|0
186388|NCT00968669|591270|P1|Overall Study|Pregnancy|0
186389|NCT00968669|591267|P4|Overall Study|Withdrawal by Subject|3
186390|NCT00968669|591268|P3|Overall Study|Withdrawal by Subject|5
186391|NCT00968669|591269|P2|Overall Study|Withdrawal by Subject|7
186392|NCT00968669|591270|P1|Overall Study|Withdrawal by Subject|9
186393|NCT00968669|591267|P4|Overall Study|Lost to Follow-up|4
186394|NCT00968669|591268|P3|Overall Study|Lost to Follow-up|1
186395|NCT00968669|591269|P2|Overall Study|Lost to Follow-up|2
186396|NCT00968669|591270|P1|Overall Study|Lost to Follow-up|5
186397|NCT00971204|591360|P1|Overall Study|Lost to Follow-up|10
186398|NCT00971204|591360|P1|Overall Study|Did not meet all criteria-not treated|14
186399|NCT00971243|591369|P5|Open-label Period|Other reason|2
186400|NCT00971243|591370|P4|Open-label Period|Other reason|0
186401|NCT00971243|591371|P3|Open-label Period|Other reason|0
186402|NCT00971243|591372|P2|Open-label Period|Other reason|0
186403|NCT00971243|591373|P1|Open-label Period|Other reason|0
186404|NCT00971243|591369|P5|Open-label Period|Withdrawal by Subject|1
186405|NCT00971243|591370|P4|Open-label Period|Withdrawal by Subject|2
186406|NCT00971243|591371|P3|Open-label Period|Withdrawal by Subject|0
186407|NCT00971243|591372|P2|Open-label Period|Withdrawal by Subject|0
186408|NCT00971243|591373|P1|Open-label Period|Withdrawal by Subject|1
186409|NCT00971243|591369|P5|Open-label Period|Protocol Violation|1
186410|NCT00971243|591370|P4|Open-label Period|Protocol Violation|0
186411|NCT00971243|591371|P3|Open-label Period|Protocol Violation|1
186412|NCT00971243|591372|P2|Open-label Period|Protocol Violation|1
186413|NCT00971243|591373|P1|Open-label Period|Protocol Violation|1
186414|NCT00971243|591369|P5|Open-label Period|Physician Decision|2
186415|NCT00971243|591370|P4|Open-label Period|Physician Decision|7
186416|NCT00971243|591371|P3|Open-label Period|Physician Decision|3
186417|NCT00971243|591372|P2|Open-label Period|Physician Decision|9
186418|NCT00971243|591373|P1|Open-label Period|Physician Decision|5
186419|NCT00971243|591369|P5|Open-label Period|Adverse Event|0
186420|NCT00971243|591370|P4|Open-label Period|Adverse Event|1
186421|NCT00971243|591371|P3|Open-label Period|Adverse Event|1
186422|NCT00971243|591372|P2|Open-label Period|Adverse Event|0
186423|NCT00971243|591373|P1|Open-label Period|Adverse Event|1
186424|NCT00971243|591369|P5|Double Blind Period|Other reasons|1
186425|NCT00971243|591370|P4|Double Blind Period|Other reasons|0
186426|NCT00971243|591371|P3|Double Blind Period|Other reasons|2
186427|NCT00971243|591372|P2|Double Blind Period|Other reasons|0
186428|NCT00971243|591373|P1|Double Blind Period|Other reasons|1
186429|NCT00971243|591369|P5|Double Blind Period|Withdrawal by Subject|4
186430|NCT00971243|591370|P4|Double Blind Period|Withdrawal by Subject|4
186431|NCT00971243|591371|P3|Double Blind Period|Withdrawal by Subject|4
186432|NCT00971243|591372|P2|Double Blind Period|Withdrawal by Subject|1
186433|NCT00971243|591373|P1|Double Blind Period|Withdrawal by Subject|4
186434|NCT00971243|591369|P5|Double Blind Period|Protocol Violation|2
186435|NCT00971243|591370|P4|Double Blind Period|Protocol Violation|2
186436|NCT00971243|591371|P3|Double Blind Period|Protocol Violation|3
186437|NCT00971243|591372|P2|Double Blind Period|Protocol Violation|0
186438|NCT00971243|591373|P1|Double Blind Period|Protocol Violation|2
186439|NCT00971243|591369|P5|Double Blind Period|Physician Decision|7
186440|NCT00971243|591370|P4|Double Blind Period|Physician Decision|6
186441|NCT00971243|591371|P3|Double Blind Period|Physician Decision|7
186442|NCT00971243|591372|P2|Double Blind Period|Physician Decision|6
186443|NCT00971243|591373|P1|Double Blind Period|Physician Decision|10
186444|NCT00971243|591369|P5|Double Blind Period|Lost to Follow-up|1
186445|NCT00971243|591370|P4|Double Blind Period|Lost to Follow-up|0
186446|NCT00971243|591371|P3|Double Blind Period|Lost to Follow-up|1
186447|NCT00971243|591372|P2|Double Blind Period|Lost to Follow-up|1
186448|NCT00971243|591373|P1|Double Blind Period|Lost to Follow-up|0
186449|NCT00971243|591369|P5|Double Blind Period|Adverse Event|3
186450|NCT00971243|591370|P4|Double Blind Period|Adverse Event|2
186451|NCT00971243|591371|P3|Double Blind Period|Adverse Event|2
186452|NCT00971243|591372|P2|Double Blind Period|Adverse Event|3
186453|NCT00971243|591373|P1|Double Blind Period|Adverse Event|2
186454|NCT00971425|591417|P2|Overall Study|Withdrawal by Subject|1
186455|NCT00971425|591418|P1|Overall Study|Withdrawal by Subject|0
186456|NCT00971425|591417|P2|Overall Study|Adverse Event|1
186457|NCT00971425|591418|P1|Overall Study|Adverse Event|1
186458|NCT00971932|591520|P1|Overall Study|Ongoing|4
186459|NCT00971932|591520|P1|Overall Study|Investigator's decision|2
186460|NCT00971932|591520|P1|Overall Study|Withdrawal by Subject|1
186461|NCT00971997|591530|P1|Overall Study|Physician Decision|7
186462|NCT00971997|591530|P1|Overall Study|Withdrawal by Subject|5
186463|NCT00971997|591530|P1|Overall Study|Protocol Violation|4
186464|NCT00971997|591530|P1|Overall Study|Death|1
186465|NCT00971997|591530|P1|Overall Study|Adverse Event|2
186466|NCT00972023|591548|P1|Overall Study|Withdrawal by Subject|1
186467|NCT00972153|591562|P3|Overall Study|Equipment malfunction during case|0
186468|NCT00972153|591563|P2|Overall Study|Equipment malfunction during case|1
186469|NCT00972153|591564|P1|Overall Study|Equipment malfunction during case|0
186470|NCT00972244|591587|P5|Overall Study|Various|2
186471|NCT00972244|591588|P4|Overall Study|Various|0
186472|NCT00972244|591589|P3|Overall Study|Various|0
186473|NCT00972244|591590|P2|Overall Study|Various|0
186474|NCT00972244|591591|P1|Overall Study|Various|0
186475|NCT00972244|591587|P5|Overall Study|Death|0
186476|NCT00972244|591588|P4|Overall Study|Death|0
186477|NCT00972244|591589|P3|Overall Study|Death|0
186478|NCT00972244|591590|P2|Overall Study|Death|0
186479|NCT00972244|591591|P1|Overall Study|Death|1
186480|NCT00972244|591587|P5|Overall Study|Safety|1
186481|NCT00972244|591588|P4|Overall Study|Safety|0
186482|NCT00972244|591589|P3|Overall Study|Safety|0
186483|NCT00972244|591590|P2|Overall Study|Safety|0
186484|NCT00972244|591591|P1|Overall Study|Safety|0
186485|NCT00972244|591587|P5|Overall Study|Withdrawal by Subject|1
186486|NCT00972244|591588|P4|Overall Study|Withdrawal by Subject|0
186487|NCT00972244|591589|P3|Overall Study|Withdrawal by Subject|1
186488|NCT00972244|591590|P2|Overall Study|Withdrawal by Subject|2
186489|NCT00972244|591591|P1|Overall Study|Withdrawal by Subject|1
186490|NCT00972244|591587|P5|Overall Study|Subject No Longer Meets Study Criteria|5
186491|NCT00972244|591588|P4|Overall Study|Subject No Longer Meets Study Criteria|0
186492|NCT00972244|591589|P3|Overall Study|Subject No Longer Meets Study Criteria|0
186493|NCT00972244|591590|P2|Overall Study|Subject No Longer Meets Study Criteria|2
186494|NCT00972244|591591|P1|Overall Study|Subject No Longer Meets Study Criteria|2
186495|NCT00972244|591587|P5|Overall Study|Adverse Event|0
186496|NCT00972244|591588|P4|Overall Study|Adverse Event|0
186497|NCT00972244|591589|P3|Overall Study|Adverse Event|1
186498|NCT00972244|591590|P2|Overall Study|Adverse Event|1
186499|NCT00972244|591591|P1|Overall Study|Adverse Event|0
186500|NCT00972244|591587|P5|Overall Study|Incorrect Enrolment|0
186501|NCT00972244|591588|P4|Overall Study|Incorrect Enrolment|0
186502|NCT00972244|591589|P3|Overall Study|Incorrect Enrolment|0
186503|NCT00972244|591590|P2|Overall Study|Incorrect Enrolment|0
186504|NCT00972244|591591|P1|Overall Study|Incorrect Enrolment|1
186505|NCT00972283|591615|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
186506|NCT00972283|591616|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
186507|NCT00972283|591615|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
186508|NCT00972283|591616|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
186509|NCT00972283|591615|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
186510|NCT00972283|591616|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
186511|NCT00972283|591615|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
186512|NCT00972283|591616|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
186513|NCT00972283|591615|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
186514|NCT00972283|591616|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
186515|NCT00972283|591615|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
186516|NCT00972283|591616|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
186517|NCT00972283|591615|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
186518|NCT00972283|591616|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
186519|NCT00972283|591615|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
186520|NCT00972283|591616|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
186521|NCT00972283|591615|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
186522|NCT00972283|591616|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
186523|NCT00972283|591615|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
186524|NCT00972283|591616|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
186525|NCT00972322|591640|P2|Overall Study|Consistently high glucose values|0
186526|NCT00972322|591641|P1|Overall Study|Consistently high glucose values|1
186527|NCT00972322|591640|P2|Overall Study|Lost to Follow-up|1
186528|NCT00972322|591641|P1|Overall Study|Lost to Follow-up|0
186529|NCT00972322|591640|P2|Overall Study|Positive drug screen|1
186530|NCT00972322|591641|P1|Overall Study|Positive drug screen|0
186531|NCT00972322|591640|P2|Overall Study|Adverse Event|1
186532|NCT00972322|591641|P1|Overall Study|Adverse Event|2
186533|NCT00972478|591677|P2|Overall Study|Not start protocol treatment|2
186534|NCT00972478|591678|P1|Overall Study|Not start protocol treatment|1
186535|NCT00972478|591677|P2|Overall Study|Ineligible|7
186536|NCT00972478|591678|P1|Overall Study|Ineligible|1
186537|NCT00972478|591677|P2|Overall Study|Not protocol specified|1
186538|NCT00972478|591678|P1|Overall Study|Not protocol specified|1
186539|NCT00972478|591677|P2|Overall Study|Death|2
186540|NCT00972478|591678|P1|Overall Study|Death|0
186541|NCT00972478|591677|P2|Overall Study|Progression/Relapse|2
186542|NCT00972478|591678|P1|Overall Study|Progression/Relapse|0
186543|NCT00972478|591677|P2|Overall Study|Withdrawal by Subject|8
186544|NCT00972478|591678|P1|Overall Study|Withdrawal by Subject|1
186545|NCT00972478|591677|P2|Overall Study|Adverse Event|16
186546|NCT00972478|591678|P1|Overall Study|Adverse Event|3
186547|NCT00972504|591688|P1|Overall Study|Investigator discretion|1
186548|NCT00972504|591688|P1|Overall Study|Adverse Event|2
186549|NCT00972543|591729|P2|Overall Study|Early study termination by sponsor|1
186550|NCT00972543|591730|P1|Overall Study|Early study termination by sponsor|4
186551|NCT00972543|591729|P2|Overall Study|Adverse Event|0
186552|NCT00972543|591730|P1|Overall Study|Adverse Event|1
186553|NCT00972595|591804|P2|Period 1|Adverse Event|0
186554|NCT00972595|591805|P1|Period 1|Adverse Event|1
186555|NCT00972738|591910|P3|Overall Study|Unspecified|1
186556|NCT00972738|591911|P2|Overall Study|Unspecified|2
186557|NCT00972738|591912|P1|Overall Study|Unspecified|1
186558|NCT00972738|591910|P3|Overall Study|Moved|1
186559|NCT00972738|591911|P2|Overall Study|Moved|0
186560|NCT00972738|591912|P1|Overall Study|Moved|0
186561|NCT00972738|591910|P3|Overall Study|Withdrawal by Subject|4
186562|NCT00972738|591911|P2|Overall Study|Withdrawal by Subject|1
186563|NCT00972738|591912|P1|Overall Study|Withdrawal by Subject|5
186564|NCT00972738|591910|P3|Overall Study|Lack of Efficacy|11
186565|NCT00972738|591911|P2|Overall Study|Lack of Efficacy|1
186566|NCT00972738|591912|P1|Overall Study|Lack of Efficacy|5
186567|NCT00972738|591910|P3|Overall Study|Lost to Follow-up|1
186568|NCT00972738|591911|P2|Overall Study|Lost to Follow-up|0
186569|NCT00972738|591912|P1|Overall Study|Lost to Follow-up|1
186570|NCT00972738|591910|P3|Overall Study|Protocol Violation|3
186571|NCT00972738|591911|P2|Overall Study|Protocol Violation|1
186572|NCT00972738|591912|P1|Overall Study|Protocol Violation|2
186573|NCT00972738|591910|P3|Overall Study|Adverse Event|8
186574|NCT00972738|591911|P2|Overall Study|Adverse Event|1
186575|NCT00972738|591912|P1|Overall Study|Adverse Event|7
186576|NCT00972777|591937|P2|Overall Study|Missed visit|0
186577|NCT00972777|591938|P1|Overall Study|Missed visit|1
186578|NCT00972777|591937|P2|Overall Study|Screening Failure|1
186579|NCT00972777|591938|P1|Overall Study|Screening Failure|2
186580|NCT00972777|591937|P2|Overall Study|Protocol Violation|2
186581|NCT00972777|591938|P1|Overall Study|Protocol Violation|0
186582|NCT00972777|591937|P2|Overall Study|Physician Decision|0
186583|NCT00972777|591938|P1|Overall Study|Physician Decision|4
186584|NCT00972777|591937|P2|Overall Study|Withdrawal by Subject|5
186585|NCT00972777|591938|P1|Overall Study|Withdrawal by Subject|4
186586|NCT00972777|591937|P2|Overall Study|Lost to Follow-up|4
186587|NCT00972777|591938|P1|Overall Study|Lost to Follow-up|0
186588|NCT00972777|591937|P2|Overall Study|Adverse Event|2
186589|NCT00972777|591938|P1|Overall Study|Adverse Event|3
186590|NCT00972816|591958|P8|Overall Study|Unable to classify|0
186591|NCT00972816|591959|P7|Overall Study|Unable to classify|0
186592|NCT00972816|591960|P6|Overall Study|Unable to classify|0
186593|NCT00972816|591961|P5|Overall Study|Unable to classify|1
186594|NCT00972816|591962|P4|Overall Study|Unable to classify|0
186595|NCT00972816|591963|P3|Overall Study|Unable to classify|0
186596|NCT00972816|591964|P2|Overall Study|Unable to classify|0
186597|NCT00972816|591965|P1|Overall Study|Unable to classify|2
186598|NCT00972816|591958|P8|Overall Study|Inappropriate enrolment|0
186599|NCT00972816|591959|P7|Overall Study|Inappropriate enrolment|2
186600|NCT00972816|591960|P6|Overall Study|Inappropriate enrolment|0
186601|NCT00972816|591961|P5|Overall Study|Inappropriate enrolment|0
186602|NCT00972816|591962|P4|Overall Study|Inappropriate enrolment|0
186603|NCT00972816|591963|P3|Overall Study|Inappropriate enrolment|0
186604|NCT00972816|591964|P2|Overall Study|Inappropriate enrolment|0
186605|NCT00972816|591965|P1|Overall Study|Inappropriate enrolment|0
186606|NCT00972816|591958|P8|Overall Study|Lost to Follow-up|7
186607|NCT00972816|591959|P7|Overall Study|Lost to Follow-up|7
186608|NCT00972816|591960|P6|Overall Study|Lost to Follow-up|10
186609|NCT00972816|591961|P5|Overall Study|Lost to Follow-up|11
186610|NCT00972816|591962|P4|Overall Study|Lost to Follow-up|5
186611|NCT00972816|591963|P3|Overall Study|Lost to Follow-up|7
186612|NCT00972816|591964|P2|Overall Study|Lost to Follow-up|9
186613|NCT00972816|591965|P1|Overall Study|Lost to Follow-up|11
186614|NCT00972816|591958|P8|Overall Study|Withdrawal by Subject|2
186615|NCT00972816|591959|P7|Overall Study|Withdrawal by Subject|1
186616|NCT00972816|591960|P6|Overall Study|Withdrawal by Subject|1
186617|NCT00972816|591961|P5|Overall Study|Withdrawal by Subject|0
186618|NCT00972816|591962|P4|Overall Study|Withdrawal by Subject|3
186619|NCT00972816|591963|P3|Overall Study|Withdrawal by Subject|1
186620|NCT00972816|591964|P2|Overall Study|Withdrawal by Subject|2
186621|NCT00972816|591965|P1|Overall Study|Withdrawal by Subject|4
186622|NCT00972816|591958|P8|Overall Study|Adverse Event|0
186623|NCT00972816|591959|P7|Overall Study|Adverse Event|0
186624|NCT00972816|591960|P6|Overall Study|Adverse Event|0
186625|NCT00972816|591961|P5|Overall Study|Adverse Event|0
186626|NCT00972816|591962|P4|Overall Study|Adverse Event|0
186627|NCT00972816|591963|P3|Overall Study|Adverse Event|1
186628|NCT00972816|591964|P2|Overall Study|Adverse Event|0
186629|NCT00972816|591965|P1|Overall Study|Adverse Event|0
186630|NCT00973349|592078|P16|Overall Study|Unable to classify|0
186631|NCT00973349|592079|P15|Overall Study|Unable to classify|0
186632|NCT00973349|592080|P14|Overall Study|Unable to classify|0
186633|NCT00973349|592081|P13|Overall Study|Unable to classify|0
186634|NCT00973349|592082|P12|Overall Study|Unable to classify|0
186635|NCT00973349|592083|P11|Overall Study|Unable to classify|0
186636|NCT00973349|592084|P10|Overall Study|Unable to classify|1
186637|NCT00973349|592085|P9|Overall Study|Unable to classify|0
186638|NCT00973349|592086|P8|Overall Study|Unable to classify|0
186639|NCT00973349|592087|P7|Overall Study|Unable to classify|0
186640|NCT00973349|592088|P6|Overall Study|Unable to classify|1
186641|NCT00973349|592089|P5|Overall Study|Unable to classify|1
186642|NCT00973349|592090|P4|Overall Study|Unable to classify|0
186643|NCT00973349|592091|P3|Overall Study|Unable to classify|0
186644|NCT00973349|592092|P2|Overall Study|Unable to classify|0
186645|NCT00973349|592093|P1|Overall Study|Unable to classify|0
186646|NCT00973349|592078|P16|Overall Study|Protocol Violation|0
186647|NCT00973349|592079|P15|Overall Study|Protocol Violation|0
186648|NCT00973349|592080|P14|Overall Study|Protocol Violation|0
186649|NCT00973349|592081|P13|Overall Study|Protocol Violation|0
186650|NCT00973349|592082|P12|Overall Study|Protocol Violation|0
186651|NCT00973349|592083|P11|Overall Study|Protocol Violation|0
186652|NCT00973349|592084|P10|Overall Study|Protocol Violation|0
186653|NCT00973349|592085|P9|Overall Study|Protocol Violation|1
186654|NCT00973349|592086|P8|Overall Study|Protocol Violation|0
186655|NCT00973349|592087|P7|Overall Study|Protocol Violation|0
186656|NCT00973349|592088|P6|Overall Study|Protocol Violation|0
186657|NCT00973349|592089|P5|Overall Study|Protocol Violation|0
186658|NCT00973349|592090|P4|Overall Study|Protocol Violation|0
186659|NCT00973349|592091|P3|Overall Study|Protocol Violation|0
186660|NCT00973349|592092|P2|Overall Study|Protocol Violation|0
186661|NCT00973349|592093|P1|Overall Study|Protocol Violation|0
186662|NCT00973349|592078|P16|Overall Study|Inappropriate enrolment|1
186663|NCT00973349|592079|P15|Overall Study|Inappropriate enrolment|1
186664|NCT00973349|592080|P14|Overall Study|Inappropriate enrolment|0
186665|NCT00973349|592081|P13|Overall Study|Inappropriate enrolment|1
186666|NCT00973349|592082|P12|Overall Study|Inappropriate enrolment|0
186667|NCT00973349|592083|P11|Overall Study|Inappropriate enrolment|0
186668|NCT00973349|592084|P10|Overall Study|Inappropriate enrolment|2
186669|NCT00973349|592085|P9|Overall Study|Inappropriate enrolment|0
186670|NCT00973349|592086|P8|Overall Study|Inappropriate enrolment|0
186671|NCT00973349|592087|P7|Overall Study|Inappropriate enrolment|0
186672|NCT00973349|592088|P6|Overall Study|Inappropriate enrolment|0
186673|NCT00973349|592089|P5|Overall Study|Inappropriate enrolment|0
186674|NCT00973349|592090|P4|Overall Study|Inappropriate enrolment|0
186675|NCT00973349|592091|P3|Overall Study|Inappropriate enrolment|1
186676|NCT00973349|592092|P2|Overall Study|Inappropriate enrolment|0
186677|NCT00973349|592093|P1|Overall Study|Inappropriate enrolment|0
186678|NCT00973349|592078|P16|Overall Study|Lost to Follow-up|1
186679|NCT00973349|592079|P15|Overall Study|Lost to Follow-up|0
186680|NCT00973349|592080|P14|Overall Study|Lost to Follow-up|0
186681|NCT00973349|592081|P13|Overall Study|Lost to Follow-up|0
186682|NCT00973349|592082|P12|Overall Study|Lost to Follow-up|1
186683|NCT00973349|592083|P11|Overall Study|Lost to Follow-up|0
186684|NCT00973349|592084|P10|Overall Study|Lost to Follow-up|1
186685|NCT00973349|592085|P9|Overall Study|Lost to Follow-up|2
186686|NCT00973349|592086|P8|Overall Study|Lost to Follow-up|1
186687|NCT00973349|592087|P7|Overall Study|Lost to Follow-up|0
186688|NCT00973349|592088|P6|Overall Study|Lost to Follow-up|3
186689|NCT00973349|592089|P5|Overall Study|Lost to Follow-up|1
186690|NCT00973349|592090|P4|Overall Study|Lost to Follow-up|2
186691|NCT00973349|592091|P3|Overall Study|Lost to Follow-up|2
186692|NCT00973349|592092|P2|Overall Study|Lost to Follow-up|1
186693|NCT00973349|592093|P1|Overall Study|Lost to Follow-up|3
186694|NCT00973349|592078|P16|Overall Study|Withdrawal by Subject|0
186695|NCT00973349|592079|P15|Overall Study|Withdrawal by Subject|0
186696|NCT00973349|592080|P14|Overall Study|Withdrawal by Subject|0
186697|NCT00973349|592081|P13|Overall Study|Withdrawal by Subject|0
186698|NCT00973349|592082|P12|Overall Study|Withdrawal by Subject|1
186699|NCT00973349|592083|P11|Overall Study|Withdrawal by Subject|0
186700|NCT00973349|592084|P10|Overall Study|Withdrawal by Subject|2
186701|NCT00973349|592085|P9|Overall Study|Withdrawal by Subject|0
186702|NCT00973349|592086|P8|Overall Study|Withdrawal by Subject|2
186703|NCT00973349|592087|P7|Overall Study|Withdrawal by Subject|2
186704|NCT00973349|592088|P6|Overall Study|Withdrawal by Subject|0
186705|NCT00973349|592089|P5|Overall Study|Withdrawal by Subject|2
186706|NCT00973349|592090|P4|Overall Study|Withdrawal by Subject|3
186707|NCT00973349|592091|P3|Overall Study|Withdrawal by Subject|2
186708|NCT00973349|592092|P2|Overall Study|Withdrawal by Subject|2
186709|NCT00973349|592093|P1|Overall Study|Withdrawal by Subject|1
186710|NCT00973349|592078|P16|Overall Study|Adverse Event|0
186711|NCT00973349|592079|P15|Overall Study|Adverse Event|1
186712|NCT00973349|592080|P14|Overall Study|Adverse Event|0
186713|NCT00973349|592081|P13|Overall Study|Adverse Event|0
186714|NCT00973349|592082|P12|Overall Study|Adverse Event|0
186715|NCT00973349|592083|P11|Overall Study|Adverse Event|0
186716|NCT00973349|592084|P10|Overall Study|Adverse Event|0
186717|NCT00973349|592085|P9|Overall Study|Adverse Event|1
186718|NCT00973349|592086|P8|Overall Study|Adverse Event|0
186719|NCT00973349|592087|P7|Overall Study|Adverse Event|0
186720|NCT00973349|592088|P6|Overall Study|Adverse Event|0
186721|NCT00973349|592089|P5|Overall Study|Adverse Event|1
186722|NCT00973349|592090|P4|Overall Study|Adverse Event|0
186723|NCT00973349|592091|P3|Overall Study|Adverse Event|0
186724|NCT00973349|592092|P2|Overall Study|Adverse Event|0
186725|NCT00973349|592093|P1|Overall Study|Adverse Event|0
186726|NCT00973362|592193|P2|3-Year Follow-up|Lost to Follow-up|0
186727|NCT00973362|592194|P1|3-Year Follow-up|Lost to Follow-up|17
186728|NCT00973362|592193|P2|Baseline Evaluation|Inevaluable|223
186729|NCT00973362|592194|P1|Baseline Evaluation|Inevaluable|686
186730|NCT00973362|592193|P2|Baseline Evaluation|No colposcopy visit|0
186731|NCT00973362|592194|P1|Baseline Evaluation|No colposcopy visit|62
186732|NCT00973362|592193|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
186733|NCT00973362|592194|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
186734|NCT00973479|592205|P2|Overall Study|Not Specified|7
186735|NCT00973479|592206|P1|Overall Study|Not Specified|1
186736|NCT00973479|592205|P2|Overall Study|Protocol Violation|2
186737|NCT00973479|592206|P1|Overall Study|Protocol Violation|2
186738|NCT00973479|592205|P2|Overall Study|Adverse Event|32
186739|NCT00973479|592206|P1|Overall Study|Adverse Event|12
186740|NCT00973479|592205|P2|Overall Study|Lack of Efficacy|7
186741|NCT00973479|592206|P1|Overall Study|Lack of Efficacy|5
186742|NCT00973479|592205|P2|Overall Study|Withdrawal by Subject|16
186743|NCT00973479|592206|P1|Overall Study|Withdrawal by Subject|15
186744|NCT00973479|592205|P2|Overall Study|Death|2
186745|NCT00973479|592206|P1|Overall Study|Death|2
186746|NCT00973479|592205|P2|Overall Study|Lost to Follow-up|3
186747|NCT00973479|592206|P1|Overall Study|Lost to Follow-up|0
186748|NCT00973622|592224|P2|Overall Study|did not complete rTMS sessions|2
186749|NCT00973622|592225|P1|Overall Study|did not complete rTMS sessions|11
186750|NCT00973622|592224|P2|Overall Study|did not pass MRI screen|0
186751|NCT00973622|592225|P1|Overall Study|did not pass MRI screen|6
186752|NCT00973622|592224|P2|Overall Study|did not attend MRI|3
186753|NCT00973622|592225|P1|Overall Study|did not attend MRI|14
186754|NCT00959049|592252|P6|Overall Study|Withdrawal by Subject|0
186755|NCT00959049|592253|P5|Overall Study|Withdrawal by Subject|0
186756|NCT00959049|592254|P4|Overall Study|Withdrawal by Subject|0
186757|NCT00959049|592255|P3|Overall Study|Withdrawal by Subject|0
186758|NCT00959049|592256|P2|Overall Study|Withdrawal by Subject|2
186759|NCT00959049|592257|P1|Overall Study|Withdrawal by Subject|0
186760|NCT00959049|592252|P6|Overall Study|Contraindicated medication|0
186761|NCT00959049|592253|P5|Overall Study|Contraindicated medication|0
186762|NCT00959049|592254|P4|Overall Study|Contraindicated medication|1
186763|NCT00959049|592255|P3|Overall Study|Contraindicated medication|0
186764|NCT00959049|592256|P2|Overall Study|Contraindicated medication|0
186765|NCT00959049|592257|P1|Overall Study|Contraindicated medication|0
186766|NCT00959049|592252|P6|Overall Study|Lost to Follow-up|1
186767|NCT00959049|592253|P5|Overall Study|Lost to Follow-up|9
186768|NCT00959049|592254|P4|Overall Study|Lost to Follow-up|10
186769|NCT00959049|592255|P3|Overall Study|Lost to Follow-up|1
186770|NCT00959049|592256|P2|Overall Study|Lost to Follow-up|5
186771|NCT00959049|592257|P1|Overall Study|Lost to Follow-up|17
186772|NCT00959049|592252|P6|Overall Study|Adverse Event|0
186773|NCT00959049|592253|P5|Overall Study|Adverse Event|0
186774|NCT00959049|592254|P4|Overall Study|Adverse Event|0
186775|NCT00959049|592255|P3|Overall Study|Adverse Event|0
186776|NCT00959049|592256|P2|Overall Study|Adverse Event|0
186777|NCT00959049|592257|P1|Overall Study|Adverse Event|1
186778|NCT00959192|592311|P4|Overall Study|Caregiver Request|1
186779|NCT00959192|592312|P3|Overall Study|Caregiver Request|2
186780|NCT00959192|592313|P2|Overall Study|Caregiver Request|0
186781|NCT00959192|592314|P1|Overall Study|Caregiver Request|0
186782|NCT00959192|592311|P4|Overall Study|Investigator Request|0
186783|NCT00959192|592312|P3|Overall Study|Investigator Request|0
186784|NCT00959192|592313|P2|Overall Study|Investigator Request|0
186785|NCT00959192|592314|P1|Overall Study|Investigator Request|1
186786|NCT00959192|592311|P4|Overall Study|Adverse Event|0
186787|NCT00959192|592312|P3|Overall Study|Adverse Event|1
186788|NCT00959192|592313|P2|Overall Study|Adverse Event|1
186789|NCT00959192|592314|P1|Overall Study|Adverse Event|1
186790|NCT00959374|592356|P1|Overall Study|Physician Decision|1
186791|NCT00959374|592356|P1|Overall Study|Implant Removed/Not Replaced|4
186792|NCT00959374|592356|P1|Overall Study|Protocol Violation|1
186793|NCT00959374|592356|P1|Overall Study|Death|1
186794|NCT00959374|592356|P1|Overall Study|Lost to Follow-up|14
186795|NCT00959374|592356|P1|Overall Study|Withdrawal by Subject|2
186796|NCT00959647|592366|P1|Overall Study|Withdrawal by Subject|7
186797|NCT00959647|592366|P1|Overall Study|Study terminated by sponsor|4
186798|NCT00959647|592366|P1|Overall Study|Progressive disease|6
186799|NCT00959647|592366|P1|Overall Study|Adverse Event|2
186800|NCT00959699|592373|P2|Follow-up Period|Withdrawal by Subject|4
186801|NCT00959699|592374|P1|Follow-up Period|Withdrawal by Subject|3
186802|NCT00959699|592373|P2|Follow-up Period|Lost to Follow-up|2
186803|NCT00959699|592374|P1|Follow-up Period|Lost to Follow-up|3
186804|NCT00959699|592373|P2|Treatment Period|Futility/crossover to boceprevir|0
186805|NCT00959699|592374|P1|Treatment Period|Futility/crossover to boceprevir|4
186806|NCT00959699|592373|P2|Treatment Period|Did not receive treatment|1
186807|NCT00959699|592374|P1|Treatment Period|Did not receive treatment|0
186808|NCT00959699|592373|P2|Treatment Period|Non-Compliance with Protocol|1
186809|NCT00959699|592374|P1|Treatment Period|Non-Compliance with Protocol|0
186810|NCT00959699|592373|P2|Treatment Period|Withdrawal by Subject|3
186811|NCT00959699|592374|P1|Treatment Period|Withdrawal by Subject|1
186812|NCT00959699|592373|P2|Treatment Period|Lost to Follow-up|1
186813|NCT00959699|592374|P1|Treatment Period|Lost to Follow-up|0
186814|NCT00959699|592373|P2|Treatment Period|Lack of Efficacy|6
186815|NCT00959699|592374|P1|Treatment Period|Lack of Efficacy|15
186816|NCT00959699|592373|P2|Treatment Period|Adverse Event|13
186817|NCT00959699|592374|P1|Treatment Period|Adverse Event|3
186818|NCT00959751|592393|P2|Overall Study|No migraine headache without aura|7
186819|NCT00959751|592394|P1|Overall Study|No migraine headache without aura|7
186820|NCT00959751|592393|P2|Overall Study|Non-compliance to Study Procedures|1
186821|NCT00959751|592394|P1|Overall Study|Non-compliance to Study Procedures|0
186822|NCT00959751|592393|P2|Overall Study|Consent Withdrawn|1
186823|NCT00959751|592394|P1|Overall Study|Consent Withdrawn|0
186824|NCT00959751|592393|P2|Overall Study|Lost to Follow-up|3
186825|NCT00959751|592394|P1|Overall Study|Lost to Follow-up|2
186826|NCT00959894|592433|P1|Overall Study|Subject moved out of town|1
186827|NCT00959894|592433|P1|Overall Study|Need for contraindicated medication|1
186828|NCT00959894|592433|P1|Overall Study|Withdrawal by Subject|1
186829|NCT00959894|592433|P1|Overall Study|Adverse Event|3
186830|NCT00959894|592433|P1|Overall Study|Lost to Follow-up|10
186831|NCT00959907|592463|P2|Overall Study|Withdrawal by Subject|0
186832|NCT00959907|592464|P1|Overall Study|Withdrawal by Subject|2
186833|NCT00959907|592463|P2|Overall Study|Adverse Event|0
186834|NCT00959907|592464|P1|Overall Study|Adverse Event|1
186835|NCT00959907|592463|P2|Overall Study|Protocol Violation|1
186836|NCT00959907|592464|P1|Overall Study|Protocol Violation|0
186837|NCT00959946|592493|P8|Overall Study|Withdrawal by Subject|0
186838|NCT00959946|592494|P7|Overall Study|Withdrawal by Subject|0
186839|NCT00959946|592495|P6|Overall Study|Withdrawal by Subject|1
186840|NCT00959946|592496|P5|Overall Study|Withdrawal by Subject|0
186841|NCT00959946|592497|P4|Overall Study|Withdrawal by Subject|0
186842|NCT00959946|592498|P3|Overall Study|Withdrawal by Subject|0
186843|NCT00959946|592499|P2|Overall Study|Withdrawal by Subject|0
186844|NCT00959946|592500|P1|Overall Study|Withdrawal by Subject|0
186845|NCT00959946|592493|P8|Overall Study|Disease Progression|2
186846|NCT00959946|592494|P7|Overall Study|Disease Progression|2
186847|NCT00959946|592495|P6|Overall Study|Disease Progression|6
186848|NCT00959946|592496|P5|Overall Study|Disease Progression|4
186849|NCT00959946|592497|P4|Overall Study|Disease Progression|4
186850|NCT00959946|592498|P3|Overall Study|Disease Progression|2
186851|NCT00959946|592499|P2|Overall Study|Disease Progression|4
186852|NCT00959946|592500|P1|Overall Study|Disease Progression|2
186853|NCT00959946|592493|P8|Overall Study|Death|0
186854|NCT00959946|592494|P7|Overall Study|Death|0
186855|NCT00959946|592495|P6|Overall Study|Death|1
186856|NCT00959946|592496|P5|Overall Study|Death|0
186857|NCT00959946|592497|P4|Overall Study|Death|0
186858|NCT00959946|592498|P3|Overall Study|Death|0
186859|NCT00959946|592499|P2|Overall Study|Death|0
186860|NCT00959946|592500|P1|Overall Study|Death|0
186861|NCT00959946|592493|P8|Overall Study|Adverse Event|0
186862|NCT00959946|592494|P7|Overall Study|Adverse Event|0
186863|NCT00959946|592495|P6|Overall Study|Adverse Event|1
186864|NCT00959946|592496|P5|Overall Study|Adverse Event|0
186865|NCT00959946|592497|P4|Overall Study|Adverse Event|1
186866|NCT00959946|592498|P3|Overall Study|Adverse Event|2
186867|NCT00959946|592499|P2|Overall Study|Adverse Event|0
186868|NCT00959946|592500|P1|Overall Study|Adverse Event|0
186869|NCT00960063|592599|P3|Overall Study|Progression of Disease|3
186870|NCT00960063|592600|P2|Overall Study|Progression of Disease|0
186871|NCT00960063|592601|P1|Overall Study|Progression of Disease|0
186872|NCT00960063|592599|P3|Overall Study|Adverse Event|0
186873|NCT00960063|592600|P2|Overall Study|Adverse Event|0
186874|NCT00960063|592601|P1|Overall Study|Adverse Event|1
186875|NCT00960076|592641|P2|Overall Study|Did not attend the termination visit|1
186876|NCT00960076|592642|P1|Overall Study|Did not attend the termination visit|0
186877|NCT00960076|592641|P2|Overall Study|Hyperglycemia|5
186878|NCT00960076|592642|P1|Overall Study|Hyperglycemia|1
186879|NCT00960076|592641|P2|Overall Study|Severe non-compliance to protocol|2
186880|NCT00960076|592642|P1|Overall Study|Severe non-compliance to protocol|1
186881|NCT00960076|592641|P2|Overall Study|Lost to Follow-up|3
186882|NCT00960076|592642|P1|Overall Study|Lost to Follow-up|3
186883|NCT00960076|592641|P2|Overall Study|Withdrawal by Subject|2
186884|NCT00960076|592642|P1|Overall Study|Withdrawal by Subject|1
186885|NCT00960076|592641|P2|Overall Study|No longer met study criteria|5
186886|NCT00960076|592642|P1|Overall Study|No longer met study criteria|1
186887|NCT00960076|592641|P2|Overall Study|Adverse Event|7
186888|NCT00960076|592642|P1|Overall Study|Adverse Event|1
186889|NCT00960115|592656|P2|Overall Study|Ongoing treatment at data cut-off date|15
186890|NCT00960115|592657|P1|Overall Study|Ongoing treatment at data cut-off date|19
186891|NCT00960141|592672|P3|Overall Study|Withdrawal by Subject|1
186892|NCT00960141|592673|P2|Overall Study|Withdrawal by Subject|2
186893|NCT00960141|592674|P1|Overall Study|Withdrawal by Subject|1
186894|NCT00960141|592672|P3|Overall Study|Protocol Violation|2
186895|NCT00960141|592673|P2|Overall Study|Protocol Violation|3
186896|NCT00960141|592674|P1|Overall Study|Protocol Violation|1
186897|NCT00960141|592672|P3|Overall Study|Lost to Follow-up|0
186898|NCT00960141|592673|P2|Overall Study|Lost to Follow-up|0
186899|NCT00960141|592674|P1|Overall Study|Lost to Follow-up|1
186900|NCT00960141|592672|P3|Overall Study|Lack of Efficacy|2
186901|NCT00960141|592673|P2|Overall Study|Lack of Efficacy|4
186902|NCT00960141|592674|P1|Overall Study|Lack of Efficacy|3
186903|NCT00960141|592672|P3|Overall Study|Adverse Event|2
186904|NCT00960141|592673|P2|Overall Study|Adverse Event|8
186905|NCT00960141|592674|P1|Overall Study|Adverse Event|4
186906|NCT00960154|592699|P2|Overall Study|Study termination|25
186907|NCT00960154|592700|P1|Overall Study|Study termination|25
186908|NCT00960193|592708|P1|14 Day Washout Period|Withdrawal by Subject|1
186909|NCT00960206|592722|P3|Overall Study|Missing 10 year data|1
186910|NCT00960206|592723|P2|Overall Study|Missing 10 year data|1
186911|NCT00960206|592724|P1|Overall Study|Missing 10 year data|20
186912|NCT00960206|592722|P3|Overall Study|Revision of study component|2
186913|NCT00960206|592723|P2|Overall Study|Revision of study component|2
186914|NCT00960206|592724|P1|Overall Study|Revision of study component|2
186915|NCT00960206|592722|P3|Overall Study|Withdrawal by Subject|0
186916|NCT00960206|592723|P2|Overall Study|Withdrawal by Subject|4
186917|NCT00960206|592724|P1|Overall Study|Withdrawal by Subject|2
186918|NCT00960206|592722|P3|Overall Study|Lost to Follow-up|8
186919|NCT00960206|592723|P2|Overall Study|Lost to Follow-up|14
186920|NCT00960206|592724|P1|Overall Study|Lost to Follow-up|8
186921|NCT00960206|592722|P3|Overall Study|Unwilling/Unable to return|0
186922|NCT00960206|592723|P2|Overall Study|Unwilling/Unable to return|2
186923|NCT00960206|592724|P1|Overall Study|Unwilling/Unable to return|1
186924|NCT00960206|592722|P3|Overall Study|Death|1
186925|NCT00960206|592723|P2|Overall Study|Death|4
186926|NCT00960206|592724|P1|Overall Study|Death|7
186927|NCT00965718|592742|P1|Overall Study|Withdrawal by Subject|4
186928|NCT00965731|592754|P2|Overall Study|Not specified|15
186929|NCT00965731|592755|P1|Overall Study|Not specified|7
186930|NCT00965731|592754|P2|Overall Study|Withdrawal by Subject|1
186931|NCT00965731|592755|P1|Overall Study|Withdrawal by Subject|0
186932|NCT00965731|592754|P2|Overall Study|Death|4
186933|NCT00965731|592755|P1|Overall Study|Death|0
186934|NCT00965757|592821|P4|Extension Phase|Not Specified|1
186935|NCT00965757|592822|P3|Extension Phase|Not Specified|2
186936|NCT00965757|592823|P2|Extension Phase|Not Specified|0
186937|NCT00965757|592824|P1|Extension Phase|Not Specified|0
186938|NCT00965757|592821|P4|Extension Phase|Protocol Violation|1
186939|NCT00965757|592822|P3|Extension Phase|Protocol Violation|0
186940|NCT00965757|592823|P2|Extension Phase|Protocol Violation|0
186941|NCT00965757|592824|P1|Extension Phase|Protocol Violation|0
186942|NCT00965757|592821|P4|Extension Phase|Ineligible after Taking Study Drug|3
186943|NCT00965757|592822|P3|Extension Phase|Ineligible after Taking Study Drug|3
186944|NCT00965757|592823|P2|Extension Phase|Ineligible after Taking Study Drug|0
186945|NCT00965757|592824|P1|Extension Phase|Ineligible after Taking Study Drug|0
186946|NCT00965757|592821|P4|Extension Phase|Lost to Follow-up|1
186947|NCT00965757|592822|P3|Extension Phase|Lost to Follow-up|0
186948|NCT00965757|592823|P2|Extension Phase|Lost to Follow-up|0
186949|NCT00965757|592824|P1|Extension Phase|Lost to Follow-up|0
186950|NCT00965757|592821|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
186951|NCT00965757|592822|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
186952|NCT00965757|592823|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
186953|NCT00965757|592824|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
186954|NCT00965757|592821|P4|Extension Phase|Lack of Efficacy|12
186955|NCT00965757|592822|P3|Extension Phase|Lack of Efficacy|8
186956|NCT00965757|592823|P2|Extension Phase|Lack of Efficacy|0
186957|NCT00965757|592824|P1|Extension Phase|Lack of Efficacy|0
186958|NCT00965757|592821|P4|Extension Phase|Abnormal Laboratory Value|1
186959|NCT00965757|592822|P3|Extension Phase|Abnormal Laboratory Value|6
186960|NCT00965757|592823|P2|Extension Phase|Abnormal Laboratory Value|0
186961|NCT00965757|592824|P1|Extension Phase|Abnormal Laboratory Value|0
186962|NCT00965757|592821|P4|Extension Phase|Adverse drug reaction|3
186963|NCT00965757|592822|P3|Extension Phase|Adverse drug reaction|6
186964|NCT00965757|592823|P2|Extension Phase|Adverse drug reaction|0
186965|NCT00965757|592824|P1|Extension Phase|Adverse drug reaction|0
186966|NCT00965757|592821|P4|Extension Phase|Progression of concomitant disease|2
186967|NCT00965757|592822|P3|Extension Phase|Progression of concomitant disease|4
186968|NCT00965757|592823|P2|Extension Phase|Progression of concomitant disease|0
186969|NCT00965757|592824|P1|Extension Phase|Progression of concomitant disease|0
186970|NCT00965757|592821|P4|Double-blind Phase|Not specified|0
186971|NCT00965757|592822|P3|Double-blind Phase|Not specified|0
186972|NCT00965757|592823|P2|Double-blind Phase|Not specified|0
186973|NCT00965757|592824|P1|Double-blind Phase|Not specified|1
186974|NCT00965757|592821|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
186975|NCT00965757|592822|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
186976|NCT00965757|592823|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
186977|NCT00965757|592824|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
186978|NCT00965757|592821|P4|Double-blind Phase|Lost to Follow-up|0
186979|NCT00965757|592822|P3|Double-blind Phase|Lost to Follow-up|0
186980|NCT00965757|592823|P2|Double-blind Phase|Lost to Follow-up|1
186981|NCT00965757|592824|P1|Double-blind Phase|Lost to Follow-up|0
186982|NCT00965757|592821|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
186983|NCT00965757|592822|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
186984|NCT00965757|592823|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
186985|NCT00965757|592824|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
186986|NCT00965757|592821|P4|Double-blind Phase|Lack of Efficacy|0
186987|NCT00965757|592822|P3|Double-blind Phase|Lack of Efficacy|0
186988|NCT00965757|592823|P2|Double-blind Phase|Lack of Efficacy|11
186989|NCT00965757|592824|P1|Double-blind Phase|Lack of Efficacy|7
186990|NCT00965757|592821|P4|Double-blind Phase|Abnormal Laboratory Value|0
186991|NCT00965757|592822|P3|Double-blind Phase|Abnormal Laboratory Value|0
186992|NCT00965757|592823|P2|Double-blind Phase|Abnormal Laboratory Value|0
186993|NCT00965757|592824|P1|Double-blind Phase|Abnormal Laboratory Value|2
186994|NCT00965757|592821|P4|Double-blind Phase|Adverse drug reaction|0
186995|NCT00965757|592822|P3|Double-blind Phase|Adverse drug reaction|0
186996|NCT00965757|592823|P2|Double-blind Phase|Adverse drug reaction|1
186997|NCT00965757|592824|P1|Double-blind Phase|Adverse drug reaction|2
186998|NCT00965757|592821|P4|Double-blind Phase|Progression of concomitant disease|0
186999|NCT00965757|592822|P3|Double-blind Phase|Progression of concomitant disease|0
187000|NCT00965757|592823|P2|Double-blind Phase|Progression of concomitant disease|2
187001|NCT00965757|592824|P1|Double-blind Phase|Progression of concomitant disease|1
187002|NCT00965848|592856|P3|Overall Study|Unspecified|1
187003|NCT00965848|592857|P2|Overall Study|Unspecified|0
187004|NCT00965848|592858|P1|Overall Study|Unspecified|5
187005|NCT00965848|592856|P3|Overall Study|Not Clinically Evaluable|1
187006|NCT00965848|592857|P2|Overall Study|Not Clinically Evaluable|1
187007|NCT00965848|592858|P1|Overall Study|Not Clinically Evaluable|7
187008|NCT00965848|592856|P3|Overall Study|Indeterminate Clinical Outcome|1
187009|NCT00965848|592857|P2|Overall Study|Indeterminate Clinical Outcome|0
187010|NCT00965848|592858|P1|Overall Study|Indeterminate Clinical Outcome|2
187011|NCT00965848|592856|P3|Overall Study|Withdrawal by Subject|0
187012|NCT00965848|592857|P2|Overall Study|Withdrawal by Subject|0
187013|NCT00965848|592858|P1|Overall Study|Withdrawal by Subject|1
187014|NCT00965848|592856|P3|Overall Study|Lost to Follow-up|1
187015|NCT00965848|592857|P2|Overall Study|Lost to Follow-up|0
187016|NCT00965848|592858|P1|Overall Study|Lost to Follow-up|0
187017|NCT00965848|592856|P3|Overall Study|Death|5
187018|NCT00965848|592857|P2|Overall Study|Death|1
187019|NCT00965848|592858|P1|Overall Study|Death|11
187020|NCT00965848|592856|P3|Overall Study|Protocol Violation|1
187021|NCT00965848|592857|P2|Overall Study|Protocol Violation|0
187022|NCT00965848|592858|P1|Overall Study|Protocol Violation|3
187023|NCT00973700|592880|P5|Overall Study|Unable to Classify|1
187024|NCT00973700|592881|P4|Overall Study|Unable to Classify|2
187025|NCT00973700|592882|P3|Overall Study|Unable to Classify|1
187026|NCT00973700|592883|P2|Overall Study|Unable to Classify|0
187027|NCT00973700|592884|P1|Overall Study|Unable to Classify|0
187028|NCT00973700|592880|P5|Overall Study|Inappropriate enrolment|0
187029|NCT00973700|592881|P4|Overall Study|Inappropriate enrolment|4
187030|NCT00973700|592882|P3|Overall Study|Inappropriate enrolment|0
187031|NCT00973700|592883|P2|Overall Study|Inappropriate enrolment|0
187032|NCT00973700|592884|P1|Overall Study|Inappropriate enrolment|0
187033|NCT00973700|592880|P5|Overall Study|Lost to Follow-up|5
187034|NCT00973700|592881|P4|Overall Study|Lost to Follow-up|8
187035|NCT00973700|592882|P3|Overall Study|Lost to Follow-up|1
187036|NCT00973700|592883|P2|Overall Study|Lost to Follow-up|0
187037|NCT00973700|592884|P1|Overall Study|Lost to Follow-up|5
187038|NCT00973700|592880|P5|Overall Study|Withdrawal by Subject|4
187039|NCT00973700|592881|P4|Overall Study|Withdrawal by Subject|4
187040|NCT00973700|592882|P3|Overall Study|Withdrawal by Subject|8
187041|NCT00973700|592883|P2|Overall Study|Withdrawal by Subject|2
187042|NCT00973700|592884|P1|Overall Study|Withdrawal by Subject|2
187043|NCT00973765|592944|P2|Overall Study|Lost to Follow-up|14
187044|NCT00973765|592945|P1|Overall Study|Lost to Follow-up|8
187045|NCT00973921|592951|P1|Overall Study|IVUS results were not available|9
187046|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Various|0
187047|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Various|4
187048|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
187049|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
187050|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
187051|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
187052|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
187053|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
187054|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
187055|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
187056|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
187057|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
187058|NCT00974974|592969|P2|Maintenance - Double Blind Treatment|Adverse Event|3
187059|NCT00974974|592970|P1|Maintenance - Double Blind Treatment|Adverse Event|3
187060|NCT00974974|592969|P2|IPX066 Dose Conversion|Protocol Violation|0
187061|NCT00974974|592970|P1|IPX066 Dose Conversion|Protocol Violation|4
187062|NCT00974974|592969|P2|IPX066 Dose Conversion|Various|0
187063|NCT00974974|592970|P1|IPX066 Dose Conversion|Various|3
187064|NCT00974974|592969|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
187065|NCT00974974|592970|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
187066|NCT00974974|592969|P2|IPX066 Dose Conversion|Lack of Efficacy|0
187067|NCT00974974|592970|P1|IPX066 Dose Conversion|Lack of Efficacy|13
187068|NCT00974974|592969|P2|IPX066 Dose Conversion|Death|0
187069|NCT00974974|592970|P1|IPX066 Dose Conversion|Death|2
187070|NCT00974974|592969|P2|IPX066 Dose Conversion|Adverse Event|0
187071|NCT00974974|592970|P1|IPX066 Dose Conversion|Adverse Event|23
187072|NCT00974974|592969|P2|IR CD-LD Dose Adjustment|Various|9
187073|NCT00974974|592970|P1|IR CD-LD Dose Adjustment|Various|0
187074|NCT00974974|592969|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
187075|NCT00974974|592970|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
187076|NCT00974974|592969|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
187077|NCT00974974|592970|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
187078|NCT00974974|592969|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
187079|NCT00974974|592970|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
187080|NCT00974974|592969|P2|IR CD-LD Dose Adjustment|Adverse Event|3
187081|NCT00974974|592970|P1|IR CD-LD Dose Adjustment|Adverse Event|0
187082|NCT00975000|592982|P2|Overall Study|Non-compliance|1
187083|NCT00975000|592983|P1|Overall Study|Non-compliance|0
187084|NCT00975000|592982|P2|Overall Study|Protocol-specified Criteria|0
187085|NCT00975000|592983|P1|Overall Study|Protocol-specified Criteria|1
187086|NCT00975000|592982|P2|Overall Study|Lost to Follow-up|1
187087|NCT00975000|592983|P1|Overall Study|Lost to Follow-up|0
187088|NCT00975000|592982|P2|Overall Study|Withdrawal by Subject|2
187089|NCT00975000|592983|P1|Overall Study|Withdrawal by Subject|2
187090|NCT00975000|592982|P2|Overall Study|Adverse Event|1
187091|NCT00975000|592983|P1|Overall Study|Adverse Event|1
187092|NCT00975000|592982|P2|Overall Study|Other|0
187093|NCT00975000|592983|P1|Overall Study|Other|1
187094|NCT00975130|593005|P3|Study Part 2|Protocol Violation|1
187095|NCT00975130|593006|P2|Study Part 2|Protocol Violation|0
187096|NCT00975130|593007|P1|Study Part 2|Protocol Violation|0
187097|NCT00975130|593005|P3|Study Part 2|Administrative|0
187098|NCT00975130|593006|P2|Study Part 2|Administrative|1
187099|NCT00975130|593007|P1|Study Part 2|Administrative|0
187100|NCT00975130|593005|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
187101|NCT00975130|593006|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
187102|NCT00975130|593007|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
187103|NCT00975130|593005|P3|Study Part 2|Withdrew Consent|2
187104|NCT00975130|593006|P2|Study Part 2|Withdrew Consent|6
187105|NCT00975130|593007|P1|Study Part 2|Withdrew Consent|0
187106|NCT00975130|593005|P3|Study Part 2|Withdrawal by Subject|5
187107|NCT00975130|593006|P2|Study Part 2|Withdrawal by Subject|13
187108|NCT00975130|593007|P1|Study Part 2|Withdrawal by Subject|0
187109|NCT00975130|593005|P3|Study Part 2|Lost to Follow-up|1
187110|NCT00975130|593006|P2|Study Part 2|Lost to Follow-up|0
187111|NCT00975130|593007|P1|Study Part 2|Lost to Follow-up|0
187112|NCT00975130|593005|P3|Study Part 2|Adverse Event|7
187113|NCT00975130|593006|P2|Study Part 2|Adverse Event|14
187114|NCT00975130|593007|P1|Study Part 2|Adverse Event|0
187115|NCT00975130|593005|P3|Study Part 1|Withdrew Consent|0
187116|NCT00975130|593006|P2|Study Part 1|Withdrew Consent|0
187117|NCT00975130|593007|P1|Study Part 1|Withdrew Consent|24
187118|NCT00975130|593005|P3|Study Part 1|Administrative|0
187119|NCT00975130|593006|P2|Study Part 1|Administrative|0
187120|NCT00975130|593007|P1|Study Part 1|Administrative|4
187121|NCT00975130|593005|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
187122|NCT00975130|593006|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
187123|NCT00975130|593007|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
187124|NCT00975130|593005|P3|Study Part 1|Protocol Violation|0
187125|NCT00975130|593006|P2|Study Part 1|Protocol Violation|0
187126|NCT00975130|593007|P1|Study Part 1|Protocol Violation|13
187127|NCT00975130|593005|P3|Study Part 1|Withdrawal by Subject|0
187128|NCT00975130|593006|P2|Study Part 1|Withdrawal by Subject|0
187129|NCT00975130|593007|P1|Study Part 1|Withdrawal by Subject|61
187130|NCT00975130|593005|P3|Study Part 1|Lost to Follow-up|0
187131|NCT00975130|593006|P2|Study Part 1|Lost to Follow-up|0
187132|NCT00975130|593007|P1|Study Part 1|Lost to Follow-up|19
187133|NCT00975130|593005|P3|Study Part 1|Adverse Event|0
187134|NCT00975130|593006|P2|Study Part 1|Adverse Event|0
187135|NCT00975130|593007|P1|Study Part 1|Adverse Event|150
187136|NCT00975143|593191|P2|Overall Study|Details not available|4
187137|NCT00975143|593192|P1|Overall Study|Details not available|10
187138|NCT00975143|593191|P2|Overall Study|Physician Decision|2
187139|NCT00975143|593192|P1|Overall Study|Physician Decision|1
187140|NCT00975143|593191|P2|Overall Study|Non-compliance|8
187141|NCT00975143|593192|P1|Overall Study|Non-compliance|5
187142|NCT00975143|593191|P2|Overall Study|Lost to Follow-up|16
187143|NCT00975143|593192|P1|Overall Study|Lost to Follow-up|20
187144|NCT00975143|593191|P2|Overall Study|Withdrawal by Subject|15
187145|NCT00975143|593192|P1|Overall Study|Withdrawal by Subject|15
187146|NCT00975143|593191|P2|Overall Study|Adverse Event|15
187147|NCT00975143|593192|P1|Overall Study|Adverse Event|19
187148|NCT00975156|593204|P2|Overall Study|Protocol Violation|1
187149|NCT00975156|593205|P1|Overall Study|Protocol Violation|0
187150|NCT00975195|593217|P2|Overall Study|Not treated|2
187151|NCT00975195|593218|P1|Overall Study|Not treated|1
187152|NCT00975195|593217|P2|Overall Study|Other reason not defined above|33
187153|NCT00975195|593218|P1|Overall Study|Other reason not defined above|29
187154|NCT00975195|593217|P2|Overall Study|Withdrawal by Subject|61
187155|NCT00975195|593218|P1|Overall Study|Withdrawal by Subject|48
187156|NCT00975195|593217|P2|Overall Study|Lost to Follow-up|7
187157|NCT00975195|593218|P1|Overall Study|Lost to Follow-up|9
187158|NCT00975195|593217|P2|Overall Study|Protocol Violation|23
187159|NCT00975195|593218|P1|Overall Study|Protocol Violation|27
187160|NCT00975195|593217|P2|Overall Study|Lack of Efficacy|6
187161|NCT00975195|593218|P1|Overall Study|Lack of Efficacy|6
187162|NCT00975195|593217|P2|Overall Study|Adverse Event|101
187163|NCT00975195|593218|P1|Overall Study|Adverse Event|108
187164|NCT00975221|593278|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
187165|NCT00975221|593279|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
187166|NCT00975221|593278|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
187167|NCT00975221|593279|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
187168|NCT00975221|593278|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
187169|NCT00975221|593279|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
187170|NCT00975221|593278|P2|Titration Phase (Weeks 1-12)|Other|1
187171|NCT00975221|593279|P1|Titration Phase (Weeks 1-12)|Other|0
187172|NCT00975221|593278|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
187173|NCT00975221|593279|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
187174|NCT00975221|593278|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
187175|NCT00975221|593279|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
187176|NCT00975286|593295|P2|Overall Study|Sponsor Decision|2
187177|NCT00975286|593296|P1|Overall Study|Sponsor Decision|0
187178|NCT00975286|593295|P2|Overall Study|Poor Compliance to Protocol|2
187179|NCT00975286|593296|P1|Overall Study|Poor Compliance to Protocol|0
187180|NCT00975286|593295|P2|Overall Study|Familial and Personal Reasons|2
187181|NCT00975286|593296|P1|Overall Study|Familial and Personal Reasons|2
187182|NCT00975286|593295|P2|Overall Study|Withdrawal by Subject|2
187183|NCT00975286|593296|P1|Overall Study|Withdrawal by Subject|0
187184|NCT00975286|593295|P2|Overall Study|Protocol Violation|2
187185|NCT00975286|593296|P1|Overall Study|Protocol Violation|1
187186|NCT00975286|593295|P2|Overall Study|Adverse Event|19
187187|NCT00975286|593296|P1|Overall Study|Adverse Event|9
187188|NCT00975416|593328|P2|Overall Study|early discharge from tx|5
187189|NCT00975416|593329|P1|Overall Study|early discharge from tx|3
187190|NCT00975481|593336|P6|Fifth Intervention Period|Withdrawal by Subject|0
187191|NCT00975481|593337|P5|Fifth Intervention Period|Withdrawal by Subject|1
187192|NCT00975481|593338|P4|Fifth Intervention Period|Withdrawal by Subject|0
187193|NCT00975481|593339|P3|Fifth Intervention Period|Withdrawal by Subject|0
187194|NCT00975481|593340|P2|Fifth Intervention Period|Withdrawal by Subject|0
187195|NCT00975481|593341|P1|Fifth Intervention Period|Withdrawal by Subject|0
187196|NCT00975481|593336|P6|Fourth Intervention Period|Withdrawal by Subject|0
187197|NCT00975481|593337|P5|Fourth Intervention Period|Withdrawal by Subject|0
187198|NCT00975481|593338|P4|Fourth Intervention Period|Withdrawal by Subject|1
187199|NCT00975481|593339|P3|Fourth Intervention Period|Withdrawal by Subject|1
187200|NCT00975481|593340|P2|Fourth Intervention Period|Withdrawal by Subject|0
187201|NCT00975481|593341|P1|Fourth Intervention Period|Withdrawal by Subject|0
187202|NCT00975481|593336|P6|Second Intervention Period|Withdrawal by Subject|0
187203|NCT00975481|593337|P5|Second Intervention Period|Withdrawal by Subject|0
187204|NCT00975481|593338|P4|Second Intervention Period|Withdrawal by Subject|0
187205|NCT00975481|593339|P3|Second Intervention Period|Withdrawal by Subject|1
187206|NCT00975481|593340|P2|Second Intervention Period|Withdrawal by Subject|0
187207|NCT00975481|593341|P1|Second Intervention Period|Withdrawal by Subject|0
187208|NCT00975481|593336|P6|Second Intervention Period|Adverse Event|0
187209|NCT00975481|593337|P5|Second Intervention Period|Adverse Event|0
187210|NCT00975481|593338|P4|Second Intervention Period|Adverse Event|0
187211|NCT00975481|593339|P3|Second Intervention Period|Adverse Event|0
187212|NCT00975481|593340|P2|Second Intervention Period|Adverse Event|1
187213|NCT00975481|593341|P1|Second Intervention Period|Adverse Event|2
187214|NCT00975507|593441|P2|Overall Study|Withdrawal by Subject|3
187215|NCT00975507|593442|P1|Overall Study|Withdrawal by Subject|10
187216|NCT00975507|593441|P2|Overall Study|Protocol Violation|0
187217|NCT00975507|593442|P1|Overall Study|Protocol Violation|2
187218|NCT00975507|593441|P2|Overall Study|Lost to Follow-up|1
187219|NCT00975507|593442|P1|Overall Study|Lost to Follow-up|7
187220|NCT00975507|593441|P2|Overall Study|Adverse Event|0
187221|NCT00975507|593442|P1|Overall Study|Adverse Event|1
187222|NCT00975585|593464|P2|Overall Study|Lens issue|2
187223|NCT00975585|593465|P1|Overall Study|Lens issue|2
187224|NCT00975585|593464|P2|Overall Study|Withdrawal by Subject|1
187225|NCT00975585|593465|P1|Overall Study|Withdrawal by Subject|2
187226|NCT00975585|593464|P2|Overall Study|Lost to Follow-up|5
187227|NCT00975585|593465|P1|Overall Study|Lost to Follow-up|3
187228|NCT00975585|593464|P2|Overall Study|Adverse Event|4
187229|NCT00975585|593465|P1|Overall Study|Adverse Event|0
187230|NCT00975611|593483|P1|Overall Study|Physician Decision|1
187231|NCT00975611|593483|P1|Overall Study|Screen Fail|16
187232|NCT00975689|593515|P2|Overall Study|Physician Decision|0
187233|NCT00975689|593516|P1|Overall Study|Physician Decision|1
187234|NCT00975689|593515|P2|Overall Study|Withdrawal by Subject|0
187235|NCT00975689|593516|P1|Overall Study|Withdrawal by Subject|1
187236|NCT00975689|593515|P2|Overall Study|Adverse Event|3
187237|NCT00975689|593516|P1|Overall Study|Adverse Event|0
187238|NCT00975715|593524|P2|Maintenance Period|Adverse Event|1
187239|NCT00975715|593525|P1|Maintenance Period|Adverse Event|2
187240|NCT00975715|593524|P2|Titration Period|Protocol Violation|0
187241|NCT00975715|593525|P1|Titration Period|Protocol Violation|1
187242|NCT00975715|593524|P2|Titration Period|Adverse Event|0
187243|NCT00975715|593525|P1|Titration Period|Adverse Event|6
187244|NCT00975780|593541|P2|Follow Up|Discharged from Facility|12
187245|NCT00975780|593542|P1|Follow Up|Discharged from Facility|7
187246|NCT00975780|593541|P2|Follow Up|Facility Withdrawal|23
187247|NCT00975780|593542|P1|Follow Up|Facility Withdrawal|7
187248|NCT00975780|593541|P2|Follow Up|Death|122
187249|NCT00975780|593542|P1|Follow Up|Death|88
187250|NCT00975806|593553|P3|Overall Study|Physician decision and disease related|1
187251|NCT00975806|593554|P2|Overall Study|Physician decision and disease related|0
187252|NCT00975806|593555|P1|Overall Study|Physician decision and disease related|1
187253|NCT00975806|593553|P3|Overall Study|Death|0
187254|NCT00975806|593554|P2|Overall Study|Death|1
187255|NCT00975806|593555|P1|Overall Study|Death|0
187256|NCT00975806|593553|P3|Overall Study|Withdrawal by Subject|0
187257|NCT00975806|593554|P2|Overall Study|Withdrawal by Subject|0
187258|NCT00975806|593555|P1|Overall Study|Withdrawal by Subject|1
187259|NCT00975806|593553|P3|Overall Study|Disease Progression|1
187260|NCT00975806|593554|P2|Overall Study|Disease Progression|5
187261|NCT00975806|593555|P1|Overall Study|Disease Progression|1
187262|NCT00975806|593553|P3|Overall Study|Adverse Event|2
187263|NCT00975806|593554|P2|Overall Study|Adverse Event|1
187264|NCT00975806|593555|P1|Overall Study|Adverse Event|2
187265|NCT00975923|593579|P2|Overall Study|Withdrawal by Subject|1
187266|NCT00975923|593580|P1|Overall Study|Withdrawal by Subject|0
187267|NCT00975975|593588|P1|Overall Study|Death|6
187268|NCT00976027|593596|P2|Overall Study|Withdrawal by Subject|66
187269|NCT00976027|593597|P1|Overall Study|Withdrawal by Subject|107
187270|NCT00976027|593596|P2|Overall Study|Lost to Follow-up|103
187271|NCT00976027|593597|P1|Overall Study|Lost to Follow-up|208
187272|NCT00976027|593596|P2|Overall Study|Protocol Violation|27
187273|NCT00976027|593597|P1|Overall Study|Protocol Violation|60
187274|NCT00976027|593596|P2|Overall Study|Adverse Event|2
187275|NCT00976027|593597|P1|Overall Study|Adverse Event|0
187276|NCT00976027|593596|P2|Overall Study|Serious Adverse Event|17
187277|NCT00976027|593597|P1|Overall Study|Serious Adverse Event|36
187278|NCT00976209|593616|P2|Treatment Period 2|Lost to Follow-up|1
187279|NCT00976209|593617|P1|Treatment Period 2|Lost to Follow-up|0
187280|NCT00976209|593616|P2|Treatment Period 2|Withdrawal by Subject|1
187281|NCT00976209|593617|P1|Treatment Period 2|Withdrawal by Subject|0
187282|NCT00976209|593616|P2|Wash-out Period|Unspecified|0
187283|NCT00976209|593617|P1|Wash-out Period|Unspecified|1
187284|NCT00976209|593616|P2|Wash-out Period|Protocol Violation|0
187285|NCT00976209|593617|P1|Wash-out Period|Protocol Violation|1
187286|NCT00976209|593616|P2|Wash-out Period|Lost to Follow-up|0
187287|NCT00976209|593617|P1|Wash-out Period|Lost to Follow-up|1
187288|NCT00976209|593616|P2|Wash-out Period|Adverse Event|2
187289|NCT00976209|593617|P1|Wash-out Period|Adverse Event|1
187290|NCT00976209|593616|P2|Treatment Period 1|Unspecified|1
187291|NCT00976209|593617|P1|Treatment Period 1|Unspecified|0
187292|NCT00976209|593616|P2|Treatment Period 1|Lost to Follow-up|0
187293|NCT00976209|593617|P1|Treatment Period 1|Lost to Follow-up|2
187294|NCT00976209|593616|P2|Treatment Period 1|Protocol Violation|0
187295|NCT00976209|593617|P1|Treatment Period 1|Protocol Violation|1
187296|NCT00976274|593631|P2|Overall Study|Physician Decision|2
187297|NCT00976274|593632|P1|Overall Study|Physician Decision|1
187298|NCT00976274|593631|P2|Overall Study|Withdrawal by Subject|1
187299|NCT00976274|593632|P1|Overall Study|Withdrawal by Subject|1
187300|NCT00976274|593631|P2|Overall Study|Lost to Follow-up|5
187301|NCT00976274|593632|P1|Overall Study|Lost to Follow-up|5
187302|NCT00976391|593646|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
187303|NCT00976391|593647|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
187304|NCT00976391|593646|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
187305|NCT00976391|593647|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
187306|NCT00976391|593646|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
187307|NCT00976391|593647|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
187308|NCT00976391|593646|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
187309|NCT00976391|593647|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
187310|NCT00976391|593646|P2|Follow-up Period (8 Weeks)|Noncompliance|2
187311|NCT00976391|593647|P1|Follow-up Period (8 Weeks)|Noncompliance|2
187312|NCT00976391|593646|P2|Follow-up Period (8 Weeks)|Adverse Event|1
187313|NCT00976391|593647|P1|Follow-up Period (8 Weeks)|Adverse Event|3
187314|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Pregnancy|0
187315|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Pregnancy|1
187316|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
187317|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
187318|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Physician Decision|1
187319|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Physician Decision|1
187320|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
187321|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
187322|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
187323|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
187324|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Noncompliance|4
187325|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Noncompliance|4
187326|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Protocol Violation|1
187327|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Protocol Violation|1
187328|NCT00976391|593646|P2|Treatment Period (52 Weeks)|Adverse Event|2
187329|NCT00976391|593647|P1|Treatment Period (52 Weeks)|Adverse Event|16
187330|NCT00976456|593686|P2|Overall Study|screening failure, unknown|4
187331|NCT00976456|593687|P1|Overall Study|screening failure, unknown|11
187332|NCT00976456|593686|P2|Overall Study|Withdrawal by Subject|1
187333|NCT00976456|593687|P1|Overall Study|Withdrawal by Subject|3
187334|NCT00976456|593686|P2|Overall Study|Lack of Efficacy|2
187335|NCT00976456|593687|P1|Overall Study|Lack of Efficacy|5
187336|NCT00976456|593686|P2|Overall Study|Death|9
187337|NCT00976456|593687|P1|Overall Study|Death|7
187338|NCT00976456|593686|P2|Overall Study|Adverse Event|22
187339|NCT00976456|593687|P1|Overall Study|Adverse Event|17
187340|NCT00976482|593695|P1|Overall Study|Protocol Violation|5
187341|NCT00976482|593695|P1|Overall Study|Center terminated|1
187342|NCT00976482|593695|P1|Overall Study|Withdrawal by Subject|45
187343|NCT00976482|593695|P1|Overall Study|Death|208
187344|NCT00976495|593702|P3|Overall Study|Withdrawal by Subject|0
187345|NCT00976495|593703|P2|Overall Study|Withdrawal by Subject|1
187346|NCT00976495|593704|P1|Overall Study|Withdrawal by Subject|0
187347|NCT00976508|593723|P2|Overall Study|Terminated by the Sponsor|1
187348|NCT00976508|593724|P1|Overall Study|Terminated by the Sponsor|0
187349|NCT00976508|593723|P2|Overall Study|Subject Enrolled in Hospice|0
187350|NCT00976508|593724|P1|Overall Study|Subject Enrolled in Hospice|1
187351|NCT00976508|593723|P2|Overall Study|Disease Progression|4
187352|NCT00976508|593724|P1|Overall Study|Disease Progression|4
187353|NCT00976508|593723|P2|Overall Study|Withdrawal by Subject|0
187354|NCT00976508|593724|P1|Overall Study|Withdrawal by Subject|1
187355|NCT00976508|593723|P2|Overall Study|Lost to Follow-up|0
187356|NCT00976508|593724|P1|Overall Study|Lost to Follow-up|1
187357|NCT00976508|593723|P2|Overall Study|Death|1
187358|NCT00976508|593724|P1|Overall Study|Death|7
187359|NCT00976573|593775|P2|Overall Study|Cancel prior to receiving treatment|2
187360|NCT00976573|593776|P1|Overall Study|Cancel prior to receiving treatment|4
187361|NCT00976573|593775|P2|Overall Study|Ineligible|1
187362|NCT00976573|593776|P1|Overall Study|Ineligible|0
187363|NCT00976677|593990|P2|Overall Study|Unknown/Missing|0
187364|NCT00976677|593991|P1|Overall Study|Unknown/Missing|1
187365|NCT00976677|593990|P2|Overall Study|Trial unblinded|2
187366|NCT00976677|593991|P1|Overall Study|Trial unblinded|2
187367|NCT00976677|593990|P2|Overall Study|Disease progression|1
187368|NCT00976677|593991|P1|Overall Study|Disease progression|1
187369|NCT00976677|593990|P2|Overall Study|Withdrawal by Subject|2
187370|NCT00976677|593991|P1|Overall Study|Withdrawal by Subject|0
187371|NCT00976677|593990|P2|Overall Study|Adverse Event|0
187372|NCT00976677|593991|P1|Overall Study|Adverse Event|1
187373|NCT00976703|593999|P2|Overall Study|ineligible for study|2
187374|NCT00976703|594000|P1|Overall Study|ineligible for study|2
187375|NCT00976703|593999|P2|Overall Study|Physician Decision|1
187376|NCT00976703|594000|P1|Overall Study|Physician Decision|1
187377|NCT00976716|594012|P1|Overall Study|Adverse Event|1
187378|NCT00976911|594030|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
187379|NCT00976911|594031|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
187380|NCT00976911|594030|P2|Overall Study|Not Specified|9
187381|NCT00976911|594031|P1|Overall Study|Not Specified|8
187382|NCT00976911|594030|P2|Overall Study|Protocol Violation|0
187383|NCT00976911|594031|P1|Overall Study|Protocol Violation|2
187384|NCT00976911|594030|P2|Overall Study|Adverse Event|1
187385|NCT00976911|594031|P1|Overall Study|Adverse Event|0
187386|NCT00976911|594030|P2|Overall Study|Death|126
187387|NCT00976911|594031|P1|Overall Study|Death|138
187388|NCT00976911|594030|P2|Overall Study|Withdrawal by Subject|6
187389|NCT00976911|594031|P1|Overall Study|Withdrawal by Subject|4
187390|NCT00976937|594051|P2|Overall Study|Personal and Familial Reason|2
187391|NCT00976937|594052|P1|Overall Study|Personal and Familial Reason|2
187392|NCT00976937|594051|P2|Overall Study|Poor compliance to protocol|0
187393|NCT00976937|594052|P1|Overall Study|Poor compliance to protocol|3
187394|NCT00976937|594051|P2|Overall Study|Withdrawal by Subject|3
187395|NCT00976937|594052|P1|Overall Study|Withdrawal by Subject|5
187396|NCT00976937|594051|P2|Overall Study|Lost to Follow-up|1
187397|NCT00976937|594052|P1|Overall Study|Lost to Follow-up|2
187398|NCT00976937|594051|P2|Overall Study|Adverse Event|5
187399|NCT00976937|594052|P1|Overall Study|Adverse Event|4
187400|NCT00976950|594092|P1|Overall Study|Events with no relationship to Aptivus|3
187401|NCT00976950|594092|P1|Overall Study|Adverse Event|3
187402|NCT00976989|594101|P3|Overall Study|Unspecified|1
187403|NCT00976989|594102|P2|Overall Study|Unspecified|0
187404|NCT00976989|594103|P1|Overall Study|Unspecified|1
187405|NCT00976989|594101|P3|Overall Study|Recurrence of Disease|0
187406|NCT00976989|594102|P2|Overall Study|Recurrence of Disease|1
187407|NCT00976989|594103|P1|Overall Study|Recurrence of Disease|0
187408|NCT00976989|594101|P3|Overall Study|Failure to Return|0
187409|NCT00976989|594102|P2|Overall Study|Failure to Return|1
187410|NCT00976989|594103|P1|Overall Study|Failure to Return|2
187411|NCT00976989|594101|P3|Overall Study|Refused Treatment|5
187412|NCT00976989|594102|P2|Overall Study|Refused Treatment|3
187413|NCT00976989|594103|P1|Overall Study|Refused Treatment|4
187414|NCT00976989|594101|P3|Overall Study|Death|10
187415|NCT00976989|594102|P2|Overall Study|Death|7
187416|NCT00976989|594103|P1|Overall Study|Death|5
187417|NCT00976989|594101|P3|Overall Study|Violation of Selection Criteria at Entry|1
187418|NCT00976989|594102|P2|Overall Study|Violation of Selection Criteria at Entry|0
187419|NCT00976989|594103|P1|Overall Study|Violation of Selection Criteria at Entry|1
187420|NCT00977080|594148|P4|Overall Study|Travel for family reasons|0
187421|NCT00977080|594149|P3|Overall Study|Travel for family reasons|0
187422|NCT00977080|594150|P2|Overall Study|Travel for family reasons|0
187423|NCT00977080|594151|P1|Overall Study|Travel for family reasons|1
187424|NCT00977080|594148|P4|Overall Study|Required kidney transplantation|1
187425|NCT00977080|594149|P3|Overall Study|Required kidney transplantation|3
187426|NCT00977080|594150|P2|Overall Study|Required kidney transplantation|3
187427|NCT00977080|594151|P1|Overall Study|Required kidney transplantation|1
187428|NCT00977080|594148|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
187429|NCT00977080|594149|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
187430|NCT00977080|594150|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
187431|NCT00977080|594151|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
187432|NCT00977080|594148|P4|Overall Study|Noncompliance|0
187433|NCT00977080|594149|P3|Overall Study|Noncompliance|1
187434|NCT00977080|594150|P2|Overall Study|Noncompliance|2
187435|NCT00977080|594151|P1|Overall Study|Noncompliance|0
187436|NCT00977080|594148|P4|Overall Study|Protocol Violation|3
187437|NCT00977080|594149|P3|Overall Study|Protocol Violation|4
187438|NCT00977080|594150|P2|Overall Study|Protocol Violation|3
187439|NCT00977080|594151|P1|Overall Study|Protocol Violation|7
187440|NCT00977080|594148|P4|Overall Study|Withdrawal by Subject|5
187441|NCT00977080|594149|P3|Overall Study|Withdrawal by Subject|1
187442|NCT00977080|594150|P2|Overall Study|Withdrawal by Subject|5
187443|NCT00977080|594151|P1|Overall Study|Withdrawal by Subject|1
187444|NCT00977080|594148|P4|Overall Study|Adverse Event|7
187445|NCT00977080|594149|P3|Overall Study|Adverse Event|7
187446|NCT00977080|594150|P2|Overall Study|Adverse Event|7
187447|NCT00977080|594151|P1|Overall Study|Adverse Event|2
187448|NCT00977106|594183|P2|Overall Study|Not specified|0
187449|NCT00977106|594184|P1|Overall Study|Not specified|1
187450|NCT00977106|594183|P2|Overall Study|Protocol Violation|1
187451|NCT00977106|594184|P1|Overall Study|Protocol Violation|0
187452|NCT00977106|594183|P2|Overall Study|Lack of Efficacy|2
187453|NCT00977106|594184|P1|Overall Study|Lack of Efficacy|2
187454|NCT00977106|594183|P2|Overall Study|Withdrawal by Subject|2
187455|NCT00977106|594184|P1|Overall Study|Withdrawal by Subject|2
187456|NCT00977106|594183|P2|Overall Study|Adverse Event|6
187457|NCT00977106|594184|P1|Overall Study|Adverse Event|5
187458|NCT00977197|594307|P2|Overall Study|Nonadherence|1
187459|NCT00977197|594308|P1|Overall Study|Nonadherence|1
187460|NCT00977197|594307|P2|Overall Study|Lost to Follow-up|3
187461|NCT00977197|594308|P1|Overall Study|Lost to Follow-up|1
187462|NCT00977197|594307|P2|Overall Study|Lack of Efficacy|0
187463|NCT00977197|594308|P1|Overall Study|Lack of Efficacy|1
187464|NCT00977197|594307|P2|Overall Study|Adverse Event|1
187465|NCT00977197|594308|P1|Overall Study|Adverse Event|3
187466|NCT00977197|594307|P2|Overall Study|Withdrawal by Subject|4
187467|NCT00977197|594308|P1|Overall Study|Withdrawal by Subject|3
187468|NCT00977314|594338|P2|Overall Study|Physician Decision|0
187469|NCT00977314|594339|P1|Overall Study|Physician Decision|1
187470|NCT00977314|594338|P2|Overall Study|Withdrawal by Subject|0
187471|NCT00977314|594339|P1|Overall Study|Withdrawal by Subject|1
187472|NCT00968708|594347|P2|Overall Study|Other|34
187473|NCT00968708|594348|P1|Overall Study|Other|26
187474|NCT00968708|594347|P2|Overall Study|Investigator Discretion|1
187475|NCT00968708|594348|P1|Overall Study|Investigator Discretion|0
187476|NCT00968708|594347|P2|Overall Study|Voluntary Withdrawal|101
187477|NCT00968708|594348|P1|Overall Study|Voluntary Withdrawal|104
187478|NCT00968708|594347|P2|Overall Study|Lost to Follow-up|11
187479|NCT00968708|594348|P1|Overall Study|Lost to Follow-up|19
187480|NCT00968708|594347|P2|Overall Study|Major Protocol Deviation|1
187481|NCT00968708|594348|P1|Overall Study|Major Protocol Deviation|0
187482|NCT00968708|594347|P2|Overall Study|Adverse Event|150
187483|NCT00968708|594348|P1|Overall Study|Adverse Event|169
187484|NCT00968799|594356|P1|Overall Study|Advanced disease, HIPEC not applicable|2
187485|NCT00968812|594367|P3|Overall Study|Not specified|40
187486|NCT00968812|594368|P2|Overall Study|Not specified|37
187487|NCT00968812|594369|P1|Overall Study|Not specified|25
187488|NCT00968812|594367|P3|Overall Study|Unable to take rescue therapy|17
187489|NCT00968812|594368|P2|Overall Study|Unable to take rescue therapy|12
187490|NCT00968812|594369|P1|Overall Study|Unable to take rescue therapy|12
187491|NCT00968812|594367|P3|Overall Study|Noncompliance with study drug|6
187492|NCT00968812|594368|P2|Overall Study|Noncompliance with study drug|1
187493|NCT00968812|594369|P1|Overall Study|Noncompliance with study drug|4
187494|NCT00968812|594367|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
187495|NCT00968812|594368|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
187496|NCT00968812|594369|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
187497|NCT00968812|594367|P3|Overall Study|Withdrawal by Subject|25
187498|NCT00968812|594368|P2|Overall Study|Withdrawal by Subject|23
187499|NCT00968812|594369|P1|Overall Study|Withdrawal by Subject|17
187500|NCT00968812|594367|P3|Overall Study|Protocol Violation|3
187501|NCT00968812|594368|P2|Overall Study|Protocol Violation|4
187502|NCT00968812|594369|P1|Overall Study|Protocol Violation|7
187503|NCT00968812|594367|P3|Overall Study|Physician Decision|9
187504|NCT00968812|594368|P2|Overall Study|Physician Decision|5
187505|NCT00968812|594369|P1|Overall Study|Physician Decision|8
187506|NCT00968812|594367|P3|Overall Study|Lost to Follow-up|11
187507|NCT00968812|594368|P2|Overall Study|Lost to Follow-up|12
187508|NCT00968812|594369|P1|Overall Study|Lost to Follow-up|17
187509|NCT00968812|594367|P3|Overall Study|Lack of Efficacy|16
187510|NCT00968812|594368|P2|Overall Study|Lack of Efficacy|7
187511|NCT00968812|594369|P1|Overall Study|Lack of Efficacy|9
187512|NCT00968812|594367|P3|Overall Study|Death|1
187513|NCT00968812|594368|P2|Overall Study|Death|2
187514|NCT00968812|594369|P1|Overall Study|Death|2
187515|NCT00968812|594367|P3|Overall Study|Adverse Event|33
187516|NCT00968812|594368|P2|Overall Study|Adverse Event|46
187517|NCT00968812|594369|P1|Overall Study|Adverse Event|30
187518|NCT00968981|594432|P3|Overall Study|Withdrawal by Subject|3
187519|NCT00968981|594433|P2|Overall Study|Withdrawal by Subject|3
187520|NCT00968981|594434|P1|Overall Study|Withdrawal by Subject|1
187521|NCT00968981|594432|P3|Overall Study|Physician Decision|5
187522|NCT00968981|594433|P2|Overall Study|Physician Decision|3
187523|NCT00968981|594434|P1|Overall Study|Physician Decision|5
187524|NCT00968981|594432|P3|Overall Study|Lost to Follow-up|1
187525|NCT00968981|594433|P2|Overall Study|Lost to Follow-up|0
187526|NCT00968981|594434|P1|Overall Study|Lost to Follow-up|0
187527|NCT00968981|594432|P3|Overall Study|Disease Progression|13
187528|NCT00968981|594433|P2|Overall Study|Disease Progression|16
187529|NCT00968981|594434|P1|Overall Study|Disease Progression|14
187530|NCT00968981|594432|P3|Overall Study|Adverse Event|0
187531|NCT00968981|594433|P2|Overall Study|Adverse Event|0
187532|NCT00968981|594434|P1|Overall Study|Adverse Event|2
187533|NCT00969124|594470|P1|Overall Study|Technical error|1
187534|NCT00969124|594470|P1|Overall Study|Previously unrecognized disease|3
187535|NCT00969124|594470|P1|Overall Study|Inability to reach cecum|9
187536|NCT00969124|594470|P1|Overall Study|Inadequate bowel preparation|15
187537|NCT00969124|594470|P1|Overall Study|Protocol Violation|2
187538|NCT00969150|594478|P2|Overall Study|Other reasons|0
187539|NCT00969150|594479|P1|Overall Study|Other reasons|1
187540|NCT00969150|594478|P2|Overall Study|Lost to Follow-up|4
187541|NCT00969150|594479|P1|Overall Study|Lost to Follow-up|5
187542|NCT00969150|594478|P2|Overall Study|Withdrawal by Subject|9
187543|NCT00969150|594479|P1|Overall Study|Withdrawal by Subject|13
187544|NCT00969150|594478|P2|Overall Study|Protocol Violation|12
187545|NCT00969150|594479|P1|Overall Study|Protocol Violation|9
187546|NCT00969150|594478|P2|Overall Study|Lack of Efficacy|1
187547|NCT00969150|594479|P1|Overall Study|Lack of Efficacy|1
187548|NCT00969150|594478|P2|Overall Study|Adverse Event|14
187549|NCT00969150|594479|P1|Overall Study|Adverse Event|4
187550|NCT00969228|594489|P2|Overall Study|Porcine circovirus detection in vaccine|14
187551|NCT00969228|594490|P1|Overall Study|Porcine circovirus detection in vaccine|38
187552|NCT00969228|594489|P2|Overall Study|Withdrawal by Subject|0
187553|NCT00969228|594490|P1|Overall Study|Withdrawal by Subject|4
187554|NCT00969228|594489|P2|Overall Study|Adverse Event|0
187555|NCT00969228|594490|P1|Overall Study|Adverse Event|1
187556|NCT00969280|594508|P2|Overall Study|infection of influenza A(H1N1)|1
187557|NCT00969280|594509|P1|Overall Study|infection of influenza A(H1N1)|0
187558|NCT00969280|594508|P2|Overall Study|Withdrawal by Subject|1
187559|NCT00969280|594509|P1|Overall Study|Withdrawal by Subject|0
187560|NCT00969280|594508|P2|Overall Study|Protocol Violation|1
187561|NCT00969280|594509|P1|Overall Study|Protocol Violation|2
187562|NCT00969540|594521|P2|Overall Study|Lost to Follow-up|1
187563|NCT00969540|594522|P1|Overall Study|Lost to Follow-up|1
187564|NCT00969618|594540|P1|Overall Study|Withdrawal by Subject|27
187565|NCT00969618|594540|P1|Overall Study|Protocol Violation|9
187566|NCT00969618|594540|P1|Overall Study|Physician Decision|1
187567|NCT00969618|594540|P1|Overall Study|Lost to Follow-up|7
187568|NCT00969618|594540|P1|Overall Study|Lack of Efficacy|2
187569|NCT00969618|594540|P1|Overall Study|Entry Criteria Not Met|3
187570|NCT00969618|594540|P1|Overall Study|Adverse Event|29
187571|NCT00969709|594555|P4|Overall Study|Other reasons|0
187572|NCT00969709|594556|P3|Overall Study|Other reasons|3
187573|NCT00969709|594557|P2|Overall Study|Other reasons|0
187574|NCT00969709|594558|P1|Overall Study|Other reasons|0
187575|NCT00969709|594555|P4|Overall Study|Lost to Follow-up|15
187576|NCT00969709|594556|P3|Overall Study|Lost to Follow-up|8
187577|NCT00969709|594557|P2|Overall Study|Lost to Follow-up|14
187578|NCT00969709|594558|P1|Overall Study|Lost to Follow-up|10
187579|NCT00969709|594555|P4|Overall Study|Withdrawal by Subject|23
187580|NCT00969709|594556|P3|Overall Study|Withdrawal by Subject|11
187581|NCT00969709|594557|P2|Overall Study|Withdrawal by Subject|12
187582|NCT00969709|594558|P1|Overall Study|Withdrawal by Subject|9
187583|NCT00969709|594555|P4|Overall Study|Protocol Violation|10
187584|NCT00969709|594556|P3|Overall Study|Protocol Violation|9
187585|NCT00969709|594557|P2|Overall Study|Protocol Violation|5
187586|NCT00969709|594558|P1|Overall Study|Protocol Violation|9
187587|NCT00969709|594555|P4|Overall Study|Lack of Efficacy|3
187588|NCT00969709|594556|P3|Overall Study|Lack of Efficacy|1
187589|NCT00969709|594557|P2|Overall Study|Lack of Efficacy|4
187590|NCT00969709|594558|P1|Overall Study|Lack of Efficacy|7
187591|NCT00969709|594555|P4|Overall Study|Adverse Event|12
187592|NCT00969709|594556|P3|Overall Study|Adverse Event|26
187593|NCT00969709|594557|P2|Overall Study|Adverse Event|13
187594|NCT00969709|594558|P1|Overall Study|Adverse Event|3
187595|NCT00970268|594589|P2|Overall Study|Inclusion/Exclusion Criteria|0
187596|NCT00970268|594590|P1|Overall Study|Inclusion/Exclusion Criteria|1
187597|NCT00970268|594589|P2|Overall Study|Lost to Follow-up|2
187598|NCT00970268|594590|P1|Overall Study|Lost to Follow-up|1
187599|NCT00970268|594589|P2|Overall Study|COPD Exacerbation|2
187600|NCT00970268|594590|P1|Overall Study|COPD Exacerbation|4
187601|NCT00970268|594589|P2|Overall Study|Other Reason|1
187602|NCT00970268|594590|P1|Overall Study|Other Reason|3
187603|NCT00970268|594589|P2|Overall Study|Protocol Violation|7
187604|NCT00970268|594590|P1|Overall Study|Protocol Violation|4
187605|NCT00970268|594589|P2|Overall Study|Lack of Efficacy|6
187606|NCT00970268|594590|P1|Overall Study|Lack of Efficacy|3
187607|NCT00970268|594589|P2|Overall Study|Adverse Event|12
187608|NCT00970268|594590|P1|Overall Study|Adverse Event|15
187609|NCT00970268|594589|P2|Overall Study|Withdrawal by Subject|19
187610|NCT00970268|594590|P1|Overall Study|Withdrawal by Subject|12
187611|NCT00970281|594606|P2|Overall Study|Physician Decision|1
187612|NCT00970281|594607|P1|Overall Study|Physician Decision|1
187613|NCT00970281|594606|P2|Overall Study|Withdrawal by Subject|1
187614|NCT00970281|594607|P1|Overall Study|Withdrawal by Subject|0
187615|NCT00970281|594606|P2|Overall Study|Lack of Efficacy|14
187616|NCT00970281|594607|P1|Overall Study|Lack of Efficacy|1
187617|NCT00970294|594623|P1|Overall Study|Withdrawal by Subject|1
187618|NCT00970294|594623|P1|Overall Study|Physician Decision|4
187619|NCT00970307|594632|P3|Overall Study|Withdrawal by Subject|2
187620|NCT00970307|594633|P2|Overall Study|Withdrawal by Subject|3
187621|NCT00970307|594634|P1|Overall Study|Withdrawal by Subject|2
187622|NCT00970307|594632|P3|Overall Study|Serious Adverse Event|0
187623|NCT00970307|594633|P2|Overall Study|Serious Adverse Event|0
187624|NCT00970307|594634|P1|Overall Study|Serious Adverse Event|1
187625|NCT00970359|594729|P1|Overall Study|Not Treated|4
187626|NCT00970489|594737|P2|Overall Study|Death/Withdrew/Criteria Violation|41
187627|NCT00970489|594738|P1|Overall Study|Death/Withdrew/Criteria Violation|54
187628|NCT00970502|594750|P1|Overall Study|Withdrawal by Subject|1
187629|NCT00970632|594771|P3|Overall Study|Sponsor decision|1
187630|NCT00970632|594772|P2|Overall Study|Sponsor decision|0
187631|NCT00970632|594773|P1|Overall Study|Sponsor decision|1
187632|NCT00970632|594771|P3|Overall Study|Entry criteria not met|2
187633|NCT00970632|594772|P2|Overall Study|Entry criteria not met|2
187634|NCT00970632|594773|P1|Overall Study|Entry criteria not met|0
187635|NCT00970632|594771|P3|Overall Study|Withdrawal by Subject|4
187636|NCT00970632|594772|P2|Overall Study|Withdrawal by Subject|6
187637|NCT00970632|594773|P1|Overall Study|Withdrawal by Subject|7
187638|NCT00970632|594771|P3|Overall Study|Protocol Violation|8
187639|NCT00970632|594772|P2|Overall Study|Protocol Violation|5
187640|NCT00970632|594773|P1|Overall Study|Protocol Violation|8
187641|NCT00970632|594771|P3|Overall Study|Lost to Follow-up|2
187642|NCT00970632|594772|P2|Overall Study|Lost to Follow-up|0
187643|NCT00970632|594773|P1|Overall Study|Lost to Follow-up|3
187644|NCT00970632|594771|P3|Overall Study|Lack of Efficacy|0
187645|NCT00970632|594772|P2|Overall Study|Lack of Efficacy|0
187646|NCT00970632|594773|P1|Overall Study|Lack of Efficacy|3
187647|NCT00970632|594771|P3|Overall Study|Adverse Event|1
187648|NCT00970632|594772|P2|Overall Study|Adverse Event|2
187649|NCT00970632|594773|P1|Overall Study|Adverse Event|2
187650|NCT00970684|594829|P1|Overall Study|Withdrawal by Subject|1
187651|NCT00970684|594829|P1|Overall Study|Adverse Event|4
187652|NCT00970684|594829|P1|Overall Study|Lack of Efficacy|5
187653|NCT00970944|594881|P2|Overall Study|Physician Decision|2
187654|NCT00970944|594882|P1|Overall Study|Physician Decision|0
187655|NCT00970944|594881|P2|Overall Study|Death|0
187656|NCT00970944|594882|P1|Overall Study|Death|1
187657|NCT00971048|594894|P4|Overall Study|Physician Decision|1
187658|NCT00971048|594895|P3|Overall Study|Physician Decision|0
187659|NCT00971048|594896|P2|Overall Study|Physician Decision|0
187660|NCT00971048|594897|P1|Overall Study|Physician Decision|0
187661|NCT00971048|594894|P4|Overall Study|Adverse Event|0
187662|NCT00971048|594895|P3|Overall Study|Adverse Event|1
187663|NCT00971048|594896|P2|Overall Study|Adverse Event|0
187664|NCT00971048|594897|P1|Overall Study|Adverse Event|0
187665|NCT00971048|594894|P4|Overall Study|Protocol Violation|1
187666|NCT00971048|594895|P3|Overall Study|Protocol Violation|0
187667|NCT00971048|594896|P2|Overall Study|Protocol Violation|2
187668|NCT00971048|594897|P1|Overall Study|Protocol Violation|1
187669|NCT00977379|594921|P2|Overall Study|Randomization Error|1
187670|NCT00977379|594922|P1|Overall Study|Randomization Error|0
187671|NCT00977379|594921|P2|Overall Study|Participant Moving House|1
187672|NCT00977379|594922|P1|Overall Study|Participant Moving House|0
187673|NCT00977379|594921|P2|Overall Study|Premature Study Termination|0
187674|NCT00977379|594922|P1|Overall Study|Premature Study Termination|4
187675|NCT00977379|594921|P2|Overall Study|Death|9
187676|NCT00977379|594922|P1|Overall Study|Death|7
187677|NCT00977379|594921|P2|Overall Study|Withdrawal by Subject|1
187678|NCT00977379|594922|P1|Overall Study|Withdrawal by Subject|1
187679|NCT00977470|594958|P2|Overall Study|Still on-study|0
187680|NCT00977470|594959|P1|Overall Study|Still on-study|2
187681|NCT00977470|594958|P2|Overall Study|prolonged recovery post-surgery|1
187682|NCT00977470|594959|P1|Overall Study|prolonged recovery post-surgery|0
187683|NCT00977470|594958|P2|Overall Study|clinical decline|1
187684|NCT00977470|594959|P1|Overall Study|clinical decline|0
187685|NCT00977470|594958|P2|Overall Study|Death|2
187686|NCT00977470|594959|P1|Overall Study|Death|0
187687|NCT00977470|594958|P2|Overall Study|Withdrawal by Subject|2
187688|NCT00977470|594959|P1|Overall Study|Withdrawal by Subject|0
187689|NCT00977470|594958|P2|Overall Study|Protocol Violation|0
187690|NCT00977470|594959|P1|Overall Study|Protocol Violation|1
187691|NCT00977470|594958|P2|Overall Study|Adverse Event|2
187692|NCT00977470|594959|P1|Overall Study|Adverse Event|1
187693|NCT00977470|594958|P2|Overall Study|Physician Decision|0
187694|NCT00977470|594959|P1|Overall Study|Physician Decision|2
187695|NCT00977470|594958|P2|Overall Study|Lack of Efficacy|30
187696|NCT00977470|594959|P1|Overall Study|Lack of Efficacy|32
187697|NCT00977548|594977|P1|Overall Study|Withdrawal by Subject|1
187698|NCT00977548|594977|P1|Overall Study|Adverse Event|8
187699|NCT00977548|594977|P1|Overall Study|Ineligible|4
187700|NCT00977561|594986|P2|Overall Study|Unspecified|0
187701|NCT00977561|594987|P1|Overall Study|Unspecified|2
187702|NCT00977561|594986|P2|Overall Study|Study terminated|2
187703|NCT00977561|594987|P1|Overall Study|Study terminated|0
187704|NCT00977561|594986|P2|Overall Study|Death|2
187705|NCT00977561|594987|P1|Overall Study|Death|3
187706|NCT00977613|595014|P1|Overall Study|Lost to Follow-up|16
187707|NCT00977665|595020|P2|Overall Study|Treatment failure|1
187708|NCT00977665|595021|P1|Overall Study|Treatment failure|0
187709|NCT00977665|595020|P2|Overall Study|Adverse Event|7
187710|NCT00977665|595021|P1|Overall Study|Adverse Event|14
187711|NCT00977665|595020|P2|Overall Study|Death|2
187712|NCT00977665|595021|P1|Overall Study|Death|3
187713|NCT00977665|595020|P2|Overall Study|Lost to Follow-up|0
187714|NCT00977665|595021|P1|Overall Study|Lost to Follow-up|1
187715|NCT00977665|595020|P2|Overall Study|Sponsor requested withdrawal|1
187716|NCT00977665|595021|P1|Overall Study|Sponsor requested withdrawal|0
187717|NCT00977665|595020|P2|Overall Study|Physician Decision|1
187718|NCT00977665|595021|P1|Overall Study|Physician Decision|2
187719|NCT00977665|595020|P2|Overall Study|Withdrawal by Subject|3
187720|NCT00977665|595021|P1|Overall Study|Withdrawal by Subject|1
187721|NCT00979420|595057|P4|Overall Study|Other reasons not related to Viramune|1
187722|NCT00979420|595058|P3|Overall Study|Other reasons not related to Viramune|0
187723|NCT00979420|595059|P2|Overall Study|Other reasons not related to Viramune|0
187724|NCT00979420|595060|P1|Overall Study|Other reasons not related to Viramune|3
187725|NCT00979420|595057|P4|Overall Study|Lack of Efficacy|1
187726|NCT00979420|595058|P3|Overall Study|Lack of Efficacy|1
187727|NCT00979420|595059|P2|Overall Study|Lack of Efficacy|0
187728|NCT00979420|595060|P1|Overall Study|Lack of Efficacy|3
187729|NCT00979420|595057|P4|Overall Study|Adverse Event|0
187730|NCT00979420|595058|P3|Overall Study|Adverse Event|0
187731|NCT00979420|595059|P2|Overall Study|Adverse Event|0
187732|NCT00979420|595060|P1|Overall Study|Adverse Event|1
187733|NCT00979576|595144|P3|Combination Followed by Monotherapy|Progressive Disease|1
187734|NCT00979576|595145|P2|Combination Followed by Monotherapy|Progressive Disease|2
187735|NCT00979576|595146|P1|Combination Followed by Monotherapy|Progressive Disease|0
187736|NCT00979576|595144|P3|Combination Treatment Phase|Adverse Event|2
187737|NCT00979576|595145|P2|Combination Treatment Phase|Adverse Event|2
187738|NCT00979576|595146|P1|Combination Treatment Phase|Adverse Event|0
187739|NCT00979576|595144|P3|Combination Treatment Phase|Dose limiting toxicity|2
187740|NCT00979576|595145|P2|Combination Treatment Phase|Dose limiting toxicity|3
187741|NCT00979576|595146|P1|Combination Treatment Phase|Dose limiting toxicity|0
187742|NCT00979576|595144|P3|Combination Treatment Phase|Progressive disease|5
187743|NCT00979576|595145|P2|Combination Treatment Phase|Progressive disease|1
187744|NCT00979576|595146|P1|Combination Treatment Phase|Progressive disease|3
187745|NCT00979628|595197|P3|Overall Study|transferred to ICU|1
187746|NCT00979628|595198|P2|Overall Study|transferred to ICU|2
187747|NCT00979628|595199|P1|Overall Study|transferred to ICU|1
187748|NCT00979628|595197|P3|Overall Study|received steroids|0
187749|NCT00979628|595198|P2|Overall Study|received steroids|1
187750|NCT00979628|595199|P1|Overall Study|received steroids|1
187751|NCT00979628|595197|P3|Overall Study|received regimen < 24 hours|5
187752|NCT00979628|595198|P2|Overall Study|received regimen < 24 hours|6
187753|NCT00979628|595199|P1|Overall Study|received regimen < 24 hours|7
187754|NCT00979654|595207|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
187755|NCT00979654|595207|P1|Overall Study|Serious Adverse Event|1
187756|NCT00979654|595207|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
187757|NCT00979654|595207|P1|Overall Study|Per Principal Investigator’s Discretion|1
187758|NCT00979654|595207|P1|Overall Study|Adverse Event of Diverticulitis|1
187759|NCT00979654|595207|P1|Overall Study|Adverse Event|1
187760|NCT00979654|595207|P1|Overall Study|Lack of Efficacy|6
187761|NCT00979654|595207|P1|Overall Study|Death|1
187762|NCT00979654|595207|P1|Overall Study|Withdrawal by Subject|22
187763|NCT00979654|595207|P1|Overall Study|Lost to Follow-up|1
187764|NCT00979901|595272|P4|Overall Study|Treatment Group Terminated by Sponsor|112
187765|NCT00979901|595273|P3|Overall Study|Treatment Group Terminated by Sponsor|0
187766|NCT00979901|595274|P2|Overall Study|Treatment Group Terminated by Sponsor|0
187767|NCT00979901|595275|P1|Overall Study|Treatment Group Terminated by Sponsor|0
187768|NCT00979901|595272|P4|Overall Study|Left Country|0
187769|NCT00979901|595273|P3|Overall Study|Left Country|1
187770|NCT00979901|595274|P2|Overall Study|Left Country|0
187771|NCT00979901|595275|P1|Overall Study|Left Country|0
187772|NCT00979901|595272|P4|Overall Study|Discontinued in Error|0
187773|NCT00979901|595273|P3|Overall Study|Discontinued in Error|0
187774|NCT00979901|595274|P2|Overall Study|Discontinued in Error|1
187775|NCT00979901|595275|P1|Overall Study|Discontinued in Error|0
187776|NCT00979901|595272|P4|Overall Study|elevated lab values pre-randomization|0
187777|NCT00979901|595273|P3|Overall Study|elevated lab values pre-randomization|0
187778|NCT00979901|595274|P2|Overall Study|elevated lab values pre-randomization|0
187779|NCT00979901|595275|P1|Overall Study|elevated lab values pre-randomization|1
187780|NCT00979901|595272|P4|Overall Study|vacation|0
187781|NCT00979901|595273|P3|Overall Study|vacation|0
187782|NCT00979901|595274|P2|Overall Study|vacation|0
187783|NCT00979901|595275|P1|Overall Study|vacation|1
187784|NCT00979901|595272|P4|Overall Study|out-of-state|0
187785|NCT00979901|595273|P3|Overall Study|out-of-state|0
187786|NCT00979901|595274|P2|Overall Study|out-of-state|0
187787|NCT00979901|595275|P1|Overall Study|out-of-state|1
187788|NCT00979901|595272|P4|Overall Study|Noncompliance|0
187789|NCT00979901|595273|P3|Overall Study|Noncompliance|0
187790|NCT00979901|595274|P2|Overall Study|Noncompliance|0
187791|NCT00979901|595275|P1|Overall Study|Noncompliance|1
187792|NCT00979901|595272|P4|Overall Study|Withdrawal by Subject|1
187793|NCT00979901|595273|P3|Overall Study|Withdrawal by Subject|1
187794|NCT00979901|595274|P2|Overall Study|Withdrawal by Subject|1
187795|NCT00979901|595275|P1|Overall Study|Withdrawal by Subject|2
187796|NCT00979901|595272|P4|Overall Study|Protocol Violation|1
187797|NCT00979901|595273|P3|Overall Study|Protocol Violation|7
187798|NCT00979901|595274|P2|Overall Study|Protocol Violation|2
187799|NCT00979901|595275|P1|Overall Study|Protocol Violation|2
187800|NCT00979901|595272|P4|Overall Study|Lost to Follow-up|0
187801|NCT00979901|595273|P3|Overall Study|Lost to Follow-up|2
187802|NCT00979901|595274|P2|Overall Study|Lost to Follow-up|1
187803|NCT00979901|595275|P1|Overall Study|Lost to Follow-up|1
187804|NCT00979901|595272|P4|Overall Study|Lack of Efficacy|0
187805|NCT00979901|595273|P3|Overall Study|Lack of Efficacy|9
187806|NCT00979901|595274|P2|Overall Study|Lack of Efficacy|4
187807|NCT00979901|595275|P1|Overall Study|Lack of Efficacy|8
187808|NCT00979901|595272|P4|Overall Study|Adverse Event|2
187809|NCT00979901|595273|P3|Overall Study|Adverse Event|9
187810|NCT00979901|595274|P2|Overall Study|Adverse Event|3
187811|NCT00979901|595275|P1|Overall Study|Adverse Event|1
187812|NCT00979953|595312|P4|Overall Study|Protocol Violation|2
187813|NCT00979953|595313|P3|Overall Study|Protocol Violation|2
187814|NCT00979953|595314|P2|Overall Study|Protocol Violation|0
187815|NCT00979953|595315|P1|Overall Study|Protocol Violation|1
187816|NCT00979953|595312|P4|Overall Study|Withdrawal by Subject|1
187817|NCT00979953|595313|P3|Overall Study|Withdrawal by Subject|2
187818|NCT00979953|595314|P2|Overall Study|Withdrawal by Subject|0
187819|NCT00979953|595315|P1|Overall Study|Withdrawal by Subject|0
187820|NCT00979953|595312|P4|Overall Study|Lost to Follow-up|0
187821|NCT00979953|595313|P3|Overall Study|Lost to Follow-up|1
187822|NCT00979953|595314|P2|Overall Study|Lost to Follow-up|1
187823|NCT00979953|595315|P1|Overall Study|Lost to Follow-up|1
187824|NCT00979953|595312|P4|Overall Study|Lack of Efficacy|0
187825|NCT00979953|595313|P3|Overall Study|Lack of Efficacy|0
187826|NCT00979953|595314|P2|Overall Study|Lack of Efficacy|2
187827|NCT00979953|595315|P1|Overall Study|Lack of Efficacy|1
187828|NCT00979953|595312|P4|Overall Study|Adverse Event|4
187829|NCT00979953|595313|P3|Overall Study|Adverse Event|17
187830|NCT00979953|595314|P2|Overall Study|Adverse Event|2
187831|NCT00979953|595315|P1|Overall Study|Adverse Event|5
187832|NCT00979992|595325|P1|Overall Study|Refused – Never Treated|2
187833|NCT00979992|595325|P1|Overall Study|Ineligible - wrong cell type|2
187834|NCT00979992|595325|P1|Overall Study|Ineligible - inadequate pathology|1
187835|NCT00980005|595335|P2|Overall Study|Unspecified|3
187836|NCT00980005|595336|P1|Overall Study|Unspecified|4
187837|NCT00980005|595335|P2|Overall Study|Lost to Follow-up|43
187838|NCT00980005|595336|P1|Overall Study|Lost to Follow-up|37
187839|NCT00980005|595335|P2|Overall Study|Withdrawal by Subject|17
187840|NCT00980005|595336|P1|Overall Study|Withdrawal by Subject|6
187841|NCT00980044|595379|P3|Overall Study|Protocol Violation|2
187842|NCT00980044|595380|P2|Overall Study|Protocol Violation|0
187843|NCT00980044|595381|P1|Overall Study|Protocol Violation|0
187844|NCT00980044|595379|P3|Overall Study|Withdrawal by Subject|3
187845|NCT00980044|595380|P2|Overall Study|Withdrawal by Subject|7
187846|NCT00980044|595381|P1|Overall Study|Withdrawal by Subject|5
187847|NCT00980148|595400|P2|Overall Study|Various other reasons|9
187848|NCT00980148|595401|P1|Overall Study|Various other reasons|8
187849|NCT00980148|595400|P2|Overall Study|Negative for chlamydia at enrollment|9
187850|NCT00980148|595401|P1|Overall Study|Negative for chlamydia at enrollment|12
187851|NCT00980148|595400|P2|Overall Study|Received other antichlamydia treatment|14
187852|NCT00980148|595401|P1|Overall Study|Received other antichlamydia treatment|20
187853|NCT00980148|595400|P2|Overall Study|Discharged from facility|96
187854|NCT00980148|595401|P1|Overall Study|Discharged from facility|89
187855|NCT00980174|595409|P2|Overall Study|Other|1
187856|NCT00980174|595410|P1|Overall Study|Other|0
187857|NCT00980174|595409|P2|Overall Study|Death|1
187858|NCT00980174|595410|P1|Overall Study|Death|1
187859|NCT00980174|595409|P2|Overall Study|Ineligibility determined|1
187860|NCT00980174|595410|P1|Overall Study|Ineligibility determined|2
187861|NCT00980174|595409|P2|Overall Study|Adverse Event|3
187862|NCT00980174|595410|P1|Overall Study|Adverse Event|0
187863|NCT00980174|595409|P2|Overall Study|Withdrawal by Subject|4
187864|NCT00980174|595410|P1|Overall Study|Withdrawal by Subject|1
187865|NCT00980200|595426|P5|7-day Treatment Period 3|Lack of Efficacy|1
187866|NCT00980200|595427|P4|7-day Treatment Period 3|Lack of Efficacy|0
187867|NCT00980200|595428|P3|7-day Treatment Period 3|Lack of Efficacy|0
187868|NCT00980200|595429|P2|7-day Treatment Period 3|Lack of Efficacy|1
187869|NCT00980200|595430|P1|7-day Treatment Period 3|Lack of Efficacy|0
187870|NCT00980200|595426|P5|7-day Treatment Period 1|Withdrawal by Subject|0
187871|NCT00980200|595427|P4|7-day Treatment Period 1|Withdrawal by Subject|0
187872|NCT00980200|595428|P3|7-day Treatment Period 1|Withdrawal by Subject|0
187873|NCT00980200|595429|P2|7-day Treatment Period 1|Withdrawal by Subject|1
187874|NCT00980200|595430|P1|7-day Treatment Period 1|Withdrawal by Subject|0
187875|NCT00980330|595471|P7|Overall Study|(not specified)|0
187876|NCT00980330|595472|P6|Overall Study|(not specified)|1
187877|NCT00980330|595473|P5|Overall Study|(not specified)|1
187878|NCT00980330|595474|P4|Overall Study|(not specified)|1
187879|NCT00980330|595475|P3|Overall Study|(not specified)|0
187880|NCT00980330|595476|P2|Overall Study|(not specified)|0
187881|NCT00980330|595477|P1|Overall Study|(not specified)|2
187882|NCT00980330|595471|P7|Overall Study|Withdrawal by Subject|5
187883|NCT00980330|595472|P6|Overall Study|Withdrawal by Subject|2
187884|NCT00980330|595473|P5|Overall Study|Withdrawal by Subject|3
187885|NCT00980330|595474|P4|Overall Study|Withdrawal by Subject|1
187886|NCT00980330|595475|P3|Overall Study|Withdrawal by Subject|4
187887|NCT00980330|595476|P2|Overall Study|Withdrawal by Subject|4
187888|NCT00980330|595477|P1|Overall Study|Withdrawal by Subject|2
187889|NCT00980330|595471|P7|Overall Study|Lost to Follow-up|2
187890|NCT00980330|595472|P6|Overall Study|Lost to Follow-up|1
187891|NCT00980330|595473|P5|Overall Study|Lost to Follow-up|1
187892|NCT00980330|595474|P4|Overall Study|Lost to Follow-up|2
187893|NCT00980330|595475|P3|Overall Study|Lost to Follow-up|4
187894|NCT00980330|595476|P2|Overall Study|Lost to Follow-up|1
187895|NCT00980330|595477|P1|Overall Study|Lost to Follow-up|1
187896|NCT00980330|595471|P7|Overall Study|Adverse Event|0
187897|NCT00980330|595472|P6|Overall Study|Adverse Event|0
187898|NCT00980330|595473|P5|Overall Study|Adverse Event|0
187899|NCT00980330|595474|P4|Overall Study|Adverse Event|1
187900|NCT00980330|595475|P3|Overall Study|Adverse Event|0
187901|NCT00980330|595476|P2|Overall Study|Adverse Event|0
187902|NCT00980330|595477|P1|Overall Study|Adverse Event|0
187903|NCT00980343|595577|P2|Overall Study|no tumor at surgery - treatment effect|3
187904|NCT00980343|595578|P1|Overall Study|no tumor at surgery - treatment effect|1
187905|NCT00980655|595625|P2|Overall Study|Unspecified|1
187906|NCT00980655|595626|P1|Overall Study|Unspecified|0
187907|NCT00980655|595625|P2|Overall Study|Parent/legal guardian request|0
187908|NCT00980655|595626|P1|Overall Study|Parent/legal guardian request|1
187909|NCT00980655|595625|P2|Overall Study|Lost to Follow-up|1
187910|NCT00980655|595626|P1|Overall Study|Lost to Follow-up|0
187911|NCT00980655|595625|P2|Overall Study|Withdrawal by Subject|4
187912|NCT00980655|595626|P1|Overall Study|Withdrawal by Subject|0
187913|NCT00980655|595625|P2|Overall Study|Protocol Violation|7
187914|NCT00980655|595626|P1|Overall Study|Protocol Violation|2
187915|NCT00980655|595625|P2|Overall Study|Death|7
187916|NCT00980655|595626|P1|Overall Study|Death|0
187917|NCT00980655|595625|P2|Overall Study|Adverse Event|31
187918|NCT00980655|595626|P1|Overall Study|Adverse Event|13
187919|NCT00980798|595705|P2|Overall Study|Other|1
187920|NCT00980798|595706|P1|Overall Study|Other|0
187921|NCT00980798|595705|P2|Overall Study|Withdrawal by Subject|11
187922|NCT00980798|595706|P1|Overall Study|Withdrawal by Subject|8
187923|NCT00980798|595705|P2|Overall Study|Physician Decision|1
187924|NCT00980798|595706|P1|Overall Study|Physician Decision|2
187925|NCT00980798|595705|P2|Overall Study|Lost to Follow-up|1
187926|NCT00980798|595706|P1|Overall Study|Lost to Follow-up|0
187927|NCT00980798|595705|P2|Overall Study|Lack of Efficacy|5
187928|NCT00980798|595706|P1|Overall Study|Lack of Efficacy|16
187929|NCT00980798|595705|P2|Overall Study|Adverse Event|36
187930|NCT00980798|595706|P1|Overall Study|Adverse Event|7
187931|NCT00980980|595717|P3|Overall Study|Withdrawal by Hospital|0
187932|NCT00980980|595718|P2|Overall Study|Withdrawal by Hospital|1
187933|NCT00980980|595719|P1|Overall Study|Withdrawal by Hospital|0
187934|NCT00981019|595748|P1|Overall Study|Hit the survey after closure|79
187935|NCT00981019|595748|P1|Overall Study|Inadvertent exclusion|239
187936|NCT00981019|595748|P1|Overall Study|Did not match target population|94
187937|NCT00981019|595748|P1|Overall Study|Did not respond|65
187938|NCT00981058|595765|P2|Overall Study|On study treatment at conclusion|0
187939|NCT00981058|595766|P1|Overall Study|On study treatment at conclusion|9
187940|NCT00981058|595765|P2|Overall Study|Withdrawal by Subject|23
187941|NCT00981058|595766|P1|Overall Study|Withdrawal by Subject|25
187942|NCT00981058|595765|P2|Overall Study|Randomization Error|2
187943|NCT00981058|595766|P1|Overall Study|Randomization Error|1
187944|NCT00981058|595765|P2|Overall Study|Radiologist Error|1
187945|NCT00981058|595766|P1|Overall Study|Radiologist Error|0
187946|NCT00981058|595765|P2|Overall Study|Noncompliance|0
187947|NCT00981058|595766|P1|Overall Study|Noncompliance|1
187948|NCT00981058|595765|P2|Overall Study|New Anticancer Therapy|6
187949|NCT00981058|595766|P1|Overall Study|New Anticancer Therapy|6
187950|NCT00981058|595765|P2|Overall Study|Lost to Follow-up|15
187951|NCT00981058|595766|P1|Overall Study|Lost to Follow-up|16
187952|NCT00981058|595765|P2|Overall Study|Progressive Disease|49
187953|NCT00981058|595766|P1|Overall Study|Progressive Disease|61
187954|NCT00981058|595765|P2|Overall Study|Adverse Event|1
187955|NCT00981058|595766|P1|Overall Study|Adverse Event|1
187956|NCT00981084|595788|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
187957|NCT00981084|595789|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
187958|NCT00981084|595788|P2|Post Intervention (Data Analysis)|poor effort|1
187959|NCT00981084|595789|P1|Post Intervention (Data Analysis)|poor effort|1
187960|NCT00981175|595806|P2|Booster Dose Vaccination|Lost to Follow-up|3
187961|NCT00981175|595807|P1|Booster Dose Vaccination|Lost to Follow-up|2
187962|NCT00981175|595806|P2|Primary Dose Vaccination|Lost to Follow-up|1
187963|NCT00981175|595807|P1|Primary Dose Vaccination|Lost to Follow-up|2
187964|NCT00981175|595806|P2|Primary Dose Vaccination|Protocol Violation|1
187965|NCT00981175|595807|P1|Primary Dose Vaccination|Protocol Violation|0
187966|NCT00981175|595806|P2|Primary Dose Vaccination|Adverse Event|0
187967|NCT00981175|595807|P1|Primary Dose Vaccination|Adverse Event|1
187968|NCT00981292|595879|P6|Day 3|Protocol Violation|1
187969|NCT00981292|595880|P5|Day 3|Protocol Violation|0
187970|NCT00981292|595881|P4|Day 3|Protocol Violation|0
187971|NCT00981292|595882|P3|Day 3|Protocol Violation|0
187972|NCT00981292|595883|P2|Day 3|Protocol Violation|0
187973|NCT00981292|595884|P1|Day 3|Protocol Violation|0
187974|NCT00981292|595879|P6|Day 2|Protocol Violation|0
187975|NCT00981292|595880|P5|Day 2|Protocol Violation|0
187976|NCT00981292|595881|P4|Day 2|Protocol Violation|0
187977|NCT00981292|595882|P3|Day 2|Protocol Violation|0
187978|NCT00981292|595883|P2|Day 2|Protocol Violation|0
187979|NCT00981292|595884|P1|Day 2|Protocol Violation|2
187980|NCT00981292|595879|P6|Day 1|Protocol Violation|2
187981|NCT00981292|595880|P5|Day 1|Protocol Violation|0
187982|NCT00981292|595881|P4|Day 1|Protocol Violation|0
187983|NCT00981292|595882|P3|Day 1|Protocol Violation|0
187984|NCT00981292|595883|P2|Day 1|Protocol Violation|0
187985|NCT00981292|595884|P1|Day 1|Protocol Violation|1
187986|NCT00981409|595922|P2|Overall Study|Prostate Cancer Treatment before Trial|0
187987|NCT00981409|595923|P1|Overall Study|Prostate Cancer Treatment before Trial|2
187988|NCT00981409|595922|P2|Overall Study|Protocol Violation|1
187989|NCT00981409|595923|P1|Overall Study|Protocol Violation|0
187990|NCT00981409|595922|P2|Overall Study|Adverse Event|0
187991|NCT00981409|595923|P1|Overall Study|Adverse Event|4
187992|NCT00981461|595955|P2|Overall Study|Lost to Follow-up|2
187993|NCT00981461|595956|P1|Overall Study|Lost to Follow-up|5
187994|NCT00974090|596045|P2|Period 2: Open-label Period|Withdrawal by Subject|0
187995|NCT00974090|596046|P1|Period 2: Open-label Period|Withdrawal by Subject|1
187996|NCT00974090|596045|P2|Period 2: Open-label Period|Physician Decision|3
187997|NCT00974090|596046|P1|Period 2: Open-label Period|Physician Decision|0
187998|NCT00974090|596045|P2|Period 2: Open-label Period|Lack of Efficacy|1
187999|NCT00974090|596046|P1|Period 2: Open-label Period|Lack of Efficacy|3
188000|NCT00974090|596045|P2|Period 2: Open-label Period|Adverse Event|6
188001|NCT00974090|596046|P1|Period 2: Open-label Period|Adverse Event|4
188002|NCT00974090|596045|P2|Period 1: Double Blind Period|Physician Decision|0
188003|NCT00974090|596046|P1|Period 1: Double Blind Period|Physician Decision|1
188004|NCT00974090|596045|P2|Period 1: Double Blind Period|Adverse Event|1
188005|NCT00974090|596046|P1|Period 1: Double Blind Period|Adverse Event|2
188006|NCT00974220|596062|P2|Treatment Period 1|noncompliant subjects|1
188007|NCT00974220|596063|P1|Treatment Period 1|noncompliant subjects|0
188008|NCT00974220|596062|P2|Treatment Period 1|Adverse Event|1
188009|NCT00974220|596063|P1|Treatment Period 1|Adverse Event|2
188010|NCT00974233|596071|P1|Maintenance Lenalidomide|Adverse Event|8
188011|NCT00974233|596071|P1|Maintenance Lenalidomide|Lack of Efficacy|5
188012|NCT00974233|596071|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
188013|NCT00974233|596071|P1|Induction Chemoimmunotherapy|Adverse Event|7
188014|NCT00974233|596071|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
188015|NCT00974233|596071|P1|Induction Chemoimmunotherapy|Death|2
188016|NCT00974311|596092|P2|Overall Study|Continuing Treatment|19
188017|NCT00974311|596093|P1|Overall Study|Continuing Treatment|231
188018|NCT00974311|596092|P2|Overall Study|Withdrawal of consent|5
188019|NCT00974311|596093|P1|Overall Study|Withdrawal of consent|9
188020|NCT00974311|596092|P2|Overall Study|Death|211
188021|NCT00974311|596093|P1|Overall Study|Death|305
188022|NCT00974311|596092|P2|Overall Study|Lost to Follow-up|1
188023|NCT00974311|596093|P1|Overall Study|Lost to Follow-up|1
188024|NCT00974571|596191|P3|Overall Study|Unspecified|10
188025|NCT00974571|596192|P2|Overall Study|Unspecified|0
188026|NCT00974571|596193|P1|Overall Study|Unspecified|4
188027|NCT00974571|596191|P3|Overall Study|Patient Moved|1
188028|NCT00974571|596192|P2|Overall Study|Patient Moved|0
188029|NCT00974571|596193|P1|Overall Study|Patient Moved|1
188030|NCT00974571|596191|P3|Overall Study|Withdrawal by Subject|16
188031|NCT00974571|596192|P2|Overall Study|Withdrawal by Subject|5
188032|NCT00974571|596193|P1|Overall Study|Withdrawal by Subject|14
188033|NCT00974571|596191|P3|Overall Study|Protocol Violation|18
188034|NCT00974571|596192|P2|Overall Study|Protocol Violation|4
188035|NCT00974571|596193|P1|Overall Study|Protocol Violation|13
188036|NCT00974571|596191|P3|Overall Study|Lost to Follow-up|2
188037|NCT00974571|596192|P2|Overall Study|Lost to Follow-up|1
188038|NCT00974571|596193|P1|Overall Study|Lost to Follow-up|2
188039|NCT00974571|596191|P3|Overall Study|Lack of Efficacy|9
188040|NCT00974571|596192|P2|Overall Study|Lack of Efficacy|2
188041|NCT00974571|596193|P1|Overall Study|Lack of Efficacy|3
188042|NCT00974571|596191|P3|Overall Study|Adverse Event|27
188043|NCT00974571|596192|P2|Overall Study|Adverse Event|4
188044|NCT00974571|596193|P1|Overall Study|Adverse Event|31
188045|NCT00974675|596217|P4|Overall Study|Participant on holiday; unable to attend|1
188046|NCT00974675|596218|P3|Overall Study|Participant on holiday; unable to attend|0
188047|NCT00974675|596219|P2|Overall Study|Participant on holiday; unable to attend|0
188048|NCT00974675|596220|P1|Overall Study|Participant on holiday; unable to attend|0
188049|NCT00974675|596217|P4|Overall Study|Physician Decision|0
188050|NCT00974675|596218|P3|Overall Study|Physician Decision|1
188051|NCT00974675|596219|P2|Overall Study|Physician Decision|0
188052|NCT00974675|596220|P1|Overall Study|Physician Decision|0
188053|NCT00974675|596217|P4|Overall Study|Adverse Event|1
188054|NCT00974675|596218|P3|Overall Study|Adverse Event|1
188055|NCT00974675|596219|P2|Overall Study|Adverse Event|1
188056|NCT00974675|596220|P1|Overall Study|Adverse Event|2
188057|NCT00982020|596285|P2|Overall Study|Clinical Relapse|1
188058|NCT00982020|596286|P1|Overall Study|Clinical Relapse|0
188059|NCT00982020|596285|P2|Overall Study|Protocol Violation|2
188060|NCT00982020|596286|P1|Overall Study|Protocol Violation|0
188061|NCT00982020|596285|P2|Overall Study|Entry Criteria Not Met|1
188062|NCT00982020|596286|P1|Overall Study|Entry Criteria Not Met|2
188063|NCT00982020|596285|P2|Overall Study|Physician Decision|5
188064|NCT00982020|596286|P1|Overall Study|Physician Decision|2
188065|NCT00982020|596285|P2|Overall Study|Treatment Non-compliance|6
188066|NCT00982020|596286|P1|Overall Study|Treatment Non-compliance|3
188067|NCT00982020|596285|P2|Overall Study|Parent/Caregiver Decision|5
188068|NCT00982020|596286|P1|Overall Study|Parent/Caregiver Decision|5
188069|NCT00982020|596285|P2|Overall Study|Lack of Efficacy|4
188070|NCT00982020|596286|P1|Overall Study|Lack of Efficacy|10
188071|NCT00982020|596285|P2|Overall Study|Lost to Follow-up|11
188072|NCT00982020|596286|P1|Overall Study|Lost to Follow-up|5
188073|NCT00982020|596285|P2|Overall Study|Withdrawal by Subject|14
188074|NCT00982020|596286|P1|Overall Study|Withdrawal by Subject|11
188075|NCT00982020|596285|P2|Overall Study|Adverse Event|15
188076|NCT00982020|596286|P1|Overall Study|Adverse Event|19
188077|NCT00982111|596317|P2|Overall Study|Withdrawal by Subject|17
188078|NCT00982111|596318|P1|Overall Study|Withdrawal by Subject|16
188079|NCT00982111|596317|P2|Overall Study|On Study Treatment at Conclusion|0
188080|NCT00982111|596318|P1|Overall Study|On Study Treatment at Conclusion|7
188081|NCT00982111|596317|P2|Overall Study|New Anti-Cancer Therapy|5
188082|NCT00982111|596318|P1|Overall Study|New Anti-Cancer Therapy|5
188083|NCT00982111|596317|P2|Overall Study|Lost to Follow-up|6
188084|NCT00982111|596318|P1|Overall Study|Lost to Follow-up|9
188085|NCT00982111|596317|P2|Overall Study|Progressive Disease|37
188086|NCT00982111|596318|P1|Overall Study|Progressive Disease|37
188087|NCT00982111|596317|P2|Overall Study|Adverse Event|1
188088|NCT00982111|596318|P1|Overall Study|Adverse Event|1
188089|NCT00982137|596344|P4|Overall Study|Withdrawal by Subject|0
188090|NCT00982137|596345|P3|Overall Study|Withdrawal by Subject|0
188091|NCT00982137|596346|P2|Overall Study|Withdrawal by Subject|1
188092|NCT00982137|596347|P1|Overall Study|Withdrawal by Subject|0
188093|NCT00982137|596344|P4|Overall Study|Lost to Follow-up|1
188094|NCT00982137|596345|P3|Overall Study|Lost to Follow-up|0
188095|NCT00982137|596346|P2|Overall Study|Lost to Follow-up|0
188096|NCT00982137|596347|P1|Overall Study|Lost to Follow-up|0
188097|NCT00982228|596404|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
188098|NCT00982228|596405|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
188099|NCT00982228|596404|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
188100|NCT00982228|596405|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
188101|NCT00982228|596404|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
188102|NCT00982228|596405|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
188103|NCT00982228|596404|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
188104|NCT00982228|596405|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
188105|NCT00982228|596404|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
188106|NCT00982228|596405|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
188107|NCT00982228|596404|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
188108|NCT00982228|596405|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
188109|NCT00982228|596404|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
188110|NCT00982228|596405|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
188111|NCT00982228|596404|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
188112|NCT00982228|596405|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
188113|NCT00982228|596404|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
188114|NCT00982228|596405|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
188115|NCT00982228|596404|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
188116|NCT00982228|596405|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
188117|NCT00983073|596434|P1|Maintenance Period|Other Reason|7
188118|NCT00983073|596434|P1|Maintenance Period|Lack of Efficacy|2
188119|NCT00983073|596434|P1|Maintenance Period|Withdrawal by Subject|2
188120|NCT00983073|596434|P1|Maintenance Period|Adverse Event|5
188121|NCT00983073|596434|P1|Titration and Optimal Dose Period|Other reason|4
188122|NCT00983073|596434|P1|Titration and Optimal Dose Period|Non-Compliance|1
188123|NCT00983073|596434|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
188124|NCT00983073|596434|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
188125|NCT00983073|596434|P1|Titration and Optimal Dose Period|Adverse Event|19
188126|NCT00983294|596486|P1|Colchicine With Azithromycin|Adverse Event|1
188127|NCT00983294|596486|P1|14 Day Washout Period|Withdrawal by Subject|2
188128|NCT00983372|596509|P1|Diltiazem ER Alone|Adverse Event|1
188129|NCT00983372|596509|P1|Diltiazem ER Alone|missed diltiazem dose|2
188130|NCT00983372|596509|P1|14 Day Washout Period|Withdrawal by Subject|1
188131|NCT00983385|596520|P1|Observation Period|Not Evaluable due to Non Compliance|12
188132|NCT00983385|596520|P1|Observation Period|Not eligible to be dosed|20
188133|NCT00983437|596565|P1|Overall Study|Other Reason|26
188134|NCT00983437|596565|P1|Overall Study|Lost to Follow-up|2
188135|NCT00983437|596565|P1|Overall Study|Noncompliance to Study Procedures|1
188136|NCT00983437|596565|P1|Overall Study|Withdrawal by Subject|8
188137|NCT00983437|596565|P1|Overall Study|Lack of Efficacy|1
188138|NCT00983437|596565|P1|Overall Study|Adverse Event|9
188139|NCT00983476|596587|P3|Overall Study|Did not receive intervention|0
188140|NCT00983476|596588|P2|Overall Study|Did not receive intervention|22
188141|NCT00983476|596589|P1|Overall Study|Did not receive intervention|17
188142|NCT00983515|596634|P1|Colchicine With Ritonavir|Lost to Follow-up|1
188143|NCT00983515|596634|P1|Ritonavir Alone|liver panel out of range|6
188144|NCT00983749|596672|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
188145|NCT00983749|596673|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
188146|NCT00983827|596693|P1|Overall Study|Withdrawal by Subject|1
188147|NCT00983853|596703|P6|Overall Study|Unable to come to study follow-up visits|0
188148|NCT00983853|596704|P5|Overall Study|Unable to come to study follow-up visits|0
188149|NCT00983853|596705|P4|Overall Study|Unable to come to study follow-up visits|0
188150|NCT00983853|596706|P3|Overall Study|Unable to come to study follow-up visits|0
188151|NCT00983853|596707|P2|Overall Study|Unable to come to study follow-up visits|1
188152|NCT00983853|596708|P1|Overall Study|Unable to come to study follow-up visits|0
188153|NCT00983853|596703|P6|Overall Study|Withdrawal by Subject|0
188154|NCT00983853|596704|P5|Overall Study|Withdrawal by Subject|1
188155|NCT00983853|596705|P4|Overall Study|Withdrawal by Subject|0
188156|NCT00983853|596706|P3|Overall Study|Withdrawal by Subject|1
188157|NCT00983853|596707|P2|Overall Study|Withdrawal by Subject|0
188158|NCT00983853|596708|P1|Overall Study|Withdrawal by Subject|0
188159|NCT00983853|596703|P6|Overall Study|Lost to Follow-up|1
188160|NCT00983853|596704|P5|Overall Study|Lost to Follow-up|2
188161|NCT00983853|596705|P4|Overall Study|Lost to Follow-up|2
188162|NCT00983853|596706|P3|Overall Study|Lost to Follow-up|2
188163|NCT00983853|596707|P2|Overall Study|Lost to Follow-up|1
188164|NCT00983853|596708|P1|Overall Study|Lost to Follow-up|1
188165|NCT00983892|596738|P2|Overall Study|Withdrawal by Subject|12
188166|NCT00983892|596739|P1|Overall Study|Withdrawal by Subject|10
188167|NCT00983905|596745|P1|Colchicine Alone|Adverse Event|2
188168|NCT00983905|596745|P1|Theophylline Alone|Adverse Event|1
188169|NCT00983918|596760|P4|Overall Study|conversion to open cholecystectomy|2
188170|NCT00983918|596761|P3|Overall Study|conversion to open cholecystectomy|2
188171|NCT00983918|596762|P2|Overall Study|conversion to open cholecystectomy|2
188172|NCT00983918|596763|P1|Overall Study|conversion to open cholecystectomy|0
188173|NCT00983931|596773|P1|14 Day Washout Period|Physician Decision|1
188174|NCT00983957|596783|P1|Overall Study|Personal Reasons|1
188175|NCT00983957|596783|P1|Overall Study|Adverse Event|1
188176|NCT00984009|596839|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
188177|NCT00984022|596852|P2|Overall Study|Lost to Follow-up|14
188178|NCT00984022|596853|P1|Overall Study|Lost to Follow-up|10
188179|NCT00984061|596863|P1|Clarithromycin Alone|Protocol Violation|1
188180|NCT00984126|596878|P4|Overall Study|Withdrawal criteria|9
188181|NCT00984126|596879|P3|Overall Study|Withdrawal criteria|3
188182|NCT00984126|596880|P2|Overall Study|Withdrawal criteria|1
188183|NCT00984126|596881|P1|Overall Study|Withdrawal criteria|0
188184|NCT00984126|596878|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
188185|NCT00984126|596879|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
188186|NCT00984126|596880|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
188187|NCT00984126|596881|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
188188|NCT00984126|596878|P4|Overall Study|Adverse Event|2
188189|NCT00984126|596879|P3|Overall Study|Adverse Event|0
188190|NCT00984126|596880|P2|Overall Study|Adverse Event|0
188191|NCT00984126|596881|P1|Overall Study|Adverse Event|0
188192|NCT00984126|596878|P4|Overall Study|Protocol Violation|2
188193|NCT00984126|596879|P3|Overall Study|Protocol Violation|1
188194|NCT00984126|596880|P2|Overall Study|Protocol Violation|0
188195|NCT00984126|596881|P1|Overall Study|Protocol Violation|0
188196|NCT00984165|596922|P4|Overall Study|removed with a pair recipient|1
188197|NCT00984165|596923|P3|Overall Study|removed with a pair recipient|0
188198|NCT00984165|596924|P2|Overall Study|removed with a pair recipient|0
188199|NCT00984165|596925|P1|Overall Study|removed with a pair recipient|0
188200|NCT00984165|596922|P4|Overall Study|P+/donor pair removed from protocol|1
188201|NCT00984165|596923|P3|Overall Study|P+/donor pair removed from protocol|0
188202|NCT00984165|596924|P2|Overall Study|P+/donor pair removed from protocol|0
188203|NCT00984165|596925|P1|Overall Study|P+/donor pair removed from protocol|0
188204|NCT00984165|596922|P4|Overall Study|New protocol|1
188205|NCT00984165|596923|P3|Overall Study|New protocol|0
188206|NCT00984165|596924|P2|Overall Study|New protocol|0
188207|NCT00984165|596925|P1|Overall Study|New protocol|0
188208|NCT00984165|596922|P4|Overall Study|Death of recipient|1
188209|NCT00984165|596923|P3|Overall Study|Death of recipient|0
188210|NCT00984165|596924|P2|Overall Study|Death of recipient|0
188211|NCT00984165|596925|P1|Overall Study|Death of recipient|0
188212|NCT00984165|596922|P4|Overall Study|Disease progression on study|0
188213|NCT00984165|596923|P3|Overall Study|Disease progression on study|0
188214|NCT00984165|596924|P2|Overall Study|Disease progression on study|1
188215|NCT00984165|596925|P1|Overall Study|Disease progression on study|5
188216|NCT00984165|596922|P4|Overall Study|Death on study|0
188217|NCT00984165|596923|P3|Overall Study|Death on study|0
188218|NCT00984165|596924|P2|Overall Study|Death on study|0
188219|NCT00984165|596925|P1|Overall Study|Death on study|2
188220|NCT00984204|596938|P1|Overall Study|Lack of Efficacy|10
188221|NCT00984204|596938|P1|Overall Study|Lost to Follow-up|4
188222|NCT00984204|596938|P1|Overall Study|Death|1
188223|NCT00984256|596946|P2|Overall Study|Withdrawal by Subject|1
188224|NCT00984256|596947|P1|Overall Study|Withdrawal by Subject|0
188225|NCT00984282|596969|P2|Long Term Follow-up|Ongoing with treatment|26
188226|NCT00984282|596970|P1|Long Term Follow-up|Ongoing with treatment|33
188227|NCT00984282|596969|P2|Long Term Follow-up|Lost to Follow-up|4
188228|NCT00984282|596970|P1|Long Term Follow-up|Lost to Follow-up|8
188229|NCT00984282|596969|P2|Long Term Follow-up|Death|72
188230|NCT00984282|596970|P1|Long Term Follow-up|Death|55
188231|NCT00984282|596969|P2|Long Term Follow-up|Withdrawal by Subject|15
188232|NCT00984282|596970|P1|Long Term Follow-up|Withdrawal by Subject|18
188233|NCT00984282|596969|P2|Open-label Treatment|Target lesion removed|1
188234|NCT00984282|596970|P1|Open-label Treatment|Target lesion removed|0
188235|NCT00984282|596969|P2|Open-label Treatment|Non-compliant with study medication|0
188236|NCT00984282|596970|P1|Open-label Treatment|Non-compliant with study medication|1
188237|NCT00984282|596969|P2|Open-label Treatment|Ongoing with treatment|18
188238|NCT00984282|596970|P1|Open-label Treatment|Ongoing with treatment|19
188239|NCT00984282|596969|P2|Open-label Treatment|Lost to Follow-up|0
188240|NCT00984282|596970|P1|Open-label Treatment|Lost to Follow-up|1
188241|NCT00984282|596969|P2|Open-label Treatment|Progression, recurrence or relapse|77
188242|NCT00984282|596970|P1|Open-label Treatment|Progression, recurrence or relapse|37
188243|NCT00984282|596969|P2|Open-label Treatment|Death|15
188244|NCT00984282|596970|P1|Open-label Treatment|Death|5
188245|NCT00984282|596969|P2|Open-label Treatment|Withdrawal by Subject|21
188246|NCT00984282|596970|P1|Open-label Treatment|Withdrawal by Subject|6
188247|NCT00984282|596969|P2|Open-label Treatment|Adverse Event|29
188248|NCT00984282|596970|P1|Open-label Treatment|Adverse Event|17
188249|NCT00984282|596969|P2|Double Blind Treatment|Switched to follow-up|4
188250|NCT00984282|596970|P1|Double Blind Treatment|Switched to follow-up|12
188251|NCT00984282|596969|P2|Double Blind Treatment|Not treated|1
188252|NCT00984282|596970|P1|Double Blind Treatment|Not treated|0
188253|NCT00984282|596969|P2|Double Blind Treatment|Death|4
188254|NCT00984282|596970|P1|Double Blind Treatment|Death|8
188255|NCT00984282|596969|P2|Double Blind Treatment|Lost to Follow-up|0
188256|NCT00984282|596970|P1|Double Blind Treatment|Lost to Follow-up|3
188257|NCT00984282|596969|P2|Double Blind Treatment|Withdrawal by Subject|18
188258|NCT00984282|596970|P1|Double Blind Treatment|Withdrawal by Subject|14
188259|NCT00984282|596969|P2|Double Blind Treatment|Progression by clinical judgment|0
188260|NCT00984282|596970|P1|Double Blind Treatment|Progression by clinical judgment|1
188261|NCT00984282|596969|P2|Double Blind Treatment|Noncompliance with study medication|0
188262|NCT00984282|596970|P1|Double Blind Treatment|Noncompliance with study medication|3
188263|NCT00984282|596969|P2|Double Blind Treatment|Physician Decision|2
188264|NCT00984282|596970|P1|Double Blind Treatment|Physician Decision|1
188265|NCT00984282|596969|P2|Double Blind Treatment|Progression, recurrence or relapse|3
188266|NCT00984282|596970|P1|Double Blind Treatment|Progression, recurrence or relapse|24
188267|NCT00984282|596969|P2|Double Blind Treatment|Adverse Event|6
188268|NCT00984282|596970|P1|Double Blind Treatment|Adverse Event|38
188269|NCT00984295|596994|P3|Overall Study|Incomplete safety follow-up|3
188270|NCT00984295|596995|P2|Overall Study|Incomplete safety follow-up|2
188271|NCT00984295|596996|P1|Overall Study|Incomplete safety follow-up|11
188272|NCT00984295|596994|P3|Overall Study|Missed one or more blood samplings|2
188273|NCT00984295|596995|P2|Overall Study|Missed one or more blood samplings|7
188274|NCT00984295|596996|P1|Overall Study|Missed one or more blood samplings|3
188275|NCT00984295|596994|P3|Overall Study|CAE – discontinued test vaccine|3
188276|NCT00984295|596995|P2|Overall Study|CAE – discontinued test vaccine|1
188277|NCT00984295|596996|P1|Overall Study|CAE – discontinued test vaccine|0
188278|NCT00984295|596994|P3|Overall Study|Withdrawal by Subject|12
188279|NCT00984295|596995|P2|Overall Study|Withdrawal by Subject|9
188280|NCT00984295|596996|P1|Overall Study|Withdrawal by Subject|18
188281|NCT00984295|596994|P3|Overall Study|Protocol Violation|4
188282|NCT00984295|596995|P2|Overall Study|Protocol Violation|1
188283|NCT00984295|596996|P1|Overall Study|Protocol Violation|2
188284|NCT00984295|596994|P3|Overall Study|Lost to Follow-up|13
188285|NCT00984295|596995|P2|Overall Study|Lost to Follow-up|12
188286|NCT00984295|596996|P1|Overall Study|Lost to Follow-up|31
188287|NCT00984542|597100|P1|Overall Study|clinical deterioration|2
188288|NCT00984542|597100|P1|Overall Study|Withdrawal by Subject|3
188289|NCT00984542|597100|P1|Overall Study|complicating disease|3
188290|NCT00984542|597100|P1|Overall Study|Death|7
188291|NCT00984542|597100|P1|Overall Study|toxicity|7
188292|NCT00984542|597100|P1|Overall Study|disease progression|19
188293|NCT00984568|597110|P2|Overall Study|Unknown Reason|3
188294|NCT00984568|597111|P1|Overall Study|Unknown Reason|1
188295|NCT00984568|597110|P2|Overall Study|Opportunistic Infection|0
188296|NCT00984568|597111|P1|Overall Study|Opportunistic Infection|1
188297|NCT00984568|597110|P2|Overall Study|Lost to Follow-up|1
188298|NCT00984568|597111|P1|Overall Study|Lost to Follow-up|0
188299|NCT00984568|597110|P2|Overall Study|Did Not Meet Randomization Criteria|0
188300|NCT00984568|597111|P1|Overall Study|Did Not Meet Randomization Criteria|1
188301|NCT00984568|597110|P2|Overall Study|Adverse Event|0
188302|NCT00984568|597111|P1|Overall Study|Adverse Event|2
188303|NCT00984568|597110|P2|Overall Study|Lack of Efficacy|0
188304|NCT00984568|597111|P1|Overall Study|Lack of Efficacy|2
188305|NCT00984568|597110|P2|Overall Study|Withdrawal by Subject|2
188306|NCT00984568|597111|P1|Overall Study|Withdrawal by Subject|1
188307|NCT00984594|597121|P2|Overall Study|Withdrawal by Subject|1
188308|NCT00984594|597122|P1|Overall Study|Withdrawal by Subject|0
188309|NCT00984594|597121|P2|Overall Study|Lost to Follow-up|0
188310|NCT00984594|597122|P1|Overall Study|Lost to Follow-up|1
188311|NCT00984620|597138|P2|Overall Study|reason other than listed above|4
188312|NCT00984620|597139|P1|Overall Study|reason other than listed above|0
188313|NCT00984620|597138|P2|Overall Study|Withdrawal by Subject|2
188314|NCT00984620|597139|P1|Overall Study|Withdrawal by Subject|0
188315|NCT00984620|597138|P2|Overall Study|Lost to Follow-up|1
188316|NCT00984620|597139|P1|Overall Study|Lost to Follow-up|1
188317|NCT00984620|597138|P2|Overall Study|Adverse Event|5
188318|NCT00984620|597139|P1|Overall Study|Adverse Event|5
188319|NCT00984659|597179|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
188320|NCT00984659|597180|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
188321|NCT00984659|597181|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
188322|NCT00984659|597182|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
188323|NCT00984659|597179|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
188324|NCT00984659|597180|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
188325|NCT00984659|597181|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
188326|NCT00984659|597182|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
188327|NCT00984659|597179|P4|6-week Double-blind Treatment Period|Protocol Violation|4
188328|NCT00984659|597180|P3|6-week Double-blind Treatment Period|Protocol Violation|0
188329|NCT00984659|597181|P2|6-week Double-blind Treatment Period|Protocol Violation|0
188330|NCT00984659|597182|P1|6-week Double-blind Treatment Period|Protocol Violation|0
188331|NCT00984659|597179|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
188332|NCT00984659|597180|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
188333|NCT00984659|597181|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
188334|NCT00984659|597182|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
188335|NCT00984659|597179|P4|6-week Double-blind Treatment Period|Adverse Event|7
188336|NCT00984659|597180|P3|6-week Double-blind Treatment Period|Adverse Event|3
188337|NCT00984659|597181|P2|6-week Double-blind Treatment Period|Adverse Event|3
188338|NCT00984659|597182|P1|6-week Double-blind Treatment Period|Adverse Event|0
188339|NCT00984659|597179|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
188340|NCT00984659|597180|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
188341|NCT00984659|597181|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
188342|NCT00984659|597182|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
188343|NCT00984659|597179|P4|2-week Run-in Period|Withdrawal by Subject|0
188344|NCT00984659|597180|P3|2-week Run-in Period|Withdrawal by Subject|0
188345|NCT00984659|597181|P2|2-week Run-in Period|Withdrawal by Subject|0
188346|NCT00984659|597182|P1|2-week Run-in Period|Withdrawal by Subject|10
188347|NCT00984659|597179|P4|2-week Run-in Period|Physician Decision|0
188348|NCT00984659|597180|P3|2-week Run-in Period|Physician Decision|0
188349|NCT00984659|597181|P2|2-week Run-in Period|Physician Decision|0
188350|NCT00984659|597182|P1|2-week Run-in Period|Physician Decision|10
188351|NCT00984659|597179|P4|2-week Run-in Period|Lost to Follow-up|0
188352|NCT00984659|597180|P3|2-week Run-in Period|Lost to Follow-up|0
188353|NCT00984659|597181|P2|2-week Run-in Period|Lost to Follow-up|0
188354|NCT00984659|597182|P1|2-week Run-in Period|Lost to Follow-up|3
188355|NCT00984659|597179|P4|2-week Run-in Period|Study Closed/Terminated|0
188356|NCT00984659|597180|P3|2-week Run-in Period|Study Closed/Terminated|0
188357|NCT00984659|597181|P2|2-week Run-in Period|Study Closed/Terminated|0
188358|NCT00984659|597182|P1|2-week Run-in Period|Study Closed/Terminated|2
188359|NCT00984659|597179|P4|2-week Run-in Period|Protocol Violation|0
188360|NCT00984659|597180|P3|2-week Run-in Period|Protocol Violation|0
188361|NCT00984659|597181|P2|2-week Run-in Period|Protocol Violation|0
188362|NCT00984659|597182|P1|2-week Run-in Period|Protocol Violation|5
188363|NCT00984659|597179|P4|2-week Run-in Period|Adverse Event|0
188364|NCT00984659|597180|P3|2-week Run-in Period|Adverse Event|0
188365|NCT00984659|597181|P2|2-week Run-in Period|Adverse Event|0
188366|NCT00984659|597182|P1|2-week Run-in Period|Adverse Event|8
188367|NCT00984867|597227|P2|Overall Study|lack of efficacy and subject compliance|0
188368|NCT00984867|597228|P1|Overall Study|lack of efficacy and subject compliance|1
188369|NCT00984867|597227|P2|Overall Study|site closing|0
188370|NCT00984867|597228|P1|Overall Study|site closing|1
188371|NCT00984867|597227|P2|Overall Study|Subject no longer meets study criteria|1
188372|NCT00984867|597228|P1|Overall Study|Subject no longer meets study criteria|1
188373|NCT00984867|597227|P2|Overall Study|Poor/non-compliance|1
188374|NCT00984867|597228|P1|Overall Study|Poor/non-compliance|0
188375|NCT00984867|597227|P2|Overall Study|Lost to Follow-up|4
188376|NCT00984867|597228|P1|Overall Study|Lost to Follow-up|3
188377|NCT00984867|597227|P2|Overall Study|Withdrawal by Subject|4
188378|NCT00984867|597228|P1|Overall Study|Withdrawal by Subject|13
188379|NCT00984867|597227|P2|Overall Study|Death|0
188380|NCT00984867|597228|P1|Overall Study|Death|1
188381|NCT00984867|597227|P2|Overall Study|Adverse Event|7
188382|NCT00984867|597228|P1|Overall Study|Adverse Event|3
188383|NCT00985114|597259|P2|Overall Study|Withdrawal by Subject|2
188384|NCT00985114|597260|P1|Overall Study|Withdrawal by Subject|0
188385|NCT00985114|597259|P2|Overall Study|Adverse Event|0
188386|NCT00985114|597260|P1|Overall Study|Adverse Event|1
188387|NCT00985153|597274|P4|Overall Study|Incomplete Safety Follow-up|4
188388|NCT00985153|597275|P3|Overall Study|Incomplete Safety Follow-up|4
188389|NCT00985153|597276|P2|Overall Study|Incomplete Safety Follow-up|5
188390|NCT00985153|597277|P1|Overall Study|Incomplete Safety Follow-up|3
188391|NCT00985153|597274|P4|Overall Study|Missed One or More Bleeds|10
188392|NCT00985153|597275|P3|Overall Study|Missed One or More Bleeds|8
188393|NCT00985153|597276|P2|Overall Study|Missed One or More Bleeds|7
188394|NCT00985153|597277|P1|Overall Study|Missed One or More Bleeds|7
188395|NCT00985153|597274|P4|Overall Study|Withdrawal by Subject|10
188396|NCT00985153|597275|P3|Overall Study|Withdrawal by Subject|11
188397|NCT00985153|597276|P2|Overall Study|Withdrawal by Subject|11
188398|NCT00985153|597277|P1|Overall Study|Withdrawal by Subject|6
188399|NCT00985153|597274|P4|Overall Study|Protocol Violation|3
188400|NCT00985153|597275|P3|Overall Study|Protocol Violation|4
188401|NCT00985153|597276|P2|Overall Study|Protocol Violation|2
188402|NCT00985153|597277|P1|Overall Study|Protocol Violation|3
188403|NCT00985153|597274|P4|Overall Study|Lost to Follow-up|20
188404|NCT00985153|597275|P3|Overall Study|Lost to Follow-up|17
188405|NCT00985153|597276|P2|Overall Study|Lost to Follow-up|19
188406|NCT00985153|597277|P1|Overall Study|Lost to Follow-up|16
188407|NCT00985166|597322|P3|Overall Study|Unspecified|1
188408|NCT00985166|597323|P2|Overall Study|Unspecified|0
188409|NCT00985166|597324|P1|Overall Study|Unspecified|1
188410|NCT00985166|597322|P3|Overall Study|Test not done|4
188411|NCT00985166|597323|P2|Overall Study|Test not done|0
188412|NCT00985166|597324|P1|Overall Study|Test not done|2
188413|NCT00985166|597322|P3|Overall Study|Withdrawal by Subject|0
188414|NCT00985166|597323|P2|Overall Study|Withdrawal by Subject|2
188415|NCT00985166|597324|P1|Overall Study|Withdrawal by Subject|3
188416|NCT00985166|597322|P3|Overall Study|Lost to Follow-up|2
188417|NCT00985166|597323|P2|Overall Study|Lost to Follow-up|2
188418|NCT00985166|597324|P1|Overall Study|Lost to Follow-up|3
188419|NCT00985192|597340|P1|Overall Study|Determined to be Ineligible During Trial|2
188420|NCT00985192|597340|P1|Overall Study|Disease Progression|1
188421|NCT00985192|597340|P1|Overall Study|Withdrawal by Subject|1
188422|NCT00985231|597351|P2|Overall Study|Study related symptoms & complaints|2
188423|NCT00985231|597352|P1|Overall Study|Study related symptoms & complaints|0
188424|NCT00985231|597351|P2|Overall Study|Lost to Follow-up|1
188425|NCT00985231|597352|P1|Overall Study|Lost to Follow-up|0
188426|NCT00985231|597351|P2|Overall Study|Withdrawal by Subject|0
188427|NCT00985231|597352|P1|Overall Study|Withdrawal by Subject|1
188428|NCT00985231|597351|P2|Overall Study|Protocol Violation|0
188429|NCT00985231|597352|P1|Overall Study|Protocol Violation|1
188430|NCT00985231|597351|P2|Overall Study|ineligible|0
188431|NCT00985231|597352|P1|Overall Study|ineligible|1
188432|NCT00977938|597396|P4|Observation (30-33 mo. Post Procedure)|Other|0
188433|NCT00977938|597397|P3|Observation (30-33 mo. Post Procedure)|Other|0
188434|NCT00977938|597398|P2|Observation (30-33 mo. Post Procedure)|Other|4
188435|NCT00977938|597399|P1|Observation (30-33 mo. Post Procedure)|Other|8
188436|NCT00977938|597396|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
188437|NCT00977938|597397|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
188438|NCT00977938|597398|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
188439|NCT00977938|597399|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
188440|NCT00977938|597396|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
188441|NCT00977938|597397|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
188442|NCT00977938|597398|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
188443|NCT00977938|597399|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
188444|NCT00977938|597396|P4|Treatment (12-30 mo. Post Procedure)|Other|4
188445|NCT00977938|597397|P3|Treatment (12-30 mo. Post Procedure)|Other|3
188446|NCT00977938|597398|P2|Treatment (12-30 mo. Post Procedure)|Other|18
188447|NCT00977938|597399|P1|Treatment (12-30 mo. Post Procedure)|Other|17
188448|NCT00977938|597396|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
188449|NCT00977938|597397|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
188450|NCT00977938|597398|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
188451|NCT00977938|597399|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
188452|NCT00977938|597396|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
188453|NCT00977938|597397|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
188454|NCT00977938|597398|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
188455|NCT00977938|597399|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
188456|NCT00978029|597436|P3|Overall Study|Protocol Violation|0
188457|NCT00978029|597437|P2|Overall Study|Protocol Violation|1
188458|NCT00978029|597438|P1|Overall Study|Protocol Violation|0
188459|NCT00978029|597436|P3|Overall Study|Withdrawal by Subject|1
188460|NCT00978029|597437|P2|Overall Study|Withdrawal by Subject|0
188461|NCT00978029|597438|P1|Overall Study|Withdrawal by Subject|0
188462|NCT00978029|597436|P3|Overall Study|Adverse Event|5
188463|NCT00978029|597437|P2|Overall Study|Adverse Event|2
188464|NCT00978029|597438|P1|Overall Study|Adverse Event|1
188465|NCT00978042|597463|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
188466|NCT00978042|597464|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
188467|NCT00978042|597463|P2|Initial Treatment Period|Consent withdrawn|9
188468|NCT00978042|597464|P1|Initial Treatment Period|Consent withdrawn|22
188469|NCT00978042|597463|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
188470|NCT00978042|597464|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
188471|NCT00978042|597463|P2|Initial Treatment Period|Adverse Event|0
188472|NCT00978042|597464|P1|Initial Treatment Period|Adverse Event|2
188473|NCT00978042|597463|P2|Initial Treatment Period|Lost to Follow-up|3
188474|NCT00978042|597464|P1|Initial Treatment Period|Lost to Follow-up|21
188475|NCT00978042|597463|P2|Initial Treatment Period|Ineligibility|0
188476|NCT00978042|597464|P1|Initial Treatment Period|Ineligibility|1
188477|NCT00978042|597463|P2|Initial Treatment Period|Treated in Error|3
188478|NCT00978042|597464|P1|Initial Treatment Period|Treated in Error|0
188479|NCT00978120|597478|P4|Overall Study|Moved out of state|1
188480|NCT00978120|597479|P3|Overall Study|Moved out of state|0
188481|NCT00978120|597480|P2|Overall Study|Moved out of state|0
188482|NCT00978120|597481|P1|Overall Study|Moved out of state|0
188483|NCT00978120|597478|P4|Overall Study|Withdrawal by Subject|0
188484|NCT00978120|597479|P3|Overall Study|Withdrawal by Subject|0
188485|NCT00978120|597480|P2|Overall Study|Withdrawal by Subject|0
188486|NCT00978120|597481|P1|Overall Study|Withdrawal by Subject|2
188487|NCT00978120|597478|P4|Overall Study|Lost to Follow-up|0
188488|NCT00978120|597479|P3|Overall Study|Lost to Follow-up|3
188489|NCT00978120|597480|P2|Overall Study|Lost to Follow-up|0
188490|NCT00978120|597481|P1|Overall Study|Lost to Follow-up|0
188491|NCT00978120|597478|P4|Overall Study|Death|1
188492|NCT00978120|597479|P3|Overall Study|Death|0
188493|NCT00978120|597480|P2|Overall Study|Death|0
188494|NCT00978120|597481|P1|Overall Study|Death|0
188495|NCT00978341|597531|P2|Washout Period of 2 Weeks|Adverse Event|0
188496|NCT00978341|597532|P1|Washout Period of 2 Weeks|Adverse Event|1
188497|NCT00978380|597550|P1|Overall Study|Unclassified|8
188498|NCT00978380|597550|P1|Overall Study|Withdrawal criteria|9
188499|NCT00978380|597550|P1|Overall Study|Protocol Violation|2
188500|NCT00978432|597559|P3|Overall Study|Adverse Event|1
188501|NCT00978432|597560|P2|Overall Study|Adverse Event|0
188502|NCT00978432|597561|P1|Overall Study|Adverse Event|2
188503|NCT00978432|597559|P3|Overall Study|Lack of Efficacy|3
188504|NCT00978432|597560|P2|Overall Study|Lack of Efficacy|1
188505|NCT00978432|597561|P1|Overall Study|Lack of Efficacy|1
188506|NCT00978432|597559|P3|Overall Study|Withdrawal by Subject|1
188507|NCT00978432|597560|P2|Overall Study|Withdrawal by Subject|0
188508|NCT00978432|597561|P1|Overall Study|Withdrawal by Subject|0
188509|NCT00978627|597596|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
188510|NCT00978627|597597|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
188511|NCT00978627|597596|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
188512|NCT00978627|597597|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
188513|NCT00978627|597596|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
188514|NCT00978627|597597|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
188515|NCT00978627|597596|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
188516|NCT00978627|597597|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
188517|NCT00978627|597596|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
188518|NCT00978627|597597|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
188519|NCT00978627|597596|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
188520|NCT00978627|597597|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
188521|NCT00978627|597596|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
188522|NCT00978627|597597|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
188523|NCT00978627|597596|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
188524|NCT00978627|597597|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
188525|NCT00978627|597596|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
188526|NCT00978627|597597|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
188527|NCT00978731|597623|P4|Overall Study|No response|0
188528|NCT00978731|597624|P3|Overall Study|No response|0
188529|NCT00978731|597625|P2|Overall Study|No response|0
188530|NCT00978731|597626|P1|Overall Study|No response|1
188531|NCT00978731|597623|P4|Overall Study|Study closure|1
188532|NCT00978731|597624|P3|Overall Study|Study closure|1
188533|NCT00978731|597625|P2|Overall Study|Study closure|4
188534|NCT00978731|597626|P1|Overall Study|Study closure|3
188535|NCT00978731|597623|P4|Overall Study|Disease progression/relapse|2
188536|NCT00978731|597624|P3|Overall Study|Disease progression/relapse|2
188537|NCT00978731|597625|P2|Overall Study|Disease progression/relapse|4
188538|NCT00978731|597626|P1|Overall Study|Disease progression/relapse|5
188539|NCT00978731|597623|P4|Overall Study|Deterioration without progression|0
188540|NCT00978731|597624|P3|Overall Study|Deterioration without progression|0
188541|NCT00978731|597625|P2|Overall Study|Deterioration without progression|1
188542|NCT00978731|597626|P1|Overall Study|Deterioration without progression|0
188543|NCT00978731|597623|P4|Overall Study|Administrative reason|0
188544|NCT00978731|597624|P3|Overall Study|Administrative reason|1
188545|NCT00978731|597625|P2|Overall Study|Administrative reason|3
188546|NCT00978731|597626|P1|Overall Study|Administrative reason|3
188547|NCT00978731|597623|P4|Overall Study|Participant's request|0
188548|NCT00978731|597624|P3|Overall Study|Participant's request|0
188549|NCT00978731|597625|P2|Overall Study|Participant's request|0
188550|NCT00978731|597626|P1|Overall Study|Participant's request|1
188551|NCT00978731|597623|P4|Overall Study|Adverse Event|0
188552|NCT00978731|597624|P3|Overall Study|Adverse Event|0
188553|NCT00978731|597625|P2|Overall Study|Adverse Event|2
188554|NCT00978731|597626|P1|Overall Study|Adverse Event|5
188555|NCT00978731|597623|P4|Overall Study|Lost to Follow-up|1
188556|NCT00978731|597624|P3|Overall Study|Lost to Follow-up|0
188557|NCT00978731|597625|P2|Overall Study|Lost to Follow-up|0
188558|NCT00978731|597626|P1|Overall Study|Lost to Follow-up|0
188559|NCT00978731|597623|P4|Overall Study|Death|0
188560|NCT00978731|597624|P3|Overall Study|Death|1
188561|NCT00978731|597625|P2|Overall Study|Death|1
188562|NCT00978731|597626|P1|Overall Study|Death|4
188563|NCT00978757|597666|P2|Overall Study|Physician Decision|3
188564|NCT00978757|597667|P1|Overall Study|Physician Decision|1
188565|NCT00979212|597715|P2|Overall Study|No protocol therapy received|0
188566|NCT00979212|597716|P1|Overall Study|No protocol therapy received|1
188567|NCT00979212|597715|P2|Overall Study|Protocol Violation|8
188568|NCT00979212|597716|P1|Overall Study|Protocol Violation|1
188569|NCT00985439|597738|P4|Overall Study|Adverse Event|0
188570|NCT00985439|597739|P3|Overall Study|Adverse Event|1
188571|NCT00985439|597740|P2|Overall Study|Adverse Event|0
188572|NCT00985439|597741|P1|Overall Study|Adverse Event|0
188573|NCT00985491|597751|P1|Overall Study|implant failure|3
188574|NCT00985491|597751|P1|Overall Study|Withdrawal by Subject|1
188575|NCT00985491|597751|P1|Overall Study|device migration|7
188576|NCT00985491|597751|P1|Overall Study|Adverse Event|8
188577|NCT00985504|597758|P2|Optimization Period|Withdrawal by Subject|8
188578|NCT00985504|597759|P1|Optimization Period|Withdrawal by Subject|10
188579|NCT00985504|597758|P2|Optimization Period|Protocol Violation|1
188580|NCT00985504|597759|P1|Optimization Period|Protocol Violation|3
188581|NCT00985504|597758|P2|Optimization Period|Physician Decision|0
188582|NCT00985504|597759|P1|Optimization Period|Physician Decision|1
188583|NCT00985504|597758|P2|Optimization Period|Lost to Follow-up|1
188584|NCT00985504|597759|P1|Optimization Period|Lost to Follow-up|0
188585|NCT00985504|597758|P2|Optimization Period|Lack of Efficacy|3
188586|NCT00985504|597759|P1|Optimization Period|Lack of Efficacy|5
188587|NCT00985504|597758|P2|Optimization Period|Death|1
188588|NCT00985504|597759|P1|Optimization Period|Death|0
188589|NCT00985504|597758|P2|Optimization Period|Adverse Event|9
188590|NCT00985504|597759|P1|Optimization Period|Adverse Event|7
188591|NCT00985504|597758|P2|Acute Treatment Period|Withdrawal by Subject|5
188592|NCT00985504|597759|P1|Acute Treatment Period|Withdrawal by Subject|9
188593|NCT00985504|597758|P2|Acute Treatment Period|Sponsor Decision|1
188594|NCT00985504|597759|P1|Acute Treatment Period|Sponsor Decision|0
188595|NCT00985504|597758|P2|Acute Treatment Period|Protocol Violation|0
188596|NCT00985504|597759|P1|Acute Treatment Period|Protocol Violation|2
188597|NCT00985504|597758|P2|Acute Treatment Period|Entry Criteria Not Met|2
188598|NCT00985504|597759|P1|Acute Treatment Period|Entry Criteria Not Met|1
188599|NCT00985504|597758|P2|Acute Treatment Period|Adverse Event|4
188600|NCT00985504|597759|P1|Acute Treatment Period|Adverse Event|3
188601|NCT00985673|597800|P6|Overall Study|Unspecified|0
188602|NCT00985673|597801|P5|Overall Study|Unspecified|1
188603|NCT00985673|597802|P4|Overall Study|Unspecified|0
188604|NCT00985673|597803|P3|Overall Study|Unspecified|1
188605|NCT00985673|597804|P2|Overall Study|Unspecified|0
188606|NCT00985673|597805|P1|Overall Study|Unspecified|1
188607|NCT00985673|597800|P6|Overall Study|Withdrawal by Subject|3
188608|NCT00985673|597801|P5|Overall Study|Withdrawal by Subject|2
188609|NCT00985673|597802|P4|Overall Study|Withdrawal by Subject|2
188610|NCT00985673|597803|P3|Overall Study|Withdrawal by Subject|5
188611|NCT00985673|597804|P2|Overall Study|Withdrawal by Subject|4
188612|NCT00985673|597805|P1|Overall Study|Withdrawal by Subject|0
188613|NCT00985673|597800|P6|Overall Study|Lost to Follow-up|3
188614|NCT00985673|597801|P5|Overall Study|Lost to Follow-up|5
188615|NCT00985673|597802|P4|Overall Study|Lost to Follow-up|10
188616|NCT00985673|597803|P3|Overall Study|Lost to Follow-up|6
188617|NCT00985673|597804|P2|Overall Study|Lost to Follow-up|7
188618|NCT00985673|597805|P1|Overall Study|Lost to Follow-up|6
188619|NCT00986102|598060|P4|Overall Study|Withdrawal by Subject|0
188620|NCT00986102|598061|P3|Overall Study|Withdrawal by Subject|0
188621|NCT00986102|598062|P2|Overall Study|Withdrawal by Subject|1
188622|NCT00986102|598063|P1|Overall Study|Withdrawal by Subject|1
188623|NCT00986102|598060|P4|Overall Study|Lost to Follow-up|1
188624|NCT00986102|598061|P3|Overall Study|Lost to Follow-up|0
188625|NCT00986102|598062|P2|Overall Study|Lost to Follow-up|1
188626|NCT00986102|598063|P1|Overall Study|Lost to Follow-up|0
188627|NCT00986154|598111|P2|Overall Study|never received study drug|27
188628|NCT00986154|598112|P1|Overall Study|never received study drug|25
188629|NCT00986154|598111|P2|Overall Study|investigator/subject decide not continue|3
188630|NCT00986154|598112|P1|Overall Study|investigator/subject decide not continue|6
188631|NCT00986154|598111|P2|Overall Study|Withdrawal by Subject|33
188632|NCT00986154|598112|P1|Overall Study|Withdrawal by Subject|32
188633|NCT00986154|598111|P2|Overall Study|Lost to Follow-up|4
188634|NCT00986154|598112|P1|Overall Study|Lost to Follow-up|7
188635|NCT00986154|598111|P2|Overall Study|Death|127
188636|NCT00986154|598112|P1|Overall Study|Death|136
188637|NCT00986180|598124|P2|Overall Study|Miscellanies|11
188638|NCT00986180|598125|P1|Overall Study|Miscellanies|10
188639|NCT00986180|598124|P2|Overall Study|Withdrawal by Subject|9
188640|NCT00986180|598125|P1|Overall Study|Withdrawal by Subject|1
188641|NCT00986180|598124|P2|Overall Study|Protocol Violation|0
188642|NCT00986180|598125|P1|Overall Study|Protocol Violation|2
188643|NCT00986180|598124|P2|Overall Study|Physician Decision|3
188644|NCT00986180|598125|P1|Overall Study|Physician Decision|1
188645|NCT00986180|598124|P2|Overall Study|Lost to Follow-up|7
188646|NCT00986180|598125|P1|Overall Study|Lost to Follow-up|5
188647|NCT00986180|598124|P2|Overall Study|Lack of Efficacy|3
188648|NCT00986180|598125|P1|Overall Study|Lack of Efficacy|4
188649|NCT00986180|598124|P2|Overall Study|Adverse Event|23
188650|NCT00986180|598125|P1|Overall Study|Adverse Event|21
188651|NCT00986232|598205|P4|Overall Study|Incomplete safety follow-up|2
188652|NCT00986232|598206|P3|Overall Study|Incomplete safety follow-up|2
188653|NCT00986232|598207|P2|Overall Study|Incomplete safety follow-up|7
188654|NCT00986232|598208|P1|Overall Study|Incomplete safety follow-up|3
188655|NCT00986232|598205|P4|Overall Study|Missed one or more bleeds|7
188656|NCT00986232|598206|P3|Overall Study|Missed one or more bleeds|6
188657|NCT00986232|598207|P2|Overall Study|Missed one or more bleeds|10
188658|NCT00986232|598208|P1|Overall Study|Missed one or more bleeds|13
188659|NCT00986232|598205|P4|Overall Study|Withdrawal by Subject|3
188660|NCT00986232|598206|P3|Overall Study|Withdrawal by Subject|12
188661|NCT00986232|598207|P2|Overall Study|Withdrawal by Subject|16
188662|NCT00986232|598208|P1|Overall Study|Withdrawal by Subject|13
188663|NCT00986232|598205|P4|Overall Study|Protocol Violation|1
188664|NCT00986232|598206|P3|Overall Study|Protocol Violation|0
188665|NCT00986232|598207|P2|Overall Study|Protocol Violation|3
188666|NCT00986232|598208|P1|Overall Study|Protocol Violation|2
188667|NCT00986232|598205|P4|Overall Study|Lost to Follow-up|7
188668|NCT00986232|598206|P3|Overall Study|Lost to Follow-up|12
188669|NCT00986232|598207|P2|Overall Study|Lost to Follow-up|12
188670|NCT00986232|598208|P1|Overall Study|Lost to Follow-up|19
188671|NCT00986232|598205|P4|Overall Study|Adverse Event|0
188672|NCT00986232|598206|P3|Overall Study|Adverse Event|3
188673|NCT00986232|598207|P2|Overall Study|Adverse Event|2
188674|NCT00986232|598208|P1|Overall Study|Adverse Event|1
188675|NCT00986245|598280|P2|Second Intervention|Protocol Violation|1
188676|NCT00986245|598281|P1|Second Intervention|Protocol Violation|0
188677|NCT00986245|598280|P2|Second Intervention|Lost to Follow-up|0
188678|NCT00986245|598281|P1|Second Intervention|Lost to Follow-up|1
188679|NCT00986245|598280|P2|Second Intervention|Poor compliance|0
188680|NCT00986245|598281|P1|Second Intervention|Poor compliance|1
188681|NCT00986245|598280|P2|First Intervention|Out of indication|0
188682|NCT00986245|598281|P1|First Intervention|Out of indication|1
188683|NCT00986245|598280|P2|First Intervention|Protocol Violation|1
188684|NCT00986245|598281|P1|First Intervention|Protocol Violation|0
188685|NCT00986245|598280|P2|First Intervention|Withdrawal by Subject|1
188686|NCT00986245|598281|P1|First Intervention|Withdrawal by Subject|0
188687|NCT00986245|598280|P2|First Intervention|Lack of Efficacy|2
188688|NCT00986245|598281|P1|First Intervention|Lack of Efficacy|1
188689|NCT00986245|598280|P2|First Intervention|Poor compliance|4
188690|NCT00986245|598281|P1|First Intervention|Poor compliance|8
188691|NCT00986258|598314|P1|Maintenance Period|Withdrawal by Subject|2
188692|NCT00986258|598314|P1|Maintenance Period|Lack of Efficacy|2
188693|NCT00986258|598314|P1|Maintenance Period|Adverse Event|5
188694|NCT00986258|598314|P1|Titration and Optimal Dose Period|Other|1
188695|NCT00986258|598314|P1|Titration and Optimal Dose Period|Non-Compliance|1
188696|NCT00986258|598314|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
188697|NCT00986258|598314|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
188698|NCT00986258|598314|P1|Titration and Optimal Dose Period|Adverse Event|15
188699|NCT00986258|598314|P1|Observation Period|Not eligible to be dosed|11
188700|NCT00986349|598342|P1|Overall Study|device migration|1
188701|NCT00986349|598342|P1|Overall Study|Physician Decision|1
188702|NCT00986349|598342|P1|Overall Study|Adverse Event|2
188703|NCT00986349|598342|P1|Overall Study|Unsuccessful implant procedure|3
188704|NCT00986362|598357|P2|Overall Study|Lost to Follow-up|1
188705|NCT00986362|598358|P1|Overall Study|Lost to Follow-up|0
188706|NCT00986362|598357|P2|Overall Study|Death|0
188707|NCT00986362|598358|P1|Overall Study|Death|2
188708|NCT00986427|598378|P2|Overall Study|Withdrawal by Subject|0
188709|NCT00986427|598379|P1|Overall Study|Withdrawal by Subject|1
188710|NCT00986427|598378|P2|Overall Study|Lack of Efficacy|0
188711|NCT00986427|598379|P1|Overall Study|Lack of Efficacy|1
188712|NCT00986427|598378|P2|Overall Study|Lost to Follow-up|0
188713|NCT00986427|598379|P1|Overall Study|Lost to Follow-up|2
188714|NCT00986479|598409|P2|Period 1|Administrative reasons|0
188715|NCT00986479|598410|P1|Period 1|Administrative reasons|1
188716|NCT00986479|598409|P2|Period 1|Improved mood|0
188717|NCT00986479|598410|P1|Period 1|Improved mood|1
188718|NCT00986570|598451|P1|Overall Study|Potential bias for objective assessment|1
188719|NCT00986570|598451|P1|Overall Study|Lost to Follow-up|6
188720|NCT00986674|598477|P3|Overall Study|unknown/not specify|9
188721|NCT00986674|598478|P2|Overall Study|unknown/not specify|7
188722|NCT00986674|598479|P1|Overall Study|unknown/not specify|0
188723|NCT00986674|598477|P3|Overall Study|not start protocol therapy|1
188724|NCT00986674|598478|P2|Overall Study|not start protocol therapy|3
188725|NCT00986674|598479|P1|Overall Study|not start protocol therapy|4
188726|NCT00986674|598477|P3|Overall Study|alternative therapy|1
188727|NCT00986674|598478|P2|Overall Study|alternative therapy|0
188728|NCT00986674|598479|P1|Overall Study|alternative therapy|0
188729|NCT00986674|598477|P3|Overall Study|Withdrawal by Subject|1
188730|NCT00986674|598478|P2|Overall Study|Withdrawal by Subject|2
188731|NCT00986674|598479|P1|Overall Study|Withdrawal by Subject|6
188732|NCT00986674|598477|P3|Overall Study|Death|4
188733|NCT00986674|598478|P2|Overall Study|Death|0
188734|NCT00986674|598479|P1|Overall Study|Death|5
188735|NCT00986674|598477|P3|Overall Study|Adverse Event|9
188736|NCT00986674|598478|P2|Overall Study|Adverse Event|8
188737|NCT00986674|598479|P1|Overall Study|Adverse Event|4
188738|NCT00986674|598477|P3|Overall Study|Lack of Efficacy|23
188739|NCT00986674|598478|P2|Overall Study|Lack of Efficacy|25
188740|NCT00986674|598479|P1|Overall Study|Lack of Efficacy|28
188741|NCT00986921|598518|P2|Overall Study|Physician Decision|0
188742|NCT00986921|598519|P1|Overall Study|Physician Decision|1
188743|NCT00986973|598543|P1|Overall Study|Withdrawn by study team|1
188744|NCT00986986|598555|P2|Overall Study|Lost to Follow-up|1
188745|NCT00986986|598556|P1|Overall Study|Lost to Follow-up|0
188746|NCT00987337|598578|P3|Overall Study|Participant Relapsed|5
188747|NCT00987337|598579|P2|Overall Study|Participant Relapsed|20
188748|NCT00987337|598580|P1|Overall Study|Participant Relapsed|18
188749|NCT00987337|598578|P3|Overall Study|Protocol Violation|2
188750|NCT00987337|598579|P2|Overall Study|Protocol Violation|0
188751|NCT00987337|598580|P1|Overall Study|Protocol Violation|1
188752|NCT00987337|598578|P3|Overall Study|Unspecified|5
188753|NCT00987337|598579|P2|Overall Study|Unspecified|2
188754|NCT00987337|598580|P1|Overall Study|Unspecified|0
188755|NCT00987337|598578|P3|Overall Study|Withdrawal by Subject|9
188756|NCT00987337|598579|P2|Overall Study|Withdrawal by Subject|9
188757|NCT00987337|598580|P1|Overall Study|Withdrawal by Subject|6
188758|NCT00987337|598578|P3|Overall Study|Lost to Follow-up|2
188759|NCT00987337|598579|P2|Overall Study|Lost to Follow-up|6
188760|NCT00987337|598580|P1|Overall Study|Lost to Follow-up|10
188761|NCT00987337|598578|P3|Overall Study|Virologic Breakthrough|8
188762|NCT00987337|598579|P2|Overall Study|Virologic Breakthrough|2
188763|NCT00987337|598580|P1|Overall Study|Virologic Breakthrough|2
188764|NCT00987337|598578|P3|Overall Study|Insufficient Virologic Response|12
188765|NCT00987337|598579|P2|Overall Study|Insufficient Virologic Response|7
188766|NCT00987337|598580|P1|Overall Study|Insufficient Virologic Response|10
188767|NCT00987337|598578|P3|Overall Study|Adverse Event|8
188768|NCT00987337|598579|P2|Overall Study|Adverse Event|9
188769|NCT00987337|598580|P1|Overall Study|Adverse Event|10
188770|NCT00987402|598626|P2|Overall Study|Insufficient data entry|98
188771|NCT00987402|598627|P1|Overall Study|Insufficient data entry|86
188772|NCT00987467|598650|P1|Overall Study|Lost to Follow-up|2
188773|NCT00987623|598671|P2|Overall Study|Influenza|1
188774|NCT00987623|598672|P1|Overall Study|Influenza|0
188775|NCT00987623|598671|P2|Overall Study|Biomicroscopy|1
188776|NCT00987623|598672|P1|Overall Study|Biomicroscopy|0
188777|NCT00987623|598671|P2|Overall Study|Discomfort|0
188778|NCT00987623|598672|P1|Overall Study|Discomfort|1
188779|NCT00987623|598671|P2|Overall Study|Time/job conflict|0
188780|NCT00987623|598672|P1|Overall Study|Time/job conflict|2
188781|NCT00987623|598671|P2|Overall Study|Lost to Follow-up|1
188782|NCT00987623|598672|P1|Overall Study|Lost to Follow-up|2
188783|NCT00987831|598692|P3|Overall Study|Lost to Follow-up|0
188784|NCT00987831|598693|P2|Overall Study|Lost to Follow-up|3
188785|NCT00987831|598694|P1|Overall Study|Lost to Follow-up|0
188786|NCT00987831|598692|P3|Overall Study|Never flared in 12 months|0
188787|NCT00987831|598693|P2|Overall Study|Never flared in 12 months|0
188788|NCT00987831|598694|P1|Overall Study|Never flared in 12 months|1
188789|NCT00987935|598712|P9|Overall Study|Reason other than those specified above|1
188790|NCT00987935|598713|P8|Overall Study|Reason other than those specified above|0
188791|NCT00987935|598714|P7|Overall Study|Reason other than those specified above|0
188792|NCT00987935|598715|P6|Overall Study|Reason other than those specified above|0
188793|NCT00987935|598716|P5|Overall Study|Reason other than those specified above|0
188794|NCT00987935|598717|P4|Overall Study|Reason other than those specified above|0
188795|NCT00987935|598718|P3|Overall Study|Reason other than those specified above|0
188796|NCT00987935|598719|P2|Overall Study|Reason other than those specified above|0
188797|NCT00987935|598720|P1|Overall Study|Reason other than those specified above|0
188798|NCT00987935|598712|P9|Overall Study|Refused to continue taking trial med.|2
188799|NCT00987935|598713|P8|Overall Study|Refused to continue taking trial med.|4
188800|NCT00987935|598714|P7|Overall Study|Refused to continue taking trial med.|4
188801|NCT00987935|598715|P6|Overall Study|Refused to continue taking trial med.|0
188802|NCT00987935|598716|P5|Overall Study|Refused to continue taking trial med.|1
188803|NCT00987935|598717|P4|Overall Study|Refused to continue taking trial med.|0
188804|NCT00987935|598718|P3|Overall Study|Refused to continue taking trial med.|0
188805|NCT00987935|598719|P2|Overall Study|Refused to continue taking trial med.|0
188806|NCT00987935|598720|P1|Overall Study|Refused to continue taking trial med.|1
188807|NCT00987935|598712|P9|Overall Study|Adverse Event|6
188808|NCT00987935|598713|P8|Overall Study|Adverse Event|10
188809|NCT00987935|598714|P7|Overall Study|Adverse Event|2
188810|NCT00987935|598715|P6|Overall Study|Adverse Event|0
188811|NCT00987935|598716|P5|Overall Study|Adverse Event|1
188812|NCT00987935|598717|P4|Overall Study|Adverse Event|1
188813|NCT00987935|598718|P3|Overall Study|Adverse Event|0
188814|NCT00987935|598719|P2|Overall Study|Adverse Event|1
188815|NCT00987935|598720|P1|Overall Study|Adverse Event|0
188816|NCT00987935|598712|P9|Overall Study|Progressive disease|23
188817|NCT00987935|598713|P8|Overall Study|Progressive disease|48
188818|NCT00987935|598714|P7|Overall Study|Progressive disease|9
188819|NCT00987935|598715|P6|Overall Study|Progressive disease|3
188820|NCT00987935|598716|P5|Overall Study|Progressive disease|5
188821|NCT00987935|598717|P4|Overall Study|Progressive disease|2
188822|NCT00987935|598718|P3|Overall Study|Progressive disease|3
188823|NCT00987935|598719|P2|Overall Study|Progressive disease|2
188824|NCT00987935|598720|P1|Overall Study|Progressive disease|3
188825|NCT00988065|598781|P3|Overall Study|Noncompliance with protocol|9
188826|NCT00988065|598782|P2|Overall Study|Noncompliance with protocol|6
188827|NCT00988065|598783|P1|Overall Study|Noncompliance with protocol|5
188828|NCT00988065|598781|P3|Overall Study|Subject withdrew consent|2
188829|NCT00988065|598782|P2|Overall Study|Subject withdrew consent|5
188830|NCT00988065|598783|P1|Overall Study|Subject withdrew consent|3
188831|NCT00988065|598781|P3|Overall Study|Lost to Follow-up|2
188832|NCT00988065|598782|P2|Overall Study|Lost to Follow-up|2
188833|NCT00988065|598783|P1|Overall Study|Lost to Follow-up|1
188834|NCT00988065|598781|P3|Overall Study|Adverse Event|2
188835|NCT00988065|598782|P2|Overall Study|Adverse Event|10
188836|NCT00988065|598783|P1|Overall Study|Adverse Event|4
188837|NCT00988091|598805|P2|Open-label Period|Not specified|3
188838|NCT00988091|598806|P1|Open-label Period|Not specified|2
188839|NCT00988091|598805|P2|Open-label Period|Lost to Follow-up|5
188840|NCT00988091|598806|P1|Open-label Period|Lost to Follow-up|3
188841|NCT00988091|598805|P2|Open-label Period|Withdrawal by Subject|16
188842|NCT00988091|598806|P1|Open-label Period|Withdrawal by Subject|10
188843|NCT00988091|598805|P2|Open-label Period|Protocol Violation|1
188844|NCT00988091|598806|P1|Open-label Period|Protocol Violation|1
188845|NCT00988091|598805|P2|Open-label Period|Use of exclusionary medication|1
188846|NCT00988091|598806|P1|Open-label Period|Use of exclusionary medication|1
188847|NCT00988091|598805|P2|Open-label Period|Adverse Event|7
188848|NCT00988091|598806|P1|Open-label Period|Adverse Event|4
188849|NCT00988091|598805|P2|Double-blind Period|Use of exclusionary medication|3
188850|NCT00988091|598806|P1|Double-blind Period|Use of exclusionary medication|2
188851|NCT00988091|598805|P2|Double-blind Period|Adverse Event|9
188852|NCT00988091|598806|P1|Double-blind Period|Adverse Event|6
188853|NCT00988091|598805|P2|Double-blind Period|Not specified|8
188854|NCT00988091|598806|P1|Double-blind Period|Not specified|8
188855|NCT00988091|598805|P2|Double-blind Period|Lost to Follow-up|14
188856|NCT00988091|598806|P1|Double-blind Period|Lost to Follow-up|12
188857|NCT00988091|598805|P2|Double-blind Period|Withdrawal by Subject|13
188858|NCT00988091|598806|P1|Double-blind Period|Withdrawal by Subject|15
188859|NCT00988117|598825|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
188860|NCT00988117|598825|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
188861|NCT00988169|598880|P1|Overall Study|Withdrawal by Subject|1
188862|NCT00988208|598886|P2|Overall Study|Unspecified|3
188863|NCT00988208|598887|P1|Overall Study|Unspecified|8
188864|NCT00988208|598886|P2|Overall Study|Subject decision/investigator discretion|32
188865|NCT00988208|598887|P1|Overall Study|Subject decision/investigator discretion|32
188866|NCT00988208|598886|P2|Overall Study|Clinical Deterioration|14
188867|NCT00988208|598887|P1|Overall Study|Clinical Deterioration|7
188868|NCT00988208|598886|P2|Overall Study|Biochemical Progression|7
188869|NCT00988208|598887|P1|Overall Study|Biochemical Progression|21
188870|NCT00988208|598886|P2|Overall Study|Clinical Progression|16
188871|NCT00988208|598887|P1|Overall Study|Clinical Progression|17
188872|NCT00988208|598886|P2|Overall Study|Sponsor Decision|78
188873|NCT00988208|598887|P1|Overall Study|Sponsor Decision|102
188874|NCT00988208|598886|P2|Overall Study|Protocol Violation|2
188875|NCT00988208|598887|P1|Overall Study|Protocol Violation|9
188876|NCT00988208|598886|P2|Overall Study|Lost to Follow-up|3
188877|NCT00988208|598887|P1|Overall Study|Lost to Follow-up|2
188878|NCT00988208|598886|P2|Overall Study|Death|15
188879|NCT00988208|598887|P1|Overall Study|Death|9
188880|NCT00988208|598886|P2|Overall Study|Withdrawal by Subject|57
188881|NCT00988208|598887|P1|Overall Study|Withdrawal by Subject|50
188882|NCT00988208|598886|P2|Overall Study|Disease Progression|89
188883|NCT00988208|598887|P1|Overall Study|Disease Progression|103
188884|NCT00988208|598886|P2|Overall Study|Adverse Event|122
188885|NCT00988208|598887|P1|Overall Study|Adverse Event|71
188886|NCT00988221|598902|P4|Part III|Refused Treatment|0
188887|NCT00988221|598903|P3|Part III|Refused Treatment|1
188888|NCT00988221|598904|P2|Part III|Refused Treatment|0
188889|NCT00988221|598905|P1|Part III|Refused Treatment|0
188890|NCT00988221|598902|P4|Part III|Insufficient Therapeutic Response|0
188891|NCT00988221|598903|P3|Part III|Insufficient Therapeutic Response|1
188892|NCT00988221|598904|P2|Part III|Insufficient Therapeutic Response|1
188893|NCT00988221|598905|P1|Part III|Insufficient Therapeutic Response|0
188894|NCT00988221|598902|P4|Part III|Adverse Event|0
188895|NCT00988221|598903|P3|Part III|Adverse Event|1
188896|NCT00988221|598904|P2|Part III|Adverse Event|0
188897|NCT00988221|598905|P1|Part III|Adverse Event|1
188898|NCT00988221|598902|P4|Part II|Reason not Specified|0
188899|NCT00988221|598903|P3|Part II|Reason not Specified|1
188900|NCT00988221|598904|P2|Part II|Reason not Specified|0
188901|NCT00988221|598905|P1|Part II|Reason not Specified|0
188902|NCT00988221|598902|P4|Part II|Withdrawal by Subject|2
188903|NCT00988221|598903|P3|Part II|Withdrawal by Subject|2
188904|NCT00988221|598904|P2|Part II|Withdrawal by Subject|0
188905|NCT00988221|598905|P1|Part II|Withdrawal by Subject|0
188906|NCT00988221|598902|P4|Part II|Adverse Event|1
188907|NCT00988221|598903|P3|Part II|Adverse Event|0
188908|NCT00988221|598904|P2|Part II|Adverse Event|0
188909|NCT00988221|598905|P1|Part II|Adverse Event|1
188910|NCT00988221|598902|P4|Part I|Lost to Follow-up|0
188911|NCT00988221|598903|P3|Part I|Lost to Follow-up|0
188912|NCT00988221|598904|P2|Part I|Lost to Follow-up|1
188913|NCT00988221|598905|P1|Part I|Lost to Follow-up|0
188914|NCT00988221|598902|P4|Part I|Refused Treatment|0
188915|NCT00988221|598903|P3|Part I|Refused Treatment|1
188916|NCT00988221|598904|P2|Part I|Refused Treatment|2
188917|NCT00988221|598905|P1|Part I|Refused Treatment|0
188918|NCT00988221|598902|P4|Part I|Insufficient Therapeutic Response|0
188919|NCT00988221|598903|P3|Part I|Insufficient Therapeutic Response|5
188920|NCT00988221|598904|P2|Part I|Insufficient Therapeutic Response|6
188921|NCT00988221|598905|P1|Part I|Insufficient Therapeutic Response|4
188922|NCT00988221|598902|P4|Part I|Adverse Event|0
188923|NCT00988221|598903|P3|Part I|Adverse Event|2
188924|NCT00988221|598904|P2|Part I|Adverse Event|1
188925|NCT00988221|598905|P1|Part I|Adverse Event|0
188926|NCT00988247|599078|P2|Overall Study|Not specified|0
188927|NCT00988247|599079|P1|Overall Study|Not specified|3
188928|NCT00988247|599078|P2|Overall Study|Sponsor requested withdrawal|1
188929|NCT00988247|599079|P1|Overall Study|Sponsor requested withdrawal|3
188930|NCT00988247|599078|P2|Overall Study|Protocol Violation|5
188931|NCT00988247|599079|P1|Overall Study|Protocol Violation|4
188932|NCT00988247|599078|P2|Overall Study|Lost to Follow-up|2
188933|NCT00988247|599079|P1|Overall Study|Lost to Follow-up|11
188934|NCT00988247|599078|P2|Overall Study|Pregnancy|2
188935|NCT00988247|599079|P1|Overall Study|Pregnancy|1
188936|NCT00988247|599078|P2|Overall Study|Withdrawal by Subject|13
188937|NCT00988247|599079|P1|Overall Study|Withdrawal by Subject|44
188938|NCT00988247|599078|P2|Overall Study|Adverse Event|3
188939|NCT00988247|599079|P1|Overall Study|Adverse Event|17
188940|NCT00988351|599158|P2|Overall Study|not using CPAP|3
188941|NCT00988351|599159|P1|Overall Study|not using CPAP|5
188942|NCT00988351|599158|P2|Overall Study|Lost to Follow-up|9
188943|NCT00988351|599159|P1|Overall Study|Lost to Follow-up|6
188944|NCT00988351|599158|P2|Overall Study|Withdrawal by Subject|0
188945|NCT00988351|599159|P1|Overall Study|Withdrawal by Subject|8
188946|NCT00988429|599176|P3|Overall Study|other reasons|1
188947|NCT00988429|599177|P2|Overall Study|other reasons|8
188948|NCT00988429|599178|P1|Overall Study|other reasons|8
188949|NCT00988429|599176|P3|Overall Study|Administrative Reasons|1
188950|NCT00988429|599177|P2|Overall Study|Administrative Reasons|2
188951|NCT00988429|599178|P1|Overall Study|Administrative Reasons|1
188952|NCT00988429|599176|P3|Overall Study|Withdrawal by Subject|12
188953|NCT00988429|599177|P2|Overall Study|Withdrawal by Subject|7
188954|NCT00988429|599178|P1|Overall Study|Withdrawal by Subject|7
188955|NCT00988429|599176|P3|Overall Study|Protocol Violation|3
188956|NCT00988429|599177|P2|Overall Study|Protocol Violation|3
188957|NCT00988429|599178|P1|Overall Study|Protocol Violation|4
188958|NCT00988429|599176|P3|Overall Study|Pregnancy|0
188959|NCT00988429|599177|P2|Overall Study|Pregnancy|1
188960|NCT00988429|599178|P1|Overall Study|Pregnancy|2
188961|NCT00988429|599176|P3|Overall Study|Physician Decision|3
188962|NCT00988429|599177|P2|Overall Study|Physician Decision|0
188963|NCT00988429|599178|P1|Overall Study|Physician Decision|1
188964|NCT00988429|599176|P3|Overall Study|Non-Compliance with Study Drug|3
188965|NCT00988429|599177|P2|Overall Study|Non-Compliance with Study Drug|1
188966|NCT00988429|599178|P1|Overall Study|Non-Compliance with Study Drug|5
188967|NCT00988429|599176|P3|Overall Study|Lack of Efficacy|1
188968|NCT00988429|599177|P2|Overall Study|Lack of Efficacy|0
188969|NCT00988429|599178|P1|Overall Study|Lack of Efficacy|0
188970|NCT00988429|599176|P3|Overall Study|Adverse Event|45
188971|NCT00988429|599177|P2|Overall Study|Adverse Event|21
188972|NCT00988429|599178|P1|Overall Study|Adverse Event|9
188973|NCT00988442|599191|P2|Overall Study|Early Study Closure|25
188974|NCT00988442|599192|P1|Overall Study|Early Study Closure|29
188975|NCT00988442|599191|P2|Overall Study|Lost to Follow-up|1
188976|NCT00988442|599192|P1|Overall Study|Lost to Follow-up|0
188977|NCT00988442|599191|P2|Overall Study|Death|2
188978|NCT00988442|599192|P1|Overall Study|Death|1
188979|NCT00988533|599252|P1|Overall Study|Lost to Follow-up|3
188980|NCT00982280|599264|P1|Maintenance Period|Adverse Event|1
188981|NCT00982280|599264|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
188982|NCT00982280|599264|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
188983|NCT00982280|599264|P1|Titration and Optimal Dose Period|Adverse Event|5
188984|NCT00982280|599264|P1|Observation Period|Not eligible to be dosed|19
188985|NCT00982410|599293|P2|12-month Follow-up Assessment|scheduled, no-show|0
188986|NCT00982410|599294|P1|12-month Follow-up Assessment|scheduled, no-show|1
188987|NCT00982410|599293|P2|12-month Follow-up Assessment|incarceration|1
188988|NCT00982410|599294|P1|12-month Follow-up Assessment|incarceration|2
188989|NCT00982410|599293|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
188990|NCT00982410|599294|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
188991|NCT00982410|599293|P2|12-month Follow-up Assessment|could not reach to schedule|5
188992|NCT00982410|599294|P1|12-month Follow-up Assessment|could not reach to schedule|6
188993|NCT00982410|599293|P2|12-month Follow-up Assessment|Death|2
188994|NCT00982410|599294|P1|12-month Follow-up Assessment|Death|0
188995|NCT00982410|599293|P2|6-month Follow-up Assessment|scheduled, no-show|1
188996|NCT00982410|599294|P1|6-month Follow-up Assessment|scheduled, no-show|0
188997|NCT00982410|599293|P2|6-month Follow-up Assessment|patent surgery|1
188998|NCT00982410|599294|P1|6-month Follow-up Assessment|patent surgery|0
188999|NCT00982410|599293|P2|6-month Follow-up Assessment|incarceration|2
189000|NCT00982410|599294|P1|6-month Follow-up Assessment|incarceration|0
189001|NCT00982410|599293|P2|6-month Follow-up Assessment|participant no transportation|0
189002|NCT00982410|599294|P1|6-month Follow-up Assessment|participant no transportation|1
189003|NCT00982410|599293|P2|6-month Follow-up Assessment|Could not reach to schedule|7
189004|NCT00982410|599294|P1|6-month Follow-up Assessment|Could not reach to schedule|5
189005|NCT00982410|599293|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
189006|NCT00982410|599294|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
189007|NCT00982410|599293|P2|3-month Follow-up Assessment|Scheduled, no-show|2
189008|NCT00982410|599294|P1|3-month Follow-up Assessment|Scheduled, no-show|1
189009|NCT00982410|599293|P2|3-month Follow-up Assessment|Could not reach to schedule|9
189010|NCT00982410|599294|P1|3-month Follow-up Assessment|Could not reach to schedule|8
189011|NCT00982488|599340|P5|Overall Study|Withdrawal by Subject|0
189012|NCT00982488|599341|P4|Overall Study|Withdrawal by Subject|0
189013|NCT00982488|599342|P3|Overall Study|Withdrawal by Subject|1
189014|NCT00982488|599343|P2|Overall Study|Withdrawal by Subject|1
189015|NCT00982488|599344|P1|Overall Study|Withdrawal by Subject|5
189016|NCT00982488|599340|P5|Overall Study|Study drug toxicity|0
189017|NCT00982488|599341|P4|Overall Study|Study drug toxicity|0
189018|NCT00982488|599342|P3|Overall Study|Study drug toxicity|6
189019|NCT00982488|599343|P2|Overall Study|Study drug toxicity|1
189020|NCT00982488|599344|P1|Overall Study|Study drug toxicity|34
189021|NCT00982488|599340|P5|Overall Study|Stem cell transplant|0
189022|NCT00982488|599341|P4|Overall Study|Stem cell transplant|1
189023|NCT00982488|599342|P3|Overall Study|Stem cell transplant|0
189024|NCT00982488|599343|P2|Overall Study|Stem cell transplant|0
189025|NCT00982488|599344|P1|Overall Study|Stem cell transplant|2
189026|NCT00982488|599340|P5|Overall Study|Poor compliance/noncompliance|0
189027|NCT00982488|599341|P4|Overall Study|Poor compliance/noncompliance|0
189028|NCT00982488|599342|P3|Overall Study|Poor compliance/noncompliance|0
189029|NCT00982488|599343|P2|Overall Study|Poor compliance/noncompliance|1
189030|NCT00982488|599344|P1|Overall Study|Poor compliance/noncompliance|0
189031|NCT00982488|599340|P5|Overall Study|Not specified|0
189032|NCT00982488|599341|P4|Overall Study|Not specified|1
189033|NCT00982488|599342|P3|Overall Study|Not specified|3
189034|NCT00982488|599343|P2|Overall Study|Not specified|1
189035|NCT00982488|599344|P1|Overall Study|Not specified|15
189036|NCT00982488|599340|P5|Overall Study|Maximum clinical benefit|0
189037|NCT00982488|599341|P4|Overall Study|Maximum clinical benefit|0
189038|NCT00982488|599342|P3|Overall Study|Maximum clinical benefit|1
189039|NCT00982488|599343|P2|Overall Study|Maximum clinical benefit|1
189040|NCT00982488|599344|P1|Overall Study|Maximum clinical benefit|1
189041|NCT00982488|599340|P5|Overall Study|Lost to Follow-up|0
189042|NCT00982488|599341|P4|Overall Study|Lost to Follow-up|0
189043|NCT00982488|599342|P3|Overall Study|Lost to Follow-up|0
189044|NCT00982488|599343|P2|Overall Study|Lost to Follow-up|0
189045|NCT00982488|599344|P1|Overall Study|Lost to Follow-up|1
189046|NCT00982488|599340|P5|Overall Study|Disease progression|1
189047|NCT00982488|599341|P4|Overall Study|Disease progression|1
189048|NCT00982488|599342|P3|Overall Study|Disease progression|10
189049|NCT00982488|599343|P2|Overall Study|Disease progression|5
189050|NCT00982488|599344|P1|Overall Study|Disease progression|30
189051|NCT00982488|599340|P5|Overall Study|Death|0
189052|NCT00982488|599341|P4|Overall Study|Death|0
189053|NCT00982488|599342|P3|Overall Study|Death|2
189054|NCT00982488|599343|P2|Overall Study|Death|0
189055|NCT00982488|599344|P1|Overall Study|Death|11
189056|NCT00982488|599340|P5|Overall Study|Adverse event unrelated to study drug|0
189057|NCT00982488|599341|P4|Overall Study|Adverse event unrelated to study drug|0
189058|NCT00982488|599342|P3|Overall Study|Adverse event unrelated to study drug|0
189059|NCT00982488|599343|P2|Overall Study|Adverse event unrelated to study drug|1
189060|NCT00982488|599344|P1|Overall Study|Adverse event unrelated to study drug|5
189061|NCT00982488|599340|P5|Overall Study|Administrative reason by sponsor|0
189062|NCT00982488|599341|P4|Overall Study|Administrative reason by sponsor|0
189063|NCT00982488|599342|P3|Overall Study|Administrative reason by sponsor|11
189064|NCT00982488|599343|P2|Overall Study|Administrative reason by sponsor|3
189065|NCT00982488|599344|P1|Overall Study|Administrative reason by sponsor|81
189066|NCT00982644|599382|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
189067|NCT00982644|599383|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
189068|NCT00982644|599382|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
189069|NCT00982644|599383|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
189070|NCT00982644|599382|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
189071|NCT00982644|599383|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
189072|NCT00982644|599382|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
189073|NCT00982644|599383|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
189074|NCT00982644|599382|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
189075|NCT00982644|599383|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
189076|NCT00982644|599382|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
189077|NCT00982644|599383|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
189078|NCT00982644|599382|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
189079|NCT00982644|599383|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
189080|NCT00982644|599382|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
189081|NCT00982644|599383|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
189082|NCT00982644|599382|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
189083|NCT00982644|599383|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
189084|NCT00982644|599382|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
189085|NCT00982644|599383|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
189086|NCT00982657|599409|P4|Overall Study|On going at date of cut-off|1
189087|NCT00982657|599410|P3|Overall Study|On going at date of cut-off|0
189088|NCT00982657|599411|P2|Overall Study|On going at date of cut-off|0
189089|NCT00982657|599412|P1|Overall Study|On going at date of cut-off|0
189090|NCT00982657|599409|P4|Overall Study|Unspecified|4
189091|NCT00982657|599410|P3|Overall Study|Unspecified|0
189092|NCT00982657|599411|P2|Overall Study|Unspecified|0
189093|NCT00982657|599412|P1|Overall Study|Unspecified|0
189094|NCT00982657|599409|P4|Overall Study|Withdrawal by Subject|3
189095|NCT00982657|599410|P3|Overall Study|Withdrawal by Subject|1
189096|NCT00982657|599411|P2|Overall Study|Withdrawal by Subject|0
189097|NCT00982657|599412|P1|Overall Study|Withdrawal by Subject|0
189098|NCT00982657|599409|P4|Overall Study|Death|1
189099|NCT00982657|599410|P3|Overall Study|Death|1
189100|NCT00982657|599411|P2|Overall Study|Death|0
189101|NCT00982657|599412|P1|Overall Study|Death|1
189102|NCT00982735|599451|P1|Overall Study|Patient ineligible for trial|224
189103|NCT00982735|599451|P1|Overall Study|Lost to Follow-up|6
189104|NCT00988637|599459|P2|Overall Study|non-compliance with study drug|1
189105|NCT00988637|599460|P1|Overall Study|non-compliance with study drug|0
189106|NCT00988637|599459|P2|Overall Study|Withdrawal by Subject|1
189107|NCT00988637|599460|P1|Overall Study|Withdrawal by Subject|1
189108|NCT00988637|599459|P2|Overall Study|Lost to Follow-up|1
189109|NCT00988637|599460|P1|Overall Study|Lost to Follow-up|2
189110|NCT00988858|599525|P1|Overall Study|Sponsor Decision|1
189111|NCT00988858|599525|P1|Overall Study|Physician Decision|1
189112|NCT00988858|599525|P1|Overall Study|Death|1
189113|NCT00988858|599525|P1|Overall Study|Adverse Event|7
189114|NCT00988884|599539|P2|Overall Study|Withdrawal by Subject|18
189115|NCT00988884|599540|P1|Overall Study|Withdrawal by Subject|15
189116|NCT00988884|599539|P2|Overall Study|Protocol Violation|1
189117|NCT00988884|599540|P1|Overall Study|Protocol Violation|0
189118|NCT00988884|599539|P2|Overall Study|Lost to Follow-up|16
189119|NCT00988884|599540|P1|Overall Study|Lost to Follow-up|20
189120|NCT00988884|599539|P2|Overall Study|Adverse Event|1
189121|NCT00988884|599540|P1|Overall Study|Adverse Event|0
189122|NCT00994110|599564|P2|Overall Study|Pt not eligible|5
189123|NCT00994110|599565|P1|Overall Study|Pt not eligible|10
189124|NCT00994110|599564|P2|Overall Study|Patient not resected|52
189125|NCT00994110|599565|P1|Overall Study|Patient not resected|41
189126|NCT00994110|599564|P2|Overall Study|Adverse Event|0
189127|NCT00994110|599565|P1|Overall Study|Adverse Event|1
189128|NCT00994110|599564|P2|Overall Study|Not Treated|8
189129|NCT00994110|599565|P1|Overall Study|Not Treated|4
189130|NCT00994110|599564|P2|Overall Study|Withdrawal by Subject|9
189131|NCT00994110|599565|P1|Overall Study|Withdrawal by Subject|9
189132|NCT00994214|599599|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
189133|NCT00994214|599600|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
189134|NCT00994214|599601|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
189135|NCT00994214|599602|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
189136|NCT00994214|599599|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
189137|NCT00994214|599600|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
189138|NCT00994214|599601|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
189139|NCT00994214|599602|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
189140|NCT00994214|599599|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
189141|NCT00994214|599600|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
189142|NCT00994214|599601|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
189143|NCT00994214|599602|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
189144|NCT00994214|599599|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
189145|NCT00994214|599600|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
189146|NCT00994214|599601|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
189147|NCT00994214|599602|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
189148|NCT00994214|599599|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
189149|NCT00994214|599600|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
189150|NCT00994214|599601|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
189151|NCT00994214|599602|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
189152|NCT00994214|599599|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
189153|NCT00994214|599600|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
189154|NCT00994214|599601|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
189155|NCT00994214|599602|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
189156|NCT00994240|599648|P2|Overall Study|study termination|3
189157|NCT00994240|599649|P1|Overall Study|study termination|2
189158|NCT00994240|599648|P2|Overall Study|Withdrawal by Subject|0
189159|NCT00994240|599649|P1|Overall Study|Withdrawal by Subject|1
189160|NCT00994240|599648|P2|Overall Study|Lost to Follow-up|2
189161|NCT00994240|599649|P1|Overall Study|Lost to Follow-up|3
189162|NCT00994279|599666|P2|Overall Study|Multiple reasons|3
189163|NCT00994279|599667|P1|Overall Study|Multiple reasons|1
189164|NCT00994279|599666|P2|Overall Study|Toxicity|0
189165|NCT00994279|599667|P1|Overall Study|Toxicity|1
189166|NCT00994279|599666|P2|Overall Study|Withdrawal by Subject|2
189167|NCT00994279|599667|P1|Overall Study|Withdrawal by Subject|2
189168|NCT00994422|599690|P2|Overall Study|Lost to Follow-up|1
189169|NCT00994422|599691|P1|Overall Study|Lost to Follow-up|7
189170|NCT00994448|599703|P2|Overall Study|Physician Decision|0
189171|NCT00994448|599704|P1|Overall Study|Physician Decision|1
189172|NCT00994448|599703|P2|Overall Study|Withdrawal by Subject|1
189173|NCT00994448|599704|P1|Overall Study|Withdrawal by Subject|1
189174|NCT00994448|599703|P2|Overall Study|Lost to Follow-up|1
189175|NCT00994448|599704|P1|Overall Study|Lost to Follow-up|5
189176|NCT00994448|599703|P2|Overall Study|Adverse Event|0
189177|NCT00994448|599704|P1|Overall Study|Adverse Event|1
189178|NCT00994461|599713|P3|Overall Study|Adverse Event|0
189179|NCT00994461|599714|P2|Overall Study|Adverse Event|1
189180|NCT00994461|599715|P1|Overall Study|Adverse Event|2
189181|NCT00994682|599750|P2|Pioglitazone Open Label|Physician Decision|1
189182|NCT00994682|599751|P1|Pioglitazone Open Label|Physician Decision|6
189183|NCT00994682|599750|P2|Pioglitazone Open Label|Lost to Follow-up|2
189184|NCT00994682|599751|P1|Pioglitazone Open Label|Lost to Follow-up|3
189185|NCT00994682|599750|P2|Pioglitazone Open Label|Withdrawal by Subject|4
189186|NCT00994682|599751|P1|Pioglitazone Open Label|Withdrawal by Subject|4
189187|NCT00994682|599750|P2|Double Bilnd|Adverse Event|0
189188|NCT00994682|599751|P1|Double Bilnd|Adverse Event|1
189189|NCT00994682|599750|P2|Double Bilnd|Lost to Follow-up|3
189190|NCT00994682|599751|P1|Double Bilnd|Lost to Follow-up|3
189191|NCT00994682|599750|P2|Double Bilnd|Withdrawal by Subject|6
189192|NCT00994682|599751|P1|Double Bilnd|Withdrawal by Subject|5
189193|NCT00995007|599842|P2|Overall Study|Toxicity|0
189194|NCT00995007|599843|P1|Overall Study|Toxicity|8
189195|NCT00995007|599842|P2|Overall Study|Refused further treatment|2
189196|NCT00995007|599843|P1|Overall Study|Refused further treatment|8
189197|NCT00995007|599842|P2|Overall Study|Withdrew consent|0
189198|NCT00995007|599843|P1|Overall Study|Withdrew consent|1
189199|NCT00995020|599861|P2|Overall Study|specimen fragmentation, thermal damage|2
189200|NCT00995020|599862|P1|Overall Study|specimen fragmentation, thermal damage|1
189201|NCT00995020|599861|P2|Overall Study|margin analysis not performed|5
189202|NCT00995020|599862|P1|Overall Study|margin analysis not performed|2
189203|NCT00995085|599870|P1|Overall Study|Withdrawal by Subject|5
189204|NCT00995345|599879|P5|Overall Study|all other reasons combined|3
189205|NCT00995345|599880|P4|Overall Study|all other reasons combined|1
189206|NCT00995345|599881|P3|Overall Study|all other reasons combined|2
189207|NCT00995345|599882|P2|Overall Study|all other reasons combined|2
189208|NCT00995345|599883|P1|Overall Study|all other reasons combined|2
189209|NCT00995345|599879|P5|Overall Study|Lost to Follow-up|0
189210|NCT00995345|599880|P4|Overall Study|Lost to Follow-up|1
189211|NCT00995345|599881|P3|Overall Study|Lost to Follow-up|2
189212|NCT00995345|599882|P2|Overall Study|Lost to Follow-up|2
189213|NCT00995345|599883|P1|Overall Study|Lost to Follow-up|2
189214|NCT00995345|599879|P5|Overall Study|Adverse Event|1
189215|NCT00995345|599880|P4|Overall Study|Adverse Event|0
189216|NCT00995345|599881|P3|Overall Study|Adverse Event|2
189217|NCT00995345|599882|P2|Overall Study|Adverse Event|1
189218|NCT00995345|599883|P1|Overall Study|Adverse Event|3
189219|NCT00995345|599879|P5|Overall Study|Withdrawal by Subject|1
189220|NCT00995345|599880|P4|Overall Study|Withdrawal by Subject|3
189221|NCT00995345|599881|P3|Overall Study|Withdrawal by Subject|1
189222|NCT00995345|599882|P2|Overall Study|Withdrawal by Subject|2
189223|NCT00995345|599883|P1|Overall Study|Withdrawal by Subject|4
189224|NCT00995371|599912|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
189225|NCT00995371|599913|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
189226|NCT00995410|599926|P1|Overall Study|Misc|28
189227|NCT00995410|599926|P1|Overall Study|Lost to Follow-up|2
189228|NCT00995410|599926|P1|Overall Study|Withdrawal by Subject|7
189229|NCT00995410|599926|P1|Overall Study|Adverse Event|51
189230|NCT00995436|599934|P3|Overall Study|Withdrawal by Subject|0
189231|NCT00995436|599935|P2|Overall Study|Withdrawal by Subject|5
189232|NCT00995436|599936|P1|Overall Study|Withdrawal by Subject|2
189233|NCT00995488|599959|P1|Overall Study|Withdrawal by Subject|1
189234|NCT00995553|600007|P2|Overall Study|Withdrawal by Subject|6
189235|NCT00995553|600008|P1|Overall Study|Withdrawal by Subject|2
189236|NCT00995566|600016|P1|Overall Study|Early study termination|52
189237|NCT00995566|600016|P1|Overall Study|Adverse Event|2
189238|NCT00995670|600031|P3|Overall Study|Failed arterial cannulation|3
189239|NCT00995670|600032|P2|Overall Study|Failed arterial cannulation|0
189240|NCT00995670|600033|P1|Overall Study|Failed arterial cannulation|1
189241|NCT00995709|600044|P3|Overall Study|Protocol Violation|0
189242|NCT00995709|600045|P2|Overall Study|Protocol Violation|1
189243|NCT00995709|600046|P1|Overall Study|Protocol Violation|2
189244|NCT00995709|600044|P3|Overall Study|Death|0
189245|NCT00995709|600045|P2|Overall Study|Death|1
189246|NCT00995709|600046|P1|Overall Study|Death|0
189247|NCT00995709|600044|P3|Overall Study|Lost to Follow-up|0
189248|NCT00995709|600045|P2|Overall Study|Lost to Follow-up|0
189249|NCT00995709|600046|P1|Overall Study|Lost to Follow-up|1
189250|NCT00995709|600044|P3|Overall Study|Withdrawal by Subject|1
189251|NCT00995709|600045|P2|Overall Study|Withdrawal by Subject|4
189252|NCT00995709|600046|P1|Overall Study|Withdrawal by Subject|0
189253|NCT00995709|600044|P3|Overall Study|Lack of Efficacy|4
189254|NCT00995709|600045|P2|Overall Study|Lack of Efficacy|1
189255|NCT00995709|600046|P1|Overall Study|Lack of Efficacy|0
189256|NCT00995709|600044|P3|Overall Study|Adverse Event|0
189257|NCT00995709|600045|P2|Overall Study|Adverse Event|2
189258|NCT00995709|600046|P1|Overall Study|Adverse Event|4
189259|NCT00995774|600092|P2|Training Period 2|Withdrawal by Subject|0
189260|NCT00995774|600093|P1|Training Period 2|Withdrawal by Subject|2
189261|NCT00995865|600104|P3|Overall Study|Lost to Follow-up|1
189262|NCT00995865|600105|P2|Overall Study|Lost to Follow-up|0
189263|NCT00995865|600106|P1|Overall Study|Lost to Follow-up|0
189264|NCT00995865|600104|P3|Overall Study|Protocol Violation|0
189265|NCT00995865|600105|P2|Overall Study|Protocol Violation|0
189266|NCT00995865|600106|P1|Overall Study|Protocol Violation|2
189267|NCT00995930|600147|P2|Overall Study|Adverse Event|14
189268|NCT00995930|600148|P1|Overall Study|Adverse Event|11
189269|NCT00995930|600147|P2|Overall Study|Withdrawal by Subject|4
189270|NCT00995930|600148|P1|Overall Study|Withdrawal by Subject|3
189271|NCT00995930|600147|P2|Overall Study|Lost to Follow-up|2
189272|NCT00995930|600148|P1|Overall Study|Lost to Follow-up|1
189273|NCT00995930|600147|P2|Overall Study|Administrative problems|2
189274|NCT00995930|600148|P1|Overall Study|Administrative problems|4
189275|NCT00995930|600147|P2|Overall Study|Death|1
189276|NCT00995930|600148|P1|Overall Study|Death|0
189277|NCT00995930|600147|P2|Overall Study|Protocol deviation|5
189278|NCT00995930|600148|P1|Overall Study|Protocol deviation|2
189279|NCT00996034|600177|P1|Overall Study|withdrawn by PI|1
189280|NCT00996034|600177|P1|Overall Study|Lost to Follow-up|2
189281|NCT00996125|600183|P2|Overall Study|Withdrawal by Subject|3
189282|NCT00996125|600184|P1|Overall Study|Withdrawal by Subject|4
189283|NCT00996125|600183|P2|Overall Study|Lost to Follow-up|6
189284|NCT00996125|600184|P1|Overall Study|Lost to Follow-up|1
189285|NCT00996125|600183|P2|Overall Study|Adverse Event|2
189286|NCT00996125|600184|P1|Overall Study|Adverse Event|0
189287|NCT00996203|600215|P1|Overall Study|Protocol Violation|2
189288|NCT00996203|600215|P1|Overall Study|Lack of Efficacy|1
189289|NCT00996203|600215|P1|Overall Study|Lost to Follow-up|1
189290|NCT00996203|600215|P1|Overall Study|Adverse Event|3
189291|NCT00996216|600234|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
189292|NCT00996216|600234|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
189293|NCT00996216|600234|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
189294|NCT00996281|600252|P2|Overall Study|Other|7
189295|NCT00996281|600253|P1|Overall Study|Other|5
189296|NCT00996281|600252|P2|Overall Study|Lack of Efficacy|2
189297|NCT00996281|600253|P1|Overall Study|Lack of Efficacy|0
189298|NCT00996281|600252|P2|Overall Study|Withdrawal by Subject|20
189299|NCT00996281|600253|P1|Overall Study|Withdrawal by Subject|31
189300|NCT00996281|600252|P2|Overall Study|Lost to Follow-up|16
189301|NCT00996281|600253|P1|Overall Study|Lost to Follow-up|14
189302|NCT00996281|600252|P2|Overall Study|Major Protocol Deviation|7
189303|NCT00996281|600253|P1|Overall Study|Major Protocol Deviation|6
189304|NCT00996281|600252|P2|Overall Study|Adverse Event|37
189305|NCT00996281|600253|P1|Overall Study|Adverse Event|75
189306|NCT00996307|600265|P4|Overall Study|Unable to classify|1
189307|NCT00996307|600266|P3|Overall Study|Unable to classify|2
189308|NCT00996307|600267|P2|Overall Study|Unable to classify|0
189309|NCT00996307|600268|P1|Overall Study|Unable to classify|4
189310|NCT00996307|600265|P4|Overall Study|Administrative reason|0
189311|NCT00996307|600266|P3|Overall Study|Administrative reason|0
189312|NCT00996307|600267|P2|Overall Study|Administrative reason|1
189313|NCT00996307|600268|P1|Overall Study|Administrative reason|0
189314|NCT00996307|600265|P4|Overall Study|Lost to Follow-up|15
189315|NCT00996307|600266|P3|Overall Study|Lost to Follow-up|7
189316|NCT00996307|600267|P2|Overall Study|Lost to Follow-up|13
189317|NCT00996307|600268|P1|Overall Study|Lost to Follow-up|13
189318|NCT00996307|600265|P4|Overall Study|Withdrawal by Subject|5
189319|NCT00996307|600266|P3|Overall Study|Withdrawal by Subject|5
189320|NCT00996307|600267|P2|Overall Study|Withdrawal by Subject|2
189321|NCT00996307|600268|P1|Overall Study|Withdrawal by Subject|3
189322|NCT00996307|600265|P4|Overall Study|Adverse Event|0
189323|NCT00996307|600266|P3|Overall Study|Adverse Event|0
189324|NCT00996307|600267|P2|Overall Study|Adverse Event|1
189325|NCT00996307|600268|P1|Overall Study|Adverse Event|0
189326|NCT00996333|600326|P1|Overall Study|Other|5
189327|NCT00996333|600326|P1|Overall Study|Physician Decision|1
189328|NCT00996333|600326|P1|Overall Study|Adverse Event|1
189329|NCT00996333|600326|P1|Overall Study|Death|4
189330|NCT00996333|600326|P1|Overall Study|Withdrawal by Subject|1
189331|NCT00996333|600326|P1|Overall Study|Screen failure|1
189332|NCT00996437|600359|P2|Overall Study|Missed|5
189333|NCT00996437|600360|P1|Overall Study|Missed|2
189334|NCT00996437|600359|P2|Overall Study|Dropped|2
189335|NCT00996437|600360|P1|Overall Study|Dropped|2
189336|NCT00996437|600359|P2|Overall Study|Death|0
189337|NCT00996437|600360|P1|Overall Study|Death|1
189338|NCT00996476|600385|P5|Overall Study|Adverse Event|1
189339|NCT00996476|600386|P4|Overall Study|Adverse Event|0
189340|NCT00996476|600387|P3|Overall Study|Adverse Event|0
189341|NCT00996476|600388|P2|Overall Study|Adverse Event|1
189342|NCT00996476|600389|P1|Overall Study|Adverse Event|0
189343|NCT00996476|600385|P5|Overall Study|Withdrawal by Subject|1
189344|NCT00996476|600386|P4|Overall Study|Withdrawal by Subject|0
189345|NCT00996476|600387|P3|Overall Study|Withdrawal by Subject|1
189346|NCT00996476|600388|P2|Overall Study|Withdrawal by Subject|2
189347|NCT00996476|600389|P1|Overall Study|Withdrawal by Subject|1
189348|NCT00985686|600463|P4|Overall Study|Lost to Follow-up|2
189349|NCT00985686|600464|P3|Overall Study|Lost to Follow-up|0
189350|NCT00985686|600465|P2|Overall Study|Lost to Follow-up|1
189351|NCT00985686|600466|P1|Overall Study|Lost to Follow-up|1
189352|NCT00985712|600476|P2|Overall Study|Sponsor decision|2
189353|NCT00985712|600477|P1|Overall Study|Sponsor decision|0
189354|NCT00985712|600476|P2|Overall Study|Withdrawal by Subject|1
189355|NCT00985712|600477|P1|Overall Study|Withdrawal by Subject|4
189356|NCT00985712|600476|P2|Overall Study|Protocol Violation|1
189357|NCT00985712|600477|P1|Overall Study|Protocol Violation|0
189358|NCT00985712|600476|P2|Overall Study|Lost to Follow-up|2
189359|NCT00985712|600477|P1|Overall Study|Lost to Follow-up|2
189360|NCT00985712|600476|P2|Overall Study|Adverse Event|1
189361|NCT00985712|600477|P1|Overall Study|Adverse Event|0
189362|NCT00985725|600493|P2|Overall Study|Out-of-window visits|1
189363|NCT00985725|600494|P1|Overall Study|Out-of-window visits|0
189364|NCT00985725|600493|P2|Overall Study|Non-compliance|2
189365|NCT00985725|600494|P1|Overall Study|Non-compliance|1
189366|NCT00985725|600493|P2|Overall Study|Lack of Efficacy|1
189367|NCT00985725|600494|P1|Overall Study|Lack of Efficacy|0
189368|NCT00985725|600493|P2|Overall Study|Lost to Follow-up|1
189369|NCT00985725|600494|P1|Overall Study|Lost to Follow-up|1
189370|NCT00985725|600493|P2|Overall Study|Withdrawal by Subject|4
189371|NCT00985725|600494|P1|Overall Study|Withdrawal by Subject|4
189372|NCT00985725|600493|P2|Overall Study|Protocol Violation|3
189373|NCT00985725|600494|P1|Overall Study|Protocol Violation|1
189374|NCT00985725|600493|P2|Overall Study|Adverse Event|1
189375|NCT00985725|600494|P1|Overall Study|Adverse Event|4
189376|NCT00985738|600530|P2|Overall Study|Study closed prematurely|8
189377|NCT00985738|600531|P1|Overall Study|Study closed prematurely|8
189378|NCT00985790|600539|P2|Overall Study|Lost to Follow-up|7
189379|NCT00985790|600540|P1|Overall Study|Lost to Follow-up|6
189380|NCT00985790|600539|P2|Overall Study|Withdrawal by Subject|1
189381|NCT00985790|600540|P1|Overall Study|Withdrawal by Subject|1
189382|NCT00985946|600585|P1|Overall Study|Withdrawal by Subject|1
189383|NCT00985946|600585|P1|Overall Study|Lost to Follow-up|6
189384|NCT00985959|600596|P3|Overall Study|Unspecified|11
189385|NCT00985959|600597|P2|Overall Study|Unspecified|0
189386|NCT00985959|600598|P1|Overall Study|Unspecified|0
189387|NCT00985959|600596|P3|Overall Study|Complete response observed over 2 cycles|4
189388|NCT00985959|600597|P2|Overall Study|Complete response observed over 2 cycles|1
189389|NCT00985959|600598|P1|Overall Study|Complete response observed over 2 cycles|0
189390|NCT00985959|600596|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
189391|NCT00985959|600597|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
189392|NCT00985959|600598|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
189393|NCT00985959|600596|P3|Overall Study|Unrecovered toxicity|7
189394|NCT00985959|600597|P2|Overall Study|Unrecovered toxicity|0
189395|NCT00985959|600598|P1|Overall Study|Unrecovered toxicity|0
189396|NCT00985959|600596|P3|Overall Study|Progressive disease|8
189397|NCT00985959|600597|P2|Overall Study|Progressive disease|2
189398|NCT00985959|600598|P1|Overall Study|Progressive disease|1
189399|NCT00985959|600596|P3|Overall Study|Withdrawal by Subject|8
189400|NCT00985959|600597|P2|Overall Study|Withdrawal by Subject|0
189401|NCT00985959|600598|P1|Overall Study|Withdrawal by Subject|0
189402|NCT00985959|600596|P3|Overall Study|Adverse Event|19
189403|NCT00985959|600597|P2|Overall Study|Adverse Event|0
189404|NCT00985959|600598|P1|Overall Study|Adverse Event|0
189405|NCT00985985|600625|P4|Overall Study|Other Reason|2
189406|NCT00985985|600626|P3|Overall Study|Other Reason|4
189407|NCT00985985|600627|P2|Overall Study|Other Reason|1
189408|NCT00985985|600628|P1|Overall Study|Other Reason|6
189409|NCT00985985|600625|P4|Overall Study|Withdrawal by Subject|2
189410|NCT00985985|600626|P3|Overall Study|Withdrawal by Subject|2
189411|NCT00985985|600627|P2|Overall Study|Withdrawal by Subject|2
189412|NCT00985985|600628|P1|Overall Study|Withdrawal by Subject|4
189413|NCT00985985|600625|P4|Overall Study|Lack of Efficacy|3
189414|NCT00985985|600626|P3|Overall Study|Lack of Efficacy|1
189415|NCT00985985|600627|P2|Overall Study|Lack of Efficacy|6
189416|NCT00985985|600628|P1|Overall Study|Lack of Efficacy|5
189417|NCT00985985|600625|P4|Overall Study|Protocol Violation|1
189418|NCT00985985|600626|P3|Overall Study|Protocol Violation|0
189419|NCT00985985|600627|P2|Overall Study|Protocol Violation|2
189420|NCT00985985|600628|P1|Overall Study|Protocol Violation|1
189421|NCT00985985|600625|P4|Overall Study|Lost to Follow-up|3
189422|NCT00985985|600626|P3|Overall Study|Lost to Follow-up|2
189423|NCT00985985|600627|P2|Overall Study|Lost to Follow-up|11
189424|NCT00985985|600628|P1|Overall Study|Lost to Follow-up|4
189425|NCT00985985|600625|P4|Overall Study|Adverse Event|2
189426|NCT00985985|600626|P3|Overall Study|Adverse Event|2
189427|NCT00985985|600627|P2|Overall Study|Adverse Event|2
189428|NCT00985985|600628|P1|Overall Study|Adverse Event|4
189429|NCT00996580|600666|P1|Overall Study|Not specified|29
189430|NCT00996580|600666|P1|Overall Study|Withdrawal by Subject|217
189431|NCT00996580|600666|P1|Overall Study|Sponsor requested participant withdrawal|35
189432|NCT00996580|600666|P1|Overall Study|Protocol Violation|16
189433|NCT00996580|600666|P1|Overall Study|Pregnancy|68
189434|NCT00996580|600666|P1|Overall Study|Physician Decision|5
189435|NCT00996580|600666|P1|Overall Study|Noncompliance with the protocol|137
189436|NCT00996580|600666|P1|Overall Study|Lost to Follow-up|480
189437|NCT00996580|600666|P1|Overall Study|Adverse Event|466
189438|NCT00996593|600694|P1|Long-Term Follow-Up|Site Closed|1
189439|NCT00996593|600694|P1|Long-Term Follow-Up|Withdrawal by Subject|2
189440|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
189441|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
189442|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
189443|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Death|1
189444|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
189445|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
189446|NCT00996593|600694|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
189447|NCT00996606|600722|P1|Overall Study|Withdrawal by Subject|3
189448|NCT00996606|600722|P1|Overall Study|Protocol Violation|1
189449|NCT00996606|600722|P1|Overall Study|Insufficient Therapeutic Response|2
189450|NCT00996606|600722|P1|Overall Study|Adverse Event or Intercurrent Illness|2
189451|NCT00996632|600818|P2|Overall Study|Physician Decision|0
189452|NCT00996632|600819|P1|Overall Study|Physician Decision|0
189453|NCT00996658|600829|P2|Overall Study|Other|7
189454|NCT00996658|600830|P1|Overall Study|Other|9
189455|NCT00996658|600829|P2|Overall Study|Non-compliance issues|3
189456|NCT00996658|600830|P1|Overall Study|Non-compliance issues|3
189457|NCT00996658|600829|P2|Overall Study|Lost to Follow-up|5
189458|NCT00996658|600830|P1|Overall Study|Lost to Follow-up|2
189459|NCT00996658|600829|P2|Overall Study|Protocol Violation|1
189460|NCT00996658|600830|P1|Overall Study|Protocol Violation|0
189461|NCT00996658|600829|P2|Overall Study|Adverse Event|5
189462|NCT00996658|600830|P1|Overall Study|Adverse Event|2
189463|NCT00996736|600858|P2|Overall Study|Visit not within 3-month window|3
189464|NCT00996736|600859|P1|Overall Study|Visit not within 3-month window|5
189465|NCT00996736|600858|P2|Overall Study|Lost to Follow-up|14
189466|NCT00996736|600859|P1|Overall Study|Lost to Follow-up|15
189467|NCT00996736|600858|P2|Overall Study|Death|1
189468|NCT00996736|600859|P1|Overall Study|Death|1
189469|NCT00996801|600892|P6|Overall Study|Withdrawal by Subject|9
189470|NCT00996801|600893|P5|Overall Study|Withdrawal by Subject|5
189471|NCT00996801|600894|P4|Overall Study|Withdrawal by Subject|5
189472|NCT00996801|600895|P3|Overall Study|Withdrawal by Subject|9
189473|NCT00996801|600896|P2|Overall Study|Withdrawal by Subject|6
189474|NCT00996801|600897|P1|Overall Study|Withdrawal by Subject|8
189475|NCT00996801|600892|P6|Overall Study|Study Terminated by Sponsor|0
189476|NCT00996801|600893|P5|Overall Study|Study Terminated by Sponsor|46
189477|NCT00996801|600894|P4|Overall Study|Study Terminated by Sponsor|0
189478|NCT00996801|600895|P3|Overall Study|Study Terminated by Sponsor|0
189479|NCT00996801|600896|P2|Overall Study|Study Terminated by Sponsor|1
189480|NCT00996801|600897|P1|Overall Study|Study Terminated by Sponsor|0
189481|NCT00996801|600892|P6|Overall Study|Protocol Violation|4
189482|NCT00996801|600893|P5|Overall Study|Protocol Violation|3
189483|NCT00996801|600894|P4|Overall Study|Protocol Violation|2
189484|NCT00996801|600895|P3|Overall Study|Protocol Violation|1
189485|NCT00996801|600896|P2|Overall Study|Protocol Violation|4
189486|NCT00996801|600897|P1|Overall Study|Protocol Violation|3
189487|NCT00996801|600892|P6|Overall Study|Progressive Disease|0
189488|NCT00996801|600893|P5|Overall Study|Progressive Disease|0
189489|NCT00996801|600894|P4|Overall Study|Progressive Disease|0
189490|NCT00996801|600895|P3|Overall Study|Progressive Disease|0
189491|NCT00996801|600896|P2|Overall Study|Progressive Disease|1
189492|NCT00996801|600897|P1|Overall Study|Progressive Disease|0
189493|NCT00996801|600892|P6|Overall Study|Physician Decision|0
189494|NCT00996801|600893|P5|Overall Study|Physician Decision|0
189495|NCT00996801|600894|P4|Overall Study|Physician Decision|1
189496|NCT00996801|600895|P3|Overall Study|Physician Decision|0
189497|NCT00996801|600896|P2|Overall Study|Physician Decision|0
189498|NCT00996801|600897|P1|Overall Study|Physician Decision|0
189499|NCT00996801|600892|P6|Overall Study|Lost to Follow-up|2
189500|NCT00996801|600893|P5|Overall Study|Lost to Follow-up|3
189501|NCT00996801|600894|P4|Overall Study|Lost to Follow-up|3
189502|NCT00996801|600895|P3|Overall Study|Lost to Follow-up|0
189503|NCT00996801|600896|P2|Overall Study|Lost to Follow-up|0
189504|NCT00996801|600897|P1|Overall Study|Lost to Follow-up|0
189505|NCT00996801|600892|P6|Overall Study|Lack of Efficacy|1
189506|NCT00996801|600893|P5|Overall Study|Lack of Efficacy|0
189507|NCT00996801|600894|P4|Overall Study|Lack of Efficacy|3
189508|NCT00996801|600895|P3|Overall Study|Lack of Efficacy|1
189509|NCT00996801|600896|P2|Overall Study|Lack of Efficacy|0
189510|NCT00996801|600897|P1|Overall Study|Lack of Efficacy|3
189511|NCT00996801|600892|P6|Overall Study|Adverse Event|3
189512|NCT00996801|600893|P5|Overall Study|Adverse Event|31
189513|NCT00996801|600894|P4|Overall Study|Adverse Event|17
189514|NCT00996801|600895|P3|Overall Study|Adverse Event|12
189515|NCT00996801|600896|P2|Overall Study|Adverse Event|4
189516|NCT00996801|600897|P1|Overall Study|Adverse Event|6
189517|NCT00997438|601006|P3|Overall Study|Exclusion criteria at visit 1|3
189518|NCT00997438|601007|P2|Overall Study|Exclusion criteria at visit 1|2
189519|NCT00997438|601008|P1|Overall Study|Exclusion criteria at visit 1|2
189520|NCT00997438|601006|P3|Overall Study|Withdrawal by Subject|0
189521|NCT00997438|601007|P2|Overall Study|Withdrawal by Subject|1
189522|NCT00997438|601008|P1|Overall Study|Withdrawal by Subject|1
189523|NCT00997438|601006|P3|Overall Study|Blood draw difficulty|1
189524|NCT00997438|601007|P2|Overall Study|Blood draw difficulty|0
189525|NCT00997438|601008|P1|Overall Study|Blood draw difficulty|2
189526|NCT00997503|601043|P1|Overall Study|Other reason|13
189527|NCT00997503|601043|P1|Overall Study|Missed 12-month follow-up|85
189528|NCT00997503|601043|P1|Overall Study|Physician Decision|10
189529|NCT00997503|601043|P1|Overall Study|Adverse Event|3
189530|NCT00997503|601043|P1|Overall Study|Lost to Follow-up|33
189531|NCT00997503|601043|P1|Overall Study|Withdrawal by Subject|76
189532|NCT00997503|601043|P1|Overall Study|Death|53
189533|NCT00997984|601159|P3|Overall Study|Work schedule|2
189534|NCT00997984|601160|P2|Overall Study|Work schedule|0
189535|NCT00997984|601161|P1|Overall Study|Work schedule|0
189536|NCT00997984|601159|P3|Overall Study|Suicidal ideation|1
189537|NCT00997984|601160|P2|Overall Study|Suicidal ideation|0
189538|NCT00997984|601161|P1|Overall Study|Suicidal ideation|0
189539|NCT00997984|601159|P3|Overall Study|Wrong medication dispensed|0
189540|NCT00997984|601160|P2|Overall Study|Wrong medication dispensed|1
189541|NCT00997984|601161|P1|Overall Study|Wrong medication dispensed|0
189542|NCT00997984|601159|P3|Overall Study|non-compliance|3
189543|NCT00997984|601160|P2|Overall Study|non-compliance|2
189544|NCT00997984|601161|P1|Overall Study|non-compliance|0
189545|NCT00997984|601159|P3|Overall Study|Met exclusion criteria|0
189546|NCT00997984|601160|P2|Overall Study|Met exclusion criteria|0
189547|NCT00997984|601161|P1|Overall Study|Met exclusion criteria|1
189548|NCT00997984|601159|P3|Overall Study|Lack of Efficacy|3
189549|NCT00997984|601160|P2|Overall Study|Lack of Efficacy|6
189550|NCT00997984|601161|P1|Overall Study|Lack of Efficacy|20
189551|NCT00997984|601159|P3|Overall Study|Lost to Follow-up|4
189552|NCT00997984|601160|P2|Overall Study|Lost to Follow-up|5
189553|NCT00997984|601161|P1|Overall Study|Lost to Follow-up|8
189554|NCT00997984|601159|P3|Overall Study|Withdrawal by Subject|5
189555|NCT00997984|601160|P2|Overall Study|Withdrawal by Subject|9
189556|NCT00997984|601161|P1|Overall Study|Withdrawal by Subject|6
189557|NCT00997984|601159|P3|Overall Study|Protocol Violation|0
189558|NCT00997984|601160|P2|Overall Study|Protocol Violation|3
189559|NCT00997984|601161|P1|Overall Study|Protocol Violation|1
189560|NCT00997984|601159|P3|Overall Study|Adverse Event|8
189561|NCT00997984|601160|P2|Overall Study|Adverse Event|8
189562|NCT00997984|601161|P1|Overall Study|Adverse Event|1
189563|NCT00998296|601263|P11|Overall Study|Reason other than those specified above|0
189645|NCT00998764|601511|P1|Overall Study|Lack of Efficacy|3
189564|NCT00998296|601264|P10|Overall Study|Reason other than those specified above|1
189565|NCT00998296|601265|P9|Overall Study|Reason other than those specified above|0
189566|NCT00998296|601266|P8|Overall Study|Reason other than those specified above|0
189567|NCT00998296|601267|P7|Overall Study|Reason other than those specified above|0
189568|NCT00998296|601268|P6|Overall Study|Reason other than those specified above|0
189569|NCT00998296|601269|P5|Overall Study|Reason other than those specified above|0
189570|NCT00998296|601270|P4|Overall Study|Reason other than those specified above|0
189571|NCT00998296|601271|P3|Overall Study|Reason other than those specified above|0
189572|NCT00998296|601272|P2|Overall Study|Reason other than those specified above|0
189573|NCT00998296|601273|P1|Overall Study|Reason other than those specified above|0
189574|NCT00998296|601263|P11|Overall Study|Refused to continue taking trial med.|0
189575|NCT00998296|601264|P10|Overall Study|Refused to continue taking trial med.|2
189576|NCT00998296|601265|P9|Overall Study|Refused to continue taking trial med.|0
189577|NCT00998296|601266|P8|Overall Study|Refused to continue taking trial med.|0
189578|NCT00998296|601267|P7|Overall Study|Refused to continue taking trial med.|0
189579|NCT00998296|601268|P6|Overall Study|Refused to continue taking trial med.|0
189580|NCT00998296|601269|P5|Overall Study|Refused to continue taking trial med.|0
189581|NCT00998296|601270|P4|Overall Study|Refused to continue taking trial med.|0
189582|NCT00998296|601271|P3|Overall Study|Refused to continue taking trial med.|0
189583|NCT00998296|601272|P2|Overall Study|Refused to continue taking trial med.|0
189584|NCT00998296|601273|P1|Overall Study|Refused to continue taking trial med.|0
189585|NCT00998296|601263|P11|Overall Study|Other adverse event|2
189586|NCT00998296|601264|P10|Overall Study|Other adverse event|1
189587|NCT00998296|601265|P9|Overall Study|Other adverse event|0
189588|NCT00998296|601266|P8|Overall Study|Other adverse event|0
189589|NCT00998296|601267|P7|Overall Study|Other adverse event|0
189590|NCT00998296|601268|P6|Overall Study|Other adverse event|0
189591|NCT00998296|601269|P5|Overall Study|Other adverse event|1
189592|NCT00998296|601270|P4|Overall Study|Other adverse event|0
189593|NCT00998296|601271|P3|Overall Study|Other adverse event|0
189594|NCT00998296|601272|P2|Overall Study|Other adverse event|0
189595|NCT00998296|601273|P1|Overall Study|Other adverse event|0
189596|NCT00998296|601263|P11|Overall Study|Dose limiting or dose reducing toxicity|0
189597|NCT00998296|601264|P10|Overall Study|Dose limiting or dose reducing toxicity|0
189598|NCT00998296|601265|P9|Overall Study|Dose limiting or dose reducing toxicity|2
189599|NCT00998296|601266|P8|Overall Study|Dose limiting or dose reducing toxicity|2
189600|NCT00998296|601267|P7|Overall Study|Dose limiting or dose reducing toxicity|0
189601|NCT00998296|601268|P6|Overall Study|Dose limiting or dose reducing toxicity|0
189602|NCT00998296|601269|P5|Overall Study|Dose limiting or dose reducing toxicity|1
189603|NCT00998296|601270|P4|Overall Study|Dose limiting or dose reducing toxicity|0
189604|NCT00998296|601271|P3|Overall Study|Dose limiting or dose reducing toxicity|0
189605|NCT00998296|601272|P2|Overall Study|Dose limiting or dose reducing toxicity|0
189606|NCT00998296|601273|P1|Overall Study|Dose limiting or dose reducing toxicity|0
189607|NCT00998296|601263|P11|Overall Study|Progressive disease|5
189608|NCT00998296|601264|P10|Overall Study|Progressive disease|14
189609|NCT00998296|601265|P9|Overall Study|Progressive disease|0
189610|NCT00998296|601266|P8|Overall Study|Progressive disease|0
189611|NCT00998296|601267|P7|Overall Study|Progressive disease|1
189612|NCT00998296|601268|P6|Overall Study|Progressive disease|0
189613|NCT00998296|601269|P5|Overall Study|Progressive disease|0
189614|NCT00998296|601270|P4|Overall Study|Progressive disease|0
189615|NCT00998296|601271|P3|Overall Study|Progressive disease|0
189616|NCT00998296|601272|P2|Overall Study|Progressive disease|1
189617|NCT00998296|601273|P1|Overall Study|Progressive disease|0
189618|NCT00998309|601340|P1|Overall Study|Protocol Violation|4
189619|NCT00998335|601398|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
189620|NCT00998335|601399|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
189621|NCT00998738|601496|P1|Overall Study|Uknown|1
189622|NCT00998764|601510|P2|Overall Study|Recurrent Episode of vasogenic edema|0
189623|NCT00998764|601511|P1|Overall Study|Recurrent Episode of vasogenic edema|1
189624|NCT00998764|601510|P2|Overall Study|Not specified|4
189625|NCT00998764|601511|P1|Overall Study|Not specified|4
189626|NCT00998764|601510|P2|Overall Study|Loss of Caregiver|3
189627|NCT00998764|601511|P1|Overall Study|Loss of Caregiver|0
189628|NCT00998764|601510|P2|Overall Study|Lost to Follow-up|1
189629|NCT00998764|601511|P1|Overall Study|Lost to Follow-up|1
189630|NCT00998764|601510|P2|Overall Study|Failed to Return|1
189631|NCT00998764|601511|P1|Overall Study|Failed to Return|1
189632|NCT00998764|601510|P2|Overall Study|Protocol Violation|1
189633|NCT00998764|601511|P1|Overall Study|Protocol Violation|0
189634|NCT00998764|601510|P2|Overall Study|Discontinuation of Study by Sponsor|217
189635|NCT00998764|601511|P1|Overall Study|Discontinuation of Study by Sponsor|164
189636|NCT00998764|601510|P2|Overall Study|Death|1
189637|NCT00998764|601511|P1|Overall Study|Death|3
189638|NCT00998764|601510|P2|Overall Study|Physician Decision|3
189639|NCT00998764|601511|P1|Overall Study|Physician Decision|3
189640|NCT00998764|601510|P2|Overall Study|Withdrawal by Subject|25
189641|NCT00998764|601511|P1|Overall Study|Withdrawal by Subject|19
189642|NCT00998764|601510|P2|Overall Study|Adverse Event|12
189643|NCT00998764|601511|P1|Overall Study|Adverse Event|17
189644|NCT00998764|601510|P2|Overall Study|Lack of Efficacy|6
189646|NCT00998881|601542|P2|Overall Study|Personal matter|0
189647|NCT00998881|601543|P1|Overall Study|Personal matter|1
189648|NCT00998881|601542|P2|Overall Study|Withdrawal by Subject|0
189649|NCT00998881|601543|P1|Overall Study|Withdrawal by Subject|1
189650|NCT00998881|601542|P2|Overall Study|Physician Decision|0
189651|NCT00998881|601543|P1|Overall Study|Physician Decision|3
189652|NCT00998881|601542|P2|Overall Study|Lack of Efficacy|0
189653|NCT00998881|601543|P1|Overall Study|Lack of Efficacy|1
189654|NCT00998881|601542|P2|Overall Study|Adverse Event|2
189655|NCT00998881|601543|P1|Overall Study|Adverse Event|2
189656|NCT00998985|601569|P14|Overall Study|Protocol Violation|0
189657|NCT00998985|601570|P13|Overall Study|Protocol Violation|0
189658|NCT00998985|601571|P12|Overall Study|Protocol Violation|0
189659|NCT00998985|601572|P11|Overall Study|Protocol Violation|0
189660|NCT00998985|601573|P10|Overall Study|Protocol Violation|0
189661|NCT00998985|601574|P9|Overall Study|Protocol Violation|0
189662|NCT00998985|601575|P8|Overall Study|Protocol Violation|0
189663|NCT00998985|601576|P7|Overall Study|Protocol Violation|0
189664|NCT00998985|601577|P6|Overall Study|Protocol Violation|1
189665|NCT00998985|601578|P5|Overall Study|Protocol Violation|0
189666|NCT00998985|601579|P4|Overall Study|Protocol Violation|0
189667|NCT00998985|601580|P3|Overall Study|Protocol Violation|0
189668|NCT00998985|601581|P2|Overall Study|Protocol Violation|0
189669|NCT00998985|601582|P1|Overall Study|Protocol Violation|0
189670|NCT00998985|601569|P14|Overall Study|Withdrawal by Subject|0
189671|NCT00998985|601570|P13|Overall Study|Withdrawal by Subject|0
189672|NCT00998985|601571|P12|Overall Study|Withdrawal by Subject|0
189673|NCT00998985|601572|P11|Overall Study|Withdrawal by Subject|0
189674|NCT00998985|601573|P10|Overall Study|Withdrawal by Subject|0
189675|NCT00998985|601574|P9|Overall Study|Withdrawal by Subject|1
189676|NCT00998985|601575|P8|Overall Study|Withdrawal by Subject|0
189677|NCT00998985|601576|P7|Overall Study|Withdrawal by Subject|0
189678|NCT00998985|601577|P6|Overall Study|Withdrawal by Subject|0
189679|NCT00998985|601578|P5|Overall Study|Withdrawal by Subject|0
189680|NCT00998985|601579|P4|Overall Study|Withdrawal by Subject|0
189681|NCT00998985|601580|P3|Overall Study|Withdrawal by Subject|0
189682|NCT00998985|601581|P2|Overall Study|Withdrawal by Subject|0
189683|NCT00998985|601582|P1|Overall Study|Withdrawal by Subject|0
189684|NCT00999167|601745|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
189685|NCT00999167|601746|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
189686|NCT00999167|601747|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
189687|NCT00999167|601745|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
189688|NCT00999167|601746|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
189689|NCT00999167|601747|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
189690|NCT00999167|601745|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
189691|NCT00999167|601746|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
189692|NCT00999167|601747|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
189693|NCT00999167|601745|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
189694|NCT00999167|601746|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
189695|NCT00999167|601747|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
189696|NCT00999167|601745|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
189697|NCT00999167|601746|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
189698|NCT00999167|601747|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
189699|NCT00999167|601745|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
189700|NCT00999167|601746|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
189701|NCT00999167|601747|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
189702|NCT00999167|601745|P3|Part A: Open Label Safety run-in|Adverse Event|0
189703|NCT00999167|601746|P2|Part A: Open Label Safety run-in|Adverse Event|0
189704|NCT00999167|601747|P1|Part A: Open Label Safety run-in|Adverse Event|3
189705|NCT00999167|601745|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
189706|NCT00999167|601746|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
189707|NCT00999167|601747|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
189708|NCT00999466|601764|P3|Main Part|Adverse Event|2
189709|NCT00999466|601765|P2|Main Part|Adverse Event|4
189710|NCT00999466|601766|P1|Main Part|Adverse Event|0
189711|NCT00999466|601764|P3|Main Part|Withdrawal by Subject|2
189712|NCT00999466|601765|P2|Main Part|Withdrawal by Subject|0
189713|NCT00999466|601766|P1|Main Part|Withdrawal by Subject|0
189714|NCT00999544|602041|P1|Overall Study|Withdrawal by Subject|1
189715|NCT00999596|602059|P1|Overall Study|Statistical population not required|101
189716|NCT00999661|602064|P1|Overall Study|Not meeting eligibility criteria|9
189717|NCT00999661|602064|P1|Overall Study|Withdrawal by Subject|1
189718|NCT00999661|602064|P1|Overall Study|Adverse Event|1
189719|NCT00999661|602064|P1|Overall Study|Lost to Follow-up|59
189720|NCT00999687|602070|P1|Second Intervention|Lack of Efficacy|1
189721|NCT00999687|602070|P1|Second Intervention|Withdrawal by Subject|2
189722|NCT00999687|602070|P1|First Intervention|Withdrawal by Subject|1
189723|NCT00999804|602079|P2|Overall Study|Ineligible|0
189724|NCT00999804|602080|P1|Overall Study|Ineligible|3
189725|NCT00999804|602079|P2|Overall Study|Death|0
189726|NCT00999804|602080|P1|Overall Study|Death|1
189727|NCT00999804|602079|P2|Overall Study|Withdrawal by Subject|0
189728|NCT00999804|602080|P1|Overall Study|Withdrawal by Subject|4
189729|NCT00999804|602079|P2|Overall Study|Adverse Event|3
189730|NCT00999804|602080|P1|Overall Study|Adverse Event|4
189731|NCT00999804|602079|P2|Overall Study|Lack of Efficacy|2
189732|NCT00999804|602080|P1|Overall Study|Lack of Efficacy|9
189733|NCT00989092|602124|P2|Overall Study|Did not receive study drug|0
189734|NCT00989092|602125|P1|Overall Study|Did not receive study drug|2
189735|NCT00989092|602124|P2|Overall Study|Erythropoietin therapy initiated|0
189736|NCT00989092|602125|P1|Overall Study|Erythropoietin therapy initiated|2
189737|NCT00989092|602124|P2|Overall Study|Protocol deviation|0
189738|NCT00989092|602125|P1|Overall Study|Protocol deviation|2
189739|NCT00989092|602124|P2|Overall Study|Other|1
189740|NCT00989092|602125|P1|Overall Study|Other|3
189741|NCT00989092|602124|P2|Overall Study|Lost to Follow-up|2
189742|NCT00989092|602125|P1|Overall Study|Lost to Follow-up|6
189743|NCT00989092|602124|P2|Overall Study|Ineligibility determined|3
189744|NCT00989092|602125|P1|Overall Study|Ineligibility determined|3
189745|NCT00989092|602124|P2|Overall Study|Death|2
189746|NCT00989092|602125|P1|Overall Study|Death|14
189747|NCT00989092|602124|P2|Overall Study|Withdrawal by Subject|9
189748|NCT00989092|602125|P1|Overall Study|Withdrawal by Subject|17
189749|NCT00989092|602124|P2|Overall Study|Chemotherapy initiated|4
189750|NCT00989092|602125|P1|Overall Study|Chemotherapy initiated|12
189751|NCT00989092|602124|P2|Overall Study|Adverse Event|1
189752|NCT00989092|602125|P1|Overall Study|Adverse Event|20
189753|NCT00989092|602124|P2|Overall Study|Physician Decision|6
189754|NCT00989092|602125|P1|Overall Study|Physician Decision|9
189755|NCT00989196|602175|P2|Treatment Period|Lost to Follow-up|0
189756|NCT00989196|602176|P1|Treatment Period|Lost to Follow-up|1
189757|NCT00989235|602197|P2|Overall Study|Lost to Follow-up|1
189758|NCT00989235|602198|P1|Overall Study|Lost to Follow-up|0
189759|NCT00989235|602197|P2|Overall Study|Randomized by Mistake|2
189760|NCT00989235|602198|P1|Overall Study|Randomized by Mistake|0
189761|NCT00989235|602197|P2|Overall Study|Desire to Become Pregnant|0
189762|NCT00989235|602198|P1|Overall Study|Desire to Become Pregnant|1
189763|NCT00989235|602197|P2|Overall Study|Withdrawal of Consent|1
189764|NCT00989235|602198|P1|Overall Study|Withdrawal of Consent|1
189765|NCT00989235|602197|P2|Overall Study|Lack of Efficacy|0
189766|NCT00989235|602198|P1|Overall Study|Lack of Efficacy|1
189767|NCT00989235|602197|P2|Overall Study|Adverse Event|1
189768|NCT00989235|602198|P1|Overall Study|Adverse Event|0
189769|NCT00989235|602197|P2|Overall Study|Death|1
189770|NCT00989235|602198|P1|Overall Study|Death|0
189771|NCT00989664|602259|P1|Long-Term Follow-Up|Death|3
189772|NCT00989664|602259|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
189773|NCT00989664|602259|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
189774|NCT00989664|602259|P1|Dosimetric and Therapeutic Treatment|Death|1
189775|NCT00989664|602259|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
189776|NCT00989664|602259|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
189777|NCT00989664|602259|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
189778|NCT00989833|602301|P3|Overall Study|Incorrectly randomized|0
189779|NCT00989833|602302|P2|Overall Study|Incorrectly randomized|0
189780|NCT00989833|602303|P1|Overall Study|Incorrectly randomized|1
189781|NCT00989833|602301|P3|Overall Study|Withdrawal by Subject|1
189782|NCT00989833|602302|P2|Overall Study|Withdrawal by Subject|0
189783|NCT00989833|602303|P1|Overall Study|Withdrawal by Subject|0
189784|NCT00989833|602301|P3|Overall Study|Protocol Violation|1
189785|NCT00989833|602302|P2|Overall Study|Protocol Violation|2
189786|NCT00989833|602303|P1|Overall Study|Protocol Violation|1
189787|NCT00989833|602301|P3|Overall Study|Lost to Follow-up|0
189788|NCT00989833|602302|P2|Overall Study|Lost to Follow-up|1
189789|NCT00989833|602303|P1|Overall Study|Lost to Follow-up|0
189790|NCT00989950|602340|P4|Randomized Phase|Adverse Event|0
189791|NCT00989950|602341|P3|Randomized Phase|Adverse Event|0
189792|NCT00989950|602342|P2|Randomized Phase|Adverse Event|1
189793|NCT00989950|602343|P1|Randomized Phase|Adverse Event|0
189794|NCT00989950|602340|P4|Randomized Phase|Protocol Violation|0
189795|NCT00989950|602341|P3|Randomized Phase|Protocol Violation|0
189796|NCT00989950|602342|P2|Randomized Phase|Protocol Violation|0
189797|NCT00989950|602343|P1|Randomized Phase|Protocol Violation|1
189798|NCT00990093|602396|P2|Test Period 2 (15-28 Days)|Not specified|1
189799|NCT00990093|602397|P1|Test Period 2 (15-28 Days)|Not specified|0
189800|NCT00990093|602396|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
189801|NCT00990093|602397|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
189802|NCT00990093|602396|P2|Test Period 2 (15-28 Days)|Adverse Event|0
189803|NCT00990093|602397|P1|Test Period 2 (15-28 Days)|Adverse Event|1
189804|NCT00990093|602396|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
189805|NCT00990093|602397|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
189806|NCT00990093|602396|P2|Test Period 1 (1-14 Days)|Not Specified|0
189807|NCT00990093|602397|P1|Test Period 1 (1-14 Days)|Not Specified|1
189808|NCT00990093|602396|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
189809|NCT00990093|602397|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
189810|NCT00990093|602396|P2|Test Period 1 (1-14 Days)|Adverse Event|0
189811|NCT00990093|602397|P1|Test Period 1 (1-14 Days)|Adverse Event|1
189812|NCT00990106|602405|P2|Overall Study|scheduling conflicts|2
189813|NCT00990106|602406|P1|Overall Study|scheduling conflicts|0
189814|NCT00990106|602405|P2|Overall Study|planned major surgery|1
189815|NCT00990106|602406|P1|Overall Study|planned major surgery|0
189816|NCT00990106|602405|P2|Overall Study|started exclusionary medication|1
189817|NCT00990106|602406|P1|Overall Study|started exclusionary medication|0
189818|NCT00990106|602405|P2|Overall Study|relocation/deployment|1
189819|NCT00990106|602406|P1|Overall Study|relocation/deployment|4
189820|NCT00990106|602405|P2|Overall Study|opted for open label prazosin|1
189821|NCT00990106|602406|P1|Overall Study|opted for open label prazosin|1
189822|NCT00990106|602405|P2|Overall Study|Withdrawal by Subject|1
189823|NCT00990106|602406|P1|Overall Study|Withdrawal by Subject|2
189824|NCT00990106|602405|P2|Overall Study|Lost to Follow-up|3
189825|NCT00990106|602406|P1|Overall Study|Lost to Follow-up|1
189826|NCT00990106|602405|P2|Overall Study|"too busy to continue"|2
189827|NCT00990106|602406|P1|Overall Study|"too busy to continue"|1
189828|NCT00990184|602416|P1|Overall Study|Physician Decision|1
189829|NCT00990340|602424|P2|First 14-day Treatment|Protocol Violation|2
189830|NCT00990340|602425|P1|First 14-day Treatment|Protocol Violation|2
189831|NCT00990340|602424|P2|First 14-day Treatment|Lost to Follow-up|1
189832|NCT00990340|602425|P1|First 14-day Treatment|Lost to Follow-up|2
189833|NCT00990340|602424|P2|First 14-day Treatment|Not Compliant|1
189834|NCT00990340|602425|P1|First 14-day Treatment|Not Compliant|2
189835|NCT00990652|602463|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
189836|NCT00990652|602463|P1|Pre-surgical Bortezomib|Adverse Event|1
189837|NCT00990704|602473|P2|Overall Study|Physician Decision|1
189838|NCT00990704|602474|P1|Overall Study|Physician Decision|0
189839|NCT00990704|602473|P2|Overall Study|Adverse Event|1
189840|NCT00990704|602474|P1|Overall Study|Adverse Event|1
189841|NCT00990821|602526|P14|Overall Study|Withdrawal by Subject|1
189842|NCT00990821|602527|P13|Overall Study|Withdrawal by Subject|2
189843|NCT00990821|602528|P12|Overall Study|Withdrawal by Subject|5
189844|NCT00990821|602529|P11|Overall Study|Withdrawal by Subject|3
189845|NCT00990821|602530|P10|Overall Study|Withdrawal by Subject|1
189846|NCT00990821|602531|P9|Overall Study|Withdrawal by Subject|0
189847|NCT00990821|602532|P8|Overall Study|Withdrawal by Subject|0
189848|NCT00990821|602533|P7|Overall Study|Withdrawal by Subject|1
189849|NCT00990821|602534|P6|Overall Study|Withdrawal by Subject|3
189850|NCT00990821|602535|P5|Overall Study|Withdrawal by Subject|3
189851|NCT00990821|602536|P4|Overall Study|Withdrawal by Subject|0
189852|NCT00990821|602537|P3|Overall Study|Withdrawal by Subject|0
189853|NCT00990821|602538|P2|Overall Study|Withdrawal by Subject|2
189854|NCT00990821|602539|P1|Overall Study|Withdrawal by Subject|0
189855|NCT00991939|602567|P2|Overall Study|Entire study terminated|1
189856|NCT00991939|602568|P1|Overall Study|Entire study terminated|4
189857|NCT00991939|602567|P2|Overall Study|Withdrawal by Subject|0
189858|NCT00991939|602568|P1|Overall Study|Withdrawal by Subject|1
189859|NCT00991939|602567|P2|Overall Study|Lost to Follow-up|1
189860|NCT00991939|602568|P1|Overall Study|Lost to Follow-up|0
189861|NCT00991952|602602|P2|Overall Study|Adverse Event|1
189862|NCT00991952|602603|P1|Overall Study|Adverse Event|0
189863|NCT00992017|602609|P1|Overall Study|Not adhere to study requirements|1
189864|NCT00992017|602609|P1|Overall Study|Unable to get to clinic|5
189865|NCT00992017|602609|P1|Overall Study|Withdrawal by Subject|2
189866|NCT00992017|602609|P1|Overall Study|Lost to Follow-up|2
189867|NCT00992056|602624|P2|Washout Period (2 Weeks)|Physician Decision|0
189868|NCT00992056|602625|P1|Washout Period (2 Weeks)|Physician Decision|1
189869|NCT00992056|602624|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
189870|NCT00992056|602625|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
189871|NCT00992108|602633|P2|Overall Study|Lost to Follow-up|1
189872|NCT00992108|602634|P1|Overall Study|Lost to Follow-up|0
189873|NCT00992186|602646|P1|Overall Study|Refusal To Receive Study Agent|3
189874|NCT00992186|602646|P1|Overall Study|Progressive Disease|30
189875|NCT00992186|602646|P1|Overall Study|Adverse Event|9
189876|NCT00992186|602646|P1|Overall Study|Physician Decision|1
189877|NCT00992186|602646|P1|Overall Study|Protocol Violation|1
189878|NCT00992186|602646|P1|Overall Study|Withdrawal by Subject|2
189879|NCT00992394|602710|P2|Overall Study|Other event|0
189880|NCT00992394|602711|P1|Overall Study|Other event|1
189881|NCT00992394|602710|P2|Overall Study|Lost to Follow-up|0
189882|NCT00992394|602711|P1|Overall Study|Lost to Follow-up|2
189883|NCT00992394|602710|P2|Overall Study|Protocol Violation|4
189884|NCT00992394|602711|P1|Overall Study|Protocol Violation|2
189885|NCT00992394|602710|P2|Overall Study|Physician Decision|0
189886|NCT00992394|602711|P1|Overall Study|Physician Decision|1
189887|NCT00992394|602710|P2|Overall Study|Withdrawal by Subject|2
189888|NCT00992394|602711|P1|Overall Study|Withdrawal by Subject|8
189889|NCT00992394|602710|P2|Overall Study|Adverse Event|5
189890|NCT00992394|602711|P1|Overall Study|Adverse Event|4
189891|NCT00992394|602710|P2|Overall Study|Lack of Efficacy|3
189892|NCT00992394|602711|P1|Overall Study|Lack of Efficacy|6
189893|NCT00992407|602755|P2|Overall Study|Study medication not administered|13
189894|NCT00992407|602756|P1|Overall Study|Study medication not administered|17
189895|NCT00992407|602755|P2|Overall Study|Loss of follow-up & Adverse events|1
189896|NCT00992407|602756|P1|Overall Study|Loss of follow-up & Adverse events|2
189897|NCT00992407|602755|P2|Overall Study|Unspecified|0
189898|NCT00992407|602756|P1|Overall Study|Unspecified|2
189899|NCT00992407|602755|P2|Overall Study|protocol Violation & Adverse events|4
189900|NCT00992407|602756|P1|Overall Study|protocol Violation & Adverse events|2
189901|NCT00992407|602755|P2|Overall Study|Adverse Event|2
189902|NCT00992407|602756|P1|Overall Study|Adverse Event|3
189903|NCT00992407|602755|P2|Overall Study|Lost to Follow-up|3
189904|NCT00992407|602756|P1|Overall Study|Lost to Follow-up|3
189905|NCT00992407|602755|P2|Overall Study|Protocol Violation|1
189906|NCT00992407|602756|P1|Overall Study|Protocol Violation|2
189907|NCT00992446|602869|P1|Overall Study|Maintenance Therapy Screen Fail|5
189908|NCT00992446|602869|P1|Overall Study|Withdrawal by Subject|2
189909|NCT00992446|602869|P1|Overall Study|Disease Progression|1
189910|NCT00992459|602876|P2|Overall Study|Adverse Event|0
189911|NCT00992459|602877|P1|Overall Study|Adverse Event|1
189912|NCT00992459|602876|P2|Overall Study|Withdrawal by Subject|1
189913|NCT00992459|602877|P1|Overall Study|Withdrawal by Subject|0
189914|NCT00992589|602901|P4|Double-Blind Phase|Not specified|3
189915|NCT00992589|602902|P3|Double-Blind Phase|Not specified|6
189916|NCT00992589|602903|P2|Double-Blind Phase|Not specified|1
189917|NCT00992589|602904|P1|Double-Blind Phase|Not specified|0
189918|NCT00992589|602901|P4|Double-Blind Phase|Lost to Follow-up|2
189919|NCT00992589|602902|P3|Double-Blind Phase|Lost to Follow-up|0
189920|NCT00992589|602903|P2|Double-Blind Phase|Lost to Follow-up|0
189921|NCT00992589|602904|P1|Double-Blind Phase|Lost to Follow-up|0
189922|NCT00992589|602901|P4|Double-Blind Phase|Withdrawal by Subject|2
189923|NCT00992589|602902|P3|Double-Blind Phase|Withdrawal by Subject|5
189924|NCT00992589|602903|P2|Double-Blind Phase|Withdrawal by Subject|6
189925|NCT00992589|602904|P1|Double-Blind Phase|Withdrawal by Subject|0
189926|NCT00992589|602901|P4|Double-Blind Phase|Adverse Event|3
189927|NCT00992589|602902|P3|Double-Blind Phase|Adverse Event|2
189928|NCT00992589|602903|P2|Double-Blind Phase|Adverse Event|6
189929|NCT00992589|602904|P1|Double-Blind Phase|Adverse Event|0
189930|NCT00992589|602901|P4|Open-Label Phase|Not specified|0
189931|NCT00992589|602902|P3|Open-Label Phase|Not specified|0
189932|NCT00992589|602903|P2|Open-Label Phase|Not specified|0
189933|NCT00992589|602904|P1|Open-Label Phase|Not specified|45
189934|NCT00992589|602901|P4|Open-Label Phase|Physician Decision|0
189935|NCT00992589|602902|P3|Open-Label Phase|Physician Decision|0
189936|NCT00992589|602903|P2|Open-Label Phase|Physician Decision|0
189937|NCT00992589|602904|P1|Open-Label Phase|Physician Decision|4
189938|NCT00992589|602901|P4|Open-Label Phase|Protocol Violation|0
189939|NCT00992589|602902|P3|Open-Label Phase|Protocol Violation|0
189940|NCT00992589|602903|P2|Open-Label Phase|Protocol Violation|0
189941|NCT00992589|602904|P1|Open-Label Phase|Protocol Violation|3
189942|NCT00992589|602901|P4|Open-Label Phase|Lost to Follow-up|0
189943|NCT00992589|602902|P3|Open-Label Phase|Lost to Follow-up|0
189944|NCT00992589|602903|P2|Open-Label Phase|Lost to Follow-up|0
189945|NCT00992589|602904|P1|Open-Label Phase|Lost to Follow-up|1
189946|NCT00992589|602901|P4|Open-Label Phase|Withdrawal by Subject|0
189947|NCT00992589|602902|P3|Open-Label Phase|Withdrawal by Subject|0
189948|NCT00992589|602903|P2|Open-Label Phase|Withdrawal by Subject|0
189949|NCT00992589|602904|P1|Open-Label Phase|Withdrawal by Subject|20
189950|NCT00992589|602901|P4|Open-Label Phase|Adverse Event|0
189951|NCT00992589|602902|P3|Open-Label Phase|Adverse Event|0
189952|NCT00992589|602903|P2|Open-Label Phase|Adverse Event|0
189953|NCT00992589|602904|P1|Open-Label Phase|Adverse Event|4
189954|NCT00992784|602993|P3|Overall Study|Withdrawal by Subject|1
189955|NCT00992784|602994|P2|Overall Study|Withdrawal by Subject|1
189956|NCT00992784|602995|P1|Overall Study|Withdrawal by Subject|1
189957|NCT00992784|602993|P3|Overall Study|Adverse Event|0
189958|NCT00992784|602994|P2|Overall Study|Adverse Event|1
189959|NCT00992784|602995|P1|Overall Study|Adverse Event|2
189960|NCT00992836|603063|P1|Overall Study|Protocol Violation|2
189961|NCT00992836|603063|P1|Overall Study|Withdrawal by Subject|2
189962|NCT00992836|603063|P1|Overall Study|Lost to Follow-up|1
189963|NCT00992992|603086|P1|Overall Study|Sponsor Closed the Study|4
189964|NCT00992992|603086|P1|Overall Study|GlaxoSmithKline Closed the Study|2
189965|NCT00992992|603086|P1|Overall Study|Death|16
189966|NCT00992992|603086|P1|Overall Study|Lost to Follow-up|3
189967|NCT00993044|603106|P1|Irinotecan 50 mg|Physician Decision|1
189968|NCT00993148|603111|P1|Overall Study|never initiated treatment|1
189969|NCT00993148|603111|P1|Overall Study|Lost to Follow-up|2
189970|NCT00993265|603159|P2|Overall Study|Non-compliant with study medication|0
189971|NCT00993265|603160|P1|Overall Study|Non-compliant with study medication|1
189972|NCT00993265|603159|P2|Overall Study|Changed dose of concomitant drug|0
189973|NCT00993265|603160|P1|Overall Study|Changed dose of concomitant drug|2
189974|NCT00993265|603159|P2|Overall Study|Adverse Event|0
189975|NCT00993265|603160|P1|Overall Study|Adverse Event|1
189976|NCT00993291|603178|P1|Overall Study|Withdrawal by Subject|1
189977|NCT00993317|603184|P2|Overall Study|Early study termination at the site|0
189978|NCT00993317|603185|P1|Overall Study|Early study termination at the site|1
189979|NCT00993317|603184|P2|Overall Study|Investigator's opinion|1
189980|NCT00993317|603185|P1|Overall Study|Investigator's opinion|0
189981|NCT00993317|603184|P2|Overall Study|Withdrawal by Subject|2
189982|NCT00993317|603185|P1|Overall Study|Withdrawal by Subject|0
189983|NCT00993317|603184|P2|Overall Study|Lack of Efficacy|18
189984|NCT00993317|603185|P1|Overall Study|Lack of Efficacy|18
189985|NCT00993317|603184|P2|Overall Study|Adverse Event|4
189986|NCT00993317|603185|P1|Overall Study|Adverse Event|2
189987|NCT00993421|603210|P7|Overall Study|Protocol Violation|1
189988|NCT00993421|603211|P6|Overall Study|Protocol Violation|2
189989|NCT00993421|603212|P5|Overall Study|Protocol Violation|0
189990|NCT00993421|603213|P4|Overall Study|Protocol Violation|0
189991|NCT00993421|603214|P3|Overall Study|Protocol Violation|0
189992|NCT00993421|603215|P2|Overall Study|Protocol Violation|0
189993|NCT00993421|603216|P1|Overall Study|Protocol Violation|0
189994|NCT00993421|603210|P7|Overall Study|Physician Decision|1
189995|NCT00993421|603211|P6|Overall Study|Physician Decision|1
189996|NCT00993421|603212|P5|Overall Study|Physician Decision|0
189997|NCT00993421|603213|P4|Overall Study|Physician Decision|0
189998|NCT00993421|603214|P3|Overall Study|Physician Decision|0
189999|NCT00993421|603215|P2|Overall Study|Physician Decision|0
190000|NCT00993421|603216|P1|Overall Study|Physician Decision|0
190001|NCT00993421|603210|P7|Overall Study|Entry Criteria Exclusion|0
190002|NCT00993421|603211|P6|Overall Study|Entry Criteria Exclusion|1
190003|NCT00993421|603212|P5|Overall Study|Entry Criteria Exclusion|0
190004|NCT00993421|603213|P4|Overall Study|Entry Criteria Exclusion|3
190005|NCT00993421|603214|P3|Overall Study|Entry Criteria Exclusion|1
190006|NCT00993421|603215|P2|Overall Study|Entry Criteria Exclusion|0
190007|NCT00993421|603216|P1|Overall Study|Entry Criteria Exclusion|0
190008|NCT00993421|603210|P7|Overall Study|Death|1
190009|NCT00993421|603211|P6|Overall Study|Death|0
190010|NCT00993421|603212|P5|Overall Study|Death|0
190011|NCT00993421|603213|P4|Overall Study|Death|0
190012|NCT00993421|603214|P3|Overall Study|Death|0
190013|NCT00993421|603215|P2|Overall Study|Death|0
190014|NCT00993421|603216|P1|Overall Study|Death|0
190015|NCT00993421|603210|P7|Overall Study|Withdrawal by Subject|3
190016|NCT00993421|603211|P6|Overall Study|Withdrawal by Subject|5
190017|NCT00993421|603212|P5|Overall Study|Withdrawal by Subject|3
190018|NCT00993421|603213|P4|Overall Study|Withdrawal by Subject|3
190019|NCT00993421|603214|P3|Overall Study|Withdrawal by Subject|3
190020|NCT00993421|603215|P2|Overall Study|Withdrawal by Subject|2
190021|NCT00993421|603216|P1|Overall Study|Withdrawal by Subject|3
190022|NCT00993421|603210|P7|Overall Study|Lost to Follow-up|6
190023|NCT00993421|603211|P6|Overall Study|Lost to Follow-up|0
190024|NCT00993421|603212|P5|Overall Study|Lost to Follow-up|0
190025|NCT00993421|603213|P4|Overall Study|Lost to Follow-up|0
190026|NCT00993421|603214|P3|Overall Study|Lost to Follow-up|5
190027|NCT00993421|603215|P2|Overall Study|Lost to Follow-up|5
190028|NCT00993421|603216|P1|Overall Study|Lost to Follow-up|3
190029|NCT00993421|603210|P7|Overall Study|Sponsor Decision|29
190030|NCT00993421|603211|P6|Overall Study|Sponsor Decision|30
190031|NCT00993421|603212|P5|Overall Study|Sponsor Decision|38
190032|NCT00993421|603213|P4|Overall Study|Sponsor Decision|30
190033|NCT00993421|603214|P3|Overall Study|Sponsor Decision|28
190034|NCT00993421|603215|P2|Overall Study|Sponsor Decision|31
190035|NCT00993421|603216|P1|Overall Study|Sponsor Decision|36
190036|NCT00993421|603210|P7|Overall Study|Adverse Event|1
190037|NCT00993421|603211|P6|Overall Study|Adverse Event|7
190038|NCT00993421|603212|P5|Overall Study|Adverse Event|5
190039|NCT00993421|603213|P4|Overall Study|Adverse Event|9
190040|NCT00993421|603214|P3|Overall Study|Adverse Event|6
190041|NCT00993421|603215|P2|Overall Study|Adverse Event|7
190042|NCT00993421|603216|P1|Overall Study|Adverse Event|2
190043|NCT00993447|603367|P2|Overall Study|Adverse Event|0
190044|NCT00993447|603368|P1|Overall Study|Adverse Event|1
190045|NCT00993447|603367|P2|Overall Study|Lost to Follow-up|3
190046|NCT00993447|603368|P1|Overall Study|Lost to Follow-up|1
190047|NCT00993447|603367|P2|Overall Study|Protocol Violation|8
190048|NCT00993447|603368|P1|Overall Study|Protocol Violation|12
190049|NCT00993447|603367|P2|Overall Study|Withdrawal by Subject|8
190050|NCT00993447|603368|P1|Overall Study|Withdrawal by Subject|23
190051|NCT00993473|603400|P2|Overall Study|Family event|0
190052|NCT00993473|603401|P1|Overall Study|Family event|1
190053|NCT00993473|603400|P2|Overall Study|Technical problem with CGM device|1
190054|NCT00993473|603401|P1|Overall Study|Technical problem with CGM device|0
190055|NCT00993473|603400|P2|Overall Study|Withdrawal by Subject|5
190056|NCT00993473|603401|P1|Overall Study|Withdrawal by Subject|1
190057|NCT00993473|603400|P2|Overall Study|Lost to Follow-up|0
190058|NCT00993473|603401|P1|Overall Study|Lost to Follow-up|1
190059|NCT00993473|603400|P2|Overall Study|Protocol Violation|2
190060|NCT00993473|603401|P1|Overall Study|Protocol Violation|1
190061|NCT00993473|603400|P2|Overall Study|Adverse Event|2
190062|NCT00993473|603401|P1|Overall Study|Adverse Event|0
190063|NCT00993499|603443|P6|Discontinued After Starting Course 3|Other adverse event|0
190064|NCT00993499|603444|P5|Discontinued After Starting Course 3|Other adverse event|0
190065|NCT00993499|603445|P4|Discontinued After Starting Course 3|Other adverse event|0
190066|NCT00993499|603446|P3|Discontinued After Starting Course 3|Other adverse event|1
190067|NCT00993499|603447|P2|Discontinued After Starting Course 3|Other adverse event|0
190068|NCT00993499|603448|P1|Discontinued After Starting Course 3|Other adverse event|1
190069|NCT00993499|603443|P6|Discontinued After Starting Course 3|DLT|0
190070|NCT00993499|603444|P5|Discontinued After Starting Course 3|DLT|0
190071|NCT00993499|603445|P4|Discontinued After Starting Course 3|DLT|1
190072|NCT00993499|603446|P3|Discontinued After Starting Course 3|DLT|2
190073|NCT00993499|603447|P2|Discontinued After Starting Course 3|DLT|0
190074|NCT00993499|603448|P1|Discontinued After Starting Course 3|DLT|1
190075|NCT00993499|603443|P6|Discontinued After Starting Course 3|Progressive Disease|3
190076|NCT00993499|603444|P5|Discontinued After Starting Course 3|Progressive Disease|3
190077|NCT00993499|603445|P4|Discontinued After Starting Course 3|Progressive Disease|1
190078|NCT00993499|603446|P3|Discontinued After Starting Course 3|Progressive Disease|3
190079|NCT00993499|603447|P2|Discontinued After Starting Course 3|Progressive Disease|4
190080|NCT00993499|603448|P1|Discontinued After Starting Course 3|Progressive Disease|6
190081|NCT00993499|603443|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
190082|NCT00993499|603444|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
190083|NCT00993499|603445|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
190084|NCT00993499|603446|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
190085|NCT00993499|603447|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
190086|NCT00993499|603448|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
190087|NCT00993499|603443|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
190088|NCT00993499|603444|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
190089|NCT00993499|603445|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
190090|NCT00993499|603446|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
190091|NCT00993499|603447|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
190092|NCT00993499|603448|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
190093|NCT00993499|603443|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
190094|NCT00993499|603444|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
190095|NCT00993499|603445|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
190096|NCT00993499|603446|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
190097|NCT00993499|603447|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
190098|NCT00993499|603448|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
190099|NCT00993499|603443|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
190100|NCT00993499|603444|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
190101|NCT00993499|603445|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
190102|NCT00993499|603446|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
190103|NCT00993499|603447|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
190104|NCT00993499|603448|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
190105|NCT00993499|603443|P6|Discontinued Before Starting Course 3|Progressive Disease|0
190106|NCT00993499|603444|P5|Discontinued Before Starting Course 3|Progressive Disease|0
190107|NCT00993499|603445|P4|Discontinued Before Starting Course 3|Progressive Disease|0
190108|NCT00993499|603446|P3|Discontinued Before Starting Course 3|Progressive Disease|0
190109|NCT00993499|603447|P2|Discontinued Before Starting Course 3|Progressive Disease|2
190110|NCT00993499|603448|P1|Discontinued Before Starting Course 3|Progressive Disease|2
190111|NCT00993499|603443|P6|Run-in Period (8 Days)|Progressive disease|0
190112|NCT00993499|603444|P5|Run-in Period (8 Days)|Progressive disease|0
190113|NCT00993499|603445|P4|Run-in Period (8 Days)|Progressive disease|0
190114|NCT00993499|603446|P3|Run-in Period (8 Days)|Progressive disease|1
190115|NCT00993499|603447|P2|Run-in Period (8 Days)|Progressive disease|1
190116|NCT00993499|603448|P1|Run-in Period (8 Days)|Progressive disease|0
190117|NCT00993499|603443|P6|Run-in Period (8 Days)|Consent withdrawn|0
190118|NCT00993499|603444|P5|Run-in Period (8 Days)|Consent withdrawn|0
190119|NCT00993499|603445|P4|Run-in Period (8 Days)|Consent withdrawn|0
190120|NCT00993499|603446|P3|Run-in Period (8 Days)|Consent withdrawn|0
190121|NCT00993499|603447|P2|Run-in Period (8 Days)|Consent withdrawn|1
190122|NCT00993499|603448|P1|Run-in Period (8 Days)|Consent withdrawn|0
190123|NCT00993499|603443|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
190124|NCT00993499|603444|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
190125|NCT00993499|603445|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
190126|NCT00993499|603446|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
190127|NCT00993499|603447|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
190128|NCT00993499|603448|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
190129|NCT00993499|603443|P6|Run-in Period (8 Days)|Adverse Event|0
190130|NCT00993499|603444|P5|Run-in Period (8 Days)|Adverse Event|0
190131|NCT00993499|603445|P4|Run-in Period (8 Days)|Adverse Event|0
190132|NCT00993499|603446|P3|Run-in Period (8 Days)|Adverse Event|0
190133|NCT00993499|603447|P2|Run-in Period (8 Days)|Adverse Event|1
190134|NCT00993499|603448|P1|Run-in Period (8 Days)|Adverse Event|0
190135|NCT00993616|603528|P1|Overall Study|Never treated|1
190136|NCT00993616|603528|P1|Overall Study|No tumor at entry|1
190137|NCT00993668|603553|P2|Open-Label Period|Lost to Follow-up|1
190138|NCT00993668|603554|P1|Open-Label Period|Lost to Follow-up|6
190139|NCT00993668|603553|P2|Open-Label Period|Withdrawal by Subject|3
190140|NCT00993668|603554|P1|Open-Label Period|Withdrawal by Subject|4
190141|NCT00993668|603553|P2|Open-Label Period|Lack of Efficacy|3
190142|NCT00993668|603554|P1|Open-Label Period|Lack of Efficacy|4
190143|NCT00993668|603553|P2|Open-Label Period|Adverse Event|8
190144|NCT00993668|603554|P1|Open-Label Period|Adverse Event|9
190145|NCT00993668|603553|P2|Single-Blind Period|Lost to Follow-up|1
190146|NCT00993668|603554|P1|Single-Blind Period|Lost to Follow-up|3
190147|NCT00993668|603553|P2|Single-Blind Period|Lack of Efficacy|1
190148|NCT00993668|603554|P1|Single-Blind Period|Lack of Efficacy|0
190149|NCT00993668|603553|P2|Single-Blind Period|Adverse Event|1
190150|NCT00993668|603554|P1|Single-Blind Period|Adverse Event|1
190151|NCT00993915|603594|P1|Overall Study|Ongoing|3
190152|NCT00993915|603594|P1|Overall Study|Not specified|1
190153|NCT00993915|603594|P1|Overall Study|Withdrawal by Subject|2
190154|NCT00993915|603594|P1|Overall Study|Insufficient clinical response|3
190155|NCT00993928|603605|P2|Overall Study|ineligible|0
190156|NCT00993928|603606|P1|Overall Study|ineligible|1
190157|NCT00993928|603605|P2|Overall Study|Withdrawal by Subject|7
190158|NCT00993928|603606|P1|Overall Study|Withdrawal by Subject|4
190159|NCT00993954|603622|P2|Overall Study|Protocol Violation|2
190160|NCT00993954|603623|P1|Overall Study|Protocol Violation|21
190161|NCT00999908|603634|P3|Treatment Period 2|Protocol Violation|0
190162|NCT00999908|603635|P2|Treatment Period 2|Protocol Violation|0
190163|NCT00999908|603636|P1|Treatment Period 2|Protocol Violation|1
190164|NCT00999908|603634|P3|Treatment Period 1|Subject withdrew consent|0
190165|NCT00999908|603635|P2|Treatment Period 1|Subject withdrew consent|0
190166|NCT00999908|603636|P1|Treatment Period 1|Subject withdrew consent|2
190167|NCT00999921|603652|P2|Overall Study|Lost to Follow-up|19
190168|NCT00999921|603653|P1|Overall Study|Lost to Follow-up|10
190169|NCT01000025|603665|P2|Overall Study|Intercurrent Illness|7
190170|NCT01000025|603666|P1|Overall Study|Intercurrent Illness|26
190171|NCT01000025|603665|P2|Overall Study|Lack of Efficacy|208
190172|NCT01000025|603666|P1|Overall Study|Lack of Efficacy|363
190173|NCT01000025|603665|P2|Overall Study|Death|13
190174|NCT01000025|603666|P1|Overall Study|Death|23
190175|NCT01000025|603665|P2|Overall Study|Withdrawal by Subject|8
190176|NCT01000025|603666|P1|Overall Study|Withdrawal by Subject|13
190177|NCT01000025|603665|P2|Overall Study|Adverse Event|2
190178|NCT01000025|603666|P1|Overall Study|Adverse Event|43
190179|NCT01000064|603682|P2|Overall Study|Withdrawal by Subject|1
190180|NCT01000064|603683|P1|Overall Study|Withdrawal by Subject|1
190181|NCT01000155|603704|P1|Overall Study|Adverse Event|1
190182|NCT01000155|603704|P1|Overall Study|Withdrawal by Subject|1
190183|NCT01001832|603725|P2|Follow-up Period|Not specified|1
190184|NCT01001832|603726|P1|Follow-up Period|Not specified|2
190185|NCT01001832|603725|P2|Follow-up Period|Follow-up no longer required /protocol|20
190186|NCT01001832|603726|P1|Follow-up Period|Follow-up no longer required /protocol|15
190187|NCT01001832|603725|P2|Follow-up Period|Withdrawal by Subject|0
190188|NCT01001832|603726|P1|Follow-up Period|Withdrawal by Subject|1
190189|NCT01001832|603725|P2|Long-term Period|Not specified|2
190190|NCT01001832|603726|P1|Long-term Period|Not specified|1
190191|NCT01001832|603725|P2|Long-term Period|Lack of Efficacy|2
190192|NCT01001832|603726|P1|Long-term Period|Lack of Efficacy|0
190193|NCT01001832|603725|P2|Long-term Period|Withdrawal by Subject|0
190194|NCT01001832|603726|P1|Long-term Period|Withdrawal by Subject|1
190195|NCT01001832|603725|P2|Long-term Period|Adverse Event|1
190196|NCT01001832|603726|P1|Long-term Period|Adverse Event|2
190197|NCT01001832|603725|P2|Short-term Period|Adverse Event|3
190198|NCT01001832|603726|P1|Short-term Period|Adverse Event|2
190199|NCT01002105|603782|P2|Overall Study|condition worsened|2
190200|NCT01002105|603783|P1|Overall Study|condition worsened|4
190201|NCT01002105|603782|P2|Overall Study|non compliance|3
190202|NCT01002105|603783|P1|Overall Study|non compliance|5
190203|NCT01002105|603782|P2|Overall Study|Lost to Follow-up|16
190204|NCT01002105|603783|P1|Overall Study|Lost to Follow-up|10
190205|NCT01002339|603823|P3|Overall Study|Randomized. Not transplanted|1
190206|NCT01002339|603824|P2|Overall Study|Randomized. Not transplanted|0
190207|NCT01002339|603825|P1|Overall Study|Randomized. Not transplanted|0
190208|NCT01002339|603823|P3|Overall Study|Lung cancer detected before transplant|1
190209|NCT01002339|603824|P2|Overall Study|Lung cancer detected before transplant|0
190210|NCT01002339|603825|P1|Overall Study|Lung cancer detected before transplant|0
190211|NCT01002339|603823|P3|Overall Study|Protocol Violation|2
190212|NCT01002339|603824|P2|Overall Study|Protocol Violation|0
190213|NCT01002339|603825|P1|Overall Study|Protocol Violation|0
190214|NCT01002339|603823|P3|Overall Study|Incorrect treatment assignment|1
190215|NCT01002339|603824|P2|Overall Study|Incorrect treatment assignment|0
190216|NCT01002339|603825|P1|Overall Study|Incorrect treatment assignment|0
190217|NCT01002339|603823|P3|Overall Study|Withdrawal by Subject|0
190218|NCT01002339|603824|P2|Overall Study|Withdrawal by Subject|1
190219|NCT01002339|603825|P1|Overall Study|Withdrawal by Subject|0
190220|NCT01002482|603891|P2|Overall Study|Included twice|0
190221|NCT01002482|603892|P1|Overall Study|Included twice|1
190222|NCT01002482|603891|P2|Overall Study|Withdrawal by Subject|21
190223|NCT01002482|603892|P1|Overall Study|Withdrawal by Subject|14
190224|NCT01002573|603914|P2|Overall Study|Subject did not receive at least 1 dose|7
190225|NCT01002573|603915|P1|Overall Study|Subject did not receive at least 1 dose|11
190226|NCT01002742|603935|P2|Overall Study|Determined to be ineligible|1
190227|NCT01002742|603936|P1|Overall Study|Determined to be ineligible|0
190228|NCT01002989|603970|P1|Overall Study|exclusion criteria, no consent|5
190229|NCT01003184|604030|P2|Overall Study|Physician Decision|0
190230|NCT01003184|604031|P1|Overall Study|Physician Decision|1
190231|NCT01003184|604030|P2|Overall Study|Withdrawal by Subject|6
190232|NCT01003184|604031|P1|Overall Study|Withdrawal by Subject|1
190233|NCT01003184|604030|P2|Overall Study|Protocol Violation|0
190234|NCT01003184|604031|P1|Overall Study|Protocol Violation|3
190235|NCT01003184|604030|P2|Overall Study|Loss of glucose control|1
190236|NCT01003184|604031|P1|Overall Study|Loss of glucose control|1
190237|NCT01003184|604030|P2|Overall Study|Lost to Follow-up|0
190238|NCT01003184|604031|P1|Overall Study|Lost to Follow-up|1
190239|NCT01003184|604030|P2|Overall Study|Adverse Event|5
190240|NCT01003184|604031|P1|Overall Study|Adverse Event|12
190241|NCT01003210|604065|P2|Overall Study|Lost to Follow-up|3
190242|NCT01003210|604066|P1|Overall Study|Lost to Follow-up|1
190243|NCT01003886|604099|P1|Overall Study|Adverse Event|3
190244|NCT01003886|604099|P1|Overall Study|Unspecified|14
190245|NCT01003886|604099|P1|Overall Study|Withdrawal by Subject|39
190246|NCT01003886|604099|P1|Overall Study|Lost to Follow-up|169
190247|NCT01003886|604099|P1|Overall Study|Lack of Efficacy|5
190248|NCT01003899|604108|P1|Overall Study|Progressive disease|34
190249|NCT01003899|604108|P1|Overall Study|Not treated|1
190250|NCT01003899|604108|P1|Overall Study|Not entered|4
190251|NCT01003899|604108|P1|Overall Study|Other Adverse Event|8
190252|NCT01003990|604129|P3|Overall Study|Subject Withdrew Consent|7
190253|NCT01003990|604130|P2|Overall Study|Subject Withdrew Consent|5
190254|NCT01003990|604131|P1|Overall Study|Subject Withdrew Consent|12
190255|NCT01003990|604129|P3|Overall Study|No Longer Met Study Criteria|0
190256|NCT01003990|604130|P2|Overall Study|No Longer Met Study Criteria|1
190257|NCT01003990|604131|P1|Overall Study|No Longer Met Study Criteria|4
190258|NCT01003990|604129|P3|Overall Study|Pregnancy|4
190259|NCT01003990|604130|P2|Overall Study|Pregnancy|2
190260|NCT01003990|604131|P1|Overall Study|Pregnancy|10
190261|NCT01003990|604129|P3|Overall Study|Poor/Non-compliance|2
190262|NCT01003990|604130|P2|Overall Study|Poor/Non-compliance|3
190263|NCT01003990|604131|P1|Overall Study|Poor/Non-compliance|4
190264|NCT01003990|604129|P3|Overall Study|Reasons Not Identified|8
190265|NCT01003990|604130|P2|Overall Study|Reasons Not Identified|13
190266|NCT01003990|604131|P1|Overall Study|Reasons Not Identified|14
190267|NCT01003990|604129|P3|Overall Study|Lost to Follow-up|7
190268|NCT01003990|604130|P2|Overall Study|Lost to Follow-up|12
190269|NCT01003990|604131|P1|Overall Study|Lost to Follow-up|30
190270|NCT01003990|604129|P3|Overall Study|Lack of Efficacy|3
190271|NCT01003990|604130|P2|Overall Study|Lack of Efficacy|2
190272|NCT01003990|604131|P1|Overall Study|Lack of Efficacy|10
190273|NCT01003990|604129|P3|Overall Study|Death|1
190274|NCT01003990|604130|P2|Overall Study|Death|8
190275|NCT01003990|604131|P1|Overall Study|Death|0
190276|NCT01003990|604129|P3|Overall Study|Adverse Event|11
190277|NCT01003990|604130|P2|Overall Study|Adverse Event|5
190278|NCT01003990|604131|P1|Overall Study|Adverse Event|8
190279|NCT01004003|604148|P9|Overall Study|Other|0
190280|NCT01004003|604149|P8|Overall Study|Other|0
190281|NCT01004003|604150|P7|Overall Study|Other|0
190282|NCT01004003|604151|P6|Overall Study|Other|1
190283|NCT01004003|604152|P5|Overall Study|Other|0
190284|NCT01004003|604153|P4|Overall Study|Other|0
190285|NCT01004003|604154|P3|Overall Study|Other|0
190286|NCT01004003|604155|P2|Overall Study|Other|0
190287|NCT01004003|604156|P1|Overall Study|Other|0
190288|NCT01004003|604148|P9|Overall Study|Refused to continue taking trial med.|2
190289|NCT01004003|604149|P8|Overall Study|Refused to continue taking trial med.|0
190290|NCT01004003|604150|P7|Overall Study|Refused to continue taking trial med.|0
190291|NCT01004003|604151|P6|Overall Study|Refused to continue taking trial med.|0
190292|NCT01004003|604152|P5|Overall Study|Refused to continue taking trial med.|0
190293|NCT01004003|604153|P4|Overall Study|Refused to continue taking trial med.|0
190294|NCT01004003|604154|P3|Overall Study|Refused to continue taking trial med.|0
190295|NCT01004003|604155|P2|Overall Study|Refused to continue taking trial med.|0
190296|NCT01004003|604156|P1|Overall Study|Refused to continue taking trial med.|0
190297|NCT01004003|604148|P9|Overall Study|Adverse Event|6
190298|NCT01004003|604149|P8|Overall Study|Adverse Event|21
190299|NCT01004003|604150|P7|Overall Study|Adverse Event|7
190300|NCT01004003|604151|P6|Overall Study|Adverse Event|2
190301|NCT01004003|604152|P5|Overall Study|Adverse Event|2
190302|NCT01004003|604153|P4|Overall Study|Adverse Event|3
190303|NCT01004003|604154|P3|Overall Study|Adverse Event|3
190304|NCT01004003|604155|P2|Overall Study|Adverse Event|2
190305|NCT01004003|604156|P1|Overall Study|Adverse Event|4
190306|NCT01004003|604148|P9|Overall Study|Progressive disease|22
190307|NCT01004003|604149|P8|Overall Study|Progressive disease|39
190308|NCT01004003|604150|P7|Overall Study|Progressive disease|1
190309|NCT01004003|604151|P6|Overall Study|Progressive disease|1
190310|NCT01004003|604152|P5|Overall Study|Progressive disease|2
190311|NCT01004003|604153|P4|Overall Study|Progressive disease|0
190312|NCT01004003|604154|P3|Overall Study|Progressive disease|1
190313|NCT01004003|604155|P2|Overall Study|Progressive disease|1
190314|NCT01004003|604156|P1|Overall Study|Progressive disease|2
190315|NCT01004146|604186|P2|Overall Study|Withdrawal by Subject|5
190316|NCT01004146|604187|P1|Overall Study|Withdrawal by Subject|4
190317|NCT01004159|604193|P1|Overall Study|Disease Progression|18
190318|NCT01004159|604193|P1|Overall Study|Adverse Event|2
190319|NCT01004172|604198|P1|Overall Study|Symptomatic Deterioration|2
190320|NCT01004172|604198|P1|Overall Study|Physician Decision|1
190321|NCT01004172|604198|P1|Overall Study|Adverse Event|1
190322|NCT01004172|604198|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
190323|NCT01004172|604198|P1|Overall Study|Progressive Disease in Non-CNS Only|16
190324|NCT01004172|604198|P1|Overall Study|Progressive Disease in CNS Only|16
190325|NCT01004185|604206|P2|Overall Study|Withdrawal by Subject|1
190326|NCT01004185|604207|P1|Overall Study|Withdrawal by Subject|2
190327|NCT01004185|604206|P2|Overall Study|Sponsor Terminated Study|5
190328|NCT01004185|604207|P1|Overall Study|Sponsor Terminated Study|4
190329|NCT01004185|604206|P2|Overall Study|Lack of Efficacy|1
190330|NCT01004185|604207|P1|Overall Study|Lack of Efficacy|2
190331|NCT01004185|604206|P2|Overall Study|Lost to Follow-up|1
190332|NCT01004185|604207|P1|Overall Study|Lost to Follow-up|0
190333|NCT01004185|604206|P2|Overall Study|Adverse Event|1
190334|NCT01004185|604207|P1|Overall Study|Adverse Event|1
190335|NCT01004250|604215|P1|Follow-Up (FU) Period|Lost to Follow-up|1
190336|NCT01004250|604215|P1|Maintenance Therapy Period|Physician Decision|4
190337|NCT01004250|604215|P1|Maintenance Therapy Period|Withdrawal by Subject|5
190338|NCT01004250|604215|P1|Maintenance Therapy Period|Protocol Violation|1
190339|NCT01004250|604215|P1|Maintenance Therapy Period|Lost to Follow-up|1
190340|NCT01004250|604215|P1|Maintenance Therapy Period|Adverse Event|15
190341|NCT01004250|604215|P1|Induction Therapy Period|Physician Decision|2
190342|NCT01004250|604215|P1|Induction Therapy Period|Withdrawal by Subject|2
190343|NCT01004250|604215|P1|Induction Therapy Period|Entry Criteria Not Met|1
190344|NCT01004250|604215|P1|Induction Therapy Period|Adverse Event|10
190345|NCT01004263|604225|P1|Overall Study|Lack of Qualifying Event|2
190346|NCT01004263|604225|P1|Overall Study|Physician Decision|15
190347|NCT01004263|604225|P1|Overall Study|Pregnancy|2
190348|NCT01004263|604225|P1|Overall Study|Lack of Efficacy|13
190349|NCT01004263|604225|P1|Overall Study|Lost to Follow-up|64
190350|NCT01004263|604225|P1|Overall Study|Protocol Violation|10
190351|NCT01004263|604225|P1|Overall Study|Withdrawal by Subject|58
190352|NCT01004263|604225|P1|Overall Study|Adverse Event|15
190353|NCT00991276|604284|P6|Third Intervention Period|Withdrawal by Subject|0
190354|NCT00991276|604285|P5|Third Intervention Period|Withdrawal by Subject|0
190355|NCT00991276|604286|P4|Third Intervention Period|Withdrawal by Subject|1
190356|NCT00991276|604287|P3|Third Intervention Period|Withdrawal by Subject|0
190357|NCT00991276|604288|P2|Third Intervention Period|Withdrawal by Subject|0
190358|NCT00991276|604289|P1|Third Intervention Period|Withdrawal by Subject|0
190359|NCT00991276|604284|P6|Third Intervention Period|Adverse Event|0
190360|NCT00991276|604285|P5|Third Intervention Period|Adverse Event|0
190361|NCT00991276|604286|P4|Third Intervention Period|Adverse Event|0
190362|NCT00991276|604287|P3|Third Intervention Period|Adverse Event|1
190363|NCT00991276|604288|P2|Third Intervention Period|Adverse Event|0
190364|NCT00991276|604289|P1|Third Intervention Period|Adverse Event|0
190365|NCT00991276|604284|P6|Third Intervention Period|Unspecified|1
190366|NCT00991276|604285|P5|Third Intervention Period|Unspecified|0
190367|NCT00991276|604286|P4|Third Intervention Period|Unspecified|0
190368|NCT00991276|604287|P3|Third Intervention Period|Unspecified|0
190369|NCT00991276|604288|P2|Third Intervention Period|Unspecified|0
190370|NCT00991276|604289|P1|Third Intervention Period|Unspecified|0
190371|NCT00991276|604284|P6|Third Intervention Period|Protocol Violation|0
190372|NCT00991276|604285|P5|Third Intervention Period|Protocol Violation|0
190373|NCT00991276|604286|P4|Third Intervention Period|Protocol Violation|0
190374|NCT00991276|604287|P3|Third Intervention Period|Protocol Violation|0
190375|NCT00991276|604288|P2|Third Intervention Period|Protocol Violation|0
190376|NCT00991276|604289|P1|Third Intervention Period|Protocol Violation|1
190377|NCT00991276|604284|P6|Second Intervention Period|Unspecified|1
190378|NCT00991276|604285|P5|Second Intervention Period|Unspecified|0
190379|NCT00991276|604286|P4|Second Intervention Period|Unspecified|1
190380|NCT00991276|604287|P3|Second Intervention Period|Unspecified|0
190381|NCT00991276|604288|P2|Second Intervention Period|Unspecified|0
190382|NCT00991276|604289|P1|Second Intervention Period|Unspecified|0
190383|NCT00991276|604284|P6|Second Intervention Period|Protocol Violation|0
190384|NCT00991276|604285|P5|Second Intervention Period|Protocol Violation|0
190385|NCT00991276|604286|P4|Second Intervention Period|Protocol Violation|0
190386|NCT00991276|604287|P3|Second Intervention Period|Protocol Violation|0
190387|NCT00991276|604288|P2|Second Intervention Period|Protocol Violation|0
190388|NCT00991276|604289|P1|Second Intervention Period|Protocol Violation|1
190389|NCT00991276|604284|P6|Second Intervention Period|Adverse Event|0
190390|NCT00991276|604285|P5|Second Intervention Period|Adverse Event|1
190391|NCT00991276|604286|P4|Second Intervention Period|Adverse Event|1
190392|NCT00991276|604287|P3|Second Intervention Period|Adverse Event|0
190393|NCT00991276|604288|P2|Second Intervention Period|Adverse Event|2
190394|NCT00991276|604289|P1|Second Intervention Period|Adverse Event|0
190395|NCT00991276|604284|P6|First Intervention Period|Lost to Follow-up|0
190396|NCT00991276|604285|P5|First Intervention Period|Lost to Follow-up|0
190397|NCT00991276|604286|P4|First Intervention Period|Lost to Follow-up|1
190398|NCT00991276|604287|P3|First Intervention Period|Lost to Follow-up|0
190399|NCT00991276|604288|P2|First Intervention Period|Lost to Follow-up|1
190400|NCT00991276|604289|P1|First Intervention Period|Lost to Follow-up|0
190401|NCT00991276|604284|P6|First Intervention Period|Withdrawal by Subject|1
190402|NCT00991276|604285|P5|First Intervention Period|Withdrawal by Subject|0
190403|NCT00991276|604286|P4|First Intervention Period|Withdrawal by Subject|1
190404|NCT00991276|604287|P3|First Intervention Period|Withdrawal by Subject|0
190405|NCT00991276|604288|P2|First Intervention Period|Withdrawal by Subject|1
190406|NCT00991276|604289|P1|First Intervention Period|Withdrawal by Subject|0
190407|NCT00991276|604284|P6|First Intervention Period|Unspecified|0
190408|NCT00991276|604285|P5|First Intervention Period|Unspecified|1
190409|NCT00991276|604286|P4|First Intervention Period|Unspecified|1
190410|NCT00991276|604287|P3|First Intervention Period|Unspecified|0
190411|NCT00991276|604288|P2|First Intervention Period|Unspecified|0
190412|NCT00991276|604289|P1|First Intervention Period|Unspecified|0
190413|NCT00991276|604284|P6|First Intervention Period|Insufficient clinical response|0
190414|NCT00991276|604285|P5|First Intervention Period|Insufficient clinical response|1
190415|NCT00991276|604286|P4|First Intervention Period|Insufficient clinical response|0
190416|NCT00991276|604287|P3|First Intervention Period|Insufficient clinical response|0
190417|NCT00991276|604288|P2|First Intervention Period|Insufficient clinical response|0
190418|NCT00991276|604289|P1|First Intervention Period|Insufficient clinical response|0
190419|NCT00991276|604284|P6|First Intervention Period|Protocol Violation|0
190420|NCT00991276|604285|P5|First Intervention Period|Protocol Violation|2
190421|NCT00991276|604286|P4|First Intervention Period|Protocol Violation|0
190422|NCT00991276|604287|P3|First Intervention Period|Protocol Violation|0
190423|NCT00991276|604288|P2|First Intervention Period|Protocol Violation|0
190424|NCT00991276|604289|P1|First Intervention Period|Protocol Violation|0
190425|NCT00991276|604284|P6|First Intervention Period|Adverse Event|0
190426|NCT00991276|604285|P5|First Intervention Period|Adverse Event|0
190427|NCT00991276|604286|P4|First Intervention Period|Adverse Event|1
190428|NCT00991276|604287|P3|First Intervention Period|Adverse Event|0
190429|NCT00991276|604288|P2|First Intervention Period|Adverse Event|1
190430|NCT00991276|604289|P1|First Intervention Period|Adverse Event|0
190431|NCT00991289|604387|P1|Overall Study|Protocol Violation|2
190432|NCT00991289|604387|P1|Overall Study|Lost to Follow-up|4
190433|NCT00991289|604387|P1|Overall Study|Withdrawal by Subject|3
190434|NCT00991289|604387|P1|Overall Study|Physician Decision|2
190435|NCT00991289|604387|P1|Overall Study|Adverse Event|1
190436|NCT00991302|604403|P2|Overall Study|Lost to Follow-up|12
190437|NCT00991302|604404|P1|Overall Study|Lost to Follow-up|14
190438|NCT00991302|604403|P2|Overall Study|Death|1
190439|NCT00991302|604404|P1|Overall Study|Death|0
190440|NCT00991341|604422|P2|Overall Study|Withdrawal by Subject|4
190441|NCT00991341|604423|P1|Overall Study|Withdrawal by Subject|3
190442|NCT00991341|604422|P2|Overall Study|Physician Decision|2
190443|NCT00991341|604423|P1|Overall Study|Physician Decision|1
190444|NCT00991341|604422|P2|Overall Study|no RBCs received 96hrs after randomized|155
190445|NCT00991341|604423|P1|Overall Study|no RBCs received 96hrs after randomized|186
190446|NCT00991341|604422|P2|Overall Study|Death|0
190447|NCT00991341|604423|P1|Overall Study|Death|3
190448|NCT00991341|604422|P2|Overall Study|no surgery w/in 30 days of randomization|18
190449|NCT00991341|604423|P1|Overall Study|no surgery w/in 30 days of randomization|11
190450|NCT00991510|604483|P2|Period III (Days 29-112)|Adverse Event|1
190451|NCT00991510|604484|P1|Period III (Days 29-112)|Adverse Event|1
190452|NCT00991510|604483|P2|Period I (Days 1-14)|Adverse Event|0
190453|NCT00991510|604484|P1|Period I (Days 1-14)|Adverse Event|1
190454|NCT00996892|604506|P20|Expansion Stage 2A|Disease Progression|31
190455|NCT00996892|604507|P19|Expansion Stage 2A|Disease Progression|0
190456|NCT00996892|604508|P18|Expansion Stage 2A|Disease Progression|0
190457|NCT00996892|604509|P17|Expansion Stage 2A|Disease Progression|0
190458|NCT00996892|604510|P16|Expansion Stage 2A|Disease Progression|0
190459|NCT00996892|604511|P15|Expansion Stage 2A|Disease Progression|0
190460|NCT00996892|604512|P14|Expansion Stage 2A|Disease Progression|0
190461|NCT00996892|604513|P13|Expansion Stage 2A|Disease Progression|0
190462|NCT00996892|604514|P12|Expansion Stage 2A|Disease Progression|0
190463|NCT00996892|604515|P11|Expansion Stage 2A|Disease Progression|0
190464|NCT00996892|604516|P10|Expansion Stage 2A|Disease Progression|0
190465|NCT00996892|604517|P9|Expansion Stage 2A|Disease Progression|0
190466|NCT00996892|604518|P8|Expansion Stage 2A|Disease Progression|0
190467|NCT00996892|604519|P7|Expansion Stage 2A|Disease Progression|0
190468|NCT00996892|604520|P6|Expansion Stage 2A|Disease Progression|0
190469|NCT00996892|604521|P5|Expansion Stage 2A|Disease Progression|0
190470|NCT00996892|604522|P4|Expansion Stage 2A|Disease Progression|0
190471|NCT00996892|604523|P3|Expansion Stage 2A|Disease Progression|0
190472|NCT00996892|604524|P2|Expansion Stage 2A|Disease Progression|0
190473|NCT00996892|604525|P1|Expansion Stage 2A|Disease Progression|0
190474|NCT00996892|604506|P20|Expansion Stage 2A|Withdrawal by Subject|4
190475|NCT00996892|604507|P19|Expansion Stage 2A|Withdrawal by Subject|0
190476|NCT00996892|604508|P18|Expansion Stage 2A|Withdrawal by Subject|0
190477|NCT00996892|604509|P17|Expansion Stage 2A|Withdrawal by Subject|0
190478|NCT00996892|604510|P16|Expansion Stage 2A|Withdrawal by Subject|0
190479|NCT00996892|604511|P15|Expansion Stage 2A|Withdrawal by Subject|0
190480|NCT00996892|604512|P14|Expansion Stage 2A|Withdrawal by Subject|0
190481|NCT00996892|604513|P13|Expansion Stage 2A|Withdrawal by Subject|0
190482|NCT00996892|604514|P12|Expansion Stage 2A|Withdrawal by Subject|0
190483|NCT00996892|604515|P11|Expansion Stage 2A|Withdrawal by Subject|0
190484|NCT00996892|604516|P10|Expansion Stage 2A|Withdrawal by Subject|0
190485|NCT00996892|604517|P9|Expansion Stage 2A|Withdrawal by Subject|0
190486|NCT00996892|604518|P8|Expansion Stage 2A|Withdrawal by Subject|0
190487|NCT00996892|604519|P7|Expansion Stage 2A|Withdrawal by Subject|0
190488|NCT00996892|604520|P6|Expansion Stage 2A|Withdrawal by Subject|0
190489|NCT00996892|604521|P5|Expansion Stage 2A|Withdrawal by Subject|0
190490|NCT00996892|604522|P4|Expansion Stage 2A|Withdrawal by Subject|0
190491|NCT00996892|604523|P3|Expansion Stage 2A|Withdrawal by Subject|0
190492|NCT00996892|604524|P2|Expansion Stage 2A|Withdrawal by Subject|0
190493|NCT00996892|604525|P1|Expansion Stage 2A|Withdrawal by Subject|0
190494|NCT00996892|604506|P20|Expansion Stage 2A|Physician Decision|2
190495|NCT00996892|604507|P19|Expansion Stage 2A|Physician Decision|0
190496|NCT00996892|604508|P18|Expansion Stage 2A|Physician Decision|0
190497|NCT00996892|604509|P17|Expansion Stage 2A|Physician Decision|0
190498|NCT00996892|604510|P16|Expansion Stage 2A|Physician Decision|0
190499|NCT00996892|604511|P15|Expansion Stage 2A|Physician Decision|0
190500|NCT00996892|604512|P14|Expansion Stage 2A|Physician Decision|0
190501|NCT00996892|604513|P13|Expansion Stage 2A|Physician Decision|0
190502|NCT00996892|604514|P12|Expansion Stage 2A|Physician Decision|0
190503|NCT00996892|604515|P11|Expansion Stage 2A|Physician Decision|0
190504|NCT00996892|604516|P10|Expansion Stage 2A|Physician Decision|0
190505|NCT00996892|604517|P9|Expansion Stage 2A|Physician Decision|0
190506|NCT00996892|604518|P8|Expansion Stage 2A|Physician Decision|0
190507|NCT00996892|604519|P7|Expansion Stage 2A|Physician Decision|0
190508|NCT00996892|604520|P6|Expansion Stage 2A|Physician Decision|0
190509|NCT00996892|604521|P5|Expansion Stage 2A|Physician Decision|0
190510|NCT00996892|604522|P4|Expansion Stage 2A|Physician Decision|0
190511|NCT00996892|604523|P3|Expansion Stage 2A|Physician Decision|0
190512|NCT00996892|604524|P2|Expansion Stage 2A|Physician Decision|0
190513|NCT00996892|604525|P1|Expansion Stage 2A|Physician Decision|0
190514|NCT00996892|604506|P20|Expansion Stage 2A|Adverse Event|8
190515|NCT00996892|604507|P19|Expansion Stage 2A|Adverse Event|0
190516|NCT00996892|604508|P18|Expansion Stage 2A|Adverse Event|0
190517|NCT00996892|604509|P17|Expansion Stage 2A|Adverse Event|0
190518|NCT00996892|604510|P16|Expansion Stage 2A|Adverse Event|0
190519|NCT00996892|604511|P15|Expansion Stage 2A|Adverse Event|0
190520|NCT00996892|604512|P14|Expansion Stage 2A|Adverse Event|0
190521|NCT00996892|604513|P13|Expansion Stage 2A|Adverse Event|0
190522|NCT00996892|604514|P12|Expansion Stage 2A|Adverse Event|0
190523|NCT00996892|604515|P11|Expansion Stage 2A|Adverse Event|0
190524|NCT00996892|604516|P10|Expansion Stage 2A|Adverse Event|0
190525|NCT00996892|604517|P9|Expansion Stage 2A|Adverse Event|0
190526|NCT00996892|604518|P8|Expansion Stage 2A|Adverse Event|0
190527|NCT00996892|604519|P7|Expansion Stage 2A|Adverse Event|0
190528|NCT00996892|604520|P6|Expansion Stage 2A|Adverse Event|0
190529|NCT00996892|604521|P5|Expansion Stage 2A|Adverse Event|0
190530|NCT00996892|604522|P4|Expansion Stage 2A|Adverse Event|0
190531|NCT00996892|604523|P3|Expansion Stage 2A|Adverse Event|0
190532|NCT00996892|604524|P2|Expansion Stage 2A|Adverse Event|0
190533|NCT00996892|604525|P1|Expansion Stage 2A|Adverse Event|0
190534|NCT00996892|604506|P20|Expansion Stage 2|Disease Progression|0
190535|NCT00996892|604507|P19|Expansion Stage 2|Disease Progression|28
190536|NCT00996892|604508|P18|Expansion Stage 2|Disease Progression|0
190537|NCT00996892|604509|P17|Expansion Stage 2|Disease Progression|0
190538|NCT00996892|604510|P16|Expansion Stage 2|Disease Progression|0
190539|NCT00996892|604511|P15|Expansion Stage 2|Disease Progression|0
190540|NCT00996892|604512|P14|Expansion Stage 2|Disease Progression|0
190541|NCT00996892|604513|P13|Expansion Stage 2|Disease Progression|0
190542|NCT00996892|604514|P12|Expansion Stage 2|Disease Progression|0
190543|NCT00996892|604515|P11|Expansion Stage 2|Disease Progression|0
190544|NCT00996892|604516|P10|Expansion Stage 2|Disease Progression|0
190545|NCT00996892|604517|P9|Expansion Stage 2|Disease Progression|0
190546|NCT00996892|604518|P8|Expansion Stage 2|Disease Progression|0
190547|NCT00996892|604519|P7|Expansion Stage 2|Disease Progression|0
190548|NCT00996892|604520|P6|Expansion Stage 2|Disease Progression|0
190549|NCT00996892|604521|P5|Expansion Stage 2|Disease Progression|0
190550|NCT00996892|604522|P4|Expansion Stage 2|Disease Progression|0
190551|NCT00996892|604523|P3|Expansion Stage 2|Disease Progression|0
190552|NCT00996892|604524|P2|Expansion Stage 2|Disease Progression|0
190553|NCT00996892|604525|P1|Expansion Stage 2|Disease Progression|0
190554|NCT00996892|604506|P20|Expansion Stage 2|Withdrawal by Subject|0
190555|NCT00996892|604507|P19|Expansion Stage 2|Withdrawal by Subject|1
190556|NCT00996892|604508|P18|Expansion Stage 2|Withdrawal by Subject|0
190557|NCT00996892|604509|P17|Expansion Stage 2|Withdrawal by Subject|0
190558|NCT00996892|604510|P16|Expansion Stage 2|Withdrawal by Subject|0
190559|NCT00996892|604511|P15|Expansion Stage 2|Withdrawal by Subject|0
190560|NCT00996892|604512|P14|Expansion Stage 2|Withdrawal by Subject|0
190561|NCT00996892|604513|P13|Expansion Stage 2|Withdrawal by Subject|0
190562|NCT00996892|604514|P12|Expansion Stage 2|Withdrawal by Subject|0
190563|NCT00996892|604515|P11|Expansion Stage 2|Withdrawal by Subject|0
190564|NCT00996892|604516|P10|Expansion Stage 2|Withdrawal by Subject|0
190565|NCT00996892|604517|P9|Expansion Stage 2|Withdrawal by Subject|0
190566|NCT00996892|604518|P8|Expansion Stage 2|Withdrawal by Subject|0
190567|NCT00996892|604519|P7|Expansion Stage 2|Withdrawal by Subject|0
190568|NCT00996892|604520|P6|Expansion Stage 2|Withdrawal by Subject|0
190569|NCT00996892|604521|P5|Expansion Stage 2|Withdrawal by Subject|0
190570|NCT00996892|604522|P4|Expansion Stage 2|Withdrawal by Subject|0
190571|NCT00996892|604523|P3|Expansion Stage 2|Withdrawal by Subject|0
190572|NCT00996892|604524|P2|Expansion Stage 2|Withdrawal by Subject|0
190573|NCT00996892|604525|P1|Expansion Stage 2|Withdrawal by Subject|0
190574|NCT00996892|604506|P20|Expansion Stage 2|Physician Decision|0
190575|NCT00996892|604507|P19|Expansion Stage 2|Physician Decision|1
190576|NCT00996892|604508|P18|Expansion Stage 2|Physician Decision|0
190577|NCT00996892|604509|P17|Expansion Stage 2|Physician Decision|0
190578|NCT00996892|604510|P16|Expansion Stage 2|Physician Decision|0
190579|NCT00996892|604511|P15|Expansion Stage 2|Physician Decision|0
190580|NCT00996892|604512|P14|Expansion Stage 2|Physician Decision|0
190581|NCT00996892|604513|P13|Expansion Stage 2|Physician Decision|0
190582|NCT00996892|604514|P12|Expansion Stage 2|Physician Decision|0
190583|NCT00996892|604515|P11|Expansion Stage 2|Physician Decision|0
190584|NCT00996892|604516|P10|Expansion Stage 2|Physician Decision|0
190585|NCT00996892|604517|P9|Expansion Stage 2|Physician Decision|0
190586|NCT00996892|604518|P8|Expansion Stage 2|Physician Decision|0
190587|NCT00996892|604519|P7|Expansion Stage 2|Physician Decision|0
190588|NCT00996892|604520|P6|Expansion Stage 2|Physician Decision|0
190589|NCT00996892|604521|P5|Expansion Stage 2|Physician Decision|0
190590|NCT00996892|604522|P4|Expansion Stage 2|Physician Decision|0
190591|NCT00996892|604523|P3|Expansion Stage 2|Physician Decision|0
190592|NCT00996892|604524|P2|Expansion Stage 2|Physician Decision|0
190593|NCT00996892|604525|P1|Expansion Stage 2|Physician Decision|0
190594|NCT00996892|604506|P20|Expansion Stage 2|Death|0
190595|NCT00996892|604507|P19|Expansion Stage 2|Death|2
190596|NCT00996892|604508|P18|Expansion Stage 2|Death|0
190597|NCT00996892|604509|P17|Expansion Stage 2|Death|0
190598|NCT00996892|604510|P16|Expansion Stage 2|Death|0
190599|NCT00996892|604511|P15|Expansion Stage 2|Death|0
190600|NCT00996892|604512|P14|Expansion Stage 2|Death|0
190601|NCT00996892|604513|P13|Expansion Stage 2|Death|0
190602|NCT00996892|604514|P12|Expansion Stage 2|Death|0
190603|NCT00996892|604515|P11|Expansion Stage 2|Death|0
190604|NCT00996892|604516|P10|Expansion Stage 2|Death|0
190605|NCT00996892|604517|P9|Expansion Stage 2|Death|0
190606|NCT00996892|604518|P8|Expansion Stage 2|Death|0
190607|NCT00996892|604519|P7|Expansion Stage 2|Death|0
190608|NCT00996892|604520|P6|Expansion Stage 2|Death|0
190609|NCT00996892|604521|P5|Expansion Stage 2|Death|0
190610|NCT00996892|604522|P4|Expansion Stage 2|Death|0
190611|NCT00996892|604523|P3|Expansion Stage 2|Death|0
190612|NCT00996892|604524|P2|Expansion Stage 2|Death|0
190613|NCT00996892|604525|P1|Expansion Stage 2|Death|0
190614|NCT00996892|604506|P20|Expansion Stage 2|Adverse Event|0
190615|NCT00996892|604507|P19|Expansion Stage 2|Adverse Event|3
190616|NCT00996892|604508|P18|Expansion Stage 2|Adverse Event|0
190617|NCT00996892|604509|P17|Expansion Stage 2|Adverse Event|0
190618|NCT00996892|604510|P16|Expansion Stage 2|Adverse Event|0
190619|NCT00996892|604511|P15|Expansion Stage 2|Adverse Event|0
190620|NCT00996892|604512|P14|Expansion Stage 2|Adverse Event|0
190621|NCT00996892|604513|P13|Expansion Stage 2|Adverse Event|0
190622|NCT00996892|604514|P12|Expansion Stage 2|Adverse Event|0
190623|NCT00996892|604515|P11|Expansion Stage 2|Adverse Event|0
190624|NCT00996892|604516|P10|Expansion Stage 2|Adverse Event|0
190625|NCT00996892|604517|P9|Expansion Stage 2|Adverse Event|0
190626|NCT00996892|604518|P8|Expansion Stage 2|Adverse Event|0
190627|NCT00996892|604519|P7|Expansion Stage 2|Adverse Event|0
190628|NCT00996892|604520|P6|Expansion Stage 2|Adverse Event|0
190629|NCT00996892|604521|P5|Expansion Stage 2|Adverse Event|0
190630|NCT00996892|604522|P4|Expansion Stage 2|Adverse Event|0
190631|NCT00996892|604523|P3|Expansion Stage 2|Adverse Event|0
190632|NCT00996892|604524|P2|Expansion Stage 2|Adverse Event|0
190633|NCT00996892|604525|P1|Expansion Stage 2|Adverse Event|0
190634|NCT00996892|604506|P20|Dose-Escalation Stage 1B|Disease Progression|0
190635|NCT00996892|604507|P19|Dose-Escalation Stage 1B|Disease Progression|0
190636|NCT00996892|604508|P18|Dose-Escalation Stage 1B|Disease Progression|3
190637|NCT00996892|604509|P17|Dose-Escalation Stage 1B|Disease Progression|3
190638|NCT00996892|604510|P16|Dose-Escalation Stage 1B|Disease Progression|3
190639|NCT00996892|604511|P15|Dose-Escalation Stage 1B|Disease Progression|4
190640|NCT00996892|604512|P14|Dose-Escalation Stage 1B|Disease Progression|0
190641|NCT00996892|604513|P13|Dose-Escalation Stage 1B|Disease Progression|0
190642|NCT00996892|604514|P12|Dose-Escalation Stage 1B|Disease Progression|0
190643|NCT00996892|604515|P11|Dose-Escalation Stage 1B|Disease Progression|0
190644|NCT00996892|604516|P10|Dose-Escalation Stage 1B|Disease Progression|0
190645|NCT00996892|604517|P9|Dose-Escalation Stage 1B|Disease Progression|0
190646|NCT00996892|604518|P8|Dose-Escalation Stage 1B|Disease Progression|0
190647|NCT00996892|604519|P7|Dose-Escalation Stage 1B|Disease Progression|0
190648|NCT00996892|604520|P6|Dose-Escalation Stage 1B|Disease Progression|0
190649|NCT00996892|604521|P5|Dose-Escalation Stage 1B|Disease Progression|0
190650|NCT00996892|604522|P4|Dose-Escalation Stage 1B|Disease Progression|0
190651|NCT00996892|604523|P3|Dose-Escalation Stage 1B|Disease Progression|0
190652|NCT00996892|604524|P2|Dose-Escalation Stage 1B|Disease Progression|0
190653|NCT00996892|604525|P1|Dose-Escalation Stage 1B|Disease Progression|0
190654|NCT00996892|604506|P20|Dose-Escalation Stage 1B|Physician Decision|0
190655|NCT00996892|604507|P19|Dose-Escalation Stage 1B|Physician Decision|0
190656|NCT00996892|604508|P18|Dose-Escalation Stage 1B|Physician Decision|2
190657|NCT00996892|604509|P17|Dose-Escalation Stage 1B|Physician Decision|0
190658|NCT00996892|604510|P16|Dose-Escalation Stage 1B|Physician Decision|0
190659|NCT00996892|604511|P15|Dose-Escalation Stage 1B|Physician Decision|0
190660|NCT00996892|604512|P14|Dose-Escalation Stage 1B|Physician Decision|0
190661|NCT00996892|604513|P13|Dose-Escalation Stage 1B|Physician Decision|0
190662|NCT00996892|604514|P12|Dose-Escalation Stage 1B|Physician Decision|0
190663|NCT00996892|604515|P11|Dose-Escalation Stage 1B|Physician Decision|0
190664|NCT00996892|604516|P10|Dose-Escalation Stage 1B|Physician Decision|0
190665|NCT00996892|604517|P9|Dose-Escalation Stage 1B|Physician Decision|0
190666|NCT00996892|604518|P8|Dose-Escalation Stage 1B|Physician Decision|0
190667|NCT00996892|604519|P7|Dose-Escalation Stage 1B|Physician Decision|0
190668|NCT00996892|604520|P6|Dose-Escalation Stage 1B|Physician Decision|0
190669|NCT00996892|604521|P5|Dose-Escalation Stage 1B|Physician Decision|0
190670|NCT00996892|604522|P4|Dose-Escalation Stage 1B|Physician Decision|0
190671|NCT00996892|604523|P3|Dose-Escalation Stage 1B|Physician Decision|0
190672|NCT00996892|604524|P2|Dose-Escalation Stage 1B|Physician Decision|0
190673|NCT00996892|604525|P1|Dose-Escalation Stage 1B|Physician Decision|0
190674|NCT00996892|604506|P20|Dose-Escalation Stage 1A|Disease Progression|0
190675|NCT00996892|604507|P19|Dose-Escalation Stage 1A|Disease Progression|0
190676|NCT00996892|604508|P18|Dose-Escalation Stage 1A|Disease Progression|0
190677|NCT00996892|604509|P17|Dose-Escalation Stage 1A|Disease Progression|0
190678|NCT00996892|604510|P16|Dose-Escalation Stage 1A|Disease Progression|0
190679|NCT00996892|604511|P15|Dose-Escalation Stage 1A|Disease Progression|0
190680|NCT00996892|604512|P14|Dose-Escalation Stage 1A|Disease Progression|4
190681|NCT00996892|604513|P13|Dose-Escalation Stage 1A|Disease Progression|6
190682|NCT00996892|604514|P12|Dose-Escalation Stage 1A|Disease Progression|7
190683|NCT00996892|604515|P11|Dose-Escalation Stage 1A|Disease Progression|5
190684|NCT00996892|604516|P10|Dose-Escalation Stage 1A|Disease Progression|1
190685|NCT00996892|604517|P9|Dose-Escalation Stage 1A|Disease Progression|3
190686|NCT00996892|604518|P8|Dose-Escalation Stage 1A|Disease Progression|2
190687|NCT00996892|604519|P7|Dose-Escalation Stage 1A|Disease Progression|0
190688|NCT00996892|604520|P6|Dose-Escalation Stage 1A|Disease Progression|0
190689|NCT00996892|604521|P5|Dose-Escalation Stage 1A|Disease Progression|0
190690|NCT00996892|604522|P4|Dose-Escalation Stage 1A|Disease Progression|0
190691|NCT00996892|604523|P3|Dose-Escalation Stage 1A|Disease Progression|0
190692|NCT00996892|604524|P2|Dose-Escalation Stage 1A|Disease Progression|0
190693|NCT00996892|604525|P1|Dose-Escalation Stage 1A|Disease Progression|0
190694|NCT00996892|604506|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190695|NCT00996892|604507|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190696|NCT00996892|604508|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190697|NCT00996892|604509|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190698|NCT00996892|604510|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190699|NCT00996892|604511|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190700|NCT00996892|604512|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190701|NCT00996892|604513|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
190702|NCT00996892|604514|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
190703|NCT00996892|604515|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
190704|NCT00996892|604516|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
190705|NCT00996892|604517|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190706|NCT00996892|604518|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190707|NCT00996892|604519|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190708|NCT00996892|604520|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190709|NCT00996892|604521|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190710|NCT00996892|604522|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190711|NCT00996892|604523|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190712|NCT00996892|604524|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190713|NCT00996892|604525|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
190714|NCT00996892|604506|P20|Dose-Escalation Stage 1A|Physician Decision|0
190715|NCT00996892|604507|P19|Dose-Escalation Stage 1A|Physician Decision|0
190716|NCT00996892|604508|P18|Dose-Escalation Stage 1A|Physician Decision|0
190717|NCT00996892|604509|P17|Dose-Escalation Stage 1A|Physician Decision|0
190718|NCT00996892|604510|P16|Dose-Escalation Stage 1A|Physician Decision|0
190719|NCT00996892|604511|P15|Dose-Escalation Stage 1A|Physician Decision|0
190720|NCT00996892|604512|P14|Dose-Escalation Stage 1A|Physician Decision|0
190721|NCT00996892|604513|P13|Dose-Escalation Stage 1A|Physician Decision|0
190722|NCT00996892|604514|P12|Dose-Escalation Stage 1A|Physician Decision|0
190723|NCT00996892|604515|P11|Dose-Escalation Stage 1A|Physician Decision|0
190724|NCT00996892|604516|P10|Dose-Escalation Stage 1A|Physician Decision|0
190725|NCT00996892|604517|P9|Dose-Escalation Stage 1A|Physician Decision|0
190726|NCT00996892|604518|P8|Dose-Escalation Stage 1A|Physician Decision|1
190727|NCT00996892|604519|P7|Dose-Escalation Stage 1A|Physician Decision|0
190728|NCT00996892|604520|P6|Dose-Escalation Stage 1A|Physician Decision|0
190729|NCT00996892|604521|P5|Dose-Escalation Stage 1A|Physician Decision|0
190730|NCT00996892|604522|P4|Dose-Escalation Stage 1A|Physician Decision|0
190731|NCT00996892|604523|P3|Dose-Escalation Stage 1A|Physician Decision|0
190732|NCT00996892|604524|P2|Dose-Escalation Stage 1A|Physician Decision|0
190733|NCT00996892|604525|P1|Dose-Escalation Stage 1A|Physician Decision|0
190734|NCT00996892|604506|P20|Dose-Escalation Stage 1A|Death|0
190735|NCT00996892|604507|P19|Dose-Escalation Stage 1A|Death|0
190736|NCT00996892|604508|P18|Dose-Escalation Stage 1A|Death|0
190737|NCT00996892|604509|P17|Dose-Escalation Stage 1A|Death|0
190738|NCT00996892|604510|P16|Dose-Escalation Stage 1A|Death|0
190739|NCT00996892|604511|P15|Dose-Escalation Stage 1A|Death|0
190740|NCT00996892|604512|P14|Dose-Escalation Stage 1A|Death|0
190741|NCT00996892|604513|P13|Dose-Escalation Stage 1A|Death|1
190742|NCT00996892|604514|P12|Dose-Escalation Stage 1A|Death|1
190743|NCT00996892|604515|P11|Dose-Escalation Stage 1A|Death|0
190744|NCT00996892|604516|P10|Dose-Escalation Stage 1A|Death|2
190745|NCT00996892|604517|P9|Dose-Escalation Stage 1A|Death|0
190746|NCT00996892|604518|P8|Dose-Escalation Stage 1A|Death|0
190747|NCT00996892|604519|P7|Dose-Escalation Stage 1A|Death|0
190748|NCT00996892|604520|P6|Dose-Escalation Stage 1A|Death|0
190749|NCT00996892|604521|P5|Dose-Escalation Stage 1A|Death|0
190750|NCT00996892|604522|P4|Dose-Escalation Stage 1A|Death|0
190751|NCT00996892|604523|P3|Dose-Escalation Stage 1A|Death|0
190752|NCT00996892|604524|P2|Dose-Escalation Stage 1A|Death|0
190753|NCT00996892|604525|P1|Dose-Escalation Stage 1A|Death|0
190754|NCT00996892|604506|P20|Dose-Escalation Stage 1A|Adverse Event|0
190755|NCT00996892|604507|P19|Dose-Escalation Stage 1A|Adverse Event|0
190756|NCT00996892|604508|P18|Dose-Escalation Stage 1A|Adverse Event|0
190757|NCT00996892|604509|P17|Dose-Escalation Stage 1A|Adverse Event|0
190758|NCT00996892|604510|P16|Dose-Escalation Stage 1A|Adverse Event|0
190759|NCT00996892|604511|P15|Dose-Escalation Stage 1A|Adverse Event|0
190760|NCT00996892|604512|P14|Dose-Escalation Stage 1A|Adverse Event|1
190761|NCT00996892|604513|P13|Dose-Escalation Stage 1A|Adverse Event|0
190762|NCT00996892|604514|P12|Dose-Escalation Stage 1A|Adverse Event|0
190763|NCT00996892|604515|P11|Dose-Escalation Stage 1A|Adverse Event|1
190764|NCT00996892|604516|P10|Dose-Escalation Stage 1A|Adverse Event|0
190765|NCT00996892|604517|P9|Dose-Escalation Stage 1A|Adverse Event|0
190766|NCT00996892|604518|P8|Dose-Escalation Stage 1A|Adverse Event|0
190767|NCT00996892|604519|P7|Dose-Escalation Stage 1A|Adverse Event|0
190768|NCT00996892|604520|P6|Dose-Escalation Stage 1A|Adverse Event|0
190769|NCT00996892|604521|P5|Dose-Escalation Stage 1A|Adverse Event|0
190770|NCT00996892|604522|P4|Dose-Escalation Stage 1A|Adverse Event|0
190771|NCT00996892|604523|P3|Dose-Escalation Stage 1A|Adverse Event|0
190772|NCT00996892|604524|P2|Dose-Escalation Stage 1A|Adverse Event|0
190773|NCT00996892|604525|P1|Dose-Escalation Stage 1A|Adverse Event|0
190774|NCT00996892|604506|P20|Dose-Escalation Stage 1|Disease Progression|0
190775|NCT00996892|604507|P19|Dose-Escalation Stage 1|Disease Progression|0
190776|NCT00996892|604508|P18|Dose-Escalation Stage 1|Disease Progression|0
190777|NCT00996892|604509|P17|Dose-Escalation Stage 1|Disease Progression|0
190778|NCT00996892|604510|P16|Dose-Escalation Stage 1|Disease Progression|0
190779|NCT00996892|604511|P15|Dose-Escalation Stage 1|Disease Progression|0
190780|NCT00996892|604512|P14|Dose-Escalation Stage 1|Disease Progression|0
190781|NCT00996892|604513|P13|Dose-Escalation Stage 1|Disease Progression|0
190782|NCT00996892|604514|P12|Dose-Escalation Stage 1|Disease Progression|0
190783|NCT00996892|604515|P11|Dose-Escalation Stage 1|Disease Progression|0
190784|NCT00996892|604516|P10|Dose-Escalation Stage 1|Disease Progression|0
190785|NCT00996892|604517|P9|Dose-Escalation Stage 1|Disease Progression|0
190786|NCT00996892|604518|P8|Dose-Escalation Stage 1|Disease Progression|0
190787|NCT00996892|604519|P7|Dose-Escalation Stage 1|Disease Progression|0
190788|NCT00996892|604520|P6|Dose-Escalation Stage 1|Disease Progression|7
190789|NCT00996892|604521|P5|Dose-Escalation Stage 1|Disease Progression|10
190790|NCT00996892|604522|P4|Dose-Escalation Stage 1|Disease Progression|4
190791|NCT00996892|604523|P3|Dose-Escalation Stage 1|Disease Progression|3
190792|NCT00996892|604524|P2|Dose-Escalation Stage 1|Disease Progression|2
190793|NCT00996892|604525|P1|Dose-Escalation Stage 1|Disease Progression|2
190794|NCT00996892|604506|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
190795|NCT00996892|604507|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
190796|NCT00996892|604508|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
190797|NCT00996892|604509|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
190798|NCT00996892|604510|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
190799|NCT00996892|604511|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
190800|NCT00996892|604512|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
190801|NCT00996892|604513|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
190802|NCT00996892|604514|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
190803|NCT00996892|604515|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
190804|NCT00996892|604516|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
190805|NCT00996892|604517|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
190806|NCT00996892|604518|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
190807|NCT00996892|604519|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
190808|NCT00996892|604520|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
190809|NCT00996892|604521|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
190810|NCT00996892|604522|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
190811|NCT00996892|604523|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
190812|NCT00996892|604524|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
190813|NCT00996892|604525|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
190814|NCT00996892|604506|P20|Dose-Escalation Stage 1|Physician Decision|0
190815|NCT00996892|604507|P19|Dose-Escalation Stage 1|Physician Decision|0
190816|NCT00996892|604508|P18|Dose-Escalation Stage 1|Physician Decision|0
190817|NCT00996892|604509|P17|Dose-Escalation Stage 1|Physician Decision|0
190818|NCT00996892|604510|P16|Dose-Escalation Stage 1|Physician Decision|0
190819|NCT00996892|604511|P15|Dose-Escalation Stage 1|Physician Decision|0
190820|NCT00996892|604512|P14|Dose-Escalation Stage 1|Physician Decision|0
190821|NCT00996892|604513|P13|Dose-Escalation Stage 1|Physician Decision|0
190822|NCT00996892|604514|P12|Dose-Escalation Stage 1|Physician Decision|0
190823|NCT00996892|604515|P11|Dose-Escalation Stage 1|Physician Decision|0
190824|NCT00996892|604516|P10|Dose-Escalation Stage 1|Physician Decision|0
190825|NCT00996892|604517|P9|Dose-Escalation Stage 1|Physician Decision|0
190826|NCT00996892|604518|P8|Dose-Escalation Stage 1|Physician Decision|0
190827|NCT00996892|604519|P7|Dose-Escalation Stage 1|Physician Decision|2
190828|NCT00996892|604520|P6|Dose-Escalation Stage 1|Physician Decision|1
190829|NCT00996892|604521|P5|Dose-Escalation Stage 1|Physician Decision|0
190830|NCT00996892|604522|P4|Dose-Escalation Stage 1|Physician Decision|1
190831|NCT00996892|604523|P3|Dose-Escalation Stage 1|Physician Decision|0
190832|NCT00996892|604524|P2|Dose-Escalation Stage 1|Physician Decision|0
190833|NCT00996892|604525|P1|Dose-Escalation Stage 1|Physician Decision|1
190834|NCT00996892|604506|P20|Dose-Escalation Stage 1|Death|0
190835|NCT00996892|604507|P19|Dose-Escalation Stage 1|Death|0
190836|NCT00996892|604508|P18|Dose-Escalation Stage 1|Death|0
190837|NCT00996892|604509|P17|Dose-Escalation Stage 1|Death|0
190838|NCT00996892|604510|P16|Dose-Escalation Stage 1|Death|0
190839|NCT00996892|604511|P15|Dose-Escalation Stage 1|Death|0
190840|NCT00996892|604512|P14|Dose-Escalation Stage 1|Death|0
190841|NCT00996892|604513|P13|Dose-Escalation Stage 1|Death|0
190842|NCT00996892|604514|P12|Dose-Escalation Stage 1|Death|0
190843|NCT00996892|604515|P11|Dose-Escalation Stage 1|Death|0
190844|NCT00996892|604516|P10|Dose-Escalation Stage 1|Death|0
190845|NCT00996892|604517|P9|Dose-Escalation Stage 1|Death|0
190846|NCT00996892|604518|P8|Dose-Escalation Stage 1|Death|0
190847|NCT00996892|604519|P7|Dose-Escalation Stage 1|Death|0
190848|NCT00996892|604520|P6|Dose-Escalation Stage 1|Death|1
190849|NCT00996892|604521|P5|Dose-Escalation Stage 1|Death|0
190850|NCT00996892|604522|P4|Dose-Escalation Stage 1|Death|0
190851|NCT00996892|604523|P3|Dose-Escalation Stage 1|Death|0
190852|NCT00996892|604524|P2|Dose-Escalation Stage 1|Death|0
190853|NCT00996892|604525|P1|Dose-Escalation Stage 1|Death|1
190854|NCT00996892|604506|P20|Dose-Escalation Stage 1|Adverse Event|0
190855|NCT00996892|604507|P19|Dose-Escalation Stage 1|Adverse Event|0
190856|NCT00996892|604508|P18|Dose-Escalation Stage 1|Adverse Event|0
190857|NCT00996892|604509|P17|Dose-Escalation Stage 1|Adverse Event|0
190858|NCT00996892|604510|P16|Dose-Escalation Stage 1|Adverse Event|0
190859|NCT00996892|604511|P15|Dose-Escalation Stage 1|Adverse Event|0
190860|NCT00996892|604512|P14|Dose-Escalation Stage 1|Adverse Event|0
190861|NCT00996892|604513|P13|Dose-Escalation Stage 1|Adverse Event|0
190862|NCT00996892|604514|P12|Dose-Escalation Stage 1|Adverse Event|0
190863|NCT00996892|604515|P11|Dose-Escalation Stage 1|Adverse Event|0
190864|NCT00996892|604516|P10|Dose-Escalation Stage 1|Adverse Event|0
190865|NCT00996892|604517|P9|Dose-Escalation Stage 1|Adverse Event|0
190866|NCT00996892|604518|P8|Dose-Escalation Stage 1|Adverse Event|0
190867|NCT00996892|604519|P7|Dose-Escalation Stage 1|Adverse Event|1
190868|NCT00996892|604520|P6|Dose-Escalation Stage 1|Adverse Event|0
190869|NCT00996892|604521|P5|Dose-Escalation Stage 1|Adverse Event|0
190870|NCT00996892|604522|P4|Dose-Escalation Stage 1|Adverse Event|2
190871|NCT00996892|604523|P3|Dose-Escalation Stage 1|Adverse Event|0
190872|NCT00996892|604524|P2|Dose-Escalation Stage 1|Adverse Event|0
190873|NCT00996892|604525|P1|Dose-Escalation Stage 1|Adverse Event|0
190874|NCT00996918|605119|P5|Overall Study|Not Specified|0
190875|NCT00996918|605120|P4|Overall Study|Not Specified|0
190876|NCT00996918|605121|P3|Overall Study|Not Specified|0
190877|NCT00996918|605122|P2|Overall Study|Not Specified|1
190878|NCT00996918|605123|P1|Overall Study|Not Specified|3
190879|NCT00996918|605119|P5|Overall Study|Loss of Caregiver|0
190880|NCT00996918|605120|P4|Overall Study|Loss of Caregiver|0
190881|NCT00996918|605121|P3|Overall Study|Loss of Caregiver|0
190882|NCT00996918|605122|P2|Overall Study|Loss of Caregiver|1
190883|NCT00996918|605123|P1|Overall Study|Loss of Caregiver|0
190884|NCT00996918|605119|P5|Overall Study|Discontinuation of Study by Sponsor|2
190885|NCT00996918|605120|P4|Overall Study|Discontinuation of Study by Sponsor|45
190886|NCT00996918|605121|P3|Overall Study|Discontinuation of Study by Sponsor|30
190887|NCT00996918|605122|P2|Overall Study|Discontinuation of Study by Sponsor|54
190888|NCT00996918|605123|P1|Overall Study|Discontinuation of Study by Sponsor|31
190889|NCT00996918|605119|P5|Overall Study|Physician Decision|0
190890|NCT00996918|605120|P4|Overall Study|Physician Decision|0
190891|NCT00996918|605121|P3|Overall Study|Physician Decision|0
190892|NCT00996918|605122|P2|Overall Study|Physician Decision|0
190893|NCT00996918|605123|P1|Overall Study|Physician Decision|1
190894|NCT00996918|605119|P5|Overall Study|Withdrawal by Subject|2
190895|NCT00996918|605120|P4|Overall Study|Withdrawal by Subject|3
190896|NCT00996918|605121|P3|Overall Study|Withdrawal by Subject|3
190897|NCT00996918|605122|P2|Overall Study|Withdrawal by Subject|4
190898|NCT00996918|605123|P1|Overall Study|Withdrawal by Subject|1
190899|NCT00996918|605119|P5|Overall Study|Adverse Event|0
190900|NCT00996918|605120|P4|Overall Study|Adverse Event|6
190901|NCT00996918|605121|P3|Overall Study|Adverse Event|2
190902|NCT00996918|605122|P2|Overall Study|Adverse Event|5
190903|NCT00996918|605123|P1|Overall Study|Adverse Event|2
190904|NCT00996918|605119|P5|Overall Study|Lack of Efficacy|0
190905|NCT00996918|605120|P4|Overall Study|Lack of Efficacy|2
190906|NCT00996918|605121|P3|Overall Study|Lack of Efficacy|2
190907|NCT00996918|605122|P2|Overall Study|Lack of Efficacy|1
190908|NCT00996918|605123|P1|Overall Study|Lack of Efficacy|1
190909|NCT00996944|605174|P2|Long-term Treatment Period|Study Closed/Terminated|5
190910|NCT00996944|605175|P1|Long-term Treatment Period|Study Closed/Terminated|12
190911|NCT00996944|605174|P2|Double-blind Treatment Period|Withdrawal by Subject|1
190912|NCT00996944|605175|P1|Double-blind Treatment Period|Withdrawal by Subject|1
190913|NCT00996944|605174|P2|Double-blind Treatment Period|Study Closed/Terminated|5
190914|NCT00996944|605175|P1|Double-blind Treatment Period|Study Closed/Terminated|6
190915|NCT00996944|605174|P2|Double-blind Treatment Period|Protocol Violation|0
190916|NCT00996944|605175|P1|Double-blind Treatment Period|Protocol Violation|1
190917|NCT00996944|605174|P2|Double-blind Treatment Period|Adverse Event|1
190918|NCT00996944|605175|P1|Double-blind Treatment Period|Adverse Event|2
190919|NCT00996996|605217|P1|Overall Study|Did Not Receive Study Medications|1
190920|NCT00996996|605217|P1|Overall Study|Death|5
190921|NCT00996996|605217|P1|Overall Study|Lost to Follow-up|9
190922|NCT00996996|605217|P1|Overall Study|Non-compliance|8
190923|NCT00996996|605217|P1|Overall Study|Progressive Disease|10
190924|NCT00997035|605251|P2|3-month Follow-up Visit|Lost to Follow-up|6
190925|NCT00997035|605252|P1|3-month Follow-up Visit|Lost to Follow-up|12
190926|NCT00997035|605251|P2|3-week Followup Visit|Lost to Follow-up|6
190927|NCT00997035|605252|P1|3-week Followup Visit|Lost to Follow-up|9
190928|NCT00997126|605287|P2|Overall Study|Physician Decision|11
190929|NCT00997126|605288|P1|Overall Study|Physician Decision|7
190930|NCT00997243|605322|P1|Overall Study|Early termination of study by sponsor|7
190931|NCT00997321|605334|P2|Overall Study|did not undergo sedation after enrollmen|3
190932|NCT00997321|605335|P1|Overall Study|did not undergo sedation after enrollmen|0
190933|NCT00997334|605347|P1|Overall Study|Ineligible|1
190934|NCT00997334|605347|P1|Overall Study|No lesion amenable|1
190935|NCT00997334|605347|P1|Overall Study|Urgent Palliative Care|2
190936|NCT00997334|605347|P1|Overall Study|Death|2
190937|NCT00997334|605347|P1|Overall Study|Withdrawal by Subject|3
190938|NCT00997334|605347|P1|Overall Study|Patient non-compliance|1
190939|NCT00997334|605347|P1|Overall Study|Adverse Event|3
190940|NCT00997334|605347|P1|Overall Study|still on therapy|12
190941|NCT00997373|605356|P2|Overall Study|could not have hysterectomy|0
190942|NCT00997373|605357|P1|Overall Study|could not have hysterectomy|6
190943|NCT00997373|605356|P2|Overall Study|wrong tumor type|0
190944|NCT00997373|605357|P1|Overall Study|wrong tumor type|4
190945|NCT00997373|605356|P2|Overall Study|Withdrawal by Subject|0
190946|NCT00997373|605357|P1|Overall Study|Withdrawal by Subject|5
190947|NCT01004432|605378|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
190948|NCT01004432|605379|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
190949|NCT01004432|605380|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
190950|NCT01004432|605381|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
190951|NCT01004432|605382|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
190952|NCT01004432|605378|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
190953|NCT01004432|605379|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
190954|NCT01004432|605380|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
190955|NCT01004432|605381|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
190956|NCT01004432|605382|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
190957|NCT01004432|605378|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
190958|NCT01004432|605379|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
190959|NCT01004432|605380|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
190960|NCT01004432|605381|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
190961|NCT01004432|605382|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
190962|NCT01004432|605378|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
190963|NCT01004432|605379|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
190964|NCT01004432|605380|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
190965|NCT01004432|605381|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
190966|NCT01004432|605382|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
190967|NCT01004432|605378|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
190968|NCT01004432|605379|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
190969|NCT01004432|605380|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
190970|NCT01004432|605381|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
190971|NCT01004432|605382|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
190972|NCT01004432|605378|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
190973|NCT01004432|605379|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
190974|NCT01004432|605380|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
190975|NCT01004432|605381|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
190976|NCT01004432|605382|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
190977|NCT01004432|605378|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
190978|NCT01004432|605379|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
190979|NCT01004432|605380|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
190980|NCT01004432|605381|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
190981|NCT01004432|605382|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
190982|NCT01004432|605378|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
190983|NCT01004432|605379|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
190984|NCT01004432|605380|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
190985|NCT01004432|605381|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
190986|NCT01004432|605382|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
190987|NCT01004432|605378|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
190988|NCT01004432|605379|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
190989|NCT01004432|605380|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
190990|NCT01004432|605381|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
190991|NCT01004432|605382|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
190992|NCT01004432|605378|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
190993|NCT01004432|605379|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
190994|NCT01004432|605380|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
190995|NCT01004432|605381|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
190996|NCT01004432|605382|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
190997|NCT01004432|605378|P5|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
190998|NCT01004432|605379|P4|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
190999|NCT01004432|605380|P3|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
191000|NCT01004432|605381|P2|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|0
191001|NCT01004432|605382|P1|Open-label (OL) Period (Week 0 – 16)|Lost to Follow-up|2
191002|NCT01004432|605378|P5|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
191003|NCT01004432|605379|P4|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
191004|NCT01004432|605380|P3|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
191005|NCT01004432|605381|P2|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|0
191006|NCT01004432|605382|P1|Open-label (OL) Period (Week 0 – 16)|Lack of Efficacy|15
191007|NCT01004432|605378|P5|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
191008|NCT01004432|605379|P4|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
191009|NCT01004432|605380|P3|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
191010|NCT01004432|605381|P2|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|0
191011|NCT01004432|605382|P1|Open-label (OL) Period (Week 0 – 16)|Withdrawal by Subject|17
191012|NCT01004432|605378|P5|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
191013|NCT01004432|605379|P4|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
191014|NCT01004432|605380|P3|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
191015|NCT01004432|605381|P2|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|0
191016|NCT01004432|605382|P1|Open-label (OL) Period (Week 0 – 16)|Protocol Violation|29
191017|NCT01004432|605378|P5|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
191018|NCT01004432|605379|P4|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
191019|NCT01004432|605380|P3|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
191020|NCT01004432|605381|P2|Open-label (OL) Period (Week 0 – 16)|Adverse Event|0
191021|NCT01004432|605382|P1|Open-label (OL) Period (Week 0 – 16)|Adverse Event|20
191022|NCT01004510|605402|P1|Overall Study|Adverse Event|1
191023|NCT01004614|605410|P4|Washout|Withdrawal by Subject|0
191024|NCT01004614|605411|P3|Washout|Withdrawal by Subject|0
191025|NCT01004614|605412|P2|Washout|Withdrawal by Subject|1
191026|NCT01004614|605413|P1|Washout|Withdrawal by Subject|0
191027|NCT01004822|605507|P8|Overall Study|Unspecified|0
191028|NCT01004822|605508|P7|Overall Study|Unspecified|0
191029|NCT01004822|605509|P6|Overall Study|Unspecified|1
191030|NCT01004822|605510|P5|Overall Study|Unspecified|0
191031|NCT01004822|605511|P4|Overall Study|Unspecified|1
191032|NCT01004822|605512|P3|Overall Study|Unspecified|4
191033|NCT01004822|605513|P2|Overall Study|Unspecified|0
191034|NCT01004822|605514|P1|Overall Study|Unspecified|0
191035|NCT01004822|605507|P8|Overall Study|Adverse Event|1
191036|NCT01004822|605508|P7|Overall Study|Adverse Event|1
191037|NCT01004822|605509|P6|Overall Study|Adverse Event|0
191038|NCT01004822|605510|P5|Overall Study|Adverse Event|0
191039|NCT01004822|605511|P4|Overall Study|Adverse Event|0
191040|NCT01004822|605512|P3|Overall Study|Adverse Event|0
191041|NCT01004822|605513|P2|Overall Study|Adverse Event|0
191042|NCT01004822|605514|P1|Overall Study|Adverse Event|0
191043|NCT01004822|605507|P8|Overall Study|No longer willing to continue|0
191044|NCT01004822|605508|P7|Overall Study|No longer willing to continue|1
191045|NCT01004822|605509|P6|Overall Study|No longer willing to continue|1
191046|NCT01004822|605510|P5|Overall Study|No longer willing to continue|2
191047|NCT01004822|605511|P4|Overall Study|No longer willing to continue|1
191048|NCT01004822|605512|P3|Overall Study|No longer willing to continue|0
191049|NCT01004822|605513|P2|Overall Study|No longer willing to continue|0
191050|NCT01004822|605514|P1|Overall Study|No longer willing to continue|0
191051|NCT01004822|605507|P8|Overall Study|Global deterioration of health status|0
191052|NCT01004822|605508|P7|Overall Study|Global deterioration of health status|1
191053|NCT01004822|605509|P6|Overall Study|Global deterioration of health status|0
191054|NCT01004822|605510|P5|Overall Study|Global deterioration of health status|0
191055|NCT01004822|605511|P4|Overall Study|Global deterioration of health status|1
191056|NCT01004822|605512|P3|Overall Study|Global deterioration of health status|0
191057|NCT01004822|605513|P2|Overall Study|Global deterioration of health status|0
191058|NCT01004822|605514|P1|Overall Study|Global deterioration of health status|0
191059|NCT01004822|605507|P8|Overall Study|Objective progression or relapse|4
191060|NCT01004822|605508|P7|Overall Study|Objective progression or relapse|1
191061|NCT01004822|605509|P6|Overall Study|Objective progression or relapse|2
191062|NCT01004822|605510|P5|Overall Study|Objective progression or relapse|2
191063|NCT01004822|605511|P4|Overall Study|Objective progression or relapse|1
191064|NCT01004822|605512|P3|Overall Study|Objective progression or relapse|0
191065|NCT01004822|605513|P2|Overall Study|Objective progression or relapse|3
191066|NCT01004822|605514|P1|Overall Study|Objective progression or relapse|3
191067|NCT01004848|605625|P2|Overall Study|Lost to Follow-up|45
191068|NCT01004848|605626|P1|Overall Study|Lost to Follow-up|55
191069|NCT01005251|605715|P5|Overall Study|Lack of Efficacy|0
191070|NCT01005251|605716|P4|Overall Study|Lack of Efficacy|1
191071|NCT01005251|605717|P3|Overall Study|Lack of Efficacy|1
191072|NCT01005251|605718|P2|Overall Study|Lack of Efficacy|0
191073|NCT01005251|605719|P1|Overall Study|Lack of Efficacy|0
191074|NCT01005251|605715|P5|Overall Study|Randomized in error|0
191075|NCT01005251|605716|P4|Overall Study|Randomized in error|1
191076|NCT01005251|605717|P3|Overall Study|Randomized in error|1
191077|NCT01005251|605718|P2|Overall Study|Randomized in error|0
191078|NCT01005251|605719|P1|Overall Study|Randomized in error|0
191079|NCT01005251|605715|P5|Overall Study|Wrong drug dispensed|0
191080|NCT01005251|605716|P4|Overall Study|Wrong drug dispensed|0
191081|NCT01005251|605717|P3|Overall Study|Wrong drug dispensed|0
191082|NCT01005251|605718|P2|Overall Study|Wrong drug dispensed|1
191083|NCT01005251|605719|P1|Overall Study|Wrong drug dispensed|0
191084|NCT01005251|605715|P5|Overall Study|Patient moved|0
191085|NCT01005251|605716|P4|Overall Study|Patient moved|0
191086|NCT01005251|605717|P3|Overall Study|Patient moved|0
191087|NCT01005251|605718|P2|Overall Study|Patient moved|0
191088|NCT01005251|605719|P1|Overall Study|Patient moved|1
191089|NCT01005251|605715|P5|Overall Study|Physician Decision|2
191090|NCT01005251|605716|P4|Overall Study|Physician Decision|0
191091|NCT01005251|605717|P3|Overall Study|Physician Decision|0
191092|NCT01005251|605718|P2|Overall Study|Physician Decision|0
191093|NCT01005251|605719|P1|Overall Study|Physician Decision|0
191094|NCT01005251|605715|P5|Overall Study|Lost to Follow-up|0
191095|NCT01005251|605716|P4|Overall Study|Lost to Follow-up|0
191096|NCT01005251|605717|P3|Overall Study|Lost to Follow-up|2
191097|NCT01005251|605718|P2|Overall Study|Lost to Follow-up|4
191098|NCT01005251|605719|P1|Overall Study|Lost to Follow-up|1
191099|NCT01005251|605715|P5|Overall Study|Developed study-specific withdrawal crit|1
191100|NCT01005251|605716|P4|Overall Study|Developed study-specific withdrawal crit|0
191101|NCT01005251|605717|P3|Overall Study|Developed study-specific withdrawal crit|3
191102|NCT01005251|605718|P2|Overall Study|Developed study-specific withdrawal crit|0
191103|NCT01005251|605719|P1|Overall Study|Developed study-specific withdrawal crit|2
191104|NCT01005251|605715|P5|Overall Study|Protocol Violation|2
191105|NCT01005251|605716|P4|Overall Study|Protocol Violation|0
191106|NCT01005251|605717|P3|Overall Study|Protocol Violation|0
191107|NCT01005251|605718|P2|Overall Study|Protocol Violation|0
191108|NCT01005251|605719|P1|Overall Study|Protocol Violation|1
191109|NCT01005251|605715|P5|Overall Study|Adverse Event|4
191110|NCT01005251|605716|P4|Overall Study|Adverse Event|5
191111|NCT01005251|605717|P3|Overall Study|Adverse Event|8
191112|NCT01005251|605718|P2|Overall Study|Adverse Event|6
191113|NCT01005251|605719|P1|Overall Study|Adverse Event|2
191114|NCT01005251|605715|P5|Overall Study|Eligibility criteria not fulfilled|0
191115|NCT01005251|605716|P4|Overall Study|Eligibility criteria not fulfilled|1
191116|NCT01005251|605717|P3|Overall Study|Eligibility criteria not fulfilled|4
191117|NCT01005251|605718|P2|Overall Study|Eligibility criteria not fulfilled|0
191118|NCT01005251|605719|P1|Overall Study|Eligibility criteria not fulfilled|4
191119|NCT01005251|605715|P5|Overall Study|Withdrawal by Subject|9
191120|NCT01005251|605716|P4|Overall Study|Withdrawal by Subject|4
191121|NCT01005251|605717|P3|Overall Study|Withdrawal by Subject|3
191122|NCT01005251|605718|P2|Overall Study|Withdrawal by Subject|5
191123|NCT01005251|605719|P1|Overall Study|Withdrawal by Subject|2
191124|NCT01005316|605749|P4|Overall Study|Retransplanted|0
191125|NCT01005316|605750|P3|Overall Study|Retransplanted|0
191126|NCT01005316|605751|P2|Overall Study|Retransplanted|1
191127|NCT01005316|605752|P1|Overall Study|Retransplanted|0
191128|NCT01005316|605749|P4|Overall Study|Transferred Care|3
191129|NCT01005316|605750|P3|Overall Study|Transferred Care|1
191130|NCT01005316|605751|P2|Overall Study|Transferred Care|0
191131|NCT01005316|605752|P1|Overall Study|Transferred Care|1
191132|NCT01005316|605749|P4|Overall Study|Delisted|0
191133|NCT01005316|605750|P3|Overall Study|Delisted|0
191134|NCT01005316|605751|P2|Overall Study|Delisted|0
191135|NCT01005316|605752|P1|Overall Study|Delisted|8
191136|NCT01005316|605749|P4|Overall Study|Consented to Another Study|0
191137|NCT01005316|605750|P3|Overall Study|Consented to Another Study|0
191138|NCT01005316|605751|P2|Overall Study|Consented to Another Study|0
191139|NCT01005316|605752|P1|Overall Study|Consented to Another Study|2
191140|NCT01005316|605749|P4|Overall Study|Withdrawal by Subject|2
191141|NCT01005316|605750|P3|Overall Study|Withdrawal by Subject|0
191142|NCT01005316|605751|P2|Overall Study|Withdrawal by Subject|1
191143|NCT01005316|605752|P1|Overall Study|Withdrawal by Subject|1
191144|NCT01005316|605749|P4|Overall Study|Sponsor Decision|0
191145|NCT01005316|605750|P3|Overall Study|Sponsor Decision|0
191146|NCT01005316|605751|P2|Overall Study|Sponsor Decision|3
191147|NCT01005316|605752|P1|Overall Study|Sponsor Decision|6
191148|NCT01005316|605749|P4|Overall Study|Physician Decision|0
191149|NCT01005316|605750|P3|Overall Study|Physician Decision|0
191150|NCT01005316|605751|P2|Overall Study|Physician Decision|0
191151|NCT01005316|605752|P1|Overall Study|Physician Decision|6
191152|NCT01005316|605749|P4|Overall Study|Lost to Follow-up|2
191153|NCT01005316|605750|P3|Overall Study|Lost to Follow-up|0
191154|NCT01005316|605751|P2|Overall Study|Lost to Follow-up|3
191155|NCT01005316|605752|P1|Overall Study|Lost to Follow-up|1
191156|NCT01005316|605749|P4|Overall Study|Study Termination|85
191157|NCT01005316|605750|P3|Overall Study|Study Termination|9
191158|NCT01005316|605751|P2|Overall Study|Study Termination|63
191159|NCT01005316|605752|P1|Overall Study|Study Termination|5
191160|NCT01005316|605749|P4|Overall Study|Death|15
191161|NCT01005316|605750|P3|Overall Study|Death|1
191162|NCT01005316|605751|P2|Overall Study|Death|5
191163|NCT01005316|605752|P1|Overall Study|Death|20
191164|NCT01005316|605749|P4|Overall Study|Adverse Event|1
191165|NCT01005316|605750|P3|Overall Study|Adverse Event|0
191166|NCT01005316|605751|P2|Overall Study|Adverse Event|0
191167|NCT01005316|605752|P1|Overall Study|Adverse Event|0
191168|NCT01005329|605804|P1|Overall Study|Ineligible or received no protocol trt.|4
191169|NCT01005602|605859|P2|Overall Study|Excluded due to unreliable clinical data|0
191170|NCT01005602|605860|P1|Overall Study|Excluded due to unreliable clinical data|1
191171|NCT01005680|605882|P2|Overall Study|Physician Decision|1
191172|NCT01005680|605883|P1|Overall Study|Physician Decision|1
191173|NCT01005680|605882|P2|Overall Study|Withdrawal by Subject|4
191174|NCT01005680|605883|P1|Overall Study|Withdrawal by Subject|1
191175|NCT01005680|605882|P2|Overall Study|Lost to Follow-up|6
191176|NCT01005680|605883|P1|Overall Study|Lost to Follow-up|4
191177|NCT01005719|605914|P6|Period 2|Adverse Event|1
191178|NCT01005719|605915|P5|Period 2|Adverse Event|1
191179|NCT01005719|605916|P4|Period 2|Adverse Event|0
191180|NCT01005719|605917|P3|Period 2|Adverse Event|0
191181|NCT01005719|605918|P2|Period 2|Adverse Event|0
191182|NCT01005719|605919|P1|Period 2|Adverse Event|0
191183|NCT01005719|605914|P6|Period 1|Delay in completing study procedures|1
191184|NCT01005719|605915|P5|Period 1|Delay in completing study procedures|0
191185|NCT01005719|605916|P4|Period 1|Delay in completing study procedures|0
191186|NCT01005719|605917|P3|Period 1|Delay in completing study procedures|0
191187|NCT01005719|605918|P2|Period 1|Delay in completing study procedures|0
191188|NCT01005719|605919|P1|Period 1|Delay in completing study procedures|0
191189|NCT01005719|605914|P6|Period 1|Adverse Event|0
191190|NCT01005719|605915|P5|Period 1|Adverse Event|0
191191|NCT01005719|605916|P4|Period 1|Adverse Event|1
191192|NCT01005719|605917|P3|Period 1|Adverse Event|0
191193|NCT01005719|605918|P2|Period 1|Adverse Event|0
191194|NCT01005719|605919|P1|Period 1|Adverse Event|0
191195|NCT01005732|605975|P1|Overall Study|Death|1
191196|NCT01005732|605975|P1|Overall Study|Lost to Follow-up|10
191197|NCT01005745|605991|P1|Overall Study|Inappropriate antidiuretic hormone|1
191198|NCT01005745|605991|P1|Overall Study|Death prior to treatment|1
191199|NCT01005745|605991|P1|Overall Study|Disease progressed during TIL growth|3
191200|NCT01005745|605991|P1|Overall Study|No TIL growth|1
191201|NCT01005875|605996|P1|Overall Study|Death|3
191202|NCT01005901|606031|P2|Overall Study|No longer requires study drug|1
191203|NCT01005901|606032|P1|Overall Study|No longer requires study drug|0
191204|NCT01005901|606031|P2|Overall Study|Patient's inability to use the device|1
191205|NCT01005901|606032|P1|Overall Study|Patient's inability to use the device|1
191206|NCT01005901|606031|P2|Overall Study|Lost to Follow-up|2
191207|NCT01005901|606032|P1|Overall Study|Lost to Follow-up|1
191208|NCT01005901|606031|P2|Overall Study|Death|3
191209|NCT01005901|606032|P1|Overall Study|Death|2
191210|NCT01005901|606031|P2|Overall Study|Protocol Violation|3
191211|NCT01005901|606032|P1|Overall Study|Protocol Violation|4
191212|NCT01005901|606031|P2|Overall Study|Unsatisfactory therapeutic effect|5
191213|NCT01005901|606032|P1|Overall Study|Unsatisfactory therapeutic effect|5
191214|NCT01005901|606031|P2|Overall Study|Administrative problems|13
191215|NCT01005901|606032|P1|Overall Study|Administrative problems|21
191216|NCT01005901|606031|P2|Overall Study|Adverse Event|16
191217|NCT01005901|606032|P1|Overall Study|Adverse Event|30
191218|NCT01005901|606031|P2|Overall Study|Withdrawal by Subject|14
191219|NCT01005901|606032|P1|Overall Study|Withdrawal by Subject|38
191220|NCT01005914|606070|P1|Overall Study|Withdrawal by Subject|1
191221|NCT01005914|606070|P1|Overall Study|Lack of Efficacy|1
191222|NCT01005914|606070|P1|Overall Study|Death|4
191223|NCT01005914|606070|P1|Overall Study|Adverse Event|4
191224|NCT01005966|606074|P5|Treatment Period 4 (14 Days)|Other Reason|1
191225|NCT01005966|606075|P4|Treatment Period 4 (14 Days)|Other Reason|0
191226|NCT01005966|606076|P3|Treatment Period 4 (14 Days)|Other Reason|0
191227|NCT01005966|606077|P2|Treatment Period 4 (14 Days)|Other Reason|0
191228|NCT01005966|606078|P1|Treatment Period 4 (14 Days)|Other Reason|0
191229|NCT01005966|606074|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
191230|NCT01005966|606075|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
191231|NCT01005966|606076|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
191232|NCT01005966|606077|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
191233|NCT01005966|606078|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
191234|NCT01005966|606074|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
191235|NCT01005966|606075|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
191236|NCT01005966|606076|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
191237|NCT01005966|606077|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
191238|NCT01005966|606078|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
191239|NCT01005966|606074|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
191240|NCT01005966|606075|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
191241|NCT01005966|606076|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
191242|NCT01005966|606077|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
191243|NCT01005966|606078|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
191244|NCT01005966|606074|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
191245|NCT01005966|606075|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
191246|NCT01005966|606076|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
191247|NCT01005966|606077|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
191248|NCT01005966|606078|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
191249|NCT01005966|606074|P5|Treatment Period 2 (14 Days)|Adverse Event|0
191250|NCT01005966|606075|P4|Treatment Period 2 (14 Days)|Adverse Event|0
191251|NCT01005966|606076|P3|Treatment Period 2 (14 Days)|Adverse Event|1
191252|NCT01005966|606077|P2|Treatment Period 2 (14 Days)|Adverse Event|1
191253|NCT01005966|606078|P1|Treatment Period 2 (14 Days)|Adverse Event|0
191254|NCT01005966|606074|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
191255|NCT01005966|606075|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
191256|NCT01005966|606076|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
191257|NCT01005966|606077|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
191258|NCT01005966|606078|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
191259|NCT01005966|606074|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
191260|NCT01005966|606075|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
191261|NCT01005966|606076|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
191262|NCT01005966|606077|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
191263|NCT01005966|606078|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
191264|NCT01005966|606074|P5|Treatment Period 1 (14 Days)|Adverse Event|0
191265|NCT01005966|606075|P4|Treatment Period 1 (14 Days)|Adverse Event|0
191266|NCT01005966|606076|P3|Treatment Period 1 (14 Days)|Adverse Event|0
191267|NCT01005966|606077|P2|Treatment Period 1 (14 Days)|Adverse Event|0
191268|NCT01005966|606078|P1|Treatment Period 1 (14 Days)|Adverse Event|1
191269|NCT01006122|606111|P2|Second Double-blind Intervention Period|Death|1
191270|NCT01006122|606112|P1|Second Double-blind Intervention Period|Death|0
191271|NCT01006122|606111|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
191272|NCT01006122|606112|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
191273|NCT01006122|606111|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
191274|NCT01006122|606112|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
191275|NCT01006122|606111|P2|Second Double-blind Intervention Period|Protocol Violation|0
191276|NCT01006122|606112|P1|Second Double-blind Intervention Period|Protocol Violation|1
191277|NCT01006122|606111|P2|Second Double-blind Intervention Period|Adverse Event|1
191278|NCT01006122|606112|P1|Second Double-blind Intervention Period|Adverse Event|1
191279|NCT01006122|606111|P2|First Double-blind Intervention Period|Adverse Event|4
191280|NCT01006122|606112|P1|First Double-blind Intervention Period|Adverse Event|0
191281|NCT01006122|606111|P2|First Double-blind Intervention Period|Unspecified|0
191282|NCT01006122|606112|P1|First Double-blind Intervention Period|Unspecified|3
191283|NCT01006122|606111|P2|First Double-blind Intervention Period|Lack of Efficacy|1
191284|NCT01006122|606112|P1|First Double-blind Intervention Period|Lack of Efficacy|2
191285|NCT01006122|606111|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
191286|NCT01006122|606112|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
191287|NCT01006122|606111|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
191288|NCT01006122|606112|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
191289|NCT01006122|606111|P2|First Double-blind Intervention Period|Pregnancy|1
191290|NCT01006122|606112|P1|First Double-blind Intervention Period|Pregnancy|0
191291|NCT01006122|606111|P2|First Double-blind Intervention Period|Protocol Violation|1
191292|NCT01006122|606112|P1|First Double-blind Intervention Period|Protocol Violation|1
191293|NCT01006122|606111|P2|First Double-blind Intervention Period|Lost to Follow-up|2
191294|NCT01006122|606112|P1|First Double-blind Intervention Period|Lost to Follow-up|0
191295|NCT01006135|606150|P1|Overall Study|Other|72
191296|NCT01006135|606150|P1|Overall Study|Lost to Follow-up|32
191297|NCT01006135|606150|P1|Overall Study|Protocol Violation|14
191298|NCT01006135|606150|P1|Overall Study|Adverse Event|22
191299|NCT01006291|606160|P3|Overall Study|Other|17
191300|NCT01006291|606161|P2|Overall Study|Other|14
191301|NCT01006291|606162|P1|Overall Study|Other|14
191302|NCT01006291|606160|P3|Overall Study|Withdrawal criteria|4
191303|NCT01006291|606161|P2|Overall Study|Withdrawal criteria|4
191304|NCT01006291|606162|P1|Overall Study|Withdrawal criteria|5
191305|NCT01006291|606160|P3|Overall Study|Protocol Violation|3
191306|NCT01006291|606161|P2|Overall Study|Protocol Violation|3
191307|NCT01006291|606162|P1|Overall Study|Protocol Violation|3
191308|NCT01006291|606160|P3|Overall Study|Lack of Efficacy|1
191309|NCT01006291|606161|P2|Overall Study|Lack of Efficacy|2
191310|NCT01006291|606162|P1|Overall Study|Lack of Efficacy|2
191311|NCT01006291|606160|P3|Overall Study|Adverse Event|2
191312|NCT01006291|606161|P2|Overall Study|Adverse Event|1
191313|NCT01006291|606162|P1|Overall Study|Adverse Event|2
191314|NCT01006356|606179|P1|Overall Study|unspecified|23
191315|NCT01006356|606179|P1|Overall Study|Protocol Violation|3
191316|NCT01006356|606179|P1|Overall Study|Choice by participants|2
191317|NCT01006356|606179|P1|Overall Study|Withdrawal by Subject|1
191318|NCT01006356|606179|P1|Overall Study|Paticipants did not cooperate|6
191319|NCT01006356|606179|P1|Overall Study|Physician Decision|1
191320|NCT01006356|606179|P1|Overall Study|Adverse Event|6
191321|NCT01006590|606193|P2|Overall Study|Not specified|2
191322|NCT01006590|606194|P1|Overall Study|Not specified|3
191323|NCT01006590|606193|P2|Overall Study|Study specific discontinuation criteria|23
191324|NCT01006590|606194|P1|Overall Study|Study specific discontinuation criteria|16
191325|NCT01006590|606193|P2|Overall Study|Withdrawal by Subject|2
191326|NCT01006590|606194|P1|Overall Study|Withdrawal by Subject|4
191327|NCT01006590|606193|P2|Overall Study|Protocol Violation|0
191328|NCT01006590|606194|P1|Overall Study|Protocol Violation|1
191329|NCT01006590|606193|P2|Overall Study|Lost to Follow-up|1
191330|NCT01006590|606194|P1|Overall Study|Lost to Follow-up|1
191331|NCT01006590|606193|P2|Overall Study|Death|1
191332|NCT01006590|606194|P1|Overall Study|Death|1
191333|NCT01006590|606193|P2|Overall Study|Adverse Event|3
191334|NCT01006590|606194|P1|Overall Study|Adverse Event|2
191335|NCT01006603|606212|P2|Overall Study|Other|7
191336|NCT01006603|606213|P1|Overall Study|Other|3
191337|NCT01006603|606212|P2|Overall Study|Study specific discontinuation criteria|34
191338|NCT01006603|606213|P1|Overall Study|Study specific discontinuation criteria|33
191339|NCT01006603|606212|P2|Overall Study|Death|1
191340|NCT01006603|606213|P1|Overall Study|Death|1
191341|NCT01006603|606212|P2|Overall Study|Adverse Event|7
191342|NCT01006603|606213|P1|Overall Study|Adverse Event|15
191343|NCT01006603|606212|P2|Overall Study|Incorrect enrolment|2
191344|NCT01006603|606213|P1|Overall Study|Incorrect enrolment|0
191345|NCT01006603|606212|P2|Overall Study|Protocol Violation|3
191346|NCT01006603|606213|P1|Overall Study|Protocol Violation|1
191347|NCT01006603|606212|P2|Overall Study|Safety reason|1
191348|NCT01006603|606213|P1|Overall Study|Safety reason|1
191349|NCT01006603|606212|P2|Overall Study|Lost to Follow-up|1
191350|NCT01006603|606213|P1|Overall Study|Lost to Follow-up|0
191351|NCT01006603|606212|P2|Overall Study|Withdrawal by Subject|19
191352|NCT01006603|606213|P1|Overall Study|Withdrawal by Subject|17
191353|NCT01006616|606235|P4|Period 2 (18 Months)|Study Terminated|70
191354|NCT01006616|606236|P3|Period 2 (18 Months)|Study Terminated|44
191355|NCT01006616|606237|P2|Period 2 (18 Months)|Study Terminated|46
191356|NCT01006616|606238|P1|Period 2 (18 Months)|Study Terminated|63
191357|NCT01006616|606235|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
191358|NCT01006616|606236|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
191359|NCT01006616|606237|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
191360|NCT01006616|606238|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
191361|NCT01006616|606235|P4|Period 2 (18 Months)|Withdrawal by Subject|1
191362|NCT01006616|606236|P3|Period 2 (18 Months)|Withdrawal by Subject|0
191363|NCT01006616|606237|P2|Period 2 (18 Months)|Withdrawal by Subject|4
191364|NCT01006616|606238|P1|Period 2 (18 Months)|Withdrawal by Subject|1
191365|NCT01006616|606235|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
191366|NCT01006616|606236|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
191367|NCT01006616|606237|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
191368|NCT01006616|606238|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
191369|NCT01006616|606235|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
191370|NCT01006616|606236|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
191371|NCT01006616|606237|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
191372|NCT01006616|606238|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
191373|NCT01006616|606235|P4|Period 2 (18 Months)|Lost to Follow-up|0
191374|NCT01006616|606236|P3|Period 2 (18 Months)|Lost to Follow-up|0
191375|NCT01006616|606237|P2|Period 2 (18 Months)|Lost to Follow-up|0
191376|NCT01006616|606238|P1|Period 2 (18 Months)|Lost to Follow-up|2
191377|NCT01006616|606235|P4|Period 2 (18 Months)|Lack of Efficacy|2
191378|NCT01006616|606236|P3|Period 2 (18 Months)|Lack of Efficacy|1
191379|NCT01006616|606237|P2|Period 2 (18 Months)|Lack of Efficacy|0
191380|NCT01006616|606238|P1|Period 2 (18 Months)|Lack of Efficacy|0
191381|NCT01006616|606235|P4|Period 2 (18 Months)|Adverse Event|4
191382|NCT01006616|606236|P3|Period 2 (18 Months)|Adverse Event|6
191383|NCT01006616|606237|P2|Period 2 (18 Months)|Adverse Event|6
191384|NCT01006616|606238|P1|Period 2 (18 Months)|Adverse Event|6
191385|NCT01006616|606235|P4|Period 1 (6 Months)|Not Treated|1
191386|NCT01006616|606236|P3|Period 1 (6 Months)|Not Treated|1
191387|NCT01006616|606237|P2|Period 1 (6 Months)|Not Treated|0
191388|NCT01006616|606238|P1|Period 1 (6 Months)|Not Treated|0
191389|NCT01006616|606235|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
191390|NCT01006616|606236|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
191391|NCT01006616|606237|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
191472|NCT01007149|606482|P1|Overall Study|Administrative problems|0
191392|NCT01006616|606238|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
191393|NCT01006616|606235|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
191394|NCT01006616|606236|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
191395|NCT01006616|606237|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
191396|NCT01006616|606238|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
191397|NCT01006616|606235|P4|Period 1 (6 Months)|Withdrawal by Subject|0
191398|NCT01006616|606236|P3|Period 1 (6 Months)|Withdrawal by Subject|2
191399|NCT01006616|606237|P2|Period 1 (6 Months)|Withdrawal by Subject|2
191400|NCT01006616|606238|P1|Period 1 (6 Months)|Withdrawal by Subject|2
191401|NCT01006616|606235|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
191402|NCT01006616|606236|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
191403|NCT01006616|606237|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
191404|NCT01006616|606238|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
191405|NCT01006616|606235|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
191406|NCT01006616|606236|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
191407|NCT01006616|606237|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
191408|NCT01006616|606238|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
191409|NCT01006616|606235|P4|Period 1 (6 Months)|Lost to Follow-up|0
191410|NCT01006616|606236|P3|Period 1 (6 Months)|Lost to Follow-up|1
191411|NCT01006616|606237|P2|Period 1 (6 Months)|Lost to Follow-up|0
191412|NCT01006616|606238|P1|Period 1 (6 Months)|Lost to Follow-up|0
191413|NCT01006616|606235|P4|Period 1 (6 Months)|Lack of Efficacy|4
191414|NCT01006616|606236|P3|Period 1 (6 Months)|Lack of Efficacy|0
191415|NCT01006616|606237|P2|Period 1 (6 Months)|Lack of Efficacy|4
191416|NCT01006616|606238|P1|Period 1 (6 Months)|Lack of Efficacy|3
191417|NCT01006616|606235|P4|Period 1 (6 Months)|Adverse Event|9
191418|NCT01006616|606236|P3|Period 1 (6 Months)|Adverse Event|37
191419|NCT01006616|606237|P2|Period 1 (6 Months)|Adverse Event|31
191420|NCT01006616|606238|P1|Period 1 (6 Months)|Adverse Event|10
191421|NCT01006629|606372|P1|Overall Study|Parent unable to perform site visit|4
191422|NCT01006629|606372|P1|Overall Study|Parent refused to continue participation|1
191423|NCT01006629|606372|P1|Overall Study|Adverse Event|1
191424|NCT01006889|606392|P1|Overall Study|Withdrawal by Subject|3
191425|NCT01006980|606405|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
191426|NCT01006980|606406|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
191427|NCT01006980|606405|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
191428|NCT01006980|606406|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
191429|NCT01006980|606405|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
191430|NCT01006980|606406|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
191431|NCT01006980|606405|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
191432|NCT01006980|606406|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
191433|NCT01006980|606405|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
191434|NCT01006980|606406|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
191435|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
191436|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
191437|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
191438|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
191439|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
191440|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
191441|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
191442|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
191443|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Progression|218
191444|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Progression|257
191445|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Death|12
191446|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Death|13
191447|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Adverse Event|5
191448|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Adverse Event|25
191449|NCT01006980|606405|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
191450|NCT01006980|606406|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
191451|NCT01007123|606447|P4|Overall Study|Lost to Follow-up|0
191452|NCT01007123|606448|P3|Overall Study|Lost to Follow-up|0
191453|NCT01007123|606449|P2|Overall Study|Lost to Follow-up|1
191454|NCT01007123|606450|P1|Overall Study|Lost to Follow-up|0
191455|NCT01007123|606447|P4|Overall Study|Withdrawal by Subject|0
191456|NCT01007123|606448|P3|Overall Study|Withdrawal by Subject|1
191457|NCT01007123|606449|P2|Overall Study|Withdrawal by Subject|0
191458|NCT01007123|606450|P1|Overall Study|Withdrawal by Subject|1
191459|NCT01007123|606447|P4|Overall Study|Protocol Violation|1
191460|NCT01007123|606448|P3|Overall Study|Protocol Violation|2
191461|NCT01007123|606449|P2|Overall Study|Protocol Violation|1
191462|NCT01007123|606450|P1|Overall Study|Protocol Violation|1
191463|NCT01007123|606447|P4|Overall Study|Lack of Efficacy|4
191464|NCT01007123|606448|P3|Overall Study|Lack of Efficacy|1
191465|NCT01007123|606449|P2|Overall Study|Lack of Efficacy|0
191466|NCT01007123|606450|P1|Overall Study|Lack of Efficacy|1
191467|NCT01007123|606447|P4|Overall Study|Adverse Event|1
191468|NCT01007123|606448|P3|Overall Study|Adverse Event|7
191469|NCT01007123|606449|P2|Overall Study|Adverse Event|4
191470|NCT01007123|606450|P1|Overall Study|Adverse Event|3
191471|NCT01007149|606481|P2|Overall Study|Administrative problems|1
191473|NCT01000311|606528|P2|Overall Study|Administrative reason|15
191474|NCT01000311|606529|P1|Overall Study|Administrative reason|9
191475|NCT01000311|606528|P2|Overall Study|Inappropriate enrollment|0
191476|NCT01000311|606529|P1|Overall Study|Inappropriate enrollment|2
191477|NCT01000311|606528|P2|Overall Study|Protocol Violation|2
191478|NCT01000311|606529|P1|Overall Study|Protocol Violation|1
191479|NCT01000311|606528|P2|Overall Study|Lost to Follow-up|24
191480|NCT01000311|606529|P1|Overall Study|Lost to Follow-up|15
191481|NCT01000311|606528|P2|Overall Study|Withdrawal by Subject|24
191482|NCT01000311|606529|P1|Overall Study|Withdrawal by Subject|16
191483|NCT01000311|606528|P2|Overall Study|Adverse Event|5
191484|NCT01000311|606529|P1|Overall Study|Adverse Event|2
191485|NCT01000337|606569|P2|Overall Study|Lost to Follow-up|3
191486|NCT01000337|606570|P1|Overall Study|Lost to Follow-up|4
191487|NCT01000376|606578|P2|Cycle 1 Day 1|Progressive Disease|0
191488|NCT01000376|606579|P1|Cycle 1 Day 1|Progressive Disease|1
191489|NCT01000376|606578|P2|Cycle 1 Day 1|Adverse Event|0
191490|NCT01000376|606579|P1|Cycle 1 Day 1|Adverse Event|1
191491|NCT01000480|606587|P1|Concurrent Therapy Phase|Physician Decision|1
191492|NCT01000480|606587|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
191493|NCT01000480|606587|P1|Concurrent Therapy Phase|Protocol Violation|2
191494|NCT01000480|606587|P1|Concurrent Therapy Phase|Adverse Event|4
191495|NCT01000480|606587|P1|Induction Phase|Entry Criteria Not Met|3
191496|NCT01000480|606587|P1|Induction Phase|Physician Decision|1
191497|NCT01000480|606587|P1|Induction Phase|Lost to Follow-up|1
191498|NCT01000480|606587|P1|Induction Phase|Adverse Event|2
191499|NCT01000506|606597|P4|Overall Study|Withdrawal by Subject|7
191500|NCT01000506|606598|P3|Overall Study|Withdrawal by Subject|2
191501|NCT01000506|606599|P2|Overall Study|Withdrawal by Subject|8
191502|NCT01000506|606600|P1|Overall Study|Withdrawal by Subject|11
191503|NCT01000506|606597|P4|Overall Study|Physician Decision|3
191504|NCT01000506|606598|P3|Overall Study|Physician Decision|3
191505|NCT01000506|606599|P2|Overall Study|Physician Decision|3
191506|NCT01000506|606600|P1|Overall Study|Physician Decision|1
191507|NCT01000506|606597|P4|Overall Study|Lost to Follow-up|0
191508|NCT01000506|606598|P3|Overall Study|Lost to Follow-up|4
191509|NCT01000506|606599|P2|Overall Study|Lost to Follow-up|1
191510|NCT01000506|606600|P1|Overall Study|Lost to Follow-up|1
191511|NCT01000506|606597|P4|Overall Study|Protocol Violation|0
191512|NCT01000506|606598|P3|Overall Study|Protocol Violation|0
191513|NCT01000506|606599|P2|Overall Study|Protocol Violation|1
191514|NCT01000506|606600|P1|Overall Study|Protocol Violation|1
191515|NCT01000506|606597|P4|Overall Study|Lack of Efficacy|4
191516|NCT01000506|606598|P3|Overall Study|Lack of Efficacy|4
191517|NCT01000506|606599|P2|Overall Study|Lack of Efficacy|6
191518|NCT01000506|606600|P1|Overall Study|Lack of Efficacy|8
191519|NCT01000506|606597|P4|Overall Study|Adverse Event|9
191520|NCT01000506|606598|P3|Overall Study|Adverse Event|8
191521|NCT01000506|606599|P2|Overall Study|Adverse Event|5
191522|NCT01000506|606600|P1|Overall Study|Adverse Event|6
191523|NCT01000610|606642|P1|Overall Study|Treatment failure|1
191524|NCT01000610|606642|P1|Overall Study|Lost to Follow-up|4
191525|NCT01000610|606642|P1|Overall Study|Adverse Event|1
191526|NCT01000649|606653|P4|Overall Study|Lost to Follow-up|2
191527|NCT01000649|606654|P3|Overall Study|Lost to Follow-up|0
191528|NCT01000649|606655|P2|Overall Study|Lost to Follow-up|2
191529|NCT01000649|606656|P1|Overall Study|Lost to Follow-up|0
191530|NCT01000649|606653|P4|Overall Study|Adverse Event|4
191531|NCT01000649|606654|P3|Overall Study|Adverse Event|2
191532|NCT01000649|606655|P2|Overall Study|Adverse Event|1
191533|NCT01000649|606656|P1|Overall Study|Adverse Event|5
191534|NCT01000727|606748|P2|Overall Study|Study closed/terminated|24
191535|NCT01000727|606749|P1|Overall Study|Study closed/terminated|23
191536|NCT01000727|606748|P2|Overall Study|Withdrawal by Subject|109
191537|NCT01000727|606749|P1|Overall Study|Withdrawal by Subject|111
191538|NCT01000727|606748|P2|Overall Study|Lost to Follow-up|43
191539|NCT01000727|606749|P1|Overall Study|Lost to Follow-up|41
191540|NCT01000805|606779|P2|Overall Study|Sponsor Decision|1
191541|NCT01000805|606780|P1|Overall Study|Sponsor Decision|0
191542|NCT01000805|606779|P2|Overall Study|Withdrawal by Subject|6
191543|NCT01000805|606780|P1|Overall Study|Withdrawal by Subject|16
191544|NCT01000805|606779|P2|Overall Study|Protocol Violation|8
191545|NCT01000805|606780|P1|Overall Study|Protocol Violation|12
191546|NCT01000805|606779|P2|Overall Study|Physician Decision|1
191547|NCT01000805|606780|P1|Overall Study|Physician Decision|0
191548|NCT01000805|606779|P2|Overall Study|Lost to Follow-up|21
191549|NCT01000805|606780|P1|Overall Study|Lost to Follow-up|16
191550|NCT01000805|606779|P2|Overall Study|Lack of Efficacy|16
191551|NCT01000805|606780|P1|Overall Study|Lack of Efficacy|5
191552|NCT01000805|606779|P2|Overall Study|Adverse Event|9
191553|NCT01000805|606780|P1|Overall Study|Adverse Event|21
191554|NCT01000961|606821|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
191555|NCT01000961|606822|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
191556|NCT01000961|606821|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
191557|NCT01000961|606822|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
191558|NCT01000974|606837|P3|Booster Vaccination Phase|Unspecified|4
191559|NCT01000974|606838|P2|Booster Vaccination Phase|Unspecified|6
191560|NCT01000974|606839|P1|Booster Vaccination Phase|Unspecified|24
191561|NCT01000974|606837|P3|Booster Vaccination Phase|Lost to Follow-up|7
191562|NCT01000974|606838|P2|Booster Vaccination Phase|Lost to Follow-up|5
191563|NCT01000974|606839|P1|Booster Vaccination Phase|Lost to Follow-up|40
191564|NCT01000974|606837|P3|Booster Vaccination Phase|Withdrawal by Subject|1
191565|NCT01000974|606838|P2|Booster Vaccination Phase|Withdrawal by Subject|1
191566|NCT01000974|606839|P1|Booster Vaccination Phase|Withdrawal by Subject|3
191567|NCT01000974|606837|P3|Booster Vaccination Phase|Protocol Violation|2
191568|NCT01000974|606838|P2|Booster Vaccination Phase|Protocol Violation|0
191569|NCT01000974|606839|P1|Booster Vaccination Phase|Protocol Violation|0
191570|NCT01000974|606837|P3|Primary Vaccination Phase|Unspecified|12
191571|NCT01000974|606838|P2|Primary Vaccination Phase|Unspecified|9
191572|NCT01000974|606839|P1|Primary Vaccination Phase|Unspecified|4
191573|NCT01000974|606837|P3|Primary Vaccination Phase|Adverse Event|2
191574|NCT01000974|606838|P2|Primary Vaccination Phase|Adverse Event|2
191575|NCT01000974|606839|P1|Primary Vaccination Phase|Adverse Event|14
191576|NCT01000974|606837|P3|Primary Vaccination Phase|Protocol Violation|2
191577|NCT01000974|606838|P2|Primary Vaccination Phase|Protocol Violation|3
191578|NCT01000974|606839|P1|Primary Vaccination Phase|Protocol Violation|40
191579|NCT01000974|606837|P3|Primary Vaccination Phase|Lost to Follow-up|26
191580|NCT01000974|606838|P2|Primary Vaccination Phase|Lost to Follow-up|19
191581|NCT01000974|606839|P1|Primary Vaccination Phase|Lost to Follow-up|171
191582|NCT01000974|606837|P3|Primary Vaccination Phase|Withdrawal by Subject|21
191583|NCT01000974|606838|P2|Primary Vaccination Phase|Withdrawal by Subject|17
191584|NCT01000974|606839|P1|Primary Vaccination Phase|Withdrawal by Subject|109
191585|NCT01001104|606950|P4|Overall Study|Withdrawal by Subject|2
191586|NCT01001104|606951|P3|Overall Study|Withdrawal by Subject|0
191587|NCT01001104|606952|P2|Overall Study|Withdrawal by Subject|0
191588|NCT01001104|606953|P1|Overall Study|Withdrawal by Subject|0
191589|NCT01001104|606950|P4|Overall Study|Entry Criteria Not Met|1
191590|NCT01001104|606951|P3|Overall Study|Entry Criteria Not Met|0
191591|NCT01001104|606952|P2|Overall Study|Entry Criteria Not Met|0
191592|NCT01001104|606953|P1|Overall Study|Entry Criteria Not Met|0
191593|NCT01001104|606950|P4|Overall Study|Lost to Follow-up|0
191594|NCT01001104|606951|P3|Overall Study|Lost to Follow-up|1
191595|NCT01001104|606952|P2|Overall Study|Lost to Follow-up|0
191596|NCT01001104|606953|P1|Overall Study|Lost to Follow-up|0
191597|NCT01001104|606950|P4|Overall Study|Adverse Event|0
191598|NCT01001104|606951|P3|Overall Study|Adverse Event|0
191599|NCT01001104|606952|P2|Overall Study|Adverse Event|1
191600|NCT01001104|606953|P1|Overall Study|Adverse Event|2
191601|NCT01001169|607000|P2|Overall Study|Withdrawal by Subject|1
191602|NCT01001169|607001|P1|Overall Study|Withdrawal by Subject|2
191603|NCT01001208|607124|P2|Overall Study|Other|2
191604|NCT01001208|607125|P1|Overall Study|Other|0
191605|NCT01001208|607124|P2|Overall Study|Disease Progression|3
191606|NCT01001208|607125|P1|Overall Study|Disease Progression|0
191607|NCT01001208|607124|P2|Overall Study|Noncompliance|7
191608|NCT01001208|607125|P1|Overall Study|Noncompliance|4
191609|NCT01001208|607124|P2|Overall Study|Ineligibility Determined|2
191610|NCT01001208|607125|P1|Overall Study|Ineligibility Determined|4
191611|NCT01001208|607124|P2|Overall Study|Withdrawal by Subject|5
191612|NCT01001208|607125|P1|Overall Study|Withdrawal by Subject|4
191613|NCT01001208|607124|P2|Overall Study|Physician Decision|0
191614|NCT01001208|607125|P1|Overall Study|Physician Decision|1
191615|NCT01001208|607124|P2|Overall Study|Lost to Follow-up|9
191616|NCT01001208|607125|P1|Overall Study|Lost to Follow-up|5
191617|NCT01001208|607124|P2|Overall Study|Adverse Event|5
191618|NCT01001208|607125|P1|Overall Study|Adverse Event|10
191619|NCT01001221|607153|P5|Overall Study|Not treated; protocol exclusion|0
191620|NCT01001221|607154|P4|Overall Study|Not treated; protocol exclusion|0
191621|NCT01001221|607155|P3|Overall Study|Not treated; protocol exclusion|1
191622|NCT01001221|607156|P2|Overall Study|Not treated; protocol exclusion|0
191623|NCT01001221|607157|P1|Overall Study|Not treated; protocol exclusion|0
191624|NCT01001221|607153|P5|Overall Study|Not specified|0
191625|NCT01001221|607154|P4|Overall Study|Not specified|0
191626|NCT01001221|607155|P3|Overall Study|Not specified|0
191627|NCT01001221|607156|P2|Overall Study|Not specified|1
191628|NCT01001221|607157|P1|Overall Study|Not specified|1
191629|NCT01001221|607153|P5|Overall Study|Disease progression|0
191630|NCT01001221|607154|P4|Overall Study|Disease progression|4
191631|NCT01001221|607155|P3|Overall Study|Disease progression|2
191632|NCT01001221|607156|P2|Overall Study|Disease progression|2
191633|NCT01001221|607157|P1|Overall Study|Disease progression|3
191634|NCT01001221|607153|P5|Overall Study|Adverse Event|0
191635|NCT01001221|607154|P4|Overall Study|Adverse Event|2
191636|NCT01001221|607155|P3|Overall Study|Adverse Event|0
191637|NCT01001221|607156|P2|Overall Study|Adverse Event|2
191638|NCT01001221|607157|P1|Overall Study|Adverse Event|1
191639|NCT01001234|607335|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
191640|NCT01001234|607336|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
191641|NCT01001234|607337|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
191642|NCT01001234|607338|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
191643|NCT01001234|607339|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
191644|NCT01001234|607335|P5|Overall Study|Not Treated: Physician Decision|0
191645|NCT01001234|607336|P4|Overall Study|Not Treated: Physician Decision|0
191646|NCT01001234|607337|P3|Overall Study|Not Treated: Physician Decision|0
191647|NCT01001234|607338|P2|Overall Study|Not Treated: Physician Decision|4
191648|NCT01001234|607339|P1|Overall Study|Not Treated: Physician Decision|37
191649|NCT01001234|607335|P5|Overall Study|Not Treated: Pregnancy|0
191650|NCT01001234|607336|P4|Overall Study|Not Treated: Pregnancy|0
191651|NCT01001234|607337|P3|Overall Study|Not Treated: Pregnancy|0
191652|NCT01001234|607338|P2|Overall Study|Not Treated: Pregnancy|0
191653|NCT01001234|607339|P1|Overall Study|Not Treated: Pregnancy|3
191654|NCT01001234|607335|P5|Overall Study|Not Treated: Lost to Follow-up|0
191655|NCT01001234|607336|P4|Overall Study|Not Treated: Lost to Follow-up|5
191656|NCT01001234|607337|P3|Overall Study|Not Treated: Lost to Follow-up|7
191657|NCT01001234|607338|P2|Overall Study|Not Treated: Lost to Follow-up|4
191658|NCT01001234|607339|P1|Overall Study|Not Treated: Lost to Follow-up|53
191659|NCT01001234|607335|P5|Overall Study|Not Treated: Protocol Violation|0
191660|NCT01001234|607336|P4|Overall Study|Not Treated: Protocol Violation|0
191661|NCT01001234|607337|P3|Overall Study|Not Treated: Protocol Violation|0
191662|NCT01001234|607338|P2|Overall Study|Not Treated: Protocol Violation|0
191663|NCT01001234|607339|P1|Overall Study|Not Treated: Protocol Violation|3
191664|NCT01001234|607335|P5|Overall Study|Not Treated: Withdrawal by Subject|0
191665|NCT01001234|607336|P4|Overall Study|Not Treated: Withdrawal by Subject|0
191666|NCT01001234|607337|P3|Overall Study|Not Treated: Withdrawal by Subject|2
191667|NCT01001234|607338|P2|Overall Study|Not Treated: Withdrawal by Subject|2
191668|NCT01001234|607339|P1|Overall Study|Not Treated: Withdrawal by Subject|23
191669|NCT01001234|607335|P5|Overall Study|Not Treated: Adverse Event|0
191670|NCT01001234|607336|P4|Overall Study|Not Treated: Adverse Event|0
191671|NCT01001234|607337|P3|Overall Study|Not Treated: Adverse Event|0
191672|NCT01001234|607338|P2|Overall Study|Not Treated: Adverse Event|0
191673|NCT01001234|607339|P1|Overall Study|Not Treated: Adverse Event|1
191674|NCT01001234|607335|P5|Overall Study|Physician Decision|0
191675|NCT01001234|607336|P4|Overall Study|Physician Decision|0
191676|NCT01001234|607337|P3|Overall Study|Physician Decision|0
191677|NCT01001234|607338|P2|Overall Study|Physician Decision|0
191678|NCT01001234|607339|P1|Overall Study|Physician Decision|1
191679|NCT01001234|607335|P5|Overall Study|Lost to Follow-up|0
191680|NCT01001234|607336|P4|Overall Study|Lost to Follow-up|2
191681|NCT01001234|607337|P3|Overall Study|Lost to Follow-up|1
191682|NCT01001234|607338|P2|Overall Study|Lost to Follow-up|0
191683|NCT01001234|607339|P1|Overall Study|Lost to Follow-up|0
191684|NCT01001234|607335|P5|Overall Study|Protocol Violation|0
191685|NCT01001234|607336|P4|Overall Study|Protocol Violation|18
191686|NCT01001234|607337|P3|Overall Study|Protocol Violation|19
191687|NCT01001234|607338|P2|Overall Study|Protocol Violation|3
191688|NCT01001234|607339|P1|Overall Study|Protocol Violation|34
191689|NCT01001234|607335|P5|Overall Study|Withdrawal by Subject|0
191690|NCT01001234|607336|P4|Overall Study|Withdrawal by Subject|0
191691|NCT01001234|607337|P3|Overall Study|Withdrawal by Subject|3
191692|NCT01001234|607338|P2|Overall Study|Withdrawal by Subject|0
191693|NCT01001234|607339|P1|Overall Study|Withdrawal by Subject|2
191694|NCT01001299|607351|P1|Overall Study|Withdrew Consent|1
191695|NCT01001299|607351|P1|Overall Study|Began Taking Commercially Available Drug|2
191696|NCT01001299|607351|P1|Overall Study|Death|1
191697|NCT01001299|607351|P1|Overall Study|Adverse event or Intercurrent Illness|1
191698|NCT01001299|607351|P1|Overall Study|Insufficient Therapeutic Response|20
191699|NCT01001325|607377|P2|Overall Study|Protocol Violation|0
191700|NCT01001325|607378|P1|Overall Study|Protocol Violation|2
191701|NCT01001325|607377|P2|Overall Study|Lost to Follow-up|10
191702|NCT01001325|607378|P1|Overall Study|Lost to Follow-up|16
191703|NCT01001377|607386|P2|Overall Study|Death|384
191704|NCT01001377|607387|P1|Overall Study|Death|391
191705|NCT01001377|607386|P2|Overall Study|Lost to Follow-up|17
191706|NCT01001377|607387|P1|Overall Study|Lost to Follow-up|14
191707|NCT01001377|607386|P2|Overall Study|Withdrawal by Subject|20
191708|NCT01001377|607387|P1|Overall Study|Withdrawal by Subject|19
191709|NCT01001377|607386|P2|Overall Study|Ineligibility determined|0
191710|NCT01001377|607387|P1|Overall Study|Ineligibility determined|2
191711|NCT01001390|607415|P2|Overall Study|Failure to wear AFO device|0
191712|NCT01001390|607416|P1|Overall Study|Failure to wear AFO device|2
191713|NCT01001429|607433|P2|Overall Study|surgery cancelled|1
191714|NCT01001429|607434|P1|Overall Study|surgery cancelled|0
191715|NCT01001494|607467|P3|Overall Study|Other|3
191716|NCT01001494|607468|P2|Overall Study|Other|1
191717|NCT01001494|607469|P1|Overall Study|Other|0
191718|NCT01001494|607467|P3|Overall Study|Lack of Efficacy|8
191719|NCT01001494|607468|P2|Overall Study|Lack of Efficacy|0
191720|NCT01001494|607469|P1|Overall Study|Lack of Efficacy|2
191721|NCT01001494|607467|P3|Overall Study|COPD exacerbation|5
191722|NCT01001494|607468|P2|Overall Study|COPD exacerbation|4
191723|NCT01001494|607469|P1|Overall Study|COPD exacerbation|3
191724|NCT01001494|607467|P3|Overall Study|Withdrawal by Subject|17
191725|NCT01001494|607468|P2|Overall Study|Withdrawal by Subject|7
191726|NCT01001494|607469|P1|Overall Study|Withdrawal by Subject|9
191727|NCT01001494|607467|P3|Overall Study|Lost to Follow-up|1
191728|NCT01001494|607468|P2|Overall Study|Lost to Follow-up|0
191729|NCT01001494|607469|P1|Overall Study|Lost to Follow-up|2
191730|NCT01001494|607467|P3|Overall Study|Protocol Violation|1
191731|NCT01001494|607468|P2|Overall Study|Protocol Violation|1
191732|NCT01001494|607469|P1|Overall Study|Protocol Violation|0
191733|NCT01001494|607467|P3|Overall Study|Adverse Event|6
191734|NCT01001494|607468|P2|Overall Study|Adverse Event|4
191735|NCT01001494|607469|P1|Overall Study|Adverse Event|8
191736|NCT01001520|607489|P2|Medication Period 2|Withdrawal by Subject|3
191737|NCT01001520|607490|P1|Medication Period 2|Withdrawal by Subject|0
191738|NCT01001520|607489|P2|Washout Period|Withdrawal by Subject|1
191739|NCT01001520|607490|P1|Washout Period|Withdrawal by Subject|2
191740|NCT01001520|607489|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
191741|NCT01001520|607490|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
191742|NCT01001520|607489|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
191743|NCT01001520|607490|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
191744|NCT01001520|607489|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
191745|NCT01001520|607490|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
191746|NCT01001520|607489|P2|Medication Period 1|Withdrawal by Subject|2
191747|NCT01001520|607490|P1|Medication Period 1|Withdrawal by Subject|2
191748|NCT01001572|607540|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
191749|NCT01001572|607541|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
191750|NCT01001572|607542|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
191751|NCT01001572|607540|P3|Double-Blind Treatment Phase|Protocol deviation|1
191752|NCT01001572|607541|P2|Double-Blind Treatment Phase|Protocol deviation|0
191753|NCT01001572|607542|P1|Double-Blind Treatment Phase|Protocol deviation|0
191754|NCT01001572|607540|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
191755|NCT01001572|607541|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
191756|NCT01001572|607542|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
191757|NCT01001572|607540|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
191758|NCT01001572|607541|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
191759|NCT01001572|607542|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
191760|NCT01001572|607540|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
191761|NCT01001572|607541|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
191762|NCT01001572|607542|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
191763|NCT01001572|607540|P3|Double-Blind Treatment Phase|Adverse Event|2
191764|NCT01001572|607541|P2|Double-Blind Treatment Phase|Adverse Event|2
191765|NCT01001572|607542|P1|Double-Blind Treatment Phase|Adverse Event|0
191766|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
191767|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
191768|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
191769|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
191770|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
191771|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
191772|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
191773|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
191774|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
191775|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
191776|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
191777|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
191778|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
191779|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
191780|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
191781|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
191782|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
191783|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
191784|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
191785|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
191786|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
191787|NCT01001572|607540|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
191788|NCT01001572|607541|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
191789|NCT01001572|607542|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
191790|NCT01001702|607556|P1|Overall Study|Lack of Efficacy per Investigator|3
191791|NCT01001702|607556|P1|Overall Study|Withdrawal by Subject|19
191792|NCT01001702|607556|P1|Overall Study|Investigator withdrew Subject|10
191793|NCT01001702|607556|P1|Overall Study|Subject met Withdrawal Criteria|22
191794|NCT01001702|607556|P1|Overall Study|Sponsor Discontinued Study|4
191795|NCT01001702|607556|P1|Overall Study|Adverse Event|7
191796|NCT01001702|607556|P1|Overall Study|Lost to Follow-up|7
191797|NCT01001767|607569|P2|Overall Study|Physician Decision|0
191798|NCT01001767|607570|P1|Overall Study|Physician Decision|1
191799|NCT01001767|607569|P2|Overall Study|Lost to Follow-up|0
191800|NCT01001767|607570|P1|Overall Study|Lost to Follow-up|1
191801|NCT01001767|607569|P2|Overall Study|Protocol Violation|0
191802|NCT01001767|607570|P1|Overall Study|Protocol Violation|1
191803|NCT01001767|607569|P2|Overall Study|no baseline study performed|0
191804|NCT01001767|607570|P1|Overall Study|no baseline study performed|1
191805|NCT01007253|607576|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
191806|NCT01007253|607577|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
191807|NCT01007253|607578|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
191808|NCT01007253|607579|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
191809|NCT01007396|607609|P1|Overall Study|Lost to Follow-up|47
191810|NCT01007435|607618|P4|Overall Study|Reason not Specified|1
191811|NCT01007435|607619|P3|Overall Study|Reason not Specified|2
191812|NCT01007435|607620|P2|Overall Study|Reason not Specified|1
191813|NCT01007435|607621|P1|Overall Study|Reason not Specified|1
191814|NCT01007435|607618|P4|Overall Study|Failure to Return|6
191815|NCT01007435|607619|P3|Overall Study|Failure to Return|3
191816|NCT01007435|607620|P2|Overall Study|Failure to Return|4
191817|NCT01007435|607621|P1|Overall Study|Failure to Return|5
191818|NCT01007435|607618|P4|Overall Study|Refused Treatment|8
191819|NCT01007435|607619|P3|Overall Study|Refused Treatment|5
191820|NCT01007435|607620|P2|Overall Study|Refused Treatment|13
191821|NCT01007435|607621|P1|Overall Study|Refused Treatment|13
191822|NCT01007435|607618|P4|Overall Study|Other Protocol Violation|0
191823|NCT01007435|607619|P3|Overall Study|Other Protocol Violation|1
191824|NCT01007435|607620|P2|Overall Study|Other Protocol Violation|0
191825|NCT01007435|607621|P1|Overall Study|Other Protocol Violation|2
191826|NCT01007435|607618|P4|Overall Study|Violation of Selection Criteria at Entry|0
191827|NCT01007435|607619|P3|Overall Study|Violation of Selection Criteria at Entry|2
191828|NCT01007435|607620|P2|Overall Study|Violation of Selection Criteria at Entry|5
191829|NCT01007435|607621|P1|Overall Study|Violation of Selection Criteria at Entry|3
191830|NCT01007435|607618|P4|Overall Study|Insufficient Therapeutic Response|9
191831|NCT01007435|607619|P3|Overall Study|Insufficient Therapeutic Response|2
191832|NCT01007435|607620|P2|Overall Study|Insufficient Therapeutic Response|7
191833|NCT01007435|607621|P1|Overall Study|Insufficient Therapeutic Response|21
191834|NCT01007435|607618|P4|Overall Study|Death|1
191835|NCT01007435|607619|P3|Overall Study|Death|2
191836|NCT01007435|607620|P2|Overall Study|Death|4
191837|NCT01007435|607621|P1|Overall Study|Death|2
191838|NCT01007435|607618|P4|Overall Study|Adverse Event|31
191839|NCT01007435|607619|P3|Overall Study|Adverse Event|47
191840|NCT01007435|607620|P2|Overall Study|Adverse Event|25
191841|NCT01007435|607621|P1|Overall Study|Adverse Event|16
191842|NCT01013597|607663|P1|Overall Study|Withdrawal by Subject|1
191843|NCT01013740|607675|P2|Overall Study|Ongoing: Study records not completed|2
191844|NCT01013740|607676|P1|Overall Study|Ongoing: Study records not completed|0
191845|NCT01013740|607675|P2|Overall Study|Missing|1
191846|NCT01013740|607676|P1|Overall Study|Missing|2
191847|NCT01013740|607675|P2|Overall Study|study close / terminated : done in error|1
191848|NCT01013740|607676|P1|Overall Study|study close / terminated : done in error|2
191849|NCT01013740|607675|P2|Overall Study|Withdrawal by Subject|10
191850|NCT01013740|607676|P1|Overall Study|Withdrawal by Subject|2
191851|NCT01013740|607675|P2|Overall Study|Physician Decision|0
191852|NCT01013740|607676|P1|Overall Study|Physician Decision|2
191853|NCT01013740|607675|P2|Overall Study|Lost to Follow-up|5
191854|NCT01013740|607676|P1|Overall Study|Lost to Follow-up|3
191855|NCT01013753|607700|P1|Overall Study|Other|2
191856|NCT01013753|607700|P1|Overall Study|Withdrawal by Subject|2
191857|NCT01013753|607700|P1|Overall Study|Lost to Follow-up|1
191858|NCT01013753|607700|P1|Overall Study|Protocol Violation|3
191859|NCT01013753|607700|P1|Overall Study|Adverse Event|8
191860|NCT01013792|607896|P2|Overall Study|Lost to Follow-up|1
191861|NCT01013792|607897|P1|Overall Study|Lost to Follow-up|0
191862|NCT01013792|607896|P2|Overall Study|Adverse Event|3
191863|NCT01013792|607897|P1|Overall Study|Adverse Event|0
191864|NCT01013792|607896|P2|Overall Study|Study suspended|1
191865|NCT01013792|607897|P1|Overall Study|Study suspended|2
191866|NCT01013870|607930|P2|Overall Study|Lost to Follow-up|3
191867|NCT01013870|607931|P1|Overall Study|Lost to Follow-up|1
191868|NCT01013883|607955|P2|Overall Study|Lost to Follow-up|2
191869|NCT01013883|607956|P1|Overall Study|Lost to Follow-up|2
191870|NCT01013961|607968|P2|Overall Study|Physician Decision|1
191871|NCT01013961|607969|P1|Overall Study|Physician Decision|0
191872|NCT01013961|607968|P2|Overall Study|Withdrawal by Subject|0
191873|NCT01013961|607969|P1|Overall Study|Withdrawal by Subject|1
191874|NCT01013961|607968|P2|Overall Study|Adverse Event|2
191875|NCT01013961|607969|P1|Overall Study|Adverse Event|2
191876|NCT01014013|607987|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
191877|NCT01014013|607988|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
191878|NCT01014013|607987|P2|Overall Study|Appendectomy|0
191879|NCT01014013|607988|P1|Overall Study|Appendectomy|1
191880|NCT01014013|607987|P2|Overall Study|Another antibiotic therapy required|1
191881|NCT01014013|607988|P1|Overall Study|Another antibiotic therapy required|0
191882|NCT01014013|607987|P2|Overall Study|Physician Decision|1
191883|NCT01014013|607988|P1|Overall Study|Physician Decision|0
191884|NCT01014013|607987|P2|Overall Study|Pathogen resistant|4
191885|NCT01014013|607988|P1|Overall Study|Pathogen resistant|7
191886|NCT01014013|607987|P2|Overall Study|Negative urine culture|0
191887|NCT01014013|607988|P1|Overall Study|Negative urine culture|2
191888|NCT01014013|607987|P2|Overall Study|Pathogen culture = no growth|34
191889|NCT01014013|607988|P1|Overall Study|Pathogen culture = no growth|26
191890|NCT01014013|607987|P2|Overall Study|Clinical/microbiologic failure|2
191891|NCT01014013|607988|P1|Overall Study|Clinical/microbiologic failure|1
191892|NCT01014013|607987|P2|Overall Study|Withdrawal by Subject|4
191893|NCT01014013|607988|P1|Overall Study|Withdrawal by Subject|7
191894|NCT01014013|607987|P2|Overall Study|Protocol Violation|3
191895|NCT01014013|607988|P1|Overall Study|Protocol Violation|1
191896|NCT01014013|607987|P2|Overall Study|Laboratory adverse experience|1
191897|NCT01014013|607988|P1|Overall Study|Laboratory adverse experience|1
191898|NCT01014013|607987|P2|Overall Study|Clinical adverse experience|2
191899|NCT01014013|607988|P1|Overall Study|Clinical adverse experience|4
191900|NCT01014013|607987|P2|Overall Study|Inclusion/Exclusion criteria not met|3
191901|NCT01014013|607988|P1|Overall Study|Inclusion/Exclusion criteria not met|1
191902|NCT01014143|608086|P3|Second Intervention|Lost to Follow-up|0
191903|NCT01014143|608087|P2|Second Intervention|Lost to Follow-up|0
191904|NCT01014143|608088|P1|Second Intervention|Lost to Follow-up|2
191905|NCT01014208|608111|P2|Overall Study|Study Closed/terminated|83
191906|NCT01014208|608112|P1|Overall Study|Study Closed/terminated|78
191907|NCT01014208|608111|P2|Overall Study|Did Not Receive Study Drug|0
191908|NCT01014208|608112|P1|Overall Study|Did Not Receive Study Drug|2
191909|NCT01014208|608111|P2|Overall Study|Participant Withdrew Consent|12
191910|NCT01014208|608112|P1|Overall Study|Participant Withdrew Consent|12
191911|NCT01014208|608111|P2|Overall Study|Lost to Follow-up|5
191912|NCT01014208|608112|P1|Overall Study|Lost to Follow-up|2
191913|NCT01014442|608146|P2|Overall Study|Unspecified Reason|1
191914|NCT01014442|608147|P1|Overall Study|Unspecified Reason|1
191915|NCT01014442|608146|P2|Overall Study|Lack of Compliance|1
191916|NCT01014442|608147|P1|Overall Study|Lack of Compliance|0
191917|NCT01014442|608146|P2|Overall Study|Protocol Violation|5
191918|NCT01014442|608147|P1|Overall Study|Protocol Violation|2
191919|NCT01014442|608146|P2|Overall Study|Withdrawal by Subject|4
191920|NCT01014442|608147|P1|Overall Study|Withdrawal by Subject|4
191921|NCT01014442|608146|P2|Overall Study|Adverse Event|8
191922|NCT01014442|608147|P1|Overall Study|Adverse Event|0
191923|NCT01014585|608272|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
191924|NCT01014585|608273|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
191925|NCT01014585|608274|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
191926|NCT01014585|608275|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
191927|NCT01014585|608272|P4|Overall Study|Lost to Follow-up|2
191928|NCT01014585|608273|P3|Overall Study|Lost to Follow-up|0
191929|NCT01014585|608274|P2|Overall Study|Lost to Follow-up|0
191930|NCT01014585|608275|P1|Overall Study|Lost to Follow-up|0
191931|NCT01014585|608272|P4|Overall Study|Withdrawal by Subject|3
191932|NCT01014585|608273|P3|Overall Study|Withdrawal by Subject|1
191933|NCT01014585|608274|P2|Overall Study|Withdrawal by Subject|0
191934|NCT01014585|608275|P1|Overall Study|Withdrawal by Subject|2
191935|NCT01014585|608272|P4|Overall Study|Adverse Event|3
191936|NCT01014585|608273|P3|Overall Study|Adverse Event|0
191937|NCT01014585|608274|P2|Overall Study|Adverse Event|2
191938|NCT01014585|608275|P1|Overall Study|Adverse Event|0
191939|NCT01014689|608318|P2|Overall Study|Pregnancy|0
191940|NCT01014689|608319|P1|Overall Study|Pregnancy|1
191941|NCT01014689|608318|P2|Overall Study|Lost to Follow-up|7
191942|NCT01014689|608319|P1|Overall Study|Lost to Follow-up|3
191943|NCT01014689|608318|P2|Overall Study|Protocol Violation|1
191944|NCT01014689|608319|P1|Overall Study|Protocol Violation|1
191945|NCT01014689|608318|P2|Overall Study|Withdrawal by Subject|4
191946|NCT01014689|608319|P1|Overall Study|Withdrawal by Subject|5
191947|NCT01014689|608318|P2|Overall Study|Adverse Event|0
191948|NCT01014689|608319|P1|Overall Study|Adverse Event|3
191949|NCT01014689|608318|P2|Overall Study|Lack of Efficacy|1
191950|NCT01014689|608319|P1|Overall Study|Lack of Efficacy|0
191951|NCT01014910|608363|P2|Overall Study|Withdrawal by Subject|2
191952|NCT01014910|608364|P1|Overall Study|Withdrawal by Subject|0
191953|NCT01014975|608867|P3|Overall Study|Lost to Follow-up|1
191954|NCT01014975|608868|P2|Overall Study|Lost to Follow-up|0
191955|NCT01014975|608869|P1|Overall Study|Lost to Follow-up|0
191956|NCT01014975|608867|P3|Overall Study|Death|4
191957|NCT01014975|608868|P2|Overall Study|Death|3
191958|NCT01014975|608869|P1|Overall Study|Death|3
191959|NCT01014975|608867|P3|Overall Study|Withdrawal by Subject|1
191960|NCT01014975|608868|P2|Overall Study|Withdrawal by Subject|0
191961|NCT01014975|608869|P1|Overall Study|Withdrawal by Subject|1
191962|NCT01014988|608883|P6|Overall Study|Withdrawal by Subject|0
191963|NCT01014988|608884|P5|Overall Study|Withdrawal by Subject|0
191964|NCT01014988|608885|P4|Overall Study|Withdrawal by Subject|0
191965|NCT01014988|608886|P3|Overall Study|Withdrawal by Subject|0
191966|NCT01014988|608887|P2|Overall Study|Withdrawal by Subject|0
191967|NCT01014988|608888|P1|Overall Study|Withdrawal by Subject|1
191968|NCT01014988|608883|P6|Overall Study|Physician Decision|0
191969|NCT01014988|608884|P5|Overall Study|Physician Decision|0
191970|NCT01014988|608885|P4|Overall Study|Physician Decision|0
191971|NCT01014988|608886|P3|Overall Study|Physician Decision|0
191972|NCT01014988|608887|P2|Overall Study|Physician Decision|0
191973|NCT01014988|608888|P1|Overall Study|Physician Decision|1
191974|NCT01014988|608883|P6|Overall Study|Lost to Follow-up|0
191975|NCT01014988|608884|P5|Overall Study|Lost to Follow-up|0
191976|NCT01014988|608885|P4|Overall Study|Lost to Follow-up|0
191977|NCT01014988|608886|P3|Overall Study|Lost to Follow-up|1
191978|NCT01014988|608887|P2|Overall Study|Lost to Follow-up|0
191979|NCT01014988|608888|P1|Overall Study|Lost to Follow-up|1
191980|NCT01014988|608883|P6|Overall Study|Adverse Event|3
191981|NCT01014988|608884|P5|Overall Study|Adverse Event|1
191982|NCT01014988|608885|P4|Overall Study|Adverse Event|0
191983|NCT01014988|608886|P3|Overall Study|Adverse Event|1
191984|NCT01014988|608887|P2|Overall Study|Adverse Event|0
191985|NCT01014988|608888|P1|Overall Study|Adverse Event|20
191986|NCT01015118|609062|P2|Overall Study|Other than stated above|17
191987|NCT01015118|609063|P1|Overall Study|Other than stated above|32
191988|NCT01015118|609062|P2|Overall Study|Not treated|5
191989|NCT01015118|609063|P1|Overall Study|Not treated|9
191990|NCT01015118|609062|P2|Overall Study|Progressive disease|225
191991|NCT01015118|609063|P1|Overall Study|Progressive disease|354
191992|NCT01015118|609062|P2|Overall Study|Other Adverse Event|32
191993|NCT01015118|609063|P1|Overall Study|Other Adverse Event|138
191994|NCT01015118|609062|P2|Overall Study|Withdrawal by Subject|26
191995|NCT01015118|609063|P1|Overall Study|Withdrawal by Subject|98
191996|NCT01015118|609062|P2|Overall Study|Lost to Follow-up|0
191997|NCT01015118|609063|P1|Overall Study|Lost to Follow-up|1
191998|NCT01015118|609062|P2|Overall Study|Protocol Violation|5
191999|NCT01015118|609063|P1|Overall Study|Protocol Violation|4
192000|NCT01015118|609062|P2|Overall Study|Worsening or AE of underlying disease|4
192001|NCT01015118|609063|P1|Overall Study|Worsening or AE of underlying disease|5
192002|NCT01015131|609081|P1|Overall Study|Other Protocol Specified Criteria|4
192003|NCT01015131|609081|P1|Overall Study|Withdrawal by Subject|2
192004|NCT01015131|609081|P1|Overall Study|Protocol Violation|1
192005|NCT01015131|609081|P1|Overall Study|Physician Decision|1
192006|NCT01015287|609103|P2|Overall Study|Protocol Violation|1
192007|NCT01015287|609104|P1|Overall Study|Protocol Violation|1
192008|NCT01015287|609103|P2|Overall Study|Lost to Follow-up|1
192009|NCT01015287|609104|P1|Overall Study|Lost to Follow-up|2
192010|NCT01015287|609103|P2|Overall Study|Entry Criteria not Met|14
192011|NCT01015287|609104|P1|Overall Study|Entry Criteria not Met|11
192012|NCT01015287|609103|P2|Overall Study|Withdrawal by Subject|19
192013|NCT01015287|609104|P1|Overall Study|Withdrawal by Subject|14
192014|NCT01015287|609103|P2|Overall Study|Physician Decision|21
192015|NCT01015287|609104|P1|Overall Study|Physician Decision|19
192016|NCT01015287|609103|P2|Overall Study|Sponsor Decision|7
192017|NCT01015287|609104|P1|Overall Study|Sponsor Decision|3
192018|NCT01015287|609103|P2|Overall Study|Adverse Event|0
192019|NCT01015287|609104|P1|Overall Study|Adverse Event|1
192020|NCT01015287|609103|P2|Overall Study|Death|16
192021|NCT01015287|609104|P1|Overall Study|Death|21
192022|NCT01015560|609173|P1|Overall Study|Withdrawal by Subject|1
192023|NCT01015560|609173|P1|Overall Study|Not protocol specified|1
192024|NCT01015560|609173|P1|Overall Study|Adverse Event|1
192025|NCT01015638|609179|P2|Overall Study|Withdrawal by Subject|0
192026|NCT01015638|609180|P1|Overall Study|Withdrawal by Subject|1
192027|NCT01015677|609211|P3|Overall Study|Withdrawal by Subject|0
192028|NCT01015677|609212|P2|Overall Study|Withdrawal by Subject|1
192029|NCT01015677|609213|P1|Overall Study|Withdrawal by Subject|1
192030|NCT01015677|609211|P3|Overall Study|Protocol Violation|0
192031|NCT01015677|609212|P2|Overall Study|Protocol Violation|1
192032|NCT01015677|609213|P1|Overall Study|Protocol Violation|0
192033|NCT01015677|609211|P3|Overall Study|Lack of Efficacy|0
192034|NCT01015677|609212|P2|Overall Study|Lack of Efficacy|1
192035|NCT01015677|609213|P1|Overall Study|Lack of Efficacy|0
192036|NCT01015677|609211|P3|Overall Study|Adverse Event|0
192037|NCT01015677|609212|P2|Overall Study|Adverse Event|1
192038|NCT01015677|609213|P1|Overall Study|Adverse Event|0
192039|NCT01015703|609238|P5|Overall Study|Protocol Violation|0
192040|NCT01015703|609239|P4|Overall Study|Protocol Violation|0
192041|NCT01015703|609240|P3|Overall Study|Protocol Violation|0
192042|NCT01015703|609241|P2|Overall Study|Protocol Violation|0
192043|NCT01015703|609242|P1|Overall Study|Protocol Violation|1
192044|NCT01015703|609238|P5|Overall Study|Adverse Event|0
192045|NCT01015703|609239|P4|Overall Study|Adverse Event|0
192046|NCT01015703|609240|P3|Overall Study|Adverse Event|0
192047|NCT01015703|609241|P2|Overall Study|Adverse Event|0
192048|NCT01015703|609242|P1|Overall Study|Adverse Event|1
192049|NCT01015703|609238|P5|Overall Study|Withdrawal by Subject|0
192050|NCT01015703|609239|P4|Overall Study|Withdrawal by Subject|0
192051|NCT01015703|609240|P3|Overall Study|Withdrawal by Subject|0
192052|NCT01015703|609241|P2|Overall Study|Withdrawal by Subject|1
192053|NCT01015703|609242|P1|Overall Study|Withdrawal by Subject|0
192054|NCT01015820|609278|P2|Overall Study|Suboptimal measurements|0
192055|NCT01015820|609279|P1|Overall Study|Suboptimal measurements|1
192056|NCT01016015|609292|P1|Overall Study|Adverse Event|15
192057|NCT01016015|609292|P1|Overall Study|Withdrawal by Subject|1
192058|NCT01016015|609292|P1|Overall Study|Not Treated|3
192059|NCT01016067|609298|P2|Overall Study|Withdrew due to Relocation|1
192060|NCT01016067|609299|P1|Overall Study|Withdrew due to Relocation|0
192061|NCT01016067|609298|P2|Overall Study|Physician Decision|1
192062|NCT01016067|609299|P1|Overall Study|Physician Decision|1
192063|NCT01016067|609298|P2|Overall Study|Lost to Follow-up|2
192064|NCT01016067|609299|P1|Overall Study|Lost to Follow-up|1
192065|NCT01016132|609326|P1|Overall Study|Discomfort|1
192066|NCT01017549|609356|P1|One-year Follow-up|Withdrawal by Subject|5
192067|NCT01017549|609356|P1|One-year Follow-up|Lost to Follow-up|2
192068|NCT01017549|609356|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
192069|NCT01017575|609366|P5|Overall Study|Withdrawal by Subject|0
192070|NCT01017575|609367|P4|Overall Study|Withdrawal by Subject|0
192071|NCT01017575|609368|P3|Overall Study|Withdrawal by Subject|0
192072|NCT01017575|609369|P2|Overall Study|Withdrawal by Subject|0
192073|NCT01017575|609370|P1|Overall Study|Withdrawal by Subject|1
192074|NCT01017575|609366|P5|Overall Study|Adverse Event|2
192075|NCT01017575|609367|P4|Overall Study|Adverse Event|0
192076|NCT01017575|609368|P3|Overall Study|Adverse Event|0
192077|NCT01017575|609369|P2|Overall Study|Adverse Event|1
192078|NCT01017575|609370|P1|Overall Study|Adverse Event|0
192079|NCT01017575|609366|P5|Overall Study|Lack of Efficacy|1
192080|NCT01017575|609367|P4|Overall Study|Lack of Efficacy|1
192081|NCT01017575|609368|P3|Overall Study|Lack of Efficacy|0
192082|NCT01017575|609369|P2|Overall Study|Lack of Efficacy|1
192083|NCT01017575|609370|P1|Overall Study|Lack of Efficacy|0
192084|NCT01017601|609409|P2|Overall Study|Withdrawal by Subject|1
192085|NCT01017601|609410|P1|Overall Study|Withdrawal by Subject|0
192086|NCT01017601|609409|P2|Overall Study|Disease Progression|12
192087|NCT01017601|609410|P1|Overall Study|Disease Progression|12
192088|NCT01017731|609442|P1|Overall Study|Adverse Event|1
192089|NCT01017731|609442|P1|Overall Study|Physician Decision|2
192090|NCT01017731|609442|P1|Overall Study|Withdrawal by Subject|3
192091|NCT01017731|609442|P1|Overall Study|Lost to Follow-up|2
192092|NCT01017874|609461|P2|Overall Study|Physician Decision|3
192093|NCT01017874|609462|P1|Overall Study|Physician Decision|1
192094|NCT01017874|609461|P2|Overall Study|Lost to Follow-up|2
192095|NCT01017874|609462|P1|Overall Study|Lost to Follow-up|3
192096|NCT01017874|609461|P2|Overall Study|Sponsor decision|1
192097|NCT01017874|609462|P1|Overall Study|Sponsor decision|3
192098|NCT01017874|609461|P2|Overall Study|Withdrawal by Subject|20
192099|NCT01017874|609462|P1|Overall Study|Withdrawal by Subject|23
192100|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Physician Decision|7
192101|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Physician Decision|9
192102|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Physician Decision|8
192103|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Physician Decision|10
192104|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Physician Decision|0
192105|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
192106|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
192107|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
192108|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
192109|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
192110|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
192111|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
192112|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
192113|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
192114|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
192115|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
192116|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
192117|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
192118|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
192119|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
192120|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
192121|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
192122|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
192123|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
192124|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
192125|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
192126|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
192127|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
192128|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
192129|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
192130|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
192131|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
192132|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
192133|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
192134|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
192135|NCT01017952|609484|P5|52-week, Double-blind Treatment Period|Adverse Event|30
192136|NCT01017952|609485|P4|52-week, Double-blind Treatment Period|Adverse Event|35
192137|NCT01017952|609486|P3|52-week, Double-blind Treatment Period|Adverse Event|32
192138|NCT01017952|609487|P2|52-week, Double-blind Treatment Period|Adverse Event|25
192139|NCT01017952|609488|P1|52-week, Double-blind Treatment Period|Adverse Event|0
192140|NCT01017952|609484|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
192141|NCT01017952|609485|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
192142|NCT01017952|609486|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
192143|NCT01017952|609487|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
192144|NCT01017952|609488|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
192145|NCT01017952|609484|P5|4-week, Open-label Run-In Period|Physician Decision|0
192146|NCT01017952|609485|P4|4-week, Open-label Run-In Period|Physician Decision|0
192147|NCT01017952|609486|P3|4-week, Open-label Run-In Period|Physician Decision|0
192148|NCT01017952|609487|P2|4-week, Open-label Run-In Period|Physician Decision|0
192149|NCT01017952|609488|P1|4-week, Open-label Run-In Period|Physician Decision|10
192150|NCT01017952|609484|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
192151|NCT01017952|609485|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
192152|NCT01017952|609486|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
192153|NCT01017952|609487|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
192154|NCT01017952|609488|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
192155|NCT01017952|609484|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
192156|NCT01017952|609485|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
192157|NCT01017952|609486|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
192158|NCT01017952|609487|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
192159|NCT01017952|609488|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
192160|NCT01017952|609484|P5|4-week, Open-label Run-In Period|Adverse Event|0
192161|NCT01017952|609485|P4|4-week, Open-label Run-In Period|Adverse Event|0
192162|NCT01017952|609486|P3|4-week, Open-label Run-In Period|Adverse Event|0
192163|NCT01017952|609487|P2|4-week, Open-label Run-In Period|Adverse Event|0
192164|NCT01017952|609488|P1|4-week, Open-label Run-In Period|Adverse Event|23
192165|NCT01017952|609484|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
192166|NCT01017952|609485|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
192167|NCT01017952|609486|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
192168|NCT01017952|609487|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
192169|NCT01017952|609488|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
192170|NCT01018030|609513|P3|Overall Study|Did Not Receive Study Drug|0
192171|NCT01018030|609514|P2|Overall Study|Did Not Receive Study Drug|3
192172|NCT01018030|609515|P1|Overall Study|Did Not Receive Study Drug|1
192173|NCT01018030|609513|P3|Overall Study|Lack of Efficacy|0
192174|NCT01018030|609514|P2|Overall Study|Lack of Efficacy|0
192175|NCT01018030|609515|P1|Overall Study|Lack of Efficacy|1
192176|NCT01018030|609513|P3|Overall Study|Physician Decision|1
192177|NCT01018030|609514|P2|Overall Study|Physician Decision|0
192178|NCT01018030|609515|P1|Overall Study|Physician Decision|1
192179|NCT01018030|609513|P3|Overall Study|Protocol Violation|0
192180|NCT01018030|609514|P2|Overall Study|Protocol Violation|1
192181|NCT01018030|609515|P1|Overall Study|Protocol Violation|2
192182|NCT01018030|609513|P3|Overall Study|Lost to Follow-up|3
192183|NCT01018030|609514|P2|Overall Study|Lost to Follow-up|0
192184|NCT01018030|609515|P1|Overall Study|Lost to Follow-up|2
192185|NCT01018030|609513|P3|Overall Study|Withdrawal by Subject|4
192186|NCT01018030|609514|P2|Overall Study|Withdrawal by Subject|2
192187|NCT01018030|609515|P1|Overall Study|Withdrawal by Subject|2
192188|NCT01018030|609513|P3|Overall Study|Adverse Event|5
192189|NCT01018030|609514|P2|Overall Study|Adverse Event|5
192190|NCT01018030|609515|P1|Overall Study|Adverse Event|10
192191|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
192192|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
192193|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
192194|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
192195|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Physician Decision|3
192196|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Physician Decision|0
192197|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Physician Decision|1
192198|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Physician Decision|0
192199|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
192200|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
192201|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
192202|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
192203|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
192204|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
192205|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
192206|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
192207|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Protocol Violation|2
192208|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Protocol Violation|8
192209|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Protocol Violation|8
192210|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Protocol Violation|0
192211|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
192212|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
192213|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
192214|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
192215|NCT01018186|609662|P4|52-week Double-blind Treatment Period|Adverse Event|6
192216|NCT01018186|609663|P3|52-week Double-blind Treatment Period|Adverse Event|3
192217|NCT01018186|609664|P2|52-week Double-blind Treatment Period|Adverse Event|5
192218|NCT01018186|609665|P1|52-week Double-blind Treatment Period|Adverse Event|0
192219|NCT01018186|609662|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
192220|NCT01018186|609663|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
192221|NCT01018186|609664|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
192222|NCT01018186|609665|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
192223|NCT01018186|609662|P4|2-week Run-in Period|Withdrawal by Subject|0
192224|NCT01018186|609663|P3|2-week Run-in Period|Withdrawal by Subject|0
192225|NCT01018186|609664|P2|2-week Run-in Period|Withdrawal by Subject|0
192226|NCT01018186|609665|P1|2-week Run-in Period|Withdrawal by Subject|11
192227|NCT01018186|609662|P4|2-week Run-in Period|Physician Decision|0
192228|NCT01018186|609663|P3|2-week Run-in Period|Physician Decision|0
192229|NCT01018186|609664|P2|2-week Run-in Period|Physician Decision|0
192230|NCT01018186|609665|P1|2-week Run-in Period|Physician Decision|3
192231|NCT01018186|609662|P4|2-week Run-in Period|Lost to Follow-up|0
192232|NCT01018186|609663|P3|2-week Run-in Period|Lost to Follow-up|0
192233|NCT01018186|609664|P2|2-week Run-in Period|Lost to Follow-up|0
192234|NCT01018186|609665|P1|2-week Run-in Period|Lost to Follow-up|2
192235|NCT01018186|609662|P4|2-week Run-in Period|Protocol Violation|0
192236|NCT01018186|609663|P3|2-week Run-in Period|Protocol Violation|0
192237|NCT01018186|609664|P2|2-week Run-in Period|Protocol Violation|0
192238|NCT01018186|609665|P1|2-week Run-in Period|Protocol Violation|1
192239|NCT01018264|609753|P2|Overall Study|Lost to Follow-up|1
192240|NCT01018264|609754|P1|Overall Study|Lost to Follow-up|0
192241|NCT01018264|609753|P2|Overall Study|Withdrawal by Subject|0
192242|NCT01018264|609754|P1|Overall Study|Withdrawal by Subject|1
192243|NCT01018394|609770|P2|Overall Study|Lost to Follow-up|3
192244|NCT01018394|609771|P1|Overall Study|Lost to Follow-up|4
192245|NCT01018394|609770|P2|Overall Study|Withdrawal by Subject|5
192246|NCT01018394|609771|P1|Overall Study|Withdrawal by Subject|5
192247|NCT01018511|609811|P4|Overall Study|Miscellaneous|0
192248|NCT01018511|609812|P3|Overall Study|Miscellaneous|0
192249|NCT01018511|609813|P2|Overall Study|Miscellaneous|2
192250|NCT01018511|609814|P1|Overall Study|Miscellaneous|0
192251|NCT01018511|609811|P4|Overall Study|Protocol Violation|9
192252|NCT01018511|609812|P3|Overall Study|Protocol Violation|7
192253|NCT01018511|609813|P2|Overall Study|Protocol Violation|8
192254|NCT01018511|609814|P1|Overall Study|Protocol Violation|5
192255|NCT01018511|609811|P4|Overall Study|Lost to Follow-up|0
192256|NCT01018511|609812|P3|Overall Study|Lost to Follow-up|1
192257|NCT01018511|609813|P2|Overall Study|Lost to Follow-up|0
192258|NCT01018511|609814|P1|Overall Study|Lost to Follow-up|0
192259|NCT01018511|609811|P4|Overall Study|Withdrawal by Subject|9
192260|NCT01018511|609812|P3|Overall Study|Withdrawal by Subject|11
192261|NCT01018511|609813|P2|Overall Study|Withdrawal by Subject|5
192262|NCT01018511|609814|P1|Overall Study|Withdrawal by Subject|6
192263|NCT01018511|609811|P4|Overall Study|Lack of Efficacy|2
192264|NCT01018511|609812|P3|Overall Study|Lack of Efficacy|1
192265|NCT01018511|609813|P2|Overall Study|Lack of Efficacy|1
192266|NCT01018511|609814|P1|Overall Study|Lack of Efficacy|4
192267|NCT01018511|609811|P4|Overall Study|Adverse Event|10
192268|NCT01018511|609812|P3|Overall Study|Adverse Event|13
192269|NCT01018511|609813|P2|Overall Study|Adverse Event|9
192270|NCT01018511|609814|P1|Overall Study|Adverse Event|5
192271|NCT01018511|609811|P4|Overall Study|Not fulfilling eligibility criteria|3
192272|NCT01018511|609812|P3|Overall Study|Not fulfilling eligibility criteria|7
192273|NCT01018511|609813|P2|Overall Study|Not fulfilling eligibility criteria|7
192274|NCT01018511|609814|P1|Overall Study|Not fulfilling eligibility criteria|6
192275|NCT01018680|609983|P2|Overall Study|Physician Decision|1
192276|NCT01018680|609984|P1|Overall Study|Physician Decision|3
192277|NCT01018680|609983|P2|Overall Study|Entry Criteria Not Met|4
192278|NCT01018680|609984|P1|Overall Study|Entry Criteria Not Met|1
192279|NCT01018680|609983|P2|Overall Study|Lost to Follow-up|3
192280|NCT01018680|609984|P1|Overall Study|Lost to Follow-up|5
192281|NCT01018680|609983|P2|Overall Study|Lack of Efficacy|2
192282|NCT01018680|609984|P1|Overall Study|Lack of Efficacy|8
192283|NCT01018680|609983|P2|Overall Study|Sponsor Decision|7
192284|NCT01018680|609984|P1|Overall Study|Sponsor Decision|6
192285|NCT01018680|609983|P2|Overall Study|Protocol Violation|8
192286|NCT01018680|609984|P1|Overall Study|Protocol Violation|5
192287|NCT01018680|609983|P2|Overall Study|Withdrawal by Subject|10
192288|NCT01018680|609984|P1|Overall Study|Withdrawal by Subject|10
192289|NCT01018680|609983|P2|Overall Study|Adverse Event|40
192290|NCT01018680|609984|P1|Overall Study|Adverse Event|23
192291|NCT01018732|610027|P3|Overall Study|Unable to Classify|1
192292|NCT01018732|610028|P2|Overall Study|Unable to Classify|0
192293|NCT01018732|610029|P1|Overall Study|Unable to Classify|0
192294|NCT01018732|610027|P3|Overall Study|Inappropriate Enrollment|0
192295|NCT01018732|610028|P2|Overall Study|Inappropriate Enrollment|1
192296|NCT01018732|610029|P1|Overall Study|Inappropriate Enrollment|0
192297|NCT01018732|610027|P3|Overall Study|Protocol Violation|0
192298|NCT01018732|610028|P2|Overall Study|Protocol Violation|1
192299|NCT01018732|610029|P1|Overall Study|Protocol Violation|1
192300|NCT01018732|610027|P3|Overall Study|Lost to Follow-up|3
192301|NCT01018732|610028|P2|Overall Study|Lost to Follow-up|0
192302|NCT01018732|610029|P1|Overall Study|Lost to Follow-up|0
192303|NCT01018810|610066|P5|Overall Study|Sponsor Decision|1
192304|NCT01018810|610067|P4|Overall Study|Sponsor Decision|1
192305|NCT01018810|610068|P3|Overall Study|Sponsor Decision|1
192306|NCT01018810|610069|P2|Overall Study|Sponsor Decision|0
192307|NCT01018810|610070|P1|Overall Study|Sponsor Decision|2
192308|NCT01018810|610066|P5|Overall Study|Withdrawal by Subject|0
192309|NCT01018810|610067|P4|Overall Study|Withdrawal by Subject|0
192310|NCT01018810|610068|P3|Overall Study|Withdrawal by Subject|0
192311|NCT01018810|610069|P2|Overall Study|Withdrawal by Subject|1
192312|NCT01018810|610070|P1|Overall Study|Withdrawal by Subject|0
192313|NCT01018862|610130|P3|Overall Study|administrative problems|4
192314|NCT01018862|610131|P2|Overall Study|administrative problems|4
192315|NCT01018862|610132|P1|Overall Study|administrative problems|5
192316|NCT01018862|610130|P3|Overall Study|Withdrawal by Subject|1
192317|NCT01018862|610131|P2|Overall Study|Withdrawal by Subject|2
192318|NCT01018862|610132|P1|Overall Study|Withdrawal by Subject|1
192319|NCT01018862|610130|P3|Overall Study|Protocol Violation|3
192320|NCT01018862|610131|P2|Overall Study|Protocol Violation|3
192321|NCT01018862|610132|P1|Overall Study|Protocol Violation|1
192322|NCT01018862|610130|P3|Overall Study|Lost to Follow-up|0
192323|NCT01018862|610131|P2|Overall Study|Lost to Follow-up|1
192324|NCT01018862|610132|P1|Overall Study|Lost to Follow-up|3
192325|NCT01018862|610130|P3|Overall Study|Lack of Efficacy|2
192326|NCT01018862|610131|P2|Overall Study|Lack of Efficacy|0
192327|NCT01018862|610132|P1|Overall Study|Lack of Efficacy|1
192328|NCT01018862|610130|P3|Overall Study|Adverse Event|6
192329|NCT01018862|610131|P2|Overall Study|Adverse Event|0
192330|NCT01018862|610132|P1|Overall Study|Adverse Event|2
192331|NCT01018953|610149|P1|Overall Study|Study termination by sponsor|5
192332|NCT01018953|610149|P1|Overall Study|Withdrawal by Subject|1
192333|NCT01018953|610149|P1|Overall Study|Adverse Event|2
192334|NCT01018979|610161|P2|Overall Study|Not received at least one dose|1
192335|NCT01018979|610162|P1|Overall Study|Not received at least one dose|0
192336|NCT01018979|610161|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
192337|NCT01018979|610162|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
192338|NCT01018992|610194|P2|Overall Study|Lost to Follow-up|1
192339|NCT01018992|610195|P1|Overall Study|Lost to Follow-up|5
192340|NCT01018992|610194|P2|Overall Study|Protocol Violation|4
192341|NCT01018992|610195|P1|Overall Study|Protocol Violation|0
192342|NCT01018992|610194|P2|Overall Study|Withdrawal by Subject|8
192343|NCT01018992|610195|P1|Overall Study|Withdrawal by Subject|3
192344|NCT01018992|610194|P2|Overall Study|Adverse Event|3
192345|NCT01018992|610195|P1|Overall Study|Adverse Event|8
192346|NCT01019135|610210|P3|Overall Study|Did not attend CR|6
192347|NCT01019135|610211|P2|Overall Study|Did not attend CR|13
192348|NCT01019135|610212|P1|Overall Study|Did not attend CR|8
192349|NCT01019135|610210|P3|Overall Study|Did not receive allocated intervention|25
192350|NCT01019135|610211|P2|Overall Study|Did not receive allocated intervention|6
192351|NCT01019135|610212|P1|Overall Study|Did not receive allocated intervention|12
192352|NCT01019317|610238|P1|Overall Study|Not Eligible|4
192353|NCT01019369|610244|P2|Overall Study|Withdrawal by Subject|1
192354|NCT01019369|610245|P1|Overall Study|Withdrawal by Subject|0
192355|NCT01019369|610244|P2|Overall Study|Lost to Follow-up|6
192356|NCT01019369|610245|P1|Overall Study|Lost to Follow-up|10
192357|NCT01019486|610254|P3|Overall Study|Withdrawal by Subject|1
192358|NCT01019486|610255|P2|Overall Study|Withdrawal by Subject|1
192359|NCT01019486|610256|P1|Overall Study|Withdrawal by Subject|1
192360|NCT01019694|610271|P3|Overall Study|Other reason (not specified)|6
192361|NCT01019694|610272|P2|Overall Study|Other reason (not specified)|5
192362|NCT01019694|610273|P1|Overall Study|Other reason (not specified)|1
192363|NCT01019694|610271|P3|Overall Study|Not treated|3
192364|NCT01019694|610272|P2|Overall Study|Not treated|2
192365|NCT01019694|610273|P1|Overall Study|Not treated|0
192366|NCT01019694|610271|P3|Overall Study|Withdrawal by Subject|12
192367|NCT01019694|610272|P2|Overall Study|Withdrawal by Subject|6
192368|NCT01019694|610273|P1|Overall Study|Withdrawal by Subject|4
192369|NCT01019694|610271|P3|Overall Study|Lost to Follow-up|3
192370|NCT01019694|610272|P2|Overall Study|Lost to Follow-up|3
192371|NCT01019694|610273|P1|Overall Study|Lost to Follow-up|5
192372|NCT01019694|610271|P3|Overall Study|Protocol Violation|4
192373|NCT01019694|610272|P2|Overall Study|Protocol Violation|6
192374|NCT01019694|610273|P1|Overall Study|Protocol Violation|2
192375|NCT01019694|610271|P3|Overall Study|Adverse Event|19
192376|NCT01019694|610272|P2|Overall Study|Adverse Event|16
192377|NCT01019694|610273|P1|Overall Study|Adverse Event|12
192378|NCT01007552|610406|P1|Overall Study|Withdrawal by Subject|1
192379|NCT01007812|610443|P2|Period 1, One Week|Discomfort|0
192380|NCT01007812|610444|P1|Period 1, One Week|Discomfort|1
192381|NCT01007812|610443|P2|Period 1, One Week|Lost to Follow-up|1
192382|NCT01007812|610444|P1|Period 1, One Week|Lost to Follow-up|0
192383|NCT01007838|610454|P4|Overall Study|Started home haemodialysis|0
192384|NCT01007838|610455|P3|Overall Study|Started home haemodialysis|0
192385|NCT01007838|610456|P2|Overall Study|Started home haemodialysis|0
192386|NCT01007838|610457|P1|Overall Study|Started home haemodialysis|1
192387|NCT01007838|610454|P4|Overall Study|Physician Decision|0
192388|NCT01007838|610455|P3|Overall Study|Physician Decision|0
192389|NCT01007838|610456|P2|Overall Study|Physician Decision|0
192390|NCT01007838|610457|P1|Overall Study|Physician Decision|1
192391|NCT01007838|610454|P4|Overall Study|Withdrawal by Subject|0
192392|NCT01007838|610455|P3|Overall Study|Withdrawal by Subject|0
192393|NCT01007838|610456|P2|Overall Study|Withdrawal by Subject|0
192394|NCT01007838|610457|P1|Overall Study|Withdrawal by Subject|1
192395|NCT01007916|610467|P2|Period 2, 4 Weeks of Wear|Relocation|0
192396|NCT01007916|610468|P1|Period 2, 4 Weeks of Wear|Relocation|1
192397|NCT01007916|610467|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
192398|NCT01007916|610468|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
192399|NCT01007942|610476|P2|Overall Study|Patients untreated|3
192400|NCT01007942|610477|P1|Overall Study|Patients untreated|4
192401|NCT01007942|610476|P2|Overall Study|Death|2
192402|NCT01007942|610477|P1|Overall Study|Death|3
192403|NCT01007942|610476|P2|Overall Study|Administrative problems|0
192404|NCT01007942|610477|P1|Overall Study|Administrative problems|2
192405|NCT01007942|610476|P2|Overall Study|Lost to Follow-up|0
192406|NCT01007942|610477|P1|Overall Study|Lost to Follow-up|1
192407|NCT01007942|610476|P2|Overall Study|Withdrawal by Subject|14
192408|NCT01007942|610477|P1|Overall Study|Withdrawal by Subject|19
192409|NCT01007942|610476|P2|Overall Study|Protocol Violation|1
192410|NCT01007942|610477|P1|Overall Study|Protocol Violation|1
192411|NCT01007942|610476|P2|Overall Study|New cancer therapy|1
192412|NCT01007942|610477|P1|Overall Study|New cancer therapy|5
192413|NCT01007942|610476|P2|Overall Study|Disease progression|242
192414|NCT01007942|610477|P1|Overall Study|Disease progression|217
192415|NCT01007942|610476|P2|Overall Study|Abnormal test procedure|1
192416|NCT01007942|610477|P1|Overall Study|Abnormal test procedure|0
192417|NCT01007942|610476|P2|Overall Study|Adverse Event|14
192418|NCT01007942|610477|P1|Overall Study|Adverse Event|29
192419|NCT01010971|610545|P3|Overall Study|Other|2
192420|NCT01010971|610546|P2|Overall Study|Other|0
192421|NCT01010971|610547|P1|Overall Study|Other|1
192422|NCT01010971|610545|P3|Overall Study|Lost to Follow-up|3
192423|NCT01010971|610546|P2|Overall Study|Lost to Follow-up|2
192424|NCT01010971|610547|P1|Overall Study|Lost to Follow-up|0
192425|NCT01010971|610545|P3|Overall Study|Withdrawal by Subject|5
192426|NCT01010971|610546|P2|Overall Study|Withdrawal by Subject|2
192427|NCT01010971|610547|P1|Overall Study|Withdrawal by Subject|0
192428|NCT01010971|610545|P3|Overall Study|Adverse Event|3
192429|NCT01010971|610546|P2|Overall Study|Adverse Event|4
192430|NCT01010971|610547|P1|Overall Study|Adverse Event|2
192431|NCT01011049|610636|P4|Overall Study|Withdrawal by Subject|0
192432|NCT01011049|610637|P3|Overall Study|Withdrawal by Subject|1
192433|NCT01011049|610638|P2|Overall Study|Withdrawal by Subject|0
192434|NCT01011049|610639|P1|Overall Study|Withdrawal by Subject|0
192435|NCT01011049|610636|P4|Overall Study|Lost to Follow-up|0
192436|NCT01011049|610637|P3|Overall Study|Lost to Follow-up|1
192437|NCT01011049|610638|P2|Overall Study|Lost to Follow-up|2
192438|NCT01011049|610639|P1|Overall Study|Lost to Follow-up|1
192439|NCT01011049|610636|P4|Overall Study|Protocol Violation|0
192440|NCT01011049|610637|P3|Overall Study|Protocol Violation|2
192441|NCT01011049|610638|P2|Overall Study|Protocol Violation|0
192442|NCT01011049|610639|P1|Overall Study|Protocol Violation|0
192443|NCT01011153|610671|P3|Overall Study|Less than 78 cases completed|9
192444|NCT01011153|610672|P2|Overall Study|Less than 78 cases completed|11
192445|NCT01011153|610673|P1|Overall Study|Less than 78 cases completed|8
192446|NCT01011283|610702|P2|Overall Study|Not Specified|2
192447|NCT01011283|610703|P1|Overall Study|Not Specified|2
192448|NCT01011283|610702|P2|Overall Study|Terminated by Sponsor|5
192449|NCT01011283|610703|P1|Overall Study|Terminated by Sponsor|5
192450|NCT01011283|610702|P2|Overall Study|Progressive Disease|2
192451|NCT01011283|610703|P1|Overall Study|Progressive Disease|0
192452|NCT01011283|610702|P2|Overall Study|Adverse Event|2
192453|NCT01011283|610703|P1|Overall Study|Adverse Event|4
192454|NCT01011309|610714|P3|Overall Study|Protocol Violation|3
192455|NCT01011309|610715|P2|Overall Study|Protocol Violation|1
192456|NCT01011309|610716|P1|Overall Study|Protocol Violation|0
192457|NCT01011309|610714|P3|Overall Study|Lack of Efficacy|0
192458|NCT01011309|610715|P2|Overall Study|Lack of Efficacy|1
192459|NCT01011309|610716|P1|Overall Study|Lack of Efficacy|0
192460|NCT01011309|610714|P3|Overall Study|Adverse Event|2
192461|NCT01011309|610715|P2|Overall Study|Adverse Event|1
192462|NCT01011309|610716|P1|Overall Study|Adverse Event|2
192463|NCT01011387|610730|P1|Overall Study|Protocol Violation|1
192464|NCT01011387|610730|P1|Overall Study|Adverse Event|2
192465|NCT01011387|610730|P1|Overall Study|Withdrawal by Subject|3
192466|NCT01011465|610742|P8|Overall Study|Withdrawal by Subject|0
192467|NCT01011465|610743|P7|Overall Study|Withdrawal by Subject|1
192468|NCT01011465|610744|P6|Overall Study|Withdrawal by Subject|0
192469|NCT01011465|610745|P5|Overall Study|Withdrawal by Subject|1
192470|NCT01011465|610746|P4|Overall Study|Withdrawal by Subject|0
192471|NCT01011465|610747|P3|Overall Study|Withdrawal by Subject|0
192472|NCT01011465|610748|P2|Overall Study|Withdrawal by Subject|1
192473|NCT01011465|610749|P1|Overall Study|Withdrawal by Subject|2
192474|NCT01011556|610781|P4|Overall Study|Inclusion/exclusion criteria not met|5
192475|NCT01011556|610782|P3|Overall Study|Inclusion/exclusion criteria not met|3
192476|NCT01011556|610783|P2|Overall Study|Inclusion/exclusion criteria not met|1
192477|NCT01011556|610784|P1|Overall Study|Inclusion/exclusion criteria not met|2
192478|NCT01011556|610781|P4|Overall Study|Sponsor decision|2
192479|NCT01011556|610782|P3|Overall Study|Sponsor decision|1
192480|NCT01011556|610783|P2|Overall Study|Sponsor decision|1
192481|NCT01011556|610784|P1|Overall Study|Sponsor decision|0
192482|NCT01011556|610781|P4|Overall Study|Withdrawal by Subject|4
192483|NCT01011556|610782|P3|Overall Study|Withdrawal by Subject|4
192484|NCT01011556|610783|P2|Overall Study|Withdrawal by Subject|2
192485|NCT01011556|610784|P1|Overall Study|Withdrawal by Subject|1
192486|NCT01011556|610781|P4|Overall Study|Protocol Violation|0
192487|NCT01011556|610782|P3|Overall Study|Protocol Violation|0
192488|NCT01011556|610783|P2|Overall Study|Protocol Violation|1
192489|NCT01011556|610784|P1|Overall Study|Protocol Violation|0
192490|NCT01011556|610781|P4|Overall Study|Physician Decision|1
192491|NCT01011556|610782|P3|Overall Study|Physician Decision|0
192492|NCT01011556|610783|P2|Overall Study|Physician Decision|0
192493|NCT01011556|610784|P1|Overall Study|Physician Decision|1
192494|NCT01011556|610781|P4|Overall Study|Lost to Follow-up|0
192495|NCT01011556|610782|P3|Overall Study|Lost to Follow-up|0
192496|NCT01011556|610783|P2|Overall Study|Lost to Follow-up|0
192497|NCT01011556|610784|P1|Overall Study|Lost to Follow-up|1
192498|NCT01011556|610781|P4|Overall Study|Adverse Event|1
192499|NCT01011556|610782|P3|Overall Study|Adverse Event|2
192500|NCT01011556|610783|P2|Overall Study|Adverse Event|3
192501|NCT01011556|610784|P1|Overall Study|Adverse Event|1
192502|NCT01011673|610867|P2|24 Hour Follow-up|Lost to Follow-up|3
192503|NCT01011673|610868|P1|24 Hour Follow-up|Lost to Follow-up|3
192504|NCT01011673|610867|P2|Randomized|Secondary headache|1
192505|NCT01011673|610868|P1|Randomized|Secondary headache|2
192506|NCT01011738|610879|P3|Overall Study|Unknown reasons|17
192507|NCT01011738|610880|P2|Overall Study|Unknown reasons|291
192508|NCT01011738|610881|P1|Overall Study|Unknown reasons|312
192509|NCT01011738|610879|P3|Overall Study|Death|0
192510|NCT01011738|610880|P2|Overall Study|Death|3
192511|NCT01011738|610881|P1|Overall Study|Death|12
192512|NCT01011868|610946|P3|After Week 78 Follow-up|Other reason not defined above|16
192513|NCT01011868|610947|P2|After Week 78 Follow-up|Other reason not defined above|5
192514|NCT01011868|610948|P1|After Week 78 Follow-up|Other reason not defined above|5
192515|NCT01011868|610946|P3|After Week 78 Follow-up|Withdrawal by Subject|1
192516|NCT01011868|610947|P2|After Week 78 Follow-up|Withdrawal by Subject|8
192517|NCT01011868|610948|P1|After Week 78 Follow-up|Withdrawal by Subject|9
192518|NCT01011868|610946|P3|After Week 78 Follow-up|Lost to Follow-up|4
192519|NCT01011868|610947|P2|After Week 78 Follow-up|Lost to Follow-up|6
192520|NCT01011868|610948|P1|After Week 78 Follow-up|Lost to Follow-up|11
192521|NCT01011868|610946|P3|After Week 78 Follow-up|Protocol Violation|2
192522|NCT01011868|610947|P2|After Week 78 Follow-up|Protocol Violation|1
192523|NCT01011868|610948|P1|After Week 78 Follow-up|Protocol Violation|9
192524|NCT01011868|610946|P3|After Week 78 Follow-up|Lack of Efficacy|0
192525|NCT01011868|610947|P2|After Week 78 Follow-up|Lack of Efficacy|0
192526|NCT01011868|610948|P1|After Week 78 Follow-up|Lack of Efficacy|4
192527|NCT01011868|610946|P3|After Week 78 Follow-up|Adverse Event|21
192528|NCT01011868|610947|P2|After Week 78 Follow-up|Adverse Event|18
192529|NCT01011868|610948|P1|After Week 78 Follow-up|Adverse Event|14
192530|NCT01011868|610946|P3|After Week 18 Follow-up|Other reason not defined above|12
192531|NCT01011868|610947|P2|After Week 18 Follow-up|Other reason not defined above|3
192532|NCT01011868|610948|P1|After Week 18 Follow-up|Other reason not defined above|2
192533|NCT01011868|610946|P3|After Week 18 Follow-up|Withdrawal by Subject|0
192534|NCT01011868|610947|P2|After Week 18 Follow-up|Withdrawal by Subject|3
192535|NCT01011868|610948|P1|After Week 18 Follow-up|Withdrawal by Subject|6
192536|NCT01011868|610946|P3|After Week 18 Follow-up|Lost to Follow-up|0
192537|NCT01011868|610947|P2|After Week 18 Follow-up|Lost to Follow-up|3
192538|NCT01011868|610948|P1|After Week 18 Follow-up|Lost to Follow-up|5
192539|NCT01011868|610946|P3|After Week 18 Follow-up|Protocol Violation|1
192540|NCT01011868|610947|P2|After Week 18 Follow-up|Protocol Violation|1
192541|NCT01011868|610948|P1|After Week 18 Follow-up|Protocol Violation|1
192542|NCT01011868|610946|P3|After Week 18 Follow-up|Lack of Efficacy|0
192543|NCT01011868|610947|P2|After Week 18 Follow-up|Lack of Efficacy|0
192544|NCT01011868|610948|P1|After Week 18 Follow-up|Lack of Efficacy|1
192545|NCT01011868|610946|P3|After Week 18 Follow-up|Adverse Event|13
192546|NCT01011868|610947|P2|After Week 18 Follow-up|Adverse Event|6
192547|NCT01011868|610948|P1|After Week 18 Follow-up|Adverse Event|8
192548|NCT01011907|610989|P2|Overall Study|Adverse Event|4
192549|NCT01011907|610990|P1|Overall Study|Adverse Event|1
192550|NCT01011907|610989|P2|Overall Study|Withdrawal by Subject|11
192551|NCT01011907|610990|P1|Overall Study|Withdrawal by Subject|13
192552|NCT01011933|611000|P1|Overall Study|Never treated|1
192553|NCT01011933|611000|P1|Overall Study|Inadequate pathology|1
192554|NCT01011933|611000|P1|Overall Study|Improper pre-protocol Rx|1
192555|NCT01011933|611000|P1|Overall Study|Wrong cell type|1
192556|NCT01011946|611007|P1|Overall Study|No pathological lab value|1
192557|NCT01011946|611007|P1|Overall Study|Transferred to another hospital|2
192558|NCT01012037|611014|P3|Overall Study|Other reason (not specified)|1
192559|NCT01012037|611015|P2|Overall Study|Other reason (not specified)|1
192560|NCT01012037|611016|P1|Overall Study|Other reason (not specified)|1
192561|NCT01012037|611014|P3|Overall Study|Withdrawal by Subject|1
192562|NCT01012037|611015|P2|Overall Study|Withdrawal by Subject|4
192563|NCT01012037|611016|P1|Overall Study|Withdrawal by Subject|0
192564|NCT01012037|611014|P3|Overall Study|Protocol Violation|5
192565|NCT01012037|611015|P2|Overall Study|Protocol Violation|3
192566|NCT01012037|611016|P1|Overall Study|Protocol Violation|0
192567|NCT01012037|611014|P3|Overall Study|Adverse Event|3
192568|NCT01012037|611015|P2|Overall Study|Adverse Event|8
192569|NCT01012037|611016|P1|Overall Study|Adverse Event|0
192570|NCT01012219|611310|P1|Period 2|Withdrawal by Subject|1
192571|NCT01012219|611310|P1|Period 1|Withdrawal by Subject|1
192572|NCT01012258|611358|P1|Overall Study|Ongoing|29
192573|NCT01012258|611358|P1|Overall Study|Another Tumor Discovered|1
192574|NCT01012258|611358|P1|Overall Study|Another Anti-cancer Drug Received|1
192575|NCT01012258|611358|P1|Overall Study|Symptomatic Deterioration|1
192576|NCT01012258|611358|P1|Overall Study|Progressive Disease (PD)|18
192577|NCT01012258|611358|P1|Overall Study|Adverse Event|1
192578|NCT01012258|611358|P1|Overall Study|Lost to Follow-up|1
192579|NCT01012258|611358|P1|Overall Study|Death|14
192580|NCT01012323|611379|P1|Overall Study|Investigator Judgment|1
192581|NCT01012414|611432|P1|Overall Study|Trial was stopped before completed|7
192582|NCT01012414|611432|P1|Overall Study|Lost to Follow-up|1
192583|NCT01012414|611432|P1|Overall Study|Withdrawal by Subject|2
192584|NCT01012440|611439|P1|Overall Study|Withdrawal by Subject|2
192585|NCT01012622|611443|P1|Overall Study|withdrawal of consent by a parent|2
192586|NCT01012622|611443|P1|Overall Study|screening failure|1
192587|NCT01012622|611443|P1|Overall Study|unspecified|1
192588|NCT01012622|611443|P1|Overall Study|non-compliance with the drug|9
192589|NCT01012622|611443|P1|Overall Study|Adverse Event|7
192590|NCT01012622|611443|P1|Overall Study|Lost to Follow-up|5
192591|NCT01012622|611443|P1|Overall Study|Withdrawal by Subject|6
192592|NCT01012713|611482|P1|Overall Study|Lack of Efficacy|3
192593|NCT01012739|611488|P4|Treatment Period 2|Abnormal test procedure results|1
192594|NCT01012739|611489|P3|Treatment Period 2|Abnormal test procedure results|0
192595|NCT01012739|611490|P2|Treatment Period 2|Abnormal test procedure results|0
192596|NCT01012739|611491|P1|Treatment Period 2|Abnormal test procedure results|0
192597|NCT01012739|611488|P4|Treatment Period 1|Adverse Event|1
192598|NCT01012739|611489|P3|Treatment Period 1|Adverse Event|0
192599|NCT01012739|611490|P2|Treatment Period 1|Adverse Event|0
192600|NCT01012739|611491|P1|Treatment Period 1|Adverse Event|0
192601|NCT01012765|611519|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
192602|NCT01012765|611520|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
192603|NCT01012765|611521|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
192604|NCT01012765|611522|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
192605|NCT01012765|611523|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
192606|NCT01012765|611524|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
192607|NCT01012765|611519|P6|Treatment Period 2|Adverse Event|0
192608|NCT01012765|611520|P5|Treatment Period 2|Adverse Event|0
192609|NCT01012765|611521|P4|Treatment Period 2|Adverse Event|0
192610|NCT01012765|611522|P3|Treatment Period 2|Adverse Event|1
192611|NCT01012765|611523|P2|Treatment Period 2|Adverse Event|1
192612|NCT01012765|611524|P1|Treatment Period 2|Adverse Event|0
192613|NCT01012765|611519|P6|Treatment Period 2|Abnormal laboratory value(s)|1
192614|NCT01012765|611520|P5|Treatment Period 2|Abnormal laboratory value(s)|0
192615|NCT01012765|611521|P4|Treatment Period 2|Abnormal laboratory value(s)|0
192616|NCT01012765|611522|P3|Treatment Period 2|Abnormal laboratory value(s)|0
192617|NCT01012765|611523|P2|Treatment Period 2|Abnormal laboratory value(s)|0
192618|NCT01012765|611524|P1|Treatment Period 2|Abnormal laboratory value(s)|0
192619|NCT01012765|611519|P6|Treatment Period 2|Withdrawal by Subject|0
192620|NCT01012765|611520|P5|Treatment Period 2|Withdrawal by Subject|1
192621|NCT01012765|611521|P4|Treatment Period 2|Withdrawal by Subject|0
192622|NCT01012765|611522|P3|Treatment Period 2|Withdrawal by Subject|1
192623|NCT01012765|611523|P2|Treatment Period 2|Withdrawal by Subject|0
192624|NCT01012765|611524|P1|Treatment Period 2|Withdrawal by Subject|1
192625|NCT01012765|611519|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
192626|NCT01012765|611520|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
192627|NCT01012765|611521|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
192628|NCT01012765|611522|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
192629|NCT01012765|611523|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
192630|NCT01012765|611524|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
192631|NCT01012765|611519|P6|Treatment Period 1|Protocol Violation|0
192632|NCT01012765|611520|P5|Treatment Period 1|Protocol Violation|1
192633|NCT01012765|611521|P4|Treatment Period 1|Protocol Violation|2
192634|NCT01012765|611522|P3|Treatment Period 1|Protocol Violation|0
192635|NCT01012765|611523|P2|Treatment Period 1|Protocol Violation|0
192636|NCT01012765|611524|P1|Treatment Period 1|Protocol Violation|0
192637|NCT01012765|611519|P6|Treatment Period 1|Administrative problems|0
192638|NCT01012765|611520|P5|Treatment Period 1|Administrative problems|1
192639|NCT01012765|611521|P4|Treatment Period 1|Administrative problems|1
192640|NCT01012765|611522|P3|Treatment Period 1|Administrative problems|1
192641|NCT01012765|611523|P2|Treatment Period 1|Administrative problems|0
192642|NCT01012765|611524|P1|Treatment Period 1|Administrative problems|0
192643|NCT01012765|611519|P6|Treatment Period 1|Withdrawal by Subject|0
192644|NCT01012765|611520|P5|Treatment Period 1|Withdrawal by Subject|0
192645|NCT01012765|611521|P4|Treatment Period 1|Withdrawal by Subject|0
192646|NCT01012765|611522|P3|Treatment Period 1|Withdrawal by Subject|0
192647|NCT01012765|611523|P2|Treatment Period 1|Withdrawal by Subject|0
192648|NCT01012765|611524|P1|Treatment Period 1|Withdrawal by Subject|2
192649|NCT01012765|611519|P6|Treatment Period 1|Adverse Event|0
192650|NCT01012765|611520|P5|Treatment Period 1|Adverse Event|0
192651|NCT01012765|611521|P4|Treatment Period 1|Adverse Event|0
192652|NCT01012765|611522|P3|Treatment Period 1|Adverse Event|1
192653|NCT01012765|611523|P2|Treatment Period 1|Adverse Event|0
192654|NCT01012765|611524|P1|Treatment Period 1|Adverse Event|1
192655|NCT01012947|611558|P5|Overall Study|Lost to Follow-up|142
192656|NCT01012947|611559|P4|Overall Study|Lost to Follow-up|118
192657|NCT01012947|611560|P3|Overall Study|Lost to Follow-up|130
192658|NCT01012947|611561|P2|Overall Study|Lost to Follow-up|135
192659|NCT01012947|611562|P1|Overall Study|Lost to Follow-up|131
192660|NCT01012973|611576|P2|Overall Study|Withdrawal by Subject|6
192661|NCT01012973|611577|P1|Overall Study|Withdrawal by Subject|4
192662|NCT01012973|611576|P2|Overall Study|Protocol Violation|2
192663|NCT01012973|611577|P1|Overall Study|Protocol Violation|5
192664|NCT01012973|611576|P2|Overall Study|Increase in vis. acuity, never injected|1
192665|NCT01012973|611577|P1|Overall Study|Increase in vis. acuity, never injected|0
192666|NCT01012973|611576|P2|Overall Study|(Overseas travel - indefinite period)|0
192667|NCT01012973|611577|P1|Overall Study|(Overseas travel - indefinite period)|1
192668|NCT01012973|611576|P2|Overall Study|Lost to Follow-up|0
192669|NCT01012973|611577|P1|Overall Study|Lost to Follow-up|1
192670|NCT01012973|611576|P2|Overall Study|Lack of Efficacy|5
192671|NCT01012973|611577|P1|Overall Study|Lack of Efficacy|0
192672|NCT01012973|611576|P2|Overall Study|Adverse Event|5
192673|NCT01012973|611577|P1|Overall Study|Adverse Event|5
192674|NCT01012999|611597|P1|Overall Study|Protocol Violation|1
192675|NCT01013207|611614|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
192676|NCT01019980|611664|P2|Overall Study|Drug not available.|0
192677|NCT01019980|611665|P1|Overall Study|Drug not available.|2
192678|NCT01020019|611686|P2|Overall Study|moving|2
192679|NCT01020019|611687|P1|Overall Study|moving|0
192680|NCT01020019|611686|P2|Overall Study|not interested in treatment|4
192681|NCT01020019|611687|P1|Overall Study|not interested in treatment|4
192682|NCT01020019|611686|P2|Overall Study|Adverse Event|5
192683|NCT01020019|611687|P1|Overall Study|Adverse Event|1
192684|NCT01020019|611686|P2|Overall Study|Lost to Follow-up|18
192685|NCT01020019|611687|P1|Overall Study|Lost to Follow-up|21
192686|NCT01020123|611700|P7|Extention Period|Lost to Follow-up|0
192687|NCT01020123|611701|P6|Extention Period|Lost to Follow-up|2
192688|NCT01020123|611702|P5|Extention Period|Lost to Follow-up|0
192689|NCT01020123|611703|P4|Extention Period|Lost to Follow-up|0
192690|NCT01020123|611704|P3|Extention Period|Lost to Follow-up|0
192691|NCT01020123|611705|P2|Extention Period|Lost to Follow-up|0
192692|NCT01020123|611706|P1|Extention Period|Lost to Follow-up|0
192693|NCT01020123|611700|P7|Extention Period|Protocol Violation|1
192694|NCT01020123|611701|P6|Extention Period|Protocol Violation|0
192695|NCT01020123|611702|P5|Extention Period|Protocol Violation|0
192696|NCT01020123|611703|P4|Extention Period|Protocol Violation|0
192697|NCT01020123|611704|P3|Extention Period|Protocol Violation|1
192698|NCT01020123|611705|P2|Extention Period|Protocol Violation|1
192699|NCT01020123|611706|P1|Extention Period|Protocol Violation|1
192700|NCT01020123|611700|P7|Extention Period|Adverse Event|0
192701|NCT01020123|611701|P6|Extention Period|Adverse Event|0
192702|NCT01020123|611702|P5|Extention Period|Adverse Event|0
192703|NCT01020123|611703|P4|Extention Period|Adverse Event|1
192704|NCT01020123|611704|P3|Extention Period|Adverse Event|0
192705|NCT01020123|611705|P2|Extention Period|Adverse Event|0
192706|NCT01020123|611706|P1|Extention Period|Adverse Event|0
192707|NCT01020123|611700|P7|Extention Period|Withdrawal by Subject|0
192708|NCT01020123|611701|P6|Extention Period|Withdrawal by Subject|0
192709|NCT01020123|611702|P5|Extention Period|Withdrawal by Subject|0
192710|NCT01020123|611703|P4|Extention Period|Withdrawal by Subject|0
192711|NCT01020123|611704|P3|Extention Period|Withdrawal by Subject|1
192712|NCT01020123|611705|P2|Extention Period|Withdrawal by Subject|1
192713|NCT01020123|611706|P1|Extention Period|Withdrawal by Subject|2
192714|NCT01020123|611700|P7|Main Period|Unclasified|6
192715|NCT01020123|611701|P6|Main Period|Unclasified|3
192716|NCT01020123|611702|P5|Main Period|Unclasified|1
192717|NCT01020123|611703|P4|Main Period|Unclasified|0
192718|NCT01020123|611704|P3|Main Period|Unclasified|1
192719|NCT01020123|611705|P2|Main Period|Unclasified|0
192720|NCT01020123|611706|P1|Main Period|Unclasified|2
192721|NCT01020123|611700|P7|Main Period|Lost to Follow-up|0
192722|NCT01020123|611701|P6|Main Period|Lost to Follow-up|0
192723|NCT01020123|611702|P5|Main Period|Lost to Follow-up|0
192724|NCT01020123|611703|P4|Main Period|Lost to Follow-up|0
192725|NCT01020123|611704|P3|Main Period|Lost to Follow-up|0
192726|NCT01020123|611705|P2|Main Period|Lost to Follow-up|2
192727|NCT01020123|611706|P1|Main Period|Lost to Follow-up|0
192728|NCT01020123|611700|P7|Main Period|Protocol Violation|2
192729|NCT01020123|611701|P6|Main Period|Protocol Violation|3
192730|NCT01020123|611702|P5|Main Period|Protocol Violation|2
192731|NCT01020123|611703|P4|Main Period|Protocol Violation|5
192732|NCT01020123|611704|P3|Main Period|Protocol Violation|2
192733|NCT01020123|611705|P2|Main Period|Protocol Violation|4
192734|NCT01020123|611706|P1|Main Period|Protocol Violation|4
192735|NCT01020123|611700|P7|Main Period|Adverse Event|1
192736|NCT01020123|611701|P6|Main Period|Adverse Event|2
192737|NCT01020123|611702|P5|Main Period|Adverse Event|1
192738|NCT01020123|611703|P4|Main Period|Adverse Event|1
192739|NCT01020123|611704|P3|Main Period|Adverse Event|2
192740|NCT01020123|611705|P2|Main Period|Adverse Event|2
192741|NCT01020123|611706|P1|Main Period|Adverse Event|5
192742|NCT01020123|611700|P7|Main Period|Eligibility Criteria not fullfilled|0
192743|NCT01020123|611701|P6|Main Period|Eligibility Criteria not fullfilled|0
192744|NCT01020123|611702|P5|Main Period|Eligibility Criteria not fullfilled|1
192745|NCT01020123|611703|P4|Main Period|Eligibility Criteria not fullfilled|0
192746|NCT01020123|611704|P3|Main Period|Eligibility Criteria not fullfilled|0
192747|NCT01020123|611705|P2|Main Period|Eligibility Criteria not fullfilled|1
192748|NCT01020123|611706|P1|Main Period|Eligibility Criteria not fullfilled|0
192749|NCT01020123|611700|P7|Main Period|Withdrawal by Subject|2
192750|NCT01020123|611701|P6|Main Period|Withdrawal by Subject|3
192751|NCT01020123|611702|P5|Main Period|Withdrawal by Subject|6
192752|NCT01020123|611703|P4|Main Period|Withdrawal by Subject|1
192753|NCT01020123|611704|P3|Main Period|Withdrawal by Subject|3
192754|NCT01020123|611705|P2|Main Period|Withdrawal by Subject|5
192755|NCT01020123|611706|P1|Main Period|Withdrawal by Subject|6
192756|NCT01021423|611901|P2|Overall Study|Study terminated|5
192757|NCT01021423|611902|P1|Overall Study|Study terminated|4
192758|NCT01021683|611929|P1|Overall Study|unspecified|8
192759|NCT01021683|611929|P1|Overall Study|Recovery of neutrophil count|51
192760|NCT01021683|611929|P1|Overall Study|Lack of Efficacy|12
192761|NCT01021813|611956|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
192762|NCT01021813|611957|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
192763|NCT01021813|611958|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
192764|NCT01021813|611959|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
192765|NCT01021813|611960|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
192766|NCT01021813|611956|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
192767|NCT01021813|611957|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
192768|NCT01021813|611958|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
192769|NCT01021813|611959|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
192770|NCT01021813|611960|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
192771|NCT01021813|611956|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
192772|NCT01021813|611957|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
192773|NCT01021813|611958|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
192774|NCT01021813|611959|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
192775|NCT01021813|611960|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
192776|NCT01021813|611956|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
192777|NCT01021813|611957|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
192778|NCT01021813|611958|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
192779|NCT01021813|611959|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
192780|NCT01021813|611960|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
192781|NCT01021813|611956|P5|DB Randomized Discontinuation Phase|Adverse Event|1
192782|NCT01021813|611957|P4|DB Randomized Discontinuation Phase|Adverse Event|3
192783|NCT01021813|611958|P3|DB Randomized Discontinuation Phase|Adverse Event|0
192784|NCT01021813|611959|P2|DB Randomized Discontinuation Phase|Adverse Event|0
192785|NCT01021813|611960|P1|DB Randomized Discontinuation Phase|Adverse Event|0
192786|NCT01021813|611956|P5|DB Treatment Phase|Withdrawal by Subject|0
192787|NCT01021813|611957|P4|DB Treatment Phase|Withdrawal by Subject|0
192788|NCT01021813|611958|P3|DB Treatment Phase|Withdrawal by Subject|0
192789|NCT01021813|611959|P2|DB Treatment Phase|Withdrawal by Subject|24
192790|NCT01021813|611960|P1|DB Treatment Phase|Withdrawal by Subject|60
192791|NCT01021813|611956|P5|DB Treatment Phase|Protocol Violation|0
192792|NCT01021813|611957|P4|DB Treatment Phase|Protocol Violation|0
192793|NCT01021813|611958|P3|DB Treatment Phase|Protocol Violation|0
192794|NCT01021813|611959|P2|DB Treatment Phase|Protocol Violation|3
192795|NCT01021813|611960|P1|DB Treatment Phase|Protocol Violation|4
192796|NCT01021813|611956|P5|DB Treatment Phase|Pregnancy|0
192797|NCT01021813|611957|P4|DB Treatment Phase|Pregnancy|0
192798|NCT01021813|611958|P3|DB Treatment Phase|Pregnancy|0
192799|NCT01021813|611959|P2|DB Treatment Phase|Pregnancy|0
192800|NCT01021813|611960|P1|DB Treatment Phase|Pregnancy|1
192801|NCT01021813|611956|P5|DB Treatment Phase|Physician Decision|0
192802|NCT01021813|611957|P4|DB Treatment Phase|Physician Decision|0
192803|NCT01021813|611958|P3|DB Treatment Phase|Physician Decision|0
192804|NCT01021813|611959|P2|DB Treatment Phase|Physician Decision|8
192805|NCT01021813|611960|P1|DB Treatment Phase|Physician Decision|17
192806|NCT01021813|611956|P5|DB Treatment Phase|Lost to Follow-up|0
192807|NCT01021813|611957|P4|DB Treatment Phase|Lost to Follow-up|0
192808|NCT01021813|611958|P3|DB Treatment Phase|Lost to Follow-up|0
192809|NCT01021813|611959|P2|DB Treatment Phase|Lost to Follow-up|12
192810|NCT01021813|611960|P1|DB Treatment Phase|Lost to Follow-up|14
192811|NCT01021813|611956|P5|DB Treatment Phase|Lack of Efficacy|0
192812|NCT01021813|611957|P4|DB Treatment Phase|Lack of Efficacy|0
192813|NCT01021813|611958|P3|DB Treatment Phase|Lack of Efficacy|0
192814|NCT01021813|611959|P2|DB Treatment Phase|Lack of Efficacy|28
192815|NCT01021813|611960|P1|DB Treatment Phase|Lack of Efficacy|44
192816|NCT01021813|611956|P5|DB Treatment Phase|Adverse Event|0
192817|NCT01021813|611957|P4|DB Treatment Phase|Adverse Event|0
192818|NCT01021813|611958|P3|DB Treatment Phase|Adverse Event|0
192819|NCT01021813|611959|P2|DB Treatment Phase|Adverse Event|22
192820|NCT01021813|611960|P1|DB Treatment Phase|Adverse Event|60
192821|NCT01021852|612007|P8|Treatment Period 2|Withdrawal by Subject|2
192822|NCT01021852|612008|P7|Treatment Period 2|Withdrawal by Subject|1
192823|NCT01021852|612009|P6|Treatment Period 2|Withdrawal by Subject|0
192824|NCT01021852|612010|P5|Treatment Period 2|Withdrawal by Subject|0
192825|NCT01021852|612011|P4|Treatment Period 2|Withdrawal by Subject|0
192826|NCT01021852|612012|P3|Treatment Period 2|Withdrawal by Subject|0
192827|NCT01021852|612013|P2|Treatment Period 2|Withdrawal by Subject|0
192828|NCT01021852|612014|P1|Treatment Period 2|Withdrawal by Subject|0
192829|NCT01021852|612007|P8|Treatment Period 2|Protocol Violation|0
192830|NCT01021852|612008|P7|Treatment Period 2|Protocol Violation|1
192831|NCT01021852|612009|P6|Treatment Period 2|Protocol Violation|0
192832|NCT01021852|612010|P5|Treatment Period 2|Protocol Violation|1
192833|NCT01021852|612011|P4|Treatment Period 2|Protocol Violation|0
192834|NCT01021852|612012|P3|Treatment Period 2|Protocol Violation|0
192835|NCT01021852|612013|P2|Treatment Period 2|Protocol Violation|0
192836|NCT01021852|612014|P1|Treatment Period 2|Protocol Violation|0
192837|NCT01021852|612007|P8|Treatment Period 2|Physician Decision|0
192838|NCT01021852|612008|P7|Treatment Period 2|Physician Decision|0
192839|NCT01021852|612009|P6|Treatment Period 2|Physician Decision|0
192840|NCT01021852|612010|P5|Treatment Period 2|Physician Decision|0
192841|NCT01021852|612011|P4|Treatment Period 2|Physician Decision|0
192842|NCT01021852|612012|P3|Treatment Period 2|Physician Decision|1
192843|NCT01021852|612013|P2|Treatment Period 2|Physician Decision|0
192844|NCT01021852|612014|P1|Treatment Period 2|Physician Decision|0
192845|NCT01021852|612007|P8|Treatment Period 2|Lack of Efficacy|0
192846|NCT01021852|612008|P7|Treatment Period 2|Lack of Efficacy|0
192847|NCT01021852|612009|P6|Treatment Period 2|Lack of Efficacy|1
192848|NCT01021852|612010|P5|Treatment Period 2|Lack of Efficacy|0
192849|NCT01021852|612011|P4|Treatment Period 2|Lack of Efficacy|0
192850|NCT01021852|612012|P3|Treatment Period 2|Lack of Efficacy|0
192851|NCT01021852|612013|P2|Treatment Period 2|Lack of Efficacy|0
192852|NCT01021852|612014|P1|Treatment Period 2|Lack of Efficacy|0
192853|NCT01021852|612007|P8|Treatment Period 2|Adverse Event|0
192854|NCT01021852|612008|P7|Treatment Period 2|Adverse Event|1
192855|NCT01021852|612009|P6|Treatment Period 2|Adverse Event|0
192856|NCT01021852|612010|P5|Treatment Period 2|Adverse Event|1
192857|NCT01021852|612011|P4|Treatment Period 2|Adverse Event|0
192858|NCT01021852|612012|P3|Treatment Period 2|Adverse Event|0
192859|NCT01021852|612013|P2|Treatment Period 2|Adverse Event|1
192860|NCT01021852|612014|P1|Treatment Period 2|Adverse Event|0
192861|NCT01021852|612007|P8|Washout Period-No Drug|Adverse Event|0
192862|NCT01021852|612008|P7|Washout Period-No Drug|Adverse Event|0
192863|NCT01021852|612009|P6|Washout Period-No Drug|Adverse Event|1
192864|NCT01021852|612010|P5|Washout Period-No Drug|Adverse Event|0
192865|NCT01021852|612011|P4|Washout Period-No Drug|Adverse Event|0
192866|NCT01021852|612012|P3|Washout Period-No Drug|Adverse Event|0
192867|NCT01021852|612013|P2|Washout Period-No Drug|Adverse Event|0
192868|NCT01021852|612014|P1|Washout Period-No Drug|Adverse Event|1
192869|NCT01021852|612007|P8|Washout Period-Placebo|Protocol Violation|0
192870|NCT01021852|612008|P7|Washout Period-Placebo|Protocol Violation|1
192871|NCT01021852|612009|P6|Washout Period-Placebo|Protocol Violation|0
192872|NCT01021852|612010|P5|Washout Period-Placebo|Protocol Violation|0
192873|NCT01021852|612011|P4|Washout Period-Placebo|Protocol Violation|0
192874|NCT01021852|612012|P3|Washout Period-Placebo|Protocol Violation|0
192875|NCT01021852|612013|P2|Washout Period-Placebo|Protocol Violation|0
192876|NCT01021852|612014|P1|Washout Period-Placebo|Protocol Violation|0
192877|NCT01021852|612007|P8|Washout Period-Placebo|Lost to Follow-up|0
192878|NCT01021852|612008|P7|Washout Period-Placebo|Lost to Follow-up|0
192879|NCT01021852|612009|P6|Washout Period-Placebo|Lost to Follow-up|0
192880|NCT01021852|612010|P5|Washout Period-Placebo|Lost to Follow-up|1
192881|NCT01021852|612011|P4|Washout Period-Placebo|Lost to Follow-up|0
192882|NCT01021852|612012|P3|Washout Period-Placebo|Lost to Follow-up|0
192883|NCT01021852|612013|P2|Washout Period-Placebo|Lost to Follow-up|0
192884|NCT01021852|612014|P1|Washout Period-Placebo|Lost to Follow-up|0
192885|NCT01021852|612007|P8|Washout Period-Placebo|Adverse Event|0
192886|NCT01021852|612008|P7|Washout Period-Placebo|Adverse Event|0
192887|NCT01021852|612009|P6|Washout Period-Placebo|Adverse Event|1
192888|NCT01021852|612010|P5|Washout Period-Placebo|Adverse Event|0
192889|NCT01021852|612011|P4|Washout Period-Placebo|Adverse Event|1
192890|NCT01021852|612012|P3|Washout Period-Placebo|Adverse Event|0
192891|NCT01021852|612013|P2|Washout Period-Placebo|Adverse Event|0
192892|NCT01021852|612014|P1|Washout Period-Placebo|Adverse Event|0
192893|NCT01021852|612007|P8|Treatment Period 1|Not Treated|0
192894|NCT01021852|612008|P7|Treatment Period 1|Not Treated|0
192895|NCT01021852|612009|P6|Treatment Period 1|Not Treated|0
192896|NCT01021852|612010|P5|Treatment Period 1|Not Treated|0
192897|NCT01021852|612011|P4|Treatment Period 1|Not Treated|2
192898|NCT01021852|612012|P3|Treatment Period 1|Not Treated|0
192899|NCT01021852|612013|P2|Treatment Period 1|Not Treated|0
192900|NCT01021852|612014|P1|Treatment Period 1|Not Treated|0
192901|NCT01021852|612007|P8|Treatment Period 1|Withdrawal by Subject|1
192902|NCT01021852|612008|P7|Treatment Period 1|Withdrawal by Subject|0
192903|NCT01021852|612009|P6|Treatment Period 1|Withdrawal by Subject|0
192904|NCT01021852|612010|P5|Treatment Period 1|Withdrawal by Subject|1
192905|NCT01021852|612011|P4|Treatment Period 1|Withdrawal by Subject|0
192906|NCT01021852|612012|P3|Treatment Period 1|Withdrawal by Subject|0
192907|NCT01021852|612013|P2|Treatment Period 1|Withdrawal by Subject|0
192908|NCT01021852|612014|P1|Treatment Period 1|Withdrawal by Subject|0
192909|NCT01021852|612007|P8|Treatment Period 1|Pregnancy|0
192910|NCT01021852|612008|P7|Treatment Period 1|Pregnancy|0
192911|NCT01021852|612009|P6|Treatment Period 1|Pregnancy|0
192912|NCT01021852|612010|P5|Treatment Period 1|Pregnancy|0
192913|NCT01021852|612011|P4|Treatment Period 1|Pregnancy|0
192914|NCT01021852|612012|P3|Treatment Period 1|Pregnancy|1
192915|NCT01021852|612013|P2|Treatment Period 1|Pregnancy|0
192916|NCT01021852|612014|P1|Treatment Period 1|Pregnancy|0
192917|NCT01021852|612007|P8|Treatment Period 1|Adverse Event|0
192918|NCT01021852|612008|P7|Treatment Period 1|Adverse Event|0
192919|NCT01021852|612009|P6|Treatment Period 1|Adverse Event|2
192920|NCT01021852|612010|P5|Treatment Period 1|Adverse Event|2
192921|NCT01021852|612011|P4|Treatment Period 1|Adverse Event|0
192922|NCT01021852|612012|P3|Treatment Period 1|Adverse Event|1
192923|NCT01021852|612013|P2|Treatment Period 1|Adverse Event|1
192924|NCT01021852|612014|P1|Treatment Period 1|Adverse Event|3
192925|NCT01021878|612050|P2|Overall Study|Transplantation|1
192926|NCT01021878|612051|P1|Overall Study|Transplantation|6
192927|NCT01021878|612050|P2|Overall Study|Adverse Event|5
192928|NCT01021878|612051|P1|Overall Study|Adverse Event|6
192929|NCT01021878|612050|P2|Overall Study|Death|1
192930|NCT01021878|612051|P1|Overall Study|Death|0
192931|NCT01021878|612050|P2|Overall Study|Lost to Follow-up|3
192932|NCT01021878|612051|P1|Overall Study|Lost to Follow-up|4
192933|NCT01022112|612079|P5|Overall Study|Fasting plasma glucose level increased|7
192934|NCT01022112|612080|P4|Overall Study|Fasting plasma glucose level increased|0
192935|NCT01022112|612081|P3|Overall Study|Fasting plasma glucose level increased|0
192936|NCT01022112|612082|P2|Overall Study|Fasting plasma glucose level increased|0
192937|NCT01022112|612083|P1|Overall Study|Fasting plasma glucose level increased|1
192938|NCT01022112|612079|P5|Overall Study|Withdrawal by Subject|1
192939|NCT01022112|612080|P4|Overall Study|Withdrawal by Subject|2
192940|NCT01022112|612081|P3|Overall Study|Withdrawal by Subject|2
192941|NCT01022112|612082|P2|Overall Study|Withdrawal by Subject|1
192942|NCT01022112|612083|P1|Overall Study|Withdrawal by Subject|0
192943|NCT01022112|612079|P5|Overall Study|Physician Decision|1
192944|NCT01022112|612080|P4|Overall Study|Physician Decision|0
192945|NCT01022112|612081|P3|Overall Study|Physician Decision|1
192946|NCT01022112|612082|P2|Overall Study|Physician Decision|0
192947|NCT01022112|612083|P1|Overall Study|Physician Decision|0
192948|NCT01022112|612079|P5|Overall Study|Lack of Efficacy|1
192949|NCT01022112|612080|P4|Overall Study|Lack of Efficacy|0
192950|NCT01022112|612081|P3|Overall Study|Lack of Efficacy|0
192951|NCT01022112|612082|P2|Overall Study|Lack of Efficacy|0
192952|NCT01022112|612083|P1|Overall Study|Lack of Efficacy|1
192953|NCT01022112|612079|P5|Overall Study|Adverse Event|0
192954|NCT01022112|612080|P4|Overall Study|Adverse Event|1
192955|NCT01022112|612081|P3|Overall Study|Adverse Event|0
192956|NCT01022112|612082|P2|Overall Study|Adverse Event|2
192957|NCT01022112|612083|P1|Overall Study|Adverse Event|1
192958|NCT01022203|612101|P2|Follow-Up Assessment|Lost to Follow-up|2
192959|NCT01022203|612102|P1|Follow-Up Assessment|Lost to Follow-up|2
192960|NCT01022203|612101|P2|Post Treatment Assessment|Adverse Event|2
192961|NCT01022203|612102|P1|Post Treatment Assessment|Adverse Event|0
192962|NCT01022203|612101|P2|Post Treatment Assessment|Physician Decision|0
192963|NCT01022203|612102|P1|Post Treatment Assessment|Physician Decision|2
192964|NCT01022203|612101|P2|Post Treatment Assessment|Withdrawal by Subject|12
192965|NCT01022203|612102|P1|Post Treatment Assessment|Withdrawal by Subject|12
192966|NCT01022398|612132|P2|Overall Study|Study terminated|2
192967|NCT01022398|612133|P1|Overall Study|Study terminated|2
192968|NCT01022502|612138|P1|Overall Study|Withdrawal by Subject|1
192969|NCT01022502|612138|P1|Overall Study|employment related reasons|1
192970|NCT01022502|612138|P1|Overall Study|Adverse Event|1
192971|NCT01022762|612163|P2|Overall Study|Unclassified|20
192972|NCT01022762|612164|P1|Overall Study|Unclassified|12
192973|NCT01022762|612163|P2|Overall Study|Protocol Violation|6
192974|NCT01022762|612164|P1|Overall Study|Protocol Violation|7
192975|NCT01022762|612163|P2|Overall Study|Lack of Efficacy|1
192976|NCT01022762|612164|P1|Overall Study|Lack of Efficacy|0
192977|NCT01022762|612163|P2|Overall Study|Adverse Event|1
192978|NCT01022762|612164|P1|Overall Study|Adverse Event|3
192979|NCT01022996|612190|P1|Overall Study|Protocol Violation|1
192980|NCT01022996|612190|P1|Overall Study|Disease Progression|32
192981|NCT01022996|612190|P1|Overall Study|Administrative problems|6
192982|NCT01022996|612190|P1|Overall Study|Lost to Follow-up|1
192983|NCT01022996|612190|P1|Overall Study|Withdrawal by Subject|3
192984|NCT01022996|612190|P1|Overall Study|Adverse Event|14
192985|NCT01023022|612199|P1|Overall Study|due to technical issues|2
192986|NCT01023022|612199|P1|Overall Study|Lost to Follow-up|7
192987|NCT01023022|612199|P1|Overall Study|Death|5
192988|NCT01023035|612208|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
192989|NCT01023035|612209|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
192990|NCT01023035|612210|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
192991|NCT01023035|612208|P3|Follow-up Period (up to Week 72)|Adverse Event|1
192992|NCT01023035|612209|P2|Follow-up Period (up to Week 72)|Adverse Event|0
192993|NCT01023035|612210|P1|Follow-up Period (up to Week 72)|Adverse Event|2
192994|NCT01023035|612208|P3|Treatment Period|Treatment Failure|24
192995|NCT01023035|612209|P2|Treatment Period|Treatment Failure|31
192996|NCT01023035|612210|P1|Treatment Period|Treatment Failure|26
192997|NCT01023035|612208|P3|Treatment Period|Non-Medical Reasons|44
192998|NCT01023035|612209|P2|Treatment Period|Non-Medical Reasons|22
192999|NCT01023035|612210|P1|Treatment Period|Non-Medical Reasons|19
193000|NCT01023035|612208|P3|Treatment Period|Adverse Event|50
193001|NCT01023035|612209|P2|Treatment Period|Adverse Event|32
193002|NCT01023035|612210|P1|Treatment Period|Adverse Event|27
193003|NCT01023061|612220|P1|Overall Study|Withdrawal prior to treatment|2
193004|NCT01023217|612260|P2|Overall Study|Withdrawal by Subject|0
193005|NCT01023217|612261|P1|Overall Study|Withdrawal by Subject|1
193006|NCT01023256|612271|P4|Overall Study|Withdrawal by Subject|2
193007|NCT01023256|612272|P3|Overall Study|Withdrawal by Subject|0
193008|NCT01023256|612273|P2|Overall Study|Withdrawal by Subject|0
193009|NCT01023256|612274|P1|Overall Study|Withdrawal by Subject|0
193010|NCT01023256|612271|P4|Overall Study|Adverse Event|1
193011|NCT01023256|612272|P3|Overall Study|Adverse Event|0
193012|NCT01023256|612273|P2|Overall Study|Adverse Event|0
193013|NCT01023256|612274|P1|Overall Study|Adverse Event|0
193014|NCT01023256|612271|P4|Overall Study|Not specified|2
193015|NCT01023256|612272|P3|Overall Study|Not specified|0
193016|NCT01023256|612273|P2|Overall Study|Not specified|0
193017|NCT01023256|612274|P1|Overall Study|Not specified|1
193018|NCT01023256|612271|P4|Overall Study|Randomized but not treated|0
193019|NCT01023256|612272|P3|Overall Study|Randomized but not treated|1
193020|NCT01023256|612273|P2|Overall Study|Randomized but not treated|0
193021|NCT01023256|612274|P1|Overall Study|Randomized but not treated|1
193022|NCT01023256|612271|P4|Overall Study|Protocol Violation|0
193023|NCT01023256|612272|P3|Overall Study|Protocol Violation|0
193024|NCT01023256|612273|P2|Overall Study|Protocol Violation|3
193025|NCT01023256|612274|P1|Overall Study|Protocol Violation|2
193026|NCT01023308|612316|P2|Overall Study|Withdrawal by Subject|18
193027|NCT01023308|612317|P1|Overall Study|Withdrawal by Subject|34
193028|NCT01023308|612316|P2|Overall Study|Lost to Follow-up|0
193029|NCT01023308|612317|P1|Overall Study|Lost to Follow-up|1
193030|NCT01023308|612316|P2|Overall Study|Untreated|5
193031|NCT01023308|612317|P1|Overall Study|Untreated|5
193032|NCT01023308|612316|P2|Overall Study|Protocol Violation|4
193033|NCT01023308|612317|P1|Overall Study|Protocol Violation|3
193034|NCT01023308|612316|P2|Overall Study|New Cancer therapy|7
193035|NCT01023308|612317|P1|Overall Study|New Cancer therapy|4
193036|NCT01023308|612316|P2|Overall Study|Disease progression|153
193037|NCT01023308|612317|P1|Overall Study|Disease progression|82
193038|NCT01023308|612316|P2|Overall Study|Death|17
193039|NCT01023308|612317|P1|Overall Study|Death|21
193040|NCT01023308|612316|P2|Overall Study|Adverse Event|66
193041|NCT01023308|612317|P1|Overall Study|Adverse Event|130
193042|NCT01023308|612316|P2|Overall Study|Administrative problems|1
193043|NCT01023308|612317|P1|Overall Study|Administrative problems|2
193044|NCT01023308|612316|P2|Overall Study|Abnormal test proceedure results|8
193045|NCT01023308|612317|P1|Overall Study|Abnormal test proceedure results|3
193046|NCT01023516|612345|P2|Overall Study|Incorrect enrolment|2
193047|NCT01023516|612346|P1|Overall Study|Incorrect enrolment|4
193048|NCT01023516|612345|P2|Overall Study|Study-specific criteria|2
193049|NCT01023516|612346|P1|Overall Study|Study-specific criteria|4
193050|NCT01023516|612345|P2|Overall Study|Safety reason|3
193051|NCT01023516|612346|P1|Overall Study|Safety reason|0
193052|NCT01023516|612345|P2|Overall Study|Adverse Event|6
193053|NCT01023516|612346|P1|Overall Study|Adverse Event|9
193054|NCT01023516|612345|P2|Overall Study|Voluntary discontinuation|5
193055|NCT01023516|612346|P1|Overall Study|Voluntary discontinuation|7
193056|NCT01023581|612458|P7|Overall Study|Other|0
193057|NCT01023581|612459|P6|Overall Study|Other|0
193058|NCT01023581|612460|P5|Overall Study|Other|1
193059|NCT01023581|612461|P4|Overall Study|Other|0
193060|NCT01023581|612462|P3|Overall Study|Other|1
193061|NCT01023581|612463|P2|Overall Study|Other|0
193062|NCT01023581|612464|P1|Overall Study|Other|1
193063|NCT01023581|612458|P7|Overall Study|Physician Decision|1
193064|NCT01023581|612459|P6|Overall Study|Physician Decision|1
193065|NCT01023581|612460|P5|Overall Study|Physician Decision|1
193066|NCT01023581|612461|P4|Overall Study|Physician Decision|1
193067|NCT01023581|612462|P3|Overall Study|Physician Decision|2
193068|NCT01023581|612463|P2|Overall Study|Physician Decision|0
193069|NCT01023581|612464|P1|Overall Study|Physician Decision|2
193070|NCT01023581|612458|P7|Overall Study|Lack of Efficacy|1
193071|NCT01023581|612459|P6|Overall Study|Lack of Efficacy|2
193072|NCT01023581|612460|P5|Overall Study|Lack of Efficacy|1
193073|NCT01023581|612461|P4|Overall Study|Lack of Efficacy|2
193074|NCT01023581|612462|P3|Overall Study|Lack of Efficacy|6
193075|NCT01023581|612463|P2|Overall Study|Lack of Efficacy|3
193076|NCT01023581|612464|P1|Overall Study|Lack of Efficacy|9
193077|NCT01023581|612458|P7|Overall Study|Pregnancy|0
193078|NCT01023581|612459|P6|Overall Study|Pregnancy|1
193079|NCT01023581|612460|P5|Overall Study|Pregnancy|0
193080|NCT01023581|612461|P4|Overall Study|Pregnancy|2
193081|NCT01023581|612462|P3|Overall Study|Pregnancy|0
193082|NCT01023581|612463|P2|Overall Study|Pregnancy|0
193083|NCT01023581|612464|P1|Overall Study|Pregnancy|0
193084|NCT01023581|612458|P7|Overall Study|Withdrawal by Subject|5
193085|NCT01023581|612459|P6|Overall Study|Withdrawal by Subject|8
193086|NCT01023581|612460|P5|Overall Study|Withdrawal by Subject|6
193087|NCT01023581|612461|P4|Overall Study|Withdrawal by Subject|10
193088|NCT01023581|612462|P3|Overall Study|Withdrawal by Subject|16
193089|NCT01023581|612463|P2|Overall Study|Withdrawal by Subject|8
193090|NCT01023581|612464|P1|Overall Study|Withdrawal by Subject|13
193091|NCT01023581|612458|P7|Overall Study|Lost to Follow-up|2
193092|NCT01023581|612459|P6|Overall Study|Lost to Follow-up|2
193093|NCT01023581|612460|P5|Overall Study|Lost to Follow-up|5
193094|NCT01023581|612461|P4|Overall Study|Lost to Follow-up|2
193095|NCT01023581|612462|P3|Overall Study|Lost to Follow-up|7
193096|NCT01023581|612463|P2|Overall Study|Lost to Follow-up|8
193097|NCT01023581|612464|P1|Overall Study|Lost to Follow-up|4
193098|NCT01023581|612458|P7|Overall Study|Major protocol deviation|0
193099|NCT01023581|612459|P6|Overall Study|Major protocol deviation|0
193100|NCT01023581|612460|P5|Overall Study|Major protocol deviation|0
193101|NCT01023581|612461|P4|Overall Study|Major protocol deviation|0
193102|NCT01023581|612462|P3|Overall Study|Major protocol deviation|3
193103|NCT01023581|612463|P2|Overall Study|Major protocol deviation|0
193104|NCT01023581|612464|P1|Overall Study|Major protocol deviation|2
193105|NCT01023581|612458|P7|Overall Study|Adverse Event|11
193106|NCT01023581|612459|P6|Overall Study|Adverse Event|5
193107|NCT01023581|612460|P5|Overall Study|Adverse Event|2
193108|NCT01023581|612461|P4|Overall Study|Adverse Event|3
193109|NCT01023581|612462|P3|Overall Study|Adverse Event|7
193110|NCT01023581|612463|P2|Overall Study|Adverse Event|4
193111|NCT01023581|612464|P1|Overall Study|Adverse Event|4
193112|NCT01023659|612497|P3|Overall Study|Lost to Follow-up|99
193113|NCT01023659|612498|P2|Overall Study|Lost to Follow-up|228
193114|NCT01023659|612499|P1|Overall Study|Lost to Follow-up|73
193115|NCT01023672|612508|P1|Overall Study|Death|1
193116|NCT01023672|612508|P1|Overall Study|Worsening disease|2
193117|NCT01023815|612535|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
193118|NCT01023815|612536|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
193119|NCT01023815|612537|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
193120|NCT01023815|612538|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
193121|NCT01023815|612535|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
193122|NCT01023815|612536|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
193123|NCT01023815|612537|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
193124|NCT01023815|612538|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
193125|NCT01023815|612535|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
193126|NCT01023815|612536|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
193127|NCT01023815|612537|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
193128|NCT01023815|612538|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
193129|NCT01023815|612535|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
193130|NCT01023815|612536|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
193131|NCT01023815|612537|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
193132|NCT01023815|612538|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
193133|NCT01023815|612535|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
193134|NCT01023815|612536|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
193135|NCT01023815|612537|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
193136|NCT01023815|612538|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
193137|NCT01008449|612589|P2|Overall Study|Lost to Follow-up|19
193138|NCT01008449|612590|P1|Overall Study|Lost to Follow-up|29
193139|NCT01008475|612617|P7|Overall Study|Ongoing treatment at data cut-off date|4
193140|NCT01008475|612618|P6|Overall Study|Ongoing treatment at data cut-off date|6
193141|NCT01008475|612619|P5|Overall Study|Ongoing treatment at data cut-off date|5
193142|NCT01008475|612620|P4|Overall Study|Ongoing treatment at data cut-off date|0
193143|NCT01008475|612621|P3|Overall Study|Ongoing treatment at data cut-off date|0
193144|NCT01008475|612622|P2|Overall Study|Ongoing treatment at data cut-off date|0
193145|NCT01008475|612623|P1|Overall Study|Ongoing treatment at data cut-off date|0
193146|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
193147|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
193148|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
193149|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
193150|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
193151|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
193152|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
193153|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
193154|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
193155|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
193156|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
193157|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
193158|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
193159|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
193160|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
193161|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
193162|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
193163|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
193164|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|Adverse Event|4
193165|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|Adverse Event|14
193166|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|Adverse Event|0
193167|NCT01008553|612651|P3|Period 2 (Double-Blind Period)|Physician Decision|2
193168|NCT01008553|612652|P2|Period 2 (Double-Blind Period)|Physician Decision|1
193169|NCT01008553|612653|P1|Period 2 (Double-Blind Period)|Physician Decision|0
193170|NCT01008553|612651|P3|Period 1 (Titration Period)|Not appropriate for this study|0
193171|NCT01008553|612652|P2|Period 1 (Titration Period)|Not appropriate for this study|0
193172|NCT01008553|612653|P1|Period 1 (Titration Period)|Not appropriate for this study|1
193173|NCT01008553|612651|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
193174|NCT01008553|612652|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
193175|NCT01008553|612653|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
193176|NCT01008553|612651|P3|Period 1 (Titration Period)|Determined to increase dosage|0
193177|NCT01008553|612652|P2|Period 1 (Titration Period)|Determined to increase dosage|0
193178|NCT01008553|612653|P1|Period 1 (Titration Period)|Determined to increase dosage|3
193179|NCT01008553|612651|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
193180|NCT01008553|612652|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
193181|NCT01008553|612653|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
193182|NCT01008553|612651|P3|Period 1 (Titration Period)|Adverse Event|0
193183|NCT01008553|612652|P2|Period 1 (Titration Period)|Adverse Event|0
193184|NCT01008553|612653|P1|Period 1 (Titration Period)|Adverse Event|33
193185|NCT01008553|612651|P3|Period 1 (Titration Period)|Physician Decision|0
193186|NCT01008553|612652|P2|Period 1 (Titration Period)|Physician Decision|0
193187|NCT01008553|612653|P1|Period 1 (Titration Period)|Physician Decision|2
193188|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
193189|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
193190|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
193191|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
193192|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
193193|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
193194|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
193195|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
193196|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
193197|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
193198|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
193199|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
193200|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|Physician Decision|0
193201|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|Physician Decision|1
193202|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|Physician Decision|0
193203|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
193204|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
193205|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
193206|NCT01008618|612702|P3|Period 2 (Double-Blind Period)|Adverse Event|2
193207|NCT01008618|612703|P2|Period 2 (Double-Blind Period)|Adverse Event|11
193208|NCT01008618|612704|P1|Period 2 (Double-Blind Period)|Adverse Event|0
193209|NCT01008618|612702|P3|Period 1 (Titration Period)|Aggravated symptom|0
193210|NCT01008618|612703|P2|Period 1 (Titration Period)|Aggravated symptom|0
193211|NCT01008618|612704|P1|Period 1 (Titration Period)|Aggravated symptom|2
193212|NCT01008618|612702|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
193213|NCT01008618|612703|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
193214|NCT01008618|612704|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
193215|NCT01008618|612702|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
193216|NCT01008618|612703|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
193217|NCT01008618|612704|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
193218|NCT01008618|612702|P3|Period 1 (Titration Period)|Adverse Event|0
193219|NCT01008618|612703|P2|Period 1 (Titration Period)|Adverse Event|0
193220|NCT01008618|612704|P1|Period 1 (Titration Period)|Adverse Event|33
193221|NCT01008618|612702|P3|Period 1 (Titration Period)|Physician Decision|0
193222|NCT01008618|612703|P2|Period 1 (Titration Period)|Physician Decision|0
193223|NCT01008618|612704|P1|Period 1 (Titration Period)|Physician Decision|2
193224|NCT01009515|612729|P1|Overall Study|Withdrawal by Subject|3
193225|NCT01009554|612738|P2|Overall Study|Noncompliant with Study Product|3
193226|NCT01009554|612739|P1|Overall Study|Noncompliant with Study Product|0
193227|NCT01009554|612738|P2|Overall Study|Withdrawal by Subject|3
193228|NCT01009554|612739|P1|Overall Study|Withdrawal by Subject|1
193229|NCT01009554|612738|P2|Overall Study|Adverse Event|1
193230|NCT01009554|612739|P1|Overall Study|Adverse Event|1
193231|NCT01009580|612873|P2|Overall Study|Unclassified|21
193232|NCT01009580|612874|P1|Overall Study|Unclassified|17
193233|NCT01009580|612873|P2|Overall Study|Withdrawal Criteria|6
193234|NCT01009580|612874|P1|Overall Study|Withdrawal Criteria|4
193235|NCT01009580|612873|P2|Overall Study|Protocol Violation|3
193236|NCT01009580|612874|P1|Overall Study|Protocol Violation|2
193237|NCT01009580|612873|P2|Overall Study|Lack of Efficacy|1
193238|NCT01009580|612874|P1|Overall Study|Lack of Efficacy|0
193239|NCT01009580|612873|P2|Overall Study|Adverse Event|4
193240|NCT01009580|612874|P1|Overall Study|Adverse Event|4
193241|NCT01009645|612911|P4|Overall Study|Lost to Follow-up|5
193242|NCT01009645|612912|P3|Overall Study|Lost to Follow-up|4
193243|NCT01009645|612913|P2|Overall Study|Lost to Follow-up|8
193244|NCT01009645|612914|P1|Overall Study|Lost to Follow-up|2
193245|NCT01009840|612941|P1|Overall Study|Subject Withdrew Consent to Participate|1
193246|NCT01009840|612941|P1|Overall Study|Subject was Withdrawn by Investigator|1
193247|NCT01009840|612941|P1|Overall Study|Subject Met Withdrawal Criteria|7
193248|NCT01009840|612941|P1|Overall Study|Adverse Event|4
193249|NCT01009840|612941|P1|Overall Study|Lost to Follow-up|1
193250|NCT01009983|612960|P1|Overall Study|necessary scans not completed|1
193251|NCT01010061|612985|P2|Overall Study|Failure to Return|2
193252|NCT01010061|612986|P1|Overall Study|Failure to Return|3
193253|NCT01010061|612985|P2|Overall Study|Refused Treatment/Did Not Cooperate|1
193254|NCT01010061|612986|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
193255|NCT01010061|612985|P2|Overall Study|Administrative/Other|14
193256|NCT01010061|612986|P1|Overall Study|Administrative/Other|19
193257|NCT01010061|612985|P2|Overall Study|Death|7
193258|NCT01010061|612986|P1|Overall Study|Death|23
193259|NCT01010061|612985|P2|Overall Study|Withdrew Consent|4
193260|NCT01010061|612986|P1|Overall Study|Withdrew Consent|9
193261|NCT01010061|612985|P2|Overall Study|Progression of Disease|63
193262|NCT01010061|612986|P1|Overall Study|Progression of Disease|71
193263|NCT01010061|612985|P2|Overall Study|Adverse Events or Intercurrent Illness|4
193264|NCT01010061|612986|P1|Overall Study|Adverse Events or Intercurrent Illness|7
193265|NCT01010204|613019|P2|Overall Study|psychiatric hospitalization|1
193266|NCT01010204|613020|P1|Overall Study|psychiatric hospitalization|2
193267|NCT01010204|613019|P2|Overall Study|Withdrawal by Subject|3
193268|NCT01010204|613020|P1|Overall Study|Withdrawal by Subject|2
193269|NCT01010204|613019|P2|Overall Study|Adverse Event|3
193270|NCT01010204|613020|P1|Overall Study|Adverse Event|1
193271|NCT01010204|613019|P2|Overall Study|Lost to Follow-up|2
193272|NCT01010204|613020|P1|Overall Study|Lost to Follow-up|2
193273|NCT01010230|613030|P2|Overall Study|Lost to Follow-up|2
193274|NCT01010230|613031|P1|Overall Study|Lost to Follow-up|4
193275|NCT01010230|613030|P2|Overall Study|Withdrawal by Subject|5
193276|NCT01010230|613031|P1|Overall Study|Withdrawal by Subject|6
193277|NCT01010503|613100|P1|Overall Study|Death|1
193278|NCT01010503|613100|P1|Overall Study|Adverse Event|1
193279|NCT01010633|613137|P2|Overall Study|Investigator decision|1
193280|NCT01010633|613138|P1|Overall Study|Investigator decision|0
193281|NCT01010633|613137|P2|Overall Study|Withdrawal by Subject|1
193282|NCT01010633|613138|P1|Overall Study|Withdrawal by Subject|2
193283|NCT01010633|613137|P2|Overall Study|Protocol Violation|2
193284|NCT01010633|613138|P1|Overall Study|Protocol Violation|1
193285|NCT01010633|613137|P2|Overall Study|Adverse Event|1
193286|NCT01010633|613138|P1|Overall Study|Adverse Event|1
193287|NCT01010750|613154|P6|Second Intervention|Adverse Event|0
193288|NCT01010750|613155|P5|Second Intervention|Adverse Event|0
193289|NCT01010750|613156|P4|Second Intervention|Adverse Event|0
193290|NCT01010750|613157|P3|Second Intervention|Adverse Event|0
193291|NCT01010750|613158|P2|Second Intervention|Adverse Event|1
193292|NCT01010750|613159|P1|Second Intervention|Adverse Event|0
193293|NCT01010776|613182|P1|Extension Phase|Not specified|3
193294|NCT01010776|613182|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
193295|NCT01010776|613182|P1|Main Phase|Did not received study medication|5
193296|NCT01010776|613182|P1|Main Phase|Not specified|1
193297|NCT01010776|613182|P1|Main Phase|Inform consent withdrawal|1
193298|NCT01010776|613182|P1|Main Phase|Selection failure|2
193299|NCT01010776|613182|P1|Main Phase|Non-compliance to study medication|5
193300|NCT01010776|613182|P1|Main Phase|Lost to Follow-up|6
193301|NCT01010776|613182|P1|Main Phase|Adverse Event|7
193302|NCT01010776|613182|P1|Main Phase|Lack of Efficacy|8
193303|NCT01010776|613182|P1|Main Phase|Withdrawal by Subject|14
193304|NCT01010867|613204|P1|Overall Study|< 50% adherence to probiotic|1
193305|NCT01016600|613328|P4|Overall Study|Did not start treatment|0
193306|NCT01016600|613329|P3|Overall Study|Did not start treatment|0
193307|NCT01016600|613330|P2|Overall Study|Did not start treatment|0
193308|NCT01016600|613331|P1|Overall Study|Did not start treatment|1
193309|NCT01016912|613514|P5|Follow-up Period|Other reason|0
193310|NCT01016912|613515|P4|Follow-up Period|Other reason|1
193311|NCT01016912|613516|P3|Follow-up Period|Other reason|1
193312|NCT01016912|613517|P2|Follow-up Period|Other reason|0
193313|NCT01016912|613518|P1|Follow-up Period|Other reason|0
193314|NCT01016912|613514|P5|End of Treatment Period|Completed double-blind period only|0
193315|NCT01016912|613515|P4|End of Treatment Period|Completed double-blind period only|0
193316|NCT01016912|613516|P3|End of Treatment Period|Completed double-blind period only|0
193317|NCT01016912|613517|P2|End of Treatment Period|Completed double-blind period only|1
193318|NCT01016912|613518|P1|End of Treatment Period|Completed double-blind period only|0
193319|NCT01016912|613514|P5|End of Treatment Period|Adverse Event|0
193320|NCT01016912|613515|P4|End of Treatment Period|Adverse Event|0
193321|NCT01016912|613516|P3|End of Treatment Period|Adverse Event|1
193322|NCT01016912|613517|P2|End of Treatment Period|Adverse Event|1
193323|NCT01016912|613518|P1|End of Treatment Period|Adverse Event|0
193324|NCT01016912|613514|P5|End of Treatment Period|Lack of Efficacy|4
193325|NCT01016912|613515|P4|End of Treatment Period|Lack of Efficacy|4
193326|NCT01016912|613516|P3|End of Treatment Period|Lack of Efficacy|0
193327|NCT01016912|613517|P2|End of Treatment Period|Lack of Efficacy|1
193328|NCT01016912|613518|P1|End of Treatment Period|Lack of Efficacy|0
193329|NCT01016964|613567|P2|Overall Study|Lost to Follow-up|3
193330|NCT01016964|613568|P1|Overall Study|Lost to Follow-up|3
193331|NCT01016977|613576|P2|Overall Study|Withdrawal by Subject|2
193332|NCT01016977|613577|P1|Overall Study|Withdrawal by Subject|2
193333|NCT01016977|613576|P2|Overall Study|Lost to Follow-up|0
193334|NCT01016977|613577|P1|Overall Study|Lost to Follow-up|1
193335|NCT01017029|613623|P2|Overall Study|Death|1
193336|NCT01017029|613624|P1|Overall Study|Death|3
193337|NCT01017029|613623|P2|Overall Study|Administrative problem|1
193338|NCT01017029|613624|P1|Overall Study|Administrative problem|0
193339|NCT01017029|613623|P2|Overall Study|Lost to Follow-up|0
193340|NCT01017029|613624|P1|Overall Study|Lost to Follow-up|1
193341|NCT01017120|613653|P2|Overall Study|Parent Unable to Provide Transportation|0
193342|NCT01017120|613654|P1|Overall Study|Parent Unable to Provide Transportation|1
193343|NCT01017120|613653|P2|Overall Study|Protocol Violation|0
193344|NCT01017120|613654|P1|Overall Study|Protocol Violation|1
193345|NCT01017120|613653|P2|Overall Study|Relocated Out of Town|2
193346|NCT01017120|613654|P1|Overall Study|Relocated Out of Town|0
193347|NCT01017120|613653|P2|Overall Study|Did Not Meet Eligibility Criteria|0
193348|NCT01017120|613654|P1|Overall Study|Did Not Meet Eligibility Criteria|1
193349|NCT01017120|613653|P2|Overall Study|Pregnancy|1
193350|NCT01017120|613654|P1|Overall Study|Pregnancy|1
193351|NCT01017120|613653|P2|Overall Study|Withdrawal by Subject|21
193352|NCT01017120|613654|P1|Overall Study|Withdrawal by Subject|39
193353|NCT01017120|613653|P2|Overall Study|Lack of Efficacy|0
193354|NCT01017120|613654|P1|Overall Study|Lack of Efficacy|1
193355|NCT01017120|613653|P2|Overall Study|Lost to Follow-up|11
193356|NCT01017120|613654|P1|Overall Study|Lost to Follow-up|13
193357|NCT01017120|613653|P2|Overall Study|Adverse Event|0
193358|NCT01017120|613654|P1|Overall Study|Adverse Event|9
193359|NCT01017146|613704|P2|Overall Study|Change in Work Situation|0
193360|NCT01017146|613705|P1|Overall Study|Change in Work Situation|1
193361|NCT01017146|613704|P2|Overall Study|Did Not Meet Eligibility Criteria|2
193362|NCT01017146|613705|P1|Overall Study|Did Not Meet Eligibility Criteria|1
193363|NCT01017146|613704|P2|Overall Study|Took Excluded Medication|0
193364|NCT01017146|613705|P1|Overall Study|Took Excluded Medication|2
193365|NCT01017146|613704|P2|Overall Study|Protocol Violation|0
193366|NCT01017146|613705|P1|Overall Study|Protocol Violation|2
193367|NCT01017146|613704|P2|Overall Study|Pregnancy|1
193368|NCT01017146|613705|P1|Overall Study|Pregnancy|2
193369|NCT01017146|613704|P2|Overall Study|Relocation|4
193370|NCT01017146|613705|P1|Overall Study|Relocation|0
193371|NCT01017146|613704|P2|Overall Study|Withdrawal by Subject|16
193372|NCT01017146|613705|P1|Overall Study|Withdrawal by Subject|32
193373|NCT01017146|613704|P2|Overall Study|Noncompliance with Study Product|1
193374|NCT01017146|613705|P1|Overall Study|Noncompliance with Study Product|1
193375|NCT01017146|613704|P2|Overall Study|Lost to Follow-up|14
193376|NCT01017146|613705|P1|Overall Study|Lost to Follow-up|14
193377|NCT01017146|613704|P2|Overall Study|Adverse Event|1
193378|NCT01017146|613705|P1|Overall Study|Adverse Event|11
193379|NCT01017263|613816|P1|Overall Study|not eligible|12
193380|NCT01024036|613822|P2|Unblinded Treatment|Lack of Efficacy|0
193381|NCT01024036|613823|P1|Unblinded Treatment|Lack of Efficacy|2
193382|NCT01024036|613822|P2|Unblinded Treatment|Adverse Event|0
193383|NCT01024036|613823|P1|Unblinded Treatment|Adverse Event|1
193384|NCT01024036|613822|P2|Blinded Treatment|Withdrawal by Subject|3
193385|NCT01024036|613823|P1|Blinded Treatment|Withdrawal by Subject|4
193386|NCT01024036|613822|P2|Blinded Treatment|Death|2
193387|NCT01024036|613823|P1|Blinded Treatment|Death|0
193388|NCT01024036|613822|P2|Blinded Treatment|Physician Decision|0
193389|NCT01024036|613823|P1|Blinded Treatment|Physician Decision|1
193390|NCT01024036|613822|P2|Blinded Treatment|Lack of Efficacy|14
193391|NCT01024036|613823|P1|Blinded Treatment|Lack of Efficacy|16
193392|NCT01024036|613822|P2|Blinded Treatment|Adverse Event|1
193393|NCT01024036|613823|P1|Blinded Treatment|Adverse Event|1
193394|NCT01024608|613853|P2|Overall Study|Never received study treatment|0
193395|NCT01024608|613854|P1|Overall Study|Never received study treatment|2
193396|NCT01024608|613853|P2|Overall Study|Protocol Violation|3
193397|NCT01024608|613854|P1|Overall Study|Protocol Violation|0
193398|NCT01024608|613853|P2|Overall Study|Lost to Follow-up|1
193399|NCT01024608|613854|P1|Overall Study|Lost to Follow-up|0
193400|NCT01024608|613853|P2|Overall Study|Withdrawal by Subject|0
193401|NCT01024608|613854|P1|Overall Study|Withdrawal by Subject|1
193402|NCT01024608|613853|P2|Overall Study|Adverse Event|0
193403|NCT01024608|613854|P1|Overall Study|Adverse Event|1
193404|NCT01024751|613881|P2|Eligible Participants|Ineligible|1
193405|NCT01024751|613882|P1|Eligible Participants|Ineligible|0
193406|NCT01024751|613881|P2|Eligible Participants|Lost to Follow-up|1
193407|NCT01024751|613882|P1|Eligible Participants|Lost to Follow-up|0
193408|NCT01024751|613881|P2|Eligible Participants|Withdrawal by Subject|1
193409|NCT01024751|613882|P1|Eligible Participants|Withdrawal by Subject|0
193410|NCT01024751|613881|P2|Enrolled Participants|Ineligible at baseline|4
193411|NCT01024751|613882|P1|Enrolled Participants|Ineligible at baseline|3
193412|NCT01024855|613890|P1|Overall Study|Inclusion/exclusion criteria|1
193413|NCT01024946|613895|P1|Overall Study|Adverse Event|1
193414|NCT01024946|613895|P1|Overall Study|Withdrawal by Subject|1
193415|NCT01024946|613895|P1|Overall Study|Screen Failure|3
193416|NCT01024959|613899|P1|Overall Study|missing results required for analysis|17
193417|NCT01024959|613899|P1|Overall Study|results not evaluable|12
193418|NCT01024959|613899|P1|Overall Study|ineligible|12
193419|NCT01025037|613921|P1|Overall Study|Withdrawal by Subject|1
193420|NCT01025037|613921|P1|Overall Study|Lost to Follow-up|7
193421|NCT01025037|613921|P1|Overall Study|Adverse Event|3
193422|NCT01025154|613934|P1|Overall Study|Withdrawal by Subject|1
193423|NCT01025154|613934|P1|Overall Study|Lost to Follow-up|1
193424|NCT01025193|613939|P1|Overall Study|Adverse Event|3
193425|NCT01025193|613939|P1|Overall Study|Protocol Violation|1
193426|NCT01025232|613951|P2|Overall Study|Study drug no longer available|6
193427|NCT01025232|613952|P1|Overall Study|Study drug no longer available|3
193428|NCT01025336|613980|P5|Overall Study|Protocol Violation|0
193429|NCT01025336|613981|P4|Overall Study|Protocol Violation|2
193430|NCT01025336|613982|P3|Overall Study|Protocol Violation|0
193431|NCT01025336|613983|P2|Overall Study|Protocol Violation|0
193432|NCT01025336|613984|P1|Overall Study|Protocol Violation|0
193433|NCT01025635|614042|P2|Overall Study|Reason not known|2
193434|NCT01025635|614043|P1|Overall Study|Reason not known|4
193435|NCT01025635|614042|P2|Overall Study|Lost to Follow-up|13
193436|NCT01025635|614043|P1|Overall Study|Lost to Follow-up|9
193437|NCT01025635|614042|P2|Overall Study|Lack of Efficacy|1
193438|NCT01025635|614043|P1|Overall Study|Lack of Efficacy|0
193439|NCT01025635|614042|P2|Overall Study|Protocol Violation|2
193440|NCT01025635|614043|P1|Overall Study|Protocol Violation|4
193441|NCT01025635|614042|P2|Overall Study|Withdrawal by Subject|7
193442|NCT01025635|614043|P1|Overall Study|Withdrawal by Subject|6
193443|NCT01025817|614057|P2|Completed Study|Lost to Follow-up|1
193444|NCT01025817|614058|P1|Completed Study|Lost to Follow-up|0
193445|NCT01025817|614057|P2|Completed Study|Missing|0
193446|NCT01025817|614058|P1|Completed Study|Missing|2
193447|NCT01025817|614057|P2|Completed Study|Death|5
193448|NCT01025817|614058|P1|Completed Study|Death|6
193449|NCT01025817|614057|P2|Completed Study|Withdrawal by Subject|16
193450|NCT01025817|614058|P1|Completed Study|Withdrawal by Subject|8
193451|NCT01025817|614057|P2|Completed Study Medication|Lost to Follow-up|1
193452|NCT01025817|614058|P1|Completed Study Medication|Lost to Follow-up|0
193453|NCT01025817|614057|P2|Completed Study Medication|Subject no longer required study drug|1
193454|NCT01025817|614058|P1|Completed Study Medication|Subject no longer required study drug|0
193455|NCT01025817|614057|P2|Completed Study Medication|Abnormal lab values|2
193456|NCT01025817|614058|P1|Completed Study Medication|Abnormal lab values|0
193457|NCT01025817|614057|P2|Completed Study Medication|Death|2
193458|NCT01025817|614058|P1|Completed Study Medication|Death|2
193459|NCT01025817|614057|P2|Completed Study Medication|Graft loss|5
193460|NCT01025817|614058|P1|Completed Study Medication|Graft loss|2
193461|NCT01025817|614057|P2|Completed Study Medication|Abnormal test procedure|0
193462|NCT01025817|614058|P1|Completed Study Medication|Abnormal test procedure|4
193463|NCT01025817|614057|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
193464|NCT01025817|614058|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
193465|NCT01025817|614057|P2|Completed Study Medication|Administrative problems|5
193466|NCT01025817|614058|P1|Completed Study Medication|Administrative problems|7
193467|NCT01025817|614057|P2|Completed Study Medication|Withdrawal by Subject|9
193468|NCT01025817|614058|P1|Completed Study Medication|Withdrawal by Subject|8
193469|NCT01025817|614057|P2|Completed Study Medication|Protocol Deviation|8
193470|NCT01025817|614058|P1|Completed Study Medication|Protocol Deviation|9
193471|NCT01025817|614057|P2|Completed Study Medication|Adverse Event|39
193472|NCT01025817|614058|P1|Completed Study Medication|Adverse Event|66
193473|NCT01025843|614104|P10|Washout 4|Withdrawal by Subject|0
193474|NCT01025843|614105|P9|Washout 4|Withdrawal by Subject|0
193475|NCT01025843|614106|P8|Washout 4|Withdrawal by Subject|0
193476|NCT01025843|614107|P7|Washout 4|Withdrawal by Subject|0
193477|NCT01025843|614108|P6|Washout 4|Withdrawal by Subject|0
193478|NCT01025843|614109|P5|Washout 4|Withdrawal by Subject|0
193479|NCT01025843|614110|P4|Washout 4|Withdrawal by Subject|1
193480|NCT01025843|614111|P3|Washout 4|Withdrawal by Subject|1
193481|NCT01025843|614112|P2|Washout 4|Withdrawal by Subject|0
193482|NCT01025843|614113|P1|Washout 4|Withdrawal by Subject|0
193483|NCT01026038|614194|P3|Overall Study|Lost to Follow-up|0
193484|NCT01026038|614195|P2|Overall Study|Lost to Follow-up|1
193485|NCT01026038|614196|P1|Overall Study|Lost to Follow-up|1
193486|NCT01026103|614231|P1|Overall Study|did not receive study device bc of error|1
193487|NCT01026103|614231|P1|Overall Study|Physician Decision|1
193488|NCT01026142|614240|P2|Overall Study|Reasons not specified|23
193489|NCT01026142|614241|P1|Overall Study|Reasons not specified|25
193490|NCT01026142|614240|P2|Overall Study|Death|98
193491|NCT01026142|614241|P1|Overall Study|Death|114
193492|NCT01026194|614265|P2|Period 2：Open-label Period|Withdrawal by Subject|4
193493|NCT01026194|614266|P1|Period 2：Open-label Period|Withdrawal by Subject|0
193494|NCT01026194|614265|P2|Period 2：Open-label Period|Physician Decision|1
193495|NCT01026194|614266|P1|Period 2：Open-label Period|Physician Decision|3
193496|NCT01026194|614265|P2|Period 2：Open-label Period|Adverse Event|5
193497|NCT01026194|614266|P1|Period 2：Open-label Period|Adverse Event|4
193498|NCT01026194|614265|P2|Period 1：Double Blind Period|Physician Decision|4
193499|NCT01026194|614266|P1|Period 1：Double Blind Period|Physician Decision|0
193500|NCT01026194|614265|P2|Period 1：Double Blind Period|Lack of Efficacy|0
193501|NCT01026194|614266|P1|Period 1：Double Blind Period|Lack of Efficacy|1
193502|NCT01026194|614265|P2|Period 1：Double Blind Period|Adverse Event|1
193503|NCT01026194|614266|P1|Period 1：Double Blind Period|Adverse Event|2
193504|NCT01026220|614280|P3|Consolidation Maintenance|Withdrawal by Subject|6
193505|NCT01026220|614281|P2|Consolidation Maintenance|Withdrawal by Subject|2
193506|NCT01026220|614282|P1|Consolidation Maintenance|Withdrawal by Subject|0
193507|NCT01026220|614280|P3|Consolidation Maintenance|Physician Decision|7
193508|NCT01026220|614281|P2|Consolidation Maintenance|Physician Decision|2
193509|NCT01026220|614282|P1|Consolidation Maintenance|Physician Decision|0
193510|NCT01026220|614280|P3|Consolidation Maintenance|Lack of Efficacy|1
193511|NCT01026220|614281|P2|Consolidation Maintenance|Lack of Efficacy|1
193512|NCT01026220|614282|P1|Consolidation Maintenance|Lack of Efficacy|0
193513|NCT01026220|614280|P3|Consolidation Maintenance|Death|0
193514|NCT01026220|614281|P2|Consolidation Maintenance|Death|1
193515|NCT01026220|614282|P1|Consolidation Maintenance|Death|0
193516|NCT01026220|614280|P3|Induction|Ineligible|0
193517|NCT01026220|614281|P2|Induction|Ineligible|0
193518|NCT01026220|614282|P1|Induction|Ineligible|1
193519|NCT01026220|614280|P3|Induction|Withdrawal by Subject|0
193520|NCT01026220|614281|P2|Induction|Withdrawal by Subject|0
193521|NCT01026220|614282|P1|Induction|Withdrawal by Subject|9
193522|NCT01026220|614280|P3|Induction|Physician Decision|0
193523|NCT01026220|614281|P2|Induction|Physician Decision|0
193524|NCT01026220|614282|P1|Induction|Physician Decision|12
193525|NCT01026220|614280|P3|Induction|Lack of Efficacy|0
193526|NCT01026220|614281|P2|Induction|Lack of Efficacy|0
193527|NCT01026220|614282|P1|Induction|Lack of Efficacy|2
193528|NCT01026220|614280|P3|Induction|Death|0
193529|NCT01026220|614281|P2|Induction|Death|0
193530|NCT01026220|614282|P1|Induction|Death|1
193531|NCT01026324|614307|P3|Follow up/Survival|Withdrawal by Subject|0
193532|NCT01026324|614308|P2|Follow up/Survival|Withdrawal by Subject|0
193533|NCT01026324|614309|P1|Follow up/Survival|Withdrawal by Subject|1
193534|NCT01026389|614321|P2|Overall Study|change of treatment, patient moved|2
193535|NCT01026389|614322|P1|Overall Study|change of treatment, patient moved|4
193536|NCT01026389|614321|P2|Overall Study|Withdrawal by Subject|3
193537|NCT01026389|614322|P1|Overall Study|Withdrawal by Subject|1
193538|NCT01026454|614677|P2|Second Intervention|Pregnancy|1
193539|NCT01026454|614678|P1|Second Intervention|Pregnancy|1
193540|NCT01026493|614692|P8|Overall Study|Protocol Violation|1
193541|NCT01026493|614693|P7|Overall Study|Protocol Violation|4
193542|NCT01026493|614694|P6|Overall Study|Protocol Violation|3
193543|NCT01026493|614695|P5|Overall Study|Protocol Violation|2
193544|NCT01026493|614696|P4|Overall Study|Protocol Violation|0
193545|NCT01026493|614697|P3|Overall Study|Protocol Violation|0
193546|NCT01026493|614698|P2|Overall Study|Protocol Violation|1
193547|NCT01026493|614699|P1|Overall Study|Protocol Violation|0
193548|NCT01026792|614725|P1|Overall Study|Protocol Violation|1
193549|NCT01026818|614742|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
193550|NCT01026818|614743|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
193551|NCT01026818|614744|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
193552|NCT01026818|614745|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
193553|NCT01026818|614742|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
193554|NCT01026818|614743|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
193555|NCT01026818|614744|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
193556|NCT01026818|614745|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
193557|NCT01026818|614742|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
193558|NCT01026818|614743|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
193559|NCT01026818|614744|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
193560|NCT01026818|614745|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
193561|NCT01026818|614742|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
193562|NCT01026818|614743|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
193563|NCT01026818|614744|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
193564|NCT01026818|614745|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
193565|NCT01026818|614742|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
193566|NCT01026818|614743|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
193567|NCT01026818|614744|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
193568|NCT01026818|614745|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
193569|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
193570|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
193571|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
193572|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
193573|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
193574|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
193575|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
193576|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
193577|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
193578|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
193579|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
193580|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
193581|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
193582|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
193583|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
193584|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
193585|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
193586|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
193587|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
193588|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
193589|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
193590|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
193591|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
193592|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
193593|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
193594|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
193595|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
193596|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
193597|NCT01026818|614742|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
193598|NCT01026818|614743|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
193599|NCT01026818|614744|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
193600|NCT01026818|614745|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
193601|NCT01026818|614742|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
193602|NCT01026818|614743|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
193603|NCT01026818|614744|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
193604|NCT01026818|614745|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
193605|NCT01026818|614742|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
193606|NCT01026818|614743|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
193607|NCT01026818|614744|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
193608|NCT01026818|614745|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
193609|NCT01026818|614742|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
193610|NCT01026818|614743|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
193611|NCT01026818|614744|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
193612|NCT01026818|614745|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
193613|NCT01026818|614742|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
193614|NCT01026818|614743|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
193615|NCT01026818|614744|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
193616|NCT01026818|614745|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
193617|NCT01026818|614742|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
193618|NCT01026818|614743|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
193619|NCT01026818|614744|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
193620|NCT01026818|614745|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
193621|NCT01026818|614742|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
193622|NCT01026818|614743|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
193623|NCT01026818|614744|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
193624|NCT01026818|614745|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
193625|NCT01026818|614742|P4|Screening Period|Physician Decision|0
193626|NCT01026818|614743|P3|Screening Period|Physician Decision|0
193627|NCT01026818|614744|P2|Screening Period|Physician Decision|0
193628|NCT01026818|614745|P1|Screening Period|Physician Decision|1
193629|NCT01026818|614742|P4|Screening Period|Adverse Event|0
193630|NCT01026818|614743|P3|Screening Period|Adverse Event|0
193631|NCT01026818|614744|P2|Screening Period|Adverse Event|0
193632|NCT01026818|614745|P1|Screening Period|Adverse Event|2
193633|NCT01026818|614742|P4|Screening Period|Protocol Deviation|0
193634|NCT01026818|614743|P3|Screening Period|Protocol Deviation|0
193635|NCT01026818|614744|P2|Screening Period|Protocol Deviation|0
193636|NCT01026818|614745|P1|Screening Period|Protocol Deviation|3
193637|NCT01026818|614742|P4|Screening Period|Withdrawal by Subject|0
193638|NCT01026818|614743|P3|Screening Period|Withdrawal by Subject|0
193639|NCT01026818|614744|P2|Screening Period|Withdrawal by Subject|0
193640|NCT01026818|614745|P1|Screening Period|Withdrawal by Subject|49
193641|NCT01026818|614742|P4|Screening Period|Entry Criteria Not Met|0
193642|NCT01026818|614743|P3|Screening Period|Entry Criteria Not Met|0
193643|NCT01026818|614744|P2|Screening Period|Entry Criteria Not Met|0
193644|NCT01026818|614745|P1|Screening Period|Entry Criteria Not Met|105
193645|NCT01026831|614825|P2|Overall Study|Withdrawal by Subject|5
193646|NCT01026831|614826|P1|Overall Study|Withdrawal by Subject|7
193647|NCT01026831|614825|P2|Overall Study|Protocol Violation|2
193648|NCT01026831|614826|P1|Overall Study|Protocol Violation|0
193649|NCT01026831|614825|P2|Overall Study|Physician Decision|1
193650|NCT01026831|614826|P1|Overall Study|Physician Decision|1
193651|NCT01026831|614825|P2|Overall Study|Lost to Follow-up|0
193652|NCT01026831|614826|P1|Overall Study|Lost to Follow-up|2
193653|NCT01026831|614825|P2|Overall Study|Adverse Event|3
193654|NCT01026831|614826|P1|Overall Study|Adverse Event|4
193655|NCT01026948|614860|P1|Overall Study|Physician Decision|8
193656|NCT01026974|614869|P4|Overall Study|Inappropriate enrollment|0
193657|NCT01026974|614870|P3|Overall Study|Inappropriate enrollment|1
193658|NCT01026974|614871|P2|Overall Study|Inappropriate enrollment|0
193659|NCT01026974|614872|P1|Overall Study|Inappropriate enrollment|0
193660|NCT01026974|614869|P4|Overall Study|Adverse Event|1
193661|NCT01026974|614870|P3|Overall Study|Adverse Event|0
193662|NCT01026974|614871|P2|Overall Study|Adverse Event|0
193663|NCT01026974|614872|P1|Overall Study|Adverse Event|0
193664|NCT01026974|614869|P4|Overall Study|Lost to Follow-up|0
193665|NCT01026974|614870|P3|Overall Study|Lost to Follow-up|4
193666|NCT01026974|614871|P2|Overall Study|Lost to Follow-up|1
193667|NCT01026974|614872|P1|Overall Study|Lost to Follow-up|1
193668|NCT01026974|614869|P4|Overall Study|Withdrawal by Subject|2
193669|NCT01026974|614870|P3|Overall Study|Withdrawal by Subject|7
193670|NCT01026974|614871|P2|Overall Study|Withdrawal by Subject|1
193671|NCT01026974|614872|P1|Overall Study|Withdrawal by Subject|0
193672|NCT01008696|614935|P2|Overall Study|Other|2
193673|NCT01008696|614936|P1|Overall Study|Other|0
193674|NCT01008696|614935|P2|Overall Study|Unspecified|3
193675|NCT01008696|614936|P1|Overall Study|Unspecified|2
193676|NCT01008696|614935|P2|Overall Study|Participants' non-cooperation|3
193677|NCT01008696|614936|P1|Overall Study|Participants' non-cooperation|2
193678|NCT01008696|614935|P2|Overall Study|Adverse Event|0
193679|NCT01008696|614936|P1|Overall Study|Adverse Event|1
193680|NCT01008696|614935|P2|Overall Study|Physician Decision|1
193681|NCT01008696|614936|P1|Overall Study|Physician Decision|5
193682|NCT01008696|614935|P2|Overall Study|Withdrawal by Subject|4
193683|NCT01008696|614936|P1|Overall Study|Withdrawal by Subject|2
193684|NCT01008696|614935|P2|Overall Study|Participant's evasion of hospital visit|4
193685|NCT01008696|614936|P1|Overall Study|Participant's evasion of hospital visit|5
193686|NCT01008904|614957|P1|Overall Study|unexpected unrelated surgery|1
193687|NCT01008904|614957|P1|Overall Study|Adverse Event|2
193688|NCT01008904|614957|P1|Overall Study|Lost to Follow-up|1
193689|NCT01008943|614962|P1|Overall Study|Withdrawal by Subject|1
193690|NCT01008995|614976|P4|After Controlled Period|Not specified|0
193691|NCT01008995|614977|P3|After Controlled Period|Not specified|1
193692|NCT01008995|614978|P2|After Controlled Period|Not specified|0
193693|NCT01008995|614979|P1|After Controlled Period|Not specified|0
193694|NCT01008995|614976|P4|After Controlled Period|Adverse Event|1
193695|NCT01008995|614977|P3|After Controlled Period|Adverse Event|1
193696|NCT01008995|614978|P2|After Controlled Period|Adverse Event|0
193697|NCT01008995|614979|P1|After Controlled Period|Adverse Event|0
193698|NCT01008995|614976|P4|Controlled Period|Not specified|0
193699|NCT01008995|614977|P3|Controlled Period|Not specified|0
193700|NCT01008995|614978|P2|Controlled Period|Not specified|1
193701|NCT01008995|614979|P1|Controlled Period|Not specified|2
193702|NCT01008995|614976|P4|Controlled Period|Adverse Event|0
193703|NCT01008995|614977|P3|Controlled Period|Adverse Event|0
193704|NCT01008995|614978|P2|Controlled Period|Adverse Event|2
193705|NCT01008995|614979|P1|Controlled Period|Adverse Event|1
193706|NCT01009034|614991|P1|Overall Study|Withdrawal by Subject|2
193707|NCT01009034|614991|P1|Overall Study|Lost to Follow-up|2
193708|NCT01009047|614999|P2|Overall Study|Unspecified|2
193709|NCT01009047|615000|P1|Overall Study|Unspecified|3
193710|NCT01009047|614999|P2|Overall Study|Withdrawal by consent|11
193711|NCT01009047|615000|P1|Overall Study|Withdrawal by consent|16
193712|NCT01009047|614999|P2|Overall Study|Lack of Efficacy|11
193713|NCT01009047|615000|P1|Overall Study|Lack of Efficacy|4
193714|NCT01009047|614999|P2|Overall Study|Lost to Follow-up|2
193715|NCT01009047|615000|P1|Overall Study|Lost to Follow-up|0
193716|NCT01009047|614999|P2|Overall Study|Adverse Event|0
193717|NCT01009047|615000|P1|Overall Study|Adverse Event|5
193718|NCT01009086|615025|P3|Overall Study|Unspecified|1
193719|NCT01009086|615026|P2|Overall Study|Unspecified|5
193720|NCT01009086|615027|P1|Overall Study|Unspecified|3
193721|NCT01009086|615025|P3|Overall Study|Withdrawal by Subject|13
193722|NCT01009086|615026|P2|Overall Study|Withdrawal by Subject|11
193723|NCT01009086|615027|P1|Overall Study|Withdrawal by Subject|9
193724|NCT01009086|615025|P3|Overall Study|Adverse Event|8
193725|NCT01009086|615026|P2|Overall Study|Adverse Event|11
193726|NCT01009086|615027|P1|Overall Study|Adverse Event|12
193727|NCT01009086|615025|P3|Overall Study|Lost to Follow-up|3
193728|NCT01009086|615026|P2|Overall Study|Lost to Follow-up|5
193729|NCT01009086|615027|P1|Overall Study|Lost to Follow-up|4
193730|NCT01009086|615025|P3|Overall Study|Lack of Efficacy|9
193731|NCT01009086|615026|P2|Overall Study|Lack of Efficacy|15
193732|NCT01009086|615027|P1|Overall Study|Lack of Efficacy|16
193733|NCT01009099|615062|P2|Overall Study|Death|1
193734|NCT01009099|615063|P1|Overall Study|Death|0
193735|NCT01009099|615062|P2|Overall Study|Withdrawal by Subject|1
193736|NCT01009099|615063|P1|Overall Study|Withdrawal by Subject|1
193737|NCT01009099|615062|P2|Overall Study|Physician Decision|2
193738|NCT01009099|615063|P1|Overall Study|Physician Decision|3
193739|NCT01009099|615062|P2|Overall Study|Lost to Follow-up|0
193740|NCT01009099|615063|P1|Overall Study|Lost to Follow-up|1
193741|NCT01009203|615100|P1|Overall Study|Treatment-unrelated death|1
193742|NCT01009203|615100|P1|Overall Study|Adverse Event|5
193743|NCT01009203|615100|P1|Overall Study|Withdrawal by Subject|1
193744|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Physician Decision|8
193745|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Physician Decision|6
193746|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Physician Decision|6
193747|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Physician Decision|4
193748|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Physician Decision|0
193749|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
193750|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
193751|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
193752|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
193753|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
193754|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
193755|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
193756|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
193757|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
193758|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
193759|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
193760|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
193761|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
193762|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
193763|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
193764|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
193765|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
193766|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
193767|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
193768|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
193769|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
193770|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
193771|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
193772|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
193773|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
193774|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
193775|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
193776|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
193777|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
193778|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
193779|NCT01009463|615134|P5|52-week, Double-blind Treatment Period|Adverse Event|31
193780|NCT01009463|615135|P4|52-week, Double-blind Treatment Period|Adverse Event|29
193781|NCT01009463|615136|P3|52-week, Double-blind Treatment Period|Adverse Event|25
193782|NCT01009463|615137|P2|52-week, Double-blind Treatment Period|Adverse Event|22
193783|NCT01009463|615138|P1|52-week, Double-blind Treatment Period|Adverse Event|0
193784|NCT01009463|615134|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
193785|NCT01009463|615135|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
193786|NCT01009463|615136|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
193787|NCT01009463|615137|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
193788|NCT01009463|615138|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
193789|NCT01009463|615134|P5|4-week, Open-label Run-In Period|Physician Decision|0
193790|NCT01009463|615135|P4|4-week, Open-label Run-In Period|Physician Decision|0
193791|NCT01009463|615136|P3|4-week, Open-label Run-In Period|Physician Decision|0
193792|NCT01009463|615137|P2|4-week, Open-label Run-In Period|Physician Decision|0
193793|NCT01009463|615138|P1|4-week, Open-label Run-In Period|Physician Decision|10
193794|NCT01009463|615134|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
193795|NCT01009463|615135|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
193796|NCT01009463|615136|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
193797|NCT01009463|615137|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
193798|NCT01009463|615138|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
193799|NCT01009463|615134|P5|4-week, Open-label Run-In Period|Adverse Event|0
193800|NCT01009463|615135|P4|4-week, Open-label Run-In Period|Adverse Event|0
193801|NCT01009463|615136|P3|4-week, Open-label Run-In Period|Adverse Event|0
193802|NCT01009463|615137|P2|4-week, Open-label Run-In Period|Adverse Event|0
193803|NCT01009463|615138|P1|4-week, Open-label Run-In Period|Adverse Event|10
193804|NCT01009463|615134|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
193805|NCT01009463|615135|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
193806|NCT01009463|615136|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
193807|NCT01009463|615137|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
193808|NCT01009463|615138|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
193809|NCT01020305|615160|P1|Overall Study|Adverse Event|2
193810|NCT01020448|615164|P1|Treatment|Lost to Follow-up|2
193811|NCT01020448|615164|P1|Treatment|Lack of Efficacy|8
193812|NCT01020448|615164|P1|Treatment|Disease Progression|2
193813|NCT01020448|615164|P1|Treatment|Consent Withdrawn|3
193814|NCT01020448|615164|P1|Treatment|Adverse Event|11
193815|NCT01020448|615164|P1|Pre-assignment|Does Not Meet Entry Criteria|2
193816|NCT01020448|615164|P1|Pre-assignment|Withdrawal by Subject|5
193817|NCT01020448|615164|P1|Pre-assignment|Adverse Event|6
193818|NCT01020474|615175|P2|Overall Study|Insufficient Clinical Response|3
193819|NCT01020474|615176|P1|Overall Study|Insufficient Clinical Response|0
193820|NCT01020474|615175|P2|Overall Study|Other Reasons|1
193821|NCT01020474|615176|P1|Overall Study|Other Reasons|1
193822|NCT01020474|615175|P2|Overall Study|Withdrawal by Subject|7
193823|NCT01020474|615176|P1|Overall Study|Withdrawal by Subject|5
193824|NCT01020474|615175|P2|Overall Study|Protocol Violation|2
193825|NCT01020474|615176|P1|Overall Study|Protocol Violation|0
193826|NCT01020474|615175|P2|Overall Study|Adverse Event|4
193827|NCT01020474|615176|P1|Overall Study|Adverse Event|4
193828|NCT01020487|615199|P3|Part 2 Open-label Period|Adverse Event|1
193829|NCT01020487|615200|P2|Part 2 Open-label Period|Adverse Event|4
193830|NCT01020487|615201|P1|Part 2 Open-label Period|Adverse Event|0
193831|NCT01020487|615199|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
193832|NCT01020487|615200|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
193833|NCT01020487|615201|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
193834|NCT01020487|615199|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
193835|NCT01020487|615200|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
193836|NCT01020487|615201|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
193837|NCT01020487|615199|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
193838|NCT01020487|615200|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
193839|NCT01020487|615201|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
193840|NCT01020487|615199|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
193841|NCT01020487|615200|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
193842|NCT01020487|615201|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
193843|NCT01020526|615222|P1|Overall Study|Adverse Event|2
193844|NCT01020526|615222|P1|Overall Study|Lost to Follow-up|1
193845|NCT01020526|615222|P1|Overall Study|Insufficient clinical response|3
193846|NCT01020526|615222|P1|Overall Study|Other reasons|3
193847|NCT01020526|615222|P1|Overall Study|Withdrawal by Subject|5
193848|NCT01020747|615237|P1|Overall Study|Withdrawal by Subject|1
193849|NCT01020773|615244|P2|Overall Study|Withdrawal by Subject|3
193850|NCT01020773|615245|P1|Overall Study|Withdrawal by Subject|4
193851|NCT01020786|615251|P1|Maintenance Period|Sponsor Decision|1
193852|NCT01020786|615251|P1|Maintenance Period|Withdrawal by Subject|8
193853|NCT01020786|615251|P1|Maintenance Period|Progressive Disease|43
193854|NCT01020786|615251|P1|Maintenance Period|Adverse Event|8
193855|NCT01020786|615251|P1|Induction Period|Withdrawal by Subject|3
193856|NCT01020786|615251|P1|Induction Period|Investigator Decision|3
193857|NCT01020786|615251|P1|Induction Period|Progressive Disease|31
193858|NCT01020786|615251|P1|Induction Period|Adverse Event|10
193859|NCT01020786|615251|P1|Induction Period|Entry Criteria Not Met|2
193860|NCT01020799|615266|P3|Overall Study|Lost to Follow-up|2
193861|NCT01020799|615267|P2|Overall Study|Lost to Follow-up|4
193862|NCT01020799|615268|P1|Overall Study|Lost to Follow-up|6
193863|NCT01020799|615266|P3|Overall Study|Withdrawal by Subject|3
193864|NCT01020799|615267|P2|Overall Study|Withdrawal by Subject|2
193865|NCT01020799|615268|P1|Overall Study|Withdrawal by Subject|2
193866|NCT01020799|615266|P3|Overall Study|Protocol Violation|0
193867|NCT01020799|615267|P2|Overall Study|Protocol Violation|2
193868|NCT01020799|615268|P1|Overall Study|Protocol Violation|3
193869|NCT01020799|615266|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
193870|NCT01020799|615267|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
193871|NCT01020799|615268|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
193872|NCT01020799|615266|P3|Overall Study|Adverse Event|2
193873|NCT01020799|615267|P2|Overall Study|Adverse Event|3
193874|NCT01020799|615268|P1|Overall Study|Adverse Event|4
193875|NCT01020812|615291|P1|Overall Study|Protocol Violation|1
193876|NCT01020812|615291|P1|Overall Study|Withdrawal by Subject|1
193877|NCT01020812|615291|P1|Overall Study|Physician Decision|1
193878|NCT01020838|615298|P1|Overall Study|Most common: Study ended by sponsor|77
193879|NCT01020838|615298|P1|Overall Study|Lost to Follow-up|6
193880|NCT01020838|615298|P1|Overall Study|Withdrawal by Subject|9
193881|NCT01020838|615298|P1|Overall Study|Adverse Event|1
193882|NCT01020838|615298|P1|Overall Study|Death|90
193883|NCT01020877|615315|P2|Second Intervention|Withdrawal by Subject|0
193884|NCT01020877|615316|P1|Second Intervention|Withdrawal by Subject|1
193885|NCT01020981|615337|P2|Overall Study|Participant declined to complete survey|0
193886|NCT01020981|615338|P1|Overall Study|Participant declined to complete survey|2
193887|NCT01020981|615337|P2|Overall Study|Survey returned undeliverable|32
193888|NCT01020981|615338|P1|Overall Study|Survey returned undeliverable|8
193889|NCT01020981|615337|P2|Overall Study|Did not return mailed survey|58
193890|NCT01020981|615338|P1|Overall Study|Did not return mailed survey|74
193891|NCT01021007|615350|P2|Overall Study|Adverse Event|3
193892|NCT01021007|615351|P1|Overall Study|Adverse Event|1
193893|NCT01021007|615350|P2|Overall Study|Lost to Follow-up|1
193894|NCT01021007|615351|P1|Overall Study|Lost to Follow-up|1
193895|NCT01021020|615361|P1|14 Day Washout Period A|Physician Decision|1
193896|NCT01021020|615361|P1|Period I|Withdrawal by Subject|1
193897|NCT01021020|615361|P1|Period I|Protocol Violation|1
193898|NCT01021215|615382|P2|Overall Study|Lost to Follow-up|0
193899|NCT01021215|615383|P1|Overall Study|Lost to Follow-up|3
193900|NCT01021293|615395|P2|Overall Study|Lost to Follow-up|1
193901|NCT01021293|615396|P1|Overall Study|Lost to Follow-up|1
193902|NCT01021293|615395|P2|Overall Study|Migrated/moved from study area|18
193903|NCT01021293|615396|P1|Overall Study|Migrated/moved from study area|6
193904|NCT01021293|615395|P2|Overall Study|Withdrawal by Subject|3
193905|NCT01021293|615396|P1|Overall Study|Withdrawal by Subject|1
193906|NCT01021293|615395|P2|Overall Study|Adverse Event|1
193907|NCT01021293|615396|P1|Overall Study|Adverse Event|2
193908|NCT01021293|615395|P2|Overall Study|Serious Adverse Event|1
193909|NCT01021293|615396|P1|Overall Study|Serious Adverse Event|2
193910|NCT01021332|615438|P1|Overall Study|Miscellaneous|3
193911|NCT01021332|615438|P1|Overall Study|Protocol Violation|9
193912|NCT01021332|615438|P1|Overall Study|Lost to Follow-up|4
193913|NCT01021332|615438|P1|Overall Study|Withdrawal of Consent|23
193914|NCT01021332|615438|P1|Overall Study|Lack of Efficacy|19
193915|NCT01021332|615438|P1|Overall Study|Adverse Event|43
193916|NCT01021332|615438|P1|Overall Study|Not fulfilling incl./excl.criteria|5
193917|NCT01027273|615497|P2|Overall Study|Death|2
193918|NCT01027273|615498|P1|Overall Study|Death|2
193919|NCT01027273|615497|P2|Overall Study|Lost to Follow-up|31
193920|NCT01027273|615498|P1|Overall Study|Lost to Follow-up|57
193921|NCT01027286|615516|P2|Overall Study|Lost to Follow-up|1
193922|NCT01027286|615517|P1|Overall Study|Lost to Follow-up|0
193923|NCT01027286|615516|P2|Overall Study|Unable to Obtain Required Blood Volume|0
193924|NCT01027286|615517|P1|Overall Study|Unable to Obtain Required Blood Volume|1
193925|NCT01027351|615541|P6|Overall Study|Protocol Violation|0
193926|NCT01027351|615542|P5|Overall Study|Protocol Violation|1
193927|NCT01027351|615543|P4|Overall Study|Protocol Violation|1
193928|NCT01027351|615544|P3|Overall Study|Protocol Violation|0
193929|NCT01027351|615545|P2|Overall Study|Protocol Violation|0
193930|NCT01027351|615546|P1|Overall Study|Protocol Violation|1
193931|NCT01027351|615541|P6|Overall Study|Inappropriate enrollment|0
193932|NCT01027351|615542|P5|Overall Study|Inappropriate enrollment|1
193933|NCT01027351|615543|P4|Overall Study|Inappropriate enrollment|0
193934|NCT01027351|615544|P3|Overall Study|Inappropriate enrollment|0
193935|NCT01027351|615545|P2|Overall Study|Inappropriate enrollment|0
193936|NCT01027351|615546|P1|Overall Study|Inappropriate enrollment|0
193937|NCT01027351|615541|P6|Overall Study|Lost to Follow-up|0
193938|NCT01027351|615542|P5|Overall Study|Lost to Follow-up|6
193939|NCT01027351|615543|P4|Overall Study|Lost to Follow-up|1
193940|NCT01027351|615544|P3|Overall Study|Lost to Follow-up|0
193941|NCT01027351|615545|P2|Overall Study|Lost to Follow-up|1
193942|NCT01027351|615546|P1|Overall Study|Lost to Follow-up|1
193943|NCT01027351|615541|P6|Overall Study|Withdrawal by Subject|5
193944|NCT01027351|615542|P5|Overall Study|Withdrawal by Subject|3
193945|NCT01027351|615543|P4|Overall Study|Withdrawal by Subject|0
193946|NCT01027351|615544|P3|Overall Study|Withdrawal by Subject|1
193947|NCT01027351|615545|P2|Overall Study|Withdrawal by Subject|0
193948|NCT01027351|615546|P1|Overall Study|Withdrawal by Subject|1
193949|NCT01027884|615630|P2|Overall Study|Spinal fixation surgery|3
193950|NCT01027884|615631|P1|Overall Study|Spinal fixation surgery|0
193951|NCT01027884|615630|P2|Overall Study|Lost to Follow-up|1
193952|NCT01027884|615631|P1|Overall Study|Lost to Follow-up|0
193953|NCT01027884|615630|P2|Overall Study|Withdrawal by Subject|1
193954|NCT01027884|615631|P1|Overall Study|Withdrawal by Subject|0
193955|NCT01027884|615630|P2|Overall Study|Non-compliance|1
193956|NCT01027884|615631|P1|Overall Study|Non-compliance|1
193957|NCT01027884|615630|P2|Overall Study|Protocol Violation|0
193958|NCT01027884|615631|P1|Overall Study|Protocol Violation|1
193959|NCT01027884|615630|P2|Overall Study|Adverse Event|1
193960|NCT01027884|615631|P1|Overall Study|Adverse Event|2
193961|NCT01027897|615645|P1|Overall Study|Withdrawal by Subject|1
193962|NCT01027897|615645|P1|Overall Study|Protocol Violation|1
193963|NCT01028014|615672|P6|Overall Study|Lost to Follow-up|2
193964|NCT01028014|615673|P5|Overall Study|Lost to Follow-up|1
193965|NCT01028014|615674|P4|Overall Study|Lost to Follow-up|1
193966|NCT01028014|615675|P3|Overall Study|Lost to Follow-up|0
193967|NCT01028014|615676|P2|Overall Study|Lost to Follow-up|2
193968|NCT01028014|615677|P1|Overall Study|Lost to Follow-up|1
193969|NCT01028027|615705|P2|Overall Study|Lack of Efficacy|1
193970|NCT01028027|615706|P1|Overall Study|Lack of Efficacy|0
193971|NCT01028027|615705|P2|Overall Study|Protocol Violation|1
193972|NCT01028027|615706|P1|Overall Study|Protocol Violation|3
193973|NCT01028027|615705|P2|Overall Study|Adverse Event|7
193974|NCT01028027|615706|P1|Overall Study|Adverse Event|4
193975|NCT01028027|615705|P2|Overall Study|Withdrawal by Subject|3
193976|NCT01028027|615706|P1|Overall Study|Withdrawal by Subject|5
193977|NCT01028027|615705|P2|Overall Study|Lost to Follow-up|1
193978|NCT01028027|615706|P1|Overall Study|Lost to Follow-up|4
193979|NCT01028053|615722|P1|Overall Study|Various reasons|4
193980|NCT01028053|615722|P1|Overall Study|Terminated by Sponsor|1
193981|NCT01028053|615722|P1|Overall Study|Technical Problem|1
193982|NCT01028053|615722|P1|Overall Study|Physician Decision|2
193983|NCT01028053|615722|P1|Overall Study|Protocol Violation|1
193984|NCT01028053|615722|P1|Overall Study|Patient Request|11
193985|NCT01028053|615722|P1|Overall Study|Screen Failure|113
193986|NCT01028222|615751|P2|Overall Study|Adverse Event|0
193987|NCT01028222|615752|P1|Overall Study|Adverse Event|2
193988|NCT01028222|615751|P2|Overall Study|Crossover to nilotinib w/out progression|2
193989|NCT01028222|615752|P1|Overall Study|Crossover to nilotinib w/out progression|0
193990|NCT01028222|615751|P2|Overall Study|Withdrawal by Subject|0
193991|NCT01028222|615752|P1|Overall Study|Withdrawal by Subject|1
193992|NCT01028222|615751|P2|Overall Study|Lost to Follow-up|1
193993|NCT01028222|615752|P1|Overall Study|Lost to Follow-up|0
193994|NCT01028222|615751|P2|Overall Study|Administrative problems|1
193995|NCT01028222|615752|P1|Overall Study|Administrative problems|1
193996|NCT01028222|615751|P2|Overall Study|Disease progression|9
193997|NCT01028222|615752|P1|Overall Study|Disease progression|33
193998|NCT01028222|615751|P2|Overall Study|Protocol deviation|0
193999|NCT01028222|615752|P1|Overall Study|Protocol deviation|1
194000|NCT01028300|615773|P1|Overall Study|Study Terminated|4
194001|NCT01028352|615780|P1|Overall Study|Withdrawal by Subject|1
194002|NCT01028352|615780|P1|Overall Study|Ineligible due to baseline average pain|5
194003|NCT01028378|615785|P1|Overall Study|Adminstrative Reasons|4
194004|NCT01028378|615785|P1|Overall Study|Withdrawal by Subject|1
194005|NCT01028378|615785|P1|Overall Study|Lost to Follow-up|12
194006|NCT01028391|615799|P2|Overall Study|Needed excluded medication|1
194007|NCT01028391|615800|P1|Overall Study|Needed excluded medication|1
194008|NCT01028391|615799|P2|Overall Study|Withdrawal by Subject|3
194009|NCT01028391|615800|P1|Overall Study|Withdrawal by Subject|6
194010|NCT01028391|615799|P2|Overall Study|Physician Decision|1
194011|NCT01028391|615800|P1|Overall Study|Physician Decision|0
194012|NCT01028391|615799|P2|Overall Study|Lost to Follow-up|4
194013|NCT01028391|615800|P1|Overall Study|Lost to Follow-up|3
194014|NCT01028391|615799|P2|Overall Study|Lack of Efficacy|2
194015|NCT01028391|615800|P1|Overall Study|Lack of Efficacy|0
194016|NCT01028391|615799|P2|Overall Study|Adverse Event|0
194017|NCT01028391|615800|P1|Overall Study|Adverse Event|4
194018|NCT01028651|615808|P1|Overall Study|Adverse Event|1
194019|NCT01028651|615808|P1|Overall Study|Death|2
194020|NCT01029262|615933|P2|Overall Study|Unspecified|5
194021|NCT01029262|615934|P1|Overall Study|Unspecified|1
194022|NCT01029262|615933|P2|Overall Study|Protocol Violation|3
194023|NCT01029262|615934|P1|Overall Study|Protocol Violation|2
194024|NCT01029262|615933|P2|Overall Study|Withdrawal by Subject|16
194025|NCT01029262|615934|P1|Overall Study|Withdrawal by Subject|10
194026|NCT01029262|615933|P2|Overall Study|Lack of therapeutic effect|69
194027|NCT01029262|615934|P1|Overall Study|Lack of therapeutic effect|56
194028|NCT01029262|615933|P2|Overall Study|Adverse Event|52
194029|NCT01029262|615934|P1|Overall Study|Adverse Event|9
194030|NCT01029340|615995|P6|Extension Period|Physician Decision|1
194031|NCT01029340|615996|P5|Extension Period|Physician Decision|0
194032|NCT01029340|615997|P4|Extension Period|Physician Decision|0
194033|NCT01029340|615998|P3|Extension Period|Physician Decision|0
194034|NCT01029340|615999|P2|Extension Period|Physician Decision|0
194035|NCT01029340|616000|P1|Extension Period|Physician Decision|0
194036|NCT01029340|615995|P6|Extension Period|Withdrawal by Subject|1
194037|NCT01029340|615996|P5|Extension Period|Withdrawal by Subject|0
194038|NCT01029340|615997|P4|Extension Period|Withdrawal by Subject|0
194039|NCT01029340|615998|P3|Extension Period|Withdrawal by Subject|0
194040|NCT01029340|615999|P2|Extension Period|Withdrawal by Subject|0
194041|NCT01029340|616000|P1|Extension Period|Withdrawal by Subject|0
194042|NCT01029340|615995|P6|Extension Period|non-compliance|1
194043|NCT01029340|615996|P5|Extension Period|non-compliance|0
194044|NCT01029340|615997|P4|Extension Period|non-compliance|0
194045|NCT01029340|615998|P3|Extension Period|non-compliance|0
194046|NCT01029340|615999|P2|Extension Period|non-compliance|0
194047|NCT01029340|616000|P1|Extension Period|non-compliance|0
194048|NCT01029340|615995|P6|Extension Period|starting another study|8
194049|NCT01029340|615996|P5|Extension Period|starting another study|0
194050|NCT01029340|615997|P4|Extension Period|starting another study|0
194051|NCT01029340|615998|P3|Extension Period|starting another study|0
194052|NCT01029340|615999|P2|Extension Period|starting another study|0
194053|NCT01029340|616000|P1|Extension Period|starting another study|0
194054|NCT01029340|615995|P6|Extension Period|Adverse Event|1
194055|NCT01029340|615996|P5|Extension Period|Adverse Event|0
194056|NCT01029340|615997|P4|Extension Period|Adverse Event|0
194057|NCT01029340|615998|P3|Extension Period|Adverse Event|0
194058|NCT01029340|615999|P2|Extension Period|Adverse Event|0
194059|NCT01029340|616000|P1|Extension Period|Adverse Event|0
194060|NCT01029340|615995|P6|Part B Treatment Period|Protocol Violation|0
194061|NCT01029340|615996|P5|Part B Treatment Period|Protocol Violation|0
194062|NCT01029340|615997|P4|Part B Treatment Period|Protocol Violation|0
194063|NCT01029340|615998|P3|Part B Treatment Period|Protocol Violation|1
194064|NCT01029340|615999|P2|Part B Treatment Period|Protocol Violation|0
194065|NCT01029340|616000|P1|Part B Treatment Period|Protocol Violation|0
194066|NCT01029340|615995|P6|Part B Treatment Period|Withdrawal by Subject|0
194067|NCT01029340|615996|P5|Part B Treatment Period|Withdrawal by Subject|0
194068|NCT01029340|615997|P4|Part B Treatment Period|Withdrawal by Subject|0
194069|NCT01029340|615998|P3|Part B Treatment Period|Withdrawal by Subject|1
194070|NCT01029340|615999|P2|Part B Treatment Period|Withdrawal by Subject|0
194071|NCT01029340|616000|P1|Part B Treatment Period|Withdrawal by Subject|0
194072|NCT01029366|616031|P2|Overall Study|manufacturing failure|1
194073|NCT01029366|616032|P1|Overall Study|manufacturing failure|0
194074|NCT01029366|616031|P2|Overall Study|disease progression|0
194075|NCT01029366|616032|P1|Overall Study|disease progression|2
194076|NCT01029366|616031|P2|Overall Study|Death|1
194077|NCT01029366|616032|P1|Overall Study|Death|1
194078|NCT01029366|616031|P2|Overall Study|Withdrawal by Subject|0
194079|NCT01029366|616032|P1|Overall Study|Withdrawal by Subject|1
194080|NCT01029392|616041|P2|Overall Study|Physician Decision|0
194081|NCT01029392|616042|P1|Overall Study|Physician Decision|2
194082|NCT01029392|616041|P2|Overall Study|Withdrawal by Subject|11
194083|NCT01029392|616042|P1|Overall Study|Withdrawal by Subject|18
194084|NCT01029405|616054|P4|Overall Study|Unspecified|1
194085|NCT01029405|616055|P3|Overall Study|Unspecified|0
194086|NCT01029405|616056|P2|Overall Study|Unspecified|1
194087|NCT01029405|616057|P1|Overall Study|Unspecified|0
194088|NCT01029405|616054|P4|Overall Study|Lost to Follow-up|2
194089|NCT01029405|616055|P3|Overall Study|Lost to Follow-up|1
194090|NCT01029405|616056|P2|Overall Study|Lost to Follow-up|1
194091|NCT01029405|616057|P1|Overall Study|Lost to Follow-up|2
194092|NCT01029405|616054|P4|Overall Study|Adverse Event|1
194093|NCT01029405|616055|P3|Overall Study|Adverse Event|1
194094|NCT01029405|616056|P2|Overall Study|Adverse Event|0
194095|NCT01029405|616057|P1|Overall Study|Adverse Event|0
194096|NCT01029405|616054|P4|Overall Study|Protocol Violation|1
194097|NCT01029405|616055|P3|Overall Study|Protocol Violation|0
194098|NCT01029405|616056|P2|Overall Study|Protocol Violation|0
194099|NCT01029405|616057|P1|Overall Study|Protocol Violation|0
194100|NCT01029405|616054|P4|Overall Study|Withdrawal by Subject|0
194101|NCT01029405|616055|P3|Overall Study|Withdrawal by Subject|2
194102|NCT01029405|616056|P2|Overall Study|Withdrawal by Subject|1
194103|NCT01029405|616057|P1|Overall Study|Withdrawal by Subject|0
194104|NCT01029535|616067|P1|Overall Study|Death|1
194105|NCT01029535|616067|P1|Overall Study|Use of Another Treatment|1
194106|NCT01029535|616067|P1|Overall Study|Adverse Event|1
194107|NCT01029535|616067|P1|Overall Study|Participant Withdrew Consent|2
194108|NCT01029535|616067|P1|Overall Study|Protocol Violation|2
194109|NCT01029535|616067|P1|Overall Study|Lost to Follow-up|24
194110|NCT01029652|616094|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
194111|NCT01029652|616095|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
194112|NCT01029652|616094|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
194113|NCT01029652|616095|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
194114|NCT01029652|616094|P2|Extension Study 2 (25-72 Weeks)|Death|1
194115|NCT01029652|616095|P1|Extension Study 2 (25-72 Weeks)|Death|1
194116|NCT01029652|616094|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
194117|NCT01029652|616095|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
194118|NCT01029652|616094|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
194119|NCT01029652|616095|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
194120|NCT01029652|616094|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
194121|NCT01029652|616095|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
194122|NCT01029652|616094|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
194123|NCT01029652|616095|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
194124|NCT01029652|616094|P2|Core Study (0-12 Weeks)|Death|1
194125|NCT01029652|616095|P1|Core Study (0-12 Weeks)|Death|0
194126|NCT01029652|616094|P2|Core Study (0-12 Weeks)|Administrative problems|1
194127|NCT01029652|616095|P1|Core Study (0-12 Weeks)|Administrative problems|2
194128|NCT01029652|616094|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
194129|NCT01029652|616095|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
194130|NCT01029652|616094|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
194131|NCT01029652|616095|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
194132|NCT01029652|616094|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
194133|NCT01029652|616095|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
194134|NCT01029795|616218|P2|Overall Study|Withdrawal by Subject|3
194135|NCT01029795|616219|P1|Overall Study|Withdrawal by Subject|1
194136|NCT01029795|616218|P2|Overall Study|Sponsor Decision|17
194137|NCT01029795|616219|P1|Overall Study|Sponsor Decision|11
194138|NCT01029795|616218|P2|Overall Study|Physician Decision|1
194139|NCT01029795|616219|P1|Overall Study|Physician Decision|2
194140|NCT01029795|616218|P2|Overall Study|Entry Criteria Not Met|1
194141|NCT01029795|616219|P1|Overall Study|Entry Criteria Not Met|2
194142|NCT01029886|616273|P2|Overall Study|Loss Glucose Control|1
194143|NCT01029886|616274|P1|Overall Study|Loss Glucose Control|7
194144|NCT01029886|616273|P2|Overall Study|Sponsor Decision|0
194145|NCT01029886|616274|P1|Overall Study|Sponsor Decision|1
194146|NCT01029886|616273|P2|Overall Study|Entry Criteria Not Met|5
194147|NCT01029886|616274|P1|Overall Study|Entry Criteria Not Met|13
194148|NCT01029886|616273|P2|Overall Study|Withdrawal by Subject|18
194149|NCT01029886|616274|P1|Overall Study|Withdrawal by Subject|8
194150|NCT01029886|616273|P2|Overall Study|Protocol Violation|5
194151|NCT01029886|616274|P1|Overall Study|Protocol Violation|17
194152|NCT01029886|616273|P2|Overall Study|Physician Decision|6
194153|NCT01029886|616274|P1|Overall Study|Physician Decision|2
194154|NCT01029886|616273|P2|Overall Study|Lost to Follow-up|0
194155|NCT01029886|616274|P1|Overall Study|Lost to Follow-up|1
194156|NCT01029886|616273|P2|Overall Study|Adverse Event|25
194157|NCT01029886|616274|P1|Overall Study|Adverse Event|12
194158|NCT01029925|616300|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
194159|NCT01029925|616300|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
194160|NCT01029925|616300|P1|Completion of Cycle 1 (28 Days)|Death|2
194161|NCT01024244|616309|P5|Overall Study|Withdrawal by Subject|0
194162|NCT01024244|616310|P4|Overall Study|Withdrawal by Subject|0
194163|NCT01024244|616311|P3|Overall Study|Withdrawal by Subject|0
194164|NCT01024244|616312|P2|Overall Study|Withdrawal by Subject|1
194165|NCT01024244|616313|P1|Overall Study|Withdrawal by Subject|0
194166|NCT01024244|616309|P5|Overall Study|Sponsor Decision|10
194167|NCT01024244|616310|P4|Overall Study|Sponsor Decision|12
194168|NCT01024244|616311|P3|Overall Study|Sponsor Decision|14
194169|NCT01024244|616312|P2|Overall Study|Sponsor Decision|7
194170|NCT01024244|616313|P1|Overall Study|Sponsor Decision|14
194171|NCT01024244|616309|P5|Overall Study|Protocol Violation|2
194172|NCT01024244|616310|P4|Overall Study|Protocol Violation|0
194173|NCT01024244|616311|P3|Overall Study|Protocol Violation|0
194174|NCT01024244|616312|P2|Overall Study|Protocol Violation|0
194175|NCT01024244|616313|P1|Overall Study|Protocol Violation|1
194176|NCT01024244|616309|P5|Overall Study|Lack of Efficacy|0
194177|NCT01024244|616310|P4|Overall Study|Lack of Efficacy|0
194178|NCT01024244|616311|P3|Overall Study|Lack of Efficacy|0
194179|NCT01024244|616312|P2|Overall Study|Lack of Efficacy|0
194180|NCT01024244|616313|P1|Overall Study|Lack of Efficacy|1
194181|NCT01024244|616309|P5|Overall Study|Entry Criteria Not Met|0
194182|NCT01024244|616310|P4|Overall Study|Entry Criteria Not Met|0
194183|NCT01024244|616311|P3|Overall Study|Entry Criteria Not Met|0
194184|NCT01024244|616312|P2|Overall Study|Entry Criteria Not Met|1
194185|NCT01024244|616313|P1|Overall Study|Entry Criteria Not Met|0
194186|NCT01024244|616309|P5|Overall Study|Adverse Event|2
194187|NCT01024244|616310|P4|Overall Study|Adverse Event|1
194188|NCT01024244|616311|P3|Overall Study|Adverse Event|0
194189|NCT01024244|616312|P2|Overall Study|Adverse Event|2
194190|NCT01024244|616313|P1|Overall Study|Adverse Event|1
194191|NCT01024309|616427|P2|Overall Study|Withdrawal by Subject|4
194192|NCT01024309|616428|P1|Overall Study|Withdrawal by Subject|4
194193|NCT01024309|616427|P2|Overall Study|Physician Decision|0
194194|NCT01024309|616428|P1|Overall Study|Physician Decision|4
194195|NCT01024465|616461|P1|Overall Study|Physician Decision|1
194196|NCT01024465|616461|P1|Overall Study|Adverse Event|2
194197|NCT01030458|616467|P2|Overall Study|Side effect of medication|1
194198|NCT01030458|616468|P1|Overall Study|Side effect of medication|1
194199|NCT01030458|616467|P2|Overall Study|Moved or changed job|13
194200|NCT01030458|616468|P1|Overall Study|Moved or changed job|6
194201|NCT01030458|616467|P2|Overall Study|Logistical reasons|5
194202|NCT01030458|616468|P1|Overall Study|Logistical reasons|9
194203|NCT01030458|616467|P2|Overall Study|Withdrawal by Subject|3
194204|NCT01030458|616468|P1|Overall Study|Withdrawal by Subject|2
194205|NCT01030458|616467|P2|Overall Study|Lost to Follow-up|10
194206|NCT01030458|616468|P1|Overall Study|Lost to Follow-up|9
194207|NCT01030666|616494|P2|Overall Study|Lost to Follow-up|2
194208|NCT01030666|616495|P1|Overall Study|Lost to Follow-up|3
194209|NCT01031979|616520|P2|Overall Study|Lost to Follow-up|4
194210|NCT01031979|616521|P1|Overall Study|Lost to Follow-up|5
194211|NCT01032018|616535|P2|Overall Study|Death|1
194212|NCT01032018|616536|P1|Overall Study|Death|0
194213|NCT01032018|616535|P2|Overall Study|Lost to Follow-up|5
194214|NCT01032018|616536|P1|Overall Study|Lost to Follow-up|6
194215|NCT01032044|616546|P2|Overall Study|Lost to Follow-up|11
194216|NCT01032044|616547|P1|Overall Study|Lost to Follow-up|11
194217|NCT01032044|616546|P2|Overall Study|Adverse Event|1
194218|NCT01032044|616547|P1|Overall Study|Adverse Event|0
194219|NCT01032044|616546|P2|Overall Study|Protocol Violation|8
194220|NCT01032044|616547|P1|Overall Study|Protocol Violation|14
194221|NCT01032070|616555|P2|Overall Study|Withdrawal by Subject|2
194222|NCT01032070|616556|P1|Overall Study|Withdrawal by Subject|0
194223|NCT01032070|616555|P2|Overall Study|Medical or ethical reasons|2
194224|NCT01032070|616556|P1|Overall Study|Medical or ethical reasons|0
194225|NCT01032070|616555|P2|Overall Study|Disease progression|8
194226|NCT01032070|616556|P1|Overall Study|Disease progression|13
194227|NCT01032174|616813|P2|Overall Study|Adverse Event|1
194228|NCT01032174|616814|P1|Overall Study|Adverse Event|0
194229|NCT01032200|616826|P2|Overall Study|Multiple|1
194230|NCT01032200|616827|P1|Overall Study|Multiple|1
194231|NCT01032200|616826|P2|Overall Study|Progression|0
194232|NCT01032200|616827|P1|Overall Study|Progression|1
194233|NCT01032200|616826|P2|Overall Study|Toxicity|2
194234|NCT01032200|616827|P1|Overall Study|Toxicity|0
194235|NCT01032200|616826|P2|Overall Study|Withdrawal by Subject|3
194236|NCT01032200|616827|P1|Overall Study|Withdrawal by Subject|1
194237|NCT01032200|616826|P2|Overall Study|Death|1
194238|NCT01032200|616827|P1|Overall Study|Death|1
194239|NCT01032291|616865|P3|Proof of Concept|Never Received Study Drug|0
194240|NCT01032291|616866|P2|Proof of Concept|Never Received Study Drug|1
194241|NCT01032291|616867|P1|Proof of Concept|Never Received Study Drug|0
194242|NCT01032291|616865|P3|Proof of Concept|Lack of Efficacy|0
194243|NCT01032291|616866|P2|Proof of Concept|Lack of Efficacy|1
194244|NCT01032291|616867|P1|Proof of Concept|Lack of Efficacy|0
194245|NCT01032291|616865|P3|Proof of Concept|Death|2
194246|NCT01032291|616866|P2|Proof of Concept|Death|1
194247|NCT01032291|616867|P1|Proof of Concept|Death|0
194248|NCT01032291|616865|P3|Proof of Concept|Adverse Event|1
194249|NCT01032291|616866|P2|Proof of Concept|Adverse Event|5
194250|NCT01032291|616867|P1|Proof of Concept|Adverse Event|0
194251|NCT01032291|616865|P3|Safety Lead-in|Death|0
194252|NCT01032291|616866|P2|Safety Lead-in|Death|0
194253|NCT01032291|616867|P1|Safety Lead-in|Death|1
194254|NCT01032291|616865|P3|Safety Lead-in|Adverse Event|0
194255|NCT01032291|616866|P2|Safety Lead-in|Adverse Event|0
194256|NCT01032291|616867|P1|Safety Lead-in|Adverse Event|1
194257|NCT01032382|616893|P2|Overall Study|Index lesion relapse|3
194258|NCT01032382|616894|P1|Overall Study|Index lesion relapse|1
194259|NCT01032382|616893|P2|Overall Study|Treatment failure|1
194260|NCT01032382|616894|P1|Overall Study|Treatment failure|3
194261|NCT01032382|616893|P2|Overall Study|Disease dissemination|1
194262|NCT01032382|616894|P1|Overall Study|Disease dissemination|1
194263|NCT01032837|616981|P4|Overall Study|Refused treatment|1
194264|NCT01032837|616982|P3|Overall Study|Refused treatment|0
194265|NCT01032837|616983|P2|Overall Study|Refused treatment|0
194266|NCT01032837|616984|P1|Overall Study|Refused treatment|0
194267|NCT01032837|616981|P4|Overall Study|Failed to return|0
194268|NCT01032837|616982|P3|Overall Study|Failed to return|1
194269|NCT01032837|616983|P2|Overall Study|Failed to return|0
194270|NCT01032837|616984|P1|Overall Study|Failed to return|0
194271|NCT01032837|616981|P4|Overall Study|Withdrew consent|1
194272|NCT01032837|616982|P3|Overall Study|Withdrew consent|0
194273|NCT01032837|616983|P2|Overall Study|Withdrew consent|2
194274|NCT01032837|616984|P1|Overall Study|Withdrew consent|0
194275|NCT01032837|616981|P4|Overall Study|Adverse event/internal illness|1
194276|NCT01032837|616982|P3|Overall Study|Adverse event/internal illness|0
194277|NCT01032837|616983|P2|Overall Study|Adverse event/internal illness|1
194278|NCT01032837|616984|P1|Overall Study|Adverse event/internal illness|0
194279|NCT01032889|617040|P3|Overall Study|Miscellaneous Reasons|1
194280|NCT01032889|617041|P2|Overall Study|Miscellaneous Reasons|1
194281|NCT01032889|617042|P1|Overall Study|Miscellaneous Reasons|2
194282|NCT01032889|617040|P3|Overall Study|Lack of Submental Fat|1
194283|NCT01032889|617041|P2|Overall Study|Lack of Submental Fat|8
194284|NCT01032889|617042|P1|Overall Study|Lack of Submental Fat|2
194285|NCT01032889|617040|P3|Overall Study|Lost to Follow-up|0
194286|NCT01032889|617041|P2|Overall Study|Lost to Follow-up|1
194287|NCT01032889|617042|P1|Overall Study|Lost to Follow-up|1
194288|NCT01032889|617040|P3|Overall Study|Patient Request|0
194289|NCT01032889|617041|P2|Overall Study|Patient Request|1
194290|NCT01032889|617042|P1|Overall Study|Patient Request|0
194291|NCT01032889|617040|P3|Overall Study|Withdrawal of Consent|1
194292|NCT01032889|617041|P2|Overall Study|Withdrawal of Consent|2
194293|NCT01032889|617042|P1|Overall Study|Withdrawal of Consent|1
194294|NCT01032889|617040|P3|Overall Study|Adverse Event|0
194295|NCT01032889|617041|P2|Overall Study|Adverse Event|2
194296|NCT01032889|617042|P1|Overall Study|Adverse Event|2
194297|NCT01032915|617066|P4|Overall Study|Protocol Violation|1
194298|NCT01032915|617067|P3|Overall Study|Protocol Violation|0
194299|NCT01032915|617068|P2|Overall Study|Protocol Violation|0
194300|NCT01032915|617069|P1|Overall Study|Protocol Violation|1
194301|NCT01032915|617066|P4|Overall Study|Administrative reasons|4
194302|NCT01032915|617067|P3|Overall Study|Administrative reasons|4
194303|NCT01032915|617068|P2|Overall Study|Administrative reasons|6
194304|NCT01032915|617069|P1|Overall Study|Administrative reasons|5
194305|NCT01032915|617066|P4|Overall Study|Withdrawal by Subject|1
194306|NCT01032915|617067|P3|Overall Study|Withdrawal by Subject|1
194307|NCT01032915|617068|P2|Overall Study|Withdrawal by Subject|3
194308|NCT01032915|617069|P1|Overall Study|Withdrawal by Subject|0
194309|NCT01032915|617066|P4|Overall Study|Abnormal test procedure result|0
194310|NCT01032915|617067|P3|Overall Study|Abnormal test procedure result|1
194311|NCT01032915|617068|P2|Overall Study|Abnormal test procedure result|0
194312|NCT01032915|617069|P1|Overall Study|Abnormal test procedure result|0
194313|NCT01032915|617066|P4|Overall Study|Adverse Event|1
194314|NCT01032915|617067|P3|Overall Study|Adverse Event|1
194315|NCT01032915|617068|P2|Overall Study|Adverse Event|2
194316|NCT01032915|617069|P1|Overall Study|Adverse Event|2
194317|NCT01033019|617120|P2|Overall Study|Withdrawal by Subject|0
194318|NCT01033019|617121|P1|Overall Study|Withdrawal by Subject|1
194319|NCT01033071|617141|P3|Overall Study|Other|3
194320|NCT01033071|617142|P2|Overall Study|Other|4
194321|NCT01033071|617143|P1|Overall Study|Other|6
194322|NCT01033071|617141|P3|Overall Study|Lack of Efficacy|1
194323|NCT01033071|617142|P2|Overall Study|Lack of Efficacy|1
194324|NCT01033071|617143|P1|Overall Study|Lack of Efficacy|0
194325|NCT01033071|617141|P3|Overall Study|Withdrawal by Subject|11
194326|NCT01033071|617142|P2|Overall Study|Withdrawal by Subject|14
194327|NCT01033071|617143|P1|Overall Study|Withdrawal by Subject|17
194328|NCT01033071|617141|P3|Overall Study|Lost to Follow-up|5
194329|NCT01033071|617142|P2|Overall Study|Lost to Follow-up|5
194330|NCT01033071|617143|P1|Overall Study|Lost to Follow-up|4
194331|NCT01033071|617141|P3|Overall Study|Protocol Violation|1
194332|NCT01033071|617142|P2|Overall Study|Protocol Violation|2
194333|NCT01033071|617143|P1|Overall Study|Protocol Violation|0
194334|NCT01033071|617141|P3|Overall Study|Adverse Event|26
194335|NCT01033071|617142|P2|Overall Study|Adverse Event|51
194336|NCT01033071|617143|P1|Overall Study|Adverse Event|28
194337|NCT01033487|617236|P10|Fourth Intervention Period|Adverse Event|0
194338|NCT01033487|617237|P9|Fourth Intervention Period|Adverse Event|1
194339|NCT01033487|617238|P8|Fourth Intervention Period|Adverse Event|0
194340|NCT01033487|617239|P7|Fourth Intervention Period|Adverse Event|0
194341|NCT01033487|617240|P6|Fourth Intervention Period|Adverse Event|0
194342|NCT01033487|617241|P5|Fourth Intervention Period|Adverse Event|0
194343|NCT01033487|617242|P4|Fourth Intervention Period|Adverse Event|0
194344|NCT01033487|617243|P3|Fourth Intervention Period|Adverse Event|0
194345|NCT01033487|617244|P2|Fourth Intervention Period|Adverse Event|0
194346|NCT01033487|617245|P1|Fourth Intervention Period|Adverse Event|0
194347|NCT01033734|617303|P1|Overall Study|Withdrawal by Subject|1
194348|NCT01033747|617357|P2|Overall Study|Stopped at end of Extension 1|0
194349|NCT01033747|617358|P1|Overall Study|Stopped at end of Extension 1|2
194350|NCT01033747|617357|P2|Overall Study|Stopped at end of prolongation visit 1|0
194351|NCT01033747|617358|P1|Overall Study|Stopped at end of prolongation visit 1|1
194352|NCT01033747|617357|P2|Overall Study|Withdrawal by Subject|6
194353|NCT01033747|617358|P1|Overall Study|Withdrawal by Subject|9
194354|NCT01033747|617357|P2|Overall Study|Protocol Violation|0
194355|NCT01033747|617358|P1|Overall Study|Protocol Violation|1
194356|NCT01033747|617357|P2|Overall Study|Unsatisfactory therapeutic effect|4
194357|NCT01033747|617358|P1|Overall Study|Unsatisfactory therapeutic effect|14
194358|NCT01033747|617357|P2|Overall Study|Abnormal test procedure|1
194359|NCT01033747|617358|P1|Overall Study|Abnormal test procedure|0
194360|NCT01033747|617357|P2|Overall Study|Abnormal Laboratory Value|0
194361|NCT01033747|617358|P1|Overall Study|Abnormal Laboratory Value|1
194362|NCT01033747|617357|P2|Overall Study|Adverse Event|4
194363|NCT01033747|617358|P1|Overall Study|Adverse Event|9
194364|NCT01033825|617373|P7|Overall Study|Other|0
194365|NCT01033825|617374|P6|Overall Study|Other|0
194366|NCT01033825|617375|P5|Overall Study|Other|1
194367|NCT01033825|617376|P4|Overall Study|Other|0
194368|NCT01033825|617377|P3|Overall Study|Other|0
194369|NCT01033825|617378|P2|Overall Study|Other|0
194370|NCT01033825|617379|P1|Overall Study|Other|0
194371|NCT01033825|617373|P7|Overall Study|Protocol Violation|0
194372|NCT01033825|617374|P6|Overall Study|Protocol Violation|0
194373|NCT01033825|617375|P5|Overall Study|Protocol Violation|0
194374|NCT01033825|617376|P4|Overall Study|Protocol Violation|0
194375|NCT01033825|617377|P3|Overall Study|Protocol Violation|0
194376|NCT01033825|617378|P2|Overall Study|Protocol Violation|0
194377|NCT01033825|617379|P1|Overall Study|Protocol Violation|1
194378|NCT01033825|617373|P7|Overall Study|Adverse Event|0
194379|NCT01033825|617374|P6|Overall Study|Adverse Event|0
194380|NCT01033825|617375|P5|Overall Study|Adverse Event|0
194381|NCT01033825|617376|P4|Overall Study|Adverse Event|1
194382|NCT01033825|617377|P3|Overall Study|Adverse Event|0
194383|NCT01033825|617378|P2|Overall Study|Adverse Event|0
194384|NCT01033825|617379|P1|Overall Study|Adverse Event|0
194385|NCT01033825|617373|P7|Overall Study|Withdrawal by Subject|0
194386|NCT01033825|617374|P6|Overall Study|Withdrawal by Subject|0
194387|NCT01033825|617375|P5|Overall Study|Withdrawal by Subject|1
194388|NCT01033825|617376|P4|Overall Study|Withdrawal by Subject|1
194389|NCT01033825|617377|P3|Overall Study|Withdrawal by Subject|2
194390|NCT01033825|617378|P2|Overall Study|Withdrawal by Subject|3
194391|NCT01033825|617379|P1|Overall Study|Withdrawal by Subject|2
194392|NCT01033851|617600|P2|Overall Study|Withdrawal by Subject|7
194393|NCT01033851|617601|P1|Overall Study|Withdrawal by Subject|3
194394|NCT01033942|617638|P3|Overall Study|Enrolled in Extension Study|0
194395|NCT01033942|617639|P2|Overall Study|Enrolled in Extension Study|3
194396|NCT01033942|617640|P1|Overall Study|Enrolled in Extension Study|0
194397|NCT01033942|617638|P3|Overall Study|Lost to Follow-up|0
194398|NCT01033942|617639|P2|Overall Study|Lost to Follow-up|0
194399|NCT01033942|617640|P1|Overall Study|Lost to Follow-up|1
194400|NCT01033942|617638|P3|Overall Study|Withdrawal by Subject|1
194401|NCT01033942|617639|P2|Overall Study|Withdrawal by Subject|1
194402|NCT01033942|617640|P1|Overall Study|Withdrawal by Subject|1
194403|NCT01034137|617918|P3|Overall Study|Administrative or other|4
194404|NCT01034137|617919|P2|Overall Study|Administrative or other|3
194405|NCT01034137|617920|P1|Overall Study|Administrative or other|2
194406|NCT01034137|617918|P3|Overall Study|Refused treatment or did not cooperate|1
194407|NCT01034137|617919|P2|Overall Study|Refused treatment or did not cooperate|0
194408|NCT01034137|617920|P1|Overall Study|Refused treatment or did not cooperate|2
194409|NCT01034137|617918|P3|Overall Study|Protocol Violation|1
194410|NCT01034137|617919|P2|Overall Study|Protocol Violation|2
194411|NCT01034137|617920|P1|Overall Study|Protocol Violation|2
194412|NCT01034137|617918|P3|Overall Study|Lack of Efficacy|13
194413|NCT01034137|617919|P2|Overall Study|Lack of Efficacy|4
194414|NCT01034137|617920|P1|Overall Study|Lack of Efficacy|9
194415|NCT01034137|617918|P3|Overall Study|Withdrawal by Subject|3
194416|NCT01034137|617919|P2|Overall Study|Withdrawal by Subject|3
194417|NCT01034137|617920|P1|Overall Study|Withdrawal by Subject|4
194418|NCT01034137|617918|P3|Overall Study|Adverse Event|8
194419|NCT01034137|617919|P2|Overall Study|Adverse Event|10
194420|NCT01034137|617920|P1|Overall Study|Adverse Event|9
194421|NCT01034163|618053|P2|Overall Study|Abnormal laboratory value|0
194422|NCT01034163|618054|P1|Overall Study|Abnormal laboratory value|1
194423|NCT01034163|618053|P2|Overall Study|Administrative problems|1
194424|NCT01034163|618054|P1|Overall Study|Administrative problems|0
194425|NCT01034163|618053|P2|Overall Study|Adverse Event|0
194426|NCT01034163|618054|P1|Overall Study|Adverse Event|6
194427|NCT01034163|618053|P2|Overall Study|Disease progression|4
194428|NCT01034163|618054|P1|Overall Study|Disease progression|3
194429|NCT01034163|618053|P2|Overall Study|Protocol deviation|0
194430|NCT01034163|618054|P1|Overall Study|Protocol deviation|1
194431|NCT01034163|618053|P2|Overall Study|Withdrawal by Subject|2
194432|NCT01034163|618054|P1|Overall Study|Withdrawal by Subject|8
194433|NCT01034163|618053|P2|Overall Study|Treatment completed as per protocol|7
194434|NCT01034163|618054|P1|Overall Study|Treatment completed as per protocol|8
194435|NCT01034176|618062|P2|Overall Study|Lost to Follow-up|1
194436|NCT01034176|618063|P1|Overall Study|Lost to Follow-up|0
194437|NCT01034176|618062|P2|Overall Study|Withdrawal by Subject|1
194438|NCT01034176|618063|P1|Overall Study|Withdrawal by Subject|0
194439|NCT01034176|618062|P2|Overall Study|Physician Decision|0
194440|NCT01034176|618063|P1|Overall Study|Physician Decision|2
194441|NCT01034306|618073|P2|Overall Study|Noncomplience|0
194442|NCT01034306|618074|P1|Overall Study|Noncomplience|1
194443|NCT01034306|618073|P2|Overall Study|hospitalized and decided to stop|0
194444|NCT01034306|618074|P1|Overall Study|hospitalized and decided to stop|1
194445|NCT01034306|618073|P2|Overall Study|Withdrawal by Subject|2
194446|NCT01034306|618074|P1|Overall Study|Withdrawal by Subject|2
194447|NCT01034306|618073|P2|Overall Study|Lost to Follow-up|1
194448|NCT01034306|618074|P1|Overall Study|Lost to Follow-up|0
194449|NCT01034306|618073|P2|Overall Study|Adverse Event|0
194450|NCT01034306|618074|P1|Overall Study|Adverse Event|1
194451|NCT01034358|618080|P1|Overall Study|Protocol Violation|1
194452|NCT01034358|618080|P1|Overall Study|Withdrawal by Subject|1
194453|NCT01027364|618088|P4|Overall Study|Withdrawal by Subject|0
194454|NCT01027364|618089|P3|Overall Study|Withdrawal by Subject|0
194455|NCT01027364|618090|P2|Overall Study|Withdrawal by Subject|2
194456|NCT01027364|618091|P1|Overall Study|Withdrawal by Subject|1
194457|NCT01027364|618088|P4|Overall Study|Protocol Violation|1
194458|NCT01027364|618089|P3|Overall Study|Protocol Violation|0
194459|NCT01027364|618090|P2|Overall Study|Protocol Violation|0
194460|NCT01027364|618091|P1|Overall Study|Protocol Violation|1
194461|NCT01027364|618088|P4|Overall Study|Lost to Follow-up|0
194462|NCT01027364|618089|P3|Overall Study|Lost to Follow-up|0
194463|NCT01027364|618090|P2|Overall Study|Lost to Follow-up|0
194464|NCT01027364|618091|P1|Overall Study|Lost to Follow-up|1
194465|NCT01027364|618088|P4|Overall Study|Adverse Event|0
194466|NCT01027364|618089|P3|Overall Study|Adverse Event|1
194467|NCT01027364|618090|P2|Overall Study|Adverse Event|0
194468|NCT01027364|618091|P1|Overall Study|Adverse Event|1
194469|NCT01027650|618205|P8|Overall Study|Lack of Efficacy|0
194470|NCT01027650|618206|P7|Overall Study|Lack of Efficacy|0
194471|NCT01027650|618207|P6|Overall Study|Lack of Efficacy|1
194472|NCT01027650|618208|P5|Overall Study|Lack of Efficacy|0
194473|NCT01027650|618209|P4|Overall Study|Lack of Efficacy|0
194474|NCT01027650|618210|P3|Overall Study|Lack of Efficacy|0
194475|NCT01027650|618211|P2|Overall Study|Lack of Efficacy|0
194476|NCT01027650|618212|P1|Overall Study|Lack of Efficacy|0
194477|NCT01027650|618205|P8|Overall Study|Lost to Follow-up|0
194478|NCT01027650|618206|P7|Overall Study|Lost to Follow-up|1
194479|NCT01027650|618207|P6|Overall Study|Lost to Follow-up|0
194480|NCT01027650|618208|P5|Overall Study|Lost to Follow-up|0
194481|NCT01027650|618209|P4|Overall Study|Lost to Follow-up|0
194482|NCT01027650|618210|P3|Overall Study|Lost to Follow-up|0
194483|NCT01027650|618211|P2|Overall Study|Lost to Follow-up|0
194484|NCT01027650|618212|P1|Overall Study|Lost to Follow-up|0
194485|NCT01027650|618205|P8|Overall Study|Personal Reasons|0
194486|NCT01027650|618206|P7|Overall Study|Personal Reasons|0
194487|NCT01027650|618207|P6|Overall Study|Personal Reasons|1
194488|NCT01027650|618208|P5|Overall Study|Personal Reasons|2
194489|NCT01027650|618209|P4|Overall Study|Personal Reasons|0
194490|NCT01027650|618210|P3|Overall Study|Personal Reasons|0
194491|NCT01027650|618211|P2|Overall Study|Personal Reasons|0
194492|NCT01027650|618212|P1|Overall Study|Personal Reasons|0
194493|NCT01034397|618278|P2|Overall Study|Not specified|1
194494|NCT01034397|618279|P1|Overall Study|Not specified|0
194495|NCT01034397|618278|P2|Overall Study|Adverse Event|0
194496|NCT01034397|618279|P1|Overall Study|Adverse Event|4
194497|NCT01034397|618278|P2|Overall Study|Lack of Efficacy|0
194498|NCT01034397|618279|P1|Overall Study|Lack of Efficacy|3
194499|NCT01034397|618278|P2|Overall Study|Lack of compliance|1
194500|NCT01034397|618279|P1|Overall Study|Lack of compliance|0
194501|NCT01034462|618430|P2|Overall Study|Other reasons|2
194502|NCT01034462|618431|P1|Overall Study|Other reasons|1
194503|NCT01034462|618430|P2|Overall Study|Lost to Follow-up|16
194504|NCT01034462|618431|P1|Overall Study|Lost to Follow-up|14
194505|NCT01034462|618430|P2|Overall Study|Withdrawal by Subject|8
194506|NCT01034462|618431|P1|Overall Study|Withdrawal by Subject|9
194507|NCT01034462|618430|P2|Overall Study|Protocol Violation|7
194508|NCT01034462|618431|P1|Overall Study|Protocol Violation|10
194509|NCT01034462|618430|P2|Overall Study|Lack of Efficacy|4
194510|NCT01034462|618431|P1|Overall Study|Lack of Efficacy|4
194511|NCT01034462|618430|P2|Overall Study|Adverse Event|17
194512|NCT01034462|618431|P1|Overall Study|Adverse Event|7
194513|NCT01034540|618441|P2|Overall Study|Adverse Event|1
194514|NCT01034540|618442|P1|Overall Study|Adverse Event|0
194515|NCT01034631|618499|P3|Phase II|Determined Ineligible per protocol|0
194516|NCT01034631|618500|P2|Phase II|Determined Ineligible per protocol|1
194517|NCT01034631|618501|P1|Phase II|Determined Ineligible per protocol|0
194518|NCT01034631|618499|P3|Phase II|Not Evaluable per protocol|2
194519|NCT01034631|618500|P2|Phase II|Not Evaluable per protocol|0
194520|NCT01034631|618501|P1|Phase II|Not Evaluable per protocol|0
194521|NCT01034631|618499|P3|Phase I|Symptomatic Deterioration before Treatme|0
194522|NCT01034631|618500|P2|Phase I|Symptomatic Deterioration before Treatme|0
194523|NCT01034631|618501|P1|Phase I|Symptomatic Deterioration before Treatme|3
194524|NCT01034657|618520|P3|Randomized Phase|Adverse Event|1
194525|NCT01034657|618521|P2|Randomized Phase|Adverse Event|2
194526|NCT01034657|618522|P1|Randomized Phase|Adverse Event|0
194527|NCT01034657|618520|P3|Randomized Phase|Abnormal laboratory value|0
194528|NCT01034657|618521|P2|Randomized Phase|Abnormal laboratory value|1
194529|NCT01034657|618522|P1|Randomized Phase|Abnormal laboratory value|0
194530|NCT01034657|618520|P3|Randomized Phase|Lack of Efficacy|0
194531|NCT01034657|618521|P2|Randomized Phase|Lack of Efficacy|1
194532|NCT01034657|618522|P1|Randomized Phase|Lack of Efficacy|5
194533|NCT01034657|618520|P3|Randomized Phase|Withdrawal by Subject|0
194534|NCT01034657|618521|P2|Randomized Phase|Withdrawal by Subject|2
194535|NCT01034657|618522|P1|Randomized Phase|Withdrawal by Subject|0
194536|NCT01034657|618520|P3|Core Phase|Protocol Violation|0
194537|NCT01034657|618521|P2|Core Phase|Protocol Violation|0
194538|NCT01034657|618522|P1|Core Phase|Protocol Violation|2
194539|NCT01034657|618520|P3|Core Phase|Adverse Event|0
194540|NCT01034657|618521|P2|Core Phase|Adverse Event|0
194541|NCT01034657|618522|P1|Core Phase|Adverse Event|8
194542|NCT01034657|618520|P3|Core Phase|Abnormal laboratory value|0
194543|NCT01034657|618521|P2|Core Phase|Abnormal laboratory value|0
194544|NCT01034657|618522|P1|Core Phase|Abnormal laboratory value|1
194545|NCT01034657|618520|P3|Core Phase|Lack of Efficacy|0
194546|NCT01034657|618521|P2|Core Phase|Lack of Efficacy|0
194547|NCT01034657|618522|P1|Core Phase|Lack of Efficacy|2
194548|NCT01034657|618520|P3|Core Phase|Withdrawal by Subject|0
194549|NCT01034657|618521|P2|Core Phase|Withdrawal by Subject|0
194550|NCT01034657|618522|P1|Core Phase|Withdrawal by Subject|1
194551|NCT01034709|618562|P2|Overall Study|Protocol Violation|16
194552|NCT01034709|618563|P1|Overall Study|Protocol Violation|9
194553|NCT01035905|618580|P2|Overall Study|Lack of Efficacy|1
194554|NCT01035905|618581|P1|Overall Study|Lack of Efficacy|1
194555|NCT01036022|618627|P6|Overall Study|Withdrawal by Subject|0
194556|NCT01036022|618628|P5|Overall Study|Withdrawal by Subject|2
194557|NCT01036022|618629|P4|Overall Study|Withdrawal by Subject|1
194558|NCT01036022|618630|P3|Overall Study|Withdrawal by Subject|0
194559|NCT01036022|618631|P2|Overall Study|Withdrawal by Subject|0
194560|NCT01036022|618632|P1|Overall Study|Withdrawal by Subject|0
194561|NCT01036022|618627|P6|Overall Study|Physician Decision|0
194562|NCT01036022|618628|P5|Overall Study|Physician Decision|0
194563|NCT01036022|618629|P4|Overall Study|Physician Decision|0
194564|NCT01036022|618630|P3|Overall Study|Physician Decision|1
194565|NCT01036022|618631|P2|Overall Study|Physician Decision|0
194566|NCT01036022|618632|P1|Overall Study|Physician Decision|0
194567|NCT01036022|618627|P6|Overall Study|Lack of Efficacy|1
194568|NCT01036022|618628|P5|Overall Study|Lack of Efficacy|1
194569|NCT01036022|618629|P4|Overall Study|Lack of Efficacy|0
194570|NCT01036022|618630|P3|Overall Study|Lack of Efficacy|1
194571|NCT01036022|618631|P2|Overall Study|Lack of Efficacy|1
194572|NCT01036022|618632|P1|Overall Study|Lack of Efficacy|1
194573|NCT01036022|618627|P6|Overall Study|Adverse Event|2
194574|NCT01036022|618628|P5|Overall Study|Adverse Event|0
194575|NCT01036022|618629|P4|Overall Study|Adverse Event|1
194576|NCT01036022|618630|P3|Overall Study|Adverse Event|2
194577|NCT01036022|618631|P2|Overall Study|Adverse Event|3
194578|NCT01036022|618632|P1|Overall Study|Adverse Event|1
194579|NCT01036165|618732|P1|Overall Study|Problems finding proper area to inject|1
194580|NCT01036165|618732|P1|Overall Study|Device Related Issues|3
194581|NCT01036165|618732|P1|Overall Study|Withdrawal by Subject|3
194582|NCT01036165|618732|P1|Overall Study|Lost to Follow-up|2
194583|NCT01036165|618732|P1|Overall Study|Adverse Event|6
194584|NCT01036321|618739|P2|Overall Study|Adverse Event|1
194585|NCT01036321|618740|P1|Overall Study|Adverse Event|2
194586|NCT01036321|618739|P2|Overall Study|Withdrawal by Subject|2
194587|NCT01036321|618740|P1|Overall Study|Withdrawal by Subject|3
194588|NCT01036321|618739|P2|Overall Study|Ineligible after randomization|1
194589|NCT01036321|618740|P1|Overall Study|Ineligible after randomization|0
194590|NCT01036438|618766|P2|Overall Study|No effect of study treatment|1
194591|NCT01036438|618767|P1|Overall Study|No effect of study treatment|3
194592|NCT01036438|618766|P2|Overall Study|Death|1
194593|NCT01036438|618767|P1|Overall Study|Death|0
194594|NCT01036438|618766|P2|Overall Study|Adverse Event|8
194595|NCT01036438|618767|P1|Overall Study|Adverse Event|7
194596|NCT01036529|618794|P2|Overall Study|Sponsor study termination|12
194597|NCT01036529|618795|P1|Overall Study|Sponsor study termination|11
194598|NCT01036529|618794|P2|Overall Study|Withdrawal by Subject|1
194599|NCT01036529|618795|P1|Overall Study|Withdrawal by Subject|1
194600|NCT01036529|618794|P2|Overall Study|Physician Decision|0
194601|NCT01036529|618795|P1|Overall Study|Physician Decision|1
194602|NCT01036529|618794|P2|Overall Study|Lost to Follow-up|1
194603|NCT01036529|618795|P1|Overall Study|Lost to Follow-up|0
194604|NCT01036529|618794|P2|Overall Study|Adverse Event|1
194605|NCT01036529|618795|P1|Overall Study|Adverse Event|0
194606|NCT01036724|618803|P2|Overall Study|Protocol Violation|5
194607|NCT01036724|618804|P1|Overall Study|Protocol Violation|4
194608|NCT01036724|618803|P2|Overall Study|Lack of Efficacy|1
194609|NCT01036724|618804|P1|Overall Study|Lack of Efficacy|1
194610|NCT01036724|618803|P2|Overall Study|Adverse Event|2
194611|NCT01036724|618804|P1|Overall Study|Adverse Event|1
194612|NCT01036763|618812|P1|Overall Study|Other reason (not specified)|40
194613|NCT01036763|618812|P1|Overall Study|Lost to Follow-up|28
194614|NCT01036763|618812|P1|Overall Study|Adverse Event|25
194615|NCT01037088|618843|P1|Overall Study|Withdrawal by Subject|3
194616|NCT01037114|618851|P1|Year 20|Others|1
194617|NCT01037127|618866|P2|Overall Study|Study Closed Terminated|17
194618|NCT01037127|618867|P1|Overall Study|Study Closed Terminated|2
194619|NCT01037127|618866|P2|Overall Study|Physician Decision|0
194620|NCT01037127|618867|P1|Overall Study|Physician Decision|1
194621|NCT01037127|618866|P2|Overall Study|Lost to Follow-up|4
194622|NCT01037127|618867|P1|Overall Study|Lost to Follow-up|2
194623|NCT01037218|618914|P4|Overall Study|Various|1
194624|NCT01037218|618915|P3|Overall Study|Various|3
194625|NCT01037218|618916|P2|Overall Study|Various|2
194626|NCT01037218|618917|P1|Overall Study|Various|3
194627|NCT01037218|618914|P4|Overall Study|Protocol Violation|2
194628|NCT01037218|618915|P3|Overall Study|Protocol Violation|2
194629|NCT01037218|618916|P2|Overall Study|Protocol Violation|0
194630|NCT01037218|618917|P1|Overall Study|Protocol Violation|0
194631|NCT01037218|618914|P4|Overall Study|Partner Withdrew Consent|1
194632|NCT01037218|618915|P3|Overall Study|Partner Withdrew Consent|2
194633|NCT01037218|618916|P2|Overall Study|Partner Withdrew Consent|3
194634|NCT01037218|618917|P1|Overall Study|Partner Withdrew Consent|0
194635|NCT01037218|618914|P4|Overall Study|Withdrawal by Subject|4
194636|NCT01037218|618915|P3|Overall Study|Withdrawal by Subject|7
194637|NCT01037218|618916|P2|Overall Study|Withdrawal by Subject|7
194638|NCT01037218|618917|P1|Overall Study|Withdrawal by Subject|6
194639|NCT01037218|618914|P4|Overall Study|Lost to Follow-up|2
194640|NCT01037218|618915|P3|Overall Study|Lost to Follow-up|4
194641|NCT01037218|618916|P2|Overall Study|Lost to Follow-up|5
194642|NCT01037218|618917|P1|Overall Study|Lost to Follow-up|3
194643|NCT01037218|618914|P4|Overall Study|Lack of Efficacy|5
194644|NCT01037218|618915|P3|Overall Study|Lack of Efficacy|1
194645|NCT01037218|618916|P2|Overall Study|Lack of Efficacy|2
194646|NCT01037218|618917|P1|Overall Study|Lack of Efficacy|0
194647|NCT01037218|618914|P4|Overall Study|Adverse Event|1
194648|NCT01037218|618915|P3|Overall Study|Adverse Event|2
194649|NCT01037218|618916|P2|Overall Study|Adverse Event|2
194650|NCT01037218|618917|P1|Overall Study|Adverse Event|4
194651|NCT01037244|618979|P4|Overall Study|Various|1
194652|NCT01037244|618980|P3|Overall Study|Various|1
194653|NCT01037244|618981|P2|Overall Study|Various|2
194654|NCT01037244|618982|P1|Overall Study|Various|3
194655|NCT01037244|618979|P4|Overall Study|Partner Withdrew Consent|0
194656|NCT01037244|618980|P3|Overall Study|Partner Withdrew Consent|0
194657|NCT01037244|618981|P2|Overall Study|Partner Withdrew Consent|1
194658|NCT01037244|618982|P1|Overall Study|Partner Withdrew Consent|2
194659|NCT01037244|618979|P4|Overall Study|Withdrawal by Subject|5
194660|NCT01037244|618980|P3|Overall Study|Withdrawal by Subject|3
194661|NCT01037244|618981|P2|Overall Study|Withdrawal by Subject|5
194662|NCT01037244|618982|P1|Overall Study|Withdrawal by Subject|1
194663|NCT01037244|618979|P4|Overall Study|Lost to Follow-up|4
194664|NCT01037244|618980|P3|Overall Study|Lost to Follow-up|4
194665|NCT01037244|618981|P2|Overall Study|Lost to Follow-up|3
194666|NCT01037244|618982|P1|Overall Study|Lost to Follow-up|3
194667|NCT01037244|618979|P4|Overall Study|Lack of Efficacy|1
194668|NCT01037244|618980|P3|Overall Study|Lack of Efficacy|0
194669|NCT01037244|618981|P2|Overall Study|Lack of Efficacy|1
194670|NCT01037244|618982|P1|Overall Study|Lack of Efficacy|1
194671|NCT01037244|618979|P4|Overall Study|Adverse Event|3
194672|NCT01037244|618980|P3|Overall Study|Adverse Event|6
194673|NCT01037244|618981|P2|Overall Study|Adverse Event|2
194674|NCT01037244|618982|P1|Overall Study|Adverse Event|3
194675|NCT01038128|619112|P1|Overall Study|Withdrawal by Subject|2
194676|NCT01038128|619112|P1|Overall Study|Lost to Follow-up|1
194677|NCT01038128|619112|P1|Overall Study|Lack of Efficacy|1
194678|NCT01038323|619123|P3|Overall Study|Withdrawal by Subject|4
194679|NCT01038323|619124|P2|Overall Study|Withdrawal by Subject|2
194680|NCT01038323|619125|P1|Overall Study|Withdrawal by Subject|3
194681|NCT01038609|619178|P5|Overall Study|Refusal of Blood Draws|0
194682|NCT01038609|619179|P4|Overall Study|Refusal of Blood Draws|0
194683|NCT01038609|619180|P3|Overall Study|Refusal of Blood Draws|0
194684|NCT01038609|619181|P2|Overall Study|Refusal of Blood Draws|1
194685|NCT01038609|619182|P1|Overall Study|Refusal of Blood Draws|0
194686|NCT01038609|619178|P5|Overall Study|Death in the Family|0
194687|NCT01038609|619179|P4|Overall Study|Death in the Family|0
194688|NCT01038609|619180|P3|Overall Study|Death in the Family|0
194689|NCT01038609|619181|P2|Overall Study|Death in the Family|0
194690|NCT01038609|619182|P1|Overall Study|Death in the Family|1
194691|NCT01038609|619178|P5|Overall Study|Dosing Error|1
194692|NCT01038609|619179|P4|Overall Study|Dosing Error|1
194693|NCT01038609|619180|P3|Overall Study|Dosing Error|0
194694|NCT01038609|619181|P2|Overall Study|Dosing Error|0
194695|NCT01038609|619182|P1|Overall Study|Dosing Error|0
194696|NCT01038609|619178|P5|Overall Study|Adverse Event|0
194697|NCT01038609|619179|P4|Overall Study|Adverse Event|0
194698|NCT01038609|619180|P3|Overall Study|Adverse Event|1
194699|NCT01038609|619181|P2|Overall Study|Adverse Event|0
194700|NCT01038609|619182|P1|Overall Study|Adverse Event|0
194701|NCT01038635|619233|P9|Overall Study|Death|2
194702|NCT01038635|619234|P8|Overall Study|Death|1
194703|NCT01038635|619235|P7|Overall Study|Death|1
194704|NCT01038635|619236|P6|Overall Study|Death|0
194705|NCT01038635|619237|P5|Overall Study|Death|1
194706|NCT01038635|619238|P4|Overall Study|Death|0
194707|NCT01038635|619239|P3|Overall Study|Death|0
194708|NCT01038635|619240|P2|Overall Study|Death|0
194709|NCT01038635|619241|P1|Overall Study|Death|0
194710|NCT01038635|619233|P9|Overall Study|Disease Progression|0
194711|NCT01038635|619234|P8|Overall Study|Disease Progression|4
194712|NCT01038635|619235|P7|Overall Study|Disease Progression|1
194713|NCT01038635|619236|P6|Overall Study|Disease Progression|0
194714|NCT01038635|619237|P5|Overall Study|Disease Progression|0
194715|NCT01038635|619238|P4|Overall Study|Disease Progression|0
194716|NCT01038635|619239|P3|Overall Study|Disease Progression|0
194717|NCT01038635|619240|P2|Overall Study|Disease Progression|0
194718|NCT01038635|619241|P1|Overall Study|Disease Progression|2
194719|NCT01038713|619265|P3|Overall Study|Autoimmune Pancreatitis|0
194720|NCT01038713|619266|P2|Overall Study|Autoimmune Pancreatitis|0
194721|NCT01038713|619267|P1|Overall Study|Autoimmune Pancreatitis|1
194722|NCT01038713|619265|P3|Overall Study|died from PEP|0
194723|NCT01038713|619266|P2|Overall Study|died from PEP|1
194724|NCT01038713|619267|P1|Overall Study|died from PEP|0
194725|NCT01038713|619265|P3|Overall Study|Neuroendocrine Tumor|0
194726|NCT01038713|619266|P2|Overall Study|Neuroendocrine Tumor|1
194727|NCT01038713|619267|P1|Overall Study|Neuroendocrine Tumor|0
194728|NCT01038713|619265|P3|Overall Study|Lost to Follow-up|0
194729|NCT01038713|619266|P2|Overall Study|Lost to Follow-up|0
194730|NCT01038713|619267|P1|Overall Study|Lost to Follow-up|3
194731|NCT01038713|619265|P3|Overall Study|Patient to hospice|1
194732|NCT01038713|619266|P2|Overall Study|Patient to hospice|1
194733|NCT01038713|619267|P1|Overall Study|Patient to hospice|1
194734|NCT01038752|619289|P2|Overall Study|Lost to Follow-up|3
194735|NCT01038752|619290|P1|Overall Study|Lost to Follow-up|3
194736|NCT01038752|619289|P2|Overall Study|Tumor Progression|2
194737|NCT01038752|619290|P1|Overall Study|Tumor Progression|2
194738|NCT01030718|619313|P3|Study CA180-036 Only|Other Reasons|0
194739|NCT01030718|619314|P2|Study CA180-036 Only|Other Reasons|2
194740|NCT01030718|619315|P1|Study CA180-036 Only|Other Reasons|0
194741|NCT01030718|619313|P3|Study CA180-036 Only|Death|0
194742|NCT01030718|619314|P2|Study CA180-036 Only|Death|1
194743|NCT01030718|619315|P1|Study CA180-036 Only|Death|0
194744|NCT01030718|619313|P3|Study CA180-036 Only|Adverse Event|0
194745|NCT01030718|619314|P2|Study CA180-036 Only|Adverse Event|3
194746|NCT01030718|619315|P1|Study CA180-036 Only|Adverse Event|2
194747|NCT01030718|619313|P3|Study CA180-036 Only|insufficient effect|5
194748|NCT01030718|619314|P2|Study CA180-036 Only|insufficient effect|1
194749|NCT01030718|619315|P1|Study CA180-036 Only|insufficient effect|1
194750|NCT01030718|619313|P3|Studies CA180-031 and -036 Combined|other reasons|0
194751|NCT01030718|619314|P2|Studies CA180-031 and -036 Combined|other reasons|2
194752|NCT01030718|619315|P1|Studies CA180-031 and -036 Combined|other reasons|0
194753|NCT01030718|619313|P3|Studies CA180-031 and -036 Combined|Death|0
194754|NCT01030718|619314|P2|Studies CA180-031 and -036 Combined|Death|1
194755|NCT01030718|619315|P1|Studies CA180-031 and -036 Combined|Death|0
194756|NCT01030718|619313|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
194757|NCT01030718|619314|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
194758|NCT01030718|619315|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
194759|NCT01030718|619313|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
194760|NCT01030718|619314|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
194761|NCT01030718|619315|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
194762|NCT01030822|619382|P3|Overall Study|Lost to Follow-up|7
194763|NCT01030822|619383|P2|Overall Study|Lost to Follow-up|4
194764|NCT01030822|619384|P1|Overall Study|Lost to Follow-up|9
194765|NCT01030822|619382|P3|Overall Study|Withdrawal by Subject|16
194766|NCT01030822|619383|P2|Overall Study|Withdrawal by Subject|13
194767|NCT01030822|619384|P1|Overall Study|Withdrawal by Subject|16
194768|NCT01030822|619382|P3|Overall Study|Moved/migrated from study area|3
194769|NCT01030822|619383|P2|Overall Study|Moved/migrated from study area|7
194770|NCT01030822|619384|P1|Overall Study|Moved/migrated from study area|6
194771|NCT01030952|619433|P2|Overall Study|Unexplained|1
194772|NCT01030952|619434|P1|Overall Study|Unexplained|1
194773|NCT01030952|619433|P2|Overall Study|Lost to Follow-up|1
194774|NCT01030952|619434|P1|Overall Study|Lost to Follow-up|0
194775|NCT01030952|619433|P2|Overall Study|Informed consent withdrawal|0
194776|NCT01030952|619434|P1|Overall Study|Informed consent withdrawal|1
194777|NCT01030952|619433|P2|Overall Study|Protocol Violation|1
194778|NCT01030952|619434|P1|Overall Study|Protocol Violation|0
194779|NCT01030965|619472|P4|Overall Study|Withdrawal by Subject|2
194780|NCT01030965|619473|P3|Overall Study|Withdrawal by Subject|0
194781|NCT01030965|619474|P2|Overall Study|Withdrawal by Subject|1
194782|NCT01030965|619475|P1|Overall Study|Withdrawal by Subject|0
194783|NCT01030965|619472|P4|Overall Study|Protocol-defined Stopping Criteria|0
194784|NCT01030965|619473|P3|Overall Study|Protocol-defined Stopping Criteria|1
194785|NCT01030965|619474|P2|Overall Study|Protocol-defined Stopping Criteria|1
194786|NCT01030965|619475|P1|Overall Study|Protocol-defined Stopping Criteria|0
194787|NCT01030965|619472|P4|Overall Study|Adverse Event|1
194788|NCT01030965|619473|P3|Overall Study|Adverse Event|2
194789|NCT01030965|619474|P2|Overall Study|Adverse Event|1
194790|NCT01030965|619475|P1|Overall Study|Adverse Event|0
194791|NCT01030965|619472|P4|Overall Study|Protocol Violation|1
194792|NCT01030965|619473|P3|Overall Study|Protocol Violation|1
194793|NCT01030965|619474|P2|Overall Study|Protocol Violation|1
194794|NCT01030965|619475|P1|Overall Study|Protocol Violation|1
194795|NCT01030965|619472|P4|Overall Study|Lack of Efficacy|3
194796|NCT01030965|619473|P3|Overall Study|Lack of Efficacy|0
194797|NCT01030965|619474|P2|Overall Study|Lack of Efficacy|2
194798|NCT01030965|619475|P1|Overall Study|Lack of Efficacy|3
194799|NCT01031004|619495|P2|Overall Study|Lost to Follow-up|0
194800|NCT01031004|619496|P1|Overall Study|Lost to Follow-up|1
194801|NCT01031004|619495|P2|Overall Study|Protocol Violation|1
194802|NCT01031004|619496|P1|Overall Study|Protocol Violation|0
194803|NCT01031381|619560|P1|Overall Study|Withdrawal by Subject|6
194804|NCT01031381|619560|P1|Overall Study|Physician Decision|3
194805|NCT01031446|619565|P1|Overall Study|Still on treatment|1
194806|NCT01031446|619565|P1|Overall Study|Withdrawal by Subject|3
194807|NCT01031446|619565|P1|Overall Study|Physician Decision|4
194808|NCT01031446|619565|P1|Overall Study|Adverse Event|9
194809|NCT01031446|619565|P1|Overall Study|Disease Progression|38
194810|NCT01031628|619606|P4|Overall Study|Study terminated early|0
194811|NCT01031628|619607|P3|Overall Study|Study terminated early|3
194812|NCT01031628|619608|P2|Overall Study|Study terminated early|1
194813|NCT01031628|619609|P1|Overall Study|Study terminated early|0
194814|NCT01031680|619621|P2|Overall Study|Various|2
194815|NCT01031680|619622|P1|Overall Study|Various|0
194816|NCT01031680|619621|P2|Overall Study|Administrative Reason by Sponsor|1
194817|NCT01031680|619622|P1|Overall Study|Administrative Reason by Sponsor|0
194818|NCT01031680|619621|P2|Overall Study|Incorrect Enrolment|2
194819|NCT01031680|619622|P1|Overall Study|Incorrect Enrolment|1
194820|NCT01031680|619621|P2|Overall Study|Safety|0
194821|NCT01031680|619622|P1|Overall Study|Safety|1
194822|NCT01031680|619621|P2|Overall Study|Poor/Non-compliance|6
194823|NCT01031680|619622|P1|Overall Study|Poor/Non-compliance|5
194824|NCT01031680|619621|P2|Overall Study|Subject No Longer Meets Study Criteria|17
194825|NCT01031680|619622|P1|Overall Study|Subject No Longer Meets Study Criteria|26
194826|NCT01031680|619621|P2|Overall Study|Death|1
194827|NCT01031680|619622|P1|Overall Study|Death|2
194828|NCT01031680|619621|P2|Overall Study|Withdrawal by Subject|16
194829|NCT01031680|619622|P1|Overall Study|Withdrawal by Subject|12
194830|NCT01031680|619621|P2|Overall Study|Lost to Follow-up|10
194831|NCT01031680|619622|P1|Overall Study|Lost to Follow-up|2
194832|NCT01031680|619621|P2|Overall Study|Adverse Event|3
194833|NCT01031680|619622|P1|Overall Study|Adverse Event|8
194834|NCT01031706|619640|P2|Overall Study|Withdrawal by Subject|1
194835|NCT01031706|619641|P1|Overall Study|Withdrawal by Subject|1
194836|NCT01031706|619640|P2|Overall Study|Adverse Event|0
194837|NCT01031706|619641|P1|Overall Study|Adverse Event|1
194838|NCT01038869|619658|P1|Overall Study|Lost to Follow-up|6
194839|NCT01038869|619658|P1|Overall Study|Withdrawal by Subject|1
194840|NCT01038921|619668|P2|Overall Study|Physician Decision|0
194841|NCT01038921|619669|P1|Overall Study|Physician Decision|1
194842|NCT01038921|619668|P2|Overall Study|Withdrawal by Subject|0
194843|NCT01038921|619669|P1|Overall Study|Withdrawal by Subject|1
194844|NCT01039376|619677|P2|Overall Study|Ongoing|182
194845|NCT01039376|619678|P1|Overall Study|Ongoing|189
194846|NCT01039376|619677|P2|Overall Study|Withdrawal by Subject|17
194847|NCT01039376|619678|P1|Overall Study|Withdrawal by Subject|11
194848|NCT01039376|619677|P2|Overall Study|Physician Decision|2
194849|NCT01039376|619678|P1|Overall Study|Physician Decision|4
194850|NCT01039376|619677|P2|Overall Study|Lost to Follow-up|1
194851|NCT01039376|619678|P1|Overall Study|Lost to Follow-up|2
194852|NCT01039428|619738|P2|Overall Study|Withdrawal by Subject|0
194853|NCT01039428|619739|P1|Overall Study|Withdrawal by Subject|1
194854|NCT01039428|619738|P2|Overall Study|Protocol Violation|0
194855|NCT01039428|619739|P1|Overall Study|Protocol Violation|1
194856|NCT01039519|619761|P1|Survival Follow-up|Sponsor decision|4
194857|NCT01039519|619761|P1|Survival Follow-up|Death|23
194858|NCT01039519|619761|P1|Treatment|Physician Decision|2
194859|NCT01039519|619761|P1|Treatment|Adverse Event|3
194860|NCT01039519|619761|P1|Treatment|Treatment failure|2
194861|NCT01039519|619761|P1|Treatment|Progressive disease|20
194862|NCT01039584|619773|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
194863|NCT01039584|619774|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
194864|NCT01039584|619775|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
194865|NCT01039584|619773|P3|Overall Study|Pap smear with significant pathology|3
194866|NCT01039584|619774|P2|Overall Study|Pap smear with significant pathology|10
194867|NCT01039584|619775|P1|Overall Study|Pap smear with significant pathology|10
194868|NCT01039584|619773|P3|Overall Study|other|1
194869|NCT01039584|619774|P2|Overall Study|other|3
194870|NCT01039584|619775|P1|Overall Study|other|1
194871|NCT01039584|619773|P3|Overall Study|Lack of Efficacy|10
194872|NCT01039584|619774|P2|Overall Study|Lack of Efficacy|6
194873|NCT01039584|619775|P1|Overall Study|Lack of Efficacy|7
194874|NCT01039584|619773|P3|Overall Study|Negative Baseline culture for Candida|24
194875|NCT01039584|619774|P2|Overall Study|Negative Baseline culture for Candida|59
194876|NCT01039584|619775|P1|Overall Study|Negative Baseline culture for Candida|59
194877|NCT01039584|619773|P3|Overall Study|Lost to Follow-up|4
194878|NCT01039584|619774|P2|Overall Study|Lost to Follow-up|3
194879|NCT01039584|619775|P1|Overall Study|Lost to Follow-up|5
194880|NCT01039584|619773|P3|Overall Study|Protocol Violation|6
194881|NCT01039584|619774|P2|Overall Study|Protocol Violation|4
194882|NCT01039584|619775|P1|Overall Study|Protocol Violation|10
194883|NCT01039584|619773|P3|Overall Study|Withdrawal by Subject|1
194884|NCT01039584|619774|P2|Overall Study|Withdrawal by Subject|2
194885|NCT01039584|619775|P1|Overall Study|Withdrawal by Subject|4
194886|NCT01039675|619791|P2|Overall Study|Physician Decision|1
194887|NCT01039675|619792|P1|Overall Study|Physician Decision|0
194888|NCT01039675|619791|P2|Overall Study|Lost to Follow-up|1
194889|NCT01039675|619792|P1|Overall Study|Lost to Follow-up|0
194890|NCT01039675|619791|P2|Overall Study|Withdrawal by Subject|1
194891|NCT01039675|619792|P1|Overall Study|Withdrawal by Subject|0
194892|NCT01039675|619791|P2|Overall Study|Lack of Efficacy|2
194893|NCT01039675|619792|P1|Overall Study|Lack of Efficacy|0
194894|NCT01039675|619791|P2|Overall Study|Adverse Event|2
194895|NCT01039675|619792|P1|Overall Study|Adverse Event|0
194896|NCT01040130|619815|P6|Overall Study|Other reasons not listed above|0
194897|NCT01040130|619816|P5|Overall Study|Other reasons not listed above|0
194898|NCT01040130|619817|P4|Overall Study|Other reasons not listed above|0
194899|NCT01040130|619818|P3|Overall Study|Other reasons not listed above|0
194900|NCT01040130|619819|P2|Overall Study|Other reasons not listed above|0
194901|NCT01040130|619820|P1|Overall Study|Other reasons not listed above|2
194902|NCT01040130|619815|P6|Overall Study|Withdrawal by Subject|1
194903|NCT01040130|619816|P5|Overall Study|Withdrawal by Subject|0
194904|NCT01040130|619817|P4|Overall Study|Withdrawal by Subject|0
194905|NCT01040130|619818|P3|Overall Study|Withdrawal by Subject|0
194906|NCT01040130|619819|P2|Overall Study|Withdrawal by Subject|2
194907|NCT01040130|619820|P1|Overall Study|Withdrawal by Subject|0
194908|NCT01040130|619815|P6|Overall Study|Protocol Violation|0
194909|NCT01040130|619816|P5|Overall Study|Protocol Violation|0
194910|NCT01040130|619817|P4|Overall Study|Protocol Violation|0
194911|NCT01040130|619818|P3|Overall Study|Protocol Violation|2
194912|NCT01040130|619819|P2|Overall Study|Protocol Violation|0
194913|NCT01040130|619820|P1|Overall Study|Protocol Violation|0
194914|NCT01040130|619815|P6|Overall Study|Adverse Event|3
194915|NCT01040130|619816|P5|Overall Study|Adverse Event|0
194916|NCT01040130|619817|P4|Overall Study|Adverse Event|5
194917|NCT01040130|619818|P3|Overall Study|Adverse Event|0
194918|NCT01040130|619819|P2|Overall Study|Adverse Event|1
194919|NCT01040130|619820|P1|Overall Study|Adverse Event|1
194920|NCT01040169|619899|P2|Overall Study|Lost to Follow-up|8
194921|NCT01040169|619900|P1|Overall Study|Lost to Follow-up|3
194922|NCT01040351|619938|P2|Overall Study|poor ovarian response|2
194923|NCT01040351|619939|P1|Overall Study|poor ovarian response|1
194924|NCT01040403|619947|P1|Overall Study|Other reason not defined above|6
194925|NCT01040403|619947|P1|Overall Study|Not treated|1
194926|NCT01040403|619947|P1|Overall Study|Lost to Follow-up|1
194927|NCT01040403|619947|P1|Overall Study|Protocol Violation|2
194928|NCT01040403|619947|P1|Overall Study|Adverse Event|10
194929|NCT01040689|620142|P4|Overall Study|Other reasons not listed above|0
194930|NCT01040689|620143|P3|Overall Study|Other reasons not listed above|0
194931|NCT01040689|620144|P2|Overall Study|Other reasons not listed above|1
194932|NCT01040689|620145|P1|Overall Study|Other reasons not listed above|0
194933|NCT01040689|620142|P4|Overall Study|Withdrawal by Subject|0
194934|NCT01040689|620143|P3|Overall Study|Withdrawal by Subject|1
194935|NCT01040689|620144|P2|Overall Study|Withdrawal by Subject|1
194936|NCT01040689|620145|P1|Overall Study|Withdrawal by Subject|2
194937|NCT01040689|620142|P4|Overall Study|Lost to Follow-up|0
194938|NCT01040689|620143|P3|Overall Study|Lost to Follow-up|0
194939|NCT01040689|620144|P2|Overall Study|Lost to Follow-up|0
194940|NCT01040689|620145|P1|Overall Study|Lost to Follow-up|1
194941|NCT01040689|620142|P4|Overall Study|Lack of Efficacy|0
194942|NCT01040689|620143|P3|Overall Study|Lack of Efficacy|1
194943|NCT01040689|620144|P2|Overall Study|Lack of Efficacy|0
194944|NCT01040689|620145|P1|Overall Study|Lack of Efficacy|0
194945|NCT01040689|620142|P4|Overall Study|Adverse Event|4
194946|NCT01040689|620143|P3|Overall Study|Adverse Event|2
194947|NCT01040689|620144|P2|Overall Study|Adverse Event|0
194948|NCT01040689|620145|P1|Overall Study|Adverse Event|0
194949|NCT01040728|620215|P4|Overall Study|Other reasons not listed above|0
194950|NCT01040728|620216|P3|Overall Study|Other reasons not listed above|0
194951|NCT01040728|620217|P2|Overall Study|Other reasons not listed above|1
194952|NCT01040728|620218|P1|Overall Study|Other reasons not listed above|0
194953|NCT01040728|620215|P4|Overall Study|Lack of Efficacy|1
194954|NCT01040728|620216|P3|Overall Study|Lack of Efficacy|0
194955|NCT01040728|620217|P2|Overall Study|Lack of Efficacy|1
194956|NCT01040728|620218|P1|Overall Study|Lack of Efficacy|0
194957|NCT01040728|620215|P4|Overall Study|Protocol Violation|1
194958|NCT01040728|620216|P3|Overall Study|Protocol Violation|0
194959|NCT01040728|620217|P2|Overall Study|Protocol Violation|0
194960|NCT01040728|620218|P1|Overall Study|Protocol Violation|0
194961|NCT01040728|620215|P4|Overall Study|Withdrawal by Subject|0
194962|NCT01040728|620216|P3|Overall Study|Withdrawal by Subject|1
194963|NCT01040728|620217|P2|Overall Study|Withdrawal by Subject|1
194964|NCT01040728|620218|P1|Overall Study|Withdrawal by Subject|0
194965|NCT01040728|620215|P4|Overall Study|Adverse Event|4
194966|NCT01040728|620216|P3|Overall Study|Adverse Event|0
194967|NCT01040728|620217|P2|Overall Study|Adverse Event|8
194968|NCT01040728|620218|P1|Overall Study|Adverse Event|4
194969|NCT01040780|620290|P2|Overall Study|Protocol Violation|3
194970|NCT01040780|620291|P1|Overall Study|Protocol Violation|1
194971|NCT01040793|620305|P6|Overall Study|Other reasons not listed above|0
194972|NCT01040793|620306|P5|Overall Study|Other reasons not listed above|1
194973|NCT01040793|620307|P4|Overall Study|Other reasons not listed above|0
194974|NCT01040793|620308|P3|Overall Study|Other reasons not listed above|1
194975|NCT01040793|620309|P2|Overall Study|Other reasons not listed above|0
194976|NCT01040793|620310|P1|Overall Study|Other reasons not listed above|0
194977|NCT01040793|620305|P6|Overall Study|Withdrawal by Subject|0
194978|NCT01040793|620306|P5|Overall Study|Withdrawal by Subject|0
194979|NCT01040793|620307|P4|Overall Study|Withdrawal by Subject|2
194980|NCT01040793|620308|P3|Overall Study|Withdrawal by Subject|0
194981|NCT01040793|620309|P2|Overall Study|Withdrawal by Subject|0
194982|NCT01040793|620310|P1|Overall Study|Withdrawal by Subject|0
194983|NCT01040793|620305|P6|Overall Study|Lost to Follow-up|0
194984|NCT01040793|620306|P5|Overall Study|Lost to Follow-up|0
194985|NCT01040793|620307|P4|Overall Study|Lost to Follow-up|0
194986|NCT01040793|620308|P3|Overall Study|Lost to Follow-up|1
194987|NCT01040793|620309|P2|Overall Study|Lost to Follow-up|1
194988|NCT01040793|620310|P1|Overall Study|Lost to Follow-up|0
194989|NCT01040793|620305|P6|Overall Study|Protocol Violation|0
194990|NCT01040793|620306|P5|Overall Study|Protocol Violation|1
194991|NCT01040793|620307|P4|Overall Study|Protocol Violation|0
194992|NCT01040793|620308|P3|Overall Study|Protocol Violation|1
194993|NCT01040793|620309|P2|Overall Study|Protocol Violation|1
194994|NCT01040793|620310|P1|Overall Study|Protocol Violation|1
194995|NCT01040793|620305|P6|Overall Study|Adverse Event|1
194996|NCT01040793|620306|P5|Overall Study|Adverse Event|2
194997|NCT01040793|620307|P4|Overall Study|Adverse Event|2
194998|NCT01040793|620308|P3|Overall Study|Adverse Event|0
194999|NCT01040793|620309|P2|Overall Study|Adverse Event|3
195000|NCT01040793|620310|P1|Overall Study|Adverse Event|5
195001|NCT01040832|620398|P2|Overall Study|Unspecified|1
195002|NCT01040832|620399|P1|Overall Study|Unspecified|2
195003|NCT01040832|620398|P2|Overall Study|Symptomatic deterioration|5
195004|NCT01040832|620399|P1|Overall Study|Symptomatic deterioration|2
195005|NCT01040832|620398|P2|Overall Study|Progressive disease|17
195006|NCT01040832|620399|P1|Overall Study|Progressive disease|32
195007|NCT01040832|620398|P2|Overall Study|Withdrawal by Subject|3
195008|NCT01040832|620399|P1|Overall Study|Withdrawal by Subject|2
195009|NCT01040832|620398|P2|Overall Study|Death|6
195010|NCT01040832|620399|P1|Overall Study|Death|4
195011|NCT01040832|620398|P2|Overall Study|Adverse Event|5
195012|NCT01040832|620399|P1|Overall Study|Adverse Event|4
195013|NCT01040845|620415|P2|Overall Study|Physician Decision|0
195014|NCT01040845|620416|P1|Overall Study|Physician Decision|1
195015|NCT01040845|620415|P2|Overall Study|Withdrawal by Subject|1
195016|NCT01040845|620416|P1|Overall Study|Withdrawal by Subject|1
195017|NCT01040871|620462|P2|Overall Study|Randomized and Not Treated|1
195018|NCT01040871|620463|P1|Overall Study|Randomized and Not Treated|2
195019|NCT01040871|620462|P2|Overall Study|drug supply issue|0
195020|NCT01040871|620463|P1|Overall Study|drug supply issue|1
195021|NCT01040871|620462|P2|Overall Study|Lack of Efficacy|1
195022|NCT01040871|620463|P1|Overall Study|Lack of Efficacy|1
195023|NCT01040871|620462|P2|Overall Study|Death|3
195024|NCT01040871|620463|P1|Overall Study|Death|1
195025|NCT01040871|620462|P2|Overall Study|Withdrawal by Subject|0
195026|NCT01040871|620463|P1|Overall Study|Withdrawal by Subject|2
195027|NCT01040871|620462|P2|Overall Study|Adverse Event|2
195028|NCT01040871|620463|P1|Overall Study|Adverse Event|6
195029|NCT01041287|620494|P2|Treatment Period 2 (3 Months)|Adverse Event|2
195030|NCT01041287|620495|P1|Treatment Period 2 (3 Months)|Adverse Event|0
195031|NCT01041287|620494|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
195032|NCT01041287|620495|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
195033|NCT01041404|620507|P2|Overall Study|Not Specified|23
195034|NCT01041404|620508|P1|Overall Study|Not Specified|11
195035|NCT01041404|620507|P2|Overall Study|Failure to Return|2
195036|NCT01041404|620508|P1|Overall Study|Failure to Return|1
195037|NCT01041404|620507|P2|Overall Study|Withdrawal by Subject|23
195038|NCT01041404|620508|P1|Overall Study|Withdrawal by Subject|29
195039|NCT01041404|620507|P2|Overall Study|Protocol Violation|0
195040|NCT01041404|620508|P1|Overall Study|Protocol Violation|4
195041|NCT01041404|620507|P2|Overall Study|Violation of Selection Criteria|1
195042|NCT01041404|620508|P1|Overall Study|Violation of Selection Criteria|0
195043|NCT01041404|620507|P2|Overall Study|Lack of Efficacy|210
195044|NCT01041404|620508|P1|Overall Study|Lack of Efficacy|200
195045|NCT01041404|620507|P2|Overall Study|Adverse Event|35
195046|NCT01041404|620508|P1|Overall Study|Adverse Event|45
195047|NCT01041417|620549|P2|Overall Study|Death|0
195048|NCT01041417|620550|P1|Overall Study|Death|1
195049|NCT01041417|620549|P2|Overall Study|Lost to Follow-up|1
195050|NCT01041417|620550|P1|Overall Study|Lost to Follow-up|1
195051|NCT01041417|620549|P2|Overall Study|Adverse Event|2
195052|NCT01041417|620550|P1|Overall Study|Adverse Event|5
195053|NCT01041573|620590|P4|Overall Study|positive to anti-HCV|0
195054|NCT01041573|620591|P3|Overall Study|positive to anti-HCV|0
195055|NCT01041573|620592|P2|Overall Study|positive to anti-HCV|0
195056|NCT01041573|620593|P1|Overall Study|positive to anti-HCV|1
195057|NCT01041573|620590|P4|Overall Study|further blood extraction|0
195058|NCT01041573|620591|P3|Overall Study|further blood extraction|0
195059|NCT01041573|620592|P2|Overall Study|further blood extraction|1
195060|NCT01041573|620593|P1|Overall Study|further blood extraction|0
195061|NCT01041573|620590|P4|Overall Study|relocation|1
195062|NCT01041573|620591|P3|Overall Study|relocation|3
195063|NCT01041573|620592|P2|Overall Study|relocation|4
195064|NCT01041573|620593|P1|Overall Study|relocation|1
195065|NCT01041573|620590|P4|Overall Study|Adverse Event|0
195066|NCT01041573|620591|P3|Overall Study|Adverse Event|0
195067|NCT01041573|620592|P2|Overall Study|Adverse Event|2
195068|NCT01041573|620593|P1|Overall Study|Adverse Event|0
195069|NCT01041573|620590|P4|Overall Study|Lost to Follow-up|1
195070|NCT01041573|620591|P3|Overall Study|Lost to Follow-up|2
195071|NCT01041573|620592|P2|Overall Study|Lost to Follow-up|1
195072|NCT01041573|620593|P1|Overall Study|Lost to Follow-up|0
195073|NCT01041573|620590|P4|Overall Study|Death|0
195074|NCT01041573|620591|P3|Overall Study|Death|0
195075|NCT01041573|620592|P2|Overall Study|Death|0
195076|NCT01041573|620593|P1|Overall Study|Death|1
195077|NCT01041573|620590|P4|Overall Study|Withdrawal by Subject|0
195078|NCT01041573|620591|P3|Overall Study|Withdrawal by Subject|2
195079|NCT01041573|620592|P2|Overall Study|Withdrawal by Subject|5
195080|NCT01041573|620593|P1|Overall Study|Withdrawal by Subject|2
195081|NCT01041638|620603|P1|Overall Study|Withdrawal by Subject|11
195082|NCT01041638|620603|P1|Overall Study|Physician Decision|4
195083|NCT01041638|620603|P1|Overall Study|Lack of Efficacy|7
195084|NCT01041638|620603|P1|Overall Study|Death|1
195085|NCT01041638|620603|P1|Overall Study|Adverse Event|4
195086|NCT01035060|620626|P2|Overall Study|Physician Decision|0
195087|NCT01035060|620627|P1|Overall Study|Physician Decision|2
195088|NCT01035060|620626|P2|Overall Study|Withdrawal by Subject|6
195089|NCT01035060|620627|P1|Overall Study|Withdrawal by Subject|8
195090|NCT01035060|620626|P2|Overall Study|Did not quality after 2nd screening|1
195091|NCT01035060|620627|P1|Overall Study|Did not quality after 2nd screening|14
195092|NCT01035060|620626|P2|Overall Study|Lost to Follow-up|7
195093|NCT01035060|620627|P1|Overall Study|Lost to Follow-up|0
195094|NCT01035138|620636|P3|Overall Study|Lost to Follow-up|1
195095|NCT01035138|620637|P2|Overall Study|Lost to Follow-up|0
195096|NCT01035138|620638|P1|Overall Study|Lost to Follow-up|0
195097|NCT01035138|620636|P3|Overall Study|Sponsor Decision|42
195098|NCT01035138|620637|P2|Overall Study|Sponsor Decision|60
195099|NCT01035138|620638|P1|Overall Study|Sponsor Decision|66
195100|NCT01035138|620636|P3|Overall Study|Physician Decision|1
195101|NCT01035138|620637|P2|Overall Study|Physician Decision|0
195102|NCT01035138|620638|P1|Overall Study|Physician Decision|0
195103|NCT01035138|620636|P3|Overall Study|Withdrawal by Subject|0
195104|NCT01035138|620637|P2|Overall Study|Withdrawal by Subject|0
195105|NCT01035138|620638|P1|Overall Study|Withdrawal by Subject|1
195106|NCT01035138|620636|P3|Overall Study|Caregiver Decision|1
195107|NCT01035138|620637|P2|Overall Study|Caregiver Decision|0
195108|NCT01035138|620638|P1|Overall Study|Caregiver Decision|2
195109|NCT01035138|620636|P3|Overall Study|Adverse Event|2
195110|NCT01035138|620637|P2|Overall Study|Adverse Event|0
195111|NCT01035138|620638|P1|Overall Study|Adverse Event|4
195112|NCT01035229|620694|P2|Overall Study|Disease Progression|152
195113|NCT01035229|620695|P1|Overall Study|Disease Progression|261
195114|NCT01035229|620694|P2|Overall Study|Sponsor's decision to end study|3
195115|NCT01035229|620695|P1|Overall Study|Sponsor's decision to end study|3
195116|NCT01035229|620694|P2|Overall Study|Protocol Violation|2
195117|NCT01035229|620695|P1|Overall Study|Protocol Violation|0
195118|NCT01035229|620694|P2|Overall Study|New cancer therapy|0
195119|NCT01035229|620695|P1|Overall Study|New cancer therapy|2
195120|NCT01035229|620694|P2|Overall Study|Death|5
195121|NCT01035229|620695|P1|Overall Study|Death|13
195122|NCT01035229|620694|P2|Overall Study|Administrative problems|1
195123|NCT01035229|620695|P1|Overall Study|Administrative problems|1
195124|NCT01035229|620694|P2|Overall Study|Lost to Follow-up|0
195125|NCT01035229|620695|P1|Overall Study|Lost to Follow-up|1
195126|NCT01035229|620694|P2|Overall Study|Withdrawal by Subject|7
195127|NCT01035229|620695|P1|Overall Study|Withdrawal by Subject|20
195128|NCT01035229|620694|P2|Overall Study|Adverse Event|14
195129|NCT01035229|620695|P1|Overall Study|Adverse Event|61
195130|NCT01035255|620715|P2|Overall Study|patient's request|13
195131|NCT01035255|620716|P1|Overall Study|patient's request|15
195132|NCT01035255|620715|P2|Overall Study|Lost to Follow-up|5
195133|NCT01035255|620716|P1|Overall Study|Lost to Follow-up|2
195134|NCT01035255|620715|P2|Overall Study|Death|844
195135|NCT01035255|620716|P1|Overall Study|Death|724
195136|NCT01041859|620915|P3|Double-Blind Maintenance|Withdrawal by Subject|9
195137|NCT01041859|620916|P2|Double-Blind Maintenance|Withdrawal by Subject|8
195138|NCT01041859|620917|P1|Double-Blind Maintenance|Withdrawal by Subject|0
195139|NCT01041859|620915|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
195140|NCT01041859|620916|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
195141|NCT01041859|620917|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
195142|NCT01041859|620915|P3|Double-Blind Maintenance|Other|2
195143|NCT01041859|620916|P2|Double-Blind Maintenance|Other|6
195144|NCT01041859|620917|P1|Double-Blind Maintenance|Other|0
195145|NCT01041859|620915|P3|Double-Blind Maintenance|Protocol Violation|3
195146|NCT01041859|620916|P2|Double-Blind Maintenance|Protocol Violation|1
195147|NCT01041859|620917|P1|Double-Blind Maintenance|Protocol Violation|0
195148|NCT01041859|620915|P3|Double-Blind Maintenance|Physician Decision|1
195149|NCT01041859|620916|P2|Double-Blind Maintenance|Physician Decision|2
195150|NCT01041859|620917|P1|Double-Blind Maintenance|Physician Decision|0
195151|NCT01041859|620915|P3|Double-Blind Maintenance|Lost to Follow-up|0
195152|NCT01041859|620916|P2|Double-Blind Maintenance|Lost to Follow-up|1
195153|NCT01041859|620917|P1|Double-Blind Maintenance|Lost to Follow-up|0
195154|NCT01041859|620915|P3|Double-Blind Maintenance|Lack of Efficacy|11
195155|NCT01041859|620916|P2|Double-Blind Maintenance|Lack of Efficacy|3
195156|NCT01041859|620917|P1|Double-Blind Maintenance|Lack of Efficacy|0
195157|NCT01041859|620915|P3|Double-Blind Maintenance|Adverse Event|13
195158|NCT01041859|620916|P2|Double-Blind Maintenance|Adverse Event|23
195159|NCT01041859|620917|P1|Double-Blind Maintenance|Adverse Event|0
195160|NCT01041859|620915|P3|Open-Label Titration|Withdrawal by Subject|0
195161|NCT01041859|620916|P2|Open-Label Titration|Withdrawal by Subject|0
195162|NCT01041859|620917|P1|Open-Label Titration|Withdrawal by Subject|11
195163|NCT01041859|620915|P3|Open-Label Titration|Noncompliance With Study Drug|0
195164|NCT01041859|620916|P2|Open-Label Titration|Noncompliance With Study Drug|0
195165|NCT01041859|620917|P1|Open-Label Titration|Noncompliance With Study Drug|8
195166|NCT01041859|620915|P3|Open-Label Titration|Other|0
195167|NCT01041859|620916|P2|Open-Label Titration|Other|0
195168|NCT01041859|620917|P1|Open-Label Titration|Other|7
195169|NCT01041859|620915|P3|Open-Label Titration|Protocol Violation|0
195170|NCT01041859|620916|P2|Open-Label Titration|Protocol Violation|0
195171|NCT01041859|620917|P1|Open-Label Titration|Protocol Violation|1
195172|NCT01041859|620915|P3|Open-Label Titration|Physician Decision|0
195173|NCT01041859|620916|P2|Open-Label Titration|Physician Decision|0
195174|NCT01041859|620917|P1|Open-Label Titration|Physician Decision|1
195175|NCT01041859|620915|P3|Open-Label Titration|Lost to Follow-up|0
195176|NCT01041859|620916|P2|Open-Label Titration|Lost to Follow-up|0
195177|NCT01041859|620917|P1|Open-Label Titration|Lost to Follow-up|1
195178|NCT01041859|620915|P3|Open-Label Titration|Lack of Efficacy|0
195179|NCT01041859|620916|P2|Open-Label Titration|Lack of Efficacy|0
195180|NCT01041859|620917|P1|Open-Label Titration|Lack of Efficacy|3
195181|NCT01041859|620915|P3|Open-Label Titration|Adverse Event|0
195182|NCT01041859|620916|P2|Open-Label Titration|Adverse Event|0
195183|NCT01041859|620917|P1|Open-Label Titration|Adverse Event|69
195184|NCT01041976|620934|P2|Overall Study|Death|4
195185|NCT01041976|620935|P1|Overall Study|Death|0
195186|NCT01041976|620934|P2|Overall Study|Incarceration|0
195187|NCT01041976|620935|P1|Overall Study|Incarceration|2
195188|NCT01041976|620934|P2|Overall Study|Withdrawal by Subject|0
195189|NCT01041976|620935|P1|Overall Study|Withdrawal by Subject|3
195190|NCT01042093|620947|P4|Overall Study|Withdrawal by Subject|1
195191|NCT01042093|620948|P3|Overall Study|Withdrawal by Subject|0
195192|NCT01042093|620949|P2|Overall Study|Withdrawal by Subject|0
195193|NCT01042093|620950|P1|Overall Study|Withdrawal by Subject|0
195194|NCT01042093|620947|P4|Overall Study|Protocol Violation|3
195195|NCT01042093|620948|P3|Overall Study|Protocol Violation|2
195196|NCT01042093|620949|P2|Overall Study|Protocol Violation|2
195197|NCT01042093|620950|P1|Overall Study|Protocol Violation|2
195198|NCT01043705|621043|P3|Overall Study|Unspecified|25
195199|NCT01043705|621044|P2|Overall Study|Unspecified|19
195200|NCT01043705|621045|P1|Overall Study|Unspecified|0
195201|NCT01043705|621043|P3|Overall Study|Screen Fail|0
195202|NCT01043705|621044|P2|Overall Study|Screen Fail|0
195203|NCT01043705|621045|P1|Overall Study|Screen Fail|21
195204|NCT01043705|621043|P3|Overall Study|Adverse Event|0
195205|NCT01043705|621044|P2|Overall Study|Adverse Event|2
195206|NCT01043705|621045|P1|Overall Study|Adverse Event|0
195207|NCT01043705|621043|P3|Overall Study|Subsequent Procedure|29
195208|NCT01043705|621044|P2|Overall Study|Subsequent Procedure|24
195209|NCT01043705|621045|P1|Overall Study|Subsequent Procedure|9
195210|NCT01043705|621043|P3|Overall Study|Site Closure|0
195211|NCT01043705|621044|P2|Overall Study|Site Closure|0
195212|NCT01043705|621045|P1|Overall Study|Site Closure|8
195213|NCT01043705|621043|P3|Overall Study|Withdrawal by Subject|0
195214|NCT01043705|621044|P2|Overall Study|Withdrawal by Subject|6
195215|NCT01043705|621045|P1|Overall Study|Withdrawal by Subject|8
195216|NCT01043705|621043|P3|Overall Study|Protocol Violation|0
195217|NCT01043705|621044|P2|Overall Study|Protocol Violation|1
195218|NCT01043705|621045|P1|Overall Study|Protocol Violation|2
195219|NCT01043705|621043|P3|Overall Study|Multiple Reasons|0
195220|NCT01043705|621044|P2|Overall Study|Multiple Reasons|7
195221|NCT01043705|621045|P1|Overall Study|Multiple Reasons|4
195222|NCT01043705|621043|P3|Overall Study|Lost to Follow-up|0
195223|NCT01043705|621044|P2|Overall Study|Lost to Follow-up|12
195224|NCT01043705|621045|P1|Overall Study|Lost to Follow-up|27
195225|NCT01043705|621043|P3|Overall Study|Death|26
195226|NCT01043705|621044|P2|Overall Study|Death|60
195227|NCT01043705|621045|P1|Overall Study|Death|28
195228|NCT01043874|621055|P1|Overall Study|Administrative Problems|1
195229|NCT01043874|621055|P1|Overall Study|Lack of Efficacy|1
195230|NCT01043874|621055|P1|Overall Study|Withdrawal by Subject|1
195231|NCT01043874|621055|P1|Overall Study|Adverse Event|3
195232|NCT01044290|621158|P3|Follow-Up 2|Withdrawal by Subject|1
195233|NCT01044290|621159|P2|Follow-Up 2|Withdrawal by Subject|1
195234|NCT01044290|621160|P1|Follow-Up 2|Withdrawal by Subject|0
195235|NCT01044290|621158|P3|Follow-Up 2|Death|1
195236|NCT01044290|621159|P2|Follow-Up 2|Death|1
195237|NCT01044290|621160|P1|Follow-Up 2|Death|0
195238|NCT01044290|621158|P3|Follow-up 1|Withdrawal by Subject|0
195239|NCT01044290|621159|P2|Follow-up 1|Withdrawal by Subject|2
195240|NCT01044290|621160|P1|Follow-up 1|Withdrawal by Subject|2
195241|NCT01044290|621158|P3|Follow-up 1|Death|1
195242|NCT01044290|621159|P2|Follow-up 1|Death|3
195243|NCT01044290|621160|P1|Follow-up 1|Death|3
195244|NCT01044303|621183|P1|Overall Study|Lost to Follow-up|2
195245|NCT01044459|621192|P2|Overall Study|Lost to Follow-up|12
195246|NCT01044459|621193|P1|Overall Study|Lost to Follow-up|18
195247|NCT01044459|621192|P2|Overall Study|COPD exacerbation|8
195248|NCT01044459|621193|P1|Overall Study|COPD exacerbation|9
195249|NCT01044459|621192|P2|Overall Study|Other Reason|14
195250|NCT01044459|621193|P1|Overall Study|Other Reason|7
195251|NCT01044459|621192|P2|Overall Study|Protocol Violation|16
195252|NCT01044459|621193|P1|Overall Study|Protocol Violation|11
195253|NCT01044459|621192|P2|Overall Study|Lack of Efficacy|12
195254|NCT01044459|621193|P1|Overall Study|Lack of Efficacy|23
195255|NCT01044459|621192|P2|Overall Study|Adverse Event|20
195256|NCT01044459|621193|P1|Overall Study|Adverse Event|22
195257|NCT01044459|621192|P2|Overall Study|Terminated by Sponsor|21
195258|NCT01044459|621193|P1|Overall Study|Terminated by Sponsor|22
195259|NCT01044459|621192|P2|Overall Study|Withdrawal by Subject|28
195260|NCT01044459|621193|P1|Overall Study|Withdrawal by Subject|21
195261|NCT01044498|621203|P2|Overall Study|Not specified|0
195262|NCT01044498|621204|P1|Overall Study|Not specified|1
195263|NCT01044498|621203|P2|Overall Study|Adverse Event|1
195264|NCT01044498|621204|P1|Overall Study|Adverse Event|1
195265|NCT01044498|621203|P2|Overall Study|Withdrew consent|1
195266|NCT01044498|621204|P1|Overall Study|Withdrew consent|1
195267|NCT01044732|621409|P2|Overall Study|Technical error or malfunction|14
195268|NCT01044732|621410|P1|Overall Study|Technical error or malfunction|15
195269|NCT01044732|621409|P2|Overall Study|Inability to reach cecum|2
195270|NCT01044732|621410|P1|Overall Study|Inability to reach cecum|5
195271|NCT01044732|621409|P2|Overall Study|Inadequate bowel preparation|17
195272|NCT01044732|621410|P1|Overall Study|Inadequate bowel preparation|11
195273|NCT01044732|621409|P2|Overall Study|Withdrawal by Subject|1
195274|NCT01044732|621410|P1|Overall Study|Withdrawal by Subject|0
195275|NCT01044732|621409|P2|Overall Study|Protocol Violation|12
195276|NCT01044732|621410|P1|Overall Study|Protocol Violation|11
195277|NCT01044732|621409|P2|Overall Study|Physician Decision|3
195278|NCT01044732|621410|P1|Overall Study|Physician Decision|5
195279|NCT01044732|621409|P2|Overall Study|Lost to Follow-up|1
195280|NCT01044732|621410|P1|Overall Study|Lost to Follow-up|2
195281|NCT01045096|621504|P3|Overall Study|Other|0
195282|NCT01045096|621505|P2|Overall Study|Other|0
195283|NCT01045096|621506|P1|Overall Study|Other|1
195284|NCT01045096|621504|P3|Overall Study|Withdrawal by Subject|0
195285|NCT01045096|621505|P2|Overall Study|Withdrawal by Subject|0
195286|NCT01045096|621506|P1|Overall Study|Withdrawal by Subject|2
195287|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
195288|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
195289|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
195290|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
195291|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
195292|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
195293|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
195294|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
195295|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
195381|NCT01045421|621589|P3|Phase 1|Progressive Disease|0
195296|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
195297|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
195298|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
195299|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
195300|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
195301|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
195302|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
195303|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
195304|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
195305|NCT01045161|621542|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
195306|NCT01045161|621543|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
195307|NCT01045161|621544|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
195308|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
195309|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
195310|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
195311|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
195312|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
195313|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
195314|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
195315|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
195316|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
195317|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
195318|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
195319|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
195320|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
195321|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
195322|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
195323|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
195324|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
195325|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
195326|NCT01045161|621542|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
195327|NCT01045161|621543|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
195328|NCT01045161|621544|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
195329|NCT01045421|621581|P11|Phase 2|Other|1
195330|NCT01045421|621582|P10|Phase 2|Other|0
195331|NCT01045421|621583|P9|Phase 2|Other|0
195332|NCT01045421|621584|P8|Phase 2|Other|3
195333|NCT01045421|621585|P7|Phase 2|Other|0
195334|NCT01045421|621586|P6|Phase 2|Other|0
195335|NCT01045421|621587|P5|Phase 2|Other|0
195336|NCT01045421|621588|P4|Phase 2|Other|0
195337|NCT01045421|621589|P3|Phase 2|Other|0
195338|NCT01045421|621590|P2|Phase 2|Other|0
195339|NCT01045421|621591|P1|Phase 2|Other|0
195340|NCT01045421|621581|P11|Phase 2|Death|0
195341|NCT01045421|621582|P10|Phase 2|Death|2
195342|NCT01045421|621583|P9|Phase 2|Death|1
195343|NCT01045421|621584|P8|Phase 2|Death|1
195344|NCT01045421|621585|P7|Phase 2|Death|0
195345|NCT01045421|621586|P6|Phase 2|Death|0
195346|NCT01045421|621587|P5|Phase 2|Death|0
195347|NCT01045421|621588|P4|Phase 2|Death|0
195348|NCT01045421|621589|P3|Phase 2|Death|0
195349|NCT01045421|621590|P2|Phase 2|Death|0
195350|NCT01045421|621591|P1|Phase 2|Death|0
195351|NCT01045421|621581|P11|Phase 2|Progressive Disease|1
195352|NCT01045421|621582|P10|Phase 2|Progressive Disease|1
195353|NCT01045421|621583|P9|Phase 2|Progressive Disease|1
195354|NCT01045421|621584|P8|Phase 2|Progressive Disease|1
195355|NCT01045421|621585|P7|Phase 2|Progressive Disease|0
195356|NCT01045421|621586|P6|Phase 2|Progressive Disease|0
195357|NCT01045421|621587|P5|Phase 2|Progressive Disease|0
195358|NCT01045421|621588|P4|Phase 2|Progressive Disease|0
195359|NCT01045421|621589|P3|Phase 2|Progressive Disease|0
195360|NCT01045421|621590|P2|Phase 2|Progressive Disease|0
195361|NCT01045421|621591|P1|Phase 2|Progressive Disease|0
195362|NCT01045421|621581|P11|Phase 1|Withdrawal by Subject|0
195363|NCT01045421|621582|P10|Phase 1|Withdrawal by Subject|0
195364|NCT01045421|621583|P9|Phase 1|Withdrawal by Subject|0
195365|NCT01045421|621584|P8|Phase 1|Withdrawal by Subject|0
195366|NCT01045421|621585|P7|Phase 1|Withdrawal by Subject|0
195367|NCT01045421|621586|P6|Phase 1|Withdrawal by Subject|0
195368|NCT01045421|621587|P5|Phase 1|Withdrawal by Subject|0
195369|NCT01045421|621588|P4|Phase 1|Withdrawal by Subject|1
195370|NCT01045421|621589|P3|Phase 1|Withdrawal by Subject|0
195371|NCT01045421|621590|P2|Phase 1|Withdrawal by Subject|0
195372|NCT01045421|621591|P1|Phase 1|Withdrawal by Subject|0
195373|NCT01045421|621581|P11|Phase 1|Progressive Disease|0
195374|NCT01045421|621582|P10|Phase 1|Progressive Disease|0
195375|NCT01045421|621583|P9|Phase 1|Progressive Disease|0
195376|NCT01045421|621584|P8|Phase 1|Progressive Disease|0
195377|NCT01045421|621585|P7|Phase 1|Progressive Disease|0
195378|NCT01045421|621586|P6|Phase 1|Progressive Disease|0
195379|NCT01045421|621587|P5|Phase 1|Progressive Disease|1
195380|NCT01045421|621588|P4|Phase 1|Progressive Disease|0
195382|NCT01045421|621590|P2|Phase 1|Progressive Disease|0
195383|NCT01045421|621591|P1|Phase 1|Progressive Disease|0
195384|NCT01045447|621673|P2|Overall Study|Unclassified|13
195385|NCT01045447|621674|P1|Overall Study|Unclassified|17
195386|NCT01045447|621673|P2|Overall Study|Withdrawal Criteria|10
195387|NCT01045447|621674|P1|Overall Study|Withdrawal Criteria|10
195388|NCT01045447|621673|P2|Overall Study|Protocol Violation|3
195389|NCT01045447|621674|P1|Overall Study|Protocol Violation|6
195390|NCT01045447|621673|P2|Overall Study|Lack of Efficacy|1
195391|NCT01045447|621674|P1|Overall Study|Lack of Efficacy|3
195392|NCT01045447|621673|P2|Overall Study|Adverse Event|1
195393|NCT01045447|621674|P1|Overall Study|Adverse Event|0
195394|NCT01045694|621690|P1|Overall Study|Withdrawal by Subject|2
195395|NCT01045707|621696|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
195396|NCT01045707|621697|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
195397|NCT01045707|621696|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
195398|NCT01045707|621697|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
195399|NCT01045707|621696|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
195400|NCT01045707|621697|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
195401|NCT01045707|621696|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
195402|NCT01045707|621697|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
195403|NCT01045707|621696|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
195404|NCT01045707|621697|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
195405|NCT01045707|621696|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
195406|NCT01045707|621697|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
195407|NCT01045707|621696|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
195408|NCT01045707|621697|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
195409|NCT01045707|621696|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
195410|NCT01045707|621697|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
195411|NCT01045707|621696|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
195412|NCT01045707|621697|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
195413|NCT01045798|621715|P2|Overall Study|Received Systemic Antifungal Prestudy|1
195414|NCT01045798|621716|P1|Overall Study|Received Systemic Antifungal Prestudy|0
195415|NCT01045798|621715|P2|Overall Study|Changed to Other Antifungal Therapy|2
195416|NCT01045798|621716|P1|Overall Study|Changed to Other Antifungal Therapy|1
195417|NCT01045798|621715|P2|Overall Study|Invasive Fungal Infection at Baseline|1
195418|NCT01045798|621716|P1|Overall Study|Invasive Fungal Infection at Baseline|0
195419|NCT01045798|621715|P2|Overall Study|Changed to Open-Label Caspofungin|0
195420|NCT01045798|621716|P1|Overall Study|Changed to Open-Label Caspofungin|1
195421|NCT01045967|621724|P2|Second Intervention|Protocol Violation|1
195422|NCT01045967|621725|P1|Second Intervention|Protocol Violation|0
195423|NCT01045993|621739|P4|Overall Study|Treated-later found eligibility not met|0
195424|NCT01045993|621740|P3|Overall Study|Treated-later found eligibility not met|0
195425|NCT01045993|621741|P2|Overall Study|Treated-later found eligibility not met|1
195426|NCT01045993|621742|P1|Overall Study|Treated-later found eligibility not met|0
195427|NCT01049984|621818|P2|Overall Study|Treatment failure|2
195428|NCT01049984|621819|P1|Overall Study|Treatment failure|0
195429|NCT01049984|621818|P2|Overall Study|Adverse Event|7
195430|NCT01049984|621819|P1|Overall Study|Adverse Event|13
195431|NCT01049984|621818|P2|Overall Study|Lost to Follow-up|1
195432|NCT01049984|621819|P1|Overall Study|Lost to Follow-up|2
195433|NCT01049984|621818|P2|Overall Study|Protocol Violation|4
195434|NCT01049984|621819|P1|Overall Study|Protocol Violation|3
195435|NCT01049984|621818|P2|Overall Study|Withdrawal by Subject|5
195436|NCT01049984|621819|P1|Overall Study|Withdrawal by Subject|1
195437|NCT01050062|621837|P2|Overall Study|Others|11
195438|NCT01050062|621838|P1|Overall Study|Others|17
195439|NCT01050062|621837|P2|Overall Study|Physician Decision|9
195440|NCT01050062|621838|P1|Overall Study|Physician Decision|74
195441|NCT01050062|621837|P2|Overall Study|Lack of Efficacy|35
195442|NCT01050062|621838|P1|Overall Study|Lack of Efficacy|22
195443|NCT01050062|621837|P2|Overall Study|Lost to Follow-up|35
195444|NCT01050062|621838|P1|Overall Study|Lost to Follow-up|83
195445|NCT01050062|621837|P2|Overall Study|Adverse Event|22
195446|NCT01050062|621838|P1|Overall Study|Adverse Event|75
195447|NCT01050205|621887|P2|Overall Study|Discontinued Intervention|0
195448|NCT01050205|621888|P1|Overall Study|Discontinued Intervention|2
195449|NCT01050205|621887|P2|Overall Study|Relocated from area|2
195450|NCT01050205|621888|P1|Overall Study|Relocated from area|1
195451|NCT01050205|621887|P2|Overall Study|Withdrawal by Subject|1
195452|NCT01050205|621888|P1|Overall Study|Withdrawal by Subject|1
195453|NCT01050205|621887|P2|Overall Study|Lost to Follow-up|1
195454|NCT01050205|621888|P1|Overall Study|Lost to Follow-up|7
195455|NCT01050218|621916|P1|Overall Study|Family emergency|1
195456|NCT01050218|621916|P1|Overall Study|Serious Adverse Event|1
195457|NCT01050218|621916|P1|Overall Study|Failed to return|7
195458|NCT01050218|621916|P1|Overall Study|Compliance|2
195459|NCT01050218|621916|P1|Overall Study|Discontinued by sponsor|18
195460|NCT01050218|621916|P1|Overall Study|Withdrawal by Subject|18
195461|NCT01050218|621916|P1|Overall Study|Protocol Violation|3
195462|NCT01050218|621916|P1|Overall Study|Lack of Efficacy|8
195463|NCT01050218|621916|P1|Overall Study|Adverse Event|37
195464|NCT01050257|621923|P3|Overall Study|Death|1
195465|NCT01050257|621924|P2|Overall Study|Death|0
195466|NCT01050257|621925|P1|Overall Study|Death|0
195467|NCT01050257|621923|P3|Overall Study|Failure to return|0
195468|NCT01050257|621924|P2|Overall Study|Failure to return|2
195469|NCT01050257|621925|P1|Overall Study|Failure to return|0
195470|NCT01050257|621923|P3|Overall Study|Violation criteria|0
195471|NCT01050257|621924|P2|Overall Study|Violation criteria|1
195472|NCT01050257|621925|P1|Overall Study|Violation criteria|0
195473|NCT01050257|621923|P3|Overall Study|Refused treatment/ Did not Cooperate|0
195474|NCT01050257|621924|P2|Overall Study|Refused treatment/ Did not Cooperate|1
195475|NCT01050257|621925|P1|Overall Study|Refused treatment/ Did not Cooperate|1
195476|NCT01050257|621923|P3|Overall Study|No reason specified|2
195477|NCT01050257|621924|P2|Overall Study|No reason specified|0
195478|NCT01050257|621925|P1|Overall Study|No reason specified|0
195479|NCT01050257|621923|P3|Overall Study|Withdrawal by Subject|0
195480|NCT01050257|621924|P2|Overall Study|Withdrawal by Subject|3
195481|NCT01050257|621925|P1|Overall Study|Withdrawal by Subject|0
195482|NCT01050257|621923|P3|Overall Study|Admin/Other (did not switch to oral)|2
195483|NCT01050257|621924|P2|Overall Study|Admin/Other (did not switch to oral)|2
195484|NCT01050257|621925|P1|Overall Study|Admin/Other (did not switch to oral)|6
195485|NCT01050257|621923|P3|Overall Study|Adverse Event|2
195486|NCT01050257|621924|P2|Overall Study|Adverse Event|4
195487|NCT01050257|621925|P1|Overall Study|Adverse Event|4
195488|NCT01050530|621962|P2|Overall Study|Protocol Violation|0
195489|NCT01050530|621963|P1|Overall Study|Protocol Violation|1
195490|NCT01050530|621962|P2|Overall Study|Withdrawal by Subject|3
195491|NCT01050530|621963|P1|Overall Study|Withdrawal by Subject|0
195492|NCT01050530|621962|P2|Overall Study|Lack of Efficacy|4
195493|NCT01050530|621963|P1|Overall Study|Lack of Efficacy|1
195494|NCT01050530|621962|P2|Overall Study|Adverse Event|3
195495|NCT01050530|621963|P1|Overall Study|Adverse Event|6
195496|NCT01050543|621973|P2|Overall Study|Administrative|1
195497|NCT01050543|621974|P1|Overall Study|Administrative|4
195498|NCT01050543|621973|P2|Overall Study|Protocol Violation|1
195499|NCT01050543|621974|P1|Overall Study|Protocol Violation|0
195500|NCT01050543|621973|P2|Overall Study|Withdrawal by Subject|2
195501|NCT01050543|621974|P1|Overall Study|Withdrawal by Subject|0
195502|NCT01050569|621983|P3|Overall Study|Physician Decision|3
195503|NCT01050569|621984|P2|Overall Study|Physician Decision|3
195504|NCT01050569|621985|P1|Overall Study|Physician Decision|3
195505|NCT01050569|621983|P3|Overall Study|Adverse Event|0
195506|NCT01050569|621984|P2|Overall Study|Adverse Event|0
195507|NCT01050569|621985|P1|Overall Study|Adverse Event|1
195508|NCT01050569|621983|P3|Overall Study|Lack of Efficacy|3
195509|NCT01050569|621984|P2|Overall Study|Lack of Efficacy|4
195510|NCT01050569|621985|P1|Overall Study|Lack of Efficacy|5
195511|NCT01050569|621983|P3|Overall Study|Withdrawal by Subject|11
195512|NCT01050569|621984|P2|Overall Study|Withdrawal by Subject|3
195513|NCT01050569|621985|P1|Overall Study|Withdrawal by Subject|9
195514|NCT01050569|621983|P3|Overall Study|Lost to Follow-up|16
195515|NCT01050569|621984|P2|Overall Study|Lost to Follow-up|14
195516|NCT01050569|621985|P1|Overall Study|Lost to Follow-up|20
195517|NCT01050634|622015|P1|Overall Study|Ongoing at Date of Cut-Off|5
195518|NCT01050634|622015|P1|Overall Study|Other|21
195519|NCT01050634|622015|P1|Overall Study|Lost to Follow-up|2
195520|NCT01050634|622015|P1|Overall Study|Adverse Event|42
195521|NCT01050634|622015|P1|Overall Study|Death|2
195522|NCT01050634|622015|P1|Overall Study|Enrolled, but Not Treated|56
195523|NCT01050673|622052|P2|Overall Study|Physician Decision|5
195524|NCT01050673|622053|P1|Overall Study|Physician Decision|4
195525|NCT01050764|622075|P1|Overall Study|Death, after HSCT|1
195526|NCT01050764|622075|P1|Overall Study|Donor mobilization failure, death|1
195527|NCT01050764|622075|P1|Overall Study|Death, before HSCT|1
195528|NCT01050790|622084|P1|Overall Study|Adverse Event|1
195529|NCT01050816|622094|P1|Overall Study|patient's refusal|2
195530|NCT01050816|622094|P1|Overall Study|Lost to Follow-up|2
195531|NCT01050998|622115|P5|Overall Study|Data integrity issues|4
195532|NCT01050998|622116|P4|Overall Study|Data integrity issues|1
195533|NCT01050998|622117|P3|Overall Study|Data integrity issues|1
195534|NCT01050998|622118|P2|Overall Study|Data integrity issues|0
195535|NCT01050998|622119|P1|Overall Study|Data integrity issues|0
195536|NCT01050998|622115|P5|Overall Study|Unspecified|5
195537|NCT01050998|622116|P4|Overall Study|Unspecified|1
195538|NCT01050998|622117|P3|Overall Study|Unspecified|1
195539|NCT01050998|622118|P2|Overall Study|Unspecified|2
195540|NCT01050998|622119|P1|Overall Study|Unspecified|3
195541|NCT01050998|622115|P5|Overall Study|Withdrawal by Subject|3
195542|NCT01050998|622116|P4|Overall Study|Withdrawal by Subject|1
195543|NCT01050998|622117|P3|Overall Study|Withdrawal by Subject|0
195544|NCT01050998|622118|P2|Overall Study|Withdrawal by Subject|0
195545|NCT01050998|622119|P1|Overall Study|Withdrawal by Subject|0
195546|NCT01050998|622115|P5|Overall Study|Adverse Event|2
195547|NCT01050998|622116|P4|Overall Study|Adverse Event|0
195548|NCT01050998|622117|P3|Overall Study|Adverse Event|1
195549|NCT01050998|622118|P2|Overall Study|Adverse Event|0
195550|NCT01050998|622119|P1|Overall Study|Adverse Event|1
195551|NCT01051323|622445|P1|Overall Study|Missing|37
195552|NCT01051323|622445|P1|Overall Study|Unspecified|148
195553|NCT01051323|622445|P1|Overall Study|Hospitalization|28
195554|NCT01051323|622445|P1|Overall Study|Death|129
195555|NCT01051323|622445|P1|Overall Study|Lost to Follow-up|31
195556|NCT01051323|622445|P1|Overall Study|Withdrawal by Subject|13
195557|NCT01051323|622445|P1|Overall Study|Dialysis dependency|22
195558|NCT01051323|622445|P1|Overall Study|Transplantation|28
195559|NCT01051323|622445|P1|Overall Study|Discontinuation of treatment|103
195560|NCT01051466|622482|P2|Overall Study|Physician Decision|0
195561|NCT01051466|622483|P1|Overall Study|Physician Decision|1
195562|NCT01051466|622482|P2|Overall Study|Entry Criteria Not Met|3
195563|NCT01051466|622483|P1|Overall Study|Entry Criteria Not Met|0
195564|NCT01051466|622482|P2|Overall Study|Withdrawal by Subject|1
195565|NCT01051466|622483|P1|Overall Study|Withdrawal by Subject|5
195566|NCT01051466|622482|P2|Overall Study|Lost to Follow-up|1
195567|NCT01051466|622483|P1|Overall Study|Lost to Follow-up|1
195568|NCT01051466|622482|P2|Overall Study|Adverse Event|0
195569|NCT01051466|622483|P1|Overall Study|Adverse Event|1
195570|NCT01051557|622522|P7|Overall Study|Adverse Event|4
195571|NCT01051557|622523|P6|Overall Study|Adverse Event|3
195572|NCT01051557|622524|P5|Overall Study|Adverse Event|1
195573|NCT01051557|622525|P4|Overall Study|Adverse Event|1
195574|NCT01051557|622526|P3|Overall Study|Adverse Event|0
195575|NCT01051557|622527|P2|Overall Study|Adverse Event|0
195576|NCT01051557|622528|P1|Overall Study|Adverse Event|0
195577|NCT01051557|622522|P7|Overall Study|Withdrawal by Subject|1
195578|NCT01051557|622523|P6|Overall Study|Withdrawal by Subject|0
195579|NCT01051557|622524|P5|Overall Study|Withdrawal by Subject|2
195580|NCT01051557|622525|P4|Overall Study|Withdrawal by Subject|0
195581|NCT01051557|622526|P3|Overall Study|Withdrawal by Subject|1
195582|NCT01051557|622527|P2|Overall Study|Withdrawal by Subject|0
195583|NCT01051557|622528|P1|Overall Study|Withdrawal by Subject|0
195584|NCT01051557|622522|P7|Overall Study|disease progression|1
195585|NCT01051557|622523|P6|Overall Study|disease progression|3
195586|NCT01051557|622524|P5|Overall Study|disease progression|4
195587|NCT01051557|622525|P4|Overall Study|disease progression|2
195588|NCT01051557|622526|P3|Overall Study|disease progression|5
195589|NCT01051557|622527|P2|Overall Study|disease progression|3
195590|NCT01051557|622528|P1|Overall Study|disease progression|3
195591|NCT01051557|622522|P7|Overall Study|Physician Decision|0
195592|NCT01051557|622523|P6|Overall Study|Physician Decision|0
195593|NCT01051557|622524|P5|Overall Study|Physician Decision|0
195594|NCT01051557|622525|P4|Overall Study|Physician Decision|0
195595|NCT01051557|622526|P3|Overall Study|Physician Decision|0
195596|NCT01051557|622527|P2|Overall Study|Physician Decision|0
195597|NCT01051557|622528|P1|Overall Study|Physician Decision|1
195598|NCT01051739|622544|P2|Overall Study|Withdrawal by Subject|10
195599|NCT01051739|622545|P1|Overall Study|Withdrawal by Subject|25
195600|NCT01051739|622544|P2|Overall Study|Death|3
195601|NCT01051739|622545|P1|Overall Study|Death|3
195602|NCT01051817|622562|P2|Overall Study|Protocol Violation|1
195603|NCT01051817|622563|P1|Overall Study|Protocol Violation|0
195604|NCT01051817|622562|P2|Overall Study|Withdrawal by Subject|5
195605|NCT01051817|622563|P1|Overall Study|Withdrawal by Subject|3
195606|NCT01051817|622562|P2|Overall Study|Abnormal Test Proceedure reults|1
195607|NCT01051817|622563|P1|Overall Study|Abnormal Test Proceedure reults|0
195608|NCT01051817|622562|P2|Overall Study|Adverse Event|2
195609|NCT01051817|622563|P1|Overall Study|Adverse Event|0
195610|NCT01051856|622575|P2|Overall Study|Withdrawal by Subject|0
195611|NCT01051856|622576|P1|Overall Study|Withdrawal by Subject|1
195612|NCT01051921|622584|P1|Overall Study|patient moved|1
195613|NCT01051921|622584|P1|Overall Study|virological failure|1
195614|NCT01051921|622584|P1|Overall Study|Lost to Follow-up|4
195615|NCT01051921|622584|P1|Overall Study|Withdrawal by Subject|7
195616|NCT01051921|622584|P1|Overall Study|Adverse Event|8
195617|NCT01051921|622584|P1|Overall Study|Physician Decision|9
195618|NCT01051986|622591|P2|Overall Study|Protocol Violation|3
195619|NCT01051986|622592|P1|Overall Study|Protocol Violation|2
195620|NCT01051986|622591|P2|Overall Study|Withdrawal by Subject|1
195621|NCT01051986|622592|P1|Overall Study|Withdrawal by Subject|2
195622|NCT01051986|622591|P2|Overall Study|Death|0
195623|NCT01051986|622592|P1|Overall Study|Death|1
195624|NCT01052038|622609|P3|Overall Study|Protocol Violation|3
195625|NCT01052038|622610|P2|Overall Study|Protocol Violation|3
195626|NCT01052038|622611|P1|Overall Study|Protocol Violation|2
195627|NCT01052038|622609|P3|Overall Study|Lost to Follow-up|1
195628|NCT01052038|622610|P2|Overall Study|Lost to Follow-up|3
195629|NCT01052038|622611|P1|Overall Study|Lost to Follow-up|2
195630|NCT01052077|622633|P4|Phase A+|Withdrawal by Subject|7
195631|NCT01052077|622634|P3|Phase A+|Withdrawal by Subject|0
195632|NCT01052077|622635|P2|Phase A+|Withdrawal by Subject|0
195633|NCT01052077|622636|P1|Phase A+|Withdrawal by Subject|0
195634|NCT01052077|622633|P4|Phase A+|Met Withdrawal Criteria|2
195635|NCT01052077|622634|P3|Phase A+|Met Withdrawal Criteria|0
195636|NCT01052077|622635|P2|Phase A+|Met Withdrawal Criteria|0
195637|NCT01052077|622636|P1|Phase A+|Met Withdrawal Criteria|0
195638|NCT01052077|622633|P4|Phase A+|Adverse Event|4
195639|NCT01052077|622634|P3|Phase A+|Adverse Event|0
195640|NCT01052077|622635|P2|Phase A+|Adverse Event|0
195641|NCT01052077|622636|P1|Phase A+|Adverse Event|0
195642|NCT01052077|622633|P4|Phase A+|Lost to Follow-up|8
195643|NCT01052077|622634|P3|Phase A+|Lost to Follow-up|0
195644|NCT01052077|622635|P2|Phase A+|Lost to Follow-up|0
195645|NCT01052077|622636|P1|Phase A+|Lost to Follow-up|0
195646|NCT01052077|622633|P4|Phase B|Lack of Efficacy|0
195647|NCT01052077|622634|P3|Phase B|Lack of Efficacy|0
195648|NCT01052077|622635|P2|Phase B|Lack of Efficacy|1
195649|NCT01052077|622636|P1|Phase B|Lack of Efficacy|0
195650|NCT01052077|622633|P4|Phase B|Protocol Deviation|0
195651|NCT01052077|622634|P3|Phase B|Protocol Deviation|4
195652|NCT01052077|622635|P2|Phase B|Protocol Deviation|3
195653|NCT01052077|622636|P1|Phase B|Protocol Deviation|0
195654|NCT01052077|622633|P4|Phase B|Withdrawal by Subject|0
195655|NCT01052077|622634|P3|Phase B|Withdrawal by Subject|5
195656|NCT01052077|622635|P2|Phase B|Withdrawal by Subject|0
195657|NCT01052077|622636|P1|Phase B|Withdrawal by Subject|0
195658|NCT01052077|622633|P4|Phase B|Physician Decision|0
195659|NCT01052077|622634|P3|Phase B|Physician Decision|1
195660|NCT01052077|622635|P2|Phase B|Physician Decision|1
195661|NCT01052077|622636|P1|Phase B|Physician Decision|0
195662|NCT01052077|622633|P4|Phase B|Met Withdrawal Criteria|0
195663|NCT01052077|622634|P3|Phase B|Met Withdrawal Criteria|1
195664|NCT01052077|622635|P2|Phase B|Met Withdrawal Criteria|2
195665|NCT01052077|622636|P1|Phase B|Met Withdrawal Criteria|0
195666|NCT01052077|622633|P4|Phase B|Adverse Event|0
195667|NCT01052077|622634|P3|Phase B|Adverse Event|2
195668|NCT01052077|622635|P2|Phase B|Adverse Event|9
195669|NCT01052077|622636|P1|Phase B|Adverse Event|0
195670|NCT01052077|622633|P4|Phase B|Lost to Follow-up|0
195671|NCT01052077|622634|P3|Phase B|Lost to Follow-up|3
195672|NCT01052077|622635|P2|Phase B|Lost to Follow-up|2
195673|NCT01052077|622636|P1|Phase B|Lost to Follow-up|0
195674|NCT01052077|622633|P4|Phase A|Protocol Deviation|0
195675|NCT01052077|622634|P3|Phase A|Protocol Deviation|0
195676|NCT01052077|622635|P2|Phase A|Protocol Deviation|0
195677|NCT01052077|622636|P1|Phase A|Protocol Deviation|27
195678|NCT01052077|622633|P4|Phase A|Withdrawal by Subject|0
195679|NCT01052077|622634|P3|Phase A|Withdrawal by Subject|0
195680|NCT01052077|622635|P2|Phase A|Withdrawal by Subject|0
195681|NCT01052077|622636|P1|Phase A|Withdrawal by Subject|29
195682|NCT01052077|622633|P4|Phase A|Physician Decision|0
195683|NCT01052077|622634|P3|Phase A|Physician Decision|0
195684|NCT01052077|622635|P2|Phase A|Physician Decision|0
195685|NCT01052077|622636|P1|Phase A|Physician Decision|10
195686|NCT01052077|622633|P4|Phase A|Met Withdrawal Criteria|0
195687|NCT01052077|622634|P3|Phase A|Met Withdrawal Criteria|0
195688|NCT01052077|622635|P2|Phase A|Met Withdrawal Criteria|0
195689|NCT01052077|622636|P1|Phase A|Met Withdrawal Criteria|26
195690|NCT01052077|622633|P4|Phase A|Adverse Event|0
195691|NCT01052077|622634|P3|Phase A|Adverse Event|0
195692|NCT01052077|622635|P2|Phase A|Adverse Event|0
195693|NCT01052077|622636|P1|Phase A|Adverse Event|32
195694|NCT01052077|622633|P4|Phase A|Lost to Follow-up|0
195695|NCT01052077|622634|P3|Phase A|Lost to Follow-up|0
195696|NCT01052077|622635|P2|Phase A|Lost to Follow-up|0
195697|NCT01052077|622636|P1|Phase A|Lost to Follow-up|22
195698|NCT01052116|622662|P2|Overall Study|Spirometry not performed|4
195699|NCT01052116|622663|P1|Overall Study|Spirometry not performed|0
195700|NCT01052116|622662|P2|Overall Study|Withdrawal by Subject|6
195701|NCT01052116|622663|P1|Overall Study|Withdrawal by Subject|3
195702|NCT01052116|622662|P2|Overall Study|Lost to Follow-up|17
195703|NCT01052116|622663|P1|Overall Study|Lost to Follow-up|11
195704|NCT01052272|622682|P4|Overall Study|decline in health|0
195705|NCT01052272|622683|P3|Overall Study|decline in health|1
195706|NCT01052272|622684|P2|Overall Study|decline in health|0
195707|NCT01052272|622685|P1|Overall Study|decline in health|0
195708|NCT01052272|622682|P4|Overall Study|placed in long-term care|0
195709|NCT01052272|622683|P3|Overall Study|placed in long-term care|1
195710|NCT01052272|622684|P2|Overall Study|placed in long-term care|0
195711|NCT01052272|622685|P1|Overall Study|placed in long-term care|0
195712|NCT01052272|622682|P4|Overall Study|Withdrawal by Subject|2
195713|NCT01052272|622683|P3|Overall Study|Withdrawal by Subject|3
195714|NCT01052272|622684|P2|Overall Study|Withdrawal by Subject|2
195715|NCT01052272|622685|P1|Overall Study|Withdrawal by Subject|0
195716|NCT01052272|622682|P4|Overall Study|patient refuses follow-up|4
195717|NCT01052272|622683|P3|Overall Study|patient refuses follow-up|2
195718|NCT01052272|622684|P2|Overall Study|patient refuses follow-up|4
195719|NCT01052272|622685|P1|Overall Study|patient refuses follow-up|5
195720|NCT01052272|622682|P4|Overall Study|Physician Decision|0
195721|NCT01052272|622683|P3|Overall Study|Physician Decision|0
195722|NCT01052272|622684|P2|Overall Study|Physician Decision|1
195723|NCT01052272|622685|P1|Overall Study|Physician Decision|0
195724|NCT01052272|622682|P4|Overall Study|Death|1
195725|NCT01052272|622683|P3|Overall Study|Death|1
195726|NCT01052272|622684|P2|Overall Study|Death|0
195727|NCT01052272|622685|P1|Overall Study|Death|0
195728|NCT01052428|622721|P2|Overall Study|Withdrawal by Subject|1
195729|NCT01052428|622722|P1|Overall Study|Withdrawal by Subject|0
195730|NCT01052428|622721|P2|Overall Study|Death|0
195731|NCT01052428|622722|P1|Overall Study|Death|1
195732|NCT01042236|622759|P6|Treatment Period 3|Protocol Violation|0
195733|NCT01042236|622760|P5|Treatment Period 3|Protocol Violation|0
195734|NCT01042236|622761|P4|Treatment Period 3|Protocol Violation|1
195735|NCT01042236|622762|P3|Treatment Period 3|Protocol Violation|0
195736|NCT01042236|622763|P2|Treatment Period 3|Protocol Violation|0
195737|NCT01042236|622764|P1|Treatment Period 3|Protocol Violation|0
195738|NCT01042236|622759|P6|Treatment Period 3|Adverse Event|0
195739|NCT01042236|622760|P5|Treatment Period 3|Adverse Event|0
195740|NCT01042236|622761|P4|Treatment Period 3|Adverse Event|1
195741|NCT01042236|622762|P3|Treatment Period 3|Adverse Event|0
195742|NCT01042236|622763|P2|Treatment Period 3|Adverse Event|0
195743|NCT01042236|622764|P1|Treatment Period 3|Adverse Event|0
195744|NCT01042236|622759|P6|Treatment Period 1|Adverse Event|0
195745|NCT01042236|622760|P5|Treatment Period 1|Adverse Event|1
195746|NCT01042236|622761|P4|Treatment Period 1|Adverse Event|0
195747|NCT01042236|622762|P3|Treatment Period 1|Adverse Event|0
195748|NCT01042236|622763|P2|Treatment Period 1|Adverse Event|1
195749|NCT01042236|622764|P1|Treatment Period 1|Adverse Event|0
195750|NCT01042392|622825|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
195751|NCT01042392|622826|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
195752|NCT01042392|622827|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
195753|NCT01042392|622828|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
195754|NCT01042392|622825|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
195755|NCT01042392|622826|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
195756|NCT01042392|622827|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
195757|NCT01042392|622828|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
195758|NCT01042392|622825|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
195759|NCT01042392|622826|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
195760|NCT01042392|622827|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
195840|NCT01052480|623067|P1|Overall Study|Protocol Violation|1
195761|NCT01042392|622828|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
195762|NCT01042392|622825|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
195763|NCT01042392|622826|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
195764|NCT01042392|622827|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
195765|NCT01042392|622828|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
195766|NCT01042392|622825|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
195767|NCT01042392|622826|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
195768|NCT01042392|622827|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
195769|NCT01042392|622828|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
195770|NCT01042392|622825|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
195771|NCT01042392|622826|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
195772|NCT01042392|622827|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
195773|NCT01042392|622828|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
195774|NCT01042392|622825|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
195775|NCT01042392|622826|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
195776|NCT01042392|622827|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
195777|NCT01042392|622828|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
195778|NCT01042392|622825|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
195779|NCT01042392|622826|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
195780|NCT01042392|622827|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
195781|NCT01042392|622828|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
195782|NCT01042392|622825|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
195783|NCT01042392|622826|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
195784|NCT01042392|622827|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
195785|NCT01042392|622828|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
195786|NCT01042535|622878|P1|Overall Study|complications from other disease|2
195787|NCT01042535|622878|P1|Overall Study|disease progression during treatment|3
195788|NCT01042535|622878|P1|Overall Study|disease progression prior to treatment|3
195789|NCT01042600|622888|P2|Overall Study|Ineligible|0
195790|NCT01042600|622889|P1|Overall Study|Ineligible|1
195791|NCT01042678|622913|P6|Overall Study|Physician Decision|0
195792|NCT01042678|622914|P5|Overall Study|Physician Decision|0
195793|NCT01042678|622915|P4|Overall Study|Physician Decision|0
195794|NCT01042678|622916|P3|Overall Study|Physician Decision|0
195795|NCT01042678|622917|P2|Overall Study|Physician Decision|0
195796|NCT01042678|622918|P1|Overall Study|Physician Decision|1
195797|NCT01042938|622947|P2|Overall Study|Ineligible: RTOG study conflict|0
195798|NCT01042938|622948|P1|Overall Study|Ineligible: RTOG study conflict|1
195799|NCT01042938|622947|P2|Overall Study|Protocol Violation|1
195800|NCT01042938|622948|P1|Overall Study|Protocol Violation|1
195801|NCT01042938|622947|P2|Overall Study|Withdrawal by Subject|1
195802|NCT01042938|622948|P1|Overall Study|Withdrawal by Subject|1
195803|NCT01042977|622962|P2|Overall Study|Various|0
195804|NCT01042977|622963|P1|Overall Study|Various|3
195805|NCT01042977|622962|P2|Overall Study|Administrative reason by sponsor|1
195806|NCT01042977|622963|P1|Overall Study|Administrative reason by sponsor|0
195807|NCT01042977|622962|P2|Overall Study|Safety|2
195808|NCT01042977|622963|P1|Overall Study|Safety|0
195809|NCT01042977|622962|P2|Overall Study|Incorrect enrollment|4
195810|NCT01042977|622963|P1|Overall Study|Incorrect enrollment|6
195811|NCT01042977|622962|P2|Overall Study|Subject no longer meets study criteria|13
195812|NCT01042977|622963|P1|Overall Study|Subject no longer meets study criteria|15
195813|NCT01042977|622962|P2|Overall Study|Poor/non-compliance|4
195814|NCT01042977|622963|P1|Overall Study|Poor/non-compliance|3
195815|NCT01042977|622962|P2|Overall Study|Lost to Follow-up|2
195816|NCT01042977|622963|P1|Overall Study|Lost to Follow-up|0
195817|NCT01042977|622962|P2|Overall Study|Withdrawal by Subject|16
195818|NCT01042977|622963|P1|Overall Study|Withdrawal by Subject|8
195819|NCT01042977|622962|P2|Overall Study|Death|1
195820|NCT01042977|622963|P1|Overall Study|Death|2
195821|NCT01042977|622962|P2|Overall Study|Adverse Event|12
195822|NCT01042977|622963|P1|Overall Study|Adverse Event|4
195823|NCT01043185|623028|P10|Period 6 - Third Washout Period|Protocol Violation|0
195824|NCT01043185|623029|P9|Period 6 - Third Washout Period|Protocol Violation|1
195825|NCT01043185|623030|P8|Period 6 - Third Washout Period|Protocol Violation|0
195826|NCT01043185|623031|P7|Period 6 - Third Washout Period|Protocol Violation|0
195827|NCT01043185|623032|P6|Period 6 - Third Washout Period|Protocol Violation|0
195828|NCT01043185|623033|P5|Period 6 - Third Washout Period|Protocol Violation|0
195829|NCT01043185|623034|P4|Period 6 - Third Washout Period|Protocol Violation|0
195830|NCT01043185|623035|P3|Period 6 - Third Washout Period|Protocol Violation|0
195831|NCT01043185|623036|P2|Period 6 - Third Washout Period|Protocol Violation|0
195832|NCT01043185|623037|P1|Period 6 - Third Washout Period|Protocol Violation|0
195833|NCT01052480|623066|P2|Overall Study|Death|5
195834|NCT01052480|623067|P1|Overall Study|Death|1
195835|NCT01052480|623066|P2|Overall Study|Physician Decision|2
195836|NCT01052480|623067|P1|Overall Study|Physician Decision|0
195837|NCT01052480|623066|P2|Overall Study|Withdrawal by Subject|7
195838|NCT01052480|623067|P1|Overall Study|Withdrawal by Subject|3
195839|NCT01052480|623066|P2|Overall Study|Protocol Violation|0
195841|NCT01052480|623066|P2|Overall Study|Lost to Follow-up|3
195842|NCT01052480|623067|P1|Overall Study|Lost to Follow-up|3
195843|NCT01052662|623133|P3|Overall Study|Administrative|0
195844|NCT01052662|623134|P2|Overall Study|Administrative|3
195845|NCT01052662|623135|P1|Overall Study|Administrative|0
195846|NCT01052662|623133|P3|Overall Study|Legal Problem|0
195847|NCT01052662|623134|P2|Overall Study|Legal Problem|0
195848|NCT01052662|623135|P1|Overall Study|Legal Problem|2
195849|NCT01052662|623133|P3|Overall Study|Adverse Event|0
195850|NCT01052662|623134|P2|Overall Study|Adverse Event|1
195851|NCT01052662|623135|P1|Overall Study|Adverse Event|1
195852|NCT01052662|623133|P3|Overall Study|Pharmacy issue|3
195853|NCT01052662|623134|P2|Overall Study|Pharmacy issue|3
195854|NCT01052662|623135|P1|Overall Study|Pharmacy issue|1
195855|NCT01052662|623133|P3|Overall Study|Withdrawal by Subject|1
195856|NCT01052662|623134|P2|Overall Study|Withdrawal by Subject|2
195857|NCT01052662|623135|P1|Overall Study|Withdrawal by Subject|3
195858|NCT01052662|623133|P3|Overall Study|Lost to Follow-up|18
195859|NCT01052662|623134|P2|Overall Study|Lost to Follow-up|13
195860|NCT01052662|623135|P1|Overall Study|Lost to Follow-up|15
195861|NCT01053247|623202|P3|Overall Study|Adverse Event|3
195862|NCT01053247|623203|P2|Overall Study|Adverse Event|9
195863|NCT01053247|623204|P1|Overall Study|Adverse Event|0
195864|NCT01053247|623202|P3|Overall Study|Lost to Follow-up|7
195865|NCT01053247|623203|P2|Overall Study|Lost to Follow-up|5
195866|NCT01053247|623204|P1|Overall Study|Lost to Follow-up|8
195867|NCT01053247|623202|P3|Overall Study|Protocol Violation|2
195868|NCT01053247|623203|P2|Overall Study|Protocol Violation|1
195869|NCT01053247|623204|P1|Overall Study|Protocol Violation|2
195870|NCT01053247|623202|P3|Overall Study|Lack of Efficacy|1
195871|NCT01053247|623203|P2|Overall Study|Lack of Efficacy|0
195872|NCT01053247|623204|P1|Overall Study|Lack of Efficacy|1
195873|NCT01053247|623202|P3|Overall Study|Withdrawal by Subject|15
195874|NCT01053247|623203|P2|Overall Study|Withdrawal by Subject|4
195875|NCT01053247|623204|P1|Overall Study|Withdrawal by Subject|9
195876|NCT01053429|623230|P1|Overall Study|Unspecified|309
195877|NCT01053429|623230|P1|Overall Study|Adverse Event|64
195878|NCT01053663|623259|P1|Overall Study|Negative Influenza Diagnosis|1
195879|NCT01053663|623259|P1|Overall Study|Transferred to Another Hospital|1
195880|NCT01053663|623259|P1|Overall Study|Poor IV Access|1
195881|NCT01053663|623259|P1|Overall Study|Lost to Follow-up|1
195882|NCT01053663|623259|P1|Overall Study|Death|2
195883|NCT01053741|623302|P2|2nd Study Intervention|Physician Decision|1
195884|NCT01053741|623303|P1|2nd Study Intervention|Physician Decision|0
195885|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
195886|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
195887|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
195888|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
195889|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
195890|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
195891|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Physician Decision|4
195892|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Physician Decision|5
195893|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Physician Decision|5
195894|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Physician Decision|2
195895|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Physician Decision|5
195896|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Physician Decision|0
195897|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
195898|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
195899|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
195900|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
195901|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
195902|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
195903|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
195904|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
195905|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
195906|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
195907|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
195908|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
195909|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
195910|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
195911|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
195912|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
195913|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
195914|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
195915|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
195916|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
195917|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
195918|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
195919|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
195920|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
195921|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
195922|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
195923|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
195924|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
195925|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
195926|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
195927|NCT01053988|623330|P6|24-week, Double-blind Treatment Period|Adverse Event|14
195928|NCT01053988|623331|P5|24-week, Double-blind Treatment Period|Adverse Event|17
195929|NCT01053988|623332|P4|24-week, Double-blind Treatment Period|Adverse Event|24
195930|NCT01053988|623333|P3|24-week, Double-blind Treatment Period|Adverse Event|23
195931|NCT01053988|623334|P2|24-week, Double-blind Treatment Period|Adverse Event|15
195932|NCT01053988|623335|P1|24-week, Double-blind Treatment Period|Adverse Event|0
195933|NCT01053988|623330|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
195934|NCT01053988|623331|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
195935|NCT01053988|623332|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
195936|NCT01053988|623333|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
195937|NCT01053988|623334|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
195938|NCT01053988|623335|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
195939|NCT01053988|623330|P6|2-week, Single-blind Run-In Period|Physician Decision|0
195940|NCT01053988|623331|P5|2-week, Single-blind Run-In Period|Physician Decision|0
195941|NCT01053988|623332|P4|2-week, Single-blind Run-In Period|Physician Decision|0
195942|NCT01053988|623333|P3|2-week, Single-blind Run-In Period|Physician Decision|0
195943|NCT01053988|623334|P2|2-week, Single-blind Run-In Period|Physician Decision|0
195944|NCT01053988|623335|P1|2-week, Single-blind Run-In Period|Physician Decision|5
195945|NCT01053988|623330|P6|2-week, Single-blind Run-In Period|Adverse Event|0
195946|NCT01053988|623331|P5|2-week, Single-blind Run-In Period|Adverse Event|0
195947|NCT01053988|623332|P4|2-week, Single-blind Run-In Period|Adverse Event|0
195948|NCT01053988|623333|P3|2-week, Single-blind Run-In Period|Adverse Event|0
195949|NCT01053988|623334|P2|2-week, Single-blind Run-In Period|Adverse Event|0
195950|NCT01053988|623335|P1|2-week, Single-blind Run-In Period|Adverse Event|6
195951|NCT01053988|623330|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
195952|NCT01053988|623331|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
195953|NCT01053988|623332|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
195954|NCT01053988|623333|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
195955|NCT01053988|623334|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
195956|NCT01053988|623335|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
195957|NCT01053988|623330|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
195958|NCT01053988|623331|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
195959|NCT01053988|623332|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
195960|NCT01053988|623333|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
195961|NCT01053988|623334|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
195962|NCT01053988|623335|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
195963|NCT01053988|623330|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
195964|NCT01053988|623331|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196052|NCT01054729|623707|P2|Overall Study|Randomized but Not Treated|1
195965|NCT01053988|623332|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
195966|NCT01053988|623333|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
195967|NCT01053988|623334|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
195968|NCT01053988|623335|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
195969|NCT01054170|623373|P2|Overall Study|Adverse Event|4
195970|NCT01054170|623374|P1|Overall Study|Adverse Event|0
195971|NCT01054170|623373|P2|Overall Study|Withdrawal by Subject|2
195972|NCT01054170|623374|P1|Overall Study|Withdrawal by Subject|3
195973|NCT01054170|623373|P2|Overall Study|Protocol Violation|0
195974|NCT01054170|623374|P1|Overall Study|Protocol Violation|1
195975|NCT01054222|623437|P1|Overall Study|Withdrawal by Subject|6
195976|NCT01054222|623437|P1|Overall Study|Lost to Follow-up|4
195977|NCT01054222|623437|P1|Overall Study|Lack of Efficacy|1
195978|NCT01054560|623486|P2|Overall Study|Physician Decision|0
195979|NCT01054560|623487|P1|Overall Study|Physician Decision|1
195980|NCT01054560|623486|P2|Overall Study|Withdrawal by Subject|2
195981|NCT01054560|623487|P1|Overall Study|Withdrawal by Subject|0
195982|NCT01054560|623486|P2|Overall Study|Lost to Follow-up|5
195983|NCT01054560|623487|P1|Overall Study|Lost to Follow-up|2
195984|NCT01054560|623486|P2|Overall Study|Death|21
195985|NCT01054560|623487|P1|Overall Study|Death|10
195986|NCT01054573|623513|P4|Overall Study|Withdrawal by Subject|1
195987|NCT01054573|623514|P3|Overall Study|Withdrawal by Subject|2
195988|NCT01054573|623515|P2|Overall Study|Withdrawal by Subject|2
195989|NCT01054573|623516|P1|Overall Study|Withdrawal by Subject|0
195990|NCT01054573|623513|P4|Overall Study|Lost to Follow-up|0
195991|NCT01054573|623514|P3|Overall Study|Lost to Follow-up|0
195992|NCT01054573|623515|P2|Overall Study|Lost to Follow-up|2
195993|NCT01054573|623516|P1|Overall Study|Lost to Follow-up|0
195994|NCT01054573|623513|P4|Overall Study|Adverse Event|1
195995|NCT01054573|623514|P3|Overall Study|Adverse Event|1
195996|NCT01054573|623515|P2|Overall Study|Adverse Event|0
195997|NCT01054573|623516|P1|Overall Study|Adverse Event|1
195998|NCT01054599|623657|P2|Overall Study|Withdrawal by Subject|1
195999|NCT01054599|623658|P1|Overall Study|Withdrawal by Subject|0
196000|NCT01054599|623657|P2|Overall Study|Adverse Event|1
196001|NCT01054599|623658|P1|Overall Study|Adverse Event|0
196002|NCT01054599|623657|P2|Overall Study|Lost to Follow-up|2
196003|NCT01054599|623658|P1|Overall Study|Lost to Follow-up|0
196004|NCT01054599|623657|P2|Overall Study|Visual impairment, WTAR <80|1
196005|NCT01054599|623658|P1|Overall Study|Visual impairment, WTAR <80|0
196006|NCT01054599|623657|P2|Overall Study|Timing/scheduling difficulties|1
196007|NCT01054599|623658|P1|Overall Study|Timing/scheduling difficulties|1
196008|NCT01054599|623657|P2|Overall Study|Spells/seizure-like episodes|1
196009|NCT01054599|623658|P1|Overall Study|Spells/seizure-like episodes|1
196010|NCT01054599|623657|P2|Overall Study|Protocol Violation|0
196011|NCT01054599|623658|P1|Overall Study|Protocol Violation|1
196012|NCT01054599|623657|P2|Overall Study|Dizziness due to phenytoin toxicity|0
196013|NCT01054599|623658|P1|Overall Study|Dizziness due to phenytoin toxicity|1
196014|NCT01054729|623705|P4|Overall Study|Lack of Efficacy|1
196015|NCT01054729|623706|P3|Overall Study|Lack of Efficacy|0
196016|NCT01054729|623707|P2|Overall Study|Lack of Efficacy|0
196017|NCT01054729|623708|P1|Overall Study|Lack of Efficacy|0
196018|NCT01054729|623705|P4|Overall Study|Subject moved|0
196019|NCT01054729|623706|P3|Overall Study|Subject moved|1
196020|NCT01054729|623707|P2|Overall Study|Subject moved|0
196021|NCT01054729|623708|P1|Overall Study|Subject moved|0
196022|NCT01054729|623705|P4|Overall Study|Personal/Obligations|0
196023|NCT01054729|623706|P3|Overall Study|Personal/Obligations|0
196024|NCT01054729|623707|P2|Overall Study|Personal/Obligations|1
196025|NCT01054729|623708|P1|Overall Study|Personal/Obligations|0
196026|NCT01054729|623705|P4|Overall Study|PEG/RBV Non-responder|0
196027|NCT01054729|623706|P3|Overall Study|PEG/RBV Non-responder|1
196028|NCT01054729|623707|P2|Overall Study|PEG/RBV Non-responder|0
196029|NCT01054729|623708|P1|Overall Study|PEG/RBV Non-responder|1
196030|NCT01054729|623705|P4|Overall Study|Non-responder|1
196031|NCT01054729|623706|P3|Overall Study|Non-responder|1
196032|NCT01054729|623707|P2|Overall Study|Non-responder|0
196033|NCT01054729|623708|P1|Overall Study|Non-responder|1
196034|NCT01054729|623705|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
196035|NCT01054729|623706|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
196036|NCT01054729|623707|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
196037|NCT01054729|623708|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
196038|NCT01054729|623705|P4|Overall Study|Lost to Follow-up|0
196039|NCT01054729|623706|P3|Overall Study|Lost to Follow-up|0
196040|NCT01054729|623707|P2|Overall Study|Lost to Follow-up|1
196041|NCT01054729|623708|P1|Overall Study|Lost to Follow-up|0
196042|NCT01054729|623705|P4|Overall Study|Withdrawal by Subject|0
196043|NCT01054729|623706|P3|Overall Study|Withdrawal by Subject|1
196044|NCT01054729|623707|P2|Overall Study|Withdrawal by Subject|0
196045|NCT01054729|623708|P1|Overall Study|Withdrawal by Subject|1
196046|NCT01054729|623705|P4|Overall Study|Adverse Event|1
196047|NCT01054729|623706|P3|Overall Study|Adverse Event|2
196048|NCT01054729|623707|P2|Overall Study|Adverse Event|1
196049|NCT01054729|623708|P1|Overall Study|Adverse Event|1
196050|NCT01054729|623705|P4|Overall Study|Randomized but Not Treated|0
196051|NCT01054729|623706|P3|Overall Study|Randomized but Not Treated|0
196053|NCT01054729|623708|P1|Overall Study|Randomized but Not Treated|0
196054|NCT01054820|623773|P1|Overall Study|Withdrawal by Subject|2
196055|NCT01054846|623789|P2|Overall Study|Lost to Follow-up|17
196056|NCT01054846|623790|P1|Overall Study|Lost to Follow-up|76
196057|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
196058|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
196059|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
196060|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
196061|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
196062|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
196063|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
196064|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Physician Decision|1
196065|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Physician Decision|1
196066|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Physician Decision|3
196067|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Physician Decision|6
196068|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Physician Decision|1
196069|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Physician Decision|4
196070|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Physician Decision|0
196071|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
196072|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
196073|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
196074|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
196075|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
196229|NCT01055457|623964|P4|Overall Study|Subject Ineligible|0
196076|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
196077|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
196078|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
196079|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
196080|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
196081|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
196082|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
196083|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
196084|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
196085|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
196086|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
196087|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
196088|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
196089|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
196090|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
196091|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
196092|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
196093|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
196094|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
196095|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
196096|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
196097|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
196098|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
196099|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
196100|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
196101|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
196102|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
196103|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
196104|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
196105|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
196106|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
196107|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
196108|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
196109|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
196110|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
196111|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
196112|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
196113|NCT01054885|623803|P7|24-week, Double-blind Treatment Period|Adverse Event|19
196114|NCT01054885|623804|P6|24-week, Double-blind Treatment Period|Adverse Event|17
196115|NCT01054885|623805|P5|24-week, Double-blind Treatment Period|Adverse Event|15
196116|NCT01054885|623806|P4|24-week, Double-blind Treatment Period|Adverse Event|15
196117|NCT01054885|623807|P3|24-week, Double-blind Treatment Period|Adverse Event|12
196118|NCT01054885|623808|P2|24-week, Double-blind Treatment Period|Adverse Event|18
196119|NCT01054885|623809|P1|24-week, Double-blind Treatment Period|Adverse Event|0
196120|NCT01054885|623803|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
196121|NCT01054885|623804|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
196122|NCT01054885|623805|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
196123|NCT01054885|623806|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
196124|NCT01054885|623807|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
196125|NCT01054885|623808|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
196126|NCT01054885|623809|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
196127|NCT01054885|623803|P7|2-week, Single-blind Run-In Period|Adverse Event|0
196128|NCT01054885|623804|P6|2-week, Single-blind Run-In Period|Adverse Event|0
196129|NCT01054885|623805|P5|2-week, Single-blind Run-In Period|Adverse Event|0
196130|NCT01054885|623806|P4|2-week, Single-blind Run-In Period|Adverse Event|0
196131|NCT01054885|623807|P3|2-week, Single-blind Run-In Period|Adverse Event|0
196132|NCT01054885|623808|P2|2-week, Single-blind Run-In Period|Adverse Event|0
196133|NCT01054885|623809|P1|2-week, Single-blind Run-In Period|Adverse Event|7
196134|NCT01054885|623803|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
196135|NCT01054885|623804|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
196136|NCT01054885|623805|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
196137|NCT01054885|623806|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
196138|NCT01054885|623807|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
196139|NCT01054885|623808|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
196140|NCT01054885|623809|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
196141|NCT01054885|623803|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
196142|NCT01054885|623804|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
196143|NCT01054885|623805|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
196144|NCT01054885|623806|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
196145|NCT01054885|623807|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
196146|NCT01054885|623808|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
196147|NCT01054885|623809|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
196148|NCT01054885|623803|P7|2-week, Single-blind Run-In Period|Physician Decision|0
196149|NCT01054885|623804|P6|2-week, Single-blind Run-In Period|Physician Decision|0
196150|NCT01054885|623805|P5|2-week, Single-blind Run-In Period|Physician Decision|0
196151|NCT01054885|623806|P4|2-week, Single-blind Run-In Period|Physician Decision|0
196152|NCT01054885|623807|P3|2-week, Single-blind Run-In Period|Physician Decision|0
196153|NCT01054885|623808|P2|2-week, Single-blind Run-In Period|Physician Decision|0
196154|NCT01054885|623809|P1|2-week, Single-blind Run-In Period|Physician Decision|6
196155|NCT01054885|623803|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196156|NCT01054885|623804|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196157|NCT01054885|623805|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196158|NCT01054885|623806|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196159|NCT01054885|623807|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196160|NCT01054885|623808|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
196161|NCT01054885|623809|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
196162|NCT01054976|623854|P1|Overall Study|Not specified|8
196163|NCT01054976|623854|P1|Overall Study|Withdrawal by Subject|4
196164|NCT01054976|623854|P1|Overall Study|Uncooperative participations to study|7
196165|NCT01054976|623854|P1|Overall Study|Adverse Event|16
196166|NCT01055132|623862|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
196167|NCT01055132|623863|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
196168|NCT01055132|623862|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
196169|NCT01055132|623863|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
196170|NCT01055197|623897|P2|Overall Study|Withdrawal by Subject|0
196171|NCT01055197|623898|P1|Overall Study|Withdrawal by Subject|2
196172|NCT01055197|623897|P2|Overall Study|Protocol Violation|2
196173|NCT01055197|623898|P1|Overall Study|Protocol Violation|7
196174|NCT01055262|623932|P1|Overall Study|Uncooperativeness|1
196175|NCT01055262|623932|P1|Overall Study|Protocol Violation|3
196176|NCT01055262|623932|P1|Overall Study|Adverse Event|5
196177|NCT01055314|623945|P2|Overall Study|No treatment|0
196178|NCT01055314|623946|P1|Overall Study|No treatment|1
196179|NCT01055314|623945|P2|Overall Study|Refusal of further protocol therapy|4
196180|NCT01055314|623946|P1|Overall Study|Refusal of further protocol therapy|10
196181|NCT01055314|623945|P2|Overall Study|Ineligible|5
196182|NCT01055314|623946|P1|Overall Study|Ineligible|3
196183|NCT01055314|623945|P2|Overall Study|Withdrawal by Subject|0
196184|NCT01055314|623946|P1|Overall Study|Withdrawal by Subject|1
196185|NCT01055314|623945|P2|Overall Study|Physician Decision|5
196186|NCT01055314|623946|P1|Overall Study|Physician Decision|10
196187|NCT01055314|623945|P2|Overall Study|Lack of Efficacy|19
196188|NCT01055314|623946|P1|Overall Study|Lack of Efficacy|11
196189|NCT01055314|623945|P2|Overall Study|Death|1
196190|NCT01055314|623946|P1|Overall Study|Death|2
196191|NCT01055314|623945|P2|Overall Study|Adverse Event|4
196192|NCT01055314|623946|P1|Overall Study|Adverse Event|7
196193|NCT01055457|623958|P10|Overall Study|Adverse Event|0
196194|NCT01055457|623959|P9|Overall Study|Adverse Event|0
196195|NCT01055457|623960|P8|Overall Study|Adverse Event|0
196196|NCT01055457|623961|P7|Overall Study|Adverse Event|0
196197|NCT01055457|623962|P6|Overall Study|Adverse Event|0
196198|NCT01055457|623963|P5|Overall Study|Adverse Event|0
196199|NCT01055457|623964|P4|Overall Study|Adverse Event|1
196200|NCT01055457|623965|P3|Overall Study|Adverse Event|0
196201|NCT01055457|623966|P2|Overall Study|Adverse Event|0
196202|NCT01055457|623967|P1|Overall Study|Adverse Event|0
196203|NCT01055457|623958|P10|Overall Study|Pregnancy|0
196204|NCT01055457|623959|P9|Overall Study|Pregnancy|0
196205|NCT01055457|623960|P8|Overall Study|Pregnancy|0
196206|NCT01055457|623961|P7|Overall Study|Pregnancy|0
196207|NCT01055457|623962|P6|Overall Study|Pregnancy|0
196208|NCT01055457|623963|P5|Overall Study|Pregnancy|0
196209|NCT01055457|623964|P4|Overall Study|Pregnancy|1
196210|NCT01055457|623965|P3|Overall Study|Pregnancy|0
196211|NCT01055457|623966|P2|Overall Study|Pregnancy|0
196212|NCT01055457|623967|P1|Overall Study|Pregnancy|0
196213|NCT01055457|623958|P10|Overall Study|Discomfort|0
196214|NCT01055457|623959|P9|Overall Study|Discomfort|0
196215|NCT01055457|623960|P8|Overall Study|Discomfort|0
196216|NCT01055457|623961|P7|Overall Study|Discomfort|0
196217|NCT01055457|623962|P6|Overall Study|Discomfort|0
196218|NCT01055457|623963|P5|Overall Study|Discomfort|1
196219|NCT01055457|623964|P4|Overall Study|Discomfort|0
196220|NCT01055457|623965|P3|Overall Study|Discomfort|0
196221|NCT01055457|623966|P2|Overall Study|Discomfort|0
196222|NCT01055457|623967|P1|Overall Study|Discomfort|0
196223|NCT01055457|623958|P10|Overall Study|Subject Ineligible|0
196224|NCT01055457|623959|P9|Overall Study|Subject Ineligible|0
196225|NCT01055457|623960|P8|Overall Study|Subject Ineligible|0
196226|NCT01055457|623961|P7|Overall Study|Subject Ineligible|0
196227|NCT01055457|623962|P6|Overall Study|Subject Ineligible|0
196228|NCT01055457|623963|P5|Overall Study|Subject Ineligible|1
196230|NCT01055457|623965|P3|Overall Study|Subject Ineligible|1
196231|NCT01055457|623966|P2|Overall Study|Subject Ineligible|0
196232|NCT01055457|623967|P1|Overall Study|Subject Ineligible|1
196233|NCT01055457|623958|P10|Overall Study|Subject Disinterest|0
196234|NCT01055457|623959|P9|Overall Study|Subject Disinterest|0
196235|NCT01055457|623960|P8|Overall Study|Subject Disinterest|1
196236|NCT01055457|623961|P7|Overall Study|Subject Disinterest|0
196237|NCT01055457|623962|P6|Overall Study|Subject Disinterest|0
196238|NCT01055457|623963|P5|Overall Study|Subject Disinterest|0
196239|NCT01055457|623964|P4|Overall Study|Subject Disinterest|0
196240|NCT01055457|623965|P3|Overall Study|Subject Disinterest|0
196241|NCT01055457|623966|P2|Overall Study|Subject Disinterest|0
196242|NCT01055457|623967|P1|Overall Study|Subject Disinterest|0
196243|NCT01055457|623958|P10|Overall Study|Protocol Violation|1
196244|NCT01055457|623959|P9|Overall Study|Protocol Violation|0
196245|NCT01055457|623960|P8|Overall Study|Protocol Violation|0
196246|NCT01055457|623961|P7|Overall Study|Protocol Violation|1
196247|NCT01055457|623962|P6|Overall Study|Protocol Violation|2
196248|NCT01055457|623963|P5|Overall Study|Protocol Violation|1
196249|NCT01055457|623964|P4|Overall Study|Protocol Violation|1
196250|NCT01055457|623965|P3|Overall Study|Protocol Violation|1
196251|NCT01055457|623966|P2|Overall Study|Protocol Violation|0
196252|NCT01055457|623967|P1|Overall Study|Protocol Violation|0
196253|NCT01055457|623958|P10|Overall Study|Lost to Follow-up|0
196254|NCT01055457|623959|P9|Overall Study|Lost to Follow-up|0
196255|NCT01055457|623960|P8|Overall Study|Lost to Follow-up|0
196256|NCT01055457|623961|P7|Overall Study|Lost to Follow-up|0
196257|NCT01055457|623962|P6|Overall Study|Lost to Follow-up|1
196258|NCT01055457|623963|P5|Overall Study|Lost to Follow-up|0
196259|NCT01055457|623964|P4|Overall Study|Lost to Follow-up|0
196260|NCT01055457|623965|P3|Overall Study|Lost to Follow-up|0
196261|NCT01055457|623966|P2|Overall Study|Lost to Follow-up|1
196262|NCT01055457|623967|P1|Overall Study|Lost to Follow-up|0
196263|NCT01055613|624001|P2|Overall Study|Subject Disinterest|1
196264|NCT01055613|624002|P1|Overall Study|Subject Disinterest|1
196265|NCT01055613|624001|P2|Overall Study|Protocol Violation|1
196266|NCT01055613|624002|P1|Overall Study|Protocol Violation|1
196267|NCT01055613|624001|P2|Overall Study|Lost to Follow-up|1
196268|NCT01055613|624002|P1|Overall Study|Lost to Follow-up|1
196269|NCT01055613|624001|P2|Overall Study|Discomfort|1
196270|NCT01055613|624002|P1|Overall Study|Discomfort|2
196271|NCT01055613|624001|P2|Overall Study|Unacceptable lens fit|0
196272|NCT01055613|624002|P1|Overall Study|Unacceptable lens fit|1
196273|NCT01055613|624001|P2|Overall Study|No Longer Meets Eligibility Criteria|0
196274|NCT01055613|624002|P1|Overall Study|No Longer Meets Eligibility Criteria|3
196275|NCT01055639|624012|P2|Overall Study|Withdrawal by Subject|11
196276|NCT01055639|624013|P1|Overall Study|Withdrawal by Subject|8
196277|NCT01055639|624012|P2|Overall Study|Protocol Violation|5
196278|NCT01055639|624013|P1|Overall Study|Protocol Violation|5
196279|NCT01055639|624012|P2|Overall Study|Lost to Follow-up|11
196280|NCT01055639|624013|P1|Overall Study|Lost to Follow-up|8
196281|NCT01055639|624012|P2|Overall Study|Lack of Efficacy|1
196282|NCT01055639|624013|P1|Overall Study|Lack of Efficacy|0
196283|NCT01055639|624012|P2|Overall Study|Adverse Event|1
196284|NCT01055639|624013|P1|Overall Study|Adverse Event|0
196285|NCT01046084|624037|P2|Third Washout of 7 Days|Withdrawal by Subject|0
196286|NCT01046084|624038|P1|Third Washout of 7 Days|Withdrawal by Subject|2
196287|NCT01046110|624050|P2|Overall Study|Unclassified|35
196288|NCT01046110|624051|P1|Overall Study|Unclassified|36
196289|NCT01046110|624050|P2|Overall Study|Withdrawal Criteria|5
196290|NCT01046110|624051|P1|Overall Study|Withdrawal Criteria|3
196291|NCT01046110|624050|P2|Overall Study|Protocol Violation|12
196292|NCT01046110|624051|P1|Overall Study|Protocol Violation|7
196293|NCT01046110|624050|P2|Overall Study|Lack of Efficacy|1
196294|NCT01046110|624051|P1|Overall Study|Lack of Efficacy|0
196295|NCT01046110|624050|P2|Overall Study|Adverse Event|2
196296|NCT01046110|624051|P1|Overall Study|Adverse Event|9
196297|NCT01046136|624061|P2|Overall Study|Lost to Follow-up|3
196298|NCT01046136|624062|P1|Overall Study|Lost to Follow-up|3
196299|NCT01046136|624061|P2|Overall Study|Physician Decision|1
196300|NCT01046136|624062|P1|Overall Study|Physician Decision|1
196301|NCT01046136|624061|P2|Overall Study|Withdrawal by Subject|4
196302|NCT01046136|624062|P1|Overall Study|Withdrawal by Subject|0
196303|NCT01046253|624074|P2|Second Intervention|Protocol Violation|1
196304|NCT01046253|624075|P1|Second Intervention|Protocol Violation|0
196305|NCT01046253|624074|P2|Second Intervention|Adverse Event|1
196306|NCT01046253|624075|P1|Second Intervention|Adverse Event|0
196307|NCT01046396|624085|P1|Overall Study|Withdrawal by Subject|5
196308|NCT01046565|624094|P1|Overall Study|Withdrawal by Subject|7
196309|NCT01046565|624094|P1|Overall Study|Adverse Event|2
196310|NCT01046643|624105|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
196311|NCT01046643|624106|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
196312|NCT01046643|624107|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
196313|NCT01046643|624108|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
196314|NCT01046682|624132|P2|Overall Study|Adverse Event|0
196315|NCT01046682|624133|P1|Overall Study|Adverse Event|2
196316|NCT01046695|624141|P2|Overall Study|TENS interfered with the cardiac monitor|1
196317|NCT01046695|624142|P1|Overall Study|TENS interfered with the cardiac monitor|0
196318|NCT01046695|624141|P2|Overall Study|Subject had a pacemaker|1
196319|NCT01046695|624142|P1|Overall Study|Subject had a pacemaker|0
196320|NCT01046877|624152|P1|Overall Study|Exited voluntarily after tube extrusion|11
196321|NCT01046877|624152|P1|Overall Study|Exited voluntarily before tube extrusion|7
196322|NCT01046903|624166|P1|Overall Study|Unspecified|5
196323|NCT01046903|624166|P1|Overall Study|Withdrawal by Subject|3
196324|NCT01046903|624166|P1|Overall Study|Adverse Event|4
196325|NCT01046903|624166|P1|Overall Study|Lost to Follow-up|16
196326|NCT01047553|624206|P2|Overall Study|PI's decision|1
196327|NCT01047553|624207|P1|Overall Study|PI's decision|0
196328|NCT01047553|624206|P2|Overall Study|Sever Non-Compliance to Protocol|0
196329|NCT01047553|624207|P1|Overall Study|Sever Non-Compliance to Protocol|1
196330|NCT01047553|624206|P2|Overall Study|Lost to Follow-up|0
196331|NCT01047553|624207|P1|Overall Study|Lost to Follow-up|1
196332|NCT01047553|624206|P2|Overall Study|Development of Study-Specific Withdrawal|1
196333|NCT01047553|624207|P1|Overall Study|Development of Study-Specific Withdrawal|1
196334|NCT01047553|624206|P2|Overall Study|Withdrawal by Subject|2
196335|NCT01047553|624207|P1|Overall Study|Withdrawal by Subject|4
196336|NCT01047553|624206|P2|Overall Study|Adverse Event|5
196337|NCT01047553|624207|P1|Overall Study|Adverse Event|10
196338|NCT01048099|624309|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
196339|NCT01048099|624309|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
196340|NCT01048242|624328|P2|Overall Study|See study flow chart|2
196341|NCT01048242|624329|P1|Overall Study|See study flow chart|4
196342|NCT01048333|624335|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
196343|NCT01048333|624336|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
196344|NCT01048333|624337|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
196345|NCT01048333|624338|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
196346|NCT01048333|624339|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
196347|NCT01048333|624340|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
196348|NCT01048502|624389|P4|Overall Study|Physician Decision|1
196349|NCT01048502|624390|P3|Overall Study|Physician Decision|0
196350|NCT01048502|624391|P2|Overall Study|Physician Decision|3
196351|NCT01048502|624392|P1|Overall Study|Physician Decision|0
196352|NCT01048502|624389|P4|Overall Study|Withdrawal by Subject|3
196353|NCT01048502|624390|P3|Overall Study|Withdrawal by Subject|5
196354|NCT01048502|624391|P2|Overall Study|Withdrawal by Subject|4
196355|NCT01048502|624392|P1|Overall Study|Withdrawal by Subject|1
196356|NCT01048502|624389|P4|Overall Study|Adverse Event|0
196357|NCT01048502|624390|P3|Overall Study|Adverse Event|0
196358|NCT01048502|624391|P2|Overall Study|Adverse Event|0
196359|NCT01048502|624392|P1|Overall Study|Adverse Event|1
196360|NCT01048502|624389|P4|Overall Study|Lost to Follow-up|0
196361|NCT01048502|624390|P3|Overall Study|Lost to Follow-up|0
196362|NCT01048502|624391|P2|Overall Study|Lost to Follow-up|0
196363|NCT01048502|624392|P1|Overall Study|Lost to Follow-up|2
196364|NCT01048541|624403|P2|Overall Study|Withdrawal by Subject|0
196365|NCT01048541|624404|P1|Overall Study|Withdrawal by Subject|1
196366|NCT01048671|624460|P3|Overall Study|Protocol Violation|1
196367|NCT01048671|624461|P2|Overall Study|Protocol Violation|1
196368|NCT01048671|624462|P1|Overall Study|Protocol Violation|0
196369|NCT01048788|624497|P3|Overall Study|Withdrawal by Subject|0
196370|NCT01048788|624498|P2|Overall Study|Withdrawal by Subject|1
196371|NCT01048788|624499|P1|Overall Study|Withdrawal by Subject|0
196372|NCT01048788|624497|P3|Overall Study|Lack of Efficacy|1
196373|NCT01048788|624498|P2|Overall Study|Lack of Efficacy|0
196374|NCT01048788|624499|P1|Overall Study|Lack of Efficacy|0
196375|NCT01048788|624497|P3|Overall Study|Adverse Event|1
196376|NCT01048788|624498|P2|Overall Study|Adverse Event|1
196377|NCT01048788|624499|P1|Overall Study|Adverse Event|5
196378|NCT01048944|624527|P4|Overall Study|Protocol Violation|2
196379|NCT01048944|624528|P3|Overall Study|Protocol Violation|10
196380|NCT01048944|624529|P2|Overall Study|Protocol Violation|10
196381|NCT01048944|624530|P1|Overall Study|Protocol Violation|8
196382|NCT01049009|624546|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
196383|NCT01049009|624547|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
196384|NCT01049009|624546|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
196385|NCT01049009|624547|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
196386|NCT01049009|624546|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
196387|NCT01049009|624547|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
196388|NCT01049009|624546|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
196389|NCT01049009|624547|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
196390|NCT01049217|624557|P2|Overall Study|Randomized but not Treated|2
196391|NCT01049217|624558|P1|Overall Study|Randomized but not Treated|0
196392|NCT01049217|624557|P2|Overall Study|Unspecified|2
196393|NCT01049217|624558|P1|Overall Study|Unspecified|1
196394|NCT01049217|624557|P2|Overall Study|Study Terminated by Sponsor|43
196395|NCT01049217|624558|P1|Overall Study|Study Terminated by Sponsor|43
196396|NCT01049217|624557|P2|Overall Study|Pregnancy|0
196397|NCT01049217|624558|P1|Overall Study|Pregnancy|1
196398|NCT01049217|624557|P2|Overall Study|Protocol Violation|3
196399|NCT01049217|624558|P1|Overall Study|Protocol Violation|1
196400|NCT01049217|624557|P2|Overall Study|Withdrawal by Subject|3
196401|NCT01049217|624558|P1|Overall Study|Withdrawal by Subject|4
196402|NCT01049217|624557|P2|Overall Study|Lost to Follow-up|8
196403|NCT01049217|624558|P1|Overall Study|Lost to Follow-up|3
196404|NCT01049217|624557|P2|Overall Study|Lack of Efficacy|1
196405|NCT01049217|624558|P1|Overall Study|Lack of Efficacy|1
196406|NCT01049217|624557|P2|Overall Study|Adverse Event|1
196407|NCT01049217|624558|P1|Overall Study|Adverse Event|2
196408|NCT01049308|624632|P1|Pill Counts|Withdrawal by Subject|83
196409|NCT01049360|624639|P20|Period 4|Withdrawal by Subject|0
196410|NCT01049360|624640|P19|Period 4|Withdrawal by Subject|0
196411|NCT01049360|624641|P18|Period 4|Withdrawal by Subject|0
196412|NCT01049360|624642|P17|Period 4|Withdrawal by Subject|0
196413|NCT01049360|624643|P16|Period 4|Withdrawal by Subject|0
196414|NCT01049360|624644|P15|Period 4|Withdrawal by Subject|0
196415|NCT01049360|624645|P14|Period 4|Withdrawal by Subject|0
196416|NCT01049360|624646|P13|Period 4|Withdrawal by Subject|0
196417|NCT01049360|624647|P12|Period 4|Withdrawal by Subject|0
196418|NCT01049360|624648|P11|Period 4|Withdrawal by Subject|0
196419|NCT01049360|624649|P10|Period 4|Withdrawal by Subject|0
196420|NCT01049360|624650|P9|Period 4|Withdrawal by Subject|0
196421|NCT01049360|624651|P8|Period 4|Withdrawal by Subject|0
196422|NCT01049360|624652|P7|Period 4|Withdrawal by Subject|0
196423|NCT01049360|624653|P6|Period 4|Withdrawal by Subject|0
196424|NCT01049360|624654|P5|Period 4|Withdrawal by Subject|0
196425|NCT01049360|624655|P4|Period 4|Withdrawal by Subject|1
196426|NCT01049360|624656|P3|Period 4|Withdrawal by Subject|0
196427|NCT01049360|624657|P2|Period 4|Withdrawal by Subject|0
196428|NCT01049360|624658|P1|Period 4|Withdrawal by Subject|0
196429|NCT01049360|624639|P20|Period 4|Protocol Violation|0
196430|NCT01049360|624640|P19|Period 4|Protocol Violation|0
196431|NCT01049360|624641|P18|Period 4|Protocol Violation|1
196432|NCT01049360|624642|P17|Period 4|Protocol Violation|0
196433|NCT01049360|624643|P16|Period 4|Protocol Violation|0
196434|NCT01049360|624644|P15|Period 4|Protocol Violation|0
196435|NCT01049360|624645|P14|Period 4|Protocol Violation|0
196436|NCT01049360|624646|P13|Period 4|Protocol Violation|0
196437|NCT01049360|624647|P12|Period 4|Protocol Violation|0
196438|NCT01049360|624648|P11|Period 4|Protocol Violation|0
196439|NCT01049360|624649|P10|Period 4|Protocol Violation|0
196440|NCT01049360|624650|P9|Period 4|Protocol Violation|0
196441|NCT01049360|624651|P8|Period 4|Protocol Violation|0
196442|NCT01049360|624652|P7|Period 4|Protocol Violation|0
196443|NCT01049360|624653|P6|Period 4|Protocol Violation|0
196444|NCT01049360|624654|P5|Period 4|Protocol Violation|0
196445|NCT01049360|624655|P4|Period 4|Protocol Violation|0
196446|NCT01049360|624656|P3|Period 4|Protocol Violation|0
196447|NCT01049360|624657|P2|Period 4|Protocol Violation|0
196448|NCT01049360|624658|P1|Period 4|Protocol Violation|0
196449|NCT01049360|624639|P20|Period 2|Lack of Efficacy|0
196450|NCT01049360|624640|P19|Period 2|Lack of Efficacy|0
196451|NCT01049360|624641|P18|Period 2|Lack of Efficacy|0
196452|NCT01049360|624642|P17|Period 2|Lack of Efficacy|0
196453|NCT01049360|624643|P16|Period 2|Lack of Efficacy|0
196454|NCT01049360|624644|P15|Period 2|Lack of Efficacy|0
196455|NCT01049360|624645|P14|Period 2|Lack of Efficacy|0
196456|NCT01049360|624646|P13|Period 2|Lack of Efficacy|0
196457|NCT01049360|624647|P12|Period 2|Lack of Efficacy|0
196458|NCT01049360|624648|P11|Period 2|Lack of Efficacy|0
196459|NCT01049360|624649|P10|Period 2|Lack of Efficacy|0
196460|NCT01049360|624650|P9|Period 2|Lack of Efficacy|0
196461|NCT01049360|624651|P8|Period 2|Lack of Efficacy|0
196462|NCT01049360|624652|P7|Period 2|Lack of Efficacy|0
196463|NCT01049360|624653|P6|Period 2|Lack of Efficacy|1
196464|NCT01049360|624654|P5|Period 2|Lack of Efficacy|0
196465|NCT01049360|624655|P4|Period 2|Lack of Efficacy|0
196466|NCT01049360|624656|P3|Period 2|Lack of Efficacy|0
196467|NCT01049360|624657|P2|Period 2|Lack of Efficacy|0
196468|NCT01049360|624658|P1|Period 2|Lack of Efficacy|0
196469|NCT01049360|624639|P20|Period 2|Withdrawal by Subject|1
196470|NCT01049360|624640|P19|Period 2|Withdrawal by Subject|0
196471|NCT01049360|624641|P18|Period 2|Withdrawal by Subject|0
196472|NCT01049360|624642|P17|Period 2|Withdrawal by Subject|0
196473|NCT01049360|624643|P16|Period 2|Withdrawal by Subject|0
196474|NCT01049360|624644|P15|Period 2|Withdrawal by Subject|1
196475|NCT01049360|624645|P14|Period 2|Withdrawal by Subject|0
196476|NCT01049360|624646|P13|Period 2|Withdrawal by Subject|0
196477|NCT01049360|624647|P12|Period 2|Withdrawal by Subject|0
196478|NCT01049360|624648|P11|Period 2|Withdrawal by Subject|0
196479|NCT01049360|624649|P10|Period 2|Withdrawal by Subject|0
196480|NCT01049360|624650|P9|Period 2|Withdrawal by Subject|0
196481|NCT01049360|624651|P8|Period 2|Withdrawal by Subject|0
196482|NCT01049360|624652|P7|Period 2|Withdrawal by Subject|0
196483|NCT01049360|624653|P6|Period 2|Withdrawal by Subject|0
196484|NCT01049360|624654|P5|Period 2|Withdrawal by Subject|0
196485|NCT01049360|624655|P4|Period 2|Withdrawal by Subject|1
196486|NCT01049360|624656|P3|Period 2|Withdrawal by Subject|0
196487|NCT01049360|624657|P2|Period 2|Withdrawal by Subject|0
196488|NCT01049360|624658|P1|Period 2|Withdrawal by Subject|0
196489|NCT01049360|624639|P20|Period 2|Adverse Event|1
196490|NCT01049360|624640|P19|Period 2|Adverse Event|0
196491|NCT01049360|624641|P18|Period 2|Adverse Event|0
196492|NCT01049360|624642|P17|Period 2|Adverse Event|0
196493|NCT01049360|624643|P16|Period 2|Adverse Event|0
196494|NCT01049360|624644|P15|Period 2|Adverse Event|0
196495|NCT01049360|624645|P14|Period 2|Adverse Event|0
196496|NCT01049360|624646|P13|Period 2|Adverse Event|0
196497|NCT01049360|624647|P12|Period 2|Adverse Event|0
196498|NCT01049360|624648|P11|Period 2|Adverse Event|0
196499|NCT01049360|624649|P10|Period 2|Adverse Event|0
196500|NCT01049360|624650|P9|Period 2|Adverse Event|1
196501|NCT01049360|624651|P8|Period 2|Adverse Event|0
196502|NCT01049360|624652|P7|Period 2|Adverse Event|0
196503|NCT01049360|624653|P6|Period 2|Adverse Event|0
196504|NCT01049360|624654|P5|Period 2|Adverse Event|0
196505|NCT01049360|624655|P4|Period 2|Adverse Event|0
196506|NCT01049360|624656|P3|Period 2|Adverse Event|0
196507|NCT01049360|624657|P2|Period 2|Adverse Event|1
196508|NCT01049360|624658|P1|Period 2|Adverse Event|0
196509|NCT01049360|624639|P20|Period 2|Protocol Violation|0
196510|NCT01049360|624640|P19|Period 2|Protocol Violation|0
196511|NCT01049360|624641|P18|Period 2|Protocol Violation|0
196512|NCT01049360|624642|P17|Period 2|Protocol Violation|0
196513|NCT01049360|624643|P16|Period 2|Protocol Violation|1
196514|NCT01049360|624644|P15|Period 2|Protocol Violation|1
196515|NCT01049360|624645|P14|Period 2|Protocol Violation|0
196516|NCT01049360|624646|P13|Period 2|Protocol Violation|0
196517|NCT01049360|624647|P12|Period 2|Protocol Violation|0
196518|NCT01049360|624648|P11|Period 2|Protocol Violation|0
196519|NCT01049360|624649|P10|Period 2|Protocol Violation|0
196520|NCT01049360|624650|P9|Period 2|Protocol Violation|0
196521|NCT01049360|624651|P8|Period 2|Protocol Violation|0
196522|NCT01049360|624652|P7|Period 2|Protocol Violation|0
196523|NCT01049360|624653|P6|Period 2|Protocol Violation|0
196524|NCT01049360|624654|P5|Period 2|Protocol Violation|0
196525|NCT01049360|624655|P4|Period 2|Protocol Violation|1
196526|NCT01049360|624656|P3|Period 2|Protocol Violation|0
196527|NCT01049360|624657|P2|Period 2|Protocol Violation|0
196528|NCT01049360|624658|P1|Period 2|Protocol Violation|0
196529|NCT01049360|624639|P20|Period 1|Withdrawal by Subject|0
196530|NCT01049360|624640|P19|Period 1|Withdrawal by Subject|0
196531|NCT01049360|624641|P18|Period 1|Withdrawal by Subject|0
196532|NCT01049360|624642|P17|Period 1|Withdrawal by Subject|0
196533|NCT01049360|624643|P16|Period 1|Withdrawal by Subject|0
196534|NCT01049360|624644|P15|Period 1|Withdrawal by Subject|0
196535|NCT01049360|624645|P14|Period 1|Withdrawal by Subject|0
196536|NCT01049360|624646|P13|Period 1|Withdrawal by Subject|1
196537|NCT01049360|624647|P12|Period 1|Withdrawal by Subject|0
196538|NCT01049360|624648|P11|Period 1|Withdrawal by Subject|1
196539|NCT01049360|624649|P10|Period 1|Withdrawal by Subject|0
196540|NCT01049360|624650|P9|Period 1|Withdrawal by Subject|1
196541|NCT01049360|624651|P8|Period 1|Withdrawal by Subject|0
196542|NCT01049360|624652|P7|Period 1|Withdrawal by Subject|0
196543|NCT01049360|624653|P6|Period 1|Withdrawal by Subject|0
196544|NCT01049360|624654|P5|Period 1|Withdrawal by Subject|0
196545|NCT01049360|624655|P4|Period 1|Withdrawal by Subject|0
196546|NCT01049360|624656|P3|Period 1|Withdrawal by Subject|0
196547|NCT01049360|624657|P2|Period 1|Withdrawal by Subject|0
196548|NCT01049360|624658|P1|Period 1|Withdrawal by Subject|0
196549|NCT01049360|624639|P20|Period 1|Did not meet inc/exc criteria|0
196550|NCT01049360|624640|P19|Period 1|Did not meet inc/exc criteria|0
196551|NCT01049360|624641|P18|Period 1|Did not meet inc/exc criteria|0
196552|NCT01049360|624642|P17|Period 1|Did not meet inc/exc criteria|0
196553|NCT01049360|624643|P16|Period 1|Did not meet inc/exc criteria|0
196554|NCT01049360|624644|P15|Period 1|Did not meet inc/exc criteria|0
196555|NCT01049360|624645|P14|Period 1|Did not meet inc/exc criteria|0
196556|NCT01049360|624646|P13|Period 1|Did not meet inc/exc criteria|0
196557|NCT01049360|624647|P12|Period 1|Did not meet inc/exc criteria|0
196558|NCT01049360|624648|P11|Period 1|Did not meet inc/exc criteria|0
196559|NCT01049360|624649|P10|Period 1|Did not meet inc/exc criteria|0
196560|NCT01049360|624650|P9|Period 1|Did not meet inc/exc criteria|1
196561|NCT01049360|624651|P8|Period 1|Did not meet inc/exc criteria|1
196562|NCT01049360|624652|P7|Period 1|Did not meet inc/exc criteria|0
196563|NCT01049360|624653|P6|Period 1|Did not meet inc/exc criteria|0
196564|NCT01049360|624654|P5|Period 1|Did not meet inc/exc criteria|0
196565|NCT01049360|624655|P4|Period 1|Did not meet inc/exc criteria|0
196566|NCT01049360|624656|P3|Period 1|Did not meet inc/exc criteria|0
196567|NCT01049360|624657|P2|Period 1|Did not meet inc/exc criteria|0
196568|NCT01049360|624658|P1|Period 1|Did not meet inc/exc criteria|0
196569|NCT01049360|624639|P20|Period 1|Adverse Event|0
196570|NCT01049360|624640|P19|Period 1|Adverse Event|1
196571|NCT01049360|624641|P18|Period 1|Adverse Event|0
196572|NCT01049360|624642|P17|Period 1|Adverse Event|1
196573|NCT01049360|624643|P16|Period 1|Adverse Event|0
196574|NCT01049360|624644|P15|Period 1|Adverse Event|0
196575|NCT01049360|624645|P14|Period 1|Adverse Event|1
196576|NCT01049360|624646|P13|Period 1|Adverse Event|1
196577|NCT01049360|624647|P12|Period 1|Adverse Event|0
196578|NCT01049360|624648|P11|Period 1|Adverse Event|0
196579|NCT01049360|624649|P10|Period 1|Adverse Event|0
196580|NCT01049360|624650|P9|Period 1|Adverse Event|0
196581|NCT01049360|624651|P8|Period 1|Adverse Event|1
196582|NCT01049360|624652|P7|Period 1|Adverse Event|0
196583|NCT01049360|624653|P6|Period 1|Adverse Event|0
196584|NCT01049360|624654|P5|Period 1|Adverse Event|0
196585|NCT01049360|624655|P4|Period 1|Adverse Event|1
196586|NCT01049360|624656|P3|Period 1|Adverse Event|0
196587|NCT01049360|624657|P2|Period 1|Adverse Event|1
196588|NCT01049360|624658|P1|Period 1|Adverse Event|0
196589|NCT01049373|624682|P2|Overall Study|Non-cooperation|1
196590|NCT01049373|624683|P1|Overall Study|Non-cooperation|0
196591|NCT01049373|624682|P2|Overall Study|Not specified|1
196592|NCT01049373|624683|P1|Overall Study|Not specified|1
196593|NCT01049373|624682|P2|Overall Study|no evaluable study values|21
196594|NCT01049373|624683|P1|Overall Study|no evaluable study values|9
196595|NCT01049373|624682|P2|Overall Study|Lost to Follow-up|4
196596|NCT01049373|624683|P1|Overall Study|Lost to Follow-up|9
196597|NCT01049373|624682|P2|Overall Study|Adverse Event|3
196598|NCT01049373|624683|P1|Overall Study|Adverse Event|3
196599|NCT01049373|624682|P2|Overall Study|Withdrawal by Subject|5
196600|NCT01049373|624683|P1|Overall Study|Withdrawal by Subject|8
196601|NCT01049373|624682|P2|Overall Study|Protocol Violation|9
196602|NCT01049373|624683|P1|Overall Study|Protocol Violation|9
196603|NCT01049503|624703|P6|Overall Study|Lost to Follow-up|8
196604|NCT01049503|624704|P5|Overall Study|Lost to Follow-up|27
196605|NCT01049503|624705|P4|Overall Study|Lost to Follow-up|26
196606|NCT01049503|624706|P3|Overall Study|Lost to Follow-up|24
196607|NCT01049503|624707|P2|Overall Study|Lost to Follow-up|12
196608|NCT01049503|624708|P1|Overall Study|Lost to Follow-up|11
196609|NCT01049581|624739|P2|Overall Study|Lost to Follow-up|1
196610|NCT01049581|624740|P1|Overall Study|Lost to Follow-up|2
196611|NCT01055834|624864|P2|Treatment Period I|Adverse Event|0
196612|NCT01055834|624865|P1|Treatment Period I|Adverse Event|1
196613|NCT01055886|624879|P2|Overall Study|Withdrawal by PI|1
196614|NCT01055886|624880|P1|Overall Study|Withdrawal by PI|0
196615|NCT01055886|624879|P2|Overall Study|Lost to Follow-up|1
196616|NCT01055886|624880|P1|Overall Study|Lost to Follow-up|1
196617|NCT01055886|624879|P2|Overall Study|Withdrawal by Subject|9
196618|NCT01055886|624880|P1|Overall Study|Withdrawal by Subject|4
196619|NCT01056107|624894|P4|Overall Study|Withdrawal by Subject|0
196620|NCT01056107|624895|P3|Overall Study|Withdrawal by Subject|3
196621|NCT01056107|624896|P2|Overall Study|Withdrawal by Subject|1
196622|NCT01056107|624897|P1|Overall Study|Withdrawal by Subject|0
196623|NCT01056263|624958|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
196624|NCT01056263|624958|P1|Overall Study|Objective progression or relapse|1
196625|NCT01056263|624958|P1|Overall Study|Neoplasm progression|1
196626|NCT01056263|624958|P1|Overall Study|Progressive disease|2
196627|NCT01056263|624958|P1|Overall Study|Lack of Efficacy|29
196628|NCT01056263|624958|P1|Overall Study|Withdrawal by Subject|1
196629|NCT01056263|624958|P1|Overall Study|Death|1
196630|NCT01056263|624958|P1|Overall Study|Adverse Event|12
196631|NCT01056276|624964|P2|Maintenance Therapy|Continuing maintenance therapy|14
196632|NCT01056276|624965|P1|Maintenance Therapy|Continuing maintenance therapy|0
196633|NCT01056276|624964|P2|Maintenance Therapy|Intercurrent Illness|1
196634|NCT01056276|624965|P1|Maintenance Therapy|Intercurrent Illness|0
196635|NCT01056276|624964|P2|Maintenance Therapy|Withdrawal by Subject|1
196636|NCT01056276|624965|P1|Maintenance Therapy|Withdrawal by Subject|0
196637|NCT01056276|624964|P2|Maintenance Therapy|Physician Decision|1
196638|NCT01056276|624965|P1|Maintenance Therapy|Physician Decision|0
196639|NCT01056276|624964|P2|Maintenance Therapy|Progressive Disease|9
196640|NCT01056276|624965|P1|Maintenance Therapy|Progressive Disease|0
196641|NCT01056276|624964|P2|Maintenance Therapy|Toxicity|2
196642|NCT01056276|624965|P1|Maintenance Therapy|Toxicity|0
196643|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
196644|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
196645|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Death|1
196646|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Death|3
196647|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Physician Decision|0
196648|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Physician Decision|3
196649|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
196650|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
196651|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Disease Progression|2
196652|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Disease Progression|2
196653|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
196654|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
196655|NCT01056276|624964|P2|Treatment Period-Cycles 1-8|Toxicity|1
196656|NCT01056276|624965|P1|Treatment Period-Cycles 1-8|Toxicity|2
196657|NCT01056289|624979|P4|Double-blind Phase|Physician Decision|0
196658|NCT01056289|624980|P3|Double-blind Phase|Physician Decision|1
196659|NCT01056289|624981|P2|Double-blind Phase|Physician Decision|0
196660|NCT01056289|624982|P1|Double-blind Phase|Physician Decision|0
196661|NCT01056289|624979|P4|Double-blind Phase|Discontinuation symptom|2
196662|NCT01056289|624980|P3|Double-blind Phase|Discontinuation symptom|2
196663|NCT01056289|624981|P2|Double-blind Phase|Discontinuation symptom|1
196664|NCT01056289|624982|P1|Double-blind Phase|Discontinuation symptom|0
196665|NCT01056289|624979|P4|Double-blind Phase|Withdrawal by Subject|2
196666|NCT01056289|624980|P3|Double-blind Phase|Withdrawal by Subject|4
196667|NCT01056289|624981|P2|Double-blind Phase|Withdrawal by Subject|0
196668|NCT01056289|624982|P1|Double-blind Phase|Withdrawal by Subject|0
196669|NCT01056289|624979|P4|Double-blind Phase|Protocol Violation|1
196670|NCT01056289|624980|P3|Double-blind Phase|Protocol Violation|1
196671|NCT01056289|624981|P2|Double-blind Phase|Protocol Violation|0
196672|NCT01056289|624982|P1|Double-blind Phase|Protocol Violation|0
196673|NCT01056289|624979|P4|Double-blind Phase|Unspecified|2
196674|NCT01056289|624980|P3|Double-blind Phase|Unspecified|1
196675|NCT01056289|624981|P2|Double-blind Phase|Unspecified|0
196676|NCT01056289|624982|P1|Double-blind Phase|Unspecified|0
196677|NCT01056289|624979|P4|Double-blind Phase|Lost to Follow-up|2
196678|NCT01056289|624980|P3|Double-blind Phase|Lost to Follow-up|2
196679|NCT01056289|624981|P2|Double-blind Phase|Lost to Follow-up|2
196680|NCT01056289|624982|P1|Double-blind Phase|Lost to Follow-up|0
196681|NCT01056289|624979|P4|Double-blind Phase|Adverse Event|1
196682|NCT01056289|624980|P3|Double-blind Phase|Adverse Event|2
196683|NCT01056289|624981|P2|Double-blind Phase|Adverse Event|1
196684|NCT01056289|624982|P1|Double-blind Phase|Adverse Event|0
196685|NCT01056289|624979|P4|Open-label Phase|Not randomized to Double-blind phase|0
196686|NCT01056289|624980|P3|Open-label Phase|Not randomized to Double-blind phase|0
196687|NCT01056289|624981|P2|Open-label Phase|Not randomized to Double-blind phase|0
196688|NCT01056289|624982|P1|Open-label Phase|Not randomized to Double-blind phase|1
196689|NCT01056289|624979|P4|Open-label Phase|Lack of Efficacy|0
196690|NCT01056289|624980|P3|Open-label Phase|Lack of Efficacy|0
196691|NCT01056289|624981|P2|Open-label Phase|Lack of Efficacy|0
196692|NCT01056289|624982|P1|Open-label Phase|Lack of Efficacy|18
196693|NCT01056289|624979|P4|Open-label Phase|Withdrawal by Subject|0
196694|NCT01056289|624980|P3|Open-label Phase|Withdrawal by Subject|0
196695|NCT01056289|624981|P2|Open-label Phase|Withdrawal by Subject|0
196696|NCT01056289|624982|P1|Open-label Phase|Withdrawal by Subject|26
196697|NCT01056289|624979|P4|Open-label Phase|Protocol Violation|0
196698|NCT01056289|624980|P3|Open-label Phase|Protocol Violation|0
196699|NCT01056289|624981|P2|Open-label Phase|Protocol Violation|0
196700|NCT01056289|624982|P1|Open-label Phase|Protocol Violation|6
196701|NCT01056289|624979|P4|Open-label Phase|Unspecified|0
196702|NCT01056289|624980|P3|Open-label Phase|Unspecified|0
196703|NCT01056289|624981|P2|Open-label Phase|Unspecified|0
196704|NCT01056289|624982|P1|Open-label Phase|Unspecified|9
196705|NCT01056289|624979|P4|Open-label Phase|Lost to Follow-up|0
196706|NCT01056289|624980|P3|Open-label Phase|Lost to Follow-up|0
196707|NCT01056289|624981|P2|Open-label Phase|Lost to Follow-up|0
196708|NCT01056289|624982|P1|Open-label Phase|Lost to Follow-up|30
196709|NCT01056289|624979|P4|Open-label Phase|Adverse Event|0
196710|NCT01056289|624980|P3|Open-label Phase|Adverse Event|0
196711|NCT01056289|624981|P2|Open-label Phase|Adverse Event|0
196712|NCT01056289|624982|P1|Open-label Phase|Adverse Event|29
196713|NCT01056341|625056|P5|Overall Study|Other reasons|5
196714|NCT01056341|625057|P4|Overall Study|Other reasons|9
196715|NCT01056341|625058|P3|Overall Study|Other reasons|8
196716|NCT01056341|625059|P2|Overall Study|Other reasons|4
196717|NCT01056341|625060|P1|Overall Study|Other reasons|4
196718|NCT01056341|625056|P5|Overall Study|Lack of Efficacy|9
196719|NCT01056341|625057|P4|Overall Study|Lack of Efficacy|25
196720|NCT01056341|625058|P3|Overall Study|Lack of Efficacy|7
196721|NCT01056341|625059|P2|Overall Study|Lack of Efficacy|30
196722|NCT01056341|625060|P1|Overall Study|Lack of Efficacy|32
196723|NCT01056341|625056|P5|Overall Study|Treatment Intolerance|0
196724|NCT01056341|625057|P4|Overall Study|Treatment Intolerance|2
196725|NCT01056341|625058|P3|Overall Study|Treatment Intolerance|0
196726|NCT01056341|625059|P2|Overall Study|Treatment Intolerance|2
196727|NCT01056341|625060|P1|Overall Study|Treatment Intolerance|0
196728|NCT01056380|625081|P2|Overall Study|Lost to Follow-up|3
196729|NCT01056380|625082|P1|Overall Study|Lost to Follow-up|2
196730|NCT01056484|625106|P2|Follow up - Non-randomized|Withdrawal by Subject|2
196731|NCT01056484|625107|P1|Follow up - Non-randomized|Withdrawal by Subject|0
196732|NCT01056484|625106|P2|Randomized Controlled Trial|Physician Decision|0
196733|NCT01056484|625107|P1|Randomized Controlled Trial|Physician Decision|1
196734|NCT01056484|625106|P2|Randomized Controlled Trial|Withdrawal by Subject|1
196735|NCT01056484|625107|P1|Randomized Controlled Trial|Withdrawal by Subject|6
196736|NCT01056510|625123|P2|Overall Study|Missing|1
196737|NCT01056510|625124|P1|Overall Study|Missing|0
196738|NCT01056510|625123|P2|Overall Study|Not Specified|12
196739|NCT01056510|625124|P1|Overall Study|Not Specified|10
196740|NCT01056510|625123|P2|Overall Study|Lost to Follow-up|6
196741|NCT01056510|625124|P1|Overall Study|Lost to Follow-up|5
196742|NCT01056510|625123|P2|Overall Study|Physician Decision|5
196743|NCT01056510|625124|P1|Overall Study|Physician Decision|4
196744|NCT01056510|625123|P2|Overall Study|Noncompliance|3
196745|NCT01056510|625124|P1|Overall Study|Noncompliance|1
196746|NCT01056510|625123|P2|Overall Study|Death|34
196747|NCT01056510|625124|P1|Overall Study|Death|29
196748|NCT01056510|625123|P2|Overall Study|Withdrawal by Subject|2
196749|NCT01056510|625124|P1|Overall Study|Withdrawal by Subject|4
196750|NCT01056510|625123|P2|Overall Study|Dropout Before Start of Treatment|1
196751|NCT01056510|625124|P1|Overall Study|Dropout Before Start of Treatment|1
196752|NCT01056523|625168|P7|Overall Study|Death|1
196753|NCT01056523|625169|P6|Overall Study|Death|0
196754|NCT01056523|625170|P5|Overall Study|Death|0
196755|NCT01056523|625171|P4|Overall Study|Death|3
196756|NCT01056523|625172|P3|Overall Study|Death|2
196757|NCT01056523|625173|P2|Overall Study|Death|0
196758|NCT01056523|625174|P1|Overall Study|Death|1
196759|NCT01056640|625190|P2|Overall Study|Death|4
196760|NCT01056640|625191|P1|Overall Study|Death|15
196761|NCT01056640|625190|P2|Overall Study|Withdrawal by Subject|8
196762|NCT01056640|625191|P1|Overall Study|Withdrawal by Subject|11
196763|NCT01056653|625200|P3|Overall Study|Lost to Follow-up|2
196764|NCT01056653|625201|P2|Overall Study|Lost to Follow-up|0
196765|NCT01056653|625202|P1|Overall Study|Lost to Follow-up|0
196766|NCT01056718|625216|P1|Overall Study|Ischemia on baseline stress test|1
196767|NCT01056718|625216|P1|Overall Study|Withdrawal by Subject|2
196768|NCT01056822|625248|P2|Overall Study|Lost to Follow-up|0
196769|NCT01056822|625249|P1|Overall Study|Lost to Follow-up|1
196770|NCT01056822|625248|P2|Overall Study|Withdrawal by Subject|1
196771|NCT01056822|625249|P1|Overall Study|Withdrawal by Subject|1
196772|NCT01056822|625248|P2|Overall Study|Protocol Violation|5
196773|NCT01056822|625249|P1|Overall Study|Protocol Violation|6
196774|NCT01056822|625248|P2|Overall Study|Adverse Event|1
196775|NCT01056822|625249|P1|Overall Study|Adverse Event|0
196776|NCT01057251|625368|P2|Overall Study|Other Reason|1
196777|NCT01057251|625369|P1|Overall Study|Other Reason|1
196778|NCT01057251|625368|P2|Overall Study|Lost to Follow-up|6
196779|NCT01057251|625369|P1|Overall Study|Lost to Follow-up|7
196780|NCT01057251|625368|P2|Overall Study|Withdrawal by Subject|5
196781|NCT01057251|625369|P1|Overall Study|Withdrawal by Subject|4
196782|NCT01057251|625368|P2|Overall Study|Protocol Violation|2
196783|NCT01057251|625369|P1|Overall Study|Protocol Violation|6
196784|NCT01057251|625368|P2|Overall Study|Lack of Efficacy|11
196785|NCT01057251|625369|P1|Overall Study|Lack of Efficacy|2
196786|NCT01057251|625368|P2|Overall Study|Adverse Event|2
196787|NCT01057251|625369|P1|Overall Study|Adverse Event|4
196788|NCT01057251|625368|P2|Overall Study|Did not meet InclusionExclusion criteria|2
196789|NCT01057251|625369|P1|Overall Study|Did not meet InclusionExclusion criteria|4
196790|NCT01057394|625381|P2|Overall Study|Not eligible|2
196791|NCT01057394|625382|P1|Overall Study|Not eligible|0
196792|NCT01057433|625386|P1|Overall Study|Adverse Event|1
196793|NCT01057589|625390|P1|Overall Study|Lost to Follow-up|1
196794|NCT01057589|625390|P1|Overall Study|Death|8
196795|NCT01057589|625390|P1|Overall Study|Sponsor Decision|1
196796|NCT01057589|625390|P1|Overall Study|Withdrawal by Subject|3
196797|NCT01057589|625390|P1|Overall Study|Physician Decision|8
196798|NCT01057589|625390|P1|Overall Study|Adverse Event|10
196799|NCT01057589|625390|P1|Overall Study|Disease Progression|35
196800|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
196801|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
196802|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
196803|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
196804|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Unspecified|1
196805|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Unspecified|0
196806|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
196807|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
196808|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
196809|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
196810|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
196811|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
196812|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
196813|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
196814|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
196815|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
196816|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
196817|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
196818|NCT01057693|625399|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
196819|NCT01057693|625400|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
196820|NCT01057693|625401|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
196821|NCT01057693|625399|P3|Between Single-Blind and Double-Blind|Unspecified|0
196822|NCT01057693|625400|P2|Between Single-Blind and Double-Blind|Unspecified|0
196823|NCT01057693|625401|P1|Between Single-Blind and Double-Blind|Unspecified|6
196824|NCT01057693|625399|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
196825|NCT01057693|625400|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
196826|NCT01057693|625401|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
196827|NCT01057693|625399|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
196828|NCT01057693|625400|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
196829|NCT01057693|625401|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
196830|NCT01057693|625399|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
196831|NCT01057693|625400|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
196832|NCT01057693|625401|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
196833|NCT01057693|625399|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
196834|NCT01057693|625400|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
196835|NCT01057693|625401|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
196836|NCT01057693|625399|P3|Between Single-Blind and Double-Blind|Adverse Event|0
196837|NCT01057693|625400|P2|Between Single-Blind and Double-Blind|Adverse Event|0
196838|NCT01057693|625401|P1|Between Single-Blind and Double-Blind|Adverse Event|5
196839|NCT01057693|625399|P3|Single-Blind Phase (Up to Week 6)|Unspecified|0
196840|NCT01057693|625400|P2|Single-Blind Phase (Up to Week 6)|Unspecified|0
196841|NCT01057693|625401|P1|Single-Blind Phase (Up to Week 6)|Unspecified|2
196842|NCT01057693|625399|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
196843|NCT01057693|625400|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
196844|NCT01057693|625401|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
196845|NCT01057693|625399|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
196846|NCT01057693|625400|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
196847|NCT01057693|625401|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
196848|NCT01057693|625399|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
196849|NCT01057693|625400|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
196850|NCT01057693|625401|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
196851|NCT01057693|625399|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
196852|NCT01057693|625400|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
196853|NCT01057693|625401|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
196854|NCT01057693|625399|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
196855|NCT01057693|625400|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
196856|NCT01057693|625401|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
196857|NCT01057810|625449|P2|Overall Study|Unspecified|14
196858|NCT01057810|625450|P1|Overall Study|Unspecified|7
196859|NCT01057810|625449|P2|Overall Study|No longer met study criteria|1
196860|NCT01057810|625450|P1|Overall Study|No longer met study criteria|0
196861|NCT01057810|625449|P2|Overall Study|Poor/non-compliance|1
196862|NCT01057810|625450|P1|Overall Study|Poor/non-compliance|0
196863|NCT01057810|625449|P2|Overall Study|Maximum clinical benefit|5
196864|NCT01057810|625450|P1|Overall Study|Maximum clinical benefit|5
196865|NCT01057810|625449|P2|Overall Study|Death|12
196866|NCT01057810|625450|P1|Overall Study|Death|2
196867|NCT01057810|625449|P2|Overall Study|Withdrawal by Subject|25
196868|NCT01057810|625450|P1|Overall Study|Withdrawal by Subject|10
196869|NCT01057810|625449|P2|Overall Study|Adverse event unrelated to study drug|29
196870|NCT01057810|625450|P1|Overall Study|Adverse event unrelated to study drug|13
196871|NCT01057810|625449|P2|Overall Study|Study drug toxicity|114
196872|NCT01057810|625450|P1|Overall Study|Study drug toxicity|5
196873|NCT01057810|625449|P2|Overall Study|Disease progression|197
196874|NCT01057810|625450|P1|Overall Study|Disease progression|156
196875|NCT01058005|625494|P3|Overall Study|Reason Missing|1
196876|NCT01058005|625495|P2|Overall Study|Reason Missing|3
196877|NCT01058005|625496|P1|Overall Study|Reason Missing|5
196878|NCT01058005|625494|P3|Overall Study|Withdrawn Due to Study Termination|7
196879|NCT01058005|625495|P2|Overall Study|Withdrawn Due to Study Termination|13
196880|NCT01058005|625496|P1|Overall Study|Withdrawn Due to Study Termination|27
196881|NCT01058005|625494|P3|Overall Study|Withdrawal by Subject|11
196882|NCT01058005|625495|P2|Overall Study|Withdrawal by Subject|5
196883|NCT01058005|625496|P1|Overall Study|Withdrawal by Subject|4
196884|NCT01058005|625494|P3|Overall Study|Physician Decision|0
196885|NCT01058005|625495|P2|Overall Study|Physician Decision|2
196886|NCT01058005|625496|P1|Overall Study|Physician Decision|2
196887|NCT01058005|625494|P3|Overall Study|Adverse Event|1
196888|NCT01058005|625495|P2|Overall Study|Adverse Event|2
196889|NCT01058005|625496|P1|Overall Study|Adverse Event|0
196890|NCT01058096|625511|P2|Double-blind Treatment Phase|Other Unspecified|0
196891|NCT01058096|625512|P1|Double-blind Treatment Phase|Other Unspecified|2
196892|NCT01058096|625511|P2|Double-blind Treatment Phase|Lost to Follow-up|1
196893|NCT01058096|625512|P1|Double-blind Treatment Phase|Lost to Follow-up|0
196894|NCT01058096|625511|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
196895|NCT01058096|625512|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
196896|NCT01058096|625511|P2|Double-blind Treatment Phase|Protocol Violation|1
196897|NCT01058096|625512|P1|Double-blind Treatment Phase|Protocol Violation|2
196898|NCT01058096|625511|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
196899|NCT01058096|625512|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
196900|NCT01058096|625511|P2|Double-blind Treatment Phase|Adverse Event|15
196901|NCT01058096|625512|P1|Double-blind Treatment Phase|Adverse Event|11
196902|NCT01058265|625522|P2|Overall Study|Lost to Follow-up|12
196903|NCT01058265|625523|P1|Overall Study|Lost to Follow-up|11
196904|NCT01058304|625533|P2|Overall Study|Developed exclusion criterion|12
196905|NCT01058304|625534|P1|Overall Study|Developed exclusion criterion|6
196906|NCT01058304|625533|P2|Overall Study|Lost to Follow-up|16
196907|NCT01058304|625534|P1|Overall Study|Lost to Follow-up|13
196908|NCT01058304|625533|P2|Overall Study|Withdrawal by Subject|5
196909|NCT01058304|625534|P1|Overall Study|Withdrawal by Subject|8
196910|NCT01058356|625542|P1|Overall Study|Lost to Follow-up|4
196911|NCT01058356|625542|P1|Overall Study|Withdrawal by Subject|21
196912|NCT01058356|625542|P1|Overall Study|Administration of contraindicated drugs|12
196913|NCT01058356|625542|P1|Overall Study|Adverse Event|5
196914|NCT01058421|625549|P2|6 Month Outcomes|Remained in Other Facility|3
196915|NCT01058421|625550|P1|6 Month Outcomes|Remained in Other Facility|1
196916|NCT01058421|625549|P2|6 Month Outcomes|Lost to Follow-up|21
196917|NCT01058421|625550|P1|6 Month Outcomes|Lost to Follow-up|16
196918|NCT01058421|625549|P2|6 Month Outcomes|Death|2
196919|NCT01058421|625550|P1|6 Month Outcomes|Death|2
196920|NCT01058421|625549|P2|3 Month Outcomes|Remained in Other Facility|8
196921|NCT01058421|625550|P1|3 Month Outcomes|Remained in Other Facility|5
196922|NCT01058421|625549|P2|3 Month Outcomes|Remained in Hospital|2
196923|NCT01058421|625550|P1|3 Month Outcomes|Remained in Hospital|0
196924|NCT01058421|625549|P2|3 Month Outcomes|Lost to Follow-up|11
196925|NCT01058421|625550|P1|3 Month Outcomes|Lost to Follow-up|12
196926|NCT01058421|625549|P2|3 Month Outcomes|Death|5
196927|NCT01058421|625550|P1|3 Month Outcomes|Death|3
196928|NCT01058421|625549|P2|1 Month Outcomes|Remained in Other Facility|17
196929|NCT01058421|625550|P1|1 Month Outcomes|Remained in Other Facility|16
196930|NCT01058421|625549|P2|1 Month Outcomes|Remained in Hospital|12
196931|NCT01058421|625550|P1|1 Month Outcomes|Remained in Hospital|5
196932|NCT01058421|625549|P2|1 Month Outcomes|Lost to Follow-up|7
196933|NCT01058421|625550|P1|1 Month Outcomes|Lost to Follow-up|8
196934|NCT01058421|625549|P2|1 Month Outcomes|Death|6
196935|NCT01058421|625550|P1|1 Month Outcomes|Death|10
196936|NCT01047293|625581|P4|Overall Study|DLT criteria not fulfilled|0
196937|NCT01047293|625582|P3|Overall Study|DLT criteria not fulfilled|0
196938|NCT01047293|625583|P2|Overall Study|DLT criteria not fulfilled|1
196939|NCT01047293|625584|P1|Overall Study|DLT criteria not fulfilled|1
196940|NCT01047306|625593|P2|Overall Study|Lost to Follow-up|0
196941|NCT01047306|625594|P1|Overall Study|Lost to Follow-up|1
196942|NCT01047306|625593|P2|Overall Study|Withdrawal by Subject|0
196943|NCT01047306|625594|P1|Overall Study|Withdrawal by Subject|2
196944|NCT01047332|625670|P2|Overall Study|Lost to Follow-up|3
196945|NCT01047332|625671|P1|Overall Study|Lost to Follow-up|8
196946|NCT01047332|625670|P2|Overall Study|Died Unobstructed|41
196947|NCT01047332|625671|P1|Overall Study|Died Unobstructed|38
196948|NCT01047332|625670|P2|Overall Study|SEMS Obstruction|20
196949|NCT01047332|625671|P1|Overall Study|SEMS Obstruction|11
196950|NCT01047345|625685|P3|Extension|Lost to Follow-up|5
196951|NCT01047345|625686|P2|Extension|Lost to Follow-up|0
196952|NCT01047345|625687|P1|Extension|Lost to Follow-up|0
196953|NCT01047345|625685|P3|Extension|Withdrawal by Subject|1
196954|NCT01047345|625686|P2|Extension|Withdrawal by Subject|0
196955|NCT01047345|625687|P1|Extension|Withdrawal by Subject|0
196956|NCT01047345|625685|P3|Base Study|Withdrawal by Subject|0
196957|NCT01047345|625686|P2|Base Study|Withdrawal by Subject|4
196958|NCT01047345|625687|P1|Base Study|Withdrawal by Subject|12
196959|NCT01047345|625685|P3|Base Study|Protocol Violation|0
196960|NCT01047345|625686|P2|Base Study|Protocol Violation|1
196961|NCT01047345|625687|P1|Base Study|Protocol Violation|3
196962|NCT01047345|625685|P3|Base Study|Lost to Follow-up|0
196963|NCT01047345|625686|P2|Base Study|Lost to Follow-up|1
196964|NCT01047345|625687|P1|Base Study|Lost to Follow-up|4
196965|NCT01047345|625685|P3|Base Study|Adverse Event|0
196966|NCT01047345|625686|P2|Base Study|Adverse Event|0
196967|NCT01047345|625687|P1|Base Study|Adverse Event|3
196968|NCT01047436|625716|P2|Overall Study|Protocol Violation|0
196969|NCT01047436|625717|P1|Overall Study|Protocol Violation|1
196970|NCT01052844|625755|P2|Overall Study|Adverse Event|1
196971|NCT01052844|625756|P1|Overall Study|Adverse Event|0
196972|NCT01058642|625813|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
196973|NCT01058642|625814|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
196974|NCT01058642|625815|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
196975|NCT01058642|625816|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
196976|NCT01058642|625813|P4|Treatment Period 1|Protocol Violation|1
196977|NCT01058642|625814|P3|Treatment Period 1|Protocol Violation|0
196978|NCT01058642|625815|P2|Treatment Period 1|Protocol Violation|0
196979|NCT01058642|625816|P1|Treatment Period 1|Protocol Violation|0
196980|NCT01058642|625813|P4|Treatment Period 1|Lack of Efficacy|1
196981|NCT01058642|625814|P3|Treatment Period 1|Lack of Efficacy|0
196982|NCT01058642|625815|P2|Treatment Period 1|Lack of Efficacy|0
196983|NCT01058642|625816|P1|Treatment Period 1|Lack of Efficacy|0
196984|NCT01058642|625813|P4|Treatment Period 1|Withdrawal by Subject|0
196985|NCT01058642|625814|P3|Treatment Period 1|Withdrawal by Subject|0
196986|NCT01058642|625815|P2|Treatment Period 1|Withdrawal by Subject|0
196987|NCT01058642|625816|P1|Treatment Period 1|Withdrawal by Subject|1
196988|NCT01058642|625813|P4|Treatment Period 1|Physician Decision|0
196989|NCT01058642|625814|P3|Treatment Period 1|Physician Decision|1
196990|NCT01058642|625815|P2|Treatment Period 1|Physician Decision|0
196991|NCT01058642|625816|P1|Treatment Period 1|Physician Decision|0
196992|NCT01058642|625813|P4|Treatment Period 1|Adverse Event|0
196993|NCT01058642|625814|P3|Treatment Period 1|Adverse Event|1
196994|NCT01058642|625815|P2|Treatment Period 1|Adverse Event|1
196995|NCT01058642|625816|P1|Treatment Period 1|Adverse Event|0
196996|NCT01058655|625828|P4|Overall Study|Other|4
196997|NCT01058655|625829|P3|Overall Study|Other|0
196998|NCT01058655|625830|P2|Overall Study|Other|0
196999|NCT01058655|625831|P1|Overall Study|Other|0
197000|NCT01058655|625828|P4|Overall Study|Disease Progression|24
197001|NCT01058655|625829|P3|Overall Study|Disease Progression|4
197002|NCT01058655|625830|P2|Overall Study|Disease Progression|2
197003|NCT01058655|625831|P1|Overall Study|Disease Progression|1
197004|NCT01058655|625828|P4|Overall Study|Death|0
197005|NCT01058655|625829|P3|Overall Study|Death|1
197006|NCT01058655|625830|P2|Overall Study|Death|1
197007|NCT01058655|625831|P1|Overall Study|Death|0
197008|NCT01058655|625828|P4|Overall Study|Clinical Progression (non-RECIST)|7
197009|NCT01058655|625829|P3|Overall Study|Clinical Progression (non-RECIST)|0
197010|NCT01058655|625830|P2|Overall Study|Clinical Progression (non-RECIST)|0
197011|NCT01058655|625831|P1|Overall Study|Clinical Progression (non-RECIST)|1
197012|NCT01058655|625828|P4|Overall Study|Symptomatic Deterioration|1
197013|NCT01058655|625829|P3|Overall Study|Symptomatic Deterioration|0
197014|NCT01058655|625830|P2|Overall Study|Symptomatic Deterioration|0
197015|NCT01058655|625831|P1|Overall Study|Symptomatic Deterioration|0
197016|NCT01058655|625828|P4|Overall Study|Prolonged Treatment Delay|2
197017|NCT01058655|625829|P3|Overall Study|Prolonged Treatment Delay|0
197018|NCT01058655|625830|P2|Overall Study|Prolonged Treatment Delay|0
197019|NCT01058655|625831|P1|Overall Study|Prolonged Treatment Delay|0
197020|NCT01058655|625828|P4|Overall Study|Withdrawal by Subject|4
197021|NCT01058655|625829|P3|Overall Study|Withdrawal by Subject|3
197022|NCT01058655|625830|P2|Overall Study|Withdrawal by Subject|0
197023|NCT01058655|625831|P1|Overall Study|Withdrawal by Subject|1
197024|NCT01058668|625848|P3|Double-blind Treatment Phase|Other Unspecified|0
197025|NCT01058668|625849|P2|Double-blind Treatment Phase|Other Unspecified|1
197026|NCT01058668|625850|P1|Double-blind Treatment Phase|Other Unspecified|1
197027|NCT01058668|625848|P3|Double-blind Treatment Phase|Lost to Follow-up|1
197028|NCT01058668|625849|P2|Double-blind Treatment Phase|Lost to Follow-up|1
197029|NCT01058668|625850|P1|Double-blind Treatment Phase|Lost to Follow-up|0
197030|NCT01058668|625848|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
197031|NCT01058668|625849|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
197032|NCT01058668|625850|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
197033|NCT01058668|625848|P3|Double-blind Treatment Phase|Protocol Violation|2
197034|NCT01058668|625849|P2|Double-blind Treatment Phase|Protocol Violation|1
197035|NCT01058668|625850|P1|Double-blind Treatment Phase|Protocol Violation|1
197036|NCT01058668|625848|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
197037|NCT01058668|625849|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
197038|NCT01058668|625850|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
197039|NCT01058668|625848|P3|Double-blind Treatment Phase|Adverse Event|25
197040|NCT01058668|625849|P2|Double-blind Treatment Phase|Adverse Event|15
197041|NCT01058668|625850|P1|Double-blind Treatment Phase|Adverse Event|8
197042|NCT01058863|625861|P1|Overall Study|Randomized in error|1
197043|NCT01058863|625861|P1|Overall Study|Sponsor requested withdrawal|1
197044|NCT01058863|625861|P1|Overall Study|Withdrawal by Subject|1
197045|NCT01058863|625861|P1|Overall Study|Lost to Follow-up|1
197046|NCT01060059|625881|P2|Overall Study|lack of compliance|2
197047|NCT01060059|625882|P1|Overall Study|lack of compliance|5
197048|NCT01060059|625881|P2|Overall Study|lack of glycemic control|1
197049|NCT01060059|625882|P1|Overall Study|lack of glycemic control|2
197050|NCT01060059|625881|P2|Overall Study|Withdrawal by Subject|23
197051|NCT01060059|625882|P1|Overall Study|Withdrawal by Subject|35
197052|NCT01060059|625881|P2|Overall Study|entry criteria not met|3
197053|NCT01060059|625882|P1|Overall Study|entry criteria not met|4
197054|NCT01060059|625881|P2|Overall Study|Lost to Follow-up|34
197055|NCT01060059|625882|P1|Overall Study|Lost to Follow-up|18
197056|NCT01060059|625881|P2|Overall Study|Death|3
197057|NCT01060059|625882|P1|Overall Study|Death|2
197058|NCT01060059|625881|P2|Overall Study|Adverse Event|1
197059|NCT01060059|625882|P1|Overall Study|Adverse Event|1
197060|NCT01060072|625934|P2|Overall Study|Excluded Medications|1
197061|NCT01060072|625935|P1|Overall Study|Excluded Medications|0
197062|NCT01060072|625934|P2|Overall Study|Acute cholecystitis|0
197063|NCT01060072|625935|P1|Overall Study|Acute cholecystitis|1
197064|NCT01060072|625934|P2|Overall Study|Protocol Violation|1
197065|NCT01060072|625935|P1|Overall Study|Protocol Violation|0
197066|NCT01060072|625934|P2|Overall Study|Physician Decision|2
197067|NCT01060072|625935|P1|Overall Study|Physician Decision|0
197068|NCT01060072|625934|P2|Overall Study|Adverse Event|1
197069|NCT01060072|625935|P1|Overall Study|Adverse Event|1
197070|NCT01060111|625952|P3|Overall Study|Unspecified|4
197071|NCT01060111|625953|P2|Overall Study|Unspecified|3
197072|NCT01060111|625954|P1|Overall Study|Unspecified|2
197073|NCT01060111|625952|P3|Overall Study|Participants' non-cooperation|0
197074|NCT01060111|625953|P2|Overall Study|Participants' non-cooperation|0
197075|NCT01060111|625954|P1|Overall Study|Participants' non-cooperation|1
197076|NCT01060111|625952|P3|Overall Study|Adverse event and insufficient effect|0
197077|NCT01060111|625953|P2|Overall Study|Adverse event and insufficient effect|1
197078|NCT01060111|625954|P1|Overall Study|Adverse event and insufficient effect|0
197079|NCT01060111|625952|P3|Overall Study|Participants' non-cooperation|6
197080|NCT01060111|625953|P2|Overall Study|Participants' non-cooperation|6
197081|NCT01060111|625954|P1|Overall Study|Participants' non-cooperation|8
197082|NCT01060111|625952|P3|Overall Study|Participants' evasion for hospital visit|2
197083|NCT01060111|625953|P2|Overall Study|Participants' evasion for hospital visit|3
197084|NCT01060111|625954|P1|Overall Study|Participants' evasion for hospital visit|0
197085|NCT01060111|625952|P3|Overall Study|Inappropriate participant|5
197086|NCT01060111|625953|P2|Overall Study|Inappropriate participant|4
197087|NCT01060111|625954|P1|Overall Study|Inappropriate participant|5
197088|NCT01060111|625952|P3|Overall Study|Lack of Efficacy|0
197089|NCT01060111|625953|P2|Overall Study|Lack of Efficacy|1
197090|NCT01060111|625954|P1|Overall Study|Lack of Efficacy|2
197091|NCT01060111|625952|P3|Overall Study|Adverse Event|18
197092|NCT01060111|625953|P2|Overall Study|Adverse Event|5
197093|NCT01060111|625954|P1|Overall Study|Adverse Event|9
197094|NCT01060124|625971|P1|Overall Study|Withdrawal by Subject|7
197095|NCT01060124|625971|P1|Overall Study|Adverse Event|14
197096|NCT01060124|625971|P1|Overall Study|Unspecified|16
197097|NCT01060150|625979|P1|Overall Study|Enrolled, but not treated|2
197098|NCT01060150|625979|P1|Overall Study|Withdrawal by Subject|8
197099|NCT01060150|625979|P1|Overall Study|Protocol Violation|6
197100|NCT01060150|625979|P1|Overall Study|Lost to Follow-up|1
197101|NCT01060150|625979|P1|Overall Study|Adverse Event|6
197102|NCT01060540|625996|P2|Overall Study|Physician Decision|1
197103|NCT01060540|625997|P1|Overall Study|Physician Decision|0
197104|NCT01060540|625996|P2|Overall Study|Death|1
197105|NCT01060540|625997|P1|Overall Study|Death|2
197106|NCT01060540|625996|P2|Overall Study|Lost to Follow-up|43
197107|NCT01060540|625997|P1|Overall Study|Lost to Follow-up|52
197108|NCT01060540|625996|P2|Overall Study|Withdrawal by Subject|20
197109|NCT01060540|625997|P1|Overall Study|Withdrawal by Subject|10
197110|NCT01060553|626011|P2|Overall Study|Lack of Efficacy|0
197111|NCT01060553|626012|P1|Overall Study|Lack of Efficacy|1
197112|NCT01060553|626011|P2|Overall Study|Withdrawal by Subject|5
197113|NCT01060553|626012|P1|Overall Study|Withdrawal by Subject|5
197114|NCT01060553|626011|P2|Overall Study|Lost to Follow-up|5
197115|NCT01060553|626012|P1|Overall Study|Lost to Follow-up|3
197116|NCT01060670|626036|P2|Run In|screen failure|238
197117|NCT01060670|626037|P1|Run In|screen failure|0
197118|NCT01061008|626057|P2|Overall Study|Adverse Event|1
197119|NCT01061008|626058|P1|Overall Study|Adverse Event|0
197120|NCT01061008|626057|P2|Overall Study|Unable to exercise following surgery|0
197121|NCT01061008|626058|P1|Overall Study|Unable to exercise following surgery|1
197122|NCT01061008|626057|P2|Overall Study|Withdrawal by Subject|3
197123|NCT01061008|626058|P1|Overall Study|Withdrawal by Subject|1
197124|NCT01061008|626057|P2|Overall Study|Death|0
197125|NCT01061008|626058|P1|Overall Study|Death|1
197126|NCT01061008|626057|P2|Overall Study|Badiocephalic fistula failed|2
197127|NCT01061008|626058|P1|Overall Study|Badiocephalic fistula failed|3
197128|NCT01061177|626069|P1|Overall Study|Death|4
197129|NCT01061177|626069|P1|Overall Study|Administratie problems|4
197130|NCT01061177|626069|P1|Overall Study|Abnormal test procedure results|4
197131|NCT01061177|626069|P1|Overall Study|Abnormal laboratory values|6
197132|NCT01061177|626069|P1|Overall Study|New cancer therapy|9
197133|NCT01061177|626069|P1|Overall Study|Lost to Follow-up|9
197134|NCT01061177|626069|P1|Overall Study|Protocol Violation|11
197135|NCT01061177|626069|P1|Overall Study|Disease progression|17
197136|NCT01061177|626069|P1|Overall Study|Withdrawal by Subject|27
197137|NCT01061177|626069|P1|Overall Study|Adverse Event|117
197138|NCT01061333|626088|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
197139|NCT01061333|626089|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
197140|NCT01061359|626127|P1|Overall Study|Secondary neoplasm|11
197141|NCT01061359|626127|P1|Overall Study|Relapse|187
197142|NCT01061359|626127|P1|Overall Study|Lost to Follow-up|1072
197143|NCT01061359|626127|P1|Overall Study|Death|32
197144|NCT01061385|626135|P2|Overall Study|subject decision not related to AE|1
197145|NCT01061385|626136|P1|Overall Study|subject decision not related to AE|0
197146|NCT01061385|626135|P2|Overall Study|Lost to Follow-up|0
197147|NCT01061385|626136|P1|Overall Study|Lost to Follow-up|1
197148|NCT01061567|626148|P1|Overall Study|Other reason than stated above|3
197149|NCT01061567|626148|P1|Overall Study|Withdrawal by Subject|11
197150|NCT01061567|626148|P1|Overall Study|Protocol Violation|1
197151|NCT01061567|626148|P1|Overall Study|Lost to Follow-up|24
197152|NCT01061567|626148|P1|Overall Study|Lack of Efficacy|3
197153|NCT01061567|626148|P1|Overall Study|Death|2
197154|NCT01061567|626148|P1|Overall Study|Adverse Event|32
197155|NCT01061606|626157|P1|Overall Study|alternative therapy|2
197156|NCT01061606|626157|P1|Overall Study|Disease Progression|4
197157|NCT01061606|626157|P1|Overall Study|Death|1
197158|NCT01061606|626157|P1|Overall Study|Adverse Event|1
197159|NCT01061671|626168|P2|Overall Study|Death|30
197160|NCT01061671|626169|P1|Overall Study|Death|28
197161|NCT01061671|626168|P2|Overall Study|Lost to Follow-up|5
197162|NCT01061671|626169|P1|Overall Study|Lost to Follow-up|3
197163|NCT01061671|626168|P2|Overall Study|Withdrawal by Subject|20
197164|NCT01061671|626169|P1|Overall Study|Withdrawal by Subject|16
197165|NCT01061710|626181|P1|Overall Study|Protocol Violation|14
197166|NCT01061723|626195|P6|Overall Study|Other than specified above|1
197167|NCT01061723|626196|P5|Overall Study|Other than specified above|0
197168|NCT01061723|626197|P4|Overall Study|Other than specified above|1
197169|NCT01061723|626198|P3|Overall Study|Other than specified above|1
197170|NCT01061723|626199|P2|Overall Study|Other than specified above|1
197171|NCT01061723|626200|P1|Overall Study|Other than specified above|2
197172|NCT01061723|626195|P6|Overall Study|Randomized but not treated|1
197173|NCT01061723|626196|P5|Overall Study|Randomized but not treated|0
197174|NCT01061723|626197|P4|Overall Study|Randomized but not treated|0
197175|NCT01061723|626198|P3|Overall Study|Randomized but not treated|0
197176|NCT01061723|626199|P2|Overall Study|Randomized but not treated|0
197177|NCT01061723|626200|P1|Overall Study|Randomized but not treated|0
197178|NCT01061723|626195|P6|Overall Study|Lack of Efficacy|1
197179|NCT01061723|626196|P5|Overall Study|Lack of Efficacy|1
197180|NCT01061723|626197|P4|Overall Study|Lack of Efficacy|2
197181|NCT01061723|626198|P3|Overall Study|Lack of Efficacy|4
197182|NCT01061723|626199|P2|Overall Study|Lack of Efficacy|3
197183|NCT01061723|626200|P1|Overall Study|Lack of Efficacy|2
197184|NCT01061723|626195|P6|Overall Study|Adverse Event|6
197185|NCT01061723|626196|P5|Overall Study|Adverse Event|2
197186|NCT01061723|626197|P4|Overall Study|Adverse Event|5
197187|NCT01061723|626198|P3|Overall Study|Adverse Event|5
197188|NCT01061723|626199|P2|Overall Study|Adverse Event|2
197189|NCT01061723|626200|P1|Overall Study|Adverse Event|0
197190|NCT01061736|626290|P10|Overall Study|Other than specified above|21
197191|NCT01061736|626291|P9|Overall Study|Other than specified above|15
197192|NCT01061736|626292|P8|Overall Study|Other than specified above|18
197193|NCT01061736|626293|P7|Overall Study|Other than specified above|0
197194|NCT01061736|626294|P6|Overall Study|Other than specified above|0
197195|NCT01061736|626295|P5|Overall Study|Other than specified above|1
197196|NCT01061736|626296|P4|Overall Study|Other than specified above|0
197197|NCT01061736|626297|P3|Overall Study|Other than specified above|2
197198|NCT01061736|626298|P2|Overall Study|Other than specified above|1
197199|NCT01061736|626299|P1|Overall Study|Other than specified above|0
197200|NCT01061736|626290|P10|Overall Study|Not treated|0
197201|NCT01061736|626291|P9|Overall Study|Not treated|1
197202|NCT01061736|626292|P8|Overall Study|Not treated|2
197203|NCT01061736|626293|P7|Overall Study|Not treated|0
197204|NCT01061736|626294|P6|Overall Study|Not treated|0
197205|NCT01061736|626295|P5|Overall Study|Not treated|1
197206|NCT01061736|626296|P4|Overall Study|Not treated|0
197207|NCT01061736|626297|P3|Overall Study|Not treated|0
197208|NCT01061736|626298|P2|Overall Study|Not treated|0
197209|NCT01061736|626299|P1|Overall Study|Not treated|0
197210|NCT01061736|626290|P10|Overall Study|Poor compliance to protocol|9
197211|NCT01061736|626291|P9|Overall Study|Poor compliance to protocol|5
197212|NCT01061736|626292|P8|Overall Study|Poor compliance to protocol|2
197213|NCT01061736|626293|P7|Overall Study|Poor compliance to protocol|0
197214|NCT01061736|626294|P6|Overall Study|Poor compliance to protocol|0
197215|NCT01061736|626295|P5|Overall Study|Poor compliance to protocol|0
197216|NCT01061736|626296|P4|Overall Study|Poor compliance to protocol|0
197217|NCT01061736|626297|P3|Overall Study|Poor compliance to protocol|0
197218|NCT01061736|626298|P2|Overall Study|Poor compliance to protocol|0
197219|NCT01061736|626299|P1|Overall Study|Poor compliance to protocol|0
197220|NCT01061736|626290|P10|Overall Study|Lack of Efficacy|10
197221|NCT01061736|626291|P9|Overall Study|Lack of Efficacy|9
197222|NCT01061736|626292|P8|Overall Study|Lack of Efficacy|9
197223|NCT01061736|626293|P7|Overall Study|Lack of Efficacy|1
197224|NCT01061736|626294|P6|Overall Study|Lack of Efficacy|2
197225|NCT01061736|626295|P5|Overall Study|Lack of Efficacy|1
197226|NCT01061736|626296|P4|Overall Study|Lack of Efficacy|1
197227|NCT01061736|626297|P3|Overall Study|Lack of Efficacy|1
197228|NCT01061736|626298|P2|Overall Study|Lack of Efficacy|2
197229|NCT01061736|626299|P1|Overall Study|Lack of Efficacy|0
197230|NCT01061736|626290|P10|Overall Study|Adverse Event|34
197231|NCT01061736|626291|P9|Overall Study|Adverse Event|67
197232|NCT01061736|626292|P8|Overall Study|Adverse Event|63
197233|NCT01061736|626293|P7|Overall Study|Adverse Event|4
197234|NCT01061736|626294|P6|Overall Study|Adverse Event|1
197235|NCT01061736|626295|P5|Overall Study|Adverse Event|4
197236|NCT01061736|626296|P4|Overall Study|Adverse Event|2
197237|NCT01061736|626297|P3|Overall Study|Adverse Event|3
197238|NCT01061736|626298|P2|Overall Study|Adverse Event|1
197239|NCT01061736|626299|P1|Overall Study|Adverse Event|13
197240|NCT01061736|626290|P10|Overall Study|Dose regimen not selected|0
197241|NCT01061736|626291|P9|Overall Study|Dose regimen not selected|0
197242|NCT01061736|626292|P8|Overall Study|Dose regimen not selected|0
197243|NCT01061736|626293|P7|Overall Study|Dose regimen not selected|79
197244|NCT01061736|626294|P6|Overall Study|Dose regimen not selected|0
197245|NCT01061736|626295|P5|Overall Study|Dose regimen not selected|0
197246|NCT01061736|626296|P4|Overall Study|Dose regimen not selected|0
197247|NCT01061736|626297|P3|Overall Study|Dose regimen not selected|0
197248|NCT01061736|626298|P2|Overall Study|Dose regimen not selected|0
197249|NCT01061736|626299|P1|Overall Study|Dose regimen not selected|0
197250|NCT01061775|626332|P1|Overall Study|Lost to Follow-up|1
197251|NCT01061775|626332|P1|Overall Study|Physician Decision|2
197252|NCT01061866|626339|P1|Overall Study|Adverse Event|2
197253|NCT01062061|626343|P1|Overall Study|Failed to meet inclusion criteria|2
197254|NCT01062061|626343|P1|Overall Study|Outside chief indications|10
197255|NCT01062061|626343|P1|Overall Study|Investigated before study start|13
197256|NCT01062061|626343|P1|Overall Study|Enrolled more than once|2
197257|NCT01062113|626365|P3|Overall Study|Withdrawal by Subject|0
197258|NCT01062113|626366|P2|Overall Study|Withdrawal by Subject|0
197259|NCT01062113|626367|P1|Overall Study|Withdrawal by Subject|1
197260|NCT01062113|626365|P3|Overall Study|Lack of Efficacy|31
197261|NCT01062113|626366|P2|Overall Study|Lack of Efficacy|22
197262|NCT01062113|626367|P1|Overall Study|Lack of Efficacy|38
197263|NCT01062113|626365|P3|Overall Study|Adverse Event|0
197264|NCT01062113|626366|P2|Overall Study|Adverse Event|0
197265|NCT01062113|626367|P1|Overall Study|Adverse Event|1
197266|NCT01062256|626391|P3|Overall Study|Administrative|0
197267|NCT01062256|626392|P2|Overall Study|Administrative|2
197268|NCT01062256|626393|P1|Overall Study|Administrative|0
197269|NCT01062256|626391|P3|Overall Study|Ineligible|3
197270|NCT01062256|626392|P2|Overall Study|Ineligible|4
197271|NCT01062256|626393|P1|Overall Study|Ineligible|1
197272|NCT01062256|626391|P3|Overall Study|Withdrawal by Subject|1
197273|NCT01062256|626392|P2|Overall Study|Withdrawal by Subject|1
197274|NCT01062256|626393|P1|Overall Study|Withdrawal by Subject|1
197275|NCT01062256|626391|P3|Overall Study|Adverse Event|0
197276|NCT01062256|626392|P2|Overall Study|Adverse Event|0
197277|NCT01062256|626393|P1|Overall Study|Adverse Event|1
197278|NCT01062425|626440|P2|Overall Study|Protocol Violation|6
197279|NCT01062425|626441|P1|Overall Study|Protocol Violation|3
197280|NCT01062763|626464|P2|Overall Study|Adverse Event|4
197281|NCT01062763|626465|P1|Overall Study|Adverse Event|3
197282|NCT01067846|626477|P2|Overall Study|participation in other tx study|0
197283|NCT01067846|626478|P1|Overall Study|participation in other tx study|1
197284|NCT01067846|626477|P2|Overall Study|Withdrawal by Subject|0
197285|NCT01067846|626478|P1|Overall Study|Withdrawal by Subject|1
197286|NCT01067846|626477|P2|Overall Study|Lost to Follow-up|19
197287|NCT01067846|626478|P1|Overall Study|Lost to Follow-up|17
197288|NCT01067976|626486|P1|Overall Study|Study prematurely discontinued|2
197289|NCT01067976|626486|P1|Overall Study|Study drug never administered|20
197290|NCT01068158|626547|P2|Overall Study|Protocol Violation|2
197291|NCT01068158|626548|P1|Overall Study|Protocol Violation|0
197292|NCT01068158|626547|P2|Overall Study|Lost to Follow-up|0
197293|NCT01068158|626548|P1|Overall Study|Lost to Follow-up|7
197294|NCT01068158|626547|P2|Overall Study|Withdrawal by Subject|2
197295|NCT01068158|626548|P1|Overall Study|Withdrawal by Subject|1
197296|NCT01068262|626564|P4|Overall Study|Withdrawal by Subject|0
197297|NCT01068262|626565|P3|Overall Study|Withdrawal by Subject|0
197298|NCT01068262|626566|P2|Overall Study|Withdrawal by Subject|1
197299|NCT01068262|626567|P1|Overall Study|Withdrawal by Subject|0
197300|NCT01068262|626564|P4|Overall Study|Protocol Violation|0
197301|NCT01068262|626565|P3|Overall Study|Protocol Violation|0
197302|NCT01068262|626566|P2|Overall Study|Protocol Violation|0
197303|NCT01068262|626567|P1|Overall Study|Protocol Violation|1
197304|NCT01068262|626564|P4|Overall Study|Adverse Event|0
197305|NCT01068262|626565|P3|Overall Study|Adverse Event|1
197306|NCT01068262|626566|P2|Overall Study|Adverse Event|0
197307|NCT01068262|626567|P1|Overall Study|Adverse Event|2
197308|NCT01068418|626595|P1|Overall Study|Physician Decision|12
197309|NCT01068509|626603|P3|Overall Study|Reason Not Specified|0
197310|NCT01068509|626604|P2|Overall Study|Reason Not Specified|1
197311|NCT01068509|626605|P1|Overall Study|Reason Not Specified|0
197312|NCT01068509|626603|P3|Overall Study|Withdrew Consent|2
197313|NCT01068509|626604|P2|Overall Study|Withdrew Consent|1
197314|NCT01068509|626605|P1|Overall Study|Withdrew Consent|0
197315|NCT01068509|626603|P3|Overall Study|Lost to Follow-up|0
197316|NCT01068509|626604|P2|Overall Study|Lost to Follow-up|0
197317|NCT01068509|626605|P1|Overall Study|Lost to Follow-up|1
197318|NCT01068509|626603|P3|Overall Study|Disease Progression|18
197319|NCT01068509|626604|P2|Overall Study|Disease Progression|20
197320|NCT01068509|626605|P1|Overall Study|Disease Progression|5
197321|NCT01068509|626603|P3|Overall Study|Death|1
197322|NCT01068509|626604|P2|Overall Study|Death|0
197323|NCT01068509|626605|P1|Overall Study|Death|0
197324|NCT01068600|626629|P2|Overall Study|Administrative problems|1
197325|NCT01068600|626630|P1|Overall Study|Administrative problems|0
197326|NCT01068600|626629|P2|Overall Study|Unsatisfactory therapeutic effect|4
197327|NCT01068600|626630|P1|Overall Study|Unsatisfactory therapeutic effect|0
197328|NCT01068600|626629|P2|Overall Study|Protocol deviation|1
197329|NCT01068600|626630|P1|Overall Study|Protocol deviation|1
197330|NCT01068600|626629|P2|Overall Study|Lost to Follow-up|2
197331|NCT01068600|626630|P1|Overall Study|Lost to Follow-up|1
197332|NCT01068600|626629|P2|Overall Study|Abnormal laboratory value(s)|0
197333|NCT01068600|626630|P1|Overall Study|Abnormal laboratory value(s)|1
197334|NCT01068600|626629|P2|Overall Study|Adverse Event|3
197335|NCT01068600|626630|P1|Overall Study|Adverse Event|3
197336|NCT01068600|626629|P2|Overall Study|Withdrawal by Subject|6
197337|NCT01068600|626630|P1|Overall Study|Withdrawal by Subject|5
197338|NCT01068626|626640|P2|Overall Study|Withdrawal by Subject|2
197339|NCT01068626|626641|P1|Overall Study|Withdrawal by Subject|0
197340|NCT01068626|626640|P2|Overall Study|Adverse Event|0
197341|NCT01068626|626641|P1|Overall Study|Adverse Event|3
197342|NCT01068652|626659|P2|Overall Study|Unclassified|4
197343|NCT01068652|626660|P1|Overall Study|Unclassified|7
197344|NCT01068652|626659|P2|Overall Study|Patient was not eligible|0
197345|NCT01068652|626660|P1|Overall Study|Patient was not eligible|1
197346|NCT01068652|626659|P2|Overall Study|Withdrawal criteria|2
197347|NCT01068652|626660|P1|Overall Study|Withdrawal criteria|1
197348|NCT01068652|626659|P2|Overall Study|Protocol Violation|6
197349|NCT01068652|626660|P1|Overall Study|Protocol Violation|3
197350|NCT01068652|626659|P2|Overall Study|Lost to Follow-up|1
197351|NCT01068652|626660|P1|Overall Study|Lost to Follow-up|2
197352|NCT01068652|626659|P2|Overall Study|Lack of Efficacy|2
197353|NCT01068652|626660|P1|Overall Study|Lack of Efficacy|0
197354|NCT01068652|626659|P2|Overall Study|Adverse Event|0
197355|NCT01068652|626660|P1|Overall Study|Adverse Event|4
197356|NCT01068665|626700|P2|Overall Study|Other|12
197357|NCT01068665|626701|P1|Overall Study|Other|17
197358|NCT01068665|626700|P2|Overall Study|Withdrawal Criteria|9
197359|NCT01068665|626701|P1|Overall Study|Withdrawal Criteria|3
197360|NCT01068665|626700|P2|Overall Study|Protocol Violation|2
197361|NCT01068665|626701|P1|Overall Study|Protocol Violation|5
197362|NCT01068665|626700|P2|Overall Study|Lack of Efficacy|2
197363|NCT01068665|626701|P1|Overall Study|Lack of Efficacy|0
197364|NCT01068665|626700|P2|Overall Study|Adverse Event|4
197365|NCT01068665|626701|P1|Overall Study|Adverse Event|5
197366|NCT01068678|626711|P2|Overall Study|Unclassified|15
197367|NCT01068678|626712|P1|Overall Study|Unclassified|18
197368|NCT01068678|626711|P2|Overall Study|Withdrawal criteria|6
197369|NCT01068678|626712|P1|Overall Study|Withdrawal criteria|12
197370|NCT01068678|626711|P2|Overall Study|Protocol Violation|1
197371|NCT01068678|626712|P1|Overall Study|Protocol Violation|5
197372|NCT01068678|626711|P2|Overall Study|Lack of Efficacy|2
197373|NCT01068678|626712|P1|Overall Study|Lack of Efficacy|3
197374|NCT01068717|626720|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
197375|NCT01068717|626721|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
197376|NCT01068717|626722|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
197377|NCT01068717|626723|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
197378|NCT01068730|626777|P4|Period 4|Family emergency|0
197379|NCT01068730|626778|P3|Period 4|Family emergency|0
197380|NCT01068730|626779|P2|Period 4|Family emergency|1
197381|NCT01068730|626780|P1|Period 4|Family emergency|0
197382|NCT01068730|626777|P4|Period 3|Personal reason|0
197383|NCT01068730|626778|P3|Period 3|Personal reason|0
197384|NCT01068730|626779|P2|Period 3|Personal reason|0
197385|NCT01068730|626780|P1|Period 3|Personal reason|1
197386|NCT01068743|626834|P4|Period 3|Adverse Event|0
197387|NCT01068743|626835|P3|Period 3|Adverse Event|0
197388|NCT01068743|626836|P2|Period 3|Adverse Event|1
197389|NCT01068743|626837|P1|Period 3|Adverse Event|0
197390|NCT01068769|626911|P1|Overall Study|Ineligible|1
197391|NCT01068860|626937|P10|Overall Study|Lost to Follow-up|0
197392|NCT01068860|626938|P9|Overall Study|Lost to Follow-up|0
197393|NCT01068860|626939|P8|Overall Study|Lost to Follow-up|0
197394|NCT01068860|626940|P7|Overall Study|Lost to Follow-up|0
197395|NCT01068860|626941|P6|Overall Study|Lost to Follow-up|0
197396|NCT01068860|626942|P5|Overall Study|Lost to Follow-up|0
197397|NCT01068860|626943|P4|Overall Study|Lost to Follow-up|0
197398|NCT01068860|626944|P3|Overall Study|Lost to Follow-up|0
197399|NCT01068860|626945|P2|Overall Study|Lost to Follow-up|1
197400|NCT01068860|626946|P1|Overall Study|Lost to Follow-up|0
197401|NCT01068860|626937|P10|Overall Study|Administrative problems; misrandomized|1
197402|NCT01068860|626938|P9|Overall Study|Administrative problems; misrandomized|0
197403|NCT01068860|626939|P8|Overall Study|Administrative problems; misrandomized|0
197404|NCT01068860|626940|P7|Overall Study|Administrative problems; misrandomized|0
197405|NCT01068860|626941|P6|Overall Study|Administrative problems; misrandomized|0
197406|NCT01068860|626942|P5|Overall Study|Administrative problems; misrandomized|0
197407|NCT01068860|626943|P4|Overall Study|Administrative problems; misrandomized|1
197408|NCT01068860|626944|P3|Overall Study|Administrative problems; misrandomized|0
197409|NCT01068860|626945|P2|Overall Study|Administrative problems; misrandomized|0
197410|NCT01068860|626946|P1|Overall Study|Administrative problems; misrandomized|0
197411|NCT01068860|626937|P10|Overall Study|Withdrawal by Subject|3
197412|NCT01068860|626938|P9|Overall Study|Withdrawal by Subject|0
197413|NCT01068860|626939|P8|Overall Study|Withdrawal by Subject|0
197414|NCT01068860|626940|P7|Overall Study|Withdrawal by Subject|0
197415|NCT01068860|626941|P6|Overall Study|Withdrawal by Subject|2
197416|NCT01068860|626942|P5|Overall Study|Withdrawal by Subject|0
197417|NCT01068860|626943|P4|Overall Study|Withdrawal by Subject|0
197418|NCT01068860|626944|P3|Overall Study|Withdrawal by Subject|0
197419|NCT01068860|626945|P2|Overall Study|Withdrawal by Subject|0
197420|NCT01068860|626946|P1|Overall Study|Withdrawal by Subject|0
197421|NCT01068912|627121|P3|Overall Study|other underlying illness|3
197422|NCT01068912|627122|P2|Overall Study|other underlying illness|3
197423|NCT01068912|627123|P1|Overall Study|other underlying illness|0
197424|NCT01068912|627121|P3|Overall Study|aggravation influenza|1
197425|NCT01068912|627122|P2|Overall Study|aggravation influenza|1
197426|NCT01068912|627123|P1|Overall Study|aggravation influenza|1
197427|NCT01068912|627121|P3|Overall Study|Protocol Violation|0
197428|NCT01068912|627122|P2|Overall Study|Protocol Violation|2
197429|NCT01068912|627123|P1|Overall Study|Protocol Violation|0
197430|NCT01068912|627121|P3|Overall Study|Lost to Follow-up|3
197431|NCT01068912|627122|P2|Overall Study|Lost to Follow-up|7
197432|NCT01068912|627123|P1|Overall Study|Lost to Follow-up|3
197433|NCT01068912|627121|P3|Overall Study|Withdrawal by Subject|6
197434|NCT01068912|627122|P2|Overall Study|Withdrawal by Subject|6
197435|NCT01068912|627123|P1|Overall Study|Withdrawal by Subject|5
197436|NCT01068912|627121|P3|Overall Study|Adverse Event|2
197437|NCT01068912|627122|P2|Overall Study|Adverse Event|3
197438|NCT01068912|627123|P1|Overall Study|Adverse Event|2
197439|NCT01069120|627161|P1|Overall Study|Study prematurely terminated|27
197440|NCT01069172|627167|P2|Overall Study|Withdrawal by Subject|0
197441|NCT01069172|627168|P1|Overall Study|Withdrawal by Subject|1
197442|NCT01069289|627178|P2|Overall Study|Due to deteriorating health condition|0
197443|NCT01069289|627179|P1|Overall Study|Due to deteriorating health condition|1
197444|NCT01069289|627178|P2|Overall Study|Severe non-compliance to protocol|2
197445|NCT01069289|627179|P1|Overall Study|Severe non-compliance to protocol|3
197446|NCT01069289|627178|P2|Overall Study|Eligibility criteria not fulfilled|0
197447|NCT01069289|627179|P1|Overall Study|Eligibility criteria not fulfilled|2
197448|NCT01069289|627178|P2|Overall Study|Adverse Event|28
197449|NCT01069289|627179|P1|Overall Study|Adverse Event|21
197450|NCT01069289|627178|P2|Overall Study|Withdrawal by Subject|26
197451|NCT01069289|627179|P1|Overall Study|Withdrawal by Subject|15
197452|NCT01069341|627217|P1|Overall Study|Lost to Follow-up|1
197453|NCT01069419|627228|P1|Overall Study|Missing termination information|13
197454|NCT01069419|627228|P1|Overall Study|Other Reason|43
197455|NCT01069419|627228|P1|Overall Study|Withdrawal by Subject|34
197456|NCT01069419|627228|P1|Overall Study|Remission of disease|11
197457|NCT01069419|627228|P1|Overall Study|Lost to Follow-up|49
197458|NCT01069419|627228|P1|Overall Study|Lack of Efficacy|332
197459|NCT01069419|627228|P1|Overall Study|Adverse Event|233
197460|NCT01069484|627237|P2|Overall Study|Illness mother or child|1
197461|NCT01069484|627238|P1|Overall Study|Illness mother or child|3
197462|NCT01069484|627237|P2|Overall Study|No specific reason|2
197463|NCT01069484|627238|P1|Overall Study|No specific reason|8
197464|NCT01069484|627237|P2|Overall Study|Death-in-near-family|0
197465|NCT01069484|627238|P1|Overall Study|Death-in-near-family|1
197466|NCT01069523|627248|P2|Overall Study|Withdrawal by Subject|7
197467|NCT01069523|627249|P1|Overall Study|Withdrawal by Subject|4
197468|NCT01069627|627284|P1|Overall Study|Protocol Violation|1
197469|NCT01069627|627284|P1|Overall Study|Adverse Event|12
197470|NCT01069627|627284|P1|Overall Study|Disease progression|7
197471|NCT01069861|627305|P1|Overall Study|Did not meet entrance criteria|1
197472|NCT01069861|627305|P1|Overall Study|Adverse Event|1
197473|NCT01069861|627305|P1|Overall Study|Death|1
197474|NCT01069900|627320|P2|Overall Study|Insufficient Therapeutic effect|0
197475|NCT01069900|627321|P1|Overall Study|Insufficient Therapeutic effect|1
197476|NCT01069900|627320|P2|Overall Study|Protocol Violation|1
197477|NCT01069900|627321|P1|Overall Study|Protocol Violation|4
197478|NCT01069900|627320|P2|Overall Study|Withdrawal by Subject|1
197479|NCT01069900|627321|P1|Overall Study|Withdrawal by Subject|6
197480|NCT01069900|627320|P2|Overall Study|Lost to Follow-up|1
197481|NCT01069900|627321|P1|Overall Study|Lost to Follow-up|7
197482|NCT01069900|627320|P2|Overall Study|Technical problems|1
197483|NCT01069900|627321|P1|Overall Study|Technical problems|0
197484|NCT01069939|627367|P2|Randomised and Included in the Analyses|Removal|0
197485|NCT01069939|627368|P1|Randomised and Included in the Analyses|Removal|1
197486|NCT01069939|627367|P2|Randomised and Included in the Analyses|Physician Decision|2
197487|NCT01069939|627368|P1|Randomised and Included in the Analyses|Physician Decision|0
197488|NCT01069939|627367|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
197489|NCT01069939|627368|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
197490|NCT01069939|627367|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
197491|NCT01069939|627368|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
197492|NCT01069939|627367|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
197657|NCT01059799|628030|P2|Overall Study|Lack of Efficacy|0
197493|NCT01069939|627368|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
197494|NCT01069939|627367|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
197495|NCT01069939|627368|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
197496|NCT01069939|627367|P2|Randomised and Included in the Analyses|Protocol Violation|1
197497|NCT01069939|627368|P1|Randomised and Included in the Analyses|Protocol Violation|0
197498|NCT01069939|627367|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
197499|NCT01069939|627368|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
197500|NCT01069939|627367|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
197501|NCT01069939|627368|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
197502|NCT01069939|627367|P2|Randomised and Included in the Analyses|Adverse Event|22
197503|NCT01069939|627368|P1|Randomised and Included in the Analyses|Adverse Event|17
197504|NCT01070043|627394|P3|Double-Blind Treatment|Adverse Event|2
197505|NCT01070043|627395|P2|Double-Blind Treatment|Adverse Event|0
197506|NCT01070043|627396|P1|Double-Blind Treatment|Adverse Event|0
197507|NCT01070043|627394|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
197508|NCT01070043|627395|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
197509|NCT01070043|627396|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
197510|NCT01070303|627428|P1|Overall Study|Other|18
197511|NCT01070303|627428|P1|Overall Study|Administrative Reason|1
197512|NCT01070303|627428|P1|Overall Study|Lack of Efficacy|2
197513|NCT01070303|627428|P1|Overall Study|Protocol Violation|0
197514|NCT01070303|627428|P1|Overall Study|Lost to Follow-up|9
197515|NCT01070303|627428|P1|Overall Study|Withdrawal by Subject|20
197516|NCT01070303|627428|P1|Overall Study|Adverse Event|39
197517|NCT01070316|627484|P1|Extension Phase|Withdrawal by Subject|1
197518|NCT01070316|627484|P1|Extension Phase|Lack of Efficacy|3
197519|NCT01070329|627491|P2|Overall Study|Sponsor Decision|1
197520|NCT01070329|627492|P1|Overall Study|Sponsor Decision|0
197521|NCT01070329|627491|P2|Overall Study|Entry Criteria Not Met|0
197522|NCT01070329|627492|P1|Overall Study|Entry Criteria Not Met|1
197523|NCT01070329|627491|P2|Overall Study|Physician Decision|1
197524|NCT01070329|627492|P1|Overall Study|Physician Decision|2
197525|NCT01070329|627491|P2|Overall Study|Lack of Efficacy|6
197526|NCT01070329|627492|P1|Overall Study|Lack of Efficacy|2
197527|NCT01070329|627491|P2|Overall Study|Protocol Violation|8
197528|NCT01070329|627492|P1|Overall Study|Protocol Violation|3
197529|NCT01070329|627491|P2|Overall Study|Withdrawal by Subject|11
197530|NCT01070329|627492|P1|Overall Study|Withdrawal by Subject|9
197531|NCT01070329|627491|P2|Overall Study|Lost to Follow-up|12
197532|NCT01070329|627492|P1|Overall Study|Lost to Follow-up|22
197533|NCT01070329|627491|P2|Overall Study|Adverse Event|10
197534|NCT01070329|627492|P1|Overall Study|Adverse Event|13
197535|NCT01059071|627539|P4|Overall Study|Physician Decision|1
197536|NCT01059071|627540|P3|Overall Study|Physician Decision|0
197537|NCT01059071|627541|P2|Overall Study|Physician Decision|0
197538|NCT01059071|627542|P1|Overall Study|Physician Decision|0
197539|NCT01059071|627539|P4|Overall Study|Withdrawal by Subject|2
197540|NCT01059071|627540|P3|Overall Study|Withdrawal by Subject|0
197541|NCT01059071|627541|P2|Overall Study|Withdrawal by Subject|0
197542|NCT01059071|627542|P1|Overall Study|Withdrawal by Subject|1
197543|NCT01059071|627539|P4|Overall Study|Lack of Efficacy|3
197544|NCT01059071|627540|P3|Overall Study|Lack of Efficacy|2
197545|NCT01059071|627541|P2|Overall Study|Lack of Efficacy|4
197546|NCT01059071|627542|P1|Overall Study|Lack of Efficacy|1
197547|NCT01059175|627556|P2|Overall Study|Lost to Follow-up|1
197548|NCT01059175|627557|P1|Overall Study|Lost to Follow-up|0
197549|NCT01059175|627556|P2|Overall Study|Adverse Event|2
197550|NCT01059175|627557|P1|Overall Study|Adverse Event|4
197551|NCT01059175|627556|P2|Overall Study|Death|17
197552|NCT01059175|627557|P1|Overall Study|Death|17
197553|NCT01059344|627585|P2|Overall Study|Other|6
197554|NCT01059344|627586|P1|Overall Study|Other|3
197555|NCT01059344|627585|P2|Overall Study|Lost to Follow-up|1
197556|NCT01059344|627586|P1|Overall Study|Lost to Follow-up|1
197557|NCT01059344|627585|P2|Overall Study|Withdrawal by Subject|9
197558|NCT01059344|627586|P1|Overall Study|Withdrawal by Subject|6
197559|NCT01059344|627585|P2|Overall Study|Adverse Event|30
197560|NCT01059344|627586|P1|Overall Study|Adverse Event|12
197561|NCT01059526|627606|P2|Overall Study|Patient found to be dermatographic|0
197562|NCT01059526|627607|P1|Overall Study|Patient found to be dermatographic|1
197563|NCT01059526|627606|P2|Overall Study|Lost to Follow-up|1
197564|NCT01059526|627607|P1|Overall Study|Lost to Follow-up|4
197565|NCT01059526|627606|P2|Overall Study|Withdrawal by Subject|1
197566|NCT01059526|627607|P1|Overall Study|Withdrawal by Subject|3
197567|NCT01059526|627606|P2|Overall Study|Protocol Violation|1
197568|NCT01059526|627607|P1|Overall Study|Protocol Violation|0
197569|NCT01059526|627606|P2|Overall Study|Adverse Event|2
197570|NCT01059526|627607|P1|Overall Study|Adverse Event|2
197571|NCT01059526|627606|P2|Overall Study|Patient enrolled but not treated|17
197572|NCT01059526|627607|P1|Overall Study|Patient enrolled but not treated|20
197573|NCT01059565|627617|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
197574|NCT01059565|627618|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
197575|NCT01059565|627617|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
197576|NCT01059565|627618|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
197577|NCT01059565|627617|P2|24-Week Open-Label Phase|Subject noncompliance|0
197578|NCT01059565|627618|P1|24-Week Open-Label Phase|Subject noncompliance|1
197579|NCT01059565|627617|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
197580|NCT01059565|627618|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
197581|NCT01059565|627617|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
197582|NCT01059565|627618|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
197583|NCT01059565|627617|P2|24-Week Open-Label Phase|Adverse Event|0
197584|NCT01059565|627618|P1|24-Week Open-Label Phase|Adverse Event|2
197585|NCT01059565|627617|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
197586|NCT01059565|627618|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
197587|NCT01059565|627617|P2|24-Week Randomized Phase|Lost to Follow-up|1
197588|NCT01059565|627618|P1|24-Week Randomized Phase|Lost to Follow-up|0
197589|NCT01059565|627617|P2|24-Week Randomized Phase|Withdrawal by Subject|1
197590|NCT01059565|627618|P1|24-Week Randomized Phase|Withdrawal by Subject|3
197591|NCT01059565|627617|P2|24-Week Randomized Phase|Adverse Event|0
197592|NCT01059565|627618|P1|24-Week Randomized Phase|Adverse Event|5
197593|NCT01059565|627617|P2|24-Week Randomized Phase|Randomized but not treated|0
197594|NCT01059565|627618|P1|24-Week Randomized Phase|Randomized but not treated|1
197595|NCT01059617|627656|P4|Overall Study|Unspecified|6
197596|NCT01059617|627657|P3|Overall Study|Unspecified|8
197597|NCT01059617|627658|P2|Overall Study|Unspecified|1
197598|NCT01059617|627659|P1|Overall Study|Unspecified|7
197599|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Unspecified|3
197600|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Unspecified|0
197601|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Physician Decision|2
197602|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Physician Decision|0
197603|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Death|2
197604|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Death|0
197605|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Withdrawal by Subject|3
197606|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Withdrawal by Subject|0
197607|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Progressive Disease|44
197608|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Progressive Disease|0
197609|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Adverse Event|8
197610|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Adverse Event|0
197611|NCT01059630|627829|P2|Maintenance Period (up to 2 Years)|Maintenance ongoing|46
197612|NCT01059630|627830|P1|Maintenance Period (up to 2 Years)|Maintenance ongoing|0
197613|NCT01059630|627829|P2|Induction Period (6 Months)|Randomized but not Treated|0
197614|NCT01059630|627830|P1|Induction Period (6 Months)|Randomized but not Treated|4
197615|NCT01059630|627829|P2|Induction Period (6 Months)|Unspecified|0
197616|NCT01059630|627830|P1|Induction Period (6 Months)|Unspecified|1
197617|NCT01059630|627829|P2|Induction Period (6 Months)|Physician Decision|4
197618|NCT01059630|627830|P1|Induction Period (6 Months)|Physician Decision|2
197619|NCT01059630|627829|P2|Induction Period (6 Months)|Death|2
197620|NCT01059630|627830|P1|Induction Period (6 Months)|Death|2
197621|NCT01059630|627829|P2|Induction Period (6 Months)|Withdrawal by Subject|2
197622|NCT01059630|627830|P1|Induction Period (6 Months)|Withdrawal by Subject|7
197623|NCT01059630|627829|P2|Induction Period (6 Months)|Progressive Disease|9
197624|NCT01059630|627830|P1|Induction Period (6 Months)|Progressive Disease|14
197625|NCT01059630|627829|P2|Induction Period (6 Months)|Adverse Event|15
197626|NCT01059630|627830|P1|Induction Period (6 Months)|Adverse Event|30
197627|NCT01059630|627829|P2|Induction Period (6 Months)|Induction ongoing|6
197628|NCT01059630|627830|P1|Induction Period (6 Months)|Induction ongoing|13
197629|NCT01059773|627997|P2|Overall Study|Other|3
197630|NCT01059773|627998|P1|Overall Study|Other|1
197631|NCT01059773|627997|P2|Overall Study|Ineligible follow TB screening criteria|1
197632|NCT01059773|627998|P1|Overall Study|Ineligible follow TB screening criteria|0
197633|NCT01059773|627997|P2|Overall Study|Malignancy including squamous cell skin|1
197634|NCT01059773|627998|P1|Overall Study|Malignancy including squamous cell skin|0
197635|NCT01059773|627997|P2|Overall Study|Death|1
197636|NCT01059773|627998|P1|Overall Study|Death|0
197637|NCT01059773|627997|P2|Overall Study|Lack of Efficacy|3
197638|NCT01059773|627998|P1|Overall Study|Lack of Efficacy|3
197639|NCT01059773|627997|P2|Overall Study|Physician Decision|4
197640|NCT01059773|627998|P1|Overall Study|Physician Decision|5
197641|NCT01059773|627997|P2|Overall Study|Protocol Violation|2
197642|NCT01059773|627998|P1|Overall Study|Protocol Violation|6
197643|NCT01059773|627997|P2|Overall Study|Pregnancy|1
197644|NCT01059773|627998|P1|Overall Study|Pregnancy|1
197645|NCT01059773|627997|P2|Overall Study|Lost to Follow-up|1
197646|NCT01059773|627998|P1|Overall Study|Lost to Follow-up|1
197647|NCT01059773|627997|P2|Overall Study|Withdrawal by Subject|5
197648|NCT01059773|627998|P1|Overall Study|Withdrawal by Subject|1
197649|NCT01059773|627997|P2|Overall Study|Adverse Event|2
197650|NCT01059773|627998|P1|Overall Study|Adverse Event|2
197651|NCT01059799|628030|P2|Overall Study|Other|3
197652|NCT01059799|628031|P1|Overall Study|Other|12
197653|NCT01059799|628030|P2|Overall Study|Withdrawal criteria|2
197654|NCT01059799|628031|P1|Overall Study|Withdrawal criteria|13
197655|NCT01059799|628030|P2|Overall Study|Protocol Violation|2
197656|NCT01059799|628031|P1|Overall Study|Protocol Violation|3
197658|NCT01059799|628031|P1|Overall Study|Lack of Efficacy|1
197659|NCT01059799|628030|P2|Overall Study|Adverse Event|3
197660|NCT01059799|628031|P1|Overall Study|Adverse Event|2
197661|NCT01059812|628045|P2|Overall Study|Unclassified|4
197662|NCT01059812|628046|P1|Overall Study|Unclassified|14
197663|NCT01059812|628045|P2|Overall Study|Withdrawal Criteria|4
197664|NCT01059812|628046|P1|Overall Study|Withdrawal Criteria|9
197665|NCT01059812|628045|P2|Overall Study|Protocol Violation|1
197666|NCT01059812|628046|P1|Overall Study|Protocol Violation|3
197667|NCT01059812|628045|P2|Overall Study|Lack of Efficacy|2
197668|NCT01059812|628046|P1|Overall Study|Lack of Efficacy|2
197669|NCT01059812|628045|P2|Overall Study|Adverse Event|5
197670|NCT01059812|628046|P1|Overall Study|Adverse Event|9
197671|NCT01059864|628081|P3|Double-Blind Treatment Phase|Adverse Event|3
197672|NCT01059864|628082|P2|Double-Blind Treatment Phase|Adverse Event|3
197673|NCT01059864|628083|P1|Double-Blind Treatment Phase|Adverse Event|0
197674|NCT01059864|628081|P3|Open-Label Run-In Phase|Protocol Violation|0
197675|NCT01059864|628082|P2|Open-Label Run-In Phase|Protocol Violation|0
197676|NCT01059864|628083|P1|Open-Label Run-In Phase|Protocol Violation|2
197677|NCT01059864|628081|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
197678|NCT01059864|628082|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
197679|NCT01059864|628083|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
197680|NCT01059864|628081|P3|Open-Label Run-In Phase|Lost to Follow-up|0
197681|NCT01059864|628082|P2|Open-Label Run-In Phase|Lost to Follow-up|0
197682|NCT01059864|628083|P1|Open-Label Run-In Phase|Lost to Follow-up|2
197683|NCT01059864|628081|P3|Open-Label Run-In Phase|Lack of Efficacy|0
197684|NCT01059864|628082|P2|Open-Label Run-In Phase|Lack of Efficacy|0
197685|NCT01059864|628083|P1|Open-Label Run-In Phase|Lack of Efficacy|1
197686|NCT01059864|628081|P3|Open-Label Run-In Phase|Adverse Event|0
197687|NCT01059864|628082|P2|Open-Label Run-In Phase|Adverse Event|0
197688|NCT01059864|628083|P1|Open-Label Run-In Phase|Adverse Event|7
197689|NCT01059903|628132|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
197690|NCT01059903|628133|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
197691|NCT01060007|628188|P1|Overall Study|Inevaluable for response at surgery|3
197692|NCT01060007|628188|P1|Overall Study|Withdrawal by Subject|1
197693|NCT01070381|628202|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
197694|NCT01070381|628203|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
197695|NCT01070381|628202|P2|Period 2, 1 Week of Wear|Handling|1
197696|NCT01070381|628203|P1|Period 2, 1 Week of Wear|Handling|0
197697|NCT01070394|628209|P1|Overall Study|Withdrawal by Subject|1
197698|NCT01070394|628209|P1|Overall Study|Adverse Event|6
197699|NCT01070550|628226|P6|Overall Study|Withdrawal by Subject|0
197700|NCT01070550|628227|P5|Overall Study|Withdrawal by Subject|0
197701|NCT01070550|628228|P4|Overall Study|Withdrawal by Subject|0
197702|NCT01070550|628229|P3|Overall Study|Withdrawal by Subject|3
197703|NCT01070550|628230|P2|Overall Study|Withdrawal by Subject|0
197704|NCT01070550|628231|P1|Overall Study|Withdrawal by Subject|35
197705|NCT01070550|628226|P6|Overall Study|Other|0
197706|NCT01070550|628227|P5|Overall Study|Other|0
197707|NCT01070550|628228|P4|Overall Study|Other|1
197708|NCT01070550|628229|P3|Overall Study|Other|0
197709|NCT01070550|628230|P2|Overall Study|Other|0
197710|NCT01070550|628231|P1|Overall Study|Other|5
197711|NCT01070550|628226|P6|Overall Study|Treatment was stopped early|0
197712|NCT01070550|628227|P5|Overall Study|Treatment was stopped early|0
197713|NCT01070550|628228|P4|Overall Study|Treatment was stopped early|0
197714|NCT01070550|628229|P3|Overall Study|Treatment was stopped early|0
197715|NCT01070550|628230|P2|Overall Study|Treatment was stopped early|0
197716|NCT01070550|628231|P1|Overall Study|Treatment was stopped early|7
197717|NCT01070550|628226|P6|Overall Study|Treatment unavailable|0
197718|NCT01070550|628227|P5|Overall Study|Treatment unavailable|0
197719|NCT01070550|628228|P4|Overall Study|Treatment unavailable|0
197720|NCT01070550|628229|P3|Overall Study|Treatment unavailable|0
197721|NCT01070550|628230|P2|Overall Study|Treatment unavailable|0
197722|NCT01070550|628231|P1|Overall Study|Treatment unavailable|1
197723|NCT01070550|628226|P6|Overall Study|Treatment stopped|0
197724|NCT01070550|628227|P5|Overall Study|Treatment stopped|0
197725|NCT01070550|628228|P4|Overall Study|Treatment stopped|0
197726|NCT01070550|628229|P3|Overall Study|Treatment stopped|0
197727|NCT01070550|628230|P2|Overall Study|Treatment stopped|0
197728|NCT01070550|628231|P1|Overall Study|Treatment stopped|3
197729|NCT01070550|628226|P6|Overall Study|Treatment restarted|0
197730|NCT01070550|628227|P5|Overall Study|Treatment restarted|0
197731|NCT01070550|628228|P4|Overall Study|Treatment restarted|0
197732|NCT01070550|628229|P3|Overall Study|Treatment restarted|0
197733|NCT01070550|628230|P2|Overall Study|Treatment restarted|1
197734|NCT01070550|628231|P1|Overall Study|Treatment restarted|0
197735|NCT01070550|628226|P6|Overall Study|Treatment not started|0
197736|NCT01070550|628227|P5|Overall Study|Treatment not started|0
197737|NCT01070550|628228|P4|Overall Study|Treatment not started|0
197738|NCT01070550|628229|P3|Overall Study|Treatment not started|4
197739|NCT01070550|628230|P2|Overall Study|Treatment not started|2
197740|NCT01070550|628231|P1|Overall Study|Treatment not started|14
197741|NCT01070550|628226|P6|Overall Study|Treatment interrupted|0
197742|NCT01070550|628227|P5|Overall Study|Treatment interrupted|0
197743|NCT01070550|628228|P4|Overall Study|Treatment interrupted|1
197744|NCT01070550|628229|P3|Overall Study|Treatment interrupted|1
197745|NCT01070550|628230|P2|Overall Study|Treatment interrupted|0
197746|NCT01070550|628231|P1|Overall Study|Treatment interrupted|7
197747|NCT01070550|628226|P6|Overall Study|Treatment duration shortened|0
197748|NCT01070550|628227|P5|Overall Study|Treatment duration shortened|0
197749|NCT01070550|628228|P4|Overall Study|Treatment duration shortened|0
197750|NCT01070550|628229|P3|Overall Study|Treatment duration shortened|0
197751|NCT01070550|628230|P2|Overall Study|Treatment duration shortened|0
197752|NCT01070550|628231|P1|Overall Study|Treatment duration shortened|1
197753|NCT01070550|628226|P6|Overall Study|Sponsor decision|0
197754|NCT01070550|628227|P5|Overall Study|Sponsor decision|0
197755|NCT01070550|628228|P4|Overall Study|Sponsor decision|0
197756|NCT01070550|628229|P3|Overall Study|Sponsor decision|0
197757|NCT01070550|628230|P2|Overall Study|Sponsor decision|0
197758|NCT01070550|628231|P1|Overall Study|Sponsor decision|1
197759|NCT01070550|628226|P6|Overall Study|Screen failure|0
197760|NCT01070550|628227|P5|Overall Study|Screen failure|0
197761|NCT01070550|628228|P4|Overall Study|Screen failure|0
197762|NCT01070550|628229|P3|Overall Study|Screen failure|0
197763|NCT01070550|628230|P2|Overall Study|Screen failure|0
197764|NCT01070550|628231|P1|Overall Study|Screen failure|1
197765|NCT01070550|628226|P6|Overall Study|Result not available|0
197766|NCT01070550|628227|P5|Overall Study|Result not available|0
197767|NCT01070550|628228|P4|Overall Study|Result not available|0
197768|NCT01070550|628229|P3|Overall Study|Result not available|3
197769|NCT01070550|628230|P2|Overall Study|Result not available|1
197770|NCT01070550|628231|P1|Overall Study|Result not available|3
197771|NCT01070550|628226|P6|Overall Study|Relapse|0
197772|NCT01070550|628227|P5|Overall Study|Relapse|0
197773|NCT01070550|628228|P4|Overall Study|Relapse|4
197774|NCT01070550|628229|P3|Overall Study|Relapse|14
197775|NCT01070550|628230|P2|Overall Study|Relapse|5
197776|NCT01070550|628231|P1|Overall Study|Relapse|44
197777|NCT01070550|628226|P6|Overall Study|Protocol Violation|0
197778|NCT01070550|628227|P5|Overall Study|Protocol Violation|0
197779|NCT01070550|628228|P4|Overall Study|Protocol Violation|1
197780|NCT01070550|628229|P3|Overall Study|Protocol Violation|1
197781|NCT01070550|628230|P2|Overall Study|Protocol Violation|1
197782|NCT01070550|628231|P1|Overall Study|Protocol Violation|15
197783|NCT01070550|628226|P6|Overall Study|Not categorized|1
197784|NCT01070550|628227|P5|Overall Study|Not categorized|0
197785|NCT01070550|628228|P4|Overall Study|Not categorized|1
197786|NCT01070550|628229|P3|Overall Study|Not categorized|6
197787|NCT01070550|628230|P2|Overall Study|Not categorized|2
197788|NCT01070550|628231|P1|Overall Study|Not categorized|33
197789|NCT01070550|628226|P6|Overall Study|Non-responders|2
197790|NCT01070550|628227|P5|Overall Study|Non-responders|0
197791|NCT01070550|628228|P4|Overall Study|Non-responders|20
197792|NCT01070550|628229|P3|Overall Study|Non-responders|21
197793|NCT01070550|628230|P2|Overall Study|Non-responders|4
197794|NCT01070550|628231|P1|Overall Study|Non-responders|493
197795|NCT01070550|628226|P6|Overall Study|New treatment started|0
197796|NCT01070550|628227|P5|Overall Study|New treatment started|0
197797|NCT01070550|628228|P4|Overall Study|New treatment started|2
197798|NCT01070550|628229|P3|Overall Study|New treatment started|0
197799|NCT01070550|628230|P2|Overall Study|New treatment started|1
197800|NCT01070550|628231|P1|Overall Study|New treatment started|3
197801|NCT01070550|628226|P6|Overall Study|Miscellaneous|0
197802|NCT01070550|628227|P5|Overall Study|Miscellaneous|0
197803|NCT01070550|628228|P4|Overall Study|Miscellaneous|1
197804|NCT01070550|628229|P3|Overall Study|Miscellaneous|3
197805|NCT01070550|628230|P2|Overall Study|Miscellaneous|2
197806|NCT01070550|628231|P1|Overall Study|Miscellaneous|12
197807|NCT01070550|628226|P6|Overall Study|Lack of Efficacy|1
197808|NCT01070550|628227|P5|Overall Study|Lack of Efficacy|0
197809|NCT01070550|628228|P4|Overall Study|Lack of Efficacy|5
197810|NCT01070550|628229|P3|Overall Study|Lack of Efficacy|5
197811|NCT01070550|628230|P2|Overall Study|Lack of Efficacy|1
197812|NCT01070550|628231|P1|Overall Study|Lack of Efficacy|65
197813|NCT01070550|628226|P6|Overall Study|Lab test not done|1
197814|NCT01070550|628227|P5|Overall Study|Lab test not done|0
197815|NCT01070550|628228|P4|Overall Study|Lab test not done|1
197816|NCT01070550|628229|P3|Overall Study|Lab test not done|4
197817|NCT01070550|628230|P2|Overall Study|Lab test not done|3
197818|NCT01070550|628231|P1|Overall Study|Lab test not done|22
197819|NCT01070550|628226|P6|Overall Study|Incomplete treatment|0
197820|NCT01070550|628227|P5|Overall Study|Incomplete treatment|0
197821|NCT01070550|628228|P4|Overall Study|Incomplete treatment|0
197822|NCT01070550|628229|P3|Overall Study|Incomplete treatment|0
197823|NCT01070550|628230|P2|Overall Study|Incomplete treatment|0
197824|NCT01070550|628231|P1|Overall Study|Incomplete treatment|2
197825|NCT01070550|628226|P6|Overall Study|Failed to return|2
197826|NCT01070550|628227|P5|Overall Study|Failed to return|1
197827|NCT01070550|628228|P4|Overall Study|Failed to return|40
197828|NCT01070550|628229|P3|Overall Study|Failed to return|144
197829|NCT01070550|628230|P2|Overall Study|Failed to return|33
197830|NCT01070550|628231|P1|Overall Study|Failed to return|450
197831|NCT01070550|628226|P6|Overall Study|Early termination|0
197832|NCT01070550|628227|P5|Overall Study|Early termination|0
197833|NCT01070550|628228|P4|Overall Study|Early termination|0
197834|NCT01070550|628229|P3|Overall Study|Early termination|0
197835|NCT01070550|628230|P2|Overall Study|Early termination|0
197836|NCT01070550|628231|P1|Overall Study|Early termination|3
197837|NCT01070550|628226|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
197838|NCT01070550|628227|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
197839|NCT01070550|628228|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
197840|NCT01070550|628229|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
197841|NCT01070550|628230|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
197842|NCT01070550|628231|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
197843|NCT01070550|628226|P6|Overall Study|Death|0
197844|NCT01070550|628227|P5|Overall Study|Death|0
197845|NCT01070550|628228|P4|Overall Study|Death|0
197846|NCT01070550|628229|P3|Overall Study|Death|3
197847|NCT01070550|628230|P2|Overall Study|Death|4
197848|NCT01070550|628231|P1|Overall Study|Death|20
197849|NCT01070550|628226|P6|Overall Study|Adverse Event|0
197850|NCT01070550|628227|P5|Overall Study|Adverse Event|0
197851|NCT01070550|628228|P4|Overall Study|Adverse Event|0
197852|NCT01070550|628229|P3|Overall Study|Adverse Event|3
197853|NCT01070550|628230|P2|Overall Study|Adverse Event|1
197854|NCT01070550|628231|P1|Overall Study|Adverse Event|43
197855|NCT01070771|628371|P1|Overall Study|Protocol Violation|1
197856|NCT01070771|628371|P1|Overall Study|Adverse Event|2
197857|NCT01070784|628378|P2|Overall Study|Adverse Event|9
197858|NCT01070784|628379|P1|Overall Study|Adverse Event|14
197859|NCT01070784|628378|P2|Overall Study|Withdrawal by Subject|9
197860|NCT01070784|628379|P1|Overall Study|Withdrawal by Subject|6
197861|NCT01070888|628486|P2|Washout (14 Days)|Physician Decision|0
197862|NCT01070888|628487|P1|Washout (14 Days)|Physician Decision|1
197863|NCT01070888|628486|P2|First Intervention (14 Days)|Lost to Follow-up|1
197864|NCT01070888|628487|P1|First Intervention (14 Days)|Lost to Follow-up|0
197865|NCT01070888|628486|P2|First Intervention (14 Days)|Adverse Event|1
197866|NCT01070888|628487|P1|First Intervention (14 Days)|Adverse Event|0
197867|NCT01070953|628493|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
197868|NCT01070953|628493|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
197869|NCT01070953|628493|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
197870|NCT01070953|628493|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
197871|NCT01070953|628493|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
197872|NCT01070953|628493|P1|Participants for Safety Evaluation|Uncontracted participants|4
197873|NCT01070953|628493|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
197874|NCT01070953|628493|P1|Participants for Safety Evaluation|Duplicated participants|22
197875|NCT01070953|628493|P1|Participants for Safety Evaluation|Off-label use|283
197876|NCT01070953|628493|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
197877|NCT01070966|628504|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
197878|NCT01070966|628504|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
197879|NCT01070966|628504|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
197880|NCT01070966|628504|P1|Participants for Safety Evaluation|TMT given before date of contract|3
197881|NCT01070966|628504|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
197882|NCT01070966|628504|P1|Participants for Safety Evaluation|Duplicate Participants|4
197883|NCT01070966|628504|P1|Participants for Safety Evaluation|Off-label use|9
197884|NCT01070966|628504|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
197885|NCT01070979|628518|P3|Overall Study|No study drug taken|0
197886|NCT01070979|628519|P2|Overall Study|No study drug taken|1
197887|NCT01070979|628520|P1|Overall Study|No study drug taken|0
197888|NCT01070979|628518|P3|Overall Study|Withdrawal by Subject|1
197889|NCT01070979|628519|P2|Overall Study|Withdrawal by Subject|1
197890|NCT01070979|628520|P1|Overall Study|Withdrawal by Subject|3
197891|NCT01070979|628518|P3|Overall Study|Surgery, moving, personal, abn. labs|2
197892|NCT01070979|628519|P2|Overall Study|Surgery, moving, personal, abn. labs|4
197893|NCT01070979|628520|P1|Overall Study|Surgery, moving, personal, abn. labs|4
197894|NCT01070979|628518|P3|Overall Study|Protocol Violation|6
197895|NCT01070979|628519|P2|Overall Study|Protocol Violation|2
197896|NCT01070979|628520|P1|Overall Study|Protocol Violation|0
197897|NCT01070979|628518|P3|Overall Study|Lost to Follow-up|1
197898|NCT01070979|628519|P2|Overall Study|Lost to Follow-up|1
197899|NCT01070979|628520|P1|Overall Study|Lost to Follow-up|2
197900|NCT01070979|628518|P3|Overall Study|Adverse Event|3
197901|NCT01070979|628519|P2|Overall Study|Adverse Event|3
197902|NCT01070979|628520|P1|Overall Study|Adverse Event|2
197903|NCT01071070|628569|P2|Overall Study|Hypercalcemia|0
197904|NCT01071070|628570|P1|Overall Study|Hypercalcemia|1
197905|NCT01071070|628569|P2|Overall Study|Missed 3 consecutive doses of study drug|0
197906|NCT01071070|628570|P1|Overall Study|Missed 3 consecutive doses of study drug|2
197907|NCT01071070|628569|P2|Overall Study|Withdrawal by Subject|0
197908|NCT01071070|628570|P1|Overall Study|Withdrawal by Subject|1
197909|NCT01071070|628569|P2|Overall Study|Adverse Event|3
197910|NCT01071070|628570|P1|Overall Study|Adverse Event|0
197911|NCT01071083|628597|P5|Overall Study|Subject Refused to Continue|0
197912|NCT01071083|628598|P4|Overall Study|Subject Refused to Continue|0
197913|NCT01071083|628599|P3|Overall Study|Subject Refused to Continue|0
197914|NCT01071083|628600|P2|Overall Study|Subject Refused to Continue|0
197915|NCT01071083|628601|P1|Overall Study|Subject Refused to Continue|1
197916|NCT01071083|628597|P5|Overall Study|Did Not Want Per Protocol Treatment|1
197917|NCT01071083|628598|P4|Overall Study|Did Not Want Per Protocol Treatment|0
197918|NCT01071083|628599|P3|Overall Study|Did Not Want Per Protocol Treatment|1
197919|NCT01071083|628600|P2|Overall Study|Did Not Want Per Protocol Treatment|0
197920|NCT01071083|628601|P1|Overall Study|Did Not Want Per Protocol Treatment|0
197921|NCT01071083|628597|P5|Overall Study|Did Not Meet Eligibility Criteria|1
197922|NCT01071083|628598|P4|Overall Study|Did Not Meet Eligibility Criteria|1
197923|NCT01071083|628599|P3|Overall Study|Did Not Meet Eligibility Criteria|1
197924|NCT01071083|628600|P2|Overall Study|Did Not Meet Eligibility Criteria|0
197925|NCT01071083|628601|P1|Overall Study|Did Not Meet Eligibility Criteria|0
197926|NCT01071083|628597|P5|Overall Study|Images Not Usable (Motion)|0
197927|NCT01071083|628598|P4|Overall Study|Images Not Usable (Motion)|0
197928|NCT01071083|628599|P3|Overall Study|Images Not Usable (Motion)|0
197929|NCT01071083|628600|P2|Overall Study|Images Not Usable (Motion)|1
197930|NCT01071083|628601|P1|Overall Study|Images Not Usable (Motion)|0
197931|NCT01071083|628597|P5|Overall Study|Subject Moved|0
197932|NCT01071083|628598|P4|Overall Study|Subject Moved|0
197933|NCT01071083|628599|P3|Overall Study|Subject Moved|0
197934|NCT01071083|628600|P2|Overall Study|Subject Moved|1
197935|NCT01071083|628601|P1|Overall Study|Subject Moved|0
197936|NCT01071083|628597|P5|Overall Study|Early Rescue|1
197937|NCT01071083|628598|P4|Overall Study|Early Rescue|0
197938|NCT01071083|628599|P3|Overall Study|Early Rescue|0
197939|NCT01071083|628600|P2|Overall Study|Early Rescue|0
197940|NCT01071083|628601|P1|Overall Study|Early Rescue|1
197941|NCT01071083|628597|P5|Overall Study|Physician Decision|1
197942|NCT01071083|628598|P4|Overall Study|Physician Decision|1
197943|NCT01071083|628599|P3|Overall Study|Physician Decision|0
197944|NCT01071083|628600|P2|Overall Study|Physician Decision|0
197945|NCT01071083|628601|P1|Overall Study|Physician Decision|1
197946|NCT01071083|628597|P5|Overall Study|Withdrawal by Subject|3
197947|NCT01071083|628598|P4|Overall Study|Withdrawal by Subject|0
197948|NCT01071083|628599|P3|Overall Study|Withdrawal by Subject|2
197949|NCT01071083|628600|P2|Overall Study|Withdrawal by Subject|0
197950|NCT01071083|628601|P1|Overall Study|Withdrawal by Subject|3
197951|NCT01071083|628597|P5|Overall Study|Adverse Event|1
197952|NCT01071083|628598|P4|Overall Study|Adverse Event|0
197953|NCT01071083|628599|P3|Overall Study|Adverse Event|1
197954|NCT01071083|628600|P2|Overall Study|Adverse Event|0
197955|NCT01071083|628601|P1|Overall Study|Adverse Event|1
197956|NCT01071096|628618|P2|First Intervention (90 Days)|Lost to Follow-up|0
197957|NCT01071096|628619|P1|First Intervention (90 Days)|Lost to Follow-up|1
197958|NCT01071200|628640|P2|Overall Study|No viable embryos|1
197959|NCT01071200|628641|P1|Overall Study|No viable embryos|0
197960|NCT01071200|628640|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
197961|NCT01071200|628641|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
197962|NCT01071200|628640|P2|Overall Study|No oocytes retrieved|1
197963|NCT01071200|628641|P1|Overall Study|No oocytes retrieved|1
197964|NCT01071200|628640|P2|Overall Study|No fertilization|0
197965|NCT01071200|628641|P1|Overall Study|No fertilization|4
197966|NCT01071200|628640|P2|Overall Study|Lack of ovarian response|1
197967|NCT01071200|628641|P1|Overall Study|Lack of ovarian response|1
197968|NCT01071252|628678|P5|Overall Study|Death|1
197969|NCT01071252|628679|P4|Overall Study|Death|0
197970|NCT01071252|628680|P3|Overall Study|Death|0
197971|NCT01071252|628681|P2|Overall Study|Death|0
197972|NCT01071252|628682|P1|Overall Study|Death|0
197973|NCT01071252|628678|P5|Overall Study|Adverse Event|0
197974|NCT01071252|628679|P4|Overall Study|Adverse Event|1
197975|NCT01071252|628680|P3|Overall Study|Adverse Event|0
197976|NCT01071252|628681|P2|Overall Study|Adverse Event|1
197977|NCT01071252|628682|P1|Overall Study|Adverse Event|1
197978|NCT01071252|628678|P5|Overall Study|Lost to Follow-up|0
197979|NCT01071252|628679|P4|Overall Study|Lost to Follow-up|2
197980|NCT01071252|628680|P3|Overall Study|Lost to Follow-up|1
197981|NCT01071252|628681|P2|Overall Study|Lost to Follow-up|0
197982|NCT01071252|628682|P1|Overall Study|Lost to Follow-up|1
197983|NCT01071252|628678|P5|Overall Study|administrative problems|1
197984|NCT01071252|628679|P4|Overall Study|administrative problems|2
197985|NCT01071252|628680|P3|Overall Study|administrative problems|0
197986|NCT01071252|628681|P2|Overall Study|administrative problems|1
197987|NCT01071252|628682|P1|Overall Study|administrative problems|1
197988|NCT01071252|628678|P5|Overall Study|Withdrawal by Subject|3
197989|NCT01071252|628679|P4|Overall Study|Withdrawal by Subject|2
197990|NCT01071252|628680|P3|Overall Study|Withdrawal by Subject|1
197991|NCT01071252|628681|P2|Overall Study|Withdrawal by Subject|2
197992|NCT01071252|628682|P1|Overall Study|Withdrawal by Subject|8
197993|NCT01071252|628678|P5|Overall Study|unsatisfactory therapeutic effect|6
197994|NCT01071252|628679|P4|Overall Study|unsatisfactory therapeutic effect|0
197995|NCT01071252|628680|P3|Overall Study|unsatisfactory therapeutic effect|2
197996|NCT01071252|628681|P2|Overall Study|unsatisfactory therapeutic effect|6
197997|NCT01071252|628682|P1|Overall Study|unsatisfactory therapeutic effect|4
197998|NCT01071278|628708|P1|Overall Study|Completion Status Unknown|459
197999|NCT01071278|628708|P1|Overall Study|Premature Discontinuation|254
198000|NCT01071395|628716|P2|Overall Study|Adverse Event|1
198001|NCT01071395|628717|P1|Overall Study|Adverse Event|3
198002|NCT01071395|628716|P2|Overall Study|Withdrawal by Subject|1
198003|NCT01071395|628717|P1|Overall Study|Withdrawal by Subject|2
198004|NCT01071798|628733|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
198005|NCT01071798|628733|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
198006|NCT01071798|628733|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
198007|NCT01071798|628733|P1|Subpopulation Who Received Two Cycles|Remission|1
198008|NCT01071798|628733|P1|Participants Who Received One Cycle|Severe concomitant disease|2
198009|NCT01071798|628733|P1|Participants Who Received One Cycle|Change of therapy|6
198010|NCT01071798|628733|P1|Participants Who Received One Cycle|Death|5
198011|NCT01071798|628733|P1|Participants Who Received One Cycle|Patient requirement|20
198012|NCT01071798|628733|P1|Participants Who Received One Cycle|Lack of tolerability|14
198013|NCT01071798|628733|P1|Participants Who Received One Cycle|Lack of Efficacy|18
198014|NCT01071915|628753|P1|Overall Study|Miscellaneous Reasons|2
198015|NCT01071915|628753|P1|Overall Study|Withdrawal by Subject|2
198016|NCT01071915|628753|P1|Overall Study|Physician Decision|2
198017|NCT01071915|628753|P1|Overall Study|Adverse Event|3
198018|NCT01072149|628825|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198019|NCT01072149|628826|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198020|NCT01072149|628827|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198021|NCT01072149|628828|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198022|NCT01072149|628829|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
198023|NCT01072149|628830|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198024|NCT01072149|628831|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198025|NCT01072149|628832|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198026|NCT01072149|628833|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198027|NCT01072149|628834|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198028|NCT01072149|628835|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198029|NCT01072149|628836|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198030|NCT01072149|628837|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198031|NCT01072149|628838|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198032|NCT01072149|628839|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198033|NCT01072149|628840|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
198034|NCT01072149|628841|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198035|NCT01072149|628842|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
198036|NCT01072149|628825|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
198037|NCT01072149|628826|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
198038|NCT01072149|628827|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
198039|NCT01072149|628828|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
198040|NCT01072149|628829|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
198041|NCT01072149|628830|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
198042|NCT01072149|628831|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
198043|NCT01072149|628832|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
198044|NCT01072149|628833|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
198045|NCT01072149|628834|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
198046|NCT01072149|628835|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
198047|NCT01072149|628836|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
198048|NCT01072149|628837|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
198049|NCT01072149|628838|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
198050|NCT01072149|628839|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
198051|NCT01072149|628840|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
198052|NCT01072149|628841|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
198053|NCT01072149|628842|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
198054|NCT01072149|628825|P18|Washout Period 2 (14 Days)|Adverse Event|0
198055|NCT01072149|628826|P17|Washout Period 2 (14 Days)|Adverse Event|0
198056|NCT01072149|628827|P16|Washout Period 2 (14 Days)|Adverse Event|1
198057|NCT01072149|628828|P15|Washout Period 2 (14 Days)|Adverse Event|0
198058|NCT01072149|628829|P14|Washout Period 2 (14 Days)|Adverse Event|0
198059|NCT01072149|628830|P13|Washout Period 2 (14 Days)|Adverse Event|0
198060|NCT01072149|628831|P12|Washout Period 2 (14 Days)|Adverse Event|0
198061|NCT01072149|628832|P11|Washout Period 2 (14 Days)|Adverse Event|0
198062|NCT01072149|628833|P10|Washout Period 2 (14 Days)|Adverse Event|0
198063|NCT01072149|628834|P9|Washout Period 2 (14 Days)|Adverse Event|0
198064|NCT01072149|628835|P8|Washout Period 2 (14 Days)|Adverse Event|0
198065|NCT01072149|628836|P7|Washout Period 2 (14 Days)|Adverse Event|0
198066|NCT01072149|628837|P6|Washout Period 2 (14 Days)|Adverse Event|0
198067|NCT01072149|628838|P5|Washout Period 2 (14 Days)|Adverse Event|0
198068|NCT01072149|628839|P4|Washout Period 2 (14 Days)|Adverse Event|0
198069|NCT01072149|628840|P3|Washout Period 2 (14 Days)|Adverse Event|0
198070|NCT01072149|628841|P2|Washout Period 2 (14 Days)|Adverse Event|0
198071|NCT01072149|628842|P1|Washout Period 2 (14 Days)|Adverse Event|0
198072|NCT01072149|628825|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198073|NCT01072149|628826|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198074|NCT01072149|628827|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
198075|NCT01072149|628828|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198076|NCT01072149|628829|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198077|NCT01072149|628830|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198078|NCT01072149|628831|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198079|NCT01072149|628832|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198080|NCT01072149|628833|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198081|NCT01072149|628834|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198082|NCT01072149|628835|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198083|NCT01072149|628836|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198084|NCT01072149|628837|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198085|NCT01072149|628838|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198086|NCT01072149|628839|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198087|NCT01072149|628840|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198088|NCT01072149|628841|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198089|NCT01072149|628842|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
198090|NCT01072149|628825|P18|Washout Period 2 (14 Days)|Physician Decision|0
198091|NCT01072149|628826|P17|Washout Period 2 (14 Days)|Physician Decision|0
198092|NCT01072149|628827|P16|Washout Period 2 (14 Days)|Physician Decision|0
198093|NCT01072149|628828|P15|Washout Period 2 (14 Days)|Physician Decision|0
198094|NCT01072149|628829|P14|Washout Period 2 (14 Days)|Physician Decision|0
198095|NCT01072149|628830|P13|Washout Period 2 (14 Days)|Physician Decision|0
198096|NCT01072149|628831|P12|Washout Period 2 (14 Days)|Physician Decision|0
198097|NCT01072149|628832|P11|Washout Period 2 (14 Days)|Physician Decision|0
198098|NCT01072149|628833|P10|Washout Period 2 (14 Days)|Physician Decision|0
198099|NCT01072149|628834|P9|Washout Period 2 (14 Days)|Physician Decision|0
198100|NCT01072149|628835|P8|Washout Period 2 (14 Days)|Physician Decision|0
198101|NCT01072149|628836|P7|Washout Period 2 (14 Days)|Physician Decision|0
198102|NCT01072149|628837|P6|Washout Period 2 (14 Days)|Physician Decision|0
198103|NCT01072149|628838|P5|Washout Period 2 (14 Days)|Physician Decision|0
198104|NCT01072149|628839|P4|Washout Period 2 (14 Days)|Physician Decision|0
198105|NCT01072149|628840|P3|Washout Period 2 (14 Days)|Physician Decision|0
198106|NCT01072149|628841|P2|Washout Period 2 (14 Days)|Physician Decision|0
198107|NCT01072149|628842|P1|Washout Period 2 (14 Days)|Physician Decision|1
198108|NCT01072149|628825|P18|Treatment Period 2 (28 Days)|Physician Decision|0
198109|NCT01072149|628826|P17|Treatment Period 2 (28 Days)|Physician Decision|0
198110|NCT01072149|628827|P16|Treatment Period 2 (28 Days)|Physician Decision|0
198111|NCT01072149|628828|P15|Treatment Period 2 (28 Days)|Physician Decision|0
198112|NCT01072149|628829|P14|Treatment Period 2 (28 Days)|Physician Decision|0
198113|NCT01072149|628830|P13|Treatment Period 2 (28 Days)|Physician Decision|0
198114|NCT01072149|628831|P12|Treatment Period 2 (28 Days)|Physician Decision|0
198115|NCT01072149|628832|P11|Treatment Period 2 (28 Days)|Physician Decision|0
198116|NCT01072149|628833|P10|Treatment Period 2 (28 Days)|Physician Decision|0
198117|NCT01072149|628834|P9|Treatment Period 2 (28 Days)|Physician Decision|0
198118|NCT01072149|628835|P8|Treatment Period 2 (28 Days)|Physician Decision|1
198119|NCT01072149|628836|P7|Treatment Period 2 (28 Days)|Physician Decision|0
198120|NCT01072149|628837|P6|Treatment Period 2 (28 Days)|Physician Decision|0
198121|NCT01072149|628838|P5|Treatment Period 2 (28 Days)|Physician Decision|0
198122|NCT01072149|628839|P4|Treatment Period 2 (28 Days)|Physician Decision|0
198123|NCT01072149|628840|P3|Treatment Period 2 (28 Days)|Physician Decision|0
198124|NCT01072149|628841|P2|Treatment Period 2 (28 Days)|Physician Decision|0
198125|NCT01072149|628842|P1|Treatment Period 2 (28 Days)|Physician Decision|0
198126|NCT01072149|628825|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198127|NCT01072149|628826|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198128|NCT01072149|628827|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198129|NCT01072149|628828|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198130|NCT01072149|628829|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198131|NCT01072149|628830|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198132|NCT01072149|628831|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198133|NCT01072149|628832|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198134|NCT01072149|628833|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198135|NCT01072149|628834|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198136|NCT01072149|628835|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198137|NCT01072149|628836|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198138|NCT01072149|628837|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198139|NCT01072149|628838|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198140|NCT01072149|628839|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198141|NCT01072149|628840|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
198142|NCT01072149|628841|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198143|NCT01072149|628842|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
198144|NCT01072149|628825|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198145|NCT01072149|628826|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198146|NCT01072149|628827|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198147|NCT01072149|628828|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198148|NCT01072149|628829|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198149|NCT01072149|628830|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198150|NCT01072149|628831|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198151|NCT01072149|628832|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198152|NCT01072149|628833|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198153|NCT01072149|628834|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198154|NCT01072149|628835|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198155|NCT01072149|628836|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198156|NCT01072149|628837|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198157|NCT01072149|628838|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198158|NCT01072149|628839|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198159|NCT01072149|628840|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198160|NCT01072149|628841|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
198161|NCT01072149|628842|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
198162|NCT01072149|628825|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198163|NCT01072149|628826|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198164|NCT01072149|628827|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198165|NCT01072149|628828|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198166|NCT01072149|628829|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198167|NCT01072149|628830|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198168|NCT01072149|628831|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198169|NCT01072149|628832|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
198170|NCT01072149|628833|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198171|NCT01072149|628834|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198172|NCT01072149|628835|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198173|NCT01072149|628836|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198174|NCT01072149|628837|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198175|NCT01072149|628838|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198176|NCT01072149|628839|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198177|NCT01072149|628840|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198178|NCT01072149|628841|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198179|NCT01072149|628842|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
198180|NCT01072149|628825|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
198181|NCT01072149|628826|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
198182|NCT01072149|628827|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
198183|NCT01072149|628828|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
198184|NCT01072149|628829|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
198185|NCT01072149|628830|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
198186|NCT01072149|628831|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
198187|NCT01072149|628832|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
198188|NCT01072149|628833|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
198189|NCT01072149|628834|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
198190|NCT01072149|628835|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
198191|NCT01072149|628836|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
198192|NCT01072149|628837|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
198193|NCT01072149|628838|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
198194|NCT01072149|628839|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
198195|NCT01072149|628840|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
198196|NCT01072149|628841|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
198197|NCT01072149|628842|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
198198|NCT01072149|628825|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198199|NCT01072149|628826|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198200|NCT01072149|628827|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198201|NCT01072149|628828|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198202|NCT01072149|628829|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198203|NCT01072149|628830|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198204|NCT01072149|628831|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198205|NCT01072149|628832|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198206|NCT01072149|628833|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198207|NCT01072149|628834|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198208|NCT01072149|628835|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198209|NCT01072149|628836|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198210|NCT01072149|628837|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198211|NCT01072149|628838|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198212|NCT01072149|628839|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198213|NCT01072149|628840|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
198214|NCT01072149|628841|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198215|NCT01072149|628842|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
198216|NCT01072175|628872|P13|Part D (HPMC Capsules)|Ongoing|34
198217|NCT01072175|628873|P12|Part D (HPMC Capsules)|Ongoing|34
198218|NCT01072175|628874|P11|Part D (HPMC Capsules)|Ongoing|12
198219|NCT01072175|628875|P10|Part D (HPMC Capsules)|Ongoing|10
198220|NCT01072175|628876|P9|Part D (HPMC Capsules)|Ongoing|0
198221|NCT01072175|628877|P8|Part D (HPMC Capsules)|Ongoing|0
198222|NCT01072175|628878|P7|Part D (HPMC Capsules)|Ongoing|0
198223|NCT01072175|628879|P6|Part D (HPMC Capsules)|Ongoing|0
198224|NCT01072175|628880|P5|Part D (HPMC Capsules)|Ongoing|0
198225|NCT01072175|628881|P4|Part D (HPMC Capsules)|Ongoing|0
198226|NCT01072175|628882|P3|Part D (HPMC Capsules)|Ongoing|0
198227|NCT01072175|628883|P2|Part D (HPMC Capsules)|Ongoing|0
198228|NCT01072175|628884|P1|Part D (HPMC Capsules)|Ongoing|0
198229|NCT01072175|628872|P13|Part D (HPMC Capsules)|Death|5
198230|NCT01072175|628873|P12|Part D (HPMC Capsules)|Death|6
198231|NCT01072175|628874|P11|Part D (HPMC Capsules)|Death|4
198232|NCT01072175|628875|P10|Part D (HPMC Capsules)|Death|2
198233|NCT01072175|628876|P9|Part D (HPMC Capsules)|Death|0
198234|NCT01072175|628877|P8|Part D (HPMC Capsules)|Death|0
198235|NCT01072175|628878|P7|Part D (HPMC Capsules)|Death|0
198236|NCT01072175|628879|P6|Part D (HPMC Capsules)|Death|0
198237|NCT01072175|628880|P5|Part D (HPMC Capsules)|Death|0
198238|NCT01072175|628881|P4|Part D (HPMC Capsules)|Death|0
198239|NCT01072175|628882|P3|Part D (HPMC Capsules)|Death|0
198240|NCT01072175|628883|P2|Part D (HPMC Capsules)|Death|0
198241|NCT01072175|628884|P1|Part D (HPMC Capsules)|Death|0
198242|NCT01072175|628872|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
198243|NCT01072175|628873|P12|Part D (HPMC Capsules)|Withdrawal by Subject|1
198244|NCT01072175|628874|P11|Part D (HPMC Capsules)|Withdrawal by Subject|0
198245|NCT01072175|628875|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
198246|NCT01072175|628876|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
198247|NCT01072175|628877|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
198248|NCT01072175|628878|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
198249|NCT01072175|628879|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
198250|NCT01072175|628880|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
198251|NCT01072175|628881|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
198252|NCT01072175|628882|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
198253|NCT01072175|628883|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
198254|NCT01072175|628884|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
198255|NCT01072175|628872|P13|Part D (HPMC Capsules)|Lost to Follow-up|0
198256|NCT01072175|628873|P12|Part D (HPMC Capsules)|Lost to Follow-up|2
198257|NCT01072175|628874|P11|Part D (HPMC Capsules)|Lost to Follow-up|0
198258|NCT01072175|628875|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
198259|NCT01072175|628876|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
198260|NCT01072175|628877|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
198261|NCT01072175|628878|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
198262|NCT01072175|628879|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
198263|NCT01072175|628880|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
198264|NCT01072175|628881|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
198265|NCT01072175|628882|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
198266|NCT01072175|628883|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
198267|NCT01072175|628884|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
198268|NCT01072175|628872|P13|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198269|NCT01072175|628873|P12|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198270|NCT01072175|628874|P11|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198271|NCT01072175|628875|P10|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198272|NCT01072175|628876|P9|Part C (Phase II: Crossover Phase [CP])|Ongoing|28
198273|NCT01072175|628877|P8|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198274|NCT01072175|628878|P7|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198275|NCT01072175|628879|P6|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198276|NCT01072175|628880|P5|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198277|NCT01072175|628881|P4|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198278|NCT01072175|628882|P3|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198279|NCT01072175|628883|P2|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198280|NCT01072175|628884|P1|Part C (Phase II: Crossover Phase [CP])|Ongoing|0
198281|NCT01072175|628872|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
198282|NCT01072175|628873|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
198283|NCT01072175|628874|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
198284|NCT01072175|628875|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
198285|NCT01072175|628876|P9|Part C (Phase II: Crossover Phase [CP])|Death|15
198286|NCT01072175|628877|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
198287|NCT01072175|628878|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
198288|NCT01072175|628879|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
198289|NCT01072175|628880|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
198290|NCT01072175|628881|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
198291|NCT01072175|628882|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
198292|NCT01072175|628883|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
198293|NCT01072175|628884|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
198294|NCT01072175|628872|P13|Part C (Phase II: Randomized Phase)|Ongoing|0
198295|NCT01072175|628873|P12|Part C (Phase II: Randomized Phase)|Ongoing|0
198296|NCT01072175|628874|P11|Part C (Phase II: Randomized Phase)|Ongoing|0
198297|NCT01072175|628875|P10|Part C (Phase II: Randomized Phase)|Ongoing|0
198298|NCT01072175|628876|P9|Part C (Phase II: Randomized Phase)|Ongoing|0
198299|NCT01072175|628877|P8|Part C (Phase II: Randomized Phase)|Ongoing|40
198300|NCT01072175|628878|P7|Part C (Phase II: Randomized Phase)|Ongoing|32
198301|NCT01072175|628879|P6|Part C (Phase II: Randomized Phase)|Ongoing|35
198302|NCT01072175|628880|P5|Part C (Phase II: Randomized Phase)|Ongoing|0
198303|NCT01072175|628881|P4|Part C (Phase II: Randomized Phase)|Ongoing|0
198304|NCT01072175|628882|P3|Part C (Phase II: Randomized Phase)|Ongoing|0
198305|NCT01072175|628883|P2|Part C (Phase II: Randomized Phase)|Ongoing|0
198306|NCT01072175|628884|P1|Part C (Phase II: Randomized Phase)|Ongoing|0
198307|NCT01072175|628872|P13|Part C (Phase II: Randomized Phase)|Death|0
198308|NCT01072175|628873|P12|Part C (Phase II: Randomized Phase)|Death|0
198309|NCT01072175|628874|P11|Part C (Phase II: Randomized Phase)|Death|0
198310|NCT01072175|628875|P10|Part C (Phase II: Randomized Phase)|Death|0
198311|NCT01072175|628876|P9|Part C (Phase II: Randomized Phase)|Death|0
198312|NCT01072175|628877|P8|Part C (Phase II: Randomized Phase)|Death|14
198313|NCT01072175|628878|P7|Part C (Phase II: Randomized Phase)|Death|18
198314|NCT01072175|628879|P6|Part C (Phase II: Randomized Phase)|Death|19
198315|NCT01072175|628880|P5|Part C (Phase II: Randomized Phase)|Death|0
198316|NCT01072175|628881|P4|Part C (Phase II: Randomized Phase)|Death|0
198317|NCT01072175|628882|P3|Part C (Phase II: Randomized Phase)|Death|0
198318|NCT01072175|628883|P2|Part C (Phase II: Randomized Phase)|Death|0
198319|NCT01072175|628884|P1|Part C (Phase II: Randomized Phase)|Death|0
198320|NCT01072175|628872|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198321|NCT01072175|628873|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198322|NCT01072175|628874|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198323|NCT01072175|628875|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198324|NCT01072175|628876|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198325|NCT01072175|628877|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198326|NCT01072175|628878|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|4
198327|NCT01072175|628879|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198328|NCT01072175|628880|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198329|NCT01072175|628881|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198330|NCT01072175|628882|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198331|NCT01072175|628883|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198332|NCT01072175|628884|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
198333|NCT01072175|628872|P13|Part B (Dose Escalation and Expansion)|Ongoing|0
198334|NCT01072175|628873|P12|Part B (Dose Escalation and Expansion)|Ongoing|0
198335|NCT01072175|628874|P11|Part B (Dose Escalation and Expansion)|Ongoing|0
198336|NCT01072175|628875|P10|Part B (Dose Escalation and Expansion)|Ongoing|0
198337|NCT01072175|628876|P9|Part B (Dose Escalation and Expansion)|Ongoing|0
198338|NCT01072175|628877|P8|Part B (Dose Escalation and Expansion)|Ongoing|0
198339|NCT01072175|628878|P7|Part B (Dose Escalation and Expansion)|Ongoing|0
198340|NCT01072175|628879|P6|Part B (Dose Escalation and Expansion)|Ongoing|0
198341|NCT01072175|628880|P5|Part B (Dose Escalation and Expansion)|Ongoing|28
198342|NCT01072175|628881|P4|Part B (Dose Escalation and Expansion)|Ongoing|9
198343|NCT01072175|628882|P3|Part B (Dose Escalation and Expansion)|Ongoing|10
198344|NCT01072175|628883|P2|Part B (Dose Escalation and Expansion)|Ongoing|2
198345|NCT01072175|628884|P1|Part B (Dose Escalation and Expansion)|Ongoing|0
198346|NCT01072175|628872|P13|Part B (Dose Escalation and Expansion)|Death|0
198347|NCT01072175|628873|P12|Part B (Dose Escalation and Expansion)|Death|0
198348|NCT01072175|628874|P11|Part B (Dose Escalation and Expansion)|Death|0
198349|NCT01072175|628875|P10|Part B (Dose Escalation and Expansion)|Death|0
198350|NCT01072175|628876|P9|Part B (Dose Escalation and Expansion)|Death|0
198351|NCT01072175|628877|P8|Part B (Dose Escalation and Expansion)|Death|0
198352|NCT01072175|628878|P7|Part B (Dose Escalation and Expansion)|Death|0
198353|NCT01072175|628879|P6|Part B (Dose Escalation and Expansion)|Death|0
198354|NCT01072175|628880|P5|Part B (Dose Escalation and Expansion)|Death|36
198355|NCT01072175|628881|P4|Part B (Dose Escalation and Expansion)|Death|12
198356|NCT01072175|628882|P3|Part B (Dose Escalation and Expansion)|Death|10
198357|NCT01072175|628883|P2|Part B (Dose Escalation and Expansion)|Death|3
198358|NCT01072175|628884|P1|Part B (Dose Escalation and Expansion)|Death|0
198359|NCT01072175|628872|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198360|NCT01072175|628873|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198361|NCT01072175|628874|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198362|NCT01072175|628875|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198363|NCT01072175|628876|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198364|NCT01072175|628877|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198365|NCT01072175|628878|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198366|NCT01072175|628879|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198367|NCT01072175|628880|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
198368|NCT01072175|628881|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|2
198369|NCT01072175|628882|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198370|NCT01072175|628883|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198371|NCT01072175|628884|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
198372|NCT01072175|628872|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
198373|NCT01072175|628873|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
198374|NCT01072175|628874|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
198375|NCT01072175|628875|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
198376|NCT01072175|628876|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
198377|NCT01072175|628877|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
198378|NCT01072175|628878|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
198379|NCT01072175|628879|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
198380|NCT01072175|628880|P5|Part B (Dose Escalation and Expansion)|Physician Decision|13
198381|NCT01072175|628881|P4|Part B (Dose Escalation and Expansion)|Physician Decision|4
198382|NCT01072175|628882|P3|Part B (Dose Escalation and Expansion)|Physician Decision|3
198383|NCT01072175|628883|P2|Part B (Dose Escalation and Expansion)|Physician Decision|1
198384|NCT01072175|628884|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
198385|NCT01072175|628872|P13|Part A (Drug-Drug Interaction)|Death|0
198386|NCT01072175|628873|P12|Part A (Drug-Drug Interaction)|Death|0
198387|NCT01072175|628874|P11|Part A (Drug-Drug Interaction)|Death|0
198388|NCT01072175|628875|P10|Part A (Drug-Drug Interaction)|Death|0
198389|NCT01072175|628876|P9|Part A (Drug-Drug Interaction)|Death|0
198390|NCT01072175|628877|P8|Part A (Drug-Drug Interaction)|Death|0
198391|NCT01072175|628878|P7|Part A (Drug-Drug Interaction)|Death|0
198392|NCT01072175|628879|P6|Part A (Drug-Drug Interaction)|Death|0
198393|NCT01072175|628880|P5|Part A (Drug-Drug Interaction)|Death|0
198394|NCT01072175|628881|P4|Part A (Drug-Drug Interaction)|Death|0
198395|NCT01072175|628882|P3|Part A (Drug-Drug Interaction)|Death|0
198396|NCT01072175|628883|P2|Part A (Drug-Drug Interaction)|Death|0
198397|NCT01072175|628884|P1|Part A (Drug-Drug Interaction)|Death|1
198398|NCT01072175|628872|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198399|NCT01072175|628873|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198400|NCT01072175|628874|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198401|NCT01072175|628875|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198402|NCT01072175|628876|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198403|NCT01072175|628877|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198404|NCT01072175|628878|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198405|NCT01072175|628879|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198406|NCT01072175|628880|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198407|NCT01072175|628881|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198408|NCT01072175|628882|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198409|NCT01072175|628883|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
198410|NCT01072175|628884|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
198411|NCT01072175|628872|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
198412|NCT01072175|628873|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
198413|NCT01072175|628874|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
198414|NCT01072175|628875|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
198415|NCT01072175|628876|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
198416|NCT01072175|628877|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
198417|NCT01072175|628878|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
198418|NCT01072175|628879|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
198419|NCT01072175|628880|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
198420|NCT01072175|628881|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
198421|NCT01072175|628882|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
198422|NCT01072175|628883|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
198423|NCT01072175|628884|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
198424|NCT01072201|629080|P2|Overall Study|Lost to Follow-up|1
198425|NCT01072201|629081|P1|Overall Study|Lost to Follow-up|0
198426|NCT01072344|629115|P2|Overall Study|Lost to Follow-up|4
198427|NCT01072344|629116|P1|Overall Study|Lost to Follow-up|3
198428|NCT01072344|629115|P2|Overall Study|Protocol Violation|2
198429|NCT01072344|629116|P1|Overall Study|Protocol Violation|1
198430|NCT01072344|629115|P2|Overall Study|Relasped-reached end point|12
198431|NCT01072344|629116|P1|Overall Study|Relasped-reached end point|7
198432|NCT01072357|629132|P2|Overall Study|Lost to Follow-up|1
198433|NCT01072357|629133|P1|Overall Study|Lost to Follow-up|0
198434|NCT01072396|629143|P2|Period Two|Lost to Follow-up|0
198435|NCT01072396|629144|P1|Period Two|Lost to Follow-up|1
198436|NCT01072396|629143|P2|Period Two|Adverse Event|3
198437|NCT01072396|629144|P1|Period Two|Adverse Event|0
198438|NCT01072396|629143|P2|Washout Period|Missing termination information|1
198439|NCT01072396|629144|P1|Washout Period|Missing termination information|0
198440|NCT01072396|629143|P2|Period One|Withdrawal by Subject|0
198441|NCT01072396|629144|P1|Period One|Withdrawal by Subject|2
198442|NCT01072396|629143|P2|Period One|Protocol Violation|1
198443|NCT01072396|629144|P1|Period One|Protocol Violation|2
198444|NCT01072396|629143|P2|Period One|Adverse Event|1
198445|NCT01072396|629144|P1|Period One|Adverse Event|1
198446|NCT01072448|629160|P2|Overall Study|Death|2
198447|NCT01072448|629161|P1|Overall Study|Death|0
198448|NCT01072448|629160|P2|Overall Study|Abnormal laboratory value(s)|1
198449|NCT01072448|629161|P1|Overall Study|Abnormal laboratory value(s)|0
198450|NCT01072448|629160|P2|Overall Study|Lost to Follow-up|1
198451|NCT01072448|629161|P1|Overall Study|Lost to Follow-up|1
198452|NCT01072448|629160|P2|Overall Study|Unsatisfactory therapeutic effect|3
198453|NCT01072448|629161|P1|Overall Study|Unsatisfactory therapeutic effect|1
198454|NCT01072448|629160|P2|Overall Study|Abnormal test procedure result(s)|0
198455|NCT01072448|629161|P1|Overall Study|Abnormal test procedure result(s)|1
198456|NCT01072448|629160|P2|Overall Study|Protocol deviation|4
198457|NCT01072448|629161|P1|Overall Study|Protocol deviation|3
198458|NCT01072448|629160|P2|Overall Study|Subject withdrew consent|9
198459|NCT01072448|629161|P1|Overall Study|Subject withdrew consent|4
198460|NCT01072448|629160|P2|Overall Study|Adverse Event|10
198461|NCT01072448|629161|P1|Overall Study|Adverse Event|9
198462|NCT01072500|629171|P2|Overall Study|Withdrawal by Subject|10
198463|NCT01072500|629172|P1|Overall Study|Withdrawal by Subject|17
198464|NCT01072500|629171|P2|Overall Study|Lost to Follow-up|2
198465|NCT01072500|629172|P1|Overall Study|Lost to Follow-up|5
198466|NCT01072500|629171|P2|Overall Study|Death|2
198467|NCT01072500|629172|P1|Overall Study|Death|2
198468|NCT01072539|629194|P1|Overall Study|Protocol Violation|2
198469|NCT01072539|629194|P1|Overall Study|Treated prior to the Site Initiation|1
198470|NCT01072630|629212|P3|Overall Study|Not specified|1
198471|NCT01072630|629213|P2|Overall Study|Not specified|2
198472|NCT01072630|629214|P1|Overall Study|Not specified|3
198473|NCT01072630|629212|P3|Overall Study|Noncompliance with study procedures|1
198474|NCT01072630|629213|P2|Overall Study|Noncompliance with study procedures|2
198475|NCT01072630|629214|P1|Overall Study|Noncompliance with study procedures|1
198476|NCT01072630|629212|P3|Overall Study|Noncompliance with study medication|1
198477|NCT01072630|629213|P2|Overall Study|Noncompliance with study medication|1
198478|NCT01072630|629214|P1|Overall Study|Noncompliance with study medication|1
198479|NCT01072630|629212|P3|Overall Study|Lost to Follow-up|1
198480|NCT01072630|629213|P2|Overall Study|Lost to Follow-up|11
198481|NCT01072630|629214|P1|Overall Study|Lost to Follow-up|11
198482|NCT01072630|629212|P3|Overall Study|Protocol Violation|4
198483|NCT01072630|629213|P2|Overall Study|Protocol Violation|8
198484|NCT01072630|629214|P1|Overall Study|Protocol Violation|10
198485|NCT01072630|629212|P3|Overall Study|Withdrawal by Subject|2
198486|NCT01072630|629213|P2|Overall Study|Withdrawal by Subject|7
198487|NCT01072630|629214|P1|Overall Study|Withdrawal by Subject|8
198488|NCT01072630|629212|P3|Overall Study|Lack of Efficacy|1
198489|NCT01072630|629213|P2|Overall Study|Lack of Efficacy|10
198490|NCT01072630|629214|P1|Overall Study|Lack of Efficacy|10
198491|NCT01072630|629212|P3|Overall Study|Adverse Event|2
198492|NCT01072630|629213|P2|Overall Study|Adverse Event|19
198493|NCT01072630|629214|P1|Overall Study|Adverse Event|11
198494|NCT01072877|629331|P5|Overall Study|Lost to Follow-up|0
198495|NCT01072877|629332|P4|Overall Study|Lost to Follow-up|2
198496|NCT01072877|629333|P3|Overall Study|Lost to Follow-up|0
198497|NCT01072877|629334|P2|Overall Study|Lost to Follow-up|1
198498|NCT01072877|629335|P1|Overall Study|Lost to Follow-up|1
198499|NCT01072929|629360|P3|Overall Study|Not specified|0
198500|NCT01072929|629361|P2|Overall Study|Not specified|3
198501|NCT01072929|629362|P1|Overall Study|Not specified|0
198502|NCT01072929|629360|P3|Overall Study|Noncompliance with study procedures|1
198503|NCT01072929|629361|P2|Overall Study|Noncompliance with study procedures|0
198504|NCT01072929|629362|P1|Overall Study|Noncompliance with study procedures|1
198505|NCT01072929|629360|P3|Overall Study|Noncompliance with study medication|0
198506|NCT01072929|629361|P2|Overall Study|Noncompliance with study medication|3
198507|NCT01072929|629362|P1|Overall Study|Noncompliance with study medication|0
198508|NCT01072929|629360|P3|Overall Study|Lost to Follow-up|1
198509|NCT01072929|629361|P2|Overall Study|Lost to Follow-up|4
198510|NCT01072929|629362|P1|Overall Study|Lost to Follow-up|8
198511|NCT01072929|629360|P3|Overall Study|Protocol Violation|2
198512|NCT01072929|629361|P2|Overall Study|Protocol Violation|11
198513|NCT01072929|629362|P1|Overall Study|Protocol Violation|13
198514|NCT01072929|629360|P3|Overall Study|Withdrawal by Subject|3
198515|NCT01072929|629361|P2|Overall Study|Withdrawal by Subject|15
198516|NCT01072929|629362|P1|Overall Study|Withdrawal by Subject|7
198517|NCT01072929|629360|P3|Overall Study|Lack of Efficacy|0
198518|NCT01072929|629361|P2|Overall Study|Lack of Efficacy|4
198519|NCT01072929|629362|P1|Overall Study|Lack of Efficacy|7
198520|NCT01072929|629360|P3|Overall Study|Adverse Event|2
198521|NCT01072929|629361|P2|Overall Study|Adverse Event|11
198522|NCT01072929|629362|P1|Overall Study|Adverse Event|8
198523|NCT01073163|629436|P1|Overall Study|Early termination|1
198524|NCT01073163|629436|P1|Overall Study|Disease Progression|1
198525|NCT01073163|629436|P1|Overall Study|Adverse Event|1
198526|NCT01062841|629458|P2|Overall Study|Withdrawal by Study|0
198527|NCT01062841|629459|P1|Overall Study|Withdrawal by Study|3
198528|NCT01062841|629458|P2|Overall Study|Withdrawal by Subject|0
198529|NCT01062841|629459|P1|Overall Study|Withdrawal by Subject|2
198530|NCT01062841|629458|P2|Overall Study|Death|5
198531|NCT01062841|629459|P1|Overall Study|Death|3
198532|NCT01062841|629458|P2|Overall Study|Indwelling Device Removed|48
198533|NCT01062841|629459|P1|Overall Study|Indwelling Device Removed|41
198534|NCT01063036|629487|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
198535|NCT01063036|629487|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
198536|NCT01063036|629487|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
198537|NCT01063036|629487|P1|Participants Treated With Study Drug|Pregnancy|1
198538|NCT01063036|629487|P1|Participants Treated With Study Drug|Lost to Follow-up|1
198539|NCT01063036|629487|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
198540|NCT01063036|629487|P1|Participants Treated With Study Drug|Protocol Violation|1
198541|NCT01063036|629487|P1|Participants Treated With Study Drug|Adverse Event|1
198542|NCT01063062|629519|P2|Overall Study|Miscellaneous reason|1
198543|NCT01063062|629520|P1|Overall Study|Miscellaneous reason|0
198544|NCT01063062|629519|P2|Overall Study|Lost to Follow-up|2
198545|NCT01063062|629520|P1|Overall Study|Lost to Follow-up|0
198546|NCT01063062|629519|P2|Overall Study|Investigator's request|0
198547|NCT01063062|629520|P1|Overall Study|Investigator's request|1
198548|NCT01063062|629519|P2|Overall Study|Protocol Violation|4
198549|NCT01063062|629520|P1|Overall Study|Protocol Violation|5
198550|NCT01063062|629519|P2|Overall Study|Adverse Event|4
198551|NCT01063062|629520|P1|Overall Study|Adverse Event|2
198552|NCT01063062|629519|P2|Overall Study|Patient withdrew consent|1
198553|NCT01063062|629520|P1|Overall Study|Patient withdrew consent|0
198554|NCT01063153|629579|P2|Overall Study|Physician Decision|4
198555|NCT01063153|629580|P1|Overall Study|Physician Decision|0
198556|NCT01063153|629579|P2|Overall Study|Withdrawal by Subject|1
198557|NCT01063153|629580|P1|Overall Study|Withdrawal by Subject|0
198558|NCT01063153|629579|P2|Overall Study|Lost to Follow-up|7
198559|NCT01063153|629580|P1|Overall Study|Lost to Follow-up|0
198560|NCT01063153|629579|P2|Overall Study|Found Ineligible During Screening|0
198561|NCT01063153|629580|P1|Overall Study|Found Ineligible During Screening|2
198562|NCT01063348|629592|P2|Overall Study|Lost to Follow-up|10
198563|NCT01063348|629593|P1|Overall Study|Lost to Follow-up|3
198564|NCT01063517|629603|P2|Overall Study|Death|48
198565|NCT01063517|629604|P1|Overall Study|Death|33
198566|NCT01063517|629603|P2|Overall Study|Withdrawal by Subject|2
198567|NCT01063517|629604|P1|Overall Study|Withdrawal by Subject|1
198568|NCT01063517|629603|P2|Overall Study|Lost to Follow-up|3
198569|NCT01063517|629604|P1|Overall Study|Lost to Follow-up|4
198570|NCT01063517|629603|P2|Overall Study|Study reached data cut-off|7
198571|NCT01063517|629604|P1|Overall Study|Study reached data cut-off|19
198572|NCT01063517|629603|P2|Overall Study|Consent withdrawal|0
198573|NCT01063517|629604|P1|Overall Study|Consent withdrawal|1
198574|NCT01063595|629642|P2|First Intervention|Reason not Specified|1
198575|NCT01063595|629643|P1|First Intervention|Reason not Specified|0
198576|NCT01063595|629642|P2|First Intervention|Withdrawal by Subject|0
198577|NCT01063595|629643|P1|First Intervention|Withdrawal by Subject|1
198578|NCT01063595|629642|P2|First Intervention|Adverse Event|4
198579|NCT01063595|629643|P1|First Intervention|Adverse Event|1
198580|NCT01063595|629642|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
198581|NCT01063595|629643|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
198582|NCT01063595|629642|P2|Enrolled in Study and Randomized|Adverse Event|1
198583|NCT01063595|629643|P1|Enrolled in Study and Randomized|Adverse Event|0
198584|NCT01063595|629642|P2|Enrolled in Study and Randomized|Reason not Specified|0
198585|NCT01063595|629643|P1|Enrolled in Study and Randomized|Reason not Specified|1
198586|NCT01063764|629658|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
198587|NCT01063764|629658|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
198588|NCT01063764|629658|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
198589|NCT01063764|629658|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
198590|NCT01063764|629658|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
198591|NCT01063764|629658|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
198592|NCT01063764|629658|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
198593|NCT01063855|629674|P2|Overall Study|Reason not specified|11
198594|NCT01063855|629675|P1|Overall Study|Reason not specified|13
198595|NCT01063855|629674|P2|Overall Study|Withdrawal by Subject|8
198596|NCT01063855|629675|P1|Overall Study|Withdrawal by Subject|11
198597|NCT01063855|629674|P2|Overall Study|Lack of Efficacy|1
198598|NCT01063855|629675|P1|Overall Study|Lack of Efficacy|0
198599|NCT01063855|629674|P2|Overall Study|Pregnancy|0
198600|NCT01063855|629675|P1|Overall Study|Pregnancy|1
198601|NCT01063855|629674|P2|Overall Study|Lost to Follow-up|4
198602|NCT01063855|629675|P1|Overall Study|Lost to Follow-up|8
198603|NCT01063855|629674|P2|Overall Study|Death|1
198604|NCT01063855|629675|P1|Overall Study|Death|0
198605|NCT01063855|629674|P2|Overall Study|Adverse Event|4
198606|NCT01063855|629675|P1|Overall Study|Adverse Event|4
198607|NCT01063868|629699|P2|Overall Study|Study Terminated By Sponsor|4
198608|NCT01063868|629700|P1|Overall Study|Study Terminated By Sponsor|23
198609|NCT01063868|629699|P2|Overall Study|Withdrawal by Subject|1
198610|NCT01063868|629700|P1|Overall Study|Withdrawal by Subject|3
198611|NCT01063868|629699|P2|Overall Study|Adverse Event|7
198612|NCT01063868|629700|P1|Overall Study|Adverse Event|9
198613|NCT01063881|629709|P3|Overall Study|Reason for not completed not specified|0
198614|NCT01063881|629710|P2|Overall Study|Reason for not completed not specified|1
198615|NCT01063881|629711|P1|Overall Study|Reason for not completed not specified|5
198616|NCT01063881|629709|P3|Overall Study|Withdrawal by Subject|0
198617|NCT01063881|629710|P2|Overall Study|Withdrawal by Subject|1
198618|NCT01063881|629711|P1|Overall Study|Withdrawal by Subject|25
198619|NCT01063881|629709|P3|Overall Study|Lost to Follow-up|1
198620|NCT01063881|629710|P2|Overall Study|Lost to Follow-up|7
198621|NCT01063881|629711|P1|Overall Study|Lost to Follow-up|13
198622|NCT01063881|629709|P3|Overall Study|Adverse Event|0
198623|NCT01063881|629710|P2|Overall Study|Adverse Event|2
198624|NCT01063881|629711|P1|Overall Study|Adverse Event|12
198625|NCT01064167|629771|P2|Overall Study|Protocol Violation|15
198626|NCT01064167|629772|P1|Overall Study|Protocol Violation|14
198627|NCT01064297|629806|P3|Overall Study|Lost to Follow-up|133
198628|NCT01064297|629807|P2|Overall Study|Lost to Follow-up|48
198629|NCT01064297|629808|P1|Overall Study|Lost to Follow-up|791
198630|NCT01064310|629854|P3|Open Label Pazopinib|Physician Decision|20
198631|NCT01064310|629855|P2|Open Label Pazopinib|Physician Decision|0
198632|NCT01064310|629856|P1|Open Label Pazopinib|Physician Decision|0
198633|NCT01064310|629854|P3|Open Label Pazopinib|Lack of Efficacy|51
198634|NCT01064310|629855|P2|Open Label Pazopinib|Lack of Efficacy|0
198635|NCT01064310|629856|P1|Open Label Pazopinib|Lack of Efficacy|0
198636|NCT01064310|629854|P3|Open Label Pazopinib|Adverse Event|12
198637|NCT01064310|629855|P2|Open Label Pazopinib|Adverse Event|0
198638|NCT01064310|629856|P1|Open Label Pazopinib|Adverse Event|0
198639|NCT01064310|629854|P3|Open Label Pazopinib|Withdrawal by Subject|1
198640|NCT01064310|629855|P2|Open Label Pazopinib|Withdrawal by Subject|0
198641|NCT01064310|629856|P1|Open Label Pazopinib|Withdrawal by Subject|0
198642|NCT01064310|629854|P3|Period 2|Lack of Efficacy|0
198643|NCT01064310|629855|P2|Period 2|Lack of Efficacy|4
198644|NCT01064310|629856|P1|Period 2|Lack of Efficacy|1
198645|NCT01064310|629854|P3|Period 2|Entered Open-label Period|0
198646|NCT01064310|629855|P2|Period 2|Entered Open-label Period|0
198647|NCT01064310|629856|P1|Period 2|Entered Open-label Period|1
198648|NCT01064310|629854|P3|Period 2|Physician Decision|0
198649|NCT01064310|629855|P2|Period 2|Physician Decision|1
198650|NCT01064310|629856|P1|Period 2|Physician Decision|0
198651|NCT01064310|629854|P3|Period 2|Adverse Event|0
198652|NCT01064310|629855|P2|Period 2|Adverse Event|1
198653|NCT01064310|629856|P1|Period 2|Adverse Event|2
198654|NCT01064310|629854|P3|Period 1|Entered Open-label Period|0
198655|NCT01064310|629855|P2|Period 1|Entered Open-label Period|1
198656|NCT01064310|629856|P1|Period 1|Entered Open-label Period|1
198657|NCT01064310|629854|P3|Period 1|Lack of Efficacy|0
198658|NCT01064310|629855|P2|Period 1|Lack of Efficacy|5
198659|NCT01064310|629856|P1|Period 1|Lack of Efficacy|3
198660|NCT01064310|629854|P3|Period 1|Withdrawal by Subject|0
198661|NCT01064310|629855|P2|Period 1|Withdrawal by Subject|2
198662|NCT01064310|629856|P1|Period 1|Withdrawal by Subject|2
198663|NCT01064310|629854|P3|Period 1|Physician Decision|0
198664|NCT01064310|629855|P2|Period 1|Physician Decision|0
198665|NCT01064310|629856|P1|Period 1|Physician Decision|1
198666|NCT01064310|629854|P3|Period 1|Adverse Event|0
198667|NCT01064310|629855|P2|Period 1|Adverse Event|10
198668|NCT01064310|629856|P1|Period 1|Adverse Event|7
198669|NCT01064401|629918|P2|Overall Study|Not Specified|1
198670|NCT01064401|629919|P1|Overall Study|Not Specified|2
198671|NCT01064401|629918|P2|Overall Study|Site Closure|5
198672|NCT01064401|629919|P1|Overall Study|Site Closure|4
198673|NCT01064401|629918|P2|Overall Study|Noncompliance|8
198674|NCT01064401|629919|P1|Overall Study|Noncompliance|7
198675|NCT01064401|629918|P2|Overall Study|Pregnancy|7
198676|NCT01064401|629919|P1|Overall Study|Pregnancy|4
198677|NCT01064401|629918|P2|Overall Study|Death|0
198678|NCT01064401|629919|P1|Overall Study|Death|4
198679|NCT01064401|629918|P2|Overall Study|Investigator Decision|6
198680|NCT01064401|629919|P1|Overall Study|Investigator Decision|4
198681|NCT01064401|629918|P2|Overall Study|Consent Withdrawn|80
198682|NCT01064401|629919|P1|Overall Study|Consent Withdrawn|98
198683|NCT01064401|629918|P2|Overall Study|Lost to Follow-up|9
198684|NCT01064401|629919|P1|Overall Study|Lost to Follow-up|12
198685|NCT01064401|629918|P2|Overall Study|Lack of Efficacy|23
198686|NCT01064401|629919|P1|Overall Study|Lack of Efficacy|46
198687|NCT01064401|629918|P2|Overall Study|Adverse Event|56
198688|NCT01064401|629919|P1|Overall Study|Adverse Event|47
198689|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Not specified|1
198690|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Not specified|2
198691|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Not specified|5
198692|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
198693|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
198694|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
198695|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
198696|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
198697|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
198698|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
198699|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
198700|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
198701|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
198702|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
198703|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
198704|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
198705|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
198706|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
198707|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Death|0
198708|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Death|1
198709|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Death|0
198710|NCT01064414|629936|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
198711|NCT01064414|629937|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
198712|NCT01064414|629938|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
198713|NCT01064414|629936|P3|Core Period: Baseline to Week 26|Not specified|2
198714|NCT01064414|629937|P2|Core Period: Baseline to Week 26|Not specified|7
198715|NCT01064414|629938|P1|Core Period: Baseline to Week 26|Not specified|4
198716|NCT01064414|629936|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
198717|NCT01064414|629937|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
198718|NCT01064414|629938|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
198719|NCT01064414|629936|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
198720|NCT01064414|629937|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
198721|NCT01064414|629938|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
198722|NCT01064414|629936|P3|Core Period: Baseline to Week 26|Protocol Violation|1
198723|NCT01064414|629937|P2|Core Period: Baseline to Week 26|Protocol Violation|0
198724|NCT01064414|629938|P1|Core Period: Baseline to Week 26|Protocol Violation|1
198725|NCT01064414|629936|P3|Core Period: Baseline to Week 26|Death|0
198726|NCT01064414|629937|P2|Core Period: Baseline to Week 26|Death|1
198727|NCT01064414|629938|P1|Core Period: Baseline to Week 26|Death|0
198728|NCT01064414|629936|P3|Core Period: Baseline to Week 26|Adverse Event|2
198729|NCT01064414|629937|P2|Core Period: Baseline to Week 26|Adverse Event|4
198730|NCT01064414|629938|P1|Core Period: Baseline to Week 26|Adverse Event|4
198731|NCT01064622|629958|P2|Randomized Phase II|Protocol Violation|1
198732|NCT01064622|629959|P1|Randomized Phase II|Protocol Violation|0
198733|NCT01064622|629958|P2|Randomized Phase II|Withdrawal by Subject|2
198734|NCT01064622|629959|P1|Randomized Phase II|Withdrawal by Subject|2
198735|NCT01064687|629984|P4|Overall Study|Treatment Noncompliance|0
198736|NCT01064687|629985|P3|Overall Study|Treatment Noncompliance|1
198737|NCT01064687|629986|P2|Overall Study|Treatment Noncompliance|1
198738|NCT01064687|629987|P1|Overall Study|Treatment Noncompliance|1
198739|NCT01064687|629984|P4|Overall Study|Withdrawal by Subject|5
198740|NCT01064687|629985|P3|Overall Study|Withdrawal by Subject|12
198741|NCT01064687|629986|P2|Overall Study|Withdrawal by Subject|7
198742|NCT01064687|629987|P1|Overall Study|Withdrawal by Subject|9
198743|NCT01064687|629984|P4|Overall Study|Sponsor Decision|0
198744|NCT01064687|629985|P3|Overall Study|Sponsor Decision|3
198745|NCT01064687|629986|P2|Overall Study|Sponsor Decision|0
198746|NCT01064687|629987|P1|Overall Study|Sponsor Decision|0
198747|NCT01064687|629984|P4|Overall Study|Protocol Violation|1
198748|NCT01064687|629985|P3|Overall Study|Protocol Violation|0
198749|NCT01064687|629986|P2|Overall Study|Protocol Violation|1
198750|NCT01064687|629987|P1|Overall Study|Protocol Violation|1
198751|NCT01064687|629984|P4|Overall Study|Physician Decision|0
198752|NCT01064687|629985|P3|Overall Study|Physician Decision|0
198753|NCT01064687|629986|P2|Overall Study|Physician Decision|2
198754|NCT01064687|629987|P1|Overall Study|Physician Decision|2
198755|NCT01064687|629984|P4|Overall Study|Lost to Follow-up|5
198756|NCT01064687|629985|P3|Overall Study|Lost to Follow-up|13
198757|NCT01064687|629986|P2|Overall Study|Lost to Follow-up|10
198758|NCT01064687|629987|P1|Overall Study|Lost to Follow-up|7
198759|NCT01064687|629984|P4|Overall Study|Lack of Efficacy|3
198760|NCT01064687|629985|P3|Overall Study|Lack of Efficacy|2
198761|NCT01064687|629986|P2|Overall Study|Lack of Efficacy|0
198762|NCT01064687|629987|P1|Overall Study|Lack of Efficacy|1
198763|NCT01064687|629984|P4|Overall Study|Entry Criteria Not Met|0
198764|NCT01064687|629985|P3|Overall Study|Entry Criteria Not Met|0
198765|NCT01064687|629986|P2|Overall Study|Entry Criteria Not Met|0
198766|NCT01064687|629987|P1|Overall Study|Entry Criteria Not Met|3
198767|NCT01064687|629984|P4|Overall Study|Death|0
198768|NCT01064687|629985|P3|Overall Study|Death|0
198769|NCT01064687|629986|P2|Overall Study|Death|1
198770|NCT01064687|629987|P1|Overall Study|Death|1
198771|NCT01064687|629984|P4|Overall Study|Adverse Event|3
198772|NCT01064687|629985|P3|Overall Study|Adverse Event|10
198773|NCT01064687|629986|P2|Overall Study|Adverse Event|4
198774|NCT01064687|629987|P1|Overall Study|Adverse Event|9
198775|NCT01064739|630164|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
198776|NCT01064817|630222|P2|Study Completion|Withdrawal by Subject|0
198777|NCT01064817|630223|P1|Study Completion|Withdrawal by Subject|1
198778|NCT01064817|630222|P2|Study Completion|Physician Decision|0
198779|NCT01064817|630223|P1|Study Completion|Physician Decision|1
198780|NCT01064856|630248|P4|Open-label (OL) Period|Not specified|7
198781|NCT01064856|630249|P3|Open-label (OL) Period|Not specified|7
198782|NCT01064856|630250|P2|Open-label (OL) Period|Not specified|0
198783|NCT01064856|630251|P1|Open-label (OL) Period|Not specified|0
198784|NCT01064856|630248|P4|Open-label (OL) Period|Lost to Follow-up|1
198785|NCT01064856|630249|P3|Open-label (OL) Period|Lost to Follow-up|2
198786|NCT01064856|630250|P2|Open-label (OL) Period|Lost to Follow-up|0
198787|NCT01064856|630251|P1|Open-label (OL) Period|Lost to Follow-up|0
198788|NCT01064856|630248|P4|Open-label (OL) Period|Consent withdrawn by participant|6
198789|NCT01064856|630249|P3|Open-label (OL) Period|Consent withdrawn by participant|5
198790|NCT01064856|630250|P2|Open-label (OL) Period|Consent withdrawn by participant|0
198791|NCT01064856|630251|P1|Open-label (OL) Period|Consent withdrawn by participant|0
198792|NCT01064856|630248|P4|Open-label (OL) Period|Adverse Event|6
198793|NCT01064856|630249|P3|Open-label (OL) Period|Adverse Event|12
198794|NCT01064856|630250|P2|Open-label (OL) Period|Adverse Event|0
198795|NCT01064856|630251|P1|Open-label (OL) Period|Adverse Event|0
198796|NCT01064856|630248|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
198797|NCT01064856|630249|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
198798|NCT01064856|630250|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
198799|NCT01064856|630251|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
198800|NCT01064856|630248|P4|Double-blind (DB) Period|Adverse Event|0
198801|NCT01064856|630249|P3|Double-blind (DB) Period|Adverse Event|0
198802|NCT01064856|630250|P2|Double-blind (DB) Period|Adverse Event|0
198803|NCT01064856|630251|P1|Double-blind (DB) Period|Adverse Event|1
198804|NCT01064947|630313|P1|Overall Study|negative culture|41
198805|NCT01065350|630352|P2|Overall Study|Received incorrect drug allocation|1
198806|NCT01065350|630353|P1|Overall Study|Received incorrect drug allocation|0
198807|NCT01065454|630400|P4|Follow up|study ongoing|41
198808|NCT01065454|630401|P3|Follow up|study ongoing|15
198809|NCT01065454|630402|P2|Follow up|study ongoing|22
198810|NCT01065454|630403|P1|Follow up|study ongoing|37
198811|NCT01065454|630400|P4|Follow up|Withdrawal by Subject|0
198812|NCT01065454|630401|P3|Follow up|Withdrawal by Subject|1
198813|NCT01065454|630402|P2|Follow up|Withdrawal by Subject|1
198814|NCT01065454|630403|P1|Follow up|Withdrawal by Subject|1
198815|NCT01065454|630400|P4|Follow up|Progressive disease|1
198816|NCT01065454|630401|P3|Follow up|Progressive disease|0
198817|NCT01065454|630402|P2|Follow up|Progressive disease|0
198818|NCT01065454|630403|P1|Follow up|Progressive disease|0
198819|NCT01065454|630400|P4|Follow up|Lost to Follow-up|1
198820|NCT01065454|630401|P3|Follow up|Lost to Follow-up|0
198821|NCT01065454|630402|P2|Follow up|Lost to Follow-up|0
198822|NCT01065454|630403|P1|Follow up|Lost to Follow-up|0
198823|NCT01065454|630400|P4|Follow up|Death|0
198824|NCT01065454|630401|P3|Follow up|Death|1
198825|NCT01065454|630402|P2|Follow up|Death|1
198826|NCT01065454|630403|P1|Follow up|Death|0
198827|NCT01065454|630400|P4|Follow up|Adverse Event|1
198828|NCT01065454|630401|P3|Follow up|Adverse Event|0
198829|NCT01065454|630402|P2|Follow up|Adverse Event|0
198830|NCT01065454|630403|P1|Follow up|Adverse Event|1
198831|NCT01065454|630400|P4|Treatment|Withdrawal by Subject|3
198832|NCT01065454|630401|P3|Treatment|Withdrawal by Subject|2
198833|NCT01065454|630402|P2|Treatment|Withdrawal by Subject|1
198834|NCT01065454|630403|P1|Treatment|Withdrawal by Subject|3
198835|NCT01065454|630400|P4|Treatment|Protocol Violation|0
198836|NCT01065454|630401|P3|Treatment|Protocol Violation|1
198837|NCT01065454|630402|P2|Treatment|Protocol Violation|0
198838|NCT01065454|630403|P1|Treatment|Protocol Violation|1
198839|NCT01065454|630400|P4|Treatment|Protocol Decision|2
198840|NCT01065454|630401|P3|Treatment|Protocol Decision|3
198841|NCT01065454|630402|P2|Treatment|Protocol Decision|0
198842|NCT01065454|630403|P1|Treatment|Protocol Decision|0
198843|NCT01065454|630400|P4|Treatment|Non-compliance|1
198844|NCT01065454|630401|P3|Treatment|Non-compliance|0
198845|NCT01065454|630402|P2|Treatment|Non-compliance|0
198846|NCT01065454|630403|P1|Treatment|Non-compliance|1
198847|NCT01065454|630400|P4|Treatment|Death|0
198848|NCT01065454|630401|P3|Treatment|Death|0
198849|NCT01065454|630402|P2|Treatment|Death|0
198850|NCT01065454|630403|P1|Treatment|Death|1
198851|NCT01065454|630400|P4|Treatment|Adverse Event|6
198852|NCT01065454|630401|P3|Treatment|Adverse Event|3
198853|NCT01065454|630402|P2|Treatment|Adverse Event|4
198854|NCT01065454|630403|P1|Treatment|Adverse Event|7
198855|NCT01065597|630527|P1|Overall Study|Adverse Event|1
198856|NCT01065766|630541|P1|Overall Study|Violated dosage/administration|25
198857|NCT01065766|630541|P1|Overall Study|Contraindication to administration|6
198858|NCT01065766|630541|P1|Overall Study|Assessed before the contracted date|1
198859|NCT01065779|630553|P1|Overall Study|Inclusion Criteria Violation|7
198860|NCT01065779|630553|P1|Overall Study|Failed to Follow-up|10
198861|NCT01065779|630553|P1|Overall Study|Not Administered With Study Drug|17
198862|NCT01065779|630553|P1|Overall Study|Non-enrollment Period Administration|10
198863|NCT01065779|630553|P1|Overall Study|Investigation Before Contract Date|37
198864|NCT01065779|630553|P1|Overall Study|Duplicate Investigation|1
198865|NCT01065844|630564|P1|Overall Study|Adverse Event|5
198866|NCT01066000|630568|P1|Overall Study|Adverse Event|1
198867|NCT01066000|630568|P1|Overall Study|Withdrawal by Subject|1
198868|NCT01066000|630568|P1|Overall Study|Death|3
198869|NCT01066000|630568|P1|Overall Study|Protocol Violation|4
198870|NCT01066039|630579|P1|Overall Study|Drug/Dose Adjustment Required|1
198871|NCT01066039|630579|P1|Overall Study|Failure to Control Blood Pressure|1
198872|NCT01066039|630579|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
198873|NCT01066039|630579|P1|Overall Study|Additional Antihypertensive Required|4
198874|NCT01066039|630579|P1|Overall Study|Dropout due to Insulin Administration|1
198875|NCT01066039|630579|P1|Overall Study|Investigator’s Request|1
198876|NCT01066039|630579|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
198877|NCT01066039|630579|P1|Overall Study|Protocol Violation|2
198878|NCT01066039|630579|P1|Overall Study|Withdrawal by Subject|17
198879|NCT01066039|630579|P1|Overall Study|Adverse Event|6
198880|NCT01066104|630594|P2|Overall Study|Protocol Violation|0
198881|NCT01066104|630595|P1|Overall Study|Protocol Violation|1
198882|NCT01066104|630594|P2|Overall Study|Adverse Event|1
198883|NCT01066104|630595|P1|Overall Study|Adverse Event|1
198884|NCT01066143|630603|P1|Overall Study|ineligible for the study|8
198885|NCT01066156|630607|P1|Overall Study|Withdrawal by Subject|1
198886|NCT01066156|630607|P1|Overall Study|Lost to Follow-up|7
198887|NCT01066156|630607|P1|Overall Study|ineligible|2
198888|NCT01066546|630630|P1|Overall Study|Study terminated by sponsor|5
198889|NCT01066585|630643|P2|Overall Study|Withdrawal by Subject|3
198890|NCT01066585|630644|P1|Overall Study|Withdrawal by Subject|0
198891|NCT01066585|630643|P2|Overall Study|Protocol Violation|0
198892|NCT01066585|630644|P1|Overall Study|Protocol Violation|1
198893|NCT01066780|630669|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
198894|NCT01066780|630670|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
198895|NCT01066793|630680|P6|Overall Study|Treatment Stopped|0
198896|NCT01066793|630681|P5|Overall Study|Treatment Stopped|0
198897|NCT01066793|630682|P4|Overall Study|Treatment Stopped|1
198898|NCT01066793|630683|P3|Overall Study|Treatment Stopped|0
198899|NCT01066793|630684|P2|Overall Study|Treatment Stopped|1
198900|NCT01066793|630685|P1|Overall Study|Treatment Stopped|2
198901|NCT01066793|630680|P6|Overall Study|Treatment Never Started|0
198902|NCT01066793|630681|P5|Overall Study|Treatment Never Started|0
198903|NCT01066793|630682|P4|Overall Study|Treatment Never Started|1
198904|NCT01066793|630683|P3|Overall Study|Treatment Never Started|4
198905|NCT01066793|630684|P2|Overall Study|Treatment Never Started|5
198906|NCT01066793|630685|P1|Overall Study|Treatment Never Started|18
198907|NCT01066793|630680|P6|Overall Study|Treatment Interrupted|0
198908|NCT01066793|630681|P5|Overall Study|Treatment Interrupted|0
198909|NCT01066793|630682|P4|Overall Study|Treatment Interrupted|0
198910|NCT01066793|630683|P3|Overall Study|Treatment Interrupted|0
198911|NCT01066793|630684|P2|Overall Study|Treatment Interrupted|1
198912|NCT01066793|630685|P1|Overall Study|Treatment Interrupted|1
198913|NCT01066793|630680|P6|Overall Study|Result Not Available|0
198914|NCT01066793|630681|P5|Overall Study|Result Not Available|0
198915|NCT01066793|630682|P4|Overall Study|Result Not Available|0
198916|NCT01066793|630683|P3|Overall Study|Result Not Available|0
198917|NCT01066793|630684|P2|Overall Study|Result Not Available|0
198918|NCT01066793|630685|P1|Overall Study|Result Not Available|1
198919|NCT01066793|630680|P6|Overall Study|Relapse|0
198920|NCT01066793|630681|P5|Overall Study|Relapse|0
198921|NCT01066793|630682|P4|Overall Study|Relapse|3
198922|NCT01066793|630683|P3|Overall Study|Relapse|2
198923|NCT01066793|630684|P2|Overall Study|Relapse|8
198924|NCT01066793|630685|P1|Overall Study|Relapse|20
198925|NCT01066793|630680|P6|Overall Study|Other|0
198926|NCT01066793|630681|P5|Overall Study|Other|0
198927|NCT01066793|630682|P4|Overall Study|Other|2
198928|NCT01066793|630683|P3|Overall Study|Other|6
198929|NCT01066793|630684|P2|Overall Study|Other|5
198930|NCT01066793|630685|P1|Overall Study|Other|15
198931|NCT01066793|630680|P6|Overall Study|Non-responders|0
198932|NCT01066793|630681|P5|Overall Study|Non-responders|0
198933|NCT01066793|630682|P4|Overall Study|Non-responders|25
198934|NCT01066793|630683|P3|Overall Study|Non-responders|11
198935|NCT01066793|630684|P2|Overall Study|Non-responders|5
198936|NCT01066793|630685|P1|Overall Study|Non-responders|104
198937|NCT01066793|630680|P6|Overall Study|Miscellaneous|0
198938|NCT01066793|630681|P5|Overall Study|Miscellaneous|0
198939|NCT01066793|630682|P4|Overall Study|Miscellaneous|0
198940|NCT01066793|630683|P3|Overall Study|Miscellaneous|6
198941|NCT01066793|630684|P2|Overall Study|Miscellaneous|5
198942|NCT01066793|630685|P1|Overall Study|Miscellaneous|4
198943|NCT01066793|630680|P6|Overall Study|Lab test not done|0
198944|NCT01066793|630681|P5|Overall Study|Lab test not done|0
198945|NCT01066793|630682|P4|Overall Study|Lab test not done|1
198946|NCT01066793|630683|P3|Overall Study|Lab test not done|0
198947|NCT01066793|630684|P2|Overall Study|Lab test not done|0
198948|NCT01066793|630685|P1|Overall Study|Lab test not done|7
198949|NCT01066793|630680|P6|Overall Study|Early Termination|0
198950|NCT01066793|630681|P5|Overall Study|Early Termination|0
198951|NCT01066793|630682|P4|Overall Study|Early Termination|0
198952|NCT01066793|630683|P3|Overall Study|Early Termination|0
198953|NCT01066793|630684|P2|Overall Study|Early Termination|0
198954|NCT01066793|630685|P1|Overall Study|Early Termination|3
198955|NCT01066793|630680|P6|Overall Study|Withdrawal by Subject|0
198956|NCT01066793|630681|P5|Overall Study|Withdrawal by Subject|0
198957|NCT01066793|630682|P4|Overall Study|Withdrawal by Subject|0
198958|NCT01066793|630683|P3|Overall Study|Withdrawal by Subject|1
198959|NCT01066793|630684|P2|Overall Study|Withdrawal by Subject|4
198960|NCT01066793|630685|P1|Overall Study|Withdrawal by Subject|7
198961|NCT01066793|630680|P6|Overall Study|Protocol Violation|0
198962|NCT01066793|630681|P5|Overall Study|Protocol Violation|0
198963|NCT01066793|630682|P4|Overall Study|Protocol Violation|0
198964|NCT01066793|630683|P3|Overall Study|Protocol Violation|2
198965|NCT01066793|630684|P2|Overall Study|Protocol Violation|2
198966|NCT01066793|630685|P1|Overall Study|Protocol Violation|3
198967|NCT01066793|630680|P6|Overall Study|Physician Decision|0
198968|NCT01066793|630681|P5|Overall Study|Physician Decision|0
198969|NCT01066793|630682|P4|Overall Study|Physician Decision|0
198970|NCT01066793|630683|P3|Overall Study|Physician Decision|0
198971|NCT01066793|630684|P2|Overall Study|Physician Decision|0
198972|NCT01066793|630685|P1|Overall Study|Physician Decision|3
198973|NCT01066793|630680|P6|Overall Study|Lost to Follow-up|1
198974|NCT01066793|630681|P5|Overall Study|Lost to Follow-up|0
198975|NCT01066793|630682|P4|Overall Study|Lost to Follow-up|16
198976|NCT01066793|630683|P3|Overall Study|Lost to Follow-up|82
198977|NCT01066793|630684|P2|Overall Study|Lost to Follow-up|39
198978|NCT01066793|630685|P1|Overall Study|Lost to Follow-up|180
198979|NCT01066793|630680|P6|Overall Study|Lack of Efficacy|0
198980|NCT01066793|630681|P5|Overall Study|Lack of Efficacy|0
198981|NCT01066793|630682|P4|Overall Study|Lack of Efficacy|0
198982|NCT01066793|630683|P3|Overall Study|Lack of Efficacy|0
198983|NCT01066793|630684|P2|Overall Study|Lack of Efficacy|1
198984|NCT01066793|630685|P1|Overall Study|Lack of Efficacy|2
198985|NCT01066793|630680|P6|Overall Study|Death|0
198986|NCT01066793|630681|P5|Overall Study|Death|0
198987|NCT01066793|630682|P4|Overall Study|Death|0
198988|NCT01066793|630683|P3|Overall Study|Death|1
198989|NCT01066793|630684|P2|Overall Study|Death|1
198990|NCT01066793|630685|P1|Overall Study|Death|4
198991|NCT01066819|630831|P6|Overall Study|Other|0
198992|NCT01066819|630832|P5|Overall Study|Other|0
198993|NCT01066819|630833|P4|Overall Study|Other|0
198994|NCT01066819|630834|P3|Overall Study|Other|1
198995|NCT01066819|630835|P2|Overall Study|Other|1
198996|NCT01066819|630836|P1|Overall Study|Other|5
198997|NCT01066819|630831|P6|Overall Study|Treatment stopped|0
198998|NCT01066819|630832|P5|Overall Study|Treatment stopped|0
198999|NCT01066819|630833|P4|Overall Study|Treatment stopped|1
199000|NCT01066819|630834|P3|Overall Study|Treatment stopped|2
199001|NCT01066819|630835|P2|Overall Study|Treatment stopped|1
199002|NCT01066819|630836|P1|Overall Study|Treatment stopped|12
199003|NCT01066819|630831|P6|Overall Study|Treatment never started|2
199004|NCT01066819|630832|P5|Overall Study|Treatment never started|2
199005|NCT01066819|630833|P4|Overall Study|Treatment never started|3
199006|NCT01066819|630834|P3|Overall Study|Treatment never started|19
199007|NCT01066819|630835|P2|Overall Study|Treatment never started|19
199008|NCT01066819|630836|P1|Overall Study|Treatment never started|85
199009|NCT01066819|630831|P6|Overall Study|Spontaneous cure|0
199010|NCT01066819|630832|P5|Overall Study|Spontaneous cure|0
199011|NCT01066819|630833|P4|Overall Study|Spontaneous cure|0
199012|NCT01066819|630834|P3|Overall Study|Spontaneous cure|0
199013|NCT01066819|630835|P2|Overall Study|Spontaneous cure|0
199014|NCT01066819|630836|P1|Overall Study|Spontaneous cure|1
199015|NCT01066819|630831|P6|Overall Study|Screen failure|0
199016|NCT01066819|630832|P5|Overall Study|Screen failure|0
199017|NCT01066819|630833|P4|Overall Study|Screen failure|0
199018|NCT01066819|630834|P3|Overall Study|Screen failure|0
199019|NCT01066819|630835|P2|Overall Study|Screen failure|0
199020|NCT01066819|630836|P1|Overall Study|Screen failure|1
199021|NCT01066819|630831|P6|Overall Study|Results not available|0
199022|NCT01066819|630832|P5|Overall Study|Results not available|0
199023|NCT01066819|630833|P4|Overall Study|Results not available|0
199024|NCT01066819|630834|P3|Overall Study|Results not available|0
199025|NCT01066819|630835|P2|Overall Study|Results not available|0
199026|NCT01066819|630836|P1|Overall Study|Results not available|1
199027|NCT01066819|630831|P6|Overall Study|Relapse|0
199028|NCT01066819|630832|P5|Overall Study|Relapse|0
199029|NCT01066819|630833|P4|Overall Study|Relapse|0
199030|NCT01066819|630834|P3|Overall Study|Relapse|3
199031|NCT01066819|630835|P2|Overall Study|Relapse|4
199032|NCT01066819|630836|P1|Overall Study|Relapse|16
199033|NCT01066819|630831|P6|Overall Study|Not categorised|0
199034|NCT01066819|630832|P5|Overall Study|Not categorised|0
199035|NCT01066819|630833|P4|Overall Study|Not categorised|1
199036|NCT01066819|630834|P3|Overall Study|Not categorised|6
199037|NCT01066819|630835|P2|Overall Study|Not categorised|2
199038|NCT01066819|630836|P1|Overall Study|Not categorised|9
199039|NCT01066819|630831|P6|Overall Study|Non responders|1
199040|NCT01066819|630832|P5|Overall Study|Non responders|0
199041|NCT01066819|630833|P4|Overall Study|Non responders|2
199042|NCT01066819|630834|P3|Overall Study|Non responders|7
199043|NCT01066819|630835|P2|Overall Study|Non responders|2
199044|NCT01066819|630836|P1|Overall Study|Non responders|123
199045|NCT01066819|630831|P6|Overall Study|Miscellaneous|0
199046|NCT01066819|630832|P5|Overall Study|Miscellaneous|0
199047|NCT01066819|630833|P4|Overall Study|Miscellaneous|1
199048|NCT01066819|630834|P3|Overall Study|Miscellaneous|18
199049|NCT01066819|630835|P2|Overall Study|Miscellaneous|10
199050|NCT01066819|630836|P1|Overall Study|Miscellaneous|28
199051|NCT01066819|630831|P6|Overall Study|Lab test not done|0
199052|NCT01066819|630832|P5|Overall Study|Lab test not done|0
199053|NCT01066819|630833|P4|Overall Study|Lab test not done|1
199054|NCT01066819|630834|P3|Overall Study|Lab test not done|2
199055|NCT01066819|630835|P2|Overall Study|Lab test not done|0
199056|NCT01066819|630836|P1|Overall Study|Lab test not done|9
199057|NCT01066819|630831|P6|Overall Study|Failed to return|3
199058|NCT01066819|630832|P5|Overall Study|Failed to return|2
199059|NCT01066819|630833|P4|Overall Study|Failed to return|7
199060|NCT01066819|630834|P3|Overall Study|Failed to return|68
199061|NCT01066819|630835|P2|Overall Study|Failed to return|107
199062|NCT01066819|630836|P1|Overall Study|Failed to return|298
199063|NCT01066819|630831|P6|Overall Study|Early termination|0
199064|NCT01066819|630832|P5|Overall Study|Early termination|0
199065|NCT01066819|630833|P4|Overall Study|Early termination|0
199066|NCT01066819|630834|P3|Overall Study|Early termination|0
199067|NCT01066819|630835|P2|Overall Study|Early termination|0
199068|NCT01066819|630836|P1|Overall Study|Early termination|2
199069|NCT01066819|630831|P6|Overall Study|Not met inclusion/exclusion criteria|0
199070|NCT01066819|630832|P5|Overall Study|Not met inclusion/exclusion criteria|0
199071|NCT01066819|630833|P4|Overall Study|Not met inclusion/exclusion criteria|0
199072|NCT01066819|630834|P3|Overall Study|Not met inclusion/exclusion criteria|0
199073|NCT01066819|630835|P2|Overall Study|Not met inclusion/exclusion criteria|0
199074|NCT01066819|630836|P1|Overall Study|Not met inclusion/exclusion criteria|1
199075|NCT01066819|630831|P6|Overall Study|Administrative|0
199076|NCT01066819|630832|P5|Overall Study|Administrative|0
199077|NCT01066819|630833|P4|Overall Study|Administrative|0
199078|NCT01066819|630834|P3|Overall Study|Administrative|2
199079|NCT01066819|630835|P2|Overall Study|Administrative|4
199080|NCT01066819|630836|P1|Overall Study|Administrative|6
199081|NCT01066819|630831|P6|Overall Study|Withdrawal by Subject|0
199082|NCT01066819|630832|P5|Overall Study|Withdrawal by Subject|0
199083|NCT01066819|630833|P4|Overall Study|Withdrawal by Subject|0
199084|NCT01066819|630834|P3|Overall Study|Withdrawal by Subject|6
199085|NCT01066819|630835|P2|Overall Study|Withdrawal by Subject|11
199086|NCT01066819|630836|P1|Overall Study|Withdrawal by Subject|29
199087|NCT01066819|630831|P6|Overall Study|Protocol Violation|0
199088|NCT01066819|630832|P5|Overall Study|Protocol Violation|0
199089|NCT01066819|630833|P4|Overall Study|Protocol Violation|0
199090|NCT01066819|630834|P3|Overall Study|Protocol Violation|0
199091|NCT01066819|630835|P2|Overall Study|Protocol Violation|6
199092|NCT01066819|630836|P1|Overall Study|Protocol Violation|12
199093|NCT01066819|630831|P6|Overall Study|Physician Decision|0
199094|NCT01066819|630832|P5|Overall Study|Physician Decision|0
199095|NCT01066819|630833|P4|Overall Study|Physician Decision|0
199096|NCT01066819|630834|P3|Overall Study|Physician Decision|3
199097|NCT01066819|630835|P2|Overall Study|Physician Decision|2
199098|NCT01066819|630836|P1|Overall Study|Physician Decision|6
199099|NCT01066819|630831|P6|Overall Study|Lack of Efficacy|0
199100|NCT01066819|630832|P5|Overall Study|Lack of Efficacy|0
199101|NCT01066819|630833|P4|Overall Study|Lack of Efficacy|1
199102|NCT01066819|630834|P3|Overall Study|Lack of Efficacy|2
199103|NCT01066819|630835|P2|Overall Study|Lack of Efficacy|1
199104|NCT01066819|630836|P1|Overall Study|Lack of Efficacy|22
199105|NCT01066819|630831|P6|Overall Study|Death|0
199106|NCT01066819|630832|P5|Overall Study|Death|0
199107|NCT01066819|630833|P4|Overall Study|Death|0
199108|NCT01066819|630834|P3|Overall Study|Death|1
199109|NCT01066819|630835|P2|Overall Study|Death|0
199110|NCT01066819|630836|P1|Overall Study|Death|5
199111|NCT01066819|630831|P6|Overall Study|Adverse Event|0
199112|NCT01066819|630832|P5|Overall Study|Adverse Event|0
199113|NCT01066819|630833|P4|Overall Study|Adverse Event|0
199114|NCT01066819|630834|P3|Overall Study|Adverse Event|6
199115|NCT01066819|630835|P2|Overall Study|Adverse Event|1
199116|NCT01066819|630836|P1|Overall Study|Adverse Event|18
199117|NCT01066871|630975|P4|Overall Study|Unspecified|2
199118|NCT01066871|630976|P3|Overall Study|Unspecified|1
199119|NCT01066871|630977|P2|Overall Study|Unspecified|2
199120|NCT01066871|630978|P1|Overall Study|Unspecified|0
199121|NCT01066871|630975|P4|Overall Study|Withdrawal by Subject|0
199122|NCT01066871|630976|P3|Overall Study|Withdrawal by Subject|0
199123|NCT01066871|630977|P2|Overall Study|Withdrawal by Subject|1
199124|NCT01066871|630978|P1|Overall Study|Withdrawal by Subject|3
199125|NCT01066871|630975|P4|Overall Study|Lack of Efficacy|1
199126|NCT01066871|630976|P3|Overall Study|Lack of Efficacy|0
199127|NCT01066871|630977|P2|Overall Study|Lack of Efficacy|0
199128|NCT01066871|630978|P1|Overall Study|Lack of Efficacy|0
199129|NCT01066871|630975|P4|Overall Study|Protocol Violation|2
199130|NCT01066871|630976|P3|Overall Study|Protocol Violation|3
199131|NCT01066871|630977|P2|Overall Study|Protocol Violation|0
199132|NCT01066871|630978|P1|Overall Study|Protocol Violation|1
199133|NCT01066871|630975|P4|Overall Study|Lost to Follow-up|0
199134|NCT01066871|630976|P3|Overall Study|Lost to Follow-up|2
199135|NCT01066871|630977|P2|Overall Study|Lost to Follow-up|2
199136|NCT01066871|630978|P1|Overall Study|Lost to Follow-up|0
199137|NCT01066897|631038|P2|Overall Study|stopped study after developing the flu.|0
199138|NCT01066897|631039|P1|Overall Study|stopped study after developing the flu.|1
199139|NCT01066897|631038|P2|Overall Study|Withdrawal by Subject|0
199140|NCT01066897|631039|P1|Overall Study|Withdrawal by Subject|1
199141|NCT01066923|631053|P4|Overall Study|Withdrawal by Subject|8
199142|NCT01066923|631054|P3|Overall Study|Withdrawal by Subject|8
199143|NCT01066923|631055|P2|Overall Study|Withdrawal by Subject|3
199144|NCT01066923|631056|P1|Overall Study|Withdrawal by Subject|3
199145|NCT01067105|631070|P1|Overall Study|Other|31
199146|NCT01067105|631070|P1|Overall Study|Physician Decision|6
199147|NCT01067105|631070|P1|Overall Study|Lost to Follow-up|6
199148|NCT01067105|631070|P1|Overall Study|Withdrawal by Subject|36
199149|NCT01067105|631070|P1|Overall Study|Protocol Violation|48
199150|NCT01067105|631070|P1|Overall Study|Adverse Event|14
199151|NCT01067326|631089|P2|Overall Study|Early Study Termination|1
199152|NCT01067326|631090|P1|Overall Study|Early Study Termination|1
199153|NCT01067326|631089|P2|Overall Study|Withdrawal by Subject|0
199154|NCT01067326|631090|P1|Overall Study|Withdrawal by Subject|1
199155|NCT01067326|631089|P2|Overall Study|Adverse Event|2
199156|NCT01067326|631090|P1|Overall Study|Adverse Event|0
199157|NCT01067339|631104|P2|Overall Study|Withdrawal by Subject|5
199158|NCT01067339|631105|P1|Overall Study|Withdrawal by Subject|6
199159|NCT01067352|631116|P3|Overall Study|Physician Decision|0
199160|NCT01067352|631117|P2|Overall Study|Physician Decision|1
199161|NCT01067352|631118|P1|Overall Study|Physician Decision|0
199162|NCT01067352|631116|P3|Overall Study|Withdrawal by Subject|1
199163|NCT01067352|631117|P2|Overall Study|Withdrawal by Subject|2
199164|NCT01067352|631118|P1|Overall Study|Withdrawal by Subject|1
199165|NCT01073267|631189|P1|Overall Study|Disease Progression|3
199166|NCT01073293|631195|P2|Overall Study|Withdrawal by Subject|10
199167|NCT01073293|631196|P1|Overall Study|Withdrawal by Subject|5
199168|NCT01073293|631195|P2|Overall Study|Lost to Follow-up|1
199169|NCT01073293|631196|P1|Overall Study|Lost to Follow-up|0
199170|NCT01073462|631224|P1|Overall Study|Lost to Follow-up|7
199171|NCT01073462|631224|P1|Overall Study|Serious adverse event|2
199172|NCT01073462|631224|P1|Overall Study|Low parathyroid hormone levels|8
199173|NCT01073462|631224|P1|Overall Study|Kidney transplant|10
199174|NCT01073462|631224|P1|Overall Study|Death|14
199175|NCT01073930|631237|P2|Overall Study|Inadequate prep; unable to do procedure|1
199176|NCT01073930|631238|P1|Overall Study|Inadequate prep; unable to do procedure|0
199177|NCT01073930|631237|P2|Overall Study|Noncompliance with study drug|1
199178|NCT01073930|631238|P1|Overall Study|Noncompliance with study drug|0
199179|NCT01073930|631237|P2|Overall Study|Adverse Event|1
199180|NCT01073930|631238|P1|Overall Study|Adverse Event|0
199181|NCT01073930|631237|P2|Overall Study|Lost to Follow-up|1
199182|NCT01073930|631238|P1|Overall Study|Lost to Follow-up|0
199183|NCT01073930|631237|P2|Overall Study|Withdrawal by Subject|2
199184|NCT01073930|631238|P1|Overall Study|Withdrawal by Subject|3
199185|NCT01073943|631262|P2|Overall Study|Could not tolerate prep|0
199186|NCT01073943|631263|P1|Overall Study|Could not tolerate prep|1
199187|NCT01073943|631262|P2|Overall Study|Unable to return for follow-up|1
199188|NCT01073943|631263|P1|Overall Study|Unable to return for follow-up|0
199189|NCT01073943|631262|P2|Overall Study|Subject forgot|1
199190|NCT01073943|631263|P1|Overall Study|Subject forgot|0
199191|NCT01073943|631262|P2|Overall Study|Power outage; colonoscopy not done|0
199192|NCT01073943|631263|P1|Overall Study|Power outage; colonoscopy not done|1
199193|NCT01073943|631262|P2|Overall Study|Lost to Follow-up|2
199194|NCT01073943|631263|P1|Overall Study|Lost to Follow-up|0
199195|NCT01073943|631262|P2|Overall Study|Adverse Event|1
199196|NCT01073943|631263|P1|Overall Study|Adverse Event|1
199197|NCT01073943|631262|P2|Overall Study|Protocol Violation|1
199198|NCT01073943|631263|P1|Overall Study|Protocol Violation|2
199199|NCT01073943|631262|P2|Overall Study|Withdrawal by Subject|2
199200|NCT01073943|631263|P1|Overall Study|Withdrawal by Subject|8
199201|NCT01074008|631296|P9|Overall Study|Lost to Follow-up|4
199202|NCT01074008|631297|P8|Overall Study|Lost to Follow-up|0
199203|NCT01074008|631298|P7|Overall Study|Lost to Follow-up|1
199204|NCT01074008|631299|P6|Overall Study|Lost to Follow-up|0
199205|NCT01074008|631300|P5|Overall Study|Lost to Follow-up|1
199206|NCT01074008|631301|P4|Overall Study|Lost to Follow-up|1
199207|NCT01074008|631302|P3|Overall Study|Lost to Follow-up|1
199208|NCT01074008|631303|P2|Overall Study|Lost to Follow-up|1
199209|NCT01074008|631304|P1|Overall Study|Lost to Follow-up|0
199210|NCT01074008|631296|P9|Overall Study|Withdrawal by Subject|0
199211|NCT01074008|631297|P8|Overall Study|Withdrawal by Subject|0
199212|NCT01074008|631298|P7|Overall Study|Withdrawal by Subject|0
199213|NCT01074008|631299|P6|Overall Study|Withdrawal by Subject|0
199214|NCT01074008|631300|P5|Overall Study|Withdrawal by Subject|1
199215|NCT01074008|631301|P4|Overall Study|Withdrawal by Subject|0
199216|NCT01074008|631302|P3|Overall Study|Withdrawal by Subject|1
199217|NCT01074008|631303|P2|Overall Study|Withdrawal by Subject|1
199218|NCT01074008|631304|P1|Overall Study|Withdrawal by Subject|1
199219|NCT01074008|631296|P9|Overall Study|Adverse Event|0
199220|NCT01074008|631297|P8|Overall Study|Adverse Event|0
199221|NCT01074008|631298|P7|Overall Study|Adverse Event|0
199222|NCT01074008|631299|P6|Overall Study|Adverse Event|0
199223|NCT01074008|631300|P5|Overall Study|Adverse Event|0
199224|NCT01074008|631301|P4|Overall Study|Adverse Event|0
199225|NCT01074008|631302|P3|Overall Study|Adverse Event|0
199226|NCT01074008|631303|P2|Overall Study|Adverse Event|1
199227|NCT01074008|631304|P1|Overall Study|Adverse Event|0
199228|NCT01074047|631419|P2|Extension Phase|Death|0
199229|NCT01074047|631420|P1|Extension Phase|Death|5
199230|NCT01074047|631419|P2|Extension Phase|Withdrawal by Subject|0
199231|NCT01074047|631420|P1|Extension Phase|Withdrawal by Subject|2
199232|NCT01074047|631419|P2|Extension Phase|Disease Progression|0
199233|NCT01074047|631420|P1|Extension Phase|Disease Progression|9
199234|NCT01074047|631419|P2|Extension Phase|Adverse Event|0
199235|NCT01074047|631420|P1|Extension Phase|Adverse Event|5
199236|NCT01074047|631419|P2|Extension Phase|Physician Decision|0
199237|NCT01074047|631420|P1|Extension Phase|Physician Decision|1
199238|NCT01074047|631419|P2|Survival Follow-Up Phase|Alive at study closure|3
199239|NCT01074047|631420|P1|Survival Follow-Up Phase|Alive at study closure|1
199240|NCT01074047|631419|P2|Survival Follow-Up Phase|Death|124
199241|NCT01074047|631420|P1|Survival Follow-Up Phase|Death|116
199242|NCT01074047|631419|P2|Survival Follow-Up Phase|Lost to Follow-up|1
199243|NCT01074047|631420|P1|Survival Follow-Up Phase|Lost to Follow-up|2
199244|NCT01074047|631419|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
199245|NCT01074047|631420|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
199246|NCT01074047|631419|P2|Treatment Phase|Miscellaneous|39
199247|NCT01074047|631420|P1|Treatment Phase|Miscellaneous|32
199248|NCT01074047|631419|P2|Treatment Phase|Protocol Violation|1
199249|NCT01074047|631420|P1|Treatment Phase|Protocol Violation|0
199250|NCT01074047|631419|P2|Treatment Phase|Lost to Follow-up|1
199251|NCT01074047|631420|P1|Treatment Phase|Lost to Follow-up|0
199252|NCT01074047|631419|P2|Treatment Phase|Death|58
199253|NCT01074047|631420|P1|Treatment Phase|Death|53
199254|NCT01074047|631419|P2|Treatment Phase|Withdrawal by Subject|48
199255|NCT01074047|631420|P1|Treatment Phase|Withdrawal by Subject|27
199256|NCT01074047|631419|P2|Treatment Phase|Disease Progression|21
199257|NCT01074047|631420|P1|Treatment Phase|Disease Progression|16
199258|NCT01074047|631419|P2|Treatment Phase|Adverse Event|66
199259|NCT01074047|631420|P1|Treatment Phase|Adverse Event|89
199260|NCT01074216|631545|P1|Overall Study|Not Treated|12
199261|NCT01074216|631545|P1|Overall Study|Physician Decision|1
199262|NCT01074229|631552|P3|Overall Study|Change to open surgical procedure|4
199263|NCT01074229|631553|P2|Overall Study|Change to open surgical procedure|3
199264|NCT01074229|631554|P1|Overall Study|Change to open surgical procedure|1
199265|NCT01074229|631552|P3|Overall Study|Lost to Follow-up|0
199266|NCT01074229|631553|P2|Overall Study|Lost to Follow-up|0
199267|NCT01074229|631554|P1|Overall Study|Lost to Follow-up|1
199268|NCT01074242|631565|P1|Overall Study|Duplicate Case Report Form|5
199269|NCT01074242|631565|P1|Overall Study|Violation of vaccine dose or dosage|351
199270|NCT01074242|631565|P1|Overall Study|Case report unclear|6
199271|NCT01074242|631565|P1|Overall Study|Lost to Follow-up|1
199272|NCT01074242|631565|P1|Overall Study|Case report before date of contract|40
199273|NCT01074255|631570|P1|Overall Study|Did not receive EMEND|2
199274|NCT01074268|631576|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
199275|NCT01074268|631577|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
199276|NCT01074268|631576|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
199277|NCT01074268|631577|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
199278|NCT01074268|631576|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
199279|NCT01074268|631577|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
199280|NCT01074268|631576|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
199281|NCT01074268|631577|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
199282|NCT01074268|631576|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
199283|NCT01074268|631577|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
199284|NCT01074268|631576|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
199285|NCT01074268|631577|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
199286|NCT01074268|631576|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
199287|NCT01074268|631577|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
199288|NCT01074268|631576|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
199289|NCT01074268|631577|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
199290|NCT01074268|631576|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
199291|NCT01074268|631577|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
199292|NCT01074307|631605|P2|Overall Study|Protocol Violation|5
199293|NCT01074307|631606|P1|Overall Study|Protocol Violation|8
199294|NCT01074307|631605|P2|Overall Study|Exclusion criterion|1
199295|NCT01074307|631606|P1|Overall Study|Exclusion criterion|0
199296|NCT01074307|631605|P2|Overall Study|No primary endpoint evaluation|6
199297|NCT01074307|631606|P1|Overall Study|No primary endpoint evaluation|14
199298|NCT01074450|631637|P2|Second Intervention|Physician Decision|1
199299|NCT01074450|631638|P1|Second Intervention|Physician Decision|0
199300|NCT01074450|631637|P2|Second Intervention|Protocol Violation|0
199301|NCT01074450|631638|P1|Second Intervention|Protocol Violation|1
199302|NCT01074450|631637|P2|First Intervention|Emesis in Dosing Interval|2
199303|NCT01074450|631638|P1|First Intervention|Emesis in Dosing Interval|0
199304|NCT01074502|631661|P1|Overall Study|Withdrawal by Subject|1
199305|NCT01074554|631672|P2|Overall Study|Lost to Follow-up|1
199306|NCT01074554|631673|P1|Overall Study|Lost to Follow-up|0
199307|NCT01074554|631672|P2|Overall Study|Adverse Event|3
199308|NCT01074554|631673|P1|Overall Study|Adverse Event|3
199309|NCT01074658|631683|P1|Overall Study|No implant attempted|19
199310|NCT01074931|631689|P1|Overall Study|Death|5
199311|NCT01074931|631689|P1|Overall Study|Economic reasons|1
199312|NCT01074944|631701|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
199313|NCT01074944|631702|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
199314|NCT01074944|631703|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
199315|NCT01074944|631704|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
199316|NCT01074944|631705|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
199317|NCT01074944|631701|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
199318|NCT01074944|631702|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
199319|NCT01074944|631703|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
199320|NCT01074944|631704|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
199321|NCT01074944|631705|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
199322|NCT01074944|631701|P5|Long Term Treatment|Withdrawal by Subject|0
199323|NCT01074944|631702|P4|Long Term Treatment|Withdrawal by Subject|2
199324|NCT01074944|631703|P3|Long Term Treatment|Withdrawal by Subject|0
199325|NCT01074944|631704|P2|Long Term Treatment|Withdrawal by Subject|0
199326|NCT01074944|631705|P1|Long Term Treatment|Withdrawal by Subject|0
199327|NCT01074944|631701|P5|Long Term Treatment|Entered in Period, But Not Treated|0
199328|NCT01074944|631702|P4|Long Term Treatment|Entered in Period, But Not Treated|1
199329|NCT01074944|631703|P3|Long Term Treatment|Entered in Period, But Not Treated|0
199330|NCT01074944|631704|P2|Long Term Treatment|Entered in Period, But Not Treated|0
199331|NCT01074944|631705|P1|Long Term Treatment|Entered in Period, But Not Treated|0
199332|NCT01074944|631701|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
199333|NCT01074944|631702|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
199334|NCT01074944|631703|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
199335|NCT01074944|631704|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
199336|NCT01074944|631705|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
199337|NCT01074944|631701|P5|Long Term Treatment|Lost to Follow-up|0
199338|NCT01074944|631702|P4|Long Term Treatment|Lost to Follow-up|2
199339|NCT01074944|631703|P3|Long Term Treatment|Lost to Follow-up|0
199340|NCT01074944|631704|P2|Long Term Treatment|Lost to Follow-up|0
199341|NCT01074944|631705|P1|Long Term Treatment|Lost to Follow-up|0
199342|NCT01074944|631701|P5|Long Term Treatment|Adverse Event|0
199343|NCT01074944|631702|P4|Long Term Treatment|Adverse Event|3
199344|NCT01074944|631703|P3|Long Term Treatment|Adverse Event|0
199345|NCT01074944|631704|P2|Long Term Treatment|Adverse Event|0
199346|NCT01074944|631705|P1|Long Term Treatment|Adverse Event|0
199347|NCT01074944|631701|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
199348|NCT01074944|631702|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
199349|NCT01074944|631703|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
199350|NCT01074944|631704|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
199351|NCT01074944|631705|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
199352|NCT01074944|631701|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
199353|NCT01074944|631702|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
199354|NCT01074944|631703|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
199355|NCT01074944|631704|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
199356|NCT01074944|631705|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
199357|NCT01074944|631701|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
199358|NCT01074944|631702|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
199359|NCT01074944|631703|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
199360|NCT01074944|631704|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
199361|NCT01074944|631705|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
199362|NCT01074944|631701|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
199363|NCT01074944|631702|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
199364|NCT01074944|631703|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
199365|NCT01074944|631704|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
199366|NCT01074944|631705|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
199367|NCT01074944|631701|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
199368|NCT01074944|631702|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
199369|NCT01074944|631703|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
199370|NCT01074944|631704|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
199371|NCT01074944|631705|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
199372|NCT01074944|631701|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
199373|NCT01074944|631702|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
199374|NCT01074944|631703|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
199375|NCT01074944|631704|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
199376|NCT01074944|631705|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
199377|NCT01074944|631701|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
199378|NCT01074944|631702|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
199379|NCT01074944|631703|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
199380|NCT01074944|631704|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
199381|NCT01074944|631705|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
199382|NCT01074944|631701|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
199383|NCT01074944|631702|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
199384|NCT01074944|631703|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
199385|NCT01074944|631704|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
199386|NCT01074944|631705|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
199387|NCT01074944|631701|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
199388|NCT01074944|631702|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
199389|NCT01074944|631703|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
199390|NCT01074944|631704|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
199391|NCT01074944|631705|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
199392|NCT01075074|631762|P3|Overall Study|Surgeon changed to open incisional case|2
199393|NCT01075074|631763|P2|Overall Study|Surgeon changed to open incisional case|2
199394|NCT01075074|631764|P1|Overall Study|Surgeon changed to open incisional case|1
199395|NCT01075100|631794|P2|Overall Study|Other|1
199396|NCT01075100|631795|P1|Overall Study|Other|3
199397|NCT01075100|631794|P2|Overall Study|Disease Progression|29
199398|NCT01075100|631795|P1|Overall Study|Disease Progression|25
199399|NCT01075100|631794|P2|Overall Study|Investigator Request|1
199400|NCT01075100|631795|P1|Overall Study|Investigator Request|2
199401|NCT01075100|631794|P2|Overall Study|Patient Request|4
199402|NCT01075100|631795|P1|Overall Study|Patient Request|4
199403|NCT01075100|631794|P2|Overall Study|Adverse Event|18
199404|NCT01075100|631795|P1|Overall Study|Adverse Event|15
199405|NCT01075152|631813|P2|Overall Study|Withdrawal by Subject|0
199406|NCT01075152|631814|P1|Overall Study|Withdrawal by Subject|1
199407|NCT01075178|631840|P2|Subject Chart Review|matched partner excluded (reasons above)|3
199408|NCT01075178|631841|P1|Subject Chart Review|matched partner excluded (reasons above)|6
199409|NCT01075178|631840|P2|Subject Chart Review|no data collected due to site closure|4
199410|NCT01075178|631841|P1|Subject Chart Review|no data collected due to site closure|3
199411|NCT01075178|631840|P2|Subject Chart Review|died before chart review period|2
199412|NCT01075178|631841|P1|Subject Chart Review|died before chart review period|0
199413|NCT01075178|631840|P2|Subject Matching|eligible but not matched|403
199414|NCT01075178|631841|P1|Subject Matching|eligible but not matched|130
199415|NCT01075191|631853|P1|Overall Study|Unknown Reasons|1
199416|NCT01075191|631853|P1|Overall Study|Patient's Wish|2
199417|NCT01075191|631853|P1|Overall Study|Therapy Break|3
199418|NCT01075191|631853|P1|Overall Study|Noncompliance|3
199419|NCT01075191|631853|P1|Overall Study|Adverse Event|4
199420|NCT01075191|631853|P1|Overall Study|Co-morbidities|1
199421|NCT01075191|631853|P1|Overall Study|Intensification|3
199422|NCT01075191|631853|P1|Overall Study|Death|1
199423|NCT01075217|631881|P2|Overall Study|Physician Decision|0
199424|NCT01075217|631882|P1|Overall Study|Physician Decision|1
199425|NCT01075217|631881|P2|Overall Study|Adverse Event|1
199426|NCT01075217|631882|P1|Overall Study|Adverse Event|1
199427|NCT01075243|631901|P3|Overall Study|Withdrawal by Subject|0
199428|NCT01075243|631902|P2|Overall Study|Withdrawal by Subject|1
199429|NCT01075243|631903|P1|Overall Study|Withdrawal by Subject|1
199430|NCT01075243|631901|P3|Overall Study|Lost to Follow-up|0
199431|NCT01075243|631902|P2|Overall Study|Lost to Follow-up|2
199432|NCT01075243|631903|P1|Overall Study|Lost to Follow-up|5
199433|NCT01075256|631956|P3|Overall Study|Withdrawal by Subject|0
199434|NCT01075256|631957|P2|Overall Study|Withdrawal by Subject|0
199435|NCT01075256|631958|P1|Overall Study|Withdrawal by Subject|1
199436|NCT01075282|631990|P3|Overall Study|Death|2
199437|NCT01075282|631991|P2|Overall Study|Death|1
199438|NCT01075282|631992|P1|Overall Study|Death|0
199439|NCT01075282|631990|P3|Overall Study|Protocol Violation|1
199440|NCT01075282|631991|P2|Overall Study|Protocol Violation|2
199441|NCT01075282|631992|P1|Overall Study|Protocol Violation|0
199442|NCT01075282|631990|P3|Overall Study|Treatment Non-compliance|2
199443|NCT01075282|631991|P2|Overall Study|Treatment Non-compliance|2
199444|NCT01075282|631992|P1|Overall Study|Treatment Non-compliance|1
199445|NCT01075282|631990|P3|Overall Study|Lack of Efficacy|0
199446|NCT01075282|631991|P2|Overall Study|Lack of Efficacy|1
199447|NCT01075282|631992|P1|Overall Study|Lack of Efficacy|1
199448|NCT01075282|631990|P3|Overall Study|Physician Decision|3
199449|NCT01075282|631991|P2|Overall Study|Physician Decision|3
199450|NCT01075282|631992|P1|Overall Study|Physician Decision|3
199451|NCT01075282|631990|P3|Overall Study|Lost to Follow-up|3
199452|NCT01075282|631991|P2|Overall Study|Lost to Follow-up|3
199453|NCT01075282|631992|P1|Overall Study|Lost to Follow-up|3
199454|NCT01075282|631990|P3|Overall Study|Entry Criteria Not Met|0
199455|NCT01075282|631991|P2|Overall Study|Entry Criteria Not Met|2
199456|NCT01075282|631992|P1|Overall Study|Entry Criteria Not Met|3
199457|NCT01075282|631990|P3|Overall Study|Adverse Event|5
199458|NCT01075282|631991|P2|Overall Study|Adverse Event|8
199459|NCT01075282|631992|P1|Overall Study|Adverse Event|9
199460|NCT01075282|631990|P3|Overall Study|Withdrawal by Subject|11
199461|NCT01075282|631991|P2|Overall Study|Withdrawal by Subject|7
199462|NCT01075282|631992|P1|Overall Study|Withdrawal by Subject|11
199463|NCT01075646|632091|P4|Overall Study|Lost to Follow-up|2
199464|NCT01075646|632092|P3|Overall Study|Lost to Follow-up|1
199465|NCT01075646|632093|P2|Overall Study|Lost to Follow-up|3
199466|NCT01075646|632094|P1|Overall Study|Lost to Follow-up|4
199467|NCT01075685|632126|P2|Overall Study|Lost to Follow-up|220
199468|NCT01075685|632127|P1|Overall Study|Lost to Follow-up|563
199469|NCT01075685|632126|P2|Overall Study|Withdrawal by Subject|5
199470|NCT01075685|632127|P1|Overall Study|Withdrawal by Subject|20
199471|NCT01075685|632126|P2|Overall Study|Protocol Violation|1
199472|NCT01075685|632127|P1|Overall Study|Protocol Violation|9
199473|NCT01075763|632141|P2|Overall Study|Withdrawal by Subject|2
199474|NCT01075763|632142|P1|Overall Study|Withdrawal by Subject|2
199475|NCT01075763|632141|P2|Overall Study|Lack of Efficacy|1
199476|NCT01075763|632142|P1|Overall Study|Lack of Efficacy|0
199477|NCT01075763|632141|P2|Overall Study|Lost to Follow-up|1
199478|NCT01075763|632142|P1|Overall Study|Lost to Follow-up|2
199479|NCT01075815|632166|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
199480|NCT01075815|632167|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
199481|NCT01075815|632166|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
199482|NCT01075815|632167|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
199483|NCT01075815|632166|P2|Overall Study|Withdrawal before r-hCG administration|1
199484|NCT01075815|632167|P1|Overall Study|Withdrawal before r-hCG administration|6
199485|NCT01075958|632203|P1|Overall Study|Blood sample could not be obtained|44
199486|NCT01075984|632226|P5|Follow-up Phase|Treatment failure|4
199487|NCT01075984|632227|P4|Follow-up Phase|Treatment failure|0
199488|NCT01075984|632228|P3|Follow-up Phase|Treatment failure|0
199489|NCT01075984|632229|P2|Follow-up Phase|Treatment failure|0
199490|NCT01075984|632230|P1|Follow-up Phase|Treatment failure|0
199491|NCT01075984|632226|P5|Follow-up Phase|Progression of disease|2
199492|NCT01075984|632227|P4|Follow-up Phase|Progression of disease|0
199493|NCT01075984|632228|P3|Follow-up Phase|Progression of disease|0
199494|NCT01075984|632229|P2|Follow-up Phase|Progression of disease|0
199495|NCT01075984|632230|P1|Follow-up Phase|Progression of disease|0
199496|NCT01075984|632226|P5|Follow-up Phase|Withdrawal by Subject|10
199497|NCT01075984|632227|P4|Follow-up Phase|Withdrawal by Subject|0
199498|NCT01075984|632228|P3|Follow-up Phase|Withdrawal by Subject|0
199499|NCT01075984|632229|P2|Follow-up Phase|Withdrawal by Subject|0
199500|NCT01075984|632230|P1|Follow-up Phase|Withdrawal by Subject|0
199501|NCT01075984|632226|P5|Follow-up Phase|Administrative|1
199502|NCT01075984|632227|P4|Follow-up Phase|Administrative|0
199503|NCT01075984|632228|P3|Follow-up Phase|Administrative|0
199504|NCT01075984|632229|P2|Follow-up Phase|Administrative|0
199505|NCT01075984|632230|P1|Follow-up Phase|Administrative|0
199506|NCT01075984|632226|P5|Follow-up Phase|Adverse Event|27
199507|NCT01075984|632227|P4|Follow-up Phase|Adverse Event|2
199508|NCT01075984|632228|P3|Follow-up Phase|Adverse Event|0
199509|NCT01075984|632229|P2|Follow-up Phase|Adverse Event|0
199510|NCT01075984|632230|P1|Follow-up Phase|Adverse Event|0
199511|NCT01075984|632226|P5|Follow-up Phase|Protocol Violation|3
199512|NCT01075984|632227|P4|Follow-up Phase|Protocol Violation|0
199513|NCT01075984|632228|P3|Follow-up Phase|Protocol Violation|1
199514|NCT01075984|632229|P2|Follow-up Phase|Protocol Violation|0
199515|NCT01075984|632230|P1|Follow-up Phase|Protocol Violation|0
199516|NCT01075984|632226|P5|Treatment Phase|Progression of disease|2
199517|NCT01075984|632227|P4|Treatment Phase|Progression of disease|0
199518|NCT01075984|632228|P3|Treatment Phase|Progression of disease|0
199519|NCT01075984|632229|P2|Treatment Phase|Progression of disease|0
199520|NCT01075984|632230|P1|Treatment Phase|Progression of disease|0
199521|NCT01075984|632226|P5|Treatment Phase|Treatment Failure|5
199522|NCT01075984|632227|P4|Treatment Phase|Treatment Failure|0
199523|NCT01075984|632228|P3|Treatment Phase|Treatment Failure|1
199524|NCT01075984|632229|P2|Treatment Phase|Treatment Failure|0
199525|NCT01075984|632230|P1|Treatment Phase|Treatment Failure|0
199526|NCT01075984|632226|P5|Treatment Phase|Withdrawal by Subject|15
199527|NCT01075984|632227|P4|Treatment Phase|Withdrawal by Subject|0
199528|NCT01075984|632228|P3|Treatment Phase|Withdrawal by Subject|2
199529|NCT01075984|632229|P2|Treatment Phase|Withdrawal by Subject|0
199530|NCT01075984|632230|P1|Treatment Phase|Withdrawal by Subject|0
199531|NCT01075984|632226|P5|Treatment Phase|Protocol Violation|3
199532|NCT01075984|632227|P4|Treatment Phase|Protocol Violation|0
199533|NCT01075984|632228|P3|Treatment Phase|Protocol Violation|1
199534|NCT01075984|632229|P2|Treatment Phase|Protocol Violation|0
199535|NCT01075984|632230|P1|Treatment Phase|Protocol Violation|0
199536|NCT01075984|632226|P5|Treatment Phase|Adverse Event|35
199537|NCT01075984|632227|P4|Treatment Phase|Adverse Event|7
199538|NCT01075984|632228|P3|Treatment Phase|Adverse Event|3
199539|NCT01075984|632229|P2|Treatment Phase|Adverse Event|1
199540|NCT01075984|632230|P1|Treatment Phase|Adverse Event|0
199541|NCT01076036|632284|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
199542|NCT01076075|632291|P2|Overall Study|Withdrawal by Subject|19
199543|NCT01076075|632292|P1|Overall Study|Withdrawal by Subject|8
199544|NCT01076075|632291|P2|Overall Study|Protocol Violation|1
199545|NCT01076075|632292|P1|Overall Study|Protocol Violation|0
199546|NCT01076075|632291|P2|Overall Study|other|9
199547|NCT01076075|632292|P1|Overall Study|other|19
199548|NCT01076075|632291|P2|Overall Study|Lost to Follow-up|5
199549|NCT01076075|632292|P1|Overall Study|Lost to Follow-up|6
199550|NCT01076075|632291|P2|Overall Study|Lack of Efficacy|4
199551|NCT01076075|632292|P1|Overall Study|Lack of Efficacy|5
199552|NCT01076075|632291|P2|Overall Study|Adverse Event|9
199553|NCT01076075|632292|P1|Overall Study|Adverse Event|3
199554|NCT01076088|632312|P6|Overall Study|Other protocol specified criteria|1
199555|NCT01076088|632313|P5|Overall Study|Other protocol specified criteria|0
199556|NCT01076088|632314|P4|Overall Study|Other protocol specified criteria|0
199557|NCT01076088|632315|P3|Overall Study|Other protocol specified criteria|0
199558|NCT01076088|632316|P2|Overall Study|Other protocol specified criteria|0
199559|NCT01076088|632317|P1|Overall Study|Other protocol specified criteria|0
199560|NCT01076088|632312|P6|Overall Study|Withdrawal by Subject|17
199561|NCT01076088|632313|P5|Overall Study|Withdrawal by Subject|11
199562|NCT01076088|632314|P4|Overall Study|Withdrawal by Subject|10
199563|NCT01076088|632315|P3|Overall Study|Withdrawal by Subject|14
199564|NCT01076088|632316|P2|Overall Study|Withdrawal by Subject|8
199565|NCT01076088|632317|P1|Overall Study|Withdrawal by Subject|8
199566|NCT01076088|632312|P6|Overall Study|Physician Decision|0
199567|NCT01076088|632313|P5|Overall Study|Physician Decision|1
199568|NCT01076088|632314|P4|Overall Study|Physician Decision|1
199569|NCT01076088|632315|P3|Overall Study|Physician Decision|0
199570|NCT01076088|632316|P2|Overall Study|Physician Decision|3
199571|NCT01076088|632317|P1|Overall Study|Physician Decision|1
199572|NCT01076088|632312|P6|Overall Study|Non-compliance with study drug|0
199573|NCT01076088|632313|P5|Overall Study|Non-compliance with study drug|0
199574|NCT01076088|632314|P4|Overall Study|Non-compliance with study drug|1
199575|NCT01076088|632315|P3|Overall Study|Non-compliance with study drug|0
199576|NCT01076088|632316|P2|Overall Study|Non-compliance with study drug|0
199577|NCT01076088|632317|P1|Overall Study|Non-compliance with study drug|0
199578|NCT01076088|632312|P6|Overall Study|Lost to Follow-up|2
199579|NCT01076088|632313|P5|Overall Study|Lost to Follow-up|1
199580|NCT01076088|632314|P4|Overall Study|Lost to Follow-up|1
199581|NCT01076088|632315|P3|Overall Study|Lost to Follow-up|0
199582|NCT01076088|632316|P2|Overall Study|Lost to Follow-up|1
199583|NCT01076088|632317|P1|Overall Study|Lost to Follow-up|1
199584|NCT01076088|632312|P6|Overall Study|Adverse Event|3
199585|NCT01076088|632313|P5|Overall Study|Adverse Event|3
199586|NCT01076088|632314|P4|Overall Study|Adverse Event|2
199587|NCT01076088|632315|P3|Overall Study|Adverse Event|3
199588|NCT01076088|632316|P2|Overall Study|Adverse Event|6
199589|NCT01076088|632317|P1|Overall Study|Adverse Event|1
199590|NCT01076153|632343|P1|Overall Study|Adverse Event|1
199591|NCT01076153|632343|P1|Overall Study|Symptoms improved/resolved|10
199592|NCT01076166|632351|P1|Overall Study|Symptoms improved/resolved|6
199593|NCT01076166|632351|P1|Overall Study|Adverse Event|3
199594|NCT01076179|632358|P1|Overall Study|Withdrawal by Subject|1
199595|NCT01076192|632381|P1|Overall Study|Not specified|197
199596|NCT01076335|632444|P1|Overall Study|Withdrawal without treatment|1
199597|NCT01076335|632444|P1|Overall Study|Withdrawal by Subject|3
199598|NCT01076361|632452|P1|Overall Study|22 leads were excluded from analysis|21
199599|NCT01076647|632490|P2|Overall Study|Unclassified|12
199600|NCT01076647|632491|P1|Overall Study|Unclassified|12
199601|NCT01076647|632490|P2|Overall Study|Withdrawal criteria|2
199602|NCT01076647|632491|P1|Overall Study|Withdrawal criteria|2
199603|NCT01076647|632490|P2|Overall Study|Protocol Violation|9
199604|NCT01076647|632491|P1|Overall Study|Protocol Violation|7
199605|NCT01076647|632490|P2|Overall Study|Lack of Efficacy|1
199606|NCT01076647|632491|P1|Overall Study|Lack of Efficacy|0
199607|NCT01076647|632490|P2|Overall Study|Adverse Event|1
199608|NCT01076647|632491|P1|Overall Study|Adverse Event|4
199609|NCT01085045|632516|P1|Part B|Adverse Event|6
199610|NCT01085045|632516|P1|Part B|Lost to Follow-up|1
199611|NCT01085045|632516|P1|Part B|Protocol Specified Criteria|6
199612|NCT01085045|632516|P1|Part B|Withdrawal by Subject|2
199613|NCT01085045|632516|P1|Part A|Protocol Specified Criteria|7
199614|NCT01085045|632516|P1|Part A|Protocol Violation|1
199615|NCT01085045|632516|P1|Part A|Adverse Event|6
199616|NCT01085045|632516|P1|Part A|Withdrawal by Subject|4
199617|NCT01085136|632616|P3|Part B|Other reason not defined above|3
199618|NCT01085136|632617|P2|Part B|Other reason not defined above|6
199619|NCT01085136|632618|P1|Part B|Other reason not defined above|0
199620|NCT01085136|632616|P3|Part B|Not treated|8
199621|NCT01085136|632617|P2|Part B|Not treated|4
199622|NCT01085136|632618|P1|Part B|Not treated|0
199623|NCT01085136|632616|P3|Part B|Refusal to continue trial medication|7
199624|NCT01085136|632617|P2|Part B|Refusal to continue trial medication|12
199625|NCT01085136|632618|P1|Part B|Refusal to continue trial medication|0
199626|NCT01085136|632616|P3|Part B|Other AE|8
199627|NCT01085136|632617|P2|Part B|Other AE|29
199628|NCT01085136|632618|P1|Part B|Other AE|0
199629|NCT01085136|632616|P3|Part A|Other reason not defined above|0
199630|NCT01085136|632617|P2|Part A|Other reason not defined above|0
199631|NCT01085136|632618|P1|Part A|Other reason not defined above|30
199632|NCT01085136|632616|P3|Part A|Refusal to continue trial medication|0
199633|NCT01085136|632617|P2|Part A|Refusal to continue trial medication|0
199634|NCT01085136|632618|P1|Part A|Refusal to continue trial medication|64
199635|NCT01085136|632616|P3|Part A|Lost to Follow-up|0
199636|NCT01085136|632617|P2|Part A|Lost to Follow-up|0
199637|NCT01085136|632618|P1|Part A|Lost to Follow-up|3
199638|NCT01085136|632616|P3|Part A|Protocol Violation|0
199639|NCT01085136|632617|P2|Part A|Protocol Violation|0
199640|NCT01085136|632618|P1|Part A|Protocol Violation|3
199641|NCT01085136|632616|P3|Part A|Other Adverse event|0
199642|NCT01085136|632617|P2|Part A|Other Adverse event|0
199643|NCT01085136|632618|P1|Part A|Other Adverse event|223
199644|NCT01085201|632639|P5|Overall Study|Fond ineligible after consent|0
199645|NCT01085201|632640|P4|Overall Study|Fond ineligible after consent|0
199646|NCT01085201|632641|P3|Overall Study|Fond ineligible after consent|1
199647|NCT01085201|632642|P2|Overall Study|Fond ineligible after consent|1
199648|NCT01085201|632643|P1|Overall Study|Fond ineligible after consent|0
199649|NCT01085201|632639|P5|Overall Study|Unknown- no study drug|0
199650|NCT01085201|632640|P4|Overall Study|Unknown- no study drug|0
199651|NCT01085201|632641|P3|Overall Study|Unknown- no study drug|0
199652|NCT01085201|632642|P2|Overall Study|Unknown- no study drug|0
199653|NCT01085201|632643|P1|Overall Study|Unknown- no study drug|2
199654|NCT01085201|632639|P5|Overall Study|Scheduling conflict|0
199655|NCT01085201|632640|P4|Overall Study|Scheduling conflict|0
199656|NCT01085201|632641|P3|Overall Study|Scheduling conflict|1
199657|NCT01085201|632642|P2|Overall Study|Scheduling conflict|0
199658|NCT01085201|632643|P1|Overall Study|Scheduling conflict|1
199659|NCT01085214|632665|P1|Overall Study|Alternate treatment required|1
199660|NCT01085357|632727|P2|Overall Study|Lost to Follow-up|0
199661|NCT01085357|632728|P1|Overall Study|Lost to Follow-up|2
199662|NCT01085357|632727|P2|Overall Study|Death|1
199663|NCT01085357|632728|P1|Overall Study|Death|11
199664|NCT01085357|632727|P2|Overall Study|Investigator Decision|1
199665|NCT01085357|632728|P1|Overall Study|Investigator Decision|1
199666|NCT01085357|632727|P2|Overall Study|Subject Decision|3
199667|NCT01085357|632728|P1|Overall Study|Subject Decision|4
199668|NCT01085357|632727|P2|Overall Study|Adverse Event|1
199669|NCT01085357|632728|P1|Overall Study|Adverse Event|1
199670|NCT01085591|632767|P3|Overall Study|Not Properly Consented|0
199671|NCT01085591|632768|P2|Overall Study|Not Properly Consented|0
199672|NCT01085591|632769|P1|Overall Study|Not Properly Consented|1
199673|NCT01085591|632767|P3|Overall Study|Other|0
199674|NCT01085591|632768|P2|Overall Study|Other|1
199675|NCT01085591|632769|P1|Overall Study|Other|0
199676|NCT01085591|632767|P3|Overall Study|Protocol Violation|1
199677|NCT01085591|632768|P2|Overall Study|Protocol Violation|1
199678|NCT01085591|632769|P1|Overall Study|Protocol Violation|1
199679|NCT01085591|632767|P3|Overall Study|Lost to Follow-up|1
199680|NCT01085591|632768|P2|Overall Study|Lost to Follow-up|1
199681|NCT01085591|632769|P1|Overall Study|Lost to Follow-up|0
199682|NCT01085591|632767|P3|Overall Study|Withdrawal by Subject|1
199683|NCT01085591|632768|P2|Overall Study|Withdrawal by Subject|2
199684|NCT01085591|632769|P1|Overall Study|Withdrawal by Subject|0
199685|NCT01085591|632767|P3|Overall Study|Physician Decision|1
199686|NCT01085591|632768|P2|Overall Study|Physician Decision|0
199687|NCT01085591|632769|P1|Overall Study|Physician Decision|1
199688|NCT01085591|632767|P3|Overall Study|Adverse Event|3
199689|NCT01085591|632768|P2|Overall Study|Adverse Event|1
199690|NCT01085591|632769|P1|Overall Study|Adverse Event|0
199691|NCT01085682|632803|P2|Overall Study|Withdrawal by Subject|25
199692|NCT01085682|632804|P1|Overall Study|Withdrawal by Subject|25
199693|NCT01085734|632812|P2|Overall Study|Withdrawal by Subject|1
199694|NCT01085734|632813|P1|Overall Study|Withdrawal by Subject|0
199695|NCT01085734|632812|P2|Overall Study|Lost to Follow-up|1
199696|NCT01085734|632813|P1|Overall Study|Lost to Follow-up|0
199697|NCT01085734|632812|P2|Overall Study|Death|0
199698|NCT01085734|632813|P1|Overall Study|Death|1
199699|NCT01085734|632812|P2|Overall Study|Adverse Event|2
199700|NCT01085734|632813|P1|Overall Study|Adverse Event|0
199701|NCT01086033|632915|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
199702|NCT01086033|632915|P1|Overall Study|AE and Other Reason|1
199703|NCT01086033|632915|P1|Overall Study|AE and Lost to Follow-up|1
199704|NCT01086033|632915|P1|Overall Study|Death|1
199705|NCT01086033|632915|P1|Overall Study|AE and Lack of Efficacy|4
199706|NCT01086033|632915|P1|Overall Study|Withdrew consent and Other Reason|4
199707|NCT01086033|632915|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
199708|NCT01086033|632915|P1|Overall Study|AE and Withdrew Consent|5
199709|NCT01086033|632915|P1|Overall Study|Other|13
199710|NCT01086033|632915|P1|Overall Study|Other|14
199711|NCT01086033|632915|P1|Overall Study|Withdrawal by Subject|41
199712|NCT01086033|632915|P1|Overall Study|Adverse Event|42
199713|NCT01086033|632915|P1|Overall Study|Lost to Follow-up|86
199714|NCT01086033|632915|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
199715|NCT01086215|632931|P4|Overall Study|Lost to Follow-up|2
199716|NCT01086215|632932|P3|Overall Study|Lost to Follow-up|18
199717|NCT01086215|632933|P2|Overall Study|Lost to Follow-up|39
199718|NCT01086215|632934|P1|Overall Study|Lost to Follow-up|22
199719|NCT01086215|632931|P4|Overall Study|Death|1
199720|NCT01086215|632932|P3|Overall Study|Death|8
199721|NCT01086215|632933|P2|Overall Study|Death|8
199722|NCT01086215|632934|P1|Overall Study|Death|14
199723|NCT01086384|632954|P3|Treatment Period|Received Treatment in Error|0
199724|NCT01086384|632955|P2|Treatment Period|Received Treatment in Error|1
199725|NCT01086384|632956|P1|Treatment Period|Received Treatment in Error|0
199726|NCT01086384|632954|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
199727|NCT01086384|632955|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
199728|NCT01086384|632956|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
199729|NCT01086384|632954|P3|Treatment Period|Study Closed/Terminated|8
199730|NCT01086384|632955|P2|Treatment Period|Study Closed/Terminated|7
199731|NCT01086384|632956|P1|Treatment Period|Study Closed/Terminated|0
199732|NCT01086384|632954|P3|Treatment Period|Physician Decision|6
199733|NCT01086384|632955|P2|Treatment Period|Physician Decision|9
199734|NCT01086384|632956|P1|Treatment Period|Physician Decision|0
199735|NCT01086384|632954|P3|Treatment Period|Lost to Follow-up|9
199736|NCT01086384|632955|P2|Treatment Period|Lost to Follow-up|11
199737|NCT01086384|632956|P1|Treatment Period|Lost to Follow-up|0
199738|NCT01086384|632954|P3|Treatment Period|Adverse Event|15
199739|NCT01086384|632955|P2|Treatment Period|Adverse Event|19
199740|NCT01086384|632956|P1|Treatment Period|Adverse Event|0
199741|NCT01086384|632954|P3|Treatment Period|Lack of Efficacy|13
199742|NCT01086384|632955|P2|Treatment Period|Lack of Efficacy|22
199743|NCT01086384|632956|P1|Treatment Period|Lack of Efficacy|0
199744|NCT01086384|632954|P3|Treatment Period|Protocol Violation|17
199745|NCT01086384|632955|P2|Treatment Period|Protocol Violation|26
199746|NCT01086384|632956|P1|Treatment Period|Protocol Violation|0
199747|NCT01086384|632954|P3|Treatment Period|Withdrawal by Subject|55
199748|NCT01086384|632955|P2|Treatment Period|Withdrawal by Subject|53
199749|NCT01086384|632956|P1|Treatment Period|Withdrawal by Subject|0
199750|NCT01086384|632954|P3|2-week Run-in Period|Randomized in Error|0
199751|NCT01086384|632955|P2|2-week Run-in Period|Randomized in Error|0
199752|NCT01086384|632956|P1|2-week Run-in Period|Randomized in Error|1
199753|NCT01086384|632954|P3|2-week Run-in Period|Continuation Criteria Not Met|0
199754|NCT01086384|632955|P2|2-week Run-in Period|Continuation Criteria Not Met|0
199755|NCT01086384|632956|P1|2-week Run-in Period|Continuation Criteria Not Met|92
199756|NCT01086384|632954|P3|2-week Run-in Period|Study Closed/Terminated|0
199757|NCT01086384|632955|P2|2-week Run-in Period|Study Closed/Terminated|0
199758|NCT01086384|632956|P1|2-week Run-in Period|Study Closed/Terminated|42
199759|NCT01086384|632954|P3|2-week Run-in Period|Withdrawal by Subject|0
199760|NCT01086384|632955|P2|2-week Run-in Period|Withdrawal by Subject|0
199761|NCT01086384|632956|P1|2-week Run-in Period|Withdrawal by Subject|19
199762|NCT01086384|632954|P3|2-week Run-in Period|Physician Decision|0
199763|NCT01086384|632955|P2|2-week Run-in Period|Physician Decision|0
199764|NCT01086384|632956|P1|2-week Run-in Period|Physician Decision|6
199765|NCT01086384|632954|P3|2-week Run-in Period|Lost to Follow-up|0
199766|NCT01086384|632955|P2|2-week Run-in Period|Lost to Follow-up|0
199767|NCT01086384|632956|P1|2-week Run-in Period|Lost to Follow-up|1
199768|NCT01086384|632954|P3|2-week Run-in Period|Protocol Violation|0
199769|NCT01086384|632955|P2|2-week Run-in Period|Protocol Violation|0
199770|NCT01086384|632956|P1|2-week Run-in Period|Protocol Violation|1
199771|NCT01086384|632954|P3|2-week Run-in Period|Adverse Event|0
199772|NCT01086384|632955|P2|2-week Run-in Period|Adverse Event|0
199773|NCT01086384|632956|P1|2-week Run-in Period|Adverse Event|1
199774|NCT01086410|632970|P4|Overall Study|Lost to Follow-up|0
199775|NCT01086410|632971|P3|Overall Study|Lost to Follow-up|1
199776|NCT01086410|632972|P2|Overall Study|Lost to Follow-up|0
199777|NCT01086410|632973|P1|Overall Study|Lost to Follow-up|0
199778|NCT01086410|632970|P4|Overall Study|Protocol Violation|0
199779|NCT01086410|632971|P3|Overall Study|Protocol Violation|0
199780|NCT01086410|632972|P2|Overall Study|Protocol Violation|1
199781|NCT01086410|632973|P1|Overall Study|Protocol Violation|1
199782|NCT01086410|632970|P4|Overall Study|Lack of Efficacy|0
199783|NCT01086410|632971|P3|Overall Study|Lack of Efficacy|0
199784|NCT01086410|632972|P2|Overall Study|Lack of Efficacy|1
199785|NCT01086410|632973|P1|Overall Study|Lack of Efficacy|1
199786|NCT01086410|632970|P4|Overall Study|Adverse Event|2
199787|NCT01086410|632971|P3|Overall Study|Adverse Event|0
199788|NCT01086410|632972|P2|Overall Study|Adverse Event|0
199789|NCT01086410|632973|P1|Overall Study|Adverse Event|1
199790|NCT01086423|633070|P3|Overall Study|Lost to Follow-up|1
199791|NCT01086423|633071|P2|Overall Study|Lost to Follow-up|0
199792|NCT01086423|633072|P1|Overall Study|Lost to Follow-up|0
199793|NCT01086423|633070|P3|Overall Study|Withdrawal by Subject|3
199794|NCT01086423|633071|P2|Overall Study|Withdrawal by Subject|1
199795|NCT01086423|633072|P1|Overall Study|Withdrawal by Subject|5
199796|NCT01086423|633070|P3|Overall Study|Adverse event, non-fatal|0
199797|NCT01086423|633071|P2|Overall Study|Adverse event, non-fatal|1
199798|NCT01086423|633072|P1|Overall Study|Adverse event, non-fatal|2
199799|NCT01086423|633070|P3|Overall Study|Adverse event, fatal|0
199800|NCT01086423|633071|P2|Overall Study|Adverse event, fatal|1
199801|NCT01086423|633072|P1|Overall Study|Adverse event, fatal|1
199802|NCT01086423|633070|P3|Overall Study|Migrated/moved from study area|4
199803|NCT01086423|633071|P2|Overall Study|Migrated/moved from study area|0
199804|NCT01086423|633072|P1|Overall Study|Migrated/moved from study area|2
199805|NCT01086423|633070|P3|Overall Study|Protocol Violation|1
199806|NCT01086423|633071|P2|Overall Study|Protocol Violation|0
199807|NCT01086423|633072|P1|Overall Study|Protocol Violation|0
199808|NCT01086969|633206|P3|Overall Study|Withdrawal by Subject|0
199809|NCT01086969|633207|P2|Overall Study|Withdrawal by Subject|2
199810|NCT01086969|633208|P1|Overall Study|Withdrawal by Subject|1
199811|NCT01087489|633225|P2|Overall Study|unable to survey by telephone|1
199812|NCT01087489|633226|P1|Overall Study|unable to survey by telephone|0
199813|NCT01087489|633225|P2|Overall Study|Death|1
199814|NCT01087489|633226|P1|Overall Study|Death|0
199815|NCT01087489|633225|P2|Overall Study|enrolled in another VA study|1
199816|NCT01087489|633226|P1|Overall Study|enrolled in another VA study|0
199817|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
199818|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
199819|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
199820|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
199821|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
199822|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
199823|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
199824|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
199825|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
199826|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
199827|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
199828|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
199829|NCT01087502|633238|P2|Up to Final Analysis (Week 52)|Adverse Event|10
199830|NCT01087502|633239|P1|Up to Final Analysis (Week 52)|Adverse Event|17
199831|NCT01087502|633238|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
199832|NCT01087502|633239|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
199833|NCT01087502|633238|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
199834|NCT01087502|633239|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
199835|NCT01087502|633238|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
199836|NCT01087502|633239|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
199837|NCT01087502|633238|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
199838|NCT01087502|633239|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
199839|NCT01087502|633238|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
199840|NCT01087502|633239|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
199841|NCT01073566|633260|P2|Period 2 (6 Weeks)|Adverse Event|0
199842|NCT01073566|633261|P1|Period 2 (6 Weeks)|Adverse Event|1
199843|NCT01073605|633276|P3|Overall Study|Randomized But Not Treated|1
199844|NCT01073605|633277|P2|Overall Study|Randomized But Not Treated|1
199845|NCT01073605|633278|P1|Overall Study|Randomized But Not Treated|0
199846|NCT01073605|633276|P3|Overall Study|Withdrawal by Subject|22
199847|NCT01073605|633277|P2|Overall Study|Withdrawal by Subject|39
199848|NCT01073605|633278|P1|Overall Study|Withdrawal by Subject|31
199849|NCT01073605|633276|P3|Overall Study|Other|29
199850|NCT01073605|633277|P2|Overall Study|Other|21
199851|NCT01073605|633278|P1|Overall Study|Other|25
199852|NCT01073605|633276|P3|Overall Study|Lost to Follow-up|9
199853|NCT01073605|633277|P2|Overall Study|Lost to Follow-up|4
199854|NCT01073605|633278|P1|Overall Study|Lost to Follow-up|3
199855|NCT01073605|633276|P3|Overall Study|Adverse Event|0
199856|NCT01073605|633277|P2|Overall Study|Adverse Event|1
199857|NCT01073605|633278|P1|Overall Study|Adverse Event|2
199858|NCT01073605|633276|P3|Overall Study|Ongoing at Cutoff Date|0
199859|NCT01073605|633277|P2|Overall Study|Ongoing at Cutoff Date|1
199860|NCT01073605|633278|P1|Overall Study|Ongoing at Cutoff Date|1
199861|NCT01073618|633322|P1|Overall Study|Unspecified|80
199862|NCT01073618|633322|P1|Overall Study|Adverse Event|19
199863|NCT01073618|633322|P1|Overall Study|Death|208
199864|NCT01073631|633327|P1|Overall Study|Unspecified|63
199865|NCT01073631|633327|P1|Overall Study|Adverse Event|24
199866|NCT01073631|633327|P1|Overall Study|Death|82
199867|NCT01073865|633343|P2|Overall Study|Withdrawal by Subject|5
199868|NCT01073865|633344|P1|Overall Study|Withdrawal by Subject|5
199869|NCT01073865|633343|P2|Overall Study|Death|2
199870|NCT01073865|633344|P1|Overall Study|Death|3
199871|NCT01073865|633343|P2|Overall Study|Lost to Follow-up|1
199872|NCT01073865|633344|P1|Overall Study|Lost to Follow-up|1
199873|NCT01073865|633343|P2|Overall Study|Reasons other than below|31
199874|NCT01073865|633344|P1|Overall Study|Reasons other than below|19
199875|NCT01087528|633354|P1|Overall Study|Incomplete CE procedure|6
199876|NCT01087528|633354|P1|Overall Study|Withdrawal by Subject|1
199877|NCT01087723|633379|P2|Overall Study|Reason Not Specified|2
199878|NCT01087723|633380|P1|Overall Study|Reason Not Specified|1
199879|NCT01087723|633379|P2|Overall Study|Lost to Follow-up|4
199880|NCT01087723|633380|P1|Overall Study|Lost to Follow-up|1
199881|NCT01087723|633379|P2|Overall Study|Physician Decision|0
199882|NCT01087723|633380|P1|Overall Study|Physician Decision|2
199883|NCT01087723|633379|P2|Overall Study|Withdrawal by Subject|13
199884|NCT01087723|633380|P1|Overall Study|Withdrawal by Subject|10
199885|NCT01087723|633379|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
199886|NCT01087723|633380|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
199887|NCT01087736|633404|P2|Overall Study|Withdrawal by Subject|1
199888|NCT01087736|633405|P1|Overall Study|Withdrawal by Subject|0
199889|NCT01087736|633404|P2|Overall Study|Death|1
199890|NCT01087736|633405|P1|Overall Study|Death|0
199891|NCT01087736|633404|P2|Overall Study|Lost to Follow-up|0
199892|NCT01087736|633405|P1|Overall Study|Lost to Follow-up|1
199893|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
199894|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
199895|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
199896|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
199897|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
199898|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
199899|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
199900|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
199901|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
199902|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
199903|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
199904|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
199905|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
199906|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
199907|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
199908|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|Unspecified|4
199909|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|Unspecified|2
199910|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|Unspecified|0
199911|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|Unspecified|0
199912|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|Unspecified|0
199913|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
199914|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
199915|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
199916|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
199917|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
199918|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
199919|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
199920|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
199921|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
199922|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
199998|NCT01087788|633470|P2|24-weeks Dose-blind Period|Patient moved|0
199923|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
199924|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
199925|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
199926|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
199927|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
199928|NCT01087762|633416|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
199929|NCT01087762|633417|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
199930|NCT01087762|633418|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
199931|NCT01087762|633419|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
199932|NCT01087762|633420|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
199933|NCT01087762|633416|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
199934|NCT01087762|633417|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
199935|NCT01087762|633418|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
199936|NCT01087762|633419|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
199937|NCT01087762|633420|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
199938|NCT01087762|633416|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
199939|NCT01087762|633417|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
199940|NCT01087762|633418|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
199941|NCT01087762|633419|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
199942|NCT01087762|633420|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
199943|NCT01087762|633416|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
199944|NCT01087762|633417|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
199945|NCT01087762|633418|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
199946|NCT01087762|633419|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
199947|NCT01087762|633420|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
199948|NCT01087762|633416|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
199949|NCT01087762|633417|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
199950|NCT01087762|633418|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
199951|NCT01087762|633419|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
199952|NCT01087762|633420|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
199953|NCT01087762|633416|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
199954|NCT01087762|633417|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
199955|NCT01087762|633418|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
199956|NCT01087762|633419|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
199957|NCT01087762|633420|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
199958|NCT01087788|633469|P3|Open-Label Period (OL-P)|Personal reasons|1
199959|NCT01087788|633470|P2|Open-Label Period (OL-P)|Personal reasons|0
199960|NCT01087788|633471|P1|Open-Label Period (OL-P)|Personal reasons|0
199961|NCT01087788|633469|P3|Open-Label Period (OL-P)|No participation in study extension|1
199962|NCT01087788|633470|P2|Open-Label Period (OL-P)|No participation in study extension|0
199963|NCT01087788|633471|P1|Open-Label Period (OL-P)|No participation in study extension|0
199964|NCT01087788|633469|P3|Open-Label Period (OL-P)|Principal investigator decision|2
199965|NCT01087788|633470|P2|Open-Label Period (OL-P)|Principal investigator decision|1
199966|NCT01087788|633471|P1|Open-Label Period (OL-P)|Principal investigator decision|0
199967|NCT01087788|633469|P3|Open-Label Period (OL-P)|Sponsor request|0
199968|NCT01087788|633470|P2|Open-Label Period (OL-P)|Sponsor request|0
199969|NCT01087788|633471|P1|Open-Label Period (OL-P)|Sponsor request|1
199970|NCT01087788|633469|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
199971|NCT01087788|633470|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
199972|NCT01087788|633471|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
199973|NCT01087788|633469|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
199974|NCT01087788|633470|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
199975|NCT01087788|633471|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
199976|NCT01087788|633469|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
199977|NCT01087788|633470|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
199978|NCT01087788|633471|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
199979|NCT01087788|633469|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
199980|NCT01087788|633470|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
199981|NCT01087788|633471|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
199982|NCT01087788|633469|P3|Open-Label Period (OL-P)|AE, serious fatal|1
199983|NCT01087788|633470|P2|Open-Label Period (OL-P)|AE, serious fatal|0
199984|NCT01087788|633471|P1|Open-Label Period (OL-P)|AE, serious fatal|2
199985|NCT01087788|633469|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
199986|NCT01087788|633470|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
199987|NCT01087788|633471|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
199988|NCT01087788|633469|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
199989|NCT01087788|633470|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
199990|NCT01087788|633471|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
199991|NCT01087788|633469|P3|Open-Label Period (OL-P)|Protocol Violation|0
199992|NCT01087788|633470|P2|Open-Label Period (OL-P)|Protocol Violation|1
199993|NCT01087788|633471|P1|Open-Label Period (OL-P)|Protocol Violation|2
199994|NCT01087788|633469|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
199995|NCT01087788|633470|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
199996|NCT01087788|633471|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
199997|NCT01087788|633469|P3|24-weeks Dose-blind Period|Patient moved|1
199999|NCT01087788|633471|P1|24-weeks Dose-blind Period|Patient moved|0
200000|NCT01087788|633469|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
200001|NCT01087788|633470|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
200002|NCT01087788|633471|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
200003|NCT01087788|633469|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
200004|NCT01087788|633470|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
200005|NCT01087788|633471|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
200006|NCT01087788|633469|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
200007|NCT01087788|633470|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
200008|NCT01087788|633471|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
200009|NCT01087788|633469|P3|24-weeks Dose-blind Period|AE, serious fatal|0
200010|NCT01087788|633470|P2|24-weeks Dose-blind Period|AE, serious fatal|1
200011|NCT01087788|633471|P1|24-weeks Dose-blind Period|AE, serious fatal|0
200012|NCT01087788|633469|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
200013|NCT01087788|633470|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
200014|NCT01087788|633471|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
200015|NCT01087788|633469|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
200016|NCT01087788|633470|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
200017|NCT01087788|633471|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
200018|NCT01087788|633469|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
200019|NCT01087788|633470|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
200020|NCT01087788|633471|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
200021|NCT01087788|633469|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
200022|NCT01087788|633470|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
200023|NCT01087788|633471|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
200024|NCT01087788|633469|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
200025|NCT01087788|633470|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
200026|NCT01087788|633471|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
200027|NCT01087788|633469|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
200028|NCT01087788|633470|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
200029|NCT01087788|633471|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
200030|NCT01087788|633469|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
200031|NCT01087788|633470|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
200032|NCT01087788|633471|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
200033|NCT01087788|633469|P3|24-weeks Double-blind Period|AE, unknown type|1
200034|NCT01087788|633470|P2|24-weeks Double-blind Period|AE, unknown type|0
200035|NCT01087788|633471|P1|24-weeks Double-blind Period|AE, unknown type|0
200036|NCT01087788|633469|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
200037|NCT01087788|633470|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
200038|NCT01087788|633471|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
200039|NCT01087788|633469|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
200040|NCT01087788|633470|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
200041|NCT01087788|633471|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
200042|NCT01087788|633469|P3|24-weeks Double-blind Period|AE, serious fatal|1
200043|NCT01087788|633470|P2|24-weeks Double-blind Period|AE, serious fatal|1
200044|NCT01087788|633471|P1|24-weeks Double-blind Period|AE, serious fatal|0
200045|NCT01087788|633469|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
200046|NCT01087788|633470|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
200047|NCT01087788|633471|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
200048|NCT01087788|633469|P3|24-weeks Double-blind Period|Lost to Follow-up|1
200049|NCT01087788|633470|P2|24-weeks Double-blind Period|Lost to Follow-up|1
200050|NCT01087788|633471|P1|24-weeks Double-blind Period|Lost to Follow-up|4
200051|NCT01087788|633469|P3|24-weeks Double-blind Period|Protocol Violation|0
200052|NCT01087788|633470|P2|24-weeks Double-blind Period|Protocol Violation|1
200053|NCT01087788|633471|P1|24-weeks Double-blind Period|Protocol Violation|0
200054|NCT01087788|633469|P3|24-weeks Double-blind Period|Lack of Efficacy|1
200055|NCT01087788|633470|P2|24-weeks Double-blind Period|Lack of Efficacy|0
200056|NCT01087788|633471|P1|24-weeks Double-blind Period|Lack of Efficacy|2
200057|NCT01087814|633509|P2|Second Intervention (5 Days)|Physician Decision|0
200058|NCT01087814|633510|P1|Second Intervention (5 Days)|Physician Decision|1
200059|NCT01087814|633509|P2|First Intervention (5 Days)|Withdrawal by Subject|1
200060|NCT01087814|633510|P1|First Intervention (5 Days)|Withdrawal by Subject|3
200061|NCT01088984|633559|P2|Phase 2|Not Specified|1
200062|NCT01088984|633560|P1|Phase 2|Not Specified|0
200063|NCT01088984|633559|P2|Phase 2|DIsease Progression|25
200064|NCT01088984|633560|P1|Phase 2|DIsease Progression|0
200065|NCT01088984|633559|P2|Phase 2|Withdrawal by Subject|1
200066|NCT01088984|633560|P1|Phase 2|Withdrawal by Subject|0
200067|NCT01088984|633559|P2|Phase 2|Death|5
200068|NCT01088984|633560|P1|Phase 2|Death|0
200069|NCT01088984|633559|P2|Phase 1|Not Specified|1
200070|NCT01088984|633560|P1|Phase 1|Not Specified|1
200071|NCT01088984|633559|P2|Phase 1|Disease Progression|4
200072|NCT01088984|633560|P1|Phase 1|Disease Progression|2
200073|NCT01088984|633559|P2|Phase 1|Death|1
200074|NCT01088984|633560|P1|Phase 1|Death|2
200075|NCT01088997|633580|P2|Overall Study|Excluded prior to receiving drug|1
200076|NCT01088997|633581|P1|Overall Study|Excluded prior to receiving drug|1
200077|NCT01088997|633580|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
200078|NCT01088997|633581|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
200079|NCT01088997|633580|P2|Overall Study|Physician Decision|1
200080|NCT01088997|633581|P1|Overall Study|Physician Decision|1
200081|NCT01089023|633590|P1|Overall Study|Lack of Efficacy|1
200082|NCT01089023|633590|P1|Overall Study|Protocol Violation|1
200083|NCT01089023|633590|P1|Overall Study|Withdrawal by Subject|1
200084|NCT01089023|633590|P1|Overall Study|Adverse Event|1
200085|NCT01089023|633590|P1|Overall Study|Lost to Follow-up|3
200086|NCT01089127|633642|P6|Overall Study|Protocol deviation|0
200087|NCT01089127|633643|P5|Overall Study|Protocol deviation|1
200088|NCT01089127|633644|P4|Overall Study|Protocol deviation|0
200089|NCT01089127|633645|P3|Overall Study|Protocol deviation|0
200090|NCT01089127|633646|P2|Overall Study|Protocol deviation|1
200091|NCT01089127|633647|P1|Overall Study|Protocol deviation|0
200092|NCT01089127|633642|P6|Overall Study|Lost to Follow-up|0
200093|NCT01089127|633643|P5|Overall Study|Lost to Follow-up|1
200094|NCT01089127|633644|P4|Overall Study|Lost to Follow-up|0
200095|NCT01089127|633645|P3|Overall Study|Lost to Follow-up|0
200096|NCT01089127|633646|P2|Overall Study|Lost to Follow-up|1
200097|NCT01089127|633647|P1|Overall Study|Lost to Follow-up|1
200098|NCT01089127|633642|P6|Overall Study|Abnormal test procedure result(s)|0
200099|NCT01089127|633643|P5|Overall Study|Abnormal test procedure result(s)|0
200100|NCT01089127|633644|P4|Overall Study|Abnormal test procedure result(s)|0
200101|NCT01089127|633645|P3|Overall Study|Abnormal test procedure result(s)|0
200102|NCT01089127|633646|P2|Overall Study|Abnormal test procedure result(s)|1
200103|NCT01089127|633647|P1|Overall Study|Abnormal test procedure result(s)|2
200104|NCT01089127|633642|P6|Overall Study|Subject withdrew consent|2
200105|NCT01089127|633643|P5|Overall Study|Subject withdrew consent|0
200106|NCT01089127|633644|P4|Overall Study|Subject withdrew consent|1
200107|NCT01089127|633645|P3|Overall Study|Subject withdrew consent|1
200108|NCT01089127|633646|P2|Overall Study|Subject withdrew consent|1
200109|NCT01089127|633647|P1|Overall Study|Subject withdrew consent|0
200110|NCT01089127|633642|P6|Overall Study|Adverse Event|1
200111|NCT01089127|633643|P5|Overall Study|Adverse Event|0
200112|NCT01089127|633644|P4|Overall Study|Adverse Event|0
200113|NCT01089127|633645|P3|Overall Study|Adverse Event|1
200114|NCT01089127|633646|P2|Overall Study|Adverse Event|1
200115|NCT01089127|633647|P1|Overall Study|Adverse Event|5
200116|NCT01089361|633694|P2|Overall Study|Death|0
200117|NCT01089361|633695|P1|Overall Study|Death|1
200118|NCT01089413|633716|P1|Overall Study|Unspecified|71
200119|NCT01089413|633716|P1|Overall Study|Metastasectomy|13
200120|NCT01089413|633716|P1|Overall Study|Death|10
200121|NCT01089413|633716|P1|Overall Study|Unacceptable Toxicity|12
200122|NCT01089413|633716|P1|Overall Study|Participant Withdrew Consent|1
200123|NCT01089413|633716|P1|Overall Study|Progressive Disease|93
200124|NCT01089413|633716|P1|Overall Study|Lost to Follow-up|1
200125|NCT01089504|633735|P2|Overall Study|Withdrawal by Subject|0
200126|NCT01089504|633736|P1|Overall Study|Withdrawal by Subject|2
200127|NCT01089504|633735|P2|Overall Study|Lost to Follow-up|1
200128|NCT01089504|633736|P1|Overall Study|Lost to Follow-up|1
200129|NCT01089543|633769|P4|Overall Study|Adverse Event|0
200130|NCT01089543|633770|P3|Overall Study|Adverse Event|0
200131|NCT01089543|633771|P2|Overall Study|Adverse Event|1
200132|NCT01089543|633772|P1|Overall Study|Adverse Event|0
200133|NCT01089543|633769|P4|Overall Study|Physician Decision|1
200134|NCT01089543|633770|P3|Overall Study|Physician Decision|0
200135|NCT01089543|633771|P2|Overall Study|Physician Decision|0
200136|NCT01089543|633772|P1|Overall Study|Physician Decision|1
200137|NCT01089543|633769|P4|Overall Study|Withdrawal by Subject|1
200138|NCT01089543|633770|P3|Overall Study|Withdrawal by Subject|3
200139|NCT01089543|633771|P2|Overall Study|Withdrawal by Subject|3
200140|NCT01089543|633772|P1|Overall Study|Withdrawal by Subject|2
200141|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
200142|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
200143|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
200144|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
200145|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
200146|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
200147|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
200148|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
200149|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
200150|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
200151|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
200152|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
200153|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
200154|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
200155|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
200156|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
200157|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
200158|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
200159|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
200160|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
200161|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
200162|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
200163|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
200164|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
200165|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
200166|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
200167|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
200168|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
200169|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
200170|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
200171|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
200172|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
200173|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
200174|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
200175|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
200176|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
200177|NCT01089556|633788|P6|Study Period III (Weeks 9-16)|Adverse Event|3
200178|NCT01089556|633789|P5|Study Period III (Weeks 9-16)|Adverse Event|4
200179|NCT01089556|633790|P4|Study Period III (Weeks 9-16)|Adverse Event|2
200180|NCT01089556|633791|P3|Study Period III (Weeks 9-16)|Adverse Event|4
200181|NCT01089556|633792|P2|Study Period III (Weeks 9-16)|Adverse Event|0
200182|NCT01089556|633793|P1|Study Period III (Weeks 9-16)|Adverse Event|0
200183|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
200184|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
200185|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
200186|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
200187|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
200188|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
200189|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
200190|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
200191|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
200192|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
200193|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
200194|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
200195|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
200196|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
200197|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
200198|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
200199|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
200200|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
200201|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Physician Decision|0
200202|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Physician Decision|0
200203|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Physician Decision|0
200204|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Physician Decision|0
200205|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Physician Decision|0
200206|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Physician Decision|4
200207|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
200208|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
200209|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
200210|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
200211|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
200212|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
200213|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
200214|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
200215|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
200216|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
200217|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
200218|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
200219|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
200220|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
200221|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
200222|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
200223|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
200224|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
200225|NCT01089556|633788|P6|Study Period II (Weeks 1-8)|Adverse Event|0
200226|NCT01089556|633789|P5|Study Period II (Weeks 1-8)|Adverse Event|0
200227|NCT01089556|633790|P4|Study Period II (Weeks 1-8)|Adverse Event|0
200228|NCT01089556|633791|P3|Study Period II (Weeks 1-8)|Adverse Event|0
200229|NCT01089556|633792|P2|Study Period II (Weeks 1-8)|Adverse Event|39
200230|NCT01089556|633793|P1|Study Period II (Weeks 1-8)|Adverse Event|35
200231|NCT01089582|633894|P1|Overall Study|Withdrawal by Subject|1
200232|NCT01089582|633894|P1|Overall Study|Unspecified|4
200233|NCT01089582|633894|P1|Overall Study|Lost to Follow-up|8
200234|NCT01089582|633894|P1|Overall Study|Adverse Event|15
200235|NCT01089582|633894|P1|Overall Study|Death|2
200236|NCT01089608|633917|P2|Overall Study|Lost to Follow-up|2
200237|NCT01089608|633918|P1|Overall Study|Lost to Follow-up|0
200238|NCT01089608|633917|P2|Overall Study|Adverse Event|4
200239|NCT01089608|633918|P1|Overall Study|Adverse Event|0
200240|NCT01090011|633947|P1|Overall Study|Other reason not defined above|5
200241|NCT01090011|633947|P1|Overall Study|Refusal to start/continue medication|5
200242|NCT01090011|633947|P1|Overall Study|Protocol Violation|1
200243|NCT01090011|633947|P1|Overall Study|Adverse Event|32
200244|NCT01090011|633947|P1|Overall Study|Progressive disease|128
200245|NCT01090050|634017|P2|Overall Study|Physician Decision|1
200246|NCT01090050|634018|P1|Overall Study|Physician Decision|0
200247|NCT01090050|634017|P2|Overall Study|Lack of Efficacy|5
200248|NCT01090050|634018|P1|Overall Study|Lack of Efficacy|1
200249|NCT01090050|634017|P2|Overall Study|Lost to Follow-up|1
200250|NCT01090050|634018|P1|Overall Study|Lost to Follow-up|0
200251|NCT01090063|634038|P1|Treatment|Withdrawal by Subject|4
200252|NCT01090063|634038|P1|Screen|Screen Failed|4
200253|NCT01090076|634054|P2|Overall Study|Withdrawal by Subject|1
200254|NCT01090076|634055|P1|Overall Study|Withdrawal by Subject|0
200255|NCT01090076|634054|P2|Overall Study|Death|1
200256|NCT01090076|634055|P1|Overall Study|Death|1
200257|NCT01090102|634067|P2|Second 12 Weeks|Withdrawal by Subject|1
200258|NCT01090102|634068|P1|Second 12 Weeks|Withdrawal by Subject|0
200259|NCT01090102|634067|P2|First 12 Weeks|Death|1
200260|NCT01090102|634068|P1|First 12 Weeks|Death|1
200261|NCT01090102|634067|P2|First 12 Weeks|Adverse Event|0
200262|NCT01090102|634068|P1|First 12 Weeks|Adverse Event|2
200263|NCT01090102|634067|P2|First 12 Weeks|Withdrawal by Subject|1
200264|NCT01090102|634068|P1|First 12 Weeks|Withdrawal by Subject|1
200265|NCT01090310|634091|P4|Extension Study|Subject withdrew consent|0
200266|NCT01090310|634092|P3|Extension Study|Subject withdrew consent|0
200267|NCT01090310|634093|P2|Extension Study|Subject withdrew consent|1
200268|NCT01090310|634094|P1|Extension Study|Subject withdrew consent|0
200269|NCT01090310|634091|P4|Extension Study|Unsatisfactory therapeutic effect|1
200270|NCT01090310|634092|P3|Extension Study|Unsatisfactory therapeutic effect|1
200271|NCT01090310|634093|P2|Extension Study|Unsatisfactory therapeutic effect|0
200272|NCT01090310|634094|P1|Extension Study|Unsatisfactory therapeutic effect|1
200273|NCT01090310|634091|P4|Extension Study|Adverse Event|1
200274|NCT01090310|634092|P3|Extension Study|Adverse Event|0
200275|NCT01090310|634093|P2|Extension Study|Adverse Event|0
200276|NCT01090310|634094|P1|Extension Study|Adverse Event|0
200277|NCT01090310|634091|P4|Extension Study|Aministrative problems|18
200278|NCT01090310|634092|P3|Extension Study|Aministrative problems|14
200279|NCT01090310|634093|P2|Extension Study|Aministrative problems|15
200280|NCT01090310|634094|P1|Extension Study|Aministrative problems|13
200281|NCT01090310|634091|P4|Core Study|Protocol deviation|1
200282|NCT01090310|634092|P3|Core Study|Protocol deviation|0
200283|NCT01090310|634093|P2|Core Study|Protocol deviation|0
200284|NCT01090310|634094|P1|Core Study|Protocol deviation|1
200285|NCT01090310|634091|P4|Core Study|Administrative reasons|4
200286|NCT01090310|634092|P3|Core Study|Administrative reasons|4
200287|NCT01090310|634093|P2|Core Study|Administrative reasons|6
200288|NCT01090310|634094|P1|Core Study|Administrative reasons|5
200289|NCT01090310|634091|P4|Core Study|Abnormal test procedure result|0
200290|NCT01090310|634092|P3|Core Study|Abnormal test procedure result|1
200291|NCT01090310|634093|P2|Core Study|Abnormal test procedure result|0
200292|NCT01090310|634094|P1|Core Study|Abnormal test procedure result|0
200293|NCT01090310|634091|P4|Core Study|Subject withdrew consent|1
200294|NCT01090310|634092|P3|Core Study|Subject withdrew consent|1
200295|NCT01090310|634093|P2|Core Study|Subject withdrew consent|3
200296|NCT01090310|634094|P1|Core Study|Subject withdrew consent|0
200297|NCT01090310|634091|P4|Core Study|Adverse Event|1
200298|NCT01090310|634092|P3|Core Study|Adverse Event|1
200299|NCT01090310|634093|P2|Core Study|Adverse Event|2
200300|NCT01090310|634094|P1|Core Study|Adverse Event|2
200301|NCT01090323|634122|P2|Overall Study|Stopped end of extension 1#|1
200302|NCT01090323|634123|P1|Overall Study|Stopped end of extension 1#|3
200303|NCT01090323|634122|P2|Overall Study|Stopped end of core|0
200304|NCT01090323|634123|P1|Overall Study|Stopped end of core|7
200305|NCT01090323|634122|P2|Overall Study|Death|2
200306|NCT01090323|634123|P1|Overall Study|Death|1
200307|NCT01090323|634122|P2|Overall Study|Administrative problems|4
200308|NCT01090323|634123|P1|Overall Study|Administrative problems|6
200309|NCT01090323|634122|P2|Overall Study|Lost to Follow-up|6
200310|NCT01090323|634123|P1|Overall Study|Lost to Follow-up|11
200311|NCT01090323|634122|P2|Overall Study|Withdrew consent|11
200312|NCT01090323|634123|P1|Overall Study|Withdrew consent|33
200313|NCT01090323|634122|P2|Overall Study|Protocol Violation|1
200314|NCT01090323|634123|P1|Overall Study|Protocol Violation|2
200315|NCT01090323|634122|P2|Overall Study|Condition no longer requires drug|4
200316|NCT01090323|634123|P1|Overall Study|Condition no longer requires drug|5
200317|NCT01090323|634122|P2|Overall Study|Unsatisfactory therapeutic effect|2
200318|NCT01090323|634123|P1|Overall Study|Unsatisfactory therapeutic effect|4
200319|NCT01090323|634122|P2|Overall Study|Abnormal Test Procedure Results|0
200320|NCT01090323|634123|P1|Overall Study|Abnormal Test Procedure Results|2
200321|NCT01090323|634122|P2|Overall Study|Abnormal Lab Values|1
200322|NCT01090323|634123|P1|Overall Study|Abnormal Lab Values|3
200323|NCT01090323|634122|P2|Overall Study|Adverse Event|2
200324|NCT01090323|634123|P1|Overall Study|Adverse Event|12
200325|NCT01090427|634134|P7|After Controlled Period|Adverse Event|0
200326|NCT01090427|634135|P6|After Controlled Period|Adverse Event|1
200327|NCT01090427|634136|P5|After Controlled Period|Adverse Event|0
200328|NCT01090427|634137|P4|After Controlled Period|Adverse Event|2
200329|NCT01090427|634138|P3|After Controlled Period|Adverse Event|0
200330|NCT01090427|634139|P2|After Controlled Period|Adverse Event|0
200331|NCT01090427|634140|P1|After Controlled Period|Adverse Event|0
200332|NCT01090427|634134|P7|After Controlled Period|Lack of Efficacy|2
200333|NCT01090427|634135|P6|After Controlled Period|Lack of Efficacy|3
200334|NCT01090427|634136|P5|After Controlled Period|Lack of Efficacy|0
200335|NCT01090427|634137|P4|After Controlled Period|Lack of Efficacy|0
200336|NCT01090427|634138|P3|After Controlled Period|Lack of Efficacy|0
200337|NCT01090427|634139|P2|After Controlled Period|Lack of Efficacy|0
200338|NCT01090427|634140|P1|After Controlled Period|Lack of Efficacy|0
200339|NCT01090427|634134|P7|After Controlled Period|Death|0
200340|NCT01090427|634135|P6|After Controlled Period|Death|1
200341|NCT01090427|634136|P5|After Controlled Period|Death|0
200342|NCT01090427|634137|P4|After Controlled Period|Death|0
200343|NCT01090427|634138|P3|After Controlled Period|Death|0
200344|NCT01090427|634139|P2|After Controlled Period|Death|0
200345|NCT01090427|634140|P1|After Controlled Period|Death|0
200346|NCT01090453|634175|P2|Overall Study|Eligibility Criteria|1
200347|NCT01090453|634176|P1|Overall Study|Eligibility Criteria|0
200348|NCT01090453|634175|P2|Overall Study|Unspecified|4
200349|NCT01090453|634176|P1|Overall Study|Unspecified|2
200350|NCT01090453|634175|P2|Overall Study|Protocol Violation|0
200351|NCT01090453|634176|P1|Overall Study|Protocol Violation|2
200352|NCT01090453|634175|P2|Overall Study|Non serious AEs|0
200353|NCT01090453|634176|P1|Overall Study|Non serious AEs|1
200354|NCT01090453|634175|P2|Overall Study|Lost to Follow-up|7
200355|NCT01090453|634176|P1|Overall Study|Lost to Follow-up|7
200356|NCT01090453|634175|P2|Overall Study|Withdrawal by Subject|2
200357|NCT01090453|634176|P1|Overall Study|Withdrawal by Subject|1
200358|NCT01090739|634229|P1|36 Month Follow-up|Visit still pending|17
200359|NCT01090739|634229|P1|36 Month Follow-up|Withdrawal by Subject|6
200360|NCT01090739|634229|P1|24 Month Follow-up|Death|1
200361|NCT01090739|634229|P1|24 Month Follow-up|Lost to Follow-up|1
200362|NCT01090739|634229|P1|24 Month Follow-up|Withdrawal by Subject|7
200363|NCT01090739|634229|P1|12 Month Follow-up|Death|1
200364|NCT01090739|634229|P1|12 Month Follow-up|Physician Decision|1
200365|NCT01090739|634229|P1|12 Month Follow-up|Lost to Follow-up|1
200366|NCT01090739|634229|P1|12 Month Follow-up|Withdrawal by Subject|2
200367|NCT01090739|634229|P1|Enrollment|Adverse Event|1
200368|NCT01090739|634229|P1|Enrollment|Study implant limit reached|2
200369|NCT01090739|634229|P1|Enrollment|Sponsor termination of site|4
200370|NCT01090739|634229|P1|Enrollment|Physician Decision|5
200371|NCT01090739|634229|P1|Enrollment|Lost to Follow-up|5
200372|NCT01090739|634229|P1|Enrollment|Protocol Violation|14
200373|NCT01090739|634229|P1|Enrollment|Withdrawal by Subject|24
200374|NCT01090765|634265|P6|Overall Study|Vasovagal reaction with first infusion|0
200375|NCT01090765|634266|P5|Overall Study|Vasovagal reaction with first infusion|1
200376|NCT01090765|634267|P4|Overall Study|Vasovagal reaction with first infusion|0
200377|NCT01090765|634268|P3|Overall Study|Vasovagal reaction with first infusion|0
200378|NCT01090765|634269|P2|Overall Study|Vasovagal reaction with first infusion|0
200379|NCT01090765|634270|P1|Overall Study|Vasovagal reaction with first infusion|0
200380|NCT01090765|634265|P6|Overall Study|Developed a DVT, needed anticoagulation|0
200381|NCT01090765|634266|P5|Overall Study|Developed a DVT, needed anticoagulation|0
200382|NCT01090765|634267|P4|Overall Study|Developed a DVT, needed anticoagulation|1
200383|NCT01090765|634268|P3|Overall Study|Developed a DVT, needed anticoagulation|0
200384|NCT01090765|634269|P2|Overall Study|Developed a DVT, needed anticoagulation|0
200385|NCT01090765|634270|P1|Overall Study|Developed a DVT, needed anticoagulation|0
200386|NCT01090765|634265|P6|Overall Study|Patient withdrew consent|1
200387|NCT01090765|634266|P5|Overall Study|Patient withdrew consent|1
200388|NCT01090765|634267|P4|Overall Study|Patient withdrew consent|0
200389|NCT01090765|634268|P3|Overall Study|Patient withdrew consent|0
200390|NCT01090765|634269|P2|Overall Study|Patient withdrew consent|0
200391|NCT01090765|634270|P1|Overall Study|Patient withdrew consent|0
200392|NCT01090973|634285|P1|Overall Study|Disease progression|1
200393|NCT01079130|634301|P6|Overall Study|Lost to Follow-up|0
200394|NCT01079130|634302|P5|Overall Study|Lost to Follow-up|1
200395|NCT01079130|634303|P4|Overall Study|Lost to Follow-up|0
200396|NCT01079130|634304|P3|Overall Study|Lost to Follow-up|0
200397|NCT01079130|634305|P2|Overall Study|Lost to Follow-up|0
200398|NCT01079130|634306|P1|Overall Study|Lost to Follow-up|0
200399|NCT01079130|634301|P6|Overall Study|Unsatisfactory therapeutic effect|0
200400|NCT01079130|634302|P5|Overall Study|Unsatisfactory therapeutic effect|0
200401|NCT01079130|634303|P4|Overall Study|Unsatisfactory therapeutic effect|2
200402|NCT01079130|634304|P3|Overall Study|Unsatisfactory therapeutic effect|0
200403|NCT01079130|634305|P2|Overall Study|Unsatisfactory therapeutic effect|0
200404|NCT01079130|634306|P1|Overall Study|Unsatisfactory therapeutic effect|0
200405|NCT01079130|634301|P6|Overall Study|Abnormal test procedure result(s)|0
200406|NCT01079130|634302|P5|Overall Study|Abnormal test procedure result(s)|1
200407|NCT01079130|634303|P4|Overall Study|Abnormal test procedure result(s)|0
200408|NCT01079130|634304|P3|Overall Study|Abnormal test procedure result(s)|0
200409|NCT01079130|634305|P2|Overall Study|Abnormal test procedure result(s)|0
200410|NCT01079130|634306|P1|Overall Study|Abnormal test procedure result(s)|0
200411|NCT01079130|634301|P6|Overall Study|Protocol deviation|0
200412|NCT01079130|634302|P5|Overall Study|Protocol deviation|0
200413|NCT01079130|634303|P4|Overall Study|Protocol deviation|2
200414|NCT01079130|634304|P3|Overall Study|Protocol deviation|1
200415|NCT01079130|634305|P2|Overall Study|Protocol deviation|2
200416|NCT01079130|634306|P1|Overall Study|Protocol deviation|0
200417|NCT01079130|634301|P6|Overall Study|Withdrawal by Subject|3
200418|NCT01079130|634302|P5|Overall Study|Withdrawal by Subject|1
200419|NCT01079130|634303|P4|Overall Study|Withdrawal by Subject|0
200420|NCT01079130|634304|P3|Overall Study|Withdrawal by Subject|0
200421|NCT01079130|634305|P2|Overall Study|Withdrawal by Subject|1
200422|NCT01079130|634306|P1|Overall Study|Withdrawal by Subject|0
200423|NCT01079130|634301|P6|Overall Study|Administrative problems|1
200424|NCT01079130|634302|P5|Overall Study|Administrative problems|0
200425|NCT01079130|634303|P4|Overall Study|Administrative problems|0
200426|NCT01079130|634304|P3|Overall Study|Administrative problems|0
200427|NCT01079130|634305|P2|Overall Study|Administrative problems|3
200428|NCT01079130|634306|P1|Overall Study|Administrative problems|1
200429|NCT01079130|634301|P6|Overall Study|Adverse Event|1
200430|NCT01079130|634302|P5|Overall Study|Adverse Event|5
200431|NCT01079130|634303|P4|Overall Study|Adverse Event|1
200432|NCT01079130|634304|P3|Overall Study|Adverse Event|0
200433|NCT01079130|634305|P2|Overall Study|Adverse Event|1
200434|NCT01079130|634306|P1|Overall Study|Adverse Event|1
200435|NCT01079182|634401|P1|Overall Study|Reasons not Evaluated|271
200436|NCT01079182|634401|P1|Overall Study|ADR and Lack of Effectiveness|39
200437|NCT01079182|634401|P1|Overall Study|Lack of Efficacy|514
200438|NCT01079182|634401|P1|Overall Study|Adverse Drug Reaction (ADR)|261
200439|NCT01079182|634401|P1|Overall Study|Lost to Follow-up|1634
200440|NCT01079195|634428|P1|Overall Study|Non-compliance|2
200441|NCT01079195|634428|P1|Overall Study|No Follow-up Documentation Available|4
200442|NCT01079195|634428|P1|Overall Study|Improved Status of Participant|4
200443|NCT01079195|634428|P1|Overall Study|Physician Decision|4
200444|NCT01079195|634428|P1|Overall Study|Lack of Effectiveness|12
200445|NCT01079195|634428|P1|Overall Study|Financial Reasons|15
200446|NCT01079195|634428|P1|Overall Study|Withdrawal by Subject|18
200447|NCT01079195|634428|P1|Overall Study|Reason Unknown|39
200448|NCT01079195|634428|P1|Overall Study|Adverse Event|157
200449|NCT01079195|634428|P1|Overall Study|No Documentation Available|437
200450|NCT01079195|634428|P1|Overall Study|No Documentation of Tarka Therapy|739
200451|NCT01079234|634437|P4|Extension: Week 27 to 52|Unclassified|7
200452|NCT01079234|634438|P3|Extension: Week 27 to 52|Unclassified|4
200453|NCT01079234|634439|P2|Extension: Week 27 to 52|Unclassified|0
200454|NCT01079234|634440|P1|Extension: Week 27 to 52|Unclassified|0
200455|NCT01079234|634437|P4|Extension: Week 27 to 52|Withdrawal criteria|2
200456|NCT01079234|634438|P3|Extension: Week 27 to 52|Withdrawal criteria|4
200457|NCT01079234|634439|P2|Extension: Week 27 to 52|Withdrawal criteria|0
200458|NCT01079234|634440|P1|Extension: Week 27 to 52|Withdrawal criteria|0
200459|NCT01079234|634437|P4|Extension: Week 27 to 52|Protocol Violation|5
200460|NCT01079234|634438|P3|Extension: Week 27 to 52|Protocol Violation|2
200461|NCT01079234|634439|P2|Extension: Week 27 to 52|Protocol Violation|0
200462|NCT01079234|634440|P1|Extension: Week 27 to 52|Protocol Violation|0
200463|NCT01079234|634437|P4|Extension: Week 27 to 52|Lack of Efficacy|2
200464|NCT01079234|634438|P3|Extension: Week 27 to 52|Lack of Efficacy|0
200465|NCT01079234|634439|P2|Extension: Week 27 to 52|Lack of Efficacy|0
200466|NCT01079234|634440|P1|Extension: Week 27 to 52|Lack of Efficacy|0
200467|NCT01079234|634437|P4|Extension: Week 27 to 52|Adverse Event|0
200468|NCT01079234|634438|P3|Extension: Week 27 to 52|Adverse Event|1
200469|NCT01079234|634439|P2|Extension: Week 27 to 52|Adverse Event|0
200470|NCT01079234|634440|P1|Extension: Week 27 to 52|Adverse Event|0
200471|NCT01079234|634437|P4|Main: Week 0 to 26|Unclassified|0
200472|NCT01079234|634438|P3|Main: Week 0 to 26|Unclassified|4
200473|NCT01079234|634439|P2|Main: Week 0 to 26|Unclassified|13
200474|NCT01079234|634440|P1|Main: Week 0 to 26|Unclassified|7
200475|NCT01079234|634437|P4|Main: Week 0 to 26|Withdrawal criteria|0
200476|NCT01079234|634438|P3|Main: Week 0 to 26|Withdrawal criteria|2
200477|NCT01079234|634439|P2|Main: Week 0 to 26|Withdrawal criteria|6
200478|NCT01079234|634440|P1|Main: Week 0 to 26|Withdrawal criteria|6
200479|NCT01079234|634437|P4|Main: Week 0 to 26|Protocol Violation|0
200480|NCT01079234|634438|P3|Main: Week 0 to 26|Protocol Violation|4
200481|NCT01079234|634439|P2|Main: Week 0 to 26|Protocol Violation|2
200482|NCT01079234|634440|P1|Main: Week 0 to 26|Protocol Violation|6
200483|NCT01079234|634437|P4|Main: Week 0 to 26|Lack of Efficacy|0
200484|NCT01079234|634438|P3|Main: Week 0 to 26|Lack of Efficacy|1
200485|NCT01079234|634439|P2|Main: Week 0 to 26|Lack of Efficacy|1
200486|NCT01079234|634440|P1|Main: Week 0 to 26|Lack of Efficacy|2
200487|NCT01079234|634437|P4|Main: Week 0 to 26|Adverse Event|0
200488|NCT01079234|634438|P3|Main: Week 0 to 26|Adverse Event|1
200489|NCT01079234|634439|P2|Main: Week 0 to 26|Adverse Event|4
200490|NCT01079234|634440|P1|Main: Week 0 to 26|Adverse Event|5
200574|NCT01080131|634663|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
200491|NCT01079806|634491|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|2
200492|NCT01079806|634492|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|0
200493|NCT01079806|634491|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
200494|NCT01079806|634492|P1|Day 1 to Week 96|Poor compliance or noncompliance|1
200495|NCT01079806|634491|P2|Day 1 to Week 96|Pregnancy|1
200496|NCT01079806|634492|P1|Day 1 to Week 96|Pregnancy|0
200497|NCT01079806|634491|P2|Day 1 to Week 96|Withdrawal by Subject|1
200498|NCT01079806|634492|P1|Day 1 to Week 96|Withdrawal by Subject|3
200499|NCT01079806|634491|P2|Day 1 to Week 96|Adverse Event|2
200500|NCT01079806|634492|P1|Day 1 to Week 96|Adverse Event|0
200501|NCT01079832|634512|P1|Overall Study|Withdrawal by Subject|1
200502|NCT01079936|634524|P5|Phase II|Insurance Issue|1
200503|NCT01079936|634525|P4|Phase II|Insurance Issue|0
200504|NCT01079936|634526|P3|Phase II|Insurance Issue|0
200505|NCT01079936|634527|P2|Phase II|Insurance Issue|0
200506|NCT01079936|634528|P1|Phase II|Insurance Issue|0
200507|NCT01079936|634524|P5|Phase II|Adverse Event|0
200508|NCT01079936|634525|P4|Phase II|Adverse Event|0
200509|NCT01079936|634526|P3|Phase II|Adverse Event|1
200510|NCT01079936|634527|P2|Phase II|Adverse Event|0
200511|NCT01079936|634528|P1|Phase II|Adverse Event|0
200512|NCT01079936|634524|P5|Phase I: MTD|No Stem Cell Transplantation|0
200513|NCT01079936|634525|P4|Phase I: MTD|No Stem Cell Transplantation|0
200514|NCT01079936|634526|P3|Phase I: MTD|No Stem Cell Transplantation|0
200515|NCT01079936|634527|P2|Phase I: MTD|No Stem Cell Transplantation|0
200516|NCT01079936|634528|P1|Phase I: MTD|No Stem Cell Transplantation|2
200517|NCT01079936|634524|P5|Phase I: MTD|First Remission Status|0
200518|NCT01079936|634525|P4|Phase I: MTD|First Remission Status|0
200519|NCT01079936|634526|P3|Phase I: MTD|First Remission Status|0
200520|NCT01079936|634527|P2|Phase I: MTD|First Remission Status|0
200521|NCT01079936|634528|P1|Phase I: MTD|First Remission Status|2
200522|NCT01079949|634549|P2|Overall Study|Randomized but not treated|0
200523|NCT01079949|634550|P1|Overall Study|Randomized but not treated|1
200524|NCT01079949|634549|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
200525|NCT01079949|634550|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
200526|NCT01079949|634549|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
200527|NCT01079949|634550|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
200528|NCT01079949|634549|P2|Overall Study|Withdrawal before r-hCG administration|3
200529|NCT01079949|634550|P1|Overall Study|Withdrawal before r-hCG administration|2
200530|NCT01079962|634594|P2|Overall Study|Due to arrhythmia/bradycardia|1
200531|NCT01079962|634595|P1|Overall Study|Due to arrhythmia/bradycardia|1
200532|NCT01079962|634594|P2|Overall Study|Participant not returning for next visit|0
200533|NCT01079962|634595|P1|Overall Study|Participant not returning for next visit|1
200534|NCT01079962|634594|P2|Overall Study|Inclusion/exclusion criteria|3
200535|NCT01079962|634595|P1|Overall Study|Inclusion/exclusion criteria|1
200536|NCT01079962|634594|P2|Overall Study|No blood pressure (BP) control|0
200537|NCT01079962|634595|P1|Overall Study|No blood pressure (BP) control|3
200538|NCT01079962|634594|P2|Overall Study|Protocol Violation|2
200539|NCT01079962|634595|P1|Overall Study|Protocol Violation|2
200540|NCT01079962|634594|P2|Overall Study|Withdrawal by Subject|7
200541|NCT01079962|634595|P1|Overall Study|Withdrawal by Subject|5
200542|NCT01079962|634594|P2|Overall Study|Adverse Event|2
200543|NCT01079962|634595|P1|Overall Study|Adverse Event|2
200544|NCT01079988|634626|P5|Overall Study|Other|1
200545|NCT01079988|634627|P4|Overall Study|Other|2
200546|NCT01079988|634628|P3|Overall Study|Other|0
200547|NCT01079988|634629|P2|Overall Study|Other|0
200548|NCT01079988|634630|P1|Overall Study|Other|0
200549|NCT01079988|634626|P5|Overall Study|Lack of Efficacy|0
200550|NCT01079988|634627|P4|Overall Study|Lack of Efficacy|0
200551|NCT01079988|634628|P3|Overall Study|Lack of Efficacy|0
200552|NCT01079988|634629|P2|Overall Study|Lack of Efficacy|0
200553|NCT01079988|634630|P1|Overall Study|Lack of Efficacy|1
200554|NCT01079988|634626|P5|Overall Study|Lost to Follow-up|0
200555|NCT01079988|634627|P4|Overall Study|Lost to Follow-up|1
200556|NCT01079988|634628|P3|Overall Study|Lost to Follow-up|0
200557|NCT01079988|634629|P2|Overall Study|Lost to Follow-up|0
200558|NCT01079988|634630|P1|Overall Study|Lost to Follow-up|0
200559|NCT01080131|634662|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
200560|NCT01080131|634663|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
200561|NCT01080131|634662|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
200562|NCT01080131|634663|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
200563|NCT01080131|634662|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
200564|NCT01080131|634663|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
200565|NCT01080131|634662|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
200566|NCT01080131|634663|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
200567|NCT01080131|634662|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
200568|NCT01080131|634663|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
200569|NCT01080131|634662|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
200570|NCT01080131|634663|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
200571|NCT01080131|634662|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
200572|NCT01080131|634663|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
200573|NCT01080131|634662|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
200575|NCT01080131|634662|P2|Core Study (0- 12 Weeks)|Death|0
200576|NCT01080131|634663|P1|Core Study (0- 12 Weeks)|Death|1
200577|NCT01080131|634662|P2|Core Study (0- 12 Weeks)|Administrative problems|1
200578|NCT01080131|634663|P1|Core Study (0- 12 Weeks)|Administrative problems|0
200579|NCT01080131|634662|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
200580|NCT01080131|634663|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
200581|NCT01080131|634662|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
200582|NCT01080131|634663|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
200583|NCT01080131|634662|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
200584|NCT01080131|634663|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
200585|NCT01080300|634800|P2|Overall Study|Reasons not specified|6
200586|NCT01080300|634801|P1|Overall Study|Reasons not specified|4
200587|NCT01080300|634800|P2|Overall Study|Withdrawal by Subject|28
200588|NCT01080300|634801|P1|Overall Study|Withdrawal by Subject|12
200589|NCT01080300|634800|P2|Overall Study|Death|1
200590|NCT01080300|634801|P1|Overall Study|Death|0
200591|NCT01080300|634800|P2|Overall Study|Lost to Follow-up|6
200592|NCT01080300|634801|P1|Overall Study|Lost to Follow-up|10
200593|NCT01080300|634800|P2|Overall Study|Protocol Violation|13
200594|NCT01080300|634801|P1|Overall Study|Protocol Violation|7
200595|NCT01080300|634800|P2|Overall Study|Lack of Efficacy|15
200596|NCT01080300|634801|P1|Overall Study|Lack of Efficacy|12
200597|NCT01080300|634800|P2|Overall Study|Adverse Event|35
200598|NCT01080300|634801|P1|Overall Study|Adverse Event|49
200599|NCT01080326|634809|P1|Overall Study|Surgeon decision|1
200600|NCT01080326|634809|P1|Overall Study|Patient deterioration prior to procedure|3
200601|NCT01080391|634815|P2|Overall Study|Withdrawal by Subject|10
200602|NCT01080391|634816|P1|Overall Study|Withdrawal by Subject|19
200603|NCT01080391|634815|P2|Overall Study|Lost to Follow-up|3
200604|NCT01080391|634816|P1|Overall Study|Lost to Follow-up|4
200605|NCT01080625|634837|P3|Overall Study|Physician Decision|1
200606|NCT01080625|634838|P2|Overall Study|Physician Decision|2
200607|NCT01080625|634839|P1|Overall Study|Physician Decision|0
200608|NCT01080768|634871|P2|Overall Study|Protocol Deviation|1
200609|NCT01080768|634872|P1|Overall Study|Protocol Deviation|2
200610|NCT01080807|634933|P2|Overall Study|Moved away without notifying center|0
200611|NCT01080807|634934|P1|Overall Study|Moved away without notifying center|1
200612|NCT01080807|634933|P2|Overall Study|Switched to first shift|0
200613|NCT01080807|634934|P1|Overall Study|Switched to first shift|1
200614|NCT01080807|634933|P2|Overall Study|Work schedule and travel|1
200615|NCT01080807|634934|P1|Overall Study|Work schedule and travel|0
200616|NCT01080807|634933|P2|Overall Study|Work schedule changing|1
200617|NCT01080807|634934|P1|Overall Study|Work schedule changing|1
200618|NCT01080807|634933|P2|Overall Study|Stopped working consistent night shifts|1
200619|NCT01080807|634934|P1|Overall Study|Stopped working consistent night shifts|0
200620|NCT01080807|634933|P2|Overall Study|Laid off or terminated from job|2
200621|NCT01080807|634934|P1|Overall Study|Laid off or terminated from job|1
200622|NCT01080807|634933|P2|Overall Study|Began working day shift|2
200623|NCT01080807|634934|P1|Overall Study|Began working day shift|0
200624|NCT01080807|634933|P2|Overall Study|Noncompliance to study procedures|1
200625|NCT01080807|634934|P1|Overall Study|Noncompliance to study procedures|1
200626|NCT01080807|634933|P2|Overall Study|Noncompliance with drug administration|1
200627|NCT01080807|634934|P1|Overall Study|Noncompliance with drug administration|1
200628|NCT01080807|634933|P2|Overall Study|Lost to Follow-up|4
200629|NCT01080807|634934|P1|Overall Study|Lost to Follow-up|6
200630|NCT01080807|634933|P2|Overall Study|Protocol Violation|6
200631|NCT01080807|634934|P1|Overall Study|Protocol Violation|7
200632|NCT01080807|634933|P2|Overall Study|Withdrawal by Subject|2
200633|NCT01080807|634934|P1|Overall Study|Withdrawal by Subject|7
200634|NCT01080807|634933|P2|Overall Study|Lack of Efficacy|1
200635|NCT01080807|634934|P1|Overall Study|Lack of Efficacy|0
200636|NCT01080807|634933|P2|Overall Study|Adverse Event|1
200637|NCT01080807|634934|P1|Overall Study|Adverse Event|9
200638|NCT01081132|635023|P2|Overall Study|Protocol Violation|1
200639|NCT01081132|635024|P1|Overall Study|Protocol Violation|3
200640|NCT01081132|635023|P2|Overall Study|Declined Taper Phase|1
200641|NCT01081132|635024|P1|Overall Study|Declined Taper Phase|0
200642|NCT01081132|635023|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
200643|NCT01081132|635024|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
200644|NCT01081132|635023|P2|Overall Study|Stopped Taking Meds|0
200645|NCT01081132|635024|P1|Overall Study|Stopped Taking Meds|2
200646|NCT01081132|635023|P2|Overall Study|Missed Visits|1
200647|NCT01081132|635024|P1|Overall Study|Missed Visits|1
200648|NCT01081132|635023|P2|Overall Study|Lack Of Compliance|1
200649|NCT01081132|635024|P1|Overall Study|Lack Of Compliance|0
200650|NCT01081132|635023|P2|Overall Study|Non Compliance|2
200651|NCT01081132|635024|P1|Overall Study|Non Compliance|4
200652|NCT01081132|635023|P2|Overall Study|Adverse Event|9
200653|NCT01081132|635024|P1|Overall Study|Adverse Event|3
200654|NCT01081132|635023|P2|Overall Study|Lost to Follow-up|11
200655|NCT01081132|635024|P1|Overall Study|Lost to Follow-up|4
200656|NCT01081132|635023|P2|Overall Study|Withdrawal by Subject|16
200657|NCT01081132|635024|P1|Overall Study|Withdrawal by Subject|13
200658|NCT01081132|635023|P2|Overall Study|Lack of Efficacy|9
200659|NCT01081132|635024|P1|Overall Study|Lack of Efficacy|25
200660|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Not specified|3
200661|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Not specified|4
200662|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
200663|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
200664|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
200665|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
200666|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
200667|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
200668|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
200669|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
200670|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
200671|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
200672|NCT01081145|635062|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
200673|NCT01081145|635063|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
200674|NCT01081145|635062|P2|Open-Label Phase|Protocol Violation|0
200675|NCT01081145|635063|P1|Open-Label Phase|Protocol Violation|4
200676|NCT01081145|635062|P2|Open-Label Phase|Lost to Follow-up|0
200677|NCT01081145|635063|P1|Open-Label Phase|Lost to Follow-up|11
200678|NCT01081145|635062|P2|Open-Label Phase|Not specified|0
200679|NCT01081145|635063|P1|Open-Label Phase|Not specified|12
200680|NCT01081145|635062|P2|Open-Label Phase|Withdrawal by Subject|0
200681|NCT01081145|635063|P1|Open-Label Phase|Withdrawal by Subject|41
200682|NCT01081145|635062|P2|Open-Label Phase|Adverse Event|0
200683|NCT01081145|635063|P1|Open-Label Phase|Adverse Event|42
200684|NCT01081145|635062|P2|Open-Label Phase|Response criteria not met|0
200685|NCT01081145|635063|P1|Open-Label Phase|Response criteria not met|46
200686|NCT01081145|635062|P2|Open-Label Phase|Lack of Efficacy|0
200687|NCT01081145|635063|P1|Open-Label Phase|Lack of Efficacy|56
200688|NCT01081249|635089|P2|Overall Study|Diagnosed with Bipolar Disorder|1
200689|NCT01081249|635090|P1|Overall Study|Diagnosed with Bipolar Disorder|0
200690|NCT01081301|635096|P1|Overall Study|Lost to Follow-up|4
200691|NCT01081301|635096|P1|Overall Study|Patient too ill|2
200692|NCT01081301|635096|P1|Overall Study|Too busy|5
200693|NCT01081301|635096|P1|Overall Study|Bereaved|3
200694|NCT01081626|635136|P2|Overall Study|Unspecified|30
200695|NCT01081626|635137|P1|Overall Study|Unspecified|33
200696|NCT01081626|635136|P2|Overall Study|Lost to Follow-up|1
200697|NCT01081626|635137|P1|Overall Study|Lost to Follow-up|0
200698|NCT01081626|635136|P2|Overall Study|Overstimulation|1
200699|NCT01081626|635137|P1|Overall Study|Overstimulation|0
200700|NCT01081626|635136|P2|Overall Study|Low antral follicle count|0
200701|NCT01081626|635137|P1|Overall Study|Low antral follicle count|1
200702|NCT01081626|635136|P2|Overall Study|Missing Estradiol|28
200703|NCT01081626|635137|P1|Overall Study|Missing Estradiol|25
200704|NCT01081626|635136|P2|Overall Study|Dosing error|1
200705|NCT01081626|635137|P1|Overall Study|Dosing error|1
200706|NCT01081665|635163|P1|Overall Study|Lack of Efficacy|1
200707|NCT01081665|635163|P1|Overall Study|Adverse Event|1
200708|NCT01081665|635163|P1|Overall Study|Change in renal replacement therapy|2
200709|NCT01081665|635163|P1|Overall Study|Regulation of iPTH|5
200710|NCT01081665|635163|P1|Overall Study|Change of dialysis unit|10
200711|NCT01081665|635163|P1|Overall Study|Withdrawal by Subject|17
200712|NCT01081665|635163|P1|Overall Study|Lost to Follow-up|18
200713|NCT01081665|635163|P1|Overall Study|Death|41
200714|NCT01081769|635175|P2|CORE Intent-To-Treat|Patient Moved|2
200715|NCT01081769|635176|P1|CORE Intent-To-Treat|Patient Moved|2
200716|NCT01081769|635175|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
200717|NCT01081769|635176|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
200718|NCT01081769|635175|P2|CORE Intent-To-Treat|Ineligibility|4
200719|NCT01081769|635176|P1|CORE Intent-To-Treat|Ineligibility|3
200720|NCT01081769|635175|P2|CORE Intent-To-Treat|Other|1
200721|NCT01081769|635176|P1|CORE Intent-To-Treat|Other|0
200722|NCT01081769|635175|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
200723|NCT01081769|635176|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
200724|NCT01081769|635175|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
200725|NCT01081769|635176|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
200726|NCT01081769|635175|P2|CORE Intent-To-Treat|Pregnancy|0
200727|NCT01081769|635176|P1|CORE Intent-To-Treat|Pregnancy|1
200728|NCT01081769|635175|P2|CORE Intent-To-Treat|Lost to Follow-up|5
200729|NCT01081769|635176|P1|CORE Intent-To-Treat|Lost to Follow-up|4
200730|NCT01081769|635175|P2|CORE Intent-To-Treat|Lack of Efficacy|6
200731|NCT01081769|635176|P1|CORE Intent-To-Treat|Lack of Efficacy|2
200732|NCT01081769|635175|P2|CORE Intent-To-Treat|Death|1
200733|NCT01081769|635176|P1|CORE Intent-To-Treat|Death|1
200734|NCT01081769|635175|P2|CORE Intent-To-Treat|Adverse Event|11
200735|NCT01081769|635176|P1|CORE Intent-To-Treat|Adverse Event|14
200736|NCT01081769|635175|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
200737|NCT01081769|635176|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
200738|NCT01081769|635175|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
200739|NCT01081769|635176|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
200740|NCT01081769|635175|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
200741|NCT01081769|635176|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
200742|NCT01081769|635175|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
200743|NCT01081769|635176|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
200744|NCT01081795|635213|P3|Overall Study|Unspecified|0
200745|NCT01081795|635214|P2|Overall Study|Unspecified|2
200746|NCT01081795|635215|P1|Overall Study|Unspecified|1
200747|NCT01081795|635213|P3|Overall Study|Using drug with restricted days of use|2
200748|NCT01081795|635214|P2|Overall Study|Using drug with restricted days of use|3
200749|NCT01081795|635215|P1|Overall Study|Using drug with restricted days of use|2
200750|NCT01081795|635213|P3|Overall Study|Use of a prohibited concomitant drug|1
200751|NCT01081795|635214|P2|Overall Study|Use of a prohibited concomitant drug|1
200752|NCT01081795|635215|P1|Overall Study|Use of a prohibited concomitant drug|1
200753|NCT01081795|635213|P3|Overall Study|Ineligible for participation|0
200754|NCT01081795|635214|P2|Overall Study|Ineligible for participation|0
200755|NCT01081795|635215|P1|Overall Study|Ineligible for participation|1
200756|NCT01081795|635213|P3|Overall Study|Revocation of informed consent|0
200757|NCT01081795|635214|P2|Overall Study|Revocation of informed consent|0
200758|NCT01081795|635215|P1|Overall Study|Revocation of informed consent|2
200759|NCT01081795|635213|P3|Overall Study|Subject’s schedule|2
200760|NCT01081795|635214|P2|Overall Study|Subject’s schedule|1
200761|NCT01081795|635215|P1|Overall Study|Subject’s schedule|1
200762|NCT01081795|635213|P3|Overall Study|Lack of Efficacy|19
200763|NCT01081795|635214|P2|Overall Study|Lack of Efficacy|5
200764|NCT01081795|635215|P1|Overall Study|Lack of Efficacy|7
200765|NCT01081795|635213|P3|Overall Study|Adverse Event|6
200766|NCT01081795|635214|P2|Overall Study|Adverse Event|23
200767|NCT01081795|635215|P1|Overall Study|Adverse Event|18
200768|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
200769|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
200770|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
200771|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
200772|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
200773|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
200774|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
200775|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
200776|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
200777|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
200778|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Not specified|0
200779|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Not specified|0
200780|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Not specified|4
200781|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Not specified|5
200782|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Not specified|4
200783|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
200784|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
200785|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
200786|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
200787|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
200788|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
200789|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
200790|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
200791|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
200792|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
200793|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
200794|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
200795|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
200796|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
200797|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
200798|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
200799|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
200800|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
200801|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
200802|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
200803|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
200804|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
200805|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
200806|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
200807|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
200808|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Death|0
200809|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Death|0
200810|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Death|0
200811|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Death|0
200812|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Death|1
200813|NCT01081834|635255|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
200814|NCT01081834|635256|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
200815|NCT01081834|635257|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
200816|NCT01081834|635258|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
200817|NCT01081834|635259|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
200818|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
200819|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
200820|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
200821|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
200822|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
200823|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Not specified|0
200824|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Not specified|1
200825|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Not specified|3
200826|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Not specified|4
200827|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Not specified|4
200828|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
200829|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
200830|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
200831|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
200832|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
200833|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
200834|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
200835|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
200836|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
200837|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
200838|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
200839|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
200840|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
200841|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
200842|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
200843|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Protocol Violation|2
200844|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Protocol Violation|0
200845|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Protocol Violation|0
200846|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Protocol Violation|4
200847|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Protocol Violation|0
200848|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
200849|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
200850|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
200851|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
200852|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
200853|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Death|0
200854|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Death|0
200855|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Death|0
200856|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Death|0
200857|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Death|1
200858|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Adverse Event|1
200859|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Adverse Event|1
200860|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Adverse Event|3
200861|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Adverse Event|5
200862|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Adverse Event|2
200863|NCT01081834|635255|P5|Core Period: Baseline to Week 26|Pregnancy|0
200864|NCT01081834|635256|P4|Core Period: Baseline to Week 26|Pregnancy|0
200865|NCT01081834|635257|P3|Core Period: Baseline to Week 26|Pregnancy|0
200866|NCT01081834|635258|P2|Core Period: Baseline to Week 26|Pregnancy|0
200867|NCT01081834|635259|P1|Core Period: Baseline to Week 26|Pregnancy|1
200868|NCT01082614|635345|P2|Overall Study|Physician Decision|0
200869|NCT01082614|635346|P1|Overall Study|Physician Decision|2
200870|NCT01082614|635345|P2|Overall Study|Equipment Malfunction|1
200871|NCT01082614|635346|P1|Overall Study|Equipment Malfunction|0
200872|NCT01082614|635345|P2|Overall Study|Adverse Event|4
200873|NCT01082614|635346|P1|Overall Study|Adverse Event|1
200874|NCT01082640|635355|P3|Overall Study|Other|3
200875|NCT01082640|635356|P2|Overall Study|Other|1
200876|NCT01082640|635357|P1|Overall Study|Other|2
200877|NCT01082640|635355|P3|Overall Study|Lost to Follow-up|0
200878|NCT01082640|635356|P2|Overall Study|Lost to Follow-up|3
200879|NCT01082640|635357|P1|Overall Study|Lost to Follow-up|0
200880|NCT01082640|635355|P3|Overall Study|Major protocol deviation|0
200881|NCT01082640|635356|P2|Overall Study|Major protocol deviation|3
200882|NCT01082640|635357|P1|Overall Study|Major protocol deviation|3
200883|NCT01082640|635355|P3|Overall Study|Withdrawal by Subject|2
200884|NCT01082640|635356|P2|Overall Study|Withdrawal by Subject|3
200885|NCT01082640|635357|P1|Overall Study|Withdrawal by Subject|3
200886|NCT01082640|635355|P3|Overall Study|Adverse Event|3
200887|NCT01082640|635356|P2|Overall Study|Adverse Event|5
200888|NCT01082640|635357|P1|Overall Study|Adverse Event|9
200889|NCT01082874|635381|P4|Overall Study|Withdrawal by Subject|3
200890|NCT01082874|635382|P3|Overall Study|Withdrawal by Subject|5
200891|NCT01082874|635383|P2|Overall Study|Withdrawal by Subject|2
200892|NCT01082874|635384|P1|Overall Study|Withdrawal by Subject|1
200893|NCT01082874|635381|P4|Overall Study|Lost to Follow-up|10
200894|NCT01082874|635382|P3|Overall Study|Lost to Follow-up|6
200895|NCT01082874|635383|P2|Overall Study|Lost to Follow-up|10
200896|NCT01082874|635384|P1|Overall Study|Lost to Follow-up|10
200897|NCT01082965|635411|P2|Overall Study|Unspecified|1
200898|NCT01082965|635412|P1|Overall Study|Unspecified|1
200899|NCT01082965|635411|P2|Overall Study|Protocol Violation|1
200900|NCT01082965|635412|P1|Overall Study|Protocol Violation|0
200901|NCT01083121|635430|P1|Overall Study|Use of Humira outside the approved label|81
200902|NCT01083160|635438|P1|Overall Study|Adverse Event|1
200903|NCT01083173|635445|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
200904|NCT01083173|635446|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
200905|NCT01083173|635445|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
200906|NCT01083173|635446|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
200907|NCT01083173|635445|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
200908|NCT01083173|635446|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
200909|NCT01083173|635445|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
200910|NCT01083173|635446|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
200911|NCT01083173|635445|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
200912|NCT01083173|635446|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
200913|NCT01083173|635445|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
200914|NCT01083173|635446|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
200915|NCT01083173|635445|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
200916|NCT01083173|635446|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
201005|NCT01083810|635749|P1|Overall Study|Withdrawal by Subject|7
200917|NCT01083173|635445|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
200918|NCT01083173|635446|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
200919|NCT01083173|635445|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
200920|NCT01083173|635446|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
200921|NCT01083173|635445|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
200922|NCT01083173|635446|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
200923|NCT01083173|635445|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
200924|NCT01083173|635446|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
200925|NCT01083186|635464|P1|Overall Study|Non-compliance to Study Treatment|1
200926|NCT01083186|635464|P1|Overall Study|Administrative Reasons|2
200927|NCT01083186|635464|P1|Overall Study|Hemodialysis Initiation|28
200928|NCT01083186|635464|P1|Overall Study|Lack of Efficacy|2
200929|NCT01083186|635464|P1|Overall Study|Adverse Event|3
200930|NCT01083186|635464|P1|Overall Study|Death|3
200931|NCT01083186|635464|P1|Overall Study|Consent Withdrawal|7
200932|NCT01083186|635464|P1|Overall Study|Lost to Follow-up|48
200933|NCT01083316|635510|P1|Overall Study|Withdrawal by Subject|1
200934|NCT01083316|635510|P1|Overall Study|Adverse Event|2
200935|NCT01083485|635527|P2|Overall Study|Other|0
200936|NCT01083485|635528|P1|Overall Study|Other|1
200937|NCT01083485|635527|P2|Overall Study|Withdrawal by Subject|2
200938|NCT01083485|635528|P1|Overall Study|Withdrawal by Subject|5
200939|NCT01083485|635527|P2|Overall Study|Protocol Violation|0
200940|NCT01083485|635528|P1|Overall Study|Protocol Violation|1
200941|NCT01083485|635527|P2|Overall Study|Adverse Event|1
200942|NCT01083485|635528|P1|Overall Study|Adverse Event|0
200943|NCT01083576|635538|P2|Overall Study|Treatment Failure|1
200944|NCT01083576|635539|P1|Overall Study|Treatment Failure|6
200945|NCT01083602|635567|P1|Overall Study|Lack of Efficacy|36
200946|NCT01083602|635567|P1|Overall Study|Withdrawal by Subject|5
200947|NCT01083602|635567|P1|Overall Study|Death|1
200948|NCT01083602|635567|P1|Overall Study|New Cancer Therapy|2
200949|NCT01083602|635567|P1|Overall Study|Adverse Event|11
200950|NCT01083641|635576|P1|Overall Study|Withdrawal by Subject|2
200951|NCT01083680|635597|P1|Overall Study|Withdrawal by Subject|1086
200952|NCT01083680|635597|P1|Overall Study|Lost to Follow-up|2758
200953|NCT01083693|635609|P3|Overall Study|Reason unknown|1
200954|NCT01083693|635610|P2|Overall Study|Reason unknown|0
200955|NCT01083693|635611|P1|Overall Study|Reason unknown|0
200956|NCT01083693|635609|P3|Overall Study|Withdrawal by Subject|2
200957|NCT01083693|635610|P2|Overall Study|Withdrawal by Subject|0
200958|NCT01083693|635611|P1|Overall Study|Withdrawal by Subject|3
200959|NCT01083693|635609|P3|Overall Study|Other medical condition/surgery|0
200960|NCT01083693|635610|P2|Overall Study|Other medical condition/surgery|1
200961|NCT01083693|635611|P1|Overall Study|Other medical condition/surgery|1
200962|NCT01083693|635609|P3|Overall Study|Complete remission|0
200963|NCT01083693|635610|P2|Overall Study|Complete remission|1
200964|NCT01083693|635611|P1|Overall Study|Complete remission|0
200965|NCT01083693|635609|P3|Overall Study|Patient Moved|0
200966|NCT01083693|635610|P2|Overall Study|Patient Moved|1
200967|NCT01083693|635611|P1|Overall Study|Patient Moved|0
200968|NCT01083693|635609|P3|Overall Study|Lack of effectiveness|2
200969|NCT01083693|635610|P2|Overall Study|Lack of effectiveness|2
200970|NCT01083693|635611|P1|Overall Study|Lack of effectiveness|13
200971|NCT01083693|635609|P3|Overall Study|Lost to Follow-up|2
200972|NCT01083693|635610|P2|Overall Study|Lost to Follow-up|0
200973|NCT01083693|635611|P1|Overall Study|Lost to Follow-up|2
200974|NCT01083693|635609|P3|Overall Study|Adverse Event|0
200975|NCT01083693|635610|P2|Overall Study|Adverse Event|1
200976|NCT01083693|635611|P1|Overall Study|Adverse Event|1
200977|NCT01083771|635739|P1|Overall Study|Withdrawal by Subject|3
200978|NCT01083771|635739|P1|Overall Study|non-compliant|2
200979|NCT01083810|635747|P3|Overall Study|Virologic failure|0
200980|NCT01083810|635748|P2|Overall Study|Virologic failure|8
200981|NCT01083810|635749|P1|Overall Study|Virologic failure|1
200982|NCT01083810|635747|P3|Overall Study|Therapy break|2
200983|NCT01083810|635748|P2|Overall Study|Therapy break|2
200984|NCT01083810|635749|P1|Overall Study|Therapy break|1
200985|NCT01083810|635747|P3|Overall Study|Participation in study|0
200986|NCT01083810|635748|P2|Overall Study|Participation in study|0
200987|NCT01083810|635749|P1|Overall Study|Participation in study|1
200988|NCT01083810|635747|P3|Overall Study|Co-morbidities|0
200989|NCT01083810|635748|P2|Overall Study|Co-morbidities|0
200990|NCT01083810|635749|P1|Overall Study|Co-morbidities|1
200991|NCT01083810|635747|P3|Overall Study|Death|3
200992|NCT01083810|635748|P2|Overall Study|Death|2
200993|NCT01083810|635749|P1|Overall Study|Death|2
200994|NCT01083810|635747|P3|Overall Study|Simplification|0
200995|NCT01083810|635748|P2|Overall Study|Simplification|1
200996|NCT01083810|635749|P1|Overall Study|Simplification|4
200997|NCT01083810|635747|P3|Overall Study|Non-compliance|2
200998|NCT01083810|635748|P2|Overall Study|Non-compliance|7
200999|NCT01083810|635749|P1|Overall Study|Non-compliance|4
201000|NCT01083810|635747|P3|Overall Study|Reason not reported|1
201001|NCT01083810|635748|P2|Overall Study|Reason not reported|1
201002|NCT01083810|635749|P1|Overall Study|Reason not reported|6
201003|NCT01083810|635747|P3|Overall Study|Withdrawal by Subject|4
201004|NCT01083810|635748|P2|Overall Study|Withdrawal by Subject|2
201006|NCT01083810|635747|P3|Overall Study|Adverse Event|4
201007|NCT01083810|635748|P2|Overall Study|Adverse Event|11
201008|NCT01083810|635749|P1|Overall Study|Adverse Event|15
201009|NCT01083810|635747|P3|Overall Study|Lost to Follow-up|4
201010|NCT01083810|635748|P2|Overall Study|Lost to Follow-up|11
201011|NCT01083810|635749|P1|Overall Study|Lost to Follow-up|23
201012|NCT01084005|635822|P2|Overall Study|Withdrawal by Subject|1
201013|NCT01084005|635823|P1|Overall Study|Withdrawal by Subject|1
201014|NCT01084005|635822|P2|Overall Study|Protocol Violation|7
201015|NCT01084005|635823|P1|Overall Study|Protocol Violation|3
201016|NCT01084005|635822|P2|Overall Study|Adverse Event|8
201017|NCT01084005|635823|P1|Overall Study|Adverse Event|1
201018|NCT01084083|635851|P1|Overall Study|Never started assigned therapy|1
201019|NCT01084083|635851|P1|Overall Study|Other|2
201020|NCT01084083|635851|P1|Overall Study|Complicating disease|1
201021|NCT01084083|635851|P1|Overall Study|Withdrawal by Subject|2
201022|NCT01084083|635851|P1|Overall Study|Death|1
201023|NCT01084083|635851|P1|Overall Study|Adverse Event|5
201024|NCT01084135|635861|P2|20 Week|Physician Decision|1
201025|NCT01084135|635862|P1|20 Week|Physician Decision|0
201026|NCT01084174|635883|P2|Overall Study|Participant noncompliance|1
201027|NCT01084174|635884|P1|Overall Study|Participant noncompliance|0
201028|NCT01084174|635883|P2|Overall Study|Anaphylaxis|1
201029|NCT01084174|635884|P1|Overall Study|Anaphylaxis|0
201030|NCT01084174|635883|P2|Overall Study|Eosinophilic esophagitis|1
201031|NCT01084174|635884|P1|Overall Study|Eosinophilic esophagitis|0
201032|NCT01084174|635883|P2|Overall Study|gastrointestinal symptoms|1
201033|NCT01084174|635884|P1|Overall Study|gastrointestinal symptoms|1
201034|NCT01084239|635904|P2|28-Day Follow-up|Lost to Follow-up|9
201035|NCT01084239|635905|P1|28-Day Follow-up|Lost to Follow-up|4
201036|NCT01084538|636023|P1|Overall Study|Reason unknown|8
201037|NCT01084538|636023|P1|Overall Study|Over-suppression of parathyroid gland|2
201038|NCT01084538|636023|P1|Overall Study|Change of residence|2
201039|NCT01084538|636023|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
201040|NCT01084538|636023|P1|Overall Study|Hyperphosphatemia|2
201041|NCT01084538|636023|P1|Overall Study|Patient noncompliance|2
201042|NCT01084538|636023|P1|Overall Study|Lack of effectiveness|2
201043|NCT01084538|636023|P1|Overall Study|Serious Adverse Event|3
201044|NCT01084538|636023|P1|Overall Study|Kidney transplant|6
201045|NCT01084538|636023|P1|Overall Study|Adverse Event|9
201046|NCT01084538|636023|P1|Overall Study|Drug not available|30
201047|NCT01084551|636033|P3|Overall Study|Physician Decision|0
201048|NCT01084551|636034|P2|Overall Study|Physician Decision|0
201049|NCT01084551|636035|P1|Overall Study|Physician Decision|1
201050|NCT01084551|636033|P3|Overall Study|Lost to Follow-up|3
201051|NCT01084551|636034|P2|Overall Study|Lost to Follow-up|0
201052|NCT01084551|636035|P1|Overall Study|Lost to Follow-up|0
201053|NCT01084551|636033|P3|Overall Study|Protocol Violation|0
201054|NCT01084551|636034|P2|Overall Study|Protocol Violation|4
201055|NCT01084551|636035|P1|Overall Study|Protocol Violation|2
201056|NCT01084551|636033|P3|Overall Study|Withdrawal by Subject|0
201057|NCT01084551|636034|P2|Overall Study|Withdrawal by Subject|1
201058|NCT01084551|636035|P1|Overall Study|Withdrawal by Subject|2
201059|NCT01084551|636033|P3|Overall Study|Lack of Efficacy|1
201060|NCT01084551|636034|P2|Overall Study|Lack of Efficacy|0
201061|NCT01084551|636035|P1|Overall Study|Lack of Efficacy|2
201062|NCT01084551|636033|P3|Overall Study|Adverse Event|4
201063|NCT01084551|636034|P2|Overall Study|Adverse Event|9
201064|NCT01084551|636035|P1|Overall Study|Adverse Event|2
201065|NCT01084603|636073|P1|Washout Period 4|Adverse Event|1
201066|NCT01084603|636073|P1|Oral Nicotine 1|Withdrawal by Subject|1
201067|NCT01084603|636073|P1|Nicorette® Gum|Withdrawal by Subject|1
201068|NCT01084603|636073|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
201069|NCT01084603|636073|P1|Baseline|Withdrawal by Subject|2
201070|NCT01084668|636106|P1|Overall Study|Non-compliance|1
201071|NCT01084668|636106|P1|Overall Study|Pregnancy|1
201072|NCT01084668|636106|P1|Overall Study|Withdrawal by Subject|2
201073|NCT01084668|636106|P1|Overall Study|Lack of Efficacy|5
201074|NCT01084707|636115|P1|Overall Study|Withdrawal by Subject|6
201075|NCT01076959|636164|P1|Overall Study|Other|119
201076|NCT01076959|636164|P1|Overall Study|Lost to Follow-up|241
201077|NCT01076959|636164|P1|Overall Study|Non-compliance|274
201078|NCT01076959|636164|P1|Overall Study|Lack of Efficacy|849
201079|NCT01076959|636164|P1|Overall Study|Adverse Event|767
201080|NCT01077024|636204|P2|Overall Study|unspecified|4
201081|NCT01077024|636205|P1|Overall Study|unspecified|4
201082|NCT01077024|636204|P2|Overall Study|Incarcerated|8
201083|NCT01077024|636205|P1|Overall Study|Incarcerated|7
201084|NCT01077024|636204|P2|Overall Study|Withdrawal by Subject|2
201085|NCT01077024|636205|P1|Overall Study|Withdrawal by Subject|0
201086|NCT01077024|636204|P2|Overall Study|Lost to Follow-up|14
201087|NCT01077024|636205|P1|Overall Study|Lost to Follow-up|20
201088|NCT01077050|636223|P1|Overall Study|Screen failure|8
201089|NCT01077050|636223|P1|Overall Study|Subjects signed ICF could not be located|1
201090|NCT01077063|636229|P2|Overall Study|Withdrawal by Subject|2
201091|NCT01077063|636230|P1|Overall Study|Withdrawal by Subject|0
201092|NCT01077063|636229|P2|Overall Study|Death|1
201093|NCT01077063|636230|P1|Overall Study|Death|1
201094|NCT01077063|636229|P2|Overall Study|Adverse Event|0
201095|NCT01077063|636230|P1|Overall Study|Adverse Event|3
201096|NCT01077076|636236|P6|Third Intervention|Death in the participant's family|1
201097|NCT01077076|636237|P5|Third Intervention|Death in the participant's family|0
201098|NCT01077076|636238|P4|Third Intervention|Death in the participant's family|0
201099|NCT01077076|636239|P3|Third Intervention|Death in the participant's family|0
201100|NCT01077076|636240|P2|Third Intervention|Death in the participant's family|0
201101|NCT01077076|636241|P1|Third Intervention|Death in the participant's family|0
201102|NCT01077076|636236|P6|First Intervention|Withdrawal by Subject|0
201103|NCT01077076|636237|P5|First Intervention|Withdrawal by Subject|0
201104|NCT01077076|636238|P4|First Intervention|Withdrawal by Subject|0
201105|NCT01077076|636239|P3|First Intervention|Withdrawal by Subject|0
201106|NCT01077076|636240|P2|First Intervention|Withdrawal by Subject|0
201107|NCT01077076|636241|P1|First Intervention|Withdrawal by Subject|1
201108|NCT01077128|636249|P1|Overall Study|Not available|54
201109|NCT01077128|636249|P1|Overall Study|Lack of efficacy/disease exacerbation|1
201110|NCT01077128|636249|P1|Overall Study|Adverse event and disease exacerbation|1
201111|NCT01077128|636249|P1|Overall Study|Adverse event and consent withdrawal|1
201112|NCT01077128|636249|P1|Overall Study|Disease exacerbation|1
201113|NCT01077128|636249|P1|Overall Study|Lack of Efficacy|1
201114|NCT01077128|636249|P1|Overall Study|Adverse Event|8
201115|NCT01077193|636307|P1|Overall Study|Study Terminated by Sponsor|40
201116|NCT01077193|636307|P1|Overall Study|Lack of Efficacy|1
201117|NCT01077193|636307|P1|Overall Study|Withdrawal by Subject|2
201118|NCT01077193|636307|P1|Overall Study|Lost to Follow-up|1
201119|NCT01077258|636311|P1|Overall Study|Other reasons|260
201120|NCT01077258|636311|P1|Overall Study|Clinical remission|37
201121|NCT01077258|636311|P1|Overall Study|Lack of Efficacy|663
201122|NCT01077258|636311|P1|Overall Study|Adverse drug reaction|218
201123|NCT01077258|636311|P1|Overall Study|Lost to Follow-up|1390
201124|NCT01077271|636351|P1|Overall Study|Mother unconvinced of the necessity|1
201125|NCT01077271|636351|P1|Overall Study|End of RSV season nearly reached|1
201126|NCT01077271|636351|P1|Overall Study|Parents thought too many injections|2
201127|NCT01077271|636351|P1|Overall Study|Changed doctors|2
201128|NCT01077271|636351|P1|Overall Study|Quota used up (insurance reimb issue)|2
201129|NCT01077271|636351|P1|Overall Study|Noncompliance|2
201130|NCT01077271|636351|P1|Overall Study|Screen failure, did not take palivizumab|4
201131|NCT01077271|636351|P1|Overall Study|Parental desire|8
201132|NCT01077284|636392|P3|Overall Study|Other|1
201133|NCT01077284|636393|P2|Overall Study|Other|0
201134|NCT01077284|636394|P1|Overall Study|Other|0
201135|NCT01077284|636392|P3|Overall Study|Withdrawal by Subject|1
201136|NCT01077284|636393|P2|Overall Study|Withdrawal by Subject|3
201137|NCT01077284|636394|P1|Overall Study|Withdrawal by Subject|2
201138|NCT01077284|636392|P3|Overall Study|Lost to Follow-up|0
201139|NCT01077284|636393|P2|Overall Study|Lost to Follow-up|2
201140|NCT01077284|636394|P1|Overall Study|Lost to Follow-up|1
201141|NCT01077284|636392|P3|Overall Study|Adverse Event|1
201142|NCT01077284|636393|P2|Overall Study|Adverse Event|0
201143|NCT01077284|636394|P1|Overall Study|Adverse Event|2
201144|NCT01077323|636437|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
201145|NCT01077323|636438|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
201146|NCT01077323|636439|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
201147|NCT01077323|636437|P3|Overall Study|Dispensing of drug in baseline period|256446
201148|NCT01077323|636438|P2|Overall Study|Dispensing of drug in baseline period|120229
201149|NCT01077323|636439|P1|Overall Study|Dispensing of drug in baseline period|0
201150|NCT01077323|636437|P3|Overall Study|<9 months enroll before drug dispensed|11655523
201151|NCT01077323|636438|P2|Overall Study|<9 months enroll before drug dispensed|263954
201152|NCT01077323|636439|P1|Overall Study|<9 months enroll before drug dispensed|11226
201153|NCT01077362|636459|P3|Overall Study|Not Specified|2
201154|NCT01077362|636460|P2|Overall Study|Not Specified|1
201155|NCT01077362|636461|P1|Overall Study|Not Specified|0
201156|NCT01077362|636459|P3|Overall Study|Withdrawal by Subject|5
201157|NCT01077362|636460|P2|Overall Study|Withdrawal by Subject|3
201158|NCT01077362|636461|P1|Overall Study|Withdrawal by Subject|5
201159|NCT01077362|636459|P3|Overall Study|Adverse Event|4
201160|NCT01077362|636460|P2|Overall Study|Adverse Event|7
201161|NCT01077362|636461|P1|Overall Study|Adverse Event|12
201162|NCT01077362|636459|P3|Overall Study|Lost to Follow-up|3
201163|NCT01077362|636460|P2|Overall Study|Lost to Follow-up|0
201164|NCT01077362|636461|P1|Overall Study|Lost to Follow-up|1
201165|NCT01077362|636459|P3|Overall Study|Lack of Efficacy|10
201166|NCT01077362|636460|P2|Overall Study|Lack of Efficacy|8
201167|NCT01077362|636461|P1|Overall Study|Lack of Efficacy|13
201168|NCT01077375|636496|P2|Overall Study|Other Reason|1
201169|NCT01077375|636497|P1|Overall Study|Other Reason|0
201170|NCT01077375|636496|P2|Overall Study|Lost to Follow-up|5
201171|NCT01077375|636497|P1|Overall Study|Lost to Follow-up|2
201172|NCT01077375|636496|P2|Overall Study|Withdrawal by Subject|6
201173|NCT01077375|636497|P1|Overall Study|Withdrawal by Subject|0
201174|NCT01077375|636496|P2|Overall Study|Lack of Efficacy|8
201175|NCT01077375|636497|P1|Overall Study|Lack of Efficacy|6
201176|NCT01077375|636496|P2|Overall Study|Adverse Event|15
201177|NCT01077375|636497|P1|Overall Study|Adverse Event|2
201178|NCT01077544|636520|P2|Overall Study|Disease Progression|1
201179|NCT01077544|636521|P1|Overall Study|Disease Progression|0
201180|NCT01077544|636520|P2|Overall Study|Adverse Event|1
201181|NCT01077544|636521|P1|Overall Study|Adverse Event|0
201182|NCT01077544|636520|P2|Overall Study|New Cancer Therapy|3
201183|NCT01077544|636521|P1|Overall Study|New Cancer Therapy|3
201184|NCT01077622|636619|P1|Overall Study|Withdrawal by Subject|1
201185|NCT01077622|636619|P1|Overall Study|Physician Decision|2
201186|NCT01077713|636667|P2|Overall Study|Unspecified|2
201187|NCT01077713|636668|P1|Overall Study|Unspecified|4
201188|NCT01077713|636667|P2|Overall Study|Adverse Event|1
201189|NCT01077713|636668|P1|Overall Study|Adverse Event|2
201190|NCT01077713|636667|P2|Overall Study|Lost to Follow-up|1
201191|NCT01077713|636668|P1|Overall Study|Lost to Follow-up|1
201192|NCT01077713|636667|P2|Overall Study|Death|29
201193|NCT01077713|636668|P1|Overall Study|Death|28
201194|NCT01077713|636667|P2|Overall Study|Progressive Disease (PD)|1
201195|NCT01077713|636668|P1|Overall Study|Progressive Disease (PD)|0
201196|NCT01077713|636667|P2|Overall Study|Withdrawal by Subject|2
201197|NCT01077713|636668|P1|Overall Study|Withdrawal by Subject|1
201198|NCT01077739|636694|P2|Overall Study|Not specified|2
201199|NCT01077739|636695|P1|Overall Study|Not specified|2
201200|NCT01077739|636694|P2|Overall Study|Unacceptable toxicity|2
201201|NCT01077739|636695|P1|Overall Study|Unacceptable toxicity|1
201202|NCT01077739|636694|P2|Overall Study|Death|3
201203|NCT01077739|636695|P1|Overall Study|Death|0
201204|NCT01077739|636694|P2|Overall Study|Withdrawal by Subject|0
201205|NCT01077739|636695|P1|Overall Study|Withdrawal by Subject|1
201206|NCT01077739|636694|P2|Overall Study|Premature withdrawal|3
201207|NCT01077739|636695|P1|Overall Study|Premature withdrawal|1
201208|NCT01077804|636707|P1|Overall Study|Other|18
201209|NCT01077804|636707|P1|Overall Study|Refused to continue|79
201210|NCT01077804|636707|P1|Overall Study|Unreachable|102
201211|NCT01077960|636955|P1|Overall Study|Reason unspecified|1
201212|NCT01077960|636955|P1|Overall Study|Subject decision|1
201213|NCT01077960|636955|P1|Overall Study|Lost to Follow-up|5
201214|NCT01077960|636955|P1|Overall Study|Protocol Violation|3
201215|NCT01077960|636955|P1|Overall Study|Adverse Event|6
201216|NCT01078090|637017|P1|Overall Study|Other|523
201217|NCT01078090|637017|P1|Overall Study|ADR and lack of efficacy|61
201218|NCT01078090|637017|P1|Overall Study|Lack of Efficacy|1193
201219|NCT01078090|637017|P1|Overall Study|Adverse drug reaction (ADR)|453
201220|NCT01078090|637017|P1|Overall Study|Lost to Follow-up|2363
201221|NCT01078116|637058|P1|Overall Study|Case report form not completed|3
201222|NCT01078116|637058|P1|Overall Study|Lack of effectiveness|15
201223|NCT01078116|637058|P1|Overall Study|Withdrawal by Subject|8
201224|NCT01078116|637058|P1|Overall Study|Adverse Event|5
201225|NCT01078116|637058|P1|Overall Study|Lost to Follow-up|17
201226|NCT01078155|637066|P1|Overall Study|Lost to Follow-up|15
201227|NCT01078155|637066|P1|Overall Study|Participant's Decision|6
201228|NCT01078155|637066|P1|Overall Study|Lack of Efficacy|16
201229|NCT01078155|637066|P1|Overall Study|Adverse Event|7
201230|NCT01078298|637166|P2|Overall Study|Unspecified|32
201231|NCT01078298|637167|P1|Overall Study|Unspecified|24
201232|NCT01078298|637166|P2|Overall Study|Did not meet entrance criteria|1
201233|NCT01078298|637167|P1|Overall Study|Did not meet entrance criteria|0
201234|NCT01078298|637166|P2|Overall Study|Death|0
201235|NCT01078298|637167|P1|Overall Study|Death|2
201236|NCT01078298|637166|P2|Overall Study|Adverse Event|5
201237|NCT01078298|637167|P1|Overall Study|Adverse Event|6
201238|NCT01078298|637166|P2|Overall Study|Protocol Violation|6
201239|NCT01078298|637167|P1|Overall Study|Protocol Violation|6
201240|NCT01078298|637166|P2|Overall Study|Withdrawal by Subject|33
201241|NCT01078298|637167|P1|Overall Study|Withdrawal by Subject|31
201242|NCT01078298|637166|P2|Overall Study|Lost to Follow-up|13
201243|NCT01078298|637167|P1|Overall Study|Lost to Follow-up|12
201244|NCT01078389|637340|P2|Overall Study|Other|2
201245|NCT01078389|637341|P1|Overall Study|Other|9
201246|NCT01078389|637340|P2|Overall Study|Voluntary Withdrawal|36
201247|NCT01078389|637341|P1|Overall Study|Voluntary Withdrawal|20
201248|NCT01078389|637340|P2|Overall Study|Lost to Follow-up|23
201249|NCT01078389|637341|P1|Overall Study|Lost to Follow-up|23
201250|NCT01078389|637340|P2|Overall Study|Major Protocol Deviation|0
201251|NCT01078389|637341|P1|Overall Study|Major Protocol Deviation|2
201252|NCT01078389|637340|P2|Overall Study|Adverse Event|6
201253|NCT01078389|637341|P1|Overall Study|Adverse Event|10
201254|NCT01078441|637389|P1|Overall Study|Withdrawal by Subject|1
201255|NCT01078454|637395|P2|Overall Study|Death|1
201256|NCT01078454|637396|P1|Overall Study|Death|0
201257|NCT01078454|637395|P2|Overall Study|Adverse Event|1
201258|NCT01078454|637396|P1|Overall Study|Adverse Event|1
201259|NCT01078545|637402|P1|Overall Study|Participant moved to another physician|1
201260|NCT01078545|637402|P1|Overall Study|Death|3
201261|NCT01078545|637402|P1|Overall Study|Withdrawal by Subject|3
201262|NCT01078545|637402|P1|Overall Study|Physician Decision|6
201263|NCT01078545|637402|P1|Overall Study|Lost to Follow-up|13
201264|NCT01078571|637410|P1|Overall Study|Protocol Violation|2
201265|NCT01078571|637410|P1|Overall Study|Lost to Follow-up|8
201266|NCT01078571|637410|P1|Overall Study|Withdrawal by Subject|12
201267|NCT01078571|637410|P1|Overall Study|Reason not reported|21
201268|NCT01078571|637410|P1|Overall Study|Lack of effectiveness|36
201269|NCT01078571|637410|P1|Overall Study|Adverse Event|36
201270|NCT01078584|637426|P1|Overall Study|Multiple Reasons|2
201271|NCT01078584|637426|P1|Overall Study|Serious Adverse Event|27
201272|NCT01078584|637426|P1|Overall Study|Protocol Violation|75
201273|NCT01078584|637426|P1|Overall Study|Lack of Efficacy|98
201274|NCT01078584|637426|P1|Overall Study|Physician Discontinued Patient|12
201275|NCT01078584|637426|P1|Overall Study|Physician Switched Medication|26
201276|NCT01078584|637426|P1|Overall Study|Blood Pressure Controlled|49
201277|NCT01078584|637426|P1|Overall Study|Non-compliance|67
201278|NCT01078584|637426|P1|Overall Study|Physician Withdrew from Study|90
201279|NCT01078584|637426|P1|Overall Study|Withdrawal of Consent|244
201280|NCT01078584|637426|P1|Overall Study|Non-serious Adverse Event|577
201281|NCT01078584|637426|P1|Overall Study|Lost to Follow-up|670
201282|NCT01078584|637426|P1|Overall Study|Final Status Unknown|1073
201283|NCT01078623|637507|P20|Treatment Period 4|Withdrawal by Subject|0
201284|NCT01078623|637508|P19|Treatment Period 4|Withdrawal by Subject|0
201285|NCT01078623|637509|P18|Treatment Period 4|Withdrawal by Subject|0
201286|NCT01078623|637510|P17|Treatment Period 4|Withdrawal by Subject|0
201287|NCT01078623|637511|P16|Treatment Period 4|Withdrawal by Subject|1
201288|NCT01078623|637512|P15|Treatment Period 4|Withdrawal by Subject|0
201289|NCT01078623|637513|P14|Treatment Period 4|Withdrawal by Subject|0
201290|NCT01078623|637514|P13|Treatment Period 4|Withdrawal by Subject|0
201291|NCT01078623|637515|P12|Treatment Period 4|Withdrawal by Subject|0
201292|NCT01078623|637516|P11|Treatment Period 4|Withdrawal by Subject|0
201293|NCT01078623|637517|P10|Treatment Period 4|Withdrawal by Subject|0
201294|NCT01078623|637518|P9|Treatment Period 4|Withdrawal by Subject|0
201295|NCT01078623|637519|P8|Treatment Period 4|Withdrawal by Subject|0
201296|NCT01078623|637520|P7|Treatment Period 4|Withdrawal by Subject|0
201297|NCT01078623|637521|P6|Treatment Period 4|Withdrawal by Subject|0
201298|NCT01078623|637522|P5|Treatment Period 4|Withdrawal by Subject|0
201299|NCT01078623|637523|P4|Treatment Period 4|Withdrawal by Subject|0
201300|NCT01078623|637524|P3|Treatment Period 4|Withdrawal by Subject|0
201301|NCT01078623|637525|P2|Treatment Period 4|Withdrawal by Subject|0
201302|NCT01078623|637526|P1|Treatment Period 4|Withdrawal by Subject|0
201303|NCT01078623|637507|P20|Treatment Period 4|Adverse Event|0
201304|NCT01078623|637508|P19|Treatment Period 4|Adverse Event|0
201305|NCT01078623|637509|P18|Treatment Period 4|Adverse Event|0
201306|NCT01078623|637510|P17|Treatment Period 4|Adverse Event|0
201307|NCT01078623|637511|P16|Treatment Period 4|Adverse Event|0
201308|NCT01078623|637512|P15|Treatment Period 4|Adverse Event|0
201309|NCT01078623|637513|P14|Treatment Period 4|Adverse Event|0
201310|NCT01078623|637514|P13|Treatment Period 4|Adverse Event|0
201311|NCT01078623|637515|P12|Treatment Period 4|Adverse Event|0
201312|NCT01078623|637516|P11|Treatment Period 4|Adverse Event|0
201313|NCT01078623|637517|P10|Treatment Period 4|Adverse Event|0
201314|NCT01078623|637518|P9|Treatment Period 4|Adverse Event|0
201315|NCT01078623|637519|P8|Treatment Period 4|Adverse Event|0
201316|NCT01078623|637520|P7|Treatment Period 4|Adverse Event|0
201317|NCT01078623|637521|P6|Treatment Period 4|Adverse Event|0
201318|NCT01078623|637522|P5|Treatment Period 4|Adverse Event|0
201319|NCT01078623|637523|P4|Treatment Period 4|Adverse Event|0
201320|NCT01078623|637524|P3|Treatment Period 4|Adverse Event|1
201321|NCT01078623|637525|P2|Treatment Period 4|Adverse Event|0
201322|NCT01078623|637526|P1|Treatment Period 4|Adverse Event|0
201323|NCT01078623|637507|P20|Treatment Period 3|Adverse Event|0
201324|NCT01078623|637508|P19|Treatment Period 3|Adverse Event|0
201325|NCT01078623|637509|P18|Treatment Period 3|Adverse Event|0
201326|NCT01078623|637510|P17|Treatment Period 3|Adverse Event|0
201327|NCT01078623|637511|P16|Treatment Period 3|Adverse Event|0
201328|NCT01078623|637512|P15|Treatment Period 3|Adverse Event|0
201329|NCT01078623|637513|P14|Treatment Period 3|Adverse Event|1
201330|NCT01078623|637514|P13|Treatment Period 3|Adverse Event|0
201331|NCT01078623|637515|P12|Treatment Period 3|Adverse Event|0
201332|NCT01078623|637516|P11|Treatment Period 3|Adverse Event|0
201333|NCT01078623|637517|P10|Treatment Period 3|Adverse Event|0
201334|NCT01078623|637518|P9|Treatment Period 3|Adverse Event|0
201335|NCT01078623|637519|P8|Treatment Period 3|Adverse Event|0
201336|NCT01078623|637520|P7|Treatment Period 3|Adverse Event|0
201337|NCT01078623|637521|P6|Treatment Period 3|Adverse Event|0
201338|NCT01078623|637522|P5|Treatment Period 3|Adverse Event|1
201339|NCT01078623|637523|P4|Treatment Period 3|Adverse Event|0
201340|NCT01078623|637524|P3|Treatment Period 3|Adverse Event|0
201341|NCT01078623|637525|P2|Treatment Period 3|Adverse Event|0
201342|NCT01078623|637526|P1|Treatment Period 3|Adverse Event|0
201343|NCT01078623|637507|P20|Treatment Period 2|Withdrawal by Subject|0
201344|NCT01078623|637508|P19|Treatment Period 2|Withdrawal by Subject|0
201345|NCT01078623|637509|P18|Treatment Period 2|Withdrawal by Subject|0
201346|NCT01078623|637510|P17|Treatment Period 2|Withdrawal by Subject|0
201347|NCT01078623|637511|P16|Treatment Period 2|Withdrawal by Subject|0
201348|NCT01078623|637512|P15|Treatment Period 2|Withdrawal by Subject|0
201349|NCT01078623|637513|P14|Treatment Period 2|Withdrawal by Subject|0
201350|NCT01078623|637514|P13|Treatment Period 2|Withdrawal by Subject|0
201351|NCT01078623|637515|P12|Treatment Period 2|Withdrawal by Subject|0
201352|NCT01078623|637516|P11|Treatment Period 2|Withdrawal by Subject|0
201353|NCT01078623|637517|P10|Treatment Period 2|Withdrawal by Subject|0
201354|NCT01078623|637518|P9|Treatment Period 2|Withdrawal by Subject|0
201355|NCT01078623|637519|P8|Treatment Period 2|Withdrawal by Subject|0
201356|NCT01078623|637520|P7|Treatment Period 2|Withdrawal by Subject|0
201357|NCT01078623|637521|P6|Treatment Period 2|Withdrawal by Subject|1
201358|NCT01078623|637522|P5|Treatment Period 2|Withdrawal by Subject|0
201359|NCT01078623|637523|P4|Treatment Period 2|Withdrawal by Subject|0
201360|NCT01078623|637524|P3|Treatment Period 2|Withdrawal by Subject|0
201361|NCT01078623|637525|P2|Treatment Period 2|Withdrawal by Subject|0
201362|NCT01078623|637526|P1|Treatment Period 2|Withdrawal by Subject|0
201363|NCT01078623|637507|P20|Treatment Period 2|Adverse Event|0
201364|NCT01078623|637508|P19|Treatment Period 2|Adverse Event|1
201365|NCT01078623|637509|P18|Treatment Period 2|Adverse Event|0
201366|NCT01078623|637510|P17|Treatment Period 2|Adverse Event|0
201367|NCT01078623|637511|P16|Treatment Period 2|Adverse Event|0
201368|NCT01078623|637512|P15|Treatment Period 2|Adverse Event|0
201369|NCT01078623|637513|P14|Treatment Period 2|Adverse Event|0
201370|NCT01078623|637514|P13|Treatment Period 2|Adverse Event|0
201371|NCT01078623|637515|P12|Treatment Period 2|Adverse Event|0
201372|NCT01078623|637516|P11|Treatment Period 2|Adverse Event|0
201373|NCT01078623|637517|P10|Treatment Period 2|Adverse Event|0
201374|NCT01078623|637518|P9|Treatment Period 2|Adverse Event|0
201375|NCT01078623|637519|P8|Treatment Period 2|Adverse Event|0
201376|NCT01078623|637520|P7|Treatment Period 2|Adverse Event|1
201377|NCT01078623|637521|P6|Treatment Period 2|Adverse Event|0
201378|NCT01078623|637522|P5|Treatment Period 2|Adverse Event|0
201379|NCT01078623|637523|P4|Treatment Period 2|Adverse Event|0
201380|NCT01078623|637524|P3|Treatment Period 2|Adverse Event|0
201381|NCT01078623|637525|P2|Treatment Period 2|Adverse Event|0
201382|NCT01078623|637526|P1|Treatment Period 2|Adverse Event|0
201383|NCT01078623|637507|P20|Treatment Period 1|Protocol Violation|0
201384|NCT01078623|637508|P19|Treatment Period 1|Protocol Violation|0
201385|NCT01078623|637509|P18|Treatment Period 1|Protocol Violation|0
201386|NCT01078623|637510|P17|Treatment Period 1|Protocol Violation|0
201387|NCT01078623|637511|P16|Treatment Period 1|Protocol Violation|0
201388|NCT01078623|637512|P15|Treatment Period 1|Protocol Violation|0
201389|NCT01078623|637513|P14|Treatment Period 1|Protocol Violation|0
201390|NCT01078623|637514|P13|Treatment Period 1|Protocol Violation|0
201391|NCT01078623|637515|P12|Treatment Period 1|Protocol Violation|0
201392|NCT01078623|637516|P11|Treatment Period 1|Protocol Violation|0
201393|NCT01078623|637517|P10|Treatment Period 1|Protocol Violation|0
201394|NCT01078623|637518|P9|Treatment Period 1|Protocol Violation|0
201395|NCT01078623|637519|P8|Treatment Period 1|Protocol Violation|0
201396|NCT01078623|637520|P7|Treatment Period 1|Protocol Violation|0
201397|NCT01078623|637521|P6|Treatment Period 1|Protocol Violation|1
201398|NCT01078623|637522|P5|Treatment Period 1|Protocol Violation|0
201399|NCT01078623|637523|P4|Treatment Period 1|Protocol Violation|0
201400|NCT01078623|637524|P3|Treatment Period 1|Protocol Violation|0
201401|NCT01078623|637525|P2|Treatment Period 1|Protocol Violation|0
201402|NCT01078623|637526|P1|Treatment Period 1|Protocol Violation|0
201403|NCT01078623|637507|P20|Treatment Period 1|Withdrawal by Subject|0
201404|NCT01078623|637508|P19|Treatment Period 1|Withdrawal by Subject|0
201405|NCT01078623|637509|P18|Treatment Period 1|Withdrawal by Subject|0
201406|NCT01078623|637510|P17|Treatment Period 1|Withdrawal by Subject|0
201407|NCT01078623|637511|P16|Treatment Period 1|Withdrawal by Subject|0
201408|NCT01078623|637512|P15|Treatment Period 1|Withdrawal by Subject|0
201409|NCT01078623|637513|P14|Treatment Period 1|Withdrawal by Subject|0
201410|NCT01078623|637514|P13|Treatment Period 1|Withdrawal by Subject|0
201411|NCT01078623|637515|P12|Treatment Period 1|Withdrawal by Subject|0
201412|NCT01078623|637516|P11|Treatment Period 1|Withdrawal by Subject|1
201413|NCT01078623|637517|P10|Treatment Period 1|Withdrawal by Subject|0
201414|NCT01078623|637518|P9|Treatment Period 1|Withdrawal by Subject|0
201415|NCT01078623|637519|P8|Treatment Period 1|Withdrawal by Subject|1
201416|NCT01078623|637520|P7|Treatment Period 1|Withdrawal by Subject|0
201417|NCT01078623|637521|P6|Treatment Period 1|Withdrawal by Subject|0
201418|NCT01078623|637522|P5|Treatment Period 1|Withdrawal by Subject|0
201419|NCT01078623|637523|P4|Treatment Period 1|Withdrawal by Subject|0
201420|NCT01078623|637524|P3|Treatment Period 1|Withdrawal by Subject|0
201421|NCT01078623|637525|P2|Treatment Period 1|Withdrawal by Subject|0
201422|NCT01078623|637526|P1|Treatment Period 1|Withdrawal by Subject|0
201423|NCT01078623|637507|P20|Treatment Period 1|Adverse Event|0
201424|NCT01078623|637508|P19|Treatment Period 1|Adverse Event|0
201425|NCT01078623|637509|P18|Treatment Period 1|Adverse Event|0
201426|NCT01078623|637510|P17|Treatment Period 1|Adverse Event|0
201427|NCT01078623|637511|P16|Treatment Period 1|Adverse Event|0
201428|NCT01078623|637512|P15|Treatment Period 1|Adverse Event|0
201429|NCT01078623|637513|P14|Treatment Period 1|Adverse Event|0
201430|NCT01078623|637514|P13|Treatment Period 1|Adverse Event|0
201431|NCT01078623|637515|P12|Treatment Period 1|Adverse Event|0
201432|NCT01078623|637516|P11|Treatment Period 1|Adverse Event|0
201433|NCT01078623|637517|P10|Treatment Period 1|Adverse Event|1
201434|NCT01078623|637518|P9|Treatment Period 1|Adverse Event|1
201435|NCT01078623|637519|P8|Treatment Period 1|Adverse Event|0
201436|NCT01078623|637520|P7|Treatment Period 1|Adverse Event|1
201437|NCT01078623|637521|P6|Treatment Period 1|Adverse Event|0
201438|NCT01078623|637522|P5|Treatment Period 1|Adverse Event|0
201439|NCT01078623|637523|P4|Treatment Period 1|Adverse Event|0
201440|NCT01078623|637524|P3|Treatment Period 1|Adverse Event|1
201441|NCT01078623|637525|P2|Treatment Period 1|Adverse Event|1
201442|NCT01078623|637526|P1|Treatment Period 1|Adverse Event|1
201443|NCT01078662|637553|P5|Overall Study|Lost to Follow-up|0
201444|NCT01078662|637554|P4|Overall Study|Lost to Follow-up|0
201445|NCT01078662|637555|P3|Overall Study|Lost to Follow-up|0
201446|NCT01078662|637556|P2|Overall Study|Lost to Follow-up|0
201447|NCT01078662|637557|P1|Overall Study|Lost to Follow-up|1
201448|NCT01078662|637553|P5|Overall Study|Protocol Violation|0
201449|NCT01078662|637554|P4|Overall Study|Protocol Violation|0
201450|NCT01078662|637555|P3|Overall Study|Protocol Violation|0
201451|NCT01078662|637556|P2|Overall Study|Protocol Violation|1
201452|NCT01078662|637557|P1|Overall Study|Protocol Violation|0
201453|NCT01078662|637553|P5|Overall Study|Withdrawal by Subject|0
201454|NCT01078662|637554|P4|Overall Study|Withdrawal by Subject|0
201455|NCT01078662|637555|P3|Overall Study|Withdrawal by Subject|1
201456|NCT01078662|637556|P2|Overall Study|Withdrawal by Subject|11
201457|NCT01078662|637557|P1|Overall Study|Withdrawal by Subject|4
201458|NCT01078662|637553|P5|Overall Study|Patients reached data cut-off|3
201459|NCT01078662|637554|P4|Overall Study|Patients reached data cut-off|2
201460|NCT01078662|637555|P3|Overall Study|Patients reached data cut-off|2
201461|NCT01078662|637556|P2|Overall Study|Patients reached data cut-off|53
201462|NCT01078662|637557|P1|Overall Study|Patients reached data cut-off|12
201463|NCT01078662|637553|P5|Overall Study|Death|8
201464|NCT01078662|637554|P4|Overall Study|Death|5
201465|NCT01078662|637555|P3|Overall Study|Death|18
201466|NCT01078662|637556|P2|Overall Study|Death|103
201467|NCT01078662|637557|P1|Overall Study|Death|41
201468|NCT01078675|637598|P2|Overall Study|Adverse Event|0
201469|NCT01078675|637599|P1|Overall Study|Adverse Event|3
201470|NCT01078675|637598|P2|Overall Study|Provided in CRF for specific reasons|3
201471|NCT01078675|637599|P1|Overall Study|Provided in CRF for specific reasons|2
201472|NCT01078675|637598|P2|Overall Study|Protocol Violation|0
201473|NCT01078675|637599|P1|Overall Study|Protocol Violation|56
201474|NCT01078675|637598|P2|Overall Study|Withdrawal by Subject|3
201475|NCT01078675|637599|P1|Overall Study|Withdrawal by Subject|7
201476|NCT01078805|637629|P1|Overall Study|Didn't take study drug|82
201477|NCT01078805|637629|P1|Overall Study|Other|173
201478|NCT01078805|637629|P1|Overall Study|Withdrawal by Subject|739
201479|NCT01078805|637629|P1|Overall Study|Sponsor decision|46
201480|NCT01078805|637629|P1|Overall Study|Serious adverse event|26
201481|NCT01078805|637629|P1|Overall Study|Physician Decision|169
201482|NCT01078805|637629|P1|Overall Study|Lost to Follow-up|676
201483|NCT01078805|637629|P1|Overall Study|Death|134
201484|NCT01078805|637629|P1|Overall Study|Clinically significant abnormal lab|5
201485|NCT01078922|637672|P1|Overall Study|Adverse Event|1
201486|NCT01078974|637677|P1|Overall Study|Adverse Event|3
201487|NCT01091103|637682|P1|Overall Study|Progressive Disease|3
201488|NCT01091103|637682|P1|Overall Study|Adverse Event|1
201489|NCT01091246|637770|P3|Overall Study|Subject not dosed|1
201490|NCT01091246|637771|P2|Overall Study|Subject not dosed|0
201491|NCT01091246|637772|P1|Overall Study|Subject not dosed|2
201492|NCT01091246|637770|P3|Overall Study|Withdrawal by Subject|4
201493|NCT01091246|637771|P2|Overall Study|Withdrawal by Subject|5
201494|NCT01091246|637772|P1|Overall Study|Withdrawal by Subject|9
201495|NCT01091246|637770|P3|Overall Study|Adverse Event|1
201496|NCT01091246|637771|P2|Overall Study|Adverse Event|0
201497|NCT01091246|637772|P1|Overall Study|Adverse Event|1
201498|NCT01091246|637770|P3|Overall Study|Lost to Follow-up|7
201499|NCT01091246|637771|P2|Overall Study|Lost to Follow-up|11
201500|NCT01091246|637772|P1|Overall Study|Lost to Follow-up|23
201501|NCT01091259|637846|P1|Overall Study|Lack of Efficacy|2
201502|NCT01091259|637846|P1|Overall Study|Adverse Event|3
201503|NCT01093599|637856|P2|Overall Study|Lost to Follow-up|46
201504|NCT01093599|637857|P1|Overall Study|Lost to Follow-up|32
201505|NCT01093625|637865|P2|1-Year Visit|Lost to Follow-up|3
201506|NCT01093625|637866|P1|1-Year Visit|Lost to Follow-up|5
201507|NCT01093625|637865|P2|6-Month Visit|Lost to Follow-up|2
201508|NCT01093625|637866|P1|6-Month Visit|Lost to Follow-up|2
201509|NCT01093625|637865|P2|6-Month Visit|Withdrawal by Subject|7
201510|NCT01093625|637866|P1|6-Month Visit|Withdrawal by Subject|6
201511|NCT01093625|637865|P2|3-Month Visit|Lost to Follow-up|0
201512|NCT01093625|637866|P1|3-Month Visit|Lost to Follow-up|2
201513|NCT01093625|637865|P2|1-Month Visit|Lost to Follow-up|0
201514|NCT01093625|637866|P1|1-Month Visit|Lost to Follow-up|2
201515|NCT01093625|637865|P2|2-Week Visit|Withdrawal by Subject|0
201516|NCT01093625|637866|P1|2-Week Visit|Withdrawal by Subject|1
201517|NCT01093625|637865|P2|Baseline and Dispensed|Withdrawal by Subject|0
201518|NCT01093625|637866|P1|Baseline and Dispensed|Withdrawal by Subject|2
201519|NCT01093755|637916|P2|Overall Study|Withdrawal by Subject|4
201520|NCT01093755|637917|P1|Overall Study|Withdrawal by Subject|3
201521|NCT01093846|637945|P3|Overall Study|Administrative Problems|15
201522|NCT01093846|637946|P2|Overall Study|Administrative Problems|17
201523|NCT01093846|637947|P1|Overall Study|Administrative Problems|18
201524|NCT01093846|637945|P3|Overall Study|Condition no longer required study drug|1
201525|NCT01093846|637946|P2|Overall Study|Condition no longer required study drug|1
201526|NCT01093846|637947|P1|Overall Study|Condition no longer required study drug|1
201527|NCT01093846|637945|P3|Overall Study|Lack of Efficacy|4
201528|NCT01093846|637946|P2|Overall Study|Lack of Efficacy|0
201529|NCT01093846|637947|P1|Overall Study|Lack of Efficacy|0
201530|NCT01093846|637945|P3|Overall Study|Adverse Event|1
201531|NCT01093846|637946|P2|Overall Study|Adverse Event|0
201532|NCT01093846|637947|P1|Overall Study|Adverse Event|0
201533|NCT01094119|637959|P2|Overall Study|Lack of Efficacy|4
201534|NCT01094119|637960|P1|Overall Study|Lack of Efficacy|2
201535|NCT01094171|637968|P1|Overall Study|Unspecified|1
201536|NCT01094171|637968|P1|Overall Study|Migration from the study area|3
201537|NCT01094171|637968|P1|Overall Study|Informed consent withdrawal|4
201538|NCT01094171|637968|P1|Overall Study|Lost to Follow-up|2
201539|NCT01094730|638081|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
201540|NCT01094730|638082|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
201541|NCT01094730|638081|P2|Period 2 (14 Days)|Adverse Event|1
201542|NCT01094730|638082|P1|Period 2 (14 Days)|Adverse Event|0
201543|NCT01094730|638081|P2|Period 2 (14 Days)|No time for the follow-up visit|0
201544|NCT01094730|638082|P1|Period 2 (14 Days)|No time for the follow-up visit|1
201545|NCT01094730|638081|P2|Period 2 (14 Days)|Protocol Violation|0
201546|NCT01094730|638082|P1|Period 2 (14 Days)|Protocol Violation|2
201547|NCT01094730|638081|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
201548|NCT01094730|638082|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
201549|NCT01094730|638081|P2|Period 1 (14 Days)|No time for the follow-up visit|0
201550|NCT01094730|638082|P1|Period 1 (14 Days)|No time for the follow-up visit|1
201551|NCT01094730|638081|P2|Period 1 (14 Days)|Withdrawal by Subject|1
201552|NCT01094730|638082|P1|Period 1 (14 Days)|Withdrawal by Subject|0
201553|NCT01094730|638081|P2|Period 1 (14 Days)|Lost to Follow-up|1
201554|NCT01094730|638082|P1|Period 1 (14 Days)|Lost to Follow-up|0
201555|NCT01094743|638093|P1|Period 1|Unsatisfactory comfort at lens fitting|2
201556|NCT01094808|638113|P3|Overall Study|Withdrawal by Subject|0
201557|NCT01094808|638114|P2|Overall Study|Withdrawal by Subject|1
201558|NCT01094808|638115|P1|Overall Study|Withdrawal by Subject|1
201559|NCT01094886|638150|P1|Overall Study|Withdrawal by Subject|5
201560|NCT01094886|638150|P1|Overall Study|Adverse Event|2
201561|NCT01095094|638157|P1|Overall Study|Physician Decision|1
201562|NCT01095094|638157|P1|Overall Study|Death|1
201563|NCT01095094|638157|P1|Overall Study|Withdrawal by Subject|1
201564|NCT01095250|638166|P4|Overall Study|Withdrawal by Subject|0
201565|NCT01095250|638167|P3|Overall Study|Withdrawal by Subject|1
201566|NCT01095250|638168|P2|Overall Study|Withdrawal by Subject|0
201567|NCT01095250|638169|P1|Overall Study|Withdrawal by Subject|0
201568|NCT01095250|638166|P4|Overall Study|administrative reasons|5
201569|NCT01095250|638167|P3|Overall Study|administrative reasons|7
201570|NCT01095250|638168|P2|Overall Study|administrative reasons|10
201571|NCT01095250|638169|P1|Overall Study|administrative reasons|8
201572|NCT01095653|638236|P3|Overall Study|non-compliance, not met criteria, etc.|5
201573|NCT01095653|638237|P2|Overall Study|non-compliance, not met criteria, etc.|6
201574|NCT01095653|638238|P1|Overall Study|non-compliance, not met criteria, etc.|10
201575|NCT01095653|638236|P3|Overall Study|Withdrawal by Subject|3
201576|NCT01095653|638237|P2|Overall Study|Withdrawal by Subject|5
201577|NCT01095653|638238|P1|Overall Study|Withdrawal by Subject|4
201578|NCT01095653|638236|P3|Overall Study|Lost to Follow-up|4
201579|NCT01095653|638237|P2|Overall Study|Lost to Follow-up|0
201580|NCT01095653|638238|P1|Overall Study|Lost to Follow-up|1
201581|NCT01095653|638236|P3|Overall Study|Adverse Event|4
201582|NCT01095653|638237|P2|Overall Study|Adverse Event|4
201583|NCT01095653|638238|P1|Overall Study|Adverse Event|1
201584|NCT01095653|638236|P3|Overall Study|Lack of Efficacy|0
201585|NCT01095653|638237|P2|Overall Study|Lack of Efficacy|0
201586|NCT01095653|638238|P1|Overall Study|Lack of Efficacy|3
201587|NCT01095796|638269|P2|Overall Study|Participant Transferred to Another Study|200
201588|NCT01095796|638270|P1|Overall Study|Participant Transferred to Another Study|215
201589|NCT01095796|638269|P2|Overall Study|Protocol Violation|0
201590|NCT01095796|638270|P1|Overall Study|Protocol Violation|1
201591|NCT01095796|638269|P2|Overall Study|Participant Noncompliance|10
201592|NCT01095796|638270|P1|Overall Study|Participant Noncompliance|5
201593|NCT01095796|638269|P2|Overall Study|Lost to Follow-up|29
201594|NCT01095796|638270|P1|Overall Study|Lost to Follow-up|27
201595|NCT01095796|638269|P2|Overall Study|Withdrew Consent|22
201596|NCT01095796|638270|P1|Overall Study|Withdrew Consent|16
201597|NCT01095796|638269|P2|Overall Study|Investigator's Discretion|2
201598|NCT01095796|638270|P1|Overall Study|Investigator's Discretion|7
201599|NCT01095796|638269|P2|Overall Study|Lack of Efficacy|3
201600|NCT01095796|638270|P1|Overall Study|Lack of Efficacy|5
201601|NCT01095796|638269|P2|Overall Study|Pregnancy|0
201602|NCT01095796|638270|P1|Overall Study|Pregnancy|2
201603|NCT01095796|638269|P2|Overall Study|Death|2
201604|NCT01095796|638270|P1|Overall Study|Death|3
201605|NCT01095796|638269|P2|Overall Study|Adverse Event|19
201606|NCT01095796|638270|P1|Overall Study|Adverse Event|9
201607|NCT01095796|638269|P2|Overall Study|Randomized but Not Treated|2
201608|NCT01095796|638270|P1|Overall Study|Randomized but Not Treated|5
201609|NCT01095835|638291|P3|Overall Study|Protocol Violation|0
201610|NCT01095835|638292|P2|Overall Study|Protocol Violation|2
201611|NCT01095835|638293|P1|Overall Study|Protocol Violation|1
201612|NCT01095835|638291|P3|Overall Study|Non study compliance|1
201613|NCT01095835|638292|P2|Overall Study|Non study compliance|0
201614|NCT01095835|638293|P1|Overall Study|Non study compliance|0
201615|NCT01095835|638291|P3|Overall Study|Withdrawal by Subject|0
201616|NCT01095835|638292|P2|Overall Study|Withdrawal by Subject|3
201617|NCT01095835|638293|P1|Overall Study|Withdrawal by Subject|1
201618|NCT01095835|638291|P3|Overall Study|Physician Decision|1
201619|NCT01095835|638292|P2|Overall Study|Physician Decision|0
201620|NCT01095835|638293|P1|Overall Study|Physician Decision|0
201621|NCT01095835|638291|P3|Overall Study|Lack of Efficacy|0
201622|NCT01095835|638292|P2|Overall Study|Lack of Efficacy|1
201623|NCT01095835|638293|P1|Overall Study|Lack of Efficacy|0
201624|NCT01095835|638291|P3|Overall Study|Adverse Event|6
201625|NCT01095835|638292|P2|Overall Study|Adverse Event|6
201626|NCT01095835|638293|P1|Overall Study|Adverse Event|8
201627|NCT01095978|638333|P1|Overall Study|Adverse Event|1
201628|NCT01095978|638333|P1|Overall Study|Did not take Klacid SR|2
201629|NCT01096017|638360|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
201630|NCT01096017|638361|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
201631|NCT01096056|638391|P2|Overall Study|Lost to Follow-up|1
201632|NCT01096056|638392|P1|Overall Study|Lost to Follow-up|0
201633|NCT01081873|638424|P1|Overall Study|Other|47
201634|NCT01081873|638424|P1|Overall Study|Progression of prostate cancer|13
201635|NCT01081873|638424|P1|Overall Study|Lost to Follow-up|142
201636|NCT01081873|638424|P1|Overall Study|Withdrawal by Subject|10
201637|NCT01081873|638424|P1|Overall Study|Death|86
201638|NCT01081886|638493|P2|Overall Study|Study termination|13
201639|NCT01081886|638494|P1|Overall Study|Study termination|11
201640|NCT01081912|638502|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
201641|NCT01081912|638503|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
201642|NCT01081912|638504|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
201643|NCT01081912|638502|P3|Maintenance Treatment|Non-Compliance|7
201644|NCT01081912|638503|P2|Maintenance Treatment|Non-Compliance|4
201645|NCT01081912|638504|P1|Maintenance Treatment|Non-Compliance|0
201646|NCT01081912|638502|P3|Maintenance Treatment|Withdrawal by Subject|5
201647|NCT01081912|638503|P2|Maintenance Treatment|Withdrawal by Subject|5
201648|NCT01081912|638504|P1|Maintenance Treatment|Withdrawal by Subject|0
201649|NCT01081912|638502|P3|Maintenance Treatment|Protocol Violation|2
201650|NCT01081912|638503|P2|Maintenance Treatment|Protocol Violation|1
201651|NCT01081912|638504|P1|Maintenance Treatment|Protocol Violation|0
201652|NCT01081912|638502|P3|Maintenance Treatment|Physician Decision|1
201653|NCT01081912|638503|P2|Maintenance Treatment|Physician Decision|0
201654|NCT01081912|638504|P1|Maintenance Treatment|Physician Decision|0
201655|NCT01081912|638502|P3|Maintenance Treatment|Lost to Follow-up|0
201656|NCT01081912|638503|P2|Maintenance Treatment|Lost to Follow-up|1
201657|NCT01081912|638504|P1|Maintenance Treatment|Lost to Follow-up|0
201658|NCT01081912|638502|P3|Maintenance Treatment|Lack of Efficacy|64
201659|NCT01081912|638503|P2|Maintenance Treatment|Lack of Efficacy|14
201660|NCT01081912|638504|P1|Maintenance Treatment|Lack of Efficacy|0
201661|NCT01081912|638502|P3|Maintenance Treatment|Adverse Event|12
201662|NCT01081912|638503|P2|Maintenance Treatment|Adverse Event|2
201663|NCT01081912|638504|P1|Maintenance Treatment|Adverse Event|0
201664|NCT01081912|638502|P3|Conversion/Titration|Non-Compliance|0
201665|NCT01081912|638503|P2|Conversion/Titration|Non-Compliance|0
201666|NCT01081912|638504|P1|Conversion/Titration|Non-Compliance|47
201667|NCT01081912|638502|P3|Conversion/Titration|Withdrawal by Subject|0
201668|NCT01081912|638503|P2|Conversion/Titration|Withdrawal by Subject|0
201669|NCT01081912|638504|P1|Conversion/Titration|Withdrawal by Subject|23
201670|NCT01081912|638502|P3|Conversion/Titration|Protocol Violation|0
201671|NCT01081912|638503|P2|Conversion/Titration|Protocol Violation|0
201672|NCT01081912|638504|P1|Conversion/Titration|Protocol Violation|67
201673|NCT01081912|638502|P3|Conversion/Titration|Physician Decision|0
201674|NCT01081912|638503|P2|Conversion/Titration|Physician Decision|0
201675|NCT01081912|638504|P1|Conversion/Titration|Physician Decision|2
201676|NCT01081912|638502|P3|Conversion/Titration|Lost to Follow-up|0
201677|NCT01081912|638503|P2|Conversion/Titration|Lost to Follow-up|0
201678|NCT01081912|638504|P1|Conversion/Titration|Lost to Follow-up|5
201679|NCT01081912|638502|P3|Conversion/Titration|Lack of Efficacy|0
201680|NCT01081912|638503|P2|Conversion/Titration|Lack of Efficacy|0
201681|NCT01081912|638504|P1|Conversion/Titration|Lack of Efficacy|17
201682|NCT01081912|638502|P3|Conversion/Titration|Adverse Event|0
201683|NCT01081912|638503|P2|Conversion/Titration|Adverse Event|0
201684|NCT01081912|638504|P1|Conversion/Titration|Adverse Event|47
201685|NCT01081951|638513|P2|Overall Study|Lost to Follow-up|1
201686|NCT01081951|638514|P1|Overall Study|Lost to Follow-up|0
201687|NCT01081951|638513|P2|Overall Study|Allocated treatment but did not take it|1
201688|NCT01081951|638514|P1|Overall Study|Allocated treatment but did not take it|0
201689|NCT01081951|638513|P2|Overall Study|Withdrawal by Subject|6
201690|NCT01081951|638514|P1|Overall Study|Withdrawal by Subject|2
201691|NCT01081951|638513|P2|Overall Study|Death|47
201692|NCT01081951|638514|P1|Overall Study|Death|54
201693|NCT01082081|638527|P3|Overall Study|Other Reason|0
201694|NCT01082081|638528|P2|Overall Study|Other Reason|1
201695|NCT01082081|638529|P1|Overall Study|Other Reason|0
201696|NCT01082081|638527|P3|Overall Study|Withdrawal by Subject|1
201697|NCT01082081|638528|P2|Overall Study|Withdrawal by Subject|0
201698|NCT01082081|638529|P1|Overall Study|Withdrawal by Subject|0
201699|NCT01082081|638527|P3|Overall Study|Lost to Follow-up|1
201700|NCT01082081|638528|P2|Overall Study|Lost to Follow-up|0
201701|NCT01082081|638529|P1|Overall Study|Lost to Follow-up|0
201702|NCT01082211|638585|P1|Overall Study|No protocol treatment received|3
201703|NCT01082211|638585|P1|Overall Study|Protocol Violation|4
201704|NCT01082328|638596|P1|Overall Study|Adverse Event|1
201705|NCT01082367|638607|P2|Follow-up (F-U) Period|Adverse Event|1
201706|NCT01082367|638608|P1|Follow-up (F-U) Period|Adverse Event|0
201707|NCT01082367|638607|P2|Follow-up (F-U) Period|Abnormal lab values|0
201708|NCT01082367|638608|P1|Follow-up (F-U) Period|Abnormal lab values|1
201709|NCT01082367|638607|P2|Follow-up (F-U) Period|Administrative problems|0
201710|NCT01082367|638608|P1|Follow-up (F-U) Period|Administrative problems|1
201711|NCT01082367|638607|P2|Double-blind Period|Adverse Event|1
201712|NCT01082367|638608|P1|Double-blind Period|Adverse Event|0
201713|NCT01082367|638607|P2|Double-blind Period|Lack of Efficacy|11
201714|NCT01082367|638608|P1|Double-blind Period|Lack of Efficacy|5
201715|NCT01082367|638607|P2|Double-blind Period|Administrative problems|1
201716|NCT01082367|638608|P1|Double-blind Period|Administrative problems|0
201717|NCT01087905|638663|P8|Overall Study|Withdrawal by Subject|5
201718|NCT01087905|638664|P7|Overall Study|Withdrawal by Subject|3
201719|NCT01087905|638665|P6|Overall Study|Withdrawal by Subject|3
201720|NCT01087905|638666|P5|Overall Study|Withdrawal by Subject|4
201721|NCT01087905|638667|P4|Overall Study|Withdrawal by Subject|5
201722|NCT01087905|638668|P3|Overall Study|Withdrawal by Subject|4
201723|NCT01087905|638669|P2|Overall Study|Withdrawal by Subject|4
201724|NCT01087905|638670|P1|Overall Study|Withdrawal by Subject|5
201725|NCT01087905|638663|P8|Overall Study|Lost to Follow-up|24
201726|NCT01087905|638664|P7|Overall Study|Lost to Follow-up|20
201727|NCT01087905|638665|P6|Overall Study|Lost to Follow-up|25
201728|NCT01087905|638666|P5|Overall Study|Lost to Follow-up|27
201729|NCT01087905|638667|P4|Overall Study|Lost to Follow-up|31
201730|NCT01087905|638668|P3|Overall Study|Lost to Follow-up|18
201731|NCT01087905|638669|P2|Overall Study|Lost to Follow-up|28
201732|NCT01087905|638670|P1|Overall Study|Lost to Follow-up|24
201733|NCT01087944|638719|P2|Period 2 (Week 4-6)|Adverse Event|2
201734|NCT01087944|638720|P1|Period 2 (Week 4-6)|Adverse Event|0
201735|NCT01087944|638719|P2|Period 1 (Week 1-3)|Adverse Event|0
201736|NCT01087944|638720|P1|Period 1 (Week 1-3)|Adverse Event|1
201737|NCT01087957|638750|P2|Overall Study|Physician Decision|9
201738|NCT01087957|638751|P1|Overall Study|Physician Decision|5
201739|NCT01087957|638750|P2|Overall Study|Withdrawal by Subject|15
201740|NCT01087957|638751|P1|Overall Study|Withdrawal by Subject|18
201741|NCT01087957|638750|P2|Overall Study|Protocol Violation|25
201742|NCT01087957|638751|P1|Overall Study|Protocol Violation|13
201743|NCT01087957|638750|P2|Overall Study|Lost to Follow-up|4
201744|NCT01087957|638751|P1|Overall Study|Lost to Follow-up|3
201745|NCT01087957|638750|P2|Overall Study|Death|2
201746|NCT01087957|638751|P1|Overall Study|Death|2
201747|NCT01087970|638777|P1|Overall Study|Protocol Violation|2
201748|NCT01088399|638819|P3|Overall Study|Study summary visit not completed|80
201749|NCT01088399|638820|P2|Overall Study|Study summary visit not completed|283
201750|NCT01088399|638821|P1|Overall Study|Study summary visit not completed|2398
201751|NCT01088399|638819|P3|Overall Study|Enrollment criteria not met|70
201752|NCT01088399|638820|P2|Overall Study|Enrollment criteria not met|119
201753|NCT01088399|638821|P1|Overall Study|Enrollment criteria not met|48
201754|NCT01088399|638819|P3|Overall Study|Protocol Violation|0
201755|NCT01088399|638820|P2|Overall Study|Protocol Violation|1
201756|NCT01088399|638821|P1|Overall Study|Protocol Violation|10
201757|NCT01088399|638819|P3|Overall Study|Sponsor decision|7
201758|NCT01088399|638820|P2|Overall Study|Sponsor decision|298
201759|NCT01088399|638821|P1|Overall Study|Sponsor decision|1573
201760|NCT01088399|638819|P3|Overall Study|Change to or start of somatropin therapy|12
201761|NCT01088399|638820|P2|Overall Study|Change to or start of somatropin therapy|17
201762|NCT01088399|638821|P1|Overall Study|Change to or start of somatropin therapy|234
201763|NCT01088399|638819|P3|Overall Study|Withdrawal by Subject|33
201764|NCT01088399|638820|P2|Overall Study|Withdrawal by Subject|195
201765|NCT01088399|638821|P1|Overall Study|Withdrawal by Subject|544
201766|NCT01088399|638819|P3|Overall Study|Physician Decision|16
201767|NCT01088399|638820|P2|Overall Study|Physician Decision|88
201768|NCT01088399|638821|P1|Overall Study|Physician Decision|531
201769|NCT01088399|638819|P3|Overall Study|Lost to Follow-up|58
201770|NCT01088399|638820|P2|Overall Study|Lost to Follow-up|278
201771|NCT01088399|638821|P1|Overall Study|Lost to Follow-up|1070
201772|NCT01088399|638819|P3|Overall Study|Lack of Efficacy|5
201773|NCT01088399|638820|P2|Overall Study|Lack of Efficacy|7
201774|NCT01088399|638821|P1|Overall Study|Lack of Efficacy|298
201775|NCT01088399|638819|P3|Overall Study|Death|0
201776|NCT01088399|638820|P2|Overall Study|Death|45
201777|NCT01088399|638821|P1|Overall Study|Death|204
201778|NCT01088399|638819|P3|Overall Study|Adverse Event|0
201779|NCT01088399|638820|P2|Overall Study|Adverse Event|16
201780|NCT01088399|638821|P1|Overall Study|Adverse Event|211
201781|NCT01088438|638846|P2|Overall Study|Lost to Follow-up|30
201782|NCT01088438|638847|P1|Overall Study|Lost to Follow-up|18
201783|NCT01088438|638846|P2|Overall Study|Withdrawal by Subject|6
201784|NCT01088438|638847|P1|Overall Study|Withdrawal by Subject|11
201785|NCT01088503|638915|P3|Overall Study|Death|7
201786|NCT01088503|638916|P2|Overall Study|Death|358
201787|NCT01088503|638917|P1|Overall Study|Death|64
201788|NCT01088503|638915|P3|Overall Study|Withdrawal by Subject|10
201789|NCT01088503|638916|P2|Overall Study|Withdrawal by Subject|327
201790|NCT01088503|638917|P1|Overall Study|Withdrawal by Subject|118
201791|NCT01088529|638940|P2|Overall Study|Did not receive study treatment|1
201792|NCT01088529|638941|P1|Overall Study|Did not receive study treatment|0
201793|NCT01096186|638951|P1|Overall Study|Noncompliance with study drug|1
201794|NCT01096186|638951|P1|Overall Study|Physician Decision|1
201795|NCT01096186|638951|P1|Overall Study|Withdrawal by Subject|22
201796|NCT01096186|638951|P1|Overall Study|Lost to Follow-up|2
201797|NCT01096186|638951|P1|Overall Study|Lack of Efficacy|4
201798|NCT01096186|638951|P1|Overall Study|Death|4
201799|NCT01096186|638951|P1|Overall Study|Adverse Event|16
201800|NCT01096316|638959|P2|Overall Study|Lost to Follow-up|9
201801|NCT01096316|638960|P1|Overall Study|Lost to Follow-up|15
201802|NCT01096342|638970|P1|Overall Study|Protocol Violation|1
201803|NCT01098461|638980|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
201804|NCT01098461|638981|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
201805|NCT01098461|638982|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
201806|NCT01098461|638983|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
201807|NCT01098461|638980|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
201808|NCT01098461|638981|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
201809|NCT01098461|638982|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
201810|NCT01098461|638983|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
201811|NCT01098461|638980|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
201812|NCT01098461|638981|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
201813|NCT01098461|638982|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
201814|NCT01098461|638983|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
201815|NCT01098461|638980|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
201816|NCT01098461|638981|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
201817|NCT01098461|638982|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
201818|NCT01098461|638983|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
201819|NCT01098461|638980|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
201820|NCT01098461|638981|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
201821|NCT01098461|638982|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
201822|NCT01098461|638983|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
201823|NCT01098461|638980|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
201824|NCT01098461|638981|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
201825|NCT01098461|638982|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
201826|NCT01098461|638983|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
201827|NCT01098461|638980|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
201828|NCT01098461|638981|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
201829|NCT01098461|638982|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
201830|NCT01098461|638983|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
201831|NCT01098487|639013|P1|Overall Study|Physician Decision|1
201832|NCT01098487|639013|P1|Overall Study|Lost to Follow-up|3
201833|NCT01098487|639013|P1|Overall Study|Withdrawal by Subject|7
201834|NCT01098487|639013|P1|Overall Study|Lack of Efficacy|11
201835|NCT01098487|639013|P1|Overall Study|Adverse Event|22
201836|NCT01098539|639042|P2|Overall Study|Physician Decision|3
201837|NCT01098539|639043|P1|Overall Study|Physician Decision|5
201838|NCT01098539|639042|P2|Overall Study|Withdrawal by Subject|26
201839|NCT01098539|639043|P1|Overall Study|Withdrawal by Subject|12
201840|NCT01098539|639042|P2|Overall Study|Lost to Follow-up|4
201841|NCT01098539|639043|P1|Overall Study|Lost to Follow-up|4
201842|NCT01098539|639042|P2|Overall Study|Noncompliance|5
201843|NCT01098539|639043|P1|Overall Study|Noncompliance|3
201844|NCT01098539|639042|P2|Overall Study|Protocol Violation|4
201845|NCT01098539|639043|P1|Overall Study|Protocol Violation|1
201846|NCT01098539|639042|P2|Overall Study|Adverse Event|26
201847|NCT01098539|639043|P1|Overall Study|Adverse Event|26
201848|NCT01098812|639146|P3|Overall Study|Lost to Follow-up|0
201849|NCT01098812|639147|P2|Overall Study|Lost to Follow-up|1
201850|NCT01098812|639148|P1|Overall Study|Lost to Follow-up|0
201851|NCT01098812|639146|P3|Overall Study|Death|1
201852|NCT01098812|639147|P2|Overall Study|Death|0
201853|NCT01098812|639148|P1|Overall Study|Death|2
201854|NCT01098851|639160|P2|Overall Study|Equipment failure|0
201855|NCT01098851|639161|P1|Overall Study|Equipment failure|1
201856|NCT01099215|639203|P2|Overall Study|Adverse Event|1
201857|NCT01099215|639204|P1|Overall Study|Adverse Event|0
201858|NCT01099215|639203|P2|Overall Study|Withdrawal by Subject|0
201859|NCT01099215|639204|P1|Overall Study|Withdrawal by Subject|1
201860|NCT01099267|639240|P1|MDS-003 Study|Secondary Malign Disease|1
201861|NCT01099267|639240|P1|MDS-003 Study|Loss of Response|1
201862|NCT01099267|639240|P1|MDS-003 Study|Non-Compliance|2
201863|NCT01099267|639240|P1|MDS-003 Study|Investigator Decision|2
201864|NCT01099267|639240|P1|MDS-003 Study|Disease Progression|7
201865|NCT01099267|639240|P1|MDS-003 Study|Study Closed by Sponsor|2
201866|NCT01099267|639240|P1|MDS-003 Study|Death|11
201867|NCT01099267|639240|P1|MDS-003 Study|Lost to Follow-up|1
201868|NCT01099267|639240|P1|MDS-003 Study|Withdrawal by Subject|8
201869|NCT01099267|639240|P1|MDS-003 Study|Lack of Efficacy|52
201870|NCT01099267|639240|P1|MDS-003 Study|Adverse Event|37
201871|NCT01099397|639270|P1|Overall Study|Withdrawal by Subject|5
201872|NCT01099397|639270|P1|Overall Study|Protocol Violation|4
201873|NCT01099397|639270|P1|Overall Study|Lost to Follow-up|4
201874|NCT01099579|639293|P3|Stage 2 (ATV Capsules )|Ongoing treatment|15
201875|NCT01099579|639294|P2|Stage 2 (ATV Capsules )|Ongoing treatment|13
201876|NCT01099579|639295|P1|Stage 2 (ATV Capsules )|Ongoing treatment|14
201877|NCT01099579|639293|P3|Stage 2 (ATV Capsules )|Lost to Follow-up|0
201878|NCT01099579|639294|P2|Stage 2 (ATV Capsules )|Lost to Follow-up|1
201879|NCT01099579|639295|P1|Stage 2 (ATV Capsules )|Lost to Follow-up|0
201880|NCT01099579|639293|P3|Stage 2 (ATV Capsules )|No longer met study criteria|0
201881|NCT01099579|639294|P2|Stage 2 (ATV Capsules )|No longer met study criteria|0
201882|NCT01099579|639295|P1|Stage 2 (ATV Capsules )|No longer met study criteria|2
201883|NCT01099579|639293|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
201884|NCT01099579|639294|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
201885|NCT01099579|639295|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
201886|NCT01099579|639293|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
201887|NCT01099579|639294|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
201888|NCT01099579|639295|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
201889|NCT01099579|639293|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
201890|NCT01099579|639294|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
201891|NCT01099579|639295|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
201892|NCT01099579|639293|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
201893|NCT01099579|639294|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
201894|NCT01099579|639295|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
201895|NCT01099709|639362|P2|Period 1|Adverse Event|0
201896|NCT01099709|639363|P1|Period 1|Adverse Event|1
201897|NCT01099709|639362|P2|Period 1|Positive cotinine test|1
201898|NCT01099709|639363|P1|Period 1|Positive cotinine test|0
201899|NCT01099709|639362|P2|Period 1|Withdrawal by Subject|1
201900|NCT01099709|639363|P1|Period 1|Withdrawal by Subject|0
201901|NCT01099917|639431|P1|Overall Study|Not Treated|24
201902|NCT01099917|639431|P1|Overall Study|Adverse Event|3
201903|NCT01100073|639435|P1|Overall Study|Missing|5
201904|NCT01100073|639435|P1|Overall Study|not known|8
201905|NCT01100073|639435|P1|Overall Study|Insufficient tolerability +patients wish|8
201906|NCT01100073|639435|P1|Overall Study|Lack of effect + patient's wish|2
201907|NCT01100073|639435|P1|Overall Study|Lost to Follow-up|39
201908|NCT01100073|639435|P1|Overall Study|Withdrawal by Subject|13
201909|NCT01100073|639435|P1|Overall Study|Insufficient Tolerability|21
201910|NCT01100073|639435|P1|Overall Study|Lack of Efficacy|4
201911|NCT01100086|639450|P2|Period 1|Withdrawal by Subject|0
201912|NCT01100086|639451|P1|Period 1|Withdrawal by Subject|1
201913|NCT01100307|639490|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
201914|NCT01100307|639491|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
201915|NCT01100307|639490|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
201916|NCT01100307|639491|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
201917|NCT01100307|639490|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
201918|NCT01100307|639491|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
201919|NCT01100307|639490|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
201920|NCT01100307|639491|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
201921|NCT01100307|639490|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
201922|NCT01100307|639491|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
201923|NCT01100307|639490|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
201924|NCT01100307|639491|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
201925|NCT01100320|639533|P2|Period 2|Withdrawal by Subject|1
201926|NCT01100320|639534|P1|Period 2|Withdrawal by Subject|1
201927|NCT01100320|639533|P2|Period 1|Adverse Event|2
201928|NCT01100320|639534|P1|Period 1|Adverse Event|2
201929|NCT01100320|639533|P2|Period 1|Positive Drug Screen|1
201930|NCT01100320|639534|P1|Period 1|Positive Drug Screen|1
201931|NCT01100320|639533|P2|Period 1|Withdrawal by Subject|4
201932|NCT01100320|639534|P1|Period 1|Withdrawal by Subject|2
201933|NCT01100437|639544|P3|Maintenance|Sponsor termination of study|1
201934|NCT01100437|639545|P2|Maintenance|Sponsor termination of study|0
201935|NCT01100437|639546|P1|Maintenance|Sponsor termination of study|0
201936|NCT01100437|639544|P3|Maintenance|Withdrawal by Subject|1
201937|NCT01100437|639545|P2|Maintenance|Withdrawal by Subject|0
201938|NCT01100437|639546|P1|Maintenance|Withdrawal by Subject|0
201939|NCT01100437|639544|P3|Titration/Stabilization|Sponsor canceled study|1
201940|NCT01100437|639545|P2|Titration/Stabilization|Sponsor canceled study|0
201941|NCT01100437|639546|P1|Titration/Stabilization|Sponsor canceled study|0
201942|NCT01100437|639544|P3|Titration/Stabilization|Non-compliance|1
201943|NCT01100437|639545|P2|Titration/Stabilization|Non-compliance|0
201944|NCT01100437|639546|P1|Titration/Stabilization|Non-compliance|0
201945|NCT01100437|639544|P3|Titration/Stabilization|Adverse Event|4
201946|NCT01100437|639545|P2|Titration/Stabilization|Adverse Event|0
201947|NCT01100437|639546|P1|Titration/Stabilization|Adverse Event|0
201948|NCT01100502|639585|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
201949|NCT01100502|639586|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
201950|NCT01100502|639585|P2|Long-Term Follow-up|Lost to Follow-up|2
201951|NCT01100502|639586|P1|Long-Term Follow-up|Lost to Follow-up|5
201952|NCT01100502|639585|P2|Long-Term Follow-up|Withdrawal by Subject|8
201953|NCT01100502|639586|P1|Long-Term Follow-up|Withdrawal by Subject|10
201954|NCT01100502|639585|P2|Treatment Period|Progressive Disease|69
201955|NCT01100502|639586|P1|Treatment Period|Progressive Disease|24
201956|NCT01100502|639585|P2|Treatment Period|Withdrawal by Subject|4
201957|NCT01100502|639586|P1|Treatment Period|Withdrawal by Subject|9
201958|NCT01100502|639585|P2|Treatment Period|Adverse Event|10
201959|NCT01100502|639586|P1|Treatment Period|Adverse Event|54
201960|NCT01100567|639598|P2|Overall Study|Deemed ineligible after consent|1
201961|NCT01100567|639599|P1|Overall Study|Deemed ineligible after consent|0
201962|NCT01100567|639598|P2|Overall Study|Physician Decision|1
201963|NCT01100567|639599|P1|Overall Study|Physician Decision|0
201964|NCT01100567|639598|P2|Overall Study|Lost to Follow-up|2
201965|NCT01100567|639599|P1|Overall Study|Lost to Follow-up|1
201966|NCT01100567|639598|P2|Overall Study|Early Hospital Discharge|4
201967|NCT01100567|639599|P1|Overall Study|Early Hospital Discharge|6
201968|NCT01100567|639598|P2|Overall Study|Withdrawal by Subject|8
201969|NCT01100567|639599|P1|Overall Study|Withdrawal by Subject|5
201970|NCT01100658|639632|P1|Overall Study|Withdrawal by Subject|1
201971|NCT01100853|639669|P2|Overall Study|Withdrawal by Subject|4
201972|NCT01100853|639670|P1|Overall Study|Withdrawal by Subject|6
201973|NCT01100853|639669|P2|Overall Study|Received <4 study injections|13
201974|NCT01100853|639670|P1|Overall Study|Received <4 study injections|10
201975|NCT01100853|639669|P2|Overall Study|Lost to Follow-up|6
201976|NCT01100853|639670|P1|Overall Study|Lost to Follow-up|11
201977|NCT01091454|639686|P1|Overall Study|Ineligible|1
201978|NCT01091519|639697|P2|Overall Study|Randomized not treated|4
201979|NCT01091519|639698|P1|Overall Study|Randomized not treated|4
201980|NCT01091519|639697|P2|Overall Study|Unspecified|8
201981|NCT01091519|639698|P1|Overall Study|Unspecified|6
201982|NCT01091519|639697|P2|Overall Study|Withdrawal by Subject|2
201983|NCT01091519|639698|P1|Overall Study|Withdrawal by Subject|2
201984|NCT01091519|639697|P2|Overall Study|Lost to Follow-up|24
201985|NCT01091519|639698|P1|Overall Study|Lost to Follow-up|14
201986|NCT01091519|639697|P2|Overall Study|Lack of Efficacy|19
201987|NCT01091519|639698|P1|Overall Study|Lack of Efficacy|16
201988|NCT01091519|639697|P2|Overall Study|Death|0
201989|NCT01091519|639698|P1|Overall Study|Death|1
201990|NCT01091519|639697|P2|Overall Study|Adverse Event|16
201991|NCT01091519|639698|P1|Overall Study|Adverse Event|12
201992|NCT01091662|639712|P2|Overall Study|unable to swallow capsule|1
201993|NCT01091662|639713|P1|Overall Study|unable to swallow capsule|0
201994|NCT01091662|639712|P2|Overall Study|Protocol Violation|2
201995|NCT01091662|639713|P1|Overall Study|Protocol Violation|0
201996|NCT01091662|639712|P2|Overall Study|Pregnancy|1
201997|NCT01091662|639713|P1|Overall Study|Pregnancy|0
201998|NCT01091662|639712|P2|Overall Study|Lost to Follow-up|1
201999|NCT01091662|639713|P1|Overall Study|Lost to Follow-up|0
202000|NCT01091662|639712|P2|Overall Study|met exclusion criteria|0
202001|NCT01091662|639713|P1|Overall Study|met exclusion criteria|1
202002|NCT01091662|639712|P2|Overall Study|met exit criteria|13
202003|NCT01091662|639713|P1|Overall Study|met exit criteria|7
202004|NCT01091662|639712|P2|Overall Study|Withdrawal by Subject|6
202005|NCT01091662|639713|P1|Overall Study|Withdrawal by Subject|7
202006|NCT01091662|639712|P2|Overall Study|Physician Decision|1
202007|NCT01091662|639713|P1|Overall Study|Physician Decision|1
202008|NCT01091662|639712|P2|Overall Study|Adverse Event|9
202009|NCT01091662|639713|P1|Overall Study|Adverse Event|1
202010|NCT01091675|639749|P1|Overall Study|Lack of Efficacy|27
202011|NCT01091675|639749|P1|Overall Study|Adverse Event|7
202012|NCT01091974|639778|P4|Overall Study|side-effects|2
202013|NCT01091974|639779|P3|Overall Study|side-effects|0
202014|NCT01091974|639780|P2|Overall Study|side-effects|1
202015|NCT01091974|639781|P1|Overall Study|side-effects|1
202016|NCT01091974|639778|P4|Overall Study|Withdrawal by Subject|2
202017|NCT01091974|639779|P3|Overall Study|Withdrawal by Subject|2
202018|NCT01091974|639780|P2|Overall Study|Withdrawal by Subject|3
202019|NCT01091974|639781|P1|Overall Study|Withdrawal by Subject|1
202020|NCT01091974|639778|P4|Overall Study|resumed sleep medication|2
202021|NCT01091974|639779|P3|Overall Study|resumed sleep medication|1
202022|NCT01091974|639780|P2|Overall Study|resumed sleep medication|0
202023|NCT01091974|639781|P1|Overall Study|resumed sleep medication|0
202024|NCT01091974|639778|P4|Overall Study|Did not start intervention|1
202025|NCT01091974|639779|P3|Overall Study|Did not start intervention|3
202026|NCT01091974|639780|P2|Overall Study|Did not start intervention|1
202027|NCT01091974|639781|P1|Overall Study|Did not start intervention|3
202028|NCT01092416|639806|P1|12-Month Follow-up|Data collected after close of 1Y window|2
202029|NCT01092416|639806|P1|12-Month Follow-up|Missed 1-year follow-up|1
202030|NCT01092416|639806|P1|12-Month Follow-up|Withdrawal by Subject|2
202031|NCT01092416|639806|P1|12-Month Follow-up|Lost to Follow-up|4
202032|NCT01092416|639806|P1|12-Month Follow-up|Death|16
202033|NCT01092416|639806|P1|30-Day Follow-up|Data collected after close of 30D window|5
202034|NCT01092416|639806|P1|30-Day Follow-up|Missed 30-day follow-up|3
202035|NCT01092416|639806|P1|30-Day Follow-up|Death|2
202036|NCT01092416|639806|P1|Enrollment|Atherectomy device not inserted|3
202037|NCT01092507|639834|P2|Overall Study|Withdrawal by Subject|0
202038|NCT01092507|639835|P1|Overall Study|Withdrawal by Subject|2
202039|NCT01092546|639853|P1|Overall Study|Subjects withdrawn prior to dosing|4
202040|NCT01092637|639865|P2|Overall Study|Death|49
202041|NCT01092637|639866|P1|Overall Study|Death|47
202042|NCT01092663|639878|P2|Overall Study|Protocol Violation|1
202043|NCT01092663|639879|P1|Overall Study|Protocol Violation|0
202044|NCT01092663|639878|P2|Overall Study|Adverse Event|1
202045|NCT01092663|639879|P1|Overall Study|Adverse Event|1
202046|NCT01092663|639878|P2|Overall Study|High fasting triglyceride|0
202047|NCT01092663|639879|P1|Overall Study|High fasting triglyceride|2
202048|NCT01092663|639878|P2|Overall Study|Glucose >300mg/dL|0
202049|NCT01092663|639879|P1|Overall Study|Glucose >300mg/dL|1
202050|NCT01092663|639878|P2|Overall Study|Withdrawal by Subject|2
202051|NCT01092663|639879|P1|Overall Study|Withdrawal by Subject|3
202052|NCT01092702|639925|P1|Overall Study|Lost to Follow-up|2
202053|NCT01092702|639925|P1|Overall Study|Withdrawal by Subject|7
202054|NCT01092728|639931|P2|Overall Study|Prohibited Concomitant Medications|0
202055|NCT01092728|639932|P1|Overall Study|Prohibited Concomitant Medications|1
202056|NCT01092728|639931|P2|Overall Study|Disease Progression|13
202057|NCT01092728|639932|P1|Overall Study|Disease Progression|1
202058|NCT01092728|639931|P2|Overall Study|Adverse Event|1
202059|NCT01092728|639932|P1|Overall Study|Adverse Event|0
202060|NCT01092728|639931|P2|Overall Study|Withdrawal by Subject|0
202061|NCT01092728|639932|P1|Overall Study|Withdrawal by Subject|2
202062|NCT01092780|639944|P4|Washout Period 2|Adverse Event|0
202063|NCT01092780|639945|P3|Washout Period 2|Adverse Event|1
202064|NCT01092780|639946|P2|Washout Period 2|Adverse Event|1
202065|NCT01092780|639947|P1|Washout Period 2|Adverse Event|0
202066|NCT01092780|639944|P4|Washout Period 1|Noncompliance with nCPAP|0
202067|NCT01092780|639945|P3|Washout Period 1|Noncompliance with nCPAP|0
202068|NCT01092780|639946|P2|Washout Period 1|Noncompliance with nCPAP|0
202069|NCT01092780|639947|P1|Washout Period 1|Noncompliance with nCPAP|1
202070|NCT01092780|639944|P4|Washout Period 1|Adverse Event|0
202071|NCT01092780|639945|P3|Washout Period 1|Adverse Event|0
202072|NCT01092780|639946|P2|Washout Period 1|Adverse Event|1
202073|NCT01092780|639947|P1|Washout Period 1|Adverse Event|0
202074|NCT01092832|639979|P2|Overall Study|Not specified|0
202075|NCT01092832|639980|P1|Overall Study|Not specified|1
202076|NCT01093222|640047|P1|Overall Study|Not protocol specified|1
202077|NCT01093222|640047|P1|Overall Study|Death|2
202078|NCT01093222|640047|P1|Overall Study|Progression/relapse|24
202079|NCT01093222|640047|P1|Overall Study|Adverse Event|7
202080|NCT01093222|640047|P1|Overall Study|Ineligible|6
202081|NCT01093534|640096|P3|Overall Study|Other|4
202082|NCT01093534|640097|P2|Overall Study|Other|3
202083|NCT01093534|640098|P1|Overall Study|Other|1
202084|NCT01093534|640096|P3|Overall Study|Withdrawal by Subject|2
202085|NCT01093534|640097|P2|Overall Study|Withdrawal by Subject|7
202086|NCT01093534|640098|P1|Overall Study|Withdrawal by Subject|5
202087|NCT01093534|640096|P3|Overall Study|Lack of Efficacy|1
202088|NCT01093534|640097|P2|Overall Study|Lack of Efficacy|1
202089|NCT01093534|640098|P1|Overall Study|Lack of Efficacy|2
202090|NCT01093534|640096|P3|Overall Study|Adverse Event|2
202091|NCT01093534|640097|P2|Overall Study|Adverse Event|5
202092|NCT01093534|640098|P1|Overall Study|Adverse Event|2
202093|NCT01100944|640214|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
202094|NCT01100944|640215|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
202095|NCT01100944|640216|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
202096|NCT01100944|640214|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
202097|NCT01100944|640215|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
202098|NCT01100944|640216|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
202099|NCT01100944|640214|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
202100|NCT01100944|640215|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
202101|NCT01100944|640216|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
202102|NCT01100944|640214|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
202103|NCT01100944|640215|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
202104|NCT01100944|640216|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
202105|NCT01101022|640263|P2|Overall Study|Vacation|1
202106|NCT01101022|640264|P1|Overall Study|Vacation|0
202107|NCT01101022|640263|P2|Overall Study|Work schedule|1
202108|NCT01101022|640264|P1|Overall Study|Work schedule|1
202109|NCT01101022|640263|P2|Overall Study|Non-compliance|0
202110|NCT01101022|640264|P1|Overall Study|Non-compliance|1
202111|NCT01101022|640263|P2|Overall Study|Sponsor decision|1
202112|NCT01101022|640264|P1|Overall Study|Sponsor decision|1
202113|NCT01101022|640263|P2|Overall Study|Lack of Efficacy|7
202114|NCT01101022|640264|P1|Overall Study|Lack of Efficacy|0
202115|NCT01101022|640263|P2|Overall Study|Lost to Follow-up|4
202116|NCT01101022|640264|P1|Overall Study|Lost to Follow-up|1
202117|NCT01101022|640263|P2|Overall Study|Withdrawal by Subject|8
202118|NCT01101022|640264|P1|Overall Study|Withdrawal by Subject|3
202119|NCT01101022|640263|P2|Overall Study|Protocol Violation|3
202120|NCT01101022|640264|P1|Overall Study|Protocol Violation|4
202121|NCT01101022|640263|P2|Overall Study|Adverse Event|2
202122|NCT01101022|640264|P1|Overall Study|Adverse Event|6
202123|NCT01101165|640298|P2|Period 2|Adverse Event|0
202124|NCT01101165|640299|P1|Period 2|Adverse Event|1
202125|NCT01101165|640298|P2|Period 2|Withdrawal by Subject|1
202126|NCT01101165|640299|P1|Period 2|Withdrawal by Subject|3
202127|NCT01101165|640298|P2|Period 1|Lost to Follow-up|0
202128|NCT01101165|640299|P1|Period 1|Lost to Follow-up|1
202129|NCT01101165|640298|P2|Period 1|Positive Drug Screen|1
202130|NCT01101165|640299|P1|Period 1|Positive Drug Screen|0
202131|NCT01101165|640298|P2|Period 1|Withdrawal by Subject|2
202132|NCT01101165|640299|P1|Period 1|Withdrawal by Subject|0
202133|NCT01101165|640298|P2|Period 1|Adverse Event|2
202134|NCT01101165|640299|P1|Period 1|Adverse Event|1
202135|NCT01101178|640309|P2|Period 2|Withdrawal by Subject|1
202136|NCT01101178|640310|P1|Period 2|Withdrawal by Subject|0
202137|NCT01101178|640309|P2|Period 1|Adverse Event|1
202138|NCT01101178|640310|P1|Period 1|Adverse Event|2
202139|NCT01101178|640309|P2|Period 1|Positive drug screen|1
202140|NCT01101178|640310|P1|Period 1|Positive drug screen|1
202141|NCT01101178|640309|P2|Period 1|Withdrawal by Subject|2
202142|NCT01101178|640310|P1|Period 1|Withdrawal by Subject|1
202143|NCT01101191|640321|P2|Period 1|Adverse Event|2
202144|NCT01101191|640322|P1|Period 1|Adverse Event|1
202145|NCT01101191|640321|P2|Period 1|Withdrawal by Subject|0
202146|NCT01101191|640322|P1|Period 1|Withdrawal by Subject|1
202147|NCT01101841|640335|P2|Overall Study|Eligibility Criteria|2
202148|NCT01101841|640336|P1|Overall Study|Eligibility Criteria|1
202149|NCT01101841|640335|P2|Overall Study|Suicidality Tracking Scale|1
202150|NCT01101841|640336|P1|Overall Study|Suicidality Tracking Scale|3
202151|NCT01101841|640335|P2|Overall Study|Not Specified|1
202152|NCT01101841|640336|P1|Overall Study|Not Specified|0
202153|NCT01101841|640335|P2|Overall Study|Lack of Efficacy|2
202154|NCT01101841|640336|P1|Overall Study|Lack of Efficacy|0
202155|NCT01101841|640335|P2|Overall Study|Physician Decision|2
202156|NCT01101841|640336|P1|Overall Study|Physician Decision|0
202157|NCT01101841|640335|P2|Overall Study|Protocol Violation|1
202158|NCT01101841|640336|P1|Overall Study|Protocol Violation|1
202159|NCT01101841|640335|P2|Overall Study|Withdrawal by Subject|40
202160|NCT01101841|640336|P1|Overall Study|Withdrawal by Subject|21
202161|NCT01101841|640335|P2|Overall Study|Lost to Follow-up|3
202162|NCT01101841|640336|P1|Overall Study|Lost to Follow-up|9
202163|NCT01101841|640335|P2|Overall Study|Adverse Event|15
202164|NCT01101841|640336|P1|Overall Study|Adverse Event|15
202165|NCT01102140|640402|P2|Overall Study|Investigator terminated study|2
202166|NCT01102140|640403|P1|Overall Study|Investigator terminated study|2
202167|NCT01102140|640402|P2|Overall Study|Lost to Follow-up|0
202168|NCT01102140|640403|P1|Overall Study|Lost to Follow-up|1
202169|NCT01102257|640426|P2|Overall Study|Adverse Event|0
202170|NCT01102257|640427|P1|Overall Study|Adverse Event|1
202171|NCT01102257|640426|P2|Overall Study|Adverse Event|0
202172|NCT01102257|640427|P1|Overall Study|Adverse Event|1
202173|NCT01102374|640448|P2|Overall Study|Lost to Follow-up|6
202174|NCT01102374|640449|P1|Overall Study|Lost to Follow-up|7
202175|NCT01102374|640448|P2|Overall Study|Death|13
202176|NCT01102374|640449|P1|Overall Study|Death|9
202177|NCT01102491|640496|P2|Overall Study|Protocol Violation|12
202178|NCT01102491|640497|P1|Overall Study|Protocol Violation|11
202179|NCT01102777|640518|P2|Overall Study|Lost to Follow-up|10
202180|NCT01102777|640519|P1|Overall Study|Lost to Follow-up|7
202181|NCT01102777|640518|P2|Overall Study|Death|6
202182|NCT01102777|640519|P1|Overall Study|Death|2
202183|NCT01102803|640545|P2|Post to Follow-Up|Lost to Follow-up|3
202184|NCT01102803|640546|P1|Post to Follow-Up|Lost to Follow-up|1
202185|NCT01102803|640545|P2|Baseline to Post-Treatment|Lost to Follow-up|0
202186|NCT01102803|640546|P1|Baseline to Post-Treatment|Lost to Follow-up|3
202187|NCT01102972|640570|P2|Overall Study|Withdrawal by Subject|6
202188|NCT01102972|640571|P1|Overall Study|Withdrawal by Subject|6
202189|NCT01102972|640570|P2|Overall Study|Investigator Discretion|0
202190|NCT01102972|640571|P1|Overall Study|Investigator Discretion|2
202191|NCT01102972|640570|P2|Overall Study|Lost to Follow-up|5
202192|NCT01102972|640571|P1|Overall Study|Lost to Follow-up|10
202193|NCT01102972|640570|P2|Overall Study|Protocol Violation|0
202194|NCT01102972|640571|P1|Overall Study|Protocol Violation|1
202195|NCT01102972|640570|P2|Overall Study|Lack of Efficacy|1
202196|NCT01102972|640571|P1|Overall Study|Lack of Efficacy|2
202197|NCT01102972|640570|P2|Overall Study|Adverse Event|2
202198|NCT01102972|640571|P1|Overall Study|Adverse Event|8
202199|NCT01103063|640625|P2|Overall Study|Death|1
202200|NCT01103063|640626|P1|Overall Study|Death|3
202201|NCT01103063|640625|P2|Overall Study|Study terminated by Sponsor|342
202202|NCT01103063|640626|P1|Overall Study|Study terminated by Sponsor|326
202203|NCT01103063|640625|P2|Overall Study|Protocol Violation|0
202204|NCT01103063|640626|P1|Overall Study|Protocol Violation|1
202205|NCT01103063|640625|P2|Overall Study|Not specified|11
202206|NCT01103063|640626|P1|Overall Study|Not specified|16
202207|NCT01103063|640625|P2|Overall Study|Withdrawal by Subject|15
202208|NCT01103063|640626|P1|Overall Study|Withdrawal by Subject|60
202209|NCT01103063|640625|P2|Overall Study|Lost to Follow-up|51
202210|NCT01103063|640626|P1|Overall Study|Lost to Follow-up|68
202211|NCT01103063|640625|P2|Overall Study|Adverse Event|1
202212|NCT01103063|640626|P1|Overall Study|Adverse Event|3
202213|NCT01103141|640694|P2|Overall Study|Lost to Follow-up|1
202214|NCT01103141|640695|P1|Overall Study|Lost to Follow-up|2
202215|NCT01103141|640694|P2|Overall Study|Death|1
202216|NCT01103141|640695|P1|Overall Study|Death|0
202217|NCT01103232|640703|P2|Overall Study|Protocol Violation|1
202218|NCT01103232|640704|P1|Overall Study|Protocol Violation|0
202219|NCT01103232|640703|P2|Overall Study|Withdrawal by Subject|1
202220|NCT01103232|640704|P1|Overall Study|Withdrawal by Subject|1
202221|NCT01103284|640722|P2|Overall Study|Missing CRF entries for study completion|2
202222|NCT01103284|640723|P1|Overall Study|Missing CRF entries for study completion|0
202223|NCT01103284|640722|P2|Overall Study|Not described|1
202224|NCT01103284|640723|P1|Overall Study|Not described|2
202225|NCT01103284|640722|P2|Overall Study|Termination by the Sponsor|1
202226|NCT01103284|640723|P1|Overall Study|Termination by the Sponsor|0
202227|NCT01103284|640722|P2|Overall Study|Dermal Hypersensitivity|1
202228|NCT01103284|640723|P1|Overall Study|Dermal Hypersensitivity|0
202229|NCT01103284|640722|P2|Overall Study|Withdrawal by Subject|18
202230|NCT01103284|640723|P1|Overall Study|Withdrawal by Subject|14
202231|NCT01103284|640722|P2|Overall Study|Adverse Event|5
202232|NCT01103284|640723|P1|Overall Study|Adverse Event|0
202233|NCT01103284|640722|P2|Overall Study|Protocol Violation|5
202234|NCT01103284|640723|P1|Overall Study|Protocol Violation|12
202235|NCT01103284|640722|P2|Overall Study|Pregnancy|1
202236|NCT01103284|640723|P1|Overall Study|Pregnancy|3
202237|NCT01103284|640722|P2|Overall Study|Lost to Follow-up|10
202238|NCT01103284|640723|P1|Overall Study|Lost to Follow-up|9
202239|NCT01103284|640722|P2|Overall Study|Death|0
202240|NCT01103284|640723|P1|Overall Study|Death|2
202241|NCT01103323|640739|P2|Switched From Placebo to Regorafenib|Adverse Event|1
202242|NCT01103323|640740|P1|Switched From Placebo to Regorafenib|Adverse Event|0
202243|NCT01103323|640739|P2|Without/Before Drug Switch|Switch to Regorafenib|4
202244|NCT01103323|640740|P1|Without/Before Drug Switch|Switch to Regorafenib|0
202245|NCT01103323|640739|P2|Without/Before Drug Switch|did not receive study treatment|2
202246|NCT01103323|640740|P1|Without/Before Drug Switch|did not receive study treatment|5
202247|NCT01103323|640739|P2|Without/Before Drug Switch|Physician Decision|0
202248|NCT01103323|640740|P1|Without/Before Drug Switch|Physician Decision|2
202249|NCT01103323|640739|P2|Without/Before Drug Switch|Protocol Violation|0
202250|NCT01103323|640740|P1|Without/Before Drug Switch|Protocol Violation|2
202251|NCT01103323|640739|P2|Without/Before Drug Switch|Withdrawal by Subject|5
202252|NCT01103323|640740|P1|Without/Before Drug Switch|Withdrawal by Subject|17
202253|NCT01103323|640739|P2|Without/Before Drug Switch|Adverse Event|7
202254|NCT01103323|640740|P1|Without/Before Drug Switch|Adverse Event|50
202255|NCT01103362|640755|P1|Overall Study|study terminated|596
202256|NCT01103466|640830|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
202257|NCT01103466|640831|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
202258|NCT01103466|640832|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
202259|NCT01103466|640830|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
202260|NCT01103466|640831|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
202261|NCT01103466|640832|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
202262|NCT01103466|640830|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
202263|NCT01103466|640831|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
202264|NCT01103466|640832|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
202265|NCT01103466|640830|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
202266|NCT01103466|640831|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
202267|NCT01103466|640832|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
202268|NCT01103466|640830|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
202269|NCT01103466|640831|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
202270|NCT01103466|640832|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
202271|NCT01103466|640830|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
202272|NCT01103466|640831|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
202273|NCT01103466|640832|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
202274|NCT01103479|640843|P3|Overall Study|Saw non-study physician|0
202275|NCT01103479|640844|P2|Overall Study|Saw non-study physician|0
202276|NCT01103479|640845|P1|Overall Study|Saw non-study physician|2
202277|NCT01103479|640843|P3|Overall Study|Active cancer|0
202278|NCT01103479|640844|P2|Overall Study|Active cancer|0
202279|NCT01103479|640845|P1|Overall Study|Active cancer|1
202280|NCT01103479|640843|P3|Overall Study|Family history of CRC|2
202281|NCT01103479|640844|P2|Overall Study|Family history of CRC|0
202282|NCT01103479|640845|P1|Overall Study|Family history of CRC|1
202283|NCT01103479|640843|P3|Overall Study|Up to date with CRC screening|12
202284|NCT01103479|640844|P2|Overall Study|Up to date with CRC screening|9
202285|NCT01103479|640845|P1|Overall Study|Up to date with CRC screening|1
202286|NCT01103713|640862|P1|Overall Study|Not specified|1
202287|NCT01103713|640862|P1|Overall Study|Study terminated by sponsor|2
202288|NCT01103713|640862|P1|Overall Study|Withdrawal by Subject|8
202289|NCT01103713|640862|P1|Overall Study|Lost to Follow-up|2
202290|NCT01103960|640901|P2|Overall Study|Other|0
202291|NCT01103960|640902|P1|Overall Study|Other|1
202292|NCT01103960|640901|P2|Overall Study|Withdrawal by Subject|1
202293|NCT01103960|640902|P1|Overall Study|Withdrawal by Subject|2
202294|NCT01103960|640901|P2|Overall Study|Adverse Event|1
202295|NCT01103960|640902|P1|Overall Study|Adverse Event|2
202296|NCT01096446|640937|P2|Overall Study|Protocol Violation|0
202297|NCT01096446|640938|P1|Overall Study|Protocol Violation|2
202298|NCT01096446|640937|P2|Overall Study|Death|0
202299|NCT01096446|640938|P1|Overall Study|Death|1
202300|NCT01096550|640945|P2|Overall Study|Lost to Follow-up|9
202301|NCT01096550|640946|P1|Overall Study|Lost to Follow-up|12
202302|NCT01096550|640945|P2|Overall Study|non-African American participant|6
202303|NCT01096550|640946|P1|Overall Study|non-African American participant|13
202304|NCT01096550|640945|P2|Overall Study|Withdrawal by Subject|1
202305|NCT01096550|640946|P1|Overall Study|Withdrawal by Subject|0
202306|NCT01096550|640945|P2|Overall Study|clinic readmission|1
202307|NCT01096550|640946|P1|Overall Study|clinic readmission|1
202308|NCT01096550|640945|P2|Overall Study|non-regular treatment track at clinic|1
202309|NCT01096550|640946|P1|Overall Study|non-regular treatment track at clinic|1
202310|NCT01096550|640945|P2|Overall Study|discontinued site|11
202311|NCT01096550|640946|P1|Overall Study|discontinued site|10
202312|NCT01096589|640956|P4|Overall Study|found treatment exhausting|1
202313|NCT01096589|640957|P3|Overall Study|found treatment exhausting|0
202314|NCT01096589|640958|P2|Overall Study|found treatment exhausting|0
202315|NCT01096589|640959|P1|Overall Study|found treatment exhausting|0
202316|NCT01096589|640956|P4|Overall Study|Compliance with protocol|0
202317|NCT01096589|640957|P3|Overall Study|Compliance with protocol|1
202318|NCT01096589|640958|P2|Overall Study|Compliance with protocol|0
202319|NCT01096589|640959|P1|Overall Study|Compliance with protocol|0
202320|NCT01096589|640956|P4|Overall Study|Withdrawal by Subject|1
202321|NCT01096589|640957|P3|Overall Study|Withdrawal by Subject|1
202322|NCT01096589|640958|P2|Overall Study|Withdrawal by Subject|1
202323|NCT01096589|640959|P1|Overall Study|Withdrawal by Subject|2
202324|NCT01096589|640956|P4|Overall Study|Adverse Event|1
202325|NCT01096589|640957|P3|Overall Study|Adverse Event|2
202326|NCT01096589|640958|P2|Overall Study|Adverse Event|1
202327|NCT01096589|640959|P1|Overall Study|Adverse Event|2
202328|NCT01096784|641039|P2|Overall Study|Other Unspecified|1
202329|NCT01096784|641040|P1|Overall Study|Other Unspecified|0
202330|NCT01096784|641039|P2|Overall Study|Administrative Decision|1
202331|NCT01096784|641040|P1|Overall Study|Administrative Decision|0
202332|NCT01096784|641039|P2|Overall Study|Protocol Deviation|2
202333|NCT01096784|641040|P1|Overall Study|Protocol Deviation|2
202334|NCT01096784|641039|P2|Overall Study|Adverse Event|9
202335|NCT01096784|641040|P1|Overall Study|Adverse Event|11
202336|NCT01096784|641039|P2|Overall Study|Withdrawal by Subject|1
202337|NCT01096784|641040|P1|Overall Study|Withdrawal by Subject|2
202338|NCT01097005|641108|P1|Overall Study|Discontinuance by complication|50
202339|NCT01097005|641108|P1|Overall Study|Adverse Event|14
202340|NCT01097005|641108|P1|Overall Study|Deviation from exclusion criteria|37
202341|NCT01097005|641108|P1|Overall Study|No examination data available|244
202342|NCT01097005|641108|P1|Overall Study|Poor medication compliance|1
202343|NCT01097005|641108|P1|Overall Study|Subjects cannot visit the hospital|1
202344|NCT01097005|641108|P1|Overall Study|Case Report Form not collected|18
202345|NCT01097057|641114|P1|Overall Study|Physician Decision|3
202346|NCT01097421|641132|P1|Overall Study|Withdrawal by Subject|3
202347|NCT01097421|641132|P1|Overall Study|Lost to Follow-up|1
202348|NCT01097421|641132|P1|Overall Study|Protocol Violation|2
202349|NCT01097421|641132|P1|Overall Study|Adverse Event|8
202350|NCT01097616|641149|P8|DB RO Phase|Not Treated in RO|0
202351|NCT01097616|641150|P7|DB RO Phase|Not Treated in RO|0
202352|NCT01097616|641151|P6|DB RO Phase|Not Treated in RO|1
202353|NCT01097616|641152|P5|DB RO Phase|Not Treated in RO|0
202354|NCT01097616|641153|P4|DB RO Phase|Not Treated in RO|0
202355|NCT01097616|641154|P3|DB RO Phase|Not Treated in RO|0
202356|NCT01097616|641155|P2|DB RO Phase|Not Treated in RO|0
202357|NCT01097616|641156|P1|DB RO Phase|Not Treated in RO|0
202358|NCT01097616|641149|P8|DB RO Phase|Lost to Follow-up|1
202359|NCT01097616|641150|P7|DB RO Phase|Lost to Follow-up|0
202360|NCT01097616|641151|P6|DB RO Phase|Lost to Follow-up|0
202361|NCT01097616|641152|P5|DB RO Phase|Lost to Follow-up|1
202362|NCT01097616|641153|P4|DB RO Phase|Lost to Follow-up|1
202363|NCT01097616|641154|P3|DB RO Phase|Lost to Follow-up|0
202364|NCT01097616|641155|P2|DB RO Phase|Lost to Follow-up|0
202365|NCT01097616|641156|P1|DB RO Phase|Lost to Follow-up|0
202366|NCT01097616|641149|P8|DB RO Phase|Withdrawal by Subject|0
202367|NCT01097616|641150|P7|DB RO Phase|Withdrawal by Subject|0
202368|NCT01097616|641151|P6|DB RO Phase|Withdrawal by Subject|1
202369|NCT01097616|641152|P5|DB RO Phase|Withdrawal by Subject|0
202370|NCT01097616|641153|P4|DB RO Phase|Withdrawal by Subject|0
202371|NCT01097616|641154|P3|DB RO Phase|Withdrawal by Subject|0
202372|NCT01097616|641155|P2|DB RO Phase|Withdrawal by Subject|0
202373|NCT01097616|641156|P1|DB RO Phase|Withdrawal by Subject|0
202374|NCT01097616|641149|P8|DB RO Phase|Adverse Event|0
202375|NCT01097616|641150|P7|DB RO Phase|Adverse Event|1
202376|NCT01097616|641151|P6|DB RO Phase|Adverse Event|0
202377|NCT01097616|641152|P5|DB RO Phase|Adverse Event|0
202378|NCT01097616|641153|P4|DB RO Phase|Adverse Event|0
202379|NCT01097616|641154|P3|DB RO Phase|Adverse Event|0
202380|NCT01097616|641155|P2|DB RO Phase|Adverse Event|0
202381|NCT01097616|641156|P1|DB RO Phase|Adverse Event|0
202382|NCT01097616|641149|P8|Optional DB EXT Phase|Physician Decision|0
202383|NCT01097616|641150|P7|Optional DB EXT Phase|Physician Decision|0
202384|NCT01097616|641151|P6|Optional DB EXT Phase|Physician Decision|0
202385|NCT01097616|641152|P5|Optional DB EXT Phase|Physician Decision|0
202386|NCT01097616|641153|P4|Optional DB EXT Phase|Physician Decision|0
202387|NCT01097616|641154|P3|Optional DB EXT Phase|Physician Decision|0
202388|NCT01097616|641155|P2|Optional DB EXT Phase|Physician Decision|0
202389|NCT01097616|641156|P1|Optional DB EXT Phase|Physician Decision|1
202390|NCT01097616|641149|P8|Optional DB EXT Phase|Lack of Efficacy|0
202391|NCT01097616|641150|P7|Optional DB EXT Phase|Lack of Efficacy|0
202392|NCT01097616|641151|P6|Optional DB EXT Phase|Lack of Efficacy|0
202393|NCT01097616|641152|P5|Optional DB EXT Phase|Lack of Efficacy|0
202394|NCT01097616|641153|P4|Optional DB EXT Phase|Lack of Efficacy|0
202395|NCT01097616|641154|P3|Optional DB EXT Phase|Lack of Efficacy|1
202396|NCT01097616|641155|P2|Optional DB EXT Phase|Lack of Efficacy|1
202397|NCT01097616|641156|P1|Optional DB EXT Phase|Lack of Efficacy|1
202398|NCT01097616|641149|P8|Optional DB EXT Phase|Lost to Follow-up|0
202399|NCT01097616|641150|P7|Optional DB EXT Phase|Lost to Follow-up|0
202400|NCT01097616|641151|P6|Optional DB EXT Phase|Lost to Follow-up|0
202401|NCT01097616|641152|P5|Optional DB EXT Phase|Lost to Follow-up|0
202402|NCT01097616|641153|P4|Optional DB EXT Phase|Lost to Follow-up|0
202403|NCT01097616|641154|P3|Optional DB EXT Phase|Lost to Follow-up|1
202404|NCT01097616|641155|P2|Optional DB EXT Phase|Lost to Follow-up|5
202405|NCT01097616|641156|P1|Optional DB EXT Phase|Lost to Follow-up|1
202406|NCT01097616|641149|P8|Optional DB EXT Phase|Protocol Violation|0
202407|NCT01097616|641150|P7|Optional DB EXT Phase|Protocol Violation|0
202408|NCT01097616|641151|P6|Optional DB EXT Phase|Protocol Violation|0
202409|NCT01097616|641152|P5|Optional DB EXT Phase|Protocol Violation|0
202410|NCT01097616|641153|P4|Optional DB EXT Phase|Protocol Violation|0
202411|NCT01097616|641154|P3|Optional DB EXT Phase|Protocol Violation|3
202412|NCT01097616|641155|P2|Optional DB EXT Phase|Protocol Violation|2
202413|NCT01097616|641156|P1|Optional DB EXT Phase|Protocol Violation|0
202414|NCT01097616|641149|P8|Optional DB EXT Phase|Withdrawal by Subject|0
202415|NCT01097616|641150|P7|Optional DB EXT Phase|Withdrawal by Subject|0
202416|NCT01097616|641151|P6|Optional DB EXT Phase|Withdrawal by Subject|0
202417|NCT01097616|641152|P5|Optional DB EXT Phase|Withdrawal by Subject|0
202418|NCT01097616|641153|P4|Optional DB EXT Phase|Withdrawal by Subject|0
202419|NCT01097616|641154|P3|Optional DB EXT Phase|Withdrawal by Subject|3
202420|NCT01097616|641155|P2|Optional DB EXT Phase|Withdrawal by Subject|6
202421|NCT01097616|641156|P1|Optional DB EXT Phase|Withdrawal by Subject|12
202422|NCT01097616|641149|P8|Optional DB EXT Phase|Adverse Event|0
202423|NCT01097616|641150|P7|Optional DB EXT Phase|Adverse Event|0
202424|NCT01097616|641151|P6|Optional DB EXT Phase|Adverse Event|0
202425|NCT01097616|641152|P5|Optional DB EXT Phase|Adverse Event|0
202426|NCT01097616|641153|P4|Optional DB EXT Phase|Adverse Event|0
202427|NCT01097616|641154|P3|Optional DB EXT Phase|Adverse Event|2
202428|NCT01097616|641155|P2|Optional DB EXT Phase|Adverse Event|7
202429|NCT01097616|641156|P1|Optional DB EXT Phase|Adverse Event|0
202430|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202431|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202432|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202433|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202434|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202435|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
202436|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202437|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202438|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202439|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202440|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202441|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202442|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202443|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202444|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
202445|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
202446|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
202447|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
202448|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
202449|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
202450|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
202451|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
202452|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
202453|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
202454|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202455|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202456|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202457|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202458|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202459|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
202460|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
202461|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
202462|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202463|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202464|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202465|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202466|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202467|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202468|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
202469|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
202470|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202471|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202472|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202473|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202474|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202475|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
202476|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
202477|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
202478|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202479|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202480|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202481|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202482|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202483|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
202484|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
202485|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
202486|NCT01097616|641149|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202487|NCT01097616|641150|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202488|NCT01097616|641151|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202489|NCT01097616|641152|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202490|NCT01097616|641153|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202491|NCT01097616|641154|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
202492|NCT01097616|641155|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
202493|NCT01097616|641156|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
202494|NCT01097629|641230|P8|DB RO Phase|Lost to Follow-up|0
202495|NCT01097629|641231|P7|DB RO Phase|Lost to Follow-up|2
202496|NCT01097629|641232|P6|DB RO Phase|Lost to Follow-up|0
202497|NCT01097629|641233|P5|DB RO Phase|Lost to Follow-up|0
202498|NCT01097629|641234|P4|DB RO Phase|Lost to Follow-up|0
202499|NCT01097629|641235|P3|DB RO Phase|Lost to Follow-up|0
202500|NCT01097629|641236|P2|DB RO Phase|Lost to Follow-up|0
202501|NCT01097629|641237|P1|DB RO Phase|Lost to Follow-up|0
202502|NCT01097629|641230|P8|DB RO Phase|Protocol Violation|0
202503|NCT01097629|641231|P7|DB RO Phase|Protocol Violation|1
202504|NCT01097629|641232|P6|DB RO Phase|Protocol Violation|1
202505|NCT01097629|641233|P5|DB RO Phase|Protocol Violation|0
202506|NCT01097629|641234|P4|DB RO Phase|Protocol Violation|1
202507|NCT01097629|641235|P3|DB RO Phase|Protocol Violation|0
202508|NCT01097629|641236|P2|DB RO Phase|Protocol Violation|0
202509|NCT01097629|641237|P1|DB RO Phase|Protocol Violation|0
202510|NCT01097629|641230|P8|DB RO Phase|Withdrawal by Subject|1
202511|NCT01097629|641231|P7|DB RO Phase|Withdrawal by Subject|0
202512|NCT01097629|641232|P6|DB RO Phase|Withdrawal by Subject|0
202513|NCT01097629|641233|P5|DB RO Phase|Withdrawal by Subject|0
202514|NCT01097629|641234|P4|DB RO Phase|Withdrawal by Subject|0
202515|NCT01097629|641235|P3|DB RO Phase|Withdrawal by Subject|0
202516|NCT01097629|641236|P2|DB RO Phase|Withdrawal by Subject|0
202517|NCT01097629|641237|P1|DB RO Phase|Withdrawal by Subject|0
202518|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202519|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202520|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202521|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202522|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
202523|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
202524|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
202525|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
202526|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202527|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202528|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202529|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202530|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202531|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
202532|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
202533|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
202534|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202535|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202536|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202537|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202538|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
202539|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
202540|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
202541|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
202542|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202543|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202544|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202545|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202546|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
202547|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
202548|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
202549|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
202550|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202551|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202552|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202553|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202554|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
202555|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
202556|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
202557|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
202558|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202559|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202560|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202561|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202562|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
202563|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
202564|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
202565|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
202566|NCT01097629|641230|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202567|NCT01097629|641231|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202568|NCT01097629|641232|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202569|NCT01097629|641233|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202570|NCT01097629|641234|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
202571|NCT01097629|641235|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
202572|NCT01097629|641236|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
202573|NCT01097629|641237|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
202574|NCT01097655|641285|P1|Overall Study|Did Not Meet Inclusion Criteria|8
202575|NCT01097655|641285|P1|Overall Study|Subject Documented Twice|1
202576|NCT01097655|641285|P1|Overall Study|Withdrawal by Subject|1
202577|NCT01097668|641294|P2|Overall Study|Lost to Follow-up|0
202578|NCT01097668|641295|P1|Overall Study|Lost to Follow-up|1
202579|NCT01097668|641294|P2|Overall Study|Withdrawal by Subject|2
202580|NCT01097668|641295|P1|Overall Study|Withdrawal by Subject|1
202581|NCT01097694|641307|P2|Overall Study|Withdrawal by Subject|1
202582|NCT01097694|641308|P1|Overall Study|Withdrawal by Subject|3
202583|NCT01097694|641307|P2|Overall Study|Lost to Follow-up|3
202584|NCT01097694|641308|P1|Overall Study|Lost to Follow-up|0
202585|NCT01097694|641307|P2|Overall Study|Adverse Event|0
202586|NCT01097694|641308|P1|Overall Study|Adverse Event|5
202587|NCT01097863|641382|P3|Overall Study|Did not return for final visit|1
202588|NCT01097863|641383|P2|Overall Study|Did not return for final visit|0
202589|NCT01097863|641384|P1|Overall Study|Did not return for final visit|0
202590|NCT01097863|641382|P3|Overall Study|Discomfort|1
202591|NCT01097863|641383|P2|Overall Study|Discomfort|0
202592|NCT01097863|641384|P1|Overall Study|Discomfort|1
202593|NCT01098032|641413|P2|Overall Study|Withdrawal by Subject|1
202594|NCT01098032|641414|P1|Overall Study|Withdrawal by Subject|1
202595|NCT01098071|641420|P1|Overall Study|Lost to Follow-up|13
202596|NCT01098071|641420|P1|Overall Study|Surgery (adenoidectomy)|2
202597|NCT01098097|641431|P1|Overall Study|No reason reported|31
202598|NCT01098097|641431|P1|Overall Study|Status unknown|16
202599|NCT01098097|641431|P1|Overall Study|Lost to Follow-up|18
202600|NCT01098097|641431|P1|Overall Study|Adverse Event|17
202601|NCT01098110|641443|P3|Overall Study|Untreated|0
202602|NCT01098110|641444|P2|Overall Study|Untreated|1
202603|NCT01098110|641445|P1|Overall Study|Untreated|1
202604|NCT01098110|641443|P3|Overall Study|Not Specified|5
202605|NCT01098110|641444|P2|Overall Study|Not Specified|7
202606|NCT01098110|641445|P1|Overall Study|Not Specified|4
202607|NCT01098110|641443|P3|Overall Study|Lack of Efficacy|27
202608|NCT01098110|641444|P2|Overall Study|Lack of Efficacy|9
202609|NCT01098110|641445|P1|Overall Study|Lack of Efficacy|13
202610|NCT01098110|641443|P3|Overall Study|Adverse Event|43
202611|NCT01098110|641444|P2|Overall Study|Adverse Event|32
202612|NCT01098110|641445|P1|Overall Study|Adverse Event|30
202613|NCT01098110|641443|P3|Overall Study|Withdrawal by Subject|19
202614|NCT01098110|641444|P2|Overall Study|Withdrawal by Subject|24
202615|NCT01098110|641445|P1|Overall Study|Withdrawal by Subject|14
202616|NCT01098162|641486|P1|Overall Study|Reason Unknown|26
202617|NCT01098162|641486|P1|Overall Study|Other Reason|1
202618|NCT01098162|641486|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
202619|NCT01098162|641486|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
202620|NCT01098162|641486|P1|Overall Study|Adverse Event & Lost to Follow-up|2
202621|NCT01098162|641486|P1|Overall Study|Adverse Event & Wish of Patient|13
202622|NCT01098162|641486|P1|Overall Study|Adverse Event & Lack of Efficacy|6
202623|NCT01098162|641486|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
202624|NCT01098162|641486|P1|Overall Study|Lost to Follow-up|9
202625|NCT01098162|641486|P1|Overall Study|Wish of Patient|7
202626|NCT01098162|641486|P1|Overall Study|Lack of Efficacy|4
202627|NCT01098162|641486|P1|Overall Study|Adverse Event|37
202628|NCT01098240|641495|P3|Double-Blind Phase|Adverse Event|3
202629|NCT01098240|641496|P2|Double-Blind Phase|Adverse Event|3
202630|NCT01098240|641497|P1|Double-Blind Phase|Adverse Event|0
202631|NCT01098240|641495|P3|Double-Blind Phase|Withdrawal by Subject|3
202632|NCT01098240|641496|P2|Double-Blind Phase|Withdrawal by Subject|1
202633|NCT01098240|641497|P1|Double-Blind Phase|Withdrawal by Subject|0
202634|NCT01098240|641495|P3|Double-Blind Phase|Insufficient Clinical Response|2
202635|NCT01098240|641496|P2|Double-Blind Phase|Insufficient Clinical Response|1
202636|NCT01098240|641497|P1|Double-Blind Phase|Insufficient Clinical Response|0
202637|NCT01098240|641495|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
202638|NCT01098240|641496|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
202639|NCT01098240|641497|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
202640|NCT01098240|641495|P3|Double-Blind Phase|Unspecified|2
202641|NCT01098240|641496|P2|Double-Blind Phase|Unspecified|2
202642|NCT01098240|641497|P1|Double-Blind Phase|Unspecified|0
202643|NCT01098240|641495|P3|Double-Blind Phase|Lost to Follow-up|0
202644|NCT01098240|641496|P2|Double-Blind Phase|Lost to Follow-up|2
202645|NCT01098240|641497|P1|Double-Blind Phase|Lost to Follow-up|0
202646|NCT01098240|641495|P3|Double-Blind Phase|Protocol Violation|4
202647|NCT01098240|641496|P2|Double-Blind Phase|Protocol Violation|2
202648|NCT01098240|641497|P1|Double-Blind Phase|Protocol Violation|0
202649|NCT01098240|641495|P3|Double-Blind Phase|Study Terminated by Sponsor|8
202650|NCT01098240|641496|P2|Double-Blind Phase|Study Terminated by Sponsor|5
202651|NCT01098240|641497|P1|Double-Blind Phase|Study Terminated by Sponsor|0
202652|NCT01098240|641495|P3|Open-Label Phase|Adverse Event|0
202653|NCT01098240|641496|P2|Open-Label Phase|Adverse Event|0
202654|NCT01098240|641497|P1|Open-Label Phase|Adverse Event|12
202655|NCT01098240|641495|P3|Open-Label Phase|Withdrawal by Subject|0
202656|NCT01098240|641496|P2|Open-Label Phase|Withdrawal by Subject|0
202657|NCT01098240|641497|P1|Open-Label Phase|Withdrawal by Subject|9
202658|NCT01098240|641495|P3|Open-Label Phase|Pregnancy|0
202659|NCT01098240|641496|P2|Open-Label Phase|Pregnancy|0
202660|NCT01098240|641497|P1|Open-Label Phase|Pregnancy|1
202661|NCT01098240|641495|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
202662|NCT01098240|641496|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
202663|NCT01098240|641497|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
202664|NCT01098240|641495|P3|Open-Label Phase|Unspecified|0
202665|NCT01098240|641496|P2|Open-Label Phase|Unspecified|0
202666|NCT01098240|641497|P1|Open-Label Phase|Unspecified|19
202667|NCT01098240|641495|P3|Open-Label Phase|Lost to Follow-up|0
202668|NCT01098240|641496|P2|Open-Label Phase|Lost to Follow-up|0
202669|NCT01098240|641497|P1|Open-Label Phase|Lost to Follow-up|13
202670|NCT01098240|641495|P3|Open-Label Phase|Protocol Violation|0
202671|NCT01098240|641496|P2|Open-Label Phase|Protocol Violation|0
202672|NCT01098240|641497|P1|Open-Label Phase|Protocol Violation|4
202673|NCT01098240|641495|P3|Open-Label Phase|Study Terminated by Sponsor|0
202674|NCT01098240|641496|P2|Open-Label Phase|Study Terminated by Sponsor|0
202675|NCT01098240|641497|P1|Open-Label Phase|Study Terminated by Sponsor|27
202676|NCT01098305|641540|P2|Overall Study|Lost to Follow-up|33
202677|NCT01098305|641541|P1|Overall Study|Lost to Follow-up|31
202678|NCT01104155|641580|P2|Overall Study|Not specified|4
202679|NCT01104155|641581|P1|Overall Study|Not specified|3
202680|NCT01104155|641580|P2|Overall Study|Withdrawal of consent|1
202681|NCT01104155|641581|P1|Overall Study|Withdrawal of consent|1
202682|NCT01104155|641580|P2|Overall Study|Participant choice|5
202683|NCT01104155|641581|P1|Overall Study|Participant choice|6
202684|NCT01104155|641580|P2|Overall Study|Adverse Event|8
202685|NCT01104155|641581|P1|Overall Study|Adverse Event|15
202686|NCT01104246|641604|P1|Overall Study|did not meet inclusion criteria|4
202687|NCT01104246|641604|P1|Overall Study|Withdrawal by Subject|1
202688|NCT01104311|641619|P2|Overall Study|Adverse Event|2
202689|NCT01104311|641620|P1|Overall Study|Adverse Event|1
202690|NCT01104311|641619|P2|Overall Study|low compliance|1
202691|NCT01104311|641620|P1|Overall Study|low compliance|1
202692|NCT01104311|641619|P2|Overall Study|Physician Decision|2
202693|NCT01104311|641620|P1|Overall Study|Physician Decision|2
202694|NCT01104311|641619|P2|Overall Study|Protocol Violation|1
202695|NCT01104311|641620|P1|Overall Study|Protocol Violation|0
202696|NCT01104311|641619|P2|Overall Study|Withdrawal by Subject|6
202697|NCT01104311|641620|P1|Overall Study|Withdrawal by Subject|6
202698|NCT01104636|641638|P1|Overall Study|Ongoing|21
202699|NCT01104636|641638|P1|Overall Study|Adverse Event|40
202700|NCT01104636|641638|P1|Overall Study|Pregnancy|2
202701|NCT01104636|641638|P1|Overall Study|Study terminated by sponsor|1
202702|NCT01104636|641638|P1|Overall Study|Unspecified|43
202703|NCT01104636|641638|P1|Overall Study|Withdrawal by Subject|4
202704|NCT01104636|641638|P1|Overall Study|Lost to Follow-up|24
202705|NCT01104636|641638|P1|Overall Study|Lack of Efficacy|43
202706|NCT01104662|641651|P8|Overall Study|Randomized but not treated|0
202707|NCT01104662|641652|P7|Overall Study|Randomized but not treated|0
202708|NCT01104662|641653|P6|Overall Study|Randomized but not treated|1
202709|NCT01104662|641654|P5|Overall Study|Randomized but not treated|0
202710|NCT01104662|641655|P4|Overall Study|Randomized but not treated|0
202711|NCT01104662|641656|P3|Overall Study|Randomized but not treated|1
202712|NCT01104662|641657|P2|Overall Study|Randomized but not treated|4
202713|NCT01104662|641658|P1|Overall Study|Randomized but not treated|3
202714|NCT01104662|641651|P8|Overall Study|Reason not specified|0
202715|NCT01104662|641652|P7|Overall Study|Reason not specified|0
202716|NCT01104662|641653|P6|Overall Study|Reason not specified|1
202717|NCT01104662|641654|P5|Overall Study|Reason not specified|0
202718|NCT01104662|641655|P4|Overall Study|Reason not specified|0
202719|NCT01104662|641656|P3|Overall Study|Reason not specified|0
202720|NCT01104662|641657|P2|Overall Study|Reason not specified|3
202721|NCT01104662|641658|P1|Overall Study|Reason not specified|3
202722|NCT01104662|641651|P8|Overall Study|Participant left investigator’s care|0
202723|NCT01104662|641652|P7|Overall Study|Participant left investigator’s care|0
202724|NCT01104662|641653|P6|Overall Study|Participant left investigator’s care|0
202725|NCT01104662|641654|P5|Overall Study|Participant left investigator’s care|0
202726|NCT01104662|641655|P4|Overall Study|Participant left investigator’s care|0
202727|NCT01104662|641656|P3|Overall Study|Participant left investigator’s care|0
202728|NCT01104662|641657|P2|Overall Study|Participant left investigator’s care|1
202729|NCT01104662|641658|P1|Overall Study|Participant left investigator’s care|1
202730|NCT01104662|641651|P8|Overall Study|Clinical Failure|0
202731|NCT01104662|641652|P7|Overall Study|Clinical Failure|0
202732|NCT01104662|641653|P6|Overall Study|Clinical Failure|1
202733|NCT01104662|641654|P5|Overall Study|Clinical Failure|0
202734|NCT01104662|641655|P4|Overall Study|Clinical Failure|0
202735|NCT01104662|641656|P3|Overall Study|Clinical Failure|0
202736|NCT01104662|641657|P2|Overall Study|Clinical Failure|0
202737|NCT01104662|641658|P1|Overall Study|Clinical Failure|1
202738|NCT01104662|641651|P8|Overall Study|Adverse Event|0
202739|NCT01104662|641652|P7|Overall Study|Adverse Event|0
202740|NCT01104662|641653|P6|Overall Study|Adverse Event|1
202741|NCT01104662|641654|P5|Overall Study|Adverse Event|1
202742|NCT01104662|641655|P4|Overall Study|Adverse Event|1
202743|NCT01104662|641656|P3|Overall Study|Adverse Event|0
202744|NCT01104662|641657|P2|Overall Study|Adverse Event|2
202745|NCT01104662|641658|P1|Overall Study|Adverse Event|2
202746|NCT01104701|641688|P4|Overall Study|Physician Decision|0
202747|NCT01104701|641689|P3|Overall Study|Physician Decision|0
202748|NCT01104701|641690|P2|Overall Study|Physician Decision|2
202749|NCT01104701|641691|P1|Overall Study|Physician Decision|0
202750|NCT01104701|641688|P4|Overall Study|Adverse Event|1
202751|NCT01104701|641689|P3|Overall Study|Adverse Event|0
202752|NCT01104701|641690|P2|Overall Study|Adverse Event|0
202753|NCT01104701|641691|P1|Overall Study|Adverse Event|0
202754|NCT01104701|641688|P4|Overall Study|Withdrawal by Subject|1
202755|NCT01104701|641689|P3|Overall Study|Withdrawal by Subject|2
202756|NCT01104701|641690|P2|Overall Study|Withdrawal by Subject|1
202757|NCT01104701|641691|P1|Overall Study|Withdrawal by Subject|0
202758|NCT01104870|641748|P3|Overall Study|Withdrawal by Subject|1
202759|NCT01104870|641749|P2|Overall Study|Withdrawal by Subject|0
202760|NCT01104870|641750|P1|Overall Study|Withdrawal by Subject|0
202761|NCT01104870|641748|P3|Overall Study|Death|1
202762|NCT01104870|641749|P2|Overall Study|Death|0
202763|NCT01104870|641750|P1|Overall Study|Death|0
202764|NCT01104870|641748|P3|Overall Study|Adverse Event|0
202765|NCT01104870|641749|P2|Overall Study|Adverse Event|1
202766|NCT01104870|641750|P1|Overall Study|Adverse Event|1
202767|NCT01105065|641779|P1|Overall Study|Technical Problems|1
202768|NCT01105065|641779|P1|Overall Study|Adverse Event|5
202769|NCT01105091|641787|P2|Overall Study|Death|0
202770|NCT01105091|641788|P1|Overall Study|Death|2
202771|NCT01105130|641826|P3|Overall Study|Multiple Reasons|2
202772|NCT01105130|641827|P2|Overall Study|Multiple Reasons|0
202773|NCT01105130|641828|P1|Overall Study|Multiple Reasons|3
202774|NCT01105130|641826|P3|Overall Study|Toxicity|2
202775|NCT01105130|641827|P2|Overall Study|Toxicity|3
202776|NCT01105130|641828|P1|Overall Study|Toxicity|1
202777|NCT01105130|641826|P3|Overall Study|Never Started|4
202778|NCT01105130|641827|P2|Overall Study|Never Started|2
202779|NCT01105130|641828|P1|Overall Study|Never Started|2
202780|NCT01105130|641826|P3|Overall Study|Withdrawal by Subject|2
202781|NCT01105130|641827|P2|Overall Study|Withdrawal by Subject|6
202782|NCT01105130|641828|P1|Overall Study|Withdrawal by Subject|4
202783|NCT01105377|641884|P2|Overall Study|Withdrawal by Subject|1
202784|NCT01105377|641885|P1|Overall Study|Withdrawal by Subject|0
202785|NCT01105533|641893|P9|Overall Study|Physician Decision|0
202786|NCT01105533|641894|P8|Overall Study|Physician Decision|1
202787|NCT01105533|641895|P7|Overall Study|Physician Decision|0
202788|NCT01105533|641896|P6|Overall Study|Physician Decision|0
202789|NCT01105533|641897|P5|Overall Study|Physician Decision|0
202790|NCT01105533|641898|P4|Overall Study|Physician Decision|0
202791|NCT01105533|641899|P3|Overall Study|Physician Decision|0
202792|NCT01105533|641900|P2|Overall Study|Physician Decision|0
202793|NCT01105533|641901|P1|Overall Study|Physician Decision|0
202794|NCT01105533|641893|P9|Overall Study|Unspecified|2
202795|NCT01105533|641894|P8|Overall Study|Unspecified|1
202796|NCT01105533|641895|P7|Overall Study|Unspecified|3
202797|NCT01105533|641896|P6|Overall Study|Unspecified|0
202798|NCT01105533|641897|P5|Overall Study|Unspecified|1
202799|NCT01105533|641898|P4|Overall Study|Unspecified|0
202800|NCT01105533|641899|P3|Overall Study|Unspecified|0
202801|NCT01105533|641900|P2|Overall Study|Unspecified|0
202802|NCT01105533|641901|P1|Overall Study|Unspecified|0
202803|NCT01105533|641893|P9|Overall Study|Adverse Event|1
202804|NCT01105533|641894|P8|Overall Study|Adverse Event|0
202805|NCT01105533|641895|P7|Overall Study|Adverse Event|2
202806|NCT01105533|641896|P6|Overall Study|Adverse Event|2
202807|NCT01105533|641897|P5|Overall Study|Adverse Event|1
202808|NCT01105533|641898|P4|Overall Study|Adverse Event|0
202809|NCT01105533|641899|P3|Overall Study|Adverse Event|0
202810|NCT01105533|641900|P2|Overall Study|Adverse Event|0
202811|NCT01105533|641901|P1|Overall Study|Adverse Event|0
202812|NCT01105533|641893|P9|Overall Study|Lack of Efficacy|9
202813|NCT01105533|641894|P8|Overall Study|Lack of Efficacy|2
202814|NCT01105533|641895|P7|Overall Study|Lack of Efficacy|3
202815|NCT01105533|641896|P6|Overall Study|Lack of Efficacy|5
202816|NCT01105533|641897|P5|Overall Study|Lack of Efficacy|4
202817|NCT01105533|641898|P4|Overall Study|Lack of Efficacy|3
202818|NCT01105533|641899|P3|Overall Study|Lack of Efficacy|3
202819|NCT01105533|641900|P2|Overall Study|Lack of Efficacy|1
202820|NCT01105533|641901|P1|Overall Study|Lack of Efficacy|1
202821|NCT01105533|641893|P9|Overall Study|Death|0
202822|NCT01105533|641894|P8|Overall Study|Death|0
202823|NCT01105533|641895|P7|Overall Study|Death|0
202824|NCT01105533|641896|P6|Overall Study|Death|0
202825|NCT01105533|641897|P5|Overall Study|Death|1
202826|NCT01105533|641898|P4|Overall Study|Death|0
202827|NCT01105533|641899|P3|Overall Study|Death|0
202828|NCT01105533|641900|P2|Overall Study|Death|0
202829|NCT01105533|641901|P1|Overall Study|Death|0
202830|NCT01105767|642033|P3|Overall Study|Lost to Follow-up|1184
202831|NCT01105767|642034|P2|Overall Study|Lost to Follow-up|1614
202832|NCT01105767|642035|P1|Overall Study|Lost to Follow-up|1160
202833|NCT01105936|642046|P4|Period 3|Protocol Violation|0
202834|NCT01105936|642047|P3|Period 3|Protocol Violation|0
202835|NCT01105936|642048|P2|Period 3|Protocol Violation|2
202836|NCT01105936|642049|P1|Period 3|Protocol Violation|0
202837|NCT01105936|642046|P4|Period 2|Adverse Event|0
202838|NCT01105936|642047|P3|Period 2|Adverse Event|0
202839|NCT01105936|642048|P2|Period 2|Adverse Event|0
202840|NCT01105936|642049|P1|Period 2|Adverse Event|1
202841|NCT01105936|642046|P4|Period 1|Adverse Event|1
202842|NCT01105936|642047|P3|Period 1|Adverse Event|0
202843|NCT01105936|642048|P2|Period 1|Adverse Event|0
202844|NCT01105936|642049|P1|Period 1|Adverse Event|0
202845|NCT01106014|642077|P2|Overall Study|Lost to Follow-up|3
202846|NCT01106014|642078|P1|Overall Study|Lost to Follow-up|2
202847|NCT01106014|642077|P2|Overall Study|Administrative reason|6
202848|NCT01106014|642078|P1|Overall Study|Administrative reason|7
202849|NCT01106014|642077|P2|Overall Study|Withdrawal by Subject|37
202850|NCT01106014|642078|P1|Overall Study|Withdrawal by Subject|43
202851|NCT01106014|642077|P2|Overall Study|Adverse Event|42
202852|NCT01106014|642078|P1|Overall Study|Adverse Event|78
202853|NCT01106014|642077|P2|Overall Study|Morbidity or Mortality primary endpoint|242
202854|NCT01106014|642078|P1|Overall Study|Morbidity or Mortality primary endpoint|155
202855|NCT01106092|642097|P4|Overall Study|Withdrawal by Subject|1
202856|NCT01106092|642098|P3|Overall Study|Withdrawal by Subject|0
202857|NCT01106092|642099|P2|Overall Study|Withdrawal by Subject|0
202858|NCT01106092|642100|P1|Overall Study|Withdrawal by Subject|0
202859|NCT01106157|642180|P2|Overall Study|Withdrawal by Subject|0
202860|NCT01106157|642181|P1|Overall Study|Withdrawal by Subject|1
202861|NCT01106248|642205|P1|Overall Study|Administrative|2
202862|NCT01106248|642205|P1|Overall Study|Adverse Event|1
202863|NCT01106287|642215|P4|Overall Study|Adverse Event|0
202864|NCT01106287|642216|P3|Overall Study|Adverse Event|0
202865|NCT01106287|642217|P2|Overall Study|Adverse Event|0
202866|NCT01106287|642218|P1|Overall Study|Adverse Event|1
202867|NCT01106352|642249|P5|Overall Study|Home hospice since July 2013|0
202868|NCT01106352|642250|P4|Overall Study|Home hospice since July 2013|1
202869|NCT01106352|642251|P3|Overall Study|Home hospice since July 2013|0
202870|NCT01106352|642252|P2|Overall Study|Home hospice since July 2013|0
202871|NCT01106352|642253|P1|Overall Study|Home hospice since July 2013|0
202872|NCT01106352|642249|P5|Overall Study|Subject entered hospice|0
202873|NCT01106352|642250|P4|Overall Study|Subject entered hospice|1
202874|NCT01106352|642251|P3|Overall Study|Subject entered hospice|0
202875|NCT01106352|642252|P2|Overall Study|Subject entered hospice|0
202876|NCT01106352|642253|P1|Overall Study|Subject entered hospice|0
202877|NCT01106352|642249|P5|Overall Study|Went on hospice|0
202878|NCT01106352|642250|P4|Overall Study|Went on hospice|1
202879|NCT01106352|642251|P3|Overall Study|Went on hospice|0
202880|NCT01106352|642252|P2|Overall Study|Went on hospice|0
202881|NCT01106352|642253|P1|Overall Study|Went on hospice|0
202882|NCT01106352|642249|P5|Overall Study|Withdrawal by Subject|2
202883|NCT01106352|642250|P4|Overall Study|Withdrawal by Subject|3
202884|NCT01106352|642251|P3|Overall Study|Withdrawal by Subject|0
202885|NCT01106352|642252|P2|Overall Study|Withdrawal by Subject|0
202886|NCT01106352|642253|P1|Overall Study|Withdrawal by Subject|0
202887|NCT01106352|642249|P5|Overall Study|Disease progression|0
202888|NCT01106352|642250|P4|Overall Study|Disease progression|1
202889|NCT01106352|642251|P3|Overall Study|Disease progression|0
202890|NCT01106352|642252|P2|Overall Study|Disease progression|0
202891|NCT01106352|642253|P1|Overall Study|Disease progression|0
202892|NCT01106352|642249|P5|Overall Study|Death|1
202893|NCT01106352|642250|P4|Overall Study|Death|3
202894|NCT01106352|642251|P3|Overall Study|Death|1
202895|NCT01106352|642252|P2|Overall Study|Death|0
202896|NCT01106352|642253|P1|Overall Study|Death|0
202897|NCT01106352|642249|P5|Overall Study|Lost to Follow-up|1
202898|NCT01106352|642250|P4|Overall Study|Lost to Follow-up|0
202899|NCT01106352|642251|P3|Overall Study|Lost to Follow-up|0
202900|NCT01106352|642252|P2|Overall Study|Lost to Follow-up|0
202901|NCT01106352|642253|P1|Overall Study|Lost to Follow-up|0
202902|NCT01106352|642249|P5|Overall Study|Too ill to come in for the visit|0
202903|NCT01106352|642250|P4|Overall Study|Too ill to come in for the visit|0
202904|NCT01106352|642251|P3|Overall Study|Too ill to come in for the visit|1
202905|NCT01106352|642252|P2|Overall Study|Too ill to come in for the visit|0
202906|NCT01106352|642253|P1|Overall Study|Too ill to come in for the visit|0
202907|NCT01106352|642249|P5|Overall Study|Sponsor Decision|0
202908|NCT01106352|642250|P4|Overall Study|Sponsor Decision|0
202909|NCT01106352|642251|P3|Overall Study|Sponsor Decision|0
202910|NCT01106352|642252|P2|Overall Study|Sponsor Decision|0
202911|NCT01106352|642253|P1|Overall Study|Sponsor Decision|1
202912|NCT01106352|642249|P5|Overall Study|Subjects untreated|4
202913|NCT01106352|642250|P4|Overall Study|Subjects untreated|3
202914|NCT01106352|642251|P3|Overall Study|Subjects untreated|0
202915|NCT01106352|642252|P2|Overall Study|Subjects untreated|0
202916|NCT01106352|642253|P1|Overall Study|Subjects untreated|0
202917|NCT01106404|642346|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
202918|NCT01106404|642347|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
202919|NCT01106404|642346|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
202920|NCT01106404|642347|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
202921|NCT01106404|642346|P2|Period I (First 6 Weeks)|Physician Decision|0
202922|NCT01106404|642347|P1|Period I (First 6 Weeks)|Physician Decision|1
202923|NCT01106404|642346|P2|Period I (First 6 Weeks)|Adverse Event|0
202924|NCT01106404|642347|P1|Period I (First 6 Weeks)|Adverse Event|2
202925|NCT01106430|642362|P2|Overall Study|Withdrawal by Subject|4
202926|NCT01106430|642363|P1|Overall Study|Withdrawal by Subject|8
202927|NCT01106430|642362|P2|Overall Study|Protocol Violation|2
202928|NCT01106430|642363|P1|Overall Study|Protocol Violation|7
202929|NCT01106430|642362|P2|Overall Study|Previous Use Of Marijuana|0
202930|NCT01106430|642363|P1|Overall Study|Previous Use Of Marijuana|1
202931|NCT01106430|642362|P2|Overall Study|Hard Time Swallowing The Pills|0
202932|NCT01106430|642363|P1|Overall Study|Hard Time Swallowing The Pills|1
202933|NCT01106430|642362|P2|Overall Study|Noncompliance|1
202934|NCT01106430|642363|P1|Overall Study|Noncompliance|0
202935|NCT01106430|642362|P2|Overall Study|Refused To Take Medication|1
202936|NCT01106430|642363|P1|Overall Study|Refused To Take Medication|0
202937|NCT01106430|642362|P2|Overall Study|Moved Out Of State|1
202938|NCT01106430|642363|P1|Overall Study|Moved Out Of State|0
202939|NCT01106430|642362|P2|Overall Study|Early Termination Requested By Sponsor|0
202940|NCT01106430|642363|P1|Overall Study|Early Termination Requested By Sponsor|1
202941|NCT01106430|642362|P2|Overall Study|Lost to Follow-up|1
202942|NCT01106430|642363|P1|Overall Study|Lost to Follow-up|5
202943|NCT01106430|642362|P2|Overall Study|Lack of Efficacy|13
202944|NCT01106430|642363|P1|Overall Study|Lack of Efficacy|2
202945|NCT01106430|642362|P2|Overall Study|Adverse Event|10
202946|NCT01106430|642363|P1|Overall Study|Adverse Event|8
202947|NCT01106534|642392|P1|Overall Study|Physician Decision|1
202948|NCT01106534|642392|P1|Overall Study|Death|16
202949|NCT01106534|642392|P1|Overall Study|Lost to Follow-up|2
202950|NCT01106534|642392|P1|Overall Study|Withdrawal by Subject|18
202951|NCT01106586|642415|P2|Overall Study|Participant Transferred to Another Study|197
202952|NCT01106586|642416|P1|Overall Study|Participant Transferred to Another Study|212
202953|NCT01106586|642415|P2|Overall Study|Protocol Violation|0
202954|NCT01106586|642416|P1|Overall Study|Protocol Violation|1
202955|NCT01106586|642415|P2|Overall Study|Participant Noncompliance|10
202956|NCT01106586|642416|P1|Overall Study|Participant Noncompliance|12
202957|NCT01106586|642415|P2|Overall Study|Lost to Follow-up|20
202958|NCT01106586|642416|P1|Overall Study|Lost to Follow-up|24
202959|NCT01106586|642415|P2|Overall Study|Withdrew Consent|30
202960|NCT01106586|642416|P1|Overall Study|Withdrew Consent|18
202961|NCT01106586|642415|P2|Overall Study|Investigator's Discretion|8
202962|NCT01106586|642416|P1|Overall Study|Investigator's Discretion|5
202963|NCT01106586|642415|P2|Overall Study|Lack of Efficacy|0
202964|NCT01106586|642416|P1|Overall Study|Lack of Efficacy|1
202965|NCT01106586|642415|P2|Overall Study|Pregnancy|2
202966|NCT01106586|642416|P1|Overall Study|Pregnancy|2
202967|NCT01106586|642415|P2|Overall Study|Death|3
202968|NCT01106586|642416|P1|Overall Study|Death|1
202969|NCT01106586|642415|P2|Overall Study|Adverse Event|15
202970|NCT01106586|642416|P1|Overall Study|Adverse Event|9
202971|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Not specified|4
202972|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Not specified|5
202973|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Not specified|5
202974|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
202975|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
202976|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
202977|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
202978|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
202979|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
202980|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
202981|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
202982|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
202983|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
202984|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
202985|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
202986|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
202987|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
202988|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
202989|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
202990|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
202991|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
202992|NCT01106625|642437|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
202993|NCT01106625|642438|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
202994|NCT01106625|642439|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
202995|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Not specified|4
202996|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Not specified|7
202997|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Not specified|8
202998|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
202999|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
203000|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
203001|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
203002|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
203003|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
203004|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
203005|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
203006|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
203007|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
203008|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
203009|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
203010|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Protocol Violation|3
203011|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Protocol Violation|1
203012|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Protocol Violation|2
203013|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Physician Decision|0
203014|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Physician Decision|0
203015|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Physician Decision|1
203016|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
203017|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
203018|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
203019|NCT01106625|642437|P3|Core Period: Baseline to Week 26|Adverse Event|8
203020|NCT01106625|642438|P2|Core Period: Baseline to Week 26|Adverse Event|8
203021|NCT01106625|642439|P1|Core Period: Baseline to Week 26|Adverse Event|6
203022|NCT01106651|642471|P3|Overall Study|Death|0
203023|NCT01106651|642472|P2|Overall Study|Death|3
203024|NCT01106651|642473|P1|Overall Study|Death|0
203025|NCT01106651|642471|P3|Overall Study|Not specified|21
203026|NCT01106651|642472|P2|Overall Study|Not specified|31
203027|NCT01106651|642473|P1|Overall Study|Not specified|34
203028|NCT01106651|642471|P3|Overall Study|Noncompliance with study drug|2
203029|NCT01106651|642472|P2|Overall Study|Noncompliance with study drug|0
203030|NCT01106651|642473|P1|Overall Study|Noncompliance with study drug|1
203031|NCT01106651|642471|P3|Overall Study|Withdrawal by Subject|4
203032|NCT01106651|642472|P2|Overall Study|Withdrawal by Subject|7
203033|NCT01106651|642473|P1|Overall Study|Withdrawal by Subject|14
203034|NCT01106651|642471|P3|Overall Study|Protocol Violation|1
203035|NCT01106651|642472|P2|Overall Study|Protocol Violation|2
203036|NCT01106651|642473|P1|Overall Study|Protocol Violation|1
203037|NCT01106651|642471|P3|Overall Study|Physician Decision|1
203038|NCT01106651|642472|P2|Overall Study|Physician Decision|3
203039|NCT01106651|642473|P1|Overall Study|Physician Decision|4
203040|NCT01106651|642471|P3|Overall Study|Lost to Follow-up|6
203041|NCT01106651|642472|P2|Overall Study|Lost to Follow-up|2
203042|NCT01106651|642473|P1|Overall Study|Lost to Follow-up|8
203043|NCT01106651|642471|P3|Overall Study|Adverse Event|23
203044|NCT01106651|642472|P2|Overall Study|Adverse Event|9
203045|NCT01106651|642473|P1|Overall Study|Adverse Event|17
203046|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Not specified|5
203047|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Not specified|8
203048|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Not specified|5
203049|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Not specified|6
203050|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
203051|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
203052|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
203053|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
203054|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
203055|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
203056|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
203057|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
203058|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
203059|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
203060|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
203061|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
203062|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
203063|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
203064|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
203065|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
203066|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
203067|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
203068|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
203069|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
203070|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
203071|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
203072|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
203073|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
203074|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
203075|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
203076|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
203077|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
203078|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Death|1
203079|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Death|0
203080|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Death|0
203081|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Death|0
203082|NCT01106677|642527|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
203083|NCT01106677|642528|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
203084|NCT01106677|642529|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
203085|NCT01106677|642530|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
203086|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Pregnancy|0
203087|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Pregnancy|0
203088|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Pregnancy|1
203089|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Pregnancy|0
203090|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Not specified|23
203091|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Not specified|8
203092|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Not specified|14
203093|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Not specified|8
203094|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Product quality complaint|0
203095|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Product quality complaint|1
203096|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Product quality complaint|1
203097|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Product quality complaint|0
203098|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
203099|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
203100|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
203101|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
203102|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
203103|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
203104|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
203105|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
203106|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
203107|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
203108|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
203109|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
203110|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
203111|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
203112|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
203113|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
203114|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Protocol Violation|3
203115|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Protocol Violation|0
203116|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Protocol Violation|1
203117|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Protocol Violation|0
203118|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Physician Decision|1
203119|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Physician Decision|3
203120|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Physician Decision|1
203121|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Physician Decision|2
203122|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
203123|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
203124|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
203125|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
203126|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
203127|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
203128|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
203129|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
203130|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Death|0
203131|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Death|1
203132|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Death|0
203133|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Death|0
203134|NCT01106677|642527|P4|Core Period: Baseline to Week 26|Adverse Event|8
203135|NCT01106677|642528|P3|Core Period: Baseline to Week 26|Adverse Event|6
203136|NCT01106677|642529|P2|Core Period: Baseline to Week 26|Adverse Event|18
203137|NCT01106677|642530|P1|Core Period: Baseline to Week 26|Adverse Event|7
203138|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
203139|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
203140|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
203141|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Not specified|4
203142|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Not specified|3
203143|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Not specified|8
203144|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
203145|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
203146|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
203147|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
203148|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
203149|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
203150|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
203151|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
203152|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
203153|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
203154|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
203155|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
203156|NCT01106690|642593|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
203157|NCT01106690|642594|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
203158|NCT01106690|642595|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
203159|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Not specified|6
203160|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Not specified|2
203161|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Not specified|10
203162|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
203163|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
203164|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
203165|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
203166|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
203167|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
203168|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
203169|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
203170|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
203171|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
203172|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
203173|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
203174|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
203175|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
203176|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
203177|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Protocol Violation|0
203178|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Protocol Violation|0
203179|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Protocol Violation|1
203180|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
203181|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
203182|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
203183|NCT01106690|642593|P3|Core Period: Baseline to Week 26|Adverse Event|4
203184|NCT01106690|642594|P2|Core Period: Baseline to Week 26|Adverse Event|1
203185|NCT01106690|642595|P1|Core Period: Baseline to Week 26|Adverse Event|6
203186|NCT01106846|642629|P2|Overall Study|Change in surgical procedure|1
203187|NCT01106846|642630|P1|Overall Study|Change in surgical procedure|0
203188|NCT01106911|642675|P1|Overall Study|deemed ineligible after screening|3
203189|NCT01106911|642675|P1|Overall Study|Physician Decision|2
203190|NCT01106976|642689|P1|Overall Study|Lost to Follow-up|8
203191|NCT01101308|642693|P2|Period 1|Positive for cotinine|0
203192|NCT01101308|642694|P1|Period 1|Positive for cotinine|1
203193|NCT01101308|642693|P2|Period 1|Adverse Event|1
203194|NCT01101308|642694|P1|Period 1|Adverse Event|2
203195|NCT01101321|642705|P2|Period 1|Adverse Event|3
203196|NCT01101321|642706|P1|Period 1|Adverse Event|3
203197|NCT01101321|642705|P2|Period 1|Withdrawal by Subject|1
203198|NCT01101321|642706|P1|Period 1|Withdrawal by Subject|1
203199|NCT01101477|642732|P3|Overall Study|Protocol Violation|1
203200|NCT01101477|642733|P2|Overall Study|Protocol Violation|3
203201|NCT01101477|642734|P1|Overall Study|Protocol Violation|5
203202|NCT01101542|642742|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
203203|NCT01101542|642742|P1|Year 6 Surveillance Period|Pregnancy|1
203204|NCT01101542|642742|P1|Year 6 Surveillance Period|Lost to Follow-up|986
203205|NCT01101542|642742|P1|Year 5 Surveillance Period|Pregnancy|1
203206|NCT01101542|642742|P1|Year 5 Surveillance Period|Lost to Follow-up|140
203207|NCT01101542|642742|P1|Year 4 Surveillance Period|Unspecified|287
203208|NCT01101542|642742|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
203209|NCT01101542|642742|P1|Year 3 Surveillance Period|Lost to Follow-up|7
203210|NCT01107197|642760|P2|Overall Study|Withdrawal by Subject|5
203211|NCT01107197|642761|P1|Overall Study|Withdrawal by Subject|3
203212|NCT01107197|642760|P2|Overall Study|Lost to Follow-up|8
203213|NCT01107197|642761|P1|Overall Study|Lost to Follow-up|5
203214|NCT01107197|642760|P2|Overall Study|Death|10
203215|NCT01107197|642761|P1|Overall Study|Death|12
203216|NCT01107353|642781|P2|Overall Study|Positive Drug Screen|0
203217|NCT01107353|642782|P1|Overall Study|Positive Drug Screen|1
203218|NCT01107379|642788|P1|Overall Study|Lost to Follow-up|3
203219|NCT01107379|642788|P1|Overall Study|Withdrawal by Subject|18
203220|NCT01107392|642799|P2|Overall Study|Administrative decision|0
203221|NCT01107392|642800|P1|Overall Study|Administrative decision|1
203222|NCT01107392|642799|P2|Overall Study|Personal Reasons|3
203223|NCT01107392|642800|P1|Overall Study|Personal Reasons|2
203224|NCT01107392|642799|P2|Overall Study|Adverse Event|0
203225|NCT01107392|642800|P1|Overall Study|Adverse Event|2
203226|NCT01107405|642817|P5|Overall Study|Protocol Violation|0
203227|NCT01107405|642818|P4|Overall Study|Protocol Violation|1
203228|NCT01107405|642819|P3|Overall Study|Protocol Violation|1
203229|NCT01107405|642820|P2|Overall Study|Protocol Violation|0
203230|NCT01107405|642821|P1|Overall Study|Protocol Violation|0
203231|NCT01107405|642817|P5|Overall Study|Withdrawal by Subject|1
203232|NCT01107405|642818|P4|Overall Study|Withdrawal by Subject|2
203233|NCT01107405|642819|P3|Overall Study|Withdrawal by Subject|1
203234|NCT01107405|642820|P2|Overall Study|Withdrawal by Subject|0
203235|NCT01107405|642821|P1|Overall Study|Withdrawal by Subject|1
203236|NCT01107405|642817|P5|Overall Study|Adverse Event|2
203237|NCT01107405|642818|P4|Overall Study|Adverse Event|0
203238|NCT01107405|642819|P3|Overall Study|Adverse Event|0
203239|NCT01107405|642820|P2|Overall Study|Adverse Event|1
203240|NCT01107405|642821|P1|Overall Study|Adverse Event|1
203241|NCT01107418|642862|P1|Overall Study|Entered Extension Study|1
203242|NCT01107418|642862|P1|Overall Study|Started Other Therapy|1
203243|NCT01107418|642862|P1|Overall Study|Study Closing|1
203244|NCT01107418|642862|P1|Overall Study|Withdrawal by Subject|1
203245|NCT01107418|642862|P1|Overall Study|Adverse Event|3
203246|NCT01107418|642862|P1|Overall Study|Disease Progression|45
203247|NCT01107743|642943|P1|Overall Study|Protocol Violation|46
203248|NCT01107886|643050|P2|Overall Study|Administrative withdrawal of consent|5
203249|NCT01107886|643051|P1|Overall Study|Administrative withdrawal of consent|7
203250|NCT01107886|643050|P2|Overall Study|Withdrawal by Subject|196
203251|NCT01107886|643051|P1|Overall Study|Withdrawal by Subject|180
203252|NCT01107886|643050|P2|Overall Study|Lost to Follow-up|13
203253|NCT01107886|643051|P1|Overall Study|Lost to Follow-up|15
203254|NCT01107899|643064|P3|Overall Study|Withdrawal by Subject|1
203255|NCT01107899|643065|P2|Overall Study|Withdrawal by Subject|0
203256|NCT01107899|643066|P1|Overall Study|Withdrawal by Subject|0
203257|NCT01107899|643064|P3|Overall Study|Physician Decision|3
203258|NCT01107899|643065|P2|Overall Study|Physician Decision|0
203259|NCT01107899|643066|P1|Overall Study|Physician Decision|5
203260|NCT01107912|643114|P6|Period 3|Withdrawal by Subject|0
203261|NCT01107912|643115|P5|Period 3|Withdrawal by Subject|0
203262|NCT01107912|643116|P4|Period 3|Withdrawal by Subject|1
203263|NCT01107912|643117|P3|Period 3|Withdrawal by Subject|0
203264|NCT01107912|643118|P2|Period 3|Withdrawal by Subject|0
203265|NCT01107912|643119|P1|Period 3|Withdrawal by Subject|0
203266|NCT01107912|643114|P6|Period 3|Adverse Event|0
203267|NCT01107912|643115|P5|Period 3|Adverse Event|0
203268|NCT01107912|643116|P4|Period 3|Adverse Event|0
203269|NCT01107912|643117|P3|Period 3|Adverse Event|1
203270|NCT01107912|643118|P2|Period 3|Adverse Event|1
203271|NCT01107912|643119|P1|Period 3|Adverse Event|0
203272|NCT01107912|643114|P6|Period 2|Physician Decision|0
203273|NCT01107912|643115|P5|Period 2|Physician Decision|0
203274|NCT01107912|643116|P4|Period 2|Physician Decision|0
203275|NCT01107912|643117|P3|Period 2|Physician Decision|1
203276|NCT01107912|643118|P2|Period 2|Physician Decision|0
203277|NCT01107912|643119|P1|Period 2|Physician Decision|0
203278|NCT01107912|643114|P6|Period 1|Withdrawal by Subject|0
203279|NCT01107912|643115|P5|Period 1|Withdrawal by Subject|0
203280|NCT01107912|643116|P4|Period 1|Withdrawal by Subject|0
203281|NCT01107912|643117|P3|Period 1|Withdrawal by Subject|0
203282|NCT01107912|643118|P2|Period 1|Withdrawal by Subject|0
203283|NCT01107912|643119|P1|Period 1|Withdrawal by Subject|1
203284|NCT01107912|643114|P6|Period 1|Physician Decision|0
203285|NCT01107912|643115|P5|Period 1|Physician Decision|1
203286|NCT01107912|643116|P4|Period 1|Physician Decision|0
203287|NCT01107912|643117|P3|Period 1|Physician Decision|0
203288|NCT01107912|643118|P2|Period 1|Physician Decision|0
203289|NCT01107912|643119|P1|Period 1|Physician Decision|0
203290|NCT01107912|643114|P6|Period 1|Adverse Event|0
203291|NCT01107912|643115|P5|Period 1|Adverse Event|2
203292|NCT01107912|643116|P4|Period 1|Adverse Event|0
203293|NCT01107912|643117|P3|Period 1|Adverse Event|0
203294|NCT01107912|643118|P2|Period 1|Adverse Event|0
203295|NCT01107912|643119|P1|Period 1|Adverse Event|0
203296|NCT01107925|643157|P6|Period 2|Withdrawal by Subject|1
203297|NCT01107925|643158|P5|Period 2|Withdrawal by Subject|0
203298|NCT01107925|643159|P4|Period 2|Withdrawal by Subject|0
203299|NCT01107925|643160|P3|Period 2|Withdrawal by Subject|0
203300|NCT01107925|643161|P2|Period 2|Withdrawal by Subject|1
203301|NCT01107925|643162|P1|Period 2|Withdrawal by Subject|0
203302|NCT01107925|643157|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
203303|NCT01107925|643158|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
203304|NCT01107925|643159|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
203305|NCT01107925|643160|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
203306|NCT01107925|643161|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
203307|NCT01107925|643162|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
203308|NCT01108055|643207|P1|Overall Study|Not evaluable- didn't complete treatment|4
203309|NCT01108055|643207|P1|Overall Study|Ineligible|11
203310|NCT01108185|643236|P1|Overall Study|Lost to Follow-up|12
203311|NCT01108185|643236|P1|Overall Study|Non-compliance|15
203312|NCT01108237|643251|P2|Overall Study|Did not meet criteria for analysis|0
203313|NCT01108237|643252|P1|Overall Study|Did not meet criteria for analysis|7
203314|NCT01108237|643251|P2|Overall Study|No alignment data|17
203315|NCT01108237|643252|P1|Overall Study|No alignment data|2
203316|NCT01108263|643260|P2|Overall Study|Adverse Event|1
203317|NCT01108263|643261|P1|Overall Study|Adverse Event|0
203318|NCT01108341|643269|P1|Overall Study|not specified|1
203319|NCT01108341|643269|P1|Overall Study|Lost to Follow-up|1
203320|NCT01108341|643269|P1|Overall Study|Withdrawal by Subject|1
203321|NCT01108341|643269|P1|Overall Study|Death|2
203322|NCT01108458|643317|P1|Overall Study|Withdrawal by Subject|1
203323|NCT01108510|643328|P2|Overall Study|Death|1
203324|NCT01108510|643329|P1|Overall Study|Death|1
203325|NCT01108510|643328|P2|Overall Study|Pregnancy|3
203326|NCT01108510|643329|P1|Overall Study|Pregnancy|0
203327|NCT01108510|643328|P2|Overall Study|Lack of Efficacy|0
203328|NCT01108510|643329|P1|Overall Study|Lack of Efficacy|3
203329|NCT01108510|643328|P2|Overall Study|Participant Noncompliance|7
203330|NCT01108510|643329|P1|Overall Study|Participant Noncompliance|5
203331|NCT01108510|643328|P2|Overall Study|Investigator’s Discretion|10
203332|NCT01108510|643329|P1|Overall Study|Investigator’s Discretion|12
203333|NCT01108510|643328|P2|Overall Study|Withdrew Consent|15
203334|NCT01108510|643329|P1|Overall Study|Withdrew Consent|21
203335|NCT01108510|643328|P2|Overall Study|Lost to Follow-up|17
203336|NCT01108510|643329|P1|Overall Study|Lost to Follow-up|20
203337|NCT01108510|643328|P2|Overall Study|Adverse Event|19
203338|NCT01108510|643329|P1|Overall Study|Adverse Event|26
203339|NCT01108510|643328|P2|Overall Study|Joined Another Gilead-sponsored Study|195
203340|NCT01108510|643329|P1|Overall Study|Joined Another Gilead-sponsored Study|186
203341|NCT01108510|643328|P2|Overall Study|Randomized but Not Treated|1
203342|NCT01108510|643329|P1|Overall Study|Randomized but Not Treated|5
203343|NCT01108523|643349|P1|Overall Study|Protocol Violation|4
203344|NCT01108718|643356|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
203345|NCT01108718|643357|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
203346|NCT01108731|643364|P2|Overall Study|Adverse Event|3
203347|NCT01108731|643365|P1|Overall Study|Adverse Event|3
203348|NCT01108731|643364|P2|Overall Study|Withdrawal by Subject|1
203349|NCT01108731|643365|P1|Overall Study|Withdrawal by Subject|1
203350|NCT01108796|643379|P2|Overall Study|Lost to Follow-up|6
203351|NCT01108796|643380|P1|Overall Study|Lost to Follow-up|7
203352|NCT01108796|643379|P2|Overall Study|Adverse Event|1
203353|NCT01108796|643380|P1|Overall Study|Adverse Event|0
203354|NCT01108809|643412|P1|Overall Study|Lost to Follow-up|1
203355|NCT01108809|643412|P1|Overall Study|Adverse Event|3
203356|NCT01109173|643481|P4|Overall Study|Not Specifiied|14
203357|NCT01109173|643482|P3|Overall Study|Not Specifiied|9
203358|NCT01109173|643483|P2|Overall Study|Not Specifiied|4
203359|NCT01109173|643484|P1|Overall Study|Not Specifiied|5
203360|NCT01109173|643481|P4|Overall Study|Patient Did Not Use Study Medication|7
203361|NCT01109173|643482|P3|Overall Study|Patient Did Not Use Study Medication|11
203362|NCT01109173|643483|P2|Overall Study|Patient Did Not Use Study Medication|26
203363|NCT01109173|643484|P1|Overall Study|Patient Did Not Use Study Medication|34
203364|NCT01109173|643481|P4|Overall Study|Protocol Violation|2
203365|NCT01109173|643482|P3|Overall Study|Protocol Violation|1
203366|NCT01109173|643483|P2|Overall Study|Protocol Violation|5
203367|NCT01109173|643484|P1|Overall Study|Protocol Violation|4
203368|NCT01109173|643481|P4|Overall Study|Treatment Failure|64
203369|NCT01109173|643482|P3|Overall Study|Treatment Failure|69
203370|NCT01109173|643483|P2|Overall Study|Treatment Failure|32
203371|NCT01109173|643484|P1|Overall Study|Treatment Failure|25
203372|NCT01109173|643481|P4|Overall Study|Noncompliance|0
203373|NCT01109173|643482|P3|Overall Study|Noncompliance|0
203374|NCT01109173|643483|P2|Overall Study|Noncompliance|1
203375|NCT01109173|643484|P1|Overall Study|Noncompliance|0
203376|NCT01109173|643481|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
203377|NCT01109173|643482|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
203378|NCT01109173|643483|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
203379|NCT01109173|643484|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
203380|NCT01109173|643481|P4|Overall Study|Lost to Follow-up|0
203381|NCT01109173|643482|P3|Overall Study|Lost to Follow-up|0
203382|NCT01109173|643483|P2|Overall Study|Lost to Follow-up|1
203383|NCT01109173|643484|P1|Overall Study|Lost to Follow-up|0
203384|NCT01109173|643481|P4|Overall Study|Adverse Event|6
203385|NCT01109173|643482|P3|Overall Study|Adverse Event|9
203386|NCT01109173|643483|P2|Overall Study|Adverse Event|17
203387|NCT01109173|643484|P1|Overall Study|Adverse Event|15
203388|NCT01109316|643504|P3|Study Period 3|Withdrawal by Subject|1
203389|NCT01109316|643505|P2|Study Period 3|Withdrawal by Subject|1
203390|NCT01109316|643506|P1|Study Period 3|Withdrawal by Subject|0
203391|NCT01109316|643504|P3|Study Period 3|Lost to Follow-up|0
203392|NCT01109316|643505|P2|Study Period 3|Lost to Follow-up|1
203393|NCT01109316|643506|P1|Study Period 3|Lost to Follow-up|0
203394|NCT01109316|643504|P3|Study Period 2|Withdrawal by Subject|0
203395|NCT01109316|643505|P2|Study Period 2|Withdrawal by Subject|1
203396|NCT01109316|643506|P1|Study Period 2|Withdrawal by Subject|1
203397|NCT01109316|643504|P3|Study Period 2|Protocol Violation|0
203398|NCT01109316|643505|P2|Study Period 2|Protocol Violation|1
203399|NCT01109316|643506|P1|Study Period 2|Protocol Violation|0
203400|NCT01109316|643504|P3|Study Period 2|Physician Decision|1
203401|NCT01109316|643505|P2|Study Period 2|Physician Decision|0
203402|NCT01109316|643506|P1|Study Period 2|Physician Decision|0
203403|NCT01109316|643504|P3|Study Period 2|Entry Criteria Not Met|1
203404|NCT01109316|643505|P2|Study Period 2|Entry Criteria Not Met|0
203405|NCT01109316|643506|P1|Study Period 2|Entry Criteria Not Met|0
203406|NCT01109316|643504|P3|Study Period 1|Sponsor Decision|2
203407|NCT01109316|643505|P2|Study Period 1|Sponsor Decision|0
203408|NCT01109316|643506|P1|Study Period 1|Sponsor Decision|0
203409|NCT01109316|643504|P3|Study Period 1|Withdrawal by Subject|2
203410|NCT01109316|643505|P2|Study Period 1|Withdrawal by Subject|1
203411|NCT01109316|643506|P1|Study Period 1|Withdrawal by Subject|0
203412|NCT01109316|643504|P3|Study Period 1|Lost to Follow-up|0
203413|NCT01109316|643505|P2|Study Period 1|Lost to Follow-up|2
203414|NCT01109316|643506|P1|Study Period 1|Lost to Follow-up|0
203415|NCT01109316|643504|P3|Study Period 1|Adverse Event|0
203416|NCT01109316|643505|P2|Study Period 1|Adverse Event|1
203417|NCT01109316|643506|P1|Study Period 1|Adverse Event|0
203418|NCT01109524|643556|P1|Overall Study|Not specified|5
203419|NCT01109524|643556|P1|Overall Study|Participant requested to end treatment|4
203420|NCT01109524|643556|P1|Overall Study|No longer meets criteria|2
203421|NCT01109524|643556|P1|Overall Study|Death|2
203422|NCT01109524|643556|P1|Overall Study|Maximum clinical benefit|3
203423|NCT01109524|643556|P1|Overall Study|Withdrawal by Subject|2
203424|NCT01109524|643556|P1|Overall Study|Adverse Event|4
203425|NCT01109524|643556|P1|Overall Study|Study Drug toxicity|6
203426|NCT01109524|643556|P1|Overall Study|Disease Progression|29
203427|NCT01109849|643588|P5|Adaptive Randomization: Weight Recovery|moved away|0
203428|NCT01109849|643589|P4|Adaptive Randomization: Weight Recovery|moved away|2
203429|NCT01109849|643590|P3|Adaptive Randomization: Weight Recovery|moved away|0
203430|NCT01109849|643591|P2|Adaptive Randomization: Weight Recovery|moved away|0
203431|NCT01109849|643592|P1|Adaptive Randomization: Weight Recovery|moved away|0
203432|NCT01109849|643588|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
203433|NCT01109849|643589|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
203434|NCT01109849|643590|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
203435|NCT01109849|643591|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
203436|NCT01109849|643592|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
203437|NCT01109849|643588|P5|Initial Randomization: ADHD Treatment|move away|0
203438|NCT01109849|643589|P4|Initial Randomization: ADHD Treatment|move away|0
203439|NCT01109849|643590|P3|Initial Randomization: ADHD Treatment|move away|0
203440|NCT01109849|643591|P2|Initial Randomization: ADHD Treatment|move away|7
203441|NCT01109849|643592|P1|Initial Randomization: ADHD Treatment|move away|2
203442|NCT01109849|643588|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
203443|NCT01109849|643589|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
203444|NCT01109849|643590|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
203445|NCT01109849|643591|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
203446|NCT01109849|643592|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
203447|NCT01109849|643588|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
203448|NCT01109849|643589|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
203449|NCT01109849|643590|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
203450|NCT01109849|643591|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
203451|NCT01109849|643592|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
203452|NCT01109849|643588|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
203453|NCT01109849|643589|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
203454|NCT01109849|643590|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
203455|NCT01109849|643591|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
203456|NCT01109849|643592|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
203457|NCT01109979|643643|P2|Overall Study|Withdrawal by Subject|1
203458|NCT01109979|643644|P1|Overall Study|Withdrawal by Subject|0
203459|NCT01109979|643643|P2|Overall Study|Physician Decision|0
203460|NCT01109979|643644|P1|Overall Study|Physician Decision|2
203461|NCT01110005|643652|P2|Overall Study|Withdrawal by Subject|1
203462|NCT01110005|643653|P1|Overall Study|Withdrawal by Subject|0
203463|NCT01110005|643652|P2|Overall Study|missing consent|2
203464|NCT01110005|643653|P1|Overall Study|missing consent|3
203465|NCT01110005|643652|P2|Overall Study|ineligible|2
203466|NCT01110005|643653|P1|Overall Study|ineligible|1
203467|NCT01104376|643663|P1|Overall Study|Consented but excluded after labs|13
203468|NCT01104376|643663|P1|Overall Study|Withdrawal by Subject|15
203469|NCT01104493|643669|P2|Overall Study|Lost to Follow-up|2
203470|NCT01104493|643670|P1|Overall Study|Lost to Follow-up|0
203471|NCT01104558|643688|P1|Overall Study|Missing of genetic analysis results|1
203472|NCT01104558|643688|P1|Overall Study|Missing of primary efficacy assessment|10
203473|NCT01104558|643688|P1|Overall Study|Protocol Violation|6
203474|NCT01104584|643729|P1|Overall Study|Study prematurely discontinued|2
203475|NCT01104584|643729|P1|Overall Study|Study drug never administered|21
203476|NCT01110200|643816|P2|Overall Study|Lost to Follow-up|7
203477|NCT01110200|643817|P1|Overall Study|Lost to Follow-up|10
203478|NCT01110200|643816|P2|Overall Study|Physician Decision|17
203479|NCT01110200|643817|P1|Overall Study|Physician Decision|13
203480|NCT01110200|643816|P2|Overall Study|Protocol Violation|12
203481|NCT01110200|643817|P1|Overall Study|Protocol Violation|14
203482|NCT01110200|643816|P2|Overall Study|Lack of Efficacy|25
203483|NCT01110200|643817|P1|Overall Study|Lack of Efficacy|16
203484|NCT01110200|643816|P2|Overall Study|Withdrawal by Subject|32
203485|NCT01110200|643817|P1|Overall Study|Withdrawal by Subject|25
203486|NCT01110200|643816|P2|Overall Study|Adverse Event|28
203487|NCT01110200|643817|P1|Overall Study|Adverse Event|28
203488|NCT01110239|643835|P4|7.5 Min Ischemia|Withdrawal by Subject|0
203489|NCT01110239|643836|P3|7.5 Min Ischemia|Withdrawal by Subject|1
203490|NCT01110239|643837|P2|7.5 Min Ischemia|Withdrawal by Subject|0
203491|NCT01110239|643838|P1|7.5 Min Ischemia|Withdrawal by Subject|0
203492|NCT01110239|643835|P4|Sham Preconditioning|Withdrawal by Subject|0
203493|NCT01110239|643836|P3|Sham Preconditioning|Withdrawal by Subject|1
203494|NCT01110239|643837|P2|Sham Preconditioning|Withdrawal by Subject|0
203495|NCT01110239|643838|P1|Sham Preconditioning|Withdrawal by Subject|0
203496|NCT01110330|643868|P3|Overall Study|Not specified|1
203497|NCT01110330|643869|P2|Overall Study|Not specified|1
203498|NCT01110330|643870|P1|Overall Study|Not specified|1
203499|NCT01110330|643868|P3|Overall Study|Withdrawal by Subject|2
203500|NCT01110330|643869|P2|Overall Study|Withdrawal by Subject|6
203501|NCT01110330|643870|P1|Overall Study|Withdrawal by Subject|0
203502|NCT01110330|643868|P3|Overall Study|Protocol Violation|4
203503|NCT01110330|643869|P2|Overall Study|Protocol Violation|0
203504|NCT01110330|643870|P1|Overall Study|Protocol Violation|2
203505|NCT01110330|643868|P3|Overall Study|Physician Decision|0
203506|NCT01110330|643869|P2|Overall Study|Physician Decision|1
203507|NCT01110330|643870|P1|Overall Study|Physician Decision|0
203508|NCT01110330|643868|P3|Overall Study|Lost to Follow-up|15
203509|NCT01110330|643869|P2|Overall Study|Lost to Follow-up|10
203510|NCT01110330|643870|P1|Overall Study|Lost to Follow-up|9
203511|NCT01110330|643868|P3|Overall Study|Lack of Efficacy|1
203512|NCT01110330|643869|P2|Overall Study|Lack of Efficacy|1
203513|NCT01110330|643870|P1|Overall Study|Lack of Efficacy|3
203514|NCT01110330|643868|P3|Overall Study|Adverse Event|3
203515|NCT01110330|643869|P2|Overall Study|Adverse Event|4
203516|NCT01110330|643870|P1|Overall Study|Adverse Event|0
203517|NCT01110382|643883|P2|Overall Study|Protocol Violation|1
203518|NCT01110382|643884|P1|Overall Study|Protocol Violation|0
203519|NCT01110382|643883|P2|Overall Study|Withdrawal by Subject|1
203520|NCT01110382|643884|P1|Overall Study|Withdrawal by Subject|0
203521|NCT01110408|643904|P2|Overall Study|Protocol Violation|0
203522|NCT01110408|643905|P1|Overall Study|Protocol Violation|1
203523|NCT01111838|643944|P1|Overall Study|Other Complicating Disease|1
203524|NCT01111838|643944|P1|Overall Study|Clinical deterioration|1
203525|NCT01111838|643944|P1|Overall Study|Not Treated|3
203526|NCT01111838|643944|P1|Overall Study|Patient Ineligible|2
203527|NCT01111851|643950|P2|Overall Study|All planned PET scans were not obtained.|0
203528|NCT01111851|643951|P1|Overall Study|All planned PET scans were not obtained.|2
203529|NCT01112059|643965|P2|Overall Study|Withdrawal by Subject|0
203530|NCT01112059|643966|P1|Overall Study|Withdrawal by Subject|1
203531|NCT01112267|643993|P2|Overall Study|Participants not receive any study drug|2
203532|NCT01112267|643994|P1|Overall Study|Participants not receive any study drug|1
203533|NCT01112267|643993|P2|Overall Study|Participants not compliant|2
203534|NCT01112267|643994|P1|Overall Study|Participants not compliant|1
203535|NCT01112267|643993|P2|Overall Study|Protocol Violation|3
203536|NCT01112267|643994|P1|Overall Study|Protocol Violation|5
203537|NCT01112267|643993|P2|Overall Study|Withdrawal by Subject|5
203538|NCT01112267|643994|P1|Overall Study|Withdrawal by Subject|3
203539|NCT01112267|643993|P2|Overall Study|Adverse Event|6
203540|NCT01112267|643994|P1|Overall Study|Adverse Event|24
203541|NCT01112514|644012|P1|Overall Study|Lost to Follow-up|1
203542|NCT01112579|644018|P2|Overall Study|Death|2
203543|NCT01112579|644019|P1|Overall Study|Death|0
203544|NCT01112579|644018|P2|Overall Study|Missed Visit|1
203545|NCT01112579|644019|P1|Overall Study|Missed Visit|1
203546|NCT01112917|644098|P2|Overall Study|Unable to Convert Filter|0
203547|NCT01112917|644099|P1|Overall Study|Unable to Convert Filter|3
203548|NCT01112917|644098|P2|Overall Study|Withdrawal by Subject|3
203549|NCT01112917|644099|P1|Overall Study|Withdrawal by Subject|1
203550|NCT01112917|644098|P2|Overall Study|Lost to Follow-up|1
203551|NCT01112917|644099|P1|Overall Study|Lost to Follow-up|1
203552|NCT01112917|644098|P2|Overall Study|Death|11
203553|NCT01112917|644099|P1|Overall Study|Death|2
203554|NCT01113463|644129|P1|Overall Study|Physician Decision|5
203555|NCT01113541|644134|P1|Overall Study|Adverse Event|4
203556|NCT01113541|644134|P1|Overall Study|Study Terminated by Sponsor|7
203557|NCT01113541|644134|P1|Overall Study|Protocol Violation|1
203558|NCT01113541|644134|P1|Overall Study|Withdrawal by Subject|1
203559|NCT01113580|644169|P2|Overall Study|Protocol Violation|0
203560|NCT01113580|644170|P1|Overall Study|Protocol Violation|1
203561|NCT01113710|644201|P1|Overall Study|Subject Did Not Receive Neupro|3
203562|NCT01113710|644201|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
203563|NCT01113710|644201|P1|Overall Study|Lack of Patient's Compliance/Other|1
203564|NCT01113710|644201|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
203565|NCT01113710|644201|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
203566|NCT01113710|644201|P1|Overall Study|Compliance/Efficacy/AE/Other|1
203567|NCT01113710|644201|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
203568|NCT01113710|644201|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
203569|NCT01113710|644201|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
203570|NCT01113710|644201|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
203571|NCT01113710|644201|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
203572|NCT01113710|644201|P1|Overall Study|Lack of Efficacy/Adverse Event|3
203573|NCT01113710|644201|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
203574|NCT01113710|644201|P1|Overall Study|Lack of Efficacy/Other|4
203575|NCT01113710|644201|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
203576|NCT01113710|644201|P1|Overall Study|Adverse Event/Other|5
203577|NCT01113710|644201|P1|Overall Study|Other|7
203578|NCT01113710|644201|P1|Overall Study|Lack of Patient's Compliance|8
203579|NCT01113710|644201|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
203580|NCT01113710|644201|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
203581|NCT01113710|644201|P1|Overall Study|Lost to Follow-up|20
203582|NCT01113710|644201|P1|Overall Study|Withdrawal by Subject|28
203583|NCT01113710|644201|P1|Overall Study|No Information Available|40
203584|NCT01113710|644201|P1|Overall Study|Lack of Efficacy|41
203585|NCT01113710|644201|P1|Overall Study|Adverse Event|64
203586|NCT01113749|644225|P2|Overall Study|Lost to Follow-up|2
203587|NCT01113749|644226|P1|Overall Study|Lost to Follow-up|1
203588|NCT01113931|644238|P2|Overall Study|Withdrawal by Subject|0
203589|NCT01113931|644239|P1|Overall Study|Withdrawal by Subject|3
203590|NCT01113931|644238|P2|Overall Study|Various|4
203591|NCT01113931|644239|P1|Overall Study|Various|2
203592|NCT01113931|644238|P2|Overall Study|Lost to Follow-up|9
203593|NCT01113931|644239|P1|Overall Study|Lost to Follow-up|12
203594|NCT01113931|644238|P2|Overall Study|Physician Decision|2
203595|NCT01113931|644239|P1|Overall Study|Physician Decision|0
203596|NCT01113931|644238|P2|Overall Study|Adverse Event|2
203597|NCT01113931|644239|P1|Overall Study|Adverse Event|2
203598|NCT01107457|644256|P6|Part B and C|Clinical Relapse|4
203599|NCT01107457|644257|P5|Part B and C|Clinical Relapse|0
203600|NCT01107457|644258|P4|Part B and C|Clinical Relapse|0
203601|NCT01107457|644259|P3|Part B and C|Clinical Relapse|0
203602|NCT01107457|644260|P2|Part B and C|Clinical Relapse|0
203603|NCT01107457|644261|P1|Part B and C|Clinical Relapse|0
203604|NCT01107457|644256|P6|Part B and C|Withdrawal by Subject|16
203605|NCT01107457|644257|P5|Part B and C|Withdrawal by Subject|0
203606|NCT01107457|644258|P4|Part B and C|Withdrawal by Subject|0
203607|NCT01107457|644259|P3|Part B and C|Withdrawal by Subject|0
203608|NCT01107457|644260|P2|Part B and C|Withdrawal by Subject|0
203609|NCT01107457|644261|P1|Part B and C|Withdrawal by Subject|0
203610|NCT01107457|644256|P6|Part B and C|Sponsor Decision|66
203611|NCT01107457|644257|P5|Part B and C|Sponsor Decision|0
203612|NCT01107457|644258|P4|Part B and C|Sponsor Decision|0
203613|NCT01107457|644259|P3|Part B and C|Sponsor Decision|0
203614|NCT01107457|644260|P2|Part B and C|Sponsor Decision|0
203615|NCT01107457|644261|P1|Part B and C|Sponsor Decision|0
203616|NCT01107457|644256|P6|Part B and C|Protocol Violation|1
203617|NCT01107457|644257|P5|Part B and C|Protocol Violation|0
203618|NCT01107457|644258|P4|Part B and C|Protocol Violation|0
203619|NCT01107457|644259|P3|Part B and C|Protocol Violation|0
203620|NCT01107457|644260|P2|Part B and C|Protocol Violation|0
203621|NCT01107457|644261|P1|Part B and C|Protocol Violation|0
203622|NCT01107457|644256|P6|Part B and C|Lost to Follow-up|10
203623|NCT01107457|644257|P5|Part B and C|Lost to Follow-up|0
203624|NCT01107457|644258|P4|Part B and C|Lost to Follow-up|0
203625|NCT01107457|644259|P3|Part B and C|Lost to Follow-up|0
203626|NCT01107457|644260|P2|Part B and C|Lost to Follow-up|0
203627|NCT01107457|644261|P1|Part B and C|Lost to Follow-up|0
203628|NCT01107457|644256|P6|Part B and C|Lack of Efficacy|7
203629|NCT01107457|644257|P5|Part B and C|Lack of Efficacy|0
203630|NCT01107457|644258|P4|Part B and C|Lack of Efficacy|0
203631|NCT01107457|644259|P3|Part B and C|Lack of Efficacy|0
203632|NCT01107457|644260|P2|Part B and C|Lack of Efficacy|0
203633|NCT01107457|644261|P1|Part B and C|Lack of Efficacy|0
203634|NCT01107457|644256|P6|Part B and C|Physician Decision|3
203635|NCT01107457|644257|P5|Part B and C|Physician Decision|0
203636|NCT01107457|644258|P4|Part B and C|Physician Decision|0
203637|NCT01107457|644259|P3|Part B and C|Physician Decision|0
203638|NCT01107457|644260|P2|Part B and C|Physician Decision|0
203639|NCT01107457|644261|P1|Part B and C|Physician Decision|0
203640|NCT01107457|644256|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
203641|NCT01107457|644257|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
203642|NCT01107457|644258|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
203643|NCT01107457|644259|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
203644|NCT01107457|644260|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
203645|NCT01107457|644261|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
203646|NCT01107457|644256|P6|Part B and C|Adverse Event|12
203647|NCT01107457|644257|P5|Part B and C|Adverse Event|0
203648|NCT01107457|644258|P4|Part B and C|Adverse Event|0
203649|NCT01107457|644259|P3|Part B and C|Adverse Event|0
203650|NCT01107457|644260|P2|Part B and C|Adverse Event|0
203651|NCT01107457|644261|P1|Part B and C|Adverse Event|0
203652|NCT01107457|644256|P6|Part A|Protocol Violation|0
203653|NCT01107457|644257|P5|Part A|Protocol Violation|0
203654|NCT01107457|644258|P4|Part A|Protocol Violation|0
203655|NCT01107457|644259|P3|Part A|Protocol Violation|0
203656|NCT01107457|644260|P2|Part A|Protocol Violation|1
203657|NCT01107457|644261|P1|Part A|Protocol Violation|0
203658|NCT01107457|644256|P6|Part A|Lack of Efficacy|0
203659|NCT01107457|644257|P5|Part A|Lack of Efficacy|0
203660|NCT01107457|644258|P4|Part A|Lack of Efficacy|0
203661|NCT01107457|644259|P3|Part A|Lack of Efficacy|0
203662|NCT01107457|644260|P2|Part A|Lack of Efficacy|0
203663|NCT01107457|644261|P1|Part A|Lack of Efficacy|1
203664|NCT01107457|644256|P6|Part A|Lost to Follow-up|0
203665|NCT01107457|644257|P5|Part A|Lost to Follow-up|0
203666|NCT01107457|644258|P4|Part A|Lost to Follow-up|0
203667|NCT01107457|644259|P3|Part A|Lost to Follow-up|0
203668|NCT01107457|644260|P2|Part A|Lost to Follow-up|1
203669|NCT01107457|644261|P1|Part A|Lost to Follow-up|0
203670|NCT01107457|644256|P6|Part A|Withdrawal by Subject|0
203671|NCT01107457|644257|P5|Part A|Withdrawal by Subject|1
203672|NCT01107457|644258|P4|Part A|Withdrawal by Subject|3
203673|NCT01107457|644259|P3|Part A|Withdrawal by Subject|0
203674|NCT01107457|644260|P2|Part A|Withdrawal by Subject|3
203675|NCT01107457|644261|P1|Part A|Withdrawal by Subject|3
203676|NCT01107457|644256|P6|Part A|Adverse Event|0
203677|NCT01107457|644257|P5|Part A|Adverse Event|0
203678|NCT01107457|644258|P4|Part A|Adverse Event|0
203679|NCT01107457|644259|P3|Part A|Adverse Event|1
203680|NCT01107457|644260|P2|Part A|Adverse Event|2
203681|NCT01107457|644261|P1|Part A|Adverse Event|1
203682|NCT01107535|644387|P1|Overall Study|Death|5
203683|NCT01114360|644408|P2|Intervention 1 (4 Weeks)|Physician Decision|1
203684|NCT01114360|644409|P1|Intervention 1 (4 Weeks)|Physician Decision|0
203685|NCT01114373|644445|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
203686|NCT01114373|644446|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
203687|NCT01114373|644445|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
203688|NCT01114373|644446|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
203689|NCT01114373|644445|P2|Intervention 1 (4 Weeks)|Incarceration|0
203690|NCT01114373|644446|P1|Intervention 1 (4 Weeks)|Incarceration|1
203691|NCT01114373|644445|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
203692|NCT01114373|644446|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
203693|NCT01114672|644491|P2|Overall Study|transplanted|0
203694|NCT01114672|644492|P1|Overall Study|transplanted|1
203695|NCT01114672|644491|P2|Overall Study|Lost to Follow-up|0
203696|NCT01114672|644492|P1|Overall Study|Lost to Follow-up|1
203697|NCT01114672|644491|P2|Overall Study|Withdrawal by Subject|1
203698|NCT01114672|644492|P1|Overall Study|Withdrawal by Subject|2
203699|NCT01114672|644491|P2|Overall Study|Death|1
203700|NCT01114672|644492|P1|Overall Study|Death|0
203701|NCT01114724|644498|P1|Overall Study|Withdrawal by Subject|1
203702|NCT01114724|644498|P1|Overall Study|Lost to Follow-up|1
203703|NCT01114724|644498|P1|Overall Study|Death|8
203704|NCT01114737|644518|P2|Open-Label Treatment Period|Difficult Personal Events|0
203705|NCT01114737|644519|P1|Open-Label Treatment Period|Difficult Personal Events|1
203706|NCT01114737|644518|P2|Open-Label Treatment Period|Lost to Follow-up|1
203707|NCT01114737|644519|P1|Open-Label Treatment Period|Lost to Follow-up|3
203708|NCT01114737|644518|P2|Open-Label Treatment Period|Withdrawal by Subject|1
203709|NCT01114737|644519|P1|Open-Label Treatment Period|Withdrawal by Subject|1
203710|NCT01114737|644518|P2|Randomized Treatment Period|Pregnancy|0
203711|NCT01114737|644519|P1|Randomized Treatment Period|Pregnancy|1
203712|NCT01114737|644518|P2|Randomized Treatment Period|Lost to Follow-up|1
203713|NCT01114737|644519|P1|Randomized Treatment Period|Lost to Follow-up|1
203714|NCT01114737|644518|P2|Randomized Treatment Period|Withdrawal by Subject|0
203715|NCT01114737|644519|P1|Randomized Treatment Period|Withdrawal by Subject|1
203716|NCT01114828|644569|P2|Overall Study|Withdrawal by Subject|1
203717|NCT01114828|644570|P1|Overall Study|Withdrawal by Subject|0
203718|NCT01114828|644569|P2|Overall Study|Protocol Violation|0
203719|NCT01114828|644570|P1|Overall Study|Protocol Violation|2
203720|NCT01114828|644569|P2|Overall Study|Lack of Efficacy|2
203721|NCT01114828|644570|P1|Overall Study|Lack of Efficacy|0
203722|NCT01114828|644569|P2|Overall Study|Adverse Event|1
203723|NCT01114828|644570|P1|Overall Study|Adverse Event|1
203724|NCT01114880|644580|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
203725|NCT01114880|644581|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
203726|NCT01114880|644580|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
203727|NCT01114880|644581|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
203728|NCT01114880|644580|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
203729|NCT01114880|644581|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
203730|NCT01114880|644580|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
203731|NCT01114880|644581|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
203732|NCT01114880|644580|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
203733|NCT01114880|644581|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
203734|NCT01114880|644580|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
203735|NCT01114880|644581|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
203736|NCT01115491|644782|P1|Overall Study|Physician Decision|1
203737|NCT01115491|644782|P1|Overall Study|Withdrawal by Subject|1
203738|NCT01115491|644782|P1|Overall Study|Lost to Follow-up|3
203739|NCT01115491|644782|P1|Overall Study|Adverse Event|3
203740|NCT01115491|644782|P1|Overall Study|Death|22
203741|NCT01115569|644804|P2|Maintenance Phase|Administrative|1
203742|NCT01115569|644805|P1|Maintenance Phase|Administrative|0
203743|NCT01115569|644804|P2|Maintenance Phase|Non-Compliance with Study Drug|48
203744|NCT01115569|644805|P1|Maintenance Phase|Non-Compliance with Study Drug|0
203745|NCT01115569|644804|P2|Maintenance Phase|Withdrawal by Subject|27
203746|NCT01115569|644805|P1|Maintenance Phase|Withdrawal by Subject|0
203747|NCT01115569|644804|P2|Maintenance Phase|Protocol Violation|9
203748|NCT01115569|644805|P1|Maintenance Phase|Protocol Violation|0
203749|NCT01115569|644804|P2|Maintenance Phase|Physician Decision|3
203750|NCT01115569|644805|P1|Maintenance Phase|Physician Decision|0
203751|NCT01115569|644804|P2|Maintenance Phase|Lost to Follow-up|8
203752|NCT01115569|644805|P1|Maintenance Phase|Lost to Follow-up|0
203753|NCT01115569|644804|P2|Maintenance Phase|Adverse Event|43
203754|NCT01115569|644805|P1|Maintenance Phase|Adverse Event|0
203755|NCT01115569|644804|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
203756|NCT01115569|644805|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
203757|NCT01115569|644804|P2|Conversion/Titration Phase|Withdrawal by Subject|0
203758|NCT01115569|644805|P1|Conversion/Titration Phase|Withdrawal by Subject|26
203759|NCT01115569|644804|P2|Conversion/Titration Phase|Protocol Violation|0
203760|NCT01115569|644805|P1|Conversion/Titration Phase|Protocol Violation|68
203761|NCT01115569|644804|P2|Conversion/Titration Phase|Physician Decision|0
203762|NCT01115569|644805|P1|Conversion/Titration Phase|Physician Decision|5
203763|NCT01115569|644804|P2|Conversion/Titration Phase|Lost to Follow-up|0
203764|NCT01115569|644805|P1|Conversion/Titration Phase|Lost to Follow-up|3
203765|NCT01115569|644804|P2|Conversion/Titration Phase|Adverse Event|0
203766|NCT01115569|644805|P1|Conversion/Titration Phase|Adverse Event|59
203767|NCT01115738|644977|P3|Overall Study|Withdrawal by Subject|9
203768|NCT01115738|644978|P2|Overall Study|Withdrawal by Subject|6
203769|NCT01115738|644979|P1|Overall Study|Withdrawal by Subject|6
203770|NCT01115738|644977|P3|Overall Study|Physician Decision|17
203771|NCT01115738|644978|P2|Overall Study|Physician Decision|15
203772|NCT01115738|644979|P1|Overall Study|Physician Decision|18
203773|NCT01115738|644977|P3|Overall Study|Lost to Follow-up|1
203774|NCT01115738|644978|P2|Overall Study|Lost to Follow-up|0
203775|NCT01115738|644979|P1|Overall Study|Lost to Follow-up|0
203776|NCT01115738|644977|P3|Overall Study|Death|0
203777|NCT01115738|644978|P2|Overall Study|Death|0
203778|NCT01115738|644979|P1|Overall Study|Death|1
203779|NCT01115855|645015|P2|Overall Study|Unspecified|6
203780|NCT01115855|645016|P1|Overall Study|Unspecified|8
203781|NCT01115855|645015|P2|Overall Study|Withdrawal by Subject|5
203782|NCT01115855|645016|P1|Overall Study|Withdrawal by Subject|5
203783|NCT01115855|645015|P2|Overall Study|Protocol Violation|1
203784|NCT01115855|645016|P1|Overall Study|Protocol Violation|0
203785|NCT01115855|645015|P2|Overall Study|Lab Abnormality|1
203786|NCT01115855|645016|P1|Overall Study|Lab Abnormality|1
203787|NCT01115855|645015|P2|Overall Study|Death|5
203788|NCT01115855|645016|P1|Overall Study|Death|6
203789|NCT01115855|645015|P2|Overall Study|Adverse Event|18
203790|NCT01115855|645016|P1|Overall Study|Adverse Event|16
203791|NCT01115933|645064|P1|Overall Study|Did not receive XIENCE PRIME SV|1
203792|NCT01115998|645161|P2|Overall Study|Lost to Follow-up|6
203793|NCT01115998|645162|P1|Overall Study|Lost to Follow-up|6
203794|NCT01116232|645273|P1|Overall Study|Progressive diease|4
203795|NCT01116427|645280|P2|Extension Phase|Not using appropriate birth control|0
203796|NCT01116427|645281|P1|Extension Phase|Not using appropriate birth control|1
203797|NCT01116427|645280|P2|Extension Phase|Withdrawal by Subject|1
203798|NCT01116427|645281|P1|Extension Phase|Withdrawal by Subject|5
203799|NCT01116427|645280|P2|Extension Phase|Lost to Follow-up|0
203800|NCT01116427|645281|P1|Extension Phase|Lost to Follow-up|2
203801|NCT01116427|645280|P2|Extension Phase|Adverse Event|1
203802|NCT01116427|645281|P1|Extension Phase|Adverse Event|1
203803|NCT01116427|645280|P2|Core Phase|Worsening Multiple Sclerosis|0
203804|NCT01116427|645281|P1|Core Phase|Worsening Multiple Sclerosis|1
203805|NCT01116427|645280|P2|Core Phase|Withdrawal by Subject|0
203806|NCT01116427|645281|P1|Core Phase|Withdrawal by Subject|3
203807|NCT01116427|645280|P2|Core Phase|Lost to Follow-up|0
203808|NCT01116427|645281|P1|Core Phase|Lost to Follow-up|1
203809|NCT01116427|645280|P2|Core Phase|Adverse Event|1
203810|NCT01116427|645281|P1|Core Phase|Adverse Event|0
203811|NCT01116687|645325|P1|Overall Study|Withdrawal by Subject|4
203812|NCT01116882|645334|P2|12-month|Withdrawal by Subject|8
203813|NCT01116882|645335|P1|12-month|Withdrawal by Subject|5
203814|NCT01116882|645334|P2|12-month|Other Reasons|49
203815|NCT01116882|645335|P1|12-month|Other Reasons|151
203816|NCT01116882|645334|P2|12-month|Lost to Follow-up|42
203817|NCT01116882|645335|P1|12-month|Lost to Follow-up|111
203818|NCT01116882|645334|P2|30-day|Other Reasons|6
203819|NCT01116882|645335|P1|30-day|Other Reasons|16
203820|NCT01116882|645334|P2|30-day|Withdrawal by Subject|4
203821|NCT01116882|645335|P1|30-day|Withdrawal by Subject|2
203822|NCT01116882|645334|P2|30-day|Lost to Follow-up|21
203823|NCT01116882|645335|P1|30-day|Lost to Follow-up|50
203824|NCT01117012|645498|P2|Overall Study|Undefined|3
203825|NCT01117012|645499|P1|Overall Study|Undefined|4
203826|NCT01117012|645498|P2|Overall Study|Withdrawal by Subject|0
203827|NCT01117012|645499|P1|Overall Study|Withdrawal by Subject|3
203828|NCT01117012|645498|P2|Overall Study|Death|1
203829|NCT01117012|645499|P1|Overall Study|Death|1
203830|NCT01117012|645498|P2|Overall Study|Adverse Event|1
203831|NCT01117012|645499|P1|Overall Study|Adverse Event|0
203832|NCT01117051|645517|P2|Overall Study|Convenience issue|0
203833|NCT01117051|645518|P1|Overall Study|Convenience issue|1
203834|NCT01117051|645517|P2|Overall Study|Randomized by mistake|1
203835|NCT01117051|645518|P1|Overall Study|Randomized by mistake|0
203836|NCT01117051|645517|P2|Overall Study|Surgical procedure|1
203837|NCT01117051|645518|P1|Overall Study|Surgical procedure|0
203838|NCT01117051|645517|P2|Overall Study|Sponsor's decision|1
203839|NCT01117051|645518|P1|Overall Study|Sponsor's decision|3
203840|NCT01117051|645517|P2|Overall Study|Did not meet in-/exclusion criteria|1
203841|NCT01117051|645518|P1|Overall Study|Did not meet in-/exclusion criteria|0
203842|NCT01117051|645517|P2|Overall Study|Lost to Follow-up|1
203843|NCT01117051|645518|P1|Overall Study|Lost to Follow-up|0
203844|NCT01117051|645517|P2|Overall Study|Adverse Event|3
203845|NCT01117051|645518|P1|Overall Study|Adverse Event|4
203846|NCT01117051|645517|P2|Overall Study|Withdrawal by Subject|3
203847|NCT01117051|645518|P1|Overall Study|Withdrawal by Subject|5
203848|NCT01110915|645563|P2|Overall Study|Withdrawal by Subject|1
203849|NCT01110915|645564|P1|Overall Study|Withdrawal by Subject|7
203850|NCT01110915|645563|P2|Overall Study|Lost to Follow-up|0
203851|NCT01110915|645564|P1|Overall Study|Lost to Follow-up|1
203852|NCT01110915|645563|P2|Overall Study|Death|1
203853|NCT01110915|645564|P1|Overall Study|Death|2
203854|NCT01111123|645605|P2|Maintenance Phase|Lost to Follow-up|2
203855|NCT01111123|645606|P1|Maintenance Phase|Lost to Follow-up|0
203856|NCT01111123|645605|P2|Open- Label Phase|Failed to be clear or almost cleared|0
203857|NCT01111123|645606|P1|Open- Label Phase|Failed to be clear or almost cleared|14
203858|NCT01111149|645617|P3|Overall Study|Withdrawal by Subject|2
203859|NCT01111149|645618|P2|Overall Study|Withdrawal by Subject|0
203860|NCT01111149|645619|P1|Overall Study|Withdrawal by Subject|1
203861|NCT01111149|645617|P3|Overall Study|Protocol Violation|2
203862|NCT01111149|645618|P2|Overall Study|Protocol Violation|1
203863|NCT01111149|645619|P1|Overall Study|Protocol Violation|1
203864|NCT01111240|645698|P1|Overall Study|Not Specified|312
203865|NCT01111240|645698|P1|Overall Study|Lack of Efficacy and Adverse Event|19
203866|NCT01111240|645698|P1|Overall Study|Lack of Efficacy|545
203867|NCT01111240|645698|P1|Overall Study|Adverse Event|190
203868|NCT01111292|645722|P2|Treatment|Physician Decision|1
203869|NCT01111292|645723|P1|Treatment|Physician Decision|1
203870|NCT01111461|645894|P1|Overall Study|Not specified|6
203871|NCT01111461|645894|P1|Overall Study|Withdrawal by Subject|1
203872|NCT01111461|645894|P1|Overall Study|Lost to Follow-up|1
203873|NCT01111461|645894|P1|Overall Study|Participant choice|11
203874|NCT01111461|645894|P1|Overall Study|Adverse Event|32
203875|NCT01111526|645907|P3|Overall Study|GVHD Disease Progression|2
203876|NCT01111526|645908|P2|Overall Study|GVHD Disease Progression|1
203877|NCT01111526|645909|P1|Overall Study|GVHD Disease Progression|0
203878|NCT01117181|645934|P2|Overall Study|Withdrawal by Subject|2
203879|NCT01117181|645935|P1|Overall Study|Withdrawal by Subject|0
203880|NCT01117181|645934|P2|Overall Study|Lost to Follow-up|0
203881|NCT01117181|645935|P1|Overall Study|Lost to Follow-up|1
203882|NCT01117337|645964|P2|Overall Study|Lost to Follow-up|0
203883|NCT01117337|645965|P1|Overall Study|Lost to Follow-up|4
203884|NCT01117350|645977|P2|Extension Period|Prohibited medication|1
203885|NCT01117350|645978|P1|Extension Period|Prohibited medication|0
203886|NCT01117350|645977|P2|Extension Period|Inclusion criteria not respected|1
203887|NCT01117350|645978|P1|Extension Period|Inclusion criteria not respected|0
203888|NCT01117350|645977|P2|Extension Period|Lack of Efficacy|2
203889|NCT01117350|645978|P1|Extension Period|Lack of Efficacy|0
203890|NCT01117350|645977|P2|Extension Period|Withdrawal by Subject|3
203891|NCT01117350|645978|P1|Extension Period|Withdrawal by Subject|0
203892|NCT01117350|645977|P2|Extension Period|Lost to Follow-up|2
203893|NCT01117350|645978|P1|Extension Period|Lost to Follow-up|0
203894|NCT01117350|645977|P2|Extension Period|Protocol Violation|2
203895|NCT01117350|645978|P1|Extension Period|Protocol Violation|0
203896|NCT01117350|645977|P2|Extension Period|Adverse Event|2
203897|NCT01117350|645978|P1|Extension Period|Adverse Event|0
203898|NCT01117350|645977|P2|Extension Period|Not included in extension, not treated|50
203899|NCT01117350|645978|P1|Extension Period|Not included in extension, not treated|0
203900|NCT01117350|645977|P2|Comparative Period|Move to another city/country|1
203901|NCT01117350|645978|P1|Comparative Period|Move to another city/country|2
203902|NCT01117350|645977|P2|Comparative Period|Physician Decision|1
203903|NCT01117350|645978|P1|Comparative Period|Physician Decision|0
203904|NCT01117350|645977|P2|Comparative Period|Lack of Efficacy|0
203905|NCT01117350|645978|P1|Comparative Period|Lack of Efficacy|1
203906|NCT01117350|645977|P2|Comparative Period|Protocol Violation|12
203907|NCT01117350|645978|P1|Comparative Period|Protocol Violation|8
203908|NCT01117350|645977|P2|Comparative Period|Withdrawal by Subject|13
203909|NCT01117350|645978|P1|Comparative Period|Withdrawal by Subject|9
203910|NCT01117350|645977|P2|Comparative Period|Lost to Follow-up|7
203911|NCT01117350|645978|P1|Comparative Period|Lost to Follow-up|11
203912|NCT01117350|645977|P2|Comparative Period|Adverse Event|33
203913|NCT01117350|645978|P1|Comparative Period|Adverse Event|6
203914|NCT01117350|645977|P2|Comparative Period|Not Treated|8
203915|NCT01117350|645978|P1|Comparative Period|Not Treated|5
203916|NCT01118325|646011|P3|Overall Study|Adverse Event|1
203917|NCT01118325|646012|P2|Overall Study|Adverse Event|0
203918|NCT01118325|646013|P1|Overall Study|Adverse Event|1
203919|NCT01118377|646057|P1|Overall Study|Failure to Return|3
203920|NCT01118377|646057|P1|Overall Study|Death|38
203921|NCT01118377|646057|P1|Overall Study|Did Not Receive Study Medication|1
203922|NCT01118455|646065|P2|Baseline [Visits 1 & 2]|Adverse Event|0
203923|NCT01118455|646066|P1|Baseline [Visits 1 & 2]|Adverse Event|1
203924|NCT01118663|646103|P2|Overall Study|Withdrawal by Subject|1
203925|NCT01118663|646104|P1|Overall Study|Withdrawal by Subject|0
203926|NCT01118663|646103|P2|Overall Study|Adverse Event|1
203927|NCT01118663|646104|P1|Overall Study|Adverse Event|2
203928|NCT01118728|646118|P1|Overall Study|Lost to Follow-up|4
203929|NCT01118728|646118|P1|Overall Study|Withdrawal by Subject|3
203930|NCT01118728|646118|P1|Overall Study|Sponsor's decision to discontinue study|172
203931|NCT01118728|646118|P1|Overall Study|Lack of Efficacy|27
203932|NCT01118728|646118|P1|Overall Study|Adverse Event|17
203933|NCT01118780|646134|P2|Overall Study|Withdrawal by Subject|8
203934|NCT01118780|646135|P1|Overall Study|Withdrawal by Subject|13
203935|NCT01118780|646134|P2|Overall Study|Protocol Violation|6
203936|NCT01118780|646135|P1|Overall Study|Protocol Violation|3
203937|NCT01118780|646134|P2|Overall Study|Physician Decision|0
203938|NCT01118780|646135|P1|Overall Study|Physician Decision|2
203939|NCT01118780|646134|P2|Overall Study|Lack of Efficacy|6
203940|NCT01118780|646135|P1|Overall Study|Lack of Efficacy|2
203941|NCT01118780|646134|P2|Overall Study|Death|0
203942|NCT01118780|646135|P1|Overall Study|Death|1
203943|NCT01118780|646134|P2|Overall Study|Adverse Event|15
203944|NCT01118780|646135|P1|Overall Study|Adverse Event|15
203945|NCT01118949|646201|P1|Overall Study|Withdrawal by Subject|4
203946|NCT01118949|646201|P1|Overall Study|Adverse Event|5
203947|NCT01118962|646210|P1|Overall Study|Non-compliance with Medicinal Product|1
203948|NCT01118962|646210|P1|Overall Study|Pregnancy|1
203949|NCT01118962|646210|P1|Overall Study|Withdrawal by Subject|4
203950|NCT01118962|646210|P1|Overall Study|Protocol Violation|1
203951|NCT01118962|646210|P1|Overall Study|Lack of Efficacy|1
203952|NCT01118962|646210|P1|Overall Study|Adverse Event|2
203953|NCT01118975|646217|P2|Overall Study|Adverse Event|1
203954|NCT01118975|646218|P1|Overall Study|Adverse Event|0
203955|NCT01119001|646260|P1|Overall Study|Withdrawal by Subject|2
203956|NCT01119118|646270|P1|Overall Study|Adverse Event|1
203957|NCT01119131|646281|P3|Overall Study|Physician Decision|1
203958|NCT01119131|646282|P2|Overall Study|Physician Decision|0
203959|NCT01119131|646283|P1|Overall Study|Physician Decision|0
203960|NCT01119131|646281|P3|Overall Study|Non-Compliance|4
203961|NCT01119131|646282|P2|Overall Study|Non-Compliance|0
203962|NCT01119131|646283|P1|Overall Study|Non-Compliance|1
203963|NCT01119131|646281|P3|Overall Study|Adverse Event|1
203964|NCT01119131|646282|P2|Overall Study|Adverse Event|1
203965|NCT01119131|646283|P1|Overall Study|Adverse Event|1
203966|NCT01119287|646359|P6|Overall Study|Patient Decision, not related to AE|0
203967|NCT01119287|646360|P5|Overall Study|Patient Decision, not related to AE|1
203968|NCT01119287|646361|P4|Overall Study|Patient Decision, not related to AE|2
203969|NCT01119287|646362|P3|Overall Study|Patient Decision, not related to AE|2
203970|NCT01119287|646363|P2|Overall Study|Patient Decision, not related to AE|0
203971|NCT01119287|646364|P1|Overall Study|Patient Decision, not related to AE|0
203972|NCT01119443|646379|P2|Crossover Period 1 (5 Days)|Adverse Event|1
203973|NCT01119443|646380|P1|Crossover Period 1 (5 Days)|Adverse Event|0
203974|NCT01119625|646419|P2|Overall Study|Unspecified|1
203975|NCT01119625|646420|P1|Overall Study|Unspecified|0
203976|NCT01119625|646419|P2|Overall Study|Withdrawal by Subject|1
203977|NCT01119625|646420|P1|Overall Study|Withdrawal by Subject|2
203978|NCT01119625|646419|P2|Overall Study|Lost to Follow-up|2
203979|NCT01119625|646420|P1|Overall Study|Lost to Follow-up|1
203980|NCT01119703|646462|P2|Overall Study|Adverse Event|1
203981|NCT01119703|646463|P1|Overall Study|Adverse Event|0
203982|NCT01119768|646509|P2|Treatment Period|Lack of Efficacy|25
203983|NCT01119768|646510|P1|Treatment Period|Lack of Efficacy|18
203984|NCT01119859|646538|P2|Overall Study|Failure to return|0
203985|NCT01119859|646539|P1|Overall Study|Failure to return|3
203986|NCT01119859|646538|P2|Overall Study|Refused treatment|6
203987|NCT01119859|646539|P1|Overall Study|Refused treatment|3
203988|NCT01119859|646538|P2|Overall Study|Insufficient therapeutic response|14
203989|NCT01119859|646539|P1|Overall Study|Insufficient therapeutic response|7
203990|NCT01119859|646538|P2|Overall Study|Death|0
203991|NCT01119859|646539|P1|Overall Study|Death|2
203992|NCT01119859|646538|P2|Overall Study|Adverse Event|10
203993|NCT01119859|646539|P1|Overall Study|Adverse Event|9
203994|NCT01119937|646557|P2|Overall Study|Withdrawal by Subject|1
203995|NCT01119937|646558|P1|Overall Study|Withdrawal by Subject|2
203996|NCT01119937|646557|P2|Overall Study|Unsatisfactory therapeutic effect|0
203997|NCT01119937|646558|P1|Overall Study|Unsatisfactory therapeutic effect|3
203998|NCT01119937|646557|P2|Overall Study|Protocol deviation|1
203999|NCT01119937|646558|P1|Overall Study|Protocol deviation|3
204000|NCT01119937|646557|P2|Overall Study|Adverse Event|5
204001|NCT01119937|646558|P1|Overall Study|Adverse Event|11
204002|NCT01119950|646584|P1|Overall Study|Death|1
204003|NCT01119950|646584|P1|Overall Study|Abnormal lab value|1
204004|NCT01119950|646584|P1|Overall Study|Administrative|2
204005|NCT01119950|646584|P1|Overall Study|Lost to Follow-up|4
204006|NCT01119950|646584|P1|Overall Study|Protocol Violation|5
204007|NCT01119950|646584|P1|Overall Study|Withdrawal by Subject|9
204008|NCT01119950|646584|P1|Overall Study|Adverse Event|25
204009|NCT01120067|646831|P2|Overall Study|fail to engage >3 sessions|0
204010|NCT01120067|646832|P1|Overall Study|fail to engage >3 sessions|2
204011|NCT01120067|646831|P2|Overall Study|Lost to Follow-up|1
204012|NCT01120067|646832|P1|Overall Study|Lost to Follow-up|3
204013|NCT01120093|646838|P5|Treatment Period 5|Adverse Event|0
204014|NCT01120093|646839|P4|Treatment Period 5|Adverse Event|1
204015|NCT01120093|646840|P3|Treatment Period 5|Adverse Event|0
204016|NCT01120093|646841|P2|Treatment Period 5|Adverse Event|1
204017|NCT01120093|646842|P1|Treatment Period 5|Adverse Event|0
204018|NCT01120093|646838|P5|Treatment Period 4|Adverse Event|0
204019|NCT01120093|646839|P4|Treatment Period 4|Adverse Event|0
204020|NCT01120093|646840|P3|Treatment Period 4|Adverse Event|0
204021|NCT01120093|646841|P2|Treatment Period 4|Adverse Event|0
204022|NCT01120093|646842|P1|Treatment Period 4|Adverse Event|1
204023|NCT01120093|646838|P5|Treatment Period 3|Withdrawal by Subject|0
204024|NCT01120093|646839|P4|Treatment Period 3|Withdrawal by Subject|0
204025|NCT01120093|646840|P3|Treatment Period 3|Withdrawal by Subject|1
204026|NCT01120093|646841|P2|Treatment Period 3|Withdrawal by Subject|0
204027|NCT01120093|646842|P1|Treatment Period 3|Withdrawal by Subject|0
204028|NCT01120093|646838|P5|Treatment Period 3|Adverse Event|1
204029|NCT01120093|646839|P4|Treatment Period 3|Adverse Event|0
204030|NCT01120093|646840|P3|Treatment Period 3|Adverse Event|0
204031|NCT01120093|646841|P2|Treatment Period 3|Adverse Event|0
204032|NCT01120093|646842|P1|Treatment Period 3|Adverse Event|0
204033|NCT01120093|646838|P5|Treatment Period 3|Lack of Efficacy|0
204034|NCT01120093|646839|P4|Treatment Period 3|Lack of Efficacy|1
204035|NCT01120093|646840|P3|Treatment Period 3|Lack of Efficacy|0
204036|NCT01120093|646841|P2|Treatment Period 3|Lack of Efficacy|0
204037|NCT01120093|646842|P1|Treatment Period 3|Lack of Efficacy|0
204038|NCT01120093|646838|P5|Treatment Period 2|Withdrawal by Subject|1
204039|NCT01120093|646839|P4|Treatment Period 2|Withdrawal by Subject|0
204040|NCT01120093|646840|P3|Treatment Period 2|Withdrawal by Subject|0
204041|NCT01120093|646841|P2|Treatment Period 2|Withdrawal by Subject|0
204042|NCT01120093|646842|P1|Treatment Period 2|Withdrawal by Subject|0
204043|NCT01120093|646838|P5|Treatment Period 2|Adverse Event|0
204044|NCT01120093|646839|P4|Treatment Period 2|Adverse Event|1
204045|NCT01120093|646840|P3|Treatment Period 2|Adverse Event|0
204046|NCT01120093|646841|P2|Treatment Period 2|Adverse Event|0
204047|NCT01120093|646842|P1|Treatment Period 2|Adverse Event|0
204048|NCT01120093|646838|P5|Treatment Period 1|Withdrawal by Subject|0
204049|NCT01120093|646839|P4|Treatment Period 1|Withdrawal by Subject|0
204050|NCT01120093|646840|P3|Treatment Period 1|Withdrawal by Subject|0
204051|NCT01120093|646841|P2|Treatment Period 1|Withdrawal by Subject|1
204052|NCT01120093|646842|P1|Treatment Period 1|Withdrawal by Subject|0
204053|NCT01120093|646838|P5|Treatment Period 1|Adverse Event|1
204054|NCT01120093|646839|P4|Treatment Period 1|Adverse Event|0
204055|NCT01120093|646840|P3|Treatment Period 1|Adverse Event|1
204056|NCT01120093|646841|P2|Treatment Period 1|Adverse Event|0
204057|NCT01120093|646842|P1|Treatment Period 1|Adverse Event|0
204058|NCT01120184|646872|P3|Overall Study|Not Specified|8
204059|NCT01120184|646873|P2|Overall Study|Not Specified|2
204060|NCT01120184|646874|P1|Overall Study|Not Specified|4
204061|NCT01120184|646872|P3|Overall Study|Withdrawal by Subject|22
204062|NCT01120184|646873|P2|Overall Study|Withdrawal by Subject|28
204063|NCT01120184|646874|P1|Overall Study|Withdrawal by Subject|28
204064|NCT01120184|646872|P3|Overall Study|Physician Decision|2
204065|NCT01120184|646873|P2|Overall Study|Physician Decision|2
204066|NCT01120184|646874|P1|Overall Study|Physician Decision|9
204067|NCT01120184|646872|P3|Overall Study|Lost to Follow-up|7
204068|NCT01120184|646873|P2|Overall Study|Lost to Follow-up|6
204069|NCT01120184|646874|P1|Overall Study|Lost to Follow-up|5
204070|NCT01120184|646872|P3|Overall Study|Death|115
204071|NCT01120184|646873|P2|Overall Study|Death|116
204072|NCT01120184|646874|P1|Overall Study|Death|123
204073|NCT01120210|647015|P2|MAIN INFUSION|Withdrawal by Subject|1
204074|NCT01120210|647016|P1|MAIN INFUSION|Withdrawal by Subject|0
204075|NCT01120210|647015|P2|MAIN INFUSION|Adverse Event|0
204076|NCT01120210|647016|P1|MAIN INFUSION|Adverse Event|1
204077|NCT01120275|647087|P1|Overall Study|Not specific|1
204078|NCT01120275|647087|P1|Overall Study|Refusal|1
204079|NCT01120275|647087|P1|Overall Study|Withdrawal by Subject|1
204080|NCT01120275|647087|P1|Overall Study|Ineligible|3
204081|NCT01120275|647087|P1|Overall Study|Progression|27
204082|NCT01120275|647087|P1|Overall Study|Adverse Event|3
204083|NCT01120379|647094|P1|Four Year Timepoint|Any other reason for early termination|217
204084|NCT01120379|647094|P1|Four Year Timepoint|Physician Decision|5
204085|NCT01120379|647094|P1|Four Year Timepoint|Death|131
204086|NCT01120379|647094|P1|Four Year Timepoint|Lost to Follow-up|10
204087|NCT01120379|647094|P1|Four Year Timepoint|Withdrawal by Subject|5
204088|NCT01120379|647094|P1|Three Year Timepoint|Any other reason for early termination|17
204089|NCT01120379|647094|P1|Three Year Timepoint|Physician Decision|9
204090|NCT01120379|647094|P1|Three Year Timepoint|Death|120
204091|NCT01120379|647094|P1|Three Year Timepoint|Lost to Follow-up|43
204092|NCT01120379|647094|P1|Three Year Timepoint|Withdrawal by Subject|25
204093|NCT01120379|647094|P1|Two Year Timepoint|Any other reason for early termination|4
204094|NCT01120379|647094|P1|Two Year Timepoint|Physician Decision|12
204095|NCT01120379|647094|P1|Two Year Timepoint|Death|123
204096|NCT01120379|647094|P1|Two Year Timepoint|Lost to Follow-up|87
204097|NCT01120379|647094|P1|Two Year Timepoint|Withdrawal by Subject|11
204098|NCT01120379|647094|P1|One Year Timepoint|Any other reason for early termination|5
204099|NCT01120379|647094|P1|One Year Timepoint|Physician Decision|9
204100|NCT01120379|647094|P1|One Year Timepoint|Death|108
204101|NCT01120379|647094|P1|One Year Timepoint|Lost to Follow-up|115
204102|NCT01120379|647094|P1|One Year Timepoint|Withdrawal by Subject|41
204103|NCT01120626|647163|P2|Overall Study|Withdrawal by Subject|0
204104|NCT01120626|647164|P1|Overall Study|Withdrawal by Subject|1
204105|NCT01120691|647175|P3|Overall Study|Abnormal laboratory value(s)|4
204106|NCT01120691|647176|P2|Overall Study|Abnormal laboratory value(s)|3
204107|NCT01120691|647177|P1|Overall Study|Abnormal laboratory value(s)|1
204108|NCT01120691|647175|P3|Overall Study|Patient's inability to use the device|0
204109|NCT01120691|647176|P2|Overall Study|Patient's inability to use the device|1
204110|NCT01120691|647177|P1|Overall Study|Patient's inability to use the device|3
204111|NCT01120691|647175|P3|Overall Study|Abnormal test procedure result(s)|1
204112|NCT01120691|647176|P2|Overall Study|Abnormal test procedure result(s)|2
204113|NCT01120691|647177|P1|Overall Study|Abnormal test procedure result(s)|3
204114|NCT01120691|647175|P3|Overall Study|Lost to Follow-up|4
204115|NCT01120691|647176|P2|Overall Study|Lost to Follow-up|6
204116|NCT01120691|647177|P1|Overall Study|Lost to Follow-up|5
204117|NCT01120691|647175|P3|Overall Study|Protocol deviation|12
204118|NCT01120691|647176|P2|Overall Study|Protocol deviation|12
204119|NCT01120691|647177|P1|Overall Study|Protocol deviation|13
204120|NCT01120691|647175|P3|Overall Study|Administrative problems|9
204121|NCT01120691|647176|P2|Overall Study|Administrative problems|8
204122|NCT01120691|647177|P1|Overall Study|Administrative problems|15
204123|NCT01120691|647175|P3|Overall Study|Unsatisfactory therapeutic effect|38
204124|NCT01120691|647176|P2|Overall Study|Unsatisfactory therapeutic effect|32
204125|NCT01120691|647177|P1|Overall Study|Unsatisfactory therapeutic effect|18
204126|NCT01120691|647175|P3|Overall Study|Death|24
204127|NCT01120691|647176|P2|Overall Study|Death|22
204128|NCT01120691|647177|P1|Overall Study|Death|21
204129|NCT01120691|647175|P3|Overall Study|Subject withdrew consent|44
204130|NCT01120691|647176|P2|Overall Study|Subject withdrew consent|50
204131|NCT01120691|647177|P1|Overall Study|Subject withdrew consent|33
204132|NCT01120691|647175|P3|Overall Study|Adverse Event|47
204133|NCT01120691|647176|P2|Overall Study|Adverse Event|67
204134|NCT01120691|647177|P1|Overall Study|Adverse Event|59
204135|NCT01120717|647308|P2|Overall Study|Abnormal Test Procedure Result(s)|0
204136|NCT01120717|647309|P1|Overall Study|Abnormal Test Procedure Result(s)|1
204137|NCT01120717|647308|P2|Overall Study|Death|1
204138|NCT01120717|647309|P1|Overall Study|Death|3
204139|NCT01120717|647308|P2|Overall Study|Lost to Follow-up|3
204140|NCT01120717|647309|P1|Overall Study|Lost to Follow-up|2
204141|NCT01120717|647308|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
204142|NCT01120717|647309|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
204143|NCT01120717|647308|P2|Overall Study|Protocol Deviation|5
204144|NCT01120717|647309|P1|Overall Study|Protocol Deviation|2
204145|NCT01120717|647308|P2|Overall Study|Adverse Event|6
204146|NCT01120717|647309|P1|Overall Study|Adverse Event|10
204147|NCT01120717|647308|P2|Overall Study|Withdrawal by Subject|6
204148|NCT01120717|647309|P1|Overall Study|Withdrawal by Subject|11
204149|NCT01120782|647325|P1|Overall Study|Test article shipping error|11
204150|NCT01114438|647329|P1|Overall Study|Withdrawal by Subject|2
204151|NCT01114438|647329|P1|Overall Study|Physician Decision|1
204152|NCT01114438|647329|P1|Overall Study|concomitant medication|1
204153|NCT01114438|647329|P1|Overall Study|Adverse Event|10
204154|NCT01114516|647362|P2|Overall Study|Lost to Follow-up|1
204155|NCT01114516|647363|P1|Overall Study|Lost to Follow-up|2
204156|NCT01114529|647380|P3|Completed Study Phase at Month 24|Missing|0
204157|NCT01114529|647381|P2|Completed Study Phase at Month 24|Missing|0
204158|NCT01114529|647382|P1|Completed Study Phase at Month 24|Missing|2
204159|NCT01114529|647380|P3|Completed Study Phase at Month 24|Other|0
204160|NCT01114529|647381|P2|Completed Study Phase at Month 24|Other|0
204161|NCT01114529|647382|P1|Completed Study Phase at Month 24|Other|2
204162|NCT01114529|647380|P3|Completed Study Phase at Month 24|Death|4
204163|NCT01114529|647381|P2|Completed Study Phase at Month 24|Death|5
204164|NCT01114529|647382|P1|Completed Study Phase at Month 24|Death|8
204165|NCT01114529|647380|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
204166|NCT01114529|647381|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
204167|NCT01114529|647382|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
204168|NCT01114529|647380|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
204169|NCT01114529|647381|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
204170|NCT01114529|647382|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
204171|NCT01114529|647380|P3|Completed Study Medication at Month 24|Missing|0
204172|NCT01114529|647381|P2|Completed Study Medication at Month 24|Missing|0
204173|NCT01114529|647382|P1|Completed Study Medication at Month 24|Missing|2
204174|NCT01114529|647380|P3|Completed Study Medication at Month 24|Protocol Violation|2
204175|NCT01114529|647381|P2|Completed Study Medication at Month 24|Protocol Violation|5
204176|NCT01114529|647382|P1|Completed Study Medication at Month 24|Protocol Violation|0
204177|NCT01114529|647380|P3|Completed Study Medication at Month 24|Graft loss|0
204178|NCT01114529|647381|P2|Completed Study Medication at Month 24|Graft loss|2
204179|NCT01114529|647382|P1|Completed Study Medication at Month 24|Graft loss|0
204180|NCT01114529|647380|P3|Completed Study Medication at Month 24|Death|2
204181|NCT01114529|647381|P2|Completed Study Medication at Month 24|Death|1
204182|NCT01114529|647382|P1|Completed Study Medication at Month 24|Death|2
204183|NCT01114529|647380|P3|Completed Study Medication at Month 24|Administrative problems|2
204184|NCT01114529|647381|P2|Completed Study Medication at Month 24|Administrative problems|1
204185|NCT01114529|647382|P1|Completed Study Medication at Month 24|Administrative problems|2
204186|NCT01114529|647380|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
204187|NCT01114529|647381|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
204188|NCT01114529|647382|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
204189|NCT01114529|647380|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
204190|NCT01114529|647381|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
204191|NCT01114529|647382|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
204192|NCT01114529|647380|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
204193|NCT01114529|647381|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
204194|NCT01114529|647382|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
204195|NCT01114529|647380|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
204196|NCT01114529|647381|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
204197|NCT01114529|647382|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
204198|NCT01114529|647380|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
204199|NCT01114529|647381|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
204200|NCT01114529|647382|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
204201|NCT01114529|647380|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
204202|NCT01114529|647381|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
204203|NCT01114529|647382|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
204204|NCT01114529|647380|P3|Completed Study Medication at Month 24|Adverse Event|17
204205|NCT01114529|647381|P2|Completed Study Medication at Month 24|Adverse Event|18
204206|NCT01114529|647382|P1|Completed Study Medication at Month 24|Adverse Event|87
204207|NCT01120899|647407|P1|Overall Study|Withdrawal by Subject|3
204208|NCT01121484|647436|P2|Overall Study|Randomized, not treated|4
204209|NCT01121484|647437|P1|Overall Study|Randomized, not treated|1
204210|NCT01121484|647436|P2|Overall Study|unspecified|3
204211|NCT01121484|647437|P1|Overall Study|unspecified|3
204212|NCT01121484|647436|P2|Overall Study|Discontinuation of study by sponsor|1
204213|NCT01121484|647437|P1|Overall Study|Discontinuation of study by sponsor|0
204214|NCT01121484|647436|P2|Overall Study|Withdrawal by Subject|7
204215|NCT01121484|647437|P1|Overall Study|Withdrawal by Subject|8
204216|NCT01121484|647436|P2|Overall Study|Protocol Violation|0
204217|NCT01121484|647437|P1|Overall Study|Protocol Violation|1
204218|NCT01121484|647436|P2|Overall Study|Physician Decision|3
204219|NCT01121484|647437|P1|Overall Study|Physician Decision|0
204220|NCT01121484|647436|P2|Overall Study|Lost to Follow-up|9
204221|NCT01121484|647437|P1|Overall Study|Lost to Follow-up|5
204222|NCT01121484|647436|P2|Overall Study|Lack of Efficacy|11
204223|NCT01121484|647437|P1|Overall Study|Lack of Efficacy|3
204224|NCT01121484|647436|P2|Overall Study|Adverse Event|5
204225|NCT01121484|647437|P1|Overall Study|Adverse Event|12
204226|NCT01121536|647453|P1|Overall Study|Not specified|118
204227|NCT01121536|647453|P1|Overall Study|Lost to Follow-up|39
204228|NCT01121536|647453|P1|Overall Study|Noncompliance with study procedures|9
204229|NCT01121536|647453|P1|Overall Study|Noncompliance with study medication|12
204230|NCT01121536|647453|P1|Overall Study|Protocol Violation|20
204231|NCT01121536|647453|P1|Overall Study|Withdrawal by Subject|65
204232|NCT01121536|647453|P1|Overall Study|Lack of Efficacy|35
204233|NCT01121536|647453|P1|Overall Study|Adverse Event|63
204234|NCT01121549|647472|P1|Overall Study|Unspecified|58
204235|NCT01121549|647472|P1|Overall Study|Withdrawal by Subject|16
204236|NCT01121549|647472|P1|Overall Study|Protocol Violation|33
204237|NCT01121549|647472|P1|Overall Study|Pregnancy|1
204238|NCT01121549|647472|P1|Overall Study|Study terminated by sponsor|197
204239|NCT01121549|647472|P1|Overall Study|Did not meet entrance criteria|9
204240|NCT01121549|647472|P1|Overall Study|Lost to Follow-up|12
204241|NCT01121549|647472|P1|Overall Study|Lack of Efficacy|11
204242|NCT01121549|647472|P1|Overall Study|Adverse Event|10
204243|NCT01121562|647483|P1|Overall Study|Met study discontinuation criteria|1
204244|NCT01121562|647483|P1|Overall Study|Sponsor Decision|1
204245|NCT01121562|647483|P1|Overall Study|Adverse Event|1
204246|NCT01121562|647483|P1|Overall Study|Withdrawal by Subject|1
204247|NCT01121562|647483|P1|Overall Study|Objective progression or relapse|8
204248|NCT01121575|647498|P6|Overall Study|Death|1
204249|NCT01121575|647499|P5|Overall Study|Death|7
204250|NCT01121575|647500|P4|Overall Study|Death|1
204251|NCT01121575|647501|P3|Overall Study|Death|0
204252|NCT01121575|647502|P2|Overall Study|Death|0
204253|NCT01121575|647503|P1|Overall Study|Death|6
204254|NCT01121575|647498|P6|Overall Study|Unspecified Reasons|10
204255|NCT01121575|647499|P5|Overall Study|Unspecified Reasons|13
204256|NCT01121575|647500|P4|Overall Study|Unspecified Reasons|5
204257|NCT01121575|647501|P3|Overall Study|Unspecified Reasons|7
204258|NCT01121575|647502|P2|Overall Study|Unspecified Reasons|6
204259|NCT01121575|647503|P1|Overall Study|Unspecified Reasons|8
204260|NCT01121575|647498|P6|Overall Study|Participant Refused Further Follow-Up|1
204261|NCT01121575|647499|P5|Overall Study|Participant Refused Further Follow-Up|5
204262|NCT01121575|647500|P4|Overall Study|Participant Refused Further Follow-Up|0
204263|NCT01121575|647501|P3|Overall Study|Participant Refused Further Follow-Up|0
204264|NCT01121575|647502|P2|Overall Study|Participant Refused Further Follow-Up|0
204265|NCT01121575|647503|P1|Overall Study|Participant Refused Further Follow-Up|0
204266|NCT01121666|647629|P2|Overall Study|Protocol Violation|10
204267|NCT01121666|647630|P1|Overall Study|Protocol Violation|29
204268|NCT01121757|647682|P2|Combination|Disease Progression|0
204269|NCT01121757|647683|P1|Combination|Disease Progression|2
204270|NCT01121757|647682|P2|Combination|Physician Decision|1
204271|NCT01121757|647683|P1|Combination|Physician Decision|0
204272|NCT01121757|647682|P2|First Drug|Disease Progression|2
204273|NCT01121757|647683|P1|First Drug|Disease Progression|0
204274|NCT01121757|647682|P2|First Drug|Death|0
204275|NCT01121757|647683|P1|First Drug|Death|1
204276|NCT01121900|647697|P2|Washout Period of 7 Days|Withdrawal by Subject|1
204277|NCT01121900|647698|P1|Washout Period of 7 Days|Withdrawal by Subject|0
204278|NCT01121900|647697|P2|First Intervention Period|Adverse Event|1
204279|NCT01121900|647698|P1|First Intervention Period|Adverse Event|1
204280|NCT01121913|647716|P4|Third Washout Period|Adverse Event|0
204281|NCT01121913|647717|P3|Third Washout Period|Adverse Event|0
204282|NCT01121913|647718|P2|Third Washout Period|Adverse Event|0
204283|NCT01121913|647719|P1|Third Washout Period|Adverse Event|1
204284|NCT01121913|647716|P4|Second Washout Period|Withdrawal by Subject|0
204285|NCT01121913|647717|P3|Second Washout Period|Withdrawal by Subject|1
204286|NCT01121913|647718|P2|Second Washout Period|Withdrawal by Subject|0
204287|NCT01121913|647719|P1|Second Washout Period|Withdrawal by Subject|0
204288|NCT01121913|647716|P4|Second Intervention Period|Adverse Event|0
204289|NCT01121913|647717|P3|Second Intervention Period|Adverse Event|1
204290|NCT01121913|647718|P2|Second Intervention Period|Adverse Event|0
204291|NCT01121913|647719|P1|Second Intervention Period|Adverse Event|0
204292|NCT01121913|647716|P4|First Washout Period|Withdrawal by Subject|0
204293|NCT01121913|647717|P3|First Washout Period|Withdrawal by Subject|0
204294|NCT01121913|647718|P2|First Washout Period|Withdrawal by Subject|0
204295|NCT01121913|647719|P1|First Washout Period|Withdrawal by Subject|1
204296|NCT01121913|647716|P4|First Intervention Period|Adverse Event|0
204297|NCT01121913|647717|P3|First Intervention Period|Adverse Event|1
204298|NCT01121913|647718|P2|First Intervention Period|Adverse Event|0
204299|NCT01121913|647719|P1|First Intervention Period|Adverse Event|0
204300|NCT01121926|647749|P2|Washout Period|Positive pregnancy test|1
204301|NCT01121926|647750|P1|Washout Period|Positive pregnancy test|0
204302|NCT01121926|647749|P2|Washout Period|Adverse Event|1
204303|NCT01121926|647750|P1|Washout Period|Adverse Event|0
204304|NCT01121926|647749|P2|First Intervention Period|Adverse Event|0
204305|NCT01121926|647750|P1|First Intervention Period|Adverse Event|1
204306|NCT01121991|647782|P1|Overall Study|No Fertilization|1
204307|NCT01121991|647782|P1|Overall Study|No Oocytes Retrieved|3
204308|NCT01121991|647782|P1|Overall Study|Lack of Ovarian Response|2
204309|NCT01122264|648065|P3|Overall Study|Lack of Efficacy|1
204310|NCT01122264|648066|P2|Overall Study|Lack of Efficacy|1
204311|NCT01122264|648067|P1|Overall Study|Lack of Efficacy|3
204312|NCT01122264|648065|P3|Overall Study|Physician Decision|1
204313|NCT01122264|648066|P2|Overall Study|Physician Decision|1
204314|NCT01122264|648067|P1|Overall Study|Physician Decision|3
204315|NCT01122264|648065|P3|Overall Study|Withdrawal by Subject|16
204316|NCT01122264|648066|P2|Overall Study|Withdrawal by Subject|6
204317|NCT01122264|648067|P1|Overall Study|Withdrawal by Subject|6
204318|NCT01122264|648065|P3|Overall Study|Protocol Violation|9
204319|NCT01122264|648066|P2|Overall Study|Protocol Violation|7
204320|NCT01122264|648067|P1|Overall Study|Protocol Violation|7
204321|NCT01122264|648065|P3|Overall Study|Entry Criteria Not Met|0
204322|NCT01122264|648066|P2|Overall Study|Entry Criteria Not Met|0
204323|NCT01122264|648067|P1|Overall Study|Entry Criteria Not Met|1
204324|NCT01122264|648065|P3|Overall Study|Lost to Follow-up|13
204325|NCT01122264|648066|P2|Overall Study|Lost to Follow-up|9
204326|NCT01122264|648067|P1|Overall Study|Lost to Follow-up|5
204327|NCT01122264|648065|P3|Overall Study|Death|0
204328|NCT01122264|648066|P2|Overall Study|Death|0
204329|NCT01122264|648067|P1|Overall Study|Death|1
204330|NCT01122264|648065|P3|Overall Study|Adverse Event|7
204331|NCT01122264|648066|P2|Overall Study|Adverse Event|5
204332|NCT01122264|648067|P1|Overall Study|Adverse Event|6
204333|NCT01122381|648126|P2|Overall Study|study terminated early|1
204334|NCT01122381|648127|P1|Overall Study|study terminated early|0
204335|NCT01122394|648135|P2|Overall Study|Adverse Event|1
204336|NCT01122394|648136|P1|Overall Study|Adverse Event|0
204337|NCT01122394|648135|P2|Overall Study|Lost to Follow-up|2
204338|NCT01122394|648136|P1|Overall Study|Lost to Follow-up|2
204339|NCT01122394|648135|P2|Overall Study|Withdrawal by Subject|1
204340|NCT01122394|648136|P1|Overall Study|Withdrawal by Subject|1
204341|NCT01122576|648168|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
204342|NCT01122576|648169|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
204343|NCT01122576|648170|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
204344|NCT01122576|648168|P3|Post-Cataract Surgery|Central Macular Edema|1
204345|NCT01122576|648169|P2|Post-Cataract Surgery|Central Macular Edema|0
204346|NCT01122576|648170|P1|Post-Cataract Surgery|Central Macular Edema|0
204347|NCT01122576|648168|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
204348|NCT01122576|648169|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
204349|NCT01122576|648170|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
204350|NCT01122680|648307|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
204351|NCT01122680|648308|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
204352|NCT01122680|648309|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
204353|NCT01122680|648310|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
204354|NCT01122680|648307|P4|Period 3 (4 Weeks)|Adverse Event|0
204355|NCT01122680|648308|P3|Period 3 (4 Weeks)|Adverse Event|0
204356|NCT01122680|648309|P2|Period 3 (4 Weeks)|Adverse Event|0
204357|NCT01122680|648310|P1|Period 3 (4 Weeks)|Adverse Event|1
204358|NCT01122680|648307|P4|Period 2 (4 Weeks)|Other|0
204359|NCT01122680|648308|P3|Period 2 (4 Weeks)|Other|0
204360|NCT01122680|648309|P2|Period 2 (4 Weeks)|Other|0
204361|NCT01122680|648310|P1|Period 2 (4 Weeks)|Other|1
204362|NCT01122680|648307|P4|Period 2 (4 Weeks)|Protocol Violation|1
204363|NCT01122680|648308|P3|Period 2 (4 Weeks)|Protocol Violation|0
204364|NCT01122680|648309|P2|Period 2 (4 Weeks)|Protocol Violation|0
204365|NCT01122680|648310|P1|Period 2 (4 Weeks)|Protocol Violation|0
204366|NCT01122680|648307|P4|Period 1 (4 Weeks)|Other|0
204367|NCT01122680|648308|P3|Period 1 (4 Weeks)|Other|0
204368|NCT01122680|648309|P2|Period 1 (4 Weeks)|Other|1
204369|NCT01122680|648310|P1|Period 1 (4 Weeks)|Other|1
204370|NCT01122680|648307|P4|Period 1 (4 Weeks)|Protocol Violation|0
204371|NCT01122680|648308|P3|Period 1 (4 Weeks)|Protocol Violation|0
204372|NCT01122680|648309|P2|Period 1 (4 Weeks)|Protocol Violation|0
204373|NCT01122680|648310|P1|Period 1 (4 Weeks)|Protocol Violation|1
204374|NCT01122680|648307|P4|Period 1 (4 Weeks)|Adverse Event|0
204375|NCT01122680|648308|P3|Period 1 (4 Weeks)|Adverse Event|0
204376|NCT01122680|648309|P2|Period 1 (4 Weeks)|Adverse Event|0
204377|NCT01122680|648310|P1|Period 1 (4 Weeks)|Adverse Event|1
204378|NCT01122862|648372|P3|Period 2|Adverse Event|1
204379|NCT01122862|648373|P2|Period 2|Adverse Event|0
204380|NCT01122862|648374|P1|Period 2|Adverse Event|0
204381|NCT01122862|648372|P3|Period 1|Protocol Violation|0
204382|NCT01122862|648373|P2|Period 1|Protocol Violation|1
204383|NCT01122862|648374|P1|Period 1|Protocol Violation|0
204384|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
204385|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
204386|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
204387|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
204388|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
204389|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
204390|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
204391|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
204392|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
204393|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
204394|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
204395|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
204396|NCT01122927|648413|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
204397|NCT01122927|648414|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
204398|NCT01122927|648413|P2|Period 1 - Conversion Phase|Protocol Deviation|0
204399|NCT01122927|648414|P1|Period 1 - Conversion Phase|Protocol Deviation|1
204400|NCT01122927|648413|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
204401|NCT01122927|648414|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
204402|NCT01122927|648413|P2|Period 1 - Conversion Phase|Physician Decision|0
204403|NCT01122927|648414|P1|Period 1 - Conversion Phase|Physician Decision|2
204404|NCT01122927|648413|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
204405|NCT01122927|648414|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
204406|NCT01122927|648413|P2|Period 1 - Conversion Phase|Adverse Event|0
204407|NCT01122927|648414|P1|Period 1 - Conversion Phase|Adverse Event|3
204408|NCT01123148|648445|P1|Overall Study|Didn't meet milestone criteria|1
204409|NCT01123148|648445|P1|Overall Study|Coughing caused unacceptable EEG quality|1
204410|NCT01123161|648451|P2|Overall Study|Withdrawal by Subject|0
204411|NCT01123161|648452|P1|Overall Study|Withdrawal by Subject|1
204412|NCT01123161|648451|P2|Overall Study|Lost to Follow-up|0
204413|NCT01123161|648452|P1|Overall Study|Lost to Follow-up|1
204414|NCT01123200|648470|P1|Overall Study|Withdrawal by Subject|1
204415|NCT01123356|648475|P1|Overall Study|Withdrawal by Subject|1
204416|NCT01123356|648475|P1|Overall Study|Lack of Efficacy|4
204417|NCT01123356|648475|P1|Overall Study|Adverse Event|2
204418|NCT01123395|648483|P2|Washout Period of 14 Days|Withdrawal by Subject|1
204419|NCT01123395|648484|P1|Washout Period of 14 Days|Withdrawal by Subject|0
204420|NCT01123642|648503|P1|Overall Study|ineligible at baseline assessment|36
204421|NCT01123642|648503|P1|Overall Study|Withdrawal by Subject|9
204422|NCT01123642|648503|P1|Overall Study|Lost to Follow-up|23
204423|NCT01123850|648507|P1|Overall Study|Slow enrollment|45
204424|NCT01123889|648514|P2|Overall Study|Lost to Follow-up|1
204425|NCT01123889|648515|P1|Overall Study|Lost to Follow-up|3
204426|NCT01117428|648531|P6|Overall Study|Progressive disease|17
204427|NCT01117428|648532|P5|Overall Study|Progressive disease|16
204428|NCT01117428|648533|P4|Overall Study|Progressive disease|12
204429|NCT01117428|648534|P3|Overall Study|Progressive disease|10
204430|NCT01117428|648535|P2|Overall Study|Progressive disease|27
204431|NCT01117428|648536|P1|Overall Study|Progressive disease|15
204432|NCT01117428|648531|P6|Overall Study|Withdrawal by Subject|0
204433|NCT01117428|648532|P5|Overall Study|Withdrawal by Subject|0
204434|NCT01117428|648533|P4|Overall Study|Withdrawal by Subject|0
204435|NCT01117428|648534|P3|Overall Study|Withdrawal by Subject|1
204436|NCT01117428|648535|P2|Overall Study|Withdrawal by Subject|0
204437|NCT01117428|648536|P1|Overall Study|Withdrawal by Subject|0
204438|NCT01117428|648531|P6|Overall Study|Physician Decision|0
204439|NCT01117428|648532|P5|Overall Study|Physician Decision|0
204440|NCT01117428|648533|P4|Overall Study|Physician Decision|0
204441|NCT01117428|648534|P3|Overall Study|Physician Decision|0
204442|NCT01117428|648535|P2|Overall Study|Physician Decision|1
204443|NCT01117428|648536|P1|Overall Study|Physician Decision|0
204444|NCT01117428|648531|P6|Overall Study|Death|1
204445|NCT01117428|648532|P5|Overall Study|Death|0
204446|NCT01117428|648533|P4|Overall Study|Death|0
204447|NCT01117428|648534|P3|Overall Study|Death|2
204448|NCT01117428|648535|P2|Overall Study|Death|1
204449|NCT01117428|648536|P1|Overall Study|Death|0
204450|NCT01117428|648531|P6|Overall Study|Adverse Event|2
204451|NCT01117428|648532|P5|Overall Study|Adverse Event|1
204452|NCT01117428|648533|P4|Overall Study|Adverse Event|0
204453|NCT01117428|648534|P3|Overall Study|Adverse Event|0
204454|NCT01117428|648535|P2|Overall Study|Adverse Event|0
204455|NCT01117428|648536|P1|Overall Study|Adverse Event|4
204456|NCT01117428|648531|P6|Overall Study|Lack of Efficacy|0
204457|NCT01117428|648532|P5|Overall Study|Lack of Efficacy|0
204458|NCT01117428|648533|P4|Overall Study|Lack of Efficacy|0
204459|NCT01117428|648534|P3|Overall Study|Lack of Efficacy|0
204460|NCT01117428|648535|P2|Overall Study|Lack of Efficacy|0
204461|NCT01117428|648536|P1|Overall Study|Lack of Efficacy|1
204462|NCT01117454|648570|P2|Overall Study|Pregnancy|1
204463|NCT01117454|648571|P1|Overall Study|Pregnancy|0
204464|NCT01117480|648577|P1|Overall Study|Did Not Start Adalimumab Therapy|20
204465|NCT01117480|648577|P1|Overall Study|Protocol Violation|8
204466|NCT01117623|648591|P8|Overall Study|Invest. text: completed all planned txs|0
204467|NCT01117623|648592|P7|Overall Study|Invest. text: completed all planned txs|0
204468|NCT01117623|648593|P6|Overall Study|Invest. text: completed all planned txs|1
204469|NCT01117623|648594|P5|Overall Study|Invest. text: completed all planned txs|0
204470|NCT01117623|648595|P4|Overall Study|Invest. text: completed all planned txs|0
204471|NCT01117623|648596|P3|Overall Study|Invest. text: completed all planned txs|0
204472|NCT01117623|648597|P2|Overall Study|Invest. text: completed all planned txs|0
204473|NCT01117623|648598|P1|Overall Study|Invest. text: completed all planned txs|0
204474|NCT01117623|648591|P8|Overall Study|Non-compliance with study medication|1
204475|NCT01117623|648592|P7|Overall Study|Non-compliance with study medication|0
204476|NCT01117623|648593|P6|Overall Study|Non-compliance with study medication|0
204477|NCT01117623|648594|P5|Overall Study|Non-compliance with study medication|0
204478|NCT01117623|648595|P4|Overall Study|Non-compliance with study medication|0
204479|NCT01117623|648596|P3|Overall Study|Non-compliance with study medication|0
204480|NCT01117623|648597|P2|Overall Study|Non-compliance with study medication|0
204481|NCT01117623|648598|P1|Overall Study|Non-compliance with study medication|0
204482|NCT01117623|648591|P8|Overall Study|Withdrawal by Subject|1
204483|NCT01117623|648592|P7|Overall Study|Withdrawal by Subject|1
204484|NCT01117623|648593|P6|Overall Study|Withdrawal by Subject|1
204485|NCT01117623|648594|P5|Overall Study|Withdrawal by Subject|0
204486|NCT01117623|648595|P4|Overall Study|Withdrawal by Subject|0
204487|NCT01117623|648596|P3|Overall Study|Withdrawal by Subject|2
204488|NCT01117623|648597|P2|Overall Study|Withdrawal by Subject|0
204489|NCT01117623|648598|P1|Overall Study|Withdrawal by Subject|0
204490|NCT01117623|648591|P8|Overall Study|Disease progression, recurrence, relapse|22
204491|NCT01117623|648592|P7|Overall Study|Disease progression, recurrence, relapse|5
204492|NCT01117623|648593|P6|Overall Study|Disease progression, recurrence, relapse|14
204493|NCT01117623|648594|P5|Overall Study|Disease progression, recurrence, relapse|8
204494|NCT01117623|648595|P4|Overall Study|Disease progression, recurrence, relapse|6
204495|NCT01117623|648596|P3|Overall Study|Disease progression, recurrence, relapse|5
204496|NCT01117623|648597|P2|Overall Study|Disease progression, recurrence, relapse|6
204497|NCT01117623|648598|P1|Overall Study|Disease progression, recurrence, relapse|3
204498|NCT01117623|648591|P8|Overall Study|Adverse Event|2
204499|NCT01117623|648592|P7|Overall Study|Adverse Event|0
204500|NCT01117623|648593|P6|Overall Study|Adverse Event|0
204501|NCT01117623|648594|P5|Overall Study|Adverse Event|2
204502|NCT01117623|648595|P4|Overall Study|Adverse Event|0
204503|NCT01117623|648596|P3|Overall Study|Adverse Event|4
204504|NCT01117623|648597|P2|Overall Study|Adverse Event|2
204505|NCT01117623|648598|P1|Overall Study|Adverse Event|0
204506|NCT01117766|648755|P2|Second Intervention|Withdrawal by Subject|1
204507|NCT01117766|648756|P1|Second Intervention|Withdrawal by Subject|0
204508|NCT01117766|648755|P2|Second Intervention|Adverse Event|2
204509|NCT01117766|648756|P1|Second Intervention|Adverse Event|0
204510|NCT01117766|648755|P2|Second Intervention|Unspecified|2
204511|NCT01117766|648756|P1|Second Intervention|Unspecified|1
204512|NCT01117766|648755|P2|Second Intervention|Lost to Follow-up|0
204513|NCT01117766|648756|P1|Second Intervention|Lost to Follow-up|1
204514|NCT01117766|648755|P2|Washout Period|Protocol Violation|2
204515|NCT01117766|648756|P1|Washout Period|Protocol Violation|0
204516|NCT01117766|648755|P2|First Intervention|Protocol Violation|0
204517|NCT01117766|648756|P1|First Intervention|Protocol Violation|1
204518|NCT01117766|648755|P2|First Intervention|Unspecified|0
204519|NCT01117766|648756|P1|First Intervention|Unspecified|0
204520|NCT01117766|648755|P2|First Intervention|Adverse Event|1
204521|NCT01117766|648756|P1|First Intervention|Adverse Event|0
204522|NCT01117857|648780|P1|Overall Study|Physician Decision|1
204523|NCT01117857|648780|P1|Overall Study|Withdrawal by Subject|4
204524|NCT01117857|648780|P1|Overall Study|Lost to Follow-up|4
204525|NCT01117870|648790|P2|Overall Study|Inability to place needle|0
204526|NCT01117870|648791|P1|Overall Study|Inability to place needle|1
204527|NCT01117987|648816|P2|Overall Study|Administrative problems|22
204528|NCT01117987|648817|P1|Overall Study|Administrative problems|25
204529|NCT01117987|648816|P2|Overall Study|Adverse Event|26
204530|NCT01117987|648817|P1|Overall Study|Adverse Event|19
204531|NCT01117987|648816|P2|Overall Study|Withdrawal by Subject|10
204532|NCT01117987|648817|P1|Overall Study|Withdrawal by Subject|5
204533|NCT01117987|648816|P2|Overall Study|Death|10
204534|NCT01117987|648817|P1|Overall Study|Death|5
204535|NCT01117987|648816|P2|Overall Study|Lack of Efficacy|4
204536|NCT01117987|648817|P1|Overall Study|Lack of Efficacy|3
204537|NCT01117987|648816|P2|Overall Study|Abnormal test procedure result|0
204538|NCT01117987|648817|P1|Overall Study|Abnormal test procedure result|2
204539|NCT01117987|648816|P2|Overall Study|Lost to Follow-up|1
204540|NCT01117987|648817|P1|Overall Study|Lost to Follow-up|1
204541|NCT01117987|648816|P2|Overall Study|Subject no longer requires study drug|0
204542|NCT01117987|648817|P1|Overall Study|Subject no longer requires study drug|1
204543|NCT01117987|648816|P2|Overall Study|Protocol deviation|1
204544|NCT01117987|648817|P1|Overall Study|Protocol deviation|0
204545|NCT01118117|648850|P2|Overall Study|Missed 12 Month Visit|0
204546|NCT01118117|648851|P1|Overall Study|Missed 12 Month Visit|7
204547|NCT01118117|648850|P2|Overall Study|Lost to Follow-up|0
204548|NCT01118117|648851|P1|Overall Study|Lost to Follow-up|6
204549|NCT01118117|648850|P2|Overall Study|Death|0
204550|NCT01118117|648851|P1|Overall Study|Death|8
204551|NCT01118143|648872|P2|Overall Study|Withdrawal by Subject|5
204552|NCT01118143|648873|P1|Overall Study|Withdrawal by Subject|2
204553|NCT01118312|649071|P2|Overall Study|Withdrawal by Subject|3
204554|NCT01118312|649072|P1|Overall Study|Withdrawal by Subject|1
204555|NCT01118312|649071|P2|Overall Study|Lost to Follow-up|32
204556|NCT01118312|649072|P1|Overall Study|Lost to Follow-up|33
204557|NCT01123941|649103|P2|Overall Study|Lost to Follow-up|1
204558|NCT01123941|649104|P1|Overall Study|Lost to Follow-up|2
204559|NCT01123980|649118|P2|Overall Study|Unclassified|7
204560|NCT01123980|649119|P1|Overall Study|Unclassified|6
204561|NCT01123980|649118|P2|Overall Study|Withdrawal by Subject|3
204562|NCT01123980|649119|P1|Overall Study|Withdrawal by Subject|5
204563|NCT01123980|649118|P2|Overall Study|Protocol Violation|6
204564|NCT01123980|649119|P1|Overall Study|Protocol Violation|6
204565|NCT01123980|649118|P2|Overall Study|Lost to Follow-up|6
204566|NCT01123980|649119|P1|Overall Study|Lost to Follow-up|0
204567|NCT01123980|649118|P2|Overall Study|Physician Decision|1
204568|NCT01123980|649119|P1|Overall Study|Physician Decision|0
204569|NCT01123980|649118|P2|Overall Study|Lack of Efficacy|0
204570|NCT01123980|649119|P1|Overall Study|Lack of Efficacy|1
204571|NCT01123980|649118|P2|Overall Study|Adverse Event|1
204572|NCT01123980|649119|P1|Overall Study|Adverse Event|1
204573|NCT01124006|649140|P3|Overall Study|Other|1
204574|NCT01124006|649141|P2|Overall Study|Other|0
204575|NCT01124006|649142|P1|Overall Study|Other|0
204576|NCT01124006|649140|P3|Overall Study|Lost to Follow-up|1
204577|NCT01124006|649141|P2|Overall Study|Lost to Follow-up|0
204578|NCT01124006|649142|P1|Overall Study|Lost to Follow-up|1
204579|NCT01124006|649140|P3|Overall Study|Withdrawal by Subject|0
204580|NCT01124006|649141|P2|Overall Study|Withdrawal by Subject|2
204581|NCT01124006|649142|P1|Overall Study|Withdrawal by Subject|2
204582|NCT01124045|649170|P2|Overall Study|Physician Decision|2
204583|NCT01124045|649171|P1|Overall Study|Physician Decision|0
204584|NCT01124045|649170|P2|Overall Study|Lost to Follow-up|1
204585|NCT01124045|649171|P1|Overall Study|Lost to Follow-up|0
204586|NCT01124097|649205|P4|Overall Study|Physician Decision|0
204587|NCT01124097|649206|P3|Overall Study|Physician Decision|0
204588|NCT01124097|649207|P2|Overall Study|Physician Decision|1
204589|NCT01124097|649208|P1|Overall Study|Physician Decision|2
204590|NCT01124097|649205|P4|Overall Study|Protocol Violation|1
204591|NCT01124097|649206|P3|Overall Study|Protocol Violation|2
204592|NCT01124097|649207|P2|Overall Study|Protocol Violation|0
204593|NCT01124097|649208|P1|Overall Study|Protocol Violation|2
204594|NCT01124097|649205|P4|Overall Study|Adverse Event|7
204595|NCT01124097|649206|P3|Overall Study|Adverse Event|15
204596|NCT01124097|649207|P2|Overall Study|Adverse Event|15
204597|NCT01124097|649208|P1|Overall Study|Adverse Event|24
204598|NCT01124097|649205|P4|Overall Study|Lack of Efficacy|3
204599|NCT01124097|649206|P3|Overall Study|Lack of Efficacy|1
204600|NCT01124097|649207|P2|Overall Study|Lack of Efficacy|3
204601|NCT01124097|649208|P1|Overall Study|Lack of Efficacy|2
204602|NCT01124097|649205|P4|Overall Study|Withdrawal by Subject|3
204603|NCT01124097|649206|P3|Overall Study|Withdrawal by Subject|2
204604|NCT01124097|649207|P2|Overall Study|Withdrawal by Subject|3
204605|NCT01124097|649208|P1|Overall Study|Withdrawal by Subject|4
204606|NCT01124149|649218|P1|Maintenance Phase|Non-compliance|1
204607|NCT01124149|649218|P1|Maintenance Phase|Coordinator error|1
204608|NCT01124149|649218|P1|Maintenance Phase|Protocol Violation|5
204609|NCT01124149|649218|P1|Maintenance Phase|Withdrawal by Subject|10
204610|NCT01124149|649218|P1|Maintenance Phase|Lost to Follow-up|15
204611|NCT01124149|649218|P1|Maintenance Phase|Adverse Event|24
204612|NCT01124149|649218|P1|Maintenance Phase|Lack of Efficacy|40
204613|NCT01124149|649218|P1|Acute Phase|Sponsor decision|1
204614|NCT01124149|649218|P1|Acute Phase|Travelling to another country|1
204615|NCT01124149|649218|P1|Acute Phase|Low hemoglobin|1
204616|NCT01124149|649218|P1|Acute Phase|Non-compliance|1
204617|NCT01124149|649218|P1|Acute Phase|UC symptoms not ameliorated|1
204618|NCT01124149|649218|P1|Acute Phase|Sponsor request|1
204619|NCT01124149|649218|P1|Acute Phase|Prolonged antibiotic therapy|1
204620|NCT01124149|649218|P1|Acute Phase|Lost to Follow-up|2
204621|NCT01124149|649218|P1|Acute Phase|Protocol Violation|14
204622|NCT01124149|649218|P1|Acute Phase|Lack of Efficacy|17
204623|NCT01124149|649218|P1|Acute Phase|Adverse Event|21
204624|NCT01124149|649218|P1|Acute Phase|Withdrawal by Subject|22
204625|NCT01124162|649236|P2|Washout of 7 Days|Withdrawal by Subject|0
204626|NCT01124162|649237|P1|Washout of 7 Days|Withdrawal by Subject|1
204627|NCT01124162|649236|P2|First Intervention|Adverse Event|0
204628|NCT01124162|649237|P1|First Intervention|Adverse Event|2
204629|NCT01124175|649255|P2|Washout of 7 Days|Withdrawal by Subject|2
204630|NCT01124175|649256|P1|Washout of 7 Days|Withdrawal by Subject|0
204631|NCT01127139|649296|P1|Overall Study|Reason not specified|1
204632|NCT01127139|649296|P1|Overall Study|Lack of Efficacy|4
204633|NCT01127139|649296|P1|Overall Study|Incompliance|12
204634|NCT01127139|649296|P1|Overall Study|Adverse Event|40
204635|NCT01127165|649313|P2|Overall Study|Protocol Violation|1
204636|NCT01127165|649314|P1|Overall Study|Protocol Violation|0
204637|NCT01127165|649313|P2|Overall Study|Withdrawal by Subject|3
204638|NCT01127165|649314|P1|Overall Study|Withdrawal by Subject|1
204639|NCT01127165|649313|P2|Overall Study|Lost to Follow-up|5
204640|NCT01127165|649314|P1|Overall Study|Lost to Follow-up|3
204641|NCT01127165|649313|P2|Overall Study|Lack of Efficacy|8
204642|NCT01127165|649314|P1|Overall Study|Lack of Efficacy|10
204643|NCT01127165|649313|P2|Overall Study|Adverse Event|2
204644|NCT01127165|649314|P1|Overall Study|Adverse Event|2
204645|NCT01127256|649328|P2|Overall Study|Protocol Violation|0
204646|NCT01127256|649329|P1|Overall Study|Protocol Violation|1
204647|NCT01127256|649328|P2|Overall Study|Withdrawal by Subject|9
204648|NCT01127256|649329|P1|Overall Study|Withdrawal by Subject|5
204649|NCT01127256|649328|P2|Overall Study|Lost to Follow-up|17
204650|NCT01127256|649329|P1|Overall Study|Lost to Follow-up|16
204651|NCT01127256|649328|P2|Overall Study|Lack of Efficacy|0
204652|NCT01127256|649329|P1|Overall Study|Lack of Efficacy|4
204653|NCT01127256|649328|P2|Overall Study|Adverse Event|13
204654|NCT01127256|649329|P1|Overall Study|Adverse Event|13
204655|NCT01127607|649434|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
204656|NCT01127607|649435|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
204657|NCT01127607|649434|P2|Phase II (Between Subjects)|Lost to Follow-up|2
204658|NCT01127607|649435|P1|Phase II (Between Subjects)|Lost to Follow-up|0
204659|NCT01127646|649508|P2|Overall Study|Protocol Violation|1
204660|NCT01127646|649509|P1|Overall Study|Protocol Violation|0
204661|NCT01127646|649508|P2|Overall Study|Entry Criteria Not Met|0
204662|NCT01127646|649509|P1|Overall Study|Entry Criteria Not Met|1
204663|NCT01127763|649575|P1|Overall Study|Physician Decision|2
204664|NCT01127763|649575|P1|Overall Study|Withdrawal by Subject|1
204665|NCT01127763|649575|P1|Overall Study|Adverse Event|2
204666|NCT01128114|649597|P1|Overall Study|Screening Failed|2
204667|NCT01128114|649597|P1|Overall Study|Treatment Withdrawn|6
204668|NCT01128153|649603|P2|Overall Study|Developed discontinuation criteria|1
204669|NCT01128153|649604|P1|Overall Study|Developed discontinuation criteria|1
204670|NCT01128153|649603|P2|Overall Study|Protocol Violation|0
204671|NCT01128153|649604|P1|Overall Study|Protocol Violation|2
204672|NCT01128153|649603|P2|Overall Study|Incorrect enrolment to study|1
204673|NCT01128153|649604|P1|Overall Study|Incorrect enrolment to study|2
204674|NCT01128153|649603|P2|Overall Study|Withdrawal by Subject|3
204675|NCT01128153|649604|P1|Overall Study|Withdrawal by Subject|2
204676|NCT01128153|649603|P2|Overall Study|Condition under investigation worsened|7
204677|NCT01128153|649604|P1|Overall Study|Condition under investigation worsened|8
204678|NCT01128153|649603|P2|Overall Study|Adverse Event|3
204679|NCT01128153|649604|P1|Overall Study|Adverse Event|1
204680|NCT01128179|649622|P2|Overall Study|Protocol Violation|0
204681|NCT01128179|649623|P1|Overall Study|Protocol Violation|1
204682|NCT01128179|649622|P2|Overall Study|Death|0
204683|NCT01128179|649623|P1|Overall Study|Death|1
204684|NCT01128244|649672|P1|Overall Study|Scheduling conflict|2
204685|NCT01128244|649672|P1|Overall Study|Adverse Event|1
204686|NCT01128296|649693|P6|Overall Study|Withdrawal by Subject|2
204687|NCT01128296|649694|P5|Overall Study|Withdrawal by Subject|0
204688|NCT01128296|649695|P4|Overall Study|Withdrawal by Subject|0
204689|NCT01128296|649696|P3|Overall Study|Withdrawal by Subject|0
204690|NCT01128296|649697|P2|Overall Study|Withdrawal by Subject|0
204691|NCT01128296|649698|P1|Overall Study|Withdrawal by Subject|0
204692|NCT01128296|649693|P6|Overall Study|Physician Decision|3
204693|NCT01128296|649694|P5|Overall Study|Physician Decision|0
204694|NCT01128296|649695|P4|Overall Study|Physician Decision|0
204695|NCT01128296|649696|P3|Overall Study|Physician Decision|0
204696|NCT01128296|649697|P2|Overall Study|Physician Decision|0
204697|NCT01128296|649698|P1|Overall Study|Physician Decision|0
204698|NCT01128361|649718|P2|Overall Study|Withdrawal by Subject|2
204699|NCT01128361|649719|P1|Overall Study|Withdrawal by Subject|5
204700|NCT01128361|649718|P2|Overall Study|Lost to Follow-up|1
204701|NCT01128361|649719|P1|Overall Study|Lost to Follow-up|0
204702|NCT01128400|649734|P3|Overall Study|were not invited to participate on taste|15
204703|NCT01128400|649735|P2|Overall Study|were not invited to participate on taste|0
204704|NCT01128400|649736|P1|Overall Study|were not invited to participate on taste|0
204705|NCT01128400|649734|P3|Overall Study|Screening failure|0
204706|NCT01128400|649735|P2|Overall Study|Screening failure|0
204707|NCT01128400|649736|P1|Overall Study|Screening failure|1
204708|NCT01128400|649734|P3|Overall Study|Lost to Follow-up|1
204709|NCT01128400|649735|P2|Overall Study|Lost to Follow-up|0
204710|NCT01128400|649736|P1|Overall Study|Lost to Follow-up|1
204711|NCT01128413|649749|P2|Overall Study|Pt made DNR|0
204712|NCT01128413|649750|P1|Overall Study|Pt made DNR|1
204713|NCT01128413|649749|P2|Overall Study|NICOM Monitor Problems|1
204714|NCT01128413|649750|P1|Overall Study|NICOM Monitor Problems|2
204715|NCT01128413|649749|P2|Overall Study|Withdrawal by Subject|0
204716|NCT01128413|649750|P1|Overall Study|Withdrawal by Subject|1
204717|NCT01128543|649774|P1|Overall Study|Protocol Violation|1
204718|NCT01128543|649774|P1|Overall Study|Withdrawal by Subject|3
204719|NCT01128569|649780|P6|Treatment Period 2|Withdrawal by Subject|0
204720|NCT01128569|649781|P5|Treatment Period 2|Withdrawal by Subject|0
204721|NCT01128569|649782|P4|Treatment Period 2|Withdrawal by Subject|0
204722|NCT01128569|649783|P3|Treatment Period 2|Withdrawal by Subject|0
204723|NCT01128569|649784|P2|Treatment Period 2|Withdrawal by Subject|1
204724|NCT01128569|649785|P1|Treatment Period 2|Withdrawal by Subject|0
204725|NCT01128569|649780|P6|Washout Period 1|Adverse Event|0
204726|NCT01128569|649781|P5|Washout Period 1|Adverse Event|0
204727|NCT01128569|649782|P4|Washout Period 1|Adverse Event|0
204728|NCT01128569|649783|P3|Washout Period 1|Adverse Event|1
204729|NCT01128569|649784|P2|Washout Period 1|Adverse Event|0
204730|NCT01128569|649785|P1|Washout Period 1|Adverse Event|0
204731|NCT01128595|649802|P4|Treatment Period 3|Withdrawal by Subject|0
204732|NCT01128595|649803|P3|Treatment Period 3|Withdrawal by Subject|0
204733|NCT01128595|649804|P2|Treatment Period 3|Withdrawal by Subject|1
204734|NCT01128595|649805|P1|Treatment Period 3|Withdrawal by Subject|0
204735|NCT01128738|649837|P2|Second TP|Withdrawal by Subject|2
204736|NCT01128738|649838|P1|Second TP|Withdrawal by Subject|0
204737|NCT01128738|649837|P2|Second TP|Lost to Follow-up|1
204738|NCT01128738|649838|P1|Second TP|Lost to Follow-up|0
204739|NCT01128738|649837|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
204740|NCT01128738|649838|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
204741|NCT01128738|649837|P2|First Treatment Phase (TP)|Lost to Follow-up|0
204742|NCT01128738|649838|P1|First Treatment Phase (TP)|Lost to Follow-up|1
204743|NCT01128894|649968|P2|Overall Study|Conflicting HbA1c Results at Screening|0
204744|NCT01128894|649969|P1|Overall Study|Conflicting HbA1c Results at Screening|1
204745|NCT01128894|649968|P2|Overall Study|Physician Decision|1
204746|NCT01128894|649969|P1|Overall Study|Physician Decision|2
204747|NCT01128894|649968|P2|Overall Study|Withdrawal by Subject|12
204748|NCT01128894|649969|P1|Overall Study|Withdrawal by Subject|10
204749|NCT01128894|649968|P2|Overall Study|Lost to Follow-up|8
204750|NCT01128894|649969|P1|Overall Study|Lost to Follow-up|8
204751|NCT01128894|649968|P2|Overall Study|Noncompliance|5
204752|NCT01128894|649969|P1|Overall Study|Noncompliance|4
204753|NCT01128894|649968|P2|Overall Study|Protocol Violation|1
204754|NCT01128894|649969|P1|Overall Study|Protocol Violation|2
204755|NCT01128894|649968|P2|Overall Study|Adverse Event|41
204756|NCT01128894|649969|P1|Overall Study|Adverse Event|31
204757|NCT01128946|649987|P4|Period III|Protocol Violation|0
204758|NCT01128946|649988|P3|Period III|Protocol Violation|0
204759|NCT01128946|649989|P2|Period III|Protocol Violation|0
204760|NCT01128946|649990|P1|Period III|Protocol Violation|1
204761|NCT01128946|649987|P4|Period II|Withdrawal by Subject|1
204762|NCT01128946|649988|P3|Period II|Withdrawal by Subject|0
204763|NCT01128946|649989|P2|Period II|Withdrawal by Subject|0
204764|NCT01128946|649990|P1|Period II|Withdrawal by Subject|0
204765|NCT01128946|649987|P4|Period II|Protocol Violation|0
204766|NCT01128946|649988|P3|Period II|Protocol Violation|0
204767|NCT01128946|649989|P2|Period II|Protocol Violation|1
204768|NCT01128946|649990|P1|Period II|Protocol Violation|0
204769|NCT01128946|649987|P4|Period I|Withdrawal by Subject|1
204770|NCT01128946|649988|P3|Period I|Withdrawal by Subject|1
204771|NCT01128946|649989|P2|Period I|Withdrawal by Subject|0
204772|NCT01128946|649990|P1|Period I|Withdrawal by Subject|0
204773|NCT01128946|649987|P4|Period I|Protocol Violation|0
204774|NCT01128946|649988|P3|Period I|Protocol Violation|0
204775|NCT01128946|649989|P2|Period I|Protocol Violation|1
204776|NCT01128946|649990|P1|Period I|Protocol Violation|0
204777|NCT01128959|650006|P1|Treatment Period|Withdrawal by Subject|1
204778|NCT01128959|650006|P1|Treatment Period|Adverse Event|3
204779|NCT01128959|650006|P1|Lead in Period|Adverse Event|3
204780|NCT01129011|650047|P2|Overall Study|misc|4
204781|NCT01129011|650048|P1|Overall Study|misc|7
204782|NCT01129011|650047|P2|Overall Study|Duodenal Ulcer|8
204783|NCT01129011|650048|P1|Overall Study|Duodenal Ulcer|2
204784|NCT01129011|650047|P2|Overall Study|Lost to Follow-up|7
204785|NCT01129011|650048|P1|Overall Study|Lost to Follow-up|6
204786|NCT01129011|650047|P2|Overall Study|Withdrawal by Subject|8
204787|NCT01129011|650048|P1|Overall Study|Withdrawal by Subject|24
204788|NCT01129011|650047|P2|Overall Study|Adverse Event|30
204789|NCT01129011|650048|P1|Overall Study|Adverse Event|20
204790|NCT01129102|650073|P3|Overall Study|Lost to Follow-up|0
204791|NCT01129102|650074|P2|Overall Study|Lost to Follow-up|0
204792|NCT01129102|650075|P1|Overall Study|Lost to Follow-up|2
204793|NCT01129102|650073|P3|Overall Study|Adverse Event|1
204794|NCT01129102|650074|P2|Overall Study|Adverse Event|2
204795|NCT01129102|650075|P1|Overall Study|Adverse Event|2
204796|NCT01129102|650073|P3|Overall Study|Pregnancy|1
204797|NCT01129102|650074|P2|Overall Study|Pregnancy|0
204798|NCT01129102|650075|P1|Overall Study|Pregnancy|0
204799|NCT01129102|650073|P3|Overall Study|Protocol Violation|1
204800|NCT01129102|650074|P2|Overall Study|Protocol Violation|1
204801|NCT01129102|650075|P1|Overall Study|Protocol Violation|0
204802|NCT01129102|650073|P3|Overall Study|Withdrawal by Subject|3
204803|NCT01129102|650074|P2|Overall Study|Withdrawal by Subject|0
204804|NCT01129102|650075|P1|Overall Study|Withdrawal by Subject|2
204805|NCT01129102|650073|P3|Overall Study|No study drug treatment|1
204806|NCT01129102|650074|P2|Overall Study|No study drug treatment|3
204807|NCT01129102|650075|P1|Overall Study|No study drug treatment|2
204808|NCT01129115|650088|P4|Overall Study|Protocol Violation|2
204809|NCT01129115|650089|P3|Overall Study|Protocol Violation|2
204810|NCT01129115|650090|P2|Overall Study|Protocol Violation|2
204811|NCT01129115|650091|P1|Overall Study|Protocol Violation|0
204812|NCT01129115|650088|P4|Overall Study|Withdrawal by Subject|4
204813|NCT01129115|650089|P3|Overall Study|Withdrawal by Subject|1
204814|NCT01129115|650090|P2|Overall Study|Withdrawal by Subject|3
204815|NCT01129115|650091|P1|Overall Study|Withdrawal by Subject|1
204816|NCT01129115|650088|P4|Overall Study|Adverse Event|3
204817|NCT01129115|650089|P3|Overall Study|Adverse Event|3
204818|NCT01129115|650090|P2|Overall Study|Adverse Event|2
204819|NCT01129115|650091|P1|Overall Study|Adverse Event|1
204820|NCT01129128|650128|P3|Overall Study|Physician Decision|0
204821|NCT01129128|650129|P2|Overall Study|Physician Decision|0
204822|NCT01129128|650130|P1|Overall Study|Physician Decision|1
204823|NCT01129128|650128|P3|Overall Study|Withdrawal by Subject|3
204824|NCT01129128|650129|P2|Overall Study|Withdrawal by Subject|1
204825|NCT01129128|650130|P1|Overall Study|Withdrawal by Subject|0
204826|NCT01129128|650128|P3|Overall Study|Protocol Violation|0
204827|NCT01129128|650129|P2|Overall Study|Protocol Violation|1
204828|NCT01129128|650130|P1|Overall Study|Protocol Violation|0
204829|NCT01129128|650128|P3|Overall Study|Lost to Follow-up|1
204830|NCT01129128|650129|P2|Overall Study|Lost to Follow-up|2
204831|NCT01129128|650130|P1|Overall Study|Lost to Follow-up|2
204832|NCT01129284|650179|P3|Overall Study|Adverse Event|1
204833|NCT01129284|650180|P2|Overall Study|Adverse Event|0
204834|NCT01129284|650181|P1|Overall Study|Adverse Event|2
204835|NCT01129336|650194|P2|Overall Study|Death|4
204836|NCT01129336|650195|P1|Overall Study|Death|0
204837|NCT01129336|650194|P2|Overall Study|Missing Study Completion Status|3
204838|NCT01129336|650195|P1|Overall Study|Missing Study Completion Status|2
204839|NCT01129336|650194|P2|Overall Study|Adverse Event|1
204840|NCT01129336|650195|P1|Overall Study|Adverse Event|0
204841|NCT01129336|650194|P2|Overall Study|Withdrawal by Subject|4
204842|NCT01129336|650195|P1|Overall Study|Withdrawal by Subject|7
204843|NCT01129336|650194|P2|Overall Study|Lost to Follow-up|0
204844|NCT01129336|650195|P1|Overall Study|Lost to Follow-up|1
204845|NCT01129336|650194|P2|Overall Study|Disease Progression|4
204846|NCT01129336|650195|P1|Overall Study|Disease Progression|1
204847|NCT01129336|650194|P2|Overall Study|Protocol Violation|0
204848|NCT01129336|650195|P1|Overall Study|Protocol Violation|1
204849|NCT01121146|650209|P2|Overall Study|Lost to Follow-up|16
204850|NCT01121146|650210|P1|Overall Study|Lost to Follow-up|7
204851|NCT01121146|650209|P2|Overall Study|Adverse Event|11
204852|NCT01121146|650210|P1|Overall Study|Adverse Event|2
204853|NCT01121146|650209|P2|Overall Study|Death|15
204854|NCT01121146|650210|P1|Overall Study|Death|17
204855|NCT01121185|650236|P2|Overall Study|Not transplanted|0
204856|NCT01121185|650237|P1|Overall Study|Not transplanted|1
204857|NCT01121185|650236|P2|Overall Study|Not infused|1
204858|NCT01121185|650237|P1|Overall Study|Not infused|0
204859|NCT01121263|650272|P2|Overall Study|Withdrawal by Subject|1
204860|NCT01121263|650273|P1|Overall Study|Withdrawal by Subject|0
204861|NCT01121263|650272|P2|Overall Study|Lost to Follow-up|12
204862|NCT01121263|650273|P1|Overall Study|Lost to Follow-up|22
204863|NCT01121263|650272|P2|Overall Study|Death|2
204864|NCT01121263|650273|P1|Overall Study|Death|3
204865|NCT01121393|650283|P2|Overall Study|Not treated|9
204866|NCT01121393|650284|P1|Overall Study|Not treated|3
204867|NCT01121393|650283|P2|Overall Study|Refused cont. medication|7
204868|NCT01121393|650284|P1|Overall Study|Refused cont. medication|7
204869|NCT01121393|650283|P2|Overall Study|Lost to Follow-up|0
204870|NCT01121393|650284|P1|Overall Study|Lost to Follow-up|1
204871|NCT01121393|650283|P2|Overall Study|Non-compliant with protocol|3
204872|NCT01121393|650284|P1|Overall Study|Non-compliant with protocol|0
204873|NCT01121393|650283|P2|Overall Study|Other Adverse events|45
204874|NCT01121393|650284|P1|Overall Study|Other Adverse events|22
204875|NCT01121393|650283|P2|Overall Study|Progressive disease|20
204876|NCT01121393|650284|P1|Overall Study|Progressive disease|186
204877|NCT01121406|650329|P2|Overall Study|Not treated|0
204878|NCT01121406|650330|P1|Overall Study|Not treated|1
204879|NCT01121406|650329|P2|Overall Study|Reason other than specified above|6
204880|NCT01121406|650330|P1|Overall Study|Reason other than specified above|2
204881|NCT01121406|650329|P2|Overall Study|Refused continuation of study med.|2
204882|NCT01121406|650330|P1|Overall Study|Refused continuation of study med.|1
204883|NCT01121406|650329|P2|Overall Study|Lost to Follow-up|1
204884|NCT01121406|650330|P1|Overall Study|Lost to Follow-up|0
204885|NCT01121406|650329|P2|Overall Study|Non−compliant with protocol|2
204886|NCT01121406|650330|P1|Overall Study|Non−compliant with protocol|0
204887|NCT01121406|650329|P2|Overall Study|Other AE|10
204888|NCT01121406|650330|P1|Overall Study|Other AE|3
204889|NCT01121406|650329|P2|Overall Study|Wors. or AE of underlying cancer disease|6
204890|NCT01121406|650330|P1|Overall Study|Wors. or AE of underlying cancer disease|4
204891|NCT01121406|650329|P2|Overall Study|Progressive disease RECIST|28
204892|NCT01121406|650330|P1|Overall Study|Progressive disease RECIST|44
204893|NCT01129557|650406|P3|Overall Study|Novartis terminated study early|2
204894|NCT01129557|650407|P2|Overall Study|Novartis terminated study early|3
204895|NCT01129557|650408|P1|Overall Study|Novartis terminated study early|3
204896|NCT01129557|650406|P3|Overall Study|Adverse Event|2
204897|NCT01129557|650407|P2|Overall Study|Adverse Event|2
204898|NCT01129557|650408|P1|Overall Study|Adverse Event|1
204899|NCT01129583|650478|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
204900|NCT01129583|650479|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
204901|NCT01129583|650478|P2|Overall Study|Lost to Follow-up|1
204902|NCT01129583|650479|P1|Overall Study|Lost to Follow-up|1
204903|NCT01129583|650478|P2|Overall Study|Death|0
204904|NCT01129583|650479|P1|Overall Study|Death|1
204905|NCT01129622|650489|P1|Overall Study|Withdrawal by Subject|2
204906|NCT01130831|650521|P1|Overall Study|Information was missing|3
204907|NCT01130831|650521|P1|Overall Study|Death|4
204908|NCT01130831|650521|P1|Overall Study|Withdrawal by Subject|7
204909|NCT01130883|650590|P1|Overall Study|Adverse Event|3
204910|NCT01130883|650590|P1|Overall Study|Reason Unknown|1
204911|NCT01130883|650590|P1|Overall Study|Patient Noncompliance|6
204912|NCT01130974|650606|P2|Overall Study|Ineligibility criteria|2
204913|NCT01130974|650607|P1|Overall Study|Ineligibility criteria|5
204914|NCT01130974|650606|P2|Overall Study|Withdrawal by Subject|1
204915|NCT01130974|650607|P1|Overall Study|Withdrawal by Subject|0
204916|NCT01130974|650606|P2|Overall Study|Protocol Violation|10
204917|NCT01130974|650607|P1|Overall Study|Protocol Violation|10
204918|NCT01131078|650659|P3|Overall Study|Other|0
204919|NCT01131078|650660|P2|Overall Study|Other|1
204920|NCT01131078|650661|P1|Overall Study|Other|0
204921|NCT01131078|650659|P3|Overall Study|Death|2
204922|NCT01131078|650660|P2|Overall Study|Death|0
204923|NCT01131078|650661|P1|Overall Study|Death|4
204924|NCT01131078|650659|P3|Overall Study|Physician Decision|8
204925|NCT01131078|650660|P2|Overall Study|Physician Decision|6
204926|NCT01131078|650661|P1|Overall Study|Physician Decision|10
204927|NCT01131078|650659|P3|Overall Study|Non-compliance|0
204928|NCT01131078|650660|P2|Overall Study|Non-compliance|0
204929|NCT01131078|650661|P1|Overall Study|Non-compliance|3
204930|NCT01131078|650659|P3|Overall Study|Withdrawal by Subject|3
204931|NCT01131078|650660|P2|Overall Study|Withdrawal by Subject|4
204932|NCT01131078|650661|P1|Overall Study|Withdrawal by Subject|2
204933|NCT01131078|650659|P3|Overall Study|Lost to Follow-up|1
204934|NCT01131078|650660|P2|Overall Study|Lost to Follow-up|1
204935|NCT01131078|650661|P1|Overall Study|Lost to Follow-up|1
204936|NCT01131078|650659|P3|Overall Study|Protocol Violation|0
204937|NCT01131078|650660|P2|Overall Study|Protocol Violation|0
204938|NCT01131078|650661|P1|Overall Study|Protocol Violation|1
204939|NCT01131078|650659|P3|Overall Study|Progressive Disease|71
204940|NCT01131078|650660|P2|Overall Study|Progressive Disease|77
204941|NCT01131078|650661|P1|Overall Study|Progressive Disease|58
204942|NCT01131078|650659|P3|Overall Study|Adverse Event|17
204943|NCT01131078|650660|P2|Overall Study|Adverse Event|12
204944|NCT01131078|650661|P1|Overall Study|Adverse Event|22
204945|NCT01131130|650717|P1|Period 3- Crossover|+ Slit lamp finding|1
204946|NCT01131130|650717|P1|Period 1 - Baseline|Pregnancy|1
204947|NCT01131182|650732|P2|Overall Study|Other Reason|0
204948|NCT01131182|650733|P1|Overall Study|Other Reason|1
204949|NCT01131182|650732|P2|Overall Study|Lost to Follow-up|15
204950|NCT01131182|650733|P1|Overall Study|Lost to Follow-up|14
204951|NCT01131182|650732|P2|Overall Study|Withdrawal by Subject|1
204952|NCT01131182|650733|P1|Overall Study|Withdrawal by Subject|1
204953|NCT01131299|650741|P2|Overall Study|Withdrawal by Subject|7
204954|NCT01131299|650742|P1|Overall Study|Withdrawal by Subject|4
204955|NCT01131455|650756|P3|Overall Study|Death of PI|0
204956|NCT01131455|650757|P2|Overall Study|Death of PI|4
204957|NCT01131455|650758|P1|Overall Study|Death of PI|6
204958|NCT01131494|650766|P1|Overall Study|Withdrawal by Subject|2
204959|NCT01131507|650773|P1|Overall Study|Withdrawal by Subject|1
204960|NCT01131507|650773|P1|Overall Study|Lost to Follow-up|1
204961|NCT01131507|650773|P1|Overall Study|Adverse Event|1
204962|NCT01131520|650780|P2|Overall Study|Subject changed history after enrollment|1
204963|NCT01131520|650781|P1|Overall Study|Subject changed history after enrollment|0
204964|NCT01131520|650780|P2|Overall Study|Counselor not available|3
204965|NCT01131520|650781|P1|Overall Study|Counselor not available|0
204966|NCT01131520|650780|P2|Overall Study|Computer problem|0
204967|NCT01131520|650781|P1|Overall Study|Computer problem|1
204968|NCT01131585|650805|P2|Overall Study|Study termination|32
204969|NCT01131585|650806|P1|Overall Study|Study termination|78
204970|NCT01131585|650805|P2|Overall Study|Administrative problems|1
204971|NCT01131585|650806|P1|Overall Study|Administrative problems|1
204972|NCT01131585|650805|P2|Overall Study|Lost to Follow-up|1
204973|NCT01131585|650806|P1|Overall Study|Lost to Follow-up|0
204974|NCT01131585|650805|P2|Overall Study|Withdrawal by Subject|3
204975|NCT01131585|650806|P1|Overall Study|Withdrawal by Subject|3
204976|NCT01131585|650805|P2|Overall Study|Protocol Violation|1
204977|NCT01131585|650806|P1|Overall Study|Protocol Violation|2
204978|NCT01131585|650805|P2|Overall Study|Unsatisfactory therapeutic effect|3
204979|NCT01131585|650806|P1|Overall Study|Unsatisfactory therapeutic effect|0
204980|NCT01131585|650805|P2|Overall Study|Abnormal laboratory value|0
204981|NCT01131585|650806|P1|Overall Study|Abnormal laboratory value|1
204982|NCT01131585|650805|P2|Overall Study|Adverse Event|2
204983|NCT01131585|650806|P1|Overall Study|Adverse Event|0
204984|NCT01131676|650815|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
204985|NCT01131676|650816|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
204986|NCT01131676|650817|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
204987|NCT01131676|650815|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
204988|NCT01131676|650816|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
204989|NCT01131676|650817|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
204990|NCT01131676|650815|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
204991|NCT01131676|650816|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
204992|NCT01131676|650817|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
204993|NCT01131676|650815|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
204994|NCT01131676|650816|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
204995|NCT01131676|650817|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
204996|NCT01131676|650815|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
204997|NCT01131676|650816|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
204998|NCT01131676|650817|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
204999|NCT01131676|650815|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
205000|NCT01131676|650816|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
205001|NCT01131676|650817|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
205002|NCT01131676|650815|P3|Discontinuation From Treatment|Adverse Event|273
205003|NCT01131676|650816|P2|Discontinuation From Treatment|Adverse Event|267
205004|NCT01131676|650817|P1|Discontinuation From Treatment|Adverse Event|303
205005|NCT01131676|650815|P3|Discontinuation From Treatment|Other than those specified|125
205006|NCT01131676|650816|P2|Discontinuation From Treatment|Other than those specified|142
205007|NCT01131676|650817|P1|Discontinuation From Treatment|Other than those specified|162
205008|NCT01131676|650815|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
205009|NCT01131676|650816|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
205010|NCT01131676|650817|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
205011|NCT01131676|650815|P3|Discontinuation From Treatment|Lost to Follow-up|6
205012|NCT01131676|650816|P2|Discontinuation From Treatment|Lost to Follow-up|9
205013|NCT01131676|650817|P1|Discontinuation From Treatment|Lost to Follow-up|15
205014|NCT01131676|650815|P3|Discontinuation From Treatment|Non compliant with protocol|12
205015|NCT01131676|650816|P2|Discontinuation From Treatment|Non compliant with protocol|15
205016|NCT01131676|650817|P1|Discontinuation From Treatment|Non compliant with protocol|15
205017|NCT01131676|650815|P3|Discontinuation From Treatment|Lack of Efficacy|0
205018|NCT01131676|650816|P2|Discontinuation From Treatment|Lack of Efficacy|1
205019|NCT01131676|650817|P1|Discontinuation From Treatment|Lack of Efficacy|11
205020|NCT01131676|650815|P3|Discontinuation From Treatment|Not treated|2
205021|NCT01131676|650816|P2|Discontinuation From Treatment|Not treated|2
205022|NCT01131676|650817|P1|Discontinuation From Treatment|Not treated|4
205023|NCT01131676|650815|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
205024|NCT01131676|650816|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
205025|NCT01131676|650817|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
205026|NCT01132118|650861|P2|Second Intervention (8 Weeks)|Adverse Event|1
205027|NCT01132118|650862|P1|Second Intervention (8 Weeks)|Adverse Event|0
205028|NCT01132118|650861|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
205029|NCT01132118|650862|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
205030|NCT01132118|650861|P2|First Intervention (8 Weeks)|Adverse Event|0
205031|NCT01132118|650862|P1|First Intervention (8 Weeks)|Adverse Event|1
205032|NCT01132313|650915|P12|Overall Study|Other reason not defined above|0
205033|NCT01132313|650916|P11|Overall Study|Other reason not defined above|0
205034|NCT01132313|650917|P10|Overall Study|Other reason not defined above|0
205035|NCT01132313|650918|P9|Overall Study|Other reason not defined above|0
205036|NCT01132313|650919|P8|Overall Study|Other reason not defined above|1
205037|NCT01132313|650920|P7|Overall Study|Other reason not defined above|0
205038|NCT01132313|650921|P6|Overall Study|Other reason not defined above|0
205039|NCT01132313|650922|P5|Overall Study|Other reason not defined above|0
205040|NCT01132313|650923|P4|Overall Study|Other reason not defined above|0
205041|NCT01132313|650924|P3|Overall Study|Other reason not defined above|0
205042|NCT01132313|650925|P2|Overall Study|Other reason not defined above|0
205043|NCT01132313|650926|P1|Overall Study|Other reason not defined above|0
205044|NCT01132313|650915|P12|Overall Study|Lack of antiviral response|0
205045|NCT01132313|650916|P11|Overall Study|Lack of antiviral response|1
205046|NCT01132313|650917|P10|Overall Study|Lack of antiviral response|0
205047|NCT01132313|650918|P9|Overall Study|Lack of antiviral response|0
205048|NCT01132313|650919|P8|Overall Study|Lack of antiviral response|0
205049|NCT01132313|650920|P7|Overall Study|Lack of antiviral response|21
205050|NCT01132313|650921|P6|Overall Study|Lack of antiviral response|18
205051|NCT01132313|650922|P5|Overall Study|Lack of antiviral response|18
205052|NCT01132313|650923|P4|Overall Study|Lack of antiviral response|18
205053|NCT01132313|650924|P3|Overall Study|Lack of antiviral response|12
205054|NCT01132313|650925|P2|Overall Study|Lack of antiviral response|0
205055|NCT01132313|650926|P1|Overall Study|Lack of antiviral response|0
205056|NCT01132313|650915|P12|Overall Study|Withdrawal by Subject|0
205057|NCT01132313|650916|P11|Overall Study|Withdrawal by Subject|0
205058|NCT01132313|650917|P10|Overall Study|Withdrawal by Subject|2
205059|NCT01132313|650918|P9|Overall Study|Withdrawal by Subject|0
205060|NCT01132313|650919|P8|Overall Study|Withdrawal by Subject|0
205061|NCT01132313|650920|P7|Overall Study|Withdrawal by Subject|1
205062|NCT01132313|650921|P6|Overall Study|Withdrawal by Subject|0
205063|NCT01132313|650922|P5|Overall Study|Withdrawal by Subject|6
205064|NCT01132313|650923|P4|Overall Study|Withdrawal by Subject|3
205065|NCT01132313|650924|P3|Overall Study|Withdrawal by Subject|3
205066|NCT01132313|650925|P2|Overall Study|Withdrawal by Subject|0
205067|NCT01132313|650926|P1|Overall Study|Withdrawal by Subject|0
205068|NCT01132313|650915|P12|Overall Study|Lost to Follow-up|0
205069|NCT01132313|650916|P11|Overall Study|Lost to Follow-up|0
205070|NCT01132313|650917|P10|Overall Study|Lost to Follow-up|0
205071|NCT01132313|650918|P9|Overall Study|Lost to Follow-up|0
205072|NCT01132313|650919|P8|Overall Study|Lost to Follow-up|1
205073|NCT01132313|650920|P7|Overall Study|Lost to Follow-up|0
205074|NCT01132313|650921|P6|Overall Study|Lost to Follow-up|0
205075|NCT01132313|650922|P5|Overall Study|Lost to Follow-up|0
205076|NCT01132313|650923|P4|Overall Study|Lost to Follow-up|0
205077|NCT01132313|650924|P3|Overall Study|Lost to Follow-up|1
205078|NCT01132313|650925|P2|Overall Study|Lost to Follow-up|0
205079|NCT01132313|650926|P1|Overall Study|Lost to Follow-up|0
205080|NCT01132313|650915|P12|Overall Study|Protocol Violation|0
205081|NCT01132313|650916|P11|Overall Study|Protocol Violation|0
205082|NCT01132313|650917|P10|Overall Study|Protocol Violation|0
205083|NCT01132313|650918|P9|Overall Study|Protocol Violation|0
205084|NCT01132313|650919|P8|Overall Study|Protocol Violation|0
205085|NCT01132313|650920|P7|Overall Study|Protocol Violation|0
205086|NCT01132313|650921|P6|Overall Study|Protocol Violation|0
205087|NCT01132313|650922|P5|Overall Study|Protocol Violation|0
205088|NCT01132313|650923|P4|Overall Study|Protocol Violation|1
205089|NCT01132313|650924|P3|Overall Study|Protocol Violation|0
205090|NCT01132313|650925|P2|Overall Study|Protocol Violation|0
205091|NCT01132313|650926|P1|Overall Study|Protocol Violation|0
205092|NCT01132313|650915|P12|Overall Study|Adverse Event|0
205093|NCT01132313|650916|P11|Overall Study|Adverse Event|0
205094|NCT01132313|650917|P10|Overall Study|Adverse Event|2
205095|NCT01132313|650918|P9|Overall Study|Adverse Event|7
205096|NCT01132313|650919|P8|Overall Study|Adverse Event|3
205097|NCT01132313|650920|P7|Overall Study|Adverse Event|5
205098|NCT01132313|650921|P6|Overall Study|Adverse Event|6
205099|NCT01132313|650922|P5|Overall Study|Adverse Event|19
205100|NCT01132313|650923|P4|Overall Study|Adverse Event|10
205101|NCT01132313|650924|P3|Overall Study|Adverse Event|4
205102|NCT01132313|650925|P2|Overall Study|Adverse Event|0
205103|NCT01132313|650926|P1|Overall Study|Adverse Event|0
205104|NCT01132313|650915|P12|Overall Study|Not treated|0
205105|NCT01132313|650916|P11|Overall Study|Not treated|0
205106|NCT01132313|650917|P10|Overall Study|Not treated|0
205107|NCT01132313|650918|P9|Overall Study|Not treated|0
205108|NCT01132313|650919|P8|Overall Study|Not treated|0
205109|NCT01132313|650920|P7|Overall Study|Not treated|3
205110|NCT01132313|650921|P6|Overall Study|Not treated|1
205111|NCT01132313|650922|P5|Overall Study|Not treated|2
205112|NCT01132313|650923|P4|Overall Study|Not treated|0
205113|NCT01132313|650924|P3|Overall Study|Not treated|0
205114|NCT01132313|650925|P2|Overall Study|Not treated|0
205115|NCT01132313|650926|P1|Overall Study|Not treated|2
205116|NCT01132313|650915|P12|Overall Study|Lack of Efficacy|0
205117|NCT01132313|650916|P11|Overall Study|Lack of Efficacy|0
205118|NCT01132313|650917|P10|Overall Study|Lack of Efficacy|16
205119|NCT01132313|650918|P9|Overall Study|Lack of Efficacy|14
205120|NCT01132313|650919|P8|Overall Study|Lack of Efficacy|3
205121|NCT01132313|650920|P7|Overall Study|Lack of Efficacy|0
205122|NCT01132313|650921|P6|Overall Study|Lack of Efficacy|0
205123|NCT01132313|650922|P5|Overall Study|Lack of Efficacy|0
205124|NCT01132313|650923|P4|Overall Study|Lack of Efficacy|0
205125|NCT01132313|650924|P3|Overall Study|Lack of Efficacy|0
205126|NCT01132313|650925|P2|Overall Study|Lack of Efficacy|0
205127|NCT01132313|650926|P1|Overall Study|Lack of Efficacy|1
205128|NCT01132326|650981|P1|Overall Study|Subject Unable to Come To Visits|1
205129|NCT01132326|650981|P1|Overall Study|Death|5
205130|NCT01132326|650981|P1|Overall Study|Caregiver Withdrew Consent|1
205131|NCT01132326|650981|P1|Overall Study|Pregnancy|1
205132|NCT01132326|650981|P1|Overall Study|Declining Health|1
205133|NCT01132326|650981|P1|Overall Study|Study Termination|80
205134|NCT01132326|650981|P1|Overall Study|Physician Decision|10
205135|NCT01132326|650981|P1|Overall Study|Withdrawal by Subject|40
205136|NCT01132326|650981|P1|Overall Study|Lost to Follow-up|16
205137|NCT01132326|650981|P1|Overall Study|Protocol Violation|1
205138|NCT01132326|650981|P1|Overall Study|Adverse Event|37
205139|NCT01132326|650981|P1|Overall Study|Lack of Efficacy|25
205140|NCT01132495|650994|P4|Overall Study|Various reasons|12
205141|NCT01132495|650995|P3|Overall Study|Various reasons|20
205142|NCT01132495|650996|P2|Overall Study|Various reasons|38
205143|NCT01132495|650997|P1|Overall Study|Various reasons|40
205144|NCT01132547|651063|P2|Overall Study|Death|0
205145|NCT01132547|651064|P1|Overall Study|Death|1
205146|NCT01132547|651063|P2|Overall Study|Withdrawal by Subject|1
205147|NCT01132547|651064|P1|Overall Study|Withdrawal by Subject|3
205148|NCT01132651|651076|P2|Overall Study|Lost to Follow-up|1
205149|NCT01132651|651077|P1|Overall Study|Lost to Follow-up|1
205150|NCT01132664|651090|P5|BM Cohort|Withdrawal by Subject|1
205151|NCT01132664|651091|P4|BM Cohort|Withdrawal by Subject|0
205152|NCT01132664|651092|P3|BM Cohort|Withdrawal by Subject|0
205153|NCT01132664|651093|P2|BM Cohort|Withdrawal by Subject|0
205154|NCT01132664|651094|P1|BM Cohort|Withdrawal by Subject|0
205155|NCT01132664|651090|P5|BM Cohort|Adverse Event|1
205156|NCT01132664|651091|P4|BM Cohort|Adverse Event|0
205157|NCT01132664|651092|P3|BM Cohort|Adverse Event|0
205158|NCT01132664|651093|P2|BM Cohort|Adverse Event|0
205159|NCT01132664|651094|P1|BM Cohort|Adverse Event|0
205160|NCT01132664|651090|P5|BM Cohort|Disease progression|4
205161|NCT01132664|651091|P4|BM Cohort|Disease progression|3
205162|NCT01132664|651092|P3|BM Cohort|Disease progression|0
205163|NCT01132664|651093|P2|BM Cohort|Disease progression|0
205164|NCT01132664|651094|P1|BM Cohort|Disease progression|0
205165|NCT01132664|651090|P5|Phase ll|Disease progression|0
205166|NCT01132664|651091|P4|Phase ll|Disease progression|0
205167|NCT01132664|651092|P3|Phase ll|Disease progression|35
205168|NCT01132664|651093|P2|Phase ll|Disease progression|0
205169|NCT01132664|651094|P1|Phase ll|Disease progression|0
205170|NCT01132664|651090|P5|Phase ll|Withdrawal by Subject|0
205171|NCT01132664|651091|P4|Phase ll|Withdrawal by Subject|0
205172|NCT01132664|651092|P3|Phase ll|Withdrawal by Subject|3
205173|NCT01132664|651093|P2|Phase ll|Withdrawal by Subject|0
205174|NCT01132664|651094|P1|Phase ll|Withdrawal by Subject|0
205175|NCT01132664|651090|P5|Phase ll|Adverse Event|0
205176|NCT01132664|651091|P4|Phase ll|Adverse Event|0
205177|NCT01132664|651092|P3|Phase ll|Adverse Event|10
205178|NCT01132664|651093|P2|Phase ll|Adverse Event|0
205179|NCT01132664|651094|P1|Phase ll|Adverse Event|0
205180|NCT01132664|651090|P5|Phase ll|Death|0
205181|NCT01132664|651091|P4|Phase ll|Death|0
205182|NCT01132664|651092|P3|Phase ll|Death|2
205183|NCT01132664|651093|P2|Phase ll|Death|0
205184|NCT01132664|651094|P1|Phase ll|Death|0
205185|NCT01132664|651090|P5|Phase lb|Disease Progression|0
205186|NCT01132664|651091|P4|Phase lb|Disease Progression|0
205187|NCT01132664|651092|P3|Phase lb|Disease Progression|0
205188|NCT01132664|651093|P2|Phase lb|Disease Progression|9
205189|NCT01132664|651094|P1|Phase lb|Disease Progression|4
205190|NCT01132664|651090|P5|Phase lb|Withdrawal by Subject|0
205191|NCT01132664|651091|P4|Phase lb|Withdrawal by Subject|0
205192|NCT01132664|651092|P3|Phase lb|Withdrawal by Subject|0
205193|NCT01132664|651093|P2|Phase lb|Withdrawal by Subject|2
205194|NCT01132664|651094|P1|Phase lb|Withdrawal by Subject|1
205195|NCT01132664|651090|P5|Phase lb|Adverse Event|0
205196|NCT01132664|651091|P4|Phase lb|Adverse Event|0
205197|NCT01132664|651092|P3|Phase lb|Adverse Event|0
205198|NCT01132664|651093|P2|Phase lb|Adverse Event|1
205199|NCT01132664|651094|P1|Phase lb|Adverse Event|0
205200|NCT01132820|651145|P1|Overall Study|Inadequate data|1
205201|NCT01132820|651145|P1|Overall Study|Never treated|1
205202|NCT01132820|651145|P1|Overall Study|Ineligible:Inadequate pathology|1
205203|NCT01132820|651145|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
205204|NCT01132820|651145|P1|Overall Study|Ineligible: wrong cell type|1
205205|NCT01133171|651212|P3|Overall Study|Withdrawal by Subject|0
205206|NCT01133171|651213|P2|Overall Study|Withdrawal by Subject|2
205207|NCT01133171|651214|P1|Overall Study|Withdrawal by Subject|1
205208|NCT01124604|651226|P2|Overall Study|Disease Progression|1
205209|NCT01124604|651227|P1|Overall Study|Disease Progression|0
205210|NCT01124604|651226|P2|Overall Study|Withdrawal by Subject|0
205211|NCT01124604|651227|P1|Overall Study|Withdrawal by Subject|4
205212|NCT01124604|651226|P2|Overall Study|Lack of Efficacy|0
205213|NCT01124604|651227|P1|Overall Study|Lack of Efficacy|1
205214|NCT01124604|651226|P2|Overall Study|Adverse Event|1
205215|NCT01124604|651227|P1|Overall Study|Adverse Event|10
205216|NCT01124617|651266|P2|Overall Study|Unspecified|1
205217|NCT01124617|651267|P1|Overall Study|Unspecified|2
205218|NCT01124617|651266|P2|Overall Study|Withdrawal by Subject|1
205219|NCT01124617|651267|P1|Overall Study|Withdrawal by Subject|9
205220|NCT01124617|651266|P2|Overall Study|Protocol Violation|1
205221|NCT01124617|651267|P1|Overall Study|Protocol Violation|1
205222|NCT01124617|651266|P2|Overall Study|Lack of Efficacy|1
205223|NCT01124617|651267|P1|Overall Study|Lack of Efficacy|2
205224|NCT01124617|651266|P2|Overall Study|Adverse Event|2
205225|NCT01124617|651267|P1|Overall Study|Adverse Event|5
205226|NCT01124643|651297|P1|Overall Study|Death|1
205227|NCT01124838|651334|P2|Overall Study|Lost to Follow-up|0
205228|NCT01124838|651335|P1|Overall Study|Lost to Follow-up|2
205229|NCT01124838|651334|P2|Overall Study|Withdrawal by Subject|2
205230|NCT01124838|651335|P1|Overall Study|Withdrawal by Subject|3
205231|NCT01124838|651334|P2|Overall Study|Lack of Efficacy|0
205232|NCT01124838|651335|P1|Overall Study|Lack of Efficacy|2
205233|NCT01124838|651334|P2|Overall Study|Adverse Event|11
205234|NCT01124838|651335|P1|Overall Study|Adverse Event|7
205235|NCT01124838|651334|P2|Overall Study|Miscellaneous|2
205236|NCT01124838|651335|P1|Overall Study|Miscellaneous|4
205237|NCT01124864|651385|P6|Overall Study|Protocol Violation|0
205238|NCT01124864|651386|P5|Overall Study|Protocol Violation|1
205239|NCT01124864|651387|P4|Overall Study|Protocol Violation|0
205240|NCT01124864|651388|P3|Overall Study|Protocol Violation|0
205241|NCT01124864|651389|P2|Overall Study|Protocol Violation|0
205242|NCT01124864|651390|P1|Overall Study|Protocol Violation|1
205243|NCT01124864|651385|P6|Overall Study|Lost to Follow-up|0
205244|NCT01124864|651386|P5|Overall Study|Lost to Follow-up|0
205245|NCT01124864|651387|P4|Overall Study|Lost to Follow-up|1
205246|NCT01124864|651388|P3|Overall Study|Lost to Follow-up|0
205247|NCT01124864|651389|P2|Overall Study|Lost to Follow-up|1
205248|NCT01124864|651390|P1|Overall Study|Lost to Follow-up|1
205249|NCT01124864|651385|P6|Overall Study|Withdrawal by Subject|1
205250|NCT01124864|651386|P5|Overall Study|Withdrawal by Subject|2
205251|NCT01124864|651387|P4|Overall Study|Withdrawal by Subject|0
205252|NCT01124864|651388|P3|Overall Study|Withdrawal by Subject|4
205253|NCT01124864|651389|P2|Overall Study|Withdrawal by Subject|3
205254|NCT01124864|651390|P1|Overall Study|Withdrawal by Subject|2
205255|NCT01124864|651385|P6|Overall Study|Death|0
205256|NCT01124864|651386|P5|Overall Study|Death|1
205257|NCT01124864|651387|P4|Overall Study|Death|2
205258|NCT01124864|651388|P3|Overall Study|Death|6
205259|NCT01124864|651389|P2|Overall Study|Death|9
205260|NCT01124864|651390|P1|Overall Study|Death|6
205261|NCT01124864|651385|P6|Overall Study|Follow up phase competed as per protocol|2
205262|NCT01124864|651386|P5|Overall Study|Follow up phase competed as per protocol|26
205263|NCT01124864|651387|P4|Overall Study|Follow up phase competed as per protocol|18
205264|NCT01124864|651388|P3|Overall Study|Follow up phase competed as per protocol|24
205265|NCT01124864|651389|P2|Overall Study|Follow up phase competed as per protocol|22
205266|NCT01124864|651390|P1|Overall Study|Follow up phase competed as per protocol|18
205267|NCT01124916|651424|P2|Overall Study|Lost to Follow-up|2
205268|NCT01124916|651425|P1|Overall Study|Lost to Follow-up|3
205269|NCT01125189|651462|P3|Follow up Period|Other reasons|5
205270|NCT01125189|651463|P2|Follow up Period|Other reasons|4
205271|NCT01125189|651464|P1|Follow up Period|Other reasons|4
205272|NCT01125189|651462|P3|Follow up Period|Lost to Follow-up|6
205273|NCT01125189|651463|P2|Follow up Period|Lost to Follow-up|9
205274|NCT01125189|651464|P1|Follow up Period|Lost to Follow-up|12
205275|NCT01125189|651462|P3|Follow up Period|Death|0
205276|NCT01125189|651463|P2|Follow up Period|Death|0
205277|NCT01125189|651464|P1|Follow up Period|Death|1
205278|NCT01125189|651462|P3|Follow up Period|Withdrawal by Subject|5
205279|NCT01125189|651463|P2|Follow up Period|Withdrawal by Subject|2
205280|NCT01125189|651464|P1|Follow up Period|Withdrawal by Subject|3
205281|NCT01125189|651462|P3|Treatment Period|Completed 24 week treatment period only|2
205282|NCT01125189|651463|P2|Treatment Period|Completed 24 week treatment period only|1
205283|NCT01125189|651464|P1|Treatment Period|Completed 24 week treatment period only|2
205284|NCT01125189|651462|P3|Treatment Period|Other reasons|0
205285|NCT01125189|651463|P2|Treatment Period|Other reasons|1
205286|NCT01125189|651464|P1|Treatment Period|Other reasons|1
205287|NCT01125189|651462|P3|Treatment Period|Participants requested to discontinue|4
205288|NCT01125189|651463|P2|Treatment Period|Participants requested to discontinue|3
205289|NCT01125189|651464|P1|Treatment Period|Participants requested to discontinue|1
205290|NCT01125189|651462|P3|Treatment Period|Poor compliance/noncompliance|0
205291|NCT01125189|651463|P2|Treatment Period|Poor compliance/noncompliance|1
205292|NCT01125189|651464|P1|Treatment Period|Poor compliance/noncompliance|0
205293|NCT01125189|651462|P3|Treatment Period|Lost to Follow-up|1
205294|NCT01125189|651463|P2|Treatment Period|Lost to Follow-up|2
205295|NCT01125189|651464|P1|Treatment Period|Lost to Follow-up|1
205296|NCT01125189|651462|P3|Treatment Period|Death|0
205297|NCT01125189|651463|P2|Treatment Period|Death|0
205298|NCT01125189|651464|P1|Treatment Period|Death|1
205299|NCT01125189|651462|P3|Treatment Period|Withdrawal by Subject|1
205300|NCT01125189|651463|P2|Treatment Period|Withdrawal by Subject|1
205301|NCT01125189|651464|P1|Treatment Period|Withdrawal by Subject|3
205302|NCT01125189|651462|P3|Treatment Period|Adverse Event|8
205303|NCT01125189|651463|P2|Treatment Period|Adverse Event|8
205304|NCT01125189|651464|P1|Treatment Period|Adverse Event|7
205305|NCT01125189|651462|P3|Treatment Period|Lack of Efficacy|25
205306|NCT01125189|651463|P2|Treatment Period|Lack of Efficacy|18
205307|NCT01125189|651464|P1|Treatment Period|Lack of Efficacy|15
205308|NCT01125514|651515|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
205309|NCT01125514|651515|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
205310|NCT01125514|651515|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
205311|NCT01125514|651515|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
205312|NCT01125514|651515|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
205313|NCT01125514|651515|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
205314|NCT01125566|651589|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|4
205315|NCT01125566|651590|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
205316|NCT01125566|651591|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
205317|NCT01125566|651589|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|20
205318|NCT01125566|651590|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
205319|NCT01125566|651591|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
205320|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Other than those stated above|0
205321|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Other than those stated above|5
205322|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Other than those stated above|23
205323|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Not treated|0
205324|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Not treated|0
205325|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Not treated|2
205326|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
205327|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|21
205328|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|25
205329|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
205330|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|1
205331|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
205332|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
205333|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
205334|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Adverse Event|24
205335|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
205336|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|4
205337|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|5
205338|NCT01125566|651589|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
205339|NCT01125566|651590|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|100
205340|NCT01125566|651591|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|181
205341|NCT01125722|651637|P2|Overall Study|Lost to Follow-up|0
205342|NCT01125722|651638|P1|Overall Study|Lost to Follow-up|1
205343|NCT01125722|651637|P2|Overall Study|Withdrawal by Subject|1
205344|NCT01125722|651638|P1|Overall Study|Withdrawal by Subject|2
205345|NCT01125748|651654|P2|Overall Study|Patient Decision to Withdraw|4
205346|NCT01125748|651655|P1|Overall Study|Patient Decision to Withdraw|2
205347|NCT01125748|651654|P2|Overall Study|Physician Decision|7
205348|NCT01125748|651655|P1|Overall Study|Physician Decision|8
205349|NCT01125748|651654|P2|Overall Study|Lost to Follow-up|1
205350|NCT01125748|651655|P1|Overall Study|Lost to Follow-up|0
205351|NCT01125748|651654|P2|Overall Study|Adverse Event|2
205352|NCT01125748|651655|P1|Overall Study|Adverse Event|0
205353|NCT01125800|651695|P5|Phase II|Disease progression|8
205354|NCT01125800|651696|P4|Phase II|Disease progression|1
205355|NCT01125800|651697|P3|Phase II|Disease progression|0
205356|NCT01125800|651698|P2|Phase II|Disease progression|0
205357|NCT01125800|651699|P1|Phase II|Disease progression|0
205358|NCT01125800|651695|P5|Phase II|Adverse Event|2
205359|NCT01125800|651696|P4|Phase II|Adverse Event|0
205360|NCT01125800|651697|P3|Phase II|Adverse Event|0
205361|NCT01125800|651698|P2|Phase II|Adverse Event|0
205362|NCT01125800|651699|P1|Phase II|Adverse Event|0
205363|NCT01125800|651695|P5|Phase II|Protocol Violation|1
205364|NCT01125800|651696|P4|Phase II|Protocol Violation|0
205365|NCT01125800|651697|P3|Phase II|Protocol Violation|0
205366|NCT01125800|651698|P2|Phase II|Protocol Violation|0
205367|NCT01125800|651699|P1|Phase II|Protocol Violation|0
205368|NCT01125800|651695|P5|Phase I|Disease progression|0
205369|NCT01125800|651696|P4|Phase I|Disease progression|3
205370|NCT01125800|651697|P3|Phase I|Disease progression|1
205371|NCT01125800|651698|P2|Phase I|Disease progression|4
205372|NCT01125800|651699|P1|Phase I|Disease progression|5
205373|NCT01125800|651695|P5|Phase I|Withdrawal by Subject|0
205374|NCT01125800|651696|P4|Phase I|Withdrawal by Subject|0
205375|NCT01125800|651697|P3|Phase I|Withdrawal by Subject|1
205376|NCT01125800|651698|P2|Phase I|Withdrawal by Subject|0
205377|NCT01125800|651699|P1|Phase I|Withdrawal by Subject|0
205378|NCT01125800|651695|P5|Phase I|Administrative problems|0
205379|NCT01125800|651696|P4|Phase I|Administrative problems|0
205380|NCT01125800|651697|P3|Phase I|Administrative problems|0
205381|NCT01125800|651698|P2|Phase I|Administrative problems|0
205382|NCT01125800|651699|P1|Phase I|Administrative problems|1
205383|NCT01125800|651695|P5|Phase I|Adverse Event|0
205384|NCT01125800|651696|P4|Phase I|Adverse Event|7
205385|NCT01125800|651697|P3|Phase I|Adverse Event|1
205386|NCT01125800|651698|P2|Phase I|Adverse Event|2
205387|NCT01125800|651699|P1|Phase I|Adverse Event|2
205388|NCT01125800|651695|P5|Phase I|Protocol Violation|0
205389|NCT01125800|651696|P4|Phase I|Protocol Violation|1
205390|NCT01125800|651697|P3|Phase I|Protocol Violation|1
205391|NCT01125800|651698|P2|Phase I|Protocol Violation|3
205392|NCT01125800|651699|P1|Phase I|Protocol Violation|0
205393|NCT01125813|651736|P1|Overall Study|Screen Failures|4
205394|NCT01125813|651736|P1|Overall Study|Withdrawal by Subject|1
205395|NCT01125813|651736|P1|Overall Study|Death|1
205396|NCT01125917|651741|P1|Overall Study|Lack of Efficacy|19
205397|NCT01125917|651741|P1|Overall Study|Administrative|223
205398|NCT01125917|651741|P1|Overall Study|Withdrawal by Subject|31
205399|NCT01125917|651741|P1|Overall Study|Lost to Follow-up|23
205400|NCT01125917|651741|P1|Overall Study|Adverse Event|43
205401|NCT01125930|651747|P2|Overall Study|Lost to Follow-up|2
205402|NCT01125930|651748|P1|Overall Study|Lost to Follow-up|0
205403|NCT01125930|651747|P2|Overall Study|Protocol Violation|1
205404|NCT01125930|651748|P1|Overall Study|Protocol Violation|0
205405|NCT01125930|651747|P2|Overall Study|Withdrawal by Subject|6
205406|NCT01125930|651748|P1|Overall Study|Withdrawal by Subject|1
205407|NCT01125930|651747|P2|Overall Study|Adverse Event|1
205408|NCT01125930|651748|P1|Overall Study|Adverse Event|0
205409|NCT01126060|651904|P2|Overall Study|Protocol Violation|2
205410|NCT01126060|651905|P1|Overall Study|Protocol Violation|0
205411|NCT01126268|651926|P1|Overall Study|Adverse Event|1
205412|NCT01126359|651948|P2|First Intervention (20-minutes)|Physician Decision|1
205413|NCT01126359|651949|P1|First Intervention (20-minutes)|Physician Decision|0
205414|NCT01126424|651967|P6|Overall Study|Withdrawal by Subject|0
205415|NCT01126424|651968|P5|Overall Study|Withdrawal by Subject|1
205416|NCT01126424|651969|P4|Overall Study|Withdrawal by Subject|3
205417|NCT01126424|651970|P3|Overall Study|Withdrawal by Subject|1
205418|NCT01126424|651971|P2|Overall Study|Withdrawal by Subject|0
205419|NCT01126424|651972|P1|Overall Study|Withdrawal by Subject|0
205420|NCT01126424|651967|P6|Overall Study|Adverse Event|0
205421|NCT01126424|651968|P5|Overall Study|Adverse Event|1
205422|NCT01126424|651969|P4|Overall Study|Adverse Event|0
205423|NCT01126424|651970|P3|Overall Study|Adverse Event|0
205424|NCT01126424|651971|P2|Overall Study|Adverse Event|0
205425|NCT01126424|651972|P1|Overall Study|Adverse Event|0
205426|NCT01126437|651998|P3|Overall Study|Other reason not specified|178
205427|NCT01126437|651999|P2|Overall Study|Other reason not specified|176
205428|NCT01126437|652000|P1|Overall Study|Other reason not specified|210
205429|NCT01126437|651998|P3|Overall Study|Withdrawal by Subject|319
205430|NCT01126437|651999|P2|Overall Study|Withdrawal by Subject|335
205431|NCT01126437|652000|P1|Overall Study|Withdrawal by Subject|331
205432|NCT01126437|651998|P3|Overall Study|Lost to Follow-up|55
205433|NCT01126437|651999|P2|Overall Study|Lost to Follow-up|63
205434|NCT01126437|652000|P1|Overall Study|Lost to Follow-up|52
205435|NCT01126437|651998|P3|Overall Study|Protocol Violation|41
205436|NCT01126437|651999|P2|Overall Study|Protocol Violation|66
205437|NCT01126437|652000|P1|Overall Study|Protocol Violation|64
205438|NCT01126437|651998|P3|Overall Study|Lack of Efficacy|59
205439|NCT01126437|651999|P2|Overall Study|Lack of Efficacy|60
205440|NCT01126437|652000|P1|Overall Study|Lack of Efficacy|65
205441|NCT01126437|651998|P3|Overall Study|Adverse Event|635
205442|NCT01126437|651999|P2|Overall Study|Adverse Event|606
205443|NCT01126437|652000|P1|Overall Study|Adverse Event|602
205444|NCT01126437|651998|P3|Overall Study|Sites with data irregularities/fraud|7
205445|NCT01126437|651999|P2|Overall Study|Sites with data irregularities/fraud|6
205446|NCT01126437|652000|P1|Overall Study|Sites with data irregularities/fraud|6
205447|NCT01126437|651998|P3|Overall Study|Not treated|19
205448|NCT01126437|651999|P2|Overall Study|Not treated|18
205449|NCT01126437|652000|P1|Overall Study|Not treated|11
205450|NCT01126541|652035|P3|Overall Study|Administrative reason or other|2
205451|NCT01126541|652036|P2|Overall Study|Administrative reason or other|1
205452|NCT01126541|652037|P1|Overall Study|Administrative reason or other|1
205453|NCT01126541|652035|P3|Overall Study|Protocol Violation|1
205454|NCT01126541|652036|P2|Overall Study|Protocol Violation|0
205455|NCT01126541|652037|P1|Overall Study|Protocol Violation|0
205456|NCT01126541|652035|P3|Overall Study|Withdrawal by Subject|6
205457|NCT01126541|652036|P2|Overall Study|Withdrawal by Subject|5
205458|NCT01126541|652037|P1|Overall Study|Withdrawal by Subject|2
205459|NCT01126541|652035|P3|Overall Study|Lost to Follow-up|2
205460|NCT01126541|652036|P2|Overall Study|Lost to Follow-up|2
205461|NCT01126541|652037|P1|Overall Study|Lost to Follow-up|1
205462|NCT01126541|652035|P3|Overall Study|Lack of Efficacy|11
205463|NCT01126541|652036|P2|Overall Study|Lack of Efficacy|1
205464|NCT01126541|652037|P1|Overall Study|Lack of Efficacy|6
205465|NCT01126541|652035|P3|Overall Study|Death|0
205466|NCT01126541|652036|P2|Overall Study|Death|1
205467|NCT01126541|652037|P1|Overall Study|Death|0
205468|NCT01126541|652035|P3|Overall Study|Adverse Event|4
205469|NCT01126541|652036|P2|Overall Study|Adverse Event|2
205470|NCT01126541|652037|P1|Overall Study|Adverse Event|0
205471|NCT01126580|652121|P3|Overall Study|Treatment Non-compliance|3
205472|NCT01126580|652122|P2|Overall Study|Treatment Non-compliance|2
205473|NCT01126580|652123|P1|Overall Study|Treatment Non-compliance|0
205474|NCT01126580|652121|P3|Overall Study|Lost to Follow-up|9
205475|NCT01126580|652122|P2|Overall Study|Lost to Follow-up|13
205476|NCT01126580|652123|P1|Overall Study|Lost to Follow-up|15
205477|NCT01126580|652121|P3|Overall Study|Protocol Violation|2
205478|NCT01126580|652122|P2|Overall Study|Protocol Violation|1
205479|NCT01126580|652123|P1|Overall Study|Protocol Violation|0
205480|NCT01126580|652121|P3|Overall Study|Lack of Efficacy|4
205481|NCT01126580|652122|P2|Overall Study|Lack of Efficacy|3
205482|NCT01126580|652123|P1|Overall Study|Lack of Efficacy|2
205483|NCT01126580|652121|P3|Overall Study|Entry Criteria Not Met|2
205484|NCT01126580|652122|P2|Overall Study|Entry Criteria Not Met|1
205485|NCT01126580|652123|P1|Overall Study|Entry Criteria Not Met|1
205486|NCT01126580|652121|P3|Overall Study|Physician Decision|2
205487|NCT01126580|652122|P2|Overall Study|Physician Decision|1
205488|NCT01126580|652123|P1|Overall Study|Physician Decision|1
205489|NCT01126580|652121|P3|Overall Study|Sponsor Decision|7
205490|NCT01126580|652122|P2|Overall Study|Sponsor Decision|4
205491|NCT01126580|652123|P1|Overall Study|Sponsor Decision|5
205492|NCT01126580|652121|P3|Overall Study|Withdrawal by Subject|14
205493|NCT01126580|652122|P2|Overall Study|Withdrawal by Subject|19
205494|NCT01126580|652123|P1|Overall Study|Withdrawal by Subject|11
205495|NCT01126580|652121|P3|Overall Study|Adverse Event|12
205496|NCT01126580|652122|P2|Overall Study|Adverse Event|8
205497|NCT01126580|652123|P1|Overall Study|Adverse Event|14
205498|NCT01126619|652228|P1|Overall Study|Non-compliance|1
205499|NCT01126619|652228|P1|Overall Study|Withdrawal by Subject|9
205500|NCT01126619|652228|P1|Overall Study|Serious adverse event|1
205501|NCT01126619|652228|P1|Overall Study|Investigator decision|4
205502|NCT01126619|652228|P1|Overall Study|Not eligible for the study|2
205503|NCT01133275|652274|P1|Overall Study|Cerebrovascular accident (CVA)|1
205504|NCT01133275|652274|P1|Overall Study|Withdrawal by Subject|1
205505|NCT01133288|652279|P1|Intervention Allocation|study terminated|2
205506|NCT01133288|652279|P1|Eligibility Assessment|met exclusion criteria|5
205507|NCT01133379|652287|P3|Overall Study|Lost to Follow-up|1
205508|NCT01133379|652288|P2|Overall Study|Lost to Follow-up|1
205509|NCT01133379|652289|P1|Overall Study|Lost to Follow-up|1
205510|NCT01133379|652287|P3|Overall Study|Withdrawal by Subject|1
205511|NCT01133379|652288|P2|Overall Study|Withdrawal by Subject|1
205512|NCT01133379|652289|P1|Overall Study|Withdrawal by Subject|0
205513|NCT01133392|652344|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
205514|NCT01133392|652345|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
205515|NCT01133392|652344|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
205516|NCT01133392|652345|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
205517|NCT01133418|652361|P2|Overall Study|Lost to Follow-up|6
205518|NCT01133418|652362|P1|Overall Study|Lost to Follow-up|5
205519|NCT01133522|652384|P10|Overall Study|Physician Decision|0
205520|NCT01133522|652385|P9|Overall Study|Physician Decision|0
205521|NCT01133522|652386|P8|Overall Study|Physician Decision|0
205522|NCT01133522|652387|P7|Overall Study|Physician Decision|0
205523|NCT01133522|652388|P6|Overall Study|Physician Decision|0
205524|NCT01133522|652389|P5|Overall Study|Physician Decision|1
205525|NCT01133522|652390|P4|Overall Study|Physician Decision|0
205526|NCT01133522|652391|P3|Overall Study|Physician Decision|0
205527|NCT01133522|652392|P2|Overall Study|Physician Decision|0
205528|NCT01133522|652393|P1|Overall Study|Physician Decision|0
205529|NCT01133522|652384|P10|Overall Study|Withdrawal by Subject|0
205530|NCT01133522|652385|P9|Overall Study|Withdrawal by Subject|0
205531|NCT01133522|652386|P8|Overall Study|Withdrawal by Subject|0
205532|NCT01133522|652387|P7|Overall Study|Withdrawal by Subject|0
205533|NCT01133522|652388|P6|Overall Study|Withdrawal by Subject|0
205534|NCT01133522|652389|P5|Overall Study|Withdrawal by Subject|0
205535|NCT01133522|652390|P4|Overall Study|Withdrawal by Subject|1
205536|NCT01133522|652391|P3|Overall Study|Withdrawal by Subject|0
205537|NCT01133522|652392|P2|Overall Study|Withdrawal by Subject|1
205538|NCT01133522|652393|P1|Overall Study|Withdrawal by Subject|0
205539|NCT01134042|652462|P3|Overall Study|Withdrawal by Subject|7
205540|NCT01134042|652463|P2|Overall Study|Withdrawal by Subject|4
205541|NCT01134042|652464|P1|Overall Study|Withdrawal by Subject|13
205542|NCT01134042|652462|P3|Overall Study|Physician Decision|1
205543|NCT01134042|652463|P2|Overall Study|Physician Decision|8
205544|NCT01134042|652464|P1|Overall Study|Physician Decision|4
205545|NCT01134042|652462|P3|Overall Study|Lost to Follow-up|1
205546|NCT01134042|652463|P2|Overall Study|Lost to Follow-up|0
205547|NCT01134042|652464|P1|Overall Study|Lost to Follow-up|2
205548|NCT01134042|652462|P3|Overall Study|Protocol Violation|5
205549|NCT01134042|652463|P2|Overall Study|Protocol Violation|3
205550|NCT01134042|652464|P1|Overall Study|Protocol Violation|5
205551|NCT01134042|652462|P3|Overall Study|Lack of Efficacy|18
205552|NCT01134042|652463|P2|Overall Study|Lack of Efficacy|6
205553|NCT01134042|652464|P1|Overall Study|Lack of Efficacy|21
205554|NCT01134042|652462|P3|Overall Study|Adverse Event|2
205555|NCT01134042|652463|P2|Overall Study|Adverse Event|7
205556|NCT01134042|652464|P1|Overall Study|Adverse Event|3
205557|NCT01134107|652512|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
205558|NCT01134107|652513|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
205559|NCT01134107|652512|P2|Period 2-Second Treatment Intervention|Physician Decision|0
205560|NCT01134107|652513|P1|Period 2-Second Treatment Intervention|Physician Decision|1
205561|NCT01134107|652512|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
205562|NCT01134107|652513|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
205563|NCT01134107|652512|P2|Period 1-First Treatment Intervention|Physician Decision|0
205564|NCT01134107|652513|P1|Period 1-First Treatment Intervention|Physician Decision|1
205565|NCT01134107|652512|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
205566|NCT01134107|652513|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
205567|NCT01134107|652512|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
205568|NCT01134107|652513|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
205569|NCT01134107|652512|P2|Period 1-First Treatment Intervention|Adverse Event|0
205570|NCT01134107|652513|P1|Period 1-First Treatment Intervention|Adverse Event|1
205571|NCT01134315|652560|P2|Overall Study|Other Reason|17
205572|NCT01134315|652561|P1|Overall Study|Other Reason|8
205573|NCT01134315|652560|P2|Overall Study|Adverse Event|2
205574|NCT01134315|652561|P1|Overall Study|Adverse Event|1
205575|NCT01134393|652581|P1|Overall Study|Other|6
205576|NCT01134393|652581|P1|Overall Study|Withdrawal by Subject|11
205577|NCT01134393|652581|P1|Overall Study|Lost to Follow-up|3
205578|NCT01134393|652581|P1|Overall Study|Protocol Violation|12
205579|NCT01134393|652581|P1|Overall Study|Lack of Efficacy|2
205580|NCT01134393|652581|P1|Overall Study|Adverse Event|18
205581|NCT01134614|652705|P2|Overall Study|Patient in hospice care|1
205582|NCT01134614|652706|P1|Overall Study|Patient in hospice care|0
205583|NCT01134614|652705|P2|Overall Study|Symptomatic deterioration|1
205584|NCT01134614|652706|P1|Overall Study|Symptomatic deterioration|0
205585|NCT01134614|652705|P2|Overall Study|Pt received tx not allowed on study|1
205586|NCT01134614|652706|P1|Overall Study|Pt received tx not allowed on study|0
205587|NCT01134614|652705|P2|Overall Study|Never started treatment|1
205588|NCT01134614|652706|P1|Overall Study|Never started treatment|4
205589|NCT01134614|652705|P2|Overall Study|Physician's decision|1
205590|NCT01134614|652706|P1|Overall Study|Physician's decision|0
205591|NCT01134614|652705|P2|Overall Study|Complicating disease|1
205592|NCT01134614|652706|P1|Overall Study|Complicating disease|2
205593|NCT01134614|652705|P2|Overall Study|Alternative therapy|0
205594|NCT01134614|652706|P1|Overall Study|Alternative therapy|2
205595|NCT01134614|652705|P2|Overall Study|Withdrawal by Subject|2
205596|NCT01134614|652706|P1|Overall Study|Withdrawal by Subject|3
205597|NCT01134614|652705|P2|Overall Study|Death|8
205598|NCT01134614|652706|P1|Overall Study|Death|5
205599|NCT01134614|652705|P2|Overall Study|Adverse Event|39
205600|NCT01134614|652706|P1|Overall Study|Adverse Event|26
205601|NCT01134614|652705|P2|Overall Study|Progressive disease|54
205602|NCT01134614|652706|P1|Overall Study|Progressive disease|60
205603|NCT01134614|652705|P2|Overall Study|Still on treatment as of March 2013|13
205604|NCT01134614|652706|P1|Overall Study|Still on treatment as of March 2013|21
205605|NCT01134627|652718|P2|Overall Study|Unspecified|14
205606|NCT01134627|652719|P1|Overall Study|Unspecified|11
205607|NCT01134627|652718|P2|Overall Study|Planning to become pregnant/pregnancy|0
205608|NCT01134627|652719|P1|Overall Study|Planning to become pregnant/pregnancy|1
205609|NCT01134627|652718|P2|Overall Study|Withdrawal by Subject|3
205610|NCT01134627|652719|P1|Overall Study|Withdrawal by Subject|4
205611|NCT01134627|652718|P2|Overall Study|Lack of Efficacy|12
205612|NCT01134627|652719|P1|Overall Study|Lack of Efficacy|2
205613|NCT01134627|652718|P2|Overall Study|Protocol Violation|5
205614|NCT01134627|652719|P1|Overall Study|Protocol Violation|3
205615|NCT01134627|652718|P2|Overall Study|Lost to Follow-up|2
205616|NCT01134627|652719|P1|Overall Study|Lost to Follow-up|1
205617|NCT01134627|652718|P2|Overall Study|Adverse Event|31
205618|NCT01134627|652719|P1|Overall Study|Adverse Event|47
205619|NCT01134705|652749|P2|Overall Study|Other|6
205620|NCT01134705|652750|P1|Overall Study|Other|1
205621|NCT01134705|652749|P2|Overall Study|Protocol Violation|1
205622|NCT01134705|652750|P1|Overall Study|Protocol Violation|1
205623|NCT01134705|652749|P2|Overall Study|Lost to Follow-up|2
205624|NCT01134705|652750|P1|Overall Study|Lost to Follow-up|5
205625|NCT01134705|652749|P2|Overall Study|Pregnancy|0
205626|NCT01134705|652750|P1|Overall Study|Pregnancy|1
205627|NCT01134705|652749|P2|Overall Study|Withdrawal by Subject|6
205628|NCT01134705|652750|P1|Overall Study|Withdrawal by Subject|6
205629|NCT01134705|652749|P2|Overall Study|Adverse Event|7
205630|NCT01134705|652750|P1|Overall Study|Adverse Event|1
205631|NCT01134731|652763|P3|Overall Study|Lost to Follow-up|3
205632|NCT01134731|652764|P2|Overall Study|Lost to Follow-up|4
205633|NCT01134731|652765|P1|Overall Study|Lost to Follow-up|5
205634|NCT01134731|652763|P3|Overall Study|Withdrawal by Subject|1
205635|NCT01134731|652764|P2|Overall Study|Withdrawal by Subject|3
205636|NCT01134731|652765|P1|Overall Study|Withdrawal by Subject|3
205637|NCT01134731|652763|P3|Overall Study|Lack of Efficacy|1
205638|NCT01134731|652764|P2|Overall Study|Lack of Efficacy|0
205639|NCT01134731|652765|P1|Overall Study|Lack of Efficacy|0
205640|NCT01134731|652763|P3|Overall Study|Physician Decision|2
205641|NCT01134731|652764|P2|Overall Study|Physician Decision|2
205642|NCT01134731|652765|P1|Overall Study|Physician Decision|2
205643|NCT01134731|652763|P3|Overall Study|Adverse Event|1
205644|NCT01134731|652764|P2|Overall Study|Adverse Event|2
205645|NCT01134731|652765|P1|Overall Study|Adverse Event|3
205646|NCT01134783|652778|P2|Overall Study|Lost to Follow-up|20
205647|NCT01134783|652779|P1|Overall Study|Lost to Follow-up|5
205648|NCT01134783|652778|P2|Overall Study|Withdrawal by Subject|9
205649|NCT01134783|652779|P1|Overall Study|Withdrawal by Subject|15
205650|NCT01134783|652778|P2|Overall Study|Pregnancy|8
205651|NCT01134783|652779|P1|Overall Study|Pregnancy|16
205652|NCT01134939|652829|P8|Overall Study|Termination page not available|0
205653|NCT01134939|652830|P7|Overall Study|Termination page not available|7
205654|NCT01134939|652831|P6|Overall Study|Termination page not available|3
205655|NCT01134939|652832|P5|Overall Study|Termination page not available|0
205656|NCT01134939|652833|P4|Overall Study|Termination page not available|8
205657|NCT01134939|652834|P3|Overall Study|Termination page not available|5
205658|NCT01134939|652835|P2|Overall Study|Termination page not available|6
205659|NCT01134939|652836|P1|Overall Study|Termination page not available|4
205660|NCT01134939|652829|P8|Overall Study|Death|0
205661|NCT01134939|652830|P7|Overall Study|Death|0
205662|NCT01134939|652831|P6|Overall Study|Death|0
205663|NCT01134939|652832|P5|Overall Study|Death|0
205664|NCT01134939|652833|P4|Overall Study|Death|0
205665|NCT01134939|652834|P3|Overall Study|Death|0
205666|NCT01134939|652835|P2|Overall Study|Death|1
205667|NCT01134939|652836|P1|Overall Study|Death|0
205668|NCT01134939|652829|P8|Overall Study|Lost to Follow-up|0
205669|NCT01134939|652830|P7|Overall Study|Lost to Follow-up|0
205670|NCT01134939|652831|P6|Overall Study|Lost to Follow-up|1
205671|NCT01134939|652832|P5|Overall Study|Lost to Follow-up|2
205672|NCT01134939|652833|P4|Overall Study|Lost to Follow-up|1
205673|NCT01134939|652834|P3|Overall Study|Lost to Follow-up|0
205674|NCT01134939|652835|P2|Overall Study|Lost to Follow-up|3
205675|NCT01134939|652836|P1|Overall Study|Lost to Follow-up|2
205676|NCT01134939|652829|P8|Overall Study|Lack of Efficacy|0
205677|NCT01134939|652830|P7|Overall Study|Lack of Efficacy|1
205678|NCT01134939|652831|P6|Overall Study|Lack of Efficacy|0
205679|NCT01134939|652832|P5|Overall Study|Lack of Efficacy|3
205680|NCT01134939|652833|P4|Overall Study|Lack of Efficacy|0
205681|NCT01134939|652834|P3|Overall Study|Lack of Efficacy|1
205682|NCT01134939|652835|P2|Overall Study|Lack of Efficacy|5
205683|NCT01134939|652836|P1|Overall Study|Lack of Efficacy|2
205684|NCT01134939|652829|P8|Overall Study|Adverse Event|0
205685|NCT01134939|652830|P7|Overall Study|Adverse Event|1
205686|NCT01134939|652831|P6|Overall Study|Adverse Event|5
205687|NCT01134939|652832|P5|Overall Study|Adverse Event|5
205688|NCT01134939|652833|P4|Overall Study|Adverse Event|5
205689|NCT01134939|652834|P3|Overall Study|Adverse Event|4
205690|NCT01134939|652835|P2|Overall Study|Adverse Event|3
205691|NCT01134939|652836|P1|Overall Study|Adverse Event|9
205692|NCT01135017|652962|P2|Overall Study|Other than above|4
205693|NCT01135017|652963|P1|Overall Study|Other than above|3
205694|NCT01135017|652962|P2|Overall Study|Adverse Event|8
205695|NCT01135017|652963|P1|Overall Study|Adverse Event|3
205696|NCT01135134|652994|P2|Overall Study|Did not meet protocol eligibility|0
205697|NCT01135134|652995|P1|Overall Study|Did not meet protocol eligibility|1
205698|NCT01135134|652994|P2|Overall Study|Adverse Event|1
205699|NCT01135134|652995|P1|Overall Study|Adverse Event|1
205700|NCT01135498|653160|P1|Overall Study|Ongoing at time of analysis|2
205701|NCT01135498|653160|P1|Overall Study|Death|1
205702|NCT01135498|653160|P1|Overall Study|Withdrawal by Subject|4
205703|NCT01135498|653160|P1|Overall Study|Investigator judgement|25
205704|NCT01135498|653160|P1|Overall Study|Progressive disease|38
205705|NCT01135498|653160|P1|Overall Study|Adverse Event|20
205706|NCT01135511|653178|P9|Overall Study|Withdrawal by Subject|1
205707|NCT01135511|653179|P8|Overall Study|Withdrawal by Subject|0
205708|NCT01135511|653180|P7|Overall Study|Withdrawal by Subject|1
205709|NCT01135511|653181|P6|Overall Study|Withdrawal by Subject|0
205710|NCT01135511|653182|P5|Overall Study|Withdrawal by Subject|0
205711|NCT01135511|653183|P4|Overall Study|Withdrawal by Subject|0
205712|NCT01135511|653184|P3|Overall Study|Withdrawal by Subject|0
205713|NCT01135511|653185|P2|Overall Study|Withdrawal by Subject|0
205714|NCT01135511|653186|P1|Overall Study|Withdrawal by Subject|0
205715|NCT01135511|653178|P9|Overall Study|noncompliance with study drug taken|0
205716|NCT01135511|653179|P8|Overall Study|noncompliance with study drug taken|0
205717|NCT01135511|653180|P7|Overall Study|noncompliance with study drug taken|0
205718|NCT01135511|653181|P6|Overall Study|noncompliance with study drug taken|0
205719|NCT01135511|653182|P5|Overall Study|noncompliance with study drug taken|1
205720|NCT01135511|653183|P4|Overall Study|noncompliance with study drug taken|0
205721|NCT01135511|653184|P3|Overall Study|noncompliance with study drug taken|0
205722|NCT01135511|653185|P2|Overall Study|noncompliance with study drug taken|0
205723|NCT01135511|653186|P1|Overall Study|noncompliance with study drug taken|0
205724|NCT01135511|653178|P9|Overall Study|could not visit the clinic|0
205725|NCT01135511|653179|P8|Overall Study|could not visit the clinic|0
205726|NCT01135511|653180|P7|Overall Study|could not visit the clinic|0
205727|NCT01135511|653181|P6|Overall Study|could not visit the clinic|0
205728|NCT01135511|653182|P5|Overall Study|could not visit the clinic|0
205729|NCT01135511|653183|P4|Overall Study|could not visit the clinic|0
205730|NCT01135511|653184|P3|Overall Study|could not visit the clinic|2
205731|NCT01135511|653185|P2|Overall Study|could not visit the clinic|1
205732|NCT01135511|653186|P1|Overall Study|could not visit the clinic|0
205733|NCT01135511|653178|P9|Overall Study|Pregnancy|0
205734|NCT01135511|653179|P8|Overall Study|Pregnancy|0
205735|NCT01135511|653180|P7|Overall Study|Pregnancy|0
205736|NCT01135511|653181|P6|Overall Study|Pregnancy|0
205737|NCT01135511|653182|P5|Overall Study|Pregnancy|0
205738|NCT01135511|653183|P4|Overall Study|Pregnancy|1
205739|NCT01135511|653184|P3|Overall Study|Pregnancy|0
205740|NCT01135511|653185|P2|Overall Study|Pregnancy|0
205741|NCT01135511|653186|P1|Overall Study|Pregnancy|0
205742|NCT01135511|653178|P9|Overall Study|Protocol Violation|0
205743|NCT01135511|653179|P8|Overall Study|Protocol Violation|0
205744|NCT01135511|653180|P7|Overall Study|Protocol Violation|0
205745|NCT01135511|653181|P6|Overall Study|Protocol Violation|0
205746|NCT01135511|653182|P5|Overall Study|Protocol Violation|0
205747|NCT01135511|653183|P4|Overall Study|Protocol Violation|0
205748|NCT01135511|653184|P3|Overall Study|Protocol Violation|3
205749|NCT01135511|653185|P2|Overall Study|Protocol Violation|0
205750|NCT01135511|653186|P1|Overall Study|Protocol Violation|0
205751|NCT01135511|653178|P9|Overall Study|Lack of Efficacy|0
205752|NCT01135511|653179|P8|Overall Study|Lack of Efficacy|0
205753|NCT01135511|653180|P7|Overall Study|Lack of Efficacy|0
205754|NCT01135511|653181|P6|Overall Study|Lack of Efficacy|0
205755|NCT01135511|653182|P5|Overall Study|Lack of Efficacy|0
205756|NCT01135511|653183|P4|Overall Study|Lack of Efficacy|2
205757|NCT01135511|653184|P3|Overall Study|Lack of Efficacy|1
205758|NCT01135511|653185|P2|Overall Study|Lack of Efficacy|1
205759|NCT01135511|653186|P1|Overall Study|Lack of Efficacy|0
205760|NCT01135511|653178|P9|Overall Study|Adverse Event|0
205761|NCT01135511|653179|P8|Overall Study|Adverse Event|1
205762|NCT01135511|653180|P7|Overall Study|Adverse Event|0
205763|NCT01135511|653181|P6|Overall Study|Adverse Event|1
205764|NCT01135511|653182|P5|Overall Study|Adverse Event|0
205765|NCT01135511|653183|P4|Overall Study|Adverse Event|0
205766|NCT01135511|653184|P3|Overall Study|Adverse Event|2
205767|NCT01135511|653185|P2|Overall Study|Adverse Event|1
205768|NCT01135511|653186|P1|Overall Study|Adverse Event|0
205769|NCT01135524|653468|P1|Overall Study|Lack of Efficacy|8
205770|NCT01135524|653468|P1|Overall Study|Administrative|151
205771|NCT01135524|653468|P1|Overall Study|Lost to Follow-up|3
205772|NCT01135524|653468|P1|Overall Study|Adverse Event|20
205773|NCT01135524|653468|P1|Overall Study|Withdrawal by Subject|14
205774|NCT01135914|653475|P3|Overall Study|Adverse Event|2
205775|NCT01135914|653476|P2|Overall Study|Adverse Event|1
205776|NCT01135914|653477|P1|Overall Study|Adverse Event|0
205777|NCT01135914|653475|P3|Overall Study|Lack of Efficacy|10
205778|NCT01135914|653476|P2|Overall Study|Lack of Efficacy|1
205779|NCT01135914|653477|P1|Overall Study|Lack of Efficacy|2
205780|NCT01135914|653475|P3|Overall Study|Protocol Violation|3
205781|NCT01135914|653476|P2|Overall Study|Protocol Violation|0
205782|NCT01135914|653477|P1|Overall Study|Protocol Violation|0
205783|NCT01135914|653475|P3|Overall Study|Lost to Follow-up|1
205784|NCT01135914|653476|P2|Overall Study|Lost to Follow-up|0
205785|NCT01135914|653477|P1|Overall Study|Lost to Follow-up|1
205786|NCT01135914|653475|P3|Overall Study|Withdrawal by Subject|6
205787|NCT01135914|653476|P2|Overall Study|Withdrawal by Subject|3
205788|NCT01135914|653477|P1|Overall Study|Withdrawal by Subject|1
205789|NCT01135992|653506|P1|Overall Study|Unclassified|7
205790|NCT01135992|653506|P1|Overall Study|Withdrawal criteria|10
205791|NCT01135992|653506|P1|Overall Study|Protocol Violation|2
205792|NCT01135992|653506|P1|Overall Study|Lack of Efficacy|1
205793|NCT01135992|653506|P1|Overall Study|Adverse Event|1
205794|NCT01136174|653519|P4|Overall Study|Adverse Event|4
205795|NCT01136174|653520|P3|Overall Study|Adverse Event|0
205796|NCT01136174|653521|P2|Overall Study|Adverse Event|0
205797|NCT01136174|653522|P1|Overall Study|Adverse Event|0
205798|NCT01136291|653608|P2|Overall Study|Lost to Follow-up|1
205799|NCT01136291|653609|P1|Overall Study|Lost to Follow-up|1
205800|NCT01136356|653619|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
205801|NCT01136356|653620|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
205802|NCT01136356|653619|P2|First 18-day Withdrawal|Physician Decision|0
205803|NCT01136356|653620|P1|First 18-day Withdrawal|Physician Decision|1
205804|NCT01136356|653619|P2|First 18-day Withdrawal|Withdrawal by Subject|0
205805|NCT01136356|653620|P1|First 18-day Withdrawal|Withdrawal by Subject|3
205806|NCT01136382|653631|P2|Overall Study|Withdrawal by Subject|1
205807|NCT01136382|653632|P1|Overall Study|Withdrawal by Subject|4
205808|NCT01136382|653631|P2|Overall Study|Severe Non-Compliance to Protocol|2
205809|NCT01136382|653632|P1|Overall Study|Severe Non-Compliance to Protocol|0
205810|NCT01136382|653631|P2|Overall Study|Study-Specific Withdrawal Criteria|25
205811|NCT01136382|653632|P1|Overall Study|Study-Specific Withdrawal Criteria|48
205812|NCT01136382|653631|P2|Overall Study|Not Specified|3
205813|NCT01136382|653632|P1|Overall Study|Not Specified|8
205814|NCT01136408|653661|P3|Overall Study|Protocol Violation|1
205815|NCT01136408|653662|P2|Overall Study|Protocol Violation|1
205816|NCT01136408|653663|P1|Overall Study|Protocol Violation|1
205817|NCT01136408|653661|P3|Overall Study|Adverse Event|4
205818|NCT01136408|653662|P2|Overall Study|Adverse Event|8
205819|NCT01136408|653663|P1|Overall Study|Adverse Event|4
205820|NCT01124292|653725|P3|Overall Study|piercing track closed|1
205821|NCT01124292|653726|P2|Overall Study|piercing track closed|2
205822|NCT01124292|653727|P1|Overall Study|piercing track closed|0
205823|NCT01124292|653725|P3|Overall Study|medical issue unrelated to the study|2
205824|NCT01124292|653726|P2|Overall Study|medical issue unrelated to the study|0
205825|NCT01124292|653727|P1|Overall Study|medical issue unrelated to the study|0
205826|NCT01124292|653725|P3|Overall Study|Withdrawal by Subject|2
205827|NCT01124292|653726|P2|Overall Study|Withdrawal by Subject|6
205828|NCT01124292|653727|P1|Overall Study|Withdrawal by Subject|0
205829|NCT01124292|653725|P3|Overall Study|Physician Decision|2
205830|NCT01124292|653726|P2|Overall Study|Physician Decision|3
205831|NCT01124292|653727|P1|Overall Study|Physician Decision|0
205832|NCT01124292|653725|P3|Overall Study|Lost to Follow-up|3
205833|NCT01124292|653726|P2|Overall Study|Lost to Follow-up|4
205834|NCT01124292|653727|P1|Overall Study|Lost to Follow-up|2
205835|NCT01124422|653810|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
205836|NCT01124422|653811|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
205837|NCT01124422|653812|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
205838|NCT01124422|653810|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
205839|NCT01124422|653811|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
205840|NCT01124422|653812|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
205841|NCT01124422|653810|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
205842|NCT01124422|653811|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
205843|NCT01124422|653812|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
205844|NCT01124422|653810|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
205845|NCT01124422|653811|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
205846|NCT01124422|653812|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
205847|NCT01124422|653810|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
205848|NCT01124422|653811|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
205849|NCT01124422|653812|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
205850|NCT01124422|653810|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
205851|NCT01124422|653811|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
205852|NCT01124422|653812|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
205853|NCT01124422|653810|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
205854|NCT01124422|653811|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
205855|NCT01124422|653812|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
205856|NCT01124422|653810|P3|4-Week Open-label Run-in Phase|Physician Decision|0
205857|NCT01124422|653811|P2|4-Week Open-label Run-in Phase|Physician Decision|0
205858|NCT01124422|653812|P1|4-Week Open-label Run-in Phase|Physician Decision|4
205859|NCT01124422|653810|P3|4-Week Open-label Run-in Phase|Adverse Event|0
205860|NCT01124422|653811|P2|4-Week Open-label Run-in Phase|Adverse Event|0
205861|NCT01124422|653812|P1|4-Week Open-label Run-in Phase|Adverse Event|7
205862|NCT01124422|653810|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
205863|NCT01124422|653811|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
205864|NCT01124422|653812|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
205865|NCT01124448|653856|P2|Overall Study|Protocol Violation|0
205866|NCT01124448|653857|P1|Overall Study|Protocol Violation|2
205867|NCT01124448|653856|P2|Overall Study|Lost to Follow-up|3
205868|NCT01124448|653857|P1|Overall Study|Lost to Follow-up|0
205869|NCT01129921|653865|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
205870|NCT01129921|653866|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
205871|NCT01129921|653865|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
205872|NCT01129921|653866|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
205873|NCT01129921|653865|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
205874|NCT01129921|653866|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
205875|NCT01129921|653865|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
205876|NCT01129921|653866|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
205877|NCT01129960|653880|P4|Overall Study|Pregnancy|0
205878|NCT01129960|653881|P3|Overall Study|Pregnancy|0
205879|NCT01129960|653882|P2|Overall Study|Pregnancy|0
205880|NCT01129960|653883|P1|Overall Study|Pregnancy|1
205881|NCT01129960|653880|P4|Overall Study|Physician Decision|0
205882|NCT01129960|653881|P3|Overall Study|Physician Decision|0
205883|NCT01129960|653882|P2|Overall Study|Physician Decision|0
205884|NCT01129960|653883|P1|Overall Study|Physician Decision|1
205885|NCT01129960|653880|P4|Overall Study|Discontinuation of the study by Sponsor|0
205886|NCT01129960|653881|P3|Overall Study|Discontinuation of the study by Sponsor|0
205887|NCT01129960|653882|P2|Overall Study|Discontinuation of the study by Sponsor|1
205888|NCT01129960|653883|P1|Overall Study|Discontinuation of the study by Sponsor|0
205889|NCT01129960|653880|P4|Overall Study|Lost to Follow-up|3
205890|NCT01129960|653881|P3|Overall Study|Lost to Follow-up|3
205891|NCT01129960|653882|P2|Overall Study|Lost to Follow-up|2
205892|NCT01129960|653883|P1|Overall Study|Lost to Follow-up|0
205893|NCT01129960|653880|P4|Overall Study|Protocol Violation|0
205894|NCT01129960|653881|P3|Overall Study|Protocol Violation|3
205895|NCT01129960|653882|P2|Overall Study|Protocol Violation|2
205896|NCT01129960|653883|P1|Overall Study|Protocol Violation|1
205897|NCT01129960|653880|P4|Overall Study|Adverse Event|7
205898|NCT01129960|653881|P3|Overall Study|Adverse Event|16
205899|NCT01129960|653882|P2|Overall Study|Adverse Event|16
205900|NCT01129960|653883|P1|Overall Study|Adverse Event|23
205901|NCT01129960|653880|P4|Overall Study|Lack of Efficacy|1
205902|NCT01129960|653881|P3|Overall Study|Lack of Efficacy|1
205903|NCT01129960|653882|P2|Overall Study|Lack of Efficacy|1
205904|NCT01129960|653883|P1|Overall Study|Lack of Efficacy|1
205905|NCT01129960|653880|P4|Overall Study|Withdrawal by Subject|2
205906|NCT01129960|653881|P3|Overall Study|Withdrawal by Subject|3
205907|NCT01129960|653882|P2|Overall Study|Withdrawal by Subject|0
205908|NCT01129960|653883|P1|Overall Study|Withdrawal by Subject|3
205909|NCT01130051|653893|P2|Washout Period of 14 Days|Protocol Violation|1
205910|NCT01130051|653894|P1|Washout Period of 14 Days|Protocol Violation|1
205911|NCT01130051|653893|P2|Washout Period of 14 Days|Withdrawal by Subject|1
205912|NCT01130051|653894|P1|Washout Period of 14 Days|Withdrawal by Subject|0
205913|NCT01130103|653906|P2|Maintenance Treatment|Withdrawal by Subject|0
205914|NCT01130103|653907|P1|Maintenance Treatment|Withdrawal by Subject|1
205915|NCT01130103|653906|P2|Maintenance Treatment|Lost to Follow-up|1
205916|NCT01130103|653907|P1|Maintenance Treatment|Lost to Follow-up|1
205917|NCT01130103|653906|P2|Maintenance Treatment|Lack of Efficacy|1
205918|NCT01130103|653907|P1|Maintenance Treatment|Lack of Efficacy|0
205919|NCT01130103|653906|P2|Randomized Treatment|Withdrawal by Subject|2
205920|NCT01130103|653907|P1|Randomized Treatment|Withdrawal by Subject|1
205921|NCT01130103|653906|P2|Randomized Treatment|Protocol Violation|2
205922|NCT01130103|653907|P1|Randomized Treatment|Protocol Violation|3
205923|NCT01130103|653906|P2|Randomized Treatment|Lost to Follow-up|0
205924|NCT01130103|653907|P1|Randomized Treatment|Lost to Follow-up|1
205925|NCT01130103|653906|P2|Randomized Treatment|Adverse Event|1
205926|NCT01130103|653907|P1|Randomized Treatment|Adverse Event|1
205927|NCT01130168|653921|P6|Period 1|Adverse Event|0
205928|NCT01130168|653922|P5|Period 1|Adverse Event|0
205929|NCT01130168|653923|P4|Period 1|Adverse Event|1
205930|NCT01130168|653924|P3|Period 1|Adverse Event|0
205931|NCT01130168|653925|P2|Period 1|Adverse Event|0
205932|NCT01130168|653926|P1|Period 1|Adverse Event|0
205933|NCT01130168|653921|P6|Period 1|Discontinued For Other Reason|0
205934|NCT01130168|653922|P5|Period 1|Discontinued For Other Reason|0
205935|NCT01130168|653923|P4|Period 1|Discontinued For Other Reason|1
205936|NCT01130168|653924|P3|Period 1|Discontinued For Other Reason|1
205937|NCT01130168|653925|P2|Period 1|Discontinued For Other Reason|0
205938|NCT01130168|653926|P1|Period 1|Discontinued For Other Reason|0
205939|NCT01130168|653921|P6|Period 1|Withdrawal by Subject|0
205940|NCT01130168|653922|P5|Period 1|Withdrawal by Subject|0
205941|NCT01130168|653923|P4|Period 1|Withdrawal by Subject|1
205942|NCT01130168|653924|P3|Period 1|Withdrawal by Subject|0
205943|NCT01130168|653925|P2|Period 1|Withdrawal by Subject|1
205944|NCT01130168|653926|P1|Period 1|Withdrawal by Subject|0
205945|NCT01130337|653961|P1|Overall Study|Surgical resection (R2)|1
205946|NCT01130337|653961|P1|Overall Study|Toxicity, AE/intercurrent disease|7
205947|NCT01130337|653961|P1|Overall Study|Disease progression|1
205948|NCT01130337|653961|P1|Overall Study|Death|1
205949|NCT01130337|653961|P1|Overall Study|Principal investigator decision|1
205950|NCT01130337|653961|P1|Overall Study|Withdrawal by Subject|3
205951|NCT01130532|653971|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
205952|NCT01130532|653972|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
205953|NCT01130532|653973|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
205954|NCT01130532|653974|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
205955|NCT01130532|653971|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
205956|NCT01130532|653972|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
205957|NCT01130532|653973|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
205958|NCT01130532|653974|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
205959|NCT01130532|653971|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
205960|NCT01130532|653972|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
205961|NCT01130532|653973|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
205962|NCT01130532|653974|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
205963|NCT01130532|653971|P4|Period IV (Weeks 13-16)|Adverse Event|1
205964|NCT01130532|653972|P3|Period IV (Weeks 13-16)|Adverse Event|0
205965|NCT01130532|653973|P2|Period IV (Weeks 13-16)|Adverse Event|0
205966|NCT01130532|653974|P1|Period IV (Weeks 13-16)|Adverse Event|0
205967|NCT01130532|653971|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
205968|NCT01130532|653972|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
205969|NCT01130532|653973|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
205970|NCT01130532|653974|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
205971|NCT01130532|653971|P4|Period III (Weeks 0-12)|Sponsor Decision|0
205972|NCT01130532|653972|P3|Period III (Weeks 0-12)|Sponsor Decision|2
205973|NCT01130532|653973|P2|Period III (Weeks 0-12)|Sponsor Decision|4
205974|NCT01130532|653974|P1|Period III (Weeks 0-12)|Sponsor Decision|3
205975|NCT01130532|653971|P4|Period III (Weeks 0-12)|Protocol Violation|0
205976|NCT01130532|653972|P3|Period III (Weeks 0-12)|Protocol Violation|1
205977|NCT01130532|653973|P2|Period III (Weeks 0-12)|Protocol Violation|0
205978|NCT01130532|653974|P1|Period III (Weeks 0-12)|Protocol Violation|0
205979|NCT01130532|653971|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
205980|NCT01130532|653972|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
205981|NCT01130532|653973|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
205982|NCT01130532|653974|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
205983|NCT01130532|653971|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
205984|NCT01130532|653972|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
205985|NCT01130532|653973|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
205986|NCT01130532|653974|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
205987|NCT01130532|653971|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
205988|NCT01130532|653972|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
205989|NCT01130532|653973|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
205990|NCT01130532|653974|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
205991|NCT01130532|653971|P4|Period III (Weeks 0-12)|Adverse Event|0
205992|NCT01130532|653972|P3|Period III (Weeks 0-12)|Adverse Event|2
205993|NCT01130532|653973|P2|Period III (Weeks 0-12)|Adverse Event|3
205994|NCT01130532|653974|P1|Period III (Weeks 0-12)|Adverse Event|3
205995|NCT01130597|654019|P1|Overall Study|Protocol Violation|1
205996|NCT01130597|654019|P1|Overall Study|Death|1
205997|NCT01130597|654019|P1|Overall Study|Adverse Event|4
205998|NCT01130597|654019|P1|Overall Study|Protocol-specified (High K+)|1
205999|NCT01136655|654041|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
206000|NCT01136655|654041|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
206001|NCT01136655|654041|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
206002|NCT01136655|654041|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
206003|NCT01136746|654069|P2|Overall Study|Death|0
206004|NCT01136746|654070|P1|Overall Study|Death|1
206005|NCT01136746|654069|P2|Overall Study|Protocol Violation|1
206006|NCT01136746|654070|P1|Overall Study|Protocol Violation|2
206007|NCT01136746|654069|P2|Overall Study|Lost to Follow-up|2
206008|NCT01136746|654070|P1|Overall Study|Lost to Follow-up|0
206009|NCT01136772|654132|P2|Overall Study|Did not follow up after first injection|2
206010|NCT01136772|654133|P1|Overall Study|Did not follow up after first injection|2
206011|NCT01136772|654132|P2|Overall Study|Did not receive injection|7
206012|NCT01136772|654133|P1|Overall Study|Did not receive injection|10
206013|NCT01136772|654132|P2|Overall Study|Withdrawal by Subject|36
206014|NCT01136772|654133|P1|Overall Study|Withdrawal by Subject|33
206015|NCT01136772|654132|P2|Overall Study|Administrative|12
206016|NCT01136772|654133|P1|Overall Study|Administrative|14
206017|NCT01136772|654132|P2|Overall Study|Lack of Efficacy|39
206018|NCT01136772|654133|P1|Overall Study|Lack of Efficacy|42
206019|NCT01136772|654132|P2|Overall Study|Adverse Event|14
206020|NCT01136772|654133|P1|Overall Study|Adverse Event|15
206021|NCT01136785|654143|P2|Overall Study|Protocol Violation|1
206022|NCT01136785|654144|P1|Overall Study|Protocol Violation|2
206023|NCT01137578|654162|P3|Overall Study|Not Specified|6
206024|NCT01137578|654163|P2|Overall Study|Not Specified|2
206025|NCT01137578|654164|P1|Overall Study|Not Specified|12
206026|NCT01137578|654162|P3|Overall Study|Withdrawal by Subject|0
206027|NCT01137578|654163|P2|Overall Study|Withdrawal by Subject|0
206028|NCT01137578|654164|P1|Overall Study|Withdrawal by Subject|1
206029|NCT01137578|654162|P3|Overall Study|Participant requested to Discontinue|0
206030|NCT01137578|654163|P2|Overall Study|Participant requested to Discontinue|0
206031|NCT01137578|654164|P1|Overall Study|Participant requested to Discontinue|3
206032|NCT01137604|654208|P4|Overall Study|Clinical Decline|1
206033|NCT01137604|654209|P3|Overall Study|Clinical Decline|1
206034|NCT01137604|654210|P2|Overall Study|Clinical Decline|0
206035|NCT01137604|654211|P1|Overall Study|Clinical Decline|0
206036|NCT01137604|654208|P4|Overall Study|Participant's Decision|0
206037|NCT01137604|654209|P3|Overall Study|Participant's Decision|0
206038|NCT01137604|654210|P2|Overall Study|Participant's Decision|0
206039|NCT01137604|654211|P1|Overall Study|Participant's Decision|1
206040|NCT01137604|654208|P4|Overall Study|Clinical Progression|0
206041|NCT01137604|654209|P3|Overall Study|Clinical Progression|1
206042|NCT01137604|654210|P2|Overall Study|Clinical Progression|2
206043|NCT01137604|654211|P1|Overall Study|Clinical Progression|0
206044|NCT01137604|654208|P4|Overall Study|Withdrawal by Subject|1
206045|NCT01137604|654209|P3|Overall Study|Withdrawal by Subject|2
206046|NCT01137604|654210|P2|Overall Study|Withdrawal by Subject|2
206047|NCT01137604|654211|P1|Overall Study|Withdrawal by Subject|0
206048|NCT01137604|654208|P4|Overall Study|Adverse Event|9
206049|NCT01137604|654209|P3|Overall Study|Adverse Event|9
206050|NCT01137604|654210|P2|Overall Study|Adverse Event|6
206051|NCT01137604|654211|P1|Overall Study|Adverse Event|1
206052|NCT01137682|654248|P3|Overall Study|Protocol Violation|1
206053|NCT01137682|654249|P2|Overall Study|Protocol Violation|1
206054|NCT01137682|654250|P1|Overall Study|Protocol Violation|0
206055|NCT01137682|654248|P3|Overall Study|Administrative Problems|0
206056|NCT01137682|654249|P2|Overall Study|Administrative Problems|1
206057|NCT01137682|654250|P1|Overall Study|Administrative Problems|2
206058|NCT01137682|654248|P3|Overall Study|Withdrawal by Subject|2
206059|NCT01137682|654249|P2|Overall Study|Withdrawal by Subject|2
206060|NCT01137682|654250|P1|Overall Study|Withdrawal by Subject|2
206061|NCT01137682|654248|P3|Overall Study|Adverse Event|0
206062|NCT01137682|654249|P2|Overall Study|Adverse Event|4
206063|NCT01137682|654250|P1|Overall Study|Adverse Event|2
206064|NCT01137773|654263|P2|Overall Study|Lost to Follow-up|0
206065|NCT01137773|654264|P1|Overall Study|Lost to Follow-up|6
206066|NCT01137773|654263|P2|Overall Study|Death|3
206067|NCT01137773|654264|P1|Overall Study|Death|3
206068|NCT01137786|654274|P2|Overall Study|Withdrawal by Subject|1
206069|NCT01137786|654275|P1|Overall Study|Withdrawal by Subject|1
206070|NCT01137786|654274|P2|Overall Study|Lost to Follow-up|2
206071|NCT01137786|654275|P1|Overall Study|Lost to Follow-up|0
206072|NCT01137812|654285|P2|Overall Study|Not specified|27
206073|NCT01137812|654286|P1|Overall Study|Not specified|19
206074|NCT01137812|654285|P2|Overall Study|Patient met glycemic withdrawal criteria|85
206075|NCT01137812|654286|P1|Overall Study|Patient met glycemic withdrawal criteria|40
206076|NCT01137812|654285|P2|Overall Study|Death|0
206077|NCT01137812|654286|P1|Overall Study|Death|2
206078|NCT01137812|654285|P2|Overall Study|Withdrawal by Subject|13
206079|NCT01137812|654286|P1|Overall Study|Withdrawal by Subject|5
206080|NCT01137812|654285|P2|Overall Study|Protocol Violation|4
206081|NCT01137812|654286|P1|Overall Study|Protocol Violation|5
206082|NCT01137812|654285|P2|Overall Study|Physician Decision|17
206083|NCT01137812|654286|P1|Overall Study|Physician Decision|25
206084|NCT01137812|654285|P2|Overall Study|Lost to Follow-up|8
206085|NCT01137812|654286|P1|Overall Study|Lost to Follow-up|6
206086|NCT01137812|654285|P2|Overall Study|Adverse Event|14
206087|NCT01137812|654286|P1|Overall Study|Adverse Event|21
206088|NCT01138007|654307|P3|Overall Study|Withdrawal by Subject|15
206089|NCT01138007|654308|P2|Overall Study|Withdrawal by Subject|6
206090|NCT01138007|654309|P1|Overall Study|Withdrawal by Subject|5
206091|NCT01138007|654307|P3|Overall Study|Physician Decision|3
206092|NCT01138007|654308|P2|Overall Study|Physician Decision|5
206093|NCT01138007|654309|P1|Overall Study|Physician Decision|0
206094|NCT01138007|654307|P3|Overall Study|Lost to Follow-up|5
206095|NCT01138007|654308|P2|Overall Study|Lost to Follow-up|3
206096|NCT01138007|654309|P1|Overall Study|Lost to Follow-up|3
206097|NCT01138007|654307|P3|Overall Study|Protocol-Defined Stopping Criteria|8
206098|NCT01138007|654308|P2|Overall Study|Protocol-Defined Stopping Criteria|1
206099|NCT01138007|654309|P1|Overall Study|Protocol-Defined Stopping Criteria|6
206100|NCT01138007|654307|P3|Overall Study|Protocol Violation|2
206101|NCT01138007|654308|P2|Overall Study|Protocol Violation|3
206102|NCT01138007|654309|P1|Overall Study|Protocol Violation|2
206103|NCT01138007|654307|P3|Overall Study|Lack of Efficacy|6
206104|NCT01138007|654308|P2|Overall Study|Lack of Efficacy|0
206105|NCT01138007|654309|P1|Overall Study|Lack of Efficacy|2
206106|NCT01138007|654307|P3|Overall Study|Adverse Event|9
206107|NCT01138007|654308|P2|Overall Study|Adverse Event|12
206108|NCT01138007|654309|P1|Overall Study|Adverse Event|4
206109|NCT01138046|654341|P1|Overall Study|Withdrawal due to death|6
206110|NCT01138111|654383|P1|Overall Study|Lost to Follow-up|2
206111|NCT01138111|654383|P1|Overall Study|Death|1
206112|NCT01138111|654383|P1|Overall Study|Adverse Event|1
206113|NCT01138111|654383|P1|Overall Study|Withdrawal by Subject|5
206114|NCT01138150|654443|P2|Overall Study|Physician Decision|0
206115|NCT01138150|654444|P1|Overall Study|Physician Decision|1
206116|NCT01138150|654443|P2|Overall Study|blood unable to be processed|1
206117|NCT01138150|654444|P1|Overall Study|blood unable to be processed|0
206118|NCT01138501|654533|P1|Overall Study|Withdrawal by Subject|3
206119|NCT01138501|654533|P1|Overall Study|Protocol Violation|2
206120|NCT01138657|654559|P2|Overall Study|Miscellaneous Reasons|4
206121|NCT01138657|654560|P1|Overall Study|Miscellaneous Reasons|3
206122|NCT01138657|654559|P2|Overall Study|Lost to Follow-up|3
206123|NCT01138657|654560|P1|Overall Study|Lost to Follow-up|0
206124|NCT01138657|654559|P2|Overall Study|Lack of Efficacy|1
206125|NCT01138657|654560|P1|Overall Study|Lack of Efficacy|2
206126|NCT01138657|654559|P2|Overall Study|Adverse Event|10
206127|NCT01138657|654560|P1|Overall Study|Adverse Event|3
206128|NCT01138826|654619|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
206129|NCT01138826|654620|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
206130|NCT01138826|654621|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
206131|NCT01138826|654622|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
206132|NCT01138826|654623|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
206133|NCT01138826|654624|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
206134|NCT01139008|654668|P1|Overall Study|Non-compliant, lost product|1
206135|NCT01139008|654668|P1|Overall Study|Withdrawal by Subject|5
206136|NCT01139021|654683|P6|Overall Study|Withdrawal by Subject|0
206137|NCT01139021|654684|P5|Overall Study|Withdrawal by Subject|4
206138|NCT01139021|654685|P4|Overall Study|Withdrawal by Subject|1
206139|NCT01139021|654686|P3|Overall Study|Withdrawal by Subject|0
206140|NCT01139021|654687|P2|Overall Study|Withdrawal by Subject|0
206141|NCT01139021|654688|P1|Overall Study|Withdrawal by Subject|0
206142|NCT01139021|654683|P6|Overall Study|Protocol Violation|0
206143|NCT01139021|654684|P5|Overall Study|Protocol Violation|2
206144|NCT01139021|654685|P4|Overall Study|Protocol Violation|0
206145|NCT01139021|654686|P3|Overall Study|Protocol Violation|0
206146|NCT01139021|654687|P2|Overall Study|Protocol Violation|0
206147|NCT01139021|654688|P1|Overall Study|Protocol Violation|1
206148|NCT01139021|654683|P6|Overall Study|Lost to Follow-up|0
206149|NCT01139021|654684|P5|Overall Study|Lost to Follow-up|2
206150|NCT01139021|654685|P4|Overall Study|Lost to Follow-up|0
206151|NCT01139021|654686|P3|Overall Study|Lost to Follow-up|0
206152|NCT01139021|654687|P2|Overall Study|Lost to Follow-up|0
206153|NCT01139021|654688|P1|Overall Study|Lost to Follow-up|0
206154|NCT01139021|654683|P6|Overall Study|Adverse Event|0
206155|NCT01139021|654684|P5|Overall Study|Adverse Event|1
206156|NCT01139021|654685|P4|Overall Study|Adverse Event|0
206157|NCT01139021|654686|P3|Overall Study|Adverse Event|0
206158|NCT01139021|654687|P2|Overall Study|Adverse Event|0
206159|NCT01139021|654688|P1|Overall Study|Adverse Event|0
206160|NCT01139047|654724|P1|Overall Study|Withdrawal by Subject|1
206161|NCT01139125|654733|P1|Overall Study|Withdrawal by Subject|1
206162|NCT01139164|654740|P3|Overall Study|Withdrawn prior to study start|0
206163|NCT01139164|654741|P2|Overall Study|Withdrawn prior to study start|2
206164|NCT01139164|654742|P1|Overall Study|Withdrawn prior to study start|0
206165|NCT01139450|654800|P3|Overall Study|Adverse Event|3
206166|NCT01139450|654801|P2|Overall Study|Adverse Event|2
206167|NCT01139450|654802|P1|Overall Study|Adverse Event|2
206168|NCT01139450|654800|P3|Overall Study|Administrative|1
206169|NCT01139450|654801|P2|Overall Study|Administrative|0
206170|NCT01139450|654802|P1|Overall Study|Administrative|0
206171|NCT01139450|654800|P3|Overall Study|Lost to Follow-up|11
206172|NCT01139450|654801|P2|Overall Study|Lost to Follow-up|7
206173|NCT01139450|654802|P1|Overall Study|Lost to Follow-up|9
206174|NCT01139450|654800|P3|Overall Study|Protocol Violation|2
206175|NCT01139450|654801|P2|Overall Study|Protocol Violation|5
206176|NCT01139450|654802|P1|Overall Study|Protocol Violation|6
206177|NCT01139450|654800|P3|Overall Study|Lack of Efficacy|8
206178|NCT01139450|654801|P2|Overall Study|Lack of Efficacy|1
206179|NCT01139450|654802|P1|Overall Study|Lack of Efficacy|3
206180|NCT01139450|654800|P3|Overall Study|Withdrawal by Subject|13
206181|NCT01139450|654801|P2|Overall Study|Withdrawal by Subject|10
206182|NCT01139450|654802|P1|Overall Study|Withdrawal by Subject|7
206183|NCT01139580|654841|P2|Overall Study|Participant Randomization in Error|1
206184|NCT01139580|654842|P1|Overall Study|Participant Randomization in Error|0
206185|NCT01139580|654841|P2|Overall Study|Beginning Study Exclusion Treatment|1
206186|NCT01139580|654842|P1|Overall Study|Beginning Study Exclusion Treatment|0
206187|NCT01139580|654841|P2|Overall Study|Misrandomized|0
206188|NCT01139580|654842|P1|Overall Study|Misrandomized|1
206189|NCT01139580|654841|P2|Overall Study|Did Not Meet Exclusion Criteria|0
206190|NCT01139580|654842|P1|Overall Study|Did Not Meet Exclusion Criteria|1
206191|NCT01139580|654841|P2|Overall Study|Used Excluded Medicine After Enrollment|0
206192|NCT01139580|654842|P1|Overall Study|Used Excluded Medicine After Enrollment|1
206193|NCT01139580|654841|P2|Overall Study|Withdrawal by Subject|9
206194|NCT01139580|654842|P1|Overall Study|Withdrawal by Subject|6
206195|NCT01139580|654841|P2|Overall Study|Lack of Efficacy|2
206196|NCT01139580|654842|P1|Overall Study|Lack of Efficacy|0
206197|NCT01139580|654841|P2|Overall Study|Lost to Follow-up|1
206198|NCT01139580|654842|P1|Overall Study|Lost to Follow-up|9
206199|NCT01139580|654841|P2|Overall Study|Adverse Event|4
206200|NCT01139580|654842|P1|Overall Study|Adverse Event|5
206201|NCT01139658|654860|P2|Overall Study|Not specified|75
206202|NCT01139658|654861|P1|Overall Study|Not specified|28
206203|NCT01139658|654860|P2|Overall Study|No documentation of treatment|0
206204|NCT01139658|654861|P1|Overall Study|No documentation of treatment|1
206205|NCT01139658|654860|P2|Overall Study|Withdrawal by Subject|4
206206|NCT01139658|654861|P1|Overall Study|Withdrawal by Subject|2
206207|NCT01139658|654860|P2|Overall Study|Lack of Efficacy|7
206208|NCT01139658|654861|P1|Overall Study|Lack of Efficacy|15
206209|NCT01139658|654860|P2|Overall Study|Adverse Event|27
206210|NCT01139658|654861|P1|Overall Study|Adverse Event|10
206211|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
206212|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
206213|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
206214|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
206215|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
206216|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
206217|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
206218|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
206219|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
206220|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
206221|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
206222|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
206223|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
206224|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
206225|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
206226|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
206227|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
206228|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
206229|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
206230|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
206231|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
206232|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Death|1
206233|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Death|1
206234|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Death|0
206235|NCT01139762|654899|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
206236|NCT01139762|654900|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
206237|NCT01139762|654901|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
206238|NCT01139762|654899|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
206239|NCT01139762|654900|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
206240|NCT01139762|654901|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
206241|NCT01139762|654899|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
206242|NCT01139762|654900|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
206243|NCT01139762|654901|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
206244|NCT01139762|654899|P3|Washout and Placebo Lead-In Period|Physician Decision|0
206245|NCT01139762|654900|P2|Washout and Placebo Lead-In Period|Physician Decision|0
206246|NCT01139762|654901|P1|Washout and Placebo Lead-In Period|Physician Decision|12
206247|NCT01139762|654899|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
206248|NCT01139762|654900|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
206249|NCT01139762|654901|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
206250|NCT01139762|654899|P3|Washout and Placebo Lead-In Period|Adverse Event|0
206251|NCT01139762|654900|P2|Washout and Placebo Lead-In Period|Adverse Event|0
206252|NCT01139762|654901|P1|Washout and Placebo Lead-In Period|Adverse Event|1
206253|NCT01139762|654899|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
206254|NCT01139762|654900|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
206255|NCT01139762|654901|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
206256|NCT01133626|654948|P3|Overall Study|Not specified|0
206257|NCT01133626|654949|P2|Overall Study|Not specified|2
206258|NCT01133626|654950|P1|Overall Study|Not specified|0
206259|NCT01133626|654948|P3|Overall Study|Withdrawal by Subject|2
206260|NCT01133626|654949|P2|Overall Study|Withdrawal by Subject|2
206261|NCT01133626|654950|P1|Overall Study|Withdrawal by Subject|1
206262|NCT01133626|654948|P3|Overall Study|Adverse Event|0
206263|NCT01133626|654949|P2|Overall Study|Adverse Event|1
206264|NCT01133626|654950|P1|Overall Study|Adverse Event|0
206265|NCT01133665|654958|P1|Overall Study|Physician Decision|2
206266|NCT01133704|655001|P2|Overall Study|Study Closure|0
206267|NCT01133704|655002|P1|Overall Study|Study Closure|1
206268|NCT01133704|655001|P2|Overall Study|Patient refused to continue|0
206269|NCT01133704|655002|P1|Overall Study|Patient refused to continue|4
206270|NCT01133704|655001|P2|Overall Study|Death|26
206271|NCT01133704|655002|P1|Overall Study|Death|44
206272|NCT01133756|655013|P3|Overall Study|Progression of Disease|1
206273|NCT01133756|655014|P2|Overall Study|Progression of Disease|0
206274|NCT01133756|655015|P1|Overall Study|Progression of Disease|0
206275|NCT01133756|655013|P3|Overall Study|Withdrawal by Subject|0
206276|NCT01133756|655014|P2|Overall Study|Withdrawal by Subject|1
206277|NCT01133756|655015|P1|Overall Study|Withdrawal by Subject|0
206278|NCT01133756|655013|P3|Overall Study|Investigator Decision|0
206279|NCT01133756|655014|P2|Overall Study|Investigator Decision|0
206280|NCT01133756|655015|P1|Overall Study|Investigator Decision|1
206281|NCT01133756|655013|P3|Overall Study|Adverse Event|1
206282|NCT01133756|655014|P2|Overall Study|Adverse Event|2
206283|NCT01133756|655015|P1|Overall Study|Adverse Event|1
206284|NCT01133821|655031|P2|Overall Study|Refused participation|3
206285|NCT01133821|655032|P1|Overall Study|Refused participation|1
206286|NCT01133821|655031|P2|Overall Study|Protocol Violation|1
206287|NCT01133821|655032|P1|Overall Study|Protocol Violation|0
206288|NCT01133821|655031|P2|Overall Study|preferred other treatment|1
206289|NCT01133821|655032|P1|Overall Study|preferred other treatment|1
206290|NCT01133821|655031|P2|Overall Study|Withdrawal by Subject|3
206291|NCT01133821|655032|P1|Overall Study|Withdrawal by Subject|8
206292|NCT01133821|655031|P2|Overall Study|Lost to Follow-up|11
206293|NCT01133821|655032|P1|Overall Study|Lost to Follow-up|8
206294|NCT01133847|655041|P3|Follow-Up Phase|Lost to Follow-up|7
206295|NCT01133847|655042|P2|Follow-Up Phase|Lost to Follow-up|3
206296|NCT01133847|655043|P1|Follow-Up Phase|Lost to Follow-up|1
206297|NCT01133847|655041|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
206298|NCT01133847|655042|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
206299|NCT01133847|655043|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
206300|NCT01133977|655093|P5|Overall Study|Withdrawal by Subject|1
206301|NCT01133977|655094|P4|Overall Study|Withdrawal by Subject|5
206302|NCT01133977|655095|P3|Overall Study|Withdrawal by Subject|0
206303|NCT01133977|655096|P2|Overall Study|Withdrawal by Subject|0
206304|NCT01133977|655097|P1|Overall Study|Withdrawal by Subject|0
206305|NCT01133977|655093|P5|Overall Study|Lost to Follow-up|1
206306|NCT01133977|655094|P4|Overall Study|Lost to Follow-up|2
206307|NCT01133977|655095|P3|Overall Study|Lost to Follow-up|0
206308|NCT01133977|655096|P2|Overall Study|Lost to Follow-up|0
206309|NCT01133977|655097|P1|Overall Study|Lost to Follow-up|0
206310|NCT01133977|655093|P5|Overall Study|Started a New Line of Therapy|33
206311|NCT01133977|655094|P4|Overall Study|Started a New Line of Therapy|25
206312|NCT01133977|655095|P3|Overall Study|Started a New Line of Therapy|4
206313|NCT01133977|655096|P2|Overall Study|Started a New Line of Therapy|6
206314|NCT01133977|655097|P1|Overall Study|Started a New Line of Therapy|2
206315|NCT01133977|655093|P5|Overall Study|Death|3
206316|NCT01133977|655094|P4|Overall Study|Death|7
206317|NCT01133977|655095|P3|Overall Study|Death|1
206318|NCT01133977|655096|P2|Overall Study|Death|1
206319|NCT01133977|655097|P1|Overall Study|Death|1
206320|NCT01133977|655093|P5|Overall Study|Adverse Event|0
206321|NCT01133977|655094|P4|Overall Study|Adverse Event|0
206322|NCT01133977|655095|P3|Overall Study|Adverse Event|1
206323|NCT01133977|655096|P2|Overall Study|Adverse Event|0
206324|NCT01133977|655097|P1|Overall Study|Adverse Event|0
206325|NCT01140048|655156|P1|Overall Study|Lost to Follow-up|31
206326|NCT01140048|655156|P1|Overall Study|Withdrawal by Subject|13
206327|NCT01140048|655156|P1|Overall Study|Physician Decision|1
206328|NCT01140061|655172|P10|Extension|Laboratory Adverse Event|1
206329|NCT01140061|655173|P9|Extension|Laboratory Adverse Event|0
206330|NCT01140061|655174|P8|Extension|Laboratory Adverse Event|0
206331|NCT01140061|655175|P7|Extension|Laboratory Adverse Event|0
206332|NCT01140061|655176|P6|Extension|Laboratory Adverse Event|0
206333|NCT01140061|655177|P5|Extension|Laboratory Adverse Event|0
206334|NCT01140061|655178|P4|Extension|Laboratory Adverse Event|0
206335|NCT01140061|655179|P3|Extension|Laboratory Adverse Event|0
206336|NCT01140061|655180|P2|Extension|Laboratory Adverse Event|0
206337|NCT01140061|655181|P1|Extension|Laboratory Adverse Event|0
206338|NCT01140061|655172|P10|Part I|Adverse Event|0
206339|NCT01140061|655173|P9|Part I|Adverse Event|0
206340|NCT01140061|655174|P8|Part I|Adverse Event|0
206341|NCT01140061|655175|P7|Part I|Adverse Event|0
206342|NCT01140061|655176|P6|Part I|Adverse Event|0
206343|NCT01140061|655177|P5|Part I|Adverse Event|0
206344|NCT01140061|655178|P4|Part I|Adverse Event|0
206345|NCT01140061|655179|P3|Part I|Adverse Event|0
206346|NCT01140061|655180|P2|Part I|Adverse Event|0
206347|NCT01140061|655181|P1|Part I|Adverse Event|1
206348|NCT01140477|655230|P2|Overall Study|Subject explanted|1
206349|NCT01140477|655231|P1|Overall Study|Subject explanted|0
206350|NCT01140477|655230|P2|Overall Study|Death|1
206351|NCT01140477|655231|P1|Overall Study|Death|1
206352|NCT01140477|655230|P2|Overall Study|Surgical complication preventing implant|0
206353|NCT01140477|655231|P1|Overall Study|Surgical complication preventing implant|2
206354|NCT01140477|655230|P2|Overall Study|Withdrawal by Subject|4
206355|NCT01140477|655231|P1|Overall Study|Withdrawal by Subject|1
206356|NCT01140477|655230|P2|Overall Study|Lost to Follow-up|0
206357|NCT01140477|655231|P1|Overall Study|Lost to Follow-up|4
206358|NCT01140503|655240|P1|Overall Study|Withdrawal by Subject|1
206359|NCT01140646|655246|P1|Overall Study|Refused Further Treatment|5
206360|NCT01140646|655246|P1|Overall Study|Adverse Event|4
206361|NCT01140867|655283|P1|Overall Study|Medication Noncompliance|2
206362|NCT01140867|655283|P1|Overall Study|Uncooperative patient|2
206363|NCT01140867|655283|P1|Overall Study|Protocol Violation|1
206364|NCT01140867|655283|P1|Overall Study|Withdrawal by Subject|1
206365|NCT01140867|655283|P1|Overall Study|Lost to Follow-up|2
206366|NCT01140867|655283|P1|Overall Study|Lack of Efficacy|3
206367|NCT01140867|655283|P1|Overall Study|Adverse Event|22
206368|NCT01140880|655292|P2|Overall Study|Protocol Violation|30
206369|NCT01140880|655293|P1|Overall Study|Protocol Violation|0
206370|NCT01140880|655292|P2|Overall Study|Lost to Follow-up|10
206371|NCT01140880|655293|P1|Overall Study|Lost to Follow-up|8
206372|NCT01140880|655292|P2|Overall Study|Withdrawal by Subject|3
206373|NCT01140880|655293|P1|Overall Study|Withdrawal by Subject|6
206374|NCT01140880|655292|P2|Overall Study|Death|1
206375|NCT01140880|655293|P1|Overall Study|Death|0
206376|NCT01140906|655309|P4|Overall Study|Administrative or other reason|2
206377|NCT01140906|655310|P3|Overall Study|Administrative or other reason|3
206378|NCT01140906|655311|P2|Overall Study|Administrative or other reason|5
206379|NCT01140906|655312|P1|Overall Study|Administrative or other reason|0
206380|NCT01140906|655309|P4|Overall Study|Lost to Follow-up|2
206381|NCT01140906|655310|P3|Overall Study|Lost to Follow-up|0
206382|NCT01140906|655311|P2|Overall Study|Lost to Follow-up|1
206383|NCT01140906|655312|P1|Overall Study|Lost to Follow-up|1
206384|NCT01140906|655309|P4|Overall Study|Withdrawal of consent|2
206385|NCT01140906|655310|P3|Overall Study|Withdrawal of consent|2
206386|NCT01140906|655311|P2|Overall Study|Withdrawal of consent|6
206387|NCT01140906|655312|P1|Overall Study|Withdrawal of consent|6
206388|NCT01140906|655309|P4|Overall Study|Protocol Violation|1
206389|NCT01140906|655310|P3|Overall Study|Protocol Violation|2
206390|NCT01140906|655311|P2|Overall Study|Protocol Violation|3
206391|NCT01140906|655312|P1|Overall Study|Protocol Violation|5
206392|NCT01140906|655309|P4|Overall Study|Non-compliance|1
206393|NCT01140906|655310|P3|Overall Study|Non-compliance|0
206394|NCT01140906|655311|P2|Overall Study|Non-compliance|1
206395|NCT01140906|655312|P1|Overall Study|Non-compliance|0
206396|NCT01140906|655309|P4|Overall Study|Lack of Efficacy|1
206397|NCT01140906|655310|P3|Overall Study|Lack of Efficacy|2
206398|NCT01140906|655311|P2|Overall Study|Lack of Efficacy|8
206399|NCT01140906|655312|P1|Overall Study|Lack of Efficacy|6
206400|NCT01140906|655309|P4|Overall Study|Adverse Event|7
206401|NCT01140906|655310|P3|Overall Study|Adverse Event|17
206402|NCT01140906|655311|P2|Overall Study|Adverse Event|10
206403|NCT01140906|655312|P1|Overall Study|Adverse Event|7
206404|NCT01141205|655352|P2|Overall Study|Withdrawal by Subject|1
206405|NCT01141205|655353|P1|Overall Study|Withdrawal by Subject|1
206406|NCT01141205|655352|P2|Overall Study|Lost to Follow-up|0
206407|NCT01141205|655353|P1|Overall Study|Lost to Follow-up|1
206408|NCT01141205|655352|P2|Overall Study|Physician Decision|1
206409|NCT01141205|655353|P1|Overall Study|Physician Decision|1
206410|NCT01141283|655365|P1|Overall Study|Lack of Efficacy|10
206411|NCT01141283|655365|P1|Overall Study|Administrative|4
206412|NCT01141283|655365|P1|Overall Study|Withdrawal by Subject|14
206413|NCT01141283|655365|P1|Overall Study|Lost to Follow-up|4
206414|NCT01141283|655365|P1|Overall Study|Adverse Event|56
206415|NCT01141660|655422|P2|Overall Study|Physician Decision|12
206416|NCT01141660|655423|P1|Overall Study|Physician Decision|0
206417|NCT01141712|655429|P1|Overall Study|Disease progression|3
206418|NCT01142115|655462|P2|First Intervention|Adverse Event|0
206419|NCT01142115|655463|P1|First Intervention|Adverse Event|1
206420|NCT01142115|655462|P2|First Intervention|Lack of Efficacy|1
206421|NCT01142115|655463|P1|First Intervention|Lack of Efficacy|1
206422|NCT01142128|655482|P1|Overall Study|Withdrawal by Subject|2
206423|NCT01142128|655482|P1|Overall Study|Lost to Follow-up|1
206424|NCT01142128|655482|P1|Overall Study|Physician Decision|1
206425|NCT01142193|655494|P2|Overall Study|Other|2
206426|NCT01142193|655495|P1|Overall Study|Other|1
206427|NCT01142193|655494|P2|Overall Study|Protocol Discontinuation Criterion Met|0
206428|NCT01142193|655495|P1|Overall Study|Protocol Discontinuation Criterion Met|1
206429|NCT01142193|655494|P2|Overall Study|Withdrawal by Subject|3
206430|NCT01142193|655495|P1|Overall Study|Withdrawal by Subject|4
206431|NCT01142193|655494|P2|Overall Study|Physician Decision|1
206432|NCT01142193|655495|P1|Overall Study|Physician Decision|1
206433|NCT01142193|655494|P2|Overall Study|Lack of Efficacy|1
206434|NCT01142193|655495|P1|Overall Study|Lack of Efficacy|2
206435|NCT01142193|655494|P2|Overall Study|Adverse Event|4
206436|NCT01142193|655495|P1|Overall Study|Adverse Event|12
206437|NCT01142336|655532|P2|Overall Study|Lost to Follow-up|1
206438|NCT01142336|655533|P1|Overall Study|Lost to Follow-up|0
206439|NCT01142336|655532|P2|Overall Study|Adverse Event|1
206440|NCT01142336|655533|P1|Overall Study|Adverse Event|1
206441|NCT01142388|655545|P2|Overall Study|Never started therapy|3
206442|NCT01142388|655546|P1|Overall Study|Never started therapy|7
206443|NCT01142388|655545|P2|Overall Study|Other|1
206444|NCT01142388|655546|P1|Overall Study|Other|1
206445|NCT01142388|655545|P2|Overall Study|Other complications|2
206446|NCT01142388|655546|P1|Overall Study|Other complications|0
206447|NCT01142388|655545|P2|Overall Study|Alternative therapy|0
206448|NCT01142388|655546|P1|Overall Study|Alternative therapy|1
206449|NCT01142388|655545|P2|Overall Study|Withdrawal by Subject|3
206450|NCT01142388|655546|P1|Overall Study|Withdrawal by Subject|5
206451|NCT01142388|655545|P2|Overall Study|Death|2
206452|NCT01142388|655546|P1|Overall Study|Death|3
206453|NCT01142388|655545|P2|Overall Study|Adverse Event|5
206454|NCT01142388|655546|P1|Overall Study|Adverse Event|9
206455|NCT01142388|655545|P2|Overall Study|Lack of Efficacy|31
206456|NCT01142388|655546|P1|Overall Study|Lack of Efficacy|21
206457|NCT01142466|655558|P2|Overall Study|Withdrawal by Subject|1
206458|NCT01142466|655559|P1|Overall Study|Withdrawal by Subject|1
206459|NCT01142466|655558|P2|Overall Study|Adverse Event|1
206460|NCT01142466|655559|P1|Overall Study|Adverse Event|2
206461|NCT01142596|655579|P2|Overall Study|Other reason (not specified)|4
206462|NCT01142596|655580|P1|Overall Study|Other reason (not specified)|5
206463|NCT01142596|655579|P2|Overall Study|Lost to Follow-up|3
206464|NCT01142596|655580|P1|Overall Study|Lost to Follow-up|2
206465|NCT01142596|655579|P2|Overall Study|Lack of Efficacy|9
206466|NCT01142596|655580|P1|Overall Study|Lack of Efficacy|5
206467|NCT01142596|655579|P2|Overall Study|Adverse Event|35
206468|NCT01142596|655580|P1|Overall Study|Adverse Event|8
206469|NCT01142596|655579|P2|Overall Study|Withdrawal by Subject|35
206470|NCT01142596|655580|P1|Overall Study|Withdrawal by Subject|9
206471|NCT01142661|655630|P1|Overall Study|Physician Decision|1
206472|NCT01142661|655630|P1|Overall Study|Withdrawal by Subject|1
206473|NCT01142661|655630|P1|Overall Study|Adverse Event|2
206474|NCT01142726|655638|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
206475|NCT01142726|655639|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
206476|NCT01142726|655640|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
206477|NCT01142726|655638|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
206478|NCT01142726|655639|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
206479|NCT01142726|655640|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
206480|NCT01142726|655638|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
206481|NCT01142726|655639|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
206482|NCT01142726|655640|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
206483|NCT01142726|655638|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
206484|NCT01142726|655639|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
206485|NCT01142726|655640|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
206486|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
206487|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
206488|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
206489|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
206490|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
206491|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
206492|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
206493|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
206494|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
206495|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
206496|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
206497|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
206498|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
206499|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
206500|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
206501|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
206502|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
206503|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
206504|NCT01142726|655638|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
206505|NCT01142726|655639|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
206506|NCT01142726|655640|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
206507|NCT01142726|655638|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
206508|NCT01142726|655639|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
206509|NCT01142726|655640|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
206510|NCT01142726|655638|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
206511|NCT01142726|655639|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
206512|NCT01142726|655640|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
206513|NCT01142726|655638|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
206514|NCT01142726|655639|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
206515|NCT01142726|655640|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
206516|NCT01142726|655638|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
206517|NCT01142726|655639|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
206518|NCT01142726|655640|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
206519|NCT01142726|655638|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
206520|NCT01142726|655639|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
206521|NCT01142726|655640|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
206522|NCT01142908|655705|P2|Overall Study|Withdrawal by Subject|0
206523|NCT01142908|655706|P1|Overall Study|Withdrawal by Subject|3
206524|NCT01142908|655705|P2|Overall Study|Excluded - did not meet criteria|5
206525|NCT01142908|655706|P1|Overall Study|Excluded - did not meet criteria|9
206526|NCT01142908|655705|P2|Overall Study|Death|4
206527|NCT01142908|655706|P1|Overall Study|Death|1
206528|NCT01142908|655705|P2|Overall Study|Lost to Follow-up|13
206529|NCT01142908|655706|P1|Overall Study|Lost to Follow-up|19
206530|NCT01136876|655754|P2|Overall Study|Physician Decision|5
206531|NCT01136876|655755|P1|Overall Study|Physician Decision|3
206532|NCT01136876|655754|P2|Overall Study|Lost to Follow-up|1
206533|NCT01136876|655755|P1|Overall Study|Lost to Follow-up|0
206534|NCT01136915|655765|P2|Overall Study|Exclusion criterion met|1
206535|NCT01136915|655766|P1|Overall Study|Exclusion criterion met|0
206536|NCT01136915|655765|P2|Overall Study|Lost to Follow-up|0
206537|NCT01136915|655766|P1|Overall Study|Lost to Follow-up|2
206538|NCT01136954|655776|P2|Overall Study|Not Specified|3
206539|NCT01136954|655777|P1|Overall Study|Not Specified|1
206540|NCT01136954|655776|P2|Overall Study|Physician Decision|1
206541|NCT01136954|655777|P1|Overall Study|Physician Decision|0
206542|NCT01136954|655776|P2|Overall Study|Lack of Efficacy|13
206543|NCT01136954|655777|P1|Overall Study|Lack of Efficacy|14
206544|NCT01136954|655776|P2|Overall Study|Withdrawal by Subject|2
206545|NCT01136954|655777|P1|Overall Study|Withdrawal by Subject|6
206546|NCT01136954|655776|P2|Overall Study|Adverse Event|2
206547|NCT01136954|655777|P1|Overall Study|Adverse Event|3
206548|NCT01136967|655791|P2|Overall Study|Diagnosis of Second Primary Cancer|1
206549|NCT01136967|655792|P1|Overall Study|Diagnosis of Second Primary Cancer|0
206550|NCT01136967|655791|P2|Overall Study|Increase in Lesion Size|2
206551|NCT01136967|655792|P1|Overall Study|Increase in Lesion Size|0
206552|NCT01136967|655791|P2|Overall Study|Investigator's Choice|1
206553|NCT01136967|655792|P1|Overall Study|Investigator's Choice|1
206554|NCT01136967|655791|P2|Overall Study|Non Compliance|0
206555|NCT01136967|655792|P1|Overall Study|Non Compliance|1
206556|NCT01136967|655791|P2|Overall Study|Radiation|0
206557|NCT01136967|655792|P1|Overall Study|Radiation|1
206558|NCT01136967|655791|P2|Overall Study|Clinical Progression|5
206559|NCT01136967|655792|P1|Overall Study|Clinical Progression|3
206560|NCT01136967|655791|P2|Overall Study|Withdrawal by Subject|2
206561|NCT01136967|655792|P1|Overall Study|Withdrawal by Subject|1
206562|NCT01136967|655791|P2|Overall Study|Lost to Follow-up|1
206563|NCT01136967|655792|P1|Overall Study|Lost to Follow-up|0
206564|NCT01136967|655791|P2|Overall Study|Participant Choice|3
206565|NCT01136967|655792|P1|Overall Study|Participant Choice|8
206566|NCT01136967|655791|P2|Overall Study|Adverse Event|12
206567|NCT01136967|655792|P1|Overall Study|Adverse Event|9
206568|NCT01137071|655814|P1|Overall Study|Wrongly Included|1
206569|NCT01137071|655814|P1|Overall Study|Withdrawal by Subject|2
206570|NCT01137071|655814|P1|Overall Study|Disease Progression|11
206571|NCT01137292|655875|P1|Overall Study|Unspecified|7
206572|NCT01137292|655875|P1|Overall Study|Lost to Follow-up|1
206573|NCT01137292|655875|P1|Overall Study|Lack of Efficacy|13
206574|NCT01137292|655875|P1|Overall Study|Adverse Event|3
206575|NCT01137292|655875|P1|Overall Study|Death|30
206576|NCT01137435|655902|P1|Overall Study|Off label usage|4
206577|NCT01137435|655902|P1|Overall Study|Lost to Follow-up|24
206578|NCT01137474|655913|P4|Overall Study|Administrative reason by sponsor|0
206579|NCT01137474|655914|P3|Overall Study|Administrative reason by sponsor|0
206580|NCT01137474|655915|P2|Overall Study|Administrative reason by sponsor|1
206581|NCT01137474|655916|P1|Overall Study|Administrative reason by sponsor|0
206582|NCT01137474|655913|P4|Overall Study|Pregnancy|0
206583|NCT01137474|655914|P3|Overall Study|Pregnancy|0
206584|NCT01137474|655915|P2|Overall Study|Pregnancy|1
206585|NCT01137474|655916|P1|Overall Study|Pregnancy|0
206586|NCT01137474|655913|P4|Overall Study|Not specified|0
206587|NCT01137474|655914|P3|Overall Study|Not specified|0
206588|NCT01137474|655915|P2|Overall Study|Not specified|1
206589|NCT01137474|655916|P1|Overall Study|Not specified|3
206590|NCT01137474|655913|P4|Overall Study|Lack of Efficacy|2
206591|NCT01137474|655914|P3|Overall Study|Lack of Efficacy|0
206592|NCT01137474|655915|P2|Overall Study|Lack of Efficacy|0
206593|NCT01137474|655916|P1|Overall Study|Lack of Efficacy|0
206594|NCT01137474|655913|P4|Overall Study|Lost to Follow-up|2
206595|NCT01137474|655914|P3|Overall Study|Lost to Follow-up|0
206596|NCT01137474|655915|P2|Overall Study|Lost to Follow-up|1
206597|NCT01137474|655916|P1|Overall Study|Lost to Follow-up|5
206598|NCT01137474|655913|P4|Overall Study|No longer met study criteria|5
206599|NCT01137474|655914|P3|Overall Study|No longer met study criteria|0
206600|NCT01137474|655915|P2|Overall Study|No longer met study criteria|1
206601|NCT01137474|655916|P1|Overall Study|No longer met study criteria|6
206602|NCT01137474|655913|P4|Overall Study|Withdrawal by Subject|9
206603|NCT01137474|655914|P3|Overall Study|Withdrawal by Subject|6
206604|NCT01137474|655915|P2|Overall Study|Withdrawal by Subject|2
206605|NCT01137474|655916|P1|Overall Study|Withdrawal by Subject|7
206606|NCT01137474|655913|P4|Overall Study|Adverse Event|3
206607|NCT01137474|655914|P3|Overall Study|Adverse Event|1
206608|NCT01137474|655915|P2|Overall Study|Adverse Event|5
206609|NCT01137474|655916|P1|Overall Study|Adverse Event|3
206610|NCT01143038|655934|P1|Overall Study|Death|1
206611|NCT01143038|655934|P1|Overall Study|Protocol Deviation|1
206612|NCT01143038|655934|P1|Overall Study|Lost to Follow-up|2
206613|NCT01143038|655934|P1|Overall Study|Adverse Event|3
206614|NCT01143038|655934|P1|Overall Study|Requirement for alternative therapy|5
206615|NCT01143038|655934|P1|Overall Study|Withdrawal by Subject|4
206616|NCT01143051|655948|P6|3-14 Day Washout|Withdrawal by Subject|1
206617|NCT01143051|655949|P5|3-14 Day Washout|Withdrawal by Subject|0
206618|NCT01143051|655950|P4|3-14 Day Washout|Withdrawal by Subject|0
206619|NCT01143051|655951|P3|3-14 Day Washout|Withdrawal by Subject|0
206620|NCT01143051|655952|P2|3-14 Day Washout|Withdrawal by Subject|0
206621|NCT01143051|655953|P1|3-14 Day Washout|Withdrawal by Subject|0
206622|NCT01143051|655948|P6|3-14 Day Washout|Withdrawal by Subject|0
206623|NCT01143051|655949|P5|3-14 Day Washout|Withdrawal by Subject|0
206624|NCT01143051|655950|P4|3-14 Day Washout|Withdrawal by Subject|0
206625|NCT01143051|655951|P3|3-14 Day Washout|Withdrawal by Subject|1
206626|NCT01143051|655952|P2|3-14 Day Washout|Withdrawal by Subject|0
206627|NCT01143051|655953|P1|3-14 Day Washout|Withdrawal by Subject|0
206628|NCT01143077|655979|P3|Overall Study|Principal Investigator Decision|1
206629|NCT01143077|655980|P2|Overall Study|Principal Investigator Decision|0
206630|NCT01143077|655981|P1|Overall Study|Principal Investigator Decision|2
206631|NCT01143077|655979|P3|Overall Study|Administrative|0
206632|NCT01143077|655980|P2|Overall Study|Administrative|0
206633|NCT01143077|655981|P1|Overall Study|Administrative|1
206634|NCT01143077|655979|P3|Overall Study|Non-compliance with study drug|1
206635|NCT01143077|655980|P2|Overall Study|Non-compliance with study drug|1
206636|NCT01143077|655981|P1|Overall Study|Non-compliance with study drug|0
206637|NCT01143077|655979|P3|Overall Study|Withdrawal by Subject|3
206638|NCT01143077|655980|P2|Overall Study|Withdrawal by Subject|3
206639|NCT01143077|655981|P1|Overall Study|Withdrawal by Subject|4
206640|NCT01143077|655979|P3|Overall Study|Protocol Violation|0
206641|NCT01143077|655980|P2|Overall Study|Protocol Violation|0
206642|NCT01143077|655981|P1|Overall Study|Protocol Violation|2
206643|NCT01143077|655979|P3|Overall Study|Lost to Follow-up|4
206644|NCT01143077|655980|P2|Overall Study|Lost to Follow-up|3
206645|NCT01143077|655981|P1|Overall Study|Lost to Follow-up|2
206646|NCT01143077|655979|P3|Overall Study|Adverse Event|5
206647|NCT01143077|655980|P2|Overall Study|Adverse Event|6
206648|NCT01143077|655981|P1|Overall Study|Adverse Event|5
206649|NCT01143077|655979|P3|Overall Study|Lack of Efficacy|1
206650|NCT01143077|655980|P2|Overall Study|Lack of Efficacy|2
206651|NCT01143077|655981|P1|Overall Study|Lack of Efficacy|0
206652|NCT01143090|655992|P1|Overall Study|Administrative|1
206653|NCT01143090|655992|P1|Overall Study|Failure to meet eligibility criteria|1
206654|NCT01143090|655992|P1|Overall Study|Non-compliance with study drug|1
206655|NCT01143090|655992|P1|Overall Study|Withdrawal by Subject|18
206656|NCT01143090|655992|P1|Overall Study|Protocol Violation|2
206657|NCT01143090|655992|P1|Overall Study|Lost to Follow-up|9
206658|NCT01143090|655992|P1|Overall Study|Adverse Event|17
206659|NCT01143090|655992|P1|Overall Study|Lack of Efficacy|2
206660|NCT01143207|656007|P1|Overall Study|Lost to Follow-up|2
206661|NCT01144182|656018|P2|Overall Study|Lost to Follow-up|9
206662|NCT01144182|656019|P1|Overall Study|Lost to Follow-up|9
206663|NCT01144182|656018|P2|Overall Study|Withdrawal by Subject|6
206664|NCT01144182|656019|P1|Overall Study|Withdrawal by Subject|3
206665|NCT01144182|656018|P2|Overall Study|Death|6
206666|NCT01144182|656019|P1|Overall Study|Death|5
206667|NCT01144299|656072|P2|Overall Study|Withdrawal by Subject|0
206668|NCT01144299|656073|P1|Overall Study|Withdrawal by Subject|1
206669|NCT01144299|656072|P2|Overall Study|Lost to Follow-up|0
206670|NCT01144299|656073|P1|Overall Study|Lost to Follow-up|1
206671|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Physician Decision|1
206672|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Physician Decision|0
206673|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Physician Decision|0
206674|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Relapse|5
206675|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Relapse|5
206676|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Relapse|0
206677|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
206678|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
206679|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
206680|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
206681|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
206682|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
206683|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Death|0
206684|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Death|2
206685|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Death|0
206686|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Adverse Event|1
206687|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Adverse Event|3
206688|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Adverse Event|0
206689|NCT01144364|656097|P3|Follow-Up/Maintenance Phase|Disease progression|29
206690|NCT01144364|656098|P2|Follow-Up/Maintenance Phase|Disease progression|23
206691|NCT01144364|656099|P1|Follow-Up/Maintenance Phase|Disease progression|0
206692|NCT01144364|656097|P3|Induction Phase|Protocol Violation|0
206693|NCT01144364|656098|P2|Induction Phase|Protocol Violation|0
206694|NCT01144364|656099|P1|Induction Phase|Protocol Violation|1
206695|NCT01144364|656097|P3|Induction Phase|Secondary neoplasia|0
206696|NCT01144364|656098|P2|Induction Phase|Secondary neoplasia|0
206697|NCT01144364|656099|P1|Induction Phase|Secondary neoplasia|1
206698|NCT01144364|656097|P3|Induction Phase|Stable disease|0
206699|NCT01144364|656098|P2|Induction Phase|Stable disease|0
206700|NCT01144364|656099|P1|Induction Phase|Stable disease|2
206701|NCT01144364|656097|P3|Induction Phase|Physician Decision|0
206702|NCT01144364|656098|P2|Induction Phase|Physician Decision|0
206703|NCT01144364|656099|P1|Induction Phase|Physician Decision|1
206704|NCT01144364|656097|P3|Induction Phase|Lost to Follow-up|0
206705|NCT01144364|656098|P2|Induction Phase|Lost to Follow-up|0
206706|NCT01144364|656099|P1|Induction Phase|Lost to Follow-up|2
206707|NCT01144364|656097|P3|Induction Phase|Withdrawal by Subject|0
206708|NCT01144364|656098|P2|Induction Phase|Withdrawal by Subject|0
206709|NCT01144364|656099|P1|Induction Phase|Withdrawal by Subject|1
206710|NCT01144364|656097|P3|Induction Phase|Death|0
206711|NCT01144364|656098|P2|Induction Phase|Death|0
206712|NCT01144364|656099|P1|Induction Phase|Death|1
206713|NCT01144364|656097|P3|Induction Phase|Adverse Event|0
206714|NCT01144364|656098|P2|Induction Phase|Adverse Event|0
206715|NCT01144364|656099|P1|Induction Phase|Adverse Event|9
206716|NCT01144364|656097|P3|Induction Phase|Disease progression|0
206717|NCT01144364|656098|P2|Induction Phase|Disease progression|0
206718|NCT01144364|656099|P1|Induction Phase|Disease progression|14
206719|NCT01144403|656123|P1|Overall Study|Adverse Event|1
206720|NCT01144403|656123|P1|Overall Study|Death|1
206721|NCT01144403|656123|P1|Overall Study|Lost to Follow-up|3
206722|NCT01144416|656132|P2|Intervention Period|Other|5
206723|NCT01144416|656133|P1|Intervention Period|Other|7
206724|NCT01144416|656132|P2|Intervention Period|No/too few/bad quality embryos|3
206725|NCT01144416|656133|P1|Intervention Period|No/too few/bad quality embryos|3
206726|NCT01144416|656132|P2|Intervention Period|No or abnormal fertilization|10
206727|NCT01144416|656133|P1|Intervention Period|No or abnormal fertilization|25
206728|NCT01144416|656132|P2|Intervention Period|No/too few/bad oocytes|5
206729|NCT01144416|656133|P1|Intervention Period|No/too few/bad oocytes|7
206730|NCT01144416|656132|P2|Intervention Period|Too high ovarian response|2
206731|NCT01144416|656133|P1|Intervention Period|Too high ovarian response|4
206732|NCT01144416|656132|P2|Intervention Period|Risk of OHSS|1
206733|NCT01144416|656133|P1|Intervention Period|Risk of OHSS|0
206734|NCT01144416|656132|P2|Intervention Period|Insufficient ovarian response|17
206735|NCT01144416|656133|P1|Intervention Period|Insufficient ovarian response|11
206736|NCT01144416|656132|P2|Intervention Period|Adverse Event|6
206737|NCT01144416|656133|P1|Intervention Period|Adverse Event|5
206738|NCT01144715|656193|P2|Overall Study|Adverse Event|1
206739|NCT01144715|656194|P1|Overall Study|Adverse Event|0
206740|NCT01144715|656193|P2|Overall Study|Withdrawal by Subject|1
206741|NCT01144715|656194|P1|Overall Study|Withdrawal by Subject|2
206742|NCT01144715|656193|P2|Overall Study|Lost to Follow-up|1
206743|NCT01144715|656194|P1|Overall Study|Lost to Follow-up|2
206744|NCT01145053|656246|P1|Overall Study|Other|18
206745|NCT01145053|656246|P1|Overall Study|Withdrawal by Subject|25
206746|NCT01145053|656246|P1|Overall Study|Lost to Follow-up|28
206747|NCT01145053|656246|P1|Overall Study|Adverse Event|22
206748|NCT01145352|656256|P1|Overall Study|Syringe formulation was used|1
206749|NCT01145352|656256|P1|Overall Study|Treated before marketing approval|4
206750|NCT01145352|656256|P1|Overall Study|Found to have been registered twice|6
206751|NCT01145417|656277|P2|Overall Study|Unspecified|0
206752|NCT01145417|656278|P1|Overall Study|Unspecified|1
206753|NCT01145417|656277|P2|Overall Study|Study terminated by sponsor|43
206754|NCT01145417|656278|P1|Overall Study|Study terminated by sponsor|35
206755|NCT01145417|656277|P2|Overall Study|Adverse Event|1
206756|NCT01145417|656278|P1|Overall Study|Adverse Event|0
206757|NCT01145417|656277|P2|Overall Study|Pregnancy|0
206758|NCT01145417|656278|P1|Overall Study|Pregnancy|1
206759|NCT01145417|656277|P2|Overall Study|Withdrawal by Subject|2
206760|NCT01145417|656278|P1|Overall Study|Withdrawal by Subject|1
206761|NCT01145417|656277|P2|Overall Study|Lost to Follow-up|1
206762|NCT01145417|656278|P1|Overall Study|Lost to Follow-up|2
206763|NCT01145417|656277|P2|Overall Study|Death|0
206764|NCT01145417|656278|P1|Overall Study|Death|1
206765|NCT01145482|656302|P2|First Intervention (1 Day)|Withdrawal by Subject|1
206766|NCT01145482|656303|P1|First Intervention (1 Day)|Withdrawal by Subject|0
206767|NCT01145495|656311|P1|Overall Study|Disease progression after respone|1
206768|NCT01145495|656311|P1|Overall Study|Withdrawal by Subject|5
206769|NCT01145495|656311|P1|Overall Study|Adverse Event|6
206770|NCT01145508|656317|P2|Overall Study|Never started treatment|1
206771|NCT01145508|656318|P1|Overall Study|Never started treatment|1
206772|NCT01145508|656317|P2|Overall Study|Physician Decision|1
206773|NCT01145508|656318|P1|Overall Study|Physician Decision|2
206774|NCT01145508|656317|P2|Overall Study|Death|0
206775|NCT01145508|656318|P1|Overall Study|Death|1
206776|NCT01145508|656317|P2|Overall Study|Adverse Event|0
206777|NCT01145508|656318|P1|Overall Study|Adverse Event|1
206778|NCT01145560|656334|P3|Overall Study|Withdrawal of therapy|1
206779|NCT01145560|656335|P2|Overall Study|Withdrawal of therapy|0
206780|NCT01145560|656336|P1|Overall Study|Withdrawal of therapy|0
206781|NCT01145560|656334|P3|Overall Study|False insurance information|0
206782|NCT01145560|656335|P2|Overall Study|False insurance information|1
206783|NCT01145560|656336|P1|Overall Study|False insurance information|0
206784|NCT01145560|656334|P3|Overall Study|Accidental unblinding of study treatment|0
206785|NCT01145560|656335|P2|Overall Study|Accidental unblinding of study treatment|1
206786|NCT01145560|656336|P1|Overall Study|Accidental unblinding of study treatment|0
206787|NCT01145560|656334|P3|Overall Study|No study drug by 24h after organ failure|0
206788|NCT01145560|656335|P2|Overall Study|No study drug by 24h after organ failure|0
206789|NCT01145560|656336|P1|Overall Study|No study drug by 24h after organ failure|1
206790|NCT01145560|656334|P3|Overall Study|Lost to Follow-up|1
206791|NCT01145560|656335|P2|Overall Study|Lost to Follow-up|1
206792|NCT01145560|656336|P1|Overall Study|Lost to Follow-up|1
206793|NCT01145560|656334|P3|Overall Study|Withdrawal by Subject|0
206794|NCT01145560|656335|P2|Overall Study|Withdrawal by Subject|1
206795|NCT01145560|656336|P1|Overall Study|Withdrawal by Subject|2
206796|NCT01145625|656355|P2|Overall Study|Pregnancy|1
206797|NCT01145625|656356|P1|Overall Study|Pregnancy|0
206798|NCT01145625|656355|P2|Overall Study|Withdrawal by Subject|16
206799|NCT01145625|656356|P1|Overall Study|Withdrawal by Subject|7
206800|NCT01145625|656355|P2|Overall Study|Protocol Violation|1
206801|NCT01145625|656356|P1|Overall Study|Protocol Violation|3
206802|NCT01145625|656355|P2|Overall Study|Adverse Event|4
206803|NCT01145625|656356|P1|Overall Study|Adverse Event|6
206804|NCT01145625|656355|P2|Overall Study|Lost to Follow-up|9
206805|NCT01145625|656356|P1|Overall Study|Lost to Follow-up|8
206806|NCT01145755|656380|P3|Overall Study|Positive urine ethanol|0
206807|NCT01145755|656381|P2|Overall Study|Positive urine ethanol|1
206808|NCT01145755|656382|P1|Overall Study|Positive urine ethanol|0
206809|NCT01145755|656380|P3|Overall Study|Withdrawal by Subject|1
206810|NCT01145755|656381|P2|Overall Study|Withdrawal by Subject|0
206811|NCT01145755|656382|P1|Overall Study|Withdrawal by Subject|0
206812|NCT01145755|656380|P3|Overall Study|Patient could not swollow medication|1
206813|NCT01145755|656381|P2|Overall Study|Patient could not swollow medication|0
206814|NCT01145755|656382|P1|Overall Study|Patient could not swollow medication|0
206815|NCT01145755|656380|P3|Overall Study|Lack of Efficacy|0
206816|NCT01145755|656381|P2|Overall Study|Lack of Efficacy|1
206817|NCT01145755|656382|P1|Overall Study|Lack of Efficacy|0
206818|NCT01145755|656380|P3|Overall Study|Study Closure|17
206819|NCT01145755|656381|P2|Overall Study|Study Closure|14
206820|NCT01145755|656382|P1|Overall Study|Study Closure|14
206821|NCT01145755|656380|P3|Overall Study|Protocol Violation|1
206822|NCT01145755|656381|P2|Overall Study|Protocol Violation|3
206823|NCT01145755|656382|P1|Overall Study|Protocol Violation|0
206824|NCT01145755|656380|P3|Overall Study|Lost to Follow-up|1
206825|NCT01145755|656381|P2|Overall Study|Lost to Follow-up|3
206826|NCT01145755|656382|P1|Overall Study|Lost to Follow-up|2
206827|NCT01145755|656380|P3|Overall Study|Withdrawal by Subject|2
206828|NCT01145755|656381|P2|Overall Study|Withdrawal by Subject|2
206829|NCT01145755|656382|P1|Overall Study|Withdrawal by Subject|2
206830|NCT01145755|656380|P3|Overall Study|Adverse Event|2
206831|NCT01145755|656381|P2|Overall Study|Adverse Event|4
206832|NCT01145755|656382|P1|Overall Study|Adverse Event|2
206833|NCT01145898|656398|P2|3-year Treatment|medication change by treating physician|16
206834|NCT01145898|656399|P1|3-year Treatment|medication change by treating physician|3
206835|NCT01146054|656430|P1|Overall Study|Lost to Follow-up|1
206836|NCT01146054|656430|P1|Overall Study|Other illness precluded treatment|2
206837|NCT01146054|656430|P1|Overall Study|Rapid tumor progression|2
206838|NCT01146054|656430|P1|Overall Study|Did not meet dose constraints for SBRT|5
206839|NCT01146288|656445|P2|First Intervention(1 Day)|Adverse Event|1
206840|NCT01146288|656446|P1|First Intervention(1 Day)|Adverse Event|0
206841|NCT01146613|656540|P2|Overall Study|Outpatient detox|0
206842|NCT01146613|656541|P1|Overall Study|Outpatient detox|1
206843|NCT01146613|656540|P2|Overall Study|schedule conflict|0
206844|NCT01146613|656541|P1|Overall Study|schedule conflict|1
206845|NCT01146613|656540|P2|Overall Study|Withdrawal by Subject|3
206846|NCT01146613|656541|P1|Overall Study|Withdrawal by Subject|0
206847|NCT01146613|656540|P2|Overall Study|Physician Decision|0
206848|NCT01146613|656541|P1|Overall Study|Physician Decision|1
206849|NCT01146613|656540|P2|Overall Study|Death|0
206850|NCT01146613|656541|P1|Overall Study|Death|1
206851|NCT01146613|656540|P2|Overall Study|Lack of Efficacy|1
206852|NCT01146613|656541|P1|Overall Study|Lack of Efficacy|0
206853|NCT01146613|656540|P2|Overall Study|Lost to Follow-up|8
206854|NCT01146613|656541|P1|Overall Study|Lost to Follow-up|3
206855|NCT01140347|656549|P2|Overall Study|Withdrawal by Subject|8
206856|NCT01140347|656550|P1|Overall Study|Withdrawal by Subject|13
206857|NCT01140347|656549|P2|Overall Study|Lost to Follow-up|6
206858|NCT01140347|656550|P1|Overall Study|Lost to Follow-up|5
206859|NCT01146782|656577|P1|Primary Endpoint Cohort|Physician Decision|1
206860|NCT01146782|656577|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
206861|NCT01146782|656577|P1|Safety Cohort|TST <4 hrs|14
206862|NCT01146782|656577|P1|Safety Cohort|Control AHI <5|4
206863|NCT01146782|656577|P1|Safety Cohort|Withdrawal by Subject|4
206864|NCT01146782|656577|P1|Safety Cohort|Screen Failure|61
206865|NCT01146782|656577|P1|Screening Cohort|Withdrawal by Subject|29
206866|NCT01146782|656577|P1|Screening Cohort|Physician Decision|1
206867|NCT01146782|656577|P1|Screening Cohort|Lost to Follow-up|4
206868|NCT01146782|656577|P1|Screening Cohort|Screen Failure|187
206869|NCT01146860|656592|P2|Overall Study|Withdrawal by Subject|1
206870|NCT01146860|656593|P1|Overall Study|Withdrawal by Subject|0
206871|NCT01146873|656609|P2|Overall Study|Transfer out|6
206872|NCT01146873|656610|P1|Overall Study|Transfer out|0
206873|NCT01146912|656631|P8|Overall Study|Duplicate patient|0
206874|NCT01146912|656632|P7|Overall Study|Duplicate patient|0
206875|NCT01146912|656633|P6|Overall Study|Duplicate patient|0
206876|NCT01146912|656634|P5|Overall Study|Duplicate patient|0
206877|NCT01146912|656635|P4|Overall Study|Duplicate patient|0
206878|NCT01146912|656636|P3|Overall Study|Duplicate patient|1
206879|NCT01146912|656637|P2|Overall Study|Duplicate patient|0
206880|NCT01146912|656638|P1|Overall Study|Duplicate patient|0
206881|NCT01146912|656631|P8|Overall Study|< 14 weeks gestational age|0
206882|NCT01146912|656632|P7|Overall Study|< 14 weeks gestational age|0
206883|NCT01146912|656633|P6|Overall Study|< 14 weeks gestational age|0
206884|NCT01146912|656634|P5|Overall Study|< 14 weeks gestational age|0
206885|NCT01146912|656635|P4|Overall Study|< 14 weeks gestational age|2
206886|NCT01146912|656636|P3|Overall Study|< 14 weeks gestational age|3
206887|NCT01146912|656637|P2|Overall Study|< 14 weeks gestational age|0
206888|NCT01146912|656638|P1|Overall Study|< 14 weeks gestational age|0
206889|NCT01146912|656631|P8|Overall Study|Already received influenza vaccination|0
206890|NCT01146912|656632|P7|Overall Study|Already received influenza vaccination|56
206891|NCT01146912|656633|P6|Overall Study|Already received influenza vaccination|61
206892|NCT01146912|656634|P5|Overall Study|Already received influenza vaccination|41
206893|NCT01146912|656635|P4|Overall Study|Already received influenza vaccination|15
206894|NCT01146912|656636|P3|Overall Study|Already received influenza vaccination|13
206895|NCT01146912|656637|P2|Overall Study|Already received influenza vaccination|822
206896|NCT01146912|656638|P1|Overall Study|Already received influenza vaccination|817
206897|NCT01146951|656660|P2|Overall Study|Adverse Event|1
206898|NCT01146951|656661|P1|Overall Study|Adverse Event|4
206899|NCT01147172|656675|P1|Overall Study|Lost to Follow-up|2
206900|NCT01147172|656675|P1|Overall Study|Withdrawal by Subject|2
206901|NCT01147250|656688|P2|Overall Study|Other than specified|1
206902|NCT01147250|656689|P1|Overall Study|Other than specified|0
206903|NCT01147250|656688|P2|Overall Study|Site termination by sponsor|5
206904|NCT01147250|656689|P1|Overall Study|Site termination by sponsor|13
206905|NCT01147250|656688|P2|Overall Study|Withdrawal by Subject|88
206906|NCT01147250|656689|P1|Overall Study|Withdrawal by Subject|83
206907|NCT01147250|656688|P2|Overall Study|Lost to Follow-up|11
206908|NCT01147250|656689|P1|Overall Study|Lost to Follow-up|14
206909|NCT01147341|656736|P2|Open Label Period|Subject moved|0
206910|NCT01147341|656737|P1|Open Label Period|Subject moved|1
206911|NCT01147341|656736|P2|Open Label Period|Lack of Efficacy|0
206912|NCT01147341|656737|P1|Open Label Period|Lack of Efficacy|3
206913|NCT01147341|656736|P2|Double Blind Period|Withdrawal by Subject|1
206914|NCT01147341|656737|P1|Double Blind Period|Withdrawal by Subject|0
206915|NCT01147341|656736|P2|Double Blind Period|Lack of Efficacy|1
206916|NCT01147341|656737|P1|Double Blind Period|Lack of Efficacy|1
206917|NCT01147393|656776|P1|Dose Level -1|Dose Limited Toxicity|1
206918|NCT01147393|656776|P1|Dose Level 1|Dose limiting Toxicity|2
206919|NCT01147458|656815|P4|Second Intervention|Unspecified|0
206920|NCT01147458|656816|P3|Second Intervention|Unspecified|1
206921|NCT01147458|656817|P2|Second Intervention|Unspecified|0
206922|NCT01147458|656818|P1|Second Intervention|Unspecified|0
206923|NCT01147458|656815|P4|Second Intervention|Adverse Event|1
206924|NCT01147458|656816|P3|Second Intervention|Adverse Event|1
206925|NCT01147458|656817|P2|Second Intervention|Adverse Event|0
206926|NCT01147458|656818|P1|Second Intervention|Adverse Event|2
206927|NCT01147458|656815|P4|Second Intervention|Withdrawal by Subject|0
206928|NCT01147458|656816|P3|Second Intervention|Withdrawal by Subject|0
206929|NCT01147458|656817|P2|Second Intervention|Withdrawal by Subject|1
206930|NCT01147458|656818|P1|Second Intervention|Withdrawal by Subject|0
206931|NCT01147458|656815|P4|Second Intervention|Protocol Violation|0
206932|NCT01147458|656816|P3|Second Intervention|Protocol Violation|1
206933|NCT01147458|656817|P2|Second Intervention|Protocol Violation|1
206934|NCT01147458|656818|P1|Second Intervention|Protocol Violation|0
206935|NCT01147458|656815|P4|Second Intervention|Study terminated by sponsor|3
206936|NCT01147458|656816|P3|Second Intervention|Study terminated by sponsor|5
206937|NCT01147458|656817|P2|Second Intervention|Study terminated by sponsor|5
206938|NCT01147458|656818|P1|Second Intervention|Study terminated by sponsor|7
206939|NCT01147458|656815|P4|First Intervention|Unspecified|0
206940|NCT01147458|656816|P3|First Intervention|Unspecified|0
206941|NCT01147458|656817|P2|First Intervention|Unspecified|2
206942|NCT01147458|656818|P1|First Intervention|Unspecified|1
206943|NCT01147458|656815|P4|First Intervention|Adverse Event|3
206944|NCT01147458|656816|P3|First Intervention|Adverse Event|2
206945|NCT01147458|656817|P2|First Intervention|Adverse Event|3
206946|NCT01147458|656818|P1|First Intervention|Adverse Event|0
206947|NCT01147458|656815|P4|First Intervention|Withdrawal by Subject|0
206948|NCT01147458|656816|P3|First Intervention|Withdrawal by Subject|1
206949|NCT01147458|656817|P2|First Intervention|Withdrawal by Subject|0
206950|NCT01147458|656818|P1|First Intervention|Withdrawal by Subject|3
206951|NCT01147458|656815|P4|First Intervention|Protocol Violation|3
206952|NCT01147458|656816|P3|First Intervention|Protocol Violation|2
206953|NCT01147458|656817|P2|First Intervention|Protocol Violation|3
206954|NCT01147458|656818|P1|First Intervention|Protocol Violation|2
206955|NCT01147458|656815|P4|First Intervention|Study terminated by sponsor|8
206956|NCT01147458|656816|P3|First Intervention|Study terminated by sponsor|7
206957|NCT01147458|656817|P2|First Intervention|Study terminated by sponsor|8
206958|NCT01147458|656818|P1|First Intervention|Study terminated by sponsor|8
206959|NCT01147471|656868|P2|6 Month Follow Up|Lost to Follow-up|2
206960|NCT01147471|656869|P1|6 Month Follow Up|Lost to Follow-up|4
206961|NCT01147471|656868|P2|3 Month Follow Up|Physician Decision|1
206962|NCT01147471|656869|P1|3 Month Follow Up|Physician Decision|0
206963|NCT01147471|656868|P2|3 Month Follow Up|Lost to Follow-up|1
206964|NCT01147471|656869|P1|3 Month Follow Up|Lost to Follow-up|1
206965|NCT01147471|656868|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
206966|NCT01147471|656869|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
206967|NCT01147471|656868|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
206968|NCT01147471|656869|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
206969|NCT01147471|656868|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
206970|NCT01147471|656869|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
206971|NCT01147497|656885|P2|Overall Study|failed insertion|0
206972|NCT01147497|656886|P1|Overall Study|failed insertion|2
206973|NCT01147640|656920|P2|Overall Study|Didn't meet eligibility criteria|0
206974|NCT01147640|656921|P1|Overall Study|Didn't meet eligibility criteria|1
206975|NCT01147640|656920|P2|Overall Study|Lost to Follow-up|1
206976|NCT01147640|656921|P1|Overall Study|Lost to Follow-up|0
206977|NCT01147640|656920|P2|Overall Study|Withdrawal by Subject|0
206978|NCT01147640|656921|P1|Overall Study|Withdrawal by Subject|1
206979|NCT01147640|656920|P2|Overall Study|Physician Decision|0
206980|NCT01147640|656921|P1|Overall Study|Physician Decision|1
206981|NCT01147640|656920|P2|Overall Study|Adverse Event|0
206982|NCT01147640|656921|P1|Overall Study|Adverse Event|2
206983|NCT01147653|656931|P2|Year 2|Withdrawal by Subject|3
206984|NCT01147653|656932|P1|Year 2|Withdrawal by Subject|2
206985|NCT01147809|656993|P6|Phase II (168 Days)|Ongoing|0
206986|NCT01147809|656994|P5|Phase II (168 Days)|Ongoing|1
206987|NCT01147809|656995|P4|Phase II (168 Days)|Ongoing|0
206988|NCT01147809|656996|P3|Phase II (168 Days)|Ongoing|0
206989|NCT01147809|656997|P2|Phase II (168 Days)|Ongoing|0
206990|NCT01147809|656998|P1|Phase II (168 Days)|Ongoing|0
206991|NCT01147809|656993|P6|Phase II (168 Days)|Withdrawal by Subject|15
206992|NCT01147809|656994|P5|Phase II (168 Days)|Withdrawal by Subject|7
206993|NCT01147809|656995|P4|Phase II (168 Days)|Withdrawal by Subject|0
206994|NCT01147809|656996|P3|Phase II (168 Days)|Withdrawal by Subject|0
206995|NCT01147809|656997|P2|Phase II (168 Days)|Withdrawal by Subject|0
206996|NCT01147809|656998|P1|Phase II (168 Days)|Withdrawal by Subject|0
206997|NCT01147809|656993|P6|Phase II (168 Days)|Physician Decision|11
206998|NCT01147809|656994|P5|Phase II (168 Days)|Physician Decision|5
206999|NCT01147809|656995|P4|Phase II (168 Days)|Physician Decision|0
207000|NCT01147809|656996|P3|Phase II (168 Days)|Physician Decision|0
207001|NCT01147809|656997|P2|Phase II (168 Days)|Physician Decision|0
207002|NCT01147809|656998|P1|Phase II (168 Days)|Physician Decision|0
207003|NCT01147809|656993|P6|Phase II (168 Days)|Protocol Violation|1
207004|NCT01147809|656994|P5|Phase II (168 Days)|Protocol Violation|0
207005|NCT01147809|656995|P4|Phase II (168 Days)|Protocol Violation|0
207006|NCT01147809|656996|P3|Phase II (168 Days)|Protocol Violation|0
207007|NCT01147809|656997|P2|Phase II (168 Days)|Protocol Violation|0
207008|NCT01147809|656998|P1|Phase II (168 Days)|Protocol Violation|0
207009|NCT01147809|656993|P6|Phase II (168 Days)|Adverse Event|6
207010|NCT01147809|656994|P5|Phase II (168 Days)|Adverse Event|3
207011|NCT01147809|656995|P4|Phase II (168 Days)|Adverse Event|0
207012|NCT01147809|656996|P3|Phase II (168 Days)|Adverse Event|0
207013|NCT01147809|656997|P2|Phase II (168 Days)|Adverse Event|0
207014|NCT01147809|656998|P1|Phase II (168 Days)|Adverse Event|0
207015|NCT01147809|656993|P6|Phase I (168 Days)|Withdrawal by Subject|0
207016|NCT01147809|656994|P5|Phase I (168 Days)|Withdrawal by Subject|0
207017|NCT01147809|656995|P4|Phase I (168 Days)|Withdrawal by Subject|3
207018|NCT01147809|656996|P3|Phase I (168 Days)|Withdrawal by Subject|0
207019|NCT01147809|656997|P2|Phase I (168 Days)|Withdrawal by Subject|0
207020|NCT01147809|656998|P1|Phase I (168 Days)|Withdrawal by Subject|0
207021|NCT01147809|656993|P6|Phase I (168 Days)|Physician Decision|0
207022|NCT01147809|656994|P5|Phase I (168 Days)|Physician Decision|0
207023|NCT01147809|656995|P4|Phase I (168 Days)|Physician Decision|0
207024|NCT01147809|656996|P3|Phase I (168 Days)|Physician Decision|2
207025|NCT01147809|656997|P2|Phase I (168 Days)|Physician Decision|1
207026|NCT01147809|656998|P1|Phase I (168 Days)|Physician Decision|0
207027|NCT01147809|656993|P6|Phase I (168 Days)|Lost to Follow-up|0
207028|NCT01147809|656994|P5|Phase I (168 Days)|Lost to Follow-up|0
207029|NCT01147809|656995|P4|Phase I (168 Days)|Lost to Follow-up|1
207030|NCT01147809|656996|P3|Phase I (168 Days)|Lost to Follow-up|0
207031|NCT01147809|656997|P2|Phase I (168 Days)|Lost to Follow-up|0
207032|NCT01147809|656998|P1|Phase I (168 Days)|Lost to Follow-up|1
207033|NCT01147809|656993|P6|Phase I (168 Days)|Adverse Event|0
207034|NCT01147809|656994|P5|Phase I (168 Days)|Adverse Event|0
207035|NCT01147809|656995|P4|Phase I (168 Days)|Adverse Event|1
207036|NCT01147809|656996|P3|Phase I (168 Days)|Adverse Event|0
207037|NCT01147809|656997|P2|Phase I (168 Days)|Adverse Event|0
207038|NCT01147809|656998|P1|Phase I (168 Days)|Adverse Event|0
207039|NCT01147822|657114|P2|Overall Study|Not Completed/Ongoing|102
207040|NCT01147822|657115|P1|Overall Study|Not Completed/Ongoing|111
207041|NCT01147822|657114|P2|Overall Study|Withdrawal by Subject|13
207042|NCT01147822|657115|P1|Overall Study|Withdrawal by Subject|8
207043|NCT01147822|657114|P2|Overall Study|Physician Decision|2
207044|NCT01147822|657115|P1|Overall Study|Physician Decision|0
207045|NCT01147822|657114|P2|Overall Study|Lost to Follow-up|2
207046|NCT01147822|657115|P1|Overall Study|Lost to Follow-up|3
207047|NCT01147822|657114|P2|Overall Study|Protocol Violation|1
207048|NCT01147822|657115|P1|Overall Study|Protocol Violation|0
207049|NCT01147822|657114|P2|Overall Study|Death|59
207050|NCT01147822|657115|P1|Overall Study|Death|66
207051|NCT01147848|657131|P3|Randomized Phase|Withdrawal by Subject|9
207052|NCT01147848|657132|P2|Randomized Phase|Withdrawal by Subject|7
207053|NCT01147848|657133|P1|Randomized Phase|Withdrawal by Subject|0
207054|NCT01147848|657131|P3|Randomized Phase|Physician Decision|1
207055|NCT01147848|657132|P2|Randomized Phase|Physician Decision|0
207056|NCT01147848|657133|P1|Randomized Phase|Physician Decision|0
207057|NCT01147848|657131|P3|Randomized Phase|Lost to Follow-up|7
207058|NCT01147848|657132|P2|Randomized Phase|Lost to Follow-up|5
207059|NCT01147848|657133|P1|Randomized Phase|Lost to Follow-up|0
207060|NCT01147848|657131|P3|Randomized Phase|Protocol Violation|10
207061|NCT01147848|657132|P2|Randomized Phase|Protocol Violation|7
207062|NCT01147848|657133|P1|Randomized Phase|Protocol Violation|0
207063|NCT01147848|657131|P3|Randomized Phase|Lack of Efficacy|11
207064|NCT01147848|657132|P2|Randomized Phase|Lack of Efficacy|20
207065|NCT01147848|657133|P1|Randomized Phase|Lack of Efficacy|0
207066|NCT01147848|657131|P3|Randomized Phase|Adverse Event|8
207067|NCT01147848|657132|P2|Randomized Phase|Adverse Event|6
207068|NCT01147848|657133|P1|Randomized Phase|Adverse Event|0
207069|NCT01147848|657131|P3|Run-in Period|Run-in Failure|0
207070|NCT01147848|657132|P2|Run-in Period|Run-in Failure|0
207071|NCT01147848|657133|P1|Run-in Period|Run-in Failure|135
207072|NCT01147848|657131|P3|Run-in Period|Screen Failure|0
207073|NCT01147848|657132|P2|Run-in Period|Screen Failure|0
207074|NCT01147848|657133|P1|Run-in Period|Screen Failure|623
207075|NCT01147874|657163|P1|Overall Study|Withdrawal by Subject|24
207076|NCT01147874|657163|P1|Overall Study|Sponsor's Decision|2
207077|NCT01147874|657163|P1|Overall Study|Protocol Violation|5
207078|NCT01147874|657163|P1|Overall Study|Unspecified|5
207079|NCT01147874|657163|P1|Overall Study|Lost to Follow-up|25
207080|NCT01147874|657163|P1|Overall Study|Investigator’s Request|1
207081|NCT01147874|657163|P1|Overall Study|Adverse Event|5
207082|NCT01147900|657172|P3|At Year 10|Lost to Follow-up|0
207083|NCT01147900|657173|P2|At Year 10|Lost to Follow-up|1
207084|NCT01147900|657174|P1|At Year 10|Lost to Follow-up|0
207085|NCT01147926|657235|P2|Overall Study|Colonoscopy result|1
207086|NCT01147926|657236|P1|Overall Study|Colonoscopy result|0
207087|NCT01147926|657235|P2|Overall Study|Went on holiday|1
207088|NCT01147926|657236|P1|Overall Study|Went on holiday|0
207089|NCT01147926|657235|P2|Overall Study|Too busy, no time for study|0
207090|NCT01147926|657236|P1|Overall Study|Too busy, no time for study|1
207091|NCT01147926|657235|P2|Overall Study|Lack of Efficacy|0
207092|NCT01147926|657236|P1|Overall Study|Lack of Efficacy|1
207093|NCT01147926|657235|P2|Overall Study|Sponsor's Decision|1
207094|NCT01147926|657236|P1|Overall Study|Sponsor's Decision|0
207095|NCT01147926|657235|P2|Overall Study|Lost to Follow-up|2
207096|NCT01147926|657236|P1|Overall Study|Lost to Follow-up|0
207097|NCT01147926|657235|P2|Overall Study|Selection criteria not met|1
207098|NCT01147926|657236|P1|Overall Study|Selection criteria not met|3
207099|NCT01147926|657235|P2|Overall Study|Principal investigator left hospital|3
207100|NCT01147926|657236|P1|Overall Study|Principal investigator left hospital|1
207101|NCT01147926|657235|P2|Overall Study|Subject Non-Compliant|4
207102|NCT01147926|657236|P1|Overall Study|Subject Non-Compliant|5
207103|NCT01147926|657235|P2|Overall Study|Adverse Event|6
207104|NCT01147926|657236|P1|Overall Study|Adverse Event|7
207105|NCT01147926|657235|P2|Overall Study|Subject Withdrew Consent|10
207106|NCT01147926|657236|P1|Overall Study|Subject Withdrew Consent|9
207107|NCT01148017|657272|P4|Overall Study|Unable to classify|0
207108|NCT01148017|657273|P3|Overall Study|Unable to classify|0
207109|NCT01148017|657274|P2|Overall Study|Unable to classify|1
207110|NCT01148017|657275|P1|Overall Study|Unable to classify|3
207111|NCT01148017|657272|P4|Overall Study|Administrative reason|0
207112|NCT01148017|657273|P3|Overall Study|Administrative reason|0
207113|NCT01148017|657274|P2|Overall Study|Administrative reason|9
207114|NCT01148017|657275|P1|Overall Study|Administrative reason|22
207115|NCT01148017|657272|P4|Overall Study|Inappropriate enrollment|0
207116|NCT01148017|657273|P3|Overall Study|Inappropriate enrollment|0
207117|NCT01148017|657274|P2|Overall Study|Inappropriate enrollment|0
207118|NCT01148017|657275|P1|Overall Study|Inappropriate enrollment|1
207119|NCT01148017|657272|P4|Overall Study|Lost to Follow-up|0
207120|NCT01148017|657273|P3|Overall Study|Lost to Follow-up|0
207121|NCT01148017|657274|P2|Overall Study|Lost to Follow-up|10
207122|NCT01148017|657275|P1|Overall Study|Lost to Follow-up|23
207123|NCT01148017|657272|P4|Overall Study|Withdrawal by Subject|0
207124|NCT01148017|657273|P3|Overall Study|Withdrawal by Subject|0
207125|NCT01148017|657274|P2|Overall Study|Withdrawal by Subject|14
207126|NCT01148017|657275|P1|Overall Study|Withdrawal by Subject|31
207127|NCT01148511|657329|P3|Randomized|Not Specified|1
207128|NCT01148511|657330|P2|Randomized|Not Specified|1
207129|NCT01148511|657331|P1|Randomized|Not Specified|0
207130|NCT01148511|657329|P3|Randomized|Consent withdrawal|3
207131|NCT01148511|657330|P2|Randomized|Consent withdrawal|5
207132|NCT01148511|657331|P1|Randomized|Consent withdrawal|0
207133|NCT01148511|657329|P3|Randomized|Lost to Follow-up|1
207134|NCT01148511|657330|P2|Randomized|Lost to Follow-up|1
207135|NCT01148511|657331|P1|Randomized|Lost to Follow-up|0
207136|NCT01148511|657329|P3|Randomized|Protocol Violation|1
207137|NCT01148511|657330|P2|Randomized|Protocol Violation|2
207138|NCT01148511|657331|P1|Randomized|Protocol Violation|0
207139|NCT01148511|657329|P3|Randomized|Adverse Event|0
207140|NCT01148511|657330|P2|Randomized|Adverse Event|1
207141|NCT01148511|657331|P1|Randomized|Adverse Event|0
207142|NCT01148511|657329|P3|Exposed to Study Drug|Lost to Follow-up|0
207143|NCT01148511|657330|P2|Exposed to Study Drug|Lost to Follow-up|0
207144|NCT01148511|657331|P1|Exposed to Study Drug|Lost to Follow-up|4
207145|NCT01148511|657329|P3|Exposed to Study Drug|Protocol Violation|0
207146|NCT01148511|657330|P2|Exposed to Study Drug|Protocol Violation|0
207147|NCT01148511|657331|P1|Exposed to Study Drug|Protocol Violation|2
207148|NCT01148537|657416|P3|Overall Study|Adverse Event|1
207149|NCT01148537|657417|P2|Overall Study|Adverse Event|0
207150|NCT01148537|657418|P1|Overall Study|Adverse Event|2
207151|NCT01148537|657416|P3|Overall Study|Withdrawal by Subject|2
207152|NCT01148537|657417|P2|Overall Study|Withdrawal by Subject|0
207153|NCT01148537|657418|P1|Overall Study|Withdrawal by Subject|1
207154|NCT01148693|657441|P2|Overall Study|Attempts for cannulation were failed|10
207155|NCT01148693|657442|P1|Overall Study|Attempts for cannulation were failed|13
207156|NCT01148771|657456|P2|Washout Period|Withdrawal by Subject|1
207157|NCT01148771|657457|P1|Washout Period|Withdrawal by Subject|0
207158|NCT01148862|657491|P2|Second Intervention|Withdrawal by Subject|2
207159|NCT01148862|657492|P1|Second Intervention|Withdrawal by Subject|0
207160|NCT01148979|657502|P2|Overall Study|Lost to Follow-up|1
207161|NCT01148979|657503|P1|Overall Study|Lost to Follow-up|0
207162|NCT01149057|657509|P1|Overall Study|Unspecified|6
207163|NCT01149057|657509|P1|Overall Study|High Parathyroid Hormone Value|1
207164|NCT01149057|657509|P1|Overall Study|Lost to Follow-up|1
207165|NCT01149057|657509|P1|Overall Study|Participant Non-Compliance|2
207166|NCT01149057|657509|P1|Overall Study|B Cell Depletion|4
207167|NCT01149057|657509|P1|Overall Study|Positive Hepatitis B Core Antibody|5
207168|NCT01149057|657509|P1|Overall Study|Withdrawal by Subject|9
207169|NCT01149057|657509|P1|Overall Study|Adverse Event|13
207170|NCT01149057|657509|P1|Overall Study|Lack of Efficacy|16
207171|NCT01149148|657536|P2|Overall Study|Death|0
207172|NCT01149148|657537|P1|Overall Study|Death|1
207173|NCT01149148|657536|P2|Overall Study|Lost to Follow-up|2
207174|NCT01149148|657537|P1|Overall Study|Lost to Follow-up|1
207175|NCT01149421|657548|P3|Overall Study|Protocol Violation|6
207176|NCT01149421|657549|P2|Overall Study|Protocol Violation|2
207177|NCT01149421|657550|P1|Overall Study|Protocol Violation|2
207178|NCT01149421|657548|P3|Overall Study|Entry Criteria Not Met|2
207179|NCT01149421|657549|P2|Overall Study|Entry Criteria Not Met|1
207180|NCT01149421|657550|P1|Overall Study|Entry Criteria Not Met|1
207181|NCT01149421|657548|P3|Overall Study|Physician Decision|6
207182|NCT01149421|657549|P2|Overall Study|Physician Decision|3
207183|NCT01149421|657550|P1|Overall Study|Physician Decision|5
207184|NCT01149421|657548|P3|Overall Study|Lost to Follow-up|5
207185|NCT01149421|657549|P2|Overall Study|Lost to Follow-up|4
207186|NCT01149421|657550|P1|Overall Study|Lost to Follow-up|2
207187|NCT01149421|657548|P3|Overall Study|Sponsor Decision|1
207188|NCT01149421|657549|P2|Overall Study|Sponsor Decision|1
207189|NCT01149421|657550|P1|Overall Study|Sponsor Decision|0
207190|NCT01149421|657548|P3|Overall Study|Withdrawal by Subject|13
207191|NCT01149421|657549|P2|Overall Study|Withdrawal by Subject|12
207192|NCT01149421|657550|P1|Overall Study|Withdrawal by Subject|20
207193|NCT01149421|657548|P3|Overall Study|Adverse Event|11
207194|NCT01149421|657549|P2|Overall Study|Adverse Event|6
207195|NCT01149421|657550|P1|Overall Study|Adverse Event|22
207196|NCT01149460|657645|P2|Overall Study|Withdrawal by Subject|2
207197|NCT01149460|657646|P1|Overall Study|Withdrawal by Subject|0
207198|NCT01149473|657664|P2|Washout of 7 Days|Withdrawal by Subject|1
207199|NCT01149473|657665|P1|Washout of 7 Days|Withdrawal by Subject|1
207200|NCT01149473|657664|P2|First Intervention|Adverse Event|1
207201|NCT01149473|657665|P1|First Intervention|Adverse Event|1
207202|NCT01149486|657683|P2|First Intervention|Adverse Event|1
207203|NCT01149486|657684|P1|First Intervention|Adverse Event|0
207204|NCT01149538|657713|P2|Overall Study|Withdrawal by Subject|3
207205|NCT01149538|657714|P1|Overall Study|Withdrawal by Subject|5
207206|NCT01149538|657713|P2|Overall Study|Lost to Follow-up|1
207207|NCT01149538|657714|P1|Overall Study|Lost to Follow-up|0
207208|NCT01143259|657730|P2|Overall Study|Screen Failure|9
207209|NCT01143259|657731|P1|Overall Study|Screen Failure|7
207210|NCT01143259|657730|P2|Overall Study|Protocol Violation|9
207211|NCT01143259|657731|P1|Overall Study|Protocol Violation|13
207212|NCT01143259|657730|P2|Overall Study|Withdrawal by Subject|2
207213|NCT01143259|657731|P1|Overall Study|Withdrawal by Subject|3
207214|NCT01143324|657760|P1|Overall Study|Explant of the device|4
207215|NCT01143324|657760|P1|Overall Study|Withdrawal by Subject|4
207216|NCT01143324|657760|P1|Overall Study|Lost to Follow-up|11
207217|NCT01143337|657778|P3|Overall Study|Other reason|5
207218|NCT01143337|657779|P2|Overall Study|Other reason|0
207219|NCT01143337|657780|P1|Overall Study|Other reason|0
207220|NCT01143337|657778|P3|Overall Study|Withdrawal by Subject|1
207221|NCT01143337|657779|P2|Overall Study|Withdrawal by Subject|0
207222|NCT01143337|657780|P1|Overall Study|Withdrawal by Subject|0
207223|NCT01143337|657778|P3|Overall Study|Protocol Violation|0
207224|NCT01143337|657779|P2|Overall Study|Protocol Violation|0
207225|NCT01143337|657780|P1|Overall Study|Protocol Violation|1
207226|NCT01143337|657778|P3|Overall Study|Lack of Efficacy|1
207227|NCT01143337|657779|P2|Overall Study|Lack of Efficacy|2
207228|NCT01143337|657780|P1|Overall Study|Lack of Efficacy|6
207229|NCT01143337|657778|P3|Overall Study|Adverse Event|5
207230|NCT01143337|657779|P2|Overall Study|Adverse Event|9
207231|NCT01143337|657780|P1|Overall Study|Adverse Event|3
207232|NCT01143402|657797|P3|Overall Study|Not Treated|1
207233|NCT01143402|657798|P2|Overall Study|Not Treated|0
207234|NCT01143402|657799|P1|Overall Study|Not Treated|0
207235|NCT01143402|657797|P3|Overall Study|Rapid clinical decline|0
207236|NCT01143402|657798|P2|Overall Study|Rapid clinical decline|1
207237|NCT01143402|657799|P1|Overall Study|Rapid clinical decline|1
207238|NCT01143714|657904|P2|Overall Study|wound size increased|0
207239|NCT01143714|657905|P1|Overall Study|wound size increased|1
207240|NCT01143714|657904|P2|Overall Study|wound closed = deemed healed|0
207241|NCT01143714|657905|P1|Overall Study|wound closed = deemed healed|1
207242|NCT01143714|657904|P2|Overall Study|Subject non-compliance|1
207243|NCT01143714|657905|P1|Overall Study|Subject non-compliance|0
207244|NCT01143714|657904|P2|Overall Study|Withdrawal by Subject|0
207245|NCT01143714|657905|P1|Overall Study|Withdrawal by Subject|1
207246|NCT01143714|657904|P2|Overall Study|Adverse Event|2
207247|NCT01143714|657905|P1|Overall Study|Adverse Event|4
207248|NCT01143896|657988|P2|Overall Study|Death|3
207249|NCT01143896|657989|P1|Overall Study|Death|6
207250|NCT01143896|657988|P2|Overall Study|Withdrawal by Subject|5
207251|NCT01143896|657989|P1|Overall Study|Withdrawal by Subject|13
207252|NCT01143896|657988|P2|Overall Study|Lost to Follow-up|13
207253|NCT01143896|657989|P1|Overall Study|Lost to Follow-up|18
207254|NCT01143896|657988|P2|Overall Study|Did not complete Baseline Interview|4
207255|NCT01143896|657989|P1|Overall Study|Did not complete Baseline Interview|5
207256|NCT01144052|658016|P2|Overall Study|Withdrawal by Subject|1
207257|NCT01144052|658017|P1|Overall Study|Withdrawal by Subject|1
207258|NCT01149655|658052|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
207259|NCT01149655|658053|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
207260|NCT01149655|658054|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
207261|NCT01149655|658055|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
207262|NCT01149655|658052|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
207263|NCT01149655|658053|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
207264|NCT01149655|658054|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
207265|NCT01149655|658055|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
207266|NCT01149655|658052|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
207267|NCT01149655|658053|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
207268|NCT01149655|658054|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
207269|NCT01149655|658055|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
207270|NCT01149655|658052|P4|Period 3-DB Maintenance Phase|Physician Decision|0
207271|NCT01149655|658053|P3|Period 3-DB Maintenance Phase|Physician Decision|1
207272|NCT01149655|658054|P2|Period 3-DB Maintenance Phase|Physician Decision|0
207273|NCT01149655|658055|P1|Period 3-DB Maintenance Phase|Physician Decision|0
207274|NCT01149655|658052|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
207275|NCT01149655|658053|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
207276|NCT01149655|658054|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
207277|NCT01149655|658055|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
207278|NCT01149655|658052|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
207279|NCT01149655|658053|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
207280|NCT01149655|658054|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
207281|NCT01149655|658055|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
207282|NCT01149655|658052|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
207283|NCT01149655|658053|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
207284|NCT01149655|658054|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
207285|NCT01149655|658055|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
207286|NCT01149655|658052|P4|Period 2-Stabilization Phase|Physician Decision|0
207287|NCT01149655|658053|P3|Period 2-Stabilization Phase|Physician Decision|0
207288|NCT01149655|658054|P2|Period 2-Stabilization Phase|Physician Decision|3
207289|NCT01149655|658055|P1|Period 2-Stabilization Phase|Physician Decision|0
207290|NCT01149655|658052|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
207291|NCT01149655|658053|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
207292|NCT01149655|658054|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
207293|NCT01149655|658055|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
207294|NCT01149655|658052|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
207295|NCT01149655|658053|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
207296|NCT01149655|658054|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
207297|NCT01149655|658055|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
207298|NCT01149655|658052|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
207299|NCT01149655|658053|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
207300|NCT01149655|658054|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
207301|NCT01149655|658055|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
207302|NCT01149655|658052|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
207303|NCT01149655|658053|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
207304|NCT01149655|658054|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
207305|NCT01149655|658055|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
207306|NCT01149655|658052|P4|Period 1 - Conversion Phase|Physician Decision|0
207307|NCT01149655|658053|P3|Period 1 - Conversion Phase|Physician Decision|0
207308|NCT01149655|658054|P2|Period 1 - Conversion Phase|Physician Decision|0
207309|NCT01149655|658055|P1|Period 1 - Conversion Phase|Physician Decision|2
207310|NCT01149655|658052|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
207311|NCT01149655|658053|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
207312|NCT01149655|658054|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
207313|NCT01149655|658055|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
207314|NCT01149655|658052|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
207315|NCT01149655|658053|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
207316|NCT01149655|658054|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
207317|NCT01149655|658055|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
207318|NCT01149655|658052|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
207319|NCT01149655|658053|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
207320|NCT01149655|658054|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
207321|NCT01149655|658055|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
207322|NCT01149863|658153|P1|Overall Study|Missing data or Not receiveing studydrug|3
207323|NCT01152190|658217|P2|Overall Study|Withdrawal by Subject|3
207324|NCT01152190|658218|P1|Overall Study|Withdrawal by Subject|1
207325|NCT01152190|658217|P2|Overall Study|Protocol Violation|1
207326|NCT01152190|658218|P1|Overall Study|Protocol Violation|1
207327|NCT01152190|658217|P2|Overall Study|Death|0
207328|NCT01152190|658218|P1|Overall Study|Death|1
207329|NCT01152190|658217|P2|Overall Study|Adverse Event|4
207330|NCT01152190|658218|P1|Overall Study|Adverse Event|2
207331|NCT01152385|658261|P4|Overall Study|Unspecified|3
207332|NCT01152385|658262|P3|Overall Study|Unspecified|2
207333|NCT01152385|658263|P2|Overall Study|Unspecified|3
207334|NCT01152385|658264|P1|Overall Study|Unspecified|4
207335|NCT01152385|658261|P4|Overall Study|Study-specific withdrawal criteria|0
207336|NCT01152385|658262|P3|Overall Study|Study-specific withdrawal criteria|2
207337|NCT01152385|658263|P2|Overall Study|Study-specific withdrawal criteria|1
207338|NCT01152385|658264|P1|Overall Study|Study-specific withdrawal criteria|1
207339|NCT01152385|658261|P4|Overall Study|Adverse Event|0
207340|NCT01152385|658262|P3|Overall Study|Adverse Event|0
207341|NCT01152385|658263|P2|Overall Study|Adverse Event|1
207342|NCT01152385|658264|P1|Overall Study|Adverse Event|1
207343|NCT01152385|658261|P4|Overall Study|Protocol Violation|1
207344|NCT01152385|658262|P3|Overall Study|Protocol Violation|0
207345|NCT01152385|658263|P2|Overall Study|Protocol Violation|0
207346|NCT01152385|658264|P1|Overall Study|Protocol Violation|0
207347|NCT01152385|658261|P4|Overall Study|Withdrawal by Subject|1
207348|NCT01152385|658262|P3|Overall Study|Withdrawal by Subject|1
207349|NCT01152385|658263|P2|Overall Study|Withdrawal by Subject|1
207350|NCT01152385|658264|P1|Overall Study|Withdrawal by Subject|3
207351|NCT01152437|658305|P3|Overall Study|Refusal to continue taking trial medicat|2
207352|NCT01152437|658306|P2|Overall Study|Refusal to continue taking trial medicat|0
207353|NCT01152437|658307|P1|Overall Study|Refusal to continue taking trial medicat|1
207354|NCT01152437|658305|P3|Overall Study|Progressive disease|32
207355|NCT01152437|658306|P2|Overall Study|Progressive disease|13
207356|NCT01152437|658307|P1|Overall Study|Progressive disease|27
207357|NCT01152437|658305|P3|Overall Study|Not treated|2
207358|NCT01152437|658306|P2|Overall Study|Not treated|1
207359|NCT01152437|658307|P1|Overall Study|Not treated|0
207360|NCT01152437|658305|P3|Overall Study|Other Adverse Event|7
207361|NCT01152437|658306|P2|Overall Study|Other Adverse Event|1
207362|NCT01152437|658307|P1|Overall Study|Other Adverse Event|8
207363|NCT01152450|658323|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
207364|NCT01152450|658324|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
207365|NCT01152450|658325|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
207366|NCT01152450|658326|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
207367|NCT01152450|658327|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
207368|NCT01152450|658328|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
207369|NCT01152450|658323|P6|Period 1 (4 Weeks)|Protocol Violation|0
207370|NCT01152450|658324|P5|Period 1 (4 Weeks)|Protocol Violation|1
207371|NCT01152450|658325|P4|Period 1 (4 Weeks)|Protocol Violation|0
207372|NCT01152450|658326|P3|Period 1 (4 Weeks)|Protocol Violation|0
207373|NCT01152450|658327|P2|Period 1 (4 Weeks)|Protocol Violation|0
207374|NCT01152450|658328|P1|Period 1 (4 Weeks)|Protocol Violation|0
207375|NCT01152450|658323|P6|Period 1 (4 Weeks)|Adverse Event|1
207376|NCT01152450|658324|P5|Period 1 (4 Weeks)|Adverse Event|1
207377|NCT01152450|658325|P4|Period 1 (4 Weeks)|Adverse Event|0
207378|NCT01152450|658326|P3|Period 1 (4 Weeks)|Adverse Event|0
207379|NCT01152450|658327|P2|Period 1 (4 Weeks)|Adverse Event|0
207380|NCT01152450|658328|P1|Period 1 (4 Weeks)|Adverse Event|0
207381|NCT01152554|658398|P2|Overall Study|Death|1
207382|NCT01152554|658399|P1|Overall Study|Death|1
207383|NCT01152554|658398|P2|Overall Study|Not specified|8
207384|NCT01152554|658399|P1|Overall Study|Not specified|28
207385|NCT01152554|658398|P2|Overall Study|Lost to Follow-up|32
207386|NCT01152554|658399|P1|Overall Study|Lost to Follow-up|87
207387|NCT01152554|658398|P2|Overall Study|Study-specific withdrawal criteria|8
207388|NCT01152554|658399|P1|Overall Study|Study-specific withdrawal criteria|17
207389|NCT01152554|658398|P2|Overall Study|Lack of Efficacy|3
207390|NCT01152554|658399|P1|Overall Study|Lack of Efficacy|20
207391|NCT01152554|658398|P2|Overall Study|Condition under investigation worsened|2
207392|NCT01152554|658399|P1|Overall Study|Condition under investigation worsened|5
207393|NCT01152554|658398|P2|Overall Study|Severe non-compliance to protocol|14
207394|NCT01152554|658399|P1|Overall Study|Severe non-compliance to protocol|36
207395|NCT01152554|658398|P2|Overall Study|Adverse Event|14
207396|NCT01152554|658399|P1|Overall Study|Adverse Event|67
207397|NCT01152554|658398|P2|Overall Study|Eligiblity criteria not fulfilled|1
207398|NCT01152554|658399|P1|Overall Study|Eligiblity criteria not fulfilled|0
207399|NCT01152554|658398|P2|Overall Study|Withdrawal by Subject|28
207400|NCT01152554|658399|P1|Overall Study|Withdrawal by Subject|73
207401|NCT01152580|658423|P2|Overall Study|Withdrawal by Subject|1
207402|NCT01152580|658424|P1|Overall Study|Withdrawal by Subject|0
207403|NCT01152788|658469|P2|Overall Study|No treatment|1
207404|NCT01152788|658470|P1|Overall Study|No treatment|0
207405|NCT01152788|658469|P2|Overall Study|Withdrawal by Subject|3
207406|NCT01152788|658470|P1|Overall Study|Withdrawal by Subject|0
207407|NCT01152814|658482|P1|Overall Study|Lost to Follow-up|2
207408|NCT01152996|658489|P1|Overall Study|Elevated liver enzymes|1
207409|NCT01152996|658489|P1|Overall Study|Protocol Violation|22
207410|NCT01152996|658489|P1|Overall Study|Other|36
207411|NCT01152996|658489|P1|Overall Study|Noncompliance|41
207412|NCT01152996|658489|P1|Overall Study|Lack of Efficacy|68
207413|NCT01152996|658489|P1|Overall Study|Lost to Follow-up|112
207414|NCT01152996|658489|P1|Overall Study|Adverse Event|115
207415|NCT01152996|658489|P1|Overall Study|Withdrawal by Subject|142
207416|NCT01153009|658506|P4|Overall Study|Other|2
207417|NCT01153009|658507|P3|Overall Study|Other|3
207418|NCT01153009|658508|P2|Overall Study|Other|1
207419|NCT01153009|658509|P1|Overall Study|Other|1
207420|NCT01153009|658506|P4|Overall Study|Lost to Follow-up|15
207421|NCT01153009|658507|P3|Overall Study|Lost to Follow-up|11
207422|NCT01153009|658508|P2|Overall Study|Lost to Follow-up|8
207423|NCT01153009|658509|P1|Overall Study|Lost to Follow-up|8
207424|NCT01153009|658506|P4|Overall Study|Withdrawal of Consent|6
207425|NCT01153009|658507|P3|Overall Study|Withdrawal of Consent|4
207426|NCT01153009|658508|P2|Overall Study|Withdrawal of Consent|5
207427|NCT01153009|658509|P1|Overall Study|Withdrawal of Consent|5
207428|NCT01153009|658506|P4|Overall Study|Protocol Deviations|2
207429|NCT01153009|658507|P3|Overall Study|Protocol Deviations|3
207430|NCT01153009|658508|P2|Overall Study|Protocol Deviations|3
207431|NCT01153009|658509|P1|Overall Study|Protocol Deviations|4
207432|NCT01153009|658506|P4|Overall Study|Noncompliance with Study Medication|1
207433|NCT01153009|658507|P3|Overall Study|Noncompliance with Study Medication|4
207434|NCT01153009|658508|P2|Overall Study|Noncompliance with Study Medication|3
207435|NCT01153009|658509|P1|Overall Study|Noncompliance with Study Medication|1
207436|NCT01153009|658506|P4|Overall Study|Lack of Efficacy|1
207437|NCT01153009|658507|P3|Overall Study|Lack of Efficacy|2
207438|NCT01153009|658508|P2|Overall Study|Lack of Efficacy|0
207439|NCT01153009|658509|P1|Overall Study|Lack of Efficacy|9
207440|NCT01153009|658506|P4|Overall Study|Adverse Event|10
207441|NCT01153009|658507|P3|Overall Study|Adverse Event|14
207442|NCT01153009|658508|P2|Overall Study|Adverse Event|14
207443|NCT01153009|658509|P1|Overall Study|Adverse Event|4
207444|NCT01153269|658539|P1|Overall Study|Antiretroviral therapy break|1
207445|NCT01153269|658539|P1|Overall Study|Withdrawal by Subject|1
207446|NCT01153321|658600|P2|Overall Study|Adverse Event|1
207447|NCT01153321|658601|P1|Overall Study|Adverse Event|1
207448|NCT01153321|658600|P2|Overall Study|Withdrawal by Subject|1
207449|NCT01153321|658601|P1|Overall Study|Withdrawal by Subject|0
207450|NCT01153321|658600|P2|Overall Study|Development of study withdrawal criteria|1
207451|NCT01153321|658601|P1|Overall Study|Development of study withdrawal criteria|0
207452|NCT01153347|658717|P4|Overall Study|Death|0
207453|NCT01153347|658718|P3|Overall Study|Death|0
207454|NCT01153347|658719|P2|Overall Study|Death|0
207455|NCT01153347|658720|P1|Overall Study|Death|1
207456|NCT01153347|658717|P4|Overall Study|Not specified|0
207457|NCT01153347|658718|P3|Overall Study|Not specified|4
207458|NCT01153347|658719|P2|Overall Study|Not specified|5
207459|NCT01153347|658720|P1|Overall Study|Not specified|5
207460|NCT01153347|658717|P4|Overall Study|Lost to Follow-up|8
207461|NCT01153347|658718|P3|Overall Study|Lost to Follow-up|11
207462|NCT01153347|658719|P2|Overall Study|Lost to Follow-up|9
207463|NCT01153347|658720|P1|Overall Study|Lost to Follow-up|4
207464|NCT01153347|658717|P4|Overall Study|Study-specific withdrawal criteria|2
207465|NCT01153347|658718|P3|Overall Study|Study-specific withdrawal criteria|1
207466|NCT01153347|658719|P2|Overall Study|Study-specific withdrawal criteria|3
207467|NCT01153347|658720|P1|Overall Study|Study-specific withdrawal criteria|4
207468|NCT01153347|658717|P4|Overall Study|Lack of Efficacy|4
207469|NCT01153347|658718|P3|Overall Study|Lack of Efficacy|0
207470|NCT01153347|658719|P2|Overall Study|Lack of Efficacy|2
207471|NCT01153347|658720|P1|Overall Study|Lack of Efficacy|2
207472|NCT01153347|658717|P4|Overall Study|Condition under investigation worsened|0
207473|NCT01153347|658718|P3|Overall Study|Condition under investigation worsened|0
207474|NCT01153347|658719|P2|Overall Study|Condition under investigation worsened|1
207475|NCT01153347|658720|P1|Overall Study|Condition under investigation worsened|1
207476|NCT01153347|658717|P4|Overall Study|Severe non-compliance to protocol|3
207477|NCT01153347|658718|P3|Overall Study|Severe non-compliance to protocol|4
207478|NCT01153347|658719|P2|Overall Study|Severe non-compliance to protocol|7
207479|NCT01153347|658720|P1|Overall Study|Severe non-compliance to protocol|6
207480|NCT01153347|658717|P4|Overall Study|Adverse Event|7
207481|NCT01153347|658718|P3|Overall Study|Adverse Event|21
207482|NCT01153347|658719|P2|Overall Study|Adverse Event|9
207483|NCT01153347|658720|P1|Overall Study|Adverse Event|3
207484|NCT01153347|658717|P4|Overall Study|Eligibility criteria not fulfilled|1
207485|NCT01153347|658718|P3|Overall Study|Eligibility criteria not fulfilled|2
207486|NCT01153347|658719|P2|Overall Study|Eligibility criteria not fulfilled|1
207487|NCT01153347|658720|P1|Overall Study|Eligibility criteria not fulfilled|0
207488|NCT01153347|658717|P4|Overall Study|Withdrawal by Subject|7
207489|NCT01153347|658718|P3|Overall Study|Withdrawal by Subject|7
207490|NCT01153347|658719|P2|Overall Study|Withdrawal by Subject|7
207491|NCT01153347|658720|P1|Overall Study|Withdrawal by Subject|7
207492|NCT01153425|658820|P2|Overall Study|Withdrawal by Subject|3
207493|NCT01153425|658821|P1|Overall Study|Withdrawal by Subject|3
207494|NCT01153633|658863|P2|Overall Study|Therapeutic failure|3
207495|NCT01153633|658864|P1|Overall Study|Therapeutic failure|3
207496|NCT01153633|658863|P2|Overall Study|Protocol Violation|1
207497|NCT01153633|658864|P1|Overall Study|Protocol Violation|1
207498|NCT01153698|658913|P1|Overall Study|Not treated with Pradaxa|5
207499|NCT01153698|658913|P1|Overall Study|Other|2
207500|NCT01153698|658913|P1|Overall Study|Switch to other anticoagulants|4
207501|NCT01153698|658913|P1|Overall Study|Withdrawal by Subject|2
207502|NCT01153698|658913|P1|Overall Study|Lost to Follow-up|4
207503|NCT01153698|658913|P1|Overall Study|Adverse Event|12
207504|NCT01153724|658947|P1|Treatment Period 2|Other reason not defined above|1
207505|NCT01153724|658947|P1|Treatment Period 2|Adverse Event|1
207506|NCT01153724|658947|P1|Treatment Period 1|Withdrawal by Subject|1
207507|NCT01153763|658967|P1|Overall Study|Withdrawal by Subject|2
207508|NCT01153763|658967|P1|Overall Study|Physician Decision|2
207509|NCT01153763|658967|P1|Overall Study|Lost to Follow-up|1
207510|NCT01153763|658967|P1|Overall Study|Study Closed|16
207511|NCT01153815|658985|P2|Overall Study|Withdrawal by Subject|4
207512|NCT01153815|658986|P1|Overall Study|Withdrawal by Subject|6
207513|NCT01153815|658985|P2|Overall Study|Adverse Event|1
207514|NCT01153815|658986|P1|Overall Study|Adverse Event|3
207515|NCT01153841|659010|P2|Overall Study|Lost to Follow-up|0
207516|NCT01153841|659011|P1|Overall Study|Lost to Follow-up|2
207517|NCT01153841|659010|P2|Overall Study|Protocol Violation|0
207518|NCT01153841|659011|P1|Overall Study|Protocol Violation|2
207519|NCT01153841|659010|P2|Overall Study|Withdrawal by Subject|0
207520|NCT01153841|659011|P1|Overall Study|Withdrawal by Subject|1
207521|NCT01153841|659010|P2|Overall Study|Adverse Event|0
207522|NCT01153841|659011|P1|Overall Study|Adverse Event|1
207523|NCT01153893|659027|P2|Overall Study|Adverse Event|0
207524|NCT01153893|659028|P1|Overall Study|Adverse Event|1
207525|NCT01153958|659054|P2|Overall Study|Study Terminated|32
207526|NCT01153958|659055|P1|Overall Study|Study Terminated|36
207527|NCT01153971|659071|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
207528|NCT01153971|659071|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
207529|NCT01153971|659071|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
207530|NCT01153971|659071|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
207531|NCT01153971|659071|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
207532|NCT01153971|659071|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
207533|NCT01153971|659071|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
207534|NCT01153984|659092|P1|Overall Study|Adverse Event|1
207535|NCT01153984|659092|P1|Overall Study|Withdrawal by Subject|1
207536|NCT01154010|659105|P2|Overall Study|Lost to Follow-up|1
207537|NCT01154010|659106|P1|Overall Study|Lost to Follow-up|0
207538|NCT01154036|659115|P8|Phase II|Withdrawal by Subject|4
207539|NCT01154036|659116|P7|Phase II|Withdrawal by Subject|5
207540|NCT01154036|659117|P6|Phase II|Withdrawal by Subject|2
207541|NCT01154036|659118|P5|Phase II|Withdrawal by Subject|4
207542|NCT01154036|659119|P4|Phase II|Withdrawal by Subject|0
207543|NCT01154036|659120|P3|Phase II|Withdrawal by Subject|0
207544|NCT01154036|659121|P2|Phase II|Withdrawal by Subject|0
207545|NCT01154036|659122|P1|Phase II|Withdrawal by Subject|0
207546|NCT01154036|659115|P8|Phase II|Protocol Violation|0
207547|NCT01154036|659116|P7|Phase II|Protocol Violation|0
207548|NCT01154036|659117|P6|Phase II|Protocol Violation|2
207549|NCT01154036|659118|P5|Phase II|Protocol Violation|1
207550|NCT01154036|659119|P4|Phase II|Protocol Violation|0
207551|NCT01154036|659120|P3|Phase II|Protocol Violation|0
207552|NCT01154036|659121|P2|Phase II|Protocol Violation|0
207553|NCT01154036|659122|P1|Phase II|Protocol Violation|0
207554|NCT01154036|659115|P8|Phase II|Lost to Follow-up|1
207555|NCT01154036|659116|P7|Phase II|Lost to Follow-up|2
207556|NCT01154036|659117|P6|Phase II|Lost to Follow-up|0
207557|NCT01154036|659118|P5|Phase II|Lost to Follow-up|2
207558|NCT01154036|659119|P4|Phase II|Lost to Follow-up|1
207559|NCT01154036|659120|P3|Phase II|Lost to Follow-up|0
207560|NCT01154036|659121|P2|Phase II|Lost to Follow-up|0
207561|NCT01154036|659122|P1|Phase II|Lost to Follow-up|0
207562|NCT01154036|659115|P8|Phase II|Physician Decision|0
207563|NCT01154036|659116|P7|Phase II|Physician Decision|1
207564|NCT01154036|659117|P6|Phase II|Physician Decision|0
207565|NCT01154036|659118|P5|Phase II|Physician Decision|0
207566|NCT01154036|659119|P4|Phase II|Physician Decision|0
207567|NCT01154036|659120|P3|Phase II|Physician Decision|0
207568|NCT01154036|659121|P2|Phase II|Physician Decision|0
207569|NCT01154036|659122|P1|Phase II|Physician Decision|0
207570|NCT01154036|659115|P8|Phase II|Adverse Event|1
207571|NCT01154036|659116|P7|Phase II|Adverse Event|1
207572|NCT01154036|659117|P6|Phase II|Adverse Event|1
207573|NCT01154036|659118|P5|Phase II|Adverse Event|1
207574|NCT01154036|659119|P4|Phase II|Adverse Event|0
207575|NCT01154036|659120|P3|Phase II|Adverse Event|0
207576|NCT01154036|659121|P2|Phase II|Adverse Event|0
207577|NCT01154036|659122|P1|Phase II|Adverse Event|0
207578|NCT01154036|659115|P8|Phase I|Adverse Event|0
207579|NCT01154036|659116|P7|Phase I|Adverse Event|0
207580|NCT01154036|659117|P6|Phase I|Adverse Event|0
207581|NCT01154036|659118|P5|Phase I|Adverse Event|0
207582|NCT01154036|659119|P4|Phase I|Adverse Event|0
207583|NCT01154036|659120|P3|Phase I|Adverse Event|12
207584|NCT01154036|659121|P2|Phase I|Adverse Event|11
207585|NCT01154036|659122|P1|Phase I|Adverse Event|1
207586|NCT01154036|659115|P8|Phase I|Withdrawal by Subject|0
207587|NCT01154036|659116|P7|Phase I|Withdrawal by Subject|0
207588|NCT01154036|659117|P6|Phase I|Withdrawal by Subject|0
207589|NCT01154036|659118|P5|Phase I|Withdrawal by Subject|0
207590|NCT01154036|659119|P4|Phase I|Withdrawal by Subject|0
207591|NCT01154036|659120|P3|Phase I|Withdrawal by Subject|29
207592|NCT01154036|659121|P2|Phase I|Withdrawal by Subject|10
207593|NCT01154036|659122|P1|Phase I|Withdrawal by Subject|2
207594|NCT01154036|659115|P8|Phase I|Protocol Violation|0
207595|NCT01154036|659116|P7|Phase I|Protocol Violation|0
207596|NCT01154036|659117|P6|Phase I|Protocol Violation|0
207597|NCT01154036|659118|P5|Phase I|Protocol Violation|0
207598|NCT01154036|659119|P4|Phase I|Protocol Violation|0
207599|NCT01154036|659120|P3|Phase I|Protocol Violation|9
207600|NCT01154036|659121|P2|Phase I|Protocol Violation|3
207601|NCT01154036|659122|P1|Phase I|Protocol Violation|0
207602|NCT01154036|659115|P8|Phase I|Lost to Follow-up|0
207603|NCT01154036|659116|P7|Phase I|Lost to Follow-up|0
207604|NCT01154036|659117|P6|Phase I|Lost to Follow-up|0
207605|NCT01154036|659118|P5|Phase I|Lost to Follow-up|0
207606|NCT01154036|659119|P4|Phase I|Lost to Follow-up|0
207607|NCT01154036|659120|P3|Phase I|Lost to Follow-up|6
207608|NCT01154036|659121|P2|Phase I|Lost to Follow-up|3
207609|NCT01154036|659122|P1|Phase I|Lost to Follow-up|0
207610|NCT01154036|659115|P8|Phase I|Physician Decision|0
207611|NCT01154036|659116|P7|Phase I|Physician Decision|0
207612|NCT01154036|659117|P6|Phase I|Physician Decision|0
207613|NCT01154036|659118|P5|Phase I|Physician Decision|0
207614|NCT01154036|659119|P4|Phase I|Physician Decision|0
207615|NCT01154036|659120|P3|Phase I|Physician Decision|0
207616|NCT01154036|659121|P2|Phase I|Physician Decision|1
207617|NCT01154036|659122|P1|Phase I|Physician Decision|0
207618|NCT01147055|659244|P2|First Intervention Period|Lost to Follow-up|0
207619|NCT01147055|659245|P1|First Intervention Period|Lost to Follow-up|1
207620|NCT01147068|659284|P7|Subjects That Completed Safety Follow-up|Ineligible|0
207621|NCT01147068|659285|P6|Subjects That Completed Safety Follow-up|Ineligible|0
207622|NCT01147068|659286|P5|Subjects That Completed Safety Follow-up|Ineligible|0
207623|NCT01147068|659287|P4|Subjects That Completed Safety Follow-up|Ineligible|0
207624|NCT01147068|659288|P3|Subjects That Completed Safety Follow-up|Ineligible|0
207625|NCT01147068|659289|P2|Subjects That Completed Safety Follow-up|Ineligible|1
207626|NCT01147068|659290|P1|Subjects That Completed Safety Follow-up|Ineligible|0
207627|NCT01147068|659284|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
207628|NCT01147068|659285|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
207629|NCT01147068|659286|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
207630|NCT01147068|659287|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
207631|NCT01147068|659288|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
207632|NCT01147068|659289|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
207633|NCT01147068|659290|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
207634|NCT01147068|659284|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
207635|NCT01147068|659285|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
207636|NCT01147068|659286|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
207637|NCT01147068|659287|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
207638|NCT01147068|659288|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
207639|NCT01147068|659289|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
207640|NCT01147068|659290|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
207641|NCT01147068|659284|P7|Subjects That Received 2nd Dose|Other|0
207642|NCT01147068|659285|P6|Subjects That Received 2nd Dose|Other|0
207643|NCT01147068|659286|P5|Subjects That Received 2nd Dose|Other|1
207644|NCT01147068|659287|P4|Subjects That Received 2nd Dose|Other|0
207645|NCT01147068|659288|P3|Subjects That Received 2nd Dose|Other|3
207646|NCT01147068|659289|P2|Subjects That Received 2nd Dose|Other|3
207647|NCT01147068|659290|P1|Subjects That Received 2nd Dose|Other|0
207648|NCT01147068|659284|P7|Subjects That Received 2nd Dose|Did not complete the study|0
207649|NCT01147068|659285|P6|Subjects That Received 2nd Dose|Did not complete the study|1
207650|NCT01147068|659286|P5|Subjects That Received 2nd Dose|Did not complete the study|0
207651|NCT01147068|659287|P4|Subjects That Received 2nd Dose|Did not complete the study|0
207652|NCT01147068|659288|P3|Subjects That Received 2nd Dose|Did not complete the study|0
207653|NCT01147068|659289|P2|Subjects That Received 2nd Dose|Did not complete the study|1
207654|NCT01147068|659290|P1|Subjects That Received 2nd Dose|Did not complete the study|0
207655|NCT01147068|659284|P7|Subjects That Received 2nd Dose|Ineligible|0
207656|NCT01147068|659285|P6|Subjects That Received 2nd Dose|Ineligible|0
207657|NCT01147068|659286|P5|Subjects That Received 2nd Dose|Ineligible|0
207658|NCT01147068|659287|P4|Subjects That Received 2nd Dose|Ineligible|0
207659|NCT01147068|659288|P3|Subjects That Received 2nd Dose|Ineligible|0
207660|NCT01147068|659289|P2|Subjects That Received 2nd Dose|Ineligible|1
207661|NCT01147068|659290|P1|Subjects That Received 2nd Dose|Ineligible|0
207662|NCT01147068|659284|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
207663|NCT01147068|659285|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
207664|NCT01147068|659286|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
207665|NCT01147068|659287|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
207666|NCT01147068|659288|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
207667|NCT01147068|659289|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
207668|NCT01147068|659290|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
207669|NCT01154127|659322|P2|Period 2 (21 Days)|Protocol Deviation|1
207670|NCT01154127|659323|P1|Period 2 (21 Days)|Protocol Deviation|0
207671|NCT01154127|659322|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
207672|NCT01154127|659323|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
207673|NCT01154127|659322|P2|Washout (14 - 28 Days)|Adverse Event|0
207674|NCT01154127|659323|P1|Washout (14 - 28 Days)|Adverse Event|2
207675|NCT01154127|659322|P2|Period 1 (21 Days)|Withdrawal by Subject|2
207676|NCT01154127|659323|P1|Period 1 (21 Days)|Withdrawal by Subject|0
207677|NCT01154127|659322|P2|Period 1 (21 Days)|Adverse Event|4
207678|NCT01154127|659323|P1|Period 1 (21 Days)|Adverse Event|3
207679|NCT01154140|659347|P2|Overall Study|Randomized but not treated|2
207680|NCT01154140|659348|P1|Overall Study|Randomized but not treated|1
207681|NCT01154140|659347|P2|Overall Study|Ongoing at date of cut-off|115
207682|NCT01154140|659348|P1|Overall Study|Ongoing at date of cut-off|119
207683|NCT01154140|659347|P2|Overall Study|Not specified|1
207684|NCT01154140|659348|P1|Overall Study|Not specified|1
207685|NCT01154140|659347|P2|Overall Study|Withdrawal by Subject|5
207686|NCT01154140|659348|P1|Overall Study|Withdrawal by Subject|7
207687|NCT01154140|659347|P2|Overall Study|Lost to Follow-up|2
207688|NCT01154140|659348|P1|Overall Study|Lost to Follow-up|0
207689|NCT01154140|659347|P2|Overall Study|Death|46
207690|NCT01154140|659348|P1|Overall Study|Death|44
207691|NCT01154153|659397|P2|Overall Study|Withdrew consent|0
207692|NCT01154153|659398|P1|Overall Study|Withdrew consent|1
207693|NCT01154153|659397|P2|Overall Study|Unable to use labs|3
207694|NCT01154153|659398|P1|Overall Study|Unable to use labs|2
207695|NCT01154153|659397|P2|Overall Study|Poor compliance to protocol|0
207696|NCT01154153|659398|P1|Overall Study|Poor compliance to protocol|2
207697|NCT01154166|659416|P2|Overall Study|Poor Compliance|0
207698|NCT01154166|659417|P1|Overall Study|Poor Compliance|1
207699|NCT01154166|659416|P2|Overall Study|Disease Progression|0
207700|NCT01154166|659417|P1|Overall Study|Disease Progression|1
207701|NCT01154166|659416|P2|Overall Study|Lack of Efficacy|0
207702|NCT01154166|659417|P1|Overall Study|Lack of Efficacy|3
207703|NCT01154166|659416|P2|Overall Study|Withdrawal by Subject|1
207704|NCT01154166|659417|P1|Overall Study|Withdrawal by Subject|10
207705|NCT01154166|659416|P2|Overall Study|Protocol Violation|1
207706|NCT01154166|659417|P1|Overall Study|Protocol Violation|4
207707|NCT01154166|659416|P2|Overall Study|Lost to Follow-up|1
207708|NCT01154166|659417|P1|Overall Study|Lost to Follow-up|1
207709|NCT01154166|659416|P2|Overall Study|Adverse Event|9
207710|NCT01154166|659417|P1|Overall Study|Adverse Event|14
207711|NCT01154218|659447|P4|Fourth Intervention Period|Withdrawal by Subject|0
207712|NCT01154218|659448|P3|Fourth Intervention Period|Withdrawal by Subject|0
207713|NCT01154218|659449|P2|Fourth Intervention Period|Withdrawal by Subject|0
207714|NCT01154218|659450|P1|Fourth Intervention Period|Withdrawal by Subject|1
207715|NCT01154218|659447|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
207716|NCT01154218|659448|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
207717|NCT01154218|659449|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
207718|NCT01154218|659450|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
207719|NCT01154218|659447|P4|Third Intervention Period|Adverse Event|0
207720|NCT01154218|659448|P3|Third Intervention Period|Adverse Event|0
207721|NCT01154218|659449|P2|Third Intervention Period|Adverse Event|1
207722|NCT01154218|659450|P1|Third Intervention Period|Adverse Event|0
207723|NCT01154231|659500|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
207724|NCT01154231|659500|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
207725|NCT01154283|659508|P2|7-12 Weeks|Withdrawal by Subject|1
207726|NCT01154283|659509|P1|7-12 Weeks|Withdrawal by Subject|0
207727|NCT01154283|659508|P2|7-12 Weeks|Death|0
207728|NCT01154283|659509|P1|7-12 Weeks|Death|1
207729|NCT01154283|659508|P2|0-6 Weeks|Death|1
207730|NCT01154283|659509|P1|0-6 Weeks|Death|0
207731|NCT01154283|659508|P2|0-6 Weeks|Withdrawal by Subject|2
207732|NCT01154283|659509|P1|0-6 Weeks|Withdrawal by Subject|7
207733|NCT01154296|659523|P2|6-month Follow-up|Declined by Study Coordinator|4
207734|NCT01154296|659524|P1|6-month Follow-up|Declined by Study Coordinator|5
207735|NCT01154296|659523|P2|6-month Follow-up|Death|2
207736|NCT01154296|659524|P1|6-month Follow-up|Death|3
207737|NCT01154296|659523|P2|6-month Follow-up|Withdrew consent|15
207738|NCT01154296|659524|P1|6-month Follow-up|Withdrew consent|14
207739|NCT01154296|659523|P2|6-month Follow-up|Incarcerated|32
207740|NCT01154296|659524|P1|6-month Follow-up|Incarcerated|37
207741|NCT01154296|659523|P2|6-month Follow-up|Lost contact|275
207742|NCT01154296|659524|P1|6-month Follow-up|Lost contact|269
207743|NCT01154296|659523|P2|Randomization and Intervention|Left clinic early|0
207744|NCT01154296|659524|P1|Randomization and Intervention|Left clinic early|2
207745|NCT01154296|659523|P2|Randomization and Intervention|Left before test|1
207746|NCT01154296|659524|P1|Randomization and Intervention|Left before test|0
207747|NCT01154296|659523|P2|Randomization and Intervention|Did not return|0
207748|NCT01154296|659524|P1|Randomization and Intervention|Did not return|1
207749|NCT01154296|659523|P2|Randomization and Intervention|Declined by staff|0
207750|NCT01154296|659524|P1|Randomization and Intervention|Declined by staff|1
207751|NCT01154296|659523|P2|Randomization and Intervention|Decided to decline|1
207752|NCT01154296|659524|P1|Randomization and Intervention|Decided to decline|1
207753|NCT01154816|659569|P12|Overall Study|Adverse Event|0
207754|NCT01154816|659570|P11|Overall Study|Adverse Event|0
207755|NCT01154816|659571|P10|Overall Study|Adverse Event|0
207756|NCT01154816|659572|P9|Overall Study|Adverse Event|0
207757|NCT01154816|659573|P8|Overall Study|Adverse Event|1
207758|NCT01154816|659574|P7|Overall Study|Adverse Event|1
207759|NCT01154816|659575|P6|Overall Study|Adverse Event|0
207760|NCT01154816|659576|P5|Overall Study|Adverse Event|0
207761|NCT01154816|659577|P4|Overall Study|Adverse Event|0
207762|NCT01154816|659578|P3|Overall Study|Adverse Event|0
207763|NCT01154816|659579|P2|Overall Study|Adverse Event|2
207764|NCT01154816|659580|P1|Overall Study|Adverse Event|5
207765|NCT01154816|659569|P12|Overall Study|Physician Decision|1
207766|NCT01154816|659570|P11|Overall Study|Physician Decision|1
207767|NCT01154816|659571|P10|Overall Study|Physician Decision|1
207768|NCT01154816|659572|P9|Overall Study|Physician Decision|0
207769|NCT01154816|659573|P8|Overall Study|Physician Decision|0
207770|NCT01154816|659574|P7|Overall Study|Physician Decision|0
207771|NCT01154816|659575|P6|Overall Study|Physician Decision|0
207772|NCT01154816|659576|P5|Overall Study|Physician Decision|2
207773|NCT01154816|659577|P4|Overall Study|Physician Decision|0
207774|NCT01154816|659578|P3|Overall Study|Physician Decision|1
207775|NCT01154816|659579|P2|Overall Study|Physician Decision|0
207776|NCT01154816|659580|P1|Overall Study|Physician Decision|1
207777|NCT01154816|659569|P12|Overall Study|Progressive Disease|3
207778|NCT01154816|659570|P11|Overall Study|Progressive Disease|10
207779|NCT01154816|659571|P10|Overall Study|Progressive Disease|6
207780|NCT01154816|659572|P9|Overall Study|Progressive Disease|8
207781|NCT01154816|659573|P8|Overall Study|Progressive Disease|6
207782|NCT01154816|659574|P7|Overall Study|Progressive Disease|5
207783|NCT01154816|659575|P6|Overall Study|Progressive Disease|8
207784|NCT01154816|659576|P5|Overall Study|Progressive Disease|8
207785|NCT01154816|659577|P4|Overall Study|Progressive Disease|9
207786|NCT01154816|659578|P3|Overall Study|Progressive Disease|9
207787|NCT01154816|659579|P2|Overall Study|Progressive Disease|8
207788|NCT01154816|659580|P1|Overall Study|Progressive Disease|13
207789|NCT01154816|659569|P12|Overall Study|Withdrawal by Subject|0
207790|NCT01154816|659570|P11|Overall Study|Withdrawal by Subject|0
207791|NCT01154816|659571|P10|Overall Study|Withdrawal by Subject|3
207792|NCT01154816|659572|P9|Overall Study|Withdrawal by Subject|1
207793|NCT01154816|659573|P8|Overall Study|Withdrawal by Subject|0
207794|NCT01154816|659574|P7|Overall Study|Withdrawal by Subject|0
207795|NCT01154816|659575|P6|Overall Study|Withdrawal by Subject|0
207796|NCT01154816|659576|P5|Overall Study|Withdrawal by Subject|0
207797|NCT01154816|659577|P4|Overall Study|Withdrawal by Subject|1
207798|NCT01154816|659578|P3|Overall Study|Withdrawal by Subject|0
207799|NCT01154816|659579|P2|Overall Study|Withdrawal by Subject|0
207800|NCT01154816|659580|P1|Overall Study|Withdrawal by Subject|1
207801|NCT01155011|659634|P2|6 to 12 Months|Death|5
207802|NCT01155011|659635|P1|6 to 12 Months|Death|1
207803|NCT01155011|659634|P2|6 to 12 Months|Withdrawal by Subject|5
207804|NCT01155011|659635|P1|6 to 12 Months|Withdrawal by Subject|8
207805|NCT01155011|659634|P2|Baseline to 6 Months|Death|1
207806|NCT01155011|659635|P1|Baseline to 6 Months|Death|0
207807|NCT01155011|659634|P2|Baseline to 6 Months|investigator decision, moved|5
207808|NCT01155011|659635|P1|Baseline to 6 Months|investigator decision, moved|4
207809|NCT01155011|659634|P2|Baseline to 6 Months|Withdrawal by Subject|19
207810|NCT01155011|659635|P1|Baseline to 6 Months|Withdrawal by Subject|18
207811|NCT01155024|659645|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
207812|NCT01155024|659646|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
207813|NCT01155024|659645|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
207814|NCT01155024|659646|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
207815|NCT01155024|659645|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
207816|NCT01155024|659646|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
207817|NCT01155063|659654|P1|Overall Study|Study terminated by sponsor|87
207818|NCT01155063|659654|P1|Overall Study|Withdrawal by Subject|1
207819|NCT01155063|659654|P1|Overall Study|Adverse Event|1
207820|NCT01155141|659664|P1|Overall Study|Screen Failure|1
207821|NCT01155141|659664|P1|Overall Study|Withdrawal by Subject|1
207822|NCT01155167|659691|P2|Overall Study|Access site changed to femoral artery|0
207823|NCT01155167|659692|P1|Overall Study|Access site changed to femoral artery|1
207824|NCT01155167|659691|P2|Overall Study|Insufficient ultrasound data|0
207825|NCT01155167|659692|P1|Overall Study|Insufficient ultrasound data|2
207826|NCT01155219|659713|P2|Overall Study|non-medical reason|2
207827|NCT01155219|659714|P1|Overall Study|non-medical reason|1
207828|NCT01155219|659713|P2|Overall Study|Adverse Event|1
207829|NCT01155219|659714|P1|Overall Study|Adverse Event|3
207830|NCT01155323|659720|P2|Second Intervention|Lost to Follow-up|1
207831|NCT01155323|659721|P1|Second Intervention|Lost to Follow-up|1
207832|NCT01155323|659720|P2|First Intervention|exclusion criteria|1
207833|NCT01155323|659721|P1|First Intervention|exclusion criteria|1
207834|NCT01155466|659751|P5|Overall Study|Randomized not treated|2
207835|NCT01155466|659752|P4|Overall Study|Randomized not treated|0
207836|NCT01155466|659753|P3|Overall Study|Randomized not treated|3
207837|NCT01155466|659754|P2|Overall Study|Randomized not treated|2
207838|NCT01155466|659755|P1|Overall Study|Randomized not treated|2
207839|NCT01155466|659751|P5|Overall Study|Administrative|0
207840|NCT01155466|659752|P4|Overall Study|Administrative|0
207841|NCT01155466|659753|P3|Overall Study|Administrative|0
207842|NCT01155466|659754|P2|Overall Study|Administrative|3
207843|NCT01155466|659755|P1|Overall Study|Administrative|0
207844|NCT01155466|659751|P5|Overall Study|Protocol Violation|1
207845|NCT01155466|659752|P4|Overall Study|Protocol Violation|0
207846|NCT01155466|659753|P3|Overall Study|Protocol Violation|2
207847|NCT01155466|659754|P2|Overall Study|Protocol Violation|0
207848|NCT01155466|659755|P1|Overall Study|Protocol Violation|0
207849|NCT01155466|659751|P5|Overall Study|Withdrawal by Subject|4
207850|NCT01155466|659752|P4|Overall Study|Withdrawal by Subject|4
207851|NCT01155466|659753|P3|Overall Study|Withdrawal by Subject|9
207852|NCT01155466|659754|P2|Overall Study|Withdrawal by Subject|5
207853|NCT01155466|659755|P1|Overall Study|Withdrawal by Subject|7
207854|NCT01155466|659751|P5|Overall Study|Lost to Follow-up|2
207855|NCT01155466|659752|P4|Overall Study|Lost to Follow-up|0
207856|NCT01155466|659753|P3|Overall Study|Lost to Follow-up|0
207857|NCT01155466|659754|P2|Overall Study|Lost to Follow-up|0
207858|NCT01155466|659755|P1|Overall Study|Lost to Follow-up|0
207859|NCT01155466|659751|P5|Overall Study|Adverse Event|18
207860|NCT01155466|659752|P4|Overall Study|Adverse Event|17
207861|NCT01155466|659753|P3|Overall Study|Adverse Event|6
207862|NCT01155466|659754|P2|Overall Study|Adverse Event|15
207863|NCT01155466|659755|P1|Overall Study|Adverse Event|13
207864|NCT01155479|659812|P5|Part II|Non-Compliance with Protocol|0
207865|NCT01155479|659813|P4|Part II|Non-Compliance with Protocol|2
207866|NCT01155479|659814|P3|Part II|Non-Compliance with Protocol|0
207867|NCT01155479|659815|P2|Part II|Non-Compliance with Protocol|1
207868|NCT01155479|659816|P1|Part II|Non-Compliance with Protocol|0
207869|NCT01155479|659812|P5|Part II|Treatment Failure|1
207870|NCT01155479|659813|P4|Part II|Treatment Failure|0
207871|NCT01155479|659814|P3|Part II|Treatment Failure|2
207872|NCT01155479|659815|P2|Part II|Treatment Failure|1
207873|NCT01155479|659816|P1|Part II|Treatment Failure|0
207874|NCT01155479|659812|P5|Part II|Lost to Follow-up|1
207875|NCT01155479|659813|P4|Part II|Lost to Follow-up|0
207876|NCT01155479|659814|P3|Part II|Lost to Follow-up|0
207877|NCT01155479|659815|P2|Part II|Lost to Follow-up|0
207878|NCT01155479|659816|P1|Part II|Lost to Follow-up|1
207879|NCT01155479|659812|P5|Part II|Withdrawal by Subject|3
207880|NCT01155479|659813|P4|Part II|Withdrawal by Subject|7
207881|NCT01155479|659814|P3|Part II|Withdrawal by Subject|12
207882|NCT01155479|659815|P2|Part II|Withdrawal by Subject|4
207883|NCT01155479|659816|P1|Part II|Withdrawal by Subject|8
207884|NCT01155479|659812|P5|Part II|Administrative|46
207885|NCT01155479|659813|P4|Part II|Administrative|38
207886|NCT01155479|659814|P3|Part II|Administrative|36
207887|NCT01155479|659815|P2|Part II|Administrative|49
207888|NCT01155479|659816|P1|Part II|Administrative|43
207889|NCT01155479|659812|P5|Part II|Adverse Event|4
207890|NCT01155479|659813|P4|Part II|Adverse Event|3
207891|NCT01155479|659814|P3|Part II|Adverse Event|8
207892|NCT01155479|659815|P2|Part II|Adverse Event|6
207893|NCT01155479|659816|P1|Part II|Adverse Event|7
207894|NCT01155479|659812|P5|Part I|Non-Compliance with Protocol|2
207895|NCT01155479|659813|P4|Part I|Non-Compliance with Protocol|3
207896|NCT01155479|659814|P3|Part I|Non-Compliance with Protocol|3
207897|NCT01155479|659815|P2|Part I|Non-Compliance with Protocol|1
207898|NCT01155479|659816|P1|Part I|Non-Compliance with Protocol|2
207899|NCT01155479|659812|P5|Part I|Did Not Receive Treatment|1
207900|NCT01155479|659813|P4|Part I|Did Not Receive Treatment|6
207901|NCT01155479|659814|P3|Part I|Did Not Receive Treatment|2
207902|NCT01155479|659815|P2|Part I|Did Not Receive Treatment|2
207903|NCT01155479|659816|P1|Part I|Did Not Receive Treatment|4
207904|NCT01155479|659812|P5|Part I|Treatment Failure|2
207905|NCT01155479|659813|P4|Part I|Treatment Failure|1
207906|NCT01155479|659814|P3|Part I|Treatment Failure|3
207907|NCT01155479|659815|P2|Part I|Treatment Failure|0
207908|NCT01155479|659816|P1|Part I|Treatment Failure|3
207909|NCT01155479|659812|P5|Part I|Lost to Follow-up|0
207910|NCT01155479|659813|P4|Part I|Lost to Follow-up|1
207911|NCT01155479|659814|P3|Part I|Lost to Follow-up|1
207912|NCT01155479|659815|P2|Part I|Lost to Follow-up|0
207913|NCT01155479|659816|P1|Part I|Lost to Follow-up|0
207914|NCT01155479|659812|P5|Part I|Withdrawal by Subject|9
207915|NCT01155479|659813|P4|Part I|Withdrawal by Subject|8
207916|NCT01155479|659814|P3|Part I|Withdrawal by Subject|8
207917|NCT01155479|659815|P2|Part I|Withdrawal by Subject|13
207918|NCT01155479|659816|P1|Part I|Withdrawal by Subject|11
207919|NCT01155479|659812|P5|Part I|Did Not Meet Protocol Eligibility|3
207920|NCT01155479|659813|P4|Part I|Did Not Meet Protocol Eligibility|1
207921|NCT01155479|659814|P3|Part I|Did Not Meet Protocol Eligibility|2
207922|NCT01155479|659815|P2|Part I|Did Not Meet Protocol Eligibility|1
207923|NCT01155479|659816|P1|Part I|Did Not Meet Protocol Eligibility|3
207924|NCT01155479|659812|P5|Part I|Administrative|0
207925|NCT01155479|659813|P4|Part I|Administrative|0
207926|NCT01155479|659814|P3|Part I|Administrative|2
207927|NCT01155479|659815|P2|Part I|Administrative|2
207928|NCT01155479|659816|P1|Part I|Administrative|2
207929|NCT01155479|659812|P5|Part I|Adverse Event|6
207930|NCT01155479|659813|P4|Part I|Adverse Event|7
207931|NCT01155479|659814|P3|Part I|Adverse Event|18
207932|NCT01155479|659815|P2|Part I|Adverse Event|8
207933|NCT01155479|659816|P1|Part I|Adverse Event|13
207934|NCT01155531|659867|P4|Overall Study|Withdrawal by Subject|0
207935|NCT01155531|659868|P3|Overall Study|Withdrawal by Subject|1
207936|NCT01155531|659869|P2|Overall Study|Withdrawal by Subject|0
207937|NCT01155531|659870|P1|Overall Study|Withdrawal by Subject|1
207938|NCT01155531|659867|P4|Overall Study|Lost to Follow-up|1
207939|NCT01155531|659868|P3|Overall Study|Lost to Follow-up|0
207940|NCT01155531|659869|P2|Overall Study|Lost to Follow-up|0
207941|NCT01155531|659870|P1|Overall Study|Lost to Follow-up|0
207942|NCT01155531|659867|P4|Overall Study|Adverse Event|0
207943|NCT01155531|659868|P3|Overall Study|Adverse Event|1
207944|NCT01155531|659869|P2|Overall Study|Adverse Event|0
207945|NCT01155531|659870|P1|Overall Study|Adverse Event|0
207946|NCT01155570|659888|P1|Overall Study|Other Reasons|23
207947|NCT01155570|659888|P1|Overall Study|Participant's Economic Reasons + Other|1
207948|NCT01155570|659888|P1|Overall Study|Adverse Event + Other Reasons|7
207949|NCT01155570|659888|P1|Overall Study|Adverse Event + Lack of Efficacy|2
207950|NCT01155570|659888|P1|Overall Study|No Hospital Visits|7
207951|NCT01155570|659888|P1|Overall Study|Participant's Economic Reasons|17
207952|NCT01155570|659888|P1|Overall Study|Lack of Efficacy|46
207953|NCT01155570|659888|P1|Overall Study|Adverse Event|39
207954|NCT01155726|659918|P4|Period 1, 3 Days (Masked)|Inconvenience|0
207955|NCT01155726|659919|P3|Period 1, 3 Days (Masked)|Inconvenience|2
207956|NCT01155726|659920|P2|Period 1, 3 Days (Masked)|Inconvenience|0
207957|NCT01155726|659921|P1|Period 1, 3 Days (Masked)|Inconvenience|1
207958|NCT01155869|659961|P2|Overall Study|Lost to Follow-up|1
207959|NCT01155869|659962|P1|Overall Study|Lost to Follow-up|3
207960|NCT01156012|659981|P2|Overall Study|Non respect of one of inclusion criteria|1
207961|NCT01156012|659982|P1|Overall Study|Non respect of one of inclusion criteria|2
207962|NCT01156012|659981|P2|Overall Study|use of commercial drug instead of study|1
207963|NCT01156012|659982|P1|Overall Study|use of commercial drug instead of study|0
207964|NCT01156012|659981|P2|Overall Study|Withdrawal by Subject|0
207965|NCT01156012|659982|P1|Overall Study|Withdrawal by Subject|1
207966|NCT01156012|659981|P2|Overall Study|Lost to Follow-up|0
207967|NCT01156012|659982|P1|Overall Study|Lost to Follow-up|1
207968|NCT01156012|659981|P2|Overall Study|Adverse Event|1
207969|NCT01156012|659982|P1|Overall Study|Adverse Event|3
207970|NCT01156051|659990|P2|Overall Study|patient not compliant with protocol|1
207971|NCT01156051|659991|P1|Overall Study|patient not compliant with protocol|0
207972|NCT01156051|659990|P2|Overall Study|Lost to Follow-up|0
207973|NCT01156051|659991|P1|Overall Study|Lost to Follow-up|1
207974|NCT01156116|660005|P2|Overall Study|CPAP intolerance|0
207975|NCT01156116|660006|P1|Overall Study|CPAP intolerance|2
207976|NCT01156116|660005|P2|Overall Study|Withdrawal by Subject|1
207977|NCT01156116|660006|P1|Overall Study|Withdrawal by Subject|3
207978|NCT01156142|660020|P2|Overall Study|Ineligible|1
207979|NCT01156142|660021|P1|Overall Study|Ineligible|0
207980|NCT01156142|660020|P2|Overall Study|Withdrawal by Subject|6
207981|NCT01156142|660021|P1|Overall Study|Withdrawal by Subject|8
207982|NCT01156311|660039|P4|6-month Add-on Therapy Period|Not Specified|2
207983|NCT01156311|660040|P3|6-month Add-on Therapy Period|Not Specified|1
207984|NCT01156311|660041|P2|6-month Add-on Therapy Period|Not Specified|0
207985|NCT01156311|660042|P1|6-month Add-on Therapy Period|Not Specified|0
207986|NCT01156311|660039|P4|6-month Add-on Therapy Period|Physician Decision|0
207987|NCT01156311|660040|P3|6-month Add-on Therapy Period|Physician Decision|1
207988|NCT01156311|660041|P2|6-month Add-on Therapy Period|Physician Decision|0
207989|NCT01156311|660042|P1|6-month Add-on Therapy Period|Physician Decision|0
207990|NCT01156311|660039|P4|6-month Add-on Therapy Period|Disease Activity|2
207991|NCT01156311|660040|P3|6-month Add-on Therapy Period|Disease Activity|1
207992|NCT01156311|660041|P2|6-month Add-on Therapy Period|Disease Activity|0
207993|NCT01156311|660042|P1|6-month Add-on Therapy Period|Disease Activity|0
207994|NCT01156311|660039|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
207995|NCT01156311|660040|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
207996|NCT01156311|660041|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
207997|NCT01156311|660042|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
207998|NCT01156311|660039|P4|6-month Add-on Therapy Period|Adverse Event|6
207999|NCT01156311|660040|P3|6-month Add-on Therapy Period|Adverse Event|7
208000|NCT01156311|660041|P2|6-month Add-on Therapy Period|Adverse Event|0
208001|NCT01156311|660042|P1|6-month Add-on Therapy Period|Adverse Event|0
208002|NCT01156311|660039|P4|2-Month Monotherapy Period|Not specified|0
208003|NCT01156311|660040|P3|2-Month Monotherapy Period|Not specified|0
208004|NCT01156311|660041|P2|2-Month Monotherapy Period|Not specified|0
208005|NCT01156311|660042|P1|2-Month Monotherapy Period|Not specified|1
208006|NCT01156311|660039|P4|2-Month Monotherapy Period|Physician Decision|0
208007|NCT01156311|660040|P3|2-Month Monotherapy Period|Physician Decision|0
208008|NCT01156311|660041|P2|2-Month Monotherapy Period|Physician Decision|1
208009|NCT01156311|660042|P1|2-Month Monotherapy Period|Physician Decision|0
208010|NCT01156311|660039|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
208011|NCT01156311|660040|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
208012|NCT01156311|660041|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
208013|NCT01156311|660042|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
208014|NCT01156363|660064|P1|Overall Study|Unspecified|6
208015|NCT01156363|660064|P1|Overall Study|Refused Treatment|4
208016|NCT01156363|660064|P1|Overall Study|Failure to Return|1
208017|NCT01156363|660064|P1|Overall Study|Insufficient Therapeutic Response|5
208018|NCT01156363|660064|P1|Overall Study|Adverse Event|6
208019|NCT01156376|660087|P3|Overall Study|Withdrawal by Subject|3
208020|NCT01156376|660088|P2|Overall Study|Withdrawal by Subject|0
208021|NCT01156376|660089|P1|Overall Study|Withdrawal by Subject|0
208022|NCT01156376|660087|P3|Overall Study|Adverse Event|1
208023|NCT01156376|660088|P2|Overall Study|Adverse Event|0
208024|NCT01156376|660089|P1|Overall Study|Adverse Event|1
208025|NCT01156480|660312|P2|Overall Study|change in diagnosis|1
208026|NCT01156480|660313|P1|Overall Study|change in diagnosis|0
208027|NCT01156532|660321|P1|Overall Study|Lost to Follow-up|1
208028|NCT01156532|660321|P1|Overall Study|Family Reasons|1
208029|NCT01156792|660394|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
208030|NCT01156792|660394|P1|Overall Study|Withdrawal by Subject|9
208031|NCT01156792|660394|P1|Overall Study|Physician Decision|3
208032|NCT01156792|660394|P1|Overall Study|Lost to Follow-up|3
208033|NCT01156792|660394|P1|Overall Study|Protocol Violation|6
208034|NCT01156792|660394|P1|Overall Study|Lack of Efficacy|36
208035|NCT01156792|660394|P1|Overall Study|Adverse Event|1
208036|NCT01156844|660463|P4|Overall Study|Protocol deviation|0
208037|NCT01156844|660464|P3|Overall Study|Protocol deviation|0
208038|NCT01156844|660465|P2|Overall Study|Protocol deviation|0
208039|NCT01156844|660466|P1|Overall Study|Protocol deviation|2
208040|NCT01156844|660463|P4|Overall Study|Administrative problems|1
208041|NCT01156844|660464|P3|Overall Study|Administrative problems|0
208042|NCT01156844|660465|P2|Overall Study|Administrative problems|1
208043|NCT01156844|660466|P1|Overall Study|Administrative problems|0
208044|NCT01156844|660463|P4|Overall Study|Lost to Follow-up|0
208045|NCT01156844|660464|P3|Overall Study|Lost to Follow-up|1
208046|NCT01156844|660465|P2|Overall Study|Lost to Follow-up|0
208047|NCT01156844|660466|P1|Overall Study|Lost to Follow-up|0
208048|NCT01156844|660463|P4|Overall Study|Withdrawal by Subject|2
208049|NCT01156844|660464|P3|Overall Study|Withdrawal by Subject|2
208050|NCT01156844|660465|P2|Overall Study|Withdrawal by Subject|0
208051|NCT01156844|660466|P1|Overall Study|Withdrawal by Subject|0
208052|NCT01156844|660463|P4|Overall Study|Abnormal test procedure result(s)|2
208053|NCT01156844|660464|P3|Overall Study|Abnormal test procedure result(s)|2
208054|NCT01156844|660465|P2|Overall Study|Abnormal test procedure result(s)|1
208055|NCT01156844|660466|P1|Overall Study|Abnormal test procedure result(s)|0
208056|NCT01156844|660463|P4|Overall Study|Adverse Event|1
208057|NCT01156844|660464|P3|Overall Study|Adverse Event|1
208058|NCT01156844|660465|P2|Overall Study|Adverse Event|0
208059|NCT01156844|660466|P1|Overall Study|Adverse Event|0
208060|NCT01157065|660496|P2|Overall Study|Death|1
208061|NCT01157065|660497|P1|Overall Study|Death|0
208062|NCT01157078|660507|P2|Overall Study|Not specified|4
208063|NCT01157078|660508|P1|Overall Study|Not specified|2
208064|NCT01157078|660507|P2|Overall Study|Lost to Follow-up|5
208065|NCT01157078|660508|P1|Overall Study|Lost to Follow-up|7
208066|NCT01157078|660507|P2|Overall Study|Study-specific withdrawal criteria|2
208067|NCT01157078|660508|P1|Overall Study|Study-specific withdrawal criteria|2
208068|NCT01157078|660507|P2|Overall Study|Lack of Efficacy|0
208069|NCT01157078|660508|P1|Overall Study|Lack of Efficacy|2
208070|NCT01157078|660507|P2|Overall Study|Condition under investigation worsened|1
208071|NCT01157078|660508|P1|Overall Study|Condition under investigation worsened|0
208072|NCT01157078|660507|P2|Overall Study|Severe non-compliance to protocol|4
208073|NCT01157078|660508|P1|Overall Study|Severe non-compliance to protocol|2
208074|NCT01157078|660507|P2|Overall Study|Adverse Event|6
208075|NCT01157078|660508|P1|Overall Study|Adverse Event|6
208076|NCT01157078|660507|P2|Overall Study|Eligibility criteria not fulfilled|0
208077|NCT01157078|660508|P1|Overall Study|Eligibility criteria not fulfilled|2
208078|NCT01157078|660507|P2|Overall Study|Withdrawal by Subject|14
208079|NCT01157078|660508|P1|Overall Study|Withdrawal by Subject|12
208080|NCT01157117|660559|P3|Overall Study|Unknown (Pending Final Form Submission)|13
208081|NCT01157117|660560|P2|Overall Study|Unknown (Pending Final Form Submission)|5
208082|NCT01157117|660561|P1|Overall Study|Unknown (Pending Final Form Submission)|4
208083|NCT01157117|660559|P3|Overall Study|Lost to Follow-up|1
208084|NCT01157117|660560|P2|Overall Study|Lost to Follow-up|0
208085|NCT01157117|660561|P1|Overall Study|Lost to Follow-up|0
208086|NCT01157117|660559|P3|Overall Study|Lack of Efficacy|0
208087|NCT01157117|660560|P2|Overall Study|Lack of Efficacy|1
208088|NCT01157117|660561|P1|Overall Study|Lack of Efficacy|1
208089|NCT01157117|660559|P3|Overall Study|Withdrawal by Subject|1
208090|NCT01157117|660560|P2|Overall Study|Withdrawal by Subject|1
208091|NCT01157117|660561|P1|Overall Study|Withdrawal by Subject|4
208092|NCT01157117|660559|P3|Overall Study|Dosing Symptoms|0
208093|NCT01157117|660560|P2|Overall Study|Dosing Symptoms|4
208094|NCT01157117|660561|P1|Overall Study|Dosing Symptoms|0
208095|NCT01157169|660602|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
208096|NCT01157169|660603|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
208097|NCT01157169|660602|P2|First Intervention|Emesis Within 4 hrs of Administration|2
208098|NCT01157169|660603|P1|First Intervention|Emesis Within 4 hrs of Administration|4
208099|NCT01157169|660602|P2|First Intervention|Protocol Violation|0
208100|NCT01157169|660603|P1|First Intervention|Protocol Violation|0
208101|NCT01157182|660621|P2|Washout of 28 Days|Adverse Event|0
208102|NCT01157182|660622|P1|Washout of 28 Days|Adverse Event|2
208103|NCT01150097|660671|P3|Months 24 to 48 Post-transplantation|Death|0
208104|NCT01150097|660672|P2|Months 24 to 48 Post-transplantation|Death|0
208105|NCT01150097|660673|P1|Months 24 to 48 Post-transplantation|Death|2
208106|NCT01150097|660671|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
208107|NCT01150097|660672|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
208108|NCT01150097|660673|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
208109|NCT01150097|660671|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
208110|NCT01150097|660672|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
208111|NCT01150097|660673|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
208112|NCT01150097|660671|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
208113|NCT01150097|660672|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
208114|NCT01150097|660673|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
208115|NCT01150097|660671|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
208116|NCT01150097|660672|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
208117|NCT01150097|660673|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
208118|NCT01150097|660671|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
208119|NCT01150097|660672|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
208120|NCT01150097|660673|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
208121|NCT01150097|660671|P3|Months 24 to 36 Post-transplantation|Death|0
208122|NCT01150097|660672|P2|Months 24 to 36 Post-transplantation|Death|0
208123|NCT01150097|660673|P1|Months 24 to 36 Post-transplantation|Death|2
208124|NCT01150123|660714|P18|Overall Study|Lost to Follow-up|0
208125|NCT01150123|660715|P17|Overall Study|Lost to Follow-up|0
208126|NCT01150123|660716|P16|Overall Study|Lost to Follow-up|0
208127|NCT01150123|660717|P15|Overall Study|Lost to Follow-up|0
208128|NCT01150123|660718|P14|Overall Study|Lost to Follow-up|0
208129|NCT01150123|660719|P13|Overall Study|Lost to Follow-up|2
208130|NCT01150123|660720|P12|Overall Study|Lost to Follow-up|1
208131|NCT01150123|660721|P11|Overall Study|Lost to Follow-up|1
208132|NCT01150123|660722|P10|Overall Study|Lost to Follow-up|1
208133|NCT01150123|660723|P9|Overall Study|Lost to Follow-up|3
208134|NCT01150123|660724|P8|Overall Study|Lost to Follow-up|0
208135|NCT01150123|660725|P7|Overall Study|Lost to Follow-up|0
208136|NCT01150123|660726|P6|Overall Study|Lost to Follow-up|5
208137|NCT01150123|660727|P5|Overall Study|Lost to Follow-up|2
208138|NCT01150123|660728|P4|Overall Study|Lost to Follow-up|2
208139|NCT01150123|660729|P3|Overall Study|Lost to Follow-up|2
208140|NCT01150123|660730|P2|Overall Study|Lost to Follow-up|1
208141|NCT01150123|660731|P1|Overall Study|Lost to Follow-up|2
208142|NCT01150123|660714|P18|Overall Study|Withdrawal by Subject|1
208143|NCT01150123|660715|P17|Overall Study|Withdrawal by Subject|0
208144|NCT01150123|660716|P16|Overall Study|Withdrawal by Subject|1
208145|NCT01150123|660717|P15|Overall Study|Withdrawal by Subject|0
208146|NCT01150123|660718|P14|Overall Study|Withdrawal by Subject|0
208147|NCT01150123|660719|P13|Overall Study|Withdrawal by Subject|1
208148|NCT01150123|660720|P12|Overall Study|Withdrawal by Subject|0
208149|NCT01150123|660721|P11|Overall Study|Withdrawal by Subject|1
208150|NCT01150123|660722|P10|Overall Study|Withdrawal by Subject|0
208151|NCT01150123|660723|P9|Overall Study|Withdrawal by Subject|2
208152|NCT01150123|660724|P8|Overall Study|Withdrawal by Subject|3
208153|NCT01150123|660725|P7|Overall Study|Withdrawal by Subject|0
208154|NCT01150123|660726|P6|Overall Study|Withdrawal by Subject|1
208155|NCT01150123|660727|P5|Overall Study|Withdrawal by Subject|1
208156|NCT01150123|660728|P4|Overall Study|Withdrawal by Subject|1
208157|NCT01150123|660729|P3|Overall Study|Withdrawal by Subject|2
208158|NCT01150123|660730|P2|Overall Study|Withdrawal by Subject|1
208159|NCT01150123|660731|P1|Overall Study|Withdrawal by Subject|1
208160|NCT01150357|660907|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
208161|NCT01150357|660908|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
208162|NCT01150357|660909|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
208163|NCT01150357|660907|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
208164|NCT01150357|660908|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
208165|NCT01150357|660909|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
208166|NCT01150357|660907|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
208167|NCT01150357|660908|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
208168|NCT01150357|660909|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
208169|NCT01150357|660907|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
208170|NCT01150357|660908|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
208171|NCT01150357|660909|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
208172|NCT01150357|660907|P3|Dose Response Phase (Phase 1)|Adverse Event|1
208173|NCT01150357|660908|P2|Dose Response Phase (Phase 1)|Adverse Event|0
208174|NCT01150357|660909|P1|Dose Response Phase (Phase 1)|Adverse Event|0
208175|NCT01150357|660907|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
208176|NCT01150357|660908|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
208177|NCT01150357|660909|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
208178|NCT01150357|660907|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
208179|NCT01150357|660908|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
208180|NCT01150357|660909|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
208181|NCT01150474|660993|P2|Overall Study|Surgery Changed|0
208182|NCT01150474|660994|P1|Overall Study|Surgery Changed|1
208183|NCT01150474|660993|P2|Overall Study|Drug not administered|0
208184|NCT01150474|660994|P1|Overall Study|Drug not administered|1
208185|NCT01150474|660993|P2|Overall Study|Drug did not arrive in time|0
208186|NCT01150474|660994|P1|Overall Study|Drug did not arrive in time|1
208187|NCT01150474|660993|P2|Overall Study|Rectotomy|0
208188|NCT01150474|660994|P1|Overall Study|Rectotomy|1
208189|NCT01150474|660993|P2|Overall Study|Multiple Studies|1
208190|NCT01150474|660994|P1|Overall Study|Multiple Studies|0
208191|NCT01150474|660993|P2|Overall Study|Cancer found|0
208192|NCT01150474|660994|P1|Overall Study|Cancer found|1
208193|NCT01150474|660993|P2|Overall Study|Withdrawal by Subject|2
208194|NCT01150474|660994|P1|Overall Study|Withdrawal by Subject|5
208195|NCT01151020|661088|P1|Overall Study|Still be eligible for follow-up|79
208196|NCT01151020|661088|P1|Overall Study|Patients did not receive the device|2
208197|NCT01151020|661088|P1|Overall Study|Withdrawal by Subject|12
208198|NCT01151020|661088|P1|Overall Study|Lost to Follow-up|1
208199|NCT01151020|661088|P1|Overall Study|Conversion to open repair|1
208200|NCT01151020|661088|P1|Overall Study|Death|15
208201|NCT01151085|661108|P1|Overall Study|Protocol Violation|25
208202|NCT01151085|661108|P1|Overall Study|Lost to Follow-up|31
208203|NCT01151098|661124|P1|Overall Study|Miscellaneous|13
208204|NCT01151098|661124|P1|Overall Study|Protocol Violation|1
208205|NCT01151098|661124|P1|Overall Study|Lack of Efficacy|15
208206|NCT01151098|661124|P1|Overall Study|Lost to Follow-up|6
208207|NCT01151098|661124|P1|Overall Study|Adverse Event|82
208208|NCT01151137|661130|P2|Overall Study|Lost to Follow-up|1
208209|NCT01151137|661131|P1|Overall Study|Lost to Follow-up|1
208210|NCT01151137|661130|P2|Overall Study|Death|27
208211|NCT01151137|661131|P1|Overall Study|Death|15
208212|NCT01151215|661177|P3|Overall Study|Safety as judged by the investigator|1
208213|NCT01151215|661178|P2|Overall Study|Safety as judged by the investigator|0
208214|NCT01151215|661179|P1|Overall Study|Safety as judged by the investigator|0
208215|NCT01151215|661177|P3|Overall Study|Disease progression|1
208216|NCT01151215|661178|P2|Overall Study|Disease progression|1
208217|NCT01151215|661179|P1|Overall Study|Disease progression|0
208218|NCT01151215|661177|P3|Overall Study|Withdrawal by Subject|2
208219|NCT01151215|661178|P2|Overall Study|Withdrawal by Subject|1
208220|NCT01151215|661179|P1|Overall Study|Withdrawal by Subject|3
208221|NCT01151215|661177|P3|Overall Study|Lost to Follow-up|3
208222|NCT01151215|661178|P2|Overall Study|Lost to Follow-up|0
208223|NCT01151215|661179|P1|Overall Study|Lost to Follow-up|0
208224|NCT01151215|661177|P3|Overall Study|Death|11
208225|NCT01151215|661178|P2|Overall Study|Death|20
208226|NCT01151215|661179|P1|Overall Study|Death|16
208227|NCT01151215|661177|P3|Overall Study|Worsening of condition under study|1
208228|NCT01151215|661178|P2|Overall Study|Worsening of condition under study|1
208229|NCT01151215|661179|P1|Overall Study|Worsening of condition under study|1
208230|NCT01151280|661190|P1|Overall Study|Lack of Efficacy|3
208231|NCT01151280|661190|P1|Overall Study|Adverse Event|1
208232|NCT01151345|661200|P2|First Intervention Period|Protocol Violation|1
208233|NCT01151345|661201|P1|First Intervention Period|Protocol Violation|0
208234|NCT01151410|661251|P2|Overall Study|Abnormal laboratory value(s)|1
208235|NCT01151410|661252|P1|Overall Study|Abnormal laboratory value(s)|0
208236|NCT01151410|661251|P2|Overall Study|Unsatisfactory therapeutic effect|1
208237|NCT01151410|661252|P1|Overall Study|Unsatisfactory therapeutic effect|1
208238|NCT01151410|661251|P2|Overall Study|Administrative problems|1
208239|NCT01151410|661252|P1|Overall Study|Administrative problems|1
208240|NCT01151410|661251|P2|Overall Study|Protocol deviation|1
208241|NCT01151410|661252|P1|Overall Study|Protocol deviation|2
208242|NCT01151410|661251|P2|Overall Study|Adverse Event|2
208243|NCT01151410|661252|P1|Overall Study|Adverse Event|1
208244|NCT01151410|661251|P2|Overall Study|Lost to Follow-up|4
208245|NCT01151410|661252|P1|Overall Study|Lost to Follow-up|3
208246|NCT01151410|661251|P2|Overall Study|Withdrawal by Subject|5
208247|NCT01151410|661252|P1|Overall Study|Withdrawal by Subject|3
208248|NCT01151579|661306|P2|Overall Study|Not meet inclusion criteria|4
208249|NCT01151579|661307|P1|Overall Study|Not meet inclusion criteria|6
208250|NCT01151579|661306|P2|Overall Study|Withdrawal by Subject|2
208251|NCT01151579|661307|P1|Overall Study|Withdrawal by Subject|3
208252|NCT01151579|661306|P2|Overall Study|Physician Decision|1
208253|NCT01151579|661307|P1|Overall Study|Physician Decision|3
208254|NCT01157234|661319|P2|Overall Study|Withdrawal by Subject|0
208255|NCT01157234|661320|P1|Overall Study|Withdrawal by Subject|1
208256|NCT01157351|661352|P2|Overall Study|Randomized but not Treated|2
208257|NCT01157351|661353|P1|Overall Study|Randomized but not Treated|4
208258|NCT01157351|661352|P2|Overall Study|Noncompliance with Study Drug|3
208259|NCT01157351|661353|P1|Overall Study|Noncompliance with Study Drug|0
208260|NCT01157351|661352|P2|Overall Study|Unspecified|36
208261|NCT01157351|661353|P1|Overall Study|Unspecified|32
208262|NCT01157351|661352|P2|Overall Study|Protocol Violation|1
208263|NCT01157351|661353|P1|Overall Study|Protocol Violation|0
208264|NCT01157351|661352|P2|Overall Study|Physician Decision|4
208265|NCT01157351|661353|P1|Overall Study|Physician Decision|5
208266|NCT01157351|661352|P2|Overall Study|Withdrawal by Subject|27
208267|NCT01157351|661353|P1|Overall Study|Withdrawal by Subject|37
208268|NCT01157351|661352|P2|Overall Study|Lost to Follow-up|55
208269|NCT01157351|661353|P1|Overall Study|Lost to Follow-up|53
208270|NCT01157351|661352|P2|Overall Study|Death|0
208271|NCT01157351|661353|P1|Overall Study|Death|1
208272|NCT01157351|661352|P2|Overall Study|Adverse Event|4
208273|NCT01157351|661353|P1|Overall Study|Adverse Event|5
208274|NCT01157377|661376|P7|Overall Study|Other Miscellaneous Reasons|1
208275|NCT01157377|661377|P6|Overall Study|Other Miscellaneous Reasons|1
208276|NCT01157377|661378|P5|Overall Study|Other Miscellaneous Reasons|1
208277|NCT01157377|661379|P4|Overall Study|Other Miscellaneous Reasons|0
208278|NCT01157377|661380|P3|Overall Study|Other Miscellaneous Reasons|0
208279|NCT01157377|661381|P2|Overall Study|Other Miscellaneous Reasons|2
208280|NCT01157377|661382|P1|Overall Study|Other Miscellaneous Reasons|0
208281|NCT01157377|661376|P7|Overall Study|Lack of Efficacy|1
208282|NCT01157377|661377|P6|Overall Study|Lack of Efficacy|0
208283|NCT01157377|661378|P5|Overall Study|Lack of Efficacy|0
208284|NCT01157377|661379|P4|Overall Study|Lack of Efficacy|0
208285|NCT01157377|661380|P3|Overall Study|Lack of Efficacy|0
208286|NCT01157377|661381|P2|Overall Study|Lack of Efficacy|0
208287|NCT01157377|661382|P1|Overall Study|Lack of Efficacy|0
208288|NCT01157377|661376|P7|Overall Study|Protocol Violation|0
208289|NCT01157377|661377|P6|Overall Study|Protocol Violation|1
208290|NCT01157377|661378|P5|Overall Study|Protocol Violation|0
208291|NCT01157377|661379|P4|Overall Study|Protocol Violation|0
208292|NCT01157377|661380|P3|Overall Study|Protocol Violation|0
208293|NCT01157377|661381|P2|Overall Study|Protocol Violation|0
208294|NCT01157377|661382|P1|Overall Study|Protocol Violation|0
208295|NCT01157377|661376|P7|Overall Study|Personal Reasons|0
208296|NCT01157377|661377|P6|Overall Study|Personal Reasons|0
208297|NCT01157377|661378|P5|Overall Study|Personal Reasons|0
208298|NCT01157377|661379|P4|Overall Study|Personal Reasons|1
208299|NCT01157377|661380|P3|Overall Study|Personal Reasons|0
208300|NCT01157377|661381|P2|Overall Study|Personal Reasons|1
208301|NCT01157377|661382|P1|Overall Study|Personal Reasons|2
208302|NCT01157377|661376|P7|Overall Study|Lost to Follow-up|0
208303|NCT01157377|661377|P6|Overall Study|Lost to Follow-up|1
208304|NCT01157377|661378|P5|Overall Study|Lost to Follow-up|1
208305|NCT01157377|661379|P4|Overall Study|Lost to Follow-up|0
208306|NCT01157377|661380|P3|Overall Study|Lost to Follow-up|1
208307|NCT01157377|661381|P2|Overall Study|Lost to Follow-up|0
208308|NCT01157377|661382|P1|Overall Study|Lost to Follow-up|0
208309|NCT01157845|661420|P1|Overall Study|Device malfunction|1
208310|NCT01157845|661420|P1|Overall Study|Study was ended|1
208311|NCT01157845|661420|P1|Overall Study|Protocol Violation|13
208312|NCT01157845|661420|P1|Overall Study|Physician Decision|3
208313|NCT01157845|661420|P1|Overall Study|Withdrawal by Subject|12
208314|NCT01157845|661420|P1|Overall Study|Lost to Follow-up|5
208315|NCT01158118|661427|P2|Overall Study|Death|1
208316|NCT01158118|661428|P1|Overall Study|Death|0
208317|NCT01158118|661427|P2|Overall Study|Suffered stroke prior to transplant|1
208318|NCT01158118|661428|P1|Overall Study|Suffered stroke prior to transplant|0
208319|NCT01158118|661427|P2|Overall Study|Donor match was a screen failure|1
208320|NCT01158118|661428|P1|Overall Study|Donor match was a screen failure|0
208321|NCT01158118|661427|P2|Overall Study|Screen failure|0
208322|NCT01158118|661428|P1|Overall Study|Screen failure|1
208323|NCT01158261|661444|P1|Overall Study|Withdrawal by Subject|1
208324|NCT01158261|661444|P1|Overall Study|Death|7
208325|NCT01158261|661444|P1|Overall Study|Lost to Follow-up|9
208326|NCT01158378|661450|P2|Overall Study|Withdrawal by Subject|0
208327|NCT01158378|661451|P1|Overall Study|Withdrawal by Subject|4
208328|NCT01158378|661450|P2|Overall Study|Lost to Follow-up|4
208329|NCT01158378|661451|P1|Overall Study|Lost to Follow-up|2
208330|NCT01158378|661450|P2|Overall Study|Death|5
208331|NCT01158378|661451|P1|Overall Study|Death|4
208332|NCT01158534|661463|P1|Overall Study|Other|1
208333|NCT01158534|661463|P1|Overall Study|Death|1
208334|NCT01158534|661463|P1|Overall Study|Withdrawal by Subject|1
208335|NCT01158924|661501|P2|Overall Study|Lost to Follow-up|1
208336|NCT01158924|661502|P1|Overall Study|Lost to Follow-up|0
208337|NCT01158924|661501|P2|Overall Study|Withdrawal by Subject|2
208338|NCT01158924|661502|P1|Overall Study|Withdrawal by Subject|1
208339|NCT01159171|661528|P1|Overall Study|Death|1
208340|NCT01159171|661528|P1|Overall Study|Medical Decision|4
208341|NCT01159171|661528|P1|Overall Study|Need for Surgery|5
208342|NCT01159171|661528|P1|Overall Study|Protocol Violation|1
208343|NCT01159171|661528|P1|Overall Study|Progression of Disease|28
208344|NCT01159171|661528|P1|Overall Study|Adverse Event|11
208345|NCT01159431|661582|P2|Overall Study|Lack of Efficacy|3
208346|NCT01159431|661583|P1|Overall Study|Lack of Efficacy|0
208347|NCT01159431|661582|P2|Overall Study|non-compliance|1
208348|NCT01159431|661583|P1|Overall Study|non-compliance|1
208349|NCT01159431|661582|P2|Overall Study|Adverse Event|2
208350|NCT01159431|661583|P1|Overall Study|Adverse Event|1
208351|NCT01159574|661612|P1|Follow Up Phase|still being followed for overall surviva|18
208352|NCT01159574|661612|P1|Follow Up Phase|Lost to Follow-up|2
208353|NCT01159574|661612|P1|Treatment Phase|still on treatment|2
208354|NCT01159574|661612|P1|Treatment Phase|Withdrawal by Subject|7
208355|NCT01159574|661612|P1|Treatment Phase|Physician Decision|2
208356|NCT01159574|661612|P1|Treatment Phase|Death|6
208357|NCT01159574|661612|P1|Treatment Phase|Adverse Event|3
208358|NCT01159574|661612|P1|Treatment Phase|non-evaluable/not included in analysis|1
208359|NCT01159600|661626|P8|Overall Study|Other reason not defined above|3
208360|NCT01159600|661627|P7|Overall Study|Other reason not defined above|3
208361|NCT01159600|661628|P6|Overall Study|Other reason not defined above|7
208362|NCT01159600|661629|P5|Overall Study|Other reason not defined above|5
208363|NCT01159600|661630|P4|Overall Study|Other reason not defined above|2
208364|NCT01159600|661631|P3|Overall Study|Other reason not defined above|4
208365|NCT01159600|661632|P2|Overall Study|Other reason not defined above|0
208366|NCT01159600|661633|P1|Overall Study|Other reason not defined above|3
208367|NCT01159600|661626|P8|Overall Study|Patient refusal to continue,not due toAE|5
208368|NCT01159600|661627|P7|Overall Study|Patient refusal to continue,not due toAE|2
208369|NCT01159600|661628|P6|Overall Study|Patient refusal to continue,not due toAE|4
208370|NCT01159600|661629|P5|Overall Study|Patient refusal to continue,not due toAE|4
208371|NCT01159600|661630|P4|Overall Study|Patient refusal to continue,not due toAE|5
208372|NCT01159600|661631|P3|Overall Study|Patient refusal to continue,not due toAE|4
208373|NCT01159600|661632|P2|Overall Study|Patient refusal to continue,not due toAE|2
208374|NCT01159600|661633|P1|Overall Study|Patient refusal to continue,not due toAE|7
208375|NCT01159600|661626|P8|Overall Study|Lost to Follow-up|2
208376|NCT01159600|661627|P7|Overall Study|Lost to Follow-up|3
208377|NCT01159600|661628|P6|Overall Study|Lost to Follow-up|0
208378|NCT01159600|661629|P5|Overall Study|Lost to Follow-up|3
208379|NCT01159600|661630|P4|Overall Study|Lost to Follow-up|3
208380|NCT01159600|661631|P3|Overall Study|Lost to Follow-up|4
208381|NCT01159600|661632|P2|Overall Study|Lost to Follow-up|3
208382|NCT01159600|661633|P1|Overall Study|Lost to Follow-up|2
208383|NCT01159600|661626|P8|Overall Study|Non compliant with protocol|0
208384|NCT01159600|661627|P7|Overall Study|Non compliant with protocol|2
208385|NCT01159600|661628|P6|Overall Study|Non compliant with protocol|0
208386|NCT01159600|661629|P5|Overall Study|Non compliant with protocol|2
208387|NCT01159600|661630|P4|Overall Study|Non compliant with protocol|0
208388|NCT01159600|661631|P3|Overall Study|Non compliant with protocol|0
208389|NCT01159600|661632|P2|Overall Study|Non compliant with protocol|1
208390|NCT01159600|661633|P1|Overall Study|Non compliant with protocol|2
208391|NCT01159600|661626|P8|Overall Study|Lack of Efficacy|1
208392|NCT01159600|661627|P7|Overall Study|Lack of Efficacy|0
208393|NCT01159600|661628|P6|Overall Study|Lack of Efficacy|0
208394|NCT01159600|661629|P5|Overall Study|Lack of Efficacy|2
208395|NCT01159600|661630|P4|Overall Study|Lack of Efficacy|0
208396|NCT01159600|661631|P3|Overall Study|Lack of Efficacy|0
208397|NCT01159600|661632|P2|Overall Study|Lack of Efficacy|0
208398|NCT01159600|661633|P1|Overall Study|Lack of Efficacy|0
208399|NCT01159600|661626|P8|Overall Study|Adverse Event|5
208400|NCT01159600|661627|P7|Overall Study|Adverse Event|7
208401|NCT01159600|661628|P6|Overall Study|Adverse Event|6
208402|NCT01159600|661629|P5|Overall Study|Adverse Event|8
208403|NCT01159600|661630|P4|Overall Study|Adverse Event|1
208404|NCT01159600|661631|P3|Overall Study|Adverse Event|5
208405|NCT01159600|661632|P2|Overall Study|Adverse Event|2
208406|NCT01159600|661633|P1|Overall Study|Adverse Event|7
208407|NCT01159600|661626|P8|Overall Study|Not treated|2
208408|NCT01159600|661627|P7|Overall Study|Not treated|2
208409|NCT01159600|661628|P6|Overall Study|Not treated|1
208410|NCT01159600|661629|P5|Overall Study|Not treated|0
208411|NCT01159600|661630|P4|Overall Study|Not treated|0
208412|NCT01159600|661631|P3|Overall Study|Not treated|1
208413|NCT01159600|661632|P2|Overall Study|Not treated|0
208414|NCT01159600|661633|P1|Overall Study|Not treated|0
208415|NCT01159665|661681|P6|Overall Study|Withdrawal by Subject|0
208416|NCT01159665|661682|P5|Overall Study|Withdrawal by Subject|0
208417|NCT01159665|661683|P4|Overall Study|Withdrawal by Subject|0
208418|NCT01159665|661684|P3|Overall Study|Withdrawal by Subject|0
208419|NCT01159665|661685|P2|Overall Study|Withdrawal by Subject|1
208420|NCT01159665|661686|P1|Overall Study|Withdrawal by Subject|0
208421|NCT01159691|661706|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
208422|NCT01159691|661706|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
208423|NCT01159691|661706|P1|Overall Study|Disc. Neupro other & unknown reasons|7
208424|NCT01159691|661706|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
208425|NCT01159691|661706|P1|Overall Study|Discontinued Neupro due to other reasons|1
208426|NCT01159691|661706|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
208427|NCT01159691|661706|P1|Overall Study|Unknown reasons|1
208428|NCT01159691|661706|P1|Overall Study|Lost to Follow-up|2
208429|NCT01159769|661728|P1|Overall Study|Adverse Event|1
208430|NCT01159912|661736|P3|Overall Study|Withdrawal by Subject|3
208431|NCT01159912|661737|P2|Overall Study|Withdrawal by Subject|3
208432|NCT01159912|661738|P1|Overall Study|Withdrawal by Subject|10
208433|NCT01159912|661736|P3|Overall Study|Physician Decision|3
208434|NCT01159912|661737|P2|Overall Study|Physician Decision|0
208435|NCT01159912|661738|P1|Overall Study|Physician Decision|0
208436|NCT01159912|661736|P3|Overall Study|Lost to Follow-up|0
208437|NCT01159912|661737|P2|Overall Study|Lost to Follow-up|0
208438|NCT01159912|661738|P1|Overall Study|Lost to Follow-up|4
208439|NCT01159912|661736|P3|Overall Study|Protocol Violation|3
208440|NCT01159912|661737|P2|Overall Study|Protocol Violation|2
208441|NCT01159912|661738|P1|Overall Study|Protocol Violation|1
208442|NCT01159912|661736|P3|Overall Study|Lack of Efficacy|14
208443|NCT01159912|661737|P2|Overall Study|Lack of Efficacy|15
208444|NCT01159912|661738|P1|Overall Study|Lack of Efficacy|23
208445|NCT01159912|661736|P3|Overall Study|Adverse Event|3
208446|NCT01159912|661737|P2|Overall Study|Adverse Event|2
208447|NCT01159912|661738|P1|Overall Study|Adverse Event|2
208448|NCT01159938|661764|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
208449|NCT01159938|661765|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
208450|NCT01159938|661766|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
208451|NCT01159938|661767|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
208452|NCT01159938|661768|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
208453|NCT01154452|661860|P4|Phase II|Adverse Event|4
208454|NCT01154452|661861|P3|Phase II|Adverse Event|4
208455|NCT01154452|661862|P2|Phase II|Adverse Event|0
208456|NCT01154452|661863|P1|Phase II|Adverse Event|0
208457|NCT01154452|661860|P4|Phase II|Withdrawal by Subject|2
208458|NCT01154452|661861|P3|Phase II|Withdrawal by Subject|1
208459|NCT01154452|661862|P2|Phase II|Withdrawal by Subject|0
208460|NCT01154452|661863|P1|Phase II|Withdrawal by Subject|0
208461|NCT01154452|661860|P4|Phase Ib|Adverse Event|0
208462|NCT01154452|661861|P3|Phase Ib|Adverse Event|0
208463|NCT01154452|661862|P2|Phase Ib|Adverse Event|1
208464|NCT01154452|661863|P1|Phase Ib|Adverse Event|2
208465|NCT01154452|661860|P4|Phase Ib|Not Treated|0
208466|NCT01154452|661861|P3|Phase Ib|Not Treated|0
208467|NCT01154452|661862|P2|Phase Ib|Not Treated|0
208468|NCT01154452|661863|P1|Phase Ib|Not Treated|1
208469|NCT01154673|661921|P2|Overall Study|moved out of province|0
208470|NCT01154673|661922|P1|Overall Study|moved out of province|1
208471|NCT01154673|661921|P2|Overall Study|Lost to Follow-up|0
208472|NCT01154673|661922|P1|Overall Study|Lost to Follow-up|1
208473|NCT01160484|662010|P1|Overall Study|inclusion/exclusion criteria failure|1
208474|NCT01160484|662010|P1|Overall Study|Withdrawal by Subject|2
208475|NCT01160484|662010|P1|Overall Study|Adverse Event|6
208476|NCT01160484|662010|P1|Overall Study|Lack of Efficacy|9
208477|NCT01160614|662022|P2|Overall Study|Withdrawal by Subject|2
208478|NCT01160614|662023|P1|Overall Study|Withdrawal by Subject|0
208479|NCT01160640|662073|P2|Overall Study|Withdrawal by Subject|3
208480|NCT01160640|662074|P1|Overall Study|Withdrawal by Subject|0
208481|NCT01160640|662073|P2|Overall Study|Incarceration|0
208482|NCT01160640|662074|P1|Overall Study|Incarceration|1
208483|NCT01160640|662073|P2|Overall Study|Physician Decision|3
208484|NCT01160640|662074|P1|Overall Study|Physician Decision|3
208485|NCT01161407|662101|P2|Overall Study|Protocol Violation|1
208486|NCT01161407|662102|P1|Overall Study|Protocol Violation|3
208487|NCT01161446|662126|P2|Overall Study|Withdrawal by Subject|1
208488|NCT01161446|662127|P1|Overall Study|Withdrawal by Subject|0
208489|NCT01161446|662126|P2|Overall Study|Lost to Follow-up|14
208490|NCT01161446|662127|P1|Overall Study|Lost to Follow-up|18
208491|NCT01161472|662139|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
208492|NCT01161472|662140|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
208493|NCT01161472|662141|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
208494|NCT01161472|662142|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
208495|NCT01161498|662198|P2|Overall Study|Disease Progression|1
208496|NCT01161498|662199|P1|Overall Study|Disease Progression|0
208497|NCT01161537|662223|P1|Part B|Withdrawal by Subject|2
208498|NCT01161628|662250|P1|Overall Study|Lack of Efficacy|2
208499|NCT01161628|662250|P1|Overall Study|Death|6
208500|NCT01162122|662277|P2|Overall Study|Missing primary reason|0
208501|NCT01162122|662278|P1|Overall Study|Missing primary reason|1
208502|NCT01162122|662277|P2|Overall Study|Unable to classify|7
208503|NCT01162122|662278|P1|Overall Study|Unable to classify|3
208504|NCT01162122|662277|P2|Overall Study|Administrative reason|1
208505|NCT01162122|662278|P1|Overall Study|Administrative reason|1
208506|NCT01162122|662277|P2|Overall Study|Inappropriate enrollment|4
208507|NCT01162122|662278|P1|Overall Study|Inappropriate enrollment|5
208508|NCT01162122|662277|P2|Overall Study|Protocol Violation|2
208509|NCT01162122|662278|P1|Overall Study|Protocol Violation|2
208510|NCT01162122|662277|P2|Overall Study|Death|46
208511|NCT01162122|662278|P1|Overall Study|Death|51
208512|NCT01162122|662277|P2|Overall Study|Adverse Event|2
208513|NCT01162122|662278|P1|Overall Study|Adverse Event|3
208514|NCT01162122|662277|P2|Overall Study|Lost to Follow-up|91
208515|NCT01162122|662278|P1|Overall Study|Lost to Follow-up|73
208516|NCT01162122|662277|P2|Overall Study|Withdrawal by Subject|43
208517|NCT01162122|662278|P1|Overall Study|Withdrawal by Subject|52
208518|NCT01162135|662335|P1|Overall Study|Ineligible|1
208519|NCT01162135|662335|P1|Overall Study|Severe back pain|1
208520|NCT01162135|662335|P1|Overall Study|Withdrawal by Subject|1
208521|NCT01162304|662339|P1|Overall Study|Beck scale to high|11
208522|NCT01162421|662366|P2|Overall Study|Not specified|3
208523|NCT01162421|662367|P1|Overall Study|Not specified|2
208524|NCT01162421|662366|P2|Overall Study|Lack of Efficacy|2
208525|NCT01162421|662367|P1|Overall Study|Lack of Efficacy|2
208526|NCT01162421|662366|P2|Overall Study|Lost to Follow-up|2
208527|NCT01162421|662367|P1|Overall Study|Lost to Follow-up|0
208528|NCT01162421|662366|P2|Overall Study|Adverse Event|5
208529|NCT01162421|662367|P1|Overall Study|Adverse Event|2
208530|NCT01162421|662366|P2|Overall Study|Did not receive study drug|1
208531|NCT01162421|662367|P1|Overall Study|Did not receive study drug|2
208532|NCT01162473|662447|P2|Overall Study|Withdrawal by Subject|4
208533|NCT01162473|662448|P1|Overall Study|Withdrawal by Subject|0
208534|NCT01162473|662447|P2|Overall Study|Adverse Event|1
208535|NCT01162473|662448|P1|Overall Study|Adverse Event|2
208536|NCT01162499|662454|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
208537|NCT01162499|662455|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
208538|NCT01162863|662489|P3|Overall Study|Adverse Event|0
208539|NCT01162863|662490|P2|Overall Study|Adverse Event|1
208540|NCT01162863|662491|P1|Overall Study|Adverse Event|0
208541|NCT01162863|662489|P3|Overall Study|Lack of Efficacy|0
208542|NCT01162863|662490|P2|Overall Study|Lack of Efficacy|0
208543|NCT01162863|662491|P1|Overall Study|Lack of Efficacy|1
208544|NCT01163032|662508|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
208545|NCT01163032|662509|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
208546|NCT01163032|662510|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
208547|NCT01163032|662508|P3|Open Label Extension Phase|Study Termination|7
208548|NCT01163032|662509|P2|Open Label Extension Phase|Study Termination|0
208549|NCT01163032|662510|P1|Open Label Extension Phase|Study Termination|0
208550|NCT01163032|662508|P3|Open Label Extension Phase|Protocol Violation|1
208551|NCT01163032|662509|P2|Open Label Extension Phase|Protocol Violation|0
208552|NCT01163032|662510|P1|Open Label Extension Phase|Protocol Violation|0
208553|NCT01163032|662508|P3|Open Label Extension Phase|Withdrawal by Subject|3
208554|NCT01163032|662509|P2|Open Label Extension Phase|Withdrawal by Subject|0
208555|NCT01163032|662510|P1|Open Label Extension Phase|Withdrawal by Subject|0
208556|NCT01163032|662508|P3|Open Label Extension Phase|Adverse Event|3
208557|NCT01163032|662509|P2|Open Label Extension Phase|Adverse Event|0
208558|NCT01163032|662510|P1|Open Label Extension Phase|Adverse Event|0
208559|NCT01163032|662508|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
208560|NCT01163032|662509|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
208561|NCT01163032|662510|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
208562|NCT01163032|662508|P3|Randomization Phase|Various*|0
208563|NCT01163032|662509|P2|Randomization Phase|Various*|4
208564|NCT01163032|662510|P1|Randomization Phase|Various*|5
208565|NCT01163032|662508|P3|Randomization Phase|Protocol Violation|0
208566|NCT01163032|662509|P2|Randomization Phase|Protocol Violation|1
208567|NCT01163032|662510|P1|Randomization Phase|Protocol Violation|0
208568|NCT01163032|662508|P3|Randomization Phase|Adverse Event|0
208569|NCT01163032|662509|P2|Randomization Phase|Adverse Event|3
208570|NCT01163032|662510|P1|Randomization Phase|Adverse Event|3
208571|NCT01163032|662508|P3|Randomization Phase|Withdrawal by Subject|0
208572|NCT01163032|662509|P2|Randomization Phase|Withdrawal by Subject|3
208573|NCT01163032|662510|P1|Randomization Phase|Withdrawal by Subject|2
208574|NCT01163253|662622|P2|Overall Study|Other Unspecified|34
208575|NCT01163253|662623|P1|Overall Study|Other Unspecified|170
208576|NCT01163253|662622|P2|Overall Study|Ongoing|4
208577|NCT01163253|662623|P1|Overall Study|Ongoing|13
208578|NCT01163253|662622|P2|Overall Study|Death|5
208579|NCT01163253|662623|P1|Overall Study|Death|17
208580|NCT01163253|662622|P2|Overall Study|Adverse Event|78
208581|NCT01163253|662623|P1|Overall Study|Adverse Event|300
208582|NCT01163253|662622|P2|Overall Study|Insufficient Clinical Response|29
208583|NCT01163253|662623|P1|Overall Study|Insufficient Clinical Response|423
208584|NCT01163253|662622|P2|Overall Study|Lost to Follow-up|23
208585|NCT01163253|662623|P1|Overall Study|Lost to Follow-up|125
208586|NCT01163253|662622|P2|Overall Study|Medication Error|0
208587|NCT01163253|662623|P1|Overall Study|Medication Error|1
208588|NCT01163253|662622|P2|Overall Study|Withdrawal by Subject|50
208589|NCT01163253|662623|P1|Overall Study|Withdrawal by Subject|199
208590|NCT01163253|662622|P2|Overall Study|Protocol Violation|12
208591|NCT01163253|662623|P1|Overall Study|Protocol Violation|43
208592|NCT01163253|662622|P2|Overall Study|Study Terminated by Sponsor|349
208593|NCT01163253|662623|P1|Overall Study|Study Terminated by Sponsor|978
208594|NCT01163253|662622|P2|Overall Study|Withdrawn Due to Pregnancy|2
208595|NCT01163253|662623|P1|Overall Study|Withdrawn Due to Pregnancy|12
208596|NCT01163266|662786|P3|Overall Study|Other|2
208597|NCT01163266|662787|P2|Overall Study|Other|1
208598|NCT01163266|662788|P1|Overall Study|Other|1
208599|NCT01163266|662786|P3|Overall Study|Lost to Follow-up|10
208600|NCT01163266|662787|P2|Overall Study|Lost to Follow-up|7
208601|NCT01163266|662788|P1|Overall Study|Lost to Follow-up|7
208602|NCT01163266|662786|P3|Overall Study|Withdrawal of Consent|3
208603|NCT01163266|662787|P2|Overall Study|Withdrawal of Consent|7
208604|NCT01163266|662788|P1|Overall Study|Withdrawal of Consent|5
208605|NCT01163266|662786|P3|Overall Study|Protocol Deviations|5
208606|NCT01163266|662787|P2|Overall Study|Protocol Deviations|2
208607|NCT01163266|662788|P1|Overall Study|Protocol Deviations|2
208608|NCT01163266|662786|P3|Overall Study|Noncompliance with Study Drug|0
208609|NCT01163266|662787|P2|Overall Study|Noncompliance with Study Drug|2
208610|NCT01163266|662788|P1|Overall Study|Noncompliance with Study Drug|0
208611|NCT01163266|662786|P3|Overall Study|Lack of Efficacy|1
208612|NCT01163266|662787|P2|Overall Study|Lack of Efficacy|3
208613|NCT01163266|662788|P1|Overall Study|Lack of Efficacy|1
208614|NCT01163266|662786|P3|Overall Study|Pretreatment Event or Adverse Event|7
208615|NCT01163266|662787|P2|Overall Study|Pretreatment Event or Adverse Event|9
208616|NCT01163266|662788|P1|Overall Study|Pretreatment Event or Adverse Event|2
208617|NCT01163279|662813|P2|Overall Study|Withdrawal by Subject|0
208618|NCT01163279|662814|P1|Overall Study|Withdrawal by Subject|2
208619|NCT01163292|662842|P2|Overall Study|No further visits|7
208620|NCT01163292|662843|P1|Overall Study|No further visits|5
208621|NCT01163292|662842|P2|Overall Study|Economic reasons|0
208622|NCT01163292|662843|P1|Overall Study|Economic reasons|6
208623|NCT01163292|662842|P2|Overall Study|Refusal to receive adalimumab|0
208624|NCT01163292|662843|P1|Overall Study|Refusal to receive adalimumab|7
208625|NCT01163292|662842|P2|Overall Study|Sufficient response to adalimumab|0
208626|NCT01163292|662843|P1|Overall Study|Sufficient response to adalimumab|8
208627|NCT01163292|662842|P2|Overall Study|Initiation of biological therapy|15
208628|NCT01163292|662843|P1|Overall Study|Initiation of biological therapy|0
208629|NCT01163292|662842|P2|Overall Study|Adverse Event|0
208630|NCT01163292|662843|P1|Overall Study|Adverse Event|6
208631|NCT01163292|662842|P2|Overall Study|Lack of Efficacy|0
208632|NCT01163292|662843|P1|Overall Study|Lack of Efficacy|9
208633|NCT01163318|662857|P1|Overall Study|Multiple Reasons Per Participant|224
208634|NCT01163318|662857|P1|Overall Study|Participants Without Case Report Form|7
208635|NCT01163318|662857|P1|Overall Study|History/comorbidity of malignant tumor|3
208636|NCT01163318|662857|P1|Overall Study|Did Not Continue Use of Adalimumab|26
208637|NCT01163318|662857|P1|Overall Study|Off-Label Use of Adalimumab|8
208638|NCT01163474|662869|P1|Overall Study|Lost to Follow-up|3
208639|NCT01163474|662869|P1|Overall Study|Tech barriers to videoteleconference vis|12
208640|NCT01163474|662869|P1|Overall Study|Withdrawal by Subject|1
208641|NCT01163617|662884|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208642|NCT01163617|662885|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208643|NCT01163617|662886|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208644|NCT01163617|662887|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208645|NCT01163617|662888|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208646|NCT01163617|662889|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
208647|NCT01163617|662890|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208648|NCT01163617|662891|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
208649|NCT01163617|662884|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208650|NCT01163617|662885|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208651|NCT01163617|662886|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208652|NCT01163617|662887|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208653|NCT01163617|662888|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208654|NCT01163617|662889|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208655|NCT01163617|662890|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
208656|NCT01163617|662891|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
208657|NCT01163617|662884|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208658|NCT01163617|662885|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208659|NCT01163617|662886|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208660|NCT01163617|662887|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208661|NCT01163617|662888|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208662|NCT01163617|662889|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208663|NCT01163617|662890|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
208664|NCT01163617|662891|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
208665|NCT01163721|662922|P2|Overall Study|Physician Decision|1
208666|NCT01163721|662923|P1|Overall Study|Physician Decision|0
208667|NCT01163721|662922|P2|Overall Study|Lost to Follow-up|1
208668|NCT01163721|662923|P1|Overall Study|Lost to Follow-up|0
208669|NCT01163721|662922|P2|Overall Study|Withdrawal by Subject|4
208670|NCT01163721|662923|P1|Overall Study|Withdrawal by Subject|3
208671|NCT01163721|662922|P2|Overall Study|Adverse Event|6
208672|NCT01163721|662923|P1|Overall Study|Adverse Event|5
208673|NCT01163747|662935|P2|Overall Study|Refused Treatment|4
208674|NCT01163747|662936|P1|Overall Study|Refused Treatment|6
208675|NCT01163747|662935|P2|Overall Study|Protocol Violation|1
208676|NCT01163747|662936|P1|Overall Study|Protocol Violation|0
208677|NCT01163747|662935|P2|Overall Study|Insufficient Therapeutic Response|1
208678|NCT01163747|662936|P1|Overall Study|Insufficient Therapeutic Response|0
208679|NCT01163747|662935|P2|Overall Study|Adverse Event|5
208680|NCT01163747|662936|P1|Overall Study|Adverse Event|0
208681|NCT01163851|662971|P2|Overall Study|Randomized but not treated|0
208682|NCT01163851|662972|P1|Overall Study|Randomized but not treated|1
208683|NCT01163851|662971|P2|Overall Study|Ongoing|1
208684|NCT01163851|662972|P1|Overall Study|Ongoing|0
208685|NCT01163916|663049|P3|Overall Study|Other|16
208686|NCT01163916|663050|P2|Overall Study|Other|4
208687|NCT01163916|663051|P1|Overall Study|Other|24
208688|NCT01163916|663049|P3|Overall Study|Lack of Efficacy|1
208689|NCT01163916|663050|P2|Overall Study|Lack of Efficacy|0
208690|NCT01163916|663051|P1|Overall Study|Lack of Efficacy|2
208691|NCT01163916|663049|P3|Overall Study|Adverse Event|1
208692|NCT01163916|663050|P2|Overall Study|Adverse Event|0
208693|NCT01163916|663051|P1|Overall Study|Adverse Event|2
208694|NCT01163916|663049|P3|Overall Study|Withdrawal by Subject|2
208695|NCT01163916|663050|P2|Overall Study|Withdrawal by Subject|0
208696|NCT01163916|663051|P1|Overall Study|Withdrawal by Subject|2
208697|NCT01164007|663096|P1|Overall Study|Medical Decision|3
208698|NCT01164007|663096|P1|Overall Study|Withdrawal by Subject|1
208699|NCT01164007|663096|P1|Overall Study|Protocol Violation|1
208700|NCT01164007|663096|P1|Overall Study|Progression of Disease|30
208701|NCT01164007|663096|P1|Overall Study|Adverse Event|5
208702|NCT01164722|663125|P2|Overall Study|enrolled on other study, concomitant med|3
208703|NCT01164722|663126|P1|Overall Study|enrolled on other study, concomitant med|1
208704|NCT01164722|663125|P2|Overall Study|met protocol criteria for non-treatment|1
208705|NCT01164722|663126|P1|Overall Study|met protocol criteria for non-treatment|11
208706|NCT01164722|663125|P2|Overall Study|Lost to Follow-up|6
208707|NCT01164722|663126|P1|Overall Study|Lost to Follow-up|3
208708|NCT01164722|663125|P2|Overall Study|Withdrawal by Subject|4
208709|NCT01164722|663126|P1|Overall Study|Withdrawal by Subject|3
208710|NCT01164722|663125|P2|Overall Study|Adverse Event|1
208711|NCT01164722|663126|P1|Overall Study|Adverse Event|0
208712|NCT01164865|663142|P2|Overall Study|Lost to Follow-up|1
208713|NCT01164865|663143|P1|Overall Study|Lost to Follow-up|2
208714|NCT01164891|663151|P1|Overall Study|Adverse Event|1
208715|NCT01164891|663151|P1|Overall Study|Disease Progression|5
208716|NCT01165021|663169|P1|Overall Study|Death|1
208717|NCT01165138|663191|P4|Overall Study|Withdrawal by Subject|3
208718|NCT01165138|663192|P3|Overall Study|Withdrawal by Subject|6
208719|NCT01165138|663193|P2|Overall Study|Withdrawal by Subject|6
208720|NCT01165138|663194|P1|Overall Study|Withdrawal by Subject|0
208721|NCT01165138|663191|P4|Overall Study|Physician Decision|6
208722|NCT01165138|663192|P3|Overall Study|Physician Decision|7
208723|NCT01165138|663193|P2|Overall Study|Physician Decision|6
208724|NCT01165138|663194|P1|Overall Study|Physician Decision|0
208725|NCT01165138|663191|P4|Overall Study|Lost to Follow-up|2
208726|NCT01165138|663192|P3|Overall Study|Lost to Follow-up|1
208727|NCT01165138|663193|P2|Overall Study|Lost to Follow-up|0
208728|NCT01165138|663194|P1|Overall Study|Lost to Follow-up|0
208729|NCT01165138|663191|P4|Overall Study|Protocol Violation|2
208730|NCT01165138|663192|P3|Overall Study|Protocol Violation|0
208731|NCT01165138|663193|P2|Overall Study|Protocol Violation|7
208732|NCT01165138|663194|P1|Overall Study|Protocol Violation|0
208733|NCT01165138|663191|P4|Overall Study|Lack of Efficacy|7
208734|NCT01165138|663192|P3|Overall Study|Lack of Efficacy|6
208735|NCT01165138|663193|P2|Overall Study|Lack of Efficacy|32
208736|NCT01165138|663194|P1|Overall Study|Lack of Efficacy|0
208737|NCT01165138|663191|P4|Overall Study|Adverse Event|2
208738|NCT01165138|663192|P3|Overall Study|Adverse Event|0
208739|NCT01165138|663193|P2|Overall Study|Adverse Event|1
208740|NCT01165138|663194|P1|Overall Study|Adverse Event|0
208741|NCT01165177|663255|P2|Overall Study|Death|1
208742|NCT01165177|663256|P1|Overall Study|Death|0
208743|NCT01165177|663255|P2|Overall Study|Personal Reasons|4
208744|NCT01165177|663256|P1|Overall Study|Personal Reasons|1
208745|NCT01165177|663255|P2|Overall Study|Physician Decision|1
208746|NCT01165177|663256|P1|Overall Study|Physician Decision|0
208747|NCT01165177|663255|P2|Overall Study|Non-serious Adverse Event|20
208748|NCT01165177|663256|P1|Overall Study|Non-serious Adverse Event|32
208749|NCT01165177|663255|P2|Overall Study|Migrated/moved from study area|43
208750|NCT01165177|663256|P1|Overall Study|Migrated/moved from study area|48
208751|NCT01165177|663255|P2|Overall Study|Subject missed visit|2
208752|NCT01165177|663256|P1|Overall Study|Subject missed visit|5
208753|NCT01165177|663255|P2|Overall Study|Previous health issues worsening|11
208754|NCT01165177|663256|P1|Overall Study|Previous health issues worsening|9
208755|NCT01165177|663255|P2|Overall Study|Subject non-compliant with procedures|2
208756|NCT01165177|663256|P1|Overall Study|Subject non-compliant with procedures|12
208757|NCT01165177|663255|P2|Overall Study|Site closure|5
208758|NCT01165177|663256|P1|Overall Study|Site closure|7
208759|NCT01165177|663255|P2|Overall Study|Protocol Violation|22
208760|NCT01165177|663256|P1|Overall Study|Protocol Violation|19
208761|NCT01165177|663255|P2|Overall Study|Lost to Follow-up|195
208762|NCT01165177|663256|P1|Overall Study|Lost to Follow-up|188
208763|NCT01165177|663255|P2|Overall Study|Serious Adverse Event|240
208764|NCT01165177|663256|P1|Overall Study|Serious Adverse Event|229
208765|NCT01165177|663255|P2|Overall Study|Withdrawal by Subject|356
208766|NCT01165177|663256|P1|Overall Study|Withdrawal by Subject|372
208767|NCT01165203|663380|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
208768|NCT01165203|663381|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
208769|NCT01165203|663380|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
208770|NCT01165203|663381|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
208771|NCT01165203|663380|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
208772|NCT01165203|663381|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
208773|NCT01165203|663380|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
208774|NCT01165203|663381|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
208775|NCT01165203|663380|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
208776|NCT01165203|663381|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
208777|NCT01165203|663380|P2|Active Phase|Lost to Follow-up|0
208778|NCT01165203|663381|P1|Active Phase|Lost to Follow-up|2
208779|NCT01165203|663380|P2|Active Phase|Migrated/moved from study area|1
208780|NCT01165203|663381|P1|Active Phase|Migrated/moved from study area|0
208781|NCT01165203|663380|P2|Active Phase|Withdrawal by Subject|1
208782|NCT01165203|663381|P1|Active Phase|Withdrawal by Subject|2
208783|NCT01165203|663380|P2|Active Phase|Serious Adverse Event|0
208784|NCT01165203|663381|P1|Active Phase|Serious Adverse Event|1
208785|NCT01165216|663471|P2|Overall Study|Disease progression|3
208786|NCT01165216|663472|P1|Overall Study|Disease progression|1
208787|NCT01165216|663471|P2|Overall Study|Withdrawal by Subject|1
208788|NCT01165216|663472|P1|Overall Study|Withdrawal by Subject|1
208789|NCT01165216|663471|P2|Overall Study|Adverse Event|3
208790|NCT01165216|663472|P1|Overall Study|Adverse Event|6
208791|NCT01165242|663495|P3|Overall Study|Lost to Follow-up|10
208792|NCT01165242|663496|P2|Overall Study|Lost to Follow-up|7
208793|NCT01165242|663497|P1|Overall Study|Lost to Follow-up|9
208794|NCT01165242|663495|P3|Overall Study|Extended Holiday|1
208795|NCT01165242|663496|P2|Overall Study|Extended Holiday|0
208796|NCT01165242|663497|P1|Overall Study|Extended Holiday|0
208797|NCT01165242|663495|P3|Overall Study|Withdrawal by Subject|2
208798|NCT01165242|663496|P2|Overall Study|Withdrawal by Subject|2
208799|NCT01165242|663497|P1|Overall Study|Withdrawal by Subject|0
208800|NCT01165242|663495|P3|Overall Study|Visit 2 Declined by Subject|1
208801|NCT01165242|663496|P2|Overall Study|Visit 2 Declined by Subject|0
208802|NCT01165242|663497|P1|Overall Study|Visit 2 Declined by Subject|0
208803|NCT01165242|663495|P3|Overall Study|Incarcerated Subjects|0
208804|NCT01165242|663496|P2|Overall Study|Incarcerated Subjects|1
208805|NCT01165242|663497|P1|Overall Study|Incarcerated Subjects|0
208806|NCT01165242|663495|P3|Overall Study|Unreachable Subjects|0
208807|NCT01165242|663496|P2|Overall Study|Unreachable Subjects|0
208808|NCT01165242|663497|P1|Overall Study|Unreachable Subjects|1
208809|NCT01165281|663531|P2|Overall Study|Other|0
208810|NCT01165281|663532|P1|Overall Study|Other|6
208811|NCT01165281|663531|P2|Overall Study|Progressive Disease|14
208812|NCT01165281|663532|P1|Overall Study|Progressive Disease|10
208813|NCT01165281|663531|P2|Overall Study|Noncompliance with Study Drug|4
208814|NCT01165281|663532|P1|Overall Study|Noncompliance with Study Drug|1
208815|NCT01165281|663531|P2|Overall Study|Withdrawal by Subject|7
208816|NCT01165281|663532|P1|Overall Study|Withdrawal by Subject|8
208817|NCT01165281|663531|P2|Overall Study|Protocol Violation|5
208818|NCT01165281|663532|P1|Overall Study|Protocol Violation|6
208819|NCT01165281|663531|P2|Overall Study|Physician Decision|1
208820|NCT01165281|663532|P1|Overall Study|Physician Decision|8
208821|NCT01165281|663531|P2|Overall Study|Lost to Follow-up|1
208822|NCT01165281|663532|P1|Overall Study|Lost to Follow-up|0
208823|NCT01165281|663531|P2|Overall Study|Lack of Efficacy|1
208824|NCT01165281|663532|P1|Overall Study|Lack of Efficacy|4
208825|NCT01165281|663531|P2|Overall Study|Death|4
208826|NCT01165281|663532|P1|Overall Study|Death|3
208827|NCT01165281|663531|P2|Overall Study|Adverse Event|14
208828|NCT01165281|663532|P1|Overall Study|Adverse Event|12
208829|NCT01165307|663552|P2|Overall Study|Subject not available for contact|0
208830|NCT01165307|663553|P1|Overall Study|Subject not available for contact|1
208831|NCT01165307|663552|P2|Overall Study|Withdrawal by Subject|0
208832|NCT01165307|663553|P1|Overall Study|Withdrawal by Subject|2
208833|NCT01165307|663552|P2|Overall Study|Lost to Follow-up|3
208834|NCT01165307|663553|P1|Overall Study|Lost to Follow-up|11
208835|NCT01165320|663583|P3|Overall Study|Reason unknown|0
208836|NCT01165320|663584|P2|Overall Study|Reason unknown|1
208837|NCT01165320|663585|P1|Overall Study|Reason unknown|0
208838|NCT01165320|663583|P3|Overall Study|Lack of Efficacy|0
208839|NCT01165320|663584|P2|Overall Study|Lack of Efficacy|2
208840|NCT01165320|663585|P1|Overall Study|Lack of Efficacy|0
208841|NCT01165320|663583|P3|Overall Study|Laboratory adverse experience|0
208842|NCT01165320|663584|P2|Overall Study|Laboratory adverse experience|0
208843|NCT01165320|663585|P1|Overall Study|Laboratory adverse experience|1
208844|NCT01165320|663583|P3|Overall Study|Clinical adverse experience|0
208845|NCT01165320|663584|P2|Overall Study|Clinical adverse experience|1
208846|NCT01165320|663585|P1|Overall Study|Clinical adverse experience|2
208847|NCT01165424|663593|P1|Overall Study|Participant moved (relocated)|1
208848|NCT01165424|663593|P1|Overall Study|Did not meet entry criteria|1
208849|NCT01165424|663593|P1|Overall Study|Laboratory adverse experiences|1
208850|NCT01165424|663593|P1|Overall Study|Clinical adverse experiences|1
208851|NCT01165554|663614|P1|Overall Study|Withdrawal by Subject|23
208852|NCT01165684|663623|P2|Overall Study|Unclassified|22
208853|NCT01165684|663624|P1|Overall Study|Unclassified|16
208854|NCT01165684|663623|P2|Overall Study|Withdrawal Criteria|13
208855|NCT01165684|663624|P1|Overall Study|Withdrawal Criteria|2
208856|NCT01165684|663623|P2|Overall Study|Protocol Violation|15
208857|NCT01165684|663624|P1|Overall Study|Protocol Violation|7
208858|NCT01165684|663623|P2|Overall Study|Lack of Efficacy|1
208859|NCT01165684|663624|P1|Overall Study|Lack of Efficacy|2
208860|NCT01165684|663623|P2|Overall Study|Adverse Event|1
208861|NCT01165684|663624|P1|Overall Study|Adverse Event|1
208862|NCT01165996|663717|P1|Overall Study|Physician Decision|1
208863|NCT01165996|663717|P1|Overall Study|Death|1
208864|NCT01166178|663732|P2|Overall Study|Study was terminated|8
208865|NCT01166178|663733|P1|Overall Study|Study was terminated|20
208866|NCT01166178|663732|P2|Overall Study|Withdrawal by Subject|0
208867|NCT01166178|663733|P1|Overall Study|Withdrawal by Subject|1
208868|NCT01166282|663776|P3|Open-label Period|Irregular Compliance|1
208869|NCT01166282|663777|P2|Open-label Period|Irregular Compliance|0
208870|NCT01166282|663778|P1|Open-label Period|Irregular Compliance|0
208871|NCT01166282|663776|P3|Open-label Period|Remission|4
208872|NCT01166282|663777|P2|Open-label Period|Remission|0
208873|NCT01166282|663778|P1|Open-label Period|Remission|0
208874|NCT01166282|663776|P3|Open-label Period|Lack of Efficacy|2
208875|NCT01166282|663777|P2|Open-label Period|Lack of Efficacy|0
208876|NCT01166282|663778|P1|Open-label Period|Lack of Efficacy|0
208877|NCT01166282|663776|P3|Open-label Period|Withdrawal by Subject|4
208878|NCT01166282|663777|P2|Open-label Period|Withdrawal by Subject|0
208879|NCT01166282|663778|P1|Open-label Period|Withdrawal by Subject|0
208880|NCT01166282|663776|P3|Open-label Period|Adverse Event|6
208881|NCT01166282|663777|P2|Open-label Period|Adverse Event|0
208882|NCT01166282|663778|P1|Open-label Period|Adverse Event|0
208883|NCT01166646|663802|P2|Overall Study|Adverse Event|0
208884|NCT01166646|663803|P1|Overall Study|Adverse Event|1
208885|NCT01166646|663802|P2|Overall Study|Protocol Violation|1
208886|NCT01166646|663803|P1|Overall Study|Protocol Violation|0
208887|NCT01166659|663819|P1|Overall Study|Study Closed at Site|1
208888|NCT01166659|663819|P1|Overall Study|Lost to Follow-up|1
208889|NCT01166659|663819|P1|Overall Study|Death|1
208890|NCT01166659|663819|P1|Overall Study|Investigator Decision|2
208891|NCT01166659|663819|P1|Overall Study|Subject Decision|8
208892|NCT01166750|663839|P2|Overall Study|Lost to Follow-up|0
208893|NCT01166750|663840|P1|Overall Study|Lost to Follow-up|1
208894|NCT01166763|663846|P1|Overall Study|Withdrawal by Subject|3
208895|NCT01166958|663854|P2|Overall Study|Withdrawal by Subject|0
208896|NCT01166958|663855|P1|Overall Study|Withdrawal by Subject|1
208897|NCT01167023|663891|P3|Overall Study|Withdrawal by Subject|1
208898|NCT01167023|663892|P2|Overall Study|Withdrawal by Subject|0
208899|NCT01167023|663893|P1|Overall Study|Withdrawal by Subject|0
208900|NCT01167023|663891|P3|Overall Study|Sponsor Decision|0
208901|NCT01167023|663892|P2|Overall Study|Sponsor Decision|1
208902|NCT01167023|663893|P1|Overall Study|Sponsor Decision|0
208903|NCT01167023|663891|P3|Overall Study|Screen Failure|0
208904|NCT01167023|663892|P2|Overall Study|Screen Failure|1
208905|NCT01167023|663893|P1|Overall Study|Screen Failure|0
208906|NCT01167023|663891|P3|Overall Study|Lost to Follow-up|1
208907|NCT01167023|663892|P2|Overall Study|Lost to Follow-up|1
208908|NCT01167023|663893|P1|Overall Study|Lost to Follow-up|0
208909|NCT01160744|663915|P4|Overall Study|Alive and Still on Treatment|14
208910|NCT01160744|663916|P3|Overall Study|Alive and Still on Treatment|8
208911|NCT01160744|663917|P2|Overall Study|Alive and Still on Treatment|11
208912|NCT01160744|663918|P1|Overall Study|Alive and Still on Treatment|9
208913|NCT01160744|663915|P4|Overall Study|Not Specified|4
208914|NCT01160744|663916|P3|Overall Study|Not Specified|5
208915|NCT01160744|663917|P2|Overall Study|Not Specified|9
208916|NCT01160744|663918|P1|Overall Study|Not Specified|5
208917|NCT01160744|663915|P4|Overall Study|Not meet inclusion/exclusion criteria|0
208918|NCT01160744|663916|P3|Overall Study|Not meet inclusion/exclusion criteria|1
208919|NCT01160744|663917|P2|Overall Study|Not meet inclusion/exclusion criteria|0
208920|NCT01160744|663918|P1|Overall Study|Not meet inclusion/exclusion criteria|0
208921|NCT01160744|663915|P4|Overall Study|Withdrawal by Subject|4
208922|NCT01160744|663916|P3|Overall Study|Withdrawal by Subject|6
208923|NCT01160744|663917|P2|Overall Study|Withdrawal by Subject|5
208924|NCT01160744|663918|P1|Overall Study|Withdrawal by Subject|6
208925|NCT01160770|663952|P1|Overall Study|Other Reasons|1
208926|NCT01160770|663952|P1|Overall Study|Lack of Efficacy|15
208927|NCT01160770|663952|P1|Overall Study|Death|9
208928|NCT01160770|663952|P1|Overall Study|Study termination or sponsor request|1
208929|NCT01160770|663952|P1|Overall Study|Lost to Follow-up|7
208930|NCT01160770|663952|P1|Overall Study|Physician Decision|1
208931|NCT01160770|663952|P1|Overall Study|Subject/parent/caregiver request|33
208932|NCT01160770|663952|P1|Overall Study|Protocol Violation|2
208933|NCT01160770|663952|P1|Overall Study|Adverse Event|10
208934|NCT01160822|663968|P7|Overall Study|Protocol deviation|0
208935|NCT01160822|663969|P6|Overall Study|Protocol deviation|0
208936|NCT01160822|663970|P5|Overall Study|Protocol deviation|2
208937|NCT01160822|663971|P4|Overall Study|Protocol deviation|0
208938|NCT01160822|663972|P3|Overall Study|Protocol deviation|0
208939|NCT01160822|663973|P2|Overall Study|Protocol deviation|0
208940|NCT01160822|663974|P1|Overall Study|Protocol deviation|0
208941|NCT01160822|663968|P7|Overall Study|Administrative problems|0
208942|NCT01160822|663969|P6|Overall Study|Administrative problems|0
208943|NCT01160822|663970|P5|Overall Study|Administrative problems|1
208944|NCT01160822|663971|P4|Overall Study|Administrative problems|0
208945|NCT01160822|663972|P3|Overall Study|Administrative problems|0
208946|NCT01160822|663973|P2|Overall Study|Administrative problems|0
208947|NCT01160822|663974|P1|Overall Study|Administrative problems|0
208948|NCT01160822|663968|P7|Overall Study|Lost to Follow-up|0
208949|NCT01160822|663969|P6|Overall Study|Lost to Follow-up|0
208950|NCT01160822|663970|P5|Overall Study|Lost to Follow-up|1
208951|NCT01160822|663971|P4|Overall Study|Lost to Follow-up|0
208952|NCT01160822|663972|P3|Overall Study|Lost to Follow-up|0
208953|NCT01160822|663973|P2|Overall Study|Lost to Follow-up|0
208954|NCT01160822|663974|P1|Overall Study|Lost to Follow-up|0
208955|NCT01160822|663968|P7|Overall Study|Withdrawal by Subject|1
208956|NCT01160822|663969|P6|Overall Study|Withdrawal by Subject|0
208957|NCT01160822|663970|P5|Overall Study|Withdrawal by Subject|0
208958|NCT01160822|663971|P4|Overall Study|Withdrawal by Subject|0
208959|NCT01160822|663972|P3|Overall Study|Withdrawal by Subject|0
208960|NCT01160822|663973|P2|Overall Study|Withdrawal by Subject|0
208961|NCT01160822|663974|P1|Overall Study|Withdrawal by Subject|0
208962|NCT01160822|663968|P7|Overall Study|Unsatisfactory therapeutic effect|3
208963|NCT01160822|663969|P6|Overall Study|Unsatisfactory therapeutic effect|5
208964|NCT01160822|663970|P5|Overall Study|Unsatisfactory therapeutic effect|4
208965|NCT01160822|663971|P4|Overall Study|Unsatisfactory therapeutic effect|0
208966|NCT01160822|663972|P3|Overall Study|Unsatisfactory therapeutic effect|0
208967|NCT01160822|663973|P2|Overall Study|Unsatisfactory therapeutic effect|0
208968|NCT01160822|663974|P1|Overall Study|Unsatisfactory therapeutic effect|0
208969|NCT01160822|663968|P7|Overall Study|Adverse Event|5
208970|NCT01160822|663969|P6|Overall Study|Adverse Event|2
208971|NCT01160822|663970|P5|Overall Study|Adverse Event|1
208972|NCT01160822|663971|P4|Overall Study|Adverse Event|0
208973|NCT01160822|663972|P3|Overall Study|Adverse Event|0
208974|NCT01160822|663973|P2|Overall Study|Adverse Event|0
208975|NCT01160822|663974|P1|Overall Study|Adverse Event|0
208976|NCT01161173|664174|P1|Overall Study|Reasons Not Specified|23
208977|NCT01161173|664174|P1|Overall Study|End of Study|2
208978|NCT01161173|664174|P1|Overall Study|Death|194
208979|NCT01161173|664174|P1|Overall Study|Unacceptable Toxicity|21
208980|NCT01161173|664174|P1|Overall Study|Withdrawal of Consent|5
208981|NCT01161173|664174|P1|Overall Study|Progressive Disease|82
208982|NCT01161173|664174|P1|Overall Study|Lost to Follow-up|7
208983|NCT01161173|664174|P1|Overall Study|Protocol Violation|13
208984|NCT01167140|664217|P1|Overall Study|Withdrawal by Subject|1
208985|NCT01167153|664225|P2|Overall Study|Subject initiation withdrawal, Other|8
208986|NCT01167153|664226|P1|Overall Study|Subject initiation withdrawal, Other|5
208987|NCT01167153|664225|P2|Overall Study|Withdrawal consent|1
208988|NCT01167153|664226|P1|Overall Study|Withdrawal consent|1
208989|NCT01167153|664225|P2|Overall Study|Investigator initiation withdrawal,Other|1
208990|NCT01167153|664226|P1|Overall Study|Investigator initiation withdrawal,Other|1
208991|NCT01167153|664225|P2|Overall Study|Non-compliance to concomitant medication|2
208992|NCT01167153|664226|P1|Overall Study|Non-compliance to concomitant medication|0
208993|NCT01167153|664225|P2|Overall Study|Lost to Follow-up|9
208994|NCT01167153|664226|P1|Overall Study|Lost to Follow-up|7
208995|NCT01167153|664225|P2|Overall Study|Hypotension|0
208996|NCT01167153|664226|P1|Overall Study|Hypotension|1
208997|NCT01167153|664225|P2|Overall Study|AE including clinical laboratory AE|8
208998|NCT01167153|664226|P1|Overall Study|AE including clinical laboratory AE|2
208999|NCT01167153|664225|P2|Overall Study|Non-effective therapy|4
209000|NCT01167153|664226|P1|Overall Study|Non-effective therapy|1
209001|NCT01167192|664244|P1|Overall Study|Insurance denial|1
209002|NCT01167192|664244|P1|Overall Study|Withdrawal by Subject|1
209003|NCT01167192|664244|P1|Overall Study|Death|1
209004|NCT01167192|664244|P1|Overall Study|Adverse Event|1
209005|NCT01167257|664261|P2|Overall Study|Withdrew consent|1
209006|NCT01167257|664262|P1|Overall Study|Withdrew consent|1
209007|NCT01167257|664261|P2|Overall Study|Lost to Follow-up|2
209008|NCT01167257|664262|P1|Overall Study|Lost to Follow-up|2
209009|NCT01167881|664286|P2|Overall Study|Other not defined above|55
209010|NCT01167881|664287|P1|Overall Study|Other not defined above|31
209011|NCT01167881|664286|P2|Overall Study|Not treated|0
209012|NCT01167881|664287|P1|Overall Study|Not treated|4
209013|NCT01167881|664286|P2|Overall Study|Patient refusal to cont., not due to AE|40
209014|NCT01167881|664287|P1|Overall Study|Patient refusal to cont., not due to AE|45
209015|NCT01167881|664286|P2|Overall Study|Lost to Follow-up|20
209016|NCT01167881|664287|P1|Overall Study|Lost to Follow-up|19
209017|NCT01167881|664286|P2|Overall Study|Non compliant with protocol|18
209018|NCT01167881|664287|P1|Overall Study|Non compliant with protocol|9
209019|NCT01167881|664286|P2|Overall Study|Lack of Efficacy|7
209020|NCT01167881|664287|P1|Overall Study|Lack of Efficacy|4
209021|NCT01167881|664286|P2|Overall Study|Adverse Event|51
209022|NCT01167881|664287|P1|Overall Study|Adverse Event|47
209023|NCT01168232|664326|P1|Overall Study|Ineligible-Inadequate pathology|1
209024|NCT01168232|664326|P1|Overall Study|Ineligible- Wrong cell type|6
209025|NCT01168232|664326|P1|Overall Study|Ineligible-Second primary cancer site|1
209026|NCT01168349|664333|P1|Overall Study|Protocol Violation|76
209027|NCT01168349|664333|P1|Overall Study|Unspecified|22
209028|NCT01168349|664333|P1|Overall Study|Kidney transplantation|3
209029|NCT01168349|664333|P1|Overall Study|Withdrawal by Subject|9
209030|NCT01168349|664333|P1|Overall Study|Lost to Follow-up|34
209031|NCT01168349|664333|P1|Overall Study|Death|157
209032|NCT01168427|664439|P1|Overall Study|Patient exited prior to implant|1
209033|NCT01168596|664446|P2|Overall Study|Withdrawal by Subject|1
209034|NCT01168596|664447|P1|Overall Study|Withdrawal by Subject|3
209035|NCT01168856|664532|P2|Overall Study|Protocol Violation|6
209036|NCT01168856|664533|P1|Overall Study|Protocol Violation|4
209037|NCT01168856|664532|P2|Overall Study|Unspecified|291
209038|NCT01168856|664533|P1|Overall Study|Unspecified|1
209039|NCT01168856|664532|P2|Overall Study|Death|2
209040|NCT01168856|664533|P1|Overall Study|Death|0
209041|NCT01168856|664532|P2|Overall Study|Participant received anti-HCV treatment|0
209042|NCT01168856|664533|P1|Overall Study|Participant received anti-HCV treatment|1
209043|NCT01168856|664532|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
209044|NCT01168856|664533|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
209045|NCT01168856|664532|P2|Overall Study|Physician Decision|1
209046|NCT01168856|664533|P1|Overall Study|Physician Decision|2
209047|NCT01168856|664532|P2|Overall Study|Withdrawal by Subject|8
209048|NCT01168856|664533|P1|Overall Study|Withdrawal by Subject|6
209049|NCT01168856|664532|P2|Overall Study|Lost to Follow-up|34
209050|NCT01168856|664533|P1|Overall Study|Lost to Follow-up|4
209051|NCT01168973|664625|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
209052|NCT01168973|664626|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
209053|NCT01168973|664625|P2|Overall Study|Sponsor Decision|1
209054|NCT01168973|664626|P1|Overall Study|Sponsor Decision|2
209055|NCT01168973|664625|P2|Overall Study|Physician Decision|19
209056|NCT01168973|664626|P1|Overall Study|Physician Decision|37
209057|NCT01168973|664625|P2|Overall Study|Death|45
209058|NCT01168973|664626|P1|Overall Study|Death|42
209059|NCT01168973|664625|P2|Overall Study|Withdrawal by Subject|53
209060|NCT01168973|664626|P1|Overall Study|Withdrawal by Subject|90
209061|NCT01168973|664625|P2|Overall Study|Adverse Event|55
209062|NCT01168973|664626|P1|Overall Study|Adverse Event|94
209063|NCT01168973|664625|P2|Overall Study|Progressive Disease|429
209064|NCT01168973|664626|P1|Overall Study|Progressive Disease|341
209065|NCT01168999|664673|P4|Overall Study|Lost to Follow-up|0
209066|NCT01168999|664674|P3|Overall Study|Lost to Follow-up|0
209067|NCT01168999|664675|P2|Overall Study|Lost to Follow-up|1
209068|NCT01168999|664676|P1|Overall Study|Lost to Follow-up|2
209069|NCT01169038|664718|P1|Overall Study|Required antibiotic administration|1
209070|NCT01169038|664718|P1|Overall Study|Adverse Event|5
209071|NCT01169038|664718|P1|Overall Study|Death|1
209072|NCT01169103|664737|P2|Overall Study|Withdrawal by Subject|1
209073|NCT01169103|664738|P1|Overall Study|Withdrawal by Subject|3
209074|NCT01169103|664737|P2|Overall Study|Lost to Follow-up|3
209075|NCT01169103|664738|P1|Overall Study|Lost to Follow-up|3
209076|NCT01169493|664787|P6|Period 3 (6 Months)|Physician Decision|0
209077|NCT01169493|664788|P5|Period 3 (6 Months)|Physician Decision|0
209078|NCT01169493|664789|P4|Period 3 (6 Months)|Physician Decision|0
209079|NCT01169493|664790|P3|Period 3 (6 Months)|Physician Decision|1
209080|NCT01169493|664791|P2|Period 3 (6 Months)|Physician Decision|1
209081|NCT01169493|664792|P1|Period 3 (6 Months)|Physician Decision|0
209082|NCT01169493|664787|P6|Period 3 (6 Months)|Adverse Event|0
209083|NCT01169493|664788|P5|Period 3 (6 Months)|Adverse Event|0
209084|NCT01169493|664789|P4|Period 3 (6 Months)|Adverse Event|0
209085|NCT01169493|664790|P3|Period 3 (6 Months)|Adverse Event|0
209086|NCT01169493|664791|P2|Period 3 (6 Months)|Adverse Event|1
209087|NCT01169493|664792|P1|Period 3 (6 Months)|Adverse Event|0
209088|NCT01169493|664787|P6|Period 1 (6 Months)|Withdrawal by Subject|3
209089|NCT01169493|664788|P5|Period 1 (6 Months)|Withdrawal by Subject|0
209090|NCT01169493|664789|P4|Period 1 (6 Months)|Withdrawal by Subject|0
209091|NCT01169493|664790|P3|Period 1 (6 Months)|Withdrawal by Subject|2
209092|NCT01169493|664791|P2|Period 1 (6 Months)|Withdrawal by Subject|1
209093|NCT01169493|664792|P1|Period 1 (6 Months)|Withdrawal by Subject|0
209094|NCT01169558|664833|P1|Overall Study|Partial response|2
209095|NCT01169558|664833|P1|Overall Study|Protocol Violation|2
209096|NCT01169558|664833|P1|Overall Study|Non-compliance|2
209097|NCT01169558|664833|P1|Overall Study|Need for Surgery|4
209098|NCT01169558|664833|P1|Overall Study|Lost to Follow-up|4
209099|NCT01169558|664833|P1|Overall Study|Stable Disease|4
209100|NCT01169558|664833|P1|Overall Study|Medical Decision|7
209101|NCT01169558|664833|P1|Overall Study|Withdrawal of Consent|8
209102|NCT01169558|664833|P1|Overall Study|Adverse Event|25
209103|NCT01169558|664833|P1|Overall Study|Disease progression|98
209104|NCT01169649|664848|P1|Overall Study|Patient Not Treated|3
209105|NCT01169675|664857|P5|Overall Study|Other Reason Not Defined Above|1
209106|NCT01169675|664858|P4|Overall Study|Other Reason Not Defined Above|1
209107|NCT01169675|664859|P3|Overall Study|Other Reason Not Defined Above|0
209108|NCT01169675|664860|P2|Overall Study|Other Reason Not Defined Above|0
209109|NCT01169675|664861|P1|Overall Study|Other Reason Not Defined Above|0
209110|NCT01169675|664857|P5|Overall Study|Withdrawal by Subject|2
209111|NCT01169675|664858|P4|Overall Study|Withdrawal by Subject|1
209112|NCT01169675|664859|P3|Overall Study|Withdrawal by Subject|0
209113|NCT01169675|664860|P2|Overall Study|Withdrawal by Subject|0
209114|NCT01169675|664861|P1|Overall Study|Withdrawal by Subject|1
209115|NCT01169675|664857|P5|Overall Study|Adverse Event|0
209116|NCT01169675|664858|P4|Overall Study|Adverse Event|0
209117|NCT01169675|664859|P3|Overall Study|Adverse Event|2
209118|NCT01169675|664860|P2|Overall Study|Adverse Event|1
209119|NCT01169675|664861|P1|Overall Study|Adverse Event|5
209120|NCT01169675|664857|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
209121|NCT01169675|664858|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
209122|NCT01169675|664859|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
209123|NCT01169675|664860|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
209124|NCT01169675|664861|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
209125|NCT01169675|664857|P5|Overall Study|Progressive disease|1
209126|NCT01169675|664858|P4|Overall Study|Progressive disease|15
209127|NCT01169675|664859|P3|Overall Study|Progressive disease|5
209128|NCT01169675|664860|P2|Overall Study|Progressive disease|2
209129|NCT01169675|664861|P1|Overall Study|Progressive disease|13
209130|NCT01169701|664900|P2|Overall Study|Sponsor decision|1
209131|NCT01169701|664901|P1|Overall Study|Sponsor decision|0
209132|NCT01169701|664900|P2|Overall Study|Serious adverse event|1
209133|NCT01169701|664901|P1|Overall Study|Serious adverse event|0
209134|NCT01169701|664900|P2|Overall Study|Administrative problems|1
209135|NCT01169701|664901|P1|Overall Study|Administrative problems|0
209136|NCT01169701|664900|P2|Overall Study|Death|1
209137|NCT01169701|664901|P1|Overall Study|Death|0
209138|NCT01169701|664900|P2|Overall Study|Exclusion criteria|0
209139|NCT01169701|664901|P1|Overall Study|Exclusion criteria|2
209140|NCT01169701|664900|P2|Overall Study|Adverse Event|2
209141|NCT01169701|664901|P1|Overall Study|Adverse Event|1
209142|NCT01169701|664900|P2|Overall Study|Withdrawal by Subject|3
209143|NCT01169701|664901|P1|Overall Study|Withdrawal by Subject|1
209144|NCT01169701|664900|P2|Overall Study|Lost to Follow-up|1
209145|NCT01169701|664901|P1|Overall Study|Lost to Follow-up|1
209146|NCT01169779|664944|P2|Overall Study|Familial and personal reasons|3
209147|NCT01169779|664945|P1|Overall Study|Familial and personal reasons|3
209148|NCT01169779|664944|P2|Overall Study|Withdrawal by Subject|2
209149|NCT01169779|664945|P1|Overall Study|Withdrawal by Subject|3
209150|NCT01169779|664944|P2|Overall Study|Protocol Violation|1
209151|NCT01169779|664945|P1|Overall Study|Protocol Violation|1
209152|NCT01169779|664944|P2|Overall Study|Lack of Efficacy|0
209153|NCT01169779|664945|P1|Overall Study|Lack of Efficacy|1
209154|NCT01169779|664944|P2|Overall Study|Adverse Event|11
209155|NCT01169779|664945|P1|Overall Study|Adverse Event|3
209156|NCT01169987|664969|P1|Overall Study|Not Specified|4
209157|NCT01169987|664969|P1|Overall Study|Lost to Follow-up|24
209158|NCT01169987|664969|P1|Overall Study|Withdrawal by Subject|3
209159|NCT01170039|665035|P2|Overall Study|Lack of funding, drug not available|3
209160|NCT01170039|665036|P1|Overall Study|Lack of funding, drug not available|3
209161|NCT01170039|665035|P2|Overall Study|Withdrawal by Subject|3
209162|NCT01170039|665036|P1|Overall Study|Withdrawal by Subject|5
209163|NCT01170091|665048|P1|Overall Study|Treatment duration is less than 4 weeks|21
209164|NCT01170091|665048|P1|Overall Study|Missing efficacy evaluation|3
209165|NCT01170208|665069|P3|Overall Study|Protocol Violation|1
209166|NCT01170208|665070|P2|Overall Study|Protocol Violation|0
209167|NCT01170208|665071|P1|Overall Study|Protocol Violation|1
209168|NCT01170208|665069|P3|Overall Study|Withdrawal by Subject|1
209169|NCT01170208|665070|P2|Overall Study|Withdrawal by Subject|0
209170|NCT01170208|665071|P1|Overall Study|Withdrawal by Subject|5
209171|NCT01170221|665081|P2|Overall Study|Randomized but not treated|0
209172|NCT01170221|665082|P1|Overall Study|Randomized but not treated|1
209173|NCT01170221|665081|P2|Overall Study|Subject completed only screening and LFU|0
209174|NCT01170221|665082|P1|Overall Study|Subject completed only screening and LFU|1
209175|NCT01170221|665081|P2|Overall Study|Withdrawal by Subject|7
209176|NCT01170221|665082|P1|Overall Study|Withdrawal by Subject|9
209177|NCT01170221|665081|P2|Overall Study|Lost to Follow-up|21
209178|NCT01170221|665082|P1|Overall Study|Lost to Follow-up|22
209179|NCT01170273|665113|P2|Overall Study|Adverse Event|1
209180|NCT01170273|665114|P1|Overall Study|Adverse Event|0
209181|NCT01170273|665113|P2|Overall Study|Death|0
209182|NCT01170273|665114|P1|Overall Study|Death|1
209183|NCT01170273|665113|P2|Overall Study|Protocol Violation|0
209184|NCT01170273|665114|P1|Overall Study|Protocol Violation|1
209185|NCT01170273|665113|P2|Overall Study|Lost to Follow-up|8
209186|NCT01170273|665114|P1|Overall Study|Lost to Follow-up|6
209187|NCT01164475|665139|P2|Overall Study|Protocol Violation|0
209188|NCT01164475|665140|P1|Overall Study|Protocol Violation|1
209189|NCT01164475|665139|P2|Overall Study|Progressive disease|1
209190|NCT01164475|665140|P1|Overall Study|Progressive disease|0
209191|NCT01164475|665139|P2|Overall Study|Other|1
209192|NCT01164475|665140|P1|Overall Study|Other|0
209193|NCT01164475|665139|P2|Overall Study|Lack of Efficacy|0
209194|NCT01164475|665140|P1|Overall Study|Lack of Efficacy|1
209195|NCT01164501|665167|P3|Overall Study|Other reason not defined above|4
209196|NCT01164501|665168|P2|Overall Study|Other reason not defined above|1
209197|NCT01164501|665169|P1|Overall Study|Other reason not defined above|9
209198|NCT01164501|665167|P3|Overall Study|Patient refusal to continue,not due toAE|8
209199|NCT01164501|665168|P2|Overall Study|Patient refusal to continue,not due toAE|4
209200|NCT01164501|665169|P1|Overall Study|Patient refusal to continue,not due toAE|10
209201|NCT01164501|665167|P3|Overall Study|Lost to Follow-up|3
209202|NCT01164501|665168|P2|Overall Study|Lost to Follow-up|0
209203|NCT01164501|665169|P1|Overall Study|Lost to Follow-up|3
209204|NCT01164501|665167|P3|Overall Study|Non compliant with protocol|4
209205|NCT01164501|665168|P2|Overall Study|Non compliant with protocol|1
209206|NCT01164501|665169|P1|Overall Study|Non compliant with protocol|1
209207|NCT01164501|665167|P3|Overall Study|Lack of Efficacy|1
209208|NCT01164501|665168|P2|Overall Study|Lack of Efficacy|0
209209|NCT01164501|665169|P1|Overall Study|Lack of Efficacy|0
209210|NCT01164501|665167|P3|Overall Study|Adverse Event|21
209211|NCT01164501|665168|P2|Overall Study|Adverse Event|4
209212|NCT01164501|665169|P1|Overall Study|Adverse Event|18
209213|NCT01164501|665167|P3|Overall Study|Not treated|1
209214|NCT01164501|665168|P2|Overall Study|Not treated|0
209215|NCT01164501|665169|P1|Overall Study|Not treated|2
209216|NCT01164579|665187|P3|Overall Study|Reason not specified|0
209217|NCT01164579|665188|P2|Overall Study|Reason not specified|0
209218|NCT01164579|665189|P1|Overall Study|Reason not specified|1
209219|NCT01164579|665187|P3|Overall Study|Adverse Event|5
209220|NCT01164579|665188|P2|Overall Study|Adverse Event|2
209221|NCT01164579|665189|P1|Overall Study|Adverse Event|4
209222|NCT01164579|665187|P3|Overall Study|Protocol Violation|2
209223|NCT01164579|665188|P2|Overall Study|Protocol Violation|1
209224|NCT01164579|665189|P1|Overall Study|Protocol Violation|0
209225|NCT01164579|665187|P3|Overall Study|Withdrawal by Subject|3
209226|NCT01164579|665188|P2|Overall Study|Withdrawal by Subject|5
209227|NCT01164579|665189|P1|Overall Study|Withdrawal by Subject|2
209228|NCT01164579|665187|P3|Overall Study|Lost to Follow-up|0
209229|NCT01164579|665188|P2|Overall Study|Lost to Follow-up|1
209230|NCT01164579|665189|P1|Overall Study|Lost to Follow-up|1
209231|NCT01164579|665187|P3|Overall Study|Lack of Efficacy|6
209232|NCT01164579|665188|P2|Overall Study|Lack of Efficacy|0
209233|NCT01164579|665189|P1|Overall Study|Lack of Efficacy|0
209234|NCT01170364|665268|P2|Overall Study|Protocol Violation|1
209235|NCT01170364|665269|P1|Overall Study|Protocol Violation|4
209236|NCT01170598|665321|P1|Overall Study|Refused|1
209237|NCT01170598|665321|P1|Overall Study|Lost to Follow-up|1
209238|NCT01170598|665321|P1|Overall Study|Death|3
209239|NCT01170598|665321|P1|Overall Study|Withdrawal by Subject|1
209240|NCT01170663|665338|P2|Overall Study|Withdrawal of consent without follow-up|11
209241|NCT01170663|665339|P1|Overall Study|Withdrawal of consent without follow-up|8
209242|NCT01170663|665338|P2|Overall Study|Lost to Follow-up|9
209243|NCT01170663|665339|P1|Overall Study|Lost to Follow-up|3
209244|NCT01170663|665338|P2|Overall Study|Alive on treatment at data cut-off date|7
209245|NCT01170663|665339|P1|Overall Study|Alive on treatment at data cut-off date|13
209246|NCT01170962|665397|P3|Follow up Period|Others|3
209247|NCT01170962|665398|P2|Follow up Period|Others|7
209248|NCT01170962|665399|P1|Follow up Period|Others|10
209249|NCT01170962|665397|P3|Follow up Period|Death|0
209250|NCT01170962|665398|P2|Follow up Period|Death|2
209251|NCT01170962|665399|P1|Follow up Period|Death|2
209252|NCT01170962|665397|P3|Follow up Period|Lost to Follow-up|1
209253|NCT01170962|665398|P2|Follow up Period|Lost to Follow-up|8
209254|NCT01170962|665399|P1|Follow up Period|Lost to Follow-up|13
209255|NCT01170962|665397|P3|Follow up Period|Withdrawal by Subject|2
209256|NCT01170962|665398|P2|Follow up Period|Withdrawal by Subject|10
209257|NCT01170962|665399|P1|Follow up Period|Withdrawal by Subject|14
209258|NCT01170962|665397|P3|Treatment Period|Completed 24 Week treatment period only|0
209259|NCT01170962|665398|P2|Treatment Period|Completed 24 Week treatment period only|2
209260|NCT01170962|665399|P1|Treatment Period|Completed 24 Week treatment period only|10
209261|NCT01170962|665397|P3|Treatment Period|Request to discontinue treatment|1
209262|NCT01170962|665398|P2|Treatment Period|Request to discontinue treatment|3
209263|NCT01170962|665399|P1|Treatment Period|Request to discontinue treatment|7
209264|NCT01170962|665397|P3|Treatment Period|Participant no longer meets criteria|0
209265|NCT01170962|665398|P2|Treatment Period|Participant no longer meets criteria|1
209266|NCT01170962|665399|P1|Treatment Period|Participant no longer meets criteria|0
209267|NCT01170962|665397|P3|Treatment Period|Lost to Follow-up|1
209268|NCT01170962|665398|P2|Treatment Period|Lost to Follow-up|1
209269|NCT01170962|665399|P1|Treatment Period|Lost to Follow-up|1
209270|NCT01170962|665397|P3|Treatment Period|Withdrawal by Subject|0
209271|NCT01170962|665398|P2|Treatment Period|Withdrawal by Subject|1
209272|NCT01170962|665399|P1|Treatment Period|Withdrawal by Subject|2
209273|NCT01170962|665397|P3|Treatment Period|Adverse Event|3
209274|NCT01170962|665398|P2|Treatment Period|Adverse Event|12
209275|NCT01170962|665399|P1|Treatment Period|Adverse Event|11
209276|NCT01170962|665397|P3|Treatment Period|Lack of Efficacy|7
209277|NCT01170962|665398|P2|Treatment Period|Lack of Efficacy|91
209278|NCT01170962|665399|P1|Treatment Period|Lack of Efficacy|96
209279|NCT01171183|665455|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
209280|NCT01171183|665456|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
209281|NCT01171183|665455|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
209282|NCT01171183|665456|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
209283|NCT01171183|665455|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
209284|NCT01171183|665456|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
209285|NCT01171183|665455|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
209286|NCT01171183|665456|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
209287|NCT01171183|665455|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
209288|NCT01171183|665456|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
209289|NCT01171183|665455|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
209290|NCT01171183|665456|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
209291|NCT01171521|665464|P1|Overall Study|screen failure|1
209292|NCT01171521|665464|P1|Overall Study|Lost to Follow-up|5
209293|NCT01171534|665471|P2|Overall Study|screen failure|1
209294|NCT01171534|665472|P1|Overall Study|screen failure|0
209295|NCT01171534|665471|P2|Overall Study|Lost to Follow-up|2
209296|NCT01171534|665472|P1|Overall Study|Lost to Follow-up|0
209297|NCT01171612|665480|P1|Overall Study|Lost to Follow-up|51
209298|NCT01171677|665490|P2|Overall Study|completed <70% IntenSati classes|0
209299|NCT01171677|665491|P1|Overall Study|completed <70% IntenSati classes|5
209300|NCT01171677|665490|P2|Overall Study|Adverse Event|0
209301|NCT01171677|665491|P1|Overall Study|Adverse Event|1
209302|NCT01171677|665490|P2|Overall Study|Withdrawal by Subject|3
209303|NCT01171677|665491|P1|Overall Study|Withdrawal by Subject|0
209304|NCT01171820|665547|P2|Overall Study|1-Year Missed Visit|1
209305|NCT01171820|665548|P1|Overall Study|1-Year Missed Visit|1
209306|NCT01171820|665547|P2|Overall Study|Physician Decision|1
209307|NCT01171820|665548|P1|Overall Study|Physician Decision|0
209308|NCT01171820|665547|P2|Overall Study|Withdrawal by Subject|0
209309|NCT01171820|665548|P1|Overall Study|Withdrawal by Subject|2
209310|NCT01171820|665547|P2|Overall Study|Lost to Follow-up|1
209311|NCT01171820|665548|P1|Overall Study|Lost to Follow-up|0
209312|NCT01171820|665547|P2|Overall Study|Death|3
209313|NCT01171820|665548|P1|Overall Study|Death|3
209314|NCT01171963|665613|P2|Overall Study|Withdrawal by Subject|129
209315|NCT01171963|665614|P1|Overall Study|Withdrawal by Subject|114
209316|NCT01171963|665613|P2|Overall Study|Other - diarrhoea|0
209317|NCT01171963|665614|P1|Overall Study|Other - diarrhoea|1
209318|NCT01171963|665613|P2|Overall Study|Lost to Follow-up|24
209319|NCT01171963|665614|P1|Overall Study|Lost to Follow-up|23
209320|NCT01171963|665613|P2|Overall Study|Adverse Event|15
209321|NCT01171963|665614|P1|Overall Study|Adverse Event|10
209322|NCT01171976|665673|P3|Overall Study|Adverse Event|5
209323|NCT01171976|665674|P2|Overall Study|Adverse Event|2
209324|NCT01171976|665675|P1|Overall Study|Adverse Event|6
209325|NCT01171976|665673|P3|Overall Study|Abnormal test result|0
209326|NCT01171976|665674|P2|Overall Study|Abnormal test result|0
209327|NCT01171976|665675|P1|Overall Study|Abnormal test result|1
209328|NCT01171976|665673|P3|Overall Study|Withdrawal by Subject|6
209329|NCT01171976|665674|P2|Overall Study|Withdrawal by Subject|5
209330|NCT01171976|665675|P1|Overall Study|Withdrawal by Subject|1
209331|NCT01171976|665673|P3|Overall Study|Lost to Follow-up|2
209332|NCT01171976|665674|P2|Overall Study|Lost to Follow-up|0
209333|NCT01171976|665675|P1|Overall Study|Lost to Follow-up|4
209334|NCT01171976|665673|P3|Overall Study|Death|1
209335|NCT01171976|665674|P2|Overall Study|Death|4
209336|NCT01171976|665675|P1|Overall Study|Death|2
209337|NCT01171976|665673|P3|Overall Study|Protocol Violation|1
209338|NCT01171976|665674|P2|Overall Study|Protocol Violation|0
209339|NCT01171976|665675|P1|Overall Study|Protocol Violation|0
209340|NCT01171989|665713|P3|Overall Study|Lost to Follow-up|1
209341|NCT01171989|665714|P2|Overall Study|Lost to Follow-up|0
209342|NCT01171989|665715|P1|Overall Study|Lost to Follow-up|0
209343|NCT01172288|665817|P2|Overall Study|Protocol Violation|1
209344|NCT01172288|665818|P1|Overall Study|Protocol Violation|0
209345|NCT01172288|665817|P2|Overall Study|Adverse Event|0
209346|NCT01172288|665818|P1|Overall Study|Adverse Event|1
209347|NCT01172535|665860|P1|Overall Study|Unwilling to adhere to study requirement|1
209348|NCT01172535|665860|P1|Overall Study|Ineligible at study entry|1
209349|NCT01172535|665860|P1|Overall Study|Lost to Follow-up|1
209350|NCT01172535|665860|P1|Overall Study|Withdrawal by Subject|2
209351|NCT01172535|665860|P1|Overall Study|Death|3
209352|NCT01172808|665912|P4|Overall Study|Other|7
209353|NCT01172808|665913|P3|Overall Study|Other|9
209354|NCT01172808|665914|P2|Overall Study|Other|5
209355|NCT01172808|665915|P1|Overall Study|Other|6
209356|NCT01172808|665912|P4|Overall Study|Withdrawal by Subject|2
209357|NCT01172808|665913|P3|Overall Study|Withdrawal by Subject|3
209358|NCT01172808|665914|P2|Overall Study|Withdrawal by Subject|1
209359|NCT01172808|665915|P1|Overall Study|Withdrawal by Subject|4
209360|NCT01172808|665912|P4|Overall Study|Lost to Follow-up|3
209361|NCT01172808|665913|P3|Overall Study|Lost to Follow-up|1
209362|NCT01172808|665914|P2|Overall Study|Lost to Follow-up|1
209363|NCT01172808|665915|P1|Overall Study|Lost to Follow-up|0
209364|NCT01172808|665912|P4|Overall Study|Protocol Violation|0
209365|NCT01172808|665913|P3|Overall Study|Protocol Violation|2
209366|NCT01172808|665914|P2|Overall Study|Protocol Violation|2
209367|NCT01172808|665915|P1|Overall Study|Protocol Violation|2
209368|NCT01172808|665912|P4|Overall Study|Lack of Efficacy|0
209369|NCT01172808|665913|P3|Overall Study|Lack of Efficacy|0
209370|NCT01172808|665914|P2|Overall Study|Lack of Efficacy|0
209371|NCT01172808|665915|P1|Overall Study|Lack of Efficacy|1
209372|NCT01172808|665912|P4|Overall Study|Adverse Event|3
209373|NCT01172808|665913|P3|Overall Study|Adverse Event|8
209374|NCT01172808|665914|P2|Overall Study|Adverse Event|4
209375|NCT01172808|665915|P1|Overall Study|Adverse Event|8
209376|NCT01172821|666005|P4|Overall Study|Other|3
209377|NCT01172821|666006|P3|Overall Study|Other|5
209378|NCT01172821|666007|P2|Overall Study|Other|4
209379|NCT01172821|666008|P1|Overall Study|Other|3
209380|NCT01172821|666005|P4|Overall Study|Withdrawal by Subject|3
209381|NCT01172821|666006|P3|Overall Study|Withdrawal by Subject|3
209382|NCT01172821|666007|P2|Overall Study|Withdrawal by Subject|3
209383|NCT01172821|666008|P1|Overall Study|Withdrawal by Subject|2
209384|NCT01172821|666005|P4|Overall Study|Lost to Follow-up|2
209385|NCT01172821|666006|P3|Overall Study|Lost to Follow-up|2
209386|NCT01172821|666007|P2|Overall Study|Lost to Follow-up|1
209387|NCT01172821|666008|P1|Overall Study|Lost to Follow-up|4
209388|NCT01172821|666005|P4|Overall Study|Protocol Violation|2
209389|NCT01172821|666006|P3|Overall Study|Protocol Violation|1
209390|NCT01172821|666007|P2|Overall Study|Protocol Violation|2
209391|NCT01172821|666008|P1|Overall Study|Protocol Violation|0
209392|NCT01172821|666005|P4|Overall Study|Adverse Event|7
209393|NCT01172821|666006|P3|Overall Study|Adverse Event|2
209394|NCT01172821|666007|P2|Overall Study|Adverse Event|2
209395|NCT01172821|666008|P1|Overall Study|Adverse Event|5
209396|NCT01172847|666094|P1|Overall Study|Withdrawal by Subject|3
209397|NCT01172873|666121|P2|Overall Study|Withdrawal by Subject|2
209398|NCT01172873|666122|P1|Overall Study|Withdrawal by Subject|3
209399|NCT01172938|666135|P7|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
209400|NCT01172938|666136|P6|Active Treatment Phase (Weeks 25 - 52)|Not specified|1
209401|NCT01172938|666137|P5|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
209402|NCT01172938|666138|P4|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
209403|NCT01172938|666139|P3|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
209404|NCT01172938|666140|P2|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
209405|NCT01172938|666141|P1|Active Treatment Phase (Weeks 25 - 52)|Not specified|0
209406|NCT01172938|666135|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
209407|NCT01172938|666136|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
209408|NCT01172938|666137|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
209409|NCT01172938|666138|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
209410|NCT01172938|666139|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
209411|NCT01172938|666140|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
209412|NCT01172938|666141|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
209413|NCT01172938|666135|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
209414|NCT01172938|666136|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|9
209415|NCT01172938|666137|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
209416|NCT01172938|666138|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|2
209417|NCT01172938|666139|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
209418|NCT01172938|666140|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|5
209419|NCT01172938|666141|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
209420|NCT01172938|666135|P7|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
209421|NCT01172938|666136|P6|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
209422|NCT01172938|666137|P5|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
209423|NCT01172938|666138|P4|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
209424|NCT01172938|666139|P3|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|1
209425|NCT01172938|666140|P2|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
209426|NCT01172938|666141|P1|Active Treatment Phase (Weeks 25 - 52)|Non-compliance with Study Drug|0
209427|NCT01172938|666135|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
209428|NCT01172938|666136|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
209429|NCT01172938|666137|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
209430|NCT01172938|666138|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|3
209431|NCT01172938|666139|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
209432|NCT01172938|666140|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
209433|NCT01172938|666141|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
209434|NCT01172938|666135|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
209435|NCT01172938|666136|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
209436|NCT01172938|666137|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
209437|NCT01172938|666138|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
209438|NCT01172938|666139|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|5
209439|NCT01172938|666140|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
209440|NCT01172938|666141|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
209441|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
209442|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
209443|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
209444|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
209445|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Not specified|1
209446|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Not specified|2
209447|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Not specified|0
209448|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
209449|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
209450|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
209451|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
209452|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
209453|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
209454|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
209455|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Death|0
209456|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Death|0
209457|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Death|0
209458|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Death|0
209459|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Death|0
209460|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Death|1
209461|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Death|0
209462|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
209463|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
209464|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
209465|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
209466|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
209467|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|5
209468|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|2
209469|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
209470|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
209471|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
209472|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
209473|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|2
209474|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
209475|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
209476|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
209477|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
209478|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
209479|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
209480|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
209481|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
209482|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|4
209483|NCT01172938|666135|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
209484|NCT01172938|666136|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
209485|NCT01172938|666137|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
209486|NCT01172938|666138|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
209487|NCT01172938|666139|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
209488|NCT01172938|666140|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
209489|NCT01172938|666141|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|11
209490|NCT01173055|666340|P2|Period 2 - Day 64 to 112|Adverse Event|1
209491|NCT01173055|666341|P1|Period 2 - Day 64 to 112|Adverse Event|0
209492|NCT01173055|666340|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
209493|NCT01173055|666341|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
209494|NCT01173120|666357|P1|Overall Study|Switch-Difficulty With Device|12
209495|NCT01173120|666357|P1|Overall Study|Switch-Participant Decision|12
209496|NCT01173120|666357|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
209497|NCT01173120|666357|P1|Overall Study|Participant Decision|2
209498|NCT01173120|666357|P1|Overall Study|Lost to Follow-up|1
209499|NCT01173120|666357|P1|Overall Study|Lack of Efficacy|2
209500|NCT01167426|666485|P1|Overall Study|Sponsor Decision|1
209501|NCT01167426|666485|P1|Overall Study|Withdrawal by Subject|2
209502|NCT01167426|666485|P1|Overall Study|Protocol Violation|1
209503|NCT01167426|666485|P1|Overall Study|Lost to Follow-up|6
209504|NCT01167582|666503|P2|Overall Study|Lost to Follow-up|1
209505|NCT01167582|666504|P1|Overall Study|Lost to Follow-up|0
209506|NCT01167634|666529|P4|Overall Study|Withdrawal by Subject|0
209507|NCT01167634|666530|P3|Overall Study|Withdrawal by Subject|0
209508|NCT01167634|666531|P2|Overall Study|Withdrawal by Subject|1
209509|NCT01167634|666532|P1|Overall Study|Withdrawal by Subject|1
209510|NCT01167634|666529|P4|Overall Study|Lost to Follow-up|4
209511|NCT01167634|666530|P3|Overall Study|Lost to Follow-up|3
209512|NCT01167634|666531|P2|Overall Study|Lost to Follow-up|3
209513|NCT01167634|666532|P1|Overall Study|Lost to Follow-up|1
209514|NCT01173471|666559|P4|Overall Study|Reason given as Other|0
209515|NCT01173471|666560|P3|Overall Study|Reason given as Other|1
209516|NCT01173471|666561|P2|Overall Study|Reason given as Other|0
209517|NCT01173471|666562|P1|Overall Study|Reason given as Other|0
209518|NCT01173471|666559|P4|Overall Study|Lost to Follow-up|0
209519|NCT01173471|666560|P3|Overall Study|Lost to Follow-up|1
209520|NCT01173471|666561|P2|Overall Study|Lost to Follow-up|0
209521|NCT01173471|666562|P1|Overall Study|Lost to Follow-up|0
209522|NCT01173471|666559|P4|Overall Study|Condition under investigation worsened|0
209523|NCT01173471|666560|P3|Overall Study|Condition under investigation worsened|0
209524|NCT01173471|666561|P2|Overall Study|Condition under investigation worsened|0
209525|NCT01173471|666562|P1|Overall Study|Condition under investigation worsened|2
209526|NCT01173471|666559|P4|Overall Study|Eligibility criteria not fulfilled|1
209527|NCT01173471|666560|P3|Overall Study|Eligibility criteria not fulfilled|1
209528|NCT01173471|666561|P2|Overall Study|Eligibility criteria not fulfilled|0
209529|NCT01173471|666562|P1|Overall Study|Eligibility criteria not fulfilled|0
209530|NCT01173523|666582|P2|Overall Study|Other|3
209531|NCT01173523|666583|P1|Overall Study|Other|2
209532|NCT01173523|666582|P2|Overall Study|Progressive Disease|8
209533|NCT01173523|666583|P1|Overall Study|Progressive Disease|10
209534|NCT01173523|666582|P2|Overall Study|Clinical Progression|1
209535|NCT01173523|666583|P1|Overall Study|Clinical Progression|1
209536|NCT01173718|666595|P1|Overall Study|Abandonment of study graft|27
209537|NCT01173718|666595|P1|Overall Study|Death|17
209538|NCT01174004|666629|P2|Overall Study|Physician Decision|0
209539|NCT01174004|666630|P1|Overall Study|Physician Decision|1
209540|NCT01174004|666629|P2|Overall Study|Protocol Violation|1
209541|NCT01174004|666630|P1|Overall Study|Protocol Violation|0
209542|NCT01174004|666629|P2|Overall Study|At Discretion of Sponsor|2
209543|NCT01174004|666630|P1|Overall Study|At Discretion of Sponsor|2
209544|NCT01174004|666629|P2|Overall Study|Withdrawal by Subject|3
209545|NCT01174004|666630|P1|Overall Study|Withdrawal by Subject|2
209546|NCT01174004|666629|P2|Overall Study|Adverse Event|10
209547|NCT01174004|666630|P1|Overall Study|Adverse Event|2
209548|NCT01174043|666669|P1|Overall Study|Withdrawal by Subject|2
209549|NCT01174043|666669|P1|Overall Study|Death|1
209550|NCT01174043|666669|P1|Overall Study|Adverse Event|3
209551|NCT01174043|666669|P1|Overall Study|Disease progression|5
209552|NCT01174160|666677|P2|Overall Study|Withdrawal by Subject|0
209553|NCT01174160|666678|P1|Overall Study|Withdrawal by Subject|1
209554|NCT01174160|666677|P2|Overall Study|Protocol Violation|6
209555|NCT01174160|666678|P1|Overall Study|Protocol Violation|4
209556|NCT01174160|666677|P2|Overall Study|Physician Decision|0
209557|NCT01174160|666678|P1|Overall Study|Physician Decision|1
209558|NCT01174160|666677|P2|Overall Study|Lost to Follow-up|0
209559|NCT01174160|666678|P1|Overall Study|Lost to Follow-up|1
209560|NCT01174160|666677|P2|Overall Study|Adverse Event|0
209561|NCT01174160|666678|P1|Overall Study|Adverse Event|1
209562|NCT01174173|666684|P1|Overall Study|drug-drug interaction|1
209563|NCT01174186|666694|P2|Overall Study|Withdrawal by Subject|2
209564|NCT01174186|666695|P1|Overall Study|Withdrawal by Subject|0
209565|NCT01174186|666694|P2|Overall Study|Lost to Follow-up|1
209566|NCT01174186|666695|P1|Overall Study|Lost to Follow-up|0
209567|NCT01174264|666705|P3|Steady-state Pharmacokinetics|Not evaluable|2
209568|NCT01174264|666706|P2|Steady-state Pharmacokinetics|Not evaluable|0
209569|NCT01174264|666707|P1|Steady-state Pharmacokinetics|Not evaluable|6
209570|NCT01174264|666705|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
209571|NCT01174264|666706|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
209572|NCT01174264|666707|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
209654|NCT01175590|667290|P1|Overall Study|Lost to Follow-up|1
209573|NCT01174264|666705|P3|Single Dose Pharmacokinetics|Early progressive disease|1
209574|NCT01174264|666706|P2|Single Dose Pharmacokinetics|Early progressive disease|0
209575|NCT01174264|666707|P1|Single Dose Pharmacokinetics|Early progressive disease|1
209576|NCT01174342|666739|P1|Overall Study|Conversion to cesarean section|4
209577|NCT01174446|666743|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
209578|NCT01174446|666744|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
209579|NCT01174446|666745|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
209580|NCT01174446|666746|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
209581|NCT01174446|666743|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
209582|NCT01174446|666744|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
209583|NCT01174446|666745|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
209584|NCT01174446|666746|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
209585|NCT01174446|666743|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
209586|NCT01174446|666744|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
209587|NCT01174446|666745|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
209588|NCT01174446|666746|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
209589|NCT01174446|666743|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
209590|NCT01174446|666744|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
209591|NCT01174446|666745|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
209592|NCT01174446|666746|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
209593|NCT01174459|666933|P1|Overall Study|case report form (CRF) not collected|5
209594|NCT01174550|666940|P2|Overall Study|Withdrawal by Subject|289
209595|NCT01174550|666941|P1|Overall Study|Withdrawal by Subject|543
209596|NCT01174550|666940|P2|Overall Study|Lost to Follow-up|510
209597|NCT01174550|666941|P1|Overall Study|Lost to Follow-up|652
209598|NCT01174550|666940|P2|Overall Study|Death|74
209599|NCT01174550|666941|P1|Overall Study|Death|75
209600|NCT01175018|667022|P2|Overall Study|Adverse Event|1
209601|NCT01175018|667023|P1|Overall Study|Adverse Event|3
209602|NCT01175213|667079|P2|Safety Follow-up|Adverse Event|0
209603|NCT01175213|667080|P1|Safety Follow-up|Adverse Event|1
209604|NCT01175213|667079|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
209605|NCT01175213|667080|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
209606|NCT01175213|667079|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
209607|NCT01175213|667080|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
209608|NCT01175213|667079|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
209609|NCT01175213|667080|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
209610|NCT01175213|667079|P2|IGSC, 10%/rHuPH20|Death|0
209611|NCT01175213|667080|P1|IGSC, 10%/rHuPH20|Death|1
209612|NCT01175213|667079|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
209613|NCT01175213|667080|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
209614|NCT01175382|667167|P3|Overall Study|Unable to tolerate study meds|1
209615|NCT01175382|667168|P2|Overall Study|Unable to tolerate study meds|1
209616|NCT01175382|667169|P1|Overall Study|Unable to tolerate study meds|0
209617|NCT01175382|667167|P3|Overall Study|Unwilling to follow protocol|0
209618|NCT01175382|667168|P2|Overall Study|Unwilling to follow protocol|1
209619|NCT01175382|667169|P1|Overall Study|Unwilling to follow protocol|0
209620|NCT01175382|667167|P3|Overall Study|Unable/unwilling to attend visits|2
209621|NCT01175382|667168|P2|Overall Study|Unable/unwilling to attend visits|1
209622|NCT01175382|667169|P1|Overall Study|Unable/unwilling to attend visits|3
209623|NCT01175382|667167|P3|Overall Study|No longer having problem|1
209624|NCT01175382|667168|P2|Overall Study|No longer having problem|0
209625|NCT01175382|667169|P1|Overall Study|No longer having problem|1
209626|NCT01175382|667167|P3|Overall Study|Withdrawal by Subject|1
209627|NCT01175382|667168|P2|Overall Study|Withdrawal by Subject|0
209628|NCT01175382|667169|P1|Overall Study|Withdrawal by Subject|0
209629|NCT01175382|667167|P3|Overall Study|Physician Decision|0
209630|NCT01175382|667168|P2|Overall Study|Physician Decision|1
209631|NCT01175382|667169|P1|Overall Study|Physician Decision|0
209632|NCT01175382|667167|P3|Overall Study|Lost to Follow-up|1
209633|NCT01175382|667168|P2|Overall Study|Lost to Follow-up|3
209634|NCT01175382|667169|P1|Overall Study|Lost to Follow-up|4
209635|NCT01175473|667262|P2|Overall Study|Adverse Event|2
209636|NCT01175473|667263|P1|Overall Study|Adverse Event|2
209637|NCT01175590|667289|P2|Overall Study|Protocol Violation|1
209638|NCT01175590|667290|P1|Overall Study|Protocol Violation|0
209639|NCT01175590|667289|P2|Overall Study|Herpes Simplex Dermatitis|0
209640|NCT01175590|667290|P1|Overall Study|Herpes Simplex Dermatitis|1
209641|NCT01175590|667289|P2|Overall Study|Treated not as randomized|2
209642|NCT01175590|667290|P1|Overall Study|Treated not as randomized|3
209643|NCT01175590|667289|P2|Overall Study|Residual Bacterial Conjunctivitis|0
209644|NCT01175590|667290|P1|Overall Study|Residual Bacterial Conjunctivitis|1
209645|NCT01175590|667289|P2|Overall Study|Lack of Efficacy|1
209646|NCT01175590|667290|P1|Overall Study|Lack of Efficacy|1
209647|NCT01175590|667289|P2|Overall Study|Physician Decision|4
209648|NCT01175590|667290|P1|Overall Study|Physician Decision|1
209649|NCT01175590|667289|P2|Overall Study|Adverse Event|0
209650|NCT01175590|667290|P1|Overall Study|Adverse Event|4
209651|NCT01175590|667289|P2|Overall Study|Withdrawal by Subject|2
209652|NCT01175590|667290|P1|Overall Study|Withdrawal by Subject|0
209653|NCT01175590|667289|P2|Overall Study|Lost to Follow-up|0
209655|NCT01175668|667324|P2|Overall Study|Withdrawal by Subject|0
209656|NCT01175668|667325|P1|Overall Study|Withdrawal by Subject|2
209657|NCT01175707|667335|P2|Overall Study|Adverse Event|6
209658|NCT01175707|667336|P1|Overall Study|Adverse Event|4
209659|NCT01175811|667381|P2|Overall Study|Withdrawal by Subject|7
209660|NCT01175811|667382|P1|Overall Study|Withdrawal by Subject|6
209661|NCT01175811|667381|P2|Overall Study|Protocol Violation|2
209662|NCT01175811|667382|P1|Overall Study|Protocol Violation|1
209663|NCT01175811|667381|P2|Overall Study|Physician Decision|1
209664|NCT01175811|667382|P1|Overall Study|Physician Decision|1
209665|NCT01175811|667381|P2|Overall Study|Lost to Follow-up|2
209666|NCT01175811|667382|P1|Overall Study|Lost to Follow-up|3
209667|NCT01175811|667381|P2|Overall Study|Lack of Efficacy|0
209668|NCT01175811|667382|P1|Overall Study|Lack of Efficacy|1
209669|NCT01175811|667381|P2|Overall Study|Entry criteria not met|1
209670|NCT01175811|667382|P1|Overall Study|Entry criteria not met|3
209671|NCT01175811|667381|P2|Overall Study|Adverse Event|1
209672|NCT01175811|667382|P1|Overall Study|Adverse Event|1
209673|NCT01175824|667408|P2|Overall Study|Entry Criteria Not Met|4
209674|NCT01175824|667409|P1|Overall Study|Entry Criteria Not Met|6
209675|NCT01175824|667408|P2|Overall Study|Sponsor Decision|0
209676|NCT01175824|667409|P1|Overall Study|Sponsor Decision|1
209677|NCT01175824|667408|P2|Overall Study|Withdrawal by Subject|7
209678|NCT01175824|667409|P1|Overall Study|Withdrawal by Subject|3
209679|NCT01175824|667408|P2|Overall Study|Protocol Violation|5
209680|NCT01175824|667409|P1|Overall Study|Protocol Violation|2
209681|NCT01175824|667408|P2|Overall Study|Physician Decision|4
209682|NCT01175824|667409|P1|Overall Study|Physician Decision|0
209683|NCT01175824|667408|P2|Overall Study|Lost to Follow-up|1
209684|NCT01175824|667409|P1|Overall Study|Lost to Follow-up|0
209685|NCT01175824|667408|P2|Overall Study|Lack of Efficacy|0
209686|NCT01175824|667409|P1|Overall Study|Lack of Efficacy|2
209687|NCT01175824|667408|P2|Overall Study|Adverse Event|1
209688|NCT01175824|667409|P1|Overall Study|Adverse Event|2
209689|NCT01176032|667507|P2|Overall Study|Not available|0
209690|NCT01176032|667508|P1|Overall Study|Not available|1
209691|NCT01176032|667507|P2|Overall Study|Informed consent withdrawn|0
209692|NCT01176032|667508|P1|Overall Study|Informed consent withdrawn|3
209693|NCT01176032|667507|P2|Overall Study|Protocol Violation|0
209694|NCT01176032|667508|P1|Overall Study|Protocol Violation|1
209695|NCT01176032|667507|P2|Overall Study|Unsatisfactory therapeutic effect|1
209696|NCT01176032|667508|P1|Overall Study|Unsatisfactory therapeutic effect|0
209697|NCT01176032|667507|P2|Overall Study|Adverse Event|0
209698|NCT01176032|667508|P1|Overall Study|Adverse Event|1
209699|NCT01176058|667568|P2|Overall Study|Withdrawal by Subject|0
209700|NCT01176058|667569|P1|Overall Study|Withdrawal by Subject|1
209701|NCT01176058|667568|P2|Overall Study|Insufficient mycological response|1
209702|NCT01176058|667569|P1|Overall Study|Insufficient mycological response|0
209703|NCT01176058|667568|P2|Overall Study|Insufficient clinical response|2
209704|NCT01176058|667569|P1|Overall Study|Insufficient clinical response|2
209705|NCT01176058|667568|P2|Overall Study|Adverse Event|0
209706|NCT01176058|667569|P1|Overall Study|Adverse Event|1
209707|NCT01176240|667595|P2|Study 306B|withdrew prior to dosing|1
209708|NCT01176240|667596|P1|Study 306B|withdrew prior to dosing|2
209709|NCT01176240|667595|P2|Study 306B|Lost to Follow-up|1
209710|NCT01176240|667596|P1|Study 306B|Lost to Follow-up|0
209711|NCT01176240|667595|P2|Study 306B|Supine Hypertension|2
209712|NCT01176240|667596|P1|Study 306B|Supine Hypertension|1
209713|NCT01176240|667595|P2|Study 306B|Physician Decision|1
209714|NCT01176240|667596|P1|Study 306B|Physician Decision|2
209715|NCT01176240|667595|P2|Study 306B|Withdrawal by Subject|1
209716|NCT01176240|667596|P1|Study 306B|Withdrawal by Subject|4
209717|NCT01176240|667595|P2|Study 306B|Protocol Violation|3
209718|NCT01176240|667596|P1|Study 306B|Protocol Violation|2
209719|NCT01176240|667595|P2|Study 306B|Adverse Event|5
209720|NCT01176240|667596|P1|Study 306B|Adverse Event|10
209721|NCT01176240|667595|P2|Study 306B|Lack of Efficacy|3
209722|NCT01176240|667596|P1|Study 306B|Lack of Efficacy|5
209723|NCT01176240|667595|P2|Study 306A|Stop due to diverse problems|0
209724|NCT01176240|667596|P1|Study 306A|Stop due to diverse problems|1
209725|NCT01176240|667595|P2|Study 306A|Withdrawal by Subject|1
209726|NCT01176240|667596|P1|Study 306A|Withdrawal by Subject|0
209727|NCT01176240|667595|P2|Study 306A|Protocol Violation|1
209728|NCT01176240|667596|P1|Study 306A|Protocol Violation|0
209729|NCT01176240|667595|P2|Study 306A|Lack of Efficacy|1
209730|NCT01176240|667596|P1|Study 306A|Lack of Efficacy|2
209731|NCT01176292|667622|P2|Overall Study|Has not scheduled one-year visit yet|2
209732|NCT01176292|667623|P1|Overall Study|Has not scheduled one-year visit yet|2
209733|NCT01176292|667622|P2|Overall Study|Physician Decision|2
209734|NCT01176292|667623|P1|Overall Study|Physician Decision|0
209735|NCT01176292|667622|P2|Overall Study|Adverse Event|1
209736|NCT01176292|667623|P1|Overall Study|Adverse Event|1
209737|NCT01176292|667622|P2|Overall Study|Lost to Follow-up|4
209738|NCT01176292|667623|P1|Overall Study|Lost to Follow-up|2
209739|NCT01176513|667649|P1|Overall Study|Withdrew subjects prior to dosing|3
209740|NCT01179191|667654|P1|Maintenance Phase (8 Weeks)|Unspecified|66
209741|NCT01179191|667654|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
209742|NCT01179191|667654|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
209743|NCT01179191|667654|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
209744|NCT01179191|667654|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
209745|NCT01179191|667654|P1|Titration Phase (up to 6 Weeks)|Unspecified|62
209746|NCT01179191|667654|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
209747|NCT01179191|667654|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
209748|NCT01179191|667654|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
209749|NCT01179191|667654|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
209750|NCT01179191|667654|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
209751|NCT01179334|667700|P2|Long-term Extension (LTE) Period|Adverse Event|4
209752|NCT01179334|667701|P1|Long-term Extension (LTE) Period|Adverse Event|2
209753|NCT01179334|667700|P2|Long-term Extension (LTE) Period|Death|0
209754|NCT01179334|667701|P1|Long-term Extension (LTE) Period|Death|3
209755|NCT01179334|667700|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
209756|NCT01179334|667701|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
209757|NCT01179334|667700|P2|Treatment Period|Adverse Event|0
209758|NCT01179334|667701|P1|Treatment Period|Adverse Event|1
209759|NCT01179347|667731|P2|Open-label Period (12 Weeks)|Other|4
209760|NCT01179347|667732|P1|Open-label Period (12 Weeks)|Other|7
209761|NCT01179347|667731|P2|Open-label Period (12 Weeks)|Protocol Violation|0
209762|NCT01179347|667732|P1|Open-label Period (12 Weeks)|Protocol Violation|1
209763|NCT01179347|667731|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
209764|NCT01179347|667732|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
209765|NCT01179347|667731|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
209766|NCT01179347|667732|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
209767|NCT01179347|667731|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
209768|NCT01179347|667732|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
209769|NCT01179347|667731|P2|Open-label Period (12 Weeks)|Adverse Event|9
209770|NCT01179347|667732|P1|Open-label Period (12 Weeks)|Adverse Event|5
209771|NCT01179347|667731|P2|Double-blind Period (12 Weeks)|Other|4
209772|NCT01179347|667732|P1|Double-blind Period (12 Weeks)|Other|2
209773|NCT01179347|667731|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
209774|NCT01179347|667732|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
209775|NCT01179347|667731|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
209776|NCT01179347|667732|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
209777|NCT01179347|667731|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
209778|NCT01179347|667732|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
209779|NCT01179347|667731|P2|Double-blind Period (12 Weeks)|Adverse Event|6
209780|NCT01179347|667732|P1|Double-blind Period (12 Weeks)|Adverse Event|2
209781|NCT01179399|667752|P1|Overall Study|Withdrawal by Subject|1
209782|NCT01179399|667752|P1|Overall Study|Lack of Efficacy|30
209783|NCT01179399|667752|P1|Overall Study|Adverse Event|1
209784|NCT01179516|667780|P3|Overall Study|Other|2
209785|NCT01179516|667781|P2|Overall Study|Other|0
209786|NCT01179516|667782|P1|Overall Study|Other|2
209787|NCT01179516|667780|P3|Overall Study|Lost to Follow-up|3
209788|NCT01179516|667781|P2|Overall Study|Lost to Follow-up|7
209789|NCT01179516|667782|P1|Overall Study|Lost to Follow-up|7
209790|NCT01179516|667780|P3|Overall Study|Withdrawal of Consent|10
209791|NCT01179516|667781|P2|Overall Study|Withdrawal of Consent|6
209792|NCT01179516|667782|P1|Overall Study|Withdrawal of Consent|2
209793|NCT01179516|667780|P3|Overall Study|Protocol Deviations|3
209794|NCT01179516|667781|P2|Overall Study|Protocol Deviations|3
209795|NCT01179516|667782|P1|Overall Study|Protocol Deviations|4
209796|NCT01179516|667780|P3|Overall Study|Noncompliance with Study Drug|1
209797|NCT01179516|667781|P2|Overall Study|Noncompliance with Study Drug|0
209798|NCT01179516|667782|P1|Overall Study|Noncompliance with Study Drug|2
209799|NCT01179516|667780|P3|Overall Study|Lack of Efficacy|0
209800|NCT01179516|667781|P2|Overall Study|Lack of Efficacy|2
209801|NCT01179516|667782|P1|Overall Study|Lack of Efficacy|4
209802|NCT01179516|667780|P3|Overall Study|Pretreatment Event or Adverse Event|12
209803|NCT01179516|667781|P2|Overall Study|Pretreatment Event or Adverse Event|8
209804|NCT01179516|667782|P1|Overall Study|Pretreatment Event or Adverse Event|6
209805|NCT01179672|667834|P2|Overall Study|Physician Decision|1
209806|NCT01179672|667835|P1|Overall Study|Physician Decision|1
209807|NCT01179672|667834|P2|Overall Study|Protocol Violation|2
209808|NCT01179672|667835|P1|Overall Study|Protocol Violation|2
209809|NCT01179672|667834|P2|Overall Study|Lost to Follow-up|1
209810|NCT01179672|667835|P1|Overall Study|Lost to Follow-up|0
209811|NCT01179672|667834|P2|Overall Study|Entry Criteria Not Met|2
209812|NCT01179672|667835|P1|Overall Study|Entry Criteria Not Met|0
209813|NCT01179672|667834|P2|Overall Study|Withdrawal by Subject|12
209814|NCT01179672|667835|P1|Overall Study|Withdrawal by Subject|10
209815|NCT01179672|667834|P2|Overall Study|Adverse Event|8
209816|NCT01179672|667835|P1|Overall Study|Adverse Event|17
209817|NCT01173653|667863|P2|Overall Study|Pts unwilling to provide follow-up|41
209818|NCT01173653|667864|P1|Overall Study|Pts unwilling to provide follow-up|53
209819|NCT01173679|667870|P1|Overall Study|Death|1
209820|NCT01176773|667876|P1|Overall Study|Withdrew consent|1
209821|NCT01176773|667876|P1|Overall Study|Screen Failure|2
209822|NCT01176968|667905|P2|Overall Study|Reason not defined|3
209823|NCT01176968|667906|P1|Overall Study|Reason not defined|5
209824|NCT01176968|667905|P2|Overall Study|Study terminated by sponsor|1
209825|NCT01176968|667906|P1|Overall Study|Study terminated by sponsor|0
209826|NCT01176968|667905|P2|Overall Study|Did Not Meet Entrance Criteria|0
209827|NCT01176968|667906|P1|Overall Study|Did Not Meet Entrance Criteria|1
209828|NCT01176968|667905|P2|Overall Study|Protocol Violation|1
209829|NCT01176968|667906|P1|Overall Study|Protocol Violation|2
209830|NCT01176968|667905|P2|Overall Study|Withdrawal by Subject|48
209831|NCT01176968|667906|P1|Overall Study|Withdrawal by Subject|48
209832|NCT01176968|667905|P2|Overall Study|Lost to Follow-up|14
209833|NCT01176968|667906|P1|Overall Study|Lost to Follow-up|16
209834|NCT01176968|667905|P2|Overall Study|Lack of Efficacy|1
209835|NCT01176968|667906|P1|Overall Study|Lack of Efficacy|0
209836|NCT01176968|667905|P2|Overall Study|Death|3
209837|NCT01176968|667906|P1|Overall Study|Death|2
209838|NCT01176968|667905|P2|Overall Study|Adverse Event|11
209839|NCT01176968|667906|P1|Overall Study|Adverse Event|10
209840|NCT01177007|667938|P1|Overall Study|Change in treatment modality|21
209841|NCT01177007|667938|P1|Overall Study|Required additional Y90 treatment|6
209842|NCT01177007|667938|P1|Overall Study|Entered hospice care|5
209843|NCT01177007|667938|P1|Overall Study|Death|4
209844|NCT01177007|667938|P1|Overall Study|Lost to Follow-up|2
209845|NCT01177228|667973|P4|Overall Study|Withdrawal by Subject|0
209846|NCT01177228|667974|P3|Overall Study|Withdrawal by Subject|0
209847|NCT01177228|667975|P2|Overall Study|Withdrawal by Subject|1
209848|NCT01177228|667976|P1|Overall Study|Withdrawal by Subject|0
209849|NCT01177228|667973|P4|Overall Study|Worsening disease activity|0
209850|NCT01177228|667974|P3|Overall Study|Worsening disease activity|0
209851|NCT01177228|667975|P2|Overall Study|Worsening disease activity|0
209852|NCT01177228|667976|P1|Overall Study|Worsening disease activity|1
209853|NCT01177228|667973|P4|Overall Study|Positive tuberculosis test|0
209854|NCT01177228|667974|P3|Overall Study|Positive tuberculosis test|0
209855|NCT01177228|667975|P2|Overall Study|Positive tuberculosis test|1
209856|NCT01177228|667976|P1|Overall Study|Positive tuberculosis test|0
209857|NCT01177293|668014|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
209858|NCT01177293|668015|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
209859|NCT01177384|668031|P2|Overall Study|Withdrawal by Subject|12
209860|NCT01177384|668032|P1|Overall Study|Withdrawal by Subject|5
209861|NCT01177384|668031|P2|Overall Study|Protocol Violation|2
209862|NCT01177384|668032|P1|Overall Study|Protocol Violation|0
209863|NCT01177384|668031|P2|Overall Study|Physician Decision|3
209864|NCT01177384|668032|P1|Overall Study|Physician Decision|0
209865|NCT01177384|668031|P2|Overall Study|Lost to Follow-up|4
209866|NCT01177384|668032|P1|Overall Study|Lost to Follow-up|3
209867|NCT01177384|668031|P2|Overall Study|Lack of Efficacy|1
209868|NCT01177384|668032|P1|Overall Study|Lack of Efficacy|0
209869|NCT01177384|668031|P2|Overall Study|Adverse Event|4
209870|NCT01177384|668032|P1|Overall Study|Adverse Event|6
209871|NCT01177410|668047|P3|Overall Study|Lost to Follow-up|0
209872|NCT01177410|668048|P2|Overall Study|Lost to Follow-up|1
209873|NCT01177410|668049|P1|Overall Study|Lost to Follow-up|0
209874|NCT01177410|668047|P3|Overall Study|Withdrawal by Subject|3
209875|NCT01177410|668048|P2|Overall Study|Withdrawal by Subject|4
209876|NCT01177410|668049|P1|Overall Study|Withdrawal by Subject|1
209877|NCT01177410|668047|P3|Overall Study|Adverse Event|2
209878|NCT01177410|668048|P2|Overall Study|Adverse Event|2
209879|NCT01177410|668049|P1|Overall Study|Adverse Event|0
209880|NCT01177553|668062|P2|Overall Study|babies not yet 6 months of age|0
209881|NCT01177553|668063|P1|Overall Study|babies not yet 6 months of age|1
209882|NCT01177670|668069|P1|Overall Study|Withdrawal by Subject|4
209883|NCT01177670|668069|P1|Overall Study|Physician Decision|50
209884|NCT01177670|668069|P1|Overall Study|Study Terminated|115
209885|NCT01177722|668084|P4|Overall Study|Withdrawal by Subject|6
209886|NCT01177722|668085|P3|Overall Study|Withdrawal by Subject|4
209887|NCT01177722|668086|P2|Overall Study|Withdrawal by Subject|6
209888|NCT01177722|668087|P1|Overall Study|Withdrawal by Subject|10
209889|NCT01177722|668084|P4|Overall Study|Lost to Follow-up|1
209890|NCT01177722|668085|P3|Overall Study|Lost to Follow-up|3
209891|NCT01177722|668086|P2|Overall Study|Lost to Follow-up|4
209892|NCT01177722|668087|P1|Overall Study|Lost to Follow-up|3
209893|NCT01177722|668084|P4|Overall Study|Protocol Violation|0
209894|NCT01177722|668085|P3|Overall Study|Protocol Violation|1
209895|NCT01177722|668086|P2|Overall Study|Protocol Violation|0
209896|NCT01177722|668087|P1|Overall Study|Protocol Violation|0
209897|NCT01177722|668084|P4|Overall Study|Serious Adverse Event|0
209898|NCT01177722|668085|P3|Overall Study|Serious Adverse Event|1
209899|NCT01177722|668086|P2|Overall Study|Serious Adverse Event|0
209900|NCT01177722|668087|P1|Overall Study|Serious Adverse Event|0
209901|NCT01177800|668119|P2|Overall Study|Withdrawal of informed consent|1
209902|NCT01177800|668120|P1|Overall Study|Withdrawal of informed consent|0
209903|NCT01177800|668119|P2|Overall Study|Physician Decision|0
209904|NCT01177800|668120|P1|Overall Study|Physician Decision|1
209905|NCT01177800|668119|P2|Overall Study|Protocol Violation|1
209906|NCT01177800|668120|P1|Overall Study|Protocol Violation|0
209907|NCT01177800|668119|P2|Overall Study|Adverse Event|3
209908|NCT01177800|668120|P1|Overall Study|Adverse Event|9
209909|NCT01177813|668139|P5|Overall Study|Other reason not defined above|2
209910|NCT01177813|668140|P4|Overall Study|Other reason not defined above|3
209911|NCT01177813|668141|P3|Overall Study|Other reason not defined above|2
209912|NCT01177813|668142|P2|Overall Study|Other reason not defined above|2
209913|NCT01177813|668143|P1|Overall Study|Other reason not defined above|5
209914|NCT01177813|668139|P5|Overall Study|Withdrawal by Subject|3
209915|NCT01177813|668140|P4|Overall Study|Withdrawal by Subject|5
209916|NCT01177813|668141|P3|Overall Study|Withdrawal by Subject|6
209917|NCT01177813|668142|P2|Overall Study|Withdrawal by Subject|7
209918|NCT01177813|668143|P1|Overall Study|Withdrawal by Subject|12
209919|NCT01177813|668139|P5|Overall Study|Lost to Follow-up|0
209920|NCT01177813|668140|P4|Overall Study|Lost to Follow-up|3
209921|NCT01177813|668141|P3|Overall Study|Lost to Follow-up|6
209922|NCT01177813|668142|P2|Overall Study|Lost to Follow-up|5
209923|NCT01177813|668143|P1|Overall Study|Lost to Follow-up|12
209924|NCT01177813|668139|P5|Overall Study|Protocol Violation|1
209925|NCT01177813|668140|P4|Overall Study|Protocol Violation|0
209926|NCT01177813|668141|P3|Overall Study|Protocol Violation|2
209927|NCT01177813|668142|P2|Overall Study|Protocol Violation|2
209928|NCT01177813|668143|P1|Overall Study|Protocol Violation|3
209929|NCT01177813|668139|P5|Overall Study|Lack of Efficacy|0
209930|NCT01177813|668140|P4|Overall Study|Lack of Efficacy|0
209931|NCT01177813|668141|P3|Overall Study|Lack of Efficacy|0
209932|NCT01177813|668142|P2|Overall Study|Lack of Efficacy|0
209933|NCT01177813|668143|P1|Overall Study|Lack of Efficacy|1
209934|NCT01177813|668139|P5|Overall Study|Adverse Event|3
209935|NCT01177813|668140|P4|Overall Study|Adverse Event|6
209936|NCT01177813|668141|P3|Overall Study|Adverse Event|4
209937|NCT01177813|668142|P2|Overall Study|Adverse Event|2
209938|NCT01177813|668143|P1|Overall Study|Adverse Event|8
209939|NCT01177943|668172|P2|First Intervention|Withdrawal by Subject|0
209940|NCT01177943|668173|P1|First Intervention|Withdrawal by Subject|2
209941|NCT01177969|668196|P2|Overall Study|Withdrawal by Subject|2
209942|NCT01177969|668197|P1|Overall Study|Withdrawal by Subject|1
209943|NCT01177969|668196|P2|Overall Study|Protocol Violation|1
209944|NCT01177969|668197|P1|Overall Study|Protocol Violation|2
209945|NCT01178073|668208|P3|Overall Study|Missing Completion Status|0
209946|NCT01178073|668209|P2|Overall Study|Missing Completion Status|0
209947|NCT01178073|668210|P1|Overall Study|Missing Completion Status|1
209948|NCT01178073|668208|P3|Overall Study|Withdrawal by Subject|8
209949|NCT01178073|668209|P2|Overall Study|Withdrawal by Subject|6
209950|NCT01178073|668210|P1|Overall Study|Withdrawal by Subject|10
209951|NCT01178073|668208|P3|Overall Study|Physician Decision|10
209952|NCT01178073|668209|P2|Overall Study|Physician Decision|10
209953|NCT01178073|668210|P1|Overall Study|Physician Decision|14
209954|NCT01178073|668208|P3|Overall Study|Lost to Follow-up|3
209955|NCT01178073|668209|P2|Overall Study|Lost to Follow-up|0
209956|NCT01178073|668210|P1|Overall Study|Lost to Follow-up|2
209957|NCT01178073|668208|P3|Overall Study|Protocol Violation|1
209958|NCT01178073|668209|P2|Overall Study|Protocol Violation|1
209959|NCT01178073|668210|P1|Overall Study|Protocol Violation|1
209960|NCT01178073|668208|P3|Overall Study|Adverse Event|24
209961|NCT01178073|668209|P2|Overall Study|Adverse Event|27
209962|NCT01178073|668210|P1|Overall Study|Adverse Event|34
209963|NCT01178099|668243|P2|Overall Study|Physician Decision|1
209964|NCT01178099|668244|P1|Overall Study|Physician Decision|0
209965|NCT01178125|668282|P1|Overall Study|Investigator Decision|5
209966|NCT01178125|668282|P1|Overall Study|Protocol Violation|17
209967|NCT01178125|668282|P1|Overall Study|Sponsor Decision|28
209968|NCT01178125|668282|P1|Overall Study|Other Reason|39
209969|NCT01178125|668282|P1|Overall Study|Pregnancy|55
209970|NCT01178125|668282|P1|Overall Study|Noncompliance|184
209971|NCT01178125|668282|P1|Overall Study|Withdrawal by Subject|209
209972|NCT01178125|668282|P1|Overall Study|Adverse Event|244
209973|NCT01178125|668282|P1|Overall Study|Lost to Follow-up|397
209974|NCT01178138|668309|P1|Overall Study|Physician Decision|8
209975|NCT01178138|668309|P1|Overall Study|Withdrawal by Subject|7
209976|NCT01178138|668309|P1|Overall Study|Lost to Follow-up|8
209977|NCT01178281|668552|P2|Overall Study|Prohibited Medications|2
209978|NCT01178281|668553|P1|Overall Study|Prohibited Medications|0
209979|NCT01178281|668552|P2|Overall Study|Adverse Event|9
209980|NCT01178281|668553|P1|Overall Study|Adverse Event|39
209981|NCT01178281|668552|P2|Overall Study|Withdrawal by Subject|7
209982|NCT01178281|668553|P1|Overall Study|Withdrawal by Subject|18
209983|NCT01178281|668552|P2|Overall Study|Death|5
209984|NCT01178281|668553|P1|Overall Study|Death|4
209985|NCT01178281|668552|P2|Overall Study|Disease Progression|6
209986|NCT01178281|668553|P1|Overall Study|Disease Progression|18
209987|NCT01178281|668552|P2|Overall Study|Non-compliance to study drug|0
209988|NCT01178281|668553|P1|Overall Study|Non-compliance to study drug|1
209989|NCT01178281|668552|P2|Overall Study|Lack of Efficacy|38
209990|NCT01178281|668553|P1|Overall Study|Lack of Efficacy|60
209991|NCT01178281|668552|P2|Overall Study|Loss of Clinical Benefit|7
209992|NCT01178281|668553|P1|Overall Study|Loss of Clinical Benefit|5
209993|NCT01178281|668552|P2|Overall Study|Physician Decision|3
209994|NCT01178281|668553|P1|Overall Study|Physician Decision|4
209995|NCT01178294|668559|P1|Overall Study|Completion status could not be verified|1
209996|NCT01178294|668559|P1|Overall Study|Subject status is terminal|1
209997|NCT01178294|668559|P1|Overall Study|Development of inhibitors to OBI-1|1
209998|NCT01178294|668559|P1|Overall Study|Death|1
209999|NCT01178294|668559|P1|Overall Study|Lack of Efficacy|1
210000|NCT01178294|668559|P1|Overall Study|Lost to Follow-up|2
210001|NCT01178294|668559|P1|Overall Study|Adverse Event|4
210002|NCT01178385|668641|P2|Overall Study|Withdrawal by Subject|0
210003|NCT01178385|668642|P1|Overall Study|Withdrawal by Subject|2
210004|NCT01178671|668676|P2|Overall Study|Physician Decision|6
210005|NCT01178671|668677|P1|Overall Study|Physician Decision|4
210006|NCT01178671|668676|P2|Overall Study|Lost to Follow-up|1
210007|NCT01178671|668677|P1|Overall Study|Lost to Follow-up|3
210008|NCT01178671|668676|P2|Overall Study|Lack of Efficacy|1
210009|NCT01178671|668677|P1|Overall Study|Lack of Efficacy|0
210010|NCT01178671|668676|P2|Overall Study|Protocol Violation|1
210011|NCT01178671|668677|P1|Overall Study|Protocol Violation|1
210012|NCT01178671|668676|P2|Overall Study|Adverse Event|6
210013|NCT01178671|668677|P1|Overall Study|Adverse Event|4
210014|NCT01178762|668701|P1|Overall Study|Lost to Follow-up|15
210015|NCT01178853|668741|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
210016|NCT01178853|668742|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
210017|NCT01178853|668741|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
210018|NCT01178853|668742|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
210019|NCT01178853|668741|P2|Period 3 (Warfarin Titration)|Adverse Event|0
210020|NCT01178853|668742|P1|Period 3 (Warfarin Titration)|Adverse Event|1
210021|NCT01178853|668741|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
210022|NCT01178853|668742|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
210023|NCT01178853|668741|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
210024|NCT01178853|668742|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
210025|NCT01179048|668750|P2|Overall Study|Alive|142
210026|NCT01179048|668751|P1|Overall Study|Alive|127
210027|NCT01179048|668750|P2|Overall Study|Lost to Follow-up|9
210028|NCT01179048|668751|P1|Overall Study|Lost to Follow-up|8
210029|NCT01179048|668750|P2|Overall Study|Withdrawn - does not allow contact|8
210030|NCT01179048|668751|P1|Overall Study|Withdrawn - does not allow contact|4
210031|NCT01176565|668782|P2|Overall Study|Not Analyzed (any other reason)|2
210032|NCT01176565|668783|P1|Overall Study|Not Analyzed (any other reason)|1
210033|NCT01176565|668782|P2|Overall Study|Withdrawal by Subject|1
210034|NCT01176565|668783|P1|Overall Study|Withdrawal by Subject|7
210035|NCT01176565|668782|P2|Overall Study|Lost to Follow-up|16
210036|NCT01176565|668783|P1|Overall Study|Lost to Follow-up|12
210038|NCT02223364|668878|P3|Overall Study|Physician Decision|0
210039|NCT02223364|668879|P2|Overall Study|Physician Decision|0
210040|NCT02223364|668880|P1|Overall Study|Physician Decision|1
210041|NCT02223364|668878|P3|Overall Study|subject expired before surgery|0
210042|NCT02223364|668879|P2|Overall Study|subject expired before surgery|0
210043|NCT02223364|668880|P1|Overall Study|subject expired before surgery|1
210044|NCT02223364|668878|P3|Overall Study|Protocol Violation|3
210045|NCT02223364|668879|P2|Overall Study|Protocol Violation|0
210046|NCT02223364|668880|P1|Overall Study|Protocol Violation|3
210048|NCT02116582|668960|P1|Overall Study|Other: Miscellaneous|9
210049|NCT02116582|668960|P1|Overall Study|Withdrawal by Subject|8
210050|NCT02116582|668960|P1|Overall Study|Protocol Violation|3
210051|NCT02116582|668960|P1|Overall Study|Progressive Disease|140
210052|NCT02116582|668960|P1|Overall Study|Death|7
210053|NCT02116582|668960|P1|Overall Study|Adverse Event|17
210054|NCT02116582|668960|P1|Overall Study|Enrolled but Never Received Study Drug|1
210055|NCT01262560|668971|P3|Overall Study|Protocol Violation|2
210056|NCT01262560|668972|P2|Overall Study|Protocol Violation|1
210057|NCT01262560|668973|P1|Overall Study|Protocol Violation|0
210058|NCT02283268|669031|P1|Overall Study|Withdrawal by Subject|1
210059|NCT02154425|669092|P1|Screening Period|Adverse Event|1
210105|NCT00127660|669231|P4|Overall Study|Protocol Violation|0
210106|NCT00127660|669232|P3|Overall Study|Protocol Violation|5
210107|NCT00127660|669233|P2|Overall Study|Protocol Violation|3
210108|NCT00127660|669234|P1|Overall Study|Protocol Violation|3
210109|NCT01793883|669247|P3|Overall Study|Respiratory distress during spirometry|1
210110|NCT01793883|669248|P2|Overall Study|Respiratory distress during spirometry|0
210111|NCT01793883|669249|P1|Overall Study|Respiratory distress during spirometry|0
210112|NCT01793883|669247|P3|Overall Study|Dosing error|0
210113|NCT01793883|669248|P2|Overall Study|Dosing error|1
210114|NCT01793883|669249|P1|Overall Study|Dosing error|0
210115|NCT01793883|669247|P3|Overall Study|Met exclusion criteria|0
210116|NCT01793883|669248|P2|Overall Study|Met exclusion criteria|0
210117|NCT01793883|669249|P1|Overall Study|Met exclusion criteria|1
210118|NCT01793883|669247|P3|Overall Study|Unable to complete measurements|0
210119|NCT01793883|669248|P2|Overall Study|Unable to complete measurements|0
210120|NCT01793883|669249|P1|Overall Study|Unable to complete measurements|1
210121|NCT01793883|669247|P3|Overall Study|Unable to complete spriometry|0
210122|NCT01793883|669248|P2|Overall Study|Unable to complete spriometry|0
210123|NCT01793883|669249|P1|Overall Study|Unable to complete spriometry|1
210124|NCT01793883|669247|P3|Overall Study|Randomized in error|0
210125|NCT01793883|669248|P2|Overall Study|Randomized in error|0
210126|NCT01793883|669249|P1|Overall Study|Randomized in error|1
210127|NCT01793883|669247|P3|Overall Study|Lost to Follow-up|3
210128|NCT01793883|669248|P2|Overall Study|Lost to Follow-up|1
210129|NCT01793883|669249|P1|Overall Study|Lost to Follow-up|5
210130|NCT01793883|669247|P3|Overall Study|Subject noncompliance|1
210131|NCT01793883|669248|P2|Overall Study|Subject noncompliance|1
210132|NCT01793883|669249|P1|Overall Study|Subject noncompliance|0
210133|NCT01793883|669247|P3|Overall Study|Withdrawal by Subject|3
210134|NCT01793883|669248|P2|Overall Study|Withdrawal by Subject|7
210135|NCT01793883|669249|P1|Overall Study|Withdrawal by Subject|3
210136|NCT01244893|669266|P2|1-Week Follow Up|Lost to Follow-up|0
210137|NCT01244893|669267|P1|1-Week Follow Up|Lost to Follow-up|1
210138|NCT01244893|669266|P2|Baseline|Protocol Violation|1
210139|NCT01244893|669267|P1|Baseline|Protocol Violation|0
210140|NCT01000493|669281|P2|Overall Study|Withdrawal by Subject|7
210141|NCT01000493|669282|P1|Overall Study|Withdrawal by Subject|3
210142|NCT01000493|669281|P2|Overall Study|Physician Decision|1
210143|NCT01000493|669282|P1|Overall Study|Physician Decision|1
210144|NCT01000493|669281|P2|Overall Study|Lost to Follow-up|9
210145|NCT01000493|669282|P1|Overall Study|Lost to Follow-up|5
210146|NCT01000493|669281|P2|Overall Study|Study closed/terminated|23
210147|NCT01000493|669282|P1|Overall Study|Study closed/terminated|25
210148|NCT01000493|669281|P2|Overall Study|Protocol Violation|8
210149|NCT01000493|669282|P1|Overall Study|Protocol Violation|1
210150|NCT01000493|669281|P2|Overall Study|Lack of Efficacy|1
210151|NCT01000493|669282|P1|Overall Study|Lack of Efficacy|1
210152|NCT01000493|669281|P2|Overall Study|Adverse Event|6
210153|NCT01000493|669282|P1|Overall Study|Adverse Event|3
